id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
126756975|NCT01684930|456061002|FG000|Overall Study|Withdrawal by Subject|3|||
126756976|NCT01684930|456061003|FG001|Overall Study|Withdrawal by Subject|1|||
126756977|NCT00313716|456061013|FG000|Overall Study|Death|3|||
126756978|NCT00313716|456061014|FG001|Overall Study|Death|2|||
126756979|NCT00313716|456061015|FG002|Overall Study|Death|9|||
126756980|NCT00313716|456061016|FG003|Overall Study|Death|3|||
126756981|NCT00313716|456061017|FG004|Overall Study|Death|5|||
126756982|NCT00313716|456061018|FG005|Overall Study|Death|9|||
126756983|NCT00313716|456061013|FG000|Overall Study|Lost to Follow-up|2|||
126756984|NCT00313716|456061014|FG001|Overall Study|Lost to Follow-up|5|||
126756985|NCT00313716|456061015|FG002|Overall Study|Lost to Follow-up|2|||
126756986|NCT00313716|456061016|FG003|Overall Study|Lost to Follow-up|1|||
126756987|NCT00313716|456061017|FG004|Overall Study|Lost to Follow-up|0|||
126756988|NCT00313716|456061018|FG005|Overall Study|Lost to Follow-up|4|||
126756989|NCT00313716|456061013|FG000|Overall Study|Withdrawal by Subject|0|||
126756990|NCT00313716|456061014|FG001|Overall Study|Withdrawal by Subject|1|||
126756991|NCT00313716|456061015|FG002|Overall Study|Withdrawal by Subject|1|||
126756992|NCT00313716|456061016|FG003|Overall Study|Withdrawal by Subject|0|||
126756993|NCT00313716|456061017|FG004|Overall Study|Withdrawal by Subject|1|||
126756994|NCT00313716|456061018|FG005|Overall Study|Withdrawal by Subject|0|||
126756995|NCT00039377|456061020|FG000|Initial Registration|Adverse Event|2|||
126756996|NCT00039377|456061021|FG001|Initial Registration|Adverse Event|0|||
126756997|NCT00039377|456061022|FG002|Initial Registration|Adverse Event|0|||
126756998|NCT00039377|456061023|FG003|Initial Registration|Adverse Event|0|||
126756999|NCT00039377|456061020|FG000|Initial Registration|Relapsed|6|||
126757000|NCT00039377|456061021|FG001|Initial Registration|Relapsed|0|||
126757001|NCT00039377|456061022|FG002|Initial Registration|Relapsed|0|||
126757002|NCT00039377|456061023|FG003|Initial Registration|Relapsed|0|||
126757003|NCT00039377|456061020|FG000|Initial Registration|Received non-protocol therapy|11|||
126757004|NCT00039377|456061021|FG001|Initial Registration|Received non-protocol therapy|0|||
126757005|NCT00039377|456061022|FG002|Initial Registration|Received non-protocol therapy|0|||
126757006|NCT00039377|456061023|FG003|Initial Registration|Received non-protocol therapy|0|||
126757007|NCT00039377|456061020|FG000|Initial Registration|Withdrawal by Subject|3|||
126757008|NCT00039377|456061021|FG001|Initial Registration|Withdrawal by Subject|0|||
126757009|NCT00039377|456061022|FG002|Initial Registration|Withdrawal by Subject|0|||
126757010|NCT00039377|456061023|FG003|Initial Registration|Withdrawal by Subject|0|||
126757011|NCT04067310|456061027|FG000|Overall Study|Physician Decision|2|||
126757012|NCT04067310|456061028|FG001|Overall Study|Physician Decision|6|||
126757013|NCT04067310|456061027|FG000|Overall Study|Lost to Follow-up|0|||
126757014|NCT04067310|456061028|FG001|Overall Study|Lost to Follow-up|1|||
126757015|NCT04067310|456061027|FG000|Overall Study|Withdrawal by Subject|3|||
126757016|NCT04067310|456061028|FG001|Overall Study|Withdrawal by Subject|0|||
126757017|NCT01041027|456061029|FG000|Overall Study|Withdrawal by Subject|2|||
126757018|NCT01041027|456061029|FG000|Overall Study|Protocol Violation|1|||
126757019|NCT01041027|456061029|FG000|Overall Study|Delayed Radiation Therapy|1|||
126757020|NCT01041027|456061029|FG000|Overall Study|Adverse Event|4|||
126757021|NCT01347931|456061030|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
126757022|NCT01249404|456061031|FG000|Overall Study|Study treatment not received|0|||
126757023|NCT01249404|456061032|FG001|Overall Study|Study treatment not received|1|||
126757024|NCT01249404|456061033|FG002|Overall Study|Study treatment not received|2|||
126757025|NCT01249404|456061031|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
126757026|NCT01249404|456061032|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
126757027|NCT01249404|456061033|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
126757028|NCT01249404|456061031|FG000|Overall Study|Adverse Event|2|||
126757029|NCT01249404|456061032|FG001|Overall Study|Adverse Event|2|||
126757030|NCT01249404|456061033|FG002|Overall Study|Adverse Event|2|||
126757031|NCT01249404|456061031|FG000|Overall Study|Withdrawal by Subject|2|||
126757032|NCT01249404|456061032|FG001|Overall Study|Withdrawal by Subject|2|||
126757033|NCT01249404|456061033|FG002|Overall Study|Withdrawal by Subject|0|||
126757034|NCT01249404|456061031|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
126757035|NCT01249404|456061032|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
126757036|NCT01249404|456061033|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
126757037|NCT01249404|456061031|FG000|Overall Study|Non compliance to visit schedule|0|||
126757038|NCT01249404|456061032|FG001|Overall Study|Non compliance to visit schedule|1|||
126757039|NCT01249404|456061033|FG002|Overall Study|Non compliance to visit schedule|0|||
126757040|NCT01020812|456061034|FG000|Overall Study|Physician Decision|1|||
126757041|NCT01020812|456061034|FG000|Overall Study|Withdrawal by Subject|1|||
126757042|NCT01020812|456061034|FG000|Overall Study|Protocol Violation|1|||
126533763|NCT00003508|455246640|FG000|Overall Study|Not evaluable|5|||
126757043|NCT02545270|456061035|FG000|Overall Study|technical difficulties|0|||
126533764|NCT01377480|455246641|FG000|Overall Study|Protocol Violation|0|||
126533765|NCT01377480|455246642|FG001|Overall Study|Protocol Violation|0|||
126757044|NCT02545270|456061036|FG001|Overall Study|technical difficulties|1|||
126757045|NCT02545270|456061037|FG002|Overall Study|technical difficulties|0|||
126757046|NCT02545270|456061035|FG000|Overall Study|Videos being too similar to other|0|||
126757047|NCT02545270|456061036|FG001|Overall Study|Videos being too similar to other|0|||
126757048|NCT02545270|456061037|FG002|Overall Study|Videos being too similar to other|2|||
126757049|NCT01716585|456061043|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
126757050|NCT01716585|456061044|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
126757051|NCT01716585|456061043|FG000|Double-blind Treatment|Adverse Event|2|||
126757052|NCT01716585|456061044|FG001|Double-blind Treatment|Adverse Event|1|||
126757053|NCT01716585|456061043|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
126757054|NCT01716585|456061044|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
126757055|NCT01716585|456061043|FG000|Double-blind Treatment|Lost to Follow-up|2|||
126757056|NCT01716585|456061044|FG001|Double-blind Treatment|Lost to Follow-up|0|||
126757057|NCT01716585|456061043|FG000|Double-blind Treatment|Subject Noncompliant|1|||
126757058|NCT01716585|456061044|FG001|Double-blind Treatment|Subject Noncompliant|0|||
126757059|NCT01716585|456061043|FG000|Double-blind Treatment|Other|1|||
126533766|NCT01377480|455246643|FG002|Overall Study|Protocol Violation|0|||
126533767|NCT01377480|455246644|FG003|Overall Study|Protocol Violation|4|||
126533768|NCT01377480|455246641|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
126533769|NCT01377480|455246642|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
126533770|NCT01377480|455246643|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
126533771|NCT01377480|455246644|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
126533772|NCT01377480|455246641|FG000|Overall Study|Withdrawal by Subject|0|||
126533773|NCT01377480|455246642|FG001|Overall Study|Withdrawal by Subject|0|||
126533774|NCT01377480|455246643|FG002|Overall Study|Withdrawal by Subject|1|||
126533775|NCT01377480|455246644|FG003|Overall Study|Withdrawal by Subject|0|||
126533776|NCT01377480|455246641|FG000|Overall Study|Serious adverse event|0|||
126533777|NCT01377480|455246642|FG001|Overall Study|Serious adverse event|0|||
126533778|NCT01377480|455246643|FG002|Overall Study|Serious adverse event|1|||
126533779|NCT01377480|455246644|FG003|Overall Study|Serious adverse event|1|||
126533780|NCT01377480|455246641|FG000|Overall Study|Other|0|||
126533781|NCT01377480|455246642|FG001|Overall Study|Other|0|||
126533782|NCT01377480|455246643|FG002|Overall Study|Other|7|||
126533783|NCT01377480|455246644|FG003|Overall Study|Other|6|||
126533784|NCT03576768|455246646|FG000|Overall Study|Lost to Follow-up|3|||
126533785|NCT03576768|455246647|FG001|Overall Study|Lost to Follow-up|3|||
126533786|NCT03576768|455246648|FG002|Overall Study|Lost to Follow-up|0|||
126533787|NCT03576768|455246649|FG003|Overall Study|Lost to Follow-up|0|||
126533788|NCT01986881|455246652|FG000|Overall Study|Death|228|||
126533789|NCT01986881|455246653|FG001|Overall Study|Death|233|||
126533790|NCT01986881|455246654|FG002|Overall Study|Death|247|||
126533791|NCT01986881|455246652|FG000|Overall Study|Lost to Follow-up|51|||
126533792|NCT01986881|455246653|FG001|Overall Study|Lost to Follow-up|44|||
126533793|NCT01986881|455246654|FG002|Overall Study|Lost to Follow-up|55|||
126533794|NCT01986881|455246652|FG000|Overall Study|Physician Decision|7|||
126533795|NCT01986881|455246653|FG001|Overall Study|Physician Decision|4|||
126533796|NCT01986881|455246654|FG002|Overall Study|Physician Decision|6|||
126533797|NCT01986881|455246652|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
126533798|NCT01986881|455246653|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
126533799|NCT01986881|455246654|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
126533800|NCT01986881|455246652|FG000|Overall Study|Withdrawal by Subject|41|||
126533801|NCT01986881|455246653|FG001|Overall Study|Withdrawal by Subject|60|||
126533802|NCT01986881|455246654|FG002|Overall Study|Withdrawal by Subject|45|||
126533803|NCT01986881|455246652|FG000|Overall Study|Subject Moved|0|||
126533804|NCT01986881|455246653|FG001|Overall Study|Subject Moved|1|||
126533805|NCT01986881|455246654|FG002|Overall Study|Subject Moved|0|||
126533806|NCT01986881|455246652|FG000|Overall Study|Other|1|||
126533807|NCT01986881|455246653|FG001|Overall Study|Other|2|||
126533808|NCT01986881|455246654|FG002|Overall Study|Other|2|||
126533809|NCT04179175|455246655|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
126533810|NCT04179175|455246656|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
126533811|NCT04179175|455246657|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
126533812|NCT04179175|455246658|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
126533813|NCT04179175|455246659|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
126533814|NCT04179175|455246660|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
126533815|NCT04179175|455246655|FG000|Overall Study|Adverse Event|5|||
126533816|NCT04179175|455246656|FG001|Overall Study|Adverse Event|3|||
126533817|NCT04179175|455246657|FG002|Overall Study|Adverse Event|3|||
126533818|NCT04179175|455246658|FG003|Overall Study|Adverse Event|4|||
126533819|NCT04179175|455246659|FG004|Overall Study|Adverse Event|6|||
126533820|NCT04179175|455246660|FG005|Overall Study|Adverse Event|6|||
126533821|NCT04179175|455246655|FG000|Overall Study|Lack of Efficacy|5|||
126533822|NCT04179175|455246656|FG001|Overall Study|Lack of Efficacy|1|||
126533823|NCT04179175|455246657|FG002|Overall Study|Lack of Efficacy|3|||
126533824|NCT04179175|455246658|FG003|Overall Study|Lack of Efficacy|2|||
126533825|NCT04179175|455246659|FG004|Overall Study|Lack of Efficacy|18|||
126533826|NCT04179175|455246660|FG005|Overall Study|Lack of Efficacy|7|||
126533827|NCT04179175|455246655|FG000|Overall Study|Lost to Follow-up|5|||
126757060|NCT01716585|456061044|FG001|Double-blind Treatment|Other|0|||
126757061|NCT01716585|456061043|FG000|Open-label Treatment|Adverse Event|0|||
126533828|NCT04179175|455246656|FG001|Overall Study|Lost to Follow-up|3|||
126533829|NCT04179175|455246657|FG002|Overall Study|Lost to Follow-up|2|||
126533830|NCT04179175|455246658|FG003|Overall Study|Lost to Follow-up|2|||
126533831|NCT04179175|455246659|FG004|Overall Study|Lost to Follow-up|4|||
126533832|NCT04179175|455246660|FG005|Overall Study|Lost to Follow-up|5|||
126533833|NCT04179175|455246655|FG000|Overall Study|Physician Decision|2|||
126757062|NCT01716585|456061044|FG001|Open-label Treatment|Adverse Event|2|||
126757063|NCT01716585|456061043|FG000|Open-label Treatment|Virologic Failure|0|||
126757064|NCT01716585|456061044|FG001|Open-label Treatment|Virologic Failure|2|||
126757065|NCT01716585|456061043|FG000|Open-label Treatment|Withdrawal by Subject|0|||
126757066|NCT01716585|456061044|FG001|Open-label Treatment|Withdrawal by Subject|3|||
126757067|NCT00761891|456061045|FG000|Overall Study|Withdrawal by Subject|10|||
126757068|NCT01707667|456061046|FG000|Period 1|expulsion of colonic sensor catheter|1|||
126757069|NCT01707667|456061047|FG001|Period 1|expulsion of colonic sensor catheter|0|||
126757070|NCT03802331|456061051|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
126757071|NCT03802331|456061052|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
126757072|NCT04382066|456061056|FG000|Overall Study|Adverse Event|1|||
126757073|NCT04382066|456061057|FG001|Overall Study|Adverse Event|0|||
126757074|NCT04382066|456061058|FG002|Overall Study|Adverse Event|0|||
126757075|NCT04382066|456061056|FG000|Overall Study|Death|1|||
126422223|NCT03310723|454842545|FG000|Overall Study|Withdrawal by Subject|0|||
126422224|NCT03310723|454842546|FG001|Overall Study|Withdrawal by Subject|1|||
126422225|NCT03310723|454842545|FG000|Overall Study|Protocol Violation|0|||
126422226|NCT03310723|454842546|FG001|Overall Study|Protocol Violation|2|||
126422227|NCT02098746|454842547|FG000|Overall Study|Changes of Investigator|2|||
126422228|NCT02098746|454842547|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126422229|NCT02098746|454842547|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
126422230|NCT02098746|454842547|FG000|Overall Study|Data Not Available After Treatment|1|||
126422231|NCT01410890|454842548|FG000|Overall Study|Withdrawal by Subject|0|||
126422232|NCT01410890|454842549|FG001|Overall Study|Withdrawal by Subject|1|||
126422233|NCT00217425|454842550|FG000|Overall Study|Never started treatment|2|||
126422234|NCT00217425|454842550|FG000|Overall Study|Patient ineligible|5|||
126422235|NCT00217425|454842550|FG000|Overall Study|Lack of Efficacy|13|||
126422236|NCT00217425|454842550|FG000|Overall Study|Adverse Event|8|||
126422237|NCT00217425|454842550|FG000|Overall Study|Withdrawal by Subject|4|||
126422238|NCT00217425|454842550|FG000|Overall Study|Other complicating disease|1|||
126422239|NCT00217425|454842550|FG000|Overall Study|Other|4|||
126422240|NCT01121146|454842551|FG000|Overall Study|Death|17|||
126422241|NCT01121146|454842552|FG001|Overall Study|Death|15|||
126422242|NCT01121146|454842551|FG000|Overall Study|Adverse Event|2|||
126422243|NCT01121146|454842552|FG001|Overall Study|Adverse Event|11|||
126422244|NCT01121146|454842551|FG000|Overall Study|Lost to Follow-up|7|||
126422245|NCT01121146|454842552|FG001|Overall Study|Lost to Follow-up|16|||
126422246|NCT04640311|454842555|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
126422247|NCT04640311|454842556|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422248|NCT04640311|454842557|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422249|NCT04640311|454842558|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422250|NCT04640311|454842559|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422251|NCT04640311|454842560|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422252|NCT04640311|454842561|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422253|NCT04640311|454842562|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422254|NCT04640311|454842563|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422255|NCT04640311|454842564|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422256|NCT04640311|454842565|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422257|NCT04640311|454842566|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422258|NCT04640311|454842567|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422259|NCT04640311|454842555|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422260|NCT04640311|454842556|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
126422261|NCT04640311|454842557|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422262|NCT04640311|454842558|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422263|NCT04640311|454842559|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422264|NCT04640311|454842560|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422265|NCT04640311|454842561|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422266|NCT04640311|454842562|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422267|NCT04640311|454842563|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422268|NCT04640311|454842564|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422269|NCT04640311|454842565|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126533834|NCT04179175|455246656|FG001|Overall Study|Physician Decision|0|||
126533835|NCT04179175|455246657|FG002|Overall Study|Physician Decision|2|||
126533836|NCT04179175|455246658|FG003|Overall Study|Physician Decision|3|||
126757076|NCT04382066|456061057|FG001|Overall Study|Death|0|||
126757077|NCT04382066|456061058|FG002|Overall Study|Death|1|||
126533837|NCT04179175|455246659|FG004|Overall Study|Physician Decision|1|||
126533838|NCT04179175|455246660|FG005|Overall Study|Physician Decision|1|||
126533839|NCT04179175|455246655|FG000|Overall Study|Pregnancy|3|||
126757078|NCT00504595|456061059|FG000|Overall Study|Lack of Efficacy|1|||
126757079|NCT00504595|456061060|FG001|Overall Study|Lack of Efficacy|0|||
126533840|NCT04179175|455246656|FG001|Overall Study|Pregnancy|0|||
126757080|NCT00504595|456061061|FG002|Overall Study|Lack of Efficacy|0|||
126757081|NCT00504595|456061062|FG003|Overall Study|Lack of Efficacy|0|||
126757082|NCT00504595|456061059|FG000|Overall Study|Other|0|||
126533841|NCT04179175|455246657|FG002|Overall Study|Pregnancy|3|||
126533842|NCT04179175|455246658|FG003|Overall Study|Pregnancy|0|||
126533843|NCT04179175|455246659|FG004|Overall Study|Pregnancy|1|||
126533844|NCT04179175|455246660|FG005|Overall Study|Pregnancy|2|||
126533845|NCT04179175|455246655|FG000|Overall Study|Withdrawal by Subject|22|||
126533846|NCT04179175|455246656|FG001|Overall Study|Withdrawal by Subject|10|||
126533847|NCT04179175|455246657|FG002|Overall Study|Withdrawal by Subject|12|||
126533848|NCT04179175|455246658|FG003|Overall Study|Withdrawal by Subject|8|||
126533849|NCT04179175|455246659|FG004|Overall Study|Withdrawal by Subject|23|||
126533850|NCT04179175|455246660|FG005|Overall Study|Withdrawal by Subject|31|||
126757083|NCT00504595|456061060|FG001|Overall Study|Other|0|||
126757084|NCT00504595|456061061|FG002|Overall Study|Other|2|||
126757085|NCT00504595|456061062|FG003|Overall Study|Other|0|||
126757086|NCT02764229|456061063|FG000|Overall Study|Withdrawal by Subject|15|||
126757087|NCT02764229|456061063|FG000|Overall Study|Adverse Event|9|||
126757088|NCT02764229|456061063|FG000|Overall Study|Physician Decision|5|||
126757089|NCT02764229|456061063|FG000|Overall Study|Lost to Follow-up|3|||
126757090|NCT02764229|456061063|FG000|Overall Study|Lack of Efficacy|1|||
126757091|NCT02764229|456061063|FG000|Overall Study|Study Stopped by Sponsor|69|||
126757092|NCT00779142|456061064|FG000|Overall Study|Screen Failures|3|||
126757093|NCT00851721|456061066|FG000|Overall Study|planned surgery|1|||
126757094|NCT00851721|456061067|FG001|Overall Study|planned surgery|0|||
126533851|NCT04179175|455246655|FG000|Overall Study|Technical problems|0|||
126533852|NCT04179175|455246656|FG001|Overall Study|Technical problems|0|||
126757095|NCT00851721|456061066|FG000|Overall Study|Death|1|||
126757096|NCT00851721|456061067|FG001|Overall Study|Death|0|||
126757097|NCT00851721|456061066|FG000|Overall Study|Adverse Event|0|||
126757098|NCT00851721|456061067|FG001|Overall Study|Adverse Event|1|||
126757099|NCT03137433|456061069|FG000|Overall Study|Withdrawal by Subject|11|||
126757100|NCT03137433|456061070|FG001|Overall Study|Withdrawal by Subject|11|||
126757101|NCT03137433|456061069|FG000|Overall Study|Lost to Follow-up|5|||
126757102|NCT03137433|456061070|FG001|Overall Study|Lost to Follow-up|6|||
126757103|NCT03137433|456061069|FG000|Overall Study|Physician Decision|2|||
126757104|NCT03137433|456061070|FG001|Overall Study|Physician Decision|0|||
126757105|NCT03137433|456061069|FG000|Overall Study|Moved out of study area|1|||
126757106|NCT03137433|456061070|FG001|Overall Study|Moved out of study area|0|||
126757107|NCT03137433|456061069|FG000|Overall Study|Too far out of window due to COVID|0|||
126757108|NCT03137433|456061070|FG001|Overall Study|Too far out of window due to COVID|1|||
126757109|NCT00265382|456061072|FG000|Overall Study|Adverse Event|21|||
126757110|NCT00265382|456061072|FG000|Overall Study|Laboratory Abnormality|1|||
126757111|NCT00265382|456061072|FG000|Overall Study|Lost to Follow-up|3|||
126757112|NCT00265382|456061072|FG000|Overall Study|Lack of Efficacy|6|||
126533853|NCT04179175|455246657|FG002|Overall Study|Technical problems|1|||
126533854|NCT04179175|455246658|FG003|Overall Study|Technical problems|1|||
126533855|NCT04179175|455246659|FG004|Overall Study|Technical problems|0|||
126757113|NCT00265382|456061072|FG000|Overall Study|Miscellaneous|6|||
126757114|NCT00265382|456061072|FG000|Overall Study|Withdrawal by Subject|13|||
126757115|NCT00265382|456061072|FG000|Overall Study|Study terminated by sponsor|94|||
126757116|NCT00265382|456061072|FG000|Overall Study|Death|1|||
126757117|NCT01724021|456061075|FG000|Overall Study|Adverse Event|11|||
126757118|NCT01724021|456061076|FG001|Overall Study|Adverse Event|6|||
126757119|NCT01724021|456061075|FG000|Overall Study|Death|46|||
126757120|NCT01724021|456061076|FG001|Overall Study|Death|58|||
126757121|NCT01724021|456061075|FG000|Overall Study|Participant request/ Withdrew consent|18|||
126757122|NCT01724021|456061076|FG001|Overall Study|Participant request/ Withdrew consent|14|||
126757123|NCT01724021|456061075|FG000|Overall Study|Lost to Follow-up|15|||
126757124|NCT01724021|456061076|FG001|Overall Study|Lost to Follow-up|15|||
126533856|NCT04179175|455246660|FG005|Overall Study|Technical problems|0|||
126533857|NCT02030015|455246666|FG000|Overall Study|Withdrawal by Subject|3|||
126533858|NCT02030015|455246666|FG000|Overall Study|Death|13|||
126533859|NCT03014674|455246668|FG000|Overall Study|Withdrawal by Subject|1|||
126533860|NCT03014674|455246669|FG001|Overall Study|Withdrawal by Subject|0|||
126533861|NCT03014674|455246670|FG002|Overall Study|Withdrawal by Subject|0|||
126757125|NCT01724021|456061075|FG000|Overall Study|Reason Not Specified|36|||
126533862|NCT03224182|455246681|FG000|Overall Study|Study Drug Not Instilled|6|||
126757126|NCT01724021|456061076|FG001|Overall Study|Reason Not Specified|39|||
126757127|NCT01724021|456061075|FG000|Overall Study|Missing|1|||
126757128|NCT01724021|456061076|FG001|Overall Study|Missing|1|||
126757129|NCT01874288|456061088|FG000|Overall Study|Withdrawal by Subject|1|||
126757130|NCT01874288|456061089|FG001|Overall Study|Withdrawal by Subject|0|||
126757131|NCT01874288|456061090|FG002|Overall Study|Withdrawal by Subject|2|||
126757132|NCT01874288|456061091|FG003|Overall Study|Withdrawal by Subject|1|||
126533863|NCT03224182|455246682|FG001|Overall Study|Study Drug Not Instilled|1|||
126757133|NCT01874288|456061092|FG004|Overall Study|Withdrawal by Subject|1|||
126757134|NCT01874288|456061088|FG000|Overall Study|Physician Decision|0|||
126757135|NCT01874288|456061089|FG001|Overall Study|Physician Decision|0|||
126757136|NCT01874288|456061090|FG002|Overall Study|Physician Decision|0|||
126757137|NCT01874288|456061091|FG003|Overall Study|Physician Decision|1|||
126757138|NCT01874288|456061092|FG004|Overall Study|Physician Decision|0|||
126757139|NCT01874288|456061088|FG000|Overall Study|Progressive disease|2|||
126757140|NCT01874288|456061089|FG001|Overall Study|Progressive disease|0|||
126757141|NCT01874288|456061090|FG002|Overall Study|Progressive disease|3|||
126757142|NCT01874288|456061091|FG003|Overall Study|Progressive disease|5|||
126757143|NCT01874288|456061092|FG004|Overall Study|Progressive disease|1|||
126757144|NCT01365468|456061093|FG000|Overall Study|Physician Decision|1|||
126757145|NCT01365468|456061094|FG001|Overall Study|Physician Decision|0|||
126757146|NCT01365468|456061093|FG000|Overall Study|Disease progression|1|||
126757147|NCT01365468|456061094|FG001|Overall Study|Disease progression|0|||
126757148|NCT01365468|456061093|FG000|Overall Study|Lost to Follow-up|2|||
126757149|NCT01365468|456061094|FG001|Overall Study|Lost to Follow-up|0|||
126757150|NCT03524664|456061095|FG000|Overall Study|Withdrawal by Subject|1|||
126757151|NCT03524664|456061096|FG001|Overall Study|Withdrawal by Subject|2|||
126757152|NCT03524664|456061095|FG000|Overall Study|Lost to Follow-up|4|||
126757153|NCT03524664|456061096|FG001|Overall Study|Lost to Follow-up|13|||
126757154|NCT00423267|456061097|FG000|Period A|Withdrawal by Subject|0|||
126757155|NCT00423267|456061098|FG001|Period A|Withdrawal by Subject|1|||
126757156|NCT00423267|456061097|FG000|Period A|Non-compliance with protocol|1|||
126757157|NCT00423267|456061098|FG001|Period A|Non-compliance with protocol|0|||
126757158|NCT00423267|456061097|FG000|Period A|Administrative|1|||
126757159|NCT00423267|456061098|FG001|Period A|Administrative|0|||
126757160|NCT01333865|456061099|FG000|Overall Study|Adverse Event|2|||
126757161|NCT00591786|456061104|FG000|Overall Study|Withdrawal of Informed Consent|0|||
126757162|NCT00591786|456061105|FG001|Overall Study|Withdrawal of Informed Consent|0|||
126757163|NCT00591786|456061106|FG002|Overall Study|Withdrawal of Informed Consent|1|||
126757164|NCT00591786|456061107|FG003|Overall Study|Withdrawal of Informed Consent|0|||
126757165|NCT00591786|456061108|FG004|Overall Study|Withdrawal of Informed Consent|0|||
126757166|NCT00591786|456061109|FG005|Overall Study|Withdrawal of Informed Consent|0|||
126757167|NCT00591786|456061110|FG006|Overall Study|Withdrawal of Informed Consent|0|||
126757168|NCT00591786|456061111|FG007|Overall Study|Withdrawal of Informed Consent|0|||
126757169|NCT00591786|456061112|FG008|Overall Study|Withdrawal of Informed Consent|0|||
126757170|NCT00591786|456061113|FG009|Overall Study|Withdrawal of Informed Consent|0|||
126757171|NCT00554229|456061114|FG000|Overall Study|Lost to Follow-up|3|||
126757172|NCT00554229|456061115|FG001|Overall Study|Lost to Follow-up|6|||
126757173|NCT00554229|456061114|FG000|Overall Study|Withdrawal by Subject|29|||
126757174|NCT00554229|456061115|FG001|Overall Study|Withdrawal by Subject|37|||
126757175|NCT00554229|456061114|FG000|Overall Study|Adverse Event|71|||
126757176|NCT00554229|456061115|FG001|Overall Study|Adverse Event|39|||
126757177|NCT00554229|456061114|FG000|Overall Study|Protocol Violation|3|||
126757178|NCT00554229|456061115|FG001|Overall Study|Protocol Violation|3|||
126757179|NCT00554229|456061114|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
126757180|NCT00554229|456061115|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
126757181|NCT00554229|456061114|FG000|Overall Study|Randomised but no treatment received|1|||
126757182|NCT00554229|456061115|FG001|Overall Study|Randomised but no treatment received|0|||
126757183|NCT00877929|456061116|FG000|Overall Study|Adverse Event|11|||
126757184|NCT00877929|456061117|FG001|Overall Study|Adverse Event|20|||
126757185|NCT00877929|456061116|FG000|Overall Study|Protocol Violation|3|||
126757186|NCT00877929|456061117|FG001|Overall Study|Protocol Violation|3|||
126757187|NCT00877929|456061116|FG000|Overall Study|Lost to Follow-up|0|||
126533864|NCT03224182|455246681|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
126533865|NCT03224182|455246682|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
126533866|NCT03224182|455246681|FG000|Overall Study|Withdrew of Consent|4|||
126533867|NCT03224182|455246682|FG001|Overall Study|Withdrew of Consent|2|||
126533868|NCT03224182|455246681|FG000|Overall Study|Investigator Decision|3|||
126533869|NCT03224182|455246682|FG001|Overall Study|Investigator Decision|1|||
126533870|NCT03224182|455246681|FG000|Overall Study|Sponsor Decision|26|||
126533871|NCT03224182|455246682|FG001|Overall Study|Sponsor Decision|12|||
126533872|NCT03224182|455246681|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
126533873|NCT03224182|455246682|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
126533874|NCT03224182|455246681|FG000|Overall Study|Lost to Follow-up|1|||
126757188|NCT00877929|456061117|FG001|Overall Study|Lost to Follow-up|1|||
126757189|NCT00877929|456061116|FG000|Overall Study|Withdrawal by Subject|4|||
126757190|NCT00877929|456061117|FG001|Overall Study|Withdrawal by Subject|4|||
126311178|NCT03339726|454429677|FG000|Overall Study|Withdrawal by Subject|1|||
126757191|NCT00877929|456061116|FG000|Overall Study|Lack of Efficacy|0|||
126757192|NCT00877929|456061117|FG001|Overall Study|Lack of Efficacy|1|||
126757193|NCT00877929|456061116|FG000|Overall Study|Other reason (not specified)|2|||
126306045|NCT02553499|454408873|FG004|Overall Study|Lost to Follow-up|0|||
126757194|NCT00877929|456061117|FG001|Overall Study|Other reason (not specified)|6|||
126757195|NCT01140646|456061118|FG000|Overall Study|Adverse Event|4|||
126757196|NCT01140646|456061118|FG000|Overall Study|Refused Further Treatment|5|||
126757197|NCT00689728|456061122|FG000|Double-Blind Treatment|Adverse Event|1|||
126757198|NCT00689728|456061123|FG001|Double-Blind Treatment|Adverse Event|0|||
126757199|NCT00689728|456061124|FG002|Double-Blind Treatment|Adverse Event|0|||
126757200|NCT00689728|456061122|FG000|Double-Blind Treatment|Protocol Violation|0|||
126757201|NCT00689728|456061123|FG001|Double-Blind Treatment|Protocol Violation|0|||
126757202|NCT00689728|456061124|FG002|Double-Blind Treatment|Protocol Violation|1|||
126757203|NCT00689728|456061122|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
126533875|NCT03224182|455246682|FG001|Overall Study|Lost to Follow-up|0|||
126533876|NCT03224182|455246681|FG000|Overall Study|Participant Had Recurrence|11|||
126533877|NCT03224182|455246682|FG001|Overall Study|Participant Had Recurrence|5|||
126533878|NCT03224182|455246681|FG000|Overall Study|Death|0|||
126533879|NCT03224182|455246682|FG001|Overall Study|Death|1|||
126533880|NCT03224182|455246681|FG000|Overall Study|Reason not Specified|3|||
126533881|NCT03224182|455246682|FG001|Overall Study|Reason not Specified|3|||
126533882|NCT03224182|455246681|FG000|Overall Study|Other|1|||
126757204|NCT00689728|456061123|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
126757205|NCT00689728|456061124|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
126533883|NCT03224182|455246682|FG001|Overall Study|Other|0|||
126533884|NCT04279314|455246683|FG000|Overall Study|Adverse Event|55|||
126533885|NCT04279314|455246683|FG000|Overall Study|Withdrawal by Subject|5|||
126533886|NCT04279314|455246683|FG000|Overall Study|Lack of Efficacy|5|||
126533887|NCT04279314|455246683|FG000|Overall Study|Protocol Violation|3|||
126757206|NCT00689728|456061122|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
126757207|NCT00689728|456061123|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
126757208|NCT00689728|456061124|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
126757209|NCT00689728|456061122|FG000|Rescue|Adverse Event|0|||
126757210|NCT00689728|456061123|FG001|Rescue|Adverse Event|1|||
126757211|NCT00689728|456061124|FG002|Rescue|Adverse Event|0|||
126757212|NCT00689728|456061122|FG000|Rescue|Withdrawal by Subject|1|||
126757213|NCT00689728|456061123|FG001|Rescue|Withdrawal by Subject|1|||
126757214|NCT00689728|456061124|FG002|Rescue|Withdrawal by Subject|1|||
126757215|NCT00689728|456061122|FG000|Optional Follow-Up|Adverse Event|1|||
126757216|NCT00689728|456061123|FG001|Optional Follow-Up|Adverse Event|0|||
126757217|NCT00689728|456061124|FG002|Optional Follow-Up|Adverse Event|0|||
126757218|NCT00689728|456061122|FG000|Optional Follow-Up|Lack of Efficacy|0|||
126757219|NCT00689728|456061123|FG001|Optional Follow-Up|Lack of Efficacy|1|||
126757220|NCT00689728|456061124|FG002|Optional Follow-Up|Lack of Efficacy|1|||
126757221|NCT00689728|456061122|FG000|Optional Follow-Up|Lost to Follow-up|0|||
126757222|NCT00689728|456061123|FG001|Optional Follow-Up|Lost to Follow-up|1|||
126757223|NCT00689728|456061124|FG002|Optional Follow-Up|Lost to Follow-up|1|||
126757224|NCT00689728|456061122|FG000|Optional Follow-Up|Protocol Violation|0|||
126757225|NCT00689728|456061123|FG001|Optional Follow-Up|Protocol Violation|0|||
126757226|NCT00689728|456061124|FG002|Optional Follow-Up|Protocol Violation|1|||
126757227|NCT00689728|456061122|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
126757228|NCT00689728|456061123|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
126757229|NCT00689728|456061124|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
126757230|NCT00784836|456061129|FG000|Overall Study|Early Study Termination|3|||
126757231|NCT00660829|456061131|FG000|Overall Study|Adverse Event|3|||
126757232|NCT00660829|456061132|FG001|Overall Study|Adverse Event|4|||
126757233|NCT00660829|456061131|FG000|Overall Study|Lack of Efficacy|2|||
126757234|NCT00660829|456061132|FG001|Overall Study|Lack of Efficacy|3|||
126757235|NCT00660829|456061131|FG000|Overall Study|Non-Compliance|0|||
126757236|NCT00660829|456061132|FG001|Overall Study|Non-Compliance|4|||
126757237|NCT00660829|456061131|FG000|Overall Study|Withdrawal by Subject|1|||
126757238|NCT00660829|456061132|FG001|Overall Study|Withdrawal by Subject|2|||
126306046|NCT02553499|454408874|FG005|Overall Study|Lost to Follow-up|0|||
126422270|NCT04640311|454842566|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126422271|NCT04640311|454842567|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
126463729|NCT00423670|455000234|FG003|Treatment Period|Protocol-defined clinical event|12|||
126533888|NCT04279314|455246683|FG000|Overall Study|Other (not COVID-19 related)|2|||
126533889|NCT02481310|455246684|FG000|Follow up|Still in follow up|0|||
126533890|NCT02481310|455246685|FG001|Follow up|Still in follow up|3|||
126533891|NCT02481310|455246686|FG002|Follow up|Still in follow up|0|||
126533892|NCT00160680|455246687|FG000|Overall Study|Adverse Event|0|||
126533893|NCT00160680|455246688|FG001|Overall Study|Adverse Event|1|||
126757239|NCT00660829|456061131|FG000|Overall Study|Lost to Follow-up|3|||
126757240|NCT00660829|456061132|FG001|Overall Study|Lost to Follow-up|2|||
126757241|NCT00660829|456061131|FG000|Overall Study|Other|9|||
126757242|NCT00660829|456061132|FG001|Overall Study|Other|4|||
126757243|NCT02127931|456061133|FG000|Overall Study|Glitch in Game|1|||
126757244|NCT01513460|456061134|FG000|Overall Study|Death|0|||
126757245|NCT01513460|456061135|FG001|Overall Study|Death|0|||
126757246|NCT01513460|456061136|FG002|Overall Study|Death|1|||
126757247|NCT01513460|456061134|FG000|Overall Study|Lost to Follow-up|0|||
126757248|NCT01513460|456061135|FG001|Overall Study|Lost to Follow-up|0|||
126757249|NCT01513460|456061136|FG002|Overall Study|Lost to Follow-up|2|||
126757250|NCT01513460|456061134|FG000|Overall Study|Abnormal laboratory value|1|||
126757251|NCT01513460|456061135|FG001|Overall Study|Abnormal laboratory value|0|||
126757252|NCT01513460|456061136|FG002|Overall Study|Abnormal laboratory value|1|||
126757253|NCT01513460|456061134|FG000|Overall Study|Lack of Efficacy|1|||
126757254|NCT01513460|456061135|FG001|Overall Study|Lack of Efficacy|2|||
126757255|NCT01513460|456061136|FG002|Overall Study|Lack of Efficacy|5|||
126757256|NCT01513460|456061134|FG000|Overall Study|Protocol deviations|3|||
126757257|NCT01513460|456061135|FG001|Overall Study|Protocol deviations|4|||
126757258|NCT01513460|456061136|FG002|Overall Study|Protocol deviations|3|||
126757259|NCT01513460|456061134|FG000|Overall Study|Withdrawal by Subject|7|||
126757260|NCT01513460|456061135|FG001|Overall Study|Withdrawal by Subject|8|||
126757261|NCT01513460|456061136|FG002|Overall Study|Withdrawal by Subject|21|||
126757262|NCT01513460|456061134|FG000|Overall Study|Adverse Event|16|||
126757263|NCT01513460|456061135|FG001|Overall Study|Adverse Event|18|||
126757264|NCT01513460|456061136|FG002|Overall Study|Adverse Event|23|||
126757265|NCT01513460|456061134|FG000|Overall Study|Abnormal test procedure|1|||
126757266|NCT01513460|456061135|FG001|Overall Study|Abnormal test procedure|0|||
126757267|NCT01513460|456061136|FG002|Overall Study|Abnormal test procedure|0|||
126757268|NCT00422942|456061137|FG000|Overall Study|Study terminated by Sponsor|3|||
126757269|NCT02613910|456061138|FG000|Overall Study|Termination of study|1|||
126757270|NCT03395704|456061139|FG000|Overall Study|Adverse Event|2|||
126757271|NCT03395704|456061140|FG001|Overall Study|Adverse Event|1|||
126757272|NCT03395704|456061139|FG000|Overall Study|Withdrawal by Subject|2|||
126757273|NCT03395704|456061140|FG001|Overall Study|Withdrawal by Subject|1|||
126757274|NCT03395704|456061139|FG000|Overall Study|Physician Decision|0|||
126757275|NCT03395704|456061140|FG001|Overall Study|Physician Decision|1|||
126757276|NCT04823494|456062601|FG000|Overall Study|Programming software malfunction.|1|||
126757277|NCT04823494|456062602|FG001|Overall Study|Programming software malfunction.|0|||
126757278|NCT04823494|456062601|FG000|Overall Study|Withdrawal by Subject|1|||
126757279|NCT04823494|456062602|FG001|Overall Study|Withdrawal by Subject|0|||
126757280|NCT04823494|456062601|FG000|Overall Study|Devices lost|0|||
126757281|NCT04823494|456062602|FG001|Overall Study|Devices lost|1|||
126757282|NCT03726320|456062603|FG000|Overall Study|Lost to Follow-up|2|||
126757283|NCT03726320|456062604|FG001|Overall Study|Lost to Follow-up|4|||
126757284|NCT03726320|456062605|FG002|Overall Study|Lost to Follow-up|0|||
126757285|NCT03726320|456062603|FG000|Overall Study|Time Constraints|4|||
126757286|NCT03726320|456062604|FG001|Overall Study|Time Constraints|1|||
126757287|NCT03726320|456062605|FG002|Overall Study|Time Constraints|0|||
126757288|NCT03726320|456062603|FG000|Overall Study|Ineligible after enrollment|3|||
126757289|NCT03726320|456062604|FG001|Overall Study|Ineligible after enrollment|3|||
126757290|NCT03726320|456062605|FG002|Overall Study|Ineligible after enrollment|0|||
126757291|NCT03726320|456062603|FG000|Overall Study|Clinic / insurance issue|2|||
126757292|NCT03726320|456062604|FG001|Overall Study|Clinic / insurance issue|0|||
126757293|NCT03726320|456062605|FG002|Overall Study|Clinic / insurance issue|0|||
126757294|NCT03726320|456062603|FG000|Overall Study|Language barrier|1|||
126757295|NCT03726320|456062604|FG001|Overall Study|Language barrier|0|||
126757296|NCT03726320|456062605|FG002|Overall Study|Language barrier|0|||
126757297|NCT03726320|456062603|FG000|Overall Study|Provider left the clinic|0|||
126757298|NCT03726320|456062604|FG001|Overall Study|Provider left the clinic|0|||
126757299|NCT03726320|456062605|FG002|Overall Study|Provider left the clinic|1|||
126757300|NCT03691831|456062608|FG000|Overall Study|Lost to Follow-up|16|||
126757301|NCT03691831|456062609|FG001|Overall Study|Lost to Follow-up|12|||
126757302|NCT03691831|456062608|FG000|Overall Study|Withdrawal by Subject|9|||
126757303|NCT03691831|456062609|FG001|Overall Study|Withdrawal by Subject|17|||
126757304|NCT03691831|456062608|FG000|Overall Study|Investigator Decision|2|||
126757305|NCT03691831|456062609|FG001|Overall Study|Investigator Decision|2|||
126757306|NCT03922945|456062610|FG000|Overall Study|Adverse Event|1|||
126757307|NCT03922945|456062611|FG001|Overall Study|Adverse Event|1|||
126757308|NCT03922945|456062612|FG002|Overall Study|Adverse Event|2|||
126757309|NCT03922945|456062610|FG000|Overall Study|Lost to Follow-up|13|||
126757310|NCT03922945|456062611|FG001|Overall Study|Lost to Follow-up|9|||
126757311|NCT03922945|456062612|FG002|Overall Study|Lost to Follow-up|20|||
126757312|NCT03922945|456062610|FG000|Overall Study|Lack of Efficacy|2|||
126757313|NCT03922945|456062611|FG001|Overall Study|Lack of Efficacy|0|||
126757314|NCT03922945|456062612|FG002|Overall Study|Lack of Efficacy|1|||
126757315|NCT03922945|456062610|FG000|Overall Study|Protocol Non-Compliance|0|||
126757316|NCT03922945|456062611|FG001|Overall Study|Protocol Non-Compliance|0|||
126757317|NCT03922945|456062612|FG002|Overall Study|Protocol Non-Compliance|1|||
126757318|NCT03922945|456062610|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
126757319|NCT03922945|456062611|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
126757320|NCT03922945|456062612|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
126757321|NCT03922945|456062610|FG000|Overall Study|All Other Personal Reasons|1|||
126757322|NCT03922945|456062611|FG001|Overall Study|All Other Personal Reasons|1|||
126757323|NCT03922945|456062612|FG002|Overall Study|All Other Personal Reasons|2|||
126757324|NCT02493712|456062613|FG000|Overall Study|Withdrawal by Subject|1|||
126757325|NCT02493712|456062614|FG001|Overall Study|Withdrawal by Subject|0|||
126757326|NCT02493712|456062615|FG002|Overall Study|Withdrawal by Subject|2|||
126757327|NCT02493712|456062613|FG000|Overall Study|Protocol Violation|0|||
126757328|NCT02493712|456062614|FG001|Overall Study|Protocol Violation|0|||
126757329|NCT02493712|456062615|FG002|Overall Study|Protocol Violation|1|||
126757330|NCT02493712|456062613|FG000|Overall Study|Lost to Follow-up|1|||
126757331|NCT02493712|456062614|FG001|Overall Study|Lost to Follow-up|0|||
126757332|NCT02493712|456062615|FG002|Overall Study|Lost to Follow-up|0|||
126757333|NCT02493712|456062613|FG000|Overall Study|Physician Decision|0|||
126757334|NCT02493712|456062614|FG001|Overall Study|Physician Decision|1|||
126757335|NCT02493712|456062615|FG002|Overall Study|Physician Decision|0|||
126757336|NCT02493712|456062613|FG000|Overall Study|Lack of Efficacy|0|||
126757337|NCT02493712|456062614|FG001|Overall Study|Lack of Efficacy|5|||
126757338|NCT02493712|456062615|FG002|Overall Study|Lack of Efficacy|3|||
126757339|NCT02528643|456062616|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
126757340|NCT02528643|456062617|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
126757341|NCT02528643|456062616|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
126757342|NCT02528643|456062617|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
126757343|NCT02528643|456062616|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
126757344|NCT02528643|456062617|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
126757345|NCT02528643|456062616|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
126757346|NCT02528643|456062617|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
126757347|NCT02528643|456062616|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
126757348|NCT02528643|456062617|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
126757349|NCT02528643|456062616|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
126757350|NCT02528643|456062617|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
126757351|NCT02528643|456062616|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
126757352|NCT02528643|456062617|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
126757353|NCT04120116|456062618|FG000|Overall Study|Lost to Follow-up|0|||
126757354|NCT04120116|456062619|FG001|Overall Study|Lost to Follow-up|1|||
126757355|NCT04120116|456062620|FG002|Overall Study|Lost to Follow-up|0|||
126757356|NCT04120116|456062621|FG003|Overall Study|Lost to Follow-up|2|||
126757357|NCT04120116|456062618|FG000|Overall Study|Withdrawal by Subject|1|||
126757358|NCT04120116|456062619|FG001|Overall Study|Withdrawal by Subject|0|||
126757359|NCT04120116|456062620|FG002|Overall Study|Withdrawal by Subject|1|||
126757360|NCT04120116|456062621|FG003|Overall Study|Withdrawal by Subject|1|||
126757361|NCT04120116|456062618|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
126757362|NCT04120116|456062619|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
126757363|NCT04120116|456062620|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
126757364|NCT04120116|456062621|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
126757365|NCT02087085|456062622|FG000|Overall Study|Adverse Event|10|||
126757366|NCT02087085|456062623|FG001|Overall Study|Adverse Event|14|||
126757367|NCT02087085|456062622|FG000|Overall Study|Lack of Efficacy|4|||
126757368|NCT02087085|456062623|FG001|Overall Study|Lack of Efficacy|3|||
126757369|NCT02087085|456062622|FG000|Overall Study|Lost to Follow-up|6|||
126757370|NCT02087085|456062623|FG001|Overall Study|Lost to Follow-up|4|||
126757371|NCT02087085|456062622|FG000|Overall Study|Withdrawal by Subject|9|||
126757372|NCT02087085|456062623|FG001|Overall Study|Withdrawal by Subject|11|||
126757373|NCT02087085|456062622|FG000|Overall Study|Protocol Violation|1|||
126757374|NCT02087085|456062623|FG001|Overall Study|Protocol Violation|0|||
126757375|NCT02087085|456062622|FG000|Overall Study|Study Terminated by Sponsor|87|||
126757376|NCT02087085|456062623|FG001|Overall Study|Study Terminated by Sponsor|80|||
126757377|NCT02087085|456062622|FG000|Overall Study|Other Miscellaneous Reasons|3|||
126757378|NCT02087085|456062623|FG001|Overall Study|Other Miscellaneous Reasons|4|||
126757379|NCT01191190|456062624|FG000|Overall Study|Withdrawal by Subject|1|||
126757380|NCT03339999|456062632|FG000|Overall Study|Adverse Event|1|||
126757381|NCT03339999|456062633|FG001|Overall Study|Adverse Event|2|||
126757382|NCT03339999|456062634|FG002|Overall Study|Adverse Event|2|||
126757383|NCT03339999|456062635|FG003|Overall Study|Adverse Event|1|||
126757384|NCT03339999|456062632|FG000|Overall Study|Lack of Efficacy|0|||
126757385|NCT03339999|456062633|FG001|Overall Study|Lack of Efficacy|1|||
126757386|NCT03339999|456062634|FG002|Overall Study|Lack of Efficacy|0|||
126757387|NCT03339999|456062635|FG003|Overall Study|Lack of Efficacy|0|||
126757388|NCT03339999|456062632|FG000|Overall Study|Lost to Follow-up|0|||
126757389|NCT03339999|456062633|FG001|Overall Study|Lost to Follow-up|0|||
126757390|NCT03339999|456062634|FG002|Overall Study|Lost to Follow-up|0|||
126757391|NCT03339999|456062635|FG003|Overall Study|Lost to Follow-up|1|||
126757392|NCT03339999|456062632|FG000|Overall Study|Study Terminated by Sponsor|6|||
126757393|NCT03339999|456062633|FG001|Overall Study|Study Terminated by Sponsor|3|||
126757394|NCT03339999|456062634|FG002|Overall Study|Study Terminated by Sponsor|4|||
126757395|NCT03339999|456062635|FG003|Overall Study|Study Terminated by Sponsor|3|||
126757396|NCT01729559|456062639|FG000|Overall Study|Protocol Violation|31|||
126757397|NCT01729559|456062640|FG001|Overall Study|Protocol Violation|28|||
126757398|NCT03764813|456062645|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
126757399|NCT03764813|456062646|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
126757400|NCT03764813|456062647|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
126757401|NCT03764813|456062648|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
126757402|NCT03326323|456062656|FG000|Overall Study|Unable to receive ANH protocol|3|||
126757403|NCT04225026|456062658|FG000|Overall Study|Withdrawal by Subject|4|||
126757404|NCT04225026|456062658|FG000|Overall Study|Adverse Event|1|||
126757405|NCT04225026|456062658|FG000|Overall Study|Other|1|||
126757406|NCT04225026|456062658|FG000|Overall Study|Death|11|||
126757407|NCT04225026|456062658|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
126757408|NCT00672490|456062661|FG000|Overall Study|Withdrawal by Subject|8|||
126757409|NCT00672490|456062662|FG001|Overall Study|Withdrawal by Subject|8|||
126757410|NCT00672490|456062661|FG000|Overall Study|Lack of Compliance|2|||
126757411|NCT00672490|456062662|FG001|Overall Study|Lack of Compliance|7|||
126757412|NCT00672490|456062661|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
126757413|NCT00672490|456062662|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
126757414|NCT00672490|456062661|FG000|Overall Study|Adverse Event|5|||
126757415|NCT00672490|456062662|FG001|Overall Study|Adverse Event|8|||
126757416|NCT00672490|456062661|FG000|Overall Study|Violation of Concomitant Medicine|1|||
126757417|NCT00672490|456062662|FG001|Overall Study|Violation of Concomitant Medicine|0|||
126757418|NCT00672490|456062661|FG000|Overall Study|Intolerance|0|||
126757419|NCT00672490|456062662|FG001|Overall Study|Intolerance|2|||
126757420|NCT00672490|456062661|FG000|Overall Study|Lost to Follow-up|1|||
126757421|NCT00672490|456062662|FG001|Overall Study|Lost to Follow-up|5|||
126757422|NCT00672490|456062661|FG000|Overall Study|No reason was provided|6|||
126757423|NCT00672490|456062662|FG001|Overall Study|No reason was provided|2|||
126533894|NCT00160680|455246687|FG000|Overall Study|Lack of Efficacy|2|||
126533895|NCT00160680|455246688|FG001|Overall Study|Lack of Efficacy|1|||
126533896|NCT00160680|455246687|FG000|Overall Study|Lost to Follow-up|3|||
126533897|NCT00160680|455246688|FG001|Overall Study|Lost to Follow-up|2|||
126533898|NCT00160680|455246687|FG000|Overall Study|Withdrawal by Subject|4|||
126533899|NCT00160680|455246688|FG001|Overall Study|Withdrawal by Subject|9|||
126533900|NCT00985725|455246692|FG000|Overall Study|Adverse Event|4|||
126533901|NCT00985725|455246693|FG001|Overall Study|Adverse Event|1|||
126533902|NCT00985725|455246692|FG000|Overall Study|Protocol Violation|1|||
126533903|NCT00985725|455246693|FG001|Overall Study|Protocol Violation|3|||
126533904|NCT00985725|455246692|FG000|Overall Study|Withdrawal by Subject|4|||
126533905|NCT00985725|455246693|FG001|Overall Study|Withdrawal by Subject|4|||
126533906|NCT00985725|455246692|FG000|Overall Study|Lost to Follow-up|1|||
126533907|NCT00985725|455246693|FG001|Overall Study|Lost to Follow-up|1|||
126533908|NCT00985725|455246692|FG000|Overall Study|Lack of Efficacy|0|||
126533909|NCT00985725|455246693|FG001|Overall Study|Lack of Efficacy|1|||
126533910|NCT00985725|455246692|FG000|Overall Study|Non-compliance|1|||
126533911|NCT00985725|455246693|FG001|Overall Study|Non-compliance|2|||
126533912|NCT00985725|455246692|FG000|Overall Study|Out-of-window visits|0|||
126533913|NCT00985725|455246693|FG001|Overall Study|Out-of-window visits|1|||
126533914|NCT02723864|455246694|FG000|Overall Study|Refused further treatment|1|||
126533915|NCT02723864|455246695|FG001|Overall Study|Refused further treatment|0|||
126533916|NCT02723864|455246696|FG002|Overall Study|Refused further treatment|0|||
126533917|NCT02723864|455246697|FG003|Overall Study|Refused further treatment|0|||
126533918|NCT02723864|455246698|FG004|Overall Study|Refused further treatment|1|||
126533919|NCT02723864|455246699|FG005|Overall Study|Refused further treatment|2|||
126533920|NCT02723864|455246700|FG006|Overall Study|Refused further treatment|0|||
126533921|NCT02723864|455246694|FG000|Overall Study|Exceed treatment hold time|0|||
126533922|NCT02723864|455246695|FG001|Overall Study|Exceed treatment hold time|1|||
126533923|NCT02723864|455246696|FG002|Overall Study|Exceed treatment hold time|0|||
126533924|NCT02723864|455246697|FG003|Overall Study|Exceed treatment hold time|0|||
126533925|NCT02723864|455246698|FG004|Overall Study|Exceed treatment hold time|0|||
126533926|NCT02723864|455246699|FG005|Overall Study|Exceed treatment hold time|0|||
126533927|NCT02723864|455246700|FG006|Overall Study|Exceed treatment hold time|0|||
126533928|NCT02723864|455246694|FG000|Overall Study|Clinical progression|0|||
126533929|NCT02723864|455246695|FG001|Overall Study|Clinical progression|0|||
126533930|NCT02723864|455246696|FG002|Overall Study|Clinical progression|1|||
126533931|NCT02723864|455246697|FG003|Overall Study|Clinical progression|0|||
126533932|NCT02723864|455246698|FG004|Overall Study|Clinical progression|0|||
126533933|NCT02723864|455246699|FG005|Overall Study|Clinical progression|3|||
126533934|NCT02723864|455246700|FG006|Overall Study|Clinical progression|1|||
126533935|NCT02723864|455246694|FG000|Overall Study|Physician Decision|0|||
126533936|NCT02723864|455246695|FG001|Overall Study|Physician Decision|0|||
126533937|NCT02723864|455246696|FG002|Overall Study|Physician Decision|0|||
126533938|NCT02723864|455246697|FG003|Overall Study|Physician Decision|0|||
126533939|NCT02723864|455246698|FG004|Overall Study|Physician Decision|0|||
126533940|NCT02723864|455246699|FG005|Overall Study|Physician Decision|0|||
126757424|NCT04738123|456062665|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
126770362|NCT02756078|456112461|FG000|Period 1|Withdrawal by Subject|6|||
126533941|NCT02723864|455246700|FG006|Overall Study|Physician Decision|1|||
126533942|NCT02723864|455246694|FG000|Overall Study|Changes in patient condition|0|||
126757425|NCT04738123|456062666|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
126757426|NCT04738123|456062665|FG000|Overall Study|Progressive Disease|0|||
126757427|NCT04738123|456062666|FG001|Overall Study|Progressive Disease|4|||
126757428|NCT04738123|456062665|FG000|Overall Study|Adverse Event|8|||
126757429|NCT04738123|456062666|FG001|Overall Study|Adverse Event|7|||
126757430|NCT04738123|456062665|FG000|Overall Study|Other Reasons|0|||
126757431|NCT04738123|456062666|FG001|Overall Study|Other Reasons|1|||
126757432|NCT04738123|456062665|FG000|Overall Study|Suicidal or assaultive behavior|0|||
126757433|NCT04738123|456062666|FG001|Overall Study|Suicidal or assaultive behavior|2|||
126533943|NCT02723864|455246695|FG001|Overall Study|Changes in patient condition|0|||
126533944|NCT02723864|455246696|FG002|Overall Study|Changes in patient condition|0|||
126533945|NCT02723864|455246697|FG003|Overall Study|Changes in patient condition|0|||
126533946|NCT02723864|455246698|FG004|Overall Study|Changes in patient condition|0|||
126757434|NCT04738123|456062665|FG000|Overall Study|Protocol Violation|2|||
126757435|NCT04738123|456062666|FG001|Overall Study|Protocol Violation|2|||
126757436|NCT04738123|456062665|FG000|Overall Study|Consent Withdrawn|35|||
126757437|NCT04738123|456062666|FG001|Overall Study|Consent Withdrawn|22|||
126757438|NCT03604159|456062669|FG000|Overall Study|Lost to Follow-up|6|||
126757439|NCT03604159|456062670|FG001|Overall Study|Lost to Follow-up|7|||
126757440|NCT04533204|456062673|FG000|Overall Study|Unable to understand training instructions|1|||
126757441|NCT04533204|456062674|FG001|Overall Study|Unable to understand training instructions|1|||
126757442|NCT03982069|456062675|FG000|Overall Study|Lost to Follow-up|5|||
126757443|NCT03982069|456062676|FG001|Overall Study|Lost to Follow-up|5|||
126757444|NCT03982069|456062677|FG002|Overall Study|Lost to Follow-up|3|||
126757445|NCT03982069|456062678|FG003|Overall Study|Lost to Follow-up|5|||
126757446|NCT03982069|456062675|FG000|Overall Study|Physician Decision|0|||
126757447|NCT03982069|456062676|FG001|Overall Study|Physician Decision|1|||
126757448|NCT03982069|456062677|FG002|Overall Study|Physician Decision|0|||
126757449|NCT03982069|456062678|FG003|Overall Study|Physician Decision|0|||
126757450|NCT03982069|456062675|FG000|Overall Study|Withdrawal by Subject|2|||
126757451|NCT03982069|456062676|FG001|Overall Study|Withdrawal by Subject|1|||
126533947|NCT02723864|455246699|FG005|Overall Study|Changes in patient condition|1|||
126533948|NCT02723864|455246700|FG006|Overall Study|Changes in patient condition|0|||
126533949|NCT02723864|455246694|FG000|Overall Study|Patient choice|0|||
126533950|NCT02723864|455246695|FG001|Overall Study|Patient choice|0|||
126533951|NCT02723864|455246696|FG002|Overall Study|Patient choice|0|||
126533952|NCT02723864|455246697|FG003|Overall Study|Patient choice|0|||
126757452|NCT03982069|456062677|FG002|Overall Study|Withdrawal by Subject|5|||
126757453|NCT03982069|456062678|FG003|Overall Study|Withdrawal by Subject|2|||
126757454|NCT03982069|456062675|FG000|Overall Study|Specimen loss|3|||
126757455|NCT03982069|456062676|FG001|Overall Study|Specimen loss|3|||
126757456|NCT03982069|456062677|FG002|Overall Study|Specimen loss|1|||
126757457|NCT03982069|456062678|FG003|Overall Study|Specimen loss|1|||
126757458|NCT01218477|456062679|FG000|Overall Study|Disease progression|2|||
126757459|NCT01218477|456062680|FG001|Overall Study|Disease progression|3|||
126757460|NCT01218477|456062681|FG002|Overall Study|Disease progression|6|||
126757461|NCT01218477|456062682|FG003|Overall Study|Disease progression|2|||
126533953|NCT02723864|455246698|FG004|Overall Study|Patient choice|0|||
126533954|NCT02723864|455246699|FG005|Overall Study|Patient choice|1|||
126533955|NCT02723864|455246700|FG006|Overall Study|Patient choice|0|||
126533956|NCT02723864|455246694|FG000|Overall Study|Adverse Event|0|||
126533957|NCT02723864|455246695|FG001|Overall Study|Adverse Event|0|||
126533958|NCT02723864|455246696|FG002|Overall Study|Adverse Event|0|||
126533959|NCT02723864|455246697|FG003|Overall Study|Adverse Event|0|||
126533960|NCT02723864|455246698|FG004|Overall Study|Adverse Event|0|||
126533961|NCT02723864|455246699|FG005|Overall Study|Adverse Event|1|||
126757462|NCT01218477|456062679|FG000|Overall Study|Study drug toxicity|0|||
126757463|NCT01218477|456062680|FG001|Overall Study|Study drug toxicity|2|||
126757464|NCT01218477|456062681|FG002|Overall Study|Study drug toxicity|5|||
126757465|NCT01218477|456062682|FG003|Overall Study|Study drug toxicity|0|||
126757466|NCT01218477|456062679|FG000|Overall Study|No longer meets study criteria|1|||
126757467|NCT01218477|456062680|FG001|Overall Study|No longer meets study criteria|0|||
126533962|NCT02723864|455246700|FG006|Overall Study|Adverse Event|0|||
126533963|NCT02723864|455246694|FG000|Overall Study|Started new treatment|0|||
126757468|NCT01218477|456062681|FG002|Overall Study|No longer meets study criteria|0|||
126757469|NCT01218477|456062682|FG003|Overall Study|No longer meets study criteria|0|||
126311179|NCT03339726|454429678|FG001|Overall Study|Withdrawal by Subject|0|||
126533964|NCT02723864|455246695|FG001|Overall Study|Started new treatment|0|||
126645334|NCT01253135|455660313|FG000|Original Protocol|Protocol Amendment|15|||
126757470|NCT01218477|456062679|FG000|Overall Study|Withdrawal by Subject|0|||
126757471|NCT01218477|456062680|FG001|Overall Study|Withdrawal by Subject|0|||
126757472|NCT01218477|456062681|FG002|Overall Study|Withdrawal by Subject|1|||
126757473|NCT01218477|456062682|FG003|Overall Study|Withdrawal by Subject|0|||
126757474|NCT01218477|456062679|FG000|Overall Study|Prepared for cell transplantation|0|||
126757475|NCT01218477|456062680|FG001|Overall Study|Prepared for cell transplantation|1|||
126757476|NCT01218477|456062681|FG002|Overall Study|Prepared for cell transplantation|1|||
126757477|NCT01218477|456062682|FG003|Overall Study|Prepared for cell transplantation|0|||
126757478|NCT01218477|456062679|FG000|Overall Study|Administrative reason by sponsor|0|||
126757479|NCT01218477|456062680|FG001|Overall Study|Administrative reason by sponsor|0|||
126757480|NCT01218477|456062681|FG002|Overall Study|Administrative reason by sponsor|1|||
126757481|NCT01218477|456062682|FG003|Overall Study|Administrative reason by sponsor|0|||
126757482|NCT01218477|456062679|FG000|Overall Study|Maximum clinical benefit|0|||
126757483|NCT01218477|456062680|FG001|Overall Study|Maximum clinical benefit|2|||
126757484|NCT01218477|456062681|FG002|Overall Study|Maximum clinical benefit|0|||
126757485|NCT01218477|456062682|FG003|Overall Study|Maximum clinical benefit|0|||
126757486|NCT00787527|456062683|FG000|Overall Study|Toxicity|3|||
126757487|NCT00083616|456062686|FG000|Overall Study|Disease Progression|16|||
126757488|NCT00083616|456062686|FG000|Overall Study|Lost to Follow-up|1|||
126757489|NCT00083616|456062686|FG000|Overall Study|Physician Decision|2|||
126757490|NCT00083616|456062686|FG000|Overall Study|Withdrawal by Subject|3|||
126757491|NCT00083616|456062686|FG000|Overall Study|Ineligibility determined|2|||
126757492|NCT00083616|456062686|FG000|Overall Study|Non-compliance|1|||
126757493|NCT00083616|456062686|FG000|Overall Study|Other|6|||
126757494|NCT01474993|456062689|FG000|Overall Study|Lost to Follow-up|1|||
126757495|NCT01474993|456062690|FG001|Overall Study|Lost to Follow-up|2|||
126757496|NCT01474993|456062689|FG000|Overall Study|Adverse Event|0|||
126757497|NCT01474993|456062690|FG001|Overall Study|Adverse Event|1|||
126757498|NCT00760994|456062691|FG000|Overall Study|Lost to Follow-up|4|||
126757499|NCT00760994|456062692|FG001|Overall Study|Lost to Follow-up|4|||
126757500|NCT00760994|456062693|FG002|Overall Study|Lost to Follow-up|3|||
126757501|NCT01853397|456062694|FG000|Overall Study|Withdrawal by Subject|0|||
126757502|NCT01853397|456062695|FG001|Overall Study|Withdrawal by Subject|0|||
126757503|NCT01853397|456062696|FG002|Overall Study|Withdrawal by Subject|0|||
126757504|NCT01853397|456062697|FG003|Overall Study|Withdrawal by Subject|1|||
126757505|NCT01853397|456062694|FG000|Overall Study|Subject Noncompliance|0|||
126757506|NCT01853397|456062695|FG001|Overall Study|Subject Noncompliance|0|||
126757507|NCT01853397|456062696|FG002|Overall Study|Subject Noncompliance|0|||
126757508|NCT01853397|456062697|FG003|Overall Study|Subject Noncompliance|1|||
126757509|NCT02132312|456062698|FG000|Overall Study|Adverse Event|2|||
126757510|NCT02132312|456062699|FG001|Overall Study|Adverse Event|0|||
126757511|NCT02132312|456062698|FG000|Overall Study|Physician Decision|1|||
126757512|NCT02132312|456062699|FG001|Overall Study|Physician Decision|1|||
126757513|NCT02132312|456062698|FG000|Overall Study|Protocol Violation|0|||
126757514|NCT02132312|456062699|FG001|Overall Study|Protocol Violation|1|||
126757515|NCT02132312|456062698|FG000|Overall Study|Withdrawal by Subject|1|||
126757516|NCT02132312|456062699|FG001|Overall Study|Withdrawal by Subject|0|||
126757517|NCT02132312|456062698|FG000|Overall Study|Lost to Follow-up|2|||
126757518|NCT02132312|456062699|FG001|Overall Study|Lost to Follow-up|1|||
126757519|NCT03258710|456062700|FG000|Overall Study|Adverse Event|1|||
126757520|NCT03258710|456062700|FG000|Overall Study|Protocol-defined stopping criteria|1|||
126757521|NCT03258710|456062700|FG000|Overall Study|Physician Decision|1|||
126757522|NCT02242305|456062701|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
126757523|NCT02242305|456062702|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
126757524|NCT02242305|456062701|FG000|Overall Study|Adverse Event|1|||
126757525|NCT02242305|456062702|FG001|Overall Study|Adverse Event|0|||
126757526|NCT02242305|456062701|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
126757527|NCT02242305|456062702|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
126757528|NCT02242305|456062701|FG000|Overall Study|Subject withdraws inform consent|0|||
126757529|NCT02242305|456062702|FG001|Overall Study|Subject withdraws inform consent|4|||
126757530|NCT02242305|456062701|FG000|Overall Study|Lost to Follow-up|2|||
126757531|NCT02242305|456062702|FG001|Overall Study|Lost to Follow-up|0|||
126757532|NCT03451630|456062703|FG000|Overall Study|Death|15|||
126757533|NCT03451630|456062704|FG001|Overall Study|Death|16|||
126757534|NCT03451630|456062705|FG002|Overall Study|Death|11|||
126757535|NCT03451630|456062703|FG000|Overall Study|Lost to Follow-up|9|||
126757536|NCT03451630|456062704|FG001|Overall Study|Lost to Follow-up|0|||
126757537|NCT03451630|456062705|FG002|Overall Study|Lost to Follow-up|4|||
126757538|NCT03451630|456062703|FG000|Overall Study|Withdrawal by Subject|0|||
126757539|NCT03451630|456062704|FG001|Overall Study|Withdrawal by Subject|3|||
126757540|NCT03451630|456062705|FG002|Overall Study|Withdrawal by Subject|0|||
126757541|NCT03451630|456062703|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
126757542|NCT03451630|456062704|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
126757543|NCT03451630|456062705|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
126757544|NCT00486720|456062708|FG000|Overall Study|Adverse Event|1|||
126757545|NCT00486720|456062709|FG001|Overall Study|Adverse Event|2|||
126757546|NCT00486720|456062708|FG000|Overall Study|Lack of Efficacy|4|||
126757547|NCT00486720|456062709|FG001|Overall Study|Lack of Efficacy|6|||
126757548|NCT00486720|456062708|FG000|Overall Study|Physician Decision|1|||
126757549|NCT00486720|456062709|FG001|Overall Study|Physician Decision|2|||
126757550|NCT00486720|456062708|FG000|Overall Study|Protocol Violation|1|||
126757551|NCT00486720|456062709|FG001|Overall Study|Protocol Violation|0|||
126757552|NCT00486720|456062708|FG000|Overall Study|Withdrawal by Subject|3|||
126770363|NCT02756078|456112462|FG001|Period 1|Withdrawal by Subject|6|||
126757553|NCT00486720|456062709|FG001|Overall Study|Withdrawal by Subject|1|||
126757554|NCT00486720|456062708|FG000|Overall Study|Progressive Disease|0|||
126757555|NCT00486720|456062709|FG001|Overall Study|Progressive Disease|1|||
126757556|NCT02452892|456062710|FG000|Week 1 Initial Randommization|Adverse Event|1|||
126757557|NCT02452892|456062711|FG001|Week 1 Initial Randommization|Adverse Event|0|||
126757558|NCT02452892|456062712|FG002|Week 1 Initial Randommization|Adverse Event|0|||
126757559|NCT02452892|456062713|FG003|Week 1 Initial Randommization|Adverse Event|0|||
126757560|NCT02452892|456062710|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
126757561|NCT02452892|456062711|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
126757562|NCT02452892|456062712|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
126757563|NCT02452892|456062713|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
126757564|NCT02452892|456062710|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
126757565|NCT02452892|456062711|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
126757566|NCT02452892|456062712|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
126757567|NCT02452892|456062713|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
126757568|NCT02452892|456062710|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
126757569|NCT02452892|456062711|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
126757570|NCT02452892|456062712|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
126757571|NCT02452892|456062713|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
126757572|NCT02452892|456062710|FG000|Follow-up|Withdrawal by Subject|0|||
126757573|NCT02452892|456062711|FG001|Follow-up|Withdrawal by Subject|0|||
126757574|NCT02452892|456062712|FG002|Follow-up|Withdrawal by Subject|0|||
126757575|NCT02452892|456062713|FG003|Follow-up|Withdrawal by Subject|1|||
126757576|NCT02452892|456062710|FG000|Follow-up|Subject left town on Day 42|1|||
126757577|NCT02452892|456062711|FG001|Follow-up|Subject left town on Day 42|0|||
126757578|NCT02452892|456062712|FG002|Follow-up|Subject left town on Day 42|0|||
126757579|NCT02452892|456062713|FG003|Follow-up|Subject left town on Day 42|0|||
126311180|NCT03339726|454429679|FG002|Overall Study|Withdrawal by Subject|0|||
126311181|NCT03339726|454429677|FG000|Overall Study|Lost to Follow-up|0|||
126311182|NCT03339726|454429678|FG001|Overall Study|Lost to Follow-up|1|||
126311183|NCT03339726|454429679|FG002|Overall Study|Lost to Follow-up|0|||
126311184|NCT01275755|454429680|FG000|Double-blind Treatment Period|Adverse Event|0|||
126311185|NCT01275755|454429681|FG001|Double-blind Treatment Period|Adverse Event|2|||
126311186|NCT01275755|454429680|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
126311187|NCT01275755|454429681|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
126311188|NCT01275755|454429680|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
126311189|NCT01275755|454429681|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
126311190|NCT01275755|454429680|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
126311191|NCT01275755|454429681|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
126311192|NCT00636194|454429687|FG000|Overall Study|Study related symptoms and complaints|1|||
126311193|NCT00636194|454429688|FG001|Overall Study|Study related symptoms and complaints|0|||
126311194|NCT00636194|454429687|FG000|Overall Study|Protocol Violation|2|||
126311195|NCT00636194|454429688|FG001|Overall Study|Protocol Violation|0|||
126311196|NCT04934189|454429693|FG000|Overall Study|Lost to Follow-up|4|||
126311197|NCT04934189|454429693|FG000|Overall Study|Withdrawal by Subject|17|||
126311198|NCT03962790|454429694|FG000|Period 1|Adverse Event|0|||
126311199|NCT03962790|454429695|FG001|Period 1|Adverse Event|1|||
126311200|NCT03962790|454429694|FG000|Period 1|Failed to meet all eligibility criteria|1|||
126311201|NCT03962790|454429695|FG001|Period 1|Failed to meet all eligibility criteria|1|||
126311202|NCT03962790|454429694|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
126311203|NCT03962790|454429695|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
126311204|NCT03962790|454429694|FG000|Period 1|Withdrawal by Subject|1|||
126311205|NCT03962790|454429695|FG001|Period 1|Withdrawal by Subject|0|||
126311206|NCT01286168|454429697|FG000|Overall Study|Withdrawal by Subject|1|||
126311207|NCT01286168|454429697|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
126311208|NCT04598451|454429698|FG000|Overall Study|Adverse Event|3|||
126311209|NCT04598451|454429699|FG001|Overall Study|Adverse Event|2|||
126311210|NCT04598451|454429698|FG000|Overall Study|Withdrawal by Subject|3|||
126311211|NCT04598451|454429699|FG001|Overall Study|Withdrawal by Subject|7|||
126311212|NCT04598451|454429698|FG000|Overall Study|Lost to Follow-up|2|||
126311213|NCT04598451|454429699|FG001|Overall Study|Lost to Follow-up|0|||
126311214|NCT04598451|454429698|FG000|Overall Study|Physician Decision|4|||
126311215|NCT04598451|454429699|FG001|Overall Study|Physician Decision|1|||
126311216|NCT04598451|454429698|FG000|Overall Study|Requires Prohibited Medication|1|||
126311217|NCT04598451|454429699|FG001|Overall Study|Requires Prohibited Medication|0|||
126311218|NCT04598451|454429698|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
126311219|NCT04598451|454429699|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
126311220|NCT04594941|454429700|FG000|Overall Study|Other|0|||
126311221|NCT04594941|454429701|FG001|Overall Study|Other|3|||
126311222|NCT04594941|454429702|FG002|Overall Study|Other|1|||
126311223|NCT04594941|454429703|FG003|Overall Study|Other|0|||
126311224|NCT03535194|454429704|FG000|Induction Period|Adverse Event|2|||
126311225|NCT03535194|454429705|FG001|Induction Period|Adverse Event|2|||
126311226|NCT03535194|454429706|FG002|Induction Period|Adverse Event|1|||
126311227|NCT03535194|454429707|FG003|Induction Period|Adverse Event|3|||
126311228|NCT03535194|454429708|FG004|Induction Period|Adverse Event|0|||
126311229|NCT03535194|454429704|FG000|Induction Period|Death|0|||
126311230|NCT03535194|454429705|FG001|Induction Period|Death|1|||
126311231|NCT03535194|454429706|FG002|Induction Period|Death|0|||
126311232|NCT03535194|454429707|FG003|Induction Period|Death|0|||
126311233|NCT03535194|454429708|FG004|Induction Period|Death|0|||
126311234|NCT03535194|454429704|FG000|Induction Period|Lack of Efficacy|1|||
126311235|NCT03535194|454429705|FG001|Induction Period|Lack of Efficacy|3|||
126311236|NCT03535194|454429706|FG002|Induction Period|Lack of Efficacy|2|||
126311237|NCT03535194|454429707|FG003|Induction Period|Lack of Efficacy|2|||
126311238|NCT03535194|454429708|FG004|Induction Period|Lack of Efficacy|0|||
126311239|NCT03535194|454429704|FG000|Induction Period|Lost to Follow-up|3|||
126311240|NCT03535194|454429705|FG001|Induction Period|Lost to Follow-up|5|||
126311241|NCT03535194|454429706|FG002|Induction Period|Lost to Follow-up|2|||
126311242|NCT03535194|454429707|FG003|Induction Period|Lost to Follow-up|3|||
126311243|NCT03535194|454429708|FG004|Induction Period|Lost to Follow-up|0|||
126311244|NCT03535194|454429704|FG000|Induction Period|Physician Decision|1|||
126311245|NCT03535194|454429705|FG001|Induction Period|Physician Decision|1|||
126311246|NCT03535194|454429706|FG002|Induction Period|Physician Decision|0|||
126311247|NCT03535194|454429707|FG003|Induction Period|Physician Decision|0|||
126311248|NCT03535194|454429708|FG004|Induction Period|Physician Decision|0|||
126311249|NCT03535194|454429704|FG000|Induction Period|Protocol Violation|1|||
126311250|NCT03535194|454429705|FG001|Induction Period|Protocol Violation|0|||
126311251|NCT03535194|454429706|FG002|Induction Period|Protocol Violation|0|||
126311252|NCT03535194|454429707|FG003|Induction Period|Protocol Violation|1|||
126311253|NCT03535194|454429708|FG004|Induction Period|Protocol Violation|0|||
126311254|NCT03535194|454429704|FG000|Induction Period|Screen Failure|0|||
126311255|NCT03535194|454429705|FG001|Induction Period|Screen Failure|1|||
126311256|NCT03535194|454429706|FG002|Induction Period|Screen Failure|0|||
126311257|NCT03535194|454429707|FG003|Induction Period|Screen Failure|0|||
126311258|NCT03535194|454429708|FG004|Induction Period|Screen Failure|0|||
126311259|NCT03535194|454429704|FG000|Induction Period|Withdrawal by Subject|3|||
126311260|NCT03535194|454429705|FG001|Induction Period|Withdrawal by Subject|4|||
126311261|NCT03535194|454429706|FG002|Induction Period|Withdrawal by Subject|3|||
126311262|NCT03535194|454429707|FG003|Induction Period|Withdrawal by Subject|2|||
126311263|NCT03535194|454429708|FG004|Induction Period|Withdrawal by Subject|0|||
126311264|NCT03535194|454429704|FG000|Maintenance Period|Adverse Event|6|||
126311265|NCT03535194|454429705|FG001|Maintenance Period|Adverse Event|5|||
126311266|NCT03535194|454429706|FG002|Maintenance Period|Adverse Event|1|||
126311267|NCT03535194|454429707|FG003|Maintenance Period|Adverse Event|11|||
126311268|NCT03535194|454429708|FG004|Maintenance Period|Adverse Event|4|||
126311269|NCT03535194|454429704|FG000|Maintenance Period|Lack of Efficacy|3|||
126311270|NCT03535194|454429705|FG001|Maintenance Period|Lack of Efficacy|2|||
126311271|NCT03535194|454429706|FG002|Maintenance Period|Lack of Efficacy|5|||
126311272|NCT03535194|454429707|FG003|Maintenance Period|Lack of Efficacy|9|||
126311273|NCT03535194|454429708|FG004|Maintenance Period|Lack of Efficacy|0|||
126311274|NCT03535194|454429704|FG000|Maintenance Period|Lost to Follow-up|4|||
126311275|NCT03535194|454429705|FG001|Maintenance Period|Lost to Follow-up|2|||
126311276|NCT03535194|454429706|FG002|Maintenance Period|Lost to Follow-up|1|||
126311277|NCT03535194|454429707|FG003|Maintenance Period|Lost to Follow-up|5|||
126311278|NCT03535194|454429708|FG004|Maintenance Period|Lost to Follow-up|2|||
126311279|NCT03535194|454429704|FG000|Maintenance Period|Other|1|||
126311280|NCT03535194|454429705|FG001|Maintenance Period|Other|2|||
126311281|NCT03535194|454429706|FG002|Maintenance Period|Other|0|||
126311282|NCT03535194|454429707|FG003|Maintenance Period|Other|0|||
126311283|NCT03535194|454429708|FG004|Maintenance Period|Other|0|||
126311284|NCT03535194|454429704|FG000|Maintenance Period|Physician Decision|1|||
126311285|NCT03535194|454429705|FG001|Maintenance Period|Physician Decision|2|||
126757580|NCT00955682|456062714|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
126757581|NCT00955682|456062715|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
126757582|NCT02041533|456062717|FG000|Pre-Treatment Period|Disease Progression|1|||
126311286|NCT03535194|454429706|FG002|Maintenance Period|Physician Decision|0|||
126311287|NCT03535194|454429707|FG003|Maintenance Period|Physician Decision|2|||
126311288|NCT03535194|454429708|FG004|Maintenance Period|Physician Decision|0|||
126311289|NCT03535194|454429704|FG000|Maintenance Period|Pregnancy|0|||
126533965|NCT02723864|455246696|FG002|Overall Study|Started new treatment|0|||
126311290|NCT03535194|454429705|FG001|Maintenance Period|Pregnancy|0|||
126311291|NCT03535194|454429706|FG002|Maintenance Period|Pregnancy|0|||
126311292|NCT03535194|454429707|FG003|Maintenance Period|Pregnancy|2|||
126311293|NCT03535194|454429708|FG004|Maintenance Period|Pregnancy|0|||
126311294|NCT03535194|454429704|FG000|Maintenance Period|Protocol Violation|0|||
126311295|NCT03535194|454429705|FG001|Maintenance Period|Protocol Violation|1|||
126311296|NCT03535194|454429706|FG002|Maintenance Period|Protocol Violation|0|||
126311297|NCT03535194|454429707|FG003|Maintenance Period|Protocol Violation|0|||
126311298|NCT03535194|454429708|FG004|Maintenance Period|Protocol Violation|0|||
126311299|NCT03535194|454429704|FG000|Maintenance Period|Withdrawal by Subject|7|||
126311300|NCT03535194|454429705|FG001|Maintenance Period|Withdrawal by Subject|2|||
126311301|NCT03535194|454429706|FG002|Maintenance Period|Withdrawal by Subject|1|||
126311302|NCT03535194|454429707|FG003|Maintenance Period|Withdrawal by Subject|8|||
126311303|NCT03535194|454429708|FG004|Maintenance Period|Withdrawal by Subject|0|||
126311304|NCT03535194|454429704|FG000|Post-Treatment Followup Period|Adverse Event|4|||
126311305|NCT03535194|454429705|FG001|Post-Treatment Followup Period|Adverse Event|5|||
126311306|NCT03535194|454429706|FG002|Post-Treatment Followup Period|Adverse Event|1|||
126311307|NCT03535194|454429707|FG003|Post-Treatment Followup Period|Adverse Event|8|||
126311308|NCT03535194|454429708|FG004|Post-Treatment Followup Period|Adverse Event|0|||
126311309|NCT03535194|454429704|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
126311310|NCT03535194|454429705|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
126311311|NCT03535194|454429706|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
126311312|NCT03535194|454429707|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
126311313|NCT03535194|454429708|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
126311314|NCT03535194|454429704|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
126311315|NCT03535194|454429705|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
126311316|NCT03535194|454429706|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
126311317|NCT03535194|454429707|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
126311318|NCT03535194|454429708|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
126311319|NCT03535194|454429704|FG000|Post-Treatment Followup Period|Other|1|||
126311320|NCT03535194|454429705|FG001|Post-Treatment Followup Period|Other|0|||
126311321|NCT03535194|454429706|FG002|Post-Treatment Followup Period|Other|0|||
126311322|NCT03535194|454429707|FG003|Post-Treatment Followup Period|Other|5|||
126311323|NCT03535194|454429708|FG004|Post-Treatment Followup Period|Other|0|||
126311324|NCT03535194|454429704|FG000|Post-Treatment Followup Period|Physician Decision|0|||
126311325|NCT03535194|454429705|FG001|Post-Treatment Followup Period|Physician Decision|2|||
126311326|NCT03535194|454429706|FG002|Post-Treatment Followup Period|Physician Decision|1|||
126311327|NCT03535194|454429707|FG003|Post-Treatment Followup Period|Physician Decision|1|||
126311328|NCT03535194|454429708|FG004|Post-Treatment Followup Period|Physician Decision|0|||
126311329|NCT03535194|454429704|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
126311330|NCT03535194|454429705|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
126311331|NCT03535194|454429706|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
126311332|NCT03535194|454429707|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
126311333|NCT03535194|454429708|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126311334|NCT02091960|454429709|FG000|Overall Study|Death|7|||
126311335|NCT02091960|454429709|FG000|Overall Study|Withdrawal by Subject|1|||
126311336|NCT02091960|454429709|FG000|Overall Study|Miscellaneous Reasons|37|||
126311337|NCT02005692|454429724|FG000|Overall Study|Protocol Violation|1|||
126422272|NCT04640311|454842555|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422273|NCT04640311|454842556|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
126422274|NCT04640311|454842557|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422275|NCT04640311|454842558|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422276|NCT04640311|454842559|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422277|NCT04640311|454842560|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422278|NCT04640311|454842561|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422279|NCT04640311|454842562|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422280|NCT04640311|454842563|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422281|NCT04640311|454842564|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422282|NCT04640311|454842565|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422283|NCT04640311|454842566|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422284|NCT04640311|454842567|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422285|NCT04640311|454842555|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
126422286|NCT04640311|454842556|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
126422287|NCT04640311|454842557|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
126422288|NCT04640311|454842558|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422289|NCT04640311|454842559|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422290|NCT04640311|454842560|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422291|NCT04640311|454842561|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422292|NCT04640311|454842562|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126551802|NCT01807221|455315867|FG004|Overall Study|Adverse Event|18|||
126422293|NCT04640311|454842563|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422294|NCT04640311|454842564|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422295|NCT04640311|454842565|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422296|NCT04640311|454842566|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422297|NCT04640311|454842567|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
126422298|NCT04640311|454842555|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422299|NCT04640311|454842556|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422300|NCT04640311|454842557|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
126422301|NCT04640311|454842558|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422302|NCT04640311|454842559|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422303|NCT04640311|454842560|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422304|NCT04640311|454842561|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422305|NCT04640311|454842562|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422306|NCT04640311|454842563|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422307|NCT04640311|454842564|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422308|NCT04640311|454842565|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422309|NCT04640311|454842566|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422310|NCT04640311|454842567|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
126422311|NCT04640311|454842555|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126311338|NCT02005692|454429724|FG000|Overall Study|Withdrawal by Subject|1|||
126422312|NCT04640311|454842556|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422313|NCT04640311|454842557|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422314|NCT04640311|454842558|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
126422315|NCT04640311|454842559|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422316|NCT04640311|454842560|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422317|NCT04640311|454842561|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
126422318|NCT04640311|454842562|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422319|NCT04640311|454842563|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422320|NCT04640311|454842564|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422321|NCT04640311|454842565|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422322|NCT04640311|454842566|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422323|NCT04640311|454842567|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
126422324|NCT04640311|454842555|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422325|NCT04640311|454842556|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422326|NCT04640311|454842557|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422327|NCT04640311|454842558|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422328|NCT04640311|454842559|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422329|NCT04640311|454842560|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
126422330|NCT04640311|454842561|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422331|NCT04640311|454842562|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422332|NCT04640311|454842563|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
126422333|NCT04640311|454842564|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422334|NCT04640311|454842565|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422335|NCT04640311|454842566|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422336|NCT04640311|454842567|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
126422337|NCT04640311|454842555|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422338|NCT04640311|454842556|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422339|NCT04640311|454842557|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422340|NCT04640311|454842558|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422341|NCT04640311|454842559|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422342|NCT04640311|454842560|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422343|NCT04640311|454842561|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
126422344|NCT04640311|454842562|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422345|NCT04640311|454842563|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422346|NCT04640311|454842564|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422347|NCT04640311|454842565|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
126422348|NCT04640311|454842566|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422349|NCT04640311|454842567|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
126422350|NCT04640311|454842555|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422351|NCT04640311|454842556|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422352|NCT04640311|454842557|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422353|NCT04640311|454842558|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126757583|NCT02041533|456062718|FG001|Pre-Treatment Period|Disease Progression|1|||
126311339|NCT02005692|454429724|FG000|Overall Study|Discharged earlier than anticipated|5|||
126311340|NCT02091375|454429726|FG000|Overall Study|Adverse Event|8|||
126311341|NCT02091375|454429727|FG001|Overall Study|Adverse Event|1|||
126311342|NCT02091375|454429726|FG000|Overall Study|Lost to Follow-up|0|||
126311343|NCT02091375|454429727|FG001|Overall Study|Lost to Follow-up|1|||
126311344|NCT02091375|454429726|FG000|Overall Study|Withdrawal by Subject|0|||
126311345|NCT02091375|454429727|FG001|Overall Study|Withdrawal by Subject|1|||
126311346|NCT02091375|454429726|FG000|Overall Study|Withdrawn by the investigator|1|||
126311347|NCT02091375|454429727|FG001|Overall Study|Withdrawn by the investigator|0|||
126311348|NCT02682823|454429728|FG000|Overall Study|Withdrawal by Subject|0|||
126311349|NCT02682823|454429729|FG001|Overall Study|Withdrawal by Subject|0|||
126311350|NCT02682823|454429730|FG002|Overall Study|Withdrawal by Subject|1|||
126311351|NCT02682823|454429731|FG003|Overall Study|Withdrawal by Subject|0|||
126311352|NCT02682823|454429732|FG004|Overall Study|Withdrawal by Subject|1|||
126311353|NCT02682823|454429728|FG000|Overall Study|Protocol Deviation|0|||
126311354|NCT02682823|454429729|FG001|Overall Study|Protocol Deviation|1|||
126311355|NCT02682823|454429730|FG002|Overall Study|Protocol Deviation|0|||
126311356|NCT02682823|454429731|FG003|Overall Study|Protocol Deviation|0|||
126311357|NCT02682823|454429732|FG004|Overall Study|Protocol Deviation|0|||
126311358|NCT02682823|454429728|FG000|Overall Study|Adverse Event|0|||
126311359|NCT02682823|454429729|FG001|Overall Study|Adverse Event|0|||
126311360|NCT02682823|454429730|FG002|Overall Study|Adverse Event|0|||
126311361|NCT02682823|454429731|FG003|Overall Study|Adverse Event|1|||
126311362|NCT02682823|454429732|FG004|Overall Study|Adverse Event|0|||
126311363|NCT01938430|454429733|FG000|Overall Study|Randomized but Not Treated|0|||
126311364|NCT01938430|454429734|FG001|Overall Study|Randomized but Not Treated|0|||
126311365|NCT01938430|454429735|FG002|Overall Study|Randomized but Not Treated|0|||
126311366|NCT01938430|454429736|FG003|Overall Study|Randomized but Not Treated|0|||
126311367|NCT01938430|454429737|FG004|Overall Study|Randomized but Not Treated|0|||
126311368|NCT01938430|454429738|FG005|Overall Study|Randomized but Not Treated|0|||
126311369|NCT01938430|454429739|FG006|Overall Study|Randomized but Not Treated|0|||
126311370|NCT01938430|454429740|FG007|Overall Study|Randomized but Not Treated|0|||
126311371|NCT01938430|454429741|FG008|Overall Study|Randomized but Not Treated|0|||
126311372|NCT01938430|454429742|FG009|Overall Study|Randomized but Not Treated|0|||
126311373|NCT01938430|454429743|FG010|Overall Study|Randomized but Not Treated|1|||
126311374|NCT01938430|454429744|FG011|Overall Study|Randomized but Not Treated|0|||
126311375|NCT01938430|454429745|FG012|Overall Study|Randomized but Not Treated|0|||
126311376|NCT01938430|454429746|FG013|Overall Study|Randomized but Not Treated|1|||
126311377|NCT01938430|454429733|FG000|Overall Study|Adverse Event|0|||
126311378|NCT01938430|454429734|FG001|Overall Study|Adverse Event|0|||
126311379|NCT01938430|454429735|FG002|Overall Study|Adverse Event|0|||
126311380|NCT01938430|454429736|FG003|Overall Study|Adverse Event|0|||
126311381|NCT01938430|454429737|FG004|Overall Study|Adverse Event|0|||
126311382|NCT01938430|454429738|FG005|Overall Study|Adverse Event|0|||
126311383|NCT01938430|454429739|FG006|Overall Study|Adverse Event|1|||
126311384|NCT01938430|454429740|FG007|Overall Study|Adverse Event|0|||
126311385|NCT01938430|454429741|FG008|Overall Study|Adverse Event|0|||
126311386|NCT01938430|454429742|FG009|Overall Study|Adverse Event|0|||
126311387|NCT01938430|454429743|FG010|Overall Study|Adverse Event|0|||
126311388|NCT01938430|454429744|FG011|Overall Study|Adverse Event|0|||
126311389|NCT01938430|454429745|FG012|Overall Study|Adverse Event|0|||
126311390|NCT01938430|454429746|FG013|Overall Study|Adverse Event|0|||
126311391|NCT01938430|454429733|FG000|Overall Study|Death|1|||
126311392|NCT01938430|454429734|FG001|Overall Study|Death|2|||
126311393|NCT01938430|454429735|FG002|Overall Study|Death|2|||
126311394|NCT01938430|454429736|FG003|Overall Study|Death|1|||
126311395|NCT01938430|454429737|FG004|Overall Study|Death|0|||
126311396|NCT01938430|454429738|FG005|Overall Study|Death|0|||
126311397|NCT01938430|454429739|FG006|Overall Study|Death|1|||
126311398|NCT01938430|454429740|FG007|Overall Study|Death|1|||
126311399|NCT01938430|454429741|FG008|Overall Study|Death|2|||
126311400|NCT01938430|454429742|FG009|Overall Study|Death|3|||
126311401|NCT01938430|454429743|FG010|Overall Study|Death|0|||
126311402|NCT01938430|454429744|FG011|Overall Study|Death|0|||
126311403|NCT01938430|454429745|FG012|Overall Study|Death|0|||
126311404|NCT01938430|454429746|FG013|Overall Study|Death|0|||
126311405|NCT01938430|454429733|FG000|Overall Study|Investigator's Discretion|0|||
126311406|NCT01938430|454429734|FG001|Overall Study|Investigator's Discretion|0|||
126311407|NCT01938430|454429735|FG002|Overall Study|Investigator's Discretion|1|||
126311408|NCT01938430|454429736|FG003|Overall Study|Investigator's Discretion|0|||
126311409|NCT01938430|454429737|FG004|Overall Study|Investigator's Discretion|0|||
126311410|NCT01938430|454429738|FG005|Overall Study|Investigator's Discretion|0|||
126311411|NCT01938430|454429739|FG006|Overall Study|Investigator's Discretion|0|||
126311412|NCT01938430|454429740|FG007|Overall Study|Investigator's Discretion|0|||
126311413|NCT01938430|454429741|FG008|Overall Study|Investigator's Discretion|0|||
126311414|NCT01938430|454429742|FG009|Overall Study|Investigator's Discretion|0|||
126311415|NCT01938430|454429743|FG010|Overall Study|Investigator's Discretion|0|||
126311416|NCT01938430|454429744|FG011|Overall Study|Investigator's Discretion|0|||
126311417|NCT01938430|454429745|FG012|Overall Study|Investigator's Discretion|0|||
126311418|NCT01938430|454429746|FG013|Overall Study|Investigator's Discretion|0|||
126311419|NCT01938430|454429733|FG000|Overall Study|Lack of Efficacy|3|||
126311420|NCT01938430|454429734|FG001|Overall Study|Lack of Efficacy|1|||
126311421|NCT01938430|454429735|FG002|Overall Study|Lack of Efficacy|1|||
126311422|NCT01938430|454429736|FG003|Overall Study|Lack of Efficacy|1|||
126311423|NCT01938430|454429737|FG004|Overall Study|Lack of Efficacy|0|||
126311424|NCT01938430|454429738|FG005|Overall Study|Lack of Efficacy|0|||
126311425|NCT01938430|454429739|FG006|Overall Study|Lack of Efficacy|0|||
126311426|NCT01938430|454429740|FG007|Overall Study|Lack of Efficacy|0|||
126311427|NCT01938430|454429741|FG008|Overall Study|Lack of Efficacy|1|||
126311428|NCT01938430|454429742|FG009|Overall Study|Lack of Efficacy|0|||
126311429|NCT01938430|454429743|FG010|Overall Study|Lack of Efficacy|2|||
126311430|NCT01938430|454429744|FG011|Overall Study|Lack of Efficacy|1|||
126311431|NCT01938430|454429745|FG012|Overall Study|Lack of Efficacy|0|||
126311432|NCT01938430|454429746|FG013|Overall Study|Lack of Efficacy|0|||
126311433|NCT01938430|454429733|FG000|Overall Study|Lost to Follow-up|0|||
126311434|NCT01938430|454429734|FG001|Overall Study|Lost to Follow-up|0|||
126311435|NCT01938430|454429735|FG002|Overall Study|Lost to Follow-up|1|||
126311436|NCT01938430|454429736|FG003|Overall Study|Lost to Follow-up|0|||
126311437|NCT01938430|454429737|FG004|Overall Study|Lost to Follow-up|0|||
126311438|NCT01938430|454429738|FG005|Overall Study|Lost to Follow-up|1|||
126311439|NCT01938430|454429739|FG006|Overall Study|Lost to Follow-up|0|||
126311440|NCT01938430|454429740|FG007|Overall Study|Lost to Follow-up|0|||
126311441|NCT01938430|454429741|FG008|Overall Study|Lost to Follow-up|0|||
126311442|NCT01938430|454429742|FG009|Overall Study|Lost to Follow-up|0|||
126311443|NCT01938430|454429743|FG010|Overall Study|Lost to Follow-up|0|||
126311444|NCT01938430|454429744|FG011|Overall Study|Lost to Follow-up|0|||
126311445|NCT01938430|454429745|FG012|Overall Study|Lost to Follow-up|0|||
126311446|NCT01938430|454429746|FG013|Overall Study|Lost to Follow-up|0|||
126311447|NCT01938430|454429733|FG000|Overall Study|Withdrew Consent|0|||
126311448|NCT01938430|454429734|FG001|Overall Study|Withdrew Consent|0|||
126311449|NCT01938430|454429735|FG002|Overall Study|Withdrew Consent|0|||
126311450|NCT01938430|454429736|FG003|Overall Study|Withdrew Consent|0|||
126311451|NCT01938430|454429737|FG004|Overall Study|Withdrew Consent|0|||
126311452|NCT01938430|454429738|FG005|Overall Study|Withdrew Consent|0|||
126311453|NCT01938430|454429739|FG006|Overall Study|Withdrew Consent|0|||
126311454|NCT01938430|454429740|FG007|Overall Study|Withdrew Consent|0|||
126311455|NCT01938430|454429741|FG008|Overall Study|Withdrew Consent|1|||
126311456|NCT01938430|454429742|FG009|Overall Study|Withdrew Consent|0|||
126311457|NCT01938430|454429743|FG010|Overall Study|Withdrew Consent|0|||
126311458|NCT01938430|454429744|FG011|Overall Study|Withdrew Consent|0|||
126311459|NCT01938430|454429745|FG012|Overall Study|Withdrew Consent|0|||
126311460|NCT01938430|454429746|FG013|Overall Study|Withdrew Consent|0|||
126311461|NCT03875482|454429747|FG000|Overall Study|Adverse Event|0|||
126311462|NCT03875482|454429748|FG001|Overall Study|Adverse Event|1|||
126311463|NCT03875482|454429747|FG000|Overall Study|Withdrew consent|5|||
126311464|NCT03875482|454429748|FG001|Overall Study|Withdrew consent|6|||
126311465|NCT03875482|454429747|FG000|Overall Study|Lost to Follow-up|8|||
126311466|NCT03875482|454429748|FG001|Overall Study|Lost to Follow-up|2|||
126311467|NCT03875482|454429747|FG000|Overall Study|Lack of Efficacy|0|||
126311468|NCT03875482|454429748|FG001|Overall Study|Lack of Efficacy|11|||
126311469|NCT02738879|454429755|FG000|Overall Study|Adverse Event|1|||
126311470|NCT02738879|454429756|FG001|Overall Study|Adverse Event|1|||
126311471|NCT02738879|454429755|FG000|Overall Study|Death|0|||
126311472|NCT02738879|454429756|FG001|Overall Study|Death|2|||
126311473|NCT02738879|454429755|FG000|Overall Study|Lost to Follow-up|1|||
126311474|NCT02738879|454429756|FG001|Overall Study|Lost to Follow-up|5|||
126311475|NCT02738879|454429755|FG000|Overall Study|Protocol Violation|1|||
126311476|NCT02738879|454429756|FG001|Overall Study|Protocol Violation|3|||
126311477|NCT02738879|454429755|FG000|Overall Study|Physician Decision|3|||
126311478|NCT02738879|454429756|FG001|Overall Study|Physician Decision|4|||
126311479|NCT02738879|454429755|FG000|Overall Study|Pregnancy|0|||
126311480|NCT02738879|454429756|FG001|Overall Study|Pregnancy|1|||
126311481|NCT02738879|454429755|FG000|Overall Study|Screen Failure|1|||
126311482|NCT02738879|454429756|FG001|Overall Study|Screen Failure|2|||
126311483|NCT02738879|454429755|FG000|Overall Study|Site Discontinued Study Participation|1|||
126311484|NCT02738879|454429756|FG001|Overall Study|Site Discontinued Study Participation|0|||
126311485|NCT02738879|454429755|FG000|Overall Study|Withdrawal by Subject|5|||
126311486|NCT02738879|454429756|FG001|Overall Study|Withdrawal by Subject|7|||
126311487|NCT01438294|454429757|FG000|Overall Study|Lost to Follow-up|3|||
126533966|NCT02723864|455246697|FG003|Overall Study|Started new treatment|0|||
126311488|NCT01438294|454429758|FG001|Overall Study|Lost to Follow-up|7|||
126311489|NCT01346189|454429761|FG000|Overall Study|Withdrawal by Subject|7|||
126311490|NCT01346189|454429762|FG001|Overall Study|Withdrawal by Subject|5|||
126311491|NCT01346189|454429763|FG002|Overall Study|Withdrawal by Subject|3|||
126311492|NCT01346189|454429764|FG003|Overall Study|Withdrawal by Subject|5|||
126311493|NCT01346189|454429761|FG000|Overall Study|Physician Decision|4|||
126311494|NCT01346189|454429762|FG001|Overall Study|Physician Decision|0|||
126311495|NCT01346189|454429763|FG002|Overall Study|Physician Decision|0|||
126422354|NCT04640311|454842559|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422355|NCT04640311|454842560|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422356|NCT04640311|454842561|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422357|NCT04640311|454842562|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422358|NCT04640311|454842563|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422359|NCT04640311|454842564|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126311496|NCT01346189|454429764|FG003|Overall Study|Physician Decision|0|||
126311497|NCT01346189|454429761|FG000|Overall Study|Moved|3|||
126311498|NCT01346189|454429762|FG001|Overall Study|Moved|0|||
126422360|NCT04640311|454842565|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422361|NCT04640311|454842566|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
126422362|NCT04640311|454842567|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
126422363|NCT00592904|454842568|FG000|Overall Study|Adverse Event|15|||
126422364|NCT00592904|454842569|FG001|Overall Study|Adverse Event|25|||
126422365|NCT00592904|454842570|FG002|Overall Study|Adverse Event|13|||
126422366|NCT00592904|454842571|FG003|Overall Study|Adverse Event|5|||
126422367|NCT00592904|454842568|FG000|Overall Study|Protocol Violation|1|||
126422368|NCT00592904|454842569|FG001|Overall Study|Protocol Violation|1|||
126422369|NCT00592904|454842570|FG002|Overall Study|Protocol Violation|0|||
126422370|NCT00592904|454842571|FG003|Overall Study|Protocol Violation|1|||
126422371|NCT00592904|454842568|FG000|Overall Study|Withdrawal by Subject|4|||
126422372|NCT00592904|454842569|FG001|Overall Study|Withdrawal by Subject|16|||
126422373|NCT00592904|454842570|FG002|Overall Study|Withdrawal by Subject|1|||
126422374|NCT00592904|454842571|FG003|Overall Study|Withdrawal by Subject|2|||
126422375|NCT00592904|454842568|FG000|Overall Study|Lack of Efficacy|2|||
126422376|NCT00592904|454842569|FG001|Overall Study|Lack of Efficacy|7|||
126422377|NCT00592904|454842570|FG002|Overall Study|Lack of Efficacy|2|||
126422378|NCT00592904|454842571|FG003|Overall Study|Lack of Efficacy|3|||
126422379|NCT00592904|454842568|FG000|Overall Study|Physician Decision|0|||
126422380|NCT00592904|454842569|FG001|Overall Study|Physician Decision|3|||
126422381|NCT00592904|454842570|FG002|Overall Study|Physician Decision|1|||
126422382|NCT00592904|454842571|FG003|Overall Study|Physician Decision|0|||
126422383|NCT00592904|454842568|FG000|Overall Study|Other|3|||
126422384|NCT00592904|454842569|FG001|Overall Study|Other|3|||
126422385|NCT00592904|454842570|FG002|Overall Study|Other|0|||
126422386|NCT00592904|454842571|FG003|Overall Study|Other|0|||
126422387|NCT03191630|454842572|FG000|Overall Study|Lost to Follow-up|7|||
126757584|NCT02041533|456062717|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
126311499|NCT01346189|454429763|FG002|Overall Study|Moved|4|||
126311500|NCT01346189|454429764|FG003|Overall Study|Moved|0|||
126311501|NCT01346189|454429761|FG000|Overall Study|Other|2|||
126311502|NCT01346189|454429762|FG001|Overall Study|Other|4|||
126311503|NCT01346189|454429763|FG002|Overall Study|Other|7|||
126311504|NCT01346189|454429764|FG003|Overall Study|Other|3|||
126311505|NCT01346189|454429761|FG000|Overall Study|Death|0|||
126311506|NCT01346189|454429762|FG001|Overall Study|Death|3|||
126311507|NCT01346189|454429763|FG002|Overall Study|Death|0|||
126311508|NCT01346189|454429764|FG003|Overall Study|Death|0|||
126311509|NCT01346189|454429761|FG000|Overall Study|Non-health system primary care physician|0|||
126311510|NCT01346189|454429762|FG001|Overall Study|Non-health system primary care physician|5|||
126311511|NCT01346189|454429763|FG002|Overall Study|Non-health system primary care physician|0|||
126311512|NCT01346189|454429764|FG003|Overall Study|Non-health system primary care physician|0|||
126311513|NCT01346189|454429761|FG000|Overall Study|Travel|0|||
126311514|NCT01346189|454429762|FG001|Overall Study|Travel|0|||
126311515|NCT01346189|454429763|FG002|Overall Study|Travel|0|||
126311516|NCT01346189|454429764|FG003|Overall Study|Travel|3|||
126311517|NCT01730534|454429766|FG000|Overall Study|Withdrawal by Subject|97|||
126311518|NCT01730534|454429767|FG001|Overall Study|Withdrawal by Subject|127|||
126311519|NCT01730534|454429766|FG000|Overall Study|Lost to Follow-up|12|||
126311520|NCT01730534|454429767|FG001|Overall Study|Lost to Follow-up|18|||
126311521|NCT02256982|454429768|FG000|Overall Study|Disease Progression|0|||
126311522|NCT02256982|454429769|FG001|Overall Study|Disease Progression|1|||
126311523|NCT02658734|454429772|FG000|Overall Study|Adverse Event|2|||
126311524|NCT02658734|454429772|FG000|Overall Study|Death|4|||
126311525|NCT02658734|454429772|FG000|Overall Study|Lost to Follow-up|7|||
126311526|NCT02658734|454429772|FG000|Overall Study|Withdrawal of Consent|16|||
126311527|NCT02658734|454429772|FG000|Overall Study|Disease Progression|28|||
126311528|NCT00459706|454429773|FG000|Overall Study|Adverse Event|19|||
126311529|NCT00459706|454429774|FG001|Overall Study|Adverse Event|13|||
126422388|NCT03191630|454842573|FG001|Overall Study|Lost to Follow-up|7|||
126422389|NCT01367834|454842580|FG000|Overall Study|Withdrawal by Subject|2|||
126422390|NCT01367834|454842581|FG001|Overall Study|Withdrawal by Subject|2|||
126422391|NCT01367834|454842580|FG000|Overall Study|Study was ended.|0|||
126422392|NCT01367834|454842581|FG001|Overall Study|Study was ended.|1|||
126311530|NCT00459706|454429773|FG000|Overall Study|Withdrawal by Subject|1|||
126311531|NCT00459706|454429774|FG001|Overall Study|Withdrawal by Subject|6|||
126311532|NCT00459706|454429773|FG000|Overall Study|Physician Decision|2|||
126311533|NCT00459706|454429774|FG001|Overall Study|Physician Decision|0|||
126311534|NCT00459706|454429773|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
126311535|NCT00459706|454429774|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
126311536|NCT00459706|454429773|FG000|Overall Study|Protocol Violation|2|||
126311537|NCT00459706|454429774|FG001|Overall Study|Protocol Violation|1|||
126311538|NCT00459706|454429773|FG000|Overall Study|Failed to Return|1|||
126311539|NCT00459706|454429774|FG001|Overall Study|Failed to Return|0|||
126311540|NCT00459706|454429773|FG000|Overall Study|Other|0|||
126311541|NCT00459706|454429774|FG001|Overall Study|Other|1|||
126311542|NCT03843632|454429778|FG000|Overall Study|Withdrawal by Subject|1|||
126311543|NCT03843632|454429779|FG001|Overall Study|Withdrawal by Subject|0|||
126311544|NCT03843632|454429780|FG002|Overall Study|Withdrawal by Subject|0|||
126311545|NCT03843632|454429781|FG003|Overall Study|Withdrawal by Subject|0|||
126311546|NCT05036668|454429785|FG000|Overall Study|lost to follow Up|0|||
126311547|NCT05036668|454429786|FG001|Overall Study|lost to follow Up|0|||
126311548|NCT05036668|454429787|FG002|Overall Study|lost to follow Up|1|||
126311549|NCT01190267|454429790|FG000|Overall Study|Adverse Event|10|||
126311550|NCT01190267|454429791|FG001|Overall Study|Adverse Event|0|||
126311551|NCT01190267|454429790|FG000|Overall Study|Treatment Failure|8|||
126311552|NCT01190267|454429791|FG001|Overall Study|Treatment Failure|2|||
126311553|NCT01190267|454429790|FG000|Overall Study|Lost to Follow-up|2|||
126311554|NCT01190267|454429791|FG001|Overall Study|Lost to Follow-up|0|||
126311555|NCT01190267|454429790|FG000|Overall Study|Withdrawal by Subject|13|||
126311556|NCT01190267|454429791|FG001|Overall Study|Withdrawal by Subject|1|||
126311557|NCT01190267|454429790|FG000|Overall Study|Protocol Violation|8|||
126311558|NCT01190267|454429791|FG001|Overall Study|Protocol Violation|1|||
126311559|NCT01901653|454429797|FG000|Overall Study|Death|2|||
126311560|NCT01901653|454429798|FG001|Overall Study|Death|1|||
126757585|NCT02041533|456062718|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
126757586|NCT02041533|456062717|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
126757587|NCT02041533|456062718|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
126757588|NCT02041533|456062717|FG000|Treatment Period|Disease progression|189|||
126757589|NCT02041533|456062718|FG001|Treatment Period|Disease progression|146|||
126757590|NCT02041533|456062717|FG000|Treatment Period|Study drug toxicity|30|||
126757591|NCT02041533|456062718|FG001|Treatment Period|Study drug toxicity|34|||
126757592|NCT02041533|456062717|FG000|Treatment Period|Death|1|||
126757593|NCT02041533|456062718|FG001|Treatment Period|Death|0|||
126757594|NCT02041533|456062717|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
126757595|NCT02041533|456062718|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
126757596|NCT02041533|456062717|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
126757597|NCT02041533|456062718|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
126757598|NCT02041533|456062717|FG000|Treatment Period|Participant withdrew consent|2|||
126757599|NCT02041533|456062718|FG001|Treatment Period|Participant withdrew consent|2|||
126757600|NCT02041533|456062717|FG000|Treatment Period|Maximum clinical benefit|0|||
126757601|NCT02041533|456062718|FG001|Treatment Period|Maximum clinical benefit|18|||
126757602|NCT02041533|456062717|FG000|Treatment Period|Poor/Non-compliance|1|||
126757603|NCT02041533|456062718|FG001|Treatment Period|Poor/Non-compliance|0|||
126757604|NCT02041533|456062717|FG000|Treatment Period|Administrative reason by sponsor|1|||
126757605|NCT02041533|456062718|FG001|Treatment Period|Administrative reason by sponsor|0|||
126757606|NCT02041533|456062717|FG000|Treatment Period|Other reasons|9|||
126757607|NCT02041533|456062718|FG001|Treatment Period|Other reasons|2|||
126757608|NCT02041533|456062717|FG000|Treatment Period|Not Reported|0|||
126757609|NCT02041533|456062718|FG001|Treatment Period|Not Reported|1|||
126757610|NCT02117024|456062719|FG000|Overall Study|Progressive Disease|26|||
126757611|NCT02117024|456062720|FG001|Overall Study|Progressive Disease|9|||
126757612|NCT02117024|456062719|FG000|Overall Study|Significant Clinical Progression|7|||
126757613|NCT02117024|456062720|FG001|Overall Study|Significant Clinical Progression|4|||
126757614|NCT02117024|456062719|FG000|Overall Study|Death|5|||
126757615|NCT02117024|456062720|FG001|Overall Study|Death|0|||
126757616|NCT02117024|456062719|FG000|Overall Study|Withdrawal by Subject|3|||
126757617|NCT02117024|456062720|FG001|Overall Study|Withdrawal by Subject|1|||
126757618|NCT02117024|456062719|FG000|Overall Study|Protocol Violation|1|||
126757619|NCT02117024|456062720|FG001|Overall Study|Protocol Violation|0|||
126757620|NCT02117024|456062719|FG000|Overall Study|Adverse Event|1|||
126757621|NCT02117024|456062720|FG001|Overall Study|Adverse Event|2|||
126757622|NCT02117024|456062719|FG000|Overall Study|Randomized in Error|1|||
126757623|NCT02117024|456062720|FG001|Overall Study|Randomized in Error|0|||
126533967|NCT02723864|455246698|FG004|Overall Study|Started new treatment|0|||
126533968|NCT02723864|455246699|FG005|Overall Study|Started new treatment|1|||
126757624|NCT02117024|456062719|FG000|Overall Study|Patient returned to primary oncologist|0|||
126757625|NCT02117024|456062720|FG001|Overall Study|Patient returned to primary oncologist|1|||
126757626|NCT02117024|456062719|FG000|Overall Study|Patient took treatment break|0|||
126757627|NCT02117024|456062720|FG001|Overall Study|Patient took treatment break|1|||
126311561|NCT01901653|454429799|FG002|Overall Study|Death|8|||
126311562|NCT01901653|454429800|FG003|Overall Study|Death|3|||
126311563|NCT01901653|454429801|FG004|Overall Study|Death|2|||
126311564|NCT01901653|454429802|FG005|Overall Study|Death|2|||
126311565|NCT01901653|454429803|FG006|Overall Study|Death|6|||
126757628|NCT02117024|456062719|FG000|Overall Study|Physician Decision|0|||
126757629|NCT02117024|456062720|FG001|Overall Study|Physician Decision|2|||
126757630|NCT00565721|456062723|FG000|Overall Study|Screen Failure|2|||
126757631|NCT00565721|456062723|FG000|Overall Study|Lost to Follow-up|6|||
126757632|NCT00565721|456062723|FG000|Overall Study|Technical Problems|1|||
126757633|NCT00565721|456062723|FG000|Overall Study|Physician Decision|2|||
126757634|NCT00565721|456062723|FG000|Overall Study|Other reasons|6|||
126757635|NCT02813681|456062724|FG000|Overall Study|Physician Decision|5|||
126757636|NCT02813681|456062725|FG001|Overall Study|Physician Decision|5|||
126311566|NCT01901653|454429804|FG007|Overall Study|Death|9|||
126422393|NCT01020786|454842586|FG000|Induction Period|Entry Criteria Not Met|2|||
126422394|NCT01020786|454842586|FG000|Induction Period|Adverse Event|10|||
126422395|NCT01020786|454842586|FG000|Induction Period|Progressive Disease|31|||
126422396|NCT01020786|454842586|FG000|Induction Period|Investigator Decision|3|||
126422397|NCT01020786|454842586|FG000|Induction Period|Withdrawal by Subject|3|||
126422398|NCT01020786|454842586|FG000|Maintenance Period|Adverse Event|8|||
126533969|NCT02723864|455246700|FG006|Overall Study|Started new treatment|0|||
126533970|NCT02723864|455246694|FG000|Overall Study|Switched to alternative treatment|0|||
126533971|NCT02723864|455246695|FG001|Overall Study|Switched to alternative treatment|0|||
126533972|NCT02723864|455246696|FG002|Overall Study|Switched to alternative treatment|0|||
126533973|NCT02723864|455246697|FG003|Overall Study|Switched to alternative treatment|0|||
126533974|NCT02723864|455246698|FG004|Overall Study|Switched to alternative treatment|0|||
126533975|NCT02723864|455246699|FG005|Overall Study|Switched to alternative treatment|1|||
126533976|NCT02723864|455246700|FG006|Overall Study|Switched to alternative treatment|0|||
126533977|NCT02723864|455246694|FG000|Overall Study|Late determination of ineligibility|0|||
126533978|NCT02723864|455246695|FG001|Overall Study|Late determination of ineligibility|0|||
126533979|NCT02723864|455246696|FG002|Overall Study|Late determination of ineligibility|0|||
126533980|NCT02723864|455246697|FG003|Overall Study|Late determination of ineligibility|0|||
126533981|NCT02723864|455246698|FG004|Overall Study|Late determination of ineligibility|0|||
126533982|NCT02723864|455246699|FG005|Overall Study|Late determination of ineligibility|1|||
126533983|NCT02723864|455246700|FG006|Overall Study|Late determination of ineligibility|0|||
126533984|NCT02548455|455246701|FG000|Overall Study|Withdrawal by Subject|27|||
126533985|NCT02548455|455246701|FG000|Overall Study|Death|26|||
126533986|NCT02548455|455246701|FG000|Overall Study|Lost to Follow-up|14|||
126533987|NCT02548455|455246701|FG000|Overall Study|Visit not completed|173|||
126533988|NCT02261493|455246702|FG000|Overall Study|Noncompliance|0|||
126533989|NCT02261493|455246703|FG001|Overall Study|Noncompliance|0|||
126533990|NCT02261493|455246704|FG002|Overall Study|Noncompliance|2|||
126533991|NCT02261493|455246702|FG000|Overall Study|Physician Decision|0|||
126533992|NCT02261493|455246703|FG001|Overall Study|Physician Decision|1|||
126533993|NCT02261493|455246704|FG002|Overall Study|Physician Decision|0|||
126533994|NCT02261493|455246702|FG000|Overall Study|Undisclosed alcohol abuse|0|||
126533995|NCT02261493|455246703|FG001|Overall Study|Undisclosed alcohol abuse|1|||
126533996|NCT02261493|455246704|FG002|Overall Study|Undisclosed alcohol abuse|0|||
126533997|NCT02261493|455246702|FG000|Overall Study|Protocol Violation|1|||
126533998|NCT02261493|455246703|FG001|Overall Study|Protocol Violation|0|||
126533999|NCT02261493|455246704|FG002|Overall Study|Protocol Violation|0|||
126534000|NCT02261493|455246702|FG000|Overall Study|Personal Reasons|14|||
126534001|NCT02261493|455246703|FG001|Overall Study|Personal Reasons|14|||
126534002|NCT02261493|455246704|FG002|Overall Study|Personal Reasons|16|||
126534003|NCT02261493|455246702|FG000|Overall Study|Lost to Follow-up|14|||
126534004|NCT02261493|455246703|FG001|Overall Study|Lost to Follow-up|27|||
126534005|NCT02261493|455246704|FG002|Overall Study|Lost to Follow-up|8|||
126534006|NCT02261493|455246702|FG000|Overall Study|Pregnancy|1|||
126534007|NCT02261493|455246703|FG001|Overall Study|Pregnancy|2|||
126534008|NCT02261493|455246704|FG002|Overall Study|Pregnancy|0|||
126534009|NCT02261493|455246702|FG000|Overall Study|Lack of Efficacy|0|||
126534010|NCT02261493|455246703|FG001|Overall Study|Lack of Efficacy|1|||
126422399|NCT01020786|454842586|FG000|Maintenance Period|Progressive Disease|43|||
126534011|NCT02261493|455246704|FG002|Overall Study|Lack of Efficacy|0|||
126534012|NCT02261493|455246702|FG000|Overall Study|Adverse Event|0|||
126534013|NCT02261493|455246703|FG001|Overall Study|Adverse Event|1|||
126534014|NCT02261493|455246704|FG002|Overall Study|Adverse Event|0|||
126534015|NCT02436330|455246706|FG000|Cohort 1|Lost to Follow-up|5|||
126534016|NCT02436330|455246707|FG001|Cohort 1|Lost to Follow-up|2|||
126534017|NCT02436330|455246706|FG000|Cohort 1|Withdrawal by Subject|0|||
126534018|NCT02436330|455246707|FG001|Cohort 1|Withdrawal by Subject|1|||
126534019|NCT02436330|455246706|FG000|Cohort 2|Lost to Follow-up|2|||
126757637|NCT02813681|456062726|FG002|Overall Study|Physician Decision|0|||
126757638|NCT02813681|456062724|FG000|Overall Study|Lost to Follow-up|0|||
126757639|NCT02813681|456062725|FG001|Overall Study|Lost to Follow-up|1|||
126757640|NCT02813681|456062726|FG002|Overall Study|Lost to Follow-up|0|||
126757641|NCT02500706|456062727|FG000|Overall Study|Adverse Event|0|||
126757642|NCT02500706|456062728|FG001|Overall Study|Adverse Event|0|||
126757643|NCT02500706|456062729|FG002|Overall Study|Adverse Event|1|||
126757644|NCT02500706|456062727|FG000|Overall Study|Lost to Follow-up|0|||
126757645|NCT02500706|456062728|FG001|Overall Study|Lost to Follow-up|1|||
126757646|NCT02500706|456062729|FG002|Overall Study|Lost to Follow-up|1|||
126770364|NCT02756078|456112461|FG000|Period 1|Lens Discomfort|2|||
126534020|NCT02436330|455246707|FG001|Cohort 2|Lost to Follow-up|0|||
126534021|NCT02436330|455246706|FG000|Cohort 2|Withdrawal by Subject|2|||
126534022|NCT02436330|455246707|FG001|Cohort 2|Withdrawal by Subject|3|||
126534023|NCT02436330|455246706|FG000|Cohort 3|Lost to Follow-up|1|||
126534024|NCT02436330|455246707|FG001|Cohort 3|Lost to Follow-up|0|||
126534025|NCT02436330|455246706|FG000|Cohort 3|Withdrawal by Subject|4|||
126757647|NCT02500706|456062727|FG000|Overall Study|Withdrawal by Subject|4|||
126757648|NCT02500706|456062728|FG001|Overall Study|Withdrawal by Subject|6|||
126757649|NCT02500706|456062729|FG002|Overall Study|Withdrawal by Subject|4|||
126757650|NCT02500706|456062727|FG000|Overall Study|Unclassified|0|||
126757651|NCT02500706|456062728|FG001|Overall Study|Unclassified|0|||
126757652|NCT02500706|456062729|FG002|Overall Study|Unclassified|1|||
126757653|NCT00529152|456062730|FG000|Overall Study|Adverse Event|2|||
126311567|NCT01901653|454429805|FG008|Overall Study|Death|1|||
126311568|NCT01901653|454429806|FG009|Overall Study|Death|16|||
126311569|NCT01901653|454429807|FG010|Overall Study|Death|2|||
126311570|NCT01901653|454429808|FG011|Overall Study|Death|15|||
126422400|NCT01020786|454842586|FG000|Maintenance Period|Withdrawal by Subject|8|||
126422401|NCT01020786|454842586|FG000|Maintenance Period|Sponsor Decision|1|||
126422402|NCT01818596|454842595|FG000|Overall Study|Enrolled but Not Treated|4|||
126422403|NCT01818596|454842596|FG001|Overall Study|Enrolled but Not Treated|0|||
126422404|NCT01818596|454842595|FG000|Overall Study|Adverse Event|7|||
126422405|NCT01818596|454842596|FG001|Overall Study|Adverse Event|0|||
126422406|NCT01818596|454842595|FG000|Overall Study|Death|3|||
126422407|NCT01818596|454842596|FG001|Overall Study|Death|0|||
126422408|NCT01818596|454842595|FG000|Overall Study|Investigator's Discretion|4|||
126422409|NCT01818596|454842596|FG001|Overall Study|Investigator's Discretion|0|||
126422410|NCT01818596|454842595|FG000|Overall Study|Protocol Violation|1|||
126422411|NCT01818596|454842596|FG001|Overall Study|Protocol Violation|0|||
126422412|NCT01818596|454842595|FG000|Overall Study|Withdrew Consent|5|||
126422413|NCT01818596|454842596|FG001|Overall Study|Withdrew Consent|0|||
126422414|NCT01818596|454842595|FG000|Overall Study|Lost to Follow-up|7|||
126422415|NCT01818596|454842596|FG001|Overall Study|Lost to Follow-up|0|||
126422416|NCT03801174|454842597|FG000|Overall Study|Withdrawal by Subject|14|||
126422417|NCT03801174|454842598|FG001|Overall Study|Withdrawal by Subject|15|||
126422418|NCT03801174|454842597|FG000|Overall Study|Death|1|||
126422419|NCT03801174|454842598|FG001|Overall Study|Death|0|||
126422420|NCT03801174|454842597|FG000|Overall Study|Pregnancy|2|||
126422421|NCT03801174|454842598|FG001|Overall Study|Pregnancy|2|||
126422422|NCT03801174|454842597|FG000|Overall Study|Lost to Follow-up|19|||
126422423|NCT03801174|454842598|FG001|Overall Study|Lost to Follow-up|10|||
126422424|NCT03801174|454842597|FG000|Overall Study|Other|4|||
126422425|NCT03801174|454842598|FG001|Overall Study|Other|3|||
126422426|NCT03801174|454842597|FG000|Overall Study|Lack of Efficacy|4|||
126422427|NCT03801174|454842598|FG001|Overall Study|Lack of Efficacy|0|||
126422428|NCT03801174|454842597|FG000|Overall Study|Unwilling to complete activities|5|||
126422429|NCT03801174|454842598|FG001|Overall Study|Unwilling to complete activities|6|||
126422430|NCT03801174|454842597|FG000|Overall Study|Moved out of area|3|||
126422431|NCT03801174|454842598|FG001|Overall Study|Moved out of area|0|||
126311571|NCT01901653|454429809|FG012|Overall Study|Death|4|||
126311572|NCT01901653|454429797|FG000|Overall Study|Lost to Follow-up|1|||
126311573|NCT01901653|454429798|FG001|Overall Study|Lost to Follow-up|0|||
126311574|NCT01901653|454429799|FG002|Overall Study|Lost to Follow-up|2|||
126311575|NCT01901653|454429800|FG003|Overall Study|Lost to Follow-up|0|||
126311576|NCT01901653|454429801|FG004|Overall Study|Lost to Follow-up|0|||
126311577|NCT01901653|454429802|FG005|Overall Study|Lost to Follow-up|1|||
126311578|NCT01901653|454429803|FG006|Overall Study|Lost to Follow-up|0|||
126311579|NCT01901653|454429804|FG007|Overall Study|Lost to Follow-up|1|||
126311580|NCT01901653|454429805|FG008|Overall Study|Lost to Follow-up|0|||
126311581|NCT01901653|454429806|FG009|Overall Study|Lost to Follow-up|0|||
126311582|NCT01901653|454429807|FG010|Overall Study|Lost to Follow-up|0|||
126311583|NCT01901653|454429808|FG011|Overall Study|Lost to Follow-up|0|||
126311584|NCT01901653|454429809|FG012|Overall Study|Lost to Follow-up|0|||
126422432|NCT02915263|454842611|FG000|Overall Study|Covid|3|||
126422433|NCT02915263|454842612|FG001|Overall Study|Covid|2|||
126422434|NCT01879683|454842613|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
126534026|NCT02436330|455246707|FG001|Cohort 3|Withdrawal by Subject|0|||
126534027|NCT02436330|455246706|FG000|Cohort 4|Lost to Follow-up|1|||
126422435|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Progressive disease|50|||
126422436|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Progressive disease|110|||
126422437|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Progressive disease|0|||
126422438|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Progressive disease|0|||
126422439|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
126422440|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
126534028|NCT02436330|455246707|FG001|Cohort 4|Lost to Follow-up|0|||
126534029|NCT02436330|455246706|FG000|Cohort 4|Withdrawal by Subject|1|||
126757654|NCT00529152|456062730|FG000|Overall Study|Withdrawal by Subject|2|||
126311585|NCT01901653|454429797|FG000|Overall Study|Withdrawal by Subject|0|||
126311586|NCT01901653|454429798|FG001|Overall Study|Withdrawal by Subject|0|||
126757655|NCT00529152|456062730|FG000|Overall Study|Lost to Follow-up|1|||
126422441|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126422442|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126422443|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Adverse Event|7|||
126422444|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Adverse Event|7|||
126422445|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Adverse Event|0|||
126422446|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Adverse Event|0|||
126422447|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Other|1|||
126422448|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Other|3|||
126422449|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Other|0|||
126534030|NCT02436330|455246707|FG001|Cohort 4|Withdrawal by Subject|0|||
126534031|NCT02436330|455246706|FG000|Cohort 5|Lost to Follow-up|3|||
126534032|NCT02436330|455246707|FG001|Cohort 5|Lost to Follow-up|2|||
126534033|NCT02436330|455246706|FG000|Cohort 5|Withdrawal by Subject|3|||
126534034|NCT02436330|455246707|FG001|Cohort 5|Withdrawal by Subject|2|||
126534035|NCT02436330|455246706|FG000|Cohort 6|Lost to Follow-up|2|||
126534036|NCT02436330|455246707|FG001|Cohort 6|Lost to Follow-up|0|||
126534037|NCT02436330|455246706|FG000|Cohort 6|Withdrawal by Subject|1|||
126534038|NCT02436330|455246707|FG001|Cohort 6|Withdrawal by Subject|1|||
126534039|NCT05711641|455246713|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
126534040|NCT05711641|455246714|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
126534041|NCT05711641|455246713|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
126534042|NCT05711641|455246714|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
126534043|NCT00162370|455246715|FG000|Efficacy Population|Lost to Follow-up|51|||
126534044|NCT04575051|455246716|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
126534045|NCT04575051|455246717|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
126534046|NCT04575051|455246718|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
126534047|NCT04575051|455246719|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
126534048|NCT04575051|455246720|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
126534049|NCT04575051|455246716|FG000|Time Period 1|Missing follow up|1|||
126534050|NCT04575051|455246717|FG001|Time Period 1|Missing follow up|3|||
126534051|NCT04575051|455246718|FG002|Time Period 1|Missing follow up|1|||
126534052|NCT04575051|455246719|FG003|Time Period 1|Missing follow up|3|||
126534053|NCT04575051|455246720|FG004|Time Period 1|Missing follow up|2|||
126534054|NCT04575051|455246716|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
126534055|NCT04575051|455246717|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
126534056|NCT04575051|455246718|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
126534057|NCT04575051|455246719|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
126534058|NCT04575051|455246720|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
126534059|NCT04575051|455246716|FG000|Time Period 2|Missing follow up|1|||
126534060|NCT04575051|455246717|FG001|Time Period 2|Missing follow up|8|||
126534061|NCT04575051|455246718|FG002|Time Period 2|Missing follow up|7|||
126534062|NCT04575051|455246719|FG003|Time Period 2|Missing follow up|0|||
126534063|NCT04575051|455246720|FG004|Time Period 2|Missing follow up|1|||
126534064|NCT04575051|455246716|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
126534065|NCT04575051|455246717|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
126534066|NCT04575051|455246718|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
126534067|NCT04575051|455246719|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
126534068|NCT04575051|455246720|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
126534069|NCT04575051|455246716|FG000|Time Period 3|Missing follow up|8|||
126534070|NCT04575051|455246717|FG001|Time Period 3|Missing follow up|6|||
126534071|NCT04575051|455246718|FG002|Time Period 3|Missing follow up|4|||
126534072|NCT04575051|455246719|FG003|Time Period 3|Missing follow up|3|||
126534073|NCT04575051|455246720|FG004|Time Period 3|Missing follow up|0|||
126534074|NCT04575051|455246716|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
126534075|NCT04575051|455246717|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
126534076|NCT04575051|455246718|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
126534077|NCT04575051|455246719|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
126534078|NCT04575051|455246720|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
126534079|NCT04575051|455246716|FG000|Time Period 4|Missing follow up|17|||
126534080|NCT04575051|455246717|FG001|Time Period 4|Missing follow up|3|||
126422450|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Other|0|||
126534081|NCT04575051|455246718|FG002|Time Period 4|Missing follow up|4|||
126534082|NCT04575051|455246719|FG003|Time Period 4|Missing follow up|2|||
126534083|NCT04575051|455246720|FG004|Time Period 4|Missing follow up|1|||
126534084|NCT04575051|455246716|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
126534085|NCT04575051|455246717|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
126534086|NCT04575051|455246718|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
126422451|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Physician Decision|6|||
126311587|NCT01901653|454429799|FG002|Overall Study|Withdrawal by Subject|0|||
126422452|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Physician Decision|3|||
126422453|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Physician Decision|0|||
126422454|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Physician Decision|0|||
126422455|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Death|1|||
126422456|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Death|1|||
126422457|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Death|0|||
126422458|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Death|0|||
126422459|NCT01695135|454842614|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
126422460|NCT01695135|454842615|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
126422461|NCT01695135|454842616|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
126422462|NCT01695135|454842617|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
126422463|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
126422464|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
126422465|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
126422466|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
126422467|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
126422468|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
126422469|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
126422470|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
126422471|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
126422472|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
126422473|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
126422474|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
126422475|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Other|0|||
126422476|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Other|0|||
126422477|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Other|4|||
126311588|NCT01901653|454429800|FG003|Overall Study|Withdrawal by Subject|0|||
126311589|NCT01901653|454429801|FG004|Overall Study|Withdrawal by Subject|0|||
126311590|NCT01901653|454429802|FG005|Overall Study|Withdrawal by Subject|0|||
126422478|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Other|7|||
126422479|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
126422480|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
126422481|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
126422482|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
126422483|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Death|0|||
126422484|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Death|0|||
126422485|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Death|2|||
126422486|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Death|7|||
126422487|NCT01695135|454842614|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
126422488|NCT01695135|454842615|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
126534087|NCT04575051|455246719|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
126534088|NCT04575051|455246720|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
126534089|NCT04575051|455246716|FG000|Time Period 5|Missing follow up|11|||
126534090|NCT04575051|455246717|FG001|Time Period 5|Missing follow up|8|||
126534091|NCT04575051|455246718|FG002|Time Period 5|Missing follow up|12|||
126534092|NCT04575051|455246719|FG003|Time Period 5|Missing follow up|3|||
126534093|NCT04575051|455246720|FG004|Time Period 5|Missing follow up|11|||
126534094|NCT03624504|455246721|FG000|Overall Study|Unsuccessful Implant|1|||
126534095|NCT02862457|455246722|FG000|Overall Study|Death|1|||
126534096|NCT02862457|455246723|FG001|Overall Study|Death|3|||
126534097|NCT02862457|455246724|FG002|Overall Study|Death|2|||
126534098|NCT02862457|455246725|FG003|Overall Study|Death|3|||
126534099|NCT02862457|455246726|FG004|Overall Study|Death|0|||
126534100|NCT02862457|455246727|FG005|Overall Study|Death|2|||
126534101|NCT02862457|455246728|FG006|Overall Study|Death|1|||
126534102|NCT02862457|455246722|FG000|Overall Study|Lost to Follow-up|1|||
126534103|NCT02862457|455246723|FG001|Overall Study|Lost to Follow-up|0|||
126534104|NCT02862457|455246724|FG002|Overall Study|Lost to Follow-up|0|||
126534105|NCT02862457|455246725|FG003|Overall Study|Lost to Follow-up|1|||
126534106|NCT02862457|455246726|FG004|Overall Study|Lost to Follow-up|0|||
126534107|NCT02862457|455246727|FG005|Overall Study|Lost to Follow-up|0|||
126534108|NCT02862457|455246728|FG006|Overall Study|Lost to Follow-up|0|||
126534109|NCT02862457|455246722|FG000|Overall Study|Withdrawal by Subject|0|||
126534110|NCT02862457|455246723|FG001|Overall Study|Withdrawal by Subject|0|||
126534111|NCT02862457|455246724|FG002|Overall Study|Withdrawal by Subject|1|||
126534112|NCT02862457|455246725|FG003|Overall Study|Withdrawal by Subject|0|||
126311591|NCT01901653|454429803|FG006|Overall Study|Withdrawal by Subject|1|||
126311592|NCT01901653|454429804|FG007|Overall Study|Withdrawal by Subject|0|||
126311593|NCT01901653|454429805|FG008|Overall Study|Withdrawal by Subject|0|||
126311594|NCT01901653|454429806|FG009|Overall Study|Withdrawal by Subject|0|||
126534113|NCT02862457|455246726|FG004|Overall Study|Withdrawal by Subject|0|||
126534114|NCT02862457|455246727|FG005|Overall Study|Withdrawal by Subject|1|||
126534115|NCT02862457|455246728|FG006|Overall Study|Withdrawal by Subject|0|||
126534116|NCT01328080|455246731|FG000|Overall Study|Lost to Follow-up|5|||
126534117|NCT00862134|455246732|FG000|Overall Study|Death|1|||
126534118|NCT00862134|455246733|FG001|Overall Study|Death|0|||
126534119|NCT00862134|455246732|FG000|Overall Study|Physician Decision|0|||
126534120|NCT00862134|455246733|FG001|Overall Study|Physician Decision|1|||
126534121|NCT00862134|455246732|FG000|Overall Study|Withdrawal by Subject|1|||
126534122|NCT00862134|455246733|FG001|Overall Study|Withdrawal by Subject|2|||
126534123|NCT00862134|455246732|FG000|Overall Study|Sponsor terminated study|5|||
126534124|NCT00862134|455246733|FG001|Overall Study|Sponsor terminated study|7|||
126534125|NCT00862134|455246732|FG000|Overall Study|Adverse Event|2|||
126534126|NCT00862134|455246733|FG001|Overall Study|Adverse Event|2|||
126534127|NCT00862134|455246732|FG000|Overall Study|Withdrew prior to dosing|2|||
126534128|NCT00862134|455246733|FG001|Overall Study|Withdrew prior to dosing|0|||
126534129|NCT02191267|455246734|FG000|Overall Study|Withdrawal by Subject|1|||
126534130|NCT02191267|455246735|FG001|Overall Study|Withdrawal by Subject|0|||
126534131|NCT02191267|455246736|FG002|Overall Study|Withdrawal by Subject|0|||
126534132|NCT00765674|455246737|FG000|Overall Study|Adverse Event|7|||
126534133|NCT00765674|455246738|FG001|Overall Study|Adverse Event|2|||
126757656|NCT01497899|456062735|FG000|Double-Blind Phase|Randomized but not Treated|1|||
126757657|NCT01497899|456062736|FG001|Double-Blind Phase|Randomized but not Treated|0|||
126757658|NCT01497899|456062737|FG002|Double-Blind Phase|Randomized but not Treated|0|||
126757659|NCT01497899|456062738|FG003|Double-Blind Phase|Randomized but not Treated|0|||
126757660|NCT01497899|456062735|FG000|Double-Blind Phase|Adverse Event|1|||
126757661|NCT01497899|456062736|FG001|Double-Blind Phase|Adverse Event|0|||
126757662|NCT01497899|456062737|FG002|Double-Blind Phase|Adverse Event|0|||
126757663|NCT01497899|456062738|FG003|Double-Blind Phase|Adverse Event|0|||
126757664|NCT01497899|456062735|FG000|Double-Blind Phase|Lack of Efficacy|0|||
126757665|NCT01497899|456062736|FG001|Double-Blind Phase|Lack of Efficacy|1|||
126757666|NCT01497899|456062737|FG002|Double-Blind Phase|Lack of Efficacy|0|||
126757667|NCT01497899|456062738|FG003|Double-Blind Phase|Lack of Efficacy|0|||
126757668|NCT01497899|456062735|FG000|Double-Blind Phase|Investigator's Discretion|1|||
126757669|NCT01497899|456062736|FG001|Double-Blind Phase|Investigator's Discretion|0|||
126757670|NCT01497899|456062737|FG002|Double-Blind Phase|Investigator's Discretion|0|||
126757671|NCT01497899|456062738|FG003|Double-Blind Phase|Investigator's Discretion|0|||
126311595|NCT01901653|454429807|FG010|Overall Study|Withdrawal by Subject|0|||
126311596|NCT01901653|454429808|FG011|Overall Study|Withdrawal by Subject|0|||
126757672|NCT01497899|456062735|FG000|Double-Blind Phase|Withdrew Consent|0|||
126757673|NCT01497899|456062736|FG001|Double-Blind Phase|Withdrew Consent|1|||
126757674|NCT01497899|456062737|FG002|Double-Blind Phase|Withdrew Consent|0|||
126757675|NCT01497899|456062738|FG003|Double-Blind Phase|Withdrew Consent|0|||
126757676|NCT01497899|456062735|FG000|Double-Blind Phase|Lost to Follow-up|3|||
126757677|NCT01497899|456062736|FG001|Double-Blind Phase|Lost to Follow-up|2|||
126311597|NCT01901653|454429809|FG012|Overall Study|Withdrawal by Subject|0|||
126311598|NCT01901653|454429797|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
126311599|NCT01901653|454429798|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
126311600|NCT01901653|454429799|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
126311601|NCT01901653|454429800|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
126311602|NCT01901653|454429801|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
126311603|NCT01901653|454429802|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
126311604|NCT01901653|454429803|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
126311605|NCT01901653|454429804|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
126311606|NCT01901653|454429805|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
126311607|NCT01901653|454429806|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
126311608|NCT01901653|454429807|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
126311609|NCT01901653|454429808|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
126311610|NCT01901653|454429809|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
126311611|NCT02091986|454429810|FG000|Overall Study|7 rand in error 1 patient decision|2|||
126311612|NCT02091986|454429811|FG001|Overall Study|7 rand in error 1 patient decision|3|||
126311613|NCT02091986|454429812|FG002|Overall Study|7 rand in error 1 patient decision|3|||
126311614|NCT02091986|454429810|FG000|Overall Study|Lost to Follow-up|1|||
126311615|NCT02091986|454429811|FG001|Overall Study|Lost to Follow-up|0|||
126311616|NCT02091986|454429812|FG002|Overall Study|Lost to Follow-up|0|||
126311617|NCT02091986|454429810|FG000|Overall Study|Withdrawal by Subject|4|||
126311618|NCT02091986|454429811|FG001|Overall Study|Withdrawal by Subject|8|||
126311619|NCT02091986|454429812|FG002|Overall Study|Withdrawal by Subject|3|||
126311620|NCT02091986|454429810|FG000|Overall Study|Adverse Event|0|||
126311621|NCT02091986|454429811|FG001|Overall Study|Adverse Event|0|||
126311622|NCT02091986|454429812|FG002|Overall Study|Adverse Event|2|||
126311623|NCT00957268|454429816|FG000|Overall Study|Voluntary Withdrawal|0|||
126534134|NCT00765674|455246739|FG002|Overall Study|Adverse Event|8|||
126534135|NCT00765674|455246740|FG003|Overall Study|Adverse Event|11|||
126534136|NCT00765674|455246737|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
126534137|NCT00765674|455246738|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
126534138|NCT00765674|455246739|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
126534139|NCT00765674|455246740|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
126534140|NCT00765674|455246737|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
126534141|NCT00765674|455246738|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
126534142|NCT00765674|455246739|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
126534143|NCT00765674|455246740|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
126534144|NCT00765674|455246737|FG000|Overall Study|Lack of Efficacy|2|||
126534145|NCT00765674|455246738|FG001|Overall Study|Lack of Efficacy|3|||
126534146|NCT00765674|455246739|FG002|Overall Study|Lack of Efficacy|1|||
126534147|NCT00765674|455246740|FG003|Overall Study|Lack of Efficacy|2|||
126534148|NCT00765674|455246737|FG000|Overall Study|Protocol Violation|2|||
126534149|NCT00765674|455246738|FG001|Overall Study|Protocol Violation|0|||
126534150|NCT00765674|455246739|FG002|Overall Study|Protocol Violation|1|||
126534151|NCT00765674|455246740|FG003|Overall Study|Protocol Violation|0|||
126534152|NCT00765674|455246737|FG000|Overall Study|Withdrawal by Subject|5|||
126534153|NCT00765674|455246738|FG001|Overall Study|Withdrawal by Subject|7|||
126534154|NCT00765674|455246739|FG002|Overall Study|Withdrawal by Subject|3|||
126534155|NCT00765674|455246740|FG003|Overall Study|Withdrawal by Subject|8|||
126534156|NCT00765674|455246737|FG000|Overall Study|Lost to Follow-up|4|||
126534157|NCT00765674|455246738|FG001|Overall Study|Lost to Follow-up|6|||
126534158|NCT00765674|455246739|FG002|Overall Study|Lost to Follow-up|2|||
126534159|NCT00765674|455246740|FG003|Overall Study|Lost to Follow-up|1|||
126534160|NCT00765674|455246737|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
126534161|NCT00765674|455246738|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
126534162|NCT00765674|455246739|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
126534163|NCT00765674|455246740|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
126534164|NCT01813474|455246741|FG000|Overall Study|Withdrawal by Subject|0|||
126534165|NCT01813474|455246742|FG001|Overall Study|Withdrawal by Subject|0|||
126534166|NCT01813474|455246743|FG002|Overall Study|Withdrawal by Subject|1|||
126534167|NCT01813474|455246741|FG000|Overall Study|Adverse Event|1|||
126534168|NCT01813474|455246742|FG001|Overall Study|Adverse Event|1|||
126534169|NCT01813474|455246743|FG002|Overall Study|Adverse Event|0|||
126534170|NCT01813474|455246741|FG000|Overall Study|Lack of Efficacy|2|||
126534171|NCT01813474|455246742|FG001|Overall Study|Lack of Efficacy|6|||
126534172|NCT01813474|455246743|FG002|Overall Study|Lack of Efficacy|9|||
126534173|NCT01813474|455246741|FG000|Overall Study|Death|0|||
126534174|NCT01813474|455246742|FG001|Overall Study|Death|0|||
126534175|NCT01813474|455246743|FG002|Overall Study|Death|1|||
126534176|NCT00316082|455246746|FG000|Overall Study|Lack of Efficacy|2|||
126534177|NCT00316082|455246747|FG001|Overall Study|Lack of Efficacy|3|||
126534178|NCT00316082|455246748|FG002|Overall Study|Lack of Efficacy|3|||
126534179|NCT00316082|455246749|FG003|Overall Study|Lack of Efficacy|4|||
126534180|NCT00316082|455246750|FG004|Overall Study|Lack of Efficacy|6|||
126757678|NCT01497899|456062737|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126757679|NCT01497899|456062738|FG003|Double-Blind Phase|Lost to Follow-up|0|||
126757680|NCT01497899|456062735|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
126757681|NCT01497899|456062736|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
126757682|NCT01497899|456062737|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
126757683|NCT01497899|456062738|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
126757684|NCT01497899|456062735|FG000|Open-Label Extension Phase|Adverse Event|1|||
126757685|NCT01497899|456062736|FG001|Open-Label Extension Phase|Adverse Event|0|||
126757686|NCT01497899|456062737|FG002|Open-Label Extension Phase|Adverse Event|0|||
126757687|NCT01497899|456062738|FG003|Open-Label Extension Phase|Adverse Event|0|||
126757688|NCT01497899|456062735|FG000|Open-Label Extension Phase|Death|1|||
126757689|NCT01497899|456062736|FG001|Open-Label Extension Phase|Death|0|||
126757690|NCT01497899|456062737|FG002|Open-Label Extension Phase|Death|0|||
126757691|NCT01497899|456062738|FG003|Open-Label Extension Phase|Death|0|||
126757692|NCT01497899|456062735|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
126757693|NCT01497899|456062736|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
126757694|NCT01497899|456062737|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
126757695|NCT01497899|456062738|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
126757696|NCT01497899|456062735|FG000|Open-Label Extension Phase|Pregnancy|0|||
126757697|NCT01497899|456062736|FG001|Open-Label Extension Phase|Pregnancy|1|||
126757698|NCT01497899|456062737|FG002|Open-Label Extension Phase|Pregnancy|1|||
126757699|NCT01497899|456062738|FG003|Open-Label Extension Phase|Pregnancy|0|||
126306047|NCT02553499|454408875|FG006|Overall Study|Lost to Follow-up|1|||
126534181|NCT00316082|455246746|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
126534182|NCT00316082|455246747|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
126534183|NCT00316082|455246748|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
126534184|NCT00316082|455246749|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
126534185|NCT00316082|455246750|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
126534186|NCT00316082|455246746|FG000|Overall Study|Lost to Follow-up|7|||
126534187|NCT00316082|455246747|FG001|Overall Study|Lost to Follow-up|6|||
126534188|NCT00316082|455246748|FG002|Overall Study|Lost to Follow-up|7|||
126757700|NCT01497899|456062735|FG000|Open-Label Extension Phase|Protocol Violation|0|||
126757701|NCT01497899|456062736|FG001|Open-Label Extension Phase|Protocol Violation|0|||
126757702|NCT01497899|456062737|FG002|Open-Label Extension Phase|Protocol Violation|1|||
126757703|NCT01497899|456062738|FG003|Open-Label Extension Phase|Protocol Violation|0|||
126757704|NCT01497899|456062735|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
126757705|NCT01497899|456062736|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
126757706|NCT01497899|456062737|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
126757707|NCT01497899|456062738|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
126757708|NCT05047601|456062740|FG000|Overall Study|Lost to Follow-up|9|||
126757709|NCT05047601|456062741|FG001|Overall Study|Lost to Follow-up|11|||
126757710|NCT05047601|456062742|FG002|Overall Study|Lost to Follow-up|7|||
126757711|NCT05047601|456062740|FG000|Overall Study|Withdrawal by Subject|25|||
126757712|NCT05047601|456062741|FG001|Overall Study|Withdrawal by Subject|36|||
126757713|NCT05047601|456062742|FG002|Overall Study|Withdrawal by Subject|23|||
126311624|NCT00957268|454429817|FG001|Overall Study|Voluntary Withdrawal|0|||
126534189|NCT00316082|455246749|FG003|Overall Study|Lost to Follow-up|8|||
126534190|NCT00316082|455246750|FG004|Overall Study|Lost to Follow-up|6|||
126534191|NCT00316082|455246746|FG000|Overall Study|Poor/noncompliance|6|||
126534192|NCT00316082|455246747|FG001|Overall Study|Poor/noncompliance|1|||
126534193|NCT00316082|455246748|FG002|Overall Study|Poor/noncompliance|4|||
126534194|NCT00316082|455246749|FG003|Overall Study|Poor/noncompliance|1|||
126534195|NCT00316082|455246750|FG004|Overall Study|Poor/noncompliance|4|||
126534196|NCT00316082|455246746|FG000|Overall Study|Adverse Event|4|||
126534197|NCT00316082|455246747|FG001|Overall Study|Adverse Event|2|||
126534198|NCT00316082|455246748|FG002|Overall Study|Adverse Event|5|||
126534199|NCT00316082|455246749|FG003|Overall Study|Adverse Event|1|||
126534200|NCT00316082|455246750|FG004|Overall Study|Adverse Event|3|||
126534201|NCT00316082|455246746|FG000|Overall Study|Subject no longer meets study criteria|3|||
126534202|NCT00316082|455246747|FG001|Overall Study|Subject no longer meets study criteria|1|||
126534203|NCT00316082|455246748|FG002|Overall Study|Subject no longer meets study criteria|2|||
126534204|NCT00316082|455246749|FG003|Overall Study|Subject no longer meets study criteria|2|||
126534205|NCT00316082|455246750|FG004|Overall Study|Subject no longer meets study criteria|1|||
126534206|NCT00316082|455246746|FG000|Overall Study|Physician Decision|1|||
126534207|NCT00316082|455246747|FG001|Overall Study|Physician Decision|1|||
126534208|NCT00316082|455246748|FG002|Overall Study|Physician Decision|2|||
126534209|NCT00316082|455246749|FG003|Overall Study|Physician Decision|1|||
126757714|NCT05047601|456062740|FG000|Overall Study|Other|10|||
126757715|NCT05047601|456062741|FG001|Overall Study|Other|6|||
126757716|NCT05047601|456062742|FG002|Overall Study|Other|5|||
126757717|NCT00286234|456062743|FG000|Overall Study|Protocol Violation|1|||
126757718|NCT00286234|456062744|FG001|Overall Study|Protocol Violation|2|||
126757719|NCT00286234|456062745|FG002|Overall Study|Protocol Violation|0|||
126757720|NCT00286234|456062746|FG003|Overall Study|Protocol Violation|1|||
126757721|NCT00286234|456062743|FG000|Overall Study|Physician Decision|1|||
126757722|NCT00286234|456062744|FG001|Overall Study|Physician Decision|0|||
126757723|NCT00286234|456062745|FG002|Overall Study|Physician Decision|0|||
126757724|NCT00286234|456062746|FG003|Overall Study|Physician Decision|1|||
126757725|NCT00286234|456062743|FG000|Overall Study|Adverse Event|0|||
126757726|NCT00286234|456062744|FG001|Overall Study|Adverse Event|0|||
126757727|NCT00286234|456062745|FG002|Overall Study|Adverse Event|0|||
126757728|NCT00286234|456062746|FG003|Overall Study|Adverse Event|1|||
126757729|NCT00286234|456062743|FG000|Overall Study|Adverse Event|0|||
126757730|NCT00286234|456062744|FG001|Overall Study|Adverse Event|0|||
126757731|NCT00286234|456062745|FG002|Overall Study|Adverse Event|0|||
126757732|NCT00286234|456062746|FG003|Overall Study|Adverse Event|1|||
126757733|NCT03137173|456062747|FG000|Overall Study|Withdrawal by Subject|8|||
126757734|NCT03137173|456062748|FG001|Overall Study|Withdrawal by Subject|13|||
126757735|NCT03137173|456062747|FG000|Overall Study|Death|1|||
126757736|NCT03137173|456062748|FG001|Overall Study|Death|3|||
126757737|NCT03137173|456062747|FG000|Overall Study|Physician Decision|1|||
126757738|NCT03137173|456062748|FG001|Overall Study|Physician Decision|0|||
126757739|NCT03137173|456062747|FG000|Overall Study|Lost to Follow-up|13|||
126757740|NCT03137173|456062748|FG001|Overall Study|Lost to Follow-up|18|||
126757741|NCT03137173|456062747|FG000|Overall Study|Other reasons|3|||
126757742|NCT03137173|456062748|FG001|Overall Study|Other reasons|2|||
126757743|NCT01475214|456062749|FG000|Overall Study|Lost to Follow-up|1|||
126757744|NCT01475214|456062750|FG001|Overall Study|Lost to Follow-up|0|||
126757745|NCT01475214|456062751|FG002|Overall Study|Lost to Follow-up|1|||
126757746|NCT01475214|456062749|FG000|Overall Study|Physician Decision|2|||
126757747|NCT01475214|456062750|FG001|Overall Study|Physician Decision|0|||
126757748|NCT01475214|456062751|FG002|Overall Study|Physician Decision|0|||
126311625|NCT00957268|454429818|FG002|Overall Study|Voluntary Withdrawal|1|||
126311626|NCT00957268|454429819|FG003|Overall Study|Voluntary Withdrawal|0|||
126534210|NCT00316082|455246750|FG004|Overall Study|Physician Decision|1|||
126534211|NCT00316082|455246746|FG000|Overall Study|Death|0|||
126534212|NCT00316082|455246747|FG001|Overall Study|Death|0|||
126534213|NCT00316082|455246748|FG002|Overall Study|Death|1|||
126534214|NCT00316082|455246749|FG003|Overall Study|Death|0|||
126757749|NCT01475214|456062749|FG000|Overall Study|Withdrawal by Subject|2|||
126757750|NCT01475214|456062750|FG001|Overall Study|Withdrawal by Subject|4|||
126757751|NCT01475214|456062751|FG002|Overall Study|Withdrawal by Subject|1|||
126534215|NCT00316082|455246750|FG004|Overall Study|Death|0|||
126534216|NCT00316082|455246746|FG000|Overall Study|Administrative reason by sponsor|0|||
126534217|NCT00316082|455246747|FG001|Overall Study|Administrative reason by sponsor|0|||
126534218|NCT00316082|455246748|FG002|Overall Study|Administrative reason by sponsor|1|||
126534219|NCT00316082|455246749|FG003|Overall Study|Administrative reason by sponsor|0|||
126534220|NCT00316082|455246750|FG004|Overall Study|Administrative reason by sponsor|0|||
126534221|NCT00528775|455246753|FG000|Overall Study|Other not specified|1|||
126534222|NCT00587964|455246758|FG000|Overall Study|Withdrawal by Subject|1|||
126534223|NCT00587964|455246758|FG000|Overall Study|Lost to Follow-up|1|||
126534224|NCT00587964|455246758|FG000|Overall Study|Patient found to be ineligible|1|||
126534225|NCT00587964|455246758|FG000|Overall Study|Patient did not receive intervention|5|||
126534226|NCT00587964|455246758|FG000|Overall Study|Progression of Disease|4|||
126534227|NCT00540124|455246759|FG000|Overall Study|Adverse Event|0|||
126534228|NCT00540124|455246760|FG001|Overall Study|Adverse Event|2|||
126534229|NCT00540124|455246761|FG002|Overall Study|Adverse Event|1|||
126534230|NCT00540124|455246759|FG000|Overall Study|Entry Criteria Not Met|2|||
126534231|NCT00540124|455246760|FG001|Overall Study|Entry Criteria Not Met|0|||
126534232|NCT00540124|455246761|FG002|Overall Study|Entry Criteria Not Met|0|||
126534233|NCT00540124|455246759|FG000|Overall Study|Lack of Efficacy|1|||
126534234|NCT00540124|455246760|FG001|Overall Study|Lack of Efficacy|0|||
126534235|NCT00540124|455246761|FG002|Overall Study|Lack of Efficacy|0|||
126534236|NCT00540124|455246759|FG000|Overall Study|Withdrawal by Subject|1|||
126534237|NCT00540124|455246760|FG001|Overall Study|Withdrawal by Subject|1|||
126534238|NCT00540124|455246761|FG002|Overall Study|Withdrawal by Subject|0|||
126534239|NCT01207102|455246768|FG000|Overall Study|Withdrawal by Subject|5|||
126534240|NCT01207102|455246768|FG000|Overall Study|Adverse Event|2|||
126534241|NCT01207102|455246768|FG000|Overall Study|progression|2|||
126534242|NCT01207102|455246768|FG000|Overall Study|Withdrawal by Treating Physician|1|||
126534243|NCT01777854|455246769|FG000|Overall Study|Physician Decision|3|||
126534244|NCT01777854|455246770|FG001|Overall Study|Physician Decision|3|||
126534245|NCT01239030|455246775|FG000|Double Blind|Adverse Event|0|||
126534246|NCT01239030|455246776|FG001|Double Blind|Adverse Event|1|||
126534247|NCT01239030|455246777|FG002|Double Blind|Adverse Event|0|||
126534248|NCT01239030|455246778|FG003|Double Blind|Adverse Event|2|||
126534249|NCT01239030|455246779|FG004|Double Blind|Adverse Event|0|||
126534250|NCT01239030|455246775|FG000|Double Blind|Withdrawal by Subject|0|||
126534251|NCT01239030|455246776|FG001|Double Blind|Withdrawal by Subject|1|||
126534252|NCT01239030|455246777|FG002|Double Blind|Withdrawal by Subject|1|||
126757752|NCT02828982|456062752|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126757753|NCT02828982|456062753|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126770365|NCT02756078|456112462|FG001|Period 1|Lens Discomfort|2|||
126770366|NCT02756078|456112461|FG000|Period 2|Adverse Event|3|||
126770367|NCT02756078|456112462|FG001|Period 2|Adverse Event|5|||
126770368|NCT02756078|456112461|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
126770369|NCT02756078|456112462|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
126770370|NCT02756078|456112461|FG000|Period 2|Withdrawal by Subject|3|||
126770371|NCT02756078|456112462|FG001|Period 2|Withdrawal by Subject|1|||
126770372|NCT05349188|456112463|FG000|Overall Study|Withdrawal by Subject|1|||
126770373|NCT05349188|456112464|FG001|Overall Study|Withdrawal by Subject|0|||
126770374|NCT00835068|456112467|FG000|Overall Study|Death|1|||
126770375|NCT00835068|456112468|FG001|Overall Study|Death|0|||
126770376|NCT00835068|456112467|FG000|Overall Study|Adverse Event|0|||
126770377|NCT00835068|456112468|FG001|Overall Study|Adverse Event|1|||
126770378|NCT00835068|456112467|FG000|Overall Study|Other|8|||
126770379|NCT00835068|456112468|FG001|Overall Study|Other|0|||
126770380|NCT00835068|456112467|FG000|Overall Study|Withdrawal by Subject|1|||
126770381|NCT00835068|456112468|FG001|Overall Study|Withdrawal by Subject|0|||
126770382|NCT02575807|456112469|FG000|Overall Study|Death|8|||
126770383|NCT02575807|456112470|FG001|Overall Study|Death|3|||
126770384|NCT02575807|456112471|FG002|Overall Study|Death|7|||
126770385|NCT02575807|456112472|FG003|Overall Study|Death|0|||
126770386|NCT02575807|456112473|FG004|Overall Study|Death|1|||
126770387|NCT02575807|456112469|FG000|Overall Study|Study terminated by Sponsor|0|||
126770388|NCT02575807|456112470|FG001|Overall Study|Study terminated by Sponsor|1|||
126770389|NCT02575807|456112471|FG002|Overall Study|Study terminated by Sponsor|7|||
126770390|NCT02575807|456112472|FG003|Overall Study|Study terminated by Sponsor|0|||
126770391|NCT02575807|456112473|FG004|Overall Study|Study terminated by Sponsor|1|||
126770392|NCT02575807|456112469|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
126770393|NCT02575807|456112470|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
126770394|NCT02575807|456112471|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
126770395|NCT02575807|456112472|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
126770396|NCT02575807|456112473|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
126534253|NCT01239030|455246778|FG003|Double Blind|Withdrawal by Subject|0|||
126534254|NCT01239030|455246779|FG004|Double Blind|Withdrawal by Subject|1|||
126534255|NCT01239030|455246775|FG000|Double Blind|Lost to Follow-up|1|||
126534256|NCT01239030|455246776|FG001|Double Blind|Lost to Follow-up|1|||
126534257|NCT01239030|455246777|FG002|Double Blind|Lost to Follow-up|0|||
126757754|NCT00690612|456064363|FG000|Overall Study|Adverse Event|1|||
126757755|NCT00690612|456064363|FG000|Overall Study|Withdrawal by Subject|2|||
126757756|NCT00911508|456064364|FG000|Overall Study|Lost to Follow-up|27|||
126757757|NCT00911508|456064365|FG001|Overall Study|Lost to Follow-up|18|||
126757758|NCT00911508|456064364|FG000|Overall Study|Withdrawal by Subject|79|||
126757759|NCT00911508|456064365|FG001|Overall Study|Withdrawal by Subject|112|||
126757760|NCT01409382|456064366|FG000|Overall Study|Lost to Follow-up|1|||
126757761|NCT01409382|456064367|FG001|Overall Study|Lost to Follow-up|1|||
126757762|NCT01409382|456064366|FG000|Overall Study|Protocol Violation|0|||
126757763|NCT01409382|456064367|FG001|Overall Study|Protocol Violation|3|||
126757764|NCT01409382|456064366|FG000|Overall Study|Multiple pregnancy|2|||
126757765|NCT01409382|456064367|FG001|Overall Study|Multiple pregnancy|4|||
126757766|NCT01409382|456064366|FG000|Overall Study|Still pregnant when study ended|13|||
126757767|NCT01409382|456064367|FG001|Overall Study|Still pregnant when study ended|2|||
126757768|NCT01409382|456064366|FG000|Overall Study|Did not manage to get pregnant|64|||
126757769|NCT01409382|456064367|FG001|Overall Study|Did not manage to get pregnant|70|||
126534258|NCT01239030|455246778|FG003|Double Blind|Lost to Follow-up|0|||
126534259|NCT01239030|455246779|FG004|Double Blind|Lost to Follow-up|0|||
126534260|NCT01239030|455246775|FG000|Double Blind|Physician Decision|0|||
126534261|NCT01239030|455246776|FG001|Double Blind|Physician Decision|1|||
126757770|NCT01409382|456064366|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
126757771|NCT01409382|456064367|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
126757772|NCT01233076|456064368|FG000|Period 2, One Week|Lost to Follow-up|1|||
126757773|NCT01233076|456064369|FG001|Period 2, One Week|Lost to Follow-up|0|||
126757774|NCT01786707|456064371|FG000|Overall Study|Lost to Follow-up|1|||
126757775|NCT01786707|456064372|FG001|Overall Study|Lost to Follow-up|1|||
126757776|NCT02058940|456064374|FG000|Overall Study|Discharged from Critical Care Unit|1|||
126757777|NCT01519700|456064375|FG000|Overall Study|Death|1|||
126757778|NCT01519700|456064376|FG001|Overall Study|Death|0|||
126757779|NCT01519700|456064377|FG002|Overall Study|Death|0|||
126757780|NCT01519700|456064378|FG003|Overall Study|Death|0|||
126757781|NCT01519700|456064375|FG000|Overall Study|Lost to Follow-up|0|||
126757782|NCT01519700|456064376|FG001|Overall Study|Lost to Follow-up|0|||
126757783|NCT01519700|456064377|FG002|Overall Study|Lost to Follow-up|1|||
126757784|NCT01519700|456064378|FG003|Overall Study|Lost to Follow-up|1|||
126757785|NCT01519700|456064375|FG000|Overall Study|Physician Decision|1|||
126757786|NCT01519700|456064376|FG001|Overall Study|Physician Decision|1|||
126757787|NCT01519700|456064377|FG002|Overall Study|Physician Decision|3|||
126757788|NCT01519700|456064378|FG003|Overall Study|Physician Decision|0|||
126757789|NCT01519700|456064375|FG000|Overall Study|Withdrawal by Subject|5|||
126757790|NCT01519700|456064376|FG001|Overall Study|Withdrawal by Subject|3|||
126757791|NCT01519700|456064377|FG002|Overall Study|Withdrawal by Subject|3|||
126757792|NCT01519700|456064378|FG003|Overall Study|Withdrawal by Subject|2|||
126757793|NCT01519700|456064375|FG000|Overall Study|Other Reason|2|||
126757794|NCT01519700|456064376|FG001|Overall Study|Other Reason|2|||
126757795|NCT01519700|456064377|FG002|Overall Study|Other Reason|0|||
126757796|NCT01519700|456064378|FG003|Overall Study|Other Reason|4|||
126757797|NCT01789476|456064384|FG000|Overall Study|Lack of Efficacy|6|||
126757798|NCT01789476|456064385|FG001|Overall Study|Lack of Efficacy|2|||
126757799|NCT01789476|456064384|FG000|Overall Study|Adverse Event|1|||
126757800|NCT01789476|456064385|FG001|Overall Study|Adverse Event|0|||
126757801|NCT01789476|456064384|FG000|Overall Study|Unable to get IV access|1|||
126757802|NCT01789476|456064385|FG001|Overall Study|Unable to get IV access|0|||
126757803|NCT00965458|456064386|FG000|Overall Study|Adverse Event|1|||
126757804|NCT00965458|456064387|FG001|Overall Study|Adverse Event|0|||
126757805|NCT00965458|456064386|FG000|Overall Study|Lost to Follow-up|1|||
126757806|NCT00965458|456064387|FG001|Overall Study|Lost to Follow-up|3|||
126757807|NCT00965458|456064386|FG000|Overall Study|Withdrawal by Subject|0|||
126757808|NCT00965458|456064387|FG001|Overall Study|Withdrawal by Subject|1|||
126757809|NCT05637515|456064391|FG000|Overall Study|Withdrawal by Subject|17|||
126757810|NCT05637515|456064392|FG001|Overall Study|Withdrawal by Subject|17|||
126757811|NCT03039686|456064393|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
126757812|NCT03039686|456064394|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
126757813|NCT03039686|456064395|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
126757814|NCT03039686|456064393|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
126757815|NCT03039686|456064394|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
126757816|NCT03039686|456064395|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
126757817|NCT03039686|456064393|FG000|Double-blind Period|Withdrawal by Subject|2|||
126757818|NCT03039686|456064394|FG001|Double-blind Period|Withdrawal by Subject|2|||
126757819|NCT03039686|456064395|FG002|Double-blind Period|Withdrawal by Subject|1|||
126757820|NCT03039686|456064393|FG000|Double-blind Period|Death|0|||
126757821|NCT03039686|456064394|FG001|Double-blind Period|Death|0|||
126757822|NCT03039686|456064395|FG002|Double-blind Period|Death|1|||
126757823|NCT03039686|456064393|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
126757824|NCT03039686|456064394|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
126534262|NCT01239030|455246777|FG002|Double Blind|Physician Decision|0|||
126757825|NCT03039686|456064395|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
126757826|NCT03039686|456064393|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
126757827|NCT03039686|456064394|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
126757828|NCT03039686|456064395|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
126757829|NCT03039686|456064393|FG000|Open Label Period|Withdrawal by Subject|0|||
126757830|NCT03039686|456064394|FG001|Open Label Period|Withdrawal by Subject|3|||
126757831|NCT03039686|456064395|FG002|Open Label Period|Withdrawal by Subject|1|||
126757832|NCT02158949|456064396|FG000|Overall Study|Withdrawal by Subject|1|||
126757833|NCT02158949|456064397|FG001|Overall Study|Withdrawal by Subject|0|||
126757834|NCT02158949|456064396|FG000|Overall Study|Lost to Follow-up|5|||
126757835|NCT02158949|456064397|FG001|Overall Study|Lost to Follow-up|11|||
126757836|NCT02079077|456064399|FG000|Overall Study|Lost to Follow-up|5|||
126757837|NCT02079077|456064400|FG001|Overall Study|Lost to Follow-up|7|||
126757838|NCT02079077|456064399|FG000|Overall Study|Became STIs Positive|1|||
126757839|NCT02079077|456064400|FG001|Overall Study|Became STIs Positive|2|||
126757840|NCT00772031|456064401|FG000|Overall Study|Early termination of trial|12|||
126757841|NCT00772031|456064402|FG001|Overall Study|Early termination of trial|10|||
126757842|NCT00772031|456064401|FG000|Overall Study|Lost to Follow-up|20|||
126757843|NCT00772031|456064402|FG001|Overall Study|Lost to Follow-up|33|||
126757844|NCT00656136|456064403|FG000|Overall Study|Progressive disease|177|||
126757845|NCT00656136|456064404|FG001|Overall Study|Progressive disease|322|||
126757846|NCT00656136|456064403|FG000|Overall Study|Other Adverse Event|5|||
126757847|NCT00656136|456064404|FG001|Overall Study|Other Adverse Event|51|||
126757848|NCT00656136|456064403|FG000|Overall Study|Protocol Violation|2|||
126757849|NCT00656136|456064404|FG001|Overall Study|Protocol Violation|3|||
126757850|NCT00656136|456064403|FG000|Overall Study|Patient refused to take study medication|7|||
126757851|NCT00656136|456064404|FG001|Overall Study|Patient refused to take study medication|10|||
126757852|NCT00656136|456064403|FG000|Overall Study|Unknown and others|4|||
126757853|NCT00656136|456064404|FG001|Overall Study|Unknown and others|4|||
126757854|NCT02505945|456064405|FG000|Overall Study|Withdrawal by Subject|13|||
126757855|NCT02505945|456064406|FG001|Overall Study|Withdrawal by Subject|2|||
126757856|NCT02505945|456064405|FG000|Overall Study|Adverse Event|1|||
126757857|NCT02505945|456064406|FG001|Overall Study|Adverse Event|0|||
126757858|NCT02505945|456064405|FG000|Overall Study|Physician Decision|2|||
126757859|NCT02505945|456064406|FG001|Overall Study|Physician Decision|1|||
126757860|NCT02505945|456064405|FG000|Overall Study|Lost to Follow-up|6|||
126757861|NCT02505945|456064406|FG001|Overall Study|Lost to Follow-up|1|||
126757862|NCT00635804|456064407|FG000|Overall Study|Adverse Event|0|||
126757863|NCT00635804|456064408|FG001|Overall Study|Adverse Event|0|||
126757864|NCT00635804|456064409|FG002|Overall Study|Adverse Event|0|||
126757865|NCT00635804|456064410|FG003|Overall Study|Adverse Event|0|||
126757866|NCT00635804|456064411|FG004|Overall Study|Adverse Event|0|||
126757867|NCT00635804|456064412|FG005|Overall Study|Adverse Event|1|||
126757868|NCT00635804|456064413|FG006|Overall Study|Adverse Event|0|||
126757869|NCT00635804|456064414|FG007|Overall Study|Adverse Event|0|||
126757870|NCT00635804|456064407|FG000|Overall Study|Withdrawal by Subject|1|||
126534263|NCT01239030|455246778|FG003|Double Blind|Physician Decision|0|||
126534264|NCT01239030|455246779|FG004|Double Blind|Physician Decision|0|||
126534265|NCT01239030|455246775|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
126534266|NCT01239030|455246776|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
126534267|NCT01239030|455246777|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
126534268|NCT01239030|455246778|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
126534269|NCT01239030|455246779|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
126534270|NCT01239030|455246775|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
126534271|NCT01239030|455246776|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
126534272|NCT01239030|455246777|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
126534273|NCT01239030|455246778|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
126534274|NCT01239030|455246779|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
126534275|NCT01239030|455246775|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
126534276|NCT01239030|455246776|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
126534277|NCT01239030|455246777|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
126534278|NCT01239030|455246778|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
126534279|NCT01239030|455246779|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
126534280|NCT01239030|455246775|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
126757871|NCT00635804|456064408|FG001|Overall Study|Withdrawal by Subject|0|||
126757872|NCT00635804|456064409|FG002|Overall Study|Withdrawal by Subject|0|||
126757873|NCT00635804|456064410|FG003|Overall Study|Withdrawal by Subject|0|||
126757874|NCT00635804|456064411|FG004|Overall Study|Withdrawal by Subject|0|||
126757875|NCT00635804|456064412|FG005|Overall Study|Withdrawal by Subject|0|||
126757876|NCT00635804|456064413|FG006|Overall Study|Withdrawal by Subject|0|||
126645335|NCT01253135|455660313|FG000|Amended Protocol|Non-compliance|1|||
126757877|NCT00635804|456064414|FG007|Overall Study|Withdrawal by Subject|0|||
126757878|NCT02718131|456064415|FG000|Overall Study|Withdrawal by Subject|1|||
126757879|NCT02718131|456064416|FG001|Overall Study|Withdrawal by Subject|0|||
126534281|NCT01239030|455246776|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
126534282|NCT01239030|455246777|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
126534283|NCT01239030|455246778|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
126534284|NCT01239030|455246779|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
126534285|NCT01212770|455246780|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
126534286|NCT01212770|455246781|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
126534287|NCT01212770|455246782|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
126534288|NCT01212770|455246783|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126534289|NCT01212770|455246784|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126534290|NCT01212770|455246785|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126534291|NCT01212770|455246786|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126534292|NCT01212770|455246787|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126534293|NCT01212770|455246788|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126534294|NCT01212770|455246780|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
126534295|NCT01212770|455246781|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
126534296|NCT01212770|455246782|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
126534297|NCT01212770|455246783|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126534298|NCT01212770|455246784|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126534299|NCT01212770|455246785|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126534300|NCT01212770|455246786|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126534301|NCT01212770|455246787|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126534302|NCT01212770|455246788|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126534303|NCT01212770|455246780|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
126534304|NCT01212770|455246781|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
126534305|NCT01212770|455246782|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
126534306|NCT01212770|455246783|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126534307|NCT01212770|455246784|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126534308|NCT01212770|455246785|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126534309|NCT01212770|455246786|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126534310|NCT01212770|455246787|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126534311|NCT01212770|455246788|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126534312|NCT01212770|455246780|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
126534313|NCT01212770|455246781|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126534314|NCT01212770|455246782|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
126534315|NCT01212770|455246783|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126534316|NCT01212770|455246784|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126534317|NCT01212770|455246785|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126534318|NCT01212770|455246786|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126534319|NCT01212770|455246787|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126534320|NCT01212770|455246788|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126534321|NCT01212770|455246780|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126534322|NCT01212770|455246781|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126534323|NCT01212770|455246782|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
126534324|NCT01212770|455246783|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126534325|NCT01212770|455246784|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126534326|NCT01212770|455246785|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126534327|NCT01212770|455246786|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126534328|NCT01212770|455246787|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126534329|NCT01212770|455246788|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126534330|NCT01212770|455246780|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
126534331|NCT01212770|455246781|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
126534332|NCT01212770|455246782|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
126534333|NCT01212770|455246783|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
126534334|NCT01212770|455246784|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
126534335|NCT01212770|455246785|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
126534336|NCT01212770|455246786|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
126534337|NCT01212770|455246787|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
126534338|NCT01212770|455246788|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
126534339|NCT01212770|455246780|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
126534340|NCT01212770|455246781|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
126534341|NCT01212770|455246782|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
126534342|NCT01212770|455246783|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
126534343|NCT01212770|455246784|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
126645336|NCT01901432|455660318|FG000|Overall Study|Adverse Event|0|||
126757880|NCT02718131|456064415|FG000|Overall Study|Adverse Event|1|||
126463730|NCT00423670|455000235|FG004|Treatment Period|Protocol-defined clinical event|5|||
126757881|NCT02718131|456064416|FG001|Overall Study|Adverse Event|0|||
126534344|NCT01212770|455246785|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
126534345|NCT01212770|455246786|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
126534346|NCT01212770|455246787|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
126534347|NCT01212770|455246788|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
126534348|NCT01212770|455246780|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
126534349|NCT01212770|455246781|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
126534350|NCT01212770|455246782|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
126534351|NCT01212770|455246783|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
126534352|NCT01212770|455246784|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
126534353|NCT01212770|455246785|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
126534354|NCT01212770|455246786|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
126534355|NCT01212770|455246787|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
126534356|NCT01212770|455246788|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
126534357|NCT01212770|455246780|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
126534358|NCT01212770|455246781|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
126534359|NCT01212770|455246782|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
126757882|NCT02718131|456064415|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
126757883|NCT02718131|456064416|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
126534360|NCT01212770|455246783|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
126534361|NCT01212770|455246784|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
126534362|NCT01212770|455246785|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
126534363|NCT01212770|455246786|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
126534364|NCT01212770|455246787|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
126534365|NCT01212770|455246788|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
126757884|NCT01097057|456064417|FG000|Overall Study|Physician Decision|3|||
126757885|NCT01101321|456064418|FG000|Period 1|Withdrawal by Subject|1|||
126534366|NCT01212770|455246780|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
126534367|NCT01212770|455246781|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
126534368|NCT01212770|455246782|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
126534369|NCT01212770|455246783|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
126534370|NCT01212770|455246784|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
126534371|NCT01212770|455246785|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
126534372|NCT01212770|455246786|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
126534373|NCT01212770|455246787|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
126534374|NCT01212770|455246788|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
126534375|NCT01212770|455246780|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
126534376|NCT01212770|455246781|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
126534377|NCT01212770|455246782|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
126534378|NCT01212770|455246783|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
126534379|NCT01212770|455246784|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
126534380|NCT01212770|455246785|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
126534381|NCT01212770|455246786|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
126534382|NCT01212770|455246787|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
126534383|NCT01212770|455246788|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
126534384|NCT01212770|455246780|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
126534385|NCT01212770|455246781|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
126534386|NCT01212770|455246782|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
126534387|NCT01212770|455246783|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
126534388|NCT01212770|455246784|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
126534389|NCT01212770|455246785|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
126534390|NCT01212770|455246786|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
126534391|NCT01212770|455246787|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
126534392|NCT01212770|455246788|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
126534393|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126534394|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
126534395|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
126534396|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126534397|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126534398|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126534399|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126534400|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126534401|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
126534402|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126534403|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
126534404|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
126757886|NCT01101321|456064419|FG001|Period 1|Withdrawal by Subject|1|||
126534405|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126534406|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126534407|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126534408|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126534409|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
126534410|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
126534411|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
126534412|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
126534413|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
126534414|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
126534415|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
126534416|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
126534417|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
126534418|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
126534419|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
126534420|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126534421|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
126534422|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
126534423|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126534424|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126534425|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126534426|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126534427|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
126534428|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
126534429|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
126534430|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
126534431|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
126534432|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
126534433|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
126534434|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
126534435|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
126534436|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
126534437|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
126534438|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126534439|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
126534440|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
126534441|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126534442|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126534443|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126534444|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126534445|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126534446|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
126534447|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126534448|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
126534449|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
126534450|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126534451|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126534452|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126534453|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126534454|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
126534455|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
126534456|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126534457|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
126534458|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
126534459|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126534460|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126534461|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126534462|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126534463|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
126534464|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
126534465|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126534466|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
126534467|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
126534468|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126534469|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126534470|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126534471|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126534472|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
126534473|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
126534474|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126534475|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
126534476|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126534477|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126534478|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126534479|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126534480|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126534481|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126534482|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126534483|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
126534484|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
126534485|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
126534486|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
126534487|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
126534488|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
126534489|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
126534490|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
126534491|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
126534492|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126534493|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
126534494|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
126534495|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126534496|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126534497|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126534498|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126534499|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
126534500|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
126534501|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126534502|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
126534503|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
126534504|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126534505|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126534506|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126534507|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126534508|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126534509|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
126534510|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126534511|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
126534512|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
126534513|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126534514|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126534515|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126534516|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126534517|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
126534518|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126534519|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
126534520|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
126534521|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
126534522|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
126534523|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
126534524|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
126534525|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
126534526|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
126534527|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
126534528|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126534529|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
126534530|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
126534531|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126534532|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126422489|NCT01695135|454842616|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
126422490|NCT01695135|454842617|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
126422491|NCT00684996|454842618|FG000|Overall Study|Adverse Event|1|||
126534533|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126534534|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126534535|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126757887|NCT01101321|456064418|FG000|Period 1|Adverse Event|3|||
126757888|NCT01101321|456064419|FG001|Period 1|Adverse Event|3|||
126422492|NCT00684996|454842618|FG000|Overall Study|Refusal unrelated to adverse event|1|||
126422493|NCT00684996|454842618|FG000|Overall Study|Progression/relapse|2|||
126422494|NCT00684996|454842618|FG000|Overall Study|Other reasons not protocol specified|1|||
126422495|NCT02491983|454842619|FG000|Overall Study|Physician Decision|1|||
126422496|NCT02491983|454842620|FG001|Overall Study|Physician Decision|0|||
126422497|NCT02491983|454842619|FG000|Overall Study|Not meet selection criteria|1|||
126422498|NCT02491983|454842620|FG001|Overall Study|Not meet selection criteria|0|||
126422499|NCT02491983|454842619|FG000|Overall Study|Withdrawal by Subject|0|||
126422500|NCT02491983|454842620|FG001|Overall Study|Withdrawal by Subject|1|||
126534536|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126534537|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126534538|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126534539|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
126534540|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126534541|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126534542|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126534543|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126534544|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126534545|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126534546|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126534547|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
126534548|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126534549|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126534550|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126534551|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126534552|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126534553|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126534554|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
126534555|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
126534556|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
126534557|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
126534558|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
126534559|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
126534560|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
126534561|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
126534562|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
126534563|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
126534564|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126534565|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126534566|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
126534567|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126534568|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126534569|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126534570|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126534571|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126534572|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126534573|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126534574|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126534575|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
126534576|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126534577|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126534578|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126534579|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126534580|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126757889|NCT00310440|456064420|FG000|Overall Study|Lost to Follow-up|17|||
126757890|NCT00310440|456064421|FG001|Overall Study|Lost to Follow-up|8|||
126534581|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
126534582|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126534583|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126534584|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
126534585|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126534586|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126422501|NCT02714569|454842621|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
126422502|NCT02714569|454842622|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
126534587|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126534588|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126534589|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126534590|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126757891|NCT00310440|456064420|FG000|Overall Study|Withdrawal by Subject|2|||
126422503|NCT02714569|454842623|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
126422504|NCT02714569|454842624|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
126534591|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126534592|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
126534593|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
126534594|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126534595|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126534596|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126534597|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126534598|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
126534599|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126534600|NCT01212770|455246780|FG000|Long-term Safety Phase (Year 5)|Death|0|||
126534601|NCT01212770|455246781|FG001|Long-term Safety Phase (Year 5)|Death|0|||
126534602|NCT01212770|455246782|FG002|Long-term Safety Phase (Year 5)|Death|0|||
126534603|NCT01212770|455246783|FG003|Long-term Safety Phase (Year 5)|Death|0|||
126534604|NCT01212770|455246784|FG004|Long-term Safety Phase (Year 5)|Death|0|||
126645337|NCT01901432|455660319|FG001|Overall Study|Adverse Event|1|||
126645338|NCT01901432|455660320|FG002|Overall Study|Adverse Event|1|||
126645339|NCT01901432|455660321|FG003|Overall Study|Adverse Event|0|||
126645340|NCT01901432|455660322|FG004|Overall Study|Adverse Event|1|||
126645341|NCT01901432|455660318|FG000|Overall Study|Withdrawal by Subject|0|||
126645342|NCT01901432|455660319|FG001|Overall Study|Withdrawal by Subject|0|||
126645343|NCT01901432|455660320|FG002|Overall Study|Withdrawal by Subject|1|||
126645344|NCT01901432|455660321|FG003|Overall Study|Withdrawal by Subject|0|||
126645345|NCT01901432|455660322|FG004|Overall Study|Withdrawal by Subject|5|||
126645346|NCT01901432|455660318|FG000|Overall Study|Physician Decision|0|||
126645347|NCT01901432|455660319|FG001|Overall Study|Physician Decision|0|||
126645348|NCT01901432|455660320|FG002|Overall Study|Physician Decision|0|||
126645349|NCT01901432|455660321|FG003|Overall Study|Physician Decision|0|||
126645350|NCT01901432|455660322|FG004|Overall Study|Physician Decision|2|||
126645351|NCT01901432|455660318|FG000|Overall Study|Patient decision to stop study drug|0|||
126645352|NCT01901432|455660319|FG001|Overall Study|Patient decision to stop study drug|0|||
126645353|NCT01901432|455660320|FG002|Overall Study|Patient decision to stop study drug|0|||
126645354|NCT01901432|455660321|FG003|Overall Study|Patient decision to stop study drug|0|||
126645355|NCT01901432|455660322|FG004|Overall Study|Patient decision to stop study drug|1|||
126645356|NCT00379288|455660325|FG000|Overall Study|Adverse Event|5|||
126645357|NCT00379288|455660326|FG001|Overall Study|Adverse Event|6|||
126645358|NCT00379288|455660327|FG002|Overall Study|Adverse Event|2|||
126645359|NCT00379288|455660328|FG003|Overall Study|Adverse Event|0|||
126645360|NCT00379288|455660325|FG000|Overall Study|Treatment Failure|0|||
126645361|NCT00379288|455660326|FG001|Overall Study|Treatment Failure|1|||
126645362|NCT00379288|455660327|FG002|Overall Study|Treatment Failure|0|||
126645363|NCT00379288|455660328|FG003|Overall Study|Treatment Failure|1|||
126645364|NCT00379288|455660325|FG000|Overall Study|Lost to Follow-up|3|||
126645365|NCT00379288|455660326|FG001|Overall Study|Lost to Follow-up|3|||
126422505|NCT02714569|454842625|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
126422506|NCT02714569|454842626|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
126422507|NCT02714569|454842627|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
126422508|NCT02714569|454842628|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
126422509|NCT02714569|454842629|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
126422510|NCT02714569|454842630|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
126422511|NCT02714569|454842631|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
126422512|NCT02714569|454842621|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422513|NCT02714569|454842622|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422514|NCT02714569|454842623|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422515|NCT02714569|454842624|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
126422516|NCT02714569|454842625|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422517|NCT02714569|454842626|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422518|NCT02714569|454842627|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422519|NCT02714569|454842628|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422520|NCT02714569|454842629|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422521|NCT02714569|454842630|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422522|NCT02714569|454842631|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
126422523|NCT02714569|454842621|FG000|Part A Third Intervention|Adverse Event|0|||
126422524|NCT02714569|454842622|FG001|Part A Third Intervention|Adverse Event|0|||
126645366|NCT00379288|455660327|FG002|Overall Study|Lost to Follow-up|2|||
126645367|NCT00379288|455660328|FG003|Overall Study|Lost to Follow-up|0|||
126645368|NCT00379288|455660325|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
126645369|NCT00379288|455660326|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
126645370|NCT00379288|455660327|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
126645371|NCT00379288|455660328|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
126645372|NCT00379288|455660325|FG000|Overall Study|Subject withdrew-related to study drug|1|||
126645373|NCT00379288|455660326|FG001|Overall Study|Subject withdrew-related to study drug|0|||
126534605|NCT01212770|455246785|FG005|Long-term Safety Phase (Year 5)|Death|0|||
126534606|NCT01212770|455246786|FG006|Long-term Safety Phase (Year 5)|Death|0|||
126534607|NCT01212770|455246787|FG007|Long-term Safety Phase (Year 5)|Death|1|||
126534608|NCT01212770|455246788|FG008|Long-term Safety Phase (Year 5)|Death|0|||
126534609|NCT00829387|455246789|FG000|Overall Study|Withdrawal by Subject|2|||
126534610|NCT00829387|455246790|FG001|Overall Study|Withdrawal by Subject|3|||
126534611|NCT00829387|455246789|FG000|Overall Study|Disqualified by PI|1|||
126534612|NCT00829387|455246790|FG001|Overall Study|Disqualified by PI|0|||
126534613|NCT04304833|455246798|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
126534614|NCT04304833|455246799|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
126534615|NCT01951625|455246800|FG000|Treatment Period|Protocol Violation|2|||
126534616|NCT01951625|455246801|FG001|Treatment Period|Protocol Violation|0|||
126534617|NCT01951625|455246802|FG002|Treatment Period|Protocol Violation|1|||
126534618|NCT01951625|455246803|FG003|Treatment Period|Protocol Violation|3|||
126534619|NCT01951625|455246804|FG004|Treatment Period|Protocol Violation|2|||
126534620|NCT01951625|455246800|FG000|Treatment Period|Physician Decision|0|||
126534621|NCT01951625|455246801|FG001|Treatment Period|Physician Decision|0|||
126534622|NCT01951625|455246802|FG002|Treatment Period|Physician Decision|0|||
126534623|NCT01951625|455246803|FG003|Treatment Period|Physician Decision|0|||
126534624|NCT01951625|455246804|FG004|Treatment Period|Physician Decision|1|||
126534625|NCT01951625|455246800|FG000|Treatment Period|Protocol driven decision point|0|||
126534626|NCT01951625|455246801|FG001|Treatment Period|Protocol driven decision point|5|||
126534627|NCT01951625|455246802|FG002|Treatment Period|Protocol driven decision point|0|||
126534628|NCT01951625|455246803|FG003|Treatment Period|Protocol driven decision point|2|||
126534629|NCT01951625|455246804|FG004|Treatment Period|Protocol driven decision point|1|||
126534630|NCT01951625|455246800|FG000|Treatment Period|Non compliance with study drug|1|||
126534631|NCT01951625|455246801|FG001|Treatment Period|Non compliance with study drug|2|||
126534632|NCT01951625|455246802|FG002|Treatment Period|Non compliance with study drug|2|||
126534633|NCT01951625|455246803|FG003|Treatment Period|Non compliance with study drug|0|||
126757892|NCT00310440|456064421|FG001|Overall Study|Withdrawal by Subject|1|||
126757893|NCT00310440|456064420|FG000|Overall Study|Missed 12 Month Visit|7|||
126757894|NCT00310440|456064421|FG001|Overall Study|Missed 12 Month Visit|4|||
126757895|NCT01098266|456064422|FG000|Overall Study|Physician Decision|1|||
126757896|NCT01098266|456064423|FG001|Overall Study|Physician Decision|0|||
126757897|NCT01098266|456064422|FG000|Overall Study|Death|3|||
126551803|NCT01807221|455315868|FG005|Overall Study|Adverse Event|21|||
126645374|NCT00379288|455660327|FG002|Overall Study|Subject withdrew-related to study drug|0|||
126645375|NCT00379288|455660328|FG003|Overall Study|Subject withdrew-related to study drug|1|||
126645376|NCT00379288|455660325|FG000|Overall Study|Noncompliance with protocol|8|||
126645377|NCT00379288|455660326|FG001|Overall Study|Noncompliance with protocol|6|||
126645378|NCT00379288|455660327|FG002|Overall Study|Noncompliance with protocol|2|||
126645379|NCT00379288|455660328|FG003|Overall Study|Noncompliance with protocol|1|||
126645380|NCT00379288|455660325|FG000|Overall Study|Did not meet protocol eligibility|0|||
126645381|NCT00379288|455660326|FG001|Overall Study|Did not meet protocol eligibility|1|||
126645382|NCT00379288|455660327|FG002|Overall Study|Did not meet protocol eligibility|0|||
126645383|NCT00379288|455660328|FG003|Overall Study|Did not meet protocol eligibility|2|||
126645384|NCT00379288|455660325|FG000|Overall Study|Administrative|2|||
126645385|NCT00379288|455660326|FG001|Overall Study|Administrative|2|||
126645386|NCT00379288|455660327|FG002|Overall Study|Administrative|0|||
126645387|NCT00379288|455660328|FG003|Overall Study|Administrative|1|||
126645388|NCT00918879|455660329|FG000|Overall Study|Withdrawal by Subject|4|||
126645389|NCT00918879|455660330|FG001|Overall Study|Withdrawal by Subject|4|||
126645390|NCT00918879|455660329|FG000|Overall Study|Lost to Follow-up|1|||
126645391|NCT00918879|455660330|FG001|Overall Study|Lost to Follow-up|1|||
126645392|NCT00918879|455660329|FG000|Overall Study|Severe non-compliance to protocol|1|||
126645393|NCT00918879|455660330|FG001|Overall Study|Severe non-compliance to protocol|1|||
126645394|NCT00833261|455660333|FG000|Overall Study|Withdrawal by Subject|4|||
126645395|NCT00357110|455660334|FG000|Overall Study|Early study termination|5|||
126645396|NCT00357110|455660335|FG001|Overall Study|Early study termination|5|||
126645397|NCT05602727|455660338|FG000|Overall Study|Physician Decision|0|||
126645398|NCT05602727|455660339|FG001|Overall Study|Physician Decision|1|||
126645399|NCT05602727|455660340|FG002|Overall Study|Physician Decision|0|||
126645400|NCT05602727|455660338|FG000|Overall Study|Randomized by mistake without study medication|1|||
126645401|NCT05602727|455660339|FG001|Overall Study|Randomized by mistake without study medication|0|||
126645402|NCT05602727|455660340|FG002|Overall Study|Randomized by mistake without study medication|0|||
126645403|NCT05602727|455660338|FG000|Overall Study|Study termination by Sponsor|18|||
126645404|NCT05602727|455660339|FG001|Overall Study|Study termination by Sponsor|15|||
126645405|NCT05602727|455660340|FG002|Overall Study|Study termination by Sponsor|19|||
126645406|NCT05602727|455660338|FG000|Overall Study|Withdrawal by Subject|2|||
126645407|NCT05602727|455660339|FG001|Overall Study|Withdrawal by Subject|1|||
126645408|NCT05602727|455660340|FG002|Overall Study|Withdrawal by Subject|1|||
126645409|NCT05602727|455660338|FG000|Overall Study|Various reasons|1|||
126645410|NCT05602727|455660339|FG001|Overall Study|Various reasons|6|||
126757898|NCT01098266|456064423|FG001|Overall Study|Death|2|||
126534634|NCT01951625|455246804|FG004|Treatment Period|Non compliance with study drug|0|||
126534635|NCT01951625|455246800|FG000|Treatment Period|Death|3|||
126534636|NCT01951625|455246801|FG001|Treatment Period|Death|2|||
126534637|NCT01951625|455246802|FG002|Treatment Period|Death|2|||
126534638|NCT01951625|455246803|FG003|Treatment Period|Death|1|||
126534639|NCT01951625|455246804|FG004|Treatment Period|Death|2|||
126534640|NCT01951625|455246800|FG000|Treatment Period|Adverse Event|7|||
126534641|NCT01951625|455246801|FG001|Treatment Period|Adverse Event|10|||
126534642|NCT01951625|455246802|FG002|Treatment Period|Adverse Event|9|||
126534643|NCT01951625|455246803|FG003|Treatment Period|Adverse Event|8|||
126534644|NCT01951625|455246804|FG004|Treatment Period|Adverse Event|8|||
126534645|NCT01951625|455246800|FG000|Treatment Period|Withdrawal by Subject|5|||
126534646|NCT01951625|455246801|FG001|Treatment Period|Withdrawal by Subject|2|||
126534647|NCT01951625|455246802|FG002|Treatment Period|Withdrawal by Subject|1|||
126534648|NCT01951625|455246803|FG003|Treatment Period|Withdrawal by Subject|7|||
126534649|NCT01951625|455246804|FG004|Treatment Period|Withdrawal by Subject|3|||
126534650|NCT01951625|455246800|FG000|Treatment Period|Lost to Follow-up|1|||
126534651|NCT01951625|455246801|FG001|Treatment Period|Lost to Follow-up|0|||
126757899|NCT01098266|456064422|FG000|Overall Study|Withdrawal by Subject|3|||
126757900|NCT01098266|456064423|FG001|Overall Study|Withdrawal by Subject|5|||
126757901|NCT00525499|456064427|FG000|Overall Study|Lost to Follow-up|2|||
126757902|NCT00525499|456064428|FG001|Overall Study|Lost to Follow-up|4|||
126757903|NCT00525499|456064429|FG002|Overall Study|Lost to Follow-up|1|||
126757904|NCT00525499|456064430|FG003|Overall Study|Lost to Follow-up|4|||
126757905|NCT00525499|456064427|FG000|Overall Study|Adverse Event|0|||
126757906|NCT00525499|456064428|FG001|Overall Study|Adverse Event|1|||
126757907|NCT00525499|456064429|FG002|Overall Study|Adverse Event|0|||
126757908|NCT00525499|456064430|FG003|Overall Study|Adverse Event|1|||
126757909|NCT00525499|456064427|FG000|Overall Study|Withdrawal by Subject|5|||
126757910|NCT00525499|456064428|FG001|Overall Study|Withdrawal by Subject|1|||
126757911|NCT00525499|456064429|FG002|Overall Study|Withdrawal by Subject|5|||
126757912|NCT00525499|456064430|FG003|Overall Study|Withdrawal by Subject|2|||
126757913|NCT00525499|456064427|FG000|Overall Study|Protocol Violation|0|||
126757914|NCT00525499|456064428|FG001|Overall Study|Protocol Violation|1|||
126757915|NCT00525499|456064429|FG002|Overall Study|Protocol Violation|1|||
126757916|NCT00525499|456064430|FG003|Overall Study|Protocol Violation|0|||
126757917|NCT00438815|456064431|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
126757918|NCT00438815|456064431|FG000|Overall Study|3-month follow-up no longer required|12|||
126757919|NCT00438815|456064431|FG000|Overall Study|Noncompliance with protocol requirements|9|||
126757920|NCT00438815|456064431|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
126757921|NCT00438815|456064431|FG000|Overall Study|Lost to Follow-up|6|||
126757922|NCT00438815|456064431|FG000|Overall Study|Withdrawal by Subject|6|||
126757923|NCT00438815|456064431|FG000|Overall Study|Death|1|||
126757924|NCT01733758|456064432|FG000|Overall Study|Adverse Event|5|||
126757925|NCT01733758|456064433|FG001|Overall Study|Adverse Event|7|||
126757926|NCT01733758|456064434|FG002|Overall Study|Adverse Event|8|||
126757927|NCT01733758|456064435|FG003|Overall Study|Adverse Event|1|||
126757928|NCT01733758|456064432|FG000|Overall Study|Withdrawal by Subject|1|||
126757929|NCT01733758|456064433|FG001|Overall Study|Withdrawal by Subject|1|||
126757930|NCT01733758|456064434|FG002|Overall Study|Withdrawal by Subject|5|||
126757931|NCT01733758|456064435|FG003|Overall Study|Withdrawal by Subject|3|||
126757932|NCT01733758|456064432|FG000|Overall Study|Persistent Hyperglycemia|3|||
126757933|NCT01733758|456064433|FG001|Overall Study|Persistent Hyperglycemia|2|||
126311627|NCT00957268|454429820|FG004|Overall Study|Voluntary Withdrawal|0|||
126757934|NCT01733758|456064434|FG002|Overall Study|Persistent Hyperglycemia|0|||
126757935|NCT01733758|456064435|FG003|Overall Study|Persistent Hyperglycemia|0|||
126757936|NCT01733758|456064432|FG000|Overall Study|Protocol Violation|0|||
126757937|NCT01733758|456064433|FG001|Overall Study|Protocol Violation|1|||
126757938|NCT01733758|456064434|FG002|Overall Study|Protocol Violation|2|||
126757939|NCT01733758|456064435|FG003|Overall Study|Protocol Violation|2|||
126757940|NCT01733758|456064432|FG000|Overall Study|Non-compliance|1|||
126757941|NCT01733758|456064433|FG001|Overall Study|Non-compliance|0|||
126757942|NCT01733758|456064434|FG002|Overall Study|Non-compliance|0|||
126757943|NCT01733758|456064435|FG003|Overall Study|Non-compliance|0|||
126757944|NCT01733758|456064432|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
126757945|NCT01733758|456064433|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
126757946|NCT01733758|456064434|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
126757947|NCT01733758|456064435|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
126757948|NCT01733758|456064432|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
126757949|NCT01733758|456064433|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
126757950|NCT01733758|456064434|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
126757951|NCT01733758|456064435|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
126757952|NCT03380091|456064443|FG000|Overall Study|Withdrawal by Subject|2|||
126757953|NCT03380091|456064444|FG001|Overall Study|Withdrawal by Subject|1|||
126757954|NCT05602818|456064445|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
126757955|NCT05602818|456064446|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
126306048|NCT02553499|454408876|FG007|Overall Study|Lost to Follow-up|0|||
126757956|NCT05602818|456064447|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
126757957|NCT05602818|456064448|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
126757958|NCT05602818|456064449|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
126757959|NCT05602818|456064450|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
126757960|NCT05602818|456064451|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
126757961|NCT05602818|456064452|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
126757962|NCT05602818|456064453|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
126757963|NCT05602818|456064454|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
126757964|NCT05602818|456064455|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
126757965|NCT05602818|456064456|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
126757966|NCT05602818|456064445|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
126757967|NCT05602818|456064446|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
126757968|NCT05602818|456064447|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126757969|NCT05602818|456064448|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126757970|NCT05602818|456064449|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126757971|NCT05602818|456064450|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126757972|NCT05602818|456064451|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126757973|NCT05602818|456064452|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126757974|NCT05602818|456064453|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126757975|NCT05602818|456064454|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126757976|NCT05602818|456064455|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126757977|NCT05602818|456064456|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
126757978|NCT05602818|456064445|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
126757979|NCT05602818|456064446|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126757980|NCT05602818|456064447|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126757981|NCT05602818|456064448|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126757982|NCT05602818|456064449|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126757983|NCT05602818|456064450|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126757984|NCT05602818|456064451|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126757985|NCT05602818|456064452|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126757986|NCT05602818|456064453|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126757987|NCT05602818|456064454|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126757988|NCT05602818|456064455|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126757989|NCT05602818|456064456|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
126757990|NCT05602818|456064445|FG000|Qualification Phase (3 Days)|Other|1|||
126311628|NCT00794040|454429821|FG000|Overall Study|Withdrawal by Subject|3|||
126311629|NCT00794040|454429822|FG001|Overall Study|Withdrawal by Subject|4|||
126311630|NCT00794040|454429821|FG000|Overall Study|Physician Decision|0|||
126311631|NCT00794040|454429822|FG001|Overall Study|Physician Decision|1|||
126311632|NCT02396420|454429823|FG000|Overall Study|Death|1|||
126311633|NCT01273623|454429824|FG000|Overall Study|did not meet IVUS criteria|29|||
126311634|NCT04064411|454429825|FG000|Overall Study|Adverse Event|29|||
126311635|NCT04064411|454429826|FG001|Overall Study|Adverse Event|19|||
126311636|NCT04064411|454429825|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
126311637|NCT04064411|454429826|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
126311638|NCT04064411|454429825|FG000|Overall Study|Protocol Deviation|0|||
126311639|NCT04064411|454429826|FG001|Overall Study|Protocol Deviation|2|||
126311640|NCT04064411|454429825|FG000|Overall Study|Withdrawal by Subject|25|||
126311641|NCT04064411|454429826|FG001|Overall Study|Withdrawal by Subject|29|||
126311642|NCT04064411|454429825|FG000|Overall Study|Lost to Follow-up|5|||
126311643|NCT04064411|454429826|FG001|Overall Study|Lost to Follow-up|2|||
126311644|NCT04064411|454429825|FG000|Overall Study|Other than Specified|4|||
126311645|NCT04064411|454429826|FG001|Overall Study|Other than Specified|1|||
126311646|NCT04064411|454429825|FG000|Overall Study|Death|1|||
126311647|NCT04064411|454429826|FG001|Overall Study|Death|0|||
126311648|NCT01970475|454429835|FG000|Overall Study|Withdrawal by Subject|11|||
126311649|NCT01970475|454429836|FG001|Overall Study|Withdrawal by Subject|6|||
126311650|NCT01970475|454429835|FG000|Overall Study|Adverse Event|7|||
126311651|NCT01970475|454429836|FG001|Overall Study|Adverse Event|3|||
126311652|NCT01970475|454429835|FG000|Overall Study|Lost to Follow-up|2|||
126311653|NCT01970475|454429836|FG001|Overall Study|Lost to Follow-up|2|||
126311654|NCT01970475|454429835|FG000|Overall Study|Protocol Violation|1|||
126311655|NCT01970475|454429836|FG001|Overall Study|Protocol Violation|0|||
126311656|NCT04413552|454429837|FG000|Overall Study|Adverse Event|0|||
126551804|NCT01807221|455315863|FG000|Overall Study|Protocol Violation|0|||
126311657|NCT04413552|454429838|FG001|Overall Study|Adverse Event|0|||
126311658|NCT04413552|454429839|FG002|Overall Study|Adverse Event|0|||
126311659|NCT04413552|454429840|FG003|Overall Study|Adverse Event|0|||
126311660|NCT04413552|454429841|FG004|Overall Study|Adverse Event|0|||
126311661|NCT04413552|454429842|FG005|Overall Study|Adverse Event|0|||
126311662|NCT04413552|454429843|FG006|Overall Study|Adverse Event|1|||
126757991|NCT05602818|456064446|FG001|Qualification Phase (3 Days)|Other|0|||
126757992|NCT05602818|456064447|FG002|Qualification Phase (3 Days)|Other|0|||
126757993|NCT05602818|456064448|FG003|Qualification Phase (3 Days)|Other|0|||
126757994|NCT05602818|456064449|FG004|Qualification Phase (3 Days)|Other|0|||
126757995|NCT05602818|456064450|FG005|Qualification Phase (3 Days)|Other|0|||
126757996|NCT05602818|456064451|FG006|Qualification Phase (3 Days)|Other|0|||
126757997|NCT05602818|456064452|FG007|Qualification Phase (3 Days)|Other|0|||
126757998|NCT05602818|456064453|FG008|Qualification Phase (3 Days)|Other|0|||
126757999|NCT05602818|456064454|FG009|Qualification Phase (3 Days)|Other|0|||
126758000|NCT05602818|456064455|FG010|Qualification Phase (3 Days)|Other|0|||
126758001|NCT05602818|456064456|FG011|Qualification Phase (3 Days)|Other|0|||
126758002|NCT05602818|456064445|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126758003|NCT05602818|456064446|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
126758004|NCT05602818|456064447|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126758005|NCT05602818|456064448|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126758006|NCT05602818|456064449|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126758007|NCT05602818|456064450|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126311663|NCT04413552|454429844|FG007|Overall Study|Adverse Event|0|||
126311664|NCT04413552|454429845|FG008|Overall Study|Adverse Event|0|||
126311665|NCT04413552|454429846|FG009|Overall Study|Adverse Event|0|||
126311666|NCT02100670|454429848|FG000|Overall Study|Adverse Event|10|||
126311667|NCT02100670|454429849|FG001|Overall Study|Adverse Event|3|||
126758008|NCT05602818|456064451|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126758009|NCT05602818|456064452|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126758010|NCT05602818|456064453|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126758011|NCT05602818|456064454|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126758012|NCT05602818|456064455|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126758013|NCT05602818|456064456|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
126758014|NCT05602818|456064445|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
126311668|NCT02100670|454429850|FG002|Overall Study|Adverse Event|3|||
126311669|NCT02100670|454429851|FG003|Overall Study|Adverse Event|0|||
126311670|NCT02100670|454429848|FG000|Overall Study|Lost to Follow-up|1|||
126311671|NCT02100670|454429849|FG001|Overall Study|Lost to Follow-up|0|||
126311672|NCT02100670|454429850|FG002|Overall Study|Lost to Follow-up|0|||
126311673|NCT02100670|454429851|FG003|Overall Study|Lost to Follow-up|0|||
126311674|NCT02100670|454429848|FG000|Overall Study|Protocol Violation|0|||
126311675|NCT02100670|454429849|FG001|Overall Study|Protocol Violation|1|||
126311676|NCT02100670|454429850|FG002|Overall Study|Protocol Violation|0|||
126311677|NCT02100670|454429851|FG003|Overall Study|Protocol Violation|1|||
126311678|NCT02100670|454429848|FG000|Overall Study|Withdrawal of Consent|0|||
126311679|NCT02100670|454429849|FG001|Overall Study|Withdrawal of Consent|1|||
126311680|NCT02100670|454429850|FG002|Overall Study|Withdrawal of Consent|1|||
126311681|NCT02100670|454429851|FG003|Overall Study|Withdrawal of Consent|0|||
126311682|NCT02100670|454429848|FG000|Overall Study|No swelling no pain|1|||
126311683|NCT02100670|454429849|FG001|Overall Study|No swelling no pain|0|||
126311684|NCT02100670|454429850|FG002|Overall Study|No swelling no pain|0|||
126311685|NCT02100670|454429851|FG003|Overall Study|No swelling no pain|0|||
126306049|NCT02553499|454408877|FG008|Overall Study|Lost to Follow-up|0|||
126311686|NCT02100670|454429848|FG000|Overall Study|Poor Efficacy|0|||
126311687|NCT02100670|454429849|FG001|Overall Study|Poor Efficacy|1|||
126311688|NCT02100670|454429850|FG002|Overall Study|Poor Efficacy|0|||
126311689|NCT02100670|454429851|FG003|Overall Study|Poor Efficacy|0|||
126311690|NCT02100670|454429848|FG000|Overall Study|Physician Decision|0|||
126311691|NCT02100670|454429849|FG001|Overall Study|Physician Decision|1|||
126311692|NCT02100670|454429850|FG002|Overall Study|Physician Decision|0|||
126311693|NCT02100670|454429851|FG003|Overall Study|Physician Decision|0|||
126311694|NCT02100670|454429848|FG000|Overall Study|Withdrawal by Subject|1|||
126311695|NCT02100670|454429849|FG001|Overall Study|Withdrawal by Subject|0|||
126311696|NCT02100670|454429850|FG002|Overall Study|Withdrawal by Subject|0|||
126311697|NCT02100670|454429851|FG003|Overall Study|Withdrawal by Subject|0|||
126311698|NCT04852679|454429852|FG000|Main Intervention Period|Withdrawal by Subject|3|||
126311699|NCT04852679|454429852|FG000|Main Intervention Period|Adverse Event|1|||
126311700|NCT04852679|454429852|FG000|Main Intervention Period|Progressive Disease|16|||
126311701|NCT04852679|454429852|FG000|Main Intervention Period|Refused study visit|1|||
126422525|NCT02714569|454842623|FG002|Part A Third Intervention|Adverse Event|1|||
126422526|NCT02714569|454842624|FG003|Part A Third Intervention|Adverse Event|0|||
126306050|NCT02553499|454408878|FG009|Overall Study|Lost to Follow-up|0|||
126306051|NCT02553499|454408879|FG010|Overall Study|Lost to Follow-up|0|||
126306052|NCT02553499|454408880|FG011|Overall Study|Lost to Follow-up|0|||
126306053|NCT02553499|454408881|FG012|Overall Study|Lost to Follow-up|0|||
126306054|NCT02553499|454408882|FG013|Overall Study|Lost to Follow-up|0|||
126311702|NCT04852679|454429852|FG000|Independent Injection Period|Missed study visit|1|||
126311703|NCT01294696|454429853|FG000|Overall Study|Screening failures|7|||
126311704|NCT01294696|454429853|FG000|Overall Study|Protocol Violation|8|||
126422527|NCT02714569|454842625|FG004|Part A Third Intervention|Adverse Event|0|||
126422528|NCT02714569|454842626|FG005|Part A Third Intervention|Adverse Event|0|||
126422529|NCT02714569|454842627|FG006|Part A Third Intervention|Adverse Event|0|||
126422530|NCT02714569|454842628|FG007|Part A Third Intervention|Adverse Event|0|||
126422531|NCT02714569|454842629|FG008|Part A Third Intervention|Adverse Event|0|||
126422532|NCT02714569|454842630|FG009|Part A Third Intervention|Adverse Event|0|||
126422533|NCT02714569|454842631|FG010|Part A Third Intervention|Adverse Event|0|||
126758015|NCT05602818|456064446|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
126758016|NCT05602818|456064447|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
126758017|NCT05602818|456064448|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
126758018|NCT05602818|456064449|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
126758019|NCT05602818|456064450|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
126422534|NCT02714569|454842621|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
126422535|NCT02714569|454842622|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422536|NCT02714569|454842623|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422537|NCT02714569|454842624|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422538|NCT02714569|454842625|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126311705|NCT01294696|454429853|FG000|Overall Study|Missing BPI Response|7|||
126311706|NCT01294696|454429853|FG000|Overall Study|Site closure|52|||
126369306|NCT02090764|454648191|FG001|Overall Study|Intercurrent illness and other|1|||
126369307|NCT02090764|454648190|FG000|Overall Study|Lost to Follow-up|2|||
126369308|NCT02090764|454648191|FG001|Overall Study|Lost to Follow-up|2|||
126369309|NCT02300233|454648193|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
126369310|NCT02300233|454648194|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
126369311|NCT02300233|454648195|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
126422539|NCT02714569|454842626|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
126369312|NCT02300233|454648193|FG000|Overall Study|Withdrawal by Subject|1|||
126369313|NCT02300233|454648194|FG001|Overall Study|Withdrawal by Subject|0|||
126422540|NCT02714569|454842627|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422541|NCT02714569|454842628|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422542|NCT02714569|454842629|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422543|NCT02714569|454842630|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126422544|NCT02714569|454842631|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
126758020|NCT05602818|456064451|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
126758021|NCT05602818|456064452|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
126758022|NCT05602818|456064453|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
126758023|NCT05602818|456064454|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
126758024|NCT05602818|456064455|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
126758025|NCT05602818|456064456|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
126758026|NCT05602818|456064445|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126758027|NCT05602818|456064446|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126758028|NCT05602818|456064447|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126758029|NCT05602818|456064448|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126758030|NCT05602818|456064449|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126758031|NCT05602818|456064450|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126758032|NCT05602818|456064451|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126758033|NCT05602818|456064452|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126369314|NCT02300233|454648195|FG002|Overall Study|Withdrawal by Subject|3|||
126369315|NCT02300233|454648193|FG000|Overall Study|Investigator Judgement|0|||
126369316|NCT02300233|454648194|FG001|Overall Study|Investigator Judgement|0|||
126369317|NCT02300233|454648195|FG002|Overall Study|Investigator Judgement|1|||
126369318|NCT02300233|454648193|FG000|Overall Study|Reason Not Specified|0|||
126369319|NCT02300233|454648194|FG001|Overall Study|Reason Not Specified|0|||
126369320|NCT02300233|454648195|FG002|Overall Study|Reason Not Specified|5|||
126369321|NCT00833690|454648196|FG000|Overall Study|Withdrawal by Subject|1|||
126369322|NCT00833690|454648197|FG001|Overall Study|Withdrawal by Subject|0|||
126369323|NCT00833690|454648198|FG002|Overall Study|Withdrawal by Subject|0|||
126369324|NCT00833690|454648196|FG000|Overall Study|Discontinued study drug|3|||
126369325|NCT00833690|454648197|FG001|Overall Study|Discontinued study drug|2|||
126369326|NCT00833690|454648198|FG002|Overall Study|Discontinued study drug|0|||
126369327|NCT02661815|454648199|FG000|Overall Study|Withdrawal by Subject|1|||
126369328|NCT02661815|454648200|FG001|Overall Study|Withdrawal by Subject|0|||
126422545|NCT02714569|454842621|FG000|Part B (Overall)|Lost to Follow-up|0|||
126422546|NCT02714569|454842622|FG001|Part B (Overall)|Lost to Follow-up|0|||
126422547|NCT02714569|454842623|FG002|Part B (Overall)|Lost to Follow-up|0|||
126758034|NCT05602818|456064453|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126758035|NCT05602818|456064454|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
126758036|NCT05602818|456064455|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
126758037|NCT05602818|456064456|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
126369329|NCT02661815|454648201|FG002|Overall Study|Withdrawal by Subject|0|||
126369330|NCT02661815|454648202|FG003|Overall Study|Withdrawal by Subject|0|||
126758038|NCT05602818|456064445|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
126758039|NCT05602818|456064446|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
126758040|NCT05602818|456064447|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
126758041|NCT05602818|456064448|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
126311707|NCT00381238|454432080|FG000|Overall Study|Adverse Event|3|||
126311708|NCT00381238|454432080|FG000|Overall Study|Protocol Violation|1|||
126311709|NCT00381238|454432080|FG000|Overall Study|Withdrawal by Subject|4|||
126311710|NCT00381238|454432080|FG000|Overall Study|Lack of Efficacy|2|||
126311711|NCT00381238|454432080|FG000|Overall Study|Withdrew by physician|1|||
126311712|NCT00381238|454432080|FG000|Overall Study|Disease progression|1|||
126311713|NCT02086448|454432084|FG000|Overall Study|Withdrawal by Subject|1|||
126311714|NCT02086448|454432085|FG001|Overall Study|Withdrawal by Subject|0|||
126311715|NCT02086448|454432086|FG002|Overall Study|Withdrawal by Subject|0|||
126311716|NCT02086448|454432087|FG003|Overall Study|Withdrawal by Subject|2|||
126311717|NCT00843037|454432090|FG000|Overall Study|Lost to Follow-up|1|||
126311718|NCT01871402|454432093|FG000|Overall Study|Lost to Follow-up|1|||
126311719|NCT01871402|454432094|FG001|Overall Study|Lost to Follow-up|0|||
126311720|NCT01871402|454432093|FG000|Overall Study|Withdrawal by Subject|0|||
126311721|NCT01871402|454432094|FG001|Overall Study|Withdrawal by Subject|2|||
126311722|NCT01871402|454432093|FG000|Overall Study|Non-compliance|0|||
126311723|NCT01871402|454432094|FG001|Overall Study|Non-compliance|1|||
126311724|NCT02424630|454432095|FG000|Overall Study|No rotator cuff tear|1|||
126311725|NCT02424630|454432096|FG001|Overall Study|No rotator cuff tear|2|||
126311726|NCT02424630|454432095|FG000|Overall Study|Open procedure|0|||
126311727|NCT02424630|454432096|FG001|Overall Study|Open procedure|1|||
126311728|NCT02703272|454432097|FG000|Overall Study|Death|4|||
126758042|NCT05602818|456064449|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
126758043|NCT05602818|456064450|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
126758044|NCT05602818|456064451|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
126758045|NCT05602818|456064452|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
126758046|NCT05602818|456064453|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
126758047|NCT05602818|456064454|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
126758048|NCT05602818|456064455|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
126758049|NCT05602818|456064456|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
126758050|NCT04594213|456064457|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
126758051|NCT04594213|456064458|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
126758052|NCT04594213|456064459|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
126758053|NCT04594213|456064460|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
126758054|NCT04594213|456064461|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
126758055|NCT04594213|456064462|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
126758056|NCT04594213|456064457|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
126311729|NCT02703272|454432098|FG001|Overall Study|Death|9|||
126311730|NCT02703272|454432099|FG002|Overall Study|Death|19|||
126311731|NCT02703272|454432100|FG003|Overall Study|Death|10|||
126311732|NCT02703272|454432097|FG000|Overall Study|Withdrawal by Subject|0|||
126311733|NCT02703272|454432098|FG001|Overall Study|Withdrawal by Subject|0|||
126311734|NCT02703272|454432099|FG002|Overall Study|Withdrawal by Subject|4|||
126758057|NCT04594213|456064458|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
126758058|NCT04594213|456064459|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
126758059|NCT04594213|456064460|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
126758060|NCT04594213|456064461|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
126758061|NCT04594213|456064462|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
126758062|NCT04594213|456064457|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
126311735|NCT02703272|454432100|FG003|Overall Study|Withdrawal by Subject|2|||
126758063|NCT04594213|456064458|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
126758064|NCT04594213|456064459|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
126758065|NCT04594213|456064460|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
126758066|NCT04594213|456064461|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
126758067|NCT04594213|456064462|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
126758068|NCT04594213|456064457|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126758069|NCT04594213|456064458|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126758070|NCT04594213|456064459|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126758071|NCT04594213|456064460|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126758072|NCT04594213|456064461|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
126758073|NCT04594213|456064462|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126758074|NCT04594213|456064457|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
126311736|NCT02703272|454432097|FG000|Overall Study|Study Terminated by Sponsor|6|||
126311737|NCT02703272|454432098|FG001|Overall Study|Study Terminated by Sponsor|1|||
126311738|NCT02703272|454432099|FG002|Overall Study|Study Terminated by Sponsor|12|||
126311739|NCT02703272|454432100|FG003|Overall Study|Study Terminated by Sponsor|4|||
126311740|NCT02703272|454432097|FG000|Overall Study|Other|1|||
126311741|NCT02703272|454432098|FG001|Overall Study|Other|0|||
126311742|NCT02703272|454432099|FG002|Overall Study|Other|0|||
126311743|NCT02703272|454432100|FG003|Overall Study|Other|0|||
126758075|NCT04594213|456064458|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
126758076|NCT04594213|456064459|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
126758077|NCT04594213|456064460|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
126758078|NCT04594213|456064461|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
126758079|NCT04594213|456064462|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
126758080|NCT04594213|456064457|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126758081|NCT04594213|456064458|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126758082|NCT04594213|456064459|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126758083|NCT04594213|456064460|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126758084|NCT04594213|456064461|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126758085|NCT04594213|456064462|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
126758086|NCT04594213|456064457|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126758087|NCT04594213|456064458|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126758088|NCT04594213|456064459|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126758089|NCT04594213|456064460|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
126758090|NCT04594213|456064461|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126758091|NCT04594213|456064462|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126758092|NCT04594213|456064457|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
126758093|NCT04594213|456064458|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
126758094|NCT04594213|456064459|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
126758095|NCT04594213|456064460|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
126758096|NCT04594213|456064461|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
126758097|NCT04594213|456064462|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
126758098|NCT04594213|456064457|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
126758099|NCT04594213|456064458|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
126758100|NCT04594213|456064459|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
126758101|NCT04594213|456064460|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
126758102|NCT04594213|456064461|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
126758103|NCT04594213|456064462|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
126758104|NCT04594213|456064457|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
126758105|NCT04594213|456064458|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
126758106|NCT04594213|456064459|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
126758107|NCT04594213|456064460|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
126758108|NCT04594213|456064461|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
126758109|NCT04594213|456064462|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
126758110|NCT04594213|456064457|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
126758111|NCT04594213|456064458|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
126758112|NCT04594213|456064459|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
126311744|NCT02637895|454432101|FG000|Overall Study|Lost to Follow-up|4|||
126311745|NCT02637895|454432102|FG001|Overall Study|Lost to Follow-up|0|||
126311746|NCT02637895|454432101|FG000|Overall Study|Protocol Violation|0|||
126311747|NCT02637895|454432102|FG001|Overall Study|Protocol Violation|1|||
126311748|NCT02637895|454432101|FG000|Overall Study|Lack of Efficacy|1|||
126311749|NCT02637895|454432102|FG001|Overall Study|Lack of Efficacy|0|||
126311750|NCT02637895|454432101|FG000|Overall Study|Withdrawal by Subject|1|||
126311751|NCT02637895|454432102|FG001|Overall Study|Withdrawal by Subject|1|||
126311752|NCT02637895|454432101|FG000|Overall Study|Abnormal baseline lab|0|||
126311753|NCT02637895|454432102|FG001|Overall Study|Abnormal baseline lab|1|||
126311754|NCT02222545|454432103|FG000|Overall Study|Adverse Event|1|||
126311755|NCT02222545|454432104|FG001|Overall Study|Adverse Event|0|||
126311756|NCT02222545|454432105|FG002|Overall Study|Adverse Event|2|||
126311757|NCT02222545|454432103|FG000|Overall Study|Death|0|||
126311758|NCT02222545|454432104|FG001|Overall Study|Death|0|||
126311759|NCT02222545|454432105|FG002|Overall Study|Death|9|||
126311760|NCT02222545|454432103|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
126311761|NCT02222545|454432104|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
126311762|NCT02222545|454432105|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
126311763|NCT02222545|454432103|FG000|Overall Study|Withdrawal by Subject|0|||
126311764|NCT02222545|454432104|FG001|Overall Study|Withdrawal by Subject|0|||
126311765|NCT02222545|454432105|FG002|Overall Study|Withdrawal by Subject|3|||
126311766|NCT02222545|454432103|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
126311767|NCT02222545|454432104|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
126758113|NCT04594213|456064460|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
126758114|NCT04594213|456064461|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
126311768|NCT02222545|454432105|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
126311769|NCT00761280|454432106|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
126311770|NCT00761280|454432107|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
126311771|NCT00761280|454432106|FG000|Randomization to First Dose|Sponsor decision|1|||
126311772|NCT00761280|454432107|FG001|Randomization to First Dose|Sponsor decision|0|||
126311773|NCT00761280|454432106|FG000|Randomization to First Dose|Other|1|||
126422548|NCT02714569|454842624|FG003|Part B (Overall)|Lost to Follow-up|0|||
126422549|NCT02714569|454842625|FG004|Part B (Overall)|Lost to Follow-up|0|||
126422550|NCT02714569|454842626|FG005|Part B (Overall)|Lost to Follow-up|0|||
126422551|NCT02714569|454842627|FG006|Part B (Overall)|Lost to Follow-up|1|||
126422552|NCT02714569|454842628|FG007|Part B (Overall)|Lost to Follow-up|0|||
126422553|NCT02714569|454842629|FG008|Part B (Overall)|Lost to Follow-up|0|||
126422554|NCT02714569|454842630|FG009|Part B (Overall)|Lost to Follow-up|0|||
126422555|NCT02714569|454842631|FG010|Part B (Overall)|Lost to Follow-up|0|||
126422556|NCT02714569|454842621|FG000|Part B (Overall)|Withdrawal by Subject|0|||
126422557|NCT02714569|454842622|FG001|Part B (Overall)|Withdrawal by Subject|0|||
126422558|NCT02714569|454842623|FG002|Part B (Overall)|Withdrawal by Subject|0|||
126422559|NCT02714569|454842624|FG003|Part B (Overall)|Withdrawal by Subject|0|||
126422560|NCT02714569|454842625|FG004|Part B (Overall)|Withdrawal by Subject|0|||
126758115|NCT04594213|456064462|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
126534652|NCT01951625|455246802|FG002|Treatment Period|Lost to Follow-up|0|||
126534653|NCT01951625|455246803|FG003|Treatment Period|Lost to Follow-up|1|||
126534654|NCT01951625|455246804|FG004|Treatment Period|Lost to Follow-up|0|||
126534655|NCT01951625|455246800|FG000|Follow Up Period|Non-compliance with study drug|1|||
126551805|NCT01807221|455315864|FG001|Overall Study|Protocol Violation|2|||
126758116|NCT03814499|456064468|FG000|Overall Study|Lost to Follow-up|3|||
126758117|NCT01589185|456064469|FG000|Overall Study|Death|1|||
126422561|NCT02714569|454842626|FG005|Part B (Overall)|Withdrawal by Subject|0|||
126422562|NCT02714569|454842627|FG006|Part B (Overall)|Withdrawal by Subject|0|||
126422563|NCT02714569|454842628|FG007|Part B (Overall)|Withdrawal by Subject|1|||
126422564|NCT02714569|454842629|FG008|Part B (Overall)|Withdrawal by Subject|0|||
126422565|NCT02714569|454842630|FG009|Part B (Overall)|Withdrawal by Subject|1|||
126422566|NCT02714569|454842631|FG010|Part B (Overall)|Withdrawal by Subject|0|||
126422567|NCT02714569|454842621|FG000|Part B (Overall)|Adverse Event|0|||
126422568|NCT02714569|454842622|FG001|Part B (Overall)|Adverse Event|0|||
126422569|NCT02714569|454842623|FG002|Part B (Overall)|Adverse Event|0|||
126422570|NCT02714569|454842624|FG003|Part B (Overall)|Adverse Event|0|||
126758118|NCT01589185|456064470|FG001|Overall Study|Death|2|||
126758119|NCT01589185|456064471|FG002|Overall Study|Death|2|||
126758120|NCT01589185|456064472|FG003|Overall Study|Death|0|||
126758121|NCT01589185|456064473|FG004|Overall Study|Death|1|||
126758122|NCT01589185|456064469|FG000|Overall Study|Lost to Follow-up|1|||
126758123|NCT01589185|456064470|FG001|Overall Study|Lost to Follow-up|0|||
126758124|NCT01589185|456064471|FG002|Overall Study|Lost to Follow-up|2|||
126758125|NCT01589185|456064472|FG003|Overall Study|Lost to Follow-up|3|||
126758126|NCT01589185|456064473|FG004|Overall Study|Lost to Follow-up|0|||
126758127|NCT02046993|456064474|FG000|Overall Study|Withdrawal by Subject|2|||
126758128|NCT02046993|456064475|FG001|Overall Study|Withdrawal by Subject|10|||
126758129|NCT02046993|456064474|FG000|Overall Study|Lost to Follow-up|1|||
126758130|NCT02046993|456064475|FG001|Overall Study|Lost to Follow-up|1|||
126758131|NCT00598442|456064478|FG000|Overall Study|Adverse Event|3|||
126422571|NCT02714569|454842625|FG004|Part B (Overall)|Adverse Event|0|||
126422572|NCT02714569|454842626|FG005|Part B (Overall)|Adverse Event|0|||
126422573|NCT02714569|454842627|FG006|Part B (Overall)|Adverse Event|0|||
126422574|NCT02714569|454842628|FG007|Part B (Overall)|Adverse Event|0|||
126422575|NCT02714569|454842629|FG008|Part B (Overall)|Adverse Event|0|||
126422576|NCT02714569|454842630|FG009|Part B (Overall)|Adverse Event|1|||
126422577|NCT02714569|454842631|FG010|Part B (Overall)|Adverse Event|0|||
126551806|NCT01807221|455315865|FG002|Overall Study|Protocol Violation|1|||
126551807|NCT01807221|455315866|FG003|Overall Study|Protocol Violation|2|||
126551808|NCT01807221|455315867|FG004|Overall Study|Protocol Violation|0|||
126551809|NCT01807221|455315868|FG005|Overall Study|Protocol Violation|1|||
126551810|NCT01807221|455315863|FG000|Overall Study|Non-compliance|1|||
126551811|NCT01807221|455315864|FG001|Overall Study|Non-compliance|2|||
126551812|NCT01807221|455315865|FG002|Overall Study|Non-compliance|0|||
126551813|NCT01807221|455315866|FG003|Overall Study|Non-compliance|1|||
126551814|NCT01807221|455315867|FG004|Overall Study|Non-compliance|0|||
126551815|NCT01807221|455315868|FG005|Overall Study|Non-compliance|0|||
126551816|NCT01807221|455315863|FG000|Overall Study|Logistical difficulties|0|||
126551817|NCT01807221|455315864|FG001|Overall Study|Logistical difficulties|1|||
126551818|NCT01807221|455315865|FG002|Overall Study|Logistical difficulties|0|||
126551819|NCT01807221|455315866|FG003|Overall Study|Logistical difficulties|0|||
126551820|NCT01807221|455315867|FG004|Overall Study|Logistical difficulties|1|||
126551821|NCT01807221|455315868|FG005|Overall Study|Logistical difficulties|0|||
126551822|NCT01807221|455315863|FG000|Overall Study|Withdrawal by Subject|33|||
126551823|NCT01807221|455315864|FG001|Overall Study|Withdrawal by Subject|15|||
126551824|NCT01807221|455315865|FG002|Overall Study|Withdrawal by Subject|8|||
126551825|NCT01807221|455315866|FG003|Overall Study|Withdrawal by Subject|14|||
126551826|NCT01807221|455315867|FG004|Overall Study|Withdrawal by Subject|16|||
126551827|NCT01807221|455315868|FG005|Overall Study|Withdrawal by Subject|13|||
126551828|NCT01807221|455315863|FG000|Overall Study|Sponsor decision|2|||
126551829|NCT01807221|455315864|FG001|Overall Study|Sponsor decision|0|||
126551830|NCT01807221|455315865|FG002|Overall Study|Sponsor decision|1|||
126422578|NCT04915729|454842632|FG000|Overall Study|Lost to Follow-up|20|||
126758132|NCT00598442|456064479|FG001|Overall Study|Adverse Event|0|||
126758133|NCT00598442|456064480|FG002|Overall Study|Adverse Event|0|||
126645411|NCT05602727|455660340|FG002|Overall Study|Various reasons|1|||
126645412|NCT03889704|455660341|FG000|Overall Study|Study terminated due to pandemic|1|||
126645413|NCT03482466|455660342|FG000|Overall Study|Protocol Violation|2|||
126645414|NCT01493427|455660347|FG000|Overall Study|Adverse Event|10|||
126645415|NCT01493427|455660347|FG000|Overall Study|Personal Reasons|4|||
126645416|NCT01493427|455660347|FG000|Overall Study|Lost to Follow-up|2|||
126645417|NCT01493427|455660347|FG000|Overall Study|Inability to Follow Instructions|2|||
126645418|NCT01493427|455660347|FG000|Overall Study|Other|2|||
126645419|NCT01461811|455660348|FG000|Overall Study|Adverse Event|2|||
126645420|NCT01461811|455660349|FG001|Overall Study|Adverse Event|1|||
126645421|NCT01461811|455660348|FG000|Overall Study|Subject decision unrelated to an AE|1|||
126645422|NCT01461811|455660349|FG001|Overall Study|Subject decision unrelated to an AE|1|||
126645423|NCT01461811|455660348|FG000|Overall Study|Noncompliance|1|||
126645424|NCT01461811|455660349|FG001|Overall Study|Noncompliance|1|||
126645425|NCT02781090|455660350|FG000|3-Month Follow-Up|Missed Visit|20|||
126645426|NCT02781090|455660351|FG001|3-Month Follow-Up|Missed Visit|20|||
126645427|NCT02781090|455660350|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
126645428|NCT02781090|455660351|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
126645429|NCT02781090|455660350|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
126645430|NCT02781090|455660351|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
126645431|NCT02781090|455660350|FG000|3-Month Follow-Up|Death|1|||
126645432|NCT02781090|455660351|FG001|3-Month Follow-Up|Death|0|||
126645433|NCT02781090|455660350|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
126645434|NCT02781090|455660351|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
126645435|NCT02781090|455660350|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
126645436|NCT02781090|455660351|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
126645437|NCT02781090|455660350|FG000|6-Month Follow-Up|Death|0|||
126645438|NCT02781090|455660351|FG001|6-Month Follow-Up|Death|1|||
126645439|NCT01712061|455660352|FG000|Overall Study|Adverse Event|4|||
126645440|NCT01712061|455660353|FG001|Overall Study|Adverse Event|9|||
126645441|NCT01712061|455660354|FG002|Overall Study|Adverse Event|5|||
126645442|NCT01712061|455660352|FG000|Overall Study|Death|0|||
126645443|NCT01712061|455660353|FG001|Overall Study|Death|0|||
126645444|NCT01712061|455660354|FG002|Overall Study|Death|1|||
126645445|NCT01712061|455660352|FG000|Overall Study|Lost to Follow-up|1|||
126534656|NCT01951625|455246801|FG001|Follow Up Period|Non-compliance with study drug|0|||
126534657|NCT01951625|455246802|FG002|Follow Up Period|Non-compliance with study drug|0|||
126534658|NCT01951625|455246803|FG003|Follow Up Period|Non-compliance with study drug|0|||
126534659|NCT01951625|455246804|FG004|Follow Up Period|Non-compliance with study drug|0|||
126534660|NCT01951625|455246800|FG000|Follow Up Period|Death|1|||
126534661|NCT01951625|455246801|FG001|Follow Up Period|Death|3|||
126534662|NCT01951625|455246802|FG002|Follow Up Period|Death|2|||
126534663|NCT01951625|455246803|FG003|Follow Up Period|Death|2|||
126534664|NCT01951625|455246804|FG004|Follow Up Period|Death|1|||
126534665|NCT01951625|455246800|FG000|Follow Up Period|Logistical difficulties|1|||
126534666|NCT01951625|455246801|FG001|Follow Up Period|Logistical difficulties|2|||
126534667|NCT01951625|455246802|FG002|Follow Up Period|Logistical difficulties|0|||
126534668|NCT01951625|455246803|FG003|Follow Up Period|Logistical difficulties|0|||
126534669|NCT01951625|455246804|FG004|Follow Up Period|Logistical difficulties|0|||
126534670|NCT01951625|455246800|FG000|Follow Up Period|Adverse Event|0|||
126534671|NCT01951625|455246801|FG001|Follow Up Period|Adverse Event|3|||
126534672|NCT01951625|455246802|FG002|Follow Up Period|Adverse Event|2|||
126534673|NCT01951625|455246803|FG003|Follow Up Period|Adverse Event|3|||
126534674|NCT01951625|455246804|FG004|Follow Up Period|Adverse Event|5|||
126534675|NCT01951625|455246800|FG000|Follow Up Period|Withdrawal by Subject|4|||
126534676|NCT01951625|455246801|FG001|Follow Up Period|Withdrawal by Subject|1|||
126534677|NCT01951625|455246802|FG002|Follow Up Period|Withdrawal by Subject|0|||
126534678|NCT01951625|455246803|FG003|Follow Up Period|Withdrawal by Subject|5|||
126645446|NCT01712061|455660353|FG001|Overall Study|Lost to Follow-up|0|||
126645447|NCT01712061|455660354|FG002|Overall Study|Lost to Follow-up|1|||
126645448|NCT01712061|455660352|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
126645449|NCT01712061|455660353|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
126645450|NCT01712061|455660354|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
126645451|NCT01712061|455660352|FG000|Overall Study|Medication Error Without Associated AE|0|||
126645452|NCT01712061|455660353|FG001|Overall Study|Medication Error Without Associated AE|1|||
126758134|NCT00598442|456064478|FG000|Overall Study|Death|19|||
126758135|NCT00598442|456064479|FG001|Overall Study|Death|11|||
126758136|NCT00598442|456064480|FG002|Overall Study|Death|11|||
126758137|NCT00598442|456064478|FG000|Overall Study|Lost to Follow-up|4|||
126758138|NCT00598442|456064479|FG001|Overall Study|Lost to Follow-up|3|||
126758139|NCT00598442|456064480|FG002|Overall Study|Lost to Follow-up|3|||
126758140|NCT00598442|456064478|FG000|Overall Study|Physician Decision|2|||
126645453|NCT01712061|455660354|FG002|Overall Study|Medication Error Without Associated AE|0|||
126645454|NCT01712061|455660352|FG000|Overall Study|Withdrawal by Subject|1|||
126306055|NCT02553499|454408869|FG000|Overall Study|Physician Decision|0|||
126758141|NCT00598442|456064479|FG001|Overall Study|Physician Decision|1|||
126645455|NCT01712061|455660353|FG001|Overall Study|Withdrawal by Subject|7|||
126645456|NCT01712061|455660354|FG002|Overall Study|Withdrawal by Subject|1|||
126645457|NCT01712061|455660352|FG000|Overall Study|Other|0|||
126645458|NCT01712061|455660353|FG001|Overall Study|Other|3|||
126645459|NCT01712061|455660354|FG002|Overall Study|Other|0|||
126645460|NCT00879775|455660357|FG000|Overall Study|Lost to Follow-up|2|||
126645461|NCT00879775|455660358|FG001|Overall Study|Lost to Follow-up|1|||
126645462|NCT01195623|455660359|FG000|Overall Study|Lost to Follow-up|35|||
126645463|NCT01195623|455660360|FG001|Overall Study|Lost to Follow-up|37|||
126645464|NCT01401153|455660362|FG000|First Test Day|Learning disabilities; illness|1|||
126645465|NCT01401153|455660363|FG001|First Test Day|Learning disabilities; illness|10|||
126645466|NCT01401153|455660362|FG000|Second Test Day|illness|0|||
126645467|NCT01401153|455660363|FG001|Second Test Day|illness|5|||
126645468|NCT01677767|455660364|FG000|Overall Study|Adverse Event|1|||
126645469|NCT01677767|455660364|FG000|Overall Study|Death|4|||
126645470|NCT01677767|455660364|FG000|Overall Study|Protocol Violation|4|||
126645471|NCT01677767|455660364|FG000|Overall Study|Withdrawal by Subject|10|||
126645472|NCT01677767|455660364|FG000|Overall Study|Non-compliance by the participants|3|||
126645473|NCT03846453|455660365|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
126534679|NCT01951625|455246804|FG004|Follow Up Period|Withdrawal by Subject|3|||
126534680|NCT01951625|455246800|FG000|Follow Up Period|Lost to Follow-up|1|||
126534681|NCT01951625|455246801|FG001|Follow Up Period|Lost to Follow-up|0|||
126534682|NCT01951625|455246802|FG002|Follow Up Period|Lost to Follow-up|0|||
126534683|NCT01951625|455246803|FG003|Follow Up Period|Lost to Follow-up|1|||
126534684|NCT01951625|455246804|FG004|Follow Up Period|Lost to Follow-up|1|||
126534685|NCT02459574|455246805|FG000|Overall Study|Withdrawal by Subject|6|||
126534686|NCT02459574|455246806|FG001|Overall Study|Withdrawal by Subject|6|||
126534687|NCT02459574|455246807|FG002|Overall Study|Withdrawal by Subject|2|||
126534688|NCT02459574|455246805|FG000|Overall Study|Lost to Follow-up|1|||
126534689|NCT02459574|455246806|FG001|Overall Study|Lost to Follow-up|1|||
126534690|NCT02459574|455246807|FG002|Overall Study|Lost to Follow-up|0|||
126534691|NCT02459574|455246805|FG000|Overall Study|Death|0|||
126534692|NCT02459574|455246806|FG001|Overall Study|Death|1|||
126534693|NCT02459574|455246807|FG002|Overall Study|Death|0|||
126534694|NCT00251745|455246808|FG000|Overall Study|Adverse Event|7|||
126534695|NCT00251745|455246809|FG001|Overall Study|Adverse Event|9|||
126534696|NCT00251745|455246810|FG002|Overall Study|Adverse Event|11|||
126534697|NCT00251745|455246808|FG000|Overall Study|Lost to Follow-up|4|||
126534698|NCT00251745|455246809|FG001|Overall Study|Lost to Follow-up|2|||
126534699|NCT00251745|455246810|FG002|Overall Study|Lost to Follow-up|5|||
126534700|NCT00251745|455246808|FG000|Overall Study|Withdrawal by Subject|13|||
126534701|NCT00251745|455246809|FG001|Overall Study|Withdrawal by Subject|7|||
126534702|NCT00251745|455246810|FG002|Overall Study|Withdrawal by Subject|3|||
126534703|NCT00251745|455246808|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
126534704|NCT00251745|455246809|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
126534705|NCT00251745|455246810|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
126534706|NCT00251745|455246808|FG000|Overall Study|Lack of Efficacy|3|||
126534707|NCT00251745|455246809|FG001|Overall Study|Lack of Efficacy|0|||
126534708|NCT00251745|455246810|FG002|Overall Study|Lack of Efficacy|0|||
126534709|NCT00251745|455246808|FG000|Overall Study|Noncompliant|0|||
126534710|NCT00251745|455246809|FG001|Overall Study|Noncompliant|2|||
126534711|NCT00251745|455246810|FG002|Overall Study|Noncompliant|2|||
126534712|NCT00251745|455246808|FG000|Overall Study|Pregnancy|0|||
126534713|NCT00251745|455246809|FG001|Overall Study|Pregnancy|1|||
126534714|NCT00251745|455246810|FG002|Overall Study|Pregnancy|0|||
126534715|NCT00251745|455246808|FG000|Overall Study|Per Subject Request|0|||
126534716|NCT00251745|455246809|FG001|Overall Study|Per Subject Request|0|||
126534717|NCT00251745|455246810|FG002|Overall Study|Per Subject Request|1|||
126534718|NCT00251745|455246808|FG000|Overall Study|Per Investigator Request|1|||
126534719|NCT00251745|455246809|FG001|Overall Study|Per Investigator Request|0|||
126534720|NCT00251745|455246810|FG002|Overall Study|Per Investigator Request|0|||
126534721|NCT04508699|455246813|FG000|Overall Study|Lack of Efficacy|2|||
126534722|NCT04508699|455246814|FG001|Overall Study|Lack of Efficacy|15|||
126534723|NCT04508699|455246813|FG000|Overall Study|Withdrawal by Subject|0|||
126534724|NCT04508699|455246814|FG001|Overall Study|Withdrawal by Subject|2|||
126534725|NCT04866017|455246815|FG000|Overall Study|Study Terminated by Sponsor|13|||
126534726|NCT04866017|455246816|FG001|Overall Study|Study Terminated by Sponsor|14|||
126534727|NCT04866017|455246817|FG002|Overall Study|Study Terminated by Sponsor|13|||
126534728|NCT04866017|455246815|FG000|Overall Study|Death|8|||
126534729|NCT04866017|455246816|FG001|Overall Study|Death|4|||
126534730|NCT04866017|455246817|FG002|Overall Study|Death|8|||
126534731|NCT04866017|455246815|FG000|Overall Study|Withdrawal by Subject|1|||
126534732|NCT04866017|455246816|FG001|Overall Study|Withdrawal by Subject|0|||
126534733|NCT04866017|455246817|FG002|Overall Study|Withdrawal by Subject|1|||
126534734|NCT04866017|455246815|FG000|Overall Study|Physician Decision|0|||
126534735|NCT04866017|455246816|FG001|Overall Study|Physician Decision|1|||
126534736|NCT04866017|455246817|FG002|Overall Study|Physician Decision|0|||
126645474|NCT03846453|455660366|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
126534737|NCT01475136|455246818|FG000|Overall Study|Sponsor Decision|0|||
126645475|NCT03846453|455660367|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
126645476|NCT03846453|455660365|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
126645477|NCT03846453|455660366|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
126645478|NCT03846453|455660367|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
126645479|NCT03846453|455660365|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
126645480|NCT03846453|455660366|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
126645481|NCT03846453|455660367|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
126645482|NCT03846453|455660365|FG000|Placebo Run-in (14 Days)|Other|2|||
126645483|NCT03846453|455660366|FG001|Placebo Run-in (14 Days)|Other|0|||
126645484|NCT03846453|455660367|FG002|Placebo Run-in (14 Days)|Other|0|||
126645485|NCT03846453|455660365|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
126645486|NCT03846453|455660366|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
126645487|NCT03846453|455660367|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
126645488|NCT03846453|455660365|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
126645489|NCT03846453|455660366|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
126645490|NCT03846453|455660367|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
126645491|NCT03846453|455660365|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
126645492|NCT03846453|455660366|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
126645493|NCT03846453|455660367|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
126645494|NCT03846453|455660365|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
126645495|NCT03846453|455660366|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
126645496|NCT03846453|455660367|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
126645497|NCT03846453|455660365|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
126645498|NCT03846453|455660366|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
126645499|NCT03846453|455660367|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
126645500|NCT00757627|455660368|FG000|Overall Study|Adverse Event|15|||
126645501|NCT00757627|455660368|FG000|Overall Study|Lack of Efficacy|10|||
126645502|NCT00757627|455660368|FG000|Overall Study|Lost to Follow-up|28|||
126645503|NCT00757627|455660368|FG000|Overall Study|Withdrawal by Subject|27|||
126645504|NCT00757627|455660368|FG000|Overall Study|Other|1|||
126645505|NCT00468143|455660369|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
126645506|NCT00468143|455660370|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
126645507|NCT00468143|455660369|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
126645508|NCT00468143|455660370|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
126645509|NCT01606670|455660373|FG000|Overall Study|Adverse Event|6|||
126311774|NCT00761280|454432107|FG001|Randomization to First Dose|Other|0|||
126311775|NCT00761280|454432106|FG000|First Dose to End of Study|End of trial|5|||
126311776|NCT00761280|454432107|FG001|First Dose to End of Study|End of trial|5|||
126311777|NCT00761280|454432106|FG000|First Dose to End of Study|Progressive disease|5|||
126311778|NCT00761280|454432107|FG001|First Dose to End of Study|Progressive disease|3|||
126311779|NCT00761280|454432106|FG000|First Dose to End of Study|Sponsor decision|1|||
126311780|NCT00761280|454432107|FG001|First Dose to End of Study|Sponsor decision|2|||
126311781|NCT00761280|454432106|FG000|First Dose to End of Study|Death|1|||
126311782|NCT00761280|454432107|FG001|First Dose to End of Study|Death|0|||
126311783|NCT00761280|454432106|FG000|First Dose to End of Study|Lost to Follow-up|0|||
126311784|NCT00761280|454432107|FG001|First Dose to End of Study|Lost to Follow-up|1|||
126311785|NCT02691013|454432109|FG000|Overall Study|Withdrawal by Subject|3|||
126311786|NCT02691013|454432110|FG001|Overall Study|Withdrawal by Subject|0|||
126311787|NCT02111785|454432114|FG000|Overall Study|Death|0|||
126311788|NCT02111785|454432115|FG001|Overall Study|Death|1|||
126311789|NCT02111785|454432116|FG002|Overall Study|Death|0|||
126311790|NCT02111785|454432117|FG003|Overall Study|Death|0|||
126311791|NCT01075646|454432120|FG000|Overall Study|Lost to Follow-up|4|||
126311792|NCT01075646|454432121|FG001|Overall Study|Lost to Follow-up|3|||
126311793|NCT01075646|454432122|FG002|Overall Study|Lost to Follow-up|1|||
126311794|NCT01075646|454432123|FG003|Overall Study|Lost to Follow-up|2|||
126311795|NCT01676896|454432127|FG000|Overall Study|Withdrawal by Subject|12|||
126311796|NCT01676896|454432128|FG001|Overall Study|Withdrawal by Subject|7|||
126311797|NCT01676896|454432129|FG002|Overall Study|Withdrawal by Subject|19|||
126311798|NCT01895608|454432130|FG000|Overall Study|change in health status|0|||
126311799|NCT01895608|454432131|FG001|Overall Study|change in health status|1|||
126311800|NCT01895608|454432132|FG002|Overall Study|change in health status|1|||
126311801|NCT01895608|454432133|FG003|Overall Study|change in health status|0|||
126645510|NCT01606670|455660373|FG000|Overall Study|Lack of Efficacy|2|||
126645511|NCT01606670|455660373|FG000|Overall Study|Lost to Follow-up|3|||
126645512|NCT01606670|455660373|FG000|Overall Study|Withdrawal by Subject|3|||
126645513|NCT01606670|455660373|FG000|Overall Study|Other Reason|2|||
126645514|NCT02636725|455660375|FG000|Overall Study|Adverse Event|1|||
126645515|NCT05330676|455660376|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
126311802|NCT01895608|454432130|FG000|Overall Study|Withdrawal by Subject|0|||
126311803|NCT01895608|454432131|FG001|Overall Study|Withdrawal by Subject|0|||
126311804|NCT01895608|454432132|FG002|Overall Study|Withdrawal by Subject|2|||
126645516|NCT05330676|455660377|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
126645517|NCT01559129|455660379|FG000|Treatment Phase|Adverse Event|0|||
126645518|NCT01559129|455660380|FG001|Treatment Phase|Adverse Event|2|||
126311805|NCT01895608|454432133|FG003|Overall Study|Withdrawal by Subject|0|||
126311806|NCT03505593|454432134|FG000|Overall Study|Withdrawal by Subject|1|||
126311807|NCT03505593|454432134|FG000|Overall Study|Died before procedure|1|||
126311808|NCT03505593|454432134|FG000|Overall Study|Anatomical abnormality|1|||
126311809|NCT03505593|454432134|FG000|Overall Study|Unable to pass through esophagus|1|||
126311810|NCT03505593|454432134|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
126311811|NCT00738881|454432137|FG000|Overall Study|Withdrawal by Subject|0|||
126311812|NCT00738881|454432138|FG001|Overall Study|Withdrawal by Subject|2|||
126311813|NCT01044290|454432139|FG000|Follow-up 1|Death|3|||
126311814|NCT01044290|454432140|FG001|Follow-up 1|Death|3|||
126311815|NCT01044290|454432141|FG002|Follow-up 1|Death|1|||
126311816|NCT01044290|454432139|FG000|Follow-up 1|Withdrawal by Subject|2|||
126311817|NCT01044290|454432140|FG001|Follow-up 1|Withdrawal by Subject|2|||
126311818|NCT01044290|454432141|FG002|Follow-up 1|Withdrawal by Subject|0|||
126311819|NCT01044290|454432139|FG000|Follow-Up 2|Death|0|||
126311820|NCT01044290|454432140|FG001|Follow-Up 2|Death|1|||
126311821|NCT01044290|454432141|FG002|Follow-Up 2|Death|1|||
126311822|NCT01044290|454432139|FG000|Follow-Up 2|Withdrawal by Subject|0|||
126311823|NCT01044290|454432140|FG001|Follow-Up 2|Withdrawal by Subject|1|||
126311824|NCT01044290|454432141|FG002|Follow-Up 2|Withdrawal by Subject|1|||
126311825|NCT00348790|454432142|FG000|Completed Treatment|Withdrawal by Subject|4|||
126311826|NCT00348790|454432142|FG000|Completed Treatment|Disease progression|14|||
126311827|NCT00348790|454432142|FG000|Completed Treatment|Adverse Event|4|||
126311828|NCT00348790|454432142|FG000|Completed Treatment|Required surgery|2|||
126311829|NCT00348790|454432142|FG000|Completed Treatment|Unable to travel to study site|1|||
126311830|NCT00759785|454432148|FG000|Overall Study|Participant sample not evaluable|11|||
126311831|NCT00759785|454432149|FG001|Overall Study|Participant sample not evaluable|2|||
126311832|NCT00759785|454432148|FG000|Overall Study|Participant sample lost|0|||
126311833|NCT00759785|454432149|FG001|Overall Study|Participant sample lost|1|||
126311834|NCT00759785|454432148|FG000|Overall Study|Protocol Violation|1|||
126311835|NCT00759785|454432149|FG001|Overall Study|Protocol Violation|0|||
126311836|NCT00759785|454432148|FG000|Overall Study|Physician Decision|0|||
126311837|NCT00759785|454432149|FG001|Overall Study|Physician Decision|1|||
126311838|NCT00759785|454432148|FG000|Overall Study|Withdrawal by Subject|0|||
126311839|NCT00759785|454432149|FG001|Overall Study|Withdrawal by Subject|1|||
126311840|NCT04712019|454432150|FG000|Overall Study|Withdrawal by Subject|2|||
126311841|NCT04712019|454432151|FG001|Overall Study|Withdrawal by Subject|2|||
126311842|NCT04712019|454432150|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
126311843|NCT04712019|454432151|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
126311844|NCT01646021|454432152|FG000|Overall Study|Death|77|||
126311845|NCT01646021|454432153|FG001|Overall Study|Death|83|||
126311846|NCT01646021|454432152|FG000|Overall Study|Study Terminated by Sponsor|50|||
126311847|NCT01646021|454432153|FG001|Overall Study|Study Terminated by Sponsor|41|||
126645519|NCT01559129|455660379|FG000|Treatment Phase|Progressive Disease|1|||
126645520|NCT01559129|455660380|FG001|Treatment Phase|Progressive Disease|1|||
126645521|NCT01559129|455660379|FG000|Treatment Phase|Lack of Efficacy|0|||
126645522|NCT01559129|455660380|FG001|Treatment Phase|Lack of Efficacy|1|||
126645523|NCT01559129|455660379|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
126645524|NCT01559129|455660380|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
126645525|NCT01559129|455660379|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
126645526|NCT01559129|455660380|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
126645527|NCT01559129|455660379|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
126645528|NCT01559129|455660380|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
126645529|NCT01559129|455660379|FG000|Open-label Extension Period|Adverse Event|1|||
126645530|NCT01559129|455660380|FG001|Open-label Extension Period|Adverse Event|0|||
126645531|NCT01559129|455660379|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
126645532|NCT01559129|455660380|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
126645533|NCT00368927|455660381|FG000|Overall Study|Lost to Follow-up|2|||
126758142|NCT00598442|456064480|FG002|Overall Study|Physician Decision|1|||
126534738|NCT01475136|455246819|FG001|Overall Study|Sponsor Decision|1|||
126758143|NCT00598442|456064478|FG000|Overall Study|Withdrawal by Subject|8|||
126758144|NCT00598442|456064479|FG001|Overall Study|Withdrawal by Subject|16|||
126758145|NCT00598442|456064480|FG002|Overall Study|Withdrawal by Subject|6|||
126758146|NCT00598442|456064478|FG000|Overall Study|Noncompliance|0|||
126758147|NCT00598442|456064479|FG001|Overall Study|Noncompliance|2|||
126758148|NCT00598442|456064480|FG002|Overall Study|Noncompliance|1|||
126758149|NCT00598442|456064478|FG000|Overall Study|Relocation|1|||
126758150|NCT00598442|456064479|FG001|Overall Study|Relocation|4|||
126758151|NCT00598442|456064480|FG002|Overall Study|Relocation|0|||
126758152|NCT00598442|456064478|FG000|Overall Study|Renal transplant|0|||
126758153|NCT00598442|456064479|FG001|Overall Study|Renal transplant|0|||
126758154|NCT00598442|456064480|FG002|Overall Study|Renal transplant|1|||
126311848|NCT01646021|454432152|FG000|Overall Study|Lost to Follow-up|2|||
126311849|NCT01646021|454432153|FG001|Overall Study|Lost to Follow-up|2|||
126311850|NCT01646021|454432152|FG000|Overall Study|Withdrawal by Subject|10|||
126311851|NCT01646021|454432153|FG001|Overall Study|Withdrawal by Subject|15|||
126311852|NCT01282164|454432154|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
126311853|NCT01282164|454432155|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
126311854|NCT04521621|454432156|FG000|Overall Study|Death|17|||
126311855|NCT04521621|454432157|FG001|Overall Study|Death|8|||
126311856|NCT04521621|454432158|FG002|Overall Study|Death|8|||
126311857|NCT04521621|454432159|FG003|Overall Study|Death|5|||
126311858|NCT04521621|454432160|FG004|Overall Study|Death|2|||
126311859|NCT04521621|454432161|FG005|Overall Study|Death|7|||
126311860|NCT04521621|454432162|FG006|Overall Study|Death|0|||
126311861|NCT04521621|454432163|FG007|Overall Study|Death|0|||
126311862|NCT04521621|454432156|FG000|Overall Study|Study Terminated by Sponsor|4|||
126311863|NCT04521621|454432157|FG001|Overall Study|Study Terminated by Sponsor|6|||
126311864|NCT04521621|454432158|FG002|Overall Study|Study Terminated by Sponsor|8|||
126311865|NCT04521621|454432159|FG003|Overall Study|Study Terminated by Sponsor|0|||
126311866|NCT04521621|454432160|FG004|Overall Study|Study Terminated by Sponsor|1|||
126311867|NCT04521621|454432161|FG005|Overall Study|Study Terminated by Sponsor|7|||
126311868|NCT04521621|454432162|FG006|Overall Study|Study Terminated by Sponsor|0|||
126311869|NCT04521621|454432163|FG007|Overall Study|Study Terminated by Sponsor|0|||
126311870|NCT04521621|454432156|FG000|Overall Study|Withdrawal by Subject|0|||
126311871|NCT04521621|454432157|FG001|Overall Study|Withdrawal by Subject|0|||
126311872|NCT04521621|454432158|FG002|Overall Study|Withdrawal by Subject|1|||
126311873|NCT04521621|454432159|FG003|Overall Study|Withdrawal by Subject|1|||
126311874|NCT04521621|454432160|FG004|Overall Study|Withdrawal by Subject|0|||
126311875|NCT04521621|454432161|FG005|Overall Study|Withdrawal by Subject|0|||
126311876|NCT04521621|454432162|FG006|Overall Study|Withdrawal by Subject|0|||
126311877|NCT04521621|454432163|FG007|Overall Study|Withdrawal by Subject|0|||
126311878|NCT04521621|454432156|FG000|Overall Study|Allocated in error without study intervention|1|||
126311879|NCT04521621|454432157|FG001|Overall Study|Allocated in error without study intervention|0|||
126311880|NCT04521621|454432158|FG002|Overall Study|Allocated in error without study intervention|0|||
126311881|NCT04521621|454432159|FG003|Overall Study|Allocated in error without study intervention|0|||
126311882|NCT04521621|454432160|FG004|Overall Study|Allocated in error without study intervention|0|||
126311883|NCT04521621|454432161|FG005|Overall Study|Allocated in error without study intervention|0|||
126311884|NCT04521621|454432162|FG006|Overall Study|Allocated in error without study intervention|0|||
126311885|NCT04521621|454432163|FG007|Overall Study|Allocated in error without study intervention|0|||
126311886|NCT01967706|454432178|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
126311887|NCT01967706|454432179|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
126311888|NCT01967706|454432180|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
126311889|NCT01967706|454432181|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
126311890|NCT02777970|454432182|FG000|Overall Study|Lost to Follow-up|0|||
126311891|NCT02777970|454432183|FG001|Overall Study|Lost to Follow-up|1|||
126311892|NCT02777970|454432184|FG002|Overall Study|Lost to Follow-up|0|||
126311893|NCT02777970|454432182|FG000|Overall Study|Protocol Violation|1|||
126311894|NCT02777970|454432183|FG001|Overall Study|Protocol Violation|0|||
126311895|NCT02777970|454432184|FG002|Overall Study|Protocol Violation|0|||
126311896|NCT02347891|454432188|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
126311897|NCT02347891|454432189|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
126311898|NCT02347891|454432188|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
126311899|NCT02347891|454432189|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
126311900|NCT05845567|454432190|FG000|Overall Study|Withdrawal by Subject|1|||
126311901|NCT02541669|454432191|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
126311902|NCT02541669|454432192|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
126311903|NCT02541669|454432193|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
126311904|NCT02541669|454432194|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
126311905|NCT02541669|454432195|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
126311906|NCT00725608|454432196|FG000|Overall Study|Lost to Follow-up|60|||
126311907|NCT00725608|454432196|FG000|Overall Study|Adverse Event|14|||
126311908|NCT00725608|454432196|FG000|Overall Study|Individual reasons|86|||
126311909|NCT00725608|454432196|FG000|Overall Study|Other|7|||
126311910|NCT03409107|454432197|FG000|Overall Study|Withdrawal by Subject|4|||
126311911|NCT03409107|454432198|FG001|Overall Study|Withdrawal by Subject|2|||
126311912|NCT03409107|454432197|FG000|Overall Study|Physician Decision|1|||
126311913|NCT03409107|454432198|FG001|Overall Study|Physician Decision|0|||
126311914|NCT03409107|454432197|FG000|Overall Study|Lost to Follow-up|7|||
126311915|NCT03409107|454432198|FG001|Overall Study|Lost to Follow-up|2|||
126311916|NCT03409107|454432197|FG000|Overall Study|Adverse Event|5|||
126311917|NCT03409107|454432198|FG001|Overall Study|Adverse Event|3|||
126311918|NCT01084668|454432202|FG000|Overall Study|Lack of Efficacy|5|||
126311919|NCT01084668|454432202|FG000|Overall Study|Withdrawal by Subject|2|||
126311920|NCT01084668|454432202|FG000|Overall Study|Pregnancy|1|||
126311921|NCT01084668|454432202|FG000|Overall Study|Non-compliance|1|||
126311922|NCT01083186|454432204|FG000|Overall Study|Lost to Follow-up|48|||
126311923|NCT01083186|454432204|FG000|Overall Study|Consent Withdrawal|7|||
126311924|NCT01083186|454432204|FG000|Overall Study|Death|3|||
126311925|NCT01083186|454432204|FG000|Overall Study|Adverse Event|3|||
126311926|NCT01083186|454432204|FG000|Overall Study|Lack of Efficacy|2|||
126311927|NCT01083186|454432204|FG000|Overall Study|Hemodialysis Initiation|28|||
126311928|NCT01083186|454432204|FG000|Overall Study|Administrative Reasons|2|||
126311929|NCT01083186|454432204|FG000|Overall Study|Non-compliance to Study Treatment|1|||
126311930|NCT00655733|454432214|FG000|Overall Study|Lost to Follow-up|2|||
126311931|NCT00655733|454432215|FG001|Overall Study|Lost to Follow-up|2|||
126311932|NCT00655733|454432214|FG000|Overall Study|Adverse Event|2|||
126311933|NCT00655733|454432215|FG001|Overall Study|Adverse Event|2|||
126311934|NCT00655733|454432214|FG000|Overall Study|Withdrawal by Subject|3|||
126758155|NCT00598442|456064478|FG000|Overall Study|Site closed by sponsor|5|||
126758156|NCT00598442|456064479|FG001|Overall Study|Site closed by sponsor|2|||
126758157|NCT00598442|456064480|FG002|Overall Study|Site closed by sponsor|1|||
126758158|NCT00598442|456064478|FG000|Overall Study|Started dialysis|1|||
126758159|NCT00598442|456064479|FG001|Overall Study|Started dialysis|0|||
126758160|NCT00598442|456064480|FG002|Overall Study|Started dialysis|0|||
126758161|NCT00679354|456064484|FG000|Overall Study|Death|3|||
126758162|NCT00679354|456064484|FG000|Overall Study|Lack of Efficacy|22|||
126758163|NCT00679354|456064484|FG000|Overall Study|Physician Decision|4|||
126758164|NCT00679354|456064484|FG000|Overall Study|Ineligible|1|||
126758165|NCT01654666|456064489|FG000|Overall Study|Protocol Violation|7|||
126758166|NCT01654666|456064490|FG001|Overall Study|Protocol Violation|4|||
126758167|NCT01654666|456064491|FG002|Overall Study|Protocol Violation|8|||
126758168|NCT01654666|456064489|FG000|Overall Study|Lost to Follow-up|4|||
126758169|NCT01654666|456064490|FG001|Overall Study|Lost to Follow-up|5|||
126758170|NCT01654666|456064491|FG002|Overall Study|Lost to Follow-up|5|||
126758171|NCT01654666|456064489|FG000|Overall Study|Withdrawal by Subject|4|||
126758172|NCT01654666|456064490|FG001|Overall Study|Withdrawal by Subject|4|||
126758173|NCT01654666|456064491|FG002|Overall Study|Withdrawal by Subject|1|||
126758174|NCT00535262|456064494|FG000|Overall Study|No funding|3|||
126758175|NCT02898662|456064495|FG000|Overall Study|Adverse Event|1|||
126758176|NCT02898662|456064496|FG001|Overall Study|Adverse Event|0|||
126758177|NCT02898662|456064495|FG000|Overall Study|Loss of asthma control|23|||
126758178|NCT02898662|456064496|FG001|Overall Study|Loss of asthma control|24|||
126758179|NCT02898662|456064495|FG000|Overall Study|Withdrawal by Subject|4|||
126758180|NCT02898662|456064496|FG001|Overall Study|Withdrawal by Subject|1|||
126758181|NCT02898662|456064495|FG000|Overall Study|Technical issue|0|||
126758182|NCT02898662|456064496|FG001|Overall Study|Technical issue|1|||
126758183|NCT02898662|456064495|FG000|Overall Study|Randomized in error|0|||
126758184|NCT02898662|456064496|FG001|Overall Study|Randomized in error|1|||
126758185|NCT02898662|456064495|FG000|Overall Study|Subject decision|1|||
126758186|NCT02898662|456064496|FG001|Overall Study|Subject decision|0|||
126758187|NCT02898662|456064495|FG000|Overall Study|Other|0|||
126758188|NCT02898662|456064496|FG001|Overall Study|Other|1|||
126758189|NCT00917553|456064497|FG000|Overall Study|Lost to Follow-up|2|||
126758190|NCT00917553|456064498|FG001|Overall Study|Lost to Follow-up|1|||
126758191|NCT01616173|456064499|FG000|Overall Study|Lost to Follow-up|0|||
126758192|NCT01616173|456064500|FG001|Overall Study|Lost to Follow-up|2|||
126758193|NCT01616173|456064501|FG002|Overall Study|Lost to Follow-up|0|||
126758194|NCT03432819|456064504|FG000|Overall Study|Lost to Follow-up|2|||
126758195|NCT03432819|456064505|FG001|Overall Study|Lost to Follow-up|2|||
126758196|NCT03432819|456064504|FG000|Overall Study|Withdrawal by Subject|5|||
126758197|NCT03432819|456064505|FG001|Overall Study|Withdrawal by Subject|3|||
126758198|NCT00283062|456064508|FG000|Overall Study|Did not receive any study medication|5|||
126311935|NCT00655733|454432215|FG001|Overall Study|Withdrawal by Subject|3|||
126311936|NCT00655733|454432214|FG000|Overall Study|Physician Decision|0|||
126311937|NCT00655733|454432215|FG001|Overall Study|Physician Decision|1|||
126311938|NCT02122770|454432216|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
126311939|NCT02122770|454432217|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
126311940|NCT02122770|454432218|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
126311941|NCT02122770|454432219|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
126311942|NCT02122770|454432220|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
126758199|NCT00283062|456064509|FG001|Overall Study|Did not receive any study medication|4|||
126758200|NCT00283062|456064510|FG002|Overall Study|Did not receive any study medication|36|||
126758201|NCT00283062|456064511|FG003|Overall Study|Did not receive any study medication|45|||
126758202|NCT00283062|456064508|FG000|Overall Study|Adverse Event|2|||
126758203|NCT00283062|456064509|FG001|Overall Study|Adverse Event|0|||
126758204|NCT00283062|456064510|FG002|Overall Study|Adverse Event|1|||
126758205|NCT00283062|456064511|FG003|Overall Study|Adverse Event|0|||
126758206|NCT00283062|456064508|FG000|Overall Study|Lost to Follow-up|1|||
126758207|NCT00283062|456064509|FG001|Overall Study|Lost to Follow-up|0|||
126758208|NCT00283062|456064510|FG002|Overall Study|Lost to Follow-up|1|||
126758209|NCT00283062|456064511|FG003|Overall Study|Lost to Follow-up|0|||
126758210|NCT00283062|456064508|FG000|Overall Study|Progressive disease|0|||
126758211|NCT00283062|456064509|FG001|Overall Study|Progressive disease|0|||
126758212|NCT00283062|456064510|FG002|Overall Study|Progressive disease|1|||
126758213|NCT00283062|456064511|FG003|Overall Study|Progressive disease|0|||
126306056|NCT02553499|454408870|FG001|Overall Study|Physician Decision|1|||
126311943|NCT02122770|454432221|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
126311944|NCT02122770|454432216|FG000|Part A: Drug-drug Interaction 2|Other|0|||
126311945|NCT02122770|454432217|FG001|Part A: Drug-drug Interaction 2|Other|0|||
126311946|NCT02122770|454432218|FG002|Part A: Drug-drug Interaction 2|Other|1|||
126311947|NCT02122770|454432219|FG003|Part A: Drug-drug Interaction 2|Other|0|||
126311948|NCT02122770|454432220|FG004|Part A: Drug-drug Interaction 2|Other|0|||
126311949|NCT02122770|454432221|FG005|Part A: Drug-drug Interaction 2|Other|0|||
126311950|NCT02122770|454432216|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
126311951|NCT02122770|454432217|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
126311952|NCT02122770|454432218|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
126311953|NCT02122770|454432219|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
126311954|NCT02122770|454432220|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
126311955|NCT02122770|454432221|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
126311956|NCT02122770|454432216|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
126311957|NCT02122770|454432217|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
126311958|NCT02122770|454432218|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
126311959|NCT02122770|454432219|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
126311960|NCT02122770|454432220|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
126758214|NCT00283062|456064508|FG000|Overall Study|Participant did not wish to continue|3|||
126758215|NCT00283062|456064509|FG001|Overall Study|Participant did not wish to continue|2|||
126758216|NCT00283062|456064510|FG002|Overall Study|Participant did not wish to continue|1|||
126758217|NCT00283062|456064511|FG003|Overall Study|Participant did not wish to continue|0|||
126758218|NCT00283062|456064508|FG000|Overall Study|Undefined|0|||
126758219|NCT00283062|456064509|FG001|Overall Study|Undefined|1|||
126758220|NCT00283062|456064510|FG002|Overall Study|Undefined|1|||
126758221|NCT00283062|456064511|FG003|Overall Study|Undefined|4|||
126758222|NCT00283062|456064508|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
126758223|NCT00283062|456064509|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
126758224|NCT00283062|456064510|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
126758225|NCT00283062|456064511|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
126758226|NCT00827112|456064514|FG000|Overall Study|Adverse Event|2|||
126758227|NCT00827112|456064515|FG001|Overall Study|Adverse Event|0|||
126758228|NCT00827112|456064514|FG000|Overall Study|Lack of Efficacy|2|||
126758229|NCT00827112|456064515|FG001|Overall Study|Lack of Efficacy|0|||
126758230|NCT00827112|456064514|FG000|Overall Study|Lost to Follow-up|3|||
126758231|NCT00827112|456064515|FG001|Overall Study|Lost to Follow-up|2|||
126758232|NCT00827112|456064514|FG000|Overall Study|Pregnancy|0|||
126758233|NCT00827112|456064515|FG001|Overall Study|Pregnancy|1|||
126758234|NCT00827112|456064514|FG000|Overall Study|Protocol Violation|0|||
126758235|NCT00827112|456064515|FG001|Overall Study|Protocol Violation|2|||
126758236|NCT00827112|456064514|FG000|Overall Study|Withdrawal by Subject|2|||
126758237|NCT00827112|456064515|FG001|Overall Study|Withdrawal by Subject|1|||
126758238|NCT00827112|456064514|FG000|Overall Study|Randomized but not treated|5|||
126758239|NCT00827112|456064515|FG001|Overall Study|Randomized but not treated|3|||
126758240|NCT00827112|456064514|FG000|Overall Study|Other|1|||
126758241|NCT00827112|456064515|FG001|Overall Study|Other|3|||
126758242|NCT03044730|456064525|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
126758243|NCT03044730|456064525|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
126758244|NCT03044730|456064525|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
126758245|NCT03044730|456064525|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
126758246|NCT03044730|456064525|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
126758247|NCT03044730|456064525|FG000|Cycles 4 and Beyond|Adverse Event|1|||
126758248|NCT03044730|456064525|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
126758249|NCT03044730|456064525|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
126758250|NCT03044730|456064525|FG000|On Follow-up for 2 Years|Death|17|||
126758251|NCT01336647|456066595|FG000|Overall Study|Lost to Follow-up|4|||
126758252|NCT01336647|456066596|FG001|Overall Study|Lost to Follow-up|1|||
126758253|NCT01336647|456066597|FG002|Overall Study|Lost to Follow-up|3|||
126758254|NCT04177862|456066605|FG000|Overall Study|Protocol Violation|2|||
126758255|NCT04177862|456066606|FG001|Overall Study|Protocol Violation|7|||
126758256|NCT00379639|456066607|FG000|Overall Study|Disease Progression|3|||
126758257|NCT00379639|456066608|FG001|Overall Study|Disease Progression|3|||
126758258|NCT00379639|456066609|FG002|Overall Study|Disease Progression|3|||
126758259|NCT00379639|456066610|FG003|Overall Study|Disease Progression|4|||
126758260|NCT00379639|456066611|FG004|Overall Study|Disease Progression|4|||
126758261|NCT00379639|456066607|FG000|Overall Study|Physician Decision|0|||
126758262|NCT00379639|456066608|FG001|Overall Study|Physician Decision|2|||
126311961|NCT02122770|454432221|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
126311962|NCT02122770|454432216|FG000|Part B: Standard of Care|Adverse Event|0|||
126758263|NCT00379639|456066609|FG002|Overall Study|Physician Decision|1|||
126758264|NCT00379639|456066610|FG003|Overall Study|Physician Decision|1|||
126758265|NCT00379639|456066611|FG004|Overall Study|Physician Decision|0|||
126758266|NCT00379639|456066607|FG000|Overall Study|Symptomatic Deterioration|0|||
126758267|NCT00379639|456066608|FG001|Overall Study|Symptomatic Deterioration|0|||
126758268|NCT00379639|456066609|FG002|Overall Study|Symptomatic Deterioration|1|||
126758269|NCT00379639|456066610|FG003|Overall Study|Symptomatic Deterioration|0|||
126758270|NCT00379639|456066611|FG004|Overall Study|Symptomatic Deterioration|1|||
126758271|NCT00379639|456066607|FG000|Overall Study|Adverse Event|0|||
126758272|NCT00379639|456066608|FG001|Overall Study|Adverse Event|0|||
126758273|NCT00379639|456066609|FG002|Overall Study|Adverse Event|1|||
126758274|NCT00379639|456066610|FG003|Overall Study|Adverse Event|0|||
126758275|NCT00379639|456066611|FG004|Overall Study|Adverse Event|1|||
126758276|NCT00379639|456066607|FG000|Overall Study|Lost to Follow-up|0|||
126758277|NCT00379639|456066608|FG001|Overall Study|Lost to Follow-up|0|||
126758278|NCT00379639|456066609|FG002|Overall Study|Lost to Follow-up|0|||
126758279|NCT00379639|456066610|FG003|Overall Study|Lost to Follow-up|1|||
126758280|NCT00379639|456066611|FG004|Overall Study|Lost to Follow-up|0|||
126758281|NCT00379639|456066607|FG000|Overall Study|Other|0|||
126758282|NCT00379639|456066608|FG001|Overall Study|Other|0|||
126758283|NCT00379639|456066609|FG002|Overall Study|Other|3|||
126758284|NCT00379639|456066610|FG003|Overall Study|Other|0|||
126758285|NCT00379639|456066611|FG004|Overall Study|Other|0|||
126758286|NCT00594958|456066612|FG000|Overall Study|Withdrawal by Subject|1|||
126758287|NCT00594958|456066613|FG001|Overall Study|Withdrawal by Subject|0|||
126758288|NCT00594958|456066614|FG002|Overall Study|Withdrawal by Subject|1|||
126758289|NCT00594958|456066612|FG000|Overall Study|Adverse Event|4|||
126758290|NCT00594958|456066613|FG001|Overall Study|Adverse Event|1|||
126758291|NCT00594958|456066614|FG002|Overall Study|Adverse Event|2|||
126758292|NCT00594958|456066612|FG000|Overall Study|Pregnancy|0|||
126758293|NCT00594958|456066613|FG001|Overall Study|Pregnancy|2|||
126758294|NCT00594958|456066614|FG002|Overall Study|Pregnancy|0|||
126758295|NCT00594958|456066612|FG000|Overall Study|Protocol Violation|1|||
126758296|NCT00594958|456066613|FG001|Overall Study|Protocol Violation|0|||
126758297|NCT00594958|456066614|FG002|Overall Study|Protocol Violation|2|||
126758298|NCT00594958|456066612|FG000|Overall Study|Lost to Follow-up|5|||
126758299|NCT00594958|456066613|FG001|Overall Study|Lost to Follow-up|0|||
126758300|NCT00594958|456066614|FG002|Overall Study|Lost to Follow-up|3|||
126758301|NCT00594958|456066612|FG000|Overall Study|administrative|3|||
126758302|NCT00594958|456066613|FG001|Overall Study|administrative|0|||
126758303|NCT00594958|456066614|FG002|Overall Study|administrative|2|||
126758304|NCT03233009|456066615|FG000|Overall Study|Lost to Follow-up|1|||
126758305|NCT00151775|456066616|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
126758306|NCT00151775|456066617|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
126758307|NCT00151775|456066618|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126758308|NCT00151775|456066619|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126758309|NCT00151775|456066620|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126758310|NCT00151775|456066621|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126758311|NCT00151775|456066622|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126758312|NCT00151775|456066623|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126758313|NCT00151775|456066624|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126758314|NCT00151775|456066625|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126758315|NCT00151775|456066626|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126758316|NCT00151775|456066627|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
126758317|NCT00151775|456066616|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
126758318|NCT00151775|456066617|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126758319|NCT00151775|456066618|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126758320|NCT00151775|456066619|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126758321|NCT00151775|456066620|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126758322|NCT00151775|456066621|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126758323|NCT00151775|456066622|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
126758324|NCT00151775|456066623|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126758325|NCT00151775|456066624|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126758326|NCT00151775|456066625|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126758327|NCT00151775|456066626|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
126758328|NCT00151775|456066627|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
126758329|NCT00151775|456066616|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126758330|NCT00151775|456066617|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
126758331|NCT00151775|456066618|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126758332|NCT00151775|456066619|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126758333|NCT00151775|456066620|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126758334|NCT00151775|456066621|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126311963|NCT02122770|454432217|FG001|Part B: Standard of Care|Adverse Event|0|||
126758335|NCT00151775|456066622|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126311964|NCT02122770|454432218|FG002|Part B: Standard of Care|Adverse Event|0|||
126311965|NCT02122770|454432219|FG003|Part B: Standard of Care|Adverse Event|0|||
126758336|NCT00151775|456066623|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126758337|NCT00151775|456066624|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126758338|NCT00151775|456066625|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126758339|NCT00151775|456066626|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126758340|NCT00151775|456066627|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
126758341|NCT00151775|456066616|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
126758342|NCT00151775|456066617|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
126758343|NCT00151775|456066618|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
126758344|NCT00151775|456066619|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
126758345|NCT00151775|456066620|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
126758346|NCT00151775|456066621|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
126758347|NCT00151775|456066622|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
126758348|NCT00151775|456066623|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
126758349|NCT00151775|456066624|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
126758350|NCT00151775|456066625|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
126758351|NCT00151775|456066626|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
126758352|NCT00151775|456066627|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
126758353|NCT00151775|456066616|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126758354|NCT00151775|456066617|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126758355|NCT00151775|456066618|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126758356|NCT00151775|456066619|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126758357|NCT00151775|456066620|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126758358|NCT00151775|456066621|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
126758359|NCT00151775|456066622|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126758360|NCT00151775|456066623|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126758361|NCT00151775|456066624|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126758362|NCT00151775|456066625|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126758363|NCT00151775|456066626|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126758364|NCT00151775|456066627|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
126758365|NCT00151775|456066616|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126758366|NCT00151775|456066617|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126758367|NCT00151775|456066618|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126758368|NCT00151775|456066619|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126758369|NCT00151775|456066620|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126758370|NCT00151775|456066621|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
126758371|NCT00151775|456066622|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126758372|NCT00151775|456066623|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126758373|NCT00151775|456066624|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126758374|NCT00151775|456066625|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126758375|NCT00151775|456066626|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126758376|NCT00151775|456066627|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
126758377|NCT00151775|456066616|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126758378|NCT00151775|456066617|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126758379|NCT00151775|456066618|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126758380|NCT00151775|456066619|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126758381|NCT00151775|456066620|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126758382|NCT00151775|456066621|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126758383|NCT00151775|456066622|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
126758384|NCT00151775|456066623|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126758385|NCT00151775|456066624|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126758386|NCT00151775|456066625|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126758387|NCT00151775|456066626|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126758388|NCT00151775|456066627|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
126758389|NCT00151775|456066616|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126758390|NCT00151775|456066617|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126758391|NCT00151775|456066618|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126758392|NCT00151775|456066619|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126758393|NCT00151775|456066620|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126758394|NCT00151775|456066621|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
126758395|NCT00151775|456066622|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126758396|NCT00151775|456066623|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126758397|NCT00151775|456066624|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126758398|NCT00151775|456066625|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126306057|NCT02553499|454408871|FG002|Overall Study|Physician Decision|1|||
126311966|NCT02122770|454432220|FG004|Part B: Standard of Care|Adverse Event|4|||
126758399|NCT00151775|456066626|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126758400|NCT00151775|456066627|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
126758401|NCT00151775|456066616|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
126758402|NCT00151775|456066617|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
126758403|NCT00151775|456066618|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
126758404|NCT00151775|456066619|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
126758405|NCT00151775|456066620|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
126758406|NCT00151775|456066621|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
126758407|NCT00151775|456066622|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
126758408|NCT00151775|456066623|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
126758409|NCT00151775|456066624|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
126758410|NCT00151775|456066625|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
126758411|NCT00151775|456066626|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
126758412|NCT00151775|456066627|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
126758413|NCT00151775|456066616|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126758414|NCT00151775|456066617|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126758415|NCT00151775|456066618|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126758416|NCT00151775|456066619|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126758417|NCT00151775|456066620|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126758418|NCT00151775|456066621|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126758419|NCT00151775|456066622|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
126758420|NCT00151775|456066623|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126758421|NCT00151775|456066624|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126758422|NCT00151775|456066625|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126758423|NCT00151775|456066626|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126758424|NCT00151775|456066627|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
126758425|NCT00151775|456066616|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126758426|NCT00151775|456066617|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126758427|NCT00151775|456066618|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
126758428|NCT00151775|456066619|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126758429|NCT00151775|456066620|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126758430|NCT00151775|456066621|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126758431|NCT00151775|456066622|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126758432|NCT00151775|456066623|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126758433|NCT00151775|456066624|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126758434|NCT00151775|456066625|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126758435|NCT00151775|456066626|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126758436|NCT00151775|456066627|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
126758437|NCT00151775|456066616|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126758438|NCT00151775|456066617|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126758439|NCT00151775|456066618|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
126758440|NCT00151775|456066619|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126758441|NCT00151775|456066620|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126758442|NCT00151775|456066621|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126758443|NCT00151775|456066622|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126758444|NCT00151775|456066623|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126758445|NCT00151775|456066624|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126758446|NCT00151775|456066625|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126758447|NCT00151775|456066626|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126758448|NCT00151775|456066627|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
126758449|NCT00151775|456066616|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126758450|NCT00151775|456066617|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126758451|NCT00151775|456066618|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126758452|NCT00151775|456066619|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126758453|NCT00151775|456066620|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126758454|NCT00151775|456066621|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126534739|NCT01475136|455246820|FG002|Overall Study|Sponsor Decision|0|||
126534740|NCT01475136|455246821|FG003|Overall Study|Sponsor Decision|0|||
126758455|NCT00151775|456066622|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126758456|NCT00151775|456066623|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126758457|NCT00151775|456066624|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126758458|NCT00151775|456066625|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126758459|NCT00151775|456066626|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
126758460|NCT00151775|456066627|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
126758461|NCT00151775|456066616|FG000|Period 4: Open Label|Increased blood pressure|0|||
126758462|NCT00151775|456066617|FG001|Period 4: Open Label|Increased blood pressure|0|||
126758463|NCT00151775|456066618|FG002|Period 4: Open Label|Increased blood pressure|0|||
126758464|NCT00151775|456066619|FG003|Period 4: Open Label|Increased blood pressure|0|||
126758465|NCT00151775|456066620|FG004|Period 4: Open Label|Increased blood pressure|1|||
126758466|NCT00151775|456066621|FG005|Period 4: Open Label|Increased blood pressure|0|||
126758467|NCT00151775|456066622|FG006|Period 4: Open Label|Increased blood pressure|0|||
126758468|NCT00151775|456066623|FG007|Period 4: Open Label|Increased blood pressure|0|||
126758469|NCT00151775|456066624|FG008|Period 4: Open Label|Increased blood pressure|0|||
126758470|NCT00151775|456066625|FG009|Period 4: Open Label|Increased blood pressure|1|||
126758471|NCT00151775|456066626|FG010|Period 4: Open Label|Increased blood pressure|0|||
126758472|NCT00151775|456066627|FG011|Period 4: Open Label|Increased blood pressure|0|||
126758473|NCT00151775|456066616|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
126758474|NCT00151775|456066617|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
126758475|NCT00151775|456066618|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
126758476|NCT00151775|456066619|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
126758477|NCT00151775|456066620|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
126758478|NCT00151775|456066621|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
126758479|NCT00151775|456066622|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
126758480|NCT00151775|456066623|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
126758481|NCT00151775|456066624|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
126758482|NCT00151775|456066625|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
126758483|NCT00151775|456066626|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
126758484|NCT00151775|456066627|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
126758485|NCT00151775|456066616|FG000|Period 4: Open Label|Adverse Event|0|||
126758486|NCT00151775|456066617|FG001|Period 4: Open Label|Adverse Event|0|||
126758487|NCT00151775|456066618|FG002|Period 4: Open Label|Adverse Event|0|||
126758488|NCT00151775|456066619|FG003|Period 4: Open Label|Adverse Event|0|||
126758489|NCT00151775|456066620|FG004|Period 4: Open Label|Adverse Event|1|||
126758490|NCT00151775|456066621|FG005|Period 4: Open Label|Adverse Event|0|||
126758491|NCT00151775|456066622|FG006|Period 4: Open Label|Adverse Event|0|||
126758492|NCT00151775|456066623|FG007|Period 4: Open Label|Adverse Event|0|||
126758493|NCT00151775|456066624|FG008|Period 4: Open Label|Adverse Event|0|||
126758494|NCT00151775|456066625|FG009|Period 4: Open Label|Adverse Event|2|||
126758495|NCT00151775|456066626|FG010|Period 4: Open Label|Adverse Event|0|||
126758496|NCT00151775|456066627|FG011|Period 4: Open Label|Adverse Event|0|||
126758497|NCT00151775|456066616|FG000|Period 4: Open Label|Lost to Follow-up|0|||
126758498|NCT00151775|456066617|FG001|Period 4: Open Label|Lost to Follow-up|0|||
126758499|NCT00151775|456066618|FG002|Period 4: Open Label|Lost to Follow-up|0|||
126758500|NCT00151775|456066619|FG003|Period 4: Open Label|Lost to Follow-up|0|||
126758501|NCT00151775|456066620|FG004|Period 4: Open Label|Lost to Follow-up|17|||
126758502|NCT00151775|456066621|FG005|Period 4: Open Label|Lost to Follow-up|0|||
126758503|NCT00151775|456066622|FG006|Period 4: Open Label|Lost to Follow-up|0|||
126758504|NCT00151775|456066623|FG007|Period 4: Open Label|Lost to Follow-up|0|||
126758505|NCT00151775|456066624|FG008|Period 4: Open Label|Lost to Follow-up|0|||
126758506|NCT00151775|456066625|FG009|Period 4: Open Label|Lost to Follow-up|7|||
126758507|NCT00151775|456066626|FG010|Period 4: Open Label|Lost to Follow-up|0|||
126758508|NCT00151775|456066627|FG011|Period 4: Open Label|Lost to Follow-up|0|||
126758509|NCT00151775|456066616|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
126758510|NCT00151775|456066617|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
126758511|NCT00151775|456066618|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
126758512|NCT00151775|456066619|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
126758513|NCT00151775|456066620|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
126758514|NCT00151775|456066621|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
126758515|NCT00151775|456066622|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
126758516|NCT00151775|456066623|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
126758517|NCT00151775|456066624|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
126758518|NCT00151775|456066625|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
126758519|NCT00151775|456066626|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
126758520|NCT00151775|456066627|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
126758521|NCT00151775|456066616|FG000|Period 4: Open Label|Other|0|||
126758522|NCT00151775|456066617|FG001|Period 4: Open Label|Other|0|||
126758523|NCT00151775|456066618|FG002|Period 4: Open Label|Other|0|||
126758524|NCT00151775|456066619|FG003|Period 4: Open Label|Other|0|||
126758525|NCT00151775|456066620|FG004|Period 4: Open Label|Other|1|||
126758526|NCT00151775|456066621|FG005|Period 4: Open Label|Other|0|||
126758527|NCT00151775|456066622|FG006|Period 4: Open Label|Other|0|||
126758528|NCT00151775|456066623|FG007|Period 4: Open Label|Other|0|||
126758529|NCT00151775|456066624|FG008|Period 4: Open Label|Other|0|||
126758530|NCT00151775|456066625|FG009|Period 4: Open Label|Other|3|||
126758531|NCT00151775|456066626|FG010|Period 4: Open Label|Other|0|||
126758532|NCT00151775|456066627|FG011|Period 4: Open Label|Other|0|||
126758533|NCT00151775|456066616|FG000|Period 4: Open Label|Physician Decision|0|||
126758534|NCT00151775|456066617|FG001|Period 4: Open Label|Physician Decision|0|||
126311967|NCT02122770|454432221|FG005|Part B: Standard of Care|Adverse Event|1|||
126311968|NCT02122770|454432216|FG000|Part B: Standard of Care|Other|0|||
126311969|NCT02122770|454432217|FG001|Part B: Standard of Care|Other|0|||
126311970|NCT02122770|454432218|FG002|Part B: Standard of Care|Other|0|||
126311971|NCT02122770|454432219|FG003|Part B: Standard of Care|Other|0|||
126311972|NCT02122770|454432220|FG004|Part B: Standard of Care|Other|0|||
126311973|NCT02122770|454432221|FG005|Part B: Standard of Care|Other|2|||
126311974|NCT02122770|454432216|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
126311975|NCT02122770|454432217|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
126311976|NCT02122770|454432218|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
126311977|NCT02122770|454432219|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
126311978|NCT02122770|454432220|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
126311979|NCT02122770|454432221|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
126311980|NCT02122770|454432216|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
126311981|NCT02122770|454432217|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
126311982|NCT02122770|454432218|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
126311983|NCT02122770|454432219|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
126311984|NCT02122770|454432220|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
126311985|NCT02122770|454432221|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
126311986|NCT02122770|454432216|FG000|Part B: Standard of Care|Progressive Disease|0|||
126311987|NCT02122770|454432217|FG001|Part B: Standard of Care|Progressive Disease|0|||
126311988|NCT02122770|454432218|FG002|Part B: Standard of Care|Progressive Disease|0|||
126311989|NCT02122770|454432219|FG003|Part B: Standard of Care|Progressive Disease|0|||
126311990|NCT02122770|454432220|FG004|Part B: Standard of Care|Progressive Disease|10|||
126311991|NCT02122770|454432221|FG005|Part B: Standard of Care|Progressive Disease|8|||
126311992|NCT00189306|454432223|FG000|Treatment Period|Withdrawal by Subject|2|||
126311993|NCT00189306|454432223|FG000|Treatment Period|Adverse Event|2|||
126311994|NCT00189306|454432223|FG000|Treatment Period|Protocol Violation|1|||
126311995|NCT00189306|454432223|FG000|Posttreatment Period|Death|1|||
126311996|NCT00189306|454432223|FG000|Posttreatment Period|Withdrawal by Subject|2|||
126311997|NCT00189306|454432223|FG000|Posttreatment Period|Noncompliance|1|||
126311998|NCT00189306|454432223|FG000|Posttreatment Period|Target lesion excised|1|||
126311999|NCT00189306|454432223|FG000|Posttreatment Period|Protocol Violation|1|||
126312000|NCT00189306|454432223|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
126312001|NCT00189306|454432223|FG000|Posttreatment Period|Local skin reaction/sign|1|||
126312002|NCT00189306|454432223|FG000|Long-Term Follow-up|Adverse Event|2|||
126312003|NCT00189306|454432223|FG000|Long-Term Follow-up|Death|4|||
126312004|NCT00189306|454432223|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
126312005|NCT00189306|454432223|FG000|Long-Term Follow-up|Intercurrent disease|2|||
126312006|NCT00189306|454432223|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
126312007|NCT00189306|454432223|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
126312008|NCT03640481|454432224|FG000|Overall Study|Death|14|||
126312009|NCT03640481|454432225|FG001|Overall Study|Death|14|||
126312010|NCT03640481|454432226|FG002|Overall Study|Death|0|||
126312011|NCT03640481|454432227|FG003|Overall Study|Death|0|||
126312012|NCT03640481|454432224|FG000|Overall Study|Lost to Follow-up|2|||
126312013|NCT03640481|454432225|FG001|Overall Study|Lost to Follow-up|0|||
126312014|NCT03640481|454432226|FG002|Overall Study|Lost to Follow-up|0|||
126312015|NCT03640481|454432227|FG003|Overall Study|Lost to Follow-up|0|||
126312016|NCT03640481|454432224|FG000|Overall Study|Site terminated by sponsor|1|||
126312017|NCT03640481|454432225|FG001|Overall Study|Site terminated by sponsor|3|||
126312018|NCT03640481|454432226|FG002|Overall Study|Site terminated by sponsor|0|||
126312019|NCT03640481|454432227|FG003|Overall Study|Site terminated by sponsor|0|||
126312020|NCT03640481|454432224|FG000|Overall Study|Study terminated by sponsor|29|||
126312021|NCT03640481|454432225|FG001|Overall Study|Study terminated by sponsor|42|||
126312022|NCT03640481|454432226|FG002|Overall Study|Study terminated by sponsor|1|||
126312023|NCT03640481|454432227|FG003|Overall Study|Study terminated by sponsor|0|||
126312024|NCT03640481|454432224|FG000|Overall Study|Withdrawal by Subject|5|||
126312025|NCT03640481|454432225|FG001|Overall Study|Withdrawal by Subject|4|||
126312026|NCT03640481|454432226|FG002|Overall Study|Withdrawal by Subject|0|||
126312027|NCT03640481|454432227|FG003|Overall Study|Withdrawal by Subject|1|||
126312028|NCT03640481|454432224|FG000|Overall Study|Other|26|||
126312029|NCT03640481|454432225|FG001|Overall Study|Other|12|||
126312030|NCT03640481|454432226|FG002|Overall Study|Other|1|||
126312031|NCT03640481|454432227|FG003|Overall Study|Other|0|||
126312032|NCT03640481|454432224|FG000|Overall Study|Randomized, but not treated|1|||
126758535|NCT00151775|456066618|FG002|Period 4: Open Label|Physician Decision|0|||
126758536|NCT00151775|456066619|FG003|Period 4: Open Label|Physician Decision|0|||
126312033|NCT03640481|454432225|FG001|Overall Study|Randomized, but not treated|3|||
126312034|NCT03640481|454432226|FG002|Overall Study|Randomized, but not treated|0|||
126312035|NCT03640481|454432227|FG003|Overall Study|Randomized, but not treated|0|||
126312036|NCT00535847|454432228|FG000|Overall Study|Adverse Event|5|||
126312037|NCT00535847|454432229|FG001|Overall Study|Adverse Event|3|||
126312038|NCT00535847|454432230|FG002|Overall Study|Adverse Event|2|||
126312039|NCT00535847|454432228|FG000|Overall Study|Non compliance|1|||
126312040|NCT00535847|454432229|FG001|Overall Study|Non compliance|1|||
126312041|NCT00535847|454432230|FG002|Overall Study|Non compliance|0|||
126312042|NCT00535847|454432228|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
126312043|NCT00535847|454432229|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
126312044|NCT00535847|454432230|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
126312045|NCT00727844|454432231|FG000|Initial Randomization|Physician Decision|2|||
126758537|NCT00151775|456066620|FG004|Period 4: Open Label|Physician Decision|0|||
126758538|NCT00151775|456066621|FG005|Period 4: Open Label|Physician Decision|0|||
126758539|NCT00151775|456066622|FG006|Period 4: Open Label|Physician Decision|0|||
126758540|NCT00151775|456066623|FG007|Period 4: Open Label|Physician Decision|0|||
126758541|NCT00151775|456066624|FG008|Period 4: Open Label|Physician Decision|0|||
126758542|NCT00151775|456066625|FG009|Period 4: Open Label|Physician Decision|2|||
126758543|NCT00151775|456066626|FG010|Period 4: Open Label|Physician Decision|0|||
126758544|NCT00151775|456066627|FG011|Period 4: Open Label|Physician Decision|0|||
126758545|NCT00151775|456066616|FG000|Period 4: Open Label|Protocol Violation|0|||
126758546|NCT00151775|456066617|FG001|Period 4: Open Label|Protocol Violation|0|||
126758547|NCT00151775|456066618|FG002|Period 4: Open Label|Protocol Violation|0|||
126758548|NCT00151775|456066619|FG003|Period 4: Open Label|Protocol Violation|0|||
126758549|NCT00151775|456066620|FG004|Period 4: Open Label|Protocol Violation|1|||
126758550|NCT00151775|456066621|FG005|Period 4: Open Label|Protocol Violation|0|||
126758551|NCT00151775|456066622|FG006|Period 4: Open Label|Protocol Violation|0|||
126758552|NCT00151775|456066623|FG007|Period 4: Open Label|Protocol Violation|0|||
126312046|NCT00727844|454432232|FG001|Initial Randomization|Physician Decision|0|||
126312047|NCT00727844|454432233|FG002|Initial Randomization|Physician Decision|0|||
126312048|NCT00727844|454432234|FG003|Initial Randomization|Physician Decision|0|||
126312049|NCT04569968|454432235|FG000|Overall Study|Lost to Follow-up|2|||
126312050|NCT04569968|454432236|FG001|Overall Study|Lost to Follow-up|5|||
126312051|NCT04569968|454432235|FG000|Overall Study|Story of head and/or neck surgery|2|||
126312052|NCT04569968|454432236|FG001|Overall Study|Story of head and/or neck surgery|2|||
126312053|NCT04569968|454432235|FG000|Overall Study|Time of stroke onset|8|||
126312054|NCT04569968|454432236|FG001|Overall Study|Time of stroke onset|7|||
126312055|NCT04569968|454432235|FG000|Overall Study|Type of strokr|12|||
126312056|NCT04569968|454432236|FG001|Overall Study|Type of strokr|8|||
126312057|NCT04569968|454432235|FG000|Overall Study|Cooperation|8|||
126312058|NCT04569968|454432236|FG001|Overall Study|Cooperation|8|||
126312059|NCT04569968|454432235|FG000|Overall Study|Age interval|17|||
126312060|NCT04569968|454432236|FG001|Overall Study|Age interval|6|||
126312061|NCT04569968|454432235|FG000|Overall Study|Denial of participation to the study|0|||
126312062|NCT04569968|454432236|FG001|Overall Study|Denial of participation to the study|3|||
126312063|NCT04569968|454432235|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
126312064|NCT04569968|454432236|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
126312065|NCT04569968|454432235|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
126312066|NCT04569968|454432236|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
126312067|NCT04569968|454432235|FG000|Overall Study|Quarantine|1|||
126312068|NCT04569968|454432236|FG001|Overall Study|Quarantine|0|||
126312069|NCT04569968|454432235|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
126312070|NCT04569968|454432236|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
126312071|NCT04569968|454432235|FG000|Overall Study|Repetitive stroke|8|||
126312072|NCT04569968|454432236|FG001|Overall Study|Repetitive stroke|0|||
126312073|NCT04569968|454432235|FG000|Overall Study|Insufficient mastication|1|||
126312074|NCT04569968|454432236|FG001|Overall Study|Insufficient mastication|0|||
126312075|NCT04569968|454432235|FG000|Overall Study|Infection|1|||
126312076|NCT04569968|454432236|FG001|Overall Study|Infection|0|||
126312077|NCT00373958|454432237|FG000|Infant Series|Withdrawal by Subject|13|||
126312078|NCT00373958|454432238|FG001|Infant Series|Withdrawal by Subject|15|||
126312079|NCT00373958|454432237|FG000|Infant Series|Failed to return|8|||
126312080|NCT00373958|454432238|FG001|Infant Series|Failed to return|13|||
126312081|NCT00373958|454432237|FG000|Infant Series|Lost to Follow-up|6|||
126312082|NCT00373958|454432238|FG001|Infant Series|Lost to Follow-up|5|||
126312083|NCT00373958|454432237|FG000|Infant Series|Protocol Violation|3|||
126312084|NCT00373958|454432238|FG001|Infant Series|Protocol Violation|7|||
126312085|NCT00373958|454432237|FG000|Infant Series|Lost Kaiser coverage|4|||
126312086|NCT00373958|454432238|FG001|Infant Series|Lost Kaiser coverage|0|||
126312087|NCT00373958|454432237|FG000|Infant Series|Child relocated|1|||
126312088|NCT00373958|454432238|FG001|Infant Series|Child relocated|0|||
126758553|NCT00151775|456066624|FG008|Period 4: Open Label|Protocol Violation|0|||
126312089|NCT00373958|454432237|FG000|Infant Series|Consent was not received|1|||
126312090|NCT00373958|454432238|FG001|Infant Series|Consent was not received|0|||
126312091|NCT00373958|454432237|FG000|Infant Series|Adverse Event|3|||
126422579|NCT04915729|454842633|FG001|Overall Study|Lost to Follow-up|10|||
126758554|NCT00151775|456066625|FG009|Period 4: Open Label|Protocol Violation|0|||
126758555|NCT00151775|456066626|FG010|Period 4: Open Label|Protocol Violation|0|||
126758556|NCT00151775|456066627|FG011|Period 4: Open Label|Protocol Violation|0|||
126758557|NCT00474994|456066637|FG000|Overall Study|Patient Not treated|1|||
126758558|NCT00474994|456066637|FG000|Overall Study|Patient evaluable for toxicity only|3|||
126758559|NCT00474994|456066637|FG000|Overall Study|Patient found to be ineligible|1|||
126758560|NCT00278473|456066638|FG000|Overall Study|drop out|4|||
126758561|NCT00278473|456066639|FG001|Overall Study|drop out|3|||
126758562|NCT02322866|456066641|FG000|Overall Study|Adverse Event|6|||
126758563|NCT02322866|456066642|FG001|Overall Study|Adverse Event|11|||
126758564|NCT02322866|456066641|FG000|Overall Study|Withdrawal of Consent|16|||
126758565|NCT02322866|456066642|FG001|Overall Study|Withdrawal of Consent|25|||
126758566|NCT02322866|456066641|FG000|Overall Study|Lost to Follow-up|36|||
126758567|NCT02322866|456066642|FG001|Overall Study|Lost to Follow-up|39|||
126758568|NCT02322866|456066641|FG000|Overall Study|Protocol Violation|1|||
126422580|NCT04915729|454842632|FG000|Overall Study|Withdrawal by Subject|12|||
126758569|NCT02322866|456066642|FG001|Overall Study|Protocol Violation|0|||
126312092|NCT00373958|454432238|FG001|Infant Series|Adverse Event|1|||
126312093|NCT00373958|454432237|FG000|Infant Series|Physician Decision|1|||
126312094|NCT00373958|454432238|FG001|Infant Series|Physician Decision|1|||
126312095|NCT00373958|454432237|FG000|Toddler Dose|Lost to Follow-up|5|||
126312096|NCT00373958|454432238|FG001|Toddler Dose|Lost to Follow-up|8|||
126312097|NCT00373958|454432237|FG000|Toddler Dose|Withdrawal by Subject|2|||
126312098|NCT00373958|454432238|FG001|Toddler Dose|Withdrawal by Subject|2|||
126312099|NCT00373958|454432237|FG000|Toddler Dose|Failed to return|1|||
126312100|NCT00373958|454432238|FG001|Toddler Dose|Failed to return|2|||
126312101|NCT00373958|454432237|FG000|Toddler Dose|Protocol Violation|0|||
126312102|NCT00373958|454432238|FG001|Toddler Dose|Protocol Violation|1|||
126312103|NCT00373958|454432237|FG000|Toddler Dose|Withdrawn after infant series|22|||
126312104|NCT00373958|454432238|FG001|Toddler Dose|Withdrawn after infant series|25|||
126312105|NCT01552915|454432239|FG000|Overall Study|Adverse Event|3|||
126312106|NCT01552915|454432240|FG001|Overall Study|Adverse Event|14|||
126312107|NCT01552915|454432241|FG002|Overall Study|Adverse Event|3|||
126312108|NCT01552915|454432239|FG000|Overall Study|Lost to Follow-up|4|||
126312109|NCT01552915|454432240|FG001|Overall Study|Lost to Follow-up|6|||
126312110|NCT01552915|454432241|FG002|Overall Study|Lost to Follow-up|5|||
126312111|NCT01552915|454432239|FG000|Overall Study|Withdrawal by Subject|6|||
126312112|NCT01552915|454432240|FG001|Overall Study|Withdrawal by Subject|4|||
126312113|NCT01552915|454432241|FG002|Overall Study|Withdrawal by Subject|5|||
126312114|NCT01552915|454432239|FG000|Overall Study|Protocol Violation|0|||
126312115|NCT01552915|454432240|FG001|Overall Study|Protocol Violation|4|||
126312116|NCT01552915|454432241|FG002|Overall Study|Protocol Violation|4|||
126312117|NCT01552915|454432239|FG000|Overall Study|Lack of Efficacy|8|||
126312118|NCT01552915|454432240|FG001|Overall Study|Lack of Efficacy|1|||
126312119|NCT01552915|454432241|FG002|Overall Study|Lack of Efficacy|4|||
126312120|NCT01552915|454432239|FG000|Overall Study|Other|2|||
126312121|NCT01552915|454432240|FG001|Overall Study|Other|0|||
126312122|NCT01552915|454432241|FG002|Overall Study|Other|6|||
126312123|NCT02457832|454432242|FG000|Training|Lost to Follow-up|10|||
126312124|NCT02457832|454432243|FG001|Training|Lost to Follow-up|6|||
126312125|NCT02457832|454432244|FG002|Training|Lost to Follow-up|3|||
126312126|NCT02457832|454432242|FG000|One Month Washout|Lost to Follow-up|0|||
126312127|NCT02457832|454432243|FG001|One Month Washout|Lost to Follow-up|1|||
126312128|NCT02457832|454432244|FG002|One Month Washout|Lost to Follow-up|1|||
126312129|NCT03973918|454432249|FG000|Overall Study|Adverse Event|0|||
126312130|NCT03973918|454432250|FG001|Overall Study|Adverse Event|0|||
126312131|NCT03973918|454432251|FG002|Overall Study|Adverse Event|0|||
126312132|NCT03973918|454432252|FG003|Overall Study|Adverse Event|1|||
126312133|NCT03973918|454432249|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
126312134|NCT03973918|454432250|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
126312135|NCT03973918|454432251|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
126312136|NCT03973918|454432252|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
126312137|NCT02951533|454432253|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
126312138|NCT02951533|454432254|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
126312139|NCT02951533|454432255|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
126312140|NCT02951533|454432253|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
126312141|NCT02951533|454432254|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
126312142|NCT02951533|454432255|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
126312143|NCT02951533|454432253|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
126312144|NCT02951533|454432254|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
126312145|NCT02951533|454432255|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
126312146|NCT02951533|454432253|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
126312147|NCT02951533|454432254|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
126312148|NCT02951533|454432255|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
126312149|NCT02951533|454432253|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
126312150|NCT02951533|454432254|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
126312151|NCT02951533|454432255|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
126312152|NCT02951533|454432253|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
126312153|NCT02951533|454432254|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
126312154|NCT02951533|454432255|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
126312155|NCT02951533|454432253|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
126312156|NCT02951533|454432254|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
126312157|NCT02951533|454432255|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
126312158|NCT02951533|454432253|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
126312159|NCT02951533|454432254|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
126312160|NCT02951533|454432255|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
126312161|NCT02951533|454432253|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
126312162|NCT02951533|454432254|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
126312163|NCT02951533|454432255|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
126312164|NCT02951533|454432253|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
126312165|NCT02951533|454432254|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
126312166|NCT02951533|454432255|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
126312167|NCT02951533|454432253|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
126312168|NCT02951533|454432254|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
126312169|NCT02951533|454432255|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
126312170|NCT00520481|454432256|FG000|Overall Study|Adverse Event|4|||
126312171|NCT00520481|454432257|FG001|Overall Study|Adverse Event|1|||
126312172|NCT00520481|454432256|FG000|Overall Study|Withdrawal by Subject|3|||
126312173|NCT00520481|454432257|FG001|Overall Study|Withdrawal by Subject|0|||
126312174|NCT00742508|454432265|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
126312175|NCT00742508|454432266|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
126312176|NCT00742508|454432265|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
126312177|NCT00742508|454432266|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
126312178|NCT00742508|454432265|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
126312179|NCT00742508|454432266|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
126312180|NCT00742508|454432265|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
126312181|NCT00742508|454432266|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
126312182|NCT00742508|454432265|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
126312183|NCT00742508|454432266|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
126312184|NCT04017832|454432267|FG000|Overall Study|Withdrawal by Subject|13|||
126312185|NCT04017832|454432268|FG001|Overall Study|Withdrawal by Subject|12|||
126312186|NCT04017832|454432269|FG002|Overall Study|Withdrawal by Subject|21|||
126312187|NCT04017832|454432270|FG003|Overall Study|Withdrawal by Subject|7|||
126312188|NCT04017832|454432267|FG000|Overall Study|Lost to Follow-up|0|||
126312189|NCT04017832|454432268|FG001|Overall Study|Lost to Follow-up|3|||
126312190|NCT04017832|454432269|FG002|Overall Study|Lost to Follow-up|3|||
126312191|NCT04017832|454432270|FG003|Overall Study|Lost to Follow-up|1|||
126312192|NCT04017832|454432267|FG000|Overall Study|Physician Decision|1|||
126312193|NCT04017832|454432268|FG001|Overall Study|Physician Decision|1|||
126312194|NCT04017832|454432269|FG002|Overall Study|Physician Decision|1|||
126312195|NCT04017832|454432270|FG003|Overall Study|Physician Decision|1|||
126312196|NCT04017832|454432267|FG000|Overall Study|Death|2|||
126312197|NCT04017832|454432268|FG001|Overall Study|Death|2|||
126312198|NCT04017832|454432269|FG002|Overall Study|Death|1|||
126312199|NCT04017832|454432270|FG003|Overall Study|Death|0|||
126312200|NCT00860249|454434145|FG000|Overall Study|trial was terminated prior to completion|21|||
126312201|NCT00860249|454434146|FG001|Overall Study|trial was terminated prior to completion|18|||
126312202|NCT00860249|454434147|FG002|Overall Study|trial was terminated prior to completion|21|||
126312203|NCT00174967|454434148|FG000|Overall Study|Adverse Event|1|||
126312204|NCT00174967|454434149|FG001|Overall Study|Adverse Event|2|||
126312205|NCT00174967|454434150|FG002|Overall Study|Adverse Event|2|||
126312206|NCT00174967|454434151|FG003|Overall Study|Adverse Event|1|||
126312207|NCT00174967|454434148|FG000|Overall Study|Gout Flare|0|||
126312208|NCT00174967|454434149|FG001|Overall Study|Gout Flare|0|||
126312209|NCT00174967|454434150|FG002|Overall Study|Gout Flare|0|||
126312210|NCT00174967|454434151|FG003|Overall Study|Gout Flare|1|||
126312211|NCT00174967|454434148|FG000|Overall Study|Other|0|||
126312212|NCT00174967|454434149|FG001|Overall Study|Other|1|||
126312213|NCT00174967|454434150|FG002|Overall Study|Other|0|||
126312214|NCT00174967|454434151|FG003|Overall Study|Other|0|||
126422581|NCT04915729|454842633|FG001|Overall Study|Withdrawal by Subject|5|||
126312215|NCT02031640|454434152|FG000|Screening Period|Adverse Event|1|||
126312216|NCT02031640|454434153|FG001|Screening Period|Adverse Event|0|||
126312217|NCT02031640|454434154|FG002|Screening Period|Adverse Event|0|||
126312218|NCT02031640|454434155|FG003|Screening Period|Adverse Event|0|||
126312219|NCT02031640|454434156|FG004|Screening Period|Adverse Event|0|||
126312220|NCT02031640|454434157|FG005|Screening Period|Adverse Event|0|||
126312221|NCT02031640|454434152|FG000|Screening Period|Withdrawal by Subject|29|||
126312222|NCT02031640|454434153|FG001|Screening Period|Withdrawal by Subject|0|||
126312223|NCT02031640|454434154|FG002|Screening Period|Withdrawal by Subject|0|||
126312224|NCT02031640|454434155|FG003|Screening Period|Withdrawal by Subject|0|||
126312225|NCT02031640|454434156|FG004|Screening Period|Withdrawal by Subject|0|||
126312226|NCT02031640|454434157|FG005|Screening Period|Withdrawal by Subject|0|||
126312227|NCT02031640|454434152|FG000|Screening Period|Inclusion criteria not met|312|||
126312228|NCT02031640|454434153|FG001|Screening Period|Inclusion criteria not met|0|||
126312229|NCT02031640|454434154|FG002|Screening Period|Inclusion criteria not met|0|||
126312230|NCT02031640|454434155|FG003|Screening Period|Inclusion criteria not met|0|||
126312231|NCT02031640|454434156|FG004|Screening Period|Inclusion criteria not met|0|||
126312232|NCT02031640|454434157|FG005|Screening Period|Inclusion criteria not met|0|||
126312233|NCT02031640|454434152|FG000|Screening Period|Exclusion criteria met|30|||
126312234|NCT02031640|454434153|FG001|Screening Period|Exclusion criteria met|0|||
126312235|NCT02031640|454434154|FG002|Screening Period|Exclusion criteria met|0|||
126312236|NCT02031640|454434155|FG003|Screening Period|Exclusion criteria met|0|||
126312237|NCT02031640|454434156|FG004|Screening Period|Exclusion criteria met|0|||
126312238|NCT02031640|454434157|FG005|Screening Period|Exclusion criteria met|0|||
126312239|NCT02031640|454434152|FG000|Screening Period|Lost to Follow-up|14|||
126312240|NCT02031640|454434153|FG001|Screening Period|Lost to Follow-up|0|||
126312241|NCT02031640|454434154|FG002|Screening Period|Lost to Follow-up|0|||
126312242|NCT02031640|454434155|FG003|Screening Period|Lost to Follow-up|0|||
126312243|NCT02031640|454434156|FG004|Screening Period|Lost to Follow-up|0|||
126312244|NCT02031640|454434157|FG005|Screening Period|Lost to Follow-up|0|||
126312245|NCT02031640|454434152|FG000|Screening Period|Enrollment closed|26|||
126312246|NCT02031640|454434153|FG001|Screening Period|Enrollment closed|0|||
126312247|NCT02031640|454434154|FG002|Screening Period|Enrollment closed|0|||
126312248|NCT02031640|454434155|FG003|Screening Period|Enrollment closed|0|||
126312249|NCT02031640|454434156|FG004|Screening Period|Enrollment closed|0|||
126312250|NCT02031640|454434157|FG005|Screening Period|Enrollment closed|0|||
126312251|NCT02031640|454434152|FG000|Run-In Period|Adverse Event|4|||
126312252|NCT02031640|454434153|FG001|Run-In Period|Adverse Event|0|||
126312253|NCT02031640|454434154|FG002|Run-In Period|Adverse Event|0|||
126312254|NCT02031640|454434155|FG003|Run-In Period|Adverse Event|0|||
126312255|NCT02031640|454434156|FG004|Run-In Period|Adverse Event|0|||
126312256|NCT02031640|454434157|FG005|Run-In Period|Adverse Event|0|||
126312257|NCT02031640|454434152|FG000|Run-In Period|Withdrawal by Subject|17|||
126312258|NCT02031640|454434153|FG001|Run-In Period|Withdrawal by Subject|0|||
126312259|NCT02031640|454434154|FG002|Run-In Period|Withdrawal by Subject|0|||
126312260|NCT02031640|454434155|FG003|Run-In Period|Withdrawal by Subject|0|||
126312261|NCT02031640|454434156|FG004|Run-In Period|Withdrawal by Subject|0|||
126312262|NCT02031640|454434157|FG005|Run-In Period|Withdrawal by Subject|0|||
126312263|NCT02031640|454434152|FG000|Run-In Period|Inclusion criteria not met|38|||
126312264|NCT02031640|454434153|FG001|Run-In Period|Inclusion criteria not met|0|||
126312265|NCT02031640|454434154|FG002|Run-In Period|Inclusion criteria not met|0|||
126312266|NCT02031640|454434155|FG003|Run-In Period|Inclusion criteria not met|0|||
126312267|NCT02031640|454434156|FG004|Run-In Period|Inclusion criteria not met|0|||
126312268|NCT02031640|454434157|FG005|Run-In Period|Inclusion criteria not met|0|||
126312269|NCT02031640|454434152|FG000|Run-In Period|Exclusion criteria met|8|||
126312270|NCT02031640|454434153|FG001|Run-In Period|Exclusion criteria met|0|||
126312271|NCT02031640|454434154|FG002|Run-In Period|Exclusion criteria met|0|||
126312272|NCT02031640|454434155|FG003|Run-In Period|Exclusion criteria met|0|||
126312273|NCT02031640|454434156|FG004|Run-In Period|Exclusion criteria met|0|||
126312274|NCT02031640|454434157|FG005|Run-In Period|Exclusion criteria met|0|||
126312275|NCT02031640|454434152|FG000|Run-In Period|Randomization criteria not met|85|||
126312276|NCT02031640|454434153|FG001|Run-In Period|Randomization criteria not met|0|||
126312277|NCT02031640|454434154|FG002|Run-In Period|Randomization criteria not met|0|||
126312278|NCT02031640|454434155|FG003|Run-In Period|Randomization criteria not met|0|||
126312279|NCT02031640|454434156|FG004|Run-In Period|Randomization criteria not met|0|||
126312280|NCT02031640|454434157|FG005|Run-In Period|Randomization criteria not met|0|||
126312281|NCT02031640|454434152|FG000|Run-In Period|Various administrative reasons|17|||
126312282|NCT02031640|454434153|FG001|Run-In Period|Various administrative reasons|0|||
126312283|NCT02031640|454434154|FG002|Run-In Period|Various administrative reasons|0|||
126312284|NCT02031640|454434155|FG003|Run-In Period|Various administrative reasons|0|||
126312285|NCT02031640|454434156|FG004|Run-In Period|Various administrative reasons|0|||
126312286|NCT02031640|454434157|FG005|Run-In Period|Various administrative reasons|0|||
126312287|NCT02031640|454434152|FG000|Double-blind Treatment Period|Protocol deviation|0|||
126312288|NCT02031640|454434153|FG001|Double-blind Treatment Period|Protocol deviation|2|||
126422582|NCT04915729|454842632|FG000|Overall Study|Death|34|||
126422583|NCT04915729|454842633|FG001|Overall Study|Death|44|||
126312289|NCT02031640|454434154|FG002|Double-blind Treatment Period|Protocol deviation|0|||
126312290|NCT02031640|454434155|FG003|Double-blind Treatment Period|Protocol deviation|1|||
126312291|NCT02031640|454434156|FG004|Double-blind Treatment Period|Protocol deviation|3|||
126312292|NCT02031640|454434157|FG005|Double-blind Treatment Period|Protocol deviation|1|||
126312293|NCT02031640|454434152|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
126312294|NCT02031640|454434153|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
126312295|NCT02031640|454434154|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
126312296|NCT02031640|454434155|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
126312297|NCT02031640|454434156|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
126312298|NCT02031640|454434157|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
126312299|NCT02031640|454434152|FG000|Double-blind Treatment Period|Non-compliance|0|||
126312300|NCT02031640|454434153|FG001|Double-blind Treatment Period|Non-compliance|1|||
126312301|NCT02031640|454434154|FG002|Double-blind Treatment Period|Non-compliance|0|||
126312302|NCT02031640|454434155|FG003|Double-blind Treatment Period|Non-compliance|1|||
126312303|NCT02031640|454434156|FG004|Double-blind Treatment Period|Non-compliance|1|||
126312304|NCT02031640|454434157|FG005|Double-blind Treatment Period|Non-compliance|0|||
126312305|NCT02031640|454434152|FG000|Double-blind Treatment Period|Adverse Event|0|||
126312306|NCT02031640|454434153|FG001|Double-blind Treatment Period|Adverse Event|0|||
126312307|NCT02031640|454434154|FG002|Double-blind Treatment Period|Adverse Event|0|||
126312308|NCT02031640|454434155|FG003|Double-blind Treatment Period|Adverse Event|2|||
126312309|NCT02031640|454434156|FG004|Double-blind Treatment Period|Adverse Event|0|||
126312310|NCT02031640|454434157|FG005|Double-blind Treatment Period|Adverse Event|0|||
126312311|NCT02031640|454434152|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
126312312|NCT02031640|454434153|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
126312313|NCT02031640|454434154|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
126312314|NCT02031640|454434155|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
126312315|NCT02031640|454434156|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
126312316|NCT02031640|454434157|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
126312317|NCT02031640|454434152|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126312318|NCT02031640|454434153|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
126312319|NCT02031640|454434154|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
126312320|NCT02031640|454434155|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
126312321|NCT02031640|454434156|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
126312322|NCT02031640|454434157|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
126312323|NCT03085238|454434162|FG000|Overall Study|Adverse Event|2|||
126312324|NCT03085238|454434162|FG000|Overall Study|Death|2|||
126312325|NCT05896527|454434163|FG000|Overall Study|Withdrawal by Subject|11|||
126312326|NCT05896527|454434164|FG001|Overall Study|Withdrawal by Subject|10|||
126312327|NCT05896527|454434165|FG002|Overall Study|Withdrawal by Subject|4|||
126312328|NCT05896527|454434166|FG003|Overall Study|Withdrawal by Subject|3|||
126312329|NCT05896527|454434167|FG004|Overall Study|Withdrawal by Subject|2|||
126312330|NCT05896527|454434163|FG000|Overall Study|Lost to Follow-up|0|||
126312331|NCT05896527|454434164|FG001|Overall Study|Lost to Follow-up|2|||
126312332|NCT05896527|454434165|FG002|Overall Study|Lost to Follow-up|2|||
126312333|NCT05896527|454434166|FG003|Overall Study|Lost to Follow-up|2|||
126312334|NCT05896527|454434167|FG004|Overall Study|Lost to Follow-up|1|||
126312335|NCT05896527|454434163|FG000|Overall Study|Significant protocol noncompliance|0|||
126312336|NCT05896527|454434164|FG001|Overall Study|Significant protocol noncompliance|1|||
126312337|NCT05896527|454434165|FG002|Overall Study|Significant protocol noncompliance|0|||
126312338|NCT05896527|454434166|FG003|Overall Study|Significant protocol noncompliance|0|||
126312339|NCT05896527|454434167|FG004|Overall Study|Significant protocol noncompliance|0|||
126312340|NCT05896527|454434163|FG000|Overall Study|Eligibility criteria not met|1|||
126312341|NCT05896527|454434164|FG001|Overall Study|Eligibility criteria not met|0|||
126312342|NCT05896527|454434165|FG002|Overall Study|Eligibility criteria not met|0|||
126312343|NCT05896527|454434166|FG003|Overall Study|Eligibility criteria not met|0|||
126312344|NCT05896527|454434167|FG004|Overall Study|Eligibility criteria not met|0|||
126312345|NCT05896527|454434163|FG000|Overall Study|Sponsor's decision|0|||
126312346|NCT05896527|454434164|FG001|Overall Study|Sponsor's decision|0|||
126312347|NCT05896527|454434165|FG002|Overall Study|Sponsor's decision|0|||
126312348|NCT05896527|454434166|FG003|Overall Study|Sponsor's decision|1|||
126312349|NCT05896527|454434167|FG004|Overall Study|Sponsor's decision|0|||
126312350|NCT05896527|454434163|FG000|Overall Study|Investigator's decision|0|||
126312351|NCT05896527|454434164|FG001|Overall Study|Investigator's decision|1|||
126312352|NCT05896527|454434165|FG002|Overall Study|Investigator's decision|0|||
126312353|NCT05896527|454434166|FG003|Overall Study|Investigator's decision|0|||
126312354|NCT05896527|454434167|FG004|Overall Study|Investigator's decision|0|||
126422584|NCT04915729|454842632|FG000|Overall Study|not treated|3|||
126422585|NCT04915729|454842633|FG001|Overall Study|not treated|6|||
126422586|NCT04915729|454842632|FG000|Overall Study|Investigator removed subject|1|||
126422587|NCT04915729|454842633|FG001|Overall Study|Investigator removed subject|2|||
126312355|NCT05896527|454434163|FG000|Overall Study|Pregnancy of his partner|0|||
126312356|NCT05896527|454434164|FG001|Overall Study|Pregnancy of his partner|0|||
126312357|NCT05896527|454434165|FG002|Overall Study|Pregnancy of his partner|0|||
126312358|NCT05896527|454434166|FG003|Overall Study|Pregnancy of his partner|1|||
126312359|NCT05896527|454434167|FG004|Overall Study|Pregnancy of his partner|0|||
126534741|NCT01475136|455246818|FG000|Overall Study|Entry Criteria Not Met|0|||
126534742|NCT01475136|455246819|FG001|Overall Study|Entry Criteria Not Met|2|||
126534743|NCT01475136|455246820|FG002|Overall Study|Entry Criteria Not Met|3|||
126534744|NCT01475136|455246821|FG003|Overall Study|Entry Criteria Not Met|1|||
126312360|NCT01279070|454434168|FG000|Overall Study|Withdrawal by Subject|2|||
126312361|NCT01279070|454434169|FG001|Overall Study|Withdrawal by Subject|3|||
126312362|NCT01279070|454434168|FG000|Overall Study|Acute exacerbation|3|||
126312363|NCT01279070|454434169|FG001|Overall Study|Acute exacerbation|1|||
126312364|NCT03781583|454434170|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
126312365|NCT03781583|454434171|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
126312366|NCT03781583|454434172|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
126312367|NCT03781583|454434173|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
126312368|NCT03781583|454434170|FG000|Overall Study|Technology did not work for that person in that environment|1|||
126312369|NCT03781583|454434171|FG001|Overall Study|Technology did not work for that person in that environment|0|||
126312370|NCT03781583|454434172|FG002|Overall Study|Technology did not work for that person in that environment|0|||
126312371|NCT03781583|454434173|FG003|Overall Study|Technology did not work for that person in that environment|0|||
126312372|NCT03781583|454434170|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
126312373|NCT03781583|454434171|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
126312374|NCT03781583|454434172|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
126312375|NCT03781583|454434173|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
126312376|NCT03781583|454434170|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
126312377|NCT03781583|454434171|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
126312378|NCT03781583|454434172|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
126312379|NCT03781583|454434173|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
126312380|NCT05139303|454434174|FG000|Overall Study|Lost to Follow-up|3|||
126312381|NCT05139303|454434175|FG001|Overall Study|Lost to Follow-up|0|||
126312382|NCT05139303|454434174|FG000|Overall Study|Adverse Event|1|||
126312383|NCT05139303|454434175|FG001|Overall Study|Adverse Event|0|||
126312384|NCT02045862|454434176|FG000|Overall Study|Death|0|||
126312385|NCT02045862|454434177|FG001|Overall Study|Death|0|||
126312386|NCT02045862|454434178|FG002|Overall Study|Death|1|||
126312387|NCT02045862|454434176|FG000|Overall Study|Miscellaneous|5|||
126312388|NCT02045862|454434177|FG001|Overall Study|Miscellaneous|0|||
126312389|NCT02045862|454434178|FG002|Overall Study|Miscellaneous|8|||
126312390|NCT02045862|454434176|FG000|Overall Study|Withdrawal by Patient|18|||
126312391|NCT02045862|454434177|FG001|Overall Study|Withdrawal by Patient|27|||
126312392|NCT02045862|454434178|FG002|Overall Study|Withdrawal by Patient|57|||
126312393|NCT02045862|454434176|FG000|Overall Study|Protocol Violation|0|||
126312394|NCT02045862|454434177|FG001|Overall Study|Protocol Violation|0|||
126312395|NCT02045862|454434178|FG002|Overall Study|Protocol Violation|6|||
126312396|NCT02045862|454434176|FG000|Overall Study|Lack of Efficacy|8|||
126312397|NCT02045862|454434177|FG001|Overall Study|Lack of Efficacy|4|||
126312398|NCT02045862|454434178|FG002|Overall Study|Lack of Efficacy|13|||
126312399|NCT02045862|454434176|FG000|Overall Study|Randomized but not Received Study Drug|0|||
126312400|NCT02045862|454434177|FG001|Overall Study|Randomized but not Received Study Drug|2|||
126312401|NCT02045862|454434178|FG002|Overall Study|Randomized but not Received Study Drug|8|||
126312402|NCT02045862|454434176|FG000|Overall Study|Adverse Event|7|||
126312403|NCT02045862|454434177|FG001|Overall Study|Adverse Event|5|||
126422588|NCT04915729|454842632|FG000|Overall Study|questionnaire result not evaluated|1|||
126422589|NCT04915729|454842633|FG001|Overall Study|questionnaire result not evaluated|0|||
126422590|NCT04915729|454842632|FG000|Overall Study|refuse of hospital visit|1|||
126422591|NCT04915729|454842633|FG001|Overall Study|refuse of hospital visit|3|||
126422592|NCT04915729|454842632|FG000|Overall Study|Subject withdrew|1|||
126422593|NCT04915729|454842633|FG001|Overall Study|Subject withdrew|0|||
126422594|NCT02294058|454842644|FG000|Overall Study|Adverse Event|16|||
126422595|NCT02294058|454842645|FG001|Overall Study|Adverse Event|7|||
126422596|NCT02294058|454842646|FG002|Overall Study|Adverse Event|13|||
126422597|NCT02294058|454842644|FG000|Overall Study|Lack of Efficacy|3|||
126422598|NCT02294058|454842645|FG001|Overall Study|Lack of Efficacy|3|||
126422599|NCT02294058|454842646|FG002|Overall Study|Lack of Efficacy|0|||
126422600|NCT02294058|454842644|FG000|Overall Study|Lost to Follow-up|1|||
126422601|NCT02294058|454842645|FG001|Overall Study|Lost to Follow-up|0|||
126422602|NCT02294058|454842646|FG002|Overall Study|Lost to Follow-up|2|||
126422603|NCT02294058|454842644|FG000|Overall Study|Withdrawal by Subject|10|||
126422604|NCT02294058|454842645|FG001|Overall Study|Withdrawal by Subject|14|||
126422605|NCT02294058|454842646|FG002|Overall Study|Withdrawal by Subject|13|||
126422606|NCT02294058|454842644|FG000|Overall Study|Physician Decision|2|||
126422607|NCT02294058|454842645|FG001|Overall Study|Physician Decision|1|||
126422608|NCT02294058|454842646|FG002|Overall Study|Physician Decision|0|||
126312404|NCT02045862|454434178|FG002|Overall Study|Adverse Event|27|||
126312405|NCT02045862|454434176|FG000|Overall Study|Lost to Follow-up|1|||
126312406|NCT02045862|454434177|FG001|Overall Study|Lost to Follow-up|2|||
126312407|NCT02045862|454434178|FG002|Overall Study|Lost to Follow-up|6|||
126312408|NCT03164564|454434179|FG000|Overall Study|Death|3|||
126312409|NCT03164564|454434180|FG001|Overall Study|Death|0|||
126312410|NCT03164564|454434179|FG000|Overall Study|Withdrawal by Subject|20|||
126312411|NCT03164564|454434180|FG001|Overall Study|Withdrawal by Subject|15|||
126312412|NCT03164564|454434179|FG000|Overall Study|Lost to Follow-up|2|||
126312413|NCT03164564|454434180|FG001|Overall Study|Lost to Follow-up|0|||
126312414|NCT03164564|454434179|FG000|Overall Study|Physician Decision|0|||
126312415|NCT03164564|454434180|FG001|Overall Study|Physician Decision|1|||
126312416|NCT03164564|454434179|FG000|Overall Study|Adverse Event|0|||
126312417|NCT03164564|454434180|FG001|Overall Study|Adverse Event|1|||
126312418|NCT03164564|454434179|FG000|Overall Study|Ongoing|1586|||
126312419|NCT03164564|454434180|FG001|Overall Study|Ongoing|1586|||
126312420|NCT02822573|454434186|FG000|Overall Study|Lost to Follow-up|5|||
126312421|NCT02822573|454434187|FG001|Overall Study|Lost to Follow-up|3|||
126312422|NCT02822573|454434186|FG000|Overall Study|Physician Decision|1|||
126312423|NCT02822573|454434187|FG001|Overall Study|Physician Decision|1|||
126312424|NCT02822573|454434186|FG000|Overall Study|Withdrawal by Subject|9|||
126312425|NCT02822573|454434187|FG001|Overall Study|Withdrawal by Subject|5|||
126312426|NCT02822573|454434186|FG000|Overall Study|Protocol Violation|6|||
126312427|NCT02822573|454434187|FG001|Overall Study|Protocol Violation|4|||
126312428|NCT02822573|454434186|FG000|Overall Study|Too sick or ill|2|||
126312429|NCT02822573|454434187|FG001|Overall Study|Too sick or ill|1|||
126312430|NCT02822573|454434186|FG000|Overall Study|Disease Progression|1|||
126312431|NCT02822573|454434187|FG001|Overall Study|Disease Progression|1|||
126312432|NCT02822573|454434186|FG000|Overall Study|No reason given|6|||
126312433|NCT02822573|454434187|FG001|Overall Study|No reason given|4|||
126312434|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Adverse Event|6|||
126312435|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Adverse Event|14|||
126312436|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Death|3|||
126312437|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Death|1|||
126312438|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
126312439|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
126312440|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
126312441|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
126312442|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
126312443|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
126312444|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
126312445|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
126312446|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
126312447|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
126312448|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Physician Decision|2|||
126312449|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Physician Decision|4|||
126312450|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Pregnancy|2|||
126312451|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Pregnancy|1|||
126312452|NCT02275780|454434188|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
126312453|NCT02275780|454434189|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
126312454|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
126312455|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
126312456|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
126312457|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
126312458|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
126312459|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
126312460|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
126312461|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
126312462|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
126312463|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
126312464|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
126312465|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
126312466|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
126312467|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
126312468|NCT02275780|454434188|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
126312469|NCT02275780|454434189|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
126312470|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
126312471|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
126312472|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
126312473|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
126312474|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
126422609|NCT02294058|454842644|FG000|Overall Study|Miscellaneous|4|||
126645534|NCT00368927|455660382|FG001|Overall Study|Lost to Follow-up|0|||
126312475|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
126312476|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
126312477|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
126312478|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
126312479|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
126312480|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
126312481|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
126312482|NCT02275780|454434188|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
126312483|NCT02275780|454434189|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
126312484|NCT02275780|454434188|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
126312485|NCT02275780|454434189|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
126312486|NCT02275780|454434188|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
126312487|NCT02275780|454434189|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
126312488|NCT02275780|454434188|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
126312489|NCT02275780|454434189|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
126312490|NCT02275780|454434188|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
126312491|NCT02275780|454434189|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
126312492|NCT02275780|454434188|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
126312493|NCT02275780|454434189|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
126312494|NCT02275780|454434188|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
126312495|NCT02275780|454434189|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
126312496|NCT02855359|454434192|FG000|Overall Study|Death|2|||
126312497|NCT02855359|454434193|FG001|Overall Study|Death|2|||
126312498|NCT02855359|454434194|FG002|Overall Study|Death|0|||
126312499|NCT02855359|454434195|FG003|Overall Study|Death|0|||
126312500|NCT02855359|454434192|FG000|Overall Study|Study Termination by Sponsor|9|||
126312501|NCT02855359|454434193|FG001|Overall Study|Study Termination by Sponsor|11|||
126422610|NCT02294058|454842645|FG001|Overall Study|Miscellaneous|1|||
126422611|NCT02294058|454842646|FG002|Overall Study|Miscellaneous|1|||
126422612|NCT03575403|454842648|FG000|Overall Study|Adverse Event|1|||
126422613|NCT03575403|454842649|FG001|Overall Study|Adverse Event|0|||
126422614|NCT03575403|454842650|FG002|Overall Study|Adverse Event|0|||
126422615|NCT03575403|454842648|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
126422616|NCT03575403|454842649|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
126422617|NCT03575403|454842650|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
126422618|NCT02330055|454842651|FG000|Overall Study|technical issues|2|||
126422619|NCT02330055|454842652|FG001|Overall Study|technical issues|0|||
126422620|NCT02330055|454842651|FG000|Overall Study|participant forgot to wear device|5|||
126422621|NCT02330055|454842652|FG001|Overall Study|participant forgot to wear device|5|||
126422622|NCT02330055|454842651|FG000|Overall Study|data for less than 60 minutes|3|||
126422623|NCT02330055|454842652|FG001|Overall Study|data for less than 60 minutes|3|||
126422624|NCT02330055|454842651|FG000|Overall Study|participant did not sleep|0|||
126422625|NCT02330055|454842652|FG001|Overall Study|participant did not sleep|1|||
126422626|NCT02728089|454842654|FG000|Overall Study|Physician Decision|2|||
126422627|NCT02728089|454842654|FG000|Overall Study|Withdrawal by Subject|1|||
126422628|NCT03359174|454842657|FG000|Overall Study|Adverse Event|1|||
126422629|NCT01332994|454842661|FG000|Overall Study|Adverse Event|34|||
126422630|NCT01332994|454842661|FG000|Overall Study|Death|1|||
126422631|NCT01332994|454842661|FG000|Overall Study|Lack of Efficacy|1|||
126422632|NCT01332994|454842661|FG000|Overall Study|Lost to Follow-up|4|||
126422633|NCT01332994|454842661|FG000|Overall Study|Protocol Violation|6|||
126422634|NCT01332994|454842661|FG000|Overall Study|Withdrawal by Subject|15|||
126422635|NCT01332994|454842661|FG000|Overall Study|Administrative Problem|2|||
126422636|NCT01332994|454842661|FG000|Overall Study|Other|8|||
126312502|NCT02855359|454434194|FG002|Overall Study|Study Termination by Sponsor|0|||
126312503|NCT02855359|454434195|FG003|Overall Study|Study Termination by Sponsor|0|||
126312504|NCT00308087|454434196|FG000|Overall Study|Progressive Disease|19|||
126312505|NCT00308087|454434197|FG001|Overall Study|Progressive Disease|21|||
126312506|NCT00308087|454434196|FG000|Overall Study|Study Closure|11|||
126312507|NCT00308087|454434197|FG001|Overall Study|Study Closure|12|||
126312508|NCT00308087|454434196|FG000|Overall Study|Withdrawal by Subject|2|||
126312509|NCT00308087|454434197|FG001|Overall Study|Withdrawal by Subject|1|||
126312510|NCT00308087|454434196|FG000|Overall Study|Other|4|||
126312511|NCT00308087|454434197|FG001|Overall Study|Other|3|||
126312512|NCT05007041|454434204|FG000|Overall Study|Missing Diary Entries|0|||
126312513|NCT05007041|454434205|FG001|Overall Study|Missing Diary Entries|1|||
126312514|NCT02850016|454434206|FG000|Overall Study|Withdrawal by Subject|1|||
126312515|NCT02850016|454434207|FG001|Overall Study|Withdrawal by Subject|2|||
126312516|NCT00423189|454434210|FG000|Overall Study|Death|0|||
126312517|NCT00423189|454434211|FG001|Overall Study|Death|1|||
126312518|NCT00423189|454434212|FG002|Overall Study|Death|0|||
126312519|NCT01459718|454434217|FG000|Overall Study|Physician Decision|1|||
126312520|NCT01459718|454434217|FG000|Overall Study|Lost to Follow-up|1|||
126312521|NCT01459718|454434217|FG000|Overall Study|Adverse Event|1|||
126312522|NCT01258075|454434223|FG000|Overall Study|Adverse Event|8|||
126312523|NCT01258075|454434224|FG001|Overall Study|Adverse Event|3|||
126312524|NCT01258075|454434223|FG000|Overall Study|Lost to Follow-up|11|||
126312525|NCT01258075|454434224|FG001|Overall Study|Lost to Follow-up|6|||
126312526|NCT01258075|454434223|FG000|Overall Study|Withdrawal by Subject|10|||
126312527|NCT01258075|454434224|FG001|Overall Study|Withdrawal by Subject|7|||
126312528|NCT01258075|454434223|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
126312529|NCT01258075|454434224|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
126312530|NCT01258075|454434223|FG000|Overall Study|Other|12|||
126312531|NCT01258075|454434224|FG001|Overall Study|Other|5|||
126312532|NCT01500213|454434227|FG000|Overall Study|Adverse Event|35|||
126312533|NCT01500213|454434228|FG001|Overall Study|Adverse Event|35|||
126312534|NCT01500213|454434227|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
126312535|NCT01500213|454434228|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
126312536|NCT01500213|454434227|FG000|Overall Study|Withdrawal by Subject|28|||
126312537|NCT01500213|454434228|FG001|Overall Study|Withdrawal by Subject|37|||
126312538|NCT01500213|454434227|FG000|Overall Study|Death|7|||
126312539|NCT01500213|454434228|FG001|Overall Study|Death|3|||
126312540|NCT01500213|454434227|FG000|Overall Study|Disease Progression|13|||
126312541|NCT01500213|454434228|FG001|Overall Study|Disease Progression|21|||
126312542|NCT01500213|454434227|FG000|Overall Study|Protocol Violation|19|||
126312543|NCT01500213|454434228|FG001|Overall Study|Protocol Violation|19|||
126312544|NCT01500213|454434227|FG000|Overall Study|Physician Decision|12|||
126312545|NCT01500213|454434228|FG001|Overall Study|Physician Decision|10|||
126312546|NCT01500213|454434227|FG000|Overall Study|Lack of Efficacy|9|||
126312547|NCT01500213|454434228|FG001|Overall Study|Lack of Efficacy|7|||
126312548|NCT01500213|454434227|FG000|Overall Study|Lost to Follow-up|3|||
126312549|NCT01500213|454434228|FG001|Overall Study|Lost to Follow-up|6|||
126312550|NCT01500213|454434227|FG000|Overall Study|Other Reasons|7|||
126312551|NCT01500213|454434228|FG001|Overall Study|Other Reasons|5|||
126312552|NCT03197870|454434233|FG000|Overall Study|Adverse Event|9|||
126312553|NCT03197870|454434234|FG001|Overall Study|Adverse Event|4|||
126312554|NCT03197870|454434235|FG002|Overall Study|Adverse Event|6|||
126312555|NCT03197870|454434233|FG000|Overall Study|Withdrawal by Subject|2|||
126312556|NCT03197870|454434234|FG001|Overall Study|Withdrawal by Subject|3|||
126312557|NCT03197870|454434235|FG002|Overall Study|Withdrawal by Subject|0|||
126312558|NCT03197870|454434233|FG000|Overall Study|Lost to Follow-up|2|||
126312559|NCT03197870|454434234|FG001|Overall Study|Lost to Follow-up|2|||
126312560|NCT03197870|454434235|FG002|Overall Study|Lost to Follow-up|0|||
126312561|NCT03197870|454434233|FG000|Overall Study|data not available|1|||
126312562|NCT03197870|454434234|FG001|Overall Study|data not available|1|||
126312563|NCT03197870|454434235|FG002|Overall Study|data not available|0|||
126312564|NCT01618019|454434237|FG000|Overall Study|Withdrawal by Subject|14|||
126312565|NCT01618019|454434238|FG001|Overall Study|Withdrawal by Subject|14|||
126312566|NCT01542034|454434239|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
126312567|NCT01542034|454434240|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
126312568|NCT01542034|454434239|FG000|Overall Study|Administrative decision|0|||
126312569|NCT01542034|454434240|FG001|Overall Study|Administrative decision|3|||
126312570|NCT01542034|454434239|FG000|Overall Study|Subject Noncompliance|1|||
126312571|NCT01542034|454434240|FG001|Overall Study|Subject Noncompliance|0|||
126312572|NCT01542034|454434239|FG000|Overall Study|Adverse Event|2|||
126312573|NCT01542034|454434240|FG001|Overall Study|Adverse Event|2|||
126312574|NCT01542034|454434239|FG000|Overall Study|Lost to Follow-up|7|||
126312575|NCT01542034|454434240|FG001|Overall Study|Lost to Follow-up|6|||
126312576|NCT02612610|454434241|FG000|Overall Study|Withdrawal by Subject|1|||
126312577|NCT02612610|454434242|FG001|Overall Study|Withdrawal by Subject|1|||
126312578|NCT02612610|454434243|FG002|Overall Study|Withdrawal by Subject|0|||
126312579|NCT02612610|454434244|FG003|Overall Study|Withdrawal by Subject|2|||
126312580|NCT02612610|454434241|FG000|Overall Study|Adverse Event|2|||
126312581|NCT02612610|454434242|FG001|Overall Study|Adverse Event|2|||
126312582|NCT02612610|454434243|FG002|Overall Study|Adverse Event|3|||
126312583|NCT02612610|454434244|FG003|Overall Study|Adverse Event|10|||
126312584|NCT02612610|454434241|FG000|Overall Study|Lost to Follow-up|0|||
126312585|NCT02612610|454434242|FG001|Overall Study|Lost to Follow-up|1|||
126312586|NCT02612610|454434243|FG002|Overall Study|Lost to Follow-up|0|||
126312587|NCT02612610|454434244|FG003|Overall Study|Lost to Follow-up|0|||
126312588|NCT02612610|454434241|FG000|Overall Study|Protocol Violation|0|||
126312589|NCT02612610|454434242|FG001|Overall Study|Protocol Violation|1|||
126312590|NCT02612610|454434243|FG002|Overall Study|Protocol Violation|1|||
126312591|NCT02612610|454434244|FG003|Overall Study|Protocol Violation|0|||
126312592|NCT02612610|454434241|FG000|Overall Study|Lack of Efficacy|1|||
126312593|NCT02612610|454434242|FG001|Overall Study|Lack of Efficacy|2|||
126312594|NCT02612610|454434243|FG002|Overall Study|Lack of Efficacy|0|||
126312595|NCT02612610|454434244|FG003|Overall Study|Lack of Efficacy|1|||
126312596|NCT02612610|454434241|FG000|Overall Study|Physician Decision|0|||
126312597|NCT02612610|454434242|FG001|Overall Study|Physician Decision|1|||
126312598|NCT02612610|454434243|FG002|Overall Study|Physician Decision|0|||
126312599|NCT02612610|454434244|FG003|Overall Study|Physician Decision|0|||
126312600|NCT02612610|454434241|FG000|Overall Study|Noncompliance|1|||
126312601|NCT02612610|454434242|FG001|Overall Study|Noncompliance|0|||
126312602|NCT02612610|454434243|FG002|Overall Study|Noncompliance|0|||
126312603|NCT02612610|454434244|FG003|Overall Study|Noncompliance|0|||
126312604|NCT02612610|454434241|FG000|Overall Study|Cough Improvement|0|||
126312605|NCT02612610|454434242|FG001|Overall Study|Cough Improvement|0|||
126312606|NCT02612610|454434243|FG002|Overall Study|Cough Improvement|1|||
126312607|NCT02612610|454434244|FG003|Overall Study|Cough Improvement|0|||
126312608|NCT01801280|454434245|FG000|Period 1|Withdrawal by Subject|0|||
126312609|NCT01801280|454434246|FG001|Period 1|Withdrawal by Subject|1|||
126312610|NCT01801280|454434247|FG002|Period 1|Withdrawal by Subject|0|||
126312611|NCT01801280|454434248|FG003|Period 1|Withdrawal by Subject|0|||
126312612|NCT01801280|454434245|FG000|Period 2|Withdrawal by Subject|1|||
126312613|NCT01801280|454434246|FG001|Period 2|Withdrawal by Subject|0|||
126312614|NCT01801280|454434247|FG002|Period 2|Withdrawal by Subject|0|||
126312615|NCT01801280|454434248|FG003|Period 2|Withdrawal by Subject|0|||
126312616|NCT01801280|454434245|FG000|Period 4|Protocol Violation|0|||
126312617|NCT01801280|454434246|FG001|Period 4|Protocol Violation|0|||
126312618|NCT01801280|454434247|FG002|Period 4|Protocol Violation|1|||
126312619|NCT01801280|454434248|FG003|Period 4|Protocol Violation|0|||
126312620|NCT00176644|454434249|FG000|Overall Study|Withdrawal by Subject|1|||
126312621|NCT02783729|454434250|FG000|Overall Study|Lack of Efficacy|1|||
126312622|NCT02783729|454434251|FG001|Overall Study|Lack of Efficacy|0|||
126312623|NCT02783729|454434252|FG002|Overall Study|Lack of Efficacy|0|||
126312624|NCT02783729|454434253|FG003|Overall Study|Lack of Efficacy|0|||
126312625|NCT02783729|454434250|FG000|Overall Study|Adverse Event|2|||
126312626|NCT02783729|454434251|FG001|Overall Study|Adverse Event|6|||
126312627|NCT02783729|454434252|FG002|Overall Study|Adverse Event|2|||
126312628|NCT02783729|454434253|FG003|Overall Study|Adverse Event|3|||
126312629|NCT02783729|454434250|FG000|Overall Study|Other|1|||
126312630|NCT02783729|454434251|FG001|Overall Study|Other|6|||
126312631|NCT02783729|454434252|FG002|Overall Study|Other|2|||
126312632|NCT02783729|454434253|FG003|Overall Study|Other|3|||
126312633|NCT02783729|454434250|FG000|Overall Study|Withdrawal by Subject|2|||
126312634|NCT02783729|454434251|FG001|Overall Study|Withdrawal by Subject|3|||
126312635|NCT02783729|454434252|FG002|Overall Study|Withdrawal by Subject|1|||
126312636|NCT02783729|454434253|FG003|Overall Study|Withdrawal by Subject|2|||
126312637|NCT02783729|454434250|FG000|Overall Study|Participant's choice|2|||
126312638|NCT02783729|454434251|FG001|Overall Study|Participant's choice|1|||
126312639|NCT02783729|454434252|FG002|Overall Study|Participant's choice|2|||
126312640|NCT02783729|454434253|FG003|Overall Study|Participant's choice|1|||
126312641|NCT02783729|454434250|FG000|Overall Study|Lost to Follow-up|2|||
126312642|NCT02783729|454434251|FG001|Overall Study|Lost to Follow-up|1|||
126312643|NCT02783729|454434252|FG002|Overall Study|Lost to Follow-up|1|||
126312644|NCT02783729|454434253|FG003|Overall Study|Lost to Follow-up|0|||
126312645|NCT02693171|454434254|FG000|Overall Study|Adverse Event|1|||
126312646|NCT02693171|454434254|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
126312647|NCT01866657|454434262|FG000|Overall Study|Surgery canceled|2|||
126312648|NCT01866657|454434263|FG001|Overall Study|Surgery canceled|0|||
126312649|NCT04021121|454434271|FG000|Overall Study|Death|3|||
126312650|NCT04021121|454434272|FG001|Overall Study|Death|3|||
126312651|NCT04021121|454434273|FG002|Overall Study|Death|5|||
126312652|NCT04021121|454434274|FG003|Overall Study|Death|4|||
126312653|NCT02288091|454434275|FG000|Overall Study|Lost to Follow-up|1|||
126312654|NCT02288091|454434275|FG000|Overall Study|Screen fail|7|||
126312655|NCT00978250|454434280|FG000|Overall Study|Late determination of ineligibility|0|||
126312656|NCT00978250|454434281|FG001|Overall Study|Late determination of ineligibility|1|||
126312657|NCT00978250|454434282|FG002|Overall Study|Late determination of ineligibility|0|||
126312658|NCT00978250|454434283|FG003|Overall Study|Late determination of ineligibility|1|||
126312659|NCT05174949|454434288|FG000|Overall Study|Physician Decision|1|||
126312660|NCT05174949|454434289|FG001|Overall Study|Physician Decision|2|||
126312661|NCT05174949|454434290|FG002|Overall Study|Physician Decision|0|||
126312662|NCT05174949|454434291|FG003|Overall Study|Physician Decision|1|||
126312663|NCT05174949|454434292|FG004|Overall Study|Physician Decision|0|||
126312664|NCT05174949|454434293|FG005|Overall Study|Physician Decision|0|||
126312665|NCT05174949|454434288|FG000|Overall Study|Withdrawal by Subject|0|||
126312666|NCT05174949|454434289|FG001|Overall Study|Withdrawal by Subject|1|||
126312667|NCT05174949|454434290|FG002|Overall Study|Withdrawal by Subject|0|||
126312668|NCT05174949|454434291|FG003|Overall Study|Withdrawal by Subject|0|||
126312669|NCT05174949|454434292|FG004|Overall Study|Withdrawal by Subject|0|||
126312670|NCT05174949|454434293|FG005|Overall Study|Withdrawal by Subject|0|||
126312671|NCT05174949|454434288|FG000|Overall Study|Lost to Follow-up|0|||
126312672|NCT05174949|454434289|FG001|Overall Study|Lost to Follow-up|0|||
126312673|NCT05174949|454434290|FG002|Overall Study|Lost to Follow-up|0|||
126312674|NCT05174949|454434291|FG003|Overall Study|Lost to Follow-up|1|||
126312675|NCT05174949|454434292|FG004|Overall Study|Lost to Follow-up|0|||
126312676|NCT05174949|454434293|FG005|Overall Study|Lost to Follow-up|0|||
126312677|NCT02029989|454434294|FG000|Overall Study|Withdrawal by Subject|1|||
126312678|NCT02029989|454434295|FG001|Overall Study|Withdrawal by Subject|0|||
126312679|NCT02029989|454434294|FG000|Overall Study|Withdrawal: Fear of needles|1|||
126312680|NCT02029989|454434295|FG001|Overall Study|Withdrawal: Fear of needles|0|||
126312681|NCT02029989|454434294|FG000|Overall Study|Change of location|2|||
126312682|NCT02029989|454434295|FG001|Overall Study|Change of location|3|||
126312683|NCT02029989|454434294|FG000|Overall Study|Physician Decision|2|||
126312684|NCT02029989|454434295|FG001|Overall Study|Physician Decision|0|||
126312685|NCT02029989|454434294|FG000|Overall Study|Lost to Follow-up|9|||
126312686|NCT02029989|454434295|FG001|Overall Study|Lost to Follow-up|7|||
126312687|NCT02029989|454434294|FG000|Overall Study|Death|0|||
126312688|NCT02029989|454434295|FG001|Overall Study|Death|1|||
126312689|NCT02029989|454434294|FG000|Overall Study|Protocol Violation|1|||
126312690|NCT02029989|454434295|FG001|Overall Study|Protocol Violation|0|||
126312691|NCT04351373|454434296|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
126312692|NCT02880865|454434298|FG000|Overall Study|Adverse Event|1|||
126312693|NCT02880865|454434299|FG001|Overall Study|Adverse Event|0|||
126422637|NCT02800863|454842662|FG000|Overall Study|Adverse Event|14|||
126422638|NCT02800863|454842662|FG000|Overall Study|Another Device Implanted|1|||
126422639|NCT02800863|454842662|FG000|Overall Study|Device Explanted|1|||
126422640|NCT02800863|454842662|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
126422641|NCT02800863|454842662|FG000|Overall Study|Health Issues|1|||
126422642|NCT02800863|454842662|FG000|Overall Study|Insurance Denial|8|||
126422643|NCT02800863|454842662|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
126422644|NCT02800863|454842662|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
126422645|NCT02800863|454842662|FG000|Overall Study|Screen Failure|1|||
126422646|NCT02800863|454842662|FG000|Overall Study|Sponsor Request|6|||
126422647|NCT02800863|454842662|FG000|Overall Study|Death|3|||
126422648|NCT02800863|454842662|FG000|Overall Study|Subject Implant at Another Facility|1|||
126422649|NCT02800863|454842662|FG000|Overall Study|Lost to Follow-up|26|||
126422650|NCT02800863|454842662|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
126422651|NCT02800863|454842662|FG000|Overall Study|Subject and/or Family Request|64|||
126422652|NCT02800863|454842662|FG000|Overall Study|Trial Failure|81|||
126422653|NCT02800863|454842662|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
126422654|NCT00279916|454842663|FG000|Overall Study|Withdrawal by Subject|4|||
126422655|NCT00279916|454842664|FG001|Overall Study|Withdrawal by Subject|3|||
126422656|NCT00279916|454842663|FG000|Overall Study|Lost to Follow-up|3|||
126422657|NCT00279916|454842664|FG001|Overall Study|Lost to Follow-up|2|||
126422658|NCT01807598|454842665|FG000|Overall Study|Withdrawal by Subject|4|||
126422659|NCT01807598|454842665|FG000|Overall Study|Adverse Event|1|||
126422660|NCT01807598|454842665|FG000|Overall Study|Other Physician Decision|1|||
126422661|NCT02717494|454842667|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
126534745|NCT01475136|455246818|FG000|Overall Study|Withdrawal by Subject|0|||
126534746|NCT01475136|455246819|FG001|Overall Study|Withdrawal by Subject|0|||
126534747|NCT01475136|455246820|FG002|Overall Study|Withdrawal by Subject|0|||
126534748|NCT01475136|455246821|FG003|Overall Study|Withdrawal by Subject|2|||
126534749|NCT01475136|455246818|FG000|Overall Study|Adverse Event|1|||
126534750|NCT01475136|455246819|FG001|Overall Study|Adverse Event|0|||
126534751|NCT01475136|455246820|FG002|Overall Study|Adverse Event|0|||
126534752|NCT01475136|455246821|FG003|Overall Study|Adverse Event|1|||
126534753|NCT01475136|455246818|FG000|Overall Study|Death|0|||
126534754|NCT01475136|455246819|FG001|Overall Study|Death|0|||
126534755|NCT01475136|455246820|FG002|Overall Study|Death|0|||
126534756|NCT01475136|455246821|FG003|Overall Study|Death|1|||
126534757|NCT03355326|455246824|FG000|Overall Study|Protocol Violation|3|||
126534758|NCT03355326|455246825|FG001|Overall Study|Protocol Violation|3|||
126551831|NCT01807221|455315866|FG003|Overall Study|Sponsor decision|1|||
126551832|NCT01807221|455315867|FG004|Overall Study|Sponsor decision|0|||
126551833|NCT01807221|455315868|FG005|Overall Study|Sponsor decision|0|||
126551834|NCT01807221|455315863|FG000|Overall Study|Lost to Follow-up|1|||
126551835|NCT01807221|455315864|FG001|Overall Study|Lost to Follow-up|0|||
126551836|NCT01807221|455315865|FG002|Overall Study|Lost to Follow-up|2|||
126551837|NCT01807221|455315866|FG003|Overall Study|Lost to Follow-up|1|||
126551838|NCT01807221|455315867|FG004|Overall Study|Lost to Follow-up|0|||
126551839|NCT01807221|455315868|FG005|Overall Study|Lost to Follow-up|0|||
126551840|NCT02609659|455315869|FG000|Overall Study|Adverse Event|1|||
126306058|NCT02553499|454408872|FG003|Overall Study|Physician Decision|0|||
126312694|NCT02880865|454434298|FG000|Overall Study|Withdrawal by Subject|0|||
126312695|NCT02880865|454434299|FG001|Overall Study|Withdrawal by Subject|2|||
126551841|NCT02609659|455315869|FG000|Overall Study|Lost to Follow-up|6|||
126551842|NCT02609659|455315869|FG000|Overall Study|Other|1|||
126312696|NCT02880865|454434298|FG000|Overall Study|Physician Decision|0|||
126312697|NCT02880865|454434299|FG001|Overall Study|Physician Decision|1|||
126312698|NCT01446237|454434302|FG000|Overall Study|Adverse Event|1|||
126312699|NCT01446237|454434302|FG000|Overall Study|Lost to Follow-up|2|||
126312700|NCT01446237|454434302|FG000|Overall Study|Withdrawal by Subject|7|||
126312701|NCT03634033|454435905|FG000|Overall Study|Did not have a post-assessment|384|||
126312702|NCT03634033|454435906|FG001|Overall Study|Did not have a post-assessment|291|||
126312703|NCT03634033|454435907|FG002|Overall Study|Did not have a post-assessment|114|||
126312704|NCT03634033|454435908|FG003|Overall Study|Did not have a post-assessment|161|||
126312705|NCT03634033|454435909|FG004|Overall Study|Did not have a post-assessment|5|||
126312706|NCT03634033|454435910|FG005|Overall Study|Did not have a post-assessment|0|||
126312707|NCT03634033|454435911|FG006|Overall Study|Did not have a post-assessment|0|||
126312708|NCT03634033|454435905|FG000|Overall Study|Death|0|||
126312709|NCT03634033|454435906|FG001|Overall Study|Death|0|||
126312710|NCT03634033|454435907|FG002|Overall Study|Death|0|||
126312711|NCT03634033|454435908|FG003|Overall Study|Death|0|||
126312712|NCT03634033|454435909|FG004|Overall Study|Death|0|||
126312713|NCT03634033|454435910|FG005|Overall Study|Death|7|||
126312714|NCT03634033|454435911|FG006|Overall Study|Death|7|||
126312715|NCT03634033|454435905|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
126312716|NCT03634033|454435906|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
126312717|NCT03634033|454435907|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
126312718|NCT03634033|454435908|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
126312719|NCT03634033|454435909|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
126312720|NCT03634033|454435910|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
126312721|NCT03634033|454435911|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
126312722|NCT03634033|454435905|FG000|Overall Study|Lost to Follow-up|0|||
126312723|NCT03634033|454435906|FG001|Overall Study|Lost to Follow-up|0|||
126312724|NCT03634033|454435907|FG002|Overall Study|Lost to Follow-up|0|||
126312725|NCT03634033|454435908|FG003|Overall Study|Lost to Follow-up|0|||
126312726|NCT03634033|454435909|FG004|Overall Study|Lost to Follow-up|0|||
126312727|NCT03634033|454435910|FG005|Overall Study|Lost to Follow-up|1|||
126312728|NCT03634033|454435911|FG006|Overall Study|Lost to Follow-up|2|||
126312729|NCT03634033|454435905|FG000|Overall Study|Withdrawal by Subject|0|||
126312730|NCT03634033|454435906|FG001|Overall Study|Withdrawal by Subject|0|||
126312731|NCT03634033|454435907|FG002|Overall Study|Withdrawal by Subject|0|||
126312732|NCT03634033|454435908|FG003|Overall Study|Withdrawal by Subject|0|||
126312733|NCT03634033|454435909|FG004|Overall Study|Withdrawal by Subject|0|||
126312734|NCT03634033|454435910|FG005|Overall Study|Withdrawal by Subject|0|||
126312735|NCT03634033|454435911|FG006|Overall Study|Withdrawal by Subject|1|||
126312736|NCT06366087|454435912|FG000|Overall Study|Withdrawal by Subject|0|||
126312737|NCT06366087|454435913|FG001|Overall Study|Withdrawal by Subject|1|||
126312738|NCT01944670|454435917|FG000|Overall Study|Lost to Follow-up|2|||
126312739|NCT00743288|454435918|FG000|Overall Study|Adverse Event|1|||
126312740|NCT00743288|454435919|FG001|Overall Study|Adverse Event|1|||
126312741|NCT00743288|454435920|FG002|Overall Study|Adverse Event|2|||
126312742|NCT00743288|454435921|FG003|Overall Study|Adverse Event|2|||
126312743|NCT00743288|454435922|FG004|Overall Study|Adverse Event|1|||
126312744|NCT00743288|454435923|FG005|Overall Study|Adverse Event|1|||
126312745|NCT00743288|454435924|FG006|Overall Study|Adverse Event|2|||
126312746|NCT00743288|454435918|FG000|Overall Study|Withdrawal by Subject|0|||
126312747|NCT00743288|454435919|FG001|Overall Study|Withdrawal by Subject|0|||
126312748|NCT00743288|454435920|FG002|Overall Study|Withdrawal by Subject|1|||
126312749|NCT00743288|454435921|FG003|Overall Study|Withdrawal by Subject|0|||
126534759|NCT02822222|455248385|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
126534760|NCT02822222|455248386|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
126534761|NCT00833560|455248387|FG000|Overall Study|Toxicity|13|||
126534762|NCT00833560|455248387|FG000|Overall Study|Adverse Event|11|||
126534763|NCT00833560|455248387|FG000|Overall Study|Protocol Violation|6|||
126534764|NCT00833560|455248387|FG000|Overall Study|Lack of Efficacy|4|||
126534765|NCT00833560|455248387|FG000|Overall Study|Death|2|||
126534766|NCT00833560|455248387|FG000|Overall Study|Pregression of other disease|1|||
126534767|NCT00833560|455248387|FG000|Overall Study|Other|5|||
126534768|NCT00643916|455248388|FG000|Overall Study|Protocol Violation|0|||
126534769|NCT00643916|455248389|FG001|Overall Study|Protocol Violation|1|||
126534770|NCT00643916|455248390|FG002|Overall Study|Protocol Violation|1|||
126534771|NCT00643916|455248391|FG003|Overall Study|Protocol Violation|1|||
126534772|NCT00643916|455248392|FG004|Overall Study|Protocol Violation|0|||
126534773|NCT00643916|455248393|FG005|Overall Study|Protocol Violation|0|||
126534774|NCT00643916|455248388|FG000|Overall Study|Lost to Follow-up|0|||
126645535|NCT00368927|455660381|FG000|Overall Study|Adverse Event|1|||
126645536|NCT00368927|455660382|FG001|Overall Study|Adverse Event|1|||
126312750|NCT00743288|454435922|FG004|Overall Study|Withdrawal by Subject|0|||
126312751|NCT00743288|454435923|FG005|Overall Study|Withdrawal by Subject|1|||
126312752|NCT00743288|454435924|FG006|Overall Study|Withdrawal by Subject|1|||
126312753|NCT00743288|454435918|FG000|Overall Study|Progressive disease (PD)|2|||
126534775|NCT00643916|455248389|FG001|Overall Study|Lost to Follow-up|1|||
126312754|NCT00743288|454435919|FG001|Overall Study|Progressive disease (PD)|0|||
126312755|NCT00743288|454435920|FG002|Overall Study|Progressive disease (PD)|1|||
126312756|NCT00743288|454435921|FG003|Overall Study|Progressive disease (PD)|4|||
126312757|NCT00743288|454435922|FG004|Overall Study|Progressive disease (PD)|5|||
126312758|NCT00743288|454435923|FG005|Overall Study|Progressive disease (PD)|3|||
126312759|NCT00743288|454435924|FG006|Overall Study|Progressive disease (PD)|6|||
126312760|NCT00743288|454435918|FG000|Overall Study|Worsening of condition (Not PD)|0|||
126312761|NCT00743288|454435919|FG001|Overall Study|Worsening of condition (Not PD)|2|||
126312762|NCT00743288|454435920|FG002|Overall Study|Worsening of condition (Not PD)|1|||
126312763|NCT00743288|454435921|FG003|Overall Study|Worsening of condition (Not PD)|1|||
126312764|NCT00743288|454435922|FG004|Overall Study|Worsening of condition (Not PD)|0|||
126312765|NCT00743288|454435923|FG005|Overall Study|Worsening of condition (Not PD)|0|||
126312766|NCT00743288|454435924|FG006|Overall Study|Worsening of condition (Not PD)|0|||
126312767|NCT05903924|454435925|FG000|Overall Study|Lost to Follow-up|1|||
126312768|NCT05903924|454435926|FG001|Overall Study|Lost to Follow-up|0|||
126312769|NCT05903924|454435927|FG002|Overall Study|Lost to Follow-up|0|||
126312770|NCT04338269|454435928|FG000|Overall Study|Death|86|||
126312771|NCT04338269|454435929|FG001|Overall Study|Death|89|||
126312772|NCT04338269|454435928|FG000|Overall Study|Lost to Follow-up|1|||
126312773|NCT04338269|454435929|FG001|Overall Study|Lost to Follow-up|2|||
126312774|NCT04338269|454435928|FG000|Overall Study|Physician Decision|1|||
126312775|NCT04338269|454435929|FG001|Overall Study|Physician Decision|0|||
126312776|NCT04338269|454435928|FG000|Overall Study|Withdrawal by Subject|14|||
126312777|NCT04338269|454435929|FG001|Overall Study|Withdrawal by Subject|11|||
126312778|NCT04166591|454435934|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
126312779|NCT04166591|454435935|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
126312780|NCT04166591|454435936|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126312781|NCT04166591|454435937|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126312782|NCT04166591|454435934|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
126312783|NCT04166591|454435935|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
126312784|NCT04166591|454435936|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126312785|NCT04166591|454435937|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126312786|NCT02730377|454435938|FG000|Overall Study|Other|5|||
126312787|NCT02730377|454435939|FG001|Overall Study|Other|4|||
126312788|NCT02730377|454435938|FG000|Overall Study|Death|1|||
126312789|NCT02730377|454435939|FG001|Overall Study|Death|8|||
126312790|NCT02730377|454435938|FG000|Overall Study|Inadequate glycaemic control|368|||
126312791|NCT02730377|454435939|FG001|Overall Study|Inadequate glycaemic control|473|||
126312792|NCT02730377|454435938|FG000|Overall Study|Adverse Event|79|||
126312793|NCT02730377|454435939|FG001|Overall Study|Adverse Event|41|||
126312794|NCT02730377|454435938|FG000|Overall Study|Protocol Violation|23|||
126312795|NCT02730377|454435939|FG001|Overall Study|Protocol Violation|30|||
126312796|NCT02730377|454435938|FG000|Overall Study|Lack of Efficacy|4|||
126312797|NCT02730377|454435939|FG001|Overall Study|Lack of Efficacy|13|||
126312798|NCT02730377|454435938|FG000|Overall Study|Pregnancy|0|||
126312799|NCT02730377|454435939|FG001|Overall Study|Pregnancy|1|||
126312800|NCT02730377|454435938|FG000|Overall Study|Withdrawal by Subject|45|||
126312801|NCT02730377|454435939|FG001|Overall Study|Withdrawal by Subject|42|||
126312802|NCT02730377|454435938|FG000|Overall Study|Lost to Follow-up|25|||
126312803|NCT02730377|454435939|FG001|Overall Study|Lost to Follow-up|21|||
126312804|NCT02203851|454435942|FG000|Overall Study|Lost to Follow-up|4|||
126312805|NCT02203851|454435942|FG000|Overall Study|Withdrawal by Subject|6|||
126312806|NCT02203851|454435942|FG000|Overall Study|Other|1|||
126312807|NCT04045132|454435945|FG000|Overall Study|Lost to Follow-up|3|||
126312808|NCT04045132|454435946|FG001|Overall Study|Lost to Follow-up|6|||
126312809|NCT01054300|454435956|FG000|Period 1|Adverse Event|1|||
126312810|NCT01054300|454435957|FG001|Period 1|Adverse Event|0|||
126312811|NCT01054300|454435958|FG002|Period 1|Adverse Event|0|||
126312812|NCT01054300|454435959|FG003|Period 1|Adverse Event|0|||
126312813|NCT01054300|454435956|FG000|Period 2|Withdrawal by Subject|0|||
126312814|NCT01054300|454435957|FG001|Period 2|Withdrawal by Subject|0|||
126312815|NCT01054300|454435958|FG002|Period 2|Withdrawal by Subject|1|||
126312816|NCT01054300|454435959|FG003|Period 2|Withdrawal by Subject|0|||
126312817|NCT04186806|454435967|FG000|Period 1: 7 Days|Adverse Event|1|||
126312818|NCT04186806|454435968|FG001|Period 1: 7 Days|Adverse Event|0|||
126312819|NCT00177307|454435969|FG000|Overall Study|Withdrawal by Subject|1|||
126312820|NCT02677038|454435973|FG000|Overall Study|Physician Decision|1|||
126312821|NCT02677038|454435973|FG000|Overall Study|Withdrawal by Subject|1|||
126312822|NCT03671564|454435974|FG000|Overall Study|Progressive Disease|3|||
126312823|NCT03671564|454435975|FG001|Overall Study|Progressive Disease|5|||
126312824|NCT03671564|454435976|FG002|Overall Study|Progressive Disease|3|||
126312825|NCT03671564|454435974|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
126422662|NCT02717494|454842668|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
126422663|NCT02717494|454842669|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
126422664|NCT02717494|454842667|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
126422665|NCT02717494|454842668|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
126422666|NCT02717494|454842669|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
126422667|NCT02717494|454842667|FG000|First Intervention (Step 1)|Death|0|||
126422668|NCT02717494|454842668|FG001|First Intervention (Step 1)|Death|0|||
126422669|NCT02717494|454842669|FG002|First Intervention (Step 1)|Death|1|||
126422670|NCT02717494|454842667|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
126422671|NCT02717494|454842668|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
126422672|NCT02717494|454842669|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
126422673|NCT00731679|454842672|FG000|Overall Study|Adverse Event|7|||
126422674|NCT00731679|454842673|FG001|Overall Study|Adverse Event|8|||
126422675|NCT00731679|454842672|FG000|Overall Study|Withdrawal by Subject|8|||
126422676|NCT00731679|454842673|FG001|Overall Study|Withdrawal by Subject|8|||
126422677|NCT00731679|454842672|FG000|Overall Study|Lost to Follow-up|7|||
126422678|NCT00731679|454842673|FG001|Overall Study|Lost to Follow-up|8|||
126422679|NCT00731679|454842672|FG000|Overall Study|Noncompliance|0|||
126422680|NCT00731679|454842673|FG001|Overall Study|Noncompliance|1|||
126422681|NCT00731679|454842672|FG000|Overall Study|Pregnancy|0|||
126422682|NCT00731679|454842673|FG001|Overall Study|Pregnancy|1|||
126422683|NCT02488005|454842674|FG000|Overall Study|Lost to Follow-up|2|||
126422684|NCT02326597|454842677|FG000|Overall Study|Lost to Follow-up|42|||
126422685|NCT02326597|454842678|FG001|Overall Study|Lost to Follow-up|32|||
126422686|NCT04089761|454842681|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
126422687|NCT04089761|454842681|FG000|"Run In Phase"|Lost to Follow-up|1|||
126422688|NCT04089761|454842681|FG000|"Treatment Phase"|No evaluable data|5|||
126422689|NCT04089761|454842681|FG000|"Treatment Phase"|Lost to Follow-up|1|||
126422690|NCT04739436|454842683|FG000|Overall Study|Lost to Follow-up|21|||
126422691|NCT04739436|454842684|FG001|Overall Study|Lost to Follow-up|23|||
126422692|NCT04739436|454842683|FG000|Overall Study|Withdrawal by Subject|4|||
126422693|NCT04739436|454842684|FG001|Overall Study|Withdrawal by Subject|6|||
126422694|NCT04739436|454842683|FG000|Overall Study|not randomized properly|1|||
126422695|NCT04739436|454842684|FG001|Overall Study|not randomized properly|0|||
126422696|NCT00428948|454842686|FG000|Overall Study|Lost to Follow-up|15|||
126422697|NCT00428948|454842687|FG001|Overall Study|Lost to Follow-up|8|||
126422698|NCT00428948|454842686|FG000|Overall Study|Adverse Event|148|||
126422699|NCT00428948|454842687|FG001|Overall Study|Adverse Event|24|||
126422700|NCT00428948|454842686|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
126422701|NCT00428948|454842687|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
126422702|NCT00428948|454842686|FG000|Overall Study|Investigator Withdrew Subject|3|||
126422703|NCT00428948|454842687|FG001|Overall Study|Investigator Withdrew Subject|4|||
126422704|NCT00428948|454842686|FG000|Overall Study|Subject Withdrew Consent|50|||
126422705|NCT00428948|454842687|FG001|Overall Study|Subject Withdrew Consent|30|||
126422706|NCT00428948|454842686|FG000|Overall Study|Protocol Deviation|1|||
126422707|NCT00428948|454842687|FG001|Overall Study|Protocol Deviation|1|||
126422708|NCT04965688|454842693|FG000|Overall Study|Withdrawal by Subject|2|||
126422709|NCT05864586|454842694|FG000|Overall Study|Ineligible|4|||
126422710|NCT05864586|454842695|FG001|Overall Study|Ineligible|12|||
126422711|NCT05864586|454842694|FG000|Overall Study|Pregnancy|0|||
126422712|NCT05864586|454842695|FG001|Overall Study|Pregnancy|1|||
126422713|NCT05864586|454842694|FG000|Overall Study|Withdrawal by Subject|0|||
126422714|NCT05864586|454842695|FG001|Overall Study|Withdrawal by Subject|1|||
126422715|NCT00319254|454842699|FG000|Overall Study|Withdrawal by Subject|4|||
126422716|NCT00319254|454842699|FG000|Overall Study|Death|46|||
126422717|NCT00319254|454842699|FG000|Overall Study|Lost to Follow-up|2|||
126422718|NCT00319254|454842699|FG000|Overall Study|Enrolled, Not Treated|2|||
126422719|NCT01505374|454842700|FG000|Overall Study|Lost to Follow-up|1|||
126422720|NCT01505374|454842701|FG001|Overall Study|Lost to Follow-up|0|||
126422721|NCT02452424|454842702|FG000|Overall Study|Death|2|||
126422722|NCT02452424|454842703|FG001|Overall Study|Death|2|||
126422723|NCT02452424|454842704|FG002|Overall Study|Death|2|||
126422724|NCT02452424|454842705|FG003|Overall Study|Death|6|||
126422725|NCT02452424|454842706|FG004|Overall Study|Death|2|||
126422726|NCT02452424|454842707|FG005|Overall Study|Death|0|||
126422727|NCT02452424|454842708|FG006|Overall Study|Death|5|||
126422728|NCT02452424|454842709|FG007|Overall Study|Death|1|||
126422729|NCT02452424|454842710|FG008|Overall Study|Death|3|||
126422730|NCT02452424|454842711|FG009|Overall Study|Death|1|||
126422731|NCT02452424|454842712|FG010|Overall Study|Death|0|||
126422732|NCT02452424|454842702|FG000|Overall Study|Lost to Follow-up|0|||
126422733|NCT02452424|454842703|FG001|Overall Study|Lost to Follow-up|1|||
126422734|NCT02452424|454842704|FG002|Overall Study|Lost to Follow-up|1|||
126422735|NCT02452424|454842705|FG003|Overall Study|Lost to Follow-up|0|||
126422736|NCT02452424|454842706|FG004|Overall Study|Lost to Follow-up|0|||
126422737|NCT02452424|454842707|FG005|Overall Study|Lost to Follow-up|0|||
126422738|NCT02452424|454842708|FG006|Overall Study|Lost to Follow-up|0|||
126422739|NCT02452424|454842709|FG007|Overall Study|Lost to Follow-up|0|||
126422740|NCT02452424|454842710|FG008|Overall Study|Lost to Follow-up|0|||
126422741|NCT02452424|454842711|FG009|Overall Study|Lost to Follow-up|0|||
126422742|NCT02452424|454842712|FG010|Overall Study|Lost to Follow-up|0|||
126422743|NCT02452424|454842702|FG000|Overall Study|Withdrawal by Subject|0|||
126422744|NCT02452424|454842703|FG001|Overall Study|Withdrawal by Subject|0|||
126422745|NCT02452424|454842704|FG002|Overall Study|Withdrawal by Subject|3|||
126422746|NCT02452424|454842705|FG003|Overall Study|Withdrawal by Subject|2|||
126422747|NCT02452424|454842706|FG004|Overall Study|Withdrawal by Subject|0|||
126422748|NCT02452424|454842707|FG005|Overall Study|Withdrawal by Subject|0|||
126422749|NCT02452424|454842708|FG006|Overall Study|Withdrawal by Subject|1|||
126422750|NCT02452424|454842709|FG007|Overall Study|Withdrawal by Subject|0|||
126422751|NCT02452424|454842710|FG008|Overall Study|Withdrawal by Subject|1|||
126422752|NCT02452424|454842711|FG009|Overall Study|Withdrawal by Subject|1|||
126422753|NCT02452424|454842712|FG010|Overall Study|Withdrawal by Subject|0|||
126422754|NCT02452424|454842702|FG000|Overall Study|Other|0|||
126422755|NCT02452424|454842703|FG001|Overall Study|Other|0|||
126422756|NCT02452424|454842704|FG002|Overall Study|Other|1|||
126422757|NCT02452424|454842705|FG003|Overall Study|Other|0|||
126422758|NCT02452424|454842706|FG004|Overall Study|Other|0|||
126422759|NCT02452424|454842707|FG005|Overall Study|Other|1|||
126422760|NCT02452424|454842708|FG006|Overall Study|Other|4|||
126422761|NCT02452424|454842709|FG007|Overall Study|Other|3|||
126422762|NCT02452424|454842710|FG008|Overall Study|Other|0|||
126422763|NCT02452424|454842711|FG009|Overall Study|Other|0|||
126422764|NCT02452424|454842712|FG010|Overall Study|Other|1|||
126422765|NCT02452424|454842702|FG000|Overall Study|Progressive disease (per RECIST)|0|||
126422766|NCT02452424|454842703|FG001|Overall Study|Progressive disease (per RECIST)|0|||
126422767|NCT02452424|454842704|FG002|Overall Study|Progressive disease (per RECIST)|0|||
126422768|NCT02452424|454842705|FG003|Overall Study|Progressive disease (per RECIST)|0|||
126422769|NCT02452424|454842706|FG004|Overall Study|Progressive disease (per RECIST)|0|||
126422770|NCT02452424|454842707|FG005|Overall Study|Progressive disease (per RECIST)|0|||
126422771|NCT02452424|454842708|FG006|Overall Study|Progressive disease (per RECIST)|0|||
126422772|NCT02452424|454842709|FG007|Overall Study|Progressive disease (per RECIST)|0|||
126422773|NCT02452424|454842710|FG008|Overall Study|Progressive disease (per RECIST)|2|||
126422774|NCT02452424|454842711|FG009|Overall Study|Progressive disease (per RECIST)|0|||
126422775|NCT02452424|454842712|FG010|Overall Study|Progressive disease (per RECIST)|0|||
126422776|NCT02452424|454842702|FG000|Overall Study|Adverse Event|0|||
126422777|NCT02452424|454842703|FG001|Overall Study|Adverse Event|0|||
126422778|NCT02452424|454842704|FG002|Overall Study|Adverse Event|0|||
126422779|NCT02452424|454842705|FG003|Overall Study|Adverse Event|0|||
126422780|NCT02452424|454842706|FG004|Overall Study|Adverse Event|0|||
126422781|NCT02452424|454842707|FG005|Overall Study|Adverse Event|0|||
126422782|NCT02452424|454842708|FG006|Overall Study|Adverse Event|0|||
126422783|NCT02452424|454842709|FG007|Overall Study|Adverse Event|0|||
126422784|NCT02452424|454842710|FG008|Overall Study|Adverse Event|0|||
126422785|NCT02452424|454842711|FG009|Overall Study|Adverse Event|0|||
126422786|NCT02452424|454842712|FG010|Overall Study|Adverse Event|1|||
126422787|NCT00543387|454842717|FG000|Panel 1 + Panel 2|Adverse Event|0|||
126422788|NCT00543387|454842718|FG001|Panel 1 + Panel 2|Adverse Event|1|||
126422789|NCT00543387|454842719|FG002|Panel 1 + Panel 2|Adverse Event|0|||
126422790|NCT00543387|454842720|FG003|Panel 1 + Panel 2|Adverse Event|0|||
126422791|NCT00543387|454842721|FG004|Panel 1 + Panel 2|Adverse Event|0|||
126422792|NCT00543387|454842722|FG005|Panel 1 + Panel 2|Adverse Event|0|||
126422793|NCT00543387|454842723|FG006|Panel 1 + Panel 2|Adverse Event|0|||
126422794|NCT00543387|454842724|FG007|Panel 1 + Panel 2|Adverse Event|1|||
126422795|NCT00543387|454842725|FG008|Panel 1 + Panel 2|Adverse Event|1|||
126422796|NCT00543387|454842726|FG009|Panel 1 + Panel 2|Adverse Event|0|||
126422797|NCT00543387|454842727|FG010|Panel 1 + Panel 2|Adverse Event|0|||
126422798|NCT00543387|454842717|FG000|Panel 1 + Panel 2|Physician Decision|0|||
126422799|NCT00543387|454842718|FG001|Panel 1 + Panel 2|Physician Decision|0|||
126422800|NCT00543387|454842719|FG002|Panel 1 + Panel 2|Physician Decision|1|||
126422801|NCT00543387|454842720|FG003|Panel 1 + Panel 2|Physician Decision|0|||
126422802|NCT00543387|454842721|FG004|Panel 1 + Panel 2|Physician Decision|0|||
126422803|NCT00543387|454842722|FG005|Panel 1 + Panel 2|Physician Decision|0|||
126422804|NCT00543387|454842723|FG006|Panel 1 + Panel 2|Physician Decision|0|||
126422805|NCT00543387|454842724|FG007|Panel 1 + Panel 2|Physician Decision|1|||
126422806|NCT00543387|454842725|FG008|Panel 1 + Panel 2|Physician Decision|0|||
126422807|NCT00543387|454842726|FG009|Panel 1 + Panel 2|Physician Decision|0|||
126422808|NCT00543387|454842727|FG010|Panel 1 + Panel 2|Physician Decision|0|||
126422809|NCT00543387|454842717|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
126422810|NCT00543387|454842718|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
126422811|NCT00543387|454842719|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
126422812|NCT00543387|454842720|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
126422813|NCT00543387|454842721|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
126422814|NCT00543387|454842722|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
126422815|NCT00543387|454842723|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
126422816|NCT00543387|454842724|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
126422817|NCT00543387|454842725|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
126422818|NCT00543387|454842726|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
126422819|NCT00543387|454842727|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
126422820|NCT00543387|454842717|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422821|NCT00543387|454842718|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422822|NCT00543387|454842719|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422823|NCT00543387|454842720|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422824|NCT00543387|454842721|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422825|NCT00543387|454842722|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422826|NCT00543387|454842723|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
126422827|NCT00543387|454842724|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422828|NCT00543387|454842725|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422829|NCT00543387|454842726|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422830|NCT00543387|454842727|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
126422831|NCT00543387|454842717|FG000|Crossover Participants|Progressive Disease|0|||
126422832|NCT00543387|454842718|FG001|Crossover Participants|Progressive Disease|0|||
126422833|NCT00543387|454842719|FG002|Crossover Participants|Progressive Disease|0|||
126422834|NCT00543387|454842720|FG003|Crossover Participants|Progressive Disease|0|||
126422835|NCT00543387|454842721|FG004|Crossover Participants|Progressive Disease|0|||
126422836|NCT00543387|454842722|FG005|Crossover Participants|Progressive Disease|0|||
126422837|NCT00543387|454842723|FG006|Crossover Participants|Progressive Disease|0|||
126422838|NCT00543387|454842724|FG007|Crossover Participants|Progressive Disease|0|||
126422839|NCT00543387|454842725|FG008|Crossover Participants|Progressive Disease|0|||
126422840|NCT00543387|454842726|FG009|Crossover Participants|Progressive Disease|1|||
126422841|NCT00543387|454842727|FG010|Crossover Participants|Progressive Disease|2|||
126422842|NCT00543387|454842717|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
126422843|NCT00543387|454842718|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
126422844|NCT00543387|454842719|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
126422845|NCT00543387|454842720|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
126422846|NCT00543387|454842721|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
126422847|NCT00543387|454842722|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
126422848|NCT00543387|454842723|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
126422849|NCT00543387|454842724|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
126422850|NCT00543387|454842725|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
126422851|NCT00543387|454842726|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
126422852|NCT00543387|454842727|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
126422853|NCT00940498|454842728|FG000|Overall Study|Death|2|||
126422854|NCT00940498|454842729|FG001|Overall Study|Death|0|||
126422855|NCT00940498|454842730|FG002|Overall Study|Death|0|||
126422856|NCT00940498|454842731|FG003|Overall Study|Death|1|||
126422857|NCT00940498|454842732|FG004|Overall Study|Death|5|||
126422858|NCT00940498|454842733|FG005|Overall Study|Death|0|||
126422859|NCT00940498|454842734|FG006|Overall Study|Death|1|||
126422860|NCT00940498|454842735|FG007|Overall Study|Death|0|||
126422861|NCT00940498|454842728|FG000|Overall Study|Lost to Follow-up|1|||
126422862|NCT00940498|454842729|FG001|Overall Study|Lost to Follow-up|1|||
126422863|NCT00940498|454842730|FG002|Overall Study|Lost to Follow-up|2|||
126422864|NCT00940498|454842731|FG003|Overall Study|Lost to Follow-up|0|||
126422865|NCT00940498|454842732|FG004|Overall Study|Lost to Follow-up|1|||
126422866|NCT00940498|454842733|FG005|Overall Study|Lost to Follow-up|0|||
126422867|NCT00940498|454842734|FG006|Overall Study|Lost to Follow-up|0|||
126422868|NCT00940498|454842735|FG007|Overall Study|Lost to Follow-up|1|||
126422869|NCT00940498|454842728|FG000|Overall Study|Disease Progression|0|||
126422870|NCT00940498|454842729|FG001|Overall Study|Disease Progression|0|||
126422871|NCT00940498|454842730|FG002|Overall Study|Disease Progression|1|||
126422872|NCT00940498|454842731|FG003|Overall Study|Disease Progression|1|||
126422873|NCT00940498|454842732|FG004|Overall Study|Disease Progression|0|||
126422874|NCT00940498|454842733|FG005|Overall Study|Disease Progression|1|||
126422875|NCT00940498|454842734|FG006|Overall Study|Disease Progression|0|||
126422876|NCT00940498|454842735|FG007|Overall Study|Disease Progression|0|||
126422877|NCT00940498|454842728|FG000|Overall Study|Physician Decision|0|||
126422878|NCT00940498|454842729|FG001|Overall Study|Physician Decision|0|||
126422879|NCT00940498|454842730|FG002|Overall Study|Physician Decision|0|||
126422880|NCT00940498|454842731|FG003|Overall Study|Physician Decision|0|||
126422881|NCT00940498|454842732|FG004|Overall Study|Physician Decision|2|||
126422882|NCT00940498|454842733|FG005|Overall Study|Physician Decision|0|||
126422883|NCT00940498|454842734|FG006|Overall Study|Physician Decision|0|||
126422884|NCT00940498|454842735|FG007|Overall Study|Physician Decision|0|||
126422885|NCT00940498|454842728|FG000|Overall Study|Not treated due to disease related pain|0|||
126422886|NCT00940498|454842729|FG001|Overall Study|Not treated due to disease related pain|0|||
126422887|NCT00940498|454842730|FG002|Overall Study|Not treated due to disease related pain|0|||
126422888|NCT00940498|454842731|FG003|Overall Study|Not treated due to disease related pain|0|||
126422889|NCT00940498|454842732|FG004|Overall Study|Not treated due to disease related pain|1|||
126422890|NCT00940498|454842733|FG005|Overall Study|Not treated due to disease related pain|0|||
126422891|NCT00940498|454842734|FG006|Overall Study|Not treated due to disease related pain|0|||
126422892|NCT00940498|454842735|FG007|Overall Study|Not treated due to disease related pain|0|||
126463731|NCT00423670|455000236|FG005|Treatment Period|Protocol-defined clinical event|4|||
126463732|NCT00423670|455000237|FG006|Treatment Period|Protocol-defined clinical event|16|||
126463733|NCT00423670|455000238|FG007|Treatment Period|Protocol-defined clinical event|15|||
126463734|NCT00423670|455000231|FG000|Treatment Period|Lost to Follow-up|2|||
126463735|NCT00423670|455000232|FG001|Treatment Period|Lost to Follow-up|1|||
126463736|NCT00423670|455000233|FG002|Treatment Period|Lost to Follow-up|3|||
126463737|NCT00423670|455000234|FG003|Treatment Period|Lost to Follow-up|1|||
126463738|NCT00423670|455000235|FG004|Treatment Period|Lost to Follow-up|6|||
126463739|NCT00423670|455000236|FG005|Treatment Period|Lost to Follow-up|0|||
126463740|NCT00423670|455000237|FG006|Treatment Period|Lost to Follow-up|3|||
126463741|NCT00423670|455000238|FG007|Treatment Period|Lost to Follow-up|1|||
126463742|NCT00423670|455000231|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
126463743|NCT00423670|455000232|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
126463744|NCT00423670|455000233|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
126463745|NCT00423670|455000234|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
126463746|NCT00423670|455000235|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
126463747|NCT00423670|455000236|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
126463748|NCT00423670|455000237|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
126463749|NCT00423670|455000238|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
126463750|NCT00423670|455000231|FG000|Treatment Period|Investigator decision|0|||
126463751|NCT00423670|455000232|FG001|Treatment Period|Investigator decision|0|||
126463752|NCT00423670|455000233|FG002|Treatment Period|Investigator decision|0|||
126463753|NCT00423670|455000234|FG003|Treatment Period|Investigator decision|0|||
126463754|NCT00423670|455000235|FG004|Treatment Period|Investigator decision|0|||
126463755|NCT00423670|455000236|FG005|Treatment Period|Investigator decision|0|||
126463756|NCT00423670|455000237|FG006|Treatment Period|Investigator decision|0|||
126463757|NCT00423670|455000238|FG007|Treatment Period|Investigator decision|1|||
126463758|NCT00423670|455000231|FG000|Treatment Period|Non-compliance with protocol|3|||
126463759|NCT00423670|455000232|FG001|Treatment Period|Non-compliance with protocol|1|||
126463760|NCT00423670|455000233|FG002|Treatment Period|Non-compliance with protocol|1|||
126463761|NCT00423670|455000234|FG003|Treatment Period|Non-compliance with protocol|3|||
126463762|NCT00423670|455000235|FG004|Treatment Period|Non-compliance with protocol|2|||
126463763|NCT00423670|455000236|FG005|Treatment Period|Non-compliance with protocol|0|||
126463764|NCT00423670|455000237|FG006|Treatment Period|Non-compliance with protocol|2|||
126463765|NCT00423670|455000238|FG007|Treatment Period|Non-compliance with protocol|2|||
126463766|NCT00423670|455000231|FG000|Follow-up Period|Lost to Follow-up|0|||
126463767|NCT00423670|455000232|FG001|Follow-up Period|Lost to Follow-up|12|||
126463768|NCT00423670|455000233|FG002|Follow-up Period|Lost to Follow-up|8|||
126463769|NCT00423670|455000234|FG003|Follow-up Period|Lost to Follow-up|3|||
126463770|NCT00423670|455000235|FG004|Follow-up Period|Lost to Follow-up|1|||
126463771|NCT00423670|455000236|FG005|Follow-up Period|Lost to Follow-up|0|||
126463772|NCT00423670|455000237|FG006|Follow-up Period|Lost to Follow-up|5|||
126463773|NCT00423670|455000238|FG007|Follow-up Period|Lost to Follow-up|0|||
126463774|NCT00423670|455000231|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
126463775|NCT00423670|455000232|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
126463776|NCT00423670|455000233|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
126463777|NCT00423670|455000234|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
126463778|NCT00423670|455000235|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
126463779|NCT00423670|455000236|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
126463780|NCT00423670|455000237|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
126463781|NCT00423670|455000238|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
126463782|NCT00423670|455000231|FG000|Follow-up Period|Non-compliance with protocol|2|||
126463783|NCT00423670|455000232|FG001|Follow-up Period|Non-compliance with protocol|0|||
126463784|NCT00423670|455000233|FG002|Follow-up Period|Non-compliance with protocol|1|||
126463785|NCT00423670|455000234|FG003|Follow-up Period|Non-compliance with protocol|1|||
126463786|NCT00423670|455000235|FG004|Follow-up Period|Non-compliance with protocol|0|||
126463787|NCT00423670|455000236|FG005|Follow-up Period|Non-compliance with protocol|0|||
126534776|NCT00643916|455248390|FG002|Overall Study|Lost to Follow-up|0|||
126422893|NCT00330759|454844039|FG000|Overall Study|Death|316|||
126422894|NCT00330759|454844040|FG001|Overall Study|Death|310|||
126422895|NCT00330759|454844039|FG000|Overall Study|Disease progression|104|||
126422896|NCT00330759|454844040|FG001|Overall Study|Disease progression|126|||
126422897|NCT00330759|454844039|FG000|Overall Study|Withdrawal by Subject|143|||
126422898|NCT00330759|454844040|FG001|Overall Study|Withdrawal by Subject|124|||
126422899|NCT00330759|454844039|FG000|Overall Study|Adverse Event|48|||
126422900|NCT00330759|454844040|FG001|Overall Study|Adverse Event|36|||
126422901|NCT00330759|454844039|FG000|Overall Study|Participant request|31|||
126422902|NCT00330759|454844040|FG001|Overall Study|Participant request|22|||
126422903|NCT00330759|454844039|FG000|Overall Study|Lost to Follow-up|16|||
126422904|NCT00330759|454844040|FG001|Overall Study|Lost to Follow-up|22|||
126422905|NCT00330759|454844039|FG000|Overall Study|Noncompliance|15|||
126422906|NCT00330759|454844040|FG001|Overall Study|Noncompliance|17|||
126422907|NCT00330759|454844039|FG000|Overall Study|Physician Decision|1|||
126422908|NCT00330759|454844040|FG001|Overall Study|Physician Decision|2|||
126422909|NCT00330759|454844039|FG000|Overall Study|Protocol deviation|0|||
126422910|NCT00330759|454844040|FG001|Overall Study|Protocol deviation|2|||
126422911|NCT00330759|454844039|FG000|Overall Study|Ineligibility determined|2|||
126422912|NCT00330759|454844040|FG001|Overall Study|Ineligibility determined|1|||
126422913|NCT00330759|454844039|FG000|Overall Study|Other|36|||
126422914|NCT00330759|454844040|FG001|Overall Study|Other|44|||
126422915|NCT00997035|454844041|FG000|3-week Followup Visit|Lost to Follow-up|9|||
126422916|NCT00997035|454844042|FG001|3-week Followup Visit|Lost to Follow-up|6|||
126422917|NCT00997035|454844041|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
126422918|NCT00997035|454844042|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
126422919|NCT01380769|454844047|FG000|Overall Study|Withdrawal by Subject|7|||
126422920|NCT01380769|454844048|FG001|Overall Study|Withdrawal by Subject|11|||
126422921|NCT01380769|454844047|FG000|Overall Study|Physician Decision|1|||
126422922|NCT01380769|454844048|FG001|Overall Study|Physician Decision|1|||
126422923|NCT01380769|454844047|FG000|Overall Study|Adverse Event|1|||
126422924|NCT01380769|454844048|FG001|Overall Study|Adverse Event|1|||
126422925|NCT01380769|454844047|FG000|Overall Study|Protocol Violation|0|||
126422926|NCT01380769|454844048|FG001|Overall Study|Protocol Violation|1|||
126422927|NCT03654690|454844049|FG000|Overall Study|Withdrawal by Subject|1|||
126422928|NCT03654690|454844050|FG001|Overall Study|Withdrawal by Subject|0|||
126422929|NCT03654690|454844051|FG002|Overall Study|Withdrawal by Subject|0|||
126422930|NCT00742183|454844054|FG000|Overall Study|Adverse Event|2|||
126422931|NCT00742183|454844055|FG001|Overall Study|Adverse Event|2|||
126422932|NCT00742183|454844054|FG000|Overall Study|Death|1|||
126422933|NCT00742183|454844055|FG001|Overall Study|Death|0|||
126422934|NCT00742183|454844054|FG000|Overall Study|Physician Decision|0|||
126422935|NCT00742183|454844055|FG001|Overall Study|Physician Decision|2|||
126422936|NCT00742183|454844054|FG000|Overall Study|Lost to Follow-up|4|||
126422937|NCT00742183|454844055|FG001|Overall Study|Lost to Follow-up|4|||
126422938|NCT00742183|454844054|FG000|Overall Study|Required skin-graft|1|||
126422939|NCT00742183|454844055|FG001|Overall Study|Required skin-graft|1|||
126422940|NCT00742183|454844054|FG000|Overall Study|Withdrawal by Subject|1|||
126422941|NCT00742183|454844055|FG001|Overall Study|Withdrawal by Subject|0|||
126422942|NCT00742183|454844054|FG000|Overall Study|Lack of Efficacy|0|||
126422943|NCT00742183|454844055|FG001|Overall Study|Lack of Efficacy|3|||
126422944|NCT00786799|454844059|FG000|Overall Study|Lost to Follow-up|1|||
126422945|NCT00786799|454844060|FG001|Overall Study|Lost to Follow-up|1|||
126422946|NCT02544503|454844061|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
126422947|NCT02544503|454844062|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
126422948|NCT02544503|454844061|FG000|Overall Study|Lost to Follow-up|9|||
126422949|NCT02544503|454844062|FG001|Overall Study|Lost to Follow-up|0|||
126422950|NCT02544503|454844061|FG000|Overall Study|Withdrawal by Subject|1|||
126422951|NCT02544503|454844062|FG001|Overall Study|Withdrawal by Subject|0|||
126422952|NCT01080807|454844066|FG000|Overall Study|Adverse Event|9|||
126422953|NCT01080807|454844067|FG001|Overall Study|Adverse Event|1|||
126422954|NCT01080807|454844066|FG000|Overall Study|Lack of Efficacy|0|||
126422955|NCT01080807|454844067|FG001|Overall Study|Lack of Efficacy|1|||
126422956|NCT01080807|454844066|FG000|Overall Study|Withdrawal by Subject|7|||
126422957|NCT01080807|454844067|FG001|Overall Study|Withdrawal by Subject|2|||
126422958|NCT01080807|454844066|FG000|Overall Study|Protocol Violation|7|||
126422959|NCT01080807|454844067|FG001|Overall Study|Protocol Violation|6|||
126422960|NCT01080807|454844066|FG000|Overall Study|Lost to Follow-up|6|||
126422961|NCT01080807|454844067|FG001|Overall Study|Lost to Follow-up|4|||
126422962|NCT01080807|454844066|FG000|Overall Study|Noncompliance with drug administration|1|||
126422963|NCT01080807|454844067|FG001|Overall Study|Noncompliance with drug administration|1|||
126422964|NCT01080807|454844066|FG000|Overall Study|Noncompliance to study procedures|1|||
126306059|NCT02553499|454408873|FG004|Overall Study|Physician Decision|1|||
126422965|NCT01080807|454844067|FG001|Overall Study|Noncompliance to study procedures|1|||
126422966|NCT01080807|454844066|FG000|Overall Study|Began working day shift|0|||
126422967|NCT01080807|454844067|FG001|Overall Study|Began working day shift|2|||
126422968|NCT01080807|454844066|FG000|Overall Study|Laid off or terminated from job|1|||
126422969|NCT01080807|454844067|FG001|Overall Study|Laid off or terminated from job|2|||
126422970|NCT01080807|454844066|FG000|Overall Study|Stopped working consistent night shifts|0|||
126422971|NCT01080807|454844067|FG001|Overall Study|Stopped working consistent night shifts|1|||
126422972|NCT01080807|454844066|FG000|Overall Study|Work schedule changing|1|||
126422973|NCT01080807|454844067|FG001|Overall Study|Work schedule changing|1|||
126422974|NCT01080807|454844066|FG000|Overall Study|Work schedule and travel|0|||
126422975|NCT01080807|454844067|FG001|Overall Study|Work schedule and travel|1|||
126422976|NCT01080807|454844066|FG000|Overall Study|Switched to first shift|1|||
126422977|NCT01080807|454844067|FG001|Overall Study|Switched to first shift|0|||
126422978|NCT01080807|454844066|FG000|Overall Study|Moved away without notifying center|1|||
126422979|NCT01080807|454844067|FG001|Overall Study|Moved away without notifying center|0|||
126422980|NCT03922581|454844073|FG000|Overall Study|Lost to Follow-up|20|||
126422981|NCT03922581|454844074|FG001|Overall Study|Lost to Follow-up|9|||
126422982|NCT03922581|454844073|FG000|Overall Study|Physician Decision|1|||
126422983|NCT03922581|454844074|FG001|Overall Study|Physician Decision|1|||
126422984|NCT03922581|454844073|FG000|Overall Study|Withdrawal by Subject|1|||
126422985|NCT03922581|454844074|FG001|Overall Study|Withdrawal by Subject|0|||
126422986|NCT04685798|454844077|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
126422987|NCT02223715|454844078|FG000|Overall Study|Death|31|||
126422988|NCT02223715|454844078|FG000|Overall Study|Lost to Follow-up|73|||
126422989|NCT03956550|454844079|FG000|Overall Study|Sponsor decision|65|||
126422990|NCT03956550|454844080|FG001|Overall Study|Sponsor decision|66|||
126422991|NCT03956550|454844081|FG002|Overall Study|Sponsor decision|64|||
126422992|NCT03956550|454844079|FG000|Overall Study|Adverse Event|0|||
126422993|NCT03956550|454844080|FG001|Overall Study|Adverse Event|1|||
126422994|NCT03956550|454844081|FG002|Overall Study|Adverse Event|0|||
126422995|NCT03956550|454844079|FG000|Overall Study|Withdrawal by Subject|5|||
126422996|NCT03956550|454844080|FG001|Overall Study|Withdrawal by Subject|5|||
126422997|NCT03956550|454844081|FG002|Overall Study|Withdrawal by Subject|6|||
126422998|NCT01745367|454844084|FG000|Overall Study|Death|1|||
126422999|NCT01745367|454844085|FG001|Overall Study|Death|0|||
126423000|NCT01745367|454844084|FG000|Overall Study|Withdrawal by Subject|1|||
126423001|NCT01745367|454844085|FG001|Overall Study|Withdrawal by Subject|2|||
126423002|NCT01745367|454844084|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
126423003|NCT01745367|454844085|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
126423004|NCT01745367|454844084|FG000|Overall Study|Other Reasons Unspecified|0|||
126423005|NCT01745367|454844085|FG001|Overall Study|Other Reasons Unspecified|2|||
126423006|NCT00824473|454844087|FG000|Overall Study|Adverse Event|4|||
126423007|NCT00824473|454844088|FG001|Overall Study|Adverse Event|5|||
126423008|NCT00824473|454844087|FG000|Overall Study|Lack of Efficacy|2|||
126423009|NCT00824473|454844088|FG001|Overall Study|Lack of Efficacy|2|||
126423010|NCT00824473|454844087|FG000|Overall Study|Protocol Violation|2|||
126423011|NCT00824473|454844088|FG001|Overall Study|Protocol Violation|0|||
126423012|NCT00824473|454844087|FG000|Overall Study|Non-Compliance|4|||
126423013|NCT00824473|454844088|FG001|Overall Study|Non-Compliance|2|||
126423014|NCT00824473|454844087|FG000|Overall Study|Withdrawal by Subject|2|||
126423015|NCT00824473|454844088|FG001|Overall Study|Withdrawal by Subject|3|||
126423016|NCT00824473|454844087|FG000|Overall Study|Other|1|||
126423017|NCT00824473|454844088|FG001|Overall Study|Other|1|||
126423018|NCT01359904|454844089|FG000|Overall Study|Withdrawal by Subject|1|||
126423019|NCT01359904|454844090|FG001|Overall Study|Withdrawal by Subject|0|||
126423020|NCT02640547|454844091|FG000|Overall Study|Failure to Return|1|||
126423021|NCT02640547|454844091|FG000|Overall Study|Withdrawal by Subject|1|||
126423022|NCT02640547|454844091|FG000|Overall Study|Death|6|||
126423023|NCT02640547|454844091|FG000|Overall Study|Miscellaneous|3|||
126423024|NCT02525588|454844092|FG000|Overall Study|Death|3|||
126423025|NCT02525588|454844093|FG001|Overall Study|Death|1|||
126423026|NCT02525588|454844092|FG000|Overall Study|Lost to Follow-up|2|||
126423027|NCT02525588|454844093|FG001|Overall Study|Lost to Follow-up|0|||
126423028|NCT02525588|454844092|FG000|Overall Study|Withdrawal by Subject|1|||
126423029|NCT02525588|454844093|FG001|Overall Study|Withdrawal by Subject|1|||
126423030|NCT02525588|454844092|FG000|Overall Study|Adverse Event|0|||
126423031|NCT02525588|454844093|FG001|Overall Study|Adverse Event|1|||
126423032|NCT03369418|454844095|FG000|Overall Study|Withdrawal by Subject|3|||
126423033|NCT03369418|454844096|FG001|Overall Study|Withdrawal by Subject|3|||
126423034|NCT01485094|454844097|FG000|Overall Study|Adverse Event|1|||
126423035|NCT01485094|454844098|FG001|Overall Study|Adverse Event|1|||
126423036|NCT01485094|454844099|FG002|Overall Study|Adverse Event|1|||
126423037|NCT01485094|454844097|FG000|Overall Study|Lost to Follow-up|1|||
126423038|NCT01485094|454844098|FG001|Overall Study|Lost to Follow-up|0|||
126423039|NCT01485094|454844099|FG002|Overall Study|Lost to Follow-up|0|||
126423040|NCT01485094|454844097|FG000|Overall Study|Withdrawal by Subject|1|||
126423041|NCT01485094|454844098|FG001|Overall Study|Withdrawal by Subject|1|||
126423042|NCT01485094|454844099|FG002|Overall Study|Withdrawal by Subject|0|||
126423043|NCT02753946|454844113|FG000|Overall Study|Adverse Event|7|||
126423044|NCT02753946|454844114|FG001|Overall Study|Adverse Event|6|||
126423045|NCT02753946|454844113|FG000|Overall Study|Withdrawal by Subject|6|||
126423046|NCT02753946|454844114|FG001|Overall Study|Withdrawal by Subject|1|||
126423047|NCT02753946|454844113|FG000|Overall Study|Lack of Efficacy|1|||
126423048|NCT02753946|454844114|FG001|Overall Study|Lack of Efficacy|0|||
126423049|NCT02753946|454844113|FG000|Overall Study|Physician Decision|0|||
126423050|NCT02753946|454844114|FG001|Overall Study|Physician Decision|2|||
126423051|NCT02519439|454844115|FG000|Overall Study|Study Termination|19|||
126423052|NCT02519439|454844115|FG000|Overall Study|Withdrawal by Subject|1|||
126423053|NCT02519439|454844115|FG000|Overall Study|Adverse Event|1|||
126423054|NCT01539759|454844120|FG000|Overall Study|Lost to Follow-up|6|||
126423055|NCT01539759|454844121|FG001|Overall Study|Lost to Follow-up|8|||
126423056|NCT03901144|454844122|FG000|Overall Study|Lost to Follow-up|1|||
126423057|NCT03901144|454844123|FG001|Overall Study|Lost to Follow-up|1|||
126423058|NCT03901144|454844124|FG002|Overall Study|Lost to Follow-up|1|||
126423059|NCT03901144|454844125|FG003|Overall Study|Lost to Follow-up|1|||
126423060|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
126423061|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
126423062|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
126423063|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
126423064|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
126423065|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
126423066|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Death|7|||
126423067|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Death|5|||
126423068|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Death|6|||
126423069|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
126423070|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
126423071|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
126423072|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
126423073|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
126423074|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
126423075|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Other|1|||
126423076|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Other|0|||
126423077|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Other|0|||
126423078|NCT00104650|454844126|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
126423079|NCT00104650|454844127|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
126423080|NCT00104650|454844128|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
126423081|NCT00104650|454844126|FG000|Follow-up Period|Physician Decision|1|||
126423082|NCT00104650|454844127|FG001|Follow-up Period|Physician Decision|1|||
126423083|NCT00104650|454844128|FG002|Follow-up Period|Physician Decision|0|||
126534777|NCT00643916|455248391|FG003|Overall Study|Lost to Follow-up|0|||
126534778|NCT00643916|455248392|FG004|Overall Study|Lost to Follow-up|0|||
126534779|NCT00643916|455248393|FG005|Overall Study|Lost to Follow-up|0|||
126534780|NCT00643916|455248388|FG000|Overall Study|Withdrawal by Subject|2|||
126534781|NCT00643916|455248389|FG001|Overall Study|Withdrawal by Subject|2|||
126534782|NCT00643916|455248390|FG002|Overall Study|Withdrawal by Subject|2|||
126534783|NCT00643916|455248391|FG003|Overall Study|Withdrawal by Subject|1|||
126534784|NCT00643916|455248392|FG004|Overall Study|Withdrawal by Subject|0|||
126534785|NCT00643916|455248393|FG005|Overall Study|Withdrawal by Subject|1|||
126534786|NCT00643916|455248388|FG000|Overall Study|Not Vaccinated|2|||
126534787|NCT00643916|455248389|FG001|Overall Study|Not Vaccinated|2|||
126534788|NCT00643916|455248390|FG002|Overall Study|Not Vaccinated|3|||
126534789|NCT00643916|455248391|FG003|Overall Study|Not Vaccinated|0|||
126534790|NCT00643916|455248392|FG004|Overall Study|Not Vaccinated|2|||
126534791|NCT00643916|455248393|FG005|Overall Study|Not Vaccinated|0|||
126534792|NCT00499031|455248394|FG000|Overall Study|Improper pre-protocol treatment|1|||
126534793|NCT00499031|455248394|FG000|Overall Study|Required test not done|1|||
126534794|NCT00499031|455248394|FG000|Overall Study|Never treated|1|||
126534795|NCT03409666|455248400|FG000|Overall Study|Physician Decision|0|||
126534796|NCT03409666|455248401|FG001|Overall Study|Physician Decision|1|||
126534797|NCT03409666|455248400|FG000|Overall Study|Protocol Violation|0|||
126534798|NCT03409666|455248401|FG001|Overall Study|Protocol Violation|3|||
126534799|NCT01791725|455248402|FG000|Overall Study|Withdrawal by Subject|0|||
126534800|NCT01791725|455248403|FG001|Overall Study|Withdrawal by Subject|1|||
126534801|NCT01791725|455248404|FG002|Overall Study|Withdrawal by Subject|0|||
126534802|NCT00512148|455248405|FG000|Primay Study Period|Withdrawal by Subject|1|||
126534803|NCT00677833|455248406|FG000|Overall Study|Withdrawal by Subject|4|||
126534804|NCT00677833|455248407|FG001|Overall Study|Withdrawal by Subject|0|||
126534805|NCT00677833|455248408|FG002|Overall Study|Withdrawal by Subject|1|||
126534806|NCT00677833|455248409|FG003|Overall Study|Withdrawal by Subject|3|||
126534807|NCT00677833|455248406|FG000|Overall Study|Lost to Follow-up|0|||
126534808|NCT00677833|455248407|FG001|Overall Study|Lost to Follow-up|0|||
126534809|NCT00677833|455248408|FG002|Overall Study|Lost to Follow-up|1|||
126534810|NCT00677833|455248409|FG003|Overall Study|Lost to Follow-up|0|||
126306060|NCT02553499|454408874|FG005|Overall Study|Physician Decision|0|||
126534811|NCT02001194|455248415|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
126534812|NCT02001194|455248416|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
126534813|NCT02001194|455248417|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
126534814|NCT02001194|455248418|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
126423084|NCT00104650|454844126|FG000|Follow-up Period|Adverse Event|1|||
126423085|NCT00104650|454844127|FG001|Follow-up Period|Adverse Event|0|||
126423086|NCT00104650|454844128|FG002|Follow-up Period|Adverse Event|1|||
126423087|NCT00104650|454844126|FG000|Follow-up Period|Withdrawal by Subject|0|||
126423088|NCT00104650|454844127|FG001|Follow-up Period|Withdrawal by Subject|3|||
126423089|NCT00104650|454844128|FG002|Follow-up Period|Withdrawal by Subject|3|||
126423090|NCT00104650|454844126|FG000|Follow-up Period|Death|6|||
126423091|NCT00104650|454844127|FG001|Follow-up Period|Death|6|||
126423092|NCT00104650|454844128|FG002|Follow-up Period|Death|4|||
126423093|NCT00104650|454844126|FG000|Follow-up Period|Disease progression|3|||
126423094|NCT00104650|454844127|FG001|Follow-up Period|Disease progression|1|||
126423095|NCT00104650|454844128|FG002|Follow-up Period|Disease progression|0|||
126423096|NCT00104650|454844126|FG000|Follow-up Period|Lost to Follow-up|0|||
126423097|NCT00104650|454844127|FG001|Follow-up Period|Lost to Follow-up|1|||
126423098|NCT00104650|454844128|FG002|Follow-up Period|Lost to Follow-up|2|||
126423099|NCT00104650|454844126|FG000|Follow-up Period|Other|0|||
126423100|NCT00104650|454844127|FG001|Follow-up Period|Other|1|||
126423101|NCT00104650|454844128|FG002|Follow-up Period|Other|0|||
126423102|NCT03384940|454844133|FG000|Overall Study|Progressive disease|36|||
126423103|NCT03384940|454844134|FG001|Overall Study|Progressive disease|11|||
126423104|NCT03384940|454844135|FG002|Overall Study|Progressive disease|13|||
126423105|NCT03384940|454844133|FG000|Overall Study|Clinical progression|4|||
126423106|NCT03384940|454844134|FG001|Overall Study|Clinical progression|0|||
126423107|NCT03384940|454844135|FG002|Overall Study|Clinical progression|3|||
126423108|NCT03384940|454844133|FG000|Overall Study|Adverse Event|7|||
126423109|NCT03384940|454844134|FG001|Overall Study|Adverse Event|1|||
126423110|NCT03384940|454844135|FG002|Overall Study|Adverse Event|1|||
126423111|NCT03384940|454844133|FG000|Overall Study|Withdrawal by Subject|3|||
126423112|NCT03384940|454844134|FG001|Overall Study|Withdrawal by Subject|1|||
126423113|NCT03384940|454844135|FG002|Overall Study|Withdrawal by Subject|0|||
126423114|NCT03384940|454844133|FG000|Overall Study|Physician Decision|1|||
126423115|NCT03384940|454844134|FG001|Overall Study|Physician Decision|1|||
126423116|NCT03384940|454844135|FG002|Overall Study|Physician Decision|0|||
126423117|NCT03384940|454844133|FG000|Overall Study|Death|2|||
126423118|NCT03384940|454844134|FG001|Overall Study|Death|1|||
126423119|NCT03384940|454844135|FG002|Overall Study|Death|0|||
126423120|NCT03384940|454844133|FG000|Overall Study|Other|0|||
126423121|NCT03384940|454844134|FG001|Overall Study|Other|0|||
126423122|NCT03384940|454844135|FG002|Overall Study|Other|1|||
126423123|NCT03089580|454844141|FG000|Overall Study|Lost to Follow-up|2|||
126423124|NCT03087513|454844142|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
126423125|NCT00770601|454844143|FG000|Overall Study|Withdrawal by Subject|1|||
126423126|NCT04417361|454844145|FG000|Overall Study|Withdrawal by Subject|1|||
126423127|NCT04417361|454844146|FG001|Overall Study|Withdrawal by Subject|0|||
126423128|NCT04417361|454844145|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
126423129|NCT04417361|454844146|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
126423130|NCT00801216|454844147|FG000|Overall Study|Screening Failure|2|||
126423131|NCT01463306|454844150|FG000|Overall Study|Adverse Event|6|||
126423132|NCT01463306|454844151|FG001|Overall Study|Adverse Event|9|||
126423133|NCT01463306|454844152|FG002|Overall Study|Adverse Event|3|||
126423134|NCT01463306|454844150|FG000|Overall Study|Death|3|||
126423135|NCT01463306|454844151|FG001|Overall Study|Death|3|||
126423136|NCT01463306|454844152|FG002|Overall Study|Death|0|||
126423137|NCT01463306|454844150|FG000|Overall Study|Lack of Efficacy|22|||
126423138|NCT01463306|454844151|FG001|Overall Study|Lack of Efficacy|16|||
126423139|NCT01463306|454844152|FG002|Overall Study|Lack of Efficacy|1|||
126423140|NCT01463306|454844150|FG000|Overall Study|Lost to Follow-up|5|||
126423141|NCT01463306|454844151|FG001|Overall Study|Lost to Follow-up|2|||
126423142|NCT01463306|454844152|FG002|Overall Study|Lost to Follow-up|0|||
126423143|NCT01463306|454844150|FG000|Overall Study|Protocol Violation|4|||
126423144|NCT01463306|454844151|FG001|Overall Study|Protocol Violation|0|||
126423145|NCT01463306|454844152|FG002|Overall Study|Protocol Violation|0|||
126423146|NCT01463306|454844150|FG000|Overall Study|Withdrawal by Subject|19|||
126423147|NCT01463306|454844151|FG001|Overall Study|Withdrawal by Subject|9|||
126423148|NCT01463306|454844152|FG002|Overall Study|Withdrawal by Subject|1|||
126423149|NCT01463306|454844150|FG000|Overall Study|Other|26|||
126423150|NCT01463306|454844151|FG001|Overall Study|Other|13|||
126423151|NCT01463306|454844152|FG002|Overall Study|Other|0|||
126423152|NCT01463306|454844150|FG000|Overall Study|Approval expiry at site|1|||
126423153|NCT01463306|454844151|FG001|Overall Study|Approval expiry at site|0|||
126423154|NCT01463306|454844152|FG002|Overall Study|Approval expiry at site|0|||
126423155|NCT02679287|454844153|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
126423156|NCT02679287|454844154|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
126423157|NCT02679287|454844153|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
126423158|NCT02679287|454844154|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
126423159|NCT02679287|454844153|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
126423160|NCT02679287|454844154|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
126423161|NCT02679287|454844153|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
126423162|NCT02679287|454844154|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
126423163|NCT02679287|454844153|FG000|Period 2|Work/Scheduling Conflict|1|||
126423164|NCT02679287|454844154|FG001|Period 2|Work/Scheduling Conflict|0|||
126423165|NCT02679287|454844153|FG000|Period 2|Disliked Mobile System|2|||
126423166|NCT02679287|454844154|FG001|Period 2|Disliked Mobile System|0|||
126423167|NCT02679287|454844153|FG000|Period 3|Work/Scheduling Conflict|0|||
126423168|NCT02679287|454844154|FG001|Period 3|Work/Scheduling Conflict|1|||
126423169|NCT00992459|454844159|FG000|Overall Study|Withdrawal by Subject|0|||
126423170|NCT00992459|454844160|FG001|Overall Study|Withdrawal by Subject|1|||
126423171|NCT00992459|454844159|FG000|Overall Study|Adverse Event|1|||
126423172|NCT00992459|454844160|FG001|Overall Study|Adverse Event|0|||
126423173|NCT01943591|454844161|FG000|Overall Study|Lost to Follow-up|3|||
126423174|NCT01943591|454844162|FG001|Overall Study|Lost to Follow-up|4|||
126423175|NCT01943591|454844161|FG000|Overall Study|Death|2|||
126423176|NCT01943591|454844162|FG001|Overall Study|Death|7|||
126423177|NCT00227721|454845588|FG000|Overall Study|On study, but never treated.|1|||
126423178|NCT01389882|454845597|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
126423179|NCT01389882|454845598|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
126423180|NCT01389882|454845597|FG000|Overall Study|Withdrawal by Subject|0|||
126423181|NCT01389882|454845598|FG001|Overall Study|Withdrawal by Subject|1|||
126423182|NCT00859547|454845613|FG000|Overall Study|Lost to Follow-up|1|||
126423183|NCT00859547|454845613|FG000|Overall Study|Parent withdrew consent|1|||
126423184|NCT01276639|454845627|FG000|Week 0 to 16|Death|1|||
126423185|NCT01276639|454845628|FG001|Week 0 to 16|Death|0|||
126423186|NCT01276639|454845629|FG002|Week 0 to 16|Death|0|||
126423187|NCT01276639|454845630|FG003|Week 0 to 16|Death|0|||
126423188|NCT01276639|454845631|FG004|Week 0 to 16|Death|0|||
126423189|NCT01276639|454845627|FG000|Week 0 to 16|Adverse Event|11|||
126423190|NCT01276639|454845628|FG001|Week 0 to 16|Adverse Event|8|||
126423191|NCT01276639|454845629|FG002|Week 0 to 16|Adverse Event|11|||
126423192|NCT01276639|454845630|FG003|Week 0 to 16|Adverse Event|0|||
126423193|NCT01276639|454845631|FG004|Week 0 to 16|Adverse Event|0|||
126423194|NCT01276639|454845627|FG000|Week 0 to 16|Lack of Efficacy|20|||
126423195|NCT01276639|454845628|FG001|Week 0 to 16|Lack of Efficacy|15|||
126423196|NCT01276639|454845629|FG002|Week 0 to 16|Lack of Efficacy|25|||
126423197|NCT01276639|454845630|FG003|Week 0 to 16|Lack of Efficacy|0|||
126423198|NCT01276639|454845631|FG004|Week 0 to 16|Lack of Efficacy|0|||
126423199|NCT01276639|454845627|FG000|Week 0 to 16|Lost to Follow-up|3|||
126423200|NCT01276639|454845628|FG001|Week 0 to 16|Lost to Follow-up|5|||
126423201|NCT01276639|454845629|FG002|Week 0 to 16|Lost to Follow-up|3|||
126423202|NCT01276639|454845630|FG003|Week 0 to 16|Lost to Follow-up|0|||
126423203|NCT01276639|454845631|FG004|Week 0 to 16|Lost to Follow-up|0|||
126423204|NCT01276639|454845627|FG000|Week 0 to 16|Withdrawal by Subject|8|||
126423205|NCT01276639|454845628|FG001|Week 0 to 16|Withdrawal by Subject|5|||
126423206|NCT01276639|454845629|FG002|Week 0 to 16|Withdrawal by Subject|4|||
126423207|NCT01276639|454845630|FG003|Week 0 to 16|Withdrawal by Subject|0|||
126423208|NCT01276639|454845631|FG004|Week 0 to 16|Withdrawal by Subject|0|||
126423209|NCT01276639|454845627|FG000|Week 0 to 16|Other|7|||
126423210|NCT01276639|454845628|FG001|Week 0 to 16|Other|7|||
126423211|NCT01276639|454845629|FG002|Week 0 to 16|Other|2|||
126423212|NCT01276639|454845630|FG003|Week 0 to 16|Other|0|||
126423213|NCT01276639|454845631|FG004|Week 0 to 16|Other|0|||
126423214|NCT01276639|454845627|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
126423215|NCT01276639|454845628|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
126423216|NCT01276639|454845629|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
126423217|NCT01276639|454845630|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
126423218|NCT01276639|454845631|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
126423219|NCT01276639|454845627|FG000|Week 16 to 52|Death|1|||
126423220|NCT01276639|454845628|FG001|Week 16 to 52|Death|0|||
126423221|NCT01276639|454845629|FG002|Week 16 to 52|Death|0|||
126423222|NCT01276639|454845630|FG003|Week 16 to 52|Death|0|||
126423223|NCT01276639|454845631|FG004|Week 16 to 52|Death|0|||
126423224|NCT01276639|454845627|FG000|Week 16 to 52|Adverse Event|10|||
126423225|NCT01276639|454845628|FG001|Week 16 to 52|Adverse Event|13|||
126423226|NCT01276639|454845629|FG002|Week 16 to 52|Adverse Event|0|||
126423227|NCT01276639|454845630|FG003|Week 16 to 52|Adverse Event|1|||
126423228|NCT01276639|454845631|FG004|Week 16 to 52|Adverse Event|3|||
126423229|NCT01276639|454845627|FG000|Week 16 to 52|Lack of Efficacy|99|||
126423230|NCT01276639|454845628|FG001|Week 16 to 52|Lack of Efficacy|71|||
126423231|NCT01276639|454845629|FG002|Week 16 to 52|Lack of Efficacy|0|||
126423232|NCT01276639|454845630|FG003|Week 16 to 52|Lack of Efficacy|14|||
126423233|NCT01276639|454845631|FG004|Week 16 to 52|Lack of Efficacy|13|||
126423234|NCT01276639|454845627|FG000|Week 16 to 52|Lost to Follow-up|3|||
126423235|NCT01276639|454845628|FG001|Week 16 to 52|Lost to Follow-up|1|||
126423236|NCT01276639|454845629|FG002|Week 16 to 52|Lost to Follow-up|0|||
126423237|NCT01276639|454845630|FG003|Week 16 to 52|Lost to Follow-up|0|||
126423238|NCT01276639|454845631|FG004|Week 16 to 52|Lost to Follow-up|1|||
126423239|NCT01276639|454845627|FG000|Week 16 to 52|Withdrawal by Subject|4|||
126423240|NCT01276639|454845628|FG001|Week 16 to 52|Withdrawal by Subject|4|||
126423241|NCT01276639|454845629|FG002|Week 16 to 52|Withdrawal by Subject|0|||
126423242|NCT01276639|454845630|FG003|Week 16 to 52|Withdrawal by Subject|0|||
126423243|NCT01276639|454845631|FG004|Week 16 to 52|Withdrawal by Subject|1|||
126423244|NCT01276639|454845627|FG000|Week 16 to 52|Other|10|||
126423245|NCT01276639|454845628|FG001|Week 16 to 52|Other|12|||
126423246|NCT01276639|454845629|FG002|Week 16 to 52|Other|0|||
126423247|NCT01276639|454845630|FG003|Week 16 to 52|Other|1|||
126423248|NCT01276639|454845631|FG004|Week 16 to 52|Other|3|||
126423249|NCT03018691|454845642|FG000|Overall Study|Adverse Event|1|||
126423250|NCT03018691|454845643|FG001|Overall Study|Adverse Event|1|||
126423251|NCT03018691|454845644|FG002|Overall Study|Adverse Event|4|||
126423252|NCT03018691|454845642|FG000|Overall Study|Lack of Efficacy|0|||
126423253|NCT03018691|454845643|FG001|Overall Study|Lack of Efficacy|0|||
126423254|NCT03018691|454845644|FG002|Overall Study|Lack of Efficacy|1|||
126423255|NCT03018691|454845642|FG000|Overall Study|Withdrawal by Subject|0|||
126423256|NCT03018691|454845643|FG001|Overall Study|Withdrawal by Subject|0|||
126423257|NCT03018691|454845644|FG002|Overall Study|Withdrawal by Subject|1|||
126423258|NCT03018691|454845642|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126423259|NCT03018691|454845643|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126423260|NCT03018691|454845644|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126423261|NCT00796666|454845646|FG000|Overall Study|Death|2|||
126423262|NCT00796666|454845647|FG001|Overall Study|Death|4|||
126423263|NCT00796666|454845646|FG000|Overall Study|Withdrawal by Subject|2|||
126423264|NCT00796666|454845647|FG001|Overall Study|Withdrawal by Subject|0|||
126423265|NCT00796666|454845646|FG000|Overall Study|Adverse Event|7|||
126423266|NCT00796666|454845647|FG001|Overall Study|Adverse Event|5|||
126423267|NCT00796666|454845646|FG000|Overall Study|Protocol Violation|1|||
126423268|NCT00796666|454845647|FG001|Overall Study|Protocol Violation|0|||
126423269|NCT00796666|454845646|FG000|Overall Study|Other|1|||
126423270|NCT00796666|454845647|FG001|Overall Study|Other|0|||
126423271|NCT00796666|454845646|FG000|Overall Study|Terminated by sponsor|53|||
126423272|NCT00796666|454845647|FG001|Overall Study|Terminated by sponsor|55|||
126423273|NCT00796666|454845646|FG000|Overall Study|Randomized and not treated|1|||
126423274|NCT00796666|454845647|FG001|Overall Study|Randomized and not treated|0|||
126423275|NCT02576639|454845648|FG000|Overall Study|Withdrawal by Subject|1|||
126423276|NCT02576639|454845649|FG001|Overall Study|Withdrawal by Subject|2|||
126423277|NCT02576639|454845650|FG002|Overall Study|Withdrawal by Subject|1|||
126423278|NCT02576639|454845651|FG003|Overall Study|Withdrawal by Subject|0|||
126423279|NCT02576639|454845652|FG004|Overall Study|Withdrawal by Subject|1|||
126423280|NCT02576639|454845648|FG000|Overall Study|Adverse Event|1|||
126423281|NCT02576639|454845649|FG001|Overall Study|Adverse Event|0|||
126423282|NCT02576639|454845650|FG002|Overall Study|Adverse Event|1|||
126423283|NCT02576639|454845651|FG003|Overall Study|Adverse Event|1|||
126423284|NCT02576639|454845652|FG004|Overall Study|Adverse Event|2|||
126423285|NCT02576639|454845648|FG000|Overall Study|Physician Decision|0|||
126423286|NCT02576639|454845649|FG001|Overall Study|Physician Decision|0|||
126423287|NCT02576639|454845650|FG002|Overall Study|Physician Decision|0|||
126423288|NCT02576639|454845651|FG003|Overall Study|Physician Decision|0|||
126423289|NCT02576639|454845652|FG004|Overall Study|Physician Decision|1|||
126423290|NCT00057863|454845654|FG000|Overall Study|Death|1|||
126423291|NCT00057863|454845654|FG000|Overall Study|Withdrawal by Subject|2|||
126423292|NCT01521507|454845655|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
126423293|NCT01521507|454845656|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
126423294|NCT01521507|454845655|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
126423295|NCT01521507|454845656|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
126423296|NCT01521507|454845655|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
126423297|NCT01521507|454845656|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
126423298|NCT01521507|454845655|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
126423299|NCT01521507|454845656|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
126423300|NCT01521507|454845655|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
126423301|NCT01521507|454845656|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
126423302|NCT01521507|454845655|FG000|Stage 2: Observational Design|Physician Decision|1|||
126423303|NCT01521507|454845656|FG001|Stage 2: Observational Design|Physician Decision|0|||
126423304|NCT02079038|454845657|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
126423305|NCT02079038|454845658|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
126423306|NCT02079038|454845657|FG000|Modified Intent to Treat Population|Death|1|||
126423307|NCT02079038|454845658|FG001|Modified Intent to Treat Population|Death|0|||
126423308|NCT02079038|454845657|FG000|Completed 6 Months|Lost to Follow-up|2|||
126423309|NCT02079038|454845658|FG001|Completed 6 Months|Lost to Follow-up|1|||
126423310|NCT02478463|454845659|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
126423311|NCT02478463|454845659|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
126423312|NCT02478463|454845659|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
126423313|NCT01358825|454845662|FG000|Overall Study|Blood sample not drawn|0|||
126423314|NCT01358825|454845663|FG001|Overall Study|Blood sample not drawn|1|||
126423315|NCT01479868|454845664|FG000|Overall Study|Adverse Event|1|||
126423316|NCT01479868|454845664|FG000|Overall Study|Lost to Follow-up|4|||
126423317|NCT01479868|454845664|FG000|Overall Study|Protocol Violation|1|||
126423318|NCT01479868|454845664|FG000|Overall Study|Withdrawal by Subject|1|||
126423319|NCT01479868|454845664|FG000|Overall Study|Sponsor's Decision|1|||
126423320|NCT01479868|454845664|FG000|Overall Study|Initiation of new HCV Therapy|1|||
126423321|NCT01508169|454845665|FG000|Overall Study|Adverse Event|1|||
126423322|NCT01508169|454845666|FG001|Overall Study|Adverse Event|0|||
126423323|NCT01508169|454845665|FG000|Overall Study|Withdrawal by Subject|1|||
126423324|NCT01508169|454845666|FG001|Overall Study|Withdrawal by Subject|0|||
126423325|NCT01508169|454845665|FG000|Overall Study|Lost to Follow-up|1|||
126423326|NCT01508169|454845666|FG001|Overall Study|Lost to Follow-up|2|||
126423327|NCT01292187|454845670|FG000|Overall Study|Adverse Event|10|||
126423328|NCT01292187|454845671|FG001|Overall Study|Adverse Event|5|||
126423329|NCT01292187|454845670|FG000|Overall Study|Withdrawal by Subject|6|||
126423330|NCT01292187|454845671|FG001|Overall Study|Withdrawal by Subject|5|||
126423331|NCT01292187|454845670|FG000|Overall Study|All other reasons|1|||
126423332|NCT01292187|454845671|FG001|Overall Study|All other reasons|3|||
126423333|NCT01814527|454845673|FG000|Overall Study|RTP greater than 30 days|6|||
126423334|NCT01814527|454845674|FG001|Overall Study|RTP greater than 30 days|1|||
126423335|NCT04524858|454845677|FG000|Overall Study|Adverse Event|1|||
126423336|NCT03571204|454845678|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
126423337|NCT03571204|454845679|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
126423338|NCT03571204|454845680|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
126423339|NCT03571204|454845678|FG000|Overall Study|Physician Decision|0|||
126423340|NCT03571204|454845679|FG001|Overall Study|Physician Decision|1|||
126423341|NCT03571204|454845680|FG002|Overall Study|Physician Decision|0|||
126423342|NCT02396212|454845681|FG000|Overall Study|Adverse Event|1|||
126423343|NCT02396212|454845681|FG000|Overall Study|Lack of Efficacy|2|||
126423344|NCT01363700|454845684|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
126423345|NCT01363700|454845685|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
126423346|NCT01363700|454845686|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
126423347|NCT01363700|454845687|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
126423348|NCT01363700|454845688|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
126423349|NCT00113841|454845696|FG000|Overall Study|Disease progression|0|||
126423350|NCT00113841|454845697|FG001|Overall Study|Disease progression|2|||
126423351|NCT00113841|454845696|FG000|Overall Study|Non-compliant|1|||
126423352|NCT00113841|454845697|FG001|Overall Study|Non-compliant|0|||
126423353|NCT01454596|454845698|FG000|Overall Study|Death|0|||
126423354|NCT01454596|454845699|FG001|Overall Study|Death|0|||
126423355|NCT01454596|454845700|FG002|Overall Study|Death|0|||
126423356|NCT01454596|454845701|FG003|Overall Study|Death|0|||
126423357|NCT01454596|454845702|FG004|Overall Study|Death|0|||
126423358|NCT01454596|454845703|FG005|Overall Study|Death|0|||
126423359|NCT01454596|454845704|FG006|Overall Study|Death|0|||
126423360|NCT01454596|454845705|FG007|Overall Study|Death|0|||
126423361|NCT01454596|454845706|FG008|Overall Study|Death|0|||
126423362|NCT01454596|454845707|FG009|Overall Study|Death|1|||
126423363|NCT01454596|454845708|FG010|Overall Study|Death|1|||
126423364|NCT01454596|454845709|FG011|Overall Study|Death|0|||
126423365|NCT02721875|454845711|FG000|Overall Study|Progressive disease/relapse|1|||
126423366|NCT02721875|454845712|FG001|Overall Study|Progressive disease/relapse|0|||
126423367|NCT00430716|454845713|FG000|Double Blind Phase|Death|1|||
126423368|NCT00430716|454845714|FG001|Double Blind Phase|Death|0|||
126423369|NCT00430716|454845715|FG002|Double Blind Phase|Death|0|||
126423370|NCT00430716|454845713|FG000|Double Blind Phase|No longer willing to participate|2|||
126423371|NCT00430716|454845714|FG001|Double Blind Phase|No longer willing to participate|1|||
126423372|NCT00430716|454845715|FG002|Double Blind Phase|No longer willing to participate|1|||
126423373|NCT00430716|454845713|FG000|Double Blind Phase|Other|0|||
126423374|NCT00430716|454845714|FG001|Double Blind Phase|Other|2|||
126423375|NCT00430716|454845715|FG002|Double Blind Phase|Other|0|||
126423376|NCT00430716|454845713|FG000|Double Blind Phase|Study terminated by sponsor|1|||
126423377|NCT00430716|454845714|FG001|Double Blind Phase|Study terminated by sponsor|1|||
126423378|NCT00430716|454845715|FG002|Double Blind Phase|Study terminated by sponsor|2|||
126423379|NCT00430716|454845713|FG000|Double Blind Phase|Adverse Event|1|||
126423380|NCT00430716|454845714|FG001|Double Blind Phase|Adverse Event|1|||
126423381|NCT00430716|454845715|FG002|Double Blind Phase|Adverse Event|3|||
126423382|NCT00430716|454845713|FG000|Double Blind Phase|Not treated|1|||
126423383|NCT00430716|454845714|FG001|Double Blind Phase|Not treated|0|||
126423384|NCT00430716|454845715|FG002|Double Blind Phase|Not treated|0|||
126423385|NCT00430716|454845713|FG000|Open Label Phase|Lost to Follow-up|1|||
126423386|NCT00430716|454845714|FG001|Open Label Phase|Lost to Follow-up|0|||
126551843|NCT01155388|455315870|FG000|Overall Study|Adverse Event|1|||
126423387|NCT00430716|454845715|FG002|Open Label Phase|Lost to Follow-up|1|||
126423388|NCT00430716|454845713|FG000|Open Label Phase|No longer willing to participate|0|||
126423389|NCT00430716|454845714|FG001|Open Label Phase|No longer willing to participate|1|||
126423390|NCT00430716|454845715|FG002|Open Label Phase|No longer willing to participate|1|||
126423391|NCT00430716|454845713|FG000|Open Label Phase|Other|3|||
126423392|NCT00430716|454845714|FG001|Open Label Phase|Other|1|||
126423393|NCT00430716|454845715|FG002|Open Label Phase|Other|1|||
126423394|NCT00430716|454845713|FG000|Open Label Phase|Protocol Violation|1|||
126423395|NCT00430716|454845714|FG001|Open Label Phase|Protocol Violation|0|||
126423396|NCT00430716|454845715|FG002|Open Label Phase|Protocol Violation|0|||
126423397|NCT00430716|454845713|FG000|Open Label Phase|Study terminated by sponsor|4|||
126423398|NCT00430716|454845714|FG001|Open Label Phase|Study terminated by sponsor|5|||
126423399|NCT00430716|454845715|FG002|Open Label Phase|Study terminated by sponsor|4|||
126423400|NCT01433172|454845716|FG000|Overall Study|Withdrawal by Subject|0|||
126423401|NCT01433172|454845717|FG001|Overall Study|Withdrawal by Subject|1|||
126423402|NCT01433172|454845718|FG002|Overall Study|Withdrawal by Subject|0|||
126423403|NCT01433172|454845716|FG000|Overall Study|Disease Progression|0|||
126423404|NCT01433172|454845717|FG001|Overall Study|Disease Progression|0|||
126423405|NCT01433172|454845718|FG002|Overall Study|Disease Progression|1|||
126423406|NCT01433172|454845716|FG000|Overall Study|Death|0|||
126423407|NCT01433172|454845717|FG001|Overall Study|Death|2|||
126423408|NCT01433172|454845718|FG002|Overall Study|Death|0|||
126423409|NCT00773513|454845719|FG000|Overall Study|Renal Transplant|254|||
126423410|NCT00773513|454845720|FG001|Overall Study|Renal Transplant|263|||
126423411|NCT00773513|454845719|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
126423412|NCT00773513|454845720|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
126423413|NCT00773513|454845719|FG000|Overall Study|Withdrew Consent|68|||
126423414|NCT00773513|454845720|FG001|Overall Study|Withdrew Consent|69|||
126423415|NCT00773513|454845719|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
126423416|NCT00773513|454845720|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
126423417|NCT00773513|454845719|FG000|Overall Study|Failure to Return|22|||
126423418|NCT00773513|454845720|FG001|Overall Study|Failure to Return|8|||
126423419|NCT00773513|454845719|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126423420|NCT00773513|454845720|FG001|Overall Study|Insufficient Therapeutic Response|18|||
126423421|NCT00773513|454845719|FG000|Overall Study|Reason Not Specified|159|||
126423422|NCT00773513|454845720|FG001|Overall Study|Reason Not Specified|126|||
126423423|NCT00773513|454845719|FG000|Overall Study|Death|531|||
126423424|NCT00773513|454845720|FG001|Overall Study|Death|545|||
126423425|NCT03116685|454845725|FG000|Overall Study|Physician Decision|0|||
126423426|NCT03116685|454845726|FG001|Overall Study|Physician Decision|1|||
126423427|NCT05481359|454845727|FG000|Overall Study|Lost to Follow-up|3|||
126423428|NCT05481359|454845727|FG000|Overall Study|Withdrawal by Subject|1|||
126423429|NCT01712204|454845728|FG000|Overall Study|Adverse Event|3|||
126423430|NCT01712204|454845729|FG001|Overall Study|Adverse Event|1|||
126423431|NCT01712204|454845728|FG000|Overall Study|Withdrawal by Subject|3|||
126423432|NCT01712204|454845729|FG001|Overall Study|Withdrawal by Subject|3|||
126423433|NCT01712204|454845728|FG000|Overall Study|Lost to Follow-up|1|||
126423434|NCT01712204|454845729|FG001|Overall Study|Lost to Follow-up|0|||
126423435|NCT01712204|454845728|FG000|Overall Study|Protocol Violation|1|||
126423436|NCT01712204|454845729|FG001|Overall Study|Protocol Violation|1|||
126423437|NCT01045694|454845737|FG000|Overall Study|Withdrawal by Subject|2|||
126423438|NCT01150097|454845738|FG000|Months 24 to 36 Post-transplantation|Death|2|||
126423439|NCT01150097|454845739|FG001|Months 24 to 36 Post-transplantation|Death|0|||
126423440|NCT01150097|454845740|FG002|Months 24 to 36 Post-transplantation|Death|0|||
126423441|NCT01150097|454845738|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
126423442|NCT01150097|454845739|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
126423443|NCT01150097|454845740|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
126423444|NCT01150097|454845738|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
126423445|NCT01150097|454845739|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
126423446|NCT01150097|454845740|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
126423447|NCT01150097|454845738|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
126423448|NCT01150097|454845739|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
126423449|NCT01150097|454845740|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
126423450|NCT01150097|454845738|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
126423451|NCT01150097|454845739|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
126423452|NCT01150097|454845740|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
126423453|NCT01150097|454845738|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
126423454|NCT01150097|454845739|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
126423455|NCT01150097|454845740|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
126423456|NCT01150097|454845738|FG000|Months 24 to 48 Post-transplantation|Death|2|||
126423457|NCT01150097|454845739|FG001|Months 24 to 48 Post-transplantation|Death|0|||
126423458|NCT01150097|454845740|FG002|Months 24 to 48 Post-transplantation|Death|0|||
126423459|NCT01114828|454845743|FG000|Overall Study|Adverse Event|1|||
126423460|NCT01114828|454845744|FG001|Overall Study|Adverse Event|1|||
126423461|NCT01114828|454845743|FG000|Overall Study|Lack of Efficacy|0|||
126423462|NCT01114828|454845744|FG001|Overall Study|Lack of Efficacy|2|||
126423463|NCT01114828|454845743|FG000|Overall Study|Protocol Violation|2|||
126423464|NCT01114828|454845744|FG001|Overall Study|Protocol Violation|0|||
126423465|NCT01114828|454845743|FG000|Overall Study|Withdrawal by Subject|0|||
126423466|NCT01114828|454845744|FG001|Overall Study|Withdrawal by Subject|1|||
126423467|NCT00549445|454845745|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
126423468|NCT00549445|454845746|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
126423469|NCT02719171|454846968|FG000|Overall Study|Adverse Event|1|||
126423470|NCT02719171|454846969|FG001|Overall Study|Adverse Event|2|||
126423471|NCT02719171|454846970|FG002|Overall Study|Adverse Event|0|||
126423472|NCT02719171|454846971|FG003|Overall Study|Adverse Event|0|||
126423473|NCT02719171|454846972|FG004|Overall Study|Adverse Event|2|||
126423474|NCT02719171|454846968|FG000|Overall Study|Lost to Follow-up|0|||
126423475|NCT02719171|454846969|FG001|Overall Study|Lost to Follow-up|0|||
126423476|NCT02719171|454846970|FG002|Overall Study|Lost to Follow-up|1|||
126423477|NCT02719171|454846971|FG003|Overall Study|Lost to Follow-up|0|||
126423478|NCT02719171|454846972|FG004|Overall Study|Lost to Follow-up|0|||
126423479|NCT02719171|454846968|FG000|Overall Study|Subject Withdrawal|0|||
126423480|NCT02719171|454846969|FG001|Overall Study|Subject Withdrawal|2|||
126423481|NCT02719171|454846970|FG002|Overall Study|Subject Withdrawal|2|||
126423482|NCT02719171|454846971|FG003|Overall Study|Subject Withdrawal|1|||
126423483|NCT02719171|454846972|FG004|Overall Study|Subject Withdrawal|0|||
126423484|NCT02719171|454846968|FG000|Overall Study|Other|0|||
126423485|NCT02719171|454846969|FG001|Overall Study|Other|0|||
126423486|NCT02719171|454846970|FG002|Overall Study|Other|0|||
126423487|NCT02719171|454846971|FG003|Overall Study|Other|1|||
126423488|NCT02719171|454846972|FG004|Overall Study|Other|0|||
126423489|NCT02796677|454846973|FG000|Overall Study|Adverse Event|11|||
126423490|NCT02796677|454846974|FG001|Overall Study|Adverse Event|22|||
126423491|NCT02796677|454846975|FG002|Overall Study|Adverse Event|14|||
126423492|NCT02796677|454846976|FG003|Overall Study|Adverse Event|14|||
126423493|NCT02796677|454846973|FG000|Overall Study|Protocol Violation|7|||
126423494|NCT02796677|454846974|FG001|Overall Study|Protocol Violation|5|||
126423495|NCT02796677|454846975|FG002|Overall Study|Protocol Violation|4|||
126423496|NCT02796677|454846976|FG003|Overall Study|Protocol Violation|8|||
126423497|NCT02796677|454846973|FG000|Overall Study|Lost to Follow-up|1|||
126423498|NCT02796677|454846974|FG001|Overall Study|Lost to Follow-up|5|||
126423499|NCT02796677|454846975|FG002|Overall Study|Lost to Follow-up|2|||
126423500|NCT02796677|454846976|FG003|Overall Study|Lost to Follow-up|2|||
126423501|NCT02796677|454846973|FG000|Overall Study|Lack of Efficacy|7|||
126423502|NCT02796677|454846974|FG001|Overall Study|Lack of Efficacy|9|||
126423503|NCT02796677|454846975|FG002|Overall Study|Lack of Efficacy|14|||
126423504|NCT02796677|454846976|FG003|Overall Study|Lack of Efficacy|20|||
126423505|NCT02796677|454846973|FG000|Overall Study|Withdrawal by Subject|4|||
126423506|NCT02796677|454846974|FG001|Overall Study|Withdrawal by Subject|14|||
126423507|NCT02796677|454846975|FG002|Overall Study|Withdrawal by Subject|6|||
126423508|NCT02796677|454846976|FG003|Overall Study|Withdrawal by Subject|7|||
126423509|NCT02796677|454846973|FG000|Overall Study|Progressive disease|6|||
126423510|NCT02796677|454846974|FG001|Overall Study|Progressive disease|15|||
126423511|NCT02796677|454846975|FG002|Overall Study|Progressive disease|13|||
126423512|NCT02796677|454846976|FG003|Overall Study|Progressive disease|18|||
126423513|NCT02796677|454846973|FG000|Overall Study|Reason not mentioned|2|||
126423514|NCT02796677|454846974|FG001|Overall Study|Reason not mentioned|3|||
126423515|NCT02796677|454846975|FG002|Overall Study|Reason not mentioned|0|||
126423516|NCT02796677|454846976|FG003|Overall Study|Reason not mentioned|5|||
126423517|NCT00961181|454846977|FG000|Overall Study|Death|2|||
126423518|NCT00961181|454846977|FG000|Overall Study|Withdrawal by Subject|2|||
126423519|NCT00961181|454846977|FG000|Overall Study|Lost to Follow-up|1|||
126423520|NCT03811340|454846978|FG000|Overall Study|subjects did not complete the survey.|90|||
126423521|NCT01045967|454846979|FG000|Second Intervention|Protocol Violation|0|||
126423522|NCT01045967|454846980|FG001|Second Intervention|Protocol Violation|1|||
126423523|NCT00764361|454846983|FG000|Overall Study|Withdrawal by Subject|2|||
126423524|NCT00764361|454846984|FG001|Overall Study|Withdrawal by Subject|3|||
126423525|NCT00764361|454846983|FG000|Overall Study|Adverse Event|0|||
126423526|NCT00764361|454846984|FG001|Overall Study|Adverse Event|1|||
126423527|NCT02090426|454846985|FG000|Overall Study|Lost to Follow-up|12|||
126423528|NCT02090426|454846986|FG001|Overall Study|Lost to Follow-up|6|||
126423529|NCT01141712|454846990|FG000|Overall Study|Disease progression|3|||
126423530|NCT01308736|454846991|FG000|Overall Study|Did not attend a single session|6|||
126423531|NCT01308736|454846992|FG001|Overall Study|Did not attend a single session|5|||
126423532|NCT00296816|454846993|FG000|Overall Study|Disease Progression|37|||
126423533|NCT00296816|454846993|FG000|Overall Study|Adverse Event|18|||
126423534|NCT00296816|454846993|FG000|Overall Study|Investigator/Participant request|5|||
126423535|NCT00296816|454846993|FG000|Overall Study|Non-compliance|1|||
126423536|NCT00296816|454846993|FG000|Overall Study|Missing for end of treatment|4|||
126423537|NCT00296816|454846993|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
126423538|NCT00296816|454846993|FG000|Overall Study|Poor performance status|1|||
126423539|NCT00296816|454846993|FG000|Overall Study|Relocation to Florida|1|||
126423540|NCT00296816|454846993|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
126423541|NCT00296816|454846993|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
126423542|NCT00296816|454846993|FG000|Overall Study|Neuropathy/patient preference|1|||
126423543|NCT00296816|454846993|FG000|Overall Study|Proteinuria|1|||
126423544|NCT00296816|454846993|FG000|Overall Study|ineligibility due to radiation treatment|1|||
126423545|NCT00985465|454846999|FG000|Overall Study|Withdrawal by Subject|1|||
126423546|NCT00985465|454847000|FG001|Overall Study|Withdrawal by Subject|2|||
126423547|NCT00985465|454846999|FG000|Overall Study|Considered to be part of the other group|0|||
126423548|NCT00985465|454847000|FG001|Overall Study|Considered to be part of the other group|1|||
126423549|NCT04701333|454847001|FG000|Overall Study|Lost to Follow-up|3|||
126423550|NCT04701333|454847002|FG001|Overall Study|Lost to Follow-up|7|||
126423551|NCT04701333|454847001|FG000|Overall Study|Withdrawal by Subject|0|||
126423552|NCT04701333|454847002|FG001|Overall Study|Withdrawal by Subject|1|||
126423553|NCT01012258|454847003|FG000|Overall Study|Death|14|||
126423554|NCT01012258|454847003|FG000|Overall Study|Lost to Follow-up|1|||
126423555|NCT01012258|454847003|FG000|Overall Study|Adverse Event|1|||
126423556|NCT01012258|454847003|FG000|Overall Study|Progressive Disease (PD)|18|||
126423557|NCT01012258|454847003|FG000|Overall Study|Symptomatic Deterioration|1|||
126423558|NCT01012258|454847003|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
126423559|NCT01012258|454847003|FG000|Overall Study|Another Tumor Discovered|1|||
126423560|NCT01012258|454847003|FG000|Overall Study|Ongoing|29|||
126423561|NCT03600740|454847004|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
126423562|NCT01623115|454847005|FG000|Overall Study|Randomized but not treated|0|||
126423563|NCT01623115|454847006|FG001|Overall Study|Randomized but not treated|1|||
126423564|NCT01623115|454847005|FG000|Overall Study|Physician Decision|1|||
126423565|NCT01623115|454847006|FG001|Overall Study|Physician Decision|0|||
126423566|NCT01623115|454847005|FG000|Overall Study|Participants moved|1|||
126423567|NCT01623115|454847006|FG001|Overall Study|Participants moved|5|||
126423568|NCT01623115|454847005|FG000|Overall Study|Adverse Event|10|||
126423569|NCT01623115|454847006|FG001|Overall Study|Adverse Event|13|||
126423570|NCT01623115|454847005|FG000|Overall Study|Poor compliance to protocol|4|||
126423571|NCT01623115|454847006|FG001|Overall Study|Poor compliance to protocol|10|||
126423572|NCT01623115|454847005|FG000|Overall Study|Consent withdrawn by participant|2|||
126423573|NCT01623115|454847006|FG001|Overall Study|Consent withdrawn by participant|6|||
126423574|NCT01623115|454847005|FG000|Overall Study|Related to study drug administration|0|||
126423575|NCT01623115|454847006|FG001|Overall Study|Related to study drug administration|2|||
126423576|NCT01623115|454847005|FG000|Overall Study|Last visit outside protocol visit window|14|||
126423577|NCT01623115|454847006|FG001|Overall Study|Last visit outside protocol visit window|26|||
126423578|NCT01623115|454847005|FG000|Overall Study|Site closure|1|||
126423579|NCT01623115|454847006|FG001|Overall Study|Site closure|7|||
126423580|NCT01623115|454847005|FG000|Overall Study|Death|0|||
126423581|NCT01623115|454847006|FG001|Overall Study|Death|4|||
126423582|NCT01623115|454847005|FG000|Overall Study|Other than specified above|0|||
126423583|NCT01623115|454847006|FG001|Overall Study|Other than specified above|3|||
126423584|NCT00580723|454847012|FG000|Overall Study|Did not want to participate in extension|3|||
126423585|NCT00580723|454847012|FG000|Overall Study|Lost to Follow-up|5|||
126423586|NCT00148759|454847013|FG000|Overall Study|Withdrawal by Subject|1|||
126423587|NCT00148759|454847014|FG001|Overall Study|Withdrawal by Subject|1|||
126423588|NCT00148759|454847013|FG000|Overall Study|Lost to Follow-up|1|||
126423589|NCT00148759|454847014|FG001|Overall Study|Lost to Follow-up|0|||
126423590|NCT05202418|454847015|FG000|Overall Study|Withdrawal by Subject|2|||
126423591|NCT05202418|454847016|FG001|Overall Study|Withdrawal by Subject|1|||
126423592|NCT05202418|454847015|FG000|Overall Study|Lost to Follow-up|1|||
126423593|NCT05202418|454847016|FG001|Overall Study|Lost to Follow-up|1|||
126423594|NCT00857285|454847017|FG000|Overall Study|Adverse Event|4|||
126423595|NCT00857285|454847018|FG001|Overall Study|Adverse Event|2|||
126423596|NCT00857285|454847017|FG000|Overall Study|Lack of Efficacy|0|||
126423597|NCT00857285|454847018|FG001|Overall Study|Lack of Efficacy|2|||
126423598|NCT00857285|454847017|FG000|Overall Study|Protocol Violation|3|||
126423599|NCT00857285|454847018|FG001|Overall Study|Protocol Violation|1|||
126423600|NCT00857285|454847017|FG000|Overall Study|Withdrawal by Subject|4|||
126423601|NCT00857285|454847018|FG001|Overall Study|Withdrawal by Subject|0|||
126423602|NCT00857285|454847017|FG000|Overall Study|Randomization criteria not met|1|||
126423603|NCT00857285|454847018|FG001|Overall Study|Randomization criteria not met|1|||
126423604|NCT01329978|454847024|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
126423605|NCT01329978|454847025|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
126423606|NCT01329978|454847026|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
126423607|NCT01329978|454847027|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
126423608|NCT01329978|454847028|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
126423609|NCT01329978|454847024|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
126423610|NCT01329978|454847025|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
126423611|NCT01329978|454847026|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
126423612|NCT01329978|454847027|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
126551844|NCT01155388|455315871|FG001|Overall Study|Adverse Event|0|||
126423613|NCT01329978|454847028|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
126423614|NCT01329978|454847024|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
126423615|NCT01329978|454847025|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
126423616|NCT01329978|454847026|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
126423617|NCT01329978|454847027|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
126423618|NCT01329978|454847028|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
126423619|NCT01329978|454847024|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
126423620|NCT01329978|454847025|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
126423621|NCT01329978|454847026|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
126423622|NCT01329978|454847027|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
126423623|NCT01329978|454847028|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
126423624|NCT01329978|454847024|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
126423625|NCT01329978|454847025|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
126423626|NCT01329978|454847026|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
126423627|NCT01329978|454847027|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
126423628|NCT01329978|454847028|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
126423629|NCT01329978|454847024|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
126423630|NCT01329978|454847025|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
126423631|NCT01329978|454847026|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
126423632|NCT01329978|454847027|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
126423633|NCT01329978|454847028|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
126423634|NCT01329978|454847024|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
126423635|NCT01329978|454847025|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
126423636|NCT01329978|454847026|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
126423637|NCT01329978|454847027|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
126423638|NCT01329978|454847028|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
126423639|NCT04170543|454847039|FG000|Overall Study|Death|1|||
126423640|NCT04170543|454847040|FG001|Overall Study|Death|1|||
126423641|NCT04170543|454847041|FG002|Overall Study|Death|1|||
126423642|NCT04170543|454847042|FG003|Overall Study|Death|1|||
126423643|NCT04170543|454847043|FG004|Overall Study|Death|1|||
126423644|NCT04170543|454847039|FG000|Overall Study|Lost to Follow-up|3|||
126423645|NCT04170543|454847040|FG001|Overall Study|Lost to Follow-up|3|||
126423646|NCT04170543|454847041|FG002|Overall Study|Lost to Follow-up|0|||
126423647|NCT04170543|454847042|FG003|Overall Study|Lost to Follow-up|3|||
126423648|NCT04170543|454847043|FG004|Overall Study|Lost to Follow-up|1|||
126423649|NCT04170543|454847039|FG000|Overall Study|Withdrawal by Subject|13|||
126423650|NCT04170543|454847040|FG001|Overall Study|Withdrawal by Subject|6|||
126423651|NCT04170543|454847041|FG002|Overall Study|Withdrawal by Subject|5|||
126423652|NCT04170543|454847042|FG003|Overall Study|Withdrawal by Subject|4|||
126423653|NCT04170543|454847043|FG004|Overall Study|Withdrawal by Subject|9|||
126423654|NCT04170543|454847039|FG000|Overall Study|Not able to transition to phase 2b|8|||
126423655|NCT04170543|454847040|FG001|Overall Study|Not able to transition to phase 2b|0|||
126423656|NCT04170543|454847041|FG002|Overall Study|Not able to transition to phase 2b|10|||
126423657|NCT04170543|454847042|FG003|Overall Study|Not able to transition to phase 2b|0|||
126423658|NCT04170543|454847043|FG004|Overall Study|Not able to transition to phase 2b|6|||
126423659|NCT04170543|454847039|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
126423660|NCT04170543|454847040|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
126423661|NCT04170543|454847041|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
126423662|NCT04170543|454847042|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
126423663|NCT04170543|454847043|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
126423664|NCT04170543|454847039|FG000|Overall Study|Not Treated|0|||
126423665|NCT04170543|454847040|FG001|Overall Study|Not Treated|0|||
126423666|NCT04170543|454847041|FG002|Overall Study|Not Treated|0|||
126423667|NCT04170543|454847042|FG003|Overall Study|Not Treated|0|||
126423668|NCT04170543|454847043|FG004|Overall Study|Not Treated|2|||
126423669|NCT04170543|454847039|FG000|Overall Study|(CRF)|16|||
126423670|NCT04170543|454847040|FG001|Overall Study|(CRF)|15|||
126423671|NCT04170543|454847041|FG002|Overall Study|(CRF)|12|||
126423672|NCT04170543|454847042|FG003|Overall Study|(CRF)|17|||
126534815|NCT02001194|455248415|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
126534816|NCT02001194|455248416|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
126534817|NCT02001194|455248417|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
126534818|NCT02001194|455248418|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
126534819|NCT02606279|455248419|FG000|Overall Study|Lost to Follow-up|0|||
126534820|NCT02606279|455248420|FG001|Overall Study|Lost to Follow-up|1|||
126534821|NCT02690974|455248422|FG000|Overall Study|Adverse Event|16|||
126534822|NCT02690974|455248422|FG000|Overall Study|Death|9|||
126534823|NCT02690974|455248422|FG000|Overall Study|Subject/guardian decision|4|||
126534824|NCT02690974|455248422|FG000|Overall Study|Lost to Follow-up|3|||
126534825|NCT02690974|455248422|FG000|Overall Study|Withdrawal of Informed Consent|3|||
126534826|NCT02690974|455248422|FG000|Overall Study|Physician Decision|2|||
126534827|NCT02690974|455248422|FG000|Overall Study|Non-compliance with study treatment|1|||
126534828|NCT02690974|455248422|FG000|Overall Study|Protocol-defined stopping criteria|1|||
126534829|NCT02690974|455248422|FG000|Overall Study|Protocol Deviation|1|||
126534830|NCT02184611|455248427|FG000|Overall Study|Lack of Efficacy|11|||
126534831|NCT02184611|455248428|FG001|Overall Study|Lack of Efficacy|15|||
126534832|NCT02184611|455248427|FG000|Overall Study|Withdrawal by Subject|5|||
126534833|NCT02184611|455248428|FG001|Overall Study|Withdrawal by Subject|6|||
126534834|NCT02184611|455248427|FG000|Overall Study|Adverse Event|4|||
126534835|NCT02184611|455248428|FG001|Overall Study|Adverse Event|5|||
126534836|NCT02184611|455248427|FG000|Overall Study|Protocol Violation|1|||
126534837|NCT02184611|455248428|FG001|Overall Study|Protocol Violation|1|||
126534838|NCT02184611|455248427|FG000|Overall Study|Protocol defined stopping criteria|0|||
126534839|NCT02184611|455248428|FG001|Overall Study|Protocol defined stopping criteria|1|||
126534840|NCT00522301|455248429|FG000|Overall Study|Withdrawal by Subject|1|||
126534841|NCT00522301|455248429|FG000|Overall Study|Adverse Event|5|||
126534842|NCT01666951|455248430|FG000|Overall Study|Not dosed|1|||
126534843|NCT01666951|455248431|FG001|Overall Study|Not dosed|1|||
126534844|NCT02366910|455248435|FG000|Overall Study|Withdrawal by Subject|2|||
126534845|NCT02366910|455248435|FG000|Overall Study|Screen Failure|3|||
126534846|NCT02623322|455248441|FG000|Overall Study|Lost to Follow-up|2|||
126534847|NCT02623322|455248442|FG001|Overall Study|Lost to Follow-up|1|||
126534848|NCT02623322|455248443|FG002|Overall Study|Lost to Follow-up|0|||
126534849|NCT03563716|455248444|FG000|Overall Study|Death|20|||
126534850|NCT03563716|455248445|FG001|Overall Study|Death|14|||
126534851|NCT03563716|455248444|FG000|Overall Study|Withdrawal by Subject|3|||
126534852|NCT03563716|455248445|FG001|Overall Study|Withdrawal by Subject|3|||
126534853|NCT03563716|455248444|FG000|Overall Study|Still on Study|45|||
126534854|NCT03563716|455248445|FG001|Overall Study|Still on Study|50|||
126534855|NCT04605978|455248449|FG000|Overall Study|Adverse Event|2|||
126534856|NCT04605978|455248450|FG001|Overall Study|Adverse Event|1|||
126534857|NCT04605978|455248449|FG000|Overall Study|Withdrawal nonmedical reason|1|||
126534858|NCT04605978|455248450|FG001|Overall Study|Withdrawal nonmedical reason|1|||
126534859|NCT03813238|455248451|FG000|Overall Study|Adverse Event|0|||
126534860|NCT03813238|455248452|FG001|Overall Study|Adverse Event|6|||
126534861|NCT03813238|455248451|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126534862|NCT03813238|455248452|FG001|Overall Study|Withdrawal by parent/guardian|2|||
126534863|NCT03813238|455248451|FG000|Overall Study|Lost to Follow-up|0|||
126534864|NCT03813238|455248452|FG001|Overall Study|Lost to Follow-up|1|||
126534865|NCT03813238|455248451|FG000|Overall Study|Other than specified|1|||
126534866|NCT03813238|455248452|FG001|Overall Study|Other than specified|2|||
126534867|NCT02583425|455248453|FG000|Screening|Did not meet entry criteria|12|||
126534868|NCT02583425|455248453|FG000|Baseline|Did not meet continued criteria|5|||
126534869|NCT02583425|455248453|FG000|Treatment Period|Adverse Event|1|||
126534870|NCT01690130|455248456|FG000|Overall Study|Subject have cancelled visit.|1|||
126534871|NCT01690130|455248457|FG001|Overall Study|Subject have cancelled visit.|0|||
126534872|NCT03318523|455248458|FG000|PC Period: Up to Year 1|Adverse Event|1|||
126534873|NCT03318523|455248459|FG001|PC Period: Up to Year 1|Adverse Event|0|||
126534874|NCT03318523|455248460|FG002|PC Period: Up to Year 1|Adverse Event|2|||
126534875|NCT03318523|455248461|FG003|PC Period: Up to Year 1|Adverse Event|0|||
126534876|NCT03318523|455248462|FG004|PC Period: Up to Year 1|Adverse Event|0|||
126534877|NCT03318523|455248463|FG005|PC Period: Up to Year 1|Adverse Event|0|||
126534878|NCT03318523|455248464|FG006|PC Period: Up to Year 1|Adverse Event|0|||
126534879|NCT03318523|455248465|FG007|PC Period: Up to Year 1|Adverse Event|0|||
126534880|NCT03318523|455248466|FG008|PC Period: Up to Year 1|Adverse Event|0|||
126534881|NCT03318523|455248467|FG009|PC Period: Up to Year 1|Adverse Event|0|||
126534882|NCT03318523|455248458|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
126534883|NCT03318523|455248459|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
126534884|NCT03318523|455248460|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
126534885|NCT03318523|455248461|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
126534886|NCT03318523|455248462|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
126534887|NCT03318523|455248463|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
126534888|NCT03318523|455248464|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
126534889|NCT03318523|455248465|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
126534890|NCT03318523|455248466|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
126534891|NCT03318523|455248467|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
126534892|NCT03318523|455248458|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
126534893|NCT03318523|455248459|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
126534894|NCT03318523|455248460|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
126534895|NCT03318523|455248461|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
126534896|NCT03318523|455248462|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
126534897|NCT03318523|455248463|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
126534898|NCT03318523|455248464|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
126534899|NCT03318523|455248465|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
126534900|NCT03318523|455248466|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
126534901|NCT03318523|455248467|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
126534902|NCT03318523|455248458|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
126534903|NCT03318523|455248459|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
126534904|NCT03318523|455248460|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
126534905|NCT03318523|455248461|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
126534906|NCT03318523|455248462|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
126534907|NCT03318523|455248463|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
126534908|NCT03318523|455248464|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
126534909|NCT03318523|455248465|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
126534910|NCT03318523|455248466|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
126534911|NCT03318523|455248467|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
126534912|NCT03318523|455248458|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
126534913|NCT03318523|455248459|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
126534914|NCT03318523|455248460|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
126534915|NCT03318523|455248461|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
126534916|NCT03318523|455248462|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
126534917|NCT03318523|455248463|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
126534918|NCT03318523|455248464|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
126534919|NCT03318523|455248465|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
126534920|NCT03318523|455248466|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
126534921|NCT03318523|455248467|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
126534922|NCT03318523|455248458|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
126534923|NCT03318523|455248459|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
126423673|NCT04170543|454847043|FG004|Overall Study|(CRF)|17|||
126423674|NCT04170543|454847039|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
126423675|NCT04170543|454847040|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
126423676|NCT04170543|454847041|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
126423677|NCT04170543|454847042|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
126423678|NCT04170543|454847043|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
126423679|NCT04303559|454847044|FG000|Overall Study|Study closed due to poor enrollment.|1|||
126534924|NCT03318523|455248460|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
126534925|NCT03318523|455248461|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
126534926|NCT03318523|455248462|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
126534927|NCT03318523|455248463|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
126534928|NCT03318523|455248464|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
126534929|NCT03318523|455248465|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
126534930|NCT03318523|455248466|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
126534931|NCT03318523|455248467|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
126534932|NCT03318523|455248458|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
126534933|NCT03318523|455248459|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
126534934|NCT03318523|455248460|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
126534935|NCT03318523|455248461|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
126534936|NCT03318523|455248462|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
126534937|NCT03318523|455248463|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
126534938|NCT03318523|455248464|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
126534939|NCT03318523|455248465|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
126534940|NCT03318523|455248466|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
126534941|NCT03318523|455248467|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
126534942|NCT03318523|455248458|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
126423680|NCT01987102|454847045|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
126423681|NCT01987102|454847046|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
126423682|NCT01987102|454847045|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
126423683|NCT01987102|454847046|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
126423684|NCT01987102|454847045|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
126423685|NCT01987102|454847046|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
126423686|NCT01987102|454847045|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
126423687|NCT01987102|454847046|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
126423688|NCT01987102|454847045|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
126423689|NCT01987102|454847046|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
126423690|NCT01987102|454847045|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
126423691|NCT01987102|454847046|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
126423692|NCT01236521|454847049|FG000|Overall Study|Withdrawal by Subject|12|||
126534943|NCT03318523|455248459|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
126534944|NCT03318523|455248460|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
126534945|NCT03318523|455248461|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
126534946|NCT03318523|455248462|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
126645537|NCT00368927|455660381|FG000|Overall Study|Withdrawal by Subject|1|||
126645538|NCT00368927|455660382|FG001|Overall Study|Withdrawal by Subject|2|||
126645539|NCT00368927|455660381|FG000|Overall Study|Physician Decision|1|||
126645540|NCT00368927|455660382|FG001|Overall Study|Physician Decision|0|||
126645541|NCT03525392|455660383|FG000|Overall Study|Adverse Event|1|||
126645542|NCT03525392|455660384|FG001|Overall Study|Adverse Event|0|||
126645543|NCT03525392|455660385|FG002|Overall Study|Adverse Event|2|||
126645544|NCT03525392|455660386|FG003|Overall Study|Adverse Event|0|||
126645545|NCT03525392|455660387|FG004|Overall Study|Adverse Event|0|||
126645546|NCT03525392|455660383|FG000|Overall Study|Progressive disease|0|||
126645547|NCT03525392|455660384|FG001|Overall Study|Progressive disease|1|||
126645548|NCT03525392|455660385|FG002|Overall Study|Progressive disease|1|||
126645549|NCT03525392|455660386|FG003|Overall Study|Progressive disease|3|||
126645550|NCT03525392|455660387|FG004|Overall Study|Progressive disease|1|||
126645551|NCT03284203|455660390|FG000|Overall Study|Lost to Follow-up|3|||
126645552|NCT02229851|455660391|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
126645553|NCT02229851|455660392|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
126645554|NCT02229851|455660393|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
126645555|NCT02229851|455660394|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
126645556|NCT02229851|455660395|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
126645557|NCT02229851|455660396|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
126645558|NCT02229851|455660397|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
126645559|NCT02229851|455660391|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
126645560|NCT02229851|455660392|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
126645561|NCT02229851|455660393|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
126645562|NCT02229851|455660394|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
126645563|NCT02229851|455660395|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
126645564|NCT02229851|455660396|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
126645565|NCT02229851|455660397|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
126645566|NCT02229851|455660391|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
126645567|NCT02229851|455660392|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
126645568|NCT02229851|455660393|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
126645569|NCT02229851|455660394|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
126645570|NCT02229851|455660395|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
126645571|NCT02229851|455660396|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
126645572|NCT02229851|455660397|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
126645573|NCT02229851|455660391|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
126645574|NCT02229851|455660392|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
126645575|NCT02229851|455660393|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
126645576|NCT02229851|455660394|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
126645577|NCT02229851|455660395|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
126645578|NCT02229851|455660396|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
126645579|NCT02229851|455660397|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
126645580|NCT02229851|455660391|FG000|Main Phase (Double-blind Phase)|Death|1|||
126645581|NCT02229851|455660392|FG001|Main Phase (Double-blind Phase)|Death|1|||
126645582|NCT02229851|455660393|FG002|Main Phase (Double-blind Phase)|Death|0|||
126645583|NCT02229851|455660394|FG003|Main Phase (Double-blind Phase)|Death|0|||
126645584|NCT02229851|455660395|FG004|Main Phase (Double-blind Phase)|Death|0|||
126645585|NCT02229851|455660396|FG005|Main Phase (Double-blind Phase)|Death|0|||
126645586|NCT02229851|455660397|FG006|Main Phase (Double-blind Phase)|Death|0|||
126645587|NCT02229851|455660391|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
126645588|NCT02229851|455660392|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
126645589|NCT02229851|455660393|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
126645590|NCT02229851|455660394|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
126645591|NCT02229851|455660395|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
126645592|NCT02229851|455660396|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
126645593|NCT02229851|455660397|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
126645594|NCT02229851|455660391|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
126645595|NCT02229851|455660392|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
126645596|NCT02229851|455660393|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
126645597|NCT02229851|455660394|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
126645598|NCT02229851|455660395|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
126645599|NCT02229851|455660396|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
126645600|NCT02229851|455660397|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
126645601|NCT02229851|455660391|FG000|Extension Phase (Open-label Phase)|Death|0|||
126645602|NCT02229851|455660392|FG001|Extension Phase (Open-label Phase)|Death|0|||
126645603|NCT02229851|455660393|FG002|Extension Phase (Open-label Phase)|Death|0|||
126645604|NCT02229851|455660394|FG003|Extension Phase (Open-label Phase)|Death|1|||
126645605|NCT02229851|455660395|FG004|Extension Phase (Open-label Phase)|Death|0|||
126645606|NCT02229851|455660396|FG005|Extension Phase (Open-label Phase)|Death|1|||
126645607|NCT02229851|455660397|FG006|Extension Phase (Open-label Phase)|Death|1|||
126645608|NCT01111240|455660398|FG000|Overall Study|Adverse Event|190|||
126645609|NCT01111240|455660398|FG000|Overall Study|Lack of Efficacy|545|||
126645610|NCT01111240|455660398|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
126645611|NCT01111240|455660398|FG000|Overall Study|Other|312|||
126645612|NCT04187326|455660399|FG000|Overall Study|Lost to Follow-up|2|||
126645613|NCT04187326|455660400|FG001|Overall Study|Lost to Follow-up|1|||
126645614|NCT04187326|455660399|FG000|Overall Study|Computer error- task was only partially completed.|0|||
126645615|NCT04187326|455660400|FG001|Overall Study|Computer error- task was only partially completed.|1|||
126645616|NCT01607476|455660401|FG000|Overall Study|Withdrawal by Subject|1|||
126645617|NCT01607476|455660402|FG001|Overall Study|Withdrawal by Subject|0|||
126645618|NCT01607476|455660403|FG002|Overall Study|Withdrawal by Subject|1|||
126645619|NCT01607476|455660401|FG000|Overall Study|Lost to Follow-up|0|||
126645620|NCT01607476|455660402|FG001|Overall Study|Lost to Follow-up|0|||
126645621|NCT01607476|455660403|FG002|Overall Study|Lost to Follow-up|2|||
126645622|NCT04958200|455660406|FG000|Overall Study|Withdrawal by Subject|0|||
126645623|NCT04958200|455660407|FG001|Overall Study|Withdrawal by Subject|2|||
126645624|NCT04958200|455660406|FG000|Overall Study|Lost to Follow-up|3|||
126645625|NCT04958200|455660407|FG001|Overall Study|Lost to Follow-up|2|||
126645626|NCT00623805|455660408|FG000|Overall Study|Adverse Event|9|||
126645627|NCT00623805|455660409|FG001|Overall Study|Adverse Event|6|||
126645628|NCT00623805|455660408|FG000|Overall Study|Death|2|||
126645629|NCT00623805|455660409|FG001|Overall Study|Death|0|||
126645630|NCT00623805|455660408|FG000|Overall Study|Lack of Efficacy|3|||
126645631|NCT00623805|455660409|FG001|Overall Study|Lack of Efficacy|7|||
126645632|NCT00623805|455660408|FG000|Overall Study|Lost to Follow-up|2|||
126645633|NCT00623805|455660409|FG001|Overall Study|Lost to Follow-up|2|||
126645634|NCT00623805|455660408|FG000|Overall Study|Protocol Violation|1|||
126645635|NCT00623805|455660409|FG001|Overall Study|Protocol Violation|1|||
126645636|NCT00623805|455660408|FG000|Overall Study|Reason not Specified|3|||
126645637|NCT00623805|455660409|FG001|Overall Study|Reason not Specified|6|||
126645638|NCT04655027|455660413|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
126645639|NCT04655027|455660414|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
126645640|NCT03519997|455660417|FG000|Overall Study|Adverse Event|4|||
126645641|NCT03519997|455660417|FG000|Overall Study|Withdrawal by Subject|2|||
126645642|NCT03519997|455660417|FG000|Overall Study|Protocol Violation|1|||
126645643|NCT06655558|455660421|FG000|Overall Study|Protocol Violation|1|||
126645644|NCT03578887|455660422|FG000|Overall Study|Withdrawal by Subject|7|||
126645645|NCT03578887|455660423|FG001|Overall Study|Withdrawal by Subject|2|||
126645646|NCT03578887|455660424|FG002|Overall Study|Withdrawal by Subject|1|||
126645647|NCT03578887|455660422|FG000|Overall Study|Lost to Follow-up|13|||
126645648|NCT03578887|455660423|FG001|Overall Study|Lost to Follow-up|1|||
126645649|NCT03578887|455660424|FG002|Overall Study|Lost to Follow-up|4|||
126645650|NCT03578887|455660422|FG000|Overall Study|Physician Decision|0|||
126645651|NCT03578887|455660423|FG001|Overall Study|Physician Decision|1|||
126645652|NCT03578887|455660424|FG002|Overall Study|Physician Decision|1|||
126715000|NCT03408873|455908639|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
126715001|NCT03408873|455908639|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
126715002|NCT03408873|455908639|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
126715003|NCT03408873|455908639|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
126715004|NCT03408873|455908639|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
126715005|NCT01312428|455908643|FG000|Overall Study|Study Termination|3|||
126715006|NCT01312428|455908644|FG001|Overall Study|Study Termination|4|||
126715007|NCT03799718|455908646|FG000|Overall Study|Adverse Event|2|||
126715008|NCT02214186|455908648|FG000|Overall Study|Lost to Follow-up|1|||
126715009|NCT02214186|455908649|FG001|Overall Study|Lost to Follow-up|1|||
126715010|NCT02214186|455908648|FG000|Overall Study|Protocol Violation|1|||
126715011|NCT02214186|455908649|FG001|Overall Study|Protocol Violation|1|||
126715012|NCT01651052|455908650|FG000|Overall Study|Death|21|||
126715013|NCT01651052|455908650|FG000|Overall Study|Explant|1|||
126715014|NCT01651052|455908650|FG000|Overall Study|Withdrawal by Subject|1|||
126715015|NCT01651052|455908650|FG000|Overall Study|Lost to Follow-up|3|||
126715016|NCT00611130|455908659|FG000|Overall Study|Lost to Follow-up|25|||
126715017|NCT00611130|455908660|FG001|Overall Study|Lost to Follow-up|29|||
126715018|NCT00611130|455908659|FG000|Overall Study|Protocol noncompliance|7|||
126715019|NCT00611130|455908660|FG001|Overall Study|Protocol noncompliance|6|||
126715020|NCT00611130|455908659|FG000|Overall Study|Withdrawal by Subject|6|||
126715021|NCT00611130|455908660|FG001|Overall Study|Withdrawal by Subject|5|||
126715022|NCT00611130|455908659|FG000|Overall Study|Other|5|||
126715023|NCT00611130|455908660|FG001|Overall Study|Other|4|||
126715024|NCT00611130|455908659|FG000|Overall Study|Incarceration|3|||
126715025|NCT00611130|455908660|FG001|Overall Study|Incarceration|2|||
126715026|NCT00611130|455908659|FG000|Overall Study|Administrative|1|||
126715027|NCT00611130|455908660|FG001|Overall Study|Administrative|1|||
126715028|NCT00611130|455908659|FG000|Overall Study|Adverse Event|1|||
126715029|NCT00611130|455908660|FG001|Overall Study|Adverse Event|0|||
126715030|NCT00611130|455908659|FG000|Overall Study|Death|1|||
126715031|NCT00611130|455908660|FG001|Overall Study|Death|0|||
126715032|NCT03964415|455908662|FG000|Overall Study|Sponsor's decision|1563|||
126715033|NCT03964415|455908663|FG001|Overall Study|Sponsor's decision|1528|||
126715034|NCT03964415|455908662|FG000|Overall Study|Lost to Follow-up|139|||
126715035|NCT03964415|455908663|FG001|Overall Study|Lost to Follow-up|146|||
126715036|NCT03964415|455908662|FG000|Overall Study|Withdrawal by Subject|68|||
126715037|NCT03964415|455908663|FG001|Overall Study|Withdrawal by Subject|72|||
126715038|NCT03964415|455908662|FG000|Overall Study|Physician Decision|34|||
126715039|NCT03964415|455908663|FG001|Overall Study|Physician Decision|48|||
126715040|NCT03964415|455908662|FG000|Overall Study|Adverse Event|3|||
126715041|NCT03964415|455908663|FG001|Overall Study|Adverse Event|0|||
126715042|NCT03964415|455908662|FG000|Overall Study|Death|4|||
126715043|NCT03964415|455908663|FG001|Overall Study|Death|6|||
126715044|NCT03964415|455908662|FG000|Overall Study|Protocol Violation|1|||
126715045|NCT03964415|455908663|FG001|Overall Study|Protocol Violation|4|||
126715046|NCT03964415|455908662|FG000|Overall Study|Other|35|||
126715047|NCT03964415|455908663|FG001|Overall Study|Other|38|||
126715048|NCT03964415|455908662|FG000|Overall Study|Randomized but not treated|6|||
126715049|NCT03964415|455908663|FG001|Overall Study|Randomized but not treated|7|||
126715050|NCT01024465|455908664|FG000|Overall Study|Adverse Event|2|||
126715051|NCT01024465|455908664|FG000|Overall Study|Physician Decision|1|||
126715052|NCT01734993|455908665|FG000|Overall Study|Adverse Event|1|||
126715053|NCT01734993|455908665|FG000|Overall Study|Lack of Efficacy|1|||
126715054|NCT02086565|455908669|FG000|Overall Study|Lost to Follow-up|9|||
126715055|NCT02086565|455908670|FG001|Overall Study|Lost to Follow-up|7|||
126715056|NCT02086565|455908669|FG000|Overall Study|Withdrawal by Subject|2|||
126715057|NCT02086565|455908670|FG001|Overall Study|Withdrawal by Subject|1|||
126715058|NCT02086565|455908669|FG000|Overall Study|Death|3|||
126715059|NCT02086565|455908670|FG001|Overall Study|Death|2|||
126715060|NCT02086565|455908669|FG000|Overall Study|withdrawn by research team|2|||
126715061|NCT02086565|455908670|FG001|Overall Study|withdrawn by research team|2|||
126715062|NCT02116972|455908671|FG000|Overall Study|Adverse Event|4|||
126715063|NCT02116972|455908672|FG001|Overall Study|Adverse Event|4|||
126715064|NCT02116972|455908673|FG002|Overall Study|Adverse Event|1|||
126715065|NCT02116972|455908671|FG000|Overall Study|Withdrawal by Subject|1|||
126715066|NCT02116972|455908672|FG001|Overall Study|Withdrawal by Subject|1|||
126715067|NCT02116972|455908673|FG002|Overall Study|Withdrawal by Subject|5|||
126715068|NCT02116972|455908671|FG000|Overall Study|Protocol Violation|1|||
126715069|NCT02116972|455908672|FG001|Overall Study|Protocol Violation|0|||
126715070|NCT02116972|455908673|FG002|Overall Study|Protocol Violation|1|||
126715071|NCT02116972|455908671|FG000|Overall Study|Lost to Follow-up|4|||
126715072|NCT02116972|455908672|FG001|Overall Study|Lost to Follow-up|3|||
126715073|NCT02116972|455908673|FG002|Overall Study|Lost to Follow-up|1|||
126715074|NCT02116972|455908671|FG000|Overall Study|Lack of Efficacy|6|||
126715075|NCT02116972|455908672|FG001|Overall Study|Lack of Efficacy|6|||
126715076|NCT02116972|455908673|FG002|Overall Study|Lack of Efficacy|5|||
126715077|NCT02116972|455908671|FG000|Overall Study|scheduling conflicts and relocation|3|||
126645653|NCT00387426|455662046|FG000|Overall Study|Lack of Response|7|||
126645654|NCT00387426|455662046|FG000|Overall Study|Toxicities|4|||
126645655|NCT00387426|455662046|FG000|Overall Study|Disease Progression|3|||
126645656|NCT02218606|455662047|FG000|Overall Study|Adverse Event|1|||
126645657|NCT02218606|455662048|FG001|Overall Study|Adverse Event|1|||
126645658|NCT02218606|455662047|FG000|Overall Study|Death|15|||
126645659|NCT02218606|455662048|FG001|Overall Study|Death|28|||
126645660|NCT02218606|455662047|FG000|Overall Study|Physician Decision|0|||
126645661|NCT02218606|455662048|FG001|Overall Study|Physician Decision|1|||
126645662|NCT02218606|455662047|FG000|Overall Study|Withdrawal by Subject|4|||
126645663|NCT02218606|455662048|FG001|Overall Study|Withdrawal by Subject|0|||
126645664|NCT02218606|455662047|FG000|Overall Study|Noncompliance|1|||
126645665|NCT02218606|455662048|FG001|Overall Study|Noncompliance|0|||
126645666|NCT02218606|455662047|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
126645667|NCT02218606|455662048|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
126645668|NCT02218606|455662047|FG000|Overall Study|Other|2|||
126645669|NCT02218606|455662048|FG001|Overall Study|Other|1|||
126645670|NCT02218606|455662047|FG000|Overall Study|Never started treatment|0|||
126645671|NCT02218606|455662048|FG001|Overall Study|Never started treatment|1|||
126645672|NCT03203473|455662049|FG000|Induction Phase|Never started primary treatment|2|||
126645673|NCT03203473|455662050|FG001|Induction Phase|Never started primary treatment|0|||
126645674|NCT03203473|455662051|FG002|Induction Phase|Never started primary treatment|0|||
126645675|NCT03203473|455662049|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
126645676|NCT03203473|455662050|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
126645677|NCT03203473|455662051|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
126645678|NCT03203473|455662049|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
126645679|NCT03203473|455662050|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
126645680|NCT03203473|455662051|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
126645681|NCT03203473|455662049|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
126645682|NCT03203473|455662050|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
126645683|NCT03203473|455662051|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
126645684|NCT03203473|455662049|FG000|Arm Allocation Phase|started salvage therapy|0|||
126645685|NCT03203473|455662050|FG001|Arm Allocation Phase|started salvage therapy|5|||
126645686|NCT03203473|455662051|FG002|Arm Allocation Phase|started salvage therapy|0|||
126645687|NCT03203473|455662049|FG000|Arm Allocation Phase|Disease progression|0|||
126645688|NCT03203473|455662050|FG001|Arm Allocation Phase|Disease progression|0|||
126645689|NCT03203473|455662051|FG002|Arm Allocation Phase|Disease progression|37|||
126645690|NCT03203473|455662049|FG000|Arm Allocation Phase|Adverse Event|0|||
126645691|NCT03203473|455662050|FG001|Arm Allocation Phase|Adverse Event|0|||
126645692|NCT03203473|455662051|FG002|Arm Allocation Phase|Adverse Event|11|||
126645693|NCT03203473|455662049|FG000|Arm Allocation Phase|Physician Decision|0|||
126645694|NCT03203473|455662050|FG001|Arm Allocation Phase|Physician Decision|0|||
126645695|NCT03203473|455662051|FG002|Arm Allocation Phase|Physician Decision|3|||
126645696|NCT03203473|455662049|FG000|Arm Allocation Phase|Death|0|||
126645697|NCT03203473|455662050|FG001|Arm Allocation Phase|Death|0|||
126645698|NCT03203473|455662051|FG002|Arm Allocation Phase|Death|1|||
126645699|NCT03203473|455662049|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
126645700|NCT03203473|455662050|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
126645701|NCT03203473|455662051|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
126645702|NCT03203473|455662049|FG000|Arm Allocation Phase|Intercurrent illness|0|||
126645703|NCT03203473|455662050|FG001|Arm Allocation Phase|Intercurrent illness|0|||
126645704|NCT03203473|455662051|FG002|Arm Allocation Phase|Intercurrent illness|1|||
126645705|NCT03203473|455662049|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
126645706|NCT03203473|455662050|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
126645707|NCT03203473|455662051|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
126645708|NCT00890695|455662052|FG000|Overall Study|Protocol Violation|1|||
126645709|NCT00890695|455662053|FG001|Overall Study|Protocol Violation|0|||
126645710|NCT01531673|455662054|FG000|Overall Study|Non-Compliance|0|||
126645711|NCT01531673|455662055|FG001|Overall Study|Non-Compliance|0|||
126645712|NCT01531673|455662056|FG002|Overall Study|Non-Compliance|0|||
126645713|NCT01531673|455662057|FG003|Overall Study|Non-Compliance|0|||
126645714|NCT01531673|455662058|FG004|Overall Study|Non-Compliance|0|||
126645715|NCT01531673|455662059|FG005|Overall Study|Non-Compliance|1|||
126645716|NCT01531673|455662060|FG006|Overall Study|Non-Compliance|0|||
126645717|NCT01531673|455662061|FG007|Overall Study|Non-Compliance|0|||
126645718|NCT01531673|455662062|FG008|Overall Study|Non-Compliance|0|||
126645719|NCT01531673|455662063|FG009|Overall Study|Non-Compliance|0|||
126645720|NCT01531673|455662064|FG010|Overall Study|Non-Compliance|0|||
126645721|NCT01531673|455662065|FG011|Overall Study|Non-Compliance|0|||
126645722|NCT01531673|455662066|FG012|Overall Study|Non-Compliance|0|||
126645723|NCT01531673|455662054|FG000|Overall Study|Adverse Event|0|||
126645724|NCT01531673|455662055|FG001|Overall Study|Adverse Event|1|||
126645725|NCT01531673|455662056|FG002|Overall Study|Adverse Event|0|||
126645726|NCT01531673|455662057|FG003|Overall Study|Adverse Event|0|||
126645727|NCT01531673|455662058|FG004|Overall Study|Adverse Event|0|||
126645728|NCT01531673|455662059|FG005|Overall Study|Adverse Event|0|||
126645729|NCT01531673|455662060|FG006|Overall Study|Adverse Event|0|||
126645730|NCT01531673|455662061|FG007|Overall Study|Adverse Event|0|||
126645731|NCT01531673|455662062|FG008|Overall Study|Adverse Event|0|||
126645732|NCT01531673|455662063|FG009|Overall Study|Adverse Event|0|||
126645733|NCT01531673|455662064|FG010|Overall Study|Adverse Event|0|||
126645734|NCT01531673|455662065|FG011|Overall Study|Adverse Event|0|||
126645735|NCT01531673|455662066|FG012|Overall Study|Adverse Event|0|||
126645736|NCT01531673|455662054|FG000|Overall Study|Lost to Follow-up|0|||
126645737|NCT01531673|455662055|FG001|Overall Study|Lost to Follow-up|0|||
126645738|NCT01531673|455662056|FG002|Overall Study|Lost to Follow-up|0|||
126645739|NCT01531673|455662057|FG003|Overall Study|Lost to Follow-up|0|||
126645740|NCT01531673|455662058|FG004|Overall Study|Lost to Follow-up|1|||
126645741|NCT01531673|455662059|FG005|Overall Study|Lost to Follow-up|0|||
126645742|NCT01531673|455662060|FG006|Overall Study|Lost to Follow-up|0|||
126645743|NCT01531673|455662061|FG007|Overall Study|Lost to Follow-up|0|||
126645744|NCT01531673|455662062|FG008|Overall Study|Lost to Follow-up|0|||
126645745|NCT01531673|455662063|FG009|Overall Study|Lost to Follow-up|0|||
126645746|NCT01531673|455662064|FG010|Overall Study|Lost to Follow-up|0|||
126645747|NCT01531673|455662065|FG011|Overall Study|Lost to Follow-up|0|||
126645748|NCT01531673|455662066|FG012|Overall Study|Lost to Follow-up|0|||
126645749|NCT01531673|455662054|FG000|Overall Study|Other|0|||
126645750|NCT01531673|455662055|FG001|Overall Study|Other|0|||
126645751|NCT01531673|455662056|FG002|Overall Study|Other|0|||
126645752|NCT01531673|455662057|FG003|Overall Study|Other|1|||
126645753|NCT01531673|455662058|FG004|Overall Study|Other|0|||
126645754|NCT01531673|455662059|FG005|Overall Study|Other|0|||
126645755|NCT01531673|455662060|FG006|Overall Study|Other|0|||
126645756|NCT01531673|455662061|FG007|Overall Study|Other|0|||
126645757|NCT01531673|455662062|FG008|Overall Study|Other|0|||
126645758|NCT01531673|455662063|FG009|Overall Study|Other|1|||
126645759|NCT01531673|455662064|FG010|Overall Study|Other|0|||
126645760|NCT01531673|455662065|FG011|Overall Study|Other|0|||
126645761|NCT01531673|455662066|FG012|Overall Study|Other|0|||
126645762|NCT00568178|455662067|FG000|Double Blind Base Study|Adverse Event|0|||
126645763|NCT00568178|455662068|FG001|Double Blind Base Study|Adverse Event|2|||
126645764|NCT00568178|455662069|FG002|Double Blind Base Study|Adverse Event|1|||
126645765|NCT00568178|455662070|FG003|Double Blind Base Study|Adverse Event|2|||
126645766|NCT00568178|455662071|FG004|Double Blind Base Study|Adverse Event|0|||
126645767|NCT00568178|455662072|FG005|Double Blind Base Study|Adverse Event|0|||
126645768|NCT00568178|455662067|FG000|Double Blind Base Study|Lost to Follow-up|1|||
126645769|NCT00568178|455662068|FG001|Double Blind Base Study|Lost to Follow-up|0|||
126645770|NCT00568178|455662069|FG002|Double Blind Base Study|Lost to Follow-up|0|||
126645771|NCT00568178|455662070|FG003|Double Blind Base Study|Lost to Follow-up|1|||
126645772|NCT00568178|455662071|FG004|Double Blind Base Study|Lost to Follow-up|0|||
126645773|NCT00568178|455662072|FG005|Double Blind Base Study|Lost to Follow-up|0|||
126645774|NCT00568178|455662067|FG000|Double Blind Base Study|Physician Decision|1|||
126645775|NCT00568178|455662068|FG001|Double Blind Base Study|Physician Decision|1|||
126645776|NCT00568178|455662069|FG002|Double Blind Base Study|Physician Decision|0|||
126645777|NCT00568178|455662070|FG003|Double Blind Base Study|Physician Decision|1|||
126645778|NCT00568178|455662071|FG004|Double Blind Base Study|Physician Decision|0|||
126645779|NCT00568178|455662072|FG005|Double Blind Base Study|Physician Decision|0|||
126645780|NCT00568178|455662067|FG000|Double Blind Base Study|Protocol Violation|3|||
126645781|NCT00568178|455662068|FG001|Double Blind Base Study|Protocol Violation|2|||
126645782|NCT00568178|455662069|FG002|Double Blind Base Study|Protocol Violation|0|||
126645783|NCT00568178|455662070|FG003|Double Blind Base Study|Protocol Violation|0|||
126645784|NCT00568178|455662071|FG004|Double Blind Base Study|Protocol Violation|0|||
126645785|NCT00568178|455662072|FG005|Double Blind Base Study|Protocol Violation|0|||
126645786|NCT00568178|455662067|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
126645787|NCT00568178|455662068|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
126645788|NCT00568178|455662069|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
126645789|NCT00568178|455662070|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
126645790|NCT00568178|455662071|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
126645791|NCT00568178|455662072|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
126645792|NCT00568178|455662067|FG000|Double Blind Base Study|Progressive Disease|0|||
126645793|NCT00568178|455662068|FG001|Double Blind Base Study|Progressive Disease|0|||
126645794|NCT00568178|455662069|FG002|Double Blind Base Study|Progressive Disease|0|||
126645795|NCT00568178|455662070|FG003|Double Blind Base Study|Progressive Disease|1|||
126645796|NCT00568178|455662071|FG004|Double Blind Base Study|Progressive Disease|0|||
126645797|NCT00568178|455662072|FG005|Double Blind Base Study|Progressive Disease|0|||
126645798|NCT00568178|455662067|FG000|Open Label Extension|Adverse Event|0|||
126645799|NCT00568178|455662068|FG001|Open Label Extension|Adverse Event|0|||
126645800|NCT00568178|455662069|FG002|Open Label Extension|Adverse Event|0|||
126645801|NCT00568178|455662070|FG003|Open Label Extension|Adverse Event|0|||
126645802|NCT00568178|455662071|FG004|Open Label Extension|Adverse Event|11|||
126645803|NCT00568178|455662072|FG005|Open Label Extension|Adverse Event|8|||
126645804|NCT00568178|455662067|FG000|Open Label Extension|Protocol Violation|0|||
126645805|NCT00568178|455662068|FG001|Open Label Extension|Protocol Violation|0|||
126645806|NCT00568178|455662069|FG002|Open Label Extension|Protocol Violation|0|||
126645807|NCT00568178|455662070|FG003|Open Label Extension|Protocol Violation|0|||
126645808|NCT00568178|455662071|FG004|Open Label Extension|Protocol Violation|1|||
126645809|NCT00568178|455662072|FG005|Open Label Extension|Protocol Violation|0|||
126645810|NCT00568178|455662067|FG000|Open Label Extension|Lost to Follow-up|0|||
126645811|NCT00568178|455662068|FG001|Open Label Extension|Lost to Follow-up|0|||
126645812|NCT00568178|455662069|FG002|Open Label Extension|Lost to Follow-up|0|||
126645813|NCT00568178|455662070|FG003|Open Label Extension|Lost to Follow-up|0|||
126645814|NCT00568178|455662071|FG004|Open Label Extension|Lost to Follow-up|6|||
126645815|NCT00568178|455662072|FG005|Open Label Extension|Lost to Follow-up|11|||
126645816|NCT00568178|455662067|FG000|Open Label Extension|Physician Decision|0|||
126645817|NCT00568178|455662068|FG001|Open Label Extension|Physician Decision|0|||
126645818|NCT00568178|455662069|FG002|Open Label Extension|Physician Decision|0|||
126645819|NCT00568178|455662070|FG003|Open Label Extension|Physician Decision|0|||
126645820|NCT00568178|455662071|FG004|Open Label Extension|Physician Decision|9|||
126645821|NCT00568178|455662072|FG005|Open Label Extension|Physician Decision|8|||
126645822|NCT00568178|455662067|FG000|Open Label Extension|Pregnancy|0|||
126645823|NCT00568178|455662068|FG001|Open Label Extension|Pregnancy|0|||
126645824|NCT00568178|455662069|FG002|Open Label Extension|Pregnancy|0|||
126645825|NCT00568178|455662070|FG003|Open Label Extension|Pregnancy|0|||
126645826|NCT00568178|455662071|FG004|Open Label Extension|Pregnancy|0|||
126645827|NCT00568178|455662072|FG005|Open Label Extension|Pregnancy|1|||
126645828|NCT00568178|455662067|FG000|Open Label Extension|Progressive Disease|0|||
126645829|NCT00568178|455662068|FG001|Open Label Extension|Progressive Disease|0|||
126645830|NCT00568178|455662069|FG002|Open Label Extension|Progressive Disease|0|||
126645831|NCT00568178|455662070|FG003|Open Label Extension|Progressive Disease|0|||
126645832|NCT00568178|455662071|FG004|Open Label Extension|Progressive Disease|3|||
126645833|NCT00568178|455662072|FG005|Open Label Extension|Progressive Disease|1|||
126645834|NCT00568178|455662067|FG000|Open Label Extension|Termination of Trial|0|||
126645835|NCT00568178|455662068|FG001|Open Label Extension|Termination of Trial|0|||
126645836|NCT00568178|455662069|FG002|Open Label Extension|Termination of Trial|0|||
126645837|NCT00568178|455662070|FG003|Open Label Extension|Termination of Trial|0|||
126645838|NCT00568178|455662071|FG004|Open Label Extension|Termination of Trial|45|||
126645839|NCT00568178|455662072|FG005|Open Label Extension|Termination of Trial|47|||
126645840|NCT00568178|455662067|FG000|Open Label Extension|Withdrawal by Subject|0|||
126645841|NCT00568178|455662068|FG001|Open Label Extension|Withdrawal by Subject|0|||
126645842|NCT00568178|455662069|FG002|Open Label Extension|Withdrawal by Subject|0|||
126645843|NCT00568178|455662070|FG003|Open Label Extension|Withdrawal by Subject|0|||
126645844|NCT00568178|455662071|FG004|Open Label Extension|Withdrawal by Subject|4|||
126645845|NCT00568178|455662072|FG005|Open Label Extension|Withdrawal by Subject|4|||
126645846|NCT01008553|455662073|FG000|Period 1 (Titration Period)|Physician Decision|2|||
126645847|NCT01008553|455662074|FG001|Period 1 (Titration Period)|Physician Decision|0|||
126645848|NCT01008553|455662075|FG002|Period 1 (Titration Period)|Physician Decision|0|||
126645849|NCT01008553|455662073|FG000|Period 1 (Titration Period)|Adverse Event|33|||
126645850|NCT01008553|455662074|FG001|Period 1 (Titration Period)|Adverse Event|0|||
126645851|NCT01008553|455662075|FG002|Period 1 (Titration Period)|Adverse Event|0|||
126645852|NCT01008553|455662073|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
126645853|NCT01008553|455662074|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
126645854|NCT01008553|455662075|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
126645855|NCT01008553|455662073|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
126645856|NCT01008553|455662074|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
126645857|NCT01008553|455662075|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
126645858|NCT01008553|455662073|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
126645859|NCT01008553|455662074|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
126645860|NCT01008553|455662075|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
126645861|NCT01008553|455662073|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
126645862|NCT01008553|455662074|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
126645863|NCT01008553|455662075|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
126645864|NCT01008553|455662073|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
126645865|NCT01008553|455662074|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
126645866|NCT01008553|455662075|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
126645867|NCT01008553|455662073|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
126645868|NCT01008553|455662074|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
126645869|NCT01008553|455662075|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
126715196|NCT01052012|455908711|FG005|Overall Study|Physician Decision|1|||
126312826|NCT03671564|454435975|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
126306061|NCT02553499|454408875|FG006|Overall Study|Physician Decision|0|||
126312827|NCT03671564|454435976|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
126312828|NCT03671564|454435974|FG000|Overall Study|Withdrawal by Subject|1|||
126312829|NCT03671564|454435975|FG001|Overall Study|Withdrawal by Subject|1|||
126312830|NCT03671564|454435976|FG002|Overall Study|Withdrawal by Subject|0|||
126312831|NCT04739722|454435982|FG000|Overall Study|Lost to Follow-up|5301|||
126312832|NCT04739722|454435982|FG000|Overall Study|Withdrawal by Subject|42|||
126312833|NCT04739722|454435982|FG000|Overall Study|Non Average-risk|1157|||
126312834|NCT01185509|454435983|FG000|Overall Study|Progression/Relapse|9|||
126312835|NCT01185509|454435984|FG001|Overall Study|Progression/Relapse|15|||
126312836|NCT01185509|454435983|FG000|Overall Study|Physician Decision|2|||
126312837|NCT01185509|454435984|FG001|Overall Study|Physician Decision|2|||
126312838|NCT01185509|454435983|FG000|Overall Study|Withdrawal by Subject|0|||
126312839|NCT01185509|454435984|FG001|Overall Study|Withdrawal by Subject|1|||
126312840|NCT01185509|454435983|FG000|Overall Study|Death|0|||
126312841|NCT01185509|454435984|FG001|Overall Study|Death|1|||
126312842|NCT01185509|454435983|FG000|Overall Study|Intercurrent Illness|0|||
126312843|NCT01185509|454435984|FG001|Overall Study|Intercurrent Illness|1|||
126312844|NCT03687372|454435985|FG000|Overall Study|Lost to Follow-up|12|||
126312845|NCT03687372|454435986|FG001|Overall Study|Lost to Follow-up|21|||
126312846|NCT03687372|454435985|FG000|Overall Study|Withdrawal by Subject|4|||
126312847|NCT03687372|454435986|FG001|Overall Study|Withdrawal by Subject|17|||
126312848|NCT03687372|454435985|FG000|Overall Study|Investigator Decision|1|||
126312849|NCT03687372|454435986|FG001|Overall Study|Investigator Decision|1|||
126312850|NCT03419598|454435991|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
126312851|NCT02474589|454435992|FG000|Overall Study|Adverse Event|6|||
126312852|NCT02474589|454435993|FG001|Overall Study|Adverse Event|2|||
126312853|NCT02474589|454435992|FG000|Overall Study|Lost to Follow-up|6|||
126312854|NCT02474589|454435993|FG001|Overall Study|Lost to Follow-up|1|||
126312855|NCT02474589|454435992|FG000|Overall Study|Protocol Violation|4|||
126312856|NCT02474589|454435993|FG001|Overall Study|Protocol Violation|1|||
126312857|NCT02474589|454435992|FG000|Overall Study|Withdrawal by Subject|4|||
126312858|NCT02474589|454435993|FG001|Overall Study|Withdrawal by Subject|0|||
126312859|NCT02474589|454435992|FG000|Overall Study|Inability to complete study procedures|5|||
126312860|NCT02474589|454435993|FG001|Overall Study|Inability to complete study procedures|1|||
126312861|NCT01740128|454435994|FG000|Overall Study|Pregnancy|0|||
126312862|NCT01740128|454435995|FG001|Overall Study|Pregnancy|1|||
126312863|NCT01740128|454435994|FG000|Overall Study|Protocol Violation|1|||
126312864|NCT01740128|454435995|FG001|Overall Study|Protocol Violation|2|||
126312865|NCT01740128|454435994|FG000|Overall Study|Lost to Follow-up|2|||
126312866|NCT01740128|454435995|FG001|Overall Study|Lost to Follow-up|2|||
126312867|NCT01740128|454435994|FG000|Overall Study|Withdrawal by Subject|1|||
126312868|NCT01740128|454435995|FG001|Overall Study|Withdrawal by Subject|0|||
126312869|NCT01740128|454435994|FG000|Overall Study|Insufficient protocol compliance|2|||
126312870|NCT01740128|454435995|FG001|Overall Study|Insufficient protocol compliance|2|||
126312871|NCT02370667|454435998|FG000|Overall Study|Lost to Follow-up|0|||
126312872|NCT02370667|454435999|FG001|Overall Study|Lost to Follow-up|1|||
126312873|NCT02370667|454436000|FG002|Overall Study|Lost to Follow-up|0|||
126312874|NCT01546168|454436001|FG000|Overall Study|Lost to Follow-up|1|||
126312875|NCT01546168|454436002|FG001|Overall Study|Lost to Follow-up|0|||
126312876|NCT01546168|454436001|FG000|Overall Study|Withdrawal by Subject|1|||
126312877|NCT01546168|454436002|FG001|Overall Study|Withdrawal by Subject|0|||
126312878|NCT01546168|454436001|FG000|Overall Study|ineligible after signing consent|2|||
126312879|NCT01546168|454436002|FG001|Overall Study|ineligible after signing consent|0|||
126312880|NCT02954653|454436003|FG000|Overall Study|Death|3|||
126312881|NCT02954653|454436004|FG001|Overall Study|Death|1|||
126312882|NCT02954653|454436005|FG002|Overall Study|Death|0|||
126312883|NCT02954653|454436006|FG003|Overall Study|Death|0|||
126312884|NCT02954653|454436007|FG004|Overall Study|Death|0|||
126312885|NCT02954653|454436008|FG005|Overall Study|Death|0|||
126312886|NCT02954653|454436009|FG006|Overall Study|Death|0|||
126645870|NCT01008553|455662073|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
126645871|NCT01008553|455662074|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
126645872|NCT01008553|455662075|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
126312887|NCT02954653|454436010|FG007|Overall Study|Death|0|||
126312888|NCT02954653|454436011|FG008|Overall Study|Death|0|||
126312889|NCT02954653|454436003|FG000|Overall Study|Randomized but did not receive treatment|1|||
126312890|NCT02954653|454436004|FG001|Overall Study|Randomized but did not receive treatment|0|||
126312891|NCT02954653|454436005|FG002|Overall Study|Randomized but did not receive treatment|0|||
126312892|NCT02954653|454436006|FG003|Overall Study|Randomized but did not receive treatment|0|||
126312893|NCT02954653|454436007|FG004|Overall Study|Randomized but did not receive treatment|0|||
126312894|NCT02954653|454436008|FG005|Overall Study|Randomized but did not receive treatment|0|||
126312895|NCT02954653|454436009|FG006|Overall Study|Randomized but did not receive treatment|0|||
126312896|NCT02954653|454436010|FG007|Overall Study|Randomized but did not receive treatment|0|||
126312897|NCT02954653|454436011|FG008|Overall Study|Randomized but did not receive treatment|0|||
126312898|NCT02954653|454436003|FG000|Overall Study|Started another anti-cancer therapy|0|||
126312899|NCT02954653|454436004|FG001|Overall Study|Started another anti-cancer therapy|1|||
126312900|NCT02954653|454436005|FG002|Overall Study|Started another anti-cancer therapy|0|||
126312901|NCT02954653|454436006|FG003|Overall Study|Started another anti-cancer therapy|0|||
126312902|NCT02954653|454436007|FG004|Overall Study|Started another anti-cancer therapy|0|||
126312903|NCT02954653|454436008|FG005|Overall Study|Started another anti-cancer therapy|0|||
126312904|NCT02954653|454436009|FG006|Overall Study|Started another anti-cancer therapy|0|||
126312905|NCT02954653|454436010|FG007|Overall Study|Started another anti-cancer therapy|0|||
126312906|NCT02954653|454436011|FG008|Overall Study|Started another anti-cancer therapy|0|||
126312907|NCT02954653|454436003|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
126312908|NCT02954653|454436004|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
126312909|NCT02954653|454436005|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
126312910|NCT02954653|454436006|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
126312911|NCT02954653|454436007|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
126312912|NCT02954653|454436008|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
126312913|NCT02954653|454436009|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
126312914|NCT02954653|454436010|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
126312915|NCT02954653|454436011|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
126312916|NCT03054064|454436012|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
126312917|NCT03054064|454436012|FG000|Overall Study|Investigator Decision|2|||
126312918|NCT03054064|454436012|FG000|Overall Study|Bladder Issue|1|||
126312919|NCT03054064|454436012|FG000|Overall Study|High Blood Pressure|1|||
126312920|NCT03054064|454436012|FG000|Overall Study|Change in Status|1|||
126312921|NCT00471718|454436025|FG000|Overall Study|Adverse Event|3|||
126312922|NCT00471718|454436025|FG000|Overall Study|other complicating disease|1|||
126312923|NCT00471718|454436025|FG000|Overall Study|disease progression|22|||
126312924|NCT00471718|454436025|FG000|Overall Study|Withdrawal by Subject|1|||
126312925|NCT04696354|454436032|FG000|Overall Study|Study termination|6|||
126312926|NCT04696354|454436033|FG001|Overall Study|Study termination|6|||
126312927|NCT00965341|454436034|FG000|Overall Study|Withdrew consent|1|||
126312928|NCT00965341|454436035|FG001|Overall Study|Withdrew consent|5|||
126312929|NCT00965341|454436034|FG000|Overall Study|Lost to Follow-up|1|||
126312930|NCT00965341|454436035|FG001|Overall Study|Lost to Follow-up|0|||
126312931|NCT00965341|454436034|FG000|Overall Study|Transportation issues|4|||
126312932|NCT00965341|454436035|FG001|Overall Study|Transportation issues|3|||
126312933|NCT03057054|454436041|FG000|Overall Study|Death|4|||
126312934|NCT03057054|454436042|FG001|Overall Study|Death|4|||
126312935|NCT03057054|454436041|FG000|Overall Study|Withdrawal by Subject|6|||
126312936|NCT03057054|454436042|FG001|Overall Study|Withdrawal by Subject|3|||
126312937|NCT03057054|454436041|FG000|Overall Study|Ineligible|1|||
126312938|NCT03057054|454436042|FG001|Overall Study|Ineligible|1|||
126312939|NCT00960986|454436043|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
126312940|NCT00960986|454436044|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
126312941|NCT00960986|454436045|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
126312942|NCT00960986|454436046|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
126312943|NCT00960986|454436043|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
126312944|NCT00960986|454436044|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
126312945|NCT00960986|454436045|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
126312946|NCT00960986|454436046|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
126312947|NCT00960986|454436043|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
126312948|NCT00960986|454436044|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
126312949|NCT00960986|454436045|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
126312950|NCT00960986|454436046|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
126312951|NCT00960986|454436043|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
126312952|NCT00960986|454436044|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
126312953|NCT00960986|454436045|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
126312954|NCT00960986|454436046|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
126312955|NCT00960986|454436043|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
126645873|NCT01008553|455662073|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
126645874|NCT01008553|455662074|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
126645875|NCT01008553|455662075|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
126645876|NCT01008553|455662073|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
126645877|NCT01008553|455662074|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
126645878|NCT01008553|455662075|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
126645879|NCT01008553|455662073|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
126645880|NCT01008553|455662074|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
126645881|NCT01008553|455662075|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
126645882|NCT01008553|455662073|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
126645883|NCT01008553|455662074|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
126645884|NCT01008553|455662075|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
126645885|NCT01008553|455662073|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
126645886|NCT01008553|455662074|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
126645887|NCT01008553|455662075|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
126645888|NCT03563157|455662082|FG000|Overall Study|Progressive Disease|2|||
126645889|NCT02187159|455662083|FG000|Overall Study|Protocol Violation|4|||
126645890|NCT02187159|455662084|FG001|Overall Study|Protocol Violation|6|||
126645891|NCT02187159|455662085|FG002|Overall Study|Protocol Violation|3|||
126645892|NCT02187159|455662086|FG003|Overall Study|Protocol Violation|4|||
126645893|NCT02187159|455662083|FG000|Overall Study|Lack of Efficacy|10|||
126645894|NCT02187159|455662084|FG001|Overall Study|Lack of Efficacy|5|||
126645895|NCT02187159|455662085|FG002|Overall Study|Lack of Efficacy|4|||
126645896|NCT02187159|455662086|FG003|Overall Study|Lack of Efficacy|7|||
126645897|NCT02187159|455662083|FG000|Overall Study|Adverse Event|28|||
126645898|NCT02187159|455662084|FG001|Overall Study|Adverse Event|33|||
126312956|NCT00960986|454436044|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
126312957|NCT00960986|454436045|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
126312958|NCT00960986|454436046|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
126312959|NCT00960986|454436043|FG000|Period 3 (7-week Therapy Period)|Death|0|||
126312960|NCT00960986|454436044|FG001|Period 3 (7-week Therapy Period)|Death|0|||
126312961|NCT00960986|454436045|FG002|Period 3 (7-week Therapy Period)|Death|1|||
126312962|NCT00960986|454436046|FG003|Period 3 (7-week Therapy Period)|Death|0|||
126312963|NCT00960986|454436043|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
126312964|NCT00960986|454436044|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
126312965|NCT00960986|454436045|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
126312966|NCT00960986|454436046|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
126312967|NCT00960986|454436043|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
126312968|NCT00960986|454436044|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
126312969|NCT00960986|454436045|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
126312970|NCT00960986|454436046|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
126312971|NCT00960986|454436043|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
126312972|NCT00960986|454436044|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
126312973|NCT00960986|454436045|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
126312974|NCT00960986|454436046|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
126312975|NCT00960986|454436043|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
126312976|NCT00960986|454436044|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
126312977|NCT00960986|454436045|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
126312978|NCT00960986|454436046|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
126312979|NCT01077739|454436047|FG000|Overall Study|Premature withdrawal|1|||
126312980|NCT01077739|454436048|FG001|Overall Study|Premature withdrawal|3|||
126312981|NCT01077739|454436047|FG000|Overall Study|Withdrawal by Subject|1|||
126312982|NCT01077739|454436048|FG001|Overall Study|Withdrawal by Subject|0|||
126312983|NCT01077739|454436047|FG000|Overall Study|Death|0|||
126312984|NCT01077739|454436048|FG001|Overall Study|Death|3|||
126312985|NCT01077739|454436047|FG000|Overall Study|Unacceptable toxicity|1|||
126312986|NCT01077739|454436048|FG001|Overall Study|Unacceptable toxicity|2|||
126312987|NCT01077739|454436047|FG000|Overall Study|Other|2|||
126312988|NCT01077739|454436048|FG001|Overall Study|Other|2|||
126312989|NCT00877071|454436049|FG000|Overall Study|disease progression|2|||
126312990|NCT01984892|454436050|FG000|Overall Study|Progressive disease|7|||
126312991|NCT04464720|454436051|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
126312992|NCT05723328|454436057|FG000|Overall Study|Investigator's Decision|5|||
126312993|NCT05723328|454436058|FG001|Overall Study|Investigator's Decision|2|||
126312994|NCT00954512|454436062|FG000|Overall Study|Withdrawal by Subject|0|||
126312995|NCT00954512|454436063|FG001|Overall Study|Withdrawal by Subject|0|||
126312996|NCT00954512|454436064|FG002|Overall Study|Withdrawal by Subject|0|||
126312997|NCT00954512|454436065|FG003|Overall Study|Withdrawal by Subject|0|||
126312998|NCT00954512|454436066|FG004|Overall Study|Withdrawal by Subject|0|||
126312999|NCT00954512|454436067|FG005|Overall Study|Withdrawal by Subject|1|||
126313000|NCT00954512|454436062|FG000|Overall Study|Adverse Event|0|||
126313001|NCT00954512|454436063|FG001|Overall Study|Adverse Event|0|||
126313002|NCT00954512|454436064|FG002|Overall Study|Adverse Event|0|||
126313003|NCT00954512|454436065|FG003|Overall Study|Adverse Event|0|||
126313004|NCT00954512|454436066|FG004|Overall Study|Adverse Event|1|||
126313005|NCT00954512|454436067|FG005|Overall Study|Adverse Event|2|||
126313006|NCT00954512|454436062|FG000|Overall Study|Physician Decision|0|||
126313007|NCT00954512|454436063|FG001|Overall Study|Physician Decision|1|||
126313008|NCT00954512|454436064|FG002|Overall Study|Physician Decision|0|||
126313009|NCT00954512|454436065|FG003|Overall Study|Physician Decision|1|||
126313010|NCT00954512|454436066|FG004|Overall Study|Physician Decision|0|||
126313011|NCT00954512|454436067|FG005|Overall Study|Physician Decision|0|||
126313012|NCT00954512|454436062|FG000|Overall Study|Symptomatic Deterioration|0|||
126313013|NCT00954512|454436063|FG001|Overall Study|Symptomatic Deterioration|1|||
126313014|NCT00954512|454436064|FG002|Overall Study|Symptomatic Deterioration|0|||
126313015|NCT00954512|454436065|FG003|Overall Study|Symptomatic Deterioration|0|||
126313016|NCT00954512|454436066|FG004|Overall Study|Symptomatic Deterioration|2|||
126313017|NCT00954512|454436067|FG005|Overall Study|Symptomatic Deterioration|0|||
126313018|NCT00954512|454436062|FG000|Overall Study|Progression of Disease|2|||
126313019|NCT00954512|454436063|FG001|Overall Study|Progression of Disease|1|||
126313020|NCT00954512|454436064|FG002|Overall Study|Progression of Disease|0|||
126313021|NCT00954512|454436065|FG003|Overall Study|Progression of Disease|1|||
126313022|NCT00954512|454436066|FG004|Overall Study|Progression of Disease|1|||
126313023|NCT00954512|454436067|FG005|Overall Study|Progression of Disease|1|||
126313024|NCT01794793|454436068|FG000|Treatment Period|Withdrawal by Subject|24|||
126313025|NCT01794793|454436068|FG000|Treatment Period|Lack of Efficacy|22|||
126313026|NCT01794793|454436068|FG000|Treatment Period|Adverse Event|17|||
126313027|NCT01794793|454436068|FG000|Treatment Period|Physician Decision|14|||
126313028|NCT01794793|454436068|FG000|Treatment Period|Lost to Follow-up|7|||
126313029|NCT01794793|454436068|FG000|Treatment Period|Death|6|||
126313030|NCT01794793|454436068|FG000|Treatment Period|Protocol Violation|5|||
126313031|NCT01794793|454436068|FG000|Treatment Period|administrative problem|3|||
126313032|NCT01794793|454436068|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
126313033|NCT01794793|454436068|FG000|Post-treatment Follow-up|Adverse Event|8|||
126313034|NCT01794793|454436068|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
126313035|NCT01794793|454436068|FG000|Post-treatment Follow-up|administrative problem|5|||
126313036|NCT01794793|454436068|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
126313037|NCT01794793|454436068|FG000|Post-treatment Follow-up|Protocol Violation|3|||
126313038|NCT03495154|454436069|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
126313039|NCT03495154|454436069|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
126313040|NCT03495154|454436069|FG000|Overall Study|Screen Failures During Surgery|6|||
126313041|NCT03495154|454436069|FG000|Overall Study|Death|2|||
126313042|NCT03495154|454436069|FG000|Overall Study|Lost to Follow-up|16|||
126313043|NCT03495154|454436069|FG000|Overall Study|Withdrawal by Subject|2|||
126313044|NCT03495154|454436069|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
126313045|NCT05685732|454436070|FG000|Overall Study|Withdrawal by Subject|2|||
126313046|NCT05685732|454436071|FG001|Overall Study|Withdrawal by Subject|0|||
126313047|NCT05685732|454436072|FG002|Overall Study|Withdrawal by Subject|2|||
126313048|NCT05685732|454436073|FG003|Overall Study|Withdrawal by Subject|3|||
126313049|NCT05685732|454436070|FG000|Overall Study|Protocol Violation|1|||
126313050|NCT05685732|454436071|FG001|Overall Study|Protocol Violation|2|||
126313051|NCT05685732|454436072|FG002|Overall Study|Protocol Violation|4|||
126313052|NCT05685732|454436073|FG003|Overall Study|Protocol Violation|1|||
126313053|NCT05685732|454436070|FG000|Overall Study|Lost to Follow-up|5|||
126313054|NCT05685732|454436071|FG001|Overall Study|Lost to Follow-up|1|||
126313055|NCT05685732|454436072|FG002|Overall Study|Lost to Follow-up|3|||
126313056|NCT05685732|454436073|FG003|Overall Study|Lost to Follow-up|1|||
126313057|NCT05685732|454436070|FG000|Overall Study|Adverse Event|2|||
126313058|NCT05685732|454436071|FG001|Overall Study|Adverse Event|1|||
126313059|NCT05685732|454436072|FG002|Overall Study|Adverse Event|0|||
126313060|NCT05685732|454436073|FG003|Overall Study|Adverse Event|0|||
126313061|NCT05685732|454436070|FG000|Overall Study|Physician Decision|1|||
126313062|NCT05685732|454436071|FG001|Overall Study|Physician Decision|0|||
126313063|NCT05685732|454436072|FG002|Overall Study|Physician Decision|0|||
126313064|NCT05685732|454436073|FG003|Overall Study|Physician Decision|0|||
126313065|NCT02640404|454436074|FG000|Overall Study|Protocol Violation|1|||
126313066|NCT02640404|454436075|FG001|Overall Study|Protocol Violation|0|||
126313067|NCT02640404|454436074|FG000|Overall Study|Withdrawal by Subject|1|||
126313068|NCT02640404|454436075|FG001|Overall Study|Withdrawal by Subject|0|||
126313069|NCT05397171|454436076|FG000|Overall Study|Death|2|||
126313070|NCT05397171|454436077|FG001|Overall Study|Death|3|||
126313071|NCT05397171|454436078|FG002|Overall Study|Death|3|||
126313072|NCT05397171|454436076|FG000|Overall Study|Study Terminated By Sponsor|1|||
126313073|NCT05397171|454436077|FG001|Overall Study|Study Terminated By Sponsor|2|||
126313074|NCT05397171|454436078|FG002|Overall Study|Study Terminated By Sponsor|3|||
126313075|NCT05397171|454436076|FG000|Overall Study|Withdrawal by Subject|0|||
126313076|NCT05397171|454436077|FG001|Overall Study|Withdrawal by Subject|1|||
126313077|NCT05397171|454436078|FG002|Overall Study|Withdrawal by Subject|1|||
126313078|NCT02234596|454436079|FG000|Overall Study|Participant not treated|2|||
126313079|NCT02143791|454437508|FG000|Enrolled|Withdrawal by Subject|4|||
126313080|NCT02143791|454437508|FG000|Trial Stimulation|Lack of Efficacy|21|||
126313081|NCT02143791|454437508|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
126313082|NCT02143791|454437508|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
126313083|NCT02143791|454437508|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
126313084|NCT02143791|454437508|FG000|Any Programming (3-6 Months)|Missing Data|1|||
126313085|NCT02143791|454437508|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
126313086|NCT00401544|454437509|FG000|Overall Study|Adverse Event|5|||
126313087|NCT00401544|454437510|FG001|Overall Study|Adverse Event|1|||
126313088|NCT00401544|454437511|FG002|Overall Study|Adverse Event|1|||
126313089|NCT00401544|454437512|FG003|Overall Study|Adverse Event|1|||
126313090|NCT00401544|454437509|FG000|Overall Study|Death|3|||
126313091|NCT00401544|454437510|FG001|Overall Study|Death|6|||
126313092|NCT00401544|454437511|FG002|Overall Study|Death|2|||
126313093|NCT00401544|454437512|FG003|Overall Study|Death|5|||
126313094|NCT00401544|454437509|FG000|Overall Study|Lost to Follow-up|2|||
126313095|NCT00401544|454437510|FG001|Overall Study|Lost to Follow-up|0|||
126313096|NCT00401544|454437511|FG002|Overall Study|Lost to Follow-up|1|||
126313097|NCT00401544|454437512|FG003|Overall Study|Lost to Follow-up|1|||
126313098|NCT00401544|454437509|FG000|Overall Study|Withdrawal by Subject|7|||
126313099|NCT00401544|454437510|FG001|Overall Study|Withdrawal by Subject|6|||
126313100|NCT00401544|454437511|FG002|Overall Study|Withdrawal by Subject|6|||
126313101|NCT00401544|454437512|FG003|Overall Study|Withdrawal by Subject|5|||
126313102|NCT00401544|454437509|FG000|Overall Study|Physician Decision|1|||
126313103|NCT00401544|454437510|FG001|Overall Study|Physician Decision|3|||
126313104|NCT00401544|454437511|FG002|Overall Study|Physician Decision|0|||
126313105|NCT00401544|454437512|FG003|Overall Study|Physician Decision|0|||
126313106|NCT00401544|454437509|FG000|Overall Study|Ineligibility determined|0|||
126313107|NCT00401544|454437510|FG001|Overall Study|Ineligibility determined|1|||
126313108|NCT00401544|454437511|FG002|Overall Study|Ineligibility determined|0|||
126313109|NCT00401544|454437512|FG003|Overall Study|Ineligibility determined|2|||
126313110|NCT00401544|454437509|FG000|Overall Study|Disease progression|0|||
126313111|NCT00401544|454437510|FG001|Overall Study|Disease progression|1|||
126313112|NCT00401544|454437511|FG002|Overall Study|Disease progression|0|||
126313113|NCT00401544|454437512|FG003|Overall Study|Disease progression|0|||
126313114|NCT00401544|454437509|FG000|Overall Study|Other|0|||
126313115|NCT00401544|454437510|FG001|Overall Study|Other|0|||
126313116|NCT00401544|454437511|FG002|Overall Study|Other|2|||
126313117|NCT00401544|454437512|FG003|Overall Study|Other|2|||
126313118|NCT00878969|454437520|FG000|Overall Study|Physician Decision|5|||
126313119|NCT00878969|454437521|FG001|Overall Study|Physician Decision|3|||
126313120|NCT00878969|454437522|FG002|Overall Study|Physician Decision|2|||
126313121|NCT00878969|454437520|FG000|Overall Study|Withdrawal by Subject|1|||
126313122|NCT00878969|454437521|FG001|Overall Study|Withdrawal by Subject|6|||
126313123|NCT00878969|454437522|FG002|Overall Study|Withdrawal by Subject|3|||
126313124|NCT00878969|454437520|FG000|Overall Study|kidney transplant|2|||
126313125|NCT00878969|454437521|FG001|Overall Study|kidney transplant|3|||
126313126|NCT00878969|454437522|FG002|Overall Study|kidney transplant|2|||
126313127|NCT00878969|454437520|FG000|Overall Study|Adverse Event|3|||
126313128|NCT00878969|454437521|FG001|Overall Study|Adverse Event|1|||
126313129|NCT00878969|454437522|FG002|Overall Study|Adverse Event|2|||
126313130|NCT00878969|454437520|FG000|Overall Study|Lost to Follow-up|2|||
126313131|NCT00878969|454437521|FG001|Overall Study|Lost to Follow-up|1|||
126313132|NCT00878969|454437522|FG002|Overall Study|Lost to Follow-up|0|||
126313133|NCT00878969|454437520|FG000|Overall Study|Protocol Violation|2|||
126313134|NCT00878969|454437521|FG001|Overall Study|Protocol Violation|0|||
126313135|NCT00878969|454437522|FG002|Overall Study|Protocol Violation|0|||
126313136|NCT00878969|454437520|FG000|Overall Study|Death|0|||
126313137|NCT00878969|454437521|FG001|Overall Study|Death|0|||
126313138|NCT00878969|454437522|FG002|Overall Study|Death|2|||
126313139|NCT00878969|454437520|FG000|Overall Study|Pregnancy|0|||
126313140|NCT00878969|454437521|FG001|Overall Study|Pregnancy|1|||
126313141|NCT00878969|454437522|FG002|Overall Study|Pregnancy|0|||
126313142|NCT02083185|454437523|FG000|Overall Study|Lost to Follow-up|0|||
126313143|NCT02083185|454437524|FG001|Overall Study|Lost to Follow-up|3|||
126313144|NCT02083185|454437525|FG002|Overall Study|Lost to Follow-up|0|||
126313145|NCT02083185|454437523|FG000|Overall Study|Withdrawal by Subject|9|||
126313146|NCT02083185|454437524|FG001|Overall Study|Withdrawal by Subject|15|||
126313147|NCT02083185|454437525|FG002|Overall Study|Withdrawal by Subject|1|||
126313148|NCT02083185|454437523|FG000|Overall Study|Death|2|||
126313149|NCT02083185|454437524|FG001|Overall Study|Death|2|||
126313150|NCT02083185|454437525|FG002|Overall Study|Death|1|||
126313151|NCT02083185|454437523|FG000|Overall Study|Reason not Specified|9|||
126313152|NCT02083185|454437524|FG001|Overall Study|Reason not Specified|6|||
126313153|NCT02083185|454437525|FG002|Overall Study|Reason not Specified|5|||
126313154|NCT02083185|454437523|FG000|Overall Study|Study Terminated by Sponsor|0|||
126313155|NCT02083185|454437524|FG001|Overall Study|Study Terminated by Sponsor|1|||
126313156|NCT02083185|454437525|FG002|Overall Study|Study Terminated by Sponsor|0|||
126313157|NCT02083185|454437523|FG000|Overall Study|Did not Receive Study Drug|0|||
126313158|NCT02083185|454437524|FG001|Overall Study|Did not Receive Study Drug|2|||
126313159|NCT02083185|454437525|FG002|Overall Study|Did not Receive Study Drug|0|||
126313160|NCT01041976|454437526|FG000|Overall Study|Withdrawal by Subject|3|||
126313161|NCT01041976|454437527|FG001|Overall Study|Withdrawal by Subject|0|||
126313162|NCT01041976|454437526|FG000|Overall Study|Incarceration|2|||
126313163|NCT01041976|454437527|FG001|Overall Study|Incarceration|0|||
126313164|NCT01041976|454437526|FG000|Overall Study|Death|0|||
126313165|NCT01041976|454437527|FG001|Overall Study|Death|4|||
126313166|NCT00380081|454437528|FG000|Overall Study|Withdrawal by Subject|0|||
126313167|NCT00380081|454437529|FG001|Overall Study|Withdrawal by Subject|0|||
126645899|NCT02187159|455662085|FG002|Overall Study|Adverse Event|42|||
126313168|NCT00380081|454437530|FG002|Overall Study|Withdrawal by Subject|0|||
126313169|NCT00380081|454437531|FG003|Overall Study|Withdrawal by Subject|0|||
126313170|NCT00380081|454437532|FG004|Overall Study|Withdrawal by Subject|1|||
126313171|NCT00380081|454437533|FG005|Overall Study|Withdrawal by Subject|0|||
126313172|NCT00380081|454437528|FG000|Overall Study|Family Emergency|0|||
126313173|NCT00380081|454437529|FG001|Overall Study|Family Emergency|0|||
126313174|NCT00380081|454437530|FG002|Overall Study|Family Emergency|0|||
126313175|NCT00380081|454437531|FG003|Overall Study|Family Emergency|0|||
126313176|NCT00380081|454437532|FG004|Overall Study|Family Emergency|0|||
126313177|NCT00380081|454437533|FG005|Overall Study|Family Emergency|1|||
126313178|NCT02231879|454437534|FG000|Overall Study|Adverse Event|2|||
126313179|NCT02231879|454437535|FG001|Overall Study|Adverse Event|1|||
126313180|NCT02231879|454437534|FG000|Overall Study|Lack of Efficacy|0|||
126313181|NCT02231879|454437535|FG001|Overall Study|Lack of Efficacy|1|||
126313182|NCT03787303|454437536|FG000|Overall Study|Death|1|||
126313183|NCT03787303|454437536|FG000|Overall Study|Premature Termination of Study|1|||
126313184|NCT01384019|454437537|FG000|Overall Study|Withdrawal by Subject|3|||
126313185|NCT01384019|454437538|FG001|Overall Study|Withdrawal by Subject|0|||
126313186|NCT01384019|454437537|FG000|Overall Study|Death|1|||
126313187|NCT01384019|454437538|FG001|Overall Study|Death|0|||
126313188|NCT01384019|454437537|FG000|Overall Study|MRI refusal|6|||
126313189|NCT01384019|454437538|FG001|Overall Study|MRI refusal|6|||
126313190|NCT04489381|454437545|FG000|Overall Study|Lost to Follow-up|2|||
126313191|NCT04489381|454437546|FG001|Overall Study|Lost to Follow-up|3|||
126313192|NCT04489381|454437545|FG000|Overall Study|Withdrawal by Subject|1|||
126313193|NCT04489381|454437546|FG001|Overall Study|Withdrawal by Subject|0|||
126313194|NCT00070018|454437547|FG000|Overall Study|Adverse Event|2|||
126313195|NCT00070018|454437547|FG000|Overall Study|Lack of Efficacy|1|||
126313196|NCT00070018|454437547|FG000|Overall Study|Withdrawal by Subject|1|||
126313197|NCT02543892|454437548|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
126313198|NCT02543892|454437549|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
126313199|NCT02543892|454437550|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
126423693|NCT01236521|454847050|FG001|Overall Study|Withdrawal by Subject|17|||
126423694|NCT01236521|454847049|FG000|Overall Study|Death|2|||
126313200|NCT02543892|454437551|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
126313201|NCT02543892|454437552|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
126313202|NCT02543892|454437553|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
126313203|NCT02543892|454437554|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
126313204|NCT02543892|454437555|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
126313205|NCT02543892|454437548|FG000|Received Vaccination 2|Physician Decision|0|||
126313206|NCT02543892|454437549|FG001|Received Vaccination 2|Physician Decision|0|||
126313207|NCT02543892|454437550|FG002|Received Vaccination 2|Physician Decision|0|||
126313208|NCT02543892|454437551|FG003|Received Vaccination 2|Physician Decision|0|||
126313209|NCT02543892|454437552|FG004|Received Vaccination 2|Physician Decision|0|||
126313210|NCT02543892|454437553|FG005|Received Vaccination 2|Physician Decision|1|||
126313211|NCT02543892|454437554|FG006|Received Vaccination 2|Physician Decision|0|||
126313212|NCT02543892|454437555|FG007|Received Vaccination 2|Physician Decision|0|||
126313213|NCT02543892|454437548|FG000|Received Vaccination 2|Adverse Event|0|||
126313214|NCT02543892|454437549|FG001|Received Vaccination 2|Adverse Event|1|||
126313215|NCT02543892|454437550|FG002|Received Vaccination 2|Adverse Event|0|||
126423695|NCT01236521|454847050|FG001|Overall Study|Death|1|||
126423696|NCT01236521|454847049|FG000|Overall Study|Lost to Follow-up|9|||
126423697|NCT01236521|454847050|FG001|Overall Study|Lost to Follow-up|7|||
126423698|NCT04037891|454847051|FG000|Open-label Period|Withdrawal by Subject|1|||
126423699|NCT04037891|454847052|FG001|Open-label Period|Withdrawal by Subject|0|||
126423700|NCT04037891|454847053|FG002|Open-label Period|Withdrawal by Subject|0|||
126423701|NCT04037891|454847051|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
126423702|NCT04037891|454847052|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
126423703|NCT04037891|454847053|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
126423704|NCT03446313|454847054|FG000|Overall Study|Lost to Follow-up|1|||
126423705|NCT03446313|454847055|FG001|Overall Study|Lost to Follow-up|2|||
126423706|NCT03446313|454847054|FG000|Overall Study|Failed primary screening|3|||
126423707|NCT03446313|454847055|FG001|Overall Study|Failed primary screening|0|||
126423708|NCT03446313|454847054|FG000|Overall Study|Diagnosed with terminal cancer|1|||
126423709|NCT03446313|454847055|FG001|Overall Study|Diagnosed with terminal cancer|0|||
126423710|NCT03446313|454847054|FG000|Overall Study|Excluded from analysis|1|||
126423711|NCT03446313|454847055|FG001|Overall Study|Excluded from analysis|1|||
126423712|NCT05274958|454847056|FG000|Overall Study|Only completed 1 set of PROMs|22|||
126423713|NCT05274958|454847057|FG001|Overall Study|Only completed 1 set of PROMs|35|||
126423714|NCT04491136|454847062|FG000|Overall Study|Patient withdraw informed consent|9|||
126423715|NCT04491136|454847062|FG000|Overall Study|Adverse Event|2|||
126423716|NCT04491136|454847062|FG000|Overall Study|Death|3|||
126423717|NCT04491136|454847062|FG000|Overall Study|Lost to Follow-up|3|||
126423718|NCT04491136|454847062|FG000|Overall Study|Physician Decision|45|||
126423719|NCT04491136|454847062|FG000|Overall Study|sponsor terminated the study early|16|||
126423720|NCT04491136|454847062|FG000|Overall Study|Patient/guardian's decision|1|||
126313216|NCT02543892|454437551|FG003|Received Vaccination 2|Adverse Event|0|||
126313217|NCT02543892|454437552|FG004|Received Vaccination 2|Adverse Event|0|||
126313218|NCT02543892|454437553|FG005|Received Vaccination 2|Adverse Event|0|||
126313219|NCT02543892|454437554|FG006|Received Vaccination 2|Adverse Event|0|||
126313220|NCT02543892|454437555|FG007|Received Vaccination 2|Adverse Event|0|||
126313221|NCT02543892|454437548|FG000|Had Immunology Data|Withdrawal by Subject|0|||
126313222|NCT02543892|454437549|FG001|Had Immunology Data|Withdrawal by Subject|0|||
126313223|NCT02543892|454437550|FG002|Had Immunology Data|Withdrawal by Subject|0|||
126313224|NCT02543892|454437551|FG003|Had Immunology Data|Withdrawal by Subject|0|||
126313225|NCT02543892|454437552|FG004|Had Immunology Data|Withdrawal by Subject|0|||
126313226|NCT02543892|454437553|FG005|Had Immunology Data|Withdrawal by Subject|0|||
126313227|NCT02543892|454437554|FG006|Had Immunology Data|Withdrawal by Subject|1|||
126313228|NCT02543892|454437555|FG007|Had Immunology Data|Withdrawal by Subject|0|||
126313229|NCT00525902|454437556|FG000|Overall Study|Lack of Efficacy|1|||
126313230|NCT00985959|454437557|FG000|Overall Study|Adverse Event|0|||
126313231|NCT00985959|454437558|FG001|Overall Study|Adverse Event|0|||
126313232|NCT00985959|454437559|FG002|Overall Study|Adverse Event|19|||
126313233|NCT00985959|454437557|FG000|Overall Study|Withdrawal by Subject|0|||
126313234|NCT00985959|454437558|FG001|Overall Study|Withdrawal by Subject|0|||
126313235|NCT00985959|454437559|FG002|Overall Study|Withdrawal by Subject|8|||
126313236|NCT00985959|454437557|FG000|Overall Study|Progressive disease|1|||
126313237|NCT00985959|454437558|FG001|Overall Study|Progressive disease|2|||
126313238|NCT00985959|454437559|FG002|Overall Study|Progressive disease|8|||
126313239|NCT00985959|454437557|FG000|Overall Study|Unrecovered toxicity|0|||
126313240|NCT00985959|454437558|FG001|Overall Study|Unrecovered toxicity|0|||
126313241|NCT00985959|454437559|FG002|Overall Study|Unrecovered toxicity|7|||
126313242|NCT00985959|454437557|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
126313243|NCT00985959|454437558|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
126313244|NCT00985959|454437559|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
126313245|NCT00985959|454437557|FG000|Overall Study|Complete response observed over 2 cycles|0|||
126313246|NCT00985959|454437558|FG001|Overall Study|Complete response observed over 2 cycles|1|||
126313247|NCT00985959|454437559|FG002|Overall Study|Complete response observed over 2 cycles|4|||
126313248|NCT00985959|454437557|FG000|Overall Study|Other|0|||
126313249|NCT00985959|454437558|FG001|Overall Study|Other|0|||
126313250|NCT00985959|454437559|FG002|Overall Study|Other|11|||
126313251|NCT00976209|454437560|FG000|Treatment Period 1|Protocol Violation|1|||
126313252|NCT00976209|454437561|FG001|Treatment Period 1|Protocol Violation|0|||
126313253|NCT00976209|454437560|FG000|Treatment Period 1|Lost to Follow-up|2|||
126313254|NCT00976209|454437561|FG001|Treatment Period 1|Lost to Follow-up|0|||
126313255|NCT00976209|454437560|FG000|Treatment Period 1|Other|0|||
126313256|NCT00976209|454437561|FG001|Treatment Period 1|Other|1|||
126313257|NCT00976209|454437560|FG000|Wash-out Period|Adverse Event|1|||
126313258|NCT00976209|454437561|FG001|Wash-out Period|Adverse Event|2|||
126313259|NCT00976209|454437560|FG000|Wash-out Period|Lost to Follow-up|1|||
126313260|NCT00976209|454437561|FG001|Wash-out Period|Lost to Follow-up|0|||
126313261|NCT00976209|454437560|FG000|Wash-out Period|Protocol Violation|1|||
126313262|NCT00976209|454437561|FG001|Wash-out Period|Protocol Violation|0|||
126313263|NCT00976209|454437560|FG000|Wash-out Period|Other|1|||
126313264|NCT00976209|454437561|FG001|Wash-out Period|Other|0|||
126313265|NCT00976209|454437560|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126313266|NCT00976209|454437561|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126313267|NCT00976209|454437560|FG000|Treatment Period 2|Lost to Follow-up|0|||
126313268|NCT00976209|454437561|FG001|Treatment Period 2|Lost to Follow-up|1|||
126313269|NCT00844480|454437568|FG000|Overall Study|Withdrawal by Subject|2|||
126313270|NCT00844480|454437569|FG001|Overall Study|Withdrawal by Subject|3|||
126313271|NCT02858180|454437570|FG000|Overall Study|Lost to Follow-up|0|||
126313272|NCT02858180|454437571|FG001|Overall Study|Lost to Follow-up|2|||
126313273|NCT00979420|454437572|FG000|Overall Study|Adverse Event|1|||
126313274|NCT00979420|454437573|FG001|Overall Study|Adverse Event|0|||
126313275|NCT00979420|454437574|FG002|Overall Study|Adverse Event|0|||
126313276|NCT00979420|454437575|FG003|Overall Study|Adverse Event|0|||
126313277|NCT00979420|454437572|FG000|Overall Study|Lack of Efficacy|3|||
126313278|NCT00979420|454437573|FG001|Overall Study|Lack of Efficacy|0|||
126313279|NCT00979420|454437574|FG002|Overall Study|Lack of Efficacy|1|||
126313280|NCT00979420|454437575|FG003|Overall Study|Lack of Efficacy|1|||
126313281|NCT00979420|454437572|FG000|Overall Study|Other reasons not related to Viramune|3|||
126313282|NCT00979420|454437573|FG001|Overall Study|Other reasons not related to Viramune|0|||
126313283|NCT00979420|454437574|FG002|Overall Study|Other reasons not related to Viramune|0|||
126313284|NCT00979420|454437575|FG003|Overall Study|Other reasons not related to Viramune|1|||
126313285|NCT00526331|454437576|FG000|Overall Study|Sponsor Termination|55|||
126313286|NCT00574249|454437577|FG000|Overall Study|Adverse Event|6|||
126313287|NCT00574249|454437578|FG001|Overall Study|Adverse Event|18|||
126313288|NCT00574249|454437577|FG000|Overall Study|Lack of Efficacy|5|||
126313289|NCT00574249|454437578|FG001|Overall Study|Lack of Efficacy|3|||
126313290|NCT00574249|454437577|FG000|Overall Study|Lost to Follow-up|4|||
126313291|NCT00574249|454437578|FG001|Overall Study|Lost to Follow-up|3|||
126313292|NCT00574249|454437577|FG000|Overall Study|Protocol Violation|5|||
126313293|NCT00574249|454437578|FG001|Overall Study|Protocol Violation|2|||
126313294|NCT00574249|454437577|FG000|Overall Study|History of carcinoma|1|||
126313295|NCT00574249|454437578|FG001|Overall Study|History of carcinoma|0|||
126313296|NCT00574249|454437577|FG000|Overall Study|Withdrawal by Subject|3|||
126313297|NCT00574249|454437578|FG001|Overall Study|Withdrawal by Subject|0|||
126313298|NCT00574249|454437577|FG000|Overall Study|Physician Decision|1|||
126313299|NCT00574249|454437578|FG001|Overall Study|Physician Decision|0|||
126313300|NCT00574249|454437577|FG000|Overall Study|Pregnancy|1|||
126313301|NCT00574249|454437578|FG001|Overall Study|Pregnancy|0|||
126313302|NCT00574249|454437577|FG000|Overall Study|Excluded by company|0|||
126645900|NCT02187159|455662086|FG003|Overall Study|Adverse Event|50|||
126645901|NCT02187159|455662083|FG000|Overall Study|Withdrawal by Subject|24|||
126313303|NCT00574249|454437578|FG001|Overall Study|Excluded by company|1|||
126313304|NCT00574249|454437577|FG000|Overall Study|PPD test taken twice|0|||
126313305|NCT00574249|454437578|FG001|Overall Study|PPD test taken twice|1|||
126313306|NCT01259375|454437579|FG000|Overall Study|Adverse Event|1|||
126313307|NCT00478699|454437582|FG000|Overall Study|Inclusion Error|1|||
126313308|NCT00478699|454437583|FG001|Overall Study|Inclusion Error|7|||
126313309|NCT00478699|454437582|FG000|Overall Study|Not receive study treatment|6|||
126423721|NCT01611194|454847065|FG000|Overall Study|Lost to Follow-up|0|||
126423722|NCT01611194|454847066|FG001|Overall Study|Lost to Follow-up|1|||
126423723|NCT01611194|454847065|FG000|Overall Study|Withdrawal by Subject|0|||
126423724|NCT01611194|454847066|FG001|Overall Study|Withdrawal by Subject|1|||
126423725|NCT01611194|454847065|FG000|Overall Study|drug use|0|||
126423726|NCT01611194|454847066|FG001|Overall Study|drug use|1|||
126423727|NCT00452790|454847067|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
126423728|NCT00452790|454847068|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
126423729|NCT00452790|454847067|FG000|Infant Series|Parent/legal guardian request|8|||
126645902|NCT02187159|455662084|FG001|Overall Study|Withdrawal by Subject|28|||
126313310|NCT00478699|454437583|FG001|Overall Study|Not receive study treatment|30|||
126313311|NCT01043705|454437588|FG000|Overall Study|Death|28|||
126313312|NCT01043705|454437589|FG001|Overall Study|Death|60|||
126313313|NCT01043705|454437590|FG002|Overall Study|Death|26|||
126313314|NCT01043705|454437588|FG000|Overall Study|Lost to Follow-up|27|||
126313315|NCT01043705|454437589|FG001|Overall Study|Lost to Follow-up|12|||
126313316|NCT01043705|454437590|FG002|Overall Study|Lost to Follow-up|0|||
126313317|NCT01043705|454437588|FG000|Overall Study|Multiple Reasons|4|||
126313318|NCT01043705|454437589|FG001|Overall Study|Multiple Reasons|7|||
126313319|NCT01043705|454437590|FG002|Overall Study|Multiple Reasons|0|||
126313320|NCT01043705|454437588|FG000|Overall Study|Protocol Violation|2|||
126313321|NCT01043705|454437589|FG001|Overall Study|Protocol Violation|1|||
126313322|NCT01043705|454437590|FG002|Overall Study|Protocol Violation|0|||
126313323|NCT01043705|454437588|FG000|Overall Study|Withdrawal by Subject|8|||
126313324|NCT01043705|454437589|FG001|Overall Study|Withdrawal by Subject|6|||
126313325|NCT01043705|454437590|FG002|Overall Study|Withdrawal by Subject|0|||
126313326|NCT01043705|454437588|FG000|Overall Study|Site Closure|8|||
126313327|NCT01043705|454437589|FG001|Overall Study|Site Closure|0|||
126313328|NCT01043705|454437590|FG002|Overall Study|Site Closure|0|||
126313329|NCT01043705|454437588|FG000|Overall Study|Subsequent Procedure|9|||
126313330|NCT01043705|454437589|FG001|Overall Study|Subsequent Procedure|24|||
126313331|NCT01043705|454437590|FG002|Overall Study|Subsequent Procedure|29|||
126313332|NCT01043705|454437588|FG000|Overall Study|Adverse Event|0|||
126313333|NCT01043705|454437589|FG001|Overall Study|Adverse Event|2|||
126313334|NCT01043705|454437590|FG002|Overall Study|Adverse Event|0|||
126313335|NCT01043705|454437588|FG000|Overall Study|Screen Fail|21|||
126313336|NCT01043705|454437589|FG001|Overall Study|Screen Fail|0|||
126313337|NCT01043705|454437590|FG002|Overall Study|Screen Fail|0|||
126313338|NCT01043705|454437588|FG000|Overall Study|Other|0|||
126313339|NCT01043705|454437589|FG001|Overall Study|Other|19|||
126313340|NCT01043705|454437590|FG002|Overall Study|Other|25|||
126313341|NCT00581542|454437592|FG000|Overall Study|they met an exclusion criteria|2|||
126313342|NCT00581542|454437593|FG001|Overall Study|they met an exclusion criteria|2|||
126313343|NCT00581542|454437592|FG000|Overall Study|Lost to Follow-up|9|||
126313344|NCT00581542|454437593|FG001|Overall Study|Lost to Follow-up|21|||
126313345|NCT00656851|454437595|FG000|Overall Study|Withdrawal by Subject|0|||
126313346|NCT00656851|454437596|FG001|Overall Study|Withdrawal by Subject|4|||
126313347|NCT01123941|454437597|FG000|Overall Study|Lost to Follow-up|2|||
126313348|NCT01123941|454437598|FG001|Overall Study|Lost to Follow-up|1|||
126313349|NCT04601103|454437599|FG000|Overall Study|Needed crown & cleaning|0|||
126313350|NCT04601103|454437600|FG001|Overall Study|Needed crown & cleaning|0|||
126313351|NCT04601103|454437601|FG002|Overall Study|Needed crown & cleaning|1|||
126313352|NCT04601103|454437599|FG000|Overall Study|study was terminated|18|||
126313353|NCT04601103|454437600|FG001|Overall Study|study was terminated|18|||
126313354|NCT04601103|454437601|FG002|Overall Study|study was terminated|16|||
126313355|NCT06011161|454437605|FG000|Overall Study|Withdrawal by Subject|2|||
126313356|NCT06011161|454437605|FG000|Overall Study|Lost to Follow-up|5|||
126313357|NCT03099694|454437606|FG000|Overall Study|Withdrawal by Subject|11|||
126313358|NCT03099694|454437607|FG001|Overall Study|Withdrawal by Subject|13|||
126313359|NCT03099694|454437606|FG000|Overall Study|Lost to Follow-up|9|||
126645903|NCT02187159|455662085|FG002|Overall Study|Withdrawal by Subject|25|||
126645904|NCT02187159|455662086|FG003|Overall Study|Withdrawal by Subject|26|||
126645905|NCT02187159|455662083|FG000|Overall Study|Other|3|||
126645906|NCT02187159|455662084|FG001|Overall Study|Other|7|||
126645907|NCT02187159|455662085|FG002|Overall Study|Other|3|||
126645908|NCT02187159|455662086|FG003|Overall Study|Other|9|||
126645909|NCT00567567|455662087|FG000|Overall Study|Adverse Event|0|||
126645910|NCT00567567|455662088|FG001|Overall Study|Adverse Event|2|||
126645911|NCT00567567|455662089|FG002|Overall Study|Adverse Event|5|||
126645912|NCT00567567|455662087|FG000|Overall Study|Death|8|||
126645913|NCT00567567|455662088|FG001|Overall Study|Death|1|||
126645914|NCT00567567|455662089|FG002|Overall Study|Death|5|||
126645915|NCT00567567|455662087|FG000|Overall Study|Lack of Efficacy|16|||
126645916|NCT00567567|455662088|FG001|Overall Study|Lack of Efficacy|17|||
126645917|NCT00567567|455662089|FG002|Overall Study|Lack of Efficacy|48|||
126645918|NCT00567567|455662087|FG000|Overall Study|Lost to Follow-up|0|||
126645919|NCT00567567|455662088|FG001|Overall Study|Lost to Follow-up|0|||
126645920|NCT00567567|455662089|FG002|Overall Study|Lost to Follow-up|1|||
126645921|NCT00567567|455662087|FG000|Overall Study|Physician Decision|16|||
126645922|NCT00567567|455662088|FG001|Overall Study|Physician Decision|18|||
126645923|NCT00567567|455662089|FG002|Overall Study|Physician Decision|84|||
126645924|NCT00567567|455662087|FG000|Overall Study|Withdrawal by Subject|0|||
126645925|NCT00567567|455662088|FG001|Overall Study|Withdrawal by Subject|0|||
126645926|NCT00567567|455662089|FG002|Overall Study|Withdrawal by Subject|2|||
126645927|NCT00567567|455662087|FG000|Overall Study|Ineligible|4|||
126645928|NCT00567567|455662088|FG001|Overall Study|Ineligible|0|||
126645929|NCT00567567|455662089|FG002|Overall Study|Ineligible|9|||
126645930|NCT00567567|455662087|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
126645931|NCT00567567|455662088|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
126645932|NCT00567567|455662089|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
126645933|NCT00567567|455662087|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
126645934|NCT00567567|455662088|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
126645935|NCT00567567|455662089|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
126645936|NCT00567567|455662087|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
126645937|NCT00567567|455662088|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
126645938|NCT00567567|455662089|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
126645939|NCT04335591|455662090|FG000|Overall Study|Adverse Event|5|||
126645940|NCT04335591|455662091|FG001|Overall Study|Adverse Event|2|||
126645941|NCT04335591|455662092|FG002|Overall Study|Adverse Event|3|||
126645942|NCT04335591|455662093|FG003|Overall Study|Adverse Event|2|||
126645943|NCT04335591|455662090|FG000|Overall Study|Protocol Violation|1|||
126645944|NCT04335591|455662091|FG001|Overall Study|Protocol Violation|0|||
126645945|NCT04335591|455662092|FG002|Overall Study|Protocol Violation|0|||
126645946|NCT04335591|455662093|FG003|Overall Study|Protocol Violation|0|||
126645947|NCT04335591|455662090|FG000|Overall Study|Withdrawal by Subject|8|||
126645948|NCT04335591|455662091|FG001|Overall Study|Withdrawal by Subject|4|||
126645949|NCT04335591|455662092|FG002|Overall Study|Withdrawal by Subject|4|||
126645950|NCT04335591|455662093|FG003|Overall Study|Withdrawal by Subject|5|||
126645951|NCT04335591|455662090|FG000|Overall Study|Subject planning pregnancy|0|||
126313360|NCT03099694|454437607|FG001|Overall Study|Lost to Follow-up|5|||
126313361|NCT02291601|454437608|FG000|Abdomen|Did not qualify|333|||
126313362|NCT02291601|454437609|FG001|Abdomen|Did not qualify|54|||
126313363|NCT02291601|454437610|FG002|Abdomen|Did not qualify|339|||
126313364|NCT02291601|454437608|FG000|Groin|Did not qualify|183|||
126313365|NCT02291601|454437609|FG001|Groin|Did not qualify|30|||
126313366|NCT02291601|454437610|FG002|Groin|Did not qualify|177|||
126313367|NCT00381043|454437611|FG000|Overall Study|Lost to Follow-up|8|||
126313368|NCT00381043|454437612|FG001|Overall Study|Lost to Follow-up|6|||
126313369|NCT00381043|454437611|FG000|Overall Study|Withdrawal by Subject|3|||
126313370|NCT00381043|454437612|FG001|Overall Study|Withdrawal by Subject|1|||
126313371|NCT00381043|454437611|FG000|Overall Study|wanted more care|0|||
126645952|NCT04335591|455662091|FG001|Overall Study|Subject planning pregnancy|1|||
126645953|NCT04335591|455662092|FG002|Overall Study|Subject planning pregnancy|0|||
126645954|NCT04335591|455662093|FG003|Overall Study|Subject planning pregnancy|0|||
126313372|NCT00381043|454437612|FG001|Overall Study|wanted more care|1|||
126313373|NCT00381043|454437611|FG000|Overall Study|incarcerated|1|||
126313374|NCT00381043|454437612|FG001|Overall Study|incarcerated|0|||
126313375|NCT03045276|454437615|FG000|Intervention Phase|Withdrawal by Subject|7|||
126645955|NCT04335591|455662090|FG000|Overall Study|Ukrainian Russian war conflict|4|||
126645956|NCT04335591|455662091|FG001|Overall Study|Ukrainian Russian war conflict|5|||
126645957|NCT04335591|455662092|FG002|Overall Study|Ukrainian Russian war conflict|2|||
126645958|NCT04335591|455662093|FG003|Overall Study|Ukrainian Russian war conflict|0|||
126645959|NCT03268603|455662094|FG000|Overall Study|Withdrawal by Subject|6|||
126645960|NCT03268603|455662094|FG000|Overall Study|Physician Decision|1|||
126645961|NCT03268603|455662094|FG000|Overall Study|Withdrawn due to disease progression|2|||
126313376|NCT03045276|454437616|FG001|Intervention Phase|Withdrawal by Subject|2|||
126313377|NCT03045276|454437617|FG002|Intervention Phase|Withdrawal by Subject|3|||
126313378|NCT03045276|454437618|FG003|Intervention Phase|Withdrawal by Subject|7|||
126313379|NCT03045276|454437615|FG000|Intervention Phase|Developed exclusionary criteria|3|||
126313380|NCT03045276|454437616|FG001|Intervention Phase|Developed exclusionary criteria|3|||
126313381|NCT03045276|454437617|FG002|Intervention Phase|Developed exclusionary criteria|0|||
126313382|NCT03045276|454437618|FG003|Intervention Phase|Developed exclusionary criteria|0|||
126313383|NCT03045276|454437615|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
126313384|NCT03045276|454437616|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
126313385|NCT03045276|454437617|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
126313386|NCT03045276|454437618|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
126313387|NCT03045276|454437615|FG000|Follow-Up Phase|Lost to Follow-up|0|||
126313388|NCT03045276|454437616|FG001|Follow-Up Phase|Lost to Follow-up|1|||
126313389|NCT03045276|454437617|FG002|Follow-Up Phase|Lost to Follow-up|0|||
126313390|NCT03045276|454437618|FG003|Follow-Up Phase|Lost to Follow-up|1|||
126313391|NCT03045276|454437615|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
126313392|NCT03045276|454437616|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
126313393|NCT03045276|454437617|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
126313394|NCT03045276|454437618|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
126313395|NCT01597375|454437619|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
126313396|NCT01597375|454437620|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
126313397|NCT01597375|454437619|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
126313398|NCT01597375|454437620|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
126313399|NCT01597375|454437619|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
126313400|NCT01597375|454437620|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
126645962|NCT02060370|455662095|FG000|Overall Study|Physician Decision|1|||
126645963|NCT00356408|455662096|FG000|Overall Study|Adverse Event|9|||
126645964|NCT00356408|455662096|FG000|Overall Study|Lack of Efficacy|36|||
126645965|NCT00356408|455662096|FG000|Overall Study|Lost to Follow-up|2|||
126645966|NCT00356408|455662096|FG000|Overall Study|Withdrawal by Subject|6|||
126645967|NCT00356408|455662096|FG000|Overall Study|Other: Principal investigator discretion|3|||
126645968|NCT00356408|455662096|FG000|Overall Study|Other: Sponsor request|1|||
126645969|NCT00356408|455662096|FG000|Overall Study|Other: Azathioprine stopped|1|||
126645970|NCT00356408|455662096|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
126645971|NCT00356408|455662096|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
126645972|NCT05775991|455662098|FG000|Overall Study|Withdrawal by Subject|0|||
126645973|NCT05775991|455662099|FG001|Overall Study|Withdrawal by Subject|0|||
126645974|NCT05775991|455662100|FG002|Overall Study|Withdrawal by Subject|2|||
126645975|NCT04514510|455662101|FG000|Overall Study|Lost to Follow-up|0|||
126645976|NCT04514510|455662102|FG001|Overall Study|Lost to Follow-up|1|||
126645977|NCT04514510|455662101|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
126645978|NCT04514510|455662102|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
126645979|NCT00406692|455662103|FG000|Overall Study|Withdrawal by Subject|4|||
126645980|NCT00406692|455662103|FG000|Overall Study|Physician Decision|1|||
126645981|NCT00406692|455662103|FG000|Overall Study|Adverse Event|1|||
126645982|NCT00406692|455662103|FG000|Overall Study|Lack of Efficacy|1|||
126645983|NCT01145898|455662104|FG000|3-year Treatment|medication change by treating physician|3|||
126645984|NCT01145898|455662105|FG001|3-year Treatment|medication change by treating physician|16|||
126645985|NCT00214019|455662106|FG000|Overall Study|Lost to Follow-up|11|||
126645986|NCT00214019|455662106|FG000|Overall Study|Withdrawal by Subject|2|||
126645987|NCT00214019|455662106|FG000|Overall Study|Screen Failed prior to randomization|17|||
126645988|NCT00842244|455662109|FG000|Overall Study|Death|3|||
126645989|NCT00842244|455662109|FG000|Overall Study|Withdrawal by Subject|1|||
126645990|NCT00842244|455662109|FG000|Overall Study|Other|17|||
126645991|NCT00403767|455662115|FG000|Overall Study|Adverse Event|993|||
126645992|NCT00403767|455662116|FG001|Overall Study|Adverse Event|919|||
126645993|NCT00403767|455662115|FG000|Overall Study|Non-compliant with study medication|134|||
126645994|NCT00403767|455662116|FG001|Overall Study|Non-compliant with study medication|164|||
126645995|NCT00403767|455662115|FG000|Overall Study|Consent withdrawn|671|||
126645996|NCT00403767|455662116|FG001|Overall Study|Consent withdrawn|673|||
126645997|NCT00403767|455662115|FG000|Overall Study|Investigator dec./not protocol-related|191|||
126645998|NCT00403767|455662116|FG001|Overall Study|Investigator dec./not protocol-related|178|||
126645999|NCT00403767|455662115|FG000|Overall Study|Lost to Follow-up|6|||
126313401|NCT01597375|454437619|FG000|Washout (2 Weeks)|Adverse Event|1|||
126313402|NCT01597375|454437620|FG001|Washout (2 Weeks)|Adverse Event|0|||
126313403|NCT01597375|454437619|FG000|Second Intervention|Failed to react at both Aspirin|1|||
126646000|NCT00403767|455662116|FG001|Overall Study|Lost to Follow-up|8|||
126646001|NCT00403767|455662115|FG000|Overall Study|Protocol Violation|142|||
126646002|NCT00403767|455662116|FG001|Overall Study|Protocol Violation|124|||
126646003|NCT00403767|455662115|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
126646004|NCT00403767|455662116|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
126646005|NCT00403767|455662115|FG000|Overall Study|Study terminated by sponsor|82|||
126646006|NCT00403767|455662116|FG001|Overall Study|Study terminated by sponsor|69|||
126646007|NCT00403767|455662115|FG000|Overall Study|Missing/incomplete data|1|||
126646008|NCT00403767|455662116|FG001|Overall Study|Missing/incomplete data|1|||
126313404|NCT01597375|454437620|FG001|Second Intervention|Failed to react at both Aspirin|1|||
126313405|NCT03379753|454437621|FG000|Overall Study|Withdrawal by Subject|2|||
126646009|NCT00436605|455662117|FG000|Overall Study|Protocol Violation|3|||
126646010|NCT01696045|455662120|FG000|Overall Study|Study drug toxicity|1|||
126646011|NCT01696045|455662121|FG001|Overall Study|Study drug toxicity|5|||
126646012|NCT01696045|455662120|FG000|Overall Study|Disease progression|2|||
126646013|NCT01696045|455662121|FG001|Overall Study|Disease progression|2|||
126646014|NCT02206061|455662122|FG000|Overall Study|Withdrawal by Subject|4|||
126646015|NCT02206061|455662123|FG001|Overall Study|Withdrawal by Subject|7|||
126646016|NCT02206061|455662124|FG002|Overall Study|Withdrawal by Subject|1|||
126646017|NCT02206061|455662122|FG000|Overall Study|Lost to Follow-up|14|||
126646018|NCT02206061|455662123|FG001|Overall Study|Lost to Follow-up|7|||
126646019|NCT02206061|455662124|FG002|Overall Study|Lost to Follow-up|20|||
126646020|NCT04445987|455662125|FG000|Overall Study|Adverse Event|0|||
126646021|NCT04445987|455662126|FG001|Overall Study|Adverse Event|0|||
126646022|NCT04445987|455662127|FG002|Overall Study|Adverse Event|1|||
126646023|NCT04445987|455662128|FG003|Overall Study|Adverse Event|0|||
126646024|NCT04445987|455662129|FG004|Overall Study|Adverse Event|4|||
126646025|NCT04445987|455662130|FG005|Overall Study|Adverse Event|0|||
126646026|NCT04445987|455662125|FG000|Overall Study|Lost to Follow-up|4|||
126646027|NCT04445987|455662126|FG001|Overall Study|Lost to Follow-up|3|||
126646028|NCT04445987|455662127|FG002|Overall Study|Lost to Follow-up|1|||
126646029|NCT04445987|455662128|FG003|Overall Study|Lost to Follow-up|1|||
126646030|NCT04445987|455662129|FG004|Overall Study|Lost to Follow-up|29|||
126646031|NCT04445987|455662130|FG005|Overall Study|Lost to Follow-up|0|||
126646032|NCT04445987|455662125|FG000|Overall Study|Physician Decision|0|||
126646033|NCT04445987|455662126|FG001|Overall Study|Physician Decision|0|||
126646034|NCT04445987|455662127|FG002|Overall Study|Physician Decision|0|||
126646035|NCT04445987|455662128|FG003|Overall Study|Physician Decision|0|||
126646036|NCT04445987|455662129|FG004|Overall Study|Physician Decision|1|||
126646037|NCT04445987|455662130|FG005|Overall Study|Physician Decision|0|||
126646038|NCT04445987|455662125|FG000|Overall Study|Protocol Violation|1|||
126646039|NCT04445987|455662126|FG001|Overall Study|Protocol Violation|0|||
126646040|NCT04445987|455662127|FG002|Overall Study|Protocol Violation|0|||
126646041|NCT04445987|455662128|FG003|Overall Study|Protocol Violation|0|||
126646042|NCT04445987|455662129|FG004|Overall Study|Protocol Violation|2|||
126646043|NCT04445987|455662130|FG005|Overall Study|Protocol Violation|0|||
126646044|NCT04445987|455662125|FG000|Overall Study|Withdrawal by Subject|4|||
126646045|NCT04445987|455662126|FG001|Overall Study|Withdrawal by Subject|0|||
126646046|NCT04445987|455662127|FG002|Overall Study|Withdrawal by Subject|1|||
126646047|NCT04445987|455662128|FG003|Overall Study|Withdrawal by Subject|0|||
126646048|NCT04445987|455662129|FG004|Overall Study|Withdrawal by Subject|18|||
126646049|NCT04445987|455662130|FG005|Overall Study|Withdrawal by Subject|1|||
126646050|NCT04445987|455662125|FG000|Overall Study|Other reason|0|||
126646051|NCT04445987|455662126|FG001|Overall Study|Other reason|0|||
126646052|NCT04445987|455662127|FG002|Overall Study|Other reason|1|||
126646053|NCT04445987|455662128|FG003|Overall Study|Other reason|0|||
126646054|NCT04445987|455662129|FG004|Overall Study|Other reason|2|||
126646055|NCT04445987|455662130|FG005|Overall Study|Other reason|0|||
126646056|NCT04531098|455662140|FG000|Stage I|Adverse Event|0|||
126646057|NCT04531098|455662141|FG001|Stage I|Adverse Event|0|||
126646058|NCT04531098|455662142|FG002|Stage I|Adverse Event|3|||
126646059|NCT04531098|455662140|FG000|Stage I|Protocol Violation|0|||
126646060|NCT04531098|455662141|FG001|Stage I|Protocol Violation|0|||
126646061|NCT04531098|455662142|FG002|Stage I|Protocol Violation|5|||
126646062|NCT04531098|455662140|FG000|Stage I|Withdrawal by Subject|0|||
126646063|NCT04531098|455662141|FG001|Stage I|Withdrawal by Subject|5|||
126646064|NCT04531098|455662142|FG002|Stage I|Withdrawal by Subject|10|||
126646065|NCT04531098|455662140|FG000|Stage II|Adverse Event|1|||
126646066|NCT04531098|455662141|FG001|Stage II|Adverse Event|2|||
126646067|NCT04531098|455662142|FG002|Stage II|Adverse Event|0|||
126646068|NCT04531098|455662140|FG000|Stage II|Protocol Violation|1|||
126646069|NCT04531098|455662141|FG001|Stage II|Protocol Violation|2|||
126646070|NCT04531098|455662142|FG002|Stage II|Protocol Violation|0|||
126646071|NCT04531098|455662140|FG000|Stage II|Withdrawal by Subject|3|||
126646072|NCT04531098|455662141|FG001|Stage II|Withdrawal by Subject|1|||
126646073|NCT04531098|455662142|FG002|Stage II|Withdrawal by Subject|0|||
126313406|NCT03379753|454437622|FG001|Overall Study|Withdrawal by Subject|1|||
126646074|NCT04531098|455662140|FG000|Stage II|Moved from study area|8|||
126646075|NCT04531098|455662141|FG001|Stage II|Moved from study area|5|||
126646076|NCT04531098|455662142|FG002|Stage II|Moved from study area|0|||
126646077|NCT02628028|455662143|FG000|Dosing Period|Withdrawal by Subject|0|||
126646078|NCT02628028|455662144|FG001|Dosing Period|Withdrawal by Subject|0|||
126646079|NCT02628028|455662145|FG002|Dosing Period|Withdrawal by Subject|1|||
126646080|NCT02628028|455662146|FG003|Dosing Period|Withdrawal by Subject|0|||
126646081|NCT02628028|455662147|FG004|Dosing Period|Withdrawal by Subject|2|||
126646082|NCT02628028|455662148|FG005|Dosing Period|Withdrawal by Subject|4|||
126646083|NCT02628028|455662149|FG006|Dosing Period|Withdrawal by Subject|1|||
126646084|NCT02628028|455662150|FG007|Dosing Period|Withdrawal by Subject|1|||
126646085|NCT02628028|455662143|FG000|Dosing Period|Adverse Event|0|||
126646086|NCT02628028|455662144|FG001|Dosing Period|Adverse Event|0|||
126646087|NCT02628028|455662145|FG002|Dosing Period|Adverse Event|0|||
126646088|NCT02628028|455662146|FG003|Dosing Period|Adverse Event|0|||
126646089|NCT02628028|455662147|FG004|Dosing Period|Adverse Event|2|||
126646090|NCT02628028|455662148|FG005|Dosing Period|Adverse Event|1|||
126646091|NCT02628028|455662149|FG006|Dosing Period|Adverse Event|3|||
126646092|NCT02628028|455662150|FG007|Dosing Period|Adverse Event|2|||
126646093|NCT02628028|455662143|FG000|Dosing Period|Death|0|||
126646094|NCT02628028|455662144|FG001|Dosing Period|Death|0|||
126646095|NCT02628028|455662145|FG002|Dosing Period|Death|0|||
126646096|NCT02628028|455662146|FG003|Dosing Period|Death|0|||
126646097|NCT02628028|455662147|FG004|Dosing Period|Death|0|||
126646098|NCT02628028|455662148|FG005|Dosing Period|Death|0|||
126646099|NCT02628028|455662149|FG006|Dosing Period|Death|0|||
126646100|NCT02628028|455662150|FG007|Dosing Period|Death|1|||
126646101|NCT02628028|455662143|FG000|Dosing Period|Lack of Efficacy|0|||
126646102|NCT02628028|455662144|FG001|Dosing Period|Lack of Efficacy|0|||
126646103|NCT02628028|455662145|FG002|Dosing Period|Lack of Efficacy|0|||
126646104|NCT02628028|455662146|FG003|Dosing Period|Lack of Efficacy|0|||
126646105|NCT02628028|455662147|FG004|Dosing Period|Lack of Efficacy|3|||
126646106|NCT02628028|455662148|FG005|Dosing Period|Lack of Efficacy|0|||
126646107|NCT02628028|455662149|FG006|Dosing Period|Lack of Efficacy|1|||
126646108|NCT02628028|455662150|FG007|Dosing Period|Lack of Efficacy|0|||
126646109|NCT02628028|455662143|FG000|Dosing Period|Study Terminated by Sponsor|0|||
126646110|NCT02628028|455662144|FG001|Dosing Period|Study Terminated by Sponsor|0|||
126646111|NCT02628028|455662145|FG002|Dosing Period|Study Terminated by Sponsor|0|||
126646112|NCT02628028|455662146|FG003|Dosing Period|Study Terminated by Sponsor|0|||
126646113|NCT02628028|455662147|FG004|Dosing Period|Study Terminated by Sponsor|7|||
126646114|NCT02628028|455662148|FG005|Dosing Period|Study Terminated by Sponsor|6|||
126646115|NCT02628028|455662149|FG006|Dosing Period|Study Terminated by Sponsor|7|||
126646116|NCT02628028|455662150|FG007|Dosing Period|Study Terminated by Sponsor|7|||
126646117|NCT02628028|455662143|FG000|Dosing Period|Physician Decision|0|||
126646118|NCT02628028|455662144|FG001|Dosing Period|Physician Decision|0|||
126646119|NCT02628028|455662145|FG002|Dosing Period|Physician Decision|0|||
126646120|NCT02628028|455662146|FG003|Dosing Period|Physician Decision|0|||
126646121|NCT02628028|455662147|FG004|Dosing Period|Physician Decision|0|||
126646122|NCT02628028|455662148|FG005|Dosing Period|Physician Decision|1|||
126646123|NCT02628028|455662149|FG006|Dosing Period|Physician Decision|0|||
126646124|NCT02628028|455662150|FG007|Dosing Period|Physician Decision|0|||
126646125|NCT02628028|455662143|FG000|Dosing Period|Site Terminated by Sponsor|0|||
126646126|NCT02628028|455662144|FG001|Dosing Period|Site Terminated by Sponsor|0|||
126646127|NCT02628028|455662145|FG002|Dosing Period|Site Terminated by Sponsor|0|||
126646128|NCT02628028|455662146|FG003|Dosing Period|Site Terminated by Sponsor|0|||
126646129|NCT02628028|455662147|FG004|Dosing Period|Site Terminated by Sponsor|0|||
126646130|NCT02628028|455662148|FG005|Dosing Period|Site Terminated by Sponsor|1|||
126646131|NCT02628028|455662149|FG006|Dosing Period|Site Terminated by Sponsor|1|||
126646132|NCT02628028|455662150|FG007|Dosing Period|Site Terminated by Sponsor|0|||
126646133|NCT02628028|455662143|FG000|Dosing Period|Lost to Follow-up|0|||
126646134|NCT02628028|455662144|FG001|Dosing Period|Lost to Follow-up|0|||
126646135|NCT02628028|455662145|FG002|Dosing Period|Lost to Follow-up|0|||
126646136|NCT02628028|455662146|FG003|Dosing Period|Lost to Follow-up|0|||
126646137|NCT02628028|455662147|FG004|Dosing Period|Lost to Follow-up|0|||
126646138|NCT02628028|455662148|FG005|Dosing Period|Lost to Follow-up|0|||
126646139|NCT02628028|455662149|FG006|Dosing Period|Lost to Follow-up|1|||
126646140|NCT02628028|455662150|FG007|Dosing Period|Lost to Follow-up|0|||
126646141|NCT02628028|455662143|FG000|Dosing Period|Other|0|||
126646142|NCT02628028|455662144|FG001|Dosing Period|Other|0|||
126646143|NCT02628028|455662145|FG002|Dosing Period|Other|0|||
126646144|NCT02628028|455662146|FG003|Dosing Period|Other|0|||
126646145|NCT02628028|455662147|FG004|Dosing Period|Other|2|||
126646146|NCT02628028|455662148|FG005|Dosing Period|Other|1|||
126646147|NCT02628028|455662149|FG006|Dosing Period|Other|2|||
126646148|NCT02628028|455662150|FG007|Dosing Period|Other|4|||
126646149|NCT02628028|455662143|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
126646150|NCT02628028|455662144|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
126646151|NCT02628028|455662145|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
126646152|NCT02628028|455662146|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
126646153|NCT02628028|455662147|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
126646154|NCT02628028|455662148|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
126646155|NCT02628028|455662149|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
126646156|NCT02628028|455662150|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
126646157|NCT02628028|455662143|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
126646158|NCT02628028|455662144|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
126646159|NCT02628028|455662145|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
126646160|NCT02628028|455662146|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
126646161|NCT02628028|455662147|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
126646162|NCT02628028|455662148|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
126646163|NCT02628028|455662149|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
126646164|NCT02628028|455662150|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
126646165|NCT02628028|455662143|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
126646166|NCT02628028|455662144|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
126646167|NCT02628028|455662145|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
126646168|NCT02628028|455662146|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
126646169|NCT02628028|455662147|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
126646170|NCT02628028|455662148|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
126646171|NCT02628028|455662149|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
126646172|NCT02628028|455662150|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
126646173|NCT02628028|455662143|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
126646174|NCT02628028|455662144|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
126646175|NCT02628028|455662145|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
126646176|NCT02628028|455662146|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
126646177|NCT02628028|455662147|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
126646178|NCT02628028|455662148|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
126646179|NCT02628028|455662149|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
126646180|NCT02628028|455662150|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
126646181|NCT02628028|455662143|FG000|Long-term Extension (LTE) Period|Other|0|||
126646182|NCT02628028|455662144|FG001|Long-term Extension (LTE) Period|Other|0|||
126646183|NCT02628028|455662145|FG002|Long-term Extension (LTE) Period|Other|0|||
126646184|NCT02628028|455662146|FG003|Long-term Extension (LTE) Period|Other|0|||
126646185|NCT02628028|455662147|FG004|Long-term Extension (LTE) Period|Other|0|||
126646186|NCT02628028|455662148|FG005|Long-term Extension (LTE) Period|Other|3|||
126646187|NCT02628028|455662149|FG006|Long-term Extension (LTE) Period|Other|4|||
126646188|NCT02628028|455662150|FG007|Long-term Extension (LTE) Period|Other|3|||
126646189|NCT02145468|455662151|FG000|Overall Study|Withdrawal by Subject|5|||
126646190|NCT02145468|455662152|FG001|Overall Study|Withdrawal by Subject|8|||
126646191|NCT04157400|455662153|FG000|Overall Study|Withdrawal by Subject|1|||
126646192|NCT04157400|455662153|FG000|Overall Study|Lost to Follow-up|3|||
126646193|NCT05543707|455662155|FG000|Overall Study|Study drug non-compliance/|5|||
126646194|NCT05543707|455662156|FG001|Overall Study|Study drug non-compliance/|0|||
126646195|NCT05543707|455662155|FG000|Overall Study|Withdrawal by Subject|1|||
126646196|NCT05543707|455662156|FG001|Overall Study|Withdrawal by Subject|1|||
126646197|NCT05543707|455662155|FG000|Overall Study|Adverse Event|1|||
126646198|NCT05543707|455662156|FG001|Overall Study|Adverse Event|0|||
126646199|NCT05543707|455662155|FG000|Overall Study|concurrent illness|0|||
126646200|NCT05543707|455662156|FG001|Overall Study|concurrent illness|1|||
126646201|NCT05543707|455662155|FG000|Overall Study|Pregnancy|1|||
126646202|NCT05543707|455662156|FG001|Overall Study|Pregnancy|1|||
126646203|NCT00186888|455662157|FG000|Overall Study|Toxicity|0|||
126646204|NCT00186888|455662158|FG001|Overall Study|Toxicity|1|||
126646205|NCT00186888|455662159|FG002|Overall Study|Toxicity|0|||
126646206|NCT00186888|455662157|FG000|Overall Study|Relapse or progression of disease|4|||
126646207|NCT00186888|455662158|FG001|Overall Study|Relapse or progression of disease|2|||
126646208|NCT00186888|455662159|FG002|Overall Study|Relapse or progression of disease|0|||
126646209|NCT02108964|455662160|FG000|Overall Study|Progressive disease|15|||
126646210|NCT02108964|455662161|FG001|Overall Study|Progressive disease|31|||
126646211|NCT02108964|455662162|FG002|Overall Study|Progressive disease|54|||
126646212|NCT02108964|455662163|FG003|Overall Study|Progressive disease|7|||
126646213|NCT02108964|455662164|FG004|Overall Study|Progressive disease|20|||
126646214|NCT02108964|455662165|FG005|Overall Study|Progressive disease|4|||
126646215|NCT02108964|455662166|FG006|Overall Study|Progressive disease|6|||
126646216|NCT02108964|455662167|FG007|Overall Study|Progressive disease|33|||
126646217|NCT02108964|455662160|FG000|Overall Study|Physician Decision|1|||
126646218|NCT02108964|455662161|FG001|Overall Study|Physician Decision|5|||
126646219|NCT02108964|455662162|FG002|Overall Study|Physician Decision|7|||
126646220|NCT02108964|455662163|FG003|Overall Study|Physician Decision|1|||
126646221|NCT02108964|455662164|FG004|Overall Study|Physician Decision|2|||
126646222|NCT02108964|455662165|FG005|Overall Study|Physician Decision|1|||
126646223|NCT02108964|455662166|FG006|Overall Study|Physician Decision|1|||
126646224|NCT02108964|455662167|FG007|Overall Study|Physician Decision|3|||
126646225|NCT02108964|455662160|FG000|Overall Study|Adverse Event|0|||
126646226|NCT02108964|455662161|FG001|Overall Study|Adverse Event|0|||
126646227|NCT02108964|455662162|FG002|Overall Study|Adverse Event|4|||
126646228|NCT02108964|455662163|FG003|Overall Study|Adverse Event|0|||
126646229|NCT02108964|455662164|FG004|Overall Study|Adverse Event|1|||
126646230|NCT02108964|455662165|FG005|Overall Study|Adverse Event|0|||
126646231|NCT02108964|455662166|FG006|Overall Study|Adverse Event|3|||
126646232|NCT02108964|455662167|FG007|Overall Study|Adverse Event|2|||
126646233|NCT02108964|455662160|FG000|Overall Study|Death|1|||
126646234|NCT02108964|455662161|FG001|Overall Study|Death|1|||
126646235|NCT02108964|455662162|FG002|Overall Study|Death|4|||
126646236|NCT02108964|455662163|FG003|Overall Study|Death|0|||
126646237|NCT02108964|455662164|FG004|Overall Study|Death|3|||
126646238|NCT02108964|455662165|FG005|Overall Study|Death|0|||
126646239|NCT02108964|455662166|FG006|Overall Study|Death|0|||
126313407|NCT03379753|454437621|FG000|Overall Study|not having correct procedure|1|||
126313408|NCT03379753|454437622|FG001|Overall Study|not having correct procedure|2|||
126313409|NCT03379753|454437621|FG000|Overall Study|No primary outcome|12|||
126313410|NCT03379753|454437622|FG001|Overall Study|No primary outcome|22|||
126313411|NCT00347919|454437623|FG000|Overall Study|Lost to Follow-up|11|||
126313412|NCT00347919|454437624|FG001|Overall Study|Lost to Follow-up|13|||
126313413|NCT00347919|454437625|FG002|Overall Study|Lost to Follow-up|0|||
126313414|NCT00347919|454437623|FG000|Overall Study|Withdrawal by Subject|6|||
126313415|NCT00347919|454437624|FG001|Overall Study|Withdrawal by Subject|8|||
126313416|NCT00347919|454437625|FG002|Overall Study|Withdrawal by Subject|0|||
126313417|NCT00347919|454437623|FG000|Overall Study|Physician Decision|1|||
126313418|NCT00347919|454437624|FG001|Overall Study|Physician Decision|1|||
126313419|NCT00347919|454437625|FG002|Overall Study|Physician Decision|0|||
126313420|NCT00347919|454437623|FG000|Overall Study|Sponsor terminated study|15|||
126313421|NCT00347919|454437624|FG001|Overall Study|Sponsor terminated study|10|||
126313422|NCT00347919|454437625|FG002|Overall Study|Sponsor terminated study|16|||
126313423|NCT00347919|454437623|FG000|Overall Study|Death|35|||
126313424|NCT00347919|454437624|FG001|Overall Study|Death|42|||
126313425|NCT00347919|454437625|FG002|Overall Study|Death|19|||
126313426|NCT00347919|454437623|FG000|Overall Study|Par. Started Other Treatment|1|||
126313427|NCT00347919|454437624|FG001|Overall Study|Par. Started Other Treatment|1|||
126313428|NCT00347919|454437625|FG002|Overall Study|Par. Started Other Treatment|1|||
126313429|NCT00347919|454437623|FG000|Overall Study|Missing|2|||
126313430|NCT00347919|454437624|FG001|Overall Study|Missing|1|||
126313431|NCT00347919|454437625|FG002|Overall Study|Missing|2|||
126313432|NCT01032239|454437626|FG000|Overall Study|Lost to Follow-up|3|||
126313433|NCT01032239|454437627|FG001|Overall Study|Lost to Follow-up|2|||
126313434|NCT01032239|454437626|FG000|Overall Study|Withdrawal by Subject|2|||
126313435|NCT01032239|454437627|FG001|Overall Study|Withdrawal by Subject|3|||
126313436|NCT01032239|454437626|FG000|Overall Study|Death|1|||
126313437|NCT01032239|454437627|FG001|Overall Study|Death|0|||
126313438|NCT01032239|454437626|FG000|Overall Study|Protocol Violation|1|||
126313439|NCT01032239|454437627|FG001|Overall Study|Protocol Violation|0|||
126313440|NCT01940900|454437632|FG000|Overall Study|Physician Decision|4|||
126313441|NCT01940900|454437633|FG001|Overall Study|Physician Decision|0|||
126313442|NCT01940900|454437632|FG000|Overall Study|Adverse Event|10|||
126313443|NCT01940900|454437633|FG001|Overall Study|Adverse Event|15|||
126313444|NCT01940900|454437632|FG000|Overall Study|Withdrawal by Subject|11|||
126313445|NCT01940900|454437633|FG001|Overall Study|Withdrawal by Subject|15|||
126313446|NCT01940900|454437632|FG000|Overall Study|Lost to Follow-up|1|||
126313447|NCT01940900|454437633|FG001|Overall Study|Lost to Follow-up|0|||
126313448|NCT01940900|454437632|FG000|Overall Study|Sponsor Decision|1|||
126313449|NCT01940900|454437633|FG001|Overall Study|Sponsor Decision|0|||
126313450|NCT01940900|454437632|FG000|Overall Study|subject non-compliance|1|||
126313451|NCT01940900|454437633|FG001|Overall Study|subject non-compliance|1|||
126313452|NCT01940900|454437632|FG000|Overall Study|other|1|||
126313453|NCT01940900|454437633|FG001|Overall Study|other|0|||
126313454|NCT02225366|454437636|FG000|Overall Study|Lack of Efficacy|1|||
126313455|NCT02225366|454437637|FG001|Overall Study|Lack of Efficacy|0|||
126313456|NCT04713592|454437642|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
126313457|NCT04713592|454437643|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
126313458|NCT04713592|454437644|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
126313459|NCT04713592|454437645|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
126313460|NCT04713592|454437642|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
126313461|NCT04713592|454437643|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
126313462|NCT04713592|454437644|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
126313463|NCT04713592|454437645|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
126313464|NCT04713592|454437642|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
126313465|NCT04713592|454437643|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
126313466|NCT04713592|454437644|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
126313467|NCT04713592|454437645|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
126313468|NCT04713592|454437642|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126313469|NCT04713592|454437643|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126313470|NCT04713592|454437644|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
126313471|NCT04713592|454437645|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
126313472|NCT04713592|454437642|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
126313473|NCT04713592|454437643|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
126313474|NCT04713592|454437644|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
126313475|NCT04713592|454437645|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
126313476|NCT04713592|454437642|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126313477|NCT04713592|454437643|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126313478|NCT04713592|454437644|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
126313479|NCT04713592|454437645|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
126313480|NCT04713592|454437642|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
126646240|NCT02108964|455662167|FG007|Overall Study|Death|2|||
126646241|NCT02108964|455662160|FG000|Overall Study|Subject/Guardian decision|0|||
126646242|NCT02108964|455662161|FG001|Overall Study|Subject/Guardian decision|1|||
126646243|NCT02108964|455662162|FG002|Overall Study|Subject/Guardian decision|4|||
126646244|NCT02108964|455662163|FG003|Overall Study|Subject/Guardian decision|0|||
126646245|NCT02108964|455662164|FG004|Overall Study|Subject/Guardian decision|2|||
126646246|NCT02108964|455662165|FG005|Overall Study|Subject/Guardian decision|0|||
126646247|NCT02108964|455662166|FG006|Overall Study|Subject/Guardian decision|1|||
126646248|NCT02108964|455662167|FG007|Overall Study|Subject/Guardian decision|2|||
126646249|NCT02108964|455662160|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126646250|NCT02108964|455662161|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126646251|NCT02108964|455662162|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126646252|NCT02108964|455662163|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126646253|NCT02108964|455662164|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126646254|NCT02108964|455662165|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126646255|NCT02108964|455662166|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
126646256|NCT02108964|455662167|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
126646257|NCT01214642|455662170|FG000|Overall Study|Progressive Disease|3|||
126646258|NCT01214642|455662171|FG001|Overall Study|Progressive Disease|2|||
126646259|NCT01214642|455662172|FG002|Overall Study|Progressive Disease|3|||
126646260|NCT01214642|455662173|FG003|Overall Study|Progressive Disease|5|||
126646261|NCT01214642|455662174|FG004|Overall Study|Progressive Disease|5|||
126646262|NCT01214642|455662175|FG005|Overall Study|Progressive Disease|3|||
126646263|NCT01214642|455662176|FG006|Overall Study|Progressive Disease|5|||
126646264|NCT01214642|455662177|FG007|Overall Study|Progressive Disease|3|||
126646265|NCT01214642|455662178|FG008|Overall Study|Progressive Disease|10|||
126646266|NCT01214642|455662179|FG009|Overall Study|Progressive Disease|2|||
126646267|NCT01214642|455662180|FG010|Overall Study|Progressive Disease|1|||
126646268|NCT01214642|455662181|FG011|Overall Study|Progressive Disease|4|||
126646269|NCT01214642|455662170|FG000|Overall Study|Adverse Event|0|||
126646270|NCT01214642|455662171|FG001|Overall Study|Adverse Event|1|||
126646271|NCT01214642|455662172|FG002|Overall Study|Adverse Event|0|||
126646272|NCT01214642|455662173|FG003|Overall Study|Adverse Event|0|||
126646273|NCT01214642|455662174|FG004|Overall Study|Adverse Event|0|||
126646274|NCT01214642|455662175|FG005|Overall Study|Adverse Event|0|||
126646275|NCT01214642|455662176|FG006|Overall Study|Adverse Event|1|||
126646276|NCT01214642|455662177|FG007|Overall Study|Adverse Event|0|||
126646277|NCT01214642|455662178|FG008|Overall Study|Adverse Event|0|||
126646278|NCT01214642|455662179|FG009|Overall Study|Adverse Event|1|||
126646279|NCT01214642|455662180|FG010|Overall Study|Adverse Event|1|||
126646280|NCT01214642|455662181|FG011|Overall Study|Adverse Event|0|||
126646281|NCT01214642|455662170|FG000|Overall Study|Death|0|||
126646282|NCT01214642|455662171|FG001|Overall Study|Death|0|||
126646283|NCT01214642|455662172|FG002|Overall Study|Death|1|||
126646284|NCT01214642|455662173|FG003|Overall Study|Death|0|||
126646285|NCT01214642|455662174|FG004|Overall Study|Death|0|||
126646286|NCT01214642|455662175|FG005|Overall Study|Death|0|||
126646287|NCT01214642|455662176|FG006|Overall Study|Death|0|||
126646288|NCT01214642|455662177|FG007|Overall Study|Death|0|||
126646289|NCT01214642|455662178|FG008|Overall Study|Death|0|||
126646290|NCT01214642|455662179|FG009|Overall Study|Death|0|||
126646291|NCT01214642|455662180|FG010|Overall Study|Death|1|||
126646292|NCT01214642|455662181|FG011|Overall Study|Death|0|||
126646293|NCT01214642|455662170|FG000|Overall Study|Withdrawal by Subject|0|||
126646294|NCT01214642|455662171|FG001|Overall Study|Withdrawal by Subject|0|||
126646295|NCT01214642|455662172|FG002|Overall Study|Withdrawal by Subject|1|||
126646296|NCT01214642|455662173|FG003|Overall Study|Withdrawal by Subject|0|||
126646297|NCT01214642|455662174|FG004|Overall Study|Withdrawal by Subject|0|||
126646298|NCT01214642|455662175|FG005|Overall Study|Withdrawal by Subject|0|||
126646299|NCT01214642|455662176|FG006|Overall Study|Withdrawal by Subject|0|||
126646300|NCT01214642|455662177|FG007|Overall Study|Withdrawal by Subject|0|||
126646301|NCT01214642|455662178|FG008|Overall Study|Withdrawal by Subject|3|||
126646302|NCT01214642|455662179|FG009|Overall Study|Withdrawal by Subject|1|||
126313481|NCT04713592|454437643|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
126313482|NCT04713592|454437644|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
126313483|NCT04713592|454437645|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
126646303|NCT01214642|455662180|FG010|Overall Study|Withdrawal by Subject|1|||
126646304|NCT01214642|455662181|FG011|Overall Study|Withdrawal by Subject|0|||
126313484|NCT03782298|454437646|FG000|Overall Study|Protocol Deviation|4|||
126313485|NCT01382225|454437656|FG000|Overall Study|Adverse Event|3|||
126646305|NCT01214642|455662170|FG000|Overall Study|Physician Decision|0|||
126646306|NCT01214642|455662171|FG001|Overall Study|Physician Decision|0|||
126646307|NCT01214642|455662172|FG002|Overall Study|Physician Decision|1|||
126646308|NCT01214642|455662173|FG003|Overall Study|Physician Decision|1|||
126646309|NCT01214642|455662174|FG004|Overall Study|Physician Decision|1|||
126646310|NCT01214642|455662175|FG005|Overall Study|Physician Decision|0|||
126646311|NCT01214642|455662176|FG006|Overall Study|Physician Decision|0|||
126646312|NCT01214642|455662177|FG007|Overall Study|Physician Decision|0|||
126646313|NCT01214642|455662178|FG008|Overall Study|Physician Decision|0|||
126646314|NCT01214642|455662179|FG009|Overall Study|Physician Decision|0|||
126646315|NCT01214642|455662180|FG010|Overall Study|Physician Decision|0|||
126646316|NCT01214642|455662181|FG011|Overall Study|Physician Decision|2|||
126646317|NCT02336451|455662182|FG000|Overall Study|Adverse Event|1|||
126646318|NCT02336451|455662183|FG001|Overall Study|Adverse Event|2|||
126646319|NCT02336451|455662184|FG002|Overall Study|Adverse Event|0|||
126646320|NCT02336451|455662185|FG003|Overall Study|Adverse Event|6|||
126646321|NCT02336451|455662186|FG004|Overall Study|Adverse Event|4|||
126646322|NCT02336451|455662182|FG000|Overall Study|Death|6|||
126646323|NCT02336451|455662183|FG001|Overall Study|Death|2|||
126646324|NCT02336451|455662184|FG002|Overall Study|Death|3|||
126646325|NCT02336451|455662185|FG003|Overall Study|Death|6|||
126646326|NCT02336451|455662186|FG004|Overall Study|Death|6|||
126646327|NCT02336451|455662182|FG000|Overall Study|Physician Decision|9|||
126646328|NCT02336451|455662183|FG001|Overall Study|Physician Decision|6|||
126646329|NCT02336451|455662184|FG002|Overall Study|Physician Decision|7|||
126646330|NCT02336451|455662185|FG003|Overall Study|Physician Decision|16|||
126646331|NCT02336451|455662186|FG004|Overall Study|Physician Decision|3|||
126646332|NCT02336451|455662182|FG000|Overall Study|Progressive disease|23|||
126646333|NCT02336451|455662183|FG001|Overall Study|Progressive disease|26|||
126646334|NCT02336451|455662184|FG002|Overall Study|Progressive disease|2|||
126646335|NCT02336451|455662185|FG003|Overall Study|Progressive disease|14|||
126646336|NCT02336451|455662186|FG004|Overall Study|Progressive disease|4|||
126646337|NCT02336451|455662182|FG000|Overall Study|Protocol Violation|1|||
126646338|NCT02336451|455662183|FG001|Overall Study|Protocol Violation|0|||
126646339|NCT02336451|455662184|FG002|Overall Study|Protocol Violation|0|||
126646340|NCT02336451|455662185|FG003|Overall Study|Protocol Violation|0|||
126646341|NCT02336451|455662186|FG004|Overall Study|Protocol Violation|0|||
126646342|NCT02336451|455662182|FG000|Overall Study|Patient/guardian decision|2|||
126646343|NCT02336451|455662183|FG001|Overall Study|Patient/guardian decision|4|||
126646344|NCT02336451|455662184|FG002|Overall Study|Patient/guardian decision|0|||
126646345|NCT02336451|455662185|FG003|Overall Study|Patient/guardian decision|2|||
126646346|NCT02336451|455662186|FG004|Overall Study|Patient/guardian decision|1|||
126646347|NCT02344290|455662191|FG000|Overall Study|Withdrawal by Subject|315|||
126646348|NCT02344290|455662192|FG001|Overall Study|Withdrawal by Subject|324|||
126646349|NCT02344290|455662191|FG000|Overall Study|Lost to Follow-up|258|||
126646350|NCT02344290|455662192|FG001|Overall Study|Lost to Follow-up|249|||
126646351|NCT02344290|455662191|FG000|Overall Study|Unable to get to clinic|69|||
126646352|NCT02344290|455662192|FG001|Overall Study|Unable to get to clinic|60|||
126646353|NCT02344290|455662191|FG000|Overall Study|Physician Decision|25|||
126646354|NCT02344290|455662192|FG001|Overall Study|Physician Decision|25|||
126646355|NCT02344290|455662191|FG000|Overall Study|Site Closure|15|||
126646356|NCT02344290|455662192|FG001|Overall Study|Site Closure|19|||
126646357|NCT02344290|455662191|FG000|Overall Study|Other|5|||
126646358|NCT02344290|455662192|FG001|Overall Study|Other|3|||
126646359|NCT04998812|455662193|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
126646360|NCT04998812|455662194|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
126646361|NCT04998812|455662193|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
126646362|NCT04998812|455662194|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
126646363|NCT04998812|455662193|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
126646364|NCT04998812|455662194|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
126646365|NCT04998812|455662193|FG000|Vaccination Period|Ongoing in study|23|||
126646366|NCT04998812|455662194|FG001|Vaccination Period|Ongoing in study|23|||
126646367|NCT03826030|455662195|FG000|Overall Study|Withdrawal by Subject|2|||
126646368|NCT03826030|455662196|FG001|Overall Study|Withdrawal by Subject|0|||
126646369|NCT03826030|455662197|FG002|Overall Study|Withdrawal by Subject|1|||
126646370|NCT03826030|455662195|FG000|Overall Study|Lost to Follow-up|1|||
126646371|NCT03826030|455662196|FG001|Overall Study|Lost to Follow-up|1|||
126646372|NCT03826030|455662197|FG002|Overall Study|Lost to Follow-up|1|||
126646373|NCT03826030|455662195|FG000|Overall Study|Too busy to return for visits|1|||
126646374|NCT03826030|455662196|FG001|Overall Study|Too busy to return for visits|0|||
126646375|NCT03826030|455662197|FG002|Overall Study|Too busy to return for visits|0|||
126646376|NCT04893460|455662202|FG000|Overall Study|Lost to Follow-up|18|||
126646377|NCT03820947|455662205|FG000|Overall Study|Physician Decision|0|||
126646378|NCT03820947|455662206|FG001|Overall Study|Physician Decision|1|||
126646379|NCT03820947|455662207|FG002|Overall Study|Physician Decision|1|||
126646380|NCT03820947|455662208|FG003|Overall Study|Physician Decision|0|||
126646381|NCT03820947|455662209|FG004|Overall Study|Physician Decision|3|||
126646382|NCT03820947|455662205|FG000|Overall Study|Withdrawal by Subject|6|||
126646383|NCT03820947|455662206|FG001|Overall Study|Withdrawal by Subject|10|||
126646384|NCT03820947|455662207|FG002|Overall Study|Withdrawal by Subject|3|||
126646385|NCT03820947|455662208|FG003|Overall Study|Withdrawal by Subject|8|||
126646386|NCT03820947|455662209|FG004|Overall Study|Withdrawal by Subject|5|||
126646387|NCT03820947|455662205|FG000|Overall Study|Procedure Not Attempted|0|||
126646388|NCT03820947|455662206|FG001|Overall Study|Procedure Not Attempted|2|||
126646389|NCT03820947|455662207|FG002|Overall Study|Procedure Not Attempted|1|||
126646390|NCT03820947|455662208|FG003|Overall Study|Procedure Not Attempted|0|||
126646391|NCT03820947|455662209|FG004|Overall Study|Procedure Not Attempted|0|||
126646392|NCT03820947|455662205|FG000|Overall Study|Other Exit|1|||
126646393|NCT03820947|455662206|FG001|Overall Study|Other Exit|3|||
126646394|NCT03820947|455662207|FG002|Overall Study|Other Exit|3|||
126646395|NCT03820947|455662208|FG003|Overall Study|Other Exit|3|||
126646396|NCT03820947|455662209|FG004|Overall Study|Other Exit|0|||
126646397|NCT03820947|455662205|FG000|Overall Study|Follow-up Not Done|10|||
126646398|NCT03820947|455662206|FG001|Overall Study|Follow-up Not Done|13|||
126646399|NCT03820947|455662207|FG002|Overall Study|Follow-up Not Done|2|||
126646400|NCT03820947|455662208|FG003|Overall Study|Follow-up Not Done|3|||
126646401|NCT03820947|455662209|FG004|Overall Study|Follow-up Not Done|12|||
126646402|NCT03820947|455662205|FG000|Overall Study|Death|0|||
126646403|NCT03820947|455662206|FG001|Overall Study|Death|0|||
126646404|NCT03820947|455662207|FG002|Overall Study|Death|0|||
126646405|NCT03820947|455662208|FG003|Overall Study|Death|0|||
126646406|NCT03820947|455662209|FG004|Overall Study|Death|9|||
126646407|NCT03820947|455662205|FG000|Overall Study|Lost to Follow-up|4|||
126646408|NCT03820947|455662206|FG001|Overall Study|Lost to Follow-up|6|||
126646409|NCT03820947|455662207|FG002|Overall Study|Lost to Follow-up|0|||
126646410|NCT03820947|455662208|FG003|Overall Study|Lost to Follow-up|0|||
126646411|NCT03820947|455662209|FG004|Overall Study|Lost to Follow-up|9|||
126646412|NCT05718466|455664105|FG000|Overall Study|Withdrawal by Subject|1|||
126646413|NCT05718466|455664106|FG001|Overall Study|Withdrawal by Subject|2|||
126646414|NCT05718466|455664105|FG000|Overall Study|Death|0|||
126646415|NCT05718466|455664106|FG001|Overall Study|Death|1|||
126646416|NCT01732822|455664111|FG000|Overall Study|Withdrawal by Subject|123|||
126646417|NCT01732822|455664112|FG001|Overall Study|Withdrawal by Subject|113|||
126646418|NCT01183260|455664113|FG000|Overall Study|Intraop screen failure|2|||
126646419|NCT01183260|455664114|FG001|Overall Study|Intraop screen failure|0|||
126646420|NCT01183260|455664113|FG000|Overall Study|Withdrawal by Subject|1|||
126646421|NCT01183260|455664114|FG001|Overall Study|Withdrawal by Subject|1|||
126646422|NCT01183260|455664113|FG000|Overall Study|Revised within 30 days|0|||
126646423|NCT01183260|455664114|FG001|Overall Study|Revised within 30 days|1|||
126646424|NCT01183260|455664113|FG000|Overall Study|Death|1|||
126646425|NCT01183260|455664114|FG001|Overall Study|Death|0|||
126646426|NCT01255631|455664115|FG000|Overall Study|poor enrollment, no data analyzed|9|||
126646427|NCT01255631|455664116|FG001|Overall Study|poor enrollment, no data analyzed|6|||
126646428|NCT02815579|455664126|FG000|Overall Study|Non-payment of loan down-payment|16|||
126646429|NCT02815579|455664127|FG001|Overall Study|Non-payment of loan down-payment|0|||
126646430|NCT02815579|455664126|FG000|Overall Study|Withdrawal by Subject|7|||
126646431|NCT02815579|455664127|FG001|Overall Study|Withdrawal by Subject|1|||
126646432|NCT02815579|455664126|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
126646433|NCT02815579|455664127|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
126646434|NCT02815579|455664126|FG000|Overall Study|Lost to Follow-up|7|||
126646435|NCT02815579|455664127|FG001|Overall Study|Lost to Follow-up|4|||
126646436|NCT02815579|455664126|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
126646437|NCT02815579|455664127|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
126646438|NCT02815579|455664126|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
126646439|NCT02815579|455664127|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
126646440|NCT02815579|455664126|FG000|Overall Study|Death|5|||
126646441|NCT02815579|455664127|FG001|Overall Study|Death|4|||
126646442|NCT02815579|455664126|FG000|Overall Study|Imprisoned|0|||
126646443|NCT02815579|455664127|FG001|Overall Study|Imprisoned|2|||
126646444|NCT02815579|455664126|FG000|Overall Study|Did not meet enrollment criteria|0|||
126646445|NCT02815579|455664127|FG001|Overall Study|Did not meet enrollment criteria|1|||
126646446|NCT00264303|455664128|FG000|Overall Study|Adverse Event|4|||
126646447|NCT00264303|455664129|FG001|Overall Study|Adverse Event|3|||
126646448|NCT00264303|455664128|FG000|Overall Study|Lack of Efficacy|10|||
126646449|NCT00264303|455664129|FG001|Overall Study|Lack of Efficacy|13|||
126646450|NCT00264303|455664128|FG000|Overall Study|Lost to Follow-up|3|||
126646451|NCT00264303|455664129|FG001|Overall Study|Lost to Follow-up|3|||
126646452|NCT00264303|455664128|FG000|Overall Study|Withdrawal by Subject|2|||
126646453|NCT00264303|455664129|FG001|Overall Study|Withdrawal by Subject|3|||
126646454|NCT00264303|455664128|FG000|Overall Study|Various reasons listed in study report|6|||
126646455|NCT00264303|455664129|FG001|Overall Study|Various reasons listed in study report|7|||
126646456|NCT02389452|455664130|FG000|Overall Study|Lost to Follow-up|13|||
126646457|NCT02389452|455664130|FG000|Overall Study|Adverse Event|1|||
126646458|NCT02389452|455664130|FG000|Overall Study|Withdrawal by Subject|5|||
126646459|NCT02389452|455664130|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
126646460|NCT02311673|455664131|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
126646461|NCT02311673|455664132|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
126646462|NCT02311673|455664133|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
126646463|NCT02311673|455664134|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
126646464|NCT00414908|455664140|FG000|Overall Study|Protocol Violation|1|||
126646465|NCT00414908|455664141|FG001|Overall Study|Protocol Violation|1|||
126646466|NCT00818168|455664142|FG000|Overall Study|Lack of Efficacy|18|||
126646467|NCT00818168|455664142|FG000|Overall Study|Pregnancy|2|||
126646468|NCT00818168|455664142|FG000|Overall Study|Withdrawal by Subject|16|||
126646469|NCT00818168|455664142|FG000|Overall Study|Lost to Follow-up|7|||
126646470|NCT00818168|455664142|FG000|Overall Study|Adverse Event|19|||
126646471|NCT00818168|455664142|FG000|Overall Study|Reason for Non-completion Not reported|6|||
126646472|NCT00818168|455664142|FG000|Overall Study|Participant Moved|2|||
126646473|NCT02040259|455664143|FG000|Overall Study|Death|280|||
126646474|NCT02040259|455664143|FG000|Overall Study|Lost to Follow-up|76|||
126646475|NCT02040259|455664143|FG000|Overall Study|Assessment not completed|3|||
126646476|NCT02040259|455664143|FG000|Overall Study|Withdrawal by Subject|4|||
126646477|NCT04476251|455664144|FG000|Overall Study|Not treated|1|||
126646478|NCT00316602|455664154|FG000|Overall Study|Withdrawal by Subject|3|||
126646479|NCT00316602|455664155|FG001|Overall Study|Withdrawal by Subject|2|||
126646480|NCT00316602|455664154|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
126646481|NCT00316602|455664155|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
126646482|NCT00316602|455664154|FG000|Overall Study|Adverse Event|1|||
126646483|NCT00316602|455664155|FG001|Overall Study|Adverse Event|0|||
126646484|NCT00316602|455664154|FG000|Overall Study|Other|3|||
126646485|NCT00316602|455664155|FG001|Overall Study|Other|6|||
126646486|NCT00626990|455664156|FG000|Overall Study|Lack of Efficacy|6|||
126646487|NCT00626990|455664157|FG001|Overall Study|Lack of Efficacy|7|||
126646488|NCT00626990|455664158|FG002|Overall Study|Lack of Efficacy|49|||
126646489|NCT00626990|455664159|FG003|Overall Study|Lack of Efficacy|40|||
126646490|NCT00626990|455664156|FG000|Overall Study|Adverse Event|1|||
126646491|NCT00626990|455664157|FG001|Overall Study|Adverse Event|7|||
126646492|NCT00626990|455664158|FG002|Overall Study|Adverse Event|14|||
126646493|NCT00626990|455664159|FG003|Overall Study|Adverse Event|28|||
126646494|NCT00626990|455664156|FG000|Overall Study|Death|0|||
126646495|NCT00626990|455664157|FG001|Overall Study|Death|1|||
126646496|NCT00626990|455664158|FG002|Overall Study|Death|0|||
126646497|NCT00626990|455664159|FG003|Overall Study|Death|0|||
126646498|NCT00626990|455664156|FG000|Overall Study|Withdrawal by Subject|3|||
126646499|NCT00626990|455664157|FG001|Overall Study|Withdrawal by Subject|1|||
126646500|NCT00626990|455664158|FG002|Overall Study|Withdrawal by Subject|5|||
126646501|NCT00626990|455664159|FG003|Overall Study|Withdrawal by Subject|11|||
126646502|NCT00626990|455664156|FG000|Overall Study|Protocol Violation|0|||
126646503|NCT00626990|455664157|FG001|Overall Study|Protocol Violation|1|||
126646504|NCT00626990|455664158|FG002|Overall Study|Protocol Violation|1|||
126646505|NCT00626990|455664159|FG003|Overall Study|Protocol Violation|0|||
126646506|NCT00626990|455664156|FG000|Overall Study|Various different reasons/missing|4|||
126646507|NCT00626990|455664157|FG001|Overall Study|Various different reasons/missing|8|||
126646508|NCT00626990|455664158|FG002|Overall Study|Various different reasons/missing|8|||
126646509|NCT00626990|455664159|FG003|Overall Study|Various different reasons/missing|16|||
126646510|NCT04138576|455664164|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
126646511|NCT01008410|455664166|FG000|Overall Study|Adverse Event|13|||
126646512|NCT01008410|455664167|FG001|Overall Study|Adverse Event|7|||
126646513|NCT01008410|455664166|FG000|Overall Study|Withdrawal by Subject|6|||
126646514|NCT01008410|455664167|FG001|Overall Study|Withdrawal by Subject|2|||
126646515|NCT01008410|455664166|FG000|Overall Study|Lost to Follow-up|1|||
126646516|NCT01008410|455664167|FG001|Overall Study|Lost to Follow-up|0|||
126646517|NCT01008410|455664166|FG000|Overall Study|Noncompliance|1|||
126646518|NCT01008410|455664167|FG001|Overall Study|Noncompliance|0|||
126646519|NCT01008410|455664166|FG000|Overall Study|Low Cortisol|2|||
126646520|NCT01008410|455664167|FG001|Overall Study|Low Cortisol|0|||
126646521|NCT01008410|455664166|FG000|Overall Study|Lack of Efficacy|2|||
126646522|NCT01008410|455664167|FG001|Overall Study|Lack of Efficacy|6|||
126646523|NCT01008410|455664166|FG000|Overall Study|Met Exclusion Criterion|0|||
126646524|NCT01008410|455664167|FG001|Overall Study|Met Exclusion Criterion|1|||
126646525|NCT03056300|455664168|FG000|Overall Study|Surgical reason per study protocol|3|||
126646526|NCT03248882|455664169|FG000|Overall Study|Adverse Event|3|||
126646527|NCT03248882|455664170|FG001|Overall Study|Adverse Event|3|||
126646528|NCT03248882|455664171|FG002|Overall Study|Adverse Event|2|||
126646529|NCT03248882|455664172|FG003|Overall Study|Adverse Event|6|||
126646530|NCT03248882|455664173|FG004|Overall Study|Adverse Event|9|||
126646531|NCT03248882|455664169|FG000|Overall Study|Lost to Follow-up|0|||
126646532|NCT03248882|455664170|FG001|Overall Study|Lost to Follow-up|0|||
126646533|NCT03248882|455664171|FG002|Overall Study|Lost to Follow-up|0|||
126646534|NCT03248882|455664172|FG003|Overall Study|Lost to Follow-up|0|||
126646535|NCT03248882|455664173|FG004|Overall Study|Lost to Follow-up|1|||
126646536|NCT03248882|455664169|FG000|Overall Study|Protocol Violation|2|||
126646537|NCT03248882|455664170|FG001|Overall Study|Protocol Violation|0|||
126646538|NCT03248882|455664171|FG002|Overall Study|Protocol Violation|2|||
126646539|NCT03248882|455664172|FG003|Overall Study|Protocol Violation|0|||
126646540|NCT03248882|455664173|FG004|Overall Study|Protocol Violation|1|||
126646541|NCT03248882|455664169|FG000|Overall Study|Withdrawal by Subject|2|||
126646542|NCT03248882|455664170|FG001|Overall Study|Withdrawal by Subject|2|||
126646543|NCT03248882|455664171|FG002|Overall Study|Withdrawal by Subject|3|||
126646544|NCT03248882|455664172|FG003|Overall Study|Withdrawal by Subject|4|||
126646545|NCT03248882|455664173|FG004|Overall Study|Withdrawal by Subject|2|||
126646546|NCT01656200|455664174|FG000|Overall Study|Withdrawal by Subject|1|||
126646547|NCT03174431|455664175|FG000|Overall Study|Withdrawal by Subject|14|||
126646548|NCT03174431|455664176|FG001|Overall Study|Withdrawal by Subject|11|||
126646549|NCT03174431|455664175|FG000|Overall Study|alternative treatment|2|||
126646550|NCT03174431|455664176|FG001|Overall Study|alternative treatment|0|||
126646551|NCT03174431|455664175|FG000|Overall Study|Lost to Follow-up|1|||
126646552|NCT03174431|455664176|FG001|Overall Study|Lost to Follow-up|5|||
126646553|NCT01867333|455664177|FG000|Overall Study|Withdrawal by Subject|1|||
126646554|NCT01867333|455664178|FG001|Overall Study|Withdrawal by Subject|0|||
126646555|NCT01867333|455664177|FG000|Overall Study|Adverse Event|1|||
126646556|NCT01867333|455664178|FG001|Overall Study|Adverse Event|0|||
126646557|NCT01867333|455664177|FG000|Overall Study|Participant choice|1|||
126646558|NCT01867333|455664178|FG001|Overall Study|Participant choice|2|||
126646559|NCT01867333|455664177|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
126313486|NCT01382225|454437657|FG001|Overall Study|Adverse Event|2|||
126313487|NCT01382225|454437656|FG000|Overall Study|Protocol Violation|2|||
126313488|NCT01382225|454437657|FG001|Overall Study|Protocol Violation|1|||
126313489|NCT01382225|454437656|FG000|Overall Study|Subject Withdrew Consent|5|||
126313490|NCT01382225|454437657|FG001|Overall Study|Subject Withdrew Consent|2|||
126313491|NCT01382225|454437656|FG000|Overall Study|Other|4|||
126313492|NCT01382225|454437657|FG001|Overall Study|Other|2|||
126313493|NCT01797081|454437658|FG000|Overall Study|Adverse Event|1|||
126313494|NCT01797081|454437659|FG001|Overall Study|Adverse Event|0|||
126313495|NCT01797081|454437660|FG002|Overall Study|Adverse Event|1|||
126313496|NCT01797081|454437661|FG003|Overall Study|Adverse Event|0|||
126313497|NCT01797081|454437658|FG000|Overall Study|Pregnancy|1|||
126313498|NCT01797081|454437659|FG001|Overall Study|Pregnancy|0|||
126313499|NCT01797081|454437660|FG002|Overall Study|Pregnancy|0|||
126313500|NCT01797081|454437661|FG003|Overall Study|Pregnancy|0|||
126313501|NCT01797081|454437658|FG000|Overall Study|Personal Reasons|12|||
126313502|NCT01797081|454437659|FG001|Overall Study|Personal Reasons|4|||
126313503|NCT01797081|454437660|FG002|Overall Study|Personal Reasons|4|||
126313504|NCT01797081|454437661|FG003|Overall Study|Personal Reasons|8|||
126313505|NCT01797081|454437658|FG000|Overall Study|Protocol Violation|0|||
126313506|NCT01797081|454437659|FG001|Overall Study|Protocol Violation|0|||
126313507|NCT01797081|454437660|FG002|Overall Study|Protocol Violation|0|||
126313508|NCT01797081|454437661|FG003|Overall Study|Protocol Violation|1|||
126313509|NCT02294175|454437669|FG000|Overall Study|Withdrawal by Subject|1|||
126313510|NCT02294175|454437670|FG001|Overall Study|Withdrawal by Subject|2|||
126313511|NCT02294175|454437669|FG000|Overall Study|pt taking excluded medication|3|||
126313512|NCT02294175|454437670|FG001|Overall Study|pt taking excluded medication|1|||
126313513|NCT02294175|454437669|FG000|Overall Study|Protocol Violation|1|||
126313514|NCT02294175|454437670|FG001|Overall Study|Protocol Violation|0|||
126313515|NCT02294175|454437669|FG000|Overall Study|Lost to Follow-up|0|||
126313516|NCT02294175|454437670|FG001|Overall Study|Lost to Follow-up|1|||
126313517|NCT02294175|454437669|FG000|Overall Study|wound healed|0|||
126313518|NCT02294175|454437670|FG001|Overall Study|wound healed|2|||
126313519|NCT02548351|454437671|FG000|Overall Study|Withdrawal by Subject|149|||
126313520|NCT02548351|454437672|FG001|Overall Study|Withdrawal by Subject|154|||
126313521|NCT02548351|454437673|FG002|Overall Study|Withdrawal by Subject|152|||
126313522|NCT02548351|454437671|FG000|Overall Study|Death|11|||
126313523|NCT02548351|454437672|FG001|Overall Study|Death|15|||
126313524|NCT02548351|454437673|FG002|Overall Study|Death|12|||
126313525|NCT02548351|454437671|FG000|Overall Study|Adverse Event|22|||
126313526|NCT02548351|454437672|FG001|Overall Study|Adverse Event|56|||
126313527|NCT02548351|454437673|FG002|Overall Study|Adverse Event|36|||
126313528|NCT02548351|454437671|FG000|Overall Study|Study Terminated by Sponsor|549|||
126646560|NCT01867333|455664178|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
126646561|NCT01867333|455664177|FG000|Overall Study|Death|0|||
126646562|NCT01867333|455664178|FG001|Overall Study|Death|1|||
126313529|NCT02548351|454437672|FG001|Overall Study|Study Terminated by Sponsor|509|||
126313530|NCT02548351|454437673|FG002|Overall Study|Study Terminated by Sponsor|528|||
126313531|NCT02548351|454437671|FG000|Overall Study|Site Closure|14|||
126313532|NCT02548351|454437672|FG001|Overall Study|Site Closure|5|||
126313533|NCT02548351|454437673|FG002|Overall Study|Site Closure|7|||
126313534|NCT02548351|454437671|FG000|Overall Study|Non-compliance with Study Drug|4|||
126313535|NCT02548351|454437672|FG001|Overall Study|Non-compliance with Study Drug|2|||
126313536|NCT02548351|454437673|FG002|Overall Study|Non-compliance with Study Drug|0|||
126313537|NCT02548351|454437671|FG000|Overall Study|Protocol Violation|2|||
126646563|NCT01867333|455664177|FG000|Overall Study|Physician Decision|3|||
126313538|NCT02548351|454437672|FG001|Overall Study|Protocol Violation|1|||
126313539|NCT02548351|454437673|FG002|Overall Study|Protocol Violation|2|||
126646564|NCT01867333|455664178|FG001|Overall Study|Physician Decision|2|||
126646565|NCT01867333|455664177|FG000|Overall Study|Switched to alternative treatment|1|||
126646566|NCT01867333|455664178|FG001|Overall Study|Switched to alternative treatment|0|||
126646567|NCT00951015|455664181|FG000|Randomization Phase 96 Week|Adverse Event|1|||
126646568|NCT00951015|455664182|FG001|Randomization Phase 96 Week|Adverse Event|1|||
126646569|NCT00951015|455664183|FG002|Randomization Phase 96 Week|Adverse Event|2|||
126646570|NCT00951015|455664184|FG003|Randomization Phase 96 Week|Adverse Event|5|||
126646571|NCT00951015|455664185|FG004|Randomization Phase 96 Week|Adverse Event|0|||
126646572|NCT00951015|455664181|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
126646573|NCT00951015|455664182|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
126646574|NCT00951015|455664183|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
126646575|NCT00951015|455664184|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
126646576|NCT00951015|455664185|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
126646577|NCT00951015|455664181|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
126646578|NCT00951015|455664182|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
126646579|NCT00951015|455664183|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
126646580|NCT00951015|455664184|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
126646581|NCT00951015|455664185|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
126646582|NCT00951015|455664181|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
126646583|NCT00951015|455664182|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
126646584|NCT00951015|455664183|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
126646585|NCT00951015|455664184|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
126646586|NCT00951015|455664185|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
126646587|NCT00951015|455664181|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
126646588|NCT00951015|455664182|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
126646589|NCT00951015|455664183|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
126646590|NCT00951015|455664184|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
126646591|NCT00951015|455664185|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
126646592|NCT00951015|455664181|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
126646593|NCT00951015|455664182|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
126646594|NCT00951015|455664183|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
126646595|NCT00951015|455664184|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
126646596|NCT00951015|455664185|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
126646597|NCT00951015|455664181|FG000|Open-label Phase|Adverse Event|0|||
126646598|NCT00951015|455664182|FG001|Open-label Phase|Adverse Event|0|||
126646599|NCT00951015|455664183|FG002|Open-label Phase|Adverse Event|0|||
126646600|NCT00951015|455664184|FG003|Open-label Phase|Adverse Event|0|||
126646601|NCT00951015|455664185|FG004|Open-label Phase|Adverse Event|3|||
126646602|NCT00951015|455664181|FG000|Open-label Phase|Lack of Efficacy|0|||
126646603|NCT00951015|455664182|FG001|Open-label Phase|Lack of Efficacy|0|||
126646604|NCT00951015|455664183|FG002|Open-label Phase|Lack of Efficacy|0|||
126646605|NCT00951015|455664184|FG003|Open-label Phase|Lack of Efficacy|0|||
126646606|NCT00951015|455664185|FG004|Open-label Phase|Lack of Efficacy|1|||
126646607|NCT00951015|455664181|FG000|Open-label Phase|Protocol Violation|0|||
126646608|NCT00951015|455664182|FG001|Open-label Phase|Protocol Violation|0|||
126646609|NCT00951015|455664183|FG002|Open-label Phase|Protocol Violation|0|||
126646610|NCT00951015|455664184|FG003|Open-label Phase|Protocol Violation|0|||
126646611|NCT00951015|455664185|FG004|Open-label Phase|Protocol Violation|12|||
126646612|NCT00951015|455664181|FG000|Open-label Phase|Lost to Follow-up|0|||
126646613|NCT00951015|455664182|FG001|Open-label Phase|Lost to Follow-up|0|||
126646614|NCT00951015|455664183|FG002|Open-label Phase|Lost to Follow-up|0|||
126646615|NCT00951015|455664184|FG003|Open-label Phase|Lost to Follow-up|0|||
126646616|NCT00951015|455664185|FG004|Open-label Phase|Lost to Follow-up|12|||
126646617|NCT00951015|455664181|FG000|Open-label Phase|Withdrawal by Subject|0|||
126646618|NCT00951015|455664182|FG001|Open-label Phase|Withdrawal by Subject|0|||
126646619|NCT00951015|455664183|FG002|Open-label Phase|Withdrawal by Subject|0|||
126646620|NCT00951015|455664184|FG003|Open-label Phase|Withdrawal by Subject|0|||
126646621|NCT00951015|455664185|FG004|Open-label Phase|Withdrawal by Subject|14|||
126646622|NCT00951015|455664181|FG000|Open-label Phase|Physician Decision|0|||
126646623|NCT00951015|455664182|FG001|Open-label Phase|Physician Decision|0|||
126646624|NCT00951015|455664183|FG002|Open-label Phase|Physician Decision|0|||
126646625|NCT00951015|455664184|FG003|Open-label Phase|Physician Decision|0|||
126646626|NCT00951015|455664185|FG004|Open-label Phase|Physician Decision|8|||
126646627|NCT03819634|455664187|FG000|Overall Study|Physician Decision|2|||
126646628|NCT01208103|455664188|FG000|Overall Study|Adverse Event|1|||
126646629|NCT01208103|455664188|FG000|Overall Study|Withdrawal by Subject|1|||
126646630|NCT00299494|455664189|FG000|Overall Study|Withdrawal by Subject|0|||
126646631|NCT00299494|455664190|FG001|Overall Study|Withdrawal by Subject|0|||
126646632|NCT00299494|455664191|FG002|Overall Study|Withdrawal by Subject|0|||
126646633|NCT00299494|455664192|FG003|Overall Study|Withdrawal by Subject|3|||
126646634|NCT00299494|455664193|FG004|Overall Study|Withdrawal by Subject|1|||
126646635|NCT00299494|455664194|FG005|Overall Study|Withdrawal by Subject|4|||
126646636|NCT00299494|455664189|FG000|Overall Study|Physician Decision|0|||
126646637|NCT00299494|455664190|FG001|Overall Study|Physician Decision|0|||
126646638|NCT00299494|455664191|FG002|Overall Study|Physician Decision|0|||
126646639|NCT00299494|455664192|FG003|Overall Study|Physician Decision|0|||
126646640|NCT00299494|455664193|FG004|Overall Study|Physician Decision|1|||
126646641|NCT00299494|455664194|FG005|Overall Study|Physician Decision|0|||
126646642|NCT00299494|455664189|FG000|Overall Study|Death|3|||
126646643|NCT00299494|455664190|FG001|Overall Study|Death|1|||
126646644|NCT00299494|455664191|FG002|Overall Study|Death|4|||
126646645|NCT00299494|455664192|FG003|Overall Study|Death|6|||
126646646|NCT00299494|455664193|FG004|Overall Study|Death|18|||
126646647|NCT00299494|455664194|FG005|Overall Study|Death|19|||
126646648|NCT00299494|455664189|FG000|Overall Study|Lost to Follow-up|0|||
126646649|NCT00299494|455664190|FG001|Overall Study|Lost to Follow-up|0|||
126646650|NCT00299494|455664191|FG002|Overall Study|Lost to Follow-up|0|||
126646651|NCT00299494|455664192|FG003|Overall Study|Lost to Follow-up|0|||
126646652|NCT00299494|455664193|FG004|Overall Study|Lost to Follow-up|3|||
126646653|NCT00299494|455664194|FG005|Overall Study|Lost to Follow-up|1|||
126646654|NCT00299494|455664189|FG000|Overall Study|Other - Unspecified|0|||
126646655|NCT00299494|455664190|FG001|Overall Study|Other - Unspecified|0|||
126646656|NCT00299494|455664191|FG002|Overall Study|Other - Unspecified|0|||
126646657|NCT00299494|455664192|FG003|Overall Study|Other - Unspecified|0|||
126646658|NCT00299494|455664193|FG004|Overall Study|Other - Unspecified|3|||
126646659|NCT00299494|455664194|FG005|Overall Study|Other - Unspecified|1|||
126646660|NCT00299494|455664189|FG000|Overall Study|Other - site closure|0|||
126646661|NCT00299494|455664190|FG001|Overall Study|Other - site closure|0|||
126646662|NCT00299494|455664191|FG002|Overall Study|Other - site closure|0|||
126646663|NCT00299494|455664192|FG003|Overall Study|Other - site closure|1|||
126646664|NCT00299494|455664193|FG004|Overall Study|Other - site closure|1|||
126646665|NCT00299494|455664194|FG005|Overall Study|Other - site closure|1|||
126646666|NCT00416195|455664195|FG000|Overall Study|Adverse Event|1|||
126646667|NCT00416195|455664196|FG001|Overall Study|Adverse Event|2|||
126646668|NCT00416195|455664195|FG000|Overall Study|Protocol Violation|1|||
126646669|NCT00416195|455664196|FG001|Overall Study|Protocol Violation|1|||
126646670|NCT00416195|455664195|FG000|Overall Study|Other|0|||
126646671|NCT00416195|455664196|FG001|Overall Study|Other|1|||
126646672|NCT01417104|455664201|FG000|Overall Study|Withdrawal by Subject|5|||
126646673|NCT01417104|455664202|FG001|Overall Study|Withdrawal by Subject|1|||
126646674|NCT01417104|455664201|FG000|Overall Study|Failure to make contact|0|||
126646675|NCT01417104|455664202|FG001|Overall Study|Failure to make contact|1|||
126646676|NCT01417104|455664201|FG000|Overall Study|Adverse Event|1|||
126646677|NCT01417104|455664202|FG001|Overall Study|Adverse Event|0|||
126646678|NCT03101462|455664203|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
126646679|NCT03101462|455664204|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
126646680|NCT00635661|455664205|FG000|Overall Study|Withdrawal by Subject|4|||
126646681|NCT01696955|455664208|FG000|Main Study|Protocol Violation|1|||
126646682|NCT01696955|455664209|FG001|Main Study|Protocol Violation|0|||
126646683|NCT01696955|455664208|FG000|Main Study|Withdrawal by Subject|1|||
126646684|NCT01696955|455664209|FG001|Main Study|Withdrawal by Subject|1|||
126646685|NCT03192475|455664210|FG000|Overall Study|Death|0|||
126646686|NCT03192475|455664211|FG001|Overall Study|Death|1|||
126646687|NCT03192475|455664210|FG000|Overall Study|Lost to Follow-up|13|||
126646688|NCT03192475|455664211|FG001|Overall Study|Lost to Follow-up|8|||
126646689|NCT00573859|455664214|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
126646690|NCT00573859|455664214|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
126646691|NCT03541200|455664223|FG000|Overall Study|Adverse Event|19|||
126646692|NCT03541200|455664223|FG000|Overall Study|Death|1|||
126646693|NCT03541200|455664223|FG000|Overall Study|Lost to Follow-up|10|||
126646694|NCT03541200|455664223|FG000|Overall Study|Physician Decision|1|||
126646695|NCT03541200|455664223|FG000|Overall Study|Protocol Violation|51|||
126646696|NCT03541200|455664223|FG000|Overall Study|Withdrawal by Subject|23|||
126646697|NCT03541200|455664223|FG000|Overall Study|other|8|||
126646698|NCT01204710|455664225|FG000|Randomization Treatment|Lost to Follow-up|1|||
126646699|NCT01204710|455664226|FG001|Randomization Treatment|Lost to Follow-up|0|||
126646700|NCT01204710|455664225|FG000|Randomization Treatment|Withdrawal by Subject|6|||
126646701|NCT01204710|455664226|FG001|Randomization Treatment|Withdrawal by Subject|5|||
126646702|NCT01204710|455664225|FG000|Randomization Treatment|Physician Decision|3|||
126646703|NCT01204710|455664226|FG001|Randomization Treatment|Physician Decision|2|||
126646704|NCT01204710|455664225|FG000|Randomization Treatment|Entry criteria not met|0|||
126646705|NCT01204710|455664226|FG001|Randomization Treatment|Entry criteria not met|1|||
126646706|NCT01204710|455664225|FG000|Randomization Treatment|Adverse Event|4|||
126646707|NCT01204710|455664226|FG001|Randomization Treatment|Adverse Event|2|||
126646708|NCT01204710|455664225|FG000|Randomization Treatment|Sponsor Decision|0|||
126313540|NCT02548351|454437671|FG000|Overall Study|Physician Decision|11|||
126646709|NCT01204710|455664226|FG001|Randomization Treatment|Sponsor Decision|1|||
126646710|NCT01204710|455664225|FG000|Randomization Treatment|Worsening of General condition|0|||
126646711|NCT01204710|455664226|FG001|Randomization Treatment|Worsening of General condition|1|||
126646712|NCT01204710|455664225|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
126646713|NCT01204710|455664226|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
126646714|NCT01204710|455664225|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
126646715|NCT01204710|455664226|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
126646716|NCT01204710|455664225|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
126646717|NCT01204710|455664226|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
126646718|NCT01204710|455664225|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
126646719|NCT01204710|455664226|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
126646720|NCT01276379|455664227|FG000|Overall Study|Screening failure|40|||
126646721|NCT00864253|455664228|FG000|Overall Study|Adverse Event|56|||
126646722|NCT00864253|455664229|FG001|Overall Study|Adverse Event|11|||
126646723|NCT00864253|455664228|FG000|Overall Study|Unrelated Adverse Event|3|||
126646724|NCT00864253|455664229|FG001|Overall Study|Unrelated Adverse Event|1|||
126646725|NCT00864253|455664228|FG000|Overall Study|Physician Decision|11|||
126646726|NCT00864253|455664229|FG001|Overall Study|Physician Decision|15|||
126646727|NCT00864253|455664228|FG000|Overall Study|Protocol Violation|0|||
126646728|NCT00864253|455664229|FG001|Overall Study|Protocol Violation|2|||
126646729|NCT00864253|455664228|FG000|Overall Study|Lost to Follow-up|1|||
126646730|NCT00864253|455664229|FG001|Overall Study|Lost to Follow-up|1|||
126646731|NCT00864253|455664228|FG000|Overall Study|Withdrawal by Subject|18|||
126646732|NCT00864253|455664229|FG001|Overall Study|Withdrawal by Subject|18|||
126646733|NCT00864253|455664228|FG000|Overall Study|Death|1|||
126646734|NCT00864253|455664229|FG001|Overall Study|Death|0|||
126646735|NCT00864253|455664228|FG000|Overall Study|Ongoing|2|||
126646736|NCT00864253|455664229|FG001|Overall Study|Ongoing|3|||
126646737|NCT00864253|455664228|FG000|Overall Study|Untreated|7|||
126646738|NCT00864253|455664229|FG001|Overall Study|Untreated|7|||
126646739|NCT01896726|455664230|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
126646740|NCT01896726|455664230|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
126646741|NCT01128114|455664231|FG000|Overall Study|Treatment Withdrawn|6|||
126646742|NCT01128114|455664231|FG000|Overall Study|Screening Failed|2|||
126646743|NCT00208325|455664232|FG000|Overall Study|Death|18|||
126646744|NCT00208325|455664233|FG001|Overall Study|Death|19|||
126646745|NCT00208325|455664234|FG002|Overall Study|Death|7|||
126646746|NCT00208325|455664235|FG003|Overall Study|Death|5|||
126646747|NCT00208325|455664232|FG000|Overall Study|Withdrawal by Subject|0|||
126646748|NCT00208325|455664233|FG001|Overall Study|Withdrawal by Subject|1|||
126646749|NCT00208325|455664234|FG002|Overall Study|Withdrawal by Subject|0|||
126646750|NCT00208325|455664235|FG003|Overall Study|Withdrawal by Subject|0|||
126646751|NCT00208325|455664232|FG000|Overall Study|Revision|4|||
126646752|NCT00208325|455664233|FG001|Overall Study|Revision|1|||
126646753|NCT00208325|455664234|FG002|Overall Study|Revision|0|||
126646754|NCT00208325|455664235|FG003|Overall Study|Revision|4|||
126646755|NCT00208325|455664232|FG000|Overall Study|Lost to Follow-up|1|||
126646756|NCT00208325|455664233|FG001|Overall Study|Lost to Follow-up|0|||
126646757|NCT00208325|455664234|FG002|Overall Study|Lost to Follow-up|2|||
126646758|NCT00208325|455664235|FG003|Overall Study|Lost to Follow-up|0|||
126646759|NCT00208325|455664232|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
126646760|NCT00208325|455664233|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
126646761|NCT00208325|455664234|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
126646762|NCT00208325|455664235|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
126646763|NCT00208325|455664232|FG000|Overall Study|Does not wish to Continue in Study|5|||
126646764|NCT00208325|455664233|FG001|Overall Study|Does not wish to Continue in Study|8|||
126646765|NCT00208325|455664234|FG002|Overall Study|Does not wish to Continue in Study|3|||
126646766|NCT00208325|455664235|FG003|Overall Study|Does not wish to Continue in Study|2|||
126646767|NCT00208325|455664232|FG000|Overall Study|Other|2|||
126646768|NCT00208325|455664233|FG001|Overall Study|Other|1|||
126646769|NCT00208325|455664234|FG002|Overall Study|Other|1|||
126646770|NCT00208325|455664235|FG003|Overall Study|Other|0|||
126646771|NCT00208325|455664232|FG000|Overall Study|Mis-Randomized|17|||
126646772|NCT00208325|455664233|FG001|Overall Study|Mis-Randomized|20|||
126646773|NCT00208325|455664234|FG002|Overall Study|Mis-Randomized|0|||
126646774|NCT00208325|455664235|FG003|Overall Study|Mis-Randomized|0|||
126646775|NCT00586612|455664236|FG000|Primary Phase|Protocol Violation|1|||
126646776|NCT00586612|455664237|FG001|Primary Phase|Protocol Violation|0|||
126646777|NCT00586612|455664236|FG000|Primary Phase|Lost to Follow-up|0|||
126646778|NCT00586612|455664237|FG001|Primary Phase|Lost to Follow-up|1|||
126646779|NCT00586612|455664236|FG000|Primary Phase|Withdrawal by Subject|0|||
126646780|NCT00586612|455664237|FG001|Primary Phase|Withdrawal by Subject|2|||
126646781|NCT00586612|455664236|FG000|Booster Phase|Lost to Follow-up|3|||
126646782|NCT00586612|455664237|FG001|Booster Phase|Lost to Follow-up|1|||
126646783|NCT02001064|455664240|FG000|Overall Study|Withdrawal by Subject|2|||
126646784|NCT02001064|455664241|FG001|Overall Study|Withdrawal by Subject|1|||
126646785|NCT01609062|455664242|FG000|Extension Phase|Terminated by Sponsor|14|||
126646786|NCT01609062|455664243|FG001|Extension Phase|Terminated by Sponsor|9|||
126646787|NCT01609062|455664242|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
126646788|NCT01609062|455664243|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
126646789|NCT01609062|455664242|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
126646790|NCT01609062|455664243|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
126646791|NCT02738853|455664244|FG000|Enrollment|Inclusion/Exclusion not met|21|||
126646792|NCT02738853|455664244|FG000|Enrollment|Withdrawal by Subject|3|||
126646793|NCT02738853|455664244|FG000|Enrollment|Subject treated with commercially available device|6|||
126646794|NCT02738853|455664244|FG000|Enrollment|Study Enrollment Closed|3|||
126646795|NCT02738853|455664244|FG000|Procedure|Death|1|||
126646796|NCT02738853|455664244|FG000|1 Month|Death|2|||
126646797|NCT02738853|455664244|FG000|6 Month|Death|4|||
126646798|NCT02738853|455664244|FG000|6 Month|Withdrawal by Subject|2|||
126646799|NCT02738853|455664244|FG000|1 Year|Death|6|||
126646800|NCT02738853|455664244|FG000|1 Year|Withdrawal by Subject|1|||
126646801|NCT02738853|455664244|FG000|2 Year|Death|2|||
126646802|NCT02738853|455664244|FG000|2 Year|Lost to Follow-up|1|||
126646803|NCT02738853|455664244|FG000|3 Year|Death|2|||
126646804|NCT02738853|455664244|FG000|3 Year|Withdrawal by Subject|1|||
126646805|NCT02738853|455664244|FG000|4 Year|Death|9|||
126646806|NCT02738853|455664244|FG000|5 Year|Lost to Follow-up|4|||
126646807|NCT01803282|455664245|FG000|Overall Study|Progressive Disease|4|||
126646808|NCT01803282|455664246|FG001|Overall Study|Progressive Disease|3|||
126646809|NCT01803282|455664247|FG002|Overall Study|Progressive Disease|6|||
126646810|NCT01803282|455664248|FG003|Overall Study|Progressive Disease|22|||
126646811|NCT01803282|455664249|FG004|Overall Study|Progressive Disease|5|||
126646812|NCT01803282|455664250|FG005|Overall Study|Progressive Disease|8|||
126646813|NCT01803282|455664251|FG006|Overall Study|Progressive Disease|23|||
126646814|NCT01803282|455664252|FG007|Overall Study|Progressive Disease|24|||
126646815|NCT01803282|455664253|FG008|Overall Study|Progressive Disease|3|||
126646816|NCT01803282|455664254|FG009|Overall Study|Progressive Disease|29|||
126646817|NCT01803282|455664255|FG010|Overall Study|Progressive Disease|6|||
126646818|NCT01803282|455664256|FG011|Overall Study|Progressive Disease|11|||
126646819|NCT01803282|455664245|FG000|Overall Study|Death|0|||
126646820|NCT01803282|455664246|FG001|Overall Study|Death|0|||
126646821|NCT01803282|455664247|FG002|Overall Study|Death|0|||
126646822|NCT01803282|455664248|FG003|Overall Study|Death|0|||
126646823|NCT01803282|455664249|FG004|Overall Study|Death|2|||
126646824|NCT01803282|455664250|FG005|Overall Study|Death|1|||
126646825|NCT01803282|455664251|FG006|Overall Study|Death|1|||
126646826|NCT01803282|455664252|FG007|Overall Study|Death|5|||
126646827|NCT01803282|455664253|FG008|Overall Study|Death|1|||
126646828|NCT01803282|455664254|FG009|Overall Study|Death|1|||
126646829|NCT01803282|455664255|FG010|Overall Study|Death|0|||
126646830|NCT01803282|455664256|FG011|Overall Study|Death|0|||
126646831|NCT01803282|455664245|FG000|Overall Study|Withdrew Consent|0|||
126646832|NCT01803282|455664246|FG001|Overall Study|Withdrew Consent|0|||
126646833|NCT01803282|455664247|FG002|Overall Study|Withdrew Consent|0|||
126646834|NCT01803282|455664248|FG003|Overall Study|Withdrew Consent|6|||
126646835|NCT01803282|455664249|FG004|Overall Study|Withdrew Consent|1|||
126646836|NCT01803282|455664250|FG005|Overall Study|Withdrew Consent|0|||
126646837|NCT01803282|455664251|FG006|Overall Study|Withdrew Consent|8|||
126646838|NCT01803282|455664252|FG007|Overall Study|Withdrew Consent|3|||
126646839|NCT01803282|455664253|FG008|Overall Study|Withdrew Consent|1|||
126646840|NCT01803282|455664254|FG009|Overall Study|Withdrew Consent|5|||
126646841|NCT01803282|455664255|FG010|Overall Study|Withdrew Consent|0|||
126646842|NCT01803282|455664256|FG011|Overall Study|Withdrew Consent|1|||
126646843|NCT01803282|455664245|FG000|Overall Study|Investigator's Discretion|0|||
126646844|NCT01803282|455664246|FG001|Overall Study|Investigator's Discretion|0|||
126646845|NCT01803282|455664247|FG002|Overall Study|Investigator's Discretion|0|||
126646846|NCT01803282|455664248|FG003|Overall Study|Investigator's Discretion|7|||
126646847|NCT01803282|455664249|FG004|Overall Study|Investigator's Discretion|2|||
126646848|NCT01803282|455664250|FG005|Overall Study|Investigator's Discretion|1|||
126646849|NCT01803282|455664251|FG006|Overall Study|Investigator's Discretion|7|||
126646850|NCT01803282|455664252|FG007|Overall Study|Investigator's Discretion|10|||
126646851|NCT01803282|455664253|FG008|Overall Study|Investigator's Discretion|6|||
126646852|NCT01803282|455664254|FG009|Overall Study|Investigator's Discretion|7|||
126646853|NCT01803282|455664255|FG010|Overall Study|Investigator's Discretion|1|||
126646854|NCT01803282|455664256|FG011|Overall Study|Investigator's Discretion|0|||
126646855|NCT01803282|455664245|FG000|Overall Study|Adverse Event|0|||
126646856|NCT01803282|455664246|FG001|Overall Study|Adverse Event|0|||
126646857|NCT01803282|455664247|FG002|Overall Study|Adverse Event|0|||
126646858|NCT01803282|455664248|FG003|Overall Study|Adverse Event|0|||
126646859|NCT01803282|455664249|FG004|Overall Study|Adverse Event|0|||
126646860|NCT01803282|455664250|FG005|Overall Study|Adverse Event|0|||
126646861|NCT01803282|455664251|FG006|Overall Study|Adverse Event|1|||
126646862|NCT01803282|455664252|FG007|Overall Study|Adverse Event|2|||
126646863|NCT01803282|455664253|FG008|Overall Study|Adverse Event|0|||
126646864|NCT01803282|455664254|FG009|Overall Study|Adverse Event|1|||
126646865|NCT01803282|455664255|FG010|Overall Study|Adverse Event|0|||
126646866|NCT01803282|455664256|FG011|Overall Study|Adverse Event|3|||
126646867|NCT01803282|455664245|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126646868|NCT01803282|455664246|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126646869|NCT01803282|455664247|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126646870|NCT01803282|455664248|FG003|Overall Study|Non-Compliance with Study Drug|1|||
126646871|NCT01803282|455664249|FG004|Overall Study|Non-Compliance with Study Drug|0|||
126646872|NCT01803282|455664250|FG005|Overall Study|Non-Compliance with Study Drug|0|||
126646873|NCT01803282|455664251|FG006|Overall Study|Non-Compliance with Study Drug|0|||
126646874|NCT01803282|455664252|FG007|Overall Study|Non-Compliance with Study Drug|0|||
126646875|NCT01803282|455664253|FG008|Overall Study|Non-Compliance with Study Drug|0|||
126646876|NCT01803282|455664254|FG009|Overall Study|Non-Compliance with Study Drug|0|||
126646877|NCT01803282|455664255|FG010|Overall Study|Non-Compliance with Study Drug|0|||
126646878|NCT01803282|455664256|FG011|Overall Study|Non-Compliance with Study Drug|0|||
126646879|NCT01803282|455664245|FG000|Overall Study|Unknown Reason|0|||
126646880|NCT01803282|455664246|FG001|Overall Study|Unknown Reason|0|||
126646881|NCT01803282|455664247|FG002|Overall Study|Unknown Reason|0|||
126646882|NCT01803282|455664248|FG003|Overall Study|Unknown Reason|0|||
126646883|NCT01803282|455664249|FG004|Overall Study|Unknown Reason|0|||
126646884|NCT01803282|455664250|FG005|Overall Study|Unknown Reason|0|||
126646885|NCT01803282|455664251|FG006|Overall Study|Unknown Reason|0|||
126646886|NCT01803282|455664252|FG007|Overall Study|Unknown Reason|1|||
126646887|NCT01803282|455664253|FG008|Overall Study|Unknown Reason|0|||
126646888|NCT01803282|455664254|FG009|Overall Study|Unknown Reason|0|||
126646889|NCT01803282|455664255|FG010|Overall Study|Unknown Reason|0|||
126646890|NCT01803282|455664256|FG011|Overall Study|Unknown Reason|0|||
126646891|NCT01803282|455664245|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
126646892|NCT01803282|455664246|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
126646893|NCT01803282|455664247|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
126646894|NCT01803282|455664248|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
126646895|NCT01803282|455664249|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
126646896|NCT01803282|455664250|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
126646897|NCT01803282|455664251|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
126646898|NCT01803282|455664252|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
126646899|NCT01803282|455664253|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
126646900|NCT01803282|455664254|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
126646901|NCT01803282|455664255|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
126646902|NCT01803282|455664256|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
126646903|NCT01803282|455664245|FG000|Overall Study|Enrolled but Never Treated|0|||
126646904|NCT01803282|455664246|FG001|Overall Study|Enrolled but Never Treated|0|||
126646905|NCT01803282|455664247|FG002|Overall Study|Enrolled but Never Treated|0|||
126646906|NCT01803282|455664248|FG003|Overall Study|Enrolled but Never Treated|0|||
126646907|NCT01803282|455664249|FG004|Overall Study|Enrolled but Never Treated|1|||
126646908|NCT01803282|455664250|FG005|Overall Study|Enrolled but Never Treated|0|||
126646909|NCT01803282|455664251|FG006|Overall Study|Enrolled but Never Treated|1|||
126646910|NCT01803282|455664252|FG007|Overall Study|Enrolled but Never Treated|1|||
126646911|NCT01803282|455664253|FG008|Overall Study|Enrolled but Never Treated|0|||
126646912|NCT01803282|455664254|FG009|Overall Study|Enrolled but Never Treated|1|||
126646913|NCT01803282|455664255|FG010|Overall Study|Enrolled but Never Treated|0|||
126646914|NCT01803282|455664256|FG011|Overall Study|Enrolled but Never Treated|0|||
126646915|NCT01743989|455664257|FG000|Treatment Phase|Unstable MR4.0|0|||
126646916|NCT01743989|455664258|FG001|Treatment Phase|Unstable MR4.0|6|||
126646917|NCT01743989|455664259|FG002|Treatment Phase|Unstable MR4.0|263|||
126646918|NCT01743989|455664257|FG000|Treatment Phase|Adverse Event|0|||
126646919|NCT01743989|455664258|FG001|Treatment Phase|Adverse Event|4|||
126646920|NCT01743989|455664259|FG002|Treatment Phase|Adverse Event|67|||
126646921|NCT01743989|455664257|FG000|Treatment Phase|Withdrawal by Subject|1|||
126646922|NCT01743989|455664258|FG001|Treatment Phase|Withdrawal by Subject|3|||
126646923|NCT01743989|455664259|FG002|Treatment Phase|Withdrawal by Subject|28|||
126646924|NCT01743989|455664257|FG000|Treatment Phase|Death|0|||
126646925|NCT01743989|455664258|FG001|Treatment Phase|Death|1|||
126646926|NCT01743989|455664259|FG002|Treatment Phase|Death|3|||
126646927|NCT01743989|455664257|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
126646928|NCT01743989|455664258|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
126646929|NCT01743989|455664259|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
126646930|NCT01743989|455664257|FG000|Treatment Phase|Protocol deviation|0|||
126646931|NCT01743989|455664258|FG001|Treatment Phase|Protocol deviation|0|||
126646932|NCT01743989|455664259|FG002|Treatment Phase|Protocol deviation|3|||
126646933|NCT01743989|455664257|FG000|Treatment Phase|Pregnancy|0|||
126646934|NCT01743989|455664258|FG001|Treatment Phase|Pregnancy|0|||
126646935|NCT01743989|455664259|FG002|Treatment Phase|Pregnancy|2|||
126646936|NCT01743989|455664257|FG000|Treatment Phase|Lost to Follow-up|0|||
126646937|NCT01743989|455664258|FG001|Treatment Phase|Lost to Follow-up|0|||
126313541|NCT02548351|454437672|FG001|Overall Study|Physician Decision|18|||
126646938|NCT01743989|455664259|FG002|Treatment Phase|Lost to Follow-up|2|||
126646939|NCT01743989|455664257|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
126646940|NCT01743989|455664258|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
126646941|NCT01743989|455664259|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
126646942|NCT01743989|455664257|FG000|Treatment Phase|Administrative problems|0|||
126646943|NCT01743989|455664258|FG001|Treatment Phase|Administrative problems|0|||
126646944|NCT01743989|455664259|FG002|Treatment Phase|Administrative problems|1|||
126646945|NCT01743989|455664257|FG000|Treatment Phase|New cancer (CML) therapy|0|||
126646946|NCT01743989|455664258|FG001|Treatment Phase|New cancer (CML) therapy|1|||
126646947|NCT01743989|455664259|FG002|Treatment Phase|New cancer (CML) therapy|0|||
126646948|NCT01743989|455664257|FG000|Treatment Phase|Physician Decision|0|||
126646949|NCT01743989|455664258|FG001|Treatment Phase|Physician Decision|0|||
126646950|NCT01743989|455664259|FG002|Treatment Phase|Physician Decision|3|||
126646951|NCT01743989|455664257|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
126646952|NCT01743989|455664258|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
126646953|NCT01743989|455664259|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
126646954|NCT01743989|455664257|FG000|Treatment Phase|Not randomized by mistake|0|||
126646955|NCT01743989|455664258|FG001|Treatment Phase|Not randomized by mistake|0|||
126646956|NCT01743989|455664259|FG002|Treatment Phase|Not randomized by mistake|1|||
126646957|NCT01743989|455664257|FG000|Treatment Phase|Included by mistake|0|||
126646958|NCT01743989|455664258|FG001|Treatment Phase|Included by mistake|0|||
126646959|NCT01743989|455664259|FG002|Treatment Phase|Included by mistake|1|||
126646960|NCT01743989|455664257|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
126646961|NCT01743989|455664258|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
126646962|NCT01743989|455664259|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
126646963|NCT01743989|455664257|FG000|TFR Phase|Adverse Event|0|||
126646964|NCT01743989|455664258|FG001|TFR Phase|Adverse Event|1|||
126646965|NCT01743989|455664259|FG002|TFR Phase|Adverse Event|0|||
126646966|NCT01743989|455664257|FG000|TFR Phase|Lost to Follow-up|0|||
126646967|NCT01743989|455664258|FG001|TFR Phase|Lost to Follow-up|2|||
126646968|NCT01743989|455664259|FG002|TFR Phase|Lost to Follow-up|0|||
126646969|NCT01743989|455664257|FG000|TFR Phase|Physician Decision|0|||
126646970|NCT01743989|455664258|FG001|TFR Phase|Physician Decision|1|||
126646971|NCT01743989|455664259|FG002|TFR Phase|Physician Decision|0|||
126646972|NCT01743989|455664257|FG000|TFR Phase|Logistical problems|0|||
126646973|NCT01743989|455664258|FG001|TFR Phase|Logistical problems|2|||
126646974|NCT01743989|455664259|FG002|TFR Phase|Logistical problems|0|||
126646975|NCT01743989|455664257|FG000|TFR Phase|Protocol deviation|0|||
126646976|NCT01743989|455664258|FG001|TFR Phase|Protocol deviation|1|||
126646977|NCT01743989|455664259|FG002|TFR Phase|Protocol deviation|0|||
126646978|NCT01743989|455664257|FG000|TFR Phase|Withdrawal by Subject|0|||
126646979|NCT01743989|455664258|FG001|TFR Phase|Withdrawal by Subject|2|||
126646980|NCT01743989|455664259|FG002|TFR Phase|Withdrawal by Subject|0|||
126646981|NCT01743989|455664257|FG000|Re-treatment Phase|Adverse Event|8|||
126646982|NCT01743989|455664258|FG001|Re-treatment Phase|Adverse Event|4|||
126646983|NCT01743989|455664259|FG002|Re-treatment Phase|Adverse Event|0|||
126646984|NCT01743989|455664257|FG000|Re-treatment Phase|Death|1|||
126646985|NCT01743989|455664258|FG001|Re-treatment Phase|Death|1|||
126646986|NCT01743989|455664259|FG002|Re-treatment Phase|Death|0|||
126646987|NCT01743989|455664257|FG000|Re-treatment Phase|Administrative problems|1|||
126646988|NCT01743989|455664258|FG001|Re-treatment Phase|Administrative problems|1|||
126646989|NCT01743989|455664259|FG002|Re-treatment Phase|Administrative problems|0|||
126646990|NCT01743989|455664257|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
126646991|NCT01743989|455664258|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
126646992|NCT01743989|455664259|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
126646993|NCT01743989|455664257|FG000|Re-treatment Phase|Unstable MR|1|||
126646994|NCT01743989|455664258|FG001|Re-treatment Phase|Unstable MR|0|||
126646995|NCT01743989|455664259|FG002|Re-treatment Phase|Unstable MR|0|||
126646996|NCT01743989|455664257|FG000|Re-treatment Phase|Physician Decision|0|||
126646997|NCT01743989|455664258|FG001|Re-treatment Phase|Physician Decision|1|||
126646998|NCT01743989|455664259|FG002|Re-treatment Phase|Physician Decision|0|||
126646999|NCT01743989|455664257|FG000|Re-treatment Phase|Lost to Follow-up|0|||
126647000|NCT01743989|455664258|FG001|Re-treatment Phase|Lost to Follow-up|1|||
126647001|NCT01743989|455664259|FG002|Re-treatment Phase|Lost to Follow-up|0|||
126647002|NCT02235311|455664266|FG000|Overall Study|Lost to Follow-up|0|||
126647003|NCT02235311|455664267|FG001|Overall Study|Lost to Follow-up|1|||
126647004|NCT02235311|455664266|FG000|Overall Study|Protocol Violation|0|||
126647005|NCT02235311|455664267|FG001|Overall Study|Protocol Violation|1|||
126647006|NCT03006848|455664268|FG000|Overall Study|Adverse Event|1|||
126647007|NCT03006848|455664268|FG000|Overall Study|Physician Decision|1|||
126647008|NCT03006848|455664268|FG000|Overall Study|Lack of Efficacy|16|||
126647009|NCT04500769|455666157|FG000|Overall Study|Withdrawal by Subject|5|||
126647010|NCT01967147|455666158|FG000|Overall Study|Adverse Event|5|||
126647011|NCT01967147|455666159|FG001|Overall Study|Adverse Event|2|||
126647012|NCT01967147|455666158|FG000|Overall Study|Lack of Efficacy|1|||
126647013|NCT01967147|455666159|FG001|Overall Study|Lack of Efficacy|4|||
126647014|NCT01967147|455666158|FG000|Overall Study|Lost to Follow-up|1|||
126647015|NCT01967147|455666159|FG001|Overall Study|Lost to Follow-up|2|||
126647016|NCT01967147|455666158|FG000|Overall Study|Withdrawal by Subject|2|||
126647017|NCT01967147|455666159|FG001|Overall Study|Withdrawal by Subject|4|||
126647018|NCT01967147|455666158|FG000|Overall Study|Non-compliance with Study Drug|0|||
126647019|NCT01967147|455666159|FG001|Overall Study|Non-compliance with Study Drug|3|||
126647020|NCT01967147|455666158|FG000|Overall Study|Other|4|||
126647021|NCT01967147|455666159|FG001|Overall Study|Other|5|||
126647022|NCT02314780|455666160|FG000|Overall Study|organizational reasons|0|||
126647023|NCT02314780|455666161|FG001|Overall Study|organizational reasons|2|||
126647024|NCT02314780|455666162|FG002|Overall Study|organizational reasons|0|||
126647025|NCT02314780|455666160|FG000|Overall Study|Adverse Event|0|||
126647026|NCT02314780|455666161|FG001|Overall Study|Adverse Event|1|||
126647027|NCT02314780|455666162|FG002|Overall Study|Adverse Event|0|||
126647028|NCT00215137|455666166|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
126647029|NCT00215137|455666167|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
126647030|NCT00215137|455666168|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
126647031|NCT00215137|455666166|FG000|Randomization Period|Lost to Follow-up|0|||
126647032|NCT00215137|455666167|FG001|Randomization Period|Lost to Follow-up|1|||
126647033|NCT00215137|455666168|FG002|Randomization Period|Lost to Follow-up|0|||
126647034|NCT00215137|455666166|FG000|Randomization Period|Withdrawal by Subject|0|||
126647035|NCT00215137|455666167|FG001|Randomization Period|Withdrawal by Subject|1|||
126647036|NCT00215137|455666168|FG002|Randomization Period|Withdrawal by Subject|0|||
126647037|NCT01076153|455666175|FG000|Overall Study|Symptoms improved/resolved|10|||
126647038|NCT01076153|455666175|FG000|Overall Study|Adverse Event|1|||
126647039|NCT01142232|455666179|FG000|Overall Study|Adverse Event|1|||
126647040|NCT01142232|455666180|FG001|Overall Study|Adverse Event|2|||
126647041|NCT01142232|455666181|FG002|Overall Study|Adverse Event|1|||
126647042|NCT01142232|455666182|FG003|Overall Study|Adverse Event|0|||
126647043|NCT01142232|455666183|FG004|Overall Study|Adverse Event|4|||
126647044|NCT01142232|455666179|FG000|Overall Study|Death|0|||
126647045|NCT01142232|455666180|FG001|Overall Study|Death|0|||
126647046|NCT01142232|455666181|FG002|Overall Study|Death|0|||
126647047|NCT01142232|455666182|FG003|Overall Study|Death|0|||
126647048|NCT01142232|455666183|FG004|Overall Study|Death|1|||
126647049|NCT01142232|455666179|FG000|Overall Study|Disease Progression|2|||
126647050|NCT01142232|455666180|FG001|Overall Study|Disease Progression|0|||
126647051|NCT01142232|455666181|FG002|Overall Study|Disease Progression|1|||
126647052|NCT01142232|455666182|FG003|Overall Study|Disease Progression|2|||
126647053|NCT01142232|455666183|FG004|Overall Study|Disease Progression|12|||
126647054|NCT01142232|455666179|FG000|Overall Study|Withdrawal by Subject|0|||
126647055|NCT01142232|455666180|FG001|Overall Study|Withdrawal by Subject|0|||
126647056|NCT01142232|455666181|FG002|Overall Study|Withdrawal by Subject|0|||
126647057|NCT01142232|455666182|FG003|Overall Study|Withdrawal by Subject|1|||
126647058|NCT01142232|455666183|FG004|Overall Study|Withdrawal by Subject|3|||
126647059|NCT01142232|455666179|FG000|Overall Study|Physician Decision|0|||
126647060|NCT01142232|455666180|FG001|Overall Study|Physician Decision|1|||
126647061|NCT01142232|455666181|FG002|Overall Study|Physician Decision|0|||
126647062|NCT01142232|455666182|FG003|Overall Study|Physician Decision|2|||
126647063|NCT01142232|455666183|FG004|Overall Study|Physician Decision|10|||
126647064|NCT01142232|455666179|FG000|Overall Study|Alternative Therapy|0|||
126647065|NCT01142232|455666180|FG001|Overall Study|Alternative Therapy|1|||
126647066|NCT01142232|455666181|FG002|Overall Study|Alternative Therapy|1|||
126647067|NCT01142232|455666182|FG003|Overall Study|Alternative Therapy|0|||
126647068|NCT01142232|455666183|FG004|Overall Study|Alternative Therapy|1|||
126647069|NCT01142232|455666179|FG000|Overall Study|Off Trt for other complicating disease|0|||
126647070|NCT01142232|455666180|FG001|Overall Study|Off Trt for other complicating disease|0|||
126647071|NCT01142232|455666181|FG002|Overall Study|Off Trt for other complicating disease|0|||
126647072|NCT01142232|455666182|FG003|Overall Study|Off Trt for other complicating disease|0|||
126647073|NCT01142232|455666183|FG004|Overall Study|Off Trt for other complicating disease|1|||
126647074|NCT01142232|455666179|FG000|Overall Study|Noncompliance|0|||
126647075|NCT01142232|455666180|FG001|Overall Study|Noncompliance|0|||
126647076|NCT01142232|455666181|FG002|Overall Study|Noncompliance|0|||
126647077|NCT01142232|455666182|FG003|Overall Study|Noncompliance|0|||
126647078|NCT01142232|455666183|FG004|Overall Study|Noncompliance|2|||
126647079|NCT00297427|455666188|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
126647080|NCT00297427|455666189|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
126647081|NCT00297427|455666188|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
126647082|NCT00297427|455666189|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
126647083|NCT00297427|455666188|FG000|Phase 1: Initial Intervention|Death|0|||
126647084|NCT00297427|455666189|FG001|Phase 1: Initial Intervention|Death|1|||
126647085|NCT00297427|455666188|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
126647086|NCT00297427|455666189|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
126647087|NCT00297427|455666188|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
126647088|NCT00297427|455666189|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
126647089|NCT00297427|455666188|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
126647090|NCT00297427|455666189|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
126647091|NCT00297427|455666188|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
126647092|NCT00297427|455666189|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
126313542|NCT02548351|454437673|FG002|Overall Study|Physician Decision|11|||
126647093|NCT00297427|455666188|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
126647094|NCT00297427|455666189|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
126647095|NCT02787044|455666192|FG000|Overall Study|Lost to Follow-up|15|||
126647096|NCT02787044|455666193|FG001|Overall Study|Lost to Follow-up|19|||
126647097|NCT02182947|455666194|FG000|Overall Study|Withdrawal by Subject|7|||
126647098|NCT02182947|455666194|FG000|Overall Study|Lost to Follow-up|3|||
126647099|NCT02182947|455666194|FG000|Overall Study|Failed screening activities|8|||
126647100|NCT00730275|455666197|FG000|Overall Study|Withdrawal by Subject|0|||
126647101|NCT00730275|455666198|FG001|Overall Study|Withdrawal by Subject|0|||
126647102|NCT00730275|455666199|FG002|Overall Study|Withdrawal by Subject|0|||
126647103|NCT00730275|455666200|FG003|Overall Study|Withdrawal by Subject|1|||
126647104|NCT03053518|455666206|FG000|Overall Study|Withdrawal by Subject|3|||
126647105|NCT03053518|455666206|FG000|Overall Study|Lost to Follow-up|2|||
126647106|NCT03053518|455666206|FG000|Overall Study|Ineligible|5|||
126647107|NCT01156376|455666207|FG000|Overall Study|Adverse Event|1|||
126647108|NCT01156376|455666208|FG001|Overall Study|Adverse Event|0|||
126647109|NCT01156376|455666209|FG002|Overall Study|Adverse Event|1|||
126647110|NCT01156376|455666207|FG000|Overall Study|Withdrawal by Subject|0|||
126647111|NCT01156376|455666208|FG001|Overall Study|Withdrawal by Subject|0|||
126647112|NCT01156376|455666209|FG002|Overall Study|Withdrawal by Subject|3|||
126647113|NCT02071290|455666210|FG000|Overall Study|Death|1|||
126647114|NCT02071290|455666211|FG001|Overall Study|Death|0|||
126647115|NCT02071290|455666210|FG000|Overall Study|Withdrawal by Subject|0|||
126647116|NCT02071290|455666211|FG001|Overall Study|Withdrawal by Subject|1|||
126647117|NCT02071290|455666210|FG000|Overall Study|Protocol Violation|3|||
126647118|NCT02071290|455666211|FG001|Overall Study|Protocol Violation|5|||
126647119|NCT02071290|455666210|FG000|Overall Study|Physician Decision|0|||
126647120|NCT02071290|455666211|FG001|Overall Study|Physician Decision|1|||
126647121|NCT04488770|455666214|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126647122|NCT04488770|455666215|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126647123|NCT04488770|455666216|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126647124|NCT04488770|455666217|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
126647125|NCT04488770|455666218|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126647126|NCT04488770|455666219|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126647127|NCT04488770|455666220|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126647128|NCT04488770|455666221|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126647129|NCT04488770|455666222|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126647130|NCT04488770|455666223|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126647131|NCT04488770|455666224|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126647132|NCT04488770|455666225|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126647133|NCT04488770|455666226|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
126647134|NCT04488770|455666214|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
126647135|NCT04488770|455666215|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126647136|NCT04488770|455666216|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126647137|NCT04488770|455666217|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126647138|NCT04488770|455666218|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126647139|NCT04488770|455666219|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126647140|NCT04488770|455666220|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126647141|NCT04488770|455666221|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126647142|NCT04488770|455666222|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126647143|NCT04488770|455666223|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126647144|NCT04488770|455666224|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126647145|NCT04488770|455666225|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126647146|NCT04488770|455666226|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
126647147|NCT04488770|455666214|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126647148|NCT04488770|455666215|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126647149|NCT04488770|455666216|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126647150|NCT04488770|455666217|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126647151|NCT04488770|455666218|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126647152|NCT04488770|455666219|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
126647153|NCT04488770|455666220|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
126647154|NCT04488770|455666221|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126647155|NCT04488770|455666222|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126647156|NCT04488770|455666223|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126647157|NCT04488770|455666224|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126647158|NCT04488770|455666225|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126647159|NCT04488770|455666226|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126647160|NCT04488770|455666214|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126647161|NCT04488770|455666215|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126647162|NCT04488770|455666216|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126647163|NCT04488770|455666217|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126647164|NCT04488770|455666218|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
126715197|NCT01052012|455908706|FG000|Overall Study|Other|0|||
126647165|NCT04488770|455666219|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126647166|NCT04488770|455666220|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126647167|NCT04488770|455666221|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126647168|NCT04488770|455666222|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126647169|NCT04488770|455666223|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126647170|NCT04488770|455666224|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126647171|NCT04488770|455666225|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126647172|NCT04488770|455666226|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
126647173|NCT02075073|455666227|FG000|Overall Study|Withdrawal by Subject|0|||
126647174|NCT02075073|455666228|FG001|Overall Study|Withdrawal by Subject|1|||
126647175|NCT02075073|455666229|FG002|Overall Study|Withdrawal by Subject|0|||
126647176|NCT02797080|455666235|FG000|Overall Study|Lost to Follow-up|1|||
126647177|NCT02797080|455666235|FG000|Overall Study|Withdrawal by Subject|1|||
126647178|NCT01305408|455666236|FG000|Overall Study|Adverse Event|10|||
126647179|NCT01305408|455666237|FG001|Overall Study|Adverse Event|7|||
126647180|NCT01305408|455666236|FG000|Overall Study|Lack of Efficacy|3|||
126647181|NCT01305408|455666237|FG001|Overall Study|Lack of Efficacy|4|||
126647182|NCT01305408|455666236|FG000|Overall Study|Withdrawal by Subject|9|||
126647183|NCT01305408|455666237|FG001|Overall Study|Withdrawal by Subject|9|||
126647184|NCT01305408|455666236|FG000|Overall Study|Protocol Violation|4|||
126647185|NCT01305408|455666237|FG001|Overall Study|Protocol Violation|6|||
126647186|NCT01305408|455666236|FG000|Overall Study|Lost to Follow-up|5|||
126647187|NCT01305408|455666237|FG001|Overall Study|Lost to Follow-up|3|||
126647188|NCT01305408|455666236|FG000|Overall Study|Noncompliance with study medication|0|||
126647189|NCT01305408|455666237|FG001|Overall Study|Noncompliance with study medication|1|||
126647190|NCT01305408|455666236|FG000|Overall Study|Noncompliance with study procedures|0|||
126647191|NCT01305408|455666237|FG001|Overall Study|Noncompliance with study procedures|1|||
126647192|NCT01305408|455666236|FG000|Overall Study|Other|1|||
126647193|NCT01305408|455666237|FG001|Overall Study|Other|0|||
126647194|NCT01641159|455666250|FG000|Overall Study|Lost to Follow-up|2|||
126647195|NCT01641159|455666251|FG001|Overall Study|Lost to Follow-up|1|||
126647196|NCT01641159|455666250|FG000|Overall Study|Withdrawal by Subject|0|||
126647197|NCT01641159|455666251|FG001|Overall Study|Withdrawal by Subject|1|||
126647198|NCT03653208|455666255|FG000|Overall Study|Withdrawal by Subject|0|||
126647199|NCT03653208|455666256|FG001|Overall Study|Withdrawal by Subject|0|||
126647200|NCT03653208|455666257|FG002|Overall Study|Withdrawal by Subject|0|||
126647201|NCT03653208|455666258|FG003|Overall Study|Withdrawal by Subject|0|||
126647202|NCT03653208|455666259|FG004|Overall Study|Withdrawal by Subject|1|||
126647203|NCT03653208|455666260|FG005|Overall Study|Withdrawal by Subject|0|||
126647204|NCT03653208|455666261|FG006|Overall Study|Withdrawal by Subject|0|||
126647205|NCT03653208|455666262|FG007|Overall Study|Withdrawal by Subject|1|||
126647206|NCT03653208|455666263|FG008|Overall Study|Withdrawal by Subject|1|||
126647207|NCT03752970|455666265|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
126647208|NCT03752970|455666266|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
126647209|NCT03752970|455666267|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
126647210|NCT03752970|455666265|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
126647211|NCT03752970|455666266|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
126647212|NCT03752970|455666267|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
126647213|NCT03752970|455666265|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
126647214|NCT03752970|455666266|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
126647215|NCT03752970|455666267|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
126647216|NCT03752970|455666265|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
126647217|NCT03752970|455666266|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
126647218|NCT03752970|455666267|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
126647219|NCT03752970|455666265|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
126647220|NCT03752970|455666266|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
126647221|NCT03752970|455666267|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
126647222|NCT01152814|455666269|FG000|Overall Study|Lost to Follow-up|2|||
126647223|NCT01669577|455666273|FG000|Overall Study|Death|22|||
126647224|NCT01669577|455666273|FG000|Overall Study|Lost to Follow-up|78|||
126647225|NCT01669577|455666273|FG000|Overall Study|Physician Decision|34|||
126647226|NCT01283516|455666274|FG000|Overall Study|Adverse Event|0|||
126647227|NCT01283516|455666275|FG001|Overall Study|Adverse Event|0|||
126647228|NCT01283516|455666276|FG002|Overall Study|Adverse Event|0|||
126647229|NCT01283516|455666277|FG003|Overall Study|Adverse Event|0|||
126647230|NCT01283516|455666278|FG004|Overall Study|Adverse Event|0|||
126647231|NCT01283516|455666279|FG005|Overall Study|Adverse Event|0|||
126647232|NCT01283516|455666280|FG006|Overall Study|Adverse Event|2|||
126647233|NCT01283516|455666281|FG007|Overall Study|Adverse Event|0|||
126647234|NCT01283516|455666282|FG008|Overall Study|Adverse Event|28|||
126647235|NCT01283516|455666274|FG000|Overall Study|Death|0|||
126647236|NCT01283516|455666275|FG001|Overall Study|Death|0|||
126647237|NCT01283516|455666276|FG002|Overall Study|Death|0|||
126647238|NCT01283516|455666277|FG003|Overall Study|Death|0|||
126647239|NCT01283516|455666278|FG004|Overall Study|Death|0|||
126647240|NCT01283516|455666279|FG005|Overall Study|Death|1|||
126647241|NCT01283516|455666280|FG006|Overall Study|Death|0|||
126647242|NCT01283516|455666281|FG007|Overall Study|Death|1|||
126647243|NCT01283516|455666282|FG008|Overall Study|Death|12|||
126647244|NCT01283516|455666274|FG000|Overall Study|Disease Progression|2|||
126647245|NCT01283516|455666275|FG001|Overall Study|Disease Progression|2|||
126647246|NCT01283516|455666276|FG002|Overall Study|Disease Progression|3|||
126647247|NCT01283516|455666277|FG003|Overall Study|Disease Progression|3|||
126647248|NCT01283516|455666278|FG004|Overall Study|Disease Progression|13|||
126647249|NCT01283516|455666279|FG005|Overall Study|Disease Progression|8|||
126647250|NCT01283516|455666280|FG006|Overall Study|Disease Progression|6|||
126647251|NCT01283516|455666281|FG007|Overall Study|Disease Progression|3|||
126647252|NCT01283516|455666282|FG008|Overall Study|Disease Progression|139|||
126647253|NCT01283516|455666274|FG000|Overall Study|Withdrawal by Subject|0|||
126647254|NCT01283516|455666275|FG001|Overall Study|Withdrawal by Subject|0|||
126647255|NCT01283516|455666276|FG002|Overall Study|Withdrawal by Subject|0|||
126647256|NCT01283516|455666277|FG003|Overall Study|Withdrawal by Subject|0|||
126647257|NCT01283516|455666278|FG004|Overall Study|Withdrawal by Subject|1|||
126647258|NCT01283516|455666279|FG005|Overall Study|Withdrawal by Subject|0|||
126647259|NCT01283516|455666280|FG006|Overall Study|Withdrawal by Subject|1|||
126647260|NCT01283516|455666281|FG007|Overall Study|Withdrawal by Subject|0|||
126647261|NCT01283516|455666282|FG008|Overall Study|Withdrawal by Subject|36|||
126647262|NCT01283516|455666274|FG000|Overall Study|Administrative problems|0|||
126647263|NCT01283516|455666275|FG001|Overall Study|Administrative problems|0|||
126647264|NCT01283516|455666276|FG002|Overall Study|Administrative problems|0|||
126647265|NCT01283516|455666277|FG003|Overall Study|Administrative problems|0|||
126647266|NCT01283516|455666278|FG004|Overall Study|Administrative problems|0|||
126647267|NCT01283516|455666279|FG005|Overall Study|Administrative problems|1|||
126647268|NCT01283516|455666280|FG006|Overall Study|Administrative problems|1|||
126647269|NCT01283516|455666281|FG007|Overall Study|Administrative problems|1|||
126647270|NCT01283516|455666282|FG008|Overall Study|Administrative problems|39|||
126647271|NCT01283516|455666274|FG000|Overall Study|Lost to Follow-up|0|||
126647272|NCT01283516|455666275|FG001|Overall Study|Lost to Follow-up|0|||
126647273|NCT01283516|455666276|FG002|Overall Study|Lost to Follow-up|0|||
126647274|NCT01283516|455666277|FG003|Overall Study|Lost to Follow-up|0|||
126647275|NCT01283516|455666278|FG004|Overall Study|Lost to Follow-up|0|||
126647276|NCT01283516|455666279|FG005|Overall Study|Lost to Follow-up|0|||
126647277|NCT01283516|455666280|FG006|Overall Study|Lost to Follow-up|0|||
126647278|NCT01283516|455666281|FG007|Overall Study|Lost to Follow-up|0|||
126647279|NCT01283516|455666282|FG008|Overall Study|Lost to Follow-up|1|||
126647280|NCT00132873|455666286|FG000|Overall Study|Adverse Event|3|||
126647281|NCT00132873|455666286|FG000|Overall Study|Lost to Follow-up|1|||
126647282|NCT00132873|455666286|FG000|Overall Study|Lack of Efficacy|1|||
126647283|NCT00132873|455666286|FG000|Overall Study|Withdrawal by Subject|3|||
126647284|NCT00132873|455666286|FG000|Overall Study|Planned Pregnancy|1|||
126647285|NCT00444275|455666287|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
126647286|NCT00444275|455666288|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
126647287|NCT00444275|455666289|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
126647288|NCT00444275|455666290|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
126647289|NCT00444275|455666291|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
126647290|NCT00444275|455666287|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
126647291|NCT00444275|455666288|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
126647292|NCT00444275|455666289|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
126647293|NCT00444275|455666290|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
126647294|NCT00444275|455666291|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
126647295|NCT00444275|455666287|FG000|Maintenance Treatment Phase|Adverse Event|0|||
126647296|NCT00444275|455666288|FG001|Maintenance Treatment Phase|Adverse Event|0|||
126647297|NCT00444275|455666289|FG002|Maintenance Treatment Phase|Adverse Event|3|||
126647298|NCT00444275|455666290|FG003|Maintenance Treatment Phase|Adverse Event|2|||
126647299|NCT00444275|455666291|FG004|Maintenance Treatment Phase|Adverse Event|13|||
126647300|NCT00444275|455666287|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
126647301|NCT00444275|455666288|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
126647302|NCT00444275|455666289|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
126647303|NCT00444275|455666290|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
126647304|NCT00444275|455666291|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
126647305|NCT00444275|455666287|FG000|Maintenance Treatment Phase|Patient's wish|0|||
126647306|NCT00444275|455666288|FG001|Maintenance Treatment Phase|Patient's wish|0|||
126647307|NCT00444275|455666289|FG002|Maintenance Treatment Phase|Patient's wish|19|||
126647308|NCT00444275|455666290|FG003|Maintenance Treatment Phase|Patient's wish|9|||
126647309|NCT00444275|455666291|FG004|Maintenance Treatment Phase|Patient's wish|20|||
126647310|NCT00444275|455666287|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
126647311|NCT00444275|455666288|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
126647312|NCT00444275|455666289|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
126647313|NCT00444275|455666290|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
126647314|NCT00444275|455666291|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
126647315|NCT00444275|455666287|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
126647316|NCT00444275|455666288|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
126647317|NCT00444275|455666289|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
126647318|NCT00444275|455666290|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
126647319|NCT00444275|455666291|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
126647320|NCT02045875|455666292|FG000|Overall Study|Lost to Follow-up|3|||
126647321|NCT02045875|455666293|FG001|Overall Study|Lost to Follow-up|0|||
126647322|NCT02045875|455666292|FG000|Overall Study|Withdrawal by Subject|4|||
126647323|NCT02045875|455666293|FG001|Overall Study|Withdrawal by Subject|3|||
126647324|NCT01114880|455666297|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
126647325|NCT01114880|455666298|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
126647326|NCT01114880|455666297|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
126647327|NCT01114880|455666298|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
126647328|NCT01114880|455666297|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
126647329|NCT01114880|455666298|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
126647330|NCT01114880|455666297|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
126647331|NCT01114880|455666298|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
126647332|NCT01114880|455666297|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
126647333|NCT01114880|455666298|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
126647334|NCT01114880|455666297|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
126647335|NCT01114880|455666298|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
126647336|NCT02626455|455666299|FG000|Overall Study|Other|1|||
126647337|NCT02626455|455666300|FG001|Overall Study|Other|1|||
126647338|NCT02626455|455666301|FG002|Overall Study|Other|0|||
126647339|NCT02626455|455666302|FG003|Overall Study|Other|0|||
126647340|NCT02626455|455666303|FG004|Overall Study|Other|0|||
126647341|NCT02626455|455666304|FG005|Overall Study|Other|17|||
126647342|NCT02626455|455666305|FG006|Overall Study|Other|23|||
126647343|NCT02626455|455666299|FG000|Overall Study|Withdrawal by Subject|1|||
126647344|NCT02626455|455666300|FG001|Overall Study|Withdrawal by Subject|0|||
126647345|NCT02626455|455666301|FG002|Overall Study|Withdrawal by Subject|0|||
126647346|NCT02626455|455666302|FG003|Overall Study|Withdrawal by Subject|0|||
126647347|NCT02626455|455666303|FG004|Overall Study|Withdrawal by Subject|0|||
126647348|NCT02626455|455666304|FG005|Overall Study|Withdrawal by Subject|10|||
126647349|NCT02626455|455666305|FG006|Overall Study|Withdrawal by Subject|6|||
126647350|NCT02626455|455666299|FG000|Overall Study|Physician Decision|0|||
126647351|NCT02626455|455666300|FG001|Overall Study|Physician Decision|2|||
126647352|NCT02626455|455666301|FG002|Overall Study|Physician Decision|2|||
126647353|NCT02626455|455666302|FG003|Overall Study|Physician Decision|2|||
126647354|NCT02626455|455666303|FG004|Overall Study|Physician Decision|1|||
126647355|NCT02626455|455666304|FG005|Overall Study|Physician Decision|10|||
126647356|NCT02626455|455666305|FG006|Overall Study|Physician Decision|3|||
126647357|NCT02626455|455666299|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126647358|NCT02626455|455666300|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126647359|NCT02626455|455666301|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126647360|NCT02626455|455666302|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126647361|NCT02626455|455666303|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126647362|NCT02626455|455666304|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126647363|NCT02626455|455666305|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
126647364|NCT02626455|455666299|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
126647365|NCT02626455|455666300|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
126647366|NCT02626455|455666301|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
126647367|NCT02626455|455666302|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
126647368|NCT02626455|455666303|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
126647369|NCT02626455|455666304|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
126647370|NCT02626455|455666305|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
126647371|NCT02626455|455666299|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
126647372|NCT02626455|455666300|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
126647373|NCT02626455|455666301|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
126647374|NCT02626455|455666302|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
126647375|NCT02626455|455666303|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
126647376|NCT02626455|455666304|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
126647377|NCT02626455|455666305|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
126647378|NCT02626455|455666299|FG000|Overall Study|Patient decision|0|||
126647379|NCT02626455|455666300|FG001|Overall Study|Patient decision|1|||
126647380|NCT02626455|455666301|FG002|Overall Study|Patient decision|0|||
126647381|NCT02626455|455666302|FG003|Overall Study|Patient decision|0|||
126647382|NCT02626455|455666303|FG004|Overall Study|Patient decision|1|||
126647383|NCT02626455|455666304|FG005|Overall Study|Patient decision|36|||
126647384|NCT02626455|455666305|FG006|Overall Study|Patient decision|22|||
126647385|NCT02626455|455666299|FG000|Overall Study|Protocol Violation|0|||
126647386|NCT02626455|455666300|FG001|Overall Study|Protocol Violation|0|||
126647387|NCT02626455|455666301|FG002|Overall Study|Protocol Violation|0|||
126647388|NCT02626455|455666302|FG003|Overall Study|Protocol Violation|0|||
126647389|NCT02626455|455666303|FG004|Overall Study|Protocol Violation|0|||
126647390|NCT02626455|455666304|FG005|Overall Study|Protocol Violation|0|||
126647391|NCT02626455|455666305|FG006|Overall Study|Protocol Violation|1|||
126647392|NCT02626455|455666299|FG000|Overall Study|Progressive disease - radiological progression|0|||
126647393|NCT02626455|455666300|FG001|Overall Study|Progressive disease - radiological progression|0|||
126647394|NCT02626455|455666301|FG002|Overall Study|Progressive disease - radiological progression|0|||
126647395|NCT02626455|455666302|FG003|Overall Study|Progressive disease - radiological progression|0|||
126647396|NCT02626455|455666303|FG004|Overall Study|Progressive disease - radiological progression|0|||
126647397|NCT02626455|455666304|FG005|Overall Study|Progressive disease - radiological progression|11|||
126647398|NCT02626455|455666305|FG006|Overall Study|Progressive disease - radiological progression|22|||
126647399|NCT02626455|455666299|FG000|Overall Study|Progressive disease - clinical progression|0|||
126647400|NCT02626455|455666300|FG001|Overall Study|Progressive disease - clinical progression|0|||
126647401|NCT02626455|455666301|FG002|Overall Study|Progressive disease - clinical progression|0|||
126647402|NCT02626455|455666302|FG003|Overall Study|Progressive disease - clinical progression|0|||
126647403|NCT02626455|455666303|FG004|Overall Study|Progressive disease - clinical progression|0|||
126647404|NCT02626455|455666304|FG005|Overall Study|Progressive disease - clinical progression|1|||
126647405|NCT02626455|455666305|FG006|Overall Study|Progressive disease - clinical progression|2|||
126647406|NCT02626455|455666299|FG000|Overall Study|Lost to Follow-up|0|||
126647407|NCT02626455|455666300|FG001|Overall Study|Lost to Follow-up|0|||
126647408|NCT02626455|455666301|FG002|Overall Study|Lost to Follow-up|0|||
126647409|NCT02626455|455666302|FG003|Overall Study|Lost to Follow-up|0|||
126647410|NCT02626455|455666303|FG004|Overall Study|Lost to Follow-up|0|||
126647411|NCT02626455|455666304|FG005|Overall Study|Lost to Follow-up|1|||
126647412|NCT02626455|455666305|FG006|Overall Study|Lost to Follow-up|0|||
126647413|NCT02626455|455666299|FG000|Overall Study|AE not associated with clinical disease progression|1|||
126647414|NCT02626455|455666300|FG001|Overall Study|AE not associated with clinical disease progression|1|||
126647415|NCT02626455|455666301|FG002|Overall Study|AE not associated with clinical disease progression|0|||
126647416|NCT02626455|455666302|FG003|Overall Study|AE not associated with clinical disease progression|2|||
126647417|NCT02626455|455666303|FG004|Overall Study|AE not associated with clinical disease progression|1|||
126647418|NCT02626455|455666304|FG005|Overall Study|AE not associated with clinical disease progression|65|||
126647419|NCT02626455|455666305|FG006|Overall Study|AE not associated with clinical disease progression|21|||
126647420|NCT02626455|455666299|FG000|Overall Study|AE associated with clinical disease progression|0|||
126647421|NCT02626455|455666300|FG001|Overall Study|AE associated with clinical disease progression|0|||
126647422|NCT02626455|455666301|FG002|Overall Study|AE associated with clinical disease progression|0|||
126647423|NCT02626455|455666302|FG003|Overall Study|AE associated with clinical disease progression|0|||
126647424|NCT02626455|455666303|FG004|Overall Study|AE associated with clinical disease progression|0|||
126647425|NCT02626455|455666304|FG005|Overall Study|AE associated with clinical disease progression|1|||
126647426|NCT02626455|455666305|FG006|Overall Study|AE associated with clinical disease progression|2|||
126647427|NCT02626455|455666299|FG000|Overall Study|Study intervention never administered|0|||
126647428|NCT02626455|455666300|FG001|Overall Study|Study intervention never administered|0|||
126647429|NCT02626455|455666301|FG002|Overall Study|Study intervention never administered|0|||
126647430|NCT02626455|455666302|FG003|Overall Study|Study intervention never administered|0|||
126647431|NCT02626455|455666303|FG004|Overall Study|Study intervention never administered|0|||
126647432|NCT02626455|455666304|FG005|Overall Study|Study intervention never administered|1|||
126647433|NCT02626455|455666305|FG006|Overall Study|Study intervention never administered|3|||
126647434|NCT00384397|455666308|FG000|Overall Study|Adverse Event|0|||
126647435|NCT00384397|455666309|FG001|Overall Study|Adverse Event|1|||
126647436|NCT00384397|455666310|FG002|Overall Study|Adverse Event|2|||
126647437|NCT00384397|455666308|FG000|Overall Study|Protocol Violation|7|||
126647438|NCT00384397|455666309|FG001|Overall Study|Protocol Violation|15|||
126647439|NCT00384397|455666310|FG002|Overall Study|Protocol Violation|13|||
126647440|NCT00384397|455666308|FG000|Overall Study|Lost to Follow-up|11|||
126647441|NCT00384397|455666309|FG001|Overall Study|Lost to Follow-up|13|||
126647442|NCT00384397|455666310|FG002|Overall Study|Lost to Follow-up|3|||
126647443|NCT00384397|455666308|FG000|Overall Study|Withdrawal by Subject|14|||
126647444|NCT00384397|455666309|FG001|Overall Study|Withdrawal by Subject|17|||
126647445|NCT00384397|455666310|FG002|Overall Study|Withdrawal by Subject|15|||
126647446|NCT04372121|455666315|FG000|Overall Study|Lost to Follow-up|0|||
126647447|NCT04372121|455666316|FG001|Overall Study|Lost to Follow-up|0|||
126647448|NCT04372121|455666317|FG002|Overall Study|Lost to Follow-up|0|||
126647449|NCT04372121|455666318|FG003|Overall Study|Lost to Follow-up|1|||
126647450|NCT04372121|455666315|FG000|Overall Study|Protocol Violation|0|||
126647451|NCT04372121|455666316|FG001|Overall Study|Protocol Violation|0|||
126647452|NCT04372121|455666317|FG002|Overall Study|Protocol Violation|1|||
126647453|NCT04372121|455666318|FG003|Overall Study|Protocol Violation|0|||
126647454|NCT04372121|455666315|FG000|Overall Study|Withdrawal by Subject|3|||
126647455|NCT04372121|455666316|FG001|Overall Study|Withdrawal by Subject|1|||
126647456|NCT04372121|455666317|FG002|Overall Study|Withdrawal by Subject|0|||
126647457|NCT04372121|455666318|FG003|Overall Study|Withdrawal by Subject|0|||
126647458|NCT04372121|455666315|FG000|Overall Study|Study termination|6|||
126647459|NCT04372121|455666316|FG001|Overall Study|Study termination|5|||
126647460|NCT04372121|455666317|FG002|Overall Study|Study termination|1|||
126647461|NCT04372121|455666318|FG003|Overall Study|Study termination|1|||
126647462|NCT04372121|455666315|FG000|Overall Study|Hysterectomy planned|1|||
126647463|NCT04372121|455666316|FG001|Overall Study|Hysterectomy planned|0|||
126647464|NCT04372121|455666317|FG002|Overall Study|Hysterectomy planned|0|||
126647465|NCT04372121|455666318|FG003|Overall Study|Hysterectomy planned|0|||
126647466|NCT03345576|455666319|FG000|Overall Study|Withdrawal by Subject|2|||
126647467|NCT03345576|455666320|FG001|Overall Study|Withdrawal by Subject|2|||
126647468|NCT03345576|455666319|FG000|Overall Study|Adverse Event|1|||
126647469|NCT03345576|455666320|FG001|Overall Study|Adverse Event|0|||
126647470|NCT03002220|455668042|FG000|Overall Study|Lack of Efficacy|2|||
126647471|NCT03002220|455668042|FG000|Overall Study|Withdrawal by Subject|3|||
126647472|NCT03002220|455668042|FG000|Overall Study|Adverse Event|2|||
126647473|NCT03002220|455668042|FG000|Overall Study|Disease progression|13|||
126647474|NCT03002220|455668042|FG000|Overall Study|Physician Decision|1|||
126647475|NCT01302080|455668046|FG000|Overall Study|Withdrew Consent|92|||
126647476|NCT01302080|455668047|FG001|Overall Study|Withdrew Consent|39|||
126647477|NCT01302080|455668046|FG000|Overall Study|Patient/Family Moved|28|||
126647478|NCT01302080|455668047|FG001|Overall Study|Patient/Family Moved|3|||
126647479|NCT01302080|455668046|FG000|Overall Study|Lost to Follow-up|192|||
126647480|NCT01302080|455668047|FG001|Overall Study|Lost to Follow-up|93|||
126647481|NCT01302080|455668046|FG000|Overall Study|Death|1|||
126647482|NCT01302080|455668047|FG001|Overall Study|Death|0|||
126647483|NCT01302080|455668046|FG000|Overall Study|Other|52|||
126647484|NCT01302080|455668047|FG001|Overall Study|Other|8|||
126647485|NCT01302080|455668046|FG000|Overall Study|Reason Missing For Discontinuation|1|||
126647486|NCT01302080|455668047|FG001|Overall Study|Reason Missing For Discontinuation|0|||
126647487|NCT00574873|455668050|FG000|Overall Study|Withdrawal by Subject|18|||
126647488|NCT00574873|455668051|FG001|Overall Study|Withdrawal by Subject|19|||
126647489|NCT00574873|455668050|FG000|Overall Study|Investigator request|18|||
126647490|NCT00574873|455668051|FG001|Overall Study|Investigator request|8|||
126647491|NCT00574873|455668050|FG000|Overall Study|Death|15|||
126647492|NCT00574873|455668051|FG001|Overall Study|Death|14|||
126647493|NCT00574873|455668050|FG000|Overall Study|Lost to Follow-up|14|||
126647494|NCT00574873|455668051|FG001|Overall Study|Lost to Follow-up|5|||
126647495|NCT00574873|455668050|FG000|Overall Study|Other|40|||
126647496|NCT00574873|455668051|FG001|Overall Study|Other|4|||
126647497|NCT00574873|455668050|FG000|Overall Study|Discontinuation of study by sponsor|5|||
126647498|NCT00574873|455668051|FG001|Overall Study|Discontinuation of study by sponsor|199|||
126647499|NCT00574873|455668050|FG000|Overall Study|Blank, site closed per local regulations|2|||
126647500|NCT00574873|455668051|FG001|Overall Study|Blank, site closed per local regulations|2|||
126647501|NCT00574873|455668050|FG000|Overall Study|Extension Study|126|||
126647502|NCT00574873|455668051|FG001|Overall Study|Extension Study|0|||
126647503|NCT00201643|455668052|FG000|Overall Study|Withdrawal by Subject|5|||
126647504|NCT00201643|455668053|FG001|Overall Study|Withdrawal by Subject|4|||
126647505|NCT01638429|455668060|FG000|Overall Study|Withdrawal by Subject|1|||
126647506|NCT02040584|455668063|FG000|Overall Study|Adverse Event|13|||
126647507|NCT02040584|455668064|FG001|Overall Study|Adverse Event|6|||
126647508|NCT02040584|455668063|FG000|Overall Study|Protocol Violation|9|||
126647509|NCT02040584|455668064|FG001|Overall Study|Protocol Violation|11|||
126647510|NCT02040584|455668063|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126647511|NCT02040584|455668064|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126647512|NCT02040584|455668063|FG000|Overall Study|Death|6|||
126647513|NCT02040584|455668064|FG001|Overall Study|Death|3|||
126647514|NCT02040584|455668063|FG000|Overall Study|Transplant rejection/retransplant|0|||
126647515|NCT02040584|455668064|FG001|Overall Study|Transplant rejection/retransplant|1|||
126647516|NCT02040584|455668063|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
126647517|NCT02040584|455668064|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
126647518|NCT00996476|455668065|FG000|Overall Study|Withdrawal by Subject|1|||
126647519|NCT00996476|455668066|FG001|Overall Study|Withdrawal by Subject|2|||
126647520|NCT00996476|455668067|FG002|Overall Study|Withdrawal by Subject|1|||
126647521|NCT00996476|455668068|FG003|Overall Study|Withdrawal by Subject|0|||
126647522|NCT00996476|455668069|FG004|Overall Study|Withdrawal by Subject|1|||
126647523|NCT00996476|455668065|FG000|Overall Study|Adverse Event|0|||
126647524|NCT00996476|455668066|FG001|Overall Study|Adverse Event|1|||
126647525|NCT00996476|455668067|FG002|Overall Study|Adverse Event|0|||
126647526|NCT00996476|455668068|FG003|Overall Study|Adverse Event|0|||
126647527|NCT00996476|455668069|FG004|Overall Study|Adverse Event|1|||
126647528|NCT05540717|455668070|FG000|Overall Study|Lost to Follow-up|2|||
126647529|NCT05540717|455668071|FG001|Overall Study|Lost to Follow-up|5|||
126313543|NCT02548351|454437671|FG000|Overall Study|Lost to Follow-up|43|||
126647530|NCT05540717|455668070|FG000|Overall Study|Withdrawal by Subject|6|||
126647531|NCT05540717|455668071|FG001|Overall Study|Withdrawal by Subject|6|||
126647532|NCT05540717|455668070|FG000|Overall Study|Sponsor request|1|||
126647533|NCT05540717|455668071|FG001|Overall Study|Sponsor request|0|||
126647534|NCT05540717|455668070|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
126647535|NCT05540717|455668071|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
126647536|NCT05540717|455668070|FG000|Overall Study|Other|0|||
126647537|NCT05540717|455668071|FG001|Overall Study|Other|1|||
126647538|NCT00473265|455668072|FG000|Overall Study|Unrelated adverse event|5|||
126647539|NCT00473265|455668072|FG000|Overall Study|Off treatment early|15|||
126647540|NCT01802567|455668073|FG000|Overall Study|Withdrawal by Subject|2|||
126647541|NCT01802567|455668073|FG000|Overall Study|Physician Decision|1|||
126647542|NCT01802567|455668073|FG000|Overall Study|Lack of Efficacy|7|||
126647543|NCT01802567|455668073|FG000|Overall Study|Consented but did not start therapy|7|||
126647544|NCT01802567|455668073|FG000|Overall Study|Protocol Violation|1|||
126647545|NCT01940939|455668076|FG000|Overall Study|Withdrawal by Subject|2|||
126647546|NCT01940939|455668077|FG001|Overall Study|Withdrawal by Subject|8|||
126647547|NCT01470001|455668078|FG000|Overall Study|Lost to Follow-up|1|||
126647548|NCT01470001|455668079|FG001|Overall Study|Lost to Follow-up|1|||
126647549|NCT01470001|455668078|FG000|Overall Study|Physician Decision|2|||
126647550|NCT01470001|455668079|FG001|Overall Study|Physician Decision|0|||
126647551|NCT01470001|455668078|FG000|Overall Study|Withdrawal by Subject|2|||
126647552|NCT01470001|455668079|FG001|Overall Study|Withdrawal by Subject|1|||
126647553|NCT01895101|455668080|FG000|Overall Study|OPCAB procedure|1|||
126647554|NCT01895101|455668081|FG001|Overall Study|OPCAB procedure|1|||
126647555|NCT01895101|455668082|FG002|Overall Study|OPCAB procedure|3|||
126647556|NCT01895101|455668080|FG000|Overall Study|Withdrawal by Subject|0|||
126647557|NCT01895101|455668081|FG001|Overall Study|Withdrawal by Subject|1|||
126647558|NCT01895101|455668082|FG002|Overall Study|Withdrawal by Subject|2|||
126647559|NCT01895101|455668080|FG000|Overall Study|another study, enrolled in other study|0|||
126758570|NCT02322866|456066641|FG000|Overall Study|Noncompliance with Treatment|3|||
126758571|NCT02322866|456066642|FG001|Overall Study|Noncompliance with Treatment|4|||
126758572|NCT02322866|456066641|FG000|Overall Study|Lack of Efficacy|3|||
126758573|NCT02322866|456066642|FG001|Overall Study|Lack of Efficacy|1|||
126758574|NCT02322866|456066641|FG000|Overall Study|Other Miscellaneous Reasons|6|||
126758575|NCT02322866|456066642|FG001|Overall Study|Other Miscellaneous Reasons|6|||
126758576|NCT02181634|456066645|FG000|Overall Study|Lack of Efficacy|33|||
126758577|NCT02181634|456066645|FG000|Overall Study|Adverse Event|17|||
126758578|NCT02181634|456066645|FG000|Overall Study|Physician Decision|8|||
126758579|NCT02181634|456066645|FG000|Overall Study|Withdrawal by Subject|5|||
126758580|NCT02181634|456066645|FG000|Overall Study|Death|2|||
126758581|NCT02181634|456066645|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
126758582|NCT02181634|456066645|FG000|Overall Study|Ineligible|1|||
126758583|NCT02181634|456066645|FG000|Overall Study|Max number of dose reduction|1|||
126758584|NCT02181634|456066645|FG000|Overall Study|Symptomatic progression|1|||
126758585|NCT02181634|456066645|FG000|Overall Study|Patient opted to proceed to surgery|1|||
126758586|NCT01928758|456066661|FG000|Overall Study|Lost to Follow-up|14|||
126758587|NCT01928758|456066662|FG001|Overall Study|Lost to Follow-up|9|||
126758588|NCT01928758|456066661|FG000|Overall Study|Withdrawal by Subject|5|||
126758589|NCT01928758|456066662|FG001|Overall Study|Withdrawal by Subject|2|||
126758590|NCT01928758|456066661|FG000|Overall Study|Adverse Event|3|||
126758591|NCT01928758|456066662|FG001|Overall Study|Adverse Event|5|||
126758592|NCT01928758|456066661|FG000|Overall Study|Protocol Violation|3|||
126758593|NCT01928758|456066662|FG001|Overall Study|Protocol Violation|4|||
126758594|NCT00719706|456066663|FG000|Overall Study|Adverse Event|5|||
126758595|NCT00719706|456066664|FG001|Overall Study|Adverse Event|4|||
126758596|NCT00719706|456066663|FG000|Overall Study|Withdrawal by Subject|1|||
126758597|NCT00719706|456066664|FG001|Overall Study|Withdrawal by Subject|2|||
126758598|NCT00719706|456066663|FG000|Overall Study|Protocol Violation|3|||
126758599|NCT00719706|456066664|FG001|Overall Study|Protocol Violation|0|||
126758600|NCT02681094|456066665|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
126758601|NCT02681094|456066666|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
126758602|NCT02681094|456066667|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
126313544|NCT02548351|454437672|FG001|Overall Study|Lost to Follow-up|50|||
126313545|NCT02548351|454437673|FG002|Overall Study|Lost to Follow-up|57|||
126313546|NCT02548351|454437671|FG000|Overall Study|Other|19|||
126758603|NCT02681094|456066665|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
126758604|NCT02681094|456066666|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
126758605|NCT02681094|456066667|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
126313547|NCT02548351|454437672|FG001|Overall Study|Other|16|||
126647560|NCT01895101|455668081|FG001|Overall Study|another study, enrolled in other study|1|||
126647561|NCT01895101|455668082|FG002|Overall Study|another study, enrolled in other study|0|||
126758606|NCT02681094|456066665|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
126758607|NCT02681094|456066666|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
126647562|NCT01895101|455668080|FG000|Overall Study|Death|0|||
126647563|NCT01895101|455668081|FG001|Overall Study|Death|1|||
126647564|NCT01895101|455668082|FG002|Overall Study|Death|0|||
126647565|NCT01895101|455668080|FG000|Overall Study|coagulation disorder|0|||
126647566|NCT01895101|455668081|FG001|Overall Study|coagulation disorder|1|||
126647567|NCT01895101|455668082|FG002|Overall Study|coagulation disorder|0|||
126647568|NCT02591953|455668085|FG000|Overall Study|Lost to Follow-up|6|||
126647569|NCT02591953|455668086|FG001|Overall Study|Lost to Follow-up|6|||
126647570|NCT03167359|455668089|FG000|Overall Study|Physician Decision|1|||
126647571|NCT03167359|455668089|FG000|Overall Study|Lost to Follow-up|1|||
126647572|NCT01896557|455668090|FG000|Clopidogrel Alone|Adverse Event|1|||
126647573|NCT01896557|455668091|FG001|Clopidogrel Alone|Adverse Event|0|||
126647574|NCT01896557|455668090|FG000|Clopidogrel + GI Protector|low adherence|1|||
126647575|NCT01896557|455668091|FG001|Clopidogrel + GI Protector|low adherence|1|||
126647576|NCT01896557|455668090|FG000|Clopidogrel + GI Protector|Reading error|1|||
126647577|NCT01896557|455668091|FG001|Clopidogrel + GI Protector|Reading error|3|||
126647578|NCT01517295|455668092|FG000|Overall Study|Physician Decision|1|||
126647579|NCT01517295|455668093|FG001|Overall Study|Physician Decision|0|||
126647580|NCT02236988|455668094|FG000|Overall Study|Lost to Follow-up|0|||
126647581|NCT02236988|455668095|FG001|Overall Study|Lost to Follow-up|0|||
126647582|NCT02236988|455668096|FG002|Overall Study|Lost to Follow-up|0|||
126647583|NCT02236988|455668097|FG003|Overall Study|Lost to Follow-up|1|||
126647584|NCT02236988|455668094|FG000|Overall Study|Unable to Comply with Study Visits|0|||
126647585|NCT02236988|455668095|FG001|Overall Study|Unable to Comply with Study Visits|0|||
126647586|NCT02236988|455668096|FG002|Overall Study|Unable to Comply with Study Visits|0|||
126647587|NCT02236988|455668097|FG003|Overall Study|Unable to Comply with Study Visits|2|||
126647588|NCT04032613|455668098|FG000|Overall Study|Did not complete post-program assessment|5|||
126647589|NCT04032613|455668099|FG001|Overall Study|Did not complete post-program assessment|2|||
126647590|NCT01659853|455668100|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
126647591|NCT01659853|455668101|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
126647592|NCT01659853|455668100|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
126647593|NCT01659853|455668101|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
126647594|NCT05560243|455668103|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
126647595|NCT00939822|455668106|FG000|Overall Study|Lost to Follow-up|1|||
126647596|NCT00939822|455668107|FG001|Overall Study|Lost to Follow-up|0|||
126647597|NCT00939822|455668106|FG000|Overall Study|withdrew from study due to busy schedule|1|||
126647598|NCT00939822|455668107|FG001|Overall Study|withdrew from study due to busy schedule|1|||
126647599|NCT00939822|455668106|FG000|Overall Study|Mental health issues|0|||
126647600|NCT00939822|455668107|FG001|Overall Study|Mental health issues|2|||
126647601|NCT01232738|455668108|FG000|Overall Study|Death|3|||
126647602|NCT01232738|455668108|FG000|Overall Study|Physician Decision|2|||
126647603|NCT01232738|455668108|FG000|Overall Study|Lost to Follow-up|1|||
126647604|NCT01232738|455668108|FG000|Overall Study|Withdrawal by Subject|2|||
126647605|NCT01232738|455668108|FG000|Overall Study|Adverse Event|5|||
126647606|NCT03046121|455668109|FG000|Overall Study|Death|32|||
126647607|NCT03046121|455668110|FG001|Overall Study|Death|60|||
126647608|NCT03046121|455668109|FG000|Overall Study|Withdrawal by Subject|14|||
126647609|NCT03046121|455668110|FG001|Overall Study|Withdrawal by Subject|12|||
126647610|NCT04155047|455668113|FG000|Overall Study|Adverse Event|1|||
126647611|NCT04155047|455668114|FG001|Overall Study|Adverse Event|0|||
126647612|NCT04155047|455668113|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
126647613|NCT04155047|455668114|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
126647614|NCT03361605|455668121|FG000|Overall Study|Analyzable data not available|3|||
126647615|NCT02530970|455668122|FG000|Overall Study|Adverse Event|8|||
126647616|NCT02530970|455668122|FG000|Overall Study|Lost to Follow-up|88|||
126647617|NCT02530970|455668122|FG000|Overall Study|Physician Decision|5|||
126647618|NCT02530970|455668122|FG000|Overall Study|Withdrawal by Subject|14|||
126647619|NCT02530970|455668122|FG000|Overall Study|Death|6|||
126647620|NCT02530970|455668122|FG000|Overall Study|Hospitalization|1|||
126647621|NCT02530970|455668122|FG000|Overall Study|Insurance|2|||
126647622|NCT02530970|455668122|FG000|Overall Study|Explant|2|||
126647623|NCT02530970|455668122|FG000|Overall Study|Change in Provider|5|||
126647624|NCT02530970|455668122|FG000|Overall Study|Relocation|3|||
126647625|NCT02770612|455668123|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
126647626|NCT01365481|455668124|FG000|Overall Study|Adverse Event|6|||
126647627|NCT01365481|455668125|FG001|Overall Study|Adverse Event|9|||
126647628|NCT01365481|455668126|FG002|Overall Study|Adverse Event|0|||
126647629|NCT01365481|455668127|FG003|Overall Study|Adverse Event|2|||
126647630|NCT01365481|455668124|FG000|Overall Study|Withdrawal by Subject|0|||
126647631|NCT01365481|455668125|FG001|Overall Study|Withdrawal by Subject|2|||
126647632|NCT01365481|455668126|FG002|Overall Study|Withdrawal by Subject|1|||
126647633|NCT01365481|455668127|FG003|Overall Study|Withdrawal by Subject|1|||
126647634|NCT01365481|455668124|FG000|Overall Study|Lost to Follow-up|1|||
126647635|NCT01365481|455668125|FG001|Overall Study|Lost to Follow-up|1|||
126647636|NCT01365481|455668126|FG002|Overall Study|Lost to Follow-up|2|||
126647637|NCT01365481|455668127|FG003|Overall Study|Lost to Follow-up|3|||
126647638|NCT01365481|455668124|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126647639|NCT01365481|455668125|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126647640|NCT01365481|455668126|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126647641|NCT01365481|455668127|FG003|Overall Study|Abnormal laboratory value(s)|0|||
126647642|NCT01365481|455668124|FG000|Overall Study|Administrative problems|0|||
126647643|NCT01365481|455668125|FG001|Overall Study|Administrative problems|1|||
126647644|NCT01365481|455668126|FG002|Overall Study|Administrative problems|0|||
126647645|NCT01365481|455668127|FG003|Overall Study|Administrative problems|0|||
126647646|NCT01365481|455668124|FG000|Overall Study|Protocol deviation|0|||
126647647|NCT01365481|455668125|FG001|Overall Study|Protocol deviation|1|||
126647648|NCT01365481|455668126|FG002|Overall Study|Protocol deviation|0|||
126647649|NCT01365481|455668127|FG003|Overall Study|Protocol deviation|1|||
126647650|NCT01365481|455668124|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126647651|NCT01365481|455668125|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126647652|NCT01365481|455668126|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
126647653|NCT01365481|455668127|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
126647654|NCT00958841|455668132|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126647655|NCT00958841|455668132|FG000|Overall Study|Abnormal test procedure result(s)|3|||
126647656|NCT00958841|455668132|FG000|Overall Study|Administrative problems|1|||
126647657|NCT00958841|455668132|FG000|Overall Study|Adverse Event|8|||
126647658|NCT00958841|455668132|FG000|Overall Study|New cancer therapy|5|||
126647659|NCT00958841|455668132|FG000|Overall Study|Withdrawal by Subject|1|||
126647660|NCT00958841|455668132|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
126647661|NCT00958841|455668132|FG000|Overall Study|Completed M6/did not enter extension|27|||
126647662|NCT00958841|455668132|FG000|Overall Study|Discontinued prior to M*|28|||
126647663|NCT03014011|455668136|FG000|First Intervention|Withdrawal by Subject|1|||
126647664|NCT03014011|455668137|FG001|First Intervention|Withdrawal by Subject|0|||
126647665|NCT03014011|455668136|FG000|Washout|Withdrawal by Subject|1|||
126647666|NCT03014011|455668137|FG001|Washout|Withdrawal by Subject|0|||
126647667|NCT02416453|455668138|FG000|Overall Study|Adverse Event|0|||
126647668|NCT02416453|455668139|FG001|Overall Study|Adverse Event|0|||
126647669|NCT02416453|455668140|FG002|Overall Study|Adverse Event|0|||
126647670|NCT02416453|455668141|FG003|Overall Study|Adverse Event|2|||
126647671|NCT02416453|455668142|FG004|Overall Study|Adverse Event|0|||
126647672|NCT02416453|455668143|FG005|Overall Study|Adverse Event|1|||
126647673|NCT02416453|455668144|FG006|Overall Study|Adverse Event|0|||
126647674|NCT02416453|455668145|FG007|Overall Study|Adverse Event|0|||
126647675|NCT02416453|455668146|FG008|Overall Study|Adverse Event|0|||
126647676|NCT02416453|455668147|FG009|Overall Study|Adverse Event|0|||
126647677|NCT02416453|455668148|FG010|Overall Study|Adverse Event|0|||
126647678|NCT02416453|455668138|FG000|Overall Study|Lost to Follow-up|1|||
126647679|NCT02416453|455668139|FG001|Overall Study|Lost to Follow-up|3|||
126647680|NCT02416453|455668140|FG002|Overall Study|Lost to Follow-up|0|||
126647681|NCT02416453|455668141|FG003|Overall Study|Lost to Follow-up|8|||
126647682|NCT02416453|455668142|FG004|Overall Study|Lost to Follow-up|0|||
126647683|NCT02416453|455668143|FG005|Overall Study|Lost to Follow-up|5|||
126647684|NCT02416453|455668144|FG006|Overall Study|Lost to Follow-up|1|||
126647685|NCT02416453|455668145|FG007|Overall Study|Lost to Follow-up|3|||
126647686|NCT02416453|455668146|FG008|Overall Study|Lost to Follow-up|1|||
126647687|NCT02416453|455668147|FG009|Overall Study|Lost to Follow-up|0|||
126647688|NCT02416453|455668148|FG010|Overall Study|Lost to Follow-up|0|||
126647689|NCT02416453|455668138|FG000|Overall Study|Physician Decision|0|||
126647690|NCT02416453|455668139|FG001|Overall Study|Physician Decision|0|||
126647691|NCT02416453|455668140|FG002|Overall Study|Physician Decision|0|||
126647692|NCT02416453|455668141|FG003|Overall Study|Physician Decision|0|||
126647693|NCT02416453|455668142|FG004|Overall Study|Physician Decision|0|||
126647694|NCT02416453|455668143|FG005|Overall Study|Physician Decision|1|||
126647695|NCT02416453|455668144|FG006|Overall Study|Physician Decision|1|||
126647696|NCT02416453|455668145|FG007|Overall Study|Physician Decision|1|||
126647697|NCT02416453|455668146|FG008|Overall Study|Physician Decision|0|||
126647698|NCT02416453|455668147|FG009|Overall Study|Physician Decision|0|||
126647699|NCT02416453|455668148|FG010|Overall Study|Physician Decision|0|||
126647700|NCT02416453|455668138|FG000|Overall Study|Withdrawal by Subject|2|||
126647701|NCT02416453|455668139|FG001|Overall Study|Withdrawal by Subject|0|||
126647702|NCT02416453|455668140|FG002|Overall Study|Withdrawal by Subject|0|||
126647703|NCT02416453|455668141|FG003|Overall Study|Withdrawal by Subject|5|||
126647704|NCT02416453|455668142|FG004|Overall Study|Withdrawal by Subject|1|||
126647705|NCT02416453|455668143|FG005|Overall Study|Withdrawal by Subject|8|||
126647706|NCT02416453|455668144|FG006|Overall Study|Withdrawal by Subject|0|||
126647707|NCT02416453|455668145|FG007|Overall Study|Withdrawal by Subject|8|||
126647708|NCT02416453|455668146|FG008|Overall Study|Withdrawal by Subject|4|||
126647709|NCT02416453|455668147|FG009|Overall Study|Withdrawal by Subject|0|||
126647710|NCT02416453|455668148|FG010|Overall Study|Withdrawal by Subject|0|||
126647711|NCT02416453|455668138|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126647712|NCT02416453|455668139|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126647713|NCT02416453|455668140|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
126647714|NCT02416453|455668141|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126647715|NCT02416453|455668142|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126647716|NCT02416453|455668143|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126647717|NCT02416453|455668144|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126647718|NCT02416453|455668145|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126647719|NCT02416453|455668146|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126647720|NCT02416453|455668147|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126647721|NCT02416453|455668148|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
126647722|NCT02416453|455668138|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126647723|NCT02416453|455668139|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126647724|NCT02416453|455668140|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126647725|NCT02416453|455668141|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126647726|NCT02416453|455668142|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126647727|NCT02416453|455668143|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
126647728|NCT02416453|455668144|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126647729|NCT02416453|455668145|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126647730|NCT02416453|455668146|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126647731|NCT02416453|455668147|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126647732|NCT02416453|455668148|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
126647733|NCT00831129|455668156|FG000|Overall Study|Adverse Event|0|||
126647734|NCT00831129|455668157|FG001|Overall Study|Adverse Event|1|||
126647735|NCT00831129|455668156|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
126647736|NCT00831129|455668157|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
126647737|NCT01877239|455668158|FG000|Overall Study|Adverse Event|4|||
126647738|NCT01877239|455668158|FG000|Overall Study|Disease Remission|1|||
126647739|NCT01877239|455668158|FG000|Overall Study|Withdrawal by Subject|4|||
126647740|NCT01877239|455668158|FG000|Overall Study|Other|2|||
126647741|NCT01877239|455668158|FG000|Overall Study|Lack of Efficacy|4|||
126647742|NCT01877239|455668158|FG000|Overall Study|Data not available|35|||
126647743|NCT00743431|455668164|FG000|Overall Study|Toxicity|6|||
126647744|NCT00743431|455668164|FG000|Overall Study|Tumor progression|56|||
126647745|NCT00743431|455668164|FG000|Overall Study|Withdrawal by Subject|13|||
126647746|NCT00743431|455668164|FG000|Overall Study|Death|9|||
126647747|NCT00743431|455668164|FG000|Overall Study|Reason for discontinuation not specified|29|||
126647748|NCT00743431|455668164|FG000|Overall Study|No documentation available|13|||
126647749|NCT03291288|455668165|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
126647750|NCT03291288|455668166|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
126647751|NCT03291288|455668165|FG000|Drug-drug Interaction Phase|Disease progression|1|||
126647752|NCT03291288|455668166|FG001|Drug-drug Interaction Phase|Disease progression|0|||
126647753|NCT03291288|455668165|FG000|Drug-drug Interaction Phase|Other|3|||
126647754|NCT03291288|455668166|FG001|Drug-drug Interaction Phase|Other|0|||
126647755|NCT03291288|455668165|FG000|Pexidartinib Only|Ongoing|0|||
126647756|NCT03291288|455668166|FG001|Pexidartinib Only|Ongoing|2|||
126647757|NCT04276415|455668167|FG000|Overall Study|Adverse Event|0|||
126647758|NCT04276415|455668168|FG001|Overall Study|Adverse Event|0|||
126647759|NCT04276415|455668169|FG002|Overall Study|Adverse Event|0|||
126647760|NCT04276415|455668170|FG003|Overall Study|Adverse Event|3|||
126647761|NCT04276415|455668171|FG004|Overall Study|Adverse Event|0|||
126647762|NCT04276415|455668172|FG005|Overall Study|Adverse Event|0|||
126647763|NCT04276415|455668167|FG000|Overall Study|Clinical progression|1|||
126647764|NCT04276415|455668168|FG001|Overall Study|Clinical progression|1|||
126647765|NCT04276415|455668169|FG002|Overall Study|Clinical progression|0|||
126647766|NCT04276415|455668170|FG003|Overall Study|Clinical progression|0|||
126647767|NCT04276415|455668171|FG004|Overall Study|Clinical progression|1|||
126647768|NCT04276415|455668172|FG005|Overall Study|Clinical progression|0|||
126647769|NCT04276415|455668167|FG000|Overall Study|Other|0|||
126647770|NCT04276415|455668168|FG001|Overall Study|Other|0|||
126647771|NCT04276415|455668169|FG002|Overall Study|Other|0|||
126647772|NCT04276415|455668170|FG003|Overall Study|Other|1|||
126647773|NCT04276415|455668171|FG004|Overall Study|Other|0|||
126647774|NCT04276415|455668172|FG005|Overall Study|Other|0|||
126647775|NCT04276415|455668167|FG000|Overall Study|Physician Decision|0|||
126647776|NCT04276415|455668168|FG001|Overall Study|Physician Decision|0|||
126647777|NCT04276415|455668169|FG002|Overall Study|Physician Decision|1|||
126647778|NCT04276415|455668170|FG003|Overall Study|Physician Decision|3|||
126647779|NCT04276415|455668171|FG004|Overall Study|Physician Decision|2|||
126647780|NCT04276415|455668172|FG005|Overall Study|Physician Decision|0|||
126647781|NCT04276415|455668167|FG000|Overall Study|Progressive disease|3|||
126647782|NCT04276415|455668168|FG001|Overall Study|Progressive disease|3|||
126647783|NCT04276415|455668169|FG002|Overall Study|Progressive disease|4|||
126647784|NCT04276415|455668170|FG003|Overall Study|Progressive disease|5|||
126647785|NCT04276415|455668171|FG004|Overall Study|Progressive disease|1|||
126647786|NCT04276415|455668172|FG005|Overall Study|Progressive disease|2|||
126647787|NCT04276415|455668167|FG000|Overall Study|Withdrawal by patient|0|||
126647788|NCT04276415|455668168|FG001|Overall Study|Withdrawal by patient|0|||
126647789|NCT04276415|455668169|FG002|Overall Study|Withdrawal by patient|0|||
126647790|NCT04276415|455668170|FG003|Overall Study|Withdrawal by patient|1|||
126647791|NCT04276415|455668171|FG004|Overall Study|Withdrawal by patient|2|||
126647792|NCT04276415|455668172|FG005|Overall Study|Withdrawal by patient|0|||
126647793|NCT03309813|455668173|FG000|Main Randomized Study|Withdrawal by Subject|1|||
126647794|NCT03309813|455668174|FG001|Main Randomized Study|Withdrawal by Subject|0|||
126647795|NCT01989169|455668177|FG000|Period 2|Adverse Event|0|||
126647796|NCT01989169|455668178|FG001|Period 2|Adverse Event|1|||
126647797|NCT02406677|455668179|FG000|Overall Study|Death|16|||
126647798|NCT02406677|455668180|FG001|Overall Study|Death|8|||
126647799|NCT02406677|455668179|FG000|Overall Study|Discharged without P2Y12|1|||
126313548|NCT02548351|454437673|FG002|Overall Study|Other|20|||
126313549|NCT02548351|454437671|FG000|Overall Study|Missing|1|||
126313550|NCT02548351|454437672|FG001|Overall Study|Missing|1|||
126313551|NCT02548351|454437673|FG002|Overall Study|Missing|0|||
126313552|NCT00125242|454437677|FG000|Overall Study|did not qualify|7|||
126313553|NCT00125242|454437678|FG001|Overall Study|did not qualify|2|||
126313554|NCT01664949|454437679|FG000|Overall Study|Adverse Event|11|||
126313555|NCT01664949|454437680|FG001|Overall Study|Adverse Event|12|||
126313556|NCT01664949|454437679|FG000|Overall Study|Lack of Efficacy|1|||
126313557|NCT01664949|454437680|FG001|Overall Study|Lack of Efficacy|1|||
126313558|NCT01664949|454437679|FG000|Overall Study|Lost to Follow-up|1|||
126313559|NCT01664949|454437680|FG001|Overall Study|Lost to Follow-up|2|||
126313560|NCT01664949|454437679|FG000|Overall Study|Personal Reasons|3|||
126313561|NCT01664949|454437680|FG001|Overall Study|Personal Reasons|4|||
126313562|NCT01664949|454437679|FG000|Overall Study|Protocol Violation|5|||
126313563|NCT01664949|454437680|FG001|Overall Study|Protocol Violation|5|||
126313564|NCT01664949|454437679|FG000|Overall Study|Other Miscellaneous Reasons|3|||
126313565|NCT01664949|454437680|FG001|Overall Study|Other Miscellaneous Reasons|1|||
126313566|NCT03003494|454437681|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
126313567|NCT05238025|454437682|FG000|Overall Study|Adverse Event|2|||
126313568|NCT05238025|454437683|FG001|Overall Study|Adverse Event|2|||
126313569|NCT05238025|454437682|FG000|Overall Study|Lost to Follow-up|334|||
126313570|NCT05238025|454437683|FG001|Overall Study|Lost to Follow-up|339|||
126313571|NCT05238025|454437682|FG000|Overall Study|Withdrawal by Subject|203|||
126313572|NCT05238025|454437683|FG001|Overall Study|Withdrawal by Subject|222|||
126313573|NCT05238025|454437682|FG000|Overall Study|Physician Decision|20|||
126313574|NCT05238025|454437683|FG001|Overall Study|Physician Decision|8|||
126313575|NCT05238025|454437682|FG000|Overall Study|Protocol Violation|6|||
126313576|NCT05238025|454437683|FG001|Overall Study|Protocol Violation|2|||
126313577|NCT05238025|454437682|FG000|Overall Study|Death|38|||
126313578|NCT05238025|454437683|FG001|Overall Study|Death|32|||
126313579|NCT05238025|454437682|FG000|Overall Study|Study terminated by Sponsor|6358|||
126313580|NCT05238025|454437683|FG001|Overall Study|Study terminated by Sponsor|6358|||
126313581|NCT05238025|454437682|FG000|Overall Study|Other Reason|669|||
126313582|NCT05238025|454437683|FG001|Overall Study|Other Reason|690|||
126313583|NCT03814720|454437685|FG000|Overall Study|Lost to Follow-up|0|||
126313584|NCT03814720|454437686|FG001|Overall Study|Lost to Follow-up|1|||
126313585|NCT03814720|454437687|FG002|Overall Study|Lost to Follow-up|0|||
126313586|NCT03814720|454437688|FG003|Overall Study|Lost to Follow-up|0|||
126313587|NCT03814720|454437689|FG004|Overall Study|Lost to Follow-up|0|||
126313588|NCT03197324|454437690|FG000|Overall Study|Adverse Event|0|||
126313589|NCT03197324|454437691|FG001|Overall Study|Adverse Event|1|||
126313590|NCT01632150|454439251|FG000|Overall Study|Disease progression|27|||
126313591|NCT01632150|454439251|FG000|Overall Study|Study drug toxicity|1|||
126313592|NCT01632150|454439251|FG000|Overall Study|Unrelated adverse event|7|||
126313593|NCT01632150|454439251|FG000|Overall Study|Withdrawal by Subject|2|||
126313594|NCT01632150|454439251|FG000|Overall Study|Patient underwent autologous transplant|1|||
126313595|NCT01632150|454439251|FG000|Overall Study|Moved to compassionate program|2|||
126313596|NCT02339155|454439257|FG000|Overall Study|Adverse Event|0|||
126313597|NCT02339155|454439258|FG001|Overall Study|Adverse Event|6|||
126313598|NCT02339155|454439257|FG000|Overall Study|Death|1|||
126313599|NCT02339155|454439258|FG001|Overall Study|Death|1|||
126313600|NCT02339155|454439257|FG000|Overall Study|Lost to Follow-up|8|||
126313601|NCT02339155|454439258|FG001|Overall Study|Lost to Follow-up|9|||
126313602|NCT02339155|454439257|FG000|Overall Study|Physician Decision|2|||
126313603|NCT02339155|454439258|FG001|Overall Study|Physician Decision|1|||
126313604|NCT02339155|454439257|FG000|Overall Study|Withdrawal by Subject|4|||
126313605|NCT02339155|454439258|FG001|Overall Study|Withdrawal by Subject|4|||
126313606|NCT01214252|454439259|FG000|Overall Study|Not eligible per protocol|82|||
126313607|NCT04327661|454439262|FG000|Overall Study|Withdrawal by Subject|1|||
126313608|NCT04327661|454439263|FG001|Overall Study|Withdrawal by Subject|0|||
126313609|NCT04327661|454439264|FG002|Overall Study|Withdrawal by Subject|0|||
126313610|NCT01877551|454439267|FG000|Overall Study|Physician Decision|0|||
126313611|NCT01877551|454439268|FG001|Overall Study|Physician Decision|1|||
126313612|NCT02659514|454439271|FG000|Overall Study|Adverse Event|3|||
126313613|NCT02659514|454439272|FG001|Overall Study|Adverse Event|12|||
126313614|NCT02659514|454439271|FG000|Overall Study|Disease Progression|23|||
126313615|NCT02659514|454439272|FG001|Overall Study|Disease Progression|13|||
126313616|NCT02659514|454439271|FG000|Overall Study|Withdrawal by Subject|0|||
126313617|NCT02659514|454439272|FG001|Overall Study|Withdrawal by Subject|4|||
126313618|NCT02659514|454439271|FG000|Overall Study|Lost to Follow-up|0|||
126313619|NCT02659514|454439272|FG001|Overall Study|Lost to Follow-up|1|||
126313620|NCT02659514|454439271|FG000|Overall Study|Death|6|||
126313621|NCT02659514|454439272|FG001|Overall Study|Death|1|||
126313622|NCT02659514|454439271|FG000|Overall Study|Reason Unspecified|0|||
126313623|NCT02659514|454439272|FG001|Overall Study|Reason Unspecified|3|||
126313624|NCT01968707|454439278|FG000|Overall Study|Did not meet treatment day baseline|49|||
126313625|NCT01968707|454439279|FG001|Overall Study|Did not meet treatment day baseline|12|||
126313626|NCT01968707|454439280|FG002|Overall Study|Did not meet treatment day baseline|41|||
126313627|NCT01968707|454439281|FG003|Overall Study|Did not meet treatment day baseline|44|||
126313628|NCT01968707|454439282|FG004|Overall Study|Did not meet treatment day baseline|36|||
126647800|NCT02406677|455668180|FG001|Overall Study|Discharged without P2Y12|3|||
126647801|NCT02406677|455668179|FG000|Overall Study|Discharged on prasugrel|283|||
126647802|NCT02406677|455668180|FG001|Overall Study|Discharged on prasugrel|587|||
126647803|NCT02406677|455668179|FG000|Overall Study|Withdrawal by Subject|1|||
126647804|NCT02406677|455668180|FG001|Overall Study|Withdrawal by Subject|0|||
126647805|NCT04531904|455668181|FG000|Overall Study|Lost to Follow-up|1|||
126647806|NCT04531904|455668181|FG000|Overall Study|Death|14|||
126647807|NCT00283244|455668182|FG000|Overall Study|Adverse Event|0|||
126647808|NCT00283244|455668183|FG001|Overall Study|Adverse Event|8|||
126647809|NCT00283244|455668184|FG002|Overall Study|Adverse Event|11|||
126647810|NCT00283244|455668182|FG000|Overall Study|Death|4|||
126647811|NCT00283244|455668183|FG001|Overall Study|Death|3|||
126647812|NCT00283244|455668184|FG002|Overall Study|Death|2|||
126647813|NCT00283244|455668182|FG000|Overall Study|Lack of Efficacy|8|||
126647814|NCT00283244|455668183|FG001|Overall Study|Lack of Efficacy|32|||
126647815|NCT00283244|455668184|FG002|Overall Study|Lack of Efficacy|26|||
126647816|NCT00283244|455668182|FG000|Overall Study|Withdrawal by Subject|1|||
126647817|NCT00283244|455668183|FG001|Overall Study|Withdrawal by Subject|2|||
126647818|NCT00283244|455668184|FG002|Overall Study|Withdrawal by Subject|2|||
126647819|NCT00283244|455668182|FG000|Overall Study|Physician Decision|0|||
126647820|NCT00283244|455668183|FG001|Overall Study|Physician Decision|0|||
126647821|NCT00283244|455668184|FG002|Overall Study|Physician Decision|1|||
126647822|NCT00283244|455668182|FG000|Overall Study|Medical illness (other complicating dz)|4|||
126647823|NCT00283244|455668183|FG001|Overall Study|Medical illness (other complicating dz)|3|||
126647824|NCT00283244|455668184|FG002|Overall Study|Medical illness (other complicating dz)|6|||
126647825|NCT00283244|455668182|FG000|Overall Study|Clinical deterioration|1|||
126647826|NCT00283244|455668183|FG001|Overall Study|Clinical deterioration|3|||
126647827|NCT00283244|455668184|FG002|Overall Study|Clinical deterioration|3|||
126647828|NCT00658788|455668185|FG000|Overall Study|Adverse Event|11|||
126647829|NCT00658788|455668185|FG000|Overall Study|Withdrawal by Subject|13|||
126647830|NCT00658788|455668185|FG000|Overall Study|Lost to Follow-up|18|||
126647831|NCT00658788|455668185|FG000|Overall Study|Treatment Discontinuation|32|||
126647832|NCT00653523|455668186|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
126647833|NCT00653523|455668186|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
126647834|NCT00653523|455668186|FG000|Overall Study|Adverse Event|7|||
126647835|NCT00653523|455668186|FG000|Overall Study|Withdrawal by Subject|6|||
126647836|NCT00653523|455668186|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
126647837|NCT00653523|455668186|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
126647838|NCT05384938|455668187|FG000|Overall Study|Withdrawal by Subject|8|||
126647839|NCT05384938|455668187|FG000|Overall Study|Lost to Follow-up|6|||
126647840|NCT05384938|455668187|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
126647841|NCT04396366|455669606|FG000|Overall Study|Adverse Event|1|||
126647842|NCT04396366|455669607|FG001|Overall Study|Adverse Event|0|||
126647843|NCT00166712|455669609|FG000|Overall Study|Death|0|||
126647844|NCT00166712|455669610|FG001|Overall Study|Death|1|||
126647845|NCT00166712|455669609|FG000|Overall Study|Adverse Event|1|||
126647846|NCT00166712|455669610|FG001|Overall Study|Adverse Event|0|||
126647847|NCT00166712|455669609|FG000|Overall Study|Withdrawal by Subject|1|||
126647848|NCT00166712|455669610|FG001|Overall Study|Withdrawal by Subject|2|||
126647849|NCT00166712|455669609|FG000|Overall Study|Physician Decision|0|||
126313629|NCT01968707|454439283|FG005|Overall Study|Did not meet treatment day baseline|11|||
126313630|NCT01968707|454439284|FG006|Overall Study|Did not meet treatment day baseline|34|||
126647850|NCT00166712|455669610|FG001|Overall Study|Physician Decision|2|||
126647851|NCT03986944|455669611|FG000|Overall Study|Adverse Event|1|||
126313631|NCT01968707|454439285|FG007|Overall Study|Did not meet treatment day baseline|35|||
126313632|NCT00916344|454439286|FG000|Overall Study|Death|2|||
126647852|NCT03986944|455669612|FG001|Overall Study|Adverse Event|2|||
126647853|NCT03986944|455669613|FG002|Overall Study|Adverse Event|3|||
126647854|NCT03986944|455669611|FG000|Overall Study|Protocol Violation|0|||
126647855|NCT03986944|455669612|FG001|Overall Study|Protocol Violation|1|||
126647856|NCT03986944|455669613|FG002|Overall Study|Protocol Violation|1|||
126647857|NCT03986944|455669611|FG000|Overall Study|Withdrawal by Subject|3|||
126647858|NCT03986944|455669612|FG001|Overall Study|Withdrawal by Subject|5|||
126647859|NCT03986944|455669613|FG002|Overall Study|Withdrawal by Subject|5|||
126647860|NCT03986944|455669611|FG000|Overall Study|Study termination|10|||
126647861|NCT03986944|455669612|FG001|Overall Study|Study termination|10|||
126647862|NCT03986944|455669613|FG002|Overall Study|Study termination|10|||
126647863|NCT03986944|455669611|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
126647864|NCT03986944|455669612|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
126647865|NCT03986944|455669613|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
126647866|NCT03986944|455669611|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
126647867|NCT03986944|455669612|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
126647868|NCT03986944|455669613|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
126647869|NCT01015560|455669615|FG000|Overall Study|Adverse Event|1|||
126647870|NCT01015560|455669615|FG000|Overall Study|Not protocol specified|1|||
126647871|NCT01015560|455669615|FG000|Overall Study|Withdrawal by Subject|1|||
126647872|NCT00640133|455669616|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
126647873|NCT00640133|455669617|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
126647874|NCT00640133|455669616|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
126647875|NCT00640133|455669617|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
126647876|NCT00640133|455669616|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
126647877|NCT00640133|455669617|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
126647878|NCT00128102|455669620|FG000|Overall Study|Site Discontinued|3|||
126647879|NCT00128102|455669621|FG001|Overall Study|Site Discontinued|6|||
126647880|NCT00128102|455669620|FG000|Overall Study|Other|0|||
126647881|NCT00128102|455669621|FG001|Overall Study|Other|1|||
126647882|NCT00128102|455669620|FG000|Overall Study|Progressive Disease|255|||
126647883|NCT00128102|455669621|FG001|Overall Study|Progressive Disease|285|||
126647884|NCT00128102|455669620|FG000|Overall Study|Adverse Event|34|||
126647885|NCT00128102|455669621|FG001|Overall Study|Adverse Event|11|||
126647886|NCT00128102|455669620|FG000|Overall Study|Death|12|||
126647887|NCT00128102|455669621|FG001|Overall Study|Death|13|||
126647888|NCT00128102|455669620|FG000|Overall Study|Physician Decision|3|||
126647889|NCT00128102|455669621|FG001|Overall Study|Physician Decision|3|||
126647890|NCT00128102|455669620|FG000|Overall Study|Withdrawal by Subject|19|||
126647891|NCT00128102|455669621|FG001|Overall Study|Withdrawal by Subject|11|||
126647892|NCT00128102|455669620|FG000|Overall Study|Protocol Violation|2|||
126647893|NCT00128102|455669621|FG001|Overall Study|Protocol Violation|2|||
126647894|NCT01202903|455669622|FG000|Overall Study|Administrative Probelms|1|||
126647895|NCT01202903|455669623|FG001|Overall Study|Administrative Probelms|4|||
126647896|NCT01202903|455669622|FG000|Overall Study|Protocol Violation|0|||
126647897|NCT01202903|455669623|FG001|Overall Study|Protocol Violation|1|||
126647898|NCT01202903|455669622|FG000|Overall Study|Death|1|||
126647899|NCT01202903|455669623|FG001|Overall Study|Death|0|||
126647900|NCT01202903|455669622|FG000|Overall Study|Lost to Follow-up|1|||
126647901|NCT01202903|455669623|FG001|Overall Study|Lost to Follow-up|1|||
126647902|NCT01202903|455669622|FG000|Overall Study|Lack of Efficacy|1|||
126647903|NCT01202903|455669623|FG001|Overall Study|Lack of Efficacy|3|||
126647904|NCT01202903|455669622|FG000|Overall Study|Adverse Event|3|||
126647905|NCT01202903|455669623|FG001|Overall Study|Adverse Event|3|||
126647906|NCT01202903|455669622|FG000|Overall Study|Withdrawal by Subject|4|||
126647907|NCT01202903|455669623|FG001|Overall Study|Withdrawal by Subject|4|||
126313633|NCT00916344|454439286|FG000|Overall Study|ICD upgrade|1|||
126647908|NCT03339245|455669624|FG000|Overall Study|Adverse Event|1|||
126647909|NCT03339245|455669625|FG001|Overall Study|Adverse Event|1|||
126647910|NCT03339245|455669624|FG000|Overall Study|Withdrawal by Subject|1|||
126647911|NCT03339245|455669625|FG001|Overall Study|Withdrawal by Subject|0|||
126647912|NCT00837694|455669626|FG000|Overall Study|Lost to Follow-up|2|||
126647913|NCT00837694|455669627|FG001|Overall Study|Lost to Follow-up|0|||
126647914|NCT00837694|455669628|FG002|Overall Study|Lost to Follow-up|2|||
126647915|NCT00837694|455669629|FG003|Overall Study|Lost to Follow-up|1|||
126647916|NCT00837694|455669630|FG004|Overall Study|Lost to Follow-up|1|||
126647917|NCT00837694|455669631|FG005|Overall Study|Lost to Follow-up|1|||
126647918|NCT00306670|455669638|FG000|Overall Study|patients recruited; Genentech, the st|0|||
126647919|NCT00306670|455669639|FG001|Overall Study|patients recruited; Genentech, the st|2|||
126647920|NCT00503139|455669640|FG000|Overall Study|Case Report Forms were not collected|4|||
126647921|NCT00503139|455669640|FG000|Overall Study|Protocol Violation|4|||
126647922|NCT02735577|455669641|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
126647923|NCT02735577|455669641|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
126647924|NCT02731690|455669642|FG000|Overall Study|Adverse Event|1|||
126647925|NCT02731690|455669642|FG000|Overall Study|Withdrawal by Subject|3|||
126647926|NCT02731690|455669642|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
126647927|NCT00833833|455669643|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
126647928|NCT00833833|455669644|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
126647929|NCT00833833|455669645|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
126647930|NCT00833833|455669646|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
126647931|NCT00833833|455669647|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
126647932|NCT00833833|455669648|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
126647933|NCT00833833|455669643|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
126647934|NCT00833833|455669644|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
126647935|NCT00833833|455669645|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
126647936|NCT00833833|455669646|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
126647937|NCT00833833|455669647|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
126647938|NCT00833833|455669648|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
126647939|NCT00833833|455669643|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
126647940|NCT00833833|455669644|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
126647941|NCT00833833|455669645|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
126647942|NCT00833833|455669646|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
126647943|NCT00833833|455669647|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
126647944|NCT00833833|455669648|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
126647945|NCT00833833|455669643|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
126647946|NCT00833833|455669644|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
126647947|NCT00833833|455669645|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
126647948|NCT00833833|455669646|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
126306062|NCT02553499|454408876|FG007|Overall Study|Physician Decision|1|||
126306063|NCT02553499|454408877|FG008|Overall Study|Physician Decision|1|||
126313634|NCT00916344|454439286|FG000|Overall Study|Drop-out|5|||
126313635|NCT00108485|454439290|FG000|Overall Study|Withdrawal by Subject|3|||
126313636|NCT00108485|454439291|FG001|Overall Study|Withdrawal by Subject|0|||
126313637|NCT00108485|454439290|FG000|Overall Study|Lost to Follow-up|0|||
126313638|NCT00108485|454439291|FG001|Overall Study|Lost to Follow-up|2|||
126313639|NCT01097421|454439292|FG000|Overall Study|Adverse Event|8|||
126313640|NCT01097421|454439292|FG000|Overall Study|Protocol Violation|2|||
126313641|NCT01097421|454439292|FG000|Overall Study|Lost to Follow-up|1|||
126313642|NCT01097421|454439292|FG000|Overall Study|Withdrawal by Subject|3|||
126313643|NCT01701193|454439297|FG000|Overall Study|Withdrawal by Subject|2|||
126313644|NCT01701193|454439298|FG001|Overall Study|Withdrawal by Subject|2|||
126313645|NCT01701193|454439299|FG002|Overall Study|Withdrawal by Subject|1|||
126313646|NCT01701193|454439300|FG003|Overall Study|Withdrawal by Subject|2|||
126313647|NCT01701193|454439297|FG000|Overall Study|Adverse Event|1|||
126313648|NCT01701193|454439298|FG001|Overall Study|Adverse Event|0|||
126313649|NCT01701193|454439299|FG002|Overall Study|Adverse Event|0|||
126313650|NCT01701193|454439300|FG003|Overall Study|Adverse Event|0|||
126313651|NCT02062944|454439301|FG000|Overall Study|Lost to Follow-up|1|||
126313652|NCT02062944|454439301|FG000|Overall Study|New hemotological disorder identified|1|||
126313653|NCT02062944|454439301|FG000|Overall Study|Uncontrolled Hypertension|1|||
126313654|NCT02062944|454439301|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
126313655|NCT00278148|454439302|FG000|Phase II - Expansion Phase|Disease progression|0|||
126313656|NCT00278148|454439303|FG001|Phase II - Expansion Phase|Disease progression|0|||
126313657|NCT00278148|454439304|FG002|Phase II - Expansion Phase|Disease progression|4|||
126313658|NCT00278148|454439302|FG000|Phase II - Expansion Phase|Adverse Event|0|||
126313659|NCT00278148|454439303|FG001|Phase II - Expansion Phase|Adverse Event|0|||
126313660|NCT00278148|454439304|FG002|Phase II - Expansion Phase|Adverse Event|2|||
126313661|NCT02035748|454439305|FG000|Overall Study|Adverse Event|5|||
126313662|NCT02035748|454439305|FG000|Overall Study|Death|3|||
126313663|NCT02035748|454439305|FG000|Overall Study|Lost to Follow-up|2|||
126313664|NCT02035748|454439305|FG000|Overall Study|Physician Decision|3|||
126313665|NCT02035748|454439305|FG000|Overall Study|Withdrawal by Subject|6|||
126313666|NCT02035748|454439305|FG000|Overall Study|Progressive Disease|1|||
126313667|NCT01088243|454439307|FG000|Overall Study|Adverse Event|1|||
126313668|NCT01088243|454439308|FG001|Overall Study|Adverse Event|0|||
126313669|NCT01210495|454439309|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
126313670|NCT01210495|454439310|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
126313671|NCT01210495|454439311|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
126313672|NCT01210495|454439312|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
126313673|NCT01210495|454439309|FG000|Overall Study|Death|14|||
126313674|NCT01210495|454439310|FG001|Overall Study|Death|7|||
126423730|NCT00452790|454847068|FG001|Infant Series|Parent/legal guardian request|6|||
126313675|NCT01210495|454439311|FG002|Overall Study|Death|112|||
126313676|NCT01210495|454439312|FG003|Overall Study|Death|54|||
126313677|NCT01210495|454439309|FG000|Overall Study|Study Terminated by Sponsor|0|||
126313678|NCT01210495|454439310|FG001|Overall Study|Study Terminated by Sponsor|0|||
126313679|NCT01210495|454439311|FG002|Overall Study|Study Terminated by Sponsor|4|||
126313680|NCT01210495|454439312|FG003|Overall Study|Study Terminated by Sponsor|11|||
126313681|NCT01210495|454439309|FG000|Overall Study|Lost to Follow-up|0|||
126313682|NCT01210495|454439310|FG001|Overall Study|Lost to Follow-up|0|||
126313683|NCT01210495|454439311|FG002|Overall Study|Lost to Follow-up|1|||
126313684|NCT01210495|454439312|FG003|Overall Study|Lost to Follow-up|1|||
126313685|NCT01210495|454439309|FG000|Overall Study|Other unspecified|0|||
126313686|NCT01210495|454439310|FG001|Overall Study|Other unspecified|0|||
126313687|NCT01210495|454439311|FG002|Overall Study|Other unspecified|6|||
126313688|NCT01210495|454439312|FG003|Overall Study|Other unspecified|0|||
126313689|NCT00454818|454439315|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
126313690|NCT00454818|454439316|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
126313691|NCT00454818|454439317|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
126313692|NCT00454818|454439318|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
126313693|NCT00454818|454439319|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
126313694|NCT00454818|454439315|FG000|Phase I: Open-label Dose-escalation|Death|0|||
126313695|NCT00454818|454439316|FG001|Phase I: Open-label Dose-escalation|Death|1|||
126313696|NCT00454818|454439317|FG002|Phase I: Open-label Dose-escalation|Death|0|||
126313697|NCT00454818|454439318|FG003|Phase I: Open-label Dose-escalation|Death|0|||
126313698|NCT00454818|454439319|FG004|Phase I: Open-label Dose-escalation|Death|0|||
126313699|NCT00454818|454439315|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
126313700|NCT00454818|454439316|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
126313701|NCT00454818|454439317|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
126313702|NCT00454818|454439318|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
126313703|NCT00454818|454439319|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
126313704|NCT00454818|454439315|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
126313705|NCT00454818|454439316|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
126313706|NCT00454818|454439317|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
126313707|NCT00454818|454439318|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
126313708|NCT00454818|454439319|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
126313709|NCT00454818|454439315|FG000|Phase 2: Randomized Double-blind|Death|0|||
126313710|NCT00454818|454439316|FG001|Phase 2: Randomized Double-blind|Death|1|||
126313711|NCT00454818|454439317|FG002|Phase 2: Randomized Double-blind|Death|0|||
126313712|NCT00454818|454439318|FG003|Phase 2: Randomized Double-blind|Death|0|||
126313713|NCT00454818|454439319|FG004|Phase 2: Randomized Double-blind|Death|1|||
126313714|NCT00454818|454439315|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
126313715|NCT00454818|454439316|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
126313716|NCT00454818|454439317|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
126313717|NCT00454818|454439318|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
126313718|NCT00454818|454439319|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
126313719|NCT00454818|454439315|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
126313720|NCT00454818|454439316|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
126313721|NCT00454818|454439317|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
126313722|NCT00454818|454439318|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
126313723|NCT00454818|454439319|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
126313724|NCT00767039|454439320|FG000|Overall Study|Death|5|||
126313725|NCT00767039|454439321|FG001|Overall Study|Death|2|||
126313726|NCT01826370|454439322|FG000|Overall Study|Protocol Violation|6|||
126313727|NCT01826370|454439322|FG000|Overall Study|Lost to Follow-up|12|||
126313728|NCT01826370|454439322|FG000|Overall Study|Other reason not defined above|2|||
126313729|NCT04416737|454439324|FG000|Week 1 (First Injection)|Physician Decision|0|||
126313730|NCT04416737|454439325|FG001|Week 1 (First Injection)|Physician Decision|1|||
126306064|NCT02553499|454408878|FG009|Overall Study|Physician Decision|2|||
126306065|NCT02553499|454408879|FG010|Overall Study|Physician Decision|1|||
126306066|NCT02553499|454408880|FG011|Overall Study|Physician Decision|3|||
126306067|NCT02553499|454408881|FG012|Overall Study|Physician Decision|1|||
126306068|NCT02553499|454408882|FG013|Overall Study|Physician Decision|0|||
126306069|NCT02553499|454408869|FG000|Overall Study|Progressive Disease|0|||
126306070|NCT02553499|454408870|FG001|Overall Study|Progressive Disease|0|||
126306071|NCT02553499|454408871|FG002|Overall Study|Progressive Disease|0|||
126306072|NCT02553499|454408872|FG003|Overall Study|Progressive Disease|2|||
126306073|NCT02553499|454408873|FG004|Overall Study|Progressive Disease|1|||
126306074|NCT02553499|454408874|FG005|Overall Study|Progressive Disease|1|||
126306075|NCT02553499|454408875|FG006|Overall Study|Progressive Disease|1|||
126306076|NCT02553499|454408876|FG007|Overall Study|Progressive Disease|0|||
126306077|NCT02553499|454408877|FG008|Overall Study|Progressive Disease|0|||
126306078|NCT02553499|454408878|FG009|Overall Study|Progressive Disease|1|||
126306079|NCT02553499|454408879|FG010|Overall Study|Progressive Disease|0|||
126306080|NCT02553499|454408880|FG011|Overall Study|Progressive Disease|0|||
126313731|NCT03332628|454439326|FG000|Overall Study|Physician Decision|2|||
126313732|NCT01472757|454439327|FG000|Overall Study|Withdrawal by Subject|1|||
126313733|NCT01472757|454439328|FG001|Overall Study|Withdrawal by Subject|2|||
126313734|NCT01472757|454439329|FG002|Overall Study|Withdrawal by Subject|2|||
126313735|NCT01472757|454439330|FG003|Overall Study|Withdrawal by Subject|0|||
126313736|NCT01472757|454439327|FG000|Overall Study|Asthma exacerbation|4|||
126313737|NCT01472757|454439328|FG001|Overall Study|Asthma exacerbation|1|||
126313738|NCT01472757|454439329|FG002|Overall Study|Asthma exacerbation|2|||
126313739|NCT01472757|454439330|FG003|Overall Study|Asthma exacerbation|1|||
126313740|NCT01472757|454439327|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
126313741|NCT01472757|454439328|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
126313742|NCT01472757|454439329|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
126313743|NCT01472757|454439330|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
126313744|NCT01472757|454439327|FG000|Overall Study|Protocol Violation|3|||
126313745|NCT01472757|454439328|FG001|Overall Study|Protocol Violation|2|||
126313746|NCT01472757|454439329|FG002|Overall Study|Protocol Violation|4|||
126313747|NCT01472757|454439330|FG003|Overall Study|Protocol Violation|4|||
126313748|NCT01472757|454439327|FG000|Overall Study|Other reasons|1|||
126313749|NCT01472757|454439328|FG001|Overall Study|Other reasons|0|||
126313750|NCT01472757|454439329|FG002|Overall Study|Other reasons|2|||
126313751|NCT01472757|454439330|FG003|Overall Study|Other reasons|2|||
126313752|NCT02939716|454439336|FG000|Overall Study|scanner failure|0|||
126313753|NCT02939716|454439337|FG001|Overall Study|scanner failure|0|||
126313754|NCT02939716|454439338|FG002|Overall Study|scanner failure|0|||
126313755|NCT02939716|454439339|FG003|Overall Study|scanner failure|1|||
126313756|NCT02939716|454439340|FG004|Overall Study|scanner failure|1|||
126313757|NCT02939716|454439341|FG005|Overall Study|scanner failure|1|||
126313758|NCT00785213|454439347|FG000|Quinine Sulfate Alone|Adverse Event|4|||
126313759|NCT00785213|454439347|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
126313760|NCT02375555|454439358|FG000|Induction Period|Adverse Event|7|||
126313761|NCT02375555|454439358|FG000|Induction Period|Withdrawal by Subject|2|||
126313762|NCT02375555|454439358|FG000|Induction Period|Other|1|||
126313763|NCT02375555|454439358|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
126313764|NCT02375555|454439358|FG000|Maintenance Period|Adverse Event|2|||
126313765|NCT02375555|454439358|FG000|Maintenance Period|Withdrawal by Subject|4|||
126313766|NCT02375555|454439358|FG000|Maintenance Period|Death|1|||
126313767|NCT02375555|454439358|FG000|Maintenance Period|Disease Progression|5|||
126313768|NCT02375555|454439358|FG000|Maintenance Period|Patient Non-compliance|1|||
126313769|NCT02375555|454439358|FG000|Maintenance Period|Still on maintenance|16|||
126313770|NCT01744184|454439370|FG000|Overall Study|Adverse Event|1|||
126313771|NCT01744184|454439371|FG001|Overall Study|Adverse Event|0|||
126313772|NCT01744184|454439370|FG000|Overall Study|Withdrawal by Subject|0|||
126313773|NCT01744184|454439371|FG001|Overall Study|Withdrawal by Subject|1|||
126313774|NCT01263782|454439379|FG000|Overall Study|Death|0|||
126313775|NCT01263782|454439380|FG001|Overall Study|Death|0|||
126313776|NCT01263782|454439381|FG002|Overall Study|Death|1|||
126313777|NCT01263782|454439382|FG003|Overall Study|Death|0|||
126313778|NCT01263782|454439379|FG000|Overall Study|Progressive disease|0|||
126313779|NCT01263782|454439380|FG001|Overall Study|Progressive disease|0|||
126313780|NCT01263782|454439381|FG002|Overall Study|Progressive disease|0|||
126313781|NCT01263782|454439382|FG003|Overall Study|Progressive disease|1|||
126313782|NCT01263782|454439379|FG000|Overall Study|Too early|0|||
126313783|NCT01263782|454439380|FG001|Overall Study|Too early|0|||
126313784|NCT01263782|454439381|FG002|Overall Study|Too early|1|||
126313785|NCT01263782|454439382|FG003|Overall Study|Too early|0|||
126313786|NCT01263782|454439379|FG000|Overall Study|Inevaluable|0|||
126423731|NCT00452790|454847067|FG000|Infant Series|Failed to return|4|||
126423732|NCT00452790|454847068|FG001|Infant Series|Failed to return|1|||
126423733|NCT00452790|454847067|FG000|Infant Series|Protocol Violation|1|||
126423734|NCT00452790|454847068|FG001|Infant Series|Protocol Violation|3|||
126423735|NCT00452790|454847067|FG000|Infant Series|Lost to Follow-up|2|||
126423736|NCT00452790|454847068|FG001|Infant Series|Lost to Follow-up|2|||
126423737|NCT00452790|454847067|FG000|Infant Series|Adverse Event|1|||
126423738|NCT00452790|454847068|FG001|Infant Series|Adverse Event|2|||
126423739|NCT00452790|454847067|FG000|Infant Series|Other reasons|1|||
126423740|NCT00452790|454847068|FG001|Infant Series|Other reasons|2|||
126423741|NCT00452790|454847067|FG000|Infant Series|Investigator request|0|||
126423742|NCT00452790|454847068|FG001|Infant Series|Investigator request|1|||
126423743|NCT00452790|454847067|FG000|Infant Series|Death|0|||
126423744|NCT00452790|454847068|FG001|Infant Series|Death|1|||
126423745|NCT00452790|454847067|FG000|After Infant Series|Investigator request|10|||
126423746|NCT00452790|454847068|FG001|After Infant Series|Investigator request|10|||
126423747|NCT00452790|454847067|FG000|After Infant Series|Adverse Event|4|||
126423748|NCT00452790|454847068|FG001|After Infant Series|Adverse Event|1|||
126423749|NCT00452790|454847067|FG000|After Infant Series|Parent/legal guardian request|1|||
126423750|NCT00452790|454847068|FG001|After Infant Series|Parent/legal guardian request|3|||
126423751|NCT00452790|454847067|FG000|After Infant Series|Lost to Follow-up|4|||
126423752|NCT00452790|454847068|FG001|After Infant Series|Lost to Follow-up|0|||
126423753|NCT00452790|454847067|FG000|After Infant Series|Failed to return|1|||
126423754|NCT00452790|454847068|FG001|After Infant Series|Failed to return|0|||
126423755|NCT00452790|454847067|FG000|After Infant Series|Other reasons|1|||
126423756|NCT00452790|454847068|FG001|After Infant Series|Other reasons|0|||
126423757|NCT00452790|454847067|FG000|Toddler Dose|Failed to return|0|||
126423758|NCT00452790|454847068|FG001|Toddler Dose|Failed to return|1|||
126423759|NCT00452790|454847067|FG000|Toddler Dose|Parent/legal guardian request|0|||
126423760|NCT00452790|454847068|FG001|Toddler Dose|Parent/legal guardian request|1|||
126423761|NCT00348673|454847081|FG000|Stage 1|Randomized but not Treated|0|||
126423762|NCT00348673|454847082|FG001|Stage 1|Randomized but not Treated|0|||
126423763|NCT00348673|454847083|FG002|Stage 1|Randomized but not Treated|1|||
126423764|NCT00348673|454847084|FG003|Stage 1|Randomized but not Treated|0|||
126423765|NCT00348673|454847085|FG004|Stage 1|Randomized but not Treated|0|||
126313787|NCT01263782|454439380|FG001|Overall Study|Inevaluable|0|||
126313788|NCT01263782|454439381|FG002|Overall Study|Inevaluable|1|||
126313789|NCT01263782|454439382|FG003|Overall Study|Inevaluable|0|||
126313790|NCT04545567|454439384|FG000|Overall Study|tested positive for SARS-co-V2|1|||
126423766|NCT00348673|454847086|FG005|Stage 1|Randomized but not Treated|0|||
126423767|NCT00348673|454847087|FG006|Stage 1|Randomized but not Treated|0|||
126423768|NCT00348673|454847088|FG007|Stage 1|Randomized but not Treated|0|||
126423769|NCT00348673|454847089|FG008|Stage 1|Randomized but not Treated|0|||
126423770|NCT02614729|454849148|FG000|Overall Study|Withdrawal by Subject|1|||
126423771|NCT02614729|454849149|FG001|Overall Study|Withdrawal by Subject|0|||
126423772|NCT03790111|454849154|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
126423773|NCT03798717|454849159|FG000|Overall Study|Failed Screening|0|||
126423774|NCT03798717|454849160|FG001|Overall Study|Failed Screening|0|||
126423775|NCT03798717|454849161|FG002|Overall Study|Failed Screening|0|||
126647949|NCT00833833|455669647|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
126423776|NCT03798717|454849162|FG003|Overall Study|Failed Screening|0|||
126423777|NCT03798717|454849163|FG004|Overall Study|Failed Screening|0|||
126423778|NCT03798717|454849164|FG005|Overall Study|Failed Screening|1|||
126423779|NCT03798717|454849159|FG000|Overall Study|Physician Decision|1|||
126423780|NCT03798717|454849160|FG001|Overall Study|Physician Decision|0|||
126423781|NCT03798717|454849161|FG002|Overall Study|Physician Decision|1|||
126423782|NCT03798717|454849162|FG003|Overall Study|Physician Decision|0|||
126423783|NCT03798717|454849163|FG004|Overall Study|Physician Decision|0|||
126423784|NCT03798717|454849164|FG005|Overall Study|Physician Decision|0|||
126423785|NCT03798717|454849159|FG000|Overall Study|Withdrawal by Subject|0|||
126423786|NCT03798717|454849160|FG001|Overall Study|Withdrawal by Subject|0|||
126423787|NCT03798717|454849161|FG002|Overall Study|Withdrawal by Subject|0|||
126423788|NCT03798717|454849162|FG003|Overall Study|Withdrawal by Subject|1|||
126423789|NCT03798717|454849163|FG004|Overall Study|Withdrawal by Subject|0|||
126423790|NCT03798717|454849164|FG005|Overall Study|Withdrawal by Subject|0|||
126423791|NCT03798717|454849159|FG000|Overall Study|Lost to Follow-up|1|||
126423792|NCT03798717|454849160|FG001|Overall Study|Lost to Follow-up|0|||
126423793|NCT03798717|454849161|FG002|Overall Study|Lost to Follow-up|0|||
126423794|NCT03798717|454849162|FG003|Overall Study|Lost to Follow-up|1|||
126423795|NCT03798717|454849163|FG004|Overall Study|Lost to Follow-up|0|||
126423796|NCT03798717|454849164|FG005|Overall Study|Lost to Follow-up|0|||
126423797|NCT03798717|454849159|FG000|Overall Study|Adverse Event|0|||
126423798|NCT03798717|454849160|FG001|Overall Study|Adverse Event|1|||
126423799|NCT03798717|454849161|FG002|Overall Study|Adverse Event|0|||
126423800|NCT03798717|454849162|FG003|Overall Study|Adverse Event|0|||
126423801|NCT03798717|454849163|FG004|Overall Study|Adverse Event|0|||
126423802|NCT03798717|454849164|FG005|Overall Study|Adverse Event|0|||
126423803|NCT03798717|454849159|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
126423804|NCT03798717|454849160|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
126423805|NCT03798717|454849161|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
126423806|NCT03798717|454849162|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
126423807|NCT03798717|454849163|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
126423808|NCT03798717|454849164|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
126423809|NCT01777308|454849168|FG000|Overall Study|Withdrawal by Subject|5|||
126423810|NCT01777308|454849169|FG001|Overall Study|Withdrawal by Subject|1|||
126423811|NCT01777308|454849168|FG000|Overall Study|Migrated/moved from study area|1|||
126423812|NCT01777308|454849169|FG001|Overall Study|Migrated/moved from study area|0|||
126534947|NCT03318523|455248463|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
126534948|NCT03318523|455248464|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
126534949|NCT03318523|455248465|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
126534950|NCT03318523|455248466|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
126423813|NCT01777308|454849168|FG000|Overall Study|Lost to Follow-up|7|||
126423814|NCT01777308|454849169|FG001|Overall Study|Lost to Follow-up|2|||
126534951|NCT03318523|455248467|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
126534952|NCT03581981|455248468|FG000|Overall Study|Withdrawal by Subject|12|||
126534953|NCT03581981|455248469|FG001|Overall Study|Withdrawal by Subject|13|||
126534954|NCT03581981|455248468|FG000|Overall Study|Physician Decision|1|||
126534955|NCT03581981|455248469|FG001|Overall Study|Physician Decision|2|||
126534956|NCT03581981|455248468|FG000|Overall Study|Lost to Follow-up|0|||
126534957|NCT03581981|455248469|FG001|Overall Study|Lost to Follow-up|4|||
126534958|NCT02080871|455248470|FG000|Overall Study|Death|1|||
126534959|NCT02080871|455248470|FG000|Overall Study|Lost to Follow-up|1|||
126534960|NCT00234052|455248471|FG000|Treatment|Withdrawal by Subject|3|||
126534961|NCT00234052|455248471|FG000|Treatment|Adverse Event|5|||
126534962|NCT00234052|455248471|FG000|Treatment|Death|2|||
126534963|NCT00234052|455248471|FG000|Treatment|Progressive Disease|11|||
126534964|NCT00234052|455248471|FG000|Follow-up for 5 Years|Death|41|||
126534965|NCT00234052|455248471|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
126534966|NCT00234052|455248471|FG000|Follow-up for 5 Years|Other|7|||
126534967|NCT01410474|455248472|FG000|Overall Study|Withdrawal by Subject|0|||
126534968|NCT01410474|455248473|FG001|Overall Study|Withdrawal by Subject|1|||
126534969|NCT02428296|455248474|FG000|Overall Study|Adverse Event|7|||
126534970|NCT02428296|455248474|FG000|Overall Study|Withdrawal by Subject|2|||
126534971|NCT00828984|455248475|FG000|Overall Study|Adverse Event|2|||
126534972|NCT00828984|455248476|FG001|Overall Study|Adverse Event|3|||
126534973|NCT00828984|455248477|FG002|Overall Study|Adverse Event|0|||
126534974|NCT00828984|455248475|FG000|Overall Study|Lost to Follow-up|5|||
126534975|NCT00828984|455248476|FG001|Overall Study|Lost to Follow-up|3|||
126534976|NCT00828984|455248477|FG002|Overall Study|Lost to Follow-up|1|||
126534977|NCT00828984|455248475|FG000|Overall Study|Withdrawal by Subject|4|||
126534978|NCT00828984|455248476|FG001|Overall Study|Withdrawal by Subject|4|||
126534979|NCT00828984|455248477|FG002|Overall Study|Withdrawal by Subject|4|||
126423815|NCT01777308|454849168|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
126423816|NCT01777308|454849169|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
126423817|NCT03212326|454849171|FG000|Overall Study|Physician Decision|4|||
126423818|NCT00985673|454849183|FG000|Overall Study|Lost to Follow-up|6|||
126423819|NCT00985673|454849184|FG001|Overall Study|Lost to Follow-up|7|||
126423820|NCT00985673|454849185|FG002|Overall Study|Lost to Follow-up|6|||
126423821|NCT00985673|454849186|FG003|Overall Study|Lost to Follow-up|10|||
126423822|NCT00985673|454849187|FG004|Overall Study|Lost to Follow-up|5|||
126423823|NCT00985673|454849188|FG005|Overall Study|Lost to Follow-up|3|||
126423824|NCT00985673|454849183|FG000|Overall Study|Withdrawal by Subject|0|||
126423825|NCT00985673|454849184|FG001|Overall Study|Withdrawal by Subject|4|||
126423826|NCT00985673|454849185|FG002|Overall Study|Withdrawal by Subject|5|||
126423827|NCT00985673|454849186|FG003|Overall Study|Withdrawal by Subject|2|||
126423828|NCT00985673|454849187|FG004|Overall Study|Withdrawal by Subject|2|||
126423829|NCT00985673|454849188|FG005|Overall Study|Withdrawal by Subject|3|||
126423830|NCT00985673|454849183|FG000|Overall Study|Other|1|||
126423831|NCT00985673|454849184|FG001|Overall Study|Other|0|||
126423832|NCT00985673|454849185|FG002|Overall Study|Other|1|||
126423833|NCT00985673|454849186|FG003|Overall Study|Other|0|||
126423834|NCT00985673|454849187|FG004|Overall Study|Other|1|||
126423835|NCT00985673|454849188|FG005|Overall Study|Other|0|||
126423836|NCT02252146|454849189|FG000|Overall Study|Lack of Efficacy|4|||
126534980|NCT00828984|455248475|FG000|Overall Study|Ineligable|1|||
126423837|NCT02252146|454849189|FG000|Overall Study|Entered hospice care|1|||
126423838|NCT02252146|454849189|FG000|Overall Study|Inability to travel to study site|1|||
126423839|NCT00531284|454849192|FG000|Overall Study|Progressive Disease|1|||
126423840|NCT00531284|454849193|FG001|Overall Study|Progressive Disease|3|||
126423841|NCT00531284|454849194|FG002|Overall Study|Progressive Disease|5|||
126423842|NCT00531284|454849195|FG003|Overall Study|Progressive Disease|42|||
126423843|NCT00531284|454849196|FG004|Overall Study|Progressive Disease|4|||
126423844|NCT00531284|454849197|FG005|Overall Study|Progressive Disease|4|||
126423845|NCT00531284|454849198|FG006|Overall Study|Progressive Disease|3|||
126423846|NCT00531284|454849199|FG007|Overall Study|Progressive Disease|8|||
126423847|NCT00531284|454849200|FG008|Overall Study|Progressive Disease|6|||
126423848|NCT00531284|454849201|FG009|Overall Study|Progressive Disease|3|||
126423849|NCT00531284|454849202|FG010|Overall Study|Progressive Disease|3|||
126423850|NCT00531284|454849203|FG011|Overall Study|Progressive Disease|14|||
126423851|NCT00531284|454849204|FG012|Overall Study|Progressive Disease|2|||
126423852|NCT00531284|454849205|FG013|Overall Study|Progressive Disease|1|||
126423853|NCT00531284|454849206|FG014|Overall Study|Progressive Disease|2|||
126423854|NCT00531284|454849207|FG015|Overall Study|Progressive Disease|11|||
126423855|NCT00531284|454849208|FG016|Overall Study|Progressive Disease|5|||
126423856|NCT00531284|454849192|FG000|Overall Study|Adverse Event|0|||
126423857|NCT00531284|454849193|FG001|Overall Study|Adverse Event|1|||
126423858|NCT00531284|454849194|FG002|Overall Study|Adverse Event|1|||
126423859|NCT00531284|454849195|FG003|Overall Study|Adverse Event|7|||
126423860|NCT00531284|454849196|FG004|Overall Study|Adverse Event|0|||
126423861|NCT00531284|454849197|FG005|Overall Study|Adverse Event|2|||
126423862|NCT00531284|454849198|FG006|Overall Study|Adverse Event|3|||
126423863|NCT00531284|454849199|FG007|Overall Study|Adverse Event|2|||
126423864|NCT00531284|454849200|FG008|Overall Study|Adverse Event|3|||
126423865|NCT00531284|454849201|FG009|Overall Study|Adverse Event|0|||
126423866|NCT00531284|454849202|FG010|Overall Study|Adverse Event|0|||
126423867|NCT00531284|454849203|FG011|Overall Study|Adverse Event|5|||
126423868|NCT00531284|454849204|FG012|Overall Study|Adverse Event|0|||
126423869|NCT00531284|454849205|FG013|Overall Study|Adverse Event|1|||
126423870|NCT00531284|454849206|FG014|Overall Study|Adverse Event|1|||
126423871|NCT00531284|454849207|FG015|Overall Study|Adverse Event|0|||
126423872|NCT00531284|454849208|FG016|Overall Study|Adverse Event|2|||
126423873|NCT00531284|454849192|FG000|Overall Study|Withdrawal by Subject|1|||
126423874|NCT00531284|454849193|FG001|Overall Study|Withdrawal by Subject|0|||
126423875|NCT00531284|454849194|FG002|Overall Study|Withdrawal by Subject|0|||
126423876|NCT00531284|454849195|FG003|Overall Study|Withdrawal by Subject|4|||
126423877|NCT00531284|454849196|FG004|Overall Study|Withdrawal by Subject|0|||
126423878|NCT00531284|454849197|FG005|Overall Study|Withdrawal by Subject|0|||
126423879|NCT00531284|454849198|FG006|Overall Study|Withdrawal by Subject|0|||
126423880|NCT00531284|454849199|FG007|Overall Study|Withdrawal by Subject|0|||
126534981|NCT00828984|455248476|FG001|Overall Study|Ineligable|2|||
126534982|NCT00828984|455248477|FG002|Overall Study|Ineligable|0|||
126534983|NCT00828984|455248475|FG000|Overall Study|Medical Contraindication|0|||
126534984|NCT00828984|455248476|FG001|Overall Study|Medical Contraindication|1|||
126534985|NCT00828984|455248477|FG002|Overall Study|Medical Contraindication|0|||
126534986|NCT00828984|455248475|FG000|Overall Study|Noncompliant|1|||
126534987|NCT00828984|455248476|FG001|Overall Study|Noncompliant|2|||
126534988|NCT00828984|455248477|FG002|Overall Study|Noncompliant|3|||
126534989|NCT00828984|455248475|FG000|Overall Study|ConMed|1|||
126534990|NCT00828984|455248476|FG001|Overall Study|ConMed|1|||
126534991|NCT00828984|455248477|FG002|Overall Study|ConMed|1|||
126534992|NCT01615328|455248481|FG000|Overall Study|Lost to Follow-up|3|||
126534993|NCT01615328|455248482|FG001|Overall Study|Lost to Follow-up|5|||
126534994|NCT03338894|455248483|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
126534995|NCT04465357|455248484|FG000|Overall Study|Adverse Event|2|||
126534996|NCT04465357|455248484|FG000|Overall Study|Lack of Efficacy|1|||
126534997|NCT04465357|455248484|FG000|Overall Study|Lost to Follow-up|2|||
126534998|NCT04465357|455248484|FG000|Overall Study|Withdrawal by Subject|6|||
126534999|NCT04465357|455248484|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
126535000|NCT00626028|455248487|FG000|Overall Study|Adverse Event|1|||
126535001|NCT00626028|455248488|FG001|Overall Study|Adverse Event|1|||
126535002|NCT00626028|455248487|FG000|Overall Study|Device Failure|0|||
126535003|NCT00626028|455248488|FG001|Overall Study|Device Failure|1|||
126535004|NCT00626028|455248487|FG000|Overall Study|Physician Decision|2|||
126535005|NCT00626028|455248488|FG001|Overall Study|Physician Decision|1|||
126535006|NCT00626028|455248487|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
126535007|NCT00626028|455248488|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
126535008|NCT00831779|455248489|FG000|Overall Study|Lost to Follow-up|1|||
126535009|NCT00831779|455248490|FG001|Overall Study|Lost to Follow-up|0|||
126535010|NCT00831779|455248489|FG000|Overall Study|No longer met criteria|0|||
126535011|NCT00831779|455248490|FG001|Overall Study|No longer met criteria|1|||
126535012|NCT02230956|455248491|FG000|Overall Study|Adverse Event|1|||
126535013|NCT02230956|455248492|FG001|Overall Study|Adverse Event|1|||
126535014|NCT02230956|455248493|FG002|Overall Study|Adverse Event|0|||
126535015|NCT02230956|455248491|FG000|Overall Study|Lack of Efficacy|1|||
126535016|NCT02230956|455248492|FG001|Overall Study|Lack of Efficacy|1|||
126535017|NCT02230956|455248493|FG002|Overall Study|Lack of Efficacy|1|||
126423881|NCT00531284|454849200|FG008|Overall Study|Withdrawal by Subject|0|||
126423882|NCT00531284|454849201|FG009|Overall Study|Withdrawal by Subject|0|||
126535018|NCT02230956|455248491|FG000|Overall Study|Lost to Follow-up|1|||
126535019|NCT02230956|455248492|FG001|Overall Study|Lost to Follow-up|1|||
126535020|NCT02230956|455248493|FG002|Overall Study|Lost to Follow-up|2|||
126535021|NCT02230956|455248491|FG000|Overall Study|Personal Reasons|2|||
126535022|NCT02230956|455248492|FG001|Overall Study|Personal Reasons|1|||
126423883|NCT00531284|454849202|FG010|Overall Study|Withdrawal by Subject|0|||
126535023|NCT02230956|455248493|FG002|Overall Study|Personal Reasons|1|||
126535024|NCT02230956|455248491|FG000|Overall Study|Protocol Violation|0|||
126423884|NCT00531284|454849203|FG011|Overall Study|Withdrawal by Subject|3|||
126423885|NCT00531284|454849204|FG012|Overall Study|Withdrawal by Subject|0|||
126423886|NCT00531284|454849205|FG013|Overall Study|Withdrawal by Subject|1|||
126423887|NCT00531284|454849206|FG014|Overall Study|Withdrawal by Subject|0|||
126423888|NCT00531284|454849207|FG015|Overall Study|Withdrawal by Subject|1|||
126423889|NCT00531284|454849208|FG016|Overall Study|Withdrawal by Subject|1|||
126423890|NCT00531284|454849192|FG000|Overall Study|Other|1|||
126423891|NCT00531284|454849193|FG001|Overall Study|Other|0|||
126423892|NCT00531284|454849194|FG002|Overall Study|Other|0|||
126423893|NCT00531284|454849195|FG003|Overall Study|Other|10|||
126423894|NCT00531284|454849196|FG004|Overall Study|Other|2|||
126423895|NCT00531284|454849197|FG005|Overall Study|Other|1|||
126423896|NCT00531284|454849198|FG006|Overall Study|Other|0|||
126423897|NCT00531284|454849199|FG007|Overall Study|Other|0|||
126423898|NCT00531284|454849200|FG008|Overall Study|Other|2|||
126423899|NCT00531284|454849201|FG009|Overall Study|Other|1|||
126423900|NCT00531284|454849202|FG010|Overall Study|Other|0|||
126423901|NCT00531284|454849203|FG011|Overall Study|Other|2|||
126423902|NCT00531284|454849204|FG012|Overall Study|Other|0|||
126423903|NCT00531284|454849205|FG013|Overall Study|Other|0|||
126423904|NCT00531284|454849206|FG014|Overall Study|Other|1|||
126423905|NCT00531284|454849207|FG015|Overall Study|Other|0|||
126423906|NCT00531284|454849208|FG016|Overall Study|Other|0|||
126423907|NCT02219464|454849210|FG000|Overall Study|Withdrawal by Subject|1|||
126423908|NCT02219464|454849211|FG001|Overall Study|Withdrawal by Subject|0|||
126423909|NCT02219464|454849210|FG000|Overall Study|case cancelled|1|||
126423910|NCT02219464|454849211|FG001|Overall Study|case cancelled|0|||
126423911|NCT02219464|454849210|FG000|Overall Study|catheter malfunction|1|||
126423912|NCT02219464|454849211|FG001|Overall Study|catheter malfunction|0|||
126423913|NCT00984256|454849212|FG000|Overall Study|Withdrawal by Subject|0|||
126423914|NCT00984256|454849213|FG001|Overall Study|Withdrawal by Subject|1|||
126423915|NCT03057496|454849214|FG000|Overall Study|Withdrawal by Subject|8|||
126423916|NCT03057496|454849214|FG000|Overall Study|Lost to Follow-up|5|||
126423917|NCT03057496|454849214|FG000|Overall Study|Did not use device during home trial|3|||
126423918|NCT03057496|454849214|FG000|Overall Study|Device failure|2|||
126423919|NCT00280917|454849220|FG000|Overall Study|Adverse Event|1|||
126423920|NCT00280917|454849221|FG001|Overall Study|Adverse Event|1|||
126423921|NCT00280917|454849222|FG002|Overall Study|Adverse Event|4|||
126423922|NCT00280917|454849223|FG003|Overall Study|Adverse Event|1|||
126423923|NCT00280917|454849220|FG000|Overall Study|Change Therapy|1|||
126423924|NCT00280917|454849221|FG001|Overall Study|Change Therapy|2|||
126423925|NCT00280917|454849222|FG002|Overall Study|Change Therapy|0|||
126423926|NCT00280917|454849223|FG003|Overall Study|Change Therapy|0|||
126423927|NCT00280917|454849220|FG000|Overall Study|Withdrawal by Subject|0|||
126423928|NCT00280917|454849221|FG001|Overall Study|Withdrawal by Subject|2|||
126423929|NCT00280917|454849222|FG002|Overall Study|Withdrawal by Subject|0|||
126423930|NCT00280917|454849223|FG003|Overall Study|Withdrawal by Subject|1|||
126423931|NCT00280917|454849220|FG000|Overall Study|Noncompliance|0|||
126423932|NCT00280917|454849221|FG001|Overall Study|Noncompliance|1|||
126423933|NCT00280917|454849222|FG002|Overall Study|Noncompliance|2|||
126423934|NCT00280917|454849223|FG003|Overall Study|Noncompliance|0|||
126423935|NCT02544321|454849230|FG000|Overall Study|Withdrawal by Subject|1|||
126423936|NCT02544321|454849231|FG001|Overall Study|Withdrawal by Subject|2|||
126423937|NCT02544321|454849230|FG000|Overall Study|Adverse Event|1|||
126423938|NCT02544321|454849231|FG001|Overall Study|Adverse Event|1|||
126423939|NCT02544321|454849230|FG000|Overall Study|Protocol Violation|0|||
126423940|NCT02544321|454849231|FG001|Overall Study|Protocol Violation|1|||
126423941|NCT01584232|454849232|FG000|Overall Study|Adverse Event|3|||
126423942|NCT01584232|454849233|FG001|Overall Study|Adverse Event|1|||
126423943|NCT01584232|454849232|FG000|Overall Study|Withdrawal by Subject|2|||
126423944|NCT01584232|454849233|FG001|Overall Study|Withdrawal by Subject|1|||
126423945|NCT01584232|454849232|FG000|Overall Study|Physician Decision|2|||
126423946|NCT01584232|454849233|FG001|Overall Study|Physician Decision|1|||
126423947|NCT01584232|454849232|FG000|Overall Study|Lost to Follow-up|1|||
126423948|NCT01584232|454849233|FG001|Overall Study|Lost to Follow-up|0|||
126423949|NCT01307319|454849234|FG000|Overall Study|Adverse Event|2|||
126423950|NCT01307319|454849235|FG001|Overall Study|Adverse Event|2|||
126423951|NCT01307319|454849236|FG002|Overall Study|Adverse Event|1|||
126423952|NCT01307319|454849234|FG000|Overall Study|Lost to Follow-up|1|||
126423953|NCT01307319|454849235|FG001|Overall Study|Lost to Follow-up|0|||
126423954|NCT01307319|454849236|FG002|Overall Study|Lost to Follow-up|1|||
126423955|NCT01307319|454849234|FG000|Overall Study|Protocol Violation|1|||
126423956|NCT01307319|454849235|FG001|Overall Study|Protocol Violation|1|||
126423957|NCT01307319|454849236|FG002|Overall Study|Protocol Violation|0|||
126423958|NCT01307319|454849234|FG000|Overall Study|Withdrawal by Subject|0|||
126423959|NCT01307319|454849235|FG001|Overall Study|Withdrawal by Subject|1|||
126423960|NCT01307319|454849236|FG002|Overall Study|Withdrawal by Subject|2|||
126423961|NCT01307319|454849234|FG000|Overall Study|Other|0|||
126423962|NCT01307319|454849235|FG001|Overall Study|Other|4|||
126423963|NCT01307319|454849236|FG002|Overall Study|Other|3|||
126423964|NCT03347123|454849238|FG000|Overall Study|Death|1|||
126423965|NCT03347123|454849239|FG001|Overall Study|Death|2|||
126423966|NCT03347123|454849240|FG002|Overall Study|Death|0|||
126423967|NCT03347123|454849241|FG003|Overall Study|Death|0|||
126423968|NCT03347123|454849242|FG004|Overall Study|Death|0|||
126423969|NCT03347123|454849243|FG005|Overall Study|Death|0|||
126423970|NCT03347123|454849244|FG006|Overall Study|Death|0|||
126423971|NCT03347123|454849238|FG000|Overall Study|Withdrawal by Subject|1|||
126423972|NCT03347123|454849239|FG001|Overall Study|Withdrawal by Subject|0|||
126423973|NCT03347123|454849240|FG002|Overall Study|Withdrawal by Subject|0|||
126423974|NCT03347123|454849241|FG003|Overall Study|Withdrawal by Subject|0|||
126423975|NCT03347123|454849242|FG004|Overall Study|Withdrawal by Subject|0|||
126423976|NCT03347123|454849243|FG005|Overall Study|Withdrawal by Subject|0|||
126423977|NCT03347123|454849244|FG006|Overall Study|Withdrawal by Subject|0|||
126423978|NCT03347123|454849238|FG000|Overall Study|Reason not Specified|3|||
126423979|NCT03347123|454849239|FG001|Overall Study|Reason not Specified|4|||
126423980|NCT03347123|454849240|FG002|Overall Study|Reason not Specified|0|||
126423981|NCT03347123|454849241|FG003|Overall Study|Reason not Specified|0|||
126423982|NCT03347123|454849242|FG004|Overall Study|Reason not Specified|0|||
126423983|NCT03347123|454849243|FG005|Overall Study|Reason not Specified|0|||
126423984|NCT03347123|454849244|FG006|Overall Study|Reason not Specified|0|||
126423985|NCT01132807|454849246|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
126423986|NCT01132807|454849247|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
126423987|NCT01132807|454849248|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
126423988|NCT01132807|454849246|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
126423989|NCT01132807|454849247|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
126423990|NCT01132807|454849248|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
126423991|NCT01731912|454849252|FG000|Overall Study|noncompliance|2|||
126423992|NCT02043938|454849253|FG000|Overall Study|Withdrawal by Subject|7|||
126535025|NCT02230956|455248492|FG001|Overall Study|Protocol Violation|1|||
126535026|NCT02230956|455248493|FG002|Overall Study|Protocol Violation|1|||
126535027|NCT02230956|455248491|FG000|Overall Study|Other Miscellaneous Reason|0|||
126535028|NCT02230956|455248492|FG001|Overall Study|Other Miscellaneous Reason|1|||
126535029|NCT02230956|455248493|FG002|Overall Study|Other Miscellaneous Reason|2|||
126535030|NCT00338884|455248494|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
126535031|NCT00338884|455248494|FG000|Overall Study|Adverse Event|14|||
126535032|NCT00338884|455248494|FG000|Overall Study|Death|8|||
126535033|NCT00338884|455248494|FG000|Overall Study|Other|4|||
126535034|NCT00338884|455248494|FG000|Overall Study|Global Deterioration of Health Status|3|||
126535035|NCT00338884|455248494|FG000|Overall Study|Withdrawal by Subject|3|||
126535036|NCT00338884|455248494|FG000|Overall Study|Lost to Follow-up|1|||
126535037|NCT00338884|455248494|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
126535038|NCT01970982|455248496|FG000|Overall Study|Withdrawal by Subject|0|||
126535039|NCT01970982|455248497|FG001|Overall Study|Withdrawal by Subject|0|||
126535040|NCT01970982|455248498|FG002|Overall Study|Withdrawal by Subject|2|||
126535041|NCT00951483|455248499|FG000|Overall Study|Physician Decision|4|||
126535042|NCT00951483|455248500|FG001|Overall Study|Physician Decision|0|||
126535043|NCT00951483|455248499|FG000|Overall Study|Withdrawal by Subject|15|||
126535044|NCT00951483|455248500|FG001|Overall Study|Withdrawal by Subject|0|||
126535045|NCT03583554|455248501|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
126535046|NCT03583554|455248502|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
126535047|NCT03583554|455248503|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
126535048|NCT03178266|455248504|FG000|Overall Study|Death|0|||
126535049|NCT03178266|455248505|FG001|Overall Study|Death|1|||
126535050|NCT03178266|455248504|FG000|Overall Study|Disont. Early|0|||
126535051|NCT03178266|455248505|FG001|Overall Study|Disont. Early|1|||
126535052|NCT03178266|455248504|FG000|Overall Study|Withdrawal by Subject|0|||
126423993|NCT02043938|454849253|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
126535053|NCT03178266|455248505|FG001|Overall Study|Withdrawal by Subject|2|||
126535054|NCT02342886|455248506|FG000|Overall Study|Treatment non-compliance|1|||
126535055|NCT02342886|455248507|FG001|Overall Study|Treatment non-compliance|0|||
126535056|NCT02342886|455248508|FG002|Overall Study|Treatment non-compliance|0|||
126535057|NCT02342886|455248509|FG003|Overall Study|Treatment non-compliance|1|||
126535058|NCT02342886|455248510|FG004|Overall Study|Treatment non-compliance|0|||
126535059|NCT02342886|455248506|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
126535060|NCT02342886|455248507|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
126535061|NCT02342886|455248508|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
126535062|NCT02342886|455248509|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
126535063|NCT02342886|455248510|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
126535064|NCT02342886|455248506|FG000|Overall Study|Adverse event/specific toxicity|4|||
126535065|NCT02342886|455248507|FG001|Overall Study|Adverse event/specific toxicity|3|||
126535066|NCT02342886|455248508|FG002|Overall Study|Adverse event/specific toxicity|11|||
126535067|NCT02342886|455248509|FG003|Overall Study|Adverse event/specific toxicity|2|||
126535068|NCT02342886|455248510|FG004|Overall Study|Adverse event/specific toxicity|1|||
126535069|NCT02342886|455248506|FG000|Overall Study|Lost to Follow-up|1|||
126535070|NCT02342886|455248507|FG001|Overall Study|Lost to Follow-up|0|||
126535071|NCT02342886|455248508|FG002|Overall Study|Lost to Follow-up|0|||
126535072|NCT02342886|455248509|FG003|Overall Study|Lost to Follow-up|0|||
126535073|NCT02342886|455248510|FG004|Overall Study|Lost to Follow-up|0|||
126535074|NCT02342886|455248506|FG000|Overall Study|Death|1|||
126535075|NCT02342886|455248507|FG001|Overall Study|Death|2|||
126535076|NCT02342886|455248508|FG002|Overall Study|Death|1|||
126535077|NCT02342886|455248509|FG003|Overall Study|Death|0|||
126535078|NCT02342886|455248510|FG004|Overall Study|Death|1|||
126535079|NCT02342886|455248506|FG000|Overall Study|Withdrawal by Subject|0|||
126535080|NCT02342886|455248507|FG001|Overall Study|Withdrawal by Subject|1|||
126535081|NCT02342886|455248508|FG002|Overall Study|Withdrawal by Subject|0|||
126535082|NCT02342886|455248509|FG003|Overall Study|Withdrawal by Subject|1|||
126535083|NCT02342886|455248510|FG004|Overall Study|Withdrawal by Subject|0|||
126535084|NCT02342886|455248506|FG000|Overall Study|Investigator/sponsor decision|0|||
126535085|NCT02342886|455248507|FG001|Overall Study|Investigator/sponsor decision|2|||
126535086|NCT02342886|455248508|FG002|Overall Study|Investigator/sponsor decision|0|||
126535087|NCT02342886|455248509|FG003|Overall Study|Investigator/sponsor decision|3|||
126535088|NCT02342886|455248510|FG004|Overall Study|Investigator/sponsor decision|1|||
126535089|NCT02342886|455248506|FG000|Overall Study|Pregnancy|0|||
126535090|NCT02342886|455248507|FG001|Overall Study|Pregnancy|0|||
126535091|NCT02342886|455248508|FG002|Overall Study|Pregnancy|2|||
126535092|NCT02342886|455248509|FG003|Overall Study|Pregnancy|0|||
126535093|NCT02342886|455248510|FG004|Overall Study|Pregnancy|0|||
126535094|NCT02342886|455248506|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
126535095|NCT02342886|455248507|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
126535096|NCT02342886|455248508|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
126535097|NCT02342886|455248509|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
126535098|NCT02342886|455248510|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
126535099|NCT02342886|455248506|FG000|Overall Study|Protocol Violation|0|||
126535100|NCT02342886|455248507|FG001|Overall Study|Protocol Violation|0|||
126535101|NCT02342886|455248508|FG002|Overall Study|Protocol Violation|0|||
126535102|NCT02342886|455248509|FG003|Overall Study|Protocol Violation|2|||
126535103|NCT02342886|455248510|FG004|Overall Study|Protocol Violation|0|||
126535104|NCT01569438|455248511|FG000|Overall Study|Lack of Efficacy|1|||
126535105|NCT01569438|455248512|FG001|Overall Study|Lack of Efficacy|2|||
126535106|NCT01569438|455248511|FG000|Overall Study|Withdrawal by Subject|0|||
126535107|NCT01569438|455248512|FG001|Overall Study|Withdrawal by Subject|3|||
126535108|NCT01569438|455248511|FG000|Overall Study|Adverse Event|2|||
126535109|NCT01569438|455248512|FG001|Overall Study|Adverse Event|15|||
126535110|NCT01569438|455248511|FG000|Overall Study|Protocol Violation|2|||
126535111|NCT01569438|455248512|FG001|Overall Study|Protocol Violation|0|||
126535112|NCT01569438|455248511|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
126535113|NCT01569438|455248512|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
126535114|NCT01569438|455248511|FG000|Overall Study|Sponsor/Physician decision|1|||
126535115|NCT01569438|455248512|FG001|Overall Study|Sponsor/Physician decision|1|||
126535116|NCT01569438|455248511|FG000|Overall Study|Unable to adhere to study schedule|0|||
126535117|NCT01569438|455248512|FG001|Overall Study|Unable to adhere to study schedule|1|||
126535118|NCT03649230|455248514|FG000|Overall Study|Adverse Event|12|||
126535119|NCT03649230|455248514|FG000|Overall Study|Death|8|||
126535120|NCT03649230|455248514|FG000|Overall Study|Withdrawal by Subject|6|||
126535121|NCT03649230|455248514|FG000|Overall Study|Physician Decision|5|||
126535122|NCT03649230|455248514|FG000|Overall Study|Disease progression|5|||
126535123|NCT03649230|455248514|FG000|Overall Study|Switched to non-HEC|5|||
126535124|NCT03649230|455248514|FG000|Overall Study|Chemotherapy discontinued|4|||
126535125|NCT03649230|455248514|FG000|Overall Study|Received only 3 HEC cycles|4|||
126535126|NCT03649230|455248514|FG000|Overall Study|Screen Failure|3|||
126535127|NCT03649230|455248514|FG000|Overall Study|Patient stopped treatment|2|||
126535128|NCT03649230|455248514|FG000|Overall Study|Protocol Violation|1|||
126535129|NCT03649230|455248514|FG000|Overall Study|Non-compliance|1|||
126535130|NCT03649230|455248514|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
126535131|NCT01693068|455248518|FG000|Randomization Period|On-study|2|||
126535132|NCT01693068|455248519|FG001|Randomization Period|On-study|5|||
126535133|NCT01693068|455248520|FG002|Randomization Period|On-study|0|||
126535134|NCT01693068|455248518|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
126535135|NCT01693068|455248519|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
126535136|NCT01693068|455248520|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
126535137|NCT00977665|455248523|FG000|Overall Study|Withdrawal by Subject|1|||
126535138|NCT00977665|455248524|FG001|Overall Study|Withdrawal by Subject|3|||
126535139|NCT00977665|455248523|FG000|Overall Study|Physician Decision|2|||
126535140|NCT00977665|455248524|FG001|Overall Study|Physician Decision|1|||
126535141|NCT00977665|455248523|FG000|Overall Study|Sponsor requested withdrawal|0|||
126535142|NCT00977665|455248524|FG001|Overall Study|Sponsor requested withdrawal|1|||
126535143|NCT00977665|455248523|FG000|Overall Study|Lost to Follow-up|1|||
126535144|NCT00977665|455248524|FG001|Overall Study|Lost to Follow-up|0|||
126535145|NCT00977665|455248523|FG000|Overall Study|Death|3|||
126535146|NCT00977665|455248524|FG001|Overall Study|Death|2|||
126535147|NCT00977665|455248523|FG000|Overall Study|Adverse Event|14|||
126535148|NCT00977665|455248524|FG001|Overall Study|Adverse Event|7|||
126535149|NCT00977665|455248523|FG000|Overall Study|Treatment failure|0|||
126535150|NCT00977665|455248524|FG001|Overall Study|Treatment failure|1|||
126535151|NCT02432105|455248529|FG000|Overall Study|Lost to Follow-up|1|||
126535152|NCT02432105|455248530|FG001|Overall Study|Lost to Follow-up|1|||
126535153|NCT02432105|455248531|FG002|Overall Study|Lost to Follow-up|0|||
126535154|NCT02432105|455248529|FG000|Overall Study|Withdrawal by Subject|1|||
126535155|NCT02432105|455248530|FG001|Overall Study|Withdrawal by Subject|0|||
126535156|NCT02432105|455248531|FG002|Overall Study|Withdrawal by Subject|1|||
126535157|NCT02432105|455248529|FG000|Overall Study|Culture positive for yeast|0|||
126535158|NCT02432105|455248530|FG001|Overall Study|Culture positive for yeast|1|||
126535159|NCT02432105|455248531|FG002|Overall Study|Culture positive for yeast|0|||
126535160|NCT02432105|455248529|FG000|Overall Study|Randomized in error|0|||
126535161|NCT02432105|455248530|FG001|Overall Study|Randomized in error|0|||
126535162|NCT02432105|455248531|FG002|Overall Study|Randomized in error|2|||
126535163|NCT01400503|455248532|FG000|Overall Study|Withdrawal by Subject|1|||
126535164|NCT01400503|455248532|FG000|Overall Study|Study Terminated by Sponsor|58|||
126535165|NCT01400503|455248532|FG000|Overall Study|Other|1|||
126535166|NCT00058123|455248533|FG000|Overall Study|Wrong histology|9|||
126535167|NCT00058123|455248533|FG000|Overall Study|Received >3 prior treatments|1|||
126535168|NCT03053050|455248534|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
126535169|NCT03053050|455248535|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
126535170|NCT03053050|455248536|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
126535171|NCT03053050|455248537|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
126535172|NCT03053050|455248534|FG000|Randomized Phase|Withdrew Consent|16|||
126535173|NCT03053050|455248535|FG001|Randomized Phase|Withdrew Consent|8|||
126535174|NCT03053050|455248536|FG002|Randomized Phase|Withdrew Consent|9|||
126535175|NCT03053050|455248537|FG003|Randomized Phase|Withdrew Consent|0|||
126535176|NCT03053050|455248534|FG000|Randomized Phase|Investigator's Discretion|6|||
126535177|NCT03053050|455248535|FG001|Randomized Phase|Investigator's Discretion|6|||
126535178|NCT03053050|455248536|FG002|Randomized Phase|Investigator's Discretion|3|||
126535179|NCT03053050|455248537|FG003|Randomized Phase|Investigator's Discretion|0|||
126535180|NCT03053050|455248534|FG000|Randomized Phase|Lost to Follow-up|5|||
126535181|NCT03053050|455248535|FG001|Randomized Phase|Lost to Follow-up|1|||
126535182|NCT03053050|455248536|FG002|Randomized Phase|Lost to Follow-up|1|||
126535183|NCT03053050|455248537|FG003|Randomized Phase|Lost to Follow-up|0|||
126535184|NCT03053050|455248534|FG000|Randomized Phase|Adverse Event|0|||
126535185|NCT03053050|455248535|FG001|Randomized Phase|Adverse Event|1|||
126535186|NCT03053050|455248536|FG002|Randomized Phase|Adverse Event|0|||
126535187|NCT03053050|455248537|FG003|Randomized Phase|Adverse Event|0|||
126535188|NCT03053050|455248534|FG000|Randomized Phase|Randomized but Never Treated|2|||
126535189|NCT03053050|455248535|FG001|Randomized Phase|Randomized but Never Treated|2|||
126535190|NCT03053050|455248536|FG002|Randomized Phase|Randomized but Never Treated|2|||
126535191|NCT03053050|455248537|FG003|Randomized Phase|Randomized but Never Treated|0|||
126535192|NCT03053050|455248534|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
126535193|NCT03053050|455248535|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
126535194|NCT03053050|455248536|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
126535195|NCT03053050|455248537|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
126535196|NCT03053050|455248534|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
126535197|NCT03053050|455248535|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
126535198|NCT03053050|455248536|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
126535199|NCT03053050|455248537|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
126535200|NCT03053050|455248534|FG000|Open-label Phase|Withdrew Consent|0|||
126535201|NCT03053050|455248535|FG001|Open-label Phase|Withdrew Consent|0|||
126535202|NCT03053050|455248536|FG002|Open-label Phase|Withdrew Consent|0|||
126535203|NCT03053050|455248537|FG003|Open-label Phase|Withdrew Consent|6|||
126535204|NCT03053050|455248534|FG000|Open-label Phase|Investigator's Discretion|0|||
126535205|NCT03053050|455248535|FG001|Open-label Phase|Investigator's Discretion|0|||
126535206|NCT03053050|455248536|FG002|Open-label Phase|Investigator's Discretion|0|||
126715198|NCT01052012|455908707|FG001|Overall Study|Other|0|||
126535207|NCT03053050|455248537|FG003|Open-label Phase|Investigator's Discretion|4|||
126535208|NCT03703466|455248538|FG000|Overall Study|Death|2|||
126535209|NCT03703466|455248539|FG001|Overall Study|Death|1|||
126535210|NCT03703466|455248540|FG002|Overall Study|Death|0|||
126535211|NCT03703466|455248538|FG000|Overall Study|Withdrawal by Subject|0|||
126535212|NCT03703466|455248539|FG001|Overall Study|Withdrawal by Subject|3|||
126306081|NCT02553499|454408881|FG012|Overall Study|Progressive Disease|2|||
126313791|NCT04545567|454439385|FG001|Overall Study|tested positive for SARS-co-V2|1|||
126313792|NCT04545567|454439384|FG000|Overall Study|Withdrawal by Subject|0|||
126313793|NCT04545567|454439385|FG001|Overall Study|Withdrawal by Subject|1|||
126313794|NCT02419612|454439392|FG000|Short-term Treatment Period|Adverse Event|1|||
126313795|NCT02419612|454439393|FG001|Short-term Treatment Period|Adverse Event|1|||
126313796|NCT02419612|454439392|FG000|Short-term Treatment Period|Death|0|||
126313797|NCT02419612|454439393|FG001|Short-term Treatment Period|Death|2|||
126313798|NCT02419612|454439392|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
126313799|NCT02419612|454439393|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
126313800|NCT02419612|454439392|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
126313801|NCT02419612|454439393|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
126313802|NCT02419612|454439392|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
126313803|NCT02419612|454439393|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
126313804|NCT02419612|454439392|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
126313805|NCT02419612|454439393|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
126313806|NCT02419612|454439392|FG000|Short-term Treatment Period|Worsening of liver function|0|||
126313807|NCT02419612|454439393|FG001|Short-term Treatment Period|Worsening of liver function|1|||
126313808|NCT02419612|454439392|FG000|Short-term Treatment Period|Subject moved out of state|0|||
126313809|NCT02419612|454439393|FG001|Short-term Treatment Period|Subject moved out of state|1|||
126313810|NCT02419612|454439392|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
126313811|NCT02419612|454439393|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
126313812|NCT02419612|454439392|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
126313813|NCT02419612|454439393|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
126313814|NCT02419612|454439392|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
126313815|NCT02419612|454439393|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
126313816|NCT02419612|454439392|FG000|Long-term Treatment Period|Death|0|||
126313817|NCT02419612|454439393|FG001|Long-term Treatment Period|Death|1|||
126313818|NCT02419612|454439392|FG000|Long-term Treatment Period|Adverse Event|0|||
126313819|NCT02419612|454439393|FG001|Long-term Treatment Period|Adverse Event|5|||
126313820|NCT02419612|454439392|FG000|Long-term Treatment Period|Other|4|||
126313821|NCT02419612|454439393|FG001|Long-term Treatment Period|Other|4|||
126313822|NCT02419612|454439392|FG000|Long-term Treatment Period|Subject Decision|2|||
126313823|NCT02419612|454439393|FG001|Long-term Treatment Period|Subject Decision|4|||
126313824|NCT02419612|454439392|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
126313825|NCT02419612|454439393|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
126313826|NCT02135107|454439394|FG000|Treatment Period|Withdrawal by Subject|11|||
126313827|NCT02135107|454439395|FG001|Treatment Period|Withdrawal by Subject|0|||
126313828|NCT02135107|454439396|FG002|Treatment Period|Withdrawal by Subject|0|||
126313829|NCT02135107|454439397|FG003|Treatment Period|Withdrawal by Subject|0|||
126313830|NCT02135107|454439394|FG000|Treatment Period|Adverse Event|5|||
126313831|NCT02135107|454439395|FG001|Treatment Period|Adverse Event|2|||
126313832|NCT02135107|454439396|FG002|Treatment Period|Adverse Event|0|||
126313833|NCT02135107|454439397|FG003|Treatment Period|Adverse Event|0|||
126313834|NCT02135107|454439394|FG000|Treatment Period|Pregnancy|1|||
126313835|NCT02135107|454439395|FG001|Treatment Period|Pregnancy|0|||
126313836|NCT02135107|454439396|FG002|Treatment Period|Pregnancy|0|||
126313837|NCT02135107|454439397|FG003|Treatment Period|Pregnancy|0|||
126313838|NCT02135107|454439394|FG000|Treatment Period|Other|115|||
126313839|NCT02135107|454439395|FG001|Treatment Period|Other|24|||
126313840|NCT02135107|454439396|FG002|Treatment Period|Other|0|||
126313841|NCT02135107|454439397|FG003|Treatment Period|Other|0|||
126313842|NCT02135107|454439394|FG000|Maintenance Therapy Period|Adverse Event|0|||
126313843|NCT02135107|454439395|FG001|Maintenance Therapy Period|Adverse Event|0|||
126313844|NCT02135107|454439396|FG002|Maintenance Therapy Period|Adverse Event|3|||
126313845|NCT02135107|454439397|FG003|Maintenance Therapy Period|Adverse Event|7|||
126535213|NCT03703466|455248540|FG002|Overall Study|Withdrawal by Subject|0|||
126535214|NCT03703466|455248538|FG000|Overall Study|Completed < 3 Cycles|2|||
126535215|NCT03703466|455248539|FG001|Overall Study|Completed < 3 Cycles|2|||
126535216|NCT03703466|455248540|FG002|Overall Study|Completed < 3 Cycles|2|||
126535217|NCT05338333|455248541|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
126535218|NCT05338333|455248542|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
126535219|NCT05073133|455248546|FG000|Overall Study|Death|2|||
126535220|NCT00289887|455250357|FG000|Overall Study|Adverse Event|3|||
126535221|NCT00289887|455250358|FG001|Overall Study|Adverse Event|3|||
126535222|NCT00289887|455250357|FG000|Overall Study|Lack of Efficacy|3|||
126535223|NCT00289887|455250358|FG001|Overall Study|Lack of Efficacy|11|||
126647950|NCT00833833|455669648|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
126647951|NCT00833833|455669643|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
126647952|NCT00833833|455669644|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126647953|NCT00833833|455669645|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
126647954|NCT00833833|455669646|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126647955|NCT00833833|455669647|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126647956|NCT00833833|455669648|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126647957|NCT00833833|455669643|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
126647958|NCT00833833|455669644|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
126647959|NCT00833833|455669645|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
126647960|NCT00833833|455669646|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
126647961|NCT00833833|455669647|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
126647962|NCT00833833|455669648|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
126647963|NCT00833833|455669643|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
126647964|NCT00833833|455669644|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
126647965|NCT00833833|455669645|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
126647966|NCT00833833|455669646|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
126647967|NCT00833833|455669647|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
126647968|NCT00833833|455669648|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
126647969|NCT00833833|455669643|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
126647970|NCT00833833|455669644|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
126647971|NCT00833833|455669645|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
126647972|NCT00833833|455669646|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
126647973|NCT00833833|455669647|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
126647974|NCT00833833|455669648|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
126647975|NCT00833833|455669643|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
126647976|NCT00833833|455669644|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
126647977|NCT00833833|455669645|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
126647978|NCT00833833|455669646|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
126647979|NCT00833833|455669647|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
126647980|NCT00833833|455669648|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
126647981|NCT00833833|455669643|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126647982|NCT00833833|455669644|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126647983|NCT00833833|455669645|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126647984|NCT00833833|455669646|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
126647985|NCT00833833|455669647|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
126647986|NCT00833833|455669648|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
126647987|NCT00833833|455669643|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
126647988|NCT00833833|455669644|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
126647989|NCT00833833|455669645|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
126647990|NCT00833833|455669646|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
126647991|NCT00833833|455669647|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
126647992|NCT00833833|455669648|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
126647993|NCT00833833|455669643|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
126647994|NCT00833833|455669644|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
126647995|NCT00833833|455669645|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
126647996|NCT00833833|455669646|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
126647997|NCT00833833|455669647|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
126647998|NCT00833833|455669648|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
126647999|NCT00833833|455669643|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
126648000|NCT00833833|455669644|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
126648001|NCT00833833|455669645|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
126648002|NCT00833833|455669646|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
126648003|NCT00833833|455669647|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
126648004|NCT00833833|455669648|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
126648005|NCT01994837|455669649|FG000|Overall Study|Progressive disease per protocol|23|||
126648006|NCT01994837|455669649|FG000|Overall Study|Adv event related to progressive disease|3|||
126648007|NCT01994837|455669649|FG000|Overall Study|Fatal progressive disease|2|||
126648008|NCT01994837|455669649|FG000|Overall Study|Adverse event not related to progression|1|||
126648009|NCT01994837|455669649|FG000|Overall Study|Chose palliative care|1|||
126648010|NCT01994837|455669649|FG000|Overall Study|Proceeded to transplant|1|||
126648011|NCT01994837|455669649|FG000|Overall Study|Removed from study due to no response|1|||
126648012|NCT01127893|455669650|FG000|Overall Study|Study Termination by the Sponsor|1|||
126648013|NCT01262677|455669651|FG000|Overall Study|Does not meet entrance criteria|0|||
126535224|NCT00289887|455250357|FG000|Overall Study|Lost to Follow-up|3|||
126535225|NCT00289887|455250358|FG001|Overall Study|Lost to Follow-up|3|||
126535226|NCT00289887|455250357|FG000|Overall Study|Protocol Violation|3|||
126535227|NCT00289887|455250358|FG001|Overall Study|Protocol Violation|1|||
126715199|NCT01052012|455908708|FG002|Overall Study|Other|0|||
126306082|NCT02553499|454408882|FG013|Overall Study|Progressive Disease|1|||
126423994|NCT02043938|454849253|FG000|Overall Study|No show by subject|1|||
126423995|NCT02043938|454849253|FG000|Overall Study|Investigator decision|1|||
126535228|NCT00289887|455250357|FG000|Overall Study|Withdrawal by Subject|3|||
126648014|NCT01262677|455669652|FG001|Overall Study|Does not meet entrance criteria|2|||
126648015|NCT01262677|455669653|FG002|Overall Study|Does not meet entrance criteria|0|||
126648016|NCT01262677|455669651|FG000|Overall Study|Insufficient clinical response|0|||
126648017|NCT01262677|455669652|FG001|Overall Study|Insufficient clinical response|0|||
126648018|NCT01262677|455669653|FG002|Overall Study|Insufficient clinical response|1|||
126648019|NCT01262677|455669651|FG000|Overall Study|Lost to Follow-up|1|||
126648020|NCT01262677|455669652|FG001|Overall Study|Lost to Follow-up|0|||
126648021|NCT01262677|455669653|FG002|Overall Study|Lost to Follow-up|2|||
126648022|NCT01262677|455669651|FG000|Overall Study|No longer willing to participate|3|||
126648023|NCT01262677|455669652|FG001|Overall Study|No longer willing to participate|3|||
126648024|NCT01262677|455669653|FG002|Overall Study|No longer willing to participate|2|||
126648025|NCT01262677|455669651|FG000|Overall Study|Reason not provided|2|||
126648026|NCT01262677|455669652|FG001|Overall Study|Reason not provided|1|||
126648027|NCT01262677|455669653|FG002|Overall Study|Reason not provided|3|||
126648028|NCT01262677|455669651|FG000|Overall Study|Protocol Violation|0|||
126648029|NCT01262677|455669652|FG001|Overall Study|Protocol Violation|1|||
126648030|NCT01262677|455669653|FG002|Overall Study|Protocol Violation|1|||
126648031|NCT01262677|455669651|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
126648032|NCT01262677|455669652|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
126648033|NCT01262677|455669653|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
126648034|NCT00490490|455669667|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
126648035|NCT00490490|455669667|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
126648036|NCT03207451|455669668|FG000|Overall Study|scheduling conflict|1|||
126648037|NCT03207451|455669669|FG001|Overall Study|scheduling conflict|0|||
126648038|NCT03207451|455669670|FG002|Overall Study|scheduling conflict|2|||
126648039|NCT03207451|455669671|FG003|Overall Study|scheduling conflict|2|||
126648040|NCT03207451|455669668|FG000|Overall Study|Adverse Event|0|||
126648041|NCT03207451|455669669|FG001|Overall Study|Adverse Event|0|||
126648042|NCT03207451|455669670|FG002|Overall Study|Adverse Event|0|||
126648043|NCT03207451|455669671|FG003|Overall Study|Adverse Event|1|||
126648044|NCT03339583|455669674|FG000|First Intervention (14 Days)|Adverse Event|1|||
126648045|NCT03339583|455669675|FG001|First Intervention (14 Days)|Adverse Event|0|||
126648046|NCT03339583|455669674|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
126648047|NCT03339583|455669675|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
126648048|NCT03339583|455669674|FG000|Second Intervention (14 Days)|Adverse Event|0|||
126648049|NCT03339583|455669675|FG001|Second Intervention (14 Days)|Adverse Event|1|||
126648050|NCT03339583|455669674|FG000|Follow-up (14 Days)|Physician Decision|6|||
126648051|NCT03339583|455669675|FG001|Follow-up (14 Days)|Physician Decision|3|||
126648052|NCT00734591|455669676|FG000|Screening for Prospective Period|Site did not participate|1604|||
126648053|NCT00734591|455669677|FG001|Screening for Prospective Period|Site did not participate|1488|||
126648054|NCT00734591|455669676|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
126648055|NCT00734591|455669677|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
126648056|NCT00734591|455669676|FG000|Prospective Period|Withdrawal by Subject|11|||
126648057|NCT00734591|455669677|FG001|Prospective Period|Withdrawal by Subject|9|||
126648058|NCT00734591|455669676|FG000|Prospective Period|Lost to Follow-up|37|||
126648059|NCT00734591|455669677|FG001|Prospective Period|Lost to Follow-up|33|||
126648060|NCT00734591|455669676|FG000|Prospective Period|Study Terminated|1|||
126648061|NCT00734591|455669677|FG001|Prospective Period|Study Terminated|0|||
126648062|NCT00734591|455669676|FG000|Prospective Period|Other|2|||
126648063|NCT00734591|455669677|FG001|Prospective Period|Other|2|||
126648064|NCT01072630|455669684|FG000|Overall Study|Adverse Event|11|||
126648065|NCT01072630|455669685|FG001|Overall Study|Adverse Event|19|||
126648066|NCT01072630|455669686|FG002|Overall Study|Adverse Event|2|||
126648067|NCT01072630|455669684|FG000|Overall Study|Lack of Efficacy|10|||
126648068|NCT01072630|455669685|FG001|Overall Study|Lack of Efficacy|10|||
126648069|NCT01072630|455669686|FG002|Overall Study|Lack of Efficacy|1|||
126648070|NCT01072630|455669684|FG000|Overall Study|Withdrawal by Subject|8|||
126648071|NCT01072630|455669685|FG001|Overall Study|Withdrawal by Subject|7|||
126648072|NCT01072630|455669686|FG002|Overall Study|Withdrawal by Subject|2|||
126648073|NCT01072630|455669684|FG000|Overall Study|Protocol Violation|10|||
126648074|NCT01072630|455669685|FG001|Overall Study|Protocol Violation|8|||
126648075|NCT01072630|455669686|FG002|Overall Study|Protocol Violation|4|||
126648076|NCT01072630|455669684|FG000|Overall Study|Lost to Follow-up|11|||
126648077|NCT01072630|455669685|FG001|Overall Study|Lost to Follow-up|11|||
126648078|NCT01072630|455669686|FG002|Overall Study|Lost to Follow-up|1|||
126648079|NCT01072630|455669684|FG000|Overall Study|Noncompliance with study medication|1|||
126648080|NCT01072630|455669685|FG001|Overall Study|Noncompliance with study medication|1|||
126648081|NCT01072630|455669686|FG002|Overall Study|Noncompliance with study medication|1|||
126648082|NCT01072630|455669684|FG000|Overall Study|Noncompliance with study procedures|1|||
126648083|NCT01072630|455669685|FG001|Overall Study|Noncompliance with study procedures|2|||
126648084|NCT01072630|455669686|FG002|Overall Study|Noncompliance with study procedures|1|||
126648085|NCT01072630|455669684|FG000|Overall Study|Other|3|||
126648086|NCT01072630|455669685|FG001|Overall Study|Other|2|||
126648087|NCT01072630|455669686|FG002|Overall Study|Other|1|||
126313846|NCT02135107|454439394|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
126313847|NCT02135107|454439395|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
126535229|NCT00289887|455250358|FG001|Overall Study|Withdrawal by Subject|8|||
126535230|NCT00289887|455250357|FG000|Overall Study|Other|7|||
126535231|NCT00289887|455250358|FG001|Overall Study|Other|3|||
126535232|NCT01266850|455250359|FG000|Overall Study|Lost to Follow-up|19|||
126535233|NCT01266850|455250360|FG001|Overall Study|Lost to Follow-up|19|||
126313848|NCT02135107|454439396|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
126313849|NCT02135107|454439397|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
126313850|NCT02135107|454439394|FG000|Maintenance Therapy Period|Pregnancy|0|||
126313851|NCT02135107|454439395|FG001|Maintenance Therapy Period|Pregnancy|0|||
126313852|NCT02135107|454439396|FG002|Maintenance Therapy Period|Pregnancy|0|||
126313853|NCT02135107|454439397|FG003|Maintenance Therapy Period|Pregnancy|1|||
126313854|NCT02135107|454439394|FG000|Maintenance Therapy Period|Other|0|||
126313855|NCT02135107|454439395|FG001|Maintenance Therapy Period|Other|0|||
126313856|NCT02135107|454439396|FG002|Maintenance Therapy Period|Other|7|||
126313857|NCT02135107|454439397|FG003|Maintenance Therapy Period|Other|8|||
126313858|NCT00474045|454439398|FG000|Overall Study|Adverse Event|18|||
126313859|NCT00474045|454439399|FG001|Overall Study|Adverse Event|8|||
126313860|NCT00474045|454439398|FG000|Overall Study|Unclassified|1|||
126313861|NCT00474045|454439399|FG001|Overall Study|Unclassified|3|||
126313862|NCT00474045|454439398|FG000|Overall Study|Lack of Efficacy|0|||
126313863|NCT00474045|454439399|FG001|Overall Study|Lack of Efficacy|9|||
126313864|NCT00474045|454439398|FG000|Overall Study|Lost to Follow-up|1|||
126313865|NCT00474045|454439399|FG001|Overall Study|Lost to Follow-up|1|||
126313866|NCT00474045|454439398|FG000|Overall Study|Protocol Violation|10|||
126313867|NCT00474045|454439399|FG001|Overall Study|Protocol Violation|12|||
126313868|NCT00474045|454439398|FG000|Overall Study|Withdrawal by Subject|16|||
126313869|NCT00474045|454439399|FG001|Overall Study|Withdrawal by Subject|18|||
126313870|NCT00474045|454439398|FG000|Overall Study|Withdrawal criteria|60|||
126313871|NCT00474045|454439399|FG001|Overall Study|Withdrawal criteria|50|||
126313872|NCT01095978|454439400|FG000|Overall Study|Did not take Klacid SR|2|||
126313873|NCT01095978|454439400|FG000|Overall Study|Adverse Event|1|||
126313874|NCT02009397|454439408|FG000|Overall Study|Protocol Violation|6|||
126313875|NCT02009397|454439408|FG000|Overall Study|Death|8|||
126313876|NCT02009397|454439408|FG000|Overall Study|Lost to Follow-up|6|||
126313877|NCT02278120|454439410|FG000|Treatment Period|Progressive disease|234|||
126313878|NCT02278120|454439411|FG001|Treatment Period|Progressive disease|260|||
126313879|NCT02278120|454439410|FG000|Treatment Period|Subject/guardian decision|23|||
126313880|NCT02278120|454439411|FG001|Treatment Period|Subject/guardian decision|20|||
126313881|NCT02278120|454439410|FG000|Treatment Period|Adverse Event|16|||
126313882|NCT02278120|454439411|FG001|Treatment Period|Adverse Event|14|||
126313883|NCT02278120|454439410|FG000|Treatment Period|Physician Decision|14|||
126313884|NCT02278120|454439411|FG001|Treatment Period|Physician Decision|27|||
126313885|NCT02278120|454439410|FG000|Treatment Period|Death|3|||
126313886|NCT02278120|454439411|FG001|Treatment Period|Death|3|||
126313887|NCT02278120|454439410|FG000|Treatment Period|Lost to Follow-up|2|||
126313888|NCT02278120|454439411|FG001|Treatment Period|Lost to Follow-up|0|||
126313889|NCT02278120|454439410|FG000|Treatment Period|Protocol deviation|0|||
126313890|NCT02278120|454439411|FG001|Treatment Period|Protocol deviation|2|||
126313891|NCT02278120|454439410|FG000|Treatment Period|Study terminated as per protocol|43|||
126313892|NCT02278120|454439411|FG001|Treatment Period|Study terminated as per protocol|11|||
126313893|NCT02278120|454439410|FG000|Post-treatment Efficacy Follow-up|Death|0|||
126313894|NCT02278120|454439411|FG001|Post-treatment Efficacy Follow-up|Death|1|||
126313895|NCT02278120|454439410|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
126313896|NCT02278120|454439411|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
126313897|NCT02278120|454439410|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
126313898|NCT02278120|454439411|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
126313899|NCT02278120|454439410|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
126313900|NCT02278120|454439411|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
126313901|NCT02278120|454439410|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126313902|NCT02278120|454439411|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126313903|NCT00808639|454439417|FG000|Overall Study|Disease progression before surgery.|1|||
126313904|NCT01966068|454439418|FG000|Overall Study|Withdrawal by Subject|57|||
126535234|NCT01266850|455250361|FG002|Overall Study|Lost to Follow-up|13|||
126313905|NCT01966068|454439418|FG000|Overall Study|Lost to Follow-up|81|||
126313906|NCT00191282|454439421|FG000|Overall Study|Adverse Event|5|||
126313907|NCT00191282|454439422|FG001|Overall Study|Adverse Event|6|||
126313908|NCT00191282|454439421|FG000|Overall Study|Death|51|||
126313909|NCT00191282|454439422|FG001|Overall Study|Death|51|||
126313910|NCT00191282|454439421|FG000|Overall Study|Lack of Efficacy|11|||
126648088|NCT00338962|455669687|FG000|Overall Study|Lost to Follow-up|3|||
126648089|NCT00338962|455669688|FG001|Overall Study|Lost to Follow-up|3|||
126648090|NCT00338962|455669689|FG002|Overall Study|Lost to Follow-up|2|||
126648091|NCT00338962|455669690|FG003|Overall Study|Lost to Follow-up|3|||
126648092|NCT00338962|455669687|FG000|Overall Study|Withdrawal by Subject|1|||
126648093|NCT00338962|455669688|FG001|Overall Study|Withdrawal by Subject|0|||
126648094|NCT00338962|455669689|FG002|Overall Study|Withdrawal by Subject|0|||
126648095|NCT00338962|455669690|FG003|Overall Study|Withdrawal by Subject|0|||
126648096|NCT00338962|455669687|FG000|Overall Study|No Transportation|2|||
126648097|NCT00338962|455669688|FG001|Overall Study|No Transportation|0|||
126648098|NCT00338962|455669689|FG002|Overall Study|No Transportation|0|||
126648099|NCT00338962|455669690|FG003|Overall Study|No Transportation|0|||
126648100|NCT00338962|455669687|FG000|Overall Study|Time Constraint|2|||
126648101|NCT00338962|455669688|FG001|Overall Study|Time Constraint|0|||
126648102|NCT00338962|455669689|FG002|Overall Study|Time Constraint|0|||
126648103|NCT00338962|455669690|FG003|Overall Study|Time Constraint|0|||
126648104|NCT00338962|455669687|FG000|Overall Study|Moved|0|||
126648105|NCT00338962|455669688|FG001|Overall Study|Moved|1|||
126648106|NCT00338962|455669689|FG002|Overall Study|Moved|0|||
126648107|NCT00338962|455669690|FG003|Overall Study|Moved|0|||
126648108|NCT00338962|455669687|FG000|Overall Study|Adverse Event|0|||
126648109|NCT00338962|455669688|FG001|Overall Study|Adverse Event|0|||
126648110|NCT00338962|455669689|FG002|Overall Study|Adverse Event|2|||
126648111|NCT00338962|455669690|FG003|Overall Study|Adverse Event|0|||
126648112|NCT00338962|455669687|FG000|Overall Study|Poor Compliance|0|||
126648113|NCT00338962|455669688|FG001|Overall Study|Poor Compliance|0|||
126648114|NCT00338962|455669689|FG002|Overall Study|Poor Compliance|2|||
126648115|NCT00338962|455669690|FG003|Overall Study|Poor Compliance|0|||
126648116|NCT03214640|455669691|FG000|Overall Study|Protocol Violation|1|||
126648117|NCT03214640|455669692|FG001|Overall Study|Protocol Violation|2|||
126648118|NCT03214640|455669693|FG002|Overall Study|Protocol Violation|1|||
126648119|NCT03214640|455669694|FG003|Overall Study|Protocol Violation|4|||
126648120|NCT00910039|455669695|FG000|Overall Study|Physician Decision|1|||
126648121|NCT03547739|455669703|FG000|Overall Study|Death|0|||
126648122|NCT03547739|455669704|FG001|Overall Study|Death|1|||
126648123|NCT03547739|455669705|FG002|Overall Study|Death|5|||
126648124|NCT03547739|455669703|FG000|Overall Study|Adverse Event|24|||
126648125|NCT03547739|455669704|FG001|Overall Study|Adverse Event|11|||
126648126|NCT03547739|455669705|FG002|Overall Study|Adverse Event|13|||
126648127|NCT03547739|455669703|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
126648128|NCT03547739|455669704|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
126648129|NCT03547739|455669705|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
126648130|NCT03547739|455669703|FG000|Overall Study|Lost to Follow-up|80|||
126648131|NCT03547739|455669704|FG001|Overall Study|Lost to Follow-up|84|||
126648132|NCT03547739|455669705|FG002|Overall Study|Lost to Follow-up|116|||
126648133|NCT04035499|455669708|FG000|Overall Study|Death|2|||
126648134|NCT04035499|455669708|FG000|Overall Study|Withdrawal by Subject|1|||
126648135|NCT02003222|455669709|FG000|Induction|Never started treatment|0|||
126648136|NCT02003222|455669710|FG001|Induction|Never started treatment|0|||
126648137|NCT02003222|455669711|FG002|Induction|Never started treatment|0|||
126648138|NCT02003222|455669712|FG003|Induction|Never started treatment|0|||
126648139|NCT02003222|455669713|FG004|Induction|Never started treatment|8|||
126648140|NCT02003222|455669709|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
126648141|NCT02003222|455669710|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
126648142|NCT02003222|455669711|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
126648143|NCT02003222|455669712|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
126648144|NCT02003222|455669713|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
126648145|NCT02003222|455669709|FG000|Induction|Adverse Event|0|||
126648146|NCT02003222|455669710|FG001|Induction|Adverse Event|0|||
126648147|NCT02003222|455669711|FG002|Induction|Adverse Event|0|||
126648148|NCT02003222|455669712|FG003|Induction|Adverse Event|0|||
126648149|NCT02003222|455669713|FG004|Induction|Adverse Event|13|||
126648150|NCT02003222|455669709|FG000|Induction|Alternative therapy|0|||
126648151|NCT02003222|455669710|FG001|Induction|Alternative therapy|0|||
126648152|NCT02003222|455669711|FG002|Induction|Alternative therapy|0|||
126648153|NCT02003222|455669712|FG003|Induction|Alternative therapy|0|||
126648154|NCT02003222|455669713|FG004|Induction|Alternative therapy|12|||
126648155|NCT02003222|455669709|FG000|Induction|Disease progression|0|||
126648156|NCT02003222|455669710|FG001|Induction|Disease progression|0|||
126648157|NCT02003222|455669711|FG002|Induction|Disease progression|0|||
126648158|NCT02003222|455669712|FG003|Induction|Disease progression|0|||
126648159|NCT02003222|455669713|FG004|Induction|Disease progression|22|||
126648160|NCT02003222|455669709|FG000|Induction|Death|0|||
126648161|NCT02003222|455669710|FG001|Induction|Death|0|||
126648162|NCT02003222|455669711|FG002|Induction|Death|0|||
126648163|NCT02003222|455669712|FG003|Induction|Death|0|||
126648164|NCT02003222|455669713|FG004|Induction|Death|3|||
126648165|NCT02003222|455669709|FG000|Induction|Withdrawal by Subject|0|||
126535235|NCT01266850|455250362|FG003|Overall Study|Lost to Follow-up|13|||
126535236|NCT01266850|455250363|FG004|Overall Study|Lost to Follow-up|12|||
126535237|NCT01266850|455250359|FG000|Overall Study|Withdrawal by Subject|8|||
126535238|NCT01266850|455250360|FG001|Overall Study|Withdrawal by Subject|9|||
126535239|NCT01266850|455250361|FG002|Overall Study|Withdrawal by Subject|6|||
126535240|NCT01266850|455250362|FG003|Overall Study|Withdrawal by Subject|9|||
126535241|NCT01266850|455250363|FG004|Overall Study|Withdrawal by Subject|12|||
126535242|NCT01266850|455250359|FG000|Overall Study|Physician Decision|3|||
126535243|NCT01266850|455250360|FG001|Overall Study|Physician Decision|6|||
126313911|NCT00191282|454439422|FG001|Overall Study|Lack of Efficacy|6|||
126313912|NCT00191282|454439421|FG000|Overall Study|Noncompliance|14|||
126535244|NCT01266850|455250361|FG002|Overall Study|Physician Decision|4|||
126535245|NCT01266850|455250362|FG003|Overall Study|Physician Decision|4|||
126535246|NCT01266850|455250363|FG004|Overall Study|Physician Decision|3|||
126535247|NCT01266850|455250359|FG000|Overall Study|Protocol Violation|0|||
126535248|NCT01266850|455250360|FG001|Overall Study|Protocol Violation|1|||
126535249|NCT01266850|455250361|FG002|Overall Study|Protocol Violation|0|||
126535250|NCT01266850|455250362|FG003|Overall Study|Protocol Violation|1|||
126535251|NCT01266850|455250363|FG004|Overall Study|Protocol Violation|2|||
126535252|NCT01266850|455250359|FG000|Overall Study|Adverse Event|0|||
126535253|NCT01266850|455250360|FG001|Overall Study|Adverse Event|0|||
126535254|NCT01266850|455250361|FG002|Overall Study|Adverse Event|0|||
126535255|NCT01266850|455250362|FG003|Overall Study|Adverse Event|0|||
126535256|NCT01266850|455250363|FG004|Overall Study|Adverse Event|1|||
126535257|NCT01266850|455250359|FG000|Overall Study|Site Closure|0|||
126535258|NCT01266850|455250360|FG001|Overall Study|Site Closure|1|||
126535259|NCT01266850|455250361|FG002|Overall Study|Site Closure|1|||
126535260|NCT01266850|455250362|FG003|Overall Study|Site Closure|1|||
126535261|NCT01266850|455250363|FG004|Overall Study|Site Closure|0|||
126535262|NCT00437645|455250365|FG000|Overall Study|Adverse Event|15|||
126535263|NCT00437645|455250366|FG001|Overall Study|Adverse Event|84|||
126535264|NCT00437645|455250365|FG000|Overall Study|Withdrawal by Subject|10|||
126535265|NCT00437645|455250366|FG001|Overall Study|Withdrawal by Subject|22|||
126535266|NCT00437645|455250365|FG000|Overall Study|Protocol Violation|3|||
126535267|NCT00437645|455250366|FG001|Overall Study|Protocol Violation|3|||
126535268|NCT00437645|455250365|FG000|Overall Study|Lost to Follow-up|2|||
126535269|NCT00437645|455250366|FG001|Overall Study|Lost to Follow-up|3|||
126535270|NCT00437645|455250365|FG000|Overall Study|Administrative problems|2|||
126535271|NCT00437645|455250366|FG001|Overall Study|Administrative problems|1|||
126535272|NCT00437645|455250365|FG000|Overall Study|Lack of Efficacy|2|||
126535273|NCT00437645|455250366|FG001|Overall Study|Lack of Efficacy|1|||
126535274|NCT00437645|455250365|FG000|Overall Study|Condition no longer requires study drug|1|||
126535275|NCT00437645|455250366|FG001|Overall Study|Condition no longer requires study drug|1|||
126535276|NCT03751631|455250367|FG000|Overall Study|Withdrawal by Subject|0|||
126535277|NCT03751631|455250368|FG001|Overall Study|Withdrawal by Subject|0|||
126535278|NCT03751631|455250369|FG002|Overall Study|Withdrawal by Subject|1|||
126535279|NCT03751631|455250370|FG003|Overall Study|Withdrawal by Subject|1|||
126535280|NCT03751631|455250371|FG004|Overall Study|Withdrawal by Subject|0|||
126535281|NCT03751631|455250372|FG005|Overall Study|Withdrawal by Subject|0|||
126535282|NCT03382782|455250374|FG000|Cohort 1|Withdrawal by Subject|11|||
126535283|NCT03382782|455250375|FG001|Cohort 1|Withdrawal by Subject|5|||
126535284|NCT03382782|455250376|FG002|Cohort 1|Withdrawal by Subject|0|||
126535285|NCT03382782|455250374|FG000|Cohort 2|Withdrawal by Subject|1|||
126535286|NCT03382782|455250375|FG001|Cohort 2|Withdrawal by Subject|1|||
126535287|NCT03382782|455250376|FG002|Cohort 2|Withdrawal by Subject|0|||
126535288|NCT03382782|455250374|FG000|Cohort 3|Withdrawal by Subject|1|||
126535289|NCT03382782|455250375|FG001|Cohort 3|Withdrawal by Subject|2|||
126535290|NCT03382782|455250376|FG002|Cohort 3|Withdrawal by Subject|0|||
126535291|NCT00428090|455250379|FG000|Overall Study|Adverse Event|10|||
126535292|NCT00428090|455250380|FG001|Overall Study|Adverse Event|8|||
126535293|NCT00428090|455250381|FG002|Overall Study|Adverse Event|10|||
126535294|NCT00428090|455250382|FG003|Overall Study|Adverse Event|11|||
126535295|NCT00428090|455250379|FG000|Overall Study|Lost to Follow-up|3|||
126535296|NCT00428090|455250380|FG001|Overall Study|Lost to Follow-up|6|||
126535297|NCT00428090|455250381|FG002|Overall Study|Lost to Follow-up|1|||
126535298|NCT00428090|455250382|FG003|Overall Study|Lost to Follow-up|4|||
126535299|NCT00428090|455250379|FG000|Overall Study|Protocol Violation|3|||
126535300|NCT00428090|455250380|FG001|Overall Study|Protocol Violation|1|||
126535301|NCT00428090|455250381|FG002|Overall Study|Protocol Violation|3|||
126535302|NCT00428090|455250382|FG003|Overall Study|Protocol Violation|3|||
126535303|NCT00428090|455250379|FG000|Overall Study|Withdrawal by Subject|10|||
126535304|NCT00428090|455250380|FG001|Overall Study|Withdrawal by Subject|12|||
126535305|NCT00428090|455250381|FG002|Overall Study|Withdrawal by Subject|15|||
126535306|NCT00428090|455250382|FG003|Overall Study|Withdrawal by Subject|5|||
126535307|NCT00428090|455250379|FG000|Overall Study|Sponsor terminated study|0|||
126535308|NCT00428090|455250380|FG001|Overall Study|Sponsor terminated study|1|||
126535309|NCT00428090|455250381|FG002|Overall Study|Sponsor terminated study|0|||
126535310|NCT00428090|455250382|FG003|Overall Study|Sponsor terminated study|0|||
126535311|NCT00428090|455250379|FG000|Overall Study|Non-compliance|4|||
126535312|NCT00428090|455250380|FG001|Overall Study|Non-compliance|0|||
126535313|NCT00428090|455250381|FG002|Overall Study|Non-compliance|1|||
126535314|NCT00428090|455250382|FG003|Overall Study|Non-compliance|3|||
126535315|NCT00428090|455250379|FG000|Overall Study|Par. did not returned to visit|1|||
126535316|NCT00428090|455250380|FG001|Overall Study|Par. did not returned to visit|0|||
126535317|NCT00428090|455250381|FG002|Overall Study|Par. did not returned to visit|0|||
126535318|NCT00428090|455250382|FG003|Overall Study|Par. did not returned to visit|1|||
126535319|NCT00428090|455250379|FG000|Overall Study|Follow-Up visit not possible|1|||
126535320|NCT00428090|455250380|FG001|Overall Study|Follow-Up visit not possible|0|||
126535321|NCT00428090|455250381|FG002|Overall Study|Follow-Up visit not possible|0|||
126535322|NCT00428090|455250382|FG003|Overall Study|Follow-Up visit not possible|0|||
126535323|NCT00428090|455250379|FG000|Overall Study|Prohibited medication used for SAE|1|||
126535324|NCT00428090|455250380|FG001|Overall Study|Prohibited medication used for SAE|0|||
126535325|NCT00428090|455250381|FG002|Overall Study|Prohibited medication used for SAE|0|||
126535326|NCT00428090|455250382|FG003|Overall Study|Prohibited medication used for SAE|0|||
126535327|NCT00428090|455250379|FG000|Overall Study|Death of par.|1|||
126535328|NCT00428090|455250380|FG001|Overall Study|Death of par.|0|||
126535329|NCT00428090|455250381|FG002|Overall Study|Death of par.|1|||
126535330|NCT00428090|455250382|FG003|Overall Study|Death of par.|0|||
126535331|NCT00428090|455250379|FG000|Overall Study|Visit 7 exceed the visit window|0|||
126535332|NCT00428090|455250380|FG001|Overall Study|Visit 7 exceed the visit window|1|||
126535333|NCT00428090|455250381|FG002|Overall Study|Visit 7 exceed the visit window|0|||
126535334|NCT00428090|455250382|FG003|Overall Study|Visit 7 exceed the visit window|0|||
126535335|NCT00428090|455250379|FG000|Overall Study|Medical monitor terminated par.|0|||
126535336|NCT00428090|455250380|FG001|Overall Study|Medical monitor terminated par.|1|||
126535337|NCT00428090|455250381|FG002|Overall Study|Medical monitor terminated par.|0|||
126648166|NCT02003222|455669710|FG001|Induction|Withdrawal by Subject|0|||
126535338|NCT00428090|455250382|FG003|Overall Study|Medical monitor terminated par.|0|||
126535339|NCT00428090|455250379|FG000|Overall Study|Mental status of par. was|0|||
126535340|NCT00428090|455250380|FG001|Overall Study|Mental status of par. was|1|||
126535341|NCT00428090|455250381|FG002|Overall Study|Mental status of par. was|0|||
126535342|NCT00428090|455250382|FG003|Overall Study|Mental status of par. was|0|||
126535343|NCT00428090|455250379|FG000|Overall Study|Worsening of AD|0|||
126535344|NCT00428090|455250380|FG001|Overall Study|Worsening of AD|0|||
126535345|NCT00428090|455250381|FG002|Overall Study|Worsening of AD|1|||
126535346|NCT00428090|455250382|FG003|Overall Study|Worsening of AD|0|||
126535347|NCT00428090|455250379|FG000|Overall Study|Excluded for concerning QTc value|0|||
126535348|NCT00428090|455250380|FG001|Overall Study|Excluded for concerning QTc value|0|||
126535349|NCT00428090|455250381|FG002|Overall Study|Excluded for concerning QTc value|1|||
126535350|NCT00428090|455250382|FG003|Overall Study|Excluded for concerning QTc value|0|||
126535351|NCT00428090|455250379|FG000|Overall Study|Insufficient AD documentation|0|||
126535352|NCT00428090|455250380|FG001|Overall Study|Insufficient AD documentation|0|||
126535353|NCT00428090|455250381|FG002|Overall Study|Insufficient AD documentation|1|||
126535354|NCT00428090|455250382|FG003|Overall Study|Insufficient AD documentation|0|||
126535355|NCT00428090|455250379|FG000|Overall Study|High MMSE scores|0|||
126535356|NCT00428090|455250380|FG001|Overall Study|High MMSE scores|0|||
126535357|NCT00428090|455250381|FG002|Overall Study|High MMSE scores|1|||
126535358|NCT00428090|455250382|FG003|Overall Study|High MMSE scores|0|||
126535359|NCT00428090|455250379|FG000|Overall Study|Deterioration of cognitive status|0|||
126535360|NCT00428090|455250380|FG001|Overall Study|Deterioration of cognitive status|0|||
126535361|NCT00428090|455250381|FG002|Overall Study|Deterioration of cognitive status|1|||
126535362|NCT00428090|455250382|FG003|Overall Study|Deterioration of cognitive status|0|||
126535363|NCT00428090|455250379|FG000|Overall Study|Serious adverse event|0|||
126535364|NCT00428090|455250380|FG001|Overall Study|Serious adverse event|0|||
126535365|NCT00428090|455250381|FG002|Overall Study|Serious adverse event|1|||
126535366|NCT00428090|455250382|FG003|Overall Study|Serious adverse event|0|||
126535367|NCT00428090|455250379|FG000|Overall Study|Excluded for heart insufficiency|0|||
126535368|NCT00428090|455250380|FG001|Overall Study|Excluded for heart insufficiency|0|||
126535369|NCT00428090|455250381|FG002|Overall Study|Excluded for heart insufficiency|1|||
126535370|NCT00428090|455250382|FG003|Overall Study|Excluded for heart insufficiency|0|||
126535371|NCT00428090|455250379|FG000|Overall Study|Raised Creatinine Value|0|||
126535372|NCT00428090|455250380|FG001|Overall Study|Raised Creatinine Value|0|||
126535373|NCT00428090|455250381|FG002|Overall Study|Raised Creatinine Value|0|||
126535374|NCT00428090|455250382|FG003|Overall Study|Raised Creatinine Value|1|||
126535375|NCT03255824|455250386|FG000|Overall Study|Under-sedation|2|||
126535376|NCT03255824|455250387|FG001|Overall Study|Under-sedation|1|||
126535377|NCT05159622|455250390|FG000|Overall Study|Lost to Follow-up|4|||
126535378|NCT05159622|455250391|FG001|Overall Study|Lost to Follow-up|5|||
126535379|NCT00863655|455250396|FG000|Overall Study|Protocol Violation|4|||
126535380|NCT00863655|455250397|FG001|Overall Study|Protocol Violation|0|||
126535381|NCT00863655|455250396|FG000|Overall Study|Adverse Event|52|||
126535382|NCT00863655|455250397|FG001|Overall Study|Adverse Event|8|||
126535383|NCT00863655|455250396|FG000|Overall Study|Withdrawal by Subject|47|||
126535384|NCT00863655|455250397|FG001|Overall Study|Withdrawal by Subject|7|||
126535385|NCT00863655|455250396|FG000|Overall Study|Administrative problems|1|||
126535386|NCT00863655|455250397|FG001|Overall Study|Administrative problems|0|||
126535387|NCT00863655|455250396|FG000|Overall Study|Death|7|||
126535388|NCT00863655|455250397|FG001|Overall Study|Death|1|||
126535389|NCT00863655|455250396|FG000|Overall Study|New cancer therapy|5|||
126535390|NCT00863655|455250397|FG001|Overall Study|New cancer therapy|1|||
126535391|NCT00863655|455250396|FG000|Overall Study|Disease progression|364|||
126535392|NCT00863655|455250397|FG001|Overall Study|Disease progression|221|||
126535393|NCT00863655|455250396|FG000|Overall Study|Treatment completed as per protocol|5|||
126535394|NCT00863655|455250397|FG001|Overall Study|Treatment completed as per protocol|1|||
126535395|NCT02157779|455250398|FG000|Overall Study|Logistical|9|||
126535396|NCT02157779|455250399|FG001|Overall Study|Logistical|3|||
126535397|NCT02157779|455250398|FG000|Overall Study|Stopped attending, reason unknown|11|||
126535398|NCT02157779|455250399|FG001|Overall Study|Stopped attending, reason unknown|7|||
126535399|NCT02157779|455250398|FG000|Overall Study|No response to outreach after Baseline|1|||
126535400|NCT02157779|455250399|FG001|Overall Study|No response to outreach after Baseline|1|||
126535401|NCT02157779|455250398|FG000|Overall Study|Moved|1|||
126535402|NCT02157779|455250399|FG001|Overall Study|Moved|0|||
126535403|NCT02157779|455250398|FG000|Overall Study|Medical|1|||
126535404|NCT02157779|455250399|FG001|Overall Study|Medical|0|||
126535405|NCT02157779|455250398|FG000|Overall Study|Legal issue|1|||
126535406|NCT02157779|455250399|FG001|Overall Study|Legal issue|0|||
126535407|NCT00430248|455250402|FG000|Overall Study|Adverse Event|49|||
126535408|NCT00430248|455250403|FG001|Overall Study|Adverse Event|61|||
126535409|NCT00430248|455250404|FG002|Overall Study|Adverse Event|64|||
126535410|NCT00430248|455250402|FG000|Overall Study|Protocol Violation|10|||
126535411|NCT00430248|455250403|FG001|Overall Study|Protocol Violation|2|||
126535412|NCT00430248|455250404|FG002|Overall Study|Protocol Violation|4|||
126535413|NCT00430248|455250402|FG000|Overall Study|Personal Reasons|12|||
126535414|NCT00430248|455250403|FG001|Overall Study|Personal Reasons|24|||
126535415|NCT00430248|455250404|FG002|Overall Study|Personal Reasons|9|||
126535416|NCT00430248|455250402|FG000|Overall Study|Lost to Follow-up|28|||
126535417|NCT00430248|455250403|FG001|Overall Study|Lost to Follow-up|33|||
126535418|NCT00430248|455250404|FG002|Overall Study|Lost to Follow-up|28|||
126535419|NCT00430248|455250402|FG000|Overall Study|Therapeutic Failure|1|||
126535420|NCT00430248|455250403|FG001|Overall Study|Therapeutic Failure|1|||
126535421|NCT00430248|455250404|FG002|Overall Study|Therapeutic Failure|1|||
126535422|NCT00430248|455250402|FG000|Overall Study|Withdrawal by Subject|14|||
126535423|NCT00430248|455250403|FG001|Overall Study|Withdrawal by Subject|20|||
126535424|NCT00430248|455250404|FG002|Overall Study|Withdrawal by Subject|16|||
126535425|NCT00430248|455250402|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126535426|NCT00430248|455250403|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
126535427|NCT00430248|455250404|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126535428|NCT00430248|455250402|FG000|Overall Study|Gout Flare|3|||
126535429|NCT00430248|455250403|FG001|Overall Study|Gout Flare|7|||
126535430|NCT00430248|455250404|FG002|Overall Study|Gout Flare|2|||
126535431|NCT00430248|455250402|FG000|Overall Study|Reason Not Specified|8|||
126535432|NCT00430248|455250403|FG001|Overall Study|Reason Not Specified|8|||
126535433|NCT00430248|455250404|FG002|Overall Study|Reason Not Specified|11|||
126535434|NCT00002558|455250407|FG000|Overall Study|Withdrawal by Subject|0|||
126535435|NCT00002558|455250408|FG001|Overall Study|Withdrawal by Subject|1|||
126535436|NCT01754467|455250409|FG000|Overall Study|Lost to Follow-up|1|||
126535437|NCT02065336|455250410|FG000|Extension Phase|Study Terminated by Sponsor|0|||
126535438|NCT02065336|455250411|FG001|Extension Phase|Study Terminated by Sponsor|0|||
126535439|NCT02065336|455250412|FG002|Extension Phase|Study Terminated by Sponsor|0|||
126535440|NCT02065336|455250413|FG003|Extension Phase|Study Terminated by Sponsor|0|||
126535441|NCT02065336|455250414|FG004|Extension Phase|Study Terminated by Sponsor|0|||
126535442|NCT02065336|455250415|FG005|Extension Phase|Study Terminated by Sponsor|0|||
126535443|NCT02065336|455250416|FG006|Extension Phase|Study Terminated by Sponsor|0|||
126535444|NCT02065336|455250417|FG007|Extension Phase|Study Terminated by Sponsor|0|||
126535445|NCT02065336|455250418|FG008|Extension Phase|Study Terminated by Sponsor|2|||
126535446|NCT02065336|455250419|FG009|Extension Phase|Study Terminated by Sponsor|8|||
126535447|NCT01970462|455250420|FG000|Overall Study|Lost to Follow-up|0|||
126535448|NCT01970462|455250421|FG001|Overall Study|Lost to Follow-up|2|||
126535449|NCT00929162|455250422|FG000|Overall Study|Adverse Event|8|||
126535450|NCT00929162|455250423|FG001|Overall Study|Adverse Event|5|||
126535451|NCT00929162|455250422|FG000|Overall Study|Withdrawal by Subject|3|||
126535452|NCT00929162|455250423|FG001|Overall Study|Withdrawal by Subject|1|||
126535453|NCT00929162|455250422|FG000|Overall Study|Protocol Violation|32|||
126535454|NCT00929162|455250423|FG001|Overall Study|Protocol Violation|30|||
126535455|NCT00929162|455250422|FG000|Overall Study|Other termination reason|5|||
126535456|NCT00929162|455250423|FG001|Overall Study|Other termination reason|6|||
126535457|NCT01274182|455250425|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
126535458|NCT01274182|455250426|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126535459|NCT01274182|455250427|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
126535460|NCT01274182|455250425|FG000|Overall Study|Adverse Event|4|||
126535461|NCT01274182|455250426|FG001|Overall Study|Adverse Event|5|||
126535462|NCT01274182|455250427|FG002|Overall Study|Adverse Event|3|||
126535463|NCT01274182|455250425|FG000|Overall Study|Withdrawal by Subject|5|||
126535464|NCT01274182|455250426|FG001|Overall Study|Withdrawal by Subject|5|||
126535465|NCT01274182|455250427|FG002|Overall Study|Withdrawal by Subject|3|||
126535466|NCT01274182|455250425|FG000|Overall Study|Lost to Follow-up|2|||
126535467|NCT01274182|455250426|FG001|Overall Study|Lost to Follow-up|3|||
126535468|NCT01274182|455250427|FG002|Overall Study|Lost to Follow-up|1|||
126535469|NCT01274182|455250425|FG000|Overall Study|Protocol Violation|3|||
126535470|NCT01274182|455250426|FG001|Overall Study|Protocol Violation|2|||
126535471|NCT01274182|455250427|FG002|Overall Study|Protocol Violation|0|||
126535472|NCT01274182|455250425|FG000|Overall Study|Death|1|||
126535473|NCT01274182|455250426|FG001|Overall Study|Death|0|||
126535474|NCT01274182|455250427|FG002|Overall Study|Death|1|||
126535475|NCT02355002|455250428|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
126535476|NCT02355002|455250429|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
126535477|NCT02355002|455250428|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
126535478|NCT02355002|455250429|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
126535479|NCT02355002|455250428|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
126535480|NCT02355002|455250429|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
126535481|NCT02355002|455250428|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
126535482|NCT02355002|455250429|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
126535483|NCT02355002|455250428|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
126535484|NCT02355002|455250429|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
126535485|NCT02355002|455250428|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
126535486|NCT02355002|455250429|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
126535487|NCT02355002|455250428|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
126535488|NCT02355002|455250429|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
126535489|NCT01984684|455250430|FG000|Overall Study|Lost to Follow-up|25|||
126535490|NCT01984684|455250431|FG001|Overall Study|Lost to Follow-up|24|||
126535491|NCT01984684|455250430|FG000|Overall Study|Adverse Event|8|||
126535492|NCT01984684|455250431|FG001|Overall Study|Adverse Event|12|||
126535493|NCT01984684|455250430|FG000|Overall Study|Withdrawal by Subject|9|||
126535494|NCT01984684|455250431|FG001|Overall Study|Withdrawal by Subject|9|||
126535495|NCT01984684|455250430|FG000|Overall Study|Lack of Efficacy|3|||
126535496|NCT01984684|455250431|FG001|Overall Study|Lack of Efficacy|6|||
126535497|NCT01984684|455250430|FG000|Overall Study|Physician Decision|4|||
126535498|NCT01984684|455250431|FG001|Overall Study|Physician Decision|2|||
126535499|NCT01984684|455250430|FG000|Overall Study|Protocol Violation|4|||
126535500|NCT01984684|455250431|FG001|Overall Study|Protocol Violation|2|||
126535501|NCT01984684|455250430|FG000|Overall Study|Death|0|||
126535502|NCT01984684|455250431|FG001|Overall Study|Death|1|||
126535503|NCT01984684|455250430|FG000|Overall Study|Noncompliance with study drug|2|||
126535504|NCT01984684|455250431|FG001|Overall Study|Noncompliance with study drug|1|||
126535505|NCT01984684|455250430|FG000|Overall Study|Subject incarcerated|1|||
126535506|NCT01984684|455250431|FG001|Overall Study|Subject incarcerated|0|||
126535507|NCT01984684|455250430|FG000|Overall Study|Study drug not available at site|1|||
126535508|NCT01984684|455250431|FG001|Overall Study|Study drug not available at site|1|||
126535509|NCT01984684|455250430|FG000|Overall Study|Subject had inadequate IV access|0|||
126535510|NCT01984684|455250431|FG001|Overall Study|Subject had inadequate IV access|1|||
126535511|NCT01375114|455250432|FG000|Overall Study|Lost to Follow-up|1|||
126535512|NCT01375114|455250433|FG001|Overall Study|Lost to Follow-up|0|||
126535513|NCT01375114|455250434|FG002|Overall Study|Lost to Follow-up|1|||
126535514|NCT01375114|455250432|FG000|Overall Study|Disease Progression|3|||
126535515|NCT01375114|455250433|FG001|Overall Study|Disease Progression|2|||
126535516|NCT01375114|455250434|FG002|Overall Study|Disease Progression|2|||
126535517|NCT01375114|455250432|FG000|Overall Study|Patient Changed Mind|0|||
126535518|NCT01375114|455250433|FG001|Overall Study|Patient Changed Mind|0|||
126535519|NCT01375114|455250434|FG002|Overall Study|Patient Changed Mind|2|||
126535520|NCT01375114|455250432|FG000|Overall Study|Pruritus|0|||
126535521|NCT01375114|455250433|FG001|Overall Study|Pruritus|0|||
126535522|NCT01375114|455250434|FG002|Overall Study|Pruritus|1|||
126535523|NCT01375114|455250432|FG000|Overall Study|Restlessness|0|||
126535524|NCT01375114|455250433|FG001|Overall Study|Restlessness|0|||
126535525|NCT01375114|455250434|FG002|Overall Study|Restlessness|1|||
126535526|NCT01375114|455250432|FG000|Overall Study|Diarrhea|0|||
126535527|NCT01375114|455250433|FG001|Overall Study|Diarrhea|0|||
126535528|NCT01375114|455250434|FG002|Overall Study|Diarrhea|1|||
126535529|NCT01375114|455250432|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
126535530|NCT01375114|455250433|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
126535531|NCT01375114|455250434|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
126535532|NCT01375114|455250432|FG000|Overall Study|Nausea|0|||
126535533|NCT01375114|455250433|FG001|Overall Study|Nausea|1|||
126535534|NCT01375114|455250434|FG002|Overall Study|Nausea|0|||
126535535|NCT01375114|455250432|FG000|Overall Study|Increased AST/ALT|0|||
126535536|NCT01375114|455250433|FG001|Overall Study|Increased AST/ALT|1|||
126535537|NCT01375114|455250434|FG002|Overall Study|Increased AST/ALT|0|||
126535538|NCT01375114|455250432|FG000|Overall Study|Vaginal Hemorrhage|0|||
126535539|NCT01375114|455250433|FG001|Overall Study|Vaginal Hemorrhage|1|||
126535540|NCT01375114|455250434|FG002|Overall Study|Vaginal Hemorrhage|0|||
126535541|NCT01375114|455250432|FG000|Overall Study|Family problem|0|||
126535542|NCT01375114|455250433|FG001|Overall Study|Family problem|1|||
126535543|NCT01375114|455250434|FG002|Overall Study|Family problem|0|||
126535544|NCT01375114|455250432|FG000|Overall Study|Protocol Violation|2|||
126535545|NCT01375114|455250433|FG001|Overall Study|Protocol Violation|0|||
126535546|NCT01375114|455250434|FG002|Overall Study|Protocol Violation|0|||
126535547|NCT02472964|455250440|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
126535548|NCT02472964|455250441|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
126535549|NCT02472964|455250440|FG000|Part 1 (up to Week 24)|disease progression|58|||
126535550|NCT02472964|455250441|FG001|Part 1 (up to Week 24)|disease progression|47|||
126535551|NCT02472964|455250440|FG000|Part 1 (up to Week 24)|Death|3|||
126535552|NCT02472964|455250441|FG001|Part 1 (up to Week 24)|Death|6|||
126535553|NCT02472964|455250440|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
126535554|NCT02472964|455250441|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
126535555|NCT02472964|455250440|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
126535556|NCT02472964|455250441|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
126535557|NCT02472964|455250440|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
126535558|NCT02472964|455250441|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
126535559|NCT02472964|455250440|FG000|Part 1 (up to Week 24)|Other|2|||
126535560|NCT02472964|455250441|FG001|Part 1 (up to Week 24)|Other|1|||
126535561|NCT02472964|455250440|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
126535562|NCT02472964|455250441|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
126535563|NCT02472964|455250440|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
126535564|NCT02472964|455250441|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
126535565|NCT02472964|455250440|FG000|Part 2 (Week 24-week 48)|Death|0|||
126535566|NCT02472964|455250441|FG001|Part 2 (Week 24-week 48)|Death|1|||
126535567|NCT02472964|455250440|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
126535568|NCT02472964|455250441|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
126535569|NCT02472964|455250440|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
126535570|NCT02472964|455250441|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
126535571|NCT02472964|455250440|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
126535572|NCT02472964|455250441|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
126535573|NCT02472964|455250440|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
126535574|NCT02472964|455250441|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
126535575|NCT00689221|455250447|FG000|Overall Study|Ongoing at cut-off date|39|||
126535576|NCT00689221|455250448|FG001|Overall Study|Ongoing at cut-off date|36|||
126535577|NCT01749982|455250449|FG000|Overall Study|Physician Decision|0|||
126535578|NCT01749982|455250450|FG001|Overall Study|Physician Decision|0|||
126535579|NCT01749982|455250451|FG002|Overall Study|Physician Decision|0|||
126535580|NCT01749982|455250452|FG003|Overall Study|Physician Decision|1|||
126535581|NCT01749982|455250449|FG000|Overall Study|Lost to Follow-up|0|||
126535582|NCT01749982|455250450|FG001|Overall Study|Lost to Follow-up|0|||
126535583|NCT01749982|455250451|FG002|Overall Study|Lost to Follow-up|0|||
126535584|NCT01749982|455250452|FG003|Overall Study|Lost to Follow-up|1|||
126535585|NCT01749982|455250449|FG000|Overall Study|Withdrawal by Subject|0|||
126535586|NCT01749982|455250450|FG001|Overall Study|Withdrawal by Subject|0|||
126535587|NCT01749982|455250451|FG002|Overall Study|Withdrawal by Subject|0|||
126535588|NCT01749982|455250452|FG003|Overall Study|Withdrawal by Subject|1|||
126535589|NCT01596582|455250454|FG000|Overall Study|Deemed ineligible after study visit|3|||
126535590|NCT01596582|455250455|FG001|Overall Study|Deemed ineligible after study visit|6|||
126535591|NCT01596582|455250454|FG000|Overall Study|Missing all outcome data|1|||
126535592|NCT01596582|455250455|FG001|Overall Study|Missing all outcome data|1|||
126535593|NCT04435665|455250456|FG000|Overall Study|Lost to Follow-up|0|||
126535594|NCT04435665|455250457|FG001|Overall Study|Lost to Follow-up|0|||
126535595|NCT04435665|455250458|FG002|Overall Study|Lost to Follow-up|0|||
126535596|NCT04435665|455250459|FG003|Overall Study|Lost to Follow-up|1|||
126535597|NCT04672941|455250460|FG000|Overall Study|Investigator decision|1|||
126535598|NCT04672941|455250460|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
126535599|NCT04672941|455250460|FG000|Overall Study|COVID-19 related but no adverse event|1|||
126535600|NCT04672941|455250460|FG000|Overall Study|Adverse Event|2|||
126535601|NCT04672941|455250460|FG000|Overall Study|Lost to Follow-up|2|||
126535602|NCT00765388|455250462|FG000|Period 1|Lack of Efficacy|1|||
126535603|NCT00765388|455250463|FG001|Period 1|Lack of Efficacy|2|||
126535604|NCT00765388|455250462|FG000|Period 1|Lost to Follow-up|0|||
126535605|NCT00765388|455250463|FG001|Period 1|Lost to Follow-up|1|||
126535606|NCT00765388|455250462|FG000|Period 1|Herpes Zoster|0|||
126535607|NCT00765388|455250463|FG001|Period 1|Herpes Zoster|1|||
126535608|NCT00765388|455250462|FG000|Period 1|Hip operation|0|||
126535609|NCT00765388|455250463|FG001|Period 1|Hip operation|1|||
126535610|NCT03923933|455250467|FG000|Overall Study|Lost to Follow-up|1|||
126535611|NCT03923933|455250468|FG001|Overall Study|Lost to Follow-up|0|||
126535612|NCT03923933|455250467|FG000|Overall Study|Withdrawal by Subject|0|||
126535613|NCT03923933|455250468|FG001|Overall Study|Withdrawal by Subject|1|||
126535614|NCT00419263|455250469|FG000|Overall Study|Lost to Follow-up|2|||
126535615|NCT00419263|455250470|FG001|Overall Study|Lost to Follow-up|1|||
126535616|NCT00419263|455250471|FG002|Overall Study|Lost to Follow-up|1|||
126535617|NCT00419263|455250469|FG000|Overall Study|Randomized in Error, Not Treated|1|||
126535618|NCT00419263|455250470|FG001|Overall Study|Randomized in Error, Not Treated|1|||
126535619|NCT00419263|455250471|FG002|Overall Study|Randomized in Error, Not Treated|0|||
126535620|NCT00419263|455250469|FG000|Overall Study|Adverse Event|0|||
126535621|NCT00419263|455250470|FG001|Overall Study|Adverse Event|0|||
126535622|NCT00419263|455250471|FG002|Overall Study|Adverse Event|1|||
126535623|NCT00419263|455250469|FG000|Overall Study|Withdrawal by Subject|0|||
126535624|NCT00419263|455250470|FG001|Overall Study|Withdrawal by Subject|0|||
126535625|NCT00419263|455250471|FG002|Overall Study|Withdrawal by Subject|1|||
126535626|NCT03311373|455250472|FG000|Overall Study|Adverse Event|1|||
126535627|NCT03311373|455250472|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
126535628|NCT03311373|455250472|FG000|Overall Study|Lost to Follow-up|1|||
126535629|NCT03311373|455250472|FG000|Overall Study|Physician Decision|1|||
126535630|NCT03311373|455250472|FG000|Overall Study|Withdrawal by Subject|3|||
126535631|NCT01563536|455250475|FG000|Overall Study|Withdrawal by Subject|0|||
126535632|NCT01563536|455250476|FG001|Overall Study|Withdrawal by Subject|2|||
126535633|NCT01563536|455250475|FG000|Overall Study|Lost to Follow-up|1|||
126535634|NCT01563536|455250476|FG001|Overall Study|Lost to Follow-up|0|||
126535635|NCT00538590|455250479|FG000|Overall Study|Death|1|||
126535636|NCT00538590|455250480|FG001|Overall Study|Death|0|||
126535637|NCT01256567|455250481|FG000|Overall Study|Withdrawal by Subject|1|||
126535638|NCT00671931|455250487|FG000|Overall Study|Physician Decision|1|||
126535639|NCT00671931|455250488|FG001|Overall Study|Physician Decision|0|||
126535640|NCT00671931|455250489|FG002|Overall Study|Physician Decision|0|||
126535641|NCT00671931|455250490|FG003|Overall Study|Physician Decision|2|||
126535642|NCT00671931|455250491|FG004|Overall Study|Physician Decision|1|||
126535643|NCT03260868|455250492|FG000|Overall Study|Poor Compliance to Protocol|0|||
126648167|NCT02003222|455669711|FG002|Induction|Withdrawal by Subject|0|||
126535644|NCT03260868|455250493|FG001|Overall Study|Poor Compliance to Protocol|2|||
126535645|NCT03260868|455250492|FG000|Overall Study|Study Terminated By Sponsor|2|||
126535646|NCT03260868|455250493|FG001|Overall Study|Study Terminated By Sponsor|1|||
126535647|NCT03260868|455250492|FG000|Overall Study|Other than specified above|1|||
126535648|NCT03260868|455250493|FG001|Overall Study|Other than specified above|0|||
126535649|NCT02925676|455250494|FG000|Overall Study|Withdrawal by Subject|1|||
126535650|NCT01298999|455250495|FG000|Overall Study|Physician Decision|0|||
126535651|NCT01298999|455250496|FG001|Overall Study|Physician Decision|1|||
126535652|NCT01298999|455250495|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
126535653|NCT01298999|455250496|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
126535654|NCT00541450|455250497|FG000|Phase A|Adverse Event|3|||
126535655|NCT00541450|455250498|FG001|Phase A|Adverse Event|0|||
126535656|NCT00541450|455250497|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
126535657|NCT00541450|455250498|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
126535658|NCT00541450|455250497|FG000|Phase A|Hyperglycemia|0|||
126535659|NCT00541450|455250498|FG001|Phase A|Hyperglycemia|1|||
126535660|NCT00541450|455250497|FG000|Phase A|Lost to Follow-up|6|||
126535661|NCT00541450|455250498|FG001|Phase A|Lost to Follow-up|4|||
126535662|NCT00541450|455250497|FG000|Phase A|Physician Decision|2|||
126535663|NCT00541450|455250498|FG001|Phase A|Physician Decision|0|||
126535664|NCT00541450|455250497|FG000|Phase A|Protocol Violation|2|||
126535665|NCT00541450|455250498|FG001|Phase A|Protocol Violation|3|||
126535666|NCT00541450|455250497|FG000|Phase A|Withdrawal by Subject|7|||
126535667|NCT00541450|455250498|FG001|Phase A|Withdrawal by Subject|7|||
126535668|NCT00541450|455250497|FG000|Phase B|Adverse Event|6|||
126535669|NCT00541450|455250498|FG001|Phase B|Adverse Event|6|||
126535670|NCT00541450|455250497|FG000|Phase B|Hyperglycemia|10|||
126535671|NCT00541450|455250498|FG001|Phase B|Hyperglycemia|9|||
126535672|NCT00541450|455250497|FG000|Phase B|Lost to Follow-up|6|||
126535673|NCT00541450|455250498|FG001|Phase B|Lost to Follow-up|4|||
126535674|NCT00541450|455250497|FG000|Phase B|Physician Decision|4|||
126535675|NCT00541450|455250498|FG001|Phase B|Physician Decision|2|||
126535676|NCT00541450|455250497|FG000|Phase B|Pregnancy|0|||
126535677|NCT00541450|455250498|FG001|Phase B|Pregnancy|1|||
126535678|NCT00541450|455250497|FG000|Phase B|Protocol Violation|3|||
126535679|NCT00541450|455250498|FG001|Phase B|Protocol Violation|3|||
126535680|NCT00541450|455250497|FG000|Phase B|Withdrawal by Subject|8|||
126535681|NCT00541450|455250498|FG001|Phase B|Withdrawal by Subject|6|||
126535682|NCT02151266|455250499|FG000|Overall Study|Lost to Follow-up|1|||
126535683|NCT02151266|455250500|FG001|Overall Study|Lost to Follow-up|4|||
126535684|NCT02151266|455250501|FG002|Overall Study|Lost to Follow-up|1|||
126535685|NCT02151266|455250499|FG000|Overall Study|Did NOT receive intervention|3|||
126535686|NCT02151266|455250500|FG001|Overall Study|Did NOT receive intervention|6|||
126535687|NCT02151266|455250501|FG002|Overall Study|Did NOT receive intervention|2|||
126535688|NCT02151266|455250499|FG000|Overall Study|Not able to exercise|4|||
126535689|NCT02151266|455250500|FG001|Overall Study|Not able to exercise|5|||
126535690|NCT02151266|455250501|FG002|Overall Study|Not able to exercise|4|||
126535691|NCT01169675|455250502|FG000|Overall Study|Progressive disease|13|||
126535692|NCT01169675|455250503|FG001|Overall Study|Progressive disease|2|||
126535693|NCT01169675|455250504|FG002|Overall Study|Progressive disease|5|||
126535694|NCT01169675|455250505|FG003|Overall Study|Progressive disease|15|||
126535695|NCT01169675|455250506|FG004|Overall Study|Progressive disease|1|||
126535696|NCT01169675|455250502|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
126535697|NCT01169675|455250503|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126535698|NCT01169675|455250504|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126535699|NCT01169675|455250505|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126535700|NCT01169675|455250506|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
126535701|NCT01169675|455250502|FG000|Overall Study|Adverse Event|5|||
126535702|NCT01169675|455250503|FG001|Overall Study|Adverse Event|1|||
126535703|NCT01169675|455250504|FG002|Overall Study|Adverse Event|2|||
126535704|NCT01169675|455250505|FG003|Overall Study|Adverse Event|0|||
126535705|NCT01169675|455250506|FG004|Overall Study|Adverse Event|0|||
126535706|NCT01169675|455250502|FG000|Overall Study|Withdrawal by Subject|1|||
126535707|NCT01169675|455250503|FG001|Overall Study|Withdrawal by Subject|0|||
126535708|NCT01169675|455250504|FG002|Overall Study|Withdrawal by Subject|0|||
126535709|NCT01169675|455250505|FG003|Overall Study|Withdrawal by Subject|1|||
126535710|NCT01169675|455250506|FG004|Overall Study|Withdrawal by Subject|2|||
126535711|NCT01169675|455250502|FG000|Overall Study|Other Reason Not Defined Above|0|||
126535712|NCT01169675|455250503|FG001|Overall Study|Other Reason Not Defined Above|0|||
126535713|NCT01169675|455250504|FG002|Overall Study|Other Reason Not Defined Above|0|||
126535714|NCT01169675|455250505|FG003|Overall Study|Other Reason Not Defined Above|1|||
126535715|NCT01169675|455250506|FG004|Overall Study|Other Reason Not Defined Above|1|||
126535716|NCT00803452|455250507|FG000|Overall Study|Adverse Event|0|||
126535717|NCT00803452|455250508|FG001|Overall Study|Adverse Event|2|||
126535718|NCT00803452|455250507|FG000|Overall Study|Lost to Follow-up|0|||
126535719|NCT00803452|455250508|FG001|Overall Study|Lost to Follow-up|3|||
126535720|NCT02816138|455250512|FG000|Overall Study|Adverse Event|1|||
126535721|NCT04839965|455250513|FG000|Overall Study|Death|6|||
126535722|NCT04839965|455250514|FG001|Overall Study|Death|6|||
126535723|NCT04839965|455250513|FG000|Overall Study|Lost to Follow-up|1|||
126535724|NCT04839965|455250514|FG001|Overall Study|Lost to Follow-up|0|||
126535725|NCT02365519|455250515|FG000|Randomized and Treated|Adverse Event|0|||
126535726|NCT02365519|455250516|FG001|Randomized and Treated|Adverse Event|1|||
126535727|NCT02365519|455250517|FG002|Randomized and Treated|Adverse Event|0|||
126535728|NCT02365519|455250515|FG000|Randomized and Treated|Withdrawal by Subject|0|||
126535729|NCT02365519|455250516|FG001|Randomized and Treated|Withdrawal by Subject|1|||
126535730|NCT02365519|455250517|FG002|Randomized and Treated|Withdrawal by Subject|1|||
126535731|NCT00981084|455250518|FG000|Post Intervention (Data Analysis)|poor effort|1|||
126535732|NCT00981084|455250519|FG001|Post Intervention (Data Analysis)|poor effort|1|||
126535733|NCT00981084|455250518|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
126535734|NCT00981084|455250519|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
126535735|NCT02291679|455250520|FG000|Overall Study|Adverse Event|2|||
126535736|NCT02291679|455250521|FG001|Overall Study|Adverse Event|12|||
126535737|NCT02291679|455250522|FG002|Overall Study|Adverse Event|19|||
126535738|NCT02291679|455250520|FG000|Overall Study|Protocol Violation|5|||
126535739|NCT02291679|455250521|FG001|Overall Study|Protocol Violation|1|||
126535740|NCT02291679|455250522|FG002|Overall Study|Protocol Violation|7|||
126535741|NCT02291679|455250520|FG000|Overall Study|Withdrew Consent|18|||
126535742|NCT02291679|455250521|FG001|Overall Study|Withdrew Consent|10|||
126535743|NCT02291679|455250522|FG002|Overall Study|Withdrew Consent|15|||
126535744|NCT02291679|455250520|FG000|Overall Study|Lost to Follow-up|12|||
126535745|NCT02291679|455250521|FG001|Overall Study|Lost to Follow-up|10|||
126535746|NCT02291679|455250522|FG002|Overall Study|Lost to Follow-up|9|||
126535747|NCT02291679|455250520|FG000|Overall Study|Insufficient Therapeutic Response|5|||
126535748|NCT02291679|455250521|FG001|Overall Study|Insufficient Therapeutic Response|5|||
126535749|NCT02291679|455250522|FG002|Overall Study|Insufficient Therapeutic Response|7|||
126535750|NCT02291679|455250520|FG000|Overall Study|Other|2|||
126535751|NCT02291679|455250521|FG001|Overall Study|Other|4|||
126535752|NCT02291679|455250522|FG002|Overall Study|Other|2|||
126535753|NCT02048072|455250523|FG000|Overall Study|Adverse Event|3|||
126535754|NCT02048072|455250523|FG000|Overall Study|Lost to Follow-up|1|||
126535755|NCT00725296|455250524|FG000|Overall Study|Adverse Event|11|||
126535756|NCT00725296|455250524|FG000|Overall Study|Lack of Efficacy|7|||
126535757|NCT00725296|455250524|FG000|Overall Study|Withdrawal by Subject|3|||
126535758|NCT00725296|455250524|FG000|Overall Study|Non-Compliance|2|||
126535759|NCT00725296|455250524|FG000|Overall Study|Lost to Follow-up|1|||
126535760|NCT00725296|455250524|FG000|Overall Study|Other|38|||
126535761|NCT03360942|455250526|FG000|Overall Study|Device explanted|2|||
126535762|NCT03360942|455250526|FG000|Overall Study|Study closure|1|||
126535763|NCT03360942|455250526|FG000|Overall Study|Withdrawal by Subject|2|||
126535764|NCT01592370|455250532|FG000|Overall Study|Disease Progression|62|||
126535765|NCT01592370|455250533|FG001|Overall Study|Disease Progression|16|||
126535766|NCT01592370|455250534|FG002|Overall Study|Disease Progression|52|||
126535767|NCT01592370|455250535|FG003|Overall Study|Disease Progression|3|||
126535768|NCT01592370|455250536|FG004|Overall Study|Disease Progression|3|||
126535769|NCT01592370|455250537|FG005|Overall Study|Disease Progression|31|||
126535770|NCT01592370|455250538|FG006|Overall Study|Disease Progression|14|||
126535771|NCT01592370|455250532|FG000|Overall Study|Study Drug Toxicity|14|||
126535772|NCT01592370|455250533|FG001|Overall Study|Study Drug Toxicity|3|||
126535773|NCT01592370|455250534|FG002|Overall Study|Study Drug Toxicity|0|||
126535774|NCT01592370|455250535|FG003|Overall Study|Study Drug Toxicity|0|||
126535775|NCT01592370|455250536|FG004|Overall Study|Study Drug Toxicity|0|||
126535776|NCT01592370|455250537|FG005|Overall Study|Study Drug Toxicity|0|||
126535777|NCT01592370|455250538|FG006|Overall Study|Study Drug Toxicity|1|||
126535778|NCT01592370|455250532|FG000|Overall Study|AE unrelated to study drug|4|||
126535779|NCT01592370|455250533|FG001|Overall Study|AE unrelated to study drug|3|||
126535780|NCT01592370|455250534|FG002|Overall Study|AE unrelated to study drug|0|||
126535781|NCT01592370|455250535|FG003|Overall Study|AE unrelated to study drug|0|||
126535782|NCT01592370|455250536|FG004|Overall Study|AE unrelated to study drug|0|||
126535783|NCT01592370|455250537|FG005|Overall Study|AE unrelated to study drug|0|||
126535784|NCT01592370|455250538|FG006|Overall Study|AE unrelated to study drug|1|||
126535785|NCT01592370|455250532|FG000|Overall Study|Request to discontinue study treatment|5|||
126535786|NCT01592370|455250533|FG001|Overall Study|Request to discontinue study treatment|0|||
126535787|NCT01592370|455250534|FG002|Overall Study|Request to discontinue study treatment|2|||
126535788|NCT01592370|455250535|FG003|Overall Study|Request to discontinue study treatment|0|||
126535789|NCT01592370|455250536|FG004|Overall Study|Request to discontinue study treatment|1|||
126535790|NCT01592370|455250537|FG005|Overall Study|Request to discontinue study treatment|2|||
126535791|NCT01592370|455250538|FG006|Overall Study|Request to discontinue study treatment|0|||
126535792|NCT01592370|455250532|FG000|Overall Study|Withdrew consent|1|||
126535793|NCT01592370|455250533|FG001|Overall Study|Withdrew consent|2|||
126535794|NCT01592370|455250534|FG002|Overall Study|Withdrew consent|1|||
126535795|NCT01592370|455250535|FG003|Overall Study|Withdrew consent|1|||
126535796|NCT01592370|455250536|FG004|Overall Study|Withdrew consent|0|||
126535797|NCT01592370|455250537|FG005|Overall Study|Withdrew consent|0|||
126535798|NCT01592370|455250538|FG006|Overall Study|Withdrew consent|0|||
126535799|NCT01592370|455250532|FG000|Overall Study|Maximum clinical benefit|11|||
126535800|NCT01592370|455250533|FG001|Overall Study|Maximum clinical benefit|1|||
126535801|NCT01592370|455250534|FG002|Overall Study|Maximum clinical benefit|7|||
126535802|NCT01592370|455250535|FG003|Overall Study|Maximum clinical benefit|1|||
126535803|NCT01592370|455250536|FG004|Overall Study|Maximum clinical benefit|0|||
126535804|NCT01592370|455250537|FG005|Overall Study|Maximum clinical benefit|0|||
126535805|NCT01592370|455250538|FG006|Overall Study|Maximum clinical benefit|0|||
126535806|NCT01592370|455250532|FG000|Overall Study|No longer meets study criteria|1|||
126535807|NCT01592370|455250533|FG001|Overall Study|No longer meets study criteria|0|||
126535808|NCT01592370|455250534|FG002|Overall Study|No longer meets study criteria|0|||
126535809|NCT01592370|455250535|FG003|Overall Study|No longer meets study criteria|0|||
126535810|NCT01592370|455250536|FG004|Overall Study|No longer meets study criteria|0|||
126535811|NCT01592370|455250537|FG005|Overall Study|No longer meets study criteria|0|||
126535812|NCT01592370|455250538|FG006|Overall Study|No longer meets study criteria|0|||
126535813|NCT01592370|455250532|FG000|Overall Study|Other Reasons|6|||
126535814|NCT01592370|455250533|FG001|Overall Study|Other Reasons|0|||
126535815|NCT01592370|455250534|FG002|Overall Study|Other Reasons|10|||
126535816|NCT01592370|455250535|FG003|Overall Study|Other Reasons|0|||
126535817|NCT01592370|455250536|FG004|Overall Study|Other Reasons|0|||
126535818|NCT01592370|455250537|FG005|Overall Study|Other Reasons|1|||
126535819|NCT01592370|455250538|FG006|Overall Study|Other Reasons|0|||
126535820|NCT03432364|455251732|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
126535821|NCT00337272|455251733|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
126535822|NCT00337272|455251734|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
126535823|NCT00337272|455251733|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
126535824|NCT00337272|455251734|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
126535825|NCT00337272|455251733|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
126535826|NCT00337272|455251734|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
126535827|NCT00337272|455251733|FG000|Treatment Period|Non-compliance|1|||
126535828|NCT00337272|455251734|FG001|Treatment Period|Non-compliance|1|||
126535829|NCT00337272|455251733|FG000|Treatment Period|Withdrawal by Subject|0|||
126535830|NCT00337272|455251734|FG001|Treatment Period|Withdrawal by Subject|1|||
126535831|NCT00337272|455251733|FG000|Withdrawal Period|Non-compliance|0|||
126535832|NCT00337272|455251734|FG001|Withdrawal Period|Non-compliance|1|||
126535833|NCT03320018|455251735|FG000|Treatment Period|Withdrawal by Subject|1|||
126535834|NCT03320018|455251736|FG001|Treatment Period|Withdrawal by Subject|0|||
126535835|NCT03320018|455251735|FG000|Day 90 Follow up|Death|0|||
126535836|NCT03320018|455251736|FG001|Day 90 Follow up|Death|1|||
126535837|NCT03284788|455251740|FG000|Overall Study|Withdrawal by Subject|2|||
126535838|NCT03104699|455251747|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
126535839|NCT03104699|455251748|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
126535840|NCT03104699|455251749|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
126535841|NCT03104699|455251750|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
126535842|NCT03104699|455251751|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
126535843|NCT03104699|455251752|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126535844|NCT03104699|455251747|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
126535845|NCT03104699|455251748|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
126535846|NCT03104699|455251749|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
126535847|NCT03104699|455251750|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
126535848|NCT03104699|455251751|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
126535849|NCT03104699|455251752|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
126535850|NCT03104699|455251747|FG000|Phase 1: Dose Escalation|Death|6|||
126535851|NCT03104699|455251748|FG001|Phase 1: Dose Escalation|Death|3|||
126535852|NCT03104699|455251749|FG002|Phase 1: Dose Escalation|Death|0|||
126535853|NCT03104699|455251750|FG003|Phase 1: Dose Escalation|Death|1|||
126535854|NCT03104699|455251751|FG004|Phase 1: Dose Escalation|Death|1|||
126535855|NCT03104699|455251752|FG005|Phase 1: Dose Escalation|Death|0|||
126535856|NCT03104699|455251747|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
126535857|NCT03104699|455251748|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
126535858|NCT03104699|455251749|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
126535859|NCT03104699|455251750|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
126535860|NCT03104699|455251751|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
126535861|NCT03104699|455251752|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
126535862|NCT03104699|455251747|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
126535863|NCT03104699|455251748|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
126535864|NCT03104699|455251749|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
126535865|NCT03104699|455251750|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
126535866|NCT03104699|455251751|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
126535867|NCT03104699|455251752|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
126535868|NCT03104699|455251747|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
126535869|NCT03104699|455251748|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
126535870|NCT03104699|455251749|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
126648168|NCT02003222|455669712|FG003|Induction|Withdrawal by Subject|0|||
126535871|NCT03104699|455251750|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
126535872|NCT03104699|455251751|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
126535873|NCT03104699|455251752|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
126535874|NCT03104699|455251747|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
126535875|NCT03104699|455251748|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
126535876|NCT03104699|455251749|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
126535877|NCT03104699|455251750|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
126535878|NCT03104699|455251751|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
126535879|NCT03104699|455251752|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
126535880|NCT03104699|455251747|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
126535881|NCT03104699|455251748|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
126535882|NCT03104699|455251749|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
126535883|NCT03104699|455251750|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
126535884|NCT03104699|455251751|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
126535885|NCT03104699|455251752|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
126535886|NCT03104699|455251747|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
126535887|NCT03104699|455251748|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
126535888|NCT03104699|455251749|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
126535889|NCT03104699|455251750|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
126535890|NCT03104699|455251751|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
126535891|NCT03104699|455251752|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
126535892|NCT03104699|455251747|FG000|Phase 2: Dose Expansion|Death|0|||
126535893|NCT03104699|455251748|FG001|Phase 2: Dose Expansion|Death|0|||
126535894|NCT03104699|455251749|FG002|Phase 2: Dose Expansion|Death|0|||
126535895|NCT03104699|455251750|FG003|Phase 2: Dose Expansion|Death|0|||
126535896|NCT03104699|455251751|FG004|Phase 2: Dose Expansion|Death|0|||
126535897|NCT03104699|455251752|FG005|Phase 2: Dose Expansion|Death|107|||
126535898|NCT03104699|455251747|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
126535899|NCT03104699|455251748|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
126535900|NCT03104699|455251749|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
126535901|NCT03104699|455251750|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
126535902|NCT03104699|455251751|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
126535903|NCT03104699|455251752|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
126535904|NCT03104699|455251747|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
126535905|NCT03104699|455251748|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
126535906|NCT03104699|455251749|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
126535907|NCT03104699|455251750|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
126535908|NCT03104699|455251751|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
126535909|NCT03104699|455251752|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
126535910|NCT03104699|455251747|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126535911|NCT03104699|455251748|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126535912|NCT03104699|455251749|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126535913|NCT03104699|455251750|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126535914|NCT03104699|455251751|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126535915|NCT03104699|455251752|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
126535916|NCT03104699|455251747|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
126535917|NCT03104699|455251748|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
126535918|NCT03104699|455251749|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
126535919|NCT03104699|455251750|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
126535920|NCT03104699|455251751|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
126535921|NCT03104699|455251752|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
126535922|NCT00152464|455251753|FG000|Overall Study|Adverse Event|3|||
126535923|NCT00152464|455251754|FG001|Overall Study|Adverse Event|6|||
126535924|NCT00152464|455251753|FG000|Overall Study|Lost to Follow-up|8|||
126535925|NCT00152464|455251754|FG001|Overall Study|Lost to Follow-up|4|||
126535926|NCT00152464|455251753|FG000|Overall Study|Protocol Violation|3|||
126535927|NCT00152464|455251754|FG001|Overall Study|Protocol Violation|1|||
126535928|NCT00152464|455251753|FG000|Overall Study|Withdrawal by Subject|21|||
126535929|NCT00152464|455251754|FG001|Overall Study|Withdrawal by Subject|22|||
126535930|NCT00152464|455251753|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
126535931|NCT00152464|455251754|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
126535932|NCT00152464|455251753|FG000|Overall Study|Eczema deterioration|0|||
126535933|NCT00152464|455251754|FG001|Overall Study|Eczema deterioration|1|||
126535934|NCT00152464|455251753|FG000|Overall Study|Parent decision|1|||
126535935|NCT00152464|455251754|FG001|Overall Study|Parent decision|1|||
126535936|NCT00152464|455251753|FG000|Overall Study|Investigator decision|1|||
126535937|NCT00152464|455251754|FG001|Overall Study|Investigator decision|0|||
126535938|NCT00152464|455251753|FG000|Overall Study|Lack of Efficacy|1|||
126535939|NCT00152464|455251754|FG001|Overall Study|Lack of Efficacy|0|||
126535940|NCT00152464|455251753|FG000|Overall Study|Eczema poorly controlled|1|||
126535941|NCT00152464|455251754|FG001|Overall Study|Eczema poorly controlled|0|||
126535942|NCT00152464|455251753|FG000|Overall Study|Patient relocated|1|||
126535943|NCT00152464|455251754|FG001|Overall Study|Patient relocated|0|||
126535944|NCT01644734|455251755|FG000|Overall Study|Adverse Event|4|||
126535945|NCT01644734|455251755|FG000|Overall Study|Lost to Follow-up|17|||
126535946|NCT01644734|455251755|FG000|Overall Study|Reasons other than stated above|7|||
126535947|NCT01644734|455251755|FG000|Overall Study|Missing documentation|238|||
126535948|NCT02835339|455251761|FG000|Overall Study|Did not receive allocated intervention|13|||
126535949|NCT02835339|455251762|FG001|Overall Study|Did not receive allocated intervention|16|||
126535950|NCT01077544|455251763|FG000|Overall Study|New Cancer Therapy|3|||
126535951|NCT01077544|455251764|FG001|Overall Study|New Cancer Therapy|3|||
126535952|NCT01077544|455251763|FG000|Overall Study|Adverse Event|0|||
126535953|NCT01077544|455251764|FG001|Overall Study|Adverse Event|1|||
126535954|NCT01077544|455251763|FG000|Overall Study|Disease Progression|0|||
126535955|NCT01077544|455251764|FG001|Overall Study|Disease Progression|1|||
126535956|NCT04393441|455251765|FG000|Overall Study|Adverse Event|0|||
126535957|NCT04393441|455251766|FG001|Overall Study|Adverse Event|3|||
126535958|NCT04393441|455251765|FG000|Overall Study|Withdrawal by Subject|5|||
126535959|NCT04393441|455251766|FG001|Overall Study|Withdrawal by Subject|7|||
126535960|NCT04393441|455251765|FG000|Overall Study|Lost to Follow-up|0|||
126535961|NCT04393441|455251766|FG001|Overall Study|Lost to Follow-up|2|||
126535962|NCT04393441|455251765|FG000|Overall Study|Protocol Deviation|2|||
126535963|NCT04393441|455251766|FG001|Overall Study|Protocol Deviation|1|||
126535964|NCT04393441|455251765|FG000|Overall Study|Reason not Specified|1|||
126535965|NCT04393441|455251766|FG001|Overall Study|Reason not Specified|1|||
126535966|NCT01812655|455251767|FG000|Overall Study|Protocol Violation|1|||
126535967|NCT01812655|455251768|FG001|Overall Study|Protocol Violation|1|||
126535968|NCT01812655|455251769|FG002|Overall Study|Protocol Violation|0|||
126535969|NCT02454101|455251770|FG000|Overall Study|Adverse Event|2|||
126535970|NCT02454101|455251771|FG001|Overall Study|Adverse Event|3|||
126535971|NCT02454101|455251770|FG000|Overall Study|Lost to Follow-up|3|||
126535972|NCT02454101|455251771|FG001|Overall Study|Lost to Follow-up|4|||
126535973|NCT00344461|455251800|FG000|Overall Study|Adverse Event|6|||
126535974|NCT00344461|455251800|FG000|Overall Study|Death|1|||
126535975|NCT00344461|455251800|FG000|Overall Study|Lack of Efficacy|2|||
126535976|NCT00344461|455251800|FG000|Overall Study|Lost to Follow-up|2|||
126535977|NCT00344461|455251800|FG000|Overall Study|Physician Decision|2|||
126535978|NCT00344461|455251800|FG000|Overall Study|Protocol Violation|6|||
126535979|NCT00344461|455251800|FG000|Overall Study|Withdrawal by Subject|2|||
126535980|NCT00636610|455251803|FG000|Overall Study|Adverse Event|4|||
126535981|NCT00636610|455251804|FG001|Overall Study|Adverse Event|4|||
126535982|NCT00636610|455251803|FG000|Overall Study|Death|6|||
126535983|NCT00636610|455251804|FG001|Overall Study|Death|3|||
126535984|NCT00636610|455251803|FG000|Overall Study|Physician decision to withdraw patient|15|||
126535985|NCT00636610|455251804|FG001|Overall Study|Physician decision to withdraw patient|9|||
126535986|NCT00636610|455251803|FG000|Overall Study|Subject decision to withdraw|15|||
126535987|NCT00636610|455251804|FG001|Overall Study|Subject decision to withdraw|11|||
126535988|NCT00636610|455251803|FG000|Overall Study|Disease progression - radiographic|41|||
126535989|NCT00636610|455251804|FG001|Overall Study|Disease progression - radiographic|51|||
126535990|NCT00636610|455251803|FG000|Overall Study|Disease progression - clinical|8|||
126535991|NCT00636610|455251804|FG001|Overall Study|Disease progression - clinical|3|||
126535992|NCT00636610|455251803|FG000|Overall Study|Reason for discontinuation not available|3|||
126535993|NCT00636610|455251804|FG001|Overall Study|Reason for discontinuation not available|2|||
126535994|NCT00553696|455251812|FG000|Overall Study|Adverse Event|2|||
126535995|NCT00553696|455251813|FG001|Overall Study|Adverse Event|4|||
126535996|NCT00553696|455251814|FG002|Overall Study|Adverse Event|0|||
126535997|NCT00553696|455251815|FG003|Overall Study|Adverse Event|1|||
126535998|NCT00553696|455251812|FG000|Overall Study|Global deterioration of health status|0|||
126535999|NCT00553696|455251813|FG001|Overall Study|Global deterioration of health status|2|||
126536000|NCT00553696|455251814|FG002|Overall Study|Global deterioration of health status|0|||
126536001|NCT00553696|455251815|FG003|Overall Study|Global deterioration of health status|0|||
126536002|NCT00553696|455251812|FG000|Overall Study|Objective progression or relapse|2|||
126536003|NCT00553696|455251813|FG001|Overall Study|Objective progression or relapse|9|||
126536004|NCT00553696|455251814|FG002|Overall Study|Objective progression or relapse|6|||
126536005|NCT00553696|455251815|FG003|Overall Study|Objective progression or relapse|0|||
126536006|NCT00553696|455251812|FG000|Overall Study|Withdrawal by Subject|0|||
126536007|NCT00553696|455251813|FG001|Overall Study|Withdrawal by Subject|1|||
126536008|NCT00553696|455251814|FG002|Overall Study|Withdrawal by Subject|0|||
126536009|NCT00553696|455251815|FG003|Overall Study|Withdrawal by Subject|0|||
126648169|NCT02003222|455669713|FG004|Induction|Withdrawal by Subject|8|||
126536010|NCT00686881|455251816|FG000|Overall Study|Withdrawal by Subject|11|||
126536011|NCT00686881|455251817|FG001|Overall Study|Withdrawal by Subject|18|||
126536012|NCT00686881|455251816|FG000|Overall Study|Lost to Follow-up|0|||
126536013|NCT00686881|455251817|FG001|Overall Study|Lost to Follow-up|1|||
126536014|NCT00686881|455251816|FG000|Overall Study|Treatment-related adverse event|10|||
126536015|NCT00686881|455251817|FG001|Overall Study|Treatment-related adverse event|9|||
126536016|NCT00686881|455251816|FG000|Overall Study|Met discontinuation criteria|5|||
126536017|NCT00686881|455251817|FG001|Overall Study|Met discontinuation criteria|0|||
126536018|NCT00686881|455251816|FG000|Overall Study|Onset of malignant tumor|11|||
126536019|NCT00686881|455251817|FG001|Overall Study|Onset of malignant tumor|11|||
126536020|NCT00686881|455251816|FG000|Overall Study|Lack of Efficacy|4|||
126536021|NCT00686881|455251817|FG001|Overall Study|Lack of Efficacy|3|||
126536022|NCT00686881|455251816|FG000|Overall Study|Physician Decision|1|||
126536023|NCT00686881|455251817|FG001|Overall Study|Physician Decision|0|||
126536024|NCT00686881|455251816|FG000|Overall Study|Circumstances of site|1|||
126536025|NCT00686881|455251817|FG001|Overall Study|Circumstances of site|1|||
126536026|NCT00686881|455251816|FG000|Overall Study|Did not meet protocol eligibility|1|||
126536027|NCT00686881|455251817|FG001|Overall Study|Did not meet protocol eligibility|0|||
126536028|NCT00686881|455251816|FG000|Overall Study|Irregular visits|1|||
126536029|NCT00686881|455251817|FG001|Overall Study|Irregular visits|0|||
126536030|NCT00686881|455251816|FG000|Overall Study|Study discontinuation|35|||
126536031|NCT00686881|455251817|FG001|Overall Study|Study discontinuation|32|||
126536032|NCT00686881|455251816|FG000|Overall Study|Never received study drug|2|||
126536033|NCT00686881|455251817|FG001|Overall Study|Never received study drug|6|||
126536034|NCT02355028|455251823|FG000|Overall Study|Adverse Event|2|||
126536035|NCT02355028|455251824|FG001|Overall Study|Adverse Event|0|||
126536036|NCT02355028|455251823|FG000|Overall Study|Withdrawal by Subject|1|||
126536037|NCT02355028|455251824|FG001|Overall Study|Withdrawal by Subject|1|||
126536038|NCT02355028|455251823|FG000|Overall Study|Deemed ineligible after randomization|8|||
126536039|NCT02355028|455251824|FG001|Overall Study|Deemed ineligible after randomization|4|||
126536040|NCT02276222|455251825|FG000|Overall Study|Adverse Event|62|||
126536041|NCT02276222|455251826|FG001|Overall Study|Adverse Event|11|||
126536042|NCT02276222|455251825|FG000|Overall Study|Death|3|||
126536043|NCT02276222|455251826|FG001|Overall Study|Death|4|||
126536044|NCT02276222|455251825|FG000|Overall Study|Lack of Efficacy|13|||
126536045|NCT02276222|455251826|FG001|Overall Study|Lack of Efficacy|3|||
126536046|NCT02276222|455251825|FG000|Overall Study|Protocol Violation|3|||
126536047|NCT02276222|455251826|FG001|Overall Study|Protocol Violation|2|||
126536048|NCT02276222|455251825|FG000|Overall Study|Withdrawal by Subject|79|||
126536049|NCT02276222|455251826|FG001|Overall Study|Withdrawal by Subject|33|||
126536050|NCT02276222|455251825|FG000|Overall Study|non compliance with study medication|6|||
126536051|NCT02276222|455251826|FG001|Overall Study|non compliance with study medication|2|||
126536052|NCT02276222|455251825|FG000|Overall Study|sponsor decision|0|||
126536053|NCT02276222|455251826|FG001|Overall Study|sponsor decision|3|||
126536054|NCT02276222|455251825|FG000|Overall Study|Lost to Follow-up|15|||
126536055|NCT02276222|455251826|FG001|Overall Study|Lost to Follow-up|5|||
126536056|NCT02276222|455251825|FG000|Overall Study|Physician Decision|2|||
126536057|NCT02276222|455251826|FG001|Overall Study|Physician Decision|1|||
126536058|NCT02276222|455251825|FG000|Overall Study|sheduling conflict|1|||
126536059|NCT02276222|455251826|FG001|Overall Study|sheduling conflict|0|||
126536060|NCT02276222|455251825|FG000|Overall Study|subject withdrew after randomization|1|||
126536061|NCT02276222|455251826|FG001|Overall Study|subject withdrew after randomization|0|||
126536062|NCT01971723|455251827|FG000|Overall Study|Withdrawal by Subject|1|||
126536063|NCT01971723|455251828|FG001|Overall Study|Withdrawal by Subject|1|||
126536064|NCT01971723|455251827|FG000|Overall Study|Protocol Violation|1|||
126536065|NCT01971723|455251828|FG001|Overall Study|Protocol Violation|2|||
126536066|NCT05899686|455251829|FG000|Overall Study|Protocol Violation|1|||
126536067|NCT03645759|455251830|FG000|Overall Study|Lost to Follow-up|3|||
126536068|NCT03645759|455251831|FG001|Overall Study|Lost to Follow-up|2|||
126536069|NCT01648270|455251832|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
126536070|NCT00902694|455251833|FG000|Overall Study|Death|1|||
126536071|NCT00902694|455251834|FG001|Overall Study|Death|3|||
126536072|NCT00902694|455251833|FG000|Overall Study|Lost to Follow-up|1|||
126536073|NCT00902694|455251834|FG001|Overall Study|Lost to Follow-up|0|||
126536074|NCT00902694|455251833|FG000|Overall Study|Censored per protocol|3|||
126536075|NCT00902694|455251834|FG001|Overall Study|Censored per protocol|1|||
126536076|NCT00902694|455251833|FG000|Overall Study|Pregnancy|1|||
126536077|NCT00902694|455251834|FG001|Overall Study|Pregnancy|1|||
126536078|NCT00902694|455251833|FG000|Overall Study|Incarceration|1|||
126536079|NCT00902694|455251834|FG001|Overall Study|Incarceration|0|||
126536080|NCT04969263|455251835|FG000|Overall Study|Death|1|||
126536081|NCT04969263|455251835|FG000|Overall Study|Lost to Follow-up|2|||
126536082|NCT04969263|455251835|FG000|Overall Study|Withdrawal by Subject|5|||
126536083|NCT04969263|455251835|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
126648170|NCT02003222|455669709|FG000|Induction|Other reasons|0|||
126536084|NCT03657277|455251837|FG000|Overall Study|Physician Decision|2|||
126536085|NCT03657277|455251837|FG000|Overall Study|Lost to Follow-up|1|||
126536086|NCT03657277|455251837|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
126536087|NCT02693743|455251838|FG000|Overall Study|Physician Decision|1|||
126536088|NCT02693743|455251839|FG001|Overall Study|Physician Decision|0|||
126536089|NCT01024608|455251840|FG000|Overall Study|Adverse Event|1|||
126536090|NCT01024608|455251841|FG001|Overall Study|Adverse Event|0|||
126536091|NCT01024608|455251840|FG000|Overall Study|Withdrawal by Subject|1|||
126536092|NCT01024608|455251841|FG001|Overall Study|Withdrawal by Subject|0|||
126536093|NCT01024608|455251840|FG000|Overall Study|Lost to Follow-up|0|||
126536094|NCT01024608|455251841|FG001|Overall Study|Lost to Follow-up|1|||
126536095|NCT01024608|455251840|FG000|Overall Study|Protocol Violation|0|||
126536096|NCT01024608|455251841|FG001|Overall Study|Protocol Violation|3|||
126536097|NCT01024608|455251840|FG000|Overall Study|Never received study treatment|2|||
126536098|NCT01024608|455251841|FG001|Overall Study|Never received study treatment|0|||
126536099|NCT00657618|455251848|FG000|Overall Study|Adverse Event|32|||
126536100|NCT00657618|455251848|FG000|Overall Study|Withdrawal by Subject|8|||
126536101|NCT00657618|455251848|FG000|Overall Study|negative for leishmaniasis|2|||
126536102|NCT00657618|455251848|FG000|Overall Study|didn't start due to schedule conflicts|1|||
126536103|NCT02412137|455251853|FG000|Overall Study|Withdrawal by Subject|2|||
126536104|NCT02412137|455251854|FG001|Overall Study|Withdrawal by Subject|0|||
126536105|NCT02412137|455251853|FG000|Overall Study|Lost to Follow-up|21|||
126536106|NCT02412137|455251854|FG001|Overall Study|Lost to Follow-up|14|||
126536107|NCT02412137|455251853|FG000|Overall Study|Physician Decision|28|||
126536108|NCT02412137|455251854|FG001|Overall Study|Physician Decision|9|||
126536109|NCT04981678|455251861|FG000|Overall Study|Lost to Follow-up|0|||
126536110|NCT04981678|455251862|FG001|Overall Study|Lost to Follow-up|1|||
126536111|NCT04922554|455251863|FG000|Overall Study|Adverse Event|4|||
126536112|NCT04922554|455251864|FG001|Overall Study|Adverse Event|0|||
126536113|NCT04922554|455251863|FG000|Overall Study|Withdrawal by Subject|1|||
126536114|NCT04922554|455251864|FG001|Overall Study|Withdrawal by Subject|0|||
126536115|NCT01735201|455253665|FG000|Overall Study|Adverse Event|1|||
126536116|NCT01735201|455253666|FG001|Overall Study|Adverse Event|1|||
126536117|NCT01735201|455253667|FG002|Overall Study|Adverse Event|0|||
126536118|NCT01735201|455253668|FG003|Overall Study|Adverse Event|1|||
126536119|NCT01735201|455253669|FG004|Overall Study|Adverse Event|1|||
126536120|NCT01735201|455253670|FG005|Overall Study|Adverse Event|3|||
126536121|NCT01735201|455253671|FG006|Overall Study|Adverse Event|2|||
126536122|NCT01735201|455253672|FG007|Overall Study|Adverse Event|1|||
126536123|NCT01735201|455253665|FG000|Overall Study|Personal Reasons|1|||
126536124|NCT01735201|455253666|FG001|Overall Study|Personal Reasons|0|||
126536125|NCT01735201|455253667|FG002|Overall Study|Personal Reasons|0|||
126536126|NCT01735201|455253668|FG003|Overall Study|Personal Reasons|0|||
126536127|NCT01735201|455253669|FG004|Overall Study|Personal Reasons|0|||
126536128|NCT01735201|455253670|FG005|Overall Study|Personal Reasons|0|||
126536129|NCT01735201|455253671|FG006|Overall Study|Personal Reasons|0|||
126536130|NCT01735201|455253672|FG007|Overall Study|Personal Reasons|0|||
126536131|NCT01735201|455253665|FG000|Overall Study|Protocol Violation|1|||
126536132|NCT01735201|455253666|FG001|Overall Study|Protocol Violation|0|||
126536133|NCT01735201|455253667|FG002|Overall Study|Protocol Violation|0|||
126536134|NCT01735201|455253668|FG003|Overall Study|Protocol Violation|0|||
126536135|NCT01735201|455253669|FG004|Overall Study|Protocol Violation|0|||
126536136|NCT01735201|455253670|FG005|Overall Study|Protocol Violation|0|||
126536137|NCT01735201|455253671|FG006|Overall Study|Protocol Violation|0|||
126536138|NCT01735201|455253672|FG007|Overall Study|Protocol Violation|0|||
126536139|NCT01735201|455253665|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126536140|NCT01735201|455253666|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126536141|NCT01735201|455253667|FG002|Overall Study|Other Miscellaneous Reasons|0|||
126536142|NCT01735201|455253668|FG003|Overall Study|Other Miscellaneous Reasons|1|||
126536143|NCT01735201|455253669|FG004|Overall Study|Other Miscellaneous Reasons|0|||
126536144|NCT01735201|455253670|FG005|Overall Study|Other Miscellaneous Reasons|2|||
126536145|NCT01735201|455253671|FG006|Overall Study|Other Miscellaneous Reasons|1|||
126536146|NCT01735201|455253672|FG007|Overall Study|Other Miscellaneous Reasons|1|||
126536147|NCT01553318|455253673|FG000|Overall Study|Protocol Violation|3|||
126536148|NCT01553318|455253674|FG001|Overall Study|Protocol Violation|2|||
126536149|NCT02127372|455253679|FG000|Overall Study|Withdrawal by Subject|1|||
126536150|NCT02127372|455253680|FG001|Overall Study|Withdrawal by Subject|0|||
126536151|NCT03597568|455253681|FG000|Overall Study|Withdrawal by Subject|1|||
126536152|NCT03597568|455253682|FG001|Overall Study|Withdrawal by Subject|1|||
126536153|NCT03597568|455253681|FG000|Overall Study|Unable to analyze vascular data|1|||
126536154|NCT03597568|455253682|FG001|Overall Study|Unable to analyze vascular data|1|||
126536155|NCT01699022|455253686|FG000|Overall Study|Early discontinuation from the study|3|||
126536156|NCT02052310|455253687|FG000|Overall Study|Death|64|||
126536157|NCT02052310|455253688|FG001|Overall Study|Death|54|||
126536158|NCT02052310|455253687|FG000|Overall Study|Withdrawal by Subject|37|||
126536159|NCT02052310|455253688|FG001|Overall Study|Withdrawal by Subject|49|||
126536160|NCT02052310|455253687|FG000|Overall Study|Other than specified|32|||
126648171|NCT02003222|455669710|FG001|Induction|Other reasons|0|||
126536161|NCT02052310|455253688|FG001|Overall Study|Other than specified|29|||
126536162|NCT02052310|455253687|FG000|Overall Study|Adverse Event|29|||
126536163|NCT02052310|455253688|FG001|Overall Study|Adverse Event|22|||
126536164|NCT02052310|455253687|FG000|Overall Study|Kidney Transplant|23|||
126536165|NCT02052310|455253688|FG001|Overall Study|Kidney Transplant|29|||
126536166|NCT02052310|455253687|FG000|Overall Study|Physician Decision|14|||
126536167|NCT02052310|455253688|FG001|Overall Study|Physician Decision|7|||
126536168|NCT02052310|455253687|FG000|Overall Study|Lack of Efficacy|6|||
126536169|NCT02052310|455253688|FG001|Overall Study|Lack of Efficacy|1|||
126536170|NCT02052310|455253687|FG000|Overall Study|Site Terminated by Sponsor|5|||
126648172|NCT02003222|455669711|FG002|Induction|Other reasons|0|||
126536171|NCT02052310|455253688|FG001|Overall Study|Site Terminated by Sponsor|13|||
126536172|NCT02052310|455253687|FG000|Overall Study|Lost to Follow-up|4|||
126536173|NCT02052310|455253688|FG001|Overall Study|Lost to Follow-up|2|||
126536174|NCT02052310|455253687|FG000|Overall Study|Protocol Violation|1|||
126536175|NCT02052310|455253688|FG001|Overall Study|Protocol Violation|6|||
126536176|NCT02565914|455253691|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
126536177|NCT02565914|455253691|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
126536178|NCT02565914|455253691|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
126536179|NCT02565914|455253691|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
126536180|NCT02565914|455253691|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
126536181|NCT02565914|455253691|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
126536182|NCT02565914|455253691|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
126536183|NCT02565914|455253691|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
126536184|NCT02565914|455253691|FG000|Part A (Up to 96 Weeks)|Other|18|||
126536185|NCT02565914|455253691|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
126536186|NCT02565914|455253691|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
126536187|NCT02565914|455253691|FG000|Part B (Up to 96 Weeks)|Other|1|||
126536188|NCT02565914|455253691|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
126536189|NCT02565914|455253691|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
126536190|NCT02565914|455253691|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
126536191|NCT02565914|455253691|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
126536192|NCT02565914|455253691|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
126536193|NCT02565914|455253691|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
126536194|NCT02565914|455253691|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
126536195|NCT02565914|455253691|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
126536196|NCT02565914|455253691|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
126536197|NCT02565914|455253691|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
126536198|NCT02565914|455253691|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
126536199|NCT02565914|455253691|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
126536200|NCT00420199|455253698|FG000|Overall Study|Participant no longer met study criteria|1|||
126536201|NCT00420199|455253699|FG001|Overall Study|Participant no longer met study criteria|0|||
126536202|NCT00266825|455253701|FG000|Completed Follow-Up|Lost to Follow-up|14|||
126536203|NCT00266825|455253702|FG001|Completed Follow-Up|Lost to Follow-up|19|||
126536204|NCT00266825|455253701|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
126536205|NCT00266825|455253702|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
126536206|NCT01301391|455253705|FG000|Overall Study|Death|13|||
126536207|NCT01301391|455253705|FG000|Overall Study|Lost to Follow-up|3|||
126536208|NCT01301391|455253705|FG000|Overall Study|Physician Decision|2|||
126536209|NCT01301391|455253705|FG000|Overall Study|Sponsor's decision|8|||
126536210|NCT02799784|455253709|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
126536211|NCT02799784|455253710|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
126536212|NCT02799784|455253709|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
126536213|NCT02799784|455253710|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
126536214|NCT02799784|455253709|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
126536215|NCT02799784|455253710|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
126536216|NCT02799784|455253709|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
126536217|NCT02799784|455253710|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
126536218|NCT02799784|455253709|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
126536219|NCT02799784|455253710|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
126536220|NCT02799784|455253709|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
126536221|NCT02799784|455253710|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
126536222|NCT03466086|455253716|FG000|Period 1|Sponsor decision due to study timeline|1|||
126536223|NCT03466086|455253717|FG001|Period 1|Sponsor decision due to study timeline|0|||
126536224|NCT03466086|455253716|FG000|Period 1|Withdrawal by Subject|1|||
126536225|NCT03466086|455253717|FG001|Period 1|Withdrawal by Subject|0|||
126536226|NCT00595504|455253718|FG000|Overall Study|Withdrawal by Subject|1|||
126536227|NCT00595504|455253719|FG001|Overall Study|Withdrawal by Subject|3|||
126536228|NCT00595504|455253718|FG000|Overall Study|Physician Decision|1|||
126536229|NCT00595504|455253719|FG001|Overall Study|Physician Decision|0|||
126536230|NCT01949870|455253721|FG000|Overall Study|Lack of Efficacy|2|||
126536231|NCT01949870|455253721|FG000|Overall Study|Adverse Event|1|||
126536232|NCT01949870|455253721|FG000|Overall Study|Study termination|1|||
126536233|NCT01949870|455253721|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
126536234|NCT02570126|455253725|FG000|Overall Study|Lost to Follow-up|2|||
126536235|NCT02570126|455253726|FG001|Overall Study|Lost to Follow-up|0|||
126536236|NCT02570126|455253725|FG000|Overall Study|Unable To Arrange Visit 3|1|||
126536237|NCT02570126|455253726|FG001|Overall Study|Unable To Arrange Visit 3|0|||
126536238|NCT02570126|455253725|FG000|Overall Study|Violation Of Procedures GSK|0|||
126536239|NCT02570126|455253726|FG001|Overall Study|Violation Of Procedures GSK|1|||
126536240|NCT02570126|455253725|FG000|Overall Study|Protocol Violation|0|||
126536241|NCT02570126|455253726|FG001|Overall Study|Protocol Violation|1|||
126536242|NCT02570126|455253725|FG000|Overall Study|Withdrawal by Subject|3|||
126536243|NCT02570126|455253726|FG001|Overall Study|Withdrawal by Subject|7|||
126536244|NCT00917579|455253727|FG000|Washout >= 2 Weeks|Adverse Event|1|||
126536245|NCT00917579|455253728|FG001|Washout >= 2 Weeks|Adverse Event|0|||
126536246|NCT00917579|455253727|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
126536247|NCT00917579|455253728|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
126536248|NCT00754338|455253729|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
126536249|NCT00754338|455253730|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
126536250|NCT00754338|455253731|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
126536251|NCT00754338|455253732|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
126536252|NCT00754338|455253729|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
126536253|NCT00754338|455253730|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
126536254|NCT00754338|455253731|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
126536255|NCT00754338|455253732|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
126536256|NCT04020341|455253735|FG000|Overall Study|Adverse Event|8|||
126536257|NCT04020341|455253736|FG001|Overall Study|Adverse Event|6|||
126536258|NCT04020341|455253735|FG000|Overall Study|Lost to Follow-up|8|||
126536259|NCT04020341|455253736|FG001|Overall Study|Lost to Follow-up|2|||
126536260|NCT04020341|455253735|FG000|Overall Study|Withdrawal by Subject|16|||
126536261|NCT04020341|455253736|FG001|Overall Study|Withdrawal by Subject|16|||
126536262|NCT04020341|455253735|FG000|Overall Study|Participant not able to swallow the tablet|1|||
126536263|NCT04020341|455253736|FG001|Overall Study|Participant not able to swallow the tablet|0|||
126536264|NCT04020341|455253735|FG000|Overall Study|Physician Decision|0|||
126536265|NCT04020341|455253736|FG001|Overall Study|Physician Decision|2|||
126536266|NCT04020341|455253735|FG000|Overall Study|Protocol Deviation|0|||
126536267|NCT04020341|455253736|FG001|Overall Study|Protocol Deviation|2|||
126536268|NCT00677352|455253737|FG000|Treatment Phase|Adverse Event|14|||
126536269|NCT00677352|455253738|FG001|Treatment Phase|Adverse Event|22|||
126536270|NCT00677352|455253737|FG000|Treatment Phase|Lack of Efficacy|2|||
126536271|NCT00677352|455253738|FG001|Treatment Phase|Lack of Efficacy|3|||
126536272|NCT00677352|455253737|FG000|Treatment Phase|Lost to Follow-up|0|||
126536273|NCT00677352|455253738|FG001|Treatment Phase|Lost to Follow-up|1|||
126536274|NCT00677352|455253737|FG000|Treatment Phase|Withdrawal by Subject|7|||
126536275|NCT00677352|455253738|FG001|Treatment Phase|Withdrawal by Subject|7|||
126536276|NCT00677352|455253737|FG000|Treatment Phase|Physician Decision|1|||
126536277|NCT00677352|455253738|FG001|Treatment Phase|Physician Decision|0|||
126536278|NCT00677352|455253737|FG000|Treatment Phase|Pregnancy|0|||
126536279|NCT00677352|455253738|FG001|Treatment Phase|Pregnancy|1|||
126536280|NCT00677352|455253737|FG000|Treatment Phase|Protocol Violation|1|||
126536281|NCT00677352|455253738|FG001|Treatment Phase|Protocol Violation|1|||
126536282|NCT00677352|455253737|FG000|Treatment Phase|Transference or work related matter|0|||
126536283|NCT00677352|455253738|FG001|Treatment Phase|Transference or work related matter|5|||
126536284|NCT00677352|455253737|FG000|Treatment Phase|Not treated|0|||
126536285|NCT00677352|455253738|FG001|Treatment Phase|Not treated|2|||
126536286|NCT00677352|455253737|FG000|Tapering Phase|Adverse Event|1|||
126536287|NCT00677352|455253738|FG001|Tapering Phase|Adverse Event|5|||
126536288|NCT00677352|455253737|FG000|Tapering Phase|Withdrawal by Subject|5|||
126536289|NCT00677352|455253738|FG001|Tapering Phase|Withdrawal by Subject|3|||
126536290|NCT00677352|455253737|FG000|Tapering Phase|Pregnancy|0|||
126536291|NCT00677352|455253738|FG001|Tapering Phase|Pregnancy|1|||
126536292|NCT00677352|455253737|FG000|Tapering Phase|Job transfer|0|||
126536293|NCT00677352|455253738|FG001|Tapering Phase|Job transfer|1|||
126536294|NCT05763628|455253739|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
126536295|NCT05763628|455253740|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
126536296|NCT05763628|455253739|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
126536297|NCT05763628|455253740|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
126536298|NCT05763628|455253739|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
126536299|NCT05763628|455253740|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
126536300|NCT04683926|455253741|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
126536301|NCT04683926|455253742|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
126536302|NCT04683926|455253743|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
126536303|NCT04683926|455253744|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
126536304|NCT04385368|455253746|FG000|Overall Study|Death|5|||
126536305|NCT04385368|455253747|FG001|Overall Study|Death|5|||
126536306|NCT04385368|455253746|FG000|Overall Study|Physician Decision|3|||
126536307|NCT04385368|455253747|FG001|Overall Study|Physician Decision|0|||
126536308|NCT04385368|455253746|FG000|Overall Study|Withdrawal by Subject|4|||
126536309|NCT04385368|455253747|FG001|Overall Study|Withdrawal by Subject|3|||
126536310|NCT01235546|455253748|FG000|Overall Study|Staff error, medication not administered|1|||
126536311|NCT01235546|455253749|FG001|Overall Study|Staff error, medication not administered|0|||
126536312|NCT01235546|455253748|FG000|Overall Study|Protocol Violation|1|||
126536313|NCT01235546|455253749|FG001|Overall Study|Protocol Violation|1|||
126536314|NCT01256411|455253750|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
126536315|NCT01256411|455253751|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
126536316|NCT01256411|455253752|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
126536317|NCT01256411|455253753|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
126536318|NCT01256411|455253754|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
126536319|NCT01256411|455253755|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
126536320|NCT01256411|455253750|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
126536321|NCT01256411|455253751|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
126536322|NCT01256411|455253752|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
126536323|NCT01256411|455253753|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
126536324|NCT01256411|455253754|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
126536325|NCT01256411|455253755|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
126536326|NCT01256411|455253750|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
126536327|NCT01256411|455253751|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
126536328|NCT01256411|455253752|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
126536329|NCT01256411|455253753|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
126536330|NCT01256411|455253754|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
126536331|NCT01256411|455253755|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
126536332|NCT01256411|455253750|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
126536333|NCT01256411|455253751|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
126536334|NCT01256411|455253752|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
126536335|NCT01256411|455253753|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
126536336|NCT01256411|455253754|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
126536337|NCT01256411|455253755|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
126313913|NCT00191282|454439422|FG001|Overall Study|Noncompliance|17|||
126313914|NCT00191282|454439421|FG000|Overall Study|Patient moved|11|||
126313915|NCT00191282|454439422|FG001|Overall Study|Patient moved|14|||
126313916|NCT00191282|454439421|FG000|Overall Study|Withdrawal by Subject|59|||
126313917|NCT00191282|454439422|FG001|Overall Study|Withdrawal by Subject|44|||
126313918|NCT00191282|454439421|FG000|Overall Study|Physician Decision|18|||
126313919|NCT00191282|454439422|FG001|Overall Study|Physician Decision|15|||
126313920|NCT00191282|454439421|FG000|Overall Study|Protocol entry criteria not met|14|||
126313921|NCT00191282|454439422|FG001|Overall Study|Protocol entry criteria not met|9|||
126313922|NCT00191282|454439421|FG000|Overall Study|Protocol Violation|9|||
126313923|NCT00191282|454439422|FG001|Overall Study|Protocol Violation|12|||
126313924|NCT00191282|454439421|FG000|Overall Study|Severity of outcome|2|||
126313925|NCT00191282|454439422|FG001|Overall Study|Severity of outcome|5|||
126313926|NCT00191282|454439421|FG000|Overall Study|Sponsor's decision|2|||
126313927|NCT00191282|454439422|FG001|Overall Study|Sponsor's decision|2|||
126313928|NCT00191282|454439421|FG000|Overall Study|Lost to Follow-up|24|||
126313929|NCT00191282|454439422|FG001|Overall Study|Lost to Follow-up|31|||
126313930|NCT00102531|454439425|FG000|Overall Study|Adverse Event|0|||
126313931|NCT00102531|454439426|FG001|Overall Study|Adverse Event|1|||
126313932|NCT00102531|454439425|FG000|Overall Study|Disease Progression|5|||
126313933|NCT00102531|454439426|FG001|Overall Study|Disease Progression|9|||
126313934|NCT00102531|454439425|FG000|Overall Study|Physician Decision|0|||
126313935|NCT00102531|454439426|FG001|Overall Study|Physician Decision|1|||
126313936|NCT04756154|454439428|FG000|Overall Study|Did not meet treatment day baseline|30|||
126313937|NCT04756154|454439429|FG001|Overall Study|Did not meet treatment day baseline|28|||
126313938|NCT04756154|454439430|FG002|Overall Study|Did not meet treatment day baseline|7|||
126313939|NCT04756154|454439428|FG000|Overall Study|Did not return for final sample collection|1|||
126313940|NCT04756154|454439429|FG001|Overall Study|Did not return for final sample collection|1|||
126313941|NCT04756154|454439430|FG002|Overall Study|Did not return for final sample collection|0|||
126313942|NCT03055494|454440750|FG000|Overall Study|Lost to Follow-up|6|||
126313943|NCT03055494|454440751|FG001|Overall Study|Lost to Follow-up|0|||
126313944|NCT03055494|454440750|FG000|Overall Study|Physician Decision|2|||
126313945|NCT03055494|454440751|FG001|Overall Study|Physician Decision|0|||
126313946|NCT03055494|454440750|FG000|Overall Study|Withdrawal by Subject|1|||
126313947|NCT03055494|454440751|FG001|Overall Study|Withdrawal by Subject|0|||
126313948|NCT03055494|454440750|FG000|Overall Study|Adverse Event|0|||
126313949|NCT03055494|454440751|FG001|Overall Study|Adverse Event|1|||
126313950|NCT03055494|454440750|FG000|Overall Study|Non-compliance with study treatment|1|||
126313951|NCT03055494|454440751|FG001|Overall Study|Non-compliance with study treatment|0|||
126313952|NCT05079750|454440752|FG000|Overall Study|Lost to Follow-up|0|||
126313953|NCT05079750|454440753|FG001|Overall Study|Lost to Follow-up|0|||
126313954|NCT05079750|454440754|FG002|Overall Study|Lost to Follow-up|1|||
126313955|NCT05897827|454440755|FG000|Overall Study|Lost to Follow-up|33|||
126313956|NCT05897827|454440756|FG001|Overall Study|Lost to Follow-up|14|||
126313957|NCT05897827|454440755|FG000|Overall Study|Withdrawal by Subject|1|||
126313958|NCT05897827|454440756|FG001|Overall Study|Withdrawal by Subject|1|||
126313959|NCT00197002|454440757|FG000|Overall Study|Adverse Event|0|||
126313960|NCT00197002|454440758|FG001|Overall Study|Adverse Event|1|||
126313961|NCT00197002|454440759|FG002|Overall Study|Adverse Event|0|||
126536338|NCT01256411|455253750|FG000|Extension by Maximum Treatment|Adverse Event|4|||
126536339|NCT01256411|455253751|FG001|Extension by Maximum Treatment|Adverse Event|2|||
126313962|NCT00197002|454440757|FG000|Overall Study|Protocol Violation|1|||
126536340|NCT01256411|455253752|FG002|Extension by Maximum Treatment|Adverse Event|1|||
126536341|NCT01256411|455253753|FG003|Extension by Maximum Treatment|Adverse Event|0|||
126536342|NCT01256411|455253754|FG004|Extension by Maximum Treatment|Adverse Event|0|||
126536343|NCT01256411|455253755|FG005|Extension by Maximum Treatment|Adverse Event|0|||
126536344|NCT01256411|455253750|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
126536345|NCT01256411|455253751|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
126536346|NCT01256411|455253752|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
126536347|NCT01256411|455253753|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
126536348|NCT01256411|455253754|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
126536349|NCT01256411|455253755|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
126536350|NCT01256411|455253750|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
126536351|NCT01256411|455253751|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
126536352|NCT01256411|455253752|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
126536353|NCT01256411|455253753|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
126536354|NCT01256411|455253754|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
126536355|NCT01256411|455253755|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
126536356|NCT01256411|455253750|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
126536357|NCT01256411|455253751|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
126536358|NCT01256411|455253752|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
126536359|NCT01256411|455253753|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
126536360|NCT01256411|455253754|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
126536361|NCT01256411|455253755|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
126536362|NCT01256411|455253750|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
126536363|NCT01256411|455253751|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
126536364|NCT01256411|455253752|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
126536365|NCT01256411|455253753|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
126536366|NCT01256411|455253754|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
126536367|NCT01256411|455253755|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
126536368|NCT01256411|455253750|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
126536369|NCT01256411|455253751|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
126536370|NCT01256411|455253752|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
126536371|NCT01256411|455253753|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
126536372|NCT01256411|455253754|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
126536373|NCT01256411|455253755|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
126536374|NCT02740049|455253756|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
126536375|NCT02123108|455253759|FG000|Overall Study|Death|2|||
126536376|NCT02123108|455253760|FG001|Overall Study|Death|3|||
126536377|NCT00716092|455253761|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
126536378|NCT00716092|455253762|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
126536379|NCT00716092|455253763|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
126536380|NCT02316769|455253764|FG000|Overall Study|Physician Decision|1|||
126536381|NCT02316769|455253765|FG001|Overall Study|Physician Decision|0|||
126536382|NCT02316769|455253764|FG000|Overall Study|Withdrawal by Subject|1|||
126536383|NCT02316769|455253765|FG001|Overall Study|Withdrawal by Subject|0|||
126536384|NCT01132326|455253766|FG000|Overall Study|Lack of Efficacy|25|||
126536385|NCT01132326|455253766|FG000|Overall Study|Adverse Event|37|||
126536386|NCT01132326|455253766|FG000|Overall Study|Protocol Violation|1|||
126536387|NCT01132326|455253766|FG000|Overall Study|Lost to Follow-up|16|||
126536388|NCT01132326|455253766|FG000|Overall Study|Withdrawal by Subject|40|||
126536389|NCT01132326|455253766|FG000|Overall Study|Physician Decision|10|||
126536390|NCT01132326|455253766|FG000|Overall Study|Study Termination|80|||
126536391|NCT01132326|455253766|FG000|Overall Study|Declining Health|1|||
126536392|NCT01132326|455253766|FG000|Overall Study|Pregnancy|1|||
126536393|NCT01132326|455253766|FG000|Overall Study|Caregiver Withdrew Consent|1|||
126536394|NCT01132326|455253766|FG000|Overall Study|Death|5|||
126536395|NCT01132326|455253766|FG000|Overall Study|Subject Unable to Come To Visits|1|||
126536396|NCT00677235|455253767|FG000|Overall Study|Withdrawal by Subject|1|||
126536397|NCT00677235|455253768|FG001|Overall Study|Withdrawal by Subject|1|||
126536398|NCT00677235|455253767|FG000|Overall Study|Lost to Follow-up|2|||
126536399|NCT00677235|455253768|FG001|Overall Study|Lost to Follow-up|1|||
126536400|NCT00677235|455253767|FG000|Overall Study|Death|37|||
126536401|NCT00677235|455253768|FG001|Overall Study|Death|36|||
126536402|NCT00677235|455253767|FG000|Overall Study|Adverse Experience|1|||
126536403|NCT00677235|455253768|FG001|Overall Study|Adverse Experience|0|||
126536404|NCT00952367|455253769|FG000|Overall Study|Withdrawal by Subject|2|||
126536405|NCT00952367|455253769|FG000|Overall Study|Noncoordination|1|||
126536406|NCT00952367|455253769|FG000|Overall Study|Protocol Violation|3|||
126536407|NCT01040260|455253770|FG000|Overall Study|Withdrawal by Subject|12|||
126536408|NCT01040260|455253771|FG001|Overall Study|Withdrawal by Subject|6|||
126536409|NCT01040260|455253770|FG000|Overall Study|Lost to Follow-up|3|||
126536410|NCT01040260|455253771|FG001|Overall Study|Lost to Follow-up|5|||
126536411|NCT04570436|455253775|FG000|Overall Study|Adverse Event|0|||
126536412|NCT04570436|455253776|FG001|Overall Study|Adverse Event|0|||
126536413|NCT04570436|455253777|FG002|Overall Study|Adverse Event|1|||
126536414|NCT04570436|455253778|FG003|Overall Study|Adverse Event|0|||
126536415|NCT04570436|455253779|FG004|Overall Study|Adverse Event|0|||
126536416|NCT04570436|455253780|FG005|Overall Study|Adverse Event|0|||
126536417|NCT04570436|455253781|FG006|Overall Study|Adverse Event|0|||
126536418|NCT04570436|455253782|FG007|Overall Study|Adverse Event|0|||
126536419|NCT04570436|455253783|FG008|Overall Study|Adverse Event|0|||
126536420|NCT04570436|455253784|FG009|Overall Study|Adverse Event|0|||
126536421|NCT04570436|455253775|FG000|Overall Study|Physician Decision|1|||
126536422|NCT04570436|455253776|FG001|Overall Study|Physician Decision|0|||
126536423|NCT04570436|455253777|FG002|Overall Study|Physician Decision|0|||
126536424|NCT04570436|455253778|FG003|Overall Study|Physician Decision|0|||
126536425|NCT04570436|455253779|FG004|Overall Study|Physician Decision|0|||
126536426|NCT04570436|455253780|FG005|Overall Study|Physician Decision|0|||
126536427|NCT04570436|455253781|FG006|Overall Study|Physician Decision|0|||
126536428|NCT04570436|455253782|FG007|Overall Study|Physician Decision|0|||
126536429|NCT04570436|455253783|FG008|Overall Study|Physician Decision|0|||
126536430|NCT04570436|455253784|FG009|Overall Study|Physician Decision|0|||
126536431|NCT00781391|455253785|FG000|Overall Study|never received study drug|24|||
126536432|NCT00781391|455253786|FG001|Overall Study|never received study drug|23|||
126536433|NCT00781391|455253787|FG002|Overall Study|never received study drug|32|||
126536434|NCT00781391|455253785|FG000|Overall Study|Protocol Violation|19|||
126536435|NCT00781391|455253786|FG001|Overall Study|Protocol Violation|17|||
126536436|NCT00781391|455253787|FG002|Overall Study|Protocol Violation|20|||
126536437|NCT00781391|455253785|FG000|Overall Study|Death|789|||
126536438|NCT00781391|455253786|FG001|Overall Study|Death|730|||
126536439|NCT00781391|455253787|FG002|Overall Study|Death|706|||
126536440|NCT00781391|455253785|FG000|Overall Study|Withdrawal by Subject|47|||
126536441|NCT00781391|455253786|FG001|Overall Study|Withdrawal by Subject|37|||
126536442|NCT00781391|455253787|FG002|Overall Study|Withdrawal by Subject|25|||
126536443|NCT00781391|455253785|FG000|Overall Study|Lost to Follow-up|0|||
126536444|NCT00781391|455253786|FG001|Overall Study|Lost to Follow-up|0|||
126536445|NCT00781391|455253787|FG002|Overall Study|Lost to Follow-up|1|||
126536446|NCT01822587|455253790|FG000|Overall Study|Lost to Follow-up|7|||
126536447|NCT01822587|455253791|FG001|Overall Study|Lost to Follow-up|9|||
126536448|NCT01822587|455253792|FG002|Overall Study|Lost to Follow-up|12|||
126536449|NCT01822587|455253790|FG000|Overall Study|Physician Decision|9|||
126536450|NCT01822587|455253791|FG001|Overall Study|Physician Decision|6|||
126536451|NCT01822587|455253792|FG002|Overall Study|Physician Decision|6|||
126536452|NCT00708916|455253793|FG000|Overall Study|Subject Noncompliance|2|||
126536453|NCT00708916|455253793|FG000|Overall Study|Adverse Event|2|||
126536454|NCT03205371|455253800|FG000|Overall Study|Withdrawal by Subject|4|||
126536455|NCT03205371|455253801|FG001|Overall Study|Withdrawal by Subject|1|||
126536456|NCT03205371|455253802|FG002|Overall Study|Withdrawal by Subject|0|||
126536457|NCT03205371|455253803|FG003|Overall Study|Withdrawal by Subject|0|||
126536458|NCT03205371|455253804|FG004|Overall Study|Withdrawal by Subject|0|||
126536459|NCT03205371|455253805|FG005|Overall Study|Withdrawal by Subject|0|||
126536460|NCT03205371|455253806|FG006|Overall Study|Withdrawal by Subject|4|||
126536461|NCT03205371|455253807|FG007|Overall Study|Withdrawal by Subject|0|||
126536462|NCT03205371|455253808|FG008|Overall Study|Withdrawal by Subject|2|||
126536463|NCT03205371|455253809|FG009|Overall Study|Withdrawal by Subject|0|||
126536464|NCT03205371|455253810|FG010|Overall Study|Withdrawal by Subject|0|||
126536465|NCT03205371|455253811|FG011|Overall Study|Withdrawal by Subject|1|||
126536466|NCT03205371|455253800|FG000|Overall Study|Lost to Follow-up|0|||
126536467|NCT03205371|455253801|FG001|Overall Study|Lost to Follow-up|0|||
126536468|NCT03205371|455253802|FG002|Overall Study|Lost to Follow-up|0|||
126536469|NCT03205371|455253803|FG003|Overall Study|Lost to Follow-up|0|||
126536470|NCT03205371|455253804|FG004|Overall Study|Lost to Follow-up|0|||
126536471|NCT03205371|455253805|FG005|Overall Study|Lost to Follow-up|0|||
126536472|NCT03205371|455253806|FG006|Overall Study|Lost to Follow-up|5|||
126536473|NCT03205371|455253807|FG007|Overall Study|Lost to Follow-up|2|||
126536474|NCT03205371|455253808|FG008|Overall Study|Lost to Follow-up|3|||
126536475|NCT03205371|455253809|FG009|Overall Study|Lost to Follow-up|0|||
126536476|NCT03205371|455253810|FG010|Overall Study|Lost to Follow-up|0|||
126536477|NCT03205371|455253811|FG011|Overall Study|Lost to Follow-up|0|||
126536478|NCT03205371|455253800|FG000|Overall Study|Protocol Violation|0|||
126536479|NCT03205371|455253801|FG001|Overall Study|Protocol Violation|0|||
126536480|NCT03205371|455253802|FG002|Overall Study|Protocol Violation|0|||
126536481|NCT03205371|455253803|FG003|Overall Study|Protocol Violation|0|||
126536482|NCT03205371|455253804|FG004|Overall Study|Protocol Violation|0|||
126536483|NCT03205371|455253805|FG005|Overall Study|Protocol Violation|0|||
126536484|NCT03205371|455253806|FG006|Overall Study|Protocol Violation|1|||
126536485|NCT03205371|455253807|FG007|Overall Study|Protocol Violation|0|||
126536486|NCT03205371|455253808|FG008|Overall Study|Protocol Violation|0|||
126536487|NCT03205371|455253809|FG009|Overall Study|Protocol Violation|0|||
126536488|NCT03205371|455253810|FG010|Overall Study|Protocol Violation|0|||
126536489|NCT03205371|455253811|FG011|Overall Study|Protocol Violation|0|||
126536490|NCT03205371|455253800|FG000|Overall Study|Adverse Event|0|||
126536491|NCT03205371|455253801|FG001|Overall Study|Adverse Event|0|||
126536492|NCT03205371|455253802|FG002|Overall Study|Adverse Event|0|||
126536493|NCT03205371|455253803|FG003|Overall Study|Adverse Event|0|||
126536494|NCT03205371|455253804|FG004|Overall Study|Adverse Event|0|||
126536495|NCT03205371|455253805|FG005|Overall Study|Adverse Event|0|||
126536496|NCT03205371|455253806|FG006|Overall Study|Adverse Event|0|||
126536497|NCT03205371|455253807|FG007|Overall Study|Adverse Event|1|||
126536498|NCT03205371|455253808|FG008|Overall Study|Adverse Event|0|||
126536499|NCT03205371|455253809|FG009|Overall Study|Adverse Event|0|||
126536500|NCT03205371|455253810|FG010|Overall Study|Adverse Event|0|||
126536501|NCT03205371|455253811|FG011|Overall Study|Adverse Event|0|||
126536502|NCT03923959|455253814|FG000|Overall Study|Death|16|||
126536503|NCT03923959|455253815|FG001|Overall Study|Death|12|||
126536504|NCT03923959|455253814|FG000|Overall Study|Lost to Follow-up|56|||
126536505|NCT03923959|455253815|FG001|Overall Study|Lost to Follow-up|56|||
126536506|NCT03923959|455253814|FG000|Overall Study|Withdrawal by Subject|1|||
126536507|NCT03923959|455253815|FG001|Overall Study|Withdrawal by Subject|1|||
126536508|NCT03923959|455253814|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
126536509|NCT03923959|455253815|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
126536510|NCT04918147|455253816|FG000|Overall Study|Disease flare as defined in protocol|0|||
126536511|NCT04918147|455253817|FG001|Overall Study|Disease flare as defined in protocol|2|||
126536512|NCT02954354|455253819|FG000|Overall Study|Adverse Event|2|||
126536513|NCT02954354|455253820|FG001|Overall Study|Adverse Event|2|||
126536514|NCT02954354|455253821|FG002|Overall Study|Adverse Event|4|||
126536515|NCT02954354|455253819|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
126536516|NCT02954354|455253820|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
126536517|NCT02954354|455253821|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
126536518|NCT02954354|455253819|FG000|Overall Study|Lack of Efficacy|0|||
126536519|NCT02954354|455253820|FG001|Overall Study|Lack of Efficacy|2|||
126536520|NCT02954354|455253821|FG002|Overall Study|Lack of Efficacy|0|||
126536521|NCT02954354|455253819|FG000|Overall Study|Withdrawal by Subject|17|||
126536522|NCT02954354|455253820|FG001|Overall Study|Withdrawal by Subject|9|||
126536523|NCT02954354|455253821|FG002|Overall Study|Withdrawal by Subject|11|||
126536524|NCT02954354|455253819|FG000|Overall Study|Lost to Follow-up|12|||
126536525|NCT02954354|455253820|FG001|Overall Study|Lost to Follow-up|5|||
126536526|NCT02954354|455253821|FG002|Overall Study|Lost to Follow-up|0|||
126536527|NCT02954354|455253819|FG000|Overall Study|Miscellaneous|2|||
126536528|NCT02954354|455253820|FG001|Overall Study|Miscellaneous|2|||
126536529|NCT02954354|455253821|FG002|Overall Study|Miscellaneous|1|||
126536530|NCT03338829|455253822|FG000|Overall Study|Lost to Follow-up|4|||
126536531|NCT03338829|455253823|FG001|Overall Study|Lost to Follow-up|2|||
126536532|NCT03338829|455253824|FG002|Overall Study|Lost to Follow-up|4|||
126536533|NCT03338829|455253822|FG000|Overall Study|Pregnancy loss|1|||
126536534|NCT03338829|455253823|FG001|Overall Study|Pregnancy loss|1|||
126536535|NCT03338829|455253824|FG002|Overall Study|Pregnancy loss|0|||
126536536|NCT03338829|455253822|FG000|Overall Study|Protocol Violation|0|||
126536537|NCT03338829|455253823|FG001|Overall Study|Protocol Violation|1|||
126536538|NCT03338829|455253824|FG002|Overall Study|Protocol Violation|0|||
126536539|NCT03575325|455253825|FG000|Overall Study|Death|1|||
126536540|NCT04495179|455253826|FG000|Overall Study|Lost to Follow-up|0|||
126536541|NCT04495179|455253827|FG001|Overall Study|Lost to Follow-up|1|||
126536542|NCT04495179|455253826|FG000|Overall Study|Withdrawal by Subject|2|||
126536543|NCT04495179|455253827|FG001|Overall Study|Withdrawal by Subject|4|||
126536544|NCT04495179|455253826|FG000|Overall Study|Study terminated by sponsor|0|||
126536545|NCT04495179|455253827|FG001|Overall Study|Study terminated by sponsor|18|||
126536546|NCT04495179|455253826|FG000|Overall Study|Death|0|||
126536547|NCT04495179|455253827|FG001|Overall Study|Death|4|||
126536548|NCT04495179|455253826|FG000|Overall Study|Adverse Event|0|||
126536549|NCT04495179|455253827|FG001|Overall Study|Adverse Event|1|||
126536550|NCT02618967|455253831|FG000|Overall Study|Lost to Follow-up|0|||
126536551|NCT02618967|455253832|FG001|Overall Study|Lost to Follow-up|0|||
126536552|NCT02618967|455253833|FG002|Overall Study|Lost to Follow-up|1|||
126536553|NCT02618967|455253834|FG003|Overall Study|Lost to Follow-up|0|||
126536554|NCT02618967|455253835|FG004|Overall Study|Lost to Follow-up|2|||
126536555|NCT02618967|455253836|FG005|Overall Study|Lost to Follow-up|0|||
126536556|NCT02618967|455253837|FG006|Overall Study|Lost to Follow-up|0|||
126536557|NCT02618967|455253838|FG007|Overall Study|Lost to Follow-up|0|||
126536558|NCT02618967|455253831|FG000|Overall Study|Withdrawal by Subject|1|||
126536559|NCT02618967|455253832|FG001|Overall Study|Withdrawal by Subject|0|||
126536560|NCT02618967|455253833|FG002|Overall Study|Withdrawal by Subject|0|||
126536561|NCT02618967|455253834|FG003|Overall Study|Withdrawal by Subject|0|||
126536562|NCT02618967|455253835|FG004|Overall Study|Withdrawal by Subject|0|||
126536563|NCT02618967|455253836|FG005|Overall Study|Withdrawal by Subject|0|||
126536564|NCT02618967|455253837|FG006|Overall Study|Withdrawal by Subject|0|||
126536565|NCT02618967|455253838|FG007|Overall Study|Withdrawal by Subject|0|||
126536566|NCT01368965|455253839|FG000|Overall Study|Lost to Follow-up|12|||
126536567|NCT02355743|455253850|FG000|Overall Study|Withdrawal by Subject|1|||
126536568|NCT02355743|455253850|FG000|Overall Study|Lost to Follow-up|1|||
126536569|NCT04212091|455253851|FG000|Overall Study|Lost to Follow-up|0|||
126536570|NCT04212091|455253852|FG001|Overall Study|Lost to Follow-up|0|||
126536571|NCT04212091|455253853|FG002|Overall Study|Lost to Follow-up|0|||
126536572|NCT04212091|455253854|FG003|Overall Study|Lost to Follow-up|0|||
126536573|NCT04212091|455253855|FG004|Overall Study|Lost to Follow-up|1|||
126536574|NCT04212091|455253856|FG005|Overall Study|Lost to Follow-up|1|||
126536575|NCT04212091|455253851|FG000|Overall Study|Participant unable to adhere to visit|0|||
126536576|NCT04212091|455253852|FG001|Overall Study|Participant unable to adhere to visit|0|||
126536577|NCT04212091|455253853|FG002|Overall Study|Participant unable to adhere to visit|0|||
126536578|NCT04212091|455253854|FG003|Overall Study|Participant unable to adhere to visit|0|||
126536579|NCT04212091|455253855|FG004|Overall Study|Participant unable to adhere to visit|1|||
126536580|NCT04212091|455253856|FG005|Overall Study|Participant unable to adhere to visit|0|||
126536581|NCT02612311|455253857|FG000|Overall Study|Adverse Event|16|||
126536582|NCT02612311|455253858|FG001|Overall Study|Adverse Event|12|||
126536583|NCT02612311|455253859|FG002|Overall Study|Adverse Event|7|||
126536584|NCT02612311|455253860|FG003|Overall Study|Adverse Event|13|||
126536585|NCT02612311|455253857|FG000|Overall Study|Death|29|||
126536586|NCT02612311|455253858|FG001|Overall Study|Death|10|||
126536587|NCT02612311|455253859|FG002|Overall Study|Death|11|||
126536588|NCT02612311|455253860|FG003|Overall Study|Death|11|||
126536589|NCT02612311|455253857|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
126536590|NCT02612311|455253858|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
126536591|NCT02612311|455253859|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
126536592|NCT02612311|455253860|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
126536593|NCT02612311|455253857|FG000|Overall Study|Investigator's Decision|11|||
126536594|NCT02612311|455253858|FG001|Overall Study|Investigator's Decision|15|||
126536595|NCT02612311|455253859|FG002|Overall Study|Investigator's Decision|6|||
126536596|NCT02612311|455253860|FG003|Overall Study|Investigator's Decision|6|||
126536597|NCT02612311|455253857|FG000|Overall Study|Lack of Efficacy|0|||
126536598|NCT02612311|455253858|FG001|Overall Study|Lack of Efficacy|0|||
126536599|NCT02612311|455253859|FG002|Overall Study|Lack of Efficacy|1|||
126536600|NCT02612311|455253860|FG003|Overall Study|Lack of Efficacy|1|||
126536601|NCT02612311|455253857|FG000|Overall Study|Lost to Follow-up|2|||
126536602|NCT02612311|455253858|FG001|Overall Study|Lost to Follow-up|2|||
126536603|NCT02612311|455253859|FG002|Overall Study|Lost to Follow-up|1|||
126536604|NCT02612311|455253860|FG003|Overall Study|Lost to Follow-up|2|||
126536605|NCT02612311|455253857|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
126536606|NCT02612311|455253858|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
126536607|NCT02612311|455253859|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
126536608|NCT02612311|455253860|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
126536609|NCT02612311|455253857|FG000|Overall Study|Site Terminated by Sponsor|29|||
126536610|NCT02612311|455253858|FG001|Overall Study|Site Terminated by Sponsor|12|||
126536611|NCT02612311|455253859|FG002|Overall Study|Site Terminated by Sponsor|13|||
126536612|NCT02612311|455253860|FG003|Overall Study|Site Terminated by Sponsor|5|||
126536613|NCT02612311|455253857|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
126536614|NCT02612311|455253858|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
126536615|NCT02612311|455253859|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
126536616|NCT02612311|455253860|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
126536617|NCT02612311|455253857|FG000|Overall Study|Reason Not Specified|3|||
126536618|NCT02612311|455253858|FG001|Overall Study|Reason Not Specified|7|||
126536619|NCT02612311|455253859|FG002|Overall Study|Reason Not Specified|4|||
126536620|NCT02612311|455253860|FG003|Overall Study|Reason Not Specified|5|||
126536621|NCT02612311|455253857|FG000|Overall Study|Unknown/Missing|10|||
126536622|NCT02612311|455253858|FG001|Overall Study|Unknown/Missing|13|||
126536623|NCT02612311|455253859|FG002|Overall Study|Unknown/Missing|4|||
126536624|NCT02612311|455253860|FG003|Overall Study|Unknown/Missing|0|||
126536625|NCT02612311|455253857|FG000|Overall Study|Non-Compliance with Study|1|||
126536626|NCT02612311|455253858|FG001|Overall Study|Non-Compliance with Study|0|||
126536627|NCT02612311|455253859|FG002|Overall Study|Non-Compliance with Study|0|||
126536628|NCT02612311|455253860|FG003|Overall Study|Non-Compliance with Study|0|||
126536629|NCT00715429|455253861|FG000|Overall Study|Did not complete the study diary|0|||
126536630|NCT00715429|455253862|FG001|Overall Study|Did not complete the study diary|1|||
126536631|NCT04085328|455253863|FG000|Overall Study|Witihdrew Consent|16|||
126536632|NCT04085328|455253864|FG001|Overall Study|Witihdrew Consent|16|||
126536633|NCT04085328|455253863|FG000|Overall Study|Adverse Event|8|||
126536634|NCT04085328|455253864|FG001|Overall Study|Adverse Event|7|||
126536635|NCT04085328|455253863|FG000|Overall Study|Lost to Follow-up|7|||
126536636|NCT04085328|455253864|FG001|Overall Study|Lost to Follow-up|2|||
126536637|NCT04085328|455253863|FG000|Overall Study|Physician Decision|0|||
126536638|NCT04085328|455253864|FG001|Overall Study|Physician Decision|1|||
126536639|NCT04085328|455253863|FG000|Overall Study|Pregnancy|0|||
126536640|NCT04085328|455253864|FG001|Overall Study|Pregnancy|1|||
126536641|NCT04085328|455253863|FG000|Overall Study|Reasons Related to COVID-19|5|||
126536642|NCT04085328|455253864|FG001|Overall Study|Reasons Related to COVID-19|8|||
126536643|NCT04085328|455253863|FG000|Overall Study|Did not meet inclusion criteria|1|||
126536644|NCT04085328|455253864|FG001|Overall Study|Did not meet inclusion criteria|1|||
126536645|NCT04085328|455253863|FG000|Overall Study|Early termination|1|||
126536646|NCT04085328|455253864|FG001|Overall Study|Early termination|0|||
126536647|NCT00514735|455253865|FG000|Overall Study|Withdrawal by Subject|13|||
126536648|NCT00514735|455253866|FG001|Overall Study|Withdrawal by Subject|5|||
126536649|NCT00514735|455253865|FG000|Overall Study|Death|1|||
126536650|NCT00514735|455253866|FG001|Overall Study|Death|0|||
126536651|NCT00514735|455253865|FG000|Overall Study|Lost to Follow-up|0|||
126536652|NCT00514735|455253866|FG001|Overall Study|Lost to Follow-up|1|||
126536653|NCT02170025|455253867|FG000|Overall Study|Adverse Event|2|||
126536654|NCT02170025|455253868|FG001|Overall Study|Adverse Event|0|||
126536655|NCT00572195|455253869|FG000|Overall Study|Withdrawal by Subject|50|||
126536656|NCT00572195|455253869|FG000|Overall Study|Death|9|||
126536657|NCT00572195|455253869|FG000|Overall Study|Adverse Event|4|||
126536658|NCT00572195|455253869|FG000|Overall Study|Lost to Follow-up|5|||
126536659|NCT01323530|455255920|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
126536660|NCT01323530|455255921|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
126536661|NCT01323530|455255922|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
126536662|NCT01323530|455255923|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
126536663|NCT01323530|455255924|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
126536664|NCT01323530|455255925|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
126536665|NCT01323530|455255926|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
126536666|NCT01323530|455255920|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
126536667|NCT01323530|455255921|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
126536668|NCT01323530|455255922|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
126536669|NCT01323530|455255923|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
126536670|NCT01323530|455255924|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
126536671|NCT01323530|455255925|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
126536672|NCT01323530|455255926|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
126536673|NCT01323530|455255920|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
126536674|NCT01323530|455255921|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
126536675|NCT01323530|455255922|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
126536676|NCT01323530|455255923|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
126536677|NCT01323530|455255924|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
126536678|NCT01323530|455255925|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
126536679|NCT01323530|455255926|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
126536680|NCT01323530|455255920|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
126536681|NCT01323530|455255921|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
126536682|NCT01323530|455255922|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
126536683|NCT01323530|455255923|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
126536684|NCT01323530|455255924|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
126536685|NCT01323530|455255925|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
126536686|NCT01323530|455255926|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
126536687|NCT01323530|455255920|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
126536688|NCT01323530|455255921|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
126536689|NCT01323530|455255922|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
126536690|NCT01323530|455255923|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
126536691|NCT01323530|455255924|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
126536692|NCT01323530|455255925|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
126536693|NCT01323530|455255926|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
126536694|NCT01323530|455255920|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
126536695|NCT01323530|455255921|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
126536696|NCT01323530|455255922|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
126536697|NCT01323530|455255923|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
126536698|NCT01323530|455255924|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
126536699|NCT01323530|455255925|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
126536700|NCT01323530|455255926|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
126536701|NCT01323530|455255920|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
126536702|NCT01323530|455255921|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
126536703|NCT01323530|455255922|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
126536704|NCT01323530|455255923|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
126536705|NCT01323530|455255924|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
126536706|NCT01323530|455255925|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
126536707|NCT01323530|455255926|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
126536708|NCT01323530|455255920|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
126536709|NCT01323530|455255921|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
126536710|NCT01323530|455255922|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
126536711|NCT01323530|455255923|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
126536712|NCT01323530|455255924|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
126536713|NCT01323530|455255925|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
126536714|NCT01323530|455255926|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
126536715|NCT04128293|455255933|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
126536716|NCT04128293|455255934|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
126536717|NCT04128293|455255935|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
126536718|NCT04128293|455255936|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
126536719|NCT01357616|455255937|FG000|Overall Study|Adverse Event|1|||
126536720|NCT01357616|455255938|FG001|Overall Study|Adverse Event|1|||
126536721|NCT01357616|455255937|FG000|Overall Study|Lost to Follow-up|4|||
126536722|NCT01357616|455255938|FG001|Overall Study|Lost to Follow-up|3|||
126536723|NCT01357616|455255937|FG000|Overall Study|Protocol Violation|0|||
126536724|NCT01357616|455255938|FG001|Overall Study|Protocol Violation|2|||
126536725|NCT01357616|455255937|FG000|Overall Study|Inadequate Control of IOP|1|||
126536726|NCT01357616|455255938|FG001|Overall Study|Inadequate Control of IOP|2|||
126536727|NCT01357616|455255937|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
126536728|NCT01357616|455255938|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
126536729|NCT01357616|455255937|FG000|Overall Study|Withdrawal by Subject|1|||
126536730|NCT01357616|455255938|FG001|Overall Study|Withdrawal by Subject|0|||
126536731|NCT02066402|455255943|FG000|Overall Study|Adverse Event|1|||
126536732|NCT02066402|455255944|FG001|Overall Study|Adverse Event|2|||
126536733|NCT02066402|455255943|FG000|Overall Study|Lost to Follow-up|11|||
126536734|NCT02066402|455255944|FG001|Overall Study|Lost to Follow-up|8|||
126536735|NCT02066402|455255943|FG000|Overall Study|Withdrawal by Subject|14|||
126536736|NCT02066402|455255944|FG001|Overall Study|Withdrawal by Subject|11|||
126536737|NCT02066402|455255943|FG000|Overall Study|Progressive disease-clinical progression|0|||
126536738|NCT02066402|455255944|FG001|Overall Study|Progressive disease-clinical progression|1|||
126536739|NCT02066402|455255943|FG000|Overall Study|Protocol driven decision point|0|||
126536740|NCT02066402|455255944|FG001|Overall Study|Protocol driven decision point|1|||
126536741|NCT01505387|455255945|FG000|Overall Study|Protocol Violation|1|||
126536742|NCT01505387|455255946|FG001|Overall Study|Protocol Violation|0|||
126536743|NCT01505387|455255945|FG000|Overall Study|Withdrawal by Subject|1|||
126536744|NCT01505387|455255946|FG001|Overall Study|Withdrawal by Subject|1|||
126536745|NCT04493931|455255948|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
126536746|NCT04493931|455255949|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
126536747|NCT04493931|455255950|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
126536748|NCT04493931|455255951|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
126536749|NCT04493931|455255952|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
126536750|NCT04493931|455255953|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
126536751|NCT04493931|455255954|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
126536752|NCT04493931|455255948|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
126536753|NCT04493931|455255949|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
126536754|NCT04493931|455255950|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
126536755|NCT04493931|455255951|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
126536756|NCT04493931|455255952|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
126536757|NCT04493931|455255953|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
126536758|NCT04493931|455255954|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
126536759|NCT04493931|455255948|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
126536760|NCT04493931|455255949|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
126536761|NCT04493931|455255950|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
126536762|NCT04493931|455255951|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
126536763|NCT04493931|455255952|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
126536764|NCT04493931|455255953|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
126536765|NCT04493931|455255954|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
126536766|NCT04493931|455255948|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
126536767|NCT04493931|455255949|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
126536768|NCT04493931|455255950|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
126536769|NCT04493931|455255951|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
126536770|NCT04493931|455255952|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
126536771|NCT04493931|455255953|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
126536772|NCT04493931|455255954|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
126536773|NCT01197508|455255955|FG000|Overall Study|Withdrawal by Subject|8|||
126536774|NCT01197508|455255956|FG001|Overall Study|Withdrawal by Subject|7|||
126536775|NCT01197508|455255957|FG002|Overall Study|Withdrawal by Subject|15|||
126536776|NCT01197508|455255958|FG003|Overall Study|Withdrawal by Subject|4|||
126536777|NCT01197508|455255955|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
126536778|NCT01197508|455255956|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
126536779|NCT01197508|455255957|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
126536780|NCT01197508|455255958|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
126536781|NCT01197508|455255955|FG000|Overall Study|Adverse Event|10|||
126536782|NCT01197508|455255956|FG001|Overall Study|Adverse Event|13|||
126536783|NCT01197508|455255957|FG002|Overall Study|Adverse Event|23|||
126536784|NCT01197508|455255958|FG003|Overall Study|Adverse Event|3|||
126536785|NCT01197508|455255955|FG000|Overall Study|Severe non-compliance to protocol|0|||
126536786|NCT01197508|455255956|FG001|Overall Study|Severe non-compliance to protocol|3|||
126536787|NCT01197508|455255957|FG002|Overall Study|Severe non-compliance to protocol|1|||
126536788|NCT01197508|455255958|FG003|Overall Study|Severe non-compliance to protocol|3|||
126536789|NCT01197508|455255955|FG000|Overall Study|Condition under investigation worsened|1|||
126536790|NCT01197508|455255956|FG001|Overall Study|Condition under investigation worsened|1|||
126536791|NCT01197508|455255957|FG002|Overall Study|Condition under investigation worsened|1|||
126536792|NCT01197508|455255958|FG003|Overall Study|Condition under investigation worsened|1|||
126536793|NCT01197508|455255955|FG000|Overall Study|Lack of Efficacy|1|||
126536794|NCT01197508|455255956|FG001|Overall Study|Lack of Efficacy|2|||
126536795|NCT01197508|455255957|FG002|Overall Study|Lack of Efficacy|2|||
126536796|NCT01197508|455255958|FG003|Overall Study|Lack of Efficacy|1|||
126536797|NCT01197508|455255955|FG000|Overall Study|Study-specific withdrawal criteria|0|||
126536798|NCT01197508|455255956|FG001|Overall Study|Study-specific withdrawal criteria|0|||
126536799|NCT01197508|455255957|FG002|Overall Study|Study-specific withdrawal criteria|1|||
126536800|NCT01197508|455255958|FG003|Overall Study|Study-specific withdrawal criteria|2|||
126536801|NCT01197508|455255955|FG000|Overall Study|Lost to Follow-up|1|||
126536802|NCT01197508|455255956|FG001|Overall Study|Lost to Follow-up|1|||
126536803|NCT01197508|455255957|FG002|Overall Study|Lost to Follow-up|2|||
126536804|NCT01197508|455255958|FG003|Overall Study|Lost to Follow-up|0|||
126536805|NCT01197508|455255955|FG000|Overall Study|Other|2|||
126536806|NCT01197508|455255956|FG001|Overall Study|Other|3|||
126536807|NCT01197508|455255957|FG002|Overall Study|Other|2|||
126536808|NCT01197508|455255958|FG003|Overall Study|Other|2|||
126536809|NCT02182973|455255966|FG000|Overall Study|Withdrawal by Subject|3|||
126536810|NCT02182973|455255967|FG001|Overall Study|Withdrawal by Subject|0|||
126536811|NCT01123382|455255968|FG000|Overall Study|Withdrawal by Subject|1|||
126536812|NCT01123382|455255969|FG001|Overall Study|Withdrawal by Subject|4|||
126536813|NCT01123382|455255968|FG000|Overall Study|Lost to Follow-up|1|||
126536814|NCT01123382|455255969|FG001|Overall Study|Lost to Follow-up|2|||
126536815|NCT04721925|455255970|FG000|2-Month Assessment|Lost to Follow-up|5|||
126536816|NCT04721925|455255971|FG001|2-Month Assessment|Lost to Follow-up|3|||
126536817|NCT04721925|455255970|FG000|4-Month Assessment|Lost to Follow-up|3|||
126536818|NCT04721925|455255971|FG001|4-Month Assessment|Lost to Follow-up|6|||
126536819|NCT04535947|455255975|FG000|Overall Study|Adverse Event|1|||
126536820|NCT04535947|455255976|FG001|Overall Study|Adverse Event|4|||
126536821|NCT04535947|455255975|FG000|Overall Study|Other reasons not specified|2|||
126536822|NCT04535947|455255976|FG001|Overall Study|Other reasons not specified|0|||
126536823|NCT04535947|455255975|FG000|Overall Study|Withdrawal by Subject|1|||
126536824|NCT04535947|455255976|FG001|Overall Study|Withdrawal by Subject|1|||
126536825|NCT03802123|455255977|FG000|Overall Study|Withdrawal by Subject|3|||
126536826|NCT03802123|455255977|FG000|Overall Study|Physician Decision|1|||
126536827|NCT03802123|455255977|FG000|Overall Study|Subject moved to hospice care|1|||
126536828|NCT03802123|455255977|FG000|Overall Study|technician error|1|||
126536829|NCT03802123|455255977|FG000|Overall Study|Death|3|||
126536830|NCT00658567|455255979|FG000|Overall Study|Adverse Event|5|||
126536831|NCT00658567|455255980|FG001|Overall Study|Adverse Event|2|||
126536832|NCT00658567|455255981|FG002|Overall Study|Adverse Event|3|||
126536833|NCT00658567|455255979|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
126536834|NCT00658567|455255980|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
126536835|NCT00658567|455255981|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
126536836|NCT00658567|455255979|FG000|Overall Study|Physician Decision|0|||
126536837|NCT00658567|455255980|FG001|Overall Study|Physician Decision|1|||
126536838|NCT00658567|455255981|FG002|Overall Study|Physician Decision|0|||
126536839|NCT00658567|455255979|FG000|Overall Study|At Discretion of Sponsor|1|||
126536840|NCT00658567|455255980|FG001|Overall Study|At Discretion of Sponsor|1|||
126536841|NCT00658567|455255981|FG002|Overall Study|At Discretion of Sponsor|1|||
126536842|NCT01281644|455255982|FG000|Overall Study|Lost to Follow-up|3|||
126536843|NCT01281644|455255982|FG000|Overall Study|Withdrawal by Subject|2|||
126536844|NCT00611858|455255988|FG000|Overall Study|Adverse Event|2|||
126536845|NCT00611858|455255988|FG000|Overall Study|Withdrawal by Subject|2|||
126536846|NCT01844284|455255989|FG000|Overall Study|Lost to Follow-up|12|||
126536847|NCT01844284|455255990|FG001|Overall Study|Lost to Follow-up|7|||
126536848|NCT01058304|455255991|FG000|Overall Study|Withdrawal by Subject|8|||
126536849|NCT01058304|455255992|FG001|Overall Study|Withdrawal by Subject|5|||
126536850|NCT01058304|455255991|FG000|Overall Study|Lost to Follow-up|13|||
126536851|NCT01058304|455255992|FG001|Overall Study|Lost to Follow-up|16|||
126536852|NCT01058304|455255991|FG000|Overall Study|Developed exclusion criterion|6|||
126648173|NCT02003222|455669712|FG003|Induction|Other reasons|0|||
126648174|NCT02003222|455669713|FG004|Induction|Other reasons|22|||
126648175|NCT02003222|455669709|FG000|Intensification|Never started treatment|0|||
126648176|NCT02003222|455669710|FG001|Intensification|Never started treatment|0|||
126536853|NCT01058304|455255992|FG001|Overall Study|Developed exclusion criterion|12|||
126536854|NCT01820559|455255993|FG000|Overall Study|Adverse Event|4|||
126536855|NCT01820559|455255994|FG001|Overall Study|Adverse Event|6|||
126536856|NCT01820559|455255995|FG002|Overall Study|Adverse Event|13|||
126536857|NCT01820559|455255993|FG000|Overall Study|Withdrawal by Subject|1|||
126536858|NCT01820559|455255994|FG001|Overall Study|Withdrawal by Subject|2|||
126536859|NCT01820559|455255995|FG002|Overall Study|Withdrawal by Subject|5|||
126536860|NCT01820559|455255993|FG000|Overall Study|Protocol Violation|2|||
126536861|NCT01820559|455255994|FG001|Overall Study|Protocol Violation|1|||
126536862|NCT01820559|455255995|FG002|Overall Study|Protocol Violation|3|||
126536863|NCT01820559|455255993|FG000|Overall Study|Subject's non-compliance|1|||
126536864|NCT01820559|455255994|FG001|Overall Study|Subject's non-compliance|0|||
126536865|NCT01820559|455255995|FG002|Overall Study|Subject's non-compliance|2|||
126536866|NCT01820559|455255993|FG000|Overall Study|Lost to Follow-up|3|||
126536867|NCT01820559|455255994|FG001|Overall Study|Lost to Follow-up|2|||
126536868|NCT01820559|455255995|FG002|Overall Study|Lost to Follow-up|2|||
126536869|NCT01820559|455255993|FG000|Overall Study|At sponsor request|0|||
126536870|NCT01820559|455255994|FG001|Overall Study|At sponsor request|0|||
126536871|NCT01820559|455255995|FG002|Overall Study|At sponsor request|1|||
126536872|NCT01820559|455255993|FG000|Overall Study|Lack of Efficacy|3|||
126536873|NCT01820559|455255994|FG001|Overall Study|Lack of Efficacy|2|||
126536874|NCT01820559|455255995|FG002|Overall Study|Lack of Efficacy|3|||
126536875|NCT02755597|455255996|FG000|Overall Study|Withdrew consent|27|||
126536876|NCT02755597|455255997|FG001|Overall Study|Withdrew consent|11|||
126536877|NCT02755597|455255996|FG000|Overall Study|Lost to Follow-up|1|||
126536878|NCT02755597|455255997|FG001|Overall Study|Lost to Follow-up|0|||
126536879|NCT02755597|455255996|FG000|Overall Study|Death|78|||
126536880|NCT02755597|455255997|FG001|Overall Study|Death|36|||
126536881|NCT02755597|455255996|FG000|Overall Study|Study terminated by Sponsor|67|||
126536882|NCT02755597|455255997|FG001|Overall Study|Study terminated by Sponsor|47|||
126313963|NCT00197002|454440758|FG001|Overall Study|Protocol Violation|0|||
126536883|NCT02755597|455255996|FG000|Overall Study|Other, not specified|20|||
126536884|NCT02755597|455255997|FG001|Overall Study|Other, not specified|3|||
126536885|NCT02755597|455255996|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
126536886|NCT02755597|455255997|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
126536887|NCT00594854|455255999|FG000|Overall Study|Study terminated|7|||
126536888|NCT00594854|455256000|FG001|Overall Study|Study terminated|10|||
126536889|NCT03172702|455256001|FG000|Overall Study|Adverse Event|9|||
126536890|NCT03172702|455256001|FG000|Overall Study|Death|2|||
126536891|NCT03172702|455256001|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
126536892|NCT03172702|455256001|FG000|Overall Study|Withdrawal by Subject|5|||
126536893|NCT03172702|455256001|FG000|Overall Study|Other|2|||
126536894|NCT06134180|455256002|FG000|Overall Study|Lost to Follow-up|4|||
126536895|NCT02152982|455256003|FG000|Overall Study|Ineligible|4|||
126648177|NCT02003222|455669711|FG002|Intensification|Never started treatment|0|||
126648178|NCT02003222|455669712|FG003|Intensification|Never started treatment|0|||
126648179|NCT02003222|455669713|FG004|Intensification|Never started treatment|2|||
126648180|NCT02003222|455669709|FG000|Intensification|Adverse Event|0|||
126648181|NCT02003222|455669710|FG001|Intensification|Adverse Event|0|||
126648182|NCT02003222|455669711|FG002|Intensification|Adverse Event|0|||
126648183|NCT02003222|455669712|FG003|Intensification|Adverse Event|0|||
126648184|NCT02003222|455669713|FG004|Intensification|Adverse Event|6|||
126648185|NCT02003222|455669709|FG000|Intensification|Alternative therapy|0|||
126648186|NCT02003222|455669710|FG001|Intensification|Alternative therapy|0|||
126648187|NCT02003222|455669711|FG002|Intensification|Alternative therapy|0|||
126648188|NCT02003222|455669712|FG003|Intensification|Alternative therapy|0|||
126648189|NCT02003222|455669713|FG004|Intensification|Alternative therapy|8|||
126648190|NCT02003222|455669709|FG000|Intensification|Disease progression|0|||
126648191|NCT02003222|455669710|FG001|Intensification|Disease progression|0|||
126648192|NCT02003222|455669711|FG002|Intensification|Disease progression|0|||
126536896|NCT02152982|455256004|FG001|Overall Study|Ineligible|4|||
126536897|NCT02152982|455256003|FG000|Overall Study|Did not start treatment|12|||
126536898|NCT02152982|455256004|FG001|Overall Study|Did not start treatment|6|||
126536899|NCT02684006|455256005|FG000|Overall Study|Other|18|||
126536900|NCT02684006|455256006|FG001|Overall Study|Other|6|||
126313964|NCT00197002|454440759|FG002|Overall Study|Protocol Violation|2|||
126536901|NCT02684006|455256005|FG000|Overall Study|Protocol Violation|2|||
126536902|NCT02684006|455256006|FG001|Overall Study|Protocol Violation|1|||
126536903|NCT02684006|455256005|FG000|Overall Study|Non-compliance with study drug|1|||
126715200|NCT01052012|455908709|FG003|Overall Study|Other|0|||
126313965|NCT00197002|454440757|FG000|Overall Study|Withdrawal by Subject|9|||
126536904|NCT02684006|455256006|FG001|Overall Study|Non-compliance with study drug|1|||
126536905|NCT02684006|455256005|FG000|Overall Study|No longer met eligibility criteria|6|||
126536906|NCT02684006|455256006|FG001|Overall Study|No longer met eligibility criteria|2|||
126536907|NCT02684006|455256005|FG000|Overall Study|Lost to Follow-up|0|||
126536908|NCT02684006|455256006|FG001|Overall Study|Lost to Follow-up|1|||
126536909|NCT02684006|455256005|FG000|Overall Study|Death|25|||
126536910|NCT02684006|455256006|FG001|Overall Study|Death|22|||
126536911|NCT02684006|455256005|FG000|Overall Study|Global deterioration of health status|18|||
126536912|NCT02684006|455256006|FG001|Overall Study|Global deterioration of health status|20|||
126536913|NCT02684006|455256005|FG000|Overall Study|Physician Decision|15|||
126536914|NCT02684006|455256006|FG001|Overall Study|Physician Decision|8|||
126536915|NCT02684006|455256005|FG000|Overall Study|Adverse Event|86|||
126536916|NCT02684006|455256006|FG001|Overall Study|Adverse Event|65|||
126536917|NCT02684006|455256005|FG000|Overall Study|Withdrawal by Subject|29|||
126536918|NCT02684006|455256006|FG001|Overall Study|Withdrawal by Subject|43|||
126536919|NCT02684006|455256005|FG000|Overall Study|Progressive disease|236|||
126536920|NCT02684006|455256006|FG001|Overall Study|Progressive disease|266|||
126536921|NCT02684006|455256005|FG000|Overall Study|Participation terminated by sponsor|6|||
126536922|NCT02684006|455256006|FG001|Overall Study|Participation terminated by sponsor|9|||
126536923|NCT03804710|455256020|FG000|Overall Study|Adverse Event|0|||
126536924|NCT03804710|455256021|FG001|Overall Study|Adverse Event|3|||
126536925|NCT03804710|455256020|FG000|Overall Study|Withdrawal by Subject|2|||
126536926|NCT03804710|455256021|FG001|Overall Study|Withdrawal by Subject|1|||
126536927|NCT03804710|455256020|FG000|Overall Study|Other|0|||
126536928|NCT03804710|455256021|FG001|Overall Study|Other|1|||
126536929|NCT04542018|455256022|FG000|Overall Study|Withdrawal by Subject|0|||
126536930|NCT04542018|455256023|FG001|Overall Study|Withdrawal by Subject|0|||
126536931|NCT04542018|455256024|FG002|Overall Study|Withdrawal by Subject|4|||
126536932|NCT04542018|455256022|FG000|Overall Study|Protocol Violation|0|||
126536933|NCT04542018|455256023|FG001|Overall Study|Protocol Violation|0|||
126536934|NCT04542018|455256024|FG002|Overall Study|Protocol Violation|2|||
126536935|NCT02660827|455256028|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
126536936|NCT02660827|455256028|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
126536937|NCT02660827|455256028|FG000|From Study to End of Continued Access|Adverse Event|3|||
126536938|NCT02660827|455256028|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
126536939|NCT02660827|455256028|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
126536940|NCT02660827|455256028|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
126536941|NCT02660827|455256028|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
126536942|NCT02660827|455256028|FG000|Period 2: Continued Access Period|Adverse Event|3|||
126536943|NCT01428076|455256029|FG000|Overall Study|Adverse Event|0|||
126536944|NCT01428076|455256030|FG001|Overall Study|Adverse Event|1|||
126536945|NCT02953938|455256031|FG000|Overall Study|Adverse Event|0|||
126536946|NCT02953938|455256032|FG001|Overall Study|Adverse Event|1|||
126536947|NCT02953938|455256031|FG000|Overall Study|Withdrawal by Subject|1|||
126536948|NCT02953938|455256032|FG001|Overall Study|Withdrawal by Subject|1|||
126536949|NCT00045305|455256036|FG000|Overall Study|Lack of Efficacy|6|||
126536950|NCT00045305|455256036|FG000|Overall Study|Adverse Event|3|||
126536951|NCT00045305|455256036|FG000|Overall Study|Death|3|||
126536952|NCT00045305|455256036|FG000|Overall Study|site error|2|||
126536953|NCT02216773|455256042|FG000|Overall Study|Disease progression|4|||
126536954|NCT02216773|455256043|FG001|Overall Study|Disease progression|2|||
126536955|NCT02216773|455256042|FG000|Overall Study|Insufficient FLRV|4|||
126536956|NCT02216773|455256043|FG001|Overall Study|Insufficient FLRV|0|||
126536957|NCT02216773|455256042|FG000|Overall Study|Abandoned|4|||
126536958|NCT02216773|455256043|FG001|Overall Study|Abandoned|3|||
126536959|NCT04274894|455256044|FG000|Overall Study|Adverse Event|7|||
126536960|NCT04274894|455256044|FG000|Overall Study|Withdrew consent|5|||
126536961|NCT04274894|455256044|FG000|Overall Study|Lost to Follow-up|9|||
126536962|NCT04274894|455256044|FG000|Overall Study|COVID-19 infection|1|||
126536963|NCT04274894|455256044|FG000|Overall Study|Other, not specified|20|||
126536964|NCT01936857|455256045|FG000|Overall Study|Sent to prison or 06 center|11|||
126536965|NCT01936857|455256046|FG001|Overall Study|Sent to prison or 06 center|12|||
126536966|NCT01936857|455256045|FG000|Overall Study|Lost to Follow-up|10|||
126536967|NCT01936857|455256046|FG001|Overall Study|Lost to Follow-up|7|||
126536968|NCT01936857|455256045|FG000|Overall Study|Death|7|||
126536969|NCT01936857|455256046|FG001|Overall Study|Death|3|||
126536970|NCT01936857|455256045|FG000|Overall Study|Moved|2|||
126536971|NCT01936857|455256046|FG001|Overall Study|Moved|1|||
126536972|NCT01936857|455256045|FG000|Overall Study|Withdrawal by Subject|1|||
126536973|NCT01936857|455256046|FG001|Overall Study|Withdrawal by Subject|0|||
126536974|NCT01936857|455256045|FG000|Overall Study|Side effect of medication|1|||
126536975|NCT01936857|455256046|FG001|Overall Study|Side effect of medication|0|||
126536976|NCT01936857|455256045|FG000|Overall Study|Other|2|||
126536977|NCT01936857|455256046|FG001|Overall Study|Other|2|||
126536978|NCT03848403|455256047|FG000|Period 2 (Day 8)|Adverse Event|1|||
126536979|NCT03848403|455256048|FG001|Period 2 (Day 8)|Adverse Event|2|||
126536980|NCT03848403|455256049|FG002|Period 2 (Day 8)|Adverse Event|2|||
126536981|NCT03848403|455256047|FG000|Period 2 (Day 8)|Physician Decision|0|||
126536982|NCT03848403|455256048|FG001|Period 2 (Day 8)|Physician Decision|1|||
126536983|NCT03848403|455256049|FG002|Period 2 (Day 8)|Physician Decision|0|||
126536984|NCT03848403|455256047|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
126536985|NCT03848403|455256048|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
126536986|NCT03848403|455256049|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
126536987|NCT02279043|455256050|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
126536988|NCT02279043|455256051|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
126648193|NCT02003222|455669712|FG003|Intensification|Disease progression|0|||
126715201|NCT01052012|455908710|FG004|Overall Study|Other|1|||
126536989|NCT02279043|455256052|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
126536990|NCT02279043|455256050|FG000|Overall Study|Lost to Follow-up|46|||
126536991|NCT02279043|455256051|FG001|Overall Study|Lost to Follow-up|88|||
126536992|NCT02279043|455256052|FG002|Overall Study|Lost to Follow-up|0|||
126536993|NCT02124265|455256053|FG000|Overall Study|Adverse Event|1|||
126536994|NCT01939548|455256054|FG000|Overall Study|Non compliance|0|||
126536995|NCT01939548|455256055|FG001|Overall Study|Non compliance|2|||
126536996|NCT01939548|455256056|FG002|Overall Study|Non compliance|0|||
126536997|NCT01939548|455256054|FG000|Overall Study|Study Terminated by Sponsor|17|||
126536998|NCT01939548|455256055|FG001|Overall Study|Study Terminated by Sponsor|19|||
126536999|NCT01939548|455256056|FG002|Overall Study|Study Terminated by Sponsor|12|||
126537000|NCT01939548|455256054|FG000|Overall Study|Insufficient Clinical Response|1|||
126648194|NCT02003222|455669713|FG004|Intensification|Disease progression|18|||
126537001|NCT01939548|455256055|FG001|Overall Study|Insufficient Clinical Response|0|||
126537002|NCT01939548|455256056|FG002|Overall Study|Insufficient Clinical Response|0|||
126648195|NCT02003222|455669709|FG000|Intensification|Withdrawal by Subject|0|||
126313966|NCT00197002|454440758|FG001|Overall Study|Withdrawal by Subject|5|||
126537003|NCT01939548|455256054|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
126537004|NCT01939548|455256055|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
126537005|NCT01939548|455256056|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
126537006|NCT01939548|455256054|FG000|Overall Study|Withdrawal by Subject|4|||
126537007|NCT01939548|455256055|FG001|Overall Study|Withdrawal by Subject|4|||
126537008|NCT01939548|455256056|FG002|Overall Study|Withdrawal by Subject|1|||
126537009|NCT01939548|455256054|FG000|Overall Study|Protocol Violation|7|||
126537010|NCT01939548|455256055|FG001|Overall Study|Protocol Violation|6|||
126537011|NCT01939548|455256056|FG002|Overall Study|Protocol Violation|5|||
126537012|NCT01939548|455256054|FG000|Overall Study|Lost to Follow-up|5|||
126537013|NCT01939548|455256055|FG001|Overall Study|Lost to Follow-up|5|||
126537014|NCT01939548|455256056|FG002|Overall Study|Lost to Follow-up|3|||
126537015|NCT01939548|455256054|FG000|Overall Study|Adverse Event|2|||
126537016|NCT01939548|455256055|FG001|Overall Study|Adverse Event|9|||
126537017|NCT01939548|455256056|FG002|Overall Study|Adverse Event|7|||
126537018|NCT01939548|455256054|FG000|Overall Study|Death|0|||
126537019|NCT01939548|455256055|FG001|Overall Study|Death|0|||
126537020|NCT01939548|455256056|FG002|Overall Study|Death|1|||
126537021|NCT01939548|455256054|FG000|Overall Study|Participant dropped|0|||
126537022|NCT01939548|455256055|FG001|Overall Study|Participant dropped|0|||
126537023|NCT01939548|455256056|FG002|Overall Study|Participant dropped|1|||
126537024|NCT01939548|455256054|FG000|Overall Study|Participant unwilling to continue|0|||
126537025|NCT01939548|455256055|FG001|Overall Study|Participant unwilling to continue|1|||
126537026|NCT01939548|455256056|FG002|Overall Study|Participant unwilling to continue|0|||
126537027|NCT01939548|455256054|FG000|Overall Study|Participant withdrew consent|0|||
126313967|NCT00197002|454440759|FG002|Overall Study|Withdrawal by Subject|7|||
126313968|NCT00197002|454440757|FG000|Overall Study|Migrated/moved from study area|3|||
126313969|NCT00197002|454440758|FG001|Overall Study|Migrated/moved from study area|5|||
126313970|NCT00197002|454440759|FG002|Overall Study|Migrated/moved from study area|1|||
126313971|NCT00197002|454440757|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
126313972|NCT00197002|454440758|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
126313973|NCT00197002|454440759|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
126313974|NCT00197002|454440757|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
126313975|NCT00197002|454440758|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
126313976|NCT00197002|454440759|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
126313977|NCT00197002|454440757|FG000|Overall Study|Others|3|||
126313978|NCT00197002|454440758|FG001|Overall Study|Others|1|||
126313979|NCT00197002|454440759|FG002|Overall Study|Others|1|||
126313980|NCT02017717|454440760|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313981|NCT02017717|454440761|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313982|NCT02017717|454440762|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313983|NCT02017717|454440763|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313984|NCT02017717|454440764|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313985|NCT02017717|454440765|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313986|NCT02017717|454440766|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313987|NCT02017717|454440767|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
126313988|NCT02017717|454440768|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
126313989|NCT02017717|454440760|FG000|Before Treatment Period|Participant request to stop therapy|0|||
126313990|NCT02017717|454440761|FG001|Before Treatment Period|Participant request to stop therapy|0|||
126313991|NCT02017717|454440762|FG002|Before Treatment Period|Participant request to stop therapy|0|||
126313992|NCT02017717|454440763|FG003|Before Treatment Period|Participant request to stop therapy|0|||
126313993|NCT02017717|454440764|FG004|Before Treatment Period|Participant request to stop therapy|0|||
126313994|NCT02017717|454440765|FG005|Before Treatment Period|Participant request to stop therapy|0|||
126313995|NCT02017717|454440766|FG006|Before Treatment Period|Participant request to stop therapy|0|||
126313996|NCT02017717|454440767|FG007|Before Treatment Period|Participant request to stop therapy|0|||
126313997|NCT02017717|454440768|FG008|Before Treatment Period|Participant request to stop therapy|5|||
126648196|NCT02003222|455669710|FG001|Intensification|Withdrawal by Subject|0|||
126313998|NCT02017717|454440760|FG000|Before Treatment Period|Participant withdrew consent|0|||
126313999|NCT02017717|454440761|FG001|Before Treatment Period|Participant withdrew consent|0|||
126314000|NCT02017717|454440762|FG002|Before Treatment Period|Participant withdrew consent|0|||
126314001|NCT02017717|454440763|FG003|Before Treatment Period|Participant withdrew consent|0|||
126314002|NCT02017717|454440764|FG004|Before Treatment Period|Participant withdrew consent|0|||
126314003|NCT02017717|454440765|FG005|Before Treatment Period|Participant withdrew consent|0|||
126314004|NCT02017717|454440766|FG006|Before Treatment Period|Participant withdrew consent|2|||
126314005|NCT02017717|454440767|FG007|Before Treatment Period|Participant withdrew consent|0|||
126314006|NCT02017717|454440768|FG008|Before Treatment Period|Participant withdrew consent|11|||
126314007|NCT02017717|454440760|FG000|Before Treatment Period|Lost to Follow-up|0|||
126314008|NCT02017717|454440761|FG001|Before Treatment Period|Lost to Follow-up|0|||
126314009|NCT02017717|454440762|FG002|Before Treatment Period|Lost to Follow-up|0|||
126314010|NCT02017717|454440763|FG003|Before Treatment Period|Lost to Follow-up|0|||
126314011|NCT02017717|454440764|FG004|Before Treatment Period|Lost to Follow-up|0|||
126314012|NCT02017717|454440765|FG005|Before Treatment Period|Lost to Follow-up|0|||
126314013|NCT02017717|454440766|FG006|Before Treatment Period|Lost to Follow-up|0|||
126314014|NCT02017717|454440767|FG007|Before Treatment Period|Lost to Follow-up|0|||
126314015|NCT02017717|454440768|FG008|Before Treatment Period|Lost to Follow-up|1|||
126314016|NCT02017717|454440760|FG000|Before Treatment Period|Participant no longer met criteria|0|||
126314017|NCT02017717|454440761|FG001|Before Treatment Period|Participant no longer met criteria|0|||
126314018|NCT02017717|454440762|FG002|Before Treatment Period|Participant no longer met criteria|0|||
126537028|NCT01939548|455256055|FG001|Overall Study|Participant withdrew consent|2|||
126537029|NCT01939548|455256056|FG002|Overall Study|Participant withdrew consent|0|||
126537030|NCT01939548|455256054|FG000|Overall Study|Did not complete follow-up|0|||
126537031|NCT01939548|455256055|FG001|Overall Study|Did not complete follow-up|1|||
126537032|NCT01939548|455256056|FG002|Overall Study|Did not complete follow-up|0|||
126314019|NCT02017717|454440763|FG003|Before Treatment Period|Participant no longer met criteria|0|||
126314020|NCT02017717|454440764|FG004|Before Treatment Period|Participant no longer met criteria|0|||
126314021|NCT02017717|454440765|FG005|Before Treatment Period|Participant no longer met criteria|1|||
126314022|NCT02017717|454440766|FG006|Before Treatment Period|Participant no longer met criteria|0|||
126314023|NCT02017717|454440767|FG007|Before Treatment Period|Participant no longer met criteria|1|||
126314024|NCT02017717|454440768|FG008|Before Treatment Period|Participant no longer met criteria|2|||
126314025|NCT02017717|454440760|FG000|Before Treatment Period|other reason|0|||
126314026|NCT02017717|454440761|FG001|Before Treatment Period|other reason|0|||
126314027|NCT02017717|454440762|FG002|Before Treatment Period|other reason|0|||
126314028|NCT02017717|454440763|FG003|Before Treatment Period|other reason|0|||
126314029|NCT02017717|454440764|FG004|Before Treatment Period|other reason|0|||
126314030|NCT02017717|454440765|FG005|Before Treatment Period|other reason|0|||
126314031|NCT02017717|454440766|FG006|Before Treatment Period|other reason|0|||
126314032|NCT02017717|454440767|FG007|Before Treatment Period|other reason|0|||
126314033|NCT02017717|454440768|FG008|Before Treatment Period|other reason|1|||
126314034|NCT02017717|454440760|FG000|Treatment Period|Disease progression|7|||
126314035|NCT02017717|454440761|FG001|Treatment Period|Disease progression|9|||
126314036|NCT02017717|454440762|FG002|Treatment Period|Disease progression|12|||
126537033|NCT00490282|455256057|FG000|Overall Study|Withdrawal by Subject|3|||
126537034|NCT04510675|455256061|FG000|Overall Study|Withdrawal by Subject|5|||
126314037|NCT02017717|454440763|FG003|Treatment Period|Disease progression|20|||
126314038|NCT02017717|454440764|FG004|Treatment Period|Disease progression|26|||
126314039|NCT02017717|454440765|FG005|Treatment Period|Disease progression|16|||
126314040|NCT02017717|454440766|FG006|Treatment Period|Disease progression|22|||
126314041|NCT02017717|454440767|FG007|Treatment Period|Disease progression|165|||
126314042|NCT02017717|454440768|FG008|Treatment Period|Disease progression|135|||
126314043|NCT02017717|454440760|FG000|Treatment Period|Study drug toxicity|3|||
126314044|NCT02017717|454440761|FG001|Treatment Period|Study drug toxicity|0|||
126314045|NCT02017717|454440762|FG002|Treatment Period|Study drug toxicity|1|||
126314046|NCT02017717|454440763|FG003|Treatment Period|Study drug toxicity|4|||
126314047|NCT02017717|454440764|FG004|Treatment Period|Study drug toxicity|4|||
126314048|NCT02017717|454440765|FG005|Treatment Period|Study drug toxicity|5|||
126314049|NCT02017717|454440766|FG006|Treatment Period|Study drug toxicity|3|||
126314050|NCT02017717|454440767|FG007|Treatment Period|Study drug toxicity|7|||
126314051|NCT02017717|454440768|FG008|Treatment Period|Study drug toxicity|11|||
126314052|NCT02017717|454440760|FG000|Treatment Period|Death|0|||
126314053|NCT02017717|454440761|FG001|Treatment Period|Death|0|||
126314054|NCT02017717|454440762|FG002|Treatment Period|Death|1|||
126314055|NCT02017717|454440763|FG003|Treatment Period|Death|0|||
126314056|NCT02017717|454440764|FG004|Treatment Period|Death|0|||
126314057|NCT02017717|454440765|FG005|Treatment Period|Death|2|||
126314058|NCT02017717|454440766|FG006|Treatment Period|Death|0|||
126314059|NCT02017717|454440767|FG007|Treatment Period|Death|0|||
126314060|NCT02017717|454440768|FG008|Treatment Period|Death|0|||
126314061|NCT02017717|454440760|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
126314062|NCT02017717|454440761|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
126314063|NCT02017717|454440762|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
126314064|NCT02017717|454440763|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
126314065|NCT02017717|454440764|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
126314066|NCT02017717|454440765|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
126314067|NCT02017717|454440766|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
126314068|NCT02017717|454440767|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
126314069|NCT02017717|454440768|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
126314070|NCT02017717|454440760|FG000|Treatment Period|Participant request to stop therapy|0|||
126314071|NCT02017717|454440761|FG001|Treatment Period|Participant request to stop therapy|0|||
126314072|NCT02017717|454440762|FG002|Treatment Period|Participant request to stop therapy|3|||
126314073|NCT02017717|454440763|FG003|Treatment Period|Participant request to stop therapy|6|||
126314074|NCT02017717|454440764|FG004|Treatment Period|Participant request to stop therapy|0|||
126314075|NCT02017717|454440765|FG005|Treatment Period|Participant request to stop therapy|2|||
126314076|NCT02017717|454440766|FG006|Treatment Period|Participant request to stop therapy|1|||
126314077|NCT02017717|454440767|FG007|Treatment Period|Participant request to stop therapy|4|||
126314078|NCT02017717|454440768|FG008|Treatment Period|Participant request to stop therapy|7|||
126314079|NCT02017717|454440760|FG000|Treatment Period|Participant withdrew consent|0|||
126314080|NCT02017717|454440761|FG001|Treatment Period|Participant withdrew consent|0|||
126314081|NCT02017717|454440762|FG002|Treatment Period|Participant withdrew consent|1|||
126314082|NCT02017717|454440763|FG003|Treatment Period|Participant withdrew consent|0|||
126314083|NCT02017717|454440764|FG004|Treatment Period|Participant withdrew consent|0|||
126314084|NCT02017717|454440765|FG005|Treatment Period|Participant withdrew consent|2|||
126314085|NCT02017717|454440766|FG006|Treatment Period|Participant withdrew consent|0|||
126314086|NCT02017717|454440767|FG007|Treatment Period|Participant withdrew consent|1|||
126314087|NCT02017717|454440768|FG008|Treatment Period|Participant withdrew consent|4|||
126314088|NCT02017717|454440760|FG000|Treatment Period|Participant no longer met criteria|0|||
126314089|NCT02017717|454440761|FG001|Treatment Period|Participant no longer met criteria|0|||
126314090|NCT02017717|454440762|FG002|Treatment Period|Participant no longer met criteria|0|||
126314091|NCT02017717|454440763|FG003|Treatment Period|Participant no longer met criteria|0|||
126314092|NCT02017717|454440764|FG004|Treatment Period|Participant no longer met criteria|0|||
126314093|NCT02017717|454440765|FG005|Treatment Period|Participant no longer met criteria|0|||
126314094|NCT02017717|454440766|FG006|Treatment Period|Participant no longer met criteria|0|||
126314095|NCT02017717|454440767|FG007|Treatment Period|Participant no longer met criteria|0|||
126314096|NCT02017717|454440768|FG008|Treatment Period|Participant no longer met criteria|1|||
126314097|NCT02017717|454440760|FG000|Treatment Period|Other reasons|0|||
126314098|NCT02017717|454440761|FG001|Treatment Period|Other reasons|0|||
126314099|NCT02017717|454440762|FG002|Treatment Period|Other reasons|0|||
126314100|NCT02017717|454440763|FG003|Treatment Period|Other reasons|1|||
126314101|NCT02017717|454440764|FG004|Treatment Period|Other reasons|0|||
126314102|NCT02017717|454440765|FG005|Treatment Period|Other reasons|1|||
126314103|NCT02017717|454440766|FG006|Treatment Period|Other reasons|1|||
126314104|NCT02017717|454440767|FG007|Treatment Period|Other reasons|1|||
126314105|NCT02017717|454440768|FG008|Treatment Period|Other reasons|1|||
126314106|NCT02017717|454440760|FG000|Treatment Period|Maximum clinical benefit|0|||
126314107|NCT02017717|454440761|FG001|Treatment Period|Maximum clinical benefit|0|||
126314108|NCT02017717|454440762|FG002|Treatment Period|Maximum clinical benefit|0|||
126314109|NCT02017717|454440763|FG003|Treatment Period|Maximum clinical benefit|0|||
126314110|NCT02017717|454440764|FG004|Treatment Period|Maximum clinical benefit|0|||
126314111|NCT02017717|454440765|FG005|Treatment Period|Maximum clinical benefit|0|||
126314112|NCT02017717|454440766|FG006|Treatment Period|Maximum clinical benefit|0|||
126314113|NCT02017717|454440767|FG007|Treatment Period|Maximum clinical benefit|0|||
126314114|NCT02017717|454440768|FG008|Treatment Period|Maximum clinical benefit|1|||
126314115|NCT02017717|454440760|FG000|Treatment Period|Not reported|0|||
126314116|NCT02017717|454440761|FG001|Treatment Period|Not reported|1|||
126314117|NCT02017717|454440762|FG002|Treatment Period|Not reported|0|||
126314118|NCT02017717|454440763|FG003|Treatment Period|Not reported|0|||
126314119|NCT02017717|454440764|FG004|Treatment Period|Not reported|0|||
126314120|NCT02017717|454440765|FG005|Treatment Period|Not reported|0|||
126314121|NCT02017717|454440766|FG006|Treatment Period|Not reported|0|||
126314122|NCT02017717|454440767|FG007|Treatment Period|Not reported|0|||
126314123|NCT02017717|454440768|FG008|Treatment Period|Not reported|0|||
126314124|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
126314125|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
126314126|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
126314127|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
126314128|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
126314129|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
126314130|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
126314131|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
126314132|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
126314133|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
126314134|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
126314135|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
126314136|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
126314137|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
126314138|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
126537035|NCT04198805|455256064|FG000|Overall Study|Death|0|||
126537036|NCT04198805|455256065|FG001|Overall Study|Death|0|||
126537037|NCT04198805|455256066|FG002|Overall Study|Death|0|||
126537038|NCT04198805|455256067|FG003|Overall Study|Death|1|||
126537039|NCT04198805|455256064|FG000|Overall Study|Early Termination|8|||
126537040|NCT04198805|455256065|FG001|Overall Study|Early Termination|4|||
126537041|NCT04198805|455256066|FG002|Overall Study|Early Termination|6|||
126537042|NCT04198805|455256067|FG003|Overall Study|Early Termination|9|||
126537043|NCT01330433|455256070|FG000|Overall Study|Death|1|||
126537044|NCT01330433|455256071|FG001|Overall Study|Death|3|||
126537045|NCT01330433|455256070|FG000|Overall Study|Lost to Follow-up|1|||
126537046|NCT01330433|455256071|FG001|Overall Study|Lost to Follow-up|0|||
126537047|NCT01499082|455256072|FG000|Overall Study|Randomized but not Treated|0|||
126537048|NCT01499082|455256073|FG001|Overall Study|Randomized but not Treated|1|||
126537049|NCT01499082|455256072|FG000|Overall Study|Adverse Event|12|||
126537050|NCT01499082|455256073|FG001|Overall Study|Adverse Event|16|||
126537051|NCT01499082|455256072|FG000|Overall Study|Lack of Efficacy|1|||
126537052|NCT01499082|455256073|FG001|Overall Study|Lack of Efficacy|1|||
126537053|NCT01499082|455256072|FG000|Overall Study|Protocol Violation|6|||
126537054|NCT01499082|455256073|FG001|Overall Study|Protocol Violation|8|||
126537055|NCT01499082|455256072|FG000|Overall Study|Diverse Reasons|18|||
126537056|NCT01499082|455256073|FG001|Overall Study|Diverse Reasons|14|||
126537057|NCT01499082|455256072|FG000|Overall Study|Site Closure for Noncompliance|5|||
126537058|NCT01499082|455256073|FG001|Overall Study|Site Closure for Noncompliance|2|||
126537059|NCT01499082|455256072|FG000|Overall Study|Hypoglycemia|2|||
126537060|NCT01499082|455256073|FG001|Overall Study|Hypoglycemia|3|||
126537061|NCT01499082|455256072|FG000|Overall Study|Lost to Follow-up|1|||
126537062|NCT01499082|455256073|FG001|Overall Study|Lost to Follow-up|3|||
126537063|NCT03599349|455256074|FG000|Overall Study|Lost to Follow-up|1|||
126537064|NCT01830127|455256077|FG000|Overall Study|Adverse Event|1|||
126537065|NCT01830127|455256078|FG001|Overall Study|Adverse Event|6|||
126537066|NCT01830127|455256077|FG000|Overall Study|Lack of Efficacy|3|||
126537067|NCT01830127|455256078|FG001|Overall Study|Lack of Efficacy|0|||
126537068|NCT01830127|455256077|FG000|Overall Study|Withdrawal by Subject|1|||
126537069|NCT01830127|455256078|FG001|Overall Study|Withdrawal by Subject|1|||
126537070|NCT01830127|455256077|FG000|Overall Study|Other reason not defined above|0|||
126537071|NCT01830127|455256078|FG001|Overall Study|Other reason not defined above|2|||
126537072|NCT00567190|455256079|FG000|Overall Study|Death|235|||
126537073|NCT00567190|455256080|FG001|Overall Study|Death|280|||
126537074|NCT00567190|455256079|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
126537075|NCT00567190|455256080|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
126537076|NCT02532179|455257869|FG000|Overall Study|Lost to Follow-up|1|||
126537077|NCT02532179|455257869|FG000|Overall Study|Pregnancy|1|||
126537078|NCT02532179|455257869|FG000|Overall Study|Subject received depot steroid injection|1|||
126537079|NCT03076970|455257873|FG000|Washout Period 2|Adverse Event|0|||
126537080|NCT03076970|455257874|FG001|Washout Period 2|Adverse Event|0|||
126537081|NCT03076970|455257875|FG002|Washout Period 2|Adverse Event|0|||
126537082|NCT03076970|455257876|FG003|Washout Period 2|Adverse Event|0|||
126537083|NCT03076970|455257877|FG004|Washout Period 2|Adverse Event|1|||
126537084|NCT03076970|455257878|FG005|Washout Period 2|Adverse Event|0|||
126537085|NCT03076970|455257873|FG000|Period 3|Withdrawal by Subject|0|||
126537086|NCT03076970|455257874|FG001|Period 3|Withdrawal by Subject|0|||
126537087|NCT03076970|455257875|FG002|Period 3|Withdrawal by Subject|0|||
126537088|NCT03076970|455257876|FG003|Period 3|Withdrawal by Subject|0|||
126537089|NCT03076970|455257877|FG004|Period 3|Withdrawal by Subject|0|||
126537090|NCT03076970|455257878|FG005|Period 3|Withdrawal by Subject|1|||
126537091|NCT03076970|455257873|FG000|Period 3|Failure to meet I/E criteria|0|||
126537092|NCT03076970|455257874|FG001|Period 3|Failure to meet I/E criteria|0|||
126537093|NCT03076970|455257875|FG002|Period 3|Failure to meet I/E criteria|0|||
126537094|NCT03076970|455257876|FG003|Period 3|Failure to meet I/E criteria|0|||
126537095|NCT03076970|455257877|FG004|Period 3|Failure to meet I/E criteria|1|||
126537096|NCT03076970|455257878|FG005|Period 3|Failure to meet I/E criteria|0|||
126537097|NCT02543658|455257879|FG000|Overall Study|Lack of Efficacy|0|||
126537098|NCT02543658|455257880|FG001|Overall Study|Lack of Efficacy|4|||
126537099|NCT00789815|455257881|FG000|Overall Study|Protocol Violation|6|||
126537100|NCT00789815|455257882|FG001|Overall Study|Protocol Violation|1|||
126537101|NCT00789815|455257881|FG000|Overall Study|Intubation due to massive bleeding|1|||
126537102|NCT00789815|455257882|FG001|Overall Study|Intubation due to massive bleeding|0|||
126537103|NCT01111123|455257887|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
126537104|NCT01111123|455257888|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
126537105|NCT01111123|455257887|FG000|Maintenance Phase|Lost to Follow-up|0|||
126537106|NCT01111123|455257888|FG001|Maintenance Phase|Lost to Follow-up|2|||
126537107|NCT00119405|455257889|FG000|Overall Study|Withdrawal by Subject|1|||
126537108|NCT00662857|455257901|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
126537109|NCT00662857|455257902|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
126537110|NCT00662857|455257901|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
126537111|NCT00662857|455257902|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
126537112|NCT00662857|455257901|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
126537113|NCT00662857|455257902|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
126537114|NCT03966053|455257903|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
126537115|NCT00989092|455257904|FG000|Overall Study|Physician Decision|9|||
126537116|NCT00989092|455257905|FG001|Overall Study|Physician Decision|6|||
126537117|NCT00989092|455257904|FG000|Overall Study|Adverse Event|20|||
126537118|NCT00989092|455257905|FG001|Overall Study|Adverse Event|1|||
126537119|NCT00989092|455257904|FG000|Overall Study|Chemotherapy initiated|12|||
126537120|NCT00989092|455257905|FG001|Overall Study|Chemotherapy initiated|4|||
126537121|NCT00989092|455257904|FG000|Overall Study|Withdrawal by Subject|17|||
126537122|NCT00989092|455257905|FG001|Overall Study|Withdrawal by Subject|9|||
126537123|NCT00989092|455257904|FG000|Overall Study|Death|14|||
126537124|NCT00989092|455257905|FG001|Overall Study|Death|2|||
126537125|NCT00989092|455257904|FG000|Overall Study|Ineligibility determined|3|||
126537126|NCT00989092|455257905|FG001|Overall Study|Ineligibility determined|3|||
126537127|NCT00989092|455257904|FG000|Overall Study|Lost to Follow-up|6|||
126537128|NCT00989092|455257905|FG001|Overall Study|Lost to Follow-up|2|||
126537129|NCT00989092|455257904|FG000|Overall Study|Other|3|||
126537130|NCT00989092|455257905|FG001|Overall Study|Other|1|||
126537131|NCT00989092|455257904|FG000|Overall Study|Protocol deviation|2|||
126537132|NCT00989092|455257905|FG001|Overall Study|Protocol deviation|0|||
126537133|NCT00989092|455257904|FG000|Overall Study|Erythropoietin therapy initiated|2|||
126537134|NCT00989092|455257905|FG001|Overall Study|Erythropoietin therapy initiated|0|||
126537135|NCT00989092|455257904|FG000|Overall Study|Did not receive study drug|2|||
126537136|NCT00989092|455257905|FG001|Overall Study|Did not receive study drug|0|||
126537137|NCT01332227|455257907|FG000|Overall Study|Adverse Event|4|||
126537138|NCT01332227|455257908|FG001|Overall Study|Adverse Event|1|||
126537139|NCT01332227|455257907|FG000|Overall Study|Withdrawal by Subject|5|||
126537140|NCT01332227|455257908|FG001|Overall Study|Withdrawal by Subject|1|||
126537141|NCT01332227|455257907|FG000|Overall Study|Lost to Follow-up|2|||
126537142|NCT01332227|455257908|FG001|Overall Study|Lost to Follow-up|0|||
126537143|NCT01332227|455257907|FG000|Overall Study|Lack of Efficacy|3|||
126537144|NCT01332227|455257908|FG001|Overall Study|Lack of Efficacy|1|||
126537145|NCT01332227|455257907|FG000|Overall Study|Poor compliance/noncompliance|1|||
126537146|NCT01332227|455257908|FG001|Overall Study|Poor compliance/noncompliance|1|||
126537147|NCT01332227|455257907|FG000|Overall Study|Patient moved from area|1|||
126537148|NCT01332227|455257908|FG001|Overall Study|Patient moved from area|0|||
126537149|NCT01332227|455257907|FG000|Overall Study|Patient began prohibited medication|0|||
126537150|NCT01332227|455257908|FG001|Overall Study|Patient began prohibited medication|1|||
126537151|NCT00514943|455257909|FG000|Stage 1|Progressive disease|4|||
126537152|NCT00514943|455257910|FG001|Stage 1|Progressive disease|8|||
126537153|NCT00514943|455257909|FG000|Stage 1|Other Adverse Event|16|||
126537154|NCT00514943|455257910|FG001|Stage 1|Other Adverse Event|6|||
126537155|NCT00514943|455257909|FG000|Stage 1|Not treated|1|||
126314139|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
126537156|NCT00514943|455257910|FG001|Stage 1|Not treated|2|||
126537157|NCT00514943|455257909|FG000|Stage 1|Patient refused to continue study meds|8|||
126537158|NCT00514943|455257910|FG001|Stage 1|Patient refused to continue study meds|3|||
126537159|NCT00514943|455257909|FG000|Stage 1|Other than stated above|1|||
126537160|NCT00514943|455257910|FG001|Stage 1|Other than stated above|7|||
126537161|NCT00514943|455257909|FG000|Stage 2|Progressive disease|27|||
126537162|NCT00514943|455257910|FG001|Stage 2|Progressive disease|24|||
126537163|NCT00514943|455257909|FG000|Stage 2|Other Adverse Event|3|||
126537164|NCT00514943|455257910|FG001|Stage 2|Other Adverse Event|10|||
126537165|NCT00514943|455257909|FG000|Stage 2|Patient refused to continue study meds|2|||
126537166|NCT00514943|455257910|FG001|Stage 2|Patient refused to continue study meds|0|||
126537167|NCT00514943|455257909|FG000|Stage 2|Other than stated above|0|||
126537168|NCT00514943|455257910|FG001|Stage 2|Other than stated above|2|||
126537169|NCT02173548|455257915|FG000|Overall Study|Lost to Follow-up|0|||
126537170|NCT02173548|455257916|FG001|Overall Study|Lost to Follow-up|2|||
126537171|NCT02173548|455257915|FG000|Overall Study|Withdrawal by Subject|1|||
126537172|NCT02173548|455257916|FG001|Overall Study|Withdrawal by Subject|0|||
126537173|NCT01362439|455257924|FG000|Overall Study|Adverse Event|1|||
126537174|NCT01362439|455257924|FG000|Overall Study|Lack of Efficacy|3|||
126537175|NCT01362439|455257924|FG000|Overall Study|Lost to Follow-up|2|||
126537176|NCT01362439|455257924|FG000|Overall Study|Study medication non-compliant|1|||
126537177|NCT01362439|455257924|FG000|Overall Study|Participant who withdrew consent|8|||
126537178|NCT01755702|455257926|FG000|Wash Out Period I|Other Reason|3|||
126537179|NCT01755702|455257926|FG000|Washout Period II|Other Reason|5|||
126537180|NCT00691938|455257927|FG000|Overall Study|QTc prolongation|1|||
126537181|NCT00691938|455257928|FG001|Overall Study|QTc prolongation|0|||
126537182|NCT00691938|455257929|FG002|Overall Study|QTc prolongation|0|||
126537183|NCT00691938|455257930|FG003|Overall Study|QTc prolongation|0|||
126537184|NCT00691938|455257931|FG004|Overall Study|QTc prolongation|0|||
126537185|NCT00691938|455257932|FG005|Overall Study|QTc prolongation|0|||
126537186|NCT00691938|455257933|FG006|Overall Study|QTc prolongation|0|||
126537187|NCT04860518|455257934|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
126537188|NCT04860518|455257935|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
126537189|NCT00569582|455257950|FG000|Overall Study|Withdrawal by Subject|5|||
126537190|NCT00569582|455257950|FG000|Overall Study|Death|2|||
126537191|NCT00569582|455257950|FG000|Overall Study|Adverse Event|7|||
126537192|NCT00569582|455257950|FG000|Overall Study|Subject was too ill to travel.|1|||
126537193|NCT00569582|455257950|FG000|Overall Study|Subject was non-compliant.|1|||
126537194|NCT02782169|455257951|FG000|Overall Study|Lost to Follow-up|1|||
126537195|NCT02782169|455257952|FG001|Overall Study|Lost to Follow-up|2|||
126537196|NCT02975973|455257953|FG000|Overall Study|Adverse Event|1|||
126537197|NCT02975973|455257954|FG001|Overall Study|Adverse Event|1|||
126537198|NCT02975973|455257955|FG002|Overall Study|Adverse Event|1|||
126537199|NCT02975973|455257956|FG003|Overall Study|Adverse Event|0|||
126537200|NCT00771810|455257957|FG000|Overall Study|Adverse Event|3|||
126537201|NCT00771810|455257958|FG001|Overall Study|Adverse Event|0|||
126537202|NCT00771810|455257959|FG002|Overall Study|Adverse Event|2|||
126537203|NCT00771810|455257957|FG000|Overall Study|Lost to Follow-up|0|||
126537204|NCT00771810|455257958|FG001|Overall Study|Lost to Follow-up|0|||
126537205|NCT00771810|455257959|FG002|Overall Study|Lost to Follow-up|1|||
126537206|NCT00771810|455257957|FG000|Overall Study|Physician Decision|1|||
126537207|NCT00771810|455257958|FG001|Overall Study|Physician Decision|2|||
126537208|NCT00771810|455257959|FG002|Overall Study|Physician Decision|2|||
126537209|NCT00771810|455257957|FG000|Overall Study|Protocol Violation|0|||
126537210|NCT00771810|455257958|FG001|Overall Study|Protocol Violation|1|||
126537211|NCT00771810|455257959|FG002|Overall Study|Protocol Violation|1|||
126537212|NCT00771810|455257957|FG000|Overall Study|Withdrawal by Subject|1|||
126537213|NCT00771810|455257958|FG001|Overall Study|Withdrawal by Subject|2|||
126537214|NCT00771810|455257959|FG002|Overall Study|Withdrawal by Subject|0|||
126537215|NCT00771810|455257957|FG000|Overall Study|Other|0|||
126537216|NCT00771810|455257958|FG001|Overall Study|Other|0|||
126537217|NCT00771810|455257959|FG002|Overall Study|Other|1|||
126537218|NCT02114151|455257963|FG000|Overall Study|Death|1|||
126314140|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
126314141|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
126314142|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
126314143|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
126314144|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
126314145|NCT04488419|454440773|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
126314146|NCT04488419|454440774|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
126314147|NCT04488419|454440775|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
126314148|NCT04488419|454440773|FG000|Primary Analysis Population|Adverse Event|6|||
126314149|NCT04488419|454440774|FG001|Primary Analysis Population|Adverse Event|9|||
126314150|NCT04488419|454440775|FG002|Primary Analysis Population|Adverse Event|0|||
126314151|NCT04488419|454440773|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
126314152|NCT04488419|454440774|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
126537219|NCT02114151|455257963|FG000|Overall Study|Lost to Follow-up|1|||
126537220|NCT02114151|455257963|FG000|Overall Study|Withdrawal by Subject|5|||
126537221|NCT01494584|455257964|FG000|Overall Study|Study Closed/Terminated|1|||
126537222|NCT01666808|455257965|FG000|Overall Study|Lost to Follow-up|9|||
126537223|NCT01666808|455257966|FG001|Overall Study|Lost to Follow-up|15|||
126537224|NCT01666808|455257965|FG000|Overall Study|Withdrawal by Subject|3|||
126537225|NCT01666808|455257966|FG001|Overall Study|Withdrawal by Subject|1|||
126537226|NCT01666808|455257965|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
126537227|NCT01666808|455257966|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
126537228|NCT02638948|455257967|FG000|Overall Study|Withdrawal by Subject|4|||
126537229|NCT02638948|455257968|FG001|Overall Study|Withdrawal by Subject|5|||
126314153|NCT04488419|454440775|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
126314154|NCT04488419|454440773|FG000|Primary Analysis Population|Protocol Violation|1|||
126314155|NCT04488419|454440774|FG001|Primary Analysis Population|Protocol Violation|1|||
126537230|NCT02638948|455257969|FG002|Overall Study|Withdrawal by Subject|3|||
126537231|NCT02638948|455257970|FG003|Overall Study|Withdrawal by Subject|1|||
126537232|NCT02638948|455257967|FG000|Overall Study|Administrative Reason by Sponsor|0|||
126537233|NCT02638948|455257968|FG001|Overall Study|Administrative Reason by Sponsor|1|||
126537234|NCT02638948|455257969|FG002|Overall Study|Administrative Reason by Sponsor|0|||
126537235|NCT02638948|455257970|FG003|Overall Study|Administrative Reason by Sponsor|4|||
126537236|NCT02638948|455257967|FG000|Overall Study|Adverse Event|0|||
126537237|NCT02638948|455257968|FG001|Overall Study|Adverse Event|0|||
126537238|NCT02638948|455257969|FG002|Overall Study|Adverse Event|1|||
126537239|NCT02638948|455257970|FG003|Overall Study|Adverse Event|1|||
126537240|NCT02638948|455257967|FG000|Overall Study|Lack of Efficacy|1|||
126537241|NCT02638948|455257968|FG001|Overall Study|Lack of Efficacy|1|||
126537242|NCT02638948|455257969|FG002|Overall Study|Lack of Efficacy|0|||
126537243|NCT02638948|455257970|FG003|Overall Study|Lack of Efficacy|0|||
126537244|NCT02638948|455257967|FG000|Overall Study|Lost to Follow-up|0|||
126537245|NCT02638948|455257968|FG001|Overall Study|Lost to Follow-up|0|||
126537246|NCT02638948|455257969|FG002|Overall Study|Lost to Follow-up|1|||
126537247|NCT02638948|455257970|FG003|Overall Study|Lost to Follow-up|1|||
126537248|NCT02638948|455257967|FG000|Overall Study|Poor/Non-Compliance|0|||
126537249|NCT02638948|455257968|FG001|Overall Study|Poor/Non-Compliance|2|||
126537250|NCT02638948|455257969|FG002|Overall Study|Poor/Non-Compliance|1|||
126537251|NCT02638948|455257970|FG003|Overall Study|Poor/Non-Compliance|0|||
126537252|NCT02638948|455257967|FG000|Overall Study|Participant no longer met study criteria|0|||
126537253|NCT02638948|455257968|FG001|Overall Study|Participant no longer met study criteria|1|||
126537254|NCT02638948|455257969|FG002|Overall Study|Participant no longer met study criteria|0|||
126537255|NCT02638948|455257970|FG003|Overall Study|Participant no longer met study criteria|0|||
126537256|NCT02638948|455257967|FG000|Overall Study|Other than specified above|4|||
126537257|NCT02638948|455257968|FG001|Overall Study|Other than specified above|1|||
126537258|NCT02638948|455257969|FG002|Overall Study|Other than specified above|1|||
126537259|NCT02638948|455257970|FG003|Overall Study|Other than specified above|1|||
126537260|NCT00810264|455257974|FG000|Overall Study|Lost to Follow-up|191|||
126537261|NCT00810264|455257974|FG000|Overall Study|Withdrawal by subject or physician|721|||
126537262|NCT00810264|455257974|FG000|Overall Study|Death|641|||
126537263|NCT06213701|455257975|FG000|Overall Study|Withdrawal by Subject|2|||
126537264|NCT06213701|455257976|FG001|Overall Study|Withdrawal by Subject|1|||
126537265|NCT06213701|455257977|FG002|Overall Study|Withdrawal by Subject|0|||
126537266|NCT02495025|455257982|FG000|Overall Study|Lost to Follow-up|21|||
126537267|NCT02495025|455257983|FG001|Overall Study|Lost to Follow-up|14|||
126537268|NCT02495025|455257982|FG000|Overall Study|Withdrawal by Subject|5|||
126537269|NCT02495025|455257983|FG001|Overall Study|Withdrawal by Subject|0|||
126537270|NCT00313820|455257985|FG000|Assigned to Treatment|Other|1|||
126537271|NCT00313820|455257986|FG001|Assigned to Treatment|Other|0|||
126314156|NCT04488419|454440775|FG002|Primary Analysis Population|Protocol Violation|0|||
126314157|NCT04488419|454440773|FG000|Primary Analysis Population|Undetermined|7|||
126314158|NCT04488419|454440774|FG001|Primary Analysis Population|Undetermined|3|||
126314159|NCT04488419|454440775|FG002|Primary Analysis Population|Undetermined|0|||
126314160|NCT04488419|454440773|FG000|Primary Analysis Population|>1 Reason|2|||
126314161|NCT04488419|454440774|FG001|Primary Analysis Population|>1 Reason|4|||
126314162|NCT04488419|454440775|FG002|Primary Analysis Population|>1 Reason|0|||
126314163|NCT02276053|454440778|FG000|Overall Study|Death|2|||
126314164|NCT02276053|454440778|FG000|Overall Study|Adverse Event|5|||
126314165|NCT02276053|454440778|FG000|Overall Study|Lack of Efficacy|2|||
126314166|NCT02276053|454440778|FG000|Overall Study|Withdrawal by Subject|1|||
126314167|NCT02276053|454440778|FG000|Overall Study|Patient does not meet selection criteria|3|||
126314168|NCT02276053|454440778|FG000|Overall Study|Patient needs to increase baseline AED|1|||
126314169|NCT04542499|454440781|FG000|Overall Study|Adverse Event|23|||
126314170|NCT04542499|454440782|FG001|Overall Study|Adverse Event|43|||
126314171|NCT04542499|454440781|FG000|Overall Study|Lack of Efficacy|5|||
126314172|NCT04542499|454440782|FG001|Overall Study|Lack of Efficacy|2|||
126314173|NCT04542499|454440781|FG000|Overall Study|Lost to Follow-up|3|||
126537272|NCT00313820|455257985|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
126537273|NCT00313820|455257986|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
126537274|NCT00313820|455257985|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
126314174|NCT04542499|454440782|FG001|Overall Study|Lost to Follow-up|4|||
126314175|NCT04542499|454440781|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
126314176|NCT04542499|454440782|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
126537275|NCT00313820|455257986|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
126537276|NCT00313820|455257985|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
126537277|NCT00313820|455257986|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
126537278|NCT00313820|455257985|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
126537279|NCT00313820|455257986|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
126537280|NCT00313820|455257985|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
126537281|NCT00313820|455257986|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
126537282|NCT00265889|455257992|FG000|Overall Study|Physician Decision|1|||
126537283|NCT00265889|455257992|FG000|Overall Study|Protocol Violation|1|||
126537284|NCT00265889|455257992|FG000|Overall Study|Insurance denied the request|3|||
126537285|NCT02134587|455257993|FG000|Overall Study|Did not completed all meetings|30|||
126537286|NCT01515748|455257997|FG000|Overall Study|Withdrawal by Subject|32|||
126537287|NCT01515748|455257998|FG001|Overall Study|Withdrawal by Subject|41|||
126648197|NCT02003222|455669711|FG002|Intensification|Withdrawal by Subject|0|||
126314177|NCT04542499|454440781|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
126314178|NCT04542499|454440782|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
126314179|NCT04542499|454440781|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126314180|NCT04542499|454440782|FG001|Overall Study|Non-Compliance with Study Drug|2|||
126314181|NCT04542499|454440781|FG000|Overall Study|Physician Decision|0|||
126314182|NCT04542499|454440782|FG001|Overall Study|Physician Decision|1|||
126314183|NCT04542499|454440781|FG000|Overall Study|Site Terminated by Sponsor|3|||
126314184|NCT04542499|454440782|FG001|Overall Study|Site Terminated by Sponsor|5|||
126314185|NCT04542499|454440781|FG000|Overall Study|Withdrawal by Subject|12|||
126314186|NCT04542499|454440782|FG001|Overall Study|Withdrawal by Subject|33|||
126314187|NCT04542499|454440781|FG000|Overall Study|Other|2|||
126314188|NCT04542499|454440782|FG001|Overall Study|Other|2|||
126314189|NCT04161079|454440787|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
126314190|NCT03617861|454440790|FG000|Second Intervention (1 Day)|Adverse Event|0|||
126314191|NCT03617861|454440791|FG001|Second Intervention (1 Day)|Adverse Event|0|||
126314192|NCT03617861|454440792|FG002|Second Intervention (1 Day)|Adverse Event|1|||
126314193|NCT03617861|454440793|FG003|Second Intervention (1 Day)|Adverse Event|0|||
126314194|NCT00623597|454440794|FG000|Overall Study|Failed to return|1|||
126314195|NCT00623597|454440795|FG001|Overall Study|Failed to return|0|||
126314196|NCT02515994|454440796|FG000|Overall Study|Protocol Violation|3|||
126314197|NCT02515994|454440797|FG001|Overall Study|Protocol Violation|5|||
126314198|NCT02515994|454440796|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
126314199|NCT02515994|454440797|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
126314200|NCT02515994|454440796|FG000|Overall Study|Adverse Event|3|||
126314201|NCT02515994|454440797|FG001|Overall Study|Adverse Event|1|||
126314202|NCT02515994|454440796|FG000|Overall Study|Withdrawal by Subject|2|||
126314203|NCT02515994|454440797|FG001|Overall Study|Withdrawal by Subject|0|||
126314204|NCT01668966|454440807|FG000|Overall Study|Withdrawal by Subject|1|||
126314205|NCT01668966|454440807|FG000|Overall Study|Death|1|||
126314206|NCT01668966|454440807|FG000|Overall Study|Not treated|2|||
126314207|NCT03427268|454440811|FG000|Overall Study|Progressive disease|25|||
126314208|NCT03427268|454440811|FG000|Overall Study|Never treated|2|||
126314209|NCT03427268|454440811|FG000|Overall Study|Compassionate use|1|||
126314210|NCT03427268|454440811|FG000|Overall Study|Withdrawal by Subject|1|||
126314211|NCT03427268|454440811|FG000|Overall Study|Adverse Event|3|||
126314212|NCT00552032|454440813|FG000|Overall Study|Withdrawal by Subject|2|||
126314213|NCT00552032|454440814|FG001|Overall Study|Withdrawal by Subject|2|||
126314214|NCT00552032|454440813|FG000|Overall Study|Protocol Violation|7|||
126314215|NCT00552032|454440814|FG001|Overall Study|Protocol Violation|12|||
126314216|NCT00552032|454440813|FG000|Overall Study|Lost to Follow-up|8|||
126314217|NCT00552032|454440814|FG001|Overall Study|Lost to Follow-up|5|||
126314218|NCT00345878|454440815|FG000|Overall Study|Adverse Event|1|||
126314219|NCT00345878|454440816|FG001|Overall Study|Adverse Event|0|||
126314220|NCT00345878|454440815|FG000|Overall Study|Lost to Follow-up|2|||
126314221|NCT00345878|454440816|FG001|Overall Study|Lost to Follow-up|1|||
126314222|NCT00345878|454440815|FG000|Overall Study|Other|1|||
126314223|NCT00345878|454440816|FG001|Overall Study|Other|0|||
126314224|NCT03391232|454440817|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
126314225|NCT03391232|454440818|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
126314226|NCT03391232|454440817|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
126314227|NCT03391232|454440818|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
126314228|NCT01643798|454440819|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
126314229|NCT01643798|454440820|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
126314230|NCT01995175|454440826|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
126314231|NCT01995175|454440826|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
126314232|NCT01995175|454440826|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
126314233|NCT01995175|454440826|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
126314234|NCT01995175|454440826|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
126314235|NCT01995175|454440826|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
126314236|NCT01995175|454440826|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
126314237|NCT01995175|454440826|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
126314238|NCT01995175|454440826|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
126537288|NCT01515748|455257997|FG000|Overall Study|Lost to Follow-up|2|||
126537289|NCT01515748|455257998|FG001|Overall Study|Lost to Follow-up|4|||
126537290|NCT01515748|455257997|FG000|Overall Study|Other than specified above|5|||
126537291|NCT01515748|455257998|FG001|Overall Study|Other than specified above|10|||
126537292|NCT03221387|455258001|FG000|Overall Study|Lost to Follow-up|1|||
126537293|NCT03221387|455258001|FG000|Overall Study|Lung transplant|1|||
126537294|NCT04102579|455258005|FG000|Overall Study|Withdrawal by Subject|3|||
126537295|NCT04102579|455258006|FG001|Overall Study|Withdrawal by Subject|4|||
126537296|NCT04102579|455258005|FG000|Overall Study|Lost to Follow-up|0|||
126537297|NCT04102579|455258006|FG001|Overall Study|Lost to Follow-up|1|||
126537298|NCT04102579|455258005|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
126537299|NCT04102579|455258006|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
126537300|NCT04102579|455258005|FG000|Overall Study|Other than Specified|1|||
126537301|NCT04102579|455258006|FG001|Overall Study|Other than Specified|0|||
126537302|NCT04102579|455258005|FG000|Overall Study|Not Dosed with Study Drug|0|||
126537303|NCT04102579|455258006|FG001|Overall Study|Not Dosed with Study Drug|1|||
126537304|NCT01525602|455258007|FG000|Overall Study|Adverse Event|1|||
126537305|NCT01525602|455258008|FG001|Overall Study|Adverse Event|0|||
126537306|NCT01525602|455258009|FG002|Overall Study|Adverse Event|1|||
126537307|NCT01525602|455258010|FG003|Overall Study|Adverse Event|1|||
126537308|NCT01525602|455258011|FG004|Overall Study|Adverse Event|3|||
126537309|NCT01525602|455258012|FG005|Overall Study|Adverse Event|3|||
126537310|NCT01525602|455258013|FG006|Overall Study|Adverse Event|0|||
126537311|NCT01525602|455258014|FG007|Overall Study|Adverse Event|1|||
126537312|NCT01525602|455258007|FG000|Overall Study|Disease progression|6|||
126537313|NCT01525602|455258008|FG001|Overall Study|Disease progression|3|||
126537314|NCT01525602|455258009|FG002|Overall Study|Disease progression|2|||
126537315|NCT01525602|455258010|FG003|Overall Study|Disease progression|5|||
126537316|NCT01525602|455258011|FG004|Overall Study|Disease progression|22|||
126537317|NCT01525602|455258012|FG005|Overall Study|Disease progression|2|||
126537318|NCT01525602|455258013|FG006|Overall Study|Disease progression|3|||
126537319|NCT01525602|455258014|FG007|Overall Study|Disease progression|3|||
126537320|NCT01525602|455258007|FG000|Overall Study|Clinical progression|2|||
126537321|NCT01525602|455258008|FG001|Overall Study|Clinical progression|0|||
126537322|NCT01525602|455258009|FG002|Overall Study|Clinical progression|0|||
126537323|NCT01525602|455258010|FG003|Overall Study|Clinical progression|0|||
126537324|NCT01525602|455258011|FG004|Overall Study|Clinical progression|0|||
126537325|NCT01525602|455258012|FG005|Overall Study|Clinical progression|0|||
126537326|NCT01525602|455258013|FG006|Overall Study|Clinical progression|1|||
126537327|NCT01525602|455258014|FG007|Overall Study|Clinical progression|1|||
126537328|NCT01525602|455258007|FG000|Overall Study|Non-compliance|0|||
126537329|NCT01525602|455258008|FG001|Overall Study|Non-compliance|0|||
126537330|NCT01525602|455258009|FG002|Overall Study|Non-compliance|0|||
126314239|NCT00984061|454440827|FG000|Clarithromycin Alone|Protocol Violation|1|||
126314240|NCT00614120|454440832|FG000|Overall Study|Adverse Event|9|||
126314241|NCT00614120|454440833|FG001|Overall Study|Adverse Event|22|||
126314242|NCT00614120|454440834|FG002|Overall Study|Adverse Event|30|||
126314243|NCT00614120|454440835|FG003|Overall Study|Adverse Event|3|||
126314244|NCT00614120|454440832|FG000|Overall Study|Lack of Efficacy|3|||
126314245|NCT00614120|454440833|FG001|Overall Study|Lack of Efficacy|3|||
126314246|NCT00614120|454440834|FG002|Overall Study|Lack of Efficacy|2|||
126314247|NCT00614120|454440835|FG003|Overall Study|Lack of Efficacy|2|||
126314248|NCT00614120|454440832|FG000|Overall Study|Protocol Violation|2|||
126314249|NCT00614120|454440833|FG001|Overall Study|Protocol Violation|5|||
126314250|NCT00614120|454440834|FG002|Overall Study|Protocol Violation|3|||
126314251|NCT00614120|454440835|FG003|Overall Study|Protocol Violation|1|||
126314252|NCT00614120|454440832|FG000|Overall Study|Withdrawal criteria|1|||
126314253|NCT00614120|454440833|FG001|Overall Study|Withdrawal criteria|0|||
126314254|NCT00614120|454440834|FG002|Overall Study|Withdrawal criteria|0|||
126314255|NCT00614120|454440835|FG003|Overall Study|Withdrawal criteria|0|||
126314256|NCT00614120|454440832|FG000|Overall Study|Withdrawal by Subject|9|||
126314257|NCT00614120|454440833|FG001|Overall Study|Withdrawal by Subject|10|||
126314258|NCT00614120|454440834|FG002|Overall Study|Withdrawal by Subject|16|||
126314259|NCT00614120|454440835|FG003|Overall Study|Withdrawal by Subject|3|||
126314260|NCT00614120|454440832|FG000|Overall Study|Did not meet trial criteria|0|||
126314261|NCT00614120|454440833|FG001|Overall Study|Did not meet trial criteria|1|||
126314262|NCT00614120|454440834|FG002|Overall Study|Did not meet trial criteria|1|||
126314263|NCT00614120|454440835|FG003|Overall Study|Did not meet trial criteria|1|||
126314264|NCT00614120|454440832|FG000|Overall Study|hCG positive (not pregnant)|0|||
126314265|NCT00614120|454440833|FG001|Overall Study|hCG positive (not pregnant)|0|||
126537331|NCT01525602|455258010|FG003|Overall Study|Non-compliance|0|||
126537332|NCT01525602|455258011|FG004|Overall Study|Non-compliance|1|||
126537333|NCT01525602|455258012|FG005|Overall Study|Non-compliance|0|||
126537334|NCT01525602|455258013|FG006|Overall Study|Non-compliance|0|||
126537335|NCT01525602|455258014|FG007|Overall Study|Non-compliance|0|||
126537336|NCT01525602|455258007|FG000|Overall Study|Withdrawal by Subject|0|||
126537337|NCT01525602|455258008|FG001|Overall Study|Withdrawal by Subject|0|||
126537338|NCT01525602|455258009|FG002|Overall Study|Withdrawal by Subject|0|||
126537339|NCT01525602|455258010|FG003|Overall Study|Withdrawal by Subject|0|||
126537340|NCT01525602|455258011|FG004|Overall Study|Withdrawal by Subject|3|||
126537341|NCT01525602|455258012|FG005|Overall Study|Withdrawal by Subject|1|||
126537342|NCT01525602|455258013|FG006|Overall Study|Withdrawal by Subject|0|||
126537343|NCT01525602|455258014|FG007|Overall Study|Withdrawal by Subject|1|||
126537344|NCT01525602|455258007|FG000|Overall Study|Physician Decision|0|||
126537345|NCT01525602|455258008|FG001|Overall Study|Physician Decision|0|||
126537346|NCT01525602|455258009|FG002|Overall Study|Physician Decision|0|||
126537347|NCT01525602|455258010|FG003|Overall Study|Physician Decision|0|||
126537348|NCT01525602|455258011|FG004|Overall Study|Physician Decision|3|||
126537349|NCT01525602|455258012|FG005|Overall Study|Physician Decision|0|||
126537350|NCT01525602|455258013|FG006|Overall Study|Physician Decision|1|||
126537351|NCT01525602|455258014|FG007|Overall Study|Physician Decision|0|||
126537352|NCT01525602|455258007|FG000|Overall Study|Death|0|||
126537353|NCT01525602|455258008|FG001|Overall Study|Death|0|||
126537354|NCT01525602|455258009|FG002|Overall Study|Death|0|||
126537355|NCT01525602|455258010|FG003|Overall Study|Death|0|||
126537356|NCT01525602|455258011|FG004|Overall Study|Death|1|||
126537357|NCT01525602|455258012|FG005|Overall Study|Death|1|||
126537358|NCT01525602|455258013|FG006|Overall Study|Death|0|||
126537359|NCT01525602|455258014|FG007|Overall Study|Death|0|||
126537360|NCT01525602|455258007|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
126537361|NCT01525602|455258008|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
126537362|NCT01525602|455258009|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
126537363|NCT01525602|455258010|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
126537364|NCT01525602|455258011|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
126537365|NCT01525602|455258012|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
126537366|NCT01525602|455258013|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
126537367|NCT01525602|455258014|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
126537368|NCT04349280|455258015|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
126537369|NCT04349280|455258016|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
126537370|NCT04349280|455258015|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
126537371|NCT04349280|455258016|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
126537372|NCT04349280|455258015|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
126537373|NCT04349280|455258016|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
126537374|NCT01194570|455259383|FG000|Overall Study|Adverse Event|22|||
126537375|NCT01194570|455259384|FG001|Overall Study|Adverse Event|40|||
126537376|NCT01194570|455259383|FG000|Overall Study|Death|6|||
126537377|NCT01194570|455259384|FG001|Overall Study|Death|20|||
126537378|NCT01194570|455259383|FG000|Overall Study|Lack of Efficacy|32|||
126537379|NCT01194570|455259384|FG001|Overall Study|Lack of Efficacy|33|||
126537380|NCT01194570|455259383|FG000|Overall Study|Lost to Follow-up|4|||
126537381|NCT01194570|455259384|FG001|Overall Study|Lost to Follow-up|15|||
126537382|NCT01194570|455259383|FG000|Overall Study|Non-Compliance|2|||
126537383|NCT01194570|455259384|FG001|Overall Study|Non-Compliance|2|||
126537384|NCT01194570|455259383|FG000|Overall Study|Non-Compliance With Study Drug|2|||
126537385|NCT01194570|455259384|FG001|Overall Study|Non-Compliance With Study Drug|2|||
126537386|NCT01194570|455259383|FG000|Overall Study|Other|18|||
126537387|NCT01194570|455259384|FG001|Overall Study|Other|47|||
126537388|NCT01194570|455259383|FG000|Overall Study|Physician Decision|10|||
126537389|NCT01194570|455259384|FG001|Overall Study|Physician Decision|25|||
126537390|NCT01194570|455259383|FG000|Overall Study|Protocol Violation|1|||
126537391|NCT01194570|455259384|FG001|Overall Study|Protocol Violation|2|||
126537392|NCT01194570|455259383|FG000|Overall Study|Study Terminated By Sponsor|0|||
126537393|NCT01194570|455259384|FG001|Overall Study|Study Terminated By Sponsor|1|||
126537394|NCT01194570|455259383|FG000|Overall Study|Withdrawal by Subject|57|||
126537395|NCT01194570|455259384|FG001|Overall Study|Withdrawal by Subject|82|||
126537396|NCT01194570|455259383|FG000|Overall Study|Pregnancy|1|||
126537397|NCT01194570|455259384|FG001|Overall Study|Pregnancy|1|||
126537398|NCT01337674|455259385|FG000|Treatment Period 1|Adverse Event|0|||
126537399|NCT01337674|455259386|FG001|Treatment Period 1|Adverse Event|1|||
126537400|NCT01337674|455259387|FG002|Treatment Period 1|Adverse Event|0|||
126537401|NCT01337674|455259388|FG003|Treatment Period 1|Adverse Event|0|||
126537402|NCT01337674|455259385|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
126537403|NCT01337674|455259386|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
126537404|NCT01337674|455259387|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
126537405|NCT01337674|455259388|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
126537406|NCT01337674|455259385|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126537407|NCT01337674|455259386|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126537408|NCT01337674|455259387|FG002|Treatment Period 2|Withdrawal by Subject|1|||
126537409|NCT01337674|455259388|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126537410|NCT00939484|455259392|FG000|Overall Study|Progression/Relapse|8|||
126537411|NCT00939484|455259393|FG001|Overall Study|Progression/Relapse|20|||
126537412|NCT00939484|455259394|FG002|Overall Study|Progression/Relapse|3|||
126537413|NCT01224925|455259397|FG000|Overall Study|Lost to Follow-up|3|||
126537414|NCT01224925|455259398|FG001|Overall Study|Lost to Follow-up|2|||
126537415|NCT01203930|455259399|FG000|Overall Study|Disease Progression|0|||
126537416|NCT01203930|455259400|FG001|Overall Study|Disease Progression|4|||
126537417|NCT01203930|455259399|FG000|Overall Study|Death|3|||
126537418|NCT01203930|455259400|FG001|Overall Study|Death|1|||
126537419|NCT01203930|455259399|FG000|Overall Study|Withdrew Consent|1|||
126537420|NCT01203930|455259400|FG001|Overall Study|Withdrew Consent|10|||
126537421|NCT01203930|455259399|FG000|Overall Study|Investigator Request|0|||
126537422|NCT01203930|455259400|FG001|Overall Study|Investigator Request|8|||
126537423|NCT01203930|455259399|FG000|Overall Study|Study Terminated by Sponsor|0|||
126537424|NCT01203930|455259400|FG001|Overall Study|Study Terminated by Sponsor|12|||
126537425|NCT01203930|455259399|FG000|Overall Study|Poor tolerance of study drug|0|||
126537426|NCT01203930|455259400|FG001|Overall Study|Poor tolerance of study drug|1|||
126537427|NCT01203930|455259399|FG000|Overall Study|Adverse Event|17|||
126537428|NCT01203930|455259400|FG001|Overall Study|Adverse Event|5|||
126537429|NCT02178059|455259401|FG000|Washout|Physician Decision|1|||
126537430|NCT02178059|455259402|FG001|Washout|Physician Decision|0|||
126537431|NCT05178121|455259403|FG000|Overall Study|Other|4|||
126537432|NCT05178121|455259403|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
126537433|NCT00245102|455259404|FG000|Overall Study|Not Treated|1|||
126537434|NCT00245102|455259405|FG001|Overall Study|Not Treated|0|||
126537435|NCT00245102|455259406|FG002|Overall Study|Not Treated|1|||
126537436|NCT00245102|455259407|FG003|Overall Study|Not Treated|0|||
126537437|NCT00245102|455259408|FG004|Overall Study|Not Treated|0|||
126537438|NCT00245102|455259409|FG005|Overall Study|Not Treated|0|||
126537439|NCT00245102|455259404|FG000|Overall Study|Protocol Violation|1|||
126537440|NCT00245102|455259405|FG001|Overall Study|Protocol Violation|0|||
126537441|NCT00245102|455259406|FG002|Overall Study|Protocol Violation|0|||
126537442|NCT00245102|455259407|FG003|Overall Study|Protocol Violation|0|||
126537443|NCT00245102|455259408|FG004|Overall Study|Protocol Violation|0|||
126537444|NCT00245102|455259409|FG005|Overall Study|Protocol Violation|0|||
126537445|NCT00245102|455259404|FG000|Overall Study|Death|0|||
126537446|NCT00245102|455259405|FG001|Overall Study|Death|0|||
126537447|NCT00245102|455259406|FG002|Overall Study|Death|0|||
126537448|NCT00245102|455259407|FG003|Overall Study|Death|1|||
126537449|NCT00245102|455259408|FG004|Overall Study|Death|0|||
126537450|NCT00245102|455259409|FG005|Overall Study|Death|0|||
126537451|NCT00245102|455259404|FG000|Overall Study|Adverse Event|4|||
126537452|NCT00245102|455259405|FG001|Overall Study|Adverse Event|2|||
126537453|NCT00245102|455259406|FG002|Overall Study|Adverse Event|5|||
126537454|NCT00245102|455259407|FG003|Overall Study|Adverse Event|1|||
126537455|NCT00245102|455259408|FG004|Overall Study|Adverse Event|0|||
126537456|NCT00245102|455259409|FG005|Overall Study|Adverse Event|2|||
126537457|NCT00245102|455259404|FG000|Overall Study|Decline in performance|0|||
126537458|NCT00245102|455259405|FG001|Overall Study|Decline in performance|2|||
126537459|NCT00245102|455259406|FG002|Overall Study|Decline in performance|0|||
126537460|NCT00245102|455259407|FG003|Overall Study|Decline in performance|1|||
126537461|NCT00245102|455259408|FG004|Overall Study|Decline in performance|0|||
126537462|NCT00245102|455259409|FG005|Overall Study|Decline in performance|2|||
126537463|NCT00245102|455259404|FG000|Overall Study|Participant needed surgery|0|||
126537464|NCT00245102|455259405|FG001|Overall Study|Participant needed surgery|0|||
126537465|NCT00245102|455259406|FG002|Overall Study|Participant needed surgery|1|||
126537466|NCT00245102|455259407|FG003|Overall Study|Participant needed surgery|0|||
126537467|NCT00245102|455259408|FG004|Overall Study|Participant needed surgery|0|||
126537468|NCT00245102|455259409|FG005|Overall Study|Participant needed surgery|0|||
126537469|NCT00245102|455259404|FG000|Overall Study|Clinical progression|1|||
126537470|NCT00245102|455259405|FG001|Overall Study|Clinical progression|0|||
126537471|NCT00245102|455259406|FG002|Overall Study|Clinical progression|0|||
126537472|NCT00245102|455259407|FG003|Overall Study|Clinical progression|0|||
126537473|NCT00245102|455259408|FG004|Overall Study|Clinical progression|0|||
126537474|NCT00245102|455259409|FG005|Overall Study|Clinical progression|0|||
126537475|NCT04098406|455259415|FG000|Overall Study|Adverse Event|2|||
126537476|NCT04098406|455259416|FG001|Overall Study|Adverse Event|1|||
126537477|NCT04098406|455259415|FG000|Overall Study|Withdrawal by Subject|1|||
126314266|NCT00614120|454440834|FG002|Overall Study|hCG positive (not pregnant)|1|||
126314267|NCT00614120|454440835|FG003|Overall Study|hCG positive (not pregnant)|0|||
126537478|NCT04098406|455259416|FG001|Overall Study|Withdrawal by Subject|0|||
126537479|NCT01783418|455259417|FG000|Overall Study|Withdrawal by Subject|1|||
126537480|NCT01783418|455259418|FG001|Overall Study|Withdrawal by Subject|0|||
126537481|NCT04791761|455259419|FG000|Overall Study|Lost to Follow-up|8|||
126537482|NCT04791761|455259420|FG001|Overall Study|Lost to Follow-up|6|||
126537483|NCT04791761|455259421|FG002|Overall Study|Lost to Follow-up|10|||
126537484|NCT04791761|455259419|FG000|Overall Study|Withdrawal by Subject|0|||
126537485|NCT04791761|455259420|FG001|Overall Study|Withdrawal by Subject|1|||
126537486|NCT04791761|455259421|FG002|Overall Study|Withdrawal by Subject|1|||
126537487|NCT04791761|455259419|FG000|Overall Study|Protocol Violation|0|||
126537488|NCT04791761|455259420|FG001|Overall Study|Protocol Violation|1|||
126537489|NCT04791761|455259421|FG002|Overall Study|Protocol Violation|1|||
126537490|NCT03548207|455259422|FG000|Overall Study|Death|10|||
126537491|NCT03548207|455259423|FG001|Overall Study|Death|23|||
126537492|NCT03548207|455259424|FG002|Overall Study|Death|3|||
126537493|NCT03548207|455259422|FG000|Overall Study|Lost to Follow-up|0|||
126537494|NCT03548207|455259423|FG001|Overall Study|Lost to Follow-up|2|||
126537495|NCT03548207|455259424|FG002|Overall Study|Lost to Follow-up|0|||
126314268|NCT00614120|454440832|FG000|Overall Study|Hypoglycaemia|0|||
126314269|NCT00614120|454440833|FG001|Overall Study|Hypoglycaemia|0|||
126314270|NCT00614120|454440834|FG002|Overall Study|Hypoglycaemia|0|||
126314271|NCT00614120|454440835|FG003|Overall Study|Hypoglycaemia|1|||
126314272|NCT00614120|454440832|FG000|Overall Study|Lack of trial product|3|||
126314273|NCT00614120|454440833|FG001|Overall Study|Lack of trial product|3|||
126314274|NCT00614120|454440834|FG002|Overall Study|Lack of trial product|2|||
126314275|NCT00614120|454440835|FG003|Overall Study|Lack of trial product|0|||
126314276|NCT00614120|454440832|FG000|Overall Study|Late syphilis, latent|1|||
126314277|NCT00614120|454440833|FG001|Overall Study|Late syphilis, latent|0|||
126314278|NCT00614120|454440834|FG002|Overall Study|Late syphilis, latent|0|||
126314279|NCT00614120|454440835|FG003|Overall Study|Late syphilis, latent|0|||
126314280|NCT00614120|454440832|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
126314281|NCT00614120|454440833|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
126314282|NCT00614120|454440834|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
126314283|NCT00614120|454440835|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
126314284|NCT00614120|454440832|FG000|Overall Study|Lost to Follow-up|1|||
126314285|NCT00614120|454440833|FG001|Overall Study|Lost to Follow-up|2|||
126314286|NCT00614120|454440834|FG002|Overall Study|Lost to Follow-up|3|||
126314287|NCT00614120|454440835|FG003|Overall Study|Lost to Follow-up|4|||
126314288|NCT03047720|454440836|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
126314289|NCT03047720|454440837|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
126314290|NCT03602391|454440844|FG000|Overall Study|COVID-19|7|||
126314291|NCT03602391|454440845|FG001|Overall Study|COVID-19|6|||
126314292|NCT03729570|454440852|FG000|Overall Study|Lost to Follow-up|16|||
126314293|NCT03729570|454440853|FG001|Overall Study|Lost to Follow-up|20|||
126314294|NCT03729570|454440852|FG000|Overall Study|Seroconversion|5|||
126314295|NCT03729570|454440853|FG001|Overall Study|Seroconversion|0|||
126314296|NCT03729570|454440852|FG000|Overall Study|Moved out of the city|1|||
126314297|NCT03729570|454440853|FG001|Overall Study|Moved out of the city|0|||
126314298|NCT03729570|454440852|FG000|Overall Study|Time Conflict|1|||
126314299|NCT03729570|454440853|FG001|Overall Study|Time Conflict|0|||
126314300|NCT03729570|454440852|FG000|Overall Study|Time Commitment|2|||
126314301|NCT03729570|454440853|FG001|Overall Study|Time Commitment|0|||
126314302|NCT03729570|454440852|FG000|Overall Study|Bad Experience|0|||
126314303|NCT03729570|454440853|FG001|Overall Study|Bad Experience|1|||
126314304|NCT03729570|454440852|FG000|Overall Study|No reason provided|2|||
126314305|NCT03729570|454440853|FG001|Overall Study|No reason provided|1|||
126314306|NCT03729570|454440852|FG000|Overall Study|Family Conflict|0|||
126314307|NCT03729570|454440853|FG001|Overall Study|Family Conflict|1|||
126314308|NCT03729570|454440852|FG000|Overall Study|Did not want to continue taking medications|0|||
126314309|NCT03729570|454440853|FG001|Overall Study|Did not want to continue taking medications|1|||
126314310|NCT03729570|454440852|FG000|Overall Study|Found another PrEP provider|1|||
126314311|NCT03729570|454440853|FG001|Overall Study|Found another PrEP provider|0|||
126314312|NCT03729570|454440852|FG000|Overall Study|Did not enjoy being in the control group|0|||
126314313|NCT03729570|454440853|FG001|Overall Study|Did not enjoy being in the control group|1|||
126314314|NCT04495816|454440857|FG000|Overall Study|Lost to Follow-up|10|||
126314315|NCT04495816|454440858|FG001|Overall Study|Lost to Follow-up|4|||
126314316|NCT04495816|454440857|FG000|Overall Study|Withdrawal by Subject|3|||
126314317|NCT04495816|454440858|FG001|Overall Study|Withdrawal by Subject|5|||
126314318|NCT00558896|454440859|FG000|Overall Study|Adverse Event|1|||
126314319|NCT00558896|454440860|FG001|Overall Study|Adverse Event|1|||
126314320|NCT00558896|454440861|FG002|Overall Study|Adverse Event|1|||
126314321|NCT00558896|454440862|FG003|Overall Study|Adverse Event|3|||
126314322|NCT00558896|454440863|FG004|Overall Study|Adverse Event|4|||
126314323|NCT00558896|454440864|FG005|Overall Study|Adverse Event|10|||
126314324|NCT00558896|454440865|FG006|Overall Study|Adverse Event|3|||
126314325|NCT00558896|454440859|FG000|Overall Study|Death|3|||
126314326|NCT00558896|454440860|FG001|Overall Study|Death|0|||
126314327|NCT00558896|454440861|FG002|Overall Study|Death|2|||
126314328|NCT00558896|454440862|FG003|Overall Study|Death|3|||
126314329|NCT00558896|454440863|FG004|Overall Study|Death|2|||
126314330|NCT00558896|454440864|FG005|Overall Study|Death|2|||
126314331|NCT00558896|454440865|FG006|Overall Study|Death|6|||
126314332|NCT00558896|454440859|FG000|Overall Study|Withdrawal by Subject|2|||
126314333|NCT00558896|454440860|FG001|Overall Study|Withdrawal by Subject|1|||
126314334|NCT00558896|454440861|FG002|Overall Study|Withdrawal by Subject|1|||
126314335|NCT00558896|454440862|FG003|Overall Study|Withdrawal by Subject|1|||
126314336|NCT00558896|454440863|FG004|Overall Study|Withdrawal by Subject|1|||
126314337|NCT00558896|454440864|FG005|Overall Study|Withdrawal by Subject|5|||
126314338|NCT00558896|454440865|FG006|Overall Study|Withdrawal by Subject|5|||
126314339|NCT00558896|454440859|FG000|Overall Study|Alternative Treatment|2|||
126314340|NCT00558896|454440860|FG001|Overall Study|Alternative Treatment|2|||
126314341|NCT00558896|454440861|FG002|Overall Study|Alternative Treatment|0|||
126314342|NCT00558896|454440862|FG003|Overall Study|Alternative Treatment|2|||
126314343|NCT00558896|454440863|FG004|Overall Study|Alternative Treatment|6|||
126314344|NCT00558896|454440864|FG005|Overall Study|Alternative Treatment|7|||
126537496|NCT03548207|455259422|FG000|Overall Study|Withdrawal by Subject|0|||
126537497|NCT03548207|455259423|FG001|Overall Study|Withdrawal by Subject|3|||
126537498|NCT03548207|455259424|FG002|Overall Study|Withdrawal by Subject|0|||
126537499|NCT03548207|455259422|FG000|Overall Study|Sponsor decision|19|||
126537500|NCT03548207|455259423|FG001|Overall Study|Sponsor decision|40|||
126537501|NCT03548207|455259424|FG002|Overall Study|Sponsor decision|6|||
126537502|NCT03548207|455259422|FG000|Overall Study|Randomized but not treated|6|||
126537503|NCT03548207|455259423|FG001|Overall Study|Randomized but not treated|10|||
126537504|NCT03548207|455259424|FG002|Overall Study|Randomized but not treated|4|||
126537505|NCT01756352|455259425|FG000|Overall Study|moved away and lost to followup|1|||
126537506|NCT00415610|455259426|FG000|Overall Study|Death|3|||
126537507|NCT00415610|455259427|FG001|Overall Study|Death|2|||
126537508|NCT00415610|455259428|FG002|Overall Study|Death|5|||
126537509|NCT00999466|455259431|FG000|Main Part|Withdrawal by Subject|0|||
126537510|NCT00999466|455259432|FG001|Main Part|Withdrawal by Subject|0|||
126537511|NCT00999466|455259433|FG002|Main Part|Withdrawal by Subject|2|||
126537512|NCT00999466|455259431|FG000|Main Part|Adverse Event|0|||
126537513|NCT00999466|455259432|FG001|Main Part|Adverse Event|4|||
126537514|NCT00999466|455259433|FG002|Main Part|Adverse Event|2|||
126537515|NCT03040713|455259434|FG000|Overall Study|Positive amyloid scan|3|||
126537516|NCT04539821|455259435|FG000|Overall Study|Withdrawal by Subject|2|||
126537517|NCT04539821|455259435|FG000|Overall Study|continued care with their physician|20|||
126537518|NCT04539821|455259435|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
126537519|NCT02641392|455259436|FG000|Overall Study|Lost to Follow-up|0|||
126537520|NCT02641392|455259437|FG001|Overall Study|Lost to Follow-up|0|||
126537521|NCT02641392|455259438|FG002|Overall Study|Lost to Follow-up|2|||
126537522|NCT02641392|455259436|FG000|Overall Study|Withdrawal by Subject|0|||
126537523|NCT02641392|455259437|FG001|Overall Study|Withdrawal by Subject|0|||
126537524|NCT02641392|455259438|FG002|Overall Study|Withdrawal by Subject|17|||
126537525|NCT02641392|455259436|FG000|Overall Study|Adverse Event|0|||
126537526|NCT02641392|455259437|FG001|Overall Study|Adverse Event|1|||
126537527|NCT02641392|455259438|FG002|Overall Study|Adverse Event|25|||
126537528|NCT02641392|455259436|FG000|Overall Study|Study Terminated by Sponsor|4|||
126537529|NCT02641392|455259437|FG001|Overall Study|Study Terminated by Sponsor|12|||
126537530|NCT02641392|455259438|FG002|Overall Study|Study Terminated by Sponsor|144|||
126537531|NCT02641392|455259436|FG000|Overall Study|Lack of Efficacy|0|||
126537532|NCT02641392|455259437|FG001|Overall Study|Lack of Efficacy|0|||
126537533|NCT02641392|455259438|FG002|Overall Study|Lack of Efficacy|101|||
126537534|NCT02641392|455259436|FG000|Overall Study|Miscellaneous|0|||
126537535|NCT02641392|455259437|FG001|Overall Study|Miscellaneous|0|||
126537536|NCT02641392|455259438|FG002|Overall Study|Miscellaneous|3|||
126537537|NCT02641392|455259436|FG000|Overall Study|Death|0|||
126537538|NCT02641392|455259437|FG001|Overall Study|Death|0|||
126537539|NCT02641392|455259438|FG002|Overall Study|Death|1|||
126537540|NCT02691182|455259439|FG000|Overall Study|Withdrawal by Subject|4|||
126537541|NCT02691182|455259440|FG001|Overall Study|Withdrawal by Subject|7|||
126537542|NCT02691182|455259441|FG002|Overall Study|Withdrawal by Subject|6|||
126537543|NCT02691182|455259442|FG003|Overall Study|Withdrawal by Subject|8|||
126537544|NCT02691182|455259439|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
126537545|NCT02691182|455259440|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
126537546|NCT02691182|455259441|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
126537547|NCT02691182|455259442|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
126537548|NCT02691182|455259439|FG000|Overall Study|Lost to Follow-up|8|||
126537549|NCT02691182|455259440|FG001|Overall Study|Lost to Follow-up|33|||
126537550|NCT02691182|455259441|FG002|Overall Study|Lost to Follow-up|19|||
126537551|NCT02691182|455259442|FG003|Overall Study|Lost to Follow-up|22|||
126537552|NCT02691182|455259439|FG000|Overall Study|Adverse Event|3|||
126537553|NCT02691182|455259440|FG001|Overall Study|Adverse Event|10|||
126537554|NCT02691182|455259441|FG002|Overall Study|Adverse Event|10|||
126537555|NCT02691182|455259442|FG003|Overall Study|Adverse Event|11|||
126537556|NCT02691182|455259439|FG000|Overall Study|Physician Decision|3|||
126537557|NCT02691182|455259440|FG001|Overall Study|Physician Decision|7|||
126537558|NCT02691182|455259441|FG002|Overall Study|Physician Decision|14|||
126537559|NCT02691182|455259442|FG003|Overall Study|Physician Decision|8|||
126537560|NCT02691182|455259439|FG000|Overall Study|Lack of Efficacy|0|||
126537561|NCT02691182|455259440|FG001|Overall Study|Lack of Efficacy|0|||
126537562|NCT02691182|455259441|FG002|Overall Study|Lack of Efficacy|0|||
126537563|NCT02691182|455259442|FG003|Overall Study|Lack of Efficacy|4|||
126537564|NCT02691182|455259439|FG000|Overall Study|Protocol Violation|2|||
126537565|NCT02691182|455259440|FG001|Overall Study|Protocol Violation|6|||
126537566|NCT02691182|455259441|FG002|Overall Study|Protocol Violation|6|||
126537567|NCT02691182|455259442|FG003|Overall Study|Protocol Violation|8|||
126537568|NCT02691182|455259439|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
126537569|NCT02691182|455259440|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
126537570|NCT02691182|455259441|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
126537571|NCT02691182|455259442|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
126537572|NCT02691182|455259439|FG000|Overall Study|Missing|0|||
126537573|NCT02691182|455259440|FG001|Overall Study|Missing|5|||
126537574|NCT02691182|455259441|FG002|Overall Study|Missing|1|||
126537575|NCT02691182|455259442|FG003|Overall Study|Missing|5|||
126537576|NCT02563002|455259443|FG000|Overall Study|Death|72|||
126537577|NCT02563002|455259444|FG001|Overall Study|Death|87|||
126537578|NCT02563002|455259443|FG000|Overall Study|Lost to Follow-up|5|||
126537579|NCT02563002|455259444|FG001|Overall Study|Lost to Follow-up|0|||
126537580|NCT02563002|455259443|FG000|Overall Study|Physician Decision|0|||
126537581|NCT02563002|455259444|FG001|Overall Study|Physician Decision|2|||
126537582|NCT02563002|455259443|FG000|Overall Study|Withdrawal by Subject|2|||
126537583|NCT02563002|455259444|FG001|Overall Study|Withdrawal by Subject|10|||
126537584|NCT02563002|455259443|FG000|Overall Study|Sponsor decision|74|||
126537585|NCT02563002|455259444|FG001|Overall Study|Sponsor decision|55|||
126537586|NCT02054806|455259446|FG000|Overall Study|Sponsor Decision|31|||
126537587|NCT02054806|455259446|FG000|Overall Study|Withdrawal by Subject|43|||
126537588|NCT02054806|455259446|FG000|Overall Study|Protocol Violation|2|||
126537589|NCT02054806|455259446|FG000|Overall Study|Lost to Follow-up|10|||
126537590|NCT02054806|455259446|FG000|Overall Study|Death|391|||
126537591|NCT01113502|455259449|FG000|Overall Study|Withdrawal by Subject|1|||
126537592|NCT01113502|455259450|FG001|Overall Study|Withdrawal by Subject|0|||
126537593|NCT01113502|455259451|FG002|Overall Study|Withdrawal by Subject|1|||
126537594|NCT01113502|455259452|FG003|Overall Study|Withdrawal by Subject|1|||
126537595|NCT01113502|455259453|FG004|Overall Study|Withdrawal by Subject|0|||
126537596|NCT01113502|455259449|FG000|Overall Study|Adverse Event|0|||
126537597|NCT01113502|455259450|FG001|Overall Study|Adverse Event|0|||
126537598|NCT01113502|455259451|FG002|Overall Study|Adverse Event|3|||
126537599|NCT01113502|455259452|FG003|Overall Study|Adverse Event|2|||
126537600|NCT01113502|455259453|FG004|Overall Study|Adverse Event|0|||
126537601|NCT03002610|455259462|FG000|Overall Study|Withdrawal by Subject|6|||
126537602|NCT03002610|455259463|FG001|Overall Study|Withdrawal by Subject|25|||
126537603|NCT03002610|455259464|FG002|Overall Study|Withdrawal by Subject|13|||
126537604|NCT00645164|455259467|FG000|Overall Study|Lost to Follow-up|2|||
126537605|NCT00645164|455259467|FG000|Overall Study|Withdrawal by Subject|4|||
126537606|NCT00645164|455259467|FG000|Overall Study|Protocol Violation|1|||
126537607|NCT03641313|455259468|FG000|Overall Study|Death|1|||
126537608|NCT03641313|455259468|FG000|Overall Study|Withdrawal by Subject|2|||
126537609|NCT03641313|455259468|FG000|Overall Study|Declining health|1|||
126537610|NCT03641313|455259468|FG000|Overall Study|Adverse Event|1|||
126537611|NCT04642898|455259469|FG000|Overall Study|Withdrawal by Subject|2|||
126537612|NCT04642898|455259470|FG001|Overall Study|Withdrawal by Subject|4|||
126537613|NCT04642898|455259471|FG002|Overall Study|Withdrawal by Subject|4|||
126537614|NCT04642898|455259472|FG003|Overall Study|Withdrawal by Subject|6|||
126537615|NCT04642898|455259473|FG004|Overall Study|Withdrawal by Subject|2|||
126537616|NCT04642898|455259474|FG005|Overall Study|Withdrawal by Subject|6|||
126537617|NCT04642898|455259469|FG000|Overall Study|Lost to Follow-up|0|||
126537618|NCT04642898|455259470|FG001|Overall Study|Lost to Follow-up|0|||
126537619|NCT04642898|455259471|FG002|Overall Study|Lost to Follow-up|0|||
126537620|NCT04642898|455259472|FG003|Overall Study|Lost to Follow-up|2|||
126537621|NCT04642898|455259473|FG004|Overall Study|Lost to Follow-up|0|||
126537622|NCT04642898|455259474|FG005|Overall Study|Lost to Follow-up|1|||
126537623|NCT04642898|455259469|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
126537624|NCT04642898|455259470|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
126537625|NCT04642898|455259471|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
126537626|NCT04642898|455259472|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
126537627|NCT04642898|455259473|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
126537628|NCT04642898|455259474|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
126537629|NCT04642898|455259469|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
126537630|NCT04642898|455259470|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
126537631|NCT04642898|455259471|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
126537632|NCT04642898|455259472|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
126537633|NCT04642898|455259473|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
126537634|NCT04642898|455259474|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
126537635|NCT03574597|455259475|FG000|Overall Study|Withdrawal by Subject|67|||
126537636|NCT03574597|455259476|FG001|Overall Study|Withdrawal by Subject|96|||
126537637|NCT03574597|455259475|FG000|Overall Study|Lost to Follow-up|192|||
126537638|NCT03574597|455259476|FG001|Overall Study|Lost to Follow-up|188|||
126537639|NCT03434678|455259477|FG000|Overall Study|Withdrawal by Subject|13|||
126537640|NCT03434678|455259478|FG001|Overall Study|Withdrawal by Subject|13|||
126537641|NCT03434678|455259477|FG000|Overall Study|Found to be ineligible post randomization|2|||
126537642|NCT03434678|455259478|FG001|Overall Study|Found to be ineligible post randomization|1|||
126537643|NCT06060457|455259481|FG000|Overall Study|Adverse Event|1|||
126537644|NCT06060457|455259482|FG001|Overall Study|Adverse Event|1|||
126537645|NCT06060457|455259481|FG000|Overall Study|Death|2|||
126537646|NCT06060457|455259482|FG001|Overall Study|Death|2|||
126314345|NCT00558896|454440865|FG006|Overall Study|Alternative Treatment|1|||
126314346|NCT00558896|454440859|FG000|Overall Study|Physician discretion|3|||
126314347|NCT00558896|454440860|FG001|Overall Study|Physician discretion|2|||
126314348|NCT00558896|454440861|FG002|Overall Study|Physician discretion|1|||
126314349|NCT00558896|454440862|FG003|Overall Study|Physician discretion|2|||
126314350|NCT00558896|454440863|FG004|Overall Study|Physician discretion|1|||
126314351|NCT00558896|454440864|FG005|Overall Study|Physician discretion|3|||
126314352|NCT00558896|454440865|FG006|Overall Study|Physician discretion|3|||
126314353|NCT00558896|454440859|FG000|Overall Study|Continues on treatment|10|||
126314354|NCT00558896|454440860|FG001|Overall Study|Continues on treatment|1|||
126314355|NCT00558896|454440861|FG002|Overall Study|Continues on treatment|0|||
126314356|NCT00558896|454440862|FG003|Overall Study|Continues on treatment|1|||
126314357|NCT00558896|454440863|FG004|Overall Study|Continues on treatment|9|||
126314358|NCT00558896|454440864|FG005|Overall Study|Continues on treatment|25|||
126314359|NCT00558896|454440865|FG006|Overall Study|Continues on treatment|6|||
126314360|NCT04329091|454440866|FG000|Overall Study|Physician Decision|5|||
126314361|NCT02484651|454440869|FG000|Overall Study|Patients' data files were corrupted.|1|||
126314362|NCT02484651|454440870|FG001|Overall Study|Patients' data files were corrupted.|1|||
126314363|NCT02484651|454440869|FG000|Overall Study|BIS monitoring failed.|1|||
126314364|NCT02484651|454440870|FG001|Overall Study|BIS monitoring failed.|1|||
126314365|NCT02484651|454440869|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
126314366|NCT02484651|454440870|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
126314367|NCT00150800|454440871|FG000|Overall Study|Adverse Event|89|||
126314368|NCT00150800|454440871|FG000|Overall Study|Death|18|||
126314369|NCT00150800|454440871|FG000|Overall Study|Lack of Efficacy|166|||
126314370|NCT00150800|454440871|FG000|Overall Study|Lost to Follow-up|58|||
126314371|NCT00150800|454440871|FG000|Overall Study|Subject's choice|90|||
126314372|NCT00150800|454440871|FG000|Overall Study|No compliance|18|||
126314373|NCT00150800|454440871|FG000|Overall Study|IP misshandling|1|||
126314374|NCT00150800|454440871|FG000|Overall Study|Site closure|24|||
126314375|NCT00150800|454440871|FG000|Overall Study|Protocol non-adherence|2|||
126314376|NCT00150800|454440871|FG000|Overall Study|Nobody to accompany patient|1|||
126314377|NCT00150800|454440871|FG000|Overall Study|Distance too long for patient|1|||
126314378|NCT00150800|454440871|FG000|Overall Study|Neurosurgery|2|||
126314379|NCT00150800|454440871|FG000|Overall Study|BRV monotherapy|1|||
126314380|NCT00150800|454440871|FG000|Overall Study|Visit refusal|3|||
126314381|NCT00150800|454440871|FG000|Overall Study|Sponsor's request|2|||
126314382|NCT00150800|454440871|FG000|Overall Study|Generalized Epilepsy|1|||
126314383|NCT00150800|454440871|FG000|Overall Study|Moved from area/country|8|||
126314384|NCT00150800|454440871|FG000|Overall Study|PI retiring|2|||
126314385|NCT00150800|454440871|FG000|Overall Study|PI leaving site|2|||
126314386|NCT00150800|454440871|FG000|Overall Study|Patient insurance|1|||
126314387|NCT00150800|454440871|FG000|Overall Study|Surgical intervention|4|||
126314388|NCT00150800|454440871|FG000|Overall Study|Pregnancy planned|1|||
126314389|NCT00150800|454440871|FG000|Overall Study|PI discontinuation request|1|||
126314390|NCT01790828|454440872|FG000|Overall Study|Other|34|||
126314391|NCT03026530|454440877|FG000|Overall Study|Lost to Follow-up|19|||
126314392|NCT03026530|454440878|FG001|Overall Study|Lost to Follow-up|24|||
126314393|NCT03026530|454440877|FG000|Overall Study|Protocol Violation|2|||
126314394|NCT03026530|454440878|FG001|Overall Study|Protocol Violation|5|||
126314395|NCT03721835|454440879|FG000|Overall Study|Participant not able to return|1|||
126314396|NCT03721835|454440879|FG000|Overall Study|Lost to Follow-up|1|||
126314397|NCT03721835|454440879|FG000|Overall Study|Revision of the components of the study device|2|||
126314398|NCT03721835|454440879|FG000|Overall Study|Sponsor terminated study|6|||
126314399|NCT03721835|454440879|FG000|Overall Study|Death|1|||
126314400|NCT03721835|454440879|FG000|Overall Study|Sponsor decision|1|||
126314401|NCT05072964|454440884|FG000|Overall Study|Withdrawal by Subject|4|||
126314402|NCT05072964|454440884|FG000|Overall Study|Death|1|||
126314403|NCT01390428|454442666|FG000|Overall Study|Elective Surgery|0|||
126314404|NCT01390428|454442667|FG001|Overall Study|Elective Surgery|0|||
126314405|NCT01390428|454442668|FG002|Overall Study|Elective Surgery|0|||
126314406|NCT01390428|454442669|FG003|Overall Study|Elective Surgery|0|||
126314407|NCT01390428|454442670|FG004|Overall Study|Elective Surgery|1|||
126314408|NCT01390428|454442671|FG005|Overall Study|Elective Surgery|0|||
126314409|NCT01390428|454442666|FG000|Overall Study|Withdrawal by Subject|0|||
126314410|NCT01390428|454442667|FG001|Overall Study|Withdrawal by Subject|0|||
126314411|NCT01390428|454442668|FG002|Overall Study|Withdrawal by Subject|1|||
126314412|NCT01390428|454442669|FG003|Overall Study|Withdrawal by Subject|0|||
126314413|NCT01390428|454442670|FG004|Overall Study|Withdrawal by Subject|0|||
126314414|NCT01390428|454442671|FG005|Overall Study|Withdrawal by Subject|0|||
126314415|NCT04322539|454442680|FG000|Overall Study|Adverse Event|2|||
126314416|NCT04322539|454442681|FG001|Overall Study|Adverse Event|0|||
126314417|NCT04322539|454442680|FG000|Overall Study|Death|411|||
126314418|NCT04322539|454442681|FG001|Overall Study|Death|203|||
126314419|NCT04322539|454442680|FG000|Overall Study|Lost to Follow-up|3|||
126314420|NCT04322539|454442681|FG001|Overall Study|Lost to Follow-up|1|||
126314421|NCT04322539|454442680|FG000|Overall Study|Withdrawal of consent|14|||
126314422|NCT04322539|454442681|FG001|Overall Study|Withdrawal of consent|8|||
126537647|NCT06060457|455259481|FG000|Overall Study|Lost to Follow-up|17|||
126537648|NCT06060457|455259482|FG001|Overall Study|Lost to Follow-up|19|||
126537649|NCT06060457|455259481|FG000|Overall Study|Physician Decision|0|||
126537650|NCT06060457|455259482|FG001|Overall Study|Physician Decision|1|||
126537651|NCT06060457|455259481|FG000|Overall Study|Protocol Violation|1|||
126537652|NCT06060457|455259482|FG001|Overall Study|Protocol Violation|1|||
126537653|NCT06060457|455259481|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
126537654|NCT06060457|455259482|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
126537655|NCT06060457|455259481|FG000|Overall Study|Withdrawal by Subject|12|||
126537656|NCT06060457|455259482|FG001|Overall Study|Withdrawal by Subject|15|||
126537657|NCT06060457|455259481|FG000|Overall Study|Other Than Specified|2|||
126537658|NCT06060457|455259482|FG001|Overall Study|Other Than Specified|1|||
126537659|NCT02061202|455259483|FG000|Overall Study|Lost to Follow-up|1|||
126537660|NCT02061202|455259484|FG001|Overall Study|Lost to Follow-up|1|||
126537661|NCT01533493|455259485|FG000|Overall Study|Adverse Event|2|||
126537662|NCT01533493|455259486|FG001|Overall Study|Adverse Event|1|||
126537663|NCT01533493|455259485|FG000|Overall Study|Withdrawal by Subject|1|||
126537664|NCT01533493|455259486|FG001|Overall Study|Withdrawal by Subject|2|||
126537665|NCT01533493|455259485|FG000|Overall Study|Lost to Follow-up|2|||
126537666|NCT01533493|455259486|FG001|Overall Study|Lost to Follow-up|0|||
126537667|NCT03419364|455259487|FG000|Overall Study|Delivery due to maternal condition|2|||
126537668|NCT03419364|455259488|FG001|Overall Study|Delivery due to maternal condition|0|||
126537669|NCT03419364|455259489|FG002|Overall Study|Delivery due to maternal condition|0|||
126537670|NCT01338025|455259493|FG000|Overall Study|Unexpected closure of study|10|||
126537671|NCT01338025|455259494|FG001|Overall Study|Unexpected closure of study|9|||
126537672|NCT01338025|455259493|FG000|Overall Study|Withdrawal by Subject|0|||
126537673|NCT01338025|455259494|FG001|Overall Study|Withdrawal by Subject|2|||
126537674|NCT01338025|455259493|FG000|Overall Study|Found ineligible after starting|1|||
126537675|NCT01338025|455259494|FG001|Overall Study|Found ineligible after starting|0|||
126537676|NCT04120233|455259495|FG000|Overall Study|Adverse Event|0|||
126537677|NCT04120233|455259496|FG001|Overall Study|Adverse Event|0|||
126537678|NCT04120233|455259497|FG002|Overall Study|Adverse Event|0|||
126537679|NCT04120233|455259498|FG003|Overall Study|Adverse Event|0|||
126537680|NCT04120233|455259499|FG004|Overall Study|Adverse Event|1|||
126537681|NCT04120233|455259500|FG005|Overall Study|Adverse Event|0|||
126537682|NCT03779906|455259501|FG000|Overall Study|Lost to Follow-up|7|||
126537683|NCT03779906|455259501|FG000|Overall Study|COVID pandemic|1|||
126537684|NCT02553460|455259504|FG000|Overall Study|Death|3|||
126537685|NCT02553460|455259504|FG000|Overall Study|Withdrawal by Subject|1|||
126537686|NCT02553460|455259504|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
126537687|NCT02553460|455259504|FG000|Overall Study|Relapse or Transplant|14|||
126537688|NCT02553460|455259504|FG000|Overall Study|No response to treatment|2|||
126537689|NCT02553460|455259504|FG000|Overall Study|CAR T cells|2|||
126537690|NCT04814368|455259505|FG000|Overall Study|Study Terminated by Sponsor|0|||
126537691|NCT04814368|455259506|FG001|Overall Study|Study Terminated by Sponsor|3|||
126537692|NCT04814368|455259507|FG002|Overall Study|Study Terminated by Sponsor|0|||
126537693|NCT04814368|455259508|FG003|Overall Study|Study Terminated by Sponsor|2|||
126537694|NCT04814368|455259505|FG000|Overall Study|Subject Decision|1|||
126537695|NCT04814368|455259506|FG001|Overall Study|Subject Decision|2|||
126537696|NCT04814368|455259507|FG002|Overall Study|Subject Decision|0|||
126537697|NCT04814368|455259508|FG003|Overall Study|Subject Decision|0|||
126537698|NCT02035332|455260815|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
126537699|NCT00838682|455260816|FG000|Overall Study|Lost to Follow-up|21|||
126537700|NCT00838682|455260817|FG001|Overall Study|Lost to Follow-up|14|||
126537701|NCT00838682|455260816|FG000|Overall Study|detection of exclusion criteria|4|||
126537702|NCT00838682|455260817|FG001|Overall Study|detection of exclusion criteria|3|||
126537703|NCT00838682|455260816|FG000|Overall Study|Protocol Violation|0|||
126537704|NCT00838682|455260817|FG001|Overall Study|Protocol Violation|1|||
126537705|NCT00838682|455260816|FG000|Overall Study|Withdrawal by Subject|0|||
126537706|NCT00838682|455260817|FG001|Overall Study|Withdrawal by Subject|1|||
126537707|NCT03315143|455260819|FG000|Overall Study|Death|240|||
126537708|NCT03315143|455260820|FG001|Overall Study|Death|246|||
126537709|NCT03315143|455260819|FG000|Overall Study|Withdrawal by Subject|57|||
126537710|NCT03315143|455260820|FG001|Overall Study|Withdrawal by Subject|68|||
126537711|NCT03315143|455260819|FG000|Overall Study|Site Terminated by Sponsor|256|||
126537712|NCT03315143|455260820|FG001|Overall Study|Site Terminated by Sponsor|282|||
126537713|NCT03315143|455260819|FG000|Overall Study|Study Terminated by Sponsor|4723|||
126537714|NCT03315143|455260820|FG001|Overall Study|Study Terminated by Sponsor|4664|||
126537715|NCT03315143|455260819|FG000|Overall Study|Reason not Specified|16|||
126537716|NCT03315143|455260820|FG001|Overall Study|Reason not Specified|32|||
126537717|NCT00549757|455260821|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
126537718|NCT00549757|455260822|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
126537719|NCT00549757|455260821|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
126537720|NCT00549757|455260822|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
126537721|NCT00549757|455260821|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
126537722|NCT00549757|455260822|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
126537723|NCT00549757|455260821|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
126537724|NCT00549757|455260822|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
126537725|NCT00549757|455260821|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
126537726|NCT00549757|455260822|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
126537727|NCT00549757|455260821|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
126537728|NCT00549757|455260822|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
126537729|NCT00549757|455260821|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
126537730|NCT00549757|455260822|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
126537731|NCT00549757|455260821|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
126537732|NCT00549757|455260822|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
126537733|NCT00549757|455260821|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
126537734|NCT00549757|455260822|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
126537735|NCT00549757|455260821|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
126537736|NCT00549757|455260822|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
126537737|NCT00549757|455260821|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
126537738|NCT00549757|455260822|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
126537739|NCT00549757|455260821|FG000|Extension Period (in Average 9 Months)|Death|143|||
126537740|NCT00549757|455260822|FG001|Extension Period (in Average 9 Months)|Death|136|||
126537741|NCT00549757|455260821|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
126537742|NCT00549757|455260822|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
126537743|NCT00549757|455260821|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
126537744|NCT00549757|455260822|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
126537745|NCT00549757|455260821|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
126537746|NCT00549757|455260822|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
126537747|NCT02403180|455260827|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
126537748|NCT02403180|455260828|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
126537749|NCT02403180|455260827|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
126537750|NCT02403180|455260828|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
126537751|NCT02436811|455260832|FG000|Overall Study|Lost to Follow-up|2|||
126537752|NCT02436811|455260833|FG001|Overall Study|Lost to Follow-up|9|||
126537753|NCT02436811|455260834|FG002|Overall Study|Lost to Follow-up|7|||
126537754|NCT03595332|455260835|FG000|Overall Study|Lost to Follow-up|16|||
126537755|NCT03595332|455260836|FG001|Overall Study|Lost to Follow-up|22|||
126537756|NCT03595332|455260835|FG000|Overall Study|Unable to retrieve ID from school|0|||
126537757|NCT03595332|455260836|FG001|Overall Study|Unable to retrieve ID from school|2|||
126537758|NCT02227875|455260837|FG000|Overall Study|Protocol Violation|10|||
126537759|NCT02227875|455260838|FG001|Overall Study|Protocol Violation|7|||
126537760|NCT02227875|455260837|FG000|Overall Study|Other|1|||
126537761|NCT02227875|455260838|FG001|Overall Study|Other|3|||
126537762|NCT02227875|455260837|FG000|Overall Study|Physician Decision|1|||
126537763|NCT02227875|455260838|FG001|Overall Study|Physician Decision|0|||
126537764|NCT02227875|455260837|FG000|Overall Study|Adverse Event|3|||
126537765|NCT02227875|455260838|FG001|Overall Study|Adverse Event|0|||
126537766|NCT02227875|455260837|FG000|Overall Study|Withdrawal by Subject|12|||
126537767|NCT02227875|455260838|FG001|Overall Study|Withdrawal by Subject|13|||
126537768|NCT02227875|455260837|FG000|Overall Study|Lost to Follow-up|10|||
126537769|NCT02227875|455260838|FG001|Overall Study|Lost to Follow-up|10|||
126537770|NCT04209725|455260839|FG000|Overall Study|Adverse Event|1|||
126537771|NCT00117676|455260842|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
126537772|NCT00117676|455260843|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
126537773|NCT00117676|455260842|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
126537774|NCT00117676|455260843|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
126537775|NCT00117676|455260842|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
126537776|NCT00117676|455260843|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
126537777|NCT00117676|455260842|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
126537778|NCT00117676|455260843|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
126537779|NCT00117676|455260842|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
126537780|NCT00117676|455260843|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
126537781|NCT00117676|455260842|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
126537782|NCT00117676|455260843|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
126537783|NCT00117676|455260842|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
126537784|NCT00117676|455260843|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
126537785|NCT00117676|455260842|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
126537786|NCT00117676|455260843|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
126537787|NCT00117676|455260842|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
126537788|NCT00117676|455260843|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
126537789|NCT00117676|455260842|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
126537790|NCT00117676|455260843|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
126537791|NCT00117676|455260842|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
126537792|NCT00117676|455260843|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
126537793|NCT00117676|455260842|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
126537794|NCT00117676|455260843|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
126537795|NCT00117676|455260842|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
126537796|NCT00117676|455260843|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
126537797|NCT00117676|455260842|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
126537798|NCT00117676|455260843|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
126537799|NCT00117676|455260842|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
126537800|NCT00117676|455260843|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
126537801|NCT00117676|455260842|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
126537802|NCT00117676|455260843|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
126537803|NCT00117676|455260842|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
126537804|NCT00117676|455260843|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
126537805|NCT00117676|455260842|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
126537806|NCT00117676|455260843|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
126537807|NCT00117676|455260842|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
126537808|NCT00117676|455260843|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
126537809|NCT00117676|455260842|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
126537810|NCT00117676|455260843|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
126537811|NCT00117676|455260842|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
126537812|NCT00117676|455260843|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
126537813|NCT00117676|455260842|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
126537814|NCT00117676|455260843|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
126537815|NCT00117676|455260842|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
126537816|NCT00117676|455260843|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
126537817|NCT00117676|455260842|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
126537818|NCT00117676|455260843|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
126537819|NCT00117676|455260842|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
126537820|NCT00117676|455260843|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
126537821|NCT00117676|455260842|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
126537822|NCT00117676|455260843|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
126537823|NCT00117676|455260842|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
126537824|NCT00117676|455260843|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
126537825|NCT00117676|455260842|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
126537826|NCT00117676|455260843|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
126537827|NCT00117676|455260842|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
126537828|NCT00117676|455260843|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
126537829|NCT00117676|455260842|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
126537830|NCT00117676|455260843|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
126537831|NCT00117676|455260842|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
126537832|NCT00117676|455260843|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
126537833|NCT00117676|455260842|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
126537834|NCT00117676|455260843|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
126537835|NCT00117676|455260842|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
126537836|NCT00117676|455260843|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
126537837|NCT00117676|455260842|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
126537838|NCT00117676|455260843|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
126537839|NCT00117676|455260842|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
126314423|NCT04322539|454442680|FG000|Overall Study|Radiological Disease Progression|6|||
126537840|NCT00117676|455260843|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
126537841|NCT00952822|455260844|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
126537842|NCT00952822|455260845|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
126537843|NCT00952822|455260846|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
126537844|NCT00952822|455260847|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
126537845|NCT00952822|455260844|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
126537846|NCT00952822|455260845|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
126537847|NCT00952822|455260846|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
126537848|NCT00952822|455260847|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
126314424|NCT04322539|454442681|FG001|Overall Study|Radiological Disease Progression|0|||
126314425|NCT04322539|454442680|FG000|Overall Study|Sponsor Decision|19|||
126314426|NCT04322539|454442681|FG001|Overall Study|Sponsor Decision|14|||
126537849|NCT04555096|455260851|FG000|Overall Study|Death|4|||
126537850|NCT04555096|455260852|FG001|Overall Study|Death|4|||
126537851|NCT04555096|455260851|FG000|Overall Study|Withdrawal by Subject|1|||
126537852|NCT04555096|455260852|FG001|Overall Study|Withdrawal by Subject|0|||
126537853|NCT04555096|455260851|FG000|Overall Study|Other|0|||
126537854|NCT04555096|455260852|FG001|Overall Study|Other|1|||
126537855|NCT03033225|455260861|FG000|Overall Study|Withdrawal by Subject|5|||
126537856|NCT05163522|455260866|FG000|Overall Study|Withdrawal by Subject|0|||
126537857|NCT05163522|455260867|FG001|Overall Study|Withdrawal by Subject|0|||
126537858|NCT05163522|455260868|FG002|Overall Study|Withdrawal by Subject|1|||
126537859|NCT05163522|455260869|FG003|Overall Study|Withdrawal by Subject|0|||
126537860|NCT05163522|455260870|FG004|Overall Study|Withdrawal by Subject|0|||
126537861|NCT05163522|455260871|FG005|Overall Study|Withdrawal by Subject|0|||
126537862|NCT05163522|455260872|FG006|Overall Study|Withdrawal by Subject|0|||
126537863|NCT05163522|455260873|FG007|Overall Study|Withdrawal by Subject|0|||
126537864|NCT05163522|455260874|FG008|Overall Study|Withdrawal by Subject|0|||
126537865|NCT05163522|455260875|FG009|Overall Study|Withdrawal by Subject|0|||
126537866|NCT05163522|455260876|FG010|Overall Study|Withdrawal by Subject|0|||
126537867|NCT03412396|455260877|FG000|Overall Study|Withdrawal by Subject|2|||
126537868|NCT03412396|455260877|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
126537869|NCT03412396|455260877|FG000|Overall Study|Did not undergo RP|2|||
126537870|NCT02753595|455260888|FG000|Overall Study|Sponsor termination|2|||
126537871|NCT02753595|455260889|FG001|Overall Study|Sponsor termination|2|||
126537872|NCT01570868|455260890|FG000|Overall Study|Adverse Event|8|||
126537873|NCT01570868|455260891|FG001|Overall Study|Adverse Event|1|||
126537874|NCT01570868|455260890|FG000|Overall Study|FDA Recommendation|23|||
126537875|NCT01570868|455260891|FG001|Overall Study|FDA Recommendation|3|||
126537876|NCT01570868|455260890|FG000|Overall Study|Physician Decision|10|||
126537877|NCT01570868|455260891|FG001|Overall Study|Physician Decision|4|||
126537878|NCT01570868|455260890|FG000|Overall Study|Lost to Follow-up|1|||
126537879|NCT01570868|455260891|FG001|Overall Study|Lost to Follow-up|0|||
126537880|NCT01570868|455260890|FG000|Overall Study|Withdrawal by Subject|1|||
126537881|NCT01570868|455260891|FG001|Overall Study|Withdrawal by Subject|0|||
126537882|NCT02515279|455260897|FG000|Overall Study|Adverse Event|7|||
126537883|NCT02515279|455260897|FG000|Overall Study|Lack of Efficacy|31|||
126537884|NCT02515279|455260897|FG000|Overall Study|Lost to Follow-up|9|||
126537885|NCT02515279|455260897|FG000|Overall Study|Withdrawal by Subject|18|||
126537886|NCT02515279|455260897|FG000|Overall Study|End-of-treatment visit not attended|17|||
126537887|NCT02515279|455260897|FG000|Overall Study|Other|22|||
126537888|NCT01800968|455260898|FG000|Overall Study|Death|23|||
126537889|NCT01800968|455260899|FG001|Overall Study|Death|16|||
126537890|NCT01800968|455260898|FG000|Overall Study|Lost to Follow-up|5|||
126537891|NCT01800968|455260899|FG001|Overall Study|Lost to Follow-up|7|||
126537892|NCT01800968|455260898|FG000|Overall Study|Withdrawal by Subject|7|||
126537893|NCT01800968|455260899|FG001|Overall Study|Withdrawal by Subject|9|||
126537894|NCT01800968|455260898|FG000|Overall Study|Physician Decision|1|||
126537895|NCT01800968|455260899|FG001|Overall Study|Physician Decision|0|||
126537896|NCT03266770|455260904|FG000|Overall Study|Physician Decision|3|||
126537897|NCT03266770|455260904|FG000|Overall Study|Insufficient study supplies|1|||
126537898|NCT03266770|455260904|FG000|Overall Study|Adverse Event|1|||
126537899|NCT02657031|455260905|FG000|Overall Study|Adverse Event|1|||
126537900|NCT02657031|455260906|FG001|Overall Study|Adverse Event|2|||
126537901|NCT03078816|455260907|FG000|Overall Study|Withdrawal by Subject|1|||
126537902|NCT05007392|455260908|FG000|Overall Study|Randomized but not treated|1|||
126537903|NCT05007392|455260909|FG001|Overall Study|Randomized but not treated|2|||
126537904|NCT05007392|455260908|FG000|Overall Study|Other|5|||
126537905|NCT05007392|455260909|FG001|Overall Study|Other|4|||
126537906|NCT05007392|455260908|FG000|Overall Study|Lost to Follow-up|1|||
126537907|NCT05007392|455260909|FG001|Overall Study|Lost to Follow-up|2|||
126537908|NCT05007392|455260908|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
126537909|NCT05007392|455260909|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
126537910|NCT05007392|455260908|FG000|Overall Study|Use of prohibited concomitant drug|1|||
126537911|NCT05007392|455260909|FG001|Overall Study|Use of prohibited concomitant drug|1|||
126537912|NCT05007392|455260908|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
126537913|NCT05007392|455260909|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
126537914|NCT05007392|455260908|FG000|Overall Study|Adverse Event|10|||
126537915|NCT05007392|455260909|FG001|Overall Study|Adverse Event|6|||
126537916|NCT05007392|455260908|FG000|Overall Study|Participant choice|5|||
126537917|NCT05007392|455260909|FG001|Overall Study|Participant choice|10|||
126537918|NCT05007392|455260908|FG000|Overall Study|Withdrawal of consent|5|||
126537919|NCT05007392|455260909|FG001|Overall Study|Withdrawal of consent|4|||
126537920|NCT01218126|455260912|FG000|Overall Study|Adverse Event|8|||
126537921|NCT01218126|455260913|FG001|Overall Study|Adverse Event|10|||
126537922|NCT01218126|455260914|FG002|Overall Study|Adverse Event|12|||
126537923|NCT01218126|455260915|FG003|Overall Study|Adverse Event|16|||
126537924|NCT01218126|455260912|FG000|Overall Study|Lack of Efficacy|7|||
126537925|NCT01218126|455260913|FG001|Overall Study|Lack of Efficacy|2|||
126537926|NCT01218126|455260914|FG002|Overall Study|Lack of Efficacy|2|||
126537927|NCT01218126|455260915|FG003|Overall Study|Lack of Efficacy|6|||
126537928|NCT01218126|455260912|FG000|Overall Study|Protocol Violation|5|||
126537929|NCT01218126|455260913|FG001|Overall Study|Protocol Violation|2|||
126537930|NCT01218126|455260914|FG002|Overall Study|Protocol Violation|2|||
126537931|NCT01218126|455260915|FG003|Overall Study|Protocol Violation|3|||
126537932|NCT01218126|455260912|FG000|Overall Study|Protocol-defined stopping criteria|1|||
126537933|NCT01218126|455260913|FG001|Overall Study|Protocol-defined stopping criteria|1|||
126537934|NCT01218126|455260914|FG002|Overall Study|Protocol-defined stopping criteria|0|||
126537935|NCT01218126|455260915|FG003|Overall Study|Protocol-defined stopping criteria|0|||
126537936|NCT01218126|455260912|FG000|Overall Study|Lost to Follow-up|0|||
126537937|NCT01218126|455260913|FG001|Overall Study|Lost to Follow-up|0|||
126537938|NCT01218126|455260914|FG002|Overall Study|Lost to Follow-up|0|||
126537939|NCT01218126|455260915|FG003|Overall Study|Lost to Follow-up|2|||
126537940|NCT01218126|455260912|FG000|Overall Study|Physician Decision|1|||
126537941|NCT01218126|455260913|FG001|Overall Study|Physician Decision|2|||
126537942|NCT01218126|455260914|FG002|Overall Study|Physician Decision|4|||
126537943|NCT01218126|455260915|FG003|Overall Study|Physician Decision|2|||
126537944|NCT01218126|455260912|FG000|Overall Study|Withdrawal by Subject|2|||
126537945|NCT01218126|455260913|FG001|Overall Study|Withdrawal by Subject|5|||
126537946|NCT01218126|455260914|FG002|Overall Study|Withdrawal by Subject|4|||
126537947|NCT01218126|455260915|FG003|Overall Study|Withdrawal by Subject|6|||
126537948|NCT01860703|455260917|FG000|Overall Study|Adverse Event|1|||
126537949|NCT01860703|455260918|FG001|Overall Study|Adverse Event|4|||
126537950|NCT01860703|455260919|FG002|Overall Study|Adverse Event|0|||
126537951|NCT01860703|455260920|FG003|Overall Study|Adverse Event|2|||
126537952|NCT01860703|455260917|FG000|Overall Study|Withdrawal by Subject|0|||
126537953|NCT01860703|455260918|FG001|Overall Study|Withdrawal by Subject|1|||
126537954|NCT01860703|455260919|FG002|Overall Study|Withdrawal by Subject|0|||
126537955|NCT01860703|455260920|FG003|Overall Study|Withdrawal by Subject|0|||
126537956|NCT01860703|455260917|FG000|Overall Study|Personal reason|1|||
126537957|NCT01860703|455260918|FG001|Overall Study|Personal reason|0|||
126537958|NCT01860703|455260919|FG002|Overall Study|Personal reason|1|||
126537959|NCT01860703|455260920|FG003|Overall Study|Personal reason|0|||
126537960|NCT02453685|455260922|FG000|Overall Study|Adverse Event|0|||
126537961|NCT02453685|455260923|FG001|Overall Study|Adverse Event|1|||
126537962|NCT02453685|455260922|FG000|Overall Study|Protocol Violation|7|||
126537963|NCT02453685|455260923|FG001|Overall Study|Protocol Violation|4|||
126537964|NCT02453685|455260922|FG000|Overall Study|Lost to Follow-up|0|||
126537965|NCT02453685|455260923|FG001|Overall Study|Lost to Follow-up|1|||
126537966|NCT02453685|455260922|FG000|Overall Study|Withdrawal by Subject|8|||
126537967|NCT02453685|455260923|FG001|Overall Study|Withdrawal by Subject|4|||
126537968|NCT02453685|455260922|FG000|Overall Study|Unclassified|4|||
126537969|NCT02453685|455260923|FG001|Overall Study|Unclassified|2|||
126537970|NCT00453986|455260927|FG000|Overall Study|Lost to Follow-up|6|||
126537971|NCT00453986|455260928|FG001|Overall Study|Lost to Follow-up|5|||
126537972|NCT00453986|455260929|FG002|Overall Study|Lost to Follow-up|6|||
126537973|NCT00453986|455260930|FG003|Overall Study|Lost to Follow-up|2|||
126537974|NCT00453986|455260931|FG004|Overall Study|Lost to Follow-up|0|||
126537975|NCT02778100|455260934|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
126537976|NCT02778100|455260935|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
126537977|NCT00522626|455260938|FG000|Overall Study|Lost to Follow-up|7|||
126537978|NCT00552084|455260941|FG000|Overall Study|Adverse Event|2|||
126537979|NCT00552084|455260942|FG001|Overall Study|Adverse Event|3|||
126537980|NCT00552084|455260941|FG000|Overall Study|Withdrawal by Subject|4|||
126537981|NCT00552084|455260942|FG001|Overall Study|Withdrawal by Subject|5|||
126537982|NCT00552084|455260941|FG000|Overall Study|Protocol Violation|1|||
126537983|NCT00552084|455260942|FG001|Overall Study|Protocol Violation|0|||
126537984|NCT00552084|455260941|FG000|Overall Study|change in anti-arrythmic drug|1|||
126537985|NCT00552084|455260942|FG001|Overall Study|change in anti-arrythmic drug|1|||
126537986|NCT01953003|455262664|FG000|Overall Study|Not treated|0|||
126537987|NCT01953003|455262665|FG001|Overall Study|Not treated|1|||
126537988|NCT01953003|455262664|FG000|Overall Study|Progressive disease|35|||
126537989|NCT01953003|455262665|FG001|Overall Study|Progressive disease|45|||
126537990|NCT01953003|455262664|FG000|Overall Study|Related Adverse events|7|||
126537991|NCT01953003|455262665|FG001|Overall Study|Related Adverse events|2|||
126537992|NCT01953003|455262664|FG000|Overall Study|Non-related adverse events|0|||
126537993|NCT01953003|455262665|FG001|Overall Study|Non-related adverse events|2|||
126537994|NCT01953003|455262664|FG000|Overall Study|Protocol Violation|0|||
126537995|NCT01953003|455262665|FG001|Overall Study|Protocol Violation|1|||
126537996|NCT01953003|455262664|FG000|Overall Study|Withdrawal by Subject|14|||
126537997|NCT01953003|455262665|FG001|Overall Study|Withdrawal by Subject|4|||
126537998|NCT00508261|455262678|FG000|Overall Study|Other|0|||
126537999|NCT00508261|455262679|FG001|Overall Study|Other|1|||
126538000|NCT00508261|455262680|FG002|Overall Study|Other|1|||
126538001|NCT00508261|455262681|FG003|Overall Study|Other|0|||
126538002|NCT00508261|455262678|FG000|Overall Study|Serious Adverse Event|0|||
126538003|NCT00508261|455262679|FG001|Overall Study|Serious Adverse Event|1|||
126538004|NCT00508261|455262680|FG002|Overall Study|Serious Adverse Event|0|||
126538005|NCT00508261|455262681|FG003|Overall Study|Serious Adverse Event|0|||
126538006|NCT00508261|455262678|FG000|Overall Study|Withdrawal by Subject|3|||
126538007|NCT00508261|455262679|FG001|Overall Study|Withdrawal by Subject|4|||
126538008|NCT00508261|455262680|FG002|Overall Study|Withdrawal by Subject|4|||
126538009|NCT00508261|455262681|FG003|Overall Study|Withdrawal by Subject|0|||
126538010|NCT00508261|455262678|FG000|Overall Study|Migrated/ moved from study area|0|||
126538011|NCT00508261|455262679|FG001|Overall Study|Migrated/ moved from study area|1|||
126538012|NCT00508261|455262680|FG002|Overall Study|Migrated/ moved from study area|0|||
126538013|NCT00508261|455262681|FG003|Overall Study|Migrated/ moved from study area|0|||
126538014|NCT00508261|455262678|FG000|Overall Study|Lost to Follow-up|0|||
126538015|NCT00508261|455262679|FG001|Overall Study|Lost to Follow-up|1|||
126538016|NCT00508261|455262680|FG002|Overall Study|Lost to Follow-up|1|||
126538017|NCT00508261|455262681|FG003|Overall Study|Lost to Follow-up|1|||
126538018|NCT00526630|455262684|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
126538019|NCT00526630|455262685|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
126538020|NCT00526630|455262684|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
126538021|NCT00526630|455262685|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
126538022|NCT01078155|455262688|FG000|Overall Study|Adverse Event|7|||
126538023|NCT01078155|455262688|FG000|Overall Study|Lack of Efficacy|16|||
126538024|NCT01078155|455262688|FG000|Overall Study|Participant's Decision|6|||
126538025|NCT01078155|455262688|FG000|Overall Study|Lost to Follow-up|15|||
126538026|NCT01621880|455262689|FG000|Overall Study|Adverse Event|5|||
126538027|NCT01621880|455262690|FG001|Overall Study|Adverse Event|1|||
126538028|NCT01621880|455262689|FG000|Overall Study|Withdrawal by Subject|5|||
126538029|NCT01621880|455262690|FG001|Overall Study|Withdrawal by Subject|4|||
126538030|NCT01127646|455262691|FG000|Overall Study|Entry Criteria Not Met|1|||
126538031|NCT01127646|455262692|FG001|Overall Study|Entry Criteria Not Met|0|||
126538032|NCT01127646|455262691|FG000|Overall Study|Protocol Violation|0|||
126538033|NCT01127646|455262692|FG001|Overall Study|Protocol Violation|1|||
126538034|NCT04067401|455262693|FG000|Overall Study|Withdrawal by Subject|7|||
126538035|NCT04067401|455262694|FG001|Overall Study|Withdrawal by Subject|0|||
126538036|NCT04067401|455262693|FG000|Overall Study|no data provided|1|||
126538037|NCT04067401|455262694|FG001|Overall Study|no data provided|0|||
126538038|NCT01662063|455262697|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
126538039|NCT01662063|455262698|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
126538040|NCT01662063|455262699|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
126538041|NCT01662063|455262697|FG000|Overall Study|Lack of Efficacy|1|||
126538042|NCT01662063|455262698|FG001|Overall Study|Lack of Efficacy|6|||
126538043|NCT01662063|455262699|FG002|Overall Study|Lack of Efficacy|0|||
126538044|NCT01662063|455262697|FG000|Overall Study|Lost to Follow-up|0|||
126538045|NCT01662063|455262698|FG001|Overall Study|Lost to Follow-up|4|||
126538046|NCT01662063|455262699|FG002|Overall Study|Lost to Follow-up|0|||
126538047|NCT01662063|455262697|FG000|Overall Study|Protocol Violation|1|||
126538048|NCT01662063|455262698|FG001|Overall Study|Protocol Violation|0|||
126538049|NCT01662063|455262699|FG002|Overall Study|Protocol Violation|0|||
126538050|NCT01662063|455262697|FG000|Overall Study|Withdrawal by Subject|2|||
126538051|NCT01662063|455262698|FG001|Overall Study|Withdrawal by Subject|4|||
126538052|NCT01662063|455262699|FG002|Overall Study|Withdrawal by Subject|1|||
126538053|NCT01662063|455262697|FG000|Overall Study|Physician Decision|0|||
126538054|NCT01662063|455262698|FG001|Overall Study|Physician Decision|2|||
126538055|NCT01662063|455262699|FG002|Overall Study|Physician Decision|0|||
126538056|NCT01662063|455262697|FG000|Overall Study|Other|0|||
126538057|NCT01662063|455262698|FG001|Overall Study|Other|1|||
126538058|NCT01662063|455262699|FG002|Overall Study|Other|0|||
126538059|NCT00106184|455262701|FG000|Overall Study|Withdrawal by Subject|3|||
126538060|NCT00106184|455262702|FG001|Overall Study|Withdrawal by Subject|2|||
126538061|NCT02313909|455262703|FG000|Overall Study|Consent withdrawn by participant|33|||
126538062|NCT02313909|455262704|FG001|Overall Study|Consent withdrawn by participant|33|||
126538063|NCT02313909|455262703|FG000|Overall Study|Lost to Follow-up|24|||
126538064|NCT02313909|455262704|FG001|Overall Study|Lost to Follow-up|17|||
126538065|NCT00293267|455262710|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
126538066|NCT00293267|455262711|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
126538067|NCT00293267|455262710|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
126538068|NCT00293267|455262711|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
126538069|NCT00293267|455262710|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
126538070|NCT00293267|455262711|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
126538071|NCT00293267|455262710|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
126538072|NCT00293267|455262711|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
126538073|NCT00293267|455262710|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
126538074|NCT00293267|455262711|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
126538075|NCT00293267|455262710|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
126538076|NCT00293267|455262711|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
126538077|NCT00293267|455262710|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
126538078|NCT00293267|455262711|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
126538079|NCT00293267|455262710|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
126538080|NCT00293267|455262711|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
126538081|NCT00293267|455262710|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
126538082|NCT00293267|455262711|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
126538083|NCT00293267|455262710|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
126538084|NCT00293267|455262711|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
126538085|NCT00293267|455262710|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
126538086|NCT00293267|455262711|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
126538087|NCT00293267|455262710|FG000|Extension - Double-Blind Week 49-156|Death|3|||
126538088|NCT00293267|455262711|FG001|Extension - Double-Blind Week 49-156|Death|0|||
126538089|NCT00293267|455262710|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
126538090|NCT00293267|455262711|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
126538091|NCT00293267|455262710|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
126538092|NCT00293267|455262711|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
126538093|NCT00293267|455262710|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
126538094|NCT00293267|455262711|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
126538095|NCT00293267|455262710|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
126538096|NCT00293267|455262711|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
126538097|NCT00293267|455262710|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
126538098|NCT00293267|455262711|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
126538099|NCT00293267|455262710|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
126538100|NCT00293267|455262711|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
126538101|NCT00293267|455262710|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
126538102|NCT00293267|455262711|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
126538103|NCT00293267|455262710|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
126538104|NCT00293267|455262711|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
126538105|NCT00293267|455262710|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
126538106|NCT00293267|455262711|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
126538107|NCT00293267|455262710|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
126538108|NCT00293267|455262711|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
126538109|NCT00293267|455262710|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
126538110|NCT00293267|455262711|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
126538111|NCT00293267|455262710|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
126538112|NCT00293267|455262711|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
126538113|NCT00293267|455262710|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
126538114|NCT00293267|455262711|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
126538115|NCT00293267|455262710|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
126538116|NCT00293267|455262711|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
126538117|NCT00293267|455262710|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
126538118|NCT00293267|455262711|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
126538119|NCT00293267|455262710|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
126538120|NCT00293267|455262711|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
126538121|NCT01477853|455262712|FG000|Phase A|Adverse Event|1|||
126538122|NCT01477853|455262713|FG001|Phase A|Adverse Event|2|||
126538123|NCT01477853|455262714|FG002|Phase A|Adverse Event|2|||
126538124|NCT01477853|455262712|FG000|Phase A|Lost to Follow-up|4|||
126538125|NCT01477853|455262713|FG001|Phase A|Lost to Follow-up|3|||
126538126|NCT01477853|455262714|FG002|Phase A|Lost to Follow-up|2|||
126538127|NCT01477853|455262712|FG000|Phase A|Physician Decision|1|||
126538128|NCT01477853|455262713|FG001|Phase A|Physician Decision|0|||
126538129|NCT01477853|455262714|FG002|Phase A|Physician Decision|1|||
126538130|NCT01477853|455262712|FG000|Phase A|Study terminated by sponsor|37|||
126538131|NCT01477853|455262713|FG001|Phase A|Study terminated by sponsor|40|||
126538132|NCT01477853|455262714|FG002|Phase A|Study terminated by sponsor|39|||
126538133|NCT01477853|455262712|FG000|Phase B|Lost to Follow-up|0|||
126538134|NCT01477853|455262713|FG001|Phase B|Lost to Follow-up|1|||
126538135|NCT01477853|455262714|FG002|Phase B|Lost to Follow-up|0|||
126538136|NCT01477853|455262712|FG000|Phase B|Study terminated by sponsor|12|||
126538137|NCT01477853|455262713|FG001|Phase B|Study terminated by sponsor|10|||
126538138|NCT01477853|455262714|FG002|Phase B|Study terminated by sponsor|11|||
126538139|NCT01050816|455262715|FG000|Overall Study|Lost to Follow-up|2|||
126538140|NCT01050816|455262715|FG000|Overall Study|patient's refusal|2|||
126538141|NCT03086330|455262716|FG000|Overall Study|Withdrawal by Subject|3|||
126538142|NCT03086330|455262717|FG001|Overall Study|Withdrawal by Subject|2|||
126538143|NCT03086330|455262716|FG000|Overall Study|Lost to Follow-up|1|||
126538144|NCT03086330|455262717|FG001|Overall Study|Lost to Follow-up|2|||
126538145|NCT00948974|455262722|FG000|Overall Study|Lost to Follow-up|23|||
126538146|NCT00948974|455262723|FG001|Overall Study|Lost to Follow-up|20|||
126538147|NCT00238433|455262725|FG000|Overall Study|Screen failure|1|||
126538148|NCT00238433|455262725|FG000|Overall Study|Lost to Follow-up|1|||
126314427|NCT04322539|454442680|FG000|Overall Study|Other|6|||
126314428|NCT04322539|454442681|FG001|Overall Study|Other|4|||
126314429|NCT01702532|454442682|FG000|Overall Study|Adverse Event|0|||
126314430|NCT01702532|454442683|FG001|Overall Study|Adverse Event|1|||
126314431|NCT01451164|454442684|FG000|Overall Study|Adverse Event|19|||
126314432|NCT01451164|454442685|FG001|Overall Study|Adverse Event|12|||
126314433|NCT01451164|454442686|FG002|Overall Study|Adverse Event|18|||
126314434|NCT01451164|454442687|FG003|Overall Study|Adverse Event|21|||
126314435|NCT01451164|454442684|FG000|Overall Study|Withdrawal Criteria|1|||
126314436|NCT01451164|454442685|FG001|Overall Study|Withdrawal Criteria|1|||
126314437|NCT01451164|454442686|FG002|Overall Study|Withdrawal Criteria|1|||
126314438|NCT01451164|454442687|FG003|Overall Study|Withdrawal Criteria|1|||
126314439|NCT01451164|454442684|FG000|Overall Study|Physician Decision|2|||
126314440|NCT01451164|454442685|FG001|Overall Study|Physician Decision|0|||
126314441|NCT01451164|454442686|FG002|Overall Study|Physician Decision|1|||
126314442|NCT01451164|454442687|FG003|Overall Study|Physician Decision|0|||
126314443|NCT01451164|454442684|FG000|Overall Study|Withdrawal by Subject|14|||
126314444|NCT01451164|454442685|FG001|Overall Study|Withdrawal by Subject|11|||
126314445|NCT01451164|454442686|FG002|Overall Study|Withdrawal by Subject|16|||
126314446|NCT01451164|454442687|FG003|Overall Study|Withdrawal by Subject|17|||
126314447|NCT01451164|454442684|FG000|Overall Study|Protocol Violation|0|||
126314448|NCT01451164|454442685|FG001|Overall Study|Protocol Violation|1|||
126314449|NCT01451164|454442686|FG002|Overall Study|Protocol Violation|0|||
126314450|NCT01451164|454442687|FG003|Overall Study|Protocol Violation|0|||
126314451|NCT01451164|454442684|FG000|Overall Study|Lack of Efficacy|7|||
126314452|NCT01451164|454442685|FG001|Overall Study|Lack of Efficacy|9|||
126314453|NCT01451164|454442686|FG002|Overall Study|Lack of Efficacy|9|||
126314454|NCT01451164|454442687|FG003|Overall Study|Lack of Efficacy|7|||
126314455|NCT01846221|454442688|FG000|Overall Study|Catheter Failure|2|||
126314456|NCT01846221|454442689|FG001|Overall Study|Catheter Failure|0|||
126314457|NCT01846221|454442688|FG000|Overall Study|Age Exclusion|1|||
126314458|NCT01846221|454442689|FG001|Overall Study|Age Exclusion|0|||
126314459|NCT02879994|454442690|FG000|Overall Study|off treatment early|7|||
126314460|NCT02879994|454442690|FG000|Overall Study|Adverse Event|2|||
126314461|NCT02879994|454442690|FG000|Overall Study|Death|2|||
126314462|NCT01482962|454442693|FG000|Overall Study|Progressive Disease|65|||
126314463|NCT01482962|454442694|FG001|Overall Study|Progressive Disease|53|||
126314464|NCT01482962|454442693|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
126314465|NCT01482962|454442694|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
126314466|NCT01482962|454442693|FG000|Overall Study|Adverse Event|18|||
126314467|NCT01482962|454442694|FG001|Overall Study|Adverse Event|22|||
126538149|NCT00238433|455262725|FG000|Overall Study|Death|1|||
126538150|NCT01814748|455262728|FG000|Overall Study|Lost to Follow-up|1|||
126538151|NCT01814748|455262729|FG001|Overall Study|Lost to Follow-up|2|||
126538152|NCT01814748|455262728|FG000|Overall Study|Study site terminated by sponsor|1|||
126314468|NCT01482962|454442693|FG000|Overall Study|Withdrawal by Participant|8|||
126314469|NCT01482962|454442694|FG001|Overall Study|Withdrawal by Participant|13|||
126314470|NCT01482962|454442693|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
126314471|NCT01482962|454442694|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
126314472|NCT01482962|454442693|FG000|Overall Study|Other Reason|1|||
126314473|NCT01482962|454442694|FG001|Overall Study|Other Reason|5|||
126314474|NCT01482962|454442693|FG000|Overall Study|Study Terminated by Sponsor|5|||
126314475|NCT01482962|454442694|FG001|Overall Study|Study Terminated by Sponsor|2|||
126314476|NCT01482962|454442693|FG000|Overall Study|Did not Receive Study Drug|1|||
126314477|NCT01482962|454442694|FG001|Overall Study|Did not Receive Study Drug|6|||
126314478|NCT02407457|454442695|FG000|1 Month|Death|3|||
126314479|NCT02407457|454442696|FG001|1 Month|Death|0|||
126314480|NCT02407457|454442695|FG000|1 Month|Lost to Follow-up|1|||
126314481|NCT02407457|454442696|FG001|1 Month|Lost to Follow-up|1|||
126314482|NCT02407457|454442695|FG000|1 Month|missed visit|2|||
126314483|NCT02407457|454442696|FG001|1 Month|missed visit|5|||
126314484|NCT02407457|454442695|FG000|6-Month|Death|2|||
126314485|NCT02407457|454442696|FG001|6-Month|Death|8|||
126314486|NCT02407457|454442695|FG000|6-Month|Lost to Follow-up|2|||
126314487|NCT02407457|454442696|FG001|6-Month|Lost to Follow-up|2|||
126538153|NCT01814748|455262729|FG001|Overall Study|Study site terminated by sponsor|1|||
126538154|NCT01814748|455262728|FG000|Overall Study|Withdrawal by Subject|6|||
126538155|NCT01814748|455262729|FG001|Overall Study|Withdrawal by Subject|4|||
126538156|NCT04044456|455262730|FG000|Overall Study|Lost to Follow-up|4|||
126314488|NCT02407457|454442695|FG000|6-Month|missed visit|16|||
126314489|NCT02407457|454442696|FG001|6-Month|missed visit|14|||
126314490|NCT02407457|454442695|FG000|6-Month|Open Repair|0|||
126314491|NCT02407457|454442696|FG001|6-Month|Open Repair|1|||
126314492|NCT02407457|454442695|FG000|1 Year|Death|6|||
126314493|NCT02407457|454442696|FG001|1 Year|Death|11|||
126314494|NCT02407457|454442695|FG000|1 Year|Lost to Follow-up|3|||
126314495|NCT02407457|454442696|FG001|1 Year|Lost to Follow-up|2|||
126314496|NCT02407457|454442695|FG000|1 Year|Missed Visit|24|||
126314497|NCT02407457|454442696|FG001|1 Year|Missed Visit|14|||
126314498|NCT02407457|454442695|FG000|1 Year|Open Repair|0|||
126314499|NCT02407457|454442696|FG001|1 Year|Open Repair|1|||
126538157|NCT04044456|455262731|FG001|Overall Study|Lost to Follow-up|1|||
126538158|NCT04044456|455262730|FG000|Overall Study|Withdrawal by Subject|1|||
126538159|NCT04044456|455262731|FG001|Overall Study|Withdrawal by Subject|0|||
126538160|NCT01972529|455262732|FG000|Overall Study|Adverse Event|0|||
126538161|NCT01972529|455262733|FG001|Overall Study|Adverse Event|1|||
126538162|NCT01972529|455262734|FG002|Overall Study|Adverse Event|0|||
126538163|NCT01972529|455262735|FG003|Overall Study|Adverse Event|0|||
126538164|NCT01972529|455262732|FG000|Overall Study|Lost to Follow-up|1|||
126538165|NCT01972529|455262733|FG001|Overall Study|Lost to Follow-up|0|||
126538166|NCT01972529|455262734|FG002|Overall Study|Lost to Follow-up|0|||
126538167|NCT01972529|455262735|FG003|Overall Study|Lost to Follow-up|0|||
126538168|NCT01972529|455262732|FG000|Overall Study|Participant Choice|0|||
126538169|NCT01972529|455262733|FG001|Overall Study|Participant Choice|1|||
126538170|NCT01972529|455262734|FG002|Overall Study|Participant Choice|0|||
126538171|NCT01972529|455262735|FG003|Overall Study|Participant Choice|0|||
126538172|NCT01972529|455262732|FG000|Overall Study|Withdrawl of Consent|1|||
126538173|NCT01972529|455262733|FG001|Overall Study|Withdrawl of Consent|2|||
126538174|NCT01972529|455262734|FG002|Overall Study|Withdrawl of Consent|0|||
126538175|NCT01972529|455262735|FG003|Overall Study|Withdrawl of Consent|1|||
126538176|NCT01972529|455262732|FG000|Overall Study|Other|0|||
126538177|NCT01972529|455262733|FG001|Overall Study|Other|0|||
126538178|NCT01972529|455262734|FG002|Overall Study|Other|0|||
126538179|NCT01972529|455262735|FG003|Overall Study|Other|2|||
126538180|NCT01972529|455262732|FG000|Overall Study|Not treated|0|||
126538181|NCT01972529|455262733|FG001|Overall Study|Not treated|1|||
126538182|NCT01972529|455262734|FG002|Overall Study|Not treated|2|||
126538183|NCT01972529|455262735|FG003|Overall Study|Not treated|1|||
126538184|NCT02274857|455262736|FG000|Overall Study|Adverse Event|1|||
126538185|NCT02274857|455262737|FG001|Overall Study|Adverse Event|0|||
126538186|NCT02274857|455262736|FG000|Overall Study|Death|1|||
126538187|NCT02274857|455262737|FG001|Overall Study|Death|2|||
126538188|NCT02274857|455262736|FG000|Overall Study|Lost to Follow-up|3|||
126538189|NCT02274857|455262737|FG001|Overall Study|Lost to Follow-up|0|||
126538190|NCT02274857|455262736|FG000|Overall Study|Physician Decision|2|||
126538191|NCT02274857|455262737|FG001|Overall Study|Physician Decision|0|||
126538192|NCT02274857|455262736|FG000|Overall Study|Trial screen failure|0|||
126538193|NCT02274857|455262737|FG001|Overall Study|Trial screen failure|2|||
126538194|NCT02274857|455262736|FG000|Overall Study|Withdrawal by Subject|11|||
126538195|NCT02274857|455262737|FG001|Overall Study|Withdrawal by Subject|2|||
126538196|NCT02274857|455262736|FG000|Overall Study|Other|2|||
126538197|NCT02274857|455262737|FG001|Overall Study|Other|0|||
126538198|NCT00330174|455262740|FG000|Overall Study|Withdrawal by Subject|7|||
126538199|NCT00330174|455262741|FG001|Overall Study|Withdrawal by Subject|7|||
126538200|NCT00330174|455262740|FG000|Overall Study|Lost to Follow-up|4|||
126538201|NCT00330174|455262741|FG001|Overall Study|Lost to Follow-up|1|||
126538202|NCT00330174|455262740|FG000|Overall Study|Clinical deterioration|1|||
126538203|NCT00330174|455262741|FG001|Overall Study|Clinical deterioration|2|||
126538204|NCT00330174|455262740|FG000|Overall Study|Excessive missed visits|3|||
126538205|NCT00330174|455262741|FG001|Overall Study|Excessive missed visits|8|||
126538206|NCT00330174|455262740|FG000|Overall Study|Miscellaneous reasons|7|||
126538207|NCT00330174|455262741|FG001|Overall Study|Miscellaneous reasons|1|||
126538208|NCT00409682|455262744|FG000|Open-label Induction Period|Adverse Event|1|||
126538209|NCT00409682|455262745|FG001|Open-label Induction Period|Adverse Event|0|||
126538210|NCT00409682|455262746|FG002|Open-label Induction Period|Adverse Event|0|||
126538211|NCT00409682|455262744|FG000|Open-label Induction Period|Lack of Efficacy|1|||
126538212|NCT00409682|455262745|FG001|Open-label Induction Period|Lack of Efficacy|0|||
126538213|NCT00409682|455262746|FG002|Open-label Induction Period|Lack of Efficacy|0|||
126538214|NCT00409682|455262744|FG000|Open-label Induction Period|Protocol Violation|1|||
126538215|NCT00409682|455262745|FG001|Open-label Induction Period|Protocol Violation|0|||
126538216|NCT00409682|455262746|FG002|Open-label Induction Period|Protocol Violation|0|||
126538217|NCT00409682|455262744|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
126538218|NCT00409682|455262745|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
126538219|NCT00409682|455262746|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
126538220|NCT00409682|455262744|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
126538221|NCT00409682|455262745|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
126538222|NCT00409682|455262746|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
126538223|NCT00409682|455262744|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
126538224|NCT00409682|455262745|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
126538225|NCT00409682|455262746|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
126538226|NCT00409682|455262744|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
126538227|NCT00409682|455262745|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
126538228|NCT00409682|455262746|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
126538229|NCT00409682|455262744|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
126538230|NCT00409682|455262745|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
126538231|NCT00409682|455262746|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
126538232|NCT00409682|455262744|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
126538233|NCT00409682|455262745|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
126538234|NCT00409682|455262746|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
126538235|NCT00409682|455262744|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
126538236|NCT00409682|455262745|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
126538237|NCT00409682|455262746|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
126538238|NCT00118716|455262750|FG000|Overall Study|Adverse Event|2|||
126538239|NCT00118716|455262751|FG001|Overall Study|Adverse Event|7|||
126538240|NCT00118716|455262750|FG000|Overall Study|Protocol Violation|5|||
126538241|NCT00118716|455262751|FG001|Overall Study|Protocol Violation|4|||
126538242|NCT00118716|455262750|FG000|Overall Study|Withdrawal by Subject|0|||
126538243|NCT00118716|455262751|FG001|Overall Study|Withdrawal by Subject|1|||
126538244|NCT00118716|455262750|FG000|Overall Study|Exacerbation|2|||
126538245|NCT00118716|455262751|FG001|Overall Study|Exacerbation|2|||
126538246|NCT00118716|455262750|FG000|Overall Study|Discontinued by sponsor|1|||
126538247|NCT00118716|455262751|FG001|Overall Study|Discontinued by sponsor|1|||
126538248|NCT00118716|455262750|FG000|Overall Study|Non-compliance|1|||
126538249|NCT00118716|455262751|FG001|Overall Study|Non-compliance|3|||
126538250|NCT00118716|455262750|FG000|Overall Study|misrandomized|1|||
126538251|NCT00118716|455262751|FG001|Overall Study|misrandomized|1|||
126538252|NCT00118716|455262750|FG000|Overall Study|Expired drug use|1|||
126538253|NCT00118716|455262751|FG001|Overall Study|Expired drug use|2|||
126538254|NCT00118716|455262750|FG000|Overall Study|Investigator discretion|0|||
126538255|NCT00118716|455262751|FG001|Overall Study|Investigator discretion|1|||
126538256|NCT01445652|455262752|FG000|Overall Study|Not comfortable in lenses|5|||
126538257|NCT01445652|455262753|FG001|Overall Study|Not comfortable in lenses|0|||
126538258|NCT01445652|455262752|FG000|Overall Study|Failed to attend scheduled visit|2|||
126538259|NCT01445652|455262753|FG001|Overall Study|Failed to attend scheduled visit|3|||
126538260|NCT01445652|455262752|FG000|Overall Study|Failed teach session|2|||
126538261|NCT01445652|455262753|FG001|Overall Study|Failed teach session|0|||
126538262|NCT01445652|455262752|FG000|Overall Study|Adverse Event|1|||
126538263|NCT01445652|455262753|FG001|Overall Study|Adverse Event|0|||
126538264|NCT00454571|455262754|FG000|Overall Study|Adverse Event|2|||
126538265|NCT00454571|455262755|FG001|Overall Study|Adverse Event|0|||
126538266|NCT00454571|455262754|FG000|Overall Study|Physician Decision|0|||
126538267|NCT00454571|455262755|FG001|Overall Study|Physician Decision|1|||
126538268|NCT00454571|455262754|FG000|Overall Study|Protocol Violation|1|||
126538269|NCT00454571|455262755|FG001|Overall Study|Protocol Violation|0|||
126538270|NCT00454571|455262754|FG000|Overall Study|Withdrawal by Subject|10|||
126538271|NCT00454571|455262755|FG001|Overall Study|Withdrawal by Subject|5|||
126538272|NCT01201811|455262756|FG000|Overall Study|Adverse Event|6|||
126538273|NCT01201811|455262756|FG000|Overall Study|Disease progression|3|||
126538274|NCT01201811|455262756|FG000|Overall Study|Withdrawal by Subject|3|||
126538275|NCT01201811|455262756|FG000|Overall Study|Death|4|||
126538276|NCT01201811|455262756|FG000|Overall Study|Treatment Failure|2|||
126538277|NCT01201811|455262756|FG000|Overall Study|Physician Decision|1|||
126538278|NCT02657317|455262757|FG000|Overall Study|Withdrawal by Subject|2|||
126538279|NCT02657317|455262758|FG001|Overall Study|Withdrawal by Subject|0|||
126538280|NCT02657317|455262757|FG000|Overall Study|Lost to Follow-up|3|||
126538281|NCT02657317|455262758|FG001|Overall Study|Lost to Follow-up|3|||
126538282|NCT02856113|455262759|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
126538283|NCT02856113|455262760|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
126538284|NCT02856113|455262759|FG000|Overall Study|Significant Protocol Deviation|1|||
126538285|NCT02856113|455262760|FG001|Overall Study|Significant Protocol Deviation|0|||
126538286|NCT02856113|455262759|FG000|Overall Study|Lost to Follow-up|3|||
126538287|NCT02856113|455262760|FG001|Overall Study|Lost to Follow-up|5|||
126538288|NCT02856113|455262759|FG000|Overall Study|Voluntary Withdrawal|3|||
126538289|NCT02856113|455262760|FG001|Overall Study|Voluntary Withdrawal|5|||
126538290|NCT02856113|455262759|FG000|Overall Study|Pregnancy|0|||
126538291|NCT02856113|455262760|FG001|Overall Study|Pregnancy|1|||
126538292|NCT02856113|455262759|FG000|Overall Study|Principal Investigator Discretion|2|||
126538293|NCT02856113|455262760|FG001|Overall Study|Principal Investigator Discretion|1|||
126538294|NCT02856113|455262759|FG000|Overall Study|Randomized but not Treated|1|||
126538295|NCT02856113|455262760|FG001|Overall Study|Randomized but not Treated|0|||
126538296|NCT02856113|455262759|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
126538297|NCT02856113|455262760|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
126538298|NCT04899245|455262772|FG000|Overall Study|Withdrawal by Subject|3|||
126538299|NCT04899245|455262773|FG001|Overall Study|Withdrawal by Subject|5|||
126538300|NCT04899245|455262774|FG002|Overall Study|Withdrawal by Subject|2|||
126538301|NCT04899245|455262772|FG000|Overall Study|No longer eligible - Left staff position|0|||
126538302|NCT04899245|455262773|FG001|Overall Study|No longer eligible - Left staff position|0|||
126538303|NCT04899245|455262774|FG002|Overall Study|No longer eligible - Left staff position|1|||
126538304|NCT04899245|455262772|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
126538305|NCT04899245|455262773|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
126538306|NCT04899245|455262774|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
126715202|NCT01052012|455908711|FG005|Overall Study|Other|0|||
126538307|NCT04899245|455262772|FG000|Overall Study|No longer eligible - Moved away from area|2|||
126538308|NCT04899245|455262773|FG001|Overall Study|No longer eligible - Moved away from area|2|||
126538309|NCT04899245|455262774|FG002|Overall Study|No longer eligible - Moved away from area|0|||
126538310|NCT03185481|455262777|FG000|Overall Study|Adverse Event|1|||
126538311|NCT03185481|455262777|FG000|Overall Study|Study Terminated by Sponsor|4|||
126538312|NCT01422408|455262778|FG000|Overall Study|Adverse Event|1|||
126538313|NCT01422408|455262778|FG000|Overall Study|Withdrawal by Subject|3|||
126538314|NCT05099926|455262788|FG000|Overall Study|Lost to Follow-up|1|||
126538315|NCT00724152|455262791|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
126538316|NCT00724152|455262792|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
126538317|NCT00724152|455262793|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
126538318|NCT00724152|455262791|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
126538319|NCT00724152|455262792|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
126538320|NCT00724152|455262793|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
126538321|NCT00031486|455262799|FG000|Overall Study|Adverse Event|1|||
126538322|NCT00031486|455262800|FG001|Overall Study|Adverse Event|0|||
126538323|NCT00031486|455262799|FG000|Overall Study|Lost to Follow-up|0|||
126538324|NCT00031486|455262800|FG001|Overall Study|Lost to Follow-up|1|||
126538325|NCT00031486|455262799|FG000|Overall Study|Withdrawal by Subject|3|||
126538326|NCT00031486|455262800|FG001|Overall Study|Withdrawal by Subject|2|||
126538327|NCT00031486|455262799|FG000|Overall Study|Death|0|||
126538328|NCT00031486|455262800|FG001|Overall Study|Death|3|||
126538329|NCT00031486|455262799|FG000|Overall Study|Non-compliant|0|||
126538330|NCT00031486|455262800|FG001|Overall Study|Non-compliant|4|||
126538331|NCT00031486|455262799|FG000|Overall Study|Did not meet eligibility requirement|2|||
126538332|NCT00031486|455262800|FG001|Overall Study|Did not meet eligibility requirement|1|||
126538333|NCT00031486|455262799|FG000|Overall Study|Other|1|||
126538334|NCT00031486|455262800|FG001|Overall Study|Other|1|||
126538335|NCT03685591|455262801|FG000|Overall Study|Global Deterioration of Health Status|0|||
126538336|NCT03685591|455262802|FG001|Overall Study|Global Deterioration of Health Status|0|||
126538337|NCT03685591|455262803|FG002|Overall Study|Global Deterioration of Health Status|0|||
126538338|NCT03685591|455262804|FG003|Overall Study|Global Deterioration of Health Status|1|||
126538339|NCT03685591|455262805|FG004|Overall Study|Global Deterioration of Health Status|2|||
126538340|NCT03685591|455262806|FG005|Overall Study|Global Deterioration of Health Status|4|||
126538341|NCT03685591|455262807|FG006|Overall Study|Global Deterioration of Health Status|1|||
126538342|NCT03685591|455262808|FG007|Overall Study|Global Deterioration of Health Status|1|||
126538343|NCT03685591|455262809|FG008|Overall Study|Global Deterioration of Health Status|0|||
126538344|NCT03685591|455262801|FG000|Overall Study|Progressive Disease|1|||
126538345|NCT03685591|455262802|FG001|Overall Study|Progressive Disease|1|||
126538346|NCT03685591|455262803|FG002|Overall Study|Progressive Disease|0|||
126538347|NCT03685591|455262804|FG003|Overall Study|Progressive Disease|3|||
126538348|NCT03685591|455262805|FG004|Overall Study|Progressive Disease|5|||
126538349|NCT03685591|455262806|FG005|Overall Study|Progressive Disease|4|||
126538350|NCT03685591|455262807|FG006|Overall Study|Progressive Disease|3|||
126538351|NCT03685591|455262808|FG007|Overall Study|Progressive Disease|2|||
126538352|NCT03685591|455262809|FG008|Overall Study|Progressive Disease|1|||
126538353|NCT03685591|455262801|FG000|Overall Study|Other|0|||
126538354|NCT03685591|455262802|FG001|Overall Study|Other|0|||
126538355|NCT03685591|455262803|FG002|Overall Study|Other|1|||
126538356|NCT03685591|455262804|FG003|Overall Study|Other|0|||
126538357|NCT03685591|455262805|FG004|Overall Study|Other|2|||
126538358|NCT03685591|455262806|FG005|Overall Study|Other|3|||
126538359|NCT03685591|455262807|FG006|Overall Study|Other|0|||
126538360|NCT03685591|455262808|FG007|Overall Study|Other|0|||
126538361|NCT03685591|455262809|FG008|Overall Study|Other|0|||
126538362|NCT03685591|455262801|FG000|Overall Study|Withdrawal by Subject|0|||
126538363|NCT03685591|455262802|FG001|Overall Study|Withdrawal by Subject|0|||
126538364|NCT03685591|455262803|FG002|Overall Study|Withdrawal by Subject|0|||
126538365|NCT03685591|455262804|FG003|Overall Study|Withdrawal by Subject|0|||
126538366|NCT03685591|455262805|FG004|Overall Study|Withdrawal by Subject|3|||
126538367|NCT03685591|455262806|FG005|Overall Study|Withdrawal by Subject|2|||
126538368|NCT03685591|455262807|FG006|Overall Study|Withdrawal by Subject|0|||
126538369|NCT03685591|455262808|FG007|Overall Study|Withdrawal by Subject|0|||
126538370|NCT03685591|455262809|FG008|Overall Study|Withdrawal by Subject|1|||
126538371|NCT03685591|455262801|FG000|Overall Study|Adverse Event|0|||
126538372|NCT03685591|455262802|FG001|Overall Study|Adverse Event|0|||
126538373|NCT03685591|455262803|FG002|Overall Study|Adverse Event|0|||
126538374|NCT03685591|455262804|FG003|Overall Study|Adverse Event|1|||
126538375|NCT03685591|455262805|FG004|Overall Study|Adverse Event|1|||
126538376|NCT03685591|455262806|FG005|Overall Study|Adverse Event|4|||
126538377|NCT03685591|455262807|FG006|Overall Study|Adverse Event|0|||
126314500|NCT02407457|454442695|FG000|2-year|Death|14|||
126538378|NCT03685591|455262808|FG007|Overall Study|Adverse Event|1|||
126538379|NCT03685591|455262809|FG008|Overall Study|Adverse Event|1|||
126538380|NCT02220894|455262810|FG000|Overall Study|Adverse Event|127|||
126538381|NCT02220894|455262811|FG001|Overall Study|Adverse Event|74|||
126538382|NCT02220894|455262810|FG000|Overall Study|Death|418|||
126538383|NCT02220894|455262811|FG001|Overall Study|Death|508|||
126538384|NCT02220894|455262810|FG000|Overall Study|Lost to Follow-up|0|||
126538385|NCT02220894|455262811|FG001|Overall Study|Lost to Follow-up|4|||
126538386|NCT02220894|455262810|FG000|Overall Study|Site Terminated by Sponsor|2|||
126538387|NCT02220894|455262811|FG001|Overall Study|Site Terminated by Sponsor|0|||
126538388|NCT02220894|455262810|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
126538389|NCT02220894|455262811|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
126538390|NCT02220894|455262810|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126538391|NCT02220894|455262811|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126538392|NCT02220894|455262810|FG000|Overall Study|Withdrawal by Subject|10|||
126538393|NCT02220894|455262811|FG001|Overall Study|Withdrawal by Subject|9|||
126538394|NCT00500903|455262812|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
126538395|NCT00500903|455262813|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
126538396|NCT00500903|455262814|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
126538397|NCT00500903|455262812|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
126538398|NCT00500903|455262813|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
126538399|NCT00500903|455262814|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
126538400|NCT00500903|455262812|FG000|Overall Study|Progressive Disease|41|||
126538401|NCT00500903|455262813|FG001|Overall Study|Progressive Disease|2|||
126538402|NCT00500903|455262814|FG002|Overall Study|Progressive Disease|15|||
126538403|NCT00500903|455262812|FG000|Overall Study|Patient Declined Further Treatment|0|||
126538404|NCT00500903|455262813|FG001|Overall Study|Patient Declined Further Treatment|0|||
126538405|NCT00500903|455262814|FG002|Overall Study|Patient Declined Further Treatment|3|||
126538406|NCT00500903|455262812|FG000|Overall Study|Symptomatic Deterioration|2|||
126538407|NCT00500903|455262813|FG001|Overall Study|Symptomatic Deterioration|0|||
126538408|NCT00500903|455262814|FG002|Overall Study|Symptomatic Deterioration|0|||
126538409|NCT00500903|455262812|FG000|Overall Study|Reason Not Specified|10|||
126538410|NCT00500903|455262813|FG001|Overall Study|Reason Not Specified|0|||
126538411|NCT00500903|455262814|FG002|Overall Study|Reason Not Specified|2|||
126538412|NCT03017079|455262815|FG000|Overall Study|Physician Decision|1|||
126538413|NCT03017079|455262816|FG001|Overall Study|Physician Decision|1|||
126538414|NCT03017079|455262815|FG000|Overall Study|Death|3|||
126538415|NCT03017079|455262816|FG001|Overall Study|Death|2|||
126538416|NCT03017079|455262815|FG000|Overall Study|Lack of Efficacy|2|||
126538417|NCT03017079|455262816|FG001|Overall Study|Lack of Efficacy|2|||
126538418|NCT03017079|455262815|FG000|Overall Study|Protocol Violation|0|||
126538419|NCT03017079|455262816|FG001|Overall Study|Protocol Violation|1|||
126538420|NCT03538951|455262817|FG000|Overall Study|Withdrawal by Subject|1|||
126538421|NCT03538951|455262818|FG001|Overall Study|Withdrawal by Subject|2|||
126538422|NCT03092375|455264280|FG000|Overall Study|Lack of Efficacy|0|||
126538423|NCT03092375|455264281|FG001|Overall Study|Lack of Efficacy|1|||
126538424|NCT03092375|455264282|FG002|Overall Study|Lack of Efficacy|1|||
126538425|NCT03092375|455264283|FG003|Overall Study|Lack of Efficacy|0|||
126538426|NCT00553501|455264286|FG000|Overall Study|Adverse Event|2|||
126538427|NCT00553501|455264286|FG000|Overall Study|Death|1|||
126538428|NCT00553501|455264286|FG000|Overall Study|Progression|1|||
126314501|NCT02407457|454442696|FG001|2-year|Death|8|||
126538429|NCT02293395|455264287|FG000|Overall Study|Lost to Follow-up|1|||
126538430|NCT02293395|455264288|FG001|Overall Study|Lost to Follow-up|0|||
126538431|NCT02293395|455264287|FG000|Overall Study|Withdrawal by Subject|8|||
126538432|NCT02293395|455264288|FG001|Overall Study|Withdrawal by Subject|7|||
126538433|NCT01464021|455264290|FG000|Overall Study|Withdrawal by Subject|13|||
126538434|NCT01464021|455264290|FG000|Overall Study|Lost to Follow-up|1|||
126538435|NCT01464021|455264290|FG000|Overall Study|Lack of Efficacy|1|||
126538436|NCT01464021|455264290|FG000|Overall Study|various|11|||
126538437|NCT00224770|455264291|FG000|Overall Study|Lost to Follow-up|4|||
126538438|NCT00224770|455264292|FG001|Overall Study|Lost to Follow-up|2|||
126538439|NCT00224770|455264293|FG002|Overall Study|Lost to Follow-up|0|||
126538440|NCT01106430|455264294|FG000|Overall Study|Adverse Event|8|||
126538441|NCT01106430|455264295|FG001|Overall Study|Adverse Event|10|||
126538442|NCT01106430|455264294|FG000|Overall Study|Lack of Efficacy|2|||
126538443|NCT01106430|455264295|FG001|Overall Study|Lack of Efficacy|13|||
126314502|NCT02407457|454442695|FG000|2-year|Lost to Follow-up|7|||
126314503|NCT02407457|454442696|FG001|2-year|Lost to Follow-up|10|||
126538444|NCT01106430|455264294|FG000|Overall Study|Lost to Follow-up|5|||
126314504|NCT02407457|454442695|FG000|2-year|Missed Visit|13|||
126538445|NCT01106430|455264295|FG001|Overall Study|Lost to Follow-up|1|||
126538446|NCT01106430|455264294|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
126538447|NCT01106430|455264295|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
126538448|NCT01106430|455264294|FG000|Overall Study|Moved Out Of State|0|||
126538449|NCT01106430|455264295|FG001|Overall Study|Moved Out Of State|1|||
126538450|NCT01106430|455264294|FG000|Overall Study|Refused To Take Medication|0|||
126538451|NCT01106430|455264295|FG001|Overall Study|Refused To Take Medication|1|||
126538452|NCT01106430|455264294|FG000|Overall Study|Noncompliance|0|||
126538453|NCT01106430|455264295|FG001|Overall Study|Noncompliance|1|||
126538454|NCT01106430|455264294|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
126538455|NCT01106430|455264295|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
126538456|NCT01106430|455264294|FG000|Overall Study|Previous Use Of Marijuana|1|||
126538457|NCT01106430|455264295|FG001|Overall Study|Previous Use Of Marijuana|0|||
126538458|NCT01106430|455264294|FG000|Overall Study|Protocol Violation|7|||
126538459|NCT01106430|455264295|FG001|Overall Study|Protocol Violation|2|||
126538460|NCT01106430|455264294|FG000|Overall Study|Withdrawal by Subject|8|||
126538461|NCT01106430|455264295|FG001|Overall Study|Withdrawal by Subject|4|||
126538462|NCT00861614|455264296|FG000|Overall Study|Disease Progression|182|||
126538463|NCT00861614|455264297|FG001|Overall Study|Disease Progression|263|||
126538464|NCT00861614|455264296|FG000|Overall Study|Study Drug Toxicity|79|||
126538465|NCT00861614|455264297|FG001|Overall Study|Study Drug Toxicity|6|||
126538466|NCT00861614|455264296|FG000|Overall Study|Death|32|||
126538467|NCT00861614|455264297|FG001|Overall Study|Death|19|||
126538468|NCT00861614|455264296|FG000|Overall Study|Adverse Event|27|||
126538469|NCT00861614|455264297|FG001|Overall Study|Adverse Event|23|||
126538470|NCT00861614|455264296|FG000|Overall Study|Withdrawal by Subject|34|||
126538471|NCT00861614|455264297|FG001|Overall Study|Withdrawal by Subject|35|||
126538472|NCT00861614|455264296|FG000|Overall Study|Other|17|||
126538473|NCT00861614|455264297|FG001|Overall Study|Other|22|||
126538474|NCT03391765|455264298|FG000|Overall Study|Adverse Event|2|||
126538475|NCT03391765|455264299|FG001|Overall Study|Adverse Event|0|||
126538476|NCT03391765|455264300|FG002|Overall Study|Adverse Event|0|||
126538477|NCT03391765|455264301|FG003|Overall Study|Adverse Event|2|||
126538478|NCT03391765|455264298|FG000|Overall Study|Withdrew consent|5|||
126538479|NCT03391765|455264299|FG001|Overall Study|Withdrew consent|7|||
126538480|NCT03391765|455264300|FG002|Overall Study|Withdrew consent|2|||
126538481|NCT03391765|455264301|FG003|Overall Study|Withdrew consent|5|||
126538482|NCT03391765|455264298|FG000|Overall Study|Other, not specified|44|||
126538483|NCT03391765|455264299|FG001|Overall Study|Other, not specified|38|||
126538484|NCT03391765|455264300|FG002|Overall Study|Other, not specified|21|||
126538485|NCT03391765|455264301|FG003|Overall Study|Other, not specified|16|||
126538486|NCT00944658|455264302|FG000|Treatment 12 Weeks|Adverse Event|0|||
126538487|NCT00944658|455264303|FG001|Treatment 12 Weeks|Adverse Event|2|||
126538488|NCT01255592|455264304|FG000|Overall Study|Adverse Event|5|||
126538489|NCT01255592|455264305|FG001|Overall Study|Adverse Event|0|||
126538490|NCT01255592|455264304|FG000|Overall Study|Withdrawal by Subject|1|||
126538491|NCT01255592|455264305|FG001|Overall Study|Withdrawal by Subject|0|||
126538492|NCT01255592|455264304|FG000|Overall Study|Other|0|||
126538493|NCT01255592|455264305|FG001|Overall Study|Other|1|||
126538494|NCT03704584|455264307|FG000|Overall Study|Withdrawal by Subject|1|||
126538495|NCT03704584|455264308|FG001|Overall Study|Withdrawal by Subject|0|||
126538496|NCT01083641|455264309|FG000|Overall Study|Withdrawal by Subject|2|||
126538497|NCT03439189|455264310|FG000|Overall Study|Protocol Violation|19|||
126538498|NCT03439189|455264310|FG000|Overall Study|Lack of Efficacy|63|||
126538499|NCT01777321|455264311|FG000|Overall Study|Withdrawal by Subject|0|||
126538500|NCT01777321|455264312|FG001|Overall Study|Withdrawal by Subject|1|||
126538501|NCT01493687|455264313|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
126538502|NCT01493687|455264314|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
126538503|NCT01493687|455264313|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
126538504|NCT01493687|455264314|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
126538505|NCT01493687|455264313|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
126538506|NCT01493687|455264314|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
126538507|NCT01493687|455264313|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
126538508|NCT01493687|455264314|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
126538509|NCT01493687|455264313|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
126538510|NCT01493687|455264314|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
126538511|NCT01493687|455264313|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
126538512|NCT01493687|455264314|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
126538513|NCT01493687|455264313|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
126538514|NCT01493687|455264314|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
126538515|NCT01493687|455264313|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
126538516|NCT01493687|455264314|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
126538517|NCT01493687|455264313|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
126538518|NCT01493687|455264314|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
126538519|NCT01493687|455264313|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
126538520|NCT01493687|455264314|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
126538521|NCT01493687|455264313|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
126538522|NCT01493687|455264314|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
126314505|NCT02407457|454442696|FG001|2-year|Missed Visit|15|||
126715203|NCT02873715|455908712|FG000|Overall Study|Lost to Follow-up|84|||
126538523|NCT01493687|455264313|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
126538524|NCT01493687|455264314|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
126538525|NCT01493687|455264313|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
126538526|NCT01493687|455264314|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
126538527|NCT01493687|455264313|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
126538528|NCT01493687|455264314|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
126538529|NCT01493687|455264313|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
126538530|NCT01493687|455264314|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
126538531|NCT02323646|455264315|FG000|Treatment Course 1|Adverse Event|1|||
126538532|NCT02323646|455264316|FG001|Treatment Course 1|Adverse Event|0|||
126538533|NCT02323646|455264317|FG002|Treatment Course 1|Adverse Event|1|||
126538534|NCT02323646|455264315|FG000|Treatment Course 1|Heavy Bleeding|1|||
126538535|NCT02323646|455264316|FG001|Treatment Course 1|Heavy Bleeding|1|||
126538536|NCT02323646|455264317|FG002|Treatment Course 1|Heavy Bleeding|0|||
126538537|NCT02323646|455264315|FG000|Treatment Course 1|Lost to Follow-up|1|||
126538538|NCT02323646|455264316|FG001|Treatment Course 1|Lost to Follow-up|0|||
126538539|NCT02323646|455264317|FG002|Treatment Course 1|Lost to Follow-up|2|||
126538540|NCT02323646|455264315|FG000|Treatment Course 1|Withdrawal by Subject|0|||
126538541|NCT02323646|455264316|FG001|Treatment Course 1|Withdrawal by Subject|2|||
126538542|NCT02323646|455264317|FG002|Treatment Course 1|Withdrawal by Subject|0|||
126538543|NCT02323646|455264315|FG000|Treatment Course 2|Adverse Event|1|||
126538544|NCT02323646|455264316|FG001|Treatment Course 2|Adverse Event|0|||
126538545|NCT02323646|455264317|FG002|Treatment Course 2|Adverse Event|1|||
126538546|NCT02323646|455264315|FG000|Treatment Course 2|Lost to Follow-up|0|||
126538547|NCT02323646|455264316|FG001|Treatment Course 2|Lost to Follow-up|0|||
126538548|NCT02323646|455264317|FG002|Treatment Course 2|Lost to Follow-up|1|||
126538549|NCT02323646|455264315|FG000|Treatment Course 2|Non-compliance|0|||
126538550|NCT02323646|455264316|FG001|Treatment Course 2|Non-compliance|1|||
126538551|NCT02323646|455264317|FG002|Treatment Course 2|Non-compliance|1|||
126538552|NCT00089141|455264320|FG000|Overall Study|Termination of trial|18|||
126538553|NCT00089141|455264321|FG001|Overall Study|Termination of trial|24|||
126538554|NCT00180479|455264324|FG000|Overall Study|Death|4|||
126538555|NCT00180479|455264325|FG001|Overall Study|Death|2|||
126538556|NCT00180479|455264324|FG000|Overall Study|Lost to Follow-up|9|||
126538557|NCT00180479|455264325|FG001|Overall Study|Lost to Follow-up|7|||
126538558|NCT00180479|455264324|FG000|Overall Study|Withdrawal by Subject|3|||
126538559|NCT00180479|455264325|FG001|Overall Study|Withdrawal by Subject|3|||
126538560|NCT00180479|455264324|FG000|Overall Study|Informed consent not signed|0|||
126538561|NCT00180479|455264325|FG001|Overall Study|Informed consent not signed|1|||
126538562|NCT05131165|455264326|FG000|Overall Study|Death|1|||
126538563|NCT05131165|455264327|FG001|Overall Study|Death|1|||
126538564|NCT05131165|455264328|FG002|Overall Study|Death|0|||
126538565|NCT05131165|455264326|FG000|Overall Study|Lost to Follow-up|2|||
126538566|NCT05131165|455264327|FG001|Overall Study|Lost to Follow-up|2|||
126538567|NCT05131165|455264328|FG002|Overall Study|Lost to Follow-up|5|||
126538568|NCT05131165|455264326|FG000|Overall Study|Transferred out of clinic|1|||
126538569|NCT05131165|455264327|FG001|Overall Study|Transferred out of clinic|0|||
126538570|NCT05131165|455264328|FG002|Overall Study|Transferred out of clinic|3|||
126538571|NCT05131165|455264326|FG000|Overall Study|Dropped out|1|||
126538572|NCT05131165|455264327|FG001|Overall Study|Dropped out|2|||
126538573|NCT05131165|455264328|FG002|Overall Study|Dropped out|0|||
126538574|NCT02459262|455264340|FG000|Overall Study|Withdrawal by Subject|0|||
126538575|NCT02459262|455264341|FG001|Overall Study|Withdrawal by Subject|0|||
126538576|NCT02459262|455264342|FG002|Overall Study|Withdrawal by Subject|0|||
126538577|NCT02459262|455264343|FG003|Overall Study|Withdrawal by Subject|0|||
126538578|NCT02459262|455264344|FG004|Overall Study|Withdrawal by Subject|0|||
126538579|NCT02459262|455264345|FG005|Overall Study|Withdrawal by Subject|0|||
126538580|NCT02459262|455264346|FG006|Overall Study|Withdrawal by Subject|0|||
126538581|NCT02459262|455264347|FG007|Overall Study|Withdrawal by Subject|0|||
126538582|NCT02459262|455264348|FG008|Overall Study|Withdrawal by Subject|0|||
126538583|NCT02459262|455264349|FG009|Overall Study|Withdrawal by Subject|1|||
126538584|NCT02459262|455264350|FG010|Overall Study|Withdrawal by Subject|0|||
126538585|NCT05168579|455264351|FG000|Overall Study|Lack of Consent|1|||
126538586|NCT05168579|455264352|FG001|Overall Study|Lack of Consent|0|||
126538587|NCT05168579|455264351|FG000|Overall Study|Conflicts with time|2|||
126538588|NCT05168579|455264352|FG001|Overall Study|Conflicts with time|0|||
126538589|NCT05168579|455264351|FG000|Overall Study|Time slots were full|3|||
126538590|NCT05168579|455264352|FG001|Overall Study|Time slots were full|0|||
126538591|NCT05168579|455264351|FG000|Overall Study|Lost to Follow-up|0|||
126538592|NCT05168579|455264352|FG001|Overall Study|Lost to Follow-up|15|||
126538593|NCT01242748|455264353|FG000|Overall Study|Adverse Event|10|||
126538594|NCT01242748|455264354|FG001|Overall Study|Adverse Event|5|||
126538595|NCT01242748|455264353|FG000|Overall Study|Lost to Follow-up|6|||
126538596|NCT01242748|455264354|FG001|Overall Study|Lost to Follow-up|2|||
126538597|NCT01242748|455264353|FG000|Overall Study|Physician Decision|3|||
126538598|NCT01242748|455264354|FG001|Overall Study|Physician Decision|2|||
126538599|NCT01242748|455264353|FG000|Overall Study|Protocol Violation|1|||
126538600|NCT01242748|455264354|FG001|Overall Study|Protocol Violation|0|||
126538601|NCT01242748|455264353|FG000|Overall Study|Withdrawal by Subject|10|||
126538602|NCT01242748|455264354|FG001|Overall Study|Withdrawal by Subject|2|||
126538603|NCT01242748|455264353|FG000|Overall Study|Miscellaneous reasons|8|||
126538604|NCT01242748|455264354|FG001|Overall Study|Miscellaneous reasons|3|||
126538605|NCT00840801|455264355|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
126538606|NCT00840801|455264356|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
126538607|NCT00840801|455264357|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
126538608|NCT00840801|455264355|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
126538609|NCT00840801|455264356|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
126538610|NCT00840801|455264357|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
126538611|NCT00840801|455264355|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
126538612|NCT00840801|455264356|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
126538613|NCT00840801|455264357|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
126538614|NCT00840801|455264355|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
126538615|NCT00840801|455264356|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
126538616|NCT00840801|455264357|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
126538617|NCT03518125|455264361|FG000|Overall Study|Lost to Follow-up|0|||
126538618|NCT03518125|455264362|FG001|Overall Study|Lost to Follow-up|2|||
126538619|NCT03518125|455264363|FG002|Overall Study|Lost to Follow-up|0|||
126538620|NCT03518125|455264364|FG003|Overall Study|Lost to Follow-up|0|||
126538621|NCT03518125|455264365|FG004|Overall Study|Lost to Follow-up|3|||
126538622|NCT03518125|455264366|FG005|Overall Study|Lost to Follow-up|5|||
126538623|NCT03518125|455264361|FG000|Overall Study|Physician Decision|0|||
126538624|NCT03518125|455264362|FG001|Overall Study|Physician Decision|1|||
126538625|NCT03518125|455264363|FG002|Overall Study|Physician Decision|0|||
126538626|NCT03518125|455264364|FG003|Overall Study|Physician Decision|0|||
126538627|NCT03518125|455264365|FG004|Overall Study|Physician Decision|0|||
126538628|NCT03518125|455264366|FG005|Overall Study|Physician Decision|0|||
126538629|NCT03518125|455264361|FG000|Overall Study|Withdrawal by Subject|1|||
126538630|NCT03518125|455264362|FG001|Overall Study|Withdrawal by Subject|1|||
126538631|NCT03518125|455264363|FG002|Overall Study|Withdrawal by Subject|0|||
126538632|NCT03518125|455264364|FG003|Overall Study|Withdrawal by Subject|1|||
126538633|NCT03518125|455264365|FG004|Overall Study|Withdrawal by Subject|1|||
126538634|NCT03518125|455264366|FG005|Overall Study|Withdrawal by Subject|3|||
126538635|NCT03518125|455264361|FG000|Overall Study|Missed Day 394 Visit|1|||
126538636|NCT03518125|455264362|FG001|Overall Study|Missed Day 394 Visit|0|||
126538637|NCT03518125|455264363|FG002|Overall Study|Missed Day 394 Visit|0|||
126538638|NCT03518125|455264364|FG003|Overall Study|Missed Day 394 Visit|0|||
126538639|NCT03518125|455264365|FG004|Overall Study|Missed Day 394 Visit|0|||
126538640|NCT03518125|455264366|FG005|Overall Study|Missed Day 394 Visit|0|||
126538641|NCT01424930|455264371|FG000|Overall Study|Adverse Event|0|||
126538642|NCT01424930|455264372|FG001|Overall Study|Adverse Event|1|||
126538643|NCT01424930|455264371|FG000|Overall Study|Death|1|||
126538644|NCT01424930|455264372|FG001|Overall Study|Death|0|||
126538645|NCT01424930|455264371|FG000|Overall Study|Progressive Disease|3|||
126538646|NCT01424930|455264372|FG001|Overall Study|Progressive Disease|6|||
126538647|NCT01424930|455264371|FG000|Overall Study|Screen Failure|0|||
126538648|NCT01424930|455264372|FG001|Overall Study|Screen Failure|1|||
126538649|NCT01424930|455264371|FG000|Overall Study|Reason not specified|0|||
126538650|NCT01424930|455264372|FG001|Overall Study|Reason not specified|6|||
126538651|NCT03286751|455264373|FG000|Washout Period 1|Withdrawal by Subject|0|||
126538652|NCT03286751|455264374|FG001|Washout Period 1|Withdrawal by Subject|0|||
126538653|NCT03286751|455264375|FG002|Washout Period 1|Withdrawal by Subject|0|||
126538654|NCT03286751|455264376|FG003|Washout Period 1|Withdrawal by Subject|0|||
126538655|NCT03286751|455264377|FG004|Washout Period 1|Withdrawal by Subject|1|||
126538656|NCT03286751|455264378|FG005|Washout Period 1|Withdrawal by Subject|0|||
126538657|NCT03286751|455264373|FG000|Washout Period 2|Personal Reasons|0|||
126538658|NCT03286751|455264374|FG001|Washout Period 2|Personal Reasons|1|||
126538659|NCT03286751|455264375|FG002|Washout Period 2|Personal Reasons|0|||
126538660|NCT03286751|455264376|FG003|Washout Period 2|Personal Reasons|0|||
126538661|NCT03286751|455264377|FG004|Washout Period 2|Personal Reasons|0|||
126538662|NCT03286751|455264378|FG005|Washout Period 2|Personal Reasons|0|||
126538663|NCT03286751|455264373|FG000|Washout Period 5|Adverse Event|0|||
126538664|NCT03286751|455264374|FG001|Washout Period 5|Adverse Event|0|||
126538665|NCT03286751|455264375|FG002|Washout Period 5|Adverse Event|0|||
126538666|NCT03286751|455264376|FG003|Washout Period 5|Adverse Event|0|||
126538667|NCT03286751|455264377|FG004|Washout Period 5|Adverse Event|1|||
126538668|NCT03286751|455264378|FG005|Washout Period 5|Adverse Event|0|||
126538669|NCT01896869|455264385|FG000|Overall Study|Withdrawal by Subject|0|||
126538670|NCT01896869|455264386|FG001|Overall Study|Withdrawal by Subject|6|||
126538671|NCT01896869|455264385|FG000|Overall Study|Lost to Follow-up|1|||
126538672|NCT01896869|455264386|FG001|Overall Study|Lost to Follow-up|0|||
126538673|NCT01089374|455264394|FG000|Overall Study|Lost to Follow-up|3|||
126538674|NCT01089374|455264395|FG001|Overall Study|Lost to Follow-up|0|||
126538675|NCT01089374|455264394|FG000|Overall Study|Withdrawal by Subject|1|||
126538676|NCT01089374|455264395|FG001|Overall Study|Withdrawal by Subject|0|||
126538677|NCT01089374|455264394|FG000|Overall Study|Study closed early - low accrual|6|||
126538678|NCT01089374|455264395|FG001|Overall Study|Study closed early - low accrual|0|||
126538679|NCT03494166|455264396|FG000|Overall Study|Death|0|||
126538680|NCT03494166|455264397|FG001|Overall Study|Death|0|||
126538681|NCT03494166|455264398|FG002|Overall Study|Death|0|||
126538682|NCT03494166|455264399|FG003|Overall Study|Death|1|||
126538683|NCT03494166|455264400|FG004|Overall Study|Death|3|||
126538684|NCT03494166|455264401|FG005|Overall Study|Death|0|||
126538685|NCT03494166|455264396|FG000|Overall Study|Lost to Follow-up|2|||
126538686|NCT03494166|455264397|FG001|Overall Study|Lost to Follow-up|2|||
126538687|NCT03494166|455264398|FG002|Overall Study|Lost to Follow-up|2|||
126538688|NCT03494166|455264399|FG003|Overall Study|Lost to Follow-up|2|||
126538689|NCT03494166|455264400|FG004|Overall Study|Lost to Follow-up|14|||
126538690|NCT03494166|455264401|FG005|Overall Study|Lost to Follow-up|0|||
126538691|NCT03494166|455264396|FG000|Overall Study|Withdrawal by Subject|10|||
126538692|NCT03494166|455264397|FG001|Overall Study|Withdrawal by Subject|7|||
126538693|NCT03494166|455264398|FG002|Overall Study|Withdrawal by Subject|0|||
126538694|NCT03494166|455264399|FG003|Overall Study|Withdrawal by Subject|5|||
126538695|NCT03494166|455264400|FG004|Overall Study|Withdrawal by Subject|3|||
126538696|NCT03494166|455264401|FG005|Overall Study|Withdrawal by Subject|17|||
126538697|NCT03494166|455264396|FG000|Overall Study|Screen failure|1|||
126538698|NCT03494166|455264397|FG001|Overall Study|Screen failure|0|||
126538699|NCT03494166|455264398|FG002|Overall Study|Screen failure|0|||
126538700|NCT03494166|455264399|FG003|Overall Study|Screen failure|0|||
126538701|NCT03494166|455264400|FG004|Overall Study|Screen failure|1|||
126538702|NCT03494166|455264401|FG005|Overall Study|Screen failure|0|||
126538703|NCT02857426|455264402|FG000|Overall Study|Disease progression|34|||
126538704|NCT02857426|455264403|FG001|Overall Study|Disease progression|13|||
126538705|NCT02857426|455264402|FG000|Overall Study|Study drug toxicity|4|||
126538706|NCT02857426|455264403|FG001|Overall Study|Study drug toxicity|1|||
126538707|NCT02857426|455264402|FG000|Overall Study|Death|1|||
126538708|NCT02857426|455264403|FG001|Overall Study|Death|0|||
126538709|NCT02857426|455264402|FG000|Overall Study|Adverse event unrelated to study drug|6|||
126538710|NCT02857426|455264403|FG001|Overall Study|Adverse event unrelated to study drug|2|||
126538711|NCT02857426|455264402|FG000|Overall Study|Participant withdrew consent|1|||
126538712|NCT02857426|455264403|FG001|Overall Study|Participant withdrew consent|1|||
126538713|NCT02857426|455264402|FG000|Overall Study|Maximum clinical benefit|1|||
126538714|NCT02857426|455264403|FG001|Overall Study|Maximum clinical benefit|0|||
126538715|NCT02857426|455264402|FG000|Overall Study|Completed treatment|0|||
126538716|NCT02857426|455264403|FG001|Overall Study|Completed treatment|2|||
126538717|NCT02110901|455264407|FG000|Overall Study|Death|6|||
126538718|NCT02110901|455264408|FG001|Overall Study|Death|3|||
126538719|NCT02110901|455264407|FG000|Overall Study|Lost to Follow-up|12|||
126538720|NCT02110901|455264408|FG001|Overall Study|Lost to Follow-up|8|||
126538721|NCT02110901|455264407|FG000|Overall Study|Withdrawal by Subject|7|||
126538722|NCT02110901|455264408|FG001|Overall Study|Withdrawal by Subject|3|||
126538723|NCT02110901|455264407|FG000|Overall Study|received a kidney transplant|5|||
126538724|NCT02110901|455264408|FG001|Overall Study|received a kidney transplant|0|||
126538725|NCT00758459|455264409|FG000|Overall Study|Adverse Event|3|||
126538726|NCT00758459|455264410|FG001|Overall Study|Adverse Event|2|||
126538727|NCT00758459|455264409|FG000|Overall Study|Protocol Violation|0|||
126538728|NCT00758459|455264410|FG001|Overall Study|Protocol Violation|1|||
126538729|NCT00758459|455264409|FG000|Overall Study|Withdrawal by Subject|0|||
126538730|NCT00758459|455264410|FG001|Overall Study|Withdrawal by Subject|1|||
126538731|NCT02831257|455264412|FG000|Overall Study|Lack of Efficacy|3|||
126538732|NCT02831257|455264412|FG000|Overall Study|Adverse Event|2|||
126538733|NCT02831257|455264412|FG000|Overall Study|Physician Decision|1|||
126538734|NCT02831257|455264412|FG000|Overall Study|Withdrawal by Subject|6|||
126314506|NCT02407457|454442695|FG000|2-year|Open Repair|0|||
126538735|NCT01780935|455264413|FG000|Overall Study|Admin problems due to early termination|321|||
126314507|NCT02407457|454442696|FG001|2-year|Open Repair|2|||
126314508|NCT02407457|454442695|FG000|3-year|Death|11|||
126314509|NCT02407457|454442696|FG001|3-year|Death|10|||
126314510|NCT02407457|454442695|FG000|3-year|Lost to Follow-up|9|||
126538736|NCT01780935|455264414|FG001|Overall Study|Admin problems due to early termination|309|||
126314511|NCT02407457|454442696|FG001|3-year|Lost to Follow-up|10|||
126314512|NCT02407457|454442695|FG000|3-year|Missed Visit|19|||
126538737|NCT01780935|455264413|FG000|Overall Study|Adverse Event|2|||
126538738|NCT01780935|455264414|FG001|Overall Study|Adverse Event|4|||
126538739|NCT01780935|455264413|FG000|Overall Study|Death|1|||
126538740|NCT01780935|455264414|FG001|Overall Study|Death|6|||
126314513|NCT02407457|454442696|FG001|3-year|Missed Visit|16|||
126538741|NCT01780935|455264413|FG000|Overall Study|Lost to Follow-up|2|||
126538742|NCT01780935|455264414|FG001|Overall Study|Lost to Follow-up|6|||
126538743|NCT01780935|455264413|FG000|Overall Study|Physician Decision|1|||
126538744|NCT01780935|455264414|FG001|Overall Study|Physician Decision|1|||
126538745|NCT01780935|455264413|FG000|Overall Study|Protocol deviation|0|||
126538746|NCT01780935|455264414|FG001|Overall Study|Protocol deviation|1|||
126538747|NCT01780935|455264413|FG000|Overall Study|Patient withdrew consent|8|||
126314514|NCT02407457|454442695|FG000|4-year|Death|18|||
126314515|NCT02407457|454442696|FG001|4-year|Death|10|||
126538748|NCT01780935|455264414|FG001|Overall Study|Patient withdrew consent|9|||
126538749|NCT00855595|455264415|FG000|Overall Study|Withdrawal by Subject|1|||
126538750|NCT00855595|455264416|FG001|Overall Study|Withdrawal by Subject|2|||
126538751|NCT00855595|455264415|FG000|Overall Study|Lost to Follow-up|3|||
126538752|NCT00855595|455264416|FG001|Overall Study|Lost to Follow-up|3|||
126314516|NCT02407457|454442695|FG000|4-year|Lost to Follow-up|10|||
126314517|NCT02407457|454442696|FG001|4-year|Lost to Follow-up|12|||
126314518|NCT02407457|454442695|FG000|4-year|Missed Visit|18|||
126314519|NCT02407457|454442696|FG001|4-year|Missed Visit|16|||
126314520|NCT02407457|454442695|FG000|5-year|Death|10|||
126314521|NCT02407457|454442696|FG001|5-year|Death|3|||
126314522|NCT02407457|454442695|FG000|5-year|Lost to Follow-up|22|||
126314523|NCT02407457|454442696|FG001|5-year|Lost to Follow-up|13|||
126314524|NCT02407457|454442695|FG000|5-year|Missed Visit|9|||
126314525|NCT02407457|454442696|FG001|5-year|Missed Visit|1|||
126314526|NCT02052596|454442697|FG000|Active Phase|Adverse Event|3|||
126314527|NCT02052596|454442698|FG001|Active Phase|Adverse Event|2|||
126314528|NCT02052596|454442697|FG000|Active Phase|Lost to Follow-up|8|||
126314529|NCT02052596|454442698|FG001|Active Phase|Lost to Follow-up|11|||
126314530|NCT02052596|454442697|FG000|Active Phase|Protocol Violation|1|||
126314531|NCT02052596|454442698|FG001|Active Phase|Protocol Violation|2|||
126314532|NCT02052596|454442697|FG000|Active Phase|Withdrawal by Subject|3|||
126314533|NCT02052596|454442698|FG001|Active Phase|Withdrawal by Subject|4|||
126314534|NCT02052596|454442697|FG000|Active Phase|Enrolled in error|1|||
126314535|NCT02052596|454442698|FG001|Active Phase|Enrolled in error|0|||
126314536|NCT02052596|454442697|FG000|Active Phase|Lost due to Crohn's disease|0|||
126314537|NCT02052596|454442698|FG001|Active Phase|Lost due to Crohn's disease|1|||
126314538|NCT02052596|454442697|FG000|Safety Phase|Adverse Event|6|||
126314539|NCT02052596|454442698|FG001|Safety Phase|Adverse Event|3|||
126314540|NCT02052596|454442697|FG000|Safety Phase|Lost to Follow-up|11|||
126314541|NCT02052596|454442698|FG001|Safety Phase|Lost to Follow-up|18|||
126314542|NCT02052596|454442697|FG000|Safety Phase|Protocol Violation|1|||
126314543|NCT02052596|454442698|FG001|Safety Phase|Protocol Violation|2|||
126314544|NCT02052596|454442697|FG000|Safety Phase|Withdrawal by Subject|8|||
126314545|NCT02052596|454442698|FG001|Safety Phase|Withdrawal by Subject|11|||
126314546|NCT02052596|454442697|FG000|Safety Phase|Enrolled in error|1|||
126538753|NCT00855595|455264415|FG000|Overall Study|Adverse Event|1|||
126538754|NCT00855595|455264416|FG001|Overall Study|Adverse Event|1|||
126538755|NCT00855595|455264415|FG000|Overall Study|patient moved out of state|1|||
126538756|NCT00855595|455264416|FG001|Overall Study|patient moved out of state|0|||
126538757|NCT00855595|455264415|FG000|Overall Study|patient left country|0|||
126538758|NCT00855595|455264416|FG001|Overall Study|patient left country|1|||
126538759|NCT03371940|455264417|FG000|Overall Study|Withdrawal by Subject|8|||
126538760|NCT03371940|455264418|FG001|Overall Study|Withdrawal by Subject|1|||
126538761|NCT03371940|455264419|FG002|Overall Study|Withdrawal by Subject|3|||
126314547|NCT02052596|454442698|FG001|Safety Phase|Enrolled in error|0|||
126314548|NCT02052596|454442697|FG000|Safety Phase|Lost due to Crohn's disease|0|||
126314549|NCT02052596|454442698|FG001|Safety Phase|Lost due to Crohn's disease|1|||
126314550|NCT00705718|454442699|FG000|Overall Study|Death|6|||
126314551|NCT00705718|454442700|FG001|Overall Study|Death|6|||
126314552|NCT00705718|454442699|FG000|Overall Study|Not due for Visit|0|||
126314553|NCT00705718|454442700|FG001|Overall Study|Not due for Visit|12|||
126314554|NCT00705718|454442699|FG000|Overall Study|Follow up not done|1|||
126314555|NCT00705718|454442700|FG001|Overall Study|Follow up not done|4|||
126314556|NCT06137703|454442702|FG000|Overall Study|Other|0|||
126314557|NCT06137703|454442703|FG001|Overall Study|Other|1|||
126314558|NCT06137703|454442704|FG002|Overall Study|Other|0|||
126314559|NCT06137703|454442705|FG003|Overall Study|Other|0|||
126314560|NCT06137703|454442702|FG000|Overall Study|Adverse Event|0|||
126314561|NCT06137703|454442703|FG001|Overall Study|Adverse Event|0|||
126314562|NCT06137703|454442704|FG002|Overall Study|Adverse Event|1|||
126314563|NCT06137703|454442705|FG003|Overall Study|Adverse Event|0|||
126314564|NCT00741091|454442710|FG000|Overall Study|Death|13|||
126314565|NCT00741091|454442710|FG000|Overall Study|Lost to Follow-up|16|||
126314566|NCT00741091|454442710|FG000|Overall Study|Withdrawal by Subject|6|||
126314567|NCT00741091|454442710|FG000|Overall Study|Missed Visit|22|||
126314568|NCT01801358|454442711|FG000|Overall Study|Adverse Event|0|||
126314569|NCT01801358|454442712|FG001|Overall Study|Adverse Event|2|||
126314570|NCT01801358|454442713|FG002|Overall Study|Adverse Event|1|||
126314571|NCT01801358|454442714|FG003|Overall Study|Adverse Event|0|||
126314572|NCT01801358|454442715|FG004|Overall Study|Adverse Event|0|||
126314573|NCT01801358|454442716|FG005|Overall Study|Adverse Event|1|||
126314574|NCT01801358|454442711|FG000|Overall Study|Physician Decision|0|||
126538762|NCT03371940|455264420|FG003|Overall Study|Withdrawal by Subject|4|||
126538763|NCT00696410|455264423|FG000|Overall Study|Lost to Follow-up|2|||
126538764|NCT00696410|455264424|FG001|Overall Study|Lost to Follow-up|0|||
126538765|NCT00696410|455264423|FG000|Overall Study|Withdrawal by Subject|8|||
126314575|NCT01801358|454442712|FG001|Overall Study|Physician Decision|0|||
126314576|NCT01801358|454442713|FG002|Overall Study|Physician Decision|1|||
126314577|NCT01801358|454442714|FG003|Overall Study|Physician Decision|0|||
126314578|NCT01801358|454442715|FG004|Overall Study|Physician Decision|0|||
126314579|NCT01801358|454442716|FG005|Overall Study|Physician Decision|0|||
126314580|NCT01801358|454442711|FG000|Overall Study|Progressive Disease|6|||
126314581|NCT01801358|454442712|FG001|Overall Study|Progressive Disease|4|||
126314582|NCT01801358|454442713|FG002|Overall Study|Progressive Disease|4|||
126314583|NCT01801358|454442714|FG003|Overall Study|Progressive Disease|5|||
126314584|NCT01801358|454442715|FG004|Overall Study|Progressive Disease|6|||
126314585|NCT01801358|454442716|FG005|Overall Study|Progressive Disease|5|||
126314586|NCT01801358|454442711|FG000|Overall Study|Withdrawal by Subject|0|||
126314587|NCT01801358|454442712|FG001|Overall Study|Withdrawal by Subject|0|||
126314588|NCT01801358|454442713|FG002|Overall Study|Withdrawal by Subject|0|||
126314589|NCT01801358|454442714|FG003|Overall Study|Withdrawal by Subject|1|||
126314590|NCT01801358|454442715|FG004|Overall Study|Withdrawal by Subject|0|||
126314591|NCT01801358|454442716|FG005|Overall Study|Withdrawal by Subject|2|||
126314592|NCT01527487|454442717|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
126314593|NCT01527487|454442718|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
126314594|NCT01527487|454442717|FG000|Overall Study|Disease Progression|4|||
126314595|NCT01527487|454442718|FG001|Overall Study|Disease Progression|1|||
126314596|NCT01527487|454442717|FG000|Overall Study|Adverse Event|1|||
126314597|NCT01527487|454442718|FG001|Overall Study|Adverse Event|1|||
126314598|NCT01527487|454442717|FG000|Overall Study|Death|0|||
126314599|NCT01527487|454442718|FG001|Overall Study|Death|1|||
126314600|NCT00723190|454442722|FG000|Overall Study|Withdrawal by Subject|45|||
126314601|NCT00723190|454442722|FG000|Overall Study|Lost to Follow-up|37|||
126314602|NCT00723190|454442722|FG000|Overall Study|Adverse Event|18|||
126314603|NCT00723190|454442722|FG000|Overall Study|Lack of Efficacy|16|||
126314604|NCT00723190|454442722|FG000|Overall Study|Protocol Violation|15|||
126314605|NCT00723190|454442722|FG000|Overall Study|Other-Premature Discontinuation|9|||
126314606|NCT00723190|454442722|FG000|Overall Study|Other-Not included in safety population|2|||
126314607|NCT03181503|454442723|FG000|Overall Study|Adverse Event|2|||
126314608|NCT03181503|454442724|FG001|Overall Study|Adverse Event|2|||
126314609|NCT03181503|454442723|FG000|Overall Study|Protocol Violation|1|||
126314610|NCT03181503|454442724|FG001|Overall Study|Protocol Violation|0|||
126314611|NCT03181503|454442723|FG000|Overall Study|Withdrawal by Subject|3|||
126314612|NCT03181503|454442724|FG001|Overall Study|Withdrawal by Subject|0|||
126314613|NCT03181503|454442723|FG000|Overall Study|Lost to Follow-up|1|||
126314614|NCT03181503|454442724|FG001|Overall Study|Lost to Follow-up|1|||
126314615|NCT02505334|454442735|FG000|Main Treatment Period|Adverse Event|3|||
126314616|NCT02505334|454442736|FG001|Main Treatment Period|Adverse Event|3|||
126314617|NCT02505334|454442735|FG000|Main Treatment Period|Lack of Efficacy|7|||
126314618|NCT02505334|454442736|FG001|Main Treatment Period|Lack of Efficacy|17|||
126314619|NCT02505334|454442735|FG000|Main Treatment Period|Protocol Violation|0|||
126314620|NCT02505334|454442736|FG001|Main Treatment Period|Protocol Violation|1|||
126314621|NCT02505334|454442735|FG000|Main Treatment Period|Withdrawal by Subject|1|||
126314622|NCT02505334|454442736|FG001|Main Treatment Period|Withdrawal by Subject|8|||
126314623|NCT02505334|454442735|FG000|Main Treatment Period|Unclassified|4|||
126314624|NCT02505334|454442736|FG001|Main Treatment Period|Unclassified|10|||
126314625|NCT02505334|454442735|FG000|Extension Treatment Period|Adverse Event|5|||
126314626|NCT02505334|454442736|FG001|Extension Treatment Period|Adverse Event|0|||
126314627|NCT02505334|454442735|FG000|Extension Treatment Period|Lack of Efficacy|4|||
126314628|NCT02505334|454442736|FG001|Extension Treatment Period|Lack of Efficacy|0|||
126314629|NCT02505334|454442735|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
126314630|NCT02505334|454442736|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
126314631|NCT02505334|454442735|FG000|Extension Treatment Period|Unclassified|3|||
126314632|NCT02505334|454442736|FG001|Extension Treatment Period|Unclassified|0|||
126314633|NCT03199612|454442737|FG000|Overall Study|Adverse Event|1|||
126314634|NCT03199612|454442738|FG001|Overall Study|Adverse Event|0|||
126314635|NCT00081731|454442746|FG000|Overall Study|scientific integrity issue|8|||
126314636|NCT00081731|454442747|FG001|Overall Study|scientific integrity issue|8|||
126314637|NCT02386345|454442751|FG000|Overall Study|Not treated|14|||
126314638|NCT02386345|454442751|FG000|Overall Study|Lost to Follow-up|1|||
126314639|NCT02386345|454442751|FG000|Overall Study|Adverse Event|5|||
126314640|NCT02386345|454442751|FG000|Overall Study|Repeat Procedure|10|||
126314641|NCT02386345|454442751|FG000|Overall Study|Did not complete 12-month follow-up|72|||
126314642|NCT02258542|454442752|FG000|Overall Study|eg. not made to the visit|7|||
126538766|NCT00696410|455264424|FG001|Overall Study|Withdrawal by Subject|0|||
126314643|NCT02258542|454442753|FG001|Overall Study|eg. not made to the visit|4|||
126538767|NCT00696410|455264423|FG000|Overall Study|Physician Decision|3|||
126314644|NCT02258542|454442754|FG002|Overall Study|eg. not made to the visit|0|||
126314645|NCT02258542|454442755|FG003|Overall Study|eg. not made to the visit|1|||
126314646|NCT02258542|454442752|FG000|Overall Study|study specific discount. criteria|1|||
126314647|NCT02258542|454442753|FG001|Overall Study|study specific discount. criteria|1|||
126314648|NCT02258542|454442754|FG002|Overall Study|study specific discount. criteria|0|||
126314649|NCT02258542|454442755|FG003|Overall Study|study specific discount. criteria|0|||
126314650|NCT02258542|454442752|FG000|Overall Study|Withdrawal by Subject|20|||
126314651|NCT02258542|454442753|FG001|Overall Study|Withdrawal by Subject|20|||
126314652|NCT02258542|454442754|FG002|Overall Study|Withdrawal by Subject|7|||
126314653|NCT02258542|454442755|FG003|Overall Study|Withdrawal by Subject|1|||
126538768|NCT00696410|455264424|FG001|Overall Study|Physician Decision|0|||
126314654|NCT02258542|454442752|FG000|Overall Study|Lost to Follow-up|5|||
126314655|NCT02258542|454442753|FG001|Overall Study|Lost to Follow-up|12|||
126314656|NCT02258542|454442754|FG002|Overall Study|Lost to Follow-up|1|||
126314657|NCT02258542|454442755|FG003|Overall Study|Lost to Follow-up|2|||
126314658|NCT02258542|454442752|FG000|Overall Study|Death|5|||
126314659|NCT02258542|454442753|FG001|Overall Study|Death|4|||
126314660|NCT02258542|454442754|FG002|Overall Study|Death|0|||
126314661|NCT02258542|454442755|FG003|Overall Study|Death|1|||
126314662|NCT02258542|454442752|FG000|Overall Study|Adverse Event|3|||
126314663|NCT02258542|454442753|FG001|Overall Study|Adverse Event|4|||
126314664|NCT02258542|454442754|FG002|Overall Study|Adverse Event|0|||
126314665|NCT02258542|454442755|FG003|Overall Study|Adverse Event|0|||
126314666|NCT02258542|454442752|FG000|Overall Study|Protocol Violation|1|||
126314667|NCT02258542|454442753|FG001|Overall Study|Protocol Violation|2|||
126314668|NCT02258542|454442754|FG002|Overall Study|Protocol Violation|0|||
126314669|NCT02258542|454442755|FG003|Overall Study|Protocol Violation|0|||
126314670|NCT02258542|454442752|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126314671|NCT02258542|454442753|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
126314672|NCT02258542|454442754|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
126314673|NCT02258542|454442755|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
126314674|NCT00986986|454442756|FG000|Overall Study|Lost to Follow-up|0|||
126314675|NCT00986986|454442757|FG001|Overall Study|Lost to Follow-up|1|||
126314676|NCT04050124|454442758|FG000|Overall Study|Death|1|||
126314677|NCT04050124|454442759|FG001|Overall Study|Death|0|||
126314678|NCT01537068|454442770|FG000|Overall Study|Lost to Follow-up|2|||
126314679|NCT01537068|454442771|FG001|Overall Study|Lost to Follow-up|1|||
126314680|NCT01537068|454442770|FG000|Overall Study|Adverse Event|0|||
126314681|NCT01537068|454442771|FG001|Overall Study|Adverse Event|1|||
126314682|NCT01537068|454442770|FG000|Overall Study|Withdrawal by Subject|1|||
126314683|NCT01537068|454442771|FG001|Overall Study|Withdrawal by Subject|1|||
126314684|NCT01537068|454442770|FG000|Overall Study|Lack of Efficacy|1|||
126314685|NCT01537068|454442771|FG001|Overall Study|Lack of Efficacy|0|||
126314686|NCT00483704|454442772|FG000|Randomization|Withdrawal by Subject|19|||
126314687|NCT00483704|454442773|FG001|Randomization|Withdrawal by Subject|28|||
126314688|NCT00483704|454442774|FG002|Randomization|Withdrawal by Subject|18|||
126314689|NCT00483704|454442772|FG000|Randomization|Protocol Violation|14|||
126314690|NCT00483704|454442773|FG001|Randomization|Protocol Violation|25|||
126314691|NCT00483704|454442774|FG002|Randomization|Protocol Violation|22|||
126314692|NCT00483704|454442772|FG000|Randomization|Lost to Follow-up|14|||
126314693|NCT00483704|454442773|FG001|Randomization|Lost to Follow-up|14|||
126314694|NCT00483704|454442774|FG002|Randomization|Lost to Follow-up|19|||
126314695|NCT00483704|454442772|FG000|Randomization|Pregnancy|1|||
126314696|NCT00483704|454442773|FG001|Randomization|Pregnancy|0|||
126314697|NCT00483704|454442774|FG002|Randomization|Pregnancy|0|||
126314698|NCT00483704|454442772|FG000|Randomization|Physician Decision|2|||
126314699|NCT00483704|454442773|FG001|Randomization|Physician Decision|4|||
126314700|NCT00483704|454442774|FG002|Randomization|Physician Decision|0|||
126314701|NCT00483704|454442772|FG000|Randomization|Progressive disease|0|||
126314702|NCT00483704|454442773|FG001|Randomization|Progressive disease|0|||
126314703|NCT00483704|454442774|FG002|Randomization|Progressive disease|1|||
126314704|NCT00483704|454442772|FG000|Randomization|Lack of qualifying migraines|21|||
126314705|NCT00483704|454442773|FG001|Randomization|Lack of qualifying migraines|25|||
126314706|NCT00483704|454442774|FG002|Randomization|Lack of qualifying migraines|31|||
126314707|NCT00483704|454442772|FG000|Treatment|Lack of qualifying migraines|101|||
126314708|NCT00483704|454442773|FG001|Treatment|Lack of qualifying migraines|99|||
126314709|NCT00483704|454442774|FG002|Treatment|Lack of qualifying migraines|116|||
126314710|NCT00483704|454442772|FG000|Treatment|Adverse Event|3|||
126314711|NCT00483704|454442773|FG001|Treatment|Adverse Event|5|||
126314712|NCT00483704|454442774|FG002|Treatment|Adverse Event|4|||
126314713|NCT00483704|454442772|FG000|Treatment|Withdrawal by Subject|16|||
126314714|NCT00483704|454442773|FG001|Treatment|Withdrawal by Subject|12|||
126314715|NCT00483704|454442774|FG002|Treatment|Withdrawal by Subject|21|||
126314716|NCT00483704|454442772|FG000|Treatment|Protocol Violation|6|||
126314717|NCT00483704|454442773|FG001|Treatment|Protocol Violation|3|||
126314718|NCT00483704|454442774|FG002|Treatment|Protocol Violation|5|||
126314719|NCT00483704|454442772|FG000|Treatment|Lost to Follow-up|2|||
126314720|NCT00483704|454442773|FG001|Treatment|Lost to Follow-up|7|||
126314721|NCT00483704|454442774|FG002|Treatment|Lost to Follow-up|5|||
126314722|NCT00483704|454442772|FG000|Treatment|Lack of Efficacy|1|||
126314723|NCT00483704|454442773|FG001|Treatment|Lack of Efficacy|1|||
126314724|NCT00483704|454442774|FG002|Treatment|Lack of Efficacy|1|||
126314725|NCT00483704|454442772|FG000|Treatment|Pregnancy|0|||
126314726|NCT00483704|454442773|FG001|Treatment|Pregnancy|1|||
126314727|NCT00483704|454442774|FG002|Treatment|Pregnancy|0|||
126314728|NCT00483704|454442772|FG000|Treatment|Physician Decision|0|||
126314729|NCT00483704|454442773|FG001|Treatment|Physician Decision|1|||
126314730|NCT00483704|454442774|FG002|Treatment|Physician Decision|4|||
126314731|NCT04442269|454442775|FG000|Overall Study|Adverse Event|1|||
126314732|NCT04442269|454442776|FG001|Overall Study|Adverse Event|0|||
126314733|NCT04442269|454442775|FG000|Overall Study|Death|0|||
126314734|NCT04442269|454442776|FG001|Overall Study|Death|1|||
126314735|NCT04442269|454442775|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
126314736|NCT04442269|454442776|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
126314737|NCT04442269|454442775|FG000|Overall Study|Lost to Follow-up|1|||
126314738|NCT04442269|454442776|FG001|Overall Study|Lost to Follow-up|0|||
126314739|NCT04442269|454442775|FG000|Overall Study|Withdrawal by Subject|3|||
126314740|NCT04442269|454442776|FG001|Overall Study|Withdrawal by Subject|2|||
126314741|NCT04442269|454442775|FG000|Overall Study|Protocol Deviation|0|||
126314742|NCT04442269|454442776|FG001|Overall Study|Protocol Deviation|1|||
126314743|NCT04442269|454442775|FG000|Overall Study|Travel Limitations|1|||
126314744|NCT04442269|454442776|FG001|Overall Study|Travel Limitations|1|||
126314745|NCT00819780|454442777|FG000|Overall Study|Did not receive study drug|3|||
126314746|NCT00819780|454442778|FG001|Overall Study|Did not receive study drug|4|||
126314747|NCT00819780|454442777|FG000|Overall Study|Still in treatment|25|||
126314748|NCT00819780|454442778|FG001|Overall Study|Still in treatment|17|||
126314749|NCT01793688|454442779|FG000|Overall Study|Protocol Violation|2|||
126314750|NCT01698879|454442782|FG000|Overall Study|Withdrawal by Subject|1|||
126314751|NCT01698879|454442783|FG001|Overall Study|Withdrawal by Subject|0|||
126314752|NCT01698879|454442784|FG002|Overall Study|Withdrawal by Subject|0|||
126314753|NCT04972968|454442785|FG000|Overall Study|Adverse Event|3|||
126314754|NCT04972968|454442786|FG001|Overall Study|Adverse Event|1|||
126314755|NCT04972968|454442787|FG002|Overall Study|Adverse Event|1|||
126314756|NCT04972968|454442788|FG003|Overall Study|Adverse Event|7|||
126314757|NCT04972968|454442785|FG000|Overall Study|Lack of Efficacy|2|||
126314758|NCT04972968|454442786|FG001|Overall Study|Lack of Efficacy|1|||
126314759|NCT04972968|454442787|FG002|Overall Study|Lack of Efficacy|0|||
126314760|NCT04972968|454442788|FG003|Overall Study|Lack of Efficacy|0|||
126314761|NCT04972968|454442785|FG000|Overall Study|Withdrawal by Subject|7|||
126314762|NCT04972968|454442786|FG001|Overall Study|Withdrawal by Subject|4|||
126314763|NCT04972968|454442787|FG002|Overall Study|Withdrawal by Subject|3|||
126314764|NCT04972968|454442788|FG003|Overall Study|Withdrawal by Subject|2|||
126314765|NCT04972968|454442785|FG000|Overall Study|Study Terminated by Sponsor|25|||
126314766|NCT04972968|454442786|FG001|Overall Study|Study Terminated by Sponsor|28|||
126314767|NCT04972968|454442787|FG002|Overall Study|Study Terminated by Sponsor|32|||
126314768|NCT04972968|454442788|FG003|Overall Study|Study Terminated by Sponsor|27|||
126314769|NCT04972968|454442785|FG000|Overall Study|Other|1|||
126314770|NCT04972968|454442786|FG001|Overall Study|Other|0|||
126314771|NCT04972968|454442787|FG002|Overall Study|Other|1|||
126314772|NCT04972968|454442788|FG003|Overall Study|Other|1|||
126314773|NCT03589976|454442793|FG000|Overall Study|Death|5|||
126314774|NCT03589976|454442794|FG001|Overall Study|Death|1|||
126314775|NCT03589976|454442793|FG000|Overall Study|Adverse Event|5|||
126314776|NCT03589976|454442794|FG001|Overall Study|Adverse Event|1|||
126314777|NCT03589976|454442793|FG000|Overall Study|Withdrawal by Subject|4|||
126314778|NCT03589976|454442794|FG001|Overall Study|Withdrawal by Subject|1|||
126314779|NCT03589976|454442793|FG000|Overall Study|Lost to Follow-up|1|||
126314780|NCT03589976|454442794|FG001|Overall Study|Lost to Follow-up|0|||
126314781|NCT03589976|454442793|FG000|Overall Study|Other|4|||
126314782|NCT03589976|454442794|FG001|Overall Study|Other|3|||
126314783|NCT00514904|454442797|FG000|Overall Study|Withdrawal by Subject|3|||
126314784|NCT00514904|454442798|FG001|Overall Study|Withdrawal by Subject|2|||
126314785|NCT00514904|454442797|FG000|Overall Study|Lost to Follow-up|21|||
126314786|NCT00514904|454442798|FG001|Overall Study|Lost to Follow-up|3|||
126314787|NCT00084318|454442800|FG000|Overall Study|Withdrawal by Subject|5|||
126314788|NCT00084318|454442801|FG001|Overall Study|Withdrawal by Subject|2|||
126314789|NCT00084318|454442800|FG000|Overall Study|Protocol Violation|15|||
126314790|NCT00084318|454442801|FG001|Overall Study|Protocol Violation|11|||
126314791|NCT00084318|454442800|FG000|Overall Study|No protocol treatment|2|||
126314792|NCT00084318|454442801|FG001|Overall Study|No protocol treatment|0|||
126314793|NCT03430895|454442802|FG000|Overall Study|Not Treated|2|||
126314794|NCT01317797|454442804|FG000|Overall Study|Other|0|||
126314795|NCT01317797|454442805|FG001|Overall Study|Other|1|||
126314796|NCT01317797|454442806|FG002|Overall Study|Other|0|||
126538769|NCT01951638|455264426|FG000|Treatment Period|Protocol Violation|0|||
126538770|NCT01951638|455264427|FG001|Treatment Period|Protocol Violation|0|||
126314797|NCT01317797|454442804|FG000|Overall Study|Withdrawal of Patient|0|||
126314798|NCT01317797|454442805|FG001|Overall Study|Withdrawal of Patient|0|||
126314799|NCT01317797|454442806|FG002|Overall Study|Withdrawal of Patient|1|||
126314800|NCT03197467|454444026|FG000|Overall Study|Withdrawal by Subject|1|||
126314801|NCT04599933|454444034|FG000|Overall Study|Adverse Event|4|||
126314802|NCT04599933|454444035|FG001|Overall Study|Adverse Event|1|||
126314803|NCT04599933|454444034|FG000|Overall Study|Withdrawal by Subject|4|||
126314804|NCT04599933|454444035|FG001|Overall Study|Withdrawal by Subject|2|||
126314805|NCT04599933|454444034|FG000|Overall Study|Lost to Follow-up|0|||
126314806|NCT04599933|454444035|FG001|Overall Study|Lost to Follow-up|1|||
126538771|NCT01951638|455264428|FG002|Treatment Period|Protocol Violation|0|||
126314807|NCT04599933|454444034|FG000|Overall Study|Physician Decision|0|||
126314808|NCT04599933|454444035|FG001|Overall Study|Physician Decision|1|||
126314809|NCT04599933|454444034|FG000|Overall Study|Screen Failure|1|||
126314810|NCT04599933|454444035|FG001|Overall Study|Screen Failure|2|||
126314811|NCT04392167|454444043|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
126314812|NCT04063657|454444044|FG000|Overall Study|Lost to Follow-up|1|||
126314813|NCT04063657|454444045|FG001|Overall Study|Lost to Follow-up|0|||
126314814|NCT03408444|454444046|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
126314815|NCT03408444|454444047|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
126314816|NCT03408444|454444048|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
126314817|NCT03408444|454444049|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
126314818|NCT03408444|454444046|FG000|Overall Study|Lens Discomfort|0|||
126314819|NCT03408444|454444047|FG001|Overall Study|Lens Discomfort|1|||
126314820|NCT03408444|454444048|FG002|Overall Study|Lens Discomfort|0|||
126314821|NCT03408444|454444049|FG003|Overall Study|Lens Discomfort|0|||
126314822|NCT03408444|454444046|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
126314823|NCT03408444|454444047|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
126314824|NCT03408444|454444048|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
126314825|NCT03408444|454444049|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
126314826|NCT03408444|454444046|FG000|Overall Study|Withdrawal by Subject|0|||
126314827|NCT03408444|454444047|FG001|Overall Study|Withdrawal by Subject|2|||
126314828|NCT03408444|454444048|FG002|Overall Study|Withdrawal by Subject|3|||
126314829|NCT03408444|454444049|FG003|Overall Study|Withdrawal by Subject|0|||
126314830|NCT03408444|454444046|FG000|Overall Study|Lost to Follow-up|0|||
126314831|NCT03408444|454444047|FG001|Overall Study|Lost to Follow-up|0|||
126314832|NCT03408444|454444048|FG002|Overall Study|Lost to Follow-up|1|||
126314833|NCT03408444|454444049|FG003|Overall Study|Lost to Follow-up|0|||
126314834|NCT03408444|454444046|FG000|Overall Study|Adverse Event|0|||
126314835|NCT03408444|454444047|FG001|Overall Study|Adverse Event|0|||
126314836|NCT03408444|454444048|FG002|Overall Study|Adverse Event|0|||
126314837|NCT03408444|454444049|FG003|Overall Study|Adverse Event|1|||
126314838|NCT03408444|454444046|FG000|Overall Study|Lens Handling Difficulties|0|||
126314839|NCT03408444|454444047|FG001|Overall Study|Lens Handling Difficulties|0|||
126314840|NCT03408444|454444048|FG002|Overall Study|Lens Handling Difficulties|1|||
126314841|NCT03408444|454444049|FG003|Overall Study|Lens Handling Difficulties|0|||
126314842|NCT03408444|454444046|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
126314843|NCT03408444|454444047|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
126314844|NCT03408444|454444048|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
126314845|NCT03408444|454444049|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
126314846|NCT04984681|454444050|FG000|Overall Study|Lost to Follow-up|3|||
126314847|NCT04984681|454444051|FG001|Overall Study|Lost to Follow-up|1|||
126314848|NCT01473394|454444052|FG000|Overall Study|Adverse Event|13|||
126314849|NCT01473394|454444053|FG001|Overall Study|Adverse Event|16|||
126314850|NCT01473394|454444052|FG000|Overall Study|Insufficient Therapeutic Response|4|||
126314851|NCT01473394|454444053|FG001|Overall Study|Insufficient Therapeutic Response|1|||
126314852|NCT01473394|454444052|FG000|Overall Study|Protocol Violation|7|||
126314853|NCT01473394|454444053|FG001|Overall Study|Protocol Violation|5|||
126314854|NCT01473394|454444052|FG000|Overall Study|Withdrew Consent|12|||
126314855|NCT01473394|454444053|FG001|Overall Study|Withdrew Consent|10|||
126314856|NCT01473394|454444052|FG000|Overall Study|Lost to Follow-up|9|||
126314857|NCT01473394|454444053|FG001|Overall Study|Lost to Follow-up|11|||
126314858|NCT03536949|454444056|FG000|Overall Study|Adverse Event|4|||
126314859|NCT03536949|454444057|FG001|Overall Study|Adverse Event|0|||
126314860|NCT03536949|454444056|FG000|Overall Study|Lost to Follow-up|2|||
126314861|NCT03536949|454444057|FG001|Overall Study|Lost to Follow-up|1|||
126314862|NCT03536949|454444056|FG000|Overall Study|Withdrawal by Subject|6|||
126314863|NCT03536949|454444057|FG001|Overall Study|Withdrawal by Subject|0|||
126314864|NCT03536949|454444056|FG000|Overall Study|Non-compliance|2|||
126314865|NCT03536949|454444057|FG001|Overall Study|Non-compliance|1|||
126314866|NCT00250458|454444061|FG000|Overall Study|Lost to Follow-up|4|||
126314867|NCT00250458|454444062|FG001|Overall Study|Lost to Follow-up|2|||
126314868|NCT00250458|454444061|FG000|Overall Study|Protocol Violation|0|||
126314869|NCT00250458|454444062|FG001|Overall Study|Protocol Violation|1|||
126314870|NCT00250458|454444061|FG000|Overall Study|Withdrawal by Subject|4|||
126314871|NCT00250458|454444062|FG001|Overall Study|Withdrawal by Subject|2|||
126314872|NCT00250458|454444061|FG000|Overall Study|Lack of Migraine Attack|20|||
126314873|NCT00250458|454444062|FG001|Overall Study|Lack of Migraine Attack|9|||
126314874|NCT00250458|454444061|FG000|Overall Study|Qualifying migraine but did not treat|3|||
126314875|NCT00250458|454444062|FG001|Overall Study|Qualifying migraine but did not treat|3|||
126314876|NCT00250458|454444061|FG000|Overall Study|Other|1|||
126314877|NCT00250458|454444062|FG001|Overall Study|Other|0|||
126314878|NCT01549041|454444063|FG000|Overall Study|Lack of Efficacy|2|||
126314879|NCT01549041|454444064|FG001|Overall Study|Lack of Efficacy|4|||
126314880|NCT01549041|454444063|FG000|Overall Study|Adverse Event|0|||
126314881|NCT01549041|454444064|FG001|Overall Study|Adverse Event|4|||
126314882|NCT00597506|454444065|FG000|Overall Study|Subject is being followed for survival|1|||
126314883|NCT02609724|454444066|FG000|Overall Study|Death|2|||
126314884|NCT02609724|454444067|FG001|Overall Study|Death|0|||
126314885|NCT02609724|454444068|FG002|Overall Study|Death|1|||
126314886|NCT02609724|454444066|FG000|Overall Study|Withdrawal by Subject|1|||
126314887|NCT02609724|454444067|FG001|Overall Study|Withdrawal by Subject|2|||
126314888|NCT02609724|454444068|FG002|Overall Study|Withdrawal by Subject|3|||
126314889|NCT02609724|454444066|FG000|Overall Study|Illness|2|||
126314890|NCT02609724|454444067|FG001|Overall Study|Illness|1|||
126314891|NCT02609724|454444068|FG002|Overall Study|Illness|0|||
126314892|NCT03077659|454444069|FG000|Overall Study|Withdrawal by Subject|0|||
126314893|NCT03077659|454444070|FG001|Overall Study|Withdrawal by Subject|0|||
126314894|NCT03077659|454444071|FG002|Overall Study|Withdrawal by Subject|1|||
126314895|NCT04272606|454444074|FG000|Overall Study|Protocol Violation|1|||
126314896|NCT04272606|454444075|FG001|Overall Study|Protocol Violation|1|||
126314897|NCT04272606|454444074|FG000|Overall Study|Physician Decision|0|||
126314898|NCT04272606|454444075|FG001|Overall Study|Physician Decision|1|||
126314899|NCT04450407|454444076|FG000|Overall Study|Withdrawal by Subject|10|||
126314900|NCT04450407|454444077|FG001|Overall Study|Withdrawal by Subject|1|||
126314901|NCT04450407|454444078|FG002|Overall Study|Withdrawal by Subject|4|||
126314902|NCT04450407|454444076|FG000|Overall Study|Adverse Event|0|||
126314903|NCT04450407|454444077|FG001|Overall Study|Adverse Event|0|||
126314904|NCT04450407|454444078|FG002|Overall Study|Adverse Event|1|||
126314905|NCT04450407|454444076|FG000|Overall Study|Lost to Follow-up|1|||
126314906|NCT04450407|454444077|FG001|Overall Study|Lost to Follow-up|0|||
126314907|NCT04450407|454444078|FG002|Overall Study|Lost to Follow-up|0|||
126314908|NCT04450407|454444076|FG000|Overall Study|Physician Decision|0|||
126314909|NCT04450407|454444077|FG001|Overall Study|Physician Decision|0|||
126314910|NCT04450407|454444078|FG002|Overall Study|Physician Decision|1|||
126314911|NCT04450407|454444076|FG000|Overall Study|Pregnancy|1|||
126314912|NCT04450407|454444077|FG001|Overall Study|Pregnancy|0|||
126314913|NCT04450407|454444078|FG002|Overall Study|Pregnancy|0|||
126314914|NCT04450407|454444076|FG000|Overall Study|Protocol Violation|2|||
126314915|NCT04450407|454444077|FG001|Overall Study|Protocol Violation|0|||
126314916|NCT04450407|454444078|FG002|Overall Study|Protocol Violation|0|||
126314917|NCT04450407|454444076|FG000|Overall Study|Investigational site terminated by sponsor|3|||
126314918|NCT04450407|454444077|FG001|Overall Study|Investigational site terminated by sponsor|0|||
126314919|NCT04450407|454444078|FG002|Overall Study|Investigational site terminated by sponsor|2|||
126314920|NCT02089334|454444079|FG000|Overall Study|Withdrawal by Subject|0|||
126314921|NCT02089334|454444080|FG001|Overall Study|Withdrawal by Subject|0|||
126314922|NCT02089334|454444081|FG002|Overall Study|Withdrawal by Subject|0|||
126314923|NCT02089334|454444082|FG003|Overall Study|Withdrawal by Subject|2|||
126314924|NCT02089334|454444079|FG000|Overall Study|Adverse Event|0|||
126314925|NCT02089334|454444080|FG001|Overall Study|Adverse Event|0|||
126314926|NCT02089334|454444081|FG002|Overall Study|Adverse Event|0|||
126314927|NCT02089334|454444082|FG003|Overall Study|Adverse Event|2|||
126314928|NCT02089334|454444079|FG000|Overall Study|Progressive disease|0|||
126314929|NCT02089334|454444080|FG001|Overall Study|Progressive disease|0|||
126314930|NCT02089334|454444081|FG002|Overall Study|Progressive disease|0|||
126314931|NCT02089334|454444082|FG003|Overall Study|Progressive disease|2|||
126314932|NCT02089334|454444079|FG000|Overall Study|Physician Decision|0|||
126314933|NCT02089334|454444080|FG001|Overall Study|Physician Decision|0|||
126314934|NCT02089334|454444081|FG002|Overall Study|Physician Decision|1|||
126314935|NCT02089334|454444082|FG003|Overall Study|Physician Decision|1|||
126314936|NCT02832375|454444083|FG000|Overall Study|Lost to Follow-up|1|||
126314937|NCT02832375|454444084|FG001|Overall Study|Lost to Follow-up|0|||
126314938|NCT02832375|454444083|FG000|Overall Study|Withdrawal of Consent|1|||
126314939|NCT02832375|454444084|FG001|Overall Study|Withdrawal of Consent|0|||
126314940|NCT01645891|454444087|FG000|Overall Study|Adverse Event|6|||
126314941|NCT01645891|454444088|FG001|Overall Study|Adverse Event|10|||
126314942|NCT01645891|454444087|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
126314943|NCT01645891|454444088|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
126314944|NCT01645891|454444087|FG000|Overall Study|Withdrawal by Subject|3|||
126314945|NCT01645891|454444088|FG001|Overall Study|Withdrawal by Subject|3|||
126314946|NCT01645891|454444087|FG000|Overall Study|Protocol Violation|4|||
126314947|NCT01645891|454444088|FG001|Overall Study|Protocol Violation|0|||
126314948|NCT01645891|454444087|FG000|Overall Study|Lost to Follow-up|4|||
126314949|NCT01645891|454444088|FG001|Overall Study|Lost to Follow-up|1|||
126314950|NCT01645891|454444087|FG000|Overall Study|Death|0|||
126314951|NCT01645891|454444088|FG001|Overall Study|Death|2|||
126314952|NCT00138073|454444091|FG000|Overall Study|lack of resources|55|||
126314953|NCT03301740|454444092|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
126314954|NCT03301740|454444093|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
126314955|NCT03301740|454444092|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
126314956|NCT03301740|454444093|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
126314957|NCT01037127|454444095|FG000|Overall Study|Lost to Follow-up|2|||
126314958|NCT01037127|454444096|FG001|Overall Study|Lost to Follow-up|4|||
126314959|NCT01037127|454444095|FG000|Overall Study|Physician Decision|1|||
126314960|NCT01037127|454444096|FG001|Overall Study|Physician Decision|0|||
126314961|NCT01037127|454444095|FG000|Overall Study|Study Closed Terminated|2|||
126314962|NCT01037127|454444096|FG001|Overall Study|Study Closed Terminated|17|||
126314963|NCT02637713|454444103|FG000|Overall Study|Screen Failure|2|||
126314964|NCT02847182|454444104|FG000|Overall Study|Withdrawal by Subject|0|||
126314965|NCT02847182|454444105|FG001|Overall Study|Withdrawal by Subject|1|||
126314966|NCT02345889|454444106|FG000|Overall Study|Inadequate Bowel Prep|17|||
126314967|NCT02345889|454444107|FG001|Overall Study|Inadequate Bowel Prep|16|||
126314968|NCT02345889|454444108|FG002|Overall Study|Inadequate Bowel Prep|18|||
126314969|NCT02345889|454444109|FG003|Overall Study|Inadequate Bowel Prep|14|||
126314970|NCT02345889|454444106|FG000|Overall Study|Polyposis identified during procedure|1|||
126314971|NCT02345889|454444107|FG001|Overall Study|Polyposis identified during procedure|1|||
126314972|NCT02345889|454444108|FG002|Overall Study|Polyposis identified during procedure|0|||
126314973|NCT02345889|454444109|FG003|Overall Study|Polyposis identified during procedure|1|||
126314974|NCT02345889|454444106|FG000|Overall Study|Recognized ineligible post-randomization|1|||
126314975|NCT02345889|454444107|FG001|Overall Study|Recognized ineligible post-randomization|0|||
126314976|NCT02345889|454444108|FG002|Overall Study|Recognized ineligible post-randomization|2|||
126314977|NCT02345889|454444109|FG003|Overall Study|Recognized ineligible post-randomization|1|||
126314978|NCT02345889|454444106|FG000|Overall Study|Ulcerative Colitis identified|1|||
126314979|NCT02345889|454444107|FG001|Overall Study|Ulcerative Colitis identified|0|||
126314980|NCT02345889|454444108|FG002|Overall Study|Ulcerative Colitis identified|0|||
126314981|NCT02345889|454444109|FG003|Overall Study|Ulcerative Colitis identified|0|||
126314982|NCT02345889|454444106|FG000|Overall Study|Cecum not intubated|1|||
126314983|NCT02345889|454444107|FG001|Overall Study|Cecum not intubated|0|||
126314984|NCT02345889|454444108|FG002|Overall Study|Cecum not intubated|0|||
126314985|NCT02345889|454444109|FG003|Overall Study|Cecum not intubated|0|||
126314986|NCT01173055|454444110|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
126314987|NCT01173055|454444111|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
126314988|NCT01173055|454444110|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
126314989|NCT01173055|454444111|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
126314990|NCT04325698|454444113|FG000|Overall Study|Study Terminated By Sponsor|1|||
126314991|NCT04325698|454444114|FG001|Overall Study|Study Terminated By Sponsor|1|||
126314992|NCT04325698|454444113|FG000|Overall Study|Withdrawal by Subject|0|||
126314993|NCT04325698|454444114|FG001|Overall Study|Withdrawal by Subject|2|||
126314994|NCT00962091|454444115|FG000|Overall Study|Withdrawal by Subject|1|||
126314995|NCT00962091|454444116|FG001|Overall Study|Withdrawal by Subject|2|||
126314996|NCT00962091|454444117|FG002|Overall Study|Withdrawal by Subject|1|||
126314997|NCT00962091|454444118|FG003|Overall Study|Withdrawal by Subject|1|||
126314998|NCT00962091|454444119|FG004|Overall Study|Withdrawal by Subject|0|||
126314999|NCT00962091|454444120|FG005|Overall Study|Withdrawal by Subject|1|||
126315000|NCT00962091|454444121|FG006|Overall Study|Withdrawal by Subject|0|||
126315001|NCT00962091|454444115|FG000|Overall Study|Adverse Event|0|||
126315002|NCT00962091|454444116|FG001|Overall Study|Adverse Event|0|||
126315003|NCT00962091|454444117|FG002|Overall Study|Adverse Event|0|||
126315004|NCT00962091|454444118|FG003|Overall Study|Adverse Event|0|||
126315005|NCT00962091|454444119|FG004|Overall Study|Adverse Event|0|||
126315006|NCT00962091|454444120|FG005|Overall Study|Adverse Event|0|||
126315007|NCT00962091|454444121|FG006|Overall Study|Adverse Event|1|||
126315008|NCT04253782|454444122|FG000|Overall Study|Death|2|||
126315009|NCT04253782|454444123|FG001|Overall Study|Death|0|||
126315010|NCT04216589|454444125|FG000|Overall Study|Withdrawal by Subject|2|||
126315011|NCT04216589|454444125|FG000|Overall Study|Protocol Violation|1|||
126315012|NCT04216589|454444125|FG000|Overall Study|Incarceration|1|||
126315013|NCT02326298|454444130|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315014|NCT02326298|454444131|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315015|NCT02326298|454444132|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
126315016|NCT02326298|454444133|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315017|NCT02326298|454444134|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315018|NCT02326298|454444135|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315019|NCT02326298|454444136|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315020|NCT02326298|454444137|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126538772|NCT01951638|455264429|FG003|Treatment Period|Protocol Violation|2|||
126538773|NCT01951638|455264430|FG004|Treatment Period|Protocol Violation|0|||
126538774|NCT01951638|455264426|FG000|Treatment Period|Protocol-driven decision point|1|||
126538775|NCT01951638|455264427|FG001|Treatment Period|Protocol-driven decision point|3|||
126538776|NCT01951638|455264428|FG002|Treatment Period|Protocol-driven decision point|0|||
126538777|NCT01951638|455264429|FG003|Treatment Period|Protocol-driven decision point|0|||
126538778|NCT01951638|455264430|FG004|Treatment Period|Protocol-driven decision point|0|||
126538779|NCT01951638|455264426|FG000|Treatment Period|Logistical difficulties|0|||
126538780|NCT01951638|455264427|FG001|Treatment Period|Logistical difficulties|1|||
126315021|NCT02326298|454444138|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315022|NCT02326298|454444139|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315023|NCT02326298|454444140|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315024|NCT02326298|454444141|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315025|NCT02326298|454444142|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315026|NCT02326298|454444143|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126315027|NCT02326298|454444130|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
126315028|NCT02326298|454444131|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126538781|NCT01951638|455264428|FG002|Treatment Period|Logistical difficulties|1|||
126538782|NCT01951638|455264429|FG003|Treatment Period|Logistical difficulties|0|||
126538783|NCT01951638|455264430|FG004|Treatment Period|Logistical difficulties|0|||
126538784|NCT01951638|455264426|FG000|Treatment Period|Withdrawal by Subject|9|||
126538785|NCT01951638|455264427|FG001|Treatment Period|Withdrawal by Subject|6|||
126538786|NCT01951638|455264428|FG002|Treatment Period|Withdrawal by Subject|4|||
126538787|NCT01951638|455264429|FG003|Treatment Period|Withdrawal by Subject|5|||
126538788|NCT01951638|455264430|FG004|Treatment Period|Withdrawal by Subject|4|||
126315029|NCT02326298|454444132|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315030|NCT02326298|454444133|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315031|NCT02326298|454444134|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315032|NCT02326298|454444135|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315033|NCT02326298|454444136|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315034|NCT02326298|454444137|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315035|NCT02326298|454444138|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315036|NCT02326298|454444139|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315037|NCT02326298|454444140|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126538789|NCT01951638|455264426|FG000|Treatment Period|Death|0|||
126538790|NCT01951638|455264427|FG001|Treatment Period|Death|0|||
126538791|NCT01951638|455264428|FG002|Treatment Period|Death|0|||
126538792|NCT01951638|455264429|FG003|Treatment Period|Death|3|||
126315038|NCT02326298|454444141|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315039|NCT02326298|454444142|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315040|NCT02326298|454444143|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
126315041|NCT02326298|454444130|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
126315042|NCT02326298|454444131|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
126315043|NCT02326298|454444132|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315044|NCT02326298|454444133|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315045|NCT02326298|454444134|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315046|NCT02326298|454444135|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315047|NCT02326298|454444136|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315048|NCT02326298|454444137|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315049|NCT02326298|454444138|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315050|NCT02326298|454444139|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315051|NCT02326298|454444140|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315052|NCT02326298|454444141|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315053|NCT02326298|454444142|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315054|NCT02326298|454444143|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126315055|NCT02326298|454444130|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
126315056|NCT02326298|454444131|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
126315057|NCT02326298|454444132|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315058|NCT02326298|454444133|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315059|NCT02326298|454444134|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315060|NCT02326298|454444135|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315061|NCT02326298|454444136|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315062|NCT02326298|454444137|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315063|NCT02326298|454444138|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315064|NCT02326298|454444139|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315065|NCT02326298|454444140|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315066|NCT02326298|454444141|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315067|NCT02326298|454444142|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315068|NCT02326298|454444143|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126315069|NCT02326298|454444130|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315070|NCT02326298|454444131|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315071|NCT02326298|454444132|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
126315072|NCT02326298|454444133|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315073|NCT02326298|454444134|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315074|NCT02326298|454444135|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315075|NCT02326298|454444136|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315076|NCT02326298|454444137|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315077|NCT02326298|454444138|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126538793|NCT01951638|455264430|FG004|Treatment Period|Death|1|||
126538794|NCT01951638|455264426|FG000|Treatment Period|Adverse Event|3|||
126538795|NCT01951638|455264427|FG001|Treatment Period|Adverse Event|4|||
126538796|NCT01951638|455264428|FG002|Treatment Period|Adverse Event|8|||
126538797|NCT01951638|455264429|FG003|Treatment Period|Adverse Event|6|||
126648198|NCT02003222|455669712|FG003|Intensification|Withdrawal by Subject|0|||
126648199|NCT02003222|455669713|FG004|Intensification|Withdrawal by Subject|5|||
126315078|NCT02326298|454444139|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315079|NCT02326298|454444140|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315080|NCT02326298|454444141|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315081|NCT02326298|454444142|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315082|NCT02326298|454444143|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
126315083|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315084|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315085|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315086|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315087|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315088|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126315089|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
126315090|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126315091|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126315092|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126315093|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315094|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315095|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315096|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126315097|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315098|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315099|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315100|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315101|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315102|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
126315103|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
126315104|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315105|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
126315106|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315107|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315108|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315109|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315110|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
126315111|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315112|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315113|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315114|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315115|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315116|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
126315117|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315118|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315119|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315120|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315121|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315122|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315123|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315124|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
126315125|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315126|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315127|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315128|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315129|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315130|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315131|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
126315132|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315133|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315134|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315135|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315136|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315137|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315138|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126315139|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315140|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315141|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315142|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315143|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315144|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315145|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315146|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
126315147|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315148|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315149|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315150|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315151|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315152|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
126315153|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315154|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315155|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315156|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315157|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315158|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315159|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
126315160|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
126315161|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315162|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315163|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315164|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315165|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315166|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126315167|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315168|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315169|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315170|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315171|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315172|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315173|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315174|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
126315175|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315176|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315177|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315178|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315179|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315180|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126315181|NCT02326298|454444130|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315182|NCT02326298|454444131|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315183|NCT02326298|454444132|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315184|NCT02326298|454444133|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315185|NCT02326298|454444134|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315186|NCT02326298|454444135|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
126315187|NCT02326298|454444136|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315188|NCT02326298|454444137|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315189|NCT02326298|454444138|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315190|NCT02326298|454444139|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315191|NCT02326298|454444140|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315192|NCT02326298|454444141|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315193|NCT02326298|454444142|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315194|NCT02326298|454444143|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
126315195|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
126315196|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
126315197|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
126315198|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
126315199|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
126315200|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
126315201|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
126315202|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
126315203|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
126315204|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
126315205|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
126315206|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
126315207|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
126315208|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
126315209|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315210|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315211|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315212|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315213|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315214|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315215|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315216|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315217|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315218|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315219|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315220|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
126315221|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
126315222|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126315223|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315224|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315225|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315226|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315227|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315228|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315229|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315230|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315231|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315232|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315233|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315234|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
126315235|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
126315236|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126315237|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315238|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315239|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315240|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315241|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315242|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315243|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315244|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315245|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315246|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315247|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315248|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315249|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126315250|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
126315251|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315252|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315253|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315254|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315255|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315256|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315257|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315258|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315259|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315260|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315261|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126315262|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
126538798|NCT01951638|455264430|FG004|Treatment Period|Adverse Event|5|||
126315263|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
126315264|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
126315265|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315266|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315267|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315268|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315269|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315270|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315271|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315272|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315273|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315274|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315275|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126315276|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
126315277|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
126315278|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
126315279|NCT02326298|454444130|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315280|NCT02326298|454444131|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315281|NCT02326298|454444132|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315282|NCT02326298|454444133|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315283|NCT02326298|454444134|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315284|NCT02326298|454444135|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315285|NCT02326298|454444136|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315286|NCT02326298|454444137|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315287|NCT02326298|454444138|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315288|NCT02326298|454444139|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315289|NCT02326298|454444140|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126315290|NCT02326298|454444141|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
126315291|NCT02326298|454444142|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
126315292|NCT02326298|454444143|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
126315293|NCT03191864|454444145|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
126315294|NCT03191864|454444146|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
126315295|NCT03191864|454444147|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
126315296|NCT03191864|454444148|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
126315297|NCT03191864|454444149|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
126315298|NCT03191864|454444150|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
126315299|NCT03191864|454444145|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
126315300|NCT03191864|454444146|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
126315301|NCT03191864|454444147|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
126315302|NCT03191864|454444148|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
126315303|NCT03191864|454444149|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
126315304|NCT03191864|454444150|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
126315305|NCT03191864|454444145|FG000|Baseline Symptom Assessment|Adverse Event|0|||
126315306|NCT03191864|454444146|FG001|Baseline Symptom Assessment|Adverse Event|0|||
126315307|NCT03191864|454444147|FG002|Baseline Symptom Assessment|Adverse Event|0|||
126315308|NCT03191864|454444148|FG003|Baseline Symptom Assessment|Adverse Event|0|||
126315309|NCT03191864|454444149|FG004|Baseline Symptom Assessment|Adverse Event|0|||
126315310|NCT03191864|454444150|FG005|Baseline Symptom Assessment|Adverse Event|2|||
126315311|NCT03191864|454444145|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
126315312|NCT03191864|454444146|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
126315313|NCT03191864|454444147|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
126315314|NCT03191864|454444148|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
126315315|NCT03191864|454444149|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
126315316|NCT03191864|454444150|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
126315317|NCT03191864|454444145|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
126315318|NCT03191864|454444146|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
126315319|NCT03191864|454444147|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
126315320|NCT03191864|454444148|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
126315321|NCT03191864|454444149|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
126315322|NCT03191864|454444150|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
126315323|NCT03191864|454444145|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
126315324|NCT03191864|454444146|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
126315325|NCT03191864|454444147|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
126538799|NCT01951638|455264426|FG000|Follow-up Period|Protocol Violation|0|||
126538800|NCT01951638|455264427|FG001|Follow-up Period|Protocol Violation|0|||
126315326|NCT03191864|454444148|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
126315327|NCT03191864|454444149|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
126315328|NCT03191864|454444150|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
126315329|NCT03191864|454444145|FG000|Part 1 - Induction|Adverse Event|0|||
126315330|NCT03191864|454444146|FG001|Part 1 - Induction|Adverse Event|2|||
126315331|NCT03191864|454444147|FG002|Part 1 - Induction|Adverse Event|0|||
126315332|NCT03191864|454444148|FG003|Part 1 - Induction|Adverse Event|1|||
126315333|NCT03191864|454444149|FG004|Part 1 - Induction|Adverse Event|0|||
126315334|NCT03191864|454444150|FG005|Part 1 - Induction|Adverse Event|2|||
126315335|NCT03191864|454444145|FG000|Part 1 - Induction|Randomized but never dosed|0|||
126315336|NCT03191864|454444146|FG001|Part 1 - Induction|Randomized but never dosed|0|||
126315337|NCT03191864|454444147|FG002|Part 1 - Induction|Randomized but never dosed|1|||
126315338|NCT03191864|454444148|FG003|Part 1 - Induction|Randomized but never dosed|0|||
126315339|NCT03191864|454444149|FG004|Part 1 - Induction|Randomized but never dosed|0|||
126315340|NCT03191864|454444150|FG005|Part 1 - Induction|Randomized but never dosed|0|||
126315341|NCT03191864|454444145|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
126315342|NCT03191864|454444146|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
126315343|NCT03191864|454444147|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
126315344|NCT03191864|454444148|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
126315345|NCT03191864|454444149|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
126315346|NCT03191864|454444150|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
126315347|NCT03191864|454444145|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
126315348|NCT03191864|454444146|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
126315349|NCT03191864|454444147|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
126315350|NCT03191864|454444148|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
126315351|NCT03191864|454444149|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
126315352|NCT03191864|454444150|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
126315353|NCT03191864|454444145|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
126315354|NCT03191864|454444146|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
126315355|NCT03191864|454444147|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
126315356|NCT03191864|454444148|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
126315357|NCT03191864|454444149|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
126315358|NCT03191864|454444150|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
126315359|NCT03191864|454444145|FG000|Part 2 - Maintenance|Physician Decision|1|||
126315360|NCT03191864|454444146|FG001|Part 2 - Maintenance|Physician Decision|0|||
126315361|NCT03191864|454444147|FG002|Part 2 - Maintenance|Physician Decision|0|||
126315362|NCT03191864|454444148|FG003|Part 2 - Maintenance|Physician Decision|0|||
126315363|NCT03191864|454444149|FG004|Part 2 - Maintenance|Physician Decision|0|||
126315364|NCT03191864|454444150|FG005|Part 2 - Maintenance|Physician Decision|0|||
126315365|NCT03191864|454444145|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
126315366|NCT03191864|454444146|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
126315367|NCT03191864|454444147|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
126315368|NCT03191864|454444148|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
126315369|NCT03191864|454444149|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
126315370|NCT03191864|454444150|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
126315371|NCT03191864|454444145|FG000|Part 2 - Maintenance|Adverse Event|0|||
126315372|NCT03191864|454444146|FG001|Part 2 - Maintenance|Adverse Event|0|||
126315373|NCT03191864|454444147|FG002|Part 2 - Maintenance|Adverse Event|0|||
126315374|NCT03191864|454444148|FG003|Part 2 - Maintenance|Adverse Event|0|||
126315375|NCT03191864|454444149|FG004|Part 2 - Maintenance|Adverse Event|1|||
126315376|NCT03191864|454444150|FG005|Part 2 - Maintenance|Adverse Event|0|||
126315377|NCT03191864|454444145|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
126315378|NCT03191864|454444146|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
126315379|NCT03191864|454444147|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
126315380|NCT03191864|454444148|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
126315381|NCT03191864|454444149|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
126315382|NCT03191864|454444150|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
126315383|NCT03191864|454444145|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
126315384|NCT03191864|454444146|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
126315385|NCT03191864|454444147|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
126315386|NCT03191864|454444148|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
126315387|NCT03191864|454444149|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
126315388|NCT03191864|454444150|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
126315389|NCT02342548|454444153|FG000|Overall Study|Adverse Event|12|||
126315390|NCT02342548|454444154|FG001|Overall Study|Adverse Event|17|||
126538801|NCT01951638|455264428|FG002|Follow-up Period|Protocol Violation|0|||
126538802|NCT01951638|455264429|FG003|Follow-up Period|Protocol Violation|1|||
126315391|NCT02342548|454444155|FG002|Overall Study|Adverse Event|13|||
126315392|NCT02342548|454444153|FG000|Overall Study|Lost to Follow-up|0|||
126315393|NCT02342548|454444154|FG001|Overall Study|Lost to Follow-up|1|||
126315394|NCT02342548|454444155|FG002|Overall Study|Lost to Follow-up|0|||
126315395|NCT02342548|454444153|FG000|Overall Study|Study terminated by sponsor|20|||
126315396|NCT02342548|454444154|FG001|Overall Study|Study terminated by sponsor|39|||
126315397|NCT02342548|454444155|FG002|Overall Study|Study terminated by sponsor|25|||
126315398|NCT02342548|454444153|FG000|Overall Study|Protocol Violation|0|||
126315399|NCT02342548|454444154|FG001|Overall Study|Protocol Violation|1|||
126315400|NCT02342548|454444155|FG002|Overall Study|Protocol Violation|0|||
126315401|NCT02342548|454444153|FG000|Overall Study|Withdrawal by Subject|1|||
126315402|NCT02342548|454444154|FG001|Overall Study|Withdrawal by Subject|3|||
126315403|NCT02342548|454444155|FG002|Overall Study|Withdrawal by Subject|4|||
126315404|NCT02342548|454444153|FG000|Overall Study|Other|1|||
126315405|NCT02342548|454444154|FG001|Overall Study|Other|1|||
126315406|NCT02342548|454444155|FG002|Overall Study|Other|1|||
126315407|NCT01047332|454444156|FG000|Overall Study|SEMS Obstruction|11|||
126315408|NCT01047332|454444157|FG001|Overall Study|SEMS Obstruction|20|||
126315409|NCT01047332|454444156|FG000|Overall Study|Died Unobstructed|38|||
126315410|NCT01047332|454444157|FG001|Overall Study|Died Unobstructed|41|||
126315411|NCT01047332|454444156|FG000|Overall Study|Lost to Follow-up|8|||
126315412|NCT01047332|454444157|FG001|Overall Study|Lost to Follow-up|3|||
126315413|NCT03521817|454444162|FG000|Overall Study|Protocol Violation|0|||
126315414|NCT03521817|454444163|FG001|Overall Study|Protocol Violation|1|||
126315415|NCT02417961|454445454|FG000|Overall Study|Adverse Event|1|||
126315416|NCT02417961|454445454|FG000|Overall Study|Lost to Follow-up|1|||
126315417|NCT02417961|454445454|FG000|Overall Study|Withdrawal by Subject|2|||
126315418|NCT03666533|454445458|FG000|Overall Study|Lost to Follow-up|2|||
126315419|NCT03666533|454445459|FG001|Overall Study|Lost to Follow-up|2|||
126315420|NCT04240886|454445460|FG000|Treatment Phase|Death|4|||
126315421|NCT04240886|454445460|FG000|Treatment Phase|Discontinuation by Subject|1|||
126315422|NCT04240886|454445460|FG000|Treatment Phase|Adverse Event|5|||
126315423|NCT04240886|454445460|FG000|Follow-up Phase|Withdrawal by Subject|1|||
126315424|NCT04240886|454445460|FG000|Follow-up Phase|Discontinuation by Subject|1|||
126315425|NCT04240886|454445460|FG000|Follow-up Phase|Death|2|||
126315426|NCT04743804|454445461|FG000|Overall Study|Other|1|||
126315427|NCT04743804|454445462|FG001|Overall Study|Other|0|||
126315428|NCT04743804|454445461|FG000|Overall Study|Withdrawal by Subject|0|||
126315429|NCT04743804|454445462|FG001|Overall Study|Withdrawal by Subject|1|||
126315430|NCT04743804|454445461|FG000|Overall Study|Study Terminated by Sponsor|1|||
126315431|NCT04743804|454445462|FG001|Overall Study|Study Terminated by Sponsor|4|||
126315432|NCT04743804|454445461|FG000|Overall Study|Physician Decision|0|||
126315433|NCT04743804|454445462|FG001|Overall Study|Physician Decision|1|||
126315434|NCT04743804|454445461|FG000|Overall Study|Death|3|||
126315435|NCT04743804|454445462|FG001|Overall Study|Death|0|||
126315436|NCT01632904|454445463|FG000|Overall Study|Adverse Event|4|||
126315437|NCT01632904|454445464|FG001|Overall Study|Adverse Event|1|||
126315438|NCT01632904|454445463|FG000|Overall Study|Physician Decision|0|||
126315439|NCT01632904|454445464|FG001|Overall Study|Physician Decision|1|||
126315440|NCT01632904|454445463|FG000|Overall Study|Subject decision|3|||
126315441|NCT01632904|454445464|FG001|Overall Study|Subject decision|2|||
126315442|NCT01632904|454445463|FG000|Overall Study|Disease Progression|0|||
126315443|NCT01632904|454445464|FG001|Overall Study|Disease Progression|1|||
126315444|NCT01632904|454445463|FG000|Overall Study|Reason for discontinuation not available|0|||
126315445|NCT01632904|454445464|FG001|Overall Study|Reason for discontinuation not available|1|||
126315446|NCT02059434|454445465|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
126315447|NCT02059434|454445466|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
126315448|NCT02059434|454445467|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
126315449|NCT02059434|454445468|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
126315450|NCT02059434|454445469|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
126315451|NCT02059434|454445470|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
126315452|NCT02059434|454445471|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
126315453|NCT02059434|454445472|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
126315454|NCT02059434|454445473|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
126315455|NCT02059434|454445465|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
126315456|NCT02059434|454445466|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
126315457|NCT02059434|454445467|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
126315458|NCT02059434|454445468|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
126315459|NCT02059434|454445469|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
126315460|NCT02059434|454445470|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
126315461|NCT02059434|454445471|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
126315462|NCT02059434|454445472|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
126315463|NCT02059434|454445473|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
126315464|NCT02059434|454445465|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
126315465|NCT02059434|454445466|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
126538803|NCT01951638|455264430|FG004|Follow-up Period|Protocol Violation|0|||
126538804|NCT01951638|455264426|FG000|Follow-up Period|Logistical difficulties|0|||
126315466|NCT02059434|454445467|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
126538805|NCT01951638|455264427|FG001|Follow-up Period|Logistical difficulties|2|||
126315467|NCT02059434|454445468|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
126315468|NCT02059434|454445469|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
126315469|NCT02059434|454445470|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
126315470|NCT02059434|454445471|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
126315471|NCT02059434|454445472|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
126315472|NCT02059434|454445473|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
126315473|NCT02059434|454445465|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
126315474|NCT02059434|454445466|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
126315475|NCT02059434|454445467|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
126315476|NCT02059434|454445468|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
126315477|NCT02059434|454445469|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
126315478|NCT02059434|454445470|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
126315479|NCT02059434|454445471|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
126315480|NCT02059434|454445472|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
126315481|NCT02059434|454445473|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
126315482|NCT02059434|454445465|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315483|NCT02059434|454445466|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315484|NCT02059434|454445467|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315485|NCT02059434|454445468|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315486|NCT02059434|454445469|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315487|NCT02059434|454445470|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315488|NCT02059434|454445471|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315489|NCT02059434|454445472|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
126315490|NCT02059434|454445473|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
126315491|NCT01004406|454445478|FG000|Overall Study|Withdrawal by Subject|2|||
126315492|NCT01004406|454445479|FG001|Overall Study|Withdrawal by Subject|0|||
126315493|NCT01004406|454445478|FG000|Overall Study|Lost to Follow-up|1|||
126315494|NCT01004406|454445479|FG001|Overall Study|Lost to Follow-up|0|||
126315495|NCT02928770|454445480|FG000|Overall Study|Withdrawal by Subject|2|||
126315496|NCT03201874|454445481|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
126315497|NCT03201874|454445482|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
126315498|NCT03201874|454445481|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
126315499|NCT03201874|454445482|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
126315500|NCT02907593|454445485|FG000|Overall Study|Withdrawal by Subject|0|||
126315501|NCT02907593|454445486|FG001|Overall Study|Withdrawal by Subject|0|||
126315502|NCT02907593|454445487|FG002|Overall Study|Withdrawal by Subject|1|||
126315503|NCT02907593|454445488|FG003|Overall Study|Withdrawal by Subject|0|||
126315504|NCT04618471|454445489|FG000|Overall Study|Screen Failure|62|||
126315505|NCT04618471|454445489|FG000|Overall Study|Withdrawal by Subject|6|||
126315506|NCT04618471|454445489|FG000|Overall Study|Physician Decision|2|||
126315507|NCT04618471|454445489|FG000|Overall Study|Lost to Follow-up|1|||
126315508|NCT04618471|454445489|FG000|Overall Study|Various other reasons|2|||
126315509|NCT04618471|454445489|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
126315510|NCT01752634|454445490|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
126315511|NCT01752634|454445491|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
126315512|NCT01752634|454445492|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
126315513|NCT01752634|454445493|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
126315514|NCT01752634|454445494|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
126315515|NCT01752634|454445495|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
126315516|NCT01752634|454445490|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
126315517|NCT01752634|454445491|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
126315518|NCT01752634|454445492|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
126315519|NCT01752634|454445493|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
126315520|NCT01752634|454445494|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
126315521|NCT01752634|454445495|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
126315522|NCT01752634|454445490|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
126315523|NCT01752634|454445491|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
126315524|NCT01752634|454445492|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
126315525|NCT01752634|454445493|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
126315526|NCT01752634|454445494|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
126315527|NCT01752634|454445495|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
126315528|NCT01752634|454445490|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
126315529|NCT01752634|454445491|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
126315530|NCT01752634|454445492|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
126315531|NCT01752634|454445493|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
126315532|NCT01752634|454445494|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
126315533|NCT01752634|454445495|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
126315534|NCT01752634|454445490|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
126315535|NCT01752634|454445491|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
126315536|NCT01752634|454445492|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
126315537|NCT01752634|454445493|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
126315538|NCT01752634|454445494|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
126315539|NCT01752634|454445495|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
126315540|NCT01752634|454445490|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
126315541|NCT01752634|454445491|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
126315542|NCT01752634|454445492|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
126315543|NCT01752634|454445493|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
126315544|NCT01752634|454445494|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
126315545|NCT01752634|454445495|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
126315546|NCT01752634|454445490|FG000|Week 24 to Week 260|Physician Decision|1|||
126315547|NCT01752634|454445491|FG001|Week 24 to Week 260|Physician Decision|2|||
126315548|NCT01752634|454445492|FG002|Week 24 to Week 260|Physician Decision|4|||
126315549|NCT01752634|454445493|FG003|Week 24 to Week 260|Physician Decision|2|||
126315550|NCT01752634|454445494|FG004|Week 24 to Week 260|Physician Decision|1|||
126315551|NCT01752634|454445495|FG005|Week 24 to Week 260|Physician Decision|0|||
126315552|NCT01752634|454445490|FG000|Week 24 to Week 260|Death|0|||
126315553|NCT01752634|454445491|FG001|Week 24 to Week 260|Death|1|||
126315554|NCT01752634|454445492|FG002|Week 24 to Week 260|Death|0|||
126315555|NCT01752634|454445493|FG003|Week 24 to Week 260|Death|0|||
126315556|NCT01752634|454445494|FG004|Week 24 to Week 260|Death|0|||
126315557|NCT01752634|454445495|FG005|Week 24 to Week 260|Death|0|||
126315558|NCT01752634|454445490|FG000|Week 24 to Week 260|Pregnancy|0|||
126315559|NCT01752634|454445491|FG001|Week 24 to Week 260|Pregnancy|0|||
126315560|NCT01752634|454445492|FG002|Week 24 to Week 260|Pregnancy|1|||
126538806|NCT01951638|455264428|FG002|Follow-up Period|Logistical difficulties|0|||
126538807|NCT01951638|455264429|FG003|Follow-up Period|Logistical difficulties|0|||
126538808|NCT01951638|455264430|FG004|Follow-up Period|Logistical difficulties|1|||
126538809|NCT01951638|455264426|FG000|Follow-up Period|Withdrawal by Subject|1|||
126538810|NCT01951638|455264427|FG001|Follow-up Period|Withdrawal by Subject|5|||
126538811|NCT01951638|455264428|FG002|Follow-up Period|Withdrawal by Subject|2|||
126538812|NCT01951638|455264429|FG003|Follow-up Period|Withdrawal by Subject|1|||
126538813|NCT01951638|455264430|FG004|Follow-up Period|Withdrawal by Subject|2|||
126538814|NCT01951638|455264426|FG000|Follow-up Period|Lost to Follow-up|0|||
126538815|NCT01951638|455264427|FG001|Follow-up Period|Lost to Follow-up|1|||
126538816|NCT01951638|455264428|FG002|Follow-up Period|Lost to Follow-up|0|||
126538817|NCT01951638|455264429|FG003|Follow-up Period|Lost to Follow-up|1|||
126538818|NCT01951638|455264430|FG004|Follow-up Period|Lost to Follow-up|0|||
126538819|NCT01951638|455264426|FG000|Follow-up Period|Death|1|||
126315561|NCT01752634|454445493|FG003|Week 24 to Week 260|Pregnancy|0|||
126315562|NCT01752634|454445494|FG004|Week 24 to Week 260|Pregnancy|0|||
126315563|NCT01752634|454445495|FG005|Week 24 to Week 260|Pregnancy|0|||
126315564|NCT01752634|454445490|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
126315565|NCT01752634|454445491|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
126538820|NCT01951638|455264427|FG001|Follow-up Period|Death|0|||
126315566|NCT01752634|454445492|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
126315567|NCT01752634|454445493|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
126315568|NCT01752634|454445494|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
126315569|NCT01752634|454445495|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
126315570|NCT01752634|454445490|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
126315571|NCT01752634|454445491|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
126315572|NCT01752634|454445492|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
126315573|NCT01752634|454445493|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
126315574|NCT01752634|454445494|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
126315575|NCT01752634|454445495|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
126315576|NCT01752634|454445490|FG000|Week 24 to Week 260|Adverse Event|4|||
126315577|NCT01752634|454445491|FG001|Week 24 to Week 260|Adverse Event|8|||
126315578|NCT01752634|454445492|FG002|Week 24 to Week 260|Adverse Event|8|||
126315579|NCT01752634|454445493|FG003|Week 24 to Week 260|Adverse Event|4|||
126315580|NCT01752634|454445494|FG004|Week 24 to Week 260|Adverse Event|2|||
126315581|NCT01752634|454445495|FG005|Week 24 to Week 260|Adverse Event|0|||
126315582|NCT03226678|454445505|FG000|Part A (Core Study Phase)|Adverse Event|0|||
126315583|NCT03226678|454445506|FG001|Part A (Core Study Phase)|Adverse Event|1|||
126315584|NCT03226678|454445507|FG002|Part A (Core Study Phase)|Adverse Event|0|||
126315585|NCT03226678|454445508|FG003|Part A (Core Study Phase)|Adverse Event|0|||
126315586|NCT03226678|454445509|FG004|Part A (Core Study Phase)|Adverse Event|0|||
126315587|NCT03226678|454445510|FG005|Part A (Core Study Phase)|Adverse Event|0|||
126315588|NCT03226678|454445505|FG000|Part A (Core Study Phase)|Death|0|||
126315589|NCT03226678|454445506|FG001|Part A (Core Study Phase)|Death|0|||
126315590|NCT03226678|454445507|FG002|Part A (Core Study Phase)|Death|1|||
126315591|NCT03226678|454445508|FG003|Part A (Core Study Phase)|Death|0|||
126315592|NCT03226678|454445509|FG004|Part A (Core Study Phase)|Death|0|||
126315593|NCT03226678|454445510|FG005|Part A (Core Study Phase)|Death|0|||
126315594|NCT03226678|454445505|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
126315595|NCT03226678|454445506|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
126315596|NCT03226678|454445507|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
126315597|NCT03226678|454445508|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
126315598|NCT03226678|454445509|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
126315599|NCT03226678|454445510|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
126315600|NCT03226678|454445505|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
126315601|NCT03226678|454445506|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
126315602|NCT03226678|454445507|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
126315603|NCT03226678|454445508|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
126315604|NCT03226678|454445509|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
126315605|NCT03226678|454445510|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
126315606|NCT03226678|454445505|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
126315607|NCT03226678|454445506|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
126315608|NCT03226678|454445507|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
126315609|NCT03226678|454445508|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
126315610|NCT03226678|454445509|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
126315611|NCT03226678|454445510|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
126315612|NCT03226678|454445505|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
126315613|NCT03226678|454445506|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
126315614|NCT03226678|454445507|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
126315615|NCT03226678|454445508|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
126315616|NCT03226678|454445509|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
126315617|NCT03226678|454445510|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
126315618|NCT03226678|454445505|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
126315619|NCT03226678|454445506|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
126315620|NCT03226678|454445507|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
126315621|NCT03226678|454445508|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
126315622|NCT03226678|454445509|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
126315623|NCT03226678|454445510|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
126315624|NCT03226678|454445505|FG000|Part B (Long-Term Extension Phase)|Death|0|||
126315625|NCT03226678|454445506|FG001|Part B (Long-Term Extension Phase)|Death|0|||
126538821|NCT01951638|455264428|FG002|Follow-up Period|Death|1|||
126538822|NCT01951638|455264429|FG003|Follow-up Period|Death|4|||
126315626|NCT03226678|454445507|FG002|Part B (Long-Term Extension Phase)|Death|0|||
126538823|NCT01951638|455264430|FG004|Follow-up Period|Death|1|||
126538824|NCT01951638|455264426|FG000|Follow-up Period|Adverse Event|0|||
126538825|NCT01951638|455264427|FG001|Follow-up Period|Adverse Event|1|||
126315627|NCT03226678|454445508|FG003|Part B (Long-Term Extension Phase)|Death|0|||
126315628|NCT03226678|454445509|FG004|Part B (Long-Term Extension Phase)|Death|0|||
126315629|NCT03226678|454445510|FG005|Part B (Long-Term Extension Phase)|Death|1|||
126315630|NCT03226678|454445505|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
126315631|NCT03226678|454445506|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
126538826|NCT01951638|455264428|FG002|Follow-up Period|Adverse Event|2|||
126538827|NCT01951638|455264429|FG003|Follow-up Period|Adverse Event|1|||
126315632|NCT03226678|454445507|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
126315633|NCT03226678|454445508|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
126315634|NCT03226678|454445509|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
126315635|NCT03226678|454445510|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
126315636|NCT03226678|454445505|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
126315637|NCT03226678|454445506|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
126315638|NCT03226678|454445507|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
126315639|NCT03226678|454445508|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
126315640|NCT03226678|454445509|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
126315641|NCT03226678|454445510|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
126315642|NCT03226678|454445505|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
126315643|NCT03226678|454445506|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
126315644|NCT03226678|454445507|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
126315645|NCT03226678|454445508|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
126315646|NCT03226678|454445509|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
126315647|NCT03226678|454445510|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
126315648|NCT03117881|454445515|FG000|Baseline|Withdrawal by Subject|21|||
126315649|NCT03117881|454445516|FG001|Baseline|Withdrawal by Subject|10|||
126315650|NCT03117881|454445517|FG002|Baseline|Withdrawal by Subject|0|||
126315651|NCT03117881|454445515|FG000|Baseline|Lost to Follow-up|22|||
126315652|NCT03117881|454445516|FG001|Baseline|Lost to Follow-up|25|||
126315653|NCT03117881|454445517|FG002|Baseline|Lost to Follow-up|0|||
126538828|NCT01951638|455264430|FG004|Follow-up Period|Adverse Event|1|||
126538829|NCT00766675|455265506|FG000|Overall Study|Adverse Event|16|||
126538830|NCT00766675|455265506|FG000|Overall Study|Lost to Follow-up|2|||
126538831|NCT00766675|455265506|FG000|Overall Study|Withdrawal by Subject|11|||
126538832|NCT00766675|455265506|FG000|Overall Study|Protocol Violation|8|||
126538833|NCT00766675|455265506|FG000|Overall Study|Participant took prohibited medication|1|||
126538834|NCT00766675|455265506|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
126538835|NCT00766675|455265506|FG000|Overall Study|Insufficient therapy|1|||
126538836|NCT02240108|455265507|FG000|Overall Study|Other than specified|8|||
126538837|NCT02240108|455265508|FG001|Overall Study|Other than specified|6|||
126538838|NCT02240108|455265507|FG000|Overall Study|Adverse Event|1|||
126538839|NCT02240108|455265508|FG001|Overall Study|Adverse Event|9|||
126538840|NCT02240108|455265507|FG000|Overall Study|Pregnancy|1|||
126538841|NCT02240108|455265508|FG001|Overall Study|Pregnancy|0|||
126538842|NCT02240108|455265507|FG000|Overall Study|Withdrawal by Subject|4|||
126538843|NCT02240108|455265508|FG001|Overall Study|Withdrawal by Subject|9|||
126538844|NCT02240108|455265507|FG000|Overall Study|StudyTerminated by Sponsor|0|||
126538845|NCT02240108|455265508|FG001|Overall Study|StudyTerminated by Sponsor|1|||
126538846|NCT01345630|455265509|FG000|Overall Study|Adverse Event|22|||
126538847|NCT01345630|455265510|FG001|Overall Study|Adverse Event|23|||
126538848|NCT01345630|455265509|FG000|Overall Study|Lost to Follow-up|17|||
126315654|NCT03117881|454445515|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
126315655|NCT03117881|454445516|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
126315656|NCT03117881|454445517|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
126315657|NCT03117881|454445515|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
126315658|NCT03117881|454445516|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
126315659|NCT03117881|454445517|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
126315660|NCT03117881|454445515|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
126315661|NCT03117881|454445516|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
126315662|NCT03117881|454445517|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
126315663|NCT03117881|454445515|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
126315664|NCT03117881|454445516|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
126538849|NCT01345630|455265510|FG001|Overall Study|Lost to Follow-up|16|||
126538850|NCT01345630|455265509|FG000|Overall Study|Protocol Violation|4|||
126538851|NCT01345630|455265510|FG001|Overall Study|Protocol Violation|1|||
126538852|NCT01345630|455265509|FG000|Overall Study|Medication error without associated AE|0|||
126538853|NCT01345630|455265510|FG001|Overall Study|Medication error without associated AE|1|||
126538854|NCT01345630|455265509|FG000|Overall Study|Study terminated by sponsor|254|||
126538855|NCT01345630|455265510|FG001|Overall Study|Study terminated by sponsor|285|||
126538856|NCT01345630|455265509|FG000|Overall Study|Other reasons|6|||
126538857|NCT01345630|455265510|FG001|Overall Study|Other reasons|8|||
126538858|NCT01345630|455265509|FG000|Overall Study|Withdrawn due to pregnancy|1|||
126538859|NCT01345630|455265510|FG001|Overall Study|Withdrawn due to pregnancy|2|||
126538860|NCT01345630|455265509|FG000|Overall Study|No longer willing to participate|9|||
126538861|NCT01345630|455265510|FG001|Overall Study|No longer willing to participate|12|||
126538862|NCT01345630|455265509|FG000|Overall Study|Insufficient clinical response|48|||
126538863|NCT01345630|455265510|FG001|Overall Study|Insufficient clinical response|11|||
126538864|NCT04233372|455265511|FG000|Overall Study|Lost to Follow-up|104|||
126538865|NCT04233372|455265511|FG000|Overall Study|Adverse Event|8|||
126538866|NCT04233372|455265511|FG000|Overall Study|Withdrawal by Subject|2|||
126538867|NCT03938454|455265512|FG000|Overall Study|Protocol Violation|1|||
126538868|NCT03938454|455265512|FG000|Overall Study|Withdrawal by Subject|2|||
126538869|NCT03938454|455265512|FG000|Overall Study|Lost to Follow-up|3|||
126538870|NCT01090310|455265513|FG000|Core Study|Adverse Event|2|||
126538871|NCT01090310|455265514|FG001|Core Study|Adverse Event|2|||
126538872|NCT01090310|455265515|FG002|Core Study|Adverse Event|1|||
126538873|NCT01090310|455265516|FG003|Core Study|Adverse Event|1|||
126538874|NCT01090310|455265513|FG000|Core Study|Subject withdrew consent|0|||
126538875|NCT01090310|455265514|FG001|Core Study|Subject withdrew consent|3|||
126538876|NCT01090310|455265515|FG002|Core Study|Subject withdrew consent|1|||
126538877|NCT01090310|455265516|FG003|Core Study|Subject withdrew consent|1|||
126538878|NCT01090310|455265513|FG000|Core Study|Abnormal test procedure result|0|||
126538879|NCT01090310|455265514|FG001|Core Study|Abnormal test procedure result|0|||
126538880|NCT01090310|455265515|FG002|Core Study|Abnormal test procedure result|1|||
126538881|NCT01090310|455265516|FG003|Core Study|Abnormal test procedure result|0|||
126538882|NCT01090310|455265513|FG000|Core Study|Administrative reasons|5|||
126538883|NCT01090310|455265514|FG001|Core Study|Administrative reasons|6|||
126538884|NCT01090310|455265515|FG002|Core Study|Administrative reasons|4|||
126538885|NCT01090310|455265516|FG003|Core Study|Administrative reasons|4|||
126538886|NCT01090310|455265513|FG000|Core Study|Protocol deviation|1|||
126538887|NCT01090310|455265514|FG001|Core Study|Protocol deviation|0|||
126538888|NCT01090310|455265515|FG002|Core Study|Protocol deviation|0|||
126538889|NCT01090310|455265516|FG003|Core Study|Protocol deviation|1|||
126538890|NCT01090310|455265513|FG000|Extension Study|Aministrative problems|13|||
126538891|NCT01090310|455265514|FG001|Extension Study|Aministrative problems|15|||
126538892|NCT01090310|455265515|FG002|Extension Study|Aministrative problems|14|||
126538893|NCT01090310|455265516|FG003|Extension Study|Aministrative problems|18|||
126538894|NCT01090310|455265513|FG000|Extension Study|Adverse Event|0|||
126538895|NCT01090310|455265514|FG001|Extension Study|Adverse Event|0|||
126538896|NCT01090310|455265515|FG002|Extension Study|Adverse Event|0|||
126538897|NCT01090310|455265516|FG003|Extension Study|Adverse Event|1|||
126538898|NCT01090310|455265513|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
126538899|NCT01090310|455265514|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
126538900|NCT01090310|455265515|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
126538901|NCT01090310|455265516|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
126538902|NCT01090310|455265513|FG000|Extension Study|Subject withdrew consent|0|||
126538903|NCT01090310|455265514|FG001|Extension Study|Subject withdrew consent|1|||
126538904|NCT01090310|455265515|FG002|Extension Study|Subject withdrew consent|0|||
126315665|NCT03117881|454445517|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
126538905|NCT01090310|455265516|FG003|Extension Study|Subject withdrew consent|0|||
126538906|NCT00695786|455265517|FG000|Overall Study|Adverse Event|0|||
126538907|NCT00695786|455265518|FG001|Overall Study|Adverse Event|3|||
126538908|NCT00695786|455265519|FG002|Overall Study|Adverse Event|4|||
126538909|NCT00695786|455265520|FG003|Overall Study|Adverse Event|2|||
126538910|NCT00695786|455265517|FG000|Overall Study|Lost to Follow-up|0|||
126315666|NCT03117881|454445515|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
126538911|NCT00695786|455265518|FG001|Overall Study|Lost to Follow-up|5|||
126538912|NCT00695786|455265519|FG002|Overall Study|Lost to Follow-up|1|||
126538913|NCT00695786|455265520|FG003|Overall Study|Lost to Follow-up|1|||
126538914|NCT00695786|455265517|FG000|Overall Study|Withdrawal by Subject|0|||
126538915|NCT00695786|455265518|FG001|Overall Study|Withdrawal by Subject|4|||
126538916|NCT00695786|455265519|FG002|Overall Study|Withdrawal by Subject|3|||
126538917|NCT00695786|455265520|FG003|Overall Study|Withdrawal by Subject|1|||
126538918|NCT00695786|455265517|FG000|Overall Study|Deemed Ineligible|1|||
126315667|NCT03117881|454445516|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
126315668|NCT03117881|454445517|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
126315669|NCT03117881|454445515|FG000|6-Month Follow-Up|Did not complete test|53|||
126315670|NCT03117881|454445516|FG001|6-Month Follow-Up|Did not complete test|25|||
126315671|NCT03117881|454445517|FG002|6-Month Follow-Up|Did not complete test|7|||
126315672|NCT03117881|454445515|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
126315673|NCT03117881|454445516|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
126315674|NCT03117881|454445517|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
126315675|NCT03117881|454445515|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
126315676|NCT03117881|454445516|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
126315677|NCT03117881|454445517|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
126315678|NCT03117881|454445515|FG000|12-Month Follow-Up|Did not complete test|40|||
126315679|NCT03117881|454445516|FG001|12-Month Follow-Up|Did not complete test|0|||
126315680|NCT03117881|454445517|FG002|12-Month Follow-Up|Did not complete test|0|||
126315681|NCT01027897|454445518|FG000|Overall Study|Protocol Violation|1|||
126315682|NCT01027897|454445518|FG000|Overall Study|Withdrawal by Subject|1|||
126315683|NCT01911780|454445519|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
126315684|NCT01911780|454445520|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
126315685|NCT01911780|454445519|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
126315686|NCT01911780|454445520|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
126315687|NCT01911780|454445519|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
126315688|NCT01911780|454445520|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
126315689|NCT01911780|454445519|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
126315690|NCT01911780|454445520|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
126315691|NCT01911780|454445519|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
126315692|NCT01911780|454445520|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
126315693|NCT01911780|454445519|FG000|Extension Period (52 Weeks)|Personal reason|1|||
126315694|NCT01911780|454445520|FG001|Extension Period (52 Weeks)|Personal reason|1|||
126315695|NCT02045732|454445523|FG000|Overall Study|At the discretion of the investigator|1|||
126315696|NCT02045732|454445524|FG001|Overall Study|At the discretion of the investigator|1|||
126315697|NCT00473824|454445525|FG000|Overall Study|Virologic Breakthrough|1|||
126315698|NCT00473824|454445526|FG001|Overall Study|Virologic Breakthrough|0|||
126315699|NCT00473824|454445525|FG000|Overall Study|Adverse Event|1|||
126315700|NCT00473824|454445526|FG001|Overall Study|Adverse Event|0|||
126315701|NCT00473824|454445525|FG000|Overall Study|Death|1|||
126315702|NCT00473824|454445526|FG001|Overall Study|Death|0|||
126315703|NCT00473824|454445525|FG000|Overall Study|Lost to Follow-up|1|||
126315704|NCT00473824|454445526|FG001|Overall Study|Lost to Follow-up|0|||
126315705|NCT00473824|454445525|FG000|Overall Study|Withdrawal by physician|1|||
126315706|NCT00473824|454445526|FG001|Overall Study|Withdrawal by physician|0|||
126315707|NCT02560623|454445527|FG000|Overall Study|Unable to swallow sponge|0|||
126315708|NCT02560623|454445528|FG001|Overall Study|Unable to swallow sponge|1|||
126315709|NCT02560623|454445529|FG002|Overall Study|Unable to swallow sponge|0|||
126315710|NCT02560623|454445530|FG003|Overall Study|Unable to swallow sponge|0|||
126315711|NCT02560623|454445527|FG000|Overall Study|Intervention prior to sponge administration|0|||
126315712|NCT02560623|454445528|FG001|Overall Study|Intervention prior to sponge administration|1|||
126315713|NCT02560623|454445529|FG002|Overall Study|Intervention prior to sponge administration|0|||
126315714|NCT02560623|454445530|FG003|Overall Study|Intervention prior to sponge administration|0|||
126315715|NCT05014815|454445531|FG000|Overall Study|Death|63|||
126315716|NCT05014815|454445532|FG001|Overall Study|Death|70|||
126315717|NCT05014815|454445531|FG000|Overall Study|Withdrawal by Subject|10|||
126315718|NCT05014815|454445532|FG001|Overall Study|Withdrawal by Subject|10|||
126315719|NCT05014815|454445531|FG000|Overall Study|Lost to Follow-up|4|||
126315720|NCT05014815|454445532|FG001|Overall Study|Lost to Follow-up|2|||
126315721|NCT05014815|454445531|FG000|Overall Study|Physician Decision|2|||
126315722|NCT05014815|454445532|FG001|Overall Study|Physician Decision|4|||
126315723|NCT04247880|454445533|FG000|Overall Study|Lost to Follow-up|24|||
126538919|NCT00695786|455265518|FG001|Overall Study|Deemed Ineligible|0|||
126538920|NCT00695786|455265519|FG002|Overall Study|Deemed Ineligible|0|||
126315724|NCT04247880|454445534|FG001|Overall Study|Lost to Follow-up|17|||
126315725|NCT04247880|454445533|FG000|Overall Study|Withdrawal by Subject|3|||
126315726|NCT04247880|454445534|FG001|Overall Study|Withdrawal by Subject|0|||
126315727|NCT06303167|454445538|FG000|Overall Study|Ineligible|1|||
126315728|NCT06303167|454445538|FG000|Overall Study|Never start protocol therapy|2|||
126315729|NCT06303167|454445538|FG000|Overall Study|Disease progression|16|||
126315730|NCT02453282|454445539|FG000|Overall Study|Death|275|||
126315731|NCT02453282|454445540|FG001|Overall Study|Death|277|||
126315732|NCT02453282|454445541|FG002|Overall Study|Death|296|||
126315733|NCT02453282|454445539|FG000|Overall Study|Lost to Follow-up|1|||
126315734|NCT02453282|454445540|FG001|Overall Study|Lost to Follow-up|0|||
126315735|NCT02453282|454445541|FG002|Overall Study|Lost to Follow-up|2|||
126315736|NCT02453282|454445539|FG000|Overall Study|Withdrawal by Subject|12|||
126315737|NCT02453282|454445540|FG001|Overall Study|Withdrawal by Subject|10|||
126315738|NCT02453282|454445541|FG002|Overall Study|Withdrawal by Subject|11|||
126315739|NCT02453282|454445539|FG000|Overall Study|Participants ongoing at data cut-off|85|||
126315740|NCT02453282|454445540|FG001|Overall Study|Participants ongoing at data cut-off|84|||
126315741|NCT02453282|454445541|FG002|Overall Study|Participants ongoing at data cut-off|62|||
126315742|NCT02453282|454445539|FG000|Overall Study|Other|1|||
126315743|NCT02453282|454445540|FG001|Overall Study|Other|1|||
126315744|NCT02453282|454445541|FG002|Overall Study|Other|1|||
126315745|NCT01661933|454445542|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
126315746|NCT01661933|454445542|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
126315747|NCT01120249|454445543|FG000|Overall Study|No protocol treatment received|21|||
126315748|NCT01120249|454445544|FG001|Overall Study|No protocol treatment received|15|||
126315749|NCT01120249|454445543|FG000|Overall Study|Disease recurrence|107|||
126315750|NCT01120249|454445544|FG001|Overall Study|Disease recurrence|57|||
126315751|NCT01120249|454445543|FG000|Overall Study|Death|1|||
126315752|NCT01120249|454445544|FG001|Overall Study|Death|0|||
126315753|NCT01120249|454445543|FG000|Overall Study|Adverse Event|40|||
126315754|NCT01120249|454445544|FG001|Overall Study|Adverse Event|276|||
126315755|NCT01120249|454445543|FG000|Overall Study|Participant refusal|34|||
126315756|NCT01120249|454445544|FG001|Overall Study|Participant refusal|42|||
126315757|NCT01120249|454445543|FG000|Overall Study|Other reasons, not protocol specified|29|||
126315758|NCT01120249|454445544|FG001|Overall Study|Other reasons, not protocol specified|22|||
126315759|NCT02720744|454445545|FG000|Overall Study|Protocol Violation|0|||
126315760|NCT02720744|454445546|FG001|Overall Study|Protocol Violation|2|||
126315761|NCT02720744|454445545|FG000|Overall Study|Pregnancy|2|||
126315762|NCT02720744|454445546|FG001|Overall Study|Pregnancy|0|||
126315763|NCT02720744|454445545|FG000|Overall Study|Lack of Efficacy|2|||
126315764|NCT02720744|454445546|FG001|Overall Study|Lack of Efficacy|8|||
126315765|NCT02720744|454445545|FG000|Overall Study|Adverse Event|21|||
126315766|NCT02720744|454445546|FG001|Overall Study|Adverse Event|3|||
126315767|NCT02720744|454445545|FG000|Overall Study|Withdrawal by Subject|11|||
126315768|NCT02720744|454445546|FG001|Overall Study|Withdrawal by Subject|11|||
126315769|NCT02720744|454445545|FG000|Overall Study|Lost to follow up|2|||
126315770|NCT02720744|454445546|FG001|Overall Study|Lost to follow up|0|||
126315771|NCT02720744|454445545|FG000|Overall Study|Non Compliance with Investigational Product|0|||
126315772|NCT02720744|454445546|FG001|Overall Study|Non Compliance with Investigational Product|1|||
126315773|NCT02720744|454445545|FG000|Overall Study|Excluded Concomitant Medication|0|||
126315774|NCT02720744|454445546|FG001|Overall Study|Excluded Concomitant Medication|1|||
126315775|NCT01447446|454445547|FG000|Overall Study|Death|6|||
126538921|NCT00695786|455265520|FG003|Overall Study|Deemed Ineligible|0|||
126538922|NCT00695786|455265517|FG000|Overall Study|Lack of Efficacy|0|||
126538923|NCT00695786|455265518|FG001|Overall Study|Lack of Efficacy|0|||
126538924|NCT00695786|455265519|FG002|Overall Study|Lack of Efficacy|0|||
126538925|NCT00695786|455265520|FG003|Overall Study|Lack of Efficacy|4|||
126538926|NCT01364922|455265521|FG000|Open-label (OL) Period|Adverse Event|7|||
126538927|NCT01364922|455265522|FG001|Open-label (OL) Period|Adverse Event|0|||
126538928|NCT01364922|455265523|FG002|Open-label (OL) Period|Adverse Event|0|||
126538929|NCT01364922|455265521|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
126538930|NCT01364922|455265522|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
126538931|NCT01364922|455265523|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
126538932|NCT01364922|455265521|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
126538933|NCT01364922|455265522|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
126538934|NCT01364922|455265523|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
126315776|NCT01447446|454445548|FG001|Overall Study|Death|3|||
126315777|NCT01447446|454445549|FG002|Overall Study|Death|2|||
126315778|NCT01447446|454445550|FG003|Overall Study|Death|1|||
126315779|NCT01447446|454445551|FG004|Overall Study|Death|7|||
126538935|NCT01364922|455265521|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
126538936|NCT01364922|455265522|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
126315780|NCT01447446|454445552|FG005|Overall Study|Death|0|||
126315781|NCT01447446|454445547|FG000|Overall Study|Adverse Event|3|||
126315782|NCT01447446|454445548|FG001|Overall Study|Adverse Event|0|||
126315783|NCT01447446|454445549|FG002|Overall Study|Adverse Event|1|||
126538937|NCT01364922|455265523|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
126538938|NCT01364922|455265521|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
126538939|NCT01364922|455265522|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
126315784|NCT01447446|454445550|FG003|Overall Study|Adverse Event|0|||
126315785|NCT01447446|454445551|FG004|Overall Study|Adverse Event|2|||
126315786|NCT01447446|454445552|FG005|Overall Study|Adverse Event|0|||
126315787|NCT01447446|454445547|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
126315788|NCT01447446|454445548|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
126315789|NCT01447446|454445549|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
126315790|NCT01447446|454445550|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
126315791|NCT01447446|454445551|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
126315792|NCT01447446|454445552|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
126315793|NCT01447446|454445547|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
126538940|NCT01364922|455265523|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
126538941|NCT01364922|455265521|FG000|Open-label (OL) Period|Other, Unspecified|1|||
126538942|NCT01364922|455265522|FG001|Open-label (OL) Period|Other, Unspecified|0|||
126538943|NCT01364922|455265523|FG002|Open-label (OL) Period|Other, Unspecified|0|||
126315794|NCT01447446|454445548|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
126315795|NCT01447446|454445549|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
126315796|NCT01447446|454445550|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
126315797|NCT01447446|454445551|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
126315798|NCT01447446|454445552|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
126315799|NCT01447446|454445547|FG000|Overall Study|Administrative/Other|34|||
126315800|NCT01447446|454445548|FG001|Overall Study|Administrative/Other|9|||
126315801|NCT01447446|454445549|FG002|Overall Study|Administrative/Other|10|||
126315802|NCT01447446|454445550|FG003|Overall Study|Administrative/Other|2|||
126315803|NCT01447446|454445551|FG004|Overall Study|Administrative/Other|33|||
126315804|NCT01447446|454445552|FG005|Overall Study|Administrative/Other|4|||
126315805|NCT01447446|454445547|FG000|Overall Study|SVR12 Assessment|13|||
126315806|NCT01447446|454445548|FG001|Overall Study|SVR12 Assessment|1|||
126315807|NCT01447446|454445549|FG002|Overall Study|SVR12 Assessment|2|||
126315808|NCT01447446|454445550|FG003|Overall Study|SVR12 Assessment|1|||
126315809|NCT01447446|454445551|FG004|Overall Study|SVR12 Assessment|5|||
126315810|NCT01447446|454445552|FG005|Overall Study|SVR12 Assessment|5|||
126315811|NCT01447446|454445547|FG000|Overall Study|New Treatment Started|8|||
126538944|NCT01364922|455265521|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
126538945|NCT01364922|455265522|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
126538946|NCT01364922|455265523|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
126538947|NCT01364922|455265521|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
126538948|NCT01364922|455265522|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
126538949|NCT01364922|455265523|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
126538950|NCT01364922|455265521|FG000|Double-Blind (DB) Period|Adverse Event|0|||
126538951|NCT01364922|455265522|FG001|Double-Blind (DB) Period|Adverse Event|0|||
126538952|NCT01364922|455265523|FG002|Double-Blind (DB) Period|Adverse Event|1|||
126538953|NCT01364922|455265521|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
126538954|NCT01364922|455265522|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
126538955|NCT01364922|455265523|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
126538956|NCT04244396|455265527|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
126538957|NCT04244396|455265527|FG000|Overall Study|Withdrawal by Subject|2|||
126538958|NCT04244396|455265527|FG000|Overall Study|Study termination|37|||
126538959|NCT01787097|455265528|FG000|Overall Study|Withdrawal by Subject|1|||
126538960|NCT01787097|455265529|FG001|Overall Study|Withdrawal by Subject|0|||
126538961|NCT01787097|455265530|FG002|Overall Study|Withdrawal by Subject|0|||
126538962|NCT01787097|455265531|FG003|Overall Study|Withdrawal by Subject|0|||
126538963|NCT00949884|455265532|FG000|Overall Study|Adverse Event|14|||
126538964|NCT00949884|455265533|FG001|Overall Study|Adverse Event|3|||
126538965|NCT00949884|455265534|FG002|Overall Study|Adverse Event|12|||
126538966|NCT00949884|455265532|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
126538967|NCT00949884|455265533|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
126538968|NCT00949884|455265534|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
126538969|NCT00949884|455265532|FG000|Overall Study|Lost to Follow-up|7|||
126538970|NCT00949884|455265533|FG001|Overall Study|Lost to Follow-up|5|||
126538971|NCT00949884|455265534|FG002|Overall Study|Lost to Follow-up|5|||
126538972|NCT00949884|455265532|FG000|Overall Study|Physician Decision|5|||
126538973|NCT00949884|455265533|FG001|Overall Study|Physician Decision|0|||
126538974|NCT00949884|455265534|FG002|Overall Study|Physician Decision|6|||
126538975|NCT00949884|455265532|FG000|Overall Study|Treatment non-compliance|5|||
126538976|NCT00949884|455265533|FG001|Overall Study|Treatment non-compliance|0|||
126538977|NCT00949884|455265534|FG002|Overall Study|Treatment non-compliance|8|||
126538978|NCT00949884|455265532|FG000|Overall Study|Withdrawal by Subject|13|||
126538979|NCT00949884|455265533|FG001|Overall Study|Withdrawal by Subject|4|||
126538980|NCT00949884|455265534|FG002|Overall Study|Withdrawal by Subject|16|||
126538981|NCT00949884|455265532|FG000|Overall Study|Lack of Efficacy|4|||
126315812|NCT01447446|454445548|FG001|Overall Study|New Treatment Started|2|||
126538982|NCT00949884|455265533|FG001|Overall Study|Lack of Efficacy|2|||
126538983|NCT00949884|455265534|FG002|Overall Study|Lack of Efficacy|7|||
126538984|NCT00949884|455265532|FG000|Overall Study|Study terminated by sponsor|0|||
126315813|NCT01447446|454445549|FG002|Overall Study|New Treatment Started|1|||
126538985|NCT00949884|455265533|FG001|Overall Study|Study terminated by sponsor|0|||
126538986|NCT00949884|455265534|FG002|Overall Study|Study terminated by sponsor|1|||
126538987|NCT01281202|455265541|FG000|Overall Study|Adverse Event|2|||
126538988|NCT01281202|455265542|FG001|Overall Study|Adverse Event|0|||
126315814|NCT01447446|454445550|FG003|Overall Study|New Treatment Started|0|||
126538989|NCT01281202|455265541|FG000|Overall Study|Withdrawal by Subject|2|||
126538990|NCT01281202|455265542|FG001|Overall Study|Withdrawal by Subject|2|||
126538991|NCT01281202|455265541|FG000|Overall Study|Protocol Violation|11|||
126538992|NCT01281202|455265542|FG001|Overall Study|Protocol Violation|10|||
126538993|NCT01281202|455265541|FG000|Overall Study|Administrative|2|||
126538994|NCT01281202|455265542|FG001|Overall Study|Administrative|8|||
126538995|NCT01281202|455265541|FG000|Overall Study|Lost to Follow-up|11|||
126538996|NCT01281202|455265542|FG001|Overall Study|Lost to Follow-up|13|||
126538997|NCT01281202|455265541|FG000|Overall Study|Incarceration|0|||
126538998|NCT01281202|455265542|FG001|Overall Study|Incarceration|3|||
126538999|NCT00166296|455265543|FG000|Overall Study|Withdrawal by Subject|1|||
126539000|NCT00166296|455265544|FG001|Overall Study|Withdrawal by Subject|3|||
126539001|NCT00166296|455265543|FG000|Overall Study|Adverse Event|2|||
126315815|NCT01447446|454445551|FG004|Overall Study|New Treatment Started|2|||
126315816|NCT01447446|454445552|FG005|Overall Study|New Treatment Started|0|||
126315817|NCT01447446|454445547|FG000|Overall Study|Reason not Specified|1|||
126315818|NCT01447446|454445548|FG001|Overall Study|Reason not Specified|1|||
126315819|NCT01447446|454445549|FG002|Overall Study|Reason not Specified|1|||
126315820|NCT01447446|454445550|FG003|Overall Study|Reason not Specified|1|||
126315821|NCT01447446|454445551|FG004|Overall Study|Reason not Specified|1|||
126315822|NCT01447446|454445552|FG005|Overall Study|Reason not Specified|0|||
126315823|NCT01892085|454445566|FG000|Overall Study|Death|4|||
126539002|NCT00166296|455265544|FG001|Overall Study|Adverse Event|4|||
126539003|NCT00166296|455265543|FG000|Overall Study|Lost to Follow-up|4|||
126315824|NCT01892085|454445567|FG001|Overall Study|Death|1|||
126539004|NCT00166296|455265544|FG001|Overall Study|Lost to Follow-up|2|||
126539005|NCT04035200|455265545|FG000|Overall Study|Lost to Follow-up|0|||
126315825|NCT01892085|454445568|FG002|Overall Study|Death|3|||
126315826|NCT01892085|454445566|FG000|Overall Study|Withdrawal by Subject|2|||
126315827|NCT01892085|454445567|FG001|Overall Study|Withdrawal by Subject|0|||
126315828|NCT01892085|454445568|FG002|Overall Study|Withdrawal by Subject|2|||
126315829|NCT01629823|454445569|FG000|Trial Period|Missed visit|11|||
126315830|NCT01629823|454445570|FG001|Trial Period|Missed visit|9|||
126315831|NCT01629823|454445571|FG002|Trial Period|Missed visit|8|||
126315832|NCT01629823|454445569|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
126315833|NCT01629823|454445570|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
126315834|NCT01629823|454445571|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
126315835|NCT01629823|454445569|FG000|Trial Period|Pregnancy|1|||
126315836|NCT01629823|454445570|FG001|Trial Period|Pregnancy|0|||
126315837|NCT01629823|454445571|FG002|Trial Period|Pregnancy|0|||
126315838|NCT01629823|454445569|FG000|Trial Period|Adverse Event|0|||
126315839|NCT01629823|454445570|FG001|Trial Period|Adverse Event|1|||
126315840|NCT01629823|454445571|FG002|Trial Period|Adverse Event|0|||
126539006|NCT04035200|455265546|FG001|Overall Study|Lost to Follow-up|1|||
126539007|NCT04035200|455265547|FG002|Overall Study|Lost to Follow-up|0|||
126539008|NCT04035200|455265545|FG000|Overall Study|Withdrawal by Subject|1|||
126539009|NCT04035200|455265546|FG001|Overall Study|Withdrawal by Subject|4|||
126315841|NCT01629823|454445569|FG000|Trial Period|Out-of-window visit|0|||
126315842|NCT01629823|454445570|FG001|Trial Period|Out-of-window visit|2|||
126315843|NCT01629823|454445571|FG002|Trial Period|Out-of-window visit|0|||
126315844|NCT01629823|454445569|FG000|Trial Period|Failed to hold medication|0|||
126315845|NCT01629823|454445570|FG001|Trial Period|Failed to hold medication|0|||
126315846|NCT01629823|454445571|FG002|Trial Period|Failed to hold medication|1|||
126539010|NCT04035200|455265547|FG002|Overall Study|Withdrawal by Subject|4|||
126539011|NCT04035200|455265545|FG000|Overall Study|COVID-19|1|||
126539012|NCT04035200|455265546|FG001|Overall Study|COVID-19|0|||
126539013|NCT04035200|455265547|FG002|Overall Study|COVID-19|0|||
126539014|NCT04035200|455265545|FG000|Overall Study|Early Termination|0|||
126539015|NCT04035200|455265546|FG001|Overall Study|Early Termination|1|||
126539016|NCT04035200|455265547|FG002|Overall Study|Early Termination|0|||
126539017|NCT04035200|455265545|FG000|Overall Study|Non-compliance|0|||
126539018|NCT04035200|455265546|FG001|Overall Study|Non-compliance|1|||
126539019|NCT04035200|455265547|FG002|Overall Study|Non-compliance|0|||
126539020|NCT04252742|455265550|FG000|Overall Study|Decision by sponsor|0|||
126539021|NCT04252742|455265551|FG001|Overall Study|Decision by sponsor|2|||
126539022|NCT04252742|455265550|FG000|Overall Study|Withdrawal by Subject|15|||
126539023|NCT04252742|455265551|FG001|Overall Study|Withdrawal by Subject|9|||
126315847|NCT01629823|454445569|FG000|Washout Period|Safety|2|||
126315848|NCT01629823|454445570|FG001|Washout Period|Safety|5|||
126315849|NCT01629823|454445571|FG002|Washout Period|Safety|0|||
126315850|NCT01629823|454445569|FG000|Washout Period|Pregnancy|1|||
126315851|NCT01629823|454445570|FG001|Washout Period|Pregnancy|0|||
126539024|NCT04252742|455265550|FG000|Overall Study|Lost to Follow-up|0|||
126539025|NCT04252742|455265551|FG001|Overall Study|Lost to Follow-up|1|||
126539026|NCT04270747|455265554|FG000|Through Week 16|Adverse Event|1|||
126539027|NCT04270747|455265555|FG001|Through Week 16|Adverse Event|2|||
126315852|NCT01629823|454445571|FG002|Washout Period|Pregnancy|0|||
126315853|NCT01629823|454445569|FG000|Washout Period|Protocol Violation|0|||
126315854|NCT01629823|454445570|FG001|Washout Period|Protocol Violation|1|||
126315855|NCT01629823|454445571|FG002|Washout Period|Protocol Violation|0|||
126539028|NCT04270747|455265556|FG002|Through Week 16|Adverse Event|0|||
126539029|NCT04270747|455265554|FG000|Through Week 16|Death|0|||
126539030|NCT04270747|455265555|FG001|Through Week 16|Death|2|||
126539031|NCT04270747|455265556|FG002|Through Week 16|Death|0|||
126539032|NCT04270747|455265554|FG000|Through Week 16|Consent Withdrawn|3|||
126539033|NCT04270747|455265555|FG001|Through Week 16|Consent Withdrawn|3|||
126539034|NCT04270747|455265556|FG002|Through Week 16|Consent Withdrawn|0|||
126315856|NCT02844907|454445572|FG000|With Dexamethasone|No IV access|1|||
126315857|NCT02003963|454445575|FG000|Overall Study|Lost to Follow-up|2|||
126539035|NCT04270747|455265554|FG000|Through Week 16|Physician Decision|1|||
126539036|NCT04270747|455265555|FG001|Through Week 16|Physician Decision|1|||
126539037|NCT04270747|455265556|FG002|Through Week 16|Physician Decision|0|||
126539038|NCT04270747|455265554|FG000|Through Week 16|Lost to Follow-up|2|||
126315858|NCT02003963|454445576|FG001|Overall Study|Lost to Follow-up|1|||
126315859|NCT03589326|454445579|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
126315860|NCT03589326|454445580|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
126315861|NCT03589326|454445579|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
126315862|NCT03589326|454445580|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
126315863|NCT03589326|454445579|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
126315864|NCT03589326|454445580|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
126315865|NCT03589326|454445579|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
126315866|NCT03589326|454445580|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
126315867|NCT03589326|454445579|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
126315868|NCT03589326|454445580|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
126315869|NCT00204477|454445583|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
126315870|NCT00204477|454445584|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
126315871|NCT00204477|454445583|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
126315872|NCT00204477|454445584|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
126315873|NCT00787917|454445586|FG000|Blinded Treatment|Adverse Event|1|||
126315874|NCT00787917|454445587|FG001|Blinded Treatment|Adverse Event|0|||
126315875|NCT00787917|454445586|FG000|Blinded Treatment|Lack of Efficacy|1|||
126315876|NCT00787917|454445587|FG001|Blinded Treatment|Lack of Efficacy|0|||
126315877|NCT00787917|454445586|FG000|Blinded Treatment|Administrative problems|3|||
126315878|NCT00787917|454445587|FG001|Blinded Treatment|Administrative problems|2|||
126315879|NCT00787917|454445586|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
126315880|NCT00787917|454445587|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
126539039|NCT04270747|455265555|FG001|Through Week 16|Lost to Follow-up|0|||
126539040|NCT04270747|455265556|FG002|Through Week 16|Lost to Follow-up|0|||
126539041|NCT04270747|455265554|FG000|Through Week 16|Protocol Violation|1|||
126539042|NCT04270747|455265555|FG001|Through Week 16|Protocol Violation|2|||
126539043|NCT04270747|455265556|FG002|Through Week 16|Protocol Violation|0|||
126539044|NCT04270747|455265554|FG000|Through Week 16|Protocol Specified Criteria|6|||
126539045|NCT04270747|455265555|FG001|Through Week 16|Protocol Specified Criteria|7|||
126539046|NCT04270747|455265556|FG002|Through Week 16|Protocol Specified Criteria|0|||
126539047|NCT04270747|455265554|FG000|Through Week 16|Miscellaneous|1|||
126539048|NCT04270747|455265555|FG001|Through Week 16|Miscellaneous|1|||
126539049|NCT04270747|455265556|FG002|Through Week 16|Miscellaneous|0|||
126539050|NCT04270747|455265554|FG000|Post Week 16|Adverse Event|7|||
126539051|NCT04270747|455265555|FG001|Post Week 16|Adverse Event|5|||
126539052|NCT04270747|455265556|FG002|Post Week 16|Adverse Event|1|||
126539053|NCT04270747|455265554|FG000|Post Week 16|Death|2|||
126539054|NCT04270747|455265555|FG001|Post Week 16|Death|0|||
126539055|NCT04270747|455265556|FG002|Post Week 16|Death|2|||
126539056|NCT04270747|455265554|FG000|Post Week 16|Consent Withdrawn|4|||
126539057|NCT04270747|455265555|FG001|Post Week 16|Consent Withdrawn|3|||
126539058|NCT04270747|455265556|FG002|Post Week 16|Consent Withdrawn|6|||
126315881|NCT00787917|454445586|FG000|Open Label|Administrative problems|3|||
126315882|NCT00787917|454445587|FG001|Open Label|Administrative problems|0|||
126315883|NCT00778102|454445588|FG000|Overall Study|Adverse Event|8|||
126315884|NCT00778102|454445589|FG001|Overall Study|Adverse Event|5|||
126315885|NCT00778102|454445588|FG000|Overall Study|Death|1|||
126315886|NCT00778102|454445589|FG001|Overall Study|Death|1|||
126539059|NCT04270747|455265554|FG000|Post Week 16|Physician Decision|3|||
126539060|NCT04270747|455265555|FG001|Post Week 16|Physician Decision|1|||
126539061|NCT04270747|455265556|FG002|Post Week 16|Physician Decision|1|||
126315887|NCT00778102|454445588|FG000|Overall Study|Lost to Follow-up|1|||
126315888|NCT00778102|454445589|FG001|Overall Study|Lost to Follow-up|0|||
126315889|NCT00778102|454445588|FG000|Overall Study|Violation of Selection Criteria|1|||
126315890|NCT00778102|454445589|FG001|Overall Study|Violation of Selection Criteria|1|||
126539062|NCT04270747|455265554|FG000|Post Week 16|Lost to Follow-up|2|||
126539063|NCT04270747|455265555|FG001|Post Week 16|Lost to Follow-up|1|||
126539064|NCT04270747|455265556|FG002|Post Week 16|Lost to Follow-up|0|||
126539065|NCT04270747|455265554|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
126539066|NCT04270747|455265555|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
126539067|NCT04270747|455265556|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
126539068|NCT04270747|455265554|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
126315891|NCT00778102|454445588|FG000|Overall Study|Protocol Violation|0|||
126315892|NCT00778102|454445589|FG001|Overall Study|Protocol Violation|1|||
126315893|NCT00778102|454445588|FG000|Overall Study|Refused Treatment|2|||
126315894|NCT00778102|454445589|FG001|Overall Study|Refused Treatment|3|||
126315895|NCT00778102|454445588|FG000|Overall Study|Withdrawal by Subject|1|||
126315896|NCT00778102|454445589|FG001|Overall Study|Withdrawal by Subject|1|||
126315897|NCT00778102|454445588|FG000|Overall Study|Administrative Reason|7|||
126315898|NCT00778102|454445589|FG001|Overall Study|Administrative Reason|10|||
126315899|NCT01328548|454445590|FG000|Overall Study|Death|3|||
126315900|NCT01328548|454445591|FG001|Overall Study|Death|0|||
126315901|NCT01328548|454445590|FG000|Overall Study|Protocol Violation|1|||
126315902|NCT01328548|454445591|FG001|Overall Study|Protocol Violation|0|||
126315903|NCT00073983|454445592|FG000|Overall Study|not evaluable|1|||
126315904|NCT03800836|454445593|FG000|Overall Study|Other|2|||
126315905|NCT03800836|454445594|FG001|Overall Study|Other|1|||
126315906|NCT03800836|454445595|FG002|Overall Study|Other|0|||
126315907|NCT03800836|454445596|FG003|Overall Study|Other|2|||
126315908|NCT03800836|454445597|FG004|Overall Study|Other|0|||
126315909|NCT03800836|454445598|FG005|Overall Study|Other|1|||
126315910|NCT03800836|454445593|FG000|Overall Study|Lost to Follow-up|2|||
126315911|NCT03800836|454445594|FG001|Overall Study|Lost to Follow-up|0|||
126315912|NCT03800836|454445595|FG002|Overall Study|Lost to Follow-up|1|||
126315913|NCT03800836|454445596|FG003|Overall Study|Lost to Follow-up|1|||
126315914|NCT03800836|454445597|FG004|Overall Study|Lost to Follow-up|3|||
126315915|NCT03800836|454445598|FG005|Overall Study|Lost to Follow-up|0|||
126315916|NCT03800836|454445593|FG000|Overall Study|Withdrawal by Subject|1|||
126315917|NCT03800836|454445594|FG001|Overall Study|Withdrawal by Subject|0|||
126315918|NCT03800836|454445595|FG002|Overall Study|Withdrawal by Subject|0|||
126315919|NCT03800836|454445596|FG003|Overall Study|Withdrawal by Subject|0|||
126315920|NCT03800836|454445597|FG004|Overall Study|Withdrawal by Subject|0|||
126315921|NCT03800836|454445598|FG005|Overall Study|Withdrawal by Subject|0|||
126315922|NCT03800836|454445593|FG000|Overall Study|Physician Decision|31|||
126315923|NCT03800836|454445594|FG001|Overall Study|Physician Decision|3|||
126315924|NCT03800836|454445595|FG002|Overall Study|Physician Decision|6|||
126315925|NCT03800836|454445596|FG003|Overall Study|Physician Decision|4|||
126315926|NCT03800836|454445597|FG004|Overall Study|Physician Decision|4|||
126315927|NCT03800836|454445598|FG005|Overall Study|Physician Decision|5|||
126315928|NCT03800836|454445593|FG000|Overall Study|Death|34|||
126315929|NCT03800836|454445594|FG001|Overall Study|Death|16|||
126315930|NCT03800836|454445595|FG002|Overall Study|Death|5|||
126315931|NCT03800836|454445596|FG003|Overall Study|Death|5|||
126315932|NCT03800836|454445597|FG004|Overall Study|Death|10|||
126315933|NCT03800836|454445598|FG005|Overall Study|Death|0|||
126315934|NCT03800836|454445593|FG000|Overall Study|Symptomatic Deterioration|1|||
126315935|NCT03800836|454445594|FG001|Overall Study|Symptomatic Deterioration|0|||
126315936|NCT03800836|454445595|FG002|Overall Study|Symptomatic Deterioration|1|||
126315937|NCT03800836|454445596|FG003|Overall Study|Symptomatic Deterioration|0|||
126315938|NCT03800836|454445597|FG004|Overall Study|Symptomatic Deterioration|0|||
126315939|NCT03800836|454445598|FG005|Overall Study|Symptomatic Deterioration|0|||
126315940|NCT01250171|454447630|FG000|Overall Study|Administrative reasons|1|||
126315941|NCT01250171|454447631|FG001|Overall Study|Administrative reasons|0|||
126315942|NCT01250171|454447632|FG002|Overall Study|Administrative reasons|0|||
126315943|NCT04557124|454447637|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
126315944|NCT04557124|454447638|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
126315945|NCT04557124|454447637|FG000|Mid-point (1 Month)|Missed testing|5|||
126315946|NCT04557124|454447638|FG001|Mid-point (1 Month)|Missed testing|4|||
126315947|NCT04557124|454447637|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
126315948|NCT04557124|454447638|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
126315949|NCT04557124|454447637|FG000|Post-testing (2 Months)|Missed testing|1|||
126315950|NCT04557124|454447638|FG001|Post-testing (2 Months)|Missed testing|5|||
126315951|NCT04557124|454447637|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
126315952|NCT04557124|454447638|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
126315953|NCT04557124|454447637|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
126315954|NCT04557124|454447638|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
126315955|NCT04550832|454447639|FG000|Overall Study|Adverse Event|0|||
126315956|NCT04550832|454447640|FG001|Overall Study|Adverse Event|0|||
126315957|NCT04550832|454447641|FG002|Overall Study|Adverse Event|2|||
126315958|NCT04550832|454447642|FG003|Overall Study|Adverse Event|0|||
126315959|NCT04550832|454447643|FG004|Overall Study|Adverse Event|1|||
126315960|NCT04823130|454447644|FG000|Overall Study|Withdrawal by Subject|2|||
126315961|NCT04823130|454447645|FG001|Overall Study|Withdrawal by Subject|3|||
126315962|NCT04823130|454447644|FG000|Overall Study|Failure to meet inclusion criteria|6|||
126315963|NCT04823130|454447645|FG001|Overall Study|Failure to meet inclusion criteria|4|||
126315964|NCT04823130|454447644|FG000|Overall Study|Other-unspecified|1|||
126315965|NCT04823130|454447645|FG001|Overall Study|Other-unspecified|0|||
126315966|NCT03315455|454447646|FG000|Overall Study|Ongoing in the Study|13|||
126315967|NCT03315455|454447647|FG001|Overall Study|Ongoing in the Study|24|||
126315968|NCT03315455|454447648|FG002|Overall Study|Ongoing in the Study|17|||
126315969|NCT03315455|454447649|FG003|Overall Study|Ongoing in the Study|15|||
126315970|NCT03315455|454447646|FG000|Overall Study|Withdrawal by Subject|0|||
126315971|NCT03315455|454447647|FG001|Overall Study|Withdrawal by Subject|1|||
126315972|NCT03315455|454447648|FG002|Overall Study|Withdrawal by Subject|0|||
126315973|NCT03315455|454447649|FG003|Overall Study|Withdrawal by Subject|0|||
126315974|NCT03030118|454447653|FG000|Overall Study|Achieved SLE Diagnosis|11|||
126315975|NCT03030118|454447654|FG001|Overall Study|Achieved SLE Diagnosis|10|||
126315976|NCT03030118|454447653|FG000|Overall Study|Adverse Event|1|||
126315977|NCT03030118|454447654|FG001|Overall Study|Adverse Event|1|||
126315978|NCT03030118|454447653|FG000|Overall Study|Pregnancy|2|||
126315979|NCT03030118|454447654|FG001|Overall Study|Pregnancy|2|||
126315980|NCT03030118|454447653|FG000|Overall Study|Lost to Follow-up|5|||
126315981|NCT03030118|454447654|FG001|Overall Study|Lost to Follow-up|6|||
126315982|NCT03030118|454447653|FG000|Overall Study|Concomitant Medications|1|||
126315983|NCT03030118|454447654|FG001|Overall Study|Concomitant Medications|1|||
126315984|NCT03030118|454447653|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
126315985|NCT03030118|454447654|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
126315986|NCT03030118|454447653|FG000|Overall Study|Other|2|||
126315987|NCT03030118|454447654|FG001|Overall Study|Other|0|||
126315988|NCT03030118|454447653|FG000|Overall Study|Withdrawal by Subject|26|||
126315989|NCT03030118|454447654|FG001|Overall Study|Withdrawal by Subject|21|||
126315990|NCT03030118|454447653|FG000|Overall Study|Protocol Violation|1|||
126315991|NCT03030118|454447654|FG001|Overall Study|Protocol Violation|6|||
126315992|NCT03385304|454447656|FG000|Overall Study|Death|19|||
126315993|NCT03385304|454447657|FG001|Overall Study|Death|7|||
126315994|NCT03385304|454447656|FG000|Overall Study|Lost to Follow-up|17|||
126315995|NCT03385304|454447657|FG001|Overall Study|Lost to Follow-up|14|||
126315996|NCT03385304|454447656|FG000|Overall Study|Withdrawal by Subject|3|||
126315997|NCT03385304|454447657|FG001|Overall Study|Withdrawal by Subject|2|||
126315998|NCT03385304|454447656|FG000|Overall Study|Incarceration|2|||
126315999|NCT03385304|454447657|FG001|Overall Study|Incarceration|3|||
126316000|NCT00480493|454447664|FG000|Overall Study|moved|2|||
126316001|NCT00480493|454447665|FG001|Overall Study|moved|7|||
126316002|NCT01032070|454447666|FG000|Overall Study|Disease progression|13|||
126316003|NCT01032070|454447667|FG001|Overall Study|Disease progression|8|||
126316004|NCT01032070|454447666|FG000|Overall Study|Medical or ethical reasons|0|||
126316005|NCT01032070|454447667|FG001|Overall Study|Medical or ethical reasons|2|||
126316006|NCT01032070|454447666|FG000|Overall Study|Withdrawal by Subject|0|||
126316007|NCT01032070|454447667|FG001|Overall Study|Withdrawal by Subject|2|||
126316008|NCT00738062|454447668|FG000|Open Label Treatment|Lack of Efficacy|5|||
126316009|NCT00738062|454447669|FG001|Open Label Treatment|Lack of Efficacy|0|||
126316010|NCT00738062|454447670|FG002|Open Label Treatment|Lack of Efficacy|0|||
126316011|NCT00738062|454447668|FG000|Open Label Treatment|Adverse Event|11|||
126316012|NCT00738062|454447669|FG001|Open Label Treatment|Adverse Event|0|||
126316013|NCT00738062|454447670|FG002|Open Label Treatment|Adverse Event|0|||
126316014|NCT00738062|454447668|FG000|Open Label Treatment|Protocol Violation|2|||
126316015|NCT00738062|454447669|FG001|Open Label Treatment|Protocol Violation|0|||
126316016|NCT00738062|454447670|FG002|Open Label Treatment|Protocol Violation|0|||
126316017|NCT00738062|454447668|FG000|Open Label Treatment|Withdrawal by Subject|9|||
126316018|NCT00738062|454447669|FG001|Open Label Treatment|Withdrawal by Subject|0|||
126316019|NCT00738062|454447670|FG002|Open Label Treatment|Withdrawal by Subject|0|||
126316020|NCT00738062|454447668|FG000|Open Label Treatment|Investigator Decision|1|||
126316021|NCT00738062|454447669|FG001|Open Label Treatment|Investigator Decision|0|||
126316022|NCT00738062|454447670|FG002|Open Label Treatment|Investigator Decision|0|||
126316023|NCT00738062|454447668|FG000|Open-Label Extension|Adverse Event|5|||
126316024|NCT00738062|454447669|FG001|Open-Label Extension|Adverse Event|0|||
126316025|NCT00738062|454447670|FG002|Open-Label Extension|Adverse Event|0|||
126316026|NCT00738062|454447668|FG000|Open-Label Extension|Physician Decision|1|||
126316027|NCT00738062|454447669|FG001|Open-Label Extension|Physician Decision|0|||
126316028|NCT00738062|454447670|FG002|Open-Label Extension|Physician Decision|0|||
126316029|NCT00738062|454447668|FG000|Open-Label Extension|Lack of Efficacy|2|||
126316030|NCT00738062|454447669|FG001|Open-Label Extension|Lack of Efficacy|0|||
126316031|NCT00738062|454447670|FG002|Open-Label Extension|Lack of Efficacy|0|||
126316032|NCT00738062|454447668|FG000|Open-Label Extension|Withdrawal by Subject|6|||
126539069|NCT04270747|455265555|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
126539070|NCT04270747|455265556|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
126316033|NCT00738062|454447669|FG001|Open-Label Extension|Withdrawal by Subject|0|||
126316034|NCT00738062|454447670|FG002|Open-Label Extension|Withdrawal by Subject|0|||
126316035|NCT00738062|454447668|FG000|Open-Label Extension|Protocol Violation|1|||
126316036|NCT00738062|454447669|FG001|Open-Label Extension|Protocol Violation|0|||
126316037|NCT00738062|454447670|FG002|Open-Label Extension|Protocol Violation|0|||
126316038|NCT00738062|454447668|FG000|Open-Label Extension|Study Terminated|2|||
126316039|NCT00738062|454447669|FG001|Open-Label Extension|Study Terminated|0|||
126316040|NCT00738062|454447670|FG002|Open-Label Extension|Study Terminated|0|||
126316041|NCT00426660|454447671|FG000|Overall Study|Death|14|||
126316042|NCT00426660|454447671|FG000|Overall Study|Adverse Event|23|||
126316043|NCT00426660|454447671|FG000|Overall Study|Insufficient Clinical Response|22|||
126316044|NCT00426660|454447671|FG000|Overall Study|Lost to Follow-up|15|||
126316045|NCT00426660|454447671|FG000|Overall Study|Other|23|||
126316046|NCT00426660|454447671|FG000|Overall Study|Withdrawal by Subject|18|||
126316047|NCT00426660|454447671|FG000|Overall Study|Protocol Violation|1|||
126316048|NCT00426660|454447671|FG000|Overall Study|Enrolled Not Treated|15|||
126316049|NCT00550862|454447672|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
126316050|NCT00550862|454447673|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
126316051|NCT00550862|454447674|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
126316052|NCT00550862|454447675|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
126316053|NCT00550862|454447676|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
126316054|NCT00550862|454447672|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
126316055|NCT00550862|454447673|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
126316056|NCT00550862|454447674|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
126316057|NCT00550862|454447675|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
126316058|NCT00550862|454447676|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
126316059|NCT00550862|454447672|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
126316060|NCT00550862|454447673|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
126316061|NCT00550862|454447674|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
126316062|NCT00550862|454447675|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
126316063|NCT00550862|454447676|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
126316064|NCT00550862|454447672|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
126316065|NCT00550862|454447673|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
126316066|NCT00550862|454447674|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
126316067|NCT00550862|454447675|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
126316068|NCT00550862|454447676|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
126316069|NCT00550862|454447672|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
126316070|NCT00550862|454447673|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
126316071|NCT00550862|454447674|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
126316072|NCT00550862|454447675|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
126316073|NCT00550862|454447676|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
126316074|NCT00550862|454447672|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
126316075|NCT00550862|454447673|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
126316076|NCT00550862|454447674|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
126316077|NCT00550862|454447675|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
126316078|NCT00550862|454447676|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
126316079|NCT00550862|454447672|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
126316080|NCT00550862|454447673|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
126316081|NCT00550862|454447674|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
126316082|NCT00550862|454447675|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
126316083|NCT00550862|454447676|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
126316084|NCT00550862|454447672|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
126316085|NCT00550862|454447673|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
126316086|NCT00550862|454447674|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
126316087|NCT00550862|454447675|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
126316088|NCT00550862|454447676|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
126316089|NCT00550862|454447672|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
126316090|NCT00550862|454447673|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
126316091|NCT00550862|454447674|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
126316092|NCT00550862|454447675|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
126316093|NCT00550862|454447676|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
126316094|NCT00550862|454447672|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
126316095|NCT00550862|454447673|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
126316096|NCT00550862|454447674|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
126316097|NCT00550862|454447675|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
126316098|NCT00550862|454447676|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
126316099|NCT00980174|454447678|FG000|Overall Study|Withdrawal by Subject|1|||
126316100|NCT00980174|454447679|FG001|Overall Study|Withdrawal by Subject|4|||
126316101|NCT00980174|454447678|FG000|Overall Study|Adverse Event|0|||
126316102|NCT00980174|454447679|FG001|Overall Study|Adverse Event|3|||
126316103|NCT00980174|454447678|FG000|Overall Study|Ineligibility determined|2|||
126316104|NCT00980174|454447679|FG001|Overall Study|Ineligibility determined|1|||
126316105|NCT00980174|454447678|FG000|Overall Study|Death|1|||
126539071|NCT04270747|455265554|FG000|Post Week 16|Miscellaneous|1|||
126648200|NCT02003222|455669709|FG000|Intensification|Other reasons|0|||
126316106|NCT00980174|454447679|FG001|Overall Study|Death|1|||
126316107|NCT00980174|454447678|FG000|Overall Study|Other|0|||
126539072|NCT04270747|455265555|FG001|Post Week 16|Miscellaneous|0|||
126539073|NCT04270747|455265556|FG002|Post Week 16|Miscellaneous|1|||
126539074|NCT01784068|455265560|FG000|NTCS Phase|Adverse Event|5|||
126539075|NCT01784068|455265561|FG001|NTCS Phase|Adverse Event|0|||
126539076|NCT01784068|455265560|FG000|NTCS Phase|Physician Decision|2|||
126539077|NCT01784068|455265561|FG001|NTCS Phase|Physician Decision|0|||
126539078|NCT01784068|455265560|FG000|NTCS Phase|Patient/guardian decision|3|||
126539079|NCT01784068|455265561|FG001|NTCS Phase|Patient/guardian decision|0|||
126539080|NCT01784068|455265560|FG000|NTCS Phase|Death|2|||
126539081|NCT01784068|455265561|FG001|NTCS Phase|Death|0|||
126539082|NCT01784068|455265560|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
126539083|NCT01784068|455265561|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
126539084|NCT01784068|455265560|FG000|TFR Phase|Physician Decision|0|||
126539085|NCT01784068|455265561|FG001|TFR Phase|Physician Decision|1|||
126316108|NCT00980174|454447679|FG001|Overall Study|Other|1|||
126316109|NCT03488225|454447684|FG000|Overall Study|Off Protocol Therapy|2|||
126316110|NCT03488225|454447684|FG000|Overall Study|Stem Cell Transplant|2|||
126316111|NCT00894790|454447685|FG000|Overall Study|Protocol Violation|0|||
126316112|NCT00894790|454447686|FG001|Overall Study|Protocol Violation|1|||
126316113|NCT00894790|454447685|FG000|Overall Study|Lost to Follow-up|0|||
126316114|NCT00894790|454447686|FG001|Overall Study|Lost to Follow-up|1|||
126316115|NCT00894790|454447685|FG000|Overall Study|Did not meet entrance criteria|1|||
126316116|NCT00894790|454447686|FG001|Overall Study|Did not meet entrance criteria|0|||
126316117|NCT04093492|454447687|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
126316118|NCT04093492|454447688|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
126316119|NCT04093492|454447689|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
126316120|NCT04093492|454447690|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
126316121|NCT04093492|454447687|FG000|25 Weeks Gestational Age (GA)|No response|5|||
126316122|NCT04093492|454447688|FG001|25 Weeks Gestational Age (GA)|No response|5|||
126316123|NCT04093492|454447689|FG002|25 Weeks Gestational Age (GA)|No response|5|||
126316124|NCT04093492|454447690|FG003|25 Weeks Gestational Age (GA)|No response|2|||
126316125|NCT04093492|454447687|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
126316126|NCT04093492|454447688|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
126316127|NCT04093492|454447689|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
126316128|NCT04093492|454447690|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
126316129|NCT04093492|454447687|FG000|30 Weeks GA|Delivered before assessment|1|||
126316130|NCT04093492|454447688|FG001|30 Weeks GA|Delivered before assessment|2|||
126316131|NCT04093492|454447689|FG002|30 Weeks GA|Delivered before assessment|0|||
126316132|NCT04093492|454447690|FG003|30 Weeks GA|Delivered before assessment|0|||
126316133|NCT04093492|454447687|FG000|30 Weeks GA|No response|7|||
126316134|NCT04093492|454447688|FG001|30 Weeks GA|No response|5|||
126316135|NCT04093492|454447689|FG002|30 Weeks GA|No response|5|||
126316136|NCT04093492|454447690|FG003|30 Weeks GA|No response|2|||
126316137|NCT04093492|454447687|FG000|30 Weeks GA|Lost to Follow-up|0|||
126316138|NCT04093492|454447688|FG001|30 Weeks GA|Lost to Follow-up|1|||
126316139|NCT04093492|454447689|FG002|30 Weeks GA|Lost to Follow-up|0|||
126316140|NCT04093492|454447690|FG003|30 Weeks GA|Lost to Follow-up|0|||
126316141|NCT04093492|454447687|FG000|34 Weeks GA|Delivered before assessment|6|||
126316142|NCT04093492|454447688|FG001|34 Weeks GA|Delivered before assessment|3|||
126316143|NCT04093492|454447689|FG002|34 Weeks GA|Delivered before assessment|0|||
126316144|NCT04093492|454447690|FG003|34 Weeks GA|Delivered before assessment|0|||
126539086|NCT01784068|455265560|FG000|TFR Phase|Patient/guardian decision|0|||
126539087|NCT01784068|455265561|FG001|TFR Phase|Patient/guardian decision|3|||
126539088|NCT01784068|455265560|FG000|TFR Phase|Death|0|||
126539089|NCT01784068|455265561|FG001|TFR Phase|Death|1|||
126539090|NCT01784068|455265560|FG000|TFR Phase|Lack of Efficacy|0|||
126539091|NCT01784068|455265561|FG001|TFR Phase|Lack of Efficacy|88|||
126539092|NCT00946296|455265562|FG000|Overall Study|Physician Decision|3|||
126539093|NCT00946296|455265563|FG001|Overall Study|Physician Decision|0|||
126539094|NCT05614089|455265566|FG000|Overall Study|Pregnancy|5|||
126539095|NCT05614089|455265567|FG001|Overall Study|Pregnancy|2|||
126539096|NCT05614089|455265566|FG000|Overall Study|Lost to Follow-up|5|||
126539097|NCT05614089|455265567|FG001|Overall Study|Lost to Follow-up|1|||
126539098|NCT05614089|455265566|FG000|Overall Study|Death|0|||
126539099|NCT05614089|455265567|FG001|Overall Study|Death|1|||
126316145|NCT04093492|454447687|FG000|34 Weeks GA|No response|0|||
126316146|NCT04093492|454447688|FG001|34 Weeks GA|No response|7|||
126316147|NCT04093492|454447689|FG002|34 Weeks GA|No response|5|||
126316148|NCT04093492|454447690|FG003|34 Weeks GA|No response|3|||
126539100|NCT05614089|455265566|FG000|Overall Study|Adverse Event|1|||
126539101|NCT05614089|455265567|FG001|Overall Study|Adverse Event|0|||
126539102|NCT00701038|455265575|FG000|Overall Study|study amended pilot group of patients|4|||
126539103|NCT00701038|455265576|FG001|Overall Study|study amended pilot group of patients|4|||
126539104|NCT00386022|455265578|FG000|Plus Estrogen|Lost to Follow-up|2|||
126316149|NCT04093492|454447687|FG000|34 Weeks GA|Lost to Follow-up|0|||
126316150|NCT04093492|454447688|FG001|34 Weeks GA|Lost to Follow-up|1|||
126316151|NCT04093492|454447689|FG002|34 Weeks GA|Lost to Follow-up|0|||
126316152|NCT04093492|454447690|FG003|34 Weeks GA|Lost to Follow-up|0|||
126316153|NCT04631107|454447692|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
126316154|NCT04631107|454447692|FG000|Second Intervention (1 Night)|Adverse Event|1|||
126316155|NCT04631107|454447692|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
126316156|NCT04631107|454447692|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
126316157|NCT05385224|454447697|FG000|Overall Study|Unable to swallow capsule|2|||
126316158|NCT05385224|454447697|FG000|Overall Study|Withdrawal by Subject|2|||
126316159|NCT05385224|454447697|FG000|Overall Study|Did not meet study criteria|1|||
126316160|NCT00551161|454447698|FG000|Overall Study|Withdrawal by Subject|1|||
126316161|NCT01935128|454447699|FG000|Overall Study|Death|1|||
126316162|NCT01935128|454447699|FG000|Overall Study|Adverse Event|6|||
126316163|NCT00096993|454447700|FG000|Overall Study|Death|1|||
126316164|NCT00096993|454447701|FG001|Overall Study|Death|0|||
126316165|NCT00096993|454447700|FG000|Overall Study|Disease progression|56|||
126316166|NCT00096993|454447701|FG001|Overall Study|Disease progression|53|||
126316167|NCT00096993|454447700|FG000|Overall Study|Adverse Event|2|||
126316168|NCT00096993|454447701|FG001|Overall Study|Adverse Event|8|||
126316169|NCT00096993|454447700|FG000|Overall Study|Subject's decision|3|||
126316170|NCT00096993|454447701|FG001|Overall Study|Subject's decision|1|||
126316171|NCT00096993|454447700|FG000|Overall Study|Physician Decision|2|||
126316172|NCT00096993|454447701|FG001|Overall Study|Physician Decision|1|||
126316173|NCT00096993|454447700|FG000|Overall Study|Non-compliance|0|||
126316174|NCT00096993|454447701|FG001|Overall Study|Non-compliance|1|||
126316175|NCT00096993|454447700|FG000|Overall Study|Other unspecified|1|||
126316176|NCT00096993|454447701|FG001|Overall Study|Other unspecified|1|||
126316177|NCT00772005|454447702|FG000|Overall Study|Adverse Event|9|||
126316178|NCT00772005|454447703|FG001|Overall Study|Adverse Event|14|||
126316179|NCT00772005|454447704|FG002|Overall Study|Adverse Event|10|||
126316180|NCT00772005|454447705|FG003|Overall Study|Adverse Event|13|||
126316181|NCT00772005|454447702|FG000|Overall Study|Lack of Efficacy|0|||
126316182|NCT00772005|454447703|FG001|Overall Study|Lack of Efficacy|1|||
126316183|NCT00772005|454447704|FG002|Overall Study|Lack of Efficacy|0|||
126316184|NCT00772005|454447705|FG003|Overall Study|Lack of Efficacy|0|||
126316185|NCT00772005|454447702|FG000|Overall Study|Withdrawal by Subject|3|||
126316186|NCT00772005|454447703|FG001|Overall Study|Withdrawal by Subject|7|||
126316187|NCT00772005|454447704|FG002|Overall Study|Withdrawal by Subject|10|||
126316188|NCT00772005|454447705|FG003|Overall Study|Withdrawal by Subject|2|||
126316189|NCT00772005|454447702|FG000|Overall Study|Protocol Violation|2|||
126316190|NCT00772005|454447703|FG001|Overall Study|Protocol Violation|4|||
126316191|NCT00772005|454447704|FG002|Overall Study|Protocol Violation|1|||
126316192|NCT00772005|454447705|FG003|Overall Study|Protocol Violation|6|||
126316193|NCT00772005|454447702|FG000|Overall Study|Lost to Follow-up|7|||
126316194|NCT00772005|454447703|FG001|Overall Study|Lost to Follow-up|3|||
126316195|NCT00772005|454447704|FG002|Overall Study|Lost to Follow-up|6|||
126316196|NCT00772005|454447705|FG003|Overall Study|Lost to Follow-up|3|||
126316197|NCT00772005|454447702|FG000|Overall Study|Non-compliance with study procedures|1|||
126316198|NCT00772005|454447703|FG001|Overall Study|Non-compliance with study procedures|1|||
126316199|NCT00772005|454447704|FG002|Overall Study|Non-compliance with study procedures|0|||
126316200|NCT00772005|454447705|FG003|Overall Study|Non-compliance with study procedures|1|||
126316201|NCT00772005|454447702|FG000|Overall Study|Non-compliance with drug administration|3|||
126316202|NCT00772005|454447703|FG001|Overall Study|Non-compliance with drug administration|0|||
126316203|NCT00772005|454447704|FG002|Overall Study|Non-compliance with drug administration|1|||
126316204|NCT00772005|454447705|FG003|Overall Study|Non-compliance with drug administration|1|||
126316205|NCT01440569|454447709|FG000|Main Study|Enrolled but not treated|1|||
126316206|NCT01440569|454447710|FG001|Main Study|Enrolled but not treated|0|||
126316207|NCT01440569|454447709|FG000|Main Study|Adverse Event|9|||
126316208|NCT01440569|454447710|FG001|Main Study|Adverse Event|0|||
126316209|NCT01440569|454447709|FG000|Main Study|Pregnancy|1|||
126316210|NCT01440569|454447710|FG001|Main Study|Pregnancy|0|||
126316211|NCT01440569|454447709|FG000|Main Study|Investigator's Discretion|1|||
126316212|NCT01440569|454447710|FG001|Main Study|Investigator's Discretion|1|||
126316213|NCT01440569|454447709|FG000|Main Study|Withdrew Consent|7|||
126316214|NCT01440569|454447710|FG001|Main Study|Withdrew Consent|1|||
126539105|NCT00386022|455265579|FG001|Plus Estrogen|Lost to Follow-up|0|||
126316215|NCT01440569|454447709|FG000|Main Study|Lost to Follow-up|13|||
126316216|NCT01440569|454447710|FG001|Main Study|Lost to Follow-up|2|||
126316217|NCT01440569|454447709|FG000|Main Study|Subject Non-Compliance|3|||
126316218|NCT01440569|454447710|FG001|Main Study|Subject Non-Compliance|0|||
126316219|NCT01440569|454447709|FG000|Main Study|Protocol Violation|1|||
126316220|NCT01440569|454447710|FG001|Main Study|Protocol Violation|0|||
126316221|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Adverse Event|3|||
126316222|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Adverse Event|0|||
126316223|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Pregnancy|1|||
126316224|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Pregnancy|0|||
126316225|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
126316226|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
126316227|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
126316228|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
126316229|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
126316230|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
126316231|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
126316232|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
126316233|NCT01440569|454447709|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
126316234|NCT01440569|454447710|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
126316235|NCT05020366|454447711|FG000|Overall Study|Lost to Follow-up|2|||
126316236|NCT05020366|454447712|FG001|Overall Study|Lost to Follow-up|0|||
126316237|NCT05020366|454447711|FG000|Overall Study|Withdrawal by Subject|2|||
126316238|NCT05020366|454447712|FG001|Overall Study|Withdrawal by Subject|0|||
126316239|NCT00435487|454447726|FG000|Overall Study|Death|3|||
126316240|NCT00435487|454447727|FG001|Overall Study|Death|4|||
126316241|NCT00435487|454447726|FG000|Overall Study|Adverse Event|0|||
126316242|NCT00435487|454447727|FG001|Overall Study|Adverse Event|3|||
126316243|NCT00435487|454447726|FG000|Overall Study|Lost to Follow-up|2|||
126316244|NCT00435487|454447727|FG001|Overall Study|Lost to Follow-up|2|||
126316245|NCT00435487|454447726|FG000|Overall Study|Other|5|||
126316246|NCT00435487|454447727|FG001|Overall Study|Other|2|||
126316247|NCT00435487|454447726|FG000|Overall Study|Withdrawal by Subject|2|||
126316248|NCT00435487|454447727|FG001|Overall Study|Withdrawal by Subject|1|||
126316249|NCT00435487|454447726|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
126316250|NCT00435487|454447727|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
126316251|NCT00435487|454447726|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
126316252|NCT00435487|454447727|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
126316253|NCT03301844|454447728|FG000|Overall Study|suspected colon cancer|1|||
126316254|NCT03301844|454447729|FG001|Overall Study|suspected colon cancer|1|||
126316255|NCT05087966|454447730|FG000|Overall Study|Lost to Follow-up|1|||
126316256|NCT05087966|454447730|FG000|Overall Study|Withdrawal by Subject|5|||
126316257|NCT01267201|454447731|FG000|First Intervention Period|Withdrawal by Subject|1|||
126316258|NCT01267201|454447732|FG001|First Intervention Period|Withdrawal by Subject|0|||
126316259|NCT01267201|454447733|FG002|First Intervention Period|Withdrawal by Subject|0|||
126316260|NCT01267201|454447734|FG003|First Intervention Period|Withdrawal by Subject|0|||
126316261|NCT01267201|454447735|FG004|First Intervention Period|Withdrawal by Subject|0|||
126316262|NCT01267201|454447736|FG005|First Intervention Period|Withdrawal by Subject|0|||
126316263|NCT01267201|454447731|FG000|Second Intervention Period|Withdrawal by Subject|0|||
126316264|NCT01267201|454447732|FG001|Second Intervention Period|Withdrawal by Subject|1|||
126316265|NCT01267201|454447733|FG002|Second Intervention Period|Withdrawal by Subject|0|||
126316266|NCT01267201|454447734|FG003|Second Intervention Period|Withdrawal by Subject|0|||
126316267|NCT01267201|454447735|FG004|Second Intervention Period|Withdrawal by Subject|0|||
126316268|NCT01267201|454447736|FG005|Second Intervention Period|Withdrawal by Subject|0|||
126316269|NCT00501059|454447737|FG000|Overall Study|Protocol Violation|80|||
126316270|NCT00501059|454447738|FG001|Overall Study|Protocol Violation|69|||
126316271|NCT00501059|454447737|FG000|Overall Study|Death|140|||
126316272|NCT00501059|454447738|FG001|Overall Study|Death|137|||
126316273|NCT00501059|454447737|FG000|Overall Study|Other|236|||
126316274|NCT00501059|454447738|FG001|Overall Study|Other|239|||
126316275|NCT00501059|454447737|FG000|Overall Study|Missing end-of-study page|91|||
126316276|NCT00501059|454447738|FG001|Overall Study|Missing end-of-study page|92|||
126316277|NCT00501059|454447737|FG000|Overall Study|Clinical endpoint reached|110|||
126316278|NCT00501059|454447738|FG001|Overall Study|Clinical endpoint reached|123|||
126316279|NCT00501059|454447737|FG000|Overall Study|Insufficient therapeutic effect|4|||
126316280|NCT00501059|454447738|FG001|Overall Study|Insufficient therapeutic effect|5|||
126316281|NCT00501059|454447737|FG000|Overall Study|Consent withdrawn by subject|817|||
126316282|NCT00501059|454447738|FG001|Overall Study|Consent withdrawn by subject|873|||
126316283|NCT00501059|454447737|FG000|Overall Study|Non-compliant with study treatment|23|||
126316284|NCT00501059|454447738|FG001|Overall Study|Non-compliant with study treatment|16|||
126316285|NCT00501059|454447737|FG000|Overall Study|Reason not given|3|||
126316286|NCT00501059|454447738|FG001|Overall Study|Reason not given|1|||
126316287|NCT00501059|454447737|FG000|Overall Study|Adverse Event|129|||
126316288|NCT00501059|454447738|FG001|Overall Study|Adverse Event|122|||
126316289|NCT00501059|454447737|FG000|Overall Study|Lost to Follow-up|210|||
126316290|NCT00501059|454447738|FG001|Overall Study|Lost to Follow-up|198|||
126316291|NCT00501059|454447737|FG000|Overall Study|Not treated|25|||
126316292|NCT00501059|454447738|FG001|Overall Study|Not treated|17|||
126316293|NCT00955968|454447742|FG000|Overall Study|Death|2|||
126316294|NCT00955968|454447743|FG001|Overall Study|Death|4|||
126316295|NCT00955968|454447742|FG000|Overall Study|Withdrawal by Subject|35|||
126316296|NCT00955968|454447743|FG001|Overall Study|Withdrawal by Subject|31|||
126316297|NCT00955968|454447742|FG000|Overall Study|Lost to Follow-up|45|||
126316298|NCT00955968|454447743|FG001|Overall Study|Lost to Follow-up|39|||
126316299|NCT00955968|454447742|FG000|Overall Study|Site closed|55|||
126316300|NCT00955968|454447743|FG001|Overall Study|Site closed|52|||
126316301|NCT00430352|454447748|FG000|Overall Study|Disease progression|58|||
126316302|NCT00430352|454447748|FG000|Overall Study|Withdrawal by Subject|11|||
126316303|NCT00430352|454447748|FG000|Overall Study|Adverse Event|16|||
126316304|NCT00430352|454447748|FG000|Overall Study|Death|5|||
126316305|NCT00430352|454447748|FG000|Overall Study|Other|48|||
126316306|NCT04326439|454447751|FG000|Overall Study|Withdrawal by Subject|1|||
126539106|NCT00386022|455265578|FG000|Plus Estrogen|Adverse Event|0|||
126539107|NCT00386022|455265579|FG001|Plus Estrogen|Adverse Event|1|||
126539108|NCT01064297|455265583|FG000|Overall Study|Lost to Follow-up|791|||
126539109|NCT01064297|455265584|FG001|Overall Study|Lost to Follow-up|48|||
126539110|NCT01064297|455265585|FG002|Overall Study|Lost to Follow-up|133|||
126539111|NCT00168038|455265594|FG000|Overall Study|Adverse Event|1|||
126539112|NCT00168038|455265594|FG000|Overall Study|Therapy failure|1|||
126539113|NCT01685138|455265597|FG000|Overall Study|Lost to Follow-up|1|||
126539114|NCT01685138|455265597|FG000|Overall Study|Protocol Violation|1|||
126539115|NCT01685138|455265597|FG000|Overall Study|No longer requires treatment|1|||
126539116|NCT01685138|455265597|FG000|Overall Study|Subject/guardian decision|2|||
126539117|NCT01685138|455265597|FG000|Overall Study|Physician Decision|6|||
126316307|NCT04326439|454447752|FG001|Overall Study|Withdrawal by Subject|0|||
126316308|NCT04326439|454447751|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
126316309|NCT04326439|454447752|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
126316310|NCT04326439|454447751|FG000|Overall Study|Relapse after Induction 2|0|||
126316311|NCT04326439|454447752|FG001|Overall Study|Relapse after Induction 2|1|||
126316312|NCT04326439|454447751|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
126316313|NCT04326439|454447752|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
126316314|NCT01785849|454447755|FG000|Overall Study|Death|7|||
126316315|NCT01785849|454447756|FG001|Overall Study|Death|9|||
126316316|NCT01785849|454447755|FG000|Overall Study|Protocol Specified Criteria|29|||
126316317|NCT01785849|454447756|FG001|Overall Study|Protocol Specified Criteria|1|||
126316318|NCT01785849|454447755|FG000|Overall Study|Withdrawal by Subject|15|||
126316319|NCT01785849|454447756|FG001|Overall Study|Withdrawal by Subject|12|||
126316320|NCT01785849|454447755|FG000|Overall Study|Sponsor Decision|0|||
126316321|NCT01785849|454447756|FG001|Overall Study|Sponsor Decision|1|||
126316322|NCT01785849|454447755|FG000|Overall Study|Lost to Follow-up|10|||
126316323|NCT01785849|454447756|FG001|Overall Study|Lost to Follow-up|11|||
126316324|NCT04778059|454447757|FG000|Overall Study|Death|2|||
126316325|NCT04778059|454447758|FG001|Overall Study|Death|2|||
126316326|NCT04778059|454447759|FG002|Overall Study|Death|1|||
126316327|NCT04778059|454447760|FG003|Overall Study|Death|1|||
126316328|NCT04778059|454447761|FG004|Overall Study|Death|1|||
126316329|NCT04778059|454447757|FG000|Overall Study|Lost to Follow-up|0|||
126316330|NCT04778059|454447758|FG001|Overall Study|Lost to Follow-up|0|||
126316331|NCT04778059|454447759|FG002|Overall Study|Lost to Follow-up|0|||
126316332|NCT04778059|454447760|FG003|Overall Study|Lost to Follow-up|0|||
126316333|NCT04778059|454447761|FG004|Overall Study|Lost to Follow-up|1|||
126316334|NCT04778059|454447757|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
126316335|NCT04778059|454447758|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
126316336|NCT04778059|454447759|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
126316337|NCT04778059|454447760|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
126316338|NCT04778059|454447761|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
126316339|NCT01306045|454447768|FG000|Met General Eligibility Criteria|Screen failures|193|||
126316340|NCT01306045|454447769|FG001|Met General Eligibility Criteria|Screen failures|11|||
126316341|NCT01306045|454447770|FG002|Met General Eligibility Criteria|Screen failures|8|||
126316342|NCT02987972|454447771|FG000|Overall Study|Adverse Event|1|||
126316343|NCT02987972|454447772|FG001|Overall Study|Adverse Event|1|||
126316344|NCT02987972|454447773|FG002|Overall Study|Adverse Event|0|||
126316345|NCT02987972|454447771|FG000|Overall Study|Death|1|||
126316346|NCT02987972|454447772|FG001|Overall Study|Death|0|||
126316347|NCT02987972|454447773|FG002|Overall Study|Death|0|||
126316348|NCT02987972|454447771|FG000|Overall Study|Lack of Efficacy|9|||
126316349|NCT02987972|454447772|FG001|Overall Study|Lack of Efficacy|12|||
126539118|NCT01685138|455265597|FG000|Overall Study|Death|10|||
126316350|NCT02987972|454447773|FG002|Overall Study|Lack of Efficacy|12|||
126316351|NCT02987972|454447771|FG000|Overall Study|Lost to Follow-up|7|||
126316352|NCT02987972|454447772|FG001|Overall Study|Lost to Follow-up|8|||
126316353|NCT02987972|454447773|FG002|Overall Study|Lost to Follow-up|4|||
126316354|NCT02987972|454447771|FG000|Overall Study|Physician Decision|1|||
126316355|NCT02987972|454447772|FG001|Overall Study|Physician Decision|6|||
126316356|NCT02987972|454447773|FG002|Overall Study|Physician Decision|0|||
126316357|NCT02987972|454447771|FG000|Overall Study|Protocol Violation|2|||
126316358|NCT02987972|454447772|FG001|Overall Study|Protocol Violation|1|||
126316359|NCT02987972|454447773|FG002|Overall Study|Protocol Violation|5|||
126316360|NCT02987972|454447771|FG000|Overall Study|Withdrawal by Subject|22|||
126316361|NCT02987972|454447772|FG001|Overall Study|Withdrawal by Subject|17|||
126316362|NCT02987972|454447773|FG002|Overall Study|Withdrawal by Subject|21|||
126539119|NCT01685138|455265597|FG000|Overall Study|Adverse Event|18|||
126539120|NCT01685138|455265597|FG000|Overall Study|Progressive disease|53|||
126539121|NCT02068495|455265602|FG000|Overall Study|Case Report Forms Uncollected|60|||
126316363|NCT05128773|454449266|FG000|Overall Study|Sponsor decision to terminate study|3|||
126539122|NCT02068495|455265602|FG000|Overall Study|Protocol Deviation|49|||
126316364|NCT04250714|454449268|FG000|Overall Study|Treatment - withdrawal by subject|14|||
126316365|NCT04250714|454449268|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
126316366|NCT04250714|454449268|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
126316367|NCT04250714|454449268|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
126316368|NCT04250714|454449268|FG000|Overall Study|Treatment - Death|1|||
126316369|NCT04250714|454449268|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
126316370|NCT04250714|454449268|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
126316371|NCT04250714|454449268|FG000|Overall Study|Attempt|2|||
126316372|NCT04250714|454449268|FG000|Overall Study|Intent|7|||
126316373|NCT04676412|454449269|FG000|Overall Study|Death|28|||
126316374|NCT04676412|454449270|FG001|Overall Study|Death|31|||
126316375|NCT04676412|454449269|FG000|Overall Study|Lost to Follow-up|1|||
126316376|NCT04676412|454449270|FG001|Overall Study|Lost to Follow-up|2|||
126316377|NCT04676412|454449269|FG000|Overall Study|Sponsor Decision|20|||
126316378|NCT04676412|454449270|FG001|Overall Study|Sponsor Decision|23|||
126316379|NCT04676412|454449269|FG000|Overall Study|Withdrawal by Subject|0|||
126316380|NCT04676412|454449270|FG001|Overall Study|Withdrawal by Subject|2|||
126316381|NCT04697056|454449271|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
126316382|NCT04697056|454449272|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
126316383|NCT04439357|454449274|FG000|Overall Study|Disease Progression|4|||
126316384|NCT05906836|454449280|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
126316385|NCT05906836|454449280|FG000|Overall Study|Lost to Follow-up|1|||
126316386|NCT03747302|454449285|FG000|Overall Study|Withdrawal by Subject|1|||
126316387|NCT03747302|454449286|FG001|Overall Study|Withdrawal by Subject|2|||
126316388|NCT03769675|454449287|FG000|Overall Study|Lost to Follow-up|1|||
126316389|NCT00503997|454449290|FG000|Overall Study|disease progression|1|||
126316390|NCT00503997|454449290|FG000|Overall Study|Adverse Event|5|||
126316391|NCT00503997|454449290|FG000|Overall Study|Death|1|||
126316392|NCT00503997|454449290|FG000|Overall Study|Withdrawal by Subject|1|||
126316393|NCT01195844|454449291|FG000|Overall Study|Fecal sample not collected|40|||
126316394|NCT01432275|454449292|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
126316395|NCT01432275|454449293|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
126316396|NCT01432275|454449292|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
126316397|NCT01432275|454449293|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
126316398|NCT01432275|454449292|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
126316399|NCT01432275|454449293|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
126316400|NCT01432275|454449292|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
126316401|NCT01432275|454449293|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
126316402|NCT01432275|454449292|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
126316403|NCT01432275|454449293|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
126316404|NCT01432275|454449292|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
126316405|NCT01432275|454449293|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
126316406|NCT01432275|454449292|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
126316407|NCT01432275|454449293|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
126316408|NCT01432275|454449292|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
126316409|NCT01432275|454449293|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
126316410|NCT01432275|454449292|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
126316411|NCT01432275|454449293|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
126316412|NCT02565706|454449294|FG000|Overall Study|Withdrawal by Subject|5|||
126316413|NCT02565706|454449295|FG001|Overall Study|Withdrawal by Subject|7|||
126316414|NCT02565706|454449296|FG002|Overall Study|Withdrawal by Subject|7|||
126316415|NCT02565706|454449297|FG003|Overall Study|Withdrawal by Subject|11|||
126316416|NCT02565706|454449294|FG000|Overall Study|Lost to Follow-up|72|||
126316417|NCT02565706|454449295|FG001|Overall Study|Lost to Follow-up|75|||
126316418|NCT02565706|454449296|FG002|Overall Study|Lost to Follow-up|82|||
126539123|NCT00689026|455265603|FG000|Overall Study|Withdrawal by Subject|13|||
126316419|NCT02565706|454449297|FG003|Overall Study|Lost to Follow-up|74|||
126316420|NCT01935700|454449298|FG000|Overall Study|Withdrawal by Subject|1|||
126316421|NCT01935700|454449299|FG001|Overall Study|Withdrawal by Subject|0|||
126316422|NCT01935700|454449298|FG000|Overall Study|Physician Decision|4|||
126316423|NCT01935700|454449299|FG001|Overall Study|Physician Decision|0|||
126316424|NCT01606202|454449303|FG000|Overall Study|Adverse Event|5|||
126316425|NCT01606202|454449304|FG001|Overall Study|Adverse Event|0|||
126316426|NCT01606202|454449303|FG000|Overall Study|Withdrawal by Subject|2|||
126316427|NCT01606202|454449304|FG001|Overall Study|Withdrawal by Subject|1|||
126316428|NCT01606202|454449303|FG000|Overall Study|Personal problems|0|||
126316429|NCT01606202|454449304|FG001|Overall Study|Personal problems|1|||
126316430|NCT01606202|454449303|FG000|Overall Study|Problems with administration|0|||
126316431|NCT01606202|454449304|FG001|Overall Study|Problems with administration|1|||
126316432|NCT03802565|454449308|FG000|Overall Study|Adverse Event|0|||
126316433|NCT03802565|454449309|FG001|Overall Study|Adverse Event|1|||
126316434|NCT03802565|454449310|FG002|Overall Study|Adverse Event|2|||
126316435|NCT03802565|454449311|FG003|Overall Study|Adverse Event|1|||
126316436|NCT03802565|454449312|FG004|Overall Study|Adverse Event|1|||
126316437|NCT03802565|454449308|FG000|Overall Study|Withdrawal by Subject|2|||
126316438|NCT03802565|454449309|FG001|Overall Study|Withdrawal by Subject|2|||
126316439|NCT03802565|454449310|FG002|Overall Study|Withdrawal by Subject|2|||
126316440|NCT03802565|454449311|FG003|Overall Study|Withdrawal by Subject|0|||
126316441|NCT03802565|454449312|FG004|Overall Study|Withdrawal by Subject|1|||
126316442|NCT03802565|454449308|FG000|Overall Study|Protocol Violation|2|||
126316443|NCT03802565|454449309|FG001|Overall Study|Protocol Violation|1|||
126316444|NCT03802565|454449310|FG002|Overall Study|Protocol Violation|4|||
126316445|NCT03802565|454449311|FG003|Overall Study|Protocol Violation|5|||
126316446|NCT03802565|454449312|FG004|Overall Study|Protocol Violation|1|||
126316447|NCT03802565|454449308|FG000|Overall Study|Lost to Follow-up|0|||
126316448|NCT03802565|454449309|FG001|Overall Study|Lost to Follow-up|0|||
126316449|NCT03802565|454449310|FG002|Overall Study|Lost to Follow-up|1|||
126316450|NCT03802565|454449311|FG003|Overall Study|Lost to Follow-up|0|||
126316451|NCT03802565|454449312|FG004|Overall Study|Lost to Follow-up|0|||
126316452|NCT03802565|454449308|FG000|Overall Study|Subjects Related to Each Other|1|||
126316453|NCT03802565|454449309|FG001|Overall Study|Subjects Related to Each Other|0|||
126316454|NCT03802565|454449310|FG002|Overall Study|Subjects Related to Each Other|0|||
126316455|NCT03802565|454449311|FG003|Overall Study|Subjects Related to Each Other|2|||
126316456|NCT03802565|454449312|FG004|Overall Study|Subjects Related to Each Other|1|||
126316457|NCT03802565|454449308|FG000|Overall Study|Elevated Enzymes|0|||
126316458|NCT03802565|454449309|FG001|Overall Study|Elevated Enzymes|0|||
126316459|NCT03802565|454449310|FG002|Overall Study|Elevated Enzymes|0|||
126316460|NCT03802565|454449311|FG003|Overall Study|Elevated Enzymes|0|||
126316461|NCT03802565|454449312|FG004|Overall Study|Elevated Enzymes|2|||
126316462|NCT05020899|454449313|FG000|8 Week Follow-up|Lost to Follow-up|3|||
126316463|NCT05020899|454449314|FG001|8 Week Follow-up|Lost to Follow-up|6|||
126316464|NCT05020899|454449313|FG000|12 Week Follow-up|Lost to Follow-up|1|||
126316465|NCT05020899|454449314|FG001|12 Week Follow-up|Lost to Follow-up|0|||
126316466|NCT05020899|454449313|FG000|12 Week Follow-up|Death|0|||
126316467|NCT05020899|454449314|FG001|12 Week Follow-up|Death|1|||
126316468|NCT02124759|454449315|FG000|Overall Study|Withdrawal by Subject|3|||
126316469|NCT02124759|454449316|FG001|Overall Study|Withdrawal by Subject|1|||
126316470|NCT02124759|454449317|FG002|Overall Study|Withdrawal by Subject|1|||
126316471|NCT02124759|454449315|FG000|Overall Study|Screen Fail|2|||
126316472|NCT02124759|454449316|FG001|Overall Study|Screen Fail|2|||
126316473|NCT02124759|454449317|FG002|Overall Study|Screen Fail|3|||
126316474|NCT01068626|454449318|FG000|Overall Study|Adverse Event|3|||
126316475|NCT01068626|454449319|FG001|Overall Study|Adverse Event|0|||
126316476|NCT01068626|454449318|FG000|Overall Study|Withdrawal by Subject|0|||
126539124|NCT00689026|455265604|FG001|Overall Study|Withdrawal by Subject|6|||
126539125|NCT02703922|455265608|FG000|Overall Study|Death|5|||
126539126|NCT02703922|455265609|FG001|Overall Study|Death|8|||
126539127|NCT02703922|455265608|FG000|Overall Study|Lost to Follow-up|10|||
126539128|NCT02703922|455265609|FG001|Overall Study|Lost to Follow-up|10|||
126539129|NCT00394355|455265611|FG000|Overall Study|Adverse Event|10|||
126539130|NCT00394355|455265612|FG001|Overall Study|Adverse Event|6|||
126539131|NCT00394355|455265613|FG002|Overall Study|Adverse Event|7|||
126539132|NCT00394355|455265614|FG003|Overall Study|Adverse Event|8|||
126539133|NCT00394355|455265611|FG000|Overall Study|Did not meet protocol eligibility|1|||
126539134|NCT00394355|455265612|FG001|Overall Study|Did not meet protocol eligibility|5|||
126539135|NCT00394355|455265613|FG002|Overall Study|Did not meet protocol eligibility|4|||
126539136|NCT00394355|455265614|FG003|Overall Study|Did not meet protocol eligibility|2|||
126539137|NCT00394355|455265611|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
126539138|NCT00394355|455265612|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
126539139|NCT00394355|455265613|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
126539140|NCT00394355|455265614|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
126539141|NCT00394355|455265611|FG000|Overall Study|Subject withdrawal - related to drug|1|||
126539142|NCT00394355|455265612|FG001|Overall Study|Subject withdrawal - related to drug|0|||
126539143|NCT00394355|455265613|FG002|Overall Study|Subject withdrawal - related to drug|0|||
126539144|NCT00394355|455265614|FG003|Overall Study|Subject withdrawal - related to drug|0|||
126539145|NCT00394355|455265611|FG000|Overall Study|Lost to Follow-up|7|||
126539146|NCT00394355|455265612|FG001|Overall Study|Lost to Follow-up|5|||
126539147|NCT00394355|455265613|FG002|Overall Study|Lost to Follow-up|4|||
126539148|NCT00394355|455265614|FG003|Overall Study|Lost to Follow-up|3|||
126316477|NCT01068626|454449319|FG001|Overall Study|Withdrawal by Subject|2|||
126316478|NCT04340843|454449320|FG000|Overall Study|Adverse Event|0|||
126316479|NCT04340843|454449321|FG001|Overall Study|Adverse Event|2|||
126316480|NCT04340843|454449320|FG000|Overall Study|Withdrawal by Subject|0|||
126316481|NCT04340843|454449321|FG001|Overall Study|Withdrawal by Subject|2|||
126539149|NCT00394355|455265611|FG000|Overall Study|Noncompliance with protocol|4|||
126539150|NCT00394355|455265612|FG001|Overall Study|Noncompliance with protocol|3|||
126539151|NCT00394355|455265613|FG002|Overall Study|Noncompliance with protocol|10|||
126539152|NCT00394355|455265614|FG003|Overall Study|Noncompliance with protocol|8|||
126539153|NCT00394355|455265611|FG000|Overall Study|Administrative|0|||
126539154|NCT00394355|455265612|FG001|Overall Study|Administrative|1|||
126539155|NCT00394355|455265613|FG002|Overall Study|Administrative|1|||
126539156|NCT00394355|455265614|FG003|Overall Study|Administrative|1|||
126539157|NCT00394355|455265611|FG000|Overall Study|Lack of Efficacy|0|||
126539158|NCT00394355|455265612|FG001|Overall Study|Lack of Efficacy|0|||
126539159|NCT00394355|455265613|FG002|Overall Study|Lack of Efficacy|2|||
126539160|NCT00394355|455265614|FG003|Overall Study|Lack of Efficacy|3|||
126539161|NCT01648348|455265617|FG000|Overall Study|Cancel|1|||
126539162|NCT01648348|455265618|FG001|Overall Study|Cancel|0|||
126539163|NCT01648348|455265619|FG002|Overall Study|Cancel|0|||
126539164|NCT01648348|455265620|FG003|Overall Study|Cancel|0|||
126539165|NCT01648348|455265621|FG004|Overall Study|Cancel|3|||
126539166|NCT01648348|455265622|FG005|Overall Study|Cancel|6|||
126539167|NCT01648348|455265617|FG000|Overall Study|Replaced for MTD analysis|1|||
126539168|NCT01648348|455265618|FG001|Overall Study|Replaced for MTD analysis|0|||
126539169|NCT01648348|455265619|FG002|Overall Study|Replaced for MTD analysis|1|||
126539170|NCT01648348|455265620|FG003|Overall Study|Replaced for MTD analysis|0|||
126539171|NCT01648348|455265621|FG004|Overall Study|Replaced for MTD analysis|0|||
126539172|NCT01648348|455265622|FG005|Overall Study|Replaced for MTD analysis|0|||
126539173|NCT00459342|455265624|FG000|Overall Study|Not eligible|1|||
126539174|NCT02686034|455265625|FG000|Run-In Period 1|Eligibility|12|||
126539175|NCT02686034|455265626|FG001|Run-In Period 1|Eligibility|10|||
126539176|NCT02686034|455265625|FG000|Run-In Period 1|Withdrawal by Subject|4|||
126539177|NCT02686034|455265626|FG001|Run-In Period 1|Withdrawal by Subject|3|||
126539178|NCT02686034|455265625|FG000|Run-In Period 1|Lost to Follow-up|4|||
126539179|NCT02686034|455265626|FG001|Run-In Period 1|Lost to Follow-up|4|||
126539180|NCT02686034|455265625|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
126539181|NCT02686034|455265626|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
126539182|NCT02686034|455265625|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
126539183|NCT02686034|455265626|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
126539184|NCT02686034|455265625|FG000|Randomized Controlled Period 2|Adverse Event|0|||
126539185|NCT02686034|455265626|FG001|Randomized Controlled Period 2|Adverse Event|2|||
126539186|NCT02686034|455265625|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
126539187|NCT02686034|455265626|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
126316482|NCT04249622|454449322|FG000|Overall Study|Withdrawal by Subject|1|||
126316483|NCT04249622|454449323|FG001|Overall Study|Withdrawal by Subject|1|||
126316484|NCT04249622|454449322|FG000|Overall Study|Alternative therapy|1|||
126316485|NCT04249622|454449323|FG001|Overall Study|Alternative therapy|0|||
126316486|NCT04249622|454449322|FG000|Overall Study|Discontinuation of pertuzumab|1|||
126316487|NCT04249622|454449323|FG001|Overall Study|Discontinuation of pertuzumab|0|||
126316488|NCT01294371|454449326|FG000|Overall Study|Adverse Event|1|||
126316489|NCT01294371|454449326|FG000|Overall Study|Withdrawal by Subject|12|||
126316490|NCT01294371|454449326|FG000|Overall Study|Lost to Follow-up|6|||
126316491|NCT01294371|454449326|FG000|Overall Study|Administrative Reason|1|||
126316492|NCT01294371|454449326|FG000|Overall Study|Other|14|||
126316493|NCT05619536|454449327|FG000|Overall Study|Withdrawal by Subject|0|||
126316494|NCT05619536|454449328|FG001|Overall Study|Withdrawal by Subject|1|||
126316495|NCT05619536|454449329|FG002|Overall Study|Withdrawal by Subject|0|||
126316496|NCT05619536|454449330|FG003|Overall Study|Withdrawal by Subject|1|||
126316497|NCT05619536|454449327|FG000|Overall Study|Lost to Follow-up|0|||
126316498|NCT05619536|454449328|FG001|Overall Study|Lost to Follow-up|1|||
126316499|NCT05619536|454449329|FG002|Overall Study|Lost to Follow-up|1|||
126316500|NCT05619536|454449330|FG003|Overall Study|Lost to Follow-up|0|||
126316501|NCT02923245|454449331|FG000|Overall Study|ultrasound order was cancelled|2|||
126316502|NCT02923245|454449332|FG001|Overall Study|ultrasound order was cancelled|1|||
126316503|NCT02520427|454449333|FG000|Overall Study|Decision by sponsor|0|||
126316504|NCT02520427|454449334|FG001|Overall Study|Decision by sponsor|0|||
126316505|NCT02520427|454449335|FG002|Overall Study|Decision by sponsor|0|||
126316506|NCT02520427|454449336|FG003|Overall Study|Decision by sponsor|0|||
126316507|NCT02520427|454449337|FG004|Overall Study|Decision by sponsor|0|||
126316508|NCT02520427|454449338|FG005|Overall Study|Decision by sponsor|0|||
126316509|NCT02520427|454449339|FG006|Overall Study|Decision by sponsor|0|||
126316510|NCT02520427|454449340|FG007|Overall Study|Decision by sponsor|0|||
126316511|NCT02520427|454449341|FG008|Overall Study|Decision by sponsor|1|||
126316512|NCT02520427|454449342|FG009|Overall Study|Decision by sponsor|1|||
126316513|NCT02520427|454449343|FG010|Overall Study|Decision by sponsor|0|||
126316514|NCT02520427|454449344|FG011|Overall Study|Decision by sponsor|0|||
126539188|NCT02686034|455265625|FG000|Open Label Period 3|Lost to Follow-up|0|||
126539189|NCT02686034|455265626|FG001|Open Label Period 3|Lost to Follow-up|1|||
126539190|NCT01142388|455266698|FG000|Overall Study|Lack of Efficacy|21|||
126539191|NCT01142388|455266699|FG001|Overall Study|Lack of Efficacy|31|||
126539192|NCT01142388|455266698|FG000|Overall Study|Adverse Event|9|||
126539193|NCT01142388|455266699|FG001|Overall Study|Adverse Event|5|||
126539194|NCT01142388|455266698|FG000|Overall Study|Death|3|||
126539195|NCT01142388|455266699|FG001|Overall Study|Death|2|||
126539196|NCT01142388|455266698|FG000|Overall Study|Withdrawal by Subject|5|||
126539197|NCT01142388|455266699|FG001|Overall Study|Withdrawal by Subject|3|||
126539198|NCT01142388|455266698|FG000|Overall Study|Alternative therapy|1|||
126539199|NCT01142388|455266699|FG001|Overall Study|Alternative therapy|0|||
126316515|NCT02520427|454449345|FG012|Overall Study|Decision by sponsor|0|||
126316516|NCT02520427|454449346|FG013|Overall Study|Decision by sponsor|0|||
126316517|NCT02520427|454449347|FG014|Overall Study|Decision by sponsor|0|||
126316518|NCT02520427|454449348|FG015|Overall Study|Decision by sponsor|0|||
126316519|NCT02520427|454449349|FG016|Overall Study|Decision by sponsor|0|||
126316520|NCT02520427|454449350|FG017|Overall Study|Decision by sponsor|0|||
126316521|NCT02520427|454449351|FG018|Overall Study|Decision by sponsor|0|||
126316522|NCT02520427|454449352|FG019|Overall Study|Decision by sponsor|0|||
126316523|NCT02520427|454449353|FG020|Overall Study|Decision by sponsor|0|||
126316524|NCT02520427|454449354|FG021|Overall Study|Decision by sponsor|0|||
126316525|NCT02520427|454449355|FG022|Overall Study|Decision by sponsor|0|||
126316526|NCT02520427|454449356|FG023|Overall Study|Decision by sponsor|0|||
126316527|NCT02520427|454449357|FG024|Overall Study|Decision by sponsor|0|||
126316528|NCT02520427|454449358|FG025|Overall Study|Decision by sponsor|0|||
126316529|NCT02520427|454449333|FG000|Overall Study|Withdrawal by Subject|0|||
126316530|NCT02520427|454449334|FG001|Overall Study|Withdrawal by Subject|0|||
126316531|NCT02520427|454449335|FG002|Overall Study|Withdrawal by Subject|1|||
126316532|NCT02520427|454449336|FG003|Overall Study|Withdrawal by Subject|0|||
126316533|NCT02520427|454449337|FG004|Overall Study|Withdrawal by Subject|0|||
126316534|NCT02520427|454449338|FG005|Overall Study|Withdrawal by Subject|0|||
126316535|NCT02520427|454449339|FG006|Overall Study|Withdrawal by Subject|0|||
126316536|NCT02520427|454449340|FG007|Overall Study|Withdrawal by Subject|0|||
126316537|NCT02520427|454449341|FG008|Overall Study|Withdrawal by Subject|0|||
126316538|NCT02520427|454449342|FG009|Overall Study|Withdrawal by Subject|0|||
126316539|NCT02520427|454449343|FG010|Overall Study|Withdrawal by Subject|0|||
126316540|NCT02520427|454449344|FG011|Overall Study|Withdrawal by Subject|0|||
126316541|NCT02520427|454449345|FG012|Overall Study|Withdrawal by Subject|1|||
126316542|NCT02520427|454449346|FG013|Overall Study|Withdrawal by Subject|1|||
126316543|NCT02520427|454449347|FG014|Overall Study|Withdrawal by Subject|1|||
126316544|NCT02520427|454449348|FG015|Overall Study|Withdrawal by Subject|0|||
126316545|NCT02520427|454449349|FG016|Overall Study|Withdrawal by Subject|1|||
126316546|NCT02520427|454449350|FG017|Overall Study|Withdrawal by Subject|0|||
126316547|NCT02520427|454449351|FG018|Overall Study|Withdrawal by Subject|0|||
126316548|NCT02520427|454449352|FG019|Overall Study|Withdrawal by Subject|3|||
126316549|NCT02520427|454449353|FG020|Overall Study|Withdrawal by Subject|2|||
126316550|NCT02520427|454449354|FG021|Overall Study|Withdrawal by Subject|0|||
126316551|NCT02520427|454449355|FG022|Overall Study|Withdrawal by Subject|0|||
126316552|NCT02520427|454449356|FG023|Overall Study|Withdrawal by Subject|0|||
126316553|NCT02520427|454449357|FG024|Overall Study|Withdrawal by Subject|0|||
126316554|NCT02520427|454449358|FG025|Overall Study|Withdrawal by Subject|0|||
126316555|NCT02520427|454449333|FG000|Overall Study|Death|1|||
126316556|NCT02520427|454449334|FG001|Overall Study|Death|0|||
126316557|NCT02520427|454449335|FG002|Overall Study|Death|0|||
126316558|NCT02520427|454449336|FG003|Overall Study|Death|0|||
126316559|NCT02520427|454449337|FG004|Overall Study|Death|0|||
126316560|NCT02520427|454449338|FG005|Overall Study|Death|0|||
126316561|NCT02520427|454449339|FG006|Overall Study|Death|0|||
126316562|NCT02520427|454449340|FG007|Overall Study|Death|0|||
126316563|NCT02520427|454449341|FG008|Overall Study|Death|0|||
126316564|NCT02520427|454449342|FG009|Overall Study|Death|0|||
126316565|NCT02520427|454449343|FG010|Overall Study|Death|0|||
126316566|NCT02520427|454449344|FG011|Overall Study|Death|0|||
126316567|NCT02520427|454449345|FG012|Overall Study|Death|0|||
126316568|NCT02520427|454449346|FG013|Overall Study|Death|0|||
126316569|NCT02520427|454449347|FG014|Overall Study|Death|0|||
126316570|NCT02520427|454449348|FG015|Overall Study|Death|0|||
126316571|NCT02520427|454449349|FG016|Overall Study|Death|2|||
126316572|NCT02520427|454449350|FG017|Overall Study|Death|1|||
126316573|NCT02520427|454449351|FG018|Overall Study|Death|3|||
126316574|NCT02520427|454449352|FG019|Overall Study|Death|2|||
126316575|NCT02520427|454449353|FG020|Overall Study|Death|0|||
126316576|NCT02520427|454449354|FG021|Overall Study|Death|0|||
126316577|NCT02520427|454449355|FG022|Overall Study|Death|1|||
126316578|NCT02520427|454449356|FG023|Overall Study|Death|0|||
126316579|NCT02520427|454449357|FG024|Overall Study|Death|1|||
126316580|NCT02520427|454449358|FG025|Overall Study|Death|0|||
126316581|NCT00793624|454449361|FG000|Overall Study|Adverse Event|18|||
126316582|NCT00793624|454449362|FG001|Overall Study|Adverse Event|16|||
126316583|NCT00793624|454449363|FG002|Overall Study|Adverse Event|15|||
126316584|NCT00793624|454449364|FG003|Overall Study|Adverse Event|20|||
126316585|NCT00793624|454449361|FG000|Overall Study|Lost to Follow-up|2|||
126316586|NCT00793624|454449362|FG001|Overall Study|Lost to Follow-up|2|||
126316587|NCT00793624|454449363|FG002|Overall Study|Lost to Follow-up|4|||
126316588|NCT00793624|454449364|FG003|Overall Study|Lost to Follow-up|0|||
126316589|NCT00793624|454449361|FG000|Overall Study|Withdrawal by Subject|20|||
126316590|NCT00793624|454449362|FG001|Overall Study|Withdrawal by Subject|9|||
126316591|NCT00793624|454449363|FG002|Overall Study|Withdrawal by Subject|11|||
126316592|NCT00793624|454449364|FG003|Overall Study|Withdrawal by Subject|14|||
126316593|NCT00793624|454449361|FG000|Overall Study|Lack of Efficacy|9|||
126316594|NCT00793624|454449362|FG001|Overall Study|Lack of Efficacy|2|||
126316595|NCT00793624|454449363|FG002|Overall Study|Lack of Efficacy|1|||
126316596|NCT00793624|454449364|FG003|Overall Study|Lack of Efficacy|3|||
126316597|NCT00793624|454449361|FG000|Overall Study|Non compliance with protocol|2|||
126316598|NCT00793624|454449362|FG001|Overall Study|Non compliance with protocol|3|||
126316599|NCT00793624|454449363|FG002|Overall Study|Non compliance with protocol|2|||
126316600|NCT00793624|454449364|FG003|Overall Study|Non compliance with protocol|3|||
126316601|NCT00793624|454449361|FG000|Overall Study|Other reason not described above|6|||
126539200|NCT01142388|455266698|FG000|Overall Study|Other complications|0|||
126316602|NCT00793624|454449362|FG001|Overall Study|Other reason not described above|4|||
126316603|NCT00793624|454449363|FG002|Overall Study|Other reason not described above|6|||
126316604|NCT00793624|454449364|FG003|Overall Study|Other reason not described above|3|||
126316605|NCT00710684|454449365|FG000|Overall Study|Adverse Event|11|||
126316606|NCT00710684|454449366|FG001|Overall Study|Adverse Event|19|||
126316607|NCT00710684|454449367|FG002|Overall Study|Adverse Event|16|||
126316608|NCT00710684|454449365|FG000|Overall Study|Lack of Efficacy|4|||
126539201|NCT01142388|455266699|FG001|Overall Study|Other complications|2|||
126539202|NCT01142388|455266698|FG000|Overall Study|Other|1|||
126539203|NCT01142388|455266699|FG001|Overall Study|Other|1|||
126539204|NCT01142388|455266698|FG000|Overall Study|Never started therapy|7|||
126539205|NCT01142388|455266699|FG001|Overall Study|Never started therapy|3|||
126539206|NCT02832622|455266712|FG000|Overall Study|MPP not programmed|1259|||
126539207|NCT02832622|455266712|FG000|Overall Study|Withdrawal by Subject|123|||
126539208|NCT02832622|455266712|FG000|Overall Study|Death|119|||
126539209|NCT02832622|455266712|FG000|Overall Study|Unsuccessful CRT implant|93|||
126539210|NCT02832622|455266712|FG000|Overall Study|Lost to Follow-up|45|||
126539211|NCT02832622|455266712|FG000|Overall Study|Patient non-compliance|42|||
126539212|NCT02832622|455266712|FG000|Overall Study|Withdrawal by other reasons|25|||
126539213|NCT02832622|455266712|FG000|Overall Study|System explant|24|||
126539214|NCT02832622|455266712|FG000|Overall Study|Physician Decision|6|||
126539215|NCT02243280|455266713|FG000|Treated|Adverse Event|1|||
126539216|NCT02243280|455266714|FG001|Treated|Adverse Event|0|||
126539217|NCT02243280|455266715|FG002|Treated|Adverse Event|0|||
126539218|NCT02243280|455266716|FG003|Treated|Adverse Event|0|||
126539219|NCT02243280|455266717|FG004|Treated|Adverse Event|0|||
126539220|NCT02243280|455266718|FG005|Treated|Adverse Event|0|||
126539221|NCT02243280|455266719|FG006|Treated|Adverse Event|0|||
126539222|NCT02243280|455266720|FG007|Treated|Adverse Event|0|||
126539223|NCT02243280|455266721|FG008|Treated|Adverse Event|0|||
126539224|NCT02243280|455266722|FG009|Treated|Adverse Event|0|||
126539225|NCT02243280|455266723|FG010|Treated|Adverse Event|1|||
126539226|NCT02243280|455266713|FG000|Treated|Lost to Follow-up|0|||
126539227|NCT02243280|455266714|FG001|Treated|Lost to Follow-up|0|||
126539228|NCT02243280|455266715|FG002|Treated|Lost to Follow-up|0|||
126539229|NCT02243280|455266716|FG003|Treated|Lost to Follow-up|0|||
126539230|NCT02243280|455266717|FG004|Treated|Lost to Follow-up|0|||
126539231|NCT02243280|455266718|FG005|Treated|Lost to Follow-up|0|||
126539232|NCT02243280|455266719|FG006|Treated|Lost to Follow-up|0|||
126539233|NCT02243280|455266720|FG007|Treated|Lost to Follow-up|0|||
126539234|NCT02243280|455266721|FG008|Treated|Lost to Follow-up|1|||
126539235|NCT02243280|455266722|FG009|Treated|Lost to Follow-up|0|||
126539236|NCT02243280|455266723|FG010|Treated|Lost to Follow-up|2|||
126539237|NCT02472652|455266724|FG000|Overall Study|Lost to Follow-up|1|||
126539238|NCT00998400|455266729|FG000|Overall Study|Lack of interest/motivation|1|||
126539239|NCT00998400|455266730|FG001|Overall Study|Lack of interest/motivation|2|||
126539240|NCT00998400|455266729|FG000|Overall Study|Logistical problems|1|||
126539241|NCT00998400|455266730|FG001|Overall Study|Logistical problems|0|||
126539242|NCT03185832|455266731|FG000|Overall Study|Death|9|||
126539243|NCT03185832|455266732|FG001|Overall Study|Death|14|||
126539244|NCT03185832|455266733|FG002|Overall Study|Death|9|||
126539245|NCT03185832|455266734|FG003|Overall Study|Death|7|||
126316609|NCT00710684|454449366|FG001|Overall Study|Lack of Efficacy|3|||
126316610|NCT00710684|454449367|FG002|Overall Study|Lack of Efficacy|5|||
126316611|NCT00710684|454449365|FG000|Overall Study|Protocol Violation|5|||
126316612|NCT00710684|454449366|FG001|Overall Study|Protocol Violation|5|||
126316613|NCT00710684|454449367|FG002|Overall Study|Protocol Violation|5|||
126316614|NCT00710684|454449365|FG000|Overall Study|Lost to Follow-up|4|||
126316615|NCT00710684|454449366|FG001|Overall Study|Lost to Follow-up|6|||
126316616|NCT00710684|454449367|FG002|Overall Study|Lost to Follow-up|7|||
126316617|NCT00710684|454449365|FG000|Overall Study|Physician Decision|0|||
126316618|NCT00710684|454449366|FG001|Overall Study|Physician Decision|2|||
126316619|NCT00710684|454449367|FG002|Overall Study|Physician Decision|4|||
126316620|NCT00710684|454449365|FG000|Overall Study|Withdrawal by Subject|24|||
126316621|NCT00710684|454449366|FG001|Overall Study|Withdrawal by Subject|18|||
126316622|NCT00710684|454449367|FG002|Overall Study|Withdrawal by Subject|11|||
126539246|NCT03185832|455266731|FG000|Overall Study|Withdrawn - vital status available|0|||
126539247|NCT03185832|455266732|FG001|Overall Study|Withdrawn - vital status available|1|||
126539248|NCT03185832|455266733|FG002|Overall Study|Withdrawn - vital status available|1|||
126539249|NCT03185832|455266734|FG003|Overall Study|Withdrawn - vital status available|4|||
126539250|NCT01807156|455266735|FG000|Overall Study|Physician Decision|1|||
126539251|NCT03122119|455266738|FG000|Overall Study|Did not meet eligibility critria|1|||
126539252|NCT02364180|455266743|FG000|Overall Study|Screen Fail|1|||
126539253|NCT00521144|455266744|FG000|Overall Study|Not Treated|0|||
126539254|NCT00521144|455266745|FG001|Overall Study|Not Treated|0|||
126539255|NCT00521144|455266746|FG002|Overall Study|Not Treated|0|||
126539256|NCT00521144|455266747|FG003|Overall Study|Not Treated|1|||
126539257|NCT00521144|455266748|FG004|Overall Study|Not Treated|0|||
126539258|NCT00521144|455266744|FG000|Overall Study|Adverse Event|0|||
126539259|NCT00521144|455266745|FG001|Overall Study|Adverse Event|1|||
126539260|NCT00521144|455266746|FG002|Overall Study|Adverse Event|0|||
126539261|NCT00521144|455266747|FG003|Overall Study|Adverse Event|0|||
126539262|NCT00521144|455266748|FG004|Overall Study|Adverse Event|1|||
126539263|NCT00521144|455266744|FG000|Overall Study|Progressive Disease|4|||
126539264|NCT00521144|455266745|FG001|Overall Study|Progressive Disease|2|||
126539265|NCT00521144|455266746|FG002|Overall Study|Progressive Disease|2|||
126539266|NCT00521144|455266747|FG003|Overall Study|Progressive Disease|0|||
126539267|NCT00521144|455266748|FG004|Overall Study|Progressive Disease|6|||
126539268|NCT01370525|455266749|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
126539269|NCT01370525|455266750|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
126539270|NCT01370525|455266749|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
126539271|NCT01370525|455266750|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126539272|NCT01370525|455266749|FG000|Overall Study|Adverse Event|0|||
126539273|NCT01370525|455266750|FG001|Overall Study|Adverse Event|1|||
126539274|NCT01370525|455266749|FG000|Overall Study|Protocol Violation|2|||
126539275|NCT01370525|455266750|FG001|Overall Study|Protocol Violation|1|||
126539276|NCT01370525|455266749|FG000|Overall Study|Lost to follow up|2|||
126539277|NCT01370525|455266750|FG001|Overall Study|Lost to follow up|6|||
126539278|NCT00335452|455266753|FG000|Overall Study|Death|156|||
126539279|NCT00335452|455266754|FG001|Overall Study|Death|144|||
126539280|NCT00335452|455266755|FG002|Overall Study|Death|158|||
126539281|NCT00335452|455266756|FG003|Overall Study|Death|129|||
126539282|NCT00335452|455266753|FG000|Overall Study|Lost to Follow-up|2|||
126539283|NCT00335452|455266754|FG001|Overall Study|Lost to Follow-up|3|||
126539284|NCT00335452|455266755|FG002|Overall Study|Lost to Follow-up|1|||
126539285|NCT00335452|455266756|FG003|Overall Study|Lost to Follow-up|2|||
126539286|NCT01750879|455266770|FG000|Overall Study|Adverse Event|8|||
126539287|NCT01750879|455266771|FG001|Overall Study|Adverse Event|0|||
126539288|NCT01750879|455266770|FG000|Overall Study|Lack of Efficacy|1|||
126539289|NCT01750879|455266771|FG001|Overall Study|Lack of Efficacy|0|||
126539290|NCT01750879|455266770|FG000|Overall Study|Withdrawal by Subject|1|||
126539291|NCT01750879|455266771|FG001|Overall Study|Withdrawal by Subject|0|||
126539292|NCT01750879|455266770|FG000|Overall Study|Did not complete per protocol|0|||
126539293|NCT01750879|455266771|FG001|Overall Study|Did not complete per protocol|3|||
126539294|NCT02421666|455266774|FG000|6-month Follow-up|Lost to Follow-up|8|||
126539295|NCT02421666|455266775|FG001|6-month Follow-up|Lost to Follow-up|7|||
126539296|NCT02421666|455266774|FG000|6-month Follow-up|Withdrawal by Subject|5|||
126539297|NCT02421666|455266775|FG001|6-month Follow-up|Withdrawal by Subject|6|||
126539298|NCT02421666|455266774|FG000|12-month Follow-up|Lost to Follow-up|5|||
126539299|NCT02421666|455266775|FG001|12-month Follow-up|Lost to Follow-up|5|||
126539300|NCT02421666|455266774|FG000|12-month Follow-up|Withdrawal by Subject|6|||
126539301|NCT02421666|455266775|FG001|12-month Follow-up|Withdrawal by Subject|11|||
126539302|NCT02093663|455266780|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
126539303|NCT02093663|455266781|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
126539304|NCT02093663|455266782|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
126539305|NCT02093663|455266783|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
126539306|NCT02093663|455266784|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
126539307|NCT02093663|455266780|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
126539308|NCT02093663|455266781|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
126539309|NCT02093663|455266782|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
126539310|NCT02093663|455266783|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
126539311|NCT02093663|455266784|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
126539312|NCT02093663|455266780|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
126539313|NCT02093663|455266781|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
126539314|NCT02093663|455266782|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
126539315|NCT02093663|455266783|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
126539316|NCT02093663|455266784|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
126539317|NCT02093663|455266780|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
126539318|NCT02093663|455266781|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
126539319|NCT02093663|455266782|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
126539320|NCT02093663|455266783|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
126539321|NCT02093663|455266784|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
126539322|NCT02093663|455266780|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
126539323|NCT02093663|455266781|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
126539324|NCT02093663|455266782|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
126539325|NCT02093663|455266783|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
126539326|NCT02093663|455266784|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
126539327|NCT02093663|455266780|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
126539328|NCT02093663|455266781|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
126539329|NCT02093663|455266782|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
126539330|NCT02093663|455266783|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
126539331|NCT02093663|455266784|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
126539332|NCT02093663|455266780|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
126539333|NCT02093663|455266781|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
126539334|NCT02093663|455266782|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
126539335|NCT02093663|455266783|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
126539336|NCT02093663|455266784|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
126539337|NCT02093663|455266780|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
126539338|NCT02093663|455266781|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
126539339|NCT02093663|455266782|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
126539340|NCT02093663|455266783|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
126539341|NCT02093663|455266784|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
126539342|NCT02093663|455266780|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
126539343|NCT02093663|455266781|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
126539344|NCT02093663|455266782|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
126539345|NCT02093663|455266783|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
126539346|NCT02093663|455266784|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
126539347|NCT00508404|455266785|FG000|Overall Study|Ongoing at Data Cut-off|12|||
126539348|NCT00508404|455266785|FG000|Overall Study|Adverse Event|2|||
126539349|NCT00508404|455266785|FG000|Overall Study|Death|16|||
126539350|NCT00508404|455266785|FG000|Overall Study|Physician Decision|2|||
126539351|NCT00508404|455266785|FG000|Overall Study|Withdrawal by Subject|3|||
126539352|NCT00508404|455266785|FG000|Overall Study|Protocol-specified Criteria|2|||
126539353|NCT00508404|455266785|FG000|Overall Study|Lost to Follow-up|2|||
126539354|NCT00508404|455266785|FG000|Overall Study|Other - Not Specified|3|||
126539355|NCT01059643|455266791|FG000|Overall Study|Adverse Event|3|||
126539356|NCT01059643|455266791|FG000|Overall Study|Withdrawal by Subject|2|||
126539357|NCT01059643|455266791|FG000|Overall Study|Physician Decision|1|||
126539358|NCT00643123|455266801|FG000|Overall Study|Lost to Follow-up|4|||
126539359|NCT00643123|455266802|FG001|Overall Study|Lost to Follow-up|0|||
126539360|NCT00643123|455266801|FG000|Overall Study|Withdrawal by Subject|1|||
126539361|NCT00643123|455266802|FG001|Overall Study|Withdrawal by Subject|1|||
126539362|NCT01591382|455266805|FG000|Overall Study|Discharged Prior to Study Completion|2|||
126539363|NCT01591382|455266806|FG001|Overall Study|Discharged Prior to Study Completion|1|||
126539364|NCT01591382|455266805|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
126539365|NCT01591382|455266806|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
126539366|NCT00855062|455266812|FG000|Step1|Early Study Closure|5|||
126539367|NCT00855062|455266813|FG001|Step1|Early Study Closure|7|||
126539368|NCT00855062|455266812|FG000|Step1|Adverse Event|1|||
126539369|NCT00855062|455266813|FG001|Step1|Adverse Event|1|||
126539370|NCT00855062|455266812|FG000|Step1|Protocol Violation|1|||
126539371|NCT00855062|455266813|FG001|Step1|Protocol Violation|0|||
126539372|NCT00855062|455266812|FG000|Step1|Pregnancy|1|||
126539373|NCT00855062|455266813|FG001|Step1|Pregnancy|0|||
126539374|NCT00855062|455266812|FG000|Step1|Withdrawal by Subject|2|||
126539375|NCT00855062|455266813|FG001|Step1|Withdrawal by Subject|3|||
126539376|NCT00855062|455266812|FG000|Step2|Early Study Closure|6|||
126539377|NCT00855062|455266813|FG001|Step2|Early Study Closure|2|||
126539378|NCT00855062|455266812|FG000|Step2|Adverse Event|0|||
126539379|NCT00855062|455266813|FG001|Step2|Adverse Event|3|||
126539380|NCT00855062|455266812|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
126539381|NCT00855062|455266813|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
126539382|NCT01960725|455266816|FG000|Overall Study|Lost to Follow-up|4|||
126539383|NCT01960725|455266817|FG001|Overall Study|Lost to Follow-up|3|||
126539384|NCT01960725|455266816|FG000|Overall Study|Withdrawal by Subject|1|||
126539385|NCT01960725|455266817|FG001|Overall Study|Withdrawal by Subject|0|||
126539386|NCT01960725|455266816|FG000|Overall Study|unable to obtain blood sample|1|||
126539387|NCT01960725|455266817|FG001|Overall Study|unable to obtain blood sample|2|||
126539388|NCT02634788|455266818|FG000|Overall Study|Adverse Event|0|||
126539389|NCT02634788|455266819|FG001|Overall Study|Adverse Event|8|||
126539390|NCT02634788|455266820|FG002|Overall Study|Adverse Event|3|||
126539391|NCT02634788|455266821|FG003|Overall Study|Adverse Event|1|||
126539392|NCT02634788|455266818|FG000|Overall Study|Lack of Efficacy|4|||
126539393|NCT02634788|455266819|FG001|Overall Study|Lack of Efficacy|0|||
126539394|NCT02634788|455266820|FG002|Overall Study|Lack of Efficacy|1|||
126539395|NCT02634788|455266821|FG003|Overall Study|Lack of Efficacy|4|||
126539396|NCT02634788|455266818|FG000|Overall Study|Lost to Follow-up|0|||
126539397|NCT02634788|455266819|FG001|Overall Study|Lost to Follow-up|1|||
126539398|NCT02634788|455266820|FG002|Overall Study|Lost to Follow-up|0|||
126539399|NCT02634788|455266821|FG003|Overall Study|Lost to Follow-up|0|||
126539400|NCT02634788|455266818|FG000|Overall Study|Withdrawal by Subject|0|||
126539401|NCT02634788|455266819|FG001|Overall Study|Withdrawal by Subject|1|||
126539402|NCT02634788|455266820|FG002|Overall Study|Withdrawal by Subject|1|||
126539403|NCT02634788|455266821|FG003|Overall Study|Withdrawal by Subject|0|||
126539404|NCT02277990|455266827|FG000|Overall Study|Death|170|||
126539405|NCT02277990|455266828|FG001|Overall Study|Death|188|||
126316623|NCT00710684|454449365|FG000|Overall Study|Missing|1|||
126539406|NCT02277990|455266827|FG000|Overall Study|Withdrawal by Subject|64|||
126539407|NCT02277990|455266828|FG001|Overall Study|Withdrawal by Subject|53|||
126539408|NCT02277990|455266827|FG000|Overall Study|Physician Decision|40|||
126539409|NCT02277990|455266828|FG001|Overall Study|Physician Decision|34|||
126539410|NCT02277990|455266827|FG000|Overall Study|Lost to Follow-up|66|||
126539411|NCT02277990|455266828|FG001|Overall Study|Lost to Follow-up|69|||
126539412|NCT02277990|455266827|FG000|Overall Study|Had other reason|26|||
126539413|NCT02277990|455266828|FG001|Overall Study|Had other reason|32|||
126539414|NCT04711603|455266829|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
126539415|NCT04711603|455266830|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
126539416|NCT04711603|455266831|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
126539417|NCT04711603|455266832|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
126539418|NCT04711603|455266829|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
126539419|NCT04711603|455266830|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
126539420|NCT04711603|455266831|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
126539421|NCT04711603|455266832|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
126539422|NCT04711603|455266829|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
126539423|NCT04711603|455266830|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
126539424|NCT04711603|455266831|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
126539425|NCT04711603|455266832|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
126539426|NCT04711603|455266829|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
126539427|NCT04711603|455266830|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
126539428|NCT04711603|455266831|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
126539429|NCT04711603|455266832|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
126539430|NCT04711603|455266829|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
126539431|NCT04711603|455266830|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
126539432|NCT04711603|455266831|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
126539433|NCT04711603|455266832|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
126539434|NCT04711603|455266829|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
126539435|NCT04711603|455266830|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
126539436|NCT04711603|455266831|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
126539437|NCT04711603|455266832|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
126539438|NCT04711603|455266829|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
126539439|NCT04711603|455266830|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
126539440|NCT04711603|455266831|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
126539441|NCT04711603|455266832|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
126539442|NCT04711603|455266829|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
126539443|NCT04711603|455266830|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
126539444|NCT04711603|455266831|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
126539445|NCT04711603|455266832|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
126539446|NCT04711603|455266829|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
126539447|NCT04711603|455266830|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
126539448|NCT04711603|455266831|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
126539449|NCT04711603|455266832|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
126539450|NCT04711603|455266829|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
126539451|NCT04711603|455266830|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
126539452|NCT04711603|455266831|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
126539453|NCT04711603|455266832|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
126539454|NCT04711603|455266829|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
126539455|NCT04711603|455266830|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
126539456|NCT04711603|455266831|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
126539457|NCT04711603|455266832|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
126539458|NCT04711603|455266829|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
126539459|NCT04711603|455266830|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
126539460|NCT04711603|455266831|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
126539461|NCT04711603|455266832|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
126539462|NCT03138733|455266835|FG000|Overall Study|Death|17|||
126539463|NCT03138733|455266836|FG001|Overall Study|Death|18|||
126539464|NCT03138733|455266835|FG000|Overall Study|Withdrawal by Subject|11|||
126539465|NCT03138733|455266836|FG001|Overall Study|Withdrawal by Subject|6|||
126539466|NCT03138733|455266835|FG000|Overall Study|Lost to Follow-up|3|||
126539467|NCT03138733|455266836|FG001|Overall Study|Lost to Follow-up|2|||
126539468|NCT03138733|455266835|FG000|Overall Study|Adverse Event|1|||
126539469|NCT03138733|455266836|FG001|Overall Study|Adverse Event|0|||
126539470|NCT03138733|455266835|FG000|Overall Study|Protocol Violation|1|||
126539471|NCT03138733|455266836|FG001|Overall Study|Protocol Violation|3|||
126648201|NCT02003222|455669710|FG001|Intensification|Other reasons|0|||
126539472|NCT03138733|455266835|FG000|Overall Study|Administrative or logistical reason|1|||
126539473|NCT03138733|455266836|FG001|Overall Study|Administrative or logistical reason|0|||
126539474|NCT03138733|455266835|FG000|Overall Study|The patient was transferred to another hospital|1|||
126539475|NCT03138733|455266836|FG001|Overall Study|The patient was transferred to another hospital|0|||
126539476|NCT02612064|455266840|FG000|Overall Study|Withdrawal by Subject|1|||
126539477|NCT02612064|455266841|FG001|Overall Study|Withdrawal by Subject|1|||
126539478|NCT02612064|455266840|FG000|Overall Study|Other|0|||
126539479|NCT02612064|455266841|FG001|Overall Study|Other|2|||
126539480|NCT01669798|455266842|FG000|Overall Study|Physician Decision|5|||
126539481|NCT00717860|455266844|FG000|Overall Study|Clinical adverse experience|5|||
126539482|NCT00717860|455266845|FG001|Overall Study|Clinical adverse experience|9|||
126539483|NCT00717860|455266844|FG000|Overall Study|Laboratory adverse experience|2|||
126539484|NCT00717860|455266845|FG001|Overall Study|Laboratory adverse experience|2|||
126539485|NCT00717860|455266844|FG000|Overall Study|Lack of Efficacy|7|||
126539486|NCT00717860|455266845|FG001|Overall Study|Lack of Efficacy|13|||
126539487|NCT00717860|455266844|FG000|Overall Study|Discontinued for other reason|6|||
126539488|NCT00717860|455266845|FG001|Overall Study|Discontinued for other reason|1|||
126539489|NCT00717860|455266844|FG000|Overall Study|Withdrew consent|7|||
126539490|NCT00717860|455266845|FG001|Overall Study|Withdrew consent|3|||
126539491|NCT04058353|455266849|FG000|Overall Study|Adverse Event|2|||
126539492|NCT04058353|455266850|FG001|Overall Study|Adverse Event|1|||
126539493|NCT04058353|455266849|FG000|Overall Study|Physician Decision|1|||
126539494|NCT04058353|455266850|FG001|Overall Study|Physician Decision|0|||
126539495|NCT04058353|455266849|FG000|Overall Study|Other|1|||
126539496|NCT04058353|455266850|FG001|Overall Study|Other|0|||
126539497|NCT00698646|455266851|FG000|Overall Study|Adverse Event|8|||
126539498|NCT00698646|455266852|FG001|Overall Study|Adverse Event|7|||
126539499|NCT00698646|455266853|FG002|Overall Study|Adverse Event|8|||
126539500|NCT00698646|455266851|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
126539501|NCT00698646|455266852|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
126539502|NCT00698646|455266853|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
126539503|NCT00698646|455266851|FG000|Overall Study|Protocol Deviation|6|||
126539504|NCT00698646|455266852|FG001|Overall Study|Protocol Deviation|2|||
126539505|NCT00698646|455266853|FG002|Overall Study|Protocol Deviation|3|||
126539506|NCT00698646|455266851|FG000|Overall Study|Withdrawal by Subject|10|||
126539507|NCT00698646|455266852|FG001|Overall Study|Withdrawal by Subject|11|||
126539508|NCT00698646|455266853|FG002|Overall Study|Withdrawal by Subject|8|||
126539509|NCT00698646|455266851|FG000|Overall Study|Lost to Follow-up|0|||
126539510|NCT00698646|455266852|FG001|Overall Study|Lost to Follow-up|0|||
126539511|NCT00698646|455266853|FG002|Overall Study|Lost to Follow-up|2|||
126539512|NCT00698646|455266851|FG000|Overall Study|Administrative problems|1|||
126539513|NCT00698646|455266852|FG001|Overall Study|Administrative problems|0|||
126539514|NCT00698646|455266853|FG002|Overall Study|Administrative problems|1|||
126539515|NCT02618616|455266854|FG000|Overall Study|Lack of Efficacy|4|||
126539516|NCT02618616|455266855|FG001|Overall Study|Lack of Efficacy|0|||
126539517|NCT02618616|455266854|FG000|Overall Study|Pregnancy|0|||
126539518|NCT02618616|455266855|FG001|Overall Study|Pregnancy|1|||
126539519|NCT02618616|455266854|FG000|Overall Study|Adverse Event|8|||
126539520|NCT02618616|455266855|FG001|Overall Study|Adverse Event|0|||
126539521|NCT02618616|455266854|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
126539522|NCT02618616|455266855|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
126539523|NCT02618616|455266854|FG000|Overall Study|Consent withdrawn by subject|8|||
126539524|NCT02618616|455266855|FG001|Overall Study|Consent withdrawn by subject|5|||
126539525|NCT02618616|455266854|FG000|Overall Study|Lost to Follow-up|0|||
126539526|NCT02618616|455266855|FG001|Overall Study|Lost to Follow-up|1|||
126539527|NCT02027402|455266856|FG000|Overall Study|Withdrawal by Subject|4|||
126539528|NCT02027402|455266857|FG001|Overall Study|Withdrawal by Subject|1|||
126539529|NCT04225988|455266858|FG000|Overall Study|Withdrawal by Subject|2|||
126539530|NCT04225988|455266859|FG001|Overall Study|Withdrawal by Subject|0|||
126539531|NCT01984697|455268646|FG000|Overall Study|Adverse Event|0|||
126539532|NCT01984697|455268647|FG001|Overall Study|Adverse Event|0|||
126539533|NCT01984697|455268648|FG002|Overall Study|Adverse Event|2|||
126539534|NCT01984697|455268649|FG003|Overall Study|Adverse Event|0|||
126539535|NCT01984697|455268650|FG004|Overall Study|Adverse Event|0|||
126539536|NCT01984697|455268646|FG000|Overall Study|Lost to Follow-up|14|||
126539537|NCT01984697|455268647|FG001|Overall Study|Lost to Follow-up|5|||
126539538|NCT01984697|455268648|FG002|Overall Study|Lost to Follow-up|10|||
126539539|NCT01984697|455268649|FG003|Overall Study|Lost to Follow-up|6|||
126539540|NCT01984697|455268650|FG004|Overall Study|Lost to Follow-up|21|||
126539541|NCT01984697|455268646|FG000|Overall Study|Physician Decision|3|||
126539542|NCT01984697|455268647|FG001|Overall Study|Physician Decision|0|||
126539543|NCT01984697|455268648|FG002|Overall Study|Physician Decision|0|||
126539544|NCT01984697|455268649|FG003|Overall Study|Physician Decision|1|||
126539545|NCT01984697|455268650|FG004|Overall Study|Physician Decision|0|||
126539546|NCT01984697|455268646|FG000|Overall Study|Protocol Violation|8|||
126539547|NCT01984697|455268647|FG001|Overall Study|Protocol Violation|5|||
126539548|NCT01984697|455268648|FG002|Overall Study|Protocol Violation|3|||
126539549|NCT01984697|455268649|FG003|Overall Study|Protocol Violation|2|||
126539550|NCT01984697|455268650|FG004|Overall Study|Protocol Violation|0|||
126539551|NCT01984697|455268646|FG000|Overall Study|Withdrawal by Subject|15|||
126539552|NCT01984697|455268647|FG001|Overall Study|Withdrawal by Subject|21|||
126539553|NCT01984697|455268648|FG002|Overall Study|Withdrawal by Subject|13|||
126539554|NCT01984697|455268649|FG003|Overall Study|Withdrawal by Subject|11|||
126539555|NCT01984697|455268650|FG004|Overall Study|Withdrawal by Subject|13|||
126539556|NCT01984697|455268646|FG000|Overall Study|Missed last follow-up visit|1|||
126539557|NCT01984697|455268647|FG001|Overall Study|Missed last follow-up visit|0|||
126539558|NCT01984697|455268648|FG002|Overall Study|Missed last follow-up visit|0|||
126539559|NCT01984697|455268649|FG003|Overall Study|Missed last follow-up visit|0|||
126539560|NCT01984697|455268650|FG004|Overall Study|Missed last follow-up visit|0|||
126539561|NCT01984697|455268646|FG000|Overall Study|Death|0|||
126539562|NCT01984697|455268647|FG001|Overall Study|Death|0|||
126539563|NCT01984697|455268648|FG002|Overall Study|Death|0|||
126539564|NCT01984697|455268649|FG003|Overall Study|Death|1|||
126539565|NCT01984697|455268650|FG004|Overall Study|Death|0|||
126539566|NCT01984697|455268646|FG000|Overall Study|Pregnancy|2|||
126539567|NCT01984697|455268647|FG001|Overall Study|Pregnancy|0|||
126539568|NCT01984697|455268648|FG002|Overall Study|Pregnancy|1|||
126539569|NCT01984697|455268649|FG003|Overall Study|Pregnancy|0|||
126539570|NCT01984697|455268650|FG004|Overall Study|Pregnancy|1|||
126539571|NCT03308825|455268651|FG000|Overall Study|Lost to Follow-up|2|||
126539572|NCT03308825|455268652|FG001|Overall Study|Lost to Follow-up|2|||
126539573|NCT03308825|455268653|FG002|Overall Study|Lost to Follow-up|1|||
126539574|NCT03308825|455268654|FG003|Overall Study|Lost to Follow-up|0|||
126539575|NCT03308825|455268651|FG000|Overall Study|Protocol Violation|0|||
126539576|NCT03308825|455268652|FG001|Overall Study|Protocol Violation|2|||
126539577|NCT03308825|455268653|FG002|Overall Study|Protocol Violation|0|||
126539578|NCT03308825|455268654|FG003|Overall Study|Protocol Violation|0|||
126539579|NCT04737109|455268655|FG000|Study Treatment|Disease Progression|5|||
126539580|NCT04737109|455268656|FG001|Study Treatment|Disease Progression|0|||
126539581|NCT04737109|455268657|FG002|Study Treatment|Disease Progression|0|||
126539582|NCT04737109|455268658|FG003|Study Treatment|Disease Progression|0|||
126539583|NCT04737109|455268655|FG000|Study Treatment|Death on study|1|||
126539584|NCT04737109|455268656|FG001|Study Treatment|Death on study|0|||
126539585|NCT04737109|455268657|FG002|Study Treatment|Death on study|0|||
126539586|NCT04737109|455268658|FG003|Study Treatment|Death on study|0|||
126539587|NCT02259517|455268662|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
126539588|NCT02259517|455268663|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
126539589|NCT02259517|455268664|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
126539590|NCT02259517|455268662|FG000|Overall Study|Withdrawal by Subject|0|||
126539591|NCT02259517|455268663|FG001|Overall Study|Withdrawal by Subject|0|||
126539592|NCT02259517|455268664|FG002|Overall Study|Withdrawal by Subject|3|||
126539593|NCT01289418|455268665|FG000|Day 8 Survey|email address invalid|283|||
126539594|NCT01289418|455268665|FG000|Day 8 Survey|participants did not complete the survey|1935|||
126539595|NCT01289418|455268665|FG000|Day 29 Survey|email address invalid|283|||
126539596|NCT01289418|455268665|FG000|Day 29 Survey|participants did not complete the survey|2185|||
126539597|NCT01352585|455268666|FG000|Overall Study|Adverse Event|2|||
126539598|NCT01352585|455268667|FG001|Overall Study|Adverse Event|1|||
126539599|NCT01352585|455268666|FG000|Overall Study|Lost to Follow-up|1|||
126539600|NCT01352585|455268667|FG001|Overall Study|Lost to Follow-up|0|||
126539601|NCT01352585|455268666|FG000|Overall Study|Other|5|||
126539602|NCT01352585|455268667|FG001|Overall Study|Other|2|||
126539603|NCT02276066|455268672|FG000|Overall Study|Lost to Follow-up|21|||
126539604|NCT02276066|455268673|FG001|Overall Study|Lost to Follow-up|11|||
126539605|NCT05050578|455268674|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
126539606|NCT05050578|455268675|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
126539607|NCT05050578|455268674|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
126539608|NCT05050578|455268675|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
126539609|NCT05050578|455268674|FG000|Period 2, 30 Days|Protocol Violation|0|||
126539610|NCT05050578|455268675|FG001|Period 2, 30 Days|Protocol Violation|1|||
126539611|NCT03386032|455268682|FG000|Overall Study|Lack of Efficacy|6|||
126539612|NCT03386032|455268683|FG001|Overall Study|Lack of Efficacy|2|||
126539613|NCT03386032|455268684|FG002|Overall Study|Lack of Efficacy|0|||
126539614|NCT03386032|455268682|FG000|Overall Study|Adverse Event|2|||
126539615|NCT03386032|455268683|FG001|Overall Study|Adverse Event|2|||
126539616|NCT03386032|455268684|FG002|Overall Study|Adverse Event|0|||
126539617|NCT03386032|455268682|FG000|Overall Study|Withdrawal by Subject|1|||
126539618|NCT03386032|455268683|FG001|Overall Study|Withdrawal by Subject|0|||
126539619|NCT03386032|455268684|FG002|Overall Study|Withdrawal by Subject|0|||
126539620|NCT03386032|455268682|FG000|Overall Study|Lost to Follow-up|9|||
126539621|NCT03386032|455268683|FG001|Overall Study|Lost to Follow-up|3|||
126539622|NCT03386032|455268684|FG002|Overall Study|Lost to Follow-up|0|||
126539623|NCT02901626|455268697|FG000|Overall Study|Lost to Follow-up|1|||
126539624|NCT02901626|455268698|FG001|Overall Study|Lost to Follow-up|1|||
126539625|NCT00331344|455268699|FG000|Phase I|Adverse Event|0|||
126539626|NCT00331344|455268700|FG001|Phase I|Adverse Event|0|||
126539627|NCT00331344|455268701|FG002|Phase I|Adverse Event|0|||
126539628|NCT00331344|455268702|FG003|Phase I|Adverse Event|1|||
126539629|NCT00331344|455268703|FG004|Phase I|Adverse Event|2|||
126539630|NCT00331344|455268704|FG005|Phase I|Adverse Event|2|||
126539631|NCT00331344|455268705|FG006|Phase I|Adverse Event|0|||
126539632|NCT00331344|455268706|FG007|Phase I|Adverse Event|1|||
126539633|NCT00331344|455268707|FG008|Phase I|Adverse Event|0|||
126539634|NCT00331344|455268699|FG000|Phase II|Death|0|||
126539635|NCT00331344|455268700|FG001|Phase II|Death|0|||
126539636|NCT00331344|455268701|FG002|Phase II|Death|0|||
126539637|NCT00331344|455268702|FG003|Phase II|Death|0|||
126539638|NCT00331344|455268703|FG004|Phase II|Death|0|||
126539639|NCT00331344|455268704|FG005|Phase II|Death|0|||
126539640|NCT00331344|455268705|FG006|Phase II|Death|0|||
126539641|NCT00331344|455268706|FG007|Phase II|Death|0|||
126539642|NCT00331344|455268707|FG008|Phase II|Death|4|||
126539643|NCT02940574|455268710|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
126539644|NCT02940574|455268711|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
126539645|NCT02940574|455268710|FG000|1-year Follow-up|Lost to Follow-up|3|||
126539646|NCT02940574|455268711|FG001|1-year Follow-up|Lost to Follow-up|4|||
126539647|NCT00387894|455268712|FG000|Overall Study|Withdrawal by Subject|1|||
126539648|NCT01119768|455268713|FG000|Treatment Period|Lack of Efficacy|18|||
126539649|NCT01119768|455268714|FG001|Treatment Period|Lack of Efficacy|25|||
126539650|NCT02923739|455268721|FG000|Overall Study|Withdrawal by Subject|2|||
126539651|NCT02923739|455268722|FG001|Overall Study|Withdrawal by Subject|0|||
126539652|NCT02923739|455268723|FG002|Overall Study|Withdrawal by Subject|0|||
126539653|NCT02923739|455268724|FG003|Overall Study|Withdrawal by Subject|0|||
126539654|NCT02923739|455268721|FG000|Overall Study|Failed Screening|3|||
126539655|NCT02923739|455268722|FG001|Overall Study|Failed Screening|0|||
126539656|NCT02923739|455268723|FG002|Overall Study|Failed Screening|0|||
126539657|NCT02923739|455268724|FG003|Overall Study|Failed Screening|0|||
126539658|NCT01059630|455268727|FG000|Overall Study|Death|100|||
126539659|NCT01059630|455268728|FG001|Overall Study|Death|84|||
126539660|NCT01059630|455268727|FG000|Overall Study|Lost to Follow-up|4|||
126539661|NCT01059630|455268728|FG001|Overall Study|Lost to Follow-up|1|||
126539662|NCT01059630|455268727|FG000|Overall Study|Physician Decision|2|||
126539663|NCT01059630|455268728|FG001|Overall Study|Physician Decision|4|||
126539664|NCT01059630|455268727|FG000|Overall Study|Withdrawal by Subject|21|||
126539665|NCT01059630|455268728|FG001|Overall Study|Withdrawal by Subject|14|||
126539666|NCT03170375|455268729|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
126539667|NCT03170375|455268730|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
126539668|NCT03170375|455268731|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
126539669|NCT03170375|455268729|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
126539670|NCT03170375|455268730|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
126539671|NCT03170375|455268731|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
126539672|NCT00763958|455268732|FG000|Overall Study|did not meet final criteria|4|||
126539673|NCT00763958|455268733|FG001|Overall Study|did not meet final criteria|4|||
126539674|NCT00763958|455268732|FG000|Overall Study|Lost to Follow-up|10|||
126539675|NCT00763958|455268733|FG001|Overall Study|Lost to Follow-up|2|||
126539676|NCT00763958|455268732|FG000|Overall Study|Believed they were receiving placebo|0|||
126539677|NCT00763958|455268733|FG001|Overall Study|Believed they were receiving placebo|5|||
126539678|NCT01376323|455268735|FG000|Overall Study|Adverse Event|1|||
126539679|NCT01376323|455268736|FG001|Overall Study|Adverse Event|0|||
126539680|NCT01376323|455268737|FG002|Overall Study|Adverse Event|0|||
126539681|NCT01376323|455268738|FG003|Overall Study|Adverse Event|2|||
126539682|NCT01376323|455268739|FG004|Overall Study|Adverse Event|0|||
126539683|NCT01376323|455268735|FG000|Overall Study|Lost to Follow-up|0|||
126539684|NCT01376323|455268736|FG001|Overall Study|Lost to Follow-up|0|||
126539685|NCT01376323|455268737|FG002|Overall Study|Lost to Follow-up|0|||
126316624|NCT00710684|454449366|FG001|Overall Study|Missing|0|||
126316625|NCT00710684|454449367|FG002|Overall Study|Missing|0|||
126539686|NCT01376323|455268738|FG003|Overall Study|Lost to Follow-up|2|||
126539687|NCT01376323|455268739|FG004|Overall Study|Lost to Follow-up|0|||
126539688|NCT01376323|455268735|FG000|Overall Study|Physician Decision|1|||
126539689|NCT01376323|455268736|FG001|Overall Study|Physician Decision|0|||
126539690|NCT01376323|455268737|FG002|Overall Study|Physician Decision|2|||
126539691|NCT01376323|455268738|FG003|Overall Study|Physician Decision|1|||
126539692|NCT01376323|455268739|FG004|Overall Study|Physician Decision|1|||
126539693|NCT01376323|455268735|FG000|Overall Study|Withdrawal by Subject|0|||
126539694|NCT01376323|455268736|FG001|Overall Study|Withdrawal by Subject|1|||
126539695|NCT01376323|455268737|FG002|Overall Study|Withdrawal by Subject|1|||
126539696|NCT01376323|455268738|FG003|Overall Study|Withdrawal by Subject|0|||
126539697|NCT01376323|455268739|FG004|Overall Study|Withdrawal by Subject|0|||
126539698|NCT04681729|455268740|FG000|Overall Study|Lack of Efficacy|2|||
126539699|NCT04681729|455268741|FG001|Overall Study|Lack of Efficacy|2|||
126539700|NCT04681729|455268740|FG000|Overall Study|Withdrawal by Subject|8|||
126539701|NCT04681729|455268741|FG001|Overall Study|Withdrawal by Subject|9|||
126539702|NCT02535364|455268743|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
126539703|NCT02535364|455268743|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
126539704|NCT02535364|455268743|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
126539705|NCT02535364|455268743|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
126539706|NCT02535364|455268743|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
126539707|NCT02535364|455268743|FG000|Part B Screening|Death|2|||
126539708|NCT02535364|455268743|FG000|Part B Screening|Physician Decision|1|||
126539709|NCT02535364|455268743|FG000|Part B Screening|Withdrawal by Subject|1|||
126539710|NCT02535364|455268743|FG000|Part B Screening|Adverse Event|1|||
126539711|NCT02535364|455268743|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
126539712|NCT02535364|455268743|FG000|Study Treatment|Death|1|||
126539713|NCT02535364|455268743|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
126539714|NCT02535364|455268743|FG000|12-Month Follow-up Period|Disease progression|22|||
126539715|NCT02535364|455268743|FG000|12-Month Follow-up Period|Death|5|||
126539716|NCT02535364|455268743|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
126539717|NCT02535364|455268743|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
126539718|NCT02535364|455268743|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
126539719|NCT04766086|455268746|FG000|Overall Study|Lost to Follow-up|3|||
126539720|NCT04766086|455268747|FG001|Overall Study|Lost to Follow-up|5|||
126539721|NCT04766086|455268748|FG002|Overall Study|Lost to Follow-up|3|||
126539722|NCT04766086|455268746|FG000|Overall Study|Withdrawal by Subject|1|||
126539723|NCT04766086|455268747|FG001|Overall Study|Withdrawal by Subject|1|||
126539724|NCT04766086|455268748|FG002|Overall Study|Withdrawal by Subject|2|||
126539725|NCT04766086|455268746|FG000|Overall Study|Other|0|||
126539726|NCT04766086|455268747|FG001|Overall Study|Other|0|||
126539727|NCT04766086|455268748|FG002|Overall Study|Other|1|||
126539728|NCT02496767|455268760|FG000|Open-label Lead-in Phase|Adverse Event|176|||
126539729|NCT02496767|455268761|FG001|Open-label Lead-in Phase|Adverse Event|0|||
126539730|NCT02496767|455268762|FG002|Open-label Lead-in Phase|Adverse Event|0|||
126539731|NCT02496767|455268763|FG003|Open-label Lead-in Phase|Adverse Event|0|||
126539732|NCT02496767|455268764|FG004|Open-label Lead-in Phase|Adverse Event|0|||
126539733|NCT02496767|455268765|FG005|Open-label Lead-in Phase|Adverse Event|0|||
126539734|NCT02496767|455268766|FG006|Open-label Lead-in Phase|Adverse Event|0|||
126539735|NCT02496767|455268767|FG007|Open-label Lead-in Phase|Adverse Event|0|||
126539736|NCT02496767|455268760|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
126539737|NCT02496767|455268761|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
126539738|NCT02496767|455268762|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
126539739|NCT02496767|455268763|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
126539740|NCT02496767|455268764|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
126539741|NCT02496767|455268765|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
126539742|NCT02496767|455268766|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
126539743|NCT02496767|455268767|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
126539744|NCT02496767|455268760|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
126539745|NCT02496767|455268761|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
126539746|NCT02496767|455268762|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
126539747|NCT02496767|455268763|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
126539748|NCT02496767|455268764|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
126539749|NCT02496767|455268765|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
126539750|NCT02496767|455268766|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
126539751|NCT02496767|455268767|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
126539752|NCT02496767|455268760|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
126539753|NCT02496767|455268761|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
126539754|NCT02496767|455268762|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
126539755|NCT02496767|455268763|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
126539756|NCT02496767|455268764|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
126539757|NCT02496767|455268765|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
126539758|NCT02496767|455268766|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
126539759|NCT02496767|455268767|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
126539760|NCT02496767|455268760|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
126539761|NCT02496767|455268761|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
126539762|NCT02496767|455268762|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
126539763|NCT02496767|455268763|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
126539764|NCT02496767|455268764|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
126539765|NCT02496767|455268765|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
126539766|NCT02496767|455268766|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
126539767|NCT02496767|455268767|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
126539768|NCT02496767|455268760|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
126539769|NCT02496767|455268761|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
126539770|NCT02496767|455268762|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
126539771|NCT02496767|455268763|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
126539772|NCT02496767|455268764|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
126539773|NCT02496767|455268765|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
126539774|NCT02496767|455268766|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
126539775|NCT02496767|455268767|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
126539776|NCT02496767|455268760|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
126539777|NCT02496767|455268761|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
126539778|NCT02496767|455268762|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
126539779|NCT02496767|455268763|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
126539780|NCT02496767|455268764|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
126539781|NCT02496767|455268765|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
126539782|NCT02496767|455268766|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
126539783|NCT02496767|455268767|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
126539784|NCT02496767|455268760|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
126539785|NCT02496767|455268761|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
126539786|NCT02496767|455268762|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
126539787|NCT02496767|455268763|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
126539788|NCT02496767|455268764|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
126539789|NCT02496767|455268765|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
126539790|NCT02496767|455268766|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
126539791|NCT02496767|455268767|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
126539792|NCT02496767|455268760|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
126539793|NCT02496767|455268761|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
126539794|NCT02496767|455268762|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
126539795|NCT02496767|455268763|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
126539796|NCT02496767|455268764|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
126539797|NCT02496767|455268765|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
126539798|NCT02496767|455268766|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
126539799|NCT02496767|455268767|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
126539800|NCT02496767|455268760|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126539801|NCT02496767|455268761|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
126539802|NCT02496767|455268762|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126539803|NCT02496767|455268763|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
126539804|NCT02496767|455268764|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
126539805|NCT02496767|455268765|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126539806|NCT02496767|455268766|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126539807|NCT02496767|455268767|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126539808|NCT02496767|455268760|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
126539809|NCT02496767|455268761|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
126539810|NCT02496767|455268762|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
126539811|NCT02496767|455268763|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
126539812|NCT02496767|455268764|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
126539813|NCT02496767|455268765|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
126539814|NCT02496767|455268766|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
126539815|NCT02496767|455268767|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
126539816|NCT02496767|455268760|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
126539817|NCT02496767|455268761|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
126539818|NCT02496767|455268762|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
126539819|NCT02496767|455268763|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
126539820|NCT02496767|455268764|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
126539821|NCT02496767|455268765|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
126539822|NCT02496767|455268766|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
126539823|NCT02496767|455268767|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
126539824|NCT02496767|455268760|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
126539825|NCT02496767|455268761|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
126539826|NCT02496767|455268762|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
126539827|NCT02496767|455268763|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
126539828|NCT02496767|455268764|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
126539829|NCT02496767|455268765|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
126539830|NCT02496767|455268766|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
126539831|NCT02496767|455268767|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
126539832|NCT02496767|455268760|FG000|Double-blind, Withdrawal Phase|Death|0|||
126539833|NCT02496767|455268761|FG001|Double-blind, Withdrawal Phase|Death|0|||
126648202|NCT02003222|455669711|FG002|Intensification|Other reasons|0|||
126539834|NCT02496767|455268762|FG002|Double-blind, Withdrawal Phase|Death|0|||
126539835|NCT02496767|455268763|FG003|Double-blind, Withdrawal Phase|Death|0|||
126539836|NCT02496767|455268764|FG004|Double-blind, Withdrawal Phase|Death|0|||
126539837|NCT02496767|455268765|FG005|Double-blind, Withdrawal Phase|Death|0|||
126539838|NCT02496767|455268766|FG006|Double-blind, Withdrawal Phase|Death|1|||
126539839|NCT02496767|455268767|FG007|Double-blind, Withdrawal Phase|Death|2|||
126539840|NCT02496767|455268760|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
126539841|NCT02496767|455268761|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
126539842|NCT02496767|455268762|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
126539843|NCT02496767|455268763|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
126539844|NCT02496767|455268764|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
126539845|NCT02496767|455268765|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
126539846|NCT02496767|455268766|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
126539847|NCT02496767|455268767|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
126539848|NCT02889133|455268768|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
126539849|NCT02889133|455268769|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
126539850|NCT02889133|455268768|FG000|Completed Primary Outcome|Manufacturing error|3|||
126539851|NCT02889133|455268769|FG001|Completed Primary Outcome|Manufacturing error|8|||
126539852|NCT02889133|455268768|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
126539853|NCT02889133|455268769|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
126539854|NCT02889133|455268768|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
126539855|NCT02889133|455268769|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
126539856|NCT02889133|455268768|FG000|Completed Primary Outcome|Protocol Violation|1|||
126539857|NCT02889133|455268769|FG001|Completed Primary Outcome|Protocol Violation|0|||
126539858|NCT02889133|455268768|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
126539859|NCT02889133|455268769|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
126539860|NCT02889133|455268768|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
126539861|NCT02889133|455268769|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
126539862|NCT02889133|455268768|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
126539863|NCT02889133|455268769|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
126539864|NCT02889133|455268768|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
126539865|NCT02889133|455268769|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
126539866|NCT02889133|455268768|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
126539867|NCT02889133|455268769|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
126539868|NCT05687032|455268770|FG000|Treatment Phase|Adverse Event|13|||
126539869|NCT05687032|455268770|FG000|Treatment Phase|Death|1|||
126539870|NCT05687032|455268770|FG000|Treatment Phase|Physician Decision|3|||
126539871|NCT05687032|455268770|FG000|Treatment Phase|Progressive disease|9|||
126539872|NCT05687032|455268770|FG000|Treatment Phase|Withdrawal by Subject|5|||
126539873|NCT05687032|455268770|FG000|Follow-Up Phase|Death|16|||
126539874|NCT05687032|455268770|FG000|Follow-Up Phase|Ongoing|26|||
126539875|NCT03759834|455268771|FG000|Overall Study|Withdrawal by Subject|1|||
126539876|NCT04992546|455268780|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
126539877|NCT04992546|455268780|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
126539878|NCT04992546|455268780|FG000|Open-Label Treatment Period|Adverse Event|3|||
126539879|NCT04992546|455268780|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
126539880|NCT00279201|455268782|FG000|Initiation|Death|1|||
126539881|NCT00279201|455268783|FG001|Initiation|Death|5|||
126539882|NCT00279201|455268784|FG002|Initiation|Death|0|||
126539883|NCT00279201|455268785|FG003|Initiation|Death|0|||
126539884|NCT00279201|455268786|FG004|Initiation|Death|0|||
126539885|NCT00279201|455268787|FG005|Initiation|Death|0|||
126539886|NCT00279201|455268782|FG000|Initiation|Adverse Event|6|||
126539887|NCT00279201|455268783|FG001|Initiation|Adverse Event|15|||
126539888|NCT00279201|455268784|FG002|Initiation|Adverse Event|0|||
126539889|NCT00279201|455268785|FG003|Initiation|Adverse Event|0|||
126539890|NCT00279201|455268786|FG004|Initiation|Adverse Event|0|||
126539891|NCT00279201|455268787|FG005|Initiation|Adverse Event|0|||
126539892|NCT00279201|455268782|FG000|Initiation|Lost to Follow-up|42|||
126539893|NCT00279201|455268783|FG001|Initiation|Lost to Follow-up|41|||
126539894|NCT00279201|455268784|FG002|Initiation|Lost to Follow-up|0|||
126539895|NCT00279201|455268785|FG003|Initiation|Lost to Follow-up|0|||
126539896|NCT00279201|455268786|FG004|Initiation|Lost to Follow-up|0|||
126539897|NCT00279201|455268787|FG005|Initiation|Lost to Follow-up|0|||
126539898|NCT00279201|455268782|FG000|Initiation|Entry Criteria Exclusion|7|||
126539899|NCT00279201|455268783|FG001|Initiation|Entry Criteria Exclusion|9|||
126539900|NCT00279201|455268784|FG002|Initiation|Entry Criteria Exclusion|0|||
126539901|NCT00279201|455268785|FG003|Initiation|Entry Criteria Exclusion|0|||
126539902|NCT00279201|455268786|FG004|Initiation|Entry Criteria Exclusion|0|||
126539903|NCT00279201|455268787|FG005|Initiation|Entry Criteria Exclusion|0|||
126539904|NCT00279201|455268782|FG000|Initiation|Protocol Violation|9|||
126539905|NCT00279201|455268783|FG001|Initiation|Protocol Violation|10|||
126539906|NCT00279201|455268784|FG002|Initiation|Protocol Violation|0|||
126539907|NCT00279201|455268785|FG003|Initiation|Protocol Violation|0|||
126539908|NCT00279201|455268786|FG004|Initiation|Protocol Violation|0|||
126539909|NCT00279201|455268787|FG005|Initiation|Protocol Violation|0|||
126539910|NCT00279201|455268782|FG000|Initiation|Withdrawal by Subject|35|||
126539911|NCT00279201|455268783|FG001|Initiation|Withdrawal by Subject|41|||
126539912|NCT00279201|455268784|FG002|Initiation|Withdrawal by Subject|0|||
126539913|NCT00279201|455268785|FG003|Initiation|Withdrawal by Subject|0|||
126539914|NCT00279201|455268786|FG004|Initiation|Withdrawal by Subject|0|||
126539915|NCT00279201|455268787|FG005|Initiation|Withdrawal by Subject|0|||
126539916|NCT00279201|455268782|FG000|Initiation|Physician Decision|15|||
126539917|NCT00279201|455268783|FG001|Initiation|Physician Decision|18|||
126539918|NCT00279201|455268784|FG002|Initiation|Physician Decision|0|||
126539919|NCT00279201|455268785|FG003|Initiation|Physician Decision|0|||
126539920|NCT00279201|455268786|FG004|Initiation|Physician Decision|0|||
126539921|NCT00279201|455268787|FG005|Initiation|Physician Decision|0|||
126539922|NCT00279201|455268782|FG000|Initiation|Sponsor Decision|13|||
126539923|NCT00279201|455268783|FG001|Initiation|Sponsor Decision|5|||
126539924|NCT00279201|455268784|FG002|Initiation|Sponsor Decision|0|||
126539925|NCT00279201|455268785|FG003|Initiation|Sponsor Decision|0|||
126539926|NCT00279201|455268786|FG004|Initiation|Sponsor Decision|0|||
126539927|NCT00279201|455268787|FG005|Initiation|Sponsor Decision|0|||
126539928|NCT00279201|455268782|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
126539929|NCT00279201|455268783|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
126539930|NCT00279201|455268784|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
126539931|NCT00279201|455268785|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
126539932|NCT00279201|455268786|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
126539933|NCT00279201|455268787|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
126539934|NCT00279201|455268782|FG000|Maintenance|Lack of Efficacy|32|||
126539935|NCT00279201|455268783|FG001|Maintenance|Lack of Efficacy|30|||
126539936|NCT00279201|455268784|FG002|Maintenance|Lack of Efficacy|0|||
126539937|NCT00279201|455268785|FG003|Maintenance|Lack of Efficacy|0|||
126539938|NCT00279201|455268786|FG004|Maintenance|Lack of Efficacy|0|||
126539939|NCT00279201|455268787|FG005|Maintenance|Lack of Efficacy|0|||
126539940|NCT00279201|455268782|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
126539941|NCT00279201|455268783|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
126539942|NCT00279201|455268784|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
126539943|NCT00279201|455268785|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
126539944|NCT00279201|455268786|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
126539945|NCT00279201|455268787|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
126539946|NCT00279201|455268782|FG000|Maintenance|Adverse Event|4|||
126539947|NCT00279201|455268783|FG001|Maintenance|Adverse Event|4|||
126539948|NCT00279201|455268784|FG002|Maintenance|Adverse Event|0|||
126539949|NCT00279201|455268785|FG003|Maintenance|Adverse Event|0|||
126539950|NCT00279201|455268786|FG004|Maintenance|Adverse Event|0|||
126539951|NCT00279201|455268787|FG005|Maintenance|Adverse Event|0|||
126539952|NCT00279201|455268782|FG000|Maintenance|Death|4|||
126539953|NCT00279201|455268783|FG001|Maintenance|Death|4|||
126539954|NCT00279201|455268784|FG002|Maintenance|Death|0|||
126539955|NCT00279201|455268785|FG003|Maintenance|Death|0|||
126539956|NCT00279201|455268786|FG004|Maintenance|Death|0|||
126539957|NCT00279201|455268787|FG005|Maintenance|Death|0|||
126539958|NCT00279201|455268782|FG000|Maintenance|Lost to Follow-up|17|||
126539959|NCT00279201|455268783|FG001|Maintenance|Lost to Follow-up|13|||
126539960|NCT00279201|455268784|FG002|Maintenance|Lost to Follow-up|0|||
126539961|NCT00279201|455268785|FG003|Maintenance|Lost to Follow-up|0|||
126539962|NCT00279201|455268786|FG004|Maintenance|Lost to Follow-up|0|||
126539963|NCT00279201|455268787|FG005|Maintenance|Lost to Follow-up|0|||
126539964|NCT00279201|455268782|FG000|Maintenance|Entry Criteria Exclusion|1|||
126539965|NCT00279201|455268783|FG001|Maintenance|Entry Criteria Exclusion|4|||
126539966|NCT00279201|455268784|FG002|Maintenance|Entry Criteria Exclusion|0|||
126539967|NCT00279201|455268785|FG003|Maintenance|Entry Criteria Exclusion|0|||
126539968|NCT00279201|455268786|FG004|Maintenance|Entry Criteria Exclusion|0|||
126539969|NCT00279201|455268787|FG005|Maintenance|Entry Criteria Exclusion|0|||
126539970|NCT00279201|455268782|FG000|Maintenance|Protocol Violation|16|||
126539971|NCT00279201|455268783|FG001|Maintenance|Protocol Violation|24|||
126539972|NCT00279201|455268784|FG002|Maintenance|Protocol Violation|0|||
126539973|NCT00279201|455268785|FG003|Maintenance|Protocol Violation|0|||
126539974|NCT00279201|455268786|FG004|Maintenance|Protocol Violation|0|||
126539975|NCT00279201|455268787|FG005|Maintenance|Protocol Violation|0|||
126539976|NCT00279201|455268782|FG000|Maintenance|Withdrawal by Subject|18|||
126539977|NCT00279201|455268783|FG001|Maintenance|Withdrawal by Subject|18|||
126539978|NCT00279201|455268784|FG002|Maintenance|Withdrawal by Subject|0|||
126539979|NCT00279201|455268785|FG003|Maintenance|Withdrawal by Subject|0|||
126539980|NCT00279201|455268786|FG004|Maintenance|Withdrawal by Subject|0|||
126539981|NCT00279201|455268787|FG005|Maintenance|Withdrawal by Subject|0|||
126539982|NCT00279201|455268782|FG000|Maintenance|Physician Decision|9|||
126539983|NCT00279201|455268783|FG001|Maintenance|Physician Decision|9|||
126539984|NCT00279201|455268784|FG002|Maintenance|Physician Decision|0|||
126539985|NCT00279201|455268785|FG003|Maintenance|Physician Decision|0|||
126539986|NCT00279201|455268786|FG004|Maintenance|Physician Decision|0|||
126539987|NCT00279201|455268787|FG005|Maintenance|Physician Decision|0|||
126539988|NCT00279201|455268782|FG000|Maintenance|Sponsor Decision|4|||
126316626|NCT00710684|454449365|FG000|Overall Study|Did not continue after week 24|25|||
126316627|NCT00710684|454449366|FG001|Overall Study|Did not continue after week 24|21|||
126539989|NCT00279201|455268783|FG001|Maintenance|Sponsor Decision|0|||
126539990|NCT00279201|455268784|FG002|Maintenance|Sponsor Decision|0|||
126539991|NCT00279201|455268785|FG003|Maintenance|Sponsor Decision|0|||
126539992|NCT00279201|455268786|FG004|Maintenance|Sponsor Decision|0|||
126539993|NCT00279201|455268787|FG005|Maintenance|Sponsor Decision|0|||
126539994|NCT00279201|455268782|FG000|Maintenance|HbA1c>7.5%|123|||
126539995|NCT00279201|455268783|FG001|Maintenance|HbA1c>7.5%|126|||
126539996|NCT00279201|455268784|FG002|Maintenance|HbA1c>7.5%|0|||
126539997|NCT00279201|455268785|FG003|Maintenance|HbA1c>7.5%|0|||
126539998|NCT00279201|455268786|FG004|Maintenance|HbA1c>7.5%|0|||
126539999|NCT00279201|455268787|FG005|Maintenance|HbA1c>7.5%|0|||
126540000|NCT00279201|455268782|FG000|Intensification Addendum|Withdrawal by Subject|0|||
126540001|NCT00279201|455268783|FG001|Intensification Addendum|Withdrawal by Subject|0|||
126540002|NCT00279201|455268784|FG002|Intensification Addendum|Withdrawal by Subject|12|||
126540003|NCT00279201|455268785|FG003|Intensification Addendum|Withdrawal by Subject|14|||
126540004|NCT00279201|455268786|FG004|Intensification Addendum|Withdrawal by Subject|9|||
126540005|NCT00279201|455268787|FG005|Intensification Addendum|Withdrawal by Subject|18|||
126540006|NCT00279201|455268782|FG000|Intensification Addendum|Lost to Follow-up|0|||
126540007|NCT00279201|455268783|FG001|Intensification Addendum|Lost to Follow-up|0|||
126540008|NCT00279201|455268784|FG002|Intensification Addendum|Lost to Follow-up|4|||
126540009|NCT00279201|455268785|FG003|Intensification Addendum|Lost to Follow-up|6|||
126540010|NCT00279201|455268786|FG004|Intensification Addendum|Lost to Follow-up|7|||
126540011|NCT00279201|455268787|FG005|Intensification Addendum|Lost to Follow-up|7|||
126540012|NCT00279201|455268782|FG000|Intensification Addendum|Protocol Violation|0|||
126540013|NCT00279201|455268783|FG001|Intensification Addendum|Protocol Violation|0|||
126540014|NCT00279201|455268784|FG002|Intensification Addendum|Protocol Violation|2|||
126540015|NCT00279201|455268785|FG003|Intensification Addendum|Protocol Violation|2|||
126540016|NCT00279201|455268786|FG004|Intensification Addendum|Protocol Violation|6|||
126540017|NCT00279201|455268787|FG005|Intensification Addendum|Protocol Violation|6|||
126540018|NCT00279201|455268782|FG000|Intensification Addendum|Adverse Event|0|||
126540019|NCT00279201|455268783|FG001|Intensification Addendum|Adverse Event|0|||
126540020|NCT00279201|455268784|FG002|Intensification Addendum|Adverse Event|0|||
126540021|NCT00279201|455268785|FG003|Intensification Addendum|Adverse Event|4|||
126540022|NCT00279201|455268786|FG004|Intensification Addendum|Adverse Event|1|||
126540023|NCT00279201|455268787|FG005|Intensification Addendum|Adverse Event|3|||
126540024|NCT00279201|455268782|FG000|Intensification Addendum|Physician Decision|0|||
126540025|NCT00279201|455268783|FG001|Intensification Addendum|Physician Decision|0|||
126540026|NCT00279201|455268784|FG002|Intensification Addendum|Physician Decision|4|||
126540027|NCT00279201|455268785|FG003|Intensification Addendum|Physician Decision|1|||
126540028|NCT00279201|455268786|FG004|Intensification Addendum|Physician Decision|3|||
126540029|NCT00279201|455268787|FG005|Intensification Addendum|Physician Decision|2|||
126540030|NCT00279201|455268782|FG000|Intensification Addendum|Sponsor Decision|0|||
126540031|NCT00279201|455268783|FG001|Intensification Addendum|Sponsor Decision|0|||
126540032|NCT00279201|455268784|FG002|Intensification Addendum|Sponsor Decision|0|||
126540033|NCT00279201|455268785|FG003|Intensification Addendum|Sponsor Decision|0|||
126540034|NCT00279201|455268786|FG004|Intensification Addendum|Sponsor Decision|1|||
126540035|NCT00279201|455268787|FG005|Intensification Addendum|Sponsor Decision|1|||
126540036|NCT00279201|455268782|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
126540037|NCT00279201|455268783|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
126540038|NCT00279201|455268784|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
126540039|NCT00279201|455268785|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
126540040|NCT00279201|455268786|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
126540041|NCT00279201|455268787|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
126648203|NCT02003222|455669712|FG003|Intensification|Other reasons|0|||
126540042|NCT00279201|455268782|FG000|Intensification Addendum|Lack of Efficacy|0|||
126540043|NCT00279201|455268783|FG001|Intensification Addendum|Lack of Efficacy|0|||
126540044|NCT00279201|455268784|FG002|Intensification Addendum|Lack of Efficacy|0|||
126540045|NCT00279201|455268785|FG003|Intensification Addendum|Lack of Efficacy|1|||
126540046|NCT00279201|455268786|FG004|Intensification Addendum|Lack of Efficacy|1|||
126540047|NCT00279201|455268787|FG005|Intensification Addendum|Lack of Efficacy|0|||
126540048|NCT00279201|455268782|FG000|Intensification Addendum|Death|0|||
126540049|NCT00279201|455268783|FG001|Intensification Addendum|Death|0|||
126540050|NCT00279201|455268784|FG002|Intensification Addendum|Death|0|||
126540051|NCT00279201|455268785|FG003|Intensification Addendum|Death|0|||
126540052|NCT00279201|455268786|FG004|Intensification Addendum|Death|1|||
126540053|NCT00279201|455268787|FG005|Intensification Addendum|Death|0|||
126540054|NCT00316173|455268788|FG000|Run-in Phase|Adverse Event|1|||
126540055|NCT00316173|455268789|FG001|Run-in Phase|Adverse Event|0|||
126540056|NCT00316173|455268788|FG000|Run-in Phase|Protocol Violation|1|||
126540057|NCT00316173|455268789|FG001|Run-in Phase|Protocol Violation|0|||
126540058|NCT00316173|455268788|FG000|Run-in Phase|Study Follow-up Stopped|5|||
126540059|NCT00316173|455268789|FG001|Run-in Phase|Study Follow-up Stopped|0|||
126540060|NCT00316173|455268788|FG000|Treatment Phase|Adverse Event|0|||
126540061|NCT00316173|455268789|FG001|Treatment Phase|Adverse Event|1|||
126540062|NCT00316173|455268788|FG000|Treatment Phase|Lack of Efficacy|0|||
126540063|NCT00316173|455268789|FG001|Treatment Phase|Lack of Efficacy|3|||
126540064|NCT00316173|455268788|FG000|Treatment Phase|Lost to Follow-up|0|||
126540065|NCT00316173|455268789|FG001|Treatment Phase|Lost to Follow-up|3|||
126540066|NCT00316173|455268788|FG000|Treatment Phase|Withdrawal by Subject|0|||
126540067|NCT00316173|455268789|FG001|Treatment Phase|Withdrawal by Subject|1|||
126540068|NCT00316173|455268788|FG000|Treatment Phase|Study Follow-up Stopped|0|||
126540069|NCT00316173|455268789|FG001|Treatment Phase|Study Follow-up Stopped|34|||
126540070|NCT02390531|455268790|FG000|Overall Study|Death|0|||
126540071|NCT02390531|455268791|FG001|Overall Study|Death|2|||
126540072|NCT02390531|455268792|FG002|Overall Study|Death|0|||
126540073|NCT02390531|455268793|FG003|Overall Study|Death|1|||
126540074|NCT02390531|455268794|FG004|Overall Study|Death|0|||
126540075|NCT02390531|455268795|FG005|Overall Study|Death|0|||
126540076|NCT02390531|455268796|FG006|Overall Study|Death|0|||
126540077|NCT02390531|455268797|FG007|Overall Study|Death|1|||
126540078|NCT02390531|455268790|FG000|Overall Study|Protocol Violation|0|||
126540079|NCT02390531|455268791|FG001|Overall Study|Protocol Violation|0|||
126540080|NCT02390531|455268792|FG002|Overall Study|Protocol Violation|0|||
126540081|NCT02390531|455268793|FG003|Overall Study|Protocol Violation|0|||
126540082|NCT02390531|455268794|FG004|Overall Study|Protocol Violation|1|||
126540083|NCT02390531|455268795|FG005|Overall Study|Protocol Violation|0|||
126540084|NCT02390531|455268796|FG006|Overall Study|Protocol Violation|2|||
126540085|NCT02390531|455268797|FG007|Overall Study|Protocol Violation|0|||
126540086|NCT00511875|455268798|FG000|Overall Study|Lost to Follow-up|4|||
126540087|NCT00511875|455268799|FG001|Overall Study|Lost to Follow-up|0|||
126540088|NCT00511875|455268798|FG000|Overall Study|Missing variables|1|||
126540089|NCT00511875|455268799|FG001|Overall Study|Missing variables|0|||
126540090|NCT00542880|455268801|FG000|Period 1|Eligibility criteria not fulfilled|2|||
126540091|NCT00542880|455268802|FG001|Period 1|Eligibility criteria not fulfilled|6|||
126540092|NCT00542880|455268801|FG000|Period 1|Adverse Event|2|||
126540093|NCT00542880|455268802|FG001|Period 1|Adverse Event|2|||
126540094|NCT00542880|455268801|FG000|Period 1|Development of study-specific criteria|1|||
126540095|NCT00542880|455268802|FG001|Period 1|Development of study-specific criteria|2|||
126540096|NCT00542880|455268801|FG000|Period 1|Withdrawal by Subject|1|||
126540097|NCT00542880|455268802|FG001|Period 1|Withdrawal by Subject|1|||
126540098|NCT00542880|455268801|FG000|Period 1|Protocol Violation|0|||
126540099|NCT00542880|455268802|FG001|Period 1|Protocol Violation|1|||
126540100|NCT00542880|455268801|FG000|Period 2|Adverse Event|5|||
126540101|NCT00542880|455268802|FG001|Period 2|Adverse Event|7|||
126540102|NCT00542880|455268801|FG000|Period 2|Eligibility not fulfilled|0|||
126540103|NCT00542880|455268802|FG001|Period 2|Eligibility not fulfilled|1|||
126540104|NCT00542880|455268801|FG000|Period 2|Discontinuation criteria|2|||
126540105|NCT00542880|455268802|FG001|Period 2|Discontinuation criteria|0|||
126540106|NCT00542880|455268801|FG000|Period 2|Severe non-compliance|0|||
126540107|NCT00542880|455268802|FG001|Period 2|Severe non-compliance|1|||
126540108|NCT00542880|455268801|FG000|Period 2|Other|0|||
126540109|NCT00542880|455268802|FG001|Period 2|Other|1|||
126648204|NCT02003222|455669713|FG004|Intensification|Other reasons|8|||
126540110|NCT00542880|455268801|FG000|Period 3|Adverse Event|0|||
126540111|NCT00542880|455268802|FG001|Period 3|Adverse Event|2|||
126540112|NCT00696384|455268803|FG000|Open Label Phase|Adverse Event|27|||
126540113|NCT00696384|455268804|FG001|Open Label Phase|Adverse Event|0|||
126540114|NCT00696384|455268805|FG002|Open Label Phase|Adverse Event|0|||
126540115|NCT00696384|455268803|FG000|Open Label Phase|Protocol Violation|18|||
126540116|NCT00696384|455268804|FG001|Open Label Phase|Protocol Violation|0|||
126540117|NCT00696384|455268805|FG002|Open Label Phase|Protocol Violation|0|||
126540118|NCT00696384|455268803|FG000|Open Label Phase|Lost to Follow-up|24|||
126540119|NCT00696384|455268804|FG001|Open Label Phase|Lost to Follow-up|0|||
126540120|NCT00696384|455268805|FG002|Open Label Phase|Lost to Follow-up|0|||
126540121|NCT00696384|455268803|FG000|Open Label Phase|Withdrawal by Subject|37|||
126540122|NCT00696384|455268804|FG001|Open Label Phase|Withdrawal by Subject|0|||
126540123|NCT00696384|455268805|FG002|Open Label Phase|Withdrawal by Subject|0|||
126540124|NCT00696384|455268803|FG000|Open Label Phase|Other|6|||
126540125|NCT00696384|455268804|FG001|Open Label Phase|Other|0|||
126540126|NCT00696384|455268805|FG002|Open Label Phase|Other|0|||
126540127|NCT00696384|455268803|FG000|Open Label Phase|Lack of Efficacy|3|||
126540128|NCT00696384|455268804|FG001|Open Label Phase|Lack of Efficacy|0|||
126540129|NCT00696384|455268805|FG002|Open Label Phase|Lack of Efficacy|0|||
126540130|NCT00696384|455268803|FG000|Open Label Phase|Physician Decision|4|||
126540131|NCT00696384|455268804|FG001|Open Label Phase|Physician Decision|0|||
126540132|NCT00696384|455268805|FG002|Open Label Phase|Physician Decision|0|||
126316628|NCT00710684|454449367|FG002|Overall Study|Did not continue after week 24|16|||
126540133|NCT00696384|455268803|FG000|Double Blind Phase|Adverse Event|0|||
126540134|NCT00696384|455268804|FG001|Double Blind Phase|Adverse Event|2|||
126540135|NCT00696384|455268805|FG002|Double Blind Phase|Adverse Event|2|||
126540136|NCT00696384|455268803|FG000|Double Blind Phase|Lost to Follow-up|0|||
126540137|NCT00696384|455268804|FG001|Double Blind Phase|Lost to Follow-up|2|||
126540138|NCT00696384|455268805|FG002|Double Blind Phase|Lost to Follow-up|1|||
126540139|NCT00696384|455268803|FG000|Double Blind Phase|Withdrawal by Subject|0|||
126540140|NCT00696384|455268804|FG001|Double Blind Phase|Withdrawal by Subject|4|||
126540141|NCT00696384|455268805|FG002|Double Blind Phase|Withdrawal by Subject|3|||
126540142|NCT00696384|455268803|FG000|Double Blind Phase|Lack of Efficacy|0|||
126540143|NCT00696384|455268804|FG001|Double Blind Phase|Lack of Efficacy|1|||
126540144|NCT00696384|455268805|FG002|Double Blind Phase|Lack of Efficacy|0|||
126540145|NCT00696384|455268803|FG000|Double Blind Phase|Physician Decision|0|||
126540146|NCT00696384|455268804|FG001|Double Blind Phase|Physician Decision|2|||
126540147|NCT00696384|455268805|FG002|Double Blind Phase|Physician Decision|0|||
126540148|NCT04179721|455268812|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
126540149|NCT04179721|455268813|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
126540150|NCT04179721|455268812|FG000|Overall Study|Lost to Follow-up|0|||
126540151|NCT04179721|455268813|FG001|Overall Study|Lost to Follow-up|1|||
126540152|NCT03444376|455268818|FG000|Part A|Disease relapse or Progression|1|||
126540153|NCT03444376|455268818|FG000|Part A|Withdrawal by Subject|2|||
126540154|NCT03444376|455268818|FG000|Part A|Adverse Event|1|||
126540155|NCT03444376|455268818|FG000|Part B|Disease relapse or Progression|18|||
126540156|NCT03444376|455268818|FG000|Part B|Withdrawal by Subject|2|||
126540157|NCT03444376|455268818|FG000|Part B|Adverse Event|2|||
126540158|NCT03444376|455268818|FG000|Part B|Physician Decision|1|||
126540159|NCT03444376|455268818|FG000|Part C|Disease relapse or Progression|43|||
126540160|NCT03444376|455268818|FG000|Part C|Withdrawal by Subject|5|||
126540161|NCT03444376|455268818|FG000|Part C|Adverse Event|2|||
126540162|NCT03444376|455268818|FG000|Part C|Physician Decision|2|||
126540163|NCT03444376|455268818|FG000|Part C|Death|1|||
126540164|NCT00685945|455270359|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
126540165|NCT03183388|455270360|FG000|Overall Study|Lost to Follow-up|3|||
126540166|NCT03183388|455270361|FG001|Overall Study|Lost to Follow-up|5|||
126540167|NCT03183388|455270360|FG000|Overall Study|Physician Decision|1|||
126540168|NCT03183388|455270361|FG001|Overall Study|Physician Decision|4|||
126540169|NCT03183388|455270360|FG000|Overall Study|Withdrawal by Subject|4|||
126540170|NCT03183388|455270361|FG001|Overall Study|Withdrawal by Subject|1|||
126540171|NCT03183388|455270360|FG000|Overall Study|Moved|1|||
126540172|NCT03183388|455270361|FG001|Overall Study|Moved|0|||
126540173|NCT03183388|455270360|FG000|Overall Study|Met Exclusion Criteria|2|||
126540174|NCT03183388|455270361|FG001|Overall Study|Met Exclusion Criteria|2|||
126540175|NCT03183388|455270360|FG000|Overall Study|COVID Pandemic Related|2|||
126540176|NCT03183388|455270361|FG001|Overall Study|COVID Pandemic Related|4|||
126540177|NCT00847405|455270362|FG000|First Intervention|Adverse Event|0|||
126540178|NCT00847405|455270363|FG001|First Intervention|Adverse Event|1|||
126540179|NCT00847405|455270362|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
126540180|NCT00847405|455270363|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
126540181|NCT01728792|455270364|FG000|Overall Study|Withdrawal of Consent|1|||
126540182|NCT01728792|455270365|FG001|Overall Study|Withdrawal of Consent|1|||
126540183|NCT01728792|455270366|FG002|Overall Study|Withdrawal of Consent|0|||
126540184|NCT01728792|455270367|FG003|Overall Study|Withdrawal of Consent|1|||
126540185|NCT01728792|455270368|FG004|Overall Study|Withdrawal of Consent|0|||
126540186|NCT01728792|455270364|FG000|Overall Study|Lost to Follow-up|2|||
126540187|NCT01728792|455270365|FG001|Overall Study|Lost to Follow-up|1|||
126540188|NCT01728792|455270366|FG002|Overall Study|Lost to Follow-up|4|||
126540189|NCT01728792|455270367|FG003|Overall Study|Lost to Follow-up|2|||
126540190|NCT01728792|455270368|FG004|Overall Study|Lost to Follow-up|0|||
126540191|NCT04277455|455270371|FG000|Overall Study|Lost to Follow-up|1|||
126540192|NCT00949715|455270372|FG000|Overall Study|Physician Decision|1|||
126540193|NCT00949715|455270373|FG001|Overall Study|Physician Decision|0|||
126540194|NCT00949715|455270372|FG000|Overall Study|Lost to Follow-up|1|||
126540195|NCT00949715|455270373|FG001|Overall Study|Lost to Follow-up|0|||
126540196|NCT00949715|455270372|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
126540197|NCT00949715|455270373|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
126540198|NCT03928028|455270375|FG000|Overall Study|Physician Decision|9|||
126540199|NCT03928028|455270376|FG001|Overall Study|Physician Decision|6|||
126540200|NCT03928028|455270377|FG002|Overall Study|Physician Decision|3|||
126540201|NCT03928028|455270375|FG000|Overall Study|Withdrawal by Subject|12|||
126540202|NCT03928028|455270376|FG001|Overall Study|Withdrawal by Subject|3|||
126540203|NCT03928028|455270377|FG002|Overall Study|Withdrawal by Subject|3|||
126540204|NCT02710292|455270382|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
126540205|NCT02710292|455270383|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
126540206|NCT02710292|455270382|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
126540207|NCT02710292|455270383|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
126540208|NCT04525547|455270384|FG000|Overall Study|Not treated with Ofev|2|||
126540209|NCT04525547|455270384|FG000|Overall Study|Off-label use|2|||
126540210|NCT04525547|455270384|FG000|Overall Study|Lost to Follow-up|1|||
126540211|NCT00800202|455270385|FG000|Overall Study|Adverse Event|7|||
126540212|NCT00800202|455270386|FG001|Overall Study|Adverse Event|6|||
126540213|NCT00800202|455270385|FG000|Overall Study|Death|1|||
126540214|NCT00800202|455270386|FG001|Overall Study|Death|0|||
126540215|NCT00800202|455270385|FG000|Overall Study|Other|5|||
126540216|NCT00800202|455270386|FG001|Overall Study|Other|0|||
126540217|NCT00800202|455270385|FG000|Overall Study|Disease Progression|54|||
126540218|NCT00800202|455270386|FG001|Overall Study|Disease Progression|18|||
126540219|NCT04425902|455270387|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
126540220|NCT02736825|455270393|FG000|Overall Study|Lost to Follow-up|10|||
126540221|NCT02736825|455270394|FG001|Overall Study|Lost to Follow-up|11|||
126540222|NCT02736825|455270393|FG000|Overall Study|Early Termination|0|||
126540223|NCT02736825|455270394|FG001|Overall Study|Early Termination|1|||
126540224|NCT01373931|455270395|FG000|Lead-in Period|Adverse Event|2|||
126540225|NCT01373931|455270396|FG001|Lead-in Period|Adverse Event|0|||
126540226|NCT01373931|455270395|FG000|Period 1|Adverse Event|2|||
126540227|NCT01373931|455270396|FG001|Period 1|Adverse Event|0|||
126540228|NCT01373931|455270395|FG000|Period 1|Withdrawal by Subject|0|||
126540229|NCT01373931|455270396|FG001|Period 1|Withdrawal by Subject|2|||
126540230|NCT04857034|455270397|FG000|Placebo-Controlled Period|Request to discontinue|2|||
126540231|NCT04857034|455270398|FG001|Placebo-Controlled Period|Request to discontinue|2|||
126540232|NCT04857034|455270399|FG002|Placebo-Controlled Period|Request to discontinue|0|||
126540233|NCT04857034|455270400|FG003|Placebo-Controlled Period|Request to discontinue|0|||
126540234|NCT04857034|455270401|FG004|Placebo-Controlled Period|Request to discontinue|0|||
126540235|NCT04857034|455270397|FG000|Placebo-Controlled Period|withdrew consent|1|||
126540236|NCT04857034|455270398|FG001|Placebo-Controlled Period|withdrew consent|1|||
126540237|NCT04857034|455270399|FG002|Placebo-Controlled Period|withdrew consent|2|||
126540238|NCT04857034|455270400|FG003|Placebo-Controlled Period|withdrew consent|0|||
126540239|NCT04857034|455270401|FG004|Placebo-Controlled Period|withdrew consent|0|||
126540240|NCT04857034|455270397|FG000|Placebo-Controlled Period|Pregnancy|1|||
126540241|NCT04857034|455270398|FG001|Placebo-Controlled Period|Pregnancy|1|||
126540242|NCT04857034|455270399|FG002|Placebo-Controlled Period|Pregnancy|0|||
126540243|NCT04857034|455270400|FG003|Placebo-Controlled Period|Pregnancy|0|||
126540244|NCT04857034|455270401|FG004|Placebo-Controlled Period|Pregnancy|0|||
126540245|NCT04857034|455270397|FG000|Placebo-Controlled Period|Ongoing study period|0|||
126540246|NCT04857034|455270398|FG001|Placebo-Controlled Period|Ongoing study period|1|||
126540247|NCT04857034|455270399|FG002|Placebo-Controlled Period|Ongoing study period|0|||
126540248|NCT04857034|455270400|FG003|Placebo-Controlled Period|Ongoing study period|0|||
126540249|NCT04857034|455270401|FG004|Placebo-Controlled Period|Ongoing study period|0|||
126540250|NCT04857034|455270397|FG000|Active Treatment Period|Lack of Efficacy|1|||
126540251|NCT04857034|455270398|FG001|Active Treatment Period|Lack of Efficacy|0|||
126540252|NCT04857034|455270399|FG002|Active Treatment Period|Lack of Efficacy|0|||
126540253|NCT04857034|455270400|FG003|Active Treatment Period|Lack of Efficacy|0|||
126540254|NCT04857034|455270401|FG004|Active Treatment Period|Lack of Efficacy|0|||
126540255|NCT04857034|455270397|FG000|Active Treatment Period|request to discontinue|0|||
126540256|NCT04857034|455270398|FG001|Active Treatment Period|request to discontinue|1|||
126540257|NCT04857034|455270399|FG002|Active Treatment Period|request to discontinue|0|||
126540258|NCT04857034|455270400|FG003|Active Treatment Period|request to discontinue|1|||
126540259|NCT04857034|455270401|FG004|Active Treatment Period|request to discontinue|0|||
126540260|NCT04857034|455270397|FG000|Active Treatment Period|administrative reason by sponsor|1|||
126540261|NCT04857034|455270398|FG001|Active Treatment Period|administrative reason by sponsor|5|||
126540262|NCT04857034|455270399|FG002|Active Treatment Period|administrative reason by sponsor|0|||
126540263|NCT04857034|455270400|FG003|Active Treatment Period|administrative reason by sponsor|2|||
126540264|NCT04857034|455270401|FG004|Active Treatment Period|administrative reason by sponsor|2|||
126540265|NCT04857034|455270397|FG000|Active Treatment Period|other reasons|1|||
126540266|NCT04857034|455270398|FG001|Active Treatment Period|other reasons|1|||
126316629|NCT00157248|454449368|FG000|Overall Study|Adverse Event|36|||
126540267|NCT04857034|455270399|FG002|Active Treatment Period|other reasons|0|||
126540268|NCT04857034|455270400|FG003|Active Treatment Period|other reasons|0|||
126540269|NCT04857034|455270401|FG004|Active Treatment Period|other reasons|1|||
126540270|NCT04857034|455270397|FG000|Active Treatment Period|Ongoing Study Period|2|||
126540271|NCT04857034|455270398|FG001|Active Treatment Period|Ongoing Study Period|4|||
126316630|NCT00157248|454449369|FG001|Overall Study|Adverse Event|25|||
126316631|NCT00157248|454449370|FG002|Overall Study|Adverse Event|13|||
126316632|NCT00157248|454449371|FG003|Overall Study|Adverse Event|33|||
126316633|NCT00157248|454449368|FG000|Overall Study|Protocol Violation|4|||
126316634|NCT00157248|454449369|FG001|Overall Study|Protocol Violation|0|||
126316635|NCT00157248|454449370|FG002|Overall Study|Protocol Violation|2|||
126316636|NCT00157248|454449371|FG003|Overall Study|Protocol Violation|2|||
126316637|NCT00157248|454449368|FG000|Overall Study|Lost to Follow-up|0|||
126316638|NCT00157248|454449369|FG001|Overall Study|Lost to Follow-up|1|||
126316639|NCT00157248|454449370|FG002|Overall Study|Lost to Follow-up|0|||
126316640|NCT00157248|454449371|FG003|Overall Study|Lost to Follow-up|0|||
126316641|NCT00157248|454449368|FG000|Overall Study|Withdrawal by Subject|1|||
126316642|NCT00157248|454449369|FG001|Overall Study|Withdrawal by Subject|4|||
126316643|NCT00157248|454449370|FG002|Overall Study|Withdrawal by Subject|3|||
126316644|NCT00157248|454449371|FG003|Overall Study|Withdrawal by Subject|3|||
126316645|NCT00157248|454449368|FG000|Overall Study|site closures, subject moving|7|||
126316646|NCT00157248|454449369|FG001|Overall Study|site closures, subject moving|7|||
126316647|NCT00157248|454449370|FG002|Overall Study|site closures, subject moving|3|||
126316648|NCT00157248|454449371|FG003|Overall Study|site closures, subject moving|9|||
126316649|NCT02542293|454450736|FG000|Overall Study|Death|367|||
126316650|NCT02542293|454450737|FG001|Overall Study|Death|377|||
126316651|NCT02542293|454450736|FG000|Overall Study|Withdrawal by Subject|8|||
126316652|NCT02542293|454450737|FG001|Overall Study|Withdrawal by Subject|19|||
126316653|NCT04529850|454450738|FG000|Overall Study|Death|2|||
126316654|NCT04529850|454450738|FG000|Overall Study|Physician Decision|1|||
126316655|NCT04529850|454450738|FG000|Overall Study|Withdrawal by Subject|2|||
126316656|NCT01458951|454450739|FG000|Overall Study|Other|1|||
126316657|NCT01458951|454450740|FG001|Overall Study|Other|0|||
126316658|NCT01458951|454450741|FG002|Overall Study|Other|0|||
126316659|NCT01458951|454450739|FG000|Overall Study|Protocol Violation|5|||
126316660|NCT01458951|454450740|FG001|Overall Study|Protocol Violation|1|||
126316661|NCT01458951|454450741|FG002|Overall Study|Protocol Violation|0|||
126316662|NCT01458951|454450739|FG000|Overall Study|Withdrawal by Subject|2|||
126316663|NCT01458951|454450740|FG001|Overall Study|Withdrawal by Subject|0|||
126316664|NCT01458951|454450741|FG002|Overall Study|Withdrawal by Subject|2|||
126316665|NCT01458951|454450739|FG000|Overall Study|Adverse Event|7|||
126316666|NCT01458951|454450740|FG001|Overall Study|Adverse Event|0|||
126316667|NCT01458951|454450741|FG002|Overall Study|Adverse Event|2|||
126316668|NCT01458951|454450739|FG000|Overall Study|Insufficient Clinical Response|17|||
126316669|NCT01458951|454450740|FG001|Overall Study|Insufficient Clinical Response|0|||
126316670|NCT01458951|454450741|FG002|Overall Study|Insufficient Clinical Response|11|||
126316671|NCT02963558|454450742|FG000|Overall Study|Withdrawn by investigator|1|||
126316672|NCT02963558|454450743|FG001|Overall Study|Withdrawn by investigator|0|||
126316673|NCT02963558|454450742|FG000|Overall Study|Withdrawal by Subject|0|||
126316674|NCT02963558|454450743|FG001|Overall Study|Withdrawal by Subject|1|||
126316675|NCT03309696|454450744|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
126316676|NCT03309696|454450745|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
126316677|NCT03309696|454450746|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
126316678|NCT03309696|454450747|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
126316679|NCT01573767|454450748|FG000|Overall Study|Adverse Event|0|||
126316680|NCT01573767|454450749|FG001|Overall Study|Adverse Event|1|||
126316681|NCT01573767|454450750|FG002|Overall Study|Adverse Event|0|||
126316682|NCT01573767|454450751|FG003|Overall Study|Adverse Event|1|||
126316683|NCT01573767|454450748|FG000|Overall Study|Lack of Efficacy|18|||
126316684|NCT01573767|454450749|FG001|Overall Study|Lack of Efficacy|15|||
126316685|NCT01573767|454450750|FG002|Overall Study|Lack of Efficacy|12|||
126316686|NCT01573767|454450751|FG003|Overall Study|Lack of Efficacy|17|||
126316687|NCT01573767|454450748|FG000|Overall Study|Protocol Violation|3|||
126316688|NCT01573767|454450749|FG001|Overall Study|Protocol Violation|1|||
126316689|NCT01573767|454450750|FG002|Overall Study|Protocol Violation|1|||
126316690|NCT01573767|454450751|FG003|Overall Study|Protocol Violation|3|||
126316691|NCT01573767|454450748|FG000|Overall Study|Lost to Follow-up|0|||
126316692|NCT01573767|454450749|FG001|Overall Study|Lost to Follow-up|1|||
126316693|NCT01573767|454450750|FG002|Overall Study|Lost to Follow-up|1|||
126316694|NCT01573767|454450751|FG003|Overall Study|Lost to Follow-up|1|||
126316695|NCT01573767|454450748|FG000|Overall Study|Physician Decision|1|||
126316696|NCT01573767|454450749|FG001|Overall Study|Physician Decision|2|||
126316697|NCT01573767|454450750|FG002|Overall Study|Physician Decision|0|||
126316698|NCT01573767|454450751|FG003|Overall Study|Physician Decision|2|||
126316699|NCT01573767|454450748|FG000|Overall Study|Withdrawal by Subject|0|||
126316700|NCT01573767|454450749|FG001|Overall Study|Withdrawal by Subject|1|||
126316701|NCT01573767|454450750|FG002|Overall Study|Withdrawal by Subject|0|||
126316702|NCT01573767|454450751|FG003|Overall Study|Withdrawal by Subject|0|||
126316703|NCT01371877|454450754|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
126316704|NCT01371877|454450755|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
126316705|NCT00869557|454450756|FG000|Randomized Phase|Lost to Follow-up|2|||
126316706|NCT00869557|454450757|FG001|Randomized Phase|Lost to Follow-up|1|||
126715204|NCT02873715|455908713|FG001|Overall Study|Lost to Follow-up|94|||
126540272|NCT04857034|455270399|FG002|Active Treatment Period|Ongoing Study Period|0|||
126540273|NCT04857034|455270400|FG003|Active Treatment Period|Ongoing Study Period|1|||
126540274|NCT04857034|455270401|FG004|Active Treatment Period|Ongoing Study Period|0|||
126540275|NCT00659490|455270402|FG000|Overall Study|Lost to Follow-up|2|||
126540276|NCT00659490|455270403|FG001|Overall Study|Lost to Follow-up|0|||
126540277|NCT00659490|455270404|FG002|Overall Study|Lost to Follow-up|1|||
126540278|NCT00827541|455270409|FG000|Overall Study|Exitus|1|||
126540279|NCT00827541|455270410|FG001|Overall Study|Exitus|8|||
126540280|NCT00827541|455270409|FG000|Overall Study|Other|1|||
126540281|NCT00827541|455270410|FG001|Overall Study|Other|3|||
126540282|NCT00827541|455270409|FG000|Overall Study|Pathogen not susceptible|1|||
126540283|NCT00827541|455270410|FG001|Overall Study|Pathogen not susceptible|0|||
126540284|NCT00827541|455270409|FG000|Overall Study|Lack of effectiveness|1|||
126540285|NCT00827541|455270410|FG001|Overall Study|Lack of effectiveness|0|||
126540286|NCT01649232|455270411|FG000|Overall Study|Physician Decision|2|||
126540287|NCT01649232|455270412|FG001|Overall Study|Physician Decision|0|||
126540288|NCT02228967|455270413|FG000|Overall Study|Lost to Follow-up|146|||
126540289|NCT02228967|455270414|FG001|Overall Study|Lost to Follow-up|142|||
126540290|NCT02228967|455270413|FG000|Overall Study|Withdrawal by Subject|13|||
126540291|NCT02228967|455270414|FG001|Overall Study|Withdrawal by Subject|18|||
126540292|NCT00105235|455270415|FG000|Overall Study|Death|4|||
126540293|NCT00105235|455270415|FG000|Overall Study|Physician Decision|1|||
126540294|NCT00105235|455270415|FG000|Overall Study|Withdrawal by Subject|2|||
126540295|NCT01964326|455270416|FG000|Overall Study|Adverse Event|48|||
126540296|NCT01964326|455270416|FG000|Overall Study|Death|2|||
126540297|NCT01964326|455270416|FG000|Overall Study|Protocol Violation|4|||
126540298|NCT01964326|455270416|FG000|Overall Study|Lost to Follow-up|88|||
126540299|NCT01964326|455270416|FG000|Overall Study|Withdrawal by Subject|87|||
126540300|NCT01964326|455270416|FG000|Overall Study|Pregnancy|1|||
126540301|NCT01964326|455270416|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
126540302|NCT01964326|455270416|FG000|Overall Study|Physician Decision|55|||
126540303|NCT01964326|455270416|FG000|Overall Study|Investigator Discretion|1|||
126540304|NCT01964326|455270416|FG000|Overall Study|Other|9|||
126540305|NCT01964326|455270416|FG000|Overall Study|Did not meet eligibility criteria|1|||
126540306|NCT02347657|455270417|FG000|Overall Study|Physician Decision|0|||
126540307|NCT02347657|455270418|FG001|Overall Study|Physician Decision|1|||
126540308|NCT02347657|455270417|FG000|Overall Study|Adverse Event|8|||
126540309|NCT02347657|455270418|FG001|Overall Study|Adverse Event|4|||
126540310|NCT02347657|455270417|FG000|Overall Study|Withdrawal by Subject|6|||
126540311|NCT02347657|455270418|FG001|Overall Study|Withdrawal by Subject|7|||
126540312|NCT02347657|455270417|FG000|Overall Study|Randomized but not treated|1|||
126540313|NCT02347657|455270418|FG001|Overall Study|Randomized but not treated|0|||
126540314|NCT02347657|455270417|FG000|Overall Study|Other|3|||
126540315|NCT02347657|455270418|FG001|Overall Study|Other|3|||
126540316|NCT01995539|455270419|FG000|Overall Study|Screening Failure|1|||
126540317|NCT01995539|455270419|FG000|Overall Study|Withdrawal by Investigator|15|||
126540318|NCT01995539|455270419|FG000|Overall Study|Withdrawal by Subject|11|||
126540319|NCT01995539|455270419|FG000|Overall Study|Lost to Follow-up|5|||
126540320|NCT01995539|455270419|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
126540321|NCT00261495|455270420|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
126540322|NCT00261495|455270421|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
126540323|NCT00261495|455270420|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
126540324|NCT00261495|455270421|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
126540325|NCT00261495|455270420|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
126540326|NCT00261495|455270421|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
126540327|NCT00261495|455270420|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
126540328|NCT00261495|455270421|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
126540329|NCT00261495|455270420|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
126540330|NCT00261495|455270421|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
126540331|NCT00261495|455270420|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
126540332|NCT00261495|455270421|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
126540333|NCT00261495|455270420|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
126540334|NCT00261495|455270421|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
126540335|NCT00261495|455270420|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
126540336|NCT00261495|455270421|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
126540337|NCT00261495|455270420|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
126540338|NCT00261495|455270421|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
126540339|NCT00261495|455270420|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
126540340|NCT00261495|455270421|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
126540341|NCT00261495|455270420|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
126540342|NCT00261495|455270421|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
126540343|NCT00261495|455270420|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
126540344|NCT00261495|455270421|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
126540345|NCT00261495|455270420|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
126540346|NCT00261495|455270421|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
126540347|NCT00261495|455270420|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
126540348|NCT00261495|455270421|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
126540349|NCT00261495|455270420|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
126540350|NCT00261495|455270421|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
126540351|NCT00261495|455270420|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
126540352|NCT00261495|455270421|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
126540353|NCT00261495|455270420|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
126540354|NCT00261495|455270421|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
126540355|NCT00261495|455270420|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
126540356|NCT00261495|455270421|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
126540357|NCT00261495|455270420|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126540358|NCT00261495|455270421|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
126540359|NCT00261495|455270420|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
126540360|NCT00261495|455270421|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
126540361|NCT00261495|455270420|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
126540362|NCT00261495|455270421|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126540363|NCT00642902|455270422|FG000|Overall Study|Adverse Event|0|||
126540364|NCT00642902|455270423|FG001|Overall Study|Adverse Event|1|||
126540365|NCT00642902|455270424|FG002|Overall Study|Adverse Event|3|||
126540366|NCT00642902|455270425|FG003|Overall Study|Adverse Event|1|||
126540367|NCT00642902|455270422|FG000|Overall Study|Lost to Follow-up|1|||
126540368|NCT00642902|455270423|FG001|Overall Study|Lost to Follow-up|1|||
126540369|NCT00642902|455270424|FG002|Overall Study|Lost to Follow-up|0|||
126540370|NCT00642902|455270425|FG003|Overall Study|Lost to Follow-up|0|||
126540371|NCT00642902|455270422|FG000|Overall Study|Lack of Efficacy|0|||
126540372|NCT00642902|455270423|FG001|Overall Study|Lack of Efficacy|3|||
126540373|NCT00642902|455270424|FG002|Overall Study|Lack of Efficacy|3|||
126540374|NCT00642902|455270425|FG003|Overall Study|Lack of Efficacy|0|||
126540375|NCT00642902|455270422|FG000|Overall Study|Death|1|||
126540376|NCT00642902|455270423|FG001|Overall Study|Death|0|||
126540377|NCT00642902|455270424|FG002|Overall Study|Death|0|||
126540378|NCT00642902|455270425|FG003|Overall Study|Death|0|||
126540379|NCT00642902|455270422|FG000|Overall Study|Premature termination of clinical trial|37|||
126540380|NCT00642902|455270423|FG001|Overall Study|Premature termination of clinical trial|32|||
126540381|NCT00642902|455270424|FG002|Overall Study|Premature termination of clinical trial|35|||
126540382|NCT00642902|455270425|FG003|Overall Study|Premature termination of clinical trial|35|||
126540383|NCT00642902|455270422|FG000|Overall Study|Randomized, but not treated|0|||
126540384|NCT00642902|455270423|FG001|Overall Study|Randomized, but not treated|0|||
126540385|NCT00642902|455270424|FG002|Overall Study|Randomized, but not treated|1|||
126540386|NCT00642902|455270425|FG003|Overall Study|Randomized, but not treated|0|||
126540387|NCT00642902|455270422|FG000|Overall Study|Other|1|||
126540388|NCT00642902|455270423|FG001|Overall Study|Other|5|||
126540389|NCT00642902|455270424|FG002|Overall Study|Other|1|||
126540390|NCT00642902|455270425|FG003|Overall Study|Other|4|||
126540391|NCT03953898|455270426|FG000|Overall Study|Lack of Efficacy|8|||
126540392|NCT03953898|455270426|FG000|Overall Study|Death|3|||
126540393|NCT03953898|455270426|FG000|Overall Study|Withdrawal by Subject|2|||
126540394|NCT03953898|455270426|FG000|Overall Study|Adverse Event|1|||
126540395|NCT01932697|455270427|FG000|Overall Study|Received a different amount of tx|1|||
126540396|NCT01932697|455270428|FG001|Overall Study|Received a different amount of tx|0|||
126540397|NCT01932697|455270427|FG000|Overall Study|Ineligible|1|||
126540398|NCT01932697|455270428|FG001|Overall Study|Ineligible|0|||
126540399|NCT01538472|455270429|FG000|Overall Study|Disease Progression|3|||
126540400|NCT01538472|455270429|FG000|Overall Study|Death|1|||
126540401|NCT03351738|455270430|FG000|Overall Study|Withdrawal by Subject|0|||
126540402|NCT03351738|455270431|FG001|Overall Study|Withdrawal by Subject|1|||
126540403|NCT03351738|455270432|FG002|Overall Study|Withdrawal by Subject|0|||
126540404|NCT03351738|455270433|FG003|Overall Study|Withdrawal by Subject|1|||
126540405|NCT03351738|455270434|FG004|Overall Study|Withdrawal by Subject|0|||
126540406|NCT03351738|455270435|FG005|Overall Study|Withdrawal by Subject|0|||
126540407|NCT01375205|455270438|FG000|Overall Study|Lost to Follow-up|15|||
126540408|NCT01375205|455270439|FG001|Overall Study|Lost to Follow-up|12|||
126540409|NCT01375205|455270438|FG000|Overall Study|Withdrawal by Subject|6|||
126540410|NCT01375205|455270439|FG001|Overall Study|Withdrawal by Subject|1|||
126540411|NCT05479604|455270440|FG000|Overall Study|Lost to Follow-up|1|||
126540412|NCT05479604|455270441|FG001|Overall Study|Lost to Follow-up|5|||
126540413|NCT05701995|455270446|FG000|Pre-Treatment|Randomization Error|1|||
126540414|NCT05701995|455270447|FG001|Pre-Treatment|Randomization Error|1|||
126540415|NCT05701995|455270446|FG000|Treatment|Withdrawal by Subject|8|||
126540416|NCT05701995|455270447|FG001|Treatment|Withdrawal by Subject|4|||
126540417|NCT05701995|455270446|FG000|Treatment|Lost to Follow-up|2|||
126540418|NCT05701995|455270447|FG001|Treatment|Lost to Follow-up|3|||
126540419|NCT05701995|455270446|FG000|Treatment|Adverse Event|3|||
126540420|NCT05701995|455270447|FG001|Treatment|Adverse Event|1|||
126540421|NCT05701995|455270446|FG000|Treatment|Other Reason|1|||
126540422|NCT05701995|455270447|FG001|Treatment|Other Reason|1|||
126540423|NCT05701995|455270446|FG000|Treatment|Death|1|||
126540424|NCT05701995|455270447|FG001|Treatment|Death|0|||
126540425|NCT05701995|455270446|FG000|Treatment|Physician Decision|0|||
126540426|NCT05701995|455270447|FG001|Treatment|Physician Decision|1|||
126540427|NCT04987762|455270448|FG000|Overall Study|Study was Terminated by Sponsor|103|||
126540428|NCT04803214|455270449|FG000|Overall Study|Adverse Event|1|||
126540429|NCT04803214|455270450|FG001|Overall Study|Adverse Event|0|||
126540430|NCT04803214|455270449|FG000|Overall Study|Withdrawal by Subject|1|||
126540431|NCT04803214|455270450|FG001|Overall Study|Withdrawal by Subject|2|||
126540432|NCT04803214|455270449|FG000|Overall Study|Lost to Follow-up|2|||
126316707|NCT00869557|454450756|FG000|Randomized Phase|Investigator's Discretion|1|||
126316708|NCT00869557|454450757|FG001|Randomized Phase|Investigator's Discretion|0|||
126316709|NCT00869557|454450756|FG000|Randomized Phase|Withdrew Consent|0|||
126316710|NCT00869557|454450757|FG001|Randomized Phase|Withdrew Consent|1|||
126316711|NCT00869557|454450756|FG000|Extension Phase|Adverse Event|2|||
126316712|NCT00869557|454450757|FG001|Extension Phase|Adverse Event|2|||
126316713|NCT00869557|454450756|FG000|Extension Phase|Lack of Efficacy|1|||
126316714|NCT00869557|454450757|FG001|Extension Phase|Lack of Efficacy|0|||
126540433|NCT04803214|455270450|FG001|Overall Study|Lost to Follow-up|4|||
126540434|NCT04803214|455270449|FG000|Overall Study|Physician Decision|1|||
126540435|NCT04803214|455270450|FG001|Overall Study|Physician Decision|1|||
126540436|NCT04803214|455270449|FG000|Overall Study|Missed 12 month visit|0|||
126540437|NCT04803214|455270450|FG001|Overall Study|Missed 12 month visit|3|||
126540438|NCT00504426|455270451|FG000|Overall Study|Adverse Event|0|||
126540439|NCT00504426|455270452|FG001|Overall Study|Adverse Event|0|||
126540440|NCT00504426|455270453|FG002|Overall Study|Adverse Event|2|||
126540441|NCT00504426|455270454|FG003|Overall Study|Adverse Event|0|||
126540442|NCT00504426|455270451|FG000|Overall Study|Protocol Violation|1|||
126540443|NCT00504426|455270452|FG001|Overall Study|Protocol Violation|1|||
126540444|NCT00504426|455270453|FG002|Overall Study|Protocol Violation|2|||
126540445|NCT00504426|455270454|FG003|Overall Study|Protocol Violation|0|||
126540446|NCT00504426|455270451|FG000|Overall Study|Withdrawal by Subject|2|||
126540447|NCT00504426|455270452|FG001|Overall Study|Withdrawal by Subject|0|||
126540448|NCT00504426|455270453|FG002|Overall Study|Withdrawal by Subject|0|||
126540449|NCT00504426|455270454|FG003|Overall Study|Withdrawal by Subject|0|||
126540450|NCT03988166|455270455|FG000|Overall Study|Lost to Follow-up|2|||
126540451|NCT03988166|455270455|FG000|Overall Study|Death|1|||
126540452|NCT03248375|455270456|FG000|Overall Study|Lost to Follow-up|5|||
126540453|NCT00633464|455270457|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
126540454|NCT00633464|455270458|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
126540455|NCT00633464|455270457|FG000|Overall Study|Never Treated (Randomized in error)|0|||
126540456|NCT00633464|455270458|FG001|Overall Study|Never Treated (Randomized in error)|1|||
126540457|NCT01678131|455270461|FG000|Overall Study|Adverse Event|0|||
126540458|NCT01678131|455270462|FG001|Overall Study|Adverse Event|1|||
126540459|NCT01678131|455270463|FG002|Overall Study|Adverse Event|0|||
126540460|NCT01678131|455270461|FG000|Overall Study|Withdrawal by Subject|0|||
126540461|NCT01678131|455270462|FG001|Overall Study|Withdrawal by Subject|0|||
126540462|NCT01678131|455270463|FG002|Overall Study|Withdrawal by Subject|2|||
126540463|NCT00941798|455270464|FG000|Overall Study|Withdrawal by Subject|72|||
126540464|NCT00941798|455270465|FG001|Overall Study|Withdrawal by Subject|74|||
126540465|NCT00941798|455270464|FG000|Overall Study|Adverse Event|43|||
126540466|NCT00941798|455270465|FG001|Overall Study|Adverse Event|23|||
126540467|NCT00941798|455270464|FG000|Overall Study|Lost to Follow-up|29|||
126540468|NCT00941798|455270465|FG001|Overall Study|Lost to Follow-up|23|||
126540469|NCT00941798|455270464|FG000|Overall Study|Protocol Violation|17|||
126540470|NCT00941798|455270465|FG001|Overall Study|Protocol Violation|20|||
126540471|NCT00941798|455270464|FG000|Overall Study|Administrative problems|13|||
126540472|NCT00941798|455270465|FG001|Overall Study|Administrative problems|23|||
126540473|NCT00941798|455270464|FG000|Overall Study|Lack of Efficacy|10|||
126540474|NCT00941798|455270465|FG001|Overall Study|Lack of Efficacy|17|||
126540475|NCT00941798|455270464|FG000|Overall Study|Patient's inability to use device|6|||
126540476|NCT00941798|455270465|FG001|Overall Study|Patient's inability to use device|1|||
126540477|NCT00941798|455270464|FG000|Overall Study|Abnormal test procedure results|3|||
126540478|NCT00941798|455270465|FG001|Overall Study|Abnormal test procedure results|1|||
126540479|NCT00941798|455270464|FG000|Overall Study|Abnormal laboratory values|1|||
126540480|NCT00941798|455270465|FG001|Overall Study|Abnormal laboratory values|2|||
126540481|NCT00941798|455270464|FG000|Overall Study|Death|0|||
126540482|NCT00941798|455270465|FG001|Overall Study|Death|1|||
126540483|NCT00112580|455270466|FG000|Overall Study|Adverse Event|1|||
126540484|NCT00112580|455270467|FG001|Overall Study|Adverse Event|2|||
126540485|NCT00112580|455270466|FG000|Overall Study|Disease progression|5|||
126540486|NCT00112580|455270467|FG001|Overall Study|Disease progression|16|||
126540487|NCT00112580|455270466|FG000|Overall Study|Participant withdrew consent|2|||
126540488|NCT00112580|455270467|FG001|Overall Study|Participant withdrew consent|1|||
126540489|NCT05597722|455270468|FG000|Overall Study|Study was terminated|6|||
126316715|NCT00869557|454450756|FG000|Extension Phase|Lost to Follow-up|3|||
126540490|NCT05597722|455270469|FG001|Overall Study|Study was terminated|1|||
126540491|NCT04108000|455270470|FG000|Overall Study|Death of patient|1|||
126540492|NCT04108000|455270471|FG001|Overall Study|Death of patient|0|||
126540493|NCT04108000|455270472|FG002|Overall Study|Death of patient|1|||
126540494|NCT04108000|455270473|FG003|Overall Study|Death of patient|0|||
126540495|NCT04108000|455270470|FG000|Overall Study|Withdrawal by Subject|2|||
126540496|NCT04108000|455270471|FG001|Overall Study|Withdrawal by Subject|2|||
126540497|NCT04108000|455270472|FG002|Overall Study|Withdrawal by Subject|0|||
126540498|NCT04108000|455270473|FG003|Overall Study|Withdrawal by Subject|0|||
126540499|NCT04108000|455270470|FG000|Overall Study|Death of surrogate partner|0|||
126540500|NCT04108000|455270471|FG001|Overall Study|Death of surrogate partner|1|||
126540501|NCT04108000|455270472|FG002|Overall Study|Death of surrogate partner|0|||
126540502|NCT04108000|455270473|FG003|Overall Study|Death of surrogate partner|1|||
126540503|NCT05619003|455270475|FG000|Overall Study|Adverse Event|1|||
126540504|NCT04669600|455271807|FG000|Overall Study|Withdrawal by Subject|1|||
126540505|NCT04669600|455271807|FG000|Overall Study|Other|6|||
126540506|NCT00710606|455271810|FG000|Overall Study|Adverse Event|0|||
126540507|NCT00710606|455271811|FG001|Overall Study|Adverse Event|2|||
126540508|NCT00514683|455271812|FG000|Overall Study|Not treated|2|||
126540509|NCT00514683|455271813|FG001|Overall Study|Not treated|1|||
126540510|NCT00514683|455271814|FG002|Overall Study|Not treated|0|||
126540511|NCT00514683|455271815|FG003|Overall Study|Not treated|0|||
126540512|NCT00514683|455271816|FG004|Overall Study|Not treated|1|||
126540513|NCT00514683|455271812|FG000|Overall Study|Adverse Event|21|||
126540514|NCT00514683|455271813|FG001|Overall Study|Adverse Event|20|||
126540515|NCT00514683|455271814|FG002|Overall Study|Adverse Event|15|||
126540516|NCT00514683|455271815|FG003|Overall Study|Adverse Event|13|||
126540517|NCT00514683|455271816|FG004|Overall Study|Adverse Event|27|||
126540518|NCT00514683|455271812|FG000|Overall Study|Protocol Violation|1|||
126540519|NCT00514683|455271813|FG001|Overall Study|Protocol Violation|1|||
126540520|NCT00514683|455271814|FG002|Overall Study|Protocol Violation|0|||
126540521|NCT00514683|455271815|FG003|Overall Study|Protocol Violation|1|||
126540522|NCT00514683|455271816|FG004|Overall Study|Protocol Violation|0|||
126540523|NCT00514683|455271812|FG000|Overall Study|Withdrawal by Subject|2|||
126540524|NCT00514683|455271813|FG001|Overall Study|Withdrawal by Subject|2|||
126540525|NCT00514683|455271814|FG002|Overall Study|Withdrawal by Subject|1|||
126540526|NCT00514683|455271815|FG003|Overall Study|Withdrawal by Subject|0|||
126540527|NCT00514683|455271816|FG004|Overall Study|Withdrawal by Subject|4|||
126540528|NCT00514683|455271812|FG000|Overall Study|Reason other than listed above|0|||
126540529|NCT00514683|455271813|FG001|Overall Study|Reason other than listed above|1|||
126540530|NCT00514683|455271814|FG002|Overall Study|Reason other than listed above|2|||
126540531|NCT00514683|455271815|FG003|Overall Study|Reason other than listed above|0|||
126540532|NCT00514683|455271816|FG004|Overall Study|Reason other than listed above|1|||
126540533|NCT00790452|455271817|FG000|Overall Study|Drug supply issue|1|||
126540534|NCT00790452|455271818|FG001|Overall Study|Drug supply issue|0|||
126540535|NCT01564368|455271819|FG000|Overall Study|Ineligible|18|||
126540536|NCT01564368|455271819|FG000|Overall Study|Not Randomized in Parent study|116|||
126540537|NCT01564368|455271819|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
126540538|NCT01564368|455271819|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
126540539|NCT04082884|455271820|FG000|Overall Study|Withdrawal by Subject|1|||
126540540|NCT05674890|455271821|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
126540541|NCT05674890|455271822|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
126540542|NCT05674890|455271821|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
126540543|NCT05674890|455271822|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
126540544|NCT05674890|455271821|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
126540545|NCT05674890|455271822|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
126540546|NCT00520975|455271823|FG000|Overall Study|Disease progression|31|||
126540547|NCT00520975|455271824|FG001|Overall Study|Disease progression|23|||
126540548|NCT00520975|455271823|FG000|Overall Study|Adverse Event|7|||
126540549|NCT00520975|455271824|FG001|Overall Study|Adverse Event|10|||
126540550|NCT00520975|455271823|FG000|Overall Study|Death|0|||
126540551|NCT00520975|455271824|FG001|Overall Study|Death|2|||
126540552|NCT00520975|455271823|FG000|Overall Study|Withdrawal by Subject|3|||
126540553|NCT00520975|455271824|FG001|Overall Study|Withdrawal by Subject|5|||
126540554|NCT00520975|455271823|FG000|Overall Study|Other therapy|2|||
126540555|NCT00520975|455271824|FG001|Overall Study|Other therapy|4|||
126540556|NCT00520975|455271823|FG000|Overall Study|Other reasons|4|||
126540557|NCT00520975|455271824|FG001|Overall Study|Other reasons|2|||
126540558|NCT00520975|455271823|FG000|Overall Study|Not start protocol therapy|1|||
126540559|NCT00520975|455271824|FG001|Overall Study|Not start protocol therapy|2|||
126540560|NCT04810221|455271825|FG000|Overall Study|Physician Decision|3|||
126540561|NCT03642938|455271826|FG000|Overall Study|Withdrawal by Subject|0|||
126540562|NCT03642938|455271827|FG001|Overall Study|Withdrawal by Subject|0|||
126540563|NCT03642938|455271828|FG002|Overall Study|Withdrawal by Subject|0|||
126540564|NCT03642938|455271829|FG003|Overall Study|Withdrawal by Subject|1|||
126540565|NCT01226511|455271832|FG000|Acute Treatment Period|Adverse Event|7|||
126540566|NCT01226511|455271833|FG001|Acute Treatment Period|Adverse Event|6|||
126540567|NCT01226511|455271832|FG000|Acute Treatment Period|Lack of Efficacy|2|||
126540568|NCT01226511|455271833|FG001|Acute Treatment Period|Lack of Efficacy|1|||
126540569|NCT01226511|455271832|FG000|Acute Treatment Period|Lost to Follow-up|3|||
126540570|NCT01226511|455271833|FG001|Acute Treatment Period|Lost to Follow-up|6|||
126540571|NCT01226511|455271832|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
126540572|NCT01226511|455271833|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
126540573|NCT01226511|455271832|FG000|Acute Treatment Period|Protocol Violation|5|||
126540574|NCT01226511|455271833|FG001|Acute Treatment Period|Protocol Violation|5|||
126540575|NCT01226511|455271832|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
126540576|NCT01226511|455271833|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
126540577|NCT01226511|455271832|FG000|Extension Treatment Period|Adverse Event|8|||
126540578|NCT01226511|455271833|FG001|Extension Treatment Period|Adverse Event|8|||
126540579|NCT01226511|455271832|FG000|Extension Treatment Period|Lack of Efficacy|3|||
126540580|NCT01226511|455271833|FG001|Extension Treatment Period|Lack of Efficacy|2|||
126540581|NCT01226511|455271832|FG000|Extension Treatment Period|Lost to Follow-up|4|||
126540582|NCT01226511|455271833|FG001|Extension Treatment Period|Lost to Follow-up|3|||
126540583|NCT01226511|455271832|FG000|Extension Treatment Period|Protocol Violation|2|||
126540584|NCT01226511|455271833|FG001|Extension Treatment Period|Protocol Violation|2|||
126540585|NCT01226511|455271832|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
126540586|NCT01226511|455271833|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
126540587|NCT01226511|455271832|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
126540588|NCT01226511|455271833|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
126540589|NCT01226511|455271832|FG000|Extension Treatment Period|Sponsor Decision|1|||
126540590|NCT01226511|455271833|FG001|Extension Treatment Period|Sponsor Decision|1|||
126540591|NCT01226511|455271832|FG000|Taper Period|Adverse Event|1|||
126540592|NCT01226511|455271833|FG001|Taper Period|Adverse Event|0|||
126540593|NCT01226511|455271832|FG000|Taper Period|Lost to Follow-up|2|||
126540594|NCT01226511|455271833|FG001|Taper Period|Lost to Follow-up|2|||
126540595|NCT01226511|455271832|FG000|Taper Period|Protocol Violation|1|||
126540596|NCT01226511|455271833|FG001|Taper Period|Protocol Violation|0|||
126540597|NCT01226511|455271832|FG000|Taper Period|Parent/Caregiver Decision|1|||
126540598|NCT01226511|455271833|FG001|Taper Period|Parent/Caregiver Decision|1|||
126540599|NCT01337986|455271835|FG000|Overall Study|Adverse Event|2|||
126540600|NCT01337986|455271836|FG001|Overall Study|Adverse Event|2|||
126540601|NCT01337986|455271835|FG000|Overall Study|Lost to Follow-up|1|||
126540602|NCT01337986|455271836|FG001|Overall Study|Lost to Follow-up|0|||
126540603|NCT01337986|455271835|FG000|Overall Study|Protocol Violation|0|||
126540604|NCT01337986|455271836|FG001|Overall Study|Protocol Violation|3|||
126540605|NCT02309112|455271840|FG000|Overall Study|Withdrawal by Subject|1|||
126540606|NCT02309112|455271841|FG001|Overall Study|Withdrawal by Subject|0|||
126540607|NCT02309112|455271842|FG002|Overall Study|Withdrawal by Subject|1|||
126540608|NCT02309112|455271840|FG000|Overall Study|Lost to Follow-up|0|||
126540609|NCT02309112|455271841|FG001|Overall Study|Lost to Follow-up|1|||
126540610|NCT02309112|455271842|FG002|Overall Study|Lost to Follow-up|0|||
126540611|NCT00621543|455271843|FG000|Overall Study|Lost to Follow-up|23|||
126540612|NCT00499863|455271853|FG000|Overall Study|Lack of Efficacy|21|||
126540613|NCT00499863|455271854|FG001|Overall Study|Lack of Efficacy|27|||
126540614|NCT00499863|455271853|FG000|Overall Study|Protocol Violation|12|||
126540615|NCT00499863|455271854|FG001|Overall Study|Protocol Violation|7|||
126540616|NCT00499863|455271853|FG000|Overall Study|Withdrawal by Subject|6|||
126540617|NCT00499863|455271854|FG001|Overall Study|Withdrawal by Subject|4|||
126540618|NCT00499863|455271853|FG000|Overall Study|Adverse Event|8|||
126540619|NCT00499863|455271854|FG001|Overall Study|Adverse Event|2|||
126540620|NCT00499863|455271853|FG000|Overall Study|Sponsor decision|2|||
126540621|NCT00499863|455271854|FG001|Overall Study|Sponsor decision|2|||
126540622|NCT00499863|455271853|FG000|Overall Study|Lost to Follow-up|1|||
126540623|NCT00499863|455271854|FG001|Overall Study|Lost to Follow-up|1|||
126540624|NCT00571701|455271855|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
126540625|NCT00571701|455271856|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
126540626|NCT00571701|455271855|FG000|First Intervention 12 Months|Death|1|||
126540627|NCT00571701|455271856|FG001|First Intervention 12 Months|Death|0|||
126540628|NCT00571701|455271855|FG000|Second Intervention 12 Months|Adverse Event|0|||
126540629|NCT00571701|455271856|FG001|Second Intervention 12 Months|Adverse Event|1|||
126540630|NCT00571701|455271855|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
126540631|NCT00571701|455271856|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
126540632|NCT03056534|455271862|FG000|Overall Study|Participant withdrew consent|8|||
126540633|NCT03056534|455271862|FG000|Overall Study|Participant not able to return|6|||
126540634|NCT03056534|455271862|FG000|Overall Study|Lost to Follow-up|37|||
126540635|NCT03056534|455271862|FG000|Overall Study|Investigator judgment|1|||
126540636|NCT03056534|455271862|FG000|Overall Study|Death|4|||
126540637|NCT03056534|455271862|FG000|Overall Study|Adverse Event|1|||
126540638|NCT03056534|455271862|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
126540639|NCT03815019|455271863|FG000|Overall Study|Withdrawal by Subject|6|||
126540640|NCT03815019|455271864|FG001|Overall Study|Withdrawal by Subject|8|||
126540641|NCT02063828|455271865|FG000|Overall Study|Withdrawal by Subject|4|||
126540642|NCT02063828|455271866|FG001|Overall Study|Withdrawal by Subject|6|||
126540643|NCT02063828|455271867|FG002|Overall Study|Withdrawal by Subject|3|||
126540644|NCT02063828|455271865|FG000|Overall Study|Death|0|||
126540645|NCT02063828|455271866|FG001|Overall Study|Death|0|||
126540646|NCT02063828|455271867|FG002|Overall Study|Death|1|||
126540647|NCT03937219|455271868|FG000|Overall Study|Death|223|||
126540648|NCT03937219|455271869|FG001|Overall Study|Death|211|||
126540649|NCT03937219|455271868|FG000|Overall Study|Withdrawal by Subject|17|||
126540650|NCT03937219|455271869|FG001|Overall Study|Withdrawal by Subject|25|||
126540651|NCT03937219|455271868|FG000|Overall Study|Lost to Follow-up|3|||
126540652|NCT03937219|455271869|FG001|Overall Study|Lost to Follow-up|4|||
126540653|NCT00532155|455271870|FG000|Overall Study|Adverse Event|66|||
126540654|NCT00532155|455271871|FG001|Overall Study|Adverse Event|123|||
126540655|NCT00532155|455271870|FG000|Overall Study|Lack of Efficacy|332|||
126540656|NCT00532155|455271871|FG001|Overall Study|Lack of Efficacy|255|||
126540657|NCT00532155|455271870|FG000|Overall Study|Protocol Violation|1|||
126540658|NCT00532155|455271871|FG001|Overall Study|Protocol Violation|3|||
126540659|NCT00532155|455271870|FG000|Overall Study|Lost to Follow-up|2|||
126540660|NCT00532155|455271871|FG001|Overall Study|Lost to Follow-up|0|||
126540661|NCT00532155|455271870|FG000|Overall Study|Physician Decision|16|||
126540662|NCT00532155|455271871|FG001|Overall Study|Physician Decision|15|||
126540663|NCT00532155|455271870|FG000|Overall Study|Withdrawal by Subject|23|||
126540664|NCT00532155|455271871|FG001|Overall Study|Withdrawal by Subject|44|||
126540665|NCT00532155|455271870|FG000|Overall Study|Consent withdrawn|5|||
126540666|NCT00532155|455271871|FG001|Overall Study|Consent withdrawn|7|||
126540667|NCT00532155|455271870|FG000|Overall Study|Moved|1|||
126540668|NCT00532155|455271871|FG001|Overall Study|Moved|0|||
126540669|NCT00532155|455271870|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
126540670|NCT00532155|455271871|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
126540671|NCT00532155|455271870|FG000|Overall Study|Occurence of a second cancer|0|||
126540672|NCT00532155|455271871|FG001|Overall Study|Occurence of a second cancer|1|||
126540673|NCT00532155|455271870|FG000|Overall Study|Occurence of a secondary cancer|0|||
126540674|NCT00532155|455271871|FG001|Overall Study|Occurence of a secondary cancer|1|||
126540675|NCT00532155|455271870|FG000|Overall Study|Promotor ended study|1|||
126540676|NCT00532155|455271871|FG001|Overall Study|Promotor ended study|0|||
126540677|NCT00532155|455271870|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
126540678|NCT00532155|455271871|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
126540679|NCT00532155|455271870|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
126540680|NCT00532155|455271871|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
126540681|NCT00532155|455271870|FG000|Overall Study|Study stopped|1|||
126540682|NCT00532155|455271871|FG001|Overall Study|Study stopped|0|||
126540683|NCT00532155|455271870|FG000|Overall Study|Study terminated by sponsor|1|||
126540684|NCT00532155|455271871|FG001|Overall Study|Study terminated by sponsor|0|||
126540685|NCT00532155|455271870|FG000|Overall Study|Study termination stop further treatment|4|||
126540686|NCT00532155|455271871|FG001|Overall Study|Study termination stop further treatment|0|||
126540687|NCT00532155|455271870|FG000|Overall Study|Did not receive study medication|2|||
126540688|NCT00532155|455271871|FG001|Overall Study|Did not receive study medication|6|||
126540689|NCT03483038|455271872|FG000|Overall Study|Subjects still in follow-up|18|||
126540690|NCT02134925|455271873|FG000|Overall Study|Withdrawal by Subject|1|||
126540691|NCT02134925|455271874|FG001|Overall Study|Withdrawal by Subject|0|||
126540692|NCT02134925|455271873|FG000|Overall Study|Cancel|1|||
126540693|NCT02134925|455271874|FG001|Overall Study|Cancel|6|||
126540694|NCT00654901|455271885|FG000|Overall Study|Lost to Follow-up|1|||
126540695|NCT00654901|455271886|FG001|Overall Study|Lost to Follow-up|0|||
126540696|NCT00654901|455271887|FG002|Overall Study|Lost to Follow-up|1|||
126540697|NCT00654901|455271888|FG003|Overall Study|Lost to Follow-up|0|||
126540698|NCT00654901|455271885|FG000|Overall Study|Withdrawal by Subject|3|||
126540699|NCT00654901|455271886|FG001|Overall Study|Withdrawal by Subject|0|||
126540700|NCT00654901|455271887|FG002|Overall Study|Withdrawal by Subject|1|||
126540701|NCT00654901|455271888|FG003|Overall Study|Withdrawal by Subject|0|||
126540702|NCT04241094|455271892|FG000|Overall Study|Dropped out of treatment|4|||
126540703|NCT04241094|455271892|FG000|Overall Study|Ineligible after clinical assessment|2|||
126540704|NCT04241094|455271892|FG000|Overall Study|Lost to Follow-up|2|||
126540705|NCT02332590|455271895|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
126540706|NCT02332590|455271896|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
126540707|NCT02332590|455271895|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
126540708|NCT02332590|455271896|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
126540709|NCT02332590|455271895|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
126540710|NCT02332590|455271896|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
126540711|NCT02332590|455271895|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
126540712|NCT02332590|455271896|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
126540713|NCT02332590|455271895|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
126540714|NCT02332590|455271896|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
126540715|NCT02332590|455271895|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
126540716|NCT02332590|455271896|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
126540717|NCT02332590|455271895|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
126540718|NCT02332590|455271896|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
126540719|NCT02332590|455271895|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
126540720|NCT02332590|455271896|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
126540721|NCT02332590|455271895|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
126540722|NCT02332590|455271896|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
126540723|NCT03764072|455271899|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
126540724|NCT03764072|455271900|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
126540725|NCT03764072|455271901|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
126540726|NCT03764072|455271902|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
126540727|NCT03764072|455271903|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
126540728|NCT03764072|455271904|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
126540729|NCT03764072|455271899|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
126316716|NCT00869557|454450757|FG001|Extension Phase|Lost to Follow-up|1|||
126316717|NCT00869557|454450756|FG000|Extension Phase|Investigator's Discretion|2|||
126316718|NCT00869557|454450757|FG001|Extension Phase|Investigator's Discretion|0|||
126316719|NCT00869557|454450756|FG000|Extension Phase|Withdrew Consent|2|||
126316720|NCT00869557|454450757|FG001|Extension Phase|Withdrew Consent|0|||
126316721|NCT02368210|454450758|FG000|Overall Study|Withdrawal by Subject|1|||
126316722|NCT02368210|454450759|FG001|Overall Study|Withdrawal by Subject|0|||
126540730|NCT03764072|455271900|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
126540731|NCT03764072|455271901|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
126540732|NCT03764072|455271902|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
126540733|NCT03764072|455271903|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
126540734|NCT03764072|455271904|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
126540735|NCT03764072|455271899|FG000|Overall Study|Lost to Follow-up|0|||
126540736|NCT03764072|455271900|FG001|Overall Study|Lost to Follow-up|0|||
126540737|NCT03764072|455271901|FG002|Overall Study|Lost to Follow-up|0|||
126540738|NCT03764072|455271902|FG003|Overall Study|Lost to Follow-up|0|||
126540739|NCT03764072|455271903|FG004|Overall Study|Lost to Follow-up|1|||
126540740|NCT03764072|455271904|FG005|Overall Study|Lost to Follow-up|0|||
126540741|NCT00558064|455271909|FG000|Overall Study|Adverse Event|3|||
126540742|NCT00558064|455271910|FG001|Overall Study|Adverse Event|2|||
126540743|NCT00558064|455271909|FG000|Overall Study|Lack of Efficacy|0|||
126540744|NCT00558064|455271910|FG001|Overall Study|Lack of Efficacy|1|||
126540745|NCT00558064|455271909|FG000|Overall Study|Protocol Violation|1|||
126540746|NCT00558064|455271910|FG001|Overall Study|Protocol Violation|0|||
126540747|NCT00558064|455271909|FG000|Overall Study|Lost to Follow-up|0|||
126540748|NCT00558064|455271910|FG001|Overall Study|Lost to Follow-up|1|||
126540749|NCT00558064|455271909|FG000|Overall Study|Withdrawal by Subject|0|||
126540750|NCT00558064|455271910|FG001|Overall Study|Withdrawal by Subject|1|||
126540751|NCT00558064|455271909|FG000|Overall Study|No visit within allowance period|1|||
126540752|NCT00558064|455271910|FG001|Overall Study|No visit within allowance period|0|||
126540753|NCT00982930|455271916|FG000|Overall Study|Adverse Event|1|||
126540754|NCT00982930|455271916|FG000|Overall Study|Withdrawal by Subject|1|||
126540755|NCT00982930|455271916|FG000|Overall Study|Administrative Problems|2|||
126540756|NCT01489189|455271917|FG000|Overall Study|Withdrawal by Subject|20|||
126540757|NCT01489189|455271918|FG001|Overall Study|Withdrawal by Subject|23|||
126540758|NCT01489189|455271917|FG000|Overall Study|Death|10|||
126540759|NCT01489189|455271918|FG001|Overall Study|Death|8|||
126540760|NCT01489189|455271917|FG000|Overall Study|Missed Visit|1|||
126540761|NCT01489189|455271918|FG001|Overall Study|Missed Visit|4|||
126540762|NCT03881696|455271919|FG000|Overall Study|Adverse Event|2|||
126540763|NCT03881696|455271920|FG001|Overall Study|Adverse Event|0|||
126540764|NCT03881696|455271919|FG000|Overall Study|Withdrawal by Subject|2|||
126540765|NCT03881696|455271920|FG001|Overall Study|Withdrawal by Subject|0|||
126540766|NCT03881696|455271919|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
126540767|NCT03881696|455271920|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
126540768|NCT03881696|455271919|FG000|Overall Study|Failure to meet continuation criteria|1|||
126540769|NCT03881696|455271920|FG001|Overall Study|Failure to meet continuation criteria|0|||
126540770|NCT01582789|455273178|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
126540771|NCT01582789|455273179|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
126540772|NCT01191840|455273187|FG000|Overall Study|withdrew consent|2|||
126540773|NCT01191840|455273188|FG001|Overall Study|withdrew consent|1|||
126540774|NCT01191840|455273187|FG000|Overall Study|Subject discontinued treatment|1|||
126316723|NCT02368210|454450758|FG000|Overall Study|Adverse Event|0|||
126316724|NCT02368210|454450759|FG001|Overall Study|Adverse Event|1|||
126540775|NCT01191840|455273188|FG001|Overall Study|Subject discontinued treatment|2|||
126316725|NCT00078949|454450760|FG000|Overall Study|No treated|4|||
126540776|NCT01191840|455273187|FG000|Overall Study|Lost to Follow-up|4|||
126540777|NCT01191840|455273188|FG001|Overall Study|Lost to Follow-up|6|||
126316726|NCT00078949|454450761|FG001|Overall Study|No treated|5|||
126540778|NCT01191840|455273187|FG000|Overall Study|Non Staph Infection|4|||
126540779|NCT01191840|455273188|FG001|Overall Study|Non Staph Infection|3|||
126540780|NCT01191840|455273187|FG000|Overall Study|ineligible at enrollment|1|||
126540781|NCT01191840|455273188|FG001|Overall Study|ineligible at enrollment|0|||
126540782|NCT01191840|455273187|FG000|Overall Study|IRB approval lapse|0|||
126540783|NCT01191840|455273188|FG001|Overall Study|IRB approval lapse|2|||
126540784|NCT01191840|455273187|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
126540785|NCT01191840|455273188|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
126540786|NCT01191840|455273187|FG000|Overall Study|Withdrawal by Subject|2|||
126540787|NCT01191840|455273188|FG001|Overall Study|Withdrawal by Subject|0|||
126540788|NCT01392300|455273189|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
126540789|NCT01392300|455273190|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
126540790|NCT01392300|455273191|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
126540791|NCT01392300|455273189|FG000|Main Period (MP)|Withdrawal by Subject|5|||
126540792|NCT01392300|455273190|FG001|Main Period (MP)|Withdrawal by Subject|1|||
126540793|NCT01392300|455273191|FG002|Main Period (MP)|Withdrawal by Subject|0|||
126540794|NCT01392300|455273189|FG000|Main Period (MP)|Lost to Follow-up|3|||
126540795|NCT01392300|455273190|FG001|Main Period (MP)|Lost to Follow-up|3|||
126540796|NCT01392300|455273191|FG002|Main Period (MP)|Lost to Follow-up|0|||
126540797|NCT01392300|455273189|FG000|Main Period (MP)|Non-compliance|1|||
126540798|NCT01392300|455273190|FG001|Main Period (MP)|Non-compliance|0|||
126540799|NCT01392300|455273191|FG002|Main Period (MP)|Non-compliance|0|||
126540800|NCT01392300|455273189|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
126540801|NCT01392300|455273190|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
126540802|NCT01392300|455273191|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
126540803|NCT01392300|455273189|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
126540804|NCT01392300|455273190|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
126540805|NCT01392300|455273191|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
126540806|NCT01392300|455273189|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
126540807|NCT01392300|455273190|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
126540808|NCT01392300|455273191|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
126540809|NCT01392300|455273189|FG000|Open Label Extension (OLEX) Period|Death|0|||
126540810|NCT01392300|455273190|FG001|Open Label Extension (OLEX) Period|Death|0|||
126540811|NCT01392300|455273191|FG002|Open Label Extension (OLEX) Period|Death|4|||
126540812|NCT01392300|455273189|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
126540813|NCT01392300|455273190|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
126540814|NCT01392300|455273191|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
126540815|NCT01392300|455273189|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
126540816|NCT01392300|455273190|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
126540817|NCT01392300|455273191|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
126540818|NCT01392300|455273189|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
126540819|NCT01392300|455273190|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
126540820|NCT01392300|455273191|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
126540821|NCT01802437|455273196|FG000|Overall Study|Lost to Follow-up|1|||
126540822|NCT01802437|455273197|FG001|Overall Study|Lost to Follow-up|0|||
126540823|NCT01802437|455273196|FG000|Overall Study|Withdrawal by Subject|3|||
126540824|NCT01802437|455273197|FG001|Overall Study|Withdrawal by Subject|4|||
126540825|NCT01682213|455273205|FG000|Overall Study|Withdrawal by Subject|2|||
126540826|NCT00742079|455273206|FG000|Overall Study|Lost to Follow-up|0|||
126540827|NCT00742079|455273207|FG001|Overall Study|Lost to Follow-up|1|||
126540828|NCT01181726|455273208|FG000|First Intervention|Adverse Event|1|||
126540829|NCT01181726|455273209|FG001|First Intervention|Adverse Event|0|||
126540830|NCT01264380|455273210|FG000|Period C|Disease Progression|0|||
126540831|NCT01264380|455273211|FG001|Period C|Disease Progression|0|||
126540832|NCT01264380|455273212|FG002|Period C|Disease Progression|4|||
126540833|NCT01264380|455273210|FG000|Period C|Death|0|||
126540834|NCT01264380|455273211|FG001|Period C|Death|0|||
126540835|NCT01264380|455273212|FG002|Period C|Death|2|||
126540836|NCT01264380|455273210|FG000|Period C|Follow-up for survival status|0|||
126540837|NCT01264380|455273211|FG001|Period C|Follow-up for survival status|0|||
126316727|NCT00078949|454450762|FG002|Overall Study|No treated|3|||
126316728|NCT00078949|454450763|FG003|Overall Study|No treated|3|||
126316729|NCT01143064|454450764|FG000|Overall Study|Death|109|||
126316730|NCT01143064|454450765|FG001|Overall Study|Death|91|||
126540838|NCT01264380|455273212|FG002|Period C|Follow-up for survival status|6|||
126540839|NCT01264380|455273210|FG000|Period C|Withdrawal by Subject|0|||
126540840|NCT01264380|455273211|FG001|Period C|Withdrawal by Subject|0|||
126540841|NCT01264380|455273212|FG002|Period C|Withdrawal by Subject|1|||
126540842|NCT01264380|455273210|FG000|Period C|Adverse Event|0|||
126540843|NCT01264380|455273211|FG001|Period C|Adverse Event|0|||
126540844|NCT01264380|455273212|FG002|Period C|Adverse Event|1|||
126540845|NCT01147822|455273213|FG000|Overall Study|Lost to Follow-up|14|||
126540846|NCT01147822|455273214|FG001|Overall Study|Lost to Follow-up|6|||
126316731|NCT01143064|454450764|FG000|Overall Study|Adverse Event|0|||
126316732|NCT01143064|454450765|FG001|Overall Study|Adverse Event|1|||
126540847|NCT01147822|455273213|FG000|Overall Study|Withdrawal by Subject|10|||
126540848|NCT01147822|455273214|FG001|Overall Study|Withdrawal by Subject|16|||
126540849|NCT01147822|455273213|FG000|Overall Study|Physician Decision|9|||
126540850|NCT01147822|455273214|FG001|Overall Study|Physician Decision|8|||
126540851|NCT01147822|455273213|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
126540852|NCT01147822|455273214|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
126540853|NCT01147822|455273213|FG000|Overall Study|Protocol Violation|1|||
126540854|NCT01147822|455273214|FG001|Overall Study|Protocol Violation|1|||
126540855|NCT00429663|455273217|FG000|Overall Study|Lost to Follow-up|24|||
126540856|NCT00429663|455273218|FG001|Overall Study|Lost to Follow-up|31|||
126540857|NCT00429663|455273217|FG000|Overall Study|Physician Decision|6|||
126540858|NCT00429663|455273218|FG001|Overall Study|Physician Decision|3|||
126540859|NCT00429663|455273217|FG000|Overall Study|Withdrawal by Subject|2|||
126540860|NCT00429663|455273218|FG001|Overall Study|Withdrawal by Subject|5|||
126540861|NCT00429663|455273217|FG000|Overall Study|Death|4|||
126540862|NCT00429663|455273218|FG001|Overall Study|Death|0|||
126540863|NCT01520402|455273219|FG000|Overall Study|Withdrawal by Subject|2|||
126540864|NCT01520402|455273219|FG000|Overall Study|Physician Decision|3|||
126540865|NCT01722162|455273220|FG000|Overall Study|Withdrawal by Subject|1|||
126540866|NCT01722162|455273221|FG001|Overall Study|Withdrawal by Subject|1|||
126540867|NCT01722162|455273220|FG000|Overall Study|Found ineligible|1|||
126540868|NCT01722162|455273221|FG001|Overall Study|Found ineligible|0|||
126540869|NCT01722162|455273220|FG000|Overall Study|Unrelated to study adverse event|2|||
126540870|NCT01722162|455273221|FG001|Overall Study|Unrelated to study adverse event|2|||
126540871|NCT01722162|455273220|FG000|Overall Study|Adverse Event|1|||
126540872|NCT01722162|455273221|FG001|Overall Study|Adverse Event|1|||
126540873|NCT01722162|455273220|FG000|Overall Study|Insurance denial post enrollment|0|||
126540874|NCT01722162|455273221|FG001|Overall Study|Insurance denial post enrollment|1|||
126540875|NCT01722162|455273220|FG000|Overall Study|Noncompliance|0|||
126540876|NCT01722162|455273221|FG001|Overall Study|Noncompliance|1|||
126540877|NCT03124199|455273222|FG000|Overall Study|Lost to Follow-up|4|||
126540878|NCT03086018|455273223|FG000|Final Testing for End of Trial|Adverse Event|1|||
126540879|NCT03086018|455273223|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
126540880|NCT02748694|455273224|FG000|Overall Study|Voluntary Withdrawal|0|||
126540881|NCT02748694|455273225|FG001|Overall Study|Voluntary Withdrawal|0|||
126540882|NCT02748694|455273226|FG002|Overall Study|Voluntary Withdrawal|0|||
126540883|NCT02748694|455273227|FG003|Overall Study|Voluntary Withdrawal|0|||
126540884|NCT02748694|455273228|FG004|Overall Study|Voluntary Withdrawal|0|||
126540885|NCT02748694|455273229|FG005|Overall Study|Voluntary Withdrawal|0|||
126540886|NCT02748694|455273230|FG006|Overall Study|Voluntary Withdrawal|0|||
126540887|NCT02748694|455273231|FG007|Overall Study|Voluntary Withdrawal|0|||
126540888|NCT02748694|455273232|FG008|Overall Study|Voluntary Withdrawal|0|||
126540889|NCT02748694|455273233|FG009|Overall Study|Voluntary Withdrawal|0|||
126540890|NCT02748694|455273234|FG010|Overall Study|Voluntary Withdrawal|0|||
126540891|NCT02748694|455273235|FG011|Overall Study|Voluntary Withdrawal|0|||
126540892|NCT02748694|455273236|FG012|Overall Study|Voluntary Withdrawal|0|||
126540893|NCT02748694|455273237|FG013|Overall Study|Voluntary Withdrawal|0|||
126540894|NCT02748694|455273238|FG014|Overall Study|Voluntary Withdrawal|2|||
126540895|NCT00077064|455273239|FG000|Overall Study|Adverse Event|0|||
126540896|NCT00077064|455273240|FG001|Overall Study|Adverse Event|4|||
126540897|NCT00077064|455273239|FG000|Overall Study|Patient refusal|0|||
126540898|NCT00077064|455273240|FG001|Overall Study|Patient refusal|2|||
126540899|NCT02192970|455273244|FG000|Overall Study|Lost to Follow-up|6|||
126540900|NCT02192970|455273245|FG001|Overall Study|Lost to Follow-up|0|||
126540901|NCT04074590|455273246|FG000|Overall Study|Adverse Event|1|||
126540902|NCT04074590|455273247|FG001|Overall Study|Adverse Event|0|||
126540903|NCT04074590|455273246|FG000|Overall Study|Physician Decision|1|||
126540904|NCT04074590|455273247|FG001|Overall Study|Physician Decision|0|||
126540905|NCT04074590|455273246|FG000|Overall Study|Withdrawal by Subject|2|||
126540906|NCT04074590|455273247|FG001|Overall Study|Withdrawal by Subject|0|||
126540907|NCT02709005|455273248|FG000|Overall Study|Lost to Follow-up|1|||
126540908|NCT02709005|455273249|FG001|Overall Study|Lost to Follow-up|1|||
126540909|NCT02709005|455273248|FG000|Overall Study|Withdrawal by Subject|3|||
126540910|NCT02709005|455273249|FG001|Overall Study|Withdrawal by Subject|0|||
126540911|NCT00691132|455273250|FG000|Overall Study|Adverse Event|2|||
126540912|NCT00691132|455273251|FG001|Overall Study|Adverse Event|3|||
126540913|NCT00691132|455273250|FG000|Overall Study|Withdrawal by Subject|10|||
126540914|NCT00691132|455273251|FG001|Overall Study|Withdrawal by Subject|10|||
126540915|NCT01959347|455273252|FG000|Overall Study|Protocol Violation|9|||
126540916|NCT01959347|455273253|FG001|Overall Study|Protocol Violation|7|||
126540917|NCT03954743|455273254|FG000|Overall Study|Adverse Event|1|||
126540918|NCT03954743|455273255|FG001|Overall Study|Adverse Event|0|||
126540919|NCT03954743|455273254|FG000|Overall Study|Lost to Follow-up|6|||
126540920|NCT03954743|455273255|FG001|Overall Study|Lost to Follow-up|4|||
126540921|NCT03954743|455273254|FG000|Overall Study|Protocol Violation|1|||
126540922|NCT03954743|455273255|FG001|Overall Study|Protocol Violation|0|||
126540923|NCT03954743|455273254|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
126540924|NCT03954743|455273255|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
126540925|NCT03954743|455273254|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
126540926|NCT03954743|455273255|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126540927|NCT02387996|455273258|FG000|Overall Study|Disease Progression|167|||
126540928|NCT02387996|455273258|FG000|Overall Study|Study Drug Toxicity|31|||
126540929|NCT02387996|455273258|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
126540930|NCT02387996|455273258|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
126540931|NCT02387996|455273258|FG000|Overall Study|Subject Withdrew Consent|5|||
126540932|NCT02387996|455273258|FG000|Overall Study|Lost to Follow-up|1|||
126540933|NCT02387996|455273258|FG000|Overall Study|Poor/Non-Compliance|1|||
126540934|NCT02387996|455273258|FG000|Overall Study|Other Reasons|5|||
126540935|NCT02387996|455273258|FG000|Overall Study|Death|1|||
126540936|NCT05375955|455273269|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
126540937|NCT05375955|455273270|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
126540938|NCT05375955|455273271|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
126540939|NCT05375955|455273272|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
126540940|NCT05375955|455273273|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
126540941|NCT05375955|455273274|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
126540942|NCT05375955|455273275|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
126540943|NCT05375955|455273269|FG000|Treatment (12 Weeks)|Physician Decision|4|||
126540944|NCT05375955|455273270|FG001|Treatment (12 Weeks)|Physician Decision|1|||
126540945|NCT05375955|455273271|FG002|Treatment (12 Weeks)|Physician Decision|3|||
126540946|NCT05375955|455273272|FG003|Treatment (12 Weeks)|Physician Decision|0|||
126540947|NCT05375955|455273273|FG004|Treatment (12 Weeks)|Physician Decision|0|||
126540948|NCT05375955|455273274|FG005|Treatment (12 Weeks)|Physician Decision|1|||
126540949|NCT05375955|455273275|FG006|Treatment (12 Weeks)|Physician Decision|0|||
126540950|NCT05375955|455273269|FG000|Treatment (12 Weeks)|Other|0|||
126540951|NCT05375955|455273270|FG001|Treatment (12 Weeks)|Other|1|||
126540952|NCT05375955|455273271|FG002|Treatment (12 Weeks)|Other|0|||
126540953|NCT05375955|455273272|FG003|Treatment (12 Weeks)|Other|0|||
126540954|NCT05375955|455273273|FG004|Treatment (12 Weeks)|Other|0|||
126540955|NCT05375955|455273274|FG005|Treatment (12 Weeks)|Other|0|||
126540956|NCT05375955|455273275|FG006|Treatment (12 Weeks)|Other|0|||
126540957|NCT05375955|455273269|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
126540958|NCT05375955|455273270|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
126540959|NCT05375955|455273271|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
126540960|NCT05375955|455273272|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
126540961|NCT05375955|455273273|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
126540962|NCT05375955|455273274|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
126540963|NCT05375955|455273275|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
126540964|NCT05375955|455273269|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
126540965|NCT05375955|455273270|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
126540966|NCT05375955|455273271|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
126540967|NCT05375955|455273272|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
126540968|NCT05375955|455273273|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
126540969|NCT05375955|455273274|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
126540970|NCT05375955|455273275|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
126540971|NCT05375955|455273269|FG000|Treatment (12 Weeks)|Pregnancy|0|||
126540972|NCT05375955|455273270|FG001|Treatment (12 Weeks)|Pregnancy|0|||
126540973|NCT05375955|455273271|FG002|Treatment (12 Weeks)|Pregnancy|1|||
126540974|NCT05375955|455273272|FG003|Treatment (12 Weeks)|Pregnancy|0|||
126540975|NCT05375955|455273273|FG004|Treatment (12 Weeks)|Pregnancy|0|||
126540976|NCT05375955|455273274|FG005|Treatment (12 Weeks)|Pregnancy|0|||
126540977|NCT05375955|455273275|FG006|Treatment (12 Weeks)|Pregnancy|0|||
126540978|NCT05375955|455273269|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
126540979|NCT05375955|455273270|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
126540980|NCT05375955|455273271|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
126540981|NCT05375955|455273272|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
126540982|NCT05375955|455273273|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
126540983|NCT05375955|455273274|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
126540984|NCT05375955|455273275|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
126540985|NCT05375955|455273269|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
126540986|NCT05375955|455273270|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
126540987|NCT05375955|455273271|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
126540988|NCT05375955|455273272|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
126540989|NCT05375955|455273273|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
126540990|NCT05375955|455273274|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
126540991|NCT05375955|455273275|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
126540992|NCT05375955|455273269|FG000|Follow-up (up to 5 Weeks)|Other|0|||
126540993|NCT05375955|455273270|FG001|Follow-up (up to 5 Weeks)|Other|1|||
126540994|NCT05375955|455273271|FG002|Follow-up (up to 5 Weeks)|Other|0|||
126540995|NCT05375955|455273272|FG003|Follow-up (up to 5 Weeks)|Other|0|||
126540996|NCT05375955|455273273|FG004|Follow-up (up to 5 Weeks)|Other|0|||
126540997|NCT05375955|455273274|FG005|Follow-up (up to 5 Weeks)|Other|0|||
126540998|NCT05375955|455273275|FG006|Follow-up (up to 5 Weeks)|Other|0|||
126540999|NCT05375955|455273269|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
126541000|NCT05375955|455273270|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
126541001|NCT05375955|455273271|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
126541002|NCT05375955|455273272|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
126541003|NCT05375955|455273273|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
126541004|NCT05375955|455273274|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
126541005|NCT05375955|455273275|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
126541006|NCT05375955|455273269|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
126541007|NCT05375955|455273270|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
126541008|NCT05375955|455273271|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
126541009|NCT05375955|455273272|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
126541010|NCT05375955|455273273|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
126541011|NCT05375955|455273274|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
126541012|NCT05375955|455273275|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
126541013|NCT02158884|455273276|FG000|Baseline Assessment|Missed performance assessment|3|||
126541014|NCT02158884|455273276|FG000|Baseline Assessment|Missed SMFA|1|||
126541015|NCT02158884|455273276|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
126541016|NCT02158884|455273276|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
126541017|NCT02158884|455273276|FG000|6 Month Assessment|Missed SMFA|20|||
126541018|NCT02158884|455273276|FG000|12 Month Assessment|Missed SMFA|17|||
126541019|NCT01313286|455273277|FG000|Period 1|Withdrawal by Subject|2|||
126541020|NCT01313286|455273278|FG001|Period 1|Withdrawal by Subject|0|||
126541021|NCT02010632|455273279|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
126541022|NCT02010632|455273280|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
126541023|NCT03750006|455273283|FG000|Overall Study|Withdrawal by Subject|8|||
126541024|NCT03750006|455273283|FG000|Overall Study|COVID PANDEMIC|11|||
126541025|NCT04739761|455273285|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
126541026|NCT04739761|455273286|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
126541027|NCT04739761|455273285|FG000|Overall Study|By complete response from the participant|1|||
126541028|NCT04739761|455273286|FG001|Overall Study|By complete response from the participant|0|||
126541029|NCT04739761|455273285|FG000|Overall Study|Lost to Follow-up|3|||
126541030|NCT04739761|455273286|FG001|Overall Study|Lost to Follow-up|3|||
126541031|NCT04739761|455273285|FG000|Overall Study|Death|13|||
126541032|NCT04739761|455273286|FG001|Overall Study|Death|13|||
126541033|NCT04739761|455273285|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
126541034|NCT04739761|455273286|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
126541035|NCT04739761|455273285|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
126541036|NCT04739761|455273286|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
126541037|NCT04739761|455273285|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
126541038|NCT04739761|455273286|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
126541039|NCT04739761|455273285|FG000|Overall Study|Adverse Event|0|||
126541040|NCT04739761|455273286|FG001|Overall Study|Adverse Event|3|||
126541041|NCT04739761|455273285|FG000|Overall Study|Participant decision|1|||
126541042|NCT04739761|455273286|FG001|Overall Study|Participant decision|0|||
126541043|NCT04739761|455273285|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
126541044|NCT04739761|455273286|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
126541045|NCT04739761|455273285|FG000|Overall Study|Participant immediately started next line of treatment|1|||
126541046|NCT04739761|455273286|FG001|Overall Study|Participant immediately started next line of treatment|0|||
126541047|NCT04739761|455273285|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
126541048|NCT04739761|455273286|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
126541049|NCT04739761|455273285|FG000|Overall Study|Lack of clinical benefit|1|||
126541050|NCT04739761|455273286|FG001|Overall Study|Lack of clinical benefit|0|||
126541051|NCT04739761|455273285|FG000|Overall Study|Disease progression|5|||
126541052|NCT04739761|455273286|FG001|Overall Study|Disease progression|5|||
126541053|NCT04739761|455273285|FG000|Overall Study|Withdrawal by Subject|14|||
126541054|NCT04739761|455273286|FG001|Overall Study|Withdrawal by Subject|13|||
126541055|NCT04739761|455273285|FG000|Overall Study|Protocol Violation|1|||
126541056|NCT04739761|455273286|FG001|Overall Study|Protocol Violation|0|||
126541057|NCT04739761|455273285|FG000|Overall Study|Physician Decision|2|||
126541058|NCT04739761|455273286|FG001|Overall Study|Physician Decision|0|||
126541059|NCT01061333|455273291|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
126541060|NCT01061333|455273292|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
126541061|NCT02044848|455274646|FG000|Overall Study|Administrative Problems|2|||
126541062|NCT02044848|455274647|FG001|Overall Study|Administrative Problems|3|||
126541063|NCT03237858|455274648|FG000|Overall Study|Death|19|||
126541064|NCT03237858|455274648|FG000|Overall Study|Withdrawal by Subject|37|||
126541065|NCT01160484|455274649|FG000|Overall Study|Lack of Efficacy|9|||
126541066|NCT01160484|455274649|FG000|Overall Study|Adverse Event|6|||
126541067|NCT01160484|455274649|FG000|Overall Study|Withdrawal by Subject|2|||
126541068|NCT01160484|455274649|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
126541069|NCT00803101|455274650|FG000|Overall Study|Death / Serious Adverse Event|4|||
126541070|NCT00803101|455274651|FG001|Overall Study|Death / Serious Adverse Event|6|||
126541071|NCT00803101|455274650|FG000|Overall Study|Withdrawal by Subject|6|||
126541072|NCT00803101|455274651|FG001|Overall Study|Withdrawal by Subject|4|||
126541073|NCT00803101|455274650|FG000|Overall Study|Lost to Follow-up|2|||
126541074|NCT00803101|455274651|FG001|Overall Study|Lost to Follow-up|2|||
126541075|NCT00803101|455274650|FG000|Overall Study|Protocol Violation|1|||
126541076|NCT00803101|455274651|FG001|Overall Study|Protocol Violation|7|||
126541077|NCT00803101|455274650|FG000|Overall Study|Surgery finished outside protocol window|1|||
126541078|NCT00803101|455274651|FG001|Overall Study|Surgery finished outside protocol window|1|||
126541079|NCT00803101|455274650|FG000|Overall Study|Patient died outside SAE report period|1|||
126541080|NCT00803101|455274651|FG001|Overall Study|Patient died outside SAE report period|0|||
126541081|NCT00803101|455274650|FG000|Overall Study|Patient did not attend scheduled visit|2|||
126541082|NCT00803101|455274651|FG001|Overall Study|Patient did not attend scheduled visit|1|||
126541083|NCT00803101|455274650|FG000|Overall Study|Patient did not have surgery|1|||
126541084|NCT00803101|455274651|FG001|Overall Study|Patient did not have surgery|1|||
126541085|NCT01679301|455274654|FG000|Screening Period|screen failure|3|||
126541086|NCT01679301|455274655|FG001|Screening Period|screen failure|0|||
126541087|NCT01679301|455274656|FG002|Screening Period|screen failure|0|||
126541088|NCT04858802|455274657|FG000|Overall Study|Lost to Follow-up|1|||
126541089|NCT04858802|455274658|FG001|Overall Study|Lost to Follow-up|1|||
126541090|NCT04858802|455274657|FG000|Overall Study|Withdrawal by Subject|1|||
126541091|NCT04858802|455274658|FG001|Overall Study|Withdrawal by Subject|1|||
126541092|NCT02026232|455274659|FG000|Overall Study|incomplete visit/missing data|3|||
126541093|NCT02026232|455274660|FG001|Overall Study|incomplete visit/missing data|2|||
126541094|NCT01529008|455274661|FG000|Bone Marrow Harvesting|Physician Decision|1|||
126541095|NCT01529008|455274662|FG001|Bone Marrow Harvesting|Physician Decision|1|||
126541096|NCT01529008|455274661|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
126541097|NCT01529008|455274662|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
126541098|NCT01529008|455274661|FG000|Treatment|Adverse Event|6|||
126541099|NCT01529008|455274662|FG001|Treatment|Adverse Event|0|||
126541100|NCT01529008|455274661|FG000|Treatment|Other|3|||
126541101|NCT01529008|455274662|FG001|Treatment|Other|1|||
126541102|NCT01529008|455274661|FG000|Efficacy Analysis|Protocol Violation|2|||
126541103|NCT01529008|455274662|FG001|Efficacy Analysis|Protocol Violation|0|||
126541104|NCT01529008|455274661|FG000|Efficacy Analysis|Physician Decision|0|||
126541105|NCT01529008|455274662|FG001|Efficacy Analysis|Physician Decision|1|||
126541106|NCT01529008|455274661|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
126541107|NCT01529008|455274662|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
126541108|NCT02305381|455274663|FG000|Overall Study|Unclassified|5|||
126541109|NCT02305381|455274664|FG001|Overall Study|Unclassified|5|||
126541110|NCT02305381|455274665|FG002|Overall Study|Unclassified|7|||
126541111|NCT05056870|455274671|FG000|Period 1|Site COVID-19 Related|3|||
126541112|NCT05056870|455274672|FG001|Period 1|Site COVID-19 Related|3|||
126541113|NCT05056870|455274671|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
126541114|NCT05056870|455274672|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
126541115|NCT05056870|455274671|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
126541116|NCT05056870|455274672|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
126541117|NCT05056870|455274671|FG000|Period 2|COVID-19 Related|1|||
126541118|NCT05056870|455274672|FG001|Period 2|COVID-19 Related|0|||
126541119|NCT05056870|455274671|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
126541120|NCT05056870|455274672|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
126541121|NCT02487498|455274673|FG000|Period: Period 1|Adverse Event|2|||
126541122|NCT02487498|455274674|FG001|Period: Period 1|Adverse Event|4|||
126541123|NCT02487498|455274673|FG000|Period: Period 1|Subject/guardian decision|2|||
126541124|NCT02487498|455274674|FG001|Period: Period 1|Subject/guardian decision|4|||
126541125|NCT02487498|455274673|FG000|Period: Period 1|Lost to Follow-up|0|||
126541126|NCT02487498|455274674|FG001|Period: Period 1|Lost to Follow-up|2|||
126541127|NCT02487498|455274673|FG000|Period: Period 1|Lack of Efficacy|1|||
126541128|NCT02487498|455274674|FG001|Period: Period 1|Lack of Efficacy|0|||
126541129|NCT02487498|455274673|FG000|Period: Period 1|Physician Decision|0|||
126541130|NCT02487498|455274674|FG001|Period: Period 1|Physician Decision|1|||
126541131|NCT02487498|455274673|FG000|Period: Period 1|Protocol deviation|1|||
126541132|NCT02487498|455274674|FG001|Period: Period 1|Protocol deviation|0|||
126541133|NCT02487498|455274673|FG000|Period: Washout|Subject/guardian decision|0|||
126541134|NCT02487498|455274674|FG001|Period: Washout|Subject/guardian decision|5|||
126541135|NCT02487498|455274673|FG000|Period: Washout|Lack of Efficacy|1|||
126541136|NCT02487498|455274674|FG001|Period: Washout|Lack of Efficacy|1|||
126541137|NCT02487498|455274673|FG000|Period: Washout|Physician Decision|1|||
126541138|NCT02487498|455274674|FG001|Period: Washout|Physician Decision|0|||
126541139|NCT02487498|455274673|FG000|Period: Washout|Non-compliance with study treatment|0|||
126541140|NCT02487498|455274674|FG001|Period: Washout|Non-compliance with study treatment|1|||
126541141|NCT02487498|455274673|FG000|Period: Period 2|Adverse Event|2|||
126541142|NCT02487498|455274674|FG001|Period: Period 2|Adverse Event|2|||
126541143|NCT02487498|455274673|FG000|Period: Period 2|Subject/guardian decision|2|||
126541144|NCT02487498|455274674|FG001|Period: Period 2|Subject/guardian decision|1|||
126541145|NCT02487498|455274673|FG000|Period: Period 2|Lost to Follow-up|1|||
126541146|NCT02487498|455274674|FG001|Period: Period 2|Lost to Follow-up|1|||
126541147|NCT02487498|455274673|FG000|Period: Period 2|Death|0|||
126541148|NCT02487498|455274674|FG001|Period: Period 2|Death|1|||
126541149|NCT02487498|455274673|FG000|Period: Period 2|Physician Decision|1|||
126541150|NCT02487498|455274674|FG001|Period: Period 2|Physician Decision|0|||
126541151|NCT00676130|455274675|FG000|Overall Study|Lost to Follow-up|0|||
126541152|NCT00676130|455274676|FG001|Overall Study|Lost to Follow-up|1|||
126541153|NCT00676130|455274675|FG000|Overall Study|Found ineligible|3|||
126541154|NCT00676130|455274676|FG001|Overall Study|Found ineligible|2|||
126541155|NCT00676130|455274675|FG000|Overall Study|Withdrawal by Subject|0|||
126541156|NCT00676130|455274676|FG001|Overall Study|Withdrawal by Subject|1|||
126541157|NCT05044325|455274679|FG000|Part A:Treatment Period 1|Adverse Event|0|||
126541158|NCT05044325|455274680|FG001|Part A:Treatment Period 1|Adverse Event|0|||
126541159|NCT05044325|455274681|FG002|Part A:Treatment Period 1|Adverse Event|0|||
126541160|NCT05044325|455274682|FG003|Part A:Treatment Period 1|Adverse Event|0|||
126541161|NCT05044325|455274683|FG004|Part A:Treatment Period 1|Adverse Event|0|||
126541162|NCT05044325|455274684|FG005|Part A:Treatment Period 1|Adverse Event|1|||
126541163|NCT05044325|455274685|FG006|Part A:Treatment Period 1|Adverse Event|0|||
126541164|NCT05044325|455274686|FG007|Part A:Treatment Period 1|Adverse Event|1|||
126541165|NCT05044325|455274687|FG008|Part A:Treatment Period 1|Adverse Event|0|||
126541166|NCT05044325|455274688|FG009|Part A:Treatment Period 1|Adverse Event|0|||
126541167|NCT05044325|455274679|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
126541168|NCT05044325|455274680|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
126541169|NCT05044325|455274681|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
126541170|NCT05044325|455274682|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
126541171|NCT05044325|455274683|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
126541172|NCT05044325|455274684|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
126541173|NCT05044325|455274685|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
126541174|NCT05044325|455274686|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
126541175|NCT05044325|455274687|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
126541176|NCT05044325|455274688|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
126541177|NCT05044325|455274679|FG000|Part A:Treatment Period 1|Physician Decision|0|||
126541178|NCT05044325|455274680|FG001|Part A:Treatment Period 1|Physician Decision|0|||
126541179|NCT05044325|455274681|FG002|Part A:Treatment Period 1|Physician Decision|0|||
126541180|NCT05044325|455274682|FG003|Part A:Treatment Period 1|Physician Decision|0|||
126541181|NCT05044325|455274683|FG004|Part A:Treatment Period 1|Physician Decision|0|||
126541182|NCT05044325|455274684|FG005|Part A:Treatment Period 1|Physician Decision|0|||
126541183|NCT05044325|455274685|FG006|Part A:Treatment Period 1|Physician Decision|1|||
126541184|NCT05044325|455274686|FG007|Part A:Treatment Period 1|Physician Decision|0|||
126541185|NCT05044325|455274687|FG008|Part A:Treatment Period 1|Physician Decision|0|||
126541186|NCT05044325|455274688|FG009|Part A:Treatment Period 1|Physician Decision|0|||
126541187|NCT05044325|455274679|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
126541188|NCT05044325|455274680|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
126541189|NCT05044325|455274681|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
126541190|NCT05044325|455274682|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
126541191|NCT05044325|455274683|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
126541192|NCT05044325|455274684|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
126541193|NCT05044325|455274685|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
126541194|NCT05044325|455274686|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
126541195|NCT05044325|455274687|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
126541196|NCT05044325|455274688|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
126541197|NCT05044325|455274679|FG000|Part A:Treatment Period 2|Adverse Event|0|||
126541198|NCT05044325|455274680|FG001|Part A:Treatment Period 2|Adverse Event|1|||
126541199|NCT05044325|455274681|FG002|Part A:Treatment Period 2|Adverse Event|0|||
126541200|NCT05044325|455274682|FG003|Part A:Treatment Period 2|Adverse Event|0|||
126541201|NCT05044325|455274683|FG004|Part A:Treatment Period 2|Adverse Event|1|||
126541202|NCT05044325|455274684|FG005|Part A:Treatment Period 2|Adverse Event|1|||
126541203|NCT05044325|455274685|FG006|Part A:Treatment Period 2|Adverse Event|0|||
126541204|NCT05044325|455274686|FG007|Part A:Treatment Period 2|Adverse Event|0|||
126541205|NCT05044325|455274687|FG008|Part A:Treatment Period 2|Adverse Event|0|||
126541206|NCT05044325|455274688|FG009|Part A:Treatment Period 2|Adverse Event|0|||
126541207|NCT05044325|455274679|FG000|Part A:Treatment Period 2|Physician Decision|0|||
126541208|NCT05044325|455274680|FG001|Part A:Treatment Period 2|Physician Decision|0|||
126541209|NCT05044325|455274681|FG002|Part A:Treatment Period 2|Physician Decision|0|||
126541210|NCT05044325|455274682|FG003|Part A:Treatment Period 2|Physician Decision|0|||
126541211|NCT05044325|455274683|FG004|Part A:Treatment Period 2|Physician Decision|0|||
126541212|NCT05044325|455274684|FG005|Part A:Treatment Period 2|Physician Decision|1|||
126541213|NCT05044325|455274685|FG006|Part A:Treatment Period 2|Physician Decision|0|||
126541214|NCT05044325|455274686|FG007|Part A:Treatment Period 2|Physician Decision|0|||
126541215|NCT05044325|455274687|FG008|Part A:Treatment Period 2|Physician Decision|0|||
126541216|NCT05044325|455274688|FG009|Part A:Treatment Period 2|Physician Decision|0|||
126541217|NCT05044325|455274679|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
126541218|NCT05044325|455274680|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
126541219|NCT05044325|455274681|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
126541220|NCT05044325|455274682|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
126541221|NCT05044325|455274683|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
126541222|NCT05044325|455274684|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
126541223|NCT05044325|455274685|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
126541224|NCT05044325|455274686|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
126541225|NCT05044325|455274687|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
126541226|NCT05044325|455274688|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
126541227|NCT00755222|455274689|FG000|Overall Study|Withdrawal by Subject|4|||
126541228|NCT00755222|455274690|FG001|Overall Study|Withdrawal by Subject|2|||
126541229|NCT00755222|455274689|FG000|Overall Study|Adverse Event|2|||
126541230|NCT00755222|455274690|FG001|Overall Study|Adverse Event|0|||
126541231|NCT00755222|455274689|FG000|Overall Study|Protocol Violation|2|||
126541232|NCT00755222|455274690|FG001|Overall Study|Protocol Violation|0|||
126541233|NCT04382924|455274698|FG000|Overall Study|Death|2|||
126541234|NCT04382924|455274699|FG001|Overall Study|Death|5|||
126541235|NCT04382924|455274700|FG002|Overall Study|Death|4|||
126541236|NCT04382924|455274698|FG000|Overall Study|Protocol Violation|0|||
126541237|NCT04382924|455274699|FG001|Overall Study|Protocol Violation|1|||
126541238|NCT04382924|455274700|FG002|Overall Study|Protocol Violation|1|||
126541239|NCT04382924|455274698|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
126541240|NCT04382924|455274699|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
126541241|NCT04382924|455274700|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
126541242|NCT04382924|455274698|FG000|Overall Study|Withdrawal by Subject|6|||
126541243|NCT04382924|455274699|FG001|Overall Study|Withdrawal by Subject|3|||
126541244|NCT04382924|455274700|FG002|Overall Study|Withdrawal by Subject|6|||
126541245|NCT02013388|455274701|FG000|Overall Study|work emergency|1|||
126541246|NCT02013388|455274702|FG001|Overall Study|work emergency|0|||
126541247|NCT02013388|455274703|FG002|Overall Study|work emergency|0|||
126541248|NCT02013388|455274704|FG003|Overall Study|work emergency|0|||
126541249|NCT02013388|455274705|FG004|Overall Study|work emergency|1|||
126541250|NCT02013388|455274706|FG005|Overall Study|work emergency|0|||
126541251|NCT02013388|455274707|FG006|Overall Study|work emergency|0|||
126541252|NCT02013388|455274708|FG007|Overall Study|work emergency|0|||
126541253|NCT04207840|455274709|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
126541254|NCT04207840|455274710|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
126541255|NCT04207840|455274711|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
126541256|NCT04207840|455274709|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
126541257|NCT04207840|455274710|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
126541258|NCT04207840|455274711|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
126541259|NCT03243422|455274712|FG000|Overall Study|Death|20|||
126541260|NCT03243422|455274713|FG001|Overall Study|Death|21|||
126541261|NCT03243422|455274712|FG000|Overall Study|Lost to Follow-up|9|||
126541262|NCT03243422|455274713|FG001|Overall Study|Lost to Follow-up|21|||
126541263|NCT03243422|455274712|FG000|Overall Study|Withdrawal by Subject|22|||
126541264|NCT03243422|455274713|FG001|Overall Study|Withdrawal by Subject|8|||
126541265|NCT03261271|455274717|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
126541266|NCT03261271|455274718|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
126541267|NCT02173054|455274719|FG000|Overall Study|lack of compliance|1|||
126541268|NCT02173054|455274720|FG001|Overall Study|lack of compliance|0|||
126541269|NCT02173054|455274721|FG002|Overall Study|lack of compliance|0|||
126541270|NCT02173054|455274719|FG000|Overall Study|Withdrawal by Subject|0|||
126541271|NCT02173054|455274720|FG001|Overall Study|Withdrawal by Subject|0|||
126541272|NCT02173054|455274721|FG002|Overall Study|Withdrawal by Subject|1|||
126541273|NCT01559454|455274724|FG000|Overall Study|Lost to Follow-up|3|||
126541274|NCT01559454|455274725|FG001|Overall Study|Lost to Follow-up|2|||
126541275|NCT01559454|455274724|FG000|Overall Study|Withdrawal by Subject|0|||
126541276|NCT01559454|455274725|FG001|Overall Study|Withdrawal by Subject|1|||
126541277|NCT01559454|455274724|FG000|Overall Study|Physician Decision|0|||
126316733|NCT01143064|454450764|FG000|Overall Study|Withdrawal by Subject|7|||
126316734|NCT01143064|454450765|FG001|Overall Study|Withdrawal by Subject|5|||
126541278|NCT01559454|455274725|FG001|Overall Study|Physician Decision|1|||
126541279|NCT01559454|455274724|FG000|Overall Study|Protocol Violation|0|||
126541280|NCT01559454|455274725|FG001|Overall Study|Protocol Violation|1|||
126541281|NCT01559454|455274724|FG000|Overall Study|Lack of Efficacy|0|||
126541282|NCT01559454|455274725|FG001|Overall Study|Lack of Efficacy|1|||
126541283|NCT01114204|455274726|FG000|Overall Study|Adverse Event|3|||
126541284|NCT01114204|455274727|FG001|Overall Study|Adverse Event|2|||
126541285|NCT01114204|455274726|FG000|Overall Study|Lost to Follow-up|1|||
126541286|NCT01114204|455274727|FG001|Overall Study|Lost to Follow-up|0|||
126541287|NCT01114204|455274726|FG000|Overall Study|Withdrawal by Subject|10|||
126541288|NCT01114204|455274727|FG001|Overall Study|Withdrawal by Subject|6|||
126541289|NCT01114204|455274726|FG000|Overall Study|Death|1|||
126541290|NCT01114204|455274727|FG001|Overall Study|Death|0|||
126541291|NCT01114204|455274726|FG000|Overall Study|Other-Personal reasons|2|||
126541292|NCT01114204|455274727|FG001|Overall Study|Other-Personal reasons|0|||
126541293|NCT01114204|455274726|FG000|Overall Study|Other-Medical monitor request|1|||
126541294|NCT01114204|455274727|FG001|Overall Study|Other-Medical monitor request|0|||
126541295|NCT01114204|455274726|FG000|Overall Study|Other-Participant request|2|||
126541296|NCT01114204|455274727|FG001|Overall Study|Other-Participant request|0|||
126541297|NCT01114204|455274726|FG000|Overall Study|Other-Protocol Violation|1|||
126541298|NCT01114204|455274727|FG001|Overall Study|Other-Protocol Violation|0|||
126541299|NCT00991341|455274732|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
126541300|NCT00991341|455274733|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
126541301|NCT00991341|455274732|FG000|Overall Study|Death|3|||
126541302|NCT00991341|455274733|FG001|Overall Study|Death|0|||
126541303|NCT00991341|455274732|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
126541304|NCT00991341|455274733|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
126541305|NCT00991341|455274732|FG000|Overall Study|Physician Decision|1|||
126541306|NCT00991341|455274733|FG001|Overall Study|Physician Decision|2|||
126541307|NCT00991341|455274732|FG000|Overall Study|Withdrawal by Subject|3|||
126541308|NCT00991341|455274733|FG001|Overall Study|Withdrawal by Subject|4|||
126541309|NCT03420781|455274737|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
126541310|NCT03420781|455274738|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
126541311|NCT03420781|455274739|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
126541312|NCT03420781|455274740|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
126541313|NCT03420781|455274741|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
126541314|NCT03420781|455274737|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
126541315|NCT03420781|455274738|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
126541316|NCT03420781|455274739|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
126541317|NCT03420781|455274740|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
126541318|NCT03420781|455274741|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
126541319|NCT03420781|455274737|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
126541320|NCT03420781|455274738|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
126541321|NCT03420781|455274739|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
126541322|NCT03420781|455274740|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
126541323|NCT03420781|455274741|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
126541324|NCT03420781|455274737|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
126541325|NCT03420781|455274738|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
126541326|NCT03420781|455274739|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
126541327|NCT03420781|455274740|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
126541328|NCT03420781|455274741|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
126541329|NCT03420781|455274737|FG000|Treatment Period (40 Weeks)|Death|2|||
126541330|NCT03420781|455274738|FG001|Treatment Period (40 Weeks)|Death|2|||
126541331|NCT03420781|455274739|FG002|Treatment Period (40 Weeks)|Death|0|||
126541332|NCT03420781|455274740|FG003|Treatment Period (40 Weeks)|Death|0|||
126541333|NCT03420781|455274741|FG004|Treatment Period (40 Weeks)|Death|0|||
126541334|NCT03420781|455274737|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
126541335|NCT03420781|455274738|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
126541336|NCT03420781|455274739|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
126541337|NCT03420781|455274740|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
126541338|NCT03420781|455274741|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
126541339|NCT03420781|455274737|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
126541340|NCT03420781|455274738|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
126541341|NCT03420781|455274739|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
126541342|NCT03420781|455274740|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
126541343|NCT03420781|455274741|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
126541344|NCT03420781|455274737|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
126541345|NCT03420781|455274738|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
126541346|NCT03420781|455274739|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
126541347|NCT03420781|455274740|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
126541348|NCT03420781|455274741|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
126541349|NCT03420781|455274737|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
126541350|NCT03420781|455274738|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
126541351|NCT03420781|455274739|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
126541352|NCT03420781|455274740|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
126541353|NCT03420781|455274741|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
126541354|NCT03420781|455274737|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
126541355|NCT03420781|455274738|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
126541356|NCT03420781|455274739|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
126541357|NCT03420781|455274740|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
126541358|NCT03420781|455274741|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
126541359|NCT03420781|455274737|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
126541360|NCT03420781|455274738|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
126541361|NCT03420781|455274739|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
126541362|NCT03420781|455274740|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
126541363|NCT03420781|455274741|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
126541364|NCT03420781|455274737|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
126541365|NCT03420781|455274738|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
126541366|NCT03420781|455274739|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
126541367|NCT03420781|455274740|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
126541368|NCT03420781|455274741|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
126541369|NCT03420781|455274737|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
126541370|NCT03420781|455274738|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
126541371|NCT03420781|455274739|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
126541372|NCT03420781|455274740|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
126541373|NCT03420781|455274741|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
126541374|NCT00215540|455274752|FG000|Overall Study|Withdrew from study medication|1|||
126541375|NCT00215540|455274753|FG001|Overall Study|Withdrew from study medication|0|||
126541376|NCT00215540|455274754|FG002|Overall Study|Withdrew from study medication|0|||
126541377|NCT03010462|455274755|FG000|Overall Study|Withdrawal by Subject|3|||
126541378|NCT03010462|455274756|FG001|Overall Study|Withdrawal by Subject|1|||
126541379|NCT00246337|455274759|FG000|Overall Study|Lost to Follow-up|3|||
126541380|NCT00246337|455274760|FG001|Overall Study|Lost to Follow-up|0|||
126541381|NCT00246337|455274761|FG002|Overall Study|Lost to Follow-up|0|||
126541382|NCT00246337|455274762|FG003|Overall Study|Lost to Follow-up|0|||
126541383|NCT00246337|455274763|FG004|Overall Study|Lost to Follow-up|2|||
126541384|NCT00246337|455274764|FG005|Overall Study|Lost to Follow-up|2|||
126541385|NCT00246337|455274765|FG006|Overall Study|Lost to Follow-up|1|||
126541386|NCT00246337|455274766|FG007|Overall Study|Lost to Follow-up|2|||
126541387|NCT00246337|455274767|FG008|Overall Study|Lost to Follow-up|0|||
126541388|NCT00246337|455274759|FG000|Overall Study|Protocol Violation|1|||
126541389|NCT00246337|455274760|FG001|Overall Study|Protocol Violation|0|||
126541390|NCT00246337|455274761|FG002|Overall Study|Protocol Violation|0|||
126541391|NCT00246337|455274762|FG003|Overall Study|Protocol Violation|0|||
126541392|NCT00246337|455274763|FG004|Overall Study|Protocol Violation|1|||
126541393|NCT00246337|455274764|FG005|Overall Study|Protocol Violation|0|||
126541394|NCT00246337|455274765|FG006|Overall Study|Protocol Violation|1|||
126541395|NCT00246337|455274766|FG007|Overall Study|Protocol Violation|1|||
126541396|NCT00246337|455274767|FG008|Overall Study|Protocol Violation|0|||
126541397|NCT00246337|455274759|FG000|Overall Study|Withdrawal by Subject|2|||
126541398|NCT00246337|455274760|FG001|Overall Study|Withdrawal by Subject|0|||
126541399|NCT00246337|455274761|FG002|Overall Study|Withdrawal by Subject|0|||
126541400|NCT00246337|455274762|FG003|Overall Study|Withdrawal by Subject|0|||
126541401|NCT00246337|455274763|FG004|Overall Study|Withdrawal by Subject|0|||
126541402|NCT00246337|455274764|FG005|Overall Study|Withdrawal by Subject|0|||
126541403|NCT00246337|455274765|FG006|Overall Study|Withdrawal by Subject|1|||
126541404|NCT00246337|455274766|FG007|Overall Study|Withdrawal by Subject|1|||
126541405|NCT00246337|455274767|FG008|Overall Study|Withdrawal by Subject|0|||
126541406|NCT00246337|455274759|FG000|Overall Study|Lack of Qualifying Event|8|||
126541407|NCT00246337|455274760|FG001|Overall Study|Lack of Qualifying Event|2|||
126541408|NCT00246337|455274761|FG002|Overall Study|Lack of Qualifying Event|1|||
126541409|NCT00246337|455274762|FG003|Overall Study|Lack of Qualifying Event|1|||
126541410|NCT00246337|455274763|FG004|Overall Study|Lack of Qualifying Event|1|||
126541411|NCT00246337|455274764|FG005|Overall Study|Lack of Qualifying Event|3|||
126541412|NCT00246337|455274765|FG006|Overall Study|Lack of Qualifying Event|3|||
126541413|NCT00246337|455274766|FG007|Overall Study|Lack of Qualifying Event|2|||
126541414|NCT00246337|455274767|FG008|Overall Study|Lack of Qualifying Event|5|||
126541415|NCT00246337|455274759|FG000|Overall Study|Site Terminated|10|||
126541416|NCT00246337|455274760|FG001|Overall Study|Site Terminated|0|||
126541417|NCT00246337|455274761|FG002|Overall Study|Site Terminated|0|||
126541418|NCT00246337|455274762|FG003|Overall Study|Site Terminated|0|||
126541419|NCT00246337|455274763|FG004|Overall Study|Site Terminated|0|||
126541420|NCT00246337|455274764|FG005|Overall Study|Site Terminated|7|||
126541421|NCT00246337|455274765|FG006|Overall Study|Site Terminated|1|||
126541422|NCT00246337|455274766|FG007|Overall Study|Site Terminated|6|||
126541423|NCT00246337|455274767|FG008|Overall Study|Site Terminated|2|||
126541424|NCT00246337|455274759|FG000|Overall Study|Abnormal baseline lab values|7|||
126541425|NCT00246337|455274760|FG001|Overall Study|Abnormal baseline lab values|0|||
126541426|NCT00246337|455274761|FG002|Overall Study|Abnormal baseline lab values|2|||
126541427|NCT00246337|455274762|FG003|Overall Study|Abnormal baseline lab values|0|||
126541428|NCT00246337|455274763|FG004|Overall Study|Abnormal baseline lab values|0|||
126541429|NCT00246337|455274764|FG005|Overall Study|Abnormal baseline lab values|2|||
126541430|NCT00246337|455274765|FG006|Overall Study|Abnormal baseline lab values|2|||
126541431|NCT00246337|455274766|FG007|Overall Study|Abnormal baseline lab values|0|||
126541432|NCT00246337|455274767|FG008|Overall Study|Abnormal baseline lab values|4|||
126541433|NCT00246337|455274759|FG000|Overall Study|Overwhelmed|0|||
126541434|NCT00246337|455274760|FG001|Overall Study|Overwhelmed|0|||
126541435|NCT00246337|455274761|FG002|Overall Study|Overwhelmed|0|||
126541436|NCT00246337|455274762|FG003|Overall Study|Overwhelmed|0|||
126541437|NCT00246337|455274763|FG004|Overall Study|Overwhelmed|0|||
126541438|NCT00246337|455274764|FG005|Overall Study|Overwhelmed|1|||
126541439|NCT00246337|455274765|FG006|Overall Study|Overwhelmed|0|||
126541440|NCT00246337|455274766|FG007|Overall Study|Overwhelmed|0|||
126541441|NCT00246337|455274767|FG008|Overall Study|Overwhelmed|0|||
126541442|NCT00246337|455274759|FG000|Overall Study|Protocol Violator|1|||
126541443|NCT00246337|455274760|FG001|Overall Study|Protocol Violator|0|||
126541444|NCT00246337|455274761|FG002|Overall Study|Protocol Violator|0|||
126541445|NCT00246337|455274762|FG003|Overall Study|Protocol Violator|0|||
126541446|NCT00246337|455274763|FG004|Overall Study|Protocol Violator|0|||
126541447|NCT00246337|455274764|FG005|Overall Study|Protocol Violator|0|||
126541448|NCT00246337|455274765|FG006|Overall Study|Protocol Violator|0|||
126541449|NCT00246337|455274766|FG007|Overall Study|Protocol Violator|0|||
126541450|NCT00246337|455274767|FG008|Overall Study|Protocol Violator|0|||
126541451|NCT00246337|455274759|FG000|Overall Study|Reported as completing trial in error|0|||
126541452|NCT00246337|455274760|FG001|Overall Study|Reported as completing trial in error|0|||
126541453|NCT00246337|455274761|FG002|Overall Study|Reported as completing trial in error|0|||
126541454|NCT00246337|455274762|FG003|Overall Study|Reported as completing trial in error|0|||
126541455|NCT00246337|455274763|FG004|Overall Study|Reported as completing trial in error|0|||
126541456|NCT00246337|455274764|FG005|Overall Study|Reported as completing trial in error|0|||
126541457|NCT00246337|455274765|FG006|Overall Study|Reported as completing trial in error|0|||
126541458|NCT00246337|455274766|FG007|Overall Study|Reported as completing trial in error|1|||
126541459|NCT00246337|455274767|FG008|Overall Study|Reported as completing trial in error|0|||
126541460|NCT02799472|455274775|FG000|Overall Study|Withdrawal by Subject|2|||
126541461|NCT02799472|455274776|FG001|Overall Study|Withdrawal by Subject|4|||
126541462|NCT02799472|455274775|FG000|Overall Study|Lack of Efficacy|2|||
126541463|NCT02799472|455274776|FG001|Overall Study|Lack of Efficacy|0|||
126541464|NCT02799472|455274775|FG000|Overall Study|Lost to Follow-up|0|||
126541465|NCT02799472|455274776|FG001|Overall Study|Lost to Follow-up|1|||
126541466|NCT00674570|455274777|FG000|Overall Study|Withdrawal by Subject|0|||
126541467|NCT00674570|455274778|FG001|Overall Study|Withdrawal by Subject|2|||
126541468|NCT00674570|455274779|FG002|Overall Study|Withdrawal by Subject|0|||
126541469|NCT01966003|455274780|FG000|Overall Study|Death|43|||
126541470|NCT01966003|455274781|FG001|Overall Study|Death|36|||
126541471|NCT01966003|455274780|FG000|Overall Study|Protocol Violation|6|||
126541472|NCT01966003|455274781|FG001|Overall Study|Protocol Violation|4|||
126541473|NCT01966003|455274780|FG000|Overall Study|Lost to Follow-up|4|||
126541474|NCT01966003|455274781|FG001|Overall Study|Lost to Follow-up|3|||
126541475|NCT01966003|455274780|FG000|Overall Study|Physician Decision|12|||
126541476|NCT01966003|455274781|FG001|Overall Study|Physician Decision|13|||
126541477|NCT01966003|455274780|FG000|Overall Study|Withdrawal by Subject|29|||
126541478|NCT01966003|455274781|FG001|Overall Study|Withdrawal by Subject|19|||
126541479|NCT01966003|455274780|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
126541480|NCT01966003|455274781|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
126541481|NCT01966003|455274780|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
126541482|NCT01966003|455274781|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
126541483|NCT01966003|455274780|FG000|Overall Study|Other|1|||
126541484|NCT01966003|455274781|FG001|Overall Study|Other|1|||
126541485|NCT03633929|455274783|FG000|Overall Study|Lost to Follow-up|1|||
126541486|NCT03633929|455274783|FG000|Overall Study|Did not login to software. Did not participate|3|||
126541487|NCT04461795|455274785|FG000|Overall Study|Lost to Follow-up|2|||
126316735|NCT01143064|454450764|FG000|Overall Study|Lost to Follow-up|17|||
126316736|NCT01143064|454450765|FG001|Overall Study|Lost to Follow-up|14|||
126541488|NCT04461795|455274785|FG000|Overall Study|Withdrawal by Subject|2|||
126541489|NCT04461795|455274785|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
126541490|NCT00058422|455274786|FG000|Overall Study|Not treated|2|||
126541491|NCT00185640|455274787|FG000|Overall Study|Not Eligible|4|||
126541492|NCT00185640|455274787|FG000|Overall Study|Withdrawal by Subject|3|||
126541493|NCT00185640|455274787|FG000|Overall Study|Death|138|||
126541494|NCT03299686|455274788|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
126541495|NCT03299686|455274789|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
126541496|NCT03299686|455274788|FG000|Treatment Epoch|Physician Decision|1|||
126541497|NCT03299686|455274789|FG001|Treatment Epoch|Physician Decision|0|||
126541498|NCT03299686|455274788|FG000|Treatment Epoch|Adverse Event|8|||
126541499|NCT03299686|455274789|FG001|Treatment Epoch|Adverse Event|4|||
126541500|NCT03299686|455274788|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
126541501|NCT03299686|455274789|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
126541502|NCT01320943|455274790|FG000|Overall Study|Lost to Follow-up|1|||
126541503|NCT01320943|455274791|FG001|Overall Study|Lost to Follow-up|0|||
126541504|NCT01320943|455274790|FG000|Overall Study|Physician Decision|0|||
126541505|NCT01320943|455274791|FG001|Overall Study|Physician Decision|1|||
126541506|NCT01320943|455274790|FG000|Overall Study|Randomized but not Treated|0|||
126541507|NCT01320943|455274791|FG001|Overall Study|Randomized but not Treated|1|||
126541508|NCT02034708|455274796|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
126541509|NCT02034708|455274797|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
126541510|NCT02034708|455274796|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
126541511|NCT02034708|455274797|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
126541512|NCT02034708|455274796|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
126541513|NCT02034708|455274797|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
126541514|NCT02034708|455274796|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
126541515|NCT02034708|455274797|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
126541516|NCT00733980|455274800|FG000|Overall Study|Adverse Event|5|||
126541517|NCT00733980|455274801|FG001|Overall Study|Adverse Event|2|||
126541518|NCT00733980|455274800|FG000|Overall Study|Lack of Efficacy|0|||
126541519|NCT00733980|455274801|FG001|Overall Study|Lack of Efficacy|1|||
126541520|NCT00733980|455274800|FG000|Overall Study|Protocol Violation|2|||
126541521|NCT00733980|455274801|FG001|Overall Study|Protocol Violation|1|||
126541522|NCT00733980|455274800|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
126541523|NCT00733980|455274801|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
126541524|NCT00733980|455274800|FG000|Overall Study|Lost to Follow-up|6|||
126541525|NCT00733980|455274801|FG001|Overall Study|Lost to Follow-up|11|||
126541526|NCT00733980|455274800|FG000|Overall Study|Physician Decision|2|||
126541527|NCT00733980|455274801|FG001|Overall Study|Physician Decision|3|||
126541528|NCT00733980|455274800|FG000|Overall Study|Withdrawal by Subject|6|||
126541529|NCT00733980|455274801|FG001|Overall Study|Withdrawal by Subject|2|||
126541530|NCT00779779|455274802|FG000|Overall Study|Adverse Event|1|||
126541531|NCT00779779|455274802|FG000|Overall Study|Protocol Violation|14|||
126541532|NCT00779779|455274802|FG000|Overall Study|Withdrawal by Subject|4|||
126541533|NCT00779779|455274802|FG000|Overall Study|Lost to Follow-up|5|||
126541534|NCT02719990|455274803|FG000|Overall Study|Physician Decision|2|||
126541535|NCT02719990|455274803|FG000|Overall Study|Withdrawal by Subject|2|||
126541536|NCT02719990|455274803|FG000|Overall Study|Study Terminated By Sponsor|32|||
126541537|NCT06387472|455274812|FG000|Overall Study|Withdrawal by Subject|1|||
126541538|NCT06387472|455274812|FG000|Overall Study|Lost to Follow-up|2|||
126541539|NCT06387472|455274812|FG000|Overall Study|Physician Decision|1|||
126541540|NCT00404495|455274814|FG000|Overall Study|Death|37|||
126541541|NCT00404495|455274815|FG001|Overall Study|Death|11|||
126541542|NCT00404495|455274814|FG000|Overall Study|Lost to Follow-up|5|||
126541543|NCT00404495|455274815|FG001|Overall Study|Lost to Follow-up|0|||
126541544|NCT00404495|455274814|FG000|Overall Study|Other|1|||
126541545|NCT00404495|455274815|FG001|Overall Study|Other|0|||
126541546|NCT00404495|455274814|FG000|Overall Study|Withdrawal by Subject|1|||
126541547|NCT00404495|455274815|FG001|Overall Study|Withdrawal by Subject|0|||
126541548|NCT00045708|455276968|FG000|Phase 1|early progressive disease|0|||
126541549|NCT00045708|455276969|FG001|Phase 1|early progressive disease|1|||
126541550|NCT00045708|455276970|FG002|Phase 1|early progressive disease|0|||
126541551|NCT01493960|455276972|FG000|Overall Study|Adverse Event|0|||
126541552|NCT01493960|455276973|FG001|Overall Study|Adverse Event|1|||
126541553|NCT01493960|455276972|FG000|Overall Study|Lack of Efficacy|15|||
126541554|NCT01493960|455276973|FG001|Overall Study|Lack of Efficacy|9|||
126541555|NCT01493960|455276972|FG000|Overall Study|Protocol Violation|3|||
126541556|NCT01493960|455276973|FG001|Overall Study|Protocol Violation|0|||
126541557|NCT01493960|455276972|FG000|Overall Study|Withdrawal by Subject|10|||
126541558|NCT01493960|455276973|FG001|Overall Study|Withdrawal by Subject|4|||
126541559|NCT01493960|455276972|FG000|Overall Study|Non-specified|4|||
126316737|NCT01143064|454450764|FG000|Overall Study|Physician Decision|0|||
126316738|NCT01143064|454450765|FG001|Overall Study|Physician Decision|4|||
126316739|NCT01199822|454450771|FG000|Overall Study|Investigator discontinued therapy|0|||
126316740|NCT01199822|454450772|FG001|Overall Study|Investigator discontinued therapy|1|||
126316741|NCT01199822|454450773|FG002|Overall Study|Investigator discontinued therapy|0|||
126316742|NCT04027075|454450774|FG000|Overall Study|Lost to Follow-up|41|||
126541560|NCT01493960|455276973|FG001|Overall Study|Non-specified|4|||
126541561|NCT01679236|455276978|FG000|Overall Study|Lost to Follow-up|15|||
126541562|NCT01679236|455276979|FG001|Overall Study|Lost to Follow-up|15|||
126541563|NCT00284141|455276980|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
126541564|NCT00284141|455276980|FG000|Overall Study|Adverse Event|19|||
126541565|NCT00284141|455276980|FG000|Overall Study|Participant's request|9|||
126541566|NCT00284141|455276980|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
126541567|NCT00284141|455276980|FG000|Overall Study|Clinical deterioration / death|2|||
126541568|NCT00284141|455276980|FG000|Overall Study|General decline|1|||
126541569|NCT00284141|455276980|FG000|Overall Study|Pneumonia|1|||
126541570|NCT00284141|455276980|FG000|Overall Study|Did not take study medication|2|||
126541571|NCT00284141|455276980|FG000|Overall Study|Ongoing treatment|2|||
126316743|NCT04027075|454450775|FG001|Overall Study|Lost to Follow-up|22|||
126541572|NCT00975221|455276982|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
126316744|NCT02772276|454450778|FG000|Overall Study|Lost to Follow-up|0|||
126541573|NCT00975221|455276983|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
126541574|NCT00975221|455276982|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
126541575|NCT00975221|455276983|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
126541576|NCT00975221|455276982|FG000|Titration Phase (Weeks 1-12)|Other|0|||
126541577|NCT00975221|455276983|FG001|Titration Phase (Weeks 1-12)|Other|1|||
126541578|NCT00975221|455276982|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
126541579|NCT00975221|455276983|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
126541580|NCT00975221|455276982|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
126541581|NCT00975221|455276983|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
126541582|NCT00975221|455276982|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
126541583|NCT00975221|455276983|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
126541584|NCT03935217|455276986|FG000|Overall Study|Adverse Event|1|||
126541585|NCT03935217|455276987|FG001|Overall Study|Adverse Event|0|||
126541586|NCT03935217|455276986|FG000|Overall Study|Lost to Follow-up|0|||
126541587|NCT03935217|455276987|FG001|Overall Study|Lost to Follow-up|1|||
126541588|NCT03935217|455276986|FG000|Overall Study|Withdrawal by Subject|0|||
126541589|NCT03935217|455276987|FG001|Overall Study|Withdrawal by Subject|2|||
126541590|NCT03559218|455276988|FG000|Overall Study|Withdrawal by Subject|1|||
126541591|NCT03559218|455276989|FG001|Overall Study|Withdrawal by Subject|0|||
126541592|NCT01782742|455276993|FG000|Double-blind Treatment Phase|Adverse Event|1|||
126541593|NCT01782742|455276994|FG001|Double-blind Treatment Phase|Adverse Event|0|||
126541594|NCT00332332|455276995|FG000|Overall Study|Adverse Event|13|||
126541595|NCT00332332|455276995|FG000|Overall Study|Death|1|||
126541596|NCT00332332|455276995|FG000|Overall Study|Withdrawal by Subject|8|||
126541597|NCT00332332|455276995|FG000|Overall Study|Physician Decision|1|||
126541598|NCT00332332|455276995|FG000|Overall Study|Lost to Follow-up|3|||
126541599|NCT00332332|455276995|FG000|Overall Study|Protocol deviation|4|||
126541600|NCT00332332|455276995|FG000|Overall Study|Noncompliance|2|||
126541601|NCT00332332|455276995|FG000|Overall Study|Disease progression|2|||
126541602|NCT00332332|455276995|FG000|Overall Study|Other|18|||
126541603|NCT00332332|455276995|FG000|Overall Study|Did not receive study treatment|16|||
126541604|NCT01108458|455276996|FG000|Overall Study|Withdrawal by Subject|1|||
126541605|NCT01382602|455276997|FG000|Overall Study|Protocol Violation|0|||
126541606|NCT01382602|455276998|FG001|Overall Study|Protocol Violation|3|||
126541607|NCT01382602|455276997|FG000|Overall Study|Withdrawal by Subject|0|||
126541608|NCT01382602|455276998|FG001|Overall Study|Withdrawal by Subject|1|||
126541609|NCT02790073|455276999|FG000|Overall Study|Death|1|||
126541610|NCT02790073|455276999|FG000|Overall Study|Withdrawal from HD|1|||
126541611|NCT02790073|455276999|FG000|Overall Study|Withdrawal by Subject|1|||
126541612|NCT04170686|455277000|FG000|Screening|Physician Decision|12|||
126541613|NCT04170686|455277001|FG001|Screening|Physician Decision|13|||
126541614|NCT04170686|455277000|FG000|Randomization and Treatment|Lost to Follow-up|26|||
126541615|NCT04170686|455277001|FG001|Randomization and Treatment|Lost to Follow-up|15|||
126541616|NCT03328143|455277002|FG000|Overall Study|Declined|3|||
126541617|NCT03328143|455277002|FG000|Overall Study|Required increased sedation|4|||
126541618|NCT03328143|455277002|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
126541619|NCT03328143|455277002|FG000|Overall Study|Surgery cancelled|1|||
126541620|NCT02243202|455277004|FG000|Overall Study|Adverse Event|5|||
126541621|NCT02243202|455277005|FG001|Overall Study|Adverse Event|6|||
126541622|NCT02243202|455277006|FG002|Overall Study|Adverse Event|10|||
126541623|NCT02243202|455277007|FG003|Overall Study|Adverse Event|4|||
126541624|NCT02243202|455277004|FG000|Overall Study|Lost to Follow-up|9|||
126541625|NCT02243202|455277005|FG001|Overall Study|Lost to Follow-up|9|||
126541626|NCT02243202|455277006|FG002|Overall Study|Lost to Follow-up|14|||
126541627|NCT02243202|455277007|FG003|Overall Study|Lost to Follow-up|11|||
126541628|NCT02243202|455277004|FG000|Overall Study|Protocol Violation|3|||
126541629|NCT02243202|455277005|FG001|Overall Study|Protocol Violation|1|||
126541630|NCT02243202|455277006|FG002|Overall Study|Protocol Violation|2|||
126541631|NCT02243202|455277007|FG003|Overall Study|Protocol Violation|1|||
126541632|NCT02243202|455277004|FG000|Overall Study|Withdrawal by Subject|7|||
126541633|NCT02243202|455277005|FG001|Overall Study|Withdrawal by Subject|6|||
126541634|NCT02243202|455277006|FG002|Overall Study|Withdrawal by Subject|4|||
126541635|NCT02243202|455277007|FG003|Overall Study|Withdrawal by Subject|4|||
126541636|NCT02243202|455277004|FG000|Overall Study|Other|1|||
126541637|NCT02243202|455277005|FG001|Overall Study|Other|3|||
126316745|NCT02772276|454450779|FG001|Overall Study|Lost to Follow-up|0|||
126541638|NCT02243202|455277006|FG002|Overall Study|Other|1|||
126541639|NCT02243202|455277007|FG003|Overall Study|Other|2|||
126541640|NCT02243202|455277004|FG000|Overall Study|Randomized but not received treatment|0|||
126541641|NCT02243202|455277005|FG001|Overall Study|Randomized but not received treatment|0|||
126541642|NCT02243202|455277006|FG002|Overall Study|Randomized but not received treatment|0|||
126541643|NCT02243202|455277007|FG003|Overall Study|Randomized but not received treatment|1|||
126541644|NCT01330316|455277017|FG000|Overall Study|Adverse Event|2|||
126541645|NCT01330316|455277018|FG001|Overall Study|Adverse Event|2|||
126541646|NCT01330316|455277017|FG000|Overall Study|Lack of Efficacy|0|||
126541647|NCT01330316|455277018|FG001|Overall Study|Lack of Efficacy|10|||
126541648|NCT01330316|455277017|FG000|Overall Study|Lost to Follow-up|0|||
126541649|NCT01330316|455277018|FG001|Overall Study|Lost to Follow-up|1|||
126541650|NCT01330316|455277017|FG000|Overall Study|Withdrawal by Subject|0|||
126541651|NCT01330316|455277018|FG001|Overall Study|Withdrawal by Subject|1|||
126541652|NCT01330316|455277017|FG000|Overall Study|other than above|0|||
126541653|NCT01330316|455277018|FG001|Overall Study|other than above|1|||
126541654|NCT02207725|455277019|FG000|Overall Study|Did Not Receive Treatment|0|||
126541655|NCT02207725|455277020|FG001|Overall Study|Did Not Receive Treatment|1|||
126541656|NCT02207725|455277021|FG002|Overall Study|Did Not Receive Treatment|1|||
126541657|NCT02207725|455277022|FG003|Overall Study|Did Not Receive Treatment|1|||
126541658|NCT03145766|455277023|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
126541659|NCT03145766|455277024|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
126541660|NCT03145766|455277025|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
126541661|NCT03145766|455277026|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
126541662|NCT03145766|455277027|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
126541663|NCT03145766|455277023|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
126541664|NCT03145766|455277024|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
126541665|NCT03145766|455277025|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
126541666|NCT03145766|455277026|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
126541667|NCT03145766|455277027|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
126541668|NCT03145766|455277023|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
126541669|NCT03145766|455277024|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
126541670|NCT03145766|455277025|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
126541671|NCT03145766|455277026|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
126541672|NCT03145766|455277027|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
126541673|NCT03145766|455277023|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
126541674|NCT03145766|455277024|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
126541675|NCT03145766|455277025|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
126541676|NCT03145766|455277026|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
126541677|NCT03145766|455277027|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
126541678|NCT03145766|455277023|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
126541679|NCT03145766|455277024|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
126541680|NCT03145766|455277025|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
126541681|NCT03145766|455277026|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
126541682|NCT03145766|455277027|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
126541683|NCT03145766|455277023|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
126541684|NCT03145766|455277024|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
126541685|NCT03145766|455277025|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
126541686|NCT03145766|455277026|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
126541687|NCT03145766|455277027|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
126541688|NCT03145766|455277023|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
126541689|NCT03145766|455277024|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
126541690|NCT03145766|455277025|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
126541691|NCT03145766|455277026|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
126541692|NCT03145766|455277027|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
126541693|NCT02801669|455277028|FG000|Overall Study|Death|66|||
126541694|NCT02801669|455277029|FG001|Overall Study|Death|69|||
126541695|NCT02801669|455277028|FG000|Overall Study|Withdrawal by Subject|81|||
126541696|NCT02801669|455277029|FG001|Overall Study|Withdrawal by Subject|77|||
126541697|NCT02801669|455277028|FG000|Overall Study|Other|4|||
126541698|NCT02801669|455277029|FG001|Overall Study|Other|6|||
126541699|NCT02696564|455277030|FG000|Overall Study|Death|1|||
126541700|NCT02696564|455277031|FG001|Overall Study|Death|2|||
126541701|NCT02696564|455277030|FG000|Overall Study|Withdrawal by Subject|3|||
126541702|NCT02696564|455277031|FG001|Overall Study|Withdrawal by Subject|2|||
126541703|NCT02696564|455277030|FG000|Overall Study|Lost to Follow-up|3|||
126541704|NCT02696564|455277031|FG001|Overall Study|Lost to Follow-up|3|||
126541705|NCT02696564|455277030|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
126541706|NCT02696564|455277031|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
126541707|NCT02696564|455277030|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
126541708|NCT02696564|455277031|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
126541709|NCT02696564|455277030|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
126541710|NCT02696564|455277031|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
126541711|NCT02696564|455277030|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
126541712|NCT02696564|455277031|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
126541713|NCT02696564|455277030|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
126541714|NCT02696564|455277031|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
126541715|NCT00615264|455277034|FG000|Overall Study|Withdrawal by Subject|17|||
126541716|NCT00615264|455277035|FG001|Overall Study|Withdrawal by Subject|19|||
126541717|NCT00615264|455277034|FG000|Overall Study|Lost to Follow-up|6|||
126541718|NCT00615264|455277035|FG001|Overall Study|Lost to Follow-up|13|||
126541719|NCT00615264|455277034|FG000|Overall Study|Adverse Event|8|||
126541720|NCT00615264|455277035|FG001|Overall Study|Adverse Event|5|||
126541721|NCT00615264|455277034|FG000|Overall Study|Death|1|||
126541722|NCT00615264|455277035|FG001|Overall Study|Death|1|||
126541723|NCT00615264|455277034|FG000|Overall Study|Protocol Violation|11|||
126541724|NCT00615264|455277035|FG001|Overall Study|Protocol Violation|7|||
126541725|NCT00615264|455277034|FG000|Overall Study|Not defined|7|||
126541726|NCT00615264|455277035|FG001|Overall Study|Not defined|4|||
126541727|NCT00615264|455277034|FG000|Overall Study|Dermal Hypersensitivity|0|||
126541728|NCT00615264|455277035|FG001|Overall Study|Dermal Hypersensitivity|3|||
126541729|NCT02287584|455277038|FG000|the Double-blind Phase|Adverse Event|17|||
126541730|NCT02287584|455277039|FG001|the Double-blind Phase|Adverse Event|17|||
126541731|NCT02287584|455277040|FG002|the Double-blind Phase|Adverse Event|12|||
126541732|NCT02287584|455277041|FG003|the Double-blind Phase|Adverse Event|0|||
126541733|NCT02287584|455277042|FG004|the Double-blind Phase|Adverse Event|0|||
126541734|NCT02287584|455277043|FG005|the Double-blind Phase|Adverse Event|0|||
126541735|NCT02287584|455277038|FG000|the Double-blind Phase|Lack of Efficacy|18|||
126541736|NCT02287584|455277039|FG001|the Double-blind Phase|Lack of Efficacy|8|||
126541737|NCT02287584|455277040|FG002|the Double-blind Phase|Lack of Efficacy|8|||
126541738|NCT02287584|455277041|FG003|the Double-blind Phase|Lack of Efficacy|0|||
126541739|NCT02287584|455277042|FG004|the Double-blind Phase|Lack of Efficacy|0|||
126541740|NCT02287584|455277043|FG005|the Double-blind Phase|Lack of Efficacy|0|||
126541741|NCT02287584|455277038|FG000|the Double-blind Phase|Lost to Follow-up|0|||
126541742|NCT02287584|455277039|FG001|the Double-blind Phase|Lost to Follow-up|1|||
126541743|NCT02287584|455277040|FG002|the Double-blind Phase|Lost to Follow-up|1|||
126316746|NCT02772276|454450780|FG002|Overall Study|Lost to Follow-up|0|||
126541744|NCT02287584|455277041|FG003|the Double-blind Phase|Lost to Follow-up|0|||
126541745|NCT02287584|455277042|FG004|the Double-blind Phase|Lost to Follow-up|0|||
126541746|NCT02287584|455277043|FG005|the Double-blind Phase|Lost to Follow-up|0|||
126541747|NCT02287584|455277038|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
126541748|NCT02287584|455277039|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
126541749|NCT02287584|455277040|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
126541750|NCT02287584|455277041|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
126541751|NCT02287584|455277042|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
126541752|NCT02287584|455277043|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
126541753|NCT02287584|455277038|FG000|the Double-blind Phase|Pregnancy|0|||
126541754|NCT02287584|455277039|FG001|the Double-blind Phase|Pregnancy|1|||
126541755|NCT02287584|455277040|FG002|the Double-blind Phase|Pregnancy|0|||
126541756|NCT02287584|455277041|FG003|the Double-blind Phase|Pregnancy|0|||
126541757|NCT02287584|455277042|FG004|the Double-blind Phase|Pregnancy|0|||
126541758|NCT02287584|455277043|FG005|the Double-blind Phase|Pregnancy|0|||
126541759|NCT02287584|455277038|FG000|the Double-blind Phase|Protocol Violation|0|||
126541760|NCT02287584|455277039|FG001|the Double-blind Phase|Protocol Violation|3|||
126541761|NCT02287584|455277040|FG002|the Double-blind Phase|Protocol Violation|0|||
126541762|NCT02287584|455277041|FG003|the Double-blind Phase|Protocol Violation|0|||
126541763|NCT02287584|455277042|FG004|the Double-blind Phase|Protocol Violation|0|||
126541764|NCT02287584|455277043|FG005|the Double-blind Phase|Protocol Violation|0|||
126541765|NCT02287584|455277038|FG000|the Double-blind Phase|other reasons|0|||
126541766|NCT02287584|455277039|FG001|the Double-blind Phase|other reasons|0|||
126541767|NCT02287584|455277040|FG002|the Double-blind Phase|other reasons|1|||
126541768|NCT02287584|455277041|FG003|the Double-blind Phase|other reasons|0|||
126541769|NCT02287584|455277042|FG004|the Double-blind Phase|other reasons|0|||
126541770|NCT02287584|455277043|FG005|the Double-blind Phase|other reasons|0|||
126541771|NCT02287584|455277038|FG000|the Open-label Phase|Did not receive drug|0|||
126541772|NCT02287584|455277039|FG001|the Open-label Phase|Did not receive drug|0|||
126541773|NCT02287584|455277040|FG002|the Open-label Phase|Did not receive drug|0|||
126541774|NCT02287584|455277041|FG003|the Open-label Phase|Did not receive drug|7|||
126541775|NCT02287584|455277042|FG004|the Open-label Phase|Did not receive drug|6|||
126541776|NCT02287584|455277043|FG005|the Open-label Phase|Did not receive drug|4|||
126541777|NCT02287584|455277038|FG000|the Open-label Phase|Adverse Event|0|||
126541778|NCT02287584|455277039|FG001|the Open-label Phase|Adverse Event|0|||
126541779|NCT02287584|455277040|FG002|the Open-label Phase|Adverse Event|0|||
126541780|NCT02287584|455277041|FG003|the Open-label Phase|Adverse Event|15|||
126541781|NCT02287584|455277042|FG004|the Open-label Phase|Adverse Event|12|||
126541782|NCT02287584|455277043|FG005|the Open-label Phase|Adverse Event|16|||
126541783|NCT02287584|455277038|FG000|the Open-label Phase|Lack of Efficacy|0|||
126541784|NCT02287584|455277039|FG001|the Open-label Phase|Lack of Efficacy|0|||
126541785|NCT02287584|455277040|FG002|the Open-label Phase|Lack of Efficacy|0|||
126541786|NCT02287584|455277041|FG003|the Open-label Phase|Lack of Efficacy|8|||
126541787|NCT02287584|455277042|FG004|the Open-label Phase|Lack of Efficacy|3|||
126541788|NCT02287584|455277043|FG005|the Open-label Phase|Lack of Efficacy|7|||
126541789|NCT02287584|455277038|FG000|the Open-label Phase|Lost to Follow-up|0|||
126541790|NCT02287584|455277039|FG001|the Open-label Phase|Lost to Follow-up|0|||
126541791|NCT02287584|455277040|FG002|the Open-label Phase|Lost to Follow-up|0|||
126541792|NCT02287584|455277041|FG003|the Open-label Phase|Lost to Follow-up|4|||
126541793|NCT02287584|455277042|FG004|the Open-label Phase|Lost to Follow-up|1|||
126541794|NCT02287584|455277043|FG005|the Open-label Phase|Lost to Follow-up|2|||
126541795|NCT02287584|455277038|FG000|the Open-label Phase|Withdrawal by Subject|0|||
126541796|NCT02287584|455277039|FG001|the Open-label Phase|Withdrawal by Subject|0|||
126541797|NCT02287584|455277040|FG002|the Open-label Phase|Withdrawal by Subject|0|||
126541798|NCT02287584|455277041|FG003|the Open-label Phase|Withdrawal by Subject|18|||
126541799|NCT02287584|455277042|FG004|the Open-label Phase|Withdrawal by Subject|29|||
126541800|NCT02287584|455277043|FG005|the Open-label Phase|Withdrawal by Subject|21|||
126541801|NCT02287584|455277038|FG000|the Open-label Phase|non-compliance|0|||
126541802|NCT02287584|455277039|FG001|the Open-label Phase|non-compliance|0|||
126541803|NCT02287584|455277040|FG002|the Open-label Phase|non-compliance|0|||
126541804|NCT02287584|455277041|FG003|the Open-label Phase|non-compliance|2|||
126541805|NCT02287584|455277042|FG004|the Open-label Phase|non-compliance|5|||
126541806|NCT02287584|455277043|FG005|the Open-label Phase|non-compliance|1|||
126541807|NCT02287584|455277038|FG000|the Open-label Phase|other reasons|0|||
126541808|NCT02287584|455277039|FG001|the Open-label Phase|other reasons|0|||
126541809|NCT02287584|455277040|FG002|the Open-label Phase|other reasons|0|||
126541810|NCT02287584|455277041|FG003|the Open-label Phase|other reasons|3|||
126541811|NCT02287584|455277042|FG004|the Open-label Phase|other reasons|6|||
126541812|NCT02287584|455277043|FG005|the Open-label Phase|other reasons|6|||
126541813|NCT01492686|455277047|FG000|Double-blind Phase|Adverse Event|0|||
126541814|NCT01492686|455277048|FG001|Double-blind Phase|Adverse Event|2|||
126541815|NCT01492686|455277047|FG000|Double-blind Phase|Physician Decision|0|||
126541816|NCT01492686|455277048|FG001|Double-blind Phase|Physician Decision|1|||
126541817|NCT01492686|455277047|FG000|Double-blind Phase|Withdrawal by Subject|0|||
126541818|NCT01492686|455277048|FG001|Double-blind Phase|Withdrawal by Subject|2|||
126541819|NCT01492686|455277047|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
126541820|NCT01492686|455277048|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
126541821|NCT01492686|455277047|FG000|Open-label Phase|Adverse Event|1|||
126541822|NCT01492686|455277048|FG001|Open-label Phase|Adverse Event|2|||
126541823|NCT01492686|455277047|FG000|Open-label Phase|Physician Decision|1|||
126541824|NCT01492686|455277048|FG001|Open-label Phase|Physician Decision|0|||
126541825|NCT01492686|455277047|FG000|Open-label Phase|Withdrawal by Subject|6|||
126541826|NCT01492686|455277048|FG001|Open-label Phase|Withdrawal by Subject|7|||
126541827|NCT01492686|455277047|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
126541828|NCT01492686|455277048|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
126541829|NCT03430063|455277058|FG000|Overall Study|Adverse Event|0|||
126541830|NCT03430063|455277059|FG001|Overall Study|Adverse Event|1|||
126541831|NCT03430063|455277060|FG002|Overall Study|Adverse Event|0|||
126541832|NCT03430063|455277058|FG000|Overall Study|Death|3|||
126541833|NCT03430063|455277059|FG001|Overall Study|Death|2|||
126541834|NCT03430063|455277060|FG002|Overall Study|Death|3|||
126541835|NCT03430063|455277058|FG000|Overall Study|Lost to Follow-up|0|||
126541836|NCT03430063|455277059|FG001|Overall Study|Lost to Follow-up|1|||
126541837|NCT03430063|455277060|FG002|Overall Study|Lost to Follow-up|0|||
126541838|NCT03430063|455277058|FG000|Overall Study|Withdrawal by Subject|0|||
126541839|NCT03430063|455277059|FG001|Overall Study|Withdrawal by Subject|0|||
126541840|NCT03430063|455277060|FG002|Overall Study|Withdrawal by Subject|1|||
126541841|NCT03430063|455277058|FG000|Overall Study|Withdrawal of consent|3|||
126541842|NCT03430063|455277059|FG001|Overall Study|Withdrawal of consent|1|||
126541843|NCT03430063|455277060|FG002|Overall Study|Withdrawal of consent|2|||
126541844|NCT03430063|455277058|FG000|Overall Study|Progressive disease|1|||
126541845|NCT03430063|455277059|FG001|Overall Study|Progressive disease|2|||
126541846|NCT03430063|455277060|FG002|Overall Study|Progressive disease|1|||
126541847|NCT03430063|455277058|FG000|Overall Study|Other un-specified|1|||
126541848|NCT03430063|455277059|FG001|Overall Study|Other un-specified|1|||
126541849|NCT03430063|455277060|FG002|Overall Study|Other un-specified|0|||
126541850|NCT03430063|455277058|FG000|Overall Study|Randomized, but never treated|0|||
126541851|NCT03430063|455277059|FG001|Overall Study|Randomized, but never treated|0|||
126541852|NCT03430063|455277060|FG002|Overall Study|Randomized, but never treated|1|||
126541853|NCT02798211|455277061|FG000|Period 1|Adverse Event|1|||
126541854|NCT02798211|455277062|FG001|Period 1|Adverse Event|1|||
126541855|NCT02798211|455277063|FG002|Period 1|Adverse Event|0|||
126541856|NCT02798211|455277064|FG003|Period 1|Adverse Event|0|||
126541857|NCT02798211|455277065|FG004|Period 1|Adverse Event|0|||
126541858|NCT02798211|455277066|FG005|Period 1|Adverse Event|0|||
126316747|NCT02772276|454450781|FG003|Overall Study|Lost to Follow-up|0|||
126541859|NCT02798211|455277061|FG000|Period 1|Lost to Follow-up|2|||
126541860|NCT02798211|455277062|FG001|Period 1|Lost to Follow-up|1|||
126541861|NCT02798211|455277063|FG002|Period 1|Lost to Follow-up|0|||
126541862|NCT02798211|455277064|FG003|Period 1|Lost to Follow-up|0|||
126541863|NCT02798211|455277065|FG004|Period 1|Lost to Follow-up|0|||
126541864|NCT02798211|455277066|FG005|Period 1|Lost to Follow-up|0|||
126541865|NCT02798211|455277061|FG000|Period 1|Protocol Violation|0|||
126541866|NCT02798211|455277062|FG001|Period 1|Protocol Violation|0|||
126541867|NCT02798211|455277063|FG002|Period 1|Protocol Violation|2|||
126541868|NCT02798211|455277064|FG003|Period 1|Protocol Violation|0|||
126541869|NCT02798211|455277065|FG004|Period 1|Protocol Violation|0|||
126541870|NCT02798211|455277066|FG005|Period 1|Protocol Violation|0|||
126541871|NCT02798211|455277061|FG000|Period 1|Withdrawal by Subject|1|||
126541872|NCT02798211|455277062|FG001|Period 1|Withdrawal by Subject|1|||
126541873|NCT02798211|455277063|FG002|Period 1|Withdrawal by Subject|0|||
126541874|NCT02798211|455277064|FG003|Period 1|Withdrawal by Subject|0|||
126541875|NCT02798211|455277065|FG004|Period 1|Withdrawal by Subject|0|||
126541876|NCT02798211|455277066|FG005|Period 1|Withdrawal by Subject|0|||
126541877|NCT02798211|455277061|FG000|Period 1|Death|0|||
126541878|NCT02798211|455277062|FG001|Period 1|Death|0|||
126541879|NCT02798211|455277063|FG002|Period 1|Death|1|||
126541880|NCT02798211|455277064|FG003|Period 1|Death|0|||
126541881|NCT02798211|455277065|FG004|Period 1|Death|0|||
126541882|NCT02798211|455277066|FG005|Period 1|Death|0|||
126541883|NCT02798211|455277061|FG000|Period 1|Withdrawal of Informed Consent|2|||
126541884|NCT02798211|455277062|FG001|Period 1|Withdrawal of Informed Consent|7|||
126541885|NCT02798211|455277063|FG002|Period 1|Withdrawal of Informed Consent|3|||
126541886|NCT02798211|455277064|FG003|Period 1|Withdrawal of Informed Consent|0|||
126541887|NCT02798211|455277065|FG004|Period 1|Withdrawal of Informed Consent|0|||
126541888|NCT02798211|455277066|FG005|Period 1|Withdrawal of Informed Consent|0|||
126541889|NCT02798211|455277061|FG000|Period 2|Withdrawal by Subject|2|||
126541890|NCT02798211|455277062|FG001|Period 2|Withdrawal by Subject|0|||
126541891|NCT02798211|455277063|FG002|Period 2|Withdrawal by Subject|0|||
126541892|NCT02798211|455277064|FG003|Period 2|Withdrawal by Subject|0|||
126541893|NCT02798211|455277065|FG004|Period 2|Withdrawal by Subject|2|||
126541894|NCT02798211|455277066|FG005|Period 2|Withdrawal by Subject|2|||
126541895|NCT02798211|455277061|FG000|Period 2|Adverse Event|5|||
126541896|NCT02798211|455277062|FG001|Period 2|Adverse Event|0|||
126541897|NCT02798211|455277063|FG002|Period 2|Adverse Event|0|||
126541898|NCT02798211|455277064|FG003|Period 2|Adverse Event|0|||
126541899|NCT02798211|455277065|FG004|Period 2|Adverse Event|1|||
126541900|NCT02798211|455277066|FG005|Period 2|Adverse Event|0|||
126541901|NCT02798211|455277061|FG000|Period 2|Lack of Efficacy|1|||
126541902|NCT02798211|455277062|FG001|Period 2|Lack of Efficacy|0|||
126541903|NCT02798211|455277063|FG002|Period 2|Lack of Efficacy|0|||
126541904|NCT02798211|455277064|FG003|Period 2|Lack of Efficacy|1|||
126541905|NCT02798211|455277065|FG004|Period 2|Lack of Efficacy|0|||
126541906|NCT02798211|455277066|FG005|Period 2|Lack of Efficacy|1|||
126541907|NCT02798211|455277061|FG000|Period 2|Lost to Follow-up|3|||
126541908|NCT02798211|455277062|FG001|Period 2|Lost to Follow-up|0|||
126541909|NCT02798211|455277063|FG002|Period 2|Lost to Follow-up|0|||
126541910|NCT02798211|455277064|FG003|Period 2|Lost to Follow-up|0|||
126541911|NCT02798211|455277065|FG004|Period 2|Lost to Follow-up|2|||
126541912|NCT02798211|455277066|FG005|Period 2|Lost to Follow-up|0|||
126541913|NCT02798211|455277061|FG000|Period 2|Physician Decision|1|||
126541914|NCT02798211|455277062|FG001|Period 2|Physician Decision|0|||
126541915|NCT02798211|455277063|FG002|Period 2|Physician Decision|0|||
126541916|NCT02798211|455277064|FG003|Period 2|Physician Decision|1|||
126541917|NCT02798211|455277065|FG004|Period 2|Physician Decision|1|||
126541918|NCT02798211|455277066|FG005|Period 2|Physician Decision|0|||
126541919|NCT02798211|455277061|FG000|Period 2|Pregnancy|0|||
126541920|NCT02798211|455277062|FG001|Period 2|Pregnancy|0|||
126541921|NCT02798211|455277063|FG002|Period 2|Pregnancy|0|||
126541922|NCT02798211|455277064|FG003|Period 2|Pregnancy|2|||
126541923|NCT02798211|455277065|FG004|Period 2|Pregnancy|0|||
126541924|NCT02798211|455277066|FG005|Period 2|Pregnancy|0|||
126541925|NCT02798211|455277061|FG000|Period 2|Technical problems|1|||
126541926|NCT02798211|455277062|FG001|Period 2|Technical problems|0|||
126541927|NCT02798211|455277063|FG002|Period 2|Technical problems|0|||
126541928|NCT02798211|455277064|FG003|Period 2|Technical problems|1|||
126541929|NCT02798211|455277065|FG004|Period 2|Technical problems|0|||
126541930|NCT02798211|455277066|FG005|Period 2|Technical problems|0|||
126541931|NCT02798211|455277061|FG000|Period 2|Withdrawal of Informed Consent|1|||
126541932|NCT02798211|455277062|FG001|Period 2|Withdrawal of Informed Consent|0|||
126541933|NCT02798211|455277063|FG002|Period 2|Withdrawal of Informed Consent|0|||
126541934|NCT02798211|455277064|FG003|Period 2|Withdrawal of Informed Consent|2|||
126541935|NCT02798211|455277065|FG004|Period 2|Withdrawal of Informed Consent|2|||
126541936|NCT02798211|455277066|FG005|Period 2|Withdrawal of Informed Consent|3|||
126541937|NCT01982435|455277067|FG000|Overall Study|Adverse Event|1|||
126541938|NCT01982435|455277068|FG001|Overall Study|Adverse Event|0|||
126541939|NCT05292534|455277069|FG000|Overall Study|Protocol Violation|3|||
126541940|NCT05292534|455277070|FG001|Overall Study|Protocol Violation|4|||
126541941|NCT05292534|455277069|FG000|Overall Study|Withdrawal by Subject|0|||
126541942|NCT05292534|455277070|FG001|Overall Study|Withdrawal by Subject|1|||
126541943|NCT04887948|455277071|FG000|Overall Study|Death|1|||
126541944|NCT04887948|455277072|FG001|Overall Study|Death|0|||
126541945|NCT04887948|455277073|FG002|Overall Study|Death|0|||
126541946|NCT04887948|455277071|FG000|Overall Study|Lost to Follow-up|1|||
126541947|NCT04887948|455277072|FG001|Overall Study|Lost to Follow-up|0|||
126541948|NCT04887948|455277073|FG002|Overall Study|Lost to Follow-up|3|||
126541949|NCT04887948|455277071|FG000|Overall Study|Physician Decision|0|||
126541950|NCT04887948|455277072|FG001|Overall Study|Physician Decision|4|||
126541951|NCT04887948|455277073|FG002|Overall Study|Physician Decision|1|||
126541952|NCT04887948|455277071|FG000|Overall Study|Protocol Violation|1|||
126541953|NCT04887948|455277072|FG001|Overall Study|Protocol Violation|1|||
126541954|NCT04887948|455277073|FG002|Overall Study|Protocol Violation|0|||
126541955|NCT04887948|455277071|FG000|Overall Study|Withdrawal by Subject|0|||
126541956|NCT04887948|455277072|FG001|Overall Study|Withdrawal by Subject|6|||
126541957|NCT04887948|455277073|FG002|Overall Study|Withdrawal by Subject|1|||
126541958|NCT04887948|455277071|FG000|Overall Study|No longer met eligibility criteria|1|||
126541959|NCT04887948|455277072|FG001|Overall Study|No longer met eligibility criteria|2|||
126541960|NCT04887948|455277073|FG002|Overall Study|No longer met eligibility criteria|1|||
126541961|NCT04887948|455277071|FG000|Overall Study|Other|2|||
126541962|NCT04887948|455277072|FG001|Overall Study|Other|1|||
126541963|NCT04887948|455277073|FG002|Overall Study|Other|1|||
126541964|NCT01782872|455277078|FG000|Overall Study|Protocol Violation|0|||
126541965|NCT01782872|455277079|FG001|Overall Study|Protocol Violation|0|||
126541966|NCT01782872|455277080|FG002|Overall Study|Protocol Violation|0|||
126541967|NCT01782872|455277081|FG003|Overall Study|Protocol Violation|1|||
126541968|NCT01782872|455277078|FG000|Overall Study|Withdrawal by Subject|0|||
126541969|NCT01782872|455277079|FG001|Overall Study|Withdrawal by Subject|1|||
126541970|NCT01782872|455277080|FG002|Overall Study|Withdrawal by Subject|0|||
126541971|NCT01782872|455277081|FG003|Overall Study|Withdrawal by Subject|0|||
126541972|NCT01892345|455277082|FG000|Overall Study|Adverse Event|0|||
126541973|NCT01892345|455277083|FG001|Overall Study|Adverse Event|2|||
126541974|NCT01892345|455277082|FG000|Overall Study|Death|1|||
126541975|NCT01892345|455277083|FG001|Overall Study|Death|0|||
126541976|NCT01892345|455277082|FG000|Overall Study|Lost to Follow-up|3|||
126541977|NCT01892345|455277083|FG001|Overall Study|Lost to Follow-up|0|||
126541978|NCT01892345|455277082|FG000|Overall Study|Withdrawal by Subject|12|||
126541979|NCT01892345|455277083|FG001|Overall Study|Withdrawal by Subject|1|||
126541980|NCT00638235|455277084|FG000|Overall Study|Lost to Follow-up|31|||
126541981|NCT00638235|455277085|FG001|Overall Study|Lost to Follow-up|3|||
126541982|NCT00638235|455277086|FG002|Overall Study|Lost to Follow-up|18|||
126541983|NCT00638235|455277087|FG003|Overall Study|Lost to Follow-up|10|||
126541984|NCT00638235|455277088|FG004|Overall Study|Lost to Follow-up|13|||
126541985|NCT00638235|455277089|FG005|Overall Study|Lost to Follow-up|26|||
126541986|NCT00638235|455277090|FG006|Overall Study|Lost to Follow-up|0|||
126541987|NCT00638235|455277091|FG007|Overall Study|Lost to Follow-up|1|||
126541988|NCT00638235|455277092|FG008|Overall Study|Lost to Follow-up|18|||
126541989|NCT01473381|455277093|FG000|Overall Study|Adverse Event|8|||
126541990|NCT01473381|455277094|FG001|Overall Study|Adverse Event|20|||
126541991|NCT01473381|455277095|FG002|Overall Study|Adverse Event|25|||
126541992|NCT01473381|455277096|FG003|Overall Study|Adverse Event|17|||
126541993|NCT01473381|455277093|FG000|Overall Study|Insufficient Therapeutic Response|10|||
126541994|NCT01473381|455277094|FG001|Overall Study|Insufficient Therapeutic Response|1|||
126541995|NCT01473381|455277095|FG002|Overall Study|Insufficient Therapeutic Response|2|||
126541996|NCT01473381|455277096|FG003|Overall Study|Insufficient Therapeutic Response|3|||
126541997|NCT01473381|455277093|FG000|Overall Study|Protocol Violation|17|||
126541998|NCT01473381|455277094|FG001|Overall Study|Protocol Violation|23|||
126541999|NCT01473381|455277095|FG002|Overall Study|Protocol Violation|19|||
126542000|NCT01473381|455277096|FG003|Overall Study|Protocol Violation|17|||
126542001|NCT01473381|455277093|FG000|Overall Study|Withdrawal of Consent|20|||
126542002|NCT01473381|455277094|FG001|Overall Study|Withdrawal of Consent|21|||
126542003|NCT01473381|455277095|FG002|Overall Study|Withdrawal of Consent|20|||
126542004|NCT01473381|455277096|FG003|Overall Study|Withdrawal of Consent|26|||
126542005|NCT01473381|455277093|FG000|Overall Study|Lost to Follow-up|25|||
126542006|NCT01473381|455277094|FG001|Overall Study|Lost to Follow-up|28|||
126316748|NCT02772276|454450782|FG004|Overall Study|Lost to Follow-up|0|||
126316749|NCT02772276|454450783|FG005|Overall Study|Lost to Follow-up|0|||
126542007|NCT01473381|455277095|FG002|Overall Study|Lost to Follow-up|35|||
126542008|NCT01473381|455277096|FG003|Overall Study|Lost to Follow-up|23|||
126542009|NCT01473381|455277093|FG000|Overall Study|Other Reasons|0|||
126542010|NCT01473381|455277094|FG001|Overall Study|Other Reasons|0|||
126542011|NCT01473381|455277095|FG002|Overall Study|Other Reasons|1|||
126542012|NCT01473381|455277096|FG003|Overall Study|Other Reasons|3|||
126542013|NCT04026165|455277102|FG000|Run-in Placebo Period|Enrollment Error|13|||
126542014|NCT04026165|455277103|FG001|Run-in Placebo Period|Enrollment Error|0|||
126542015|NCT04026165|455277104|FG002|Run-in Placebo Period|Enrollment Error|0|||
126542016|NCT04026165|455277105|FG003|Run-in Placebo Period|Enrollment Error|0|||
126542017|NCT04026165|455277102|FG000|Run-in Placebo Period|Run-in Failure|4|||
126542018|NCT04026165|455277103|FG001|Run-in Placebo Period|Run-in Failure|0|||
126542019|NCT04026165|455277104|FG002|Run-in Placebo Period|Run-in Failure|0|||
126542020|NCT04026165|455277105|FG003|Run-in Placebo Period|Run-in Failure|0|||
126542021|NCT04026165|455277102|FG000|Run-in Placebo Period|Protocol Violation|2|||
126542022|NCT04026165|455277103|FG001|Run-in Placebo Period|Protocol Violation|0|||
126542023|NCT04026165|455277104|FG002|Run-in Placebo Period|Protocol Violation|0|||
126542024|NCT04026165|455277105|FG003|Run-in Placebo Period|Protocol Violation|0|||
126542025|NCT04026165|455277102|FG000|Run-in Placebo Period|Withdrew Consent|2|||
126542026|NCT04026165|455277103|FG001|Run-in Placebo Period|Withdrew Consent|0|||
126542027|NCT04026165|455277104|FG002|Run-in Placebo Period|Withdrew Consent|0|||
126542028|NCT04026165|455277105|FG003|Run-in Placebo Period|Withdrew Consent|0|||
126542029|NCT04026165|455277102|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
126542030|NCT04026165|455277103|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
126542031|NCT04026165|455277104|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
126542032|NCT04026165|455277105|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
126542033|NCT04026165|455277102|FG000|Run-in SEL Period|Run-in Failure|0|||
126542034|NCT04026165|455277103|FG001|Run-in SEL Period|Run-in Failure|26|||
126542035|NCT04026165|455277104|FG002|Run-in SEL Period|Run-in Failure|0|||
126542036|NCT04026165|455277105|FG003|Run-in SEL Period|Run-in Failure|0|||
126542037|NCT04026165|455277102|FG000|Run-in SEL Period|Withdrew Consent|0|||
126542038|NCT04026165|455277103|FG001|Run-in SEL Period|Withdrew Consent|10|||
126542039|NCT04026165|455277104|FG002|Run-in SEL Period|Withdrew Consent|0|||
126542040|NCT04026165|455277105|FG003|Run-in SEL Period|Withdrew Consent|0|||
126542041|NCT04026165|455277102|FG000|Run-in SEL Period|Enrollment Error|0|||
126542042|NCT04026165|455277103|FG001|Run-in SEL Period|Enrollment Error|4|||
126542043|NCT04026165|455277104|FG002|Run-in SEL Period|Enrollment Error|0|||
126542044|NCT04026165|455277105|FG003|Run-in SEL Period|Enrollment Error|0|||
126542045|NCT04026165|455277102|FG000|Run-in SEL Period|Protocol Violation|0|||
126542046|NCT04026165|455277103|FG001|Run-in SEL Period|Protocol Violation|3|||
126542047|NCT04026165|455277104|FG002|Run-in SEL Period|Protocol Violation|0|||
126542048|NCT04026165|455277105|FG003|Run-in SEL Period|Protocol Violation|0|||
126542049|NCT04026165|455277102|FG000|Run-in SEL Period|Investigator's Discretion|0|||
126542050|NCT04026165|455277103|FG001|Run-in SEL Period|Investigator's Discretion|2|||
126542051|NCT04026165|455277104|FG002|Run-in SEL Period|Investigator's Discretion|0|||
126542052|NCT04026165|455277105|FG003|Run-in SEL Period|Investigator's Discretion|0|||
126542053|NCT04026165|455277102|FG000|Run-in SEL Period|Death|0|||
126542054|NCT04026165|455277103|FG001|Run-in SEL Period|Death|1|||
126542055|NCT04026165|455277104|FG002|Run-in SEL Period|Death|0|||
126542056|NCT04026165|455277105|FG003|Run-in SEL Period|Death|0|||
126542057|NCT04026165|455277102|FG000|Randomized Period|Withdrew Consent|0|||
126542058|NCT04026165|455277103|FG001|Randomized Period|Withdrew Consent|0|||
126542059|NCT04026165|455277104|FG002|Randomized Period|Withdrew Consent|5|||
126542060|NCT04026165|455277105|FG003|Randomized Period|Withdrew Consent|8|||
126542061|NCT04026165|455277102|FG000|Randomized Period|Death|0|||
126542062|NCT04026165|455277103|FG001|Randomized Period|Death|0|||
126542063|NCT04026165|455277104|FG002|Randomized Period|Death|5|||
126542064|NCT04026165|455277105|FG003|Randomized Period|Death|7|||
126542065|NCT04026165|455277102|FG000|Randomized Period|Investigator's Discretion|0|||
126542066|NCT04026165|455277103|FG001|Randomized Period|Investigator's Discretion|0|||
126542067|NCT04026165|455277104|FG002|Randomized Period|Investigator's Discretion|2|||
126542068|NCT04026165|455277105|FG003|Randomized Period|Investigator's Discretion|2|||
126542069|NCT04026165|455277102|FG000|Randomized Period|Lost to Follow-up|0|||
126542070|NCT04026165|455277103|FG001|Randomized Period|Lost to Follow-up|0|||
126542071|NCT04026165|455277104|FG002|Randomized Period|Lost to Follow-up|2|||
126542072|NCT04026165|455277105|FG003|Randomized Period|Lost to Follow-up|2|||
126542073|NCT02487810|455277106|FG000|Overall Study|Withdrawal by Subject|1|||
126542074|NCT02487810|455277107|FG001|Overall Study|Withdrawal by Subject|0|||
126542075|NCT01889186|455277108|FG000|Overall Study|Adverse event- not related to progression|18|||
126542076|NCT01889186|455277109|FG001|Overall Study|Adverse event- not related to progression|5|||
126542077|NCT01889186|455277108|FG000|Overall Study|Adverse event- related to progression|7|||
126542078|NCT01889186|455277109|FG001|Overall Study|Adverse event- related to progression|2|||
126542079|NCT01889186|455277108|FG000|Overall Study|COVID-19 logistical restrictions|1|||
126542080|NCT01889186|455277109|FG001|Overall Study|COVID-19 logistical restrictions|0|||
126542081|NCT01889186|455277108|FG000|Overall Study|Investigator request|1|||
126542082|NCT01889186|455277109|FG001|Overall Study|Investigator request|1|||
126542083|NCT01889186|455277108|FG000|Overall Study|Progressive disease- Richter's|12|||
126542084|NCT01889186|455277109|FG001|Overall Study|Progressive disease- Richter's|7|||
126542085|NCT01889186|455277108|FG000|Overall Study|Progressive disease per protocol|46|||
126542086|NCT01889186|455277109|FG001|Overall Study|Progressive disease per protocol|17|||
126542087|NCT01889186|455277108|FG000|Overall Study|Stem cell transplant|2|||
126542088|NCT01889186|455277109|FG001|Overall Study|Stem cell transplant|1|||
126542089|NCT01889186|455277108|FG000|Overall Study|Withdrew consent|2|||
126542090|NCT01889186|455277109|FG001|Overall Study|Withdrew consent|3|||
126542091|NCT01889186|455277108|FG000|Overall Study|Other, not specified|18|||
126542092|NCT01889186|455277109|FG001|Overall Study|Other, not specified|15|||
126542093|NCT02569437|455277114|FG000|Overall Study|Lost to Follow-up|12|||
126542094|NCT02569437|455277115|FG001|Overall Study|Lost to Follow-up|14|||
126542095|NCT00441701|455277116|FG000|Overall Study|Adverse Event|3|||
126542096|NCT00441701|455277117|FG001|Overall Study|Adverse Event|2|||
126542097|NCT00441701|455277118|FG002|Overall Study|Adverse Event|1|||
126542098|NCT00441701|455277119|FG003|Overall Study|Adverse Event|0|||
126542099|NCT00441701|455277120|FG004|Overall Study|Adverse Event|2|||
126542100|NCT00441701|455277121|FG005|Overall Study|Adverse Event|2|||
126542101|NCT00441701|455277122|FG006|Overall Study|Adverse Event|0|||
126542102|NCT00441701|455277123|FG007|Overall Study|Adverse Event|0|||
126542103|NCT00441701|455277124|FG008|Overall Study|Adverse Event|0|||
126542104|NCT00441701|455277125|FG009|Overall Study|Adverse Event|0|||
126542105|NCT00441701|455277116|FG000|Overall Study|Lack of Efficacy|2|||
126542106|NCT00441701|455277117|FG001|Overall Study|Lack of Efficacy|0|||
126542107|NCT00441701|455277118|FG002|Overall Study|Lack of Efficacy|2|||
126542108|NCT00441701|455277119|FG003|Overall Study|Lack of Efficacy|2|||
126542109|NCT00441701|455277120|FG004|Overall Study|Lack of Efficacy|0|||
126542110|NCT00441701|455277121|FG005|Overall Study|Lack of Efficacy|1|||
126542111|NCT00441701|455277122|FG006|Overall Study|Lack of Efficacy|0|||
126542112|NCT00441701|455277123|FG007|Overall Study|Lack of Efficacy|0|||
126542113|NCT00441701|455277124|FG008|Overall Study|Lack of Efficacy|0|||
126542114|NCT00441701|455277125|FG009|Overall Study|Lack of Efficacy|0|||
126542115|NCT00441701|455277116|FG000|Overall Study|Withdrawal by Subject|0|||
126542116|NCT00441701|455277117|FG001|Overall Study|Withdrawal by Subject|2|||
126542117|NCT00441701|455277118|FG002|Overall Study|Withdrawal by Subject|1|||
126542118|NCT00441701|455277119|FG003|Overall Study|Withdrawal by Subject|1|||
126542119|NCT00441701|455277120|FG004|Overall Study|Withdrawal by Subject|0|||
126542120|NCT00441701|455277121|FG005|Overall Study|Withdrawal by Subject|0|||
126542121|NCT00441701|455277122|FG006|Overall Study|Withdrawal by Subject|0|||
126542122|NCT00441701|455277123|FG007|Overall Study|Withdrawal by Subject|0|||
126542123|NCT00441701|455277124|FG008|Overall Study|Withdrawal by Subject|0|||
126542124|NCT00441701|455277125|FG009|Overall Study|Withdrawal by Subject|0|||
126542125|NCT04710927|455277129|FG000|Overall Study|Lost to Follow-up|7|||
126542126|NCT04710927|455277130|FG001|Overall Study|Lost to Follow-up|6|||
126542127|NCT04710927|455277131|FG002|Overall Study|Lost to Follow-up|5|||
126542128|NCT02007434|455277133|FG000|Overall Study|Lost to Follow-up|0|||
126542129|NCT02007434|455277134|FG001|Overall Study|Lost to Follow-up|1|||
126542130|NCT02007434|455277135|FG002|Overall Study|Lost to Follow-up|0|||
126542131|NCT02007434|455277136|FG003|Overall Study|Lost to Follow-up|0|||
126542132|NCT02007434|455277137|FG004|Overall Study|Lost to Follow-up|0|||
126542133|NCT02007434|455277138|FG005|Overall Study|Lost to Follow-up|0|||
126542134|NCT02007434|455277139|FG006|Overall Study|Lost to Follow-up|0|||
126542135|NCT02007434|455277140|FG007|Overall Study|Lost to Follow-up|0|||
126542136|NCT02007434|455277133|FG000|Overall Study|Non-compliance|1|||
126542137|NCT02007434|455277134|FG001|Overall Study|Non-compliance|0|||
126542138|NCT02007434|455277135|FG002|Overall Study|Non-compliance|1|||
126542139|NCT02007434|455277136|FG003|Overall Study|Non-compliance|0|||
126542140|NCT02007434|455277137|FG004|Overall Study|Non-compliance|0|||
126542141|NCT02007434|455277138|FG005|Overall Study|Non-compliance|0|||
126542142|NCT02007434|455277139|FG006|Overall Study|Non-compliance|0|||
126542143|NCT02007434|455277140|FG007|Overall Study|Non-compliance|0|||
126542144|NCT01287611|455277141|FG000|Overall Study|Lost to Follow-up|29|||
126542145|NCT01287611|455277142|FG001|Overall Study|Lost to Follow-up|16|||
126542146|NCT01287611|455277141|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
126542147|NCT01287611|455277142|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
126542148|NCT03745222|455277155|FG000|Overall Study|Withdrawal by Subject|0|||
126542149|NCT03745222|455277156|FG001|Overall Study|Withdrawal by Subject|1|||
126542150|NCT03745222|455277157|FG002|Overall Study|Withdrawal by Subject|0|||
126542151|NCT00860067|455277158|FG000|Overall Study|Lost to Follow-up|46|||
126542152|NCT00860067|455277159|FG001|Overall Study|Lost to Follow-up|9|||
126542153|NCT00860067|455277160|FG002|Overall Study|Lost to Follow-up|9|||
126542154|NCT00860067|455277158|FG000|Overall Study|Withdrawal by Subject|4|||
126542155|NCT00860067|455277159|FG001|Overall Study|Withdrawal by Subject|0|||
126542156|NCT00860067|455277160|FG002|Overall Study|Withdrawal by Subject|0|||
126542157|NCT00860067|455277158|FG000|Overall Study|Pregnancy|1|||
126542158|NCT00860067|455277159|FG001|Overall Study|Pregnancy|0|||
126542159|NCT00860067|455277160|FG002|Overall Study|Pregnancy|0|||
126542160|NCT01282801|455277161|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
126542161|NCT01282801|455277162|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
126542162|NCT01060553|455277165|FG000|Overall Study|Lost to Follow-up|3|||
126542163|NCT01060553|455277166|FG001|Overall Study|Lost to Follow-up|5|||
126542164|NCT01060553|455277165|FG000|Overall Study|Withdrawal by Subject|5|||
126542165|NCT01060553|455277166|FG001|Overall Study|Withdrawal by Subject|5|||
126542166|NCT01060553|455277165|FG000|Overall Study|Lack of Efficacy|1|||
126542167|NCT01060553|455277166|FG001|Overall Study|Lack of Efficacy|0|||
126542168|NCT04707196|455277168|FG000|Overall Study|Withdrawal by Subject|9|||
126542169|NCT04707196|455277169|FG001|Overall Study|Withdrawal by Subject|6|||
126542170|NCT04707196|455277168|FG000|Overall Study|Lost to Follow-up|1|||
126542171|NCT04707196|455277169|FG001|Overall Study|Lost to Follow-up|0|||
126542172|NCT04707196|455277168|FG000|Overall Study|Protocol Violation|4|||
126542173|NCT04707196|455277169|FG001|Overall Study|Protocol Violation|1|||
126542174|NCT04707196|455277168|FG000|Overall Study|Adverse Event|2|||
126542175|NCT04707196|455277169|FG001|Overall Study|Adverse Event|2|||
126542176|NCT04707196|455277168|FG000|Overall Study|Death|3|||
126542177|NCT04707196|455277169|FG001|Overall Study|Death|1|||
126542178|NCT04707196|455277168|FG000|Overall Study|Non-compliance with study drug|1|||
126542179|NCT04707196|455277169|FG001|Overall Study|Non-compliance with study drug|0|||
126542180|NCT04707196|455277168|FG000|Overall Study|Progressive disease|9|||
126542181|NCT04707196|455277169|FG001|Overall Study|Progressive disease|10|||
126542182|NCT01862796|455277170|FG000|Overall Study|Prohibited medications|0|||
126542183|NCT01862796|455277171|FG001|Overall Study|Prohibited medications|0|||
126542184|NCT01862796|455277172|FG002|Overall Study|Prohibited medications|1|||
126542185|NCT01862991|455279529|FG000|Overall Study|Lost to Follow-up|2|||
126542186|NCT01862991|455279530|FG001|Overall Study|Lost to Follow-up|1|||
126542187|NCT01862991|455279531|FG002|Overall Study|Lost to Follow-up|1|||
126542188|NCT01862991|455279529|FG000|Overall Study|Protocol Violation|1|||
126542189|NCT01862991|455279530|FG001|Overall Study|Protocol Violation|0|||
126542190|NCT01862991|455279531|FG002|Overall Study|Protocol Violation|0|||
126542191|NCT02228395|455279534|FG000|First Intervention Period|No longer willing to participate|1|||
126542192|NCT02228395|455279535|FG001|First Intervention Period|No longer willing to participate|0|||
126542193|NCT02228395|455279536|FG002|First Intervention Period|No longer willing to participate|0|||
126542194|NCT02228395|455279534|FG000|First Intervention Period|Unable to comply with study dates|0|||
126542195|NCT02228395|455279535|FG001|First Intervention Period|Unable to comply with study dates|1|||
126542196|NCT02228395|455279536|FG002|First Intervention Period|Unable to comply with study dates|1|||
126542197|NCT00985985|455279537|FG000|Overall Study|Adverse Event|4|||
126542198|NCT00985985|455279538|FG001|Overall Study|Adverse Event|2|||
126542199|NCT00985985|455279539|FG002|Overall Study|Adverse Event|2|||
126542200|NCT00985985|455279540|FG003|Overall Study|Adverse Event|2|||
126542201|NCT00985985|455279537|FG000|Overall Study|Lost to Follow-up|4|||
126542202|NCT00985985|455279538|FG001|Overall Study|Lost to Follow-up|11|||
126316750|NCT02772276|454450784|FG006|Overall Study|Lost to Follow-up|1|||
126316751|NCT02772276|454450785|FG007|Overall Study|Lost to Follow-up|0|||
126316752|NCT02772276|454450786|FG008|Overall Study|Lost to Follow-up|0|||
126316753|NCT02772276|454450787|FG009|Overall Study|Lost to Follow-up|0|||
126316754|NCT02772276|454450788|FG010|Overall Study|Lost to Follow-up|0|||
126316755|NCT02772276|454450789|FG011|Overall Study|Lost to Follow-up|0|||
126542203|NCT00985985|455279539|FG002|Overall Study|Lost to Follow-up|2|||
126542204|NCT00985985|455279540|FG003|Overall Study|Lost to Follow-up|3|||
126542205|NCT00985985|455279537|FG000|Overall Study|Protocol Violation|1|||
126542206|NCT00985985|455279538|FG001|Overall Study|Protocol Violation|2|||
126542207|NCT00985985|455279539|FG002|Overall Study|Protocol Violation|0|||
126542208|NCT00985985|455279540|FG003|Overall Study|Protocol Violation|1|||
126542209|NCT00985985|455279537|FG000|Overall Study|Lack of Efficacy|5|||
126542210|NCT00985985|455279538|FG001|Overall Study|Lack of Efficacy|6|||
126542211|NCT00985985|455279539|FG002|Overall Study|Lack of Efficacy|1|||
126542212|NCT00985985|455279540|FG003|Overall Study|Lack of Efficacy|3|||
126542213|NCT00985985|455279537|FG000|Overall Study|Withdrawal by Subject|4|||
126542214|NCT00985985|455279538|FG001|Overall Study|Withdrawal by Subject|2|||
126542215|NCT00985985|455279539|FG002|Overall Study|Withdrawal by Subject|2|||
126542216|NCT00985985|455279540|FG003|Overall Study|Withdrawal by Subject|2|||
126542217|NCT00985985|455279537|FG000|Overall Study|Other Reason|6|||
126542218|NCT00985985|455279538|FG001|Overall Study|Other Reason|1|||
126542219|NCT00985985|455279539|FG002|Overall Study|Other Reason|4|||
126542220|NCT00985985|455279540|FG003|Overall Study|Other Reason|2|||
126542221|NCT02255357|455279541|FG000|Overall Study|Physician Decision|10|||
126542222|NCT02255357|455279542|FG001|Overall Study|Physician Decision|24|||
126542223|NCT00509236|455279543|FG000|Overall Study|Adverse Event|7|||
126542224|NCT00509236|455279544|FG001|Overall Study|Adverse Event|9|||
126542225|NCT00509236|455279543|FG000|Overall Study|Withdrawal by Subject|5|||
126542226|NCT00509236|455279544|FG001|Overall Study|Withdrawal by Subject|10|||
126542227|NCT00509236|455279543|FG000|Overall Study|Protocol Violation|3|||
126542228|NCT00509236|455279544|FG001|Overall Study|Protocol Violation|0|||
126542229|NCT00509236|455279543|FG000|Overall Study|Excluded Medication|1|||
126542230|NCT00509236|455279544|FG001|Overall Study|Excluded Medication|1|||
126542231|NCT00509236|455279543|FG000|Overall Study|Scheduled Kidney Transplant|1|||
126542232|NCT00509236|455279544|FG001|Overall Study|Scheduled Kidney Transplant|0|||
126542233|NCT00792103|455279545|FG000|Overall Study|Enrolled, not treated|15|||
126542234|NCT00792103|455279545|FG000|Overall Study|Lost to Follow-up|17|||
126542235|NCT00792103|455279545|FG000|Overall Study|Adverse Event|25|||
126542236|NCT00792103|455279545|FG000|Overall Study|Withdrawal by Subject|52|||
126542237|NCT00792103|455279545|FG000|Overall Study|Protocol Violation|10|||
126542238|NCT00792103|455279545|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
126316756|NCT02772276|454450790|FG012|Overall Study|Lost to Follow-up|0|||
126316757|NCT02772276|454450778|FG000|Overall Study|Withdrew consent|0|||
126316758|NCT02772276|454450779|FG001|Overall Study|Withdrew consent|0|||
126316759|NCT02772276|454450780|FG002|Overall Study|Withdrew consent|0|||
126316760|NCT02772276|454450781|FG003|Overall Study|Withdrew consent|0|||
126542239|NCT01572389|455279547|FG000|Overall Study|Death|1|||
126542240|NCT01572389|455279548|FG001|Overall Study|Death|3|||
126542241|NCT01572389|455279547|FG000|Overall Study|Withdrawal by Subject|14|||
126316761|NCT02772276|454450782|FG004|Overall Study|Withdrew consent|0|||
126316762|NCT02772276|454450783|FG005|Overall Study|Withdrew consent|0|||
126542242|NCT01572389|455279548|FG001|Overall Study|Withdrawal by Subject|2|||
126542243|NCT01572389|455279547|FG000|Overall Study|Lost to Follow-up|25|||
126542244|NCT01572389|455279548|FG001|Overall Study|Lost to Follow-up|14|||
126542245|NCT01572389|455279547|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
126542246|NCT01572389|455279548|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
126542247|NCT01287520|455279549|FG000|Overall Study|Adverse Event|2|||
126542248|NCT01287520|455279550|FG001|Overall Study|Adverse Event|2|||
126542249|NCT01287520|455279551|FG002|Overall Study|Adverse Event|2|||
126542250|NCT01287520|455279552|FG003|Overall Study|Adverse Event|1|||
126542251|NCT01287520|455279553|FG004|Overall Study|Adverse Event|1|||
126542252|NCT01287520|455279554|FG005|Overall Study|Adverse Event|2|||
126542253|NCT01287520|455279555|FG006|Overall Study|Adverse Event|0|||
126542254|NCT01287520|455279556|FG007|Overall Study|Adverse Event|2|||
126542255|NCT01287520|455279557|FG008|Overall Study|Adverse Event|0|||
126542256|NCT01287520|455279549|FG000|Overall Study|Physician Decision|1|||
126542257|NCT01287520|455279550|FG001|Overall Study|Physician Decision|1|||
126542258|NCT01287520|455279551|FG002|Overall Study|Physician Decision|2|||
126542259|NCT01287520|455279552|FG003|Overall Study|Physician Decision|0|||
126542260|NCT01287520|455279553|FG004|Overall Study|Physician Decision|1|||
126542261|NCT01287520|455279554|FG005|Overall Study|Physician Decision|1|||
126542262|NCT01287520|455279555|FG006|Overall Study|Physician Decision|0|||
126542263|NCT01287520|455279556|FG007|Overall Study|Physician Decision|1|||
126542264|NCT01287520|455279557|FG008|Overall Study|Physician Decision|0|||
126542265|NCT01287520|455279549|FG000|Overall Study|Progressive disease|0|||
126542266|NCT01287520|455279550|FG001|Overall Study|Progressive disease|4|||
126542267|NCT01287520|455279551|FG002|Overall Study|Progressive disease|1|||
126542268|NCT01287520|455279552|FG003|Overall Study|Progressive disease|6|||
126542269|NCT01287520|455279553|FG004|Overall Study|Progressive disease|1|||
126542270|NCT01287520|455279554|FG005|Overall Study|Progressive disease|0|||
126542271|NCT01287520|455279555|FG006|Overall Study|Progressive disease|2|||
126542272|NCT01287520|455279556|FG007|Overall Study|Progressive disease|2|||
126542273|NCT01287520|455279557|FG008|Overall Study|Progressive disease|4|||
126542274|NCT01287520|455279549|FG000|Overall Study|Withdrawal by Subject|0|||
126542275|NCT01287520|455279550|FG001|Overall Study|Withdrawal by Subject|0|||
126542276|NCT01287520|455279551|FG002|Overall Study|Withdrawal by Subject|0|||
126542277|NCT01287520|455279552|FG003|Overall Study|Withdrawal by Subject|0|||
126542278|NCT01287520|455279553|FG004|Overall Study|Withdrawal by Subject|0|||
126542279|NCT01287520|455279554|FG005|Overall Study|Withdrawal by Subject|1|||
126542280|NCT01287520|455279555|FG006|Overall Study|Withdrawal by Subject|0|||
126542281|NCT01287520|455279556|FG007|Overall Study|Withdrawal by Subject|0|||
126542282|NCT01287520|455279557|FG008|Overall Study|Withdrawal by Subject|1|||
126542283|NCT03587142|455279558|FG000|Overall Study|Lost to Follow-up|5|||
126542284|NCT03587142|455279559|FG001|Overall Study|Lost to Follow-up|3|||
126542285|NCT03587142|455279558|FG000|Overall Study|Did not complete the f4 visit|3|||
126542286|NCT03587142|455279559|FG001|Overall Study|Did not complete the f4 visit|7|||
126542287|NCT02768662|455279560|FG000|Overall Study|Adverse Event|1|||
126542288|NCT02768662|455279560|FG000|Overall Study|Lost to Follow-up|4|||
126542289|NCT02768662|455279560|FG000|Overall Study|Withdrawal by Subject|3|||
126542290|NCT02768662|455279560|FG000|Overall Study|Study terminated by Sponsor|78|||
126542291|NCT03673462|455279561|FG000|Overall Study|Adverse Event|11|||
126542292|NCT03673462|455279562|FG001|Overall Study|Adverse Event|1|||
126542293|NCT03673462|455279561|FG000|Overall Study|Protocol Violation|25|||
126542294|NCT03673462|455279562|FG001|Overall Study|Protocol Violation|11|||
126542295|NCT03673462|455279561|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
126542296|NCT03673462|455279562|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
126542297|NCT03673462|455279561|FG000|Overall Study|Lost to Follow-up|102|||
126542298|NCT03673462|455279562|FG001|Overall Study|Lost to Follow-up|19|||
126542299|NCT00708435|455279563|FG000|Overall Study|Death / Serious Adverse Event|10|||
126542300|NCT00708435|455279564|FG001|Overall Study|Death / Serious Adverse Event|5|||
126542301|NCT00708435|455279563|FG000|Overall Study|Lost to Follow-up|9|||
126542302|NCT00708435|455279564|FG001|Overall Study|Lost to Follow-up|4|||
126542303|NCT00708435|455279563|FG000|Overall Study|Withdrawal by Subject|3|||
126542304|NCT00708435|455279564|FG001|Overall Study|Withdrawal by Subject|7|||
126542305|NCT00708435|455279563|FG000|Overall Study|Adverse Event|1|||
126542306|NCT00708435|455279564|FG001|Overall Study|Adverse Event|0|||
126542307|NCT00708435|455279563|FG000|Overall Study|Protocol Violation|0|||
126542308|NCT00708435|455279564|FG001|Overall Study|Protocol Violation|1|||
126542309|NCT00708435|455279563|FG000|Overall Study|Intervention by primary care physician|1|||
126542310|NCT00708435|455279564|FG001|Overall Study|Intervention by primary care physician|0|||
126542311|NCT00708435|455279563|FG000|Overall Study|Refused hospitalization|1|||
126542312|NCT00708435|455279564|FG001|Overall Study|Refused hospitalization|0|||
126542313|NCT05061537|455279567|FG000|Treatment Phase|Progressive disease|0|||
126542314|NCT05061537|455279568|FG001|Treatment Phase|Progressive disease|1|||
126542315|NCT05061537|455279569|FG002|Treatment Phase|Progressive disease|2|||
126542316|NCT05061537|455279570|FG003|Treatment Phase|Progressive disease|0|||
126542317|NCT05061537|455279571|FG004|Treatment Phase|Progressive disease|0|||
126542318|NCT05061537|455279567|FG000|Treatment Phase|Adverse Event|0|||
126542319|NCT05061537|455279568|FG001|Treatment Phase|Adverse Event|0|||
126542320|NCT05061537|455279569|FG002|Treatment Phase|Adverse Event|2|||
126542321|NCT05061537|455279570|FG003|Treatment Phase|Adverse Event|0|||
126542322|NCT05061537|455279571|FG004|Treatment Phase|Adverse Event|0|||
126542323|NCT05061537|455279567|FG000|Treatment Phase|Global deterioration of health status|0|||
126542324|NCT05061537|455279568|FG001|Treatment Phase|Global deterioration of health status|1|||
126542325|NCT05061537|455279569|FG002|Treatment Phase|Global deterioration of health status|0|||
126542326|NCT05061537|455279570|FG003|Treatment Phase|Global deterioration of health status|0|||
126542327|NCT05061537|455279571|FG004|Treatment Phase|Global deterioration of health status|0|||
126542328|NCT05061537|455279567|FG000|Follow up|Other|2|||
126542329|NCT05061537|455279568|FG001|Follow up|Other|0|||
126542330|NCT05061537|455279569|FG002|Follow up|Other|2|||
126542331|NCT05061537|455279570|FG003|Follow up|Other|0|||
126542332|NCT05061537|455279571|FG004|Follow up|Other|0|||
126542333|NCT05061537|455279567|FG000|Follow up|Study terminated by sponsor|0|||
126542334|NCT05061537|455279568|FG001|Follow up|Study terminated by sponsor|0|||
126542335|NCT05061537|455279569|FG002|Follow up|Study terminated by sponsor|2|||
126542336|NCT05061537|455279570|FG003|Follow up|Study terminated by sponsor|0|||
126542337|NCT05061537|455279571|FG004|Follow up|Study terminated by sponsor|0|||
126542338|NCT05061537|455279567|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
126542339|NCT05061537|455279568|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
126542340|NCT05061537|455279569|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
126542341|NCT05061537|455279570|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
126542342|NCT05061537|455279571|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
126542343|NCT05061537|455279567|FG000|Long-term Follow-up|Death|0|||
126542344|NCT05061537|455279568|FG001|Long-term Follow-up|Death|1|||
126542345|NCT05061537|455279569|FG002|Long-term Follow-up|Death|0|||
126542346|NCT05061537|455279570|FG003|Long-term Follow-up|Death|0|||
126542347|NCT05061537|455279571|FG004|Long-term Follow-up|Death|0|||
126542348|NCT03502616|455279572|FG000|Up to Week 16|Withdrawal by Subject|1|||
126542349|NCT03502616|455279573|FG001|Up to Week 16|Withdrawal by Subject|2|||
126542350|NCT03502616|455279572|FG000|Up to Week 16|Lost to Follow-up|0|||
126542351|NCT03502616|455279573|FG001|Up to Week 16|Lost to Follow-up|1|||
126542352|NCT03502616|455279572|FG000|Up to Week 16|Randomized, but not treated|1|||
126542353|NCT03502616|455279573|FG001|Up to Week 16|Randomized, but not treated|0|||
126542354|NCT03502616|455279572|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
126542355|NCT03502616|455279573|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
126542356|NCT03502616|455279572|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
126542357|NCT03502616|455279573|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
126542358|NCT00770432|455279588|FG000|Overall Study|Other|4|||
126542359|NCT00770432|455279589|FG001|Overall Study|Other|6|||
126542360|NCT00770432|455279588|FG000|Overall Study|Non-compliance|0|||
126542361|NCT00770432|455279589|FG001|Overall Study|Non-compliance|1|||
126542362|NCT00988221|455279592|FG000|Part I|Adverse Event|0|||
126542363|NCT00988221|455279593|FG001|Part I|Adverse Event|1|||
126542364|NCT00988221|455279594|FG002|Part I|Adverse Event|2|||
126542365|NCT00988221|455279595|FG003|Part I|Adverse Event|0|||
126542366|NCT00988221|455279592|FG000|Part I|Insufficient Therapeutic Response|4|||
126542367|NCT00988221|455279593|FG001|Part I|Insufficient Therapeutic Response|6|||
126542368|NCT00988221|455279594|FG002|Part I|Insufficient Therapeutic Response|5|||
126542369|NCT00988221|455279595|FG003|Part I|Insufficient Therapeutic Response|0|||
126542370|NCT00988221|455279592|FG000|Part I|Refused Treatment|0|||
126542371|NCT00988221|455279593|FG001|Part I|Refused Treatment|2|||
126542372|NCT00988221|455279594|FG002|Part I|Refused Treatment|1|||
126542373|NCT00988221|455279595|FG003|Part I|Refused Treatment|0|||
126542374|NCT00988221|455279592|FG000|Part I|Lost to Follow-up|0|||
126542375|NCT00988221|455279593|FG001|Part I|Lost to Follow-up|1|||
126542376|NCT00988221|455279594|FG002|Part I|Lost to Follow-up|0|||
126542377|NCT00988221|455279595|FG003|Part I|Lost to Follow-up|0|||
126542378|NCT00988221|455279592|FG000|Part II|Adverse Event|1|||
126542379|NCT00988221|455279593|FG001|Part II|Adverse Event|0|||
126542380|NCT00988221|455279594|FG002|Part II|Adverse Event|0|||
126542381|NCT00988221|455279595|FG003|Part II|Adverse Event|1|||
126542382|NCT00988221|455279592|FG000|Part II|Withdrawal by Subject|0|||
126542383|NCT00988221|455279593|FG001|Part II|Withdrawal by Subject|0|||
126542384|NCT00988221|455279594|FG002|Part II|Withdrawal by Subject|2|||
126542385|NCT00988221|455279595|FG003|Part II|Withdrawal by Subject|2|||
126542386|NCT00988221|455279592|FG000|Part II|Reason not Specified|0|||
126542387|NCT00988221|455279593|FG001|Part II|Reason not Specified|0|||
126542388|NCT00988221|455279594|FG002|Part II|Reason not Specified|1|||
126542389|NCT00988221|455279595|FG003|Part II|Reason not Specified|0|||
126542390|NCT00988221|455279592|FG000|Part III|Adverse Event|1|||
126542391|NCT00988221|455279593|FG001|Part III|Adverse Event|0|||
126542392|NCT00988221|455279594|FG002|Part III|Adverse Event|1|||
126542393|NCT00988221|455279595|FG003|Part III|Adverse Event|0|||
126542394|NCT00988221|455279592|FG000|Part III|Insufficient Therapeutic Response|0|||
126542395|NCT00988221|455279593|FG001|Part III|Insufficient Therapeutic Response|1|||
126542396|NCT00988221|455279594|FG002|Part III|Insufficient Therapeutic Response|1|||
126542397|NCT00988221|455279595|FG003|Part III|Insufficient Therapeutic Response|0|||
126542398|NCT00988221|455279592|FG000|Part III|Refused Treatment|0|||
126542399|NCT00988221|455279593|FG001|Part III|Refused Treatment|0|||
126542400|NCT00988221|455279594|FG002|Part III|Refused Treatment|1|||
126542401|NCT00988221|455279595|FG003|Part III|Refused Treatment|0|||
126542402|NCT02756832|455279598|FG000|Overall Study|Lost for Observation after Baseline|6|||
126542403|NCT02756832|455279598|FG000|Overall Study|Lost for Observation|13|||
126542404|NCT02756832|455279598|FG000|Overall Study|Patient's Unwillingness|12|||
126542405|NCT02756832|455279598|FG000|Overall Study|Insufficient Efficacy|2|||
126542406|NCT02756832|455279598|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
126542407|NCT02756832|455279598|FG000|Overall Study|Reason not Specified|9|||
126542408|NCT02756832|455279598|FG000|Overall Study|Protocol Deviation|10|||
126542409|NCT01364597|455279599|FG000|Overall Study|Adverse Event|4|||
126542410|NCT01364597|455279600|FG001|Overall Study|Adverse Event|5|||
126542411|NCT01364597|455279601|FG002|Overall Study|Adverse Event|16|||
126542412|NCT01364597|455279602|FG003|Overall Study|Adverse Event|7|||
126542413|NCT01364597|455279599|FG000|Overall Study|Lack of Efficacy|4|||
126542414|NCT01364597|455279600|FG001|Overall Study|Lack of Efficacy|4|||
126542415|NCT01364597|455279601|FG002|Overall Study|Lack of Efficacy|23|||
126542416|NCT01364597|455279602|FG003|Overall Study|Lack of Efficacy|8|||
126542417|NCT01364597|455279599|FG000|Overall Study|Protocol Violation|0|||
126542418|NCT01364597|455279600|FG001|Overall Study|Protocol Violation|0|||
126542419|NCT01364597|455279601|FG002|Overall Study|Protocol Violation|2|||
126542420|NCT01364597|455279602|FG003|Overall Study|Protocol Violation|0|||
126542421|NCT01364597|455279599|FG000|Overall Study|Lost to Follow-up|0|||
126542422|NCT01364597|455279600|FG001|Overall Study|Lost to Follow-up|0|||
126542423|NCT01364597|455279601|FG002|Overall Study|Lost to Follow-up|5|||
126542424|NCT01364597|455279602|FG003|Overall Study|Lost to Follow-up|3|||
126542425|NCT01364597|455279599|FG000|Overall Study|Withdrawal by Subject|4|||
126542426|NCT01364597|455279600|FG001|Overall Study|Withdrawal by Subject|1|||
126542427|NCT01364597|455279601|FG002|Overall Study|Withdrawal by Subject|18|||
126542428|NCT01364597|455279602|FG003|Overall Study|Withdrawal by Subject|6|||
126542429|NCT01364597|455279599|FG000|Overall Study|Non compliance|1|||
126542430|NCT01364597|455279600|FG001|Overall Study|Non compliance|0|||
126542431|NCT01364597|455279601|FG002|Overall Study|Non compliance|1|||
126542432|NCT01364597|455279602|FG003|Overall Study|Non compliance|0|||
126542433|NCT01364597|455279599|FG000|Overall Study|Lack of compliance|1|||
126542434|NCT01364597|455279600|FG001|Overall Study|Lack of compliance|0|||
126542435|NCT01364597|455279601|FG002|Overall Study|Lack of compliance|0|||
126542436|NCT01364597|455279602|FG003|Overall Study|Lack of compliance|0|||
126542437|NCT01364597|455279599|FG000|Overall Study|End of treatment epilepsy|1|||
126542438|NCT01364597|455279600|FG001|Overall Study|End of treatment epilepsy|0|||
126542439|NCT01364597|455279601|FG002|Overall Study|End of treatment epilepsy|0|||
126542440|NCT01364597|455279602|FG003|Overall Study|End of treatment epilepsy|0|||
126542441|NCT01364597|455279599|FG000|Overall Study|No Seizures|1|||
126542442|NCT01364597|455279600|FG001|Overall Study|No Seizures|0|||
126542443|NCT01364597|455279601|FG002|Overall Study|No Seizures|0|||
126542444|NCT01364597|455279602|FG003|Overall Study|No Seizures|0|||
126542445|NCT01364597|455279599|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
126542446|NCT01364597|455279600|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
126542447|NCT01364597|455279601|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
126542448|NCT01364597|455279602|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
126542449|NCT01364597|455279599|FG000|Overall Study|Cure|1|||
126542450|NCT01364597|455279600|FG001|Overall Study|Cure|0|||
126542451|NCT01364597|455279601|FG002|Overall Study|Cure|0|||
126542452|NCT01364597|455279602|FG003|Overall Study|Cure|0|||
126542453|NCT01364597|455279599|FG000|Overall Study|Patient was moving|0|||
126542454|NCT01364597|455279600|FG001|Overall Study|Patient was moving|1|||
126542455|NCT01364597|455279601|FG002|Overall Study|Patient was moving|0|||
126542456|NCT01364597|455279602|FG003|Overall Study|Patient was moving|0|||
126542457|NCT01364597|455279599|FG000|Overall Study|Seizures resolved|0|||
126542458|NCT01364597|455279600|FG001|Overall Study|Seizures resolved|0|||
126542459|NCT01364597|455279601|FG002|Overall Study|Seizures resolved|1|||
126542460|NCT01364597|455279602|FG003|Overall Study|Seizures resolved|0|||
126542461|NCT01364597|455279599|FG000|Overall Study|Patient became seizure-free after surgery|0|||
126542462|NCT01364597|455279600|FG001|Overall Study|Patient became seizure-free after surgery|0|||
126542463|NCT01364597|455279601|FG002|Overall Study|Patient became seizure-free after surgery|1|||
126542464|NCT01364597|455279602|FG003|Overall Study|Patient became seizure-free after surgery|0|||
126542465|NCT01364597|455279599|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
126542466|NCT01364597|455279600|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
126542467|NCT01364597|455279601|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
126542468|NCT01364597|455279602|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
126542469|NCT01364597|455279599|FG000|Overall Study|Patient cured from Epilepsy|0|||
126542470|NCT01364597|455279600|FG001|Overall Study|Patient cured from Epilepsy|0|||
126542471|NCT01364597|455279601|FG002|Overall Study|Patient cured from Epilepsy|1|||
126542472|NCT01364597|455279602|FG003|Overall Study|Patient cured from Epilepsy|0|||
126542473|NCT01364597|455279599|FG000|Overall Study|Investigator decision|0|||
126542474|NCT01364597|455279600|FG001|Overall Study|Investigator decision|0|||
126542475|NCT01364597|455279601|FG002|Overall Study|Investigator decision|1|||
126542476|NCT01364597|455279602|FG003|Overall Study|Investigator decision|0|||
126542477|NCT01364597|455279599|FG000|Overall Study|Sponsor recommended discontinuation|0|||
126542478|NCT01364597|455279600|FG001|Overall Study|Sponsor recommended discontinuation|0|||
126542479|NCT01364597|455279601|FG002|Overall Study|Sponsor recommended discontinuation|0|||
126542480|NCT01364597|455279602|FG003|Overall Study|Sponsor recommended discontinuation|1|||
126542481|NCT01364597|455279599|FG000|Overall Study|Parents went abroad with the patient|0|||
126542482|NCT01364597|455279600|FG001|Overall Study|Parents went abroad with the patient|0|||
126542483|NCT01364597|455279601|FG002|Overall Study|Parents went abroad with the patient|1|||
126542484|NCT01364597|455279602|FG003|Overall Study|Parents went abroad with the patient|0|||
126542485|NCT01364597|455279599|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
126542486|NCT01364597|455279600|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
126542487|NCT01364597|455279601|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
126542488|NCT01364597|455279602|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
126542489|NCT01364597|455279599|FG000|Overall Study|BRV administration dropout|0|||
126542490|NCT01364597|455279600|FG001|Overall Study|BRV administration dropout|0|||
126542491|NCT01364597|455279601|FG002|Overall Study|BRV administration dropout|1|||
126542492|NCT01364597|455279602|FG003|Overall Study|BRV administration dropout|0|||
126542493|NCT01364597|455279599|FG000|Overall Study|Dropout|0|||
126542494|NCT01364597|455279600|FG001|Overall Study|Dropout|0|||
126542495|NCT01364597|455279601|FG002|Overall Study|Dropout|3|||
126542496|NCT01364597|455279602|FG003|Overall Study|Dropout|1|||
126542497|NCT01364597|455279599|FG000|Overall Study|Unreliable subject|0|||
126542498|NCT01364597|455279600|FG001|Overall Study|Unreliable subject|0|||
126542499|NCT01364597|455279601|FG002|Overall Study|Unreliable subject|0|||
126542500|NCT01364597|455279602|FG003|Overall Study|Unreliable subject|1|||
126542501|NCT01364597|455279599|FG000|Overall Study|Other|0|||
126542502|NCT01364597|455279600|FG001|Overall Study|Other|0|||
126542503|NCT01364597|455279601|FG002|Overall Study|Other|0|||
126542504|NCT01364597|455279602|FG003|Overall Study|Other|1|||
126542505|NCT01498822|455279603|FG000|Overall Study|Protocol Violation|8|||
126542506|NCT01498822|455279604|FG001|Overall Study|Protocol Violation|4|||
126542507|NCT01498822|455279603|FG000|Overall Study|Other Reason|5|||
126542508|NCT01498822|455279604|FG001|Overall Study|Other Reason|2|||
126542509|NCT01498822|455279603|FG000|Overall Study|Lack of Efficacy|7|||
126542510|NCT01498822|455279604|FG001|Overall Study|Lack of Efficacy|2|||
126542511|NCT01498822|455279603|FG000|Overall Study|AE, non-serious non-fatal|8|||
126542512|NCT01498822|455279604|FG001|Overall Study|AE, non-serious non-fatal|17|||
126542513|NCT01498822|455279603|FG000|Overall Study|SAE, non-fatal|2|||
126542514|NCT01498822|455279604|FG001|Overall Study|SAE, non-fatal|2|||
126542515|NCT01498822|455279603|FG000|Overall Study|Adverse Event, serious fatal|1|||
126542516|NCT01498822|455279604|FG001|Overall Study|Adverse Event, serious fatal|1|||
126542517|NCT01498822|455279603|FG000|Overall Study|Withdrawal by Subject|15|||
126542518|NCT01498822|455279604|FG001|Overall Study|Withdrawal by Subject|25|||
126542519|NCT01498822|455279603|FG000|Overall Study|Lost to Follow-up|8|||
126542520|NCT01498822|455279604|FG001|Overall Study|Lost to Follow-up|3|||
126542521|NCT03579290|455279612|FG000|Overall Study|Lost to Follow-up|9|||
126542522|NCT03131960|455279615|FG000|Overall Study|Adverse Event|0|||
126542523|NCT03131960|455279616|FG001|Overall Study|Adverse Event|1|||
126542524|NCT01781390|455279617|FG000|Overall Study|Withdrawal of Consent|0|||
126542525|NCT01781390|455279618|FG001|Overall Study|Withdrawal of Consent|3|||
126542526|NCT01781390|455279619|FG002|Overall Study|Withdrawal of Consent|1|||
126542527|NCT01781390|455279617|FG000|Overall Study|Lost to Follow-up|1|||
126542528|NCT01781390|455279618|FG001|Overall Study|Lost to Follow-up|1|||
126542529|NCT01781390|455279619|FG002|Overall Study|Lost to Follow-up|1|||
126542530|NCT01781390|455279617|FG000|Overall Study|Adverse Event|1|||
126542531|NCT01781390|455279618|FG001|Overall Study|Adverse Event|2|||
126542532|NCT01781390|455279619|FG002|Overall Study|Adverse Event|1|||
126542533|NCT01781390|455279617|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
126542534|NCT01781390|455279618|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
126542535|NCT01781390|455279619|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
126542536|NCT01674621|455279620|FG000|Overall Study|Adverse Event|3|||
126542537|NCT01674621|455279621|FG001|Overall Study|Adverse Event|2|||
126542538|NCT01674621|455279622|FG002|Overall Study|Adverse Event|5|||
126542539|NCT01674621|455279623|FG003|Overall Study|Adverse Event|5|||
126316763|NCT02772276|454450784|FG006|Overall Study|Withdrew consent|0|||
126542540|NCT01674621|455279624|FG004|Overall Study|Adverse Event|1|||
126542541|NCT01674621|455279620|FG000|Overall Study|Inability to Complete Study Procedures|0|||
126316764|NCT02772276|454450785|FG007|Overall Study|Withdrew consent|1|||
126542542|NCT01674621|455279621|FG001|Overall Study|Inability to Complete Study Procedures|0|||
126542543|NCT01674621|455279622|FG002|Overall Study|Inability to Complete Study Procedures|0|||
126542544|NCT01674621|455279623|FG003|Overall Study|Inability to Complete Study Procedures|0|||
126542545|NCT01674621|455279624|FG004|Overall Study|Inability to Complete Study Procedures|2|||
126542546|NCT01674621|455279620|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
126542547|NCT01674621|455279621|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
126542548|NCT01674621|455279622|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
126542549|NCT01674621|455279623|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
126542550|NCT01674621|455279624|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
126542551|NCT01674621|455279620|FG000|Overall Study|Withdrawal by Subject|2|||
126542552|NCT01674621|455279621|FG001|Overall Study|Withdrawal by Subject|5|||
126542553|NCT01674621|455279622|FG002|Overall Study|Withdrawal by Subject|2|||
126542554|NCT01674621|455279623|FG003|Overall Study|Withdrawal by Subject|0|||
126542555|NCT01674621|455279624|FG004|Overall Study|Withdrawal by Subject|1|||
126542556|NCT01674621|455279620|FG000|Overall Study|Other than specified|0|||
126542557|NCT01674621|455279621|FG001|Overall Study|Other than specified|1|||
126542558|NCT01674621|455279622|FG002|Overall Study|Other than specified|0|||
126542559|NCT01674621|455279623|FG003|Overall Study|Other than specified|0|||
126542560|NCT01674621|455279624|FG004|Overall Study|Other than specified|2|||
126542561|NCT01859793|455279625|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
126542562|NCT01859793|455279626|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
126542563|NCT01859793|455279625|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
126542564|NCT01859793|455279626|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
126542565|NCT01859793|455279625|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
126542566|NCT01859793|455279626|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
126542567|NCT01859793|455279625|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
126542568|NCT01859793|455279626|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
126542569|NCT01735396|455279627|FG000|Overall Study|not evaluable|1|||
126542570|NCT01148862|455279628|FG000|Second Intervention|Withdrawal by Subject|0|||
126542571|NCT01148862|455279629|FG001|Second Intervention|Withdrawal by Subject|2|||
126542572|NCT00895622|455279631|FG000|Overall Study|Protocol Violation|5|||
126542573|NCT00895622|455279632|FG001|Overall Study|Protocol Violation|4|||
126542574|NCT00895622|455279633|FG002|Overall Study|Protocol Violation|4|||
126542575|NCT03724396|455279634|FG000|Overall Study|Lost to Follow-up|1|||
126542576|NCT03724396|455279635|FG001|Overall Study|Lost to Follow-up|1|||
126542577|NCT03724396|455279634|FG000|Overall Study|Withdrawal by Subject|1|||
126542578|NCT03724396|455279635|FG001|Overall Study|Withdrawal by Subject|0|||
126542579|NCT01490125|455279636|FG000|Period I|Adverse Event|4|||
126542580|NCT01490125|455279637|FG001|Period I|Adverse Event|1|||
126542581|NCT01490125|455279638|FG002|Period I|Adverse Event|1|||
126542582|NCT01490125|455279639|FG003|Period I|Adverse Event|3|||
126542583|NCT01490125|455279640|FG004|Period I|Adverse Event|2|||
126542584|NCT01490125|455279641|FG005|Period I|Adverse Event|4|||
126542585|NCT01490125|455279636|FG000|Period I|Protocol Violation|1|||
126542586|NCT01490125|455279637|FG001|Period I|Protocol Violation|1|||
126542587|NCT01490125|455279638|FG002|Period I|Protocol Violation|1|||
126542588|NCT01490125|455279639|FG003|Period I|Protocol Violation|1|||
126542589|NCT01490125|455279640|FG004|Period I|Protocol Violation|0|||
126542590|NCT01490125|455279641|FG005|Period I|Protocol Violation|0|||
126542591|NCT01490125|455279636|FG000|Period I|Withdrawal by Subject|1|||
126542592|NCT01490125|455279637|FG001|Period I|Withdrawal by Subject|3|||
126542593|NCT01490125|455279638|FG002|Period I|Withdrawal by Subject|2|||
126542594|NCT01490125|455279639|FG003|Period I|Withdrawal by Subject|1|||
126542595|NCT01490125|455279640|FG004|Period I|Withdrawal by Subject|2|||
126542596|NCT01490125|455279641|FG005|Period I|Withdrawal by Subject|1|||
126542597|NCT01490125|455279636|FG000|Period II|Adverse Event|2|||
126542598|NCT01490125|455279637|FG001|Period II|Adverse Event|3|||
126542599|NCT01490125|455279638|FG002|Period II|Adverse Event|2|||
126542600|NCT01490125|455279639|FG003|Period II|Adverse Event|2|||
126542601|NCT01490125|455279640|FG004|Period II|Adverse Event|4|||
126542602|NCT01490125|455279641|FG005|Period II|Adverse Event|2|||
126542603|NCT01490125|455279636|FG000|Period II|Protocol Violation|0|||
126542604|NCT01490125|455279637|FG001|Period II|Protocol Violation|0|||
126542605|NCT01490125|455279638|FG002|Period II|Protocol Violation|1|||
126542606|NCT01490125|455279639|FG003|Period II|Protocol Violation|1|||
126542607|NCT01490125|455279640|FG004|Period II|Protocol Violation|0|||
126542608|NCT01490125|455279641|FG005|Period II|Protocol Violation|0|||
126542609|NCT01490125|455279636|FG000|Period II|Lost to Follow-up|0|||
126542610|NCT01490125|455279637|FG001|Period II|Lost to Follow-up|1|||
126542611|NCT01490125|455279638|FG002|Period II|Lost to Follow-up|0|||
126542612|NCT01490125|455279639|FG003|Period II|Lost to Follow-up|0|||
126542613|NCT01490125|455279640|FG004|Period II|Lost to Follow-up|0|||
126542614|NCT01490125|455279641|FG005|Period II|Lost to Follow-up|0|||
126542615|NCT01490125|455279636|FG000|Period II|Withdrawal by Subject|1|||
126542616|NCT01490125|455279637|FG001|Period II|Withdrawal by Subject|0|||
126542617|NCT01490125|455279638|FG002|Period II|Withdrawal by Subject|0|||
126542618|NCT01490125|455279639|FG003|Period II|Withdrawal by Subject|0|||
126542619|NCT01490125|455279640|FG004|Period II|Withdrawal by Subject|0|||
126542620|NCT01490125|455279641|FG005|Period II|Withdrawal by Subject|0|||
126542621|NCT01490125|455279636|FG000|Period III|Adverse Event|3|||
126542622|NCT01490125|455279637|FG001|Period III|Adverse Event|1|||
126542623|NCT01490125|455279638|FG002|Period III|Adverse Event|0|||
126542624|NCT01490125|455279639|FG003|Period III|Adverse Event|1|||
126542625|NCT01490125|455279640|FG004|Period III|Adverse Event|0|||
126542626|NCT01490125|455279641|FG005|Period III|Adverse Event|0|||
126542627|NCT01490125|455279636|FG000|Period III|Death|0|||
126542628|NCT01490125|455279637|FG001|Period III|Death|0|||
126316765|NCT02772276|454450786|FG008|Overall Study|Withdrew consent|0|||
126316766|NCT02772276|454450787|FG009|Overall Study|Withdrew consent|0|||
126316767|NCT02772276|454450788|FG010|Overall Study|Withdrew consent|0|||
126316768|NCT02772276|454450789|FG011|Overall Study|Withdrew consent|0|||
126316769|NCT02772276|454450790|FG012|Overall Study|Withdrew consent|0|||
126316770|NCT00455520|454450791|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
126316771|NCT00455520|454450792|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
126316772|NCT00455520|454450791|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
126316773|NCT00455520|454450792|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
126316774|NCT00455520|454450791|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
126542629|NCT01490125|455279638|FG002|Period III|Death|0|||
126316775|NCT00455520|454450792|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
126316776|NCT00455520|454450791|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
126316777|NCT00455520|454450792|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
126316778|NCT00455520|454450791|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
126316779|NCT00455520|454450792|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
126316780|NCT00455520|454450791|FG000|Open Label Tapentadol Extended Release|All other|33|||
126316781|NCT00455520|454450792|FG001|Open Label Tapentadol Extended Release|All other|0|||
126316782|NCT00455520|454450791|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
126316783|NCT00455520|454450792|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
126316784|NCT00455520|454450791|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
126316785|NCT00455520|454450792|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
126316786|NCT00455520|454450791|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
126316787|NCT00455520|454450792|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
126316788|NCT00455520|454450791|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
126316789|NCT00455520|454450792|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
126316790|NCT00455520|454450791|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
126316791|NCT00455520|454450792|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
126316792|NCT00455520|454450791|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
126316793|NCT00455520|454450792|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
126316794|NCT03448939|454450794|FG000|Overall Study|Adverse Event|5|||
126316795|NCT03448939|454450795|FG001|Overall Study|Adverse Event|1|||
126316796|NCT03448939|454450794|FG000|Overall Study|Lost to Follow-up|6|||
126316797|NCT03448939|454450795|FG001|Overall Study|Lost to Follow-up|6|||
126316798|NCT03448939|454450794|FG000|Overall Study|Pregnancy|1|||
126316799|NCT03448939|454450795|FG001|Overall Study|Pregnancy|1|||
126316800|NCT03448939|454450794|FG000|Overall Study|Withdrawal by Subject|9|||
126316801|NCT03448939|454450795|FG001|Overall Study|Withdrawal by Subject|3|||
126316802|NCT01472965|454450796|FG000|Overall Study|Withdrawal by Subject|1|||
126316803|NCT01472965|454450797|FG001|Overall Study|Withdrawal by Subject|0|||
126316804|NCT00628095|454450798|FG000|Overall Study|Adverse Event|5|||
126316805|NCT00628095|454450799|FG001|Overall Study|Adverse Event|3|||
126316806|NCT00628095|454450798|FG000|Overall Study|Lack of Efficacy|0|||
126316807|NCT00628095|454450799|FG001|Overall Study|Lack of Efficacy|3|||
126316808|NCT00628095|454450798|FG000|Overall Study|Withdrawal by Subject|2|||
126316809|NCT00628095|454450799|FG001|Overall Study|Withdrawal by Subject|0|||
126316810|NCT00628095|454450798|FG000|Overall Study|Other|0|||
126316811|NCT00628095|454450799|FG001|Overall Study|Other|1|||
126316812|NCT03235115|454450803|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
126316813|NCT03235115|454450804|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
126316814|NCT03235115|454450805|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
126316815|NCT03235115|454450806|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
126316816|NCT03235115|454450807|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
126316817|NCT03235115|454450808|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
126316818|NCT00006305|454450809|FG000|Overall Study|Withdrawal by Subject|17|||
126316819|NCT00006305|454450810|FG001|Overall Study|Withdrawal by Subject|10|||
126542630|NCT01490125|455279639|FG003|Period III|Death|1|||
126542631|NCT01490125|455279640|FG004|Period III|Death|0|||
126542632|NCT01490125|455279641|FG005|Period III|Death|0|||
126542633|NCT01490125|455279636|FG000|Period III|Lack of Efficacy|0|||
126542634|NCT01490125|455279637|FG001|Period III|Lack of Efficacy|0|||
126542635|NCT01490125|455279638|FG002|Period III|Lack of Efficacy|0|||
126542636|NCT01490125|455279639|FG003|Period III|Lack of Efficacy|0|||
126542637|NCT01490125|455279640|FG004|Period III|Lack of Efficacy|1|||
126542638|NCT01490125|455279641|FG005|Period III|Lack of Efficacy|0|||
126542639|NCT02237508|455279643|FG000|Overall Study|Withdrawal by Subject|0|||
126542640|NCT02237508|455279644|FG001|Overall Study|Withdrawal by Subject|2|||
126316820|NCT00006305|454450811|FG002|Overall Study|Withdrawal by Subject|15|||
126316821|NCT00006305|454450812|FG003|Overall Study|Withdrawal by Subject|14|||
126542641|NCT02237508|455279645|FG002|Overall Study|Withdrawal by Subject|0|||
126542642|NCT02237508|455279646|FG003|Overall Study|Withdrawal by Subject|1|||
126542643|NCT02237508|455279647|FG004|Overall Study|Withdrawal by Subject|0|||
126542644|NCT02237508|455279648|FG005|Overall Study|Withdrawal by Subject|1|||
126542645|NCT02237508|455279649|FG006|Overall Study|Withdrawal by Subject|1|||
126542646|NCT02237508|455279650|FG007|Overall Study|Withdrawal by Subject|0|||
126542647|NCT02237508|455279651|FG008|Overall Study|Withdrawal by Subject|1|||
126542648|NCT02237508|455279652|FG009|Overall Study|Withdrawal by Subject|0|||
126542649|NCT02237508|455279643|FG000|Overall Study|Physician Decision|0|||
126542650|NCT02237508|455279644|FG001|Overall Study|Physician Decision|1|||
126542651|NCT02237508|455279645|FG002|Overall Study|Physician Decision|0|||
126542652|NCT02237508|455279646|FG003|Overall Study|Physician Decision|0|||
126542653|NCT02237508|455279647|FG004|Overall Study|Physician Decision|0|||
126542654|NCT02237508|455279648|FG005|Overall Study|Physician Decision|0|||
126542655|NCT02237508|455279649|FG006|Overall Study|Physician Decision|0|||
126542656|NCT02237508|455279650|FG007|Overall Study|Physician Decision|0|||
126542657|NCT02237508|455279651|FG008|Overall Study|Physician Decision|0|||
126542658|NCT02237508|455279652|FG009|Overall Study|Physician Decision|0|||
126542659|NCT02237508|455279643|FG000|Overall Study|Protocol Violation|0|||
126542660|NCT02237508|455279644|FG001|Overall Study|Protocol Violation|0|||
126542661|NCT02237508|455279645|FG002|Overall Study|Protocol Violation|1|||
126542662|NCT02237508|455279646|FG003|Overall Study|Protocol Violation|0|||
126542663|NCT02237508|455279647|FG004|Overall Study|Protocol Violation|0|||
126542664|NCT02237508|455279648|FG005|Overall Study|Protocol Violation|0|||
126542665|NCT02237508|455279649|FG006|Overall Study|Protocol Violation|0|||
126542666|NCT02237508|455279650|FG007|Overall Study|Protocol Violation|0|||
126542667|NCT02237508|455279651|FG008|Overall Study|Protocol Violation|0|||
126542668|NCT02237508|455279652|FG009|Overall Study|Protocol Violation|0|||
126542669|NCT04954586|455279653|FG000|Overall Study|Withdrawal by Subject|5|||
126542670|NCT04000594|455279654|FG000|Overall Study|Withdrawal by Subject|1|||
126542671|NCT04000594|455279655|FG001|Overall Study|Withdrawal by Subject|0|||
126542672|NCT04000594|455279656|FG002|Overall Study|Withdrawal by Subject|0|||
126542673|NCT04522180|455279657|FG000|Overall Study|Investigator judgement|3|||
126542674|NCT04522180|455279658|FG001|Overall Study|Investigator judgement|4|||
126542675|NCT04522180|455279657|FG000|Overall Study|Voluntary withdrawal|1|||
126542676|NCT04522180|455279658|FG001|Overall Study|Voluntary withdrawal|0|||
126542677|NCT04522180|455279657|FG000|Overall Study|Pregnancy|0|||
126542678|NCT04522180|455279658|FG001|Overall Study|Pregnancy|1|||
126542679|NCT04522180|455279657|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
126542680|NCT04522180|455279658|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
126542681|NCT04522180|455279657|FG000|Overall Study|Reason not specified|8|||
126542682|NCT04522180|455279658|FG001|Overall Study|Reason not specified|5|||
126542683|NCT01905046|455279659|FG000|Months 13-24|Withdrawal by Subject|10|||
126542684|NCT01905046|455279660|FG001|Months 13-24|Withdrawal by Subject|10|||
126542685|NCT01905046|455279659|FG000|Months 13-24|Adverse Event|3|||
126542686|NCT01905046|455279660|FG001|Months 13-24|Adverse Event|2|||
126542687|NCT01905046|455279659|FG000|Months 13-24|Protocol Violation|3|||
126542688|NCT01905046|455279660|FG001|Months 13-24|Protocol Violation|3|||
126542689|NCT01905046|455279659|FG000|Months 13-24|Physician Decision|1|||
126542690|NCT01905046|455279660|FG001|Months 13-24|Physician Decision|0|||
126542691|NCT03489057|455279665|FG000|Overall Study|Lost to Follow-up|16|||
126542692|NCT03489057|455279666|FG001|Overall Study|Lost to Follow-up|16|||
126542693|NCT03489057|455279667|FG002|Overall Study|Lost to Follow-up|14|||
126542694|NCT03489057|455279668|FG003|Overall Study|Lost to Follow-up|14|||
126542695|NCT03489057|455279665|FG000|Overall Study|Withdrawal by Subject|12|||
126542696|NCT03489057|455279666|FG001|Overall Study|Withdrawal by Subject|12|||
126542697|NCT03489057|455279667|FG002|Overall Study|Withdrawal by Subject|8|||
126542698|NCT03489057|455279668|FG003|Overall Study|Withdrawal by Subject|8|||
126542699|NCT03489057|455279665|FG000|Overall Study|Protocol Violation|7|||
126542700|NCT03489057|455279666|FG001|Overall Study|Protocol Violation|7|||
126542701|NCT03489057|455279667|FG002|Overall Study|Protocol Violation|2|||
126542702|NCT03489057|455279668|FG003|Overall Study|Protocol Violation|2|||
126542703|NCT01368900|455279671|FG000|Overall Study|Lost to Follow-up|7|||
126542704|NCT04027348|455279674|FG000|Overall Study|Adverse Event|2|||
126542705|NCT02487472|455279675|FG000|Overall Study|Did not complete telephonic interviews|9|||
126542706|NCT02487472|455279675|FG000|Overall Study|Other|2|||
126542707|NCT02277743|455279676|FG000|Overall Study|Protocol Violation|1|||
126542708|NCT02277743|455279677|FG001|Overall Study|Protocol Violation|1|||
126542709|NCT02277743|455279678|FG002|Overall Study|Protocol Violation|1|||
126542710|NCT02277743|455279676|FG000|Overall Study|Adverse Event|10|||
126542711|NCT02277743|455279677|FG001|Overall Study|Adverse Event|6|||
126542712|NCT02277743|455279678|FG002|Overall Study|Adverse Event|6|||
126542713|NCT02277743|455279676|FG000|Overall Study|Lack of Efficacy|11|||
126542714|NCT02277743|455279677|FG001|Overall Study|Lack of Efficacy|4|||
126542715|NCT02277743|455279678|FG002|Overall Study|Lack of Efficacy|3|||
126542716|NCT02277743|455279676|FG000|Overall Study|Other than specified above|18|||
126542717|NCT02277743|455279677|FG001|Overall Study|Other than specified above|5|||
126648205|NCT01280357|455669714|FG000|Overall Study|Excluded no internal monitoring|14|||
126542718|NCT02277743|455279678|FG002|Overall Study|Other than specified above|16|||
126542719|NCT01224158|455279679|FG000|Overall Study|Withdrawal by Subject|1|||
126542720|NCT01224158|455279680|FG001|Overall Study|Withdrawal by Subject|0|||
126542721|NCT02055157|455279683|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
126542722|NCT02055157|455279684|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
126542723|NCT02055157|455279685|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
126542724|NCT02055157|455279686|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
126542725|NCT02055157|455279683|FG000|Initial 6 Months|Adverse Event|0|||
126542726|NCT02055157|455279684|FG001|Initial 6 Months|Adverse Event|0|||
126542727|NCT02055157|455279685|FG002|Initial 6 Months|Adverse Event|0|||
126542728|NCT02055157|455279686|FG003|Initial 6 Months|Adverse Event|1|||
126542729|NCT02055157|455279683|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
126316822|NCT00662558|454450815|FG000|Overall Study|Adverse Event|21|||
126316823|NCT00662558|454450816|FG001|Overall Study|Adverse Event|59|||
126316824|NCT00662558|454450815|FG000|Overall Study|Lack of Efficacy|4|||
126316825|NCT00662558|454450816|FG001|Overall Study|Lack of Efficacy|7|||
126316826|NCT00662558|454450815|FG000|Overall Study|Lost to Follow-up|13|||
126316827|NCT00662558|454450816|FG001|Overall Study|Lost to Follow-up|10|||
126316828|NCT00662558|454450815|FG000|Overall Study|Other|9|||
126316829|NCT00662558|454450816|FG001|Overall Study|Other|14|||
126316830|NCT00662558|454450815|FG000|Overall Study|Withdrawal by Subject|7|||
126316831|NCT00662558|454450816|FG001|Overall Study|Withdrawal by Subject|12|||
126316832|NCT00662558|454450815|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
126316833|NCT00662558|454450816|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
126316834|NCT00329641|454450817|FG000|Overall Study|Did not start treatment|1|||
126316835|NCT00329641|454450817|FG000|Overall Study|Not eligible|1|||
126316836|NCT00329641|454450817|FG000|Overall Study|Adverse Event|3|||
126316837|NCT00329641|454450817|FG000|Overall Study|Other reason, not protocol specified|1|||
126316838|NCT00783224|454450818|FG000|Overall Study|Adverse Event|0|||
126316839|NCT00783224|454450819|FG001|Overall Study|Adverse Event|0|||
126316840|NCT00783224|454450820|FG002|Overall Study|Adverse Event|1|||
126316841|NCT00783224|454450821|FG003|Overall Study|Adverse Event|0|||
126316842|NCT00783224|454450818|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
126316843|NCT00783224|454450819|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
126316844|NCT00783224|454450820|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
126316845|NCT00783224|454450821|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
126316846|NCT00783224|454450818|FG000|Overall Study|Inappropriate as a study subject|0|||
126316847|NCT00783224|454450819|FG001|Overall Study|Inappropriate as a study subject|0|||
126316848|NCT00783224|454450820|FG002|Overall Study|Inappropriate as a study subject|0|||
126316849|NCT00783224|454450821|FG003|Overall Study|Inappropriate as a study subject|1|||
126316850|NCT01711619|454450822|FG000|Overall Study|Early study termination|10|||
126316851|NCT01711619|454450823|FG001|Overall Study|Early study termination|14|||
126316852|NCT01711619|454450822|FG000|Overall Study|Withdrawal by Subject|3|||
126316853|NCT01711619|454450823|FG001|Overall Study|Withdrawal by Subject|7|||
126316854|NCT01711619|454450822|FG000|Overall Study|Protocol Violation|2|||
126316855|NCT01711619|454450823|FG001|Overall Study|Protocol Violation|3|||
126316856|NCT01711619|454450822|FG000|Overall Study|Adverse Event|2|||
126316857|NCT01711619|454450823|FG001|Overall Study|Adverse Event|0|||
126316858|NCT01711619|454450822|FG000|Overall Study|Lost to Follow-up|1|||
126316859|NCT01711619|454450823|FG001|Overall Study|Lost to Follow-up|0|||
126316860|NCT00401960|454450830|FG000|Overall Study|Lost to Follow-up|3|||
126316861|NCT00401960|454450831|FG001|Overall Study|Lost to Follow-up|0|||
126316862|NCT00401960|454450830|FG000|Overall Study|Death|2|||
126316863|NCT00401960|454450831|FG001|Overall Study|Death|0|||
126316864|NCT02649426|454450832|FG000|Overall Study|Follow-up on going|1|||
126316865|NCT02649426|454450833|FG001|Overall Study|Follow-up on going|26|||
126316866|NCT02649426|454450834|FG002|Overall Study|Follow-up on going|28|||
126316867|NCT02649426|454450835|FG003|Overall Study|Follow-up on going|31|||
126316868|NCT02584959|454450836|FG000|Period 1|Withdrawn from study|3|||
126542730|NCT02055157|455279684|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
126542731|NCT02055157|455279685|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
126542732|NCT02055157|455279686|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
126542733|NCT02055157|455279683|FG000|18-month Extension|Investigator decision|0|||
126542734|NCT02055157|455279684|FG001|18-month Extension|Investigator decision|1|||
126542735|NCT02055157|455279685|FG002|18-month Extension|Investigator decision|0|||
126542736|NCT02055157|455279686|FG003|18-month Extension|Investigator decision|0|||
126542737|NCT02055157|455279683|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
126542738|NCT02055157|455279684|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
126542739|NCT02055157|455279685|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
126542740|NCT02055157|455279686|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
126542741|NCT03976466|455279687|FG000|Overall Study|Lost to Follow-up|1|||
126542742|NCT03976466|455279688|FG001|Overall Study|Lost to Follow-up|3|||
126542743|NCT00733499|455279689|FG000|Pre-operative|Protocol Violation|0|||
126316869|NCT02584959|454450837|FG001|Period 1|Withdrawn from study|4|||
126316870|NCT02584959|454450838|FG002|Period 1|Withdrawn from study|0|||
126316871|NCT02584959|454450836|FG000|Period 2|Withdrawn from study|6|||
126316872|NCT02584959|454450837|FG001|Period 2|Withdrawn from study|1|||
126316873|NCT02584959|454450838|FG002|Period 2|Withdrawn from study|2|||
126316874|NCT00195494|454450841|FG000|Year 1|Adverse Event|0|||
126316875|NCT00195494|454450842|FG001|Year 1|Adverse Event|0|||
126542744|NCT00733499|455279690|FG001|Pre-operative|Protocol Violation|1|||
126542745|NCT00733499|455279689|FG000|3 Months Follow-up|Death|1|||
126542746|NCT00733499|455279690|FG001|3 Months Follow-up|Death|2|||
126542747|NCT00733499|455279689|FG000|6 Months Follow-up|Death|0|||
126542748|NCT00733499|455279690|FG001|6 Months Follow-up|Death|2|||
126542749|NCT00733499|455279689|FG000|6 Months Follow-up|Adverse Event|0|||
126542750|NCT00733499|455279690|FG001|6 Months Follow-up|Adverse Event|1|||
126542751|NCT00733499|455279689|FG000|12 Months Follow-up|Death|2|||
126542752|NCT00733499|455279690|FG001|12 Months Follow-up|Death|1|||
126542753|NCT00733499|455279689|FG000|24 Months Follow-up|Death|0|||
126542754|NCT00733499|455279690|FG001|24 Months Follow-up|Death|1|||
126542755|NCT00733499|455279689|FG000|5 Year Followup|Adverse Event|2|||
126542756|NCT00733499|455279690|FG001|5 Year Followup|Adverse Event|2|||
126542757|NCT00733499|455279689|FG000|5 Year Followup|Non device related AE|0|||
126542758|NCT00733499|455279690|FG001|5 Year Followup|Non device related AE|1|||
126542759|NCT00733499|455279689|FG000|5 Year Followup|Revision of Study Implant|0|||
126542760|NCT00733499|455279690|FG001|5 Year Followup|Revision of Study Implant|1|||
126542761|NCT00733499|455279689|FG000|5 Year Followup|Lost to Follow-up|2|||
126542762|NCT00733499|455279690|FG001|5 Year Followup|Lost to Follow-up|0|||
126542763|NCT00733499|455279689|FG000|5 Year Followup|Death|13|||
126542764|NCT00733499|455279690|FG001|5 Year Followup|Death|19|||
126542765|NCT00733499|455279689|FG000|5 Year Followup|missing, unable to locate|0|||
126542766|NCT00733499|455279690|FG001|5 Year Followup|missing, unable to locate|1|||
126542767|NCT00733499|455279689|FG000|5 Year Followup|Withdrawal by Subject|4|||
126542768|NCT00733499|455279690|FG001|5 Year Followup|Withdrawal by Subject|1|||
126542769|NCT00733499|455279689|FG000|10 Year Followup|Death|9|||
126542770|NCT00733499|455279690|FG001|10 Year Followup|Death|7|||
126542771|NCT00733499|455279689|FG000|10 Year Followup|Adverse Event|3|||
126542772|NCT00733499|455279690|FG001|10 Year Followup|Adverse Event|3|||
126542773|NCT00733499|455279689|FG000|10 Year Followup|Lost to Follow-up|3|||
126542774|NCT00733499|455279690|FG001|10 Year Followup|Lost to Follow-up|2|||
126542775|NCT00733499|455279689|FG000|10 Year Followup|Withdrawal by Subject|5|||
126542776|NCT00733499|455279690|FG001|10 Year Followup|Withdrawal by Subject|5|||
126542777|NCT00733499|455279689|FG000|10 Year Followup|missing, unable to locate|0|||
126542778|NCT00733499|455279690|FG001|10 Year Followup|missing, unable to locate|2|||
126542779|NCT01552954|455279691|FG000|Overall Study|Adverse Event|1|||
126542780|NCT01552954|455279692|FG001|Overall Study|Adverse Event|2|||
126542781|NCT01552954|455279691|FG000|Overall Study|Lost to Follow-up|1|||
126542782|NCT01552954|455279692|FG001|Overall Study|Lost to Follow-up|1|||
126542783|NCT01552954|455279691|FG000|Overall Study|Withdrawal by Subject|1|||
126542784|NCT01552954|455279692|FG001|Overall Study|Withdrawal by Subject|1|||
126542785|NCT01552954|455279691|FG000|Overall Study|Protocol Violation|1|||
126542786|NCT01552954|455279692|FG001|Overall Study|Protocol Violation|2|||
126542787|NCT01552954|455279691|FG000|Overall Study|diagnosed DM|1|||
126542788|NCT01552954|455279692|FG001|Overall Study|diagnosed DM|0|||
126542789|NCT03929562|455279693|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
126542790|NCT03929562|455279694|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
126542791|NCT03929562|455279693|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
126542792|NCT03929562|455279694|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
126542793|NCT03929562|455279693|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
126542794|NCT03929562|455279694|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
126542795|NCT04843930|455279695|FG000|Randomization|Withdrawal by Subject|6|||
126542796|NCT04843930|455279696|FG001|Randomization|Withdrawal by Subject|6|||
126542797|NCT04843930|455279697|FG002|Randomization|Withdrawal by Subject|0|||
126542798|NCT04843930|455279698|FG003|Randomization|Withdrawal by Subject|0|||
126542799|NCT04843930|455279695|FG000|Week 6 Assessment|Adverse Event|3|||
126542800|NCT04843930|455279696|FG001|Week 6 Assessment|Adverse Event|0|||
126542801|NCT04843930|455279697|FG002|Week 6 Assessment|Adverse Event|0|||
126542802|NCT04843930|455279698|FG003|Week 6 Assessment|Adverse Event|0|||
126542803|NCT04843930|455279695|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
126542804|NCT04843930|455279696|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
126542805|NCT04843930|455279697|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
126542806|NCT04843930|455279698|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
126542807|NCT04843930|455279695|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
126542808|NCT04843930|455279696|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
126542809|NCT04843930|455279697|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
126542810|NCT04843930|455279698|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
126542811|NCT00652938|455279702|FG000|Overall Study|Adverse Event|1|||
126542812|NCT00652938|455279703|FG001|Overall Study|Adverse Event|0|||
126542813|NCT00652938|455279704|FG002|Overall Study|Adverse Event|2|||
126542814|NCT00652938|455279702|FG000|Overall Study|Withdrawal by Subject|0|||
126542815|NCT00652938|455279703|FG001|Overall Study|Withdrawal by Subject|6|||
126542816|NCT00652938|455279704|FG002|Overall Study|Withdrawal by Subject|1|||
126542817|NCT00652938|455279702|FG000|Overall Study|Lost to Follow-up|0|||
126542818|NCT00652938|455279703|FG001|Overall Study|Lost to Follow-up|0|||
126542819|NCT00652938|455279704|FG002|Overall Study|Lost to Follow-up|2|||
126542820|NCT00652938|455279702|FG000|Overall Study|fear of blood sampling|0|||
126316876|NCT00195494|454450843|FG002|Year 1|Adverse Event|0|||
126542821|NCT00652938|455279703|FG001|Overall Study|fear of blood sampling|1|||
126542822|NCT00652938|455279704|FG002|Overall Study|fear of blood sampling|0|||
126542823|NCT01547299|455279705|FG000|Overall Study|Withdrawal by Subject|2|||
126542824|NCT01547299|455279706|FG001|Overall Study|Withdrawal by Subject|2|||
126542825|NCT01987817|455279707|FG000|Overall Study|Adverse Event|4|||
126542826|NCT01987817|455279708|FG001|Overall Study|Adverse Event|0|||
126542827|NCT01987817|455279707|FG000|Overall Study|Withdrawal by Subject|1|||
126542828|NCT01987817|455279708|FG001|Overall Study|Withdrawal by Subject|1|||
126542829|NCT01987817|455279707|FG000|Overall Study|Physician Decision|1|||
126542830|NCT01987817|455279708|FG001|Overall Study|Physician Decision|0|||
126542831|NCT01336621|455279709|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
126542832|NCT01336621|455279709|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
126542833|NCT01336621|455279709|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
126542834|NCT01336621|455279709|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
126542835|NCT01336621|455279709|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
126542836|NCT01336621|455279709|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
126542837|NCT01336621|455279709|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
126542838|NCT01336621|455279709|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
126542839|NCT01336621|455279709|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
126542840|NCT01336621|455279709|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
126542841|NCT01336621|455279709|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
126542842|NCT01336621|455279709|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
126542843|NCT01336621|455279709|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
126542844|NCT01336621|455279709|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
126542845|NCT01576718|455279710|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
126542846|NCT01576718|455279711|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
126542847|NCT01576718|455279712|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
126542848|NCT01576718|455279713|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
126542849|NCT01576718|455279714|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
126542850|NCT01576718|455279715|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
126542851|NCT01576718|455279716|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
126542852|NCT01576718|455279710|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
126542853|NCT01576718|455279711|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
126542854|NCT01576718|455279712|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
126542855|NCT01576718|455279713|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
126542856|NCT01576718|455279714|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
126542857|NCT01576718|455279715|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
126542858|NCT01576718|455279716|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
126542859|NCT01576718|455279710|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
126542860|NCT01576718|455279711|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126542861|NCT01576718|455279712|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126542862|NCT01576718|455279713|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126542863|NCT01576718|455279714|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126542864|NCT01576718|455279715|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126542865|NCT01576718|455279716|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126542866|NCT01576718|455279710|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
126542867|NCT01576718|455279711|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
126542868|NCT01576718|455279712|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
126542869|NCT01576718|455279713|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
126542870|NCT01576718|455279714|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
126542871|NCT01576718|455279715|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
126542872|NCT01576718|455279716|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
126542873|NCT01576718|455279710|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
126542874|NCT01576718|455279711|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
126542875|NCT01576718|455279712|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
126542876|NCT01576718|455279713|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
126542877|NCT01576718|455279714|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
126542878|NCT01576718|455279715|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
126542879|NCT01576718|455279716|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
126542880|NCT01576718|455279710|FG000|Treatment Period|Adverse Event|0|||
126542881|NCT01576718|455279711|FG001|Treatment Period|Adverse Event|1|||
126542882|NCT01576718|455279712|FG002|Treatment Period|Adverse Event|1|||
126542883|NCT01576718|455279713|FG003|Treatment Period|Adverse Event|1|||
126542884|NCT01576718|455279714|FG004|Treatment Period|Adverse Event|1|||
126542885|NCT01576718|455279715|FG005|Treatment Period|Adverse Event|1|||
126542886|NCT01576718|455279716|FG006|Treatment Period|Adverse Event|0|||
126542887|NCT01576718|455279710|FG000|Treatment Period|Withdrawal by Subject|0|||
126542888|NCT01576718|455279711|FG001|Treatment Period|Withdrawal by Subject|1|||
126542889|NCT01576718|455279712|FG002|Treatment Period|Withdrawal by Subject|1|||
126542890|NCT01576718|455279713|FG003|Treatment Period|Withdrawal by Subject|0|||
126542891|NCT01576718|455279714|FG004|Treatment Period|Withdrawal by Subject|2|||
126542892|NCT01576718|455279715|FG005|Treatment Period|Withdrawal by Subject|4|||
126542893|NCT01576718|455279716|FG006|Treatment Period|Withdrawal by Subject|2|||
126542894|NCT01576718|455279710|FG000|Treatment Period|Physician Decision|0|||
126542895|NCT01576718|455279711|FG001|Treatment Period|Physician Decision|1|||
126542896|NCT01576718|455279712|FG002|Treatment Period|Physician Decision|1|||
126542897|NCT01576718|455279713|FG003|Treatment Period|Physician Decision|1|||
126542898|NCT01576718|455279714|FG004|Treatment Period|Physician Decision|1|||
126542899|NCT01576718|455279715|FG005|Treatment Period|Physician Decision|0|||
126542900|NCT01576718|455279716|FG006|Treatment Period|Physician Decision|0|||
126542901|NCT01576718|455279710|FG000|Treatment Period|Protocol Violation|0|||
126542902|NCT01576718|455279711|FG001|Treatment Period|Protocol Violation|5|||
126542903|NCT01576718|455279712|FG002|Treatment Period|Protocol Violation|4|||
126542904|NCT01576718|455279713|FG003|Treatment Period|Protocol Violation|10|||
126542905|NCT01576718|455279714|FG004|Treatment Period|Protocol Violation|6|||
126542906|NCT01576718|455279715|FG005|Treatment Period|Protocol Violation|8|||
126542907|NCT01576718|455279716|FG006|Treatment Period|Protocol Violation|12|||
126542908|NCT01576718|455279710|FG000|Treatment Period|Sponsor request|0|||
126542909|NCT01576718|455279711|FG001|Treatment Period|Sponsor request|1|||
126542910|NCT01576718|455279712|FG002|Treatment Period|Sponsor request|0|||
126542911|NCT01576718|455279713|FG003|Treatment Period|Sponsor request|0|||
126542912|NCT01576718|455279714|FG004|Treatment Period|Sponsor request|0|||
126542913|NCT01576718|455279715|FG005|Treatment Period|Sponsor request|1|||
126542914|NCT01576718|455279716|FG006|Treatment Period|Sponsor request|0|||
126542915|NCT01576718|455279710|FG000|Treatment Period|Met stopping criteria|0|||
126542916|NCT01576718|455279711|FG001|Treatment Period|Met stopping criteria|16|||
126542917|NCT01576718|455279712|FG002|Treatment Period|Met stopping criteria|13|||
126542918|NCT01576718|455279713|FG003|Treatment Period|Met stopping criteria|19|||
126542919|NCT01576718|455279714|FG004|Treatment Period|Met stopping criteria|16|||
126542920|NCT01576718|455279715|FG005|Treatment Period|Met stopping criteria|33|||
126542921|NCT01576718|455279716|FG006|Treatment Period|Met stopping criteria|15|||
126542922|NCT01576718|455279710|FG000|Treatment Period|Lost to Follow-up|0|||
126542923|NCT01576718|455279711|FG001|Treatment Period|Lost to Follow-up|0|||
126542924|NCT01576718|455279712|FG002|Treatment Period|Lost to Follow-up|0|||
126542925|NCT01576718|455279713|FG003|Treatment Period|Lost to Follow-up|0|||
126542926|NCT01576718|455279714|FG004|Treatment Period|Lost to Follow-up|1|||
126542927|NCT01576718|455279715|FG005|Treatment Period|Lost to Follow-up|0|||
126542928|NCT01576718|455279716|FG006|Treatment Period|Lost to Follow-up|0|||
126542929|NCT01576718|455279710|FG000|Treatment Period|Noncompliance to study medication|0|||
126542930|NCT01576718|455279711|FG001|Treatment Period|Noncompliance to study medication|0|||
126542931|NCT01576718|455279712|FG002|Treatment Period|Noncompliance to study medication|0|||
126542932|NCT01576718|455279713|FG003|Treatment Period|Noncompliance to study medication|0|||
126542933|NCT01576718|455279714|FG004|Treatment Period|Noncompliance to study medication|0|||
126542934|NCT01576718|455279715|FG005|Treatment Period|Noncompliance to study medication|1|||
126542935|NCT01576718|455279716|FG006|Treatment Period|Noncompliance to study medication|1|||
126542936|NCT00682643|455279721|FG000|Overall Study|Adverse Event|12|||
126542937|NCT00682643|455279722|FG001|Overall Study|Adverse Event|23|||
126542938|NCT00682643|455279721|FG000|Overall Study|Lack of Efficacy|2|||
126542939|NCT00682643|455279722|FG001|Overall Study|Lack of Efficacy|0|||
126542940|NCT00682643|455279721|FG000|Overall Study|Protocol Violation|38|||
126542941|NCT00682643|455279722|FG001|Overall Study|Protocol Violation|76|||
126542942|NCT00682643|455279721|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
126542943|NCT00682643|455279722|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
126542944|NCT00682643|455279721|FG000|Overall Study|Lost to Follow-up|1|||
126542945|NCT00682643|455279722|FG001|Overall Study|Lost to Follow-up|6|||
126542946|NCT00682643|455279721|FG000|Overall Study|Physician Decision|2|||
126542947|NCT00682643|455279722|FG001|Overall Study|Physician Decision|6|||
126542948|NCT00682643|455279721|FG000|Overall Study|Withdrawal by Subject|19|||
126542949|NCT00682643|455279722|FG001|Overall Study|Withdrawal by Subject|53|||
126542950|NCT00682643|455279721|FG000|Overall Study|Did Not Receive Study Drug|1|||
126542951|NCT00682643|455279722|FG001|Overall Study|Did Not Receive Study Drug|1|||
126542952|NCT01833143|455279725|FG000|Overall Study|Not Treated|1|||
126542953|NCT03995784|455279726|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
126542954|NCT01446796|455281936|FG000|Overall Study|Withdrawal by Subject|1|||
126542955|NCT01446796|455281937|FG001|Overall Study|Withdrawal by Subject|0|||
126542956|NCT02424591|455281938|FG000|Overall Study|Protocol Violation|2|||
126542957|NCT02424591|455281939|FG001|Overall Study|Protocol Violation|3|||
126542958|NCT00312702|455281940|FG000|Immunization Phase|Lost to Follow-up|0|||
126542959|NCT00312702|455281941|FG001|Immunization Phase|Lost to Follow-up|1|||
126542960|NCT00312702|455281942|FG002|Immunization Phase|Lost to Follow-up|0|||
126542961|NCT04581200|455281945|FG000|Overall Study|Lost to Follow-up|6|||
126542962|NCT04581200|455281946|FG001|Overall Study|Lost to Follow-up|5|||
126316877|NCT00195494|454450844|FG003|Year 1|Adverse Event|0|||
126316878|NCT00195494|454450845|FG004|Year 1|Adverse Event|34|||
126316879|NCT00195494|454450846|FG005|Year 1|Adverse Event|27|||
126316880|NCT00195494|454450841|FG000|Year 1|System Toxicity|0|||
126316881|NCT00195494|454450842|FG001|Year 1|System Toxicity|0|||
126316882|NCT00195494|454450843|FG002|Year 1|System Toxicity|0|||
126316883|NCT00195494|454450844|FG003|Year 1|System Toxicity|0|||
126316884|NCT00195494|454450845|FG004|Year 1|System Toxicity|0|||
126316885|NCT00195494|454450846|FG005|Year 1|System Toxicity|1|||
126316886|NCT00195494|454450841|FG000|Year 1|Lack of Efficacy|0|||
126316887|NCT00195494|454450842|FG001|Year 1|Lack of Efficacy|0|||
126316888|NCT00195494|454450843|FG002|Year 1|Lack of Efficacy|0|||
126316889|NCT00195494|454450844|FG003|Year 1|Lack of Efficacy|0|||
126316890|NCT00195494|454450845|FG004|Year 1|Lack of Efficacy|24|||
126316891|NCT00195494|454450846|FG005|Year 1|Lack of Efficacy|9|||
126316892|NCT00195494|454450841|FG000|Year 1|Compliance|0|||
126316893|NCT00195494|454450842|FG001|Year 1|Compliance|0|||
126316894|NCT00195494|454450843|FG002|Year 1|Compliance|0|||
126316895|NCT00195494|454450844|FG003|Year 1|Compliance|0|||
126316896|NCT00195494|454450845|FG004|Year 1|Compliance|5|||
126316897|NCT00195494|454450846|FG005|Year 1|Compliance|1|||
126316898|NCT00195494|454450841|FG000|Year 1|Lost to Follow-up|0|||
126316899|NCT00195494|454450842|FG001|Year 1|Lost to Follow-up|0|||
126316900|NCT00195494|454450843|FG002|Year 1|Lost to Follow-up|0|||
126316901|NCT00195494|454450844|FG003|Year 1|Lost to Follow-up|0|||
126316902|NCT00195494|454450845|FG004|Year 1|Lost to Follow-up|1|||
126316903|NCT00195494|454450846|FG005|Year 1|Lost to Follow-up|0|||
126316904|NCT00195494|454450841|FG000|Year 1|Missed >4 consecutive doses|0|||
126316905|NCT00195494|454450842|FG001|Year 1|Missed >4 consecutive doses|0|||
126316906|NCT00195494|454450843|FG002|Year 1|Missed >4 consecutive doses|0|||
126316907|NCT00195494|454450844|FG003|Year 1|Missed >4 consecutive doses|0|||
126316908|NCT00195494|454450845|FG004|Year 1|Missed >4 consecutive doses|3|||
126316909|NCT00195494|454450846|FG005|Year 1|Missed >4 consecutive doses|2|||
126316910|NCT00195494|454450841|FG000|Year 1|Protocol deviation|0|||
126316911|NCT00195494|454450842|FG001|Year 1|Protocol deviation|0|||
126316912|NCT00195494|454450843|FG002|Year 1|Protocol deviation|0|||
126316913|NCT00195494|454450844|FG003|Year 1|Protocol deviation|0|||
126316914|NCT00195494|454450845|FG004|Year 1|Protocol deviation|2|||
126316915|NCT00195494|454450846|FG005|Year 1|Protocol deviation|3|||
126316916|NCT00195494|454450841|FG000|Year 1|Physician Decision|0|||
126316917|NCT00195494|454450842|FG001|Year 1|Physician Decision|0|||
126316918|NCT00195494|454450843|FG002|Year 1|Physician Decision|0|||
126316919|NCT00195494|454450844|FG003|Year 1|Physician Decision|0|||
126316920|NCT00195494|454450845|FG004|Year 1|Physician Decision|1|||
126316921|NCT00195494|454450846|FG005|Year 1|Physician Decision|0|||
126316922|NCT00195494|454450841|FG000|Year 1|Withdrawal by Subject|0|||
126316923|NCT00195494|454450842|FG001|Year 1|Withdrawal by Subject|0|||
126316924|NCT00195494|454450843|FG002|Year 1|Withdrawal by Subject|0|||
126316925|NCT00195494|454450844|FG003|Year 1|Withdrawal by Subject|0|||
126316926|NCT00195494|454450845|FG004|Year 1|Withdrawal by Subject|8|||
126316927|NCT00195494|454450846|FG005|Year 1|Withdrawal by Subject|9|||
126316928|NCT00195494|454450841|FG000|Year 1|Protocol Violation|0|||
126316929|NCT00195494|454450842|FG001|Year 1|Protocol Violation|0|||
126316930|NCT00195494|454450843|FG002|Year 1|Protocol Violation|0|||
126316931|NCT00195494|454450844|FG003|Year 1|Protocol Violation|0|||
126316932|NCT00195494|454450845|FG004|Year 1|Protocol Violation|1|||
126316933|NCT00195494|454450846|FG005|Year 1|Protocol Violation|1|||
126316934|NCT00195494|454450841|FG000|Year 2|Adverse Event|3|||
126316935|NCT00195494|454450842|FG001|Year 2|Adverse Event|7|||
126316936|NCT00195494|454450843|FG002|Year 2|Adverse Event|5|||
126316937|NCT00195494|454450844|FG003|Year 2|Adverse Event|9|||
126316938|NCT00195494|454450845|FG004|Year 2|Adverse Event|0|||
126316939|NCT00195494|454450846|FG005|Year 2|Adverse Event|0|||
126316940|NCT00195494|454450841|FG000|Year 2|Lack of Efficacy|0|||
126316941|NCT00195494|454450842|FG001|Year 2|Lack of Efficacy|1|||
126316942|NCT00195494|454450843|FG002|Year 2|Lack of Efficacy|7|||
126316943|NCT00195494|454450844|FG003|Year 2|Lack of Efficacy|7|||
126316944|NCT00195494|454450845|FG004|Year 2|Lack of Efficacy|0|||
126316945|NCT00195494|454450846|FG005|Year 2|Lack of Efficacy|0|||
126316946|NCT00195494|454450841|FG000|Year 2|Compliance|1|||
126316947|NCT00195494|454450842|FG001|Year 2|Compliance|0|||
126316948|NCT00195494|454450843|FG002|Year 2|Compliance|0|||
126316949|NCT00195494|454450844|FG003|Year 2|Compliance|2|||
126316950|NCT00195494|454450845|FG004|Year 2|Compliance|0|||
126316951|NCT00195494|454450846|FG005|Year 2|Compliance|0|||
126316952|NCT00195494|454450841|FG000|Year 2|Lost to Follow-up|0|||
126316953|NCT00195494|454450842|FG001|Year 2|Lost to Follow-up|0|||
126316954|NCT00195494|454450843|FG002|Year 2|Lost to Follow-up|1|||
126316955|NCT00195494|454450844|FG003|Year 2|Lost to Follow-up|1|||
126316956|NCT00195494|454450845|FG004|Year 2|Lost to Follow-up|0|||
126316957|NCT00195494|454450846|FG005|Year 2|Lost to Follow-up|0|||
126316958|NCT00195494|454450841|FG000|Year 2|Missed >4 consecutive doses|1|||
126316959|NCT00195494|454450842|FG001|Year 2|Missed >4 consecutive doses|1|||
126316960|NCT00195494|454450843|FG002|Year 2|Missed >4 consecutive doses|1|||
126316961|NCT00195494|454450844|FG003|Year 2|Missed >4 consecutive doses|0|||
126316962|NCT00195494|454450845|FG004|Year 2|Missed >4 consecutive doses|0|||
126316963|NCT00195494|454450846|FG005|Year 2|Missed >4 consecutive doses|0|||
126316964|NCT00195494|454450841|FG000|Year 2|Protocol deviation|0|||
126316965|NCT00195494|454450842|FG001|Year 2|Protocol deviation|1|||
126316966|NCT00195494|454450843|FG002|Year 2|Protocol deviation|0|||
126316967|NCT00195494|454450844|FG003|Year 2|Protocol deviation|0|||
126316968|NCT00195494|454450845|FG004|Year 2|Protocol deviation|0|||
126316969|NCT00195494|454450846|FG005|Year 2|Protocol deviation|0|||
126316970|NCT00195494|454450841|FG000|Year 2|Physician Decision|1|||
126316971|NCT00195494|454450842|FG001|Year 2|Physician Decision|1|||
126316972|NCT00195494|454450843|FG002|Year 2|Physician Decision|0|||
126316973|NCT00195494|454450844|FG003|Year 2|Physician Decision|0|||
126316974|NCT00195494|454450845|FG004|Year 2|Physician Decision|0|||
126316975|NCT00195494|454450846|FG005|Year 2|Physician Decision|0|||
126316976|NCT00195494|454450841|FG000|Year 2|Withdrawal by Subject|1|||
126316977|NCT00195494|454450842|FG001|Year 2|Withdrawal by Subject|5|||
126316978|NCT00195494|454450843|FG002|Year 2|Withdrawal by Subject|4|||
126316979|NCT00195494|454450844|FG003|Year 2|Withdrawal by Subject|3|||
126316980|NCT00195494|454450845|FG004|Year 2|Withdrawal by Subject|0|||
126316981|NCT00195494|454450846|FG005|Year 2|Withdrawal by Subject|0|||
126316982|NCT00195494|454450841|FG000|Year 2|System toxicity|0|||
126316983|NCT00195494|454450842|FG001|Year 2|System toxicity|0|||
126316984|NCT00195494|454450843|FG002|Year 2|System toxicity|0|||
126316985|NCT00195494|454450844|FG003|Year 2|System toxicity|1|||
126316986|NCT00195494|454450845|FG004|Year 2|System toxicity|0|||
126316987|NCT00195494|454450846|FG005|Year 2|System toxicity|0|||
126316988|NCT03008278|454450847|FG000|Overall Study|Progressive Disease|0|||
126316989|NCT03008278|454450848|FG001|Overall Study|Progressive Disease|0|||
126316990|NCT03008278|454450849|FG002|Overall Study|Progressive Disease|32|||
126316991|NCT03008278|454450847|FG000|Overall Study|Adverse Event|0|||
126316992|NCT03008278|454450848|FG001|Overall Study|Adverse Event|0|||
126316993|NCT03008278|454450849|FG002|Overall Study|Adverse Event|4|||
126316994|NCT03008278|454450847|FG000|Overall Study|Withdrawal by Subject|0|||
126316995|NCT03008278|454450848|FG001|Overall Study|Withdrawal by Subject|0|||
126316996|NCT03008278|454450849|FG002|Overall Study|Withdrawal by Subject|3|||
126316997|NCT03008278|454450847|FG000|Overall Study|Physician Decision|0|||
126316998|NCT03008278|454450848|FG001|Overall Study|Physician Decision|2|||
126316999|NCT03008278|454450849|FG002|Overall Study|Physician Decision|0|||
126317000|NCT01217385|454450854|FG000|Overall Study|Withdrawal by Subject|3|||
126317001|NCT01217385|454450854|FG000|Overall Study|DOSI not performed/not eval|12|||
126317002|NCT01217385|454450854|FG000|Overall Study|Central Path not Available|1|||
126317003|NCT01217385|454450854|FG000|Overall Study|Normal Breast TOI not available|10|||
126317004|NCT00835679|454450856|FG000|Overall Study|Withdrawal by Subject|1|||
126317005|NCT00835679|454450857|FG001|Overall Study|Withdrawal by Subject|0|||
126317006|NCT00835679|454450858|FG002|Overall Study|Withdrawal by Subject|0|||
126317007|NCT00835679|454450859|FG003|Overall Study|Withdrawal by Subject|0|||
126317008|NCT04769739|454450861|FG000|Overall Study|Colorectal cancer obstruction|2|||
126317009|NCT04769739|454450862|FG001|Overall Study|Colorectal cancer obstruction|0|||
126317010|NCT04769739|454450863|FG002|Overall Study|Colorectal cancer obstruction|0|||
126317011|NCT04769739|454450864|FG003|Overall Study|Colorectal cancer obstruction|0|||
126317012|NCT04769739|454450861|FG000|Overall Study|Failed cecal intubation|1|||
126317013|NCT04769739|454450862|FG001|Overall Study|Failed cecal intubation|0|||
126317014|NCT04769739|454450863|FG002|Overall Study|Failed cecal intubation|0|||
126317015|NCT04769739|454450864|FG003|Overall Study|Failed cecal intubation|1|||
126317016|NCT04769739|454450861|FG000|Overall Study|Poor bowel preparation|0|||
126317017|NCT04769739|454450862|FG001|Overall Study|Poor bowel preparation|0|||
126317018|NCT04769739|454450863|FG002|Overall Study|Poor bowel preparation|0|||
126317019|NCT04769739|454450864|FG003|Overall Study|Poor bowel preparation|1|||
126317020|NCT03689543|454450866|FG000|Overall Study|Adverse Event|0|||
126317021|NCT03689543|454450867|FG001|Overall Study|Adverse Event|0|||
126317022|NCT03689543|454450868|FG002|Overall Study|Adverse Event|1|||
126317023|NCT01634659|454450874|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
126317024|NCT01634659|454450875|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
126317025|NCT01634659|454450874|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
126317026|NCT01634659|454450875|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
126317027|NCT02431806|454450876|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
126317028|NCT02431806|454450877|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
126317029|NCT02431806|454450878|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
126317030|NCT02431806|454450879|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
126317031|NCT02431806|454450876|FG000|Double-blind Treatment Period|Adverse Event|4|||
126317032|NCT02431806|454450877|FG001|Double-blind Treatment Period|Adverse Event|7|||
126317033|NCT02431806|454450878|FG002|Double-blind Treatment Period|Adverse Event|11|||
126317034|NCT02431806|454450879|FG003|Double-blind Treatment Period|Adverse Event|7|||
126317035|NCT02431806|454450876|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
126317036|NCT02431806|454450877|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
126317037|NCT02431806|454450878|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
126317038|NCT02431806|454450879|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
126317039|NCT02431806|454450876|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
126317040|NCT02431806|454450877|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
126317041|NCT02431806|454450878|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
126317042|NCT02431806|454450879|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
126317043|NCT02431806|454450876|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
126317044|NCT02431806|454450877|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
126317045|NCT02431806|454450878|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
126317046|NCT02431806|454450879|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
126317047|NCT02431806|454450876|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
126317048|NCT02431806|454450877|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
126317049|NCT02431806|454450878|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
126317050|NCT02431806|454450879|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
126317051|NCT02431806|454450876|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
126317052|NCT02431806|454450877|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
126317053|NCT02431806|454450878|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
126317054|NCT02431806|454450879|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
126317055|NCT03627416|454450880|FG000|Overall Study|Adverse Event|0|||
126317056|NCT03627416|454450881|FG001|Overall Study|Adverse Event|1|||
126317057|NCT02968433|454450882|FG000|Overall Study|Withdrawal by Subject|1|||
126317058|NCT03619902|454450883|FG000|Overall Study|Termination of Study by Investigator|1|||
126317059|NCT03619902|454450883|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
126317060|NCT04506905|454450884|FG000|Overall Study|Lost to Follow-up|1|||
126317061|NCT04506905|454450885|FG001|Overall Study|Lost to Follow-up|0|||
126317062|NCT04506905|454450886|FG002|Overall Study|Lost to Follow-up|0|||
126317063|NCT04506905|454450887|FG003|Overall Study|Lost to Follow-up|1|||
126317064|NCT04506905|454450888|FG004|Overall Study|Lost to Follow-up|0|||
126317065|NCT04506905|454450889|FG005|Overall Study|Lost to Follow-up|0|||
126542963|NCT04404478|455281950|FG000|Overall Study|Withdrawal by Subject|1|||
126542964|NCT04404478|455281951|FG001|Overall Study|Withdrawal by Subject|3|||
126542965|NCT02904902|455281952|FG000|Overall Study|Withdrawal by Subject|1|||
126542966|NCT01216163|455281956|FG000|Overall Study|Withdrawal by Subject|1|||
126542967|NCT01216163|455281957|FG001|Overall Study|Withdrawal by Subject|1|||
126542968|NCT01216163|455281958|FG002|Overall Study|Withdrawal by Subject|0|||
126542969|NCT02002182|455281966|FG000|Overall Study|Withdraw from study|3|||
126542970|NCT02002182|455281967|FG001|Overall Study|Withdraw from study|1|||
126542971|NCT02002182|455281966|FG000|Overall Study|Health Reasons|1|||
126542972|NCT02002182|455281967|FG001|Overall Study|Health Reasons|0|||
126542973|NCT02002182|455281966|FG000|Overall Study|Death|1|||
126542974|NCT02002182|455281967|FG001|Overall Study|Death|0|||
126542975|NCT01597505|455281970|FG000|Overall Study|Physician Decision|5|||
126542976|NCT01597505|455281971|FG001|Overall Study|Physician Decision|0|||
126542977|NCT01597505|455281970|FG000|Overall Study|Adverse Event|19|||
126542978|NCT01597505|455281971|FG001|Overall Study|Adverse Event|7|||
126542979|NCT01597505|455281970|FG000|Overall Study|Lost to Follow-up|4|||
126542980|NCT01597505|455281971|FG001|Overall Study|Lost to Follow-up|2|||
126542981|NCT01597505|455281970|FG000|Overall Study|Withdrawal by Subject|10|||
126542982|NCT01597505|455281971|FG001|Overall Study|Withdrawal by Subject|18|||
126542983|NCT01597505|455281970|FG000|Overall Study|Other|5|||
126542984|NCT01597505|455281971|FG001|Overall Study|Other|6|||
126542985|NCT01597505|455281970|FG000|Overall Study|Missing|1|||
126542986|NCT01597505|455281971|FG001|Overall Study|Missing|0|||
126317066|NCT04506905|454450890|FG006|Overall Study|Lost to Follow-up|0|||
126317067|NCT04506905|454450891|FG007|Overall Study|Lost to Follow-up|0|||
126317068|NCT04506905|454450892|FG008|Overall Study|Lost to Follow-up|0|||
126317069|NCT04506905|454450884|FG000|Overall Study|Withdrawal by Subject|0|||
126317070|NCT04506905|454450885|FG001|Overall Study|Withdrawal by Subject|0|||
126317071|NCT04506905|454450886|FG002|Overall Study|Withdrawal by Subject|0|||
126317072|NCT04506905|454450887|FG003|Overall Study|Withdrawal by Subject|2|||
126317073|NCT04506905|454450888|FG004|Overall Study|Withdrawal by Subject|0|||
126317074|NCT04506905|454450889|FG005|Overall Study|Withdrawal by Subject|0|||
126317075|NCT04506905|454450890|FG006|Overall Study|Withdrawal by Subject|0|||
126317076|NCT04506905|454450891|FG007|Overall Study|Withdrawal by Subject|0|||
126317077|NCT04506905|454450892|FG008|Overall Study|Withdrawal by Subject|0|||
126317078|NCT05072106|454452035|FG000|Overall Study|Progressive disease|3|||
126317079|NCT05072106|454452036|FG001|Overall Study|Progressive disease|3|||
126317080|NCT05072106|454452035|FG000|Overall Study|Compassionate use|3|||
126317081|NCT05072106|454452036|FG001|Overall Study|Compassionate use|1|||
126317082|NCT05072106|454452035|FG000|Overall Study|Withdrawal by Subject|1|||
126317083|NCT05072106|454452036|FG001|Overall Study|Withdrawal by Subject|0|||
126317084|NCT03839459|454452037|FG000|Overall Study|Withdrawal by Subject|2|||
126317085|NCT03839459|454452037|FG000|Overall Study|progression of disease|3|||
126317086|NCT05940077|454452038|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
126317087|NCT02304380|454452039|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
126317088|NCT02304380|454452040|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
126317089|NCT02304380|454452041|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
126317090|NCT02304380|454452042|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
126317091|NCT02304380|454452043|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
126317092|NCT02304380|454452044|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
126317093|NCT00328094|454452047|FG000|Overall Study|Physician Decision|3|||
126317094|NCT00328094|454452048|FG001|Overall Study|Physician Decision|3|||
126317095|NCT00590538|454452049|FG000|Overall Study|Study terminated before completed|2|||
126317096|NCT02309723|454452050|FG000|Overall Study|Withdrawal by Subject|24|||
126317097|NCT02309723|454452051|FG001|Overall Study|Withdrawal by Subject|23|||
126317098|NCT02309723|454452052|FG002|Overall Study|Withdrawal by Subject|24|||
126317099|NCT01125813|454452053|FG000|Overall Study|Death|1|||
126317100|NCT01125813|454452053|FG000|Overall Study|Withdrawal by Subject|1|||
126317101|NCT01125813|454452053|FG000|Overall Study|Screen Failures|4|||
126317102|NCT00985426|454452054|FG000|Overall Study|Adverse Event|0|||
126317103|NCT00985426|454452055|FG001|Overall Study|Adverse Event|1|||
126542987|NCT04296890|455281972|FG000|Overall Study|Withdrawal by Subject|1|||
126542988|NCT04296890|455281972|FG000|Overall Study|Death|62|||
126542989|NCT04296890|455281972|FG000|Overall Study|Lost to Follow-up|3|||
126542990|NCT04296890|455281972|FG000|Overall Study|Other than specified|2|||
126542991|NCT05400746|455281973|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
126542992|NCT05400746|455281974|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
126542993|NCT05400746|455281975|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
126542994|NCT05454410|455281976|FG000|Overall Study|Withdrawal by Subject|0|||
126542995|NCT05454410|455281977|FG001|Overall Study|Withdrawal by Subject|0|||
126542996|NCT05454410|455281978|FG002|Overall Study|Withdrawal by Subject|1|||
126542997|NCT05454410|455281979|FG003|Overall Study|Withdrawal by Subject|1|||
126542998|NCT05004688|455281990|FG000|Overall Study|Protocol Violation|7|||
126542999|NCT05004688|455281990|FG000|Overall Study|Physician Decision|2|||
126543000|NCT05004688|455281990|FG000|Overall Study|Withdrawal by Subject|2|||
126543001|NCT03879408|455281991|FG000|Overall Study|Lost to Follow-up|0|||
126543002|NCT03879408|455281992|FG001|Overall Study|Lost to Follow-up|3|||
126543003|NCT03879408|455281993|FG002|Overall Study|Lost to Follow-up|2|||
126543004|NCT03879408|455281994|FG003|Overall Study|Lost to Follow-up|1|||
126543005|NCT03879408|455281995|FG004|Overall Study|Lost to Follow-up|0|||
126543006|NCT03879408|455281991|FG000|Overall Study|Withdrawal by Subject|2|||
126543007|NCT03879408|455281992|FG001|Overall Study|Withdrawal by Subject|1|||
126543008|NCT03879408|455281993|FG002|Overall Study|Withdrawal by Subject|1|||
126543009|NCT03879408|455281994|FG003|Overall Study|Withdrawal by Subject|0|||
126317104|NCT00985426|454452054|FG000|Overall Study|Subject Non-Compliance|3|||
126317105|NCT00985426|454452055|FG001|Overall Study|Subject Non-Compliance|3|||
126317106|NCT00985426|454452054|FG000|Overall Study|Withdrawal by Subject|12|||
126317107|NCT00985426|454452055|FG001|Overall Study|Withdrawal by Subject|16|||
126317108|NCT00985426|454452054|FG000|Overall Study|Lost to Follow-up|8|||
126317109|NCT00985426|454452055|FG001|Overall Study|Lost to Follow-up|10|||
126317110|NCT00985426|454452054|FG000|Overall Study|Death|7|||
126317111|NCT00985426|454452055|FG001|Overall Study|Death|3|||
126543010|NCT03879408|455281995|FG004|Overall Study|Withdrawal by Subject|1|||
126648206|NCT01280357|455669714|FG000|Overall Study|IInsufficient data/No data supplied|12|||
126317112|NCT00985426|454452054|FG000|Overall Study|Protocol Violation|2|||
126317113|NCT00985426|454452055|FG001|Overall Study|Protocol Violation|0|||
126543011|NCT00728962|455281999|FG000|Implant Placement Surgery|Adverse Event|8|||
126543012|NCT00728962|455281999|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
126317114|NCT00985426|454452054|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
126317115|NCT00985426|454452055|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
126317116|NCT02327013|454452056|FG000|Overall Study|Adverse Event|4|||
126317117|NCT02327013|454452057|FG001|Overall Study|Adverse Event|4|||
126317118|NCT02327013|454452058|FG002|Overall Study|Adverse Event|3|||
126317119|NCT02327013|454452059|FG003|Overall Study|Adverse Event|0|||
126317120|NCT02327013|454452060|FG004|Overall Study|Adverse Event|1|||
126317121|NCT02327013|454452056|FG000|Overall Study|Lack of Efficacy|2|||
126317122|NCT02327013|454452057|FG001|Overall Study|Lack of Efficacy|0|||
126317123|NCT02327013|454452058|FG002|Overall Study|Lack of Efficacy|5|||
126317124|NCT02327013|454452059|FG003|Overall Study|Lack of Efficacy|0|||
126317125|NCT02327013|454452060|FG004|Overall Study|Lack of Efficacy|1|||
126317126|NCT02327013|454452056|FG000|Overall Study|Non-compliance with IMP|1|||
126317127|NCT02327013|454452057|FG001|Overall Study|Non-compliance with IMP|2|||
126317128|NCT02327013|454452058|FG002|Overall Study|Non-compliance with IMP|7|||
126317129|NCT02327013|454452059|FG003|Overall Study|Non-compliance with IMP|0|||
126317130|NCT02327013|454452060|FG004|Overall Study|Non-compliance with IMP|0|||
126317131|NCT02327013|454452056|FG000|Overall Study|Withdrawal of Consent|1|||
126317132|NCT02327013|454452057|FG001|Overall Study|Withdrawal of Consent|0|||
126317133|NCT02327013|454452058|FG002|Overall Study|Withdrawal of Consent|3|||
126317134|NCT02327013|454452059|FG003|Overall Study|Withdrawal of Consent|0|||
126317135|NCT02327013|454452060|FG004|Overall Study|Withdrawal of Consent|0|||
126317136|NCT02327013|454452056|FG000|Overall Study|Lost to Follow-up|2|||
126317137|NCT02327013|454452057|FG001|Overall Study|Lost to Follow-up|4|||
126317138|NCT02327013|454452058|FG002|Overall Study|Lost to Follow-up|5|||
126317139|NCT02327013|454452059|FG003|Overall Study|Lost to Follow-up|0|||
126317140|NCT02327013|454452060|FG004|Overall Study|Lost to Follow-up|0|||
126317141|NCT02327013|454452056|FG000|Overall Study|Administrative or other reason(s)|1|||
126317142|NCT02327013|454452057|FG001|Overall Study|Administrative or other reason(s)|5|||
126317143|NCT02327013|454452058|FG002|Overall Study|Administrative or other reason(s)|11|||
126317144|NCT02327013|454452059|FG003|Overall Study|Administrative or other reason(s)|1|||
126317145|NCT02327013|454452060|FG004|Overall Study|Administrative or other reason(s)|1|||
126317146|NCT02327013|454452056|FG000|Overall Study|Protocol Violation|0|||
126317147|NCT02327013|454452057|FG001|Overall Study|Protocol Violation|0|||
126317148|NCT02327013|454452058|FG002|Overall Study|Protocol Violation|3|||
126317149|NCT02327013|454452059|FG003|Overall Study|Protocol Violation|0|||
126317150|NCT02327013|454452060|FG004|Overall Study|Protocol Violation|1|||
126317151|NCT02327013|454452056|FG000|Overall Study|Withdrawal before treatment|2|||
126317152|NCT02327013|454452057|FG001|Overall Study|Withdrawal before treatment|1|||
126317153|NCT02327013|454452058|FG002|Overall Study|Withdrawal before treatment|5|||
126317154|NCT02327013|454452059|FG003|Overall Study|Withdrawal before treatment|0|||
126317155|NCT02327013|454452060|FG004|Overall Study|Withdrawal before treatment|0|||
126317156|NCT01565668|454452061|FG000|Overall Study|Death|2|||
126317157|NCT01565668|454452062|FG001|Overall Study|Death|1|||
126317158|NCT01565668|454452061|FG000|Overall Study|Lack of Efficacy|4|||
126317159|NCT01565668|454452062|FG001|Overall Study|Lack of Efficacy|2|||
126317160|NCT01565668|454452061|FG000|Overall Study|Participant went on Hospice Care|1|||
126317161|NCT01565668|454452062|FG001|Overall Study|Participant went on Hospice Care|0|||
126317162|NCT01565668|454452061|FG000|Overall Study|Adverse Event|6|||
126317163|NCT01565668|454452062|FG001|Overall Study|Adverse Event|1|||
126317164|NCT01565668|454452061|FG000|Overall Study|Randomized, but never received drug|0|||
126317165|NCT01565668|454452062|FG001|Overall Study|Randomized, but never received drug|2|||
126317166|NCT01565668|454452061|FG000|Overall Study|Progressive disease|13|||
126317167|NCT01565668|454452062|FG001|Overall Study|Progressive disease|14|||
126317168|NCT01565668|454452061|FG000|Overall Study|Withdrawal by Subject|1|||
126317169|NCT01565668|454452062|FG001|Overall Study|Withdrawal by Subject|3|||
126317170|NCT01565668|454452061|FG000|Overall Study|HSCT Transplant|11|||
126317171|NCT01565668|454452062|FG001|Overall Study|HSCT Transplant|15|||
126317172|NCT02255552|454452063|FG000|Overall Study|Participants enrolled into another study|0|||
126317173|NCT02255552|454452064|FG001|Overall Study|Participants enrolled into another study|11|||
126317174|NCT02255552|454452063|FG000|Overall Study|Withdrawal by Subject|1|||
126317175|NCT02255552|454452064|FG001|Overall Study|Withdrawal by Subject|4|||
126317176|NCT02956057|454452070|FG000|Overall Study|Discontinued intervention|14|||
126317177|NCT02956057|454452071|FG001|Overall Study|Discontinued intervention|10|||
126317178|NCT02956057|454452072|FG002|Overall Study|Discontinued intervention|7|||
126317179|NCT02956057|454452073|FG003|Overall Study|Discontinued intervention|14|||
126317180|NCT02956057|454452074|FG004|Overall Study|Discontinued intervention|4|||
126317181|NCT02956057|454452075|FG005|Overall Study|Discontinued intervention|17|||
126317182|NCT02956057|454452070|FG000|Overall Study|Lost to Follow-up|0|||
126317183|NCT02956057|454452071|FG001|Overall Study|Lost to Follow-up|2|||
126317184|NCT02956057|454452072|FG002|Overall Study|Lost to Follow-up|1|||
126317185|NCT02956057|454452073|FG003|Overall Study|Lost to Follow-up|1|||
126317186|NCT02956057|454452074|FG004|Overall Study|Lost to Follow-up|1|||
126317187|NCT02956057|454452075|FG005|Overall Study|Lost to Follow-up|0|||
126317188|NCT03422159|454452081|FG000|Overall Study|Exclusion due to terminal disease|2|||
126317189|NCT03422159|454452082|FG001|Overall Study|Exclusion due to terminal disease|1|||
126317190|NCT00087126|454452086|FG000|Overall Study|Ineligible - second primary|1|||
126317191|NCT00087126|454452086|FG000|Overall Study|Never treated|1|||
126317192|NCT00934856|454452087|FG000|Feasibility Part|Progressive disease|4|||
126317193|NCT00934856|454452088|FG001|Feasibility Part|Progressive disease|4|||
126317194|NCT00934856|454452089|FG002|Feasibility Part|Progressive disease|2|||
126317195|NCT00934856|454452090|FG003|Feasibility Part|Progressive disease|3|||
126317196|NCT00934856|454452091|FG004|Feasibility Part|Progressive disease|0|||
126317197|NCT00934856|454452092|FG005|Feasibility Part|Progressive disease|0|||
126317198|NCT00934856|454452087|FG000|Feasibility Part|Physician Decision|0|||
126317199|NCT00934856|454452088|FG001|Feasibility Part|Physician Decision|0|||
126317200|NCT00934856|454452089|FG002|Feasibility Part|Physician Decision|1|||
126317201|NCT00934856|454452090|FG003|Feasibility Part|Physician Decision|0|||
126317202|NCT00934856|454452091|FG004|Feasibility Part|Physician Decision|0|||
126317203|NCT00934856|454452092|FG005|Feasibility Part|Physician Decision|0|||
126317204|NCT00934856|454452087|FG000|Feasibility Part|Adverse Event|1|||
126317205|NCT00934856|454452088|FG001|Feasibility Part|Adverse Event|1|||
126317206|NCT00934856|454452089|FG002|Feasibility Part|Adverse Event|0|||
126317207|NCT00934856|454452090|FG003|Feasibility Part|Adverse Event|1|||
126317208|NCT00934856|454452091|FG004|Feasibility Part|Adverse Event|0|||
126317209|NCT00934856|454452092|FG005|Feasibility Part|Adverse Event|2|||
126317210|NCT00934856|454452087|FG000|Feasibility Part|Withdrawal by Subject|0|||
126317211|NCT00934856|454452088|FG001|Feasibility Part|Withdrawal by Subject|0|||
126317212|NCT00934856|454452089|FG002|Feasibility Part|Withdrawal by Subject|0|||
126317213|NCT00934856|454452090|FG003|Feasibility Part|Withdrawal by Subject|1|||
126317214|NCT00934856|454452091|FG004|Feasibility Part|Withdrawal by Subject|0|||
126317215|NCT00934856|454452092|FG005|Feasibility Part|Withdrawal by Subject|1|||
126317216|NCT00934856|454452087|FG000|Extension Part|Adverse Event|0|||
126317217|NCT00934856|454452088|FG001|Extension Part|Adverse Event|0|||
126317218|NCT00934856|454452089|FG002|Extension Part|Adverse Event|0|||
126317219|NCT00934856|454452090|FG003|Extension Part|Adverse Event|1|||
126317220|NCT00934856|454452091|FG004|Extension Part|Adverse Event|4|||
126317221|NCT00934856|454452092|FG005|Extension Part|Adverse Event|4|||
126317222|NCT00934856|454452087|FG000|Extension Part|Progressive disease|0|||
126317223|NCT00934856|454452088|FG001|Extension Part|Progressive disease|0|||
126317224|NCT00934856|454452089|FG002|Extension Part|Progressive disease|0|||
126317225|NCT00934856|454452090|FG003|Extension Part|Progressive disease|1|||
126317226|NCT00934856|454452091|FG004|Extension Part|Progressive disease|0|||
126317227|NCT00934856|454452092|FG005|Extension Part|Progressive disease|0|||
126317228|NCT00934856|454452087|FG000|Extension Part|Non-compliance with drug|0|||
126317229|NCT00934856|454452088|FG001|Extension Part|Non-compliance with drug|0|||
126317230|NCT00934856|454452089|FG002|Extension Part|Non-compliance with drug|0|||
126317231|NCT00934856|454452090|FG003|Extension Part|Non-compliance with drug|0|||
126317232|NCT00934856|454452091|FG004|Extension Part|Non-compliance with drug|0|||
126317233|NCT00934856|454452092|FG005|Extension Part|Non-compliance with drug|1|||
126317234|NCT01256385|454452093|FG000|Overall Study|Physician Decision|1|||
126317235|NCT01256385|454452094|FG001|Overall Study|Physician Decision|1|||
126317236|NCT01256385|454452093|FG000|Overall Study|Withdrawal by Subject|2|||
126317237|NCT01256385|454452094|FG001|Overall Study|Withdrawal by Subject|2|||
126317238|NCT00513357|454452095|FG000|Overall Study|did not receive allocated placebo|2|||
126317239|NCT00513357|454452096|FG001|Overall Study|did not receive allocated placebo|3|||
126317240|NCT00513357|454452095|FG000|Overall Study|Adverse Event|4|||
126317241|NCT00513357|454452096|FG001|Overall Study|Adverse Event|2|||
126317242|NCT00513357|454452095|FG000|Overall Study|Death|2|||
126317243|NCT00513357|454452096|FG001|Overall Study|Death|0|||
126317244|NCT00513357|454452095|FG000|Overall Study|Withdrawal by Subject|5|||
126317245|NCT00513357|454452096|FG001|Overall Study|Withdrawal by Subject|4|||
126317246|NCT00513357|454452095|FG000|Overall Study|Disease Progression|2|||
126317247|NCT00513357|454452096|FG001|Overall Study|Disease Progression|1|||
126317248|NCT00090987|454452097|FG000|Overall Study|Adverse Event|5|||
126317249|NCT00090987|454452097|FG000|Overall Study|Lack of Efficacy|7|||
126317250|NCT00090987|454452097|FG000|Overall Study|Withdrawal by Subject|3|||
126317251|NCT00090987|454452097|FG000|Overall Study|alternative therapy|1|||
126317252|NCT00090987|454452097|FG000|Overall Study|Non-compliance|4|||
126317253|NCT00090987|454452097|FG000|Overall Study|Incarcerated|1|||
126317254|NCT02079636|454452110|FG000|Overall Study|Death|2|||
126317255|NCT02079636|454452111|FG001|Overall Study|Death|1|||
126317256|NCT02079636|454452112|FG002|Overall Study|Death|0|||
126543013|NCT00728962|455281999|FG000|Implant Placement Surgery|Protocol Violation|1|||
126543014|NCT00728962|455281999|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
126543015|NCT00728962|455281999|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
126317257|NCT02079636|454452113|FG003|Overall Study|Death|5|||
126317258|NCT02079636|454452114|FG004|Overall Study|Death|1|||
126317259|NCT02079636|454452115|FG005|Overall Study|Death|2|||
126317260|NCT02079636|454452116|FG006|Overall Study|Death|1|||
126317261|NCT02079636|454452117|FG007|Overall Study|Death|0|||
126317262|NCT02079636|454452118|FG008|Overall Study|Death|0|||
126317263|NCT02079636|454452119|FG009|Overall Study|Death|0|||
126317264|NCT02079636|454452120|FG010|Overall Study|Death|0|||
126317265|NCT02079636|454452121|FG011|Overall Study|Death|1|||
126317266|NCT02079636|454452122|FG012|Overall Study|Death|1|||
126317267|NCT02079636|454452123|FG013|Overall Study|Death|0|||
126317268|NCT02079636|454452124|FG014|Overall Study|Death|2|||
126317269|NCT02079636|454452110|FG000|Overall Study|Adverse Event|1|||
126317270|NCT02079636|454452111|FG001|Overall Study|Adverse Event|1|||
126317271|NCT02079636|454452112|FG002|Overall Study|Adverse Event|0|||
126317272|NCT02079636|454452113|FG003|Overall Study|Adverse Event|1|||
126317273|NCT02079636|454452114|FG004|Overall Study|Adverse Event|1|||
126317274|NCT02079636|454452115|FG005|Overall Study|Adverse Event|2|||
126317275|NCT02079636|454452116|FG006|Overall Study|Adverse Event|0|||
126317276|NCT02079636|454452117|FG007|Overall Study|Adverse Event|0|||
126317277|NCT02079636|454452118|FG008|Overall Study|Adverse Event|0|||
126317278|NCT02079636|454452119|FG009|Overall Study|Adverse Event|0|||
126317279|NCT02079636|454452120|FG010|Overall Study|Adverse Event|0|||
126317280|NCT02079636|454452121|FG011|Overall Study|Adverse Event|0|||
126317281|NCT02079636|454452122|FG012|Overall Study|Adverse Event|0|||
126317282|NCT02079636|454452123|FG013|Overall Study|Adverse Event|0|||
126317283|NCT02079636|454452124|FG014|Overall Study|Adverse Event|0|||
126317284|NCT02079636|454452110|FG000|Overall Study|Progressive disease|0|||
126317285|NCT02079636|454452111|FG001|Overall Study|Progressive disease|0|||
126317286|NCT02079636|454452112|FG002|Overall Study|Progressive disease|0|||
126317287|NCT02079636|454452113|FG003|Overall Study|Progressive disease|2|||
126317288|NCT02079636|454452114|FG004|Overall Study|Progressive disease|0|||
126317289|NCT02079636|454452115|FG005|Overall Study|Progressive disease|0|||
126317290|NCT02079636|454452116|FG006|Overall Study|Progressive disease|0|||
126317291|NCT02079636|454452117|FG007|Overall Study|Progressive disease|0|||
126317292|NCT02079636|454452118|FG008|Overall Study|Progressive disease|0|||
126317293|NCT02079636|454452119|FG009|Overall Study|Progressive disease|0|||
126317294|NCT02079636|454452120|FG010|Overall Study|Progressive disease|0|||
126317295|NCT02079636|454452121|FG011|Overall Study|Progressive disease|0|||
126317296|NCT02079636|454452122|FG012|Overall Study|Progressive disease|1|||
126317297|NCT02079636|454452123|FG013|Overall Study|Progressive disease|0|||
126317298|NCT02079636|454452124|FG014|Overall Study|Progressive disease|0|||
126317299|NCT02079636|454452110|FG000|Overall Study|Withdrawal by Subject|0|||
126317300|NCT02079636|454452111|FG001|Overall Study|Withdrawal by Subject|0|||
126317301|NCT02079636|454452112|FG002|Overall Study|Withdrawal by Subject|0|||
126317302|NCT02079636|454452113|FG003|Overall Study|Withdrawal by Subject|4|||
126317303|NCT02079636|454452114|FG004|Overall Study|Withdrawal by Subject|0|||
126317304|NCT02079636|454452115|FG005|Overall Study|Withdrawal by Subject|1|||
126317305|NCT02079636|454452116|FG006|Overall Study|Withdrawal by Subject|0|||
126317306|NCT02079636|454452117|FG007|Overall Study|Withdrawal by Subject|0|||
126317307|NCT02079636|454452118|FG008|Overall Study|Withdrawal by Subject|0|||
126317308|NCT02079636|454452119|FG009|Overall Study|Withdrawal by Subject|2|||
126317309|NCT02079636|454452120|FG010|Overall Study|Withdrawal by Subject|1|||
126317310|NCT02079636|454452121|FG011|Overall Study|Withdrawal by Subject|1|||
126317311|NCT02079636|454452122|FG012|Overall Study|Withdrawal by Subject|1|||
126317312|NCT02079636|454452123|FG013|Overall Study|Withdrawal by Subject|0|||
126317313|NCT02079636|454452124|FG014|Overall Study|Withdrawal by Subject|2|||
126317314|NCT02079636|454452110|FG000|Overall Study|Physician Decision|0|||
126317315|NCT02079636|454452111|FG001|Overall Study|Physician Decision|0|||
126317316|NCT02079636|454452112|FG002|Overall Study|Physician Decision|0|||
126317317|NCT02079636|454452113|FG003|Overall Study|Physician Decision|0|||
126317318|NCT02079636|454452114|FG004|Overall Study|Physician Decision|0|||
126317319|NCT02079636|454452115|FG005|Overall Study|Physician Decision|1|||
126317320|NCT02079636|454452116|FG006|Overall Study|Physician Decision|0|||
126317321|NCT02079636|454452117|FG007|Overall Study|Physician Decision|0|||
126543016|NCT05807919|455282000|FG000|Overall Study|Received antibiotics - excluded|0|||
126543017|NCT05807919|455282001|FG001|Overall Study|Received antibiotics - excluded|1|||
126317322|NCT02079636|454452118|FG008|Overall Study|Physician Decision|0|||
126317323|NCT02079636|454452119|FG009|Overall Study|Physician Decision|1|||
126543018|NCT05807919|455282000|FG000|Overall Study|Withdrawal by Subject|0|||
126317324|NCT02079636|454452120|FG010|Overall Study|Physician Decision|1|||
126317325|NCT02079636|454452121|FG011|Overall Study|Physician Decision|0|||
126543019|NCT05807919|455282001|FG001|Overall Study|Withdrawal by Subject|3|||
126543020|NCT05807919|455282000|FG000|Overall Study|Adverse Event|1|||
126543021|NCT05807919|455282001|FG001|Overall Study|Adverse Event|1|||
126317326|NCT02079636|454452122|FG012|Overall Study|Physician Decision|0|||
126317327|NCT02079636|454452123|FG013|Overall Study|Physician Decision|0|||
126317328|NCT02079636|454452124|FG014|Overall Study|Physician Decision|1|||
126317329|NCT02079636|454452110|FG000|Overall Study|Lost to Follow-up|0|||
126543022|NCT02739347|455282006|FG000|Overall Study|Adverse Event|3|||
126317330|NCT02079636|454452111|FG001|Overall Study|Lost to Follow-up|0|||
126317331|NCT02079636|454452112|FG002|Overall Study|Lost to Follow-up|0|||
126317332|NCT02079636|454452113|FG003|Overall Study|Lost to Follow-up|0|||
126317333|NCT02079636|454452114|FG004|Overall Study|Lost to Follow-up|0|||
126317334|NCT02079636|454452115|FG005|Overall Study|Lost to Follow-up|0|||
126317335|NCT02079636|454452116|FG006|Overall Study|Lost to Follow-up|0|||
126317336|NCT02079636|454452117|FG007|Overall Study|Lost to Follow-up|1|||
126543023|NCT02739347|455282007|FG001|Overall Study|Adverse Event|0|||
126543024|NCT02739347|455282006|FG000|Overall Study|Protocol Violation|0|||
126543025|NCT02739347|455282007|FG001|Overall Study|Protocol Violation|1|||
126543026|NCT02739347|455282006|FG000|Overall Study|Lost to Follow-up|0|||
126543027|NCT02739347|455282007|FG001|Overall Study|Lost to Follow-up|2|||
126543028|NCT01931735|455282008|FG000|Randomized Phase|Lost to Follow-up|2|||
126543029|NCT01931735|455282009|FG001|Randomized Phase|Lost to Follow-up|2|||
126543030|NCT01931735|455282010|FG002|Randomized Phase|Lost to Follow-up|5|||
126543031|NCT01931735|455282011|FG003|Randomized Phase|Lost to Follow-up|0|||
126543032|NCT01931735|455282008|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
126543033|NCT01931735|455282009|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
126543034|NCT01931735|455282010|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
126543035|NCT01931735|455282011|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
126543036|NCT01931735|455282008|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
126543037|NCT01931735|455282009|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
126543038|NCT01931735|455282010|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
126543039|NCT01931735|455282011|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
126543040|NCT02552238|455282016|FG000|Overall Study|Withdrawal by Subject|2|||
126543041|NCT02552238|455282016|FG000|Overall Study|Adverse Event|2|||
126543042|NCT05158296|455282017|FG000|Overall Study|Sponsor Decision|2|||
126543043|NCT05158296|455282018|FG001|Overall Study|Sponsor Decision|3|||
126543044|NCT05158296|455282019|FG002|Overall Study|Sponsor Decision|2|||
126543045|NCT02036645|455282022|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
126543046|NCT02036645|455282023|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
126543047|NCT02036645|455282024|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
126543048|NCT02036645|455282025|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
126543049|NCT02036645|455282026|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
126543050|NCT02036645|455282027|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
126543051|NCT02036645|455282028|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
126543052|NCT02036645|455282029|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
126543053|NCT02036645|455282030|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
126543054|NCT02036645|455282031|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
126543055|NCT02036645|455282032|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
126543056|NCT02036645|455282033|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
126543057|NCT02036645|455282022|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
126543058|NCT02036645|455282023|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
126543059|NCT02036645|455282024|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
126543060|NCT02036645|455282025|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
126543061|NCT02036645|455282026|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
126543062|NCT02036645|455282027|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
126543063|NCT02036645|455282028|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
126543064|NCT02036645|455282029|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
126543065|NCT02036645|455282030|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
126543066|NCT02036645|455282031|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
126543067|NCT02036645|455282032|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
126543068|NCT02036645|455282033|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
126543069|NCT01778556|455282037|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
126543070|NCT01778556|455282038|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
126543071|NCT01778556|455282037|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
126543072|NCT01778556|455282038|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
126543073|NCT01778556|455282037|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
126543074|NCT01778556|455282038|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
126543075|NCT01778556|455282037|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
126543076|NCT01778556|455282038|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
126543077|NCT02404389|455282039|FG000|Overall Study|Adverse Event|1|||
126543078|NCT02404389|455282040|FG001|Overall Study|Adverse Event|0|||
126543079|NCT02404389|455282041|FG002|Overall Study|Adverse Event|1|||
126543080|NCT02404389|455282042|FG003|Overall Study|Adverse Event|0|||
126543081|NCT02404389|455282043|FG004|Overall Study|Adverse Event|2|||
126543082|NCT02404389|455282039|FG000|Overall Study|Subject/guardian decision|1|||
126543083|NCT02404389|455282040|FG001|Overall Study|Subject/guardian decision|0|||
126543084|NCT02404389|455282041|FG002|Overall Study|Subject/guardian decision|0|||
126543085|NCT02404389|455282042|FG003|Overall Study|Subject/guardian decision|1|||
126543086|NCT02404389|455282043|FG004|Overall Study|Subject/guardian decision|1|||
126543087|NCT03324880|455282044|FG000|Overall Study|Adverse Event|0|||
126543088|NCT03324880|455282045|FG001|Overall Study|Adverse Event|2|||
126543089|NCT03324880|455282044|FG000|Overall Study|Withdrawal by Subject|2|||
126543090|NCT03324880|455282045|FG001|Overall Study|Withdrawal by Subject|2|||
126543091|NCT03324880|455282044|FG000|Overall Study|Lost to Follow-up|0|||
126317337|NCT02079636|454452118|FG008|Overall Study|Lost to Follow-up|0|||
126543092|NCT03324880|455282045|FG001|Overall Study|Lost to Follow-up|1|||
126317338|NCT02079636|454452119|FG009|Overall Study|Lost to Follow-up|0|||
126543093|NCT03324880|455282044|FG000|Overall Study|Product Recall|0|||
126543094|NCT03324880|455282045|FG001|Overall Study|Product Recall|1|||
126543095|NCT01412801|455282049|FG000|Overall Study|Death|0|||
126543096|NCT01412801|455282050|FG001|Overall Study|Death|1|||
126543097|NCT01412801|455282051|FG002|Overall Study|Death|0|||
126543098|NCT01412801|455282052|FG003|Overall Study|Death|4|||
126543099|NCT01412801|455282053|FG004|Overall Study|Death|2|||
126543100|NCT01412801|455282054|FG005|Overall Study|Death|2|||
126543101|NCT01412801|455282049|FG000|Overall Study|Lost to Follow-up|1|||
126543102|NCT01412801|455282050|FG001|Overall Study|Lost to Follow-up|2|||
126543103|NCT01412801|455282051|FG002|Overall Study|Lost to Follow-up|4|||
126543104|NCT01412801|455282052|FG003|Overall Study|Lost to Follow-up|0|||
126543105|NCT01412801|455282053|FG004|Overall Study|Lost to Follow-up|1|||
126543106|NCT01412801|455282054|FG005|Overall Study|Lost to Follow-up|1|||
126543107|NCT01412801|455282049|FG000|Overall Study|Withdrawal by Subject|3|||
126543108|NCT01412801|455282050|FG001|Overall Study|Withdrawal by Subject|2|||
126543109|NCT01412801|455282051|FG002|Overall Study|Withdrawal by Subject|1|||
126543110|NCT01412801|455282052|FG003|Overall Study|Withdrawal by Subject|0|||
126543111|NCT01412801|455282053|FG004|Overall Study|Withdrawal by Subject|0|||
126543112|NCT01412801|455282054|FG005|Overall Study|Withdrawal by Subject|0|||
126543113|NCT01412801|455282049|FG000|Overall Study|Relocated to another area|0|||
126543114|NCT01412801|455282050|FG001|Overall Study|Relocated to another area|0|||
126543115|NCT01412801|455282051|FG002|Overall Study|Relocated to another area|2|||
126543116|NCT01412801|455282052|FG003|Overall Study|Relocated to another area|0|||
126543117|NCT01412801|455282053|FG004|Overall Study|Relocated to another area|0|||
126543118|NCT01412801|455282054|FG005|Overall Study|Relocated to another area|0|||
126543119|NCT03300570|455282055|FG000|Overall Study|Adverse Event|0|||
126543120|NCT03300570|455282056|FG001|Overall Study|Adverse Event|1|||
126543121|NCT03300570|455282055|FG000|Overall Study|Withdrawal by Subject|1|||
126543122|NCT03300570|455282056|FG001|Overall Study|Withdrawal by Subject|0|||
126543123|NCT03300570|455282055|FG000|Overall Study|Inadequate bowel prep|1|||
126543124|NCT03300570|455282056|FG001|Overall Study|Inadequate bowel prep|0|||
126543125|NCT00116272|455282057|FG000|Overall Study|Lost to Follow-up|11|||
126543126|NCT00116272|455282058|FG001|Overall Study|Lost to Follow-up|6|||
126543127|NCT03188120|455282060|FG000|Overall Study|Adverse Event|4|||
126543128|NCT03188120|455282060|FG000|Overall Study|Insufficient Effectiveness|8|||
126543129|NCT03188120|455282060|FG000|Overall Study|Improved|12|||
126543130|NCT03188120|455282060|FG000|Overall Study|Lost to Follow-up|7|||
126543131|NCT03188120|455282060|FG000|Overall Study|Other than specified|3|||
126543132|NCT03188120|455282060|FG000|Overall Study|No visit after the first visit|13|||
126543133|NCT01235403|455282063|FG000|Overall Study|Adverse Event|14|||
126543134|NCT01235403|455282063|FG000|Overall Study|Lost to Follow-up|2|||
126543135|NCT01235403|455282063|FG000|Overall Study|Withdrawal by Subject|4|||
126543136|NCT01235403|455282063|FG000|Overall Study|Lack of Efficacy|2|||
126543137|NCT01235403|455282063|FG000|Overall Study|Other reasons for premature termination|4|||
126543138|NCT02296190|455282064|FG000|Overall Study|Lost to Follow-up|0|||
126543139|NCT02296190|455282065|FG001|Overall Study|Lost to Follow-up|0|||
126543140|NCT02296190|455282066|FG002|Overall Study|Lost to Follow-up|0|||
126543141|NCT02296190|455282067|FG003|Overall Study|Lost to Follow-up|0|||
126543142|NCT02296190|455282068|FG004|Overall Study|Lost to Follow-up|1|||
126543143|NCT02296190|455282069|FG005|Overall Study|Lost to Follow-up|0|||
126543144|NCT02296190|455282064|FG000|Overall Study|Failure to induce PSVT|6|||
126543145|NCT02296190|455282065|FG001|Overall Study|Failure to induce PSVT|10|||
126543146|NCT02296190|455282066|FG002|Overall Study|Failure to induce PSVT|5|||
126543147|NCT02296190|455282067|FG003|Overall Study|Failure to induce PSVT|13|||
126543148|NCT02296190|455282068|FG004|Overall Study|Failure to induce PSVT|8|||
126543149|NCT02296190|455282069|FG005|Overall Study|Failure to induce PSVT|0|||
126543150|NCT02296190|455282064|FG000|Overall Study|Physician Decision|1|||
126543151|NCT02296190|455282065|FG001|Overall Study|Physician Decision|1|||
126543152|NCT02296190|455282066|FG002|Overall Study|Physician Decision|0|||
126543153|NCT02296190|455282067|FG003|Overall Study|Physician Decision|1|||
126543154|NCT02296190|455282068|FG004|Overall Study|Physician Decision|2|||
126543155|NCT02296190|455282069|FG005|Overall Study|Physician Decision|0|||
126543156|NCT02296190|455282064|FG000|Overall Study|Withdrawal by Subject|0|||
126543157|NCT02296190|455282065|FG001|Overall Study|Withdrawal by Subject|1|||
126543158|NCT02296190|455282066|FG002|Overall Study|Withdrawal by Subject|0|||
126543159|NCT02296190|455282067|FG003|Overall Study|Withdrawal by Subject|0|||
126543160|NCT02296190|455282068|FG004|Overall Study|Withdrawal by Subject|0|||
126543161|NCT02296190|455282069|FG005|Overall Study|Withdrawal by Subject|0|||
126317339|NCT02079636|454452120|FG010|Overall Study|Lost to Follow-up|0|||
126543162|NCT02296190|455282064|FG000|Overall Study|PSVT < 5 minutes|5|||
126543163|NCT02296190|455282065|FG001|Overall Study|PSVT < 5 minutes|6|||
126543164|NCT02296190|455282066|FG002|Overall Study|PSVT < 5 minutes|6|||
126543165|NCT02296190|455282067|FG003|Overall Study|PSVT < 5 minutes|6|||
126543166|NCT02296190|455282068|FG004|Overall Study|PSVT < 5 minutes|5|||
126543167|NCT02296190|455282069|FG005|Overall Study|PSVT < 5 minutes|0|||
126543168|NCT02296190|455282064|FG000|Overall Study|Patient was given Propofol|0|||
126543169|NCT02296190|455282065|FG001|Overall Study|Patient was given Propofol|1|||
126543170|NCT02296190|455282066|FG002|Overall Study|Patient was given Propofol|0|||
126317340|NCT02079636|454452121|FG011|Overall Study|Lost to Follow-up|0|||
126317341|NCT02079636|454452122|FG012|Overall Study|Lost to Follow-up|0|||
126317342|NCT02079636|454452123|FG013|Overall Study|Lost to Follow-up|0|||
126317343|NCT02079636|454452124|FG014|Overall Study|Lost to Follow-up|0|||
126317344|NCT00875433|454452125|FG000|Overall Study|Progressive disease|41|||
126317345|NCT00875433|454452125|FG000|Overall Study|Other Adverse Event|14|||
126543171|NCT02296190|455282067|FG003|Overall Study|Patient was given Propofol|1|||
126543172|NCT02296190|455282068|FG004|Overall Study|Patient was given Propofol|0|||
126543173|NCT02296190|455282069|FG005|Overall Study|Patient was given Propofol|0|||
126543174|NCT02296190|455282064|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
126543175|NCT02296190|455282065|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
126543176|NCT02296190|455282066|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
126543177|NCT02296190|455282067|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
126543178|NCT02296190|455282068|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
126543179|NCT02296190|455282069|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
126543180|NCT02296190|455282064|FG000|Overall Study|Blood pressure <100 after sedation|0|||
126543181|NCT02296190|455282065|FG001|Overall Study|Blood pressure <100 after sedation|0|||
126543182|NCT02296190|455282066|FG002|Overall Study|Blood pressure <100 after sedation|0|||
126543183|NCT02296190|455282067|FG003|Overall Study|Blood pressure <100 after sedation|1|||
126543184|NCT02296190|455282068|FG004|Overall Study|Blood pressure <100 after sedation|0|||
126543185|NCT02296190|455282069|FG005|Overall Study|Blood pressure <100 after sedation|0|||
126543186|NCT02296190|455282064|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
126543187|NCT02296190|455282065|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
126543188|NCT02296190|455282066|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
126543189|NCT02296190|455282067|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
126543190|NCT02296190|455282068|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
126543191|NCT02296190|455282069|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
126543192|NCT02296190|455282064|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
126543193|NCT02296190|455282065|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
126543194|NCT02296190|455282066|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
126543195|NCT02296190|455282067|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
126543196|NCT02296190|455282068|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
126543197|NCT02296190|455282069|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
126543198|NCT02296190|455282064|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
126543199|NCT02296190|455282065|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
126543200|NCT02296190|455282066|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
126543201|NCT02296190|455282067|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
126543202|NCT02296190|455282068|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
126543203|NCT02296190|455282069|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
126543204|NCT02296190|455282064|FG000|Overall Study|Lab result not available in time|1|||
126543205|NCT02296190|455282065|FG001|Overall Study|Lab result not available in time|0|||
126543206|NCT02296190|455282066|FG002|Overall Study|Lab result not available in time|0|||
126543207|NCT02296190|455282067|FG003|Overall Study|Lab result not available in time|0|||
126543208|NCT02296190|455282068|FG004|Overall Study|Lab result not available in time|0|||
126543209|NCT02296190|455282069|FG005|Overall Study|Lab result not available in time|0|||
126543210|NCT02978443|455282070|FG000|Overall Study|Withdrawal by Subject|1|||
126543211|NCT02978443|455282070|FG000|Overall Study|Adverse Event|3|||
126543212|NCT02978443|455282070|FG000|Overall Study|Disease Progression on study|6|||
126543213|NCT02978443|455282070|FG000|Overall Study|Death|1|||
126543214|NCT02978443|455282070|FG000|Overall Study|Physician Decision|1|||
126543215|NCT02978443|455282070|FG000|Overall Study|Switch to alternative therapy|1|||
126543216|NCT02978443|455282070|FG000|Overall Study|Refused further treatment|1|||
126543217|NCT00782496|455282071|FG000|Overall Study|Lost to Follow-up|14|||
126543218|NCT00782496|455282072|FG001|Overall Study|Lost to Follow-up|15|||
126543219|NCT03682705|455282073|FG000|Overall Study|Adverse Event|1|||
126543220|NCT03682705|455282074|FG001|Overall Study|Adverse Event|1|||
126543221|NCT03682705|455282075|FG002|Overall Study|Adverse Event|1|||
126543222|NCT03682705|455282076|FG003|Overall Study|Adverse Event|0|||
126543223|NCT03682705|455282077|FG004|Overall Study|Adverse Event|1|||
126543224|NCT03682705|455282078|FG005|Overall Study|Adverse Event|1|||
126543225|NCT03682705|455282073|FG000|Overall Study|Withdrawal by Subject|1|||
126543226|NCT03682705|455282074|FG001|Overall Study|Withdrawal by Subject|3|||
126543227|NCT03682705|455282075|FG002|Overall Study|Withdrawal by Subject|2|||
126543228|NCT03682705|455282076|FG003|Overall Study|Withdrawal by Subject|4|||
126543229|NCT03682705|455282077|FG004|Overall Study|Withdrawal by Subject|0|||
126543230|NCT03682705|455282078|FG005|Overall Study|Withdrawal by Subject|1|||
126317346|NCT00875433|454452125|FG000|Overall Study|Withdrawal by Subject|2|||
126317347|NCT00875433|454452125|FG000|Overall Study|Other|3|||
126317348|NCT00725101|454452126|FG000|Overall Study|Death|3|||
126543231|NCT03682705|455282073|FG000|Overall Study|Other, not specified|0|||
126543232|NCT03682705|455282074|FG001|Overall Study|Other, not specified|0|||
126543233|NCT03682705|455282075|FG002|Overall Study|Other, not specified|0|||
126543234|NCT03682705|455282076|FG003|Overall Study|Other, not specified|1|||
126543235|NCT03682705|455282077|FG004|Overall Study|Other, not specified|2|||
126543236|NCT03682705|455282078|FG005|Overall Study|Other, not specified|0|||
126543237|NCT03682705|455282073|FG000|Overall Study|Lost to Follow-up|0|||
126543238|NCT03682705|455282074|FG001|Overall Study|Lost to Follow-up|0|||
126543239|NCT03682705|455282075|FG002|Overall Study|Lost to Follow-up|0|||
126543240|NCT03682705|455282076|FG003|Overall Study|Lost to Follow-up|0|||
126543241|NCT03682705|455282077|FG004|Overall Study|Lost to Follow-up|3|||
126543242|NCT03682705|455282078|FG005|Overall Study|Lost to Follow-up|0|||
126543243|NCT00990340|455282081|FG000|First 14-day Treatment|Not Compliant|2|||
126543244|NCT00990340|455282082|FG001|First 14-day Treatment|Not Compliant|1|||
126543245|NCT00990340|455282081|FG000|First 14-day Treatment|Lost to Follow-up|2|||
126543246|NCT00990340|455282082|FG001|First 14-day Treatment|Lost to Follow-up|1|||
126543247|NCT00990340|455282081|FG000|First 14-day Treatment|Protocol Violation|2|||
126543248|NCT00990340|455282082|FG001|First 14-day Treatment|Protocol Violation|2|||
126543249|NCT04615182|455282084|FG000|Overall Study|Re-transplanted|2|||
126543250|NCT04615182|455282084|FG000|Overall Study|Protocol Violation|6|||
126543251|NCT04615182|455282084|FG000|Overall Study|Death|6|||
126543252|NCT04615182|455282084|FG000|Overall Study|Death and protocol violation|1|||
126543253|NCT02070484|455282085|FG000|Overall Study|Withdrawal by Subject|1|||
126543254|NCT02070484|455282086|FG001|Overall Study|Withdrawal by Subject|0|||
126543255|NCT02658630|455282087|FG000|Overall Study|Withdrawal by Subject|4|||
126543256|NCT01852058|455282089|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
126543257|NCT01852058|455282090|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
126543258|NCT01852058|455282091|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
126543259|NCT01852058|455282092|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
126543260|NCT01852058|455282093|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
126543261|NCT01852058|455282094|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
126543262|NCT01852058|455282095|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
126543263|NCT01852058|455282096|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
126543264|NCT01852058|455282097|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
126543265|NCT01852058|455282098|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
126543266|NCT01852058|455282099|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
126543267|NCT01852058|455282100|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
126543268|NCT01852058|455282089|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
126543269|NCT01852058|455282090|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
126543270|NCT01852058|455282091|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
126543271|NCT01852058|455282092|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
126543272|NCT01852058|455282093|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
126543273|NCT01852058|455282094|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
126317349|NCT00725101|454452126|FG000|Overall Study|Lost to Follow-up|353|||
126317350|NCT00725101|454452126|FG000|Overall Study|Protocol Violation|1|||
126317351|NCT00725101|454452126|FG000|Overall Study|Withdrawal by Subject|127|||
126543274|NCT01852058|455282095|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
126543275|NCT01852058|455282096|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
126317352|NCT00725101|454452126|FG000|Overall Study|not specified/no reason given|11|||
126317353|NCT00622336|454452127|FG000|Treatment Phase|Progression of Disease|181|||
126543276|NCT01852058|455282097|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
126543277|NCT01852058|455282098|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
126543278|NCT01852058|455282099|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
126543279|NCT01852058|455282100|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
126543280|NCT01852058|455282089|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
126543281|NCT01852058|455282090|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
126543282|NCT01852058|455282091|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
126543283|NCT01852058|455282092|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
126543284|NCT01852058|455282093|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
126543285|NCT01852058|455282094|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
126543286|NCT01852058|455282095|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
126317354|NCT00622336|454452127|FG000|Treatment Phase|Adverse Event|46|||
126317355|NCT00622336|454452127|FG000|Treatment Phase|Other|40|||
126317356|NCT00622336|454452127|FG000|Treatment Phase|Death|14|||
126317357|NCT00622336|454452127|FG000|Treatment Phase|Lack of therapeutic effect|13|||
126317358|NCT00622336|454452127|FG000|Treatment Phase|Withdrawal by Subject|13|||
126317359|NCT00622336|454452127|FG000|Treatment Phase|Lost to Follow-up|2|||
126543287|NCT01852058|455282096|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
126543288|NCT01852058|455282097|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
126543289|NCT01852058|455282098|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
126543290|NCT01852058|455282099|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
126543291|NCT01852058|455282100|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
126648207|NCT00886795|455669719|FG000|Overall Study|Lack of Efficacy|1|||
126317360|NCT00622336|454452127|FG000|Extension Phase|Adverse Event|2|||
126317361|NCT00622336|454452127|FG000|Extension Phase|Progressive Disease|6|||
126543292|NCT01852058|455282089|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
126543293|NCT01852058|455282090|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
126543294|NCT01852058|455282091|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
126543295|NCT01852058|455282092|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
126543296|NCT01852058|455282093|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
126543297|NCT01852058|455282094|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
126543298|NCT01852058|455282095|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
126543299|NCT01852058|455282096|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
126543300|NCT01852058|455282097|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
126543301|NCT01852058|455282098|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
126543302|NCT01852058|455282099|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
126543303|NCT01852058|455282100|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
126543304|NCT01852058|455282089|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
126543305|NCT01852058|455282090|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
126543306|NCT01852058|455282091|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
126543307|NCT01852058|455282092|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
126543308|NCT01852058|455282093|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
126543309|NCT01852058|455282094|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
126543310|NCT01852058|455282095|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
126543311|NCT01852058|455282096|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
126543312|NCT01852058|455282097|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
126543313|NCT01852058|455282098|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
126543314|NCT01852058|455282099|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
126543315|NCT01852058|455282100|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
126543316|NCT01852058|455282089|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126543317|NCT01852058|455282090|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126543318|NCT01852058|455282091|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126543319|NCT01852058|455282092|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
126543320|NCT01852058|455282093|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126543321|NCT01852058|455282094|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126543322|NCT01852058|455282095|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126543323|NCT01852058|455282096|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126543324|NCT01852058|455282097|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126543325|NCT01852058|455282098|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126543326|NCT01852058|455282099|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126543327|NCT01852058|455282100|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
126543328|NCT01852058|455282089|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
126543329|NCT01852058|455282090|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
126543330|NCT01852058|455282091|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
126543331|NCT01852058|455282092|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
126543332|NCT01852058|455282093|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
126543333|NCT01852058|455282094|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
126543334|NCT01852058|455282095|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
126543335|NCT01852058|455282096|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
126543336|NCT01852058|455282097|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
126543337|NCT01852058|455282098|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
126543338|NCT01852058|455282099|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
126543339|NCT01852058|455282100|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
126543340|NCT01852058|455282089|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
126543341|NCT01852058|455282090|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
126543342|NCT01852058|455282091|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
126543343|NCT01852058|455282092|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
126543344|NCT01852058|455282093|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
126543345|NCT01852058|455282094|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
126543346|NCT01852058|455282095|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
126543347|NCT01852058|455282096|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
126543348|NCT01852058|455282097|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
126543349|NCT01852058|455282098|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
126543350|NCT01852058|455282099|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
126543351|NCT01852058|455282100|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
126543352|NCT01852058|455282089|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
126543353|NCT01852058|455282090|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
126543354|NCT01852058|455282091|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
126543355|NCT01852058|455282092|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
126543356|NCT01852058|455282093|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
126543357|NCT01852058|455282094|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
126543358|NCT01852058|455282095|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
126543359|NCT01852058|455282096|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
126543360|NCT01852058|455282097|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
126543361|NCT01852058|455282098|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
126543362|NCT01852058|455282099|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
126543363|NCT01852058|455282100|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
126543364|NCT00263328|455282101|FG000|Overall Study|Death|0|||
126543365|NCT00263328|455282102|FG001|Overall Study|Death|0|||
126543366|NCT00263328|455282103|FG002|Overall Study|Death|1|||
126543367|NCT00263328|455282101|FG000|Overall Study|Lost to Follow-up|1|||
126543368|NCT00263328|455282102|FG001|Overall Study|Lost to Follow-up|1|||
126543369|NCT00263328|455282103|FG002|Overall Study|Lost to Follow-up|0|||
126543370|NCT00263328|455282101|FG000|Overall Study|Withdrawal by Subject|3|||
126543371|NCT00263328|455282102|FG001|Overall Study|Withdrawal by Subject|0|||
126543372|NCT00263328|455282103|FG002|Overall Study|Withdrawal by Subject|1|||
126543373|NCT00263328|455282101|FG000|Overall Study|Other|3|||
126543374|NCT00263328|455282102|FG001|Overall Study|Other|0|||
126543375|NCT00263328|455282103|FG002|Overall Study|Other|1|||
126543376|NCT00263328|455282101|FG000|Overall Study|Adverse Event|1|||
126543377|NCT00263328|455282102|FG001|Overall Study|Adverse Event|1|||
126543378|NCT00263328|455282103|FG002|Overall Study|Adverse Event|4|||
126543379|NCT00622180|455282104|FG000|Overall Study|Lost to Follow-up|1|||
126543380|NCT00622180|455282105|FG001|Overall Study|Lost to Follow-up|2|||
126543381|NCT01301274|455282111|FG000|Overall Study|Physician Decision|2|||
126543382|NCT01301274|455282112|FG001|Overall Study|Physician Decision|1|||
126543383|NCT04512066|455282115|FG000|Double-blind Treatment Period|Adverse Event|6|||
126543384|NCT04512066|455282116|FG001|Double-blind Treatment Period|Adverse Event|4|||
126543385|NCT04512066|455282117|FG002|Double-blind Treatment Period|Adverse Event|5|||
126543386|NCT04512066|455282118|FG003|Double-blind Treatment Period|Adverse Event|1|||
126543387|NCT04512066|455282119|FG004|Double-blind Treatment Period|Adverse Event|0|||
126543388|NCT04512066|455282120|FG005|Double-blind Treatment Period|Adverse Event|0|||
126543389|NCT04512066|455282115|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
126543390|NCT04512066|455282116|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
126543391|NCT04512066|455282117|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
126543392|NCT04512066|455282118|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
126543393|NCT04512066|455282119|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
126543394|NCT04512066|455282120|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
126543395|NCT04512066|455282115|FG000|Double-blind Treatment Period|Physician Decision|1|||
126543396|NCT04512066|455282116|FG001|Double-blind Treatment Period|Physician Decision|0|||
126543397|NCT04512066|455282117|FG002|Double-blind Treatment Period|Physician Decision|1|||
126543398|NCT04512066|455282118|FG003|Double-blind Treatment Period|Physician Decision|0|||
126543399|NCT04512066|455282119|FG004|Double-blind Treatment Period|Physician Decision|0|||
126543400|NCT04512066|455282120|FG005|Double-blind Treatment Period|Physician Decision|0|||
126543401|NCT04512066|455282115|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
126543402|NCT04512066|455282116|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
126543403|NCT04512066|455282117|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
126543404|NCT04512066|455282118|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
126543405|NCT04512066|455282119|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
126543406|NCT04512066|455282120|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
126543407|NCT04512066|455282115|FG000|Extension Period|Adverse Event|0|||
126543408|NCT04512066|455282116|FG001|Extension Period|Adverse Event|1|||
126543409|NCT04512066|455282117|FG002|Extension Period|Adverse Event|4|||
126543410|NCT04512066|455282118|FG003|Extension Period|Adverse Event|3|||
126543411|NCT04512066|455282119|FG004|Extension Period|Adverse Event|1|||
126543412|NCT04512066|455282120|FG005|Extension Period|Adverse Event|3|||
126543413|NCT04512066|455282115|FG000|Extension Period|Death|0|||
126543414|NCT04512066|455282116|FG001|Extension Period|Death|0|||
126543415|NCT04512066|455282117|FG002|Extension Period|Death|0|||
126543416|NCT04512066|455282118|FG003|Extension Period|Death|0|||
126543417|NCT04512066|455282119|FG004|Extension Period|Death|0|||
126543418|NCT04512066|455282120|FG005|Extension Period|Death|1|||
126543419|NCT04512066|455282115|FG000|Extension Period|Lack of Efficacy|0|||
126543420|NCT04512066|455282116|FG001|Extension Period|Lack of Efficacy|4|||
126543421|NCT04512066|455282117|FG002|Extension Period|Lack of Efficacy|4|||
126543422|NCT04512066|455282118|FG003|Extension Period|Lack of Efficacy|1|||
126543423|NCT04512066|455282119|FG004|Extension Period|Lack of Efficacy|3|||
126543424|NCT04512066|455282120|FG005|Extension Period|Lack of Efficacy|3|||
126543425|NCT04512066|455282115|FG000|Extension Period|Lost to Follow-up|0|||
126543426|NCT04512066|455282116|FG001|Extension Period|Lost to Follow-up|1|||
126543427|NCT04512066|455282117|FG002|Extension Period|Lost to Follow-up|5|||
126543428|NCT04512066|455282118|FG003|Extension Period|Lost to Follow-up|2|||
126543429|NCT04512066|455282119|FG004|Extension Period|Lost to Follow-up|3|||
126543430|NCT04512066|455282120|FG005|Extension Period|Lost to Follow-up|2|||
126543431|NCT04512066|455282115|FG000|Extension Period|Non-compliance with study drug|0|||
126543432|NCT04512066|455282116|FG001|Extension Period|Non-compliance with study drug|1|||
126543433|NCT04512066|455282117|FG002|Extension Period|Non-compliance with study drug|0|||
126543434|NCT04512066|455282118|FG003|Extension Period|Non-compliance with study drug|0|||
126543435|NCT04512066|455282119|FG004|Extension Period|Non-compliance with study drug|0|||
126543436|NCT04512066|455282120|FG005|Extension Period|Non-compliance with study drug|1|||
126543437|NCT04512066|455282115|FG000|Extension Period|Other|0|||
126543438|NCT04512066|455282116|FG001|Extension Period|Other|2|||
126543439|NCT04512066|455282117|FG002|Extension Period|Other|0|||
126543440|NCT04512066|455282118|FG003|Extension Period|Other|0|||
126543441|NCT04512066|455282119|FG004|Extension Period|Other|0|||
126543442|NCT04512066|455282120|FG005|Extension Period|Other|0|||
126543443|NCT04512066|455282115|FG000|Extension Period|Physician Decision|0|||
126543444|NCT04512066|455282116|FG001|Extension Period|Physician Decision|2|||
126543445|NCT04512066|455282117|FG002|Extension Period|Physician Decision|0|||
126543446|NCT04512066|455282118|FG003|Extension Period|Physician Decision|1|||
126543447|NCT04512066|455282119|FG004|Extension Period|Physician Decision|1|||
126543448|NCT04512066|455282120|FG005|Extension Period|Physician Decision|0|||
126543449|NCT04512066|455282115|FG000|Extension Period|Withdrawal by Subject|0|||
126543450|NCT04512066|455282116|FG001|Extension Period|Withdrawal by Subject|3|||
126543451|NCT04512066|455282117|FG002|Extension Period|Withdrawal by Subject|7|||
126543452|NCT04512066|455282118|FG003|Extension Period|Withdrawal by Subject|11|||
126543453|NCT04512066|455282119|FG004|Extension Period|Withdrawal by Subject|8|||
126543454|NCT04512066|455282120|FG005|Extension Period|Withdrawal by Subject|4|||
126543455|NCT03520400|455282121|FG000|Overall Study|Physician Decision|15|||
126543456|NCT03520400|455282122|FG001|Overall Study|Physician Decision|7|||
126543457|NCT00445679|455282125|FG000|Overall Study|Adverse Event|22|||
126543458|NCT00445679|455282126|FG001|Overall Study|Adverse Event|12|||
126543459|NCT00445679|455282127|FG002|Overall Study|Adverse Event|30|||
126543460|NCT00445679|455282128|FG003|Overall Study|Adverse Event|19|||
126543461|NCT00445679|455282125|FG000|Overall Study|Failed to return|1|||
126543462|NCT00445679|455282126|FG001|Overall Study|Failed to return|3|||
126317362|NCT00622336|454452127|FG000|Extension Phase|Lack of therapeutic effect|2|||
126543463|NCT00445679|455282127|FG002|Overall Study|Failed to return|2|||
126543464|NCT00445679|455282128|FG003|Overall Study|Failed to return|2|||
126543465|NCT00445679|455282125|FG000|Overall Study|Physician Decision|0|||
126543466|NCT00445679|455282126|FG001|Overall Study|Physician Decision|0|||
126543467|NCT00445679|455282127|FG002|Overall Study|Physician Decision|1|||
126543468|NCT00445679|455282128|FG003|Overall Study|Physician Decision|0|||
126543469|NCT00445679|455282125|FG000|Overall Study|Lost to Follow-up|10|||
126543470|NCT00445679|455282126|FG001|Overall Study|Lost to Follow-up|6|||
126543471|NCT00445679|455282127|FG002|Overall Study|Lost to Follow-up|6|||
126543472|NCT00445679|455282128|FG003|Overall Study|Lost to Follow-up|5|||
126543473|NCT00445679|455282125|FG000|Overall Study|Compliance|3|||
126543474|NCT00445679|455282126|FG001|Overall Study|Compliance|2|||
126543475|NCT00445679|455282127|FG002|Overall Study|Compliance|1|||
126543476|NCT00445679|455282128|FG003|Overall Study|Compliance|2|||
126543477|NCT00445679|455282125|FG000|Overall Study|Withdrawal of Informed Consent|0|||
126543478|NCT00445679|455282126|FG001|Overall Study|Withdrawal of Informed Consent|0|||
126543479|NCT00445679|455282127|FG002|Overall Study|Withdrawal of Informed Consent|1|||
126543480|NCT00445679|455282128|FG003|Overall Study|Withdrawal of Informed Consent|0|||
126543481|NCT00445679|455282125|FG000|Overall Study|Protocol Violation|2|||
126543482|NCT00445679|455282126|FG001|Overall Study|Protocol Violation|3|||
126543483|NCT00445679|455282127|FG002|Overall Study|Protocol Violation|3|||
126543484|NCT00445679|455282128|FG003|Overall Study|Protocol Violation|1|||
126543485|NCT00445679|455282125|FG000|Overall Study|Withdrawal by Subject|8|||
126543486|NCT00445679|455282126|FG001|Overall Study|Withdrawal by Subject|14|||
126543487|NCT00445679|455282127|FG002|Overall Study|Withdrawal by Subject|20|||
126543488|NCT00445679|455282128|FG003|Overall Study|Withdrawal by Subject|18|||
126543489|NCT00445679|455282125|FG000|Overall Study|Lack of Efficacy|2|||
126543490|NCT00445679|455282126|FG001|Overall Study|Lack of Efficacy|6|||
126543491|NCT00445679|455282127|FG002|Overall Study|Lack of Efficacy|2|||
126543492|NCT00445679|455282128|FG003|Overall Study|Lack of Efficacy|0|||
126543493|NCT01353222|455282130|FG000|Overall Study|Death|30|||
126543494|NCT01353222|455282131|FG001|Overall Study|Death|30|||
126543495|NCT01353222|455282130|FG000|Overall Study|Withdrawal by Subject|8|||
126543496|NCT01353222|455282131|FG001|Overall Study|Withdrawal by Subject|5|||
126543497|NCT01353222|455282130|FG000|Overall Study|Study Terminated|31|||
126543498|NCT01353222|455282131|FG001|Overall Study|Study Terminated|37|||
126543499|NCT01353222|455282130|FG000|Overall Study|Site closed research department|1|||
126543500|NCT01353222|455282131|FG001|Overall Study|Site closed research department|0|||
126543501|NCT01654601|455282132|FG000|1st Administration|Withdrawal by Subject|2|||
126543502|NCT01654601|455282133|FG001|1st Administration|Withdrawal by Subject|0|||
126543503|NCT01654601|455282132|FG000|1st Administration|Protocol Violation|0|||
126543504|NCT01654601|455282133|FG001|1st Administration|Protocol Violation|2|||
126543505|NCT01654601|455282132|FG000|2nd Administration|Adverse Event|1|||
126543506|NCT01654601|455282133|FG001|2nd Administration|Adverse Event|0|||
126543507|NCT01654601|455282132|FG000|2nd Administration|Protocol Violation|0|||
126543508|NCT01654601|455282133|FG001|2nd Administration|Protocol Violation|1|||
126543509|NCT02636270|455282134|FG000|Overall Study|Adverse Event|1|||
126543510|NCT02636270|455282135|FG001|Overall Study|Adverse Event|0|||
126543511|NCT02636270|455282136|FG002|Overall Study|Adverse Event|0|||
126543512|NCT02636270|455282134|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
126543513|NCT02636270|455282135|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
126543514|NCT02636270|455282136|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
126543515|NCT01119898|455282137|FG000|Overall Study|Adverse Event|4|||
126543516|NCT01119898|455282138|FG001|Overall Study|Adverse Event|5|||
126543517|NCT01119898|455282137|FG000|Overall Study|Withdrawal by Subject|1|||
126543518|NCT01119898|455282138|FG001|Overall Study|Withdrawal by Subject|4|||
126543519|NCT01119898|455282137|FG000|Overall Study|Lack of Efficacy|0|||
126543520|NCT01119898|455282138|FG001|Overall Study|Lack of Efficacy|2|||
126317363|NCT00622336|454452127|FG000|Extension Phase|Withdrawal by Subject|1|||
126317364|NCT00622336|454452127|FG000|Extension Phase|Lost to Follow-up|1|||
126317365|NCT00622336|454452127|FG000|Extension Phase|Other|9|||
126543521|NCT01119898|455282137|FG000|Overall Study|Protocol Violation|1|||
126317366|NCT04148287|454452129|FG000|Overall Study|Death|2|||
126317367|NCT03164265|454452130|FG000|Overall Study|Physician Decision|3|||
126543522|NCT01119898|455282138|FG001|Overall Study|Protocol Violation|1|||
126543523|NCT01119898|455282137|FG000|Overall Study|Medical procedure|1|||
126543524|NCT01119898|455282138|FG001|Overall Study|Medical procedure|0|||
126543525|NCT01119898|455282137|FG000|Overall Study|Randomized in error did not participate|1|||
126543526|NCT01119898|455282138|FG001|Overall Study|Randomized in error did not participate|0|||
126317368|NCT03912428|454452131|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
126543527|NCT01806584|455282139|FG000|Overall Study|Adverse Event|2|||
126543528|NCT01806584|455282140|FG001|Overall Study|Adverse Event|1|||
126543529|NCT01806584|455282139|FG000|Overall Study|Death|1|||
126543530|NCT01806584|455282140|FG001|Overall Study|Death|0|||
126543531|NCT01806584|455282139|FG000|Overall Study|Lost to Follow-up|0|||
126543532|NCT01806584|455282140|FG001|Overall Study|Lost to Follow-up|2|||
126543533|NCT01806584|455282139|FG000|Overall Study|Study terminated by sponsor|9|||
126543534|NCT01806584|455282140|FG001|Overall Study|Study terminated by sponsor|14|||
126543535|NCT01806584|455282139|FG000|Overall Study|Withdrawal by Subject|1|||
126543536|NCT01806584|455282140|FG001|Overall Study|Withdrawal by Subject|1|||
126543537|NCT01806584|455282139|FG000|Overall Study|Other unspecified|1|||
126543538|NCT01806584|455282140|FG001|Overall Study|Other unspecified|0|||
126543539|NCT04398537|455282147|FG000|Overall Study|Physician Decision|10|||
126543540|NCT04398537|455282148|FG001|Overall Study|Physician Decision|15|||
126543541|NCT03610737|455284208|FG000|Overall Study|Withdrawal by Subject|1|||
126543542|NCT03610737|455284209|FG001|Overall Study|Withdrawal by Subject|5|||
126543543|NCT03610737|455284208|FG000|Overall Study|Death|1|||
126543544|NCT03610737|455284209|FG001|Overall Study|Death|0|||
126543545|NCT03610737|455284208|FG000|Overall Study|Not treated|5|||
126543546|NCT03610737|455284209|FG001|Overall Study|Not treated|2|||
126543547|NCT03610737|455284208|FG000|Overall Study|Missed Visit|1|||
126543548|NCT03610737|455284209|FG001|Overall Study|Missed Visit|2|||
126543549|NCT02991482|455284210|FG000|Overall Study|Disease progression|56|||
126543550|NCT02991482|455284211|FG001|Overall Study|Disease progression|47|||
126543551|NCT02991482|455284210|FG000|Overall Study|Death|4|||
126543552|NCT02991482|455284211|FG001|Overall Study|Death|4|||
126543553|NCT02991482|455284210|FG000|Overall Study|Adverse Event|1|||
126543554|NCT02991482|455284211|FG001|Overall Study|Adverse Event|6|||
126543555|NCT02991482|455284210|FG000|Overall Study|Patient decision|1|||
126543556|NCT02991482|455284211|FG001|Overall Study|Patient decision|1|||
126543557|NCT02991482|455284210|FG000|Overall Study|Physician Decision|0|||
126543558|NCT02991482|455284211|FG001|Overall Study|Physician Decision|6|||
126543559|NCT02991482|455284210|FG000|Overall Study|Clinical deterioration|1|||
126543560|NCT02991482|455284211|FG001|Overall Study|Clinical deterioration|0|||
126543561|NCT02991482|455284210|FG000|Overall Study|Patient feeling too unwell|1|||
126543562|NCT02991482|455284211|FG001|Overall Study|Patient feeling too unwell|0|||
126543563|NCT02991482|455284210|FG000|Overall Study|Worsening of performance status|0|||
126543564|NCT02991482|455284211|FG001|Overall Study|Worsening of performance status|1|||
126543565|NCT02991482|455284210|FG000|Overall Study|Death prior to study drug initiation|1|||
126543566|NCT02991482|455284211|FG001|Overall Study|Death prior to study drug initiation|0|||
126543567|NCT02991482|455284210|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
126543568|NCT02991482|455284211|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
126543569|NCT02396537|455284214|FG000|Overall Study|Protocol Violation|0|||
126543570|NCT02396537|455284215|FG001|Overall Study|Protocol Violation|1|||
126543571|NCT00871403|455284216|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
126543572|NCT00871403|455284217|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
126543573|NCT00871403|455284218|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
126543574|NCT00871403|455284216|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
126543575|NCT00871403|455284217|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
126543576|NCT00871403|455284218|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
126543577|NCT00871403|455284216|FG000|Combination Treatment Phase|Adverse Event|0|||
126543578|NCT00871403|455284217|FG001|Combination Treatment Phase|Adverse Event|17|||
126543579|NCT00871403|455284218|FG002|Combination Treatment Phase|Adverse Event|2|||
126543580|NCT00871403|455284216|FG000|Combination Treatment Phase|Disease Progression|0|||
126543581|NCT00871403|455284217|FG001|Combination Treatment Phase|Disease Progression|8|||
126543582|NCT00871403|455284218|FG002|Combination Treatment Phase|Disease Progression|5|||
126543583|NCT00871403|455284216|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
126543584|NCT00871403|455284217|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
126543585|NCT00871403|455284218|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
126543586|NCT00871403|455284216|FG000|Combination Treatment Phase|Physician Decision|0|||
126543587|NCT00871403|455284217|FG001|Combination Treatment Phase|Physician Decision|1|||
126543588|NCT00871403|455284218|FG002|Combination Treatment Phase|Physician Decision|3|||
126543589|NCT00871403|455284216|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
126543590|NCT00871403|455284217|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
126543591|NCT00871403|455284218|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
126543592|NCT00871403|455284216|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
126543593|NCT00871403|455284217|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
126543594|NCT00871403|455284218|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
126543595|NCT00787319|455284219|FG000|Overall Study|Lost to Follow-up|2|||
126543596|NCT00787319|455284219|FG000|Overall Study|Withdrawal by Subject|15|||
126543597|NCT00787319|455284219|FG000|Overall Study|Adverse Event|3|||
126543598|NCT00787319|455284219|FG000|Overall Study|Objective progression or relapse|30|||
126543599|NCT00787319|455284219|FG000|Overall Study|Lack of Efficacy|1|||
126543600|NCT00787319|455284219|FG000|Overall Study|Budget exhausted/exceeded|1|||
126543601|NCT00787319|455284219|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
126543602|NCT00787319|455284219|FG000|Overall Study|No health insurance reimbursement|2|||
126543603|NCT00787319|455284219|FG000|Overall Study|Stabilized disease findings|3|||
126543604|NCT00787319|455284219|FG000|Overall Study|Inactive disease|5|||
126543605|NCT02312856|455284220|FG000|Overall Study|Death|1|||
126543606|NCT02312856|455284220|FG000|Overall Study|Lost to Follow-up|3|||
126543607|NCT01932294|455284221|FG000|Overall Study|Death|43|||
126543608|NCT01932294|455284221|FG000|Overall Study|Lost to Follow-up|8|||
126543609|NCT01932294|455284221|FG000|Overall Study|VAD Implantation|20|||
126543610|NCT01932294|455284221|FG000|Overall Study|Heart Transplantation|16|||
126543611|NCT01932294|455284221|FG000|Overall Study|Transferred to other hospitals|12|||
126543612|NCT04415151|455284222|FG000|Overall Study|Death|1|||
126543613|NCT04415151|455284223|FG001|Overall Study|Death|1|||
126543614|NCT04415151|455284222|FG000|Overall Study|Withdrawal by Subject|1|||
126543615|NCT04415151|455284223|FG001|Overall Study|Withdrawal by Subject|0|||
126543616|NCT00659984|455284232|FG000|Overall Study|Adverse Event|1|||
126543617|NCT00927355|455284233|FG000|Overall Study|Adverse Event|1|||
126543618|NCT00927355|455284234|FG001|Overall Study|Adverse Event|1|||
126543619|NCT01800201|455284235|FG000|Overall Study|Withdrawal by Subject|2|||
126543620|NCT01800201|455284236|FG001|Overall Study|Withdrawal by Subject|0|||
126543621|NCT01800201|455284235|FG000|Overall Study|patient privacy concerns|1|||
126543622|NCT01800201|455284236|FG001|Overall Study|patient privacy concerns|1|||
126543623|NCT01800201|455284235|FG000|Overall Study|did not want to use device|0|||
126543624|NCT01800201|455284236|FG001|Overall Study|did not want to use device|1|||
126543625|NCT01800201|455284235|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
126543626|NCT01800201|455284236|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
126543627|NCT01691521|455284240|FG000|Overall Study|Adverse Event|4|||
126543628|NCT01691521|455284241|FG001|Overall Study|Adverse Event|0|||
126543629|NCT01691521|455284242|FG002|Overall Study|Adverse Event|1|||
126543630|NCT01691521|455284240|FG000|Overall Study|Lack of Efficacy|1|||
126317369|NCT03912428|454452132|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
126543631|NCT01691521|455284241|FG001|Overall Study|Lack of Efficacy|1|||
126543632|NCT01691521|455284242|FG002|Overall Study|Lack of Efficacy|2|||
126543633|NCT01691521|455284240|FG000|Overall Study|Protocol Violation|0|||
126543634|NCT01691521|455284241|FG001|Overall Study|Protocol Violation|3|||
126543635|NCT01691521|455284242|FG002|Overall Study|Protocol Violation|0|||
126543636|NCT01691521|455284240|FG000|Overall Study|Lost to Follow-up|0|||
126543637|NCT01691521|455284241|FG001|Overall Study|Lost to Follow-up|2|||
126543638|NCT01691521|455284242|FG002|Overall Study|Lost to Follow-up|2|||
126543639|NCT01691521|455284240|FG000|Overall Study|Physician Decision|2|||
126543640|NCT01691521|455284241|FG001|Overall Study|Physician Decision|1|||
126543641|NCT01691521|455284242|FG002|Overall Study|Physician Decision|0|||
126543642|NCT01691521|455284240|FG000|Overall Study|Withdrawal by Subject|5|||
126543643|NCT01691521|455284241|FG001|Overall Study|Withdrawal by Subject|9|||
126543644|NCT01691521|455284242|FG002|Overall Study|Withdrawal by Subject|4|||
126543645|NCT01480596|455284243|FG000|Overall Study|Adverse Event|3|||
126543646|NCT01480596|455284244|FG001|Overall Study|Adverse Event|0|||
126543647|NCT01480596|455284243|FG000|Overall Study|MG exacerbation or change in medication|2|||
126543648|NCT01480596|455284244|FG001|Overall Study|MG exacerbation or change in medication|2|||
126543649|NCT04503096|455284245|FG000|Overall Study|Withdrawal by Subject|3|||
126543650|NCT02343003|455284246|FG000|Overall Study|Withdrawal by Subject|9|||
126543651|NCT02343003|455284247|FG001|Overall Study|Withdrawal by Subject|4|||
126543652|NCT02343003|455284246|FG000|Overall Study|Lost to Follow-up|5|||
126543653|NCT02343003|455284247|FG001|Overall Study|Lost to Follow-up|1|||
126543654|NCT02343003|455284246|FG000|Overall Study|Protocol Violation|1|||
126543655|NCT02343003|455284247|FG001|Overall Study|Protocol Violation|0|||
126543656|NCT02343003|455284246|FG000|Overall Study|Death|0|||
126543657|NCT02343003|455284247|FG001|Overall Study|Death|1|||
126543658|NCT02343003|455284246|FG000|Overall Study|exclusion criteria met|1|||
126543659|NCT02343003|455284247|FG001|Overall Study|exclusion criteria met|1|||
126543660|NCT02343003|455284246|FG000|Overall Study|terminated by sponsor|2|||
126543661|NCT02343003|455284247|FG001|Overall Study|terminated by sponsor|0|||
126543662|NCT01153269|455284250|FG000|Overall Study|Withdrawal by Subject|1|||
126543663|NCT01153269|455284250|FG000|Overall Study|Antiretroviral therapy break|1|||
126543664|NCT03541044|455284251|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
126543665|NCT03541044|455284252|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
126543666|NCT03541044|455284251|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
126543667|NCT03541044|455284252|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
126543668|NCT02635724|455284253|FG000|Overall Study|Withdrawal by Subject|0|||
126543669|NCT02635724|455284254|FG001|Overall Study|Withdrawal by Subject|1|||
126543670|NCT02635724|455284255|FG002|Overall Study|Withdrawal by Subject|0|||
126543671|NCT04146896|455284267|FG000|Overall Study|Adverse Event|5|||
126543672|NCT04146896|455284268|FG001|Overall Study|Adverse Event|8|||
126543673|NCT04146896|455284267|FG000|Overall Study|Lack of Efficacy|3|||
126543674|NCT04146896|455284268|FG001|Overall Study|Lack of Efficacy|2|||
126543675|NCT04146896|455284267|FG000|Overall Study|Lost to Follow-up|0|||
126543676|NCT04146896|455284268|FG001|Overall Study|Lost to Follow-up|1|||
126543677|NCT04146896|455284267|FG000|Overall Study|Non-compliance|5|||
126543678|NCT04146896|455284268|FG001|Overall Study|Non-compliance|4|||
126543679|NCT04146896|455284267|FG000|Overall Study|Withdrawal by Subject|3|||
126543680|NCT04146896|455284268|FG001|Overall Study|Withdrawal by Subject|5|||
126543681|NCT04146896|455284267|FG000|Overall Study|Randomized in error|1|||
126543682|NCT04146896|455284268|FG001|Overall Study|Randomized in error|2|||
126543683|NCT02118337|455284269|FG000|Overall Study|Other|1|||
126543684|NCT02118337|455284270|FG001|Overall Study|Other|0|||
126543685|NCT02118337|455284271|FG002|Overall Study|Other|0|||
126543686|NCT02118337|455284272|FG003|Overall Study|Other|0|||
126543687|NCT02118337|455284273|FG004|Overall Study|Other|2|||
126543688|NCT02118337|455284274|FG005|Overall Study|Other|3|||
126543689|NCT02118337|455284275|FG006|Overall Study|Other|1|||
126543690|NCT02118337|455284276|FG007|Overall Study|Other|28|||
126543691|NCT02118337|455284277|FG008|Overall Study|Other|15|||
126543692|NCT02118337|455284269|FG000|Overall Study|Lost to Follow-up|0|||
126543693|NCT02118337|455284270|FG001|Overall Study|Lost to Follow-up|0|||
126543694|NCT02118337|455284271|FG002|Overall Study|Lost to Follow-up|0|||
126543695|NCT02118337|455284272|FG003|Overall Study|Lost to Follow-up|0|||
126543696|NCT02118337|455284273|FG004|Overall Study|Lost to Follow-up|0|||
126543697|NCT02118337|455284274|FG005|Overall Study|Lost to Follow-up|0|||
126543698|NCT02118337|455284275|FG006|Overall Study|Lost to Follow-up|0|||
126543699|NCT02118337|455284276|FG007|Overall Study|Lost to Follow-up|1|||
126543700|NCT02118337|455284277|FG008|Overall Study|Lost to Follow-up|0|||
126543701|NCT02118337|455284269|FG000|Overall Study|Withdrawal by Subject|1|||
126543702|NCT02118337|455284270|FG001|Overall Study|Withdrawal by Subject|3|||
126543703|NCT02118337|455284271|FG002|Overall Study|Withdrawal by Subject|2|||
126543704|NCT02118337|455284272|FG003|Overall Study|Withdrawal by Subject|1|||
126543705|NCT02118337|455284273|FG004|Overall Study|Withdrawal by Subject|2|||
126543706|NCT02118337|455284274|FG005|Overall Study|Withdrawal by Subject|2|||
126543707|NCT02118337|455284275|FG006|Overall Study|Withdrawal by Subject|1|||
126543708|NCT02118337|455284276|FG007|Overall Study|Withdrawal by Subject|4|||
126543709|NCT02118337|455284277|FG008|Overall Study|Withdrawal by Subject|2|||
126543710|NCT02118337|455284269|FG000|Overall Study|Death|2|||
126543711|NCT02118337|455284270|FG001|Overall Study|Death|2|||
126543712|NCT02118337|455284271|FG002|Overall Study|Death|1|||
126543713|NCT02118337|455284272|FG003|Overall Study|Death|2|||
126543714|NCT02118337|455284273|FG004|Overall Study|Death|5|||
126543715|NCT02118337|455284274|FG005|Overall Study|Death|1|||
126543716|NCT02118337|455284275|FG006|Overall Study|Death|2|||
126543717|NCT02118337|455284276|FG007|Overall Study|Death|9|||
126543718|NCT02118337|455284277|FG008|Overall Study|Death|4|||
126543719|NCT00717314|455284283|FG000|Overall Study|Adverse Event|3|||
126543720|NCT00717314|455284284|FG001|Overall Study|Adverse Event|2|||
126543721|NCT00717314|455284283|FG000|Overall Study|Protocol Violation|1|||
126543722|NCT00717314|455284284|FG001|Overall Study|Protocol Violation|0|||
126543723|NCT00717314|455284283|FG000|Overall Study|Lost to Follow-up|1|||
126543724|NCT00717314|455284284|FG001|Overall Study|Lost to Follow-up|5|||
126543725|NCT00717314|455284283|FG000|Overall Study|Withdrawal by Subject|1|||
126543726|NCT00717314|455284284|FG001|Overall Study|Withdrawal by Subject|3|||
126543727|NCT00117156|455284286|FG000|Overall Study|Adverse Event|9|||
126543728|NCT00117156|455284286|FG000|Overall Study|Physician Decision|1|||
126543729|NCT00117156|455284286|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
126543730|NCT01919970|455284287|FG000|Overall Study|Withdrawal by Subject|3|||
126543731|NCT01919970|455284288|FG001|Overall Study|Withdrawal by Subject|0|||
126543732|NCT04043962|455284289|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
126543733|NCT04043962|455284289|FG000|Post-Treatment|Withdrawal by Subject|5|||
126543734|NCT04043962|455284289|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
126543735|NCT01126060|455284292|FG000|Overall Study|Protocol Violation|0|||
126543736|NCT01126060|455284293|FG001|Overall Study|Protocol Violation|2|||
126543737|NCT01874145|455284294|FG000|Core Period|Non-compliance|1|||
126543738|NCT01874145|455284295|FG001|Core Period|Non-compliance|0|||
126543739|NCT01874145|455284294|FG000|Core Period|Protocol Violation|1|||
126543740|NCT01874145|455284295|FG001|Core Period|Protocol Violation|1|||
126543741|NCT01874145|455284294|FG000|Core Period|Physician Decision|1|||
126543742|NCT01874145|455284295|FG001|Core Period|Physician Decision|1|||
126543743|NCT01874145|455284294|FG000|Core Period|Adverse Event|0|||
126543744|NCT01874145|455284295|FG001|Core Period|Adverse Event|1|||
126543745|NCT01874145|455284294|FG000|Core Period|Withdrawal by Subject|0|||
126543746|NCT01874145|455284295|FG001|Core Period|Withdrawal by Subject|4|||
126543747|NCT01874145|455284294|FG000|Extension Period|Adverse Event|3|||
126543748|NCT01874145|455284295|FG001|Extension Period|Adverse Event|2|||
126543749|NCT01874145|455284294|FG000|Extension Period|Withdrawal by Subject|2|||
126543750|NCT01874145|455284295|FG001|Extension Period|Withdrawal by Subject|1|||
126543751|NCT01874145|455284294|FG000|Extension Period|Lost to Follow-up|1|||
126543752|NCT01874145|455284295|FG001|Extension Period|Lost to Follow-up|1|||
126543753|NCT00402337|455284300|FG000|Overall Study|Adverse Event|0|||
126543754|NCT00402337|455284301|FG001|Overall Study|Adverse Event|2|||
126543755|NCT00402337|455284302|FG002|Overall Study|Adverse Event|2|||
126543756|NCT00402337|455284303|FG003|Overall Study|Adverse Event|3|||
126543757|NCT00402337|455284304|FG004|Overall Study|Adverse Event|2|||
126543758|NCT00402337|455284300|FG000|Overall Study|Noncompliance|0|||
126543759|NCT00402337|455284301|FG001|Overall Study|Noncompliance|0|||
126543760|NCT00402337|455284302|FG002|Overall Study|Noncompliance|0|||
126543761|NCT00402337|455284303|FG003|Overall Study|Noncompliance|0|||
126543762|NCT00402337|455284304|FG004|Overall Study|Noncompliance|2|||
126543763|NCT00402337|455284300|FG000|Overall Study|Withdrawal by Subject|5|||
126317370|NCT03912428|454452133|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
126317371|NCT03912428|454452134|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
126317372|NCT03912428|454452131|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
126317373|NCT03912428|454452132|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
126317374|NCT03912428|454452133|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
126317375|NCT03912428|454452134|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
126317376|NCT03912428|454452131|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
126317377|NCT03912428|454452132|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
126317378|NCT03912428|454452133|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
126317379|NCT03912428|454452134|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
126317380|NCT02889835|454452135|FG000|Overall Study|Lost to Follow-up|13|||
126317381|NCT02889835|454452136|FG001|Overall Study|Lost to Follow-up|13|||
126317382|NCT02889835|454452137|FG002|Overall Study|Lost to Follow-up|13|||
126317383|NCT02889835|454452135|FG000|Overall Study|Withdrawal by Subject|2|||
126317384|NCT02889835|454452136|FG001|Overall Study|Withdrawal by Subject|2|||
126317385|NCT02889835|454452137|FG002|Overall Study|Withdrawal by Subject|2|||
126317386|NCT02889835|454452135|FG000|Overall Study|Protocol Violation|1|||
126317387|NCT02889835|454452136|FG001|Overall Study|Protocol Violation|1|||
126317388|NCT02889835|454452137|FG002|Overall Study|Protocol Violation|1|||
126317389|NCT02889835|454452135|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
126317390|NCT02889835|454452136|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
126317391|NCT02889835|454452137|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
126317392|NCT02889835|454452135|FG000|Overall Study|Death|1|||
126317393|NCT02889835|454452136|FG001|Overall Study|Death|1|||
126317394|NCT02889835|454452137|FG002|Overall Study|Death|1|||
126317395|NCT01777139|454453942|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
126317396|NCT01777139|454453943|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
126317397|NCT01777139|454453942|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
126317398|NCT01777139|454453943|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
126317399|NCT01777139|454453942|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
126317400|NCT01777139|454453943|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
126317401|NCT01777139|454453942|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
126317402|NCT01777139|454453943|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
126317403|NCT01777139|454453942|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
126317404|NCT01777139|454453943|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
126317405|NCT01777139|454453942|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
126317406|NCT01777139|454453943|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
126317407|NCT01777139|454453942|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
126317408|NCT01777139|454453943|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
126317409|NCT01777139|454453942|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
126317410|NCT01777139|454453943|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
126317411|NCT05625477|454453944|FG000|Overall Study|Lost to Follow-up|2|||
126317412|NCT05625477|454453945|FG001|Overall Study|Lost to Follow-up|2|||
126317413|NCT05625477|454453946|FG002|Overall Study|Lost to Follow-up|1|||
126317414|NCT05625477|454453947|FG003|Overall Study|Lost to Follow-up|1|||
126543764|NCT00402337|455284301|FG001|Overall Study|Withdrawal by Subject|3|||
126543765|NCT00402337|455284302|FG002|Overall Study|Withdrawal by Subject|1|||
126543766|NCT00402337|455284303|FG003|Overall Study|Withdrawal by Subject|6|||
126543767|NCT00402337|455284304|FG004|Overall Study|Withdrawal by Subject|4|||
126543768|NCT00402337|455284300|FG000|Overall Study|Lost to Follow-up|0|||
126543769|NCT00402337|455284301|FG001|Overall Study|Lost to Follow-up|0|||
126543770|NCT00402337|455284302|FG002|Overall Study|Lost to Follow-up|1|||
126543771|NCT00402337|455284303|FG003|Overall Study|Lost to Follow-up|2|||
126543772|NCT00402337|455284304|FG004|Overall Study|Lost to Follow-up|0|||
126543773|NCT00402337|455284300|FG000|Overall Study|Physician Decision|0|||
126543774|NCT00402337|455284301|FG001|Overall Study|Physician Decision|0|||
126543775|NCT00402337|455284302|FG002|Overall Study|Physician Decision|0|||
126543776|NCT00402337|455284303|FG003|Overall Study|Physician Decision|1|||
126543777|NCT00402337|455284304|FG004|Overall Study|Physician Decision|0|||
126543778|NCT00402337|455284300|FG000|Overall Study|Other Reason|0|||
126543779|NCT00402337|455284301|FG001|Overall Study|Other Reason|1|||
126543780|NCT00402337|455284302|FG002|Overall Study|Other Reason|0|||
126543781|NCT00402337|455284303|FG003|Overall Study|Other Reason|0|||
126543782|NCT00402337|455284304|FG004|Overall Study|Other Reason|0|||
126543783|NCT02178566|455284305|FG000|Overall Study|patient did not complete due to noncompliance|0|||
126543784|NCT02178566|455284306|FG001|Overall Study|patient did not complete due to noncompliance|1|||
126543785|NCT01521884|455284313|FG000|Overall Study|Non Responders|10|||
126543786|NCT01521884|455284313|FG000|Overall Study|Adverse Event|5|||
126543787|NCT01521884|455284313|FG000|Overall Study|Pregnancy|1|||
126543788|NCT01521884|455284313|FG000|Overall Study|Withdrawal by Subject|1|||
126543789|NCT01521884|455284313|FG000|Overall Study|Physician Decision|2|||
126543790|NCT01521884|455284313|FG000|Overall Study|Protocol Violation|3|||
126543791|NCT01521884|455284313|FG000|Overall Study|Participant non-eligible|1|||
126543792|NCT01521884|455284313|FG000|Overall Study|Lost to Follow-up|4|||
126543793|NCT02821819|455284314|FG000|Overall Study|Protocol Violation|1|||
126543794|NCT03565068|455284315|FG000|Overall Study|Protocol Violation|0|||
126543795|NCT03565068|455284316|FG001|Overall Study|Protocol Violation|0|||
126543796|NCT03565068|455284317|FG002|Overall Study|Protocol Violation|0|||
126543797|NCT03565068|455284318|FG003|Overall Study|Protocol Violation|0|||
126543798|NCT03565068|455284319|FG004|Overall Study|Protocol Violation|1|||
126543799|NCT03565068|455284320|FG005|Overall Study|Protocol Violation|0|||
126543800|NCT03565068|455284321|FG006|Overall Study|Protocol Violation|0|||
126543801|NCT03565068|455284322|FG007|Overall Study|Protocol Violation|1|||
126543802|NCT03565068|455284323|FG008|Overall Study|Protocol Violation|0|||
126543803|NCT03565068|455284315|FG000|Overall Study|Sponsor decision|0|||
126543804|NCT03565068|455284316|FG001|Overall Study|Sponsor decision|0|||
126543805|NCT03565068|455284317|FG002|Overall Study|Sponsor decision|0|||
126543806|NCT03565068|455284318|FG003|Overall Study|Sponsor decision|0|||
126543807|NCT03565068|455284319|FG004|Overall Study|Sponsor decision|1|||
126543808|NCT03565068|455284320|FG005|Overall Study|Sponsor decision|1|||
126543809|NCT03565068|455284321|FG006|Overall Study|Sponsor decision|0|||
126543810|NCT03565068|455284322|FG007|Overall Study|Sponsor decision|0|||
126543811|NCT03565068|455284323|FG008|Overall Study|Sponsor decision|0|||
126543812|NCT03565068|455284315|FG000|Overall Study|Withdrawal by Subject|0|||
126543813|NCT03565068|455284316|FG001|Overall Study|Withdrawal by Subject|0|||
126543814|NCT03565068|455284317|FG002|Overall Study|Withdrawal by Subject|1|||
126543815|NCT03565068|455284318|FG003|Overall Study|Withdrawal by Subject|0|||
126543816|NCT03565068|455284319|FG004|Overall Study|Withdrawal by Subject|2|||
126543817|NCT03565068|455284320|FG005|Overall Study|Withdrawal by Subject|0|||
126543818|NCT03565068|455284321|FG006|Overall Study|Withdrawal by Subject|1|||
126543819|NCT03565068|455284322|FG007|Overall Study|Withdrawal by Subject|5|||
126543820|NCT03565068|455284323|FG008|Overall Study|Withdrawal by Subject|1|||
126543821|NCT03565068|455284315|FG000|Overall Study|Physician Decision|0|||
126543822|NCT03565068|455284316|FG001|Overall Study|Physician Decision|0|||
126543823|NCT03565068|455284317|FG002|Overall Study|Physician Decision|0|||
126543824|NCT03565068|455284318|FG003|Overall Study|Physician Decision|0|||
126543825|NCT03565068|455284319|FG004|Overall Study|Physician Decision|0|||
126543826|NCT03565068|455284320|FG005|Overall Study|Physician Decision|0|||
126543827|NCT03565068|455284321|FG006|Overall Study|Physician Decision|0|||
126543828|NCT03565068|455284322|FG007|Overall Study|Physician Decision|1|||
126543829|NCT03565068|455284323|FG008|Overall Study|Physician Decision|0|||
126543830|NCT03565068|455284315|FG000|Overall Study|Lost to Follow-up|0|||
126543831|NCT03565068|455284316|FG001|Overall Study|Lost to Follow-up|0|||
126543832|NCT03565068|455284317|FG002|Overall Study|Lost to Follow-up|0|||
126543833|NCT03565068|455284318|FG003|Overall Study|Lost to Follow-up|0|||
126543834|NCT03565068|455284319|FG004|Overall Study|Lost to Follow-up|0|||
126543835|NCT03565068|455284320|FG005|Overall Study|Lost to Follow-up|0|||
126543836|NCT03565068|455284321|FG006|Overall Study|Lost to Follow-up|0|||
126543837|NCT03565068|455284322|FG007|Overall Study|Lost to Follow-up|1|||
126543838|NCT03565068|455284323|FG008|Overall Study|Lost to Follow-up|0|||
126543839|NCT00085202|455284324|FG000|Overall Study|Still on therapy|2|||
126543840|NCT00085202|455284325|FG001|Overall Study|Still on therapy|0|||
126543841|NCT00085202|455284324|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
126543842|NCT00085202|455284325|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
126543843|NCT00085202|455284324|FG000|Overall Study|Excessive toxicity|6|||
126543844|NCT00085202|455284325|FG001|Overall Study|Excessive toxicity|5|||
126543845|NCT00085202|455284324|FG000|Overall Study|Non-specified|3|||
126543846|NCT00085202|455284325|FG001|Overall Study|Non-specified|5|||
126543847|NCT00085202|455284324|FG000|Overall Study|Withdrawal by Subject|2|||
126543848|NCT00085202|455284325|FG001|Overall Study|Withdrawal by Subject|1|||
126543849|NCT00085202|455284324|FG000|Overall Study|Physician Decision|4|||
126543850|NCT00085202|455284325|FG001|Overall Study|Physician Decision|1|||
126543851|NCT00085202|455284324|FG000|Overall Study|Progressive disease|1|||
126543852|NCT00085202|455284325|FG001|Overall Study|Progressive disease|11|||
126543853|NCT03238300|455284329|FG000|Baseline (Before Intervention)|Physician Decision|0|||
126543854|NCT03238300|455284330|FG001|Baseline (Before Intervention)|Physician Decision|1|||
126543855|NCT03238300|455284329|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
126543856|NCT03238300|455284330|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
126543857|NCT03238300|455284329|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
126543858|NCT03238300|455284330|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
126543859|NCT03238300|455284329|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
126543860|NCT03238300|455284330|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
126543861|NCT01435655|455284336|FG000|Overall Study|Death|2|||
126543862|NCT01435655|455284336|FG000|Overall Study|Other|1|||
126543863|NCT01436201|455284337|FG000|Overall Study|Adverse Event|2|||
126543864|NCT01436201|455284337|FG000|Overall Study|Withdrawal by Subject|1|||
126543865|NCT01436201|455284337|FG000|Overall Study|Protocol Violation|1|||
126543866|NCT00110890|455284339|FG000|Overall Study|Adverse Event|30|||
126543867|NCT00110890|455284340|FG001|Overall Study|Adverse Event|7|||
126543868|NCT00110890|455284339|FG000|Overall Study|Death|16|||
126543869|NCT00110890|455284340|FG001|Overall Study|Death|9|||
126543870|NCT00110890|455284339|FG000|Overall Study|Lost to Follow-up|3|||
126543871|NCT00110890|455284340|FG001|Overall Study|Lost to Follow-up|1|||
126543872|NCT00110890|455284339|FG000|Overall Study|Physician Decision|4|||
126543873|NCT00110890|455284340|FG001|Overall Study|Physician Decision|5|||
126543874|NCT00110890|455284339|FG000|Overall Study|Withdrawal by Subject|17|||
126543875|NCT00110890|455284340|FG001|Overall Study|Withdrawal by Subject|5|||
126543876|NCT00110890|455284339|FG000|Overall Study|Protocol Deviation|1|||
126543877|NCT00110890|455284340|FG001|Overall Study|Protocol Deviation|0|||
126543878|NCT00110890|455284339|FG000|Overall Study|Noncompliance|10|||
126543879|NCT00110890|455284340|FG001|Overall Study|Noncompliance|0|||
126543880|NCT00110890|455284339|FG000|Overall Study|Kidney Transplant|16|||
126543881|NCT00110890|455284340|FG001|Overall Study|Kidney Transplant|12|||
126543882|NCT00110890|455284339|FG000|Overall Study|Invest. Product Commercially Available|217|||
126543883|NCT00110890|455284340|FG001|Overall Study|Invest. Product Commercially Available|110|||
126543884|NCT00110890|455284339|FG000|Overall Study|Other|34|||
126543885|NCT00110890|455284340|FG001|Overall Study|Other|23|||
126543886|NCT00110890|455284339|FG000|Overall Study|Ineligibility determined|3|||
126543887|NCT00110890|455284340|FG001|Overall Study|Ineligibility determined|0|||
126543888|NCT00110890|455284339|FG000|Overall Study|Requirement for alternative therapy|0|||
126543889|NCT00110890|455284340|FG001|Overall Study|Requirement for alternative therapy|1|||
126543890|NCT00110890|455284339|FG000|Overall Study|Disease progression|0|||
126543891|NCT00110890|455284340|FG001|Overall Study|Disease progression|1|||
126543892|NCT00110890|455284339|FG000|Overall Study|Parathyroidectomy|0|||
126543893|NCT00110890|455284340|FG001|Overall Study|Parathyroidectomy|1|||
126543894|NCT00110890|455284339|FG000|Overall Study|Did not enter follow-up phase|10|||
126543895|NCT00110890|455284340|FG001|Overall Study|Did not enter follow-up phase|4|||
126543896|NCT01975220|455284341|FG000|Test Period 1|Not treated|0|||
126543897|NCT01975220|455284342|FG001|Test Period 1|Not treated|1|||
126543898|NCT01975220|455284343|FG002|Test Period 1|Not treated|0|||
126543899|NCT01975220|455284344|FG003|Test Period 1|Not treated|0|||
126317415|NCT05625477|454453948|FG004|Overall Study|Lost to Follow-up|0|||
126543900|NCT01975220|455284345|FG004|Test Period 1|Not treated|0|||
126543901|NCT01975220|455284346|FG005|Test Period 1|Not treated|0|||
126543902|NCT02839343|455284347|FG000|Overall Study|Withdrawal by Subject|3|||
126543903|NCT02839343|455284348|FG001|Overall Study|Withdrawal by Subject|1|||
126543904|NCT02839343|455284347|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
126543905|NCT02839343|455284348|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
126543906|NCT02839343|455284347|FG000|Overall Study|Adverse Event|1|||
126543907|NCT02839343|455284348|FG001|Overall Study|Adverse Event|0|||
126543908|NCT00661661|455284349|FG000|Overall Study|Adverse Event|99|||
126543909|NCT00661661|455284350|FG001|Overall Study|Adverse Event|24|||
126543910|NCT00661661|455284349|FG000|Overall Study|Lack of Efficacy|3|||
126543911|NCT00661661|455284350|FG001|Overall Study|Lack of Efficacy|2|||
126543912|NCT00661661|455284349|FG000|Overall Study|Lost to Follow-up|0|||
126543913|NCT00661661|455284350|FG001|Overall Study|Lost to Follow-up|1|||
126543914|NCT00661661|455284349|FG000|Overall Study|Withdrawal by Subject|15|||
126543915|NCT00661661|455284350|FG001|Overall Study|Withdrawal by Subject|5|||
126543916|NCT00661661|455284349|FG000|Overall Study|Other|22|||
126543917|NCT00661661|455284350|FG001|Overall Study|Other|7|||
126543918|NCT00661661|455284349|FG000|Overall Study|Not assigned treatment|1|||
126543919|NCT00661661|455284350|FG001|Overall Study|Not assigned treatment|0|||
126543920|NCT01893827|455284351|FG000|Overall Study|Lost to Follow-up|19|||
126543921|NCT01893827|455284352|FG001|Overall Study|Lost to Follow-up|26|||
126543922|NCT04182880|455284355|FG000|Overall Study|Pregnancy|1|||
126543923|NCT04182880|455284356|FG001|Overall Study|Pregnancy|0|||
126543924|NCT03389477|455284357|FG000|Step 1|Withdrawal by Subject|1|||
126543925|NCT03389477|455284358|FG001|Step 1|Withdrawal by Subject|0|||
126543926|NCT03389477|455284357|FG000|Step 2|Withdrawal by Subject|1|||
126543927|NCT03389477|455284358|FG001|Step 2|Withdrawal by Subject|2|||
126543928|NCT03389477|455284357|FG000|Step 2|Disease progression|1|||
126543929|NCT03389477|455284358|FG001|Step 2|Disease progression|0|||
126317416|NCT05625477|454453944|FG000|Overall Study|Covid quarantine|1|||
126543930|NCT03389477|455284357|FG000|Step 2|Death|0|||
126543931|NCT03389477|455284358|FG001|Step 2|Death|1|||
126543932|NCT03389477|455284357|FG000|Step 2|Poor performance status and nutrition|0|||
126543933|NCT03389477|455284358|FG001|Step 2|Poor performance status and nutrition|1|||
126543934|NCT03389477|455284357|FG000|Step 3|Withdrawal after 3 cycles|0|||
126543935|NCT03389477|455284358|FG001|Step 3|Withdrawal after 3 cycles|1|||
126543936|NCT03389477|455284357|FG000|Step 3|Still receiving active treatment|4|||
126543937|NCT03389477|455284358|FG001|Step 3|Still receiving active treatment|0|||
126543938|NCT03389477|455284357|FG000|Step 3|Progressive disease after 2 cycles|1|||
126543939|NCT03389477|455284358|FG001|Step 3|Progressive disease after 2 cycles|0|||
126543940|NCT03403426|455284361|FG000|Overall Study|Death|1|||
126543941|NCT03403426|455284361|FG000|Overall Study|Lost to Follow-up|2|||
126543942|NCT03021668|455284364|FG000|Overall Study|Physician Decision|0|||
126543943|NCT03021668|455284365|FG001|Overall Study|Physician Decision|1|||
126543944|NCT00909428|455284366|FG000|Overall Study|Lost to Follow-up|13|||
126543945|NCT00909428|455284367|FG001|Overall Study|Lost to Follow-up|10|||
126543946|NCT00909428|455284368|FG002|Overall Study|Lost to Follow-up|9|||
126543947|NCT03535337|455284371|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
126543948|NCT03535337|455284372|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
126543949|NCT03535337|455284373|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
126543950|NCT03535337|455284374|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
126543951|NCT03535337|455284375|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
126543952|NCT03535337|455284376|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
126543953|NCT03535337|455284377|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
126543954|NCT03535337|455284378|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
126543955|NCT03535337|455284379|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
126543956|NCT03535337|455284380|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
126543957|NCT02089230|455284381|FG000|Overall Study|Death|0|||
126543958|NCT02089230|455284382|FG001|Overall Study|Death|0|||
126543959|NCT02089230|455284383|FG002|Overall Study|Death|2|||
126543960|NCT02089230|455284381|FG000|Overall Study|Seeking Alternative Therapy|0|||
126317417|NCT05625477|454453945|FG001|Overall Study|Covid quarantine|0|||
126317418|NCT05625477|454453946|FG002|Overall Study|Covid quarantine|0|||
126317419|NCT05625477|454453947|FG003|Overall Study|Covid quarantine|0|||
126317420|NCT05625477|454453948|FG004|Overall Study|Covid quarantine|0|||
126317421|NCT02502266|454453949|FG000|Overall Study|Adverse Event|0|||
126317422|NCT02502266|454453950|FG001|Overall Study|Adverse Event|0|||
126317423|NCT02502266|454453951|FG002|Overall Study|Adverse Event|0|||
126317424|NCT02502266|454453952|FG003|Overall Study|Adverse Event|0|||
126317425|NCT02502266|454453953|FG004|Overall Study|Adverse Event|1|||
126317426|NCT02502266|454453954|FG005|Overall Study|Adverse Event|1|||
126317427|NCT02502266|454453955|FG006|Overall Study|Adverse Event|1|||
126317428|NCT02502266|454453949|FG000|Overall Study|Withdrawal by Subject|30|||
126317429|NCT02502266|454453950|FG001|Overall Study|Withdrawal by Subject|15|||
126317430|NCT02502266|454453951|FG002|Overall Study|Withdrawal by Subject|16|||
126317431|NCT02502266|454453952|FG003|Overall Study|Withdrawal by Subject|0|||
126317432|NCT02502266|454453953|FG004|Overall Study|Withdrawal by Subject|0|||
126543961|NCT02089230|455284382|FG001|Overall Study|Seeking Alternative Therapy|0|||
126543962|NCT02089230|455284383|FG002|Overall Study|Seeking Alternative Therapy|4|||
126543963|NCT02272725|455284384|FG000|Overall Study|equipment malfunction|2|||
126543964|NCT02272725|455284385|FG001|Overall Study|equipment malfunction|0|||
126543965|NCT00369681|455286043|FG000|Overall Study|Death|1|||
126543966|NCT03505476|455286044|FG000|Overall Study|Physician Decision|18|||
126543967|NCT03505476|455286044|FG000|Overall Study|Device Malfunctioned|101|||
126648208|NCT01259089|455669720|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
126543968|NCT03505476|455286044|FG000|Overall Study|Data Corrupt|6|||
126543969|NCT03505476|455286044|FG000|Overall Study|Device application insufficiant|3|||
126543970|NCT03075904|455286045|FG000|Overall Study|Physician Decision|3|||
126543971|NCT03075904|455286045|FG000|Overall Study|Need for Medication not Permitted|1|||
126543972|NCT00539643|455286046|FG000|Overall Study|Adverse Event|1|||
126543973|NCT00539643|455286047|FG001|Overall Study|Adverse Event|0|||
126543974|NCT00539643|455286046|FG000|Overall Study|Death|2|||
126543975|NCT00539643|455286047|FG001|Overall Study|Death|1|||
126543976|NCT00539643|455286046|FG000|Overall Study|Physician Decision|3|||
126543977|NCT00539643|455286047|FG001|Overall Study|Physician Decision|1|||
126543978|NCT00539643|455286046|FG000|Overall Study|Withdrawal by Subject|0|||
126543979|NCT00539643|455286047|FG001|Overall Study|Withdrawal by Subject|1|||
126543980|NCT02281760|455286052|FG000|Overall Study|Withdrawal by Subject|1|||
126543981|NCT01576367|455286053|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126543982|NCT01576367|455286053|FG000|Overall Study|Moved to commercial use after 6 months|1|||
126543983|NCT01453348|455286054|FG000|Overall Study|Death|0|||
126543984|NCT01453348|455286055|FG001|Overall Study|Death|0|||
126543985|NCT01453348|455286056|FG002|Overall Study|Death|1|||
126543986|NCT01453348|455286054|FG000|Overall Study|Withdrawal by Subject|0|||
126543987|NCT01453348|455286055|FG001|Overall Study|Withdrawal by Subject|1|||
126543988|NCT01453348|455286056|FG002|Overall Study|Withdrawal by Subject|0|||
126543989|NCT01453348|455286054|FG000|Overall Study|Protocol Violation|1|||
126543990|NCT01453348|455286055|FG001|Overall Study|Protocol Violation|0|||
126543991|NCT01453348|455286056|FG002|Overall Study|Protocol Violation|0|||
126543992|NCT04359771|455286061|FG000|Overall Study|Lack of Efficacy|2|||
126543993|NCT04359771|455286062|FG001|Overall Study|Lack of Efficacy|2|||
126543994|NCT00954733|455286063|FG000|Overall Study|blood gas machine did not work|1|||
126543995|NCT03592277|455286064|FG000|Overall Study|Withdrawal by Subject|6|||
126543996|NCT03592277|455286065|FG001|Overall Study|Withdrawal by Subject|8|||
126543997|NCT00622713|455286066|FG000|Overall Study|Adverse Event|35|||
126543998|NCT00622713|455286066|FG000|Overall Study|Administrative problems|4|||
126543999|NCT00622713|455286066|FG000|Overall Study|Withdrawal by Subject|11|||
126544000|NCT00622713|455286066|FG000|Overall Study|Lost to Follow-up|5|||
126317433|NCT02502266|454453954|FG005|Overall Study|Withdrawal by Subject|0|||
126317434|NCT02502266|454453955|FG006|Overall Study|Withdrawal by Subject|0|||
126317435|NCT02502266|454453949|FG000|Overall Study|Still on Treatment|0|||
126317436|NCT02502266|454453950|FG001|Overall Study|Still on Treatment|0|||
126317437|NCT02502266|454453951|FG002|Overall Study|Still on Treatment|1|||
126317438|NCT02502266|454453952|FG003|Overall Study|Still on Treatment|0|||
126317439|NCT02502266|454453953|FG004|Overall Study|Still on Treatment|0|||
126317440|NCT02502266|454453954|FG005|Overall Study|Still on Treatment|0|||
126317441|NCT02502266|454453955|FG006|Overall Study|Still on Treatment|0|||
126317442|NCT02502266|454453949|FG000|Overall Study|Other Reasons|19|||
126544001|NCT00622713|455286066|FG000|Overall Study|Death|2|||
126544002|NCT00622713|455286066|FG000|Overall Study|Subject no longer required study drug|1|||
126544003|NCT00622713|455286066|FG000|Overall Study|Did not meet eligibility criteria|1|||
126544004|NCT01462162|455286071|FG000|Overall Study|Adverse Event|5|||
126544005|NCT01462162|455286071|FG000|Overall Study|Lack of Efficacy|4|||
126544006|NCT01462162|455286071|FG000|Overall Study|Abnormal laboratory parameters|1|||
126544007|NCT01462162|455286071|FG000|Overall Study|Other|2|||
126544008|NCT03485911|455286072|FG000|Part 1|Perceived lack of efficacy|1|||
126544009|NCT03485911|455286073|FG001|Part 1|Perceived lack of efficacy|1|||
126544010|NCT03485911|455286074|FG002|Part 1|Perceived lack of efficacy|2|||
126544011|NCT03485911|455286075|FG003|Part 1|Perceived lack of efficacy|0|||
126544012|NCT03485911|455286072|FG000|Part 1|Subject withdrew consent|0|||
126544013|NCT03485911|455286073|FG001|Part 1|Subject withdrew consent|1|||
126544014|NCT03485911|455286074|FG002|Part 1|Subject withdrew consent|0|||
126544015|NCT03485911|455286075|FG003|Part 1|Subject withdrew consent|1|||
126544016|NCT03485911|455286072|FG000|Part 1|Lab abnormalities/AEs|3|||
126544017|NCT03485911|455286073|FG001|Part 1|Lab abnormalities/AEs|1|||
126544018|NCT03485911|455286074|FG002|Part 1|Lab abnormalities/AEs|1|||
126544019|NCT03485911|455286075|FG003|Part 1|Lab abnormalities/AEs|0|||
126544020|NCT03485911|455286072|FG000|Part 1|Withdrew Consent prior to dosing|0|||
126544021|NCT03485911|455286073|FG001|Part 1|Withdrew Consent prior to dosing|0|||
126544022|NCT03485911|455286074|FG002|Part 1|Withdrew Consent prior to dosing|0|||
126544023|NCT03485911|455286075|FG003|Part 1|Withdrew Consent prior to dosing|1|||
126544024|NCT03485911|455286072|FG000|Part 1|Other NOS|0|||
126317443|NCT02502266|454453950|FG001|Overall Study|Other Reasons|6|||
126317444|NCT02502266|454453951|FG002|Overall Study|Other Reasons|14|||
126317445|NCT02502266|454453952|FG003|Overall Study|Other Reasons|0|||
126544025|NCT03485911|455286073|FG001|Part 1|Other NOS|0|||
126544026|NCT03485911|455286074|FG002|Part 1|Other NOS|0|||
126544027|NCT03485911|455286075|FG003|Part 1|Other NOS|1|||
126544028|NCT03485911|455286072|FG000|Part 2|Perceived lack of efficacy|5|||
126544029|NCT03485911|455286073|FG001|Part 2|Perceived lack of efficacy|3|||
126544030|NCT03485911|455286074|FG002|Part 2|Perceived lack of efficacy|0|||
126544031|NCT03485911|455286075|FG003|Part 2|Perceived lack of efficacy|2|||
126544032|NCT03485911|455286072|FG000|Part 2|Subject withdrew consent|1|||
126544033|NCT03485911|455286073|FG001|Part 2|Subject withdrew consent|0|||
126544034|NCT03485911|455286074|FG002|Part 2|Subject withdrew consent|2|||
126544035|NCT03485911|455286075|FG003|Part 2|Subject withdrew consent|1|||
126648209|NCT01259089|455669721|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
126317446|NCT02502266|454453953|FG004|Overall Study|Other Reasons|1|||
126317447|NCT02502266|454453954|FG005|Overall Study|Other Reasons|1|||
126544036|NCT03485911|455286072|FG000|Part 2|Lab abnormalities/AEs|1|||
126544037|NCT03485911|455286073|FG001|Part 2|Lab abnormalities/AEs|2|||
126317448|NCT02502266|454453955|FG006|Overall Study|Other Reasons|0|||
126317449|NCT02502266|454453949|FG000|Overall Study|Arm 4 Discontinued|0|||
126317450|NCT02502266|454453950|FG001|Overall Study|Arm 4 Discontinued|0|||
126317451|NCT02502266|454453951|FG002|Overall Study|Arm 4 Discontinued|0|||
126317452|NCT02502266|454453952|FG003|Overall Study|Arm 4 Discontinued|52|||
126317453|NCT02502266|454453953|FG004|Overall Study|Arm 4 Discontinued|0|||
126317454|NCT02502266|454453954|FG005|Overall Study|Arm 4 Discontinued|0|||
126317455|NCT02502266|454453955|FG006|Overall Study|Arm 4 Discontinued|0|||
126317456|NCT02502266|454453949|FG000|Overall Study|Never treated|0|||
126317457|NCT02502266|454453950|FG001|Overall Study|Never treated|0|||
126317458|NCT02502266|454453951|FG002|Overall Study|Never treated|0|||
126317459|NCT02502266|454453952|FG003|Overall Study|Never treated|0|||
126317460|NCT02502266|454453953|FG004|Overall Study|Never treated|0|||
126317461|NCT02502266|454453954|FG005|Overall Study|Never treated|1|||
126317462|NCT02502266|454453955|FG006|Overall Study|Never treated|0|||
126317463|NCT02921750|454453956|FG000|Overall Study|Adverse Event|1|||
126317464|NCT02921750|454453957|FG001|Overall Study|Adverse Event|2|||
126317465|NCT02921750|454453956|FG000|Overall Study|Withdrawal by Subject|1|||
126317466|NCT02921750|454453957|FG001|Overall Study|Withdrawal by Subject|1|||
126317467|NCT02921750|454453956|FG000|Overall Study|Lost to Follow-up|3|||
126317468|NCT02921750|454453957|FG001|Overall Study|Lost to Follow-up|3|||
126317469|NCT02921750|454453956|FG000|Overall Study|Wound healed|3|||
126544038|NCT03485911|455286074|FG002|Part 2|Lab abnormalities/AEs|0|||
126544039|NCT03485911|455286075|FG003|Part 2|Lab abnormalities/AEs|0|||
126544040|NCT03485911|455286072|FG000|Part 2|Other NOS|0|||
126544041|NCT03485911|455286073|FG001|Part 2|Other NOS|1|||
126544042|NCT03485911|455286074|FG002|Part 2|Other NOS|0|||
126544043|NCT03485911|455286075|FG003|Part 2|Other NOS|0|||
126544044|NCT03485911|455286072|FG000|Part 2|Intercurrent illness/new medical condition|1|||
126544045|NCT03485911|455286073|FG001|Part 2|Intercurrent illness/new medical condition|0|||
126544046|NCT03485911|455286074|FG002|Part 2|Intercurrent illness/new medical condition|0|||
126544047|NCT03485911|455286075|FG003|Part 2|Intercurrent illness/new medical condition|0|||
126544048|NCT03485911|455286072|FG000|Part 2|Investigator judgement|1|||
126544049|NCT03485911|455286073|FG001|Part 2|Investigator judgement|0|||
126544050|NCT03485911|455286074|FG002|Part 2|Investigator judgement|0|||
126544051|NCT03485911|455286075|FG003|Part 2|Investigator judgement|0|||
126544052|NCT03485911|455286072|FG000|Part 3|Perceived lack of efficacy|2|||
126544053|NCT03485911|455286073|FG001|Part 3|Perceived lack of efficacy|2|||
126544054|NCT03485911|455286074|FG002|Part 3|Perceived lack of efficacy|2|||
126544055|NCT03485911|455286075|FG003|Part 3|Perceived lack of efficacy|0|||
126544056|NCT03485911|455286072|FG000|Part 3|Subject withdrew consent|1|||
126544057|NCT03485911|455286073|FG001|Part 3|Subject withdrew consent|4|||
126544058|NCT03485911|455286074|FG002|Part 3|Subject withdrew consent|0|||
126544059|NCT03485911|455286075|FG003|Part 3|Subject withdrew consent|1|||
126544060|NCT03485911|455286072|FG000|Part 3|Lab abnormalities/AEs|1|||
126544061|NCT03485911|455286073|FG001|Part 3|Lab abnormalities/AEs|1|||
126544062|NCT03485911|455286074|FG002|Part 3|Lab abnormalities/AEs|0|||
126544063|NCT03485911|455286075|FG003|Part 3|Lab abnormalities/AEs|2|||
126544064|NCT03485911|455286072|FG000|Part 3|Other NOS|1|||
126544065|NCT03485911|455286073|FG001|Part 3|Other NOS|1|||
126544066|NCT03485911|455286074|FG002|Part 3|Other NOS|0|||
126544067|NCT03485911|455286075|FG003|Part 3|Other NOS|0|||
126544068|NCT03485911|455286072|FG000|Part 3|Intercurrent illness/new medical condition|0|||
126544069|NCT03485911|455286073|FG001|Part 3|Intercurrent illness/new medical condition|1|||
126544070|NCT03485911|455286074|FG002|Part 3|Intercurrent illness/new medical condition|1|||
126544071|NCT03485911|455286075|FG003|Part 3|Intercurrent illness/new medical condition|0|||
126544072|NCT03485911|455286072|FG000|Part 3|Sponsor discontinuation|1|||
126544073|NCT03485911|455286073|FG001|Part 3|Sponsor discontinuation|0|||
126544074|NCT03485911|455286074|FG002|Part 3|Sponsor discontinuation|0|||
126544075|NCT03485911|455286075|FG003|Part 3|Sponsor discontinuation|0|||
126544076|NCT03485911|455286072|FG000|Part 3|Berotralstat provided by alternative means|13|||
126544077|NCT03485911|455286073|FG001|Part 3|Berotralstat provided by alternative means|13|||
126544078|NCT03485911|455286074|FG002|Part 3|Berotralstat provided by alternative means|7|||
126544079|NCT03485911|455286075|FG003|Part 3|Berotralstat provided by alternative means|7|||
126544080|NCT01346514|455286076|FG000|Overall Study|Lost to Follow-up|19|||
126544081|NCT01346514|455286077|FG001|Overall Study|Lost to Follow-up|30|||
126544082|NCT01346514|455286076|FG000|Overall Study|Withdrawal by Subject|7|||
126544083|NCT01346514|455286077|FG001|Overall Study|Withdrawal by Subject|3|||
126544084|NCT01346514|455286076|FG000|Overall Study|Death|3|||
126544085|NCT01346514|455286077|FG001|Overall Study|Death|4|||
126544086|NCT01215357|455286081|FG000|Overall Study|Withdrawal by Subject|3|||
126544087|NCT01215357|455286081|FG000|Overall Study|Protocol Violation|9|||
126544088|NCT00909480|455286082|FG000|Overall Study|Adverse Event|5|||
126317470|NCT02921750|454453957|FG001|Overall Study|Wound healed|3|||
126317471|NCT02921750|454453956|FG000|Overall Study|Serious Adverse Event|1|||
126317472|NCT02921750|454453957|FG001|Overall Study|Serious Adverse Event|2|||
126317473|NCT04258254|454453958|FG000|Overall Study|Withdrawal by Subject|0|||
126544089|NCT00909480|455286083|FG001|Overall Study|Adverse Event|3|||
126544090|NCT00909480|455286082|FG000|Overall Study|Protocol Violation|6|||
126544091|NCT00909480|455286083|FG001|Overall Study|Protocol Violation|8|||
126317474|NCT04258254|454453959|FG001|Overall Study|Withdrawal by Subject|1|||
126317475|NCT04258254|454453960|FG002|Overall Study|Withdrawal by Subject|0|||
126317476|NCT04829331|454453961|FG000|Overall Study|Lost to Follow-up|1|||
126317477|NCT04829331|454453962|FG001|Overall Study|Lost to Follow-up|0|||
126317478|NCT03570554|454453963|FG000|Overall Study|Non-compliance with study drug|0|||
126317479|NCT03570554|454453964|FG001|Overall Study|Non-compliance with study drug|0|||
126317480|NCT03570554|454453965|FG002|Overall Study|Non-compliance with study drug|1|||
126317481|NCT03570554|454453966|FG003|Overall Study|Non-compliance with study drug|0|||
126317482|NCT03570554|454453963|FG000|Overall Study|Adverse Event|0|||
126317483|NCT03570554|454453964|FG001|Overall Study|Adverse Event|0|||
126317484|NCT03570554|454453965|FG002|Overall Study|Adverse Event|0|||
126317485|NCT03570554|454453966|FG003|Overall Study|Adverse Event|1|||
126317486|NCT03435224|454453968|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
126317487|NCT02604550|454453971|FG000|Overall Study|Lost to Follow-up|7|||
126317488|NCT02604550|454453972|FG001|Overall Study|Lost to Follow-up|6|||
126317489|NCT02604550|454453971|FG000|Overall Study|Withdrawal by Subject|0|||
126317490|NCT02604550|454453972|FG001|Overall Study|Withdrawal by Subject|1|||
126317491|NCT02604550|454453971|FG000|Overall Study|Incomplete data using paper journal|18|||
126317492|NCT02604550|454453972|FG001|Overall Study|Incomplete data using paper journal|19|||
126317493|NCT01404208|454453973|FG000|Overall Study|Discontinued|3|||
126317494|NCT01404208|454453974|FG001|Overall Study|Discontinued|0|||
126317495|NCT01777295|454453977|FG000|Overall Study|Withdrawal by Subject|2|||
126317496|NCT01777295|454453978|FG001|Overall Study|Withdrawal by Subject|2|||
126317497|NCT01777295|454453977|FG000|Overall Study|Pregnancy|0|||
126317498|NCT01777295|454453978|FG001|Overall Study|Pregnancy|1|||
126317499|NCT01777295|454453977|FG000|Overall Study|Personal problem|1|||
126317500|NCT01777295|454453978|FG001|Overall Study|Personal problem|0|||
126317501|NCT01777295|454453977|FG000|Overall Study|Investigator call for AEs check|1|||
126317502|NCT01777295|454453978|FG001|Overall Study|Investigator call for AEs check|0|||
126317503|NCT04007107|454453979|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
126317504|NCT04007107|454453980|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
126317505|NCT04007107|454453981|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
126317506|NCT04007107|454453982|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
126317507|NCT04068688|454453983|FG000|Overall Study|Lost to Follow-up|1|||
126317508|NCT04068688|454453984|FG001|Overall Study|Lost to Follow-up|1|||
126317509|NCT04068688|454453985|FG002|Overall Study|Lost to Follow-up|0|||
126317510|NCT04068688|454453986|FG003|Overall Study|Lost to Follow-up|0|||
126317511|NCT04068688|454453987|FG004|Overall Study|Lost to Follow-up|5|||
126317512|NCT04068688|454453988|FG005|Overall Study|Lost to Follow-up|5|||
126317513|NCT04068688|454453989|FG006|Overall Study|Lost to Follow-up|0|||
126317514|NCT04068688|454453990|FG007|Overall Study|Lost to Follow-up|0|||
126317515|NCT04068688|454453991|FG008|Overall Study|Lost to Follow-up|1|||
126317516|NCT04068688|454453992|FG009|Overall Study|Lost to Follow-up|0|||
126317517|NCT04068688|454453983|FG000|Overall Study|Withdrawal by Subject|1|||
126317518|NCT04068688|454453984|FG001|Overall Study|Withdrawal by Subject|1|||
126317519|NCT04068688|454453985|FG002|Overall Study|Withdrawal by Subject|0|||
126317520|NCT04068688|454453986|FG003|Overall Study|Withdrawal by Subject|0|||
126317521|NCT04068688|454453987|FG004|Overall Study|Withdrawal by Subject|0|||
126317522|NCT04068688|454453988|FG005|Overall Study|Withdrawal by Subject|0|||
126317523|NCT04068688|454453989|FG006|Overall Study|Withdrawal by Subject|0|||
126317524|NCT04068688|454453990|FG007|Overall Study|Withdrawal by Subject|0|||
126317525|NCT04068688|454453991|FG008|Overall Study|Withdrawal by Subject|0|||
126317526|NCT04068688|454453992|FG009|Overall Study|Withdrawal by Subject|0|||
126317527|NCT04068688|454453983|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
126317528|NCT04068688|454453984|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
126317529|NCT04068688|454453985|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317530|NCT04068688|454453986|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317531|NCT04068688|454453987|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317532|NCT04068688|454453988|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317533|NCT04068688|454453989|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317534|NCT04068688|454453990|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317535|NCT04068688|454453991|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317536|NCT04068688|454453992|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
126317537|NCT04679051|454453993|FG000|Overall Study|felt tired after restricted time in bed|3|||
126317538|NCT04679051|454453994|FG001|Overall Study|felt tired after restricted time in bed|0|||
126317539|NCT04679051|454453993|FG000|Overall Study|discomfort with blood pressure cuff|2|||
126317540|NCT04679051|454453994|FG001|Overall Study|discomfort with blood pressure cuff|0|||
126317541|NCT04679051|454453993|FG000|Overall Study|scheduling conflict|1|||
126317542|NCT04679051|454453994|FG001|Overall Study|scheduling conflict|1|||
126317543|NCT04679051|454453993|FG000|Overall Study|Protocol Violation|0|||
126317544|NCT04679051|454453994|FG001|Overall Study|Protocol Violation|4|||
126317545|NCT02554318|454453995|FG000|Overall Study|Withdrawal by Subject|10|||
126544092|NCT00909480|455286082|FG000|Overall Study|Withdrawal criteria|9|||
126544093|NCT00909480|455286083|FG001|Overall Study|Withdrawal criteria|11|||
126544094|NCT00909480|455286082|FG000|Overall Study|Unclassified|18|||
126544095|NCT00909480|455286083|FG001|Overall Study|Unclassified|19|||
126544096|NCT03528174|455286090|FG000|Overall Study|Adverse Event|1|||
126544097|NCT03528174|455286090|FG000|Overall Study|sensors dislodged|1|||
126544098|NCT03002038|455286091|FG000|Overall Study|Adverse Event|3|||
126544099|NCT03002038|455286092|FG001|Overall Study|Adverse Event|1|||
126544100|NCT03002038|455286091|FG000|Overall Study|Withdrawal by Subject|8|||
126544101|NCT03002038|455286092|FG001|Overall Study|Withdrawal by Subject|4|||
126544102|NCT03002038|455286091|FG000|Overall Study|Immigration to another region|0|||
126544103|NCT03002038|455286092|FG001|Overall Study|Immigration to another region|2|||
126544104|NCT05266963|455286104|FG000|Drug Period A|Withdrawal by Subject|0|||
126544105|NCT05266963|455286105|FG001|Drug Period A|Withdrawal by Subject|1|||
126544106|NCT01719237|455286106|FG000|Overall Study|Physician Decision|0|||
126544107|NCT01719237|455286107|FG001|Overall Study|Physician Decision|1|||
126544108|NCT01725386|455286108|FG000|Overall Study|Death|84|||
126544109|NCT01725386|455286109|FG001|Overall Study|Death|40|||
126544110|NCT01725386|455286108|FG000|Overall Study|Lost to Follow-up|81|||
126544111|NCT01725386|455286109|FG001|Overall Study|Lost to Follow-up|6|||
126544112|NCT01725386|455286108|FG000|Overall Study|Withdrawal by Subject|10|||
126544113|NCT01725386|455286109|FG001|Overall Study|Withdrawal by Subject|0|||
126544114|NCT03812536|455286110|FG000|Overall Study|Protocol Violation|2|||
126544115|NCT03812536|455286111|FG001|Overall Study|Protocol Violation|0|||
126544116|NCT03812536|455286110|FG000|Overall Study|Withdrawal by Subject|1|||
126544117|NCT03812536|455286111|FG001|Overall Study|Withdrawal by Subject|1|||
126544118|NCT00152009|455286112|FG000|Overall Study|Adverse Event|9|||
126544119|NCT00152009|455286113|FG001|Overall Study|Adverse Event|13|||
126544120|NCT00152009|455286114|FG002|Overall Study|Adverse Event|20|||
126544121|NCT00152009|455286115|FG003|Overall Study|Adverse Event|1|||
126544122|NCT00152009|455286112|FG000|Overall Study|Protocol Violation|3|||
126544123|NCT00152009|455286113|FG001|Overall Study|Protocol Violation|0|||
126544124|NCT00152009|455286114|FG002|Overall Study|Protocol Violation|0|||
126544125|NCT00152009|455286115|FG003|Overall Study|Protocol Violation|1|||
126544126|NCT00152009|455286112|FG000|Overall Study|Withdrawal by Subject|2|||
126544127|NCT00152009|455286113|FG001|Overall Study|Withdrawal by Subject|3|||
126544128|NCT00152009|455286114|FG002|Overall Study|Withdrawal by Subject|4|||
126544129|NCT00152009|455286115|FG003|Overall Study|Withdrawal by Subject|9|||
126544130|NCT00152009|455286112|FG000|Overall Study|Lost to Follow-up|2|||
126544131|NCT00152009|455286113|FG001|Overall Study|Lost to Follow-up|4|||
126544132|NCT00152009|455286114|FG002|Overall Study|Lost to Follow-up|3|||
126544133|NCT00152009|455286115|FG003|Overall Study|Lost to Follow-up|3|||
126544134|NCT00152009|455286112|FG000|Overall Study|Lack of Efficacy|8|||
126544135|NCT00152009|455286113|FG001|Overall Study|Lack of Efficacy|6|||
126544136|NCT00152009|455286114|FG002|Overall Study|Lack of Efficacy|7|||
126544137|NCT00152009|455286115|FG003|Overall Study|Lack of Efficacy|15|||
126544138|NCT00152009|455286112|FG000|Overall Study|ECG abnormalities|2|||
126544139|NCT00152009|455286113|FG001|Overall Study|ECG abnormalities|2|||
126544140|NCT00152009|455286114|FG002|Overall Study|ECG abnormalities|2|||
126544141|NCT00152009|455286115|FG003|Overall Study|ECG abnormalities|1|||
126544142|NCT00152009|455286112|FG000|Overall Study|Sponsor's decision|3|||
126544143|NCT00152009|455286113|FG001|Overall Study|Sponsor's decision|3|||
126544144|NCT00152009|455286114|FG002|Overall Study|Sponsor's decision|1|||
126544145|NCT00152009|455286115|FG003|Overall Study|Sponsor's decision|3|||
126544146|NCT02914314|455286116|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
126544147|NCT02914314|455286117|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
126544148|NCT02914314|455286118|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
126317546|NCT02554318|454453996|FG001|Overall Study|Withdrawal by Subject|8|||
126317547|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
126317548|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
126317549|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
126544149|NCT02914314|455286119|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
126544150|NCT02914314|455286116|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
126544151|NCT02914314|455286117|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
126544152|NCT02914314|455286118|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
126544153|NCT02914314|455286119|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
126544154|NCT02914314|455286116|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
126544155|NCT02914314|455286117|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
126544156|NCT02914314|455286118|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
126544157|NCT02914314|455286119|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
126544158|NCT02914314|455286116|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
126544159|NCT02914314|455286117|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
126544160|NCT02914314|455286118|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
126544161|NCT02914314|455286119|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
126544162|NCT02914314|455286116|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
126544163|NCT02914314|455286117|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
126544164|NCT02914314|455286118|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
126544165|NCT02914314|455286119|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
126544166|NCT01306201|455286122|FG000|Overall Study|Arrhythmia|4|||
126544167|NCT01306201|455286122|FG000|Overall Study|Files could not be processed|3|||
126544168|NCT01306201|455286122|FG000|Overall Study|Files unreadable|3|||
126544169|NCT04702568|455286123|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
126544170|NCT04702568|455286124|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
126544171|NCT04702568|455286123|FG000|Overall Study|Pregnancy|1|||
126544172|NCT04702568|455286124|FG001|Overall Study|Pregnancy|0|||
126544173|NCT04702568|455286123|FG000|Overall Study|Bone marrow transplant|1|||
126544174|NCT04702568|455286124|FG001|Overall Study|Bone marrow transplant|0|||
126544175|NCT04702568|455286123|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
126544176|NCT04702568|455286124|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
126544177|NCT04702568|455286123|FG000|Overall Study|Withdrawal by Subject|0|||
126544178|NCT04702568|455286124|FG001|Overall Study|Withdrawal by Subject|2|||
126544179|NCT00393523|455286125|FG000|Overall Study|Lost to Follow-up|0|||
126544180|NCT00393523|455286126|FG001|Overall Study|Lost to Follow-up|0|||
126544181|NCT00393523|455286127|FG002|Overall Study|Lost to Follow-up|0|||
126544182|NCT00393523|455286128|FG003|Overall Study|Lost to Follow-up|2|||
126544183|NCT00393523|455286129|FG004|Overall Study|Lost to Follow-up|1|||
126544184|NCT00393523|455286125|FG000|Overall Study|Protocol Violation|6|||
126544185|NCT00393523|455286126|FG001|Overall Study|Protocol Violation|2|||
126544186|NCT00393523|455286127|FG002|Overall Study|Protocol Violation|0|||
126544187|NCT00393523|455286128|FG003|Overall Study|Protocol Violation|1|||
126544188|NCT00393523|455286129|FG004|Overall Study|Protocol Violation|0|||
126544189|NCT00393523|455286125|FG000|Overall Study|Withdrawal by Subject|6|||
126544190|NCT00393523|455286126|FG001|Overall Study|Withdrawal by Subject|7|||
126544191|NCT00393523|455286127|FG002|Overall Study|Withdrawal by Subject|2|||
126544192|NCT00393523|455286128|FG003|Overall Study|Withdrawal by Subject|3|||
126544193|NCT00393523|455286129|FG004|Overall Study|Withdrawal by Subject|0|||
126544194|NCT00393523|455286125|FG000|Overall Study|Difficulties in specimen collection|0|||
126544195|NCT00393523|455286126|FG001|Overall Study|Difficulties in specimen collection|0|||
126317550|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
126317551|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|Death|1|||
126317552|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|Death|1|||
126317553|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
126317554|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
126317555|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
126317556|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
126317557|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
126317558|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
126317559|NCT00033657|454453997|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
126317560|NCT00033657|454453998|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
126317561|NCT00033657|454453997|FG000|Surgical Resection|not complete resection|0|||
126317562|NCT00033657|454453998|FG001|Surgical Resection|not complete resection|3|||
126317563|NCT00033657|454453997|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
126317564|NCT00033657|454453998|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
126317565|NCT00033657|454453997|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
126544196|NCT00393523|455286127|FG002|Overall Study|Difficulties in specimen collection|1|||
126544197|NCT00393523|455286128|FG003|Overall Study|Difficulties in specimen collection|0|||
126544198|NCT00393523|455286129|FG004|Overall Study|Difficulties in specimen collection|0|||
126317566|NCT00033657|454453998|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
126317567|NCT00033657|454453997|FG000|Adjuvant Chemotherapy|Death|2|||
126317568|NCT00033657|454453998|FG001|Adjuvant Chemotherapy|Death|1|||
126317569|NCT00033657|454453997|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
126317570|NCT00033657|454453998|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
126317571|NCT00033657|454453997|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
126317572|NCT00033657|454453998|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
126317573|NCT00033657|454453997|FG000|Adjuvant Chemotherapy|Other|0|||
126317574|NCT00033657|454453998|FG001|Adjuvant Chemotherapy|Other|2|||
126317575|NCT02248974|454453999|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
126317576|NCT02248974|454454000|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
126317577|NCT02248974|454453999|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
126317578|NCT02248974|454454000|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
126317579|NCT02248974|454453999|FG000|1-Day Follow-Up|Enrolled in another study|1|||
126317580|NCT02248974|454454000|FG001|1-Day Follow-Up|Enrolled in another study|0|||
126317581|NCT02248974|454453999|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
126317582|NCT02248974|454454000|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
126317583|NCT02248974|454453999|FG000|1-Week Follow-Up|Enrolled in another study|1|||
126317584|NCT02248974|454454000|FG001|1-Week Follow-Up|Enrolled in another study|1|||
126317585|NCT02248974|454453999|FG000|1-Week Follow-Up|Transferred to another facility|1|||
126317586|NCT02248974|454454000|FG001|1-Week Follow-Up|Transferred to another facility|0|||
126317587|NCT02248974|454453999|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
126317588|NCT02248974|454454000|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
126317589|NCT02248974|454453999|FG000|1-Week Follow-Up|Death|1|||
126317590|NCT02248974|454454000|FG001|1-Week Follow-Up|Death|1|||
126317591|NCT02248974|454453999|FG000|1-Week Follow-Up|Excluded because of age|0|||
126317592|NCT02248974|454454000|FG001|1-Week Follow-Up|Excluded because of age|1|||
126317593|NCT02248974|454453999|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
126317594|NCT02248974|454454000|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
126317595|NCT02248974|454453999|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
126317596|NCT02248974|454454000|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
126317597|NCT02248974|454453999|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
126317598|NCT02248974|454454000|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
126317599|NCT02248974|454453999|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
126317600|NCT02248974|454454000|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
126317601|NCT02248974|454453999|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
126317602|NCT02248974|454454000|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
126317603|NCT02332239|454454001|FG000|Overall Study|Lost to Follow-up|4|||
126317604|NCT02332239|454454002|FG001|Overall Study|Lost to Follow-up|6|||
126317605|NCT00115037|454454003|FG000|Phase1|Lost to Follow-up|16|||
126317606|NCT00115037|454454004|FG001|Phase1|Lost to Follow-up|23|||
126317607|NCT00115037|454454005|FG002|Phase1|Lost to Follow-up|0|||
126317608|NCT00115037|454454006|FG003|Phase1|Lost to Follow-up|0|||
126317609|NCT00115037|454454007|FG004|Phase1|Lost to Follow-up|0|||
126317610|NCT00115037|454454008|FG005|Phase1|Lost to Follow-up|0|||
126317611|NCT00115037|454454003|FG000|Phase1|Withdrawal by Subject|9|||
126544199|NCT00393523|455286125|FG000|Overall Study|Vaccine supply issue|0|||
126544200|NCT00393523|455286126|FG001|Overall Study|Vaccine supply issue|0|||
126544201|NCT00393523|455286127|FG002|Overall Study|Vaccine supply issue|1|||
126544202|NCT00393523|455286128|FG003|Overall Study|Vaccine supply issue|0|||
126544203|NCT00393523|455286129|FG004|Overall Study|Vaccine supply issue|0|||
126544204|NCT01122381|455286137|FG000|Overall Study|study terminated early|0|||
126544205|NCT01122381|455286138|FG001|Overall Study|study terminated early|1|||
126544206|NCT02217280|455286139|FG000|Overall Study|Withdrawal by Subject|2|||
126544207|NCT02217280|455286139|FG000|Overall Study|Post-consent sceen fail|2|||
126544208|NCT00736489|455286142|FG000|Period 1|Lost to Follow-up|1|||
126544209|NCT00736489|455286143|FG001|Period 1|Lost to Follow-up|0|||
126544210|NCT00736489|455286144|FG002|Period 1|Lost to Follow-up|0|||
126544211|NCT00736489|455286145|FG003|Period 1|Lost to Follow-up|0|||
126544212|NCT00736489|455286146|FG004|Period 1|Lost to Follow-up|0|||
126544213|NCT00736489|455286147|FG005|Period 1|Lost to Follow-up|0|||
126544214|NCT00736489|455286142|FG000|Period 1|Withdrawal by Subject|0|||
126544215|NCT00736489|455286143|FG001|Period 1|Withdrawal by Subject|0|||
126544216|NCT00736489|455286144|FG002|Period 1|Withdrawal by Subject|0|||
126544217|NCT00736489|455286145|FG003|Period 1|Withdrawal by Subject|0|||
126544218|NCT00736489|455286146|FG004|Period 1|Withdrawal by Subject|0|||
126544219|NCT00736489|455286147|FG005|Period 1|Withdrawal by Subject|1|||
126544220|NCT00116844|455286148|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
126544221|NCT00116844|455286149|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
126544222|NCT00116844|455286148|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
126544223|NCT00116844|455286149|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
126544224|NCT00116844|455286148|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
126544225|NCT00116844|455286149|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
126317612|NCT00115037|454454004|FG001|Phase1|Withdrawal by Subject|4|||
126317613|NCT00115037|454454005|FG002|Phase1|Withdrawal by Subject|0|||
126317614|NCT00115037|454454006|FG003|Phase1|Withdrawal by Subject|0|||
126544226|NCT00116844|455286148|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
126544227|NCT00116844|455286149|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
126544228|NCT00116844|455286148|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
126544229|NCT00116844|455286149|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
126544230|NCT00116844|455286148|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
126544231|NCT00116844|455286149|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
126544232|NCT00116844|455286148|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
126544233|NCT00116844|455286149|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
126544234|NCT00116844|455286148|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
126544235|NCT00116844|455286149|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
126544236|NCT00116844|455286148|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
126544237|NCT00116844|455286149|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
126544238|NCT01933880|455286150|FG000|Overall Study|Withdrawal by Subject|5|||
126544239|NCT01933880|455286151|FG001|Overall Study|Withdrawal by Subject|0|||
126544240|NCT01933880|455286150|FG000|Overall Study|Lack of Efficacy|1|||
126544241|NCT01933880|455286151|FG001|Overall Study|Lack of Efficacy|0|||
126544242|NCT01933880|455286150|FG000|Overall Study|Concomitant medication Interference|0|||
126544243|NCT01933880|455286151|FG001|Overall Study|Concomitant medication Interference|1|||
126544244|NCT01933880|455286150|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
126544245|NCT01933880|455286151|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
126544246|NCT01933880|455286150|FG000|Overall Study|Other|4|||
126544247|NCT01933880|455286151|FG001|Overall Study|Other|0|||
126544248|NCT01933880|455286150|FG000|Overall Study|Protocol Violation|1|||
126544249|NCT01933880|455286151|FG001|Overall Study|Protocol Violation|0|||
126544250|NCT02395133|455286152|FG000|Overall Study|Adverse Event|4|||
126544251|NCT02395133|455286153|FG001|Overall Study|Adverse Event|1|||
126544252|NCT02395133|455286154|FG002|Overall Study|Adverse Event|3|||
126544253|NCT02395133|455286155|FG003|Overall Study|Adverse Event|0|||
126544254|NCT02395133|455286152|FG000|Overall Study|Lack of Efficacy|1|||
126544255|NCT02395133|455286153|FG001|Overall Study|Lack of Efficacy|0|||
126544256|NCT02395133|455286154|FG002|Overall Study|Lack of Efficacy|1|||
126544257|NCT02395133|455286155|FG003|Overall Study|Lack of Efficacy|1|||
126544258|NCT02395133|455286152|FG000|Overall Study|Protocol Violation|1|||
126544259|NCT02395133|455286153|FG001|Overall Study|Protocol Violation|1|||
126544260|NCT02395133|455286154|FG002|Overall Study|Protocol Violation|0|||
126544261|NCT02395133|455286155|FG003|Overall Study|Protocol Violation|3|||
126544262|NCT02395133|455286152|FG000|Overall Study|Lost to Follow-up|0|||
126544263|NCT02395133|455286153|FG001|Overall Study|Lost to Follow-up|1|||
126544264|NCT02395133|455286154|FG002|Overall Study|Lost to Follow-up|1|||
126544265|NCT02395133|455286155|FG003|Overall Study|Lost to Follow-up|0|||
126544266|NCT02395133|455286152|FG000|Overall Study|Pregnancy|0|||
126544267|NCT02395133|455286153|FG001|Overall Study|Pregnancy|0|||
126544268|NCT02395133|455286154|FG002|Overall Study|Pregnancy|3|||
126544269|NCT02395133|455286155|FG003|Overall Study|Pregnancy|0|||
126544270|NCT02395133|455286152|FG000|Overall Study|Consent withdrawn with no reason given|1|||
126544271|NCT02395133|455286153|FG001|Overall Study|Consent withdrawn with no reason given|3|||
126544272|NCT02395133|455286154|FG002|Overall Study|Consent withdrawn with no reason given|0|||
126544273|NCT02395133|455286155|FG003|Overall Study|Consent withdrawn with no reason given|2|||
126544274|NCT02395133|455286152|FG000|Overall Study|Consent withdrawn with personal reason|0|||
126544275|NCT02395133|455286153|FG001|Overall Study|Consent withdrawn with personal reason|1|||
126544276|NCT02395133|455286154|FG002|Overall Study|Consent withdrawn with personal reason|0|||
126544277|NCT02395133|455286155|FG003|Overall Study|Consent withdrawn with personal reason|3|||
126544278|NCT02395133|455286152|FG000|Overall Study|Sponsor decision|2|||
126544279|NCT02395133|455286153|FG001|Overall Study|Sponsor decision|0|||
126544280|NCT02395133|455286154|FG002|Overall Study|Sponsor decision|0|||
126544281|NCT02395133|455286155|FG003|Overall Study|Sponsor decision|1|||
126544282|NCT02395133|455286152|FG000|Overall Study|Other than specified above|5|||
126544283|NCT02395133|455286153|FG001|Overall Study|Other than specified above|2|||
126544284|NCT02395133|455286154|FG002|Overall Study|Other than specified above|2|||
126544285|NCT02395133|455286155|FG003|Overall Study|Other than specified above|4|||
126544286|NCT03474549|455286156|FG000|Overall Study|Death|31|||
126544287|NCT03474549|455286156|FG000|Overall Study|Lost to Follow-up|4|||
126544288|NCT03474549|455286156|FG000|Overall Study|Withdrawal by Subject|2|||
126544289|NCT00738101|455286160|FG000|Overall Study|Physician Decision|5|||
126544290|NCT00738101|455286160|FG000|Overall Study|Death|1|||
126544291|NCT00738101|455286160|FG000|Overall Study|Repeat enrollment|1|||
126544292|NCT00709059|455286165|FG000|Overall Study|Lost to Follow-up|34|||
126544293|NCT00709059|455286165|FG000|Overall Study|Withdrawal by Subject|19|||
126544294|NCT00709059|455286165|FG000|Overall Study|Physician Decision|7|||
126544295|NCT00709059|455286165|FG000|Overall Study|Disease complication|3|||
126544296|NCT00709059|455286165|FG000|Overall Study|Side effects|20|||
126544297|NCT00709059|455286165|FG000|Overall Study|Serious side effects|11|||
126544298|NCT03445065|455286168|FG000|Overall Study|Withdrawal by Subject|3|||
126544299|NCT03445065|455286169|FG001|Overall Study|Withdrawal by Subject|6|||
126544300|NCT03445065|455286170|FG002|Overall Study|Withdrawal by Subject|2|||
126544301|NCT03445065|455286171|FG003|Overall Study|Withdrawal by Subject|2|||
126544302|NCT03445065|455286168|FG000|Overall Study|Other|4|||
126544303|NCT03445065|455286169|FG001|Overall Study|Other|3|||
126544304|NCT03445065|455286170|FG002|Overall Study|Other|3|||
126544305|NCT03445065|455286171|FG003|Overall Study|Other|1|||
126544306|NCT03315130|455286172|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
126544307|NCT03315130|455286173|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
126544308|NCT03315130|455286174|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
126544309|NCT03315130|455286175|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
126317615|NCT00115037|454454007|FG004|Phase1|Withdrawal by Subject|0|||
126317616|NCT00115037|454454008|FG005|Phase1|Withdrawal by Subject|0|||
126317617|NCT00115037|454454003|FG000|Phase2|Death|0|||
126317618|NCT00115037|454454004|FG001|Phase2|Death|0|||
126317619|NCT00115037|454454005|FG002|Phase2|Death|1|||
126317620|NCT00115037|454454006|FG003|Phase2|Death|0|||
126317621|NCT00115037|454454007|FG004|Phase2|Death|0|||
126317622|NCT00115037|454454008|FG005|Phase2|Death|1|||
126317623|NCT00115037|454454003|FG000|Phase2|Withdrawal by Subject|0|||
126317624|NCT00115037|454454004|FG001|Phase2|Withdrawal by Subject|0|||
126317625|NCT00115037|454454005|FG002|Phase2|Withdrawal by Subject|2|||
126317626|NCT00115037|454454006|FG003|Phase2|Withdrawal by Subject|1|||
126317627|NCT00115037|454454007|FG004|Phase2|Withdrawal by Subject|2|||
126317628|NCT00115037|454454008|FG005|Phase2|Withdrawal by Subject|1|||
126317629|NCT00115037|454454003|FG000|Phase2|Lost to Follow-up|0|||
126317630|NCT00115037|454454004|FG001|Phase2|Lost to Follow-up|0|||
126317631|NCT00115037|454454005|FG002|Phase2|Lost to Follow-up|12|||
126317632|NCT00115037|454454006|FG003|Phase2|Lost to Follow-up|14|||
126317633|NCT00115037|454454007|FG004|Phase2|Lost to Follow-up|4|||
126317634|NCT00115037|454454008|FG005|Phase2|Lost to Follow-up|10|||
126317635|NCT00396877|454454011|FG000|Overall Study|Lost to Follow-up|2|||
126317636|NCT00396877|454454012|FG001|Overall Study|Lost to Follow-up|1|||
126317637|NCT00396877|454454011|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
126317638|NCT00396877|454454012|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
126317639|NCT02945254|454454013|FG000|Overall Study|Lost to Follow-up|1|||
126317640|NCT02945254|454454014|FG001|Overall Study|Lost to Follow-up|0|||
126317641|NCT02945254|454454013|FG000|Overall Study|Withdrawal by Subject|1|||
126317642|NCT02945254|454454014|FG001|Overall Study|Withdrawal by Subject|0|||
126317643|NCT03436199|454454019|FG000|Overall Study|Adverse Event|15|||
126317644|NCT03436199|454454020|FG001|Overall Study|Adverse Event|40|||
126317645|NCT03436199|454454021|FG002|Overall Study|Adverse Event|7|||
126317646|NCT03436199|454454019|FG000|Overall Study|Withdrawal by Subject|4|||
126317647|NCT03436199|454454020|FG001|Overall Study|Withdrawal by Subject|10|||
126317648|NCT03436199|454454021|FG002|Overall Study|Withdrawal by Subject|3|||
126317649|NCT03436199|454454019|FG000|Overall Study|Lost to Follow-up|1|||
126317650|NCT03436199|454454020|FG001|Overall Study|Lost to Follow-up|0|||
126317651|NCT03436199|454454021|FG002|Overall Study|Lost to Follow-up|2|||
126317652|NCT03436199|454454019|FG000|Overall Study|Protocol Violation|1|||
126317653|NCT03436199|454454020|FG001|Overall Study|Protocol Violation|1|||
126317654|NCT03436199|454454021|FG002|Overall Study|Protocol Violation|0|||
126317655|NCT03436199|454454019|FG000|Overall Study|Physician Decision|0|||
126317656|NCT03436199|454454020|FG001|Overall Study|Physician Decision|1|||
126317657|NCT03436199|454454021|FG002|Overall Study|Physician Decision|0|||
126317658|NCT03436199|454454019|FG000|Overall Study|Could not return to clinic|1|||
126317659|NCT03436199|454454020|FG001|Overall Study|Could not return to clinic|0|||
126317660|NCT03436199|454454021|FG002|Overall Study|Could not return to clinic|0|||
126317661|NCT03436199|454454019|FG000|Overall Study|Withdrawn per physician|0|||
126317662|NCT03436199|454454020|FG001|Overall Study|Withdrawn per physician|1|||
126317663|NCT03436199|454454021|FG002|Overall Study|Withdrawn per physician|0|||
126317664|NCT02631070|454454022|FG000|Overall Study|Withdrawal by Subject|35|||
126317665|NCT02631070|454454023|FG001|Overall Study|Withdrawal by Subject|13|||
126317666|NCT02631070|454454022|FG000|Overall Study|Death|45|||
126317667|NCT02631070|454454023|FG001|Overall Study|Death|24|||
126544310|NCT03315130|455286172|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
126544311|NCT03315130|455286173|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
126317668|NCT02631070|454454022|FG000|Overall Study|Lost to Follow-up|5|||
126317669|NCT02631070|454454023|FG001|Overall Study|Lost to Follow-up|1|||
126317670|NCT02631070|454454022|FG000|Overall Study|Transition to rollover protocol|52|||
126317671|NCT02631070|454454023|FG001|Overall Study|Transition to rollover protocol|21|||
126317672|NCT02631070|454454022|FG000|Overall Study|Other reasons|12|||
126317673|NCT02631070|454454023|FG001|Overall Study|Other reasons|5|||
126317674|NCT00085098|454454025|FG000|Overall Study|Withdrawal by Subject|0|||
126317675|NCT00085098|454454026|FG001|Overall Study|Withdrawal by Subject|1|||
126317676|NCT00085098|454454025|FG000|Overall Study|Ineligible|1|||
126317677|NCT00085098|454454026|FG001|Overall Study|Ineligible|1|||
126317678|NCT01886781|454454029|FG000|Overall Study|Protocol Violation|5|||
126317679|NCT01886781|454454030|FG001|Overall Study|Protocol Violation|0|||
126317680|NCT01886781|454454029|FG000|Overall Study|Adverse Event|1|||
126317681|NCT01886781|454454030|FG001|Overall Study|Adverse Event|0|||
126317682|NCT01886781|454454029|FG000|Overall Study|Lost to Follow-up|5|||
126544312|NCT03315130|455286174|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
126544313|NCT03315130|455286175|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
126544314|NCT03315130|455286172|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
126544315|NCT03315130|455286173|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
126544316|NCT03315130|455286174|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
126544317|NCT03315130|455286175|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
126544318|NCT03315130|455286172|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
126544319|NCT03315130|455286173|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
126544320|NCT03315130|455286174|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
126544321|NCT03315130|455286175|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
126544322|NCT03315130|455286172|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
126544323|NCT03315130|455286173|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
126544324|NCT03315130|455286174|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
126544325|NCT03315130|455286175|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
126544326|NCT03315130|455286172|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
126544327|NCT03315130|455286173|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
126544328|NCT03315130|455286174|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
126544329|NCT03315130|455286175|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
126544330|NCT00976703|455287866|FG000|Overall Study|Physician Decision|1|||
126544331|NCT00976703|455287867|FG001|Overall Study|Physician Decision|1|||
126544332|NCT00976703|455287866|FG000|Overall Study|ineligible for study|2|||
126544333|NCT00976703|455287867|FG001|Overall Study|ineligible for study|2|||
126544334|NCT02202434|455287868|FG000|Overall Study|Death|70|||
126544335|NCT02202434|455287869|FG001|Overall Study|Death|39|||
126544336|NCT02202434|455287870|FG002|Overall Study|Death|13|||
126544337|NCT02202434|455287871|FG003|Overall Study|Death|27|||
126544338|NCT02202434|455287868|FG000|Overall Study|Lost to Follow-up|1|||
126544339|NCT02202434|455287869|FG001|Overall Study|Lost to Follow-up|1|||
126544340|NCT02202434|455287870|FG002|Overall Study|Lost to Follow-up|1|||
126544341|NCT02202434|455287871|FG003|Overall Study|Lost to Follow-up|0|||
126544342|NCT02202434|455287868|FG000|Overall Study|Physician Decision|2|||
126544343|NCT02202434|455287869|FG001|Overall Study|Physician Decision|3|||
126544344|NCT02202434|455287870|FG002|Overall Study|Physician Decision|0|||
126544345|NCT02202434|455287871|FG003|Overall Study|Physician Decision|0|||
126544346|NCT02202434|455287868|FG000|Overall Study|Withdrawal by Subject|13|||
126544347|NCT02202434|455287869|FG001|Overall Study|Withdrawal by Subject|14|||
126544348|NCT02202434|455287870|FG002|Overall Study|Withdrawal by Subject|1|||
126544349|NCT02202434|455287871|FG003|Overall Study|Withdrawal by Subject|4|||
126544350|NCT02202434|455287868|FG000|Overall Study|Completed Study|1|||
126544351|NCT02202434|455287869|FG001|Overall Study|Completed Study|0|||
126544352|NCT02202434|455287870|FG002|Overall Study|Completed Study|0|||
126544353|NCT02202434|455287871|FG003|Overall Study|Completed Study|0|||
126544354|NCT02202434|455287868|FG000|Overall Study|Visit Missed|21|||
126544355|NCT02202434|455287869|FG001|Overall Study|Visit Missed|12|||
126544356|NCT02202434|455287870|FG002|Overall Study|Visit Missed|0|||
126544357|NCT02202434|455287871|FG003|Overall Study|Visit Missed|5|||
126648210|NCT01259089|455669722|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
126317683|NCT01886781|454454030|FG001|Overall Study|Lost to Follow-up|0|||
126317684|NCT01886781|454454029|FG000|Overall Study|Withdrawal by Subject|2|||
126317685|NCT01886781|454454030|FG001|Overall Study|Withdrawal by Subject|1|||
126317686|NCT01886781|454454029|FG000|Overall Study|Worsening of symptoms|1|||
126317687|NCT01886781|454454030|FG001|Overall Study|Worsening of symptoms|1|||
126317688|NCT01522235|454454031|FG000|Overall Study|Physician Decision|1|||
126317689|NCT01522235|454454032|FG001|Overall Study|Physician Decision|1|||
126317690|NCT00980018|454454033|FG000|Overall Study|Adverse Event|8|||
126317691|NCT00980018|454454033|FG000|Overall Study|Patient withdrew consent|3|||
126317692|NCT00980018|454454033|FG000|Overall Study|Lost to Follow-up|1|||
126317693|NCT03769194|454454034|FG000|Overall Study|Withdrawal by Subject|0|||
126317694|NCT03769194|454454035|FG001|Overall Study|Withdrawal by Subject|7|||
126317695|NCT03769194|454454036|FG002|Overall Study|Withdrawal by Subject|4|||
126317696|NCT03769194|454454037|FG003|Overall Study|Withdrawal by Subject|1|||
126317697|NCT03769194|454454034|FG000|Overall Study|moved from study area|0|||
126317698|NCT03769194|454454035|FG001|Overall Study|moved from study area|2|||
126317699|NCT03769194|454454036|FG002|Overall Study|moved from study area|1|||
126317700|NCT03769194|454454037|FG003|Overall Study|moved from study area|1|||
126317701|NCT03769194|454454034|FG000|Overall Study|Lost to Follow-up|3|||
126317702|NCT03769194|454454035|FG001|Overall Study|Lost to Follow-up|6|||
126317703|NCT03769194|454454036|FG002|Overall Study|Lost to Follow-up|3|||
126317704|NCT03769194|454454037|FG003|Overall Study|Lost to Follow-up|6|||
126317705|NCT03769194|454454034|FG000|Overall Study|other|1|||
126317706|NCT03769194|454454035|FG001|Overall Study|other|3|||
126317707|NCT03769194|454454036|FG002|Overall Study|other|0|||
126544358|NCT02202434|455287868|FG000|Overall Study|Other|1|||
126544359|NCT02202434|455287869|FG001|Overall Study|Other|0|||
126544360|NCT02202434|455287870|FG002|Overall Study|Other|0|||
126544361|NCT02202434|455287871|FG003|Overall Study|Other|1|||
126544362|NCT03075501|455287872|FG000|Overall Study|Scheduling difficulties|15|||
126544363|NCT03075501|455287873|FG001|Overall Study|Scheduling difficulties|9|||
126544364|NCT01062763|455287877|FG000|Overall Study|Adverse Event|3|||
126544365|NCT01062763|455287878|FG001|Overall Study|Adverse Event|4|||
126544366|NCT02494921|455287879|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
126544367|NCT02494921|455287880|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
126544368|NCT02494921|455287881|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
126544369|NCT02494921|455287882|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
126544370|NCT02494921|455287883|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
126544371|NCT02494921|455287879|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
126544372|NCT02494921|455287880|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
126544373|NCT02494921|455287881|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
126544374|NCT02494921|455287882|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
126544375|NCT02494921|455287883|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
126544376|NCT02494921|455287879|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
126544377|NCT02494921|455287880|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
126544378|NCT02494921|455287881|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
126544379|NCT02494921|455287882|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
126544380|NCT02494921|455287883|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
126317708|NCT03769194|454454037|FG003|Overall Study|other|1|||
126317709|NCT01832818|454454041|FG000|Overall Study|Lost to Follow-up|6|||
126317710|NCT01672294|454454048|FG000|Overall Study|Withdrawal by Subject|4|||
126317711|NCT01672294|454454049|FG001|Overall Study|Withdrawal by Subject|4|||
126317712|NCT01672294|454454050|FG002|Overall Study|Withdrawal by Subject|4|||
126317713|NCT01672294|454454051|FG003|Overall Study|Withdrawal by Subject|4|||
126317714|NCT01672294|454454048|FG000|Overall Study|Excluded by study|1|||
126317715|NCT01672294|454454049|FG001|Overall Study|Excluded by study|1|||
126317716|NCT01672294|454454050|FG002|Overall Study|Excluded by study|0|||
126317717|NCT01672294|454454051|FG003|Overall Study|Excluded by study|0|||
126317718|NCT01672294|454454048|FG000|Overall Study|Lost to Follow-up|1|||
126317719|NCT01672294|454454049|FG001|Overall Study|Lost to Follow-up|16|||
126317720|NCT01672294|454454050|FG002|Overall Study|Lost to Follow-up|7|||
126317721|NCT01672294|454454051|FG003|Overall Study|Lost to Follow-up|9|||
126317722|NCT01273155|454454052|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
126317723|NCT01273155|454454053|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
126317724|NCT01273155|454454054|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
126317725|NCT01273155|454454055|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
126317726|NCT01273155|454454056|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
126317727|NCT01273155|454454057|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
126317728|NCT01273155|454454058|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
126317729|NCT01273155|454454052|FG000|Overall Study|Change in liver function/no longer eval.|0|||
126317730|NCT01273155|454454053|FG001|Overall Study|Change in liver function/no longer eval.|1|||
126317731|NCT01273155|454454054|FG002|Overall Study|Change in liver function/no longer eval.|0|||
126317732|NCT01273155|454454055|FG003|Overall Study|Change in liver function/no longer eval.|0|||
126317733|NCT01273155|454454056|FG004|Overall Study|Change in liver function/no longer eval.|1|||
126317734|NCT01273155|454454057|FG005|Overall Study|Change in liver function/no longer eval.|0|||
126317735|NCT01273155|454454058|FG006|Overall Study|Change in liver function/no longer eval.|0|||
126317736|NCT01273155|454454052|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
126317737|NCT01273155|454454053|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
126317738|NCT01273155|454454054|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
126317739|NCT01273155|454454055|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
126317740|NCT01273155|454454056|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
126317741|NCT01273155|454454057|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
126317742|NCT01273155|454454058|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
126317743|NCT01273155|454454052|FG000|Overall Study|Died during Cycle 1|0|||
126317744|NCT01273155|454454053|FG001|Overall Study|Died during Cycle 1|0|||
126317745|NCT01273155|454454054|FG002|Overall Study|Died during Cycle 1|1|||
126317746|NCT01273155|454454055|FG003|Overall Study|Died during Cycle 1|1|||
126317747|NCT01273155|454454056|FG004|Overall Study|Died during Cycle 1|0|||
126317748|NCT01273155|454454057|FG005|Overall Study|Died during Cycle 1|2|||
126317749|NCT01273155|454454058|FG006|Overall Study|Died during Cycle 1|2|||
126317750|NCT01273155|454454052|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
126317751|NCT01273155|454454053|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
126317752|NCT01273155|454454054|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
126317753|NCT01273155|454454055|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
126317754|NCT01273155|454454056|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
126317755|NCT01273155|454454057|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
126317756|NCT01273155|454454058|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
126317757|NCT01438814|454454064|FG000|Overall Study|Adverse Event|3|||
126544381|NCT02714868|455287889|FG000|Overall Study|Withdrawal by Subject|3|||
126544382|NCT02714868|455287890|FG001|Overall Study|Withdrawal by Subject|0|||
126544383|NCT02714868|455287889|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
126544384|NCT02714868|455287890|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
126544385|NCT02714868|455287889|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
126544386|NCT02714868|455287890|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
126544387|NCT02948959|455287907|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
126544388|NCT02948959|455287908|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
126544389|NCT02948959|455287907|FG000|52 Weeks Treatment Period|Adverse Event|2|||
126544390|NCT02948959|455287908|FG001|52 Weeks Treatment Period|Adverse Event|5|||
126544391|NCT02948959|455287907|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
126544392|NCT02948959|455287908|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
126544393|NCT02948959|455287907|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
126544394|NCT02948959|455287908|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
126544395|NCT02948959|455287907|FG000|52 Weeks Treatment Period|Randomized by error|0|||
126544396|NCT02948959|455287908|FG001|52 Weeks Treatment Period|Randomized by error|5|||
126544397|NCT02948959|455287907|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
126544398|NCT02948959|455287908|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
126544399|NCT02948959|455287907|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
126544400|NCT02948959|455287908|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
126544401|NCT02948959|455287907|FG000|52 Weeks Treatment Period|Change of residence location|0|||
126544402|NCT02948959|455287908|FG001|52 Weeks Treatment Period|Change of residence location|1|||
126544403|NCT02948959|455287907|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
126544404|NCT02948959|455287908|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
126544405|NCT02948959|455287907|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
126544406|NCT02948959|455287908|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
126544407|NCT02948959|455287907|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
126544408|NCT02948959|455287908|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
126544409|NCT02948959|455287907|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
126544410|NCT02948959|455287908|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
126544411|NCT02948959|455287907|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
126544412|NCT02948959|455287908|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
126544413|NCT02948959|455287907|FG000|12 Weeks Follow-up Period|Study site closure|1|||
126544414|NCT02948959|455287908|FG001|12 Weeks Follow-up Period|Study site closure|0|||
126544415|NCT02508532|455287913|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
126544416|NCT02508532|455287914|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
126544417|NCT02508532|455287915|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
126544418|NCT02508532|455287916|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
126544419|NCT02508532|455287917|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
126544420|NCT02508532|455287918|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
126544421|NCT02508532|455287919|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
126544422|NCT02508532|455287920|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
126544423|NCT02508532|455287921|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
126544424|NCT02508532|455287913|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
126544425|NCT02508532|455287914|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
126544426|NCT02508532|455287915|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
126544427|NCT02508532|455287916|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
126544428|NCT02508532|455287917|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
126544429|NCT02508532|455287918|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
126544430|NCT02508532|455287919|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
126544431|NCT02508532|455287920|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
126544432|NCT02508532|455287921|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
126544433|NCT02508532|455287913|FG000|Part 2 - Treatment|Disease Progression|0|||
126544434|NCT02508532|455287914|FG001|Part 2 - Treatment|Disease Progression|0|||
126544435|NCT02508532|455287915|FG002|Part 2 - Treatment|Disease Progression|0|||
126544436|NCT02508532|455287916|FG003|Part 2 - Treatment|Disease Progression|0|||
126544437|NCT02508532|455287917|FG004|Part 2 - Treatment|Disease Progression|0|||
126544438|NCT02508532|455287918|FG005|Part 2 - Treatment|Disease Progression|0|||
126544439|NCT02508532|455287919|FG006|Part 2 - Treatment|Disease Progression|0|||
126648211|NCT01259089|455669723|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
126648212|NCT01259089|455669724|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
126648213|NCT01259089|455669725|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
126648214|NCT01259089|455669720|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
126648215|NCT01259089|455669721|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
126648216|NCT01259089|455669722|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
126648217|NCT01259089|455669723|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
126648218|NCT01259089|455669724|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
126648219|NCT01259089|455669725|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
126317758|NCT01438814|454454065|FG001|Overall Study|Adverse Event|3|||
126544440|NCT02508532|455287920|FG007|Part 2 - Treatment|Disease Progression|0|||
126544441|NCT02508532|455287921|FG008|Part 2 - Treatment|Disease Progression|118|||
126317759|NCT01438814|454454064|FG000|Overall Study|Protocol Violation|1|||
126317760|NCT01438814|454454065|FG001|Overall Study|Protocol Violation|2|||
126317761|NCT01438814|454454064|FG000|Overall Study|Lost to Follow-up|4|||
126317762|NCT01438814|454454065|FG001|Overall Study|Lost to Follow-up|3|||
126317763|NCT01438814|454454064|FG000|Overall Study|Withdrawal by Subject|4|||
126317764|NCT01438814|454454065|FG001|Overall Study|Withdrawal by Subject|2|||
126317765|NCT01438814|454454064|FG000|Overall Study|Other|2|||
126317766|NCT01438814|454454065|FG001|Overall Study|Other|4|||
126317767|NCT01870297|454454070|FG000|Overall Study|Adverse Event|0|||
126317768|NCT01870297|454454071|FG001|Overall Study|Adverse Event|0|||
126317769|NCT01870297|454454072|FG002|Overall Study|Adverse Event|0|||
126317770|NCT01870297|454454073|FG003|Overall Study|Adverse Event|0|||
126317771|NCT01870297|454454074|FG004|Overall Study|Adverse Event|2|||
126317772|NCT01870297|454454075|FG005|Overall Study|Adverse Event|0|||
126317773|NCT01870297|454454076|FG006|Overall Study|Adverse Event|0|||
126317774|NCT01870297|454454070|FG000|Overall Study|Lost to Follow-up|0|||
126317775|NCT01870297|454454071|FG001|Overall Study|Lost to Follow-up|1|||
126317776|NCT01870297|454454072|FG002|Overall Study|Lost to Follow-up|1|||
126317777|NCT01870297|454454073|FG003|Overall Study|Lost to Follow-up|0|||
126317778|NCT01870297|454454074|FG004|Overall Study|Lost to Follow-up|0|||
126317779|NCT01870297|454454075|FG005|Overall Study|Lost to Follow-up|0|||
126317780|NCT01870297|454454076|FG006|Overall Study|Lost to Follow-up|0|||
126317781|NCT01870297|454454070|FG000|Overall Study|Withdrawal by Subject|0|||
126317782|NCT01870297|454454071|FG001|Overall Study|Withdrawal by Subject|0|||
126317783|NCT01870297|454454072|FG002|Overall Study|Withdrawal by Subject|0|||
126317784|NCT01870297|454454073|FG003|Overall Study|Withdrawal by Subject|0|||
126317785|NCT01870297|454454074|FG004|Overall Study|Withdrawal by Subject|1|||
126317786|NCT01870297|454454075|FG005|Overall Study|Withdrawal by Subject|1|||
126317787|NCT01870297|454454076|FG006|Overall Study|Withdrawal by Subject|1|||
126317788|NCT01870297|454454070|FG000|Overall Study|Sponsor Decision|0|||
126317789|NCT01870297|454454071|FG001|Overall Study|Sponsor Decision|6|||
126317790|NCT01870297|454454072|FG002|Overall Study|Sponsor Decision|0|||
126317791|NCT01870297|454454073|FG003|Overall Study|Sponsor Decision|0|||
126317792|NCT01870297|454454074|FG004|Overall Study|Sponsor Decision|0|||
126317793|NCT01870297|454454075|FG005|Overall Study|Sponsor Decision|0|||
126317794|NCT01870297|454454076|FG006|Overall Study|Sponsor Decision|1|||
126317795|NCT00337779|454454077|FG000|Overall Study|Withdrawal by Subject|10|||
126317796|NCT00337779|454454078|FG001|Overall Study|Withdrawal by Subject|12|||
126317797|NCT00337779|454454077|FG000|Overall Study|Sponsor decision|1|||
126317798|NCT00337779|454454078|FG001|Overall Study|Sponsor decision|1|||
126317799|NCT00337779|454454077|FG000|Overall Study|Physician Decision|3|||
126317800|NCT00337779|454454078|FG001|Overall Study|Physician Decision|6|||
126317801|NCT00337779|454454077|FG000|Overall Study|Protocol Violation|1|||
126317802|NCT00337779|454454078|FG001|Overall Study|Protocol Violation|1|||
126317803|NCT00337779|454454077|FG000|Overall Study|Lost to Follow-up|6|||
126317804|NCT00337779|454454078|FG001|Overall Study|Lost to Follow-up|5|||
126317805|NCT00337779|454454077|FG000|Overall Study|Adverse Event|28|||
126317806|NCT00337779|454454078|FG001|Overall Study|Adverse Event|51|||
126317807|NCT00337779|454454077|FG000|Overall Study|Pregnancy|3|||
126317808|NCT00337779|454454078|FG001|Overall Study|Pregnancy|2|||
126317809|NCT00337779|454454077|FG000|Overall Study|Death|0|||
126317810|NCT00337779|454454078|FG001|Overall Study|Death|1|||
126317811|NCT01162122|454454079|FG000|Overall Study|Withdrawal by Subject|52|||
126317812|NCT01162122|454454080|FG001|Overall Study|Withdrawal by Subject|43|||
126317813|NCT01162122|454454079|FG000|Overall Study|Lost to Follow-up|73|||
126317814|NCT01162122|454454080|FG001|Overall Study|Lost to Follow-up|91|||
126317815|NCT01162122|454454079|FG000|Overall Study|Adverse Event|3|||
126317816|NCT01162122|454454080|FG001|Overall Study|Adverse Event|2|||
126317817|NCT01162122|454454079|FG000|Overall Study|Death|51|||
126317818|NCT01162122|454454080|FG001|Overall Study|Death|46|||
126317819|NCT01162122|454454079|FG000|Overall Study|Protocol Violation|2|||
126317820|NCT01162122|454454080|FG001|Overall Study|Protocol Violation|2|||
126317821|NCT01162122|454454079|FG000|Overall Study|Inappropriate enrollment|5|||
126544442|NCT02508532|455287913|FG000|Part 2 - Treatment|Adverse Event|0|||
126544443|NCT02508532|455287914|FG001|Part 2 - Treatment|Adverse Event|0|||
126317822|NCT01162122|454454080|FG001|Overall Study|Inappropriate enrollment|4|||
126317823|NCT01162122|454454079|FG000|Overall Study|Administrative reason|1|||
126317824|NCT01162122|454454080|FG001|Overall Study|Administrative reason|1|||
126544444|NCT02508532|455287915|FG002|Part 2 - Treatment|Adverse Event|0|||
126648220|NCT01259089|455669720|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
126317825|NCT01162122|454454079|FG000|Overall Study|Unable to classify|3|||
126317826|NCT01162122|454454080|FG001|Overall Study|Unable to classify|7|||
126317827|NCT01162122|454454079|FG000|Overall Study|Missing primary reason|1|||
126317828|NCT01162122|454454080|FG001|Overall Study|Missing primary reason|0|||
126317829|NCT02020512|454454081|FG000|Overall Study|Adverse Event|1|||
126317830|NCT02020512|454454081|FG000|Overall Study|Lost to Follow-up|3|||
126317831|NCT02020512|454454081|FG000|Overall Study|Protocol Violation|4|||
126317832|NCT00422422|454454085|FG000|Overall Study|Lack of Efficacy|1|||
126317833|NCT00422422|454454085|FG000|Overall Study|Protocol Violation|1|||
126317834|NCT00422422|454454085|FG000|Overall Study|Withdrawal by Subject|2|||
126544445|NCT02508532|455287916|FG003|Part 2 - Treatment|Adverse Event|0|||
126544446|NCT02508532|455287917|FG004|Part 2 - Treatment|Adverse Event|0|||
126544447|NCT02508532|455287918|FG005|Part 2 - Treatment|Adverse Event|0|||
126544448|NCT02508532|455287919|FG006|Part 2 - Treatment|Adverse Event|0|||
126544449|NCT02508532|455287920|FG007|Part 2 - Treatment|Adverse Event|0|||
126544450|NCT02508532|455287921|FG008|Part 2 - Treatment|Adverse Event|49|||
126544451|NCT02508532|455287913|FG000|Part 2 - Treatment|Physician Decision|0|||
126544452|NCT02508532|455287914|FG001|Part 2 - Treatment|Physician Decision|0|||
126544453|NCT02508532|455287915|FG002|Part 2 - Treatment|Physician Decision|0|||
126544454|NCT02508532|455287916|FG003|Part 2 - Treatment|Physician Decision|0|||
126544455|NCT02508532|455287917|FG004|Part 2 - Treatment|Physician Decision|0|||
126544456|NCT02508532|455287918|FG005|Part 2 - Treatment|Physician Decision|0|||
126544457|NCT02508532|455287919|FG006|Part 2 - Treatment|Physician Decision|0|||
126544458|NCT02508532|455287920|FG007|Part 2 - Treatment|Physician Decision|0|||
126544459|NCT02508532|455287921|FG008|Part 2 - Treatment|Physician Decision|12|||
126317835|NCT00422422|454454085|FG000|Overall Study|SAE, non-fatal|1|||
126317836|NCT00422422|454454085|FG000|Overall Study|AE, non-serious non-fatal|5|||
126317837|NCT03313310|454454086|FG000|Phase 2|Lost to Follow-up|4|||
126544460|NCT02508532|455287913|FG000|Part 2 - Treatment|Administrative|0|||
126544461|NCT02508532|455287914|FG001|Part 2 - Treatment|Administrative|0|||
126544462|NCT02508532|455287915|FG002|Part 2 - Treatment|Administrative|0|||
126544463|NCT02508532|455287916|FG003|Part 2 - Treatment|Administrative|0|||
126544464|NCT02508532|455287917|FG004|Part 2 - Treatment|Administrative|0|||
126544465|NCT02508532|455287918|FG005|Part 2 - Treatment|Administrative|0|||
126544466|NCT02508532|455287919|FG006|Part 2 - Treatment|Administrative|0|||
126544467|NCT02508532|455287920|FG007|Part 2 - Treatment|Administrative|0|||
126544468|NCT02508532|455287921|FG008|Part 2 - Treatment|Administrative|3|||
126544469|NCT02508532|455287913|FG000|Part 2 - Treatment|Sponsor Decision|0|||
126544470|NCT02508532|455287914|FG001|Part 2 - Treatment|Sponsor Decision|0|||
126544471|NCT02508532|455287915|FG002|Part 2 - Treatment|Sponsor Decision|0|||
126544472|NCT02508532|455287916|FG003|Part 2 - Treatment|Sponsor Decision|0|||
126544473|NCT02508532|455287917|FG004|Part 2 - Treatment|Sponsor Decision|0|||
126544474|NCT02508532|455287918|FG005|Part 2 - Treatment|Sponsor Decision|0|||
126544475|NCT02508532|455287919|FG006|Part 2 - Treatment|Sponsor Decision|0|||
126544476|NCT02508532|455287920|FG007|Part 2 - Treatment|Sponsor Decision|0|||
126544477|NCT02508532|455287921|FG008|Part 2 - Treatment|Sponsor Decision|28|||
126544478|NCT02508532|455287913|FG000|Part 2 - Treatment|Death|0|||
126544479|NCT02508532|455287914|FG001|Part 2 - Treatment|Death|0|||
126544480|NCT02508532|455287915|FG002|Part 2 - Treatment|Death|0|||
126544481|NCT02508532|455287916|FG003|Part 2 - Treatment|Death|0|||
126544482|NCT02508532|455287917|FG004|Part 2 - Treatment|Death|0|||
126544483|NCT02508532|455287918|FG005|Part 2 - Treatment|Death|0|||
126544484|NCT02508532|455287919|FG006|Part 2 - Treatment|Death|0|||
126544485|NCT02508532|455287920|FG007|Part 2 - Treatment|Death|0|||
126544486|NCT02508532|455287921|FG008|Part 2 - Treatment|Death|1|||
126544487|NCT02508532|455287913|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
126544488|NCT02508532|455287914|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
126544489|NCT02508532|455287915|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
126544490|NCT02508532|455287916|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
126544491|NCT02508532|455287917|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
126544492|NCT02508532|455287918|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
126544493|NCT02508532|455287919|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
126317838|NCT03313310|454454087|FG001|Phase 2|Lost to Follow-up|0|||
126317839|NCT03313310|454454086|FG000|Phase 3|Lost to Follow-up|0|||
126317840|NCT03313310|454454087|FG001|Phase 3|Lost to Follow-up|1|||
126317841|NCT00932451|454454090|FG000|Overall Study|Withdrawal by Subject|69|||
126317842|NCT00932451|454454090|FG000|Overall Study|Lost to Follow-up|22|||
126317843|NCT00932451|454454090|FG000|Overall Study|Death|726|||
126317844|NCT00932451|454454090|FG000|Overall Study|Other reasons|5|||
126317845|NCT03434249|454454093|FG000|Overall Study|Adverse Event|1|||
126317846|NCT03434249|454454094|FG001|Overall Study|Adverse Event|0|||
126317847|NCT03434249|454454093|FG000|Overall Study|Lost to Follow-up|0|||
126317848|NCT03434249|454454094|FG001|Overall Study|Lost to Follow-up|1|||
126317849|NCT03434249|454454093|FG000|Overall Study|Non-compliance of family|2|||
126544494|NCT02508532|455287920|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
126317850|NCT03434249|454454094|FG001|Overall Study|Non-compliance of family|1|||
126317851|NCT03434249|454454093|FG000|Overall Study|Difficulties in completing daily diary|2|||
126317852|NCT03434249|454454094|FG001|Overall Study|Difficulties in completing daily diary|1|||
126544495|NCT02508532|455287921|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
126544496|NCT02508532|455287913|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
126544497|NCT02508532|455287914|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
126544498|NCT02508532|455287915|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
126544499|NCT02508532|455287916|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
126544500|NCT02508532|455287917|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
126317853|NCT00561470|454454095|FG000|Overall Study|Adverse Event|74|||
126317854|NCT00561470|454454096|FG001|Overall Study|Adverse Event|163|||
126544501|NCT02508532|455287918|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
126544502|NCT02508532|455287919|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
126544503|NCT02508532|455287920|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
126544504|NCT02508532|455287921|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
126544505|NCT02508532|455287913|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
126544506|NCT02508532|455287914|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
126544507|NCT02508532|455287915|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
126544508|NCT02508532|455287916|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
126544509|NCT02508532|455287917|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
126544510|NCT02508532|455287918|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
126544511|NCT02508532|455287919|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
126544512|NCT02508532|455287920|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
126544513|NCT02508532|455287921|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
126544514|NCT02508532|455287913|FG000|Part 1 and Part 2 End of Study|Death|0|||
126544515|NCT02508532|455287914|FG001|Part 1 and Part 2 End of Study|Death|4|||
126544516|NCT02508532|455287915|FG002|Part 1 and Part 2 End of Study|Death|2|||
126544517|NCT02508532|455287916|FG003|Part 1 and Part 2 End of Study|Death|4|||
126544518|NCT02508532|455287917|FG004|Part 1 and Part 2 End of Study|Death|3|||
126544519|NCT02508532|455287918|FG005|Part 1 and Part 2 End of Study|Death|0|||
126544520|NCT02508532|455287919|FG006|Part 1 and Part 2 End of Study|Death|0|||
126544521|NCT02508532|455287920|FG007|Part 1 and Part 2 End of Study|Death|1|||
126544522|NCT02508532|455287921|FG008|Part 1 and Part 2 End of Study|Death|111|||
126544523|NCT02508532|455287913|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
126544524|NCT02508532|455287914|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
126544525|NCT02508532|455287915|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
126544526|NCT02508532|455287916|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
126544527|NCT02508532|455287917|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
126544528|NCT02508532|455287918|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
126544529|NCT02508532|455287919|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
126544530|NCT02508532|455287920|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
126544531|NCT02508532|455287921|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
126544532|NCT02508532|455287913|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
126544533|NCT02508532|455287914|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
126544534|NCT02508532|455287915|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
126544535|NCT02508532|455287916|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
126544536|NCT02508532|455287917|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
126544537|NCT02508532|455287918|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
126544538|NCT02508532|455287919|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
126544539|NCT02508532|455287920|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
126544540|NCT02508532|455287921|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
126544541|NCT02508532|455287913|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
126544542|NCT02508532|455287914|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
126544543|NCT02508532|455287915|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
126544544|NCT02508532|455287916|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
126544545|NCT02508532|455287917|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
126544546|NCT02508532|455287918|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
126544547|NCT02508532|455287919|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
126544548|NCT02508532|455287920|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
126544549|NCT02508532|455287921|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
126544550|NCT02508532|455287913|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
126544551|NCT02508532|455287914|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
126544552|NCT02508532|455287915|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
126544553|NCT02508532|455287916|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
126544554|NCT02508532|455287917|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
126544555|NCT02508532|455287918|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
126544556|NCT02508532|455287919|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
126544557|NCT02508532|455287920|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
126544558|NCT02508532|455287921|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
126544559|NCT02508532|455287913|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
126544560|NCT02508532|455287914|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
126544561|NCT02508532|455287915|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
126544562|NCT02508532|455287916|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
126544563|NCT02508532|455287917|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
126544564|NCT02508532|455287918|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
126544565|NCT02508532|455287919|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
126544566|NCT02508532|455287920|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
126544567|NCT02508532|455287921|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
126544568|NCT03097861|455287922|FG000|Overall Study|Adverse Event|3|||
126544569|NCT03097861|455287923|FG001|Overall Study|Adverse Event|8|||
126544570|NCT03097861|455287924|FG002|Overall Study|Adverse Event|4|||
126648221|NCT01259089|455669721|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
126317855|NCT00561470|454454095|FG000|Overall Study|Disease progression|437|||
126317856|NCT00561470|454454096|FG001|Overall Study|Disease progression|305|||
126317857|NCT00561470|454454095|FG000|Overall Study|poor compliance to protocol|4|||
126317858|NCT00561470|454454096|FG001|Overall Study|poor compliance to protocol|4|||
126317859|NCT00561470|454454095|FG000|Overall Study|Lost to Follow-up|2|||
126317860|NCT00561470|454454096|FG001|Overall Study|Lost to Follow-up|0|||
126317861|NCT00561470|454454095|FG000|Overall Study|Physician Decision|21|||
126317862|NCT00561470|454454096|FG001|Overall Study|Physician Decision|20|||
126317863|NCT00561470|454454095|FG000|Overall Study|Consent Withdrawn|2|||
126317864|NCT00561470|454454096|FG001|Overall Study|Consent Withdrawn|6|||
126317865|NCT00561470|454454095|FG000|Overall Study|Subject request|43|||
126317866|NCT00561470|454454096|FG001|Overall Study|Subject request|77|||
126317867|NCT00561470|454454095|FG000|Overall Study|Metastatic surgery|10|||
126317868|NCT00561470|454454096|FG001|Overall Study|Metastatic surgery|12|||
126317869|NCT00561470|454454095|FG000|Overall Study|Unauthorized procedure|3|||
126317870|NCT00561470|454454096|FG001|Overall Study|Unauthorized procedure|1|||
126317871|NCT00561470|454454095|FG000|Overall Study|Randomized but not treated|5|||
126317872|NCT00561470|454454096|FG001|Overall Study|Randomized but not treated|5|||
126317873|NCT00561470|454454095|FG000|Overall Study|Missed visit window|1|||
126317874|NCT00561470|454454096|FG001|Overall Study|Missed visit window|4|||
126648222|NCT01259089|455669722|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
126648223|NCT01259089|455669723|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
126648224|NCT01259089|455669724|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
126648225|NCT01259089|455669725|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
126648226|NCT01259089|455669720|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
126648227|NCT01259089|455669721|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
126648228|NCT01259089|455669722|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
126648229|NCT01259089|455669723|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
126648230|NCT01259089|455669724|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
126648231|NCT01259089|455669725|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
126544571|NCT03097861|455287922|FG000|Overall Study|Investigator Decision|0|||
126544572|NCT03097861|455287923|FG001|Overall Study|Investigator Decision|1|||
126544573|NCT03097861|455287924|FG002|Overall Study|Investigator Decision|0|||
126544574|NCT03097861|455287922|FG000|Overall Study|Lost to Follow-up|0|||
126544575|NCT03097861|455287923|FG001|Overall Study|Lost to Follow-up|7|||
126544576|NCT03097861|455287924|FG002|Overall Study|Lost to Follow-up|1|||
126544577|NCT03097861|455287922|FG000|Overall Study|Withdrawal by Subject|1|||
126544578|NCT03097861|455287923|FG001|Overall Study|Withdrawal by Subject|5|||
126648232|NCT01259089|455669720|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
126648233|NCT01259089|455669721|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
126648234|NCT01259089|455669722|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
126648235|NCT01259089|455669723|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
126648236|NCT01259089|455669724|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
126648237|NCT01259089|455669725|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
126648238|NCT01259089|455669720|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
126648239|NCT01259089|455669721|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
126648240|NCT01259089|455669722|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
126648241|NCT01259089|455669723|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
126648242|NCT01259089|455669724|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
126648243|NCT01259089|455669725|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
126648244|NCT01259089|455669720|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
126648245|NCT01259089|455669721|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
126648246|NCT01259089|455669722|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
126648247|NCT01259089|455669723|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
126648248|NCT01259089|455669724|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
126648249|NCT01259089|455669725|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
126648250|NCT01259089|455669720|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
126648251|NCT01259089|455669721|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
126648252|NCT01259089|455669722|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
126648253|NCT01259089|455669723|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
126648254|NCT01259089|455669724|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
126648255|NCT01259089|455669725|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
126648256|NCT01259089|455669720|FG000|Survival Follow up for Two Years|Death|3|||
126648257|NCT01259089|455669721|FG001|Survival Follow up for Two Years|Death|2|||
126544579|NCT03097861|455287924|FG002|Overall Study|Withdrawal by Subject|3|||
126648258|NCT01259089|455669722|FG002|Survival Follow up for Two Years|Death|2|||
126648259|NCT01259089|455669723|FG003|Survival Follow up for Two Years|Death|3|||
126648260|NCT01259089|455669724|FG004|Survival Follow up for Two Years|Death|6|||
126544580|NCT03097861|455287922|FG000|Overall Study|Reason not provided|3|||
126544581|NCT03097861|455287923|FG001|Overall Study|Reason not provided|1|||
126317875|NCT00561470|454454095|FG000|Overall Study|Planning surgery|1|||
126317876|NCT00561470|454454096|FG001|Overall Study|Planning surgery|1|||
126544582|NCT03097861|455287924|FG002|Overall Study|Reason not provided|1|||
126648261|NCT01259089|455669725|FG005|Survival Follow up for Two Years|Death|13|||
126648262|NCT01259089|455669720|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
126648263|NCT01259089|455669721|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
126544583|NCT00154310|455287925|FG000|Overall Study|Adverse Event|19|||
126544584|NCT00154310|455287926|FG001|Overall Study|Adverse Event|9|||
126544585|NCT00154310|455287925|FG000|Overall Study|Lack of Efficacy|5|||
126544586|NCT00154310|455287926|FG001|Overall Study|Lack of Efficacy|4|||
126544587|NCT00154310|455287925|FG000|Overall Study|Protocol Violation|4|||
126544588|NCT00154310|455287926|FG001|Overall Study|Protocol Violation|2|||
126544589|NCT00154310|455287925|FG000|Overall Study|Withdrawal by Subject|9|||
126544590|NCT00154310|455287926|FG001|Overall Study|Withdrawal by Subject|3|||
126544591|NCT00154310|455287925|FG000|Overall Study|Lost to Follow-up|0|||
126544592|NCT00154310|455287926|FG001|Overall Study|Lost to Follow-up|8|||
126544593|NCT00154310|455287925|FG000|Overall Study|Administrative problems|0|||
126648264|NCT01259089|455669722|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
126648265|NCT01259089|455669723|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
126544594|NCT00154310|455287926|FG001|Overall Study|Administrative problems|1|||
126544595|NCT00154310|455287925|FG000|Overall Study|Death|0|||
126544596|NCT00154310|455287926|FG001|Overall Study|Death|1|||
126544597|NCT04251065|455287927|FG000|Overall Study|Death|2|||
126544598|NCT04251065|455287927|FG000|Overall Study|Lack of Efficacy|3|||
126544599|NCT04251065|455287927|FG000|Overall Study|Death|1|||
126544600|NCT01054573|455287928|FG000|Overall Study|Adverse Event|1|||
126544601|NCT01054573|455287929|FG001|Overall Study|Adverse Event|0|||
126544602|NCT01054573|455287930|FG002|Overall Study|Adverse Event|1|||
126544603|NCT01054573|455287931|FG003|Overall Study|Adverse Event|1|||
126544604|NCT01054573|455287928|FG000|Overall Study|Lost to Follow-up|0|||
126544605|NCT01054573|455287929|FG001|Overall Study|Lost to Follow-up|2|||
126544606|NCT01054573|455287930|FG002|Overall Study|Lost to Follow-up|0|||
126544607|NCT01054573|455287931|FG003|Overall Study|Lost to Follow-up|0|||
126544608|NCT01054573|455287928|FG000|Overall Study|Withdrawal by Subject|0|||
126544609|NCT01054573|455287929|FG001|Overall Study|Withdrawal by Subject|2|||
126544610|NCT01054573|455287930|FG002|Overall Study|Withdrawal by Subject|2|||
126544611|NCT01054573|455287931|FG003|Overall Study|Withdrawal by Subject|1|||
126544612|NCT00979602|455287932|FG000|Overall Study|Serious Adverse Event|5|||
126544613|NCT00979602|455287933|FG001|Overall Study|Serious Adverse Event|3|||
126544614|NCT00979602|455287932|FG000|Overall Study|Protocol Violation|3|||
126544615|NCT00979602|455287933|FG001|Overall Study|Protocol Violation|0|||
126544616|NCT00979602|455287932|FG000|Overall Study|Withdrawal by Subject|31|||
126544617|NCT00979602|455287933|FG001|Overall Study|Withdrawal by Subject|25|||
126544618|NCT00979602|455287932|FG000|Overall Study|Lost to Follow-up|100|||
126544619|NCT00979602|455287933|FG001|Overall Study|Lost to Follow-up|96|||
126544620|NCT00979602|455287932|FG000|Overall Study|Migrated/moved from study area|3|||
126544621|NCT00979602|455287933|FG001|Overall Study|Migrated/moved from study area|6|||
126544622|NCT00979602|455287932|FG000|Overall Study|Others|3|||
126544623|NCT00979602|455287933|FG001|Overall Study|Others|3|||
126544624|NCT02712398|455287934|FG000|Overall Study|Withdrawal by Subject|6|||
126544625|NCT02712398|455287934|FG000|Overall Study|Lost to Follow-up|6|||
126544626|NCT02712398|455287934|FG000|Overall Study|Sponsor Decision|1|||
126544627|NCT02712398|455287934|FG000|Overall Study|Physician Decision|1|||
126544628|NCT02712398|455287934|FG000|Overall Study|Death|2|||
126544629|NCT02712398|455287934|FG000|Overall Study|Re-operation|21|||
126544630|NCT04091360|455287935|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
126544631|NCT04091360|455287936|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
126648266|NCT01259089|455669724|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
126648267|NCT01259089|455669725|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
126544632|NCT04091360|455287937|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
126544633|NCT04091360|455287938|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
126544634|NCT04091360|455287939|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
126544635|NCT04091360|455287940|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
126544636|NCT04091360|455287941|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
126544637|NCT04091360|455287942|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
126544638|NCT04091360|455287943|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
126544639|NCT04091360|455287944|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
126544640|NCT04091360|455287935|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
126648268|NCT01259089|455669720|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
126544641|NCT04091360|455287936|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
126544642|NCT04091360|455287937|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
126544643|NCT04091360|455287938|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
126544644|NCT04091360|455287939|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
126544645|NCT04091360|455287940|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
126544646|NCT04091360|455287941|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
126544647|NCT04091360|455287942|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
126544648|NCT04091360|455287943|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
126544649|NCT04091360|455287944|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
126544650|NCT04091360|455287935|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
126544651|NCT04091360|455287936|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
126544652|NCT04091360|455287937|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
126544653|NCT04091360|455287938|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
126544654|NCT04091360|455287939|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
126544655|NCT04091360|455287940|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
126544656|NCT04091360|455287941|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
126544657|NCT04091360|455287942|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
126544658|NCT04091360|455287943|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
126544659|NCT04091360|455287944|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
126544660|NCT04772053|455287947|FG000|Overall Study|Physician Decision|2|||
126544661|NCT04772053|455287947|FG000|Overall Study|Withdrawal by Subject|3|||
126544662|NCT04772053|455287947|FG000|Overall Study|Study Terminated by Sponsor|1|||
126544663|NCT04599101|455287948|FG000|Overall Study|Lost to Follow-up|5|||
126544664|NCT04599101|455287949|FG001|Overall Study|Lost to Follow-up|5|||
126544665|NCT00098254|455287952|FG000|Overall Study|Adverse Event|2|||
126544666|NCT00098254|455287952|FG000|Overall Study|Death|1|||
126544667|NCT01515189|455287955|FG000|Induction|Disease Progression|109|||
126544668|NCT01515189|455287956|FG001|Induction|Disease Progression|155|||
126544669|NCT01515189|455287955|FG000|Induction|Study drug toxicity|86|||
126544670|NCT01515189|455287956|FG001|Induction|Study drug toxicity|36|||
126544671|NCT01515189|455287955|FG000|Induction|Death|24|||
126544672|NCT01515189|455287956|FG001|Induction|Death|17|||
126544673|NCT01515189|455287955|FG000|Induction|Adverse Event|14|||
126544674|NCT01515189|455287956|FG001|Induction|Adverse Event|9|||
126544675|NCT01515189|455287955|FG000|Induction|Withdrawal by Subject|3|||
126544676|NCT01515189|455287956|FG001|Induction|Withdrawal by Subject|9|||
126544677|NCT01515189|455287955|FG000|Induction|No longer meets study criteria|0|||
126544678|NCT01515189|455287956|FG001|Induction|No longer meets study criteria|2|||
126544679|NCT01515189|455287955|FG000|Induction|Lost to Follow-up|1|||
126544680|NCT01515189|455287956|FG001|Induction|Lost to Follow-up|0|||
126544681|NCT01515189|455287955|FG000|Induction|Other|0|||
126544682|NCT01515189|455287956|FG001|Induction|Other|4|||
126648269|NCT01259089|455669721|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
126648270|NCT01259089|455669722|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
126648271|NCT01259089|455669723|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
126648272|NCT01259089|455669724|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
126648273|NCT01259089|455669725|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
126648274|NCT02310100|455669726|FG000|Overall Study|Physician Decision|3|||
126648275|NCT02310100|455669726|FG000|Overall Study|Withdrawal by Subject|10|||
126648276|NCT02310100|455669726|FG000|Overall Study|Enrollment closure|1|||
126648277|NCT02310100|455669726|FG000|Overall Study|Unapproved ablation operator|1|||
126648278|NCT02310100|455669726|FG000|Overall Study|Visit compliance|1|||
126648279|NCT02310100|455669726|FG000|Overall Study|Lost to Follow-up|2|||
126648280|NCT00688870|455669729|FG000|Infant Series|Parent or legal guardian request|4|||
126648281|NCT00688870|455669730|FG001|Infant Series|Parent or legal guardian request|0|||
126648282|NCT01253018|455669741|FG000|Overall Study|Lost to Follow-up|1|||
126648283|NCT01253018|455669742|FG001|Overall Study|Lost to Follow-up|1|||
126648284|NCT01253018|455669741|FG000|Overall Study|Robot Repair Issues|2|||
126648285|NCT01253018|455669742|FG001|Overall Study|Robot Repair Issues|0|||
126648286|NCT01253018|455669741|FG000|Overall Study|Withdrawal by Subject|1|||
126648287|NCT01253018|455669742|FG001|Overall Study|Withdrawal by Subject|1|||
126648288|NCT03449901|455669743|FG000|Overall Study|Progression|57|||
126648289|NCT03449901|455669744|FG001|Overall Study|Progression|12|||
126648290|NCT03449901|455669743|FG000|Overall Study|Adverse Event|3|||
126648291|NCT03449901|455669744|FG001|Overall Study|Adverse Event|0|||
126648292|NCT03449901|455669743|FG000|Overall Study|Death|6|||
126648293|NCT03449901|455669744|FG001|Overall Study|Death|2|||
126544683|NCT01515189|455287955|FG000|First Re-Induction Phase|Disease progression|6|||
126544684|NCT01515189|455287956|FG001|First Re-Induction Phase|Disease progression|14|||
126544685|NCT01515189|455287955|FG000|First Re-Induction Phase|Study drug toxicity|5|||
126648294|NCT03449901|455669743|FG000|Overall Study|Withdrawal by Subject|12|||
126544686|NCT01515189|455287956|FG001|First Re-Induction Phase|Study drug toxicity|0|||
126544687|NCT01515189|455287955|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
126544688|NCT01515189|455287956|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
126544689|NCT01515189|455287955|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
126544690|NCT01515189|455287956|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
126544691|NCT01515189|455287955|FG000|First Re-Induction Phase|Other|1|||
126544692|NCT01515189|455287956|FG001|First Re-Induction Phase|Other|0|||
126544693|NCT03787680|455287957|FG000|Overall Study|Physician Decision|2|||
126544694|NCT03787680|455287958|FG001|Overall Study|Physician Decision|3|||
126544695|NCT03787680|455287957|FG000|Overall Study|Adverse Event|7|||
126544696|NCT03787680|455287958|FG001|Overall Study|Adverse Event|3|||
126544697|NCT03787680|455287957|FG000|Overall Study|Withdrawal by Subject|2|||
126544698|NCT03787680|455287958|FG001|Overall Study|Withdrawal by Subject|1|||
126544699|NCT00594217|455287959|FG000|Overall Study|Withdrawal by Subject|1|||
126544700|NCT00594217|455287960|FG001|Overall Study|Withdrawal by Subject|3|||
126544701|NCT01395823|455287964|FG000|Overall Study|Death|4|||
126544702|NCT01395823|455287965|FG001|Overall Study|Death|4|||
126544703|NCT01395823|455287964|FG000|Overall Study|Physician Decision|3|||
126544704|NCT01395823|455287965|FG001|Overall Study|Physician Decision|1|||
126544705|NCT01395823|455287964|FG000|Overall Study|Lost to Follow-up|1|||
126544706|NCT01395823|455287965|FG001|Overall Study|Lost to Follow-up|0|||
126544707|NCT01395823|455287964|FG000|Overall Study|Transplant|1|||
126544708|NCT01395823|455287965|FG001|Overall Study|Transplant|0|||
126544709|NCT01395823|455287964|FG000|Overall Study|GI symptoms|1|||
126544710|NCT01395823|455287965|FG001|Overall Study|GI symptoms|0|||
126544711|NCT01395823|455287964|FG000|Overall Study|Withdrawal by Subject|5|||
126544712|NCT01395823|455287965|FG001|Overall Study|Withdrawal by Subject|4|||
126544713|NCT05076149|455287966|FG000|Overall Study|Adverse Event|3|||
126544714|NCT05076149|455287967|FG001|Overall Study|Adverse Event|9|||
126544715|NCT05076149|455287966|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
126544716|NCT05076149|455287967|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
126544717|NCT05076149|455287966|FG000|Overall Study|Lost to Follow-up|0|||
126544718|NCT05076149|455287967|FG001|Overall Study|Lost to Follow-up|1|||
126544719|NCT05076149|455287966|FG000|Overall Study|Commercial drug is available for participant|0|||
126544720|NCT05076149|455287967|FG001|Overall Study|Commercial drug is available for participant|1|||
126544721|NCT05076149|455287966|FG000|Overall Study|Other non compliance|1|||
126544722|NCT05076149|455287967|FG001|Overall Study|Other non compliance|1|||
126544723|NCT05076149|455287966|FG000|Overall Study|Physician Decision|0|||
126544724|NCT05076149|455287967|FG001|Overall Study|Physician Decision|1|||
126544725|NCT05076149|455287966|FG000|Overall Study|Other|5|||
126544726|NCT05076149|455287967|FG001|Overall Study|Other|4|||
126544727|NCT02087501|455287968|FG000|Overall Study|Death|7|||
126544728|NCT02087501|455287968|FG000|Overall Study|Open repair of aneurysm|1|||
126544729|NCT02087501|455287968|FG000|Overall Study|Lost to Follow-up|2|||
126544730|NCT00094328|455287969|FG000|Overall Study|Lost to Follow-up|1|||
126544731|NCT02487095|455287972|FG000|Dose Expansion|Unable to scan/restage participant|0|||
126544732|NCT02487095|455287973|FG001|Dose Expansion|Unable to scan/restage participant|0|||
126544733|NCT02487095|455287974|FG002|Dose Expansion|Unable to scan/restage participant|0|||
126544734|NCT02487095|455287975|FG003|Dose Expansion|Unable to scan/restage participant|0|||
126544735|NCT02487095|455287976|FG004|Dose Expansion|Unable to scan/restage participant|1|||
126544736|NCT04631705|455287977|FG000|Overall Study|Withdrawal by Subject|0|||
126544737|NCT04631705|455287978|FG001|Overall Study|Withdrawal by Subject|0|||
126544738|NCT04631705|455287979|FG002|Overall Study|Withdrawal by Subject|0|||
126544739|NCT04631705|455287980|FG003|Overall Study|Withdrawal by Subject|0|||
126544740|NCT04631705|455287981|FG004|Overall Study|Withdrawal by Subject|0|||
126544741|NCT04631705|455287982|FG005|Overall Study|Withdrawal by Subject|0|||
126544742|NCT04631705|455287983|FG006|Overall Study|Withdrawal by Subject|1|||
126544743|NCT04631705|455287984|FG007|Overall Study|Withdrawal by Subject|0|||
126544744|NCT04631705|455287985|FG008|Overall Study|Withdrawal by Subject|0|||
126544745|NCT02130284|455287986|FG000|Overall Study|Withdrawal by Subject|3|||
126544746|NCT02130284|455287986|FG000|Overall Study|Subject Withdrew Consent|1|||
126544747|NCT02130284|455287986|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
126544748|NCT02130284|455287986|FG000|Overall Study|Subject was screened as backup for study|3|||
126544749|NCT02130284|455287986|FG000|Overall Study|Screen Failure|1|||
126544750|NCT01875185|455287987|FG000|Overall Study|study was terminated|52|||
126544751|NCT01875185|455287988|FG001|Overall Study|study was terminated|48|||
126544752|NCT04838613|455287989|FG000|Overall Study|Withdrawal by Subject|3|||
126544753|NCT04838613|455287990|FG001|Overall Study|Withdrawal by Subject|6|||
126544754|NCT04838613|455287989|FG000|Overall Study|Protocol Deviation|3|||
126544755|NCT04838613|455287990|FG001|Overall Study|Protocol Deviation|2|||
126544756|NCT04838613|455287989|FG000|Overall Study|Technical Problems|0|||
126544757|NCT04838613|455287990|FG001|Overall Study|Technical Problems|5|||
126544758|NCT04838613|455287989|FG000|Overall Study|Physician Decision|2|||
126544759|NCT04838613|455287990|FG001|Overall Study|Physician Decision|0|||
126544760|NCT01686581|455287991|FG000|Overall Study|Side-effects or Health Problems|15|||
126544761|NCT01686581|455287991|FG000|Overall Study|Lack of Efficacy|90|||
126544762|NCT01686581|455287991|FG000|Overall Study|Participant Concerned about Risks|6|||
126544763|NCT01686581|455287991|FG000|Overall Study|Thinks Injections Too Painful|8|||
126544764|NCT01686581|455287991|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
126544765|NCT01686581|455287991|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
126544766|NCT01686581|455287991|FG000|Overall Study|Thinks it is Inconvenient|17|||
126544767|NCT01686581|455287991|FG000|Overall Study|Other Miscellaneous Reasons|36|||
126544768|NCT01686581|455287991|FG000|Overall Study|Reason Missing|1|||
126544769|NCT01807650|455287992|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
126544770|NCT01807650|455287992|FG000|Overall Study|Adverse Event|5|||
126544771|NCT01807650|455287992|FG000|Overall Study|Other|2|||
126544772|NCT00962247|455287993|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
126544773|NCT00962247|455287993|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
126544774|NCT01786330|455287997|FG000|Overall Study|Withdrawal by Subject|0|||
126544775|NCT01786330|455287998|FG001|Overall Study|Withdrawal by Subject|1|||
126544776|NCT01786330|455287997|FG000|Overall Study|Lost to Follow-up|0|||
126544777|NCT01786330|455287998|FG001|Overall Study|Lost to Follow-up|1|||
126544778|NCT01786330|455287997|FG000|Overall Study|Excluded intraoperatively|0|||
126544779|NCT01786330|455287998|FG001|Overall Study|Excluded intraoperatively|1|||
126544780|NCT01786330|455287997|FG000|Overall Study|Protocol Violation|1|||
126544781|NCT01786330|455287998|FG001|Overall Study|Protocol Violation|0|||
126544782|NCT02969525|455288001|FG000|Double-Blind Period|Adverse Event|0|||
126544783|NCT02969525|455288002|FG001|Double-Blind Period|Adverse Event|0|||
126544784|NCT02969525|455288003|FG002|Double-Blind Period|Adverse Event|1|||
126544785|NCT02969525|455288004|FG003|Double-Blind Period|Adverse Event|1|||
126544786|NCT02969525|455288005|FG004|Double-Blind Period|Adverse Event|0|||
126544787|NCT02969525|455288006|FG005|Double-Blind Period|Adverse Event|0|||
126544788|NCT02969525|455288007|FG006|Double-Blind Period|Adverse Event|0|||
126544789|NCT02969525|455288008|FG007|Double-Blind Period|Adverse Event|0|||
126544790|NCT02969525|455288009|FG008|Double-Blind Period|Adverse Event|0|||
126544791|NCT02969525|455288010|FG009|Double-Blind Period|Adverse Event|0|||
126544792|NCT02969525|455288011|FG010|Double-Blind Period|Adverse Event|0|||
126544793|NCT02969525|455288012|FG011|Double-Blind Period|Adverse Event|0|||
126544794|NCT02969525|455288001|FG000|Double-Blind Period|LOW EGFR|0|||
126544795|NCT02969525|455288002|FG001|Double-Blind Period|LOW EGFR|0|||
126544796|NCT02969525|455288003|FG002|Double-Blind Period|LOW EGFR|0|||
126544797|NCT02969525|455288004|FG003|Double-Blind Period|LOW EGFR|1|||
126544798|NCT02969525|455288005|FG004|Double-Blind Period|LOW EGFR|0|||
126544799|NCT02969525|455288006|FG005|Double-Blind Period|LOW EGFR|0|||
126544800|NCT02969525|455288007|FG006|Double-Blind Period|LOW EGFR|0|||
126544801|NCT02969525|455288008|FG007|Double-Blind Period|LOW EGFR|0|||
126544802|NCT02969525|455288009|FG008|Double-Blind Period|LOW EGFR|0|||
126544803|NCT02969525|455288010|FG009|Double-Blind Period|LOW EGFR|0|||
126544804|NCT02969525|455288011|FG010|Double-Blind Period|LOW EGFR|0|||
126544805|NCT02969525|455288012|FG011|Double-Blind Period|LOW EGFR|0|||
126544806|NCT02969525|455288001|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
126544807|NCT02969525|455288002|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
126544808|NCT02969525|455288003|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
126544809|NCT02969525|455288004|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
126544810|NCT02969525|455288005|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
126544811|NCT02969525|455288006|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
126544812|NCT02969525|455288007|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
126544813|NCT02969525|455288008|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
126544814|NCT02969525|455288009|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
126544815|NCT02969525|455288010|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
126544816|NCT02969525|455288011|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
126544817|NCT02969525|455288012|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
126544818|NCT02969525|455288001|FG000|Dose-Blind Period|Adverse Event|0|||
126544819|NCT02969525|455288002|FG001|Dose-Blind Period|Adverse Event|0|||
126544820|NCT02969525|455288003|FG002|Dose-Blind Period|Adverse Event|0|||
126544821|NCT02969525|455288004|FG003|Dose-Blind Period|Adverse Event|0|||
126544822|NCT02969525|455288005|FG004|Dose-Blind Period|Adverse Event|0|||
126544823|NCT02969525|455288006|FG005|Dose-Blind Period|Adverse Event|0|||
126544824|NCT02969525|455288007|FG006|Dose-Blind Period|Adverse Event|0|||
126544825|NCT02969525|455288008|FG007|Dose-Blind Period|Adverse Event|0|||
126544826|NCT02969525|455288009|FG008|Dose-Blind Period|Adverse Event|0|||
126544827|NCT02969525|455288010|FG009|Dose-Blind Period|Adverse Event|1|||
126544828|NCT02969525|455288011|FG010|Dose-Blind Period|Adverse Event|1|||
126544829|NCT02969525|455288012|FG011|Dose-Blind Period|Adverse Event|1|||
126544830|NCT02969525|455288001|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
126544831|NCT02969525|455288002|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
126544832|NCT02969525|455288003|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
126544833|NCT02969525|455288004|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
126544834|NCT02969525|455288005|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
126544835|NCT02969525|455288006|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
126544836|NCT02969525|455288007|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
126648295|NCT03449901|455669744|FG001|Overall Study|Withdrawal by Subject|1|||
126544837|NCT02969525|455288008|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
126544838|NCT02969525|455288009|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
126544839|NCT02969525|455288010|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
126544840|NCT02969525|455288011|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
126544841|NCT02969525|455288012|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
126544842|NCT02969525|455288001|FG000|Dose-Blind Period|Non-cooperating patient|0|||
126544843|NCT02969525|455288002|FG001|Dose-Blind Period|Non-cooperating patient|0|||
126544844|NCT02969525|455288003|FG002|Dose-Blind Period|Non-cooperating patient|0|||
126544845|NCT02969525|455288004|FG003|Dose-Blind Period|Non-cooperating patient|0|||
126544846|NCT02969525|455288005|FG004|Dose-Blind Period|Non-cooperating patient|0|||
126544847|NCT02969525|455288006|FG005|Dose-Blind Period|Non-cooperating patient|0|||
126544848|NCT02969525|455288007|FG006|Dose-Blind Period|Non-cooperating patient|0|||
126544849|NCT02969525|455288008|FG007|Dose-Blind Period|Non-cooperating patient|0|||
126544850|NCT02969525|455288009|FG008|Dose-Blind Period|Non-cooperating patient|0|||
126544851|NCT02969525|455288010|FG009|Dose-Blind Period|Non-cooperating patient|0|||
126544852|NCT02969525|455288011|FG010|Dose-Blind Period|Non-cooperating patient|0|||
126544853|NCT02969525|455288012|FG011|Dose-Blind Period|Non-cooperating patient|1|||
126544854|NCT02969525|455288001|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
126544855|NCT02969525|455288002|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
126544856|NCT02969525|455288003|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
126544857|NCT02969525|455288004|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
126544858|NCT02969525|455288005|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
126544859|NCT02969525|455288006|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
126544860|NCT02969525|455288007|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
126544861|NCT02969525|455288008|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
126544862|NCT02969525|455288009|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
126544863|NCT02969525|455288010|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
126544864|NCT02969525|455288011|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
126544865|NCT02969525|455288012|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
126544866|NCT02172625|455288013|FG000|Overall Study|Adverse Event|0|||
126544867|NCT02172625|455288014|FG001|Overall Study|Adverse Event|1|||
126544868|NCT02172625|455288013|FG000|Overall Study|Pregnancy|0|||
126544869|NCT02172625|455288014|FG001|Overall Study|Pregnancy|1|||
126544870|NCT02172625|455288013|FG000|Overall Study|car accident|0|||
126544871|NCT02172625|455288014|FG001|Overall Study|car accident|1|||
126544872|NCT00524030|455288015|FG000|Overall Study|Lack of Efficacy|10|||
126544873|NCT00524030|455288016|FG001|Overall Study|Lack of Efficacy|24|||
126544874|NCT00524030|455288015|FG000|Overall Study|Lost to Follow-up|0|||
126544875|NCT00524030|455288016|FG001|Overall Study|Lost to Follow-up|2|||
126544876|NCT00524030|455288015|FG000|Overall Study|Withdrawal by Subject|3|||
126544877|NCT00524030|455288016|FG001|Overall Study|Withdrawal by Subject|8|||
126544878|NCT00524030|455288015|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
126544879|NCT00524030|455288016|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
126544880|NCT00524030|455288015|FG000|Overall Study|Protocol Violation|0|||
126544881|NCT00524030|455288016|FG001|Overall Study|Protocol Violation|1|||
126544882|NCT00524030|455288015|FG000|Overall Study|Pregnancy|1|||
126544883|NCT00524030|455288016|FG001|Overall Study|Pregnancy|0|||
126544884|NCT00524030|455288015|FG000|Overall Study|Adverse Event|3|||
126544885|NCT00524030|455288016|FG001|Overall Study|Adverse Event|21|||
126544886|NCT00524030|455288015|FG000|Overall Study|Death|0|||
126544887|NCT00524030|455288016|FG001|Overall Study|Death|1|||
126544888|NCT01816763|455289134|FG000|Overall Study|The main reason for an incomplete survey|4|||
126544889|NCT01816763|455289135|FG001|Overall Study|The main reason for an incomplete survey|15|||
126544890|NCT01816763|455289136|FG002|Overall Study|The main reason for an incomplete survey|11|||
126544891|NCT00311155|455289139|FG000|Overall Study|Adverse Event|21|||
126544892|NCT00311155|455289139|FG000|Overall Study|Withdrawal by Subject|17|||
126544893|NCT00311155|455289139|FG000|Overall Study|Did not meet entry criteria|55|||
126544894|NCT00429494|455289141|FG000|Overall Study|Withdrawal by Subject|9|||
126544895|NCT00429494|455289141|FG000|Overall Study|Death|6|||
126544896|NCT02392611|455289146|FG000|Overall Study|Adverse Event|0|||
126544897|NCT02392611|455289147|FG001|Overall Study|Adverse Event|0|||
126544898|NCT02392611|455289148|FG002|Overall Study|Adverse Event|0|||
126544899|NCT02392611|455289149|FG003|Overall Study|Adverse Event|1|||
126544900|NCT02392611|455289150|FG004|Overall Study|Adverse Event|0|||
126544901|NCT02392611|455289151|FG005|Overall Study|Adverse Event|0|||
126544902|NCT02392611|455289152|FG006|Overall Study|Adverse Event|0|||
126544903|NCT02392611|455289153|FG007|Overall Study|Adverse Event|0|||
126544904|NCT02392611|455289154|FG008|Overall Study|Adverse Event|0|||
126544905|NCT02392611|455289146|FG000|Overall Study|Progressive disease|0|||
126544906|NCT02392611|455289147|FG001|Overall Study|Progressive disease|0|||
126544907|NCT02392611|455289148|FG002|Overall Study|Progressive disease|0|||
126544908|NCT02392611|455289149|FG003|Overall Study|Progressive disease|2|||
126544909|NCT02392611|455289150|FG004|Overall Study|Progressive disease|1|||
126544910|NCT02392611|455289151|FG005|Overall Study|Progressive disease|0|||
126544911|NCT02392611|455289152|FG006|Overall Study|Progressive disease|0|||
126544912|NCT02392611|455289153|FG007|Overall Study|Progressive disease|0|||
126544913|NCT02392611|455289154|FG008|Overall Study|Progressive disease|0|||
126544914|NCT02392611|455289146|FG000|Overall Study|Death|1|||
126544915|NCT02392611|455289147|FG001|Overall Study|Death|0|||
126544916|NCT02392611|455289148|FG002|Overall Study|Death|0|||
126544917|NCT02392611|455289149|FG003|Overall Study|Death|0|||
126544918|NCT02392611|455289150|FG004|Overall Study|Death|0|||
126544919|NCT02392611|455289151|FG005|Overall Study|Death|1|||
126544920|NCT02392611|455289152|FG006|Overall Study|Death|0|||
126544921|NCT02392611|455289153|FG007|Overall Study|Death|0|||
126544922|NCT02392611|455289154|FG008|Overall Study|Death|0|||
126544923|NCT02392611|455289146|FG000|Overall Study|Withdrawal by Subject|0|||
126544924|NCT02392611|455289147|FG001|Overall Study|Withdrawal by Subject|0|||
126544925|NCT02392611|455289148|FG002|Overall Study|Withdrawal by Subject|0|||
126544926|NCT02392611|455289149|FG003|Overall Study|Withdrawal by Subject|1|||
126544927|NCT02392611|455289150|FG004|Overall Study|Withdrawal by Subject|0|||
126544928|NCT02392611|455289151|FG005|Overall Study|Withdrawal by Subject|0|||
126544929|NCT02392611|455289152|FG006|Overall Study|Withdrawal by Subject|0|||
126544930|NCT02392611|455289153|FG007|Overall Study|Withdrawal by Subject|0|||
126544931|NCT02392611|455289154|FG008|Overall Study|Withdrawal by Subject|0|||
126544932|NCT02392611|455289146|FG000|Overall Study|Lost to Follow-up|0|||
126544933|NCT02392611|455289147|FG001|Overall Study|Lost to Follow-up|0|||
126544934|NCT02392611|455289148|FG002|Overall Study|Lost to Follow-up|0|||
126544935|NCT02392611|455289149|FG003|Overall Study|Lost to Follow-up|0|||
126648296|NCT03449901|455669743|FG000|Overall Study|Physician Decision|1|||
126648297|NCT03449901|455669744|FG001|Overall Study|Physician Decision|0|||
126648298|NCT03449901|455669743|FG000|Overall Study|Patient elected for surgical intervention|1|||
126648299|NCT03449901|455669744|FG001|Overall Study|Patient elected for surgical intervention|0|||
126648300|NCT03449901|455669743|FG000|Overall Study|Patient off for other complicating disease|1|||
126648301|NCT03449901|455669744|FG001|Overall Study|Patient off for other complicating disease|0|||
126648302|NCT03466073|455669745|FG000|Overall Study|Death|1|||
126648303|NCT03466073|455669746|FG001|Overall Study|Death|0|||
126544936|NCT02392611|455289150|FG004|Overall Study|Lost to Follow-up|0|||
126544937|NCT02392611|455289151|FG005|Overall Study|Lost to Follow-up|0|||
126544938|NCT02392611|455289152|FG006|Overall Study|Lost to Follow-up|1|||
126544939|NCT02392611|455289153|FG007|Overall Study|Lost to Follow-up|0|||
126544940|NCT02392611|455289154|FG008|Overall Study|Lost to Follow-up|0|||
126544941|NCT02392611|455289146|FG000|Overall Study|Enrolled, not treated|0|||
126544942|NCT02392611|455289147|FG001|Overall Study|Enrolled, not treated|0|||
126544943|NCT02392611|455289148|FG002|Overall Study|Enrolled, not treated|0|||
126544944|NCT02392611|455289149|FG003|Overall Study|Enrolled, not treated|2|||
126648304|NCT03466073|455669747|FG002|Overall Study|Death|0|||
126648305|NCT03466073|455669748|FG003|Overall Study|Death|0|||
126648306|NCT03466073|455669749|FG004|Overall Study|Death|0|||
126648307|NCT03466073|455669750|FG005|Overall Study|Death|1|||
126648308|NCT00744757|455669751|FG000|Overall Study|Objective disease progression|7|||
126648309|NCT00744757|455669751|FG000|Overall Study|Physician Decision|5|||
126648310|NCT00744757|455669751|FG000|Overall Study|Withdrawal by Subject|1|||
126648311|NCT00744757|455669751|FG000|Overall Study|Death|6|||
126648312|NCT00744757|455669751|FG000|Overall Study|Adverse Event|2|||
126648313|NCT03682302|455669752|FG000|Overall Study|Lost to Follow-up|1|||
126648314|NCT03682302|455669753|FG001|Overall Study|Lost to Follow-up|2|||
126648315|NCT03682302|455669754|FG002|Overall Study|Lost to Follow-up|0|||
126648316|NCT03682302|455669755|FG003|Overall Study|Lost to Follow-up|1|||
126648317|NCT03682302|455669752|FG000|Overall Study|Study drug was not administered|0|||
126648318|NCT03682302|455669753|FG001|Overall Study|Study drug was not administered|0|||
126648319|NCT03682302|455669754|FG002|Overall Study|Study drug was not administered|1|||
126648320|NCT03682302|455669755|FG003|Overall Study|Study drug was not administered|1|||
126648321|NCT05051462|455669756|FG000|Overall Study|Lost to Follow-up|1|||
126648322|NCT05051462|455669757|FG001|Overall Study|Lost to Follow-up|8|||
126648323|NCT05051462|455669756|FG000|Overall Study|Withdrawal by Subject|1|||
126648324|NCT05051462|455669757|FG001|Overall Study|Withdrawal by Subject|0|||
126648325|NCT05051462|455669756|FG000|Overall Study|Protocol Violation|0|||
126648326|NCT05051462|455669757|FG001|Overall Study|Protocol Violation|2|||
126648327|NCT02425904|455669758|FG000|Overall Study|Lost to Follow-up|1|||
126648328|NCT02425904|455669759|FG001|Overall Study|Lost to Follow-up|0|||
126648329|NCT02425904|455669758|FG000|Overall Study|Withdrawal by Subject|2|||
126648330|NCT02425904|455669759|FG001|Overall Study|Withdrawal by Subject|0|||
126648331|NCT02425904|455669758|FG000|Overall Study|Death|0|||
126648332|NCT02425904|455669759|FG001|Overall Study|Death|3|||
126648333|NCT05260021|455669764|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
126648334|NCT05260021|455669765|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
126648335|NCT05260021|455669766|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
126648336|NCT05260021|455669764|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
126648337|NCT05260021|455669765|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
126648338|NCT05260021|455669766|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
126648339|NCT05260021|455669764|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
126648340|NCT05260021|455669765|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
126648341|NCT05260021|455669766|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
126648342|NCT05260021|455669764|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
126648343|NCT05260021|455669765|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
126648344|NCT05260021|455669766|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
126648345|NCT05260021|455669764|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
126648346|NCT05260021|455669765|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
126648347|NCT05260021|455669766|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
126648348|NCT03842358|455669768|FG000|Overall Study|Poor DOT probe contact with breast|2|||
126648349|NCT03842358|455669768|FG000|Overall Study|DOT system problem|1|||
126648350|NCT03842358|455669768|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
126648351|NCT03842358|455669768|FG000|Overall Study|No biopsy after physician review|4|||
126648352|NCT03842358|455669768|FG000|Overall Study|Patient withdrew|2|||
126648353|NCT03843554|455670825|FG000|Overall Study|Physician Decision|0|||
126648354|NCT03843554|455670826|FG001|Overall Study|Physician Decision|2|||
126648355|NCT03446781|455670829|FG000|Overall Study|Lost to Follow-up|11|||
126648356|NCT03446781|455670830|FG001|Overall Study|Lost to Follow-up|5|||
126648357|NCT03446781|455670829|FG000|Overall Study|Withdrawal by Subject|9|||
126648358|NCT03446781|455670830|FG001|Overall Study|Withdrawal by Subject|7|||
126648359|NCT03446781|455670829|FG000|Overall Study|Adverse Event|8|||
126648360|NCT03446781|455670830|FG001|Overall Study|Adverse Event|2|||
126648361|NCT03446781|455670829|FG000|Overall Study|Protocol Violation|0|||
126648362|NCT03446781|455670830|FG001|Overall Study|Protocol Violation|3|||
126648363|NCT03568318|455670833|FG000|Overall Study|Adverse Event|3|||
126648364|NCT03568318|455670834|FG001|Overall Study|Adverse Event|1|||
126648365|NCT03568318|455670835|FG002|Overall Study|Adverse Event|1|||
126648366|NCT03568318|455670836|FG003|Overall Study|Adverse Event|0|||
126648367|NCT03568318|455670837|FG004|Overall Study|Adverse Event|1|||
126648368|NCT03568318|455670838|FG005|Overall Study|Adverse Event|0|||
126648369|NCT03568318|455670833|FG000|Overall Study|Withdrawal by Subject|6|||
126648370|NCT03568318|455670834|FG001|Overall Study|Withdrawal by Subject|5|||
126648371|NCT03568318|455670835|FG002|Overall Study|Withdrawal by Subject|2|||
126648372|NCT03568318|455670836|FG003|Overall Study|Withdrawal by Subject|1|||
126648373|NCT03568318|455670837|FG004|Overall Study|Withdrawal by Subject|0|||
126648374|NCT03568318|455670838|FG005|Overall Study|Withdrawal by Subject|0|||
126648375|NCT03568318|455670833|FG000|Overall Study|Lost to Follow-up|3|||
126648376|NCT03568318|455670834|FG001|Overall Study|Lost to Follow-up|2|||
126648377|NCT03568318|455670835|FG002|Overall Study|Lost to Follow-up|2|||
126648378|NCT03568318|455670836|FG003|Overall Study|Lost to Follow-up|2|||
126648379|NCT03568318|455670837|FG004|Overall Study|Lost to Follow-up|1|||
126648380|NCT03568318|455670838|FG005|Overall Study|Lost to Follow-up|0|||
126648381|NCT03568318|455670833|FG000|Overall Study|Other|3|||
126648382|NCT03568318|455670834|FG001|Overall Study|Other|1|||
126648383|NCT03568318|455670835|FG002|Overall Study|Other|3|||
126648384|NCT03568318|455670836|FG003|Overall Study|Other|0|||
126648385|NCT03568318|455670837|FG004|Overall Study|Other|0|||
126648386|NCT03568318|455670838|FG005|Overall Study|Other|0|||
126648387|NCT03568318|455670833|FG000|Overall Study|Ongoing at Time of Analysis|5|||
126648388|NCT03568318|455670834|FG001|Overall Study|Ongoing at Time of Analysis|3|||
126648389|NCT03568318|455670835|FG002|Overall Study|Ongoing at Time of Analysis|2|||
126648390|NCT03568318|455670836|FG003|Overall Study|Ongoing at Time of Analysis|1|||
126648391|NCT03568318|455670837|FG004|Overall Study|Ongoing at Time of Analysis|0|||
126648392|NCT03568318|455670838|FG005|Overall Study|Ongoing at Time of Analysis|0|||
126648393|NCT05870228|455670845|FG000|Overall Study|Lost to Follow-up|2|||
126648394|NCT05870228|455670846|FG001|Overall Study|Lost to Follow-up|0|||
126648395|NCT05870228|455670845|FG000|Overall Study|Withdrawal by Subject|1|||
126648396|NCT05870228|455670846|FG001|Overall Study|Withdrawal by Subject|0|||
126648397|NCT04662931|455670847|FG000|Overall Study|Withdrawal by Subject|17|||
126648398|NCT04662931|455670847|FG000|Overall Study|Death|3|||
126648399|NCT04662931|455670847|FG000|Overall Study|Lost to Follow-up|3|||
126648400|NCT04662931|455670847|FG000|Overall Study|Guardian Decision|1|||
126648401|NCT06665919|455670849|FG000|Overall Study|Withdrawal by Subject|4|||
126648402|NCT06665919|455670850|FG001|Overall Study|Withdrawal by Subject|4|||
126648403|NCT06665919|455670851|FG002|Overall Study|Withdrawal by Subject|4|||
126648404|NCT06665919|455670849|FG000|Overall Study|Non-compliance to Treatment|4|||
126648405|NCT06665919|455670850|FG001|Overall Study|Non-compliance to Treatment|1|||
126648406|NCT06665919|455670851|FG002|Overall Study|Non-compliance to Treatment|6|||
126648407|NCT06665919|455670849|FG000|Overall Study|Lost to Follow-up|3|||
126648408|NCT06665919|455670850|FG001|Overall Study|Lost to Follow-up|0|||
126648409|NCT06665919|455670851|FG002|Overall Study|Lost to Follow-up|2|||
126648410|NCT06665919|455670849|FG000|Overall Study|Physician Decision|4|||
126648411|NCT06665919|455670850|FG001|Overall Study|Physician Decision|0|||
126648412|NCT06665919|455670851|FG002|Overall Study|Physician Decision|1|||
126648413|NCT04150068|455670852|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
126648414|NCT04150068|455670853|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
126648415|NCT04150068|455670854|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
126648416|NCT04150068|455670852|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
126648417|NCT04150068|455670853|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
126648418|NCT04150068|455670854|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
126648419|NCT05316701|455670855|FG000|Overall Study|Adverse Event|0|||
126648420|NCT05316701|455670856|FG001|Overall Study|Adverse Event|1|||
126648421|NCT05316701|455670855|FG000|Overall Study|Death|3|||
126648422|NCT05316701|455670856|FG001|Overall Study|Death|9|||
126648423|NCT05316701|455670855|FG000|Overall Study|Lost to Follow-up|1|||
126648424|NCT05316701|455670856|FG001|Overall Study|Lost to Follow-up|0|||
126648425|NCT05316701|455670855|FG000|Overall Study|Physician Decision|1|||
126648426|NCT05316701|455670856|FG001|Overall Study|Physician Decision|4|||
126648427|NCT05316701|455670855|FG000|Overall Study|Withdrawal by Subject|3|||
126648428|NCT05316701|455670856|FG001|Overall Study|Withdrawal by Subject|5|||
126648429|NCT05316701|455670855|FG000|Overall Study|Progression/Relapse|14|||
126648430|NCT05316701|455670856|FG001|Overall Study|Progression/Relapse|9|||
126648431|NCT05316701|455670855|FG000|Overall Study|Received Standard of Care|1|||
126648432|NCT05316701|455670856|FG001|Overall Study|Received Standard of Care|0|||
126648433|NCT05316701|455670855|FG000|Overall Study|Ongoing|70|||
126648434|NCT05316701|455670856|FG001|Overall Study|Ongoing|64|||
126648435|NCT04696653|455670857|FG000|Overall Study|left organization|18|||
126648436|NCT04696653|455670857|FG000|Overall Study|Lost to Follow-up|3|||
126648437|NCT04625413|455670858|FG000|Overall Study|Hospice|2|||
126648438|NCT04625413|455670858|FG000|Overall Study|Distress|1|||
126648439|NCT04625413|455670858|FG000|Overall Study|Not feeling well|1|||
126648440|NCT04679935|455670859|FG000|Overall Study|Death|0|||
126648441|NCT04679935|455670860|FG001|Overall Study|Death|1|||
126648442|NCT02993146|455670861|FG000|Overall Study|Withdrawal by Subject|0|||
126648443|NCT02993146|455670862|FG001|Overall Study|Withdrawal by Subject|0|||
126648444|NCT02993146|455670863|FG002|Overall Study|Withdrawal by Subject|1|||
126648445|NCT02993146|455670864|FG003|Overall Study|Withdrawal by Subject|1|||
126648446|NCT04362189|455670865|FG000|Overall Study|Lost to Follow-up|0|||
126648447|NCT04362189|455670866|FG001|Overall Study|Lost to Follow-up|1|||
126648448|NCT04362189|455670865|FG000|Overall Study|Withdrawal by Subject|1|||
126648449|NCT04362189|455670866|FG001|Overall Study|Withdrawal by Subject|0|||
126648450|NCT04362189|455670865|FG000|Overall Study|FDA Clinical Hold|7|||
126648451|NCT04362189|455670866|FG001|Overall Study|FDA Clinical Hold|2|||
126648452|NCT04362189|455670865|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
126648453|NCT04362189|455670866|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
126648454|NCT04362189|455670865|FG000|Overall Study|Adverse Event|0|||
126648455|NCT04362189|455670866|FG001|Overall Study|Adverse Event|2|||
126648456|NCT04362189|455670865|FG000|Overall Study|Death|4|||
126648457|NCT04362189|455670866|FG001|Overall Study|Death|1|||
126648458|NCT02111681|455670867|FG000|Overall Study|Death|5|||
126648459|NCT02111681|455670867|FG000|Overall Study|Lack of Efficacy|2|||
126648460|NCT02111681|455670867|FG000|Overall Study|Progression of disease|4|||
126648461|NCT04349631|455670874|FG000|Overall Study|Lost to Follow-up|3|||
126648462|NCT04349631|455670874|FG000|Overall Study|Withdrawal by Subject|7|||
126648463|NCT01982448|455670875|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
126648464|NCT01982448|455670876|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
126648465|NCT01982448|455670875|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
126648466|NCT01982448|455670876|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
126648467|NCT01982448|455670875|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
126648468|NCT01982448|455670876|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
126648469|NCT01982448|455670875|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
126648470|NCT01982448|455670876|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
126648471|NCT02898077|455672807|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
126648472|NCT02898077|455672808|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
126648473|NCT02898077|455672807|FG000|Overall Study|Lost to Follow-up|4|||
126648474|NCT02898077|455672808|FG001|Overall Study|Lost to Follow-up|3|||
126648475|NCT02898077|455672807|FG000|Overall Study|Physician Decision|0|||
126648476|NCT02898077|455672808|FG001|Overall Study|Physician Decision|2|||
126648477|NCT02898077|455672807|FG000|Overall Study|Sponsor Decision|32|||
126648478|NCT02898077|455672808|FG001|Overall Study|Sponsor Decision|13|||
126648479|NCT02898077|455672807|FG000|Overall Study|Withdrawal by Subject|6|||
126648480|NCT02898077|455672808|FG001|Overall Study|Withdrawal by Subject|3|||
126648481|NCT02898077|455672807|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
126648482|NCT02898077|455672808|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
126648483|NCT02898077|455672807|FG000|Overall Study|Ended extension period|3|||
126648484|NCT02898077|455672808|FG001|Overall Study|Ended extension period|0|||
126648485|NCT00621777|455672809|FG000|Open Phase|Adverse Event|20|||
126648486|NCT00621777|455672810|FG001|Open Phase|Adverse Event|0|||
126648487|NCT00621777|455672809|FG000|Open Phase|Did not abstain during open phase|56|||
126648488|NCT00621777|455672810|FG001|Open Phase|Did not abstain during open phase|0|||
126648489|NCT00621777|455672809|FG000|Open Phase|Withdrawal by Subject|17|||
126648490|NCT00621777|455672810|FG001|Open Phase|Withdrawal by Subject|0|||
126648491|NCT00621777|455672809|FG000|Open Phase|administrative|13|||
126648492|NCT00621777|455672810|FG001|Open Phase|administrative|0|||
126648493|NCT00621777|455672809|FG000|Open Phase|Lost to Follow-up|10|||
126648494|NCT00621777|455672810|FG001|Open Phase|Lost to Follow-up|0|||
126648495|NCT00621777|455672809|FG000|Randomized Phase|Adverse Event|3|||
126648496|NCT00621777|455672810|FG001|Randomized Phase|Adverse Event|3|||
126648497|NCT00621777|455672809|FG000|Randomized Phase|Lost to Follow-up|3|||
126648498|NCT00621777|455672810|FG001|Randomized Phase|Lost to Follow-up|3|||
126648499|NCT00621777|455672809|FG000|Randomized Phase|Withdrawal by Subject|1|||
126648500|NCT00621777|455672810|FG001|Randomized Phase|Withdrawal by Subject|9|||
126648501|NCT00621777|455672809|FG000|Randomized Phase|administrative|0|||
126648502|NCT00621777|455672810|FG001|Randomized Phase|administrative|3|||
126648503|NCT00621777|455672809|FG000|Randomized Phase|Death|0|||
126648504|NCT00621777|455672810|FG001|Randomized Phase|Death|1|||
126648505|NCT04410523|455672811|FG000|Overall Study|Study terminated by sponsor|1|||
126648506|NCT04410523|455672812|FG001|Overall Study|Study terminated by sponsor|3|||
126648507|NCT04410523|455672813|FG002|Overall Study|Study terminated by sponsor|2|||
126648508|NCT04410523|455672814|FG003|Overall Study|Study terminated by sponsor|6|||
126317877|NCT00561470|454454095|FG000|Overall Study|Ongoing Treatment|11|||
126317878|NCT00561470|454454096|FG001|Overall Study|Ongoing Treatment|14|||
126317879|NCT00637806|454454097|FG000|Double-blind Phase|Study Discontinued|2|||
126317880|NCT00637806|454454098|FG001|Double-blind Phase|Study Discontinued|0|||
126648509|NCT04410523|455672815|FG004|Overall Study|Study terminated by sponsor|3|||
126648510|NCT04410523|455672816|FG005|Overall Study|Study terminated by sponsor|4|||
126648511|NCT04410523|455672811|FG000|Overall Study|Adverse Event|1|||
126648512|NCT04410523|455672812|FG001|Overall Study|Adverse Event|0|||
126648513|NCT04410523|455672813|FG002|Overall Study|Adverse Event|0|||
126648514|NCT04410523|455672814|FG003|Overall Study|Adverse Event|0|||
126648515|NCT04410523|455672815|FG004|Overall Study|Adverse Event|0|||
126648516|NCT04410523|455672816|FG005|Overall Study|Adverse Event|2|||
126648517|NCT04410523|455672811|FG000|Overall Study|Lost to Follow-up|0|||
126648518|NCT04410523|455672812|FG001|Overall Study|Lost to Follow-up|1|||
126648519|NCT04410523|455672813|FG002|Overall Study|Lost to Follow-up|0|||
126648520|NCT04410523|455672814|FG003|Overall Study|Lost to Follow-up|0|||
126648521|NCT04410523|455672815|FG004|Overall Study|Lost to Follow-up|0|||
126648522|NCT04410523|455672816|FG005|Overall Study|Lost to Follow-up|0|||
126648523|NCT04410523|455672811|FG000|Overall Study|Physician Decision|0|||
126648524|NCT04410523|455672812|FG001|Overall Study|Physician Decision|1|||
126648525|NCT04410523|455672813|FG002|Overall Study|Physician Decision|0|||
126648526|NCT04410523|455672814|FG003|Overall Study|Physician Decision|0|||
126648527|NCT04410523|455672815|FG004|Overall Study|Physician Decision|0|||
126648528|NCT04410523|455672816|FG005|Overall Study|Physician Decision|0|||
126648529|NCT04410523|455672811|FG000|Overall Study|Pregnancy|0|||
126648530|NCT04410523|455672812|FG001|Overall Study|Pregnancy|0|||
126648531|NCT04410523|455672813|FG002|Overall Study|Pregnancy|0|||
126648532|NCT04410523|455672814|FG003|Overall Study|Pregnancy|0|||
126648533|NCT04410523|455672815|FG004|Overall Study|Pregnancy|0|||
126648534|NCT04410523|455672816|FG005|Overall Study|Pregnancy|1|||
126648535|NCT04410523|455672811|FG000|Overall Study|Protocol deviation|0|||
126648536|NCT04410523|455672812|FG001|Overall Study|Protocol deviation|0|||
126648537|NCT04410523|455672813|FG002|Overall Study|Protocol deviation|0|||
126648538|NCT04410523|455672814|FG003|Overall Study|Protocol deviation|0|||
126648539|NCT04410523|455672815|FG004|Overall Study|Protocol deviation|0|||
126648540|NCT04410523|455672816|FG005|Overall Study|Protocol deviation|2|||
126648541|NCT04410523|455672811|FG000|Overall Study|Subject decision|2|||
126648542|NCT04410523|455672812|FG001|Overall Study|Subject decision|0|||
126648543|NCT04410523|455672813|FG002|Overall Study|Subject decision|0|||
126648544|NCT04410523|455672814|FG003|Overall Study|Subject decision|1|||
126648545|NCT04410523|455672815|FG004|Overall Study|Subject decision|0|||
126648546|NCT04410523|455672816|FG005|Overall Study|Subject decision|1|||
126648547|NCT01239043|455672817|FG000|Overall Study|Protocol Violation|2|||
126648548|NCT01239043|455672818|FG001|Overall Study|Protocol Violation|1|||
126648549|NCT00436852|455672824|FG000|Overall Study|Death|23|||
126648550|NCT00436852|455672825|FG001|Overall Study|Death|34|||
126648551|NCT00436852|455672824|FG000|Overall Study|Lack of Efficacy|9|||
126648552|NCT00436852|455672825|FG001|Overall Study|Lack of Efficacy|7|||
126648553|NCT00436852|455672824|FG000|Overall Study|Withdrawal by Subject|2|||
126648554|NCT00436852|455672825|FG001|Overall Study|Withdrawal by Subject|4|||
126648555|NCT00436852|455672824|FG000|Overall Study|Ineligible|1|||
126648556|NCT00436852|455672825|FG001|Overall Study|Ineligible|0|||
126648557|NCT00370682|455672826|FG000|Overall Study|Moved from area|0|||
126648558|NCT00370682|455672827|FG001|Overall Study|Moved from area|2|||
126648559|NCT00370682|455672828|FG002|Overall Study|Moved from area|0|||
126648560|NCT00370682|455672826|FG000|Overall Study|Lost to Follow-up|0|||
126648561|NCT00370682|455672827|FG001|Overall Study|Lost to Follow-up|1|||
126648562|NCT00370682|455672828|FG002|Overall Study|Lost to Follow-up|1|||
126648563|NCT02141620|455672829|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
126648564|NCT02141620|455672830|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
126648565|NCT03651622|455672831|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
126648566|NCT03651622|455672832|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
126648567|NCT03651622|455672833|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
126648568|NCT03651622|455672831|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
126648569|NCT03651622|455672832|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
126648570|NCT03651622|455672833|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
126648571|NCT03651622|455672831|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
126648572|NCT03651622|455672832|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
126648573|NCT03651622|455672833|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
126648574|NCT03651622|455672831|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
126648575|NCT03651622|455672832|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
126648576|NCT03651622|455672833|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
126648577|NCT03651622|455672831|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
126648578|NCT03651622|455672832|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
126648579|NCT03651622|455672833|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
126648580|NCT01519089|455672834|FG000|Overall Study|Adverse Event|4|||
126648581|NCT01519089|455672835|FG001|Overall Study|Adverse Event|4|||
126648582|NCT01519089|455672834|FG000|Overall Study|Lack of Efficacy|0|||
126648583|NCT01519089|455672835|FG001|Overall Study|Lack of Efficacy|2|||
126648584|NCT01519089|455672834|FG000|Overall Study|Lost to Follow-up|1|||
126648585|NCT01519089|455672835|FG001|Overall Study|Lost to Follow-up|0|||
126648586|NCT01519089|455672834|FG000|Overall Study|Withdrawal by Subject|0|||
126648587|NCT01519089|455672835|FG001|Overall Study|Withdrawal by Subject|2|||
126648588|NCT01519089|455672834|FG000|Overall Study|Other|2|||
126648589|NCT01519089|455672835|FG001|Overall Study|Other|6|||
126648590|NCT01519089|455672834|FG000|Overall Study|Not received study drug|0|||
126648591|NCT01519089|455672835|FG001|Overall Study|Not received study drug|1|||
126648592|NCT00127205|455672836|FG000|Overall Study|Adverse Event|228|||
126648593|NCT00127205|455672837|FG001|Overall Study|Adverse Event|387|||
126648594|NCT00127205|455672838|FG002|Overall Study|Adverse Event|273|||
126648595|NCT00127205|455672836|FG000|Overall Study|Death|8|||
126648596|NCT00127205|455672837|FG001|Overall Study|Death|6|||
126648597|NCT00127205|455672838|FG002|Overall Study|Death|5|||
126648598|NCT00127205|455672836|FG000|Overall Study|Withdrawal by Subject|318|||
126648599|NCT00127205|455672837|FG001|Overall Study|Withdrawal by Subject|310|||
126648600|NCT00127205|455672838|FG002|Overall Study|Withdrawal by Subject|172|||
126648601|NCT00127205|455672836|FG000|Overall Study|Other-non protocol specified|142|||
126648602|NCT00127205|455672837|FG001|Overall Study|Other-non protocol specified|129|||
126648603|NCT00127205|455672838|FG002|Overall Study|Other-non protocol specified|77|||
126648604|NCT00127205|455672836|FG000|Overall Study|Data not reported|6|||
126648605|NCT00127205|455672837|FG001|Overall Study|Data not reported|10|||
126648606|NCT00127205|455672838|FG002|Overall Study|Data not reported|1|||
126648607|NCT00127205|455672836|FG000|Overall Study|Progression|127|||
126648608|NCT00127205|455672837|FG001|Overall Study|Progression|131|||
126648609|NCT00127205|455672838|FG002|Overall Study|Progression|84|||
126648610|NCT00307684|455672842|FG000|Open Label Phase|Lack of Efficacy|0|||
126648611|NCT00307684|455672843|FG001|Open Label Phase|Lack of Efficacy|0|||
126648612|NCT00307684|455672844|FG002|Open Label Phase|Lack of Efficacy|3|||
126648613|NCT00307684|455672842|FG000|Open Label Phase|Adverse Event|0|||
126648614|NCT00307684|455672843|FG001|Open Label Phase|Adverse Event|0|||
126648615|NCT00307684|455672844|FG002|Open Label Phase|Adverse Event|16|||
126648616|NCT00307684|455672842|FG000|Open Label Phase|Withdrawal by Subject|0|||
126648617|NCT00307684|455672843|FG001|Open Label Phase|Withdrawal by Subject|0|||
126648618|NCT00307684|455672844|FG002|Open Label Phase|Withdrawal by Subject|15|||
126648619|NCT00307684|455672842|FG000|Open Label Phase|Lost to Follow-up|0|||
126648620|NCT00307684|455672843|FG001|Open Label Phase|Lost to Follow-up|0|||
126648621|NCT00307684|455672844|FG002|Open Label Phase|Lost to Follow-up|11|||
126648622|NCT00307684|455672842|FG000|Open Label Phase|non compliance|0|||
126648623|NCT00307684|455672843|FG001|Open Label Phase|non compliance|0|||
126648624|NCT00307684|455672844|FG002|Open Label Phase|non compliance|5|||
126648625|NCT00307684|455672842|FG000|Open Label Phase|other|0|||
126648626|NCT00307684|455672843|FG001|Open Label Phase|other|0|||
126648627|NCT00307684|455672844|FG002|Open Label Phase|other|6|||
126648628|NCT00307684|455672842|FG000|Double Blind Phase|Lack of Efficacy|2|||
126648629|NCT00307684|455672843|FG001|Double Blind Phase|Lack of Efficacy|5|||
126648630|NCT00307684|455672844|FG002|Double Blind Phase|Lack of Efficacy|0|||
126648631|NCT03377699|455672845|FG000|Overall Study|Withdrawal by Subject|2|||
126648632|NCT03377699|455672846|FG001|Overall Study|Withdrawal by Subject|9|||
126648633|NCT03377699|455672845|FG000|Overall Study|Lost to Follow-up|1|||
126648634|NCT03377699|455672846|FG001|Overall Study|Lost to Follow-up|1|||
126648635|NCT03377699|455672845|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
126648636|NCT03377699|455672846|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
126648637|NCT03377699|455672845|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
126648638|NCT03377699|455672846|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
126648639|NCT03377699|455672845|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
126648640|NCT03377699|455672846|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
126648641|NCT03377699|455672845|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
126648642|NCT03377699|455672846|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
126648643|NCT02580305|455672847|FG000|Overall Study|Adverse Event|15|||
126317881|NCT00637806|454454099|FG002|Double-blind Phase|Study Discontinued|1|||
126317882|NCT00637806|454454100|FG003|Double-blind Phase|Study Discontinued|0|||
126317883|NCT00637806|454454097|FG000|Extension Phase|Study Discontinued|0|||
126317884|NCT00637806|454454098|FG001|Extension Phase|Study Discontinued|0|||
126648644|NCT02580305|455672848|FG001|Overall Study|Adverse Event|19|||
126648645|NCT02580305|455672849|FG002|Overall Study|Adverse Event|10|||
126648646|NCT02580305|455672847|FG000|Overall Study|Lack of Efficacy|5|||
126648647|NCT02580305|455672848|FG001|Overall Study|Lack of Efficacy|0|||
126317885|NCT00637806|454454099|FG002|Extension Phase|Study Discontinued|0|||
126317886|NCT00637806|454454100|FG003|Extension Phase|Study Discontinued|1|||
126317887|NCT01731470|454454101|FG000|Overall Study|Withdrawal by Subject|1|||
126317888|NCT01731470|454454101|FG000|Overall Study|Did not meet study criteria|1|||
126317889|NCT04395274|454454102|FG000|Overall Study|Lost to Follow-up|20|||
126317890|NCT04395274|454454103|FG001|Overall Study|Lost to Follow-up|11|||
126317891|NCT04395274|454454102|FG000|Overall Study|Withdrawal by Subject|13|||
126317892|NCT04395274|454454103|FG001|Overall Study|Withdrawal by Subject|10|||
126317893|NCT04395274|454454102|FG000|Overall Study|Moved Abroad|0|||
126317894|NCT04395274|454454103|FG001|Overall Study|Moved Abroad|1|||
126317895|NCT01592292|454454106|FG000|Overall Study|Follow-up loss|3|||
126317896|NCT01592292|454454107|FG001|Overall Study|Follow-up loss|3|||
126317897|NCT01592292|454454108|FG002|Overall Study|Follow-up loss|1|||
126317898|NCT01592292|454454109|FG003|Overall Study|Follow-up loss|0|||
126317899|NCT01592292|454454106|FG000|Overall Study|Withdrew consent|2|||
126317900|NCT01592292|454454107|FG001|Overall Study|Withdrew consent|1|||
126317901|NCT01592292|454454108|FG002|Overall Study|Withdrew consent|0|||
126317902|NCT01592292|454454109|FG003|Overall Study|Withdrew consent|0|||
126648648|NCT02580305|455672849|FG002|Overall Study|Lack of Efficacy|2|||
126648649|NCT02580305|455672847|FG000|Overall Study|Protocol Violation|4|||
126648650|NCT02580305|455672848|FG001|Overall Study|Protocol Violation|9|||
126648651|NCT02580305|455672849|FG002|Overall Study|Protocol Violation|6|||
126648652|NCT02580305|455672847|FG000|Overall Study|Lost to Follow-up|4|||
126648653|NCT02580305|455672848|FG001|Overall Study|Lost to Follow-up|4|||
126648654|NCT02580305|455672849|FG002|Overall Study|Lost to Follow-up|2|||
126648655|NCT02580305|455672847|FG000|Overall Study|Withdrawal by Subject|11|||
126648656|NCT02580305|455672848|FG001|Overall Study|Withdrawal by Subject|9|||
126648657|NCT02580305|455672849|FG002|Overall Study|Withdrawal by Subject|7|||
126317903|NCT01592292|454454106|FG000|Overall Study|Other|1|||
126317904|NCT01592292|454454107|FG001|Overall Study|Other|1|||
126317905|NCT01592292|454454108|FG002|Overall Study|Other|2|||
126317906|NCT01592292|454454109|FG003|Overall Study|Other|1|||
126317907|NCT00335959|454454110|FG000|Overall Study|Adverse Event|2|||
126317908|NCT00335959|454454110|FG000|Overall Study|Ineligible|1|||
126317909|NCT02450552|454454112|FG000|Overall Study|Withdrawal by Subject|4|||
126648658|NCT02580305|455672847|FG000|Overall Study|Randomized in error and never treated|4|||
126648659|NCT02580305|455672848|FG001|Overall Study|Randomized in error and never treated|8|||
126648660|NCT02580305|455672849|FG002|Overall Study|Randomized in error and never treated|5|||
126648661|NCT00224887|455672850|FG000|Overall Study|Pregnancy|6|||
126648662|NCT00224887|455672851|FG001|Overall Study|Pregnancy|6|||
126648663|NCT03582943|455672856|FG000|Allocated to Groups|Withdrawal by Subject|1|||
126648664|NCT03582943|455672857|FG001|Allocated to Groups|Withdrawal by Subject|1|||
126648665|NCT03582943|455672856|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
126648666|NCT03582943|455672857|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
126648667|NCT03582943|455672856|FG000|Analyzed|Protocol Violation|4|||
126648668|NCT03582943|455672857|FG001|Analyzed|Protocol Violation|1|||
126648669|NCT05032872|455672858|FG000|Overall Study|Adverse Event|1|||
126648670|NCT05032872|455672859|FG001|Overall Study|Adverse Event|0|||
126648671|NCT05032872|455672858|FG000|Overall Study|Lost to Follow-up|2|||
126648672|NCT05032872|455672859|FG001|Overall Study|Lost to Follow-up|4|||
126648673|NCT05032872|455672858|FG000|Overall Study|Withdrawal by Subject|4|||
126648674|NCT05032872|455672859|FG001|Overall Study|Withdrawal by Subject|3|||
126648675|NCT00488475|455672860|FG000|Overall Study|Other|1754|||
126648676|NCT00798590|455672881|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
126648677|NCT00798590|455672882|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
126648678|NCT01163292|455672888|FG000|Overall Study|Lack of Efficacy|9|||
126648679|NCT01163292|455672889|FG001|Overall Study|Lack of Efficacy|0|||
126648680|NCT01163292|455672888|FG000|Overall Study|Adverse Event|6|||
126648681|NCT01163292|455672889|FG001|Overall Study|Adverse Event|0|||
126648682|NCT01163292|455672888|FG000|Overall Study|Initiation of biological therapy|0|||
126648683|NCT01163292|455672889|FG001|Overall Study|Initiation of biological therapy|15|||
126648684|NCT01163292|455672888|FG000|Overall Study|Sufficient response to adalimumab|8|||
126648685|NCT01163292|455672889|FG001|Overall Study|Sufficient response to adalimumab|0|||
126648686|NCT01163292|455672888|FG000|Overall Study|Refusal to receive adalimumab|7|||
126648687|NCT01163292|455672889|FG001|Overall Study|Refusal to receive adalimumab|0|||
126648688|NCT01163292|455672888|FG000|Overall Study|Economic reasons|6|||
126648689|NCT01163292|455672889|FG001|Overall Study|Economic reasons|0|||
126648690|NCT01163292|455672888|FG000|Overall Study|No further visits|5|||
126648691|NCT01163292|455672889|FG001|Overall Study|No further visits|7|||
126317910|NCT02450552|454454113|FG001|Overall Study|Withdrawal by Subject|0|||
126648692|NCT03223662|455672890|FG000|Overall Study|Physician Decision|1|||
126648693|NCT03223662|455672890|FG000|Overall Study|Study closure|1|||
126648694|NCT02217475|455672891|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
126648695|NCT02217475|455672892|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
126648696|NCT02217475|455672893|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
126648697|NCT02217475|455672891|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
126648698|NCT02217475|455672892|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
126648699|NCT02217475|455672893|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
126648700|NCT02217475|455672891|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
126648701|NCT02217475|455672892|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
126648702|NCT02217475|455672893|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
126648703|NCT02217475|455672891|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
126648704|NCT02217475|455672892|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
126648705|NCT02217475|455672893|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
126648706|NCT02217475|455672891|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
126648707|NCT02217475|455672892|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
126648708|NCT02217475|455672893|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
126648709|NCT02217475|455672891|FG000|Discontinued After Period 1|Adverse Event|1|||
126648710|NCT02217475|455672892|FG001|Discontinued After Period 1|Adverse Event|2|||
126648711|NCT02217475|455672893|FG002|Discontinued After Period 1|Adverse Event|0|||
126648712|NCT02217475|455672891|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
126648713|NCT02217475|455672892|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
126648714|NCT02217475|455672893|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
126648715|NCT02217475|455672891|FG000|Discontinued After Period 1|Physician Decision|0|||
126648716|NCT02217475|455672892|FG001|Discontinued After Period 1|Physician Decision|0|||
126648717|NCT02217475|455672893|FG002|Discontinued After Period 1|Physician Decision|1|||
126648718|NCT02217475|455672891|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
126648719|NCT02217475|455672892|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
126648720|NCT02217475|455672893|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
126648721|NCT02217475|455672891|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
126648722|NCT02217475|455672892|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
126648723|NCT02217475|455672893|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
126648724|NCT02217475|455672891|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
126648725|NCT02217475|455672892|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
126648726|NCT02217475|455672893|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
126648727|NCT02217475|455672891|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
126648728|NCT02217475|455672892|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
126648729|NCT02217475|455672893|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
126648730|NCT02217475|455672891|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
126648731|NCT02217475|455672892|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
126648732|NCT02217475|455672893|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
126648733|NCT02643472|455672894|FG000|Overall Study|Death|2|||
126648734|NCT02643472|455672895|FG001|Overall Study|Death|5|||
126648735|NCT02643472|455672894|FG000|Overall Study|Withdrawal by Subject|3|||
126648736|NCT02643472|455672895|FG001|Overall Study|Withdrawal by Subject|2|||
126648737|NCT02643472|455672894|FG000|Overall Study|Protocol Violation|0|||
126648738|NCT02643472|455672895|FG001|Overall Study|Protocol Violation|1|||
126648739|NCT02643472|455672894|FG000|Overall Study|Lost to Follow-up|22|||
126648740|NCT02643472|455672895|FG001|Overall Study|Lost to Follow-up|26|||
126648741|NCT01012414|455672896|FG000|Overall Study|Withdrawal by Subject|2|||
126648742|NCT01012414|455672896|FG000|Overall Study|Lost to Follow-up|1|||
126648743|NCT01012414|455672896|FG000|Overall Study|Trial was stopped before completed|7|||
126648744|NCT00506441|455672897|FG000|Period 1; Open-label Period|Adverse Event|21|||
126648745|NCT00506441|455672898|FG001|Period 1; Open-label Period|Adverse Event|0|||
126648746|NCT00506441|455672897|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
126648747|NCT00506441|455672898|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
126648748|NCT00506441|455672897|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
126648749|NCT00506441|455672898|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
126648750|NCT00506441|455672897|FG000|Period 1; Open-label Period|Physician Decision|5|||
126648751|NCT00506441|455672898|FG001|Period 1; Open-label Period|Physician Decision|0|||
126648752|NCT00506441|455672897|FG000|Period 1; Open-label Period|Protocol Violation|9|||
126648753|NCT00506441|455672898|FG001|Period 1; Open-label Period|Protocol Violation|0|||
126648754|NCT00506441|455672897|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
126648755|NCT00506441|455672898|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
126648756|NCT00506441|455672897|FG000|Period 1; Open-label Period|Other Reasons|13|||
126648757|NCT00506441|455672898|FG001|Period 1; Open-label Period|Other Reasons|0|||
126648758|NCT00506441|455672897|FG000|Period 2; Double-blind Period|Adverse Event|0|||
126648759|NCT00506441|455672898|FG001|Period 2; Double-blind Period|Adverse Event|1|||
126648760|NCT00506441|455672897|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
126648761|NCT00506441|455672898|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
126648762|NCT00506441|455672897|FG000|Period 2; Double-blind Period|Physician Decision|1|||
126648763|NCT00506441|455672898|FG001|Period 2; Double-blind Period|Physician Decision|1|||
126648764|NCT00506441|455672897|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
126648765|NCT00506441|455672898|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
126648766|NCT00506441|455672897|FG000|Period 2; Double-blind Period|Other Reason|1|||
126648767|NCT00506441|455672898|FG001|Period 2; Double-blind Period|Other Reason|1|||
126648768|NCT01215188|455672899|FG000|Overall Study|Lost to Follow-up|22|||
126648769|NCT01215188|455672900|FG001|Overall Study|Lost to Follow-up|22|||
126648770|NCT01215188|455672901|FG002|Overall Study|Lost to Follow-up|16|||
126648771|NCT01215188|455672899|FG000|Overall Study|Adverse Event|1|||
126648772|NCT01215188|455672900|FG001|Overall Study|Adverse Event|1|||
126648773|NCT01215188|455672901|FG002|Overall Study|Adverse Event|3|||
126648774|NCT01215188|455672899|FG000|Overall Study|Physician Decision|2|||
126648775|NCT01215188|455672900|FG001|Overall Study|Physician Decision|1|||
126648776|NCT01215188|455672901|FG002|Overall Study|Physician Decision|0|||
126648777|NCT01215188|455672899|FG000|Overall Study|Lack of Efficacy|0|||
126648778|NCT01215188|455672900|FG001|Overall Study|Lack of Efficacy|0|||
126648779|NCT01215188|455672901|FG002|Overall Study|Lack of Efficacy|1|||
126648780|NCT01215188|455672899|FG000|Overall Study|Protocol Violation|1|||
126648781|NCT01215188|455672900|FG001|Overall Study|Protocol Violation|1|||
126648782|NCT01215188|455672901|FG002|Overall Study|Protocol Violation|1|||
126648783|NCT01215188|455672899|FG000|Overall Study|Withdrawal by Subject|32|||
126648784|NCT01215188|455672900|FG001|Overall Study|Withdrawal by Subject|34|||
126648785|NCT01215188|455672901|FG002|Overall Study|Withdrawal by Subject|31|||
126648786|NCT02601300|455672902|FG000|Induction Phase|Lack of Efficacy|2|||
126648787|NCT02601300|455672902|FG000|Induction Phase|Protocol Violation|1|||
126648788|NCT02601300|455672902|FG000|Extension Phase|Withdrawal by Subject|3|||
126648789|NCT02601300|455672902|FG000|Extension Phase|Adverse Event|4|||
126648790|NCT02601300|455672902|FG000|Extension Phase|Lack of Efficacy|10|||
126648791|NCT00528931|455672906|FG000|Overall Study|Lost to Follow-up|1|||
126648792|NCT00992225|455672907|FG000|Overall Study|Entry Criteria Not Met|8|||
126648793|NCT00992225|455672907|FG000|Overall Study|Adverse Event|2|||
126648794|NCT00291642|455672910|FG000|Overall Study|Adverse Event|1|||
126648795|NCT00291642|455672911|FG001|Overall Study|Adverse Event|0|||
126648796|NCT00291642|455672912|FG002|Overall Study|Adverse Event|1|||
126648797|NCT00291642|455672913|FG003|Overall Study|Adverse Event|0|||
126648798|NCT00291642|455672914|FG004|Overall Study|Adverse Event|1|||
126648799|NCT00291642|455672910|FG000|Overall Study|Patient missed visit|0|||
126648800|NCT00291642|455672911|FG001|Overall Study|Patient missed visit|0|||
126648801|NCT00291642|455672912|FG002|Overall Study|Patient missed visit|1|||
126648802|NCT00291642|455672913|FG003|Overall Study|Patient missed visit|0|||
126648803|NCT00291642|455672914|FG004|Overall Study|Patient missed visit|0|||
126648804|NCT00291642|455672910|FG000|Overall Study|Intake of prohibited medication|1|||
126648805|NCT00291642|455672911|FG001|Overall Study|Intake of prohibited medication|0|||
126648806|NCT00291642|455672912|FG002|Overall Study|Intake of prohibited medication|0|||
126648807|NCT00291642|455672913|FG003|Overall Study|Intake of prohibited medication|0|||
126317911|NCT02450552|454454114|FG002|Overall Study|Withdrawal by Subject|4|||
126317912|NCT02450552|454454112|FG000|Overall Study|Physician Decision|1|||
126317913|NCT02450552|454454113|FG001|Overall Study|Physician Decision|0|||
126317914|NCT02450552|454454114|FG002|Overall Study|Physician Decision|1|||
126648808|NCT00291642|455672914|FG004|Overall Study|Intake of prohibited medication|0|||
126648809|NCT02576587|455672919|FG000|Baseline|Equipment failure|0|||
126648810|NCT02576587|455672920|FG001|Baseline|Equipment failure|1|||
126648811|NCT02576587|455672919|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
126648812|NCT02576587|455672920|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
126648813|NCT02576587|455672919|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
126648814|NCT02576587|455672920|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
126648815|NCT02576587|455672919|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
126648816|NCT02576587|455672920|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
126648817|NCT00532493|455672921|FG000|Overall Study|Death|1|||
126317915|NCT01876979|454454115|FG000|Overall Study|Physician Decision|2|||
126317916|NCT01876979|454454116|FG001|Overall Study|Physician Decision|3|||
126317917|NCT00948506|454454117|FG000|Overall Study|Withdrawal by Subject|3|||
126317918|NCT00948506|454454118|FG001|Overall Study|Withdrawal by Subject|1|||
126317919|NCT03233204|454454121|FG000|Overall Study|Adverse Event|1|||
126317920|NCT03233204|454454121|FG000|Overall Study|Death|1|||
126317921|NCT03233204|454454121|FG000|Overall Study|Withdrawal by Subject|1|||
126317922|NCT03233204|454454121|FG000|Overall Study|Progressive Disease|3|||
126317923|NCT00721279|454454122|FG000|Overall Study|Lack of Efficacy|6|||
126317924|NCT00721279|454454123|FG001|Overall Study|Lack of Efficacy|3|||
126317925|NCT00721279|454454122|FG000|Overall Study|Tolerability insufficient|5|||
126317926|NCT00721279|454454123|FG001|Overall Study|Tolerability insufficient|2|||
126317927|NCT00721279|454454122|FG000|Overall Study|Withdrawal by Subject|13|||
126317928|NCT00721279|454454123|FG001|Overall Study|Withdrawal by Subject|3|||
126317929|NCT00721279|454454122|FG000|Overall Study|Other|12|||
126317930|NCT00721279|454454123|FG001|Overall Study|Other|16|||
126317931|NCT02680834|454454124|FG000|Overall Study|Physician Decision|5|||
126317932|NCT02680834|454454125|FG001|Overall Study|Physician Decision|2|||
126317933|NCT02680834|454454124|FG000|Overall Study|Withdrawal by Subject|6|||
126317934|NCT02680834|454454125|FG001|Overall Study|Withdrawal by Subject|0|||
126317935|NCT02680834|454454124|FG000|Overall Study|Lost to Follow-up|0|||
126317936|NCT02680834|454454125|FG001|Overall Study|Lost to Follow-up|1|||
126317937|NCT03467763|454454126|FG000|Overall Study|Lost to Follow-up|1|||
126317938|NCT03467763|454454126|FG000|Overall Study|Protocol Violation|2|||
126317939|NCT04918355|454454127|FG000|Overall Study|no qualifying health encounter|497|||
126317940|NCT04918355|454454128|FG001|Overall Study|no qualifying health encounter|192|||
126317941|NCT04918355|454454129|FG002|Overall Study|no qualifying health encounter|438|||
126317942|NCT04918355|454454130|FG003|Overall Study|no qualifying health encounter|424|||
126317943|NCT00224406|454455875|FG000|Overall Study|Re-transplant|0|||
126317944|NCT00224406|454455876|FG001|Overall Study|Re-transplant|2|||
126317945|NCT00224406|454455875|FG000|Overall Study|Death|0|||
126317946|NCT00224406|454455876|FG001|Overall Study|Death|1|||
126317947|NCT00224406|454455875|FG000|Overall Study|Transplant cancelled|0|||
126317948|NCT00224406|454455876|FG001|Overall Study|Transplant cancelled|4|||
126317949|NCT00224406|454455875|FG000|Overall Study|Drug not delivered|2|||
126317950|NCT00224406|454455876|FG001|Overall Study|Drug not delivered|0|||
126317951|NCT00224406|454455875|FG000|Overall Study|Other|4|||
126317952|NCT00224406|454455876|FG001|Overall Study|Other|0|||
126317953|NCT00224406|454455875|FG000|Overall Study|Transplant cancelled|3|||
126317954|NCT00224406|454455876|FG001|Overall Study|Transplant cancelled|0|||
126317955|NCT01556997|454455877|FG000|Overall Study|Adverse Event|10|||
126317956|NCT01556997|454455878|FG001|Overall Study|Adverse Event|12|||
126317957|NCT01556997|454455879|FG002|Overall Study|Adverse Event|12|||
126317958|NCT01556997|454455877|FG000|Overall Study|Lost to Follow-up|6|||
126317959|NCT01556997|454455878|FG001|Overall Study|Lost to Follow-up|6|||
126317960|NCT01556997|454455879|FG002|Overall Study|Lost to Follow-up|4|||
126317961|NCT01556997|454455877|FG000|Overall Study|Physician Decision|1|||
126317962|NCT01556997|454455878|FG001|Overall Study|Physician Decision|1|||
126317963|NCT01556997|454455879|FG002|Overall Study|Physician Decision|1|||
126317964|NCT01556997|454455877|FG000|Overall Study|Withdrawal by Subject|7|||
126317965|NCT01556997|454455878|FG001|Overall Study|Withdrawal by Subject|6|||
126317966|NCT01556997|454455879|FG002|Overall Study|Withdrawal by Subject|8|||
126317967|NCT01556997|454455877|FG000|Overall Study|Other|2|||
126317968|NCT01556997|454455878|FG001|Overall Study|Other|3|||
126648818|NCT00532493|455672922|FG001|Overall Study|Death|1|||
126648819|NCT00532493|455672921|FG000|Overall Study|Lost to Follow-up|10|||
126317969|NCT01556997|454455879|FG002|Overall Study|Other|7|||
126317970|NCT03605849|454455882|FG000|Overall Study|Adverse Event|20|||
126317971|NCT03605849|454455883|FG001|Overall Study|Adverse Event|21|||
126317972|NCT03605849|454455884|FG002|Overall Study|Adverse Event|29|||
126317973|NCT03605849|454455885|FG003|Overall Study|Adverse Event|11|||
126317974|NCT03605849|454455882|FG000|Overall Study|Lack of Efficacy|4|||
126317975|NCT03605849|454455883|FG001|Overall Study|Lack of Efficacy|7|||
126317976|NCT03605849|454455884|FG002|Overall Study|Lack of Efficacy|9|||
126317977|NCT03605849|454455885|FG003|Overall Study|Lack of Efficacy|2|||
126317978|NCT03605849|454455882|FG000|Overall Study|Lost to Follow-up|8|||
126648820|NCT00532493|455672922|FG001|Overall Study|Lost to Follow-up|7|||
126317979|NCT03605849|454455883|FG001|Overall Study|Lost to Follow-up|8|||
126317980|NCT03605849|454455884|FG002|Overall Study|Lost to Follow-up|14|||
126317981|NCT03605849|454455885|FG003|Overall Study|Lost to Follow-up|11|||
126648821|NCT00532493|455672921|FG000|Overall Study|Withdrawal by Subject|7|||
126648822|NCT00532493|455672922|FG001|Overall Study|Withdrawal by Subject|9|||
126648823|NCT00532493|455672921|FG000|Overall Study|Physician Decision|1|||
126648824|NCT00532493|455672922|FG001|Overall Study|Physician Decision|6|||
126648825|NCT00532493|455672921|FG000|Overall Study|Adverse Event|6|||
126648826|NCT00532493|455672922|FG001|Overall Study|Adverse Event|5|||
126648827|NCT00532493|455672921|FG000|Overall Study|Protocol Deviation|1|||
126648828|NCT00532493|455672922|FG001|Overall Study|Protocol Deviation|0|||
126648829|NCT00532493|455672921|FG000|Overall Study|Subject Moved Away|3|||
126648830|NCT00532493|455672922|FG001|Overall Study|Subject Moved Away|1|||
126317982|NCT03605849|454455882|FG000|Overall Study|Non-compliance With IMP|6|||
126317983|NCT03605849|454455883|FG001|Overall Study|Non-compliance With IMP|5|||
126317984|NCT03605849|454455884|FG002|Overall Study|Non-compliance With IMP|2|||
126317985|NCT03605849|454455885|FG003|Overall Study|Non-compliance With IMP|1|||
126317986|NCT03605849|454455882|FG000|Overall Study|Protocol Deviation|1|||
126317987|NCT03605849|454455883|FG001|Overall Study|Protocol Deviation|2|||
126317988|NCT03605849|454455884|FG002|Overall Study|Protocol Deviation|1|||
126317989|NCT03605849|454455885|FG003|Overall Study|Protocol Deviation|3|||
126317990|NCT03605849|454455882|FG000|Overall Study|Withdrawal by Subject|33|||
126317991|NCT03605849|454455883|FG001|Overall Study|Withdrawal by Subject|28|||
126317992|NCT03605849|454455884|FG002|Overall Study|Withdrawal by Subject|30|||
126317993|NCT03605849|454455885|FG003|Overall Study|Withdrawal by Subject|28|||
126317994|NCT03605849|454455882|FG000|Overall Study|Site Terminated by Sponsor|0|||
126317995|NCT03605849|454455883|FG001|Overall Study|Site Terminated by Sponsor|0|||
126317996|NCT03605849|454455884|FG002|Overall Study|Site Terminated by Sponsor|0|||
126317997|NCT03605849|454455885|FG003|Overall Study|Site Terminated by Sponsor|1|||
126317998|NCT03605849|454455882|FG000|Overall Study|Physician Decision|2|||
126317999|NCT03605849|454455883|FG001|Overall Study|Physician Decision|1|||
126318000|NCT03605849|454455884|FG002|Overall Study|Physician Decision|2|||
126648831|NCT00532493|455672921|FG000|Overall Study|Contraindicative Medication|1|||
126648832|NCT00532493|455672922|FG001|Overall Study|Contraindicative Medication|0|||
126648833|NCT00738894|455672925|FG000|Overall Study|Lost to Follow-up|23|||
126648834|NCT00738894|455672926|FG001|Overall Study|Lost to Follow-up|13|||
126648835|NCT00738894|455672925|FG000|Overall Study|Withdrawal by Subject|10|||
126648836|NCT00738894|455672926|FG001|Overall Study|Withdrawal by Subject|15|||
126648837|NCT00738894|455672925|FG000|Overall Study|Physician Decision|4|||
126648838|NCT00738894|455672926|FG001|Overall Study|Physician Decision|5|||
126648839|NCT00738894|455672925|FG000|Overall Study|Death|2|||
126648840|NCT00738894|455672926|FG001|Overall Study|Death|0|||
126648841|NCT02546921|455672933|FG000|Overall Study|Adverse Event|0|||
126318001|NCT03605849|454455885|FG003|Overall Study|Physician Decision|1|||
126318002|NCT03605849|454455882|FG000|Overall Study|Enrolled, but not Treated|2|||
126318003|NCT03605849|454455883|FG001|Overall Study|Enrolled, but not Treated|2|||
126318004|NCT03605849|454455884|FG002|Overall Study|Enrolled, but not Treated|3|||
126318005|NCT03605849|454455885|FG003|Overall Study|Enrolled, but not Treated|2|||
126318006|NCT03605849|454455882|FG000|Overall Study|Other (COVID-19 Related)|0|||
126318007|NCT03605849|454455883|FG001|Overall Study|Other (COVID-19 Related)|1|||
126318008|NCT03605849|454455884|FG002|Overall Study|Other (COVID-19 Related)|1|||
126318009|NCT03605849|454455885|FG003|Overall Study|Other (COVID-19 Related)|0|||
126318010|NCT03605849|454455882|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
126318011|NCT03605849|454455883|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
126318012|NCT03605849|454455884|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
126318013|NCT03605849|454455885|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
126318014|NCT01149421|454455887|FG000|Overall Study|Adverse Event|22|||
126318015|NCT01149421|454455888|FG001|Overall Study|Adverse Event|6|||
126318016|NCT01149421|454455889|FG002|Overall Study|Adverse Event|11|||
126318017|NCT01149421|454455887|FG000|Overall Study|Withdrawal by Subject|20|||
126318018|NCT01149421|454455888|FG001|Overall Study|Withdrawal by Subject|12|||
126318019|NCT01149421|454455889|FG002|Overall Study|Withdrawal by Subject|13|||
126318020|NCT01149421|454455887|FG000|Overall Study|Sponsor Decision|0|||
126318021|NCT01149421|454455888|FG001|Overall Study|Sponsor Decision|1|||
126318022|NCT01149421|454455889|FG002|Overall Study|Sponsor Decision|1|||
126318023|NCT01149421|454455887|FG000|Overall Study|Lost to Follow-up|2|||
126318024|NCT01149421|454455888|FG001|Overall Study|Lost to Follow-up|4|||
126318025|NCT01149421|454455889|FG002|Overall Study|Lost to Follow-up|5|||
126318026|NCT01149421|454455887|FG000|Overall Study|Physician Decision|5|||
126318027|NCT01149421|454455888|FG001|Overall Study|Physician Decision|3|||
126318028|NCT01149421|454455889|FG002|Overall Study|Physician Decision|6|||
126318029|NCT01149421|454455887|FG000|Overall Study|Entry Criteria Not Met|1|||
126318030|NCT01149421|454455888|FG001|Overall Study|Entry Criteria Not Met|1|||
126318031|NCT01149421|454455889|FG002|Overall Study|Entry Criteria Not Met|2|||
126318032|NCT01149421|454455887|FG000|Overall Study|Protocol Violation|2|||
126318033|NCT01149421|454455888|FG001|Overall Study|Protocol Violation|2|||
126318034|NCT01149421|454455889|FG002|Overall Study|Protocol Violation|6|||
126318035|NCT00616603|454455890|FG000|Overall Study|Physician Decision|2|||
126318036|NCT00616603|454455891|FG001|Overall Study|Physician Decision|0|||
126648842|NCT02546921|455672934|FG001|Overall Study|Adverse Event|5|||
126648843|NCT02546921|455672935|FG002|Overall Study|Adverse Event|2|||
126648844|NCT02546921|455672936|FG003|Overall Study|Adverse Event|0|||
126648845|NCT02546921|455672937|FG004|Overall Study|Adverse Event|0|||
126648846|NCT02546921|455672938|FG005|Overall Study|Adverse Event|0|||
126648847|NCT02546921|455672939|FG006|Overall Study|Adverse Event|0|||
126648848|NCT02546921|455672933|FG000|Overall Study|Evidence of Disease Progression|1|||
126318037|NCT00616603|454455892|FG002|Overall Study|Physician Decision|2|||
126318038|NCT03738800|454455895|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
126318039|NCT03738800|454455896|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
126648849|NCT02546921|455672934|FG001|Overall Study|Evidence of Disease Progression|0|||
126648850|NCT02546921|455672935|FG002|Overall Study|Evidence of Disease Progression|0|||
126648851|NCT02546921|455672936|FG003|Overall Study|Evidence of Disease Progression|0|||
126648852|NCT02546921|455672937|FG004|Overall Study|Evidence of Disease Progression|1|||
126648853|NCT02546921|455672938|FG005|Overall Study|Evidence of Disease Progression|0|||
126648854|NCT02546921|455672939|FG006|Overall Study|Evidence of Disease Progression|0|||
126648855|NCT02546921|455672933|FG000|Overall Study|Patient Choice|0|||
126648856|NCT02546921|455672934|FG001|Overall Study|Patient Choice|1|||
126648857|NCT02546921|455672935|FG002|Overall Study|Patient Choice|0|||
126648858|NCT02546921|455672936|FG003|Overall Study|Patient Choice|0|||
126648859|NCT02546921|455672937|FG004|Overall Study|Patient Choice|0|||
126648860|NCT02546921|455672938|FG005|Overall Study|Patient Choice|1|||
126648861|NCT02546921|455672939|FG006|Overall Study|Patient Choice|0|||
126648862|NCT00680992|455672943|FG000|Overall Study|Complete Resection (as per protocol)|25|||
126648863|NCT00680992|455672944|FG001|Overall Study|Complete Resection (as per protocol)|121|||
126648864|NCT00680992|455672945|FG002|Overall Study|Complete Resection (as per protocol)|0|||
126648865|NCT00680992|455672943|FG000|Overall Study|Administrative Decision|83|||
126648866|NCT00680992|455672944|FG001|Overall Study|Administrative Decision|42|||
126648867|NCT00680992|455672945|FG002|Overall Study|Administrative Decision|5|||
126648868|NCT00680992|455672943|FG000|Overall Study|End of Trial|32|||
126648869|NCT00680992|455672944|FG001|Overall Study|End of Trial|12|||
126648870|NCT00680992|455672945|FG002|Overall Study|End of Trial|3|||
126648871|NCT00680992|455672943|FG000|Overall Study|Withdrawal by Subject|33|||
126648872|NCT00680992|455672944|FG001|Overall Study|Withdrawal by Subject|11|||
126648873|NCT00680992|455672945|FG002|Overall Study|Withdrawal by Subject|1|||
126648874|NCT00680992|455672943|FG000|Overall Study|Adverse Event|21|||
126648875|NCT00680992|455672944|FG001|Overall Study|Adverse Event|19|||
126648876|NCT00680992|455672945|FG002|Overall Study|Adverse Event|1|||
126648877|NCT00680992|455672943|FG000|Overall Study|Other|19|||
126648878|NCT00680992|455672944|FG001|Overall Study|Other|14|||
126648879|NCT00680992|455672945|FG002|Overall Study|Other|1|||
126648880|NCT00680992|455672943|FG000|Overall Study|Disease Progression|21|||
126648881|NCT00680992|455672944|FG001|Overall Study|Disease Progression|9|||
126648882|NCT00680992|455672945|FG002|Overall Study|Disease Progression|0|||
126648883|NCT00680992|455672943|FG000|Overall Study|Lost to Follow-up|12|||
126648884|NCT00680992|455672944|FG001|Overall Study|Lost to Follow-up|14|||
126648885|NCT00680992|455672945|FG002|Overall Study|Lost to Follow-up|0|||
126648886|NCT00680992|455672943|FG000|Overall Study|Noncompliance|4|||
126648887|NCT00680992|455672944|FG001|Overall Study|Noncompliance|6|||
126648888|NCT00680992|455672945|FG002|Overall Study|Noncompliance|0|||
126648889|NCT00680992|455672943|FG000|Overall Study|Requirement for Alternative Therapy|8|||
126648890|NCT00680992|455672944|FG001|Overall Study|Requirement for Alternative Therapy|2|||
126648891|NCT00680992|455672945|FG002|Overall Study|Requirement for Alternative Therapy|0|||
126648892|NCT00680992|455672943|FG000|Overall Study|Pregnancy|5|||
126648893|NCT00680992|455672944|FG001|Overall Study|Pregnancy|0|||
126648894|NCT00680992|455672945|FG002|Overall Study|Pregnancy|1|||
126648895|NCT00680992|455672943|FG000|Overall Study|Death|5|||
126648896|NCT00680992|455672944|FG001|Overall Study|Death|1|||
126648897|NCT00680992|455672945|FG002|Overall Study|Death|0|||
126648898|NCT00680992|455672943|FG000|Overall Study|Ineligibility Determined|0|||
126648899|NCT00680992|455672944|FG001|Overall Study|Ineligibility Determined|1|||
126648900|NCT00680992|455672945|FG002|Overall Study|Ineligibility Determined|0|||
126648901|NCT01585155|455672946|FG000|Overall Study|Adverse Event|1|||
126648902|NCT01585155|455672946|FG000|Overall Study|Lack of Efficacy|2|||
126648903|NCT01585155|455672946|FG000|Overall Study|Worsening ulcerative colitis|2|||
126648904|NCT01397422|455672951|FG000|Overall Study|Adverse Event|0|||
126648905|NCT01397422|455672952|FG001|Overall Study|Adverse Event|3|||
126648906|NCT01397422|455672953|FG002|Overall Study|Adverse Event|3|||
126648907|NCT01397422|455672954|FG003|Overall Study|Adverse Event|8|||
126648908|NCT01397422|455672951|FG000|Overall Study|Withdrawal by Subject|1|||
126648909|NCT01397422|455672952|FG001|Overall Study|Withdrawal by Subject|0|||
126648910|NCT01397422|455672953|FG002|Overall Study|Withdrawal by Subject|0|||
126648911|NCT01397422|455672954|FG003|Overall Study|Withdrawal by Subject|0|||
126648912|NCT01397422|455672951|FG000|Overall Study|Increased bradykinesia related to PD|1|||
126648913|NCT01397422|455672952|FG001|Overall Study|Increased bradykinesia related to PD|0|||
126648914|NCT01397422|455672953|FG002|Overall Study|Increased bradykinesia related to PD|0|||
126648915|NCT01397422|455672954|FG003|Overall Study|Increased bradykinesia related to PD|0|||
126648916|NCT03772587|455672955|FG000|Overall Study|COVID-19|0|||
126648917|NCT03772587|455672956|FG001|Overall Study|COVID-19|0|||
126648918|NCT03772587|455672957|FG002|Overall Study|COVID-19|1|||
126648919|NCT03772587|455672958|FG003|Overall Study|COVID-19|1|||
126648920|NCT03772587|455672959|FG004|Overall Study|COVID-19|0|||
126648921|NCT03772587|455672955|FG000|Overall Study|Withdrawal by Subject|1|||
126648922|NCT03772587|455672956|FG001|Overall Study|Withdrawal by Subject|0|||
126648923|NCT03772587|455672957|FG002|Overall Study|Withdrawal by Subject|0|||
126648924|NCT03772587|455672958|FG003|Overall Study|Withdrawal by Subject|0|||
126648925|NCT03772587|455672959|FG004|Overall Study|Withdrawal by Subject|0|||
126648926|NCT00513305|455672960|FG000|Overall Study|Adverse Event|6|||
126648927|NCT00513305|455672961|FG001|Overall Study|Adverse Event|2|||
126648928|NCT00513305|455672960|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
126648929|NCT00513305|455672961|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
126648930|NCT00513305|455672960|FG000|Overall Study|Lack of Efficacy|8|||
126648931|NCT00513305|455672961|FG001|Overall Study|Lack of Efficacy|13|||
126648932|NCT00513305|455672960|FG000|Overall Study|Withdrawal by Subject|1|||
126648933|NCT00513305|455672961|FG001|Overall Study|Withdrawal by Subject|2|||
126648934|NCT00513305|455672960|FG000|Overall Study|Disease progression|8|||
126648935|NCT00513305|455672961|FG001|Overall Study|Disease progression|5|||
126648936|NCT00513305|455672960|FG000|Overall Study|Eligible for stem cell transplant|1|||
126648937|NCT00513305|455672961|FG001|Overall Study|Eligible for stem cell transplant|0|||
126648938|NCT00513305|455672960|FG000|Overall Study|Hematologic counts did not recover|1|||
126648939|NCT00513305|455672961|FG001|Overall Study|Hematologic counts did not recover|0|||
126648940|NCT00513305|455672960|FG000|Overall Study|Physician Decision|1|||
126648941|NCT00513305|455672961|FG001|Overall Study|Physician Decision|0|||
126648942|NCT00513305|455672960|FG000|Overall Study|Persistent hypocellularity|0|||
126648943|NCT00513305|455672961|FG001|Overall Study|Persistent hypocellularity|1|||
126648944|NCT00513305|455672960|FG000|Overall Study|Sponsor Decision|0|||
126648945|NCT00513305|455672961|FG001|Overall Study|Sponsor Decision|2|||
126648946|NCT03798691|455672962|FG000|Overall Study|Lost to Follow-up|2|||
126648947|NCT03798691|455672963|FG001|Overall Study|Lost to Follow-up|2|||
126648948|NCT05148962|455672964|FG000|Overall Study|Withdrawal by Subject|1|||
126648949|NCT05148962|455672965|FG001|Overall Study|Withdrawal by Subject|1|||
126648950|NCT05148962|455672966|FG002|Overall Study|Withdrawal by Subject|0|||
126648951|NCT05148962|455672967|FG003|Overall Study|Withdrawal by Subject|1|||
126648952|NCT05148962|455672968|FG004|Overall Study|Withdrawal by Subject|0|||
126648953|NCT05148962|455672964|FG000|Overall Study|Participant was early terminated per protocol|0|||
126648954|NCT05148962|455672965|FG001|Overall Study|Participant was early terminated per protocol|0|||
126648955|NCT05148962|455672966|FG002|Overall Study|Participant was early terminated per protocol|3|||
126648956|NCT05148962|455672967|FG003|Overall Study|Participant was early terminated per protocol|5|||
126648957|NCT05148962|455672968|FG004|Overall Study|Participant was early terminated per protocol|2|||
126648958|NCT05148962|455672964|FG000|Overall Study|Miscellaneous|0|||
126648959|NCT05148962|455672965|FG001|Overall Study|Miscellaneous|0|||
126648960|NCT05148962|455672966|FG002|Overall Study|Miscellaneous|0|||
126648961|NCT05148962|455672967|FG003|Overall Study|Miscellaneous|1|||
126648962|NCT05148962|455672968|FG004|Overall Study|Miscellaneous|0|||
126648963|NCT01525238|455672971|FG000|Overall Study|Withdrawal by Subject|1|||
126648964|NCT01525238|455672972|FG001|Overall Study|Withdrawal by Subject|0|||
126648965|NCT01525238|455672973|FG002|Overall Study|Withdrawal by Subject|0|||
126648966|NCT00151281|455672974|FG000|Overall Study|Not evaluable|3|||
126648967|NCT01133418|455672975|FG000|Overall Study|Lost to Follow-up|5|||
126648968|NCT01133418|455672976|FG001|Overall Study|Lost to Follow-up|6|||
126648969|NCT01077271|455674934|FG000|Overall Study|Parental desire|8|||
126648970|NCT01077271|455674934|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
126770397|NCT02575807|456112469|FG000|Overall Study|Terminated due to physician decision|0|||
126648971|NCT01077271|455674934|FG000|Overall Study|Noncompliance|2|||
126648972|NCT01077271|455674934|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
126648973|NCT01077271|455674934|FG000|Overall Study|Changed doctors|2|||
126648974|NCT01077271|455674934|FG000|Overall Study|Parents thought too many injections|2|||
126648975|NCT01077271|455674934|FG000|Overall Study|End of RSV season nearly reached|1|||
126648976|NCT01077271|455674934|FG000|Overall Study|Mother unconvinced of the necessity|1|||
126648977|NCT03333876|455674935|FG000|Screening Period|Screen Failure|4|||
126648978|NCT03333876|455674935|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
126648979|NCT03333876|455674935|FG000|Mandibular Advancement|Adverse Event|2|||
126648980|NCT03333876|455674935|FG000|Mandibular Advancement|Product Damage|2|||
126648981|NCT00095498|455674936|FG000|Overall Study|Physician Decision|9|||
126648982|NCT00095498|455674937|FG001|Overall Study|Physician Decision|10|||
126648983|NCT00095498|455674938|FG002|Overall Study|Physician Decision|8|||
126318040|NCT03738800|454455897|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126318041|NCT03738800|454455895|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
126648984|NCT00095498|455674936|FG000|Overall Study|Adverse Event|1|||
126648985|NCT00095498|455674937|FG001|Overall Study|Adverse Event|0|||
126648986|NCT00095498|455674938|FG002|Overall Study|Adverse Event|1|||
126648987|NCT00095498|455674936|FG000|Overall Study|Withdrawal by Subject|15|||
126318042|NCT03738800|454455896|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
126318043|NCT03738800|454455897|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
126318044|NCT03738800|454455895|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
126318045|NCT03738800|454455896|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
126318046|NCT03738800|454455897|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
126318047|NCT00766467|454455907|FG000|Overall Study|Withdrawal by Subject|7|||
126318048|NCT00766467|454455908|FG001|Overall Study|Withdrawal by Subject|2|||
126318049|NCT00766467|454455907|FG000|Overall Study|Adverse Event|1|||
126648988|NCT00095498|455674937|FG001|Overall Study|Withdrawal by Subject|16|||
126648989|NCT00095498|455674938|FG002|Overall Study|Withdrawal by Subject|15|||
126648990|NCT00095498|455674936|FG000|Overall Study|Disease progression|0|||
126318050|NCT00766467|454455908|FG001|Overall Study|Adverse Event|1|||
126648991|NCT00095498|455674937|FG001|Overall Study|Disease progression|1|||
126648992|NCT00095498|455674938|FG002|Overall Study|Disease progression|1|||
126648993|NCT00095498|455674936|FG000|Overall Study|Ineligibility determined|3|||
126648994|NCT00095498|455674937|FG001|Overall Study|Ineligibility determined|0|||
126648995|NCT00095498|455674938|FG002|Overall Study|Ineligibility determined|2|||
126648996|NCT00095498|455674936|FG000|Overall Study|Lost to Follow-up|1|||
126648997|NCT00095498|455674937|FG001|Overall Study|Lost to Follow-up|1|||
126648998|NCT00095498|455674938|FG002|Overall Study|Lost to Follow-up|2|||
126648999|NCT00095498|455674936|FG000|Overall Study|Noncompliance|1|||
126649000|NCT00095498|455674937|FG001|Overall Study|Noncompliance|0|||
126649001|NCT00095498|455674938|FG002|Overall Study|Noncompliance|1|||
126649002|NCT00095498|455674936|FG000|Overall Study|Other|6|||
126649003|NCT00095498|455674937|FG001|Overall Study|Other|7|||
126649004|NCT00095498|455674938|FG002|Overall Study|Other|6|||
126649005|NCT00095498|455674936|FG000|Overall Study|Protocol Violation|0|||
126649006|NCT00095498|455674937|FG001|Overall Study|Protocol Violation|0|||
126649007|NCT00095498|455674938|FG002|Overall Study|Protocol Violation|1|||
126649008|NCT00095498|455674936|FG000|Overall Study|Requirement for alternative therapy|1|||
126649009|NCT00095498|455674937|FG001|Overall Study|Requirement for alternative therapy|0|||
126649010|NCT00095498|455674938|FG002|Overall Study|Requirement for alternative therapy|2|||
126649011|NCT05020327|455674939|FG000|Overall Study|Physician Decision|3|||
126649012|NCT05020327|455674940|FG001|Overall Study|Physician Decision|0|||
126649013|NCT05020327|455674941|FG002|Overall Study|Physician Decision|0|||
126649014|NCT05020327|455674939|FG000|Overall Study|Withdrawal by Subject|1|||
126649015|NCT05020327|455674940|FG001|Overall Study|Withdrawal by Subject|1|||
126649016|NCT05020327|455674941|FG002|Overall Study|Withdrawal by Subject|0|||
126649017|NCT05020327|455674939|FG000|Overall Study|personal/cultural, ineligible|12|||
126649018|NCT05020327|455674940|FG001|Overall Study|personal/cultural, ineligible|0|||
126649019|NCT05020327|455674941|FG002|Overall Study|personal/cultural, ineligible|0|||
126649020|NCT04684394|455674942|FG000|Overall Study|Death|1|||
126649021|NCT04684394|455674943|FG001|Overall Study|Death|2|||
126649022|NCT04684394|455674942|FG000|Overall Study|Lost to Follow-up|1|||
126649023|NCT04684394|455674943|FG001|Overall Study|Lost to Follow-up|0|||
126318051|NCT00766467|454455907|FG000|Overall Study|Protocol Violation|2|||
126318052|NCT00766467|454455908|FG001|Overall Study|Protocol Violation|4|||
126318053|NCT00766467|454455907|FG000|Overall Study|Tumor Progression on Study|0|||
126318054|NCT00766467|454455908|FG001|Overall Study|Tumor Progression on Study|1|||
126318055|NCT00766467|454455907|FG000|Overall Study|Physician Decision|1|||
126318056|NCT00766467|454455908|FG001|Overall Study|Physician Decision|0|||
126318057|NCT02223819|454455914|FG000|Overall Study|Lost to Follow-up|2|||
126318058|NCT01420679|454455921|FG000|Overall Study|Disease Progression|3|||
126318059|NCT01420679|454455922|FG001|Overall Study|Disease Progression|2|||
126318060|NCT01420679|454455921|FG000|Overall Study|Adverse Event|4|||
126318061|NCT01420679|454455922|FG001|Overall Study|Adverse Event|0|||
126318062|NCT01420679|454455921|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
126318063|NCT01420679|454455922|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
126318064|NCT01420679|454455921|FG000|Overall Study|Patient Decision|1|||
126318065|NCT01420679|454455922|FG001|Overall Study|Patient Decision|0|||
126318066|NCT01420679|454455921|FG000|Overall Study|Investigator Decision|1|||
126318067|NCT01420679|454455922|FG001|Overall Study|Investigator Decision|2|||
126318068|NCT01420679|454455921|FG000|Overall Study|Sponsor Decision|3|||
126318069|NCT01420679|454455922|FG001|Overall Study|Sponsor Decision|3|||
126318070|NCT01420679|454455921|FG000|Overall Study|Other|1|||
126318071|NCT01420679|454455922|FG001|Overall Study|Other|0|||
126318072|NCT00367484|454455923|FG000|Overall Study|Adverse Event|7|||
126318073|NCT00367484|454455923|FG000|Overall Study|Withdrew informed consent|5|||
126318074|NCT00367484|454455923|FG000|Overall Study|Travel to USA|1|||
126649024|NCT04684394|455674942|FG000|Overall Study|Withdrawal by Subject|2|||
126649025|NCT04684394|455674943|FG001|Overall Study|Withdrawal by Subject|0|||
126649026|NCT04684394|455674942|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
126649027|NCT04684394|455674943|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
126649028|NCT00591370|455674945|FG000|Overall Study|Not Treated|2|||
126318075|NCT00367484|454455923|FG000|Overall Study|Lost to Follow-up|1|||
126649029|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
126649030|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
126649031|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
126649032|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
126649033|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
126649034|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
126649035|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
126649036|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
126649037|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
126649038|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
126715078|NCT02116972|455908672|FG001|Overall Study|scheduling conflicts and relocation|3|||
126318076|NCT00367484|454455923|FG000|Overall Study|Protocol Violation|1|||
126649039|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
126649040|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
126649041|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Death|1|||
126649042|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Death|2|||
126649043|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Death|2|||
126649044|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Death|0|||
126649045|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Death|0|||
126649046|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Death|0|||
126649047|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
126649048|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
126649049|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
126318077|NCT00367484|454455923|FG000|Overall Study|The choice of the patient|1|||
126318078|NCT00367484|454455923|FG000|Overall Study|Lack of Efficacy|1|||
126649050|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
126649051|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
126649052|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
126649053|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
126649054|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
126649055|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
126649056|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
126649057|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
126649058|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
126649059|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
126649060|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
126649061|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
126649062|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
126649063|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
126649064|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
126649065|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
126649066|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
126649067|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
126649068|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
126649069|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
126649070|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
126649071|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
126649072|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
126649073|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
126649074|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
126649075|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
126649076|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
126649077|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
126649078|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
126649079|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
126649080|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
126649081|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
126649082|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
126649083|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
126649084|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
126649085|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
126649086|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
126649087|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
126649088|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
126649089|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Site closure|0|||
126649090|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Site closure|0|||
126649091|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Site closure|1|||
126649092|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Site closure|0|||
126318079|NCT00943670|454455924|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
126318080|NCT00943670|454455924|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
126318081|NCT00943670|454455924|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
126318082|NCT00943670|454455924|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
126318083|NCT00943670|454455924|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
126318084|NCT00943670|454455924|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
126318085|NCT00943670|454455924|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
126318086|NCT00943670|454455924|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
126318087|NCT00943670|454455924|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
126318088|NCT00943670|454455924|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
126318089|NCT03956615|454455925|FG000|Overall Study|No multiple myeloma confirmed|2|||
126318090|NCT03956615|454455925|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
126318091|NCT03956615|454455925|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
126318092|NCT03956615|454455925|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
126318093|NCT04472026|454455926|FG000|Overall Study|Lost to Follow-up|5|||
126649093|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Site closure|0|||
126649094|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Site closure|0|||
126649095|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
126649096|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
126649097|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
126649098|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
126649099|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
126649100|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
126649101|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
126649102|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
126649103|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
126649104|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
126649105|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
126649106|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
126649107|NCT03439254|455674946|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
126649108|NCT03439254|455674947|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
126649109|NCT03439254|455674948|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
126649110|NCT03439254|455674949|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
126649111|NCT03439254|455674950|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
126649112|NCT03439254|455674951|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
126649113|NCT03439254|455674946|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
126649114|NCT03439254|455674947|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
126649115|NCT03439254|455674948|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
126649116|NCT03439254|455674949|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
126649117|NCT03439254|455674950|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
126649118|NCT03439254|455674951|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
126649119|NCT03439254|455674946|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
126649120|NCT03439254|455674947|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
126649121|NCT03439254|455674948|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
126649122|NCT03439254|455674949|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
126649123|NCT03439254|455674950|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
126649124|NCT03439254|455674951|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
126649125|NCT03439254|455674946|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
126649126|NCT03439254|455674947|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
126649127|NCT03439254|455674948|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
126649128|NCT03439254|455674949|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
126649129|NCT03439254|455674950|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
126649130|NCT03439254|455674951|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
126649131|NCT03439254|455674946|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
126649132|NCT03439254|455674947|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
126649133|NCT03439254|455674948|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
126649134|NCT03439254|455674949|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
126649135|NCT03439254|455674950|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
126649136|NCT03439254|455674951|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
126649137|NCT03439254|455674946|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
126649138|NCT03439254|455674947|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
126649139|NCT03439254|455674948|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
126649140|NCT03439254|455674949|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
126649141|NCT03439254|455674950|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
126649142|NCT03439254|455674951|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
126649143|NCT03439254|455674946|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
126649144|NCT03439254|455674947|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
126649145|NCT03439254|455674948|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
126649146|NCT03439254|455674949|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
126649147|NCT03439254|455674950|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
126649148|NCT03439254|455674951|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
126649149|NCT03439254|455674946|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
126649150|NCT03439254|455674947|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
126649151|NCT03439254|455674948|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
126649152|NCT03439254|455674949|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
126649153|NCT03439254|455674950|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
126649154|NCT03439254|455674951|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
126649155|NCT03439254|455674946|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
126649156|NCT03439254|455674947|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
126649157|NCT03439254|455674948|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
126649158|NCT03439254|455674949|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
126649159|NCT03439254|455674950|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
126649160|NCT03439254|455674951|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
126649161|NCT03439254|455674946|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
126649162|NCT03439254|455674947|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
126649163|NCT03439254|455674948|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
126649164|NCT03439254|455674949|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
126649165|NCT03439254|455674950|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
126649166|NCT03439254|455674951|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
126649167|NCT02075476|455674953|FG000|Overall Study|Death|2|||
126649168|NCT02075476|455674954|FG001|Overall Study|Death|2|||
126649169|NCT02075476|455674953|FG000|Overall Study|Lost to Follow-up|1|||
126649170|NCT02075476|455674954|FG001|Overall Study|Lost to Follow-up|3|||
126649171|NCT00095056|455674955|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
126649172|NCT00095056|455674956|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
126649173|NCT00095056|455674955|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
126649174|NCT00095056|455674956|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
126649175|NCT00095056|455674955|FG000|Phase A (Weeks 0-12)|Death|1|||
126649176|NCT00095056|455674956|FG001|Phase A (Weeks 0-12)|Death|0|||
126649177|NCT00095056|455674955|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
126649178|NCT00095056|455674956|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
126649179|NCT00095056|455674955|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
126649180|NCT00095056|455674956|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
126649181|NCT00095056|455674955|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
126649182|NCT00095056|455674956|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
126649183|NCT00095056|455674955|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
126649184|NCT00095056|455674956|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
126758608|NCT02681094|456066667|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
126758609|NCT02681094|456066665|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
126758610|NCT02681094|456066666|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
126758611|NCT02681094|456066667|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
126758612|NCT02681094|456066665|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
126758613|NCT02681094|456066666|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
126758614|NCT02681094|456066667|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
126758615|NCT02681094|456066665|FG000|1 -Modified Enrolled Participants Set|Other|6|||
126758616|NCT02681094|456066666|FG001|1 -Modified Enrolled Participants Set|Other|6|||
126758617|NCT02681094|456066667|FG002|1 -Modified Enrolled Participants Set|Other|7|||
126758618|NCT02681094|456066665|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
126318094|NCT01069419|454455927|FG000|Overall Study|Adverse Event|233|||
126318095|NCT01069419|454455927|FG000|Overall Study|Lack of Efficacy|332|||
126758619|NCT02681094|456066666|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
126758620|NCT02681094|456066667|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
126758621|NCT02681094|456066665|FG000|2 - Enrolled Participants Set|Participant decision|7|||
126758622|NCT02681094|456066666|FG001|2 - Enrolled Participants Set|Participant decision|10|||
126649185|NCT00095056|455674955|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
126649186|NCT00095056|455674956|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
126649187|NCT00095056|455674955|FG000|Phase B (Weeks 12-54)|Death|3|||
126649188|NCT00095056|455674956|FG001|Phase B (Weeks 12-54)|Death|1|||
126649189|NCT00095056|455674955|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
126649190|NCT00095056|455674956|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
126649191|NCT00095056|455674955|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
126649192|NCT00095056|455674956|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
126649193|NCT00923260|455674962|FG000|Overall Study|Lost to Follow-up|1|||
126649194|NCT00923260|455674963|FG001|Overall Study|Lost to Follow-up|1|||
126649195|NCT00836745|455674967|FG000|Overall Study|Death|2|||
126649196|NCT00836745|455674967|FG000|Overall Study|Lost to Follow-up|10|||
126649197|NCT00836745|455674967|FG000|Overall Study|Adverse Event|3|||
126649198|NCT00836745|455674967|FG000|Overall Study|Objective progression or relapse|4|||
126649199|NCT00836745|455674967|FG000|Overall Study|Other|2|||
126649200|NCT02121301|455674969|FG000|Overall Study|Protocol Violation|1|||
126318096|NCT01069419|454455927|FG000|Overall Study|Lost to Follow-up|49|||
126649201|NCT02121301|455674970|FG001|Overall Study|Protocol Violation|4|||
126649202|NCT02121301|455674971|FG002|Overall Study|Protocol Violation|1|||
126649203|NCT00943852|455674972|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126649204|NCT00943852|455674973|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126649205|NCT00943852|455674974|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126318097|NCT01069419|454455927|FG000|Overall Study|Remission of disease|11|||
126318098|NCT01069419|454455927|FG000|Overall Study|Withdrawal by Subject|34|||
126318099|NCT01069419|454455927|FG000|Overall Study|Other Reason|43|||
126318100|NCT01069419|454455927|FG000|Overall Study|Missing termination information|13|||
126318101|NCT00908076|454455928|FG000|Overall Study|Lack of Efficacy|1|||
126318102|NCT00908076|454455929|FG001|Overall Study|Lack of Efficacy|1|||
126318103|NCT02382796|454455930|FG000|Overall Study|Global deterioration of health status|1|||
126318104|NCT02382796|454455930|FG000|Overall Study|Objective progression or relapse|3|||
126318105|NCT02382796|454455930|FG000|Overall Study|Commercial dacomitinib became available|3|||
126318106|NCT00334802|454455937|FG000|Overall Study|Progressive Disease|2|||
126318107|NCT00334802|454455938|FG001|Overall Study|Progressive Disease|24|||
126318108|NCT00334802|454455937|FG000|Overall Study|Toxicity|1|||
126318109|NCT00334802|454455938|FG001|Overall Study|Toxicity|5|||
126318110|NCT00334802|454455937|FG000|Overall Study|Lack of Efficacy|1|||
126318111|NCT00334802|454455938|FG001|Overall Study|Lack of Efficacy|3|||
126318112|NCT00334802|454455937|FG000|Overall Study|Patient Condition Aggrevated|1|||
126318113|NCT00334802|454455938|FG001|Overall Study|Patient Condition Aggrevated|0|||
126318114|NCT00334802|454455937|FG000|Overall Study|Physician Decision|1|||
126318115|NCT00334802|454455938|FG001|Overall Study|Physician Decision|0|||
126318116|NCT00334802|454455937|FG000|Overall Study|Withdrawal by Subject|0|||
126318117|NCT00334802|454455938|FG001|Overall Study|Withdrawal by Subject|4|||
126318118|NCT00334802|454455937|FG000|Overall Study|Adverse Event|0|||
126318119|NCT00334802|454455938|FG001|Overall Study|Adverse Event|3|||
126318120|NCT00334802|454455937|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
126318121|NCT00334802|454455938|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
126318122|NCT03515629|454455939|FG000|Overall Study|Death|0|||
126318123|NCT03515629|454455940|FG001|Overall Study|Death|1|||
126318124|NCT03515629|454455941|FG002|Overall Study|Death|1|||
126318125|NCT03515629|454455939|FG000|Overall Study|Progressive disease|0|||
126318126|NCT03515629|454455940|FG001|Overall Study|Progressive disease|1|||
126649206|NCT00943852|455674975|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
126649207|NCT00943852|455674976|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126318127|NCT03515629|454455941|FG002|Overall Study|Progressive disease|0|||
126318128|NCT03887117|454455942|FG000|Overall Study|Discontinued prematurely|0|||
126318129|NCT03887117|454455943|FG001|Overall Study|Discontinued prematurely|1|||
126318130|NCT03887117|454455944|FG002|Overall Study|Discontinued prematurely|1|||
126318131|NCT03887117|454455945|FG003|Overall Study|Discontinued prematurely|2|||
126318132|NCT01739764|454455946|FG000|Overall Study|Adverse Event|0|||
126318133|NCT01739764|454455947|FG001|Overall Study|Adverse Event|3|||
126318134|NCT01739764|454455948|FG002|Overall Study|Adverse Event|4|||
126318135|NCT01739764|454455946|FG000|Overall Study|Death|4|||
126318136|NCT01739764|454455947|FG001|Overall Study|Death|6|||
126318137|NCT01739764|454455948|FG002|Overall Study|Death|38|||
126318138|NCT01739764|454455946|FG000|Overall Study|Lost to Follow-up|0|||
126318139|NCT01739764|454455947|FG001|Overall Study|Lost to Follow-up|0|||
126318140|NCT01739764|454455948|FG002|Overall Study|Lost to Follow-up|5|||
126318141|NCT01739764|454455946|FG000|Overall Study|Non-Compliance|0|||
126318142|NCT01739764|454455947|FG001|Overall Study|Non-Compliance|0|||
126318143|NCT01739764|454455948|FG002|Overall Study|Non-Compliance|1|||
126649208|NCT00943852|455674977|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126649209|NCT00943852|455674978|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126649210|NCT00943852|455674979|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126649211|NCT00943852|455674980|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126649212|NCT00943852|455674981|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
126318144|NCT01739764|454455946|FG000|Overall Study|Multiple Reasons|3|||
126318145|NCT01739764|454455947|FG001|Overall Study|Multiple Reasons|2|||
126318146|NCT01739764|454455948|FG002|Overall Study|Multiple Reasons|3|||
126318147|NCT01739764|454455946|FG000|Overall Study|Physician Decision|2|||
126318148|NCT01739764|454455947|FG001|Overall Study|Physician Decision|2|||
126318149|NCT01739764|454455948|FG002|Overall Study|Physician Decision|4|||
126318150|NCT01739764|454455946|FG000|Overall Study|Progressive Disease|3|||
126318151|NCT01739764|454455947|FG001|Overall Study|Progressive Disease|5|||
126318152|NCT01739764|454455948|FG002|Overall Study|Progressive Disease|16|||
126318153|NCT01739764|454455946|FG000|Overall Study|Protocol Violation|0|||
126318154|NCT01739764|454455947|FG001|Overall Study|Protocol Violation|0|||
126318155|NCT01739764|454455948|FG002|Overall Study|Protocol Violation|2|||
126318156|NCT01739764|454455946|FG000|Overall Study|Study Terminated by Sponsor|8|||
126318157|NCT01739764|454455947|FG001|Overall Study|Study Terminated by Sponsor|13|||
126318158|NCT01739764|454455948|FG002|Overall Study|Study Terminated by Sponsor|26|||
126649213|NCT00943852|455674972|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126649214|NCT00943852|455674973|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126649215|NCT00943852|455674974|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126649216|NCT00943852|455674975|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126649217|NCT00943852|455674976|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126649218|NCT00943852|455674977|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
126649219|NCT00943852|455674978|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126649220|NCT00943852|455674979|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126649221|NCT00943852|455674980|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126649222|NCT00943852|455674981|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
126649223|NCT00943852|455674972|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126649224|NCT00943852|455674973|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126649225|NCT00943852|455674974|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126649226|NCT00943852|455674975|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126649227|NCT00943852|455674976|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126649228|NCT00943852|455674977|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126649229|NCT00943852|455674978|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
126649230|NCT00943852|455674979|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126649231|NCT00943852|455674980|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126649232|NCT00943852|455674981|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
126649233|NCT00943852|455674972|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126649234|NCT00943852|455674973|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126649235|NCT00943852|455674974|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126649236|NCT00943852|455674975|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126649237|NCT00943852|455674976|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126649238|NCT00943852|455674977|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126649239|NCT00943852|455674978|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126649240|NCT00943852|455674979|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
126649241|NCT00943852|455674980|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126649242|NCT00943852|455674981|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
126649243|NCT00943852|455674972|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
126649244|NCT00943852|455674973|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
126649245|NCT00943852|455674974|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
126649246|NCT00943852|455674975|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
126649247|NCT00943852|455674976|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
126649248|NCT00943852|455674977|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
126649249|NCT00943852|455674978|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
126649250|NCT00943852|455674979|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
126649251|NCT00943852|455674980|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
126649252|NCT00943852|455674981|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
126649253|NCT00941070|455674983|FG000|Overall Study|Patient non-compliant|1|||
126649254|NCT01416389|455674986|FG000|Overall Study|Lost to Follow-up|1|||
126649255|NCT01416389|455674987|FG001|Overall Study|Lost to Follow-up|0|||
126649256|NCT01416389|455674986|FG000|Overall Study|Started New Therapy|2|||
126649257|NCT01416389|455674987|FG001|Overall Study|Started New Therapy|0|||
126649258|NCT01125514|455674988|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
126649259|NCT01125514|455674988|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
126649260|NCT01125514|455674988|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
126649261|NCT01125514|455674988|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
126649262|NCT01125514|455674988|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
126649263|NCT01125514|455674988|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
126649264|NCT00858364|455674991|FG000|Overall Study|Administrative Decision|3|||
126318159|NCT01739764|454455946|FG000|Overall Study|Withdrawal by Subject|6|||
126318160|NCT01739764|454455947|FG001|Overall Study|Withdrawal by Subject|5|||
126318161|NCT01739764|454455948|FG002|Overall Study|Withdrawal by Subject|27|||
126318162|NCT01389258|454455949|FG000|Overall Study|Lost to Follow-up|5|||
126318163|NCT00926536|454455950|FG000|Overall Study|Physician Decision|1|||
126318164|NCT00926536|454455951|FG001|Overall Study|Physician Decision|2|||
126318165|NCT00990665|454455952|FG000|Overall Study|Unsuccessful Implant|8|||
126318166|NCT00990665|454455952|FG000|Overall Study|Death|29|||
126318167|NCT00990665|454455952|FG000|Overall Study|Heart Transplant|1|||
126318168|NCT00990665|454455952|FG000|Overall Study|Withdrawal by Subject|6|||
126318169|NCT00990665|454455952|FG000|Overall Study|Lost to Follow-up|1|||
126318170|NCT00990665|454455952|FG000|Overall Study|System Explant|3|||
126318171|NCT01080391|454455953|FG000|Overall Study|Randomized but not treated|7|||
126318172|NCT01080391|454455954|FG001|Overall Study|Randomized but not treated|4|||
126318173|NCT00672841|454455955|FG000|Overall Study|Comfort care|1|||
126318174|NCT00672841|454455956|FG001|Overall Study|Comfort care|4|||
126318175|NCT00672841|454455955|FG000|Overall Study|icteric specimens|0|||
126318176|NCT00672841|454455956|FG001|Overall Study|icteric specimens|3|||
126318177|NCT00672841|454455955|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
126318178|NCT00672841|454455956|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
126318179|NCT00672841|454455955|FG000|Overall Study|Adverse Event|0|||
126318180|NCT00672841|454455956|FG001|Overall Study|Adverse Event|3|||
126318181|NCT00672841|454455955|FG000|Overall Study|Pregnancy|0|||
126318182|NCT00672841|454455956|FG001|Overall Study|Pregnancy|1|||
126318183|NCT03578146|454455957|FG000|Overall Study|Did Not Receive Treatment|1|||
126318184|NCT03578146|454455958|FG001|Overall Study|Did Not Receive Treatment|0|||
126318185|NCT03578146|454455959|FG002|Overall Study|Did Not Receive Treatment|0|||
126318186|NCT03578146|454455960|FG003|Overall Study|Did Not Receive Treatment|0|||
126318187|NCT03578146|454455961|FG004|Overall Study|Did Not Receive Treatment|0|||
126318188|NCT03578146|454455962|FG005|Overall Study|Did Not Receive Treatment|2|||
126318189|NCT03578146|454455957|FG000|Overall Study|Lost to Follow-up|0|||
126318190|NCT03578146|454455958|FG001|Overall Study|Lost to Follow-up|1|||
126318191|NCT03578146|454455959|FG002|Overall Study|Lost to Follow-up|1|||
126318192|NCT03578146|454455960|FG003|Overall Study|Lost to Follow-up|0|||
126318193|NCT03578146|454455961|FG004|Overall Study|Lost to Follow-up|0|||
126318194|NCT03578146|454455962|FG005|Overall Study|Lost to Follow-up|1|||
126318195|NCT01717391|454455963|FG000|Overall Study|Withdrawal by Subject|5|||
126318196|NCT01717391|454455963|FG000|Overall Study|Physician Decision|1|||
126318197|NCT01717391|454455963|FG000|Overall Study|FLT technical failure|3|||
126318198|NCT03677934|454455964|FG000|Overall Study|Adverse Event|1|||
126318199|NCT03677934|454455965|FG001|Overall Study|Adverse Event|1|||
126318200|NCT03677934|454455964|FG000|Overall Study|Death|8|||
126318201|NCT03677934|454455965|FG001|Overall Study|Death|4|||
126318202|NCT03677934|454455964|FG000|Overall Study|Lost to Follow-up|3|||
126649265|NCT00858364|455674992|FG001|Overall Study|Administrative Decision|2|||
126649266|NCT00858364|455674991|FG000|Overall Study|Adverse Event|5|||
126318203|NCT03677934|454455965|FG001|Overall Study|Lost to Follow-up|0|||
126318204|NCT03677934|454455964|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126318205|NCT03677934|454455965|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126318206|NCT03677934|454455964|FG000|Overall Study|Physician Decision|0|||
126318207|NCT03677934|454455965|FG001|Overall Study|Physician Decision|1|||
126318208|NCT03677934|454455964|FG000|Overall Study|Withdrawal by Subject|1|||
126318209|NCT03677934|454455965|FG001|Overall Study|Withdrawal by Subject|7|||
126318210|NCT01260584|454455966|FG000|Period 1|Protocol Violation|0|||
126649267|NCT00858364|455674992|FG001|Overall Study|Adverse Event|2|||
126649268|NCT00858364|455674991|FG000|Overall Study|Withdrawal by Subject|44|||
126649269|NCT00858364|455674992|FG001|Overall Study|Withdrawal by Subject|118|||
126649270|NCT00858364|455674991|FG000|Overall Study|Ineligibility Determined|1|||
126649271|NCT00858364|455674992|FG001|Overall Study|Ineligibility Determined|10|||
126649272|NCT00858364|455674991|FG000|Overall Study|Lost to Follow-up|24|||
126649273|NCT00858364|455674992|FG001|Overall Study|Lost to Follow-up|54|||
126649274|NCT00858364|455674991|FG000|Overall Study|Noncompliance|3|||
126649275|NCT00858364|455674992|FG001|Overall Study|Noncompliance|4|||
126649276|NCT00858364|455674991|FG000|Overall Study|Protocol Deviation|0|||
126649277|NCT00858364|455674992|FG001|Overall Study|Protocol Deviation|2|||
126649278|NCT00858364|455674991|FG000|Overall Study|Other|9|||
126649279|NCT00858364|455674992|FG001|Overall Study|Other|17|||
126649280|NCT00858364|455674991|FG000|Overall Study|Missing|1|||
126649281|NCT00858364|455674992|FG001|Overall Study|Missing|1|||
126649282|NCT00858364|455674991|FG000|Overall Study|Still on-study|114|||
126649283|NCT00858364|455674992|FG001|Overall Study|Still on-study|247|||
126649284|NCT02755818|455674993|FG000|Overall Study|Withdrawal by Subject|0|||
126649285|NCT02755818|455674994|FG001|Overall Study|Withdrawal by Subject|0|||
126649286|NCT02755818|455674995|FG002|Overall Study|Withdrawal by Subject|0|||
126649287|NCT02755818|455674996|FG003|Overall Study|Withdrawal by Subject|2|||
126649288|NCT02755818|455674993|FG000|Overall Study|withdrawal by PI|0|||
126649289|NCT02755818|455674994|FG001|Overall Study|withdrawal by PI|0|||
126649290|NCT02755818|455674995|FG002|Overall Study|withdrawal by PI|1|||
126649291|NCT02755818|455674996|FG003|Overall Study|withdrawal by PI|1|||
126649292|NCT02535091|455674999|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
126649293|NCT02535091|455675000|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
126649294|NCT02535091|455675001|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
126649295|NCT02535091|455674999|FG000|Overall Study|Withdrawal by Subject|14|||
126649296|NCT02535091|455675000|FG001|Overall Study|Withdrawal by Subject|5|||
126649297|NCT02535091|455675001|FG002|Overall Study|Withdrawal by Subject|121|||
126649298|NCT02535091|455674999|FG000|Overall Study|Adverse Event|9|||
126649299|NCT02535091|455675000|FG001|Overall Study|Adverse Event|4|||
126649300|NCT02535091|455675001|FG002|Overall Study|Adverse Event|170|||
126649301|NCT02535091|455674999|FG000|Overall Study|Other|4|||
126649302|NCT02535091|455675000|FG001|Overall Study|Other|3|||
126649303|NCT02535091|455675001|FG002|Overall Study|Other|81|||
126649304|NCT02535091|455674999|FG000|Overall Study|Lost to Follow-up|0|||
126649305|NCT02535091|455675000|FG001|Overall Study|Lost to Follow-up|1|||
126649306|NCT02535091|455675001|FG002|Overall Study|Lost to Follow-up|19|||
126649307|NCT02535091|455674999|FG000|Overall Study|Protocol Violation|0|||
126649308|NCT02535091|455675000|FG001|Overall Study|Protocol Violation|1|||
126649309|NCT02535091|455675001|FG002|Overall Study|Protocol Violation|11|||
126649310|NCT02535091|455674999|FG000|Overall Study|Pregnancy|0|||
126649311|NCT02535091|455675000|FG001|Overall Study|Pregnancy|0|||
126649312|NCT02535091|455675001|FG002|Overall Study|Pregnancy|7|||
126649313|NCT01127763|455675002|FG000|Overall Study|Adverse Event|2|||
126649314|NCT01127763|455675002|FG000|Overall Study|Withdrawal by Subject|1|||
126649315|NCT01127763|455675002|FG000|Overall Study|Physician Decision|2|||
126649316|NCT01769326|455675003|FG000|Overall Study|Lost to Follow-up|1|||
126649317|NCT01769326|455675004|FG001|Overall Study|Lost to Follow-up|2|||
126649318|NCT01769326|455675005|FG002|Overall Study|Lost to Follow-up|0|||
126649319|NCT01769326|455675006|FG003|Overall Study|Lost to Follow-up|0|||
126649320|NCT01769326|455675003|FG000|Overall Study|unrelated injry|1|||
126649321|NCT01769326|455675004|FG001|Overall Study|unrelated injry|1|||
126649322|NCT01769326|455675005|FG002|Overall Study|unrelated injry|0|||
126649323|NCT01769326|455675006|FG003|Overall Study|unrelated injry|0|||
126649324|NCT01769326|455675003|FG000|Overall Study|got a job|0|||
126649325|NCT01769326|455675004|FG001|Overall Study|got a job|1|||
126649326|NCT01769326|455675005|FG002|Overall Study|got a job|0|||
126649327|NCT01769326|455675006|FG003|Overall Study|got a job|0|||
126649328|NCT01769326|455675003|FG000|Overall Study|Got sick and could not complete study|0|||
126649329|NCT01769326|455675004|FG001|Overall Study|Got sick and could not complete study|0|||
126649330|NCT01769326|455675005|FG002|Overall Study|Got sick and could not complete study|1|||
126649331|NCT01769326|455675006|FG003|Overall Study|Got sick and could not complete study|0|||
126649332|NCT01036438|455675007|FG000|Overall Study|Adverse Event|7|||
126649333|NCT01036438|455675008|FG001|Overall Study|Adverse Event|8|||
126649334|NCT01036438|455675007|FG000|Overall Study|Death|0|||
126649335|NCT01036438|455675008|FG001|Overall Study|Death|1|||
126649336|NCT01036438|455675007|FG000|Overall Study|No effect of study treatment|3|||
126649337|NCT01036438|455675008|FG001|Overall Study|No effect of study treatment|1|||
126649338|NCT02153073|455675009|FG000|Overall Study|Case Report Forms Uncollected|230|||
126649339|NCT02153073|455675009|FG000|Overall Study|Protocol Deviation|68|||
126649340|NCT03702231|455675010|FG000|Overall Study|Withdrawal by Subject|1|||
126649341|NCT03702231|455675011|FG001|Overall Study|Withdrawal by Subject|0|||
126649342|NCT03702231|455675012|FG002|Overall Study|Withdrawal by Subject|0|||
126649343|NCT03702231|455675010|FG000|Overall Study|Protocol Violation|0|||
126649344|NCT03702231|455675011|FG001|Overall Study|Protocol Violation|0|||
126649345|NCT03702231|455675012|FG002|Overall Study|Protocol Violation|1|||
126649346|NCT03702231|455675010|FG000|Overall Study|Change in CLL Treatment|0|||
126649347|NCT03702231|455675011|FG001|Overall Study|Change in CLL Treatment|0|||
126649348|NCT03702231|455675012|FG002|Overall Study|Change in CLL Treatment|1|||
126649349|NCT03702231|455675010|FG000|Overall Study|COVID Pandemic|1|||
126649350|NCT03702231|455675011|FG001|Overall Study|COVID Pandemic|4|||
126649351|NCT03702231|455675012|FG002|Overall Study|COVID Pandemic|1|||
126649352|NCT03702231|455675010|FG000|Overall Study|Non-compliance|0|||
126649353|NCT03702231|455675011|FG001|Overall Study|Non-compliance|0|||
126649354|NCT03702231|455675012|FG002|Overall Study|Non-compliance|1|||
126649355|NCT01278173|455675013|FG000|Overall Study|Lack of Efficacy|13|||
126649356|NCT01278173|455675013|FG000|Overall Study|Adverse Event|8|||
126649357|NCT01278173|455675013|FG000|Overall Study|Administrative or other reason|4|||
126649358|NCT01278173|455675013|FG000|Overall Study|Protocol Violation|1|||
126649359|NCT01278173|455675013|FG000|Overall Study|Withdrawal by Subject|1|||
126649360|NCT03590366|455675014|FG000|Overall Study|Adverse Event|0|||
126649361|NCT03590366|455675015|FG001|Overall Study|Adverse Event|3|||
126649362|NCT03590366|455675014|FG000|Overall Study|Lost to Follow-up|3|||
126649363|NCT03590366|455675015|FG001|Overall Study|Lost to Follow-up|3|||
126649364|NCT03590366|455675014|FG000|Overall Study|Withdrawal by Subject|0|||
126649365|NCT03590366|455675015|FG001|Overall Study|Withdrawal by Subject|2|||
126649366|NCT01373151|455675016|FG000|Period 1|Lack of Efficacy|3|||
126649367|NCT01373151|455675017|FG001|Period 1|Lack of Efficacy|0|||
126649368|NCT01373151|455675018|FG002|Period 1|Lack of Efficacy|0|||
126649369|NCT01373151|455675019|FG003|Period 1|Lack of Efficacy|0|||
126649370|NCT01373151|455675020|FG004|Period 1|Lack of Efficacy|1|||
126649371|NCT01373151|455675021|FG005|Period 1|Lack of Efficacy|0|||
126649372|NCT01373151|455675022|FG006|Period 1|Lack of Efficacy|0|||
126649373|NCT01373151|455675016|FG000|Period 1|Adverse Event|0|||
126649374|NCT01373151|455675017|FG001|Period 1|Adverse Event|0|||
126649375|NCT01373151|455675018|FG002|Period 1|Adverse Event|1|||
126649376|NCT01373151|455675019|FG003|Period 1|Adverse Event|0|||
126649377|NCT01373151|455675020|FG004|Period 1|Adverse Event|4|||
126649378|NCT01373151|455675021|FG005|Period 1|Adverse Event|3|||
126649379|NCT01373151|455675022|FG006|Period 1|Adverse Event|0|||
126649380|NCT01373151|455675016|FG000|Period 1|Withdrawal by Subject|2|||
126649381|NCT01373151|455675017|FG001|Period 1|Withdrawal by Subject|0|||
126649382|NCT01373151|455675018|FG002|Period 1|Withdrawal by Subject|3|||
126649383|NCT01373151|455675019|FG003|Period 1|Withdrawal by Subject|1|||
126649384|NCT01373151|455675020|FG004|Period 1|Withdrawal by Subject|0|||
126649385|NCT01373151|455675021|FG005|Period 1|Withdrawal by Subject|1|||
126649386|NCT01373151|455675022|FG006|Period 1|Withdrawal by Subject|0|||
126649387|NCT01373151|455675016|FG000|Period 2|Lack of Efficacy|9|||
126649388|NCT01373151|455675017|FG001|Period 2|Lack of Efficacy|0|||
126649389|NCT01373151|455675018|FG002|Period 2|Lack of Efficacy|0|||
126649390|NCT01373151|455675019|FG003|Period 2|Lack of Efficacy|1|||
126649391|NCT01373151|455675020|FG004|Period 2|Lack of Efficacy|2|||
126649392|NCT01373151|455675021|FG005|Period 2|Lack of Efficacy|0|||
126649393|NCT01373151|455675022|FG006|Period 2|Lack of Efficacy|3|||
126649394|NCT01373151|455675016|FG000|Period 2|Adverse Event|0|||
126649395|NCT01373151|455675017|FG001|Period 2|Adverse Event|0|||
126649396|NCT01373151|455675018|FG002|Period 2|Adverse Event|3|||
126649397|NCT01373151|455675019|FG003|Period 2|Adverse Event|3|||
126649398|NCT01373151|455675020|FG004|Period 2|Adverse Event|0|||
126649399|NCT01373151|455675021|FG005|Period 2|Adverse Event|0|||
126649400|NCT01373151|455675022|FG006|Period 2|Adverse Event|1|||
126649401|NCT01373151|455675016|FG000|Period 2|subject request to discontinue|0|||
126649402|NCT01373151|455675017|FG001|Period 2|subject request to discontinue|1|||
126649403|NCT01373151|455675018|FG002|Period 2|subject request to discontinue|0|||
126649404|NCT01373151|455675019|FG003|Period 2|subject request to discontinue|0|||
126649405|NCT01373151|455675020|FG004|Period 2|subject request to discontinue|0|||
126649406|NCT01373151|455675021|FG005|Period 2|subject request to discontinue|0|||
126649407|NCT01373151|455675022|FG006|Period 2|subject request to discontinue|0|||
126649408|NCT01373151|455675016|FG000|Period 2|Withdrawal by Subject|0|||
126649409|NCT01373151|455675017|FG001|Period 2|Withdrawal by Subject|0|||
126649410|NCT01373151|455675018|FG002|Period 2|Withdrawal by Subject|0|||
126649411|NCT01373151|455675019|FG003|Period 2|Withdrawal by Subject|1|||
126649412|NCT01373151|455675020|FG004|Period 2|Withdrawal by Subject|0|||
126649413|NCT01373151|455675021|FG005|Period 2|Withdrawal by Subject|0|||
126649414|NCT01373151|455675022|FG006|Period 2|Withdrawal by Subject|0|||
126649415|NCT01373151|455675016|FG000|Period 2|Other|0|||
126649416|NCT01373151|455675017|FG001|Period 2|Other|0|||
126649417|NCT01373151|455675018|FG002|Period 2|Other|1|||
126649418|NCT01373151|455675019|FG003|Period 2|Other|0|||
126649419|NCT01373151|455675020|FG004|Period 2|Other|0|||
126649420|NCT01373151|455675021|FG005|Period 2|Other|0|||
126649421|NCT01373151|455675022|FG006|Period 2|Other|1|||
126649422|NCT03026075|455675026|FG000|Overall Study|Physician Decision|1|||
126649423|NCT01468181|455675027|FG000|Overall Study|Adverse Event|8|||
126649424|NCT01468181|455675028|FG001|Overall Study|Adverse Event|1|||
126649425|NCT01468181|455675029|FG002|Overall Study|Adverse Event|6|||
126649426|NCT01468181|455675030|FG003|Overall Study|Adverse Event|2|||
126649427|NCT01468181|455675031|FG004|Overall Study|Adverse Event|2|||
126649428|NCT01468181|455675027|FG000|Overall Study|Protocol Violation|2|||
126649429|NCT01468181|455675028|FG001|Overall Study|Protocol Violation|0|||
126649430|NCT01468181|455675029|FG002|Overall Study|Protocol Violation|1|||
126649431|NCT01468181|455675030|FG003|Overall Study|Protocol Violation|0|||
126649432|NCT01468181|455675031|FG004|Overall Study|Protocol Violation|1|||
126649433|NCT01468181|455675027|FG000|Overall Study|Physician Decision|0|||
126649434|NCT01468181|455675028|FG001|Overall Study|Physician Decision|0|||
126649435|NCT01468181|455675029|FG002|Overall Study|Physician Decision|0|||
126649436|NCT01468181|455675030|FG003|Overall Study|Physician Decision|1|||
126649437|NCT01468181|455675031|FG004|Overall Study|Physician Decision|1|||
126649438|NCT01468181|455675027|FG000|Overall Study|Lost to Follow-up|0|||
126649439|NCT01468181|455675028|FG001|Overall Study|Lost to Follow-up|0|||
126649440|NCT01468181|455675029|FG002|Overall Study|Lost to Follow-up|1|||
126649441|NCT01468181|455675030|FG003|Overall Study|Lost to Follow-up|0|||
126649442|NCT01468181|455675031|FG004|Overall Study|Lost to Follow-up|1|||
126649443|NCT01468181|455675027|FG000|Overall Study|Withdrawal by Subject|0|||
126649444|NCT01468181|455675028|FG001|Overall Study|Withdrawal by Subject|1|||
126649445|NCT01468181|455675029|FG002|Overall Study|Withdrawal by Subject|0|||
126649446|NCT01468181|455675030|FG003|Overall Study|Withdrawal by Subject|0|||
126649447|NCT01468181|455675031|FG004|Overall Study|Withdrawal by Subject|0|||
126649448|NCT02297139|455675040|FG000|Overall Study|Disease progression|0|||
126649449|NCT02297139|455675041|FG001|Overall Study|Disease progression|1|||
126649450|NCT02297139|455675040|FG000|Overall Study|Study drug toxicity|0|||
126649451|NCT02297139|455675041|FG001|Overall Study|Study drug toxicity|4|||
126649452|NCT02297139|455675040|FG000|Overall Study|Participant request to discontinue study treatment|0|||
126649453|NCT02297139|455675041|FG001|Overall Study|Participant request to discontinue study treatment|1|||
126649454|NCT02297139|455675040|FG000|Overall Study|Maximum clinical benefit|1|||
126649455|NCT02297139|455675041|FG001|Overall Study|Maximum clinical benefit|0|||
126649456|NCT02297139|455675040|FG000|Overall Study|Administrative reason by sponsor|0|||
126649457|NCT02297139|455675041|FG001|Overall Study|Administrative reason by sponsor|2|||
126649458|NCT02297139|455675040|FG000|Overall Study|Other reasons|0|||
126649459|NCT02297139|455675041|FG001|Overall Study|Other reasons|8|||
126649460|NCT01934790|455675044|FG000|Treatment|Adverse Event|3|||
126318211|NCT01260584|454455967|FG001|Period 1|Protocol Violation|0|||
126318212|NCT01260584|454455968|FG002|Period 1|Protocol Violation|1|||
126318213|NCT01260584|454455969|FG003|Period 1|Protocol Violation|1|||
126318214|NCT01260584|454455966|FG000|Period 1|Adverse Event|0|||
126318215|NCT01260584|454455967|FG001|Period 1|Adverse Event|0|||
126318216|NCT01260584|454455968|FG002|Period 1|Adverse Event|1|||
126318217|NCT01260584|454455969|FG003|Period 1|Adverse Event|0|||
126649461|NCT01934790|455675044|FG000|Treatment|Clinical progression|6|||
126649462|NCT01934790|455675044|FG000|Treatment|Radiological progression|4|||
126649463|NCT01934790|455675044|FG000|Treatment|Withdrawal by Subject|2|||
126649464|NCT01934790|455675044|FG000|Treatment|Study drug never administered|1|||
126649465|NCT01934790|455675044|FG000|Active Follow up|Death|20|||
126649466|NCT01934790|455675044|FG000|Active Follow up|Physician Decision|2|||
126649467|NCT01934790|455675044|FG000|Active Follow up|Progressive disease|1|||
126649468|NCT01934790|455675044|FG000|Active Follow up|Other reason|1|||
126649469|NCT01144377|455675045|FG000|52 Week Treatment Period|Adverse Event|0|||
126649470|NCT01144377|455675046|FG001|52 Week Treatment Period|Adverse Event|0|||
126649471|NCT01144377|455675047|FG002|52 Week Treatment Period|Adverse Event|3|||
126649472|NCT01144377|455675048|FG003|52 Week Treatment Period|Adverse Event|2|||
126649473|NCT01144377|455675049|FG004|52 Week Treatment Period|Adverse Event|1|||
126649474|NCT01144377|455675045|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
126649475|NCT01144377|455675046|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
126649476|NCT01144377|455675047|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
126649477|NCT01144377|455675048|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
126318218|NCT01260584|454455966|FG000|Period 2|Protocol Violation|0|||
126318219|NCT01260584|454455967|FG001|Period 2|Protocol Violation|2|||
126318220|NCT01260584|454455968|FG002|Period 2|Protocol Violation|3|||
126318221|NCT01260584|454455969|FG003|Period 2|Protocol Violation|1|||
126649478|NCT01144377|455675049|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
126649479|NCT01144377|455675045|FG000|52 Week Treatment Period|Protocol Violation|0|||
126649480|NCT01144377|455675046|FG001|52 Week Treatment Period|Protocol Violation|0|||
126649481|NCT01144377|455675047|FG002|52 Week Treatment Period|Protocol Violation|0|||
126649482|NCT01144377|455675048|FG003|52 Week Treatment Period|Protocol Violation|0|||
126649483|NCT01144377|455675049|FG004|52 Week Treatment Period|Protocol Violation|1|||
126649484|NCT01144377|455675045|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
126649485|NCT01144377|455675046|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
126649486|NCT01144377|455675047|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
126649487|NCT01144377|455675048|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
126318222|NCT01260584|454455966|FG000|Period 2|Adverse Event|1|||
126318223|NCT01260584|454455967|FG001|Period 2|Adverse Event|0|||
126318224|NCT01260584|454455968|FG002|Period 2|Adverse Event|2|||
126649488|NCT01144377|455675049|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
126649489|NCT01144377|455675045|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
126318225|NCT01260584|454455969|FG003|Period 2|Adverse Event|0|||
126318226|NCT01260584|454455966|FG000|Period 2|Withdrawal by Subject|0|||
126318227|NCT01260584|454455967|FG001|Period 2|Withdrawal by Subject|1|||
126318228|NCT01260584|454455968|FG002|Period 2|Withdrawal by Subject|0|||
126318229|NCT01260584|454455969|FG003|Period 2|Withdrawal by Subject|0|||
126318230|NCT02918552|454455972|FG000|Overall Study|Failed Pharmacokinetics|1|||
126318231|NCT02918552|454455973|FG001|Overall Study|Failed Pharmacokinetics|0|||
126318232|NCT02918552|454455972|FG000|Overall Study|Withdrawal by Subject|0|||
126318233|NCT02918552|454455973|FG001|Overall Study|Withdrawal by Subject|1|||
126318234|NCT02918552|454455972|FG000|Overall Study|Lost to Follow-up|0|||
126318235|NCT02918552|454455973|FG001|Overall Study|Lost to Follow-up|1|||
126318236|NCT03325894|454455974|FG000|Overall Study|Adverse Event|2|||
126318237|NCT03325894|454455975|FG001|Overall Study|Adverse Event|3|||
126318238|NCT03325894|454455974|FG000|Overall Study|Protocol Violation|1|||
126318239|NCT03325894|454455975|FG001|Overall Study|Protocol Violation|2|||
126318240|NCT03325894|454455974|FG000|Overall Study|Withdrawal by Subject|10|||
126318241|NCT03325894|454455975|FG001|Overall Study|Withdrawal by Subject|6|||
126318242|NCT03325894|454455974|FG000|Overall Study|Lost to Follow-up|4|||
126318243|NCT03325894|454455975|FG001|Overall Study|Lost to Follow-up|9|||
126318244|NCT03325894|454455974|FG000|Overall Study|Lack of Efficacy|8|||
126318245|NCT03325894|454455975|FG001|Overall Study|Lack of Efficacy|14|||
126318246|NCT03325894|454455974|FG000|Overall Study|Study Terminated by Sponsor|38|||
126318247|NCT03325894|454455975|FG001|Overall Study|Study Terminated by Sponsor|43|||
126318248|NCT03325894|454455974|FG000|Overall Study|Other (Not received Treatment)|1|||
126318249|NCT03325894|454455975|FG001|Overall Study|Other (Not received Treatment)|0|||
126318250|NCT00824382|454455979|FG000|Overall Study|Adverse Event|4|||
126318251|NCT00824382|454455980|FG001|Overall Study|Adverse Event|1|||
126318252|NCT00824382|454455981|FG002|Overall Study|Adverse Event|1|||
126318253|NCT00824382|454455982|FG003|Overall Study|Adverse Event|4|||
126318254|NCT00824382|454455979|FG000|Overall Study|Protocol Violation|1|||
126318255|NCT00824382|454455980|FG001|Overall Study|Protocol Violation|0|||
126318256|NCT00824382|454455981|FG002|Overall Study|Protocol Violation|0|||
126318257|NCT00824382|454455982|FG003|Overall Study|Protocol Violation|1|||
126318258|NCT00824382|454455979|FG000|Overall Study|Investigator's decision|0|||
126318259|NCT00824382|454455980|FG001|Overall Study|Investigator's decision|1|||
126318260|NCT00824382|454455981|FG002|Overall Study|Investigator's decision|2|||
126318261|NCT00824382|454455982|FG003|Overall Study|Investigator's decision|0|||
126318262|NCT01362244|454455983|FG000|Overall Study|Adverse Event|3|||
126318263|NCT01362244|454455984|FG001|Overall Study|Adverse Event|5|||
126318264|NCT01362244|454455983|FG000|Overall Study|Lack of Efficacy|5|||
126318265|NCT01362244|454455984|FG001|Overall Study|Lack of Efficacy|11|||
126318266|NCT01362244|454455983|FG000|Overall Study|Lost to Follow-up|0|||
126318267|NCT01362244|454455984|FG001|Overall Study|Lost to Follow-up|2|||
126318268|NCT01362244|454455983|FG000|Overall Study|Protocol Violation|5|||
126318269|NCT01362244|454455984|FG001|Overall Study|Protocol Violation|1|||
126318270|NCT01362244|454455983|FG000|Overall Study|Withdrawal by Subject|2|||
126318271|NCT01362244|454455984|FG001|Overall Study|Withdrawal by Subject|1|||
126318272|NCT01362244|454455983|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
126318273|NCT01362244|454455984|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
126318274|NCT01362244|454455983|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
126318275|NCT01362244|454455984|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
126318276|NCT05153148|454455985|FG000|Overall Study|Adverse Event|1|||
126318277|NCT05153148|454455986|FG001|Overall Study|Adverse Event|0|||
126318278|NCT05153148|454455987|FG002|Overall Study|Adverse Event|3|||
126318279|NCT05153148|454455988|FG003|Overall Study|Adverse Event|5|||
126318280|NCT05153148|454455985|FG000|Overall Study|Lost to Follow-up|1|||
126318281|NCT05153148|454455986|FG001|Overall Study|Lost to Follow-up|1|||
126318282|NCT05153148|454455987|FG002|Overall Study|Lost to Follow-up|2|||
126649490|NCT01144377|455675046|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
126318283|NCT05153148|454455988|FG003|Overall Study|Lost to Follow-up|0|||
126318284|NCT05153148|454455985|FG000|Overall Study|Withdrawal by Subject|6|||
126318285|NCT05153148|454455986|FG001|Overall Study|Withdrawal by Subject|8|||
126318286|NCT05153148|454455987|FG002|Overall Study|Withdrawal by Subject|6|||
126318287|NCT05153148|454455988|FG003|Overall Study|Withdrawal by Subject|8|||
126318288|NCT05153148|454455985|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
126318289|NCT05153148|454455986|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
126318290|NCT05153148|454455987|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
126318291|NCT05153148|454455988|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
126318292|NCT05153148|454455985|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
126318293|NCT05153148|454455986|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
126318294|NCT05153148|454455987|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
126318295|NCT05153148|454455988|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
126318296|NCT05153148|454455985|FG000|Overall Study|Reason not Specified|1|||
126318297|NCT05153148|454455986|FG001|Overall Study|Reason not Specified|1|||
126318298|NCT05153148|454455987|FG002|Overall Study|Reason not Specified|1|||
126318299|NCT05153148|454455988|FG003|Overall Study|Reason not Specified|1|||
126318300|NCT01712334|454455991|FG000|Treatment Period 1|Randomized in Error|0|||
126318301|NCT01712334|454455992|FG001|Treatment Period 1|Randomized in Error|2|||
126649491|NCT01144377|455675047|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
126649492|NCT01144377|455675048|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
126649493|NCT01144377|455675049|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
126649494|NCT01144377|455675045|FG000|52 Week Treatment Period|Sponsor Decision|0|||
126649495|NCT01144377|455675046|FG001|52 Week Treatment Period|Sponsor Decision|0|||
126649496|NCT01144377|455675047|FG002|52 Week Treatment Period|Sponsor Decision|0|||
126649497|NCT01144377|455675048|FG003|52 Week Treatment Period|Sponsor Decision|0|||
126649498|NCT01144377|455675049|FG004|52 Week Treatment Period|Sponsor Decision|1|||
126649499|NCT01144377|455675045|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
126649500|NCT01144377|455675046|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
126649501|NCT01144377|455675047|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
126649502|NCT01144377|455675048|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
126649503|NCT01144377|455675049|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
126649504|NCT01144377|455675045|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
126649505|NCT01144377|455675046|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
126649506|NCT01144377|455675047|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
126649507|NCT01144377|455675048|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
126649508|NCT01144377|455675049|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
126649509|NCT01144377|455675045|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
126649510|NCT01144377|455675046|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
126649511|NCT01144377|455675047|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
126649512|NCT01144377|455675048|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
126649513|NCT01144377|455675049|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
126649514|NCT00607724|455675050|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
126649515|NCT00607724|455675051|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
126649516|NCT00607724|455675052|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
126649517|NCT00607724|455675053|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
126649518|NCT00607724|455675054|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
126649519|NCT00607724|455675055|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
126649520|NCT00607724|455675056|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
126649521|NCT00607724|455675050|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
126649522|NCT00607724|455675051|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
126649523|NCT00607724|455675052|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
126649524|NCT00607724|455675053|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
126649525|NCT00607724|455675054|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
126649526|NCT00607724|455675055|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
126649527|NCT00607724|455675056|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
126649528|NCT00607724|455675050|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
126649529|NCT00607724|455675051|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
126649530|NCT00607724|455675052|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
126649531|NCT00607724|455675053|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
126649532|NCT00607724|455675054|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
126649533|NCT00607724|455675055|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
126649534|NCT00607724|455675056|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
126649535|NCT00607724|455675050|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
126649536|NCT00607724|455675051|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
126649537|NCT00607724|455675052|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
126649538|NCT00607724|455675053|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
126649539|NCT00607724|455675054|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
126649540|NCT00607724|455675055|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
126649541|NCT00607724|455675056|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
126649542|NCT00607724|455675050|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
126649543|NCT00607724|455675051|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
126649544|NCT00607724|455675052|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
126649545|NCT00607724|455675053|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
126649546|NCT00607724|455675054|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
126649547|NCT00607724|455675055|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
126649548|NCT00607724|455675056|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
126649549|NCT03738423|455675057|FG000|Overall Study|Withdrawal by Subject|9|||
126649550|NCT03738423|455675058|FG001|Overall Study|Withdrawal by Subject|12|||
126649551|NCT03738423|455675059|FG002|Overall Study|Withdrawal by Subject|9|||
126649552|NCT03738423|455675060|FG003|Overall Study|Withdrawal by Subject|12|||
126649553|NCT03738423|455675061|FG004|Overall Study|Withdrawal by Subject|10|||
126649554|NCT03738423|455675057|FG000|Overall Study|Lack of Efficacy|3|||
126649555|NCT03738423|455675058|FG001|Overall Study|Lack of Efficacy|1|||
126649556|NCT03738423|455675059|FG002|Overall Study|Lack of Efficacy|1|||
126649557|NCT03738423|455675060|FG003|Overall Study|Lack of Efficacy|1|||
126649558|NCT03738423|455675061|FG004|Overall Study|Lack of Efficacy|2|||
126649559|NCT03738423|455675057|FG000|Overall Study|Lost to Follow-up|1|||
126649560|NCT03738423|455675058|FG001|Overall Study|Lost to Follow-up|0|||
126649561|NCT03738423|455675059|FG002|Overall Study|Lost to Follow-up|1|||
126649562|NCT03738423|455675060|FG003|Overall Study|Lost to Follow-up|1|||
126649563|NCT03738423|455675061|FG004|Overall Study|Lost to Follow-up|0|||
126649564|NCT03738423|455675057|FG000|Overall Study|Protocol Violation|1|||
126649565|NCT03738423|455675058|FG001|Overall Study|Protocol Violation|0|||
126649566|NCT03738423|455675059|FG002|Overall Study|Protocol Violation|0|||
126649567|NCT03738423|455675060|FG003|Overall Study|Protocol Violation|0|||
126649568|NCT03738423|455675061|FG004|Overall Study|Protocol Violation|1|||
126649569|NCT03738423|455675057|FG000|Overall Study|Physician Decision|0|||
126649570|NCT03738423|455675058|FG001|Overall Study|Physician Decision|0|||
126649571|NCT03738423|455675059|FG002|Overall Study|Physician Decision|1|||
126649572|NCT03738423|455675060|FG003|Overall Study|Physician Decision|0|||
126649573|NCT03738423|455675061|FG004|Overall Study|Physician Decision|1|||
126649574|NCT03738423|455675057|FG000|Overall Study|Death|0|||
126649575|NCT03738423|455675058|FG001|Overall Study|Death|0|||
126649576|NCT03738423|455675059|FG002|Overall Study|Death|0|||
126649577|NCT03738423|455675060|FG003|Overall Study|Death|0|||
126649578|NCT03738423|455675061|FG004|Overall Study|Death|1|||
126649579|NCT03738423|455675057|FG000|Overall Study|Randomized but never treated|0|||
126649580|NCT03738423|455675058|FG001|Overall Study|Randomized but never treated|0|||
126649581|NCT03738423|455675059|FG002|Overall Study|Randomized but never treated|1|||
126649582|NCT03738423|455675060|FG003|Overall Study|Randomized but never treated|1|||
126649583|NCT03738423|455675061|FG004|Overall Study|Randomized but never treated|0|||
126649584|NCT02592876|455675062|FG000|Overall Study|Withdrawal by Subject|3|||
126649585|NCT02592876|455675063|FG001|Overall Study|Withdrawal by Subject|3|||
126649586|NCT02592876|455675062|FG000|Overall Study|Study Termination by Sponsor|32|||
126649587|NCT02592876|455675063|FG001|Overall Study|Study Termination by Sponsor|27|||
126649588|NCT02592876|455675062|FG000|Overall Study|Lost to Follow-up|0|||
126649589|NCT02592876|455675063|FG001|Overall Study|Lost to Follow-up|1|||
126649590|NCT02592876|455675062|FG000|Overall Study|Death|6|||
126649591|NCT02592876|455675063|FG001|Overall Study|Death|9|||
126649592|NCT00611975|455675066|FG000|Overall Study|Withdrawal by Subject|3|||
126649593|NCT00611975|455675067|FG001|Overall Study|Withdrawal by Subject|7|||
126649594|NCT00611975|455675066|FG000|Overall Study|Pregnancy|2|||
126649595|NCT00611975|455675067|FG001|Overall Study|Pregnancy|1|||
126649596|NCT02663518|455676446|FG000|Part 1: Phase 1a Escalation|Death|0|||
126649597|NCT02663518|455676447|FG001|Part 1: Phase 1a Escalation|Death|0|||
126649598|NCT02663518|455676448|FG002|Part 1: Phase 1a Escalation|Death|1|||
126649599|NCT02663518|455676449|FG003|Part 1: Phase 1a Escalation|Death|0|||
126649600|NCT02663518|455676450|FG004|Part 1: Phase 1a Escalation|Death|0|||
126649601|NCT02663518|455676451|FG005|Part 1: Phase 1a Escalation|Death|0|||
126649602|NCT02663518|455676452|FG006|Part 1: Phase 1a Escalation|Death|0|||
126649603|NCT02663518|455676453|FG007|Part 1: Phase 1a Escalation|Death|0|||
126649604|NCT02663518|455676454|FG008|Part 1: Phase 1a Escalation|Death|0|||
126649605|NCT02663518|455676455|FG009|Part 1: Phase 1a Escalation|Death|0|||
126649606|NCT02663518|455676456|FG010|Part 1: Phase 1a Escalation|Death|0|||
126649607|NCT02663518|455676457|FG011|Part 1: Phase 1a Escalation|Death|0|||
126649608|NCT02663518|455676458|FG012|Part 1: Phase 1a Escalation|Death|0|||
126649609|NCT02663518|455676459|FG013|Part 1: Phase 1a Escalation|Death|0|||
126649610|NCT02663518|455676446|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649611|NCT02663518|455676447|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649612|NCT02663518|455676448|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
126649613|NCT02663518|455676449|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649614|NCT02663518|455676450|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649615|NCT02663518|455676451|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649616|NCT02663518|455676452|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649617|NCT02663518|455676453|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649618|NCT02663518|455676454|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649619|NCT02663518|455676455|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649620|NCT02663518|455676456|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649621|NCT02663518|455676457|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649622|NCT02663518|455676458|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649623|NCT02663518|455676459|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
126649624|NCT02663518|455676446|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
126649625|NCT02663518|455676447|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
126649626|NCT02663518|455676448|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
126649627|NCT02663518|455676449|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
126649628|NCT02663518|455676450|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126649629|NCT02663518|455676451|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126649630|NCT02663518|455676452|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126649631|NCT02663518|455676453|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126649632|NCT02663518|455676454|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126649633|NCT02663518|455676455|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126649634|NCT02663518|455676456|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126649635|NCT02663518|455676457|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126649636|NCT02663518|455676458|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126649637|NCT02663518|455676459|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
126649638|NCT02663518|455676446|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
126318302|NCT00232596|454455993|FG000|6-Week Titration Phase|Adverse Event|6|||
126649639|NCT02663518|455676447|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126649640|NCT02663518|455676448|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
126649641|NCT02663518|455676449|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
126649642|NCT02663518|455676450|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126649643|NCT02663518|455676451|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126649644|NCT02663518|455676452|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126649645|NCT02663518|455676453|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126649646|NCT02663518|455676454|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126649647|NCT02663518|455676455|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126318303|NCT00232596|454455994|FG001|6-Week Titration Phase|Adverse Event|19|||
126318304|NCT00232596|454455993|FG000|6-Week Titration Phase|Failed to Return|2|||
126318305|NCT00232596|454455994|FG001|6-Week Titration Phase|Failed to Return|1|||
126318306|NCT00232596|454455993|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
126318307|NCT00232596|454455994|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
126318308|NCT00232596|454455993|FG000|6-Week Titration Phase|Protocol Violation|1|||
126318309|NCT00232596|454455994|FG001|6-Week Titration Phase|Protocol Violation|3|||
126318310|NCT00232596|454455993|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
126318311|NCT00232596|454455994|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
126318312|NCT00232596|454455993|FG000|6-Week Titration Phase|Other|3|||
126318313|NCT00232596|454455994|FG001|6-Week Titration Phase|Other|3|||
126318314|NCT00232596|454455993|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
126318315|NCT00232596|454455994|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
126318316|NCT00232596|454455993|FG000|12-Week Maintenance Phase|Adverse Event|7|||
126318317|NCT00232596|454455994|FG001|12-Week Maintenance Phase|Adverse Event|22|||
126318318|NCT00232596|454455993|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
126318319|NCT00232596|454455994|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
126318320|NCT00232596|454455993|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
126318321|NCT00232596|454455994|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
126318322|NCT00232596|454455993|FG000|12-Week Maintenance Phase|Other|1|||
126318323|NCT00232596|454455994|FG001|12-Week Maintenance Phase|Other|3|||
126318324|NCT01732471|454455995|FG000|Overall Study|Withdrawal by Subject|1|||
126318325|NCT01253174|454455996|FG000|Period 1|Randomized but not treated|0|||
126318326|NCT01253174|454455997|FG001|Period 1|Randomized but not treated|1|||
126318327|NCT01253174|454455998|FG002|Period 1|Randomized but not treated|1|||
126318328|NCT01253174|454455999|FG003|Period 1|Randomized but not treated|0|||
126318329|NCT01253174|454456000|FG004|Period 1|Randomized but not treated|1|||
126318330|NCT01253174|454456001|FG005|Period 1|Randomized but not treated|0|||
126318331|NCT01253174|454455996|FG000|Period 2|Adverse Event|0|||
126318332|NCT01253174|454455997|FG001|Period 2|Adverse Event|0|||
126318333|NCT01253174|454455998|FG002|Period 2|Adverse Event|1|||
126318334|NCT01253174|454455999|FG003|Period 2|Adverse Event|0|||
126318335|NCT01253174|454456000|FG004|Period 2|Adverse Event|0|||
126318336|NCT01253174|454456001|FG005|Period 2|Adverse Event|0|||
126318337|NCT01253174|454455996|FG000|Period 3|Withdrawal by Subject|0|||
126318338|NCT01253174|454455997|FG001|Period 3|Withdrawal by Subject|1|||
126544945|NCT02392611|455289150|FG004|Overall Study|Enrolled, not treated|0|||
126544946|NCT02392611|455289151|FG005|Overall Study|Enrolled, not treated|0|||
126544947|NCT02392611|455289152|FG006|Overall Study|Enrolled, not treated|0|||
126544948|NCT02392611|455289153|FG007|Overall Study|Enrolled, not treated|0|||
126544949|NCT02392611|455289154|FG008|Overall Study|Enrolled, not treated|0|||
126544950|NCT03585296|455289155|FG000|Overall Study|Adverse Event|1|||
126544951|NCT03585296|455289155|FG000|Overall Study|Lost to Follow-up|2|||
126544952|NCT03585296|455289155|FG000|Overall Study|Withdrawal by Subject|2|||
126544953|NCT00462670|455289159|FG000|Overall Study|Adverse Event|3|||
126318339|NCT01253174|454455998|FG002|Period 3|Withdrawal by Subject|0|||
126318340|NCT01253174|454455999|FG003|Period 3|Withdrawal by Subject|0|||
126318341|NCT01253174|454456000|FG004|Period 3|Withdrawal by Subject|1|||
126318342|NCT01253174|454456001|FG005|Period 3|Withdrawal by Subject|0|||
126318343|NCT01253174|454455996|FG000|Period 3|Pregnancy|0|||
126318344|NCT01253174|454455997|FG001|Period 3|Pregnancy|0|||
126318345|NCT01253174|454455998|FG002|Period 3|Pregnancy|1|||
126318346|NCT01253174|454455999|FG003|Period 3|Pregnancy|0|||
126318347|NCT01253174|454456000|FG004|Period 3|Pregnancy|0|||
126318348|NCT01253174|454456001|FG005|Period 3|Pregnancy|0|||
126318349|NCT03426436|454456002|FG000|Overall Study|Incorrect lead placement|12|||
126318350|NCT03426436|454456002|FG000|Overall Study|Withdrawal by Subject|2|||
126318351|NCT03426436|454456002|FG000|Overall Study|Consent issue|1|||
126318352|NCT03426436|454456002|FG000|Overall Study|ECGs not saved|4|||
126318353|NCT02892513|454456003|FG000|Overall Study|Withdrawal by Subject|0|||
126544954|NCT00462670|455289160|FG001|Overall Study|Adverse Event|5|||
126649648|NCT02663518|455676456|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126649649|NCT02663518|455676457|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126649650|NCT02663518|455676458|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126649651|NCT02663518|455676459|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
126649652|NCT02663518|455676446|FG000|Part 1: Phase 1a Escalation|Other|0|||
126649653|NCT02663518|455676447|FG001|Part 1: Phase 1a Escalation|Other|0|||
126649654|NCT02663518|455676448|FG002|Part 1: Phase 1a Escalation|Other|2|||
126649655|NCT02663518|455676449|FG003|Part 1: Phase 1a Escalation|Other|0|||
126649656|NCT02663518|455676450|FG004|Part 1: Phase 1a Escalation|Other|0|||
126649657|NCT02663518|455676451|FG005|Part 1: Phase 1a Escalation|Other|0|||
126649658|NCT02663518|455676452|FG006|Part 1: Phase 1a Escalation|Other|0|||
126649659|NCT02663518|455676453|FG007|Part 1: Phase 1a Escalation|Other|0|||
126649660|NCT02663518|455676454|FG008|Part 1: Phase 1a Escalation|Other|0|||
126649661|NCT02663518|455676455|FG009|Part 1: Phase 1a Escalation|Other|0|||
126649662|NCT02663518|455676456|FG010|Part 1: Phase 1a Escalation|Other|0|||
126649663|NCT02663518|455676457|FG011|Part 1: Phase 1a Escalation|Other|0|||
126649664|NCT02663518|455676458|FG012|Part 1: Phase 1a Escalation|Other|0|||
126649665|NCT02663518|455676459|FG013|Part 1: Phase 1a Escalation|Other|0|||
126649666|NCT02663518|455676446|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
126649667|NCT02663518|455676447|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
126649668|NCT02663518|455676448|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
126649669|NCT02663518|455676449|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
126649670|NCT02663518|455676450|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
126649671|NCT02663518|455676451|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
126649672|NCT02663518|455676452|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
126649673|NCT02663518|455676453|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
126649674|NCT02663518|455676454|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
126649675|NCT02663518|455676455|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
126649676|NCT02663518|455676456|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
126649677|NCT02663518|455676457|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
126649678|NCT02663518|455676458|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
126649679|NCT02663518|455676459|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
126649680|NCT02663518|455676446|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126649681|NCT02663518|455676447|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126649682|NCT02663518|455676448|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126649683|NCT02663518|455676449|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126649684|NCT02663518|455676450|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
126649685|NCT02663518|455676451|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126649686|NCT02663518|455676452|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
126649687|NCT02663518|455676453|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
126649688|NCT02663518|455676454|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126649689|NCT02663518|455676455|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126649690|NCT02663518|455676456|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126649691|NCT02663518|455676457|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126649692|NCT02663518|455676458|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126649693|NCT02663518|455676459|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
126649694|NCT02663518|455676446|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649695|NCT02663518|455676447|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649696|NCT02663518|455676448|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649697|NCT02663518|455676449|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649698|NCT02663518|455676450|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
126649699|NCT02663518|455676451|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649700|NCT02663518|455676452|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649701|NCT02663518|455676453|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649702|NCT02663518|455676454|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649703|NCT02663518|455676455|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649704|NCT02663518|455676456|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649705|NCT02663518|455676457|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649706|NCT02663518|455676458|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649707|NCT02663518|455676459|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
126649708|NCT02663518|455676446|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126318354|NCT02892513|454456004|FG001|Overall Study|Withdrawal by Subject|1|||
126318355|NCT02919267|454456005|FG000|Overall Study|Protocol Violation|0|||
126318356|NCT02919267|454456006|FG001|Overall Study|Protocol Violation|3|||
126318357|NCT02919267|454456007|FG002|Overall Study|Protocol Violation|3|||
126318358|NCT02919267|454456008|FG003|Overall Study|Protocol Violation|4|||
126318359|NCT02407054|454456009|FG000|Overall Study|Adverse Event|1|||
126318360|NCT02407054|454456010|FG001|Overall Study|Adverse Event|4|||
126318361|NCT02407054|454456011|FG002|Overall Study|Adverse Event|1|||
126318362|NCT02407054|454456009|FG000|Overall Study|Non-compliance with Study|0|||
126318363|NCT02407054|454456010|FG001|Overall Study|Non-compliance with Study|2|||
126318364|NCT02407054|454456011|FG002|Overall Study|Non-compliance with Study|1|||
126318365|NCT02407054|454456009|FG000|Overall Study|Physician Decision|1|||
126318366|NCT02407054|454456010|FG001|Overall Study|Physician Decision|3|||
126318367|NCT02407054|454456011|FG002|Overall Study|Physician Decision|3|||
126318368|NCT02407054|454456009|FG000|Overall Study|Withdrawal by Subject|5|||
126318369|NCT02407054|454456010|FG001|Overall Study|Withdrawal by Subject|9|||
126318370|NCT02407054|454456011|FG002|Overall Study|Withdrawal by Subject|2|||
126318371|NCT00131365|454456012|FG000|Overall Study|Withdrawal by Subject|1|||
126318372|NCT00131365|454456012|FG000|Overall Study|Alternative treatment|3|||
126318373|NCT04608344|454456013|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
126318374|NCT04608344|454456014|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
126318375|NCT04608344|454456013|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
126318376|NCT04608344|454456014|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
126318377|NCT02044874|454456015|FG000|Overall Study|Adverse Event|5|||
126318378|NCT02044874|454456016|FG001|Overall Study|Adverse Event|6|||
126318379|NCT02044874|454456017|FG002|Overall Study|Adverse Event|6|||
126318380|NCT02044874|454456015|FG000|Overall Study|Withdrawal by Subject|8|||
126318381|NCT02044874|454456016|FG001|Overall Study|Withdrawal by Subject|16|||
126318382|NCT02044874|454456017|FG002|Overall Study|Withdrawal by Subject|23|||
126318383|NCT02044874|454456015|FG000|Overall Study|Physician Decision|0|||
126318384|NCT02044874|454456016|FG001|Overall Study|Physician Decision|2|||
126318385|NCT02044874|454456017|FG002|Overall Study|Physician Decision|1|||
126318386|NCT02044874|454456015|FG000|Overall Study|Lost to Follow-up|10|||
126318387|NCT02044874|454456016|FG001|Overall Study|Lost to Follow-up|27|||
126318388|NCT02044874|454456017|FG002|Overall Study|Lost to Follow-up|21|||
126318389|NCT02044874|454456015|FG000|Overall Study|Sponsor Decision|0|||
126318390|NCT02044874|454456016|FG001|Overall Study|Sponsor Decision|1|||
126318391|NCT02044874|454456017|FG002|Overall Study|Sponsor Decision|1|||
126649709|NCT02663518|455676447|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126649710|NCT02663518|455676448|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126649711|NCT02663518|455676449|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126649712|NCT02663518|455676450|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
126649713|NCT02663518|455676451|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
126649714|NCT02663518|455676452|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
126649715|NCT02663518|455676453|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
126649716|NCT02663518|455676454|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126649717|NCT02663518|455676455|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126649718|NCT02663518|455676456|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126649719|NCT02663518|455676457|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126649720|NCT02663518|455676458|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126649721|NCT02663518|455676459|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
126649722|NCT02663518|455676446|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
126649723|NCT02663518|455676447|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
126649724|NCT02663518|455676448|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
126649725|NCT02663518|455676449|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
126649726|NCT02663518|455676450|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
126649727|NCT02663518|455676451|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
126649728|NCT02663518|455676452|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
126649729|NCT02663518|455676453|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
126649730|NCT02663518|455676454|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
126649731|NCT02663518|455676455|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
126649732|NCT02663518|455676456|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
126649733|NCT02663518|455676457|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
126649734|NCT02663518|455676458|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
126649735|NCT02663518|455676459|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
126649736|NCT02663518|455676446|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126318392|NCT02044874|454456015|FG000|Overall Study|Other|7|||
126318393|NCT02044874|454456016|FG001|Overall Study|Other|3|||
126318394|NCT02044874|454456017|FG002|Overall Study|Other|8|||
126318395|NCT00415597|454456018|FG000|Enrollment|Withdrawal by Subject|1|||
126318396|NCT00415597|454456018|FG000|Enrollment|Protocol Violation|1|||
126318397|NCT00415597|454456018|FG000|Treatment|Adverse Event|110|||
126318398|NCT00415597|454456018|FG000|Treatment|Lack of Efficacy|39|||
126318399|NCT00415597|454456018|FG000|Treatment|Protocol Violation|67|||
126649737|NCT02663518|455676447|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126649738|NCT02663518|455676448|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126649739|NCT02663518|455676449|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126649740|NCT02663518|455676450|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126649741|NCT02663518|455676451|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126649742|NCT02663518|455676452|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
126649743|NCT02663518|455676453|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126649744|NCT02663518|455676454|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126649745|NCT02663518|455676455|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126649746|NCT02663518|455676456|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126649747|NCT02663518|455676457|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126649748|NCT02663518|455676458|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126649749|NCT02663518|455676459|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
126649750|NCT02663518|455676446|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
126649751|NCT02663518|455676447|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
126649752|NCT02663518|455676448|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
126649753|NCT02663518|455676449|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
126649754|NCT02663518|455676450|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
126649755|NCT02663518|455676451|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
126649756|NCT02663518|455676452|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
126649757|NCT02663518|455676453|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
126649758|NCT02663518|455676454|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
126649759|NCT02663518|455676455|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
126649760|NCT02663518|455676456|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
126649761|NCT02663518|455676457|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
126649762|NCT02663518|455676458|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
126649763|NCT02663518|455676459|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
126649764|NCT02663518|455676446|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649765|NCT02663518|455676447|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649766|NCT02663518|455676448|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649767|NCT02663518|455676449|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649768|NCT02663518|455676450|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649769|NCT02663518|455676451|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649770|NCT02663518|455676452|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649771|NCT02663518|455676453|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649772|NCT02663518|455676454|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649773|NCT02663518|455676455|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649774|NCT02663518|455676456|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649775|NCT02663518|455676457|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649776|NCT02663518|455676458|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
126649777|NCT02663518|455676459|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
126649778|NCT02663518|455676446|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649779|NCT02663518|455676447|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649780|NCT02663518|455676448|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649781|NCT02663518|455676449|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649782|NCT02663518|455676450|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649783|NCT02663518|455676451|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649784|NCT02663518|455676452|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649785|NCT02663518|455676453|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649786|NCT02663518|455676454|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649787|NCT02663518|455676455|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649788|NCT02663518|455676456|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649789|NCT02663518|455676457|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
126649790|NCT02663518|455676458|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649791|NCT02663518|455676459|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
126649792|NCT02663518|455676446|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126649793|NCT02663518|455676447|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126649794|NCT02663518|455676448|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126649795|NCT02663518|455676449|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126649796|NCT02663518|455676450|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126649797|NCT02663518|455676451|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126649798|NCT02663518|455676452|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126649799|NCT02663518|455676453|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126649800|NCT02663518|455676454|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126649801|NCT02663518|455676455|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
126649802|NCT02663518|455676456|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
126649803|NCT02663518|455676457|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
126649804|NCT02663518|455676458|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
126649805|NCT02663518|455676459|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
126649806|NCT02663518|455676446|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
126649807|NCT02663518|455676447|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
126649808|NCT02663518|455676448|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
126649809|NCT02663518|455676449|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
126649810|NCT02663518|455676450|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
126649811|NCT02663518|455676451|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
126649812|NCT02663518|455676452|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
126649813|NCT02663518|455676453|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
126649814|NCT02663518|455676454|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
126649815|NCT02663518|455676455|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
126649816|NCT02663518|455676456|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
126649817|NCT02663518|455676457|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
126649818|NCT02663518|455676458|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
126649819|NCT02663518|455676459|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
126649820|NCT02663518|455676446|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649821|NCT02663518|455676447|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649822|NCT02663518|455676448|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649823|NCT02663518|455676449|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649824|NCT02663518|455676450|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649825|NCT02663518|455676451|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649826|NCT02663518|455676452|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649827|NCT02663518|455676453|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649828|NCT02663518|455676454|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649829|NCT02663518|455676455|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649830|NCT02663518|455676456|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649831|NCT02663518|455676457|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649832|NCT02663518|455676458|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
126649833|NCT02663518|455676459|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
126649834|NCT03896152|455676460|FG000|Overall Study|Patient/guardian decision|1|||
126649835|NCT03896152|455676461|FG001|Overall Study|Patient/guardian decision|1|||
126649836|NCT03896152|455676460|FG000|Overall Study|Adverse Event|0|||
126649837|NCT03896152|455676461|FG001|Overall Study|Adverse Event|1|||
126649838|NCT03896152|455676460|FG000|Overall Study|Physician Decision|1|||
126649839|NCT03896152|455676461|FG001|Overall Study|Physician Decision|0|||
126649840|NCT03896152|455676460|FG000|Overall Study|Technical problems|1|||
126649841|NCT03896152|455676461|FG001|Overall Study|Technical problems|0|||
126649842|NCT04075994|455676462|FG000|Overall Study|Withdrawal by Subject|8|||
126649843|NCT04075994|455676463|FG001|Overall Study|Withdrawal by Subject|9|||
126649844|NCT04075994|455676462|FG000|Overall Study|Adverse Event|2|||
126649845|NCT04075994|455676463|FG001|Overall Study|Adverse Event|2|||
126649846|NCT04075994|455676462|FG000|Overall Study|Investigator withdrew|3|||
126649847|NCT04075994|455676463|FG001|Overall Study|Investigator withdrew|1|||
126649848|NCT01941719|455676467|FG000|Overall Study|Lost to Follow-up|20|||
126649849|NCT01941719|455676468|FG001|Overall Study|Lost to Follow-up|19|||
126649850|NCT01744392|455676471|FG000|Overall Study|Physician Decision|1|||
126649851|NCT03980808|455676478|FG000|Overall Study|Lost to Follow-up|2|||
126649852|NCT03980808|455676479|FG001|Overall Study|Lost to Follow-up|2|||
126649853|NCT01655693|455676480|FG000|Overall Study|Progression of Disease|92|||
126649854|NCT01655693|455676481|FG001|Overall Study|Progression of Disease|76|||
126649855|NCT01655693|455676482|FG002|Overall Study|Progression of Disease|58|||
126649856|NCT01655693|455676480|FG000|Overall Study|Death|8|||
126649857|NCT01655693|455676481|FG001|Overall Study|Death|9|||
126649858|NCT01655693|455676482|FG002|Overall Study|Death|12|||
126649859|NCT01655693|455676480|FG000|Overall Study|Serious Adverse Event|3|||
126649860|NCT01655693|455676481|FG001|Overall Study|Serious Adverse Event|15|||
126649861|NCT01655693|455676482|FG002|Overall Study|Serious Adverse Event|11|||
126649862|NCT01655693|455676480|FG000|Overall Study|Withdrawal by Subject|3|||
126649863|NCT01655693|455676481|FG001|Overall Study|Withdrawal by Subject|2|||
126649864|NCT01655693|455676482|FG002|Overall Study|Withdrawal by Subject|20|||
126649865|NCT01655693|455676480|FG000|Overall Study|Adverse Event|3|||
126649866|NCT01655693|455676481|FG001|Overall Study|Adverse Event|11|||
126649867|NCT01655693|455676482|FG002|Overall Study|Adverse Event|3|||
126649868|NCT01655693|455676480|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
126649869|NCT01655693|455676481|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
126649870|NCT01655693|455676482|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
126649871|NCT01655693|455676480|FG000|Overall Study|Non-Compliance|0|||
126649872|NCT01655693|455676481|FG001|Overall Study|Non-Compliance|0|||
126649873|NCT01655693|455676482|FG002|Overall Study|Non-Compliance|7|||
126649874|NCT01655693|455676480|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
126318400|NCT00415597|454456018|FG000|Treatment|Physician Decision|3|||
126649875|NCT01655693|455676481|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
126649876|NCT01655693|455676482|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
126649877|NCT01655693|455676480|FG000|Overall Study|Protocol Violation|1|||
126649878|NCT01655693|455676481|FG001|Overall Study|Protocol Violation|0|||
126649879|NCT01655693|455676482|FG002|Overall Study|Protocol Violation|3|||
126649880|NCT01655693|455676480|FG000|Overall Study|Lost to Follow-up|1|||
126649881|NCT01655693|455676481|FG001|Overall Study|Lost to Follow-up|0|||
126649882|NCT01655693|455676482|FG002|Overall Study|Lost to Follow-up|1|||
126649883|NCT01655693|455676480|FG000|Overall Study|Screening Failure|1|||
126649884|NCT01655693|455676481|FG001|Overall Study|Screening Failure|0|||
126649885|NCT01655693|455676482|FG002|Overall Study|Screening Failure|0|||
126649886|NCT01655693|455676480|FG000|Overall Study|Other|8|||
126649887|NCT01655693|455676481|FG001|Overall Study|Other|6|||
126649888|NCT01655693|455676482|FG002|Overall Study|Other|15|||
126649889|NCT00929110|455676485|FG000|Overall Study|Adverse Event|40|||
126649890|NCT00929110|455676486|FG001|Overall Study|Adverse Event|29|||
126649891|NCT00929110|455676487|FG002|Overall Study|Adverse Event|18|||
126649892|NCT00929110|455676485|FG000|Overall Study|Subject withdrew consent|40|||
126649893|NCT00929110|455676486|FG001|Overall Study|Subject withdrew consent|23|||
126649894|NCT00929110|455676487|FG002|Overall Study|Subject withdrew consent|26|||
126649895|NCT00929110|455676485|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
126649896|NCT00929110|455676486|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
126649897|NCT00929110|455676487|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
126649898|NCT00929110|455676485|FG000|Overall Study|Lost to Follow-up|7|||
126649899|NCT00929110|455676486|FG001|Overall Study|Lost to Follow-up|7|||
126649900|NCT00929110|455676487|FG002|Overall Study|Lost to Follow-up|3|||
126649901|NCT00929110|455676485|FG000|Overall Study|Protocol deviation|5|||
126649902|NCT00929110|455676486|FG001|Overall Study|Protocol deviation|2|||
126649903|NCT00929110|455676487|FG002|Overall Study|Protocol deviation|4|||
126649904|NCT00929110|455676485|FG000|Overall Study|Administrative problems|4|||
126649905|NCT00929110|455676486|FG001|Overall Study|Administrative problems|1|||
126649906|NCT00929110|455676487|FG002|Overall Study|Administrative problems|2|||
126649907|NCT00929110|455676485|FG000|Overall Study|Death|2|||
126649908|NCT00929110|455676486|FG001|Overall Study|Death|2|||
126649909|NCT00929110|455676487|FG002|Overall Study|Death|2|||
126649910|NCT00929110|455676485|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126649911|NCT00929110|455676486|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126649912|NCT00929110|455676487|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126649913|NCT00929110|455676485|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126649914|NCT00929110|455676486|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126649915|NCT00929110|455676487|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126649916|NCT00929110|455676485|FG000|Overall Study|Patient inability to use the device|0|||
126649917|NCT00929110|455676486|FG001|Overall Study|Patient inability to use the device|1|||
126649918|NCT00929110|455676487|FG002|Overall Study|Patient inability to use the device|0|||
126649919|NCT02703259|455676488|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
126649920|NCT02703259|455676489|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
126649921|NCT02703259|455676488|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
126649922|NCT02703259|455676489|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
126649923|NCT02703259|455676488|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
126649924|NCT02703259|455676489|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
126649925|NCT02285153|455676495|FG000|Overall Study|Adverse Event|1|||
126649926|NCT02285153|455676496|FG001|Overall Study|Adverse Event|0|||
126649927|NCT02544451|455676498|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
126649928|NCT02544451|455676499|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
126649929|NCT02544451|455676500|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
126649930|NCT02544451|455676501|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
126649931|NCT02544451|455676498|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
126649932|NCT02544451|455676499|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
126649933|NCT02544451|455676500|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
126649934|NCT02544451|455676501|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
126649935|NCT02544451|455676498|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
126649936|NCT02544451|455676499|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
126649937|NCT02544451|455676500|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
126649938|NCT02544451|455676501|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
126649939|NCT02544451|455676498|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
126649940|NCT02544451|455676499|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
126649941|NCT02544451|455676500|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
126649942|NCT02544451|455676501|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
126649943|NCT02544451|455676498|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
126649944|NCT02544451|455676499|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
126649945|NCT02544451|455676500|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
126649946|NCT02544451|455676501|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
126649947|NCT02544451|455676498|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
126649948|NCT02544451|455676499|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
126649949|NCT02544451|455676500|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
126649950|NCT02544451|455676501|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
126649951|NCT01489891|455676504|FG000|Overall Study|Endoscopy failure|1|||
126649952|NCT01489891|455676505|FG001|Overall Study|Endoscopy failure|0|||
126649953|NCT00998790|455676506|FG000|Overall Study|Withdrawal by Subject|21|||
126649954|NCT03001076|455676507|FG000|Overall Study|Withdrawal by patient|2|||
126649955|NCT03001076|455676508|FG001|Overall Study|Withdrawal by patient|0|||
126649956|NCT03001076|455676507|FG000|Overall Study|Other|1|||
126649957|NCT03001076|455676508|FG001|Overall Study|Other|0|||
126649958|NCT03001076|455676507|FG000|Overall Study|Adverse Event|3|||
126649959|NCT03001076|455676508|FG001|Overall Study|Adverse Event|3|||
126649960|NCT03001076|455676507|FG000|Overall Study|Sponsor decision|1|||
126649961|NCT03001076|455676508|FG001|Overall Study|Sponsor decision|0|||
126649962|NCT03001076|455676507|FG000|Overall Study|Lost to Follow-up|0|||
126649963|NCT03001076|455676508|FG001|Overall Study|Lost to Follow-up|2|||
126649964|NCT00948766|455676509|FG000|Core Study|Adverse Event|73|||
126649965|NCT00948766|455676510|FG001|Core Study|Adverse Event|51|||
126649966|NCT00948766|455676509|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
126649967|NCT00948766|455676510|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
126649968|NCT00948766|455676509|FG000|Core Study|Patient Withdrew Consent|27|||
126649969|NCT00948766|455676510|FG001|Core Study|Patient Withdrew Consent|46|||
126649970|NCT00948766|455676509|FG000|Core Study|Lost to Follow-up|3|||
126649971|NCT00948766|455676510|FG001|Core Study|Lost to Follow-up|2|||
126649972|NCT00948766|455676509|FG000|Core Study|Administrative Problems|2|||
126649973|NCT00948766|455676510|FG001|Core Study|Administrative Problems|2|||
126649974|NCT00948766|455676509|FG000|Core Study|Death|1|||
126649975|NCT00948766|455676510|FG001|Core Study|Death|1|||
126649976|NCT00948766|455676509|FG000|Core Study|Protocol Deviation|8|||
126649977|NCT00948766|455676510|FG001|Core Study|Protocol Deviation|10|||
126649978|NCT00948766|455676509|FG000|Extension Study|Adverse Event|43|||
126649979|NCT00948766|455676510|FG001|Extension Study|Adverse Event|0|||
126649980|NCT00948766|455676509|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
126649981|NCT00948766|455676510|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
126649982|NCT00948766|455676509|FG000|Extension Study|Study Drug No Longer Required|1|||
126649983|NCT00948766|455676510|FG001|Extension Study|Study Drug No Longer Required|0|||
126649984|NCT00948766|455676509|FG000|Extension Study|Patient Withdrew Consent|32|||
126649985|NCT00948766|455676510|FG001|Extension Study|Patient Withdrew Consent|0|||
126649986|NCT00948766|455676509|FG000|Extension Study|Lost to Follow-up|8|||
126649987|NCT00948766|455676510|FG001|Extension Study|Lost to Follow-up|0|||
126649988|NCT00948766|455676509|FG000|Extension Study|Administrative Problems|1|||
126649989|NCT00948766|455676510|FG001|Extension Study|Administrative Problems|0|||
126649990|NCT00948766|455676509|FG000|Extension Study|Death|4|||
126649991|NCT00948766|455676510|FG001|Extension Study|Death|0|||
126649992|NCT01081665|455676514|FG000|Overall Study|Death|41|||
126649993|NCT01081665|455676514|FG000|Overall Study|Lost to Follow-up|18|||
126649994|NCT01081665|455676514|FG000|Overall Study|Withdrawal by Subject|17|||
126649995|NCT01081665|455676514|FG000|Overall Study|Change of dialysis unit|10|||
126649996|NCT01081665|455676514|FG000|Overall Study|Regulation of iPTH|5|||
126649997|NCT01081665|455676514|FG000|Overall Study|Change in renal replacement therapy|2|||
126649998|NCT01081665|455676514|FG000|Overall Study|Adverse Event|1|||
126649999|NCT01081665|455676514|FG000|Overall Study|Lack of Efficacy|1|||
126650000|NCT01413503|455676519|FG000|Overall Study|Lost to Follow-up|1|||
126650001|NCT00293059|455676520|FG000|Overall Study|Adverse Event|12|||
126650002|NCT00293059|455676521|FG001|Overall Study|Adverse Event|4|||
126650003|NCT00293059|455676520|FG000|Overall Study|Lack of Efficacy|2|||
126650004|NCT00293059|455676521|FG001|Overall Study|Lack of Efficacy|0|||
126650005|NCT00293059|455676520|FG000|Overall Study|Lost to Follow-up|2|||
126650006|NCT00293059|455676521|FG001|Overall Study|Lost to Follow-up|3|||
126650007|NCT00293059|455676520|FG000|Overall Study|Pregnancy|1|||
126650008|NCT00293059|455676521|FG001|Overall Study|Pregnancy|1|||
126650009|NCT00293059|455676520|FG000|Overall Study|Protocol Violation|2|||
126650010|NCT00293059|455676521|FG001|Overall Study|Protocol Violation|0|||
126650011|NCT00293059|455676520|FG000|Overall Study|Withdrawal by Subject|11|||
126650012|NCT00293059|455676521|FG001|Overall Study|Withdrawal by Subject|5|||
126650013|NCT00293059|455676520|FG000|Overall Study|Participant moved out of state|1|||
126650014|NCT00293059|455676521|FG001|Overall Study|Participant moved out of state|0|||
126650015|NCT00293059|455676520|FG000|Overall Study|Participant stopped study drug|1|||
126650016|NCT00293059|455676521|FG001|Overall Study|Participant stopped study drug|0|||
126650017|NCT00293059|455676520|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
126650018|NCT00293059|455676521|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
126650019|NCT00293059|455676520|FG000|Overall Study|missing|3|||
126650020|NCT00293059|455676521|FG001|Overall Study|missing|5|||
126650021|NCT01942785|455676529|FG000|Overall Study|Adverse Event|2|||
126650022|NCT01942785|455676529|FG000|Overall Study|Withdrawal by Subject|1|||
126650023|NCT01942785|455676529|FG000|Overall Study|Protocol Violation|1|||
126650024|NCT02227199|455676530|FG000|Overall Study|Physician Decision|0|||
126650025|NCT02227199|455676531|FG001|Overall Study|Physician Decision|0|||
126650026|NCT02227199|455676532|FG002|Overall Study|Physician Decision|1|||
126650027|NCT02227199|455676530|FG000|Overall Study|Adverse Event|0|||
126650028|NCT02227199|455676531|FG001|Overall Study|Adverse Event|0|||
126650029|NCT02227199|455676532|FG002|Overall Study|Adverse Event|3|||
126650030|NCT05597787|455676533|FG000|Overall Study|Withdrawal by Subject|0|||
126650031|NCT05597787|455676534|FG001|Overall Study|Withdrawal by Subject|0|||
126650032|NCT05597787|455676535|FG002|Overall Study|Withdrawal by Subject|1|||
126650033|NCT05453201|455676537|FG000|Overall Study|Withdrawal by Subject|1|||
126650034|NCT00552929|455676542|FG000|Overall Study|Lost to Follow-up|0|||
126650035|NCT00552929|455676543|FG001|Overall Study|Lost to Follow-up|0|||
126650036|NCT00552929|455676544|FG002|Overall Study|Lost to Follow-up|0|||
126650037|NCT00552929|455676545|FG003|Overall Study|Lost to Follow-up|0|||
126650038|NCT00552929|455676546|FG004|Overall Study|Lost to Follow-up|0|||
126650039|NCT00552929|455676547|FG005|Overall Study|Lost to Follow-up|0|||
126650040|NCT00552929|455676548|FG006|Overall Study|Lost to Follow-up|0|||
126650041|NCT00552929|455676549|FG007|Overall Study|Lost to Follow-up|0|||
126650042|NCT00552929|455676550|FG008|Overall Study|Lost to Follow-up|1|||
126650043|NCT00552929|455676551|FG009|Overall Study|Lost to Follow-up|0|||
126650044|NCT00552929|455676542|FG000|Overall Study|Not Eligible|0|||
126650045|NCT00552929|455676543|FG001|Overall Study|Not Eligible|0|||
126650046|NCT00552929|455676544|FG002|Overall Study|Not Eligible|0|||
126650047|NCT00552929|455676545|FG003|Overall Study|Not Eligible|0|||
126650048|NCT00552929|455676546|FG004|Overall Study|Not Eligible|0|||
126650049|NCT00552929|455676547|FG005|Overall Study|Not Eligible|1|||
126650050|NCT00552929|455676548|FG006|Overall Study|Not Eligible|0|||
126650051|NCT00552929|455676549|FG007|Overall Study|Not Eligible|0|||
126650052|NCT00552929|455676550|FG008|Overall Study|Not Eligible|0|||
126650053|NCT00552929|455676551|FG009|Overall Study|Not Eligible|0|||
126650054|NCT01200290|455676552|FG000|Treatment Period|Adverse Event|1|||
126650055|NCT01200290|455676552|FG000|Post-Treatment Follow-Up Period|Death|2|||
126650056|NCT02489968|455676561|FG000|Open-label Treatment Period|Adverse Event|14|||
126650057|NCT02489968|455676562|FG001|Open-label Treatment Period|Adverse Event|7|||
126650058|NCT02489968|455676563|FG002|Open-label Treatment Period|Adverse Event|0|||
126650059|NCT02489968|455676564|FG003|Open-label Treatment Period|Adverse Event|0|||
126650060|NCT02489968|455676565|FG004|Open-label Treatment Period|Adverse Event|0|||
126650061|NCT02489968|455676566|FG005|Open-label Treatment Period|Adverse Event|0|||
126650062|NCT02489968|455676561|FG000|Open-label Treatment Period|Protocol Violation|2|||
126650063|NCT02489968|455676562|FG001|Open-label Treatment Period|Protocol Violation|2|||
126650064|NCT02489968|455676563|FG002|Open-label Treatment Period|Protocol Violation|0|||
126650065|NCT02489968|455676564|FG003|Open-label Treatment Period|Protocol Violation|0|||
126650066|NCT02489968|455676565|FG004|Open-label Treatment Period|Protocol Violation|0|||
126650067|NCT02489968|455676566|FG005|Open-label Treatment Period|Protocol Violation|0|||
126650068|NCT02489968|455676561|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
126650069|NCT02489968|455676562|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
126650070|NCT02489968|455676563|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
126650071|NCT02489968|455676564|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
126650072|NCT02489968|455676565|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
126650073|NCT02489968|455676566|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
126650074|NCT02489968|455676561|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
126650075|NCT02489968|455676562|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
126650076|NCT02489968|455676563|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
126650077|NCT02489968|455676564|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
126650078|NCT02489968|455676565|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
126650079|NCT02489968|455676566|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
126650080|NCT02489968|455676561|FG000|Open-label Treatment Period|Other than specified above|204|||
126650081|NCT02489968|455676562|FG001|Open-label Treatment Period|Other than specified above|189|||
126650082|NCT02489968|455676563|FG002|Open-label Treatment Period|Other than specified above|0|||
126650083|NCT02489968|455676564|FG003|Open-label Treatment Period|Other than specified above|0|||
126650084|NCT02489968|455676565|FG004|Open-label Treatment Period|Other than specified above|0|||
126650085|NCT02489968|455676566|FG005|Open-label Treatment Period|Other than specified above|0|||
126650086|NCT02489968|455676561|FG000|Double-blind Treatment Period|Adverse Event|0|||
126650087|NCT02489968|455676562|FG001|Double-blind Treatment Period|Adverse Event|0|||
126650088|NCT02489968|455676563|FG002|Double-blind Treatment Period|Adverse Event|2|||
126650089|NCT02489968|455676564|FG003|Double-blind Treatment Period|Adverse Event|6|||
126650090|NCT02489968|455676565|FG004|Double-blind Treatment Period|Adverse Event|4|||
126650091|NCT02489968|455676566|FG005|Double-blind Treatment Period|Adverse Event|5|||
126650092|NCT02489968|455676561|FG000|Double-blind Treatment Period|Protocol Violation|0|||
126650093|NCT02489968|455676562|FG001|Double-blind Treatment Period|Protocol Violation|0|||
126650094|NCT02489968|455676563|FG002|Double-blind Treatment Period|Protocol Violation|0|||
126650095|NCT02489968|455676564|FG003|Double-blind Treatment Period|Protocol Violation|0|||
126650096|NCT02489968|455676565|FG004|Double-blind Treatment Period|Protocol Violation|1|||
126650097|NCT02489968|455676566|FG005|Double-blind Treatment Period|Protocol Violation|1|||
126650098|NCT02489968|455676561|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
126650099|NCT02489968|455676562|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
126650100|NCT02489968|455676563|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126650101|NCT02489968|455676564|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
126650102|NCT02489968|455676565|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
126650103|NCT02489968|455676566|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
126650104|NCT02489968|455676561|FG000|Double-blind Treatment Period|Other than specified above|0|||
126650105|NCT02489968|455676562|FG001|Double-blind Treatment Period|Other than specified above|0|||
126650106|NCT02489968|455676563|FG002|Double-blind Treatment Period|Other than specified above|0|||
126650107|NCT02489968|455676564|FG003|Double-blind Treatment Period|Other than specified above|0|||
126650108|NCT02489968|455676565|FG004|Double-blind Treatment Period|Other than specified above|1|||
126650109|NCT02489968|455676566|FG005|Double-blind Treatment Period|Other than specified above|0|||
126650110|NCT04577001|455676568|FG000|Overall Study|Subject became ineligible|0|||
126650111|NCT04577001|455676569|FG001|Overall Study|Subject became ineligible|1|||
126650112|NCT01241604|455676570|FG000|Screening Period|Screen Failure|3|||
126650113|NCT01241604|455676571|FG001|Screening Period|Screen Failure|0|||
126650114|NCT01241604|455676572|FG002|Screening Period|Screen Failure|0|||
126650115|NCT01593787|455676573|FG000|Overall Study|Adverse Event|1|||
126650116|NCT01593787|455676574|FG001|Overall Study|Adverse Event|0|||
126650117|NCT01593787|455676575|FG002|Overall Study|Adverse Event|0|||
126650118|NCT01865747|455676578|FG000|Overall Study (ITT)|Adverse Event|32|||
126650119|NCT01865747|455676579|FG001|Overall Study (ITT)|Adverse Event|31|||
126650120|NCT01865747|455676578|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
126650121|NCT01865747|455676579|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
126650122|NCT01865747|455676578|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
126650123|NCT01865747|455676579|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
126650124|NCT01865747|455676578|FG000|Overall Study (ITT)|Protocol Violation|1|||
126650125|NCT01865747|455676579|FG001|Overall Study (ITT)|Protocol Violation|1|||
126650126|NCT01865747|455676578|FG000|Overall Study (ITT)|Physician Decision|5|||
126650127|NCT01865747|455676579|FG001|Overall Study (ITT)|Physician Decision|2|||
126650128|NCT01865747|455676578|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
126650129|NCT01865747|455676579|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
126650130|NCT01865747|455676578|FG000|Overall Study (ITT)|Sponsor Decision|0|||
126650131|NCT01865747|455676579|FG001|Overall Study (ITT)|Sponsor Decision|1|||
126650132|NCT01865747|455676578|FG000|Overall Study (ITT)|Progressive Disease|122|||
126650133|NCT01865747|455676579|FG001|Overall Study (ITT)|Progressive Disease|158|||
126650134|NCT01865747|455676578|FG000|Overall Study (ITT)|Reason Not Provided|0|||
126650135|NCT01865747|455676579|FG001|Overall Study (ITT)|Reason Not Provided|1|||
126650136|NCT01865747|455676578|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
126650137|NCT01865747|455676579|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
126650138|NCT01865747|455676578|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
126650139|NCT01865747|455676579|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
126650140|NCT01865747|455676578|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
126650141|NCT01865747|455676579|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
126650142|NCT01865747|455676578|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
126650143|NCT01865747|455676579|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
126650144|NCT01865747|455676578|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
126650145|NCT01865747|455676579|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
126650146|NCT01865747|455676578|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
126650147|NCT01865747|455676579|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
126650148|NCT01865747|455676578|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
126650149|NCT01865747|455676579|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
126650150|NCT01865747|455676578|FG000|Primary Intent to Treat (PITT)|Other|0|||
126650151|NCT01865747|455676579|FG001|Primary Intent to Treat (PITT)|Other|1|||
126650152|NCT03465904|455676580|FG000|Overall Study|Withdrawal by Subject|9|||
126650153|NCT03465904|455676581|FG001|Overall Study|Withdrawal by Subject|5|||
126650154|NCT03465904|455676580|FG000|Overall Study|Lost to Follow-up|11|||
126650155|NCT03465904|455676581|FG001|Overall Study|Lost to Follow-up|9|||
126650156|NCT03465904|455676580|FG000|Overall Study|Protocol Violation|20|||
126650157|NCT03465904|455676581|FG001|Overall Study|Protocol Violation|15|||
126650158|NCT01305200|455676583|FG000|Overall Study|Physician Decision|4|||
126650159|NCT01305200|455676584|FG001|Overall Study|Physician Decision|6|||
126650160|NCT01305200|455676585|FG002|Overall Study|Physician Decision|1|||
126650161|NCT01305200|455676583|FG000|Overall Study|Withdrawal by Subject|24|||
126650162|NCT01305200|455676584|FG001|Overall Study|Withdrawal by Subject|21|||
126650163|NCT01305200|455676585|FG002|Overall Study|Withdrawal by Subject|1|||
126650164|NCT01305200|455676583|FG000|Overall Study|Ineligible|1|||
126650165|NCT01305200|455676584|FG001|Overall Study|Ineligible|2|||
126650166|NCT01305200|455676585|FG002|Overall Study|Ineligible|1|||
126650167|NCT01305200|455676583|FG000|Overall Study|Death|0|||
126650168|NCT01305200|455676584|FG001|Overall Study|Death|2|||
126650169|NCT01305200|455676585|FG002|Overall Study|Death|0|||
126650170|NCT01198756|455678166|FG000|Overall Study|Adverse Event|0|||
126650171|NCT01198756|455678167|FG001|Overall Study|Adverse Event|0|||
126650172|NCT01198756|455678168|FG002|Overall Study|Adverse Event|0|||
126318401|NCT00415597|454456018|FG000|Treatment|Withdrawal by Subject|51|||
126318402|NCT00415597|454456018|FG000|Treatment|Lost to Follow-up|28|||
126318403|NCT00415597|454456018|FG000|Treatment|Drug Screen|2|||
126318404|NCT00415597|454456018|FG000|Treatment|Administrative|3|||
126318405|NCT00415597|454456018|FG000|Treatment|Sponsor Decision|1|||
126318406|NCT00415597|454456018|FG000|Treatment|Multiple Reasons|1|||
126318407|NCT01447927|454456019|FG000|Overall Study|Adverse Event|4|||
126650173|NCT01198756|455678169|FG003|Overall Study|Adverse Event|1|||
126650174|NCT01198756|455678166|FG000|Overall Study|Protocol Violation|0|||
126650175|NCT01198756|455678167|FG001|Overall Study|Protocol Violation|0|||
126650176|NCT01198756|455678168|FG002|Overall Study|Protocol Violation|0|||
126650177|NCT01198756|455678169|FG003|Overall Study|Protocol Violation|2|||
126650178|NCT01198756|455678166|FG000|Overall Study|Withdrawal by Subject|9|||
126650179|NCT01198756|455678167|FG001|Overall Study|Withdrawal by Subject|4|||
126650180|NCT01198756|455678168|FG002|Overall Study|Withdrawal by Subject|7|||
126650181|NCT01198756|455678169|FG003|Overall Study|Withdrawal by Subject|5|||
126650182|NCT01198756|455678166|FG000|Overall Study|Lost to Follow-up|29|||
126650183|NCT01198756|455678167|FG001|Overall Study|Lost to Follow-up|36|||
126650184|NCT01198756|455678168|FG002|Overall Study|Lost to Follow-up|23|||
126650185|NCT01198756|455678169|FG003|Overall Study|Lost to Follow-up|18|||
126650186|NCT01290315|455678171|FG000|Overall Study|Adverse Event|0|||
126650187|NCT01290315|455678172|FG001|Overall Study|Adverse Event|0|||
126650188|NCT01290315|455678173|FG002|Overall Study|Adverse Event|0|||
126650189|NCT01290315|455678174|FG003|Overall Study|Adverse Event|3|||
126650190|NCT01290315|455678171|FG000|Overall Study|Selection criteria/compliance|2|||
126650191|NCT01290315|455678172|FG001|Overall Study|Selection criteria/compliance|1|||
126650192|NCT01290315|455678173|FG002|Overall Study|Selection criteria/compliance|0|||
126650193|NCT01290315|455678174|FG003|Overall Study|Selection criteria/compliance|2|||
126650194|NCT01290315|455678171|FG000|Overall Study|Lost to Follow-up|0|||
126650195|NCT01290315|455678172|FG001|Overall Study|Lost to Follow-up|1|||
126650196|NCT01290315|455678173|FG002|Overall Study|Lost to Follow-up|0|||
126650197|NCT01290315|455678174|FG003|Overall Study|Lost to Follow-up|0|||
126650198|NCT01290315|455678171|FG000|Overall Study|Withdrawal by Subject|1|||
126650199|NCT01290315|455678172|FG001|Overall Study|Withdrawal by Subject|1|||
126650200|NCT01290315|455678173|FG002|Overall Study|Withdrawal by Subject|0|||
126650201|NCT01290315|455678174|FG003|Overall Study|Withdrawal by Subject|0|||
126650202|NCT00591721|455678175|FG000|Overall Study|Withdrawal by Subject|10|||
126650203|NCT00591721|455678176|FG001|Overall Study|Withdrawal by Subject|10|||
126650204|NCT00591721|455678175|FG000|Overall Study|Lost to Follow-up|1|||
126650205|NCT00591721|455678176|FG001|Overall Study|Lost to Follow-up|4|||
126650206|NCT00591721|455678175|FG000|Overall Study|Intervention not received|10|||
126650207|NCT00591721|455678176|FG001|Overall Study|Intervention not received|8|||
126650208|NCT00901186|455678181|FG000|Overall Study|Lack of Efficacy|0|||
126650209|NCT00901186|455678182|FG001|Overall Study|Lack of Efficacy|1|||
126650210|NCT00901186|455678181|FG000|Overall Study|Abnormal laboratory values|0|||
126650211|NCT00901186|455678182|FG001|Overall Study|Abnormal laboratory values|1|||
126650212|NCT00901186|455678181|FG000|Overall Study|Lost to Follow-up|2|||
126650213|NCT00901186|455678182|FG001|Overall Study|Lost to Follow-up|0|||
126650214|NCT00901186|455678181|FG000|Overall Study|Adverse Event|2|||
126650215|NCT00901186|455678182|FG001|Overall Study|Adverse Event|4|||
126650216|NCT00901186|455678181|FG000|Overall Study|Administration problems|0|||
126650217|NCT00901186|455678182|FG001|Overall Study|Administration problems|1|||
126650218|NCT00901186|455678181|FG000|Overall Study|Protocol deviations|5|||
126650219|NCT00901186|455678182|FG001|Overall Study|Protocol deviations|4|||
126650220|NCT00581555|455678185|FG000|Overall Study|Adverse Event|4|||
126650221|NCT00581555|455678186|FG001|Overall Study|Adverse Event|3|||
126650222|NCT00581555|455678185|FG000|Overall Study|Physician Decision|3|||
126650223|NCT00581555|455678186|FG001|Overall Study|Physician Decision|2|||
126650224|NCT00581555|455678185|FG000|Overall Study|Withdrawal by Subject|18|||
126650225|NCT00581555|455678186|FG001|Overall Study|Withdrawal by Subject|9|||
126650226|NCT00581555|455678185|FG000|Overall Study|Lost to Follow-up|2|||
126650227|NCT00581555|455678186|FG001|Overall Study|Lost to Follow-up|2|||
126650228|NCT00581555|455678185|FG000|Overall Study|Other reasons|16|||
126650229|NCT00581555|455678186|FG001|Overall Study|Other reasons|4|||
126650230|NCT03828747|455678187|FG000|Double-Blind Treatment Period|Adverse Event|6|||
126650231|NCT03828747|455678188|FG001|Double-Blind Treatment Period|Adverse Event|6|||
126650232|NCT03828747|455678187|FG000|Double-Blind Treatment Period|Death|1|||
126650233|NCT03828747|455678188|FG001|Double-Blind Treatment Period|Death|1|||
126318408|NCT01447927|454456020|FG001|Overall Study|Adverse Event|3|||
126318409|NCT01447927|454456019|FG000|Overall Study|Withdrawal by Subject|1|||
126650234|NCT03828747|455678187|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126650235|NCT03828747|455678188|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
126650236|NCT03828747|455678187|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
126650237|NCT03828747|455678188|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
126650238|NCT03828747|455678187|FG000|Double-Blind Treatment Period|Physician Decision|1|||
126650239|NCT03828747|455678188|FG001|Double-Blind Treatment Period|Physician Decision|4|||
126650240|NCT03828747|455678187|FG000|Double-Blind Treatment Period|Various reasons|5|||
126650241|NCT03828747|455678188|FG001|Double-Blind Treatment Period|Various reasons|3|||
126650242|NCT03828747|455678187|FG000|Open-Label Extension|Adverse Event|9|||
126650243|NCT03828747|455678188|FG001|Open-Label Extension|Adverse Event|7|||
126650244|NCT03828747|455678187|FG000|Open-Label Extension|Death|0|||
126650245|NCT03828747|455678188|FG001|Open-Label Extension|Death|2|||
126318410|NCT01447927|454456020|FG001|Overall Study|Withdrawal by Subject|0|||
126318411|NCT04102865|454456022|FG000|Overall Study|Adverse Event|4|||
126318412|NCT04102865|454456023|FG001|Overall Study|Adverse Event|0|||
126318413|NCT04102865|454456022|FG000|Overall Study|Lost to Follow-up|1|||
126318414|NCT04102865|454456023|FG001|Overall Study|Lost to Follow-up|0|||
126318415|NCT04102865|454456022|FG000|Overall Study|Withdrawal by Subject|2|||
126318416|NCT04102865|454456023|FG001|Overall Study|Withdrawal by Subject|0|||
126318417|NCT01764997|454456024|FG000|Run-in Period|Adverse Event|15|||
126318418|NCT01764997|454456025|FG001|Run-in Period|Adverse Event|0|||
126318419|NCT01764997|454456026|FG002|Run-in Period|Adverse Event|0|||
126318420|NCT01764997|454456027|FG003|Run-in Period|Adverse Event|0|||
126318421|NCT01764997|454456028|FG004|Run-in Period|Adverse Event|0|||
126318422|NCT01764997|454456024|FG000|Run-in Period|Lack of Efficacy|5|||
126318423|NCT01764997|454456025|FG001|Run-in Period|Lack of Efficacy|0|||
126318424|NCT01764997|454456026|FG002|Run-in Period|Lack of Efficacy|0|||
126318425|NCT01764997|454456027|FG003|Run-in Period|Lack of Efficacy|0|||
126318426|NCT01764997|454456028|FG004|Run-in Period|Lack of Efficacy|0|||
126318427|NCT01764997|454456024|FG000|Run-in Period|Poor compliance to protocol|1|||
126318428|NCT01764997|454456025|FG001|Run-in Period|Poor compliance to protocol|0|||
126318429|NCT01764997|454456026|FG002|Run-in Period|Poor compliance to protocol|0|||
126318430|NCT01764997|454456027|FG003|Run-in Period|Poor compliance to protocol|0|||
126318431|NCT01764997|454456028|FG004|Run-in Period|Poor compliance to protocol|0|||
126318432|NCT01764997|454456024|FG000|Run-in Period|Other than specified above|17|||
126318433|NCT01764997|454456025|FG001|Run-in Period|Other than specified above|0|||
126318434|NCT01764997|454456026|FG002|Run-in Period|Other than specified above|0|||
126318435|NCT01764997|454456027|FG003|Run-in Period|Other than specified above|0|||
126318436|NCT01764997|454456028|FG004|Run-in Period|Other than specified above|0|||
126318437|NCT01764997|454456024|FG000|Study Drug Treatment Period|Adverse Event|0|||
126318438|NCT01764997|454456025|FG001|Study Drug Treatment Period|Adverse Event|1|||
126318439|NCT01764997|454456026|FG002|Study Drug Treatment Period|Adverse Event|0|||
126318440|NCT01764997|454456027|FG003|Study Drug Treatment Period|Adverse Event|0|||
126318441|NCT01764997|454456028|FG004|Study Drug Treatment Period|Adverse Event|24|||
126318442|NCT01764997|454456024|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
126318443|NCT01764997|454456025|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
126318444|NCT01764997|454456026|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
126318445|NCT01764997|454456027|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
126318446|NCT01764997|454456028|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
126318447|NCT01764997|454456024|FG000|Study Drug Treatment Period|Other than specified above|0|||
126318448|NCT01764997|454456025|FG001|Study Drug Treatment Period|Other than specified above|0|||
126318449|NCT01764997|454456026|FG002|Study Drug Treatment Period|Other than specified above|0|||
126318450|NCT01764997|454456027|FG003|Study Drug Treatment Period|Other than specified above|0|||
126318451|NCT01764997|454456028|FG004|Study Drug Treatment Period|Other than specified above|10|||
126318452|NCT04438499|454456037|FG000|Overall Study|Lack of Efficacy|3|||
126318453|NCT04683939|454456038|FG000|Overall Study|Study termination by the sponsor|0|||
126318454|NCT04683939|454456039|FG001|Overall Study|Study termination by the sponsor|1|||
126318455|NCT04683939|454456040|FG002|Overall Study|Study termination by the sponsor|2|||
126318456|NCT04683939|454456041|FG003|Overall Study|Study termination by the sponsor|2|||
126318457|NCT04683939|454456038|FG000|Overall Study|Death|1|||
126318458|NCT04683939|454456039|FG001|Overall Study|Death|1|||
126318459|NCT04683939|454456040|FG002|Overall Study|Death|2|||
126318460|NCT04683939|454456041|FG003|Overall Study|Death|1|||
126318461|NCT04683939|454456038|FG000|Overall Study|Withdrawal by Subject|1|||
126650246|NCT03828747|455678187|FG000|Open-Label Extension|Lost to Follow-up|4|||
126650247|NCT03828747|455678188|FG001|Open-Label Extension|Lost to Follow-up|0|||
126650248|NCT03828747|455678187|FG000|Open-Label Extension|Withdrawal by Subject|31|||
126318462|NCT04683939|454456039|FG001|Overall Study|Withdrawal by Subject|0|||
126318463|NCT04683939|454456040|FG002|Overall Study|Withdrawal by Subject|0|||
126318464|NCT04683939|454456041|FG003|Overall Study|Withdrawal by Subject|0|||
126318465|NCT04683939|454456038|FG000|Overall Study|Physician Decision|1|||
126318466|NCT04683939|454456039|FG001|Overall Study|Physician Decision|0|||
126318467|NCT04683939|454456040|FG002|Overall Study|Physician Decision|0|||
126318468|NCT04683939|454456041|FG003|Overall Study|Physician Decision|0|||
126318469|NCT04683939|454456038|FG000|Overall Study|Lost to Follow-up|0|||
126318470|NCT04683939|454456039|FG001|Overall Study|Lost to Follow-up|1|||
126318471|NCT04683939|454456040|FG002|Overall Study|Lost to Follow-up|0|||
126318472|NCT04683939|454456041|FG003|Overall Study|Lost to Follow-up|0|||
126650249|NCT03828747|455678188|FG001|Open-Label Extension|Withdrawal by Subject|30|||
126650250|NCT03828747|455678187|FG000|Open-Label Extension|Various reasons|4|||
126650251|NCT03828747|455678188|FG001|Open-Label Extension|Various reasons|4|||
126318473|NCT01172808|454457923|FG000|Overall Study|Adverse Event|8|||
126650252|NCT03828747|455678187|FG000|Open-Label Extension|Physician Decision|6|||
126650253|NCT03828747|455678188|FG001|Open-Label Extension|Physician Decision|2|||
126650254|NCT05816330|455678189|FG000|Overall Study|Withdrawal by Subject|4|||
126650255|NCT05816330|455678190|FG001|Overall Study|Withdrawal by Subject|1|||
126650256|NCT03900416|455678191|FG000|Six Week Follow-up|Lost to Follow-up|1|||
126650257|NCT03900416|455678192|FG001|Six Week Follow-up|Lost to Follow-up|0|||
126650258|NCT03900416|455678191|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
126650259|NCT03900416|455678192|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
126650260|NCT03900416|455678191|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
126650261|NCT03900416|455678192|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
126650262|NCT03900416|455678191|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
126650263|NCT03900416|455678192|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
126650264|NCT03900416|455678191|FG000|Twelve Week Follow-up|Adverse Event|1|||
126650265|NCT03900416|455678192|FG001|Twelve Week Follow-up|Adverse Event|1|||
126650266|NCT03900416|455678191|FG000|Six Month Follow-up|Lost to Follow-up|4|||
126650267|NCT03900416|455678192|FG001|Six Month Follow-up|Lost to Follow-up|3|||
126650268|NCT03900416|455678191|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
126650269|NCT03900416|455678192|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
126650270|NCT00772330|455678193|FG000|Overall Study|Lost to Follow-up|3|||
126650271|NCT01353859|455678194|FG000|Overall Study|Adverse Event|3|||
126650272|NCT01353859|455678194|FG000|Overall Study|Lack of Efficacy|1|||
126650273|NCT00700427|455678195|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
126650274|NCT00700427|455678196|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
126650275|NCT00700427|455678197|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
126650276|NCT00700427|455678198|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
126650277|NCT00700427|455678199|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
126650278|NCT00700427|455678195|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
126650279|NCT00700427|455678196|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
126650280|NCT00700427|455678197|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
126650281|NCT00700427|455678198|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
126650282|NCT00700427|455678199|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
126650283|NCT00700427|455678195|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
126650284|NCT00700427|455678196|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
126650285|NCT00700427|455678197|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
126650286|NCT00700427|455678198|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
126650287|NCT00700427|455678199|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
126650288|NCT00700427|455678195|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
126650289|NCT00700427|455678196|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
126650290|NCT00700427|455678197|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
126650291|NCT00700427|455678198|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
126650292|NCT00700427|455678199|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
126650293|NCT00700427|455678195|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
126650294|NCT00700427|455678196|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
126650295|NCT00700427|455678197|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
126650296|NCT00700427|455678198|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
126650297|NCT00700427|455678199|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
126650298|NCT00700427|455678195|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
126650299|NCT00700427|455678196|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
126650300|NCT00700427|455678197|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
126650301|NCT00700427|455678198|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
126650302|NCT00700427|455678199|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
126650303|NCT00700427|455678195|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
126650304|NCT00700427|455678196|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
126650305|NCT00700427|455678197|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
126650306|NCT00700427|455678198|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
126650307|NCT00700427|455678199|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
126650308|NCT00700427|455678195|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
126650309|NCT00700427|455678196|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
126650310|NCT00700427|455678197|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
126650311|NCT00700427|455678198|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
126650312|NCT00700427|455678199|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
126650313|NCT00700427|455678195|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
126650314|NCT00700427|455678196|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
126650315|NCT00700427|455678197|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
126650316|NCT00700427|455678198|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
126650317|NCT00700427|455678199|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
126650318|NCT00700427|455678195|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
126650319|NCT00700427|455678196|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
126650320|NCT00700427|455678197|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
126650321|NCT00700427|455678198|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
126650322|NCT00700427|455678199|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
126650323|NCT00700427|455678195|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
126650324|NCT00700427|455678196|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
126650325|NCT00700427|455678197|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
126650326|NCT00700427|455678198|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
126650327|NCT00700427|455678199|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
126650328|NCT00700427|455678195|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
126650329|NCT00700427|455678196|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
126650330|NCT00700427|455678197|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
126650331|NCT00700427|455678198|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
126650332|NCT00700427|455678199|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
126650333|NCT00700427|455678195|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
126650334|NCT00700427|455678196|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
126650335|NCT00700427|455678197|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
126650336|NCT00700427|455678198|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
126650337|NCT00700427|455678199|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
126650338|NCT00700427|455678195|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
126650339|NCT00700427|455678196|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
126650340|NCT00700427|455678197|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
126650341|NCT00700427|455678198|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
126650342|NCT00700427|455678199|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
126650343|NCT00700427|455678195|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
126650344|NCT00700427|455678196|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
126650345|NCT00700427|455678197|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
126650346|NCT00700427|455678198|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
126650347|NCT00700427|455678199|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
126650348|NCT00700427|455678195|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
126650349|NCT00700427|455678196|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
126650350|NCT00700427|455678197|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
126650351|NCT00700427|455678198|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
126650352|NCT00700427|455678199|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
126650353|NCT00700427|455678195|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
126650354|NCT00700427|455678196|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
126650355|NCT00700427|455678197|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
126650356|NCT00700427|455678198|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
126650357|NCT00700427|455678199|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
126650358|NCT00700427|455678195|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
126650359|NCT00700427|455678196|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
126650360|NCT00700427|455678197|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
126650361|NCT00700427|455678198|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
126650362|NCT00700427|455678199|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
126650363|NCT00700427|455678195|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
126650364|NCT00700427|455678196|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
126650365|NCT00700427|455678197|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
126650366|NCT00700427|455678198|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
126650367|NCT00700427|455678199|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
126650368|NCT00700427|455678195|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
126650369|NCT00700427|455678196|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
126650370|NCT00700427|455678197|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
126650371|NCT00700427|455678198|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
126650372|NCT00700427|455678199|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
126650373|NCT00700427|455678195|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
126650374|NCT00700427|455678196|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
126650375|NCT00700427|455678197|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
126650376|NCT00700427|455678198|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
126650377|NCT00700427|455678199|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
126650378|NCT00700427|455678195|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
126650379|NCT00700427|455678196|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
126650380|NCT00700427|455678197|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
126650381|NCT00700427|455678198|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
126650382|NCT00700427|455678199|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
126318474|NCT01172808|454457924|FG001|Overall Study|Adverse Event|4|||
126318475|NCT01172808|454457925|FG002|Overall Study|Adverse Event|8|||
126318476|NCT01172808|454457926|FG003|Overall Study|Adverse Event|3|||
126318477|NCT01172808|454457923|FG000|Overall Study|Lack of Efficacy|1|||
126318478|NCT01172808|454457924|FG001|Overall Study|Lack of Efficacy|0|||
126318479|NCT01172808|454457925|FG002|Overall Study|Lack of Efficacy|0|||
126318480|NCT01172808|454457926|FG003|Overall Study|Lack of Efficacy|0|||
126318481|NCT01172808|454457923|FG000|Overall Study|Protocol Violation|2|||
126650383|NCT00700427|455678195|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
126650384|NCT00700427|455678196|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
126650385|NCT00700427|455678197|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
126650386|NCT00700427|455678198|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
126650387|NCT00700427|455678199|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
126650388|NCT00700427|455678195|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
126650389|NCT00700427|455678196|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
126650390|NCT00700427|455678197|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
126650391|NCT00700427|455678198|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
126650392|NCT00700427|455678199|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
126650393|NCT00700427|455678195|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
126650394|NCT00700427|455678196|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
126650395|NCT00700427|455678197|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
126650396|NCT00700427|455678198|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
126650397|NCT00700427|455678199|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
126650398|NCT00700427|455678195|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
126650399|NCT00700427|455678196|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
126650400|NCT00700427|455678197|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
126650401|NCT00700427|455678198|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
126650402|NCT00700427|455678199|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
126650403|NCT00700427|455678195|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
126650404|NCT00700427|455678196|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
126650405|NCT00700427|455678197|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
126650406|NCT00700427|455678198|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
126650407|NCT00700427|455678199|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
126650408|NCT00700427|455678195|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
126650409|NCT00700427|455678196|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
126650410|NCT00700427|455678197|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
126650411|NCT00700427|455678198|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
126650412|NCT00700427|455678199|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
126650413|NCT00700427|455678195|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
126650414|NCT00700427|455678196|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
126650415|NCT00700427|455678197|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
126650416|NCT00700427|455678198|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
126650417|NCT00700427|455678199|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
126650418|NCT00700427|455678195|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
126650419|NCT00700427|455678196|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
126650420|NCT00700427|455678197|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
126650421|NCT00700427|455678198|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
126650422|NCT00700427|455678199|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
126650423|NCT00700427|455678195|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
126650424|NCT00700427|455678196|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
126650425|NCT00700427|455678197|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
126650426|NCT00700427|455678198|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
126650427|NCT00700427|455678199|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
126650428|NCT00700427|455678195|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
126650429|NCT00700427|455678196|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
126650430|NCT00700427|455678197|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
126650431|NCT00700427|455678198|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
126650432|NCT00700427|455678199|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
126650433|NCT00700427|455678195|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
126318482|NCT01172808|454457924|FG001|Overall Study|Protocol Violation|2|||
126318483|NCT01172808|454457925|FG002|Overall Study|Protocol Violation|2|||
126318484|NCT01172808|454457926|FG003|Overall Study|Protocol Violation|0|||
126650434|NCT00700427|455678196|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
126650435|NCT00700427|455678197|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
126318485|NCT01172808|454457923|FG000|Overall Study|Lost to Follow-up|0|||
126650436|NCT00700427|455678198|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
126318486|NCT01172808|454457924|FG001|Overall Study|Lost to Follow-up|1|||
126318487|NCT01172808|454457925|FG002|Overall Study|Lost to Follow-up|1|||
126650437|NCT00700427|455678199|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
126650438|NCT00700427|455678195|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
126650439|NCT00700427|455678196|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
126650440|NCT00700427|455678197|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
126650441|NCT00700427|455678198|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
126650442|NCT00700427|455678199|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
126650443|NCT00700427|455678195|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
126650444|NCT00700427|455678196|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
126650445|NCT00700427|455678197|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
126650446|NCT00700427|455678198|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
126650447|NCT00700427|455678199|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
126650448|NCT00700427|455678195|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
126650449|NCT00700427|455678196|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
126650450|NCT00700427|455678197|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
126650451|NCT00700427|455678198|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
126650452|NCT00700427|455678199|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
126650453|NCT00700427|455678195|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
126650454|NCT00700427|455678196|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
126650455|NCT00700427|455678197|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
126650456|NCT00700427|455678198|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
126650457|NCT00700427|455678199|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
126650458|NCT00700427|455678195|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
126650459|NCT00700427|455678196|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
126650460|NCT00700427|455678197|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
126650461|NCT00700427|455678198|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
126650462|NCT00700427|455678199|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
126650463|NCT00424385|455678200|FG000|Cohort 0|Withdrawal by Subject|5|||
126650464|NCT00424385|455678200|FG000|Cohort 0|Physician Decision|1|||
126650465|NCT00424385|455678200|FG000|Cohort 1|Withdrawal by Subject|1|||
126650466|NCT02683876|455678201|FG000|Overall Study|samples damaged during shipping|2|||
126650467|NCT02683876|455678202|FG001|Overall Study|samples damaged during shipping|0|||
126650468|NCT03231800|455678209|FG000|Overall Study|Lost to Follow-up|0|||
126650469|NCT03231800|455678210|FG001|Overall Study|Lost to Follow-up|2|||
126650470|NCT03231800|455678209|FG000|Overall Study|Protocol Violation|1|||
126650471|NCT03231800|455678210|FG001|Overall Study|Protocol Violation|1|||
126650472|NCT03231800|455678209|FG000|Overall Study|reason not provided|2|||
126650473|NCT03231800|455678210|FG001|Overall Study|reason not provided|0|||
126650474|NCT00859222|455678211|FG000|Overall Study|Adverse Event|2|||
126650475|NCT00859222|455678212|FG001|Overall Study|Adverse Event|3|||
126650476|NCT00859222|455678213|FG002|Overall Study|Adverse Event|6|||
126650477|NCT00859222|455678214|FG003|Overall Study|Adverse Event|24|||
126650478|NCT00859222|455678215|FG004|Overall Study|Adverse Event|15|||
126650479|NCT00859222|455678211|FG000|Overall Study|DLT|1|||
126650480|NCT00859222|455678212|FG001|Overall Study|DLT|0|||
126650481|NCT00859222|455678213|FG002|Overall Study|DLT|0|||
126650482|NCT00859222|455678214|FG003|Overall Study|DLT|0|||
126650483|NCT00859222|455678215|FG004|Overall Study|DLT|0|||
126650484|NCT00400725|455678226|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
126650485|NCT00400725|455678227|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
126650486|NCT00400725|455678228|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
126650487|NCT00400725|455678226|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
126650488|NCT00400725|455678227|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
126650489|NCT00400725|455678228|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
126650490|NCT00400725|455678226|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
126650491|NCT00400725|455678227|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
126650492|NCT00400725|455678228|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
126650493|NCT00400725|455678226|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
126650494|NCT00400725|455678227|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
126650495|NCT00400725|455678228|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
126650496|NCT00400725|455678226|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
126650497|NCT00400725|455678227|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
126650498|NCT00400725|455678228|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
126650499|NCT00400725|455678226|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
126650500|NCT00400725|455678227|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
126650501|NCT00400725|455678228|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
126650502|NCT00400725|455678226|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
126650503|NCT00400725|455678227|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
126650504|NCT00400725|455678228|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
126650505|NCT00400725|455678226|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
126650506|NCT00400725|455678227|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
126650507|NCT00400725|455678228|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
126318488|NCT01172808|454457926|FG003|Overall Study|Lost to Follow-up|3|||
126318489|NCT01172808|454457923|FG000|Overall Study|Withdrawal by Subject|4|||
126318490|NCT01172808|454457924|FG001|Overall Study|Withdrawal by Subject|1|||
126318491|NCT01172808|454457925|FG002|Overall Study|Withdrawal by Subject|3|||
126318492|NCT01172808|454457926|FG003|Overall Study|Withdrawal by Subject|2|||
126650508|NCT00400725|455678226|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
126650509|NCT00400725|455678227|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
126318493|NCT01172808|454457923|FG000|Overall Study|Other|6|||
126318494|NCT01172808|454457924|FG001|Overall Study|Other|5|||
126318495|NCT01172808|454457925|FG002|Overall Study|Other|9|||
126318496|NCT01172808|454457926|FG003|Overall Study|Other|7|||
126318497|NCT01937715|454457938|FG000|Overall Study|Death|0|||
126318498|NCT01937715|454457939|FG001|Overall Study|Death|0|||
126318499|NCT01937715|454457940|FG002|Overall Study|Death|0|||
126318500|NCT01937715|454457941|FG003|Overall Study|Death|1|||
126318501|NCT01937715|454457942|FG004|Overall Study|Death|0|||
126318502|NCT01937715|454457938|FG000|Overall Study|Withdrawal by Subject|0|||
126318503|NCT01937715|454457939|FG001|Overall Study|Withdrawal by Subject|1|||
126318504|NCT01937715|454457940|FG002|Overall Study|Withdrawal by Subject|0|||
126318505|NCT01937715|454457941|FG003|Overall Study|Withdrawal by Subject|0|||
126318506|NCT01937715|454457942|FG004|Overall Study|Withdrawal by Subject|2|||
126318507|NCT01937715|454457938|FG000|Overall Study|Other|0|||
126318508|NCT01937715|454457939|FG001|Overall Study|Other|0|||
126318509|NCT01937715|454457940|FG002|Overall Study|Other|0|||
126318510|NCT01937715|454457941|FG003|Overall Study|Other|3|||
126318511|NCT01937715|454457942|FG004|Overall Study|Other|0|||
126318512|NCT05459558|454457943|FG000|Overall Study|Adverse Event|1|||
126318513|NCT05459558|454457944|FG001|Overall Study|Adverse Event|0|||
126318514|NCT05459558|454457945|FG002|Overall Study|Adverse Event|0|||
126318515|NCT05459558|454457943|FG000|Overall Study|Scheduling issue|0|||
126318516|NCT05459558|454457944|FG001|Overall Study|Scheduling issue|1|||
126318517|NCT05459558|454457945|FG002|Overall Study|Scheduling issue|3|||
126318518|NCT05459558|454457943|FG000|Overall Study|Withdrawal by Subject|0|||
126318519|NCT05459558|454457944|FG001|Overall Study|Withdrawal by Subject|0|||
126318520|NCT05459558|454457945|FG002|Overall Study|Withdrawal by Subject|2|||
126318521|NCT01092637|454457947|FG000|Overall Study|Death|47|||
126318522|NCT01092637|454457948|FG001|Overall Study|Death|49|||
126318523|NCT03292458|454457950|FG000|Period 1|Adverse Event|2|||
126318524|NCT03292458|454457951|FG001|Period 1|Adverse Event|0|||
126318525|NCT00593606|454457952|FG000|Overall Study|Adverse Event|13|||
126318526|NCT00593606|454457952|FG000|Overall Study|Withdrawal by Subject|1|||
126318527|NCT00593606|454457952|FG000|Overall Study|Protocol Violation|3|||
126318528|NCT00593606|454457952|FG000|Overall Study|Lost to Follow-up|2|||
126318529|NCT00593606|454457952|FG000|Overall Study|Run-In Failure|5|||
126318530|NCT00593606|454457952|FG000|Overall Study|Screen Failure|3|||
126318531|NCT02278367|454457953|FG000|Overall Study|Physician Decision|5|||
126318532|NCT02278367|454457954|FG001|Overall Study|Physician Decision|0|||
126318533|NCT02278367|454457953|FG000|Overall Study|Withdrawal by Subject|5|||
126318534|NCT02278367|454457954|FG001|Overall Study|Withdrawal by Subject|0|||
126318535|NCT04643964|454457956|FG000|Overall Study|Lost to Follow-up|55|||
126318536|NCT04643964|454457957|FG001|Overall Study|Lost to Follow-up|59|||
126318537|NCT04643964|454457958|FG002|Overall Study|Lost to Follow-up|54|||
126318538|NCT04643964|454457959|FG003|Overall Study|Lost to Follow-up|129|||
126318539|NCT04643964|454457960|FG004|Overall Study|Lost to Follow-up|48|||
126318540|NCT04643964|454457956|FG000|Overall Study|Failed attention check|1|||
126318541|NCT04643964|454457957|FG001|Overall Study|Failed attention check|8|||
126318542|NCT04643964|454457958|FG002|Overall Study|Failed attention check|2|||
126318543|NCT04643964|454457959|FG003|Overall Study|Failed attention check|14|||
126318544|NCT04643964|454457960|FG004|Overall Study|Failed attention check|11|||
126318545|NCT05932225|454457961|FG000|Overall Study|Lost to Follow-up|0|||
126318546|NCT05932225|454457962|FG001|Overall Study|Lost to Follow-up|1|||
126318547|NCT05932225|454457963|FG002|Overall Study|Lost to Follow-up|0|||
126318548|NCT05932225|454457961|FG000|Overall Study|Withdrawal by Subject|1|||
126650510|NCT00400725|455678228|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
126318549|NCT05932225|454457962|FG001|Overall Study|Withdrawal by Subject|0|||
126318550|NCT05932225|454457963|FG002|Overall Study|Withdrawal by Subject|0|||
126318551|NCT05932225|454457961|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
126318552|NCT05932225|454457962|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
126318553|NCT05932225|454457963|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
126318554|NCT02638129|454457964|FG000|Overall Study|Study terminated|28|||
126318555|NCT02638129|454457965|FG001|Overall Study|Study terminated|30|||
126318556|NCT02949908|454457966|FG000|Overall Study|Study termination|2|||
126318557|NCT01472939|454457967|FG000|Overall Study|Adverse Event|3|||
126650511|NCT00888927|455678236|FG000|Overall Study|Adverse Event|0|||
126318558|NCT01472939|454457968|FG001|Overall Study|Adverse Event|7|||
126318559|NCT01472939|454457969|FG002|Overall Study|Adverse Event|7|||
126318560|NCT01472939|454457970|FG003|Overall Study|Adverse Event|14|||
126318561|NCT01472939|454457967|FG000|Overall Study|Lack of Efficacy|1|||
126318562|NCT01472939|454457968|FG001|Overall Study|Lack of Efficacy|0|||
126318563|NCT01472939|454457969|FG002|Overall Study|Lack of Efficacy|0|||
126318564|NCT01472939|454457970|FG003|Overall Study|Lack of Efficacy|1|||
126318565|NCT01472939|454457967|FG000|Overall Study|Lost to Follow-up|3|||
126318566|NCT01472939|454457968|FG001|Overall Study|Lost to Follow-up|0|||
126318567|NCT01472939|454457969|FG002|Overall Study|Lost to Follow-up|2|||
126318568|NCT01472939|454457970|FG003|Overall Study|Lost to Follow-up|0|||
126318569|NCT01472939|454457967|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
126318570|NCT01472939|454457968|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
126318571|NCT01472939|454457969|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
126318572|NCT01472939|454457970|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
126318573|NCT01472939|454457967|FG000|Overall Study|Prohibited Medication|0|||
126318574|NCT01472939|454457968|FG001|Overall Study|Prohibited Medication|1|||
126318575|NCT01472939|454457969|FG002|Overall Study|Prohibited Medication|0|||
126318576|NCT01472939|454457970|FG003|Overall Study|Prohibited Medication|0|||
126318577|NCT01472939|454457967|FG000|Overall Study|Withdrawal By PI|1|||
126318578|NCT01472939|454457968|FG001|Overall Study|Withdrawal By PI|0|||
126318579|NCT01472939|454457969|FG002|Overall Study|Withdrawal By PI|0|||
126318580|NCT01472939|454457970|FG003|Overall Study|Withdrawal By PI|0|||
126318581|NCT01472939|454457967|FG000|Overall Study|Protocol Violation|3|||
126318582|NCT01472939|454457968|FG001|Overall Study|Protocol Violation|3|||
126318583|NCT01472939|454457969|FG002|Overall Study|Protocol Violation|0|||
126318584|NCT01472939|454457970|FG003|Overall Study|Protocol Violation|1|||
126318585|NCT01472939|454457967|FG000|Overall Study|Withdrawal by Subject|9|||
126318586|NCT01472939|454457968|FG001|Overall Study|Withdrawal by Subject|3|||
126318587|NCT01472939|454457969|FG002|Overall Study|Withdrawal by Subject|1|||
126318588|NCT01472939|454457970|FG003|Overall Study|Withdrawal by Subject|4|||
126318589|NCT00114738|454457971|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
126318590|NCT00114738|454457972|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
126318591|NCT00114738|454457973|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
126318592|NCT00114738|454457971|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
126318593|NCT00114738|454457972|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
126318594|NCT00114738|454457973|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
126318595|NCT00114738|454457971|FG000|Screening for Randomization|Neuropathy|17|||
126318596|NCT00114738|454457972|FG001|Screening for Randomization|Neuropathy|0|||
126318597|NCT00114738|454457973|FG002|Screening for Randomization|Neuropathy|0|||
126318598|NCT00114738|454457971|FG000|Screening for Randomization|Progressive disease|2|||
126318599|NCT00114738|454457972|FG001|Screening for Randomization|Progressive disease|0|||
126318600|NCT00114738|454457973|FG002|Screening for Randomization|Progressive disease|0|||
126318601|NCT00114738|454457971|FG000|Screening for Randomization|CNS Hemorrhage|1|||
126318602|NCT00114738|454457972|FG001|Screening for Randomization|CNS Hemorrhage|0|||
126318603|NCT00114738|454457973|FG002|Screening for Randomization|CNS Hemorrhage|0|||
126318604|NCT00114738|454457971|FG000|Screening for Randomization|Other|1|||
126318605|NCT00114738|454457972|FG001|Screening for Randomization|Other|0|||
126318606|NCT00114738|454457973|FG002|Screening for Randomization|Other|0|||
126318607|NCT00308750|454457978|FG000|Overall Study|Adverse Event|9|||
126318608|NCT00308750|454457979|FG001|Overall Study|Adverse Event|9|||
126318609|NCT00308750|454457980|FG002|Overall Study|Adverse Event|13|||
126650512|NCT00888927|455678237|FG001|Overall Study|Adverse Event|0|||
126650513|NCT00888927|455678238|FG002|Overall Study|Adverse Event|0|||
126650514|NCT00888927|455678239|FG003|Overall Study|Adverse Event|1|||
126650515|NCT00888927|455678236|FG000|Overall Study|Withdrawal of consent|0|||
126650516|NCT00888927|455678237|FG001|Overall Study|Withdrawal of consent|0|||
126650517|NCT00888927|455678238|FG002|Overall Study|Withdrawal of consent|0|||
126650518|NCT00888927|455678239|FG003|Overall Study|Withdrawal of consent|1|||
126650519|NCT03459443|455678240|FG000|Overall Study|Lack of Efficacy|3|||
126650520|NCT03459443|455678240|FG000|Overall Study|Adverse Event|1|||
126650521|NCT03459443|455678240|FG000|Overall Study|Sponsor's decision to close the study|18|||
126650522|NCT01080716|455678241|FG000|Part 1|Physician Decision|1|||
126650523|NCT01080716|455678242|FG001|Part 1|Physician Decision|0|||
126650524|NCT01080716|455678243|FG002|Part 1|Physician Decision|0|||
126650525|NCT01080716|455678244|FG003|Part 1|Physician Decision|0|||
126650526|NCT03189745|455678245|FG000|Overall Study|Conflict in work schedule of participant|1|||
126318610|NCT00308750|454457978|FG000|Overall Study|Withdrawal by Subject|6|||
126318611|NCT00308750|454457979|FG001|Overall Study|Withdrawal by Subject|2|||
126318612|NCT00308750|454457980|FG002|Overall Study|Withdrawal by Subject|3|||
126318613|NCT00308750|454457978|FG000|Overall Study|Physician Decision|3|||
126318614|NCT00308750|454457979|FG001|Overall Study|Physician Decision|4|||
126318615|NCT00308750|454457980|FG002|Overall Study|Physician Decision|3|||
126650527|NCT03189745|455678246|FG001|Overall Study|Conflict in work schedule of participant|1|||
126650528|NCT01056718|455678247|FG000|Overall Study|Withdrawal by Subject|2|||
126650529|NCT01056718|455678247|FG000|Overall Study|Ischemia on baseline stress test|1|||
126318616|NCT00308750|454457978|FG000|Overall Study|Sponsor Decision|1|||
126318617|NCT00308750|454457979|FG001|Overall Study|Sponsor Decision|0|||
126650530|NCT05086276|455678248|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
126650531|NCT05086276|455678249|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
126318618|NCT00308750|454457980|FG002|Overall Study|Sponsor Decision|0|||
126318619|NCT00308750|454457978|FG000|Overall Study|Disease Progression|47|||
126318620|NCT00308750|454457979|FG001|Overall Study|Disease Progression|24|||
126318621|NCT00308750|454457980|FG002|Overall Study|Disease Progression|28|||
126318622|NCT00308750|454457978|FG000|Overall Study|Unrelated Complication|3|||
126318623|NCT00308750|454457979|FG001|Overall Study|Unrelated Complication|0|||
126318624|NCT00308750|454457980|FG002|Overall Study|Unrelated Complication|1|||
126318625|NCT00308750|454457978|FG000|Overall Study|Death|1|||
126318626|NCT00308750|454457979|FG001|Overall Study|Death|0|||
126318627|NCT00308750|454457980|FG002|Overall Study|Death|1|||
126318628|NCT00308750|454457978|FG000|Overall Study|Protocol Violation|1|||
126318629|NCT00308750|454457979|FG001|Overall Study|Protocol Violation|0|||
126318630|NCT00308750|454457980|FG002|Overall Study|Protocol Violation|0|||
126318631|NCT00308750|454457978|FG000|Overall Study|New Primary Disease Identified|1|||
126318632|NCT00308750|454457979|FG001|Overall Study|New Primary Disease Identified|1|||
126318633|NCT00308750|454457980|FG002|Overall Study|New Primary Disease Identified|0|||
126318634|NCT01358578|454457981|FG000|Induction Period|Adverse Event|2|||
126318635|NCT01358578|454457982|FG001|Induction Period|Adverse Event|4|||
126318636|NCT01358578|454457983|FG002|Induction Period|Adverse Event|2|||
126318637|NCT01358578|454457984|FG003|Induction Period|Adverse Event|6|||
126318638|NCT01358578|454457985|FG004|Induction Period|Adverse Event|0|||
126318639|NCT01358578|454457986|FG005|Induction Period|Adverse Event|0|||
126650532|NCT00777088|455678250|FG000|Overall Study|PED Treatment not attempted|1|||
126650533|NCT00287690|455678251|FG000|Overall Study|Protocol Violation|20|||
126650534|NCT00287690|455678252|FG001|Overall Study|Protocol Violation|26|||
126650535|NCT03592745|455678253|FG000|Overall Study|Adverse Event|0|||
126650536|NCT03592745|455678254|FG001|Overall Study|Adverse Event|2|||
126650537|NCT03592745|455678253|FG000|Overall Study|Lost to Follow-up|2|||
126650538|NCT03592745|455678254|FG001|Overall Study|Lost to Follow-up|0|||
126650539|NCT03592745|455678253|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
126650540|NCT03592745|455678254|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
126650541|NCT05017103|455678255|FG000|Overall Study|Death|2|||
126650542|NCT03406078|455678257|FG000|Overall Study|Death|1|||
126650543|NCT03406078|455678258|FG001|Overall Study|Death|0|||
126650544|NCT03406078|455678257|FG000|Overall Study|Lost to Follow-up|0|||
126650545|NCT03406078|455678258|FG001|Overall Study|Lost to Follow-up|1|||
126318640|NCT01358578|454457981|FG000|Induction Period|Lack of Efficacy|0|||
126318641|NCT01358578|454457982|FG001|Induction Period|Lack of Efficacy|0|||
126318642|NCT01358578|454457983|FG002|Induction Period|Lack of Efficacy|9|||
126318643|NCT01358578|454457984|FG003|Induction Period|Lack of Efficacy|1|||
126318644|NCT01358578|454457985|FG004|Induction Period|Lack of Efficacy|0|||
126318645|NCT01358578|454457986|FG005|Induction Period|Lack of Efficacy|0|||
126650546|NCT03406078|455678257|FG000|Overall Study|Withdrawal by Subject|5|||
126650547|NCT03406078|455678258|FG001|Overall Study|Withdrawal by Subject|2|||
126650548|NCT03117998|455678260|FG000|Overall Study|Adverse Event|1|||
126650549|NCT03117998|455678261|FG001|Overall Study|Adverse Event|0|||
126318646|NCT01358578|454457981|FG000|Induction Period|Lost to Follow-up|0|||
126544955|NCT00462670|455289159|FG000|Overall Study|Lack of Efficacy|1|||
126544956|NCT00462670|455289160|FG001|Overall Study|Lack of Efficacy|0|||
126544957|NCT00462670|455289159|FG000|Overall Study|Protocol Violation|1|||
126544958|NCT00462670|455289160|FG001|Overall Study|Protocol Violation|0|||
126544959|NCT00462670|455289159|FG000|Overall Study|Resolution of signs and symptoms|0|||
126544960|NCT00462670|455289160|FG001|Overall Study|Resolution of signs and symptoms|2|||
126544961|NCT02110732|455289161|FG000|Overall Study|Physician Decision|5|||
126544962|NCT02110732|455289162|FG001|Overall Study|Physician Decision|2|||
126544963|NCT02110732|455289161|FG000|Overall Study|Lost to Follow-up|1|||
126544964|NCT02110732|455289162|FG001|Overall Study|Lost to Follow-up|1|||
126544965|NCT00633932|455289163|FG000|Overall Study|Adverse Event|1|||
126544966|NCT00633932|455289164|FG001|Overall Study|Adverse Event|3|||
126544967|NCT00633932|455289165|FG002|Overall Study|Adverse Event|4|||
126544968|NCT00633932|455289163|FG000|Overall Study|Withdrawal by Subject|3|||
126544969|NCT00633932|455289164|FG001|Overall Study|Withdrawal by Subject|9|||
126544970|NCT00633932|455289165|FG002|Overall Study|Withdrawal by Subject|1|||
126544971|NCT00633932|455289163|FG000|Overall Study|Lost to Follow-up|1|||
126650550|NCT03117998|455678262|FG002|Overall Study|Adverse Event|0|||
126650551|NCT03117998|455678263|FG003|Overall Study|Adverse Event|0|||
126650552|NCT03117998|455678264|FG004|Overall Study|Adverse Event|0|||
126544972|NCT00633932|455289164|FG001|Overall Study|Lost to Follow-up|0|||
126544973|NCT00633932|455289165|FG002|Overall Study|Lost to Follow-up|2|||
126544974|NCT00633932|455289163|FG000|Overall Study|Protocol Violation|5|||
126544975|NCT00633932|455289164|FG001|Overall Study|Protocol Violation|2|||
126650553|NCT03117998|455678265|FG005|Overall Study|Adverse Event|0|||
126650554|NCT03117998|455678260|FG000|Overall Study|Withdrawal by Subject|0|||
126650555|NCT03117998|455678261|FG001|Overall Study|Withdrawal by Subject|0|||
126318647|NCT01358578|454457982|FG001|Induction Period|Lost to Follow-up|0|||
126318648|NCT01358578|454457983|FG002|Induction Period|Lost to Follow-up|1|||
126318649|NCT01358578|454457984|FG003|Induction Period|Lost to Follow-up|4|||
126318650|NCT01358578|454457985|FG004|Induction Period|Lost to Follow-up|0|||
126544976|NCT00633932|455289165|FG002|Overall Study|Protocol Violation|3|||
126650556|NCT03117998|455678262|FG002|Overall Study|Withdrawal by Subject|2|||
126650557|NCT03117998|455678263|FG003|Overall Study|Withdrawal by Subject|3|||
126650558|NCT03117998|455678264|FG004|Overall Study|Withdrawal by Subject|3|||
126650559|NCT03117998|455678265|FG005|Overall Study|Withdrawal by Subject|0|||
126650560|NCT03117998|455678260|FG000|Overall Study|Physician Decision|0|||
126650561|NCT03117998|455678261|FG001|Overall Study|Physician Decision|1|||
126650562|NCT03117998|455678262|FG002|Overall Study|Physician Decision|1|||
126650563|NCT03117998|455678263|FG003|Overall Study|Physician Decision|0|||
126650564|NCT03117998|455678264|FG004|Overall Study|Physician Decision|0|||
126650565|NCT03117998|455678265|FG005|Overall Study|Physician Decision|0|||
126650566|NCT03117998|455678260|FG000|Overall Study|Lost to Follow-up|0|||
126650567|NCT03117998|455678261|FG001|Overall Study|Lost to Follow-up|0|||
126650568|NCT03117998|455678262|FG002|Overall Study|Lost to Follow-up|0|||
126650569|NCT03117998|455678263|FG003|Overall Study|Lost to Follow-up|1|||
126650570|NCT03117998|455678264|FG004|Overall Study|Lost to Follow-up|4|||
126650571|NCT03117998|455678265|FG005|Overall Study|Lost to Follow-up|0|||
126650572|NCT03117998|455678260|FG000|Overall Study|Subject noncompliance|0|||
126650573|NCT03117998|455678261|FG001|Overall Study|Subject noncompliance|0|||
126650574|NCT03117998|455678262|FG002|Overall Study|Subject noncompliance|1|||
126650575|NCT03117998|455678263|FG003|Overall Study|Subject noncompliance|0|||
126650576|NCT03117998|455678264|FG004|Overall Study|Subject noncompliance|0|||
126650577|NCT03117998|455678265|FG005|Overall Study|Subject noncompliance|2|||
126650578|NCT03117998|455678260|FG000|Overall Study|Protocol Violation|0|||
126650579|NCT03117998|455678261|FG001|Overall Study|Protocol Violation|0|||
126650580|NCT03117998|455678262|FG002|Overall Study|Protocol Violation|0|||
126650581|NCT03117998|455678263|FG003|Overall Study|Protocol Violation|0|||
126650582|NCT03117998|455678264|FG004|Overall Study|Protocol Violation|0|||
126650583|NCT03117998|455678265|FG005|Overall Study|Protocol Violation|1|||
126650584|NCT00350103|455678269|FG000|Overall Study|Adverse Event|12|||
126650585|NCT00350103|455678270|FG001|Overall Study|Adverse Event|29|||
126650586|NCT00350103|455678271|FG002|Overall Study|Adverse Event|17|||
126650587|NCT00350103|455678269|FG000|Overall Study|Lack of Efficacy|5|||
126650588|NCT00350103|455678270|FG001|Overall Study|Lack of Efficacy|1|||
126650589|NCT00350103|455678271|FG002|Overall Study|Lack of Efficacy|3|||
126650590|NCT00350103|455678269|FG000|Overall Study|Withdrawal by Subject|6|||
126650591|NCT00350103|455678270|FG001|Overall Study|Withdrawal by Subject|6|||
126650592|NCT00350103|455678271|FG002|Overall Study|Withdrawal by Subject|8|||
126650593|NCT00350103|455678269|FG000|Overall Study|Protocol Violation|0|||
126650594|NCT00350103|455678270|FG001|Overall Study|Protocol Violation|0|||
126650595|NCT00350103|455678271|FG002|Overall Study|Protocol Violation|1|||
126650596|NCT00350103|455678269|FG000|Overall Study|Unsatisfactory Compliance|2|||
126650597|NCT00350103|455678270|FG001|Overall Study|Unsatisfactory Compliance|2|||
126650598|NCT00350103|455678271|FG002|Overall Study|Unsatisfactory Compliance|1|||
126650599|NCT00350103|455678269|FG000|Overall Study|Investigator´s decision|1|||
126650600|NCT00350103|455678270|FG001|Overall Study|Investigator´s decision|1|||
126650601|NCT00350103|455678271|FG002|Overall Study|Investigator´s decision|0|||
126650602|NCT00350103|455678269|FG000|Overall Study|Exclusion criteria met|0|||
126650603|NCT00350103|455678270|FG001|Overall Study|Exclusion criteria met|0|||
126650604|NCT00350103|455678271|FG002|Overall Study|Exclusion criteria met|1|||
126650605|NCT00350103|455678269|FG000|Overall Study|Patient relocated|0|||
126650606|NCT00350103|455678270|FG001|Overall Study|Patient relocated|0|||
126650607|NCT00350103|455678271|FG002|Overall Study|Patient relocated|1|||
126650608|NCT00350103|455678269|FG000|Overall Study|Need for prohibited medication|1|||
126650609|NCT00350103|455678270|FG001|Overall Study|Need for prohibited medication|0|||
126650610|NCT00350103|455678271|FG002|Overall Study|Need for prohibited medication|0|||
126650611|NCT00350103|455678269|FG000|Overall Study|Personal reasons|0|||
126650612|NCT00350103|455678270|FG001|Overall Study|Personal reasons|0|||
126650613|NCT00350103|455678271|FG002|Overall Study|Personal reasons|1|||
126650614|NCT00350103|455678269|FG000|Overall Study|Patient stopped feeling pain|1|||
126650615|NCT00350103|455678270|FG001|Overall Study|Patient stopped feeling pain|0|||
126650616|NCT00350103|455678271|FG002|Overall Study|Patient stopped feeling pain|0|||
126650617|NCT00350103|455678269|FG000|Overall Study|PR greater than 250ms|0|||
126650618|NCT00350103|455678270|FG001|Overall Study|PR greater than 250ms|0|||
126650619|NCT00350103|455678271|FG002|Overall Study|PR greater than 250ms|1|||
126650620|NCT00350103|455678269|FG000|Overall Study|Wrong calculation of QT interval|0|||
126650621|NCT00350103|455678270|FG001|Overall Study|Wrong calculation of QT interval|0|||
126650622|NCT00350103|455678271|FG002|Overall Study|Wrong calculation of QT interval|1|||
126650623|NCT00350103|455678269|FG000|Overall Study|Sponsor mistake|1|||
126650624|NCT00350103|455678270|FG001|Overall Study|Sponsor mistake|0|||
126650625|NCT00350103|455678271|FG002|Overall Study|Sponsor mistake|0|||
126650626|NCT00350103|455678269|FG000|Overall Study|Randomization mistake|0|||
126650627|NCT00350103|455678270|FG001|Overall Study|Randomization mistake|1|||
126650628|NCT00350103|455678271|FG002|Overall Study|Randomization mistake|1|||
126650629|NCT00350103|455678269|FG000|Overall Study|Sponsor´s decision|0|||
126650630|NCT00350103|455678270|FG001|Overall Study|Sponsor´s decision|1|||
126650631|NCT00350103|455678271|FG002|Overall Study|Sponsor´s decision|0|||
126650632|NCT00350103|455678269|FG000|Overall Study|Lost, Reason unknown|1|||
126650633|NCT00350103|455678270|FG001|Overall Study|Lost, Reason unknown|1|||
126318651|NCT01358578|454457986|FG005|Induction Period|Lost to Follow-up|0|||
126318652|NCT01358578|454457981|FG000|Induction Period|Physician Decision|2|||
126318653|NCT01358578|454457982|FG001|Induction Period|Physician Decision|1|||
126318654|NCT01358578|454457983|FG002|Induction Period|Physician Decision|2|||
126318655|NCT01358578|454457984|FG003|Induction Period|Physician Decision|0|||
126318656|NCT01358578|454457985|FG004|Induction Period|Physician Decision|0|||
126318657|NCT01358578|454457986|FG005|Induction Period|Physician Decision|0|||
126318658|NCT01358578|454457981|FG000|Induction Period|Protocol Deviation|3|||
126318659|NCT01358578|454457982|FG001|Induction Period|Protocol Deviation|5|||
126318660|NCT01358578|454457983|FG002|Induction Period|Protocol Deviation|0|||
126318661|NCT01358578|454457984|FG003|Induction Period|Protocol Deviation|3|||
126318662|NCT01358578|454457985|FG004|Induction Period|Protocol Deviation|0|||
126318663|NCT01358578|454457986|FG005|Induction Period|Protocol Deviation|0|||
126318664|NCT01358578|454457981|FG000|Induction Period|technical problems|0|||
126318665|NCT01358578|454457982|FG001|Induction Period|technical problems|0|||
126318666|NCT01358578|454457983|FG002|Induction Period|technical problems|1|||
126318667|NCT01358578|454457984|FG003|Induction Period|technical problems|1|||
126318668|NCT01358578|454457985|FG004|Induction Period|technical problems|0|||
126318669|NCT01358578|454457986|FG005|Induction Period|technical problems|0|||
126318670|NCT01358578|454457981|FG000|Induction Period|Withdrawal by Subject|5|||
126318671|NCT01358578|454457982|FG001|Induction Period|Withdrawal by Subject|5|||
126318672|NCT01358578|454457983|FG002|Induction Period|Withdrawal by Subject|10|||
126318673|NCT01358578|454457984|FG003|Induction Period|Withdrawal by Subject|6|||
126318674|NCT01358578|454457985|FG004|Induction Period|Withdrawal by Subject|0|||
126318675|NCT01358578|454457986|FG005|Induction Period|Withdrawal by Subject|0|||
126318676|NCT01358578|454457981|FG000|Maintenance Period|Adverse Event|2|||
126318677|NCT01358578|454457982|FG001|Maintenance Period|Adverse Event|7|||
126318678|NCT01358578|454457983|FG002|Maintenance Period|Adverse Event|0|||
126650634|NCT00350103|455678271|FG002|Overall Study|Lost, Reason unknown|0|||
126650635|NCT00438672|455678272|FG000|Overall Study|Lost to Follow-up|7|||
126650636|NCT00438672|455678273|FG001|Overall Study|Lost to Follow-up|9|||
126650637|NCT02712905|455678274|FG000|Monotherapy|Death|2|||
126650638|NCT02712905|455678275|FG001|Monotherapy|Death|5|||
126650639|NCT02712905|455678276|FG002|Monotherapy|Death|0|||
126650640|NCT02712905|455678277|FG003|Monotherapy|Death|3|||
126650641|NCT02712905|455678278|FG004|Monotherapy|Death|15|||
126650642|NCT02712905|455678279|FG005|Monotherapy|Death|1|||
126650643|NCT02712905|455678280|FG006|Monotherapy|Death|3|||
126650644|NCT02712905|455678281|FG007|Monotherapy|Death|3|||
126650645|NCT02712905|455678282|FG008|Monotherapy|Death|0|||
126650646|NCT02712905|455678283|FG009|Monotherapy|Death|27|||
126650647|NCT02712905|455678284|FG010|Monotherapy|Death|2|||
126650648|NCT02712905|455678285|FG011|Monotherapy|Death|5|||
126650649|NCT02712905|455678286|FG012|Monotherapy|Death|0|||
126650650|NCT02712905|455678287|FG013|Monotherapy|Death|0|||
126650651|NCT02712905|455678288|FG014|Monotherapy|Death|0|||
126650652|NCT02712905|455678289|FG015|Monotherapy|Death|0|||
126650653|NCT02712905|455678290|FG016|Monotherapy|Death|0|||
126650654|NCT02712905|455678291|FG017|Monotherapy|Death|0|||
126650655|NCT02712905|455678274|FG000|Monotherapy|Lost to Follow-up|0|||
126650656|NCT02712905|455678275|FG001|Monotherapy|Lost to Follow-up|1|||
126650657|NCT02712905|455678276|FG002|Monotherapy|Lost to Follow-up|0|||
126650658|NCT02712905|455678277|FG003|Monotherapy|Lost to Follow-up|1|||
126650659|NCT02712905|455678278|FG004|Monotherapy|Lost to Follow-up|0|||
126650660|NCT02712905|455678279|FG005|Monotherapy|Lost to Follow-up|0|||
126650661|NCT02712905|455678280|FG006|Monotherapy|Lost to Follow-up|0|||
126650662|NCT02712905|455678281|FG007|Monotherapy|Lost to Follow-up|0|||
126650663|NCT02712905|455678282|FG008|Monotherapy|Lost to Follow-up|0|||
126650664|NCT02712905|455678283|FG009|Monotherapy|Lost to Follow-up|2|||
126650665|NCT02712905|455678284|FG010|Monotherapy|Lost to Follow-up|0|||
126650666|NCT02712905|455678285|FG011|Monotherapy|Lost to Follow-up|0|||
126650667|NCT02712905|455678286|FG012|Monotherapy|Lost to Follow-up|0|||
126650668|NCT02712905|455678287|FG013|Monotherapy|Lost to Follow-up|0|||
126650669|NCT02712905|455678288|FG014|Monotherapy|Lost to Follow-up|0|||
126318679|NCT01358578|454457984|FG003|Maintenance Period|Adverse Event|6|||
126650670|NCT02712905|455678289|FG015|Monotherapy|Lost to Follow-up|0|||
126318680|NCT01358578|454457985|FG004|Maintenance Period|Adverse Event|4|||
126318681|NCT01358578|454457986|FG005|Maintenance Period|Adverse Event|3|||
126318682|NCT01358578|454457981|FG000|Maintenance Period|Lack of Efficacy|10|||
126318683|NCT01358578|454457982|FG001|Maintenance Period|Lack of Efficacy|2|||
126650671|NCT02712905|455678290|FG016|Monotherapy|Lost to Follow-up|0|||
126650672|NCT02712905|455678291|FG017|Monotherapy|Lost to Follow-up|0|||
126650673|NCT02712905|455678274|FG000|Monotherapy|Physician Decision|1|||
126650674|NCT02712905|455678275|FG001|Monotherapy|Physician Decision|0|||
126650675|NCT02712905|455678276|FG002|Monotherapy|Physician Decision|0|||
126650676|NCT02712905|455678277|FG003|Monotherapy|Physician Decision|1|||
126650677|NCT02712905|455678278|FG004|Monotherapy|Physician Decision|0|||
126650678|NCT02712905|455678279|FG005|Monotherapy|Physician Decision|0|||
126650679|NCT02712905|455678280|FG006|Monotherapy|Physician Decision|0|||
126650680|NCT02712905|455678281|FG007|Monotherapy|Physician Decision|0|||
126650681|NCT02712905|455678282|FG008|Monotherapy|Physician Decision|0|||
126650682|NCT02712905|455678283|FG009|Monotherapy|Physician Decision|1|||
126318684|NCT01358578|454457983|FG002|Maintenance Period|Lack of Efficacy|0|||
126318685|NCT01358578|454457984|FG003|Maintenance Period|Lack of Efficacy|11|||
126318686|NCT01358578|454457985|FG004|Maintenance Period|Lack of Efficacy|3|||
126318687|NCT01358578|454457986|FG005|Maintenance Period|Lack of Efficacy|0|||
126318688|NCT01358578|454457981|FG000|Maintenance Period|Lost to Follow-up|4|||
126318689|NCT01358578|454457982|FG001|Maintenance Period|Lost to Follow-up|0|||
126318690|NCT01358578|454457983|FG002|Maintenance Period|Lost to Follow-up|0|||
126318691|NCT01358578|454457984|FG003|Maintenance Period|Lost to Follow-up|5|||
126318692|NCT01358578|454457985|FG004|Maintenance Period|Lost to Follow-up|1|||
126318693|NCT01358578|454457986|FG005|Maintenance Period|Lost to Follow-up|1|||
126318694|NCT01358578|454457981|FG000|Maintenance Period|Non-compliance with study treatment|3|||
126318695|NCT01358578|454457982|FG001|Maintenance Period|Non-compliance with study treatment|1|||
126318696|NCT01358578|454457983|FG002|Maintenance Period|Non-compliance with study treatment|0|||
126318697|NCT01358578|454457984|FG003|Maintenance Period|Non-compliance with study treatment|2|||
126318698|NCT01358578|454457985|FG004|Maintenance Period|Non-compliance with study treatment|1|||
126318699|NCT01358578|454457986|FG005|Maintenance Period|Non-compliance with study treatment|2|||
126318700|NCT01358578|454457981|FG000|Maintenance Period|Physician Decision|0|||
126318701|NCT01358578|454457982|FG001|Maintenance Period|Physician Decision|1|||
126318702|NCT01358578|454457983|FG002|Maintenance Period|Physician Decision|0|||
126318703|NCT01358578|454457984|FG003|Maintenance Period|Physician Decision|1|||
126318704|NCT01358578|454457985|FG004|Maintenance Period|Physician Decision|0|||
126318705|NCT01358578|454457986|FG005|Maintenance Period|Physician Decision|0|||
126318706|NCT01358578|454457981|FG000|Maintenance Period|Pregnancy|1|||
126650683|NCT02712905|455678284|FG010|Monotherapy|Physician Decision|0|||
126650684|NCT02712905|455678285|FG011|Monotherapy|Physician Decision|0|||
126650685|NCT02712905|455678286|FG012|Monotherapy|Physician Decision|0|||
126650686|NCT02712905|455678287|FG013|Monotherapy|Physician Decision|0|||
126650687|NCT02712905|455678288|FG014|Monotherapy|Physician Decision|0|||
126650688|NCT02712905|455678289|FG015|Monotherapy|Physician Decision|0|||
126650689|NCT02712905|455678290|FG016|Monotherapy|Physician Decision|0|||
126650690|NCT02712905|455678291|FG017|Monotherapy|Physician Decision|0|||
126650691|NCT02712905|455678274|FG000|Monotherapy|Study Terminated by Sponsor|0|||
126650692|NCT02712905|455678275|FG001|Monotherapy|Study Terminated by Sponsor|0|||
126650693|NCT02712905|455678276|FG002|Monotherapy|Study Terminated by Sponsor|0|||
126650694|NCT02712905|455678277|FG003|Monotherapy|Study Terminated by Sponsor|0|||
126650695|NCT02712905|455678278|FG004|Monotherapy|Study Terminated by Sponsor|1|||
126650696|NCT02712905|455678279|FG005|Monotherapy|Study Terminated by Sponsor|0|||
126650697|NCT02712905|455678280|FG006|Monotherapy|Study Terminated by Sponsor|0|||
126650698|NCT02712905|455678281|FG007|Monotherapy|Study Terminated by Sponsor|0|||
126650699|NCT02712905|455678282|FG008|Monotherapy|Study Terminated by Sponsor|0|||
126650700|NCT02712905|455678283|FG009|Monotherapy|Study Terminated by Sponsor|2|||
126650701|NCT02712905|455678284|FG010|Monotherapy|Study Terminated by Sponsor|0|||
126650702|NCT02712905|455678285|FG011|Monotherapy|Study Terminated by Sponsor|0|||
126650703|NCT02712905|455678286|FG012|Monotherapy|Study Terminated by Sponsor|0|||
126650704|NCT02712905|455678287|FG013|Monotherapy|Study Terminated by Sponsor|0|||
126650705|NCT02712905|455678288|FG014|Monotherapy|Study Terminated by Sponsor|0|||
126650706|NCT02712905|455678289|FG015|Monotherapy|Study Terminated by Sponsor|0|||
126650707|NCT02712905|455678290|FG016|Monotherapy|Study Terminated by Sponsor|0|||
126650708|NCT02712905|455678291|FG017|Monotherapy|Study Terminated by Sponsor|0|||
126650709|NCT02712905|455678274|FG000|Monotherapy|Withdrawal by Subject|0|||
126650710|NCT02712905|455678275|FG001|Monotherapy|Withdrawal by Subject|0|||
126650711|NCT02712905|455678276|FG002|Monotherapy|Withdrawal by Subject|1|||
126650712|NCT02712905|455678277|FG003|Monotherapy|Withdrawal by Subject|0|||
126650713|NCT02712905|455678278|FG004|Monotherapy|Withdrawal by Subject|2|||
126650714|NCT02712905|455678279|FG005|Monotherapy|Withdrawal by Subject|0|||
126650715|NCT02712905|455678280|FG006|Monotherapy|Withdrawal by Subject|0|||
126318707|NCT01358578|454457982|FG001|Maintenance Period|Pregnancy|0|||
126318708|NCT01358578|454457983|FG002|Maintenance Period|Pregnancy|0|||
126650716|NCT02712905|455678281|FG007|Monotherapy|Withdrawal by Subject|0|||
126650717|NCT02712905|455678282|FG008|Monotherapy|Withdrawal by Subject|0|||
126650718|NCT02712905|455678283|FG009|Monotherapy|Withdrawal by Subject|4|||
126650719|NCT02712905|455678284|FG010|Monotherapy|Withdrawal by Subject|1|||
126650720|NCT02712905|455678285|FG011|Monotherapy|Withdrawal by Subject|2|||
126318709|NCT01358578|454457984|FG003|Maintenance Period|Pregnancy|0|||
126650721|NCT02712905|455678286|FG012|Monotherapy|Withdrawal by Subject|0|||
126318710|NCT01358578|454457985|FG004|Maintenance Period|Pregnancy|0|||
126318711|NCT01358578|454457986|FG005|Maintenance Period|Pregnancy|0|||
126650722|NCT02712905|455678287|FG013|Monotherapy|Withdrawal by Subject|0|||
126650723|NCT02712905|455678288|FG014|Monotherapy|Withdrawal by Subject|0|||
126650724|NCT02712905|455678289|FG015|Monotherapy|Withdrawal by Subject|0|||
126650725|NCT02712905|455678290|FG016|Monotherapy|Withdrawal by Subject|0|||
126650726|NCT02712905|455678291|FG017|Monotherapy|Withdrawal by Subject|0|||
126650727|NCT02712905|455678274|FG000|Monotherapy|Started New Cancer Drug|0|||
126318712|NCT01358578|454457981|FG000|Maintenance Period|Protocol deviation|7|||
126318713|NCT01358578|454457982|FG001|Maintenance Period|Protocol deviation|4|||
126318714|NCT01358578|454457983|FG002|Maintenance Period|Protocol deviation|0|||
126650728|NCT02712905|455678275|FG001|Monotherapy|Started New Cancer Drug|0|||
126318715|NCT01358578|454457984|FG003|Maintenance Period|Protocol deviation|2|||
126318716|NCT01358578|454457985|FG004|Maintenance Period|Protocol deviation|2|||
126318717|NCT01358578|454457986|FG005|Maintenance Period|Protocol deviation|2|||
126318718|NCT01358578|454457981|FG000|Maintenance Period|Withdrawal by Subject|12|||
126318719|NCT01358578|454457982|FG001|Maintenance Period|Withdrawal by Subject|7|||
126318720|NCT01358578|454457983|FG002|Maintenance Period|Withdrawal by Subject|2|||
126318721|NCT01358578|454457984|FG003|Maintenance Period|Withdrawal by Subject|15|||
126318722|NCT01358578|454457985|FG004|Maintenance Period|Withdrawal by Subject|6|||
126318723|NCT01358578|454457986|FG005|Maintenance Period|Withdrawal by Subject|3|||
126318724|NCT01358578|454457981|FG000|Follow-up Period|Adverse Event|1|||
126318725|NCT01358578|454457982|FG001|Follow-up Period|Adverse Event|1|||
126318726|NCT01358578|454457983|FG002|Follow-up Period|Adverse Event|0|||
126318727|NCT01358578|454457984|FG003|Follow-up Period|Adverse Event|0|||
126318728|NCT01358578|454457985|FG004|Follow-up Period|Adverse Event|0|||
126318729|NCT01358578|454457986|FG005|Follow-up Period|Adverse Event|0|||
126318730|NCT01358578|454457981|FG000|Follow-up Period|Lack of Efficacy|3|||
126318731|NCT01358578|454457982|FG001|Follow-up Period|Lack of Efficacy|0|||
126318732|NCT01358578|454457983|FG002|Follow-up Period|Lack of Efficacy|4|||
126318733|NCT01358578|454457984|FG003|Follow-up Period|Lack of Efficacy|1|||
126318734|NCT01358578|454457985|FG004|Follow-up Period|Lack of Efficacy|0|||
126318735|NCT01358578|454457986|FG005|Follow-up Period|Lack of Efficacy|0|||
126318736|NCT01358578|454457981|FG000|Follow-up Period|Lost to Follow-up|0|||
126318737|NCT01358578|454457982|FG001|Follow-up Period|Lost to Follow-up|1|||
126318738|NCT01358578|454457983|FG002|Follow-up Period|Lost to Follow-up|0|||
126318739|NCT01358578|454457984|FG003|Follow-up Period|Lost to Follow-up|4|||
126318740|NCT01358578|454457985|FG004|Follow-up Period|Lost to Follow-up|0|||
126318741|NCT01358578|454457986|FG005|Follow-up Period|Lost to Follow-up|0|||
126318742|NCT01358578|454457981|FG000|Follow-up Period|non- compliance with study treatment|1|||
126318743|NCT01358578|454457982|FG001|Follow-up Period|non- compliance with study treatment|0|||
126318744|NCT01358578|454457983|FG002|Follow-up Period|non- compliance with study treatment|0|||
126318745|NCT01358578|454457984|FG003|Follow-up Period|non- compliance with study treatment|0|||
126318746|NCT01358578|454457985|FG004|Follow-up Period|non- compliance with study treatment|0|||
126318747|NCT01358578|454457986|FG005|Follow-up Period|non- compliance with study treatment|0|||
126318748|NCT01358578|454457981|FG000|Follow-up Period|Pregnancy|1|||
126318749|NCT01358578|454457982|FG001|Follow-up Period|Pregnancy|0|||
126318750|NCT01358578|454457983|FG002|Follow-up Period|Pregnancy|0|||
126318751|NCT01358578|454457984|FG003|Follow-up Period|Pregnancy|0|||
126318752|NCT01358578|454457985|FG004|Follow-up Period|Pregnancy|0|||
126318753|NCT01358578|454457986|FG005|Follow-up Period|Pregnancy|0|||
126318754|NCT01358578|454457981|FG000|Follow-up Period|Withdrawal by Subject|3|||
126318755|NCT01358578|454457982|FG001|Follow-up Period|Withdrawal by Subject|3|||
126318756|NCT01358578|454457983|FG002|Follow-up Period|Withdrawal by Subject|1|||
126318757|NCT01358578|454457984|FG003|Follow-up Period|Withdrawal by Subject|12|||
126318758|NCT01358578|454457985|FG004|Follow-up Period|Withdrawal by Subject|0|||
126318759|NCT01358578|454457986|FG005|Follow-up Period|Withdrawal by Subject|0|||
126318760|NCT01358578|454457981|FG000|Follow-up Period|Physician Decision|1|||
126318761|NCT01358578|454457982|FG001|Follow-up Period|Physician Decision|1|||
126318762|NCT01358578|454457983|FG002|Follow-up Period|Physician Decision|0|||
126318763|NCT01358578|454457984|FG003|Follow-up Period|Physician Decision|2|||
126318764|NCT01358578|454457985|FG004|Follow-up Period|Physician Decision|0|||
126318765|NCT01358578|454457986|FG005|Follow-up Period|Physician Decision|0|||
126318766|NCT00388297|454457987|FG000|Overall Study|Lost to Follow-up|16|||
126318767|NCT00388297|454457988|FG001|Overall Study|Lost to Follow-up|12|||
126318768|NCT00388297|454457989|FG002|Overall Study|Lost to Follow-up|11|||
126318769|NCT00388297|454457990|FG003|Overall Study|Lost to Follow-up|8|||
126318770|NCT02607280|454457991|FG000|Overall Study|Adverse Event|4|||
126318771|NCT02607280|454457992|FG001|Overall Study|Adverse Event|0|||
126318772|NCT02607280|454457991|FG000|Overall Study|Decrease in CrCl <15|0|||
126318773|NCT02607280|454457992|FG001|Overall Study|Decrease in CrCl <15|1|||
126318774|NCT00577005|454457993|FG000|Overall Study|Lost to Follow-up|3|||
126318775|NCT00577005|454457994|FG001|Overall Study|Lost to Follow-up|2|||
126318776|NCT00577005|454457993|FG000|Overall Study|Withdrawal by Subject|2|||
126318777|NCT00577005|454457994|FG001|Overall Study|Withdrawal by Subject|1|||
126318778|NCT01004432|454457995|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
126318779|NCT01004432|454457996|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
126318780|NCT01004432|454457997|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
126318781|NCT01004432|454457998|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
126318782|NCT01004432|454457999|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
126318783|NCT01004432|454457995|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
126318784|NCT01004432|454457996|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
126318785|NCT01004432|454457997|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
126318786|NCT01004432|454457998|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
126318787|NCT01004432|454457999|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
126318788|NCT01004432|454457995|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
126544977|NCT00633932|455289163|FG000|Overall Study|Physician Decision|0|||
126318789|NCT01004432|454457996|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
126318790|NCT01004432|454457997|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
126318791|NCT01004432|454457998|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
126318792|NCT01004432|454457999|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
126318793|NCT01004432|454457995|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
126318794|NCT01004432|454457996|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
126318795|NCT01004432|454457997|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
126318796|NCT01004432|454457998|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
126318797|NCT01004432|454457999|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
126318798|NCT01004432|454457995|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
126318799|NCT01004432|454457996|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
126318800|NCT01004432|454457997|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
126318801|NCT01004432|454457998|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
126318802|NCT01004432|454457999|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
126318803|NCT01004432|454457995|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
126318804|NCT01004432|454457996|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
126318805|NCT01004432|454457997|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
126318806|NCT01004432|454457998|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
126318807|NCT01004432|454457999|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
126318808|NCT01004432|454457995|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
126318809|NCT01004432|454457996|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
126318810|NCT01004432|454457997|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
126318811|NCT01004432|454457998|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
126318812|NCT01004432|454457999|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
126318813|NCT01004432|454457995|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
126318814|NCT01004432|454457996|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
126318815|NCT01004432|454457997|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
126318816|NCT01004432|454457998|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
126318817|NCT01004432|454457999|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
126318818|NCT01004432|454457995|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
126318819|NCT01004432|454457996|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
126318820|NCT01004432|454457997|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
126318821|NCT01004432|454457998|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
126318822|NCT01004432|454457999|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
126318823|NCT01004432|454457995|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
126318824|NCT01004432|454457996|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
126318825|NCT01004432|454457997|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
126318826|NCT01004432|454457998|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
126318827|NCT01004432|454457999|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
126318828|NCT01004432|454457995|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
126318829|NCT01004432|454457996|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
126318830|NCT01004432|454457997|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
126318831|NCT01004432|454457998|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
126318832|NCT01004432|454457999|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
126318833|NCT01004432|454457995|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
126318834|NCT01004432|454457996|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
126318835|NCT01004432|454457997|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
126318836|NCT01004432|454457998|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
126318837|NCT01004432|454457999|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
126318838|NCT01004432|454457995|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
126318839|NCT01004432|454457996|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
126318840|NCT01004432|454457997|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
126650729|NCT02712905|455678276|FG002|Monotherapy|Started New Cancer Drug|0|||
126650730|NCT02712905|455678277|FG003|Monotherapy|Started New Cancer Drug|0|||
126650731|NCT02712905|455678278|FG004|Monotherapy|Started New Cancer Drug|0|||
126650732|NCT02712905|455678279|FG005|Monotherapy|Started New Cancer Drug|1|||
126650733|NCT02712905|455678280|FG006|Monotherapy|Started New Cancer Drug|0|||
126650734|NCT02712905|455678281|FG007|Monotherapy|Started New Cancer Drug|0|||
126650735|NCT02712905|455678282|FG008|Monotherapy|Started New Cancer Drug|0|||
126650736|NCT02712905|455678283|FG009|Monotherapy|Started New Cancer Drug|0|||
126650737|NCT02712905|455678284|FG010|Monotherapy|Started New Cancer Drug|0|||
126650738|NCT02712905|455678285|FG011|Monotherapy|Started New Cancer Drug|0|||
126318841|NCT01004432|454457998|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
126318842|NCT01004432|454457999|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
126318843|NCT01004432|454457995|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
126650739|NCT02712905|455678286|FG012|Monotherapy|Started New Cancer Drug|0|||
126650740|NCT02712905|455678287|FG013|Monotherapy|Started New Cancer Drug|0|||
126650741|NCT02712905|455678288|FG014|Monotherapy|Started New Cancer Drug|0|||
126650742|NCT02712905|455678289|FG015|Monotherapy|Started New Cancer Drug|0|||
126650743|NCT02712905|455678290|FG016|Monotherapy|Started New Cancer Drug|0|||
126650744|NCT02712905|455678291|FG017|Monotherapy|Started New Cancer Drug|0|||
126650745|NCT02712905|455678274|FG000|Monotherapy|Adverse Event|0|||
126650746|NCT02712905|455678275|FG001|Monotherapy|Adverse Event|0|||
126650747|NCT02712905|455678276|FG002|Monotherapy|Adverse Event|0|||
126650748|NCT02712905|455678277|FG003|Monotherapy|Adverse Event|0|||
126650749|NCT02712905|455678278|FG004|Monotherapy|Adverse Event|0|||
126650750|NCT02712905|455678279|FG005|Monotherapy|Adverse Event|0|||
126650751|NCT02712905|455678280|FG006|Monotherapy|Adverse Event|0|||
126650752|NCT02712905|455678281|FG007|Monotherapy|Adverse Event|0|||
126650753|NCT02712905|455678282|FG008|Monotherapy|Adverse Event|1|||
126650754|NCT02712905|455678283|FG009|Monotherapy|Adverse Event|0|||
126650755|NCT02712905|455678284|FG010|Monotherapy|Adverse Event|0|||
126650756|NCT02712905|455678285|FG011|Monotherapy|Adverse Event|0|||
126650757|NCT02712905|455678286|FG012|Monotherapy|Adverse Event|0|||
126650758|NCT02712905|455678287|FG013|Monotherapy|Adverse Event|0|||
126650759|NCT02712905|455678288|FG014|Monotherapy|Adverse Event|0|||
126650760|NCT02712905|455678289|FG015|Monotherapy|Adverse Event|0|||
126650761|NCT02712905|455678290|FG016|Monotherapy|Adverse Event|0|||
126650762|NCT02712905|455678291|FG017|Monotherapy|Adverse Event|0|||
126650763|NCT02712905|455678274|FG000|Combination Therapy|Death|0|||
126650764|NCT02712905|455678275|FG001|Combination Therapy|Death|0|||
126650765|NCT02712905|455678276|FG002|Combination Therapy|Death|0|||
126650766|NCT02712905|455678277|FG003|Combination Therapy|Death|0|||
126650767|NCT02712905|455678278|FG004|Combination Therapy|Death|0|||
126650768|NCT02712905|455678279|FG005|Combination Therapy|Death|0|||
126650769|NCT02712905|455678280|FG006|Combination Therapy|Death|0|||
126650770|NCT02712905|455678281|FG007|Combination Therapy|Death|0|||
126650771|NCT02712905|455678282|FG008|Combination Therapy|Death|0|||
126650772|NCT02712905|455678283|FG009|Combination Therapy|Death|0|||
126650773|NCT02712905|455678284|FG010|Combination Therapy|Death|0|||
126650774|NCT02712905|455678285|FG011|Combination Therapy|Death|0|||
126650775|NCT02712905|455678286|FG012|Combination Therapy|Death|5|||
126650776|NCT02712905|455678287|FG013|Combination Therapy|Death|6|||
126650777|NCT02712905|455678288|FG014|Combination Therapy|Death|1|||
126650778|NCT02712905|455678289|FG015|Combination Therapy|Death|3|||
126650779|NCT02712905|455678290|FG016|Combination Therapy|Death|1|||
126650780|NCT02712905|455678291|FG017|Combination Therapy|Death|3|||
126650781|NCT02712905|455678274|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
126650782|NCT02712905|455678275|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
126650783|NCT02712905|455678276|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
126650784|NCT02712905|455678277|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
126650785|NCT02712905|455678278|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
126650786|NCT02712905|455678279|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
126650787|NCT02712905|455678280|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
126650788|NCT02712905|455678281|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
126650789|NCT02712905|455678282|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
126650790|NCT02712905|455678283|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
126650791|NCT02712905|455678284|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
126650792|NCT02712905|455678285|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
126650793|NCT02712905|455678286|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
126650794|NCT02712905|455678287|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
126650795|NCT02712905|455678288|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
126650796|NCT02712905|455678289|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
126650797|NCT02712905|455678290|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
126650798|NCT02712905|455678291|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
126650799|NCT02712905|455678274|FG000|Combination Therapy|Withdrawal by Subject|0|||
126650800|NCT02712905|455678275|FG001|Combination Therapy|Withdrawal by Subject|0|||
126650801|NCT02712905|455678276|FG002|Combination Therapy|Withdrawal by Subject|0|||
126650802|NCT02712905|455678277|FG003|Combination Therapy|Withdrawal by Subject|0|||
126650803|NCT02712905|455678278|FG004|Combination Therapy|Withdrawal by Subject|0|||
126650804|NCT02712905|455678279|FG005|Combination Therapy|Withdrawal by Subject|0|||
126650805|NCT02712905|455678280|FG006|Combination Therapy|Withdrawal by Subject|0|||
126650806|NCT02712905|455678281|FG007|Combination Therapy|Withdrawal by Subject|0|||
126650807|NCT02712905|455678282|FG008|Combination Therapy|Withdrawal by Subject|0|||
126650808|NCT02712905|455678283|FG009|Combination Therapy|Withdrawal by Subject|0|||
126650809|NCT02712905|455678284|FG010|Combination Therapy|Withdrawal by Subject|0|||
126650810|NCT02712905|455678285|FG011|Combination Therapy|Withdrawal by Subject|0|||
126650811|NCT02712905|455678286|FG012|Combination Therapy|Withdrawal by Subject|0|||
126650812|NCT02712905|455678287|FG013|Combination Therapy|Withdrawal by Subject|0|||
126650813|NCT02712905|455678288|FG014|Combination Therapy|Withdrawal by Subject|0|||
126650814|NCT02712905|455678289|FG015|Combination Therapy|Withdrawal by Subject|1|||
126650815|NCT02712905|455678290|FG016|Combination Therapy|Withdrawal by Subject|0|||
126650816|NCT02712905|455678291|FG017|Combination Therapy|Withdrawal by Subject|2|||
126650817|NCT02712905|455678274|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126318844|NCT01004432|454457996|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
126318845|NCT01004432|454457997|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
126318846|NCT01004432|454457998|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
126318847|NCT01004432|454457999|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
126318848|NCT01004432|454457995|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
126318849|NCT01004432|454457996|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
126318850|NCT01004432|454457997|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
126318851|NCT01004432|454457998|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
126318852|NCT01004432|454457999|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
126318853|NCT02667626|454458000|FG000|Overall Study|Withdrawal by Subject|0|||
126318854|NCT02667626|454458001|FG001|Overall Study|Withdrawal by Subject|1|||
126318855|NCT02696434|454458003|FG000|Overall Study|Adverse Event|3|||
126318856|NCT02696434|454458004|FG001|Overall Study|Adverse Event|1|||
126318857|NCT02696434|454458003|FG000|Overall Study|Lost to Follow-up|5|||
126318858|NCT02696434|454458004|FG001|Overall Study|Lost to Follow-up|4|||
126318859|NCT02696434|454458003|FG000|Overall Study|Withdrawal by Subject|14|||
126318860|NCT02696434|454458004|FG001|Overall Study|Withdrawal by Subject|12|||
126318861|NCT02696434|454458003|FG000|Overall Study|Physician Decision|0|||
126318862|NCT02696434|454458004|FG001|Overall Study|Physician Decision|1|||
126318863|NCT02539134|454458005|FG000|Overall Study|Lost to Follow-up|1|||
126318864|NCT02539134|454458006|FG001|Overall Study|Lost to Follow-up|0|||
126318865|NCT02539134|454458007|FG002|Overall Study|Lost to Follow-up|0|||
126318866|NCT02539134|454458008|FG003|Overall Study|Lost to Follow-up|0|||
126318867|NCT02539134|454458009|FG004|Overall Study|Lost to Follow-up|0|||
126318868|NCT02539134|454458010|FG005|Overall Study|Lost to Follow-up|0|||
126318869|NCT02971800|454458013|FG000|Overall Study|Protocol Violation|1|||
126318870|NCT02971800|454458013|FG000|Overall Study|Withdrawal by Subject|1|||
126318871|NCT02971800|454458013|FG000|Overall Study|Exclusion criteria prior intervention|1|||
126318872|NCT02971800|454458013|FG000|Overall Study|Number evaluable participant already reached|4|||
126318873|NCT05323994|454458014|FG000|Overall Study|Protocol Violation|1|||
126318874|NCT04526574|454458020|FG000|Overall Study|Protocol Violation|3|||
126318875|NCT04526574|454458021|FG001|Overall Study|Protocol Violation|1|||
126318876|NCT04526574|454458020|FG000|Overall Study|Withdrawal by Subject|12|||
126318877|NCT04526574|454458021|FG001|Overall Study|Withdrawal by Subject|9|||
126318878|NCT04526574|454458020|FG000|Overall Study|Other|1|||
126318879|NCT04526574|454458021|FG001|Overall Study|Other|2|||
126318880|NCT04526574|454458020|FG000|Overall Study|Adverse Event|1|||
126318881|NCT04526574|454458021|FG001|Overall Study|Adverse Event|1|||
126318882|NCT04526574|454458020|FG000|Overall Study|Death|2|||
126318883|NCT04526574|454458021|FG001|Overall Study|Death|3|||
126318884|NCT04526574|454458020|FG000|Overall Study|Lost to Follow-up|9|||
126318885|NCT04526574|454458021|FG001|Overall Study|Lost to Follow-up|9|||
126318886|NCT04526574|454458020|FG000|Overall Study|No longer meets eligibility criteria|8|||
126318887|NCT04526574|454458021|FG001|Overall Study|No longer meets eligibility criteria|8|||
126318888|NCT01534208|454458029|FG000|Overall Study|Lost to Follow-up|19|||
126318889|NCT01534208|454458030|FG001|Overall Study|Lost to Follow-up|14|||
126318890|NCT01534208|454458029|FG000|Overall Study|Withdrawal by Subject|6|||
126318891|NCT01534208|454458030|FG001|Overall Study|Withdrawal by Subject|20|||
126318892|NCT01534208|454458029|FG000|Overall Study|Adverse Event|15|||
126318893|NCT01534208|454458030|FG001|Overall Study|Adverse Event|8|||
126318894|NCT01534208|454458029|FG000|Overall Study|Physician Decision|2|||
126318895|NCT01534208|454458030|FG001|Overall Study|Physician Decision|0|||
126318896|NCT01534208|454458029|FG000|Overall Study|Lack of Efficacy|0|||
126650818|NCT02712905|455678275|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650819|NCT02712905|455678276|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650820|NCT02712905|455678277|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650821|NCT02712905|455678278|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650822|NCT02712905|455678279|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650823|NCT02712905|455678280|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650824|NCT02712905|455678281|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650825|NCT02712905|455678282|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650826|NCT02712905|455678283|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126318897|NCT01534208|454458030|FG001|Overall Study|Lack of Efficacy|3|||
126318898|NCT01534208|454458029|FG000|Overall Study|Protocol Violation|2|||
126318899|NCT01534208|454458030|FG001|Overall Study|Protocol Violation|2|||
126318900|NCT01534208|454458029|FG000|Overall Study|Sponsor decision|4|||
126318901|NCT01534208|454458030|FG001|Overall Study|Sponsor decision|1|||
126318902|NCT01534208|454458029|FG000|Overall Study|Subject relocation|2|||
126318903|NCT01534208|454458030|FG001|Overall Study|Subject relocation|0|||
126318904|NCT01534208|454458029|FG000|Overall Study|Lab assessment|2|||
126318905|NCT01534208|454458030|FG001|Overall Study|Lab assessment|1|||
126318906|NCT01534208|454458029|FG000|Overall Study|Eligibility error|3|||
126318907|NCT01534208|454458030|FG001|Overall Study|Eligibility error|0|||
126318908|NCT01534208|454458029|FG000|Overall Study|PCP decision|1|||
126318909|NCT01534208|454458030|FG001|Overall Study|PCP decision|0|||
126318910|NCT01534208|454458029|FG000|Overall Study|Needed prohibited meds|1|||
126318911|NCT01534208|454458030|FG001|Overall Study|Needed prohibited meds|0|||
126318912|NCT01904903|454458031|FG000|Overall Study|Withdrawal by Subject|1|||
126318913|NCT00045734|454458032|FG000|Overall Study|Protocol Violation|1|||
126318914|NCT03482167|454458035|FG000|Allocated to Intervention|Physician Decision|1|||
126318915|NCT03482167|454458036|FG001|Allocated to Intervention|Physician Decision|2|||
126318916|NCT03482167|454458035|FG000|Received Intervention|Adverse Event|3|||
126318917|NCT03482167|454458036|FG001|Received Intervention|Adverse Event|1|||
126318918|NCT03482167|454458035|FG000|Received Intervention|Physician Decision|1|||
126318919|NCT03482167|454458036|FG001|Received Intervention|Physician Decision|1|||
126318920|NCT03482167|454458035|FG000|Received Intervention|Withdrawal by Subject|1|||
126318921|NCT03482167|454458036|FG001|Received Intervention|Withdrawal by Subject|0|||
126318922|NCT01001598|454458038|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
126318923|NCT01001598|454458038|FG000|Overall Study|Adverse Event|1|||
126318924|NCT05079230|454458054|FG000|Overall Study|Study Terminated by Sponsor|101|||
126318925|NCT05079230|454458055|FG001|Overall Study|Study Terminated by Sponsor|102|||
126318926|NCT05079230|454458054|FG000|Overall Study|Death|72|||
126318927|NCT05079230|454458055|FG001|Overall Study|Death|66|||
126318928|NCT05079230|454458054|FG000|Overall Study|Withdrew Consent|16|||
126318929|NCT05079230|454458055|FG001|Overall Study|Withdrew Consent|18|||
126318930|NCT05079230|454458054|FG000|Overall Study|Lost to Follow-up|0|||
126318931|NCT05079230|454458055|FG001|Overall Study|Lost to Follow-up|3|||
126318932|NCT01524783|454458056|FG000|Blinded Period|Adverse Event|64|||
126318933|NCT01524783|454458057|FG001|Blinded Period|Adverse Event|7|||
126318934|NCT01524783|454458058|FG002|Blinded Period|Adverse Event|0|||
126318935|NCT01524783|454458056|FG000|Blinded Period|Disease Progression|89|||
126318936|NCT01524783|454458057|FG001|Blinded Period|Disease Progression|75|||
126318937|NCT01524783|454458058|FG002|Blinded Period|Disease Progression|0|||
126318938|NCT01524783|454458056|FG000|Blinded Period|Withdrawal by Subject|19|||
126318939|NCT01524783|454458057|FG001|Blinded Period|Withdrawal by Subject|6|||
126318940|NCT01524783|454458058|FG002|Blinded Period|Withdrawal by Subject|0|||
126318941|NCT01524783|454458056|FG000|Blinded Period|Protocol deviation|2|||
126318942|NCT01524783|454458057|FG001|Blinded Period|Protocol deviation|1|||
126318943|NCT01524783|454458058|FG002|Blinded Period|Protocol deviation|0|||
126318944|NCT01524783|454458056|FG000|Blinded Period|Death|5|||
126318945|NCT01524783|454458057|FG001|Blinded Period|Death|2|||
126318946|NCT01524783|454458058|FG002|Blinded Period|Death|0|||
126318947|NCT01524783|454458056|FG000|Open-label Period|Disease progression|13|||
126318948|NCT01524783|454458057|FG001|Open-label Period|Disease progression|0|||
126318949|NCT01524783|454458058|FG002|Open-label Period|Disease progression|2|||
126318950|NCT01524783|454458056|FG000|Open-label Period|Administrative problems|5|||
126318951|NCT01524783|454458057|FG001|Open-label Period|Administrative problems|0|||
126318952|NCT01524783|454458058|FG002|Open-label Period|Administrative problems|2|||
126318953|NCT01524783|454458056|FG000|Open-label Period|Adverse Event|5|||
126318954|NCT01524783|454458057|FG001|Open-label Period|Adverse Event|0|||
126318955|NCT01524783|454458058|FG002|Open-label Period|Adverse Event|1|||
126318956|NCT01524783|454458056|FG000|Open-label Period|Withdrawal by Subject|2|||
126318957|NCT01524783|454458057|FG001|Open-label Period|Withdrawal by Subject|0|||
126318958|NCT01524783|454458058|FG002|Open-label Period|Withdrawal by Subject|1|||
126318959|NCT01524783|454458056|FG000|Open-label Period|Protocol deviation|1|||
126318960|NCT01524783|454458057|FG001|Open-label Period|Protocol deviation|0|||
126318961|NCT01524783|454458058|FG002|Open-label Period|Protocol deviation|0|||
126318962|NCT02920177|454458060|FG000|Overall Study|Withdrawal by Subject|1|||
126318963|NCT02920177|454458061|FG001|Overall Study|Withdrawal by Subject|1|||
126318964|NCT02920177|454458060|FG000|Overall Study|Physician Decision|1|||
126318965|NCT02920177|454458061|FG001|Overall Study|Physician Decision|0|||
126318966|NCT02920177|454458060|FG000|Overall Study|Lost to Follow-up|0|||
126318967|NCT02920177|454458061|FG001|Overall Study|Lost to Follow-up|1|||
126318968|NCT02054910|454458062|FG000|Overall Study|Lost to Follow-up|4|||
126318969|NCT02054910|454458063|FG001|Overall Study|Lost to Follow-up|1|||
126318970|NCT01096589|454458069|FG000|Overall Study|Adverse Event|2|||
126318971|NCT01096589|454458070|FG001|Overall Study|Adverse Event|1|||
126544978|NCT00633932|455289164|FG001|Overall Study|Physician Decision|0|||
126544979|NCT00633932|455289165|FG002|Overall Study|Physician Decision|1|||
126544980|NCT00633932|455289163|FG000|Overall Study|Doctor's judgement|1|||
126544981|NCT00633932|455289164|FG001|Overall Study|Doctor's judgement|0|||
126544982|NCT00633932|455289165|FG002|Overall Study|Doctor's judgement|0|||
126544983|NCT00633932|455289163|FG000|Overall Study|Moved Away|1|||
126544984|NCT00633932|455289164|FG001|Overall Study|Moved Away|0|||
126544985|NCT00633932|455289165|FG002|Overall Study|Moved Away|0|||
126544986|NCT00482274|455289166|FG000|Overall Study|Adverse Event|1|||
126544987|NCT04836858|455289167|FG000|Overall Study|Adverse Event|0|||
126544988|NCT04836858|455289168|FG001|Overall Study|Adverse Event|0|||
126544989|NCT04836858|455289169|FG002|Overall Study|Adverse Event|0|||
126544990|NCT04836858|455289170|FG003|Overall Study|Adverse Event|1|||
126544991|NCT04836858|455289167|FG000|Overall Study|Lost to Follow-up|1|||
126650827|NCT02712905|455678284|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650828|NCT02712905|455678285|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650829|NCT02712905|455678286|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650830|NCT02712905|455678287|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650831|NCT02712905|455678288|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650832|NCT02712905|455678289|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
126650833|NCT02712905|455678290|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650834|NCT02712905|455678291|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
126650835|NCT04828837|455678292|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
126650836|NCT04828837|455678293|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
126650837|NCT04828837|455678292|FG000|Overall Study|Lost to Follow-up|2|||
126650838|NCT04828837|455678293|FG001|Overall Study|Lost to Follow-up|6|||
126650839|NCT04828837|455678292|FG000|Overall Study|Lack of Efficacy|1|||
126650840|NCT04828837|455678293|FG001|Overall Study|Lack of Efficacy|0|||
126650841|NCT04828837|455678292|FG000|Overall Study|Admitted due to pneumothorax.|1|||
126650842|NCT04828837|455678293|FG001|Overall Study|Admitted due to pneumothorax.|0|||
126650843|NCT04828837|455678292|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
126650844|NCT04828837|455678293|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
126650845|NCT00320528|455678294|FG000|Study Period II|Adverse Event|3|||
126650846|NCT00320528|455678295|FG001|Study Period II|Adverse Event|4|||
126650847|NCT00320528|455678296|FG002|Study Period II|Adverse Event|8|||
126650848|NCT00320528|455678294|FG000|Study Period II|Parent/Caregiver Decision|8|||
126650849|NCT00320528|455678295|FG001|Study Period II|Parent/Caregiver Decision|3|||
126650850|NCT00320528|455678296|FG002|Study Period II|Parent/Caregiver Decision|11|||
126650851|NCT00320528|455678294|FG000|Study Period II|Withdrawal by Subject|0|||
126650852|NCT00320528|455678295|FG001|Study Period II|Withdrawal by Subject|1|||
126650853|NCT00320528|455678296|FG002|Study Period II|Withdrawal by Subject|1|||
126650854|NCT00320528|455678294|FG000|Study Period II|Entry Criteria Exclusion|0|||
126650855|NCT00320528|455678295|FG001|Study Period II|Entry Criteria Exclusion|2|||
126318972|NCT01096589|454458071|FG002|Overall Study|Adverse Event|2|||
126318973|NCT01096589|454458072|FG003|Overall Study|Adverse Event|1|||
126318974|NCT01096589|454458069|FG000|Overall Study|Withdrawal by Subject|2|||
126650856|NCT00320528|455678296|FG002|Study Period II|Entry Criteria Exclusion|2|||
126650857|NCT00320528|455678294|FG000|Study Period III|Adverse Event|1|||
126650858|NCT00320528|455678295|FG001|Study Period III|Adverse Event|0|||
126650859|NCT00320528|455678296|FG002|Study Period III|Adverse Event|0|||
126650860|NCT00320528|455678294|FG000|Study Period III|Lost to Follow-up|1|||
126318975|NCT01096589|454458070|FG001|Overall Study|Withdrawal by Subject|1|||
126318976|NCT01096589|454458071|FG002|Overall Study|Withdrawal by Subject|1|||
126318977|NCT01096589|454458072|FG003|Overall Study|Withdrawal by Subject|1|||
126318978|NCT01096589|454458069|FG000|Overall Study|Compliance with protocol|0|||
126318979|NCT01096589|454458070|FG001|Overall Study|Compliance with protocol|0|||
126318980|NCT01096589|454458071|FG002|Overall Study|Compliance with protocol|1|||
126318981|NCT01096589|454458072|FG003|Overall Study|Compliance with protocol|0|||
126318982|NCT01096589|454458069|FG000|Overall Study|found treatment exhausting|0|||
126318983|NCT01096589|454458070|FG001|Overall Study|found treatment exhausting|0|||
126318984|NCT01096589|454458071|FG002|Overall Study|found treatment exhausting|0|||
126318985|NCT01096589|454458072|FG003|Overall Study|found treatment exhausting|1|||
126318986|NCT03673345|454458074|FG000|Overall Study|Lost to Follow-up|1|||
126318987|NCT03673345|454458075|FG001|Overall Study|Lost to Follow-up|0|||
126318988|NCT03673345|454458076|FG002|Overall Study|Lost to Follow-up|3|||
126318989|NCT03673345|454458077|FG003|Overall Study|Lost to Follow-up|3|||
126318990|NCT03673345|454458078|FG004|Overall Study|Lost to Follow-up|2|||
126318991|NCT03673345|454458079|FG005|Overall Study|Lost to Follow-up|1|||
126318992|NCT03673345|454458080|FG006|Overall Study|Lost to Follow-up|0|||
126318993|NCT03673345|454458081|FG007|Overall Study|Lost to Follow-up|0|||
126318994|NCT03673345|454458074|FG000|Overall Study|Withdrawal by Subject|1|||
126318995|NCT03673345|454458075|FG001|Overall Study|Withdrawal by Subject|0|||
126318996|NCT03673345|454458076|FG002|Overall Study|Withdrawal by Subject|4|||
126650861|NCT00320528|455678295|FG001|Study Period III|Lost to Follow-up|0|||
126650862|NCT00320528|455678296|FG002|Study Period III|Lost to Follow-up|0|||
126650863|NCT00320528|455678294|FG000|Study Period III|Withdrawal by Subject|1|||
126318997|NCT03673345|454458077|FG003|Overall Study|Withdrawal by Subject|2|||
126318998|NCT03673345|454458078|FG004|Overall Study|Withdrawal by Subject|0|||
126318999|NCT03673345|454458079|FG005|Overall Study|Withdrawal by Subject|0|||
126319000|NCT03673345|454458080|FG006|Overall Study|Withdrawal by Subject|0|||
126319001|NCT03673345|454458081|FG007|Overall Study|Withdrawal by Subject|0|||
126319002|NCT03673345|454458074|FG000|Overall Study|Physician Decision|0|||
126319003|NCT03673345|454458075|FG001|Overall Study|Physician Decision|0|||
126319004|NCT03673345|454458076|FG002|Overall Study|Physician Decision|2|||
126319005|NCT03673345|454458077|FG003|Overall Study|Physician Decision|0|||
126319006|NCT03673345|454458078|FG004|Overall Study|Physician Decision|0|||
126319007|NCT03673345|454458079|FG005|Overall Study|Physician Decision|0|||
126319008|NCT03673345|454458080|FG006|Overall Study|Physician Decision|0|||
126319009|NCT03673345|454458081|FG007|Overall Study|Physician Decision|0|||
126319010|NCT02267135|454458082|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
126319011|NCT02267135|454458083|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
126319012|NCT02267135|454458082|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
126319013|NCT02267135|454458083|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
126319014|NCT02267135|454458082|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
126319015|NCT02267135|454458083|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
126319016|NCT02267135|454458082|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
126319017|NCT02267135|454458083|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
126319018|NCT02267135|454458082|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
126319019|NCT02267135|454458083|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
126319020|NCT03806231|454458084|FG000|Overall Study|Physician Decision|1|||
126319021|NCT03806231|454458085|FG001|Overall Study|Physician Decision|0|||
126319022|NCT03806231|454458084|FG000|Overall Study|Withdrawal by Subject|1|||
126319023|NCT03806231|454458085|FG001|Overall Study|Withdrawal by Subject|0|||
126319024|NCT00900731|454458086|FG000|Overall Study|Adverse Event|31|||
126319025|NCT00900731|454458087|FG001|Overall Study|Adverse Event|27|||
126319026|NCT00900731|454458086|FG000|Overall Study|Withdrawal by Subject|8|||
126319027|NCT00900731|454458087|FG001|Overall Study|Withdrawal by Subject|7|||
126319028|NCT00900731|454458086|FG000|Overall Study|Protocol Deviation|8|||
126319029|NCT00900731|454458087|FG001|Overall Study|Protocol Deviation|11|||
126319030|NCT00900731|454458086|FG000|Overall Study|Administrative Problems|5|||
126319031|NCT00900731|454458087|FG001|Overall Study|Administrative Problems|4|||
126319032|NCT00900731|454458086|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
126319033|NCT00900731|454458087|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
126319034|NCT00900731|454458086|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
126319035|NCT00900731|454458087|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
126319036|NCT00900731|454458086|FG000|Overall Study|Lost to Follow-up|2|||
126319037|NCT00900731|454458087|FG001|Overall Study|Lost to Follow-up|3|||
126319038|NCT00900731|454458086|FG000|Overall Study|Lack of Efficacy|1|||
126319039|NCT00900731|454458087|FG001|Overall Study|Lack of Efficacy|3|||
126319040|NCT00900731|454458086|FG000|Overall Study|Death|0|||
126319041|NCT00900731|454458087|FG001|Overall Study|Death|2|||
126319042|NCT01764659|454458088|FG000|Overall Study|Death|1|||
126319043|NCT01764659|454458088|FG000|Overall Study|Physician Decision|1|||
126319044|NCT01210352|454458089|FG000|Overall Study|Adverse Event|0|||
126319045|NCT01210352|454458090|FG001|Overall Study|Adverse Event|0|||
126319046|NCT01210352|454458091|FG002|Overall Study|Adverse Event|0|||
126319047|NCT01210352|454458092|FG003|Overall Study|Adverse Event|0|||
126319048|NCT01210352|454458093|FG004|Overall Study|Adverse Event|0|||
126319049|NCT01210352|454458094|FG005|Overall Study|Adverse Event|0|||
126319050|NCT01210352|454458095|FG006|Overall Study|Adverse Event|0|||
126319051|NCT01210352|454458096|FG007|Overall Study|Adverse Event|2|||
126319052|NCT01210352|454458097|FG008|Overall Study|Adverse Event|1|||
126319053|NCT01210352|454458089|FG000|Overall Study|Lack of Efficacy|0|||
126319054|NCT01210352|454458090|FG001|Overall Study|Lack of Efficacy|0|||
126319055|NCT01210352|454458091|FG002|Overall Study|Lack of Efficacy|0|||
126319056|NCT01210352|454458092|FG003|Overall Study|Lack of Efficacy|0|||
126319057|NCT01210352|454458093|FG004|Overall Study|Lack of Efficacy|0|||
126319058|NCT01210352|454458094|FG005|Overall Study|Lack of Efficacy|0|||
126319059|NCT01210352|454458095|FG006|Overall Study|Lack of Efficacy|1|||
126319060|NCT01210352|454458096|FG007|Overall Study|Lack of Efficacy|0|||
126319061|NCT01210352|454458097|FG008|Overall Study|Lack of Efficacy|0|||
126319062|NCT01210352|454458089|FG000|Overall Study|Physician Decision|0|||
126319063|NCT01210352|454458090|FG001|Overall Study|Physician Decision|0|||
126319064|NCT01210352|454458091|FG002|Overall Study|Physician Decision|0|||
126319065|NCT01210352|454458092|FG003|Overall Study|Physician Decision|0|||
126319066|NCT01210352|454458093|FG004|Overall Study|Physician Decision|0|||
126319067|NCT01210352|454458094|FG005|Overall Study|Physician Decision|0|||
126650864|NCT00320528|455678295|FG001|Study Period III|Withdrawal by Subject|1|||
126650865|NCT00320528|455678296|FG002|Study Period III|Withdrawal by Subject|2|||
126319068|NCT01210352|454458095|FG006|Overall Study|Physician Decision|0|||
126650866|NCT00320528|455678294|FG000|Study Period III|Lack of Efficacy|2|||
126319069|NCT01210352|454458096|FG007|Overall Study|Physician Decision|1|||
126319070|NCT01210352|454458097|FG008|Overall Study|Physician Decision|2|||
126319071|NCT01210352|454458089|FG000|Overall Study|Withdrawal by Subject|0|||
126650867|NCT00320528|455678295|FG001|Study Period III|Lack of Efficacy|0|||
126650868|NCT00320528|455678296|FG002|Study Period III|Lack of Efficacy|0|||
126650869|NCT00320528|455678294|FG000|Study Period III|Parent/Caregiver Decision|14|||
126319072|NCT01210352|454458090|FG001|Overall Study|Withdrawal by Subject|0|||
126319073|NCT01210352|454458091|FG002|Overall Study|Withdrawal by Subject|1|||
126319074|NCT01210352|454458092|FG003|Overall Study|Withdrawal by Subject|0|||
126319075|NCT01210352|454458093|FG004|Overall Study|Withdrawal by Subject|0|||
126319076|NCT01210352|454458094|FG005|Overall Study|Withdrawal by Subject|0|||
126319077|NCT01210352|454458095|FG006|Overall Study|Withdrawal by Subject|1|||
126319078|NCT01210352|454458096|FG007|Overall Study|Withdrawal by Subject|0|||
126319079|NCT01210352|454458097|FG008|Overall Study|Withdrawal by Subject|1|||
126319080|NCT01210352|454458089|FG000|Overall Study|Patient Discharged Early|0|||
126319081|NCT01210352|454458090|FG001|Overall Study|Patient Discharged Early|0|||
126319082|NCT01210352|454458091|FG002|Overall Study|Patient Discharged Early|1|||
126319083|NCT01210352|454458092|FG003|Overall Study|Patient Discharged Early|0|||
126319084|NCT01210352|454458093|FG004|Overall Study|Patient Discharged Early|0|||
126319085|NCT01210352|454458094|FG005|Overall Study|Patient Discharged Early|0|||
126319086|NCT01210352|454458095|FG006|Overall Study|Patient Discharged Early|0|||
126319087|NCT01210352|454458096|FG007|Overall Study|Patient Discharged Early|0|||
126319088|NCT01210352|454458097|FG008|Overall Study|Patient Discharged Early|0|||
126319089|NCT00628927|454458098|FG000|Overall Study|Problems performing blood draw|6|||
126319090|NCT00628927|454458099|FG001|Overall Study|Problems performing blood draw|0|||
126319091|NCT00628927|454458098|FG000|Overall Study|Lost to Follow-up|1|||
126319092|NCT00628927|454458099|FG001|Overall Study|Lost to Follow-up|0|||
126319093|NCT00628927|454458098|FG000|Overall Study|Equipment failure|1|||
126319094|NCT00628927|454458099|FG001|Overall Study|Equipment failure|0|||
126319095|NCT01298141|454458100|FG000|Overall Study|Adverse Event|3|||
126319096|NCT01298141|454458100|FG000|Overall Study|Refusal of Required Study Procedures|1|||
126319097|NCT01298141|454458100|FG000|Overall Study|Withdrawal by Subject|6|||
126319098|NCT01298141|454458100|FG000|Overall Study|Termination of Study by the Investigator|5|||
126319099|NCT01298141|454458100|FG000|Overall Study|Other|5|||
126319100|NCT01298141|454458100|FG000|Overall Study|Lost to Follow-up|1|||
126319101|NCT01298141|454458100|FG000|Overall Study|Death|6|||
126319102|NCT01298141|454458100|FG000|Overall Study|Not treated|4|||
126319103|NCT02093390|454458104|FG000|Overall Study|Withdrawal by Subject|0|||
126319104|NCT02093390|454458105|FG001|Overall Study|Withdrawal by Subject|1|||
126319105|NCT02000882|454459654|FG000|Overall Study|Adverse Event|3|||
126319106|NCT02000882|454459654|FG000|Overall Study|Physician Decision|2|||
126319107|NCT02000882|454459654|FG000|Overall Study|Withdrawal by Subject|1|||
126319108|NCT00549601|454459655|FG000|Randomized|Protocol Violation|0|||
126319109|NCT00549601|454459656|FG001|Randomized|Protocol Violation|0|||
126319110|NCT00549601|454459657|FG002|Randomized|Protocol Violation|1|||
126319111|NCT00549601|454459655|FG000|Randomized|Withdrawal by Subject|0|||
126319112|NCT00549601|454459656|FG001|Randomized|Withdrawal by Subject|1|||
126319113|NCT00549601|454459657|FG002|Randomized|Withdrawal by Subject|1|||
126319114|NCT00549601|454459655|FG000|Received Study Drug|Adverse Event|2|||
126319115|NCT00549601|454459656|FG001|Received Study Drug|Adverse Event|5|||
126319116|NCT00549601|454459657|FG002|Received Study Drug|Adverse Event|1|||
126319117|NCT00549601|454459655|FG000|Received Study Drug|Death|0|||
126319118|NCT00549601|454459656|FG001|Received Study Drug|Death|1|||
126319119|NCT00549601|454459657|FG002|Received Study Drug|Death|0|||
126319120|NCT00549601|454459655|FG000|Received Study Drug|Lost to Follow-up|0|||
126319121|NCT00549601|454459656|FG001|Received Study Drug|Lost to Follow-up|1|||
126319122|NCT00549601|454459657|FG002|Received Study Drug|Lost to Follow-up|1|||
126319123|NCT00549601|454459655|FG000|Received Study Drug|Protocol Violation|3|||
126319124|NCT00549601|454459656|FG001|Received Study Drug|Protocol Violation|4|||
126319125|NCT00549601|454459657|FG002|Received Study Drug|Protocol Violation|1|||
126319126|NCT00549601|454459655|FG000|Received Study Drug|Withdrawal by Subject|2|||
126319127|NCT00549601|454459656|FG001|Received Study Drug|Withdrawal by Subject|0|||
126319128|NCT00549601|454459657|FG002|Received Study Drug|Withdrawal by Subject|1|||
126319129|NCT00908596|454459661|FG000|Overall Study|Other reasons|46|||
126319130|NCT00908596|454459662|FG001|Overall Study|Other reasons|6|||
126319131|NCT00908596|454459663|FG002|Overall Study|Other reasons|2|||
126319132|NCT00908596|454459664|FG003|Overall Study|Other reasons|0|||
126319133|NCT00908596|454459661|FG000|Overall Study|Lost to Follow-up|0|||
126319134|NCT00908596|454459662|FG001|Overall Study|Lost to Follow-up|1|||
126319135|NCT00908596|454459663|FG002|Overall Study|Lost to Follow-up|12|||
126319136|NCT00908596|454459664|FG003|Overall Study|Lost to Follow-up|4|||
126319137|NCT00908596|454459661|FG000|Overall Study|Death|0|||
126319138|NCT00908596|454459662|FG001|Overall Study|Death|5|||
126319139|NCT00908596|454459663|FG002|Overall Study|Death|57|||
126319140|NCT00908596|454459664|FG003|Overall Study|Death|32|||
126319141|NCT00908596|454459661|FG000|Overall Study|Protocol Violation|1|||
126319142|NCT00908596|454459662|FG001|Overall Study|Protocol Violation|0|||
126544992|NCT04836858|455289168|FG001|Overall Study|Lost to Follow-up|0|||
126544993|NCT04836858|455289169|FG002|Overall Study|Lost to Follow-up|0|||
126544994|NCT04836858|455289170|FG003|Overall Study|Lost to Follow-up|0|||
126544995|NCT04836858|455289167|FG000|Overall Study|Subject/Guardian decision|3|||
126544996|NCT04836858|455289168|FG001|Overall Study|Subject/Guardian decision|0|||
126544997|NCT04836858|455289169|FG002|Overall Study|Subject/Guardian decision|0|||
126544998|NCT04836858|455289170|FG003|Overall Study|Subject/Guardian decision|1|||
126544999|NCT04836858|455289167|FG000|Overall Study|Randomized but not treated|4|||
126319143|NCT00908596|454459663|FG002|Overall Study|Protocol Violation|0|||
126319144|NCT00908596|454459664|FG003|Overall Study|Protocol Violation|0|||
126319145|NCT00908596|454459661|FG000|Overall Study|Withdrawal by Subject|0|||
126319146|NCT00908596|454459662|FG001|Overall Study|Withdrawal by Subject|1|||
126319147|NCT00908596|454459663|FG002|Overall Study|Withdrawal by Subject|3|||
126319148|NCT00908596|454459664|FG003|Overall Study|Withdrawal by Subject|1|||
126545000|NCT04836858|455289168|FG001|Overall Study|Randomized but not treated|0|||
126319149|NCT02437188|454459667|FG000|Overall Study|Randomized but did not receive surgery|4|||
126319150|NCT02437188|454459668|FG001|Overall Study|Randomized but did not receive surgery|8|||
126319151|NCT02437188|454459667|FG000|Overall Study|Adverse Event|0|||
126319152|NCT02437188|454459668|FG001|Overall Study|Adverse Event|1|||
126319153|NCT02661061|454459671|FG000|Overall Study|Lack of Efficacy|1|||
126319154|NCT02661061|454459672|FG001|Overall Study|Lack of Efficacy|1|||
126319155|NCT02661061|454459671|FG000|Overall Study|Withdrawal by Subject|1|||
126319156|NCT02661061|454459672|FG001|Overall Study|Withdrawal by Subject|1|||
126319157|NCT03246061|454459673|FG000|Overall Study|Still in follow-up|15|||
126319158|NCT03246061|454459674|FG001|Overall Study|Still in follow-up|21|||
126319159|NCT01492101|454459676|FG000|Overall Study|Death|323|||
126319160|NCT01492101|454459677|FG001|Overall Study|Death|322|||
126319161|NCT01492101|454459676|FG000|Overall Study|Withdrawal by Subject|14|||
126319162|NCT01492101|454459677|FG001|Overall Study|Withdrawal by Subject|18|||
126319163|NCT01492101|454459676|FG000|Overall Study|Lost to Follow-up|0|||
126319164|NCT01492101|454459677|FG001|Overall Study|Lost to Follow-up|2|||
126319165|NCT01675154|454459678|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
126319166|NCT01675154|454459679|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
126319167|NCT01675154|454459680|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
126319168|NCT01675154|454459681|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
126319169|NCT00460265|454459682|FG000|Overall Study|Lost to Follow-up|14|||
126319170|NCT00460265|454459683|FG001|Overall Study|Lost to Follow-up|15|||
126545001|NCT04836858|455289169|FG002|Overall Study|Randomized but not treated|0|||
126545002|NCT04836858|455289170|FG003|Overall Study|Randomized but not treated|0|||
126545003|NCT00597714|455289171|FG000|Overall Study|Death|56|||
126545004|NCT00597714|455289172|FG001|Overall Study|Death|46|||
126545005|NCT00597714|455289173|FG002|Overall Study|Death|0|||
126545006|NCT00597714|455289171|FG000|Overall Study|Recipient death|0|||
126545007|NCT00597714|455289172|FG001|Overall Study|Recipient death|0|||
126545008|NCT00597714|455289173|FG002|Overall Study|Recipient death|10|||
126545009|NCT01350141|455289174|FG000|Overall Study|Lost to Follow-up|1|||
126545010|NCT01350141|455289175|FG001|Overall Study|Lost to Follow-up|0|||
126545011|NCT01350141|455289176|FG002|Overall Study|Lost to Follow-up|1|||
126545012|NCT01350141|455289174|FG000|Overall Study|Withdrawal by Subject|1|||
126545013|NCT01350141|455289175|FG001|Overall Study|Withdrawal by Subject|0|||
126545014|NCT01350141|455289176|FG002|Overall Study|Withdrawal by Subject|0|||
126545015|NCT01350141|455289174|FG000|Overall Study|Randomized but not treated|1|||
126545016|NCT01350141|455289175|FG001|Overall Study|Randomized but not treated|0|||
126545017|NCT01350141|455289176|FG002|Overall Study|Randomized but not treated|0|||
126545018|NCT00519896|455289177|FG000|Overall Study|Protocol Violation|1|||
126545019|NCT00519896|455289177|FG000|Overall Study|Adverse Event|1|||
126545020|NCT00810082|455289178|FG000|Overall Study|Lost to Follow-up|0|||
126545021|NCT00810082|455289179|FG001|Overall Study|Lost to Follow-up|4|||
126545022|NCT01588990|455289180|FG000|Phase A|Withdrawal by Subject|5|||
126545023|NCT01588990|455289180|FG000|Phase A|Physician Decision|11|||
126545024|NCT01588990|455289180|FG000|Phase A|Other|14|||
126545025|NCT01588990|455289180|FG000|Phase A|Lost to Follow-up|1|||
126545026|NCT01588990|455289180|FG000|Phase A|Death|5|||
126545027|NCT01588990|455289180|FG000|Phase A|Adverse Event|28|||
126545028|NCT01588990|455289180|FG000|Phase A|Still on therapy at end of study|6|||
126545029|NCT01588990|455289180|FG000|Phase B|Adverse Event|2|||
126545030|NCT01588990|455289180|FG000|Phase B|Still on therapy at end of study|5|||
126545031|NCT01588990|455289180|FG000|Phase B|Withdrawal by Subject|3|||
126545032|NCT01588990|455289180|FG000|Phase B|Physician Decision|4|||
126545033|NCT01588990|455289180|FG000|Phase B|Other|2|||
126545034|NCT02367716|455289185|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
126545035|NCT04399356|455289186|FG000|Overall Study|Lost to Follow-up|1|||
126545036|NCT04399356|455289187|FG001|Overall Study|Lost to Follow-up|1|||
126545037|NCT04399356|455289186|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
126545038|NCT04399356|455289187|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
126545039|NCT04399356|455289186|FG000|Overall Study|Withdrawal by Subject|1|||
126545040|NCT04399356|455289187|FG001|Overall Study|Withdrawal by Subject|0|||
126545041|NCT03447730|455289188|FG000|Overall Study|Adverse Event|0|||
126545042|NCT03447730|455289189|FG001|Overall Study|Adverse Event|2|||
126545043|NCT03447730|455289190|FG002|Overall Study|Adverse Event|0|||
126545044|NCT01834222|455289199|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
126545045|NCT00423852|455289200|FG000|Overall Study|Removed pior to the high-dose portion|3|||
126545046|NCT00572624|455289201|FG000|Overall Study|Lost to Follow-up|10|||
126319171|NCT00460265|454459682|FG000|Overall Study|Physician Decision|1|||
126319172|NCT00460265|454459683|FG001|Overall Study|Physician Decision|2|||
126545047|NCT00572624|455289202|FG001|Overall Study|Lost to Follow-up|4|||
126545048|NCT00572624|455289201|FG000|Overall Study|Wanted to do a different diet program|1|||
126545049|NCT00572624|455289202|FG001|Overall Study|Wanted to do a different diet program|0|||
126545050|NCT00572624|455289201|FG000|Overall Study|Medication change|1|||
126545051|NCT00572624|455289202|FG001|Overall Study|Medication change|0|||
126545052|NCT00572624|455289201|FG000|Overall Study|Started a new job-- no time for study|1|||
126545053|NCT00572624|455289202|FG001|Overall Study|Started a new job-- no time for study|0|||
126545054|NCT00572624|455289201|FG000|Overall Study|Admitted to being a smoker|1|||
126319173|NCT00460265|454459682|FG000|Overall Study|Withdrawal by Subject|10|||
126319174|NCT00460265|454459683|FG001|Overall Study|Withdrawal by Subject|25|||
126319175|NCT00460265|454459682|FG000|Overall Study|Ongoing|60|||
126319176|NCT00460265|454459683|FG001|Overall Study|Ongoing|47|||
126319177|NCT02719353|454459684|FG000|First Intervention|Physician Decision|0|||
126319178|NCT02719353|454459685|FG001|First Intervention|Physician Decision|1|||
126319179|NCT01917344|454459689|FG000|Overall Study|Withdrawal by Subject|1|||
126319180|NCT00717275|454459691|FG000|Overall Study|Premature study termination.|3|||
126319181|NCT00424021|454459692|FG000|NCT00046319 Study Period|Adverse Event|1|||
126319182|NCT00424021|454459693|FG001|NCT00046319 Study Period|Adverse Event|0|||
126319183|NCT00424021|454459694|FG002|NCT00046319 Study Period|Adverse Event|1|||
126319184|NCT00424021|454459695|FG003|NCT00046319 Study Period|Adverse Event|1|||
126319185|NCT00424021|454459692|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
126319186|NCT00424021|454459693|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
126319187|NCT00424021|454459694|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
126319188|NCT00424021|454459695|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
126319189|NCT00424021|454459692|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
126319190|NCT00424021|454459693|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
126319191|NCT00424021|454459694|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
126319192|NCT00424021|454459695|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
126319193|NCT00424021|454459692|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
126319194|NCT00424021|454459693|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
126319195|NCT00424021|454459694|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
126319196|NCT00424021|454459695|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
126319197|NCT00424021|454459692|FG000|AMB-220-E Study Period|Adverse Event|1|||
126319198|NCT00424021|454459693|FG001|AMB-220-E Study Period|Adverse Event|1|||
126319199|NCT00424021|454459694|FG002|AMB-220-E Study Period|Adverse Event|3|||
126319200|NCT00424021|454459695|FG003|AMB-220-E Study Period|Adverse Event|7|||
126319201|NCT00424021|454459692|FG000|AMB-220-E Study Period|Death|0|||
126319202|NCT00424021|454459693|FG001|AMB-220-E Study Period|Death|0|||
126319203|NCT00424021|454459694|FG002|AMB-220-E Study Period|Death|1|||
126319204|NCT00424021|454459695|FG003|AMB-220-E Study Period|Death|1|||
126319205|NCT00424021|454459692|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
126319206|NCT00424021|454459693|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
126319207|NCT00424021|454459694|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
126319208|NCT00424021|454459695|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
126319209|NCT00424021|454459692|FG000|AMB-220-E Study Period|Physician Decision|0|||
126319210|NCT00424021|454459693|FG001|AMB-220-E Study Period|Physician Decision|0|||
126319211|NCT00424021|454459694|FG002|AMB-220-E Study Period|Physician Decision|0|||
126319212|NCT00424021|454459695|FG003|AMB-220-E Study Period|Physician Decision|1|||
126319213|NCT03000530|454459696|FG000|Overall Study|Adverse Event|0|||
126319214|NCT03000530|454459697|FG001|Overall Study|Adverse Event|0|||
126319215|NCT03000530|454459698|FG002|Overall Study|Adverse Event|2|||
126319216|NCT03000530|454459696|FG000|Overall Study|Lost to Follow-up|0|||
126319217|NCT03000530|454459697|FG001|Overall Study|Lost to Follow-up|3|||
126319218|NCT03000530|454459698|FG002|Overall Study|Lost to Follow-up|1|||
126319219|NCT03000530|454459696|FG000|Overall Study|Withdrawal by Subject|0|||
126319220|NCT03000530|454459697|FG001|Overall Study|Withdrawal by Subject|2|||
126319221|NCT03000530|454459698|FG002|Overall Study|Withdrawal by Subject|1|||
126319222|NCT00312572|454459702|FG000|Overall Study|Adverse Event|10|||
126319223|NCT00312572|454459703|FG001|Overall Study|Adverse Event|16|||
126319224|NCT00312572|454459702|FG000|Overall Study|Lost to Follow-up|1|||
126319225|NCT00312572|454459703|FG001|Overall Study|Lost to Follow-up|1|||
126319226|NCT00312572|454459702|FG000|Overall Study|Administrative|4|||
126319227|NCT00312572|454459703|FG001|Overall Study|Administrative|2|||
126319228|NCT00312572|454459702|FG000|Overall Study|Lack of Efficacy|1|||
126319229|NCT00312572|454459703|FG001|Overall Study|Lack of Efficacy|2|||
126319230|NCT03597022|454459704|FG000|Overall Study|Premature termination of the study|7|||
126319231|NCT03597022|454459705|FG001|Overall Study|Premature termination of the study|7|||
126319232|NCT03597022|454459706|FG002|Overall Study|Premature termination of the study|8|||
126319233|NCT03597022|454459704|FG000|Overall Study|Serious adverse event|1|||
126319234|NCT03597022|454459705|FG001|Overall Study|Serious adverse event|1|||
126319235|NCT03597022|454459706|FG002|Overall Study|Serious adverse event|0|||
126319236|NCT02614131|454459707|FG000|Overall Study|Withdrawal by Subject|1|||
126650870|NCT00320528|455678295|FG001|Study Period III|Parent/Caregiver Decision|3|||
126319237|NCT02614131|454459708|FG001|Overall Study|Withdrawal by Subject|0|||
126319238|NCT02614131|454459709|FG002|Overall Study|Withdrawal by Subject|0|||
126319239|NCT02614131|454459710|FG003|Overall Study|Withdrawal by Subject|0|||
126319240|NCT02614131|454459711|FG004|Overall Study|Withdrawal by Subject|0|||
126319241|NCT02614131|454459712|FG005|Overall Study|Withdrawal by Subject|0|||
126319242|NCT02614131|454459713|FG006|Overall Study|Withdrawal by Subject|0|||
126319243|NCT02614131|454459707|FG000|Overall Study|Adverse Event|0|||
126319244|NCT02614131|454459708|FG001|Overall Study|Adverse Event|0|||
126319245|NCT02614131|454459709|FG002|Overall Study|Adverse Event|0|||
126319246|NCT02614131|454459710|FG003|Overall Study|Adverse Event|0|||
126319247|NCT02614131|454459711|FG004|Overall Study|Adverse Event|0|||
126319248|NCT02614131|454459712|FG005|Overall Study|Adverse Event|0|||
126319249|NCT02614131|454459713|FG006|Overall Study|Adverse Event|1|||
126319250|NCT01285492|454459718|FG000|Overall Study|Adverse Event|11|||
126319251|NCT01285492|454459719|FG001|Overall Study|Adverse Event|0|||
126319252|NCT01285492|454459718|FG000|Overall Study|Protocol Violation|3|||
126319253|NCT01285492|454459719|FG001|Overall Study|Protocol Violation|0|||
126319254|NCT01285492|454459718|FG000|Overall Study|Withdrawal by Subject|2|||
126319255|NCT01285492|454459719|FG001|Overall Study|Withdrawal by Subject|1|||
126319256|NCT01285492|454459718|FG000|Overall Study|Death|1|||
126319257|NCT01285492|454459719|FG001|Overall Study|Death|0|||
126319258|NCT01797094|454459720|FG000|Overall Study|Adverse Event|1|||
126319259|NCT01797094|454459721|FG001|Overall Study|Adverse Event|1|||
126319260|NCT01797094|454459720|FG000|Overall Study|Personal Reasons|4|||
126319261|NCT01797094|454459721|FG001|Overall Study|Personal Reasons|0|||
126319262|NCT01797094|454459720|FG000|Overall Study|Protocol Violation|0|||
126319263|NCT01797094|454459721|FG001|Overall Study|Protocol Violation|1|||
126319264|NCT01797094|454459720|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126319265|NCT01797094|454459721|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126319266|NCT03217968|454459726|FG000|Overall Study|Withdrawal by Subject|4|||
126319267|NCT03217968|454459726|FG000|Overall Study|Lost to Follow-up|1|||
126319268|NCT03217968|454459726|FG000|Overall Study|Protocol Violation|6|||
126319269|NCT01887678|454459730|FG000|Overall Study|Adverse Event|4|||
126319270|NCT01887678|454459731|FG001|Overall Study|Adverse Event|6|||
126319271|NCT01887678|454459730|FG000|Overall Study|Exceeded rescue medication dosage|4|||
126319272|NCT01887678|454459731|FG001|Overall Study|Exceeded rescue medication dosage|5|||
126319273|NCT01887678|454459730|FG000|Overall Study|Withdrawal of consent|3|||
126319274|NCT01887678|454459731|FG001|Overall Study|Withdrawal of consent|4|||
126319275|NCT01887678|454459730|FG000|Overall Study|Lost to Follow-up|4|||
126319276|NCT01887678|454459731|FG001|Overall Study|Lost to Follow-up|2|||
126319277|NCT01887678|454459730|FG000|Overall Study|Deterioration of clinical condition|0|||
126319278|NCT01887678|454459731|FG001|Overall Study|Deterioration of clinical condition|4|||
126319279|NCT01887678|454459730|FG000|Overall Study|Lack of Efficacy|1|||
126319280|NCT01887678|454459731|FG001|Overall Study|Lack of Efficacy|2|||
126319281|NCT01887678|454459730|FG000|Overall Study|Non-compliance|0|||
126319282|NCT01887678|454459731|FG001|Overall Study|Non-compliance|3|||
126319283|NCT01887678|454459730|FG000|Overall Study|Specified|1|||
126319284|NCT01887678|454459731|FG001|Overall Study|Specified|2|||
126319285|NCT03013985|454459732|FG000|Overall Study|Protocol Violation|2|||
126319286|NCT03013985|454459733|FG001|Overall Study|Protocol Violation|2|||
126319287|NCT03013985|454459732|FG000|Overall Study|Withdrawal by Subject|14|||
126319288|NCT03013985|454459733|FG001|Overall Study|Withdrawal by Subject|17|||
126319289|NCT00791492|454459736|FG000|Overall Study|Withdrawal by Subject|1|||
126319290|NCT00791492|454459737|FG001|Overall Study|Withdrawal by Subject|2|||
126319291|NCT00791492|454459736|FG000|Overall Study|Liver transplantation|5|||
126319292|NCT00791492|454459737|FG001|Overall Study|Liver transplantation|1|||
126319293|NCT00634049|454459752|FG000|Overall Study|Never received study drug|1|||
126319294|NCT00634049|454459752|FG000|Overall Study|Died prior to receiving study drug|1|||
126319295|NCT00634049|454459752|FG000|Overall Study|Screening failure|1|||
126319296|NCT00314132|454459754|FG000|Overall Study|Lost to Follow-up|3|||
126319297|NCT00314132|454459755|FG001|Overall Study|Lost to Follow-up|13|||
126319298|NCT00314132|454459754|FG000|Overall Study|Withdrawal by Subject|3|||
126319299|NCT00314132|454459755|FG001|Overall Study|Withdrawal by Subject|5|||
126319300|NCT00314132|454459754|FG000|Overall Study|Adverse Event|1|||
126319301|NCT00314132|454459755|FG001|Overall Study|Adverse Event|0|||
126319302|NCT00314132|454459754|FG000|Overall Study|Physician Decision|1|||
126319303|NCT00314132|454459755|FG001|Overall Study|Physician Decision|0|||
126319304|NCT01380691|454459757|FG000|Washout (7 Days)|Protocol Violation|0|||
126319305|NCT01380691|454459758|FG001|Washout (7 Days)|Protocol Violation|0|||
126319306|NCT01380691|454459759|FG002|Washout (7 Days)|Protocol Violation|0|||
126319307|NCT01380691|454459760|FG003|Washout (7 Days)|Protocol Violation|1|||
126319308|NCT01380691|454459757|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
126319309|NCT01380691|454459758|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
126545055|NCT00572624|455289202|FG001|Overall Study|Admitted to being a smoker|0|||
126319310|NCT01380691|454459759|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
126319311|NCT01380691|454459760|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
126319312|NCT01987232|454459763|FG000|Overall Study|Ongoing in Study|0|||
126319313|NCT01987232|454459764|FG001|Overall Study|Ongoing in Study|0|||
126319314|NCT01987232|454459765|FG002|Overall Study|Ongoing in Study|0|||
126319315|NCT01987232|454459766|FG003|Overall Study|Ongoing in Study|1|||
126319316|NCT01987232|454459767|FG004|Overall Study|Ongoing in Study|0|||
126319317|NCT00586508|454459768|FG000|Overall Study|Progressive disease|52|||
126319318|NCT00586508|454459769|FG001|Overall Study|Progressive disease|8|||
126319319|NCT00586508|454459768|FG000|Overall Study|Death|0|||
126319320|NCT00586508|454459769|FG001|Overall Study|Death|1|||
126319321|NCT00586508|454459768|FG000|Overall Study|Adverse Event|12|||
126319322|NCT00586508|454459769|FG001|Overall Study|Adverse Event|4|||
126319323|NCT00586508|454459768|FG000|Overall Study|Withdrawal by Subject|4|||
126545056|NCT00572624|455289201|FG000|Overall Study|Refused to do the stress test|1|||
126319324|NCT00586508|454459769|FG001|Overall Study|Withdrawal by Subject|0|||
126319325|NCT00932698|454459770|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
126319326|NCT00932698|454459771|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
126319327|NCT00932698|454459772|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
126319328|NCT00932698|454459773|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
126319329|NCT00932698|454459774|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
126319330|NCT00932698|454459775|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
126319331|NCT00932698|454459776|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
126319332|NCT00932698|454459777|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
126319333|NCT00932698|454459778|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
126319334|NCT00932698|454459779|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
126319335|NCT00932698|454459780|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
126319336|NCT00932698|454459770|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319337|NCT00932698|454459771|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
126319338|NCT00932698|454459772|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319339|NCT00932698|454459773|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
126319340|NCT00932698|454459774|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319341|NCT00932698|454459775|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
126319342|NCT00932698|454459776|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
126319343|NCT00932698|454459777|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319344|NCT00932698|454459778|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319345|NCT00932698|454459779|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319346|NCT00932698|454459780|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
126319347|NCT00932698|454459770|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
126319348|NCT00932698|454459771|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
126319349|NCT00932698|454459772|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
126319350|NCT00932698|454459773|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
126319351|NCT00932698|454459774|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
126319352|NCT00932698|454459775|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
126319353|NCT00932698|454459776|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
126319354|NCT00932698|454459777|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
126319355|NCT00932698|454459778|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
126319356|NCT00932698|454459779|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
126319357|NCT00932698|454459780|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
126319358|NCT00932698|454459770|FG000|Part 1 (Dose Escalation)|Other|0|||
126319359|NCT00932698|454459771|FG001|Part 1 (Dose Escalation)|Other|0|||
126319360|NCT00932698|454459772|FG002|Part 1 (Dose Escalation)|Other|1|||
126319361|NCT00932698|454459773|FG003|Part 1 (Dose Escalation)|Other|0|||
126319362|NCT00932698|454459774|FG004|Part 1 (Dose Escalation)|Other|0|||
126319363|NCT00932698|454459775|FG005|Part 1 (Dose Escalation)|Other|0|||
126319364|NCT00932698|454459776|FG006|Part 1 (Dose Escalation)|Other|1|||
126319365|NCT00932698|454459777|FG007|Part 1 (Dose Escalation)|Other|0|||
126319366|NCT00932698|454459778|FG008|Part 1 (Dose Escalation)|Other|0|||
126319367|NCT00932698|454459779|FG009|Part 1 (Dose Escalation)|Other|0|||
126319368|NCT00932698|454459780|FG010|Part 1 (Dose Escalation)|Other|0|||
126319369|NCT00932698|454459770|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
126319370|NCT00932698|454459771|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
126319371|NCT00932698|454459772|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
126650871|NCT00320528|455678296|FG002|Study Period III|Parent/Caregiver Decision|11|||
126650872|NCT00320528|455678294|FG000|Study Period III|Protocol Violation|0|||
126650873|NCT00320528|455678295|FG001|Study Period III|Protocol Violation|1|||
126650874|NCT00320528|455678296|FG002|Study Period III|Protocol Violation|0|||
126650875|NCT00320528|455678294|FG000|Study Period III|Physician Decision|0|||
126319372|NCT00932698|454459773|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
126319373|NCT00932698|454459774|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
126319374|NCT00932698|454459775|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
126319375|NCT00932698|454459776|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
126319376|NCT00932698|454459777|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
126319377|NCT00932698|454459778|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
126545057|NCT00572624|455289202|FG001|Overall Study|Refused to do the stress test|0|||
126545058|NCT00572624|455289201|FG000|Overall Study|Problem with vascular access|1|||
126545059|NCT00572624|455289202|FG001|Overall Study|Problem with vascular access|0|||
126545060|NCT00572624|455289201|FG000|Overall Study|Health issues unrelated to the study|1|||
126545061|NCT00572624|455289202|FG001|Overall Study|Health issues unrelated to the study|0|||
126545062|NCT05229653|455289204|FG000|Overall Study|Lost to Follow-up|1|||
126545063|NCT05229653|455289205|FG001|Overall Study|Lost to Follow-up|0|||
126545064|NCT05672680|455289206|FG000|Overall Study|Patient Did Not Complete the Form|5|||
126545065|NCT05672680|455289207|FG001|Overall Study|Patient Did Not Complete the Form|4|||
126319378|NCT00932698|454459779|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
126319379|NCT00932698|454459780|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
126319380|NCT00932698|454459770|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126545066|NCT05672680|455289206|FG000|Overall Study|Procedure Aborted|1|||
126319381|NCT00932698|454459771|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319382|NCT00932698|454459772|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319383|NCT00932698|454459773|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319384|NCT00932698|454459774|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319385|NCT00932698|454459775|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319386|NCT00932698|454459776|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319387|NCT00932698|454459777|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
126319388|NCT00932698|454459778|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
126319389|NCT00932698|454459779|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
126319390|NCT00932698|454459780|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
126319391|NCT00932698|454459770|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
126319392|NCT00932698|454459771|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
126319393|NCT00932698|454459772|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
126319394|NCT00932698|454459773|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
126319395|NCT00932698|454459774|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
126319396|NCT00932698|454459775|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
126319397|NCT00932698|454459776|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
126319398|NCT00932698|454459777|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
126319399|NCT00932698|454459778|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
126319400|NCT00932698|454459779|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
126319401|NCT00932698|454459780|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
126319402|NCT00655681|454459781|FG000|Overall Study|Lost to Follow-up|1|||
126319403|NCT00655681|454459782|FG001|Overall Study|Lost to Follow-up|1|||
126319404|NCT02429310|454459783|FG000|Overall Study|Lost to Follow-up|1|||
126319405|NCT02429310|454459784|FG001|Overall Study|Lost to Follow-up|2|||
126319406|NCT02429310|454459783|FG000|Overall Study|Protocol Violation|1|||
126319407|NCT02429310|454459784|FG001|Overall Study|Protocol Violation|1|||
126319408|NCT00394433|454459785|FG000|Overall Study|Adverse Event|2|||
126319409|NCT00394433|454459785|FG000|Overall Study|Alternative Therapy|1|||
126319410|NCT01554176|454459786|FG000|Treatment Phase|Protocol Violation|1|||
126319411|NCT01554176|454459787|FG001|Treatment Phase|Protocol Violation|2|||
126319412|NCT01554176|454459788|FG002|Treatment Phase|Protocol Violation|0|||
126319413|NCT01554176|454459789|FG003|Treatment Phase|Protocol Violation|0|||
126319414|NCT01554176|454459790|FG004|Treatment Phase|Protocol Violation|0|||
126319415|NCT01554176|454459786|FG000|Treatment Phase|Physician Decision|1|||
126319416|NCT01554176|454459787|FG001|Treatment Phase|Physician Decision|1|||
126319417|NCT01554176|454459788|FG002|Treatment Phase|Physician Decision|0|||
126319418|NCT01554176|454459789|FG003|Treatment Phase|Physician Decision|0|||
126319419|NCT01554176|454459790|FG004|Treatment Phase|Physician Decision|0|||
126319420|NCT01554176|454459786|FG000|Treatment Phase|Lack of Efficacy|0|||
126319421|NCT01554176|454459787|FG001|Treatment Phase|Lack of Efficacy|1|||
126319422|NCT01554176|454459788|FG002|Treatment Phase|Lack of Efficacy|0|||
126319423|NCT01554176|454459789|FG003|Treatment Phase|Lack of Efficacy|0|||
126319424|NCT01554176|454459790|FG004|Treatment Phase|Lack of Efficacy|0|||
126319425|NCT01554176|454459786|FG000|Treatment Phase|Adverse event, non-fatal|1|||
126319426|NCT01554176|454459787|FG001|Treatment Phase|Adverse event, non-fatal|1|||
126319427|NCT01554176|454459788|FG002|Treatment Phase|Adverse event, non-fatal|0|||
126319428|NCT01554176|454459789|FG003|Treatment Phase|Adverse event, non-fatal|0|||
126319429|NCT01554176|454459790|FG004|Treatment Phase|Adverse event, non-fatal|0|||
126319430|NCT01554176|454459786|FG000|Treatment Phase|Non-compliance with study drug|1|||
126319431|NCT01554176|454459787|FG001|Treatment Phase|Non-compliance with study drug|0|||
126319432|NCT01554176|454459788|FG002|Treatment Phase|Non-compliance with study drug|0|||
126319433|NCT01554176|454459789|FG003|Treatment Phase|Non-compliance with study drug|0|||
126319434|NCT01554176|454459790|FG004|Treatment Phase|Non-compliance with study drug|0|||
126545067|NCT05672680|455289207|FG001|Overall Study|Procedure Aborted|0|||
126545068|NCT03635489|455289208|FG000|Overall Study|Death|19|||
126545069|NCT03635489|455289209|FG001|Overall Study|Death|13|||
126545070|NCT03635489|455289208|FG000|Overall Study|Lost to Follow-up|1|||
126319435|NCT01554176|454459786|FG000|Treatment Phase|Withdrawal by Subject|1|||
126319436|NCT01554176|454459787|FG001|Treatment Phase|Withdrawal by Subject|0|||
126545071|NCT03635489|455289209|FG001|Overall Study|Lost to Follow-up|2|||
126319437|NCT01554176|454459788|FG002|Treatment Phase|Withdrawal by Subject|0|||
126319438|NCT01554176|454459789|FG003|Treatment Phase|Withdrawal by Subject|0|||
126319439|NCT01554176|454459790|FG004|Treatment Phase|Withdrawal by Subject|0|||
126545072|NCT03635489|455289208|FG000|Overall Study|Withdrawal by Subject|1|||
126319440|NCT01554176|454459786|FG000|Treatment Phase|Lost to Follow-up|3|||
126319441|NCT01554176|454459787|FG001|Treatment Phase|Lost to Follow-up|0|||
126319442|NCT01554176|454459788|FG002|Treatment Phase|Lost to Follow-up|0|||
126319443|NCT01554176|454459789|FG003|Treatment Phase|Lost to Follow-up|0|||
126319444|NCT01554176|454459790|FG004|Treatment Phase|Lost to Follow-up|0|||
126319445|NCT01554176|454459786|FG000|Run-out Phase|Protocol Violation|0|||
126319446|NCT01554176|454459787|FG001|Run-out Phase|Protocol Violation|0|||
126319447|NCT01554176|454459788|FG002|Run-out Phase|Protocol Violation|0|||
126319448|NCT01554176|454459789|FG003|Run-out Phase|Protocol Violation|1|||
126319449|NCT01554176|454459790|FG004|Run-out Phase|Protocol Violation|0|||
126545073|NCT03635489|455289209|FG001|Overall Study|Withdrawal by Subject|2|||
126319450|NCT01085136|454459791|FG000|Part A|Other Adverse event|223|||
126319451|NCT01085136|454459792|FG001|Part A|Other Adverse event|0|||
126319452|NCT01085136|454459793|FG002|Part A|Other Adverse event|0|||
126319453|NCT01085136|454459791|FG000|Part A|Protocol Violation|3|||
126319454|NCT01085136|454459792|FG001|Part A|Protocol Violation|0|||
126319455|NCT01085136|454459793|FG002|Part A|Protocol Violation|0|||
126319456|NCT01085136|454459791|FG000|Part A|Lost to Follow-up|3|||
126319457|NCT01085136|454459792|FG001|Part A|Lost to Follow-up|0|||
126319458|NCT01085136|454459793|FG002|Part A|Lost to Follow-up|0|||
126319459|NCT01085136|454459791|FG000|Part A|Refusal to continue trial medication|64|||
126319460|NCT01085136|454459792|FG001|Part A|Refusal to continue trial medication|0|||
126319461|NCT01085136|454459793|FG002|Part A|Refusal to continue trial medication|0|||
126319462|NCT01085136|454459791|FG000|Part A|Other reason not defined above|30|||
126319463|NCT01085136|454459792|FG001|Part A|Other reason not defined above|0|||
126319464|NCT01085136|454459793|FG002|Part A|Other reason not defined above|0|||
126319465|NCT01085136|454459791|FG000|Part B|Other AE|0|||
126319466|NCT01085136|454459792|FG001|Part B|Other AE|29|||
126319467|NCT01085136|454459793|FG002|Part B|Other AE|8|||
126319468|NCT01085136|454459791|FG000|Part B|Refusal to continue trial medication|0|||
126319469|NCT01085136|454459792|FG001|Part B|Refusal to continue trial medication|12|||
126319470|NCT01085136|454459793|FG002|Part B|Refusal to continue trial medication|7|||
126319471|NCT01085136|454459791|FG000|Part B|Not treated|0|||
126319472|NCT01085136|454459792|FG001|Part B|Not treated|4|||
126319473|NCT01085136|454459793|FG002|Part B|Not treated|8|||
126319474|NCT01085136|454459791|FG000|Part B|Other reason not defined above|0|||
126319475|NCT01085136|454459792|FG001|Part B|Other reason not defined above|6|||
126319476|NCT01085136|454459793|FG002|Part B|Other reason not defined above|3|||
126319477|NCT01854879|454459796|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
126319478|NCT01854879|454459796|FG000|Overall Study|screen fail|3|||
126319479|NCT01854879|454459796|FG000|Overall Study|incomplete data set|1|||
126319480|NCT01709864|454461424|FG000|Overall Study|Physician Decision|0|||
126319481|NCT01709864|454461425|FG001|Overall Study|Physician Decision|1|||
126319482|NCT01709864|454461424|FG000|Overall Study|subject/guardian decision|5|||
126319483|NCT01709864|454461425|FG001|Overall Study|subject/guardian decision|6|||
126319484|NCT01709864|454461424|FG000|Overall Study|Lost to Follow-up|1|||
126319485|NCT01709864|454461425|FG001|Overall Study|Lost to Follow-up|0|||
126319486|NCT01709864|454461424|FG000|Overall Study|non-compliance with study treatment|1|||
126319487|NCT01709864|454461425|FG001|Overall Study|non-compliance with study treatment|1|||
126319488|NCT01709864|454461424|FG000|Overall Study|Adverse Event|0|||
126319489|NCT01709864|454461425|FG001|Overall Study|Adverse Event|2|||
126319490|NCT01709864|454461424|FG000|Overall Study|Death|0|||
126319491|NCT01709864|454461425|FG001|Overall Study|Death|1|||
126319492|NCT00316914|454461446|FG000|Overall Study|Withdrawal by Subject|5|||
126319493|NCT00316914|454461447|FG001|Overall Study|Withdrawal by Subject|3|||
126319494|NCT00316914|454461446|FG000|Overall Study|Adverse Event|8|||
126319495|NCT00316914|454461447|FG001|Overall Study|Adverse Event|7|||
126319496|NCT00316914|454461446|FG000|Overall Study|Other Problems|6|||
126319497|NCT00316914|454461447|FG001|Overall Study|Other Problems|11|||
126319498|NCT00316914|454461446|FG000|Overall Study|Missing end of treatment documentation|14|||
126319499|NCT00316914|454461447|FG001|Overall Study|Missing end of treatment documentation|15|||
126319500|NCT04105010|454461448|FG000|Overall Study|Death|3|||
126319501|NCT04105010|454461449|FG001|Overall Study|Death|1|||
126319502|NCT04105010|454461450|FG002|Overall Study|Death|1|||
126319503|NCT04105010|454461451|FG003|Overall Study|Death|54|||
126319504|NCT04105010|454461448|FG000|Overall Study|Lost to Follow-up|0|||
126319505|NCT04105010|454461449|FG001|Overall Study|Lost to Follow-up|0|||
126319506|NCT04105010|454461450|FG002|Overall Study|Lost to Follow-up|0|||
126319507|NCT04105010|454461451|FG003|Overall Study|Lost to Follow-up|4|||
126319508|NCT04105010|454461448|FG000|Overall Study|Withdrawal by Subject|8|||
126319509|NCT04105010|454461449|FG001|Overall Study|Withdrawal by Subject|1|||
126319510|NCT04105010|454461450|FG002|Overall Study|Withdrawal by Subject|1|||
126319511|NCT04105010|454461451|FG003|Overall Study|Withdrawal by Subject|4|||
126545074|NCT03635489|455289208|FG000|Overall Study|Study Ended by Sponsor|28|||
126545075|NCT03635489|455289209|FG001|Overall Study|Study Ended by Sponsor|34|||
126319512|NCT04105010|454461448|FG000|Overall Study|Other reason|4|||
126319513|NCT04105010|454461449|FG001|Overall Study|Other reason|7|||
126319514|NCT04105010|454461450|FG002|Overall Study|Other reason|0|||
126319515|NCT04105010|454461451|FG003|Overall Study|Other reason|19|||
126319516|NCT00427999|454461452|FG000|Overall Study|Adverse Event|6|||
126319517|NCT00427999|454461452|FG000|Overall Study|Abnormal laboratory values|1|||
126319518|NCT00427999|454461452|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
126319519|NCT00427999|454461452|FG000|Overall Study|Protocol Violation|2|||
126319520|NCT00427999|454461452|FG000|Overall Study|Withdrawal by Subject|9|||
126319521|NCT00427999|454461452|FG000|Overall Study|Death|1|||
126319522|NCT02380859|454461453|FG000|Overall Study|Withdrawal by Subject|2|||
126319523|NCT02380859|454461454|FG001|Overall Study|Withdrawal by Subject|0|||
126319524|NCT02284568|454461455|FG000|Overall Study|Adverse Event|2|||
126319525|NCT02284568|454461456|FG001|Overall Study|Adverse Event|9|||
126319526|NCT02284568|454461457|FG002|Overall Study|Adverse Event|4|||
126319527|NCT02284568|454461455|FG000|Overall Study|Withdrawal by Subject|22|||
126319528|NCT02284568|454461456|FG001|Overall Study|Withdrawal by Subject|21|||
126319529|NCT02284568|454461457|FG002|Overall Study|Withdrawal by Subject|1|||
126319530|NCT02284568|454461455|FG000|Overall Study|Noncompliance with study drug admin|1|||
126319531|NCT02284568|454461456|FG001|Overall Study|Noncompliance with study drug admin|2|||
126319532|NCT02284568|454461457|FG002|Overall Study|Noncompliance with study drug admin|0|||
126319533|NCT02284568|454461455|FG000|Overall Study|Noncompliance|1|||
126319534|NCT02284568|454461456|FG001|Overall Study|Noncompliance|0|||
126319535|NCT02284568|454461457|FG002|Overall Study|Noncompliance|0|||
126319536|NCT02284568|454461455|FG000|Overall Study|Protocol Violation|0|||
126319537|NCT02284568|454461456|FG001|Overall Study|Protocol Violation|1|||
126319538|NCT02284568|454461457|FG002|Overall Study|Protocol Violation|0|||
126319539|NCT02284568|454461455|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
126319540|NCT02284568|454461456|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
126319541|NCT02284568|454461457|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
126319542|NCT02284568|454461455|FG000|Overall Study|Lost to Follow-up|0|||
126319543|NCT02284568|454461456|FG001|Overall Study|Lost to Follow-up|3|||
126319544|NCT02284568|454461457|FG002|Overall Study|Lost to Follow-up|0|||
126319545|NCT02284568|454461455|FG000|Overall Study|Lack of Efficacy|4|||
126319546|NCT02284568|454461456|FG001|Overall Study|Lack of Efficacy|7|||
126319547|NCT02284568|454461457|FG002|Overall Study|Lack of Efficacy|0|||
126319548|NCT02284568|454461455|FG000|Overall Study|Other|1|||
126319549|NCT02284568|454461456|FG001|Overall Study|Other|2|||
126319550|NCT02284568|454461457|FG002|Overall Study|Other|0|||
126319551|NCT02284568|454461455|FG000|Overall Study|Withdrew before taking study drug|0|||
126319552|NCT02284568|454461456|FG001|Overall Study|Withdrew before taking study drug|1|||
126319553|NCT02284568|454461457|FG002|Overall Study|Withdrew before taking study drug|0|||
126319554|NCT00412217|454461458|FG000|Overall Study|Insufficient Data Available|8|||
126319555|NCT00412217|454461459|FG001|Overall Study|Insufficient Data Available|3|||
126319556|NCT00412217|454461458|FG000|Overall Study|Death|5|||
126319557|NCT00412217|454461459|FG001|Overall Study|Death|4|||
126319558|NCT00412217|454461458|FG000|Overall Study|Disease Progression|2|||
126319559|NCT00412217|454461459|FG001|Overall Study|Disease Progression|3|||
126319560|NCT00412217|454461458|FG000|Overall Study|Investigator Decision|1|||
126319561|NCT00412217|454461459|FG001|Overall Study|Investigator Decision|0|||
126319562|NCT00412217|454461458|FG000|Overall Study|Withdrawal by Subject|2|||
126319563|NCT00412217|454461459|FG001|Overall Study|Withdrawal by Subject|0|||
126319564|NCT00412217|454461458|FG000|Overall Study|Lost to Follow-up|1|||
126319565|NCT00412217|454461459|FG001|Overall Study|Lost to Follow-up|4|||
126319566|NCT00412217|454461458|FG000|Overall Study|Study Terminated by Sponsor|26|||
126319567|NCT00412217|454461459|FG001|Overall Study|Study Terminated by Sponsor|33|||
126319568|NCT00412217|454461458|FG000|Overall Study|Other|1|||
126319569|NCT00412217|454461459|FG001|Overall Study|Other|1|||
126319570|NCT03114657|454461461|FG000|Overall Study|Adverse Event|9|||
126319571|NCT03114657|454461462|FG001|Overall Study|Adverse Event|6|||
126319572|NCT03114657|454461461|FG000|Overall Study|Death|4|||
126319573|NCT03114657|454461462|FG001|Overall Study|Death|0|||
126319574|NCT03114657|454461461|FG000|Overall Study|Multiple Reasons|1|||
126319575|NCT03114657|454461462|FG001|Overall Study|Multiple Reasons|2|||
126319576|NCT03114657|454461461|FG000|Overall Study|Physician Decision|2|||
126319577|NCT03114657|454461462|FG001|Overall Study|Physician Decision|2|||
126319578|NCT03114657|454461461|FG000|Overall Study|Study Terminated By Sponsor|355|||
126319579|NCT03114657|454461462|FG001|Overall Study|Study Terminated By Sponsor|374|||
126319580|NCT03114657|454461461|FG000|Overall Study|Symptomatic Deterioration|0|||
126319581|NCT03114657|454461462|FG001|Overall Study|Symptomatic Deterioration|1|||
126319582|NCT03114657|454461461|FG000|Overall Study|Withdrawal by Subject|28|||
126319583|NCT03114657|454461462|FG001|Overall Study|Withdrawal by Subject|22|||
126319584|NCT01179737|454461463|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
126319585|NCT01179737|454461464|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
126319586|NCT01179737|454461465|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
126319587|NCT01179737|454461466|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
126319588|NCT01179737|454461463|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
126319589|NCT01179737|454461464|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
126319590|NCT01179737|454461465|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
126545076|NCT00943306|455289210|FG000|Overall Study|Physician Decision|1|||
126319591|NCT01179737|454461466|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
126319592|NCT01179737|454461463|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
126319593|NCT01179737|454461464|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
126319594|NCT01179737|454461465|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
126319595|NCT01179737|454461466|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
126319596|NCT01179737|454461463|FG000|Cohort 1 & Cohort 2|Death|0|||
126319597|NCT01179737|454461464|FG001|Cohort 1 & Cohort 2|Death|0|||
126319598|NCT01179737|454461465|FG002|Cohort 1 & Cohort 2|Death|1|||
126319599|NCT01179737|454461466|FG003|Cohort 1 & Cohort 2|Death|0|||
126319600|NCT01179737|454461463|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
126319601|NCT01179737|454461464|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
126319602|NCT01179737|454461465|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
126319603|NCT01179737|454461466|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
126319604|NCT01179737|454461463|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
126319605|NCT01179737|454461464|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
126319606|NCT01179737|454461465|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
126319607|NCT01179737|454461466|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
126319608|NCT01179737|454461463|FG000|Extension|The study was terminated|3|||
126319609|NCT01179737|454461464|FG001|Extension|The study was terminated|0|||
126319610|NCT01179737|454461465|FG002|Extension|The study was terminated|0|||
126319611|NCT01179737|454461466|FG003|Extension|The study was terminated|0|||
126319612|NCT01546038|454461467|FG000|Overall Study|Death|15|||
126319613|NCT01546038|454461468|FG001|Overall Study|Death|6|||
126319614|NCT01546038|454461469|FG002|Overall Study|Death|4|||
126319615|NCT01546038|454461470|FG003|Overall Study|Death|2|||
126319616|NCT01546038|454461471|FG004|Overall Study|Death|9|||
126319617|NCT01546038|454461472|FG005|Overall Study|Death|3|||
126319618|NCT01546038|454461473|FG006|Overall Study|Death|46|||
126319619|NCT01546038|454461474|FG007|Overall Study|Death|76|||
126319620|NCT01546038|454461475|FG008|Overall Study|Death|39|||
126319621|NCT01546038|454461467|FG000|Overall Study|Lost to Follow-up|0|||
126319622|NCT01546038|454461468|FG001|Overall Study|Lost to Follow-up|0|||
126319623|NCT01546038|454461469|FG002|Overall Study|Lost to Follow-up|0|||
126319624|NCT01546038|454461470|FG003|Overall Study|Lost to Follow-up|0|||
126319625|NCT01546038|454461471|FG004|Overall Study|Lost to Follow-up|1|||
126319626|NCT01546038|454461472|FG005|Overall Study|Lost to Follow-up|0|||
126319627|NCT01546038|454461473|FG006|Overall Study|Lost to Follow-up|2|||
126319628|NCT01546038|454461474|FG007|Overall Study|Lost to Follow-up|1|||
126319629|NCT01546038|454461475|FG008|Overall Study|Lost to Follow-up|0|||
126319630|NCT01546038|454461467|FG000|Overall Study|Withdrawal by Subject|1|||
126319631|NCT01546038|454461468|FG001|Overall Study|Withdrawal by Subject|0|||
126319632|NCT01546038|454461469|FG002|Overall Study|Withdrawal by Subject|0|||
126319633|NCT01546038|454461470|FG003|Overall Study|Withdrawal by Subject|1|||
126319634|NCT01546038|454461471|FG004|Overall Study|Withdrawal by Subject|0|||
126319635|NCT01546038|454461472|FG005|Overall Study|Withdrawal by Subject|1|||
126319636|NCT01546038|454461473|FG006|Overall Study|Withdrawal by Subject|3|||
126319637|NCT01546038|454461474|FG007|Overall Study|Withdrawal by Subject|3|||
126319638|NCT01546038|454461475|FG008|Overall Study|Withdrawal by Subject|1|||
126319639|NCT01546038|454461467|FG000|Overall Study|: Randomized, not treated|0|||
126319640|NCT01546038|454461468|FG001|Overall Study|: Randomized, not treated|0|||
126319641|NCT01546038|454461469|FG002|Overall Study|: Randomized, not treated|0|||
126319642|NCT01546038|454461470|FG003|Overall Study|: Randomized, not treated|0|||
126319643|NCT01546038|454461471|FG004|Overall Study|: Randomized, not treated|0|||
126319644|NCT01546038|454461472|FG005|Overall Study|: Randomized, not treated|0|||
126319645|NCT01546038|454461473|FG006|Overall Study|: Randomized, not treated|2|||
126319646|NCT01546038|454461474|FG007|Overall Study|: Randomized, not treated|4|||
126319647|NCT01546038|454461475|FG008|Overall Study|: Randomized, not treated|3|||
126319648|NCT03329248|454461479|FG000|Overall Study|Progressive Disease|6|||
126319649|NCT01254721|454461480|FG000|Overall Study|Lost to Follow-up|0|||
126319650|NCT01254721|454461481|FG001|Overall Study|Lost to Follow-up|4|||
126319651|NCT01254721|454461480|FG000|Overall Study|Lack of Efficacy|4|||
126319652|NCT01254721|454461481|FG001|Overall Study|Lack of Efficacy|2|||
126319653|NCT01254721|454461480|FG000|Overall Study|Death|0|||
126545077|NCT00943306|455289210|FG000|Overall Study|Death|1|||
126319654|NCT01254721|454461481|FG001|Overall Study|Death|1|||
126319655|NCT01254721|454461480|FG000|Overall Study|technical problum|1|||
126319656|NCT01254721|454461481|FG001|Overall Study|technical problum|0|||
126319657|NCT01254721|454461480|FG000|Overall Study|Adverse Event|2|||
126319658|NCT01254721|454461481|FG001|Overall Study|Adverse Event|3|||
126319659|NCT01254721|454461480|FG000|Overall Study|Withdrawal by Subject|8|||
126319660|NCT01254721|454461481|FG001|Overall Study|Withdrawal by Subject|11|||
126319661|NCT01254721|454461480|FG000|Overall Study|Wrongly randomization|0|||
126319662|NCT01254721|454461481|FG001|Overall Study|Wrongly randomization|1|||
126319663|NCT00987402|454461482|FG000|Overall Study|Insufficient data entry|86|||
126319664|NCT00987402|454461483|FG001|Overall Study|Insufficient data entry|98|||
126319665|NCT01362517|454461488|FG000|Overall Study|Protocol Violation|1|||
126319666|NCT01362517|454461488|FG000|Overall Study|Lost to Follow-up|1|||
126319667|NCT03209518|454461491|FG000|Overall Study|Case Report Forms Uncollected|1|||
126319668|NCT03209518|454461491|FG000|Overall Study|Protocol Deviation|1|||
126319669|NCT00236899|454461492|FG000|Overall Study|Adverse Event (Study Related)|1|||
126319670|NCT00236899|454461493|FG001|Overall Study|Adverse Event (Study Related)|1|||
126319671|NCT00236899|454461494|FG002|Overall Study|Adverse Event (Study Related)|2|||
126319672|NCT00236899|454461495|FG003|Overall Study|Adverse Event (Study Related)|1|||
126319673|NCT00236899|454461492|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
126319674|NCT00236899|454461493|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
126319675|NCT00236899|454461494|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
126319676|NCT00236899|454461495|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
126319677|NCT00236899|454461492|FG000|Overall Study|Death (Study Disease)|1|||
126319678|NCT00236899|454461493|FG001|Overall Study|Death (Study Disease)|4|||
126319679|NCT00236899|454461494|FG002|Overall Study|Death (Study Disease)|0|||
126319680|NCT00236899|454461495|FG003|Overall Study|Death (Study Disease)|0|||
126319681|NCT00236899|454461492|FG000|Overall Study|Death (Not Study Related)|2|||
126319682|NCT00236899|454461493|FG001|Overall Study|Death (Not Study Related)|0|||
126319683|NCT00236899|454461494|FG002|Overall Study|Death (Not Study Related)|0|||
126319684|NCT00236899|454461495|FG003|Overall Study|Death (Not Study Related)|0|||
126319685|NCT00236899|454461492|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
126319686|NCT00236899|454461493|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
126319687|NCT00236899|454461494|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
126319688|NCT00236899|454461495|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
126319689|NCT00236899|454461492|FG000|Overall Study|Lost to Follow-up|0|||
126319690|NCT00236899|454461493|FG001|Overall Study|Lost to Follow-up|1|||
126319691|NCT00236899|454461494|FG002|Overall Study|Lost to Follow-up|0|||
126319692|NCT00236899|454461495|FG003|Overall Study|Lost to Follow-up|0|||
126319693|NCT00236899|454461492|FG000|Overall Study|Entry Criteria Exclusion|0|||
126319694|NCT00236899|454461493|FG001|Overall Study|Entry Criteria Exclusion|1|||
126319695|NCT00236899|454461494|FG002|Overall Study|Entry Criteria Exclusion|1|||
126319696|NCT00236899|454461495|FG003|Overall Study|Entry Criteria Exclusion|0|||
126319697|NCT00236899|454461492|FG000|Overall Study|Protocol Violation|1|||
126319698|NCT00236899|454461493|FG001|Overall Study|Protocol Violation|0|||
126319699|NCT00236899|454461494|FG002|Overall Study|Protocol Violation|0|||
126319700|NCT00236899|454461495|FG003|Overall Study|Protocol Violation|0|||
126319701|NCT00236899|454461492|FG000|Overall Study|Withdrawal by Subject|6|||
126319702|NCT00236899|454461493|FG001|Overall Study|Withdrawal by Subject|4|||
126319703|NCT00236899|454461494|FG002|Overall Study|Withdrawal by Subject|5|||
126319704|NCT00236899|454461495|FG003|Overall Study|Withdrawal by Subject|2|||
126319705|NCT00236899|454461492|FG000|Overall Study|Physician Decision|7|||
126319706|NCT00236899|454461493|FG001|Overall Study|Physician Decision|8|||
126319707|NCT00236899|454461494|FG002|Overall Study|Physician Decision|7|||
126319708|NCT00236899|454461495|FG003|Overall Study|Physician Decision|6|||
126319709|NCT00236899|454461492|FG000|Overall Study|Satisfactory Response|2|||
126319710|NCT00236899|454461493|FG001|Overall Study|Satisfactory Response|0|||
126319711|NCT00236899|454461494|FG002|Overall Study|Satisfactory Response|0|||
126319712|NCT00236899|454461495|FG003|Overall Study|Satisfactory Response|1|||
126319713|NCT00236899|454461492|FG000|Overall Study|Lack of Efficacy|18|||
126319714|NCT00236899|454461493|FG001|Overall Study|Lack of Efficacy|18|||
126319715|NCT00236899|454461494|FG002|Overall Study|Lack of Efficacy|25|||
126319716|NCT00236899|454461495|FG003|Overall Study|Lack of Efficacy|23|||
126319717|NCT03379792|454461497|FG000|Overall Study|Physician Decision|0|||
126319718|NCT03379792|454461498|FG001|Overall Study|Physician Decision|0|||
126319719|NCT03379792|454461499|FG002|Overall Study|Physician Decision|0|||
126319720|NCT03379792|454461500|FG003|Overall Study|Physician Decision|1|||
126319721|NCT03379792|454461501|FG004|Overall Study|Physician Decision|0|||
126319722|NCT03379792|454461502|FG005|Overall Study|Physician Decision|0|||
126319723|NCT03379792|454461497|FG000|Overall Study|Withdrawal by Subject|0|||
126319724|NCT03379792|454461498|FG001|Overall Study|Withdrawal by Subject|0|||
126319725|NCT03379792|454461499|FG002|Overall Study|Withdrawal by Subject|0|||
126319726|NCT03379792|454461500|FG003|Overall Study|Withdrawal by Subject|0|||
126319727|NCT03379792|454461501|FG004|Overall Study|Withdrawal by Subject|1|||
126319728|NCT03379792|454461502|FG005|Overall Study|Withdrawal by Subject|1|||
126319729|NCT01121536|454461503|FG000|Overall Study|Adverse Event|63|||
126319730|NCT01121536|454461503|FG000|Overall Study|Lack of Efficacy|35|||
126650876|NCT00320528|455678295|FG001|Study Period III|Physician Decision|1|||
126650877|NCT00320528|455678296|FG002|Study Period III|Physician Decision|2|||
126319731|NCT01121536|454461503|FG000|Overall Study|Withdrawal by Subject|65|||
126319732|NCT01121536|454461503|FG000|Overall Study|Protocol Violation|20|||
126319733|NCT01121536|454461503|FG000|Overall Study|Noncompliance with study medication|12|||
126319734|NCT01121536|454461503|FG000|Overall Study|Noncompliance with study procedures|9|||
126319735|NCT01121536|454461503|FG000|Overall Study|Lost to Follow-up|39|||
126319736|NCT01121536|454461503|FG000|Overall Study|Other|118|||
126319737|NCT02854605|454461504|FG000|Overall Study|Adverse Event|1|||
126319738|NCT02854605|454461505|FG001|Overall Study|Adverse Event|5|||
126319739|NCT02854605|454461506|FG002|Overall Study|Adverse Event|2|||
126319740|NCT02854605|454461504|FG000|Overall Study|Lost to Follow-up|0|||
126319741|NCT02854605|454461505|FG001|Overall Study|Lost to Follow-up|2|||
126319742|NCT02854605|454461506|FG002|Overall Study|Lost to Follow-up|0|||
126319743|NCT02854605|454461504|FG000|Overall Study|Withdrew Consent|1|||
126319744|NCT02854605|454461505|FG001|Overall Study|Withdrew Consent|0|||
126319745|NCT02854605|454461506|FG002|Overall Study|Withdrew Consent|1|||
126319746|NCT02854605|454461504|FG000|Overall Study|Investigator's Discretion|1|||
126319747|NCT02854605|454461505|FG001|Overall Study|Investigator's Discretion|0|||
126650878|NCT00320528|455678294|FG000|Study Period III|Sponsor Decision|0|||
126650879|NCT00320528|455678295|FG001|Study Period III|Sponsor Decision|0|||
126650880|NCT00320528|455678296|FG002|Study Period III|Sponsor Decision|1|||
126650881|NCT00320528|455678294|FG000|Study Period III|Atomoxetine Commercially Available|68|||
126650882|NCT00320528|455678295|FG001|Study Period III|Atomoxetine Commercially Available|25|||
126650883|NCT00320528|455678296|FG002|Study Period III|Atomoxetine Commercially Available|90|||
126650884|NCT00545753|455678297|FG000|Overall Study|Withdrawal by Subject|0|||
126650885|NCT00545753|455678298|FG001|Overall Study|Withdrawal by Subject|1|||
126650886|NCT00545753|455678299|FG002|Overall Study|Withdrawal by Subject|10|||
126650887|NCT00545753|455678297|FG000|Overall Study|Lost to Follow-up|13|||
126650888|NCT00545753|455678298|FG001|Overall Study|Lost to Follow-up|3|||
126650889|NCT00545753|455678299|FG002|Overall Study|Lost to Follow-up|12|||
126650890|NCT00545753|455678297|FG000|Overall Study|Protocol Violation|3|||
126650891|NCT00545753|455678298|FG001|Overall Study|Protocol Violation|1|||
126650892|NCT00545753|455678299|FG002|Overall Study|Protocol Violation|4|||
126650893|NCT03014479|455678300|FG000|Overall Study|Adverse Event|0|||
126650894|NCT03014479|455678301|FG001|Overall Study|Adverse Event|1|||
126650895|NCT03014479|455678300|FG000|Overall Study|Voluntary Withdrawal|0|||
126650896|NCT03014479|455678301|FG001|Overall Study|Voluntary Withdrawal|2|||
126650897|NCT03014479|455678300|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
126319748|NCT02854605|454461506|FG002|Overall Study|Investigator's Discretion|0|||
126319749|NCT02854605|454461504|FG000|Overall Study|Protocol Violation|0|||
126319750|NCT02854605|454461505|FG001|Overall Study|Protocol Violation|0|||
126319751|NCT02854605|454461506|FG002|Overall Study|Protocol Violation|1|||
126319752|NCT00568334|454461511|FG000|Overall Study|Withdrawal by Subject|0|||
126319753|NCT00568334|454461512|FG001|Overall Study|Withdrawal by Subject|1|||
126319754|NCT00568334|454461511|FG000|Overall Study|Lost to Follow-up|1|||
126319755|NCT00568334|454461512|FG001|Overall Study|Lost to Follow-up|0|||
126319756|NCT01897571|454461513|FG000|Overall Study|Lost to Follow-up|3|||
126319757|NCT01897571|454461514|FG001|Overall Study|Lost to Follow-up|0|||
126319758|NCT01897571|454461515|FG002|Overall Study|Lost to Follow-up|0|||
126319759|NCT01897571|454461516|FG003|Overall Study|Lost to Follow-up|0|||
126319760|NCT01897571|454461517|FG004|Overall Study|Lost to Follow-up|2|||
126319761|NCT01897571|454461518|FG005|Overall Study|Lost to Follow-up|0|||
126319762|NCT01897571|454461519|FG006|Overall Study|Lost to Follow-up|0|||
126319763|NCT01897571|454461520|FG007|Overall Study|Lost to Follow-up|0|||
126319764|NCT01897571|454461521|FG008|Overall Study|Lost to Follow-up|1|||
126319765|NCT01897571|454461522|FG009|Overall Study|Lost to Follow-up|2|||
126319766|NCT01897571|454461523|FG010|Overall Study|Lost to Follow-up|4|||
126319767|NCT01897571|454461513|FG000|Overall Study|Withdrawal by Subject|0|||
126319768|NCT01897571|454461514|FG001|Overall Study|Withdrawal by Subject|0|||
126319769|NCT01897571|454461515|FG002|Overall Study|Withdrawal by Subject|0|||
126319770|NCT01897571|454461516|FG003|Overall Study|Withdrawal by Subject|0|||
126319771|NCT01897571|454461517|FG004|Overall Study|Withdrawal by Subject|0|||
126319772|NCT01897571|454461518|FG005|Overall Study|Withdrawal by Subject|0|||
126319773|NCT01897571|454461519|FG006|Overall Study|Withdrawal by Subject|0|||
126319774|NCT01897571|454461520|FG007|Overall Study|Withdrawal by Subject|1|||
126319775|NCT01897571|454461521|FG008|Overall Study|Withdrawal by Subject|4|||
126319776|NCT01897571|454461522|FG009|Overall Study|Withdrawal by Subject|3|||
126319777|NCT01897571|454461523|FG010|Overall Study|Withdrawal by Subject|1|||
126319778|NCT01897571|454461513|FG000|Overall Study|Other|1|||
126319779|NCT01897571|454461514|FG001|Overall Study|Other|0|||
126319780|NCT01897571|454461515|FG002|Overall Study|Other|0|||
126319781|NCT01897571|454461516|FG003|Overall Study|Other|3|||
126319782|NCT01897571|454461517|FG004|Overall Study|Other|3|||
126319783|NCT01897571|454461518|FG005|Overall Study|Other|4|||
126319784|NCT01897571|454461519|FG006|Overall Study|Other|7|||
126319785|NCT01897571|454461520|FG007|Overall Study|Other|0|||
126319786|NCT01897571|454461521|FG008|Overall Study|Other|0|||
126650898|NCT03014479|455678301|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
126650899|NCT01394978|455678307|FG000|Overall Study|Withdrawal by Subject|2|||
126319787|NCT01897571|454461522|FG009|Overall Study|Other|0|||
126319788|NCT01897571|454461523|FG010|Overall Study|Other|0|||
126319789|NCT01897571|454461513|FG000|Overall Study|Enrolled in rollover study|0|||
126319790|NCT01897571|454461514|FG001|Overall Study|Enrolled in rollover study|0|||
126319791|NCT01897571|454461515|FG002|Overall Study|Enrolled in rollover study|0|||
126319792|NCT01897571|454461516|FG003|Overall Study|Enrolled in rollover study|0|||
126319793|NCT01897571|454461517|FG004|Overall Study|Enrolled in rollover study|0|||
126319794|NCT01897571|454461518|FG005|Overall Study|Enrolled in rollover study|0|||
126319795|NCT01897571|454461519|FG006|Overall Study|Enrolled in rollover study|0|||
126319796|NCT01897571|454461520|FG007|Overall Study|Enrolled in rollover study|9|||
126319797|NCT01897571|454461521|FG008|Overall Study|Enrolled in rollover study|7|||
126650900|NCT01394978|455678308|FG001|Overall Study|Withdrawal by Subject|4|||
126319798|NCT01897571|454461522|FG009|Overall Study|Enrolled in rollover study|9|||
126319799|NCT01897571|454461523|FG010|Overall Study|Enrolled in rollover study|1|||
126319800|NCT01897571|454461513|FG000|Overall Study|Death|2|||
126319801|NCT01897571|454461514|FG001|Overall Study|Death|2|||
126319802|NCT01897571|454461515|FG002|Overall Study|Death|3|||
126319803|NCT01897571|454461516|FG003|Overall Study|Death|6|||
126319804|NCT01897571|454461517|FG004|Overall Study|Death|7|||
126319805|NCT01897571|454461518|FG005|Overall Study|Death|9|||
126319806|NCT01897571|454461519|FG006|Overall Study|Death|5|||
126319807|NCT01897571|454461520|FG007|Overall Study|Death|22|||
126319808|NCT01897571|454461521|FG008|Overall Study|Death|23|||
126319809|NCT01897571|454461522|FG009|Overall Study|Death|129|||
126319810|NCT01897571|454461523|FG010|Overall Study|Death|59|||
126319811|NCT00306787|454461525|FG000|Overall Study|Discontinued without taking study drug|208|||
126319812|NCT00306787|454461526|FG001|Overall Study|Discontinued without taking study drug|215|||
126319813|NCT00306787|454461525|FG000|Overall Study|Adverse Event|1|||
126319814|NCT00306787|454461526|FG001|Overall Study|Adverse Event|1|||
126319815|NCT00306787|454461525|FG000|Overall Study|Lack of Efficacy|1|||
126319816|NCT00306787|454461526|FG001|Overall Study|Lack of Efficacy|0|||
126319817|NCT00306787|454461525|FG000|Overall Study|Protocol Violation|8|||
126319818|NCT00306787|454461526|FG001|Overall Study|Protocol Violation|10|||
126319819|NCT00306787|454461525|FG000|Overall Study|Withdrawal by Subject|2|||
126319820|NCT00306787|454461526|FG001|Overall Study|Withdrawal by Subject|9|||
126319821|NCT00306787|454461525|FG000|Overall Study|Lost to Follow-up|9|||
126319822|NCT00306787|454461526|FG001|Overall Study|Lost to Follow-up|6|||
126319823|NCT00306787|454461525|FG000|Overall Study|Administrative problems|4|||
126319824|NCT00306787|454461526|FG001|Overall Study|Administrative problems|0|||
126319825|NCT00306787|454461525|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126319826|NCT00306787|454461526|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126319827|NCT02273908|454461527|FG000|Overall Study|Adverse Event|16|||
126319828|NCT02273908|454461528|FG001|Overall Study|Adverse Event|0|||
126319829|NCT02273908|454461527|FG000|Overall Study|Lost to Follow-up|10|||
126319830|NCT02273908|454461528|FG001|Overall Study|Lost to Follow-up|1|||
126319831|NCT02273908|454461527|FG000|Overall Study|Did not meet entrance criteria|3|||
126319832|NCT02273908|454461528|FG001|Overall Study|Did not meet entrance criteria|2|||
126319833|NCT02273908|454461527|FG000|Overall Study|Withdrawal by Subject|4|||
126319834|NCT02273908|454461528|FG001|Overall Study|Withdrawal by Subject|2|||
126319835|NCT04908475|454461529|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
126319836|NCT04908475|454461530|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126319837|NCT04908475|454461531|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126319838|NCT04908475|454461532|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126319839|NCT04908475|454461533|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126319840|NCT04908475|454461534|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126319841|NCT04908475|454461529|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
126319842|NCT04908475|454461530|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
126319843|NCT04908475|454461531|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
126319844|NCT04908475|454461532|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
126319845|NCT04908475|454461533|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
126319846|NCT04908475|454461534|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
126319847|NCT04908475|454461529|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
126319848|NCT04908475|454461530|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
126319849|NCT04908475|454461531|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
126319850|NCT04908475|454461532|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
126319851|NCT04908475|454461533|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
126319852|NCT04908475|454461534|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
126319853|NCT04908475|454461529|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126319854|NCT04908475|454461530|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
126319855|NCT04908475|454461531|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
126319856|NCT04908475|454461532|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
126319857|NCT04908475|454461533|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126319858|NCT04908475|454461534|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126319859|NCT04908475|454461529|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
126319860|NCT04908475|454461530|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
126319861|NCT04908475|454461531|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
126319862|NCT04908475|454461532|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
126319863|NCT04908475|454461533|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
126319864|NCT04908475|454461534|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
126319865|NCT04908475|454461529|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
126319866|NCT04908475|454461530|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
126319867|NCT04908475|454461531|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
126319868|NCT04908475|454461532|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
126319869|NCT04908475|454461533|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
126319870|NCT04908475|454461534|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
126319871|NCT03913104|454461537|FG000|Overall Study|Lost to Follow-up|20|||
126650901|NCT01394978|455678307|FG000|Overall Study|Lost to Follow-up|13|||
126650902|NCT01394978|455678308|FG001|Overall Study|Lost to Follow-up|20|||
126650903|NCT01394978|455678307|FG000|Overall Study|Death|6|||
126650904|NCT01394978|455678308|FG001|Overall Study|Death|7|||
126650905|NCT01081132|455678309|FG000|Overall Study|Lack of Efficacy|25|||
126319872|NCT03913104|454461537|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
126319873|NCT03913104|454461537|FG000|Overall Study|Withdrawal by Subject|2|||
126319874|NCT00089635|454461538|FG000|Overall Study|Adverse Event|2|||
126319875|NCT00089635|454461538|FG000|Overall Study|Death|17|||
126319876|NCT00089635|454461538|FG000|Overall Study|Disease Progression|12|||
126319877|NCT00089635|454461538|FG000|Overall Study|Lost to Follow-up|3|||
126319878|NCT00089635|454461538|FG000|Overall Study|Withdrawal by Subject|6|||
126319879|NCT00089635|454461538|FG000|Overall Study|Ineligibility determined|1|||
126319880|NCT00089635|454461538|FG000|Overall Study|Other|2|||
126319881|NCT01593254|454461542|FG000|Overall Study|Disease progression|2|||
126319882|NCT01593254|454461543|FG001|Overall Study|Disease progression|7|||
126319883|NCT01593254|454461542|FG000|Overall Study|Study drug toxicity|6|||
126319884|NCT01593254|454461543|FG001|Overall Study|Study drug toxicity|20|||
126319885|NCT01593254|454461542|FG000|Overall Study|Death|3|||
126319886|NCT01593254|454461543|FG001|Overall Study|Death|3|||
126319887|NCT01593254|454461542|FG000|Overall Study|AE unrelated to study drug|0|||
126319888|NCT01593254|454461543|FG001|Overall Study|AE unrelated to study drug|1|||
126319889|NCT01593254|454461542|FG000|Overall Study|participant request to discontinue study treatment|1|||
126319890|NCT01593254|454461543|FG001|Overall Study|participant request to discontinue study treatment|3|||
126319891|NCT01593254|454461542|FG000|Overall Study|participant withdrew consent|0|||
126319892|NCT01593254|454461543|FG001|Overall Study|participant withdrew consent|9|||
126319893|NCT01593254|454461542|FG000|Overall Study|lost to follow up|1|||
126319894|NCT01593254|454461543|FG001|Overall Study|lost to follow up|6|||
126319895|NCT01593254|454461542|FG000|Overall Study|maximum clinical benefit|1|||
126319896|NCT01593254|454461543|FG001|Overall Study|maximum clinical benefit|2|||
126319897|NCT01593254|454461542|FG000|Overall Study|Poor/non compliance|1|||
126319898|NCT01593254|454461543|FG001|Overall Study|Poor/non compliance|1|||
126319899|NCT01593254|454461542|FG000|Overall Study|Pregnancy|0|||
126319900|NCT01593254|454461543|FG001|Overall Study|Pregnancy|3|||
126319901|NCT01593254|454461542|FG000|Overall Study|participant no longer meets study criteria|1|||
126319902|NCT01593254|454461543|FG001|Overall Study|participant no longer meets study criteria|1|||
126319903|NCT01593254|454461542|FG000|Overall Study|Admin reason by sponsor|7|||
126319904|NCT01593254|454461543|FG001|Overall Study|Admin reason by sponsor|3|||
126319905|NCT01593254|454461542|FG000|Overall Study|Imatinib treatment failure|2|||
126319906|NCT01593254|454461543|FG001|Overall Study|Imatinib treatment failure|0|||
126319907|NCT01593254|454461542|FG000|Overall Study|Other Reasons|61|||
126319908|NCT01593254|454461543|FG001|Overall Study|Other Reasons|115|||
126319909|NCT00076999|454461548|FG000|Overall Study|Adverse Event|2|||
126319910|NCT00076999|454461549|FG001|Overall Study|Adverse Event|8|||
126319911|NCT00076999|454461550|FG002|Overall Study|Adverse Event|6|||
126319912|NCT00076999|454461551|FG003|Overall Study|Adverse Event|0|||
126319913|NCT00076999|454461552|FG004|Overall Study|Adverse Event|2|||
126319914|NCT00076999|454461548|FG000|Overall Study|Protocol Violation|0|||
126319915|NCT00076999|454461549|FG001|Overall Study|Protocol Violation|3|||
126319916|NCT00076999|454461550|FG002|Overall Study|Protocol Violation|4|||
126319917|NCT00076999|454461551|FG003|Overall Study|Protocol Violation|0|||
126319918|NCT00076999|454461552|FG004|Overall Study|Protocol Violation|9|||
126319919|NCT00076999|454461548|FG000|Overall Study|Lost to Follow-up|2|||
126319920|NCT00076999|454461549|FG001|Overall Study|Lost to Follow-up|1|||
126319921|NCT00076999|454461550|FG002|Overall Study|Lost to Follow-up|0|||
126319922|NCT00076999|454461551|FG003|Overall Study|Lost to Follow-up|0|||
126319923|NCT00076999|454461552|FG004|Overall Study|Lost to Follow-up|0|||
126319924|NCT00076999|454461548|FG000|Overall Study|Withdrawal by Subject|0|||
126319925|NCT00076999|454461549|FG001|Overall Study|Withdrawal by Subject|4|||
126319926|NCT00076999|454461550|FG002|Overall Study|Withdrawal by Subject|3|||
126319927|NCT00076999|454461551|FG003|Overall Study|Withdrawal by Subject|0|||
126319928|NCT00076999|454461552|FG004|Overall Study|Withdrawal by Subject|1|||
126650906|NCT01081132|455678310|FG001|Overall Study|Lack of Efficacy|9|||
126650907|NCT01081132|455678309|FG000|Overall Study|Withdrawal by Subject|13|||
126319929|NCT00076999|454461548|FG000|Overall Study|Other reason (not specified)|8|||
126319930|NCT00076999|454461549|FG001|Overall Study|Other reason (not specified)|8|||
126319931|NCT00076999|454461550|FG002|Overall Study|Other reason (not specified)|4|||
126319932|NCT00076999|454461551|FG003|Overall Study|Other reason (not specified)|1|||
126319933|NCT00076999|454461552|FG004|Overall Study|Other reason (not specified)|13|||
126319934|NCT01857102|454461554|FG000|Period 1|No longer meets Eligibility Criteria|0|||
126319935|NCT01857102|454461555|FG001|Period 1|No longer meets Eligibility Criteria|2|||
126319936|NCT01857102|454461554|FG000|Period 1|Lost to Follow-up|0|||
126319937|NCT01857102|454461555|FG001|Period 1|Lost to Follow-up|3|||
126319938|NCT01857102|454461554|FG000|Period 1|Unsatisfactory Lens Fit|1|||
126319939|NCT01857102|454461555|FG001|Period 1|Unsatisfactory Lens Fit|0|||
126319940|NCT01857102|454461554|FG000|Period 1|Unsatisfactory Visual Response|1|||
126319941|NCT01857102|454461555|FG001|Period 1|Unsatisfactory Visual Response|0|||
126319942|NCT01857102|454461554|FG000|Period 1|Physician Decision|1|||
126319943|NCT01857102|454461555|FG001|Period 1|Physician Decision|0|||
126319944|NCT01857102|454461554|FG000|Period 2|Lens Discomfort|1|||
126319945|NCT01857102|454461555|FG001|Period 2|Lens Discomfort|0|||
126319946|NCT01857102|454461554|FG000|Period 2|Unsatisfactory Lens Fit|1|||
126319947|NCT01857102|454461555|FG001|Period 2|Unsatisfactory Lens Fit|0|||
126319948|NCT02603562|454461560|FG000|Overall Study|Lost to Follow-up|1|||
126319949|NCT03564795|454461572|FG000|Overall Study|Withdrawal by Subject|3|||
126319950|NCT03564795|454461572|FG000|Overall Study|Lost to Follow-up|6|||
126319951|NCT03564795|454461572|FG000|Overall Study|Physician Decision|2|||
126319952|NCT02906033|454461577|FG000|Baseline|Protocol Violation|37|||
126319953|NCT02906033|454461578|FG001|Baseline|Protocol Violation|33|||
126319954|NCT02906033|454461577|FG000|Follow-up|Lost to Follow-up|46|||
126319955|NCT02906033|454461578|FG001|Follow-up|Lost to Follow-up|62|||
126319956|NCT00386425|454461580|FG000|Overall Study|Physician Decision|3|||
126319957|NCT00386425|454461581|FG001|Overall Study|Physician Decision|0|||
126319958|NCT00386425|454461582|FG002|Overall Study|Physician Decision|0|||
126319959|NCT00386425|454461580|FG000|Overall Study|Withdrawal by Subject|0|||
126319960|NCT00386425|454461581|FG001|Overall Study|Withdrawal by Subject|1|||
126319961|NCT00386425|454461582|FG002|Overall Study|Withdrawal by Subject|0|||
126319962|NCT02678000|454461583|FG000|PART 2|Adverse Event|0|||
126319963|NCT02678000|454461584|FG001|PART 2|Adverse Event|0|||
126319964|NCT02678000|454461585|FG002|PART 2|Adverse Event|2|||
126319965|NCT02678000|454461586|FG003|PART 2|Adverse Event|1|||
126319966|NCT02678000|454461587|FG004|PART 2|Adverse Event|0|||
126319967|NCT02678000|454461583|FG000|PART 2|Withdrawal by Subject|0|||
126319968|NCT02678000|454461584|FG001|PART 2|Withdrawal by Subject|0|||
126319969|NCT02678000|454461585|FG002|PART 2|Withdrawal by Subject|1|||
126319970|NCT02678000|454461586|FG003|PART 2|Withdrawal by Subject|0|||
126319971|NCT02678000|454461587|FG004|PART 2|Withdrawal by Subject|0|||
126319972|NCT01324570|454461589|FG000|Overall Study|Adverse Event|4|||
126319973|NCT01324570|454461590|FG001|Overall Study|Adverse Event|7|||
126319974|NCT01324570|454461589|FG000|Overall Study|Withdrawal by Subject|0|||
126319975|NCT01324570|454461590|FG001|Overall Study|Withdrawal by Subject|3|||
126319976|NCT01324570|454461589|FG000|Overall Study|Lack of Efficacy|0|||
126319977|NCT01324570|454461590|FG001|Overall Study|Lack of Efficacy|1|||
126319978|NCT01324570|454461589|FG000|Overall Study|Confirmed or suspected diversion|0|||
126319979|NCT01324570|454461590|FG001|Overall Study|Confirmed or suspected diversion|1|||
126319980|NCT01324570|454461589|FG000|Overall Study|Administrative|0|||
126319981|NCT01324570|454461590|FG001|Overall Study|Administrative|2|||
126319982|NCT02360475|454461593|FG000|Overall Study|Lost to Follow-up|4|||
126319983|NCT02360475|454461594|FG001|Overall Study|Lost to Follow-up|12|||
126319984|NCT02360475|454461595|FG002|Overall Study|Lost to Follow-up|6|||
126319985|NCT02360475|454461596|FG003|Overall Study|Lost to Follow-up|4|||
126319986|NCT02360475|454461593|FG000|Overall Study|Withdrawal by Subject|0|||
126319987|NCT02360475|454461594|FG001|Overall Study|Withdrawal by Subject|1|||
126319988|NCT02360475|454461595|FG002|Overall Study|Withdrawal by Subject|2|||
126319989|NCT02360475|454461596|FG003|Overall Study|Withdrawal by Subject|0|||
126319990|NCT02360475|454461593|FG000|Overall Study|Migrated/moved from study area|0|||
126319991|NCT02360475|454461594|FG001|Overall Study|Migrated/moved from study area|0|||
126319992|NCT02360475|454461595|FG002|Overall Study|Migrated/moved from study area|0|||
126319993|NCT02360475|454461596|FG003|Overall Study|Migrated/moved from study area|1|||
126319994|NCT00207727|454461597|FG000|Overall Study|Withdrawal by Subject|0|||
126319995|NCT00207727|454461598|FG001|Overall Study|Withdrawal by Subject|0|||
126319996|NCT00207727|454461599|FG002|Overall Study|Withdrawal by Subject|0|||
126319997|NCT00207727|454461600|FG003|Overall Study|Withdrawal by Subject|0|||
126319998|NCT00207727|454461601|FG004|Overall Study|Withdrawal by Subject|1|||
126319999|NCT00207727|454461597|FG000|Overall Study|Lost to Follow-up|0|||
126320000|NCT00207727|454461598|FG001|Overall Study|Lost to Follow-up|1|||
126320001|NCT00207727|454461599|FG002|Overall Study|Lost to Follow-up|0|||
126320002|NCT00207727|454461600|FG003|Overall Study|Lost to Follow-up|0|||
126320003|NCT00207727|454461601|FG004|Overall Study|Lost to Follow-up|0|||
126320004|NCT00207727|454461597|FG000|Overall Study|Other|38|||
126320005|NCT00207727|454461598|FG001|Overall Study|Other|41|||
126320006|NCT00207727|454461599|FG002|Overall Study|Other|41|||
126320007|NCT00207727|454461600|FG003|Overall Study|Other|37|||
126320008|NCT00207727|454461601|FG004|Overall Study|Other|33|||
126320009|NCT00435019|454461606|FG000|Overall Study|Adverse Event|1|||
126320010|NCT00435019|454461607|FG001|Overall Study|Adverse Event|0|||
126320011|NCT00435019|454461606|FG000|Overall Study|Lack of Efficacy|1|||
126320012|NCT00435019|454461607|FG001|Overall Study|Lack of Efficacy|2|||
126320013|NCT00435019|454461606|FG000|Overall Study|Protocol Violation|3|||
126320014|NCT00435019|454461607|FG001|Overall Study|Protocol Violation|1|||
126320015|NCT00435019|454461606|FG000|Overall Study|Personal reasons for withdrawal|8|||
126320016|NCT00435019|454461607|FG001|Overall Study|Personal reasons for withdrawal|7|||
126320017|NCT02440854|454461611|FG000|Overall Study|Relocation of patient|1|||
126320018|NCT02440854|454461611|FG000|Overall Study|Death|6|||
126320019|NCT02440854|454461611|FG000|Overall Study|Lost to Follow-up|10|||
126320020|NCT02440854|454461611|FG000|Overall Study|Afatinib discontinuation|46|||
126650908|NCT01081132|455678310|FG001|Overall Study|Withdrawal by Subject|16|||
126650909|NCT01081132|455678309|FG000|Overall Study|Lost to Follow-up|4|||
126650910|NCT01081132|455678310|FG001|Overall Study|Lost to Follow-up|11|||
126650911|NCT01081132|455678309|FG000|Overall Study|Adverse Event|3|||
126650912|NCT01081132|455678310|FG001|Overall Study|Adverse Event|9|||
126650913|NCT01081132|455678309|FG000|Overall Study|Non Compliance|4|||
126650914|NCT01081132|455678310|FG001|Overall Study|Non Compliance|2|||
126650915|NCT01081132|455678309|FG000|Overall Study|Lack Of Compliance|0|||
126650916|NCT01081132|455678310|FG001|Overall Study|Lack Of Compliance|1|||
126650917|NCT01081132|455678309|FG000|Overall Study|Missed Visits|1|||
126650918|NCT01081132|455678310|FG001|Overall Study|Missed Visits|1|||
126650919|NCT01081132|455678309|FG000|Overall Study|Stopped Taking Meds|2|||
126650920|NCT01081132|455678310|FG001|Overall Study|Stopped Taking Meds|0|||
126650921|NCT01081132|455678309|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
126650922|NCT01081132|455678310|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
126650923|NCT01081132|455678309|FG000|Overall Study|Declined Taper Phase|0|||
126650924|NCT01081132|455678310|FG001|Overall Study|Declined Taper Phase|1|||
126650925|NCT01081132|455678309|FG000|Overall Study|Protocol Violation|3|||
126650926|NCT01081132|455678310|FG001|Overall Study|Protocol Violation|1|||
126650927|NCT02101385|455678313|FG000|Study Treatment|Disease Progression|9|||
126650928|NCT02101385|455678314|FG001|Study Treatment|Disease Progression|3|||
126650929|NCT02101385|455678313|FG000|Study Treatment|Alternative therapy|0|||
126650930|NCT02101385|455678314|FG001|Study Treatment|Alternative therapy|1|||
126650931|NCT02101385|455678313|FG000|Study Treatment|No treatment, per protocol criteria|0|||
126650932|NCT02101385|455678314|FG001|Study Treatment|No treatment, per protocol criteria|4|||
126650933|NCT02101385|455678313|FG000|Study Treatment|Patient Non compliance|0|||
126650934|NCT02101385|455678314|FG001|Study Treatment|Patient Non compliance|2|||
126650935|NCT02101385|455678313|FG000|Study Treatment|Withdrawal by Subject|5|||
126650936|NCT02101385|455678314|FG001|Study Treatment|Withdrawal by Subject|2|||
126650937|NCT02101385|455678313|FG000|Study Treatment|screen failure|1|||
126650938|NCT02101385|455678314|FG001|Study Treatment|screen failure|0|||
126650939|NCT02101385|455678313|FG000|Study Treatment|AE/Side Effects/Complications|8|||
126650940|NCT02101385|455678314|FG001|Study Treatment|AE/Side Effects/Complications|0|||
126650941|NCT02101385|455678313|FG000|Study Treatment|Lost to Follow-up|1|||
126650942|NCT02101385|455678314|FG001|Study Treatment|Lost to Follow-up|0|||
126650943|NCT02101385|455678313|FG000|Study Treatment|Disease Progression before treatment|1|||
126650944|NCT02101385|455678314|FG001|Study Treatment|Disease Progression before treatment|0|||
126650945|NCT02101385|455678313|FG000|Study Treatment|Death|1|||
126650946|NCT02101385|455678314|FG001|Study Treatment|Death|0|||
126650947|NCT02101385|455678313|FG000|Follow up|Lost to Follow-up|4|||
126650948|NCT02101385|455678314|FG001|Follow up|Lost to Follow-up|9|||
126650949|NCT02101385|455678313|FG000|Follow up|Refused to follow up|5|||
126650950|NCT02101385|455678314|FG001|Follow up|Refused to follow up|4|||
126650951|NCT02101385|455678313|FG000|Follow up|Death|21|||
126650952|NCT02101385|455678314|FG001|Follow up|Death|39|||
126650953|NCT02101385|455678313|FG000|Follow up|study completed|33|||
126650954|NCT02101385|455678314|FG001|Follow up|study completed|52|||
126650955|NCT02101385|455678313|FG000|Follow up|screen failure|2|||
126650956|NCT02101385|455678314|FG001|Follow up|screen failure|0|||
126650957|NCT02101385|455678313|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
126650958|NCT02101385|455678314|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
126650959|NCT02101385|455678313|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
126650960|NCT02101385|455678314|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
126650961|NCT02101385|455678313|FG000|Follow up|Withdrawal by Subject|2|||
126650962|NCT02101385|455678314|FG001|Follow up|Withdrawal by Subject|2|||
126650963|NCT02101385|455678313|FG000|Follow up|PI requested closure of site|0|||
126650964|NCT02101385|455678314|FG001|Follow up|PI requested closure of site|5|||
126650965|NCT02432196|455678315|FG000|Overall Study|Exit - did not receive study device|1|||
126650966|NCT02432196|455678315|FG000|Overall Study|Death|2|||
126650967|NCT02432196|455678315|FG000|Overall Study|Reoperation|3|||
126320021|NCT02440854|454461611|FG000|Overall Study|stopped study at earlier timepoint|14|||
126650968|NCT05038163|455678316|FG000|Stage 1|Did not complete survey|374|||
126650969|NCT05038163|455678317|FG001|Stage 1|Did not complete survey|0|||
126650970|NCT05038163|455678318|FG002|Stage 1|Did not complete survey|0|||
126650971|NCT05038163|455678319|FG003|Stage 1|Did not complete survey|0|||
126320022|NCT02440854|454461611|FG000|Overall Study|Study medication not received|1|||
126650972|NCT05038163|455678320|FG004|Stage 1|Did not complete survey|0|||
126650973|NCT05038163|455678321|FG005|Stage 1|Did not complete survey|0|||
126650974|NCT05038163|455678316|FG000|Stage 2|Did not complete Stage 2 survey|0|||
126650975|NCT05038163|455678317|FG001|Stage 2|Did not complete Stage 2 survey|29|||
126650976|NCT05038163|455678318|FG002|Stage 2|Did not complete Stage 2 survey|30|||
126650977|NCT05038163|455678319|FG003|Stage 2|Did not complete Stage 2 survey|24|||
126650978|NCT05038163|455678320|FG004|Stage 2|Did not complete Stage 2 survey|21|||
126650979|NCT05038163|455678321|FG005|Stage 2|Did not complete Stage 2 survey|100|||
126650980|NCT01905150|455678322|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
126320023|NCT02440854|454461611|FG000|Overall Study|Violation of inclusion criteria|2|||
126320024|NCT02669082|454461612|FG000|Overall Study|Adverse Event|1|||
126320025|NCT04852276|454461613|FG000|Overall Study|Death|2|||
126320026|NCT04852276|454461614|FG001|Overall Study|Death|0|||
126320027|NCT04852276|454461613|FG000|Overall Study|Lost to Follow-up|15|||
126320028|NCT04852276|454461614|FG001|Overall Study|Lost to Follow-up|9|||
126320029|NCT04852276|454461613|FG000|Overall Study|Withdrawal by Subject|26|||
126320030|NCT04852276|454461614|FG001|Overall Study|Withdrawal by Subject|6|||
126320031|NCT02824562|454463942|FG000|Overall Study|Lost to Follow-up|3|||
126320032|NCT02824562|454463943|FG001|Overall Study|Lost to Follow-up|4|||
126320033|NCT02824562|454463942|FG000|Overall Study|Death|0|||
126320034|NCT02824562|454463943|FG001|Overall Study|Death|1|||
126320035|NCT05243563|454463944|FG000|Overall Study|Withdrawal by Subject|1|||
126320036|NCT05243563|454463945|FG001|Overall Study|Withdrawal by Subject|0|||
126320037|NCT05243563|454463944|FG000|Overall Study|Physician Decision|1|||
126320038|NCT05243563|454463945|FG001|Overall Study|Physician Decision|0|||
126320039|NCT03774394|454463946|FG000|Overall Study|Withdrawal by Subject|2|||
126320040|NCT03774394|454463947|FG001|Overall Study|Withdrawal by Subject|0|||
126320041|NCT02864316|454463950|FG000|Overall Study|Progressive Disease|2|||
126320042|NCT02864316|454463951|FG001|Overall Study|Progressive Disease|1|||
126320043|NCT02864316|454463950|FG000|Overall Study|Adverse Event|0|||
126320044|NCT02864316|454463951|FG001|Overall Study|Adverse Event|1|||
126320045|NCT00298363|454463952|FG000|Overall Study|Lost to Follow-up|0|||
126320046|NCT00298363|454463953|FG001|Overall Study|Lost to Follow-up|0|||
126320047|NCT00298363|454463954|FG002|Overall Study|Lost to Follow-up|1|||
126320048|NCT00298363|454463952|FG000|Overall Study|Physician Decision|4|||
126320049|NCT00298363|454463953|FG001|Overall Study|Physician Decision|1|||
126320050|NCT00298363|454463954|FG002|Overall Study|Physician Decision|0|||
126320051|NCT00298363|454463952|FG000|Overall Study|Protocol Violation|1|||
126650981|NCT01905150|455678323|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
126650982|NCT01147536|455678324|FG000|Overall Study|Administrative study close|2|||
126650983|NCT01147536|455678324|FG000|Overall Study|Death|1|||
126320052|NCT00298363|454463953|FG001|Overall Study|Protocol Violation|1|||
126320053|NCT00298363|454463954|FG002|Overall Study|Protocol Violation|0|||
126320054|NCT00298363|454463952|FG000|Overall Study|Withdrawal by Subject|5|||
126320055|NCT00298363|454463953|FG001|Overall Study|Withdrawal by Subject|1|||
126320056|NCT00298363|454463954|FG002|Overall Study|Withdrawal by Subject|3|||
126320057|NCT00298363|454463952|FG000|Overall Study|Adverse Event|5|||
126320058|NCT00298363|454463953|FG001|Overall Study|Adverse Event|2|||
126320059|NCT00298363|454463954|FG002|Overall Study|Adverse Event|2|||
126320060|NCT00298363|454463952|FG000|Overall Study|Lack of Efficacy|2|||
126320061|NCT00298363|454463953|FG001|Overall Study|Lack of Efficacy|3|||
126320062|NCT00298363|454463954|FG002|Overall Study|Lack of Efficacy|0|||
126320063|NCT04710368|454463955|FG000|Overall Study|Withdrawal by Subject|9|||
126320064|NCT04710368|454463955|FG000|Overall Study|Lost to Follow-up|4|||
126320065|NCT04710368|454463955|FG000|Overall Study|Death|2|||
126320066|NCT04710368|454463955|FG000|Overall Study|Patient preference|11|||
126320067|NCT04710368|454463955|FG000|Overall Study|Treatment discontinuation|1|||
126320068|NCT00135356|454463956|FG000|Overall Study|Adverse Event|6|||
126320069|NCT00135356|454463957|FG001|Overall Study|Adverse Event|2|||
126320070|NCT00135356|454463956|FG000|Overall Study|Lack of Efficacy|2|||
126320071|NCT00135356|454463957|FG001|Overall Study|Lack of Efficacy|0|||
126320072|NCT00135356|454463956|FG000|Overall Study|Lost to Follow-up|3|||
126320073|NCT00135356|454463957|FG001|Overall Study|Lost to Follow-up|1|||
126320074|NCT00135356|454463956|FG000|Overall Study|Surgery for abdominal fat|1|||
126320075|NCT00135356|454463957|FG001|Overall Study|Surgery for abdominal fat|0|||
126320076|NCT00135356|454463956|FG000|Overall Study|Change in antiviral regimen|0|||
126320077|NCT00135356|454463957|FG001|Overall Study|Change in antiviral regimen|1|||
126320078|NCT00135356|454463956|FG000|Overall Study|Poor/noncompliance|1|||
126320079|NCT00135356|454463957|FG001|Overall Study|Poor/noncompliance|1|||
126320080|NCT00135356|454463956|FG000|Overall Study|No longer meets study criteria|2|||
126650984|NCT03762200|455678325|FG000|Overall Study|Death|2|||
126320081|NCT00135356|454463957|FG001|Overall Study|No longer meets study criteria|0|||
126320082|NCT00135356|454463956|FG000|Overall Study|Withdrawal by Subject|2|||
126320083|NCT00135356|454463957|FG001|Overall Study|Withdrawal by Subject|4|||
126320084|NCT00153816|454463958|FG000|Overall Study|Death|6|||
126320085|NCT00153816|454463959|FG001|Overall Study|Death|5|||
126320086|NCT00153816|454463960|FG002|Overall Study|Death|4|||
126320087|NCT00153816|454463961|FG003|Overall Study|Death|6|||
126320088|NCT00153816|454463962|FG004|Overall Study|Death|0|||
126650985|NCT05110690|455678327|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
126650986|NCT05110690|455678327|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
126320089|NCT00153816|454463963|FG005|Overall Study|Death|2|||
126320090|NCT00153816|454463958|FG000|Overall Study|Lost to Follow-up|7|||
126320091|NCT00153816|454463959|FG001|Overall Study|Lost to Follow-up|8|||
126320092|NCT00153816|454463960|FG002|Overall Study|Lost to Follow-up|5|||
126320093|NCT00153816|454463961|FG003|Overall Study|Lost to Follow-up|8|||
126320094|NCT00153816|454463962|FG004|Overall Study|Lost to Follow-up|7|||
126320095|NCT00153816|454463963|FG005|Overall Study|Lost to Follow-up|9|||
126320096|NCT00153816|454463958|FG000|Overall Study|Withdrawal by Subject|9|||
126320097|NCT00153816|454463959|FG001|Overall Study|Withdrawal by Subject|9|||
126320098|NCT00153816|454463960|FG002|Overall Study|Withdrawal by Subject|9|||
126320099|NCT00153816|454463961|FG003|Overall Study|Withdrawal by Subject|4|||
126320100|NCT00153816|454463962|FG004|Overall Study|Withdrawal by Subject|1|||
126320101|NCT00153816|454463963|FG005|Overall Study|Withdrawal by Subject|5|||
126320102|NCT00153816|454463958|FG000|Overall Study|Follow-up exam not done|8|||
126320103|NCT00153816|454463959|FG001|Overall Study|Follow-up exam not done|7|||
126320104|NCT00153816|454463960|FG002|Overall Study|Follow-up exam not done|11|||
126320105|NCT00153816|454463961|FG003|Overall Study|Follow-up exam not done|10|||
126320106|NCT00153816|454463962|FG004|Overall Study|Follow-up exam not done|8|||
126320107|NCT00153816|454463963|FG005|Overall Study|Follow-up exam not done|9|||
126320108|NCT00153816|454463958|FG000|Overall Study|Follow-up exam done, histology missing|2|||
126320109|NCT00153816|454463959|FG001|Overall Study|Follow-up exam done, histology missing|3|||
126320110|NCT00153816|454463960|FG002|Overall Study|Follow-up exam done, histology missing|3|||
126320111|NCT00153816|454463961|FG003|Overall Study|Follow-up exam done, histology missing|3|||
126320112|NCT00153816|454463962|FG004|Overall Study|Follow-up exam done, histology missing|1|||
126320113|NCT00153816|454463963|FG005|Overall Study|Follow-up exam done, histology missing|2|||
126320114|NCT01887288|454463968|FG000|Overall Study|The study was terminated and the PI has|16|||
126320115|NCT00253370|454463971|FG000|Overall Study|Adverse Event|18|||
126320116|NCT00253370|454463971|FG000|Overall Study|Disease progression|13|||
126320117|NCT00253370|454463971|FG000|Overall Study|Death|2|||
126320118|NCT00253370|454463971|FG000|Overall Study|Withdrawal by Subject|6|||
126320119|NCT00253370|454463971|FG000|Overall Study|Non-protocol therapy|1|||
126320120|NCT00253370|454463971|FG000|Overall Study|Physician Decision|1|||
126320121|NCT00253370|454463971|FG000|Overall Study|Protocol Violation|1|||
126320122|NCT00253370|454463971|FG000|Overall Study|Abdominal pain due to disease|1|||
126320123|NCT05916131|454463972|FG000|Overall Study|Lost to Follow-up|0|||
126320124|NCT05916131|454463973|FG001|Overall Study|Lost to Follow-up|0|||
126320125|NCT05916131|454463974|FG002|Overall Study|Lost to Follow-up|1|||
126320126|NCT05916131|454463975|FG003|Overall Study|Lost to Follow-up|0|||
126320127|NCT01211483|454463985|FG000|Phase 1b|Death|6|||
126320128|NCT01211483|454463986|FG001|Phase 1b|Death|0|||
126320129|NCT01211483|454463987|FG002|Phase 1b|Death|0|||
126320130|NCT01211483|454463988|FG003|Phase 1b|Death|0|||
126320131|NCT01211483|454463985|FG000|Phase 1b|Withdrawal by Subject|1|||
126320132|NCT01211483|454463986|FG001|Phase 1b|Withdrawal by Subject|0|||
126320133|NCT01211483|454463987|FG002|Phase 1b|Withdrawal by Subject|0|||
126320134|NCT01211483|454463988|FG003|Phase 1b|Withdrawal by Subject|0|||
126320135|NCT01211483|454463985|FG000|Phase 2|Lost to Follow-up|0|||
126320136|NCT01211483|454463986|FG001|Phase 2|Lost to Follow-up|1|||
126320137|NCT01211483|454463987|FG002|Phase 2|Lost to Follow-up|1|||
126320138|NCT01211483|454463988|FG003|Phase 2|Lost to Follow-up|2|||
126320139|NCT01211483|454463985|FG000|Phase 2|Death|0|||
126320140|NCT01211483|454463986|FG001|Phase 2|Death|64|||
126320141|NCT01211483|454463987|FG002|Phase 2|Death|53|||
126320142|NCT01211483|454463988|FG003|Phase 2|Death|53|||
126320143|NCT01211483|454463985|FG000|Phase 2|Withdrawal by Subject|0|||
126320144|NCT01211483|454463986|FG001|Phase 2|Withdrawal by Subject|1|||
126320145|NCT01211483|454463987|FG002|Phase 2|Withdrawal by Subject|10|||
126320146|NCT01211483|454463988|FG003|Phase 2|Withdrawal by Subject|5|||
126320147|NCT01211483|454463985|FG000|Phase 2|Study terminated by Sponsor|0|||
126320148|NCT01211483|454463986|FG001|Phase 2|Study terminated by Sponsor|6|||
126320149|NCT01211483|454463987|FG002|Phase 2|Study terminated by Sponsor|8|||
126320150|NCT01211483|454463988|FG003|Phase 2|Study terminated by Sponsor|11|||
126320151|NCT01398410|454463990|FG000|Overall Study|Adverse Event|12|||
126320152|NCT01398410|454463991|FG001|Overall Study|Adverse Event|16|||
126320153|NCT01398410|454463990|FG000|Overall Study|Participants Choice|8|||
126320154|NCT01398410|454463991|FG001|Overall Study|Participants Choice|11|||
126320155|NCT01398410|454463990|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
126320156|NCT01398410|454463991|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
126320157|NCT01398410|454463990|FG000|Overall Study|Other|36|||
126320158|NCT01398410|454463991|FG001|Overall Study|Other|29|||
126320159|NCT04245202|454463992|FG000|Overall Study|Lack of Efficacy|10|||
126320160|NCT04245202|454463993|FG001|Overall Study|Lack of Efficacy|1|||
126320161|NCT02470403|454463994|FG000|Overall Study|Adverse Event|1|||
126320162|NCT02470403|454463995|FG001|Overall Study|Adverse Event|0|||
126320163|NCT02470403|454463996|FG002|Overall Study|Adverse Event|0|||
126320164|NCT02470403|454463997|FG003|Overall Study|Adverse Event|0|||
126320165|NCT02470403|454463998|FG004|Overall Study|Adverse Event|0|||
126545078|NCT00943306|455289210|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
126545079|NCT01036022|455289211|FG000|Overall Study|Adverse Event|1|||
126320166|NCT02470403|454463994|FG000|Overall Study|Lost to Follow-up|0|||
126320167|NCT02470403|454463995|FG001|Overall Study|Lost to Follow-up|1|||
126320168|NCT02470403|454463996|FG002|Overall Study|Lost to Follow-up|0|||
126320169|NCT02470403|454463997|FG003|Overall Study|Lost to Follow-up|0|||
126320170|NCT02470403|454463998|FG004|Overall Study|Lost to Follow-up|0|||
126320171|NCT02470403|454463994|FG000|Overall Study|Subject/guardian decision|1|||
126320172|NCT02470403|454463995|FG001|Overall Study|Subject/guardian decision|0|||
126320173|NCT02470403|454463996|FG002|Overall Study|Subject/guardian decision|0|||
126320174|NCT02470403|454463997|FG003|Overall Study|Subject/guardian decision|4|||
126320175|NCT02470403|454463998|FG004|Overall Study|Subject/guardian decision|0|||
126320176|NCT00904839|454464005|FG000|Overall Study|Adverse Event|0|||
126320177|NCT00904839|454464006|FG001|Overall Study|Adverse Event|5|||
126320178|NCT00904839|454464007|FG002|Overall Study|Adverse Event|4|||
126320179|NCT00904839|454464005|FG000|Overall Study|Protocol Violation|0|||
126320180|NCT00904839|454464006|FG001|Overall Study|Protocol Violation|1|||
126320181|NCT00904839|454464007|FG002|Overall Study|Protocol Violation|1|||
126320182|NCT00904839|454464005|FG000|Overall Study|Lost to Follow-up|0|||
126320183|NCT00904839|454464006|FG001|Overall Study|Lost to Follow-up|1|||
126320184|NCT00904839|454464007|FG002|Overall Study|Lost to Follow-up|2|||
126320185|NCT00904839|454464005|FG000|Overall Study|Withdrawal by Subject|0|||
126320186|NCT00904839|454464006|FG001|Overall Study|Withdrawal by Subject|2|||
126320187|NCT00904839|454464007|FG002|Overall Study|Withdrawal by Subject|0|||
126320188|NCT00904839|454464005|FG000|Overall Study|Not treated|1|||
126320189|NCT00904839|454464006|FG001|Overall Study|Not treated|0|||
126320190|NCT00904839|454464007|FG002|Overall Study|Not treated|1|||
126320191|NCT00904839|454464005|FG000|Overall Study|Other than above|0|||
126320192|NCT00904839|454464006|FG001|Overall Study|Other than above|9|||
126320193|NCT00904839|454464007|FG002|Overall Study|Other than above|7|||
126320194|NCT01430624|454464008|FG000|Overall Study|Lost to Follow-up|23|||
126320195|NCT01430624|454464009|FG001|Overall Study|Lost to Follow-up|29|||
126320196|NCT01430624|454464010|FG002|Overall Study|Lost to Follow-up|27|||
126320197|NCT01430624|454464008|FG000|Overall Study|technical or eligibility|5|||
126320198|NCT01430624|454464009|FG001|Overall Study|technical or eligibility|5|||
126320199|NCT01430624|454464010|FG002|Overall Study|technical or eligibility|2|||
126320200|NCT01167634|454464015|FG000|Overall Study|Lost to Follow-up|1|||
126320201|NCT01167634|454464016|FG001|Overall Study|Lost to Follow-up|3|||
126320202|NCT01167634|454464017|FG002|Overall Study|Lost to Follow-up|3|||
126320203|NCT01167634|454464018|FG003|Overall Study|Lost to Follow-up|4|||
126320204|NCT01167634|454464015|FG000|Overall Study|Withdrawal by Subject|1|||
126320205|NCT01167634|454464016|FG001|Overall Study|Withdrawal by Subject|1|||
126320206|NCT01167634|454464017|FG002|Overall Study|Withdrawal by Subject|0|||
126320207|NCT01167634|454464018|FG003|Overall Study|Withdrawal by Subject|0|||
126320208|NCT00553358|454464019|FG000|Overall Study|Randomized but did not receive treatment|3|||
126320209|NCT00553358|454464020|FG001|Overall Study|Randomized but did not receive treatment|3|||
126320210|NCT00553358|454464021|FG002|Overall Study|Randomized but did not receive treatment|1|||
126320211|NCT00553358|454464019|FG000|Overall Study|Lost to Follow-up|22|||
126320212|NCT00553358|454464020|FG001|Overall Study|Lost to Follow-up|26|||
126320213|NCT00553358|454464021|FG002|Overall Study|Lost to Follow-up|18|||
126320214|NCT00553358|454464019|FG000|Overall Study|Withdrew completely|23|||
126320215|NCT00553358|454464020|FG001|Overall Study|Withdrew completely|33|||
126320216|NCT00553358|454464021|FG002|Overall Study|Withdrew completely|34|||
126320217|NCT00553358|454464019|FG000|Overall Study|Died during clinical follow-up|25|||
126320218|NCT00553358|454464020|FG001|Overall Study|Died during clinical follow-up|29|||
126320219|NCT00553358|454464021|FG002|Overall Study|Died during clinical follow-up|32|||
126320220|NCT00553358|454464019|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
126320221|NCT00553358|454464020|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
126320222|NCT00553358|454464021|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
126320223|NCT00553358|454464019|FG000|Overall Study|Died after clinical follow-up ended|1|||
126320224|NCT00553358|454464020|FG001|Overall Study|Died after clinical follow-up ended|2|||
126320225|NCT00553358|454464021|FG002|Overall Study|Died after clinical follow-up ended|0|||
126320226|NCT00553358|454464019|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
126320227|NCT00553358|454464020|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
126320228|NCT00553358|454464021|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
126320229|NCT05268016|454464023|FG000|Overall Study|Unacceptable toxicity or AE|2|||
126320230|NCT05268016|454464024|FG001|Overall Study|Unacceptable toxicity or AE|2|||
126320231|NCT05268016|454464025|FG002|Overall Study|Unacceptable toxicity or AE|4|||
126320232|NCT05268016|454464026|FG003|Overall Study|Unacceptable toxicity or AE|3|||
126320233|NCT05268016|454464027|FG004|Overall Study|Unacceptable toxicity or AE|1|||
126320234|NCT05268016|454464023|FG000|Overall Study|Withdrawal by Subject|1|||
126320235|NCT05268016|454464024|FG001|Overall Study|Withdrawal by Subject|3|||
126320236|NCT05268016|454464025|FG002|Overall Study|Withdrawal by Subject|2|||
126320237|NCT05268016|454464026|FG003|Overall Study|Withdrawal by Subject|2|||
126320238|NCT05268016|454464027|FG004|Overall Study|Withdrawal by Subject|1|||
126320239|NCT05268016|454464023|FG000|Overall Study|Lost to Follow-up|4|||
126320240|NCT05268016|454464024|FG001|Overall Study|Lost to Follow-up|7|||
126320241|NCT05268016|454464025|FG002|Overall Study|Lost to Follow-up|1|||
126320242|NCT05268016|454464026|FG003|Overall Study|Lost to Follow-up|3|||
126320243|NCT05268016|454464027|FG004|Overall Study|Lost to Follow-up|5|||
126320244|NCT05268016|454464023|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
126320245|NCT05268016|454464024|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
126545080|NCT01036022|455289212|FG001|Overall Study|Adverse Event|3|||
126320246|NCT05268016|454464025|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
126320247|NCT05268016|454464026|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
126320248|NCT05268016|454464027|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
126320249|NCT05268016|454464023|FG000|Overall Study|Lack of Efficacy|0|||
126320250|NCT05268016|454464024|FG001|Overall Study|Lack of Efficacy|0|||
126320251|NCT05268016|454464025|FG002|Overall Study|Lack of Efficacy|0|||
126320252|NCT05268016|454464026|FG003|Overall Study|Lack of Efficacy|0|||
126320253|NCT05268016|454464027|FG004|Overall Study|Lack of Efficacy|4|||
126320254|NCT05268016|454464023|FG000|Overall Study|Physician Decision|0|||
126320255|NCT05268016|454464024|FG001|Overall Study|Physician Decision|0|||
126320256|NCT05268016|454464025|FG002|Overall Study|Physician Decision|0|||
126320257|NCT05268016|454464026|FG003|Overall Study|Physician Decision|1|||
126320258|NCT05268016|454464027|FG004|Overall Study|Physician Decision|0|||
126320259|NCT05268016|454464023|FG000|Overall Study|Other|1|||
126320260|NCT05268016|454464024|FG001|Overall Study|Other|0|||
126320261|NCT05268016|454464025|FG002|Overall Study|Other|1|||
126320262|NCT05268016|454464026|FG003|Overall Study|Other|2|||
126320263|NCT05268016|454464027|FG004|Overall Study|Other|0|||
126320264|NCT00404924|454464028|FG000|Overall Study|Adverse Event|75|||
126320265|NCT00404924|454464029|FG001|Overall Study|Adverse Event|16|||
126320266|NCT00404924|454464028|FG000|Overall Study|Condition under investigation worsened|475|||
126320267|NCT00404924|454464029|FG001|Overall Study|Condition under investigation worsened|264|||
126320268|NCT00404924|454464028|FG000|Overall Study|Lost to Follow-up|1|||
126320269|NCT00404924|454464029|FG001|Overall Study|Lost to Follow-up|1|||
126320270|NCT00404924|454464028|FG000|Overall Study|Withdrawal by Subject|26|||
126320271|NCT00404924|454464029|FG001|Overall Study|Withdrawal by Subject|13|||
126320272|NCT00404924|454464028|FG000|Overall Study|Other|25|||
126320273|NCT00404924|454464029|FG001|Overall Study|Other|11|||
126320274|NCT00404924|454464028|FG000|Overall Study|Randomised but not received treatment|1|||
126320275|NCT00404924|454464029|FG001|Overall Study|Randomised but not received treatment|1|||
126320276|NCT01074255|454464034|FG000|Overall Study|Did not receive EMEND|2|||
126320277|NCT02943785|454464036|FG000|Overall Study|Adverse Event|112|||
126320278|NCT02943785|454464037|FG001|Overall Study|Adverse Event|97|||
126320279|NCT02943785|454464036|FG000|Overall Study|Withdrawal by Subject|63|||
126320280|NCT02943785|454464037|FG001|Overall Study|Withdrawal by Subject|126|||
126320281|NCT02943785|454464036|FG000|Overall Study|Physician Decision|23|||
126320282|NCT02943785|454464037|FG001|Overall Study|Physician Decision|47|||
126320283|NCT02943785|454464036|FG000|Overall Study|Death|46|||
126320284|NCT02943785|454464037|FG001|Overall Study|Death|46|||
126320285|NCT02943785|454464036|FG000|Overall Study|Lost to Follow-up|1|||
126320286|NCT02943785|454464037|FG001|Overall Study|Lost to Follow-up|0|||
126320287|NCT02943785|454464036|FG000|Overall Study|Other|16|||
126320288|NCT02943785|454464037|FG001|Overall Study|Other|19|||
126320289|NCT02943785|454464036|FG000|Overall Study|Did not receive any study medication|21|||
126320290|NCT02943785|454464037|FG001|Overall Study|Did not receive any study medication|28|||
126320291|NCT00821015|454464040|FG000|Overall Study|Lost to Follow-up|12|||
126320292|NCT01281956|454464041|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
126320293|NCT01281956|454464042|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
126320294|NCT03170609|454464043|FG000|Overall Study|Death|0|||
126320295|NCT03170609|454464044|FG001|Overall Study|Death|0|||
126320296|NCT03170609|454464045|FG002|Overall Study|Death|1|||
126320297|NCT03170609|454464046|FG003|Overall Study|Death|0|||
126320298|NCT03170609|454464047|FG004|Overall Study|Death|0|||
126320299|NCT03170609|454464048|FG005|Overall Study|Death|0|||
126320300|NCT03170609|454464049|FG006|Overall Study|Death|0|||
126320301|NCT03170609|454464043|FG000|Overall Study|Withdrawal by Subject|1|||
126320302|NCT03170609|454464044|FG001|Overall Study|Withdrawal by Subject|2|||
126320303|NCT03170609|454464045|FG002|Overall Study|Withdrawal by Subject|0|||
126320304|NCT03170609|454464046|FG003|Overall Study|Withdrawal by Subject|0|||
126320305|NCT03170609|454464047|FG004|Overall Study|Withdrawal by Subject|0|||
126320306|NCT03170609|454464048|FG005|Overall Study|Withdrawal by Subject|0|||
126320307|NCT03170609|454464049|FG006|Overall Study|Withdrawal by Subject|1|||
126320308|NCT03170609|454464043|FG000|Overall Study|Lost to Follow-up|1|||
126320309|NCT03170609|454464044|FG001|Overall Study|Lost to Follow-up|0|||
126320310|NCT03170609|454464045|FG002|Overall Study|Lost to Follow-up|5|||
126320311|NCT03170609|454464046|FG003|Overall Study|Lost to Follow-up|2|||
126320312|NCT03170609|454464047|FG004|Overall Study|Lost to Follow-up|1|||
126320313|NCT03170609|454464048|FG005|Overall Study|Lost to Follow-up|1|||
126320314|NCT03170609|454464049|FG006|Overall Study|Lost to Follow-up|0|||
126320315|NCT03170609|454464043|FG000|Overall Study|Other|1|||
126320316|NCT03170609|454464044|FG001|Overall Study|Other|0|||
126320317|NCT03170609|454464045|FG002|Overall Study|Other|0|||
126320318|NCT03170609|454464046|FG003|Overall Study|Other|0|||
126320319|NCT03170609|454464047|FG004|Overall Study|Other|0|||
126320320|NCT03170609|454464048|FG005|Overall Study|Other|1|||
126320321|NCT03170609|454464049|FG006|Overall Study|Other|0|||
126320322|NCT01490697|454464057|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
126320323|NCT01490697|454464058|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
126320324|NCT00090584|454464059|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
126650987|NCT05110690|455678327|FG000|Completion of Intervention|Lost to Follow-up|1|||
126650988|NCT05110690|455678327|FG000|Completion of Intervention|Death|1|||
126320325|NCT00090584|454464060|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
126320326|NCT00090584|454464059|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
126320327|NCT00090584|454464060|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
126320328|NCT00270231|454464061|FG000|First Intervention|Lost to Follow-up|1|||
126320329|NCT00270231|454464062|FG001|First Intervention|Lost to Follow-up|1|||
126320330|NCT00270231|454464061|FG000|Washout Period|Lost to Follow-up|1|||
126320331|NCT00270231|454464062|FG001|Washout Period|Lost to Follow-up|0|||
126320332|NCT00270231|454464061|FG000|Second Intervention|Lost to Follow-up|0|||
126320333|NCT00270231|454464062|FG001|Second Intervention|Lost to Follow-up|1|||
126320334|NCT02117713|454464072|FG000|Week 48|Adverse Event|4|||
126320335|NCT02117713|454464072|FG000|Week 48|Withdrawal by caregiver|2|||
126320336|NCT02117713|454464072|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
126320337|NCT02117713|454464072|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
126320338|NCT02117713|454464072|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
126320339|NCT02117713|454464072|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
126320340|NCT00574795|454464073|FG000|Infant Series|Withdrawal by Subject|2|||
126320341|NCT00574795|454464073|FG000|Infant Series|Protocol Violation|2|||
126320342|NCT00574795|454464073|FG000|Infant Series|Adverse Event|1|||
126320343|NCT00574795|454464073|FG000|After Infant Series|Withdrawal by Subject|1|||
126320344|NCT00574795|454464073|FG000|After Infant Series|Adverse Event|2|||
126320345|NCT00574795|454464073|FG000|Toddler Dose|Withdrawal by Subject|1|||
126320346|NCT01333956|454464081|FG000|Overall Study|Lost to Follow-up|1|||
126320347|NCT01333956|454464082|FG001|Overall Study|Lost to Follow-up|2|||
126320348|NCT01333956|454464083|FG002|Overall Study|Lost to Follow-up|0|||
126320349|NCT01333956|454464084|FG003|Overall Study|Lost to Follow-up|1|||
126320350|NCT01333956|454464081|FG000|Overall Study|Unable to complete study procedure|1|||
126320351|NCT01333956|454464082|FG001|Overall Study|Unable to complete study procedure|0|||
126320352|NCT01333956|454464083|FG002|Overall Study|Unable to complete study procedure|0|||
126320353|NCT01333956|454464084|FG003|Overall Study|Unable to complete study procedure|1|||
126320354|NCT01333956|454464081|FG000|Overall Study|Withdrawal by Subject|0|||
126320355|NCT01333956|454464082|FG001|Overall Study|Withdrawal by Subject|2|||
126320356|NCT01333956|454464083|FG002|Overall Study|Withdrawal by Subject|1|||
126320357|NCT01333956|454464084|FG003|Overall Study|Withdrawal by Subject|0|||
126320358|NCT00432276|454464087|FG000|Overall Study|Hyperglycemic Rescue|44|||
126320359|NCT00432276|454464088|FG001|Overall Study|Hyperglycemic Rescue|87|||
126320360|NCT00432276|454464087|FG000|Overall Study|Adverse Event|13|||
126320361|NCT00432276|454464088|FG001|Overall Study|Adverse Event|16|||
126320362|NCT00432276|454464087|FG000|Overall Study|Protocol Violation|25|||
126320363|NCT00432276|454464088|FG001|Overall Study|Protocol Violation|20|||
126320364|NCT00432276|454464087|FG000|Overall Study|Lost to Follow-up|6|||
126320365|NCT00432276|454464088|FG001|Overall Study|Lost to Follow-up|2|||
126320366|NCT00432276|454464087|FG000|Overall Study|Withdrawal by Subject|25|||
126320367|NCT00432276|454464088|FG001|Overall Study|Withdrawal by Subject|20|||
126320368|NCT00432276|454464087|FG000|Overall Study|Physician Decision|6|||
126320369|NCT00432276|454464088|FG001|Overall Study|Physician Decision|8|||
126320370|NCT00432276|454464087|FG000|Overall Study|Other|2|||
126320371|NCT00432276|454464088|FG001|Overall Study|Other|3|||
126320372|NCT00467961|454464089|FG000|Overall Study|Technical Failures|5|||
126320373|NCT00467961|454464089|FG000|Overall Study|Disease Progression|2|||
126320374|NCT05249127|454464090|FG000|Overall Study|Protocol Violation|13|||
126320375|NCT05249127|454464090|FG000|Overall Study|Physician Decision|4|||
126320376|NCT05249127|454464090|FG000|Overall Study|Withdrawal by Subject|2|||
126320377|NCT05249127|454464090|FG000|Overall Study|Participant Non-compliance|1|||
126320378|NCT02073565|454464091|FG000|Cohort A|Withdrawal by Subject|1|||
126320379|NCT02073565|454464092|FG001|Cohort A|Withdrawal by Subject|0|||
126320380|NCT02073565|454464091|FG000|Cohort B|Withdrawal by Subject|1|||
126320381|NCT02073565|454464092|FG001|Cohort B|Withdrawal by Subject|2|||
126320382|NCT02073565|454464091|FG000|Cohort C|Withdrawal by Subject|0|||
126320383|NCT02073565|454464092|FG001|Cohort C|Withdrawal by Subject|2|||
126320384|NCT02073565|454464091|FG000|Cohort C|Lost to Follow-up|0|||
126320385|NCT02073565|454464092|FG001|Cohort C|Lost to Follow-up|2|||
126320386|NCT03646305|454464093|FG000|Overall Study|Lost to Follow-up|4|||
126320387|NCT03646305|454464094|FG001|Overall Study|Lost to Follow-up|2|||
126320388|NCT03646305|454464095|FG002|Overall Study|Lost to Follow-up|2|||
126320389|NCT03646305|454464096|FG003|Overall Study|Lost to Follow-up|1|||
126320390|NCT03646305|454464093|FG000|Overall Study|Withdrawal by Subject|1|||
126320391|NCT03646305|454464094|FG001|Overall Study|Withdrawal by Subject|0|||
126320392|NCT03646305|454464095|FG002|Overall Study|Withdrawal by Subject|0|||
126320393|NCT03646305|454464096|FG003|Overall Study|Withdrawal by Subject|1|||
126320394|NCT03417024|454464097|FG000|Overall Study|Study Termination prior to follow-up|11|||
126320395|NCT03417024|454464097|FG000|Overall Study|Physician Decision|2|||
126320396|NCT03168919|454464098|FG000|Overall Study|Withdrawal by Subject|2|||
126320397|NCT04015518|454464099|FG000|Overall Study|Adverse Event|6|||
126320398|NCT04015518|454464100|FG001|Overall Study|Adverse Event|1|||
126320399|NCT04015518|454464101|FG002|Overall Study|Adverse Event|1|||
126320400|NCT04015518|454464102|FG003|Overall Study|Adverse Event|3|||
126320401|NCT04015518|454464103|FG004|Overall Study|Adverse Event|3|||
126320402|NCT04015518|454464099|FG000|Overall Study|Lack of Efficacy|1|||
126320403|NCT04015518|454464100|FG001|Overall Study|Lack of Efficacy|0|||
126320404|NCT04015518|454464101|FG002|Overall Study|Lack of Efficacy|1|||
126320405|NCT04015518|454464102|FG003|Overall Study|Lack of Efficacy|0|||
126320406|NCT04015518|454464103|FG004|Overall Study|Lack of Efficacy|4|||
126320407|NCT04015518|454464099|FG000|Overall Study|Lost to Follow-up|0|||
126320408|NCT04015518|454464100|FG001|Overall Study|Lost to Follow-up|0|||
126320409|NCT04015518|454464101|FG002|Overall Study|Lost to Follow-up|0|||
126320410|NCT04015518|454464102|FG003|Overall Study|Lost to Follow-up|0|||
126320411|NCT04015518|454464103|FG004|Overall Study|Lost to Follow-up|1|||
126320412|NCT04015518|454464099|FG000|Overall Study|Withdrawal by Subject|0|||
126320413|NCT04015518|454464100|FG001|Overall Study|Withdrawal by Subject|1|||
126320414|NCT04015518|454464101|FG002|Overall Study|Withdrawal by Subject|0|||
126320415|NCT04015518|454464102|FG003|Overall Study|Withdrawal by Subject|1|||
126320416|NCT04015518|454464103|FG004|Overall Study|Withdrawal by Subject|1|||
126320417|NCT04015518|454464099|FG000|Overall Study|Patient did not come for consecutive visits|0|||
126320418|NCT04015518|454464100|FG001|Overall Study|Patient did not come for consecutive visits|1|||
126320419|NCT04015518|454464101|FG002|Overall Study|Patient did not come for consecutive visits|0|||
126320420|NCT04015518|454464102|FG003|Overall Study|Patient did not come for consecutive visits|0|||
126320421|NCT04015518|454464103|FG004|Overall Study|Patient did not come for consecutive visits|0|||
126320422|NCT04015518|454464099|FG000|Overall Study|not willing to travel due to Covid-19|0|||
126320423|NCT04015518|454464100|FG001|Overall Study|not willing to travel due to Covid-19|0|||
126320424|NCT04015518|454464101|FG002|Overall Study|not willing to travel due to Covid-19|1|||
126320425|NCT04015518|454464102|FG003|Overall Study|not willing to travel due to Covid-19|0|||
126320426|NCT04015518|454464103|FG004|Overall Study|not willing to travel due to Covid-19|0|||
126320427|NCT04015518|454464099|FG000|Overall Study|Patient wants to discontinue treatment|0|||
126320428|NCT04015518|454464100|FG001|Overall Study|Patient wants to discontinue treatment|0|||
126320429|NCT04015518|454464101|FG002|Overall Study|Patient wants to discontinue treatment|0|||
126320430|NCT04015518|454464102|FG003|Overall Study|Patient wants to discontinue treatment|1|||
126320431|NCT04015518|454464103|FG004|Overall Study|Patient wants to discontinue treatment|0|||
126320432|NCT04015518|454464099|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
126320433|NCT04015518|454464100|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
126320434|NCT04015518|454464101|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
126320435|NCT04015518|454464102|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
126320436|NCT04015518|454464103|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
126320437|NCT04015518|454464099|FG000|Overall Study|Pregnancy|0|||
126320438|NCT04015518|454464100|FG001|Overall Study|Pregnancy|0|||
126320439|NCT04015518|454464101|FG002|Overall Study|Pregnancy|0|||
126320440|NCT04015518|454464102|FG003|Overall Study|Pregnancy|0|||
126320441|NCT04015518|454464103|FG004|Overall Study|Pregnancy|1|||
126320442|NCT04015518|454464099|FG000|Overall Study|Personal reasons|1|||
126320443|NCT04015518|454464100|FG001|Overall Study|Personal reasons|0|||
126320444|NCT04015518|454464101|FG002|Overall Study|Personal reasons|0|||
126320445|NCT04015518|454464102|FG003|Overall Study|Personal reasons|0|||
126320446|NCT04015518|454464103|FG004|Overall Study|Personal reasons|1|||
126320447|NCT04015518|454464099|FG000|Overall Study|Withdrew consent|1|||
126320448|NCT04015518|454464100|FG001|Overall Study|Withdrew consent|0|||
126320449|NCT04015518|454464101|FG002|Overall Study|Withdrew consent|0|||
126320450|NCT04015518|454464102|FG003|Overall Study|Withdrew consent|0|||
126320451|NCT04015518|454464103|FG004|Overall Study|Withdrew consent|0|||
126320452|NCT04015518|454464099|FG000|Overall Study|Prostate carcinoma|1|||
126320453|NCT04015518|454464100|FG001|Overall Study|Prostate carcinoma|0|||
126650989|NCT05110690|455678327|FG000|Completion of Intervention|Withdrawal by Subject|2|||
126650990|NCT03973931|455678328|FG000|Overall Study|Lost to Follow-up|47|||
126320454|NCT04015518|454464101|FG002|Overall Study|Prostate carcinoma|0|||
126320455|NCT04015518|454464102|FG003|Overall Study|Prostate carcinoma|0|||
126320456|NCT04015518|454464103|FG004|Overall Study|Prostate carcinoma|0|||
126320457|NCT04015518|454464099|FG000|Overall Study|Could not keep appointments due to work|1|||
126320458|NCT04015518|454464100|FG001|Overall Study|Could not keep appointments due to work|0|||
126320459|NCT04015518|454464101|FG002|Overall Study|Could not keep appointments due to work|0|||
126320460|NCT04015518|454464102|FG003|Overall Study|Could not keep appointments due to work|0|||
126320461|NCT04015518|454464103|FG004|Overall Study|Could not keep appointments due to work|0|||
126320462|NCT02195427|454464104|FG000|Overall Study|Did not consent to study extension|13|||
126320463|NCT02195427|454464105|FG001|Overall Study|Did not consent to study extension|9|||
126320464|NCT02195427|454464104|FG000|Overall Study|Withdrawal by Subject|4|||
126320465|NCT02195427|454464105|FG001|Overall Study|Withdrawal by Subject|2|||
126320466|NCT02195427|454464104|FG000|Overall Study|Lost to Follow-up|0|||
126650991|NCT03973931|455678329|FG001|Overall Study|Lost to Follow-up|63|||
126650992|NCT03973931|455678330|FG002|Overall Study|Lost to Follow-up|51|||
126320467|NCT02195427|454464105|FG001|Overall Study|Lost to Follow-up|1|||
126320468|NCT02195427|454464104|FG000|Overall Study|Protocol Violation|7|||
126320469|NCT02195427|454464105|FG001|Overall Study|Protocol Violation|14|||
126320470|NCT02195427|454464104|FG000|Overall Study|Conditional re-treatment at W52|2|||
126320471|NCT02195427|454464105|FG001|Overall Study|Conditional re-treatment at W52|1|||
126320472|NCT03053427|454464106|FG000|Overall Study|Adverse Event|4|||
126320473|NCT03053427|454464107|FG001|Overall Study|Adverse Event|4|||
126320474|NCT03053427|454464106|FG000|Overall Study|Lack of Efficacy|1|||
126320475|NCT03053427|454464107|FG001|Overall Study|Lack of Efficacy|3|||
126320476|NCT03053427|454464106|FG000|Overall Study|Lost to Follow-up|2|||
126320477|NCT03053427|454464107|FG001|Overall Study|Lost to Follow-up|2|||
126320478|NCT03053427|454464106|FG000|Overall Study|Worsening of the target disease|0|||
126320479|NCT03053427|454464107|FG001|Overall Study|Worsening of the target disease|1|||
126320480|NCT03053427|454464106|FG000|Overall Study|Protocol Deviation|3|||
126320481|NCT03053427|454464107|FG001|Overall Study|Protocol Deviation|3|||
126320482|NCT03053427|454464106|FG000|Overall Study|Withdrawal by Subject|3|||
126320483|NCT03053427|454464107|FG001|Overall Study|Withdrawal by Subject|2|||
126320484|NCT03053427|454464106|FG000|Overall Study|Miscellaneous|0|||
126320485|NCT03053427|454464107|FG001|Overall Study|Miscellaneous|1|||
126320486|NCT02172040|454464113|FG000|Overall Study|Adverse Event|0|||
126320487|NCT02172040|454464114|FG001|Overall Study|Adverse Event|2|||
126320488|NCT02172040|454464115|FG002|Overall Study|Adverse Event|0|||
126320489|NCT02172040|454464116|FG003|Overall Study|Adverse Event|0|||
126320490|NCT02172040|454464113|FG000|Overall Study|Protocol Violation|0|||
126320491|NCT02172040|454464114|FG001|Overall Study|Protocol Violation|1|||
126320492|NCT02172040|454464115|FG002|Overall Study|Protocol Violation|0|||
126320493|NCT02172040|454464116|FG003|Overall Study|Protocol Violation|0|||
126320494|NCT02172040|454464113|FG000|Overall Study|Withdrawal by Subject|0|||
126320495|NCT02172040|454464114|FG001|Overall Study|Withdrawal by Subject|0|||
126320496|NCT02172040|454464115|FG002|Overall Study|Withdrawal by Subject|1|||
126320497|NCT02172040|454464116|FG003|Overall Study|Withdrawal by Subject|0|||
126320498|NCT02172040|454464113|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
126320499|NCT02172040|454464114|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
126320500|NCT02172040|454464115|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
126320501|NCT02172040|454464116|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
126320502|NCT02172040|454464113|FG000|Overall Study|Family emergency abroad|0|||
126320503|NCT02172040|454464114|FG001|Overall Study|Family emergency abroad|0|||
126320504|NCT02172040|454464115|FG002|Overall Study|Family emergency abroad|0|||
126320505|NCT02172040|454464116|FG003|Overall Study|Family emergency abroad|1|||
126320506|NCT02607306|454464121|FG000|Overall Study|Adverse Event|8|||
126320507|NCT02607306|454464122|FG001|Overall Study|Adverse Event|6|||
126320508|NCT02607306|454464123|FG002|Overall Study|Adverse Event|6|||
126320509|NCT02607306|454464121|FG000|Overall Study|Unclassified|1|||
126320510|NCT02607306|454464122|FG001|Overall Study|Unclassified|4|||
126320511|NCT02607306|454464123|FG002|Overall Study|Unclassified|0|||
126320512|NCT02607306|454464121|FG000|Overall Study|Withdrawal by Subject|8|||
126320513|NCT02607306|454464122|FG001|Overall Study|Withdrawal by Subject|10|||
126320514|NCT02607306|454464123|FG002|Overall Study|Withdrawal by Subject|2|||
126320515|NCT02607306|454464121|FG000|Overall Study|Lack of Efficacy|0|||
126320516|NCT02607306|454464122|FG001|Overall Study|Lack of Efficacy|1|||
126320517|NCT02607306|454464123|FG002|Overall Study|Lack of Efficacy|1|||
126320518|NCT02607306|454464121|FG000|Overall Study|Protocol Violation|4|||
126320519|NCT02607306|454464122|FG001|Overall Study|Protocol Violation|2|||
126320520|NCT02607306|454464123|FG002|Overall Study|Protocol Violation|1|||
126320521|NCT03759366|454464124|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
126320522|NCT03759366|454464124|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
126320523|NCT03759366|454464124|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
126320524|NCT03759366|454464124|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
126320525|NCT03759366|454464124|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
126650993|NCT03973931|455678331|FG003|Overall Study|Lost to Follow-up|54|||
126650994|NCT03973931|455678328|FG000|Overall Study|opted out|6|||
126650995|NCT03973931|455678329|FG001|Overall Study|opted out|5|||
126650996|NCT03973931|455678330|FG002|Overall Study|opted out|5|||
126650997|NCT03973931|455678331|FG003|Overall Study|opted out|1|||
126650998|NCT01022112|455678332|FG000|Overall Study|Adverse Event|1|||
126650999|NCT01022112|455678333|FG001|Overall Study|Adverse Event|2|||
126651000|NCT01022112|455678334|FG002|Overall Study|Adverse Event|0|||
126320526|NCT03759366|454464124|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
126320527|NCT03759366|454464124|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
126320528|NCT04226495|454464125|FG000|Overall Study|Withdrawal by Subject|3|||
126320529|NCT04226495|454464126|FG001|Overall Study|Withdrawal by Subject|3|||
126320530|NCT04226495|454464125|FG000|Overall Study|PI discretion|3|||
126320531|NCT04226495|454464126|FG001|Overall Study|PI discretion|4|||
126320532|NCT00539032|454464127|FG000|Overall Study|Withdrawal by Subject|2|||
126320533|NCT00539032|454464128|FG001|Overall Study|Withdrawal by Subject|1|||
126320534|NCT02168777|454466253|FG000|Overall Study|Withdrawal by Subject|1|||
126320535|NCT02168777|454466254|FG001|Overall Study|Withdrawal by Subject|0|||
126320536|NCT02168777|454466255|FG002|Overall Study|Withdrawal by Subject|2|||
126651001|NCT01022112|455678335|FG003|Overall Study|Adverse Event|1|||
126320537|NCT02168777|454466253|FG000|Overall Study|Adverse Event|1|||
126320538|NCT02168777|454466254|FG001|Overall Study|Adverse Event|0|||
126320539|NCT02168777|454466255|FG002|Overall Study|Adverse Event|1|||
126320540|NCT02168777|454466253|FG000|Overall Study|Disease recurrence|0|||
126320541|NCT02168777|454466254|FG001|Overall Study|Disease recurrence|0|||
126320542|NCT02168777|454466255|FG002|Overall Study|Disease recurrence|1|||
126320543|NCT02168777|454466253|FG000|Overall Study|Radiological disease progression|0|||
126320544|NCT02168777|454466254|FG001|Overall Study|Radiological disease progression|5|||
126320545|NCT02168777|454466255|FG002|Overall Study|Radiological disease progression|5|||
126320546|NCT02168777|454466253|FG000|Overall Study|Clinical disease progression|0|||
126320547|NCT02168777|454466254|FG001|Overall Study|Clinical disease progression|1|||
126320548|NCT02168777|454466255|FG002|Overall Study|Clinical disease progression|2|||
126320549|NCT02168777|454466253|FG000|Overall Study|Other reason|0|||
126320550|NCT02168777|454466254|FG001|Overall Study|Other reason|1|||
126320551|NCT02168777|454466255|FG002|Overall Study|Other reason|0|||
126320552|NCT03334422|454466257|FG000|Overall Study|Adverse Event|1|||
126320553|NCT03334422|454466258|FG001|Overall Study|Adverse Event|3|||
126320554|NCT03334422|454466259|FG002|Overall Study|Adverse Event|2|||
126320555|NCT03334422|454466260|FG003|Overall Study|Adverse Event|2|||
126320556|NCT03334422|454466257|FG000|Overall Study|Lack of Efficacy|10|||
126320557|NCT03334422|454466258|FG001|Overall Study|Lack of Efficacy|2|||
126320558|NCT03334422|454466259|FG002|Overall Study|Lack of Efficacy|7|||
126320559|NCT03334422|454466260|FG003|Overall Study|Lack of Efficacy|3|||
126320560|NCT03334422|454466257|FG000|Overall Study|Withdrawal by Subject|8|||
126320561|NCT03334422|454466258|FG001|Overall Study|Withdrawal by Subject|3|||
126320562|NCT03334422|454466259|FG002|Overall Study|Withdrawal by Subject|1|||
126320563|NCT03334422|454466260|FG003|Overall Study|Withdrawal by Subject|0|||
126320564|NCT03334422|454466257|FG000|Overall Study|Lost to Follow-up|0|||
126320565|NCT03334422|454466258|FG001|Overall Study|Lost to Follow-up|0|||
126320566|NCT03334422|454466259|FG002|Overall Study|Lost to Follow-up|0|||
126320567|NCT03334422|454466260|FG003|Overall Study|Lost to Follow-up|1|||
126320568|NCT03334422|454466257|FG000|Overall Study|Inability to obtain laboratory samples|0|||
126320569|NCT03334422|454466258|FG001|Overall Study|Inability to obtain laboratory samples|1|||
126320570|NCT03334422|454466259|FG002|Overall Study|Inability to obtain laboratory samples|0|||
126320571|NCT03334422|454466260|FG003|Overall Study|Inability to obtain laboratory samples|0|||
126320572|NCT03334422|454466257|FG000|Overall Study|Pregnancy|0|||
126320573|NCT03334422|454466258|FG001|Overall Study|Pregnancy|1|||
126320574|NCT03334422|454466259|FG002|Overall Study|Pregnancy|0|||
126320575|NCT03334422|454466260|FG003|Overall Study|Pregnancy|0|||
126320576|NCT02697916|454466261|FG000|Overall Study|Death|357|||
126320577|NCT02697916|454466262|FG001|Overall Study|Death|315|||
126320578|NCT02697916|454466261|FG000|Overall Study|Withdrawal by Subject|221|||
126320579|NCT02697916|454466262|FG001|Overall Study|Withdrawal by Subject|393|||
126320580|NCT01698268|454466263|FG000|Overall Study|Physician Decision|2|||
126320581|NCT01698268|454466264|FG001|Overall Study|Physician Decision|1|||
126320582|NCT01533688|454466265|FG000|Overall Study|Withdrawal by Subject|5|||
126320583|NCT01533688|454466266|FG001|Overall Study|Withdrawal by Subject|4|||
126320584|NCT01533688|454466267|FG002|Overall Study|Withdrawal by Subject|3|||
126320585|NCT01533688|454466265|FG000|Overall Study|Medically unstable|1|||
126320586|NCT01533688|454466266|FG001|Overall Study|Medically unstable|3|||
126320587|NCT01533688|454466267|FG002|Overall Study|Medically unstable|3|||
126320588|NCT01533688|454466265|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
126320589|NCT01533688|454466266|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
126320590|NCT01533688|454466267|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
126320591|NCT04591015|454466268|FG000|Overall Study|Death|6|||
126320592|NCT04591015|454466269|FG001|Overall Study|Death|4|||
126320593|NCT04591015|454466268|FG000|Overall Study|Withdrawal by Subject|6|||
126320594|NCT04591015|454466269|FG001|Overall Study|Withdrawal by Subject|3|||
126320595|NCT04591015|454466268|FG000|Overall Study|Lost to Follow-up|16|||
126320596|NCT04591015|454466269|FG001|Overall Study|Lost to Follow-up|11|||
126320597|NCT02509078|454466270|FG000|Overall Study|Protocol Violation|1|||
126320598|NCT02509078|454466271|FG001|Overall Study|Protocol Violation|1|||
126320599|NCT02686814|454466272|FG000|Overall Study|Physician Decision|14|||
126320600|NCT02686814|454466272|FG000|Overall Study|Withdrawal by Subject|4|||
126320601|NCT02686814|454466272|FG000|Overall Study|Death|1|||
126320602|NCT00290693|454466273|FG000|Overall Study|Withdrawal by Subject|2|||
126320603|NCT02907619|454466274|FG000|Overall Study|Study terminated by sponsor|18|||
126320604|NCT02907619|454466275|FG001|Overall Study|Study terminated by sponsor|18|||
126320605|NCT02907619|454466276|FG002|Overall Study|Study terminated by sponsor|19|||
126320606|NCT02907619|454466274|FG000|Overall Study|Death|0|||
126320607|NCT02907619|454466275|FG001|Overall Study|Death|0|||
126320608|NCT02907619|454466276|FG002|Overall Study|Death|1|||
126320609|NCT02907619|454466274|FG000|Overall Study|Withdrawal by Subject|1|||
126320610|NCT02907619|454466275|FG001|Overall Study|Withdrawal by Subject|1|||
126320611|NCT02907619|454466276|FG002|Overall Study|Withdrawal by Subject|0|||
126320612|NCT02907619|454466274|FG000|Overall Study|Other|0|||
126320613|NCT02907619|454466275|FG001|Overall Study|Other|1|||
126320614|NCT02907619|454466276|FG002|Overall Study|Other|0|||
126320615|NCT02603107|454466277|FG000|Randomized Phase|Withdrew consent|8|||
126320616|NCT02603107|454466278|FG001|Randomized Phase|Withdrew consent|15|||
126320617|NCT02603107|454466277|FG000|Randomized Phase|Lost to Follow-up|1|||
126320618|NCT02603107|454466278|FG001|Randomized Phase|Lost to Follow-up|3|||
126320619|NCT02603107|454466277|FG000|Randomized Phase|Adverse Event|2|||
126320620|NCT02603107|454466278|FG001|Randomized Phase|Adverse Event|0|||
126320621|NCT02603107|454466277|FG000|Randomized Phase|Death|1|||
126320622|NCT02603107|454466278|FG001|Randomized Phase|Death|1|||
126320623|NCT02603107|454466277|FG000|Randomized Phase|Non-compliance with study drug|1|||
126320624|NCT02603107|454466278|FG001|Randomized Phase|Non-compliance with study drug|1|||
126320625|NCT02603107|454466277|FG000|Randomized Phase|Investigator's discretion|0|||
126320626|NCT02603107|454466278|FG001|Randomized Phase|Investigator's discretion|1|||
126320627|NCT02603107|454466277|FG000|Randomized Phase|Lack of Efficacy|1|||
126320628|NCT02603107|454466278|FG001|Randomized Phase|Lack of Efficacy|0|||
126320629|NCT02603107|454466277|FG000|Randomized Phase|Protocol Violation|1|||
126320630|NCT02603107|454466278|FG001|Randomized Phase|Protocol Violation|0|||
126320631|NCT02603107|454466277|FG000|Optional Extension Phase|Lost to Follow-up|3|||
126320632|NCT02603107|454466278|FG001|Optional Extension Phase|Lost to Follow-up|3|||
126320633|NCT02603107|454466277|FG000|Optional Extension Phase|Withdrew consent|3|||
126320634|NCT02603107|454466278|FG001|Optional Extension Phase|Withdrew consent|2|||
126320635|NCT02603107|454466277|FG000|Optional Extension Phase|Investigator's discretion|2|||
126320636|NCT02603107|454466278|FG001|Optional Extension Phase|Investigator's discretion|2|||
126320637|NCT02603107|454466277|FG000|Optional Extension Phase|Pregnancy|0|||
126320638|NCT02603107|454466278|FG001|Optional Extension Phase|Pregnancy|3|||
126320639|NCT02603107|454466277|FG000|Optional Extension Phase|Adverse Event|0|||
126320640|NCT02603107|454466278|FG001|Optional Extension Phase|Adverse Event|2|||
126320641|NCT02603107|454466277|FG000|Optional Extension Phase|Not treated in extension phase|0|||
126320642|NCT02603107|454466278|FG001|Optional Extension Phase|Not treated in extension phase|1|||
126320643|NCT02603107|454466277|FG000|Optional Extension Phase|Protocol Violation|1|||
126320644|NCT02603107|454466278|FG001|Optional Extension Phase|Protocol Violation|0|||
126320645|NCT03411902|454466279|FG000|Overall Study|Lost to Follow-up|3|||
126320646|NCT03411902|454466280|FG001|Overall Study|Lost to Follow-up|0|||
126320647|NCT00419159|454466281|FG000|Overall Study|Adverse Event|7|||
126320648|NCT00419159|454466282|FG001|Overall Study|Adverse Event|15|||
126320649|NCT00419159|454466281|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126320650|NCT00419159|454466282|FG001|Overall Study|Abnormal laboratory value(s)|2|||
126320651|NCT00419159|454466281|FG000|Overall Study|Subject's no longer requires study drug|0|||
126320652|NCT00419159|454466282|FG001|Overall Study|Subject's no longer requires study drug|1|||
126320653|NCT00419159|454466281|FG000|Overall Study|Protocol Violation|1|||
126320654|NCT00419159|454466282|FG001|Overall Study|Protocol Violation|0|||
126320655|NCT00419159|454466281|FG000|Overall Study|Withdrawal by Subject|10|||
126320656|NCT00419159|454466282|FG001|Overall Study|Withdrawal by Subject|3|||
126320657|NCT00419159|454466281|FG000|Overall Study|Lost to Follow-up|0|||
126320658|NCT00419159|454466282|FG001|Overall Study|Lost to Follow-up|1|||
126320659|NCT00419159|454466281|FG000|Overall Study|Death|2|||
126320660|NCT00419159|454466282|FG001|Overall Study|Death|2|||
126320661|NCT00419159|454466281|FG000|Overall Study|Disease progression|79|||
126320662|NCT00419159|454466282|FG001|Overall Study|Disease progression|76|||
126320663|NCT00187278|454466283|FG000|Overall Study|Protocol Violation|10|||
126320664|NCT00187278|454466284|FG001|Overall Study|Protocol Violation|13|||
126320665|NCT00803205|454466285|FG000|Overall Study|Adverse Event|7|||
126320666|NCT00803205|454466286|FG001|Overall Study|Adverse Event|2|||
126320667|NCT00803205|454466285|FG000|Overall Study|Lost to Follow-up|1|||
126320668|NCT00803205|454466286|FG001|Overall Study|Lost to Follow-up|0|||
126320669|NCT00803205|454466285|FG000|Overall Study|Withdrawal by Subject|9|||
126320670|NCT00803205|454466286|FG001|Overall Study|Withdrawal by Subject|9|||
126320671|NCT00803205|454466285|FG000|Overall Study|Physician Decision|1|||
126320672|NCT00803205|454466286|FG001|Overall Study|Physician Decision|0|||
126320673|NCT00803205|454466285|FG000|Overall Study|Protocol Violation|1|||
126320674|NCT00803205|454466286|FG001|Overall Study|Protocol Violation|1|||
126320675|NCT00803205|454466285|FG000|Overall Study|Medical Monitor Decision|1|||
126320676|NCT00803205|454466286|FG001|Overall Study|Medical Monitor Decision|0|||
126320677|NCT00803205|454466285|FG000|Overall Study|Acquired a Lung Infection|0|||
126320678|NCT00803205|454466286|FG001|Overall Study|Acquired a Lung Infection|1|||
126320679|NCT00803205|454466285|FG000|Overall Study|Sponsor Decision|0|||
126320680|NCT00803205|454466286|FG001|Overall Study|Sponsor Decision|1|||
126320681|NCT02735096|454466287|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
126320682|NCT00379808|454466288|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
126320683|NCT00379808|454466289|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
126320684|NCT04299048|454466294|FG000|Overall Study|Death|1|||
126545081|NCT01036022|455289213|FG002|Overall Study|Adverse Event|2|||
126320685|NCT04299048|454466294|FG000|Overall Study|Global deterioration of health status|2|||
126320686|NCT04299048|454466294|FG000|Overall Study|Enrolled and not treated|1|||
126320687|NCT01706575|454466295|FG000|Overall Study|Participant Withdrew Consent|4|||
126320688|NCT01706575|454466295|FG000|Overall Study|Lost to Follow-up|2|||
126320689|NCT01706575|454466295|FG000|Overall Study|Started but not Treated|6|||
126320690|NCT02536781|454466312|FG000|Overall Study|Lost to Follow-up|2|||
126320691|NCT02536781|454466313|FG001|Overall Study|Lost to Follow-up|0|||
126320692|NCT02069093|454466314|FG000|Overall Study|Disease progression|14|||
126320693|NCT02069093|454466314|FG000|Overall Study|New cancer therapy|1|||
126320694|NCT02069093|454466314|FG000|Overall Study|Death|1|||
126320695|NCT02069093|454466314|FG000|Overall Study|Administrative problems|1|||
126320696|NCT02069093|454466314|FG000|Overall Study|Withdrawal by Subject|2|||
126320697|NCT02069093|454466314|FG000|Overall Study|Abnormal laboratory values|1|||
126320698|NCT02069093|454466314|FG000|Overall Study|Adverse Event|10|||
126320699|NCT02028169|454466315|FG000|Overall Study|Lost to Follow-up|21|||
126320700|NCT02028169|454466315|FG000|Overall Study|Lack of Efficacy|2|||
126320701|NCT02028169|454466315|FG000|Overall Study|Withdrawal by Subject|2|||
126320702|NCT02028169|454466315|FG000|Overall Study|Adverse Event|1|||
126320703|NCT02028169|454466315|FG000|Overall Study|Cessation of Drug|1|||
126320704|NCT02028169|454466315|FG000|Overall Study|Concomitant Medication Usage|1|||
126320705|NCT02258334|454466316|FG000|Overall Study|Adverse Event|1|||
126320706|NCT02258334|454466317|FG001|Overall Study|Adverse Event|0|||
126320707|NCT02258334|454466318|FG002|Overall Study|Adverse Event|0|||
126320708|NCT02258334|454466319|FG003|Overall Study|Adverse Event|0|||
126320709|NCT01969084|454466320|FG000|Overall Study|Adverse Event|0|||
126320710|NCT01969084|454466321|FG001|Overall Study|Adverse Event|1|||
126320711|NCT00862459|454466322|FG000|Overall Study|Lost to Follow-up|1|||
126320712|NCT00862459|454466323|FG001|Overall Study|Lost to Follow-up|2|||
126320713|NCT00862459|454466324|FG002|Overall Study|Lost to Follow-up|2|||
126320714|NCT00862459|454466322|FG000|Overall Study|Protocol Violation|1|||
126320715|NCT00862459|454466323|FG001|Overall Study|Protocol Violation|0|||
126651002|NCT01022112|455678336|FG004|Overall Study|Adverse Event|0|||
126320716|NCT00862459|454466324|FG002|Overall Study|Protocol Violation|0|||
126320717|NCT00862459|454466322|FG000|Overall Study|Withdrawal by Subject|1|||
126320718|NCT00862459|454466323|FG001|Overall Study|Withdrawal by Subject|1|||
126320719|NCT00862459|454466324|FG002|Overall Study|Withdrawal by Subject|3|||
126320720|NCT00862459|454466322|FG000|Overall Study|Adverse Event|0|||
126320721|NCT00862459|454466323|FG001|Overall Study|Adverse Event|1|||
126320722|NCT00862459|454466324|FG002|Overall Study|Adverse Event|0|||
126320723|NCT00862459|454466322|FG000|Overall Study|Personal reasons|1|||
126320724|NCT00862459|454466323|FG001|Overall Study|Personal reasons|0|||
126320725|NCT00862459|454466324|FG002|Overall Study|Personal reasons|0|||
126320726|NCT00862459|454466322|FG000|Overall Study|Operation|1|||
126320727|NCT00862459|454466323|FG001|Overall Study|Operation|1|||
126320728|NCT00862459|454466324|FG002|Overall Study|Operation|0|||
126320729|NCT00862459|454466322|FG000|Overall Study|Intravenous (IV) site problems|1|||
126320730|NCT00862459|454466323|FG001|Overall Study|Intravenous (IV) site problems|0|||
126320731|NCT00862459|454466324|FG002|Overall Study|Intravenous (IV) site problems|1|||
126320732|NCT00862459|454466322|FG000|Overall Study|Unable to hold still for imaging|0|||
126320733|NCT00862459|454466323|FG001|Overall Study|Unable to hold still for imaging|1|||
126320734|NCT00862459|454466324|FG002|Overall Study|Unable to hold still for imaging|0|||
126320735|NCT00862459|454466322|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
126320736|NCT00862459|454466323|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
126320737|NCT00862459|454466324|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
126320738|NCT00862459|454466322|FG000|Overall Study|Administrative problems|0|||
126320739|NCT00862459|454466323|FG001|Overall Study|Administrative problems|1|||
126320740|NCT00862459|454466324|FG002|Overall Study|Administrative problems|0|||
126320741|NCT04907227|454466331|FG000|Overall Study|Death|12|||
126320742|NCT04907227|454466332|FG001|Overall Study|Death|8|||
126320743|NCT04907227|454466331|FG000|Overall Study|Withdrawal by Subject|2|||
126320744|NCT04907227|454466332|FG001|Overall Study|Withdrawal by Subject|2|||
126651003|NCT01022112|455678332|FG000|Overall Study|Lack of Efficacy|1|||
126320745|NCT04907227|454466331|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
126320746|NCT04907227|454466332|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
126320747|NCT04907227|454466331|FG000|Overall Study|Sponsor Decision|25|||
126320748|NCT04907227|454466332|FG001|Overall Study|Sponsor Decision|30|||
126320749|NCT04907227|454466331|FG000|Overall Study|Physician Decision|1|||
126320750|NCT04907227|454466332|FG001|Overall Study|Physician Decision|0|||
126320751|NCT02240069|454466333|FG000|Overall Study|Withdrawal by Subject|5|||
126320752|NCT02240069|454466334|FG001|Overall Study|Withdrawal by Subject|5|||
126320753|NCT02240069|454466335|FG002|Overall Study|Withdrawal by Subject|2|||
126320754|NCT03723070|454466336|FG000|Overall Study|Lost to Follow-up|2|||
126320755|NCT03723070|454466336|FG000|Overall Study|Physician Decision|1|||
126320756|NCT03723070|454466336|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
126320757|NCT02208050|454466337|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
126320758|NCT02208050|454466338|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
126320759|NCT02134353|454466339|FG000|Overall Study|Adverse Event|10|||
126320760|NCT02134353|454466340|FG001|Overall Study|Adverse Event|6|||
126320761|NCT02134353|454466339|FG000|Overall Study|Lost to Follow-up|1|||
126651004|NCT01022112|455678333|FG001|Overall Study|Lack of Efficacy|0|||
126320762|NCT02134353|454466340|FG001|Overall Study|Lost to Follow-up|1|||
126320763|NCT02134353|454466339|FG000|Overall Study|Lack of Efficacy|2|||
126320764|NCT02134353|454466340|FG001|Overall Study|Lack of Efficacy|1|||
126320765|NCT02134353|454466339|FG000|Overall Study|Withdrawal by Subject|12|||
126320766|NCT02134353|454466340|FG001|Overall Study|Withdrawal by Subject|13|||
126320767|NCT02134353|454466339|FG000|Overall Study|Death|0|||
126320768|NCT02134353|454466340|FG001|Overall Study|Death|1|||
126320769|NCT02134353|454466339|FG000|Overall Study|Pregnancy|0|||
126320770|NCT02134353|454466340|FG001|Overall Study|Pregnancy|1|||
126320771|NCT02134353|454466339|FG000|Overall Study|Relocation|1|||
126320772|NCT02134353|454466340|FG001|Overall Study|Relocation|0|||
126320773|NCT02134353|454466339|FG000|Overall Study|Other - Patient's Choice|0|||
126320774|NCT02134353|454466340|FG001|Overall Study|Other - Patient's Choice|1|||
126320775|NCT00474786|454466342|FG000|Overall Study|Not Meeting Study Criteria|0|||
126320776|NCT00474786|454466343|FG001|Overall Study|Not Meeting Study Criteria|1|||
126320777|NCT00474786|454466342|FG000|Overall Study|Investigator Request|2|||
126320778|NCT00474786|454466343|FG001|Overall Study|Investigator Request|1|||
126320779|NCT00474786|454466342|FG000|Overall Study|Death|189|||
126320780|NCT00474786|454466343|FG001|Overall Study|Death|170|||
126320781|NCT00474786|454466342|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
126320782|NCT00474786|454466343|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
126320783|NCT00474786|454466342|FG000|Overall Study|Lost to Follow-up|4|||
126320784|NCT00474786|454466343|FG001|Overall Study|Lost to Follow-up|7|||
126320785|NCT00474786|454466342|FG000|Overall Study|Protocol Violation|2|||
126320786|NCT00474786|454466343|FG001|Overall Study|Protocol Violation|0|||
126320787|NCT00474786|454466342|FG000|Overall Study|Withdrawal by Subject|15|||
126320788|NCT00474786|454466343|FG001|Overall Study|Withdrawal by Subject|15|||
126320789|NCT00474786|454466342|FG000|Overall Study|Other|5|||
126320790|NCT00474786|454466343|FG001|Overall Study|Other|0|||
126320791|NCT00358956|454466344|FG000|Overall Study|Adverse Event|3|||
126320792|NCT00358956|454466344|FG000|Overall Study|condition under investigation worsened|4|||
126320793|NCT00358956|454466344|FG000|Overall Study|Withdrawal by Subject|1|||
126320794|NCT04776018|454466345|FG000|Overall Study|Death|0|||
126320795|NCT04776018|454466346|FG001|Overall Study|Death|1|||
126320796|NCT04776018|454466347|FG002|Overall Study|Death|4|||
126320797|NCT04776018|454466348|FG003|Overall Study|Death|1|||
126320798|NCT04776018|454466349|FG004|Overall Study|Death|4|||
126320799|NCT04776018|454466350|FG005|Overall Study|Death|0|||
126320800|NCT04776018|454466351|FG006|Overall Study|Death|0|||
126320801|NCT04776018|454466345|FG000|Overall Study|Study terminated by sponsor|2|||
126320802|NCT04776018|454466346|FG001|Overall Study|Study terminated by sponsor|1|||
126320803|NCT04776018|454466347|FG002|Overall Study|Study terminated by sponsor|4|||
126320804|NCT04776018|454466348|FG003|Overall Study|Study terminated by sponsor|0|||
126320805|NCT04776018|454466349|FG004|Overall Study|Study terminated by sponsor|3|||
126320806|NCT04776018|454466350|FG005|Overall Study|Study terminated by sponsor|0|||
126320807|NCT04776018|454466351|FG006|Overall Study|Study terminated by sponsor|0|||
126320808|NCT04776018|454466345|FG000|Overall Study|Withdrawal by Subject|1|||
126320809|NCT04776018|454466346|FG001|Overall Study|Withdrawal by Subject|0|||
126320810|NCT04776018|454466347|FG002|Overall Study|Withdrawal by Subject|0|||
126320811|NCT04776018|454466348|FG003|Overall Study|Withdrawal by Subject|2|||
126320812|NCT04776018|454466349|FG004|Overall Study|Withdrawal by Subject|1|||
126320813|NCT04776018|454466350|FG005|Overall Study|Withdrawal by Subject|0|||
126320814|NCT04776018|454466351|FG006|Overall Study|Withdrawal by Subject|0|||
126320815|NCT04776018|454466345|FG000|Overall Study|Other|0|||
126320816|NCT04776018|454466346|FG001|Overall Study|Other|1|||
126320817|NCT04776018|454466347|FG002|Overall Study|Other|1|||
126320818|NCT04776018|454466348|FG003|Overall Study|Other|0|||
126320819|NCT04776018|454466349|FG004|Overall Study|Other|0|||
126320820|NCT04776018|454466350|FG005|Overall Study|Other|0|||
126320821|NCT04776018|454466351|FG006|Overall Study|Other|0|||
126320822|NCT04776018|454466345|FG000|Overall Study|Lost to Follow-up|0|||
126320823|NCT04776018|454466346|FG001|Overall Study|Lost to Follow-up|0|||
126320824|NCT04776018|454466347|FG002|Overall Study|Lost to Follow-up|1|||
126320825|NCT04776018|454466348|FG003|Overall Study|Lost to Follow-up|0|||
126320826|NCT04776018|454466349|FG004|Overall Study|Lost to Follow-up|0|||
126320827|NCT04776018|454466350|FG005|Overall Study|Lost to Follow-up|0|||
126651005|NCT01022112|455678334|FG002|Overall Study|Lack of Efficacy|0|||
126651006|NCT01022112|455678335|FG003|Overall Study|Lack of Efficacy|0|||
126651007|NCT01022112|455678336|FG004|Overall Study|Lack of Efficacy|1|||
126651008|NCT01022112|455678332|FG000|Overall Study|Physician Decision|0|||
126320828|NCT04776018|454466351|FG006|Overall Study|Lost to Follow-up|0|||
126320829|NCT02908074|454466353|FG000|Overall Study|sponsor/ICON decision|0|||
126320830|NCT02908074|454466354|FG001|Overall Study|sponsor/ICON decision|0|||
126320831|NCT02908074|454466355|FG002|Overall Study|sponsor/ICON decision|1|||
126651009|NCT01022112|455678333|FG001|Overall Study|Physician Decision|0|||
126651010|NCT01022112|455678334|FG002|Overall Study|Physician Decision|1|||
126651011|NCT01022112|455678335|FG003|Overall Study|Physician Decision|0|||
126320832|NCT02908074|454466356|FG003|Overall Study|sponsor/ICON decision|0|||
126320833|NCT02908074|454466357|FG004|Overall Study|sponsor/ICON decision|0|||
126320834|NCT02908074|454466358|FG005|Overall Study|sponsor/ICON decision|0|||
126320835|NCT02908074|454466353|FG000|Overall Study|Protocol Violation|0|||
126320836|NCT02908074|454466354|FG001|Overall Study|Protocol Violation|1|||
126320837|NCT02908074|454466355|FG002|Overall Study|Protocol Violation|0|||
126320838|NCT02908074|454466356|FG003|Overall Study|Protocol Violation|0|||
126320839|NCT02908074|454466357|FG004|Overall Study|Protocol Violation|0|||
126320840|NCT02908074|454466358|FG005|Overall Study|Protocol Violation|0|||
126320841|NCT02908074|454466353|FG000|Overall Study|Adverse Event|5|||
126320842|NCT02908074|454466354|FG001|Overall Study|Adverse Event|2|||
126320843|NCT02908074|454466355|FG002|Overall Study|Adverse Event|0|||
126320844|NCT02908074|454466356|FG003|Overall Study|Adverse Event|0|||
126320845|NCT02908074|454466357|FG004|Overall Study|Adverse Event|1|||
126320846|NCT02908074|454466358|FG005|Overall Study|Adverse Event|0|||
126320847|NCT02908074|454466353|FG000|Overall Study|AESI|1|||
126320848|NCT02908074|454466354|FG001|Overall Study|AESI|0|||
126320849|NCT02908074|454466355|FG002|Overall Study|AESI|1|||
126320850|NCT02908074|454466356|FG003|Overall Study|AESI|0|||
126320851|NCT02908074|454466357|FG004|Overall Study|AESI|1|||
126320852|NCT02908074|454466358|FG005|Overall Study|AESI|0|||
126320853|NCT02908074|454466353|FG000|Overall Study|Discontinuation criteria per protocol|0|||
126320854|NCT02908074|454466354|FG001|Overall Study|Discontinuation criteria per protocol|0|||
126320855|NCT02908074|454466355|FG002|Overall Study|Discontinuation criteria per protocol|1|||
126320856|NCT02908074|454466356|FG003|Overall Study|Discontinuation criteria per protocol|0|||
126320857|NCT02908074|454466357|FG004|Overall Study|Discontinuation criteria per protocol|0|||
126320858|NCT02908074|454466358|FG005|Overall Study|Discontinuation criteria per protocol|1|||
126320859|NCT02908074|454466353|FG000|Overall Study|Withdrawal by Subject|3|||
126320860|NCT02908074|454466354|FG001|Overall Study|Withdrawal by Subject|2|||
126320861|NCT02908074|454466355|FG002|Overall Study|Withdrawal by Subject|2|||
126320862|NCT02908074|454466356|FG003|Overall Study|Withdrawal by Subject|2|||
126320863|NCT02908074|454466357|FG004|Overall Study|Withdrawal by Subject|2|||
126320864|NCT02908074|454466358|FG005|Overall Study|Withdrawal by Subject|2|||
126320865|NCT02908074|454466353|FG000|Overall Study|Lost to Follow-up|0|||
126320866|NCT02908074|454466354|FG001|Overall Study|Lost to Follow-up|1|||
126320867|NCT02908074|454466355|FG002|Overall Study|Lost to Follow-up|1|||
126320868|NCT02908074|454466356|FG003|Overall Study|Lost to Follow-up|1|||
126320869|NCT02908074|454466357|FG004|Overall Study|Lost to Follow-up|0|||
126320870|NCT02908074|454466358|FG005|Overall Study|Lost to Follow-up|1|||
126320871|NCT02655419|454466363|FG000|Overall Study|Enrolled but not treated|1|||
126320872|NCT02655419|454466364|FG001|Overall Study|Enrolled but not treated|5|||
126320873|NCT02655419|454466363|FG000|Overall Study|Withdrawal by Subject|4|||
126320874|NCT02655419|454466364|FG001|Overall Study|Withdrawal by Subject|1|||
126320875|NCT02655419|454466363|FG000|Overall Study|Other|0|||
126320876|NCT02655419|454466364|FG001|Overall Study|Other|1|||
126320877|NCT03403621|454466365|FG000|Overall Study|Withdrawal by Subject|2|||
126320878|NCT03403621|454466366|FG001|Overall Study|Withdrawal by Subject|2|||
126320879|NCT00583102|454466367|FG000|Overall Study|Adverse Event|3|||
126320880|NCT00505661|454466370|FG000|Overall Study|Not Eligible|4|||
126320881|NCT03611582|454466371|FG000|Overall Study|Adverse Event|26|||
126320882|NCT03611582|454466372|FG001|Overall Study|Adverse Event|6|||
126320883|NCT03611582|454466371|FG000|Overall Study|Protocol Violation|0|||
126320884|NCT03611582|454466372|FG001|Overall Study|Protocol Violation|1|||
126320885|NCT03611582|454466371|FG000|Overall Study|Pregnancy|1|||
126320886|NCT03611582|454466372|FG001|Overall Study|Pregnancy|2|||
126320887|NCT03611582|454466371|FG000|Overall Study|Lack of Efficacy|0|||
126320888|NCT03611582|454466372|FG001|Overall Study|Lack of Efficacy|1|||
126320889|NCT03611582|454466371|FG000|Overall Study|At the discretion of the investigator|1|||
126320890|NCT03611582|454466372|FG001|Overall Study|At the discretion of the investigator|0|||
126320891|NCT03611582|454466371|FG000|Overall Study|Safety concern as judged by the investigator|1|||
126320892|NCT03611582|454466372|FG001|Overall Study|Safety concern as judged by the investigator|2|||
126320893|NCT03611582|454466371|FG000|Overall Study|Withdrawal by Subject|4|||
126320894|NCT03611582|454466372|FG001|Overall Study|Withdrawal by Subject|3|||
126651012|NCT01022112|455678336|FG004|Overall Study|Physician Decision|1|||
126320895|NCT03611582|454466371|FG000|Overall Study|Lost to Follow-up|18|||
126320896|NCT03611582|454466372|FG001|Overall Study|Lost to Follow-up|7|||
126320897|NCT03611582|454466371|FG000|Overall Study|other|17|||
126320898|NCT03611582|454466372|FG001|Overall Study|other|16|||
126320899|NCT04459598|454466373|FG000|Overall Study|Adverse Event|1|||
126320900|NCT04459598|454466374|FG001|Overall Study|Adverse Event|1|||
126320901|NCT01078298|454466375|FG000|Overall Study|Lost to Follow-up|12|||
126320902|NCT01078298|454466376|FG001|Overall Study|Lost to Follow-up|13|||
126651013|NCT01022112|455678332|FG000|Overall Study|Withdrawal by Subject|0|||
126320903|NCT01078298|454466375|FG000|Overall Study|Withdrawal by Subject|31|||
126320904|NCT01078298|454466376|FG001|Overall Study|Withdrawal by Subject|33|||
126320905|NCT01078298|454466375|FG000|Overall Study|Protocol Violation|6|||
126320906|NCT01078298|454466376|FG001|Overall Study|Protocol Violation|6|||
126320907|NCT01078298|454466375|FG000|Overall Study|Adverse Event|6|||
126320908|NCT01078298|454466376|FG001|Overall Study|Adverse Event|5|||
126320909|NCT01078298|454466375|FG000|Overall Study|Death|2|||
126320910|NCT01078298|454466376|FG001|Overall Study|Death|0|||
126651014|NCT01022112|455678333|FG001|Overall Study|Withdrawal by Subject|1|||
126320911|NCT01078298|454466375|FG000|Overall Study|Did not meet entrance criteria|0|||
126320912|NCT01078298|454466376|FG001|Overall Study|Did not meet entrance criteria|1|||
126320913|NCT01078298|454466375|FG000|Overall Study|Other|24|||
126320914|NCT01078298|454466376|FG001|Overall Study|Other|32|||
126320915|NCT00463840|454466377|FG000|Overall Study|Disease progression|7|||
126320916|NCT00463840|454466377|FG000|Overall Study|Withdrawal by Subject|2|||
126320917|NCT00463840|454466377|FG000|Overall Study|Adverse Event|3|||
126320918|NCT00866333|454466378|FG000|Overall Study|Withdrawal of consent|0|||
126320919|NCT00866333|454466379|FG001|Overall Study|Withdrawal of consent|1|||
126320920|NCT00866333|454466380|FG002|Overall Study|Withdrawal of consent|2|||
126320921|NCT00866333|454466378|FG000|Overall Study|Reason not Specified|3|||
126320922|NCT00866333|454466379|FG001|Overall Study|Reason not Specified|1|||
126320923|NCT00866333|454466380|FG002|Overall Study|Reason not Specified|1|||
126320924|NCT00866333|454466378|FG000|Overall Study|Study Terminated by Sponsor|2|||
126320925|NCT00866333|454466379|FG001|Overall Study|Study Terminated by Sponsor|5|||
126320926|NCT00866333|454466380|FG002|Overall Study|Study Terminated by Sponsor|9|||
126320927|NCT01653327|454466381|FG000|Overall Study|Withdrawal by Subject|1|||
126320928|NCT01738191|454466382|FG000|Overall Study|Withdrawal by Subject|4|||
126320929|NCT01738191|454466383|FG001|Overall Study|Withdrawal by Subject|1|||
126320930|NCT00422292|454466384|FG000|Overall Study|Serious adverse events|1|||
126320931|NCT00422292|454466385|FG001|Overall Study|Serious adverse events|4|||
126320932|NCT00422292|454466386|FG002|Overall Study|Serious adverse events|0|||
126320933|NCT00422292|454466387|FG003|Overall Study|Serious adverse events|0|||
126320934|NCT00422292|454466384|FG000|Overall Study|Adverse Event|1|||
126320935|NCT00422292|454466385|FG001|Overall Study|Adverse Event|0|||
126320936|NCT00422292|454466386|FG002|Overall Study|Adverse Event|1|||
126320937|NCT00422292|454466387|FG003|Overall Study|Adverse Event|0|||
126320938|NCT00422292|454466384|FG000|Overall Study|Protocol Violation|4|||
126320939|NCT00422292|454466385|FG001|Overall Study|Protocol Violation|25|||
126320940|NCT00422292|454466386|FG002|Overall Study|Protocol Violation|8|||
126320941|NCT00422292|454466387|FG003|Overall Study|Protocol Violation|5|||
126320942|NCT00422292|454466384|FG000|Overall Study|Lost to Follow-up|6|||
126320943|NCT00422292|454466385|FG001|Overall Study|Lost to Follow-up|12|||
126320944|NCT00422292|454466386|FG002|Overall Study|Lost to Follow-up|6|||
126320945|NCT00422292|454466387|FG003|Overall Study|Lost to Follow-up|6|||
126320946|NCT00422292|454466384|FG000|Overall Study|Withdrawal by Subject|6|||
126320947|NCT00422292|454466385|FG001|Overall Study|Withdrawal by Subject|25|||
126320948|NCT00422292|454466386|FG002|Overall Study|Withdrawal by Subject|7|||
126320949|NCT00422292|454466387|FG003|Overall Study|Withdrawal by Subject|13|||
126320950|NCT02243046|454466388|FG000|Overall Study|Lost to Follow-up|1|||
126320951|NCT02243046|454466389|FG001|Overall Study|Lost to Follow-up|1|||
126320952|NCT02243046|454466390|FG002|Overall Study|Lost to Follow-up|4|||
126320953|NCT03338569|454466391|FG000|Overall Study|Physician Decision|8|||
126320954|NCT03338569|454466392|FG001|Overall Study|Physician Decision|3|||
126320955|NCT03338569|454466391|FG000|Overall Study|Withdrawal by Subject|0|||
126320956|NCT03338569|454466392|FG001|Overall Study|Withdrawal by Subject|1|||
126320957|NCT03338569|454466391|FG000|Overall Study|Lost to Follow-up|0|||
126320958|NCT03338569|454466392|FG001|Overall Study|Lost to Follow-up|1|||
126320959|NCT04607980|454466393|FG000|Overall Study|Adverse Event|3|||
126320960|NCT04607980|454466394|FG001|Overall Study|Adverse Event|4|||
126320961|NCT04607980|454466393|FG000|Overall Study|Death|0|||
126320962|NCT04607980|454466394|FG001|Overall Study|Death|1|||
126320963|NCT04607980|454466393|FG000|Overall Study|Withdrawal by Subject|2|||
126320964|NCT04607980|454466394|FG001|Overall Study|Withdrawal by Subject|5|||
126320965|NCT04607980|454466393|FG000|Overall Study|Lost to Follow-up|4|||
126320966|NCT04607980|454466394|FG001|Overall Study|Lost to Follow-up|8|||
126320967|NCT04607980|454466393|FG000|Overall Study|Protocol Violation|0|||
126320968|NCT04607980|454466394|FG001|Overall Study|Protocol Violation|3|||
126320969|NCT04607980|454466393|FG000|Overall Study|Other|3|||
126320970|NCT04607980|454466394|FG001|Overall Study|Other|0|||
126320971|NCT02109445|454466397|FG000|Overall Study|Symptomatic deterioration|2|||
126320972|NCT02109445|454466397|FG000|Overall Study|Adverse Event|1|||
126320973|NCT00441363|454467602|FG000|Overall Study|Adverse Event|4|||
126320974|NCT00441363|454467603|FG001|Overall Study|Adverse Event|2|||
126320975|NCT00441363|454467602|FG000|Overall Study|Withdrawal by Subject|3|||
126320976|NCT00441363|454467603|FG001|Overall Study|Withdrawal by Subject|4|||
126320977|NCT00441363|454467602|FG000|Overall Study|Physician Decision|6|||
126320978|NCT00441363|454467603|FG001|Overall Study|Physician Decision|7|||
126320979|NCT00441363|454467602|FG000|Overall Study|Lost to Follow-up|2|||
126320980|NCT00441363|454467603|FG001|Overall Study|Lost to Follow-up|2|||
126320981|NCT00441363|454467602|FG000|Overall Study|Other|2|||
126320982|NCT00441363|454467603|FG001|Overall Study|Other|0|||
126320983|NCT02474355|454467609|FG000|Overall Study|Other|43|||
126320984|NCT02474355|454467609|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
126320985|NCT02474355|454467609|FG000|Overall Study|Lost to Follow-up|98|||
126320986|NCT02474355|454467609|FG000|Overall Study|Withdrawal by Subject|124|||
126320987|NCT02474355|454467609|FG000|Overall Study|Death|1361|||
126320988|NCT01066793|454467610|FG000|Overall Study|Death|4|||
126320989|NCT01066793|454467611|FG001|Overall Study|Death|1|||
126320990|NCT01066793|454467612|FG002|Overall Study|Death|1|||
126320991|NCT01066793|454467613|FG003|Overall Study|Death|0|||
126320992|NCT01066793|454467614|FG004|Overall Study|Death|0|||
126320993|NCT01066793|454467615|FG005|Overall Study|Death|0|||
126320994|NCT01066793|454467610|FG000|Overall Study|Lack of Efficacy|2|||
126320995|NCT01066793|454467611|FG001|Overall Study|Lack of Efficacy|1|||
126320996|NCT01066793|454467612|FG002|Overall Study|Lack of Efficacy|0|||
126320997|NCT01066793|454467613|FG003|Overall Study|Lack of Efficacy|0|||
126320998|NCT01066793|454467614|FG004|Overall Study|Lack of Efficacy|0|||
126320999|NCT01066793|454467615|FG005|Overall Study|Lack of Efficacy|0|||
126321000|NCT01066793|454467610|FG000|Overall Study|Lost to Follow-up|180|||
126321001|NCT01066793|454467611|FG001|Overall Study|Lost to Follow-up|39|||
126321002|NCT01066793|454467612|FG002|Overall Study|Lost to Follow-up|82|||
126321003|NCT01066793|454467613|FG003|Overall Study|Lost to Follow-up|16|||
126321004|NCT01066793|454467614|FG004|Overall Study|Lost to Follow-up|0|||
126321005|NCT01066793|454467615|FG005|Overall Study|Lost to Follow-up|1|||
126321006|NCT01066793|454467610|FG000|Overall Study|Physician Decision|3|||
126321007|NCT01066793|454467611|FG001|Overall Study|Physician Decision|0|||
126321008|NCT01066793|454467612|FG002|Overall Study|Physician Decision|0|||
126321009|NCT01066793|454467613|FG003|Overall Study|Physician Decision|0|||
126321010|NCT01066793|454467614|FG004|Overall Study|Physician Decision|0|||
126321011|NCT01066793|454467615|FG005|Overall Study|Physician Decision|0|||
126321012|NCT01066793|454467610|FG000|Overall Study|Protocol Violation|3|||
126321013|NCT01066793|454467611|FG001|Overall Study|Protocol Violation|2|||
126321014|NCT01066793|454467612|FG002|Overall Study|Protocol Violation|2|||
126321015|NCT01066793|454467613|FG003|Overall Study|Protocol Violation|0|||
126321016|NCT01066793|454467614|FG004|Overall Study|Protocol Violation|0|||
126321017|NCT01066793|454467615|FG005|Overall Study|Protocol Violation|0|||
126321018|NCT01066793|454467610|FG000|Overall Study|Withdrawal by Subject|7|||
126321019|NCT01066793|454467611|FG001|Overall Study|Withdrawal by Subject|4|||
126321020|NCT01066793|454467612|FG002|Overall Study|Withdrawal by Subject|1|||
126321021|NCT01066793|454467613|FG003|Overall Study|Withdrawal by Subject|0|||
126321022|NCT01066793|454467614|FG004|Overall Study|Withdrawal by Subject|0|||
126321023|NCT01066793|454467615|FG005|Overall Study|Withdrawal by Subject|0|||
126321024|NCT01066793|454467610|FG000|Overall Study|Early Termination|3|||
126321025|NCT01066793|454467611|FG001|Overall Study|Early Termination|0|||
126321026|NCT01066793|454467612|FG002|Overall Study|Early Termination|0|||
126321027|NCT01066793|454467613|FG003|Overall Study|Early Termination|0|||
126321028|NCT01066793|454467614|FG004|Overall Study|Early Termination|0|||
126321029|NCT01066793|454467615|FG005|Overall Study|Early Termination|0|||
126321030|NCT01066793|454467610|FG000|Overall Study|Lab test not done|7|||
126321031|NCT01066793|454467611|FG001|Overall Study|Lab test not done|0|||
126321032|NCT01066793|454467612|FG002|Overall Study|Lab test not done|0|||
126321033|NCT01066793|454467613|FG003|Overall Study|Lab test not done|1|||
126321034|NCT01066793|454467614|FG004|Overall Study|Lab test not done|0|||
126321035|NCT01066793|454467615|FG005|Overall Study|Lab test not done|0|||
126321036|NCT01066793|454467610|FG000|Overall Study|Miscellaneous|4|||
126321037|NCT01066793|454467611|FG001|Overall Study|Miscellaneous|5|||
126321038|NCT01066793|454467612|FG002|Overall Study|Miscellaneous|6|||
126321039|NCT01066793|454467613|FG003|Overall Study|Miscellaneous|0|||
126321040|NCT01066793|454467614|FG004|Overall Study|Miscellaneous|0|||
126321041|NCT01066793|454467615|FG005|Overall Study|Miscellaneous|0|||
126321042|NCT01066793|454467610|FG000|Overall Study|Non-responders|104|||
126321043|NCT01066793|454467611|FG001|Overall Study|Non-responders|5|||
126321044|NCT01066793|454467612|FG002|Overall Study|Non-responders|11|||
126321045|NCT01066793|454467613|FG003|Overall Study|Non-responders|25|||
126321046|NCT01066793|454467614|FG004|Overall Study|Non-responders|0|||
126321047|NCT01066793|454467615|FG005|Overall Study|Non-responders|0|||
126321048|NCT01066793|454467610|FG000|Overall Study|Other|15|||
126321049|NCT01066793|454467611|FG001|Overall Study|Other|5|||
126321050|NCT01066793|454467612|FG002|Overall Study|Other|6|||
126321051|NCT01066793|454467613|FG003|Overall Study|Other|2|||
126321052|NCT01066793|454467614|FG004|Overall Study|Other|0|||
126321053|NCT01066793|454467615|FG005|Overall Study|Other|0|||
126321054|NCT01066793|454467610|FG000|Overall Study|Relapse|20|||
126321055|NCT01066793|454467611|FG001|Overall Study|Relapse|8|||
126321056|NCT01066793|454467612|FG002|Overall Study|Relapse|2|||
126321057|NCT01066793|454467613|FG003|Overall Study|Relapse|3|||
126321058|NCT01066793|454467614|FG004|Overall Study|Relapse|0|||
126321059|NCT01066793|454467615|FG005|Overall Study|Relapse|0|||
126321060|NCT01066793|454467610|FG000|Overall Study|Result Not Available|1|||
126321061|NCT01066793|454467611|FG001|Overall Study|Result Not Available|0|||
126321062|NCT01066793|454467612|FG002|Overall Study|Result Not Available|0|||
126321063|NCT01066793|454467613|FG003|Overall Study|Result Not Available|0|||
126321064|NCT01066793|454467614|FG004|Overall Study|Result Not Available|0|||
126321065|NCT01066793|454467615|FG005|Overall Study|Result Not Available|0|||
126321066|NCT01066793|454467610|FG000|Overall Study|Treatment Interrupted|1|||
126321067|NCT01066793|454467611|FG001|Overall Study|Treatment Interrupted|1|||
126321068|NCT01066793|454467612|FG002|Overall Study|Treatment Interrupted|0|||
126321069|NCT01066793|454467613|FG003|Overall Study|Treatment Interrupted|0|||
126321070|NCT01066793|454467614|FG004|Overall Study|Treatment Interrupted|0|||
126321071|NCT01066793|454467615|FG005|Overall Study|Treatment Interrupted|0|||
126321072|NCT01066793|454467610|FG000|Overall Study|Treatment Never Started|18|||
126321073|NCT01066793|454467611|FG001|Overall Study|Treatment Never Started|5|||
126321074|NCT01066793|454467612|FG002|Overall Study|Treatment Never Started|4|||
126321075|NCT01066793|454467613|FG003|Overall Study|Treatment Never Started|1|||
126321076|NCT01066793|454467614|FG004|Overall Study|Treatment Never Started|0|||
126321077|NCT01066793|454467615|FG005|Overall Study|Treatment Never Started|0|||
126321078|NCT01066793|454467610|FG000|Overall Study|Treatment Stopped|2|||
126321079|NCT01066793|454467611|FG001|Overall Study|Treatment Stopped|1|||
126321080|NCT01066793|454467612|FG002|Overall Study|Treatment Stopped|0|||
126321081|NCT01066793|454467613|FG003|Overall Study|Treatment Stopped|1|||
126321082|NCT01066793|454467614|FG004|Overall Study|Treatment Stopped|0|||
126321083|NCT01066793|454467615|FG005|Overall Study|Treatment Stopped|0|||
126321084|NCT01911793|454467616|FG000|Overall Study|Physician Decision|1|||
126321085|NCT01911793|454467617|FG001|Overall Study|Physician Decision|5|||
126321086|NCT01313221|454467620|FG000|Overall Study|Protocol Violation|0|||
126321087|NCT01313221|454467621|FG001|Overall Study|Protocol Violation|1|||
126321088|NCT01313221|454467622|FG002|Overall Study|Protocol Violation|1|||
126321089|NCT01313221|454467620|FG000|Overall Study|Non-compliance|3|||
126321090|NCT01313221|454467621|FG001|Overall Study|Non-compliance|0|||
126321091|NCT01313221|454467622|FG002|Overall Study|Non-compliance|2|||
126321092|NCT01313221|454467620|FG000|Overall Study|Withdrawal by Subject|2|||
126321093|NCT01313221|454467621|FG001|Overall Study|Withdrawal by Subject|3|||
126321094|NCT01313221|454467622|FG002|Overall Study|Withdrawal by Subject|5|||
126321095|NCT01313221|454467620|FG000|Overall Study|Requirement for alternative therapy|0|||
126321096|NCT01313221|454467621|FG001|Overall Study|Requirement for alternative therapy|1|||
126321097|NCT01313221|454467622|FG002|Overall Study|Requirement for alternative therapy|1|||
126321098|NCT01313221|454467620|FG000|Overall Study|Lost to Follow-up|6|||
126321099|NCT01313221|454467621|FG001|Overall Study|Lost to Follow-up|3|||
126321100|NCT01313221|454467622|FG002|Overall Study|Lost to Follow-up|1|||
126321101|NCT01313221|454467620|FG000|Overall Study|Other|1|||
126321102|NCT01313221|454467621|FG001|Overall Study|Other|0|||
126321103|NCT01313221|454467622|FG002|Overall Study|Other|0|||
126321104|NCT01313221|454467620|FG000|Overall Study|Adverse Event|0|||
126321105|NCT01313221|454467621|FG001|Overall Study|Adverse Event|0|||
126321106|NCT01313221|454467622|FG002|Overall Study|Adverse Event|7|||
126321107|NCT01313221|454467620|FG000|Overall Study|Disease progression|0|||
126321108|NCT01313221|454467621|FG001|Overall Study|Disease progression|0|||
126321109|NCT01313221|454467622|FG002|Overall Study|Disease progression|2|||
126321110|NCT01313221|454467620|FG000|Overall Study|Physician Decision|0|||
126321111|NCT01313221|454467621|FG001|Overall Study|Physician Decision|0|||
126321112|NCT01313221|454467622|FG002|Overall Study|Physician Decision|2|||
126321113|NCT01313221|454467620|FG000|Overall Study|Pregnancy|0|||
126321114|NCT01313221|454467621|FG001|Overall Study|Pregnancy|0|||
126321115|NCT01313221|454467622|FG002|Overall Study|Pregnancy|2|||
126321116|NCT00994214|454467623|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
126321117|NCT00994214|454467624|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
126321118|NCT00994214|454467625|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
126321119|NCT00994214|454467626|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
126321120|NCT00994214|454467623|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
126321121|NCT00994214|454467624|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
126321122|NCT00994214|454467625|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
126321123|NCT00994214|454467626|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
126321124|NCT00994214|454467623|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
126321125|NCT00994214|454467624|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
126321126|NCT00994214|454467625|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
126321127|NCT00994214|454467626|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
126321128|NCT00994214|454467623|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
126321129|NCT00994214|454467624|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
126321130|NCT00994214|454467625|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
126321131|NCT00994214|454467626|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
126321132|NCT00994214|454467623|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
126321133|NCT00994214|454467624|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
126321134|NCT00994214|454467625|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
126321135|NCT00994214|454467626|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
126321136|NCT00994214|454467623|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
126321137|NCT00994214|454467624|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
126321138|NCT00994214|454467625|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
126321139|NCT00994214|454467626|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
126321140|NCT02636699|454467634|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
126321141|NCT02636699|454467635|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
126321142|NCT02636699|454467636|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
126545082|NCT01036022|455289214|FG003|Overall Study|Adverse Event|1|||
126545083|NCT01036022|455289215|FG004|Overall Study|Adverse Event|0|||
126321143|NCT02636699|454467634|FG000|Screening Period|Withdrawal by Subject|0|||
126321144|NCT02636699|454467635|FG001|Screening Period|Withdrawal by Subject|0|||
126321145|NCT02636699|454467636|FG002|Screening Period|Withdrawal by Subject|23|||
126321146|NCT02636699|454467634|FG000|Screening Period|Adverse Event|0|||
126321147|NCT02636699|454467635|FG001|Screening Period|Adverse Event|0|||
126321148|NCT02636699|454467636|FG002|Screening Period|Adverse Event|1|||
126321149|NCT02636699|454467634|FG000|Screening Period|Other not specified|0|||
126321150|NCT02636699|454467635|FG001|Screening Period|Other not specified|0|||
126321151|NCT02636699|454467636|FG002|Screening Period|Other not specified|3|||
126321152|NCT02636699|454467634|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
126321153|NCT02636699|454467635|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
126321154|NCT02636699|454467636|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
126321155|NCT02636699|454467634|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
126321156|NCT02636699|454467635|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
126321157|NCT02636699|454467636|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
126321158|NCT02636699|454467634|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
126321159|NCT02636699|454467635|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
126321160|NCT02636699|454467636|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
126321161|NCT02636699|454467634|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
126321162|NCT02636699|454467635|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
126321163|NCT02636699|454467636|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
126321164|NCT02636699|454467634|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
126321165|NCT02636699|454467635|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
126321166|NCT02636699|454467636|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
126321167|NCT02636699|454467634|FG000|Treatment and Follow-up Periods|Other|3|||
126321168|NCT02636699|454467635|FG001|Treatment and Follow-up Periods|Other|1|||
126321169|NCT02636699|454467636|FG002|Treatment and Follow-up Periods|Other|0|||
126321170|NCT02305446|454467645|FG000|Overall Study|Adverse Event|1|||
126321171|NCT01636947|454467646|FG000|Overall Study|Not Treated|2|||
126321172|NCT01636947|454467647|FG001|Overall Study|Not Treated|2|||
126321173|NCT01636947|454467646|FG000|Overall Study|Lost to Follow-up|4|||
126321174|NCT01636947|454467647|FG001|Overall Study|Lost to Follow-up|0|||
126321175|NCT01636947|454467646|FG000|Overall Study|Protocol Violation|1|||
126321176|NCT01636947|454467647|FG001|Overall Study|Protocol Violation|1|||
126321177|NCT01636947|454467646|FG000|Overall Study|Withdrawal by Subject|3|||
126321178|NCT01636947|454467647|FG001|Overall Study|Withdrawal by Subject|3|||
126321179|NCT01636947|454467646|FG000|Overall Study|Adverse Event|1|||
126321180|NCT01636947|454467647|FG001|Overall Study|Adverse Event|1|||
126321181|NCT01636947|454467646|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
126321182|NCT01636947|454467647|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
126321183|NCT00957424|454467648|FG000|Overall Study|Lost to Follow-up|19|||
126321184|NCT00957424|454467648|FG000|Overall Study|Protocol Violation|3|||
126321185|NCT00957424|454467648|FG000|Overall Study|Withdrawal by Subject|1|||
126321186|NCT05182606|454467656|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
126321187|NCT01955109|454467659|FG000|Overall Study|Adverse Event|2|||
126321188|NCT01955109|454467660|FG001|Overall Study|Adverse Event|0|||
126321189|NCT01955109|454467659|FG000|Overall Study|Participant unwilling to continue|35|||
126321190|NCT01955109|454467660|FG001|Overall Study|Participant unwilling to continue|7|||
126321191|NCT01955109|454467659|FG000|Overall Study|Physician Decision|2|||
126321192|NCT01955109|454467660|FG001|Overall Study|Physician Decision|0|||
126321193|NCT01955109|454467659|FG000|Overall Study|Lost to Follow-up|3|||
126321194|NCT01955109|454467660|FG001|Overall Study|Lost to Follow-up|1|||
126321195|NCT01955109|454467659|FG000|Overall Study|Non-compliance|3|||
126321196|NCT01955109|454467660|FG001|Overall Study|Non-compliance|1|||
126321197|NCT01618916|454467662|FG000|Overall Study|Adverse Event|1|||
126321198|NCT01618916|454467663|FG001|Overall Study|Adverse Event|0|||
126321199|NCT01618916|454467664|FG002|Overall Study|Adverse Event|0|||
126321200|NCT01618916|454467665|FG003|Overall Study|Adverse Event|0|||
126321201|NCT01618916|454467666|FG004|Overall Study|Adverse Event|0|||
126321202|NCT01618916|454467667|FG005|Overall Study|Adverse Event|0|||
126321203|NCT01618916|454467662|FG000|Overall Study|Withdrawal by Subject|0|||
126321204|NCT01618916|454467663|FG001|Overall Study|Withdrawal by Subject|1|||
126321205|NCT01618916|454467664|FG002|Overall Study|Withdrawal by Subject|1|||
126321206|NCT01618916|454467665|FG003|Overall Study|Withdrawal by Subject|0|||
126651015|NCT01022112|455678334|FG002|Overall Study|Withdrawal by Subject|2|||
126651016|NCT01022112|455678335|FG003|Overall Study|Withdrawal by Subject|2|||
126321207|NCT01618916|454467666|FG004|Overall Study|Withdrawal by Subject|1|||
126321208|NCT01618916|454467667|FG005|Overall Study|Withdrawal by Subject|0|||
126321209|NCT01618916|454467662|FG000|Overall Study|Lost to Follow-up|1|||
126321210|NCT01618916|454467663|FG001|Overall Study|Lost to Follow-up|0|||
126321211|NCT01618916|454467664|FG002|Overall Study|Lost to Follow-up|0|||
126321212|NCT01618916|454467665|FG003|Overall Study|Lost to Follow-up|2|||
126321213|NCT01618916|454467666|FG004|Overall Study|Lost to Follow-up|0|||
126321214|NCT01618916|454467667|FG005|Overall Study|Lost to Follow-up|0|||
126321215|NCT04521114|454467668|FG000|Overall Study|Lost to Follow-up|1|||
126321216|NCT04521114|454467669|FG001|Overall Study|Lost to Follow-up|2|||
126321217|NCT04521114|454467670|FG002|Overall Study|Lost to Follow-up|0|||
126321218|NCT04521114|454467668|FG000|Overall Study|Withdrawal by Subject|1|||
126321219|NCT04521114|454467669|FG001|Overall Study|Withdrawal by Subject|2|||
126321220|NCT04521114|454467670|FG002|Overall Study|Withdrawal by Subject|2|||
126321221|NCT04521114|454467668|FG000|Overall Study|Adverse Event|1|||
126321222|NCT04521114|454467669|FG001|Overall Study|Adverse Event|0|||
126321223|NCT04521114|454467670|FG002|Overall Study|Adverse Event|0|||
126321224|NCT04521114|454467668|FG000|Overall Study|Sponsor Wish|1|||
126321225|NCT04521114|454467669|FG001|Overall Study|Sponsor Wish|0|||
126321226|NCT04521114|454467670|FG002|Overall Study|Sponsor Wish|0|||
126321227|NCT04521114|454467668|FG000|Overall Study|Withdrawal of Consent|2|||
126321228|NCT04521114|454467669|FG001|Overall Study|Withdrawal of Consent|2|||
126321229|NCT04521114|454467670|FG002|Overall Study|Withdrawal of Consent|0|||
126321230|NCT01133288|454467673|FG000|Eligibility Assessment|met exclusion criteria|5|||
126321231|NCT01133288|454467673|FG000|Intervention Allocation|study terminated|2|||
126321232|NCT00438256|454467674|FG000|Overall Study|Ineligible for Resection|2|||
126321233|NCT00438256|454467675|FG001|Overall Study|Ineligible for Resection|1|||
126321234|NCT00438256|454467676|FG002|Overall Study|Ineligible for Resection|1|||
126321235|NCT00438256|454467677|FG003|Overall Study|Ineligible for Resection|7|||
126321236|NCT00438256|454467674|FG000|Overall Study|Excluded final Diagnosis|0|||
126321237|NCT00438256|454467675|FG001|Overall Study|Excluded final Diagnosis|0|||
126321238|NCT00438256|454467676|FG002|Overall Study|Excluded final Diagnosis|0|||
126321239|NCT00438256|454467677|FG003|Overall Study|Excluded final Diagnosis|2|||
126321240|NCT00369161|454467686|FG000|Overall Study|Adverse Event|15|||
126321241|NCT00369161|454467687|FG001|Overall Study|Adverse Event|13|||
126321242|NCT00369161|454467686|FG000|Overall Study|Abnormal laboratory value|0|||
126321243|NCT00369161|454467687|FG001|Overall Study|Abnormal laboratory value|1|||
126321244|NCT00369161|454467686|FG000|Overall Study|Lack of Efficacy|3|||
126321245|NCT00369161|454467687|FG001|Overall Study|Lack of Efficacy|1|||
126321246|NCT00369161|454467686|FG000|Overall Study|Protocol Violation|0|||
126321247|NCT00369161|454467687|FG001|Overall Study|Protocol Violation|2|||
126321248|NCT00369161|454467686|FG000|Overall Study|Withdrawal by Subject|2|||
126321249|NCT00369161|454467687|FG001|Overall Study|Withdrawal by Subject|3|||
126321250|NCT00369161|454467686|FG000|Overall Study|Death|1|||
126321251|NCT00369161|454467687|FG001|Overall Study|Death|2|||
126321252|NCT00369161|454467686|FG000|Overall Study|Graft loss|4|||
126321253|NCT00369161|454467687|FG001|Overall Study|Graft loss|0|||
126321254|NCT00369161|454467686|FG000|Overall Study|Administrative Problem|2|||
126321255|NCT00369161|454467687|FG001|Overall Study|Administrative Problem|2|||
126321256|NCT00750919|454467688|FG000|Overall Study|Adverse Event|9|||
126321257|NCT00750919|454467688|FG000|Overall Study|Withdrawal by Subject|1|||
126321258|NCT00750919|454467688|FG000|Overall Study|Lack of Efficacy|8|||
126321259|NCT00750919|454467688|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
126321260|NCT00750919|454467688|FG000|Overall Study|Other|36|||
126321261|NCT02147067|454467691|FG000|Overall Study|Withdrawal by Subject|2|||
126321262|NCT02147067|454467692|FG001|Overall Study|Withdrawal by Subject|2|||
126321263|NCT01404949|454467693|FG000|Overall Study|Not Treated|1|||
126321264|NCT01017601|454467696|FG000|Overall Study|Disease Progression|12|||
126321265|NCT01017601|454467697|FG001|Overall Study|Disease Progression|12|||
126321266|NCT01017601|454467696|FG000|Overall Study|Withdrawal by Subject|0|||
126321267|NCT01017601|454467697|FG001|Overall Study|Withdrawal by Subject|1|||
126321268|NCT02638259|454467702|FG000|Treatment Period 1|Adverse Event|1|||
126321269|NCT02638259|454467703|FG001|Treatment Period 1|Adverse Event|5|||
126321270|NCT02638259|454467702|FG000|Treatment Period 1|Death|0|||
126321271|NCT02638259|454467703|FG001|Treatment Period 1|Death|1|||
126321272|NCT02638259|454467702|FG000|Treatment Period 1|Lack of Efficacy|0|||
126321273|NCT02638259|454467703|FG001|Treatment Period 1|Lack of Efficacy|1|||
126321274|NCT02638259|454467702|FG000|Treatment Period 1|Protocol Violation|0|||
126651017|NCT01022112|455678336|FG004|Overall Study|Withdrawal by Subject|1|||
126651018|NCT01022112|455678332|FG000|Overall Study|Fasting plasma glucose level increased|1|||
126651019|NCT01022112|455678333|FG001|Overall Study|Fasting plasma glucose level increased|0|||
126651020|NCT01022112|455678334|FG002|Overall Study|Fasting plasma glucose level increased|0|||
126321275|NCT02638259|454467703|FG001|Treatment Period 1|Protocol Violation|3|||
126321276|NCT02638259|454467702|FG000|Treatment Period 1|Withdrawal by Subject|4|||
126321277|NCT02638259|454467703|FG001|Treatment Period 1|Withdrawal by Subject|6|||
126321278|NCT02638259|454467702|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
126321279|NCT02638259|454467703|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
126321280|NCT02638259|454467702|FG000|Treatment Period 2|Adverse Event|5|||
126321281|NCT02638259|454467703|FG001|Treatment Period 2|Adverse Event|4|||
126321282|NCT02638259|454467702|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126321283|NCT02638259|454467703|FG001|Treatment Period 2|Withdrawal by Subject|7|||
126321284|NCT01094782|454467704|FG000|Overall Study|Withdrawal by Subject|5|||
126321285|NCT01094782|454467705|FG001|Overall Study|Withdrawal by Subject|5|||
126321286|NCT01094782|454467706|FG002|Overall Study|Withdrawal by Subject|1|||
126321287|NCT01094782|454467707|FG003|Overall Study|Withdrawal by Subject|5|||
126321288|NCT01094782|454467708|FG004|Overall Study|Withdrawal by Subject|5|||
126321289|NCT01094782|454467709|FG005|Overall Study|Withdrawal by Subject|0|||
126321290|NCT01094782|454467704|FG000|Overall Study|Lost to Follow-up|1|||
126321291|NCT01094782|454467705|FG001|Overall Study|Lost to Follow-up|0|||
126321292|NCT01094782|454467706|FG002|Overall Study|Lost to Follow-up|0|||
126321293|NCT01094782|454467707|FG003|Overall Study|Lost to Follow-up|2|||
126321294|NCT01094782|454467708|FG004|Overall Study|Lost to Follow-up|1|||
126321295|NCT01094782|454467709|FG005|Overall Study|Lost to Follow-up|4|||
126321296|NCT01094782|454467704|FG000|Overall Study|Positive Drug Screen|2|||
126321297|NCT01094782|454467705|FG001|Overall Study|Positive Drug Screen|2|||
126321298|NCT01094782|454467706|FG002|Overall Study|Positive Drug Screen|1|||
126321299|NCT01094782|454467707|FG003|Overall Study|Positive Drug Screen|1|||
126321300|NCT01094782|454467708|FG004|Overall Study|Positive Drug Screen|3|||
126321301|NCT01094782|454467709|FG005|Overall Study|Positive Drug Screen|2|||
126321302|NCT01094782|454467704|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
126321303|NCT01094782|454467705|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
126321304|NCT01094782|454467706|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
126321305|NCT01094782|454467707|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
126321306|NCT01094782|454467708|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
126321307|NCT01094782|454467709|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
126321308|NCT01094782|454467704|FG000|Overall Study|Unable to Complete Questionnaires|0|||
126321309|NCT01094782|454467705|FG001|Overall Study|Unable to Complete Questionnaires|1|||
126321310|NCT01094782|454467706|FG002|Overall Study|Unable to Complete Questionnaires|0|||
126321311|NCT01094782|454467707|FG003|Overall Study|Unable to Complete Questionnaires|0|||
126321312|NCT01094782|454467708|FG004|Overall Study|Unable to Complete Questionnaires|0|||
126321313|NCT01094782|454467709|FG005|Overall Study|Unable to Complete Questionnaires|0|||
126321314|NCT01094782|454467704|FG000|Overall Study|Healthy Subject Had Pain|0|||
126321315|NCT01094782|454467705|FG001|Overall Study|Healthy Subject Had Pain|1|||
126321316|NCT01094782|454467706|FG002|Overall Study|Healthy Subject Had Pain|0|||
126321317|NCT01094782|454467707|FG003|Overall Study|Healthy Subject Had Pain|0|||
126321318|NCT01094782|454467708|FG004|Overall Study|Healthy Subject Had Pain|0|||
126321319|NCT01094782|454467709|FG005|Overall Study|Healthy Subject Had Pain|0|||
126321320|NCT01094782|454467704|FG000|Overall Study|Hypertension|0|||
126321321|NCT01094782|454467705|FG001|Overall Study|Hypertension|0|||
126321322|NCT01094782|454467706|FG002|Overall Study|Hypertension|1|||
126321323|NCT01094782|454467707|FG003|Overall Study|Hypertension|0|||
126321324|NCT01094782|454467708|FG004|Overall Study|Hypertension|0|||
126321325|NCT01094782|454467709|FG005|Overall Study|Hypertension|0|||
126321326|NCT01094782|454467704|FG000|Overall Study|Wrong Pain Condition|0|||
126321327|NCT01094782|454467705|FG001|Overall Study|Wrong Pain Condition|0|||
126321328|NCT01094782|454467706|FG002|Overall Study|Wrong Pain Condition|0|||
126321329|NCT01094782|454467707|FG003|Overall Study|Wrong Pain Condition|2|||
126321330|NCT01094782|454467708|FG004|Overall Study|Wrong Pain Condition|1|||
126321331|NCT01094782|454467709|FG005|Overall Study|Wrong Pain Condition|1|||
126321332|NCT01094782|454467704|FG000|Overall Study|Recent Interventional Injection|0|||
126321333|NCT01094782|454467705|FG001|Overall Study|Recent Interventional Injection|0|||
126321334|NCT01094782|454467706|FG002|Overall Study|Recent Interventional Injection|0|||
126321335|NCT01094782|454467707|FG003|Overall Study|Recent Interventional Injection|0|||
126321336|NCT01094782|454467708|FG004|Overall Study|Recent Interventional Injection|0|||
126321337|NCT01094782|454467709|FG005|Overall Study|Recent Interventional Injection|1|||
126321338|NCT01094782|454467704|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
126321339|NCT01094782|454467705|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
126321340|NCT01094782|454467706|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
126321341|NCT01094782|454467707|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
126321342|NCT01094782|454467708|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
126321343|NCT01094782|454467709|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
126321344|NCT01094782|454467704|FG000|Overall Study|Noncompliance With Study Schedule|0|||
126321345|NCT01094782|454467705|FG001|Overall Study|Noncompliance With Study Schedule|0|||
126321346|NCT01094782|454467706|FG002|Overall Study|Noncompliance With Study Schedule|0|||
126321347|NCT01094782|454467707|FG003|Overall Study|Noncompliance With Study Schedule|1|||
126321348|NCT01094782|454467708|FG004|Overall Study|Noncompliance With Study Schedule|0|||
126321349|NCT01094782|454467709|FG005|Overall Study|Noncompliance With Study Schedule|0|||
126321350|NCT00957905|454467710|FG000|Part B|Not Treated|0|||
126321351|NCT00957905|454467711|FG001|Part B|Not Treated|1|||
126321352|NCT00957905|454467710|FG000|Part B|Physician Decision|0|||
126321353|NCT00957905|454467711|FG001|Part B|Physician Decision|1|||
126321354|NCT00957905|454467710|FG000|Part B|Death|0|||
126321355|NCT00957905|454467711|FG001|Part B|Death|1|||
126321356|NCT00957905|454467710|FG000|Part B|Protocol Violation|0|||
126321357|NCT00957905|454467711|FG001|Part B|Protocol Violation|1|||
126321358|NCT02073656|454467712|FG000|Primary Study|Lost to Follow-up|6|||
126321359|NCT02073656|454467712|FG000|Primary Study|Death|1|||
126321360|NCT02073656|454467712|FG000|Primary Study|Withdrew Consent|1|||
126321361|NCT03423147|454467716|FG000|Overall Study|Lost to Follow-up|5|||
126321362|NCT03423147|454467717|FG001|Overall Study|Lost to Follow-up|8|||
126321363|NCT03423147|454467716|FG000|Overall Study|Withdrawal by Subject|1|||
126651021|NCT01022112|455678335|FG003|Overall Study|Fasting plasma glucose level increased|0|||
126651022|NCT01022112|455678336|FG004|Overall Study|Fasting plasma glucose level increased|7|||
126651023|NCT00925353|455678337|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
126651024|NCT01302067|455679810|FG000|Overall Study|Death|0|||
126651025|NCT01302067|455679811|FG001|Overall Study|Death|0|||
126321364|NCT03423147|454467717|FG001|Overall Study|Withdrawal by Subject|0|||
126651026|NCT01302067|455679812|FG002|Overall Study|Death|1|||
126651027|NCT01302067|455679810|FG000|Overall Study|Physician Decision|9|||
126321365|NCT03423147|454467716|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
126321366|NCT03423147|454467717|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
126321367|NCT03423147|454467716|FG000|Overall Study|Age < 18|1|||
126321368|NCT03423147|454467717|FG001|Overall Study|Age < 18|0|||
126321369|NCT03423147|454467716|FG000|Overall Study|No Trial of Labor|0|||
126321370|NCT03423147|454467717|FG001|Overall Study|No Trial of Labor|1|||
126321371|NCT01048099|454467718|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
126321372|NCT01048099|454467718|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
126321373|NCT00508157|454467719|FG000|Overall Study|Adverse Event|0|||
126321374|NCT00508157|454467720|FG001|Overall Study|Adverse Event|1|||
126321375|NCT00508157|454467719|FG000|Overall Study|Subject Withdrew Consent|1|||
126321376|NCT00508157|454467720|FG001|Overall Study|Subject Withdrew Consent|0|||
126321377|NCT00508157|454467719|FG000|Overall Study|Lost to Follow-up|1|||
126321378|NCT00508157|454467720|FG001|Overall Study|Lost to Follow-up|0|||
126321379|NCT00508157|454467719|FG000|Overall Study|Subject no longer met study criteria|0|||
126321380|NCT00508157|454467720|FG001|Overall Study|Subject no longer met study criteria|1|||
126321381|NCT00508157|454467719|FG000|Overall Study|Other known cause|0|||
126321382|NCT00508157|454467720|FG001|Overall Study|Other known cause|1|||
126321383|NCT03089853|454469322|FG000|Overall Study|Lost to Follow-up|2|||
126321384|NCT03089853|454469323|FG001|Overall Study|Lost to Follow-up|1|||
126321385|NCT04114656|454469324|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
126321386|NCT04114656|454469325|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
126321387|NCT04114656|454469324|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
126321388|NCT04114656|454469325|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
126321389|NCT04114656|454469324|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
126321390|NCT04114656|454469325|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
126321391|NCT04114656|454469324|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
126321392|NCT04114656|454469325|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
126321393|NCT04114656|454469324|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
126321394|NCT04114656|454469325|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
126321395|NCT02578940|454469326|FG000|Overall Study|Screening failure|5|||
126321396|NCT02578940|454469326|FG000|Overall Study|Lost to Follow-up|1|||
126321397|NCT03326518|454469334|FG000|Overall Study|Protocol Violation|1|||
126321398|NCT03326518|454469335|FG001|Overall Study|Protocol Violation|0|||
126321399|NCT03326518|454469336|FG002|Overall Study|Protocol Violation|0|||
126321400|NCT03326518|454469334|FG000|Overall Study|Withdrawal by Subject|1|||
126321401|NCT03326518|454469335|FG001|Overall Study|Withdrawal by Subject|0|||
126321402|NCT03326518|454469336|FG002|Overall Study|Withdrawal by Subject|0|||
126321403|NCT03326518|454469334|FG000|Overall Study|Lost to Follow-up|1|||
126321404|NCT03326518|454469335|FG001|Overall Study|Lost to Follow-up|0|||
126321405|NCT03326518|454469336|FG002|Overall Study|Lost to Follow-up|1|||
126321406|NCT01375374|454469339|FG000|Overall Study|Adverse Event|1|||
126321407|NCT01908582|454469340|FG000|Period 2|Physician Decision|1|||
126321408|NCT01908582|454469340|FG000|Period 2|Withdrawal by Subject|1|||
126321409|NCT01108237|454469342|FG000|Overall Study|No alignment data|2|||
126321410|NCT01108237|454469343|FG001|Overall Study|No alignment data|15|||
126321411|NCT01108237|454469342|FG000|Overall Study|Did not meet criteria for analysis|7|||
126321412|NCT01108237|454469343|FG001|Overall Study|Did not meet criteria for analysis|0|||
126321413|NCT02065518|454469345|FG000|Overall Study|Lost to Follow-up|3|||
126321414|NCT02065518|454469346|FG001|Overall Study|Lost to Follow-up|4|||
126321415|NCT02065518|454469347|FG002|Overall Study|Lost to Follow-up|0|||
126321416|NCT02065518|454469348|FG003|Overall Study|Lost to Follow-up|3|||
126321417|NCT02065518|454469345|FG000|Overall Study|Withdrawal by Subject|3|||
126321418|NCT02065518|454469346|FG001|Overall Study|Withdrawal by Subject|4|||
126321419|NCT02065518|454469347|FG002|Overall Study|Withdrawal by Subject|9|||
126321420|NCT02065518|454469348|FG003|Overall Study|Withdrawal by Subject|2|||
126321421|NCT03484403|454469351|FG000|Overall Study|Withdrawal by Subject|6|||
126651028|NCT01302067|455679811|FG001|Overall Study|Physician Decision|5|||
126651029|NCT01302067|455679812|FG002|Overall Study|Physician Decision|14|||
126651030|NCT01302067|455679810|FG000|Overall Study|Lack of Efficacy|8|||
126651031|NCT01302067|455679811|FG001|Overall Study|Lack of Efficacy|4|||
126651032|NCT01302067|455679812|FG002|Overall Study|Lack of Efficacy|2|||
126651033|NCT01302067|455679810|FG000|Overall Study|Lost to Follow-up|9|||
126651034|NCT01302067|455679811|FG001|Overall Study|Lost to Follow-up|4|||
126651035|NCT01302067|455679812|FG002|Overall Study|Lost to Follow-up|15|||
126651036|NCT01302067|455679810|FG000|Overall Study|Withdrawal by Subject|13|||
126651037|NCT01302067|455679811|FG001|Overall Study|Withdrawal by Subject|6|||
126651038|NCT01302067|455679812|FG002|Overall Study|Withdrawal by Subject|10|||
126651039|NCT01302067|455679810|FG000|Overall Study|Other|1|||
126651040|NCT01302067|455679811|FG001|Overall Study|Other|1|||
126651041|NCT01302067|455679812|FG002|Overall Study|Other|3|||
126651042|NCT01302067|455679810|FG000|Overall Study|Protocol Violation|11|||
126651043|NCT01302067|455679811|FG001|Overall Study|Protocol Violation|0|||
126651044|NCT01302067|455679812|FG002|Overall Study|Protocol Violation|8|||
126651045|NCT01302067|455679810|FG000|Overall Study|Adverse Event|27|||
126651046|NCT01302067|455679811|FG001|Overall Study|Adverse Event|14|||
126321422|NCT03484403|454469352|FG001|Overall Study|Withdrawal by Subject|4|||
126321423|NCT02173379|454469353|FG000|Overall Study|Lost to Follow-up|89|||
126321424|NCT02173379|454469354|FG001|Overall Study|Lost to Follow-up|81|||
126321425|NCT02173379|454469353|FG000|Overall Study|Withdrawal by Subject|24|||
126321426|NCT02173379|454469354|FG001|Overall Study|Withdrawal by Subject|29|||
126321427|NCT02173379|454469353|FG000|Overall Study|Physician Decision|8|||
126321428|NCT02173379|454469354|FG001|Overall Study|Physician Decision|8|||
126321429|NCT02173379|454469353|FG000|Overall Study|Death|75|||
126321430|NCT02173379|454469354|FG001|Overall Study|Death|72|||
126321431|NCT02173379|454469353|FG000|Overall Study|Other Reason|1|||
126321432|NCT02173379|454469354|FG001|Overall Study|Other Reason|0|||
126321433|NCT06226649|454469358|FG000|Overall Study|Withdrawal by Subject|4|||
126321434|NCT06226649|454469359|FG001|Overall Study|Withdrawal by Subject|1|||
126321435|NCT04767529|454469364|FG000|Overall Study|Adverse Event|0|||
126321436|NCT04767529|454469365|FG001|Overall Study|Adverse Event|4|||
126321437|NCT04767529|454469366|FG002|Overall Study|Adverse Event|3|||
126321438|NCT04767529|454469364|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
126321439|NCT04767529|454469365|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
126321440|NCT04767529|454469366|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
126321441|NCT04767529|454469364|FG000|Overall Study|Required use of a prohibited medication|0|||
126321442|NCT04767529|454469365|FG001|Overall Study|Required use of a prohibited medication|1|||
126321443|NCT04767529|454469366|FG002|Overall Study|Required use of a prohibited medication|0|||
126321444|NCT04767529|454469364|FG000|Overall Study|Withdrawal by Subject|7|||
126321445|NCT04767529|454469365|FG001|Overall Study|Withdrawal by Subject|5|||
126321446|NCT04767529|454469366|FG002|Overall Study|Withdrawal by Subject|4|||
126321447|NCT04767529|454469364|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
126321448|NCT04767529|454469365|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
126321449|NCT04767529|454469366|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
126321450|NCT04767529|454469364|FG000|Overall Study|Lost to Follow-up|0|||
126321451|NCT04767529|454469365|FG001|Overall Study|Lost to Follow-up|2|||
126321452|NCT04767529|454469366|FG002|Overall Study|Lost to Follow-up|3|||
126321453|NCT04942210|454469374|FG000|Overall Study|Adverse Event|0|||
126321454|NCT04942210|454469375|FG001|Overall Study|Adverse Event|1|||
126321455|NCT04942210|454469374|FG000|Overall Study|Protocol Deviation|4|||
126321456|NCT04942210|454469375|FG001|Overall Study|Protocol Deviation|1|||
126321457|NCT04942210|454469374|FG000|Overall Study|Withdrawal by Subject|5|||
126321458|NCT04942210|454469375|FG001|Overall Study|Withdrawal by Subject|2|||
126321459|NCT04942210|454469374|FG000|Overall Study|Lost to Follow-up|16|||
126321460|NCT04942210|454469375|FG001|Overall Study|Lost to Follow-up|7|||
126321461|NCT04942210|454469374|FG000|Overall Study|Ongoing at the time of DBL date|60|||
126321462|NCT04942210|454469375|FG001|Overall Study|Ongoing at the time of DBL date|25|||
126321463|NCT04942210|454469374|FG000|Overall Study|Randomized but did not receive vaccination|3|||
126321464|NCT04942210|454469375|FG001|Overall Study|Randomized but did not receive vaccination|0|||
126321465|NCT05697627|454469378|FG000|Overall Study|Adverse Event|1|||
126321466|NCT02570750|454469379|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
126321467|NCT02570750|454469380|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
126321468|NCT02570750|454469379|FG000|Overall Study|Protocol deviation|4|||
126321469|NCT02570750|454469380|FG001|Overall Study|Protocol deviation|2|||
126321470|NCT02570750|454469379|FG000|Overall Study|Withdrawal by Subject|5|||
126321471|NCT02570750|454469380|FG001|Overall Study|Withdrawal by Subject|0|||
126321472|NCT02570750|454469379|FG000|Overall Study|Lost to Follow-up|2|||
126321473|NCT02570750|454469380|FG001|Overall Study|Lost to Follow-up|2|||
126321474|NCT02570750|454469379|FG000|Overall Study|Adverse Event|2|||
126321475|NCT02570750|454469380|FG001|Overall Study|Adverse Event|1|||
126321476|NCT04122625|454469381|FG000|Part A (up to 2.92 Years)|Death|2|||
126321477|NCT04122625|454469382|FG001|Part A (up to 2.92 Years)|Death|4|||
126321478|NCT04122625|454469383|FG002|Part A (up to 2.92 Years)|Death|0|||
126651047|NCT01302067|455679812|FG002|Overall Study|Adverse Event|45|||
126651048|NCT02738203|455679814|FG000|Overall Study|Failed IUD Insertion|2|||
126651049|NCT02738203|455679815|FG001|Overall Study|Failed IUD Insertion|2|||
126651050|NCT02738203|455679814|FG000|Overall Study|Protocol Violation|0|||
126651051|NCT02738203|455679815|FG001|Overall Study|Protocol Violation|1|||
126651052|NCT03241927|455679816|FG000|Overall Study|study terminated|1|||
126651053|NCT03241927|455679817|FG001|Overall Study|study terminated|0|||
126651054|NCT00423943|455679818|FG000|Overall Study|Withdrawal by Subject|3|||
126321479|NCT04122625|454469384|FG003|Part A (up to 2.92 Years)|Death|0|||
126321480|NCT04122625|454469385|FG004|Part A (up to 2.92 Years)|Death|0|||
126321481|NCT04122625|454469386|FG005|Part A (up to 2.92 Years)|Death|0|||
126321482|NCT04122625|454469381|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
126321483|NCT04122625|454469382|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
126321484|NCT04122625|454469383|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
126321485|NCT04122625|454469384|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
126321486|NCT04122625|454469385|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
126321487|NCT04122625|454469386|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
126321488|NCT04122625|454469381|FG000|Part B (up to 2.33 Years)|Death|0|||
126321489|NCT04122625|454469382|FG001|Part B (up to 2.33 Years)|Death|0|||
126321490|NCT04122625|454469383|FG002|Part B (up to 2.33 Years)|Death|5|||
126321491|NCT04122625|454469384|FG003|Part B (up to 2.33 Years)|Death|7|||
126321492|NCT04122625|454469385|FG004|Part B (up to 2.33 Years)|Death|6|||
126321493|NCT04122625|454469386|FG005|Part B (up to 2.33 Years)|Death|7|||
126321494|NCT04348500|454469387|FG000|Overall Study|Death|2|||
126321495|NCT04348500|454469388|FG001|Overall Study|Death|2|||
126321496|NCT04348500|454469387|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
126321497|NCT04348500|454469388|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
126321498|NCT01410240|454469389|FG000|Overall Study|Physician Decision|0|||
126321499|NCT01410240|454469390|FG001|Overall Study|Physician Decision|0|||
126321500|NCT01410240|454469391|FG002|Overall Study|Physician Decision|1|||
126321501|NCT01410240|454469389|FG000|Overall Study|Missed week 6 assessments|1|||
126321502|NCT01410240|454469390|FG001|Overall Study|Missed week 6 assessments|1|||
126321503|NCT01410240|454469391|FG002|Overall Study|Missed week 6 assessments|1|||
126321504|NCT02776670|454469392|FG000|Overall Study|Adverse Event|0|||
126321505|NCT02776670|454469393|FG001|Overall Study|Adverse Event|2|||
126321506|NCT02776670|454469392|FG000|Overall Study|Protocol Violation|0|||
126321507|NCT02776670|454469393|FG001|Overall Study|Protocol Violation|2|||
126321508|NCT02776670|454469392|FG000|Overall Study|Withdrawal by Subject|0|||
126321509|NCT02776670|454469393|FG001|Overall Study|Withdrawal by Subject|1|||
126321510|NCT02776670|454469392|FG000|Overall Study|Other - Reason not given|0|||
126321511|NCT02776670|454469393|FG001|Overall Study|Other - Reason not given|1|||
126321512|NCT01937884|454469398|FG000|Overall Study|Withdrawal by Subject|1|||
126321513|NCT01937884|454469399|FG001|Overall Study|Withdrawal by Subject|0|||
126321514|NCT00004088|454469400|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
126321515|NCT00004088|454469400|FG000|Overall Study|Withdrawal by Subject|1|||
126321516|NCT00004088|454469400|FG000|Overall Study|Protocol Violation|3|||
126651055|NCT00423943|455679819|FG001|Overall Study|Withdrawal by Subject|1|||
126651056|NCT02383056|455679820|FG000|Overall Study|Adverse Event|1|||
126651057|NCT02383056|455679821|FG001|Overall Study|Adverse Event|0|||
126651058|NCT02383056|455679820|FG000|Overall Study|Lost to Follow-up|0|||
126651059|NCT02383056|455679821|FG001|Overall Study|Lost to Follow-up|2|||
126651060|NCT03245151|455679822|FG000|Overall Study|Withdrawal by Subject|2|||
126651061|NCT03245151|455679823|FG001|Overall Study|Withdrawal by Subject|0|||
126651062|NCT03245151|455679824|FG002|Overall Study|Withdrawal by Subject|0|||
126651063|NCT03245151|455679825|FG003|Overall Study|Withdrawal by Subject|2|||
126651064|NCT03245151|455679826|FG004|Overall Study|Withdrawal by Subject|1|||
126651065|NCT03245151|455679822|FG000|Overall Study|Death|3|||
126651066|NCT03245151|455679823|FG001|Overall Study|Death|14|||
126651067|NCT03245151|455679824|FG002|Overall Study|Death|9|||
126651068|NCT03245151|455679825|FG003|Overall Study|Death|16|||
126651069|NCT03245151|455679826|FG004|Overall Study|Death|7|||
126651070|NCT03245151|455679822|FG000|Overall Study|Sponsor's decision|0|||
126651071|NCT03245151|455679823|FG001|Overall Study|Sponsor's decision|1|||
126651072|NCT03245151|455679824|FG002|Overall Study|Sponsor's decision|0|||
126651073|NCT03245151|455679825|FG003|Overall Study|Sponsor's decision|0|||
126651074|NCT03245151|455679826|FG004|Overall Study|Sponsor's decision|0|||
126651075|NCT03507777|455679827|FG000|Overall Study|Lost to Follow-up|5|||
126651076|NCT03507777|455679828|FG001|Overall Study|Lost to Follow-up|7|||
126651077|NCT03507777|455679827|FG000|Overall Study|Withdrawal by Subject|6|||
126651078|NCT03507777|455679828|FG001|Overall Study|Withdrawal by Subject|11|||
126651079|NCT03507777|455679827|FG000|Overall Study|Death|30|||
126651080|NCT03507777|455679828|FG001|Overall Study|Death|44|||
126651081|NCT03507777|455679827|FG000|Overall Study|Other Reasons|3|||
126651082|NCT03507777|455679828|FG001|Overall Study|Other Reasons|8|||
126651083|NCT04772898|455679831|FG000|Overall Study|Withdrawal by Subject|0|||
126651084|NCT04772898|455679832|FG001|Overall Study|Withdrawal by Subject|1|||
126651085|NCT01327495|455679833|FG000|Overall Study|Adverse Event|2|||
126651086|NCT01327495|455679834|FG001|Overall Study|Adverse Event|1|||
126651087|NCT01327495|455679835|FG002|Overall Study|Adverse Event|1|||
126651088|NCT01327495|455679836|FG003|Overall Study|Adverse Event|0|||
126651089|NCT01327495|455679837|FG004|Overall Study|Adverse Event|0|||
126651090|NCT01327495|455679838|FG005|Overall Study|Adverse Event|2|||
126651091|NCT01327495|455679833|FG000|Overall Study|Withdrawal by Subject|0|||
126651092|NCT01327495|455679834|FG001|Overall Study|Withdrawal by Subject|1|||
126651093|NCT01327495|455679835|FG002|Overall Study|Withdrawal by Subject|1|||
126651094|NCT01327495|455679836|FG003|Overall Study|Withdrawal by Subject|0|||
126651095|NCT01327495|455679837|FG004|Overall Study|Withdrawal by Subject|1|||
126651096|NCT01327495|455679838|FG005|Overall Study|Withdrawal by Subject|0|||
126321517|NCT00004088|454469400|FG000|Overall Study|Physician Decision|1|||
126321518|NCT02722746|454469401|FG000|Overall Study|Withdrawal by Subject|0|||
126651097|NCT01327495|455679833|FG000|Overall Study|Physician Decision|0|||
126651098|NCT01327495|455679834|FG001|Overall Study|Physician Decision|0|||
126321519|NCT02722746|454469402|FG001|Overall Study|Withdrawal by Subject|1|||
126321520|NCT02722746|454469403|FG002|Overall Study|Withdrawal by Subject|0|||
126651099|NCT01327495|455679835|FG002|Overall Study|Physician Decision|0|||
126651100|NCT01327495|455679836|FG003|Overall Study|Physician Decision|0|||
126321521|NCT02722746|454469401|FG000|Overall Study|Protocol Violation|8|||
126321522|NCT02722746|454469402|FG001|Overall Study|Protocol Violation|4|||
126321523|NCT02722746|454469403|FG002|Overall Study|Protocol Violation|6|||
126321524|NCT00981058|454469408|FG000|Overall Study|Progressive Disease|38|||
126321525|NCT00981058|454469409|FG001|Overall Study|Progressive Disease|31|||
126321526|NCT00981058|454469408|FG000|Overall Study|Lost to Follow-up|3|||
126321527|NCT00981058|454469409|FG001|Overall Study|Lost to Follow-up|2|||
126321528|NCT00981058|454469408|FG000|Overall Study|Physician Decision|4|||
126321529|NCT00981058|454469409|FG001|Overall Study|Physician Decision|5|||
126321530|NCT00981058|454469408|FG000|Overall Study|Randomization Error|0|||
126321531|NCT00981058|454469409|FG001|Overall Study|Randomization Error|1|||
126321532|NCT00981058|454469408|FG000|Overall Study|Withdrawal by Subject|24|||
126321533|NCT00981058|454469409|FG001|Overall Study|Withdrawal by Subject|22|||
126321534|NCT02667587|454469410|FG000|Pre-Treatment|Not reported|1|||
126321535|NCT02667587|454469411|FG001|Pre-Treatment|Not reported|0|||
126321536|NCT02667587|454469410|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
126321537|NCT02667587|454469411|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
126321538|NCT02667587|454469410|FG000|Pre-Treatment|Participant withdrew consent|0|||
126321539|NCT02667587|454469411|FG001|Pre-Treatment|Participant withdrew consent|1|||
126321540|NCT02667587|454469410|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
126321541|NCT02667587|454469411|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
126321542|NCT02667587|454469410|FG000|End of Treatment|Disease Progression|193|||
126321543|NCT02667587|454469411|FG001|End of Treatment|Disease Progression|226|||
126321544|NCT02667587|454469410|FG000|End of Treatment|Study Drug Toxicity|75|||
126321545|NCT02667587|454469411|FG001|End of Treatment|Study Drug Toxicity|19|||
126321546|NCT02667587|454469410|FG000|End of Treatment|Death|2|||
126321547|NCT02667587|454469411|FG001|End of Treatment|Death|1|||
126651101|NCT01327495|455679837|FG004|Overall Study|Physician Decision|2|||
126651102|NCT01327495|455679838|FG005|Overall Study|Physician Decision|0|||
126651103|NCT00006011|455679839|FG000|Overall Study|Disease progression|13|||
126651104|NCT00006011|455679840|FG001|Overall Study|Disease progression|6|||
126651105|NCT00006011|455679841|FG002|Overall Study|Disease progression|26|||
126321548|NCT02667587|454469410|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
126321549|NCT02667587|454469411|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
126321550|NCT02667587|454469410|FG000|End of Treatment|participant request to discontinue treatment|33|||
126321551|NCT02667587|454469411|FG001|End of Treatment|participant request to discontinue treatment|35|||
126321552|NCT02667587|454469410|FG000|End of Treatment|participant withdrew consent|5|||
126321553|NCT02667587|454469411|FG001|End of Treatment|participant withdrew consent|6|||
126321554|NCT02667587|454469410|FG000|End of Treatment|Lost to Follow-up|1|||
126321555|NCT02667587|454469411|FG001|End of Treatment|Lost to Follow-up|2|||
126321556|NCT02667587|454469410|FG000|End of Treatment|maximum clinical benefit|4|||
126321557|NCT02667587|454469411|FG001|End of Treatment|maximum clinical benefit|4|||
126321558|NCT02667587|454469410|FG000|End of Treatment|poor or non compliant|0|||
126321559|NCT02667587|454469411|FG001|End of Treatment|poor or non compliant|1|||
126321560|NCT02667587|454469410|FG000|End of Treatment|participant no longer meets study criteria|1|||
126321561|NCT02667587|454469411|FG001|End of Treatment|participant no longer meets study criteria|1|||
126321562|NCT02667587|454469410|FG000|End of Treatment|administrative reason by sponsor|1|||
126321563|NCT02667587|454469411|FG001|End of Treatment|administrative reason by sponsor|29|||
126651106|NCT00006011|455679839|FG000|Overall Study|Refused further treatment|15|||
126651107|NCT00006011|455679840|FG001|Overall Study|Refused further treatment|13|||
126651108|NCT00006011|455679841|FG002|Overall Study|Refused further treatment|26|||
126651109|NCT00006011|455679839|FG000|Overall Study|Adverse Event|15|||
126651110|NCT00006011|455679840|FG001|Overall Study|Adverse Event|39|||
126651111|NCT00006011|455679841|FG002|Overall Study|Adverse Event|5|||
126651112|NCT00006011|455679839|FG000|Overall Study|Death|0|||
126651113|NCT00006011|455679840|FG001|Overall Study|Death|1|||
126651114|NCT00006011|455679841|FG002|Overall Study|Death|2|||
126651115|NCT00006011|455679839|FG000|Overall Study|Other|4|||
126651116|NCT00006011|455679840|FG001|Overall Study|Other|2|||
126651117|NCT00006011|455679841|FG002|Overall Study|Other|5|||
126651118|NCT00006011|455679839|FG000|Overall Study|Ineligible|18|||
126651119|NCT00006011|455679840|FG001|Overall Study|Ineligible|16|||
126651120|NCT00006011|455679841|FG002|Overall Study|Ineligible|9|||
126321564|NCT02667587|454469410|FG000|End of Treatment|other reasonse|21|||
126321565|NCT02667587|454469411|FG001|End of Treatment|other reasonse|10|||
126321566|NCT01134263|454469412|FG000|Overall Study|Serious adverse event|2|||
126651121|NCT00774930|455679847|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
126651122|NCT00774930|455679848|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
126321567|NCT01134263|454469413|FG001|Overall Study|Serious adverse event|1|||
126321568|NCT01134263|454469414|FG002|Overall Study|Serious adverse event|1|||
126651123|NCT00774930|455679847|FG000|DB Phase|Adverse Event|1|||
126651124|NCT00774930|455679848|FG001|DB Phase|Adverse Event|2|||
126651125|NCT00774930|455679847|FG000|DB Phase|Subject Decision|1|||
126651126|NCT00774930|455679848|FG001|DB Phase|Subject Decision|5|||
126651127|NCT00774930|455679847|FG000|DB Phase|Sponsor Decision|0|||
126651128|NCT00774930|455679848|FG001|DB Phase|Sponsor Decision|1|||
126321569|NCT01134263|454469415|FG003|Overall Study|Serious adverse event|1|||
126651129|NCT00774930|455679847|FG000|DB Phase|Disease Progression|1|||
126651130|NCT00774930|455679848|FG001|DB Phase|Disease Progression|1|||
126651131|NCT00774930|455679847|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
126651132|NCT00774930|455679848|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
126651133|NCT00774930|455679847|FG000|IOL Phase|Adverse Event|1|||
126651134|NCT00774930|455679848|FG001|IOL Phase|Adverse Event|1|||
126651135|NCT00774930|455679847|FG000|IOL Phase|Subject Decision|4|||
126651136|NCT00774930|455679848|FG001|IOL Phase|Subject Decision|3|||
126651137|NCT00774930|455679847|FG000|IOL Phase|Physician Decision|3|||
126651138|NCT00774930|455679848|FG001|IOL Phase|Physician Decision|2|||
126651139|NCT00774930|455679847|FG000|IOL Phase|Sponsor Decision|1|||
126651140|NCT00774930|455679848|FG001|IOL Phase|Sponsor Decision|0|||
126651141|NCT00774930|455679847|FG000|IOL Phase|Disease Progression|2|||
126651142|NCT00774930|455679848|FG001|IOL Phase|Disease Progression|1|||
126651143|NCT00774930|455679847|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
126651144|NCT00774930|455679848|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
126651145|NCT00774930|455679847|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
126651146|NCT00774930|455679848|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
126651147|NCT00774930|455679847|FG000|IOL Phase|Other|1|||
126651148|NCT00774930|455679848|FG001|IOL Phase|Other|0|||
126651149|NCT00774930|455679847|FG000|IOL Phase|Brain radiation|0|||
126651150|NCT00774930|455679848|FG001|IOL Phase|Brain radiation|1|||
126651151|NCT00774930|455679847|FG000|LTOLE Phase|Adverse Event|7|||
126651152|NCT00774930|455679848|FG001|LTOLE Phase|Adverse Event|3|||
126651153|NCT00774930|455679847|FG000|LTOLE Phase|Subject decision|0|||
126651154|NCT00774930|455679848|FG001|LTOLE Phase|Subject decision|5|||
126651155|NCT00774930|455679847|FG000|LTOLE Phase|Physician Decision|4|||
126651156|NCT00774930|455679848|FG001|LTOLE Phase|Physician Decision|1|||
126651157|NCT00774930|455679847|FG000|LTOLE Phase|Sponsor decision|2|||
126651158|NCT00774930|455679848|FG001|LTOLE Phase|Sponsor decision|1|||
126651159|NCT00774930|455679847|FG000|LTOLE Phase|Disease Progression|2|||
126651160|NCT00774930|455679848|FG001|LTOLE Phase|Disease Progression|5|||
126651161|NCT00774930|455679847|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
126651162|NCT00774930|455679848|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
126651163|NCT00774930|455679847|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
126651164|NCT00774930|455679848|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
126651165|NCT00766363|455679853|FG000|Overall Study|Withdrawal by Subject|1|||
126651166|NCT00766363|455679854|FG001|Overall Study|Withdrawal by Subject|0|||
126651167|NCT00766363|455679855|FG002|Overall Study|Withdrawal by Subject|0|||
126651168|NCT00766363|455679856|FG003|Overall Study|Withdrawal by Subject|0|||
126651169|NCT00766363|455679853|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
126651170|NCT00766363|455679854|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
126651171|NCT00766363|455679855|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
126651172|NCT00766363|455679856|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
126651173|NCT01153321|455679857|FG000|Overall Study|Development of study withdrawal criteria|0|||
126651174|NCT01153321|455679858|FG001|Overall Study|Development of study withdrawal criteria|1|||
126651175|NCT01153321|455679857|FG000|Overall Study|Withdrawal by Subject|0|||
126651176|NCT01153321|455679858|FG001|Overall Study|Withdrawal by Subject|1|||
126651177|NCT01153321|455679857|FG000|Overall Study|Adverse Event|1|||
126651178|NCT01153321|455679858|FG001|Overall Study|Adverse Event|1|||
126651179|NCT01177800|455679860|FG000|Overall Study|Adverse Event|9|||
126651180|NCT01177800|455679861|FG001|Overall Study|Adverse Event|3|||
126651181|NCT01177800|455679860|FG000|Overall Study|Protocol Violation|0|||
126651182|NCT01177800|455679861|FG001|Overall Study|Protocol Violation|1|||
126651183|NCT01177800|455679860|FG000|Overall Study|Physician Decision|1|||
126651184|NCT01177800|455679861|FG001|Overall Study|Physician Decision|0|||
126651185|NCT01177800|455679860|FG000|Overall Study|Withdrawal of informed consent|0|||
126651186|NCT01177800|455679861|FG001|Overall Study|Withdrawal of informed consent|1|||
126651187|NCT03527550|455679862|FG000|Overall Study|Lost to Follow-up|4|||
126321570|NCT01134263|454469416|FG004|Overall Study|Serious adverse event|1|||
126321571|NCT01134263|454469412|FG000|Overall Study|Other adverse event|1|||
126321572|NCT01134263|454469413|FG001|Overall Study|Other adverse event|2|||
126321573|NCT01134263|454469414|FG002|Overall Study|Other adverse event|5|||
126651188|NCT03527550|455679863|FG001|Overall Study|Lost to Follow-up|2|||
126651189|NCT03527550|455679862|FG000|Overall Study|Withdrawal by Subject|4|||
126651190|NCT03527550|455679863|FG001|Overall Study|Withdrawal by Subject|1|||
126321574|NCT01134263|454469415|FG003|Overall Study|Other adverse event|3|||
126321575|NCT01134263|454469416|FG004|Overall Study|Other adverse event|0|||
126321576|NCT01134263|454469412|FG000|Overall Study|Protocol Violation|8|||
126651191|NCT03527550|455679862|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
126651192|NCT03527550|455679863|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
126651193|NCT00911937|455679864|FG000|Overall Study|Death|1|||
126651194|NCT00911937|455679865|FG001|Overall Study|Death|0|||
126651195|NCT00911937|455679864|FG000|Overall Study|Lost to Follow-up|8|||
126651196|NCT00911937|455679865|FG001|Overall Study|Lost to Follow-up|5|||
126651197|NCT00911937|455679864|FG000|Overall Study|Withdrawal by Subject|10|||
126651198|NCT00911937|455679865|FG001|Overall Study|Withdrawal by Subject|7|||
126321577|NCT01134263|454469413|FG001|Overall Study|Protocol Violation|7|||
126321578|NCT01134263|454469414|FG002|Overall Study|Protocol Violation|2|||
126321579|NCT01134263|454469415|FG003|Overall Study|Protocol Violation|4|||
126321580|NCT01134263|454469416|FG004|Overall Study|Protocol Violation|2|||
126321581|NCT01134263|454469412|FG000|Overall Study|Lost to Follow-up|4|||
126321582|NCT01134263|454469413|FG001|Overall Study|Lost to Follow-up|3|||
126321583|NCT01134263|454469414|FG002|Overall Study|Lost to Follow-up|5|||
126321584|NCT01134263|454469415|FG003|Overall Study|Lost to Follow-up|3|||
126321585|NCT01134263|454469416|FG004|Overall Study|Lost to Follow-up|1|||
126321586|NCT01134263|454469412|FG000|Overall Study|Withdrawal by Subject|8|||
126321587|NCT01134263|454469413|FG001|Overall Study|Withdrawal by Subject|6|||
126321588|NCT01134263|454469414|FG002|Overall Study|Withdrawal by Subject|16|||
126321589|NCT01134263|454469415|FG003|Overall Study|Withdrawal by Subject|7|||
126321590|NCT01134263|454469416|FG004|Overall Study|Withdrawal by Subject|5|||
126321591|NCT01134263|454469412|FG000|Overall Study|Enrolled, but not treated|1|||
126321592|NCT01134263|454469413|FG001|Overall Study|Enrolled, but not treated|1|||
126321593|NCT01134263|454469414|FG002|Overall Study|Enrolled, but not treated|0|||
126321594|NCT01134263|454469415|FG003|Overall Study|Enrolled, but not treated|1|||
126321595|NCT01134263|454469416|FG004|Overall Study|Enrolled, but not treated|0|||
126321596|NCT04165135|454469417|FG000|Overall Study|Protocol Violation|10|||
126321597|NCT04165135|454469417|FG000|Overall Study|Participants withdrawal of consent|5|||
126321598|NCT02886884|454469426|FG000|Follow-up|Withdrawal by Subject|0|||
126321599|NCT02886884|454469427|FG001|Follow-up|Withdrawal by Subject|0|||
126321600|NCT02886884|454469428|FG002|Follow-up|Withdrawal by Subject|0|||
126321601|NCT02886884|454469429|FG003|Follow-up|Withdrawal by Subject|1|||
126321602|NCT00575510|454469432|FG000|Overall Study|Lost to Follow-up|4|||
126321603|NCT00575510|454469433|FG001|Overall Study|Lost to Follow-up|6|||
126321604|NCT00575510|454469434|FG002|Overall Study|Lost to Follow-up|9|||
126321605|NCT00575510|454469432|FG000|Overall Study|Withdrawal by Subject|1|||
126321606|NCT00575510|454469433|FG001|Overall Study|Withdrawal by Subject|0|||
126321607|NCT00575510|454469434|FG002|Overall Study|Withdrawal by Subject|0|||
126321608|NCT00575510|454469432|FG000|Overall Study|Clinic Called Patient|7|||
126321609|NCT00575510|454469433|FG001|Overall Study|Clinic Called Patient|7|||
126321610|NCT00575510|454469434|FG002|Overall Study|Clinic Called Patient|7|||
126321611|NCT00575510|454469432|FG000|Overall Study|Pregnancy|0|||
126321612|NCT00575510|454469433|FG001|Overall Study|Pregnancy|0|||
126321613|NCT00575510|454469434|FG002|Overall Study|Pregnancy|1|||
126321614|NCT00380718|454469438|FG000|Overall Study|Adverse Event|1|||
126321615|NCT00380718|454469438|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
126321616|NCT02912455|454469439|FG000|Overall Study|Withdrawal by Subject|0|||
126321617|NCT02912455|454469440|FG001|Overall Study|Withdrawal by Subject|1|||
126321618|NCT02912455|454469439|FG000|Overall Study|Lack of Efficacy|0|||
126321619|NCT02912455|454469440|FG001|Overall Study|Lack of Efficacy|1|||
126321620|NCT02912455|454469439|FG000|Overall Study|Lost to Follow-up|2|||
126321621|NCT02912455|454469440|FG001|Overall Study|Lost to Follow-up|1|||
126321622|NCT01625689|454469443|FG000|Overall Study|Migration|2|||
126321623|NCT01625689|454469444|FG001|Overall Study|Migration|1|||
126321624|NCT01810783|454469447|FG000|Overall Study|Adverse Event|32|||
126321625|NCT01810783|454469447|FG000|Overall Study|Withdrawal by Subject|22|||
126321626|NCT01810783|454469447|FG000|Overall Study|Lack of Efficacy|12|||
126321627|NCT01810783|454469447|FG000|Overall Study|Lost to Follow-up|10|||
126321628|NCT01810783|454469447|FG000|Overall Study|Protocol Violation|5|||
126321629|NCT01810783|454469447|FG000|Overall Study|Non-compliance with IMP|4|||
126321630|NCT01810783|454469447|FG000|Overall Study|Adminstrative or other reason(s)|23|||
126321631|NCT01810783|454469447|FG000|Overall Study|Enrolled, not treated|1|||
126321632|NCT00477607|454469448|FG000|Overall Study|Lost to Follow-up|7|||
126321633|NCT00477607|454469449|FG001|Overall Study|Lost to Follow-up|7|||
126321634|NCT00564278|454470662|FG000|Overall Study|Lost to Follow-up|35|||
126321635|NCT00564278|454470663|FG001|Overall Study|Lost to Follow-up|33|||
126321636|NCT00564278|454470662|FG000|Overall Study|Physician Decision|1|||
126321637|NCT00564278|454470663|FG001|Overall Study|Physician Decision|2|||
126321638|NCT00564278|454470662|FG000|Overall Study|Withdrawal by Subject|11|||
126651199|NCT00911937|455679864|FG000|Overall Study|Withdrawn due to pregnancy|1|||
126651200|NCT00911937|455679865|FG001|Overall Study|Withdrawn due to pregnancy|0|||
126321639|NCT00564278|454470663|FG001|Overall Study|Withdrawal by Subject|7|||
126321640|NCT06439095|454470664|FG000|Overall Study|Lost to Follow-up|2|||
126321641|NCT03341936|454470665|FG000|Overall Study|Ineligible|1|||
126651201|NCT00911937|455679864|FG000|Overall Study|Adverse Event|11|||
126321642|NCT03341936|454470665|FG000|Overall Study|Disease Progression|2|||
126321643|NCT03341936|454470665|FG000|Overall Study|Withdrew Consent|4|||
126321644|NCT03341936|454470665|FG000|Overall Study|Non-Compliance|1|||
126321645|NCT03341936|454470665|FG000|Overall Study|Physician Decision|1|||
126321646|NCT03341936|454470665|FG000|Overall Study|Withdrawal by Subject|1|||
126321647|NCT03341936|454470665|FG000|Overall Study|Other|1|||
126321648|NCT02368886|454470666|FG000|Overall Study|Cancel|1|||
126321649|NCT02368886|454470667|FG001|Overall Study|Cancel|1|||
126321650|NCT02368886|454470668|FG002|Overall Study|Cancel|1|||
126321651|NCT02368886|454470669|FG003|Overall Study|Cancel|3|||
126651202|NCT00911937|455679865|FG001|Overall Study|Adverse Event|25|||
126651203|NCT00911937|455679864|FG000|Overall Study|Lack of Efficacy|11|||
126651204|NCT00911937|455679865|FG001|Overall Study|Lack of Efficacy|6|||
126651205|NCT00911937|455679864|FG000|Overall Study|Did not meet inclusion criteria|9|||
126651206|NCT00911937|455679865|FG001|Overall Study|Did not meet inclusion criteria|11|||
126651207|NCT00911937|455679864|FG000|Overall Study|Protocol Violation|14|||
126651208|NCT00911937|455679865|FG001|Overall Study|Protocol Violation|23|||
126651209|NCT00911937|455679864|FG000|Overall Study|Randomized but not treated|13|||
126651210|NCT00911937|455679865|FG001|Overall Study|Randomized but not treated|13|||
126651211|NCT00911937|455679864|FG000|Overall Study|Other|9|||
126651212|NCT00911937|455679865|FG001|Overall Study|Other|5|||
126651213|NCT01498679|455679867|FG000|Overall Study|Adverse Event|1|||
126651214|NCT01498679|455679868|FG001|Overall Study|Adverse Event|4|||
126651215|NCT01498679|455679867|FG000|Overall Study|Lack of Efficacy|72|||
126651216|NCT01498679|455679868|FG001|Overall Study|Lack of Efficacy|12|||
126651217|NCT01498679|455679867|FG000|Overall Study|Protocol Violation|4|||
126651218|NCT01498679|455679868|FG001|Overall Study|Protocol Violation|0|||
126651219|NCT01498679|455679867|FG000|Overall Study|Physician Decision|0|||
126651220|NCT01498679|455679868|FG001|Overall Study|Physician Decision|2|||
126321652|NCT02368886|454470666|FG000|Overall Study|Ineligible|0|||
126321653|NCT02368886|454470667|FG001|Overall Study|Ineligible|0|||
126321654|NCT02368886|454470668|FG002|Overall Study|Ineligible|0|||
126321655|NCT02368886|454470669|FG003|Overall Study|Ineligible|1|||
126321656|NCT04849416|454470671|FG000|Overall Study|Ongoing Treatment|12|||
126321657|NCT04849416|454470672|FG001|Overall Study|Ongoing Treatment|5|||
126321658|NCT04849416|454470673|FG002|Overall Study|Ongoing Treatment|3|||
126651221|NCT01498679|455679867|FG000|Overall Study|Withdrawal by Subject|12|||
126651222|NCT01498679|455679868|FG001|Overall Study|Withdrawal by Subject|4|||
126321659|NCT04849416|454470671|FG000|Overall Study|On Post-Treatment Follow-up|8|||
126651223|NCT03212989|455679873|FG000|Overall Study|Physician Decision|8|||
126651224|NCT00252577|455679876|FG000|Overall Study|Lost to Follow-up|20|||
126651225|NCT01801735|455679879|FG000|Overall Study|Adverse Event|79|||
126651226|NCT01801735|455679879|FG000|Overall Study|Lack of Efficacy|28|||
126651227|NCT01801735|455679879|FG000|Overall Study|Withdrawal by Subject|27|||
126651228|NCT01801735|455679879|FG000|Overall Study|Protocol Violation|25|||
126651229|NCT01801735|455679879|FG000|Overall Study|Lost to Follow-up|15|||
126651230|NCT01801735|455679879|FG000|Overall Study|Non-compliance with Trial Drug|13|||
126651231|NCT01801735|455679879|FG000|Overall Study|Physician Decision|3|||
126651232|NCT01801735|455679879|FG000|Overall Study|Death|1|||
126651233|NCT01801735|455679879|FG000|Overall Study|Other, including site closure|19|||
126651234|NCT00560066|455679880|FG000|Overall Study|Death|2|||
126651235|NCT00560066|455679881|FG001|Overall Study|Death|1|||
126651236|NCT00560066|455679880|FG000|Overall Study|Withdrawal by Subject|0|||
126321660|NCT04849416|454470672|FG001|Overall Study|On Post-Treatment Follow-up|9|||
126321661|NCT04849416|454470673|FG002|Overall Study|On Post-Treatment Follow-up|10|||
126321662|NCT04849416|454470671|FG000|Overall Study|Withdrawal by Subject|0|||
126321663|NCT04849416|454470672|FG001|Overall Study|Withdrawal by Subject|0|||
126321664|NCT04849416|454470673|FG002|Overall Study|Withdrawal by Subject|1|||
126321665|NCT04849416|454470671|FG000|Overall Study|Lost to Follow-up|1|||
126321666|NCT04849416|454470672|FG001|Overall Study|Lost to Follow-up|0|||
126321667|NCT04849416|454470673|FG002|Overall Study|Lost to Follow-up|0|||
126321668|NCT02131636|454470678|FG000|Overall Study|Personal Reasons|4|||
126321669|NCT02131636|454470679|FG001|Overall Study|Personal Reasons|4|||
126321670|NCT02131636|454470678|FG000|Overall Study|Lost to Follow-up|4|||
126321671|NCT02131636|454470679|FG001|Overall Study|Lost to Follow-up|0|||
126321672|NCT02131636|454470678|FG000|Overall Study|Adverse Event|4|||
126321673|NCT02131636|454470679|FG001|Overall Study|Adverse Event|1|||
126321674|NCT04847232|454470682|FG000|Overall Study|Death|123|||
126321675|NCT04847232|454470683|FG001|Overall Study|Death|115|||
126321676|NCT04847232|454470682|FG000|Overall Study|Lost to Follow-up|3|||
126651237|NCT00560066|455679881|FG001|Overall Study|Withdrawal by Subject|3|||
126651238|NCT00560066|455679880|FG000|Overall Study|Lost to Follow-up|4|||
126651239|NCT00560066|455679881|FG001|Overall Study|Lost to Follow-up|10|||
126651240|NCT00560066|455679880|FG000|Overall Study|Protocol Violation|0|||
126651241|NCT00560066|455679881|FG001|Overall Study|Protocol Violation|1|||
126651242|NCT00560066|455679880|FG000|Overall Study|Administrative reason|0|||
126651243|NCT00560066|455679881|FG001|Overall Study|Administrative reason|5|||
126321677|NCT04847232|454470683|FG001|Overall Study|Lost to Follow-up|10|||
126321678|NCT04847232|454470682|FG000|Overall Study|Withdrawal by Subject|73|||
126321679|NCT04847232|454470683|FG001|Overall Study|Withdrawal by Subject|101|||
126321680|NCT04847232|454470682|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
126321681|NCT04847232|454470683|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
126321682|NCT02290925|454470689|FG000|First Period of Three Months|Lost to Follow-up|2|||
126321683|NCT02290925|454470690|FG001|First Period of Three Months|Lost to Follow-up|1|||
126651244|NCT00560066|455679880|FG000|Overall Study|Missing primary reason|0|||
126651245|NCT00560066|455679881|FG001|Overall Study|Missing primary reason|2|||
126651246|NCT00620282|455679882|FG000|Overall Study|Adverse Event|0|||
126651247|NCT00620282|455679883|FG001|Overall Study|Adverse Event|1|||
126651248|NCT00620282|455679884|FG002|Overall Study|Adverse Event|0|||
126321684|NCT02290925|454470689|FG000|First Period of Three Months|Death|1|||
126321685|NCT02290925|454470690|FG001|First Period of Three Months|Death|0|||
126321686|NCT02290925|454470689|FG000|First Period of Three Months|Insulin Started|1|||
126321687|NCT02290925|454470690|FG001|First Period of Three Months|Insulin Started|1|||
126321688|NCT02290925|454470689|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
126321689|NCT02290925|454470690|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
126321690|NCT02290925|454470689|FG000|Second Period of 3 Months|insulin started|0|||
126321691|NCT02290925|454470690|FG001|Second Period of 3 Months|insulin started|1|||
126321692|NCT01716520|454470691|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
126321693|NCT01716520|454470692|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
126321694|NCT01716520|454470693|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
126321695|NCT01716520|454470694|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
126321696|NCT01716520|454470695|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
126321697|NCT01716520|454470696|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
126321698|NCT01716520|454470691|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
126321699|NCT01716520|454470692|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
126321700|NCT01716520|454470693|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
126321701|NCT01716520|454470694|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
126321702|NCT01716520|454470695|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
126321703|NCT01716520|454470696|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
126321704|NCT01716520|454470691|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126321705|NCT01716520|454470692|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126321706|NCT01716520|454470693|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126321707|NCT01716520|454470694|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126321708|NCT01716520|454470695|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126321709|NCT01716520|454470696|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126321710|NCT01716520|454470691|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
126321711|NCT01716520|454470692|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
126321712|NCT01716520|454470693|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
126321713|NCT01716520|454470694|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
126321714|NCT01716520|454470695|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
126321715|NCT01716520|454470696|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
126321716|NCT01716520|454470691|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126321717|NCT01716520|454470692|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126321718|NCT01716520|454470693|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126321719|NCT01716520|454470694|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126321720|NCT01716520|454470695|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126321721|NCT01716520|454470696|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
126321722|NCT01716520|454470691|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
126321723|NCT01716520|454470692|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
126321724|NCT01716520|454470693|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
126321725|NCT01716520|454470694|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
126321726|NCT01716520|454470695|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
126321727|NCT01716520|454470696|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
126321728|NCT01716520|454470691|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
126321729|NCT01716520|454470692|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
126321730|NCT01716520|454470693|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
126321731|NCT01716520|454470694|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
126321732|NCT01716520|454470695|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
126321733|NCT01716520|454470696|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
126321734|NCT01716520|454470691|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126321735|NCT01716520|454470692|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126321736|NCT01716520|454470693|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126321737|NCT01716520|454470694|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126321738|NCT01716520|454470695|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
126321739|NCT01716520|454470696|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126321740|NCT01716520|454470691|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
126545084|NCT01036022|455289216|FG005|Overall Study|Adverse Event|2|||
126545085|NCT01036022|455289211|FG000|Overall Study|Lack of Efficacy|1|||
126545086|NCT01036022|455289212|FG001|Overall Study|Lack of Efficacy|1|||
126545087|NCT01036022|455289213|FG002|Overall Study|Lack of Efficacy|1|||
126545088|NCT01036022|455289214|FG003|Overall Study|Lack of Efficacy|0|||
126545089|NCT01036022|455289215|FG004|Overall Study|Lack of Efficacy|1|||
126545090|NCT01036022|455289216|FG005|Overall Study|Lack of Efficacy|1|||
126545091|NCT01036022|455289211|FG000|Overall Study|Physician Decision|0|||
126545092|NCT01036022|455289212|FG001|Overall Study|Physician Decision|0|||
126545093|NCT01036022|455289213|FG002|Overall Study|Physician Decision|1|||
126321741|NCT01716520|454470692|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
126545094|NCT01036022|455289214|FG003|Overall Study|Physician Decision|0|||
126545095|NCT01036022|455289215|FG004|Overall Study|Physician Decision|0|||
126321742|NCT01716520|454470693|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
126321743|NCT01716520|454470694|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
126321744|NCT01716520|454470695|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
126321745|NCT01716520|454470696|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
126321746|NCT01716520|454470691|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
126321747|NCT01716520|454470692|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
126321748|NCT01716520|454470693|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
126321749|NCT01716520|454470694|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
126321750|NCT01716520|454470695|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
126321751|NCT01716520|454470696|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
126321752|NCT01716520|454470691|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
126321753|NCT01716520|454470692|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
126321754|NCT01716520|454470693|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
126321755|NCT01716520|454470694|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
126321756|NCT01716520|454470695|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
126321757|NCT01716520|454470696|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
126321758|NCT01716520|454470691|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
126321759|NCT01716520|454470692|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
126321760|NCT01716520|454470693|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
126321761|NCT01716520|454470694|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
126321762|NCT01716520|454470695|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
126321763|NCT01716520|454470696|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
126321764|NCT01716520|454470691|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
126321765|NCT01716520|454470692|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
126321766|NCT01716520|454470693|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
126651249|NCT00620282|455679882|FG000|Overall Study|Arterial line unable to be placed|0|||
126651250|NCT00620282|455679883|FG001|Overall Study|Arterial line unable to be placed|0|||
126651251|NCT00620282|455679884|FG002|Overall Study|Arterial line unable to be placed|1|||
126651252|NCT00620282|455679882|FG000|Overall Study|Withdrawal by Subject|0|||
126651253|NCT00620282|455679883|FG001|Overall Study|Withdrawal by Subject|1|||
126321767|NCT01716520|454470694|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
126321768|NCT01716520|454470695|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
126321769|NCT01716520|454470696|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
126321770|NCT01716520|454470691|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126321771|NCT01716520|454470692|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126321772|NCT01716520|454470693|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126321773|NCT01716520|454470694|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126321774|NCT01716520|454470695|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126321775|NCT01716520|454470696|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
126321776|NCT01716520|454470691|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126321777|NCT01716520|454470692|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126321778|NCT01716520|454470693|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
126321779|NCT01716520|454470694|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126651254|NCT00620282|455679884|FG002|Overall Study|Withdrawal by Subject|0|||
126651255|NCT01258595|455679885|FG000|Overall Study|Lost to Follow-up|1|||
126651256|NCT01258595|455679886|FG001|Overall Study|Lost to Follow-up|0|||
126651257|NCT01258595|455679885|FG000|Overall Study|Withdrawal by Subject|0|||
126651258|NCT01258595|455679886|FG001|Overall Study|Withdrawal by Subject|1|||
126651259|NCT01820585|455679887|FG000|Overall Study|Adverse Event|9|||
126651260|NCT01820585|455679888|FG001|Overall Study|Adverse Event|13|||
126651261|NCT01820585|455679889|FG002|Overall Study|Adverse Event|23|||
126651262|NCT01820585|455679890|FG003|Overall Study|Adverse Event|34|||
126651263|NCT01820585|455679887|FG000|Overall Study|Lack of Efficacy|9|||
126651264|NCT01820585|455679888|FG001|Overall Study|Lack of Efficacy|7|||
126651265|NCT01820585|455679889|FG002|Overall Study|Lack of Efficacy|5|||
126651266|NCT01820585|455679890|FG003|Overall Study|Lack of Efficacy|1|||
126651267|NCT01820585|455679887|FG000|Overall Study|Withdrawal by Subject|3|||
126651268|NCT01820585|455679888|FG001|Overall Study|Withdrawal by Subject|7|||
126651269|NCT01820585|455679889|FG002|Overall Study|Withdrawal by Subject|3|||
126321780|NCT01716520|454470695|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126321781|NCT01716520|454470696|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126321782|NCT03699540|454470697|FG000|Overall Study|Lost to Follow-up|1|||
126321783|NCT02697591|454470702|FG000|Overall Study|Lost to Follow-up|0|||
126321784|NCT02697591|454470703|FG001|Overall Study|Lost to Follow-up|0|||
126321785|NCT02697591|454470704|FG002|Overall Study|Lost to Follow-up|0|||
126651270|NCT01820585|455679890|FG003|Overall Study|Withdrawal by Subject|8|||
126651271|NCT01820585|455679887|FG000|Overall Study|Lost to Follow-up|3|||
126651272|NCT01820585|455679888|FG001|Overall Study|Lost to Follow-up|3|||
126651273|NCT01820585|455679889|FG002|Overall Study|Lost to Follow-up|0|||
126651274|NCT01820585|455679890|FG003|Overall Study|Lost to Follow-up|3|||
126651275|NCT01820585|455679887|FG000|Overall Study|Protocol Violation|3|||
126321786|NCT02697591|454470705|FG003|Overall Study|Lost to Follow-up|0|||
126321787|NCT02697591|454470706|FG004|Overall Study|Lost to Follow-up|0|||
126321788|NCT02697591|454470707|FG005|Overall Study|Lost to Follow-up|1|||
126321789|NCT02697591|454470708|FG006|Overall Study|Lost to Follow-up|1|||
126321790|NCT02697591|454470709|FG007|Overall Study|Lost to Follow-up|0|||
126321791|NCT02697591|454470710|FG008|Overall Study|Lost to Follow-up|0|||
126651276|NCT01820585|455679888|FG001|Overall Study|Protocol Violation|1|||
126651277|NCT01820585|455679889|FG002|Overall Study|Protocol Violation|1|||
126651278|NCT01820585|455679890|FG003|Overall Study|Protocol Violation|1|||
126651279|NCT01820585|455679887|FG000|Overall Study|Subject non-compliance|0|||
126651280|NCT01820585|455679888|FG001|Overall Study|Subject non-compliance|0|||
126651281|NCT01820585|455679889|FG002|Overall Study|Subject non-compliance|1|||
126651282|NCT01820585|455679890|FG003|Overall Study|Subject non-compliance|2|||
126651283|NCT01820585|455679887|FG000|Overall Study|at sponsor request|0|||
126651284|NCT01820585|455679888|FG001|Overall Study|at sponsor request|0|||
126651285|NCT01820585|455679889|FG002|Overall Study|at sponsor request|1|||
126651286|NCT01820585|455679890|FG003|Overall Study|at sponsor request|0|||
126651287|NCT01820585|455679887|FG000|Overall Study|Pregnancy|0|||
126651288|NCT01820585|455679888|FG001|Overall Study|Pregnancy|1|||
126651289|NCT01820585|455679889|FG002|Overall Study|Pregnancy|0|||
126651290|NCT01820585|455679890|FG003|Overall Study|Pregnancy|0|||
126651291|NCT01712659|455679891|FG000|Dose Escalation|Physician Decision|0|||
126651292|NCT01712659|455679892|FG001|Dose Escalation|Physician Decision|1|||
126651293|NCT01712659|455679893|FG002|Dose Escalation|Physician Decision|0|||
126651294|NCT01712659|455679894|FG003|Dose Escalation|Physician Decision|0|||
126651295|NCT01712659|455679895|FG004|Dose Escalation|Physician Decision|0|||
126651296|NCT01712659|455679891|FG000|Dose Escalation|Unable to take study drug|0|||
126651297|NCT01712659|455679892|FG001|Dose Escalation|Unable to take study drug|1|||
126651298|NCT01712659|455679893|FG002|Dose Escalation|Unable to take study drug|0|||
126651299|NCT01712659|455679894|FG003|Dose Escalation|Unable to take study drug|0|||
126651300|NCT01712659|455679895|FG004|Dose Escalation|Unable to take study drug|0|||
126651301|NCT01712659|455679891|FG000|Dose Expansion|Early disease progression|1|||
126651302|NCT01712659|455679892|FG001|Dose Expansion|Early disease progression|0|||
126651303|NCT01712659|455679893|FG002|Dose Expansion|Early disease progression|0|||
126651304|NCT01712659|455679894|FG003|Dose Expansion|Early disease progression|0|||
126651305|NCT01712659|455679895|FG004|Dose Expansion|Early disease progression|0|||
126651306|NCT01712659|455679891|FG000|Dose Expansion|Physician Decision|1|||
126651307|NCT01712659|455679892|FG001|Dose Expansion|Physician Decision|0|||
126651308|NCT01712659|455679893|FG002|Dose Expansion|Physician Decision|0|||
126651309|NCT01712659|455679894|FG003|Dose Expansion|Physician Decision|0|||
126651310|NCT01712659|455679895|FG004|Dose Expansion|Physician Decision|0|||
126651311|NCT00548262|455679896|FG000|Overall Study|Death|21|||
126651312|NCT00548262|455679896|FG000|Overall Study|Adverse Event|2|||
126651313|NCT00548262|455679896|FG000|Overall Study|Lack of Efficacy|4|||
126651314|NCT00548262|455679896|FG000|Overall Study|Lost to Follow-up|1|||
126651315|NCT00548262|455679896|FG000|Overall Study|Other|3|||
126651316|NCT00548262|455679896|FG000|Overall Study|Withdrawal by Subject|1|||
126651317|NCT01993927|455679899|FG000|Overall Study|Case Report Forms Uncollected|18|||
126651318|NCT01993927|455679899|FG000|Overall Study|Protocol Violation|11|||
126651319|NCT00895154|455679900|FG000|Overall Study|Lost to Follow-up|1|||
126651320|NCT00895154|455679901|FG001|Overall Study|Lost to Follow-up|1|||
126651321|NCT00895154|455679900|FG000|Overall Study|Withdrawal by Subject|0|||
126651322|NCT00895154|455679901|FG001|Overall Study|Withdrawal by Subject|1|||
126651323|NCT02729831|455679903|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
126651324|NCT02729831|455679904|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
126651325|NCT02729831|455679905|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
126651326|NCT02729831|455679906|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
126651327|NCT02729831|455679903|FG000|1 Week Post-visit|Lost to Follow-up|43|||
126651328|NCT02729831|455679904|FG001|1 Week Post-visit|Lost to Follow-up|40|||
126651329|NCT02729831|455679905|FG002|1 Week Post-visit|Lost to Follow-up|38|||
126321792|NCT02697591|454470711|FG009|Overall Study|Lost to Follow-up|1|||
126321793|NCT02697591|454470702|FG000|Overall Study|Withdrawal by Subject|1|||
126651330|NCT02729831|455679906|FG003|1 Week Post-visit|Lost to Follow-up|36|||
126321794|NCT02697591|454470703|FG001|Overall Study|Withdrawal by Subject|1|||
126651331|NCT02729831|455679903|FG000|6 Month Follow-up|Lost to Follow-up|54|||
126321795|NCT02697591|454470704|FG002|Overall Study|Withdrawal by Subject|2|||
126321796|NCT02697591|454470705|FG003|Overall Study|Withdrawal by Subject|1|||
126321797|NCT02697591|454470706|FG004|Overall Study|Withdrawal by Subject|7|||
126651332|NCT02729831|455679904|FG001|6 Month Follow-up|Lost to Follow-up|51|||
126651333|NCT02729831|455679905|FG002|6 Month Follow-up|Lost to Follow-up|48|||
126651334|NCT02729831|455679906|FG003|6 Month Follow-up|Lost to Follow-up|42|||
126651335|NCT02729831|455679903|FG000|6 Month Follow-up|Death|1|||
126651336|NCT02729831|455679904|FG001|6 Month Follow-up|Death|3|||
126321798|NCT02697591|454470707|FG005|Overall Study|Withdrawal by Subject|6|||
126321799|NCT02697591|454470708|FG006|Overall Study|Withdrawal by Subject|9|||
126651337|NCT02729831|455679905|FG002|6 Month Follow-up|Death|0|||
126651338|NCT02729831|455679906|FG003|6 Month Follow-up|Death|1|||
126651339|NCT01747551|455679907|FG000|Overall Study|Progressive Disease|24|||
126651340|NCT01747551|455679908|FG001|Overall Study|Progressive Disease|17|||
126651341|NCT01747551|455679907|FG000|Overall Study|Death|3|||
126651342|NCT01747551|455679908|FG001|Overall Study|Death|1|||
126651343|NCT01747551|455679907|FG000|Overall Study|Adverse Event|7|||
126651344|NCT01747551|455679908|FG001|Overall Study|Adverse Event|1|||
126651345|NCT01747551|455679907|FG000|Overall Study|Prolonged Treatment Delay|2|||
126651346|NCT01747551|455679908|FG001|Overall Study|Prolonged Treatment Delay|0|||
126651347|NCT01747551|455679907|FG000|Overall Study|Withdrawal by Subject|3|||
126651348|NCT01747551|455679908|FG001|Overall Study|Withdrawal by Subject|1|||
126651349|NCT01747551|455679907|FG000|Overall Study|Physician Decision|2|||
126651350|NCT01747551|455679908|FG001|Overall Study|Physician Decision|1|||
126651351|NCT01747551|455679907|FG000|Overall Study|Other|2|||
126651352|NCT01747551|455679908|FG001|Overall Study|Other|0|||
126651353|NCT01142115|455679909|FG000|First Intervention|Lack of Efficacy|1|||
126651354|NCT01142115|455679910|FG001|First Intervention|Lack of Efficacy|1|||
126651355|NCT01142115|455679909|FG000|First Intervention|Adverse Event|1|||
126651356|NCT01142115|455679910|FG001|First Intervention|Adverse Event|0|||
126651357|NCT02091206|455679911|FG000|Treatment Period|Adverse Event|0|||
126651358|NCT02091206|455679912|FG001|Treatment Period|Adverse Event|1|||
126651359|NCT02091206|455679913|FG002|Treatment Period|Adverse Event|0|||
126651360|NCT02091206|455679914|FG003|Treatment Period|Adverse Event|0|||
126651361|NCT02091206|455679911|FG000|Treatment Period|Met withdrawal criteria|0|||
126651362|NCT02091206|455679912|FG001|Treatment Period|Met withdrawal criteria|0|||
126651363|NCT02091206|455679913|FG002|Treatment Period|Met withdrawal criteria|1|||
126651364|NCT02091206|455679914|FG003|Treatment Period|Met withdrawal criteria|0|||
126651365|NCT02091206|455679911|FG000|Taper Period|Participant refused study drug|1|||
126651366|NCT02091206|455679912|FG001|Taper Period|Participant refused study drug|0|||
126651367|NCT02091206|455679913|FG002|Taper Period|Participant refused study drug|0|||
126651368|NCT02091206|455679914|FG003|Taper Period|Participant refused study drug|1|||
126651369|NCT02091206|455679911|FG000|Taper Period|Lost to Follow-up|0|||
126651370|NCT02091206|455679912|FG001|Taper Period|Lost to Follow-up|0|||
126651371|NCT02091206|455679913|FG002|Taper Period|Lost to Follow-up|0|||
126651372|NCT02091206|455679914|FG003|Taper Period|Lost to Follow-up|1|||
126651373|NCT00700778|455679915|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
126651374|NCT03381339|455679916|FG000|Overall Study|Protocol Violation|4|||
126651375|NCT03381339|455679917|FG001|Overall Study|Protocol Violation|3|||
126651376|NCT03381339|455679916|FG000|Overall Study|Lost to Follow-up|0|||
126651377|NCT03381339|455679917|FG001|Overall Study|Lost to Follow-up|1|||
126651378|NCT04927247|455679920|FG000|Overall Study|Other|2|||
126651379|NCT04927247|455679921|FG001|Overall Study|Other|1|||
126651380|NCT04927247|455679920|FG000|Overall Study|Physician Decision|0|||
126651381|NCT04927247|455679921|FG001|Overall Study|Physician Decision|1|||
126651382|NCT04927247|455679920|FG000|Overall Study|Adverse Event|1|||
126651383|NCT04927247|455679921|FG001|Overall Study|Adverse Event|0|||
126651384|NCT00760474|455679922|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
126651385|NCT00760474|455679923|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
126651386|NCT00760474|455679922|FG000|Placebo Washout Period|Other|0|||
126651387|NCT00760474|455679923|FG001|Placebo Washout Period|Other|1|||
126651388|NCT00760474|455679922|FG000|Period 2 (P2)|Lost to Follow-up|1|||
126651389|NCT00760474|455679923|FG001|Period 2 (P2)|Lost to Follow-up|0|||
126651390|NCT00760474|455679922|FG000|Period 2 (P2)|Adverse Event|0|||
126651391|NCT00760474|455679923|FG001|Period 2 (P2)|Adverse Event|1|||
126651392|NCT04664400|455679924|FG000|Overall Study|Withdrawal by Subject|2|||
126651393|NCT01011153|455679929|FG000|Overall Study|Less than 78 cases completed|8|||
126651394|NCT01011153|455679930|FG001|Overall Study|Less than 78 cases completed|11|||
126651395|NCT01011153|455679931|FG002|Overall Study|Less than 78 cases completed|9|||
126651396|NCT02019667|455679932|FG000|First Intervention (6 Months)|Adverse Event|0|||
126651397|NCT02019667|455679933|FG001|First Intervention (6 Months)|Adverse Event|1|||
126651398|NCT02019667|455679932|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
126651399|NCT02019667|455679933|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
126651400|NCT02019667|455679932|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
126651401|NCT02019667|455679933|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
126651402|NCT02631577|455679936|FG000|Overall Study|Death|1|||
126651403|NCT02631577|455679937|FG001|Overall Study|Death|7|||
126651404|NCT02631577|455679936|FG000|Overall Study|Withdrawal by Subject|0|||
126651405|NCT02631577|455679937|FG001|Overall Study|Withdrawal by Subject|3|||
126651406|NCT03981861|455679943|FG000|Overall Study|Withdrawal by Subject|3|||
126651407|NCT05618912|455679944|FG000|Overall Study|Lost to Follow-up|14|||
126651408|NCT05618912|455679945|FG001|Overall Study|Lost to Follow-up|19|||
126651409|NCT00432666|455681850|FG000|Main Period|Adverse Event|1|||
126651410|NCT00432666|455681851|FG001|Main Period|Adverse Event|1|||
126651411|NCT00432666|455681850|FG000|Main Period|Consent Withdrawn|1|||
126651412|NCT00432666|455681851|FG001|Main Period|Consent Withdrawn|0|||
126651413|NCT00432666|455681850|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
126651414|NCT00432666|455681851|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
126651415|NCT00432666|455681850|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
126321800|NCT02697591|454470709|FG007|Overall Study|Withdrawal by Subject|1|||
126321801|NCT02697591|454470710|FG008|Overall Study|Withdrawal by Subject|6|||
126321802|NCT02697591|454470711|FG009|Overall Study|Withdrawal by Subject|10|||
126321803|NCT02697591|454470702|FG000|Overall Study|Physician Decision|1|||
126321804|NCT02697591|454470703|FG001|Overall Study|Physician Decision|0|||
126321805|NCT02697591|454470704|FG002|Overall Study|Physician Decision|0|||
126321806|NCT02697591|454470705|FG003|Overall Study|Physician Decision|0|||
126321807|NCT02697591|454470706|FG004|Overall Study|Physician Decision|1|||
126321808|NCT02697591|454470707|FG005|Overall Study|Physician Decision|2|||
126321809|NCT02697591|454470708|FG006|Overall Study|Physician Decision|0|||
126321810|NCT02697591|454470709|FG007|Overall Study|Physician Decision|0|||
126321811|NCT02697591|454470710|FG008|Overall Study|Physician Decision|1|||
126321812|NCT02697591|454470711|FG009|Overall Study|Physician Decision|1|||
126321813|NCT02697591|454470702|FG000|Overall Study|Death|2|||
126321814|NCT02697591|454470703|FG001|Overall Study|Death|3|||
126321815|NCT02697591|454470704|FG002|Overall Study|Death|1|||
126321816|NCT02697591|454470705|FG003|Overall Study|Death|1|||
126321817|NCT02697591|454470706|FG004|Overall Study|Death|4|||
126321818|NCT02697591|454470707|FG005|Overall Study|Death|5|||
126321819|NCT02697591|454470708|FG006|Overall Study|Death|3|||
126321820|NCT02697591|454470709|FG007|Overall Study|Death|1|||
126321821|NCT02697591|454470710|FG008|Overall Study|Death|1|||
126321822|NCT02697591|454470711|FG009|Overall Study|Death|5|||
126321823|NCT02697591|454470702|FG000|Overall Study|Reason not Specified|0|||
126321824|NCT02697591|454470703|FG001|Overall Study|Reason not Specified|0|||
126321825|NCT02697591|454470704|FG002|Overall Study|Reason not Specified|0|||
126321826|NCT02697591|454470705|FG003|Overall Study|Reason not Specified|1|||
126321827|NCT02697591|454470706|FG004|Overall Study|Reason not Specified|1|||
126321828|NCT02697591|454470707|FG005|Overall Study|Reason not Specified|2|||
126321829|NCT02697591|454470708|FG006|Overall Study|Reason not Specified|3|||
126321830|NCT02697591|454470709|FG007|Overall Study|Reason not Specified|1|||
126321831|NCT02697591|454470710|FG008|Overall Study|Reason not Specified|1|||
126321832|NCT02697591|454470711|FG009|Overall Study|Reason not Specified|3|||
126321833|NCT01038752|454470713|FG000|Overall Study|Tumor Progression|2|||
126321834|NCT01038752|454470714|FG001|Overall Study|Tumor Progression|2|||
126321835|NCT01038752|454470713|FG000|Overall Study|Lost to Follow-up|3|||
126321836|NCT01038752|454470714|FG001|Overall Study|Lost to Follow-up|3|||
126321837|NCT00530790|454470715|FG000|Overall Study|Adverse Event|2|||
126321838|NCT00530790|454470715|FG000|Overall Study|Withdrawal by Subject|2|||
126321839|NCT00530790|454470715|FG000|Overall Study|Physician Decision|1|||
126321840|NCT01084538|454470718|FG000|Overall Study|Drug not available|30|||
126321841|NCT01084538|454470718|FG000|Overall Study|Adverse Event|9|||
126321842|NCT01084538|454470718|FG000|Overall Study|Kidney transplant|6|||
126321843|NCT01084538|454470718|FG000|Overall Study|Serious Adverse Event|3|||
126321844|NCT01084538|454470718|FG000|Overall Study|Lack of effectiveness|2|||
126321845|NCT01084538|454470718|FG000|Overall Study|Patient noncompliance|2|||
126321846|NCT01084538|454470718|FG000|Overall Study|Hyperphosphatemia|2|||
126321847|NCT01084538|454470718|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
126321848|NCT01084538|454470718|FG000|Overall Study|Change of residence|2|||
126321849|NCT01084538|454470718|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
126321850|NCT01084538|454470718|FG000|Overall Study|Reason unknown|8|||
126321851|NCT02279745|454470719|FG000|Overall Study|Adverse Event|7|||
126321852|NCT02279745|454470719|FG000|Overall Study|Death|6|||
126545096|NCT01036022|455289216|FG005|Overall Study|Physician Decision|0|||
126545097|NCT01036022|455289211|FG000|Overall Study|Withdrawal by Subject|0|||
126545098|NCT01036022|455289212|FG001|Overall Study|Withdrawal by Subject|0|||
126545099|NCT01036022|455289213|FG002|Overall Study|Withdrawal by Subject|0|||
126545100|NCT01036022|455289214|FG003|Overall Study|Withdrawal by Subject|1|||
126545101|NCT01036022|455289215|FG004|Overall Study|Withdrawal by Subject|2|||
126545102|NCT01036022|455289216|FG005|Overall Study|Withdrawal by Subject|0|||
126545103|NCT00576732|455289217|FG000|DOUBLE BLIND|Adverse Event|0|||
126545104|NCT00576732|455289218|FG001|DOUBLE BLIND|Adverse Event|0|||
126545105|NCT00576732|455289219|FG002|DOUBLE BLIND|Adverse Event|1|||
126545106|NCT00576732|455289220|FG003|DOUBLE BLIND|Adverse Event|0|||
126545107|NCT00576732|455289221|FG004|DOUBLE BLIND|Adverse Event|0|||
126545108|NCT00576732|455289222|FG005|DOUBLE BLIND|Adverse Event|0|||
126545109|NCT00576732|455289217|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
126545110|NCT00576732|455289218|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
126545111|NCT00576732|455289219|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
126321853|NCT02279745|454470719|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
126321854|NCT02279745|454470719|FG000|Overall Study|Withdrawal by Subject|2|||
126321855|NCT02279745|454470719|FG000|Overall Study|Pregnancy|1|||
126321856|NCT02279745|454470719|FG000|Overall Study|Study Non-compliance|1|||
126321857|NCT02279745|454470719|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
126321858|NCT00106639|454470728|FG000|Overall Study|Adverse Event|3|||
126321859|NCT00106639|454470729|FG001|Overall Study|Adverse Event|4|||
126545112|NCT00576732|455289220|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
126545113|NCT00576732|455289221|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
126545114|NCT00576732|455289222|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
126651416|NCT00432666|455681851|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
126651417|NCT00432666|455681850|FG000|Open-Label Extension Period|Adverse Event|5|||
126651418|NCT00432666|455681851|FG001|Open-Label Extension Period|Adverse Event|0|||
126651419|NCT00432666|455681850|FG000|Open-Label Extension Period|Consent withdrawn|10|||
126651420|NCT00432666|455681851|FG001|Open-Label Extension Period|Consent withdrawn|0|||
126651421|NCT00432666|455681850|FG000|Open-Label Extension Period|Physician Decision|3|||
126651422|NCT00432666|455681851|FG001|Open-Label Extension Period|Physician Decision|0|||
126651423|NCT00978627|455681852|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
126651424|NCT00978627|455681853|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
126651425|NCT00978627|455681852|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
126651426|NCT00978627|455681853|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
126651427|NCT00978627|455681852|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
126651428|NCT00978627|455681853|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
126651429|NCT00978627|455681852|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
126651430|NCT00978627|455681853|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
126651431|NCT00978627|455681852|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
126651432|NCT00978627|455681853|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
126651433|NCT00978627|455681852|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
126651434|NCT00978627|455681853|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
126651435|NCT00978627|455681852|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
126651436|NCT00978627|455681853|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
126651437|NCT00978627|455681852|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
126651438|NCT00978627|455681853|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
126651439|NCT00978627|455681852|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
126651440|NCT00978627|455681853|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
126651441|NCT02980731|455681856|FG000|Overall Study|Death|63|||
126651442|NCT02980731|455681856|FG000|Overall Study|Withdrawal by Subject|6|||
126651443|NCT02980731|455681856|FG000|Overall Study|Lost to Follow-up|5|||
126651444|NCT02980731|455681856|FG000|Overall Study|Study terminated by Sponsor|4|||
126651445|NCT02980731|455681856|FG000|Overall Study|Completed survival follow-up period|65|||
126651446|NCT02980731|455681856|FG000|Overall Study|COVID-19 infection|1|||
126651447|NCT02980731|455681856|FG000|Overall Study|Other, not specified|66|||
126651448|NCT02516332|455681857|FG000|Overall Study|Withdrawal by Subject|2|||
126651449|NCT02516332|455681858|FG001|Overall Study|Withdrawal by Subject|1|||
126651450|NCT02516332|455681859|FG002|Overall Study|Withdrawal by Subject|2|||
126651451|NCT03037931|455681860|FG000|Overall Study|Death|354|||
126651452|NCT03037931|455681861|FG001|Overall Study|Death|367|||
126651453|NCT03037931|455681860|FG000|Overall Study|Lost to Follow-up|7|||
126651454|NCT03037931|455681861|FG001|Overall Study|Lost to Follow-up|4|||
126651455|NCT03037931|455681860|FG000|Overall Study|Withdrawal by Subject|48|||
126651456|NCT03037931|455681861|FG001|Overall Study|Withdrawal by Subject|41|||
126651457|NCT00605215|455681862|FG000|Overall Study|Death|0|||
126651458|NCT00605215|455681863|FG001|Overall Study|Death|0|||
126651459|NCT00605215|455681864|FG002|Overall Study|Death|1|||
126651460|NCT00605215|455681862|FG000|Overall Study|Adverse Event|19|||
126651461|NCT00605215|455681863|FG001|Overall Study|Adverse Event|21|||
126651462|NCT00605215|455681864|FG002|Overall Study|Adverse Event|26|||
126651463|NCT00605215|455681862|FG000|Overall Study|Refusal to sign the re-consent form|8|||
126651464|NCT00605215|455681863|FG001|Overall Study|Refusal to sign the re-consent form|3|||
126651465|NCT00605215|455681864|FG002|Overall Study|Refusal to sign the re-consent form|3|||
126651466|NCT00605215|455681862|FG000|Overall Study|Withdrawal by Subject|39|||
126651467|NCT00605215|455681863|FG001|Overall Study|Withdrawal by Subject|37|||
126651468|NCT00605215|455681864|FG002|Overall Study|Withdrawal by Subject|27|||
126651469|NCT00605215|455681862|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
126651470|NCT00605215|455681863|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
126651471|NCT00605215|455681864|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
126651472|NCT00605215|455681862|FG000|Overall Study|Protocol Violation|3|||
126651473|NCT00605215|455681863|FG001|Overall Study|Protocol Violation|4|||
126651474|NCT00605215|455681864|FG002|Overall Study|Protocol Violation|1|||
126651475|NCT00605215|455681862|FG000|Overall Study|Pregnancy|8|||
126651476|NCT00605215|455681863|FG001|Overall Study|Pregnancy|5|||
126651477|NCT00605215|455681864|FG002|Overall Study|Pregnancy|4|||
126651478|NCT00605215|455681862|FG000|Overall Study|Lost to Follow-up|8|||
126651479|NCT00605215|455681863|FG001|Overall Study|Lost to Follow-up|5|||
126651480|NCT00605215|455681864|FG002|Overall Study|Lost to Follow-up|2|||
126651481|NCT00605215|455681862|FG000|Overall Study|Other than specified|0|||
126651482|NCT00605215|455681863|FG001|Overall Study|Other than specified|2|||
126651483|NCT00605215|455681864|FG002|Overall Study|Other than specified|1|||
126651484|NCT01342341|455681865|FG000|Overall Study|Lost to Follow-up|4|||
126651485|NCT01342341|455681866|FG001|Overall Study|Lost to Follow-up|4|||
126651486|NCT02914275|455681867|FG000|Overall Study|Lost to Follow-up|84|||
126651487|NCT02914275|455681868|FG001|Overall Study|Lost to Follow-up|29|||
126651488|NCT02914275|455681867|FG000|Overall Study|Withdrawal by Subject|26|||
126321860|NCT00106639|454470730|FG002|Overall Study|Adverse Event|1|||
126321861|NCT00106639|454470728|FG000|Overall Study|Protocol Violation|0|||
126321862|NCT00106639|454470729|FG001|Overall Study|Protocol Violation|1|||
126321863|NCT00106639|454470730|FG002|Overall Study|Protocol Violation|0|||
126321864|NCT00106639|454470728|FG000|Overall Study|Withdrawal by Subject|0|||
126321865|NCT00106639|454470729|FG001|Overall Study|Withdrawal by Subject|1|||
126321866|NCT00106639|454470730|FG002|Overall Study|Withdrawal by Subject|0|||
126321867|NCT00106639|454470728|FG000|Overall Study|Participant defaulted|0|||
126321868|NCT00106639|454470729|FG001|Overall Study|Participant defaulted|1|||
126321869|NCT00106639|454470730|FG002|Overall Study|Participant defaulted|1|||
126321870|NCT00594386|454470732|FG000|Overall Study|Major protocol violation|2|||
126321871|NCT00594386|454470732|FG000|Overall Study|Lack of Efficacy|12|||
126321872|NCT00594386|454470732|FG000|Overall Study|Adverse Event|68|||
126321873|NCT00594386|454470732|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
126321874|NCT00594386|454470732|FG000|Overall Study|Subject withdrew consent|35|||
126321875|NCT00594386|454470732|FG000|Overall Study|Study ended per sponsor|115|||
126321876|NCT00594386|454470732|FG000|Overall Study|Lost to Follow-up|6|||
126321877|NCT00594386|454470732|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
126321878|NCT00594386|454470732|FG000|Overall Study|Other: Subject moved to Seattle|1|||
126321879|NCT00594386|454470732|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
126321880|NCT00594386|454470732|FG000|Overall Study|Other: Study terminated per investigator|2|||
126321881|NCT00594386|454470732|FG000|Overall Study|Other: Sponsor closure of study|1|||
126321882|NCT00594386|454470732|FG000|Overall Study|Other: Site terminated participation|1|||
126321883|NCT00594386|454470732|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
126321884|NCT00594386|454470732|FG000|Overall Study|Other: Loss of drivers license|1|||
126321885|NCT01210144|454470733|FG000|Overall Study|Lack of ovarian response|1|||
126321886|NCT01210144|454470734|FG001|Overall Study|Lack of ovarian response|0|||
126321887|NCT01210144|454470733|FG000|Overall Study|No fertilization|1|||
126321888|NCT01210144|454470734|FG001|Overall Study|No fertilization|0|||
126321889|NCT01210144|454470733|FG000|Overall Study|No transfer|1|||
126321890|NCT01210144|454470734|FG001|Overall Study|No transfer|0|||
126321891|NCT00094536|454470741|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
126321892|NCT00094536|454470741|FG000|Treatment and Follow-up|Adverse Event|4|||
126321893|NCT00094536|454470741|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
126321894|NCT00094536|454470741|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
126321895|NCT00094536|454470741|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
126321896|NCT00094536|454470741|FG000|Treatment and Follow-up|Subject non-compliance|9|||
126321897|NCT00094536|454470741|FG000|Treatment and Follow-up|Unable to attend visits|1|||
126321898|NCT00494221|454470742|FG000|Overall Study|Death|15|||
126321899|NCT00494221|454470743|FG001|Overall Study|Death|9|||
126321900|NCT00494221|454470744|FG002|Overall Study|Death|14|||
126321901|NCT00494221|454470742|FG000|Overall Study|Withdrawal by Subject|1|||
126321902|NCT00494221|454470743|FG001|Overall Study|Withdrawal by Subject|2|||
126321903|NCT00494221|454470744|FG002|Overall Study|Withdrawal by Subject|0|||
126321904|NCT01900431|454470746|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
126321905|NCT01900431|454470747|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
126321906|NCT01900431|454470748|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
126321907|NCT01900431|454470746|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
126321908|NCT01900431|454470747|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
126321909|NCT01900431|454470748|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
126321910|NCT01900431|454470746|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
126321911|NCT01900431|454470747|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
126321912|NCT01900431|454470748|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
126321913|NCT01900431|454470746|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
126321914|NCT01900431|454470747|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
126321915|NCT01900431|454470748|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
126321916|NCT01900431|454470746|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
126321917|NCT01900431|454470747|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
126651489|NCT02914275|455681868|FG001|Overall Study|Withdrawal by Subject|10|||
126651490|NCT02914275|455681867|FG000|Overall Study|Protocol Violation|1|||
126651491|NCT02914275|455681868|FG001|Overall Study|Protocol Violation|1|||
126651492|NCT02914275|455681867|FG000|Overall Study|Physician Decision|3|||
126651493|NCT02914275|455681868|FG001|Overall Study|Physician Decision|1|||
126651494|NCT02914275|455681867|FG000|Overall Study|Other|4|||
126321918|NCT01900431|454470748|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
126321919|NCT01900431|454470746|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
126321920|NCT01900431|454470747|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
126321921|NCT01900431|454470748|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
126321922|NCT01900431|454470746|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
126321923|NCT01900431|454470747|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
126321924|NCT01900431|454470748|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
126651495|NCT02914275|455681868|FG001|Overall Study|Other|1|||
126651496|NCT02914275|455681867|FG000|Overall Study|Excluded due to invalid informed consent|3|||
126321925|NCT01900431|454470746|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
126321926|NCT01900431|454470747|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
126321927|NCT01900431|454470748|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
126321928|NCT01900431|454470746|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
126321929|NCT01900431|454470747|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
126321930|NCT01900431|454470748|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
126321931|NCT03172364|454470752|FG000|Overall Study|Adverse Event|1|||
126321932|NCT03172364|454470753|FG001|Overall Study|Adverse Event|1|||
126321933|NCT03172364|454470752|FG000|Overall Study|Protocol Violation|1|||
126321934|NCT03172364|454470753|FG001|Overall Study|Protocol Violation|0|||
126321935|NCT03755518|454470754|FG000|Overall Study|Lack of Efficacy|10|||
126321936|NCT03755518|454470754|FG000|Overall Study|Adverse Event|7|||
126321937|NCT03755518|454470754|FG000|Overall Study|Study Terminated by Sponsor|5|||
126321938|NCT03755518|454470754|FG000|Overall Study|Death|1|||
126321939|NCT03755518|454470754|FG000|Overall Study|Withdrawal by Subject|3|||
126321940|NCT03755518|454470754|FG000|Overall Study|Progressive Disease|4|||
126321941|NCT03755518|454470754|FG000|Overall Study|Bone Marrow Transplant|4|||
126321942|NCT03755518|454470754|FG000|Overall Study|Physicians Decision|1|||
126321943|NCT03755518|454470754|FG000|Overall Study|Relapse|1|||
126321944|NCT03755518|454470754|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
126321945|NCT03755518|454470754|FG000|Overall Study|Withdrawal by PI|1|||
126321946|NCT01714609|454470755|FG000|Overall Study|Protocol Violation|1|||
126321947|NCT01714609|454470756|FG001|Overall Study|Protocol Violation|0|||
126321948|NCT00630747|454470757|FG000|Overall Study|Death|1|||
126321949|NCT00630747|454470757|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
126321950|NCT00630747|454470757|FG000|Overall Study|Returned to country of origin|1|||
126321951|NCT04503668|454470760|FG000|Overall Study|Incomplete data|4|||
126321952|NCT04503668|454470761|FG001|Overall Study|Incomplete data|3|||
126321953|NCT04503668|454470760|FG000|Overall Study|Withdrawal by Subject|1|||
126321954|NCT04503668|454470761|FG001|Overall Study|Withdrawal by Subject|1|||
126321955|NCT04503668|454470760|FG000|Overall Study|Adverse Event|2|||
126321956|NCT04503668|454470761|FG001|Overall Study|Adverse Event|0|||
126321957|NCT02306694|454470762|FG000|Overall Study|Withdrawal by Subject|3|||
126321958|NCT02306694|454470762|FG000|Overall Study|Lost to Follow-up|1|||
126321959|NCT00603382|454470763|FG000|Overall Study|Adverse Event|0|||
126321960|NCT00603382|454470764|FG001|Overall Study|Adverse Event|1|||
126321961|NCT00603382|454470765|FG002|Overall Study|Adverse Event|1|||
126321962|NCT00603382|454470766|FG003|Overall Study|Adverse Event|2|||
126321963|NCT00603382|454470767|FG004|Overall Study|Adverse Event|1|||
126321964|NCT00603382|454470768|FG005|Overall Study|Adverse Event|2|||
126321965|NCT00603382|454470763|FG000|Overall Study|Lack of Efficacy|14|||
126321966|NCT00603382|454470764|FG001|Overall Study|Lack of Efficacy|9|||
126321967|NCT00603382|454470765|FG002|Overall Study|Lack of Efficacy|3|||
126321968|NCT00603382|454470766|FG003|Overall Study|Lack of Efficacy|6|||
126321969|NCT00603382|454470767|FG004|Overall Study|Lack of Efficacy|6|||
126321970|NCT00603382|454470768|FG005|Overall Study|Lack of Efficacy|11|||
126321971|NCT00603382|454470763|FG000|Overall Study|Protocol Violation|1|||
126321972|NCT00603382|454470764|FG001|Overall Study|Protocol Violation|0|||
126321973|NCT00603382|454470765|FG002|Overall Study|Protocol Violation|1|||
126321974|NCT00603382|454470766|FG003|Overall Study|Protocol Violation|2|||
126321975|NCT00603382|454470767|FG004|Overall Study|Protocol Violation|1|||
126321976|NCT00603382|454470768|FG005|Overall Study|Protocol Violation|0|||
126321977|NCT00603382|454470763|FG000|Overall Study|Lost to Follow-up|0|||
126321978|NCT00603382|454470764|FG001|Overall Study|Lost to Follow-up|1|||
126321979|NCT00603382|454470765|FG002|Overall Study|Lost to Follow-up|1|||
126321980|NCT00603382|454470766|FG003|Overall Study|Lost to Follow-up|1|||
126321981|NCT00603382|454470767|FG004|Overall Study|Lost to Follow-up|0|||
126321982|NCT00603382|454470768|FG005|Overall Study|Lost to Follow-up|1|||
126321983|NCT00603382|454470763|FG000|Overall Study|Physician Decision|0|||
126321984|NCT00603382|454470764|FG001|Overall Study|Physician Decision|0|||
126321985|NCT00603382|454470765|FG002|Overall Study|Physician Decision|2|||
126321986|NCT00603382|454470766|FG003|Overall Study|Physician Decision|0|||
126321987|NCT00603382|454470767|FG004|Overall Study|Physician Decision|1|||
126651497|NCT02914275|455681868|FG001|Overall Study|Excluded due to invalid informed consent|0|||
126651498|NCT02704754|455681873|FG000|Overall Study|Lost to Follow-up|1|||
126321988|NCT00603382|454470768|FG005|Overall Study|Physician Decision|3|||
126321989|NCT00603382|454470763|FG000|Overall Study|Withdrawal by Subject|3|||
126321990|NCT00603382|454470764|FG001|Overall Study|Withdrawal by Subject|3|||
126321991|NCT00603382|454470765|FG002|Overall Study|Withdrawal by Subject|1|||
126321992|NCT00603382|454470766|FG003|Overall Study|Withdrawal by Subject|1|||
126321993|NCT00603382|454470767|FG004|Overall Study|Withdrawal by Subject|0|||
126321994|NCT00603382|454470768|FG005|Overall Study|Withdrawal by Subject|1|||
126321995|NCT03782974|454470769|FG000|Overall Study|Withdrawal by Subject|7|||
126321996|NCT03782974|454470770|FG001|Overall Study|Withdrawal by Subject|7|||
126321997|NCT03782974|454470769|FG000|Overall Study|Pregnancy|1|||
126321998|NCT03782974|454470770|FG001|Overall Study|Pregnancy|0|||
126321999|NCT02012959|454470771|FG000|Treatment Phase A|Adverse Event|2|||
126322000|NCT02012959|454470772|FG001|Treatment Phase A|Adverse Event|0|||
126322001|NCT02012959|454470773|FG002|Treatment Phase A|Adverse Event|0|||
126322002|NCT02012959|454470774|FG003|Treatment Phase A|Adverse Event|0|||
126322003|NCT02012959|454470775|FG004|Treatment Phase A|Adverse Event|0|||
126322004|NCT00395642|454470776|FG000|Overall Study|Death|4|||
126322005|NCT00395642|454470776|FG000|Overall Study|Lost to Follow-up|1|||
126322006|NCT00395642|454470776|FG000|Overall Study|Physician Decision|7|||
126322007|NCT00395642|454470776|FG000|Overall Study|Withdrawal by Subject|1|||
126322008|NCT01783821|454470779|FG000|Overall Study|Screen Failure|1|||
126322009|NCT01783821|454470780|FG001|Overall Study|Screen Failure|1|||
126322010|NCT02333383|454470783|FG000|Overall Study|Adalimumab discontinuation|21|||
126322011|NCT02333383|454470783|FG000|Overall Study|Lost to Follow-up|15|||
126322012|NCT02333383|454470783|FG000|Overall Study|Withdrawal by Subject|3|||
126651499|NCT02704754|455681874|FG001|Overall Study|Lost to Follow-up|1|||
126651500|NCT02704754|455681873|FG000|Overall Study|Lack of Efficacy|1|||
126651501|NCT02704754|455681874|FG001|Overall Study|Lack of Efficacy|0|||
126651502|NCT02704754|455681873|FG000|Overall Study|Withdrawal by Subject|1|||
126651503|NCT02704754|455681874|FG001|Overall Study|Withdrawal by Subject|0|||
126651504|NCT03809429|455681878|FG000|Overall Study|Withdrawal by Subject|7|||
126651505|NCT03809429|455681879|FG001|Overall Study|Withdrawal by Subject|3|||
126651506|NCT03809429|455681878|FG000|Overall Study|Adverse Event|6|||
126651507|NCT03809429|455681879|FG001|Overall Study|Adverse Event|9|||
126651508|NCT03809429|455681878|FG000|Overall Study|COVID-19|3|||
126651509|NCT03809429|455681879|FG001|Overall Study|COVID-19|1|||
126651510|NCT03809429|455681878|FG000|Overall Study|Participant was discontinued by investigator|12|||
126651511|NCT03809429|455681879|FG001|Overall Study|Participant was discontinued by investigator|7|||
126651512|NCT04214600|455681881|FG000|Overall Study|Lost to Follow-up|9|||
126651513|NCT04214600|455681882|FG001|Overall Study|Lost to Follow-up|14|||
126651514|NCT02366468|455681883|FG000|Overall Study|Adverse Event|2|||
126651515|NCT02366468|455681884|FG001|Overall Study|Adverse Event|0|||
126651516|NCT02366468|455681883|FG000|Overall Study|Withdrawal by Subject|1|||
126651517|NCT02366468|455681884|FG001|Overall Study|Withdrawal by Subject|5|||
126651518|NCT02366468|455681883|FG000|Overall Study|Lost to Follow-up|2|||
126651519|NCT02366468|455681884|FG001|Overall Study|Lost to Follow-up|0|||
126651520|NCT02366468|455681883|FG000|Overall Study|Death|1|||
126651521|NCT02366468|455681884|FG001|Overall Study|Death|2|||
126651522|NCT02366468|455681883|FG000|Overall Study|Other|0|||
126651523|NCT02366468|455681884|FG001|Overall Study|Other|2|||
126651524|NCT01552603|455681885|FG000|Overall Study|Physician Decision|1|||
126651525|NCT04797650|455681890|FG000|Overall Study|Reason Not Specified|5|||
126651526|NCT04797650|455681891|FG001|Overall Study|Reason Not Specified|12|||
126651527|NCT04797650|455681892|FG002|Overall Study|Reason Not Specified|5|||
126651528|NCT04797650|455681890|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
126651529|NCT04797650|455681891|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
126651530|NCT04797650|455681892|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
126651531|NCT04797650|455681890|FG000|Overall Study|Lack of Efficacy|1|||
126651532|NCT04797650|455681891|FG001|Overall Study|Lack of Efficacy|0|||
126651533|NCT04797650|455681892|FG002|Overall Study|Lack of Efficacy|1|||
126651534|NCT04797650|455681890|FG000|Overall Study|Non-compliance with Study Drug|0|||
126651535|NCT04797650|455681891|FG001|Overall Study|Non-compliance with Study Drug|0|||
126651536|NCT04797650|455681892|FG002|Overall Study|Non-compliance with Study Drug|2|||
126651537|NCT04797650|455681890|FG000|Overall Study|Lost to Follow-up|4|||
126651538|NCT04797650|455681891|FG001|Overall Study|Lost to Follow-up|6|||
126651539|NCT04797650|455681892|FG002|Overall Study|Lost to Follow-up|1|||
126651540|NCT00446043|455681893|FG000|Overall Study|Adverse Event|9|||
126651541|NCT00446043|455681893|FG000|Overall Study|Withdrawal by Subject|70|||
126651542|NCT00446043|455681893|FG000|Overall Study|Protocol Violation|2|||
126651543|NCT00446043|455681893|FG000|Overall Study|Lost to Follow-up|42|||
126651544|NCT00446043|455681893|FG000|Overall Study|Pregnancy|2|||
126651545|NCT00657020|455681896|FG000|PERIOD 1|Adverse Event|0|||
126651546|NCT00657020|455681897|FG001|PERIOD 1|Adverse Event|1|||
126651547|NCT01144052|455681898|FG000|Overall Study|Withdrawal by Subject|1|||
126651548|NCT01144052|455681899|FG001|Overall Study|Withdrawal by Subject|1|||
126322013|NCT02333383|454470783|FG000|Overall Study|Transfer to another hospital|2|||
126322014|NCT01907217|454470784|FG000|Overall Study|Withdrawal by Subject|0|||
126322015|NCT01907217|454470785|FG001|Overall Study|Withdrawal by Subject|2|||
126322016|NCT00659776|454470794|FG000|Overall Study|Withdrawal by Subject|12|||
126651549|NCT02947087|455681900|FG000|Overall Study|Withdrawal by Subject|3|||
126651550|NCT02947087|455681901|FG001|Overall Study|Withdrawal by Subject|2|||
126651551|NCT01879722|455681905|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126651552|NCT01879722|455681906|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
126651553|NCT01879722|455681907|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
126322017|NCT00659776|454470795|FG001|Overall Study|Withdrawal by Subject|2|||
126322018|NCT00659776|454470796|FG002|Overall Study|Withdrawal by Subject|0|||
126651554|NCT01879722|455681908|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
126651555|NCT01879722|455681909|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
126322019|NCT01180049|454470797|FG000|Overall Study|Other|9|||
126322020|NCT01180049|454470798|FG001|Overall Study|Other|7|||
126322021|NCT01180049|454470797|FG000|Overall Study|Lost to Follow-up|8|||
126651556|NCT01879722|455681910|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
126651557|NCT01879722|455681911|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
126651558|NCT01879722|455681912|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
126651559|NCT01879722|455681913|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
126651560|NCT01879722|455681914|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
126651561|NCT01879722|455681905|FG000|Overall Study|Voluntary Withdrawal|0|||
126651562|NCT01879722|455681906|FG001|Overall Study|Voluntary Withdrawal|0|||
126651563|NCT01879722|455681907|FG002|Overall Study|Voluntary Withdrawal|0|||
126651564|NCT01879722|455681908|FG003|Overall Study|Voluntary Withdrawal|0|||
126651565|NCT01879722|455681909|FG004|Overall Study|Voluntary Withdrawal|0|||
126651566|NCT01879722|455681910|FG005|Overall Study|Voluntary Withdrawal|0|||
126651567|NCT01879722|455681911|FG006|Overall Study|Voluntary Withdrawal|0|||
126651568|NCT01879722|455681912|FG007|Overall Study|Voluntary Withdrawal|0|||
126322022|NCT01180049|454470798|FG001|Overall Study|Lost to Follow-up|6|||
126322023|NCT01180049|454470797|FG000|Overall Study|Death|36|||
126322024|NCT01180049|454470798|FG001|Overall Study|Death|35|||
126322025|NCT01687283|454471968|FG000|Overall Study|Adverse Event|11|||
126322026|NCT01687283|454471969|FG001|Overall Study|Adverse Event|4|||
126322027|NCT01687283|454471968|FG000|Overall Study|Lack of Efficacy|3|||
126322028|NCT01687283|454471969|FG001|Overall Study|Lack of Efficacy|1|||
126322029|NCT01687283|454471968|FG000|Overall Study|Protocol Violation|1|||
126322030|NCT01687283|454471969|FG001|Overall Study|Protocol Violation|3|||
126322031|NCT01687283|454471968|FG000|Overall Study|protocol defined stopping criteria|8|||
126322032|NCT01687283|454471969|FG001|Overall Study|protocol defined stopping criteria|10|||
126322033|NCT01687283|454471968|FG000|Overall Study|Lost to Follow-up|1|||
126322034|NCT01687283|454471969|FG001|Overall Study|Lost to Follow-up|1|||
126322035|NCT01687283|454471968|FG000|Overall Study|Investigator discretion|2|||
126322036|NCT01687283|454471969|FG001|Overall Study|Investigator discretion|0|||
126322037|NCT01687283|454471968|FG000|Overall Study|Withdrawal by Subject|9|||
126322038|NCT01687283|454471969|FG001|Overall Study|Withdrawal by Subject|8|||
126322039|NCT00642954|454471970|FG000|Overall Study|Progressive Disease|3|||
126322040|NCT00642954|454471971|FG001|Overall Study|Progressive Disease|3|||
126322041|NCT00642954|454471972|FG002|Overall Study|Progressive Disease|3|||
126322042|NCT00642954|454471973|FG003|Overall Study|Progressive Disease|3|||
126322043|NCT00642954|454471974|FG004|Overall Study|Progressive Disease|9|||
126322044|NCT00642954|454471970|FG000|Overall Study|Withdrawal by Subject|0|||
126322045|NCT00642954|454471971|FG001|Overall Study|Withdrawal by Subject|0|||
126322046|NCT00642954|454471972|FG002|Overall Study|Withdrawal by Subject|0|||
126322047|NCT00642954|454471973|FG003|Overall Study|Withdrawal by Subject|0|||
126322048|NCT00642954|454471974|FG004|Overall Study|Withdrawal by Subject|1|||
126322049|NCT00642954|454471970|FG000|Overall Study|Adverse Event|1|||
126322050|NCT00642954|454471971|FG001|Overall Study|Adverse Event|1|||
126322051|NCT00642954|454471972|FG002|Overall Study|Adverse Event|0|||
126322052|NCT00642954|454471973|FG003|Overall Study|Adverse Event|0|||
126322053|NCT00642954|454471974|FG004|Overall Study|Adverse Event|6|||
126322054|NCT01663857|454471975|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
126322055|NCT01663857|454471976|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
126322056|NCT01663857|454471977|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
126322057|NCT01663857|454471978|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
126322058|NCT01663857|454471975|FG000|Overall Study|Lost to Follow-up|0|||
126322059|NCT01663857|454471976|FG001|Overall Study|Lost to Follow-up|0|||
126322060|NCT01663857|454471977|FG002|Overall Study|Lost to Follow-up|3|||
126322061|NCT01663857|454471978|FG003|Overall Study|Lost to Follow-up|1|||
126322062|NCT03041467|454471979|FG000|Overall Study|Death|46|||
126322063|NCT03041467|454471980|FG001|Overall Study|Death|39|||
126322064|NCT03041467|454471979|FG000|Overall Study|Withdrawal by Subject|36|||
126322065|NCT03041467|454471980|FG001|Overall Study|Withdrawal by Subject|37|||
126322066|NCT03041467|454471979|FG000|Overall Study|Lost to Follow-up|6|||
126322067|NCT03041467|454471980|FG001|Overall Study|Lost to Follow-up|8|||
126322068|NCT03041467|454471979|FG000|Overall Study|Declined consent for study extension|21|||
126322069|NCT03041467|454471980|FG001|Overall Study|Declined consent for study extension|33|||
126322070|NCT03041467|454471979|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
126322071|NCT03041467|454471980|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
126322072|NCT02732015|454471981|FG000|Overall Study|Lost to Follow-up|0|||
126322073|NCT02732015|454471982|FG001|Overall Study|Lost to Follow-up|1|||
126322074|NCT03052920|454471983|FG000|Overall Study|Withdrawal by Subject|1|||
126322075|NCT01980628|454471984|FG000|Overall Study|Adverse Event|12|||
126322076|NCT01980628|454471984|FG000|Overall Study|Physician Decision|5|||
126322077|NCT01980628|454471984|FG000|Overall Study|Withdrawal by Subject|4|||
126322078|NCT01980628|454471984|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
126322079|NCT03015194|454471985|FG000|Overall Study|Death|10|||
126322080|NCT03015194|454471985|FG000|Overall Study|Withdrawal by Subject|2|||
126322081|NCT02469168|454471988|FG000|Overall Study|Trial closed|1|||
126322082|NCT02469168|454471989|FG001|Overall Study|Trial closed|0|||
126651569|NCT01879722|455681913|FG008|Overall Study|Voluntary Withdrawal|1|||
126322083|NCT00433017|454471990|FG000|Overall Study|Adverse Event|5|||
126322084|NCT00433017|454471991|FG001|Overall Study|Adverse Event|3|||
126322085|NCT00433017|454471990|FG000|Overall Study|Withdrawal by Subject|4|||
126322086|NCT00433017|454471991|FG001|Overall Study|Withdrawal by Subject|5|||
126322087|NCT00433017|454471990|FG000|Overall Study|Lost to Follow-up|3|||
126322088|NCT00433017|454471991|FG001|Overall Study|Lost to Follow-up|4|||
126322089|NCT00433017|454471990|FG000|Overall Study|Administrative problems|80|||
126322090|NCT00433017|454471991|FG001|Overall Study|Administrative problems|86|||
126322091|NCT00433017|454471990|FG000|Overall Study|Protocol Violation|1|||
126322092|NCT00433017|454471991|FG001|Overall Study|Protocol Violation|0|||
126322093|NCT00433017|454471990|FG000|Overall Study|Death|2|||
126322094|NCT00433017|454471991|FG001|Overall Study|Death|2|||
126322095|NCT00433017|454471990|FG000|Overall Study|Subject no longer requires study drug|1|||
126322096|NCT00433017|454471991|FG001|Overall Study|Subject no longer requires study drug|1|||
126322097|NCT00255840|454471994|FG000|Overall Study|Lost to Follow-up|10|||
126322098|NCT00255840|454471995|FG001|Overall Study|Lost to Follow-up|14|||
126322099|NCT00255840|454471994|FG000|Overall Study|Discontinued intervention|53|||
126322100|NCT00255840|454471995|FG001|Overall Study|Discontinued intervention|56|||
126322101|NCT00715520|454471996|FG000|Overall Study|Screen failure|8|||
126322102|NCT00715520|454471997|FG001|Overall Study|Screen failure|1|||
126322103|NCT00715520|454471998|FG002|Overall Study|Screen failure|1|||
126322104|NCT00715520|454471996|FG000|Overall Study|Withdrawal by Subject|2|||
126322105|NCT00715520|454471997|FG001|Overall Study|Withdrawal by Subject|0|||
126322106|NCT00715520|454471998|FG002|Overall Study|Withdrawal by Subject|1|||
126322107|NCT03332095|454471999|FG000|Overall Study|Lost to Follow-up|1|||
126322108|NCT03332095|454472000|FG001|Overall Study|Lost to Follow-up|0|||
126322109|NCT03332095|454471999|FG000|Overall Study|Pregnancy|0|||
126322110|NCT03332095|454472000|FG001|Overall Study|Pregnancy|1|||
126322111|NCT00624832|454472005|FG000|Overall Study|Adverse Event|0|||
126322112|NCT00624832|454472006|FG001|Overall Study|Adverse Event|1|||
126322113|NCT00624832|454472007|FG002|Overall Study|Adverse Event|0|||
126322114|NCT00624832|454472008|FG003|Overall Study|Adverse Event|1|||
126322115|NCT00624832|454472005|FG000|Overall Study|Abnormal Laboratory Value|2|||
126322116|NCT00624832|454472006|FG001|Overall Study|Abnormal Laboratory Value|0|||
126322117|NCT00624832|454472007|FG002|Overall Study|Abnormal Laboratory Value|0|||
126322118|NCT00624832|454472008|FG003|Overall Study|Abnormal Laboratory Value|0|||
126322119|NCT04379700|454472009|FG000|Overall Study|Withdrawal by Subject|10|||
126322120|NCT04379700|454472009|FG000|Overall Study|Screen Fail|4|||
126322121|NCT04379700|454472009|FG000|Overall Study|Lost to Follow-up|3|||
126322122|NCT00592592|454472010|FG000|Overall Study|Patient found ineligible upon chart review|1|||
126322123|NCT05053035|454472013|FG000|Overall Study|Withdrawal by Subject|1|||
126322124|NCT05053035|454472014|FG001|Overall Study|Withdrawal by Subject|0|||
126322125|NCT03003000|454472019|FG000|Overall Study|Adverse Event|1|||
126322126|NCT03003000|454472020|FG001|Overall Study|Adverse Event|2|||
126322127|NCT03003000|454472021|FG002|Overall Study|Adverse Event|3|||
126322128|NCT03003000|454472019|FG000|Overall Study|Lack of Efficacy|1|||
126322129|NCT03003000|454472020|FG001|Overall Study|Lack of Efficacy|0|||
126322130|NCT03003000|454472021|FG002|Overall Study|Lack of Efficacy|0|||
126322131|NCT03003000|454472019|FG000|Overall Study|Non-compliant with protocol|0|||
126322132|NCT03003000|454472020|FG001|Overall Study|Non-compliant with protocol|1|||
126322133|NCT03003000|454472021|FG002|Overall Study|Non-compliant with protocol|1|||
126322134|NCT03003000|454472019|FG000|Overall Study|Refused to continue medication|2|||
126322135|NCT03003000|454472020|FG001|Overall Study|Refused to continue medication|0|||
126322136|NCT03003000|454472021|FG002|Overall Study|Refused to continue medication|0|||
126322137|NCT03003000|454472019|FG000|Overall Study|Other than listed|1|||
126322138|NCT03003000|454472020|FG001|Overall Study|Other than listed|1|||
126322139|NCT03003000|454472021|FG002|Overall Study|Other than listed|1|||
126322140|NCT02191046|454472024|FG000|Overall Study|low compliance|5|||
126322141|NCT02191046|454472025|FG001|Overall Study|low compliance|1|||
126322142|NCT00048997|454472028|FG000|Overall Study|Protocol Violation|7|||
126322143|NCT00048997|454472029|FG001|Overall Study|Protocol Violation|2|||
126651570|NCT01879722|455681914|FG009|Overall Study|Voluntary Withdrawal|0|||
126322144|NCT00048997|454472028|FG000|Overall Study|Withdrawal by Subject|6|||
126651571|NCT01631227|455681918|FG000|Overall Study|withdrawn consent|27|||
126651572|NCT01631227|455681919|FG001|Overall Study|withdrawn consent|21|||
126322145|NCT00048997|454472029|FG001|Overall Study|Withdrawal by Subject|1|||
126651573|NCT01631227|455681918|FG000|Overall Study|Adverse Event|1|||
126651574|NCT01631227|455681919|FG001|Overall Study|Adverse Event|0|||
126322146|NCT02819440|454472030|FG000|Overall Study|Adverse Event|3|||
126322147|NCT02819440|454472031|FG001|Overall Study|Adverse Event|1|||
126322148|NCT02819440|454472030|FG000|Overall Study|Lost to Follow-up|1|||
126322149|NCT02819440|454472031|FG001|Overall Study|Lost to Follow-up|3|||
126322150|NCT02819440|454472030|FG000|Overall Study|Withdrawal by Subject|9|||
126322151|NCT02819440|454472031|FG001|Overall Study|Withdrawal by Subject|8|||
126322152|NCT02007278|454472032|FG000|Overall Study|Failure to comply with an eligibility|0|||
126651575|NCT01631227|455681918|FG000|Overall Study|administrative|2|||
126322153|NCT02007278|454472033|FG001|Overall Study|Failure to comply with an eligibility|1|||
126651576|NCT01631227|455681919|FG001|Overall Study|administrative|1|||
126322154|NCT02007278|454472032|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
126322155|NCT02007278|454472033|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
126322156|NCT02007278|454472032|FG000|Overall Study|Incorrect medication administration|1|||
126322157|NCT02007278|454472033|FG001|Overall Study|Incorrect medication administration|0|||
126322158|NCT02007278|454472032|FG000|Overall Study|Mis-randomization|1|||
126322159|NCT02007278|454472033|FG001|Overall Study|Mis-randomization|1|||
126322160|NCT00435188|454472035|FG000|Overall Study|Death|1|||
126322161|NCT00435188|454472036|FG001|Overall Study|Death|6|||
126322162|NCT00435188|454472035|FG000|Overall Study|Withdrawal by Subject|16|||
126322163|NCT00435188|454472036|FG001|Overall Study|Withdrawal by Subject|11|||
126322164|NCT00435188|454472035|FG000|Overall Study|Lost to Follow-up|5|||
126322165|NCT00435188|454472036|FG001|Overall Study|Lost to Follow-up|6|||
126322166|NCT00055497|454472041|FG000|Overall Study|Adverse Event|1|||
126322167|NCT00055497|454472042|FG001|Overall Study|Adverse Event|1|||
126322168|NCT00055497|454472043|FG002|Overall Study|Adverse Event|1|||
126322169|NCT00055497|454472044|FG003|Overall Study|Adverse Event|28|||
126322170|NCT00055497|454472041|FG000|Overall Study|Withdrawal by Subject|3|||
126322171|NCT00055497|454472042|FG001|Overall Study|Withdrawal by Subject|1|||
126322172|NCT00055497|454472043|FG002|Overall Study|Withdrawal by Subject|1|||
126322173|NCT00055497|454472044|FG003|Overall Study|Withdrawal by Subject|15|||
126322174|NCT00055497|454472041|FG000|Overall Study|Lost to Follow-up|0|||
126322175|NCT00055497|454472042|FG001|Overall Study|Lost to Follow-up|1|||
126322176|NCT00055497|454472043|FG002|Overall Study|Lost to Follow-up|0|||
126322177|NCT00055497|454472044|FG003|Overall Study|Lost to Follow-up|5|||
126322178|NCT00055497|454472041|FG000|Overall Study|Protocol Violation|0|||
126322179|NCT00055497|454472042|FG001|Overall Study|Protocol Violation|0|||
126322180|NCT00055497|454472043|FG002|Overall Study|Protocol Violation|0|||
126322181|NCT00055497|454472044|FG003|Overall Study|Protocol Violation|3|||
126322182|NCT00055497|454472041|FG000|Overall Study|Lack of Efficacy|1|||
126322183|NCT00055497|454472042|FG001|Overall Study|Lack of Efficacy|0|||
126322184|NCT00055497|454472043|FG002|Overall Study|Lack of Efficacy|0|||
126322185|NCT00055497|454472044|FG003|Overall Study|Lack of Efficacy|27|||
126322186|NCT00055497|454472041|FG000|Overall Study|Administrative Reasons|0|||
126322187|NCT00055497|454472042|FG001|Overall Study|Administrative Reasons|0|||
126322188|NCT00055497|454472043|FG002|Overall Study|Administrative Reasons|0|||
126322189|NCT00055497|454472044|FG003|Overall Study|Administrative Reasons|1|||
126322190|NCT00055497|454472041|FG000|Overall Study|Other|0|||
126322191|NCT00055497|454472042|FG001|Overall Study|Other|0|||
126322192|NCT00055497|454472043|FG002|Overall Study|Other|0|||
126322193|NCT00055497|454472044|FG003|Overall Study|Other|11|||
126322194|NCT00048165|454472045|FG000|Completed 6 Months Study|Administration/Other|8|||
126322195|NCT00048165|454472046|FG001|Completed 6 Months Study|Administration/Other|8|||
126322196|NCT00048165|454472045|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
126322197|NCT00048165|454472046|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
126322198|NCT00048165|454472045|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
126322199|NCT00048165|454472046|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
126322200|NCT00048165|454472045|FG000|Completed 6 Months Study|Death|12|||
126322201|NCT00048165|454472046|FG001|Completed 6 Months Study|Death|6|||
126322202|NCT00048165|454472045|FG000|Completed 6 Months Study|Insufficient therapy|1|||
126322203|NCT00048165|454472046|FG001|Completed 6 Months Study|Insufficient therapy|4|||
126322204|NCT00048165|454472045|FG000|Completed 6 Months Study|Other violation|4|||
126322205|NCT00048165|454472046|FG001|Completed 6 Months Study|Other violation|6|||
126322206|NCT00048165|454472045|FG000|Completed 6 Months Study|Refused treatment|5|||
126322207|NCT00048165|454472046|FG001|Completed 6 Months Study|Refused treatment|5|||
126322208|NCT00048165|454472045|FG000|Completed 6 Months Study|Violation criteria|0|||
126322209|NCT00048165|454472046|FG001|Completed 6 Months Study|Violation criteria|2|||
126322210|NCT00048165|454472045|FG000|Completed 6 Months Study|Did not receive study drug|6|||
126322211|NCT00048165|454472046|FG001|Completed 6 Months Study|Did not receive study drug|6|||
126322212|NCT00048165|454472045|FG000|Completed 12 Months Study|Administration/Other|0|||
126322213|NCT00048165|454472046|FG001|Completed 12 Months Study|Administration/Other|2|||
126322214|NCT00048165|454472045|FG000|Completed 12 Months Study|Death|2|||
126322215|NCT00048165|454472046|FG001|Completed 12 Months Study|Death|1|||
126322216|NCT00048165|454472045|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
126322217|NCT00048165|454472046|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
126322218|NCT00731731|454472047|FG000|Overall Study|Protocol Violation|0|||
126322219|NCT00731731|454472048|FG001|Overall Study|Protocol Violation|0|||
126322220|NCT00731731|454472049|FG002|Overall Study|Protocol Violation|1|||
126322221|NCT00731731|454472047|FG000|Overall Study|Cancel prior to treatment|0|||
126322222|NCT00731731|454472048|FG001|Overall Study|Cancel prior to treatment|0|||
126322223|NCT00731731|454472049|FG002|Overall Study|Cancel prior to treatment|2|||
126322224|NCT03970200|454472050|FG000|Overall Study|Death|2|||
126322225|NCT03970200|454472051|FG001|Overall Study|Death|2|||
126322226|NCT03970200|454472052|FG002|Overall Study|Death|1|||
126322227|NCT03970200|454472050|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
126322228|NCT03970200|454472051|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
126322229|NCT03970200|454472052|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
126322230|NCT02112877|454472053|FG000|Overall Study|Withdrawal by Subject|1|||
126322231|NCT02112877|454472054|FG001|Overall Study|Withdrawal by Subject|7|||
126322232|NCT02112877|454472053|FG000|Overall Study|Visit Missed|1|||
126322233|NCT02112877|454472054|FG001|Overall Study|Visit Missed|6|||
126322234|NCT01693185|454472055|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
126322235|NCT01693185|454472056|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
126322236|NCT01606748|454472061|FG000|Overall Study|Adverse Event|1|||
126322237|NCT01606748|454472062|FG001|Overall Study|Adverse Event|0|||
126322238|NCT01606748|454472061|FG000|Overall Study|Progressive Disease|1|||
126322239|NCT01606748|454472062|FG001|Overall Study|Progressive Disease|0|||
126322240|NCT01606748|454472061|FG000|Overall Study|Withdrawal by Subject|1|||
126322241|NCT01606748|454472062|FG001|Overall Study|Withdrawal by Subject|0|||
126322242|NCT03742258|454472064|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
126322243|NCT03742258|454472065|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
126651577|NCT03020576|455681920|FG000|Overall Study|Withdrawal by Subject|1|||
126651578|NCT03020576|455681921|FG001|Overall Study|Withdrawal by Subject|2|||
126651579|NCT01097707|455681922|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126651580|NCT01097707|455681923|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126651581|NCT01097707|455681924|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
126651582|NCT01097707|455681925|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
126651583|NCT01097707|455681926|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
126651584|NCT01097707|455681922|FG000|Overall Study|Adverse Event|4|||
126651585|NCT01097707|455681923|FG001|Overall Study|Adverse Event|2|||
126651586|NCT01097707|455681924|FG002|Overall Study|Adverse Event|3|||
126651587|NCT01097707|455681925|FG003|Overall Study|Adverse Event|1|||
126651588|NCT01097707|455681926|FG004|Overall Study|Adverse Event|3|||
126651589|NCT01097707|455681922|FG000|Overall Study|Entry Criteria Not Met|2|||
126651590|NCT01097707|455681923|FG001|Overall Study|Entry Criteria Not Met|1|||
126651591|NCT01097707|455681924|FG002|Overall Study|Entry Criteria Not Met|1|||
126651592|NCT01097707|455681925|FG003|Overall Study|Entry Criteria Not Met|0|||
126651593|NCT01097707|455681926|FG004|Overall Study|Entry Criteria Not Met|1|||
126651594|NCT01097707|455681922|FG000|Overall Study|Lack of Efficacy|1|||
126651595|NCT01097707|455681923|FG001|Overall Study|Lack of Efficacy|0|||
126651596|NCT01097707|455681924|FG002|Overall Study|Lack of Efficacy|0|||
126651597|NCT01097707|455681925|FG003|Overall Study|Lack of Efficacy|1|||
126651598|NCT01097707|455681926|FG004|Overall Study|Lack of Efficacy|0|||
126651599|NCT01097707|455681922|FG000|Overall Study|Lost to Follow-up|1|||
126651600|NCT01097707|455681923|FG001|Overall Study|Lost to Follow-up|1|||
126651601|NCT01097707|455681924|FG002|Overall Study|Lost to Follow-up|2|||
126651602|NCT01097707|455681925|FG003|Overall Study|Lost to Follow-up|0|||
126651603|NCT01097707|455681926|FG004|Overall Study|Lost to Follow-up|3|||
126651604|NCT01097707|455681922|FG000|Overall Study|Protocol Violation|2|||
126651605|NCT01097707|455681923|FG001|Overall Study|Protocol Violation|2|||
126651606|NCT01097707|455681924|FG002|Overall Study|Protocol Violation|3|||
126651607|NCT01097707|455681925|FG003|Overall Study|Protocol Violation|2|||
126651608|NCT01097707|455681926|FG004|Overall Study|Protocol Violation|2|||
126651609|NCT01097707|455681922|FG000|Overall Study|Sponsor Decision|31|||
126651610|NCT01097707|455681923|FG001|Overall Study|Sponsor Decision|31|||
126651611|NCT01097707|455681924|FG002|Overall Study|Sponsor Decision|34|||
126651612|NCT01097707|455681925|FG003|Overall Study|Sponsor Decision|35|||
126651613|NCT01097707|455681926|FG004|Overall Study|Sponsor Decision|36|||
126651614|NCT01097707|455681922|FG000|Overall Study|Withdrawal by Subject|3|||
126651615|NCT01097707|455681923|FG001|Overall Study|Withdrawal by Subject|6|||
126651616|NCT01097707|455681924|FG002|Overall Study|Withdrawal by Subject|1|||
126651617|NCT01097707|455681925|FG003|Overall Study|Withdrawal by Subject|4|||
126651618|NCT01097707|455681926|FG004|Overall Study|Withdrawal by Subject|3|||
126651619|NCT01097707|455681922|FG000|Overall Study|Reason unknown|0|||
126651620|NCT01097707|455681923|FG001|Overall Study|Reason unknown|0|||
126651621|NCT01097707|455681924|FG002|Overall Study|Reason unknown|0|||
126651622|NCT01097707|455681925|FG003|Overall Study|Reason unknown|0|||
126651623|NCT01097707|455681926|FG004|Overall Study|Reason unknown|1|||
126651624|NCT01844687|455681929|FG000|Visit 1|Protocol Violation|3|||
126651625|NCT01844687|455681929|FG000|Visit 1|Lost to Follow-up|5|||
126651626|NCT01844687|455681929|FG000|Visit 2|Withdrawal by Subject|1|||
126651627|NCT01844687|455681929|FG000|Visit 2|Protocol Violation|1|||
126651628|NCT01844687|455681929|FG000|Visit 3|Lost to Follow-up|1|||
126322244|NCT03742258|454472066|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
126651629|NCT01844687|455681929|FG000|Visit 3|Withdrawal by Subject|3|||
126651630|NCT01844687|455681929|FG000|Visit 3|child care problems|1|||
126651631|NCT01844687|455681929|FG000|Visit 4|Pregnancy|1|||
126651632|NCT01844687|455681929|FG000|Visit 4|Lost to Follow-up|1|||
126322245|NCT03742258|454472064|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
126322246|NCT03742258|454472065|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
126651633|NCT01844687|455681929|FG000|Visit 4|Withdrawal by Subject|2|||
126651634|NCT05383508|455681938|FG000|Overall Study|Withdrawal by Subject|1|||
126651635|NCT05383508|455681939|FG001|Overall Study|Withdrawal by Subject|0|||
126651636|NCT05383508|455681940|FG002|Overall Study|Withdrawal by Subject|1|||
126322247|NCT03742258|454472066|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
126322248|NCT03742258|454472064|FG000|Survival Follow-Up|Still in Follow-up|0|||
126322249|NCT03742258|454472065|FG001|Survival Follow-Up|Still in Follow-up|0|||
126322250|NCT03742258|454472066|FG002|Survival Follow-Up|Still in Follow-up|2|||
126322251|NCT02083653|454472069|FG000|Overall Study|Randomized but not Treated|0|||
126322252|NCT02083653|454472070|FG001|Overall Study|Randomized but not Treated|2|||
126322253|NCT02083653|454472071|FG002|Overall Study|Randomized but not Treated|7|||
126322254|NCT02083653|454472069|FG000|Overall Study|Adverse Event|12|||
126322255|NCT02083653|454472070|FG001|Overall Study|Adverse Event|5|||
126322256|NCT02083653|454472071|FG002|Overall Study|Adverse Event|4|||
126322257|NCT02083653|454472069|FG000|Overall Study|Lost to Follow-up|1|||
126322258|NCT02083653|454472070|FG001|Overall Study|Lost to Follow-up|0|||
126322259|NCT02083653|454472071|FG002|Overall Study|Lost to Follow-up|0|||
126322260|NCT02083653|454472069|FG000|Overall Study|Death|2|||
126322261|NCT02083653|454472070|FG001|Overall Study|Death|2|||
126322262|NCT02083653|454472071|FG002|Overall Study|Death|2|||
126322263|NCT02083653|454472069|FG000|Overall Study|Progressive Disease|65|||
126322264|NCT02083653|454472070|FG001|Overall Study|Progressive Disease|73|||
126322265|NCT02083653|454472071|FG002|Overall Study|Progressive Disease|63|||
126322266|NCT02083653|454472069|FG000|Overall Study|Withdrawal by Subject|2|||
126322267|NCT02083653|454472070|FG001|Overall Study|Withdrawal by Subject|1|||
126322268|NCT02083653|454472071|FG002|Overall Study|Withdrawal by Subject|2|||
126322269|NCT02083653|454472069|FG000|Overall Study|Other Events|0|||
126322270|NCT02083653|454472070|FG001|Overall Study|Other Events|2|||
126322271|NCT02083653|454472071|FG002|Overall Study|Other Events|2|||
126322272|NCT02083653|454472069|FG000|Overall Study|Reason Missing|0|||
126322273|NCT02083653|454472070|FG001|Overall Study|Reason Missing|0|||
126322274|NCT02083653|454472071|FG002|Overall Study|Reason Missing|4|||
126322275|NCT03084315|454472072|FG000|Overall Study|Lost to Follow-up|8|||
126322276|NCT03084315|454472073|FG001|Overall Study|Lost to Follow-up|7|||
126322277|NCT03084315|454472072|FG000|Overall Study|Withdrawal by Subject|2|||
126322278|NCT03084315|454472073|FG001|Overall Study|Withdrawal by Subject|2|||
126322279|NCT01952080|454472074|FG000|Overall Study|Withdrawal by Subject|0|||
126322280|NCT01952080|454472075|FG001|Overall Study|Withdrawal by Subject|0|||
126322281|NCT01952080|454472076|FG002|Overall Study|Withdrawal by Subject|0|||
126322282|NCT01952080|454472077|FG003|Overall Study|Withdrawal by Subject|1|||
126322283|NCT01952080|454472074|FG000|Overall Study|Protocol Non-compliance|0|||
126322284|NCT01952080|454472075|FG001|Overall Study|Protocol Non-compliance|1|||
126322285|NCT01952080|454472076|FG002|Overall Study|Protocol Non-compliance|0|||
126322286|NCT01952080|454472077|FG003|Overall Study|Protocol Non-compliance|0|||
126322287|NCT02732327|454472078|FG000|Overall Study|Protocol Violation|0|||
126322288|NCT02732327|454472079|FG001|Overall Study|Protocol Violation|1|||
126322289|NCT00350779|454472080|FG000|Overall Study|Adverse Event|4|||
126322290|NCT00350779|454472081|FG001|Overall Study|Adverse Event|2|||
126322291|NCT00350779|454472080|FG000|Overall Study|Lack of Efficacy|0|||
126322292|NCT00350779|454472081|FG001|Overall Study|Lack of Efficacy|4|||
126322293|NCT00350779|454472080|FG000|Overall Study|Lost to Follow-up|2|||
126322294|NCT00350779|454472081|FG001|Overall Study|Lost to Follow-up|0|||
126322295|NCT00350779|454472080|FG000|Overall Study|Physician Decision|2|||
126322296|NCT00350779|454472081|FG001|Overall Study|Physician Decision|4|||
126322297|NCT00350779|454472080|FG000|Overall Study|Protocol Violation|3|||
126322298|NCT00350779|454472081|FG001|Overall Study|Protocol Violation|1|||
126322299|NCT00350779|454472080|FG000|Overall Study|Withdrawal by Subject|9|||
126322300|NCT00350779|454472081|FG001|Overall Study|Withdrawal by Subject|8|||
126322301|NCT00350779|454472080|FG000|Overall Study|Patient Moved|2|||
126322302|NCT00350779|454472081|FG001|Overall Study|Patient Moved|1|||
126322303|NCT00350779|454472080|FG000|Overall Study|Non-compliance with study procedures|0|||
126322304|NCT00350779|454472081|FG001|Overall Study|Non-compliance with study procedures|1|||
126322305|NCT01905592|454472083|FG000|Overall Study|Disease Progression|51|||
126322306|NCT01905592|454472084|FG001|Overall Study|Disease Progression|110|||
126322307|NCT01905592|454472083|FG000|Overall Study|Toxicity|1|||
126322308|NCT01905592|454472084|FG001|Overall Study|Toxicity|16|||
126322309|NCT01905592|454472083|FG000|Overall Study|Physician Decision|0|||
126322310|NCT01905592|454472084|FG001|Overall Study|Physician Decision|2|||
126322311|NCT01905592|454472083|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
126322312|NCT01905592|454472084|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
126322313|NCT01905592|454472083|FG000|Overall Study|Protocol Violation|0|||
126322314|NCT01905592|454472084|FG001|Overall Study|Protocol Violation|1|||
126545115|NCT00576732|455289217|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
126322315|NCT01905592|454472083|FG000|Overall Study|Sponsor's decision|1|||
126322316|NCT01905592|454472084|FG001|Overall Study|Sponsor's decision|1|||
126322317|NCT01905592|454472083|FG000|Overall Study|Not treated|7|||
126322318|NCT01905592|454472084|FG001|Overall Study|Not treated|3|||
126322319|NCT01905592|454472083|FG000|Overall Study|Withdrawal by Subject|10|||
126322320|NCT01905592|454472084|FG001|Overall Study|Withdrawal by Subject|2|||
126322321|NCT02227368|454474029|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
126322322|NCT02227368|454474030|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
126322323|NCT02227368|454474029|FG000|Overall Study|Lost to Follow-up|1|||
126322324|NCT02227368|454474030|FG001|Overall Study|Lost to Follow-up|0|||
126322325|NCT02227368|454474029|FG000|Overall Study|Adverse Event|1|||
126322326|NCT02227368|454474030|FG001|Overall Study|Adverse Event|0|||
126322327|NCT04494425|454474031|FG000|Overall Study|Death|160|||
126322328|NCT04494425|454474032|FG001|Overall Study|Death|166|||
126322329|NCT04494425|454474031|FG000|Overall Study|Withdrawal by Subject|10|||
126322330|NCT04494425|454474032|FG001|Overall Study|Withdrawal by Subject|40|||
126322331|NCT04494425|454474031|FG000|Overall Study|Other|1|||
126322332|NCT04494425|454474032|FG001|Overall Study|Other|1|||
126322333|NCT04494425|454474031|FG000|Overall Study|Ongoing at the time of PCD|265|||
126322334|NCT04494425|454474032|FG001|Overall Study|Ongoing at the time of PCD|223|||
126322335|NCT01760447|454474034|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
126322336|NCT01760447|454474035|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
126322337|NCT01760447|454474036|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
126322338|NCT01760447|454474037|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
126322339|NCT01760447|454474034|FG000|Weeks 0-20|Withdrawal by Subject|2|||
126322340|NCT01760447|454474035|FG001|Weeks 0-20|Withdrawal by Subject|0|||
126322341|NCT01760447|454474036|FG002|Weeks 0-20|Withdrawal by Subject|1|||
126322342|NCT01760447|454474037|FG003|Weeks 0-20|Withdrawal by Subject|0|||
126322343|NCT01760447|454474034|FG000|Weeks 0-20|Lost to Follow-up|1|||
126322344|NCT01760447|454474035|FG001|Weeks 0-20|Lost to Follow-up|0|||
126322345|NCT01760447|454474036|FG002|Weeks 0-20|Lost to Follow-up|1|||
126322346|NCT01760447|454474037|FG003|Weeks 0-20|Lost to Follow-up|1|||
126322347|NCT01760447|454474034|FG000|Weeks 0-20|Randomized but not treated|0|||
126322348|NCT01760447|454474035|FG001|Weeks 0-20|Randomized but not treated|0|||
126322349|NCT01760447|454474036|FG002|Weeks 0-20|Randomized but not treated|2|||
126322350|NCT01760447|454474037|FG003|Weeks 0-20|Randomized but not treated|0|||
126322351|NCT01760447|454474034|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
126322352|NCT01760447|454474035|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
126322353|NCT01760447|454474036|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
126322354|NCT01760447|454474037|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
126322355|NCT01760447|454474034|FG000|Weeks 20-54|Withdrawal by Subject|2|||
126322356|NCT01760447|454474035|FG001|Weeks 20-54|Withdrawal by Subject|1|||
126322357|NCT01760447|454474036|FG002|Weeks 20-54|Withdrawal by Subject|1|||
126322358|NCT01760447|454474037|FG003|Weeks 20-54|Withdrawal by Subject|2|||
126322359|NCT01760447|454474034|FG000|Weeks 20-54|Lost to Follow-up|0|||
126322360|NCT01760447|454474035|FG001|Weeks 20-54|Lost to Follow-up|0|||
126322361|NCT01760447|454474036|FG002|Weeks 20-54|Lost to Follow-up|1|||
126322362|NCT01760447|454474037|FG003|Weeks 20-54|Lost to Follow-up|2|||
126322363|NCT01641471|454474038|FG000|Overall Study|Withdrawal by Subject|19|||
126322364|NCT01641471|454474039|FG001|Overall Study|Withdrawal by Subject|19|||
126322365|NCT01641471|454474038|FG000|Overall Study|Lost to Follow-up|2|||
126322366|NCT01641471|454474039|FG001|Overall Study|Lost to Follow-up|4|||
126322367|NCT01641471|454474038|FG000|Overall Study|Protocol Violation|2|||
126322368|NCT01641471|454474039|FG001|Overall Study|Protocol Violation|4|||
126322369|NCT04575584|454474040|FG000|Overall Study|Death|6|||
126322370|NCT04575584|454474041|FG001|Overall Study|Death|4|||
126322371|NCT04575584|454474042|FG002|Overall Study|Death|6|||
126322372|NCT04575584|454474043|FG003|Overall Study|Death|2|||
126322373|NCT04575584|454474044|FG004|Overall Study|Death|0|||
126322374|NCT04575584|454474045|FG005|Overall Study|Death|0|||
126322375|NCT04575584|454474040|FG000|Overall Study|Lost to Follow-up|1|||
126322376|NCT04575584|454474041|FG001|Overall Study|Lost to Follow-up|1|||
126322377|NCT04575584|454474042|FG002|Overall Study|Lost to Follow-up|1|||
126322378|NCT04575584|454474043|FG003|Overall Study|Lost to Follow-up|1|||
126322379|NCT04575584|454474044|FG004|Overall Study|Lost to Follow-up|0|||
126322380|NCT04575584|454474045|FG005|Overall Study|Lost to Follow-up|0|||
126322381|NCT04575584|454474040|FG000|Overall Study|Physician Decision|0|||
126322382|NCT04575584|454474041|FG001|Overall Study|Physician Decision|1|||
126322383|NCT04575584|454474042|FG002|Overall Study|Physician Decision|1|||
126322384|NCT04575584|454474043|FG003|Overall Study|Physician Decision|1|||
126322385|NCT04575584|454474044|FG004|Overall Study|Physician Decision|0|||
126322386|NCT04575584|454474045|FG005|Overall Study|Physician Decision|0|||
126322387|NCT04575584|454474040|FG000|Overall Study|Withdrawal by Subject|7|||
126322388|NCT04575584|454474041|FG001|Overall Study|Withdrawal by Subject|9|||
126322389|NCT04575584|454474042|FG002|Overall Study|Withdrawal by Subject|5|||
126322390|NCT04575584|454474043|FG003|Overall Study|Withdrawal by Subject|3|||
126322391|NCT04575584|454474044|FG004|Overall Study|Withdrawal by Subject|0|||
126322392|NCT04575584|454474045|FG005|Overall Study|Withdrawal by Subject|0|||
126322393|NCT04575584|454474040|FG000|Overall Study|Not recorded|0|||
126651637|NCT05383508|455681941|FG003|Overall Study|Withdrawal by Subject|1|||
126651638|NCT05383508|455681942|FG004|Overall Study|Withdrawal by Subject|2|||
126322394|NCT04575584|454474041|FG001|Overall Study|Not recorded|0|||
126322395|NCT04575584|454474042|FG002|Overall Study|Not recorded|0|||
126322396|NCT04575584|454474043|FG003|Overall Study|Not recorded|1|||
126322397|NCT04575584|454474044|FG004|Overall Study|Not recorded|0|||
126322398|NCT04575584|454474045|FG005|Overall Study|Not recorded|0|||
126322399|NCT03488563|454474046|FG000|Overall Study|Lost to Follow-up|7|||
126322400|NCT03488563|454474047|FG001|Overall Study|Lost to Follow-up|6|||
126322401|NCT03488563|454474048|FG002|Overall Study|Lost to Follow-up|7|||
126651639|NCT05383508|455681943|FG005|Overall Study|Withdrawal by Subject|0|||
126651640|NCT00635427|455681944|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
126651641|NCT00635427|455681945|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
126651642|NCT00635427|455681946|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
126651643|NCT00635427|455681947|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
126651644|NCT00635427|455681948|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
126651645|NCT00635427|455681944|FG000|Overall Study|Death|0|||
126651646|NCT00635427|455681945|FG001|Overall Study|Death|0|||
126651647|NCT00635427|455681946|FG002|Overall Study|Death|0|||
126651648|NCT00635427|455681947|FG003|Overall Study|Death|1|||
126651649|NCT00635427|455681948|FG004|Overall Study|Death|0|||
126651650|NCT00635427|455681944|FG000|Overall Study|Termination Of Study By Sponsor|12|||
126651651|NCT00635427|455681945|FG001|Overall Study|Termination Of Study By Sponsor|6|||
126651652|NCT00635427|455681946|FG002|Overall Study|Termination Of Study By Sponsor|10|||
126651653|NCT00635427|455681947|FG003|Overall Study|Termination Of Study By Sponsor|6|||
126651654|NCT00635427|455681948|FG004|Overall Study|Termination Of Study By Sponsor|6|||
126651655|NCT00635427|455681944|FG000|Overall Study|Withdrawal Of Consent|0|||
126651656|NCT00635427|455681945|FG001|Overall Study|Withdrawal Of Consent|0|||
126651657|NCT00635427|455681946|FG002|Overall Study|Withdrawal Of Consent|0|||
126651658|NCT00635427|455681947|FG003|Overall Study|Withdrawal Of Consent|2|||
126651659|NCT00635427|455681948|FG004|Overall Study|Withdrawal Of Consent|2|||
126651660|NCT03484273|455681951|FG000|Overall Study|Equipment Malfunction|1|||
126651661|NCT03484273|455681951|FG000|Overall Study|Data excluded from analysis|1|||
126651662|NCT01157676|455681952|FG000|Randomization|Death|1|||
126651663|NCT01157676|455681953|FG001|Randomization|Death|1|||
126651664|NCT01157676|455681952|FG000|Randomization|unresectable|2|||
126651665|NCT01157676|455681953|FG001|Randomization|unresectable|3|||
126651666|NCT01157676|455681952|FG000|Randomization|Withdrawal by Subject|17|||
126651667|NCT01157676|455681953|FG001|Randomization|Withdrawal by Subject|13|||
126651668|NCT01157676|455681952|FG000|Randomization|Physician Decision|1|||
126651669|NCT01157676|455681953|FG001|Randomization|Physician Decision|0|||
126651670|NCT01157676|455681952|FG000|Surgery|underwent open cystectomy|0|||
126651671|NCT01157676|455681953|FG001|Surgery|underwent open cystectomy|4|||
126651672|NCT01157676|455681952|FG000|Surgery|converted to open procedure|0|||
126651673|NCT01157676|455681953|FG001|Surgery|converted to open procedure|5|||
126651674|NCT01157676|455681952|FG000|Surgery|underwent robotic cystectomy|1|||
126651675|NCT01157676|455681953|FG001|Surgery|underwent robotic cystectomy|0|||
126651676|NCT02706899|455681957|FG000|Overall Study|Withdrawal by Subject|1|||
126651677|NCT02706899|455681958|FG001|Overall Study|Withdrawal by Subject|0|||
126651678|NCT02706899|455681957|FG000|Overall Study|Death|8|||
126651679|NCT02706899|455681958|FG001|Overall Study|Death|0|||
126651680|NCT02706899|455681957|FG000|Overall Study|Study Termination by Sponsor|4|||
126651681|NCT02706899|455681958|FG001|Overall Study|Study Termination by Sponsor|6|||
126651682|NCT01435616|455681959|FG000|Overall Study|Adverse Event|39|||
126651683|NCT01435616|455681960|FG001|Overall Study|Adverse Event|21|||
126651684|NCT01435616|455681959|FG000|Overall Study|Death|7|||
126651685|NCT01435616|455681960|FG001|Overall Study|Death|2|||
126651686|NCT01435616|455681959|FG000|Overall Study|Lost to Follow-up|22|||
126651687|NCT01435616|455681960|FG001|Overall Study|Lost to Follow-up|13|||
126651688|NCT01435616|455681959|FG000|Overall Study|Protocol Violation|16|||
126651689|NCT01435616|455681960|FG001|Overall Study|Protocol Violation|13|||
126651690|NCT01435616|455681959|FG000|Overall Study|Withdrawal by Subject|66|||
126651691|NCT01435616|455681960|FG001|Overall Study|Withdrawal by Subject|24|||
126651692|NCT01435616|455681959|FG000|Overall Study|Physician Decision|20|||
126651693|NCT01435616|455681960|FG001|Overall Study|Physician Decision|7|||
126651694|NCT01435616|455681959|FG000|Overall Study|Sponsor Decision|1|||
126651695|NCT01435616|455681960|FG001|Overall Study|Sponsor Decision|0|||
126651696|NCT04738292|455681961|FG000|Overall Study|Death|1|||
126651697|NCT03122223|455681962|FG000|Overall Study|Withdrawal by Subject|2|||
126651698|NCT03122223|455681963|FG001|Overall Study|Withdrawal by Subject|2|||
126651699|NCT03122223|455681964|FG002|Overall Study|Withdrawal by Subject|1|||
126651700|NCT03122223|455681965|FG003|Overall Study|Withdrawal by Subject|0|||
126322402|NCT03488563|454474046|FG000|Overall Study|Withdrawal by Subject|8|||
126322403|NCT03488563|454474047|FG001|Overall Study|Withdrawal by Subject|7|||
126651701|NCT03122223|455681962|FG000|Overall Study|Lost to Follow-up|0|||
126651702|NCT03122223|455681963|FG001|Overall Study|Lost to Follow-up|2|||
126651703|NCT03122223|455681964|FG002|Overall Study|Lost to Follow-up|2|||
126651704|NCT03122223|455681965|FG003|Overall Study|Lost to Follow-up|0|||
126651705|NCT03122223|455681962|FG000|Overall Study|Participant unable to adhere|1|||
126651706|NCT03122223|455681963|FG001|Overall Study|Participant unable to adhere|1|||
126651707|NCT03122223|455681964|FG002|Overall Study|Participant unable to adhere|1|||
126651708|NCT03122223|455681965|FG003|Overall Study|Participant unable to adhere|0|||
126651709|NCT01151410|455681966|FG000|Overall Study|Withdrawal by Subject|3|||
126651710|NCT01151410|455681967|FG001|Overall Study|Withdrawal by Subject|5|||
126651711|NCT01151410|455681966|FG000|Overall Study|Lost to Follow-up|3|||
126651712|NCT01151410|455681967|FG001|Overall Study|Lost to Follow-up|4|||
126322404|NCT03488563|454474048|FG002|Overall Study|Withdrawal by Subject|7|||
126322405|NCT03488563|454474046|FG000|Overall Study|Physician Decision|0|||
126322406|NCT03488563|454474047|FG001|Overall Study|Physician Decision|0|||
126322407|NCT03488563|454474048|FG002|Overall Study|Physician Decision|1|||
126322408|NCT03488563|454474046|FG000|Overall Study|Protocol Violation|3|||
126322409|NCT03488563|454474047|FG001|Overall Study|Protocol Violation|2|||
126322410|NCT03488563|454474048|FG002|Overall Study|Protocol Violation|6|||
126322411|NCT03488563|454474046|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
126322412|NCT03488563|454474047|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
126322413|NCT03488563|454474048|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
126322414|NCT03488563|454474046|FG000|Overall Study|Use of prohibited medication|2|||
126322415|NCT03488563|454474047|FG001|Overall Study|Use of prohibited medication|0|||
126322416|NCT03488563|454474048|FG002|Overall Study|Use of prohibited medication|0|||
126322417|NCT03488563|454474046|FG000|Overall Study|Adverse Event|1|||
126322418|NCT03488563|454474047|FG001|Overall Study|Adverse Event|0|||
126322419|NCT03488563|454474048|FG002|Overall Study|Adverse Event|1|||
126322420|NCT03488563|454474046|FG000|Overall Study|Subject returned for ET visit|0|||
126322421|NCT03488563|454474047|FG001|Overall Study|Subject returned for ET visit|1|||
126322422|NCT03488563|454474048|FG002|Overall Study|Subject returned for ET visit|0|||
126322423|NCT03488563|454474046|FG000|Overall Study|Sponsor's decision|0|||
126322424|NCT03488563|454474047|FG001|Overall Study|Sponsor's decision|0|||
126322425|NCT03488563|454474048|FG002|Overall Study|Sponsor's decision|1|||
126322426|NCT02815267|454474056|FG000|Double-Blind Phase|Adverse Event|0|||
126651713|NCT01151410|455681966|FG000|Overall Study|Adverse Event|1|||
126322427|NCT02815267|454474057|FG001|Double-Blind Phase|Adverse Event|3|||
126322428|NCT02815267|454474056|FG000|Double-Blind Phase|Lost to Follow-up|17|||
126322429|NCT02815267|454474057|FG001|Double-Blind Phase|Lost to Follow-up|9|||
126322430|NCT02815267|454474056|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
126322431|NCT02815267|454474057|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
126322432|NCT02815267|454474056|FG000|Double-Blind Phase|Protocol Violation|3|||
126322433|NCT02815267|454474057|FG001|Double-Blind Phase|Protocol Violation|2|||
126322434|NCT02815267|454474056|FG000|Double-Blind Phase|Site withdrawal|1|||
126322435|NCT02815267|454474057|FG001|Double-Blind Phase|Site withdrawal|6|||
126322436|NCT02815267|454474056|FG000|Double-Blind Phase|Received a disallowed medication|1|||
126322437|NCT02815267|454474057|FG001|Double-Blind Phase|Received a disallowed medication|1|||
126322438|NCT02815267|454474056|FG000|Open-Label Phase|Adverse Event|1|||
126322439|NCT02815267|454474057|FG001|Open-Label Phase|Adverse Event|1|||
126322440|NCT02815267|454474056|FG000|Open-Label Phase|Lost to Follow-up|23|||
126322441|NCT02815267|454474057|FG001|Open-Label Phase|Lost to Follow-up|9|||
126322442|NCT02815267|454474056|FG000|Open-Label Phase|Withdrawal by Subject|24|||
126322443|NCT02815267|454474057|FG001|Open-Label Phase|Withdrawal by Subject|13|||
126651714|NCT01151410|455681967|FG001|Overall Study|Adverse Event|2|||
126651715|NCT01151410|455681966|FG000|Overall Study|Protocol deviation|2|||
126651716|NCT01151410|455681967|FG001|Overall Study|Protocol deviation|1|||
126651717|NCT01151410|455681966|FG000|Overall Study|Administrative problems|1|||
126651718|NCT01151410|455681967|FG001|Overall Study|Administrative problems|1|||
126651719|NCT01151410|455681966|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126651720|NCT01151410|455681967|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126651721|NCT01151410|455681966|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126651722|NCT01151410|455681967|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126651723|NCT02442336|455681969|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
126651724|NCT02442336|455681969|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
126651725|NCT02442336|455681969|FG000|Overall Study|Lost to Follow-up|11|||
126651726|NCT00844532|455681972|FG000|Overall Study|Death|16|||
126651727|NCT00844532|455681972|FG000|Overall Study|Withdrawal by Subject|16|||
126651728|NCT00844532|455681972|FG000|Overall Study|Lost to Follow-up|7|||
126651729|NCT01237587|455681977|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
126651730|NCT01237587|455681978|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
126651731|NCT01237587|455681977|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
126651732|NCT01237587|455681978|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
126651733|NCT01237587|455681977|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
126651734|NCT01237587|455681978|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
126651735|NCT01237587|455681977|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
126322444|NCT02815267|454474056|FG000|Open-Label Phase|Protocol Violation|0|||
126322445|NCT02815267|454474057|FG001|Open-Label Phase|Protocol Violation|1|||
126322446|NCT02815267|454474056|FG000|Open-Label Phase|Administrative|21|||
126322447|NCT02815267|454474057|FG001|Open-Label Phase|Administrative|12|||
126322448|NCT02815267|454474056|FG000|Open-Label Phase|Other|2|||
126322449|NCT02815267|454474057|FG001|Open-Label Phase|Other|5|||
126322450|NCT03594955|454474060|FG000|Overall Study|Adverse Event|1|||
126322451|NCT03594955|454474060|FG000|Overall Study|Progressive disease|5|||
126322452|NCT03594955|454474060|FG000|Overall Study|Sponsor's decision|1|||
126651736|NCT01237587|455681978|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
126322453|NCT04278924|454474063|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
126322454|NCT04278924|454474064|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
126322455|NCT04278924|454474065|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
126322456|NCT04278924|454474066|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
126322457|NCT04278924|454474067|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
126322458|NCT04278924|454474068|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
126322459|NCT04278924|454474069|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
126322460|NCT04278924|454474063|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
126322461|NCT04278924|454474064|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
126322462|NCT04278924|454474065|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
126322463|NCT04278924|454474066|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
126322464|NCT04278924|454474067|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
126322465|NCT04278924|454474068|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
126322466|NCT04278924|454474069|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
126322467|NCT05600036|454474070|FG000|Overall Study|Adverse Event|0|||
126322468|NCT05600036|454474071|FG001|Overall Study|Adverse Event|2|||
126322469|NCT05600036|454474072|FG002|Overall Study|Adverse Event|1|||
126322470|NCT05600036|454474073|FG003|Overall Study|Adverse Event|0|||
126322471|NCT05600036|454474074|FG004|Overall Study|Adverse Event|1|||
126322472|NCT05600036|454474075|FG005|Overall Study|Adverse Event|0|||
126322473|NCT05600036|454474070|FG000|Overall Study|Lost to Follow-up|0|||
126322474|NCT05600036|454474071|FG001|Overall Study|Lost to Follow-up|2|||
126322475|NCT05600036|454474072|FG002|Overall Study|Lost to Follow-up|1|||
126322476|NCT05600036|454474073|FG003|Overall Study|Lost to Follow-up|1|||
126322477|NCT05600036|454474074|FG004|Overall Study|Lost to Follow-up|0|||
126322478|NCT05600036|454474075|FG005|Overall Study|Lost to Follow-up|0|||
126322479|NCT05600036|454474070|FG000|Overall Study|Protocol Violation|0|||
126322480|NCT05600036|454474071|FG001|Overall Study|Protocol Violation|0|||
126322481|NCT05600036|454474072|FG002|Overall Study|Protocol Violation|2|||
126322482|NCT05600036|454474073|FG003|Overall Study|Protocol Violation|0|||
126322483|NCT05600036|454474074|FG004|Overall Study|Protocol Violation|0|||
126322484|NCT05600036|454474075|FG005|Overall Study|Protocol Violation|0|||
126322485|NCT05600036|454474070|FG000|Overall Study|Withdrawal by Subject|0|||
126322486|NCT05600036|454474071|FG001|Overall Study|Withdrawal by Subject|1|||
126322487|NCT05600036|454474072|FG002|Overall Study|Withdrawal by Subject|2|||
126322488|NCT05600036|454474073|FG003|Overall Study|Withdrawal by Subject|0|||
126322489|NCT05600036|454474074|FG004|Overall Study|Withdrawal by Subject|3|||
126322490|NCT05600036|454474075|FG005|Overall Study|Withdrawal by Subject|5|||
126322491|NCT05600036|454474070|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
126322492|NCT05600036|454474071|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
126322493|NCT05600036|454474072|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
126322494|NCT05600036|454474073|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
126322495|NCT05600036|454474074|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
126322496|NCT05600036|454474075|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
126322497|NCT05600036|454474070|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
126322498|NCT05600036|454474071|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
126322499|NCT05600036|454474072|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
126322500|NCT05600036|454474073|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
126322501|NCT05600036|454474074|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
126322502|NCT05600036|454474075|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
126322503|NCT05600036|454474070|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
126322504|NCT05600036|454474071|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
126322505|NCT05600036|454474072|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
126322506|NCT05600036|454474073|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
126322507|NCT05600036|454474074|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
126322508|NCT05600036|454474075|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
126322509|NCT01006590|454474076|FG000|Overall Study|Adverse Event|2|||
126322510|NCT01006590|454474077|FG001|Overall Study|Adverse Event|3|||
126322511|NCT01006590|454474076|FG000|Overall Study|Death|1|||
126322512|NCT01006590|454474077|FG001|Overall Study|Death|1|||
126322513|NCT01006590|454474076|FG000|Overall Study|Lost to Follow-up|1|||
126322514|NCT01006590|454474077|FG001|Overall Study|Lost to Follow-up|1|||
126322515|NCT01006590|454474076|FG000|Overall Study|Protocol Violation|1|||
126322516|NCT01006590|454474077|FG001|Overall Study|Protocol Violation|0|||
126322517|NCT01006590|454474076|FG000|Overall Study|Withdrawal by Subject|4|||
126322518|NCT01006590|454474077|FG001|Overall Study|Withdrawal by Subject|2|||
126322519|NCT01006590|454474076|FG000|Overall Study|Study specific discontinuation criteria|16|||
126322520|NCT01006590|454474077|FG001|Overall Study|Study specific discontinuation criteria|23|||
126322521|NCT01006590|454474076|FG000|Overall Study|Other|3|||
126322522|NCT01006590|454474077|FG001|Overall Study|Other|2|||
126322523|NCT00329745|454474078|FG000|Overall Study|Protocol Violation|1|||
126322524|NCT00329745|454474079|FG001|Overall Study|Protocol Violation|0|||
126322525|NCT00329745|454474078|FG000|Overall Study|Withdrawal by Subject|0|||
126322526|NCT00329745|454474079|FG001|Overall Study|Withdrawal by Subject|1|||
126322527|NCT00329745|454474078|FG000|Overall Study|Lost to Follow-up|86|||
126322528|NCT00329745|454474079|FG001|Overall Study|Lost to Follow-up|101|||
126322529|NCT02700698|454474080|FG000|Overall Study|Withdrawal by Subject|1|||
126322530|NCT02700698|454474081|FG001|Overall Study|Withdrawal by Subject|0|||
126322531|NCT00703118|454474084|FG000|Overall Study|Adverse Event|1|||
126322532|NCT00703118|454474085|FG001|Overall Study|Adverse Event|2|||
126322533|NCT00703118|454474086|FG002|Overall Study|Adverse Event|2|||
126322534|NCT00703118|454474084|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
126322535|NCT00703118|454474085|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
126322536|NCT00703118|454474086|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
126322537|NCT00703118|454474084|FG000|Overall Study|Lost to Follow-up|6|||
126322538|NCT00703118|454474085|FG001|Overall Study|Lost to Follow-up|4|||
126322539|NCT00703118|454474086|FG002|Overall Study|Lost to Follow-up|4|||
126322540|NCT00703118|454474084|FG000|Overall Study|Withdrawal by Subject|8|||
126322541|NCT00703118|454474085|FG001|Overall Study|Withdrawal by Subject|7|||
126322542|NCT00703118|454474086|FG002|Overall Study|Withdrawal by Subject|13|||
126322543|NCT00703118|454474084|FG000|Overall Study|Other|0|||
126322544|NCT00703118|454474085|FG001|Overall Study|Other|0|||
126322545|NCT00703118|454474086|FG002|Overall Study|Other|1|||
126322546|NCT01204918|454474089|FG000|Overall Study|Withdrawal by Subject|4|||
126651737|NCT01237587|455681977|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
126322547|NCT01204918|454474090|FG001|Overall Study|Withdrawal by Subject|10|||
126322548|NCT01204918|454474091|FG002|Overall Study|Withdrawal by Subject|5|||
126322549|NCT02005627|454474096|FG000|Overall Study|Lost to Follow-up|1|||
126322550|NCT02005627|454474097|FG001|Overall Study|Lost to Follow-up|2|||
126322551|NCT02005627|454474096|FG000|Overall Study|Withdrawal by Subject|1|||
126322552|NCT02005627|454474097|FG001|Overall Study|Withdrawal by Subject|2|||
126322553|NCT00938587|454474098|FG000|Overall Study|Adverse Event|2|||
126322554|NCT00938587|454474099|FG001|Overall Study|Adverse Event|0|||
126322555|NCT00938587|454474100|FG002|Overall Study|Adverse Event|0|||
126322556|NCT00938587|454474101|FG003|Overall Study|Adverse Event|2|||
126322557|NCT00938587|454474098|FG000|Overall Study|Did not meet entrance criteria|0|||
126322558|NCT00938587|454474099|FG001|Overall Study|Did not meet entrance criteria|0|||
126322559|NCT00938587|454474100|FG002|Overall Study|Did not meet entrance criteria|1|||
126322560|NCT00938587|454474101|FG003|Overall Study|Did not meet entrance criteria|0|||
126322561|NCT00938587|454474098|FG000|Overall Study|Withdrawal by Subject|1|||
126322562|NCT00938587|454474099|FG001|Overall Study|Withdrawal by Subject|1|||
126322563|NCT00938587|454474100|FG002|Overall Study|Withdrawal by Subject|0|||
126322564|NCT00938587|454474101|FG003|Overall Study|Withdrawal by Subject|0|||
126322565|NCT00849290|454474102|FG000|Overall Study|Adverse Event|3|||
126322566|NCT00849290|454474102|FG000|Overall Study|Death|14|||
126322567|NCT00849290|454474102|FG000|Overall Study|Withdrawal by Subject|11|||
126322568|NCT00849290|454474102|FG000|Overall Study|Lost to Follow-up|2|||
126322569|NCT00849290|454474102|FG000|Overall Study|Protocol Violation|5|||
126322570|NCT00849290|454474102|FG000|Overall Study|Disease Progression|20|||
126322571|NCT00548249|454474103|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
126651738|NCT01237587|455681978|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
126651739|NCT01237587|455681977|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
126651740|NCT01237587|455681978|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
126651741|NCT01237587|455681977|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
126651742|NCT01237587|455681978|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
126651743|NCT01237587|455681977|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
126651744|NCT01237587|455681978|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
126651745|NCT01237587|455681977|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
126651746|NCT01237587|455681978|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
126651747|NCT01237587|455681977|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
126651748|NCT01237587|455681978|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
126651749|NCT01237587|455681977|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
126651750|NCT01237587|455681978|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
126651751|NCT01237587|455681977|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
126651752|NCT01237587|455681978|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
126651753|NCT01237587|455681977|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
126322572|NCT00548249|454474104|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
126322573|NCT00548249|454474105|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
126322574|NCT00548249|454474106|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
126322575|NCT00548249|454474107|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
126322576|NCT00548249|454474103|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
126322577|NCT00548249|454474104|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
126322578|NCT00548249|454474105|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
126322579|NCT00548249|454474106|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
126322580|NCT00548249|454474107|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
126322581|NCT00548249|454474103|FG000|Overall Study|Protocol Violation|1|||
126322582|NCT00548249|454474104|FG001|Overall Study|Protocol Violation|1|||
126322583|NCT00548249|454474105|FG002|Overall Study|Protocol Violation|4|||
126322584|NCT00548249|454474106|FG003|Overall Study|Protocol Violation|0|||
126322585|NCT00548249|454474107|FG004|Overall Study|Protocol Violation|3|||
126322586|NCT00548249|454474103|FG000|Overall Study|Miscellaneous|2|||
126322587|NCT00548249|454474104|FG001|Overall Study|Miscellaneous|3|||
126322588|NCT00548249|454474105|FG002|Overall Study|Miscellaneous|2|||
126322589|NCT00548249|454474106|FG003|Overall Study|Miscellaneous|0|||
126322590|NCT00548249|454474107|FG004|Overall Study|Miscellaneous|2|||
126322591|NCT00548249|454474103|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
126322592|NCT00548249|454474104|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
126322593|NCT00548249|454474105|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
126322594|NCT00548249|454474106|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
126322595|NCT00548249|454474107|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
126322596|NCT00548249|454474103|FG000|Overall Study|Adverse Event|2|||
126322597|NCT00548249|454474104|FG001|Overall Study|Adverse Event|2|||
126322598|NCT00548249|454474105|FG002|Overall Study|Adverse Event|0|||
126322599|NCT00548249|454474106|FG003|Overall Study|Adverse Event|1|||
126322600|NCT00548249|454474107|FG004|Overall Study|Adverse Event|1|||
126322601|NCT00548249|454474103|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
126322602|NCT00548249|454474104|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
126322603|NCT00548249|454474105|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
126322604|NCT00548249|454474106|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
126322605|NCT00548249|454474107|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
126322606|NCT00548249|454474103|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
126322607|NCT00548249|454474104|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
126322608|NCT00548249|454474105|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
126322609|NCT00548249|454474106|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
126322610|NCT00548249|454474107|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
126322611|NCT00548249|454474103|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
126322612|NCT00548249|454474104|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
126322613|NCT00548249|454474105|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
126322614|NCT00548249|454474106|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
126322615|NCT00548249|454474107|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
126322616|NCT00548249|454474103|FG000|Overall Study|Prolonged hospitalization|0|||
126322617|NCT00548249|454474104|FG001|Overall Study|Prolonged hospitalization|0|||
126322618|NCT00548249|454474105|FG002|Overall Study|Prolonged hospitalization|2|||
126322619|NCT00548249|454474106|FG003|Overall Study|Prolonged hospitalization|1|||
126322620|NCT00548249|454474107|FG004|Overall Study|Prolonged hospitalization|0|||
126322621|NCT00548249|454474103|FG000|Overall Study|Withdrawal by Subject|2|||
126322622|NCT00548249|454474104|FG001|Overall Study|Withdrawal by Subject|0|||
126322623|NCT00548249|454474105|FG002|Overall Study|Withdrawal by Subject|0|||
126322624|NCT00548249|454474106|FG003|Overall Study|Withdrawal by Subject|0|||
126322625|NCT00548249|454474107|FG004|Overall Study|Withdrawal by Subject|0|||
126322626|NCT00548249|454474103|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
126322627|NCT00548249|454474104|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
126322628|NCT00548249|454474105|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
126322629|NCT00548249|454474106|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
126322630|NCT00548249|454474107|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
126322631|NCT00548249|454474103|FG000|Overall Study|Sponsor's request|0|||
126322632|NCT00548249|454474104|FG001|Overall Study|Sponsor's request|0|||
126322633|NCT00548249|454474105|FG002|Overall Study|Sponsor's request|0|||
126322634|NCT00548249|454474106|FG003|Overall Study|Sponsor's request|1|||
126322635|NCT00548249|454474107|FG004|Overall Study|Sponsor's request|0|||
126322636|NCT04933617|454474110|FG000|Dose Escalation|Early closure of study|0|||
126322637|NCT04933617|454474111|FG001|Dose Escalation|Early closure of study|3|||
126651754|NCT01237587|455681978|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
126651755|NCT01237587|455681977|FG000|Taper Phase|Adverse Event|0|||
126322638|NCT04933617|454474112|FG002|Dose Escalation|Early closure of study|0|||
126651756|NCT01237587|455681978|FG001|Taper Phase|Adverse Event|2|||
126322639|NCT04933617|454474113|FG003|Dose Escalation|Early closure of study|0|||
126651757|NCT01237587|455681977|FG000|Taper Phase|Protocol Violation|2|||
126322640|NCT04933617|454474114|FG004|Dose Escalation|Early closure of study|0|||
126322641|NCT03760458|454474116|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
126322642|NCT03760458|454474117|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
126322643|NCT03760458|454474118|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
126322644|NCT03760458|454474119|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
126651758|NCT01237587|455681978|FG001|Taper Phase|Protocol Violation|0|||
126651759|NCT01237587|455681977|FG000|Taper Phase|Lack of Efficacy|2|||
126651760|NCT01237587|455681978|FG001|Taper Phase|Lack of Efficacy|5|||
126322645|NCT03760458|454474120|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
126322646|NCT00002525|454474132|FG000|Overall Study|Adverse Event|36|||
126322647|NCT00002525|454474133|FG001|Overall Study|Adverse Event|0|||
126322648|NCT00002525|454474132|FG000|Overall Study|Death|5|||
126322649|NCT00002525|454474133|FG001|Overall Study|Death|0|||
126322650|NCT00002525|454474132|FG000|Overall Study|Withdrawal by Subject|11|||
126322651|NCT00002525|454474133|FG001|Overall Study|Withdrawal by Subject|0|||
126322652|NCT00002525|454474132|FG000|Overall Study|Start non-protocol therapy|1|||
126322653|NCT00002525|454474133|FG001|Overall Study|Start non-protocol therapy|0|||
126322654|NCT00002525|454474132|FG000|Overall Study|Other complicating disease|1|||
126322655|NCT00002525|454474133|FG001|Overall Study|Other complicating disease|0|||
126322656|NCT00002525|454474132|FG000|Overall Study|Duke's A, B1, D disease|92|||
126322657|NCT00002525|454474133|FG001|Overall Study|Duke's A, B1, D disease|0|||
126322658|NCT00002525|454474132|FG000|Overall Study|Error|6|||
126322659|NCT00002525|454474133|FG001|Overall Study|Error|0|||
126322660|NCT00002525|454474132|FG000|Overall Study|Other|26|||
126322661|NCT00002525|454474133|FG001|Overall Study|Other|0|||
126322662|NCT00002525|454474132|FG000|Overall Study|Never start protocol therapy|8|||
126322663|NCT00002525|454474133|FG001|Overall Study|Never start protocol therapy|0|||
126322664|NCT03230838|454474134|FG000|Overall Study|Withdrawal by Subject|3|||
126322665|NCT03230838|454474135|FG001|Overall Study|Withdrawal by Subject|0|||
126322666|NCT03230838|454474134|FG000|Overall Study|Temperature excursion|1|||
126322667|NCT03230838|454474135|FG001|Overall Study|Temperature excursion|0|||
126322668|NCT01915771|454474138|FG000|Day 1|Withdrawal by Subject|1|||
126322669|NCT01915771|454474138|FG000|Day 15|Withdrawal by Subject|1|||
126322670|NCT03420222|454474139|FG000|Overall Study|Withdrawal by Subject|5|||
126322671|NCT03420222|454474140|FG001|Overall Study|Withdrawal by Subject|0|||
126322672|NCT03420222|454474139|FG000|Overall Study|Physician Decision|0|||
126322673|NCT03420222|454474140|FG001|Overall Study|Physician Decision|1|||
126322674|NCT02697734|454474141|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
126322675|NCT02697734|454474142|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
126322676|NCT02697734|454474141|FG000|Core Phase - up to Week 48|Adverse Event|1|||
126322677|NCT02697734|454474142|FG001|Core Phase - up to Week 48|Adverse Event|2|||
126322678|NCT02697734|454474141|FG000|Core Phase - up to Week 48|Physician Decision|1|||
126322679|NCT02697734|454474142|FG001|Core Phase - up to Week 48|Physician Decision|0|||
126322680|NCT02697734|454474141|FG000|Optional Extension Phase|Adverse Event|5|||
126322681|NCT02697734|454474142|FG001|Optional Extension Phase|Adverse Event|1|||
126322682|NCT02697734|454474141|FG000|Optional Extension Phase|Physician Decision|0|||
126322683|NCT02697734|454474142|FG001|Optional Extension Phase|Physician Decision|1|||
126322684|NCT02334384|454474143|FG000|Overall Study|Lost to Follow-up|1|||
126322685|NCT02334384|454474144|FG001|Overall Study|Lost to Follow-up|1|||
126322686|NCT02651688|454474145|FG000|Overall Study|Non-compliance|0|||
126322687|NCT02651688|454474146|FG001|Overall Study|Non-compliance|0|||
126322688|NCT02651688|454474147|FG002|Overall Study|Non-compliance|1|||
126322689|NCT02651688|454474145|FG000|Overall Study|Principal Investigator (PI) decision|0|||
126322690|NCT02651688|454474146|FG001|Overall Study|Principal Investigator (PI) decision|2|||
126322691|NCT02651688|454474147|FG002|Overall Study|Principal Investigator (PI) decision|0|||
126322692|NCT02651688|454474145|FG000|Overall Study|Lost to Follow-up|1|||
126322693|NCT02651688|454474146|FG001|Overall Study|Lost to Follow-up|3|||
126322694|NCT02651688|454474147|FG002|Overall Study|Lost to Follow-up|0|||
126322695|NCT02651688|454474145|FG000|Overall Study|Withdrawal by Subject|1|||
126322696|NCT02651688|454474146|FG001|Overall Study|Withdrawal by Subject|0|||
126322697|NCT02651688|454474147|FG002|Overall Study|Withdrawal by Subject|2|||
126322698|NCT01429441|454474148|FG000|Overall Study|Adverse Event|5|||
126322699|NCT01429441|454474149|FG001|Overall Study|Adverse Event|1|||
126322700|NCT01429441|454474148|FG000|Overall Study|Death|0|||
126322701|NCT01429441|454474149|FG001|Overall Study|Death|2|||
126651761|NCT01237587|455681977|FG000|Taper Phase|Parent/Guardian Decision|0|||
126651762|NCT01237587|455681978|FG001|Taper Phase|Parent/Guardian Decision|2|||
126651763|NCT01237587|455681977|FG000|Taper Phase|Sponsor Decision|1|||
126651764|NCT01237587|455681978|FG001|Taper Phase|Sponsor Decision|0|||
126322702|NCT01429441|454474148|FG000|Overall Study|Lost to Follow-up|5|||
126322703|NCT01429441|454474149|FG001|Overall Study|Lost to Follow-up|2|||
126322704|NCT01429441|454474148|FG000|Overall Study|Physician Decision|1|||
126322705|NCT01429441|454474149|FG001|Overall Study|Physician Decision|0|||
126322706|NCT01429441|454474148|FG000|Overall Study|Withdrawal by Subject|27|||
126322707|NCT01429441|454474149|FG001|Overall Study|Withdrawal by Subject|18|||
126322708|NCT00621517|454474155|FG000|Overall Study|Lost to Follow-up|3|||
126322709|NCT00621517|454474156|FG001|Overall Study|Lost to Follow-up|3|||
126322710|NCT00621517|454474155|FG000|Overall Study|Withdrawal by Subject|3|||
126322711|NCT00621517|454474156|FG001|Overall Study|Withdrawal by Subject|4|||
126322712|NCT00621517|454474155|FG000|Overall Study|Adverse Event|1|||
126322713|NCT00621517|454474156|FG001|Overall Study|Adverse Event|0|||
126651765|NCT01237587|455681977|FG000|Taper Phase|Withdrawal by Subject|0|||
126322714|NCT02155322|454474158|FG000|Overall Study|Adverse Event|1|||
126322715|NCT02155322|454474158|FG000|Overall Study|Physician Decision|1|||
126322716|NCT02155322|454474158|FG000|Overall Study|Relapse/Recurrence|8|||
126322717|NCT02155322|454474158|FG000|Overall Study|Withdrawal by Subject|4|||
126322718|NCT00073008|454474159|FG000|Overall Study|Missing|6|||
126322719|NCT00073008|454474160|FG001|Overall Study|Missing|6|||
126322720|NCT00073008|454474159|FG000|Overall Study|Withdrawal by Subject|2|||
126322721|NCT00073008|454474160|FG001|Overall Study|Withdrawal by Subject|2|||
126322722|NCT00073008|454474159|FG000|Overall Study|Lost to Follow-up|1|||
126322723|NCT00073008|454474160|FG001|Overall Study|Lost to Follow-up|3|||
126322724|NCT00073008|454474159|FG000|Overall Study|Death|46|||
126322725|NCT00073008|454474160|FG001|Overall Study|Death|47|||
126322726|NCT00073008|454474159|FG000|Overall Study|"Other selected on Case Report Form"|7|||
126322727|NCT00073008|454474160|FG001|Overall Study|"Other selected on Case Report Form"|5|||
126322728|NCT00913770|454474161|FG000|Overall Study|Unable to contact|24|||
126322729|NCT00913770|454474162|FG001|Overall Study|Unable to contact|19|||
126322730|NCT00913770|454474163|FG002|Overall Study|Unable to contact|13|||
126322731|NCT00913770|454474161|FG000|Overall Study|Refused|11|||
126322732|NCT00913770|454474162|FG001|Overall Study|Refused|10|||
126322733|NCT00913770|454474163|FG002|Overall Study|Refused|8|||
126322734|NCT03337048|454474167|FG000|Overall Study|Withdrawal by Subject|2|||
126322735|NCT03337048|454474168|FG001|Overall Study|Withdrawal by Subject|0|||
126322736|NCT03337048|454474169|FG002|Overall Study|Withdrawal by Subject|0|||
126322737|NCT02791438|454474172|FG000|Treatment Period|Adverse Event|1|||
126322738|NCT02791438|454474173|FG001|Treatment Period|Adverse Event|0|||
126322739|NCT02791438|454474172|FG000|Treatment Period|Withdrawal by Subject|0|||
126322740|NCT02791438|454474173|FG001|Treatment Period|Withdrawal by Subject|1|||
126322741|NCT02791438|454474172|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
126322742|NCT02791438|454474173|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
126322743|NCT02669667|454474175|FG000|Overall Study|Lost to Follow-up|0|||
126322744|NCT02669667|454474176|FG001|Overall Study|Lost to Follow-up|0|||
126322745|NCT02669667|454474177|FG002|Overall Study|Lost to Follow-up|0|||
126322746|NCT02669667|454474178|FG003|Overall Study|Lost to Follow-up|0|||
126322747|NCT02669667|454474179|FG004|Overall Study|Lost to Follow-up|0|||
126322748|NCT02669667|454474180|FG005|Overall Study|Lost to Follow-up|1|||
126322749|NCT02669667|454474181|FG006|Overall Study|Lost to Follow-up|0|||
126322750|NCT02839876|454474182|FG000|Overall Study|Protocol Violation|10|||
126322751|NCT02839876|454474183|FG001|Overall Study|Protocol Violation|11|||
126322752|NCT00564395|454474187|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
126322753|NCT00564395|454474188|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
126322754|NCT00564395|454474187|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
126322755|NCT00564395|454474188|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
126322756|NCT01428115|454474189|FG000|Overall Study|Lack of Efficacy|3|||
126322757|NCT01428115|454474189|FG000|Overall Study|Lost to Follow-up|10|||
126322758|NCT01428115|454474189|FG000|Overall Study|Pregnancy|1|||
126322759|NCT01428115|454474189|FG000|Overall Study|Protocol Violation|3|||
126322760|NCT01428115|454474189|FG000|Overall Study|Withdrawal by Subject|4|||
126322761|NCT02071082|454474194|FG000|Overall Study|Enrolled and Never Treated|1|||
126322762|NCT02071082|454474195|FG001|Overall Study|Enrolled and Never Treated|1|||
126322763|NCT02071082|454474194|FG000|Overall Study|Adverse Event|0|||
126322764|NCT02071082|454474195|FG001|Overall Study|Adverse Event|1|||
126322765|NCT02071082|454474194|FG000|Overall Study|Withdrew Consent|0|||
126322766|NCT02071082|454474195|FG001|Overall Study|Withdrew Consent|4|||
126322767|NCT02071082|454474194|FG000|Overall Study|Lost to Follow-up|1|||
126322768|NCT02071082|454474195|FG001|Overall Study|Lost to Follow-up|1|||
126322769|NCT02494401|454474199|FG000|Overall Study|Lost to Follow-up|22|||
126322770|NCT02494401|454474200|FG001|Overall Study|Lost to Follow-up|25|||
126322771|NCT02494401|454474199|FG000|Overall Study|Withdrawal by Subject|3|||
126322772|NCT02494401|454474200|FG001|Overall Study|Withdrawal by Subject|2|||
126322773|NCT00966355|454474201|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
126322774|NCT00966355|454474202|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
126322775|NCT00966355|454474203|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
126322776|NCT00966355|454474201|FG000|Overall Study|newly diagnosed advanced HCC|11|||
126322777|NCT00966355|454474202|FG001|Overall Study|newly diagnosed advanced HCC|12|||
126322778|NCT00966355|454474203|FG002|Overall Study|newly diagnosed advanced HCC|10|||
126322779|NCT00966355|454474201|FG000|Overall Study|Lost to Follow-up|5|||
126322780|NCT00966355|454474202|FG001|Overall Study|Lost to Follow-up|4|||
126322781|NCT00966355|454474203|FG002|Overall Study|Lost to Follow-up|3|||
126322782|NCT00958412|454474204|FG000|Overall Study|Study prematurely terminated|18|||
126322783|NCT02510820|454476117|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
126322784|NCT02510820|454476118|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
126322785|NCT02510820|454476117|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126322786|NCT02510820|454476118|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
126322787|NCT03046056|454476119|FG000|Overall Study|Non-responder at Week 10|6|||
126322788|NCT03046056|454476120|FG001|Overall Study|Non-responder at Week 10|6|||
126545116|NCT00576732|455289218|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
126322789|NCT03046056|454476121|FG002|Overall Study|Non-responder at Week 10|4|||
126322790|NCT03046056|454476119|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
126322791|NCT03046056|454476120|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
126322792|NCT03046056|454476121|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
126322793|NCT03046056|454476119|FG000|Overall Study|Adverse Event|1|||
126322794|NCT03046056|454476120|FG001|Overall Study|Adverse Event|5|||
126322795|NCT03046056|454476121|FG002|Overall Study|Adverse Event|0|||
126322796|NCT03046056|454476119|FG000|Overall Study|Non-compliance With Study Drug|0|||
126322797|NCT03046056|454476120|FG001|Overall Study|Non-compliance With Study Drug|0|||
126322798|NCT03046056|454476121|FG002|Overall Study|Non-compliance With Study Drug|2|||
126322799|NCT03046056|454476119|FG000|Overall Study|Protocol Violation|1|||
126322800|NCT03046056|454476120|FG001|Overall Study|Protocol Violation|1|||
126322801|NCT03046056|454476121|FG002|Overall Study|Protocol Violation|0|||
126322802|NCT03046056|454476119|FG000|Overall Study|Investigator's Discretion|0|||
126322803|NCT03046056|454476120|FG001|Overall Study|Investigator's Discretion|1|||
126322804|NCT03046056|454476121|FG002|Overall Study|Investigator's Discretion|0|||
126322805|NCT03046056|454476119|FG000|Overall Study|Withdrew Consent|1|||
126322806|NCT03046056|454476120|FG001|Overall Study|Withdrew Consent|0|||
126322807|NCT03046056|454476121|FG002|Overall Study|Withdrew Consent|0|||
126322808|NCT02913105|454476122|FG000|Overall Study|Adverse Event|11|||
126322809|NCT02913105|454476123|FG001|Overall Study|Adverse Event|0|||
126322810|NCT02913105|454476124|FG002|Overall Study|Adverse Event|4|||
126322811|NCT02913105|454476122|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126322812|NCT02913105|454476123|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126322813|NCT02913105|454476124|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126322814|NCT02913105|454476122|FG000|Overall Study|Reason Not Specified|3|||
126322815|NCT02913105|454476123|FG001|Overall Study|Reason Not Specified|1|||
126322816|NCT02913105|454476124|FG002|Overall Study|Reason Not Specified|1|||
126322817|NCT02913105|454476122|FG000|Overall Study|Physician Decision|1|||
126322818|NCT02913105|454476123|FG001|Overall Study|Physician Decision|1|||
126322819|NCT02913105|454476124|FG002|Overall Study|Physician Decision|0|||
126322820|NCT02913105|454476122|FG000|Overall Study|Withdrawal by Subject|0|||
126322821|NCT02913105|454476123|FG001|Overall Study|Withdrawal by Subject|3|||
126322822|NCT02913105|454476124|FG002|Overall Study|Withdrawal by Subject|1|||
126322823|NCT01317004|454476125|FG000|Overall Study|Withdrawal by Subject|1|||
126322824|NCT01317004|454476126|FG001|Overall Study|Withdrawal by Subject|4|||
126322825|NCT01317004|454476125|FG000|Overall Study|Protocol Violation|0|||
126322826|NCT01317004|454476126|FG001|Overall Study|Protocol Violation|2|||
126322827|NCT01317004|454476125|FG000|Overall Study|Adverse Event|3|||
126322828|NCT01317004|454476126|FG001|Overall Study|Adverse Event|3|||
126322829|NCT01344759|454476130|FG000|Overall Study|Patients failed to reach sedation level|0|||
126322830|NCT01344759|454476131|FG001|Overall Study|Patients failed to reach sedation level|2|||
126322831|NCT01153009|454476132|FG000|Overall Study|Adverse Event|4|||
126322832|NCT01153009|454476133|FG001|Overall Study|Adverse Event|14|||
126322833|NCT01153009|454476134|FG002|Overall Study|Adverse Event|14|||
126322834|NCT01153009|454476135|FG003|Overall Study|Adverse Event|10|||
126322835|NCT01153009|454476132|FG000|Overall Study|Lack of Efficacy|9|||
126322836|NCT01153009|454476133|FG001|Overall Study|Lack of Efficacy|0|||
126322837|NCT01153009|454476134|FG002|Overall Study|Lack of Efficacy|2|||
126322838|NCT01153009|454476135|FG003|Overall Study|Lack of Efficacy|1|||
126322839|NCT01153009|454476132|FG000|Overall Study|Noncompliance with Study Medication|1|||
126322840|NCT01153009|454476133|FG001|Overall Study|Noncompliance with Study Medication|3|||
126322841|NCT01153009|454476134|FG002|Overall Study|Noncompliance with Study Medication|4|||
126322842|NCT01153009|454476135|FG003|Overall Study|Noncompliance with Study Medication|1|||
126322843|NCT01153009|454476132|FG000|Overall Study|Protocol Deviations|4|||
126322844|NCT01153009|454476133|FG001|Overall Study|Protocol Deviations|3|||
126322845|NCT01153009|454476134|FG002|Overall Study|Protocol Deviations|3|||
126322846|NCT01153009|454476135|FG003|Overall Study|Protocol Deviations|2|||
126322847|NCT01153009|454476132|FG000|Overall Study|Withdrawal of Consent|5|||
126322848|NCT01153009|454476133|FG001|Overall Study|Withdrawal of Consent|5|||
126322849|NCT01153009|454476134|FG002|Overall Study|Withdrawal of Consent|4|||
126322850|NCT01153009|454476135|FG003|Overall Study|Withdrawal of Consent|6|||
126322851|NCT01153009|454476132|FG000|Overall Study|Lost to Follow-up|8|||
126322852|NCT01153009|454476133|FG001|Overall Study|Lost to Follow-up|8|||
126322853|NCT01153009|454476134|FG002|Overall Study|Lost to Follow-up|11|||
126322854|NCT01153009|454476135|FG003|Overall Study|Lost to Follow-up|15|||
126322855|NCT01153009|454476132|FG000|Overall Study|Other|1|||
126322856|NCT01153009|454476133|FG001|Overall Study|Other|1|||
126322857|NCT01153009|454476134|FG002|Overall Study|Other|3|||
126322858|NCT01153009|454476135|FG003|Overall Study|Other|2|||
126322859|NCT04003623|454476139|FG000|Overall Study|Withdrawal by Subject|1|||
126322860|NCT04003623|454476140|FG001|Overall Study|Withdrawal by Subject|0|||
126322861|NCT00703326|454476142|FG000|Overall Study|Lost to Follow-up|47|||
126322862|NCT00703326|454476143|FG001|Overall Study|Lost to Follow-up|18|||
126322863|NCT00703326|454476142|FG000|Overall Study|Withdrawal by Subject|54|||
126322864|NCT00703326|454476143|FG001|Overall Study|Withdrawal by Subject|20|||
126322865|NCT00703326|454476142|FG000|Overall Study|Adverse Event|1|||
126322866|NCT00703326|454476143|FG001|Overall Study|Adverse Event|0|||
126651766|NCT01237587|455681978|FG001|Taper Phase|Withdrawal by Subject|1|||
126322867|NCT01744483|454476147|FG000|Overall Study|Death|9|||
126322868|NCT01744483|454476148|FG001|Overall Study|Death|4|||
126322869|NCT01744483|454476149|FG002|Overall Study|Death|11|||
126322870|NCT01744483|454476147|FG000|Overall Study|Lost to Follow-up|8|||
126322871|NCT01744483|454476148|FG001|Overall Study|Lost to Follow-up|9|||
126322872|NCT01744483|454476149|FG002|Overall Study|Lost to Follow-up|11|||
126322873|NCT01744483|454476147|FG000|Overall Study|Protocol Violation|1|||
126322874|NCT01744483|454476148|FG001|Overall Study|Protocol Violation|2|||
126322875|NCT01744483|454476149|FG002|Overall Study|Protocol Violation|1|||
126322876|NCT01744483|454476147|FG000|Overall Study|Withdrawal by Subject|4|||
126322877|NCT01744483|454476148|FG001|Overall Study|Withdrawal by Subject|6|||
126322878|NCT01744483|454476149|FG002|Overall Study|Withdrawal by Subject|2|||
126322879|NCT01744483|454476147|FG000|Overall Study|No ICU Admit|5|||
126322880|NCT01744483|454476148|FG001|Overall Study|No ICU Admit|1|||
126322881|NCT01744483|454476149|FG002|Overall Study|No ICU Admit|2|||
126322882|NCT01744483|454476147|FG000|Overall Study|Routed to OSH|2|||
126322883|NCT01744483|454476148|FG001|Overall Study|Routed to OSH|0|||
126322884|NCT01744483|454476149|FG002|Overall Study|Routed to OSH|1|||
126322885|NCT01190189|454476150|FG000|Overall Study|Lost to Follow-up|4|||
126322886|NCT01190189|454476150|FG000|Overall Study|Withdrawal by Subject|1|||
126322887|NCT01190189|454476150|FG000|Overall Study|Migrated/moved from study area|1|||
126322888|NCT03214679|454476152|FG000|Overall Study|Lost to Follow-up|12|||
126322889|NCT03214679|454476153|FG001|Overall Study|Lost to Follow-up|14|||
126322890|NCT03214679|454476152|FG000|Overall Study|not eligible|2|||
126322891|NCT03214679|454476153|FG001|Overall Study|not eligible|0|||
126322892|NCT01754766|454476166|FG000|Overall Study|Personal reasons|1|||
126322893|NCT01754766|454476167|FG001|Overall Study|Personal reasons|1|||
126322894|NCT01754766|454476168|FG002|Overall Study|Personal reasons|0|||
126322895|NCT01709409|454476171|FG000|Overall Study|Protocol Violation|1|||
126322896|NCT01709409|454476172|FG001|Overall Study|Protocol Violation|0|||
126322897|NCT02412878|454476173|FG000|Overall Study|Withdrawal by Subject|19|||
126322898|NCT02412878|454476174|FG001|Overall Study|Withdrawal by Subject|10|||
126322899|NCT02412878|454476173|FG000|Overall Study|Lost to Follow-up|2|||
126322900|NCT02412878|454476174|FG001|Overall Study|Lost to Follow-up|3|||
126322901|NCT02190721|454476175|FG000|Overall Study|Patient was out of the city|0|||
126322902|NCT02190721|454476176|FG001|Overall Study|Patient was out of the city|1|||
126322903|NCT02190721|454476177|FG002|Overall Study|Patient was out of the city|0|||
126322904|NCT04571385|454476178|FG000|Overall Study|Participant non-compliance|1|||
126322905|NCT04571385|454476179|FG001|Overall Study|Participant non-compliance|0|||
126322906|NCT04571385|454476180|FG002|Overall Study|Participant non-compliance|0|||
126322907|NCT04571385|454476178|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
126322908|NCT04571385|454476179|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
126322909|NCT04571385|454476180|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
126322910|NCT04571385|454476178|FG000|Overall Study|Screen failure|0|||
126322911|NCT04571385|454476179|FG001|Overall Study|Screen failure|0|||
126322912|NCT04571385|454476180|FG002|Overall Study|Screen failure|1|||
126322913|NCT02263729|454476182|FG000|Overall Study|Lost to Follow-up|1|||
126322914|NCT02263729|454476183|FG001|Overall Study|Lost to Follow-up|1|||
126322915|NCT05025332|454476184|FG000|Screening|Screen failure|12|||
126322916|NCT05025332|454476184|FG000|Treatment & Follow Up|Protocol Violation|1|||
126322917|NCT05025332|454476184|FG000|Treatment & Follow Up|Adverse Event|4|||
126322918|NCT01212159|454476185|FG000|Overall Study|Withdrawal by Subject|12|||
126322919|NCT01212159|454476186|FG001|Overall Study|Withdrawal by Subject|12|||
126322920|NCT01306214|454476187|FG000|Overall Study|Death|0|||
126322921|NCT01306214|454476188|FG001|Overall Study|Death|0|||
126322922|NCT01306214|454476189|FG002|Overall Study|Death|1|||
126322923|NCT01306214|454476187|FG000|Overall Study|Lost to Follow-up|3|||
126322924|NCT01306214|454476188|FG001|Overall Study|Lost to Follow-up|5|||
126322925|NCT01306214|454476189|FG002|Overall Study|Lost to Follow-up|4|||
126651767|NCT02656329|455681979|FG000|Overall Study|Lost to Follow-up|2|||
126651768|NCT02656329|455681980|FG001|Overall Study|Lost to Follow-up|3|||
126651769|NCT02656329|455681979|FG000|Overall Study|Withdrawal by Subject|7|||
126322926|NCT01306214|454476187|FG000|Overall Study|Withdrawal by Subject|24|||
126322927|NCT01306214|454476188|FG001|Overall Study|Withdrawal by Subject|22|||
126322928|NCT01306214|454476189|FG002|Overall Study|Withdrawal by Subject|16|||
126322929|NCT01306214|454476187|FG000|Overall Study|Not treated|1|||
126322930|NCT01306214|454476188|FG001|Overall Study|Not treated|1|||
126322931|NCT01306214|454476189|FG002|Overall Study|Not treated|1|||
126322932|NCT01928199|454476192|FG000|Overall Study|Lost to Follow-up|2|||
126322933|NCT01928199|454476193|FG001|Overall Study|Lost to Follow-up|1|||
126322934|NCT01928199|454476192|FG000|Overall Study|Withdrawal by Subject|3|||
126322935|NCT01928199|454476193|FG001|Overall Study|Withdrawal by Subject|5|||
126322936|NCT01502956|454476200|FG000|Overall Study|Death|0|||
126322937|NCT01502956|454476201|FG001|Overall Study|Death|2|||
126322938|NCT01502956|454476200|FG000|Overall Study|Lost to Follow-up|14|||
126322939|NCT01502956|454476201|FG001|Overall Study|Lost to Follow-up|11|||
126651770|NCT02656329|455681980|FG001|Overall Study|Withdrawal by Subject|6|||
126322940|NCT01502956|454476200|FG000|Overall Study|Physician Decision|2|||
126322941|NCT01502956|454476201|FG001|Overall Study|Physician Decision|3|||
126322942|NCT01502956|454476200|FG000|Overall Study|Withdrawal by Subject|8|||
126322943|NCT01502956|454476201|FG001|Overall Study|Withdrawal by Subject|10|||
126322944|NCT03959488|454476202|FG000|Season 1|Other|6|||
126322945|NCT03959488|454476203|FG001|Season 1|Other|7|||
126322946|NCT03959488|454476204|FG002|Season 1|Other|0|||
126651771|NCT02656329|455681979|FG000|Overall Study|Study termination by Sponsor|150|||
126651772|NCT02656329|455681980|FG001|Overall Study|Study termination by Sponsor|142|||
126651773|NCT02656329|455681979|FG000|Overall Study|Other than specified above|5|||
126651774|NCT02656329|455681980|FG001|Overall Study|Other than specified above|6|||
126651775|NCT01139580|455681981|FG000|Overall Study|Adverse Event|5|||
126651776|NCT01139580|455681982|FG001|Overall Study|Adverse Event|4|||
126322947|NCT03959488|454476205|FG003|Season 1|Other|0|||
126322948|NCT03959488|454476206|FG004|Season 1|Other|0|||
126322949|NCT03959488|454476202|FG000|Season 1|Withdrawal by parent/guardian|43|||
126322950|NCT03959488|454476203|FG001|Season 1|Withdrawal by parent/guardian|28|||
126322951|NCT03959488|454476204|FG002|Season 1|Withdrawal by parent/guardian|0|||
126322952|NCT03959488|454476205|FG003|Season 1|Withdrawal by parent/guardian|0|||
126322953|NCT03959488|454476206|FG004|Season 1|Withdrawal by parent/guardian|0|||
126322954|NCT03959488|454476202|FG000|Season 1|Due to COVID-19 pandemic|2|||
126322955|NCT03959488|454476203|FG001|Season 1|Due to COVID-19 pandemic|3|||
126322956|NCT03959488|454476204|FG002|Season 1|Due to COVID-19 pandemic|0|||
126322957|NCT03959488|454476205|FG003|Season 1|Due to COVID-19 pandemic|0|||
126322958|NCT03959488|454476206|FG004|Season 1|Due to COVID-19 pandemic|0|||
126322959|NCT03959488|454476202|FG000|Season 1|Lost to Follow-up|17|||
126322960|NCT03959488|454476203|FG001|Season 1|Lost to Follow-up|7|||
126322961|NCT03959488|454476204|FG002|Season 1|Lost to Follow-up|0|||
126322962|NCT03959488|454476205|FG003|Season 1|Lost to Follow-up|0|||
126322963|NCT03959488|454476206|FG004|Season 1|Lost to Follow-up|0|||
126322964|NCT03959488|454476202|FG000|Season 1|Death|5|||
126322965|NCT03959488|454476203|FG001|Season 1|Death|1|||
126322966|NCT03959488|454476204|FG002|Season 1|Death|0|||
126322967|NCT03959488|454476205|FG003|Season 1|Death|0|||
126322968|NCT03959488|454476206|FG004|Season 1|Death|0|||
126322969|NCT03959488|454476202|FG000|Season 2|Other|0|||
126322970|NCT03959488|454476203|FG001|Season 2|Other|0|||
126322971|NCT03959488|454476204|FG002|Season 2|Other|2|||
126322972|NCT03959488|454476205|FG003|Season 2|Other|0|||
126651777|NCT01139580|455681981|FG000|Overall Study|Lost to Follow-up|9|||
126651778|NCT01139580|455681982|FG001|Overall Study|Lost to Follow-up|1|||
126651779|NCT01139580|455681981|FG000|Overall Study|Lack of Efficacy|0|||
126651780|NCT01139580|455681982|FG001|Overall Study|Lack of Efficacy|2|||
126651781|NCT01139580|455681981|FG000|Overall Study|Withdrawal by Subject|6|||
126651782|NCT01139580|455681982|FG001|Overall Study|Withdrawal by Subject|9|||
126651783|NCT01139580|455681981|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
126651784|NCT01139580|455681982|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
126651785|NCT01139580|455681981|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
126651786|NCT01139580|455681982|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
126651787|NCT01139580|455681981|FG000|Overall Study|Misrandomized|1|||
126651788|NCT01139580|455681982|FG001|Overall Study|Misrandomized|0|||
126651789|NCT01139580|455681981|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
126651790|NCT01139580|455681982|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
126651791|NCT01139580|455681981|FG000|Overall Study|Participant Randomization in Error|0|||
126651792|NCT01139580|455681982|FG001|Overall Study|Participant Randomization in Error|1|||
126651793|NCT00633880|455681987|FG000|Open Label Titration|Lack of Efficacy|1|||
126651794|NCT00633880|455681988|FG001|Open Label Titration|Lack of Efficacy|0|||
126322973|NCT03959488|454476206|FG004|Season 2|Other|0|||
126322974|NCT03959488|454476202|FG000|Season 2|Withdrawal by parent/guardian|0|||
126322975|NCT03959488|454476203|FG001|Season 2|Withdrawal by parent/guardian|0|||
126322976|NCT03959488|454476204|FG002|Season 2|Withdrawal by parent/guardian|3|||
126322977|NCT03959488|454476205|FG003|Season 2|Withdrawal by parent/guardian|1|||
126322978|NCT03959488|454476206|FG004|Season 2|Withdrawal by parent/guardian|1|||
126322979|NCT03959488|454476202|FG000|Season 2|Lost to Follow-up|0|||
126322980|NCT03959488|454476203|FG001|Season 2|Lost to Follow-up|0|||
126322981|NCT03959488|454476204|FG002|Season 2|Lost to Follow-up|1|||
126322982|NCT03959488|454476205|FG003|Season 2|Lost to Follow-up|0|||
126322983|NCT03959488|454476206|FG004|Season 2|Lost to Follow-up|1|||
126322984|NCT01026818|454476209|FG000|Screening Period|Entry Criteria Not Met|105|||
126322985|NCT01026818|454476210|FG001|Screening Period|Entry Criteria Not Met|0|||
126322986|NCT01026818|454476211|FG002|Screening Period|Entry Criteria Not Met|0|||
126651795|NCT00633880|455681989|FG002|Open Label Titration|Lack of Efficacy|0|||
126651796|NCT00633880|455681987|FG000|Open Label Titration|Adverse Event|13|||
126651797|NCT00633880|455681988|FG001|Open Label Titration|Adverse Event|0|||
126651798|NCT00633880|455681989|FG002|Open Label Titration|Adverse Event|0|||
126322987|NCT01026818|454476212|FG003|Screening Period|Entry Criteria Not Met|0|||
126322988|NCT01026818|454476209|FG000|Screening Period|Withdrawal by Subject|49|||
126651799|NCT00633880|455681987|FG000|Open Label Titration|Treatment Failure|55|||
126651800|NCT00633880|455681988|FG001|Open Label Titration|Treatment Failure|0|||
126651801|NCT00633880|455681989|FG002|Open Label Titration|Treatment Failure|0|||
126651802|NCT00633880|455681987|FG000|Open Label Titration|Protocol Violation|6|||
126322989|NCT01026818|454476210|FG001|Screening Period|Withdrawal by Subject|0|||
126322990|NCT01026818|454476211|FG002|Screening Period|Withdrawal by Subject|0|||
126322991|NCT01026818|454476212|FG003|Screening Period|Withdrawal by Subject|0|||
126322992|NCT01026818|454476209|FG000|Screening Period|Protocol Deviation|3|||
126322993|NCT01026818|454476210|FG001|Screening Period|Protocol Deviation|0|||
126322994|NCT01026818|454476211|FG002|Screening Period|Protocol Deviation|0|||
126322995|NCT01026818|454476212|FG003|Screening Period|Protocol Deviation|0|||
126322996|NCT01026818|454476209|FG000|Screening Period|Adverse Event|2|||
126322997|NCT01026818|454476210|FG001|Screening Period|Adverse Event|0|||
126322998|NCT01026818|454476211|FG002|Screening Period|Adverse Event|0|||
126322999|NCT01026818|454476212|FG003|Screening Period|Adverse Event|0|||
126323000|NCT01026818|454476209|FG000|Screening Period|Physician Decision|1|||
126323001|NCT01026818|454476210|FG001|Screening Period|Physician Decision|0|||
126323002|NCT01026818|454476211|FG002|Screening Period|Physician Decision|0|||
126323003|NCT01026818|454476212|FG003|Screening Period|Physician Decision|0|||
126323004|NCT01026818|454476209|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
126323005|NCT01026818|454476210|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
126323006|NCT01026818|454476211|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
126323007|NCT01026818|454476212|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
126323008|NCT01026818|454476209|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
126323009|NCT01026818|454476210|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
126323010|NCT01026818|454476211|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
126323011|NCT01026818|454476212|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
126323012|NCT01026818|454476209|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
126323013|NCT01026818|454476210|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
126323014|NCT01026818|454476211|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
126323015|NCT01026818|454476212|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
126323016|NCT01026818|454476209|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
126323017|NCT01026818|454476210|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
126323018|NCT01026818|454476211|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
126323019|NCT01026818|454476212|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
126323020|NCT01026818|454476209|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
126323021|NCT01026818|454476210|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
126323022|NCT01026818|454476211|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
126323023|NCT01026818|454476212|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
126323024|NCT01026818|454476209|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
126323025|NCT01026818|454476210|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
126323026|NCT01026818|454476211|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
126323027|NCT01026818|454476212|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
126323028|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
126323029|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
126651803|NCT00633880|455681988|FG001|Open Label Titration|Protocol Violation|0|||
126651804|NCT00633880|455681989|FG002|Open Label Titration|Protocol Violation|0|||
126651805|NCT00633880|455681987|FG000|Open Label Titration|Physician Decision|1|||
126651806|NCT00633880|455681988|FG001|Open Label Titration|Physician Decision|0|||
126651807|NCT00633880|455681989|FG002|Open Label Titration|Physician Decision|0|||
126651808|NCT00633880|455681987|FG000|Open Label Titration|Withdrawal by Subject|4|||
126651809|NCT00633880|455681988|FG001|Open Label Titration|Withdrawal by Subject|0|||
126651810|NCT00633880|455681989|FG002|Open Label Titration|Withdrawal by Subject|0|||
126651811|NCT03208036|455681990|FG000|Baseline Assessment|Withdrawal by Subject|1|||
126651812|NCT03208036|455681991|FG001|Baseline Assessment|Withdrawal by Subject|1|||
126651813|NCT03208036|455681990|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
126651814|NCT03208036|455681991|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
126651815|NCT03208036|455681990|FG000|Intervention|Withdrawal by Subject|3|||
126651816|NCT03208036|455681991|FG001|Intervention|Withdrawal by Subject|2|||
126651817|NCT03208036|455681990|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
126651818|NCT03208036|455681991|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
126323030|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
126323031|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
126323032|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
126323033|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
126323034|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
126323035|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
126651819|NCT00591851|455681993|FG000|Overall Study|Withdrawal by Subject|3|||
126651820|NCT00591851|455681993|FG000|Overall Study|Adverse Event|2|||
126651821|NCT00591851|455681993|FG000|Overall Study|Progressive Disease|1|||
126651822|NCT00515853|455681996|FG000|Overall Study|Lost to Follow-up|9|||
126651823|NCT00515853|455681997|FG001|Overall Study|Lost to Follow-up|13|||
126651824|NCT00515853|455681996|FG000|Overall Study|Withdrawal by Subject|6|||
126651825|NCT00515853|455681997|FG001|Overall Study|Withdrawal by Subject|4|||
126651826|NCT02217501|455682003|FG000|Overall Study|Death|3|||
126651827|NCT02217501|455682004|FG001|Overall Study|Death|4|||
126651828|NCT03725085|455683787|FG000|Overall Study|Lost to Follow-up|2|||
126651829|NCT01775475|455683788|FG000|Overall Study|Death|3|||
126651830|NCT01775475|455683789|FG001|Overall Study|Death|3|||
126651831|NCT02245737|455683794|FG000|Overall Study|Adverse Event|23|||
126651832|NCT02245737|455683795|FG001|Overall Study|Adverse Event|26|||
126651833|NCT02245737|455683796|FG002|Overall Study|Adverse Event|33|||
126651834|NCT02245737|455683794|FG000|Overall Study|Condition Worsened|9|||
126651835|NCT02245737|455683795|FG001|Overall Study|Condition Worsened|10|||
126651836|NCT02245737|455683796|FG002|Overall Study|Condition Worsened|9|||
126651837|NCT02245737|455683794|FG000|Overall Study|Death|2|||
126651838|NCT02245737|455683795|FG001|Overall Study|Death|4|||
126651839|NCT02245737|455683796|FG002|Overall Study|Death|4|||
126651840|NCT02245737|455683794|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
126651841|NCT02245737|455683795|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
126651842|NCT02245737|455683796|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
126651843|NCT02245737|455683794|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
126651844|NCT02245737|455683795|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
126323036|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
126323037|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
126323038|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
126323039|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
126323040|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
126323041|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
126323042|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
126323043|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
126323044|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
126323045|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
126323046|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
126323047|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
126323048|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
126323049|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
126323050|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
126323051|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
126323052|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
126323053|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
126323054|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
126323055|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
126323056|NCT01026818|454476209|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
126323057|NCT01026818|454476210|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
126323058|NCT01026818|454476211|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
126323059|NCT01026818|454476212|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
126323060|NCT01026818|454476209|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
126323061|NCT01026818|454476210|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
126323062|NCT01026818|454476211|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
126323063|NCT01026818|454476212|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
126323064|NCT01026818|454476209|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
126323065|NCT01026818|454476210|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
126323066|NCT01026818|454476211|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
126323067|NCT01026818|454476212|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
126323068|NCT01026818|454476209|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
126323069|NCT01026818|454476210|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
126323070|NCT01026818|454476211|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
126323071|NCT01026818|454476212|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
126323072|NCT01026818|454476209|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
126323073|NCT01026818|454476210|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
126323074|NCT01026818|454476211|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
126323075|NCT01026818|454476212|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
126651845|NCT02245737|455683796|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
126651846|NCT02245737|455683794|FG000|Overall Study|Lost to Follow-up|2|||
126651847|NCT02245737|455683795|FG001|Overall Study|Lost to Follow-up|5|||
126651848|NCT02245737|455683796|FG002|Overall Study|Lost to Follow-up|4|||
126651849|NCT02245737|455683794|FG000|Overall Study|Other-determined by Investigator|9|||
126651850|NCT02245737|455683795|FG001|Overall Study|Other-determined by Investigator|10|||
126651851|NCT02245737|455683796|FG002|Overall Study|Other-determined by Investigator|10|||
126323076|NCT01026818|454476209|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
126323077|NCT01026818|454476210|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
126323078|NCT01026818|454476211|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
126323079|NCT01026818|454476212|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
126323080|NCT03300050|454476215|FG000|Overall Study|Lost to Follow-up|2|||
126323081|NCT03300050|454476216|FG001|Overall Study|Lost to Follow-up|1|||
126323082|NCT03300050|454476217|FG002|Overall Study|Lost to Follow-up|0|||
126323083|NCT03300050|454476218|FG003|Overall Study|Lost to Follow-up|0|||
126323084|NCT03300050|454476219|FG004|Overall Study|Lost to Follow-up|1|||
126323085|NCT03300050|454476215|FG000|Overall Study|Withdrawal by Subject|1|||
126323086|NCT03300050|454476216|FG001|Overall Study|Withdrawal by Subject|1|||
126323087|NCT03300050|454476217|FG002|Overall Study|Withdrawal by Subject|1|||
126323088|NCT03300050|454476218|FG003|Overall Study|Withdrawal by Subject|0|||
126323089|NCT03300050|454476219|FG004|Overall Study|Withdrawal by Subject|0|||
126323090|NCT03300050|454476215|FG000|Overall Study|Death|0|||
126323091|NCT03300050|454476216|FG001|Overall Study|Death|0|||
126323092|NCT03300050|454476217|FG002|Overall Study|Death|1|||
126323093|NCT03300050|454476218|FG003|Overall Study|Death|0|||
126323094|NCT03300050|454476219|FG004|Overall Study|Death|0|||
126323095|NCT03300050|454476215|FG000|Overall Study|Not Eligible at Randomization|0|||
126323096|NCT03300050|454476216|FG001|Overall Study|Not Eligible at Randomization|0|||
126323097|NCT03300050|454476217|FG002|Overall Study|Not Eligible at Randomization|1|||
126323098|NCT03300050|454476218|FG003|Overall Study|Not Eligible at Randomization|1|||
126323099|NCT03300050|454476219|FG004|Overall Study|Not Eligible at Randomization|0|||
126323100|NCT00631163|454476222|FG000|Number of Participants in Year 1|Adverse Event|12|||
126323101|NCT00631163|454476222|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
126323102|NCT00631163|454476222|FG000|Number of Participants in Year 1|Death|6|||
126323103|NCT00631163|454476222|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
126323104|NCT00631163|454476222|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
126323105|NCT00631163|454476222|FG000|Number of Participants in Year 1|Administrative problems|6|||
126323106|NCT00631163|454476222|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
126323107|NCT00631163|454476222|FG000|Number of Participants in Year 2|Adverse Event|1|||
126323108|NCT00631163|454476222|FG000|Number of Participants in Year 2|Protocol Violation|1|||
126323109|NCT00631163|454476222|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
126323110|NCT02714036|454476223|FG000|Overall Study|Adverse Event|9|||
126323111|NCT02714036|454476224|FG001|Overall Study|Adverse Event|2|||
126323112|NCT02714036|454476223|FG000|Overall Study|Withdrawal by Subject|3|||
126323113|NCT02714036|454476224|FG001|Overall Study|Withdrawal by Subject|2|||
126323114|NCT01597492|454476226|FG000|Overall Study|Withdrawal by Subject|1|||
126323115|NCT01597492|454476227|FG001|Overall Study|Withdrawal by Subject|2|||
126323116|NCT01597492|454476226|FG000|Overall Study|Adverse Event|3|||
126323117|NCT01597492|454476227|FG001|Overall Study|Adverse Event|0|||
126323118|NCT01597492|454476226|FG000|Overall Study|Lost to Follow-up|0|||
126323119|NCT01597492|454476227|FG001|Overall Study|Lost to Follow-up|2|||
126323120|NCT01597492|454476226|FG000|Overall Study|Other Reason|2|||
126323121|NCT01597492|454476227|FG001|Overall Study|Other Reason|0|||
126323122|NCT03517449|454476237|FG000|Overall Study|Death|184|||
126323123|NCT03517449|454476238|FG001|Overall Study|Death|236|||
126323124|NCT03517449|454476237|FG000|Overall Study|Lost to Follow-up|0|||
126323125|NCT03517449|454476238|FG001|Overall Study|Lost to Follow-up|2|||
126323126|NCT03517449|454476237|FG000|Overall Study|Withdrawal by Subject|7|||
126323127|NCT03517449|454476238|FG001|Overall Study|Withdrawal by Subject|26|||
126323128|NCT03517449|454476237|FG000|Overall Study|Participants Ongoing|220|||
126323129|NCT03517449|454476238|FG001|Overall Study|Participants Ongoing|152|||
126323130|NCT01853696|454476239|FG000|Overall Study|Withdrawal by Subject|1|||
126323131|NCT01853696|454476240|FG001|Overall Study|Withdrawal by Subject|1|||
126323132|NCT01853696|454476239|FG000|Overall Study|Lost to Follow-up|5|||
126323133|NCT01853696|454476240|FG001|Overall Study|Lost to Follow-up|4|||
126323134|NCT00431067|454476243|FG000|Overall Study|Other Adverse Event|9|||
126323135|NCT00431067|454476243|FG000|Overall Study|Progressive disease|30|||
126323136|NCT00431067|454476243|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
126323137|NCT03304184|454476248|FG000|Overall Study|Withdrawal by Subject|1|||
126323138|NCT03304184|454476249|FG001|Overall Study|Withdrawal by Subject|2|||
126323139|NCT04527978|454476256|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
126323140|NCT04527978|454476257|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
126323141|NCT01578499|454476258|FG000|Overall Study|Reason not Specified|0|||
126323142|NCT01578499|454476259|FG001|Overall Study|Reason not Specified|1|||
126323143|NCT01578499|454476258|FG000|Overall Study|Lost to Follow-up|2|||
126323144|NCT01578499|454476259|FG001|Overall Study|Lost to Follow-up|1|||
126323145|NCT01578499|454476258|FG000|Overall Study|Withdrawal by Subject|10|||
126323146|NCT01578499|454476259|FG001|Overall Study|Withdrawal by Subject|16|||
126323147|NCT01578499|454476258|FG000|Overall Study|Death|20|||
126323148|NCT01578499|454476259|FG001|Overall Study|Death|25|||
126323149|NCT01578499|454476258|FG000|Overall Study|Died and End of Study Page not Completed|2|||
126323150|NCT01578499|454476259|FG001|Overall Study|Died and End of Study Page not Completed|0|||
126323151|NCT00830518|454476260|FG000|Overall Study|Progressive Disease|18|||
126323152|NCT00830518|454476261|FG001|Overall Study|Progressive Disease|8|||
126323153|NCT00830518|454476260|FG000|Overall Study|Symptomatic Deterioration|4|||
126323154|NCT00830518|454476261|FG001|Overall Study|Symptomatic Deterioration|1|||
126323155|NCT00830518|454476260|FG000|Overall Study|Adverse Event|14|||
126323156|NCT00830518|454476261|FG001|Overall Study|Adverse Event|1|||
126323157|NCT00830518|454476260|FG000|Overall Study|Withdrawal by Patient|2|||
126323158|NCT00830518|454476261|FG001|Overall Study|Withdrawal by Patient|0|||
126323159|NCT00830518|454476260|FG000|Overall Study|Reason not Specified|8|||
126323160|NCT00830518|454476261|FG001|Overall Study|Reason not Specified|1|||
126323161|NCT01156051|454476269|FG000|Overall Study|Lost to Follow-up|1|||
126323162|NCT01156051|454476270|FG001|Overall Study|Lost to Follow-up|0|||
126323163|NCT01156051|454476269|FG000|Overall Study|patient not compliant with protocol|0|||
126323164|NCT01156051|454476270|FG001|Overall Study|patient not compliant with protocol|1|||
126323165|NCT01926197|454476273|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
126323166|NCT01926197|454476274|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
126323167|NCT01926197|454476273|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
126323168|NCT01926197|454476274|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
126323169|NCT02620384|454476276|FG000|Overall Study|Adverse Event|2|||
126323170|NCT02620384|454476277|FG001|Overall Study|Adverse Event|1|||
126323171|NCT02620384|454476276|FG000|Overall Study|Discharged prior to 2nd dose|2|||
126323172|NCT02620384|454476277|FG001|Overall Study|Discharged prior to 2nd dose|5|||
126323173|NCT02620384|454476276|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
126323174|NCT02620384|454476277|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
126323175|NCT02101359|454476278|FG000|Overall Study|Not included|23|||
126323176|NCT02101359|454476279|FG001|Overall Study|Not included|13|||
126323177|NCT02101359|454476278|FG000|Overall Study|Withdrawal by Subject|5|||
126323178|NCT02101359|454476279|FG001|Overall Study|Withdrawal by Subject|4|||
126323179|NCT02101359|454476278|FG000|Overall Study|Lost to Follow-up|1|||
126323180|NCT02101359|454476279|FG001|Overall Study|Lost to Follow-up|0|||
126323181|NCT02101359|454476278|FG000|Overall Study|Protocol Violation|0|||
126323182|NCT02101359|454476279|FG001|Overall Study|Protocol Violation|2|||
126323183|NCT00723697|454476281|FG000|Overall Study|Physician questionnaires not received|2|||
126323184|NCT00723697|454476281|FG000|Overall Study|Missing Informed Consent Form|10|||
126323185|NCT00723697|454476281|FG000|Overall Study|Other exclusion criteria applied|6|||
126323186|NCT01483599|454476282|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
126323187|NCT01483599|454476283|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323188|NCT01483599|454476284|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323189|NCT01483599|454476285|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
126323190|NCT01483599|454476286|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
126323191|NCT01483599|454476287|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
126323192|NCT01483599|454476288|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
126323193|NCT01483599|454476289|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323194|NCT01483599|454476290|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323195|NCT01483599|454476291|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323196|NCT01483599|454476292|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323197|NCT01483599|454476293|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323198|NCT01483599|454476294|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323199|NCT01483599|454476295|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
126323200|NCT01483599|454476282|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323201|NCT01483599|454476283|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
126323202|NCT01483599|454476284|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323203|NCT01483599|454476285|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
126323204|NCT01483599|454476286|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323205|NCT01483599|454476287|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323206|NCT01483599|454476288|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
126323207|NCT01483599|454476289|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323208|NCT01483599|454476290|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323209|NCT01483599|454476291|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323210|NCT01483599|454476292|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323211|NCT01483599|454476293|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323212|NCT01483599|454476294|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323213|NCT01483599|454476295|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
126323214|NCT01483599|454476282|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
126323215|NCT01483599|454476283|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323216|NCT01483599|454476284|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323217|NCT01483599|454476285|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323218|NCT01483599|454476286|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323219|NCT01483599|454476287|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323220|NCT01483599|454476288|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323221|NCT01483599|454476289|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323222|NCT01483599|454476290|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323223|NCT01483599|454476291|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323224|NCT01483599|454476292|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323225|NCT01483599|454476293|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323226|NCT01483599|454476294|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323227|NCT01483599|454476295|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
126323228|NCT01483599|454476282|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
126323229|NCT01483599|454476283|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
126323230|NCT01483599|454476284|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
126323231|NCT01483599|454476285|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
126323232|NCT01483599|454476286|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
126323233|NCT01483599|454476287|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
126323234|NCT01483599|454476288|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
126323235|NCT01483599|454476289|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
126323236|NCT01483599|454476290|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
126323237|NCT01483599|454476291|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
126323238|NCT01483599|454476292|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
126323239|NCT01483599|454476293|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
126323240|NCT01483599|454476294|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
126323241|NCT01483599|454476295|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
126651852|NCT02245737|455683794|FG000|Overall Study|Physician Decision|6|||
126651853|NCT02245737|455683795|FG001|Overall Study|Physician Decision|3|||
126651854|NCT02245737|455683796|FG002|Overall Study|Physician Decision|6|||
126651855|NCT02245737|455683794|FG000|Overall Study|Protocol Violation|3|||
126651856|NCT02245737|455683795|FG001|Overall Study|Protocol Violation|2|||
126651857|NCT02245737|455683796|FG002|Overall Study|Protocol Violation|3|||
126651858|NCT02245737|455683794|FG000|Overall Study|Withdrawal by Subject|40|||
126651859|NCT02245737|455683795|FG001|Overall Study|Withdrawal by Subject|41|||
126651860|NCT02245737|455683796|FG002|Overall Study|Withdrawal by Subject|44|||
126651861|NCT02245737|455683794|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
126651862|NCT02245737|455683795|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
126651863|NCT02245737|455683796|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
126651864|NCT02245737|455683794|FG000|Overall Study|Sponsor Decision|445|||
126651865|NCT02245737|455683795|FG001|Overall Study|Sponsor Decision|430|||
126651866|NCT02245737|455683796|FG002|Overall Study|Sponsor Decision|432|||
126651867|NCT00618618|455683798|FG000|Overall Study|Patient Request|0|||
126651868|NCT00618618|455683799|FG001|Overall Study|Patient Request|0|||
126651869|NCT00618618|455683800|FG002|Overall Study|Patient Request|2|||
126651870|NCT00618618|455683801|FG003|Overall Study|Patient Request|0|||
126651871|NCT00618618|455683798|FG000|Overall Study|Inability to Complete Study Procedures|0|||
126651872|NCT00618618|455683799|FG001|Overall Study|Inability to Complete Study Procedures|1|||
126651873|NCT00618618|455683800|FG002|Overall Study|Inability to Complete Study Procedures|0|||
126651874|NCT00618618|455683801|FG003|Overall Study|Inability to Complete Study Procedures|0|||
126651875|NCT00618618|455683798|FG000|Overall Study|Lost to Follow-up|3|||
126651876|NCT00618618|455683799|FG001|Overall Study|Lost to Follow-up|0|||
126651877|NCT00618618|455683800|FG002|Overall Study|Lost to Follow-up|0|||
126651878|NCT00618618|455683801|FG003|Overall Study|Lost to Follow-up|1|||
126651879|NCT00618618|455683798|FG000|Overall Study|Non-compliance|1|||
126651880|NCT00618618|455683799|FG001|Overall Study|Non-compliance|1|||
126651881|NCT00618618|455683800|FG002|Overall Study|Non-compliance|0|||
126651882|NCT00618618|455683801|FG003|Overall Study|Non-compliance|0|||
126651883|NCT00618618|455683798|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
126651884|NCT00618618|455683799|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
126651885|NCT00618618|455683800|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
126651886|NCT00618618|455683801|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
126651887|NCT00618618|455683798|FG000|Overall Study|Death|0|||
126651888|NCT00618618|455683799|FG001|Overall Study|Death|1|||
126651889|NCT00618618|455683800|FG002|Overall Study|Death|0|||
126651890|NCT00618618|455683801|FG003|Overall Study|Death|0|||
126651891|NCT02929329|455683802|FG000|Overall Study|Withdrawal by Subject|24|||
126651892|NCT02929329|455683803|FG001|Overall Study|Withdrawal by Subject|21|||
126651893|NCT02929329|455683802|FG000|Overall Study|Lost to Follow-up|26|||
126651894|NCT02929329|455683803|FG001|Overall Study|Lost to Follow-up|20|||
126651895|NCT02929329|455683802|FG000|Overall Study|Death|1054|||
126651896|NCT02929329|455683803|FG001|Overall Study|Death|1051|||
126651897|NCT00309959|455683810|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
126651898|NCT03836716|455683814|FG000|Overall Study|Adverse Event|3|||
126651899|NCT03836716|455683814|FG000|Overall Study|Death|22|||
126323242|NCT01483599|454476282|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
126323243|NCT01483599|454476283|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
126323244|NCT01483599|454476284|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
126323245|NCT01483599|454476285|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
126323246|NCT01483599|454476286|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
126323247|NCT01483599|454476287|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
126323248|NCT01483599|454476288|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
126323249|NCT01483599|454476289|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
126323250|NCT01483599|454476290|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
126323251|NCT01483599|454476291|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
126323252|NCT01483599|454476292|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
126323253|NCT01483599|454476293|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
126323254|NCT01483599|454476294|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
126323255|NCT01483599|454476295|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
126323256|NCT01483599|454476282|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323257|NCT01483599|454476283|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323258|NCT01483599|454476284|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323259|NCT01483599|454476285|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323260|NCT01483599|454476286|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323261|NCT01483599|454476287|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323262|NCT01483599|454476288|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323263|NCT01483599|454476289|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
126323264|NCT01483599|454476290|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
126323265|NCT01483599|454476291|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323266|NCT01483599|454476292|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323267|NCT01483599|454476293|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
126323268|NCT01483599|454476294|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
126323269|NCT01483599|454476295|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
126323270|NCT01483599|454476282|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323271|NCT01483599|454476283|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323272|NCT01483599|454476284|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323273|NCT01483599|454476285|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323274|NCT01483599|454476286|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323275|NCT01483599|454476287|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323276|NCT01483599|454476288|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323277|NCT01483599|454476289|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323278|NCT01483599|454476290|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
126323279|NCT01483599|454476291|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323280|NCT01483599|454476292|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323281|NCT01483599|454476293|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
126323282|NCT01483599|454476294|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
126323283|NCT01483599|454476295|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
126323284|NCT01483599|454476282|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323285|NCT01483599|454476283|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323286|NCT01483599|454476284|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323287|NCT01483599|454476285|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323288|NCT01483599|454476286|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323289|NCT01483599|454476287|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323290|NCT01483599|454476288|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126651900|NCT03836716|455683814|FG000|Overall Study|Withdrawal by Subject|8|||
126651901|NCT03836716|455683814|FG000|Overall Study|Study terminated by sponsor|87|||
126651902|NCT01983254|455683815|FG000|Overall Study|Death|6|||
126651903|NCT01983254|455683816|FG001|Overall Study|Death|6|||
126651904|NCT01983254|455683815|FG000|Overall Study|Lost to Follow-up|17|||
126651905|NCT01983254|455683816|FG001|Overall Study|Lost to Follow-up|16|||
126651906|NCT01983254|455683815|FG000|Overall Study|too ill|11|||
126651907|NCT01983254|455683816|FG001|Overall Study|too ill|8|||
126651908|NCT00434213|455683817|FG000|Overall Study|Adverse Event|12|||
126651909|NCT00434213|455683817|FG000|Overall Study|Lack of Efficacy|9|||
126651910|NCT00434213|455683817|FG000|Overall Study|Lost to Follow-up|14|||
126651911|NCT00434213|455683817|FG000|Overall Study|Withdrawal by Subject|7|||
126651912|NCT00434213|455683817|FG000|Overall Study|Protocol Violation|3|||
126651913|NCT00434213|455683817|FG000|Overall Study|Unable to comply with study visit window|2|||
126651914|NCT00434213|455683817|FG000|Overall Study|Application site reaction|1|||
126651915|NCT00434213|455683817|FG000|Overall Study|Non-compliant to study schedule|1|||
126651916|NCT01253304|455683818|FG000|Overall Study|Adverse Event|0|||
126651917|NCT01253304|455683819|FG001|Overall Study|Adverse Event|0|||
126651918|NCT01253304|455683820|FG002|Overall Study|Adverse Event|0|||
126323291|NCT01483599|454476289|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323292|NCT01483599|454476290|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
126323293|NCT01483599|454476291|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323294|NCT01483599|454476292|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
126323295|NCT01483599|454476293|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323296|NCT01483599|454476294|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
126323297|NCT01483599|454476295|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
126323298|NCT01483599|454476282|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323299|NCT01483599|454476283|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323300|NCT01483599|454476284|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323301|NCT01483599|454476285|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323302|NCT01483599|454476286|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323303|NCT01483599|454476287|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323304|NCT01483599|454476288|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323305|NCT01483599|454476289|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323306|NCT01483599|454476290|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
126323307|NCT01483599|454476291|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323308|NCT01483599|454476292|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323309|NCT01483599|454476293|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
126323310|NCT01483599|454476294|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
126323311|NCT01483599|454476295|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
126323312|NCT01483599|454476282|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
126323313|NCT01483599|454476283|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
126323314|NCT01483599|454476284|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
126323315|NCT01483599|454476285|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
126323316|NCT01483599|454476286|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
126323317|NCT01483599|454476287|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
126323318|NCT01483599|454476288|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
126323319|NCT01483599|454476289|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
126323320|NCT01483599|454476290|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
126323321|NCT01483599|454476291|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
126323322|NCT01483599|454476292|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
126323323|NCT01483599|454476293|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
126323324|NCT01483599|454476294|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
126323325|NCT01483599|454476295|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
126323326|NCT01270321|454477811|FG000|Overall Study|Death|3|||
126323327|NCT01270321|454477812|FG001|Overall Study|Death|1|||
126323328|NCT01270321|454477813|FG002|Overall Study|Death|4|||
126323329|NCT01270321|454477811|FG000|Overall Study|Adverse Event|7|||
126323330|NCT01270321|454477812|FG001|Overall Study|Adverse Event|9|||
126323331|NCT01270321|454477813|FG002|Overall Study|Adverse Event|5|||
126323332|NCT01393106|454477815|FG000|Overall Study|Adverse Event|3|||
126323333|NCT01393106|454477815|FG000|Overall Study|Withdrawal by Subject|1|||
126323334|NCT01393106|454477815|FG000|Overall Study|Lack of Efficacy|1|||
126323335|NCT05437640|454477816|FG000|Washout (1 Week)|Adverse Event|1|||
126323336|NCT05437640|454477817|FG001|Washout (1 Week)|Adverse Event|0|||
126323337|NCT00904917|454477818|FG000|Overall Study|Lost to Follow-up|2|||
126323338|NCT00904917|454477819|FG001|Overall Study|Lost to Follow-up|2|||
126323339|NCT00904917|454477820|FG002|Overall Study|Lost to Follow-up|2|||
126323340|NCT00904917|454477821|FG003|Overall Study|Lost to Follow-up|2|||
126651919|NCT01253304|455683821|FG003|Overall Study|Adverse Event|1|||
126651920|NCT00768079|455683824|FG000|Overall Study|Lost to Follow-up|2|||
126651921|NCT00768079|455683825|FG001|Overall Study|Lost to Follow-up|0|||
126651922|NCT00768079|455683826|FG002|Overall Study|Lost to Follow-up|4|||
126651923|NCT00768079|455683824|FG000|Overall Study|Participant incarcerated|0|||
126651924|NCT00768079|455683825|FG001|Overall Study|Participant incarcerated|1|||
126651925|NCT00768079|455683826|FG002|Overall Study|Participant incarcerated|0|||
126651926|NCT02207569|455683827|FG000|1-Month|Death|6|||
126651927|NCT02207569|455683827|FG000|1-Month|Withdrawal by Subject|2|||
126651928|NCT02207569|455683827|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
126651929|NCT02207569|455683827|FG000|6-Month|Death|8|||
126651930|NCT02207569|455683827|FG000|6-Month|Withdrawal by Subject|2|||
126651931|NCT02207569|455683827|FG000|12-Month|Death|14|||
126651932|NCT02207569|455683827|FG000|12-Month|Withdrawal by Subject|2|||
126651933|NCT02207569|455683827|FG000|24-Month|Death|23|||
126651934|NCT02207569|455683827|FG000|24-Month|Withdrawal by Subject|3|||
126323341|NCT04228965|454477824|FG000|Overall Study|Lost to Follow-up|26|||
126323342|NCT04228965|454477825|FG001|Overall Study|Lost to Follow-up|11|||
126651935|NCT02207569|455683827|FG000|36-Month|Death|23|||
126651936|NCT02207569|455683827|FG000|36-Month|Withdrawal by Subject|4|||
126651937|NCT02207569|455683827|FG000|48-Month|Death|25|||
126651938|NCT02207569|455683827|FG000|48-Month|Withdrawal by Subject|2|||
126651939|NCT02207569|455683827|FG000|48-Month|Lost to Follow-up|4|||
126651940|NCT02207569|455683827|FG000|60-Month|Death|1|||
126323343|NCT04228965|454477824|FG000|Overall Study|Withdrawal by Subject|18|||
126323344|NCT04228965|454477825|FG001|Overall Study|Withdrawal by Subject|5|||
126323345|NCT00734656|454477828|FG000|Lab Session 1|Withdrawal by Subject|2|||
126323346|NCT00734656|454477829|FG001|Lab Session 1|Withdrawal by Subject|0|||
126323347|NCT00734656|454477830|FG002|Lab Session 1|Withdrawal by Subject|0|||
126323348|NCT00734656|454477831|FG003|Lab Session 1|Withdrawal by Subject|0|||
126323349|NCT00734656|454477828|FG000|Washout 1|Withdrawal by Subject|1|||
126323350|NCT00734656|454477829|FG001|Washout 1|Withdrawal by Subject|5|||
126323351|NCT00734656|454477830|FG002|Washout 1|Withdrawal by Subject|2|||
126323352|NCT00734656|454477831|FG003|Washout 1|Withdrawal by Subject|3|||
126323353|NCT00734656|454477828|FG000|Lab Session 2|Withdrawal by Subject|1|||
126323354|NCT00734656|454477829|FG001|Lab Session 2|Withdrawal by Subject|0|||
126323355|NCT00734656|454477830|FG002|Lab Session 2|Withdrawal by Subject|0|||
126323356|NCT00734656|454477831|FG003|Lab Session 2|Withdrawal by Subject|1|||
126323357|NCT00734656|454477828|FG000|Washout 2|Withdrawal by Subject|1|||
126323358|NCT00734656|454477829|FG001|Washout 2|Withdrawal by Subject|1|||
126323359|NCT00734656|454477830|FG002|Washout 2|Withdrawal by Subject|1|||
126323360|NCT00734656|454477831|FG003|Washout 2|Withdrawal by Subject|0|||
126323361|NCT00734656|454477828|FG000|Washout 3|Withdrawal by Subject|1|||
126323362|NCT00734656|454477829|FG001|Washout 3|Withdrawal by Subject|0|||
126323363|NCT00734656|454477830|FG002|Washout 3|Withdrawal by Subject|0|||
126323364|NCT00734656|454477831|FG003|Washout 3|Withdrawal by Subject|1|||
126323365|NCT00734656|454477828|FG000|Lab Session 4|Withdrawal by Subject|0|||
126323366|NCT00734656|454477829|FG001|Lab Session 4|Withdrawal by Subject|0|||
126323367|NCT00734656|454477830|FG002|Lab Session 4|Withdrawal by Subject|0|||
126323368|NCT00734656|454477831|FG003|Lab Session 4|Withdrawal by Subject|1|||
126323369|NCT03915626|454477832|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
126323370|NCT04676152|454477833|FG000|Overall Study|screen fail|9|||
126651941|NCT02207569|455683827|FG000|60-Month|Lost to Follow-up|1|||
126651942|NCT02207569|455683827|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
126651943|NCT02207569|455683827|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
126651944|NCT03047395|455683830|FG000|Overall Study|Adverse Event|142|||
126651945|NCT03047395|455683830|FG000|Overall Study|Withdrawal by Subject|155|||
126651946|NCT03047395|455683830|FG000|Overall Study|Lost to Follow-up|144|||
126651947|NCT03047395|455683830|FG000|Overall Study|COVID-19 Infection|2|||
126651948|NCT03047395|455683830|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
126651949|NCT03047395|455683830|FG000|Overall Study|Other, Not Specified|117|||
126651950|NCT01859988|455683831|FG000|Overall Study|Withdrawal by Subject|6|||
126651951|NCT01859988|455683832|FG001|Overall Study|Withdrawal by Subject|3|||
126651952|NCT01859988|455683833|FG002|Overall Study|Withdrawal by Subject|4|||
126651953|NCT01859988|455683834|FG003|Overall Study|Withdrawal by Subject|3|||
126651954|NCT01859988|455683835|FG004|Overall Study|Withdrawal by Subject|2|||
126651955|NCT01859988|455683836|FG005|Overall Study|Withdrawal by Subject|2|||
126651956|NCT01859988|455683831|FG000|Overall Study|Lack of Efficacy|1|||
126651957|NCT01859988|455683832|FG001|Overall Study|Lack of Efficacy|1|||
126651958|NCT01859988|455683833|FG002|Overall Study|Lack of Efficacy|5|||
126651959|NCT01859988|455683834|FG003|Overall Study|Lack of Efficacy|0|||
126651960|NCT01859988|455683835|FG004|Overall Study|Lack of Efficacy|7|||
126651961|NCT01859988|455683836|FG005|Overall Study|Lack of Efficacy|9|||
126651962|NCT01859988|455683831|FG000|Overall Study|Physician Decision|1|||
126651963|NCT01859988|455683832|FG001|Overall Study|Physician Decision|3|||
126651964|NCT01859988|455683833|FG002|Overall Study|Physician Decision|1|||
126651965|NCT01859988|455683834|FG003|Overall Study|Physician Decision|3|||
126651966|NCT01859988|455683835|FG004|Overall Study|Physician Decision|4|||
126651967|NCT01859988|455683836|FG005|Overall Study|Physician Decision|1|||
126651968|NCT01859988|455683831|FG000|Overall Study|Adverse Event|2|||
126651969|NCT01859988|455683832|FG001|Overall Study|Adverse Event|1|||
126651970|NCT01859988|455683833|FG002|Overall Study|Adverse Event|3|||
126323371|NCT02626000|454477838|FG000|Overall Study|Decision by Sponsor|1|||
126323372|NCT02626000|454477838|FG000|Overall Study|Death|29|||
126323373|NCT02335346|454477857|FG000|Overall Study|Adverse Event|11|||
126323374|NCT02335346|454477857|FG000|Overall Study|Withdrawal by Subject|1|||
126651971|NCT01859988|455683834|FG003|Overall Study|Adverse Event|1|||
126323375|NCT02769312|454477861|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
126323376|NCT02769312|454477862|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
126323377|NCT02769312|454477861|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
126323378|NCT02769312|454477862|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
126323379|NCT02769312|454477861|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
126323380|NCT02769312|454477862|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
126651972|NCT01859988|455683835|FG004|Overall Study|Adverse Event|2|||
126651973|NCT01859988|455683836|FG005|Overall Study|Adverse Event|2|||
126651974|NCT01859988|455683831|FG000|Overall Study|Lost to Follow-up|1|||
126651975|NCT01859988|455683832|FG001|Overall Study|Lost to Follow-up|2|||
126651976|NCT01859988|455683833|FG002|Overall Study|Lost to Follow-up|3|||
126651977|NCT01859988|455683834|FG003|Overall Study|Lost to Follow-up|0|||
126651978|NCT01859988|455683835|FG004|Overall Study|Lost to Follow-up|3|||
126651979|NCT01859988|455683836|FG005|Overall Study|Lost to Follow-up|2|||
126323381|NCT02769312|454477861|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
126323382|NCT02769312|454477862|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
126323383|NCT02769312|454477861|FG000|Follow-up|Lost to Follow-up|1|||
126323384|NCT02769312|454477862|FG001|Follow-up|Lost to Follow-up|1|||
126323385|NCT02178358|454477863|FG000|Overall Study|Withdrawal by Subject|0|||
126323386|NCT02178358|454477864|FG001|Overall Study|Withdrawal by Subject|2|||
126323387|NCT02178358|454477865|FG002|Overall Study|Withdrawal by Subject|2|||
126323388|NCT02178358|454477863|FG000|Overall Study|Lost to Follow-up|1|||
126323389|NCT02178358|454477864|FG001|Overall Study|Lost to Follow-up|0|||
126323390|NCT02178358|454477865|FG002|Overall Study|Lost to Follow-up|0|||
126323391|NCT01066663|454477866|FG000|Overall Study|Adverse Event|0|||
126323392|NCT01066663|454477867|FG001|Overall Study|Adverse Event|0|||
126323393|NCT01066663|454477868|FG002|Overall Study|Adverse Event|1|||
126323394|NCT01090050|454477869|FG000|Overall Study|Lost to Follow-up|0|||
126323395|NCT01090050|454477870|FG001|Overall Study|Lost to Follow-up|1|||
126323396|NCT01090050|454477869|FG000|Overall Study|Lack of Efficacy|1|||
126323397|NCT01090050|454477870|FG001|Overall Study|Lack of Efficacy|5|||
126323398|NCT01090050|454477869|FG000|Overall Study|Physician Decision|0|||
126323399|NCT01090050|454477870|FG001|Overall Study|Physician Decision|1|||
126323400|NCT03539484|454477871|FG000|Overall Study|Death|1|||
126323401|NCT03539484|454477872|FG001|Overall Study|Death|0|||
126323402|NCT03539484|454477873|FG002|Overall Study|Death|0|||
126323403|NCT03539484|454477874|FG003|Overall Study|Death|2|||
126323404|NCT03539484|454477875|FG004|Overall Study|Death|8|||
126323405|NCT03539484|454477876|FG005|Overall Study|Death|3|||
126323406|NCT03539484|454477877|FG006|Overall Study|Death|0|||
126323407|NCT03539484|454477871|FG000|Overall Study|Lost to Follow-up|0|||
126323408|NCT03539484|454477872|FG001|Overall Study|Lost to Follow-up|1|||
126323409|NCT03539484|454477873|FG002|Overall Study|Lost to Follow-up|0|||
126323410|NCT03539484|454477874|FG003|Overall Study|Lost to Follow-up|0|||
126323411|NCT03539484|454477875|FG004|Overall Study|Lost to Follow-up|1|||
126323412|NCT03539484|454477876|FG005|Overall Study|Lost to Follow-up|0|||
126323413|NCT03539484|454477877|FG006|Overall Study|Lost to Follow-up|0|||
126323414|NCT03539484|454477871|FG000|Overall Study|Withdrawal by Subject|0|||
126323415|NCT03539484|454477872|FG001|Overall Study|Withdrawal by Subject|0|||
126323416|NCT03539484|454477873|FG002|Overall Study|Withdrawal by Subject|0|||
126323417|NCT03539484|454477874|FG003|Overall Study|Withdrawal by Subject|0|||
126323418|NCT03539484|454477875|FG004|Overall Study|Withdrawal by Subject|2|||
126323419|NCT03539484|454477876|FG005|Overall Study|Withdrawal by Subject|0|||
126323420|NCT03539484|454477877|FG006|Overall Study|Withdrawal by Subject|1|||
126323421|NCT03539484|454477871|FG000|Overall Study|Study Terminated by Sponsor|0|||
126323422|NCT03539484|454477872|FG001|Overall Study|Study Terminated by Sponsor|0|||
126323423|NCT03539484|454477873|FG002|Overall Study|Study Terminated by Sponsor|1|||
126323424|NCT03539484|454477874|FG003|Overall Study|Study Terminated by Sponsor|1|||
126323425|NCT03539484|454477875|FG004|Overall Study|Study Terminated by Sponsor|2|||
126323426|NCT03539484|454477876|FG005|Overall Study|Study Terminated by Sponsor|2|||
126323427|NCT03539484|454477877|FG006|Overall Study|Study Terminated by Sponsor|1|||
126323428|NCT02232061|454477878|FG000|Overall Study|Administrative problems|1|||
126323429|NCT02232061|454477878|FG000|Overall Study|Withdrawal by Subject|1|||
126323430|NCT00560703|454477880|FG000|Overall Study|Adverse Event|0|||
126323431|NCT00560703|454477881|FG001|Overall Study|Adverse Event|2|||
126323432|NCT00560703|454477880|FG000|Overall Study|Protocol Violation|0|||
126323433|NCT00560703|454477881|FG001|Overall Study|Protocol Violation|2|||
126323434|NCT00560703|454477880|FG000|Overall Study|Withdrawal by Subject|0|||
126323435|NCT00560703|454477881|FG001|Overall Study|Withdrawal by Subject|1|||
126323436|NCT00560703|454477880|FG000|Overall Study|non-compliance|0|||
126323437|NCT00560703|454477881|FG001|Overall Study|non-compliance|1|||
126323438|NCT00339833|454477891|FG000|Overall Study|Withdrawal by Subject|1|||
126323439|NCT00339833|454477892|FG001|Overall Study|Withdrawal by Subject|2|||
126323440|NCT00339833|454477891|FG000|Overall Study|toothache|0|||
126323441|NCT00339833|454477892|FG001|Overall Study|toothache|1|||
126323442|NCT00339833|454477891|FG000|Overall Study|indigestion|0|||
126323443|NCT00339833|454477892|FG001|Overall Study|indigestion|1|||
126323444|NCT00339833|454477891|FG000|Overall Study|Chest pain|0|||
126323445|NCT00339833|454477892|FG001|Overall Study|Chest pain|1|||
126323446|NCT00339833|454477891|FG000|Overall Study|minor infection|0|||
126323447|NCT00339833|454477892|FG001|Overall Study|minor infection|1|||
126323448|NCT00339833|454477891|FG000|Overall Study|Poor venous access|2|||
126323449|NCT00339833|454477892|FG001|Overall Study|Poor venous access|2|||
126323450|NCT00339833|454477891|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
126323451|NCT00339833|454477892|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
126323452|NCT00339833|454477891|FG000|Overall Study|Error in data records|1|||
126323453|NCT00339833|454477892|FG001|Overall Study|Error in data records|0|||
126323454|NCT03077607|454477893|FG000|Period 1 (15 Days)|Adverse Event|1|||
126323455|NCT03077607|454477894|FG001|Period 1 (15 Days)|Adverse Event|0|||
126323456|NCT03077607|454477893|FG000|Period 1 (15 Days)|Death|1|||
126323457|NCT03077607|454477894|FG001|Period 1 (15 Days)|Death|0|||
126323458|NCT03077607|454477893|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
126323459|NCT03077607|454477894|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
126323460|NCT03077607|454477893|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
126323461|NCT03077607|454477894|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
126323462|NCT02476916|454477895|FG000|Core Period|Adverse Event|2|||
126323463|NCT02476916|454477896|FG001|Core Period|Adverse Event|2|||
126323464|NCT02476916|454477895|FG000|Core Period|Investigator decision|1|||
126323465|NCT02476916|454477896|FG001|Core Period|Investigator decision|1|||
126323466|NCT02476916|454477895|FG000|Core Period|Withdrawal by Subject|3|||
126323467|NCT02476916|454477896|FG001|Core Period|Withdrawal by Subject|0|||
126323468|NCT02476916|454477895|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
126323469|NCT02476916|454477896|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
126323470|NCT02476916|454477895|FG000|Extension Period|On Treatment|12|||
126323471|NCT02476916|454477896|FG001|Extension Period|On Treatment|17|||
126323472|NCT06010732|454477897|FG000|Crossover Period 1|Protocol Violation|0|||
126323473|NCT06010732|454477898|FG001|Crossover Period 1|Protocol Violation|0|||
126323474|NCT06010732|454477899|FG002|Crossover Period 1|Protocol Violation|1|||
126323475|NCT06010732|454477900|FG003|Crossover Period 1|Protocol Violation|0|||
126323476|NCT06010732|454477901|FG004|Crossover Period 1|Protocol Violation|1|||
126323477|NCT06010732|454477902|FG005|Crossover Period 1|Protocol Violation|0|||
126323478|NCT06010732|454477897|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
126323479|NCT06010732|454477898|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
126323480|NCT06010732|454477899|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
126323481|NCT06010732|454477900|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
126323482|NCT06010732|454477901|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
126323483|NCT06010732|454477902|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
126323484|NCT06010732|454477897|FG000|Crossover Period 2|Adverse Event|0|||
126323485|NCT06010732|454477898|FG001|Crossover Period 2|Adverse Event|1|||
126323486|NCT06010732|454477899|FG002|Crossover Period 2|Adverse Event|0|||
126323487|NCT06010732|454477900|FG003|Crossover Period 2|Adverse Event|0|||
126323488|NCT06010732|454477901|FG004|Crossover Period 2|Adverse Event|0|||
126323489|NCT06010732|454477902|FG005|Crossover Period 2|Adverse Event|0|||
126323490|NCT06010732|454477897|FG000|Crossover Period 2|broken denture|0|||
126323491|NCT06010732|454477898|FG001|Crossover Period 2|broken denture|0|||
126323492|NCT06010732|454477899|FG002|Crossover Period 2|broken denture|1|||
126323493|NCT06010732|454477900|FG003|Crossover Period 2|broken denture|0|||
126323494|NCT06010732|454477901|FG004|Crossover Period 2|broken denture|0|||
126323495|NCT06010732|454477902|FG005|Crossover Period 2|broken denture|0|||
126323496|NCT04401202|454477903|FG000|Overall Study|Lost to Follow-up|2|||
126323497|NCT04401202|454477904|FG001|Overall Study|Lost to Follow-up|2|||
126323498|NCT04401202|454477903|FG000|Overall Study|Adverse Event|0|||
126323499|NCT04401202|454477904|FG001|Overall Study|Adverse Event|1|||
126323500|NCT04401202|454477903|FG000|Overall Study|Hospitalized|4|||
126323501|NCT04401202|454477904|FG001|Overall Study|Hospitalized|1|||
126323502|NCT03624569|454477908|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126323503|NCT03624569|454477909|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
126323504|NCT03624569|454477908|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
126323505|NCT03624569|454477909|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
126323506|NCT03004924|454477914|FG000|Overall Study|Adverse Event|6|||
126323507|NCT03004924|454477915|FG001|Overall Study|Adverse Event|5|||
126323508|NCT03004924|454477916|FG002|Overall Study|Adverse Event|10|||
126323509|NCT03004924|454477914|FG000|Overall Study|Protocol Violation|4|||
126323510|NCT03004924|454477915|FG001|Overall Study|Protocol Violation|0|||
126651980|NCT01859988|455683831|FG000|Overall Study|Protocol Violation|0|||
126651981|NCT01859988|455683832|FG001|Overall Study|Protocol Violation|0|||
126651982|NCT01859988|455683833|FG002|Overall Study|Protocol Violation|1|||
126651983|NCT01859988|455683834|FG003|Overall Study|Protocol Violation|0|||
126323511|NCT03004924|454477916|FG002|Overall Study|Protocol Violation|1|||
126323512|NCT03004924|454477914|FG000|Overall Study|Withdrawal by Subject|5|||
126323513|NCT03004924|454477915|FG001|Overall Study|Withdrawal by Subject|3|||
126323514|NCT03004924|454477916|FG002|Overall Study|Withdrawal by Subject|5|||
126323515|NCT03004924|454477914|FG000|Overall Study|Lost to Follow-up|6|||
126323516|NCT03004924|454477915|FG001|Overall Study|Lost to Follow-up|1|||
126323517|NCT03004924|454477916|FG002|Overall Study|Lost to Follow-up|4|||
126323518|NCT03004924|454477914|FG000|Overall Study|Lack of Efficacy|2|||
126323519|NCT03004924|454477915|FG001|Overall Study|Lack of Efficacy|4|||
126323520|NCT03004924|454477916|FG002|Overall Study|Lack of Efficacy|2|||
126323521|NCT03004924|454477914|FG000|Overall Study|Physician Decision|1|||
126323522|NCT03004924|454477915|FG001|Overall Study|Physician Decision|0|||
126323523|NCT03004924|454477916|FG002|Overall Study|Physician Decision|1|||
126323524|NCT03004924|454477914|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126323525|NCT03004924|454477915|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126323526|NCT03004924|454477916|FG002|Overall Study|Withdrawal by parent/guardian|2|||
126323527|NCT03004924|454477914|FG000|Overall Study|Screen Failure|1|||
126323528|NCT03004924|454477915|FG001|Overall Study|Screen Failure|0|||
126323529|NCT03004924|454477916|FG002|Overall Study|Screen Failure|0|||
126651984|NCT01859988|455683835|FG004|Overall Study|Protocol Violation|0|||
126323530|NCT03004924|454477914|FG000|Overall Study|Pregnancy|0|||
126323531|NCT03004924|454477915|FG001|Overall Study|Pregnancy|1|||
126323532|NCT03004924|454477916|FG002|Overall Study|Pregnancy|0|||
126651985|NCT01859988|455683836|FG005|Overall Study|Protocol Violation|0|||
126651986|NCT01859988|455683831|FG000|Overall Study|Other than specified above|0|||
126651987|NCT01859988|455683832|FG001|Overall Study|Other than specified above|2|||
126651988|NCT01859988|455683833|FG002|Overall Study|Other than specified above|11|||
126651989|NCT01859988|455683834|FG003|Overall Study|Other than specified above|3|||
126651990|NCT01859988|455683835|FG004|Overall Study|Other than specified above|5|||
126651991|NCT01859988|455683836|FG005|Overall Study|Other than specified above|3|||
126651992|NCT02081417|455683841|FG000|Overall Study|Lost to Follow-up|26|||
126651993|NCT02081417|455683842|FG001|Overall Study|Lost to Follow-up|23|||
126651994|NCT02081417|455683841|FG000|Overall Study|Moved Away|1|||
126651995|NCT02081417|455683842|FG001|Overall Study|Moved Away|2|||
126651996|NCT02081417|455683841|FG000|Overall Study|Incarcerated|2|||
126651997|NCT02081417|455683842|FG001|Overall Study|Incarcerated|2|||
126651998|NCT02081417|455683841|FG000|Overall Study|Death|4|||
126651999|NCT02081417|455683842|FG001|Overall Study|Death|3|||
126652000|NCT02081417|455683841|FG000|Overall Study|Withdrawal by Subject|4|||
126652001|NCT02081417|455683842|FG001|Overall Study|Withdrawal by Subject|0|||
126652002|NCT02081417|455683841|FG000|Overall Study|Admitted to Residential Treatment|2|||
126652003|NCT02081417|455683842|FG001|Overall Study|Admitted to Residential Treatment|0|||
126652004|NCT02081417|455683841|FG000|Overall Study|Did not start treatment|17|||
126652005|NCT02081417|455683842|FG001|Overall Study|Did not start treatment|21|||
126652006|NCT01263665|455683848|FG000|Overall Study|Withdrew Consent|1|||
126652007|NCT01263665|455683848|FG000|Overall Study|Lost to Follow-up|3|||
126652008|NCT01263665|455683848|FG000|Overall Study|Death|2|||
126652009|NCT01263665|455683848|FG000|Overall Study|Amputation above the ankle|1|||
126652010|NCT01263665|455683848|FG000|Overall Study|Surgical Bypass|2|||
126652011|NCT00324675|455683850|FG000|Overall Study|Adverse Event|1|||
126652012|NCT00324675|455683851|FG001|Overall Study|Adverse Event|0|||
126652013|NCT04860297|455683852|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
126652014|NCT04860297|455683853|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
126652015|NCT04860297|455683854|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
126652016|NCT04860297|455683855|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
126652017|NCT04860297|455683856|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
126652018|NCT04860297|455683857|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
126652019|NCT04860297|455683858|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
126652020|NCT04860297|455683859|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
126652021|NCT04860297|455683852|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
126652022|NCT04860297|455683853|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
126652023|NCT04860297|455683854|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
126652024|NCT04860297|455683855|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
126652025|NCT04860297|455683856|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
126652026|NCT04860297|455683857|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
126652027|NCT04860297|455683858|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
126652028|NCT04860297|455683859|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
126652029|NCT04860297|455683852|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
126652030|NCT04860297|455683853|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
126323533|NCT03004924|454477914|FG000|Overall Study|Terminated by Sponsor|0|||
126323534|NCT03004924|454477915|FG001|Overall Study|Terminated by Sponsor|0|||
126323535|NCT03004924|454477916|FG002|Overall Study|Terminated by Sponsor|1|||
126323536|NCT03004924|454477914|FG000|Overall Study|Missed Study Visit|0|||
126323537|NCT03004924|454477915|FG001|Overall Study|Missed Study Visit|0|||
126323538|NCT03004924|454477916|FG002|Overall Study|Missed Study Visit|2|||
126323539|NCT03004924|454477914|FG000|Overall Study|HSV1 Positive|1|||
126323540|NCT03004924|454477915|FG001|Overall Study|HSV1 Positive|0|||
126323541|NCT03004924|454477916|FG002|Overall Study|HSV1 Positive|0|||
126323542|NCT00269477|454477917|FG000|Overall Study|Protocol Violation|5|||
126323543|NCT00269477|454477918|FG001|Overall Study|Protocol Violation|5|||
126323544|NCT00269477|454477919|FG002|Overall Study|Protocol Violation|1|||
126323545|NCT00269477|454477920|FG003|Overall Study|Protocol Violation|0|||
126323546|NCT00269477|454477917|FG000|Overall Study|Missed post-vaccination blood draw|0|||
126323547|NCT00269477|454477918|FG001|Overall Study|Missed post-vaccination blood draw|1|||
126323548|NCT00269477|454477919|FG002|Overall Study|Missed post-vaccination blood draw|0|||
126323549|NCT00269477|454477920|FG003|Overall Study|Missed post-vaccination blood draw|0|||
126323550|NCT01119846|454477921|FG000|Overall Study|Adverse Event|1|||
126652031|NCT04860297|455683854|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
126652032|NCT04860297|455683855|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
126652033|NCT04860297|455683856|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
126652034|NCT04860297|455683857|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
126652035|NCT04860297|455683858|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
126652036|NCT04860297|455683859|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
126652037|NCT04860297|455683852|FG000|Part B (Booster Dose)|Other Than Specified|0|||
126652038|NCT04860297|455683853|FG001|Part B (Booster Dose)|Other Than Specified|0|||
126652039|NCT04860297|455683854|FG002|Part B (Booster Dose)|Other Than Specified|0|||
126652040|NCT04860297|455683855|FG003|Part B (Booster Dose)|Other Than Specified|0|||
126323551|NCT01119846|454477922|FG001|Overall Study|Adverse Event|0|||
126652041|NCT04860297|455683856|FG004|Part B (Booster Dose)|Other Than Specified|0|||
126652042|NCT04860297|455683857|FG005|Part B (Booster Dose)|Other Than Specified|1|||
126652043|NCT04860297|455683858|FG006|Part B (Booster Dose)|Other Than Specified|1|||
126652044|NCT04860297|455683859|FG007|Part B (Booster Dose)|Other Than Specified|0|||
126652045|NCT04860297|455683852|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
126652046|NCT04860297|455683853|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
126652047|NCT04860297|455683854|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
126652048|NCT04860297|455683855|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
126652049|NCT04860297|455683856|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
126652050|NCT04860297|455683857|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
126652051|NCT04860297|455683858|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
126652052|NCT04860297|455683859|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
126652053|NCT04860297|455683852|FG000|Part B (Booster Dose)|Death|0|||
126652054|NCT04860297|455683853|FG001|Part B (Booster Dose)|Death|0|||
126652055|NCT04860297|455683854|FG002|Part B (Booster Dose)|Death|0|||
126652056|NCT04860297|455683855|FG003|Part B (Booster Dose)|Death|0|||
126652057|NCT04860297|455683856|FG004|Part B (Booster Dose)|Death|1|||
126652058|NCT04860297|455683857|FG005|Part B (Booster Dose)|Death|2|||
126652059|NCT04860297|455683858|FG006|Part B (Booster Dose)|Death|1|||
126652060|NCT04860297|455683859|FG007|Part B (Booster Dose)|Death|0|||
126652061|NCT04860297|455683852|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
126652062|NCT04860297|455683853|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
126652063|NCT04860297|455683854|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
126652064|NCT04860297|455683855|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
126652065|NCT04860297|455683856|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
126652066|NCT04860297|455683857|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
126652067|NCT04860297|455683858|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
126652068|NCT04860297|455683859|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
126652069|NCT04811131|455683863|FG000|Overall Study|Adverse Event|0|||
126652070|NCT04811131|455683864|FG001|Overall Study|Adverse Event|0|||
126652071|NCT04811131|455683865|FG002|Overall Study|Adverse Event|1|||
126652072|NCT04811131|455683866|FG003|Overall Study|Adverse Event|0|||
126652073|NCT04811131|455683863|FG000|Overall Study|Lack of Efficacy|0|||
126652074|NCT04811131|455683864|FG001|Overall Study|Lack of Efficacy|0|||
126652075|NCT04811131|455683865|FG002|Overall Study|Lack of Efficacy|0|||
126652076|NCT04811131|455683866|FG003|Overall Study|Lack of Efficacy|1|||
126652077|NCT04811131|455683863|FG000|Overall Study|Lost to Follow-up|0|||
126652078|NCT04811131|455683864|FG001|Overall Study|Lost to Follow-up|1|||
126652079|NCT04811131|455683865|FG002|Overall Study|Lost to Follow-up|0|||
126652080|NCT04811131|455683866|FG003|Overall Study|Lost to Follow-up|0|||
126652081|NCT04811131|455683863|FG000|Overall Study|Sponsor request|31|||
126652082|NCT04811131|455683864|FG001|Overall Study|Sponsor request|35|||
126652083|NCT04811131|455683865|FG002|Overall Study|Sponsor request|27|||
126652084|NCT04811131|455683866|FG003|Overall Study|Sponsor request|10|||
126652085|NCT04811131|455683863|FG000|Overall Study|Withdrawal by Subject|3|||
126652086|NCT04811131|455683864|FG001|Overall Study|Withdrawal by Subject|1|||
126652087|NCT04811131|455683865|FG002|Overall Study|Withdrawal by Subject|3|||
126652088|NCT04811131|455683866|FG003|Overall Study|Withdrawal by Subject|1|||
126652089|NCT01528345|455683868|FG000|Overall Study|Adverse Event|10|||
126652090|NCT01528345|455683869|FG001|Overall Study|Adverse Event|1|||
126652091|NCT01528345|455683868|FG000|Overall Study|Death|1|||
126652092|NCT01528345|455683869|FG001|Overall Study|Death|1|||
126652093|NCT01528345|455683868|FG000|Overall Study|Non-compliance with study treatment|1|||
126652094|NCT01528345|455683869|FG001|Overall Study|Non-compliance with study treatment|0|||
126652095|NCT01528345|455683868|FG000|Overall Study|Progressive Disease|26|||
126652096|NCT01528345|455683869|FG001|Overall Study|Progressive Disease|40|||
126652097|NCT01528345|455683868|FG000|Overall Study|Study Terminated by Sponsor|4|||
126652098|NCT01528345|455683869|FG001|Overall Study|Study Terminated by Sponsor|8|||
126652099|NCT01528345|455683868|FG000|Overall Study|Subject/Guardian Decision|5|||
126652100|NCT01528345|455683869|FG001|Overall Study|Subject/Guardian Decision|0|||
126652101|NCT00371683|455683870|FG000|DB Treatment Period-Randomized Patients|Death|1|||
126652102|NCT00371683|455683871|FG001|DB Treatment Period-Randomized Patients|Death|1|||
126652103|NCT00371683|455683870|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
126323552|NCT01119846|454477923|FG002|Overall Study|Adverse Event|6|||
126652104|NCT00371683|455683871|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
126652105|NCT00371683|455683870|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
126652106|NCT00371683|455683871|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
126652107|NCT00371683|455683870|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
126652108|NCT00371683|455683871|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
126652109|NCT00371683|455683870|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
126652110|NCT00371683|455683871|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
126652111|NCT00371683|455683870|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
126652112|NCT00371683|455683871|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
126652113|NCT00371683|455683870|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
126323553|NCT01119846|454477921|FG000|Overall Study|Physician Decision|1|||
126323554|NCT01119846|454477922|FG001|Overall Study|Physician Decision|0|||
126323555|NCT01119846|454477923|FG002|Overall Study|Physician Decision|0|||
126323556|NCT01119846|454477921|FG000|Overall Study|Protocol Violation|0|||
126323557|NCT01119846|454477922|FG001|Overall Study|Protocol Violation|0|||
126323558|NCT01119846|454477923|FG002|Overall Study|Protocol Violation|1|||
126323559|NCT01119846|454477921|FG000|Overall Study|Withdrawal by Subject|0|||
126323560|NCT01119846|454477922|FG001|Overall Study|Withdrawal by Subject|0|||
126323561|NCT01119846|454477923|FG002|Overall Study|Withdrawal by Subject|4|||
126323562|NCT01370616|454477927|FG000|Overall Study|Adverse Event|11|||
126323563|NCT01370616|454477928|FG001|Overall Study|Adverse Event|16|||
126323564|NCT01370616|454477927|FG000|Overall Study|Death|1|||
126652114|NCT00371683|455683871|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
126652115|NCT00371683|455683870|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
126652116|NCT00371683|455683871|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
126652117|NCT00371683|455683870|FG000|Follow-Up Period - Randomized Patients|Death|0|||
126652118|NCT00371683|455683871|FG001|Follow-Up Period - Randomized Patients|Death|2|||
126652119|NCT00371683|455683870|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
126323565|NCT01370616|454477928|FG001|Overall Study|Death|0|||
126323566|NCT01370616|454477927|FG000|Overall Study|Lack of Efficacy|6|||
126323567|NCT01370616|454477928|FG001|Overall Study|Lack of Efficacy|2|||
126323568|NCT01370616|454477927|FG000|Overall Study|Lost to Follow-up|0|||
126323569|NCT01370616|454477928|FG001|Overall Study|Lost to Follow-up|3|||
126323570|NCT01370616|454477927|FG000|Overall Study|Physician Decision|6|||
126323571|NCT01370616|454477928|FG001|Overall Study|Physician Decision|6|||
126323572|NCT01370616|454477927|FG000|Overall Study|Progressive Disease|0|||
126323573|NCT01370616|454477928|FG001|Overall Study|Progressive Disease|1|||
126323574|NCT01370616|454477927|FG000|Overall Study|Recovery|1|||
126652120|NCT00371683|455683871|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
126652121|NCT00371683|455683870|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
126652122|NCT00371683|455683871|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
126652123|NCT03181789|455683873|FG000|Overall Study|Withdrawal by Subject|0|||
126652124|NCT03181789|455683874|FG001|Overall Study|Withdrawal by Subject|1|||
126652125|NCT03181789|455683875|FG002|Overall Study|Withdrawal by Subject|1|||
126652126|NCT03181789|455683876|FG003|Overall Study|Withdrawal by Subject|0|||
126652127|NCT03181789|455683873|FG000|Overall Study|Lost to Follow-up|7|||
126652128|NCT03181789|455683874|FG001|Overall Study|Lost to Follow-up|1|||
126652129|NCT03181789|455683875|FG002|Overall Study|Lost to Follow-up|0|||
126652130|NCT03181789|455683876|FG003|Overall Study|Lost to Follow-up|0|||
126652131|NCT03181789|455683873|FG000|Overall Study|Participant unable to adhere to visit|0|||
126652132|NCT03181789|455683874|FG001|Overall Study|Participant unable to adhere to visit|1|||
126652133|NCT03181789|455683875|FG002|Overall Study|Participant unable to adhere to visit|0|||
126652134|NCT03181789|455683876|FG003|Overall Study|Participant unable to adhere to visit|0|||
126652135|NCT02624791|455683877|FG000|Overall Study|Withdrawal by Subject|2|||
126652136|NCT02624791|455683878|FG001|Overall Study|Withdrawal by Subject|0|||
126652137|NCT02624791|455683879|FG002|Overall Study|Withdrawal by Subject|0|||
126652138|NCT02624791|455683880|FG003|Overall Study|Withdrawal by Subject|0|||
126652139|NCT02624791|455683881|FG004|Overall Study|Withdrawal by Subject|0|||
126652140|NCT02624791|455683882|FG005|Overall Study|Withdrawal by Subject|0|||
126652141|NCT00735475|455683883|FG000|Overall Study|Adverse Event|0|||
126652142|NCT00735475|455683884|FG001|Overall Study|Adverse Event|1|||
126652143|NCT00735475|455683883|FG000|Overall Study|Death|1|||
126652144|NCT00735475|455683884|FG001|Overall Study|Death|1|||
126652145|NCT00735475|455683883|FG000|Overall Study|Lost to Follow-up|3|||
126652146|NCT00735475|455683884|FG001|Overall Study|Lost to Follow-up|3|||
126652147|NCT00735475|455683883|FG000|Overall Study|Physician Decision|0|||
126323575|NCT01370616|454477928|FG001|Overall Study|Recovery|0|||
126323576|NCT01370616|454477927|FG000|Overall Study|Technical Problems|3|||
126323577|NCT01370616|454477928|FG001|Overall Study|Technical Problems|5|||
126323578|NCT01370616|454477927|FG000|Overall Study|Withdrawal by Subject|34|||
126323579|NCT01370616|454477928|FG001|Overall Study|Withdrawal by Subject|34|||
126323580|NCT02324699|454477929|FG000|Overall Study|study terminated|1|||
126323581|NCT01605825|454477934|FG000|Overall Study|Adverse Event|4|||
126323582|NCT01605825|454477935|FG001|Overall Study|Adverse Event|2|||
126323583|NCT01605825|454477934|FG000|Overall Study|Withdrawal by Subject|0|||
126652148|NCT00735475|455683884|FG001|Overall Study|Physician Decision|1|||
126652149|NCT00735475|455683883|FG000|Overall Study|Withdrawal by Subject|4|||
126652150|NCT00735475|455683884|FG001|Overall Study|Withdrawal by Subject|5|||
126652151|NCT00589121|455683887|FG000|Overall Study|Protocol Violation|2|||
126652152|NCT00589121|455683888|FG001|Overall Study|Protocol Violation|6|||
126323584|NCT01605825|454477935|FG001|Overall Study|Withdrawal by Subject|1|||
126323585|NCT01605825|454477934|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
126323586|NCT01605825|454477935|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
126323587|NCT01605825|454477934|FG000|Overall Study|Non-Compliance with Protocol|3|||
126323588|NCT01605825|454477935|FG001|Overall Study|Non-Compliance with Protocol|0|||
126323589|NCT02670382|454477942|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
126652153|NCT00589121|455683887|FG000|Overall Study|No protocol treatment received|0|||
126652154|NCT00589121|455683888|FG001|Overall Study|No protocol treatment received|1|||
126652155|NCT00847808|455683890|FG000|Overall Study|Adverse Event|7|||
126652156|NCT00847808|455683890|FG000|Overall Study|Protocol Violation|1|||
126652157|NCT00847808|455683890|FG000|Overall Study|Lost to Follow-up|1|||
126652158|NCT00847808|455683890|FG000|Overall Study|Withdrawal by Subject|4|||
126652159|NCT00847808|455683890|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
126652160|NCT00847808|455683890|FG000|Overall Study|Participant Took Excluded Medication|1|||
126652161|NCT01758900|455683897|FG000|Overall Study|difficulty for further intubation|7|||
126652162|NCT01758900|455683898|FG001|Overall Study|difficulty for further intubation|8|||
126652163|NCT01892540|455683900|FG000|Overall Study|Did not complete PET/MRI|0|||
126652164|NCT01892540|455683901|FG001|Overall Study|Did not complete PET/MRI|0|||
126652165|NCT01892540|455683902|FG002|Overall Study|Did not complete PET/MRI|2|||
126652166|NCT01892540|455683900|FG000|Overall Study|Did not fit in scanner|0|||
126652167|NCT01892540|455683901|FG001|Overall Study|Did not fit in scanner|0|||
126652168|NCT01892540|455683902|FG002|Overall Study|Did not fit in scanner|1|||
126652169|NCT01370590|455683903|FG000|Period 1|Adverse Event|8|||
126652170|NCT01370590|455683904|FG001|Period 1|Adverse Event|4|||
126652171|NCT01370590|455683903|FG000|Period 1|Lost to Follow-up|2|||
126652172|NCT01370590|455683904|FG001|Period 1|Lost to Follow-up|2|||
126652173|NCT01370590|455683903|FG000|Period 1|Protocol Violation|2|||
126652174|NCT01370590|455683904|FG001|Period 1|Protocol Violation|2|||
126652175|NCT01370590|455683903|FG000|Period 1|Withdrawal by Subject|4|||
126652176|NCT01370590|455683904|FG001|Period 1|Withdrawal by Subject|2|||
126652177|NCT01370590|455683903|FG000|Period 1|Could not access randomization system|0|||
126652178|NCT01370590|455683904|FG001|Period 1|Could not access randomization system|1|||
126652179|NCT01370590|455683903|FG000|Crossover Washout Period|Adverse Event|1|||
126652180|NCT01370590|455683904|FG001|Crossover Washout Period|Adverse Event|4|||
126652181|NCT01370590|455683903|FG000|Crossover Washout Period|Lost to Follow-up|2|||
126652182|NCT01370590|455683904|FG001|Crossover Washout Period|Lost to Follow-up|0|||
126652183|NCT01370590|455683903|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
126652184|NCT01370590|455683904|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
126652185|NCT01370590|455683903|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
126652186|NCT01370590|455683904|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
126652187|NCT01370590|455683903|FG000|Period 2|Adverse Event|0|||
126652188|NCT01370590|455683904|FG001|Period 2|Adverse Event|1|||
126652189|NCT01370590|455683903|FG000|Period 2|Withdrawal by Subject|1|||
126652190|NCT01370590|455683904|FG001|Period 2|Withdrawal by Subject|1|||
126652191|NCT05172050|455683905|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
126652192|NCT05172050|455683906|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
126652193|NCT05172050|455683907|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
126652194|NCT05172050|455683905|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
126652195|NCT05172050|455683906|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
126652196|NCT05172050|455683907|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
126652197|NCT05172050|455683905|FG000|Overall Study|Other|2|||
126652198|NCT05172050|455683906|FG001|Overall Study|Other|2|||
126652199|NCT05172050|455683907|FG002|Overall Study|Other|1|||
126652200|NCT00604825|455683908|FG000|Overall Study|Adverse Event|2|||
126652201|NCT00604825|455683909|FG001|Overall Study|Adverse Event|6|||
126652202|NCT00604825|455683910|FG002|Overall Study|Adverse Event|7|||
126652203|NCT00604825|455683911|FG003|Overall Study|Adverse Event|4|||
126652204|NCT00604825|455683908|FG000|Overall Study|Lost to Follow-up|0|||
126652205|NCT00604825|455683909|FG001|Overall Study|Lost to Follow-up|3|||
126652206|NCT00604825|455683910|FG002|Overall Study|Lost to Follow-up|1|||
126652207|NCT00604825|455683911|FG003|Overall Study|Lost to Follow-up|0|||
126652208|NCT00604825|455683908|FG000|Overall Study|Protocol Violation|0|||
126652209|NCT00604825|455683909|FG001|Overall Study|Protocol Violation|1|||
126652210|NCT00604825|455683910|FG002|Overall Study|Protocol Violation|0|||
126652211|NCT00604825|455683911|FG003|Overall Study|Protocol Violation|0|||
126652212|NCT00604825|455683908|FG000|Overall Study|Withdrawal by Subject|4|||
126652213|NCT00604825|455683909|FG001|Overall Study|Withdrawal by Subject|3|||
126652214|NCT00604825|455683910|FG002|Overall Study|Withdrawal by Subject|5|||
126652215|NCT00604825|455683911|FG003|Overall Study|Withdrawal by Subject|5|||
126652216|NCT00604825|455683908|FG000|Overall Study|Lack of Efficacy|3|||
126652217|NCT00604825|455683909|FG001|Overall Study|Lack of Efficacy|2|||
126652218|NCT00604825|455683910|FG002|Overall Study|Lack of Efficacy|1|||
126652219|NCT00604825|455683911|FG003|Overall Study|Lack of Efficacy|0|||
126652220|NCT00604825|455683908|FG000|Overall Study|Did not meet eligibility criteria|0|||
126652221|NCT00604825|455683909|FG001|Overall Study|Did not meet eligibility criteria|0|||
126652222|NCT00604825|455683910|FG002|Overall Study|Did not meet eligibility criteria|2|||
126652223|NCT00604825|455683911|FG003|Overall Study|Did not meet eligibility criteria|0|||
126652224|NCT00604825|455683908|FG000|Overall Study|Physician Decision|0|||
126652225|NCT00604825|455683909|FG001|Overall Study|Physician Decision|0|||
126652226|NCT00604825|455683910|FG002|Overall Study|Physician Decision|0|||
126652227|NCT00604825|455683911|FG003|Overall Study|Physician Decision|1|||
126652228|NCT00604825|455683908|FG000|Overall Study|Exclusion criterion met|0|||
126652229|NCT00604825|455683909|FG001|Overall Study|Exclusion criterion met|0|||
126652230|NCT00604825|455683910|FG002|Overall Study|Exclusion criterion met|0|||
126652231|NCT00604825|455683911|FG003|Overall Study|Exclusion criterion met|1|||
126652232|NCT04617275|455683912|FG000|Treatment Period|Adverse Event|1|||
126652233|NCT04617275|455683913|FG001|Treatment Period|Adverse Event|6|||
126652234|NCT04617275|455683914|FG002|Treatment Period|Adverse Event|4|||
126652235|NCT04617275|455683915|FG003|Treatment Period|Adverse Event|6|||
126652236|NCT04617275|455683916|FG004|Treatment Period|Adverse Event|7|||
126323590|NCT02670382|454477943|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
126323591|NCT03244618|454477944|FG000|Overall Study|Lost to Follow-up|3|||
126323592|NCT03244618|454477945|FG001|Overall Study|Lost to Follow-up|4|||
126323593|NCT03244618|454477944|FG000|Overall Study|Protocol Violation|4|||
126323594|NCT03244618|454477945|FG001|Overall Study|Protocol Violation|3|||
126652237|NCT04617275|455683917|FG005|Treatment Period|Adverse Event|8|||
126652238|NCT04617275|455683918|FG006|Treatment Period|Adverse Event|0|||
126652239|NCT04617275|455683919|FG007|Treatment Period|Adverse Event|12|||
126652240|NCT04617275|455683912|FG000|Treatment Period|Lost to Follow-up|0|||
126652241|NCT04617275|455683913|FG001|Treatment Period|Lost to Follow-up|0|||
126652242|NCT04617275|455683914|FG002|Treatment Period|Lost to Follow-up|2|||
126652243|NCT04617275|455683915|FG003|Treatment Period|Lost to Follow-up|0|||
126652244|NCT04617275|455683916|FG004|Treatment Period|Lost to Follow-up|0|||
126652245|NCT04617275|455683917|FG005|Treatment Period|Lost to Follow-up|3|||
126652246|NCT04617275|455683918|FG006|Treatment Period|Lost to Follow-up|0|||
126652247|NCT04617275|455683919|FG007|Treatment Period|Lost to Follow-up|2|||
126652248|NCT04617275|455683912|FG000|Treatment Period|No longer meets eligibility criteria|0|||
126652249|NCT04617275|455683913|FG001|Treatment Period|No longer meets eligibility criteria|0|||
126652250|NCT04617275|455683914|FG002|Treatment Period|No longer meets eligibility criteria|0|||
126652251|NCT04617275|455683915|FG003|Treatment Period|No longer meets eligibility criteria|1|||
126652252|NCT04617275|455683916|FG004|Treatment Period|No longer meets eligibility criteria|0|||
126652253|NCT04617275|455683917|FG005|Treatment Period|No longer meets eligibility criteria|0|||
126652254|NCT04617275|455683918|FG006|Treatment Period|No longer meets eligibility criteria|0|||
126652255|NCT04617275|455683919|FG007|Treatment Period|No longer meets eligibility criteria|0|||
126652256|NCT04617275|455683912|FG000|Treatment Period|Other|0|||
126652257|NCT04617275|455683913|FG001|Treatment Period|Other|1|||
126652258|NCT04617275|455683914|FG002|Treatment Period|Other|0|||
126652259|NCT04617275|455683915|FG003|Treatment Period|Other|0|||
126652260|NCT04617275|455683916|FG004|Treatment Period|Other|0|||
126652261|NCT04617275|455683917|FG005|Treatment Period|Other|0|||
126652262|NCT04617275|455683918|FG006|Treatment Period|Other|0|||
126652263|NCT04617275|455683919|FG007|Treatment Period|Other|0|||
126652264|NCT04617275|455683912|FG000|Treatment Period|Withdrawal by Subject|2|||
126652265|NCT04617275|455683913|FG001|Treatment Period|Withdrawal by Subject|0|||
126323595|NCT03244618|454477944|FG000|Overall Study|Withdrawal by Subject|0|||
126652266|NCT04617275|455683914|FG002|Treatment Period|Withdrawal by Subject|0|||
126652267|NCT04617275|455683915|FG003|Treatment Period|Withdrawal by Subject|2|||
126652268|NCT04617275|455683916|FG004|Treatment Period|Withdrawal by Subject|2|||
126652269|NCT04617275|455683917|FG005|Treatment Period|Withdrawal by Subject|0|||
126652270|NCT04617275|455683918|FG006|Treatment Period|Withdrawal by Subject|1|||
126652271|NCT04617275|455683919|FG007|Treatment Period|Withdrawal by Subject|2|||
126652272|NCT04617275|455683912|FG000|Follow-up Period|Adverse Event|1|||
126652273|NCT04617275|455683913|FG001|Follow-up Period|Adverse Event|1|||
126323596|NCT03244618|454477945|FG001|Overall Study|Withdrawal by Subject|2|||
126323597|NCT03469999|454477948|FG000|Overall Study|Lost to Follow-up|2|||
126323598|NCT00394771|454477949|FG000|Overall Study|Did not meet protocol requirements|1|||
126323599|NCT00394771|454477950|FG001|Overall Study|Did not meet protocol requirements|0|||
126323600|NCT00394771|454477951|FG002|Overall Study|Did not meet protocol requirements|2|||
126323601|NCT00394771|454477952|FG003|Overall Study|Did not meet protocol requirements|0|||
126323602|NCT00394771|454477949|FG000|Overall Study|Protocol Violation|2|||
126323603|NCT00394771|454477950|FG001|Overall Study|Protocol Violation|4|||
126323604|NCT00394771|454477951|FG002|Overall Study|Protocol Violation|9|||
126323605|NCT00394771|454477952|FG003|Overall Study|Protocol Violation|7|||
126323606|NCT00394771|454477949|FG000|Overall Study|Withdrawal by Subject|10|||
126323607|NCT00394771|454477950|FG001|Overall Study|Withdrawal by Subject|6|||
126323608|NCT00394771|454477951|FG002|Overall Study|Withdrawal by Subject|8|||
126323609|NCT00394771|454477952|FG003|Overall Study|Withdrawal by Subject|12|||
126323610|NCT00394771|454477949|FG000|Overall Study|Adverse Event|10|||
126652274|NCT04617275|455683914|FG002|Follow-up Period|Adverse Event|2|||
126323611|NCT00394771|454477950|FG001|Overall Study|Adverse Event|5|||
126323612|NCT00394771|454477951|FG002|Overall Study|Adverse Event|12|||
126323613|NCT00394771|454477952|FG003|Overall Study|Adverse Event|8|||
126323614|NCT00394771|454477949|FG000|Overall Study|Participant pregnant|0|||
126323615|NCT00394771|454477950|FG001|Overall Study|Participant pregnant|1|||
126323616|NCT00394771|454477951|FG002|Overall Study|Participant pregnant|2|||
126652275|NCT04617275|455683915|FG003|Follow-up Period|Adverse Event|3|||
126652276|NCT04617275|455683916|FG004|Follow-up Period|Adverse Event|4|||
126652277|NCT04617275|455683917|FG005|Follow-up Period|Adverse Event|3|||
126652278|NCT04617275|455683918|FG006|Follow-up Period|Adverse Event|0|||
126652279|NCT04617275|455683919|FG007|Follow-up Period|Adverse Event|3|||
126652280|NCT04617275|455683912|FG000|Follow-up Period|Lost to Follow-up|0|||
126652281|NCT04617275|455683913|FG001|Follow-up Period|Lost to Follow-up|1|||
126652282|NCT04617275|455683914|FG002|Follow-up Period|Lost to Follow-up|2|||
126652283|NCT04617275|455683915|FG003|Follow-up Period|Lost to Follow-up|0|||
126652284|NCT04617275|455683916|FG004|Follow-up Period|Lost to Follow-up|0|||
126652285|NCT04617275|455683917|FG005|Follow-up Period|Lost to Follow-up|4|||
126652286|NCT04617275|455683918|FG006|Follow-up Period|Lost to Follow-up|0|||
126652287|NCT04617275|455683919|FG007|Follow-up Period|Lost to Follow-up|3|||
126652288|NCT04617275|455683912|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
126652289|NCT04617275|455683913|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
126652290|NCT04617275|455683914|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
126652291|NCT04617275|455683915|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
126652292|NCT04617275|455683916|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
126652293|NCT04617275|455683917|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
126652294|NCT04617275|455683918|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
126652295|NCT04617275|455683919|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
126652296|NCT04617275|455683912|FG000|Follow-up Period|Other|0|||
126652297|NCT04617275|455683913|FG001|Follow-up Period|Other|1|||
126652298|NCT04617275|455683914|FG002|Follow-up Period|Other|0|||
126652299|NCT04617275|455683915|FG003|Follow-up Period|Other|0|||
126652300|NCT04617275|455683916|FG004|Follow-up Period|Other|0|||
126652301|NCT04617275|455683917|FG005|Follow-up Period|Other|0|||
126652302|NCT04617275|455683918|FG006|Follow-up Period|Other|0|||
126652303|NCT04617275|455683919|FG007|Follow-up Period|Other|0|||
126652304|NCT04617275|455683912|FG000|Follow-up Period|Withdrawal by Subject|2|||
126652305|NCT04617275|455683913|FG001|Follow-up Period|Withdrawal by Subject|0|||
126652306|NCT04617275|455683914|FG002|Follow-up Period|Withdrawal by Subject|0|||
126652307|NCT04617275|455683915|FG003|Follow-up Period|Withdrawal by Subject|2|||
126652308|NCT04617275|455683916|FG004|Follow-up Period|Withdrawal by Subject|2|||
126652309|NCT04617275|455683917|FG005|Follow-up Period|Withdrawal by Subject|0|||
126652310|NCT04617275|455683918|FG006|Follow-up Period|Withdrawal by Subject|1|||
126652311|NCT04617275|455683919|FG007|Follow-up Period|Withdrawal by Subject|2|||
126652312|NCT04927884|455683927|FG000|Overall Study|Progressive Disease|2|||
126652313|NCT05593445|455683928|FG000|12-Week DBVC Period|Adverse Event|1|||
126652314|NCT05593445|455683929|FG001|12-Week DBVC Period|Adverse Event|0|||
126652315|NCT05593445|455683930|FG002|12-Week DBVC Period|Adverse Event|0|||
126652316|NCT05593445|455683931|FG003|12-Week DBVC Period|Adverse Event|0|||
126652317|NCT05593445|455683928|FG000|12-Week DBVC Period|Physician Decision|0|||
126652318|NCT05593445|455683929|FG001|12-Week DBVC Period|Physician Decision|1|||
126652319|NCT05593445|455683930|FG002|12-Week DBVC Period|Physician Decision|0|||
126652320|NCT05593445|455683931|FG003|12-Week DBVC Period|Physician Decision|0|||
126652321|NCT05593445|455683928|FG000|12-Week DBVC Period|Protocol Violation|0|||
126652322|NCT05593445|455683929|FG001|12-Week DBVC Period|Protocol Violation|1|||
126652323|NCT05593445|455683930|FG002|12-Week DBVC Period|Protocol Violation|0|||
126652324|NCT05593445|455683931|FG003|12-Week DBVC Period|Protocol Violation|0|||
126652325|NCT05593445|455683928|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
126652326|NCT05593445|455683929|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
126652327|NCT05593445|455683930|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
126652328|NCT05593445|455683931|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
126652329|NCT05593445|455683928|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
126652330|NCT05593445|455683929|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
126652331|NCT05593445|455683930|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
126652332|NCT05593445|455683931|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
126652333|NCT05593445|455683928|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
126652334|NCT05593445|455683929|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
126652335|NCT05593445|455683930|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
126652336|NCT05593445|455683931|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
126652337|NCT05593445|455683928|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
126652338|NCT05593445|455683929|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
126652339|NCT05593445|455683930|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
126652340|NCT05593445|455683931|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
126652341|NCT05593445|455683928|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
126652342|NCT05593445|455683929|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
126652343|NCT05593445|455683930|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
126652344|NCT05593445|455683931|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
126652345|NCT05559476|455683932|FG000|Overall Study|Adverse Event|2|||
126652346|NCT05559476|455683933|FG001|Overall Study|Adverse Event|0|||
126652347|NCT05559476|455683932|FG000|Overall Study|Lost to Follow-up|13|||
126652348|NCT05559476|455683933|FG001|Overall Study|Lost to Follow-up|12|||
126652349|NCT05559476|455683932|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
126652350|NCT05559476|455683933|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
126652351|NCT05559476|455683932|FG000|Overall Study|Other|0|||
126652352|NCT05559476|455683933|FG001|Overall Study|Other|2|||
126652353|NCT00727311|455683934|FG000|Overall Study|Did not receive drug|316|||
126652354|NCT00727311|455683934|FG000|Overall Study|Missing end of therapy data|205|||
126652355|NCT00727311|455683934|FG000|Overall Study|Adverse Event|58|||
126652356|NCT00727311|455683934|FG000|Overall Study|Lack of Efficacy|242|||
126652357|NCT00727311|455683934|FG000|Overall Study|Lost to Follow-up|73|||
126652358|NCT00727311|455683934|FG000|Overall Study|Withdrawal by Subject|77|||
126652359|NCT00727311|455683934|FG000|Overall Study|Other|97|||
126652360|NCT00727311|455683934|FG000|Overall Study|Multiple reasons|39|||
126652361|NCT00969709|455685020|FG000|Overall Study|Adverse Event|3|||
126652362|NCT00969709|455685021|FG001|Overall Study|Adverse Event|13|||
126652363|NCT00969709|455685022|FG002|Overall Study|Adverse Event|26|||
126652364|NCT00969709|455685023|FG003|Overall Study|Adverse Event|12|||
126652365|NCT00969709|455685020|FG000|Overall Study|Lack of Efficacy|7|||
126652366|NCT00969709|455685021|FG001|Overall Study|Lack of Efficacy|4|||
126652367|NCT00969709|455685022|FG002|Overall Study|Lack of Efficacy|1|||
126652368|NCT00969709|455685023|FG003|Overall Study|Lack of Efficacy|3|||
126652369|NCT00969709|455685020|FG000|Overall Study|Protocol Violation|9|||
126652370|NCT00969709|455685021|FG001|Overall Study|Protocol Violation|5|||
126652371|NCT00969709|455685022|FG002|Overall Study|Protocol Violation|9|||
126652372|NCT00969709|455685023|FG003|Overall Study|Protocol Violation|10|||
126652373|NCT00969709|455685020|FG000|Overall Study|Withdrawal by Subject|9|||
126652374|NCT00969709|455685021|FG001|Overall Study|Withdrawal by Subject|12|||
126652375|NCT00969709|455685022|FG002|Overall Study|Withdrawal by Subject|11|||
126652376|NCT00969709|455685023|FG003|Overall Study|Withdrawal by Subject|23|||
126652377|NCT00969709|455685020|FG000|Overall Study|Lost to Follow-up|10|||
126652378|NCT00969709|455685021|FG001|Overall Study|Lost to Follow-up|14|||
126652379|NCT00969709|455685022|FG002|Overall Study|Lost to Follow-up|8|||
126652380|NCT00969709|455685023|FG003|Overall Study|Lost to Follow-up|15|||
126652381|NCT00969709|455685020|FG000|Overall Study|Other reasons|0|||
126652382|NCT00969709|455685021|FG001|Overall Study|Other reasons|0|||
126652383|NCT00969709|455685022|FG002|Overall Study|Other reasons|3|||
126652384|NCT00969709|455685023|FG003|Overall Study|Other reasons|0|||
126652385|NCT01238900|455685024|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
126652386|NCT01238900|455685024|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
126652387|NCT02233543|455685027|FG000|Period 1|Withdrawal by Subject|1|||
126652388|NCT02233543|455685028|FG001|Period 1|Withdrawal by Subject|0|||
126652389|NCT02233543|455685027|FG000|Period 1|Participants required other treatment.|2|||
126652390|NCT02233543|455685028|FG001|Period 1|Participants required other treatment.|3|||
126652391|NCT02233543|455685027|FG000|Period 2|Adverse Event|1|||
126652392|NCT02233543|455685028|FG001|Period 2|Adverse Event|0|||
126652393|NCT02233543|455685027|FG000|Period 2|Participant required other treatment.|0|||
126652394|NCT02233543|455685028|FG001|Period 2|Participant required other treatment.|1|||
126652395|NCT02233543|455685027|FG000|Period 2|COPD exacerbation|1|||
126652396|NCT02233543|455685028|FG001|Period 2|COPD exacerbation|0|||
126652397|NCT00616902|455685029|FG000|Overall Study|Termination of study|6|||
126652398|NCT00616902|455685030|FG001|Overall Study|Termination of study|6|||
126652399|NCT00266227|455685031|FG000|Initial Treatment|Adverse Event|0|||
126652400|NCT00266227|455685032|FG001|Initial Treatment|Adverse Event|0|||
126652401|NCT00266227|455685033|FG002|Initial Treatment|Adverse Event|13|||
126652402|NCT00266227|455685031|FG000|Initial Treatment|Lost to Follow-up|0|||
126652403|NCT00266227|455685032|FG001|Initial Treatment|Lost to Follow-up|0|||
126652404|NCT00266227|455685033|FG002|Initial Treatment|Lost to Follow-up|6|||
126652405|NCT00266227|455685031|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
126652406|NCT00266227|455685032|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
126652407|NCT00266227|455685033|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
126652408|NCT00266227|455685031|FG000|Initial Treatment|Physician decision to withdraw|0|||
126652409|NCT00266227|455685032|FG001|Initial Treatment|Physician decision to withdraw|0|||
126652410|NCT00266227|455685033|FG002|Initial Treatment|Physician decision to withdraw|12|||
126652411|NCT00266227|455685031|FG000|Initial Treatment|Pregnancy|0|||
126652412|NCT00266227|455685032|FG001|Initial Treatment|Pregnancy|0|||
126652413|NCT00266227|455685033|FG002|Initial Treatment|Pregnancy|1|||
126652414|NCT00266227|455685031|FG000|Retreatment: Up to Week 48|Death|1|||
126652415|NCT00266227|455685032|FG001|Retreatment: Up to Week 48|Death|0|||
126652416|NCT00266227|455685033|FG002|Retreatment: Up to Week 48|Death|0|||
126652417|NCT00266227|455685031|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
126652418|NCT00266227|455685032|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
126652419|NCT00266227|455685033|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
126652420|NCT00266227|455685031|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
126652421|NCT00266227|455685032|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
126652422|NCT00266227|455685033|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
126652423|NCT00266227|455685031|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
126652424|NCT00266227|455685032|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
126652425|NCT00266227|455685033|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
126652426|NCT00266227|455685031|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
126652427|NCT00266227|455685032|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
126652428|NCT00266227|455685033|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
126652429|NCT00266227|455685031|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
126652430|NCT00266227|455685032|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
126652431|NCT00266227|455685033|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
126652432|NCT00266227|455685031|FG000|Retreatment: Week 48 to Week 72|Death|1|||
126652433|NCT00266227|455685032|FG001|Retreatment: Week 48 to Week 72|Death|1|||
126652434|NCT00266227|455685033|FG002|Retreatment: Week 48 to Week 72|Death|0|||
126652435|NCT00266227|455685031|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
126652436|NCT00266227|455685032|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
126652437|NCT00266227|455685033|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
126652438|NCT00266227|455685031|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
126652439|NCT00266227|455685032|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
126652440|NCT00266227|455685033|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
126652441|NCT00266227|455685031|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
126652442|NCT00266227|455685032|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
126652443|NCT00266227|455685033|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
126652444|NCT00266227|455685031|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
126652445|NCT00266227|455685032|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
126652446|NCT00266227|455685033|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
126652447|NCT03573583|455685034|FG000|Overall Study|Lost to Follow-up|1|||
126652448|NCT03573583|455685035|FG001|Overall Study|Lost to Follow-up|0|||
126652449|NCT03573583|455685034|FG000|Overall Study|Withdrawal by Subject|1|||
126652450|NCT03573583|455685035|FG001|Overall Study|Withdrawal by Subject|1|||
126323617|NCT00394771|454477952|FG003|Overall Study|Participant pregnant|2|||
126323618|NCT00394771|454477949|FG000|Overall Study|Lost to Follow-up|15|||
126323619|NCT00394771|454477950|FG001|Overall Study|Lost to Follow-up|15|||
126323620|NCT00394771|454477951|FG002|Overall Study|Lost to Follow-up|13|||
126323621|NCT00394771|454477952|FG003|Overall Study|Lost to Follow-up|10|||
126323622|NCT00394771|454477949|FG000|Overall Study|Other|3|||
126323623|NCT00394771|454477950|FG001|Overall Study|Other|3|||
126323624|NCT00394771|454477951|FG002|Overall Study|Other|1|||
126323625|NCT00394771|454477952|FG003|Overall Study|Other|0|||
126323626|NCT03597139|454477953|FG000|Overall Study|Adverse Event|3|||
126323627|NCT03597139|454477954|FG001|Overall Study|Adverse Event|0|||
126323628|NCT03597139|454477953|FG000|Overall Study|Protocol Non-compliance|1|||
126323629|NCT03597139|454477954|FG001|Overall Study|Protocol Non-compliance|0|||
126323630|NCT00520767|454477956|FG000|Overall Study|Death|2|||
126323631|NCT00382109|454477957|FG000|Overall Study|Adverse Event|3|||
126323632|NCT00382109|454477958|FG001|Overall Study|Adverse Event|0|||
126323633|NCT00382109|454477957|FG000|Overall Study|Physician Decision|6|||
126323634|NCT00382109|454477958|FG001|Overall Study|Physician Decision|1|||
126323635|NCT00382109|454477957|FG000|Overall Study|Withdrawal by Subject|1|||
126323636|NCT00382109|454477958|FG001|Overall Study|Withdrawal by Subject|0|||
126323637|NCT00382109|454477957|FG000|Overall Study|ineligible|2|||
126323638|NCT00382109|454477958|FG001|Overall Study|ineligible|0|||
126323639|NCT00382109|454477957|FG000|Overall Study|Other|0|||
126323640|NCT00382109|454477958|FG001|Overall Study|Other|2|||
126323641|NCT00382109|454477957|FG000|Overall Study|consent withdrawal|0|||
126323642|NCT00382109|454477958|FG001|Overall Study|consent withdrawal|1|||
126323643|NCT00248833|454477959|FG000|Overall Study|Adverse Event|2|||
126323644|NCT00248833|454477960|FG001|Overall Study|Adverse Event|0|||
126323645|NCT00248833|454477961|FG002|Overall Study|Adverse Event|0|||
126323646|NCT00248833|454477959|FG000|Overall Study|Withdrawal by Subject|0|||
126323647|NCT00248833|454477960|FG001|Overall Study|Withdrawal by Subject|1|||
126323648|NCT00248833|454477961|FG002|Overall Study|Withdrawal by Subject|1|||
126323649|NCT00248833|454477959|FG000|Overall Study|Lost to Follow-up|1|||
126323650|NCT00248833|454477960|FG001|Overall Study|Lost to Follow-up|1|||
126323651|NCT00248833|454477961|FG002|Overall Study|Lost to Follow-up|1|||
126323652|NCT00248833|454477959|FG000|Overall Study|Other|0|||
126323653|NCT00248833|454477960|FG001|Overall Study|Other|1|||
126323654|NCT00248833|454477961|FG002|Overall Study|Other|0|||
126323655|NCT01900899|454477962|FG000|Overall Study|Withdrawal by Subject|7|||
126323656|NCT01900899|454477963|FG001|Overall Study|Withdrawal by Subject|1|||
126323657|NCT01900899|454477962|FG000|Overall Study|Migrated from study area|2|||
126652451|NCT01119105|455685042|FG000|Overall Study|Withdrawal by Subject|1|||
126652452|NCT01119105|455685043|FG001|Overall Study|Withdrawal by Subject|1|||
126652453|NCT01119105|455685044|FG002|Overall Study|Withdrawal by Subject|1|||
126323658|NCT01900899|454477963|FG001|Overall Study|Migrated from study area|0|||
126323659|NCT01859949|454479761|FG000|Overall Study|Family Matters|0|||
126323660|NCT01859949|454479762|FG001|Overall Study|Family Matters|1|||
126323661|NCT01859949|454479761|FG000|Overall Study|Physician Decision|2|||
126323662|NCT01859949|454479762|FG001|Overall Study|Physician Decision|4|||
126323663|NCT01859949|454479761|FG000|Overall Study|Withdrawal by Subject|11|||
126323664|NCT01859949|454479762|FG001|Overall Study|Withdrawal by Subject|10|||
126323665|NCT01859949|454479761|FG000|Overall Study|Protocol Violation|1|||
126323666|NCT01859949|454479762|FG001|Overall Study|Protocol Violation|1|||
126323667|NCT01859949|454479761|FG000|Overall Study|Adverse Event|0|||
126323668|NCT01859949|454479762|FG001|Overall Study|Adverse Event|1|||
126323669|NCT01890759|454479763|FG000|Overall Study|Protocol Violation|0|||
126323670|NCT01890759|454479764|FG001|Overall Study|Protocol Violation|2|||
126323671|NCT01890759|454479763|FG000|Overall Study|Lost to Follow-up|0|||
126323672|NCT01890759|454479764|FG001|Overall Study|Lost to Follow-up|2|||
126323673|NCT01890759|454479763|FG000|Overall Study|Withdrawal by Subject|2|||
126652454|NCT01119105|455685042|FG000|Overall Study|Lost to Follow-up|0|||
126323674|NCT01890759|454479764|FG001|Overall Study|Withdrawal by Subject|8|||
126323675|NCT00385827|454479765|FG000|Part 1|Adverse Event|1|||
126323676|NCT00385827|454479766|FG001|Part 1|Adverse Event|0|||
126323677|NCT00385827|454479767|FG002|Part 1|Adverse Event|0|||
126323678|NCT00385827|454479765|FG000|Part 1|Death|2|||
126323679|NCT00385827|454479766|FG001|Part 1|Death|0|||
126323680|NCT00385827|454479767|FG002|Part 1|Death|0|||
126323681|NCT00385827|454479765|FG000|Part 1|Lack of Efficacy|5|||
126323682|NCT00385827|454479766|FG001|Part 1|Lack of Efficacy|0|||
126323683|NCT00385827|454479767|FG002|Part 1|Lack of Efficacy|0|||
126323684|NCT00385827|454479765|FG000|Part 1|Other|1|||
126323685|NCT00385827|454479766|FG001|Part 1|Other|0|||
126323686|NCT00385827|454479767|FG002|Part 1|Other|0|||
126323687|NCT00385827|454479765|FG000|Part 2|Adverse Event|0|||
126323688|NCT00385827|454479766|FG001|Part 2|Adverse Event|6|||
126323689|NCT00385827|454479767|FG002|Part 2|Adverse Event|10|||
126323690|NCT00385827|454479765|FG000|Part 2|Death|0|||
126323691|NCT00385827|454479766|FG001|Part 2|Death|0|||
126323692|NCT00385827|454479767|FG002|Part 2|Death|2|||
126323693|NCT00385827|454479765|FG000|Part 2|Lack of Efficacy|0|||
126323694|NCT00385827|454479766|FG001|Part 2|Lack of Efficacy|14|||
126323695|NCT00385827|454479767|FG002|Part 2|Lack of Efficacy|13|||
126323696|NCT00385827|454479765|FG000|Part 2|Randomized but not treated|0|||
126323697|NCT00385827|454479766|FG001|Part 2|Randomized but not treated|2|||
126323698|NCT00385827|454479767|FG002|Part 2|Randomized but not treated|2|||
126323699|NCT00385827|454479765|FG000|Part 2|Other|0|||
126323700|NCT00385827|454479766|FG001|Part 2|Other|11|||
126323701|NCT00385827|454479767|FG002|Part 2|Other|21|||
126323702|NCT00410072|454479768|FG000|Day 1 to Week 48|Adverse Event|1|||
126323703|NCT00410072|454479769|FG001|Day 1 to Week 48|Adverse Event|2|||
126323704|NCT00410072|454479768|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
126323705|NCT00410072|454479769|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
126323706|NCT00410072|454479768|FG000|Day 1 to Week 48|Other|0|||
126323707|NCT00410072|454479769|FG001|Day 1 to Week 48|Other|1|||
126323708|NCT00410072|454479768|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
126323709|NCT00410072|454479769|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
126323710|NCT00410072|454479768|FG000|Day 1 to Week 48|Pregnancy|0|||
126652455|NCT01119105|455685043|FG001|Overall Study|Lost to Follow-up|2|||
126652456|NCT01119105|455685044|FG002|Overall Study|Lost to Follow-up|5|||
126652457|NCT01119105|455685042|FG000|Overall Study|Adverse Event|1|||
126652458|NCT01119105|455685043|FG001|Overall Study|Adverse Event|0|||
126652459|NCT01119105|455685044|FG002|Overall Study|Adverse Event|1|||
126652460|NCT01119105|455685042|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
126652461|NCT01119105|455685043|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
126652462|NCT01119105|455685044|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
126652463|NCT01119105|455685042|FG000|Overall Study|Other|1|||
126652464|NCT01119105|455685043|FG001|Overall Study|Other|1|||
126652465|NCT01119105|455685044|FG002|Overall Study|Other|0|||
126652466|NCT04988867|455685048|FG000|Overall Study|Study terminated by Sponsor|12|||
126652467|NCT04988867|455685048|FG000|Overall Study|Adverse Event|2|||
126652468|NCT04988867|455685048|FG000|Overall Study|Study drug noncompliance|1|||
126652469|NCT00037830|455685049|FG000|Overall Study|Adverse Event|2|||
126652470|NCT00037830|455685050|FG001|Overall Study|Adverse Event|0|||
126652471|NCT00037830|455685051|FG002|Overall Study|Adverse Event|0|||
126323711|NCT00410072|454479769|FG001|Day 1 to Week 48|Pregnancy|2|||
126652472|NCT00037830|455685049|FG000|Overall Study|Withdrawal by Subject|4|||
126323712|NCT00410072|454479768|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
126323713|NCT00410072|454479769|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
126652473|NCT00037830|455685050|FG001|Overall Study|Withdrawal by Subject|5|||
126652474|NCT00037830|455685051|FG002|Overall Study|Withdrawal by Subject|1|||
126323714|NCT00410072|454479768|FG000|After Week 48 to Week 96|Adverse Event|1|||
126323715|NCT00410072|454479769|FG001|After Week 48 to Week 96|Adverse Event|2|||
126323716|NCT00410072|454479768|FG000|After Week 48 to Week 96|Death|0|||
126323717|NCT00410072|454479769|FG001|After Week 48 to Week 96|Death|1|||
126323718|NCT00410072|454479768|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
126323719|NCT00410072|454479769|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
126323720|NCT00410072|454479768|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
126323721|NCT00410072|454479769|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
126323722|NCT00410072|454479768|FG000|After Week 48 to Week 96|Other|2|||
126323723|NCT00410072|454479769|FG001|After Week 48 to Week 96|Other|0|||
126323724|NCT00410072|454479768|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
126323725|NCT00410072|454479769|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
126323726|NCT00410072|454479768|FG000|After Week 48 to Week 96|Pregnancy|0|||
126652475|NCT00037830|455685049|FG000|Overall Study|Protocol Violation|2|||
126652476|NCT00037830|455685050|FG001|Overall Study|Protocol Violation|2|||
126652477|NCT00037830|455685051|FG002|Overall Study|Protocol Violation|0|||
126652478|NCT00037830|455685049|FG000|Overall Study|Unrelated Medical Problem|2|||
126652479|NCT00037830|455685050|FG001|Overall Study|Unrelated Medical Problem|0|||
126652480|NCT00037830|455685051|FG002|Overall Study|Unrelated Medical Problem|0|||
126652481|NCT01699503|455685052|FG000|Overall Study|Death|31|||
126652482|NCT01699503|455685053|FG001|Overall Study|Death|40|||
126652483|NCT01699503|455685052|FG000|Overall Study|Withdrawal by Subject|65|||
126652484|NCT01699503|455685053|FG001|Overall Study|Withdrawal by Subject|57|||
126652485|NCT01699503|455685052|FG000|Overall Study|Lost to Follow-up|121|||
126652486|NCT01699503|455685053|FG001|Overall Study|Lost to Follow-up|117|||
126652487|NCT01699503|455685052|FG000|Overall Study|Excluded due to quality|783|||
126652488|NCT01699503|455685053|FG001|Overall Study|Excluded due to quality|791|||
126652489|NCT01236534|455685058|FG000|Overall Study|Adverse Event|3|||
126652490|NCT01236534|455685059|FG001|Overall Study|Adverse Event|0|||
126652491|NCT01014143|455685060|FG000|Second Intervention|Lost to Follow-up|2|||
126652492|NCT01014143|455685061|FG001|Second Intervention|Lost to Follow-up|0|||
126652493|NCT01014143|455685062|FG002|Second Intervention|Lost to Follow-up|0|||
126652494|NCT04638920|455685067|FG000|Overall Study|Withdrawal by Subject|5|||
126652495|NCT03775434|455685068|FG000|Overall Study|Adverse Event|2|||
126652496|NCT03775434|455685068|FG000|Overall Study|Withdrawal by Subject|1|||
126652497|NCT01871805|455685071|FG000|Phase I|Death|7|||
126652498|NCT01871805|455685072|FG001|Phase I|Death|4|||
126652499|NCT01871805|455685073|FG002|Phase I|Death|6|||
126652500|NCT01871805|455685074|FG003|Phase I|Death|2|||
126652501|NCT01871805|455685075|FG004|Phase I|Death|9|||
126652502|NCT01871805|455685076|FG005|Phase I|Death|0|||
126652503|NCT01871805|455685071|FG000|Phase I|Alive in Survival Follow-up|0|||
126652504|NCT01871805|455685072|FG001|Phase I|Alive in Survival Follow-up|2|||
126652505|NCT01871805|455685073|FG002|Phase I|Alive in Survival Follow-up|4|||
126652506|NCT01871805|455685074|FG003|Phase I|Alive in Survival Follow-up|5|||
126652507|NCT01871805|455685075|FG004|Phase I|Alive in Survival Follow-up|4|||
126652508|NCT01871805|455685076|FG005|Phase I|Alive in Survival Follow-up|0|||
126652509|NCT01871805|455685071|FG000|Phase I|Lost to Follow-up|0|||
126652510|NCT01871805|455685072|FG001|Phase I|Lost to Follow-up|1|||
126652511|NCT01871805|455685073|FG002|Phase I|Lost to Follow-up|3|||
126652512|NCT01871805|455685074|FG003|Phase I|Lost to Follow-up|0|||
126652513|NCT01871805|455685075|FG004|Phase I|Lost to Follow-up|0|||
126652514|NCT01871805|455685076|FG005|Phase I|Lost to Follow-up|0|||
126652515|NCT01871805|455685071|FG000|Phase II|Death|0|||
126652516|NCT01871805|455685072|FG001|Phase II|Death|0|||
126652517|NCT01871805|455685073|FG002|Phase II|Death|0|||
126652518|NCT01871805|455685074|FG003|Phase II|Death|0|||
126652519|NCT01871805|455685075|FG004|Phase II|Death|0|||
126652520|NCT01871805|455685076|FG005|Phase II|Death|45|||
126652521|NCT01871805|455685071|FG000|Phase II|Alive in Survival Follow-up|0|||
126652522|NCT01871805|455685072|FG001|Phase II|Alive in Survival Follow-up|0|||
126652523|NCT01871805|455685073|FG002|Phase II|Alive in Survival Follow-up|0|||
126652524|NCT01871805|455685074|FG003|Phase II|Alive in Survival Follow-up|0|||
126652525|NCT01871805|455685075|FG004|Phase II|Alive in Survival Follow-up|0|||
126652526|NCT01871805|455685076|FG005|Phase II|Alive in Survival Follow-up|29|||
126652527|NCT01871805|455685071|FG000|Phase II|Lost to Follow-up|0|||
126652528|NCT01871805|455685072|FG001|Phase II|Lost to Follow-up|0|||
126652529|NCT01871805|455685073|FG002|Phase II|Lost to Follow-up|0|||
126652530|NCT01871805|455685074|FG003|Phase II|Lost to Follow-up|0|||
126652531|NCT01871805|455685075|FG004|Phase II|Lost to Follow-up|0|||
126652532|NCT01871805|455685076|FG005|Phase II|Lost to Follow-up|13|||
126652533|NCT03412747|455685079|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
126652534|NCT03412747|455685080|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
126652535|NCT03412747|455685081|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
126652536|NCT03412747|455685079|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
126652537|NCT03412747|455685080|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
126652538|NCT03412747|455685081|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
126652539|NCT03412747|455685079|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
126652540|NCT03412747|455685080|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
126652541|NCT03412747|455685081|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
126652542|NCT03412747|455685079|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
126652543|NCT03412747|455685080|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
126652544|NCT03412747|455685081|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
126652545|NCT03412747|455685079|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
126652546|NCT03412747|455685080|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
126652547|NCT03412747|455685081|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
126652548|NCT03412747|455685079|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
126652549|NCT03412747|455685080|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
126652550|NCT03412747|455685081|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
126652551|NCT03412747|455685079|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
126652552|NCT03412747|455685080|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
126652553|NCT03412747|455685081|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
126652554|NCT03412747|455685079|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
126652555|NCT03412747|455685080|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
126652556|NCT03412747|455685081|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
126652557|NCT03412747|455685079|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
126652558|NCT03412747|455685080|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
126652559|NCT03412747|455685081|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
126652560|NCT03412747|455685079|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
126652561|NCT03412747|455685080|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
126652562|NCT03412747|455685081|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
126652563|NCT03412747|455685079|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
126652564|NCT03412747|455685080|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
126652565|NCT03412747|455685081|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
126652566|NCT03412747|455685079|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
126652567|NCT03412747|455685080|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
126652568|NCT03412747|455685081|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
126652569|NCT03412747|455685079|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
126652570|NCT03412747|455685080|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
126652571|NCT03412747|455685081|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
126652572|NCT03412747|455685079|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
126652573|NCT03412747|455685080|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
126652574|NCT03412747|455685081|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
126652575|NCT03412747|455685079|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
126652576|NCT03412747|455685080|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
126652577|NCT03412747|455685081|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
126652578|NCT03412747|455685079|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
126652579|NCT03412747|455685080|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
126652580|NCT03412747|455685081|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
126652581|NCT00468104|455685082|FG000|First Intervention|Protocol Violation|2|||
126652582|NCT00468104|455685083|FG001|First Intervention|Protocol Violation|1|||
126652583|NCT00468104|455685082|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
126652584|NCT00468104|455685083|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
126652585|NCT00468104|455685082|FG000|First Intervention|died within 3 weeks|1|||
126652586|NCT00468104|455685083|FG001|First Intervention|died within 3 weeks|0|||
126652587|NCT00468104|455685082|FG000|First Intervention|malposition/blocked chest tube tube|2|||
126652588|NCT00468104|455685083|FG001|First Intervention|malposition/blocked chest tube tube|0|||
126652589|NCT00468104|455685082|FG000|First Intervention|large lung mass with minimal effusion|1|||
126323727|NCT00410072|454479769|FG001|After Week 48 to Week 96|Pregnancy|2|||
126323728|NCT00410072|454479768|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
126652590|NCT00468104|455685083|FG001|First Intervention|large lung mass with minimal effusion|0|||
126652591|NCT00468104|455685082|FG000|First Intervention|associated prolonged pneumothorax|1|||
126652592|NCT00468104|455685083|FG001|First Intervention|associated prolonged pneumothorax|0|||
126652593|NCT00468104|455685082|FG000|First Intervention|trapped lung|1|||
126652594|NCT00468104|455685083|FG001|First Intervention|trapped lung|0|||
126652595|NCT00468104|455685082|FG000|Second Intervention|Withdrawal by Subject|5|||
126652596|NCT00468104|455685083|FG001|Second Intervention|Withdrawal by Subject|2|||
126652597|NCT00468104|455685082|FG000|Second Intervention|discarded for malposition of chest tube|0|||
126652598|NCT00468104|455685083|FG001|Second Intervention|discarded for malposition of chest tube|2|||
126652599|NCT00381615|455685086|FG000|Overall Study|Withdrawal by Subject|1|||
126652600|NCT00381615|455685087|FG001|Overall Study|Withdrawal by Subject|3|||
126652601|NCT00381615|455685088|FG002|Overall Study|Withdrawal by Subject|0|||
126652602|NCT00381615|455685089|FG003|Overall Study|Withdrawal by Subject|1|||
126652603|NCT00381615|455685086|FG000|Overall Study|Lost to Follow-up|3|||
126652604|NCT00381615|455685087|FG001|Overall Study|Lost to Follow-up|2|||
126652605|NCT00381615|455685088|FG002|Overall Study|Lost to Follow-up|0|||
126652606|NCT00381615|455685089|FG003|Overall Study|Lost to Follow-up|1|||
126652607|NCT00381615|455685086|FG000|Overall Study|Protocol Violation|0|||
126652608|NCT00381615|455685087|FG001|Overall Study|Protocol Violation|0|||
126652609|NCT00381615|455685088|FG002|Overall Study|Protocol Violation|1|||
126652610|NCT00381615|455685089|FG003|Overall Study|Protocol Violation|0|||
126652611|NCT00468559|455685095|FG000|Open-label Treatment Phase|Adverse Event|5|||
126652612|NCT00468559|455685096|FG001|Open-label Treatment Phase|Adverse Event|0|||
126652613|NCT00468559|455685097|FG002|Open-label Treatment Phase|Adverse Event|0|||
126652614|NCT00468559|455685095|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
126652615|NCT00468559|455685096|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
126652616|NCT00468559|455685097|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
126652617|NCT00468559|455685095|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
126652618|NCT00468559|455685096|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
126323729|NCT00410072|454479769|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
126323730|NCT01421147|454479774|FG000|Treatment Period|Adverse Event|2|||
126652619|NCT00468559|455685097|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
126652620|NCT00468559|455685095|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
126652621|NCT00468559|455685096|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
126652622|NCT00468559|455685097|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
126652623|NCT00468559|455685095|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
126652624|NCT00468559|455685096|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
126652625|NCT00468559|455685097|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
126652626|NCT01131182|455685098|FG000|Overall Study|Withdrawal by Subject|1|||
126652627|NCT01131182|455685099|FG001|Overall Study|Withdrawal by Subject|1|||
126652628|NCT01131182|455685098|FG000|Overall Study|Lost to Follow-up|14|||
126652629|NCT01131182|455685099|FG001|Overall Study|Lost to Follow-up|15|||
126652630|NCT01131182|455685098|FG000|Overall Study|Other Reason|1|||
126652631|NCT01131182|455685099|FG001|Overall Study|Other Reason|0|||
126652632|NCT04602221|455685102|FG000|Overall Study|Discontinuation of trial treatment|0|||
126652633|NCT04602221|455685103|FG001|Overall Study|Discontinuation of trial treatment|0|||
126652634|NCT04602221|455685104|FG002|Overall Study|Discontinuation of trial treatment|1|||
126652635|NCT04602221|455685105|FG003|Overall Study|Discontinuation of trial treatment|0|||
126652636|NCT04602221|455685106|FG004|Overall Study|Discontinuation of trial treatment|0|||
126652637|NCT04602221|455685107|FG005|Overall Study|Discontinuation of trial treatment|0|||
126652638|NCT04602221|455685108|FG006|Overall Study|Discontinuation of trial treatment|0|||
126652639|NCT04602221|455685109|FG007|Overall Study|Discontinuation of trial treatment|0|||
126652640|NCT04602221|455685110|FG008|Overall Study|Discontinuation of trial treatment|0|||
126652641|NCT04602221|455685111|FG009|Overall Study|Discontinuation of trial treatment|0|||
126652642|NCT04602221|455685112|FG010|Overall Study|Discontinuation of trial treatment|0|||
126652643|NCT04602221|455685113|FG011|Overall Study|Discontinuation of trial treatment|0|||
126652644|NCT04602221|455685114|FG012|Overall Study|Discontinuation of trial treatment|0|||
126652645|NCT04602221|455685115|FG013|Overall Study|Discontinuation of trial treatment|0|||
126652646|NCT04602221|455685116|FG014|Overall Study|Discontinuation of trial treatment|0|||
126652647|NCT04602221|455685117|FG015|Overall Study|Discontinuation of trial treatment|0|||
126652648|NCT04602221|455685118|FG016|Overall Study|Discontinuation of trial treatment|0|||
126652649|NCT04602221|455685119|FG017|Overall Study|Discontinuation of trial treatment|0|||
126652650|NCT04602221|455685102|FG000|Overall Study|Other than listed|0|||
126652651|NCT04602221|455685103|FG001|Overall Study|Other than listed|0|||
126652652|NCT04602221|455685104|FG002|Overall Study|Other than listed|0|||
126652653|NCT04602221|455685105|FG003|Overall Study|Other than listed|0|||
126652654|NCT04602221|455685106|FG004|Overall Study|Other than listed|0|||
126652655|NCT04602221|455685107|FG005|Overall Study|Other than listed|0|||
126652656|NCT04602221|455685108|FG006|Overall Study|Other than listed|0|||
126652657|NCT04602221|455685109|FG007|Overall Study|Other than listed|0|||
126652658|NCT04602221|455685110|FG008|Overall Study|Other than listed|0|||
126652659|NCT04602221|455685111|FG009|Overall Study|Other than listed|0|||
126652660|NCT04602221|455685112|FG010|Overall Study|Other than listed|0|||
126652661|NCT04602221|455685113|FG011|Overall Study|Other than listed|0|||
126652662|NCT04602221|455685114|FG012|Overall Study|Other than listed|0|||
126652663|NCT04602221|455685115|FG013|Overall Study|Other than listed|0|||
126652664|NCT04602221|455685116|FG014|Overall Study|Other than listed|0|||
126652665|NCT04602221|455685117|FG015|Overall Study|Other than listed|1|||
126652666|NCT04602221|455685118|FG016|Overall Study|Other than listed|0|||
126652667|NCT04602221|455685119|FG017|Overall Study|Other than listed|1|||
126652668|NCT04602221|455685102|FG000|Overall Study|Withdrawal by Subject|0|||
126652669|NCT04602221|455685103|FG001|Overall Study|Withdrawal by Subject|0|||
126652670|NCT04602221|455685104|FG002|Overall Study|Withdrawal by Subject|0|||
126652671|NCT04602221|455685105|FG003|Overall Study|Withdrawal by Subject|0|||
126652672|NCT04602221|455685106|FG004|Overall Study|Withdrawal by Subject|0|||
126652673|NCT04602221|455685107|FG005|Overall Study|Withdrawal by Subject|0|||
126652674|NCT04602221|455685108|FG006|Overall Study|Withdrawal by Subject|0|||
126652675|NCT04602221|455685109|FG007|Overall Study|Withdrawal by Subject|0|||
126652676|NCT04602221|455685110|FG008|Overall Study|Withdrawal by Subject|0|||
126652677|NCT04602221|455685111|FG009|Overall Study|Withdrawal by Subject|0|||
126652678|NCT04602221|455685112|FG010|Overall Study|Withdrawal by Subject|0|||
126652679|NCT04602221|455685113|FG011|Overall Study|Withdrawal by Subject|0|||
126652680|NCT04602221|455685114|FG012|Overall Study|Withdrawal by Subject|1|||
126652681|NCT04602221|455685115|FG013|Overall Study|Withdrawal by Subject|0|||
126652682|NCT04602221|455685116|FG014|Overall Study|Withdrawal by Subject|0|||
126652683|NCT04602221|455685117|FG015|Overall Study|Withdrawal by Subject|0|||
126652684|NCT04602221|455685118|FG016|Overall Study|Withdrawal by Subject|0|||
126652685|NCT04602221|455685119|FG017|Overall Study|Withdrawal by Subject|0|||
126652686|NCT04602221|455685102|FG000|Overall Study|Lost to Follow-up|0|||
126652687|NCT04602221|455685103|FG001|Overall Study|Lost to Follow-up|0|||
126652688|NCT04602221|455685104|FG002|Overall Study|Lost to Follow-up|0|||
126652689|NCT04602221|455685105|FG003|Overall Study|Lost to Follow-up|0|||
126652690|NCT04602221|455685106|FG004|Overall Study|Lost to Follow-up|0|||
126652691|NCT04602221|455685107|FG005|Overall Study|Lost to Follow-up|1|||
126652692|NCT04602221|455685108|FG006|Overall Study|Lost to Follow-up|0|||
126652693|NCT04602221|455685109|FG007|Overall Study|Lost to Follow-up|0|||
126652694|NCT04602221|455685110|FG008|Overall Study|Lost to Follow-up|0|||
126652695|NCT04602221|455685111|FG009|Overall Study|Lost to Follow-up|0|||
126652696|NCT04602221|455685112|FG010|Overall Study|Lost to Follow-up|0|||
126652697|NCT04602221|455685113|FG011|Overall Study|Lost to Follow-up|0|||
126652698|NCT04602221|455685114|FG012|Overall Study|Lost to Follow-up|0|||
126652699|NCT04602221|455685115|FG013|Overall Study|Lost to Follow-up|0|||
126652700|NCT04602221|455685116|FG014|Overall Study|Lost to Follow-up|0|||
126652701|NCT04602221|455685117|FG015|Overall Study|Lost to Follow-up|0|||
126652702|NCT04602221|455685118|FG016|Overall Study|Lost to Follow-up|0|||
126652703|NCT04602221|455685119|FG017|Overall Study|Lost to Follow-up|0|||
126652704|NCT01146782|455685120|FG000|Screening Cohort|Screen Failure|187|||
126652705|NCT01146782|455685120|FG000|Screening Cohort|Lost to Follow-up|4|||
126652706|NCT01146782|455685120|FG000|Screening Cohort|Physician Decision|1|||
126652707|NCT01146782|455685120|FG000|Screening Cohort|Withdrawal by Subject|29|||
126652708|NCT01146782|455685120|FG000|Safety Cohort|Screen Failure|61|||
126652709|NCT01146782|455685120|FG000|Safety Cohort|Withdrawal by Subject|4|||
126652710|NCT01146782|455685120|FG000|Safety Cohort|Control AHI <5|4|||
126652711|NCT01146782|455685120|FG000|Safety Cohort|TST <4 hrs|14|||
126652712|NCT01146782|455685120|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
126323731|NCT01421147|454479775|FG001|Treatment Period|Adverse Event|3|||
126323732|NCT01421147|454479774|FG000|Treatment Period|Lost to Follow-up|2|||
126323733|NCT01421147|454479775|FG001|Treatment Period|Lost to Follow-up|1|||
126323734|NCT01421147|454479774|FG000|Treatment Period|Physician Decision|2|||
126323735|NCT01421147|454479775|FG001|Treatment Period|Physician Decision|2|||
126323736|NCT01421147|454479774|FG000|Treatment Period|Withdrawal by Subject|10|||
126323737|NCT01421147|454479775|FG001|Treatment Period|Withdrawal by Subject|5|||
126323738|NCT01421147|454479774|FG000|Extension Period|Adverse Event|0|||
126323739|NCT01421147|454479775|FG001|Extension Period|Adverse Event|2|||
126323740|NCT01421147|454479774|FG000|Extension Period|Death|0|||
126323741|NCT01421147|454479775|FG001|Extension Period|Death|1|||
126323742|NCT01421147|454479774|FG000|Extension Period|Lost to Follow-up|2|||
126323743|NCT01421147|454479775|FG001|Extension Period|Lost to Follow-up|5|||
126323744|NCT01421147|454479774|FG000|Extension Period|Physician Decision|1|||
126323745|NCT01421147|454479775|FG001|Extension Period|Physician Decision|0|||
126323746|NCT01421147|454479774|FG000|Extension Period|Withdrawal by Subject|5|||
126323747|NCT01421147|454479775|FG001|Extension Period|Withdrawal by Subject|3|||
126323748|NCT03307837|454479777|FG000|Overall Study|Withdrawal by Subject|0|||
126323749|NCT03307837|454479778|FG001|Overall Study|Withdrawal by Subject|0|||
126323750|NCT03307837|454479779|FG002|Overall Study|Withdrawal by Subject|1|||
126652713|NCT01146782|455685120|FG000|Primary Endpoint Cohort|Physician Decision|1|||
126652714|NCT02270515|455685121|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
126652715|NCT02270515|455685121|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
126652716|NCT02270515|455685121|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
126652717|NCT02270515|455685121|FG000|Intervention Period 1: 0-6 Months|Death|7|||
126652718|NCT02270515|455685121|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
126652719|NCT02270515|455685121|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
126652720|NCT02270515|455685121|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
126652721|NCT02270515|455685121|FG000|Intervention Period 2: 6-12 Months|Death|5|||
126652722|NCT02270515|455685121|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
126652723|NCT02270515|455685121|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
126652724|NCT02270515|455685121|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
126652725|NCT02270515|455685121|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
126652726|NCT02270515|455685121|FG000|Intervention Period 3: 12-18 Months|Death|3|||
126652727|NCT02270515|455685121|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
126652728|NCT00911768|455685123|FG000|Overall Study|Protocol Violation|5|||
126652729|NCT00911768|455685124|FG001|Overall Study|Protocol Violation|4|||
126652730|NCT00911768|455685123|FG000|Overall Study|Withdrawal by Subject|1|||
126652731|NCT00911768|455685124|FG001|Overall Study|Withdrawal by Subject|0|||
126652732|NCT03538301|455685127|FG000|Overall Study|Adverse Event|1|||
126652733|NCT03538301|455685128|FG001|Overall Study|Adverse Event|4|||
126652734|NCT03538301|455685129|FG002|Overall Study|Adverse Event|4|||
126323751|NCT03307837|454479780|FG003|Overall Study|Withdrawal by Subject|0|||
126652735|NCT03538301|455685127|FG000|Overall Study|Death|1|||
126652736|NCT03538301|455685128|FG001|Overall Study|Death|1|||
126652737|NCT03538301|455685129|FG002|Overall Study|Death|0|||
126652738|NCT03538301|455685127|FG000|Overall Study|Physician Decision|0|||
126652739|NCT03538301|455685128|FG001|Overall Study|Physician Decision|1|||
126652740|NCT03538301|455685129|FG002|Overall Study|Physician Decision|0|||
126652741|NCT03538301|455685127|FG000|Overall Study|Protocol Violation|0|||
126652742|NCT03538301|455685128|FG001|Overall Study|Protocol Violation|0|||
126652743|NCT03538301|455685129|FG002|Overall Study|Protocol Violation|1|||
126323752|NCT03307837|454479781|FG004|Overall Study|Withdrawal by Subject|0|||
126323753|NCT03307837|454479782|FG005|Overall Study|Withdrawal by Subject|1|||
126323754|NCT03307837|454479777|FG000|Overall Study|Lost to Follow-up|1|||
126323755|NCT03307837|454479778|FG001|Overall Study|Lost to Follow-up|1|||
126323756|NCT03307837|454479779|FG002|Overall Study|Lost to Follow-up|0|||
126323757|NCT03307837|454479780|FG003|Overall Study|Lost to Follow-up|0|||
126323758|NCT03307837|454479781|FG004|Overall Study|Lost to Follow-up|0|||
126323759|NCT03307837|454479782|FG005|Overall Study|Lost to Follow-up|1|||
126323760|NCT00171158|454479783|FG000|Core Study|Death|27|||
126323761|NCT00171158|454479783|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
126323762|NCT00171158|454479783|FG000|Core Study|Protocol Violation|4|||
126323763|NCT00171158|454479783|FG000|Core Study|Administrative problems|1|||
126323764|NCT00171158|454479783|FG000|Core Study|Adverse event, non-fatal|21|||
126323765|NCT00171158|454479783|FG000|Core Study|Consent withdrawn by subject|6|||
126323766|NCT00171158|454479783|FG000|Core Study|No longer required drug (BMT)|14|||
126323767|NCT00171158|454479783|FG000|Core Study|Abnormal Laboratory Values|2|||
126323768|NCT00171158|454479783|FG000|Core Study|Lost to Follow-up|1|||
126323769|NCT00171158|454479783|FG000|E2 Extension|Other|7|||
126323770|NCT03536663|454479788|FG000|Endexo|Protocol Violation|1|||
126323771|NCT01031004|454479791|FG000|Overall Study|Protocol Violation|0|||
126323772|NCT01031004|454479792|FG001|Overall Study|Protocol Violation|1|||
126323773|NCT01031004|454479791|FG000|Overall Study|Lost to Follow-up|1|||
126323774|NCT01031004|454479792|FG001|Overall Study|Lost to Follow-up|0|||
126323775|NCT02634801|454479793|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
126323776|NCT02634801|454479794|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
126323777|NCT02634801|454479795|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
126323778|NCT02634801|454479793|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
126323779|NCT02634801|454479794|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
126323780|NCT02634801|454479795|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
126323781|NCT02634801|454479793|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
126323782|NCT02634801|454479794|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
126323783|NCT02634801|454479795|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
126323784|NCT02634801|454479793|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
126323785|NCT02634801|454479794|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
126323786|NCT02634801|454479795|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
126323787|NCT02634801|454479793|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
126323788|NCT02634801|454479794|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
126323789|NCT02634801|454479795|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
126323790|NCT02634801|454479793|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
126323791|NCT02634801|454479794|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
126323792|NCT02634801|454479795|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
126323793|NCT02634801|454479793|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
126323794|NCT02634801|454479794|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
126323795|NCT02634801|454479795|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
126323796|NCT02634801|454479793|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
126323797|NCT02634801|454479794|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
126323798|NCT02634801|454479795|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
126323799|NCT02634801|454479793|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
126323800|NCT02634801|454479794|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
126323801|NCT02634801|454479795|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
126323802|NCT02634801|454479793|FG000|Follow-up Period|Lost to Follow-up|3|||
126323803|NCT02634801|454479794|FG001|Follow-up Period|Lost to Follow-up|1|||
126323804|NCT02634801|454479795|FG002|Follow-up Period|Lost to Follow-up|2|||
126323805|NCT02634801|454479793|FG000|Follow-up Period|Physician Decision|0|||
126323806|NCT02634801|454479794|FG001|Follow-up Period|Physician Decision|0|||
126323807|NCT02634801|454479795|FG002|Follow-up Period|Physician Decision|1|||
126323808|NCT02634801|454479793|FG000|Follow-up Period|Withdrawal by Subject|1|||
126323809|NCT02634801|454479794|FG001|Follow-up Period|Withdrawal by Subject|2|||
126323810|NCT02634801|454479795|FG002|Follow-up Period|Withdrawal by Subject|5|||
126323811|NCT02634801|454479793|FG000|Follow-up Period|Adverse Event|1|||
126323812|NCT02634801|454479794|FG001|Follow-up Period|Adverse Event|5|||
126323813|NCT02634801|454479795|FG002|Follow-up Period|Adverse Event|0|||
126323814|NCT00582426|454479808|FG000|Overall Study|Lost to Follow-up|0|||
126323815|NCT00582426|454479809|FG001|Overall Study|Lost to Follow-up|2|||
126652744|NCT03538301|455685127|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
126652745|NCT03538301|455685128|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
126652746|NCT03538301|455685129|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
126652747|NCT02842151|455685132|FG000|Overall Study|Adverse Event|1|||
126652748|NCT02842151|455685132|FG000|Overall Study|Subject moved too far away|1|||
126323816|NCT00582426|454479808|FG000|Overall Study|Adverse Event|4|||
126323817|NCT00582426|454479809|FG001|Overall Study|Adverse Event|2|||
126323818|NCT00582426|454479808|FG000|Overall Study|Protocol Violation|6|||
126323819|NCT00582426|454479809|FG001|Overall Study|Protocol Violation|2|||
126323820|NCT00582426|454479808|FG000|Overall Study|Death|4|||
126652749|NCT01879553|455685133|FG000|Overall Study|Withdrawal by Subject|1|||
126652750|NCT01879553|455685134|FG001|Overall Study|Withdrawal by Subject|0|||
126652751|NCT02559895|455685136|FG000|Overall Study|Adverse Event|3|||
126323821|NCT00582426|454479809|FG001|Overall Study|Death|3|||
126652752|NCT02559895|455685137|FG001|Overall Study|Adverse Event|3|||
126652753|NCT02559895|455685138|FG002|Overall Study|Adverse Event|2|||
126652754|NCT02559895|455685139|FG003|Overall Study|Adverse Event|1|||
126652755|NCT02559895|455685136|FG000|Overall Study|Lack of Efficacy|2|||
126652756|NCT02559895|455685137|FG001|Overall Study|Lack of Efficacy|3|||
126323822|NCT00582426|454479808|FG000|Overall Study|Withdrawal by Subject|3|||
126323823|NCT00582426|454479809|FG001|Overall Study|Withdrawal by Subject|2|||
126323824|NCT00582426|454479808|FG000|Overall Study|Disease Progression|2|||
126323825|NCT00582426|454479809|FG001|Overall Study|Disease Progression|2|||
126323826|NCT00582426|454479808|FG000|Overall Study|Use of illicit drugs|1|||
126323827|NCT00582426|454479809|FG001|Overall Study|Use of illicit drugs|0|||
126323828|NCT02164318|454479810|FG000|Overall Study|Withdrawal by Subject|0|||
126323829|NCT02164318|454479811|FG001|Overall Study|Withdrawal by Subject|1|||
126323830|NCT02164318|454479812|FG002|Overall Study|Withdrawal by Subject|0|||
126323831|NCT02164318|454479813|FG003|Overall Study|Withdrawal by Subject|1|||
126323832|NCT04126317|454479834|FG000|Overall Study|Adverse Event|0|||
126323833|NCT04126317|454479835|FG001|Overall Study|Adverse Event|1|||
126323834|NCT04126317|454479834|FG000|Overall Study|Withdrawal by Subject|4|||
126323835|NCT04126317|454479835|FG001|Overall Study|Withdrawal by Subject|1|||
126323836|NCT02985021|454479837|FG000|Overall Study|Inability to comply with study procedures|1|||
126323837|NCT02756819|454479838|FG000|Overall Study|Lost for observation|23|||
126323838|NCT02756819|454479838|FG000|Overall Study|Patient's unwillingness|16|||
126323839|NCT02756819|454479838|FG000|Overall Study|Insufficient efficacy|2|||
126323840|NCT02756819|454479838|FG000|Overall Study|Adverse Event|2|||
126323841|NCT02756819|454479838|FG000|Overall Study|Reason not Specified|9|||
126323842|NCT00264290|454479839|FG000|Intervention (8 Weeks)|Adverse Event|1|||
126323843|NCT00264290|454479840|FG001|Intervention (8 Weeks)|Adverse Event|0|||
126323844|NCT01939223|454479841|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
126323845|NCT01939223|454479842|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
126323846|NCT01939223|454479841|FG000|Overall Study|Disease recurrence (radiological)|1|||
126323847|NCT01939223|454479842|FG001|Overall Study|Disease recurrence (radiological)|3|||
126323848|NCT01939223|454479841|FG000|Overall Study|Study stopped by Sponsor|5|||
126323849|NCT01939223|454479842|FG001|Overall Study|Study stopped by Sponsor|7|||
126323850|NCT01939223|454479841|FG000|Overall Study|Withdrawal by Subject|6|||
126323851|NCT01939223|454479842|FG001|Overall Study|Withdrawal by Subject|0|||
126323852|NCT01557517|454479843|FG000|Overall Study|Death|1|||
126323853|NCT01557517|454479844|FG001|Overall Study|Death|0|||
126323854|NCT01557517|454479843|FG000|Overall Study|Refused further treatment|0|||
126323855|NCT01557517|454479844|FG001|Overall Study|Refused further treatment|2|||
126323856|NCT01557517|454479843|FG000|Overall Study|Adverse Event|0|||
126323857|NCT01557517|454479844|FG001|Overall Study|Adverse Event|2|||
126323858|NCT01557517|454479843|FG000|Overall Study|Pt declined before treatment started|1|||
126323859|NCT01557517|454479844|FG001|Overall Study|Pt declined before treatment started|0|||
126323860|NCT00162097|454479845|FG000|Overall Study|Participant no longer met study criteria|0|||
126323861|NCT00162097|454479846|FG001|Overall Study|Participant no longer met study criteria|0|||
126652757|NCT02559895|455685138|FG002|Overall Study|Lack of Efficacy|2|||
126652758|NCT02559895|455685139|FG003|Overall Study|Lack of Efficacy|8|||
126323862|NCT00162097|454479847|FG002|Overall Study|Participant no longer met study criteria|0|||
126323863|NCT00162097|454479848|FG003|Overall Study|Participant no longer met study criteria|1|||
126323864|NCT03585712|454479851|FG000|Treatment Period 1|Protocol Violation|1|||
126323865|NCT03585712|454479852|FG001|Treatment Period 1|Protocol Violation|0|||
126323866|NCT03585712|454479853|FG002|Treatment Period 1|Protocol Violation|0|||
126323867|NCT03585712|454479851|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
126323868|NCT03585712|454479852|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
126323869|NCT03585712|454479853|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
126652759|NCT02559895|455685136|FG000|Overall Study|Lost to Follow-up|22|||
126652760|NCT02559895|455685137|FG001|Overall Study|Lost to Follow-up|16|||
126652761|NCT02559895|455685138|FG002|Overall Study|Lost to Follow-up|12|||
126652762|NCT02559895|455685139|FG003|Overall Study|Lost to Follow-up|17|||
126652763|NCT02559895|455685136|FG000|Overall Study|Physician Decision|1|||
126652764|NCT02559895|455685137|FG001|Overall Study|Physician Decision|1|||
126323870|NCT03585712|454479851|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
126652765|NCT02559895|455685138|FG002|Overall Study|Physician Decision|3|||
126652766|NCT02559895|455685139|FG003|Overall Study|Physician Decision|0|||
126652767|NCT02559895|455685136|FG000|Overall Study|Withdrawal by Subject|16|||
126652768|NCT02559895|455685137|FG001|Overall Study|Withdrawal by Subject|9|||
126323871|NCT03585712|454479852|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
126323872|NCT03585712|454479853|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
126323873|NCT03585712|454479851|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
126323874|NCT03585712|454479852|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
126323875|NCT03585712|454479853|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
126323876|NCT01280682|454479860|FG000|Overall Study|Lost to Follow-up|0|||
126652769|NCT02559895|455685138|FG002|Overall Study|Withdrawal by Subject|20|||
126652770|NCT02559895|455685139|FG003|Overall Study|Withdrawal by Subject|9|||
126652771|NCT02559895|455685136|FG000|Overall Study|Study Burden|10|||
126652772|NCT02559895|455685137|FG001|Overall Study|Study Burden|16|||
126652773|NCT02559895|455685138|FG002|Overall Study|Study Burden|12|||
126652774|NCT02559895|455685139|FG003|Overall Study|Study Burden|22|||
126652775|NCT02559895|455685136|FG000|Overall Study|Other|1|||
126652776|NCT02559895|455685137|FG001|Overall Study|Other|5|||
126652777|NCT02559895|455685138|FG002|Overall Study|Other|3|||
126652778|NCT02559895|455685139|FG003|Overall Study|Other|3|||
126652779|NCT04540887|455685145|FG000|Overall Study|Withdrawal by Subject|2|||
126652780|NCT01262027|455685146|FG000|Overall Study|Adverse Event|1|||
126652781|NCT01262027|455685146|FG000|Overall Study|Withdrawal by Subject|3|||
126652782|NCT01262027|455685146|FG000|Overall Study|Protocol Violation|1|||
126652783|NCT02665338|455685149|FG000|Overall Study|Withdrawal by Subject|0|||
126652784|NCT02665338|455685150|FG001|Overall Study|Withdrawal by Subject|1|||
126652785|NCT00565851|455686371|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
126652786|NCT00565851|455686372|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
126652787|NCT00565851|455686373|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
126652788|NCT00565851|455686374|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
126652789|NCT00565851|455686375|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
126652790|NCT00565851|455686376|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
126652791|NCT00565851|455686377|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
126652792|NCT00565851|455686378|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
126652793|NCT00565851|455686371|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
126323877|NCT01280682|454479861|FG001|Overall Study|Lost to Follow-up|6|||
126323878|NCT01280682|454479860|FG000|Overall Study|Withdrawal by Subject|0|||
126323879|NCT01280682|454479861|FG001|Overall Study|Withdrawal by Subject|7|||
126323880|NCT01964716|454479870|FG000|Overall Study|Withdrawal by Subject|2|||
126323881|NCT01964716|454479871|FG001|Overall Study|Withdrawal by Subject|3|||
126323882|NCT01964716|454479870|FG000|Overall Study|Lost to Follow-up|1|||
126323883|NCT01964716|454479871|FG001|Overall Study|Lost to Follow-up|2|||
126323884|NCT01964716|454479870|FG000|Overall Study|No longer met eligibility criteria|1|||
126323885|NCT01964716|454479871|FG001|Overall Study|No longer met eligibility criteria|1|||
126323886|NCT01964716|454479870|FG000|Overall Study|Death|1|||
126323887|NCT01964716|454479871|FG001|Overall Study|Death|0|||
126323888|NCT01464619|454479876|FG000|Overall Study|Lost to Follow-up|3|||
126323889|NCT01464619|454479877|FG001|Overall Study|Lost to Follow-up|4|||
126323890|NCT01863732|454479878|FG000|Overall Study|Adverse Event|2|||
126323891|NCT01863732|454479879|FG001|Overall Study|Adverse Event|0|||
126323892|NCT01863732|454479880|FG002|Overall Study|Adverse Event|3|||
126323893|NCT01863732|454479881|FG003|Overall Study|Adverse Event|3|||
126323894|NCT01863732|454479878|FG000|Overall Study|Lack of Efficacy|1|||
126323895|NCT01863732|454479879|FG001|Overall Study|Lack of Efficacy|0|||
126323896|NCT01863732|454479880|FG002|Overall Study|Lack of Efficacy|2|||
126323897|NCT01863732|454479881|FG003|Overall Study|Lack of Efficacy|1|||
126323898|NCT01863732|454479878|FG000|Overall Study|Lost to Follow-up|2|||
126323899|NCT01863732|454479879|FG001|Overall Study|Lost to Follow-up|2|||
126323900|NCT01863732|454479880|FG002|Overall Study|Lost to Follow-up|1|||
126323901|NCT01863732|454479881|FG003|Overall Study|Lost to Follow-up|1|||
126323902|NCT01863732|454479878|FG000|Overall Study|Physician Decision|1|||
126323903|NCT01863732|454479879|FG001|Overall Study|Physician Decision|0|||
126323904|NCT01863732|454479880|FG002|Overall Study|Physician Decision|1|||
126323905|NCT01863732|454479881|FG003|Overall Study|Physician Decision|0|||
126323906|NCT01863732|454479878|FG000|Overall Study|Pregnancy|0|||
126323907|NCT01863732|454479879|FG001|Overall Study|Pregnancy|0|||
126323908|NCT01863732|454479880|FG002|Overall Study|Pregnancy|0|||
126323909|NCT01863732|454479881|FG003|Overall Study|Pregnancy|1|||
126323910|NCT01863732|454479878|FG000|Overall Study|Technical problems|0|||
126323911|NCT01863732|454479879|FG001|Overall Study|Technical problems|1|||
126323912|NCT01863732|454479880|FG002|Overall Study|Technical problems|1|||
126323913|NCT01863732|454479881|FG003|Overall Study|Technical problems|0|||
126323914|NCT01863732|454479878|FG000|Overall Study|Subject/guardian decision|6|||
126323915|NCT01863732|454479879|FG001|Overall Study|Subject/guardian decision|9|||
126323916|NCT01863732|454479880|FG002|Overall Study|Subject/guardian decision|3|||
126323917|NCT01863732|454479881|FG003|Overall Study|Subject/guardian decision|1|||
126652794|NCT00565851|455686372|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
126652795|NCT00565851|455686373|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
126323918|NCT01863732|454479878|FG000|Overall Study|Death|1|||
126323919|NCT01863732|454479879|FG001|Overall Study|Death|0|||
126323920|NCT01863732|454479880|FG002|Overall Study|Death|0|||
126323921|NCT01863732|454479881|FG003|Overall Study|Death|1|||
126323922|NCT01603394|454479886|FG000|Overall Study|Adverse Event|1|||
126323923|NCT00840034|454479888|FG000|Acute Treatment Phase|Adverse Event|6|||
126323924|NCT00840034|454479889|FG001|Acute Treatment Phase|Adverse Event|8|||
126323925|NCT00840034|454479888|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
126323926|NCT00840034|454479889|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
126323927|NCT00840034|454479888|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
126323928|NCT00840034|454479889|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
126652796|NCT00565851|455686374|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
126652797|NCT00565851|455686375|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
126652798|NCT00565851|455686376|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
126652799|NCT00565851|455686377|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
126652800|NCT00565851|455686378|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
126652801|NCT00775463|455686379|FG000|Overall Study|Withdrawal by Subject|0|||
126652802|NCT00775463|455686380|FG001|Overall Study|Withdrawal by Subject|1|||
126652803|NCT00775463|455686379|FG000|Overall Study|Adverse Event|7|||
126652804|NCT00775463|455686380|FG001|Overall Study|Adverse Event|9|||
126652805|NCT00775463|455686379|FG000|Overall Study|Protocol Violation|2|||
126652806|NCT00775463|455686380|FG001|Overall Study|Protocol Violation|2|||
126652807|NCT00775463|455686379|FG000|Overall Study|Lost to Follow-up|1|||
126652808|NCT00775463|455686380|FG001|Overall Study|Lost to Follow-up|0|||
126652809|NCT00775463|455686379|FG000|Overall Study|Lack of Efficacy|1|||
126652810|NCT00775463|455686380|FG001|Overall Study|Lack of Efficacy|1|||
126652811|NCT03695237|455686381|FG000|Overall Study|Withdrawal by Subject|1|||
126652812|NCT03695237|455686382|FG001|Overall Study|Withdrawal by Subject|3|||
126652813|NCT03695237|455686381|FG000|Overall Study|Lost to Follow-up|1|||
126652814|NCT03695237|455686382|FG001|Overall Study|Lost to Follow-up|2|||
126652815|NCT03695237|455686381|FG000|Overall Study|Other, Not Specified|8|||
126652816|NCT03695237|455686382|FG001|Overall Study|Other, Not Specified|2|||
126652817|NCT01789567|455686385|FG000|Overall Study|Death|6|||
126323929|NCT00840034|454479888|FG000|Acute Treatment Phase|Physician Decision|0|||
126323930|NCT00840034|454479889|FG001|Acute Treatment Phase|Physician Decision|1|||
126323931|NCT00840034|454479888|FG000|Acute Treatment Phase|Protocol Violation|2|||
126323932|NCT00840034|454479889|FG001|Acute Treatment Phase|Protocol Violation|4|||
126323933|NCT00840034|454479888|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
126323934|NCT00840034|454479889|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
126323935|NCT00840034|454479888|FG000|Taper Phase|Adverse Event|1|||
126323936|NCT00840034|454479889|FG001|Taper Phase|Adverse Event|0|||
126323937|NCT00840034|454479888|FG000|Taper Phase|Lost to Follow-up|1|||
126323938|NCT00840034|454479889|FG001|Taper Phase|Lost to Follow-up|1|||
126323939|NCT00840034|454479888|FG000|Taper Phase|Withdrawal by Subject|1|||
126323940|NCT00840034|454479889|FG001|Taper Phase|Withdrawal by Subject|1|||
126323941|NCT01215435|454479890|FG000|Overall Study|Adverse Event|1|||
126323942|NCT01215435|454479891|FG001|Overall Study|Adverse Event|0|||
126323943|NCT01215435|454479890|FG000|Overall Study|Protocol Violation|2|||
126323944|NCT01215435|454479891|FG001|Overall Study|Protocol Violation|0|||
126323945|NCT01215435|454479890|FG000|Overall Study|Withdrawal Criteria|8|||
126323946|NCT01215435|454479891|FG001|Overall Study|Withdrawal Criteria|11|||
126323947|NCT01215435|454479890|FG000|Overall Study|Lost to Follow-up|3|||
126323948|NCT01215435|454479891|FG001|Overall Study|Lost to Follow-up|0|||
126323949|NCT01215435|454479890|FG000|Overall Study|Unclassified|5|||
126323950|NCT01215435|454479891|FG001|Overall Study|Unclassified|5|||
126323951|NCT00586898|454479900|FG000|Overall Study|Adverse Event|1|||
126323952|NCT00586898|454479900|FG000|Overall Study|Patiemt Non-compliance|1|||
126323953|NCT00586898|454479900|FG000|Overall Study|Evaluable for Toxicity Only|5|||
126323954|NCT03816007|454479901|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
126323955|NCT03816007|454479902|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
126323956|NCT03816007|454479901|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
126323957|NCT03816007|454479902|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
126323958|NCT03816007|454479901|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
126323959|NCT03816007|454479902|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
126323960|NCT02179749|454479904|FG000|Overall Study|Adverse Event|0|||
126323961|NCT02179749|454479905|FG001|Overall Study|Adverse Event|0|||
126323962|NCT02179749|454479906|FG002|Overall Study|Adverse Event|1|||
126323963|NCT02179749|454479904|FG000|Overall Study|Withdrawal by Subject|0|||
126323964|NCT02179749|454479905|FG001|Overall Study|Withdrawal by Subject|0|||
126323965|NCT02179749|454479906|FG002|Overall Study|Withdrawal by Subject|1|||
126323966|NCT02756364|454479907|FG000|Overall Study|Site Terminated by Sponsor|24|||
126323967|NCT02756364|454479908|FG001|Overall Study|Site Terminated by Sponsor|30|||
126323968|NCT02756364|454479909|FG002|Overall Study|Site Terminated by Sponsor|21|||
126323969|NCT02756364|454479907|FG000|Overall Study|Death|20|||
126652818|NCT00091169|455686386|FG000|Overall Study|Disease progression|3|||
126652819|NCT00091169|455686387|FG001|Overall Study|Disease progression|1|||
126652820|NCT00091169|455686386|FG000|Overall Study|Adverse Event|11|||
126652821|NCT00091169|455686387|FG001|Overall Study|Adverse Event|17|||
126652822|NCT00091169|455686386|FG000|Overall Study|Death|4|||
126652823|NCT00091169|455686387|FG001|Overall Study|Death|1|||
126652824|NCT00091169|455686386|FG000|Overall Study|Withdrawal by Subject|10|||
126323970|NCT02756364|454479908|FG001|Overall Study|Death|15|||
126323971|NCT02756364|454479909|FG002|Overall Study|Death|18|||
126323972|NCT02756364|454479907|FG000|Overall Study|Withdrawal by Patient|2|||
126323973|NCT02756364|454479908|FG001|Overall Study|Withdrawal by Patient|1|||
126323974|NCT02756364|454479909|FG002|Overall Study|Withdrawal by Patient|8|||
126323975|NCT02756364|454479907|FG000|Overall Study|Lost to Follow-up|0|||
126323976|NCT02756364|454479908|FG001|Overall Study|Lost to Follow-up|1|||
126323977|NCT02756364|454479909|FG002|Overall Study|Lost to Follow-up|1|||
126323978|NCT02655016|454479910|FG000|Overall Study|Disease progression|6|||
126323979|NCT02655016|454479911|FG001|Overall Study|Disease progression|4|||
126323980|NCT02655016|454479910|FG000|Overall Study|Site closed|0|||
126323981|NCT02655016|454479911|FG001|Overall Study|Site closed|1|||
126323982|NCT02655016|454479910|FG000|Overall Study|Death|30|||
126323983|NCT02655016|454479911|FG001|Overall Study|Death|48|||
126323984|NCT02655016|454479910|FG000|Overall Study|Lost to Follow-up|1|||
126323985|NCT02655016|454479911|FG001|Overall Study|Lost to Follow-up|1|||
126323986|NCT02655016|454479910|FG000|Overall Study|Withdrawal by Subject|18|||
126323987|NCT02655016|454479911|FG001|Overall Study|Withdrawal by Subject|36|||
126323988|NCT02223364|454479912|FG000|Overall Study|Protocol Violation|3|||
126323989|NCT02223364|454479913|FG001|Overall Study|Protocol Violation|0|||
126323990|NCT02223364|454479914|FG002|Overall Study|Protocol Violation|3|||
126323991|NCT02223364|454479912|FG000|Overall Study|subject expired before surgery|1|||
126323992|NCT02223364|454479913|FG001|Overall Study|subject expired before surgery|0|||
126323993|NCT02223364|454479914|FG002|Overall Study|subject expired before surgery|0|||
126323994|NCT02223364|454479912|FG000|Overall Study|Physician Decision|1|||
126323995|NCT02223364|454479913|FG001|Overall Study|Physician Decision|0|||
126323996|NCT02223364|454479914|FG002|Overall Study|Physician Decision|0|||
126323997|NCT00793546|454479915|FG000|Overall Study|Death|3|||
126323998|NCT00793546|454479916|FG001|Overall Study|Death|0|||
126323999|NCT00793546|454479915|FG000|Overall Study|Lost to Follow-up|1|||
126324000|NCT00793546|454479916|FG001|Overall Study|Lost to Follow-up|0|||
126324001|NCT00793546|454479915|FG000|Overall Study|Withdrawal by Subject|1|||
126324002|NCT00793546|454479916|FG001|Overall Study|Withdrawal by Subject|1|||
126324003|NCT00793546|454479915|FG000|Overall Study|Study Terminated by Sponsor|8|||
126324004|NCT00793546|454479916|FG001|Overall Study|Study Terminated by Sponsor|27|||
126324005|NCT00793546|454479915|FG000|Overall Study|Other|1|||
126324006|NCT00793546|454479916|FG001|Overall Study|Other|0|||
126324007|NCT01841567|454479917|FG000|Overall Study|Adverse Event|3|||
126324008|NCT01416155|454479918|FG000|Overall Study|Adverse Event|8|||
126324009|NCT01416155|454479918|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
126324010|NCT01416155|454479918|FG000|Overall Study|Withdrawal by Subject|33|||
126324011|NCT01416155|454479918|FG000|Overall Study|Investigator decision|8|||
126324012|NCT01416155|454479918|FG000|Overall Study|Other|7|||
126324013|NCT02984267|454479923|FG000|Overall Study|Protocol Violation|1|||
126324014|NCT02984267|454479924|FG001|Overall Study|Protocol Violation|0|||
126324015|NCT02984267|454479923|FG000|Overall Study|Withdrawal by Subject|0|||
126324016|NCT02984267|454479924|FG001|Overall Study|Withdrawal by Subject|1|||
126324017|NCT00742027|454479925|FG000|Overall Study|Disease Progression|76|||
126324018|NCT00742027|454479925|FG000|Overall Study|New Cancer Therapy|19|||
126324019|NCT00742027|454479925|FG000|Overall Study|Withdrawal by Subject|18|||
126324020|NCT00742027|454479925|FG000|Overall Study|Death|7|||
126324021|NCT00742027|454479925|FG000|Overall Study|Lost to Follow-up|4|||
126324022|NCT00742027|454479925|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
126324023|NCT00742027|454479925|FG000|Overall Study|Missing|2|||
126324024|NCT00742027|454479925|FG000|Overall Study|Administrative Problems|1|||
126324025|NCT01249833|454479928|FG000|Overall Study|Lost to Follow-up|0|||
126324026|NCT01249833|454479929|FG001|Overall Study|Lost to Follow-up|1|||
126324027|NCT03796676|454479930|FG000|Overall Study|Adverse Event|2|||
126324028|NCT03796676|454479931|FG001|Overall Study|Adverse Event|1|||
126324029|NCT03796676|454479932|FG002|Overall Study|Adverse Event|2|||
126324030|NCT03796676|454479930|FG000|Overall Study|Lost to Follow-up|2|||
126324031|NCT03796676|454479931|FG001|Overall Study|Lost to Follow-up|1|||
126324032|NCT03796676|454479932|FG002|Overall Study|Lost to Follow-up|0|||
126324033|NCT03796676|454479930|FG000|Overall Study|Protocol Violation|0|||
126324034|NCT03796676|454479931|FG001|Overall Study|Protocol Violation|0|||
126652825|NCT00091169|455686387|FG001|Overall Study|Withdrawal by Subject|13|||
126652826|NCT00091169|455686386|FG000|Overall Study|Other|3|||
126652827|NCT00091169|455686387|FG001|Overall Study|Other|4|||
126652828|NCT00091169|455686386|FG000|Overall Study|Not start protocol therapy|26|||
126652829|NCT00091169|455686387|FG001|Overall Study|Not start protocol therapy|17|||
126652830|NCT00872989|455686388|FG000|Overall Study|Adverse Event|7|||
126652831|NCT00872989|455686389|FG001|Overall Study|Adverse Event|15|||
126652832|NCT00872989|455686388|FG000|Overall Study|Withdrawal by Subject|8|||
126324035|NCT03796676|454479932|FG002|Overall Study|Protocol Violation|1|||
126324036|NCT03796676|454479930|FG000|Overall Study|Withdrawal by Subject|1|||
126324037|NCT03796676|454479931|FG001|Overall Study|Withdrawal by Subject|1|||
126324038|NCT03796676|454479932|FG002|Overall Study|Withdrawal by Subject|0|||
126324039|NCT03796676|454479930|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
126324040|NCT03796676|454479931|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
126324041|NCT03796676|454479932|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
126324042|NCT02442206|454481998|FG000|Period 1|Adverse Event|1|||
126324043|NCT02442206|454481999|FG001|Period 1|Adverse Event|1|||
126652833|NCT00872989|455686389|FG001|Overall Study|Withdrawal by Subject|5|||
126324044|NCT02442206|454481998|FG000|Period 1|withdrew consent|0|||
126324045|NCT02442206|454481999|FG001|Period 1|withdrew consent|1|||
126324046|NCT02442206|454481998|FG000|Period 1|COPD exacerbation|0|||
126652834|NCT00872989|455686388|FG000|Overall Study|Progression/relapse|47|||
126324047|NCT02442206|454481999|FG001|Period 1|COPD exacerbation|1|||
126324048|NCT02442206|454481998|FG000|Period 2|Adverse Event|1|||
126324049|NCT02442206|454481999|FG001|Period 2|Adverse Event|0|||
126324050|NCT00497146|454482000|FG000|Treatment Period|Adverse Event|6|||
126324051|NCT00497146|454482001|FG001|Treatment Period|Adverse Event|2|||
126324052|NCT00497146|454482000|FG000|Treatment Period|Withdrawal by Subject|5|||
126324053|NCT00497146|454482001|FG001|Treatment Period|Withdrawal by Subject|9|||
126324054|NCT00497146|454482000|FG000|Treatment Period|Lost to Follow-up|1|||
126324055|NCT00497146|454482001|FG001|Treatment Period|Lost to Follow-up|3|||
126324056|NCT00497146|454482000|FG000|Treatment Period|Required dialysis|4|||
126324057|NCT00497146|454482001|FG001|Treatment Period|Required dialysis|1|||
126324058|NCT00497146|454482000|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
126324059|NCT00497146|454482001|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
126324060|NCT00497146|454482000|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
126324061|NCT00497146|454482001|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
126324062|NCT00497146|454482000|FG000|Treatment Period|Other Reason|2|||
126324063|NCT00497146|454482001|FG001|Treatment Period|Other Reason|3|||
126324064|NCT00497146|454482000|FG000|Long-term Follow-up Period|Adverse Event|2|||
126324065|NCT00497146|454482001|FG001|Long-term Follow-up Period|Adverse Event|2|||
126324066|NCT00497146|454482000|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
126324067|NCT00497146|454482001|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
126324068|NCT00497146|454482000|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
126324069|NCT00497146|454482001|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
126324070|NCT00497146|454482000|FG000|Long-term Follow-up Period|Other|0|||
126324071|NCT00497146|454482001|FG001|Long-term Follow-up Period|Other|1|||
126324072|NCT01471444|454482002|FG000|Overall Study|Physician Decision|3|||
126324073|NCT01471444|454482003|FG001|Overall Study|Physician Decision|2|||
126324074|NCT01471444|454482002|FG000|Overall Study|Withdrawal by Subject|0|||
126324075|NCT01471444|454482003|FG001|Overall Study|Withdrawal by Subject|1|||
126324076|NCT02155309|454482004|FG000|Overall Study|Protocol Violation|0|||
126324077|NCT02155309|454482005|FG001|Overall Study|Protocol Violation|0|||
126324078|NCT02155309|454482006|FG002|Overall Study|Protocol Violation|1|||
126324079|NCT00662311|454482007|FG000|Overall Study|Respiratory Infection|1|||
126324080|NCT00662311|454482008|FG001|Overall Study|Respiratory Infection|0|||
126324081|NCT00662311|454482009|FG002|Overall Study|Respiratory Infection|0|||
126324082|NCT01467271|454482010|FG000|Overall Study|Death|84|||
126324083|NCT01467271|454482010|FG000|Overall Study|Lost to Follow-up|83|||
126324084|NCT01467271|454482010|FG000|Overall Study|Retraction of patient's consent|21|||
126324085|NCT01467271|454482010|FG000|Overall Study|Other reason|14|||
126324086|NCT01548768|454482011|FG000|Overall Study|Withdrawal by Subject|0|||
126324087|NCT01548768|454482012|FG001|Overall Study|Withdrawal by Subject|2|||
126324088|NCT01548768|454482013|FG002|Overall Study|Withdrawal by Subject|1|||
126324089|NCT01548768|454482014|FG003|Overall Study|Withdrawal by Subject|0|||
126652835|NCT00872989|455686389|FG001|Overall Study|Progression/relapse|35|||
126652836|NCT00872989|455686388|FG000|Overall Study|Not protocol specified|3|||
126652837|NCT00872989|455686389|FG001|Overall Study|Not protocol specified|8|||
126652838|NCT02407990|455686390|FG000|Overall Study|Death|2|||
126652839|NCT02407990|455686391|FG001|Overall Study|Death|22|||
126652840|NCT02407990|455686392|FG002|Overall Study|Death|23|||
126652841|NCT02407990|455686393|FG003|Overall Study|Death|7|||
126652842|NCT02407990|455686394|FG004|Overall Study|Death|17|||
126652843|NCT02407990|455686395|FG005|Overall Study|Death|16|||
126652844|NCT02407990|455686396|FG006|Overall Study|Death|10|||
126652845|NCT02407990|455686397|FG007|Overall Study|Death|248|||
126652846|NCT02407990|455686390|FG000|Overall Study|Lost to Follow-up|0|||
126652847|NCT02407990|455686391|FG001|Overall Study|Lost to Follow-up|1|||
126652848|NCT02407990|455686392|FG002|Overall Study|Lost to Follow-up|0|||
126652849|NCT02407990|455686393|FG003|Overall Study|Lost to Follow-up|0|||
126652850|NCT02407990|455686394|FG004|Overall Study|Lost to Follow-up|0|||
126652851|NCT02407990|455686395|FG005|Overall Study|Lost to Follow-up|0|||
126652852|NCT02407990|455686396|FG006|Overall Study|Lost to Follow-up|0|||
126652853|NCT02407990|455686397|FG007|Overall Study|Lost to Follow-up|17|||
126652854|NCT02407990|455686390|FG000|Overall Study|Progressive Disease|0|||
126652855|NCT02407990|455686391|FG001|Overall Study|Progressive Disease|0|||
126324090|NCT01548768|454482011|FG000|Overall Study|Physician Decision|1|||
126324091|NCT01548768|454482012|FG001|Overall Study|Physician Decision|0|||
126324092|NCT01548768|454482013|FG002|Overall Study|Physician Decision|0|||
126324093|NCT01548768|454482014|FG003|Overall Study|Physician Decision|0|||
126652856|NCT02407990|455686392|FG002|Overall Study|Progressive Disease|0|||
126324094|NCT01548768|454482011|FG000|Overall Study|Adverse Event|0|||
126324095|NCT01548768|454482012|FG001|Overall Study|Adverse Event|0|||
126652857|NCT02407990|455686393|FG003|Overall Study|Progressive Disease|0|||
126652858|NCT02407990|455686394|FG004|Overall Study|Progressive Disease|0|||
126652859|NCT02407990|455686395|FG005|Overall Study|Progressive Disease|0|||
126652860|NCT02407990|455686396|FG006|Overall Study|Progressive Disease|0|||
126652861|NCT02407990|455686397|FG007|Overall Study|Progressive Disease|1|||
126652862|NCT02407990|455686390|FG000|Overall Study|Withdrawal by Subject|0|||
126652863|NCT02407990|455686391|FG001|Overall Study|Withdrawal by Subject|0|||
126652864|NCT02407990|455686392|FG002|Overall Study|Withdrawal by Subject|0|||
126652865|NCT02407990|455686393|FG003|Overall Study|Withdrawal by Subject|0|||
126652866|NCT02407990|455686394|FG004|Overall Study|Withdrawal by Subject|1|||
126652867|NCT02407990|455686395|FG005|Overall Study|Withdrawal by Subject|0|||
126652868|NCT02407990|455686396|FG006|Overall Study|Withdrawal by Subject|0|||
126652869|NCT02407990|455686397|FG007|Overall Study|Withdrawal by Subject|30|||
126652870|NCT02407990|455686390|FG000|Overall Study|Study Terminated by Sponsor|1|||
126652871|NCT02407990|455686391|FG001|Overall Study|Study Terminated by Sponsor|3|||
126652872|NCT02407990|455686392|FG002|Overall Study|Study Terminated by Sponsor|3|||
126652873|NCT02407990|455686393|FG003|Overall Study|Study Terminated by Sponsor|0|||
126652874|NCT02407990|455686394|FG004|Overall Study|Study Terminated by Sponsor|3|||
126652875|NCT02407990|455686395|FG005|Overall Study|Study Terminated by Sponsor|4|||
126652876|NCT02407990|455686396|FG006|Overall Study|Study Terminated by Sponsor|3|||
126652877|NCT02407990|455686397|FG007|Overall Study|Study Terminated by Sponsor|37|||
126652878|NCT02407990|455686390|FG000|Overall Study|Logistics|0|||
126652879|NCT02407990|455686391|FG001|Overall Study|Logistics|0|||
126652880|NCT02407990|455686392|FG002|Overall Study|Logistics|0|||
126652881|NCT02407990|455686393|FG003|Overall Study|Logistics|0|||
126652882|NCT02407990|455686394|FG004|Overall Study|Logistics|0|||
126652883|NCT02407990|455686395|FG005|Overall Study|Logistics|0|||
126652884|NCT02407990|455686396|FG006|Overall Study|Logistics|0|||
126652885|NCT02407990|455686397|FG007|Overall Study|Logistics|1|||
126652886|NCT02407990|455686390|FG000|Overall Study|Rolled into long-term extension study|0|||
126652887|NCT02407990|455686391|FG001|Overall Study|Rolled into long-term extension study|0|||
126652888|NCT02407990|455686392|FG002|Overall Study|Rolled into long-term extension study|0|||
126652889|NCT02407990|455686393|FG003|Overall Study|Rolled into long-term extension study|0|||
126652890|NCT02407990|455686394|FG004|Overall Study|Rolled into long-term extension study|0|||
126652891|NCT02407990|455686395|FG005|Overall Study|Rolled into long-term extension study|0|||
126652892|NCT02407990|455686396|FG006|Overall Study|Rolled into long-term extension study|0|||
126652893|NCT02407990|455686397|FG007|Overall Study|Rolled into long-term extension study|1|||
126652894|NCT00734097|455686398|FG000|Screening|Protocol Violation|12|||
126652895|NCT00734097|455686398|FG000|Screening|Withdrawal by Subject|5|||
126652896|NCT00734097|455686398|FG000|Screening|Lost to Follow-up|2|||
126652897|NCT00734097|455686398|FG000|Screening|Unconfirmed pregnancy|1|||
126652898|NCT00734097|455686398|FG000|Open Label|Lost to Follow-up|7|||
126652899|NCT00734097|455686398|FG000|Open Label|Withdrawal by Subject|5|||
126652900|NCT00734097|455686398|FG000|Open Label|Protocol Violation|4|||
126652901|NCT01227577|455686405|FG000|Overall Study|Protocol deviation|3|||
126652902|NCT01227577|455686405|FG000|Overall Study|Death|3|||
126652903|NCT01227577|455686405|FG000|Overall Study|Administrative problems|2|||
126652904|NCT01227577|455686405|FG000|Overall Study|Lost to Follow-up|1|||
126652905|NCT01227577|455686405|FG000|Overall Study|Withdrawal by Subject|4|||
126652906|NCT01227577|455686405|FG000|Overall Study|Lack of Efficacy|5|||
126652907|NCT01227577|455686405|FG000|Overall Study|Adverse Event|17|||
126652908|NCT00852540|455686406|FG000|Overall Study|Adverse Event|10|||
126652909|NCT00852540|455686407|FG001|Overall Study|Adverse Event|3|||
126652910|NCT00852540|455686406|FG000|Overall Study|Lack of Efficacy|15|||
126652911|NCT00852540|455686407|FG001|Overall Study|Lack of Efficacy|3|||
126652912|NCT00852540|455686406|FG000|Overall Study|Protocol Violation|1|||
126652913|NCT00852540|455686407|FG001|Overall Study|Protocol Violation|2|||
126652914|NCT00852540|455686406|FG000|Overall Study|Lost to Follow-up|2|||
126652915|NCT00852540|455686407|FG001|Overall Study|Lost to Follow-up|3|||
126652916|NCT00852540|455686406|FG000|Overall Study|Investigator Discretion|2|||
126652917|NCT00852540|455686407|FG001|Overall Study|Investigator Discretion|3|||
126652918|NCT00852540|455686406|FG000|Overall Study|Withdrawal by Subject|3|||
126652919|NCT00852540|455686407|FG001|Overall Study|Withdrawal by Subject|1|||
126652920|NCT00852540|455686406|FG000|Overall Study|Did Not Receive Study Drug|3|||
126652921|NCT00852540|455686407|FG001|Overall Study|Did Not Receive Study Drug|3|||
126652922|NCT01639495|455686408|FG000|Overall Study|Lost to Follow-up|6|||
126652923|NCT01639495|455686408|FG000|Overall Study|Consented but didn't have study catheter|4|||
126652924|NCT01639495|455686408|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
126652925|NCT01639495|455686408|FG000|Overall Study|No radiofrequency energy applied|2|||
126652926|NCT01183234|455686409|FG000|First Intervention|Adverse Event|1|||
126652927|NCT01183234|455686410|FG001|First Intervention|Adverse Event|0|||
126652928|NCT03292432|455686415|FG000|Overall Study|Lost to Follow-up|11|||
126652929|NCT03292432|455686416|FG001|Overall Study|Lost to Follow-up|8|||
126652930|NCT03292432|455686415|FG000|Overall Study|Death|2|||
126652931|NCT03292432|455686416|FG001|Overall Study|Death|1|||
126652932|NCT03292432|455686415|FG000|Overall Study|Withdrawal by Subject|1|||
126652933|NCT03292432|455686416|FG001|Overall Study|Withdrawal by Subject|2|||
126652934|NCT03292432|455686415|FG000|Overall Study|Site closed before any data collected|1|||
126652935|NCT03292432|455686416|FG001|Overall Study|Site closed before any data collected|0|||
126652936|NCT00495586|455686421|FG000|Overall Study|Withdrawal by Subject|4|||
126652937|NCT00495586|455686422|FG001|Overall Study|Withdrawal by Subject|4|||
126652938|NCT02038543|455686423|FG000|Overall Study|Screen Failure|0|||
126652939|NCT02038543|455686424|FG001|Overall Study|Screen Failure|0|||
126652940|NCT02038543|455686425|FG002|Overall Study|Screen Failure|0|||
126652941|NCT02038543|455686426|FG003|Overall Study|Screen Failure|1|||
126652942|NCT02038543|455686423|FG000|Overall Study|Withdrawal by Subject|0|||
126652943|NCT02038543|455686424|FG001|Overall Study|Withdrawal by Subject|0|||
126652944|NCT02038543|455686425|FG002|Overall Study|Withdrawal by Subject|0|||
126652945|NCT02038543|455686426|FG003|Overall Study|Withdrawal by Subject|1|||
126652946|NCT00158860|455686427|FG000|Overall Study|Adverse Event|3|||
126652947|NCT00158860|455686428|FG001|Overall Study|Adverse Event|6|||
126652948|NCT00158860|455686427|FG000|Overall Study|Lost to Follow-up|11|||
126652949|NCT00158860|455686428|FG001|Overall Study|Lost to Follow-up|17|||
126652950|NCT00158860|455686427|FG000|Overall Study|Protocol Violation|8|||
126652951|NCT00158860|455686428|FG001|Overall Study|Protocol Violation|23|||
126652952|NCT00158860|455686427|FG000|Overall Study|Withdrawal by Subject|7|||
126652953|NCT00158860|455686428|FG001|Overall Study|Withdrawal by Subject|17|||
126652954|NCT00158860|455686427|FG000|Overall Study|MOVING OUT OF STATE|1|||
126652955|NCT00158860|455686428|FG001|Overall Study|MOVING OUT OF STATE|0|||
126652956|NCT00158860|455686427|FG000|Overall Study|Pregnancy|3|||
126652957|NCT00158860|455686428|FG001|Overall Study|Pregnancy|3|||
126652958|NCT00158860|455686427|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
126652959|NCT00158860|455686428|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
126652960|NCT00158860|455686427|FG000|Overall Study|SPONSOR REQUEST|0|||
126652961|NCT00158860|455686428|FG001|Overall Study|SPONSOR REQUEST|1|||
126652962|NCT00158860|455686427|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
126652963|NCT00158860|455686428|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
126652964|NCT00158860|455686427|FG000|Overall Study|Closed per sponsor|0|||
126652965|NCT00158860|455686428|FG001|Overall Study|Closed per sponsor|1|||
126652966|NCT01029652|455686429|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
126652967|NCT01029652|455686430|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
126652968|NCT01029652|455686429|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
126652969|NCT01029652|455686430|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
126652970|NCT01029652|455686429|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
126652971|NCT01029652|455686430|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
126324096|NCT01548768|454482013|FG002|Overall Study|Adverse Event|0|||
126324097|NCT01548768|454482014|FG003|Overall Study|Adverse Event|1|||
126324098|NCT01548768|454482011|FG000|Overall Study|Non-Compliance|0|||
126324099|NCT01548768|454482012|FG001|Overall Study|Non-Compliance|0|||
126324100|NCT01548768|454482013|FG002|Overall Study|Non-Compliance|0|||
126652972|NCT01029652|455686429|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
126652973|NCT01029652|455686430|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
126652974|NCT01029652|455686429|FG000|Core Study (0-12 Weeks)|Death|0|||
126652975|NCT01029652|455686430|FG001|Core Study (0-12 Weeks)|Death|1|||
126652976|NCT01029652|455686429|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
126652977|NCT01029652|455686430|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
126652978|NCT01029652|455686429|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
126652979|NCT01029652|455686430|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
126652980|NCT01029652|455686429|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
126652981|NCT01029652|455686430|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
126652982|NCT01029652|455686429|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
126652983|NCT01029652|455686430|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
126652984|NCT01029652|455686429|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
126652985|NCT01029652|455686430|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
126652986|NCT01029652|455686429|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
126652987|NCT01029652|455686430|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
126652988|NCT01029652|455686429|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
126652989|NCT01029652|455686430|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
126652990|NCT02095951|455686431|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
126652991|NCT02095951|455686432|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
126652992|NCT00964886|455686433|FG000|Overall Study|Lost to Follow-up|2|||
126652993|NCT00964886|455686434|FG001|Overall Study|Lost to Follow-up|2|||
126652994|NCT00964886|455686435|FG002|Overall Study|Lost to Follow-up|6|||
126652995|NCT00964886|455686436|FG003|Overall Study|Lost to Follow-up|4|||
126652996|NCT00964886|455686433|FG000|Overall Study|Withdrawal by Subject|6|||
126652997|NCT00964886|455686434|FG001|Overall Study|Withdrawal by Subject|2|||
126652998|NCT00964886|455686435|FG002|Overall Study|Withdrawal by Subject|5|||
126652999|NCT00964886|455686436|FG003|Overall Study|Withdrawal by Subject|3|||
126653000|NCT00964886|455686433|FG000|Overall Study|Adverse Event|3|||
126653001|NCT00964886|455686434|FG001|Overall Study|Adverse Event|1|||
126653002|NCT00964886|455686435|FG002|Overall Study|Adverse Event|5|||
126653003|NCT00964886|455686436|FG003|Overall Study|Adverse Event|2|||
126653004|NCT00964886|455686433|FG000|Overall Study|Protocol Violation|0|||
126653005|NCT00964886|455686434|FG001|Overall Study|Protocol Violation|2|||
126653006|NCT00964886|455686435|FG002|Overall Study|Protocol Violation|0|||
126324101|NCT01548768|454482014|FG003|Overall Study|Non-Compliance|3|||
126324102|NCT03084302|454482015|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
126324103|NCT03084302|454482015|FG000|Overall Study|No valid objective monitor data|6|||
126324104|NCT00929994|454482016|FG000|Overall Study|Withdrawal by Subject|1|||
126324105|NCT00929994|454482016|FG000|Overall Study|medical issue unrelated to intervention|4|||
126324106|NCT00929994|454482016|FG000|Overall Study|employment|1|||
126324107|NCT01214668|454482017|FG000|Overall Study|Adverse Event|0|||
126324108|NCT01214668|454482018|FG001|Overall Study|Adverse Event|1|||
126324109|NCT01214668|454482019|FG002|Overall Study|Adverse Event|0|||
126324110|NCT01214668|454482020|FG003|Overall Study|Adverse Event|2|||
126324111|NCT01214668|454482021|FG004|Overall Study|Adverse Event|1|||
126324112|NCT01214668|454482022|FG005|Overall Study|Adverse Event|1|||
126324113|NCT01214668|454482017|FG000|Overall Study|Death|0|||
126324114|NCT01214668|454482018|FG001|Overall Study|Death|0|||
126324115|NCT01214668|454482019|FG002|Overall Study|Death|1|||
126324116|NCT01214668|454482020|FG003|Overall Study|Death|0|||
126324117|NCT01214668|454482021|FG004|Overall Study|Death|0|||
126324118|NCT01214668|454482022|FG005|Overall Study|Death|0|||
126324119|NCT01214668|454482017|FG000|Overall Study|Progressive Disease|4|||
126324120|NCT01214668|454482018|FG001|Overall Study|Progressive Disease|2|||
126324121|NCT01214668|454482019|FG002|Overall Study|Progressive Disease|5|||
126324122|NCT01214668|454482020|FG003|Overall Study|Progressive Disease|4|||
126324123|NCT01214668|454482021|FG004|Overall Study|Progressive Disease|4|||
126324124|NCT01214668|454482022|FG005|Overall Study|Progressive Disease|5|||
126324125|NCT01214668|454482017|FG000|Overall Study|Withdrawal by Subject|0|||
126324126|NCT01214668|454482018|FG001|Overall Study|Withdrawal by Subject|0|||
126324127|NCT01214668|454482019|FG002|Overall Study|Withdrawal by Subject|0|||
126324128|NCT01214668|454482020|FG003|Overall Study|Withdrawal by Subject|0|||
126324129|NCT01214668|454482021|FG004|Overall Study|Withdrawal by Subject|1|||
126324130|NCT01214668|454482022|FG005|Overall Study|Withdrawal by Subject|0|||
126324131|NCT01964989|454482023|FG000|Overall Study|Protocol Violation|3|||
126324132|NCT01964989|454482024|FG001|Overall Study|Protocol Violation|4|||
126324133|NCT01964989|454482023|FG000|Overall Study|Administrative Reason|103|||
126324134|NCT01964989|454482024|FG001|Overall Study|Administrative Reason|95|||
126324135|NCT01964989|454482023|FG000|Overall Study|Adverse Event|0|||
126324136|NCT01964989|454482024|FG001|Overall Study|Adverse Event|1|||
126324137|NCT01964989|454482023|FG000|Overall Study|Death|1|||
126324138|NCT01964989|454482024|FG001|Overall Study|Death|3|||
126324139|NCT01964989|454482023|FG000|Overall Study|Withdrawal by Subject|156|||
126324140|NCT01964989|454482024|FG001|Overall Study|Withdrawal by Subject|160|||
126324141|NCT01964989|454482023|FG000|Overall Study|Lost to Follow-up|254|||
126324142|NCT01964989|454482024|FG001|Overall Study|Lost to Follow-up|232|||
126324143|NCT01964989|454482023|FG000|Overall Study|Other|267|||
126324144|NCT01964989|454482024|FG001|Overall Study|Other|252|||
126324145|NCT00424593|454482025|FG000|Acute Double-Blind Period|Adverse Event|16|||
126324146|NCT00424593|454482026|FG001|Acute Double-Blind Period|Adverse Event|7|||
126324147|NCT00424593|454482025|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
126324148|NCT00424593|454482026|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
126324149|NCT00424593|454482025|FG000|Acute Double-Blind Period|Protocol Violation|2|||
126324150|NCT00424593|454482026|FG001|Acute Double-Blind Period|Protocol Violation|2|||
126324151|NCT00424593|454482025|FG000|Acute Double-Blind Period|Physician Decision|1|||
126324152|NCT00424593|454482026|FG001|Acute Double-Blind Period|Physician Decision|2|||
126324153|NCT00424593|454482025|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
126324154|NCT00424593|454482026|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
126324155|NCT00424593|454482025|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
126324156|NCT00424593|454482026|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
126324157|NCT00424593|454482025|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
126324158|NCT00424593|454482026|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
126324159|NCT00424593|454482025|FG000|Dose-Blind Extension Period|Adverse Event|18|||
126324160|NCT00424593|454482026|FG001|Dose-Blind Extension Period|Adverse Event|0|||
126324161|NCT00424593|454482025|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
126324162|NCT00424593|454482026|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
126324163|NCT00424593|454482025|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
126324164|NCT00424593|454482026|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
126324165|NCT00424593|454482025|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
126324166|NCT00424593|454482026|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
126653007|NCT00964886|455686436|FG003|Overall Study|Protocol Violation|0|||
126653008|NCT02334423|455686439|FG000|Overall Study|Protocol Violation|10|||
126653009|NCT02334423|455686440|FG001|Overall Study|Protocol Violation|3|||
126653010|NCT02930226|455686441|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
126324167|NCT00424593|454482025|FG000|Dose-Blind Extension Period|Physician Decision|3|||
126324168|NCT00424593|454482026|FG001|Dose-Blind Extension Period|Physician Decision|0|||
126324169|NCT01796301|454482027|FG000|Overall Study|Withdrawal by Subject|15|||
126324170|NCT01796301|454482028|FG001|Overall Study|Withdrawal by Subject|15|||
126324171|NCT01796301|454482027|FG000|Overall Study|Lost to Follow-up|3|||
126324172|NCT01796301|454482028|FG001|Overall Study|Lost to Follow-up|3|||
126324173|NCT01796301|454482027|FG000|Overall Study|Death|0|||
126653011|NCT02930226|455686442|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
126653012|NCT02930226|455686443|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
126653013|NCT02930226|455686444|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
126653014|NCT02930226|455686445|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
126653015|NCT02930226|455686446|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
126324174|NCT01796301|454482028|FG001|Overall Study|Death|1|||
126324175|NCT01796301|454482027|FG000|Overall Study|Decision by Sponsor|0|||
126324176|NCT01796301|454482028|FG001|Overall Study|Decision by Sponsor|1|||
126324177|NCT00667563|454482029|FG000|Overall Study|Protocol Violation|24|||
126324178|NCT00790556|454482030|FG000|Treatment Period 1|Physician Decision|1|||
126324179|NCT00790556|454482031|FG001|Treatment Period 1|Physician Decision|0|||
126324180|NCT00790556|454482030|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126324181|NCT00790556|454482031|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126324182|NCT00217581|454482034|FG000|Overall Study|Withdrawal by Subject|1|||
126324183|NCT04399889|454482035|FG000|Overall Study|Death|5|||
126324184|NCT04399889|454482036|FG001|Overall Study|Death|1|||
126324185|NCT04399889|454482037|FG002|Overall Study|Death|1|||
126324186|NCT01005901|454482042|FG000|Overall Study|Withdrawal by Subject|38|||
126324187|NCT01005901|454482043|FG001|Overall Study|Withdrawal by Subject|14|||
126324188|NCT01005901|454482042|FG000|Overall Study|Adverse Event|30|||
126324189|NCT01005901|454482043|FG001|Overall Study|Adverse Event|16|||
126324190|NCT01005901|454482042|FG000|Overall Study|Administrative problems|21|||
126324191|NCT01005901|454482043|FG001|Overall Study|Administrative problems|13|||
126324192|NCT01005901|454482042|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
126324193|NCT01005901|454482043|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
126324194|NCT01005901|454482042|FG000|Overall Study|Protocol Violation|4|||
126324195|NCT01005901|454482043|FG001|Overall Study|Protocol Violation|3|||
126324196|NCT01005901|454482042|FG000|Overall Study|Death|2|||
126324197|NCT01005901|454482043|FG001|Overall Study|Death|3|||
126324198|NCT01005901|454482042|FG000|Overall Study|Lost to Follow-up|1|||
126324199|NCT01005901|454482043|FG001|Overall Study|Lost to Follow-up|2|||
126324200|NCT01005901|454482042|FG000|Overall Study|Patient's inability to use the device|1|||
126324201|NCT01005901|454482043|FG001|Overall Study|Patient's inability to use the device|1|||
126324202|NCT01005901|454482042|FG000|Overall Study|No longer requires study drug|0|||
126324203|NCT01005901|454482043|FG001|Overall Study|No longer requires study drug|1|||
126324204|NCT00760487|454482044|FG000|Overall Study|Unilateral implantation|3|||
126324205|NCT06360588|454482045|FG000|Overall Study|Adverse Event|3|||
126324206|NCT06360588|454482045|FG000|Overall Study|Death|2|||
126324207|NCT06360588|454482045|FG000|Overall Study|Disease Progression|14|||
126324208|NCT06360588|454482045|FG000|Overall Study|Withdrawal by Subject|1|||
126324209|NCT06360588|454482045|FG000|Overall Study|Lack of Efficacy|1|||
126324210|NCT06360588|454482045|FG000|Overall Study|Ineligible|1|||
126324211|NCT02087943|454482046|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
126324212|NCT02087943|454482047|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
126324213|NCT02087943|454482048|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
126324214|NCT02087943|454482049|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
126324215|NCT02087943|454482050|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
126324216|NCT02087943|454482046|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
126324217|NCT02087943|454482047|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
126324218|NCT02087943|454482048|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
126324219|NCT02087943|454482049|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
126324220|NCT02087943|454482050|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
126324221|NCT02087943|454482046|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
126324222|NCT02087943|454482047|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
126324223|NCT02087943|454482048|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
126324224|NCT02087943|454482049|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
126324225|NCT02087943|454482050|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
126324226|NCT02087943|454482046|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
126324227|NCT02087943|454482047|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
126324228|NCT02087943|454482048|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
126324229|NCT02087943|454482049|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
126324230|NCT02087943|454482050|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
126653016|NCT00652327|455686447|FG000|Overall Study|Adverse Event|0|||
126324231|NCT02087943|454482046|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
126324232|NCT02087943|454482047|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
126324233|NCT02087943|454482048|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
126324234|NCT02087943|454482049|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
126324235|NCT02087943|454482050|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
126324236|NCT02087943|454482046|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
126324237|NCT02087943|454482047|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
126324238|NCT02087943|454482048|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
126324239|NCT02087943|454482049|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
126324240|NCT02087943|454482050|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
126324241|NCT02087943|454482046|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
126324242|NCT02087943|454482047|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
126324243|NCT02087943|454482048|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
126324244|NCT02087943|454482049|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
126324245|NCT02087943|454482050|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
126324246|NCT02087943|454482046|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
126324247|NCT02087943|454482047|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
126324248|NCT02087943|454482048|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
126324249|NCT02087943|454482049|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
126324250|NCT02087943|454482050|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
126324251|NCT02087943|454482046|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
126324252|NCT02087943|454482047|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
126324253|NCT02087943|454482048|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
126324254|NCT02087943|454482049|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
126324255|NCT02087943|454482050|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
126324256|NCT02087943|454482046|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
126653017|NCT00652327|455686448|FG001|Overall Study|Adverse Event|2|||
126653018|NCT00652327|455686447|FG000|Overall Study|Lost to Follow-up|0|||
126653019|NCT00652327|455686448|FG001|Overall Study|Lost to Follow-up|3|||
126653020|NCT01076647|455686449|FG000|Overall Study|Adverse Event|4|||
126653021|NCT01076647|455686450|FG001|Overall Study|Adverse Event|1|||
126653022|NCT01076647|455686449|FG000|Overall Study|Lack of Efficacy|0|||
126653023|NCT01076647|455686450|FG001|Overall Study|Lack of Efficacy|1|||
126653024|NCT01076647|455686449|FG000|Overall Study|Protocol Violation|7|||
126653025|NCT01076647|455686450|FG001|Overall Study|Protocol Violation|9|||
126653026|NCT01076647|455686449|FG000|Overall Study|Withdrawal criteria|2|||
126653027|NCT01076647|455686450|FG001|Overall Study|Withdrawal criteria|2|||
126653028|NCT01076647|455686449|FG000|Overall Study|Unclassified|12|||
126653029|NCT01076647|455686450|FG001|Overall Study|Unclassified|12|||
126653030|NCT02224690|455686457|FG000|Overall Study|Adverse Event|8|||
126653031|NCT02224690|455686458|FG001|Overall Study|Adverse Event|1|||
126653032|NCT02224690|455686457|FG000|Overall Study|Met Withdrawal Criteria|4|||
126653033|NCT02224690|455686458|FG001|Overall Study|Met Withdrawal Criteria|0|||
126653034|NCT02224690|455686457|FG000|Overall Study|Use of G-tube|1|||
126653035|NCT02224690|455686458|FG001|Overall Study|Use of G-tube|0|||
126653036|NCT02224690|455686457|FG000|Overall Study|Did not meet eligibility criteria|1|||
126653037|NCT02224690|455686458|FG001|Overall Study|Did not meet eligibility criteria|0|||
126653038|NCT00141219|455686459|FG000|Overall Study|Protocol violations|5|||
126653039|NCT00141219|455686460|FG001|Overall Study|Protocol violations|4|||
126653040|NCT00141219|455686459|FG000|Overall Study|Adverse Event|8|||
126653041|NCT00141219|455686460|FG001|Overall Study|Adverse Event|6|||
126653042|NCT00141219|455686459|FG000|Overall Study|Lack of Efficacy|5|||
126653043|NCT00141219|455686460|FG001|Overall Study|Lack of Efficacy|4|||
126653044|NCT00141219|455686459|FG000|Overall Study|Withdrawal by Subject|6|||
126653045|NCT00141219|455686460|FG001|Overall Study|Withdrawal by Subject|2|||
126653046|NCT01506609|455686462|FG000|Overall Study|Adverse Event Related to Progression|0|||
126653047|NCT01506609|455686463|FG001|Overall Study|Adverse Event Related to Progression|0|||
126653048|NCT01506609|455686464|FG002|Overall Study|Adverse Event Related to Progression|0|||
126653049|NCT01506609|455686465|FG003|Overall Study|Adverse Event Related to Progression|3|||
126653050|NCT01506609|455686466|FG004|Overall Study|Adverse Event Related to Progression|7|||
126653051|NCT01506609|455686467|FG005|Overall Study|Adverse Event Related to Progression|3|||
126653052|NCT01506609|455686462|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
126653053|NCT01506609|455686463|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
126653054|NCT01506609|455686464|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
126653055|NCT01506609|455686465|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
126653056|NCT01506609|455686466|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
126653057|NCT01506609|455686467|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
126324257|NCT02087943|454482047|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
126324258|NCT02087943|454482048|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
126324259|NCT02087943|454482049|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
126324260|NCT02087943|454482050|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
126324261|NCT03836209|454482052|FG000|Overall Study|Adverse Event|5|||
126653058|NCT01506609|455686462|FG000|Overall Study|Withdrawal by Subject|0|||
126653059|NCT01506609|455686463|FG001|Overall Study|Withdrawal by Subject|0|||
126324262|NCT03836209|454482053|FG001|Overall Study|Adverse Event|2|||
126324263|NCT03836209|454482052|FG000|Overall Study|Death|4|||
126324264|NCT03836209|454482053|FG001|Overall Study|Death|1|||
126653060|NCT01506609|455686464|FG002|Overall Study|Withdrawal by Subject|0|||
126653061|NCT01506609|455686465|FG003|Overall Study|Withdrawal by Subject|9|||
126653062|NCT01506609|455686466|FG004|Overall Study|Withdrawal by Subject|7|||
126653063|NCT01506609|455686467|FG005|Overall Study|Withdrawal by Subject|7|||
126324265|NCT03836209|454482052|FG000|Overall Study|Lack of Efficacy|7|||
126324266|NCT03836209|454482053|FG001|Overall Study|Lack of Efficacy|10|||
126324267|NCT03836209|454482052|FG000|Overall Study|Physician Decision|7|||
126324268|NCT03836209|454482053|FG001|Overall Study|Physician Decision|11|||
126324269|NCT03836209|454482052|FG000|Overall Study|Protocol Violation|0|||
126324270|NCT03836209|454482053|FG001|Overall Study|Protocol Violation|3|||
126324271|NCT03836209|454482052|FG000|Overall Study|Withdrawal by Subject|2|||
126324272|NCT03836209|454482053|FG001|Overall Study|Withdrawal by Subject|10|||
126324273|NCT03836209|454482052|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
126324274|NCT03836209|454482053|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
126324275|NCT03739710|454482054|FG000|Overall Study|Screen Failed|81|||
126324276|NCT01424241|454482055|FG000|Overall Study|Withdrawal by Subject|1|||
126324277|NCT01424241|454482055|FG000|Overall Study|Time constraints|2|||
126324278|NCT05259917|454482056|FG000|Overall Study|Protocol Violation|0|||
126324279|NCT05259917|454482057|FG001|Overall Study|Protocol Violation|0|||
126324280|NCT05259917|454482058|FG002|Overall Study|Protocol Violation|1|||
126653064|NCT01506609|455686462|FG000|Overall Study|Lost to Follow-up|0|||
126653065|NCT01506609|455686463|FG001|Overall Study|Lost to Follow-up|0|||
126653066|NCT01506609|455686464|FG002|Overall Study|Lost to Follow-up|0|||
126653067|NCT01506609|455686465|FG003|Overall Study|Lost to Follow-up|1|||
126653068|NCT01506609|455686466|FG004|Overall Study|Lost to Follow-up|2|||
126653069|NCT01506609|455686467|FG005|Overall Study|Lost to Follow-up|0|||
126653070|NCT01506609|455686462|FG000|Overall Study|Sponsor Discontinued Study|0|||
126653071|NCT01506609|455686463|FG001|Overall Study|Sponsor Discontinued Study|0|||
126653072|NCT01506609|455686464|FG002|Overall Study|Sponsor Discontinued Study|0|||
126653073|NCT01506609|455686465|FG003|Overall Study|Sponsor Discontinued Study|2|||
126653074|NCT01506609|455686466|FG004|Overall Study|Sponsor Discontinued Study|2|||
126653075|NCT01506609|455686467|FG005|Overall Study|Sponsor Discontinued Study|0|||
126653076|NCT01506609|455686462|FG000|Overall Study|Progressive Disease per Protocol|1|||
126653077|NCT01506609|455686463|FG001|Overall Study|Progressive Disease per Protocol|0|||
126653078|NCT01506609|455686464|FG002|Overall Study|Progressive Disease per Protocol|0|||
126653079|NCT01506609|455686465|FG003|Overall Study|Progressive Disease per Protocol|64|||
126653080|NCT01506609|455686466|FG004|Overall Study|Progressive Disease per Protocol|57|||
126653081|NCT01506609|455686467|FG005|Overall Study|Progressive Disease per Protocol|74|||
126653082|NCT01506609|455686462|FG000|Overall Study|Other, Not Specified|0|||
126653083|NCT01506609|455686463|FG001|Overall Study|Other, Not Specified|0|||
126653084|NCT01506609|455686464|FG002|Overall Study|Other, Not Specified|0|||
126653085|NCT01506609|455686465|FG003|Overall Study|Other, Not Specified|10|||
126653086|NCT01506609|455686466|FG004|Overall Study|Other, Not Specified|7|||
126653087|NCT01506609|455686467|FG005|Overall Study|Other, Not Specified|3|||
126653088|NCT01506609|455686462|FG000|Overall Study|Missing / Unknown Reason|1|||
126653089|NCT01506609|455686463|FG001|Overall Study|Missing / Unknown Reason|0|||
126653090|NCT01506609|455686464|FG002|Overall Study|Missing / Unknown Reason|1|||
126653091|NCT01506609|455686465|FG003|Overall Study|Missing / Unknown Reason|4|||
126653092|NCT01506609|455686466|FG004|Overall Study|Missing / Unknown Reason|4|||
126653093|NCT01506609|455686467|FG005|Overall Study|Missing / Unknown Reason|2|||
126653094|NCT00122460|455686468|FG000|Overall Study|investigational study phase ongoing|7|||
126653095|NCT00122460|455686469|FG001|Overall Study|investigational study phase ongoing|1|||
126653096|NCT02595073|455686470|FG000|Overall Study|Progressive Disease|0|||
126653097|NCT02595073|455686471|FG001|Overall Study|Progressive Disease|1|||
126653098|NCT02595073|455686470|FG000|Overall Study|Protocol Violation|2|||
126653099|NCT02595073|455686471|FG001|Overall Study|Protocol Violation|0|||
126653100|NCT02962960|455686472|FG000|Overall Study|Withdrawal by Subject|1|||
126653101|NCT02962960|455686473|FG001|Overall Study|Withdrawal by Subject|1|||
126653102|NCT02962960|455686474|FG002|Overall Study|Withdrawal by Subject|0|||
126653103|NCT02962960|455686472|FG000|Overall Study|Adverse Event|1|||
126653104|NCT02962960|455686473|FG001|Overall Study|Adverse Event|1|||
126653105|NCT02962960|455686474|FG002|Overall Study|Adverse Event|0|||
126653106|NCT02962960|455686472|FG000|Overall Study|Protocol Violation|1|||
126653107|NCT02962960|455686473|FG001|Overall Study|Protocol Violation|0|||
126653108|NCT02962960|455686474|FG002|Overall Study|Protocol Violation|0|||
126653109|NCT02971761|455686475|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
126324281|NCT05259917|454482059|FG003|Overall Study|Protocol Violation|0|||
126324282|NCT05259917|454482060|FG004|Overall Study|Protocol Violation|0|||
126324283|NCT05259917|454482061|FG005|Overall Study|Protocol Violation|0|||
126324284|NCT05259917|454482056|FG000|Overall Study|Lost to Follow-up|0|||
126324285|NCT05259917|454482057|FG001|Overall Study|Lost to Follow-up|0|||
126653110|NCT02549196|455686476|FG000|Overall Study|Protocol Violation|0|||
126653111|NCT02549196|455686477|FG001|Overall Study|Protocol Violation|0|||
126653112|NCT02549196|455686478|FG002|Overall Study|Protocol Violation|0|||
126653113|NCT02549196|455686479|FG003|Overall Study|Protocol Violation|1|||
126653114|NCT02549196|455686476|FG000|Overall Study|Withdrawal by Subject|1|||
126653115|NCT02549196|455686477|FG001|Overall Study|Withdrawal by Subject|0|||
126653116|NCT02549196|455686478|FG002|Overall Study|Withdrawal by Subject|1|||
126653117|NCT02549196|455686479|FG003|Overall Study|Withdrawal by Subject|0|||
126653118|NCT01103362|455686480|FG000|Overall Study|study terminated|596|||
126653119|NCT02679508|455686481|FG000|Healing Phase|Protocol Violation|1|||
126653120|NCT02679508|455686482|FG001|Healing Phase|Protocol Violation|1|||
126653121|NCT02679508|455686481|FG000|Healing Phase|Lost to Follow-up|1|||
126653122|NCT02679508|455686482|FG001|Healing Phase|Lost to Follow-up|0|||
126653123|NCT02679508|455686481|FG000|Maintenance Phase|Adverse Event|12|||
126653124|NCT02679508|455686482|FG001|Maintenance Phase|Adverse Event|2|||
126653125|NCT02679508|455686481|FG000|Maintenance Phase|Lost to Follow-up|0|||
126324286|NCT05259917|454482058|FG002|Overall Study|Lost to Follow-up|1|||
126324287|NCT05259917|454482059|FG003|Overall Study|Lost to Follow-up|0|||
126324288|NCT05259917|454482060|FG004|Overall Study|Lost to Follow-up|0|||
126324289|NCT05259917|454482061|FG005|Overall Study|Lost to Follow-up|1|||
126324290|NCT05259917|454482056|FG000|Overall Study|Physician Decision|0|||
126324291|NCT05259917|454482057|FG001|Overall Study|Physician Decision|1|||
126324292|NCT05259917|454482058|FG002|Overall Study|Physician Decision|0|||
126324293|NCT05259917|454482059|FG003|Overall Study|Physician Decision|0|||
126324294|NCT05259917|454482060|FG004|Overall Study|Physician Decision|0|||
126324295|NCT05259917|454482061|FG005|Overall Study|Physician Decision|0|||
126324296|NCT05259917|454482056|FG000|Overall Study|Withdrawal by Subject|0|||
126324297|NCT05259917|454482057|FG001|Overall Study|Withdrawal by Subject|1|||
126324298|NCT05259917|454482058|FG002|Overall Study|Withdrawal by Subject|0|||
126324299|NCT05259917|454482059|FG003|Overall Study|Withdrawal by Subject|0|||
126324300|NCT05259917|454482060|FG004|Overall Study|Withdrawal by Subject|1|||
126324301|NCT05259917|454482061|FG005|Overall Study|Withdrawal by Subject|1|||
126324302|NCT05259917|454482056|FG000|Overall Study|Trial Termination by Sponsor|7|||
126324303|NCT05259917|454482057|FG001|Overall Study|Trial Termination by Sponsor|2|||
126324304|NCT05259917|454482058|FG002|Overall Study|Trial Termination by Sponsor|3|||
126324305|NCT05259917|454482059|FG003|Overall Study|Trial Termination by Sponsor|5|||
126324306|NCT05259917|454482060|FG004|Overall Study|Trial Termination by Sponsor|11|||
126324307|NCT05259917|454482061|FG005|Overall Study|Trial Termination by Sponsor|4|||
126324308|NCT05259917|454482056|FG000|Overall Study|Other|1|||
126324309|NCT05259917|454482057|FG001|Overall Study|Other|0|||
126324310|NCT05259917|454482058|FG002|Overall Study|Other|2|||
126324311|NCT05259917|454482059|FG003|Overall Study|Other|0|||
126324312|NCT05259917|454482060|FG004|Overall Study|Other|0|||
126324313|NCT05259917|454482061|FG005|Overall Study|Other|0|||
126324314|NCT00482170|454482062|FG000|Overall Study|Adverse Event|5|||
126324315|NCT00482170|454482063|FG001|Overall Study|Adverse Event|14|||
126324316|NCT00482170|454482062|FG000|Overall Study|Withdrawal by Subject|6|||
126324317|NCT00482170|454482063|FG001|Overall Study|Withdrawal by Subject|1|||
126324318|NCT00482170|454482062|FG000|Overall Study|Protocol Violation|2|||
126324319|NCT00482170|454482063|FG001|Overall Study|Protocol Violation|3|||
126324320|NCT00482170|454482062|FG000|Overall Study|Lost to Follow-up|2|||
126324321|NCT00482170|454482063|FG001|Overall Study|Lost to Follow-up|0|||
126324322|NCT00482170|454482062|FG000|Overall Study|Unspecified reason|0|||
126324323|NCT00482170|454482063|FG001|Overall Study|Unspecified reason|2|||
126324324|NCT01658904|454482064|FG000|Overall Study|Principal Investigator discretion|2|||
126324325|NCT01658904|454482065|FG001|Overall Study|Principal Investigator discretion|0|||
126324326|NCT01658904|454482066|FG002|Overall Study|Principal Investigator discretion|0|||
126324327|NCT00080483|454482067|FG000|Overall Study|Lost to Follow-up|1|||
126324328|NCT00080483|454482068|FG001|Overall Study|Lost to Follow-up|1|||
126324329|NCT00080483|454482067|FG000|Overall Study|Physician Decision|1|||
126324330|NCT00080483|454482068|FG001|Overall Study|Physician Decision|1|||
126324331|NCT00460746|454482076|FG000|Overall Study|Adverse Event|1|||
126324332|NCT00460746|454482076|FG000|Overall Study|Lost to Follow-up|1|||
126324333|NCT04399538|454482081|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
126324334|NCT04399538|454482082|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
126324335|NCT04399538|454482083|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
126324336|NCT04399538|454482084|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
126324337|NCT04399538|454482085|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
126324338|NCT04399538|454482081|FG000|Double-Blind Treatment|Adverse Event|0|||
126324339|NCT04399538|454482082|FG001|Double-Blind Treatment|Adverse Event|0|||
126653126|NCT02679508|455686482|FG001|Maintenance Phase|Lost to Follow-up|1|||
126653127|NCT02679508|455686481|FG000|Maintenance Phase|Withdrawal by Subject|15|||
126653128|NCT02679508|455686482|FG001|Maintenance Phase|Withdrawal by Subject|8|||
126653129|NCT02679508|455686481|FG000|Maintenance Phase|Other|5|||
126653130|NCT02679508|455686482|FG001|Maintenance Phase|Other|4|||
126653131|NCT03143166|455686483|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
126324340|NCT04399538|454482083|FG002|Double-Blind Treatment|Adverse Event|0|||
126324341|NCT04399538|454482084|FG003|Double-Blind Treatment|Adverse Event|0|||
126324342|NCT04399538|454482085|FG004|Double-Blind Treatment|Adverse Event|1|||
126324343|NCT04399538|454482081|FG000|Follow-Up|Adverse Event|0|||
126653132|NCT05000931|455686485|FG000|Overall Study|Lost to Follow-up|1|||
126324344|NCT04399538|454482082|FG001|Follow-Up|Adverse Event|0|||
126324345|NCT04399538|454482083|FG002|Follow-Up|Adverse Event|0|||
126324346|NCT04399538|454482084|FG003|Follow-Up|Adverse Event|0|||
126653133|NCT05326815|455686486|FG000|Overall Study|Withdrawal by Subject|3|||
126324347|NCT04399538|454482085|FG004|Follow-Up|Adverse Event|1|||
126653134|NCT05326815|455686486|FG000|Overall Study|Did not complete required labs|6|||
126653135|NCT05326815|455686486|FG000|Overall Study|Screen fail- abnormal labs|5|||
126653136|NCT03562975|455686487|FG000|Overall Study|Death|1|||
126653137|NCT03562975|455686487|FG000|Overall Study|Lost to Follow-up|1|||
126653138|NCT03562975|455686487|FG000|Overall Study|Withdrawal by Subject|1|||
126653139|NCT00925132|455686488|FG000|Overall Study|Withdrawal by Subject|2|||
126653140|NCT00925132|455686489|FG001|Overall Study|Withdrawal by Subject|0|||
126653141|NCT00925132|455686490|FG002|Overall Study|Withdrawal by Subject|0|||
126653142|NCT00925132|455686491|FG003|Overall Study|Withdrawal by Subject|0|||
126653143|NCT00925132|455686492|FG004|Overall Study|Withdrawal by Subject|1|||
126653144|NCT00925132|455686488|FG000|Overall Study|Removed due to disease progression|0|||
126653145|NCT00925132|455686489|FG001|Overall Study|Removed due to disease progression|0|||
126653146|NCT00925132|455686490|FG002|Overall Study|Removed due to disease progression|0|||
126653147|NCT00925132|455686491|FG003|Overall Study|Removed due to disease progression|0|||
126653148|NCT00925132|455686492|FG004|Overall Study|Removed due to disease progression|4|||
126653149|NCT02545933|455686493|FG000|Overall Study|Adverse Event|3|||
126653150|NCT02545933|455686494|FG001|Overall Study|Adverse Event|0|||
126653151|NCT02545933|455686495|FG002|Overall Study|Adverse Event|0|||
126653152|NCT02545933|455686493|FG000|Overall Study|Withdrawal by Subject|2|||
126653153|NCT02545933|455686494|FG001|Overall Study|Withdrawal by Subject|3|||
126653154|NCT02545933|455686495|FG002|Overall Study|Withdrawal by Subject|3|||
126653155|NCT02545933|455686493|FG000|Overall Study|Protocol Violation|1|||
126653156|NCT02545933|455686494|FG001|Overall Study|Protocol Violation|0|||
126653157|NCT02545933|455686495|FG002|Overall Study|Protocol Violation|1|||
126653158|NCT00935818|455686498|FG000|Overall Study|Withdrawal by Subject|45|||
126653159|NCT00935818|455686499|FG001|Overall Study|Withdrawal by Subject|50|||
126653160|NCT00935818|455686498|FG000|Overall Study|Lost to Follow-up|40|||
126653161|NCT00935818|455686499|FG001|Overall Study|Lost to Follow-up|42|||
126653162|NCT00935818|455686498|FG000|Overall Study|Adverse Event|6|||
126653163|NCT00935818|455686499|FG001|Overall Study|Adverse Event|7|||
126653164|NCT00935818|455686498|FG000|Overall Study|Physician Decision|0|||
126653165|NCT00935818|455686499|FG001|Overall Study|Physician Decision|1|||
126653166|NCT00979134|455686500|FG000|Overall Study|Disease progression|18|||
126653167|NCT00979134|455686501|FG001|Overall Study|Disease progression|2|||
126653168|NCT00979134|455686502|FG002|Overall Study|Disease progression|5|||
126653169|NCT00979134|455686500|FG000|Overall Study|Adverse Event|0|||
126653170|NCT00979134|455686501|FG001|Overall Study|Adverse Event|0|||
126653171|NCT00979134|455686502|FG002|Overall Study|Adverse Event|2|||
126653172|NCT00979134|455686500|FG000|Overall Study|Withdrawal by Subject|1|||
126653173|NCT00979134|455686501|FG001|Overall Study|Withdrawal by Subject|1|||
126653174|NCT00979134|455686502|FG002|Overall Study|Withdrawal by Subject|2|||
126653175|NCT00979134|455686500|FG000|Overall Study|Lost to Follow-up|2|||
126653176|NCT00979134|455686501|FG001|Overall Study|Lost to Follow-up|2|||
126653177|NCT00979134|455686502|FG002|Overall Study|Lost to Follow-up|0|||
126653178|NCT00979134|455686500|FG000|Overall Study|Death|4|||
126653179|NCT00979134|455686501|FG001|Overall Study|Death|0|||
126653180|NCT00979134|455686502|FG002|Overall Study|Death|26|||
126653181|NCT00979134|455686500|FG000|Overall Study|Other|8|||
126653182|NCT00979134|455686501|FG001|Overall Study|Other|1|||
126653183|NCT00979134|455686502|FG002|Overall Study|Other|5|||
126653184|NCT05180500|455686505|FG000|Overall Study|Adverse Event|1|||
126653185|NCT05180500|455686506|FG001|Overall Study|Adverse Event|0|||
126653186|NCT05180500|455686505|FG000|Overall Study|Withdrawal by Subject|2|||
126653187|NCT05180500|455686506|FG001|Overall Study|Withdrawal by Subject|0|||
126653188|NCT00867308|455686507|FG000|Overall Study|Death|1|||
126653189|NCT00867308|455686508|FG001|Overall Study|Death|0|||
126653190|NCT00867308|455686507|FG000|Overall Study|Adverse Event|1|||
126653191|NCT00867308|455686508|FG001|Overall Study|Adverse Event|4|||
126653192|NCT00867308|455686507|FG000|Overall Study|Lack of Efficacy|6|||
126324348|NCT04399538|454482081|FG000|Follow-Up|Withdrawal by Subject|0|||
126324349|NCT04399538|454482082|FG001|Follow-Up|Withdrawal by Subject|0|||
126324350|NCT04399538|454482083|FG002|Follow-Up|Withdrawal by Subject|0|||
126324351|NCT04399538|454482084|FG003|Follow-Up|Withdrawal by Subject|2|||
126324352|NCT04399538|454482085|FG004|Follow-Up|Withdrawal by Subject|0|||
126324353|NCT00636961|454482090|FG000|Period 1|Administrative problems|1|||
126653193|NCT00867308|455686508|FG001|Overall Study|Lack of Efficacy|12|||
126653194|NCT00867308|455686507|FG000|Overall Study|Withdrawal by Subject|1|||
126653195|NCT00867308|455686508|FG001|Overall Study|Withdrawal by Subject|2|||
126653196|NCT05917470|455686514|FG000|Overall Study|Progressive Disease|1|||
126653197|NCT05917470|455686515|FG001|Overall Study|Progressive Disease|1|||
126653198|NCT05917470|455686516|FG002|Overall Study|Progressive Disease|2|||
126653199|NCT05917470|455686517|FG003|Overall Study|Progressive Disease|3|||
126653200|NCT05917470|455686518|FG004|Overall Study|Progressive Disease|1|||
126653201|NCT05917470|455686519|FG005|Overall Study|Progressive Disease|1|||
126324354|NCT00636961|454482091|FG001|Period 1|Administrative problems|1|||
126324355|NCT00636961|454482090|FG000|Period 2|Adverse Event|1|||
126653202|NCT05917470|455686520|FG006|Overall Study|Progressive Disease|0|||
126653203|NCT05917470|455686521|FG007|Overall Study|Progressive Disease|0|||
126653204|NCT05917470|455686514|FG000|Overall Study|Withdrawal by Subject|0|||
126653205|NCT05917470|455686515|FG001|Overall Study|Withdrawal by Subject|0|||
126324356|NCT00636961|454482091|FG001|Period 2|Adverse Event|0|||
126324357|NCT01573754|454482093|FG000|Overall Study|Noncompliance or remission not achieved|3|||
126324358|NCT01573754|454482094|FG001|Overall Study|Noncompliance or remission not achieved|15|||
126324359|NCT00829829|454482096|FG000|Overall Study|Protocol Violation|0|||
126324360|NCT00829829|454482097|FG001|Overall Study|Protocol Violation|3|||
126324361|NCT00829829|454482098|FG002|Overall Study|Protocol Violation|0|||
126324362|NCT00829829|454482096|FG000|Overall Study|Adverse Event|4|||
126324363|NCT00829829|454482097|FG001|Overall Study|Adverse Event|4|||
126324364|NCT00829829|454482098|FG002|Overall Study|Adverse Event|3|||
126324365|NCT00829829|454482096|FG000|Overall Study|Withdrawal by Subject|8|||
126324366|NCT00829829|454482097|FG001|Overall Study|Withdrawal by Subject|4|||
126324367|NCT00829829|454482098|FG002|Overall Study|Withdrawal by Subject|2|||
126324368|NCT00829829|454482096|FG000|Overall Study|Decision by the Sponsor|1|||
126324369|NCT00829829|454482097|FG001|Overall Study|Decision by the Sponsor|0|||
126324370|NCT00829829|454482098|FG002|Overall Study|Decision by the Sponsor|2|||
126324371|NCT00829829|454482096|FG000|Overall Study|Lost to Follow-up|7|||
126324372|NCT00829829|454482097|FG001|Overall Study|Lost to Follow-up|3|||
126324373|NCT00829829|454482098|FG002|Overall Study|Lost to Follow-up|3|||
126324374|NCT00829829|454482096|FG000|Overall Study|Other than specified above|2|||
126324375|NCT00829829|454482097|FG001|Overall Study|Other than specified above|2|||
126324376|NCT00829829|454482098|FG002|Overall Study|Other than specified above|1|||
126324377|NCT02685072|454482099|FG000|Treatment Period|Lost to Follow-up|12|||
126324378|NCT02685072|454482100|FG001|Treatment Period|Lost to Follow-up|6|||
126324379|NCT02685072|454482099|FG000|Treatment Period|Withdrawal by Subject|1|||
126324380|NCT02685072|454482100|FG001|Treatment Period|Withdrawal by Subject|3|||
126324381|NCT02685072|454482099|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
126324382|NCT02685072|454482100|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
126324383|NCT02634710|454482101|FG000|Overall Study|Death|4|||
126324384|NCT02717442|454482103|FG000|Overall Study|Study Terminated by Sponsor|31|||
126324385|NCT02717442|454482104|FG001|Overall Study|Study Terminated by Sponsor|29|||
126324386|NCT02717442|454482103|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
126324387|NCT02717442|454482104|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
126324388|NCT02717442|454482103|FG000|Overall Study|Other - Not Specified|2|||
126324389|NCT02717442|454482104|FG001|Overall Study|Other - Not Specified|0|||
126324390|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
126324391|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324392|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324393|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324394|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324395|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324396|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324397|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324398|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
126324399|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
126324400|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
126324401|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
126324402|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
126324403|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
126324404|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
126324405|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
126324406|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
126324407|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
126324408|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
126324409|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
126324410|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
126324411|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
126324412|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
126324413|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
126324414|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
126324415|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
126324416|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
126324417|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
126324418|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
126324419|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
126324420|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
126324421|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
126324422|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
126324423|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
126324424|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
126653206|NCT05917470|455686516|FG002|Overall Study|Withdrawal by Subject|1|||
126653207|NCT05917470|455686517|FG003|Overall Study|Withdrawal by Subject|0|||
126653208|NCT05917470|455686518|FG004|Overall Study|Withdrawal by Subject|0|||
126324425|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
126324426|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324427|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324428|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324429|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
126324430|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324431|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
126324432|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324433|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324434|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
126324435|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
126324436|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
126324437|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
126324438|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
126324439|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
126324440|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
126324441|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
126324442|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
126324443|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
126324444|NCT00528372|454482108|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
126324445|NCT00528372|454482109|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
126324446|NCT00528372|454482110|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
126324447|NCT00528372|454482111|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
126324448|NCT00528372|454482112|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
126324449|NCT00528372|454482113|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
126324450|NCT00528372|454482114|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
126324451|NCT00528372|454482115|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
126324452|NCT00528372|454482116|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
126324453|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
126324454|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
126324455|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
126324456|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
126324457|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
126324458|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
126324459|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
126324460|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
126324461|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
126324462|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
126324463|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
126324464|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
126324465|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
126324466|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
126324467|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
126324468|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
126324469|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
126324470|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
126324471|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
126324472|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
126324473|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
126324474|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
126324475|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
126324476|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
126324477|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
126324478|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
126324479|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
126324480|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
126324481|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
126324482|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
126324483|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
126653209|NCT05917470|455686519|FG005|Overall Study|Withdrawal by Subject|0|||
126653210|NCT05917470|455686520|FG006|Overall Study|Withdrawal by Subject|0|||
126324484|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
126324485|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
126324486|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
126324487|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
126324488|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
126324489|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
126324490|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
126324491|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
126324492|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
126324493|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
126324494|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
126324495|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
126324496|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
126324497|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
126324498|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
126324499|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
126324500|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
126653211|NCT05917470|455686521|FG007|Overall Study|Withdrawal by Subject|0|||
126653212|NCT05917470|455686514|FG000|Overall Study|Sponsor Decision|0|||
126653213|NCT05917470|455686515|FG001|Overall Study|Sponsor Decision|0|||
126653214|NCT05917470|455686516|FG002|Overall Study|Sponsor Decision|1|||
126653215|NCT05917470|455686517|FG003|Overall Study|Sponsor Decision|0|||
126653216|NCT05917470|455686518|FG004|Overall Study|Sponsor Decision|2|||
126653217|NCT05917470|455686519|FG005|Overall Study|Sponsor Decision|1|||
126653218|NCT05917470|455686520|FG006|Overall Study|Sponsor Decision|3|||
126324501|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
126324502|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
126324503|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
126324504|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
126653219|NCT05917470|455686521|FG007|Overall Study|Sponsor Decision|3|||
126653220|NCT05917470|455686514|FG000|Overall Study|Adverse Event|0|||
126653221|NCT05917470|455686515|FG001|Overall Study|Adverse Event|0|||
126653222|NCT05917470|455686516|FG002|Overall Study|Adverse Event|0|||
126653223|NCT05917470|455686517|FG003|Overall Study|Adverse Event|0|||
126653224|NCT05917470|455686518|FG004|Overall Study|Adverse Event|0|||
126653225|NCT05917470|455686519|FG005|Overall Study|Adverse Event|1|||
126653226|NCT05917470|455686520|FG006|Overall Study|Adverse Event|0|||
126653227|NCT05917470|455686521|FG007|Overall Study|Adverse Event|0|||
126653228|NCT02317432|455686522|FG000|Overall Study|Death|4|||
126653229|NCT02317432|455686523|FG001|Overall Study|Death|1|||
126653230|NCT02317432|455686522|FG000|Overall Study|Lost to Follow-up|0|||
126653231|NCT02317432|455686523|FG001|Overall Study|Lost to Follow-up|5|||
126653232|NCT02317432|455686522|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
126653233|NCT02317432|455686523|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
126653234|NCT03992846|455686528|FG000|Overall Study|Adverse Event|8|||
126653235|NCT03992846|455686529|FG001|Overall Study|Adverse Event|6|||
126653236|NCT03992846|455686530|FG002|Overall Study|Adverse Event|3|||
126653237|NCT03992846|455686528|FG000|Overall Study|Lost to Follow-up|0|||
126653238|NCT03992846|455686529|FG001|Overall Study|Lost to Follow-up|1|||
126653239|NCT03992846|455686530|FG002|Overall Study|Lost to Follow-up|1|||
126653240|NCT03992846|455686528|FG000|Overall Study|Pregnancy|2|||
126653241|NCT03992846|455686529|FG001|Overall Study|Pregnancy|0|||
126653242|NCT03992846|455686530|FG002|Overall Study|Pregnancy|1|||
126653243|NCT03992846|455686528|FG000|Overall Study|Protocol Violation|1|||
126653244|NCT03992846|455686529|FG001|Overall Study|Protocol Violation|2|||
126653245|NCT03992846|455686530|FG002|Overall Study|Protocol Violation|0|||
126653246|NCT03992846|455686528|FG000|Overall Study|Withdrawal by Subject|8|||
126653247|NCT03992846|455686529|FG001|Overall Study|Withdrawal by Subject|10|||
126653248|NCT03992846|455686530|FG002|Overall Study|Withdrawal by Subject|20|||
126653249|NCT03992846|455686528|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
126653250|NCT03992846|455686529|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
126653251|NCT03992846|455686530|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
126324505|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
126324506|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
126324507|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
126653252|NCT03647488|455689092|FG000|Overall Study|Progressive disease|10|||
126653253|NCT03647488|455689093|FG001|Overall Study|Progressive disease|0|||
126653254|NCT03647488|455689094|FG002|Overall Study|Progressive disease|0|||
126653255|NCT03647488|455689092|FG000|Overall Study|Adverse Event|5|||
126653256|NCT03647488|455689093|FG001|Overall Study|Adverse Event|0|||
126653257|NCT03647488|455689094|FG002|Overall Study|Adverse Event|0|||
126324508|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
126324509|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
126324510|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
126324511|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
126324512|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
126324513|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
126324514|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
126324515|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
126324516|NCT00528372|454482108|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
126324517|NCT00528372|454482109|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
126324518|NCT00528372|454482110|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
126324519|NCT00528372|454482111|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
126324520|NCT00528372|454482112|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
126324521|NCT00528372|454482113|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
126324522|NCT00528372|454482114|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
126324523|NCT00528372|454482115|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
126324524|NCT00528372|454482116|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
126324525|NCT02772809|454482117|FG000|Overall Study|not completed some tasks|6|||
126324526|NCT02774005|454482123|FG000|Overall Study|Adverse Event|8|||
126324527|NCT02774005|454482123|FG000|Overall Study|Withdrawal by Subject|23|||
126324528|NCT02774005|454482123|FG000|Overall Study|Lost to Follow-up|7|||
126324529|NCT02774005|454482123|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
126324530|NCT02774005|454482123|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
126324531|NCT02774005|454482123|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
126324532|NCT02774005|454482123|FG000|Overall Study|Death|1|||
126324533|NCT02774005|454482123|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
126324534|NCT02774005|454482123|FG000|Overall Study|Lack of compliance with study medication|4|||
126324535|NCT02774005|454482123|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
126324536|NCT02774005|454482123|FG000|Overall Study|another study|1|||
126324537|NCT02774005|454482123|FG000|Overall Study|cardiologist imposed travel restriction|1|||
126324538|NCT00534105|454482124|FG000|Overall Study|Lost to Follow-up|23|||
126324539|NCT00534105|454482125|FG001|Overall Study|Lost to Follow-up|39|||
126324540|NCT03275389|454482129|FG000|Overall Study|Lost to Follow-up|10|||
126324541|NCT03275389|454482130|FG001|Overall Study|Lost to Follow-up|10|||
126324542|NCT03275389|454482131|FG002|Overall Study|Lost to Follow-up|19|||
126324543|NCT03275389|454482132|FG003|Overall Study|Lost to Follow-up|12|||
126324544|NCT03275389|454482133|FG004|Overall Study|Lost to Follow-up|11|||
126324545|NCT03275389|454482134|FG005|Overall Study|Lost to Follow-up|12|||
126324546|NCT03275389|454482135|FG006|Overall Study|Lost to Follow-up|21|||
126324547|NCT03275389|454482136|FG007|Overall Study|Lost to Follow-up|15|||
126324548|NCT03275389|454482137|FG008|Overall Study|Lost to Follow-up|12|||
126324549|NCT03275389|454482138|FG009|Overall Study|Lost to Follow-up|14|||
126324550|NCT03275389|454482129|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324551|NCT03275389|454482130|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324552|NCT03275389|454482131|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324553|NCT03275389|454482132|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324554|NCT03275389|454482133|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324555|NCT03275389|454482134|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
126324556|NCT03275389|454482135|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324557|NCT03275389|454482136|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324558|NCT03275389|454482137|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
126324559|NCT03275389|454482138|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
126324560|NCT03275389|454482129|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
126324561|NCT03275389|454482130|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126324562|NCT03275389|454482131|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126324563|NCT03275389|454482132|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
126324564|NCT03275389|454482133|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
126324565|NCT03275389|454482134|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
126324566|NCT03275389|454482135|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
126324567|NCT03275389|454482136|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
126324568|NCT03275389|454482137|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
126324569|NCT03275389|454482138|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
126324570|NCT03275389|454482129|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324571|NCT03275389|454482130|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
126324572|NCT03275389|454482131|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324573|NCT03275389|454482132|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
126653258|NCT03647488|455689092|FG000|Overall Study|Clinical progression|2|||
126653259|NCT03647488|455689093|FG001|Overall Study|Clinical progression|0|||
126653260|NCT03647488|455689094|FG002|Overall Study|Clinical progression|0|||
126653261|NCT03647488|455689092|FG000|Overall Study|Participant refused to take investigational product|1|||
126653262|NCT03647488|455689093|FG001|Overall Study|Participant refused to take investigational product|0|||
126653263|NCT03647488|455689094|FG002|Overall Study|Participant refused to take investigational product|0|||
126653264|NCT03694275|455689095|FG000|Overall Study|Adverse Event|0|||
126653265|NCT03694275|455689096|FG001|Overall Study|Adverse Event|1|||
126653266|NCT03694275|455689095|FG000|Overall Study|Reason not Specified|0|||
126653267|NCT03694275|455689096|FG001|Overall Study|Reason not Specified|1|||
126653268|NCT03541174|455689097|FG000|Part 1 Double-Blind|Adverse Event|6|||
126653269|NCT03541174|455689098|FG001|Part 1 Double-Blind|Adverse Event|5|||
126653270|NCT03541174|455689099|FG002|Part 1 Double-Blind|Adverse Event|2|||
126653271|NCT03541174|455689100|FG003|Part 1 Double-Blind|Adverse Event|0|||
126653272|NCT03541174|455689101|FG004|Part 1 Double-Blind|Adverse Event|0|||
126653273|NCT03541174|455689102|FG005|Part 1 Double-Blind|Adverse Event|0|||
126653274|NCT03541174|455689097|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
126653275|NCT03541174|455689098|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
126653276|NCT03541174|455689099|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
126653277|NCT03541174|455689100|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
126653278|NCT03541174|455689101|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
126653279|NCT03541174|455689102|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
126653280|NCT03541174|455689097|FG000|Part 1 Double-Blind|Other reasons|3|||
126653281|NCT03541174|455689098|FG001|Part 1 Double-Blind|Other reasons|2|||
126653282|NCT03541174|455689099|FG002|Part 1 Double-Blind|Other reasons|3|||
126653283|NCT03541174|455689100|FG003|Part 1 Double-Blind|Other reasons|0|||
126653284|NCT03541174|455689101|FG004|Part 1 Double-Blind|Other reasons|0|||
126653285|NCT03541174|455689102|FG005|Part 1 Double-Blind|Other reasons|0|||
126653286|NCT03541174|455689097|FG000|Part 2 Single-Blind|Adverse Event|0|||
126653287|NCT03541174|455689098|FG001|Part 2 Single-Blind|Adverse Event|0|||
126653288|NCT03541174|455689099|FG002|Part 2 Single-Blind|Adverse Event|0|||
126653289|NCT03541174|455689100|FG003|Part 2 Single-Blind|Adverse Event|25|||
126653290|NCT03541174|455689101|FG004|Part 2 Single-Blind|Adverse Event|0|||
126653291|NCT03541174|455689102|FG005|Part 2 Single-Blind|Adverse Event|0|||
126653292|NCT03541174|455689097|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
126653293|NCT03541174|455689098|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
126653294|NCT03541174|455689099|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
126653295|NCT03541174|455689100|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
126653296|NCT03541174|455689101|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
126653297|NCT03541174|455689102|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
126653298|NCT03541174|455689097|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
126653299|NCT03541174|455689098|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
126653300|NCT03541174|455689099|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
126653301|NCT03541174|455689100|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
126653302|NCT03541174|455689101|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
126653303|NCT03541174|455689102|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
126653304|NCT03541174|455689097|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
126653305|NCT03541174|455689098|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
126653306|NCT03541174|455689099|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
126653307|NCT03541174|455689100|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
126653308|NCT03541174|455689101|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
126653309|NCT03541174|455689102|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
126653310|NCT03541174|455689097|FG000|Part 2 Single-Blind|Death|0|||
126653311|NCT03541174|455689098|FG001|Part 2 Single-Blind|Death|0|||
126653312|NCT03541174|455689099|FG002|Part 2 Single-Blind|Death|0|||
126653313|NCT03541174|455689100|FG003|Part 2 Single-Blind|Death|5|||
126324574|NCT03275389|454482133|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324575|NCT03275389|454482134|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324576|NCT03275389|454482135|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126324577|NCT03275389|454482136|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324578|NCT03275389|454482137|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324579|NCT03275389|454482138|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126324580|NCT03275389|454482129|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324581|NCT03275389|454482130|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324582|NCT03275389|454482131|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
126324583|NCT03275389|454482132|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324584|NCT03275389|454482133|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324585|NCT03275389|454482134|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324586|NCT03275389|454482135|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324587|NCT03275389|454482136|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126653314|NCT03541174|455689101|FG004|Part 2 Single-Blind|Death|0|||
126653315|NCT03541174|455689102|FG005|Part 2 Single-Blind|Death|0|||
126653316|NCT03541174|455689097|FG000|Part 2 Single-Blind|Pregnancy|0|||
126653317|NCT03541174|455689098|FG001|Part 2 Single-Blind|Pregnancy|0|||
126653318|NCT03541174|455689099|FG002|Part 2 Single-Blind|Pregnancy|0|||
126653319|NCT03541174|455689100|FG003|Part 2 Single-Blind|Pregnancy|1|||
126653320|NCT03541174|455689101|FG004|Part 2 Single-Blind|Pregnancy|0|||
126324588|NCT03275389|454482137|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126324589|NCT03275389|454482138|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
126324590|NCT03275389|454482129|FG000|Overall Study|Other|0|||
126324591|NCT03275389|454482130|FG001|Overall Study|Other|4|||
126324592|NCT03275389|454482131|FG002|Overall Study|Other|3|||
126324593|NCT03275389|454482132|FG003|Overall Study|Other|2|||
126324594|NCT03275389|454482133|FG004|Overall Study|Other|2|||
126324595|NCT03275389|454482134|FG005|Overall Study|Other|2|||
126324596|NCT03275389|454482135|FG006|Overall Study|Other|0|||
126324597|NCT03275389|454482136|FG007|Overall Study|Other|0|||
126324598|NCT03275389|454482137|FG008|Overall Study|Other|1|||
126324599|NCT03275389|454482138|FG009|Overall Study|Other|0|||
126324600|NCT02432144|454482139|FG000|Overall Study|Participant Non-Compliance|1|||
126324601|NCT00978341|454482140|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
126324602|NCT00978341|454482141|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
126324603|NCT03035916|454482142|FG000|Overall Study|Puncture failed|0|||
126324604|NCT03035916|454482143|FG001|Overall Study|Puncture failed|2|||
126324605|NCT03035916|454482144|FG002|Overall Study|Puncture failed|0|||
126324606|NCT00448812|454482145|FG000|Year 2|Missed visit but remained in study|4|||
126324607|NCT00448812|454482146|FG001|Year 2|Missed visit but remained in study|1|||
126324608|NCT00448812|454482145|FG000|Year 3|Withdrawal by Subject|1|||
126324609|NCT00448812|454482146|FG001|Year 3|Withdrawal by Subject|3|||
126324610|NCT00448812|454482145|FG000|Year 3|Lost to Follow-up|1|||
126324611|NCT00448812|454482146|FG001|Year 3|Lost to Follow-up|0|||
126324612|NCT00448812|454482145|FG000|Year 3|Missed visit but remained in study|2|||
126324613|NCT00448812|454482146|FG001|Year 3|Missed visit but remained in study|0|||
126324614|NCT00448812|454482145|FG000|Year 5|Missed visit but remained in study|1|||
126324615|NCT00448812|454482146|FG001|Year 5|Missed visit but remained in study|0|||
126324616|NCT03885999|454482147|FG000|Overall Study|Adverse Event|1|||
126324617|NCT02452554|454482148|FG000|Overall Study|Death|2|||
126324618|NCT02452554|454482149|FG001|Overall Study|Death|1|||
126324619|NCT02452554|454482150|FG002|Overall Study|Death|0|||
126324620|NCT02452554|454482151|FG003|Overall Study|Death|0|||
126324621|NCT02452554|454482152|FG004|Overall Study|Death|0|||
126324622|NCT02452554|454482153|FG005|Overall Study|Death|0|||
126324623|NCT02452554|454482148|FG000|Overall Study|Lack of Efficacy|13|||
126324624|NCT02452554|454482149|FG001|Overall Study|Lack of Efficacy|14|||
126324625|NCT02452554|454482150|FG002|Overall Study|Lack of Efficacy|9|||
126324626|NCT02452554|454482151|FG003|Overall Study|Lack of Efficacy|1|||
126324627|NCT02452554|454482152|FG004|Overall Study|Lack of Efficacy|5|||
126324628|NCT02452554|454482153|FG005|Overall Study|Lack of Efficacy|8|||
126324629|NCT02452554|454482148|FG000|Overall Study|Physician Decision|0|||
126324630|NCT02452554|454482149|FG001|Overall Study|Physician Decision|1|||
126324631|NCT02452554|454482150|FG002|Overall Study|Physician Decision|0|||
126324632|NCT02452554|454482151|FG003|Overall Study|Physician Decision|0|||
126324633|NCT02452554|454482152|FG004|Overall Study|Physician Decision|0|||
126324634|NCT02452554|454482153|FG005|Overall Study|Physician Decision|0|||
126324635|NCT02452554|454482148|FG000|Overall Study|Withdrawal by Subject|1|||
126324636|NCT02452554|454482149|FG001|Overall Study|Withdrawal by Subject|0|||
126324637|NCT02452554|454482150|FG002|Overall Study|Withdrawal by Subject|2|||
126324638|NCT02452554|454482151|FG003|Overall Study|Withdrawal by Subject|0|||
126324639|NCT02452554|454482152|FG004|Overall Study|Withdrawal by Subject|0|||
126324640|NCT02452554|454482153|FG005|Overall Study|Withdrawal by Subject|1|||
126324641|NCT02452554|454482148|FG000|Overall Study|Ineligible|0|||
126324642|NCT02452554|454482149|FG001|Overall Study|Ineligible|1|||
126324643|NCT02452554|454482150|FG002|Overall Study|Ineligible|0|||
126324644|NCT02452554|454482151|FG003|Overall Study|Ineligible|0|||
126324645|NCT02452554|454482152|FG004|Overall Study|Ineligible|0|||
126324646|NCT02452554|454482153|FG005|Overall Study|Ineligible|0|||
126324647|NCT02452554|454482148|FG000|Overall Study|Never Received Treatment|1|||
126324648|NCT02452554|454482149|FG001|Overall Study|Never Received Treatment|0|||
126324649|NCT02452554|454482150|FG002|Overall Study|Never Received Treatment|0|||
126324650|NCT02452554|454482151|FG003|Overall Study|Never Received Treatment|0|||
126324651|NCT02452554|454482152|FG004|Overall Study|Never Received Treatment|0|||
126324652|NCT02452554|454482153|FG005|Overall Study|Never Received Treatment|0|||
126324653|NCT02636439|454482156|FG000|Overall Study|Adverse Event|2|||
126324654|NCT02636439|454482157|FG001|Overall Study|Adverse Event|2|||
126324655|NCT02636439|454482156|FG000|Overall Study|Lost to Follow-up|1|||
126324656|NCT02636439|454482157|FG001|Overall Study|Lost to Follow-up|0|||
126324657|NCT02636439|454482156|FG000|Overall Study|Non-compliance|1|||
126324658|NCT02636439|454482157|FG001|Overall Study|Non-compliance|1|||
126324659|NCT02636439|454482156|FG000|Overall Study|Personal reasons|2|||
126324660|NCT02636439|454482157|FG001|Overall Study|Personal reasons|0|||
126324661|NCT05188729|454482158|FG000|Overall Study|Withdrawal by Subject|0|||
126324662|NCT05188729|454482159|FG001|Overall Study|Withdrawal by Subject|0|||
126324663|NCT05188729|454482160|FG002|Overall Study|Withdrawal by Subject|0|||
126324664|NCT05188729|454482161|FG003|Overall Study|Withdrawal by Subject|0|||
126324665|NCT05188729|454482162|FG004|Overall Study|Withdrawal by Subject|0|||
126324666|NCT05188729|454482163|FG005|Overall Study|Withdrawal by Subject|0|||
126324667|NCT05188729|454482164|FG006|Overall Study|Withdrawal by Subject|0|||
126324668|NCT05188729|454482165|FG007|Overall Study|Withdrawal by Subject|0|||
126324669|NCT05188729|454482166|FG008|Overall Study|Withdrawal by Subject|0|||
126324670|NCT05188729|454482167|FG009|Overall Study|Withdrawal by Subject|1|||
126324671|NCT05188729|454482168|FG010|Overall Study|Withdrawal by Subject|0|||
126324672|NCT05188729|454482169|FG011|Overall Study|Withdrawal by Subject|0|||
126324673|NCT05188729|454482170|FG012|Overall Study|Withdrawal by Subject|0|||
126324674|NCT05188729|454482158|FG000|Overall Study|Lost to Follow-up|0|||
126324675|NCT05188729|454482159|FG001|Overall Study|Lost to Follow-up|0|||
126324676|NCT05188729|454482160|FG002|Overall Study|Lost to Follow-up|0|||
126324677|NCT05188729|454482161|FG003|Overall Study|Lost to Follow-up|0|||
126324678|NCT05188729|454482162|FG004|Overall Study|Lost to Follow-up|0|||
126324679|NCT05188729|454482163|FG005|Overall Study|Lost to Follow-up|0|||
126324680|NCT05188729|454482164|FG006|Overall Study|Lost to Follow-up|0|||
126324681|NCT05188729|454482165|FG007|Overall Study|Lost to Follow-up|0|||
126324682|NCT05188729|454482166|FG008|Overall Study|Lost to Follow-up|0|||
126324683|NCT05188729|454482167|FG009|Overall Study|Lost to Follow-up|0|||
126324684|NCT05188729|454482168|FG010|Overall Study|Lost to Follow-up|1|||
126324685|NCT05188729|454482169|FG011|Overall Study|Lost to Follow-up|1|||
126324686|NCT05188729|454482170|FG012|Overall Study|Lost to Follow-up|0|||
126324687|NCT02552888|454482171|FG000|Overall Study|Lost to Follow-up|1|||
126324688|NCT02552888|454482172|FG001|Overall Study|Lost to Follow-up|1|||
126324689|NCT00762034|454483734|FG000|Induction Period|Protocol Violation|1|||
126324690|NCT00762034|454483735|FG001|Induction Period|Protocol Violation|2|||
126324691|NCT00762034|454483734|FG000|Induction Period|Entry Criterion Not Met|12|||
126324692|NCT00762034|454483735|FG001|Induction Period|Entry Criterion Not Met|11|||
126324693|NCT00762034|454483734|FG000|Induction Period|Adverse Event|27|||
126324694|NCT00762034|454483735|FG001|Induction Period|Adverse Event|38|||
126324695|NCT00762034|454483734|FG000|Induction Period|Lost to Follow-up|1|||
126324696|NCT00762034|454483735|FG001|Induction Period|Lost to Follow-up|1|||
126324697|NCT00762034|454483734|FG000|Induction Period|Progressive Disease|73|||
126324698|NCT00762034|454483735|FG001|Induction Period|Progressive Disease|55|||
126324699|NCT00762034|454483734|FG000|Induction Period|Physician Decision|21|||
126324700|NCT00762034|454483735|FG001|Induction Period|Physician Decision|20|||
126324701|NCT00762034|454483734|FG000|Induction Period|Withdrawal by Subject|15|||
126324702|NCT00762034|454483735|FG001|Induction Period|Withdrawal by Subject|19|||
126324703|NCT00762034|454483734|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
126324704|NCT00762034|454483735|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
126324705|NCT00762034|454483734|FG000|Induction Period|Deaths Due to Study Disease|9|||
126324706|NCT00762034|454483735|FG001|Induction Period|Deaths Due to Study Disease|9|||
126324707|NCT00762034|454483734|FG000|Maintenance Period|Protocol Violation|1|||
126324708|NCT00762034|454483735|FG001|Maintenance Period|Protocol Violation|3|||
126324709|NCT00762034|454483734|FG000|Maintenance Period|Entry Criterion Not Met|0|||
126324710|NCT00762034|454483735|FG001|Maintenance Period|Entry Criterion Not Met|2|||
126324711|NCT00762034|454483734|FG000|Maintenance Period|Adverse Event|42|||
126324712|NCT00762034|454483735|FG001|Maintenance Period|Adverse Event|26|||
126324713|NCT00762034|454483734|FG000|Maintenance Period|Progressive Disease|186|||
126324714|NCT00762034|454483735|FG001|Maintenance Period|Progressive Disease|224|||
126324715|NCT00762034|454483734|FG000|Maintenance Period|Physician Decision|25|||
126324716|NCT00762034|454483735|FG001|Maintenance Period|Physician Decision|20|||
126324717|NCT00762034|454483734|FG000|Maintenance Period|Withdrawal by Subject|34|||
126324718|NCT00762034|454483735|FG001|Maintenance Period|Withdrawal by Subject|14|||
126324719|NCT00762034|454483734|FG000|Maintenance Period|Death not due to study disease|2|||
126324720|NCT00762034|454483735|FG001|Maintenance Period|Death not due to study disease|5|||
126324721|NCT00762034|454483734|FG000|Maintenance Period|Death due to study disease|3|||
126324722|NCT00762034|454483735|FG001|Maintenance Period|Death due to study disease|3|||
126324723|NCT00762034|454483734|FG000|Maintenance Period|Other|1|||
126324724|NCT00762034|454483735|FG001|Maintenance Period|Other|1|||
126324725|NCT01299896|454483738|FG000|Overall Study|Withdrawal by Subject|1|||
126324726|NCT01299896|454483739|FG001|Overall Study|Withdrawal by Subject|7|||
126324727|NCT01299896|454483738|FG000|Overall Study|Lost to Follow-up|0|||
126324728|NCT01299896|454483739|FG001|Overall Study|Lost to Follow-up|11|||
126324729|NCT02107313|454483740|FG000|Overall Study|One participant did not do the FED cohor|0|||
126324730|NCT02107313|454483741|FG001|Overall Study|One participant did not do the FED cohor|1|||
126324731|NCT02090283|454483746|FG000|Overall Study|Withdrawal by Subject|6|||
126324732|NCT02090283|454483747|FG001|Overall Study|Withdrawal by Subject|6|||
126324733|NCT02090283|454483748|FG002|Overall Study|Withdrawal by Subject|6|||
126324734|NCT02090283|454483746|FG000|Overall Study|Sponsor Terminated Study|6|||
126324735|NCT02090283|454483747|FG001|Overall Study|Sponsor Terminated Study|6|||
126324736|NCT02090283|454483748|FG002|Overall Study|Sponsor Terminated Study|1|||
126324737|NCT02090283|454483746|FG000|Overall Study|Lost to Follow-up|2|||
126324738|NCT02090283|454483747|FG001|Overall Study|Lost to Follow-up|2|||
126324739|NCT02090283|454483748|FG002|Overall Study|Lost to Follow-up|3|||
126324740|NCT02090283|454483746|FG000|Overall Study|Adverse Event|1|||
126324741|NCT02090283|454483747|FG001|Overall Study|Adverse Event|1|||
126324742|NCT02090283|454483748|FG002|Overall Study|Adverse Event|0|||
126324743|NCT02090283|454483746|FG000|Overall Study|Protocol Violation|2|||
126324744|NCT02090283|454483747|FG001|Overall Study|Protocol Violation|0|||
126653321|NCT03541174|455689102|FG005|Part 2 Single-Blind|Pregnancy|0|||
126653322|NCT03541174|455689097|FG000|Part 2 Single-Blind|Other reasons|0|||
126653323|NCT03541174|455689098|FG001|Part 2 Single-Blind|Other reasons|0|||
126653324|NCT03541174|455689099|FG002|Part 2 Single-Blind|Other reasons|0|||
126653325|NCT03541174|455689100|FG003|Part 2 Single-Blind|Other reasons|32|||
126653326|NCT03541174|455689101|FG004|Part 2 Single-Blind|Other reasons|0|||
126653327|NCT03541174|455689102|FG005|Part 2 Single-Blind|Other reasons|0|||
126653328|NCT03541174|455689097|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
126653329|NCT03541174|455689098|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
126324745|NCT02090283|454483748|FG002|Overall Study|Protocol Violation|0|||
126324746|NCT01411319|454483752|FG000|Overall Study|Lost to Follow-up|1|||
126324747|NCT05205005|454483767|FG000|Overall Study|Withdrawal by Subject|1|||
126324748|NCT05205005|454483768|FG001|Overall Study|Withdrawal by Subject|0|||
126324749|NCT05205005|454483767|FG000|Overall Study|Adverse Event|1|||
126324750|NCT05205005|454483768|FG001|Overall Study|Adverse Event|0|||
126324751|NCT02187029|454483770|FG000|Overall Study|Adverse Event|0|||
126324752|NCT02187029|454483771|FG001|Overall Study|Adverse Event|1|||
126324753|NCT02187029|454483772|FG002|Overall Study|Adverse Event|1|||
126324754|NCT02187029|454483773|FG003|Overall Study|Adverse Event|0|||
126324755|NCT02187029|454483770|FG000|Overall Study|Study Terminated by Sponsor|0|||
126324756|NCT02187029|454483771|FG001|Overall Study|Study Terminated by Sponsor|0|||
126324757|NCT02187029|454483772|FG002|Overall Study|Study Terminated by Sponsor|10|||
126324758|NCT02187029|454483773|FG003|Overall Study|Study Terminated by Sponsor|3|||
126324759|NCT02187029|454483770|FG000|Overall Study|Withdrawal by Subject|1|||
126324760|NCT02187029|454483771|FG001|Overall Study|Withdrawal by Subject|0|||
126324761|NCT02187029|454483772|FG002|Overall Study|Withdrawal by Subject|0|||
126324762|NCT02187029|454483773|FG003|Overall Study|Withdrawal by Subject|0|||
126324763|NCT03042910|454483774|FG000|Overall Study|Adverse Event|1|||
126324764|NCT03042910|454483774|FG000|Overall Study|Disease Progression|2|||
126324765|NCT03042910|454483774|FG000|Overall Study|Withdrawal by Subject|3|||
126324766|NCT03042910|454483774|FG000|Overall Study|Enrolled but not treated|1|||
126324767|NCT01491841|454483779|FG000|Overall Study|Screen Failure|10|||
126324768|NCT01491841|454483779|FG000|Overall Study|Withdrawal by Subject|1|||
126324769|NCT02933528|454483780|FG000|Overall Study|Lost to Follow-up|2|||
126324770|NCT04472494|454483782|FG000|Pre-treatment|Other reasons|2|||
126324771|NCT04472494|454483783|FG001|Pre-treatment|Other reasons|0|||
126324772|NCT04472494|454483782|FG000|Treatment|Death|5|||
126324773|NCT04472494|454483783|FG001|Treatment|Death|2|||
126324774|NCT04472494|454483782|FG000|Treatment|Hospital discharge|1|||
126324775|NCT04472494|454483783|FG001|Treatment|Hospital discharge|1|||
126324776|NCT01308463|454483784|FG000|Overall Study|Study Discontinued|23|||
126324777|NCT01308463|454483784|FG000|Overall Study|Death|4|||
126324778|NCT01308463|454483784|FG000|Overall Study|Revision|2|||
126324779|NCT03297021|454483785|FG000|Overall Study|Incomplete/illegible data sheet|4|||
126324780|NCT03297021|454483786|FG001|Overall Study|Incomplete/illegible data sheet|2|||
126324781|NCT03297021|454483787|FG002|Overall Study|Incomplete/illegible data sheet|3|||
126324782|NCT03297021|454483785|FG000|Overall Study|Missing Post-Op Data|1|||
126324783|NCT03297021|454483786|FG001|Overall Study|Missing Post-Op Data|2|||
126324784|NCT03297021|454483787|FG002|Overall Study|Missing Post-Op Data|1|||
126324785|NCT02784288|454483788|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
126324786|NCT02734862|454483789|FG000|Part A|Death|3|||
126324787|NCT02734862|454483790|FG001|Part A|Death|4|||
126324788|NCT02734862|454483791|FG002|Part A|Death|6|||
126324789|NCT02734862|454483789|FG000|Part A|Lost to Follow-up|2|||
126324790|NCT02734862|454483790|FG001|Part A|Lost to Follow-up|1|||
126324791|NCT02734862|454483791|FG002|Part A|Lost to Follow-up|1|||
126324792|NCT02734862|454483789|FG000|Part A|Withdrawal by Subject|1|||
126324793|NCT02734862|454483790|FG001|Part A|Withdrawal by Subject|1|||
126324794|NCT02734862|454483791|FG002|Part A|Withdrawal by Subject|2|||
126324795|NCT02734862|454483789|FG000|Part A|Physician Decision|2|||
126324796|NCT02734862|454483790|FG001|Part A|Physician Decision|0|||
126324797|NCT02734862|454483791|FG002|Part A|Physician Decision|1|||
126324798|NCT02734862|454483789|FG000|Part A|Adverse Event|2|||
126324799|NCT02734862|454483790|FG001|Part A|Adverse Event|0|||
126653330|NCT03541174|455689099|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
126324800|NCT02734862|454483791|FG002|Part A|Adverse Event|1|||
126324801|NCT02734862|454483789|FG000|Part A|Noncompliance|1|||
126324802|NCT02734862|454483790|FG001|Part A|Noncompliance|1|||
126324803|NCT02734862|454483791|FG002|Part A|Noncompliance|0|||
126324804|NCT02734862|454483789|FG000|Part A|Other|1|||
126324805|NCT02734862|454483790|FG001|Part A|Other|1|||
126324806|NCT02734862|454483791|FG002|Part A|Other|3|||
126324807|NCT02734862|454483789|FG000|Part B|Death|8|||
126324808|NCT02734862|454483790|FG001|Part B|Death|3|||
126324809|NCT02734862|454483791|FG002|Part B|Death|5|||
126324810|NCT02734862|454483789|FG000|Part B|Lost to Follow-up|2|||
126324811|NCT02734862|454483790|FG001|Part B|Lost to Follow-up|2|||
126324812|NCT02734862|454483791|FG002|Part B|Lost to Follow-up|0|||
126324813|NCT02734862|454483789|FG000|Part B|Withdrawal by Subject|3|||
126324814|NCT02734862|454483790|FG001|Part B|Withdrawal by Subject|1|||
126324815|NCT02734862|454483791|FG002|Part B|Withdrawal by Subject|0|||
126324816|NCT02734862|454483789|FG000|Part B|Other|0|||
126653331|NCT03541174|455689100|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
126653332|NCT03541174|455689101|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
126324817|NCT02734862|454483790|FG001|Part B|Other|1|||
126324818|NCT02734862|454483791|FG002|Part B|Other|0|||
126324819|NCT02757625|454483792|FG000|Overall Study|Investigator's discretion|0|||
126324820|NCT02757625|454483793|FG001|Overall Study|Investigator's discretion|0|||
126324821|NCT02757625|454483794|FG002|Overall Study|Investigator's discretion|1|||
126324822|NCT02757625|454483795|FG003|Overall Study|Investigator's discretion|0|||
126324823|NCT02757625|454483792|FG000|Overall Study|Adverse Event|0|||
126324824|NCT02757625|454483793|FG001|Overall Study|Adverse Event|0|||
126324825|NCT02757625|454483794|FG002|Overall Study|Adverse Event|1|||
126324826|NCT02757625|454483795|FG003|Overall Study|Adverse Event|0|||
126324827|NCT04854057|454483796|FG000|Overall Study|Adverse Event|0|||
126324828|NCT04854057|454483797|FG001|Overall Study|Adverse Event|1|||
126324829|NCT02131233|454483798|FG000|Overall Study|Not Treated|2|||
126324830|NCT02131233|454483799|FG001|Overall Study|Not Treated|3|||
126324831|NCT02131233|454483798|FG000|Overall Study|Adverse Event|7|||
126324832|NCT02131233|454483799|FG001|Overall Study|Adverse Event|6|||
126324833|NCT02131233|454483798|FG000|Overall Study|Death|0|||
126324834|NCT02131233|454483799|FG001|Overall Study|Death|1|||
126324835|NCT02131233|454483798|FG000|Overall Study|Lack of Efficacy|6|||
126324836|NCT02131233|454483799|FG001|Overall Study|Lack of Efficacy|3|||
126324837|NCT02131233|454483798|FG000|Overall Study|Lost to Follow-up|14|||
126324838|NCT02131233|454483799|FG001|Overall Study|Lost to Follow-up|13|||
126324839|NCT02131233|454483798|FG000|Overall Study|Non-Compliance With Study Drug|8|||
126324840|NCT02131233|454483799|FG001|Overall Study|Non-Compliance With Study Drug|5|||
126324841|NCT02131233|454483798|FG000|Overall Study|Physician Decision|7|||
126324842|NCT02131233|454483799|FG001|Overall Study|Physician Decision|0|||
126324843|NCT02131233|454483798|FG000|Overall Study|Pregnancy|4|||
126324844|NCT02131233|454483799|FG001|Overall Study|Pregnancy|0|||
126324845|NCT02131233|454483798|FG000|Overall Study|Withdrawal by Subject|18|||
126324846|NCT02131233|454483799|FG001|Overall Study|Withdrawal by Subject|11|||
126324847|NCT03519919|454483800|FG000|Overall Study|Withdrawal by Subject|1|||
126324848|NCT03519919|454483800|FG000|Overall Study|Lack of Efficacy|1|||
126324849|NCT03519919|454483800|FG000|Overall Study|Screen Failure|1|||
126324850|NCT02095197|454483801|FG000|Overall Study|Lost to Follow-up|0|||
126324851|NCT02095197|454483802|FG001|Overall Study|Lost to Follow-up|3|||
126653333|NCT03541174|455689102|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
126653334|NCT03541174|455689097|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
126653335|NCT03541174|455689098|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
126653336|NCT03541174|455689099|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
126653337|NCT03541174|455689100|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
126653338|NCT03541174|455689101|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
126653339|NCT03541174|455689102|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
126653340|NCT03541174|455689097|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
126653341|NCT03541174|455689098|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
126653342|NCT03541174|455689099|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
126653343|NCT03541174|455689100|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
126653344|NCT03541174|455689101|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
126653345|NCT03541174|455689102|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
126653346|NCT03541174|455689097|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
126653347|NCT03541174|455689098|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
126653348|NCT03541174|455689099|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
126653349|NCT03541174|455689100|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
126653350|NCT03541174|455689101|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
126653351|NCT03541174|455689102|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
126653352|NCT03541174|455689097|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
126653353|NCT03541174|455689098|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
126653354|NCT03541174|455689099|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
126653355|NCT03541174|455689100|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
126653356|NCT03541174|455689101|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
126653357|NCT03541174|455689102|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
126653358|NCT02217332|455689105|FG000|Overall Study|Adverse Event|3|||
126324852|NCT02829047|454483803|FG000|Overall Study|Withdrawal by Subject|1|||
126324853|NCT01909973|454483804|FG000|Overall Study|Lost to Follow-up|1|||
126324854|NCT01909973|454483805|FG001|Overall Study|Lost to Follow-up|0|||
126324855|NCT00460239|454483806|FG000|Overall Study|Physician Decision|0|||
126324856|NCT00460239|454483807|FG001|Overall Study|Physician Decision|1|||
126324857|NCT00460239|454483808|FG002|Overall Study|Physician Decision|0|||
126324858|NCT00460239|454483809|FG003|Overall Study|Physician Decision|0|||
126324859|NCT00460239|454483810|FG004|Overall Study|Physician Decision|0|||
126324860|NCT00460239|454483811|FG005|Overall Study|Physician Decision|2|||
126324861|NCT00460239|454483812|FG006|Overall Study|Physician Decision|0|||
126653359|NCT02217332|455689105|FG000|Overall Study|Dose interruption >1 month|1|||
126653360|NCT02217332|455689105|FG000|Overall Study|Protocol Violation (eligibility)|1|||
126653361|NCT02217332|455689105|FG000|Overall Study|Withdrawal by Subject|1|||
126653362|NCT02217332|455689105|FG000|Overall Study|Lost to Follow-up|1|||
126653363|NCT04058366|455689106|FG000|Overall Study|Adverse Event|14|||
126653364|NCT04058366|455689106|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
126653365|NCT04058366|455689106|FG000|Overall Study|Commercial drug is available for participants|6|||
126653366|NCT04058366|455689106|FG000|Overall Study|Death|1|||
126653367|NCT04058366|455689106|FG000|Overall Study|Other non-compliance|2|||
126653368|NCT04058366|455689106|FG000|Overall Study|Other|6|||
126653369|NCT00603304|455689107|FG000|Overall Study|Lost to Follow-up|5|||
126653370|NCT00603304|455689108|FG001|Overall Study|Lost to Follow-up|7|||
126653371|NCT00603304|455689107|FG000|Overall Study|Withdrawal by Subject|8|||
126653372|NCT00603304|455689108|FG001|Overall Study|Withdrawal by Subject|5|||
126653373|NCT00603304|455689107|FG000|Overall Study|Protocol Violation|1|||
126653374|NCT00603304|455689108|FG001|Overall Study|Protocol Violation|0|||
126653375|NCT00603304|455689107|FG000|Overall Study|Adverse Event|4|||
126653376|NCT00603304|455689108|FG001|Overall Study|Adverse Event|2|||
126653377|NCT00603304|455689107|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
126653378|NCT00603304|455689108|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
126653379|NCT00603304|455689107|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
126653380|NCT00603304|455689108|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
126653381|NCT00603304|455689107|FG000|Overall Study|Exclusionary Medication|2|||
126653382|NCT00603304|455689108|FG001|Overall Study|Exclusionary Medication|3|||
126653383|NCT00603304|455689107|FG000|Overall Study|Non-Compliant|0|||
126653384|NCT00603304|455689108|FG001|Overall Study|Non-Compliant|1|||
126653385|NCT00603304|455689107|FG000|Overall Study|Moved Away|0|||
126653386|NCT00603304|455689108|FG001|Overall Study|Moved Away|2|||
126653387|NCT00603304|455689107|FG000|Overall Study|Other|2|||
126653388|NCT00603304|455689108|FG001|Overall Study|Other|0|||
126653389|NCT00603304|455689107|FG000|Overall Study|Patient Decision|2|||
126653390|NCT00603304|455689108|FG001|Overall Study|Patient Decision|0|||
126653391|NCT04343872|455689109|FG000|Overall Study|Lost to Follow-up|6|||
126653392|NCT04343872|455689110|FG001|Overall Study|Lost to Follow-up|3|||
126653393|NCT03730480|455689111|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
126653394|NCT02480153|455689112|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
126653395|NCT02480153|455689113|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
126653396|NCT02480153|455689114|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
126653397|NCT02480153|455689112|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
126653398|NCT02480153|455689113|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
126653399|NCT02480153|455689114|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
126653400|NCT02480153|455689112|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
126653401|NCT02480153|455689113|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
126653402|NCT02480153|455689114|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
126653403|NCT02480153|455689112|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
126653404|NCT02480153|455689113|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
126324862|NCT00460239|454483813|FG007|Overall Study|Physician Decision|0|||
126324863|NCT00460239|454483814|FG008|Overall Study|Physician Decision|0|||
126324864|NCT00460239|454483806|FG000|Overall Study|Withdrawal by Subject|0|||
126324865|NCT00460239|454483807|FG001|Overall Study|Withdrawal by Subject|0|||
126324866|NCT00460239|454483808|FG002|Overall Study|Withdrawal by Subject|0|||
126324867|NCT00460239|454483809|FG003|Overall Study|Withdrawal by Subject|0|||
126324868|NCT00460239|454483810|FG004|Overall Study|Withdrawal by Subject|0|||
126324869|NCT00460239|454483811|FG005|Overall Study|Withdrawal by Subject|1|||
126324870|NCT00460239|454483812|FG006|Overall Study|Withdrawal by Subject|0|||
126324871|NCT00460239|454483813|FG007|Overall Study|Withdrawal by Subject|0|||
126324872|NCT00460239|454483814|FG008|Overall Study|Withdrawal by Subject|0|||
126324873|NCT04217317|454483843|FG000|Overall Study|Lack of Efficacy|4|||
126324874|NCT04217317|454483843|FG000|Overall Study|Physician Decision|1|||
126324875|NCT01690299|454483844|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
126324876|NCT01690299|454483845|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
126324877|NCT01690299|454483846|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
126653405|NCT02480153|455689114|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
126653406|NCT02480153|455689112|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
126653407|NCT02480153|455689113|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
126653408|NCT02480153|455689114|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
126653409|NCT02480153|455689112|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
126653410|NCT02480153|455689113|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
126324878|NCT01690299|454483847|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
126324879|NCT01690299|454483848|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
126324880|NCT01690299|454483849|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
126653411|NCT02480153|455689114|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
126653412|NCT02480153|455689112|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
126653413|NCT02480153|455689113|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
126653414|NCT02480153|455689114|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
126653415|NCT02480153|455689112|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
126653416|NCT02480153|455689113|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
126653417|NCT02480153|455689114|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
126653418|NCT02480153|455689112|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
126653419|NCT02480153|455689113|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
126653420|NCT02480153|455689114|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
126653421|NCT02480153|455689112|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
126653422|NCT02480153|455689113|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
126653423|NCT02480153|455689114|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
126653424|NCT02480153|455689112|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
126653425|NCT02480153|455689113|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
126653426|NCT02480153|455689114|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
126653427|NCT02480153|455689112|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
126653428|NCT02480153|455689113|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
126653429|NCT02480153|455689114|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
126653430|NCT02480153|455689112|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
126653431|NCT02480153|455689113|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
126653432|NCT02480153|455689114|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
126653433|NCT02480153|455689112|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
126653434|NCT02480153|455689113|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
126653435|NCT02480153|455689114|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
126653436|NCT02480153|455689112|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
126653437|NCT02480153|455689113|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
126653438|NCT02480153|455689114|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
126653439|NCT02480153|455689112|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
126324881|NCT01690299|454483844|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
126324882|NCT01690299|454483845|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126324883|NCT01690299|454483846|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126324884|NCT01690299|454483847|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126324885|NCT01690299|454483848|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126324886|NCT01690299|454483849|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126324887|NCT01690299|454483844|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
126324888|NCT01690299|454483845|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
126324889|NCT01690299|454483846|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126324890|NCT01690299|454483847|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126324891|NCT01690299|454483848|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126324892|NCT01690299|454483849|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126324893|NCT01690299|454483844|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
126324894|NCT01690299|454483845|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
126324895|NCT01690299|454483846|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
126324896|NCT01690299|454483847|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
126324897|NCT01690299|454483848|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
126324898|NCT01690299|454483849|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
126324899|NCT01690299|454483844|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
126324900|NCT01690299|454483845|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
126324901|NCT01690299|454483846|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
126324902|NCT01690299|454483847|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
126324903|NCT01690299|454483848|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
126324904|NCT01690299|454483849|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
126324905|NCT01690299|454483844|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
126324906|NCT01690299|454483845|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
126324907|NCT01690299|454483846|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
126324908|NCT01690299|454483847|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
126324909|NCT01690299|454483848|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
126324910|NCT01690299|454483849|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
126324911|NCT01690299|454483844|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
126324912|NCT01690299|454483845|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
126324913|NCT01690299|454483846|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
126324914|NCT01690299|454483847|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
126324915|NCT01690299|454483848|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
126324916|NCT01690299|454483849|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
126653440|NCT02480153|455689113|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
126653441|NCT02480153|455689114|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
126653442|NCT02480153|455689112|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
126653443|NCT02480153|455689113|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
126653444|NCT02480153|455689114|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
126653445|NCT02480153|455689112|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
126324917|NCT01690299|454483844|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
126324918|NCT01690299|454483845|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
126324919|NCT01690299|454483846|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
126324920|NCT01690299|454483847|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
126324921|NCT01690299|454483848|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
126324922|NCT01690299|454483849|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
126324923|NCT01690299|454483844|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
126324924|NCT01690299|454483845|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
126324925|NCT01690299|454483846|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
126324926|NCT01690299|454483847|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
126324927|NCT01690299|454483848|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
126324928|NCT01690299|454483849|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
126324929|NCT01690299|454483844|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
126324930|NCT01690299|454483845|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
126324931|NCT01690299|454483846|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
126324932|NCT01690299|454483847|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
126324933|NCT01690299|454483848|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
126324934|NCT01690299|454483849|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
126324935|NCT01753115|454483850|FG000|Overall Study|Lost to Follow-up|3|||
126324936|NCT01753115|454483851|FG001|Overall Study|Lost to Follow-up|6|||
126324937|NCT01753115|454483852|FG002|Overall Study|Lost to Follow-up|8|||
126324938|NCT01753115|454483850|FG000|Overall Study|Withdrawal by Subject|6|||
126324939|NCT01753115|454483851|FG001|Overall Study|Withdrawal by Subject|5|||
126324940|NCT01753115|454483852|FG002|Overall Study|Withdrawal by Subject|6|||
126324941|NCT01753115|454483850|FG000|Overall Study|Subject non-compliant|3|||
126653446|NCT02480153|455689113|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
126653447|NCT02480153|455689114|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
126653448|NCT00512317|455689115|FG000|Overall Study|Insufficient clinical response|36|||
126653449|NCT00512317|455689115|FG000|Overall Study|Withdrawal by Subject|23|||
126653450|NCT00512317|455689115|FG000|Overall Study|Sponsor closure of study|21|||
126653451|NCT00512317|455689115|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
126653452|NCT00512317|455689115|FG000|Overall Study|Adverse Event|13|||
126653453|NCT00512317|455689115|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
126653454|NCT00512317|455689115|FG000|Overall Study|Lost to Follow-up|2|||
126653455|NCT00512317|455689115|FG000|Overall Study|Other|2|||
126653456|NCT00007345|455689116|FG000|Overall Study|Refused further treatment|0|||
126653457|NCT00007345|455689117|FG001|Overall Study|Refused further treatment|7|||
126653458|NCT00007345|455689116|FG000|Overall Study|Switched to alternative treatment|0|||
126653459|NCT00007345|455689117|FG001|Overall Study|Switched to alternative treatment|3|||
126653460|NCT00007345|455689116|FG000|Overall Study|Intercurrent illness|1|||
126653461|NCT00007345|455689117|FG001|Overall Study|Intercurrent illness|0|||
126653462|NCT00007345|455689116|FG000|Overall Study|Death on study|1|||
126653463|NCT00007345|455689117|FG001|Overall Study|Death on study|1|||
126653464|NCT04433585|455689118|FG000|Overall Study|Withdrawal by Subject|15|||
126653465|NCT04433585|455689119|FG001|Overall Study|Withdrawal by Subject|3|||
126653466|NCT04433585|455689120|FG002|Overall Study|Withdrawal by Subject|15|||
126653467|NCT04433585|455689121|FG003|Overall Study|Withdrawal by Subject|6|||
126653468|NCT04433585|455689118|FG000|Overall Study|Adverse Event|10|||
126653469|NCT04433585|455689119|FG001|Overall Study|Adverse Event|4|||
126653470|NCT04433585|455689120|FG002|Overall Study|Adverse Event|1|||
126653471|NCT04433585|455689121|FG003|Overall Study|Adverse Event|0|||
126653472|NCT04433585|455689118|FG000|Overall Study|Due to the conflict in Ukraine|2|||
126653473|NCT04433585|455689119|FG001|Overall Study|Due to the conflict in Ukraine|1|||
126653474|NCT04433585|455689120|FG002|Overall Study|Due to the conflict in Ukraine|1|||
126653475|NCT04433585|455689121|FG003|Overall Study|Due to the conflict in Ukraine|2|||
126653476|NCT04433585|455689118|FG000|Overall Study|Physician Decision|1|||
126324942|NCT01753115|454483851|FG001|Overall Study|Subject non-compliant|3|||
126653477|NCT04433585|455689119|FG001|Overall Study|Physician Decision|2|||
126653478|NCT04433585|455689120|FG002|Overall Study|Physician Decision|0|||
126653479|NCT04433585|455689121|FG003|Overall Study|Physician Decision|0|||
126653480|NCT04433585|455689118|FG000|Overall Study|Lost to Follow-up|1|||
126653481|NCT04433585|455689119|FG001|Overall Study|Lost to Follow-up|1|||
126653482|NCT04433585|455689120|FG002|Overall Study|Lost to Follow-up|1|||
126653483|NCT04433585|455689121|FG003|Overall Study|Lost to Follow-up|0|||
126324943|NCT01753115|454483852|FG002|Overall Study|Subject non-compliant|0|||
126324944|NCT01753115|454483850|FG000|Overall Study|Used excluded drug|0|||
126653484|NCT04433585|455689118|FG000|Overall Study|Lack of Efficacy|0|||
126653485|NCT04433585|455689119|FG001|Overall Study|Lack of Efficacy|1|||
126653486|NCT04433585|455689120|FG002|Overall Study|Lack of Efficacy|1|||
126653487|NCT04433585|455689121|FG003|Overall Study|Lack of Efficacy|1|||
126653488|NCT04433585|455689118|FG000|Overall Study|Death|0|||
126653489|NCT04433585|455689119|FG001|Overall Study|Death|1|||
126653490|NCT04433585|455689120|FG002|Overall Study|Death|0|||
126653491|NCT04433585|455689121|FG003|Overall Study|Death|0|||
126653492|NCT02342743|455689122|FG000|Baseline Period|Withdrawal by Subject|3|||
126653493|NCT02342743|455689122|FG000|Baseline Period|Lost to Follow-up|2|||
126653494|NCT02342743|455689122|FG000|Baseline Period|Change in prophylactic medication|3|||
126653495|NCT02342743|455689122|FG000|Baseline Period|Screening failure regarding baseline|7|||
126653496|NCT02342743|455689122|FG000|Treatment Period|Withdrawal by Subject|2|||
126653497|NCT02342743|455689122|FG000|Treatment Period|Lost to Follow-up|8|||
126653498|NCT02342743|455689122|FG000|Treatment Period|Change in prophylactic medication|1|||
126653499|NCT04875676|455689123|FG000|Overall Study|Lost to Follow-up|1|||
126653500|NCT04875676|455689124|FG001|Overall Study|Lost to Follow-up|0|||
126653501|NCT04875676|455689125|FG002|Overall Study|Lost to Follow-up|0|||
126653502|NCT02937454|455689130|FG000|Overall Study|Adverse Event|0|||
126653503|NCT02937454|455689131|FG001|Overall Study|Adverse Event|1|||
126653504|NCT02937454|455689130|FG000|Overall Study|Death|98|||
126653505|NCT02937454|455689131|FG001|Overall Study|Death|95|||
126653506|NCT02937454|455689130|FG000|Overall Study|Lost to Follow-up|1|||
126653507|NCT02937454|455689131|FG001|Overall Study|Lost to Follow-up|1|||
126653508|NCT02937454|455689130|FG000|Overall Study|Physician Decision|0|||
126653509|NCT02937454|455689131|FG001|Overall Study|Physician Decision|1|||
126653510|NCT02937454|455689130|FG000|Overall Study|Protocol Violation|6|||
126653511|NCT02937454|455689131|FG001|Overall Study|Protocol Violation|10|||
126653512|NCT02937454|455689130|FG000|Overall Study|Withdrawal by Subject|27|||
126653513|NCT02937454|455689131|FG001|Overall Study|Withdrawal by Subject|15|||
126653514|NCT02937454|455689130|FG000|Overall Study|Other|8|||
126653515|NCT02937454|455689131|FG001|Overall Study|Other|5|||
126653516|NCT02630693|455689132|FG000|Overall Study|No receive treatment|0|||
126653517|NCT02630693|455689133|FG001|Overall Study|No receive treatment|1|||
126653518|NCT01004848|455689135|FG000|Overall Study|Lost to Follow-up|55|||
126653519|NCT01004848|455689136|FG001|Overall Study|Lost to Follow-up|45|||
126653520|NCT01639560|455689137|FG000|Overall Study|Withdrawal by Subject|9|||
126653521|NCT01639560|455689138|FG001|Overall Study|Withdrawal by Subject|14|||
126653522|NCT01639560|455689137|FG000|Overall Study|Lack of Efficacy|1|||
126653523|NCT01639560|455689138|FG001|Overall Study|Lack of Efficacy|2|||
126653524|NCT01639560|455689137|FG000|Overall Study|Lost to Follow-up|9|||
126653525|NCT01639560|455689138|FG001|Overall Study|Lost to Follow-up|11|||
126653526|NCT01639560|455689137|FG000|Overall Study|Adverse Event|0|||
126653527|NCT01639560|455689138|FG001|Overall Study|Adverse Event|2|||
126653528|NCT01160289|455689139|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
126653529|NCT01160289|455689140|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
126653530|NCT01160289|455689141|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
126653531|NCT01160289|455689142|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
126653532|NCT01160289|455689143|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
126653533|NCT01160289|455689144|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
126653534|NCT01160289|455689139|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
126653535|NCT01160289|455689140|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
126653536|NCT01160289|455689141|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
126324945|NCT01753115|454483851|FG001|Overall Study|Used excluded drug|1|||
126324946|NCT01753115|454483852|FG002|Overall Study|Used excluded drug|0|||
126324947|NCT04313400|454483856|FG000|Overall Study|Withdrawal by Subject|0|||
126324948|NCT04313400|454483857|FG001|Overall Study|Withdrawal by Subject|0|||
126324949|NCT04313400|454483858|FG002|Overall Study|Withdrawal by Subject|0|||
126324950|NCT04313400|454483859|FG003|Overall Study|Withdrawal by Subject|0|||
126324951|NCT04313400|454483860|FG004|Overall Study|Withdrawal by Subject|0|||
126324952|NCT04313400|454483861|FG005|Overall Study|Withdrawal by Subject|4|||
126324953|NCT04313400|454483862|FG006|Overall Study|Withdrawal by Subject|1|||
126324954|NCT04313400|454483856|FG000|Overall Study|Adverse Event|0|||
126324955|NCT04313400|454483857|FG001|Overall Study|Adverse Event|0|||
126324956|NCT04313400|454483858|FG002|Overall Study|Adverse Event|0|||
126324957|NCT04313400|454483859|FG003|Overall Study|Adverse Event|0|||
126324958|NCT04313400|454483860|FG004|Overall Study|Adverse Event|0|||
126324959|NCT04313400|454483861|FG005|Overall Study|Adverse Event|1|||
126653537|NCT01160289|455689142|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
126653538|NCT01160289|455689143|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
126653539|NCT01160289|455689144|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
126653540|NCT01160289|455689139|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
126653541|NCT01160289|455689140|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
126653542|NCT01160289|455689141|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
126653543|NCT01160289|455689142|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
126653544|NCT01160289|455689143|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
126653545|NCT01160289|455689144|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
126653546|NCT01160289|455689139|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
126653547|NCT01160289|455689140|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
126324960|NCT04313400|454483862|FG006|Overall Study|Adverse Event|0|||
126324961|NCT04313400|454483856|FG000|Overall Study|Lost to Follow-up|0|||
126324962|NCT04313400|454483857|FG001|Overall Study|Lost to Follow-up|0|||
126324963|NCT04313400|454483858|FG002|Overall Study|Lost to Follow-up|0|||
126324964|NCT04313400|454483859|FG003|Overall Study|Lost to Follow-up|0|||
126324965|NCT04313400|454483860|FG004|Overall Study|Lost to Follow-up|0|||
126324966|NCT04313400|454483861|FG005|Overall Study|Lost to Follow-up|1|||
126324967|NCT04313400|454483862|FG006|Overall Study|Lost to Follow-up|0|||
126324968|NCT00496587|454483867|FG000|Overall Study|Adverse Event|2|||
126324969|NCT00496587|454483867|FG000|Overall Study|Progressive Disease|24|||
126324970|NCT00496587|454483867|FG000|Overall Study|Withdrawal by Subject|2|||
126653548|NCT01160289|455689141|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
126653549|NCT01160289|455689142|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
126653550|NCT01160289|455689143|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
126653551|NCT01160289|455689144|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
126653552|NCT01160289|455689139|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
126653553|NCT01160289|455689140|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
126653554|NCT01160289|455689141|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
126653555|NCT01160289|455689142|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
126653556|NCT01160289|455689143|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
126653557|NCT01160289|455689144|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
126653558|NCT01160289|455689139|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
126653559|NCT01160289|455689140|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
126653560|NCT01160289|455689141|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
126653561|NCT01160289|455689142|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
126653562|NCT01160289|455689143|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
126653563|NCT01160289|455689144|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
126653564|NCT01160289|455689139|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
126653565|NCT01160289|455689140|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
126653566|NCT01160289|455689141|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
126324971|NCT00496587|454483867|FG000|Overall Study|Death|1|||
126324972|NCT00496587|454483867|FG000|Overall Study|Complications unrelated|2|||
126324973|NCT01808222|454483870|FG000|Overall Study|mpMR scan was not performed|1|||
126324974|NCT02383355|454483871|FG000|Overall Study|Adverse Event|2|||
126324975|NCT02383355|454483872|FG001|Overall Study|Adverse Event|0|||
126324976|NCT01146561|454483874|FG000|Overall Study|Withdrawal by Subject|1|||
126324977|NCT01146561|454483874|FG000|Overall Study|Lost to Follow-up|1|||
126324978|NCT01778751|454483876|FG000|Overall Study|Lost to Follow-up|1|||
126324979|NCT01778751|454483877|FG001|Overall Study|Lost to Follow-up|0|||
126324980|NCT01778751|454483876|FG000|Overall Study|Withdrawal by Subject|0|||
126324981|NCT01778751|454483877|FG001|Overall Study|Withdrawal by Subject|2|||
126324982|NCT01778751|454483876|FG000|Overall Study|Transfered care|1|||
126324983|NCT01778751|454483877|FG001|Overall Study|Transfered care|0|||
126324984|NCT03628716|454483880|FG000|Overall Study|Adverse Event|1|||
126324985|NCT03628716|454483881|FG001|Overall Study|Adverse Event|1|||
126324986|NCT03628716|454483880|FG000|Overall Study|Death|1|||
126324987|NCT03628716|454483881|FG001|Overall Study|Death|0|||
126324988|NCT03628716|454483880|FG000|Overall Study|Lack of Efficacy|15|||
126324989|NCT03628716|454483881|FG001|Overall Study|Lack of Efficacy|20|||
126324990|NCT03628716|454483880|FG000|Overall Study|Withdrawal by Subject|1|||
126324991|NCT03628716|454483881|FG001|Overall Study|Withdrawal by Subject|2|||
126324992|NCT03628716|454483880|FG000|Overall Study|Study Terminated by Sponsor|1|||
126324993|NCT03628716|454483881|FG001|Overall Study|Study Terminated by Sponsor|0|||
126324994|NCT01994902|454483882|FG000|Test Period 1|Withdrawal by Subject|3|||
126324995|NCT01994902|454483883|FG001|Test Period 1|Withdrawal by Subject|0|||
126324996|NCT01994902|454483882|FG000|Test Period 1|device deficiency with adverse event|0|||
126324997|NCT01994902|454483883|FG001|Test Period 1|device deficiency with adverse event|1|||
126324998|NCT01994902|454483882|FG000|Test Period 1|Adverse Event|2|||
126324999|NCT01994902|454483883|FG001|Test Period 1|Adverse Event|1|||
126325000|NCT01994902|454483882|FG000|Test Period 1|Lack of Efficacy|0|||
126325001|NCT01994902|454483883|FG001|Test Period 1|Lack of Efficacy|1|||
126325002|NCT01994902|454483882|FG000|Test Period 1|bag too small|1|||
126325003|NCT01994902|454483883|FG001|Test Period 1|bag too small|0|||
126325004|NCT01994902|454483882|FG000|Test Period 2|Withdrawal by Subject|0|||
126325005|NCT01994902|454483883|FG001|Test Period 2|Withdrawal by Subject|2|||
126325006|NCT01994902|454483882|FG000|Test Period 2|Lack of Efficacy|0|||
126325007|NCT01994902|454483883|FG001|Test Period 2|Lack of Efficacy|1|||
126325008|NCT01994902|454483882|FG000|Test Period 2|Other|0|||
126325009|NCT01994902|454483883|FG001|Test Period 2|Other|3|||
126325010|NCT00467558|454483884|FG000|Overall Study|Lost to Follow-up|2|||
126653567|NCT01160289|455689142|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
126653568|NCT01160289|455689143|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
126653569|NCT01160289|455689144|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
126653570|NCT01160289|455689139|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
126653571|NCT01160289|455689140|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
126653572|NCT01160289|455689141|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
126653573|NCT01160289|455689142|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
126653574|NCT01160289|455689143|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
126653575|NCT01160289|455689144|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
126653576|NCT01160289|455689139|FG000|Post-Randomization Period|Adverse Event|0|||
126653577|NCT01160289|455689140|FG001|Post-Randomization Period|Adverse Event|4|||
126653578|NCT01160289|455689141|FG002|Post-Randomization Period|Adverse Event|4|||
126653579|NCT01160289|455689142|FG003|Post-Randomization Period|Adverse Event|2|||
126653580|NCT01160289|455689143|FG004|Post-Randomization Period|Adverse Event|0|||
126653581|NCT01160289|455689144|FG005|Post-Randomization Period|Adverse Event|0|||
126653582|NCT01160289|455689139|FG000|Post-Randomization Period|Death|0|||
126653583|NCT01160289|455689140|FG001|Post-Randomization Period|Death|0|||
126653584|NCT01160289|455689141|FG002|Post-Randomization Period|Death|0|||
126653585|NCT01160289|455689142|FG003|Post-Randomization Period|Death|1|||
126653586|NCT01160289|455689143|FG004|Post-Randomization Period|Death|0|||
126653587|NCT01160289|455689144|FG005|Post-Randomization Period|Death|0|||
126653588|NCT01160289|455689139|FG000|Post-Randomization Period|Lack of Efficacy|0|||
126653589|NCT01160289|455689140|FG001|Post-Randomization Period|Lack of Efficacy|1|||
126653590|NCT01160289|455689141|FG002|Post-Randomization Period|Lack of Efficacy|0|||
126653591|NCT01160289|455689142|FG003|Post-Randomization Period|Lack of Efficacy|3|||
126653592|NCT01160289|455689143|FG004|Post-Randomization Period|Lack of Efficacy|0|||
126653593|NCT01160289|455689144|FG005|Post-Randomization Period|Lack of Efficacy|0|||
126653594|NCT01160289|455689139|FG000|Post-Randomization Period|Lost to Follow-up|0|||
126653595|NCT01160289|455689140|FG001|Post-Randomization Period|Lost to Follow-up|3|||
126653596|NCT01160289|455689141|FG002|Post-Randomization Period|Lost to Follow-up|2|||
126653597|NCT01160289|455689142|FG003|Post-Randomization Period|Lost to Follow-up|5|||
126653598|NCT01160289|455689143|FG004|Post-Randomization Period|Lost to Follow-up|3|||
126653599|NCT01160289|455689144|FG005|Post-Randomization Period|Lost to Follow-up|4|||
126653600|NCT01160289|455689139|FG000|Post-Randomization Period|Physician Decision|0|||
126653601|NCT01160289|455689140|FG001|Post-Randomization Period|Physician Decision|0|||
126653602|NCT01160289|455689141|FG002|Post-Randomization Period|Physician Decision|1|||
126653603|NCT01160289|455689142|FG003|Post-Randomization Period|Physician Decision|0|||
126325011|NCT00467558|454483885|FG001|Overall Study|Lost to Follow-up|0|||
126325012|NCT00376532|454485447|FG000|Overall Study|Lack sufficient blood sample|6|||
126325013|NCT00376532|454485448|FG001|Overall Study|Lack sufficient blood sample|6|||
126325014|NCT04227405|454485449|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
126325015|NCT04227405|454485450|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
126325016|NCT04227405|454485449|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
126325017|NCT04227405|454485450|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
126325018|NCT04227405|454485449|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
126325019|NCT04227405|454485450|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
126325020|NCT02757352|454485453|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
126325021|NCT02757352|454485454|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325022|NCT02757352|454485455|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
126325023|NCT02757352|454485456|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325024|NCT02757352|454485457|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325025|NCT02757352|454485458|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325026|NCT02757352|454485459|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325027|NCT02757352|454485460|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325028|NCT02757352|454485461|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325029|NCT02757352|454485462|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
126325030|NCT02757352|454485453|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325031|NCT02757352|454485454|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325032|NCT02757352|454485455|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
126325033|NCT02757352|454485456|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126653604|NCT01160289|455689143|FG004|Post-Randomization Period|Physician Decision|0|||
126325034|NCT02757352|454485457|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325035|NCT02757352|454485458|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126653605|NCT01160289|455689144|FG005|Post-Randomization Period|Physician Decision|0|||
126653606|NCT01160289|455689139|FG000|Post-Randomization Period|Protocol Violation|0|||
126653607|NCT01160289|455689140|FG001|Post-Randomization Period|Protocol Violation|4|||
126653608|NCT01160289|455689141|FG002|Post-Randomization Period|Protocol Violation|2|||
126653609|NCT01160289|455689142|FG003|Post-Randomization Period|Protocol Violation|0|||
126325036|NCT02757352|454485459|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325037|NCT02757352|454485460|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325038|NCT02757352|454485461|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325039|NCT02757352|454485462|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
126325040|NCT02757352|454485453|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
126325041|NCT02757352|454485454|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
126325042|NCT02757352|454485455|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
126653610|NCT01160289|455689143|FG004|Post-Randomization Period|Protocol Violation|1|||
126653611|NCT01160289|455689144|FG005|Post-Randomization Period|Protocol Violation|3|||
126653612|NCT01160289|455689139|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
126653613|NCT01160289|455689140|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
126653614|NCT01160289|455689141|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
126653615|NCT01160289|455689142|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
126653616|NCT01160289|455689143|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
126653617|NCT01160289|455689144|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
126653618|NCT01160289|455689139|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
126653619|NCT01160289|455689140|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
126653620|NCT01160289|455689141|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
126653621|NCT01160289|455689142|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
126653622|NCT01160289|455689143|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
126653623|NCT01160289|455689144|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
126653624|NCT01160289|455689139|FG000|Post-Randomization Period|Sponsor Decision|0|||
126653625|NCT01160289|455689140|FG001|Post-Randomization Period|Sponsor Decision|1|||
126653626|NCT01160289|455689141|FG002|Post-Randomization Period|Sponsor Decision|0|||
126653627|NCT01160289|455689142|FG003|Post-Randomization Period|Sponsor Decision|0|||
126653628|NCT01160289|455689143|FG004|Post-Randomization Period|Sponsor Decision|0|||
126653629|NCT01160289|455689144|FG005|Post-Randomization Period|Sponsor Decision|0|||
126653630|NCT01156792|455689150|FG000|Overall Study|Adverse Event|1|||
126653631|NCT01156792|455689150|FG000|Overall Study|Lack of Efficacy|36|||
126653632|NCT01156792|455689150|FG000|Overall Study|Protocol Violation|6|||
126653633|NCT01156792|455689150|FG000|Overall Study|Lost to Follow-up|3|||
126653634|NCT01156792|455689150|FG000|Overall Study|Physician Decision|3|||
126653635|NCT01156792|455689150|FG000|Overall Study|Withdrawal by Subject|9|||
126653636|NCT01156792|455689150|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
126653637|NCT01474434|455689151|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
126653638|NCT01474434|455689152|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
126653639|NCT01474434|455689153|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
126653640|NCT01474434|455689154|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
126653641|NCT01474434|455689151|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
126653642|NCT01474434|455689152|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
126653643|NCT01474434|455689153|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
126653644|NCT01474434|455689154|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
126653645|NCT01474434|455689151|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
126653646|NCT01474434|455689152|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
126653647|NCT01474434|455689153|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
126653648|NCT01474434|455689154|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
126653649|NCT00993668|455689156|FG000|Single-Blind Period|Adverse Event|1|||
126653650|NCT00993668|455689157|FG001|Single-Blind Period|Adverse Event|1|||
126653651|NCT00993668|455689156|FG000|Single-Blind Period|Lack of Efficacy|0|||
126653652|NCT00993668|455689157|FG001|Single-Blind Period|Lack of Efficacy|1|||
126653653|NCT00993668|455689156|FG000|Single-Blind Period|Lost to Follow-up|3|||
126653654|NCT00993668|455689157|FG001|Single-Blind Period|Lost to Follow-up|1|||
126653655|NCT00993668|455689156|FG000|Open-Label Period|Adverse Event|9|||
126653656|NCT00993668|455689157|FG001|Open-Label Period|Adverse Event|8|||
126653657|NCT00993668|455689156|FG000|Open-Label Period|Lack of Efficacy|4|||
126653658|NCT00993668|455689157|FG001|Open-Label Period|Lack of Efficacy|3|||
126653659|NCT00993668|455689156|FG000|Open-Label Period|Withdrawal by Subject|4|||
126653660|NCT00993668|455689157|FG001|Open-Label Period|Withdrawal by Subject|3|||
126653661|NCT00993668|455689156|FG000|Open-Label Period|Lost to Follow-up|6|||
126653662|NCT00993668|455689157|FG001|Open-Label Period|Lost to Follow-up|1|||
126653663|NCT03606668|455689160|FG000|Overall Study|Screen Failure|1|||
126325043|NCT02757352|454485456|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
126325044|NCT02757352|454485457|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
126325045|NCT02757352|454485458|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
126653664|NCT03606668|455689160|FG000|Overall Study|Lost to Follow-up|1|||
126653665|NCT02057523|455689164|FG000|Overall Study|Withdrawal by Subject|1|||
126325046|NCT02757352|454485459|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
126653666|NCT02057523|455689164|FG000|Overall Study|Lack of Efficacy|1|||
126653667|NCT03618823|455689168|FG000|Overall Study|Lost to Follow-up|63|||
126653668|NCT03618823|455689169|FG001|Overall Study|Lost to Follow-up|61|||
126325047|NCT02757352|454485460|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
126325048|NCT02757352|454485461|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
126325049|NCT02757352|454485462|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
126325050|NCT02757352|454485453|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325051|NCT02757352|454485454|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
126325052|NCT02757352|454485455|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325053|NCT02757352|454485456|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325054|NCT02757352|454485457|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325055|NCT02757352|454485458|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325056|NCT02757352|454485459|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325057|NCT02757352|454485460|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325058|NCT02757352|454485461|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325059|NCT02757352|454485462|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
126325060|NCT02757352|454485453|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325061|NCT02757352|454485454|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
126325062|NCT02757352|454485455|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325063|NCT02757352|454485456|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325064|NCT02757352|454485457|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325065|NCT02757352|454485458|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325066|NCT02757352|454485459|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325067|NCT02757352|454485460|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325068|NCT02757352|454485461|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325069|NCT02757352|454485462|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325070|NCT02757352|454485453|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
126325071|NCT02757352|454485454|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
126325072|NCT02757352|454485455|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
126325073|NCT02757352|454485456|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325074|NCT02757352|454485457|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126653669|NCT00523640|455689170|FG000|Overall Study|Death|1|||
126653670|NCT01621568|455689172|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
126653671|NCT01621568|455689173|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
126653672|NCT01621568|455689172|FG000|Week 5-6 No Treatment|Death|1|||
126653673|NCT01621568|455689173|FG001|Week 5-6 No Treatment|Death|0|||
126653674|NCT02399254|455689174|FG000|Overall Study|Physician Decision|2|||
126653675|NCT00564889|455689176|FG000|Overall Study|Death|7|||
126653676|NCT00564889|455689176|FG000|Overall Study|Adverse Event|12|||
126653677|NCT00564889|455689176|FG000|Overall Study|Alternative treatment|3|||
126653678|NCT00564889|455689176|FG000|Overall Study|Disease progression|3|||
126653679|NCT00564889|455689176|FG000|Overall Study|Other, not specified|4|||
126653680|NCT03500159|455689177|FG000|Overall Study|Study Terminated|2|||
126653681|NCT03500159|455689178|FG001|Overall Study|Study Terminated|1|||
126653682|NCT02292927|455689183|FG000|Overall Study|Protocol Violation|13|||
126653683|NCT02292927|455689184|FG001|Overall Study|Protocol Violation|7|||
126653684|NCT01605916|455689186|FG000|Overall Study|Adverse Event|1|||
126653685|NCT01605916|455689187|FG001|Overall Study|Adverse Event|0|||
126653686|NCT01605916|455689188|FG002|Overall Study|Adverse Event|0|||
126653687|NCT01605916|455689189|FG003|Overall Study|Adverse Event|1|||
126653688|NCT01605916|455689190|FG004|Overall Study|Adverse Event|0|||
126653689|NCT01605916|455689186|FG000|Overall Study|Lack of Efficacy|2|||
126653690|NCT01605916|455689187|FG001|Overall Study|Lack of Efficacy|3|||
126653691|NCT01605916|455689188|FG002|Overall Study|Lack of Efficacy|3|||
126653692|NCT01605916|455689189|FG003|Overall Study|Lack of Efficacy|5|||
126653693|NCT01605916|455689190|FG004|Overall Study|Lack of Efficacy|4|||
126653694|NCT01605916|455689186|FG000|Overall Study|Withdrawal by Subject|1|||
126653695|NCT01605916|455689187|FG001|Overall Study|Withdrawal by Subject|1|||
126653696|NCT01605916|455689188|FG002|Overall Study|Withdrawal by Subject|0|||
126653697|NCT01605916|455689189|FG003|Overall Study|Withdrawal by Subject|0|||
126653698|NCT01605916|455689190|FG004|Overall Study|Withdrawal by Subject|2|||
126653699|NCT01021215|455689200|FG000|Overall Study|Lost to Follow-up|3|||
126653700|NCT01021215|455689201|FG001|Overall Study|Lost to Follow-up|0|||
126653701|NCT01011387|455689207|FG000|Overall Study|Withdrawal by Subject|3|||
126325075|NCT02757352|454485458|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325076|NCT02757352|454485459|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325077|NCT02757352|454485460|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126653702|NCT01011387|455689207|FG000|Overall Study|Adverse Event|2|||
126653703|NCT01011387|455689207|FG000|Overall Study|Protocol Violation|1|||
126653704|NCT02433340|455689208|FG000|Overall Study|Adverse Event|0|||
126653705|NCT02433340|455689209|FG001|Overall Study|Adverse Event|0|||
126653706|NCT02433340|455689210|FG002|Overall Study|Adverse Event|1|||
126653707|NCT02433340|455689211|FG003|Overall Study|Adverse Event|0|||
126653708|NCT02433340|455689208|FG000|Overall Study|Withdrawal by Subject|1|||
126325078|NCT02757352|454485461|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325079|NCT02757352|454485462|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325080|NCT02757352|454485453|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
126325081|NCT02757352|454485454|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
126325082|NCT02757352|454485455|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
126325083|NCT02757352|454485456|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325084|NCT02757352|454485457|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325085|NCT02757352|454485458|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325086|NCT02757352|454485459|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325087|NCT02757352|454485460|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325088|NCT02757352|454485461|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325089|NCT02757352|454485462|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
126325090|NCT02757352|454485453|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325091|NCT02757352|454485454|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325092|NCT02757352|454485455|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325093|NCT02757352|454485456|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
126325094|NCT02757352|454485457|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325095|NCT02757352|454485458|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
126325096|NCT02757352|454485459|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325097|NCT02757352|454485460|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325098|NCT02757352|454485461|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325099|NCT02757352|454485462|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
126325100|NCT02757352|454485453|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325101|NCT02757352|454485454|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325102|NCT02757352|454485455|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325103|NCT02757352|454485456|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
126325104|NCT02757352|454485457|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
126325105|NCT02757352|454485458|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
126325106|NCT02757352|454485459|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325107|NCT02757352|454485460|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325108|NCT02757352|454485461|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325109|NCT02757352|454485462|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
126325110|NCT02757352|454485453|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325111|NCT02757352|454485454|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325112|NCT02757352|454485455|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325113|NCT02757352|454485456|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325114|NCT02757352|454485457|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
126325115|NCT02757352|454485458|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325116|NCT02757352|454485459|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325117|NCT02757352|454485460|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325118|NCT02757352|454485461|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325119|NCT02757352|454485462|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
126325120|NCT02757352|454485453|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325121|NCT02757352|454485454|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325122|NCT02757352|454485455|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325123|NCT02757352|454485456|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325124|NCT02757352|454485457|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325125|NCT02757352|454485458|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
126325126|NCT02757352|454485459|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325127|NCT02757352|454485460|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325128|NCT02757352|454485461|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325129|NCT02757352|454485462|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
126325130|NCT02757352|454485453|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325131|NCT02757352|454485454|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325132|NCT02757352|454485455|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325133|NCT02757352|454485456|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
126325134|NCT02757352|454485457|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
126325135|NCT02757352|454485458|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
126325136|NCT02757352|454485459|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325137|NCT02757352|454485460|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325138|NCT02757352|454485461|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126325139|NCT02757352|454485462|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
126653709|NCT02433340|455689209|FG001|Overall Study|Withdrawal by Subject|0|||
126653710|NCT02433340|455689210|FG002|Overall Study|Withdrawal by Subject|1|||
126653711|NCT02433340|455689211|FG003|Overall Study|Withdrawal by Subject|2|||
126653712|NCT02433340|455689208|FG000|Overall Study|Lost to Follow-up|0|||
126653713|NCT02433340|455689209|FG001|Overall Study|Lost to Follow-up|1|||
126653714|NCT02433340|455689210|FG002|Overall Study|Lost to Follow-up|0|||
126653715|NCT02433340|455689211|FG003|Overall Study|Lost to Follow-up|0|||
126653716|NCT02433340|455689208|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
126653717|NCT02433340|455689209|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
126653718|NCT02433340|455689210|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
126653719|NCT02433340|455689211|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
126653720|NCT02433340|455689208|FG000|Overall Study|Other|0|||
126653721|NCT02433340|455689209|FG001|Overall Study|Other|1|||
126653722|NCT02433340|455689210|FG002|Overall Study|Other|0|||
126653723|NCT02433340|455689211|FG003|Overall Study|Other|0|||
126653724|NCT01178385|455689212|FG000|Overall Study|Withdrawal by Subject|2|||
126653725|NCT01178385|455689213|FG001|Overall Study|Withdrawal by Subject|0|||
126653726|NCT01226095|455689214|FG000|Overall Study|Poor compliance|1|||
126653727|NCT01688830|455689217|FG000|Overall Study|Lost to Follow-up|0|||
126653728|NCT01688830|455689218|FG001|Overall Study|Lost to Follow-up|0|||
126653729|NCT01688830|455689219|FG002|Overall Study|Lost to Follow-up|0|||
126653730|NCT01688830|455689220|FG003|Overall Study|Lost to Follow-up|0|||
126653731|NCT01688830|455689221|FG004|Overall Study|Lost to Follow-up|0|||
126653732|NCT01688830|455689222|FG005|Overall Study|Lost to Follow-up|0|||
126653733|NCT01688830|455689223|FG006|Overall Study|Lost to Follow-up|0|||
126653734|NCT01688830|455689224|FG007|Overall Study|Lost to Follow-up|0|||
126653735|NCT01688830|455689225|FG008|Overall Study|Lost to Follow-up|0|||
126653736|NCT01688830|455689226|FG009|Overall Study|Lost to Follow-up|0|||
126653737|NCT01688830|455689227|FG010|Overall Study|Lost to Follow-up|1|||
126653738|NCT01688830|455689228|FG011|Overall Study|Lost to Follow-up|0|||
126653739|NCT01688830|455689229|FG012|Overall Study|Lost to Follow-up|0|||
126653740|NCT01688830|455689230|FG013|Overall Study|Lost to Follow-up|0|||
126653741|NCT01688830|455689231|FG014|Overall Study|Lost to Follow-up|0|||
126653742|NCT01688830|455689232|FG015|Overall Study|Lost to Follow-up|0|||
126653743|NCT01688830|455689233|FG016|Overall Study|Lost to Follow-up|0|||
126653744|NCT01688830|455689234|FG017|Overall Study|Lost to Follow-up|0|||
126653745|NCT01688830|455689235|FG018|Overall Study|Lost to Follow-up|0|||
126653746|NCT01688830|455689236|FG019|Overall Study|Lost to Follow-up|0|||
126653747|NCT01688830|455689237|FG020|Overall Study|Lost to Follow-up|0|||
126653748|NCT01285609|455689238|FG000|Randomized|Progressive Disease|41|||
126653749|NCT01285609|455689239|FG001|Randomized|Progressive Disease|61|||
126653750|NCT01285609|455689238|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
126653751|NCT01285609|455689239|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
126653752|NCT01285609|455689238|FG000|Randomized|Study Drug Toxicity|13|||
126653753|NCT01285609|455689239|FG001|Randomized|Study Drug Toxicity|14|||
126653754|NCT01285609|455689238|FG000|Randomized|Death|5|||
126653755|NCT01285609|455689239|FG001|Randomized|Death|7|||
126653756|NCT01285609|455689238|FG000|Randomized|Withdrawal by Subject|8|||
126653757|NCT01285609|455689239|FG001|Randomized|Withdrawal by Subject|11|||
126653758|NCT01285609|455689238|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
126653759|NCT01285609|455689239|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
126653760|NCT01285609|455689238|FG000|Randomized|Undisclosed Reasons|1|||
126653761|NCT01285609|455689239|FG001|Randomized|Undisclosed Reasons|0|||
126653762|NCT01285609|455689238|FG000|Randomized|Randomized but not Treated|4|||
126653763|NCT01285609|455689239|FG001|Randomized|Randomized but not Treated|4|||
126653764|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
126653765|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
126653766|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
126653767|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
126653768|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
126653769|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
126653770|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
126653771|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
126653772|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Death|11|||
126653773|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Death|3|||
126653774|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
126653775|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
126653776|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Not Reported|0|||
126653777|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Not Reported|2|||
126653778|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
126653779|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
126653780|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
126653781|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
126653782|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
126653783|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
126653784|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
126653785|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
126325140|NCT02757352|454485453|FG000|Follow-Up Period|Adverse Event|0|||
126325141|NCT02757352|454485454|FG001|Follow-Up Period|Adverse Event|0|||
126325142|NCT02757352|454485455|FG002|Follow-Up Period|Adverse Event|0|||
126653786|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
126653787|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
126325143|NCT02757352|454485456|FG003|Follow-Up Period|Adverse Event|0|||
126325144|NCT02757352|454485457|FG004|Follow-Up Period|Adverse Event|0|||
126325145|NCT02757352|454485458|FG005|Follow-Up Period|Adverse Event|0|||
126325146|NCT02757352|454485459|FG006|Follow-Up Period|Adverse Event|1|||
126325147|NCT02757352|454485460|FG007|Follow-Up Period|Adverse Event|0|||
126325148|NCT02757352|454485461|FG008|Follow-Up Period|Adverse Event|2|||
126325149|NCT02757352|454485462|FG009|Follow-Up Period|Adverse Event|0|||
126325150|NCT02757352|454485453|FG000|Follow-Up Period|Lost to Follow-up|0|||
126325151|NCT02757352|454485454|FG001|Follow-Up Period|Lost to Follow-up|0|||
126325152|NCT02757352|454485455|FG002|Follow-Up Period|Lost to Follow-up|0|||
126325153|NCT02757352|454485456|FG003|Follow-Up Period|Lost to Follow-up|0|||
126325154|NCT02757352|454485457|FG004|Follow-Up Period|Lost to Follow-up|0|||
126325155|NCT02757352|454485458|FG005|Follow-Up Period|Lost to Follow-up|0|||
126325156|NCT02757352|454485459|FG006|Follow-Up Period|Lost to Follow-up|0|||
126325157|NCT02757352|454485460|FG007|Follow-Up Period|Lost to Follow-up|0|||
126325158|NCT02757352|454485461|FG008|Follow-Up Period|Lost to Follow-up|1|||
126325159|NCT02757352|454485462|FG009|Follow-Up Period|Lost to Follow-up|0|||
126325160|NCT02757352|454485453|FG000|Follow-Up Period|Lack of Efficacy|0|||
126325161|NCT02757352|454485454|FG001|Follow-Up Period|Lack of Efficacy|0|||
126325162|NCT02757352|454485455|FG002|Follow-Up Period|Lack of Efficacy|0|||
126325163|NCT02757352|454485456|FG003|Follow-Up Period|Lack of Efficacy|0|||
126325164|NCT02757352|454485457|FG004|Follow-Up Period|Lack of Efficacy|0|||
126325165|NCT02757352|454485458|FG005|Follow-Up Period|Lack of Efficacy|0|||
126325166|NCT02757352|454485459|FG006|Follow-Up Period|Lack of Efficacy|0|||
126325167|NCT02757352|454485460|FG007|Follow-Up Period|Lack of Efficacy|0|||
126325168|NCT02757352|454485461|FG008|Follow-Up Period|Lack of Efficacy|1|||
126325169|NCT02757352|454485462|FG009|Follow-Up Period|Lack of Efficacy|1|||
126325170|NCT02757352|454485453|FG000|Follow-Up Period|Withdrawal by Subject|0|||
126325171|NCT02757352|454485454|FG001|Follow-Up Period|Withdrawal by Subject|0|||
126325172|NCT02757352|454485455|FG002|Follow-Up Period|Withdrawal by Subject|0|||
126325173|NCT02757352|454485456|FG003|Follow-Up Period|Withdrawal by Subject|0|||
126325174|NCT02757352|454485457|FG004|Follow-Up Period|Withdrawal by Subject|0|||
126325175|NCT02757352|454485458|FG005|Follow-Up Period|Withdrawal by Subject|0|||
126325176|NCT02757352|454485459|FG006|Follow-Up Period|Withdrawal by Subject|0|||
126325177|NCT02757352|454485460|FG007|Follow-Up Period|Withdrawal by Subject|1|||
126325178|NCT02757352|454485461|FG008|Follow-Up Period|Withdrawal by Subject|6|||
126325179|NCT02757352|454485462|FG009|Follow-Up Period|Withdrawal by Subject|2|||
126325180|NCT00802672|454485463|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
126325181|NCT00802672|454485464|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
126325182|NCT00802672|454485465|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
126325183|NCT00802672|454485463|FG000|Overall Study|Adverse Event|1|||
126325184|NCT00802672|454485464|FG001|Overall Study|Adverse Event|1|||
126325185|NCT00802672|454485465|FG002|Overall Study|Adverse Event|1|||
126325186|NCT00802672|454485463|FG000|Overall Study|Protocol Violation|2|||
126325187|NCT00802672|454485464|FG001|Overall Study|Protocol Violation|1|||
126325188|NCT00802672|454485465|FG002|Overall Study|Protocol Violation|1|||
126325189|NCT00802672|454485463|FG000|Overall Study|Lost to Follow-up|5|||
126325190|NCT00802672|454485464|FG001|Overall Study|Lost to Follow-up|5|||
126325191|NCT00802672|454485465|FG002|Overall Study|Lost to Follow-up|3|||
126325192|NCT00802672|454485463|FG000|Overall Study|Withdrawal by Subject|1|||
126325193|NCT00802672|454485464|FG001|Overall Study|Withdrawal by Subject|1|||
126325194|NCT00802672|454485465|FG002|Overall Study|Withdrawal by Subject|2|||
126325195|NCT00802672|454485463|FG000|Overall Study|other|3|||
126325196|NCT00802672|454485464|FG001|Overall Study|other|1|||
126653788|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
126325197|NCT00802672|454485465|FG002|Overall Study|other|2|||
126325198|NCT02499263|454485466|FG000|Overall Study|Lost to Follow-up|9|||
126653789|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
126325199|NCT02499263|454485466|FG000|Overall Study|Participant's withdrawal of consent|4|||
126325200|NCT02499263|454485466|FG000|Overall Study|Lack of Efficacy|22|||
126325201|NCT02499263|454485466|FG000|Overall Study|investigator's judgment|12|||
126325202|NCT02499263|454485466|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
126325203|NCT02499263|454485466|FG000|Overall Study|Participant's decision|3|||
126325204|NCT02499263|454485466|FG000|Overall Study|Pregnancy|1|||
126325205|NCT02075008|454485471|FG000|Overall Study|Technical problems|1|||
126325206|NCT02075008|454485471|FG000|Overall Study|Pregnancy|1|||
126325207|NCT02075008|454485471|FG000|Overall Study|Physician Decision|1|||
126325208|NCT02075008|454485471|FG000|Overall Study|Lost to Follow-up|1|||
126325209|NCT02075008|454485471|FG000|Overall Study|Lack of Efficacy|1|||
126325210|NCT02075008|454485471|FG000|Overall Study|Death|1|||
126653790|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
126653791|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
126653792|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
126653793|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
126653794|NCT01285609|455689238|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
126653795|NCT01285609|455689239|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
126653796|NCT01285609|455689238|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
126653797|NCT01285609|455689239|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
126653798|NCT04822597|455689240|FG000|Overall Study|Withdrawal by Subject|0|||
126325211|NCT02075008|454485471|FG000|Overall Study|Adverse Event|5|||
126325212|NCT02075008|454485471|FG000|Overall Study|Withdrawal by Subject|6|||
126325213|NCT02075008|454485471|FG000|Overall Study|Study terminated by Sponsor|159|||
126325214|NCT00660595|454485472|FG000|Overall Study|Lost to Follow-up|0|||
126325215|NCT00660595|454485473|FG001|Overall Study|Lost to Follow-up|1|||
126325216|NCT00660595|454485472|FG000|Overall Study|Did not consent to participate in study|12|||
126325217|NCT00660595|454485473|FG001|Overall Study|Did not consent to participate in study|8|||
126325218|NCT00660595|454485472|FG000|Overall Study|Participant left hospital|1|||
126325219|NCT00660595|454485473|FG001|Overall Study|Participant left hospital|0|||
126325220|NCT00660595|454485472|FG000|Overall Study|Non Specified reasons|5|||
126325221|NCT00660595|454485473|FG001|Overall Study|Non Specified reasons|0|||
126325222|NCT01301079|454485480|FG000|Overall Study|Lost to Follow-up|2|||
126325223|NCT01301079|454485481|FG001|Overall Study|Lost to Follow-up|2|||
126325224|NCT02496039|454485484|FG000|Overall Study|Adverse Event|3|||
126325225|NCT02496039|454485484|FG000|Overall Study|Protocol Violation|1|||
126325226|NCT00571103|454485485|FG000|Overall Study|Withdrawal by Subject|1|||
126325227|NCT00571103|454485485|FG000|Overall Study|Lost to Follow-up|1|||
126325228|NCT00948922|454485488|FG000|Overall Study|Did not start study treatment|2|||
126325229|NCT00948922|454485489|FG001|Overall Study|Did not start study treatment|5|||
126325230|NCT00948922|454485490|FG002|Overall Study|Did not start study treatment|0|||
126325231|NCT00948922|454485488|FG000|Overall Study|Withdrawal by Subject|0|||
126325232|NCT00948922|454485489|FG001|Overall Study|Withdrawal by Subject|2|||
126325233|NCT00948922|454485490|FG002|Overall Study|Withdrawal by Subject|1|||
126325234|NCT00948922|454485488|FG000|Overall Study|Death|3|||
126325235|NCT00948922|454485489|FG001|Overall Study|Death|0|||
126325236|NCT00948922|454485490|FG002|Overall Study|Death|0|||
126325237|NCT00948922|454485488|FG000|Overall Study|Disease progression|0|||
126325238|NCT00948922|454485489|FG001|Overall Study|Disease progression|1|||
126325239|NCT00948922|454485490|FG002|Overall Study|Disease progression|0|||
126325240|NCT00948922|454485488|FG000|Overall Study|Insurance issues|1|||
126325241|NCT00948922|454485489|FG001|Overall Study|Insurance issues|0|||
126325242|NCT00948922|454485490|FG002|Overall Study|Insurance issues|0|||
126325243|NCT00948922|454485488|FG000|Overall Study|Transplant eligibility issues|2|||
126325244|NCT00948922|454485489|FG001|Overall Study|Transplant eligibility issues|3|||
126325245|NCT00948922|454485490|FG002|Overall Study|Transplant eligibility issues|0|||
126325246|NCT00948922|454485488|FG000|Overall Study|Not evaluable at time of analysis|0|||
126325247|NCT00948922|454485489|FG001|Overall Study|Not evaluable at time of analysis|3|||
126325248|NCT00948922|454485490|FG002|Overall Study|Not evaluable at time of analysis|0|||
126325249|NCT00645671|454485491|FG000|Overall Study|Protocol Violation|1|||
126325250|NCT00645671|454485492|FG001|Overall Study|Protocol Violation|0|||
126325251|NCT00645671|454485491|FG000|Overall Study|Withdrawal by Subject|0|||
126325252|NCT00645671|454485492|FG001|Overall Study|Withdrawal by Subject|4|||
126325253|NCT00645671|454485491|FG000|Overall Study|Adverse Event|0|||
126325254|NCT00645671|454485492|FG001|Overall Study|Adverse Event|1|||
126325255|NCT00645671|454485491|FG000|Overall Study|Physician Decision|0|||
126325256|NCT00645671|454485492|FG001|Overall Study|Physician Decision|1|||
126325257|NCT05114564|454485493|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
126325258|NCT05114564|454485494|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
126325259|NCT05114564|454485493|FG000|First Intervention|Adverse Event|0|||
126325260|NCT05114564|454485494|FG001|First Intervention|Adverse Event|1|||
126325261|NCT00493311|454485495|FG000|Overall Study|Need for rescue medication|2|||
126653799|NCT04822597|455689241|FG001|Overall Study|Withdrawal by Subject|1|||
126653800|NCT04822597|455689242|FG002|Overall Study|Withdrawal by Subject|1|||
126325262|NCT00493311|454485496|FG001|Overall Study|Need for rescue medication|2|||
126325263|NCT02779075|454485497|FG000|Overall Study|Withdrawal by Subject|1|||
126325264|NCT02779075|454485498|FG001|Overall Study|Withdrawal by Subject|3|||
126653801|NCT04822597|455689243|FG003|Overall Study|Withdrawal by Subject|0|||
126325265|NCT02779075|454485497|FG000|Overall Study|IV lost during 2nd study|1|||
126325266|NCT02779075|454485498|FG001|Overall Study|IV lost during 2nd study|0|||
126325267|NCT01951573|454485499|FG000|Washout Period|Adverse Event|0|||
126325268|NCT01951573|454485500|FG001|Washout Period|Adverse Event|1|||
126325269|NCT03959527|454485501|FG000|Overall Study|Withdrawal by Subject|8|||
126325270|NCT03959527|454485502|FG001|Overall Study|Withdrawal by Subject|3|||
126325271|NCT03959527|454485501|FG000|Overall Study|Lost to Follow-up|31|||
126325272|NCT03959527|454485502|FG001|Overall Study|Lost to Follow-up|15|||
126653802|NCT04822597|455689240|FG000|Overall Study|Physician Decision|0|||
126653803|NCT04822597|455689241|FG001|Overall Study|Physician Decision|0|||
126653804|NCT04822597|455689242|FG002|Overall Study|Physician Decision|1|||
126653805|NCT04822597|455689243|FG003|Overall Study|Physician Decision|1|||
126653806|NCT04822597|455689240|FG000|Overall Study|Subject withdrawn after enrollment|0|||
126653807|NCT04822597|455689241|FG001|Overall Study|Subject withdrawn after enrollment|1|||
126653808|NCT04822597|455689242|FG002|Overall Study|Subject withdrawn after enrollment|0|||
126653809|NCT04822597|455689243|FG003|Overall Study|Subject withdrawn after enrollment|1|||
126653810|NCT04822597|455689240|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
126653811|NCT04822597|455689241|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
126653812|NCT04822597|455689242|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
126653813|NCT04822597|455689243|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
126653814|NCT03265938|455689253|FG000|Overall Study|Withdrawal by Subject|1|||
126653815|NCT03265938|455689253|FG000|Overall Study|Physician Decision|1|||
126653816|NCT03265938|455689253|FG000|Overall Study|friable mass|6|||
126653817|NCT01034176|455691092|FG000|Overall Study|Physician Decision|2|||
126325273|NCT03959527|454485501|FG000|Overall Study|Did not meet eligibility criteria|1|||
126325274|NCT03959527|454485502|FG001|Overall Study|Did not meet eligibility criteria|1|||
126325275|NCT03959527|454485501|FG000|Overall Study|Protocol Violation|10|||
126325276|NCT03959527|454485502|FG001|Overall Study|Protocol Violation|5|||
126325277|NCT00707980|454485503|FG000|Overall Study|Adverse Event|49|||
126325278|NCT00707980|454485503|FG000|Overall Study|Lack of Efficacy|35|||
126325279|NCT00707980|454485503|FG000|Overall Study|Non-Compliance with Study Drug|28|||
126325280|NCT00707980|454485503|FG000|Overall Study|Protocol Deviations|19|||
126325281|NCT00707980|454485503|FG000|Overall Study|Withdrawal of Consent|81|||
126325282|NCT00707980|454485503|FG000|Overall Study|Lost to Follow-up|59|||
126325283|NCT00707980|454485503|FG000|Overall Study|Other|39|||
126325284|NCT01152996|454485504|FG000|Overall Study|Withdrawal by Subject|142|||
126325285|NCT01152996|454485504|FG000|Overall Study|Adverse Event|115|||
126325286|NCT01152996|454485504|FG000|Overall Study|Lost to Follow-up|112|||
126325287|NCT01152996|454485504|FG000|Overall Study|Lack of Efficacy|68|||
126325288|NCT01152996|454485504|FG000|Overall Study|Noncompliance|41|||
126325289|NCT01152996|454485504|FG000|Overall Study|Other|36|||
126325290|NCT01152996|454485504|FG000|Overall Study|Protocol Violation|22|||
126325291|NCT01152996|454485504|FG000|Overall Study|Elevated liver enzymes|1|||
126325292|NCT02072941|454485506|FG000|Overall Study|Withdrawal by Subject|29|||
126325293|NCT02072941|454485507|FG001|Overall Study|Withdrawal by Subject|21|||
126325294|NCT02072941|454485506|FG000|Overall Study|Lost to Follow-up|4|||
126325295|NCT02072941|454485507|FG001|Overall Study|Lost to Follow-up|4|||
126325296|NCT02072941|454485506|FG000|Overall Study|Death|3|||
126325297|NCT02072941|454485507|FG001|Overall Study|Death|2|||
126325298|NCT02072941|454485506|FG000|Overall Study|Removed by Study Staff|2|||
126325299|NCT02072941|454485507|FG001|Overall Study|Removed by Study Staff|2|||
126325300|NCT02020889|454485508|FG000|Overall Study|Adverse Event|0|||
126325301|NCT02020889|454485509|FG001|Overall Study|Adverse Event|1|||
126325302|NCT02020889|454485508|FG000|Overall Study|Lack of Efficacy|1|||
126325303|NCT02020889|454485509|FG001|Overall Study|Lack of Efficacy|0|||
126325304|NCT02020889|454485508|FG000|Overall Study|Lost to Follow-up|1|||
126325305|NCT02020889|454485509|FG001|Overall Study|Lost to Follow-up|0|||
126325306|NCT02020889|454485508|FG000|Overall Study|Physician Decision|2|||
126325307|NCT02020889|454485509|FG001|Overall Study|Physician Decision|0|||
126325308|NCT02020889|454485508|FG000|Overall Study|Withdrawal by Subject|3|||
126325309|NCT02020889|454485509|FG001|Overall Study|Withdrawal by Subject|2|||
126325310|NCT03146741|454485510|FG000|Overall Study|Txp with non-HCV+ heart|4|||
126325311|NCT03146741|454485510|FG000|Overall Study|Listeted for MOT|2|||
126325312|NCT03146741|454485510|FG000|Overall Study|Physician Decision|2|||
126325313|NCT03146741|454485510|FG000|Overall Study|Awaiting txp|2|||
126325314|NCT03224624|454485511|FG000|Overall Study|Lost to Follow-up|9|||
126325315|NCT03224624|454485512|FG001|Overall Study|Lost to Follow-up|4|||
126325316|NCT03224624|454485511|FG000|Overall Study|Death|1|||
126325317|NCT03224624|454485512|FG001|Overall Study|Death|0|||
126325318|NCT01884545|454485513|FG000|Overall Study|Lost to Follow-up|6|||
126325319|NCT01884545|454485514|FG001|Overall Study|Lost to Follow-up|4|||
126653818|NCT01034176|455691093|FG001|Overall Study|Physician Decision|0|||
126653819|NCT01034176|455691092|FG000|Overall Study|Withdrawal by Subject|0|||
126653820|NCT01034176|455691093|FG001|Overall Study|Withdrawal by Subject|1|||
126653821|NCT01034176|455691092|FG000|Overall Study|Lost to Follow-up|0|||
126325320|NCT01884545|454485515|FG002|Overall Study|Lost to Follow-up|9|||
126325321|NCT01884545|454485516|FG003|Overall Study|Lost to Follow-up|4|||
126325322|NCT01884545|454485513|FG000|Overall Study|Patient withdrawn|7|||
126653822|NCT01034176|455691093|FG001|Overall Study|Lost to Follow-up|1|||
126653823|NCT03207009|455691096|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
126653824|NCT03241225|455691097|FG000|Overall Study|Lost to Follow-up|2|||
126325323|NCT01884545|454485514|FG001|Overall Study|Patient withdrawn|12|||
126325324|NCT01884545|454485515|FG002|Overall Study|Patient withdrawn|5|||
126325325|NCT01884545|454485516|FG003|Overall Study|Patient withdrawn|5|||
126325326|NCT01884545|454485513|FG000|Overall Study|Non-adherence|0|||
126325327|NCT01884545|454485514|FG001|Overall Study|Non-adherence|2|||
126653825|NCT03241225|455691098|FG001|Overall Study|Lost to Follow-up|1|||
126653826|NCT03241225|455691097|FG000|Overall Study|Protocol Violation|4|||
126653827|NCT03241225|455691098|FG001|Overall Study|Protocol Violation|1|||
126653828|NCT03241225|455691097|FG000|Overall Study|Withdrawal by Subject|1|||
126653829|NCT03241225|455691098|FG001|Overall Study|Withdrawal by Subject|0|||
126653830|NCT01635920|455691103|FG000|Overall Study|Adverse Event|1|||
126325328|NCT01884545|454485515|FG002|Overall Study|Non-adherence|0|||
126325329|NCT01884545|454485516|FG003|Overall Study|Non-adherence|0|||
126325330|NCT00524680|454485526|FG000|Overall Study|progression|0|||
126325331|NCT00524680|454485527|FG001|Overall Study|progression|0|||
126325332|NCT00524680|454485528|FG002|Overall Study|progression|0|||
126325333|NCT00524680|454485529|FG003|Overall Study|progression|1|||
126325334|NCT00524680|454485526|FG000|Overall Study|Adverse Event|2|||
126653831|NCT01635920|455691104|FG001|Overall Study|Adverse Event|0|||
126325335|NCT00524680|454485527|FG001|Overall Study|Adverse Event|0|||
126325336|NCT00524680|454485528|FG002|Overall Study|Adverse Event|0|||
126325337|NCT00524680|454485529|FG003|Overall Study|Adverse Event|1|||
126325338|NCT00524680|454485526|FG000|Overall Study|Other|0|||
126325339|NCT00524680|454485527|FG001|Overall Study|Other|1|||
126325340|NCT00524680|454485528|FG002|Overall Study|Other|2|||
126325341|NCT00524680|454485529|FG003|Overall Study|Other|3|||
126325342|NCT00524680|454485526|FG000|Overall Study|Withdrawal by Subject|1|||
126325343|NCT00524680|454485527|FG001|Overall Study|Withdrawal by Subject|0|||
126325344|NCT00524680|454485528|FG002|Overall Study|Withdrawal by Subject|1|||
126325345|NCT00524680|454485529|FG003|Overall Study|Withdrawal by Subject|1|||
126325346|NCT01607346|454485530|FG000|Overall Study|Adverse Event|3|||
126653832|NCT01635920|455691103|FG000|Overall Study|Lost to Follow-up|0|||
126325347|NCT01098162|454485531|FG000|Overall Study|Adverse Event|37|||
126325348|NCT01098162|454485531|FG000|Overall Study|Lack of Efficacy|4|||
126325349|NCT01098162|454485531|FG000|Overall Study|Wish of Patient|7|||
126325350|NCT01098162|454485531|FG000|Overall Study|Lost to Follow-up|9|||
126325351|NCT01098162|454485531|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
126325352|NCT01098162|454485531|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
126325353|NCT01098162|454485531|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
126325354|NCT01098162|454485531|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
126325355|NCT01098162|454485531|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
126325356|NCT01098162|454485531|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
126325357|NCT01098162|454485531|FG000|Overall Study|Other Reason|1|||
126325358|NCT01098162|454485531|FG000|Overall Study|Reason Unknown|26|||
126325359|NCT00625183|454485532|FG000|Overall Study|Disease Progression|1|||
126325360|NCT00856843|454485534|FG000|Overall Study|Withdrawal by Subject|1|||
126325361|NCT00856843|454485535|FG001|Overall Study|Withdrawal by Subject|5|||
126325362|NCT00856843|454485534|FG000|Overall Study|Lack of Efficacy|1|||
126325363|NCT00856843|454485535|FG001|Overall Study|Lack of Efficacy|0|||
126325364|NCT01366638|454485539|FG000|Overall Study|Withdrawal by Subject|0|||
126325365|NCT01366638|454485540|FG001|Overall Study|Withdrawal by Subject|0|||
126325366|NCT01366638|454485541|FG002|Overall Study|Withdrawal by Subject|6|||
126325367|NCT01366638|454485539|FG000|Overall Study|Other|1|||
126325368|NCT01366638|454485540|FG001|Overall Study|Other|0|||
126325369|NCT01366638|454485541|FG002|Overall Study|Other|0|||
126325370|NCT01451554|454485542|FG000|Overall Study|Withdrawal by Subject|14|||
126325371|NCT01451554|454485543|FG001|Overall Study|Withdrawal by Subject|9|||
126325372|NCT01402986|454485544|FG000|Overall Study|Withdrawal by Subject|7|||
126325373|NCT01402986|454485545|FG001|Overall Study|Withdrawal by Subject|10|||
126653833|NCT01635920|455691104|FG001|Overall Study|Lost to Follow-up|1|||
126653834|NCT01635920|455691103|FG000|Overall Study|Subject decision|2|||
126653835|NCT01635920|455691104|FG001|Overall Study|Subject decision|0|||
126653836|NCT02074553|455691105|FG000|Intervention Period 1|Family Emergency|0|||
126653837|NCT02074553|455691106|FG001|Intervention Period 1|Family Emergency|0|||
126653838|NCT02074553|455691107|FG002|Intervention Period 1|Family Emergency|0|||
126653839|NCT02074553|455691108|FG003|Intervention Period 1|Family Emergency|1|||
126653840|NCT02074553|455691109|FG004|Intervention Period 1|Family Emergency|0|||
126653841|NCT02074553|455691110|FG005|Intervention Period 1|Family Emergency|0|||
126653842|NCT02074553|455691111|FG006|Intervention Period 1|Family Emergency|0|||
126653843|NCT02074553|455691112|FG007|Intervention Period 1|Family Emergency|0|||
126325374|NCT01402986|454485546|FG002|Overall Study|Withdrawal by Subject|7|||
126325375|NCT01402986|454485547|FG003|Overall Study|Withdrawal by Subject|13|||
126325376|NCT01402986|454485544|FG000|Overall Study|Death|0|||
126325377|NCT01402986|454485545|FG001|Overall Study|Death|0|||
126325378|NCT01402986|454485546|FG002|Overall Study|Death|0|||
126325379|NCT01402986|454485547|FG003|Overall Study|Death|2|||
126325380|NCT01402986|454485544|FG000|Overall Study|Lost to Follow-up|0|||
126325381|NCT01402986|454485545|FG001|Overall Study|Lost to Follow-up|0|||
126325382|NCT01402986|454485546|FG002|Overall Study|Lost to Follow-up|0|||
126653844|NCT02074553|455691105|FG000|Washout Period 1|Adverse Event|1|||
126653845|NCT02074553|455691106|FG001|Washout Period 1|Adverse Event|0|||
126325383|NCT01402986|454485547|FG003|Overall Study|Lost to Follow-up|1|||
126325384|NCT01402986|454485544|FG000|Overall Study|Other|2|||
126325385|NCT01402986|454485545|FG001|Overall Study|Other|5|||
126653846|NCT02074553|455691107|FG002|Washout Period 1|Adverse Event|0|||
126325386|NCT01402986|454485546|FG002|Overall Study|Other|1|||
126325387|NCT01402986|454485547|FG003|Overall Study|Other|6|||
126325388|NCT02427802|454485548|FG000|Overall Study|Adverse Event|11|||
126325389|NCT02427802|454485549|FG001|Overall Study|Adverse Event|3|||
126325390|NCT02427802|454485550|FG002|Overall Study|Adverse Event|7|||
126325391|NCT02427802|454485548|FG000|Overall Study|Death|0|||
126325392|NCT02427802|454485549|FG001|Overall Study|Death|4|||
126325393|NCT02427802|454485550|FG002|Overall Study|Death|1|||
126325394|NCT02427802|454485548|FG000|Overall Study|Lost to Follow-up|13|||
126325395|NCT02427802|454485549|FG001|Overall Study|Lost to Follow-up|8|||
126325396|NCT02427802|454485550|FG002|Overall Study|Lost to Follow-up|8|||
126325397|NCT02427802|454485548|FG000|Overall Study|Physician Decision|4|||
126325398|NCT02427802|454485549|FG001|Overall Study|Physician Decision|2|||
126325399|NCT02427802|454485550|FG002|Overall Study|Physician Decision|4|||
126325400|NCT02427802|454485548|FG000|Overall Study|Withdrawal by Subject|10|||
126325401|NCT02427802|454485549|FG001|Overall Study|Withdrawal by Subject|5|||
126325402|NCT02427802|454485550|FG002|Overall Study|Withdrawal by Subject|11|||
126325403|NCT02427802|454485548|FG000|Overall Study|Protocol Violation|3|||
126325404|NCT02427802|454485549|FG001|Overall Study|Protocol Violation|1|||
126325405|NCT02427802|454485550|FG002|Overall Study|Protocol Violation|1|||
126325406|NCT02427802|454485548|FG000|Overall Study|protocol specific treatment unrelated|18|||
126325407|NCT02427802|454485549|FG001|Overall Study|protocol specific treatment unrelated|11|||
126325408|NCT02427802|454485550|FG002|Overall Study|protocol specific treatment unrelated|11|||
126325409|NCT01085084|454485551|FG000|Overall Study|Withdrawal by Subject|1|||
126325410|NCT01085084|454485552|FG001|Overall Study|Withdrawal by Subject|0|||
126325411|NCT01085084|454485553|FG002|Overall Study|Withdrawal by Subject|0|||
126325412|NCT01085084|454485551|FG000|Overall Study|Lost to Follow-up|2|||
126325413|NCT01085084|454485552|FG001|Overall Study|Lost to Follow-up|1|||
126325414|NCT01085084|454485553|FG002|Overall Study|Lost to Follow-up|1|||
126325415|NCT01085084|454485551|FG000|Overall Study|Adverse Event|4|||
126325416|NCT01085084|454485552|FG001|Overall Study|Adverse Event|3|||
126325417|NCT01085084|454485553|FG002|Overall Study|Adverse Event|6|||
126325418|NCT01085084|454485551|FG000|Overall Study|Treatment Failure|0|||
126325419|NCT01085084|454485552|FG001|Overall Study|Treatment Failure|1|||
126325420|NCT01085084|454485553|FG002|Overall Study|Treatment Failure|2|||
126325421|NCT02749799|454485554|FG000|Overall Study|Adverse Event|2|||
126325422|NCT02749799|454485554|FG000|Overall Study|Lost to Follow-up|4|||
126325423|NCT02749799|454485554|FG000|Overall Study|Protocol Violation|1|||
126325424|NCT02749799|454485554|FG000|Overall Study|Withdrawal by Subject|1|||
126653847|NCT02074553|455691108|FG003|Washout Period 1|Adverse Event|0|||
126653848|NCT02074553|455691109|FG004|Washout Period 1|Adverse Event|0|||
126653849|NCT02074553|455691110|FG005|Washout Period 1|Adverse Event|0|||
126653850|NCT02074553|455691111|FG006|Washout Period 1|Adverse Event|0|||
126325425|NCT02634983|454485555|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
126325426|NCT02634983|454485556|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
126325427|NCT02070978|454485557|FG000|Overall Study|Adverse Event|6|||
126325428|NCT02070978|454485558|FG001|Overall Study|Adverse Event|2|||
126325429|NCT02070978|454485559|FG002|Overall Study|Adverse Event|0|||
126325430|NCT02070978|454485557|FG000|Overall Study|Lost to Follow-up|1|||
126325431|NCT02070978|454485558|FG001|Overall Study|Lost to Follow-up|3|||
126325432|NCT02070978|454485559|FG002|Overall Study|Lost to Follow-up|4|||
126325433|NCT02070978|454485557|FG000|Overall Study|Withdrawal by Subject|3|||
126653851|NCT02074553|455691112|FG007|Washout Period 1|Adverse Event|0|||
126653852|NCT02074553|455691105|FG000|Washout Period 1|Physician Decision|0|||
126653853|NCT02074553|455691106|FG001|Washout Period 1|Physician Decision|0|||
126653854|NCT02074553|455691107|FG002|Washout Period 1|Physician Decision|0|||
126653855|NCT02074553|455691108|FG003|Washout Period 1|Physician Decision|1|||
126653856|NCT02074553|455691109|FG004|Washout Period 1|Physician Decision|0|||
126653857|NCT02074553|455691110|FG005|Washout Period 1|Physician Decision|0|||
126653858|NCT02074553|455691111|FG006|Washout Period 1|Physician Decision|0|||
126653859|NCT02074553|455691112|FG007|Washout Period 1|Physician Decision|0|||
126325434|NCT02070978|454485558|FG001|Overall Study|Withdrawal by Subject|5|||
126325435|NCT02070978|454485559|FG002|Overall Study|Withdrawal by Subject|3|||
126325436|NCT02070978|454485557|FG000|Overall Study|Protocol Violation|1|||
126325437|NCT02070978|454485558|FG001|Overall Study|Protocol Violation|0|||
126325438|NCT02070978|454485559|FG002|Overall Study|Protocol Violation|3|||
126325439|NCT02070978|454485557|FG000|Overall Study|Lack of Efficacy|0|||
126653860|NCT02074553|455691105|FG000|Washout Period 1|Other|0|||
126653861|NCT02074553|455691106|FG001|Washout Period 1|Other|0|||
126325440|NCT02070978|454485558|FG001|Overall Study|Lack of Efficacy|1|||
126325441|NCT02070978|454485559|FG002|Overall Study|Lack of Efficacy|0|||
126325442|NCT02070978|454485557|FG000|Overall Study|Death|0|||
126325443|NCT02070978|454485558|FG001|Overall Study|Death|0|||
126325444|NCT02070978|454485559|FG002|Overall Study|Death|2|||
126325445|NCT02070978|454485557|FG000|Overall Study|Un-specified|3|||
126325446|NCT02070978|454485558|FG001|Overall Study|Un-specified|2|||
126325447|NCT02070978|454485559|FG002|Overall Study|Un-specified|2|||
126325448|NCT02070978|454485557|FG000|Overall Study|Terminated by Sponsor|33|||
126325449|NCT02070978|454485558|FG001|Overall Study|Terminated by Sponsor|40|||
126325450|NCT02070978|454485559|FG002|Overall Study|Terminated by Sponsor|39|||
126325451|NCT03749109|454485560|FG000|Overall Study|Adverse Event|2|||
126325452|NCT03749109|454485561|FG001|Overall Study|Adverse Event|0|||
126325453|NCT03951753|454485562|FG000|Overall Study|Adverse Event|1|||
126325454|NCT03951753|454485563|FG001|Overall Study|Adverse Event|0|||
126325455|NCT03951753|454485564|FG002|Overall Study|Adverse Event|3|||
126325456|NCT03951753|454485562|FG000|Overall Study|Withdrawal by Subject|3|||
126325457|NCT03951753|454485563|FG001|Overall Study|Withdrawal by Subject|1|||
126325458|NCT03951753|454485564|FG002|Overall Study|Withdrawal by Subject|0|||
126325459|NCT03951753|454485562|FG000|Overall Study|Lost to Follow-up|0|||
126325460|NCT03951753|454485563|FG001|Overall Study|Lost to Follow-up|0|||
126325461|NCT03951753|454485564|FG002|Overall Study|Lost to Follow-up|1|||
126325462|NCT03178851|454485565|FG000|Overall Study|Death|48|||
126325463|NCT03178851|454485566|FG001|Overall Study|Death|2|||
126325464|NCT03178851|454485567|FG002|Overall Study|Death|25|||
126325465|NCT03178851|454485565|FG000|Overall Study|Withdrawal by Subject|8|||
126325466|NCT03178851|454485566|FG001|Overall Study|Withdrawal by Subject|0|||
126325467|NCT03178851|454485567|FG002|Overall Study|Withdrawal by Subject|0|||
126325468|NCT03178851|454485565|FG000|Overall Study|Lost to Follow-up|5|||
126325469|NCT03178851|454485566|FG001|Overall Study|Lost to Follow-up|2|||
126325470|NCT03178851|454485567|FG002|Overall Study|Lost to Follow-up|0|||
126325471|NCT03178851|454485565|FG000|Overall Study|Adverse Event|0|||
126653862|NCT02074553|455691107|FG002|Washout Period 1|Other|0|||
126653863|NCT02074553|455691108|FG003|Washout Period 1|Other|0|||
126653864|NCT02074553|455691109|FG004|Washout Period 1|Other|0|||
126653865|NCT02074553|455691110|FG005|Washout Period 1|Other|1|||
126653866|NCT02074553|455691111|FG006|Washout Period 1|Other|0|||
126653867|NCT02074553|455691112|FG007|Washout Period 1|Other|0|||
126325472|NCT03178851|454485566|FG001|Overall Study|Adverse Event|0|||
126325473|NCT03178851|454485567|FG002|Overall Study|Adverse Event|1|||
126653868|NCT02074553|455691105|FG000|Washout Period 2|Adverse Event|0|||
126653869|NCT02074553|455691106|FG001|Washout Period 2|Adverse Event|0|||
126653870|NCT02074553|455691107|FG002|Washout Period 2|Adverse Event|0|||
126653871|NCT02074553|455691108|FG003|Washout Period 2|Adverse Event|0|||
126653872|NCT02074553|455691109|FG004|Washout Period 2|Adverse Event|0|||
126653873|NCT02074553|455691110|FG005|Washout Period 2|Adverse Event|0|||
126653874|NCT02074553|455691111|FG006|Washout Period 2|Adverse Event|1|||
126653875|NCT02074553|455691112|FG007|Washout Period 2|Adverse Event|0|||
126653876|NCT02074553|455691105|FG000|Washout Period 2|Physician Decision|0|||
126653877|NCT02074553|455691106|FG001|Washout Period 2|Physician Decision|0|||
126653878|NCT02074553|455691107|FG002|Washout Period 2|Physician Decision|0|||
126653879|NCT02074553|455691108|FG003|Washout Period 2|Physician Decision|0|||
126653880|NCT02074553|455691109|FG004|Washout Period 2|Physician Decision|0|||
126653881|NCT02074553|455691110|FG005|Washout Period 2|Physician Decision|1|||
126653882|NCT02074553|455691111|FG006|Washout Period 2|Physician Decision|0|||
126653883|NCT02074553|455691112|FG007|Washout Period 2|Physician Decision|0|||
126653884|NCT02074553|455691105|FG000|Washout Period 2|Lost to Follow-up|0|||
126653885|NCT02074553|455691106|FG001|Washout Period 2|Lost to Follow-up|0|||
126653886|NCT02074553|455691107|FG002|Washout Period 2|Lost to Follow-up|1|||
126653887|NCT02074553|455691108|FG003|Washout Period 2|Lost to Follow-up|0|||
126653888|NCT02074553|455691109|FG004|Washout Period 2|Lost to Follow-up|0|||
126653889|NCT02074553|455691110|FG005|Washout Period 2|Lost to Follow-up|0|||
126653890|NCT02074553|455691111|FG006|Washout Period 2|Lost to Follow-up|0|||
126653891|NCT02074553|455691112|FG007|Washout Period 2|Lost to Follow-up|0|||
126653892|NCT02074553|455691105|FG000|Washout Period 3|Physician Decision|0|||
126653893|NCT02074553|455691106|FG001|Washout Period 3|Physician Decision|0|||
126653894|NCT02074553|455691107|FG002|Washout Period 3|Physician Decision|0|||
126653895|NCT02074553|455691108|FG003|Washout Period 3|Physician Decision|0|||
126653896|NCT02074553|455691109|FG004|Washout Period 3|Physician Decision|0|||
126653897|NCT02074553|455691110|FG005|Washout Period 3|Physician Decision|0|||
126653898|NCT02074553|455691111|FG006|Washout Period 3|Physician Decision|0|||
126325474|NCT03178851|454485565|FG000|Overall Study|Study Termination by Sponsor|31|||
126325475|NCT03178851|454485566|FG001|Overall Study|Study Termination by Sponsor|7|||
126325476|NCT03178851|454485567|FG002|Overall Study|Study Termination by Sponsor|26|||
126325477|NCT02226120|454485570|FG000|Overall Study|Adverse Event|60|||
126325478|NCT02226120|454485570|FG000|Overall Study|Death|172|||
126653899|NCT02074553|455691112|FG007|Washout Period 3|Physician Decision|1|||
126653900|NCT00194987|455691113|FG000|Overall Study|Withdrawal by Subject|0|||
126653901|NCT00194987|455691114|FG001|Overall Study|Withdrawal by Subject|3|||
126653902|NCT01664598|455691115|FG000|Overall Study|Sponsor Decision|1|||
126653903|NCT01664598|455691115|FG000|Overall Study|Withdrawal of Informed Consent|4|||
126653904|NCT01664598|455691115|FG000|Overall Study|Adverse Event|1|||
126653905|NCT01658150|455691116|FG000|Overall Study|Withdrawal by Subject|1|||
126325479|NCT02226120|454485570|FG000|Overall Study|Study terminated by sponsor|1|||
126325480|NCT02226120|454485570|FG000|Overall Study|Technical problems|4|||
126653906|NCT04187989|455691117|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
126653907|NCT04187989|455691118|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
126653908|NCT04187989|455691117|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
126653909|NCT04187989|455691118|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
126653910|NCT03602066|455691119|FG000|Overall Study|Withdrawal by Subject|2|||
126653911|NCT03602066|455691120|FG001|Overall Study|Withdrawal by Subject|0|||
126653912|NCT03602066|455691119|FG000|Overall Study|Physician Decision|1|||
126653913|NCT03602066|455691120|FG001|Overall Study|Physician Decision|0|||
126653914|NCT03646656|455691121|FG000|Overall Study|Lost to Follow-up|1|||
126653915|NCT03646656|455691122|FG001|Overall Study|Lost to Follow-up|0|||
126653916|NCT03646656|455691121|FG000|Overall Study|Withdrawal by Subject|2|||
126653917|NCT03646656|455691122|FG001|Overall Study|Withdrawal by Subject|0|||
126653918|NCT00092495|455691123|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
126653919|NCT00092495|455691124|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
126653920|NCT00092495|455691125|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
126653921|NCT00092495|455691126|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
126325481|NCT02226120|454485570|FG000|Overall Study|Lost to Follow-up|13|||
126325482|NCT02226120|454485570|FG000|Overall Study|Physician Decision|21|||
126325483|NCT02226120|454485570|FG000|Overall Study|Withdrawal by parent/guardian|36|||
126325484|NCT02226120|454485570|FG000|Overall Study|Non-compliance with study drug|10|||
126325485|NCT02226120|454485570|FG000|Overall Study|Protocol deviation|1|||
126653922|NCT00092495|455691127|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
126653923|NCT00092495|455691123|FG000|Base Study Vaccination Period|Extended|0|||
126653924|NCT00092495|455691124|FG001|Base Study Vaccination Period|Extended|0|||
126653925|NCT00092495|455691125|FG002|Base Study Vaccination Period|Extended|0|||
126653926|NCT00092495|455691126|FG003|Base Study Vaccination Period|Extended|1|||
126325486|NCT02226120|454485570|FG000|Overall Study|missing treatment disposition pages|2|||
126325487|NCT02669043|454485573|FG000|Overall Study|Didn't meet I/E criteria|4|||
126325488|NCT00401193|454488203|FG000|Overall Study|Adverse Event|1|||
126325489|NCT00401193|454488204|FG001|Overall Study|Adverse Event|3|||
126325490|NCT00401193|454488205|FG002|Overall Study|Adverse Event|1|||
126325491|NCT00401193|454488203|FG000|Overall Study|Protocol Violation|3|||
126325492|NCT00401193|454488204|FG001|Overall Study|Protocol Violation|1|||
126325493|NCT00401193|454488205|FG002|Overall Study|Protocol Violation|1|||
126325494|NCT00401193|454488203|FG000|Overall Study|Lost to Follow-up|6|||
126325495|NCT00401193|454488204|FG001|Overall Study|Lost to Follow-up|5|||
126325496|NCT00401193|454488205|FG002|Overall Study|Lost to Follow-up|1|||
126325497|NCT00401193|454488203|FG000|Overall Study|Withdrawal by Subject|2|||
126325498|NCT00401193|454488204|FG001|Overall Study|Withdrawal by Subject|0|||
126325499|NCT00401193|454488205|FG002|Overall Study|Withdrawal by Subject|1|||
126325500|NCT00401193|454488203|FG000|Overall Study|Other Event|3|||
126325501|NCT00401193|454488204|FG001|Overall Study|Other Event|2|||
126325502|NCT00401193|454488205|FG002|Overall Study|Other Event|2|||
126325503|NCT00398216|454488206|FG000|Overall Study|Adverse Event|4|||
126325504|NCT00398216|454488207|FG001|Overall Study|Adverse Event|2|||
126325505|NCT00398216|454488208|FG002|Overall Study|Adverse Event|5|||
126325506|NCT00398216|454488209|FG003|Overall Study|Adverse Event|7|||
126325507|NCT00398216|454488210|FG004|Overall Study|Adverse Event|2|||
126325508|NCT00398216|454488206|FG000|Overall Study|Protocol Violation|2|||
126325509|NCT00398216|454488207|FG001|Overall Study|Protocol Violation|4|||
126325510|NCT00398216|454488208|FG002|Overall Study|Protocol Violation|5|||
126325511|NCT00398216|454488209|FG003|Overall Study|Protocol Violation|7|||
126325512|NCT00398216|454488210|FG004|Overall Study|Protocol Violation|5|||
126325513|NCT00398216|454488206|FG000|Overall Study|Lost to Follow-up|1|||
126325514|NCT00398216|454488207|FG001|Overall Study|Lost to Follow-up|6|||
126325515|NCT00398216|454488208|FG002|Overall Study|Lost to Follow-up|4|||
126325516|NCT00398216|454488209|FG003|Overall Study|Lost to Follow-up|4|||
126325517|NCT00398216|454488210|FG004|Overall Study|Lost to Follow-up|1|||
126325518|NCT00398216|454488206|FG000|Overall Study|Death|0|||
126325519|NCT00398216|454488207|FG001|Overall Study|Death|3|||
126325520|NCT00398216|454488208|FG002|Overall Study|Death|0|||
126325521|NCT00398216|454488209|FG003|Overall Study|Death|0|||
126325522|NCT00398216|454488210|FG004|Overall Study|Death|0|||
126325523|NCT00398216|454488206|FG000|Overall Study|Withdrawal by Subject|1|||
126325524|NCT00398216|454488207|FG001|Overall Study|Withdrawal by Subject|0|||
126325525|NCT00398216|454488208|FG002|Overall Study|Withdrawal by Subject|3|||
126325526|NCT00398216|454488209|FG003|Overall Study|Withdrawal by Subject|1|||
126325527|NCT00398216|454488210|FG004|Overall Study|Withdrawal by Subject|2|||
126325528|NCT00398216|454488206|FG000|Overall Study|administrative reasons|3|||
126325529|NCT00398216|454488207|FG001|Overall Study|administrative reasons|4|||
126325530|NCT00398216|454488208|FG002|Overall Study|administrative reasons|4|||
126325531|NCT00398216|454488209|FG003|Overall Study|administrative reasons|3|||
126653927|NCT00092495|455691127|FG004|Base Study Vaccination Period|Extended|0|||
126653928|NCT00092495|455691123|FG000|Base Study Vaccination Period|*Clinical AE|1|||
126325532|NCT00398216|454488210|FG004|Overall Study|administrative reasons|3|||
126325533|NCT00398216|454488206|FG000|Overall Study|entrance criteria|0|||
126653929|NCT00092495|455691124|FG001|Base Study Vaccination Period|*Clinical AE|0|||
126325534|NCT00398216|454488207|FG001|Overall Study|entrance criteria|0|||
126653930|NCT00092495|455691125|FG002|Base Study Vaccination Period|*Clinical AE|1|||
126653931|NCT00092495|455691126|FG003|Base Study Vaccination Period|*Clinical AE|2|||
126653932|NCT00092495|455691127|FG004|Base Study Vaccination Period|*Clinical AE|0|||
126653933|NCT00092495|455691123|FG000|Base Study Vaccination Period|*Other reasons|1|||
126653934|NCT00092495|455691124|FG001|Base Study Vaccination Period|*Other reasons|0|||
126653935|NCT00092495|455691125|FG002|Base Study Vaccination Period|*Other reasons|0|||
126653936|NCT00092495|455691126|FG003|Base Study Vaccination Period|*Other reasons|1|||
126653937|NCT00092495|455691127|FG004|Base Study Vaccination Period|*Other reasons|0|||
126325535|NCT00398216|454488208|FG002|Overall Study|entrance criteria|0|||
126325536|NCT00398216|454488209|FG003|Overall Study|entrance criteria|0|||
126325537|NCT00398216|454488210|FG004|Overall Study|entrance criteria|2|||
126325538|NCT01048944|454488211|FG000|Overall Study|Protocol Violation|8|||
126325539|NCT01048944|454488212|FG001|Overall Study|Protocol Violation|10|||
126325540|NCT01048944|454488213|FG002|Overall Study|Protocol Violation|10|||
126325541|NCT01048944|454488214|FG003|Overall Study|Protocol Violation|2|||
126325542|NCT01844817|454488215|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
126325543|NCT01844817|454488216|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
126325544|NCT01844817|454488215|FG000|Treatment|Progressive Disease|27|||
126325545|NCT01844817|454488216|FG001|Treatment|Progressive Disease|36|||
126325546|NCT01844817|454488215|FG000|Treatment|Adverse Event|17|||
126325547|NCT01844817|454488216|FG001|Treatment|Adverse Event|9|||
126325548|NCT01844817|454488215|FG000|Treatment|Withdrawal by Subject|10|||
126325549|NCT01844817|454488216|FG001|Treatment|Withdrawal by Subject|6|||
126325550|NCT01844817|454488215|FG000|Treatment|Death|10|||
126325551|NCT01844817|454488216|FG001|Treatment|Death|8|||
126325552|NCT01844817|454488215|FG000|Treatment|Lost to Follow-up|0|||
126325553|NCT01844817|454488216|FG001|Treatment|Lost to Follow-up|1|||
126325554|NCT01844817|454488215|FG000|Treatment|Other|0|||
126325555|NCT01844817|454488216|FG001|Treatment|Other|3|||
126325556|NCT02207400|454488217|FG000|Overall Study|Adverse Event|1|||
126325557|NCT02207400|454488218|FG001|Overall Study|Adverse Event|1|||
126325558|NCT02207400|454488217|FG000|Overall Study|Lost to Follow-up|6|||
126325559|NCT02207400|454488218|FG001|Overall Study|Lost to Follow-up|7|||
126325560|NCT02207400|454488217|FG000|Overall Study|Protocol Violation|1|||
126325561|NCT02207400|454488218|FG001|Overall Study|Protocol Violation|1|||
126325562|NCT02207400|454488217|FG000|Overall Study|Withdrawal by Subject|8|||
126325563|NCT02207400|454488218|FG001|Overall Study|Withdrawal by Subject|4|||
126325564|NCT02207400|454488217|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
126325565|NCT02207400|454488218|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
126325566|NCT03396822|454488219|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
126325567|NCT03396822|454488219|FG000|Overall Study|Physician Decision|1|||
126325568|NCT03638466|454488220|FG000|Overall Study|Early Termination|0|||
126653938|NCT00092495|455691123|FG000|Base Study Vaccination Period|*Pregnancy|0|||
126653939|NCT00092495|455691124|FG001|Base Study Vaccination Period|*Pregnancy|2|||
126653940|NCT00092495|455691125|FG002|Base Study Vaccination Period|*Pregnancy|5|||
126653941|NCT00092495|455691126|FG003|Base Study Vaccination Period|*Pregnancy|7|||
126325569|NCT03638466|454488221|FG001|Overall Study|Early Termination|1|||
126325570|NCT03251482|454488222|FG000|Overall Study|Withdrawal by Subject|0|||
126325571|NCT03251482|454488223|FG001|Overall Study|Withdrawal by Subject|1|||
126325572|NCT03251482|454488224|FG002|Overall Study|Withdrawal by Subject|0|||
126325573|NCT03251482|454488225|FG003|Overall Study|Withdrawal by Subject|0|||
126325574|NCT03251482|454488226|FG004|Overall Study|Withdrawal by Subject|0|||
126325575|NCT02362425|454488227|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
126325576|NCT02362425|454488228|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
126325577|NCT02362425|454488229|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
126325578|NCT02362425|454488230|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
126325579|NCT02362425|454488227|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
126325580|NCT02362425|454488228|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
126325581|NCT02362425|454488229|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
126325582|NCT02362425|454488230|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
126325583|NCT02362425|454488227|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
126325584|NCT02362425|454488228|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
126325585|NCT02362425|454488229|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
126653942|NCT00092495|455691127|FG004|Base Study Vaccination Period|*Pregnancy|0|||
126653943|NCT00092495|455691123|FG000|Base Study Vaccination Period|Adverse Event|1|||
126653944|NCT00092495|455691124|FG001|Base Study Vaccination Period|Adverse Event|0|||
126325586|NCT02362425|454488230|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
126325587|NCT02362425|454488227|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
126325588|NCT02362425|454488228|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
126325589|NCT02362425|454488229|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
126325590|NCT02362425|454488230|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
126325591|NCT02362425|454488227|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
126325592|NCT02362425|454488228|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
126325593|NCT02362425|454488229|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
126325594|NCT02362425|454488230|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
126653945|NCT00092495|455691125|FG002|Base Study Vaccination Period|Adverse Event|0|||
126325595|NCT02362425|454488227|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
126325596|NCT02362425|454488228|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
126325597|NCT02362425|454488229|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
126325598|NCT02362425|454488230|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
126325599|NCT02362425|454488227|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
126325600|NCT02362425|454488228|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
126325601|NCT02362425|454488229|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
126325602|NCT02362425|454488230|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
126325603|NCT02362425|454488227|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
126325604|NCT02362425|454488228|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
126325605|NCT02362425|454488229|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
126325606|NCT02362425|454488230|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
126325607|NCT02579382|454488235|FG000|Main Study Phase|Lost to Follow-up|0|||
126325608|NCT02579382|454488236|FG001|Main Study Phase|Lost to Follow-up|0|||
126325609|NCT02579382|454488237|FG002|Main Study Phase|Lost to Follow-up|2|||
126325610|NCT02579382|454488238|FG003|Main Study Phase|Lost to Follow-up|0|||
126325611|NCT02579382|454488235|FG000|Main Study Phase|Withdrew Consent|0|||
126325612|NCT02579382|454488236|FG001|Main Study Phase|Withdrew Consent|0|||
126325613|NCT02579382|454488237|FG002|Main Study Phase|Withdrew Consent|0|||
126325614|NCT02579382|454488238|FG003|Main Study Phase|Withdrew Consent|2|||
126325615|NCT02579382|454488235|FG000|Main Study Phase|Lack of Efficacy|0|||
126325616|NCT02579382|454488236|FG001|Main Study Phase|Lack of Efficacy|0|||
126325617|NCT02579382|454488237|FG002|Main Study Phase|Lack of Efficacy|0|||
126325618|NCT02579382|454488238|FG003|Main Study Phase|Lack of Efficacy|1|||
126325619|NCT02579382|454488235|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
126325620|NCT02579382|454488236|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
126325621|NCT02579382|454488237|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
126325622|NCT02579382|454488238|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
126325623|NCT02579382|454488235|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
126325624|NCT02579382|454488236|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
126325625|NCT02579382|454488237|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
126325626|NCT02579382|454488238|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
126325627|NCT02579382|454488235|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
126325628|NCT02579382|454488236|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
126325629|NCT02579382|454488237|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
126325630|NCT02579382|454488238|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
126325631|NCT02579382|454488235|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
126325632|NCT02579382|454488236|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
126325633|NCT02579382|454488237|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
126325634|NCT02579382|454488238|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
126325635|NCT02579382|454488235|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
126325636|NCT02579382|454488236|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
126325637|NCT02579382|454488237|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
126325638|NCT02579382|454488238|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
126325639|NCT02579382|454488235|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
126325640|NCT02579382|454488236|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
126325641|NCT02579382|454488237|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
126325642|NCT02579382|454488238|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
126325643|NCT03026283|454488240|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
126325644|NCT03026283|454488241|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
126325645|NCT03026283|454488242|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
126325646|NCT03026283|454488243|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
126325647|NCT03026283|454488244|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
126325648|NCT03026283|454488245|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
126325649|NCT03026283|454488246|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
126325650|NCT03026283|454488247|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
126325651|NCT03026283|454488240|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
126325652|NCT03026283|454488241|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
126325653|NCT03026283|454488242|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
126325654|NCT03026283|454488243|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
126325655|NCT03026283|454488244|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
126325656|NCT03026283|454488245|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
126325657|NCT03026283|454488246|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
126325658|NCT03026283|454488247|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
126325659|NCT03026283|454488240|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126653946|NCT00092495|455691126|FG003|Base Study Vaccination Period|Adverse Event|3|||
126653947|NCT00092495|455691127|FG004|Base Study Vaccination Period|Adverse Event|0|||
126653948|NCT00092495|455691123|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
126653949|NCT00092495|455691124|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
126653950|NCT00092495|455691125|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
126653951|NCT00092495|455691126|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
126653952|NCT00092495|455691127|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
126653953|NCT00092495|455691123|FG000|Base Study Vaccination Period|Moved|3|||
126653954|NCT00092495|455691124|FG001|Base Study Vaccination Period|Moved|1|||
126653955|NCT00092495|455691125|FG002|Base Study Vaccination Period|Moved|2|||
126325660|NCT03026283|454488241|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
126325661|NCT03026283|454488242|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126325662|NCT03026283|454488243|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126325663|NCT03026283|454488244|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126325664|NCT03026283|454488245|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126325665|NCT03026283|454488246|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126325666|NCT03026283|454488247|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
126325667|NCT03026283|454488240|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126325668|NCT03026283|454488241|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126653956|NCT00092495|455691126|FG003|Base Study Vaccination Period|Moved|2|||
126653957|NCT00092495|455691127|FG004|Base Study Vaccination Period|Moved|0|||
126653958|NCT00092495|455691123|FG000|Base Study Vaccination Period|Other|1|||
126653959|NCT00092495|455691124|FG001|Base Study Vaccination Period|Other|1|||
126653960|NCT00092495|455691125|FG002|Base Study Vaccination Period|Other|0|||
126653961|NCT00092495|455691126|FG003|Base Study Vaccination Period|Other|2|||
126653962|NCT00092495|455691127|FG004|Base Study Vaccination Period|Other|0|||
126653963|NCT00092495|455691123|FG000|Base Study Vaccination Period|Pregnancy|2|||
126653964|NCT00092495|455691124|FG001|Base Study Vaccination Period|Pregnancy|0|||
126653965|NCT00092495|455691125|FG002|Base Study Vaccination Period|Pregnancy|0|||
126653966|NCT00092495|455691126|FG003|Base Study Vaccination Period|Pregnancy|0|||
126325669|NCT03026283|454488242|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
126325670|NCT03026283|454488243|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126325671|NCT03026283|454488244|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126325672|NCT03026283|454488245|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126325673|NCT03026283|454488246|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126325674|NCT03026283|454488247|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
126325675|NCT03026283|454488240|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
126325676|NCT03026283|454488241|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
126325677|NCT03026283|454488242|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
126325678|NCT03026283|454488243|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
126325679|NCT03026283|454488244|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
126325680|NCT03026283|454488245|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
126325681|NCT03026283|454488246|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
126325682|NCT03026283|454488247|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
126325683|NCT03026283|454488240|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
126325684|NCT03026283|454488241|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
126325685|NCT03026283|454488242|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
126325686|NCT03026283|454488243|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
126325687|NCT03026283|454488244|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
126325688|NCT03026283|454488245|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
126325689|NCT03026283|454488246|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
126325690|NCT03026283|454488247|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
126325691|NCT03026283|454488240|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
126325692|NCT03026283|454488241|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
126325693|NCT03026283|454488242|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
126325694|NCT03026283|454488243|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
126325695|NCT03026283|454488244|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
126325696|NCT03026283|454488245|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
126325697|NCT03026283|454488246|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
126325698|NCT03026283|454488247|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
126325699|NCT03026283|454488240|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325700|NCT03026283|454488241|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325701|NCT03026283|454488242|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325702|NCT03026283|454488243|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
126653967|NCT00092495|455691127|FG004|Base Study Vaccination Period|Pregnancy|0|||
126653968|NCT00092495|455691123|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
126653969|NCT00092495|455691124|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
126653970|NCT00092495|455691125|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
126325703|NCT03026283|454488244|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325704|NCT03026283|454488245|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325705|NCT03026283|454488246|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325706|NCT03026283|454488247|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
126325707|NCT03026283|454488240|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
126325708|NCT03026283|454488241|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
126325709|NCT03026283|454488242|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
126325710|NCT03026283|454488243|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
126325711|NCT03026283|454488244|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
126325712|NCT03026283|454488245|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
126325713|NCT03026283|454488246|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
126325714|NCT03026283|454488247|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
126325715|NCT03782571|454488248|FG000|Period 1|Withdrawal by Subject|1|||
126325716|NCT03782571|454488249|FG001|Period 1|Withdrawal by Subject|0|||
126325717|NCT03782571|454488250|FG002|Period 1|Withdrawal by Subject|0|||
126325718|NCT03782571|454488251|FG003|Period 1|Withdrawal by Subject|0|||
126325719|NCT03782571|454488248|FG000|Period 3|Subject Unable to Attend V5|1|||
126325720|NCT03782571|454488249|FG001|Period 3|Subject Unable to Attend V5|0|||
126325721|NCT03782571|454488250|FG002|Period 3|Subject Unable to Attend V5|0|||
126325722|NCT03782571|454488251|FG003|Period 3|Subject Unable to Attend V5|0|||
126325723|NCT03782571|454488248|FG000|Period 3|Adverse Event|1|||
126325724|NCT03782571|454488249|FG001|Period 3|Adverse Event|0|||
126325725|NCT03782571|454488250|FG002|Period 3|Adverse Event|0|||
126325726|NCT03782571|454488251|FG003|Period 3|Adverse Event|0|||
126325727|NCT02213380|454488263|FG000|Underwent Randomization|Withdrawal by Subject|2|||
126325728|NCT02213380|454488264|FG001|Underwent Randomization|Withdrawal by Subject|0|||
126325729|NCT02213380|454488263|FG000|Underwent Randomization|Not treated|3|||
126325730|NCT02213380|454488264|FG001|Underwent Randomization|Not treated|3|||
126325731|NCT02213380|454488263|FG000|Per-protocol Analysis|Protocol Violation|32|||
126325732|NCT02213380|454488264|FG001|Per-protocol Analysis|Protocol Violation|36|||
126325733|NCT03498313|454488267|FG000|Experimental Period 1|Adverse Event|1|||
126325734|NCT03498313|454488268|FG001|Experimental Period 1|Adverse Event|0|||
126325735|NCT03498313|454488269|FG002|Experimental Period 1|Adverse Event|0|||
126325736|NCT03498313|454488270|FG003|Experimental Period 1|Adverse Event|1|||
126325737|NCT03498313|454488271|FG004|Experimental Period 1|Adverse Event|0|||
126325738|NCT03498313|454488272|FG005|Experimental Period 1|Adverse Event|0|||
126325739|NCT03498313|454488267|FG000|Experimental Period 1|Withdrawal by Subject|0|||
126325740|NCT03498313|454488268|FG001|Experimental Period 1|Withdrawal by Subject|1|||
126325741|NCT03498313|454488269|FG002|Experimental Period 1|Withdrawal by Subject|0|||
126325742|NCT03498313|454488270|FG003|Experimental Period 1|Withdrawal by Subject|0|||
126325743|NCT03498313|454488271|FG004|Experimental Period 1|Withdrawal by Subject|0|||
126325744|NCT03498313|454488272|FG005|Experimental Period 1|Withdrawal by Subject|0|||
126325745|NCT03498313|454488267|FG000|Washout Period 1|Anovulation|1|||
126325746|NCT03498313|454488268|FG001|Washout Period 1|Anovulation|0|||
126325747|NCT03498313|454488269|FG002|Washout Period 1|Anovulation|0|||
126325748|NCT03498313|454488270|FG003|Washout Period 1|Anovulation|0|||
126325749|NCT03498313|454488271|FG004|Washout Period 1|Anovulation|0|||
126653971|NCT00092495|455691126|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
126653972|NCT00092495|455691127|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
126653973|NCT00092495|455691123|FG000|Base Study Vaccination Period|Protocol Violation|1|||
126653974|NCT00092495|455691124|FG001|Base Study Vaccination Period|Protocol Violation|0|||
126653975|NCT00092495|455691125|FG002|Base Study Vaccination Period|Protocol Violation|0|||
126653976|NCT00092495|455691126|FG003|Base Study Vaccination Period|Protocol Violation|0|||
126653977|NCT00092495|455691127|FG004|Base Study Vaccination Period|Protocol Violation|0|||
126653978|NCT00092495|455691123|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
126653979|NCT00092495|455691124|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
126653980|NCT00092495|455691125|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
126653981|NCT00092495|455691126|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
126653982|NCT00092495|455691127|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
126653983|NCT00092495|455691123|FG000|Base Study Follow-up Period|Extended|0|||
126325750|NCT03498313|454488272|FG005|Washout Period 1|Anovulation|0|||
126325751|NCT03498313|454488267|FG000|Washout Period 1|Withdrawal by Subject|0|||
126325752|NCT03498313|454488268|FG001|Washout Period 1|Withdrawal by Subject|3|||
126325753|NCT03498313|454488269|FG002|Washout Period 1|Withdrawal by Subject|0|||
126653984|NCT00092495|455691124|FG001|Base Study Follow-up Period|Extended|0|||
126653985|NCT00092495|455691125|FG002|Base Study Follow-up Period|Extended|1|||
126653986|NCT00092495|455691126|FG003|Base Study Follow-up Period|Extended|2|||
126653987|NCT00092495|455691127|FG004|Base Study Follow-up Period|Extended|0|||
126325754|NCT03498313|454488270|FG003|Washout Period 1|Withdrawal by Subject|1|||
126325755|NCT03498313|454488271|FG004|Washout Period 1|Withdrawal by Subject|0|||
126325756|NCT03498313|454488272|FG005|Washout Period 1|Withdrawal by Subject|1|||
126325757|NCT03498313|454488267|FG000|Experimental Period 2|Adverse Event|0|||
126325758|NCT03498313|454488268|FG001|Experimental Period 2|Adverse Event|0|||
126325759|NCT03498313|454488269|FG002|Experimental Period 2|Adverse Event|0|||
126325760|NCT03498313|454488270|FG003|Experimental Period 2|Adverse Event|0|||
126325761|NCT03498313|454488271|FG004|Experimental Period 2|Adverse Event|1|||
126325762|NCT03498313|454488272|FG005|Experimental Period 2|Adverse Event|2|||
126325763|NCT03498313|454488267|FG000|Washout Period 2|Physician Decision|1|||
126325764|NCT03498313|454488268|FG001|Washout Period 2|Physician Decision|0|||
126325765|NCT03498313|454488269|FG002|Washout Period 2|Physician Decision|0|||
126325766|NCT03498313|454488270|FG003|Washout Period 2|Physician Decision|1|||
126325767|NCT03498313|454488271|FG004|Washout Period 2|Physician Decision|0|||
126325768|NCT03498313|454488272|FG005|Washout Period 2|Physician Decision|1|||
126325769|NCT03498313|454488267|FG000|Washout Period 2|Withdrawal by Subject|3|||
126325770|NCT03498313|454488268|FG001|Washout Period 2|Withdrawal by Subject|2|||
126325771|NCT03498313|454488269|FG002|Washout Period 2|Withdrawal by Subject|0|||
126325772|NCT03498313|454488270|FG003|Washout Period 2|Withdrawal by Subject|0|||
126325773|NCT03498313|454488271|FG004|Washout Period 2|Withdrawal by Subject|2|||
126325774|NCT03498313|454488272|FG005|Washout Period 2|Withdrawal by Subject|0|||
126325775|NCT03498313|454488267|FG000|Washout Period 2|Anovulation|0|||
126325776|NCT03498313|454488268|FG001|Washout Period 2|Anovulation|0|||
126325777|NCT03498313|454488269|FG002|Washout Period 2|Anovulation|0|||
126325778|NCT03498313|454488270|FG003|Washout Period 2|Anovulation|0|||
126325779|NCT03498313|454488271|FG004|Washout Period 2|Anovulation|0|||
126325780|NCT03498313|454488272|FG005|Washout Period 2|Anovulation|1|||
126325781|NCT00184002|454488275|FG000|Overall Study|Adverse Event|9|||
126325782|NCT00184002|454488275|FG000|Overall Study|Death|3|||
126325783|NCT00184002|454488275|FG000|Overall Study|Physician Decision|1|||
126325784|NCT00184002|454488275|FG000|Overall Study|Withdrawal by Subject|4|||
126325785|NCT02171429|454488276|FG000|Overall Study|Other|0|||
126325786|NCT02171429|454488277|FG001|Overall Study|Other|1|||
126325787|NCT02171429|454488278|FG002|Overall Study|Other|1|||
126325788|NCT02171429|454488276|FG000|Overall Study|Non-Compliance|0|||
126325789|NCT02171429|454488277|FG001|Overall Study|Non-Compliance|0|||
126325790|NCT02171429|454488278|FG002|Overall Study|Non-Compliance|1|||
126325791|NCT02171429|454488276|FG000|Overall Study|Physician Decision|0|||
126653988|NCT00092495|455691123|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
126653989|NCT00092495|455691124|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
126325792|NCT02171429|454488277|FG001|Overall Study|Physician Decision|0|||
126325793|NCT02171429|454488278|FG002|Overall Study|Physician Decision|1|||
126325794|NCT02171429|454488276|FG000|Overall Study|Withdrawal by Subject|1|||
126653990|NCT00092495|455691125|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
126653991|NCT00092495|455691126|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
126653992|NCT00092495|455691127|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
126653993|NCT00092495|455691123|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
126653994|NCT00092495|455691124|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
126653995|NCT00092495|455691125|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
126653996|NCT00092495|455691126|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
126653997|NCT00092495|455691127|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
126653998|NCT01888900|455691136|FG000|Overall Study|failed treatment|0|||
126653999|NCT01888900|455691137|FG001|Overall Study|failed treatment|2|||
126654000|NCT03932812|455691138|FG000|Overall Study|Lost to Follow-up|12|||
126654001|NCT03932812|455691139|FG001|Overall Study|Lost to Follow-up|14|||
126654002|NCT03932812|455691138|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
126654003|NCT03932812|455691139|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
126654004|NCT02585232|455691140|FG000|Overall Study|Lost to Follow-up|8|||
126654005|NCT02585232|455691141|FG001|Overall Study|Lost to Follow-up|8|||
126654006|NCT02585232|455691140|FG000|Overall Study|Withdrawal by Subject|4|||
126654007|NCT02585232|455691141|FG001|Overall Study|Withdrawal by Subject|8|||
126654008|NCT02313233|455691142|FG000|Overall Study|Withdrawal by Subject|1|||
126654009|NCT02313233|455691143|FG001|Overall Study|Withdrawal by Subject|2|||
126654010|NCT02313233|455691142|FG000|Overall Study|Administrative reason|1|||
126654011|NCT02313233|455691143|FG001|Overall Study|Administrative reason|1|||
126654012|NCT02679573|455691155|FG000|Overall Study|Adverse Event|13|||
126654013|NCT02679573|455691156|FG001|Overall Study|Adverse Event|6|||
126654014|NCT02679573|455691155|FG000|Overall Study|Lack of Efficacy|12|||
126654015|NCT02679573|455691156|FG001|Overall Study|Lack of Efficacy|15|||
126325795|NCT02171429|454488277|FG001|Overall Study|Withdrawal by Subject|1|||
126325796|NCT02171429|454488278|FG002|Overall Study|Withdrawal by Subject|1|||
126325797|NCT02171429|454488276|FG000|Overall Study|Lost to Follow-up|0|||
126325798|NCT02171429|454488277|FG001|Overall Study|Lost to Follow-up|1|||
126325799|NCT02171429|454488278|FG002|Overall Study|Lost to Follow-up|0|||
126325800|NCT02171429|454488276|FG000|Overall Study|Death|0|||
126654016|NCT02679573|455691155|FG000|Overall Study|Could not complete required study visits|6|||
126654017|NCT02679573|455691156|FG001|Overall Study|Could not complete required study visits|2|||
126654018|NCT02679573|455691155|FG000|Overall Study|Withdrawal by Subject|2|||
126325801|NCT02171429|454488277|FG001|Overall Study|Death|0|||
126325802|NCT02171429|454488278|FG002|Overall Study|Death|1|||
126654019|NCT02679573|455691156|FG001|Overall Study|Withdrawal by Subject|9|||
126654020|NCT02679573|455691155|FG000|Overall Study|Death|2|||
126654021|NCT02679573|455691156|FG001|Overall Study|Death|0|||
126654022|NCT02679573|455691155|FG000|Overall Study|Physician Decision|2|||
126654023|NCT02679573|455691156|FG001|Overall Study|Physician Decision|4|||
126654024|NCT02679573|455691155|FG000|Overall Study|Lost to Follow-up|0|||
126654025|NCT02679573|455691156|FG001|Overall Study|Lost to Follow-up|3|||
126654026|NCT00682890|455691157|FG000|Overall Study|Lost to Follow-up|1|||
126654027|NCT00682890|455691158|FG001|Overall Study|Lost to Follow-up|1|||
126654028|NCT00682890|455691157|FG000|Overall Study|subject moved away|0|||
126654029|NCT00682890|455691158|FG001|Overall Study|subject moved away|1|||
126654030|NCT00682890|455691157|FG000|Overall Study|heavy menstrual bleeding|1|||
126325803|NCT01148459|454488283|FG000|Overall Study|Serious Adverse Event|5|||
126325804|NCT01148459|454488284|FG001|Overall Study|Serious Adverse Event|4|||
126325805|NCT01148459|454488283|FG000|Overall Study|Withdrawal by Subject|1|||
126654031|NCT00682890|455691158|FG001|Overall Study|heavy menstrual bleeding|0|||
126654032|NCT03545503|455691159|FG000|Overall Study|Protocol Violation|14|||
126654033|NCT03545503|455691160|FG001|Overall Study|Protocol Violation|16|||
126654034|NCT02884908|455691163|FG000|Overall Study|Lost to Follow-up|13|||
126654035|NCT02884908|455691164|FG001|Overall Study|Lost to Follow-up|18|||
126654036|NCT01605019|455691167|FG000|Overall Study|pt did not meet transplant endpoint|3|||
126654037|NCT01605019|455691168|FG001|Overall Study|pt did not meet transplant endpoint|0|||
126654038|NCT00862719|455691169|FG000|Overall Study|Disease Progression|5|||
126654039|NCT00862719|455691170|FG001|Overall Study|Disease Progression|0|||
126654040|NCT00862719|455691171|FG002|Overall Study|Disease Progression|1|||
126654041|NCT00862719|455691172|FG003|Overall Study|Disease Progression|0|||
126654042|NCT00862719|455691169|FG000|Overall Study|Death|5|||
126654043|NCT00862719|455691170|FG001|Overall Study|Death|6|||
126654044|NCT00862719|455691171|FG002|Overall Study|Death|1|||
126654045|NCT00862719|455691172|FG003|Overall Study|Death|1|||
126654046|NCT00862719|455691169|FG000|Overall Study|Engraftment failure|0|||
126654047|NCT00862719|455691170|FG001|Overall Study|Engraftment failure|0|||
126654048|NCT00862719|455691171|FG002|Overall Study|Engraftment failure|1|||
126654049|NCT00862719|455691172|FG003|Overall Study|Engraftment failure|0|||
126654050|NCT00862719|455691169|FG000|Overall Study|Veno-Occlusive Disease|0|||
126654051|NCT00862719|455691170|FG001|Overall Study|Veno-Occlusive Disease|0|||
126654052|NCT00862719|455691171|FG002|Overall Study|Veno-Occlusive Disease|1|||
126654053|NCT00862719|455691172|FG003|Overall Study|Veno-Occlusive Disease|0|||
126654054|NCT00324116|455691173|FG000|Overall Study|Adverse Event|5|||
126654055|NCT00324116|455691173|FG000|Overall Study|Lack of Efficacy|17|||
126654056|NCT00324116|455691173|FG000|Overall Study|Withdrawal by Subject|5|||
126654057|NCT00324116|455691173|FG000|Overall Study|Other|5|||
126654058|NCT01806623|455691174|FG000|Overall Study|Withdrawal by Subject|1|||
126654059|NCT01806623|455691174|FG000|Overall Study|Adverse Event|1|||
126654060|NCT01806623|455691174|FG000|Overall Study|Did not meet the inclusion criteria|56|||
126654061|NCT01737827|455691175|FG000|Overall Study|Adverse Event|3|||
126654062|NCT01737827|455691176|FG001|Overall Study|Adverse Event|6|||
126654063|NCT01737827|455691177|FG002|Overall Study|Adverse Event|0|||
126654064|NCT01737827|455691175|FG000|Overall Study|Lost to Follow-up|0|||
126654065|NCT01737827|455691176|FG001|Overall Study|Lost to Follow-up|1|||
126654066|NCT01737827|455691177|FG002|Overall Study|Lost to Follow-up|0|||
126654067|NCT01737827|455691175|FG000|Overall Study|Physician Decision|0|||
126654068|NCT01737827|455691176|FG001|Overall Study|Physician Decision|2|||
126654069|NCT01737827|455691177|FG002|Overall Study|Physician Decision|0|||
126654070|NCT01737827|455691175|FG000|Overall Study|Progressive Disease|5|||
126654071|NCT01737827|455691176|FG001|Overall Study|Progressive Disease|16|||
126325806|NCT01148459|454488284|FG001|Overall Study|Withdrawal by Subject|0|||
126325807|NCT01148459|454488283|FG000|Overall Study|Migrated/moved from study area|3|||
126654072|NCT01737827|455691177|FG002|Overall Study|Progressive Disease|2|||
126654073|NCT01737827|455691175|FG000|Overall Study|Study Terminated by Sponsor|0|||
126654074|NCT01737827|455691176|FG001|Overall Study|Study Terminated by Sponsor|1|||
126654075|NCT01737827|455691177|FG002|Overall Study|Study Terminated by Sponsor|0|||
126654076|NCT01737827|455691175|FG000|Overall Study|Subject/Guardian Decision|0|||
126325808|NCT01148459|454488284|FG001|Overall Study|Migrated/moved from study area|6|||
126325809|NCT01148459|454488283|FG000|Overall Study|Lost to Follow-up|2|||
126325810|NCT01148459|454488284|FG001|Overall Study|Lost to Follow-up|0|||
126654077|NCT01737827|455691176|FG001|Overall Study|Subject/Guardian Decision|2|||
126654078|NCT01737827|455691177|FG002|Overall Study|Subject/Guardian Decision|0|||
126654079|NCT01451827|455691178|FG000|Overall Study|Adverse Event|2|||
126654080|NCT01451827|455691179|FG001|Overall Study|Adverse Event|0|||
126654081|NCT01451827|455691180|FG002|Overall Study|Adverse Event|1|||
126654082|NCT01451827|455691181|FG003|Overall Study|Adverse Event|1|||
126654083|NCT01451827|455691178|FG000|Overall Study|Protocol deviation|1|||
126654084|NCT01451827|455691179|FG001|Overall Study|Protocol deviation|0|||
126654085|NCT01451827|455691180|FG002|Overall Study|Protocol deviation|0|||
126654086|NCT01451827|455691181|FG003|Overall Study|Protocol deviation|0|||
126654087|NCT01451827|455691178|FG000|Overall Study|Lost to Follow-up|0|||
126654088|NCT01451827|455691179|FG001|Overall Study|Lost to Follow-up|3|||
126325811|NCT01148459|454488283|FG000|Overall Study|Refusal|1|||
126654089|NCT01451827|455691180|FG002|Overall Study|Lost to Follow-up|0|||
126654090|NCT01451827|455691181|FG003|Overall Study|Lost to Follow-up|2|||
126654091|NCT01451827|455691178|FG000|Overall Study|Participant met withdrawal criteria|0|||
126654092|NCT01451827|455691179|FG001|Overall Study|Participant met withdrawal criteria|2|||
126654093|NCT01451827|455691180|FG002|Overall Study|Participant met withdrawal criteria|0|||
126654094|NCT01451827|455691181|FG003|Overall Study|Participant met withdrawal criteria|0|||
126654095|NCT01451827|455691178|FG000|Overall Study|Withdrawal by Subject|0|||
126654096|NCT01451827|455691179|FG001|Overall Study|Withdrawal by Subject|0|||
126654097|NCT01451827|455691180|FG002|Overall Study|Withdrawal by Subject|1|||
126654098|NCT01451827|455691181|FG003|Overall Study|Withdrawal by Subject|1|||
126654099|NCT02424734|455691182|FG000|Overall Study|Treatment stopped to be discharged home|2|||
126654100|NCT02424734|455691183|FG001|Overall Study|Treatment stopped to be discharged home|2|||
126654101|NCT02424734|455691184|FG002|Overall Study|Treatment stopped to be discharged home|0|||
126654102|NCT00528645|455691185|FG000|Overall Study|Adverse Event|3|||
126654103|NCT00116753|455691186|FG000|Overall Study|Adverse Event|16|||
126654104|NCT00116753|455691187|FG001|Overall Study|Adverse Event|10|||
126654105|NCT00116753|455691188|FG002|Overall Study|Adverse Event|7|||
126654106|NCT00116753|455691186|FG000|Overall Study|Withdrawal by Subject|11|||
126654107|NCT00116753|455691187|FG001|Overall Study|Withdrawal by Subject|12|||
126654108|NCT00116753|455691188|FG002|Overall Study|Withdrawal by Subject|8|||
126654109|NCT00116753|455691186|FG000|Overall Study|Lost to Follow-up|0|||
126654110|NCT00116753|455691187|FG001|Overall Study|Lost to Follow-up|2|||
126654111|NCT00116753|455691188|FG002|Overall Study|Lost to Follow-up|1|||
126654112|NCT00116753|455691186|FG000|Overall Study|Protocol Violation|0|||
126654113|NCT00116753|455691187|FG001|Overall Study|Protocol Violation|0|||
126325812|NCT01148459|454488284|FG001|Overall Study|Refusal|0|||
126325813|NCT01148459|454488283|FG000|Overall Study|Failure to comply with study procedures|0|||
126325814|NCT01148459|454488284|FG001|Overall Study|Failure to comply with study procedures|1|||
126325815|NCT00694356|454488285|FG000|Overall Study|Adverse Event|1|||
126325816|NCT00694356|454488286|FG001|Overall Study|Adverse Event|0|||
126325817|NCT00694356|454488287|FG002|Overall Study|Adverse Event|0|||
126325818|NCT00694356|454488285|FG000|Overall Study|Progressive Disease|2|||
126325819|NCT00694356|454488286|FG001|Overall Study|Progressive Disease|6|||
126325820|NCT00694356|454488287|FG002|Overall Study|Progressive Disease|6|||
126325821|NCT01763203|454488288|FG000|Overall Study|Death|4|||
126325822|NCT01763203|454488289|FG001|Overall Study|Death|7|||
126325823|NCT01763203|454488288|FG000|Overall Study|Lost to Follow-up|12|||
126325824|NCT01763203|454488289|FG001|Overall Study|Lost to Follow-up|12|||
126325825|NCT01763203|454488288|FG000|Overall Study|Withdrawal by Subject|8|||
126325826|NCT01763203|454488289|FG001|Overall Study|Withdrawal by Subject|12|||
126325827|NCT01763203|454488288|FG000|Overall Study|Moved out of study region|7|||
126325828|NCT01763203|454488289|FG001|Overall Study|Moved out of study region|10|||
126325829|NCT01763203|454488288|FG000|Overall Study|Physician Decision|2|||
126325830|NCT01763203|454488289|FG001|Overall Study|Physician Decision|1|||
126325831|NCT02187861|454488290|FG000|Overall Study|Adverse Event|2|||
126325832|NCT02187861|454488291|FG001|Overall Study|Adverse Event|1|||
126325833|NCT02187861|454488292|FG002|Overall Study|Adverse Event|2|||
126325834|NCT02187861|454488293|FG003|Overall Study|Adverse Event|1|||
126325835|NCT02187861|454488290|FG000|Overall Study|Death|0|||
126325836|NCT02187861|454488291|FG001|Overall Study|Death|3|||
126325837|NCT02187861|454488292|FG002|Overall Study|Death|1|||
126325838|NCT02187861|454488293|FG003|Overall Study|Death|2|||
126325839|NCT02187861|454488290|FG000|Overall Study|Physician Decision|0|||
126325840|NCT02187861|454488291|FG001|Overall Study|Physician Decision|1|||
126325841|NCT02187861|454488292|FG002|Overall Study|Physician Decision|0|||
126325842|NCT02187861|454488293|FG003|Overall Study|Physician Decision|3|||
126325843|NCT02187861|454488290|FG000|Overall Study|Progressive Disease|4|||
126325844|NCT02187861|454488291|FG001|Overall Study|Progressive Disease|42|||
126325845|NCT02187861|454488292|FG002|Overall Study|Progressive Disease|19|||
126325846|NCT02187861|454488293|FG003|Overall Study|Progressive Disease|22|||
126325847|NCT02187861|454488290|FG000|Overall Study|Withdrawal by Subject|0|||
126325848|NCT02187861|454488291|FG001|Overall Study|Withdrawal by Subject|0|||
126325849|NCT02187861|454488292|FG002|Overall Study|Withdrawal by Subject|3|||
126325850|NCT02187861|454488293|FG003|Overall Study|Withdrawal by Subject|3|||
126325851|NCT02187861|454488290|FG000|Overall Study|Other|0|||
126325852|NCT02187861|454488291|FG001|Overall Study|Other|1|||
126325853|NCT02187861|454488292|FG002|Overall Study|Other|7|||
126325854|NCT02187861|454488293|FG003|Overall Study|Other|1|||
126325855|NCT02768792|454488297|FG000|Overall Study|Adverse Event|1|||
126325856|NCT05980013|454488298|FG000|Overall Study|Withdrawal by Subject|0|||
126654114|NCT00116753|455691188|FG002|Overall Study|Protocol Violation|1|||
126654115|NCT00116753|455691186|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
126654116|NCT00116753|455691187|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
126654117|NCT00116753|455691188|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
126654118|NCT00116753|455691186|FG000|Overall Study|Disease Progression|3|||
126654119|NCT00116753|455691187|FG001|Overall Study|Disease Progression|4|||
126325857|NCT05980013|454488299|FG001|Overall Study|Withdrawal by Subject|1|||
126325858|NCT05980013|454488298|FG000|Overall Study|Device Error|0|||
126325859|NCT05980013|454488299|FG001|Overall Study|Device Error|1|||
126325860|NCT01768559|454488302|FG000|Overall Study|Randomized but not treated|0|||
126325861|NCT01768559|454488303|FG001|Overall Study|Randomized but not treated|0|||
126325862|NCT01768559|454488304|FG002|Overall Study|Randomized but not treated|1|||
126325863|NCT01768559|454488302|FG000|Overall Study|Adverse Event|15|||
126325864|NCT01768559|454488303|FG001|Overall Study|Adverse Event|2|||
126325865|NCT01768559|454488304|FG002|Overall Study|Adverse Event|5|||
126325866|NCT01768559|454488302|FG000|Overall Study|Lack of Efficacy|6|||
126325867|NCT01768559|454488303|FG001|Overall Study|Lack of Efficacy|4|||
126325868|NCT01768559|454488304|FG002|Overall Study|Lack of Efficacy|0|||
126325869|NCT01768559|454488302|FG000|Overall Study|Poor compliance to protocol|0|||
126325870|NCT01768559|454488303|FG001|Overall Study|Poor compliance to protocol|3|||
126325871|NCT01768559|454488304|FG002|Overall Study|Poor compliance to protocol|2|||
126325872|NCT01768559|454488302|FG000|Overall Study|Other than specified|9|||
126325873|NCT01768559|454488303|FG001|Overall Study|Other than specified|8|||
126325874|NCT01768559|454488304|FG002|Overall Study|Other than specified|5|||
126325875|NCT02782377|454488305|FG000|Overall Study|Physician Decision|5|||
126325876|NCT02521792|454488306|FG000|Overall Study|Study Terminated|6|||
126325877|NCT00303472|454488307|FG000|Treatment Period|Adverse Event|0|||
126325878|NCT00303472|454488308|FG001|Treatment Period|Adverse Event|0|||
126325879|NCT00303472|454488309|FG002|Treatment Period|Adverse Event|0|||
126325880|NCT00303472|454488310|FG003|Treatment Period|Adverse Event|0|||
126325881|NCT00303472|454488311|FG004|Treatment Period|Adverse Event|1|||
126325882|NCT00303472|454488312|FG005|Treatment Period|Adverse Event|0|||
126325883|NCT00303472|454488313|FG006|Treatment Period|Adverse Event|0|||
126325884|NCT00303472|454488307|FG000|Treatment Period|Death|0|||
126325885|NCT00303472|454488308|FG001|Treatment Period|Death|0|||
126325886|NCT00303472|454488309|FG002|Treatment Period|Death|0|||
126325887|NCT00303472|454488310|FG003|Treatment Period|Death|1|||
126325888|NCT00303472|454488311|FG004|Treatment Period|Death|0|||
126325889|NCT00303472|454488312|FG005|Treatment Period|Death|0|||
126325890|NCT00303472|454488313|FG006|Treatment Period|Death|1|||
126325891|NCT00303472|454488307|FG000|Treatment Period|Withdrawal by Subject|0|||
126325892|NCT00303472|454488308|FG001|Treatment Period|Withdrawal by Subject|0|||
126325893|NCT00303472|454488309|FG002|Treatment Period|Withdrawal by Subject|0|||
126325894|NCT00303472|454488310|FG003|Treatment Period|Withdrawal by Subject|1|||
126325895|NCT00303472|454488311|FG004|Treatment Period|Withdrawal by Subject|0|||
126325896|NCT00303472|454488312|FG005|Treatment Period|Withdrawal by Subject|1|||
126325897|NCT00303472|454488313|FG006|Treatment Period|Withdrawal by Subject|0|||
126325898|NCT00303472|454488307|FG000|Treatment Period|Other|0|||
126325899|NCT00303472|454488308|FG001|Treatment Period|Other|0|||
126325900|NCT00303472|454488309|FG002|Treatment Period|Other|0|||
126325901|NCT00303472|454488310|FG003|Treatment Period|Other|0|||
126325902|NCT00303472|454488311|FG004|Treatment Period|Other|1|||
126325903|NCT00303472|454488312|FG005|Treatment Period|Other|0|||
126325904|NCT00303472|454488313|FG006|Treatment Period|Other|1|||
126325905|NCT00303472|454488307|FG000|Treatment Period|Disease Progression (to AML)|0|||
126325906|NCT00303472|454488308|FG001|Treatment Period|Disease Progression (to AML)|0|||
126654120|NCT00116753|455691188|FG002|Overall Study|Disease Progression|3|||
126654121|NCT00116753|455691186|FG000|Overall Study|Abnormal Echocardiogram|0|||
126654122|NCT00116753|455691187|FG001|Overall Study|Abnormal Echocardiogram|0|||
126654123|NCT00116753|455691188|FG002|Overall Study|Abnormal Echocardiogram|1|||
126654124|NCT00116753|455691186|FG000|Overall Study|Progressive Parkinson's Disease|1|||
126654125|NCT00116753|455691187|FG001|Overall Study|Progressive Parkinson's Disease|0|||
126654126|NCT00116753|455691188|FG002|Overall Study|Progressive Parkinson's Disease|0|||
126654127|NCT00116753|455691186|FG000|Overall Study|Dosing Error|0|||
126654128|NCT00116753|455691187|FG001|Overall Study|Dosing Error|1|||
126654129|NCT00116753|455691188|FG002|Overall Study|Dosing Error|0|||
126654130|NCT01642251|455691189|FG000|Overall Study|Progressive disease|0|||
126654131|NCT01642251|455691190|FG001|Overall Study|Progressive disease|0|||
126654132|NCT01642251|455691191|FG002|Overall Study|Progressive disease|3|||
126325907|NCT00303472|454488309|FG002|Treatment Period|Disease Progression (to AML)|0|||
126325908|NCT00303472|454488310|FG003|Treatment Period|Disease Progression (to AML)|0|||
126325909|NCT00303472|454488311|FG004|Treatment Period|Disease Progression (to AML)|1|||
126325910|NCT00303472|454488312|FG005|Treatment Period|Disease Progression (to AML)|0|||
126325911|NCT00303472|454488313|FG006|Treatment Period|Disease Progression (to AML)|0|||
126325912|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Adverse Event|1|||
126325913|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Adverse Event|0|||
126654133|NCT01642251|455691192|FG003|Overall Study|Progressive disease|3|||
126654134|NCT01642251|455691189|FG000|Overall Study|Adverse Event|0|||
126654135|NCT01642251|455691190|FG001|Overall Study|Adverse Event|0|||
126654136|NCT01642251|455691191|FG002|Overall Study|Adverse Event|5|||
126325914|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Adverse Event|1|||
126325915|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Adverse Event|0|||
126325916|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Adverse Event|0|||
126325917|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Adverse Event|0|||
126325918|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Adverse Event|0|||
126654137|NCT01642251|455691192|FG003|Overall Study|Adverse Event|4|||
126325919|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Death|2|||
126325920|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Death|0|||
126325921|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Death|1|||
126325922|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Death|0|||
126325923|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Death|0|||
126325924|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Death|0|||
126325925|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Death|0|||
126325926|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
126325927|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
126325928|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
126325929|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
126325930|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
126325931|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
126325932|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
126325933|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Physician Decision|0|||
126325934|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Physician Decision|4|||
126325935|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Physician Decision|2|||
126325936|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Physician Decision|3|||
126325937|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Physician Decision|2|||
126325938|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Physician Decision|0|||
126325939|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Physician Decision|0|||
126325940|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
126325941|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
126325942|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
126325943|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
126325944|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
126325945|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
126325946|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
126325947|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Other|0|||
126325948|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Other|2|||
126325949|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Other|4|||
126325950|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Other|2|||
126325951|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Other|1|||
126325952|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Other|0|||
126325953|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Other|0|||
126325954|NCT00303472|454488307|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
126325955|NCT00303472|454488308|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
126325956|NCT00303472|454488309|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
126325957|NCT00303472|454488310|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
126654138|NCT01642251|455691189|FG000|Overall Study|Death|0|||
126654139|NCT01642251|455691190|FG001|Overall Study|Death|0|||
126654140|NCT01642251|455691191|FG002|Overall Study|Death|1|||
126654141|NCT01642251|455691192|FG003|Overall Study|Death|3|||
126654142|NCT01642251|455691189|FG000|Overall Study|Withdrawal by Subject|0|||
126654143|NCT01642251|455691190|FG001|Overall Study|Withdrawal by Subject|0|||
126325958|NCT00303472|454488311|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
126325959|NCT00303472|454488312|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
126325960|NCT00303472|454488313|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
126325961|NCT02937636|454488315|FG000|Overall Study|Other (Not specified)|3|||
126325962|NCT02937636|454488316|FG001|Overall Study|Other (Not specified)|2|||
126325963|NCT00770913|454488321|FG000|Overall Study|Adverse Event|1|||
126325964|NCT00770913|454488322|FG001|Overall Study|Adverse Event|3|||
126325965|NCT00770913|454488323|FG002|Overall Study|Adverse Event|6|||
126325966|NCT00770913|454488321|FG000|Overall Study|Refusal to continue participation|6|||
126325967|NCT00770913|454488322|FG001|Overall Study|Refusal to continue participation|4|||
126325968|NCT00770913|454488323|FG002|Overall Study|Refusal to continue participation|5|||
126325969|NCT00770913|454488321|FG000|Overall Study|Physician Decision|0|||
126325970|NCT00770913|454488322|FG001|Overall Study|Physician Decision|1|||
126325971|NCT00770913|454488323|FG002|Overall Study|Physician Decision|1|||
126325972|NCT00770913|454488321|FG000|Overall Study|Protocol Violation|3|||
126325973|NCT00770913|454488322|FG001|Overall Study|Protocol Violation|0|||
126325974|NCT00770913|454488323|FG002|Overall Study|Protocol Violation|1|||
126325975|NCT00770913|454488321|FG000|Overall Study|Incorrect drug was allocated|1|||
126325976|NCT00770913|454488322|FG001|Overall Study|Incorrect drug was allocated|0|||
126325977|NCT00770913|454488323|FG002|Overall Study|Incorrect drug was allocated|0|||
126325978|NCT00359294|454488327|FG000|Overall Study|Progressive disease|1|||
126325979|NCT00359294|454488328|FG001|Overall Study|Progressive disease|1|||
126325980|NCT00359294|454488329|FG002|Overall Study|Progressive disease|2|||
126325981|NCT00359294|454488330|FG003|Overall Study|Progressive disease|3|||
126325982|NCT00359294|454488331|FG004|Overall Study|Progressive disease|2|||
126654144|NCT01642251|455691191|FG002|Overall Study|Withdrawal by Subject|1|||
126654145|NCT01642251|455691192|FG003|Overall Study|Withdrawal by Subject|3|||
126654146|NCT01642251|455691189|FG000|Overall Study|Alternative therapy|0|||
126325983|NCT00359294|454488327|FG000|Overall Study|Withdrawal by Subject|0|||
126325984|NCT00359294|454488328|FG001|Overall Study|Withdrawal by Subject|0|||
126325985|NCT00359294|454488329|FG002|Overall Study|Withdrawal by Subject|0|||
126654147|NCT01642251|455691190|FG001|Overall Study|Alternative therapy|0|||
126654148|NCT01642251|455691191|FG002|Overall Study|Alternative therapy|0|||
126654149|NCT01642251|455691192|FG003|Overall Study|Alternative therapy|2|||
126654150|NCT01642251|455691189|FG000|Overall Study|Other complicating disease|0|||
126654151|NCT01642251|455691190|FG001|Overall Study|Other complicating disease|0|||
126654152|NCT01642251|455691191|FG002|Overall Study|Other complicating disease|1|||
126654153|NCT01642251|455691192|FG003|Overall Study|Other complicating disease|0|||
126654154|NCT01642251|455691189|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
126654155|NCT01642251|455691190|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
126654156|NCT01642251|455691191|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
126654157|NCT01642251|455691192|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
126654158|NCT01445301|455691193|FG000|Overall Study|Adverse Event|15|||
126654159|NCT01445301|455691194|FG001|Overall Study|Adverse Event|25|||
126654160|NCT01445301|455691195|FG002|Overall Study|Adverse Event|4|||
126654161|NCT01445301|455691193|FG000|Overall Study|Lack of Efficacy|0|||
126654162|NCT01445301|455691194|FG001|Overall Study|Lack of Efficacy|1|||
126654163|NCT01445301|455691195|FG002|Overall Study|Lack of Efficacy|0|||
126654164|NCT01445301|455691193|FG000|Overall Study|Protocol Violation|1|||
126654165|NCT01445301|455691194|FG001|Overall Study|Protocol Violation|0|||
126654166|NCT01445301|455691195|FG002|Overall Study|Protocol Violation|0|||
126654167|NCT01445301|455691193|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
126654168|NCT01445301|455691194|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
126654169|NCT01445301|455691195|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
126654170|NCT01445301|455691193|FG000|Overall Study|Physician Decision|0|||
126654171|NCT01445301|455691194|FG001|Overall Study|Physician Decision|2|||
126654172|NCT01445301|455691195|FG002|Overall Study|Physician Decision|0|||
126654173|NCT01445301|455691193|FG000|Overall Study|Withdrawal by Subject|5|||
126654174|NCT01445301|455691194|FG001|Overall Study|Withdrawal by Subject|6|||
126654175|NCT01445301|455691195|FG002|Overall Study|Withdrawal by Subject|4|||
126654176|NCT00752557|455691196|FG000|Overall Study|Withdrawal by Subject|4|||
126654177|NCT00752557|455691197|FG001|Overall Study|Withdrawal by Subject|3|||
126654178|NCT00752557|455691198|FG002|Overall Study|Withdrawal by Subject|3|||
126654179|NCT00752557|455691196|FG000|Overall Study|Unspecified resaons|0|||
126654180|NCT00752557|455691197|FG001|Overall Study|Unspecified resaons|2|||
126654181|NCT00752557|455691198|FG002|Overall Study|Unspecified resaons|2|||
126654182|NCT00752557|455691196|FG000|Overall Study|Lost to Follow-up|1|||
126654183|NCT00752557|455691197|FG001|Overall Study|Lost to Follow-up|0|||
126654184|NCT00752557|455691198|FG002|Overall Study|Lost to Follow-up|1|||
126654185|NCT00470366|455691203|FG000|Overall Study|Adverse Event|3|||
126654186|NCT00470366|455691203|FG000|Overall Study|Poor compliance|1|||
126654187|NCT02996474|455691204|FG000|Overall Study|Physician Decision|5|||
126654188|NCT04493502|455691205|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
126654189|NCT04493502|455691206|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
126654190|NCT04493502|455691205|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
126654191|NCT04493502|455691206|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
126654192|NCT04493502|455691205|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
126654193|NCT04493502|455691206|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
126654194|NCT04493502|455691205|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
126654195|NCT04493502|455691206|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
126654196|NCT04493502|455691205|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
126654197|NCT04493502|455691206|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
126654198|NCT04493502|455691205|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
126654199|NCT04493502|455691206|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
126325986|NCT00359294|454488330|FG003|Overall Study|Withdrawal by Subject|0|||
126325987|NCT00359294|454488331|FG004|Overall Study|Withdrawal by Subject|1|||
126325988|NCT00359294|454488327|FG000|Overall Study|Not treated|0|||
126325989|NCT00359294|454488328|FG001|Overall Study|Not treated|0|||
126325990|NCT00359294|454488329|FG002|Overall Study|Not treated|0|||
126325991|NCT00359294|454488330|FG003|Overall Study|Not treated|1|||
126325992|NCT00359294|454488331|FG004|Overall Study|Not treated|0|||
126325993|NCT00359294|454488327|FG000|Overall Study|Physician Decision|0|||
126654200|NCT04493502|455691205|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
126654201|NCT04493502|455691206|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
126654202|NCT04493502|455691205|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
126654203|NCT04493502|455691206|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
126654204|NCT04493502|455691205|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
126654205|NCT04493502|455691206|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
126654206|NCT04493502|455691205|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
126325994|NCT00359294|454488328|FG001|Overall Study|Physician Decision|0|||
126325995|NCT00359294|454488329|FG002|Overall Study|Physician Decision|1|||
126325996|NCT00359294|454488330|FG003|Overall Study|Physician Decision|0|||
126325997|NCT00359294|454488331|FG004|Overall Study|Physician Decision|0|||
126325998|NCT02347072|454488332|FG000|Overall Study|Adverse Event|2|||
126325999|NCT02347072|454488332|FG000|Overall Study|Withdrawal by Subject|6|||
126326000|NCT02347072|454488332|FG000|Overall Study|Physician Decision|1|||
126326001|NCT02347072|454488332|FG000|Overall Study|Lost to Follow-up|2|||
126326002|NCT02347072|454488332|FG000|Overall Study|Protocol Violation|1|||
126326003|NCT02347072|454488332|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
126326004|NCT03148067|454488335|FG000|Overall Study|Lost to Follow-up|3|||
126326005|NCT03148067|454488335|FG000|Overall Study|Death|1|||
126326006|NCT03124537|454488337|FG000|Overall Study|Lost to Follow-up|3|||
126326007|NCT03124537|454488338|FG001|Overall Study|Lost to Follow-up|5|||
126326008|NCT03124537|454488337|FG000|Overall Study|App Crash, Incomplete Data|7|||
126326009|NCT03124537|454488338|FG001|Overall Study|App Crash, Incomplete Data|8|||
126326010|NCT03681184|454488341|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
126326011|NCT03681184|454488342|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
126326012|NCT04318132|454488345|FG000|Overall Study|Protocol Violation|0|||
126326013|NCT04318132|454488346|FG001|Overall Study|Protocol Violation|0|||
126326014|NCT04318132|454488347|FG002|Overall Study|Protocol Violation|3|||
126326015|NCT04318132|454488348|FG003|Overall Study|Protocol Violation|0|||
126326016|NCT04424914|454488349|FG000|Overall Study|Other|0|||
126326017|NCT04424914|454488350|FG001|Overall Study|Other|0|||
126326018|NCT04424914|454488351|FG002|Overall Study|Other|28|||
126326019|NCT04424914|454488349|FG000|Overall Study|Withdrawal by Subject|3|||
126326020|NCT04424914|454488350|FG001|Overall Study|Withdrawal by Subject|0|||
126326021|NCT04424914|454488351|FG002|Overall Study|Withdrawal by Subject|0|||
126326022|NCT04424914|454488349|FG000|Overall Study|Study terminated by sponsor|23|||
126326023|NCT04424914|454488350|FG001|Overall Study|Study terminated by sponsor|7|||
126326024|NCT04424914|454488351|FG002|Overall Study|Study terminated by sponsor|0|||
126326025|NCT04424914|454488349|FG000|Overall Study|Lost to Follow-up|0|||
126326026|NCT04424914|454488350|FG001|Overall Study|Lost to Follow-up|0|||
126326027|NCT04424914|454488351|FG002|Overall Study|Lost to Follow-up|1|||
126326028|NCT04424914|454488349|FG000|Overall Study|Death|3|||
126326029|NCT04424914|454488350|FG001|Overall Study|Death|1|||
126654207|NCT04493502|455691206|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
126654208|NCT04493502|455691205|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
126326030|NCT04424914|454488351|FG002|Overall Study|Death|0|||
126326031|NCT03383692|454488360|FG000|Overall Study|Progressive disease as per RECIST|3|||
126326032|NCT03383692|454488361|FG001|Overall Study|Progressive disease as per RECIST|3|||
126326033|NCT03383692|454488360|FG000|Overall Study|Clinical progression|0|||
126326034|NCT03383692|454488361|FG001|Overall Study|Clinical progression|1|||
126326035|NCT03383692|454488360|FG000|Overall Study|Adverse Event|3|||
126326036|NCT03383692|454488361|FG001|Overall Study|Adverse Event|0|||
126326037|NCT00893971|454488362|FG000|Overall Study|Physician Decision|3|||
126326038|NCT00492232|454488363|FG000|Placebo Run-in|Adverse Event|0|||
126326039|NCT00492232|454488364|FG001|Placebo Run-in|Adverse Event|2|||
126326040|NCT00492232|454488363|FG000|Placebo Run-in|Protocol Violation|0|||
126326041|NCT00492232|454488364|FG001|Placebo Run-in|Protocol Violation|3|||
126326042|NCT00492232|454488363|FG000|Placebo Run-in|Lost to Follow-up|0|||
126326043|NCT00492232|454488364|FG001|Placebo Run-in|Lost to Follow-up|3|||
126326044|NCT00492232|454488363|FG000|Placebo Run-in|Withdrawal by Subject|0|||
126326045|NCT00492232|454488364|FG001|Placebo Run-in|Withdrawal by Subject|8|||
126326046|NCT00492232|454488363|FG000|Placebo Run-in|Pregnancy|0|||
126326047|NCT00492232|454488364|FG001|Placebo Run-in|Pregnancy|1|||
126326048|NCT00492232|454488363|FG000|Placebo Run-in|Entrance criteria not met|0|||
126326049|NCT00492232|454488364|FG001|Placebo Run-in|Entrance criteria not met|45|||
126326050|NCT00492232|454488363|FG000|Placebo Run-in|Other|0|||
126326051|NCT00492232|454488364|FG001|Placebo Run-in|Other|6|||
126326052|NCT00492232|454488363|FG000|Placebo Run-in|Missing|0|||
126326053|NCT00492232|454488364|FG001|Placebo Run-in|Missing|2|||
126326054|NCT00492232|454488363|FG000|Double-Blind Treatment|Adverse Event|1|||
126326055|NCT00492232|454488364|FG001|Double-Blind Treatment|Adverse Event|2|||
126326056|NCT00492232|454488363|FG000|Double-Blind Treatment|Protocol Violation|3|||
126326057|NCT00492232|454488364|FG001|Double-Blind Treatment|Protocol Violation|7|||
126326058|NCT00492232|454488363|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
126326059|NCT00492232|454488364|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
126326060|NCT00492232|454488363|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
126326061|NCT00492232|454488364|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
126326062|NCT00492232|454488363|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
126326063|NCT00492232|454488364|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
126326064|NCT00492232|454488363|FG000|Double-Blind Treatment|Other|6|||
126326065|NCT00492232|454488364|FG001|Double-Blind Treatment|Other|5|||
126654209|NCT04493502|455691206|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
126326066|NCT00492232|454488363|FG000|Double-Blind Treatment|Randomized not treated|1|||
126326067|NCT00492232|454488364|FG001|Double-Blind Treatment|Randomized not treated|0|||
126654210|NCT04493502|455691205|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
126326068|NCT00492232|454488363|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
126326069|NCT00492232|454488364|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
126326070|NCT02453256|454488365|FG000|Double Blind Period|Death|1|||
126326071|NCT02453256|454488366|FG001|Double Blind Period|Death|1|||
126326072|NCT02453256|454488365|FG000|Double Blind Period|Adverse Event|3|||
126326073|NCT02453256|454488366|FG001|Double Blind Period|Adverse Event|2|||
126326074|NCT02453256|454488365|FG000|Double Blind Period|Withdrawal by Subject|9|||
126326075|NCT02453256|454488366|FG001|Double Blind Period|Withdrawal by Subject|5|||
126326076|NCT02453256|454488365|FG000|Double Blind Period|Other|0|||
126326077|NCT02453256|454488366|FG001|Double Blind Period|Other|1|||
126326078|NCT02453256|454488365|FG000|Open Label Period|Adverse Event|1|||
126326079|NCT02453256|454488366|FG001|Open Label Period|Adverse Event|3|||
126326080|NCT02453256|454488365|FG000|Open Label Period|Death|0|||
126326081|NCT02453256|454488366|FG001|Open Label Period|Death|1|||
126326082|NCT02453256|454488365|FG000|Open Label Period|Lost to Follow-up|1|||
126326083|NCT02453256|454488366|FG001|Open Label Period|Lost to Follow-up|0|||
126326084|NCT02453256|454488365|FG000|Open Label Period|Other|0|||
126326085|NCT02453256|454488366|FG001|Open Label Period|Other|2|||
126326086|NCT02453256|454488365|FG000|Open Label Period|Withdrawal by Subject|5|||
126326087|NCT02453256|454488366|FG001|Open Label Period|Withdrawal by Subject|1|||
126326088|NCT01216332|454488367|FG000|Overall Study|Withdrawal by Subject|4|||
126326089|NCT01216332|454488368|FG001|Overall Study|Withdrawal by Subject|0|||
126326090|NCT00636636|454488369|FG000|Overall Study|Other reason|4|||
126326091|NCT00636636|454488370|FG001|Overall Study|Other reason|6|||
126326092|NCT00636636|454488369|FG000|Overall Study|Adverse Event|19|||
126326093|NCT00636636|454488370|FG001|Overall Study|Adverse Event|8|||
126326094|NCT00636636|454488369|FG000|Overall Study|Lack of Efficacy|7|||
126326095|NCT00636636|454488370|FG001|Overall Study|Lack of Efficacy|12|||
126326096|NCT00636636|454488369|FG000|Overall Study|Protocol Violation|2|||
126326097|NCT00636636|454488370|FG001|Overall Study|Protocol Violation|2|||
126326098|NCT00636636|454488369|FG000|Overall Study|Lost to Follow-up|0|||
126326099|NCT00636636|454488370|FG001|Overall Study|Lost to Follow-up|1|||
126326100|NCT00636636|454488369|FG000|Overall Study|Death|0|||
126326101|NCT00636636|454488370|FG001|Overall Study|Death|1|||
126326102|NCT00636636|454488369|FG000|Overall Study|Withdrawal by Subject|4|||
126326103|NCT00636636|454488370|FG001|Overall Study|Withdrawal by Subject|9|||
126326104|NCT01237327|454488371|FG000|Overall Study|Protocol Violation: Core Study|1|||
126326105|NCT01237327|454488372|FG001|Overall Study|Protocol Violation: Core Study|0|||
126326106|NCT01237327|454488371|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
126326107|NCT01237327|454488372|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
126654211|NCT04493502|455691206|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
126654212|NCT04493502|455691205|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
126654213|NCT04493502|455691206|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
126654214|NCT00540046|455691207|FG000|Overall Study|Lost to Follow-up|33|||
126654215|NCT00540046|455691208|FG001|Overall Study|Lost to Follow-up|23|||
126654216|NCT02891837|455691209|FG000|Overall Study|Lost to Follow-up|2|||
126654217|NCT02891837|455691210|FG001|Overall Study|Lost to Follow-up|0|||
126654218|NCT02891837|455691209|FG000|Overall Study|Withdrawal by Subject|1|||
126654219|NCT02891837|455691210|FG001|Overall Study|Withdrawal by Subject|0|||
126654220|NCT02751320|455691211|FG000|Overall Study|Adverse Event|2|||
126654221|NCT02751320|455691211|FG000|Overall Study|Withdrawal by Subject|1|||
126326108|NCT01237327|454488371|FG000|Overall Study|Progression of Disease: Core Study|18|||
126326109|NCT01237327|454488372|FG001|Overall Study|Progression of Disease: Core Study|22|||
126326110|NCT01237327|454488371|FG000|Overall Study|Progression of Disease: Extension Study|15|||
126326111|NCT01237327|454488372|FG001|Overall Study|Progression of Disease: Extension Study|13|||
126326112|NCT01237327|454488371|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
126326113|NCT01237327|454488372|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
126326114|NCT01237327|454488371|FG000|Overall Study|Withdrawal by Subject|1|||
126326115|NCT01237327|454488372|FG001|Overall Study|Withdrawal by Subject|3|||
126326116|NCT01237327|454488371|FG000|Overall Study|Lost to Follow-up|3|||
126326117|NCT01237327|454488372|FG001|Overall Study|Lost to Follow-up|0|||
126326118|NCT00524173|454488373|FG000|Overall Study|Lost to Follow-up|0|||
126326119|NCT00524173|454488374|FG001|Overall Study|Lost to Follow-up|1|||
126326120|NCT00524173|454488373|FG000|Overall Study|Death|1|||
126654222|NCT00185965|455691212|FG000|Overall Study|Adverse Event|0|||
126326121|NCT00524173|454488374|FG001|Overall Study|Death|0|||
126326122|NCT00524173|454488373|FG000|Overall Study|Had not reached endpoint at study close|4|||
126326123|NCT00524173|454488374|FG001|Overall Study|Had not reached endpoint at study close|1|||
126326124|NCT02483572|454488377|FG000|Overall Study|Withdrawal by Subject|1|||
126654223|NCT00185965|455691213|FG001|Overall Study|Adverse Event|1|||
126654224|NCT02533531|455691214|FG000|Overall Study|Device did not turn on|1|||
126654225|NCT02047903|455691215|FG000|Overall Study|Adverse Event|14|||
126654226|NCT02047903|455691215|FG000|Overall Study|Serious adverse event|10|||
126326125|NCT02483572|454488378|FG001|Overall Study|Withdrawal by Subject|0|||
126326126|NCT02483572|454488377|FG000|Overall Study|Lost to Follow-up|1|||
126326127|NCT02483572|454488378|FG001|Overall Study|Lost to Follow-up|0|||
126326128|NCT02483572|454488377|FG000|Overall Study|Physician Decision|0|||
126326129|NCT02483572|454488378|FG001|Overall Study|Physician Decision|1|||
126326130|NCT04811664|454488379|FG000|Overall Study|Lost to Follow-up|78|||
126326131|NCT04811664|454488380|FG001|Overall Study|Lost to Follow-up|125|||
126326132|NCT04811664|454488381|FG002|Overall Study|Lost to Follow-up|46|||
126326133|NCT04811664|454488379|FG000|Overall Study|Withdrawal by Subject|39|||
126326134|NCT04811664|454488380|FG001|Overall Study|Withdrawal by Subject|76|||
126326135|NCT04811664|454488381|FG002|Overall Study|Withdrawal by Subject|12|||
126326136|NCT04811664|454488379|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
126326137|NCT04811664|454488380|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
126326138|NCT04811664|454488381|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
126326139|NCT04811664|454488379|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
126326140|NCT04811664|454488380|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
126326141|NCT04811664|454488381|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
126326142|NCT04811664|454488379|FG000|Overall Study|Protocol Violation|0|||
126326143|NCT04811664|454488380|FG001|Overall Study|Protocol Violation|5|||
126326144|NCT04811664|454488381|FG002|Overall Study|Protocol Violation|11|||
126326145|NCT04811664|454488379|FG000|Overall Study|Study Terminated by Sponsor|4|||
126326146|NCT04811664|454488380|FG001|Overall Study|Study Terminated by Sponsor|3|||
126326147|NCT04811664|454488381|FG002|Overall Study|Study Terminated by Sponsor|34|||
126326148|NCT04811664|454488379|FG000|Overall Study|Early Study Closure|3|||
126326149|NCT04811664|454488380|FG001|Overall Study|Early Study Closure|7|||
126326150|NCT04811664|454488381|FG002|Overall Study|Early Study Closure|79|||
126326151|NCT04811664|454488379|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
126326152|NCT04811664|454488380|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
126326153|NCT04811664|454488381|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
126326154|NCT05052697|454488382|FG000|Substudy A|Lost to Follow-up|0|||
126326155|NCT05052697|454488383|FG001|Substudy A|Lost to Follow-up|0|||
126326156|NCT05052697|454488384|FG002|Substudy A|Lost to Follow-up|0|||
126326157|NCT05052697|454488385|FG003|Substudy A|Lost to Follow-up|0|||
126326158|NCT05052697|454488386|FG004|Substudy A|Lost to Follow-up|0|||
126326159|NCT05052697|454488387|FG005|Substudy A|Lost to Follow-up|1|||
126326160|NCT05052697|454488388|FG006|Substudy A|Lost to Follow-up|0|||
126326161|NCT05052697|454488389|FG007|Substudy A|Lost to Follow-up|0|||
126326162|NCT05052697|454488390|FG008|Substudy A|Lost to Follow-up|0|||
126326163|NCT05052697|454488391|FG009|Substudy A|Lost to Follow-up|0|||
126326164|NCT05052697|454488392|FG010|Substudy A|Lost to Follow-up|0|||
126326165|NCT05052697|454488393|FG011|Substudy A|Lost to Follow-up|0|||
126326166|NCT05052697|454488394|FG012|Substudy A|Lost to Follow-up|0|||
126326167|NCT05052697|454488395|FG013|Substudy A|Lost to Follow-up|0|||
126326168|NCT05052697|454488396|FG014|Substudy A|Lost to Follow-up|0|||
126326169|NCT05052697|454488397|FG015|Substudy A|Lost to Follow-up|2|||
126326170|NCT05052697|454488398|FG016|Substudy A|Lost to Follow-up|0|||
126326171|NCT05052697|454488399|FG017|Substudy A|Lost to Follow-up|0|||
126326172|NCT05052697|454488400|FG018|Substudy A|Lost to Follow-up|0|||
126326173|NCT05052697|454488401|FG019|Substudy A|Lost to Follow-up|0|||
126326174|NCT05052697|454488402|FG020|Substudy A|Lost to Follow-up|0|||
126326175|NCT05052697|454488403|FG021|Substudy A|Lost to Follow-up|0|||
126326176|NCT05052697|454488404|FG022|Substudy A|Lost to Follow-up|0|||
126326177|NCT05052697|454488405|FG023|Substudy A|Lost to Follow-up|0|||
126326178|NCT05052697|454488406|FG024|Substudy A|Lost to Follow-up|0|||
126326179|NCT05052697|454488407|FG025|Substudy A|Lost to Follow-up|0|||
126326180|NCT05052697|454488408|FG026|Substudy A|Lost to Follow-up|0|||
126326181|NCT05052697|454488409|FG027|Substudy A|Lost to Follow-up|0|||
126326182|NCT05052697|454488410|FG028|Substudy A|Lost to Follow-up|0|||
126326183|NCT05052697|454488411|FG029|Substudy A|Lost to Follow-up|0|||
126326184|NCT05052697|454488412|FG030|Substudy A|Lost to Follow-up|0|||
126326185|NCT05052697|454488413|FG031|Substudy A|Lost to Follow-up|0|||
126326186|NCT05052697|454488414|FG032|Substudy A|Lost to Follow-up|0|||
126326187|NCT05052697|454488415|FG033|Substudy A|Lost to Follow-up|0|||
126326188|NCT05052697|454488382|FG000|Substudy A|No longer met eligibility criteria|0|||
126326189|NCT05052697|454488383|FG001|Substudy A|No longer met eligibility criteria|0|||
126326190|NCT05052697|454488384|FG002|Substudy A|No longer met eligibility criteria|0|||
126326191|NCT05052697|454488385|FG003|Substudy A|No longer met eligibility criteria|0|||
126326192|NCT05052697|454488386|FG004|Substudy A|No longer met eligibility criteria|0|||
126326193|NCT05052697|454488387|FG005|Substudy A|No longer met eligibility criteria|0|||
126326194|NCT05052697|454488388|FG006|Substudy A|No longer met eligibility criteria|0|||
126326195|NCT05052697|454488389|FG007|Substudy A|No longer met eligibility criteria|0|||
126326196|NCT05052697|454488390|FG008|Substudy A|No longer met eligibility criteria|0|||
126326197|NCT05052697|454488391|FG009|Substudy A|No longer met eligibility criteria|0|||
126326198|NCT05052697|454488392|FG010|Substudy A|No longer met eligibility criteria|0|||
126326199|NCT05052697|454488393|FG011|Substudy A|No longer met eligibility criteria|0|||
126326200|NCT05052697|454488394|FG012|Substudy A|No longer met eligibility criteria|0|||
126326201|NCT05052697|454488395|FG013|Substudy A|No longer met eligibility criteria|1|||
126326202|NCT05052697|454488396|FG014|Substudy A|No longer met eligibility criteria|0|||
126326203|NCT05052697|454488397|FG015|Substudy A|No longer met eligibility criteria|0|||
126326204|NCT05052697|454488398|FG016|Substudy A|No longer met eligibility criteria|0|||
126654227|NCT02047903|455691215|FG000|Overall Study|Withdrawal by Subject|16|||
126654228|NCT02047903|455691215|FG000|Overall Study|Lost to Follow-up|4|||
126654229|NCT02047903|455691215|FG000|Overall Study|Reason not listed|6|||
126654230|NCT02047903|455691215|FG000|Overall Study|Not Treated|9|||
126654231|NCT01014533|455691216|FG000|Overall Study|Protocol Violation|3|||
126654232|NCT01014533|455691217|FG001|Overall Study|Protocol Violation|2|||
126654233|NCT01014533|455691216|FG000|Overall Study|Withdrawal by Subject|2|||
126654234|NCT01014533|455691217|FG001|Overall Study|Withdrawal by Subject|0|||
126654235|NCT01014533|455691216|FG000|Overall Study|unable to come to appointment|0|||
126654236|NCT01014533|455691217|FG001|Overall Study|unable to come to appointment|3|||
126654237|NCT00296400|455691221|FG000|Overall Study|Adverse Event|7|||
126654238|NCT00296400|455691222|FG001|Overall Study|Adverse Event|7|||
126654239|NCT00296400|455691223|FG002|Overall Study|Adverse Event|7|||
126654240|NCT00296400|455691221|FG000|Overall Study|Withdrawal by Subject|5|||
126654241|NCT00296400|455691222|FG001|Overall Study|Withdrawal by Subject|6|||
126654242|NCT00296400|455691223|FG002|Overall Study|Withdrawal by Subject|2|||
126654243|NCT00296400|455691221|FG000|Overall Study|Incorrect enrollment|2|||
126654244|NCT00296400|455691222|FG001|Overall Study|Incorrect enrollment|0|||
126654245|NCT00296400|455691223|FG002|Overall Study|Incorrect enrollment|0|||
126654246|NCT00296400|455691221|FG000|Overall Study|Protocol Violation|1|||
126654247|NCT00296400|455691222|FG001|Overall Study|Protocol Violation|1|||
126654248|NCT00296400|455691223|FG002|Overall Study|Protocol Violation|1|||
126326205|NCT05052697|454488399|FG017|Substudy A|No longer met eligibility criteria|0|||
126326206|NCT05052697|454488400|FG018|Substudy A|No longer met eligibility criteria|0|||
126326207|NCT05052697|454488401|FG019|Substudy A|No longer met eligibility criteria|0|||
126326208|NCT05052697|454488402|FG020|Substudy A|No longer met eligibility criteria|0|||
126326209|NCT05052697|454488403|FG021|Substudy A|No longer met eligibility criteria|0|||
126326210|NCT05052697|454488404|FG022|Substudy A|No longer met eligibility criteria|0|||
126326211|NCT05052697|454488405|FG023|Substudy A|No longer met eligibility criteria|0|||
126326212|NCT05052697|454488406|FG024|Substudy A|No longer met eligibility criteria|0|||
126326213|NCT05052697|454488407|FG025|Substudy A|No longer met eligibility criteria|0|||
126326214|NCT05052697|454488408|FG026|Substudy A|No longer met eligibility criteria|0|||
126326215|NCT05052697|454488409|FG027|Substudy A|No longer met eligibility criteria|0|||
126326216|NCT05052697|454488410|FG028|Substudy A|No longer met eligibility criteria|0|||
126326217|NCT05052697|454488411|FG029|Substudy A|No longer met eligibility criteria|0|||
126326218|NCT05052697|454488412|FG030|Substudy A|No longer met eligibility criteria|0|||
126326219|NCT05052697|454488413|FG031|Substudy A|No longer met eligibility criteria|0|||
126326220|NCT05052697|454488414|FG032|Substudy A|No longer met eligibility criteria|0|||
126326221|NCT05052697|454488415|FG033|Substudy A|No longer met eligibility criteria|0|||
126326222|NCT05052697|454488382|FG000|Substudy A|Not vaccinated|0|||
126326223|NCT05052697|454488383|FG001|Substudy A|Not vaccinated|0|||
126326224|NCT05052697|454488384|FG002|Substudy A|Not vaccinated|0|||
126326225|NCT05052697|454488385|FG003|Substudy A|Not vaccinated|1|||
126326226|NCT05052697|454488386|FG004|Substudy A|Not vaccinated|0|||
126326227|NCT05052697|454488387|FG005|Substudy A|Not vaccinated|0|||
126326228|NCT05052697|454488388|FG006|Substudy A|Not vaccinated|0|||
126326229|NCT05052697|454488389|FG007|Substudy A|Not vaccinated|0|||
126326230|NCT05052697|454488390|FG008|Substudy A|Not vaccinated|1|||
126326231|NCT05052697|454488391|FG009|Substudy A|Not vaccinated|0|||
126326232|NCT05052697|454488392|FG010|Substudy A|Not vaccinated|0|||
126326233|NCT05052697|454488393|FG011|Substudy A|Not vaccinated|0|||
126326234|NCT05052697|454488394|FG012|Substudy A|Not vaccinated|0|||
126326235|NCT05052697|454488395|FG013|Substudy A|Not vaccinated|0|||
126326236|NCT05052697|454488396|FG014|Substudy A|Not vaccinated|0|||
126326237|NCT05052697|454488397|FG015|Substudy A|Not vaccinated|0|||
126326238|NCT05052697|454488398|FG016|Substudy A|Not vaccinated|0|||
126326239|NCT05052697|454488399|FG017|Substudy A|Not vaccinated|0|||
126326240|NCT05052697|454488400|FG018|Substudy A|Not vaccinated|0|||
126654249|NCT00296400|455691221|FG000|Overall Study|Lost to Follow-up|1|||
126326241|NCT05052697|454488401|FG019|Substudy A|Not vaccinated|0|||
126654250|NCT00296400|455691222|FG001|Overall Study|Lost to Follow-up|1|||
126654251|NCT00296400|455691223|FG002|Overall Study|Lost to Follow-up|2|||
126654252|NCT00296400|455691221|FG000|Overall Study|Study specific discontinuation criteria|0|||
126654253|NCT00296400|455691222|FG001|Overall Study|Study specific discontinuation criteria|0|||
126326242|NCT05052697|454488402|FG020|Substudy A|Not vaccinated|0|||
126326243|NCT05052697|454488403|FG021|Substudy A|Not vaccinated|0|||
126326244|NCT05052697|454488404|FG022|Substudy A|Not vaccinated|0|||
126326245|NCT05052697|454488405|FG023|Substudy A|Not vaccinated|0|||
126654254|NCT00296400|455691223|FG002|Overall Study|Study specific discontinuation criteria|1|||
126654255|NCT00296400|455691221|FG000|Overall Study|Visit 10 was performed earlier|0|||
126654256|NCT00296400|455691222|FG001|Overall Study|Visit 10 was performed earlier|1|||
126326246|NCT05052697|454488406|FG024|Substudy A|Not vaccinated|0|||
126326247|NCT05052697|454488407|FG025|Substudy A|Not vaccinated|0|||
126654257|NCT00296400|455691223|FG002|Overall Study|Visit 10 was performed earlier|0|||
126654258|NCT00296400|455691221|FG000|Overall Study|Pregnancy|1|||
126654259|NCT00296400|455691222|FG001|Overall Study|Pregnancy|2|||
126326248|NCT05052697|454488408|FG026|Substudy A|Not vaccinated|0|||
126326249|NCT05052697|454488409|FG027|Substudy A|Not vaccinated|0|||
126326250|NCT05052697|454488410|FG028|Substudy A|Not vaccinated|0|||
126326251|NCT05052697|454488411|FG029|Substudy A|Not vaccinated|0|||
126654260|NCT00296400|455691223|FG002|Overall Study|Pregnancy|0|||
126654261|NCT00412061|455691225|FG000|Double Blind Phase|Disease Progression|101|||
126654262|NCT00412061|455691226|FG001|Double Blind Phase|Disease Progression|154|||
126654263|NCT00412061|455691225|FG000|Double Blind Phase|Adverse Event|61|||
126654264|NCT00412061|455691226|FG001|Double Blind Phase|Adverse Event|16|||
126654265|NCT00412061|455691225|FG000|Double Blind Phase|Final Primary Analysis|26|||
126654266|NCT00412061|455691226|FG001|Double Blind Phase|Final Primary Analysis|14|||
126326252|NCT05052697|454488412|FG030|Substudy A|Not vaccinated|0|||
126326253|NCT05052697|454488413|FG031|Substudy A|Not vaccinated|0|||
126326254|NCT05052697|454488414|FG032|Substudy A|Not vaccinated|0|||
126326255|NCT05052697|454488415|FG033|Substudy A|Not vaccinated|0|||
126326256|NCT05052697|454488382|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326257|NCT05052697|454488383|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326258|NCT05052697|454488384|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326259|NCT05052697|454488385|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126654267|NCT00412061|455691225|FG000|Double Blind Phase|Withdrawal by Subject|18|||
126654268|NCT00412061|455691226|FG001|Double Blind Phase|Withdrawal by Subject|20|||
126654269|NCT00412061|455691225|FG000|Double Blind Phase|Death|6|||
126654270|NCT00412061|455691226|FG001|Double Blind Phase|Death|3|||
126654271|NCT00412061|455691225|FG000|Double Blind Phase|Protocol Violation|3|||
126654272|NCT00412061|455691226|FG001|Double Blind Phase|Protocol Violation|4|||
126326260|NCT05052697|454488386|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326261|NCT05052697|454488387|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326262|NCT05052697|454488388|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326263|NCT05052697|454488389|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326264|NCT05052697|454488390|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326265|NCT05052697|454488391|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326266|NCT05052697|454488392|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326267|NCT05052697|454488393|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326268|NCT05052697|454488394|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326269|NCT05052697|454488395|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326270|NCT05052697|454488396|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326271|NCT05052697|454488397|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326272|NCT05052697|454488398|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326273|NCT05052697|454488399|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326274|NCT05052697|454488400|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
126326275|NCT05052697|454488401|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
126326276|NCT05052697|454488402|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326277|NCT05052697|454488403|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
126326278|NCT05052697|454488404|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
126326279|NCT05052697|454488405|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326280|NCT05052697|454488406|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326281|NCT05052697|454488407|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326282|NCT05052697|454488408|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326283|NCT05052697|454488409|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326284|NCT05052697|454488410|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326285|NCT05052697|454488411|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326286|NCT05052697|454488412|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326287|NCT05052697|454488413|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326288|NCT05052697|454488414|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126326289|NCT05052697|454488415|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
126654273|NCT00412061|455691225|FG000|Double Blind Phase|New Cander Therapy|1|||
126654274|NCT00412061|455691226|FG001|Double Blind Phase|New Cander Therapy|1|||
126326290|NCT05052697|454488382|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
126654275|NCT00412061|455691225|FG000|Double Blind Phase|Lost to Follow-up|0|||
126654276|NCT00412061|455691226|FG001|Double Blind Phase|Lost to Follow-up|1|||
126654277|NCT00412061|455691225|FG000|Open Label Phase|Disease Progression|0|||
126654278|NCT00412061|455691226|FG001|Open Label Phase|Disease Progression|86|||
126654279|NCT00412061|455691225|FG000|Open Label Phase|Adverse Event|0|||
126654280|NCT00412061|455691226|FG001|Open Label Phase|Adverse Event|46|||
126654281|NCT00412061|455691225|FG000|Open Label Phase|Withdrawal by Subject|0|||
126326291|NCT05052697|454488383|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326292|NCT05052697|454488384|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326293|NCT05052697|454488385|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326294|NCT05052697|454488386|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326295|NCT05052697|454488387|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326296|NCT05052697|454488388|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326297|NCT05052697|454488389|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326298|NCT05052697|454488390|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326299|NCT05052697|454488391|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326300|NCT05052697|454488392|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326301|NCT05052697|454488393|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326302|NCT05052697|454488394|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326303|NCT05052697|454488395|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326304|NCT05052697|454488396|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326305|NCT05052697|454488397|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326306|NCT05052697|454488398|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326307|NCT05052697|454488399|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
126326308|NCT05052697|454488400|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326309|NCT05052697|454488401|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326310|NCT05052697|454488402|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326311|NCT05052697|454488403|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326312|NCT05052697|454488404|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326313|NCT05052697|454488405|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326314|NCT05052697|454488406|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326315|NCT05052697|454488407|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326316|NCT05052697|454488408|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326317|NCT05052697|454488409|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326318|NCT05052697|454488410|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326319|NCT05052697|454488411|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326320|NCT05052697|454488412|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326321|NCT05052697|454488413|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326322|NCT05052697|454488414|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326323|NCT05052697|454488415|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
126326324|NCT05052697|454488382|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326325|NCT05052697|454488383|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326326|NCT05052697|454488384|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326327|NCT05052697|454488385|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326328|NCT05052697|454488386|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326329|NCT05052697|454488387|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326330|NCT05052697|454488388|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326331|NCT05052697|454488389|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326332|NCT05052697|454488390|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326333|NCT05052697|454488391|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326334|NCT05052697|454488392|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326335|NCT05052697|454488393|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326336|NCT05052697|454488394|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326337|NCT05052697|454488395|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326338|NCT05052697|454488396|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326339|NCT05052697|454488397|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326340|NCT05052697|454488398|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326341|NCT05052697|454488399|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326342|NCT05052697|454488400|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326343|NCT05052697|454488401|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
126326344|NCT05052697|454488402|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326345|NCT05052697|454488403|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326346|NCT05052697|454488404|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326347|NCT05052697|454488405|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326348|NCT05052697|454488406|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326349|NCT05052697|454488407|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326350|NCT05052697|454488408|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326351|NCT05052697|454488409|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326352|NCT05052697|454488410|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326353|NCT05052697|454488411|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326354|NCT05052697|454488412|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326355|NCT05052697|454488413|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326356|NCT05052697|454488414|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326357|NCT05052697|454488415|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
126326358|NCT05052697|454488382|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326359|NCT05052697|454488383|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326360|NCT05052697|454488384|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326361|NCT05052697|454488385|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326362|NCT05052697|454488386|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326363|NCT05052697|454488387|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326364|NCT05052697|454488388|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326365|NCT05052697|454488389|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326366|NCT05052697|454488390|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326367|NCT05052697|454488391|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326368|NCT05052697|454488392|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326369|NCT05052697|454488393|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326370|NCT05052697|454488394|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326371|NCT05052697|454488395|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326372|NCT05052697|454488396|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326373|NCT05052697|454488397|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326374|NCT05052697|454488398|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326375|NCT05052697|454488399|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
126326376|NCT05052697|454488400|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326377|NCT05052697|454488401|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326378|NCT05052697|454488402|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326379|NCT05052697|454488403|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326380|NCT05052697|454488404|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326381|NCT05052697|454488405|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326382|NCT05052697|454488406|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326383|NCT05052697|454488407|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
126326384|NCT05052697|454488408|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326385|NCT05052697|454488409|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
126326386|NCT05052697|454488410|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326387|NCT05052697|454488411|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326388|NCT05052697|454488412|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326389|NCT05052697|454488413|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326390|NCT05052697|454488414|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326391|NCT05052697|454488415|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
126326392|NCT05052697|454488382|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326393|NCT05052697|454488383|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326394|NCT05052697|454488384|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326395|NCT05052697|454488385|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326396|NCT05052697|454488386|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326397|NCT05052697|454488387|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326398|NCT05052697|454488388|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326399|NCT05052697|454488389|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326400|NCT05052697|454488390|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326401|NCT05052697|454488391|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326402|NCT05052697|454488392|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326403|NCT05052697|454488393|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326404|NCT05052697|454488394|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326405|NCT05052697|454488395|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326406|NCT05052697|454488396|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326407|NCT05052697|454488397|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126654282|NCT00412061|455691226|FG001|Open Label Phase|Withdrawal by Subject|15|||
126654283|NCT00412061|455691225|FG000|Open Label Phase|Administrative Problems|0|||
126654284|NCT00412061|455691226|FG001|Open Label Phase|Administrative Problems|13|||
126654285|NCT00412061|455691225|FG000|Open Label Phase|Death|0|||
126654286|NCT00412061|455691226|FG001|Open Label Phase|Death|7|||
126654287|NCT00412061|455691225|FG000|Open Label Phase|Lost to Follow-up|0|||
126654288|NCT00412061|455691226|FG001|Open Label Phase|Lost to Follow-up|2|||
126654289|NCT00412061|455691225|FG000|Open Label Phase|New Cancer Therapy|0|||
126654290|NCT00412061|455691226|FG001|Open Label Phase|New Cancer Therapy|1|||
126654291|NCT01942590|455691227|FG000|Overall Study|Withdrawal by Subject|0|||
126654292|NCT01942590|455691228|FG001|Overall Study|Withdrawal by Subject|1|||
126654293|NCT01942590|455691227|FG000|Overall Study|Adverse Event|1|||
126654294|NCT01942590|455691228|FG001|Overall Study|Adverse Event|0|||
126654295|NCT03616977|455691230|FG000|Period 1|Physician Decision|0|||
126326408|NCT05052697|454488398|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326409|NCT05052697|454488399|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326410|NCT05052697|454488400|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326411|NCT05052697|454488401|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326412|NCT05052697|454488402|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126654296|NCT03616977|455691231|FG001|Period 1|Physician Decision|1|||
126654297|NCT03616977|455691230|FG000|Period 3|Adverse Event|1|||
126654298|NCT03616977|455691231|FG001|Period 3|Adverse Event|1|||
126654299|NCT03683823|455691232|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
126654300|NCT03683823|455691233|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
126654301|NCT03683823|455691232|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
126654302|NCT03683823|455691233|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
126654303|NCT03683823|455691232|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
126654304|NCT03683823|455691233|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
126654305|NCT01323972|455691235|FG000|Overall Study|Withdrawal by Subject|1|||
126654306|NCT01323972|455691236|FG001|Overall Study|Withdrawal by Subject|0|||
126654307|NCT01323972|455691237|FG002|Overall Study|Withdrawal by Subject|1|||
126654308|NCT01323972|455691238|FG003|Overall Study|Withdrawal by Subject|0|||
126654309|NCT01323972|455691235|FG000|Overall Study|Migrated/moved from study area|1|||
126654310|NCT01323972|455691236|FG001|Overall Study|Migrated/moved from study area|2|||
126654311|NCT01323972|455691237|FG002|Overall Study|Migrated/moved from study area|0|||
126654312|NCT01323972|455691238|FG003|Overall Study|Migrated/moved from study area|0|||
126654313|NCT01323972|455691235|FG000|Overall Study|Lost to Follow-up|0|||
126654314|NCT01323972|455691236|FG001|Overall Study|Lost to Follow-up|1|||
126654315|NCT01323972|455691237|FG002|Overall Study|Lost to Follow-up|1|||
126654316|NCT01323972|455691238|FG003|Overall Study|Lost to Follow-up|1|||
126654317|NCT02008877|455691239|FG000|Overall Study|Inevaluable|0|||
126654318|NCT02008877|455691240|FG001|Overall Study|Inevaluable|1|||
126654319|NCT02008877|455691241|FG002|Overall Study|Inevaluable|0|||
126654320|NCT02412371|455691242|FG000|Overall Study|Withdrawal by Subject|0|||
126654321|NCT02412371|455691243|FG001|Overall Study|Withdrawal by Subject|2|||
126654322|NCT02412371|455691244|FG002|Overall Study|Withdrawal by Subject|0|||
126654323|NCT02412371|455691245|FG003|Overall Study|Withdrawal by Subject|1|||
126654324|NCT02412371|455691246|FG004|Overall Study|Withdrawal by Subject|1|||
126654325|NCT02412371|455691247|FG005|Overall Study|Withdrawal by Subject|0|||
126654326|NCT02412371|455691242|FG000|Overall Study|Sponsor Discontinued Study|1|||
126654327|NCT02412371|455691243|FG001|Overall Study|Sponsor Discontinued Study|4|||
126654328|NCT02412371|455691244|FG002|Overall Study|Sponsor Discontinued Study|6|||
126654329|NCT02412371|455691245|FG003|Overall Study|Sponsor Discontinued Study|4|||
126654330|NCT02412371|455691246|FG004|Overall Study|Sponsor Discontinued Study|5|||
126654331|NCT02412371|455691247|FG005|Overall Study|Sponsor Discontinued Study|0|||
126654332|NCT02412371|455691242|FG000|Overall Study|Death|4|||
126654333|NCT02412371|455691243|FG001|Overall Study|Death|2|||
126654334|NCT02412371|455691244|FG002|Overall Study|Death|1|||
126654335|NCT02412371|455691245|FG003|Overall Study|Death|3|||
126654336|NCT02412371|455691246|FG004|Overall Study|Death|5|||
126654337|NCT02412371|455691247|FG005|Overall Study|Death|2|||
126654338|NCT02412371|455691242|FG000|Overall Study|Other|2|||
126654339|NCT02412371|455691243|FG001|Overall Study|Other|1|||
126654340|NCT02412371|455691244|FG002|Overall Study|Other|0|||
126654341|NCT02412371|455691245|FG003|Overall Study|Other|0|||
126654342|NCT02412371|455691246|FG004|Overall Study|Other|1|||
126654343|NCT02412371|455691247|FG005|Overall Study|Other|3|||
126654344|NCT02053792|455691248|FG000|Overall Study|Physician Decision|0|||
126654345|NCT02053792|455691249|FG001|Overall Study|Physician Decision|1|||
126654346|NCT02053792|455691248|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
126654347|NCT02053792|455691249|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
126654348|NCT02053792|455691248|FG000|Overall Study|Lack of Efficacy|1|||
126654349|NCT02053792|455691249|FG001|Overall Study|Lack of Efficacy|0|||
126654350|NCT02053792|455691248|FG000|Overall Study|Adverse Event|1|||
126654351|NCT02053792|455691249|FG001|Overall Study|Adverse Event|0|||
126654352|NCT02053792|455691248|FG000|Overall Study|Withdrawal by Subject|2|||
126654353|NCT02053792|455691249|FG001|Overall Study|Withdrawal by Subject|2|||
126654354|NCT02053792|455691248|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
126654355|NCT02053792|455691249|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
126654356|NCT02053792|455691248|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
126654357|NCT02053792|455691249|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
126654358|NCT01028027|455691250|FG000|Overall Study|Lost to Follow-up|4|||
126654359|NCT01028027|455691251|FG001|Overall Study|Lost to Follow-up|1|||
126326413|NCT05052697|454488403|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326414|NCT05052697|454488404|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326415|NCT05052697|454488405|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326416|NCT05052697|454488406|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126654360|NCT01028027|455691250|FG000|Overall Study|Withdrawal by Subject|5|||
126654361|NCT01028027|455691251|FG001|Overall Study|Withdrawal by Subject|3|||
126654362|NCT01028027|455691250|FG000|Overall Study|Adverse Event|4|||
126654363|NCT01028027|455691251|FG001|Overall Study|Adverse Event|7|||
126654364|NCT01028027|455691250|FG000|Overall Study|Protocol Violation|3|||
126654365|NCT01028027|455691251|FG001|Overall Study|Protocol Violation|1|||
126654366|NCT01028027|455691250|FG000|Overall Study|Lack of Efficacy|0|||
126654367|NCT01028027|455691251|FG001|Overall Study|Lack of Efficacy|1|||
126654368|NCT03149549|455691260|FG000|Study Discontinuation--Treatment Period|Death|0|||
126654369|NCT03149549|455691261|FG001|Study Discontinuation--Treatment Period|Death|0|||
126654370|NCT03149549|455691262|FG002|Study Discontinuation--Treatment Period|Death|0|||
126654371|NCT03149549|455691263|FG003|Study Discontinuation--Treatment Period|Death|1|||
126654372|NCT03149549|455691264|FG004|Study Discontinuation--Treatment Period|Death|2|||
126654373|NCT03149549|455691265|FG005|Study Discontinuation--Treatment Period|Death|1|||
126654374|NCT03149549|455691266|FG006|Study Discontinuation--Treatment Period|Death|1|||
126654375|NCT03149549|455691267|FG007|Study Discontinuation--Treatment Period|Death|2|||
126654376|NCT03149549|455691268|FG008|Study Discontinuation--Treatment Period|Death|4|||
126654377|NCT03149549|455691269|FG009|Study Discontinuation--Treatment Period|Death|1|||
126654378|NCT03149549|455691270|FG010|Study Discontinuation--Treatment Period|Death|0|||
126654379|NCT03149549|455691271|FG011|Study Discontinuation--Treatment Period|Death|0|||
126654380|NCT03149549|455691272|FG012|Study Discontinuation--Treatment Period|Death|1|||
126654381|NCT03149549|455691260|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126654382|NCT03149549|455691261|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126326417|NCT05052697|454488407|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326418|NCT05052697|454488408|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326419|NCT05052697|454488409|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326420|NCT05052697|454488410|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
126326421|NCT05052697|454488411|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326422|NCT05052697|454488412|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
126654383|NCT03149549|455691262|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126654384|NCT03149549|455691263|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126654385|NCT03149549|455691264|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126654386|NCT03149549|455691265|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126654387|NCT03149549|455691266|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126654388|NCT03149549|455691267|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
126654389|NCT03149549|455691268|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126654390|NCT03149549|455691269|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126326423|NCT05052697|454488413|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
126326424|NCT05052697|454488414|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
126326425|NCT05052697|454488415|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
126326426|NCT05052697|454488382|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326427|NCT05052697|454488383|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326428|NCT05052697|454488384|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326429|NCT05052697|454488385|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326430|NCT05052697|454488386|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326431|NCT05052697|454488387|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326432|NCT05052697|454488388|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326433|NCT05052697|454488389|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326434|NCT05052697|454488390|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326435|NCT05052697|454488391|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326436|NCT05052697|454488392|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326437|NCT05052697|454488393|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326438|NCT05052697|454488394|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326439|NCT05052697|454488395|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326440|NCT05052697|454488396|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326441|NCT05052697|454488397|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326442|NCT05052697|454488398|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326443|NCT05052697|454488399|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326444|NCT05052697|454488400|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326445|NCT05052697|454488401|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326446|NCT05052697|454488402|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326447|NCT05052697|454488403|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326448|NCT05052697|454488404|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326449|NCT05052697|454488405|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326450|NCT05052697|454488406|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326451|NCT05052697|454488407|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326452|NCT05052697|454488408|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326453|NCT05052697|454488409|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326454|NCT05052697|454488410|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
126326455|NCT05052697|454488411|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
126326456|NCT05052697|454488412|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
126326457|NCT05052697|454488413|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
126326458|NCT05052697|454488414|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
126326459|NCT05052697|454488415|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
126326460|NCT05052697|454488382|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326461|NCT05052697|454488383|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326462|NCT05052697|454488384|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126654391|NCT03149549|455691270|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126654392|NCT03149549|455691271|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
126654393|NCT03149549|455691272|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
126654394|NCT03149549|455691260|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126654395|NCT03149549|455691261|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126654396|NCT03149549|455691262|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126654397|NCT03149549|455691263|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
126654398|NCT03149549|455691264|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
126654399|NCT03149549|455691265|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
126654400|NCT03149549|455691266|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
126654401|NCT03149549|455691267|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126654402|NCT03149549|455691268|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
126654403|NCT03149549|455691269|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126654404|NCT03149549|455691270|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126654405|NCT03149549|455691271|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126654406|NCT03149549|455691272|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
126654407|NCT03149549|455691260|FG000|Study Discontinuation--Treatment Period|Other|0|||
126654408|NCT03149549|455691261|FG001|Study Discontinuation--Treatment Period|Other|0|||
126326463|NCT05052697|454488385|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326464|NCT05052697|454488386|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326465|NCT05052697|454488387|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326466|NCT05052697|454488388|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326467|NCT05052697|454488389|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126654409|NCT03149549|455691262|FG002|Study Discontinuation--Treatment Period|Other|0|||
126654410|NCT03149549|455691263|FG003|Study Discontinuation--Treatment Period|Other|0|||
126654411|NCT03149549|455691264|FG004|Study Discontinuation--Treatment Period|Other|0|||
126654412|NCT03149549|455691265|FG005|Study Discontinuation--Treatment Period|Other|0|||
126654413|NCT03149549|455691266|FG006|Study Discontinuation--Treatment Period|Other|0|||
126654414|NCT03149549|455691267|FG007|Study Discontinuation--Treatment Period|Other|1|||
126654415|NCT03149549|455691268|FG008|Study Discontinuation--Treatment Period|Other|0|||
126654416|NCT03149549|455691269|FG009|Study Discontinuation--Treatment Period|Other|1|||
126654417|NCT03149549|455691270|FG010|Study Discontinuation--Treatment Period|Other|0|||
126654418|NCT03149549|455691271|FG011|Study Discontinuation--Treatment Period|Other|0|||
126654419|NCT03149549|455691272|FG012|Study Discontinuation--Treatment Period|Other|0|||
126654420|NCT03149549|455691260|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126654421|NCT03149549|455691261|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126654422|NCT03149549|455691262|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126654423|NCT03149549|455691263|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126654424|NCT03149549|455691264|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126654425|NCT03149549|455691265|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
126654426|NCT03149549|455691266|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
126654427|NCT03149549|455691267|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126654428|NCT03149549|455691268|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
126654429|NCT03149549|455691269|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126654430|NCT03149549|455691270|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126654431|NCT03149549|455691271|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126654432|NCT03149549|455691272|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
126654433|NCT03149549|455691260|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126654434|NCT03149549|455691261|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126654435|NCT03149549|455691262|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126654436|NCT03149549|455691263|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126654437|NCT03149549|455691264|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
126654438|NCT03149549|455691265|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126654439|NCT03149549|455691266|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126654440|NCT03149549|455691267|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
126654441|NCT03149549|455691268|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
126654442|NCT03149549|455691269|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126654443|NCT03149549|455691270|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
126654444|NCT03149549|455691271|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
126654445|NCT03149549|455691272|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
126654446|NCT03149549|455691260|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126654447|NCT03149549|455691261|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126654448|NCT03149549|455691262|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126654449|NCT03149549|455691263|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126326468|NCT05052697|454488390|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126654450|NCT03149549|455691264|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
126654451|NCT03149549|455691265|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126654452|NCT03149549|455691266|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126654453|NCT03149549|455691267|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
126654454|NCT03149549|455691268|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
126654455|NCT03149549|455691269|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
126654456|NCT03149549|455691270|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
126654457|NCT03149549|455691271|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
126654458|NCT03149549|455691272|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
126654459|NCT03149549|455691260|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
126654460|NCT03149549|455691261|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
126654461|NCT03149549|455691262|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
126654462|NCT03149549|455691263|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
126654463|NCT03149549|455691264|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
126654464|NCT03149549|455691265|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
126654465|NCT03149549|455691266|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
126654466|NCT03149549|455691267|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
126654467|NCT03149549|455691268|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
126654468|NCT03149549|455691269|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
126654469|NCT03149549|455691270|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
126654470|NCT03149549|455691271|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
126654471|NCT03149549|455691272|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
126654472|NCT03149549|455691260|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
126654473|NCT03149549|455691261|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
126654474|NCT03149549|455691262|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
126654475|NCT03149549|455691263|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
126654476|NCT03149549|455691264|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
126654477|NCT03149549|455691265|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
126654478|NCT03149549|455691266|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
126654479|NCT03149549|455691267|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
126654480|NCT03149549|455691268|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
126654481|NCT03149549|455691269|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
126654482|NCT03149549|455691270|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
126654483|NCT03149549|455691271|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
126654484|NCT03149549|455691272|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
126654485|NCT02502799|455693358|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
126654486|NCT02502799|455693359|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
126654487|NCT02502799|455693360|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
126654488|NCT02502799|455693361|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
126654489|NCT02502799|455693358|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
126654490|NCT02502799|455693359|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
126654491|NCT02502799|455693360|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
126654492|NCT02502799|455693361|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
126654493|NCT02502799|455693358|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
126654494|NCT02502799|455693359|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
126654495|NCT02502799|455693360|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
126654496|NCT02502799|455693361|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
126654497|NCT02502799|455693358|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
126654498|NCT02502799|455693359|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
126654499|NCT02502799|455693360|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
126654500|NCT02502799|455693361|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
126654501|NCT02502799|455693358|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
126654502|NCT02502799|455693359|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
126654503|NCT02502799|455693360|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
126654504|NCT02502799|455693361|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
126654505|NCT01076192|455693375|FG000|Overall Study|Other|197|||
126654506|NCT05087979|455693376|FG000|Overall Study|Converted to general anesthesia|1|||
126654507|NCT05087979|455693377|FG001|Overall Study|Converted to general anesthesia|0|||
126654508|NCT02924428|455693378|FG000|Overall Study|Adverse Event|1|||
126654509|NCT02924428|455693379|FG001|Overall Study|Adverse Event|0|||
126654510|NCT02924428|455693378|FG000|Overall Study|Physician Decision|1|||
126654511|NCT02924428|455693379|FG001|Overall Study|Physician Decision|0|||
126654512|NCT02924428|455693378|FG000|Overall Study|Lost to Follow-up|2|||
126654513|NCT02924428|455693379|FG001|Overall Study|Lost to Follow-up|4|||
126654514|NCT02924428|455693378|FG000|Overall Study|Pregnancy|0|||
126654515|NCT02924428|455693379|FG001|Overall Study|Pregnancy|1|||
126654516|NCT01850446|455693380|FG000|Overall Study|Lack of Efficacy|1|||
126654517|NCT01850446|455693381|FG001|Overall Study|Lack of Efficacy|0|||
126654518|NCT01850446|455693380|FG000|Overall Study|Withdrawal by Subject|4|||
126654519|NCT01850446|455693381|FG001|Overall Study|Withdrawal by Subject|0|||
126654520|NCT01850446|455693380|FG000|Overall Study|Protocol Violation|0|||
126654521|NCT01850446|455693381|FG001|Overall Study|Protocol Violation|2|||
126654522|NCT02680002|455693382|FG000|Overall Study|Lost to Follow-up|5|||
126654523|NCT02680002|455693383|FG001|Overall Study|Lost to Follow-up|1|||
126654524|NCT02680002|455693384|FG002|Overall Study|Lost to Follow-up|4|||
126654525|NCT02680002|455693385|FG003|Overall Study|Lost to Follow-up|2|||
126654526|NCT02680002|455693386|FG004|Overall Study|Lost to Follow-up|0|||
126654527|NCT02680002|455693387|FG005|Overall Study|Lost to Follow-up|2|||
126654528|NCT02680002|455693382|FG000|Overall Study|Physician Decision|5|||
126654529|NCT02680002|455693383|FG001|Overall Study|Physician Decision|1|||
126654530|NCT02680002|455693384|FG002|Overall Study|Physician Decision|1|||
126654531|NCT02680002|455693385|FG003|Overall Study|Physician Decision|1|||
126654532|NCT02680002|455693386|FG004|Overall Study|Physician Decision|1|||
126654533|NCT02680002|455693387|FG005|Overall Study|Physician Decision|1|||
126654534|NCT02680002|455693382|FG000|Overall Study|Protocol Violation|1|||
126654535|NCT02680002|455693383|FG001|Overall Study|Protocol Violation|0|||
126654536|NCT02680002|455693384|FG002|Overall Study|Protocol Violation|1|||
126654537|NCT02680002|455693385|FG003|Overall Study|Protocol Violation|0|||
126654538|NCT02680002|455693386|FG004|Overall Study|Protocol Violation|1|||
126654539|NCT02680002|455693387|FG005|Overall Study|Protocol Violation|2|||
126654540|NCT02680002|455693382|FG000|Overall Study|Withdrawal by Subject|0|||
126654541|NCT02680002|455693383|FG001|Overall Study|Withdrawal by Subject|0|||
126654542|NCT02680002|455693384|FG002|Overall Study|Withdrawal by Subject|1|||
126654543|NCT02680002|455693385|FG003|Overall Study|Withdrawal by Subject|0|||
126654544|NCT02680002|455693386|FG004|Overall Study|Withdrawal by Subject|2|||
126654545|NCT02680002|455693387|FG005|Overall Study|Withdrawal by Subject|2|||
126654546|NCT02680002|455693382|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
126654547|NCT02680002|455693383|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
126654548|NCT02680002|455693384|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
126654549|NCT02680002|455693385|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
126654550|NCT02680002|455693386|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
126654551|NCT02680002|455693387|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
126654552|NCT02680002|455693382|FG000|Overall Study|Other|0|||
126654553|NCT02680002|455693383|FG001|Overall Study|Other|1|||
126654554|NCT02680002|455693384|FG002|Overall Study|Other|0|||
126654555|NCT02680002|455693385|FG003|Overall Study|Other|0|||
126654556|NCT02680002|455693386|FG004|Overall Study|Other|1|||
126654557|NCT02680002|455693387|FG005|Overall Study|Other|0|||
126654558|NCT02680002|455693382|FG000|Overall Study|Adverse Event|0|||
126654559|NCT02680002|455693383|FG001|Overall Study|Adverse Event|0|||
126654560|NCT02680002|455693384|FG002|Overall Study|Adverse Event|0|||
126654561|NCT02680002|455693385|FG003|Overall Study|Adverse Event|0|||
126654562|NCT02680002|455693386|FG004|Overall Study|Adverse Event|1|||
126654563|NCT02680002|455693387|FG005|Overall Study|Adverse Event|2|||
126654564|NCT00759915|455693388|FG000|Overall Study|Withdrawal by Subject|1|||
126654565|NCT00759915|455693389|FG001|Overall Study|Withdrawal by Subject|0|||
126654566|NCT00759915|455693388|FG000|Overall Study|Adverse Event|0|||
126654567|NCT00759915|455693389|FG001|Overall Study|Adverse Event|1|||
126654568|NCT03527173|455693392|FG000|Overall Study|Lost to Follow-up|4|||
126654569|NCT03527173|455693393|FG001|Overall Study|Lost to Follow-up|2|||
126654570|NCT03527173|455693392|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
126654571|NCT03527173|455693393|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
126654572|NCT03527173|455693392|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
126654573|NCT03527173|455693393|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
126654574|NCT03527173|455693392|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
126654575|NCT03527173|455693393|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126654576|NCT01248780|455693398|FG000|Overall Study|Lack of Efficacy|2|||
126654577|NCT01248780|455693399|FG001|Overall Study|Lack of Efficacy|0|||
126654578|NCT01248780|455693398|FG000|Overall Study|Lost to Follow-up|0|||
126654579|NCT01248780|455693399|FG001|Overall Study|Lost to Follow-up|1|||
126654580|NCT01248780|455693398|FG000|Overall Study|Death|0|||
126654581|NCT01248780|455693399|FG001|Overall Study|Death|1|||
126654582|NCT01248780|455693398|FG000|Overall Study|Adverse Event|2|||
126654583|NCT01248780|455693399|FG001|Overall Study|Adverse Event|7|||
126654584|NCT01248780|455693398|FG000|Overall Study|Protocol Violation|1|||
126654585|NCT01248780|455693399|FG001|Overall Study|Protocol Violation|1|||
126654586|NCT01248780|455693398|FG000|Overall Study|Withdrawal by Subject|4|||
126654587|NCT01248780|455693399|FG001|Overall Study|Withdrawal by Subject|4|||
126654588|NCT01248780|455693398|FG000|Overall Study|Not treated|0|||
126654589|NCT01248780|455693399|FG001|Overall Study|Not treated|1|||
126654590|NCT04097301|455693400|FG000|Overall Study|Death|1|||
126654591|NCT04097301|455693400|FG000|Overall Study|Withdrawal by Subject|1|||
126654592|NCT04097301|455693400|FG000|Overall Study|Screening Failure|5|||
126654593|NCT00203476|455693401|FG000|Overall Study|Lost to Follow-up|1|||
126654594|NCT00203476|455693402|FG001|Overall Study|Lost to Follow-up|0|||
126654595|NCT00203476|455693403|FG002|Overall Study|Lost to Follow-up|0|||
126654596|NCT00203476|455693401|FG000|Overall Study|Withdrawal by Subject|0|||
126654597|NCT00203476|455693402|FG001|Overall Study|Withdrawal by Subject|1|||
126654598|NCT00203476|455693403|FG002|Overall Study|Withdrawal by Subject|0|||
126654599|NCT01190514|455693404|FG000|First Intervention (Period 1)|Adverse Event|1|||
126654600|NCT01190514|455693405|FG001|First Intervention (Period 1)|Adverse Event|0|||
126654601|NCT01190514|455693406|FG002|First Intervention (Period 1)|Adverse Event|0|||
126654602|NCT01190514|455693407|FG003|First Intervention (Period 1)|Adverse Event|0|||
126654603|NCT01190514|455693404|FG000|Third Intervention (Period 3)|Adverse Event|1|||
126654604|NCT01190514|455693405|FG001|Third Intervention (Period 3)|Adverse Event|0|||
126654605|NCT01190514|455693406|FG002|Third Intervention (Period 3)|Adverse Event|0|||
126654606|NCT01190514|455693407|FG003|Third Intervention (Period 3)|Adverse Event|0|||
126654607|NCT01813929|455693408|FG000|Overall Study|Withdrawal by Subject|0|||
126654608|NCT01813929|455693409|FG001|Overall Study|Withdrawal by Subject|1|||
126654609|NCT00938470|455693412|FG000|Overall Study|Disease Progression|3|||
126654610|NCT00938470|455693413|FG001|Overall Study|Disease Progression|0|||
126654611|NCT00938470|455693412|FG000|Overall Study|Alternate Treatment|1|||
126654612|NCT00938470|455693413|FG001|Overall Study|Alternate Treatment|0|||
126654613|NCT00938470|455693412|FG000|Overall Study|Death|3|||
126654614|NCT00938470|455693413|FG001|Overall Study|Death|2|||
126654615|NCT00938470|455693412|FG000|Overall Study|Other Reason|0|||
126654616|NCT00938470|455693413|FG001|Overall Study|Other Reason|1|||
126654617|NCT04279392|455693414|FG000|Overall Study|Physician Decision|1|||
126654618|NCT04279392|455693415|FG001|Overall Study|Physician Decision|0|||
126654619|NCT01171807|455693416|FG000|Overall Study|Treatment failure|2|||
126654620|NCT01171807|455693417|FG001|Overall Study|Treatment failure|4|||
126654621|NCT01171807|455693416|FG000|Overall Study|Non compliance|1|||
126654622|NCT01171807|455693417|FG001|Overall Study|Non compliance|0|||
126654623|NCT01171807|455693416|FG000|Overall Study|Lost to Follow-up|3|||
126654624|NCT01171807|455693417|FG001|Overall Study|Lost to Follow-up|0|||
126654625|NCT04101318|455693422|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
126654626|NCT04101318|455693423|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
126654627|NCT04101318|455693422|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
126654628|NCT04101318|455693423|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
126654629|NCT04101318|455693422|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
126654630|NCT04101318|455693423|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
126654631|NCT04289051|455693424|FG000|Overall Study|Lost to Follow-up|0|||
126654632|NCT04289051|455693425|FG001|Overall Study|Lost to Follow-up|0|||
126654633|NCT04289051|455693426|FG002|Overall Study|Lost to Follow-up|2|||
126654634|NCT01901341|455693427|FG000|Overall Study|Adverse Event|4|||
126654635|NCT01901341|455693428|FG001|Overall Study|Adverse Event|2|||
126654636|NCT01901341|455693427|FG000|Overall Study|Lack of Efficacy|0|||
126654637|NCT01901341|455693428|FG001|Overall Study|Lack of Efficacy|2|||
126654638|NCT01901341|455693427|FG000|Overall Study|Lost to Follow-up|0|||
126654639|NCT01901341|455693428|FG001|Overall Study|Lost to Follow-up|1|||
126654640|NCT01901341|455693427|FG000|Overall Study|Protocol Violation|2|||
126654641|NCT01901341|455693428|FG001|Overall Study|Protocol Violation|0|||
126654642|NCT01901341|455693427|FG000|Overall Study|Study Terminated by Sponsor|13|||
126654643|NCT01901341|455693428|FG001|Overall Study|Study Terminated by Sponsor|15|||
126654644|NCT01901341|455693427|FG000|Overall Study|Withdrawal by Subject|1|||
126654645|NCT01901341|455693428|FG001|Overall Study|Withdrawal by Subject|1|||
126654646|NCT00822172|455693432|FG000|Overall Study|Adverse Event|10|||
126654647|NCT00822172|455693433|FG001|Overall Study|Adverse Event|12|||
126654648|NCT00822172|455693432|FG000|Overall Study|Death|1|||
126654649|NCT00822172|455693433|FG001|Overall Study|Death|0|||
126654650|NCT00822172|455693432|FG000|Overall Study|Lost to Follow-up|3|||
126654651|NCT00822172|455693433|FG001|Overall Study|Lost to Follow-up|1|||
126654652|NCT00822172|455693432|FG000|Overall Study|Withdrawal by Subject|1|||
126654653|NCT00822172|455693433|FG001|Overall Study|Withdrawal by Subject|4|||
126654654|NCT00822172|455693432|FG000|Overall Study|site closed|0|||
126654655|NCT00822172|455693433|FG001|Overall Study|site closed|1|||
126654656|NCT00822172|455693432|FG000|Overall Study|Other|0|||
126326469|NCT05052697|454488391|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126654657|NCT00822172|455693433|FG001|Overall Study|Other|1|||
126654658|NCT01981473|455693434|FG000|Overall Study|Incorrect diagnosis of RA|0|||
126654659|NCT01981473|455693435|FG001|Overall Study|Incorrect diagnosis of RA|0|||
126654660|NCT01981473|455693436|FG002|Overall Study|Incorrect diagnosis of RA|1|||
126654661|NCT01981473|455693434|FG000|Overall Study|Received treatment for < 6 months|0|||
126654662|NCT01981473|455693435|FG001|Overall Study|Received treatment for < 6 months|0|||
126654663|NCT01981473|455693436|FG002|Overall Study|Received treatment for < 6 months|1|||
126654664|NCT01981473|455693434|FG000|Overall Study|Received treatment for >24 months|2|||
126654665|NCT01981473|455693435|FG001|Overall Study|Received treatment for >24 months|0|||
126654666|NCT01981473|455693436|FG002|Overall Study|Received treatment for >24 months|6|||
126654667|NCT02257567|455693444|FG000|Overall Study|Adverse Event|0|||
126654668|NCT02257567|455693445|FG001|Overall Study|Adverse Event|0|||
126654669|NCT02257567|455693446|FG002|Overall Study|Adverse Event|0|||
126654670|NCT02257567|455693447|FG003|Overall Study|Adverse Event|1|||
126654671|NCT02257567|455693448|FG004|Overall Study|Adverse Event|1|||
126654672|NCT02257567|455693449|FG005|Overall Study|Adverse Event|0|||
126654673|NCT02257567|455693450|FG006|Overall Study|Adverse Event|0|||
126654674|NCT02257567|455693451|FG007|Overall Study|Adverse Event|0|||
126654675|NCT02257567|455693452|FG008|Overall Study|Adverse Event|1|||
126654676|NCT02257567|455693453|FG009|Overall Study|Adverse Event|0|||
126654677|NCT02257567|455693454|FG010|Overall Study|Adverse Event|0|||
126654678|NCT02257567|455693444|FG000|Overall Study|Death|2|||
126654679|NCT02257567|455693445|FG001|Overall Study|Death|2|||
126654680|NCT02257567|455693446|FG002|Overall Study|Death|2|||
126654681|NCT02257567|455693447|FG003|Overall Study|Death|4|||
126654682|NCT02257567|455693448|FG004|Overall Study|Death|15|||
126654683|NCT02257567|455693449|FG005|Overall Study|Death|11|||
126654684|NCT02257567|455693450|FG006|Overall Study|Death|26|||
126654685|NCT02257567|455693451|FG007|Overall Study|Death|30|||
126654686|NCT02257567|455693452|FG008|Overall Study|Death|2|||
126654687|NCT02257567|455693453|FG009|Overall Study|Death|18|||
126654688|NCT02257567|455693454|FG010|Overall Study|Death|65|||
126654689|NCT02257567|455693444|FG000|Overall Study|Lost to Follow-up|0|||
126654690|NCT02257567|455693445|FG001|Overall Study|Lost to Follow-up|0|||
126654691|NCT02257567|455693446|FG002|Overall Study|Lost to Follow-up|0|||
126654692|NCT02257567|455693447|FG003|Overall Study|Lost to Follow-up|0|||
126654693|NCT02257567|455693448|FG004|Overall Study|Lost to Follow-up|2|||
126654694|NCT02257567|455693449|FG005|Overall Study|Lost to Follow-up|2|||
126654695|NCT02257567|455693450|FG006|Overall Study|Lost to Follow-up|0|||
126654696|NCT02257567|455693451|FG007|Overall Study|Lost to Follow-up|0|||
126654697|NCT02257567|455693452|FG008|Overall Study|Lost to Follow-up|0|||
126654698|NCT02257567|455693453|FG009|Overall Study|Lost to Follow-up|1|||
126654699|NCT02257567|455693454|FG010|Overall Study|Lost to Follow-up|1|||
126654700|NCT02257567|455693444|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126654701|NCT02257567|455693445|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126654702|NCT02257567|455693446|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126654703|NCT02257567|455693447|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126654704|NCT02257567|455693448|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
126654705|NCT02257567|455693449|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126654706|NCT02257567|455693450|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
126654707|NCT02257567|455693451|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126654708|NCT02257567|455693452|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126654709|NCT02257567|455693453|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126654710|NCT02257567|455693454|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
126654711|NCT02257567|455693444|FG000|Overall Study|Physician Decision|0|||
126654712|NCT02257567|455693445|FG001|Overall Study|Physician Decision|0|||
126654713|NCT02257567|455693446|FG002|Overall Study|Physician Decision|0|||
126654714|NCT02257567|455693447|FG003|Overall Study|Physician Decision|0|||
126654715|NCT02257567|455693448|FG004|Overall Study|Physician Decision|0|||
126654716|NCT02257567|455693449|FG005|Overall Study|Physician Decision|0|||
126654717|NCT02257567|455693450|FG006|Overall Study|Physician Decision|0|||
126654718|NCT02257567|455693451|FG007|Overall Study|Physician Decision|2|||
126654719|NCT02257567|455693452|FG008|Overall Study|Physician Decision|0|||
126654720|NCT02257567|455693453|FG009|Overall Study|Physician Decision|1|||
126654721|NCT02257567|455693454|FG010|Overall Study|Physician Decision|0|||
126654722|NCT02257567|455693444|FG000|Overall Study|Withdrawal by Subject|0|||
126654723|NCT02257567|455693445|FG001|Overall Study|Withdrawal by Subject|0|||
126654724|NCT02257567|455693446|FG002|Overall Study|Withdrawal by Subject|2|||
126326470|NCT05052697|454488392|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326471|NCT05052697|454488393|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126654725|NCT02257567|455693447|FG003|Overall Study|Withdrawal by Subject|0|||
126654726|NCT02257567|455693448|FG004|Overall Study|Withdrawal by Subject|0|||
126654727|NCT02257567|455693449|FG005|Overall Study|Withdrawal by Subject|6|||
126654728|NCT02257567|455693450|FG006|Overall Study|Withdrawal by Subject|6|||
126654729|NCT02257567|455693451|FG007|Overall Study|Withdrawal by Subject|6|||
126326472|NCT05052697|454488394|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126654730|NCT02257567|455693452|FG008|Overall Study|Withdrawal by Subject|1|||
126654731|NCT02257567|455693453|FG009|Overall Study|Withdrawal by Subject|1|||
126654732|NCT02257567|455693454|FG010|Overall Study|Withdrawal by Subject|10|||
126654733|NCT03215810|455693457|FG000|Overall Study|Still responding to nivolumab|1|||
126654734|NCT03215810|455693457|FG000|Overall Study|Insufficient TIL growth|1|||
126654735|NCT03215810|455693457|FG000|Overall Study|Decline in performance status|1|||
126654736|NCT03215810|455693457|FG000|Overall Study|Withdrawal by Subject|1|||
126654737|NCT01656733|455693458|FG000|Overall Study|No permission to collect birth outcomes|0|||
126654738|NCT01656733|455693459|FG001|Overall Study|No permission to collect birth outcomes|1|||
126654739|NCT01656733|455693458|FG000|Overall Study|Delivery at another hospital|0|||
126654740|NCT01656733|455693459|FG001|Overall Study|Delivery at another hospital|2|||
126654741|NCT01656733|455693458|FG000|Overall Study|Spontaneous abortion|0|||
126654742|NCT01656733|455693459|FG001|Overall Study|Spontaneous abortion|1|||
126654743|NCT01065844|455693460|FG000|Overall Study|Adverse Event|5|||
126654744|NCT01502631|455693463|FG000|Overall Study|Adverse Event|5|||
126654745|NCT01502631|455693464|FG001|Overall Study|Adverse Event|8|||
126654746|NCT01502631|455693463|FG000|Overall Study|Lost to Follow-up|2|||
126654747|NCT01502631|455693464|FG001|Overall Study|Lost to Follow-up|2|||
126654748|NCT01502631|455693463|FG000|Overall Study|Participant withdrew consent|2|||
126654749|NCT01502631|455693464|FG001|Overall Study|Participant withdrew consent|4|||
126654750|NCT01502631|455693463|FG000|Overall Study|Participant non-compliant|1|||
126654751|NCT01502631|455693464|FG001|Overall Study|Participant non-compliant|0|||
126654752|NCT01502631|455693463|FG000|Overall Study|Investigator's decision|0|||
126654753|NCT01502631|455693464|FG001|Overall Study|Investigator's decision|1|||
126654754|NCT01502631|455693463|FG000|Overall Study|Other|10|||
126654755|NCT01502631|455693464|FG001|Overall Study|Other|5|||
126654756|NCT02084056|455693465|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
126654757|NCT02084056|455693466|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126654758|NCT02084056|455693467|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126654759|NCT02084056|455693468|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126654760|NCT02084056|455693465|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
126654761|NCT02084056|455693466|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
126654762|NCT02084056|455693467|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
126654763|NCT02084056|455693468|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
126654764|NCT01293487|455693470|FG000|Overall Study|Lost to Follow-up|0|||
126654765|NCT01293487|455693471|FG001|Overall Study|Lost to Follow-up|0|||
126654766|NCT01293487|455693472|FG002|Overall Study|Lost to Follow-up|0|||
126654767|NCT01293487|455693473|FG003|Overall Study|Lost to Follow-up|1|||
126654768|NCT01293487|455693474|FG004|Overall Study|Lost to Follow-up|0|||
126654769|NCT01293487|455693475|FG005|Overall Study|Lost to Follow-up|0|||
126654770|NCT01293487|455693476|FG006|Overall Study|Lost to Follow-up|0|||
126654771|NCT01293487|455693477|FG007|Overall Study|Lost to Follow-up|0|||
126654772|NCT01293487|455693470|FG000|Overall Study|Withdrawal by Subject|0|||
126654773|NCT01293487|455693471|FG001|Overall Study|Withdrawal by Subject|0|||
126654774|NCT01293487|455693472|FG002|Overall Study|Withdrawal by Subject|0|||
126654775|NCT01293487|455693473|FG003|Overall Study|Withdrawal by Subject|0|||
126654776|NCT01293487|455693474|FG004|Overall Study|Withdrawal by Subject|0|||
126654777|NCT01293487|455693475|FG005|Overall Study|Withdrawal by Subject|0|||
126654778|NCT01293487|455693476|FG006|Overall Study|Withdrawal by Subject|0|||
126654779|NCT01293487|455693477|FG007|Overall Study|Withdrawal by Subject|2|||
126654780|NCT00395460|455693478|FG000|Overall Study|Withdrawal by Subject|1|||
126654781|NCT00395460|455693479|FG001|Overall Study|Withdrawal by Subject|0|||
126654782|NCT04223830|455693486|FG000|Overall Study|Lost to Follow-up|9|||
126654783|NCT04223830|455693486|FG000|Overall Study|Adverse Event|1|||
126654784|NCT01964924|455693487|FG000|Trametinib Monotherapy|Progression|19|||
126654785|NCT01964924|455693488|FG001|Trametinib Monotherapy|Progression|0|||
126654786|NCT00577577|455693490|FG000|Overall Study|Adverse Event|3|||
126654787|NCT00577577|455693491|FG001|Overall Study|Adverse Event|2|||
126654788|NCT00577577|455693490|FG000|Overall Study|Lost to Follow-up|1|||
126654789|NCT00577577|455693491|FG001|Overall Study|Lost to Follow-up|0|||
126654790|NCT00577577|455693490|FG000|Overall Study|Protocol Violation|0|||
126654791|NCT00577577|455693491|FG001|Overall Study|Protocol Violation|3|||
126654792|NCT00577577|455693490|FG000|Overall Study|Transportation|1|||
126654793|NCT00577577|455693491|FG001|Overall Study|Transportation|0|||
126654794|NCT01153958|455693492|FG000|Overall Study|Study Terminated|36|||
126654795|NCT01153958|455693493|FG001|Overall Study|Study Terminated|32|||
126654796|NCT01034163|455693498|FG000|Overall Study|Treatment completed as per protocol|8|||
126326473|NCT05052697|454488395|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326474|NCT05052697|454488396|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126654797|NCT01034163|455693499|FG001|Overall Study|Treatment completed as per protocol|7|||
126654798|NCT01034163|455693498|FG000|Overall Study|Withdrawal by Subject|8|||
126654799|NCT01034163|455693499|FG001|Overall Study|Withdrawal by Subject|2|||
126654800|NCT01034163|455693498|FG000|Overall Study|Protocol deviation|1|||
126654801|NCT01034163|455693499|FG001|Overall Study|Protocol deviation|0|||
126654802|NCT01034163|455693498|FG000|Overall Study|Disease progression|3|||
126654803|NCT01034163|455693499|FG001|Overall Study|Disease progression|4|||
126654804|NCT01034163|455693498|FG000|Overall Study|Adverse Event|6|||
126654805|NCT01034163|455693499|FG001|Overall Study|Adverse Event|0|||
126654806|NCT01034163|455693498|FG000|Overall Study|Administrative problems|0|||
126654807|NCT01034163|455693499|FG001|Overall Study|Administrative problems|1|||
126654808|NCT01034163|455693498|FG000|Overall Study|Abnormal laboratory value|1|||
126654809|NCT01034163|455693499|FG001|Overall Study|Abnormal laboratory value|0|||
126654810|NCT02150343|455693500|FG000|Overall Study|Adverse Event|2|||
126654811|NCT02150343|455693501|FG001|Overall Study|Adverse Event|0|||
126654812|NCT02150343|455693502|FG002|Overall Study|Adverse Event|1|||
126654813|NCT02150343|455693503|FG003|Overall Study|Adverse Event|1|||
126654814|NCT02150343|455693500|FG000|Overall Study|Withdrawal by Subject|13|||
126654815|NCT02150343|455693501|FG001|Overall Study|Withdrawal by Subject|10|||
126654816|NCT02150343|455693502|FG002|Overall Study|Withdrawal by Subject|9|||
126654817|NCT02150343|455693503|FG003|Overall Study|Withdrawal by Subject|4|||
126654818|NCT02150343|455693500|FG000|Overall Study|Lost to Follow-up|4|||
126654819|NCT02150343|455693501|FG001|Overall Study|Lost to Follow-up|4|||
126654820|NCT02150343|455693502|FG002|Overall Study|Lost to Follow-up|2|||
126654821|NCT02150343|455693503|FG003|Overall Study|Lost to Follow-up|3|||
126654822|NCT02150343|455693500|FG000|Overall Study|Other|2|||
126654823|NCT02150343|455693501|FG001|Overall Study|Other|6|||
126654824|NCT02150343|455693502|FG002|Overall Study|Other|0|||
126654825|NCT02150343|455693503|FG003|Overall Study|Other|2|||
126654826|NCT00190749|455693504|FG000|Overall Study|Lost to Follow-up|8|||
126654827|NCT00190749|455693505|FG001|Overall Study|Lost to Follow-up|11|||
126654828|NCT00190749|455693504|FG000|Overall Study|Withdrawal by Subject|10|||
126654829|NCT00190749|455693505|FG001|Overall Study|Withdrawal by Subject|6|||
126654830|NCT00190749|455693504|FG000|Overall Study|Protocol Violation|5|||
126654831|NCT00190749|455693505|FG001|Overall Study|Protocol Violation|4|||
126654832|NCT00190749|455693504|FG000|Overall Study|Adverse Event|0|||
126654833|NCT00190749|455693505|FG001|Overall Study|Adverse Event|5|||
126654834|NCT00190749|455693504|FG000|Overall Study|Lack of Efficacy|2|||
126654835|NCT00190749|455693505|FG001|Overall Study|Lack of Efficacy|3|||
126654836|NCT00190749|455693504|FG000|Overall Study|Reason Not Specified|0|||
126654837|NCT00190749|455693505|FG001|Overall Study|Reason Not Specified|2|||
126654838|NCT00190749|455693504|FG000|Overall Study|Sponsor Decision|1|||
126654839|NCT00190749|455693505|FG001|Overall Study|Sponsor Decision|0|||
126654840|NCT02729753|455693506|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
126654841|NCT02729753|455693507|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
126654842|NCT01200589|455693508|FG000|Overall Study|Withdrawal by Subject|13|||
126654843|NCT01200589|455693509|FG001|Overall Study|Withdrawal by Subject|11|||
126654844|NCT01200589|455693508|FG000|Overall Study|Physician Decision|2|||
126654845|NCT01200589|455693509|FG001|Overall Study|Physician Decision|2|||
126654846|NCT01200589|455693508|FG000|Overall Study|Lost to Follow-up|5|||
126654847|NCT01200589|455693509|FG001|Overall Study|Lost to Follow-up|4|||
126654848|NCT01200589|455693508|FG000|Overall Study|Study terminated|170|||
126654849|NCT01200589|455693509|FG001|Overall Study|Study terminated|172|||
126654850|NCT01090427|455693510|FG000|After Controlled Period|Death|0|||
126654851|NCT01090427|455693511|FG001|After Controlled Period|Death|0|||
126654852|NCT01090427|455693512|FG002|After Controlled Period|Death|0|||
126654853|NCT01090427|455693513|FG003|After Controlled Period|Death|0|||
126654854|NCT01090427|455693514|FG004|After Controlled Period|Death|0|||
126654855|NCT01090427|455693515|FG005|After Controlled Period|Death|1|||
126654856|NCT01090427|455693516|FG006|After Controlled Period|Death|0|||
126654857|NCT01090427|455693510|FG000|After Controlled Period|Lack of Efficacy|0|||
126654858|NCT01090427|455693511|FG001|After Controlled Period|Lack of Efficacy|0|||
126654859|NCT01090427|455693512|FG002|After Controlled Period|Lack of Efficacy|0|||
126654860|NCT01090427|455693513|FG003|After Controlled Period|Lack of Efficacy|0|||
126654861|NCT01090427|455693514|FG004|After Controlled Period|Lack of Efficacy|0|||
126654862|NCT01090427|455693515|FG005|After Controlled Period|Lack of Efficacy|3|||
126654863|NCT01090427|455693516|FG006|After Controlled Period|Lack of Efficacy|2|||
126654864|NCT01090427|455693510|FG000|After Controlled Period|Adverse Event|0|||
126654865|NCT01090427|455693511|FG001|After Controlled Period|Adverse Event|0|||
126654866|NCT01090427|455693512|FG002|After Controlled Period|Adverse Event|0|||
126654867|NCT01090427|455693513|FG003|After Controlled Period|Adverse Event|2|||
126654868|NCT01090427|455693514|FG004|After Controlled Period|Adverse Event|0|||
126654869|NCT01090427|455693515|FG005|After Controlled Period|Adverse Event|1|||
126654870|NCT01090427|455693516|FG006|After Controlled Period|Adverse Event|0|||
126654871|NCT01154010|455693517|FG000|Overall Study|Lost to Follow-up|0|||
126654872|NCT01154010|455693518|FG001|Overall Study|Lost to Follow-up|1|||
126654873|NCT00439231|455693519|FG000|Overall Study|Lack of Efficacy|28|||
126654874|NCT02413333|455693520|FG000|Period 1|Adverse Event|1|||
126654875|NCT02413333|455693521|FG001|Period 1|Adverse Event|0|||
126654876|NCT02413333|455693520|FG000|Period 1|Reason Not Specified|0|||
126654877|NCT02413333|455693521|FG001|Period 1|Reason Not Specified|1|||
126654878|NCT02413333|455693520|FG000|Period 2|Protocol Deviation|1|||
126654879|NCT02413333|455693521|FG001|Period 2|Protocol Deviation|0|||
126654880|NCT01049217|455693522|FG000|Overall Study|Adverse Event|2|||
126654881|NCT01049217|455693523|FG001|Overall Study|Adverse Event|1|||
126654882|NCT01049217|455693522|FG000|Overall Study|Lack of Efficacy|1|||
126326475|NCT05052697|454488397|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326476|NCT05052697|454488398|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326477|NCT05052697|454488399|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326478|NCT05052697|454488400|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326479|NCT05052697|454488401|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326480|NCT05052697|454488402|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126654883|NCT01049217|455693523|FG001|Overall Study|Lack of Efficacy|1|||
126654884|NCT01049217|455693522|FG000|Overall Study|Lost to Follow-up|3|||
126654885|NCT01049217|455693523|FG001|Overall Study|Lost to Follow-up|8|||
126654886|NCT01049217|455693522|FG000|Overall Study|Withdrawal by Subject|4|||
126654887|NCT01049217|455693523|FG001|Overall Study|Withdrawal by Subject|3|||
126654888|NCT01049217|455693522|FG000|Overall Study|Protocol Violation|1|||
126654889|NCT01049217|455693523|FG001|Overall Study|Protocol Violation|3|||
126654890|NCT01049217|455693522|FG000|Overall Study|Pregnancy|1|||
126654891|NCT01049217|455693523|FG001|Overall Study|Pregnancy|0|||
126654892|NCT01049217|455693522|FG000|Overall Study|Study Terminated by Sponsor|43|||
126654893|NCT01049217|455693523|FG001|Overall Study|Study Terminated by Sponsor|43|||
126654894|NCT01049217|455693522|FG000|Overall Study|Other|1|||
126654895|NCT01049217|455693523|FG001|Overall Study|Other|2|||
126654896|NCT01049217|455693522|FG000|Overall Study|Randomized but not Treated|0|||
126654897|NCT01049217|455693523|FG001|Overall Study|Randomized but not Treated|2|||
126654898|NCT00903682|455693524|FG000|Overall Study|Adverse Event|6|||
126654899|NCT00903682|455693525|FG001|Overall Study|Adverse Event|13|||
126654900|NCT00903682|455693524|FG000|Overall Study|Lost to Follow-up|1|||
126654901|NCT00903682|455693525|FG001|Overall Study|Lost to Follow-up|0|||
126654902|NCT00903682|455693524|FG000|Overall Study|Withdrawal by Subject|5|||
126654903|NCT00903682|455693525|FG001|Overall Study|Withdrawal by Subject|0|||
126654904|NCT00903682|455693524|FG000|Overall Study|Pregnancy|0|||
126654905|NCT00903682|455693525|FG001|Overall Study|Pregnancy|1|||
126654906|NCT00903682|455693524|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
126654907|NCT00903682|455693525|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
126654908|NCT00903682|455693524|FG000|Overall Study|Subject Non-Compliant|1|||
126654909|NCT00903682|455693525|FG001|Overall Study|Subject Non-Compliant|0|||
126654910|NCT00903682|455693524|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
126654911|NCT00903682|455693525|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
126654912|NCT00903682|455693524|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
126654913|NCT00903682|455693525|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
126654914|NCT02495792|455693526|FG000|Overall Study|Lost to Follow-up|5|||
126654915|NCT02495792|455693527|FG001|Overall Study|Lost to Follow-up|9|||
126654916|NCT02495792|455693526|FG000|Overall Study|Protocol Violation|32|||
126654917|NCT02495792|455693527|FG001|Overall Study|Protocol Violation|31|||
126654918|NCT03141905|455693530|FG000|Overall Study|Death|3|||
126654919|NCT03141905|455693531|FG001|Overall Study|Death|2|||
126654920|NCT03141905|455693530|FG000|Overall Study|Withdrawal by Subject|1|||
126654921|NCT03141905|455693531|FG001|Overall Study|Withdrawal by Subject|0|||
126654922|NCT03141905|455693530|FG000|Overall Study|Lost to Follow-up|3|||
126654923|NCT03141905|455693531|FG001|Overall Study|Lost to Follow-up|7|||
126654924|NCT03141905|455693530|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
126654925|NCT03141905|455693531|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
126654926|NCT02134977|455695675|FG000|Overall Study|Protocol Deviation|102|||
126654927|NCT01773291|455695676|FG000|Overall Study|Protocol Violation|1|||
126654928|NCT01773291|455695677|FG001|Overall Study|Protocol Violation|0|||
126654929|NCT01773291|455695678|FG002|Overall Study|Protocol Violation|0|||
126654930|NCT01773291|455695676|FG000|Overall Study|Withdrawal by Subject|0|||
126654931|NCT01773291|455695677|FG001|Overall Study|Withdrawal by Subject|0|||
126654932|NCT01773291|455695678|FG002|Overall Study|Withdrawal by Subject|1|||
126654933|NCT00107120|455695680|FG000|Overall Study|Adverse Event|4|||
126654934|NCT00107120|455695681|FG001|Overall Study|Adverse Event|1|||
126654935|NCT00107120|455695680|FG000|Overall Study|Lack of Efficacy|5|||
126654936|NCT00107120|455695681|FG001|Overall Study|Lack of Efficacy|5|||
126654937|NCT00107120|455695680|FG000|Overall Study|Protocol Violation|3|||
126654938|NCT00107120|455695681|FG001|Overall Study|Protocol Violation|0|||
126654939|NCT00107120|455695680|FG000|Overall Study|Withdrawal by Subject|8|||
126654940|NCT00107120|455695681|FG001|Overall Study|Withdrawal by Subject|9|||
126654941|NCT00107120|455695680|FG000|Overall Study|Lost to Follow-up|8|||
126654942|NCT00107120|455695681|FG001|Overall Study|Lost to Follow-up|6|||
126654943|NCT00107120|455695680|FG000|Overall Study|Pregnancy|0|||
126654944|NCT00107120|455695681|FG001|Overall Study|Pregnancy|1|||
126654945|NCT00107120|455695680|FG000|Overall Study|moving away from site|1|||
126654946|NCT00107120|455695681|FG001|Overall Study|moving away from site|1|||
126654947|NCT00107120|455695680|FG000|Overall Study|death of parent|0|||
126654948|NCT00107120|455695681|FG001|Overall Study|death of parent|1|||
126654949|NCT00896051|455695685|FG000|Overall Study|Adverse Event|2|||
126654950|NCT00896051|455695686|FG001|Overall Study|Adverse Event|1|||
126654951|NCT00896051|455695685|FG000|Overall Study|Lost to Follow-up|3|||
126654952|NCT00896051|455695686|FG001|Overall Study|Lost to Follow-up|2|||
126654953|NCT00896051|455695685|FG000|Overall Study|Withdrawal by Subject|3|||
126654954|NCT00896051|455695686|FG001|Overall Study|Withdrawal by Subject|2|||
126654955|NCT00896051|455695685|FG000|Overall Study|Subject noncompliant|1|||
126654956|NCT00896051|455695686|FG001|Overall Study|Subject noncompliant|3|||
126654957|NCT00896051|455695685|FG000|Overall Study|Other|1|||
126654958|NCT00896051|455695686|FG001|Overall Study|Other|1|||
126654959|NCT02935452|455695687|FG000|Overall Study|work and life commintment|3|||
126654960|NCT02935452|455695688|FG001|Overall Study|work and life commintment|1|||
126654961|NCT01346475|455695691|FG000|First Intervention|Lost to Follow-up|4|||
126654962|NCT01346475|455695692|FG001|First Intervention|Lost to Follow-up|3|||
126654963|NCT02029846|455695695|FG000|Overall Study|n=1 each arm|1|||
126654964|NCT02029846|455695696|FG001|Overall Study|n=1 each arm|1|||
126654965|NCT02966301|455695697|FG000|Overall Study|Death|2|||
126654966|NCT02966301|455695697|FG000|Overall Study|Withdrawal by Subject|1|||
126654967|NCT00700258|455695698|FG000|Overall Study|Premature discontinuation of documentation|136|||
126654968|NCT00700258|455695698|FG000|Overall Study|Type of study end not documented|1|||
126654969|NCT00700258|455695698|FG000|Overall Study|Lost to Follow-up|81|||
126654970|NCT00700258|455695698|FG000|Overall Study|Premature discontinuation of therapy|1013|||
126654971|NCT00370331|455695700|FG000|Overall Study|Adverse Event|4|||
126654972|NCT00370331|455695701|FG001|Overall Study|Adverse Event|13|||
126654973|NCT00370331|455695700|FG000|Overall Study|Withdrawal by Subject|2|||
126654974|NCT00370331|455695701|FG001|Overall Study|Withdrawal by Subject|4|||
126654975|NCT00370331|455695700|FG000|Overall Study|Lost to Follow-up|0|||
126654976|NCT00370331|455695701|FG001|Overall Study|Lost to Follow-up|3|||
126654977|NCT00370331|455695700|FG000|Overall Study|Lack of Efficacy|0|||
126654978|NCT00370331|455695701|FG001|Overall Study|Lack of Efficacy|1|||
126654979|NCT00370331|455695700|FG000|Overall Study|Non-compliance|0|||
126654980|NCT00370331|455695701|FG001|Overall Study|Non-compliance|1|||
126654981|NCT00370331|455695700|FG000|Overall Study|Protocol Violation|1|||
126654982|NCT00370331|455695701|FG001|Overall Study|Protocol Violation|1|||
126654983|NCT01874431|455695702|FG000|Overall Study|Physician Decision|0|||
126654984|NCT01874431|455695703|FG001|Overall Study|Physician Decision|0|||
126654985|NCT01874431|455695704|FG002|Overall Study|Physician Decision|1|||
126654986|NCT01874431|455695705|FG003|Overall Study|Physician Decision|0|||
126654987|NCT01874431|455695706|FG004|Overall Study|Physician Decision|0|||
126654988|NCT01874431|455695707|FG005|Overall Study|Physician Decision|0|||
126654989|NCT01874431|455695708|FG006|Overall Study|Physician Decision|0|||
126654990|NCT01874431|455695709|FG007|Overall Study|Physician Decision|0|||
126654991|NCT01874431|455695702|FG000|Overall Study|Adverse Event|5|||
126654992|NCT01874431|455695703|FG001|Overall Study|Adverse Event|4|||
126654993|NCT01874431|455695704|FG002|Overall Study|Adverse Event|6|||
126654994|NCT01874431|455695705|FG003|Overall Study|Adverse Event|5|||
126654995|NCT01874431|455695706|FG004|Overall Study|Adverse Event|2|||
126654996|NCT01874431|455695707|FG005|Overall Study|Adverse Event|8|||
126654997|NCT01874431|455695708|FG006|Overall Study|Adverse Event|2|||
126654998|NCT01874431|455695709|FG007|Overall Study|Adverse Event|3|||
126654999|NCT01874431|455695702|FG000|Overall Study|Protocol Violation|1|||
126655000|NCT01874431|455695703|FG001|Overall Study|Protocol Violation|1|||
126655001|NCT01874431|455695704|FG002|Overall Study|Protocol Violation|1|||
126655002|NCT01874431|455695705|FG003|Overall Study|Protocol Violation|0|||
126655003|NCT01874431|455695706|FG004|Overall Study|Protocol Violation|3|||
126655004|NCT01874431|455695707|FG005|Overall Study|Protocol Violation|2|||
126655005|NCT01874431|455695708|FG006|Overall Study|Protocol Violation|1|||
126655006|NCT01874431|455695709|FG007|Overall Study|Protocol Violation|1|||
126655007|NCT01874431|455695702|FG000|Overall Study|Non-compliance|0|||
126655008|NCT01874431|455695703|FG001|Overall Study|Non-compliance|0|||
126655009|NCT01874431|455695704|FG002|Overall Study|Non-compliance|0|||
126655010|NCT01874431|455695705|FG003|Overall Study|Non-compliance|0|||
126655011|NCT01874431|455695706|FG004|Overall Study|Non-compliance|1|||
126655012|NCT01874431|455695707|FG005|Overall Study|Non-compliance|0|||
126655013|NCT01874431|455695708|FG006|Overall Study|Non-compliance|1|||
126655014|NCT01874431|455695709|FG007|Overall Study|Non-compliance|0|||
126655015|NCT01874431|455695702|FG000|Overall Study|Logistical difficulties|0|||
126655016|NCT01874431|455695703|FG001|Overall Study|Logistical difficulties|0|||
126655017|NCT01874431|455695704|FG002|Overall Study|Logistical difficulties|0|||
126655018|NCT01874431|455695705|FG003|Overall Study|Logistical difficulties|0|||
126655019|NCT01874431|455695706|FG004|Overall Study|Logistical difficulties|0|||
126655020|NCT01874431|455695707|FG005|Overall Study|Logistical difficulties|0|||
126655021|NCT01874431|455695708|FG006|Overall Study|Logistical difficulties|1|||
126655022|NCT01874431|455695709|FG007|Overall Study|Logistical difficulties|0|||
126655023|NCT01874431|455695702|FG000|Overall Study|Withdrawal by Subject|0|||
126326481|NCT05052697|454488403|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126655024|NCT01874431|455695703|FG001|Overall Study|Withdrawal by Subject|0|||
126655025|NCT01874431|455695704|FG002|Overall Study|Withdrawal by Subject|1|||
126655026|NCT01874431|455695705|FG003|Overall Study|Withdrawal by Subject|2|||
126655027|NCT01874431|455695706|FG004|Overall Study|Withdrawal by Subject|1|||
126655028|NCT01874431|455695707|FG005|Overall Study|Withdrawal by Subject|1|||
126655029|NCT01874431|455695708|FG006|Overall Study|Withdrawal by Subject|3|||
126655030|NCT01874431|455695709|FG007|Overall Study|Withdrawal by Subject|0|||
126655031|NCT01874431|455695702|FG000|Overall Study|Sponsor decision|0|||
126655032|NCT01874431|455695703|FG001|Overall Study|Sponsor decision|0|||
126655033|NCT01874431|455695704|FG002|Overall Study|Sponsor decision|0|||
126655034|NCT01874431|455695705|FG003|Overall Study|Sponsor decision|0|||
126655035|NCT01874431|455695706|FG004|Overall Study|Sponsor decision|1|||
126655036|NCT01874431|455695707|FG005|Overall Study|Sponsor decision|0|||
126655037|NCT01874431|455695708|FG006|Overall Study|Sponsor decision|0|||
126655038|NCT01874431|455695709|FG007|Overall Study|Sponsor decision|0|||
126655039|NCT01874431|455695702|FG000|Overall Study|Lost to Follow-up|0|||
126655040|NCT01874431|455695703|FG001|Overall Study|Lost to Follow-up|0|||
126655041|NCT01874431|455695704|FG002|Overall Study|Lost to Follow-up|1|||
126655042|NCT01874431|455695705|FG003|Overall Study|Lost to Follow-up|0|||
126655043|NCT01874431|455695706|FG004|Overall Study|Lost to Follow-up|0|||
126655044|NCT01874431|455695707|FG005|Overall Study|Lost to Follow-up|0|||
126655045|NCT01874431|455695708|FG006|Overall Study|Lost to Follow-up|0|||
126655046|NCT01874431|455695709|FG007|Overall Study|Lost to Follow-up|0|||
126655047|NCT00738582|455695712|FG000|Combination Therapy|Completed Combination Therapy|1|||
126655048|NCT00738582|455695713|FG001|Combination Therapy|Completed Combination Therapy|0|||
126655049|NCT00738582|455695712|FG000|Combination Therapy|Physician Decision|1|||
126655050|NCT00738582|455695713|FG001|Combination Therapy|Physician Decision|0|||
126655051|NCT00738582|455695712|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
126655052|NCT00738582|455695713|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
126655053|NCT00738582|455695712|FG000|Combination Therapy|Other|5|||
126655054|NCT00738582|455695713|FG001|Combination Therapy|Other|0|||
126655055|NCT00738582|455695712|FG000|Combination Therapy|Adverse Event|16|||
126655056|NCT00738582|455695713|FG001|Combination Therapy|Adverse Event|0|||
126655057|NCT00738582|455695712|FG000|Combination Therapy|Progressive Disease|9|||
126655058|NCT00738582|455695713|FG001|Combination Therapy|Progressive Disease|0|||
126655059|NCT00738582|455695712|FG000|Maintenance Therapy|Other|0|||
126655060|NCT00738582|455695713|FG001|Maintenance Therapy|Other|2|||
126655061|NCT00738582|455695712|FG000|Maintenance Therapy|Adverse Event|0|||
126655062|NCT00738582|455695713|FG001|Maintenance Therapy|Adverse Event|6|||
126655063|NCT00738582|455695712|FG000|Maintenance Therapy|Progressive Disease|0|||
126655064|NCT00738582|455695713|FG001|Maintenance Therapy|Progressive Disease|47|||
126655065|NCT00738582|455695712|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
126655066|NCT00738582|455695713|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
126655067|NCT00642772|455695714|FG000|Overall Study|Lost to Follow-up|3|||
126655068|NCT00642772|455695714|FG000|Overall Study|Withdrawal by Subject|7|||
126655069|NCT00757588|455695715|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
126655070|NCT00757588|455695716|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
126655071|NCT00757588|455695715|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
126655072|NCT00757588|455695716|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
126326482|NCT05052697|454488404|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326483|NCT05052697|454488405|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326484|NCT05052697|454488406|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326485|NCT05052697|454488407|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326486|NCT05052697|454488408|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326487|NCT05052697|454488409|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326488|NCT05052697|454488410|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326489|NCT05052697|454488411|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326490|NCT05052697|454488412|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326491|NCT05052697|454488413|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326492|NCT05052697|454488414|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
126326493|NCT05052697|454488415|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
126326494|NCT05052697|454488382|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326495|NCT05052697|454488383|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326496|NCT05052697|454488384|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326497|NCT05052697|454488385|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326498|NCT05052697|454488386|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326499|NCT05052697|454488387|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326500|NCT05052697|454488388|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326501|NCT05052697|454488389|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326502|NCT05052697|454488390|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126655073|NCT00757588|455695715|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
126655074|NCT00757588|455695716|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
126655075|NCT00757588|455695715|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
126655076|NCT00757588|455695716|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
126655077|NCT00757588|455695715|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
126655078|NCT00757588|455695716|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
126655079|NCT00757588|455695715|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
126326503|NCT05052697|454488391|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326504|NCT05052697|454488392|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326505|NCT05052697|454488393|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326506|NCT05052697|454488394|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326507|NCT05052697|454488395|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326508|NCT05052697|454488396|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326509|NCT05052697|454488397|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326510|NCT05052697|454488398|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326511|NCT05052697|454488399|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326512|NCT05052697|454488400|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326513|NCT05052697|454488401|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326514|NCT05052697|454488402|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326515|NCT05052697|454488403|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326516|NCT05052697|454488404|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326517|NCT05052697|454488405|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326518|NCT05052697|454488406|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326519|NCT05052697|454488407|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326520|NCT05052697|454488408|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326521|NCT05052697|454488409|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326522|NCT05052697|454488410|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
126326523|NCT05052697|454488411|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
126326524|NCT05052697|454488412|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
126326525|NCT05052697|454488413|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326526|NCT05052697|454488414|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326527|NCT05052697|454488415|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
126326528|NCT01289574|454488416|FG000|Overall Study|Lack of Efficacy|4|||
126326529|NCT01289574|454488417|FG001|Overall Study|Lack of Efficacy|0|||
126326530|NCT01289574|454488418|FG002|Overall Study|Lack of Efficacy|1|||
126326531|NCT01289574|454488416|FG000|Overall Study|Lost to Follow-up|2|||
126326532|NCT01289574|454488417|FG001|Overall Study|Lost to Follow-up|0|||
126326533|NCT01289574|454488418|FG002|Overall Study|Lost to Follow-up|1|||
126326534|NCT01289574|454488416|FG000|Overall Study|Withdrawal by Subject|1|||
126326535|NCT01289574|454488417|FG001|Overall Study|Withdrawal by Subject|1|||
126326536|NCT01289574|454488418|FG002|Overall Study|Withdrawal by Subject|1|||
126326537|NCT01289574|454488416|FG000|Overall Study|Adverse Event|0|||
126326538|NCT01289574|454488417|FG001|Overall Study|Adverse Event|1|||
126326539|NCT01289574|454488418|FG002|Overall Study|Adverse Event|0|||
126326540|NCT01289574|454488416|FG000|Overall Study|Subject wanted alternate treatment|0|||
126326541|NCT01289574|454488417|FG001|Overall Study|Subject wanted alternate treatment|1|||
126326542|NCT01289574|454488418|FG002|Overall Study|Subject wanted alternate treatment|0|||
126326543|NCT00262002|454488419|FG000|Overall Study|Adverse Event|2|||
126326544|NCT00262002|454488420|FG001|Overall Study|Adverse Event|1|||
126326545|NCT00262002|454488421|FG002|Overall Study|Adverse Event|0|||
126326546|NCT00262002|454488422|FG003|Overall Study|Adverse Event|0|||
126326547|NCT00262002|454488423|FG004|Overall Study|Adverse Event|0|||
126326548|NCT00262002|454488424|FG005|Overall Study|Adverse Event|1|||
126326549|NCT00262002|454488425|FG006|Overall Study|Adverse Event|0|||
126326550|NCT00262002|454488419|FG000|Overall Study|Withdrawal by Subject|4|||
126326551|NCT00262002|454488420|FG001|Overall Study|Withdrawal by Subject|2|||
126326552|NCT00262002|454488421|FG002|Overall Study|Withdrawal by Subject|0|||
126326553|NCT00262002|454488422|FG003|Overall Study|Withdrawal by Subject|1|||
126326554|NCT00262002|454488423|FG004|Overall Study|Withdrawal by Subject|2|||
126326555|NCT00262002|454488424|FG005|Overall Study|Withdrawal by Subject|2|||
126326556|NCT00262002|454488425|FG006|Overall Study|Withdrawal by Subject|2|||
126326557|NCT00262002|454488419|FG000|Overall Study|Lost to Follow-up|2|||
126326558|NCT00262002|454488420|FG001|Overall Study|Lost to Follow-up|0|||
126326559|NCT00262002|454488421|FG002|Overall Study|Lost to Follow-up|0|||
126326560|NCT00262002|454488422|FG003|Overall Study|Lost to Follow-up|2|||
126326561|NCT00262002|454488423|FG004|Overall Study|Lost to Follow-up|0|||
126326562|NCT00262002|454488424|FG005|Overall Study|Lost to Follow-up|1|||
126326563|NCT00262002|454488425|FG006|Overall Study|Lost to Follow-up|0|||
126326564|NCT00262002|454488419|FG000|Overall Study|Inapropriate enrollment|0|||
126326565|NCT00262002|454488420|FG001|Overall Study|Inapropriate enrollment|1|||
126326566|NCT00262002|454488421|FG002|Overall Study|Inapropriate enrollment|0|||
126326567|NCT00262002|454488422|FG003|Overall Study|Inapropriate enrollment|0|||
126326568|NCT00262002|454488423|FG004|Overall Study|Inapropriate enrollment|0|||
126326569|NCT00262002|454488424|FG005|Overall Study|Inapropriate enrollment|0|||
126326570|NCT00262002|454488425|FG006|Overall Study|Inapropriate enrollment|0|||
126326571|NCT00262002|454488419|FG000|Overall Study|Protocol Violation|3|||
126326572|NCT00262002|454488420|FG001|Overall Study|Protocol Violation|2|||
126326573|NCT00262002|454488421|FG002|Overall Study|Protocol Violation|0|||
126326574|NCT00262002|454488422|FG003|Overall Study|Protocol Violation|2|||
126326575|NCT00262002|454488423|FG004|Overall Study|Protocol Violation|5|||
126326576|NCT00262002|454488424|FG005|Overall Study|Protocol Violation|3|||
126326577|NCT00262002|454488425|FG006|Overall Study|Protocol Violation|2|||
126326578|NCT00262002|454488419|FG000|Overall Study|Unable to classify|0|||
126326579|NCT00262002|454488420|FG001|Overall Study|Unable to classify|0|||
126326580|NCT00262002|454488421|FG002|Overall Study|Unable to classify|0|||
126326581|NCT00262002|454488422|FG003|Overall Study|Unable to classify|0|||
126326582|NCT00262002|454488423|FG004|Overall Study|Unable to classify|0|||
126326583|NCT00262002|454488424|FG005|Overall Study|Unable to classify|0|||
126326584|NCT00262002|454488425|FG006|Overall Study|Unable to classify|2|||
126326585|NCT01790516|454488426|FG000|Overall Study|Physician Decision|1|||
126326586|NCT01790516|454488427|FG001|Overall Study|Physician Decision|0|||
126326587|NCT01554163|454488428|FG000|Overall Study|Adverse Event|3|||
126326588|NCT01554163|454488429|FG001|Overall Study|Adverse Event|0|||
126326589|NCT01554163|454488428|FG000|Overall Study|Lack of Efficacy|1|||
126326590|NCT01554163|454488429|FG001|Overall Study|Lack of Efficacy|0|||
126326591|NCT01554163|454488428|FG000|Overall Study|Lost to Follow-up|1|||
126326592|NCT01554163|454488429|FG001|Overall Study|Lost to Follow-up|0|||
126326593|NCT01554163|454488428|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126326594|NCT01554163|454488429|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126326595|NCT01554163|454488428|FG000|Overall Study|Protocol Violation|0|||
126326596|NCT01554163|454488429|FG001|Overall Study|Protocol Violation|4|||
126326597|NCT01554163|454488428|FG000|Overall Study|Withdrawal by Subject|1|||
126326598|NCT01554163|454488429|FG001|Overall Study|Withdrawal by Subject|5|||
126326599|NCT01554163|454488428|FG000|Overall Study|Not Treated|1|||
126326600|NCT01554163|454488429|FG001|Overall Study|Not Treated|0|||
126326601|NCT03034135|454488430|FG000|Overall Study|Withdrawal by Subject|2|||
126326602|NCT01972464|454488434|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
126326603|NCT01972464|454488435|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
126326604|NCT01972464|454488434|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
126326605|NCT01972464|454488435|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
126326606|NCT01972464|454488434|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
126326607|NCT01972464|454488435|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
126326608|NCT01972464|454488434|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
126326609|NCT01972464|454488435|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
126326610|NCT01133704|454490002|FG000|Overall Study|Death|44|||
126326611|NCT01133704|454490003|FG001|Overall Study|Death|26|||
126326612|NCT01133704|454490002|FG000|Overall Study|Patient refused to continue|4|||
126326613|NCT01133704|454490003|FG001|Overall Study|Patient refused to continue|0|||
126326614|NCT01133704|454490002|FG000|Overall Study|Study Closure|1|||
126326615|NCT01133704|454490003|FG001|Overall Study|Study Closure|0|||
126326616|NCT04985942|454490006|FG000|Overall Study|Adverse Event|14|||
126326617|NCT04985942|454490007|FG001|Overall Study|Adverse Event|2|||
126326618|NCT04985942|454490006|FG000|Overall Study|Lack of Efficacy|0|||
126326619|NCT04985942|454490007|FG001|Overall Study|Lack of Efficacy|3|||
126326620|NCT04985942|454490006|FG000|Overall Study|Lost to Follow-up|1|||
126326621|NCT04985942|454490007|FG001|Overall Study|Lost to Follow-up|1|||
126326622|NCT04985942|454490006|FG000|Overall Study|Protocol Violation|1|||
126326623|NCT04985942|454490007|FG001|Overall Study|Protocol Violation|1|||
126326624|NCT04985942|454490006|FG000|Overall Study|Withdrawal by Subject|5|||
126326625|NCT04985942|454490007|FG001|Overall Study|Withdrawal by Subject|4|||
126326626|NCT02849704|454490009|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
126326627|NCT02849704|454490010|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
126326628|NCT02849704|454490009|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
126326629|NCT02849704|454490010|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
126326630|NCT02849704|454490009|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
126326631|NCT02849704|454490010|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
126326632|NCT02447328|454490015|FG000|Overall Study|Withdrawal by Subject|1|||
126326633|NCT01128400|454490016|FG000|Overall Study|Lost to Follow-up|1|||
126326634|NCT01128400|454490017|FG001|Overall Study|Lost to Follow-up|0|||
126326635|NCT01128400|454490018|FG002|Overall Study|Lost to Follow-up|1|||
126326636|NCT01128400|454490016|FG000|Overall Study|Screening failure|1|||
126326637|NCT01128400|454490017|FG001|Overall Study|Screening failure|0|||
126326638|NCT01128400|454490018|FG002|Overall Study|Screening failure|0|||
126326639|NCT01128400|454490016|FG000|Overall Study|were not invited to participate on taste|0|||
126326640|NCT01128400|454490017|FG001|Overall Study|were not invited to participate on taste|0|||
126326641|NCT01128400|454490018|FG002|Overall Study|were not invited to participate on taste|15|||
126326642|NCT01128400|454490016|FG000|Overall Study|Excluded due to sinus problems|0|||
126326643|NCT01128400|454490017|FG001|Overall Study|Excluded due to sinus problems|1|||
126326644|NCT01128400|454490018|FG002|Overall Study|Excluded due to sinus problems|0|||
126326645|NCT00314808|454490022|FG000|Overall Study|Disease Progression without AE|4|||
126326646|NCT00314808|454490022|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
126326647|NCT04304508|454490023|FG000|Overall Study|Subject Decision|29|||
126326648|NCT04304508|454490024|FG001|Overall Study|Subject Decision|39|||
126326649|NCT04304508|454490025|FG002|Overall Study|Subject Decision|37|||
126326650|NCT04304508|454490026|FG003|Overall Study|Subject Decision|48|||
126326651|NCT04304508|454490023|FG000|Overall Study|Death|6|||
126326652|NCT04304508|454490024|FG001|Overall Study|Death|1|||
126326653|NCT04304508|454490025|FG002|Overall Study|Death|8|||
126326654|NCT04304508|454490026|FG003|Overall Study|Death|5|||
126326655|NCT04304508|454490023|FG000|Overall Study|Non-compliance With Study Drug|3|||
126326656|NCT04304508|454490024|FG001|Overall Study|Non-compliance With Study Drug|1|||
126326657|NCT04304508|454490025|FG002|Overall Study|Non-compliance With Study Drug|2|||
126326658|NCT04304508|454490026|FG003|Overall Study|Non-compliance With Study Drug|0|||
126326659|NCT04304508|454490023|FG000|Overall Study|Switching To Other Therapy|1|||
126326660|NCT04304508|454490024|FG001|Overall Study|Switching To Other Therapy|1|||
126326661|NCT04304508|454490025|FG002|Overall Study|Switching To Other Therapy|1|||
126326662|NCT04304508|454490026|FG003|Overall Study|Switching To Other Therapy|2|||
126326663|NCT04304508|454490023|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
126326664|NCT04304508|454490024|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
126326665|NCT04304508|454490025|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
126326666|NCT04304508|454490026|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
126326667|NCT04304508|454490023|FG000|Overall Study|Withdrawal by Subject|7|||
126326668|NCT04304508|454490024|FG001|Overall Study|Withdrawal by Subject|5|||
126326669|NCT04304508|454490025|FG002|Overall Study|Withdrawal by Subject|11|||
126326670|NCT04304508|454490026|FG003|Overall Study|Withdrawal by Subject|6|||
126326671|NCT04304508|454490023|FG000|Overall Study|Logistical Difficulties|2|||
126326672|NCT04304508|454490024|FG001|Overall Study|Logistical Difficulties|2|||
126326673|NCT04304508|454490025|FG002|Overall Study|Logistical Difficulties|3|||
126326674|NCT04304508|454490026|FG003|Overall Study|Logistical Difficulties|2|||
126326675|NCT04304508|454490023|FG000|Overall Study|Missing Information|1|||
126326676|NCT04304508|454490024|FG001|Overall Study|Missing Information|2|||
126326677|NCT04304508|454490025|FG002|Overall Study|Missing Information|1|||
126326678|NCT04304508|454490026|FG003|Overall Study|Missing Information|3|||
126326679|NCT04304508|454490023|FG000|Overall Study|Other|7|||
126326680|NCT04304508|454490024|FG001|Overall Study|Other|6|||
126326681|NCT04304508|454490025|FG002|Overall Study|Other|5|||
126655080|NCT00757588|455695716|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
126326682|NCT04304508|454490026|FG003|Overall Study|Other|4|||
126326683|NCT04304508|454490023|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
126326684|NCT04304508|454490024|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
126326685|NCT04304508|454490025|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
126326686|NCT04304508|454490026|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
126326687|NCT04304508|454490023|FG000|Overall Study|Physician Decision|3|||
126326688|NCT04304508|454490024|FG001|Overall Study|Physician Decision|4|||
126326689|NCT04304508|454490025|FG002|Overall Study|Physician Decision|9|||
126326690|NCT04304508|454490026|FG003|Overall Study|Physician Decision|7|||
126326691|NCT04304508|454490023|FG000|Overall Study|Study drug never administered|10|||
126326692|NCT04304508|454490024|FG001|Overall Study|Study drug never administered|4|||
126326693|NCT04304508|454490025|FG002|Overall Study|Study drug never administered|4|||
126326694|NCT04304508|454490026|FG003|Overall Study|Study drug never administered|4|||
126326695|NCT04304508|454490023|FG000|Overall Study|Adverse Event|49|||
126326696|NCT04304508|454490024|FG001|Overall Study|Adverse Event|50|||
126326697|NCT04304508|454490025|FG002|Overall Study|Adverse Event|51|||
126326698|NCT04304508|454490026|FG003|Overall Study|Adverse Event|56|||
126326699|NCT04304508|454490023|FG000|Overall Study|Lost to Follow-up|1|||
126326700|NCT04304508|454490024|FG001|Overall Study|Lost to Follow-up|5|||
126326701|NCT04304508|454490025|FG002|Overall Study|Lost to Follow-up|2|||
126326702|NCT04304508|454490026|FG003|Overall Study|Lost to Follow-up|3|||
126326703|NCT02688764|454490033|FG000|Overall Study|Adverse Event|3|||
126326704|NCT02688764|454490034|FG001|Overall Study|Adverse Event|3|||
126326705|NCT02688764|454490033|FG000|Overall Study|AE/Kidney transplant|1|||
126326706|NCT02688764|454490034|FG001|Overall Study|AE/Kidney transplant|0|||
126326707|NCT02688764|454490033|FG000|Overall Study|AE/Lack of efficacy|1|||
126326708|NCT02688764|454490034|FG001|Overall Study|AE/Lack of efficacy|0|||
126326709|NCT02688764|454490033|FG000|Overall Study|AE/Non-compl.|1|||
126326710|NCT02688764|454490034|FG001|Overall Study|AE/Non-compl.|0|||
126326711|NCT02688764|454490033|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
126326712|NCT02688764|454490034|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
126326713|NCT02688764|454490033|FG000|Overall Study|AE/Other|0|||
126326714|NCT02688764|454490034|FG001|Overall Study|AE/Other|1|||
126326715|NCT02688764|454490033|FG000|Overall Study|AE/Physician decision|1|||
126326716|NCT02688764|454490034|FG001|Overall Study|AE/Physician decision|0|||
126326717|NCT02688764|454490033|FG000|Overall Study|AE/Withd. parent|3|||
126326718|NCT02688764|454490034|FG001|Overall Study|AE/Withd. parent|0|||
126326719|NCT02688764|454490033|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
126326720|NCT02688764|454490034|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
126326721|NCT02688764|454490033|FG000|Overall Study|AE/Withd. subject|1|||
126326722|NCT02688764|454490034|FG001|Overall Study|AE/Withd. subject|0|||
126326723|NCT02688764|454490033|FG000|Overall Study|Kidney transplant|10|||
126326724|NCT02688764|454490034|FG001|Overall Study|Kidney transplant|4|||
126326725|NCT02688764|454490033|FG000|Overall Study|Lack of Efficacy|3|||
126326726|NCT02688764|454490034|FG001|Overall Study|Lack of Efficacy|2|||
126326727|NCT02688764|454490033|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
126326728|NCT02688764|454490034|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
126326729|NCT02688764|454490033|FG000|Overall Study|Non-compliance with study drug|4|||
126326730|NCT02688764|454490034|FG001|Overall Study|Non-compliance with study drug|0|||
126326731|NCT02688764|454490033|FG000|Overall Study|Non-compl./Physician decision|2|||
126326732|NCT02688764|454490034|FG001|Overall Study|Non-compl./Physician decision|0|||
126326733|NCT02688764|454490033|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
126326734|NCT02688764|454490034|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
126326735|NCT02688764|454490033|FG000|Overall Study|Non-compl./Withd. subject|0|||
126326736|NCT02688764|454490034|FG001|Overall Study|Non-compl./Withd. subject|2|||
126326737|NCT02688764|454490033|FG000|Overall Study|Phosphorus level outside safe range|0|||
126326738|NCT02688764|454490034|FG001|Overall Study|Phosphorus level outside safe range|1|||
126326739|NCT02688764|454490033|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
126326740|NCT02688764|454490034|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
126326741|NCT02688764|454490033|FG000|Overall Study|Study drug taste/Withd. parent|1|||
126326742|NCT02688764|454490034|FG001|Overall Study|Study drug taste/Withd. parent|0|||
126326743|NCT02688764|454490033|FG000|Overall Study|Subject moving out|2|||
126326744|NCT02688764|454490034|FG001|Overall Study|Subject moving out|0|||
126326745|NCT02688764|454490033|FG000|Overall Study|Subject taken off dialysis|1|||
126326746|NCT02688764|454490034|FG001|Overall Study|Subject taken off dialysis|0|||
126326747|NCT02688764|454490033|FG000|Overall Study|Withdrawal by parent|3|||
126326748|NCT02688764|454490034|FG001|Overall Study|Withdrawal by parent|0|||
126326749|NCT02113007|454490035|FG000|Overall Study|Progressive disease|2|||
126326750|NCT00885378|454490036|FG000|Overall Study|Lack of Efficacy|2|||
126326751|NCT00885378|454490037|FG001|Overall Study|Lack of Efficacy|2|||
126326752|NCT00885378|454490036|FG000|Overall Study|Withdrawal by Subject|1|||
126326753|NCT00885378|454490037|FG001|Overall Study|Withdrawal by Subject|2|||
126326754|NCT00885378|454490036|FG000|Overall Study|Lost to Follow-up|1|||
126326755|NCT00885378|454490037|FG001|Overall Study|Lost to Follow-up|2|||
126326756|NCT00885378|454490036|FG000|Overall Study|Poor/Noncompliance|2|||
126326757|NCT00885378|454490037|FG001|Overall Study|Poor/Noncompliance|2|||
126326758|NCT00885378|454490036|FG000|Overall Study|Protocol Violation|2|||
126326759|NCT00885378|454490037|FG001|Overall Study|Protocol Violation|0|||
126326760|NCT04750278|454490039|FG000|Overall Study|Death|9|||
126326761|NCT04750278|454490040|FG001|Overall Study|Death|10|||
126326762|NCT04750278|454490041|FG002|Overall Study|Death|10|||
126326763|NCT04750278|454490039|FG000|Overall Study|Withdrawal by Subject|4|||
126326764|NCT04750278|454490040|FG001|Overall Study|Withdrawal by Subject|1|||
126326765|NCT04750278|454490041|FG002|Overall Study|Withdrawal by Subject|2|||
126326766|NCT04750278|454490039|FG000|Overall Study|Lost to Follow-up|1|||
126326767|NCT04750278|454490040|FG001|Overall Study|Lost to Follow-up|1|||
126326768|NCT04750278|454490041|FG002|Overall Study|Lost to Follow-up|1|||
126326769|NCT04750278|454490039|FG000|Overall Study|Pregnancy|1|||
126326770|NCT04750278|454490040|FG001|Overall Study|Pregnancy|0|||
126326771|NCT04750278|454490041|FG002|Overall Study|Pregnancy|0|||
126326772|NCT04750278|454490039|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
126326773|NCT04750278|454490040|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
126326774|NCT04750278|454490041|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
126326775|NCT04750278|454490039|FG000|Overall Study|Non-compliance|0|||
126326776|NCT04750278|454490040|FG001|Overall Study|Non-compliance|0|||
126326777|NCT04750278|454490041|FG002|Overall Study|Non-compliance|1|||
126326778|NCT04750278|454490039|FG000|Overall Study|Transfer to Outside Facility|0|||
126326779|NCT04750278|454490040|FG001|Overall Study|Transfer to Outside Facility|2|||
126326780|NCT04750278|454490041|FG002|Overall Study|Transfer to Outside Facility|1|||
126326781|NCT04750278|454490039|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
126326782|NCT04750278|454490040|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
126326783|NCT04750278|454490041|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
126326784|NCT04750278|454490039|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
126326785|NCT04750278|454490040|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
126326786|NCT04750278|454490041|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
126326787|NCT01775787|454490042|FG000|First 7-10 Days|Adverse Event|0|||
126326788|NCT01775787|454490043|FG001|First 7-10 Days|Adverse Event|1|||
126326789|NCT01775787|454490042|FG000|First 7-10 Days|family emergency|0|||
126326790|NCT01775787|454490043|FG001|First 7-10 Days|family emergency|1|||
126326791|NCT01775787|454490042|FG000|First 7-10 Days|time commitment|0|||
126326792|NCT01775787|454490043|FG001|First 7-10 Days|time commitment|2|||
126655081|NCT00757588|455695715|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
126326793|NCT01775787|454490042|FG000|First 7-10 Days|concerns with using IV|1|||
126326794|NCT01775787|454490043|FG001|First 7-10 Days|concerns with using IV|2|||
126326795|NCT01775787|454490042|FG000|Second 7-10 Days|time commitment|0|||
126326796|NCT01775787|454490043|FG001|Second 7-10 Days|time commitment|1|||
126326797|NCT01775787|454490042|FG000|Second 7-10 Days|concerns with using IV|0|||
126326798|NCT01775787|454490043|FG001|Second 7-10 Days|concerns with using IV|1|||
126326799|NCT01616758|454490048|FG000|Overall Study|Adverse Event|1|||
126326800|NCT01616758|454490048|FG000|Overall Study|Withdrawal by Subject|2|||
126326801|NCT01616758|454490048|FG000|Overall Study|Disease progression|18|||
126326802|NCT01616758|454490048|FG000|Overall Study|Study termination by Sponsor|1|||
126326803|NCT04076319|454490053|FG000|Overall Study|Withdrawal by Subject|2|||
126326804|NCT04076319|454490054|FG001|Overall Study|Withdrawal by Subject|0|||
126326805|NCT04076319|454490053|FG000|Overall Study|Death|1|||
126326806|NCT04076319|454490054|FG001|Overall Study|Death|0|||
126326807|NCT01054222|454490055|FG000|Overall Study|Lack of Efficacy|1|||
126326808|NCT01054222|454490055|FG000|Overall Study|Lost to Follow-up|4|||
126326809|NCT01054222|454490055|FG000|Overall Study|Withdrawal by Subject|6|||
126326810|NCT00824655|454490056|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
126326811|NCT00824655|454490057|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
126326812|NCT00824655|454490056|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
126326813|NCT00824655|454490057|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
126326814|NCT03252145|454490058|FG000|Overall Study|Withdrawal by Subject|1|||
126326815|NCT03252145|454490059|FG001|Overall Study|Withdrawal by Subject|0|||
126326816|NCT03252145|454490058|FG000|Overall Study|Complicating Disease|1|||
126326817|NCT03252145|454490059|FG001|Overall Study|Complicating Disease|2|||
126326818|NCT03504189|454490060|FG000|Overall Study|Withdrawal by Subject|1|||
126326819|NCT03504189|454490060|FG000|Overall Study|Screening Failure|1|||
126326820|NCT03504189|454490060|FG000|Overall Study|Device Failure|2|||
126326821|NCT03091738|454490061|FG000|Overall Study|Adverse Event|1|||
126326822|NCT03091738|454490061|FG000|Overall Study|Lost to Follow-up|1|||
126326823|NCT04336475|454490062|FG000|Overall Study|pain|1|||
126326824|NCT04336475|454490063|FG001|Overall Study|pain|0|||
126326825|NCT04336475|454490062|FG000|Overall Study|upper respiratory infection|1|||
126326826|NCT04336475|454490063|FG001|Overall Study|upper respiratory infection|0|||
126326827|NCT04336475|454490062|FG000|Overall Study|Lost to Follow-up|0|||
126326828|NCT04336475|454490063|FG001|Overall Study|Lost to Follow-up|2|||
126326829|NCT00199849|454490072|FG000|Overall Study|Unrelated illness or complication|0|||
126326830|NCT00199849|454490073|FG001|Overall Study|Unrelated illness or complication|1|||
126326831|NCT00199849|454490074|FG002|Overall Study|Unrelated illness or complication|0|||
126326832|NCT00199849|454490072|FG000|Overall Study|Progressive disease requiring intervention|0|||
126326833|NCT00199849|454490073|FG001|Overall Study|Progressive disease requiring intervention|0|||
126326834|NCT00199849|454490074|FG002|Overall Study|Progressive disease requiring intervention|1|||
126326835|NCT00199849|454490072|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
126326836|NCT00199849|454490073|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
126326837|NCT00199849|454490074|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
126326838|NCT00398047|454490084|FG000|Overall Study|all patient progressed before completion|3|||
126326839|NCT01188668|454490085|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
126326840|NCT01188668|454490085|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
126326841|NCT01188668|454490085|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
126326842|NCT00902746|454490086|FG000|Overall Study|Protocol Violation|7|||
126326843|NCT00902746|454490086|FG000|Overall Study|Withdrawal by Subject|16|||
126326844|NCT00902746|454490086|FG000|Overall Study|Adverse Event|8|||
126326845|NCT00902746|454490086|FG000|Overall Study|Lost to Follow-up|3|||
126326846|NCT00902746|454490086|FG000|Overall Study|Physician Decision|2|||
126326847|NCT02081001|454490087|FG000|Overall Study|Adverse Event|0|||
126326848|NCT02081001|454490088|FG001|Overall Study|Adverse Event|0|||
126326849|NCT02081001|454490089|FG002|Overall Study|Adverse Event|0|||
126326850|NCT02081001|454490090|FG003|Overall Study|Adverse Event|0|||
126326851|NCT02081001|454490091|FG004|Overall Study|Adverse Event|1|||
126326852|NCT02081001|454490092|FG005|Overall Study|Adverse Event|0|||
126326853|NCT02081001|454490093|FG006|Overall Study|Adverse Event|0|||
126326854|NCT02081001|454490094|FG007|Overall Study|Adverse Event|0|||
126326855|NCT02081001|454490095|FG008|Overall Study|Adverse Event|0|||
126326856|NCT02081001|454490096|FG009|Overall Study|Adverse Event|0|||
126326857|NCT02081001|454490097|FG010|Overall Study|Adverse Event|0|||
126326858|NCT02081001|454490098|FG011|Overall Study|Adverse Event|0|||
126326859|NCT02588092|454490107|FG000|Overall Study|Death|4|||
126326860|NCT02588092|454490108|FG001|Overall Study|Death|3|||
126326861|NCT02588092|454490109|FG002|Overall Study|Death|3|||
126326862|NCT02588092|454490110|FG003|Overall Study|Death|3|||
126326863|NCT02588092|454490111|FG004|Overall Study|Death|2|||
126326864|NCT02588092|454490112|FG005|Overall Study|Death|2|||
126326865|NCT02588092|454490113|FG006|Overall Study|Death|2|||
126326866|NCT02588092|454490114|FG007|Overall Study|Death|1|||
126326867|NCT02588092|454490115|FG008|Overall Study|Death|5|||
126326868|NCT02588092|454490116|FG009|Overall Study|Death|2|||
126326869|NCT02588092|454490107|FG000|Overall Study|Withdrawal by Subject|0|||
126326870|NCT02588092|454490108|FG001|Overall Study|Withdrawal by Subject|0|||
126326871|NCT02588092|454490109|FG002|Overall Study|Withdrawal by Subject|0|||
126326872|NCT02588092|454490110|FG003|Overall Study|Withdrawal by Subject|0|||
126326873|NCT02588092|454490111|FG004|Overall Study|Withdrawal by Subject|0|||
126326874|NCT02588092|454490112|FG005|Overall Study|Withdrawal by Subject|1|||
126326875|NCT02588092|454490113|FG006|Overall Study|Withdrawal by Subject|1|||
126326876|NCT02588092|454490114|FG007|Overall Study|Withdrawal by Subject|2|||
126326877|NCT02588092|454490115|FG008|Overall Study|Withdrawal by Subject|0|||
126326878|NCT02588092|454490116|FG009|Overall Study|Withdrawal by Subject|0|||
126326879|NCT02588092|454490107|FG000|Overall Study|Started Another Treatment|0|||
126326880|NCT02588092|454490108|FG001|Overall Study|Started Another Treatment|0|||
126326881|NCT02588092|454490109|FG002|Overall Study|Started Another Treatment|0|||
126326882|NCT02588092|454490110|FG003|Overall Study|Started Another Treatment|0|||
126326883|NCT02588092|454490111|FG004|Overall Study|Started Another Treatment|1|||
126326884|NCT02588092|454490112|FG005|Overall Study|Started Another Treatment|0|||
126326885|NCT02588092|454490113|FG006|Overall Study|Started Another Treatment|0|||
126326886|NCT02588092|454490114|FG007|Overall Study|Started Another Treatment|1|||
126326887|NCT02588092|454490115|FG008|Overall Study|Started Another Treatment|0|||
126326888|NCT02588092|454490116|FG009|Overall Study|Started Another Treatment|0|||
126326889|NCT02588092|454490107|FG000|Overall Study|Sponsor Decision|0|||
126326890|NCT02588092|454490108|FG001|Overall Study|Sponsor Decision|0|||
126326891|NCT02588092|454490109|FG002|Overall Study|Sponsor Decision|0|||
126326892|NCT02588092|454490110|FG003|Overall Study|Sponsor Decision|0|||
126326893|NCT02588092|454490111|FG004|Overall Study|Sponsor Decision|0|||
126326894|NCT02588092|454490112|FG005|Overall Study|Sponsor Decision|0|||
126326895|NCT02588092|454490113|FG006|Overall Study|Sponsor Decision|0|||
126326896|NCT02588092|454490114|FG007|Overall Study|Sponsor Decision|0|||
126326897|NCT02588092|454490115|FG008|Overall Study|Sponsor Decision|1|||
126326898|NCT02588092|454490116|FG009|Overall Study|Sponsor Decision|1|||
126326899|NCT01030718|454490117|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
126326900|NCT01030718|454490118|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
126326901|NCT01030718|454490119|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
126326902|NCT01030718|454490117|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
126326903|NCT01030718|454490118|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
126326904|NCT01030718|454490119|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
126326905|NCT01030718|454490117|FG000|Studies CA180-031 and -036 Combined|Death|0|||
126326906|NCT01030718|454490118|FG001|Studies CA180-031 and -036 Combined|Death|1|||
126326907|NCT01030718|454490119|FG002|Studies CA180-031 and -036 Combined|Death|0|||
126326908|NCT01030718|454490117|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
126326909|NCT01030718|454490118|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
126326910|NCT01030718|454490119|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
126326911|NCT01030718|454490117|FG000|Study CA180-036 Only|insufficient effect|1|||
126326912|NCT01030718|454490118|FG001|Study CA180-036 Only|insufficient effect|1|||
126326913|NCT01030718|454490119|FG002|Study CA180-036 Only|insufficient effect|5|||
126326914|NCT01030718|454490117|FG000|Study CA180-036 Only|Adverse Event|2|||
126326915|NCT01030718|454490118|FG001|Study CA180-036 Only|Adverse Event|3|||
126326916|NCT01030718|454490119|FG002|Study CA180-036 Only|Adverse Event|0|||
126326917|NCT01030718|454490117|FG000|Study CA180-036 Only|Death|0|||
126326918|NCT01030718|454490118|FG001|Study CA180-036 Only|Death|1|||
126326919|NCT01030718|454490119|FG002|Study CA180-036 Only|Death|0|||
126326920|NCT01030718|454490117|FG000|Study CA180-036 Only|Other Reasons|0|||
126326921|NCT01030718|454490118|FG001|Study CA180-036 Only|Other Reasons|2|||
126326922|NCT01030718|454490119|FG002|Study CA180-036 Only|Other Reasons|0|||
126326923|NCT00423813|454490122|FG000|Overall Study|Adverse Event|11|||
126326924|NCT00423813|454490123|FG001|Overall Study|Adverse Event|30|||
126326925|NCT00423813|454490124|FG002|Overall Study|Adverse Event|40|||
126326926|NCT00423813|454490122|FG000|Overall Study|Withdrawal by Subject|6|||
126326927|NCT00423813|454490123|FG001|Overall Study|Withdrawal by Subject|8|||
126326928|NCT00423813|454490124|FG002|Overall Study|Withdrawal by Subject|5|||
126326929|NCT00423813|454490122|FG000|Overall Study|Lost to Follow-up|5|||
126326930|NCT00423813|454490123|FG001|Overall Study|Lost to Follow-up|4|||
126326931|NCT00423813|454490124|FG002|Overall Study|Lost to Follow-up|4|||
126326932|NCT00423813|454490122|FG000|Overall Study|Lack of Efficacy|23|||
126326933|NCT00423813|454490123|FG001|Overall Study|Lack of Efficacy|18|||
126326934|NCT00423813|454490124|FG002|Overall Study|Lack of Efficacy|19|||
126326935|NCT00423813|454490122|FG000|Overall Study|Physician Decision|2|||
126326936|NCT00423813|454490123|FG001|Overall Study|Physician Decision|0|||
126326937|NCT00423813|454490124|FG002|Overall Study|Physician Decision|0|||
126326938|NCT00423813|454490122|FG000|Overall Study|Sponsor Decision|0|||
126326939|NCT00423813|454490123|FG001|Overall Study|Sponsor Decision|1|||
126326940|NCT00423813|454490124|FG002|Overall Study|Sponsor Decision|0|||
126326941|NCT00423813|454490122|FG000|Overall Study|Protocol Violation|9|||
126326942|NCT00423813|454490123|FG001|Overall Study|Protocol Violation|4|||
126326943|NCT00423813|454490124|FG002|Overall Study|Protocol Violation|4|||
126326944|NCT00423813|454490122|FG000|Overall Study|Pregnancy|0|||
126326945|NCT00423813|454490123|FG001|Overall Study|Pregnancy|0|||
126326946|NCT00423813|454490124|FG002|Overall Study|Pregnancy|1|||
126326947|NCT00423813|454490122|FG000|Overall Study|Subject started night shift work|1|||
126326948|NCT00423813|454490123|FG001|Overall Study|Subject started night shift work|0|||
126326949|NCT00423813|454490124|FG002|Overall Study|Subject started night shift work|0|||
126326950|NCT00423813|454490122|FG000|Overall Study|Will start exclusionary medications|0|||
126326951|NCT00423813|454490123|FG001|Overall Study|Will start exclusionary medications|1|||
126326952|NCT00423813|454490124|FG002|Overall Study|Will start exclusionary medications|0|||
126326953|NCT00423813|454490122|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
126326954|NCT00423813|454490123|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
126326955|NCT00423813|454490124|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
126326956|NCT01386944|454490126|FG000|Overall Study|Adverse Event|26|||
126326957|NCT01386944|454490126|FG000|Overall Study|Lack of Efficacy|14|||
126326958|NCT01386944|454490126|FG000|Overall Study|Lost to Follow-up|8|||
126326959|NCT01386944|454490126|FG000|Overall Study|Unspecified reason|8|||
126326960|NCT03853291|454490127|FG000|Overall Study|Lost to Follow-up|1|||
126326961|NCT03853291|454490128|FG001|Overall Study|Lost to Follow-up|2|||
126326962|NCT03853291|454490129|FG002|Overall Study|Lost to Follow-up|0|||
126326963|NCT03853291|454490130|FG003|Overall Study|Lost to Follow-up|0|||
126326964|NCT03853291|454490131|FG004|Overall Study|Lost to Follow-up|0|||
126326965|NCT03853291|454490132|FG005|Overall Study|Lost to Follow-up|0|||
126326966|NCT03853291|454490127|FG000|Overall Study|Determined to be ineligible|1|||
126326967|NCT03853291|454490128|FG001|Overall Study|Determined to be ineligible|1|||
126326968|NCT03853291|454490129|FG002|Overall Study|Determined to be ineligible|0|||
126326969|NCT03853291|454490130|FG003|Overall Study|Determined to be ineligible|0|||
126326970|NCT03853291|454490131|FG004|Overall Study|Determined to be ineligible|0|||
126326971|NCT03853291|454490132|FG005|Overall Study|Determined to be ineligible|0|||
126326972|NCT03883477|454490133|FG000|Overall Study|Death|1|||
126326973|NCT03883477|454490134|FG001|Overall Study|Death|0|||
126326974|NCT03883477|454490133|FG000|Overall Study|Protocol Violation|0|||
126326975|NCT03883477|454490134|FG001|Overall Study|Protocol Violation|1|||
126326976|NCT02137226|454490140|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
126326977|NCT02137226|454490141|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
126326978|NCT02137226|454490142|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
126326979|NCT02137226|454490143|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
126326980|NCT02137226|454490144|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
126326981|NCT02137226|454490140|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
126326982|NCT02137226|454490141|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
126326983|NCT02137226|454490142|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
126326984|NCT02137226|454490143|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
126326985|NCT02137226|454490144|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
126326986|NCT02137226|454490140|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
126326987|NCT02137226|454490141|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
126326988|NCT02137226|454490142|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
126326989|NCT02137226|454490143|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
126326990|NCT02137226|454490144|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
126326991|NCT02137226|454490140|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
126326992|NCT02137226|454490141|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
126326993|NCT02137226|454490142|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
126326994|NCT02137226|454490143|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
126326995|NCT02137226|454490144|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
126326996|NCT02137226|454490140|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
126326997|NCT02137226|454490141|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
126326998|NCT02137226|454490142|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
126326999|NCT02137226|454490143|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
126327000|NCT02137226|454490144|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
126327001|NCT02137226|454490140|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
126327002|NCT02137226|454490141|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
126327003|NCT02137226|454490142|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
126327004|NCT02137226|454490143|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
126327005|NCT02137226|454490144|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
126327006|NCT02137226|454490140|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
126327007|NCT02137226|454490141|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
126327008|NCT02137226|454490142|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
126327009|NCT02137226|454490143|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
126327010|NCT02137226|454490144|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
126327011|NCT02137226|454490140|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
126327012|NCT02137226|454490141|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
126327013|NCT02137226|454490142|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
126327014|NCT02137226|454490143|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
126327015|NCT02137226|454490144|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
126327016|NCT02137226|454490140|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
126327017|NCT02137226|454490141|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
126327018|NCT02137226|454490142|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
126327019|NCT02137226|454490143|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
126327020|NCT02137226|454490144|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
126327021|NCT02137226|454490140|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
126327022|NCT02137226|454490141|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
126327023|NCT02137226|454490142|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
126327024|NCT02137226|454490143|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
126327025|NCT02137226|454490144|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
126327026|NCT02137226|454490140|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
126327027|NCT02137226|454490141|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
126327028|NCT02137226|454490142|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
126327029|NCT02137226|454490143|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
126327030|NCT02137226|454490144|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
126327031|NCT02137226|454490140|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
126327032|NCT02137226|454490141|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
126327033|NCT02137226|454490142|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
126327034|NCT02137226|454490143|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
126327035|NCT02137226|454490144|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
126327036|NCT03762681|454490145|FG000|Part 1|Withdrawal by Subject|0|||
126327037|NCT03762681|454490146|FG001|Part 1|Withdrawal by Subject|0|||
126327038|NCT03762681|454490147|FG002|Part 1|Withdrawal by Subject|0|||
126327039|NCT03762681|454490148|FG003|Part 1|Withdrawal by Subject|1|||
126327040|NCT03762681|454490149|FG004|Part 1|Withdrawal by Subject|0|||
126327041|NCT03762681|454490150|FG005|Part 1|Withdrawal by Subject|0|||
126327042|NCT03762681|454490151|FG006|Part 1|Withdrawal by Subject|0|||
126655082|NCT00757588|455695716|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
126655083|NCT00757588|455695715|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
126327043|NCT03762681|454490152|FG007|Part 1|Withdrawal by Subject|0|||
126327044|NCT03762681|454490145|FG000|Part 2a|Pandemic Travel Restrictions|0|||
126327045|NCT03762681|454490146|FG001|Part 2a|Pandemic Travel Restrictions|0|||
126327046|NCT03762681|454490147|FG002|Part 2a|Pandemic Travel Restrictions|0|||
126327047|NCT03762681|454490148|FG003|Part 2a|Pandemic Travel Restrictions|0|||
126327048|NCT03762681|454490149|FG004|Part 2a|Pandemic Travel Restrictions|0|||
126327049|NCT03762681|454490150|FG005|Part 2a|Pandemic Travel Restrictions|0|||
126327050|NCT03762681|454490151|FG006|Part 2a|Pandemic Travel Restrictions|0|||
126327051|NCT03762681|454490152|FG007|Part 2a|Pandemic Travel Restrictions|1|||
126655084|NCT00757588|455695716|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
126655085|NCT00757588|455695715|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
126655086|NCT00757588|455695716|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
126655087|NCT00757588|455695715|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
126655088|NCT00757588|455695716|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
126655089|NCT00757588|455695715|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
126655090|NCT00757588|455695716|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
126655091|NCT00757588|455695715|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
126655092|NCT00757588|455695716|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
126655093|NCT00757588|455695715|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
126655094|NCT00757588|455695716|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
126655095|NCT00757588|455695715|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
126655096|NCT00757588|455695716|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
126655097|NCT00757588|455695715|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
126655098|NCT00757588|455695716|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
126655099|NCT00757588|455695715|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
126655100|NCT00757588|455695716|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
126655101|NCT01052103|455695717|FG000|Overall Study|Adverse Event|10|||
126655102|NCT01052103|455695718|FG001|Overall Study|Adverse Event|6|||
126655103|NCT01052103|455695717|FG000|Overall Study|Entry Criteria Not Met|3|||
126655104|NCT01052103|455695718|FG001|Overall Study|Entry Criteria Not Met|1|||
126655105|NCT01052103|455695717|FG000|Overall Study|Lost to Follow-up|3|||
126655106|NCT01052103|455695718|FG001|Overall Study|Lost to Follow-up|5|||
126655107|NCT01052103|455695717|FG000|Overall Study|Protocol Violation|10|||
126655108|NCT01052103|455695718|FG001|Overall Study|Protocol Violation|4|||
126655109|NCT01052103|455695717|FG000|Overall Study|Scheduling conflict|2|||
126655110|NCT01052103|455695718|FG001|Overall Study|Scheduling conflict|1|||
126655111|NCT01052103|455695717|FG000|Overall Study|Sponsor Decision|2|||
126655112|NCT01052103|455695718|FG001|Overall Study|Sponsor Decision|0|||
126655113|NCT01052103|455695717|FG000|Overall Study|Withdrawal by Subject|3|||
126655114|NCT01052103|455695718|FG001|Overall Study|Withdrawal by Subject|6|||
126655115|NCT01052103|455695717|FG000|Overall Study|Perceived Lack of Efficacy|1|||
126655116|NCT01052103|455695718|FG001|Overall Study|Perceived Lack of Efficacy|0|||
126655117|NCT00545051|455695722|FG000|Overall Study|Adverse Event|7|||
126655118|NCT00545051|455695723|FG001|Overall Study|Adverse Event|3|||
126655119|NCT00545051|455695722|FG000|Overall Study|Death|1|||
126655120|NCT00545051|455695723|FG001|Overall Study|Death|0|||
126655121|NCT00545051|455695722|FG000|Overall Study|Violation of inclusion/exclusion|0|||
126327052|NCT00003896|454490159|FG000|Overall Study|Adverse Event|16|||
126327053|NCT00003896|454490159|FG000|Overall Study|Withdrawal by Subject|1|||
126327054|NCT00003896|454490159|FG000|Overall Study|Lack of Efficacy|1|||
126327055|NCT00003896|454490159|FG000|Overall Study|Death|3|||
126327056|NCT00003896|454490159|FG000|Overall Study|not protocol specified|3|||
126655122|NCT00545051|455695723|FG001|Overall Study|Violation of inclusion/exclusion|2|||
126327057|NCT00003896|454490159|FG000|Overall Study|ineligible|5|||
126327058|NCT01398358|454490160|FG000|Overall Study|Lost to Follow-up|11|||
126655123|NCT00545051|455695722|FG000|Overall Study|Protocol Violation|1|||
126655124|NCT00545051|455695723|FG001|Overall Study|Protocol Violation|0|||
126655125|NCT00545051|455695722|FG000|Overall Study|Withdrawal by Subject|0|||
126655126|NCT00545051|455695723|FG001|Overall Study|Withdrawal by Subject|1|||
126655127|NCT00545051|455695722|FG000|Overall Study|Administrative reasons|0|||
126655128|NCT00545051|455695723|FG001|Overall Study|Administrative reasons|1|||
126655129|NCT05398237|455695724|FG000|Overall Study|Withdrawal by Subject|1|||
126327059|NCT01398358|454490161|FG001|Overall Study|Lost to Follow-up|21|||
126327060|NCT01398358|454490162|FG002|Overall Study|Lost to Follow-up|18|||
126327061|NCT01398358|454490160|FG000|Overall Study|Withdrawal by Subject|3|||
126327062|NCT01398358|454490161|FG001|Overall Study|Withdrawal by Subject|2|||
126327063|NCT01398358|454490162|FG002|Overall Study|Withdrawal by Subject|2|||
126655130|NCT00903006|455695727|FG000|Overall Study|Withdrawal by Subject|2|||
126655131|NCT00903006|455695728|FG001|Overall Study|Withdrawal by Subject|0|||
126655132|NCT00903006|455695729|FG002|Overall Study|Withdrawal by Subject|0|||
126655133|NCT00903006|455695730|FG003|Overall Study|Withdrawal by Subject|0|||
126655134|NCT00903006|455695727|FG000|Overall Study|Progressive Disease|0|||
126655135|NCT00903006|455695728|FG001|Overall Study|Progressive Disease|3|||
126655136|NCT00903006|455695729|FG002|Overall Study|Progressive Disease|1|||
126655137|NCT00903006|455695730|FG003|Overall Study|Progressive Disease|0|||
126327064|NCT01398358|454490160|FG000|Overall Study|no longer eligible|1|||
126327065|NCT01398358|454490161|FG001|Overall Study|no longer eligible|0|||
126327066|NCT01398358|454490162|FG002|Overall Study|no longer eligible|1|||
126327067|NCT00985686|454490164|FG000|Overall Study|Lost to Follow-up|1|||
126655138|NCT03271021|455695734|FG000|Overall Study|Adverse Event|3|||
126655139|NCT03271021|455695735|FG001|Overall Study|Adverse Event|2|||
126655140|NCT03271021|455695734|FG000|Overall Study|Withdrawal by Subject|36|||
126655141|NCT03271021|455695735|FG001|Overall Study|Withdrawal by Subject|53|||
126327068|NCT00985686|454490165|FG001|Overall Study|Lost to Follow-up|1|||
126327069|NCT00985686|454490166|FG002|Overall Study|Lost to Follow-up|0|||
126327070|NCT00985686|454490167|FG003|Overall Study|Lost to Follow-up|2|||
126327071|NCT01670045|454490168|FG000|Overall Study|Withdrawal by Subject|3|||
126327072|NCT01670045|454490168|FG000|Overall Study|Adverse Event|1|||
126655142|NCT03271021|455695734|FG000|Overall Study|Lost to Follow-up|34|||
126655143|NCT03271021|455695735|FG001|Overall Study|Lost to Follow-up|39|||
126655144|NCT03271021|455695734|FG000|Overall Study|Protocol Violation|6|||
126327073|NCT01670045|454490168|FG000|Overall Study|Death|1|||
126327074|NCT01670045|454490168|FG000|Overall Study|Lost to Follow-up|11|||
126327075|NCT02559570|454490170|FG000|Overall Study|Adverse Event|0|||
126327076|NCT02559570|454490171|FG001|Overall Study|Adverse Event|2|||
126327077|NCT02559570|454490172|FG002|Overall Study|Adverse Event|0|||
126327078|NCT02559570|454490173|FG003|Overall Study|Adverse Event|1|||
126327079|NCT02559570|454490174|FG004|Overall Study|Adverse Event|0|||
126327080|NCT02559570|454490170|FG000|Overall Study|Withdrawal of Consent|0|||
126327081|NCT02559570|454490171|FG001|Overall Study|Withdrawal of Consent|0|||
126327082|NCT02559570|454490172|FG002|Overall Study|Withdrawal of Consent|1|||
126327083|NCT02559570|454490173|FG003|Overall Study|Withdrawal of Consent|2|||
126327084|NCT02559570|454490174|FG004|Overall Study|Withdrawal of Consent|1|||
126327085|NCT02559570|454490170|FG000|Overall Study|Lost to Follow-up|1|||
126327086|NCT02559570|454490171|FG001|Overall Study|Lost to Follow-up|0|||
126327087|NCT02559570|454490172|FG002|Overall Study|Lost to Follow-up|0|||
126327088|NCT02559570|454490173|FG003|Overall Study|Lost to Follow-up|0|||
126327089|NCT02559570|454490174|FG004|Overall Study|Lost to Follow-up|0|||
126327090|NCT02559570|454490170|FG000|Overall Study|Protocol Violation|1|||
126327091|NCT02559570|454490171|FG001|Overall Study|Protocol Violation|0|||
126327092|NCT02559570|454490172|FG002|Overall Study|Protocol Violation|0|||
126327093|NCT02559570|454490173|FG003|Overall Study|Protocol Violation|0|||
126327094|NCT02559570|454490174|FG004|Overall Study|Protocol Violation|1|||
126327095|NCT02559570|454490170|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126327096|NCT02559570|454490171|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126327097|NCT02559570|454490172|FG002|Overall Study|Other Miscellaneous Reasons|1|||
126327098|NCT02559570|454490173|FG003|Overall Study|Other Miscellaneous Reasons|0|||
126655145|NCT03271021|455695735|FG001|Overall Study|Protocol Violation|4|||
126655146|NCT03271021|455695734|FG000|Overall Study|Abnormal Lab Results|1|||
126655147|NCT03271021|455695735|FG001|Overall Study|Abnormal Lab Results|0|||
126327099|NCT02559570|454490174|FG004|Overall Study|Other Miscellaneous Reasons|0|||
126327100|NCT00396383|454490177|FG000|Overall Study|Death|2|||
126327101|NCT00396383|454490177|FG000|Overall Study|Lost to Follow-up|1|||
126327102|NCT00585325|454490178|FG000|Overall Study|Withdrawal by Subject|1|||
126327103|NCT00585325|454490179|FG001|Overall Study|Withdrawal by Subject|1|||
126327104|NCT00334295|454490180|FG000|Overall Study|Patients received fewer than 3 injection|5|||
126327105|NCT02526160|454492305|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
126327106|NCT02526160|454492306|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
126327107|NCT02526160|454492305|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
126327108|NCT02526160|454492306|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
126655148|NCT03271021|455695734|FG000|Overall Study|Miscellaneous|9|||
126327109|NCT02526160|454492305|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
126327110|NCT02526160|454492306|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
126327111|NCT02526160|454492305|FG000|Open-Label Treatment Extension Period I|Death|0|||
126327112|NCT02526160|454492306|FG001|Open-Label Treatment Extension Period I|Death|1|||
126327113|NCT02526160|454492305|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
126327114|NCT02526160|454492306|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
126327115|NCT02526160|454492305|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
126327116|NCT02526160|454492306|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
126327117|NCT02526160|454492305|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
126327118|NCT02526160|454492306|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
126327119|NCT02526160|454492305|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
126327120|NCT02526160|454492306|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
126327121|NCT02576977|454492307|FG000|Overall Study|Adverse Event|13|||
126327122|NCT02576977|454492308|FG001|Overall Study|Adverse Event|2|||
126327123|NCT02576977|454492307|FG000|Overall Study|Death|73|||
126327124|NCT02576977|454492308|FG001|Overall Study|Death|60|||
126327125|NCT02576977|454492307|FG000|Overall Study|Screen failure|1|||
126327126|NCT02576977|454492308|FG001|Overall Study|Screen failure|0|||
126327127|NCT02576977|454492307|FG000|Overall Study|Study Terminated at Selected Sites|27|||
126327128|NCT02576977|454492308|FG001|Overall Study|Study Terminated at Selected Sites|50|||
126327129|NCT02576977|454492307|FG000|Overall Study|Withdrawal by Subject|11|||
126327130|NCT02576977|454492308|FG001|Overall Study|Withdrawal by Subject|11|||
126327131|NCT02576977|454492307|FG000|Overall Study|Final Disposition Unknown|0|||
126327132|NCT02576977|454492308|FG001|Overall Study|Final Disposition Unknown|1|||
126327133|NCT02576977|454492307|FG000|Overall Study|Lost to Follow-up|1|||
126327134|NCT02576977|454492308|FG001|Overall Study|Lost to Follow-up|0|||
126327135|NCT02576977|454492307|FG000|Overall Study|Progressive Disease|0|||
126327136|NCT02576977|454492308|FG001|Overall Study|Progressive Disease|1|||
126327137|NCT04727528|454492309|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
126327138|NCT04727528|454492310|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
126327139|NCT04727528|454492309|FG000|Open-label Period|Randomized who did not receive treatment|1|||
126327140|NCT04727528|454492310|FG001|Open-label Period|Randomized who did not receive treatment|0|||
126327141|NCT04727528|454492309|FG000|Double-blind Treatment Phase|Adverse Event|0|||
126327142|NCT04727528|454492310|FG001|Double-blind Treatment Phase|Adverse Event|1|||
126327143|NCT04727528|454492309|FG000|Double-blind Treatment Phase|Death|0|||
126327144|NCT04727528|454492310|FG001|Double-blind Treatment Phase|Death|1|||
126327145|NCT04727528|454492309|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
126327146|NCT04727528|454492310|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
126327147|NCT04727528|454492309|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
126327148|NCT04727528|454492310|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
126327149|NCT04727528|454492309|FG000|Double-blind Treatment Phase|Physician Decision|0|||
126327150|NCT04727528|454492310|FG001|Double-blind Treatment Phase|Physician Decision|1|||
126327151|NCT04727528|454492309|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
126327152|NCT04727528|454492310|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126327153|NCT01763827|454492311|FG000|Overall Study|Withdrawal by Subject|1|||
126327154|NCT01763827|454492312|FG001|Overall Study|Withdrawal by Subject|0|||
126327155|NCT01763827|454492313|FG002|Overall Study|Withdrawal by Subject|0|||
126327156|NCT01763827|454492314|FG003|Overall Study|Withdrawal by Subject|0|||
126327157|NCT01763827|454492315|FG004|Overall Study|Withdrawal by Subject|2|||
126327158|NCT01763827|454492316|FG005|Overall Study|Withdrawal by Subject|0|||
126327159|NCT01763827|454492311|FG000|Overall Study|Decision by sponsor|2|||
126327160|NCT01763827|454492312|FG001|Overall Study|Decision by sponsor|0|||
126327161|NCT01763827|454492313|FG002|Overall Study|Decision by sponsor|3|||
126327162|NCT01763827|454492314|FG003|Overall Study|Decision by sponsor|0|||
126327163|NCT01763827|454492315|FG004|Overall Study|Decision by sponsor|2|||
126327164|NCT01763827|454492316|FG005|Overall Study|Decision by sponsor|1|||
126327165|NCT01763827|454492311|FG000|Overall Study|Lost to Follow-up|0|||
126327166|NCT01763827|454492312|FG001|Overall Study|Lost to Follow-up|1|||
126327167|NCT01763827|454492313|FG002|Overall Study|Lost to Follow-up|1|||
126327168|NCT01763827|454492314|FG003|Overall Study|Lost to Follow-up|1|||
126327169|NCT01763827|454492315|FG004|Overall Study|Lost to Follow-up|2|||
126327170|NCT01763827|454492316|FG005|Overall Study|Lost to Follow-up|1|||
126327171|NCT02906579|454492317|FG000|Overall Study|Adverse Event|1|||
126327172|NCT02906579|454492317|FG000|Overall Study|Physician Decision|1|||
126327173|NCT01826981|454492318|FG000|Overall Study|Lack of Efficacy|0|||
126327174|NCT01826981|454492319|FG001|Overall Study|Lack of Efficacy|1|||
126327175|NCT01826981|454492320|FG002|Overall Study|Lack of Efficacy|0|||
126327176|NCT01826981|454492321|FG003|Overall Study|Lack of Efficacy|0|||
126327177|NCT01826981|454492322|FG004|Overall Study|Lack of Efficacy|5|||
126327178|NCT01826981|454492323|FG005|Overall Study|Lack of Efficacy|0|||
126327179|NCT01826981|454492324|FG006|Overall Study|Lack of Efficacy|0|||
126327180|NCT01826981|454492325|FG007|Overall Study|Lack of Efficacy|8|||
126327181|NCT01826981|454492326|FG008|Overall Study|Lack of Efficacy|7|||
126327182|NCT01826981|454492327|FG009|Overall Study|Lack of Efficacy|0|||
126327183|NCT01826981|454492328|FG010|Overall Study|Lack of Efficacy|1|||
126327184|NCT01826981|454492329|FG011|Overall Study|Lack of Efficacy|0|||
126327185|NCT01826981|454492330|FG012|Overall Study|Lack of Efficacy|0|||
126327186|NCT01826981|454492331|FG013|Overall Study|Lack of Efficacy|3|||
126327187|NCT01826981|454492332|FG014|Overall Study|Lack of Efficacy|0|||
126327188|NCT01826981|454492318|FG000|Overall Study|Lost to Follow-up|0|||
126327189|NCT01826981|454492319|FG001|Overall Study|Lost to Follow-up|0|||
126327190|NCT01826981|454492320|FG002|Overall Study|Lost to Follow-up|0|||
126327191|NCT01826981|454492321|FG003|Overall Study|Lost to Follow-up|0|||
126327192|NCT01826981|454492322|FG004|Overall Study|Lost to Follow-up|1|||
126327193|NCT01826981|454492323|FG005|Overall Study|Lost to Follow-up|1|||
126327194|NCT01826981|454492324|FG006|Overall Study|Lost to Follow-up|0|||
126327195|NCT01826981|454492325|FG007|Overall Study|Lost to Follow-up|1|||
126327196|NCT01826981|454492326|FG008|Overall Study|Lost to Follow-up|0|||
126327197|NCT01826981|454492327|FG009|Overall Study|Lost to Follow-up|1|||
126327198|NCT01826981|454492328|FG010|Overall Study|Lost to Follow-up|1|||
126327199|NCT01826981|454492329|FG011|Overall Study|Lost to Follow-up|1|||
126327200|NCT01826981|454492330|FG012|Overall Study|Lost to Follow-up|1|||
126327201|NCT01826981|454492331|FG013|Overall Study|Lost to Follow-up|0|||
126327202|NCT01826981|454492332|FG014|Overall Study|Lost to Follow-up|0|||
126327203|NCT01826981|454492318|FG000|Overall Study|Withdrew Consent|0|||
126327204|NCT01826981|454492319|FG001|Overall Study|Withdrew Consent|0|||
126327205|NCT01826981|454492320|FG002|Overall Study|Withdrew Consent|0|||
126327206|NCT01826981|454492321|FG003|Overall Study|Withdrew Consent|0|||
126327207|NCT01826981|454492322|FG004|Overall Study|Withdrew Consent|0|||
126327208|NCT01826981|454492323|FG005|Overall Study|Withdrew Consent|0|||
126327209|NCT01826981|454492324|FG006|Overall Study|Withdrew Consent|1|||
126327210|NCT01826981|454492325|FG007|Overall Study|Withdrew Consent|1|||
126327211|NCT01826981|454492326|FG008|Overall Study|Withdrew Consent|0|||
126327212|NCT01826981|454492327|FG009|Overall Study|Withdrew Consent|0|||
126327213|NCT01826981|454492328|FG010|Overall Study|Withdrew Consent|0|||
126327214|NCT01826981|454492329|FG011|Overall Study|Withdrew Consent|1|||
126327215|NCT01826981|454492330|FG012|Overall Study|Withdrew Consent|0|||
126327216|NCT01826981|454492331|FG013|Overall Study|Withdrew Consent|1|||
126327217|NCT01826981|454492332|FG014|Overall Study|Withdrew Consent|0|||
126327218|NCT01826981|454492318|FG000|Overall Study|Adverse Event|0|||
126327219|NCT01826981|454492319|FG001|Overall Study|Adverse Event|0|||
126327220|NCT01826981|454492320|FG002|Overall Study|Adverse Event|0|||
126327221|NCT01826981|454492321|FG003|Overall Study|Adverse Event|0|||
126327222|NCT01826981|454492322|FG004|Overall Study|Adverse Event|1|||
126327223|NCT01826981|454492323|FG005|Overall Study|Adverse Event|0|||
126327224|NCT01826981|454492324|FG006|Overall Study|Adverse Event|0|||
126327225|NCT01826981|454492325|FG007|Overall Study|Adverse Event|0|||
126327226|NCT01826981|454492326|FG008|Overall Study|Adverse Event|0|||
126327227|NCT01826981|454492327|FG009|Overall Study|Adverse Event|0|||
126327228|NCT01826981|454492328|FG010|Overall Study|Adverse Event|0|||
126327229|NCT01826981|454492329|FG011|Overall Study|Adverse Event|0|||
126327230|NCT01826981|454492330|FG012|Overall Study|Adverse Event|0|||
126327231|NCT01826981|454492331|FG013|Overall Study|Adverse Event|0|||
126327232|NCT01826981|454492332|FG014|Overall Study|Adverse Event|0|||
126327233|NCT01826981|454492318|FG000|Overall Study|Upper G-I Haemorrhage|0|||
126327234|NCT01826981|454492319|FG001|Overall Study|Upper G-I Haemorrhage|0|||
126327235|NCT01826981|454492320|FG002|Overall Study|Upper G-I Haemorrhage|0|||
126327236|NCT01826981|454492321|FG003|Overall Study|Upper G-I Haemorrhage|0|||
126327237|NCT01826981|454492322|FG004|Overall Study|Upper G-I Haemorrhage|0|||
126327238|NCT01826981|454492323|FG005|Overall Study|Upper G-I Haemorrhage|0|||
126327239|NCT01826981|454492324|FG006|Overall Study|Upper G-I Haemorrhage|0|||
126327240|NCT01826981|454492325|FG007|Overall Study|Upper G-I Haemorrhage|0|||
126327241|NCT01826981|454492326|FG008|Overall Study|Upper G-I Haemorrhage|0|||
126327242|NCT01826981|454492327|FG009|Overall Study|Upper G-I Haemorrhage|0|||
126327243|NCT01826981|454492328|FG010|Overall Study|Upper G-I Haemorrhage|0|||
126327244|NCT01826981|454492329|FG011|Overall Study|Upper G-I Haemorrhage|0|||
126327245|NCT01826981|454492330|FG012|Overall Study|Upper G-I Haemorrhage|0|||
126327246|NCT01826981|454492331|FG013|Overall Study|Upper G-I Haemorrhage|1|||
126327247|NCT01826981|454492332|FG014|Overall Study|Upper G-I Haemorrhage|0|||
126327248|NCT01826981|454492318|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327249|NCT01826981|454492319|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327250|NCT01826981|454492320|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327251|NCT01826981|454492321|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327252|NCT01826981|454492322|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327253|NCT01826981|454492323|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327254|NCT01826981|454492324|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327255|NCT01826981|454492325|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
126327256|NCT01826981|454492326|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327257|NCT01826981|454492327|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327258|NCT01826981|454492328|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327259|NCT01826981|454492329|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327260|NCT01826981|454492330|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327261|NCT01826981|454492331|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327262|NCT01826981|454492332|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
126327263|NCT02030119|454492337|FG000|Overall Study|Withdrawal by Subject|3|||
126327264|NCT02030119|454492338|FG001|Overall Study|Withdrawal by Subject|1|||
126327265|NCT02030119|454492339|FG002|Overall Study|Withdrawal by Subject|5|||
126327266|NCT02030119|454492340|FG003|Overall Study|Withdrawal by Subject|3|||
126327267|NCT02030119|454492337|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
126327268|NCT02030119|454492338|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
126327269|NCT02030119|454492339|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
126327270|NCT02030119|454492340|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
126327271|NCT00759655|454492341|FG000|Overall Study|Termination of the study by sponsor|1|||
126327272|NCT02793947|454492342|FG000|Overall Study|Death|1|||
126327273|NCT02793947|454492343|FG001|Overall Study|Death|0|||
126327274|NCT02793947|454492342|FG000|Overall Study|Physician Decision|1|||
126327275|NCT02793947|454492343|FG001|Overall Study|Physician Decision|5|||
126327276|NCT03746405|454492351|FG000|Overall Study|Withdrawal by Subject|3|||
126327277|NCT03746405|454492352|FG001|Overall Study|Withdrawal by Subject|0|||
126327278|NCT03746405|454492351|FG000|Overall Study|technical difficulties|0|||
126327279|NCT03746405|454492352|FG001|Overall Study|technical difficulties|2|||
126327280|NCT03479008|454492353|FG000|Overall Study|Withdrawal by Subject|3|||
126327281|NCT00412932|454492354|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
126327282|NCT00412932|454492354|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
126327283|NCT00412932|454492354|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
126327284|NCT00412932|454492354|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
126327285|NCT00412932|454492354|FG000|Olmesartan (Olm) 20 mg|Other|1|||
126327286|NCT00412932|454492354|FG000|Olmesartan 40 mg|Adverse Event|4|||
126327287|NCT00412932|454492354|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
126327288|NCT00412932|454492354|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
126327289|NCT00412932|454492354|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
126327290|NCT00412932|454492354|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
126327291|NCT00412932|454492354|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
126327292|NCT00412932|454492354|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
126327293|NCT02753816|454492356|FG000|Overall Study|Protocol Violation|0|||
126327294|NCT02753816|454492357|FG001|Overall Study|Protocol Violation|1|||
126327295|NCT02753816|454492358|FG002|Overall Study|Protocol Violation|0|||
126327296|NCT01465230|454492359|FG000|Overall Study|Withdrawal by Subject|2|||
126327297|NCT00547248|454492364|FG000|Overall Study|Protocol Violation|0|||
126327298|NCT00547248|454492365|FG001|Overall Study|Protocol Violation|0|||
126327299|NCT00547248|454492366|FG002|Overall Study|Protocol Violation|1|||
126327300|NCT00547248|454492367|FG003|Overall Study|Protocol Violation|1|||
126327301|NCT00547248|454492364|FG000|Overall Study|Migrated/moved from study area|0|||
126327302|NCT00547248|454492365|FG001|Overall Study|Migrated/moved from study area|0|||
126327303|NCT00547248|454492366|FG002|Overall Study|Migrated/moved from study area|2|||
126327304|NCT00547248|454492367|FG003|Overall Study|Migrated/moved from study area|0|||
126327305|NCT00547248|454492364|FG000|Overall Study|Withdrawal by Subject|0|||
126327306|NCT00547248|454492365|FG001|Overall Study|Withdrawal by Subject|0|||
126327307|NCT00547248|454492366|FG002|Overall Study|Withdrawal by Subject|7|||
126327308|NCT00547248|454492367|FG003|Overall Study|Withdrawal by Subject|1|||
126327309|NCT00534248|454492368|FG000|Overall Study|Adverse Event|19|||
126327310|NCT00534248|454492369|FG001|Overall Study|Adverse Event|29|||
126327311|NCT00534248|454492368|FG000|Overall Study|Lost to Follow-up|353|||
126327312|NCT00534248|454492369|FG001|Overall Study|Lost to Follow-up|375|||
126327313|NCT00534248|454492368|FG000|Overall Study|Other protocol specified criteria|13|||
126327314|NCT00534248|454492369|FG001|Overall Study|Other protocol specified criteria|3|||
126327315|NCT00534248|454492368|FG000|Overall Study|Physician Decision|10|||
126327316|NCT00534248|454492369|FG001|Overall Study|Physician Decision|7|||
126327317|NCT00534248|454492368|FG000|Overall Study|Protocol Violation|3|||
126327318|NCT00534248|454492369|FG001|Overall Study|Protocol Violation|4|||
126327319|NCT00534248|454492368|FG000|Overall Study|Withdrawal by Subject|263|||
126327320|NCT00534248|454492369|FG001|Overall Study|Withdrawal by Subject|255|||
126327321|NCT02849171|454492372|FG000|Overall Study|Withdrawal by Subject|1|||
126327322|NCT02849171|454492372|FG000|Overall Study|Not treated|1|||
126327323|NCT02532257|454492373|FG000|Overall Study|Adverse Event|2|||
126327324|NCT02532257|454492373|FG000|Overall Study|Physician Decision|4|||
126327325|NCT02532257|454492373|FG000|Overall Study|Withdrawal by Subject|3|||
126327326|NCT02532257|454492373|FG000|Overall Study|Progressive Disease|10|||
126327327|NCT02259400|454492376|FG000|Overall Study|Death|0|||
126327328|NCT02259400|454492377|FG001|Overall Study|Death|2|||
126327329|NCT00697593|454492379|FG000|Overall Study|Adverse Event|3|||
126327330|NCT00697593|454492379|FG000|Overall Study|Protocol Violation|1|||
126327331|NCT00697593|454492379|FG000|Overall Study|Lack of Efficacy|3|||
126327332|NCT00697593|454492379|FG000|Overall Study|Suspension of the study by sponsor|12|||
126327333|NCT02964338|454492380|FG000|Overall Study|Sponsor terminated study for futility|12|||
126327334|NCT02964338|454492381|FG001|Overall Study|Sponsor terminated study for futility|15|||
126327335|NCT02964338|454492382|FG002|Overall Study|Sponsor terminated study for futility|14|||
126327336|NCT02964338|454492380|FG000|Overall Study|Lack of Efficacy|0|||
126327337|NCT02964338|454492381|FG001|Overall Study|Lack of Efficacy|3|||
126327338|NCT02964338|454492382|FG002|Overall Study|Lack of Efficacy|0|||
126327339|NCT02964338|454492380|FG000|Overall Study|Lost to Follow-up|1|||
126327340|NCT02964338|454492381|FG001|Overall Study|Lost to Follow-up|0|||
126327341|NCT02964338|454492382|FG002|Overall Study|Lost to Follow-up|3|||
126327342|NCT02964338|454492380|FG000|Overall Study|Protocol Violation|0|||
126327343|NCT02964338|454492381|FG001|Overall Study|Protocol Violation|1|||
126327344|NCT02964338|454492382|FG002|Overall Study|Protocol Violation|0|||
126327345|NCT02964338|454492380|FG000|Overall Study|Withdrawal by Subject|1|||
126327346|NCT02964338|454492381|FG001|Overall Study|Withdrawal by Subject|3|||
126327347|NCT02964338|454492382|FG002|Overall Study|Withdrawal by Subject|1|||
126327348|NCT02964338|454492380|FG000|Overall Study|Adverse Event|2|||
126327349|NCT02964338|454492381|FG001|Overall Study|Adverse Event|1|||
126327350|NCT02964338|454492382|FG002|Overall Study|Adverse Event|1|||
126327351|NCT02964338|454492380|FG000|Overall Study|Non-compliant with e-diary|0|||
126327352|NCT02964338|454492381|FG001|Overall Study|Non-compliant with e-diary|1|||
126327353|NCT02964338|454492382|FG002|Overall Study|Non-compliant with e-diary|0|||
126327354|NCT02964338|454492380|FG000|Overall Study|Did not meet criteria|1|||
126327355|NCT02964338|454492381|FG001|Overall Study|Did not meet criteria|0|||
126327356|NCT02964338|454492382|FG002|Overall Study|Did not meet criteria|0|||
126327357|NCT02372383|454492386|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
126327358|NCT02372383|454492387|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
126327359|NCT02372383|454492388|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
126327360|NCT01704755|454492392|FG000|Overall Study|Adverse Event|4|||
126327361|NCT01704755|454492393|FG001|Overall Study|Adverse Event|1|||
126327362|NCT01704755|454492392|FG000|Overall Study|Lost to Follow-up|3|||
126327363|NCT01704755|454492393|FG001|Overall Study|Lost to Follow-up|4|||
126327364|NCT01704755|454492392|FG000|Overall Study|Withdrew consent|1|||
126327365|NCT01704755|454492393|FG001|Overall Study|Withdrew consent|1|||
126327366|NCT01704755|454492392|FG000|Overall Study|Other (not specified)|3|||
126327367|NCT01704755|454492393|FG001|Overall Study|Other (not specified)|1|||
126327368|NCT01704755|454492392|FG000|Overall Study|Withdrew consent and personal issues|1|||
126327369|NCT01704755|454492393|FG001|Overall Study|Withdrew consent and personal issues|0|||
126327370|NCT04105842|454492394|FG000|Overall Study|Withdrawal by Subject|2|||
126327371|NCT01639703|454492395|FG000|Overall Study|Withdrawal by Subject|5|||
126327372|NCT01639703|454492395|FG000|Overall Study|Other reason|7|||
126327373|NCT02087670|454492396|FG000|Overall Study|Withdrawal by Subject|3|||
126327374|NCT02087670|454492397|FG001|Overall Study|Withdrawal by Subject|2|||
126327375|NCT01042392|454492398|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
126327376|NCT01042392|454492399|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
126327377|NCT01042392|454492400|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
126327378|NCT01042392|454492401|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
126327379|NCT01042392|454492398|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
126327380|NCT01042392|454492399|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
126327381|NCT01042392|454492400|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
126327382|NCT01042392|454492401|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
126327383|NCT01042392|454492398|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
126327384|NCT01042392|454492399|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
126327385|NCT01042392|454492400|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
126327386|NCT01042392|454492401|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
126327387|NCT01042392|454492398|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
126327388|NCT01042392|454492399|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
126327389|NCT01042392|454492400|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
126327390|NCT01042392|454492401|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
126327391|NCT01042392|454492398|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
126327392|NCT01042392|454492399|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
126327393|NCT01042392|454492400|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
126327394|NCT01042392|454492401|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
126327395|NCT01042392|454492398|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
126327396|NCT01042392|454492399|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
126327397|NCT01042392|454492400|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
126327398|NCT01042392|454492401|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
126327399|NCT01042392|454492398|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
126327400|NCT01042392|454492399|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
126327401|NCT01042392|454492400|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
126327402|NCT01042392|454492401|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
126327403|NCT01042392|454492398|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
126327404|NCT01042392|454492399|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
126327405|NCT01042392|454492400|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
126327406|NCT01042392|454492401|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
126327407|NCT01042392|454492398|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
126327408|NCT01042392|454492399|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
126327409|NCT01042392|454492400|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
126327410|NCT01042392|454492401|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
126327411|NCT00587795|454492402|FG000|Overall Study|Withdrawal by Subject|1|||
126327412|NCT00587795|454492403|FG001|Overall Study|Withdrawal by Subject|0|||
126327413|NCT02869893|454492408|FG000|Overall Study|participant aversion to IV|5|||
126327414|NCT02869893|454492408|FG000|Overall Study|participant fear of MRI scanner|2|||
126327415|NCT00551525|454492413|FG000|Overall Study|Protocol Violation|5|||
126327416|NCT04676724|454492414|FG000|Overall Study|Adverse Event|2|||
126327417|NCT04676724|454492415|FG001|Overall Study|Adverse Event|0|||
126327418|NCT04676724|454492414|FG000|Overall Study|Lost to Follow-up|1|||
126327419|NCT04676724|454492415|FG001|Overall Study|Lost to Follow-up|0|||
126327420|NCT04676724|454492414|FG000|Overall Study|Physician Decision|0|||
126327421|NCT04676724|454492415|FG001|Overall Study|Physician Decision|1|||
126327422|NCT04676724|454492414|FG000|Overall Study|Withdrawal by Subject|3|||
126327423|NCT04676724|454492415|FG001|Overall Study|Withdrawal by Subject|2|||
126327424|NCT00099632|454492428|FG000|Overall Study|Lost to Follow-up|1|||
126327425|NCT00099632|454492429|FG001|Overall Study|Lost to Follow-up|0|||
126327426|NCT00099632|454492430|FG002|Overall Study|Lost to Follow-up|3|||
126327427|NCT00099632|454492431|FG003|Overall Study|Lost to Follow-up|1|||
126327428|NCT00099632|454492432|FG004|Overall Study|Lost to Follow-up|1|||
126327429|NCT00099632|454492433|FG005|Overall Study|Lost to Follow-up|0|||
126327430|NCT00099632|454492428|FG000|Overall Study|Withdrawal by Subject|0|||
126327431|NCT00099632|454492429|FG001|Overall Study|Withdrawal by Subject|1|||
126327432|NCT00099632|454492430|FG002|Overall Study|Withdrawal by Subject|0|||
126327433|NCT00099632|454492431|FG003|Overall Study|Withdrawal by Subject|0|||
126327434|NCT00099632|454492432|FG004|Overall Study|Withdrawal by Subject|0|||
126327435|NCT00099632|454492433|FG005|Overall Study|Withdrawal by Subject|1|||
126327436|NCT00099632|454492428|FG000|Overall Study|Protocol Violation|0|||
126327437|NCT00099632|454492429|FG001|Overall Study|Protocol Violation|0|||
126327438|NCT00099632|454492430|FG002|Overall Study|Protocol Violation|0|||
126327439|NCT00099632|454492431|FG003|Overall Study|Protocol Violation|0|||
126327440|NCT00099632|454492432|FG004|Overall Study|Protocol Violation|0|||
126327441|NCT00099632|454492433|FG005|Overall Study|Protocol Violation|1|||
126327442|NCT02710084|454492441|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
126327443|NCT02710084|454492442|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
126327444|NCT05305989|454492443|FG000|Overall Study|Other|3|||
126327445|NCT05305989|454492444|FG001|Overall Study|Other|2|||
126327446|NCT05305989|454492445|FG002|Overall Study|Other|0|||
126327447|NCT05305989|454492443|FG000|Overall Study|Sponsor decision|2|||
126327448|NCT05305989|454492444|FG001|Overall Study|Sponsor decision|1|||
126327449|NCT05305989|454492445|FG002|Overall Study|Sponsor decision|0|||
126327450|NCT05305989|454492443|FG000|Overall Study|Protocol Violation|0|||
126327451|NCT05305989|454492444|FG001|Overall Study|Protocol Violation|1|||
126327452|NCT05305989|454492445|FG002|Overall Study|Protocol Violation|0|||
126327453|NCT05305989|454492443|FG000|Overall Study|Investigator decision|1|||
126327454|NCT05305989|454492444|FG001|Overall Study|Investigator decision|2|||
126327455|NCT05305989|454492445|FG002|Overall Study|Investigator decision|0|||
126327456|NCT05305989|454492443|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
126327457|NCT05305989|454492444|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
126327458|NCT05305989|454492445|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
126327459|NCT05305989|454492443|FG000|Overall Study|Adverse Event|1|||
126327460|NCT05305989|454492444|FG001|Overall Study|Adverse Event|1|||
126327461|NCT05305989|454492445|FG002|Overall Study|Adverse Event|0|||
126327462|NCT05305989|454492443|FG000|Overall Study|Enrolled but never dosed|3|||
126327463|NCT05305989|454492444|FG001|Overall Study|Enrolled but never dosed|2|||
126327464|NCT05305989|454492445|FG002|Overall Study|Enrolled but never dosed|1|||
126327465|NCT00282152|454492446|FG000|Overall Study|Withdrawal by Subject|1|||
126327466|NCT00282152|454492447|FG001|Overall Study|Withdrawal by Subject|0|||
126327467|NCT03301831|454492448|FG000|Overall Study|Lost to Follow-up|5|||
126327468|NCT03301831|454492449|FG001|Overall Study|Lost to Follow-up|3|||
126327469|NCT03301831|454492448|FG000|Overall Study|Protocol Violation|4|||
126327470|NCT03301831|454492449|FG001|Overall Study|Protocol Violation|0|||
126327471|NCT03301831|454492448|FG000|Overall Study|Withdrawal by Subject|11|||
126327472|NCT03301831|454492449|FG001|Overall Study|Withdrawal by Subject|0|||
126327473|NCT02182830|454492451|FG000|Overall Study|Not Treated|1|||
126327474|NCT02182830|454492452|FG001|Overall Study|Not Treated|1|||
126327475|NCT02182830|454492451|FG000|Overall Study|Trial stopped, reason missing|3|||
126327476|NCT02182830|454492452|FG001|Overall Study|Trial stopped, reason missing|3|||
126327477|NCT02182830|454492451|FG000|Overall Study|Consent withdrawn|8|||
126327478|NCT02182830|454492452|FG001|Overall Study|Consent withdrawn|8|||
126327479|NCT02182830|454492451|FG000|Overall Study|Lost to Follow-up|3|||
126327480|NCT02182830|454492452|FG001|Overall Study|Lost to Follow-up|3|||
126327481|NCT02348008|454492453|FG000|Overall Study|Adverse Event|2|||
126327482|NCT02348008|454492454|FG001|Overall Study|Adverse Event|3|||
126327483|NCT02348008|454492455|FG002|Overall Study|Adverse Event|3|||
126327484|NCT02348008|454492453|FG000|Overall Study|Disease Progression|1|||
126327485|NCT02348008|454492454|FG001|Overall Study|Disease Progression|5|||
126327486|NCT02348008|454492455|FG002|Overall Study|Disease Progression|16|||
126327487|NCT02348008|454492453|FG000|Overall Study|Withdrawal by Subject|0|||
126327488|NCT02348008|454492454|FG001|Overall Study|Withdrawal by Subject|1|||
126327489|NCT02348008|454492455|FG002|Overall Study|Withdrawal by Subject|0|||
126327490|NCT02348008|454492453|FG000|Overall Study|Symptomatic Deterioration|0|||
126327491|NCT02348008|454492454|FG001|Overall Study|Symptomatic Deterioration|1|||
126327492|NCT02348008|454492455|FG002|Overall Study|Symptomatic Deterioration|0|||
126327493|NCT03268005|454492460|FG000|Overall Study|Death|2|||
126327494|NCT03268005|454492461|FG001|Overall Study|Death|1|||
126327495|NCT03268005|454492460|FG000|Overall Study|Lost to Follow-up|2|||
126327496|NCT03268005|454492461|FG001|Overall Study|Lost to Follow-up|2|||
126327497|NCT03268005|454492460|FG000|Overall Study|Withdrawal by Subject|11|||
126327498|NCT03268005|454492461|FG001|Overall Study|Withdrawal by Subject|11|||
126327499|NCT00792116|454492464|FG000|Overall Study|Lost to Follow-up|0|||
126327500|NCT00792116|454492465|FG001|Overall Study|Lost to Follow-up|1|||
126327501|NCT00792116|454492464|FG000|Overall Study|Discontnued intervention|1|||
126327502|NCT00792116|454492465|FG001|Overall Study|Discontnued intervention|0|||
126327503|NCT00845676|454492468|FG000|Overall Study|Virologic breakthrough at week 20|1|||
126327504|NCT00845676|454492468|FG000|Overall Study|Adverse Event|1|||
126327505|NCT00481767|454492469|FG000|Overall Study|Withdrawal by Subject|16|||
126327506|NCT00481767|454492470|FG001|Overall Study|Withdrawal by Subject|11|||
126327507|NCT00481767|454492469|FG000|Overall Study|Lost to Follow-up|16|||
126327508|NCT00481767|454492470|FG001|Overall Study|Lost to Follow-up|10|||
126327509|NCT03630705|454494052|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
126327510|NCT03630705|454494053|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
126327511|NCT03630705|454494054|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
126327512|NCT03630705|454494055|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126327513|NCT03630705|454494052|FG000|Overall Study|Lost to Follow-up|1|||
126327514|NCT03630705|454494053|FG001|Overall Study|Lost to Follow-up|2|||
126327515|NCT03630705|454494054|FG002|Overall Study|Lost to Follow-up|0|||
126327516|NCT03630705|454494055|FG003|Overall Study|Lost to Follow-up|0|||
126327517|NCT01310127|454494056|FG000|Overall Study|Protocol Violation|1|||
126327518|NCT01310127|454494057|FG001|Overall Study|Protocol Violation|1|||
126327519|NCT01310127|454494056|FG000|Overall Study|advanced psc cataract outlier|1|||
126327520|NCT01310127|454494057|FG001|Overall Study|advanced psc cataract outlier|0|||
126327521|NCT01490840|454494058|FG000|Phase 1|Lost to Follow-up|1|||
126327522|NCT01490840|454494059|FG001|Phase 1|Lost to Follow-up|0|||
126327523|NCT01490840|454494058|FG000|Phase 1|Adverse Event|2|||
126327524|NCT01490840|454494059|FG001|Phase 1|Adverse Event|1|||
126327525|NCT01490840|454494058|FG000|Phase 1|Withdrawal by Subject|6|||
126327526|NCT01490840|454494059|FG001|Phase 1|Withdrawal by Subject|5|||
126327527|NCT01490840|454494058|FG000|Phase 1|Visit 6a omitted|1|||
126327528|NCT01490840|454494059|FG001|Phase 1|Visit 6a omitted|0|||
126327529|NCT01490840|454494058|FG000|Phase 2|Withdrawal by Subject|4|||
126327530|NCT01490840|454494059|FG001|Phase 2|Withdrawal by Subject|3|||
126327531|NCT01490840|454494058|FG000|Phase 2|Permanent interruption of fingolimod|0|||
126327532|NCT01490840|454494059|FG001|Phase 2|Permanent interruption of fingolimod|1|||
126327533|NCT01490840|454494058|FG000|Phase 2|Lost to Follow-up|1|||
126327534|NCT01490840|454494059|FG001|Phase 2|Lost to Follow-up|1|||
126327535|NCT01490840|454494058|FG000|Phase 2|Adverse Event|1|||
126327536|NCT01490840|454494059|FG001|Phase 2|Adverse Event|1|||
126327537|NCT01025284|454494060|FG000|Overall Study|Investigator Decision|0|||
126327538|NCT01025284|454494061|FG001|Overall Study|Investigator Decision|1|||
126327539|NCT01025284|454494062|FG002|Overall Study|Investigator Decision|0|||
126327540|NCT01025284|454494060|FG000|Overall Study|Withdrawal by Subject|0|||
126327541|NCT01025284|454494061|FG001|Overall Study|Withdrawal by Subject|1|||
126327542|NCT01025284|454494062|FG002|Overall Study|Withdrawal by Subject|0|||
126327543|NCT00905567|454494063|FG000|Washout|Withdrawal by Subject|0|||
126327544|NCT00905567|454494064|FG001|Washout|Withdrawal by Subject|1|||
126327545|NCT02542397|454494065|FG000|Overall Study|Death|2|||
126327546|NCT02542397|454494065|FG000|Overall Study|Physician Decision|6|||
126327547|NCT02542397|454494065|FG000|Overall Study|Withdrawal by Subject|6|||
126327548|NCT02542397|454494065|FG000|Overall Study|Lost to Follow-up|2|||
126327549|NCT01738919|454494071|FG000|Overall Study|Lost to Follow-up|1|||
126327550|NCT01738919|454494072|FG001|Overall Study|Lost to Follow-up|0|||
126327551|NCT01738919|454494071|FG000|Overall Study|Immigrated|0|||
126327552|NCT01738919|454494072|FG001|Overall Study|Immigrated|1|||
126327553|NCT01738919|454494071|FG000|Overall Study|Withdrawal by Subject|0|||
126327554|NCT01738919|454494072|FG001|Overall Study|Withdrawal by Subject|1|||
126327555|NCT01738919|454494071|FG000|Overall Study|Not treated in accordance to guidelines|0|||
126327556|NCT01738919|454494072|FG001|Overall Study|Not treated in accordance to guidelines|1|||
126327557|NCT01473940|454494073|FG000|Induction Therapy|Death|0|||
126327558|NCT01473940|454494074|FG001|Induction Therapy|Death|0|||
126327559|NCT01473940|454494075|FG002|Induction Therapy|Death|1|||
126327560|NCT01473940|454494076|FG003|Induction Therapy|Death|1|||
126327561|NCT01473940|454494073|FG000|Induction Therapy|Progressive Disease|0|||
126327562|NCT01473940|454494074|FG001|Induction Therapy|Progressive Disease|1|||
126327563|NCT01473940|454494075|FG002|Induction Therapy|Progressive Disease|1|||
126327564|NCT01473940|454494076|FG003|Induction Therapy|Progressive Disease|0|||
126327565|NCT01473940|454494073|FG000|Maintenance Therapy|Progressive Disease|1|||
126327566|NCT01473940|454494074|FG001|Maintenance Therapy|Progressive Disease|2|||
126327567|NCT01473940|454494075|FG002|Maintenance Therapy|Progressive Disease|1|||
126327568|NCT01473940|454494076|FG003|Maintenance Therapy|Progressive Disease|4|||
126327569|NCT00741598|454494077|FG000|Overall Study|Lost to Follow-up|3|||
126327570|NCT00741598|454494078|FG001|Overall Study|Lost to Follow-up|4|||
126327571|NCT00741598|454494077|FG000|Overall Study|Lack of Efficacy|1|||
126327572|NCT00741598|454494078|FG001|Overall Study|Lack of Efficacy|2|||
126327573|NCT00741598|454494077|FG000|Overall Study|Physician Decision|1|||
126327574|NCT00741598|454494078|FG001|Overall Study|Physician Decision|1|||
126327575|NCT00741598|454494077|FG000|Overall Study|Pregnancy|1|||
126327576|NCT00741598|454494078|FG001|Overall Study|Pregnancy|0|||
126327577|NCT00741598|454494077|FG000|Overall Study|Withdrawal by Subject|3|||
126327578|NCT00741598|454494078|FG001|Overall Study|Withdrawal by Subject|2|||
126327579|NCT00435461|454494081|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
126327580|NCT00435461|454494082|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
126327581|NCT00435461|454494083|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
126327582|NCT00435461|454494081|FG000|Overall Study|Protocol Violation|6|||
126327583|NCT00435461|454494082|FG001|Overall Study|Protocol Violation|9|||
126327584|NCT00435461|454494083|FG002|Overall Study|Protocol Violation|10|||
126327585|NCT00435461|454494081|FG000|Overall Study|Participant randomized(inadequate score)|1|||
126327586|NCT00435461|454494082|FG001|Overall Study|Participant randomized(inadequate score)|0|||
126327587|NCT00435461|454494083|FG002|Overall Study|Participant randomized(inadequate score)|0|||
126327588|NCT00435461|454494081|FG000|Overall Study|Compliance less than 80 percent|1|||
126327589|NCT00435461|454494082|FG001|Overall Study|Compliance less than 80 percent|0|||
126327590|NCT00435461|454494083|FG002|Overall Study|Compliance less than 80 percent|0|||
126327591|NCT00435461|454494081|FG000|Overall Study|In error, two study medications switched|1|||
126327592|NCT00435461|454494082|FG001|Overall Study|In error, two study medications switched|0|||
126327593|NCT00435461|454494083|FG002|Overall Study|In error, two study medications switched|0|||
126327594|NCT00435461|454494081|FG000|Overall Study|Lack of Efficacy|2|||
126327595|NCT00435461|454494082|FG001|Overall Study|Lack of Efficacy|1|||
126327596|NCT00435461|454494083|FG002|Overall Study|Lack of Efficacy|0|||
126327597|NCT00435461|454494081|FG000|Overall Study|Withdrawal by Subject|1|||
126327598|NCT00435461|454494082|FG001|Overall Study|Withdrawal by Subject|0|||
126327599|NCT00435461|454494083|FG002|Overall Study|Withdrawal by Subject|2|||
126327600|NCT00435461|454494081|FG000|Overall Study|Randomized in error|1|||
126327601|NCT00435461|454494082|FG001|Overall Study|Randomized in error|0|||
126327602|NCT00435461|454494083|FG002|Overall Study|Randomized in error|0|||
126327603|NCT00435461|454494081|FG000|Overall Study|Participant could not tolerate symptoms|0|||
126327604|NCT00435461|454494082|FG001|Overall Study|Participant could not tolerate symptoms|0|||
126327605|NCT00435461|454494083|FG002|Overall Study|Participant could not tolerate symptoms|1|||
126327606|NCT00435461|454494081|FG000|Overall Study|Participant could not swallow capsule|0|||
126327607|NCT00435461|454494082|FG001|Overall Study|Participant could not swallow capsule|0|||
126327608|NCT00435461|454494083|FG002|Overall Study|Participant could not swallow capsule|1|||
126327609|NCT00435461|454494081|FG000|Overall Study|Pregnancy|2|||
126327610|NCT00435461|454494082|FG001|Overall Study|Pregnancy|0|||
126327611|NCT00435461|454494083|FG002|Overall Study|Pregnancy|0|||
126327612|NCT00435461|454494081|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
126327613|NCT00435461|454494082|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
126327614|NCT00435461|454494083|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
126327615|NCT00435461|454494081|FG000|Overall Study|Participant ended study one day early|1|||
126327616|NCT00435461|454494082|FG001|Overall Study|Participant ended study one day early|0|||
126327617|NCT00435461|454494083|FG002|Overall Study|Participant ended study one day early|0|||
126327618|NCT00435461|454494081|FG000|Overall Study|Noncompliance with study requirements|1|||
126327619|NCT00435461|454494082|FG001|Overall Study|Noncompliance with study requirements|1|||
126327620|NCT00435461|454494083|FG002|Overall Study|Noncompliance with study requirements|1|||
126327621|NCT00435461|454494081|FG000|Overall Study|Adverse Event|1|||
126327622|NCT00435461|454494082|FG001|Overall Study|Adverse Event|2|||
126327623|NCT00435461|454494083|FG002|Overall Study|Adverse Event|6|||
126327624|NCT00435461|454494081|FG000|Overall Study|Non-Compliance of diary|2|||
126327625|NCT00435461|454494082|FG001|Overall Study|Non-Compliance of diary|0|||
126327626|NCT00435461|454494083|FG002|Overall Study|Non-Compliance of diary|1|||
126327627|NCT00435461|454494081|FG000|Overall Study|Lost to Follow-up|1|||
126327628|NCT00435461|454494082|FG001|Overall Study|Lost to Follow-up|1|||
126327629|NCT00435461|454494083|FG002|Overall Study|Lost to Follow-up|2|||
126327630|NCT00837967|454494084|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
126327631|NCT00837967|454494085|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
126327632|NCT05446142|454494101|FG000|Period 2|Adverse Event|1|||
126327633|NCT05446142|454494102|FG001|Period 2|Adverse Event|0|||
126327634|NCT05446142|454494103|FG002|Period 2|Adverse Event|0|||
126327635|NCT05446142|454494104|FG003|Period 2|Adverse Event|0|||
126327636|NCT05446142|454494105|FG004|Period 2|Adverse Event|0|||
126327637|NCT05446142|454494106|FG005|Period 2|Adverse Event|0|||
126327638|NCT02098395|454494107|FG000|Overall Study|Protocol Violation|2|||
126327639|NCT02098395|454494108|FG001|Overall Study|Protocol Violation|2|||
126327640|NCT02098395|454494109|FG002|Overall Study|Protocol Violation|0|||
126327641|NCT02098395|454494110|FG003|Overall Study|Protocol Violation|7|||
126327642|NCT02098395|454494107|FG000|Overall Study|Withdrawal by Subject|10|||
126327643|NCT02098395|454494108|FG001|Overall Study|Withdrawal by Subject|10|||
126327644|NCT02098395|454494109|FG002|Overall Study|Withdrawal by Subject|5|||
126327645|NCT02098395|454494110|FG003|Overall Study|Withdrawal by Subject|13|||
126327646|NCT02098395|454494107|FG000|Overall Study|Adverse Event|12|||
126327647|NCT02098395|454494108|FG001|Overall Study|Adverse Event|19|||
126327648|NCT02098395|454494109|FG002|Overall Study|Adverse Event|34|||
126327649|NCT02098395|454494110|FG003|Overall Study|Adverse Event|2|||
126327650|NCT02098395|454494107|FG000|Overall Study|Lost to Follow-up|2|||
126327651|NCT02098395|454494108|FG001|Overall Study|Lost to Follow-up|1|||
126327652|NCT02098395|454494109|FG002|Overall Study|Lost to Follow-up|0|||
126327653|NCT02098395|454494110|FG003|Overall Study|Lost to Follow-up|3|||
126327654|NCT02098395|454494107|FG000|Overall Study|Unclassified|0|||
126327655|NCT02098395|454494108|FG001|Overall Study|Unclassified|0|||
126327656|NCT02098395|454494109|FG002|Overall Study|Unclassified|3|||
126327657|NCT02098395|454494110|FG003|Overall Study|Unclassified|2|||
126327658|NCT00547157|454494113|FG000|Overall Study|Other|1|||
126327659|NCT00547157|454494114|FG001|Overall Study|Other|0|||
126327660|NCT00547157|454494113|FG000|Overall Study|Death|38|||
126327661|NCT00547157|454494114|FG001|Overall Study|Death|18|||
126327662|NCT00547157|454494113|FG000|Overall Study|Withdrawal by Subject|3|||
126327663|NCT00547157|454494114|FG001|Overall Study|Withdrawal by Subject|1|||
126327664|NCT00547157|454494113|FG000|Overall Study|Administrative decision|3|||
126327665|NCT00547157|454494114|FG001|Overall Study|Administrative decision|2|||
126327666|NCT00547157|454494113|FG000|Overall Study|Lost to Follow-up|4|||
126327667|NCT00547157|454494114|FG001|Overall Study|Lost to Follow-up|2|||
126327668|NCT00110357|454494115|FG000|Overall Study|Deterioration without progression|2|||
126327669|NCT00110357|454494116|FG001|Overall Study|Deterioration without progression|0|||
126327670|NCT00110357|454494115|FG000|Overall Study|Disease progression/relapse|20|||
126327671|NCT00110357|454494116|FG001|Overall Study|Disease progression/relapse|15|||
126327672|NCT00110357|454494115|FG000|Overall Study|Study Closure|1|||
126327673|NCT00110357|454494116|FG001|Overall Study|Study Closure|0|||
126327674|NCT00110357|454494115|FG000|Overall Study|Study Drug Toxicity|1|||
126327675|NCT00110357|454494116|FG001|Overall Study|Study Drug Toxicity|3|||
126327676|NCT00110357|454494115|FG000|Overall Study|Withdrawal by Subject|3|||
126327677|NCT00110357|454494116|FG001|Overall Study|Withdrawal by Subject|1|||
126327678|NCT03382418|454494117|FG000|Overall Study|Withdrawal by Subject|1|||
126327679|NCT03382418|454494118|FG001|Overall Study|Withdrawal by Subject|0|||
126327680|NCT03382418|454494119|FG002|Overall Study|Withdrawal by Subject|0|||
126327681|NCT03382418|454494117|FG000|Overall Study|Lost to Follow-up|2|||
126327682|NCT03382418|454494118|FG001|Overall Study|Lost to Follow-up|3|||
126327683|NCT03382418|454494119|FG002|Overall Study|Lost to Follow-up|0|||
126327684|NCT04633226|454494120|FG000|Overall Study|Withdrawal by parent/guardian|4|||
126327685|NCT04633226|454494120|FG000|Overall Study|Randomized by mistake without study treatment|1|||
126327686|NCT01151345|454494122|FG000|First Intervention Period|Protocol Violation|0|||
126327687|NCT01151345|454494123|FG001|First Intervention Period|Protocol Violation|1|||
126327688|NCT01348100|454494125|FG000|Overall Study|Subject Withdrew Consent|0|||
126327689|NCT01348100|454494126|FG001|Overall Study|Subject Withdrew Consent|0|||
126327690|NCT01348100|454494127|FG002|Overall Study|Subject Withdrew Consent|2|||
126327691|NCT01348100|454494128|FG003|Overall Study|Subject Withdrew Consent|0|||
126327692|NCT01348100|454494129|FG004|Overall Study|Subject Withdrew Consent|1|||
126327693|NCT01348100|454494130|FG005|Overall Study|Subject Withdrew Consent|0|||
126327694|NCT01348100|454494131|FG006|Overall Study|Subject Withdrew Consent|1|||
126327695|NCT01348100|454494125|FG000|Overall Study|Protocol Deviation|0|||
126327696|NCT01348100|454494126|FG001|Overall Study|Protocol Deviation|0|||
126327697|NCT01348100|454494127|FG002|Overall Study|Protocol Deviation|0|||
126327698|NCT01348100|454494128|FG003|Overall Study|Protocol Deviation|1|||
126327699|NCT01348100|454494129|FG004|Overall Study|Protocol Deviation|0|||
126327700|NCT01348100|454494130|FG005|Overall Study|Protocol Deviation|0|||
126327701|NCT01348100|454494131|FG006|Overall Study|Protocol Deviation|0|||
126327702|NCT01348100|454494125|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126327703|NCT01348100|454494126|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126327704|NCT01348100|454494127|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126327705|NCT01348100|454494128|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126327706|NCT01348100|454494129|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126327707|NCT01348100|454494130|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
126327708|NCT01348100|454494131|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126327709|NCT01348100|454494125|FG000|Overall Study|Lost to Follow-up|0|||
126327710|NCT01348100|454494126|FG001|Overall Study|Lost to Follow-up|0|||
126327711|NCT01348100|454494127|FG002|Overall Study|Lost to Follow-up|0|||
126327712|NCT01348100|454494128|FG003|Overall Study|Lost to Follow-up|0|||
126327713|NCT01348100|454494129|FG004|Overall Study|Lost to Follow-up|0|||
126327714|NCT01348100|454494130|FG005|Overall Study|Lost to Follow-up|0|||
126327715|NCT01348100|454494131|FG006|Overall Study|Lost to Follow-up|1|||
126327716|NCT01348100|454494125|FG000|Overall Study|Administrative Problems|0|||
126327717|NCT01348100|454494126|FG001|Overall Study|Administrative Problems|0|||
126327718|NCT01348100|454494127|FG002|Overall Study|Administrative Problems|0|||
126327719|NCT01348100|454494128|FG003|Overall Study|Administrative Problems|0|||
126327720|NCT01348100|454494129|FG004|Overall Study|Administrative Problems|0|||
126327721|NCT01348100|454494130|FG005|Overall Study|Administrative Problems|1|||
126327722|NCT01348100|454494131|FG006|Overall Study|Administrative Problems|1|||
126327723|NCT03882957|454494134|FG000|Overall Study|Did not complete all three arms|1|||
126327724|NCT04186221|454494139|FG000|Overall Study|Death|1|||
126327725|NCT01134393|454494140|FG000|Overall Study|Adverse Event|18|||
126327726|NCT01134393|454494140|FG000|Overall Study|Lack of Efficacy|2|||
126327727|NCT01134393|454494140|FG000|Overall Study|Protocol Violation|12|||
126327728|NCT01134393|454494140|FG000|Overall Study|Lost to Follow-up|3|||
126327729|NCT01134393|454494140|FG000|Overall Study|Withdrawal by Subject|11|||
126327730|NCT01134393|454494140|FG000|Overall Study|Other|6|||
126327731|NCT00531947|454494141|FG000|Overall Study|Adverse Event|5|||
126327732|NCT00531947|454494142|FG001|Overall Study|Adverse Event|10|||
126327733|NCT00531947|454494141|FG000|Overall Study|Lost to Follow-up|12|||
126327734|NCT00531947|454494142|FG001|Overall Study|Lost to Follow-up|9|||
126327735|NCT00531947|454494141|FG000|Overall Study|Withdrawal by Subject|14|||
126327736|NCT00531947|454494142|FG001|Overall Study|Withdrawal by Subject|19|||
126327737|NCT00531947|454494141|FG000|Overall Study|Protocol Violation|2|||
126327738|NCT00531947|454494142|FG001|Overall Study|Protocol Violation|1|||
126327739|NCT00531947|454494141|FG000|Overall Study|Non-Compliance|4|||
126327740|NCT00531947|454494142|FG001|Overall Study|Non-Compliance|7|||
126327741|NCT00531947|454494141|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
126327742|NCT00531947|454494142|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
126327743|NCT03134911|454494147|FG000|Overall Study|Screen failure|31|||
126327744|NCT03134911|454494147|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
126327745|NCT01087203|454494148|FG000|Overall Study|Lost to Follow-up|2|||
126327746|NCT01087203|454494149|FG001|Overall Study|Lost to Follow-up|0|||
126327747|NCT01087203|454494148|FG000|Overall Study|Withdrawal by Subject|2|||
126327748|NCT01087203|454494149|FG001|Overall Study|Withdrawal by Subject|6|||
126327749|NCT01087203|454494148|FG000|Overall Study|Lack of Efficacy|1|||
126327750|NCT01087203|454494149|FG001|Overall Study|Lack of Efficacy|2|||
126327751|NCT01087203|454494148|FG000|Overall Study|Study terminated by sponsor|27|||
126327752|NCT01087203|454494149|FG001|Overall Study|Study terminated by sponsor|27|||
126327753|NCT00420628|454494154|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
126327754|NCT00420628|454494155|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
126327755|NCT00420628|454494154|FG000|Overall Study|Lost to Follow-up|3|||
126327756|NCT00420628|454494155|FG001|Overall Study|Lost to Follow-up|2|||
126327757|NCT00420628|454494154|FG000|Overall Study|Adverse Event|1|||
126327758|NCT00420628|454494155|FG001|Overall Study|Adverse Event|0|||
126327759|NCT02903420|454494161|FG000|Overall Study|Death|3|||
126327760|NCT02787083|454494163|FG000|Overall Study|Adverse Event|1|||
126327761|NCT02787083|454494164|FG001|Overall Study|Adverse Event|0|||
126327762|NCT02787083|454494163|FG000|Overall Study|Withdrawal by Subject|2|||
126327763|NCT02787083|454494164|FG001|Overall Study|Withdrawal by Subject|2|||
126327764|NCT03162328|454494165|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
126327765|NCT03162328|454494166|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
126327766|NCT03162328|454494167|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
126327767|NCT03162328|454494165|FG000|Screening Period|Withdrawal by Subject|1|||
126327768|NCT03162328|454494166|FG001|Screening Period|Withdrawal by Subject|0|||
126327769|NCT03162328|454494167|FG002|Screening Period|Withdrawal by Subject|0|||
126327770|NCT03162328|454494165|FG000|Study Period|Withdrawal by Subject|0|||
126327771|NCT03162328|454494166|FG001|Study Period|Withdrawal by Subject|0|||
126327772|NCT03162328|454494167|FG002|Study Period|Withdrawal by Subject|1|||
126327773|NCT03092791|454494168|FG000|Overall Study|Lost to Follow-up|0|||
126327774|NCT03092791|454494169|FG001|Overall Study|Lost to Follow-up|0|||
126327775|NCT03092791|454494170|FG002|Overall Study|Lost to Follow-up|0|||
126327776|NCT03092791|454494171|FG003|Overall Study|Lost to Follow-up|0|||
126327777|NCT03092791|454494172|FG004|Overall Study|Lost to Follow-up|0|||
126327778|NCT03092791|454494173|FG005|Overall Study|Lost to Follow-up|0|||
126327779|NCT03092791|454494174|FG006|Overall Study|Lost to Follow-up|1|||
126327780|NCT03092791|454494175|FG007|Overall Study|Lost to Follow-up|0|||
126327781|NCT03092791|454494168|FG000|Overall Study|Withdrawal of Consent|0|||
126327782|NCT03092791|454494169|FG001|Overall Study|Withdrawal of Consent|0|||
126327783|NCT03092791|454494170|FG002|Overall Study|Withdrawal of Consent|0|||
126327784|NCT03092791|454494171|FG003|Overall Study|Withdrawal of Consent|0|||
126327785|NCT03092791|454494172|FG004|Overall Study|Withdrawal of Consent|4|||
126327786|NCT03092791|454494173|FG005|Overall Study|Withdrawal of Consent|12|||
126327787|NCT03092791|454494174|FG006|Overall Study|Withdrawal of Consent|6|||
126327788|NCT03092791|454494175|FG007|Overall Study|Withdrawal of Consent|4|||
126327789|NCT03092791|454494168|FG000|Overall Study|Study Termination|0|||
126327790|NCT03092791|454494169|FG001|Overall Study|Study Termination|0|||
126327791|NCT03092791|454494170|FG002|Overall Study|Study Termination|0|||
126327792|NCT03092791|454494171|FG003|Overall Study|Study Termination|0|||
126327793|NCT03092791|454494172|FG004|Overall Study|Study Termination|55|||
126327794|NCT03092791|454494173|FG005|Overall Study|Study Termination|46|||
126327795|NCT03092791|454494174|FG006|Overall Study|Study Termination|53|||
126327796|NCT03092791|454494175|FG007|Overall Study|Study Termination|55|||
126327797|NCT03092791|454494168|FG000|Overall Study|Death|0|||
126327798|NCT03092791|454494169|FG001|Overall Study|Death|0|||
126327799|NCT03092791|454494170|FG002|Overall Study|Death|0|||
126327800|NCT03092791|454494171|FG003|Overall Study|Death|0|||
126327801|NCT03092791|454494172|FG004|Overall Study|Death|0|||
126327802|NCT03092791|454494173|FG005|Overall Study|Death|1|||
126327803|NCT03092791|454494174|FG006|Overall Study|Death|0|||
126327804|NCT03092791|454494175|FG007|Overall Study|Death|1|||
126327805|NCT03092791|454494168|FG000|Overall Study|Reason Not Specified|0|||
126327806|NCT03092791|454494169|FG001|Overall Study|Reason Not Specified|0|||
126327807|NCT03092791|454494170|FG002|Overall Study|Reason Not Specified|0|||
126327808|NCT03092791|454494171|FG003|Overall Study|Reason Not Specified|0|||
126327809|NCT03092791|454494172|FG004|Overall Study|Reason Not Specified|1|||
126327810|NCT03092791|454494173|FG005|Overall Study|Reason Not Specified|1|||
126327811|NCT03092791|454494174|FG006|Overall Study|Reason Not Specified|0|||
126327812|NCT03092791|454494175|FG007|Overall Study|Reason Not Specified|0|||
126327813|NCT00154375|454494176|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
126327814|NCT00154375|454494177|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
126327815|NCT00154375|454494176|FG000|Overall Study|Adverse Event|18|||
126327816|NCT00154375|454494177|FG001|Overall Study|Adverse Event|20|||
126327817|NCT00154375|454494176|FG000|Overall Study|Withdrawal by Subject|14|||
126327818|NCT00154375|454494177|FG001|Overall Study|Withdrawal by Subject|10|||
126327819|NCT00154375|454494176|FG000|Overall Study|Death|5|||
126327820|NCT00154375|454494177|FG001|Overall Study|Death|13|||
126327821|NCT00154375|454494176|FG000|Overall Study|Study drug no longer required|5|||
126327822|NCT00154375|454494177|FG001|Overall Study|Study drug no longer required|3|||
126327823|NCT00154375|454494176|FG000|Overall Study|Lost to Follow-up|2|||
126327824|NCT00154375|454494177|FG001|Overall Study|Lost to Follow-up|1|||
126327825|NCT00154375|454494176|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126327826|NCT00154375|454494177|FG001|Overall Study|Abnormal laboratory value(s)|2|||
126327827|NCT00154375|454494176|FG000|Overall Study|Protocol Violation|0|||
126327828|NCT00154375|454494177|FG001|Overall Study|Protocol Violation|1|||
126327829|NCT00154375|454494176|FG000|Overall Study|Suspected progression of disease|44|||
126327830|NCT00154375|454494177|FG001|Overall Study|Suspected progression of disease|30|||
126327831|NCT00980655|454494178|FG000|Overall Study|Adverse Event|13|||
126327832|NCT00980655|454494179|FG001|Overall Study|Adverse Event|31|||
126327833|NCT00980655|454494178|FG000|Overall Study|Death|0|||
126327834|NCT00980655|454494179|FG001|Overall Study|Death|7|||
126327835|NCT00980655|454494178|FG000|Overall Study|Protocol Violation|2|||
126327836|NCT00980655|454494179|FG001|Overall Study|Protocol Violation|7|||
126327837|NCT00980655|454494178|FG000|Overall Study|Withdrawal by Subject|0|||
126327838|NCT00980655|454494179|FG001|Overall Study|Withdrawal by Subject|4|||
126327839|NCT00980655|454494178|FG000|Overall Study|Lost to Follow-up|0|||
126327840|NCT00980655|454494179|FG001|Overall Study|Lost to Follow-up|1|||
126327841|NCT00980655|454494178|FG000|Overall Study|Parent/legal guardian request|1|||
126327842|NCT00980655|454494179|FG001|Overall Study|Parent/legal guardian request|0|||
126327843|NCT00980655|454494178|FG000|Overall Study|Other|0|||
126327844|NCT00980655|454494179|FG001|Overall Study|Other|1|||
126327845|NCT01941537|454494184|FG000|Overall Study|Lack of Efficacy|1|||
126327846|NCT01941537|454494185|FG001|Overall Study|Lack of Efficacy|2|||
126327847|NCT01941537|454494184|FG000|Overall Study|Lost to Follow-up|1|||
126327848|NCT01941537|454494185|FG001|Overall Study|Lost to Follow-up|0|||
126327849|NCT01941537|454494184|FG000|Overall Study|Pregnancy|1|||
126327850|NCT01941537|454494185|FG001|Overall Study|Pregnancy|0|||
126327851|NCT01941537|454494184|FG000|Overall Study|Adverse Event|1|||
126327852|NCT01941537|454494185|FG001|Overall Study|Adverse Event|0|||
126327853|NCT01941537|454494184|FG000|Overall Study|Withdrawal by Subject|0|||
126327854|NCT01941537|454494185|FG001|Overall Study|Withdrawal by Subject|1|||
126327855|NCT02557516|454494187|FG000|Overall Study|Adverse Event|1|||
126327856|NCT02557516|454494188|FG001|Overall Study|Adverse Event|0|||
126327857|NCT02557516|454494189|FG002|Overall Study|Adverse Event|2|||
126327858|NCT02557516|454494190|FG003|Overall Study|Adverse Event|1|||
126327859|NCT02557516|454494187|FG000|Overall Study|Disease progression|0|||
126327860|NCT02557516|454494188|FG001|Overall Study|Disease progression|2|||
126327861|NCT02557516|454494189|FG002|Overall Study|Disease progression|0|||
126327862|NCT02557516|454494190|FG003|Overall Study|Disease progression|0|||
126327863|NCT02557516|454494187|FG000|Overall Study|Physician Decision|0|||
126327864|NCT02557516|454494188|FG001|Overall Study|Physician Decision|2|||
126327865|NCT02557516|454494189|FG002|Overall Study|Physician Decision|0|||
126327866|NCT02557516|454494190|FG003|Overall Study|Physician Decision|0|||
126327867|NCT02557516|454494187|FG000|Overall Study|Sponsor decision|0|||
126327868|NCT02557516|454494188|FG001|Overall Study|Sponsor decision|1|||
126327869|NCT02557516|454494189|FG002|Overall Study|Sponsor decision|2|||
126327870|NCT02557516|454494190|FG003|Overall Study|Sponsor decision|8|||
126327871|NCT04378569|454496025|FG000|Overall Study|Adverse Event|0|||
126327872|NCT04378569|454496026|FG001|Overall Study|Adverse Event|0|||
126327873|NCT04378569|454496027|FG002|Overall Study|Adverse Event|2|||
126327874|NCT04378569|454496028|FG003|Overall Study|Adverse Event|0|||
126327875|NCT04378569|454496029|FG004|Overall Study|Adverse Event|3|||
126327876|NCT04378569|454496030|FG005|Overall Study|Adverse Event|3|||
126327877|NCT04378569|454496025|FG000|Overall Study|Lost to Follow-up|0|||
126327878|NCT04378569|454496026|FG001|Overall Study|Lost to Follow-up|3|||
126327879|NCT04378569|454496027|FG002|Overall Study|Lost to Follow-up|1|||
126327880|NCT04378569|454496028|FG003|Overall Study|Lost to Follow-up|0|||
126327881|NCT04378569|454496029|FG004|Overall Study|Lost to Follow-up|1|||
126327882|NCT04378569|454496030|FG005|Overall Study|Lost to Follow-up|1|||
126327883|NCT04378569|454496025|FG000|Overall Study|Protocol Violation|0|||
126327884|NCT04378569|454496026|FG001|Overall Study|Protocol Violation|0|||
126327885|NCT04378569|454496027|FG002|Overall Study|Protocol Violation|0|||
126327886|NCT04378569|454496028|FG003|Overall Study|Protocol Violation|0|||
126327887|NCT04378569|454496029|FG004|Overall Study|Protocol Violation|0|||
126327888|NCT04378569|454496030|FG005|Overall Study|Protocol Violation|1|||
126327889|NCT04378569|454496025|FG000|Overall Study|Withdrawal by Subject|0|||
126327890|NCT04378569|454496026|FG001|Overall Study|Withdrawal by Subject|6|||
126327891|NCT04378569|454496027|FG002|Overall Study|Withdrawal by Subject|7|||
126327892|NCT04378569|454496028|FG003|Overall Study|Withdrawal by Subject|4|||
126327893|NCT04378569|454496029|FG004|Overall Study|Withdrawal by Subject|5|||
126327894|NCT04378569|454496030|FG005|Overall Study|Withdrawal by Subject|4|||
126327895|NCT04378569|454496025|FG000|Overall Study|Lack of response|0|||
126327896|NCT04378569|454496026|FG001|Overall Study|Lack of response|0|||
126327897|NCT04378569|454496027|FG002|Overall Study|Lack of response|1|||
126327898|NCT04378569|454496028|FG003|Overall Study|Lack of response|0|||
126327899|NCT04378569|454496029|FG004|Overall Study|Lack of response|1|||
126327900|NCT04378569|454496030|FG005|Overall Study|Lack of response|1|||
126327901|NCT01962948|454496031|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
126327902|NCT01962948|454496032|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
126327903|NCT01962948|454496033|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
126327904|NCT01962948|454496034|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
126327905|NCT02239640|454496046|FG000|Overall Study|Withdrawal by Subject|3|||
126327906|NCT02239640|454496046|FG000|Overall Study|Lost to Follow-up|72|||
126327907|NCT02239640|454496046|FG000|Overall Study|Death|142|||
126327908|NCT02630563|454496049|FG000|Overall Study|Administrative|1|||
126327909|NCT02061813|454496050|FG000|Overall Study|Withdrawal by Subject|1|||
126327910|NCT02061813|454496050|FG000|Overall Study|Protocol Violation|2|||
126327911|NCT01724177|454496053|FG000|Overall Study|Adverse Event|8|||
126327912|NCT01724177|454496053|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
126327913|NCT01724177|454496053|FG000|Overall Study|Nervous participant|1|||
126327914|NCT01724177|454496053|FG000|Overall Study|Serious Adverse Event Related|1|||
126327915|NCT01705080|454496054|FG000|Overall Study|Missed visit|10|||
126327916|NCT01705080|454496055|FG001|Overall Study|Missed visit|4|||
126327917|NCT01705080|454496056|FG002|Overall Study|Missed visit|1|||
126327918|NCT01705080|454496054|FG000|Overall Study|Death|4|||
126327919|NCT01705080|454496055|FG001|Overall Study|Death|4|||
126327920|NCT01705080|454496056|FG002|Overall Study|Death|6|||
126327921|NCT01705080|454496054|FG000|Overall Study|Withdrawal by Subject|61|||
126327922|NCT01705080|454496055|FG001|Overall Study|Withdrawal by Subject|44|||
126327923|NCT01705080|454496056|FG002|Overall Study|Withdrawal by Subject|9|||
126327924|NCT00206427|454496059|FG000|Overall Study|Adverse Event|2|||
126327925|NCT00281697|454496063|FG000|Overall Study|> 60 days since last dose of study drug|4|||
126327926|NCT00281697|454496064|FG001|Overall Study|> 60 days since last dose of study drug|4|||
126327927|NCT00281697|454496063|FG000|Overall Study|Adverse Event|54|||
126327928|NCT00281697|454496064|FG001|Overall Study|Adverse Event|15|||
126327929|NCT00281697|454496063|FG000|Overall Study|Death|8|||
126327930|NCT00281697|454496064|FG001|Overall Study|Death|3|||
126327931|NCT00281697|454496063|FG000|Overall Study|Disease progression|279|||
126327932|NCT00281697|454496064|FG001|Overall Study|Disease progression|149|||
126327933|NCT00281697|454496063|FG000|Overall Study|Other|5|||
126327934|NCT00281697|454496064|FG001|Overall Study|Other|6|||
126327935|NCT00281697|454496063|FG000|Overall Study|Physician's decision to withdraw|15|||
126327936|NCT00281697|454496064|FG001|Overall Study|Physician's decision to withdraw|12|||
126327937|NCT00281697|454496063|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
126327938|NCT00281697|454496064|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
126327939|NCT00281697|454496063|FG000|Overall Study|Did not receive study drug|3|||
126327940|NCT00281697|454496064|FG001|Overall Study|Did not receive study drug|2|||
126327941|NCT03130959|454496077|FG000|Overall Study|Disease progression|19|||
126327942|NCT03130959|454496078|FG001|Overall Study|Disease progression|7|||
126327943|NCT03130959|454496079|FG002|Overall Study|Disease progression|12|||
126327944|NCT03130959|454496080|FG003|Overall Study|Disease progression|7|||
126327945|NCT03130959|454496081|FG004|Overall Study|Disease progression|12|||
126327946|NCT03130959|454496082|FG005|Overall Study|Disease progression|3|||
126327947|NCT03130959|454496083|FG006|Overall Study|Disease progression|6|||
126327948|NCT03130959|454496084|FG007|Overall Study|Disease progression|3|||
126327949|NCT03130959|454496085|FG008|Overall Study|Disease progression|15|||
126327950|NCT03130959|454496086|FG009|Overall Study|Disease progression|8|||
126327951|NCT03130959|454496077|FG000|Overall Study|Study drug toxicity|2|||
126327952|NCT03130959|454496078|FG001|Overall Study|Study drug toxicity|2|||
126327953|NCT03130959|454496079|FG002|Overall Study|Study drug toxicity|1|||
126327954|NCT03130959|454496080|FG003|Overall Study|Study drug toxicity|2|||
126327955|NCT03130959|454496081|FG004|Overall Study|Study drug toxicity|1|||
126327956|NCT03130959|454496082|FG005|Overall Study|Study drug toxicity|1|||
126327957|NCT03130959|454496083|FG006|Overall Study|Study drug toxicity|3|||
126327958|NCT03130959|454496084|FG007|Overall Study|Study drug toxicity|0|||
126327959|NCT03130959|454496085|FG008|Overall Study|Study drug toxicity|3|||
126327960|NCT03130959|454496086|FG009|Overall Study|Study drug toxicity|3|||
126327961|NCT03130959|454496077|FG000|Overall Study|Other reasons|0|||
126327962|NCT03130959|454496078|FG001|Overall Study|Other reasons|0|||
126327963|NCT03130959|454496079|FG002|Overall Study|Other reasons|0|||
126327964|NCT03130959|454496080|FG003|Overall Study|Other reasons|0|||
126327965|NCT03130959|454496081|FG004|Overall Study|Other reasons|0|||
126327966|NCT03130959|454496082|FG005|Overall Study|Other reasons|1|||
126327967|NCT03130959|454496083|FG006|Overall Study|Other reasons|1|||
126327968|NCT03130959|454496084|FG007|Overall Study|Other reasons|0|||
126327969|NCT03130959|454496085|FG008|Overall Study|Other reasons|0|||
126327970|NCT03130959|454496086|FG009|Overall Study|Other reasons|0|||
126327971|NCT03130959|454496077|FG000|Overall Study|Subject request to discontinue therapy|0|||
126327972|NCT03130959|454496078|FG001|Overall Study|Subject request to discontinue therapy|0|||
126327973|NCT03130959|454496079|FG002|Overall Study|Subject request to discontinue therapy|1|||
126327974|NCT03130959|454496080|FG003|Overall Study|Subject request to discontinue therapy|1|||
126327975|NCT03130959|454496081|FG004|Overall Study|Subject request to discontinue therapy|0|||
126327976|NCT03130959|454496082|FG005|Overall Study|Subject request to discontinue therapy|0|||
126327977|NCT03130959|454496083|FG006|Overall Study|Subject request to discontinue therapy|1|||
126327978|NCT03130959|454496084|FG007|Overall Study|Subject request to discontinue therapy|1|||
126327979|NCT03130959|454496085|FG008|Overall Study|Subject request to discontinue therapy|0|||
126327980|NCT03130959|454496086|FG009|Overall Study|Subject request to discontinue therapy|0|||
126327981|NCT03130959|454496077|FG000|Overall Study|Not reported|0|||
126327982|NCT03130959|454496078|FG001|Overall Study|Not reported|0|||
126327983|NCT03130959|454496079|FG002|Overall Study|Not reported|0|||
126327984|NCT03130959|454496080|FG003|Overall Study|Not reported|1|||
126327985|NCT03130959|454496081|FG004|Overall Study|Not reported|0|||
126327986|NCT03130959|454496082|FG005|Overall Study|Not reported|1|||
126327987|NCT03130959|454496083|FG006|Overall Study|Not reported|0|||
126327988|NCT03130959|454496084|FG007|Overall Study|Not reported|0|||
126327989|NCT03130959|454496085|FG008|Overall Study|Not reported|0|||
126327990|NCT03130959|454496086|FG009|Overall Study|Not reported|1|||
126327991|NCT03130959|454496077|FG000|Overall Study|Adverse Event unrelated to drug|0|||
126327992|NCT03130959|454496078|FG001|Overall Study|Adverse Event unrelated to drug|0|||
126327993|NCT03130959|454496079|FG002|Overall Study|Adverse Event unrelated to drug|1|||
126327994|NCT03130959|454496080|FG003|Overall Study|Adverse Event unrelated to drug|1|||
126327995|NCT03130959|454496081|FG004|Overall Study|Adverse Event unrelated to drug|1|||
126327996|NCT03130959|454496082|FG005|Overall Study|Adverse Event unrelated to drug|0|||
126327997|NCT03130959|454496083|FG006|Overall Study|Adverse Event unrelated to drug|1|||
126327998|NCT03130959|454496084|FG007|Overall Study|Adverse Event unrelated to drug|0|||
126327999|NCT03130959|454496085|FG008|Overall Study|Adverse Event unrelated to drug|1|||
126328000|NCT03130959|454496086|FG009|Overall Study|Adverse Event unrelated to drug|1|||
126328001|NCT03130959|454496077|FG000|Overall Study|Participant withdrew consent|0|||
126328002|NCT03130959|454496078|FG001|Overall Study|Participant withdrew consent|1|||
126328003|NCT03130959|454496079|FG002|Overall Study|Participant withdrew consent|0|||
126328004|NCT03130959|454496080|FG003|Overall Study|Participant withdrew consent|2|||
126328005|NCT03130959|454496081|FG004|Overall Study|Participant withdrew consent|1|||
126328006|NCT03130959|454496082|FG005|Overall Study|Participant withdrew consent|0|||
126328007|NCT03130959|454496083|FG006|Overall Study|Participant withdrew consent|0|||
126328008|NCT03130959|454496084|FG007|Overall Study|Participant withdrew consent|0|||
126328009|NCT03130959|454496085|FG008|Overall Study|Participant withdrew consent|0|||
126328010|NCT03130959|454496086|FG009|Overall Study|Participant withdrew consent|2|||
126328011|NCT03130959|454496077|FG000|Overall Study|Administrative reason by sponsor|1|||
126328012|NCT03130959|454496078|FG001|Overall Study|Administrative reason by sponsor|0|||
126328013|NCT03130959|454496079|FG002|Overall Study|Administrative reason by sponsor|1|||
126328014|NCT03130959|454496080|FG003|Overall Study|Administrative reason by sponsor|0|||
126328015|NCT03130959|454496081|FG004|Overall Study|Administrative reason by sponsor|0|||
126328016|NCT03130959|454496082|FG005|Overall Study|Administrative reason by sponsor|0|||
126328017|NCT03130959|454496083|FG006|Overall Study|Administrative reason by sponsor|0|||
126328018|NCT03130959|454496084|FG007|Overall Study|Administrative reason by sponsor|0|||
126328019|NCT03130959|454496085|FG008|Overall Study|Administrative reason by sponsor|0|||
126328020|NCT03130959|454496086|FG009|Overall Study|Administrative reason by sponsor|0|||
126328021|NCT03130959|454496077|FG000|Overall Study|Lost to Follow-up|1|||
126328022|NCT03130959|454496078|FG001|Overall Study|Lost to Follow-up|0|||
126328023|NCT03130959|454496079|FG002|Overall Study|Lost to Follow-up|0|||
126328024|NCT03130959|454496080|FG003|Overall Study|Lost to Follow-up|0|||
126328025|NCT03130959|454496081|FG004|Overall Study|Lost to Follow-up|0|||
126328026|NCT03130959|454496082|FG005|Overall Study|Lost to Follow-up|0|||
126328027|NCT03130959|454496083|FG006|Overall Study|Lost to Follow-up|0|||
126328028|NCT03130959|454496084|FG007|Overall Study|Lost to Follow-up|0|||
126328029|NCT03130959|454496085|FG008|Overall Study|Lost to Follow-up|0|||
126328030|NCT03130959|454496086|FG009|Overall Study|Lost to Follow-up|0|||
126328031|NCT00313586|454496087|FG000|Overall Study|Disease progression|14|||
126328032|NCT00313586|454496088|FG001|Overall Study|Disease progression|19|||
126328033|NCT00313586|454496089|FG002|Overall Study|Disease progression|10|||
126328034|NCT00313586|454496090|FG003|Overall Study|Disease progression|3|||
126328035|NCT00313586|454496087|FG000|Overall Study|Adverse Event|12|||
126328036|NCT00313586|454496088|FG001|Overall Study|Adverse Event|18|||
126328037|NCT00313586|454496089|FG002|Overall Study|Adverse Event|3|||
126328038|NCT00313586|454496090|FG003|Overall Study|Adverse Event|10|||
126328039|NCT00313586|454496087|FG000|Overall Study|Death|11|||
126328040|NCT00313586|454496088|FG001|Overall Study|Death|8|||
126328041|NCT00313586|454496089|FG002|Overall Study|Death|1|||
126328042|NCT00313586|454496090|FG003|Overall Study|Death|7|||
126328043|NCT00313586|454496087|FG000|Overall Study|Withdrawal by Subject|13|||
126328044|NCT00313586|454496088|FG001|Overall Study|Withdrawal by Subject|6|||
126328045|NCT00313586|454496089|FG002|Overall Study|Withdrawal by Subject|6|||
126328046|NCT00313586|454496090|FG003|Overall Study|Withdrawal by Subject|2|||
126328047|NCT00313586|454496087|FG000|Overall Study|Alternative therapy|3|||
126328048|NCT00313586|454496088|FG001|Overall Study|Alternative therapy|6|||
126328049|NCT00313586|454496089|FG002|Overall Study|Alternative therapy|2|||
126328050|NCT00313586|454496090|FG003|Overall Study|Alternative therapy|0|||
126328051|NCT00313586|454496087|FG000|Overall Study|Other complicating disease|2|||
126328052|NCT00313586|454496088|FG001|Overall Study|Other complicating disease|2|||
126328053|NCT00313586|454496089|FG002|Overall Study|Other complicating disease|0|||
126328054|NCT00313586|454496090|FG003|Overall Study|Other complicating disease|0|||
126328055|NCT00313586|454496087|FG000|Overall Study|Did not achieve HI-major/better response|10|||
126328056|NCT00313586|454496088|FG001|Overall Study|Did not achieve HI-major/better response|7|||
126328057|NCT00313586|454496089|FG002|Overall Study|Did not achieve HI-major/better response|2|||
126328058|NCT00313586|454496090|FG003|Overall Study|Did not achieve HI-major/better response|1|||
126328059|NCT00313586|454496087|FG000|Overall Study|Physician Decision|2|||
126328060|NCT00313586|454496088|FG001|Overall Study|Physician Decision|1|||
126328061|NCT00313586|454496089|FG002|Overall Study|Physician Decision|0|||
126328062|NCT00313586|454496090|FG003|Overall Study|Physician Decision|0|||
126328063|NCT00313586|454496087|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
126328064|NCT00313586|454496088|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
126328065|NCT00313586|454496089|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
126328066|NCT00313586|454496090|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
126328067|NCT00313586|454496087|FG000|Overall Study|Lost insurance|0|||
126328068|NCT00313586|454496088|FG001|Overall Study|Lost insurance|1|||
126328069|NCT00313586|454496089|FG002|Overall Study|Lost insurance|0|||
126328070|NCT00313586|454496090|FG003|Overall Study|Lost insurance|0|||
126328071|NCT00313586|454496087|FG000|Overall Study|Moved|0|||
126328072|NCT00313586|454496088|FG001|Overall Study|Moved|1|||
126328073|NCT00313586|454496089|FG002|Overall Study|Moved|0|||
126328074|NCT00313586|454496090|FG003|Overall Study|Moved|0|||
126328075|NCT00313586|454496087|FG000|Overall Study|Death before starting treatment|1|||
126328076|NCT00313586|454496088|FG001|Overall Study|Death before starting treatment|0|||
126328077|NCT00313586|454496089|FG002|Overall Study|Death before starting treatment|0|||
126328078|NCT00313586|454496090|FG003|Overall Study|Death before starting treatment|0|||
126328079|NCT03076996|454496091|FG000|Overall Study|Withdrawal by Subject|2|||
126328080|NCT03076996|454496091|FG000|Overall Study|Lost to Follow-up|3|||
126328081|NCT03076996|454496091|FG000|Overall Study|Literacy precluded participation|1|||
126328082|NCT03117361|454496093|FG000|Overall Study|Progressive disease|5|||
126328083|NCT03117361|454496093|FG000|Overall Study|Death|1|||
126328084|NCT03117361|454496093|FG000|Overall Study|Physician Decision|2|||
126328085|NCT03117361|454496093|FG000|Overall Study|On study treatment at the end of study|1|||
126328086|NCT03117361|454496093|FG000|Overall Study|Treatment-related adverse event|1|||
126328087|NCT03280056|454496097|FG000|Overall Study|Withdrawal by Subject|12|||
126328088|NCT03280056|454496098|FG001|Overall Study|Withdrawal by Subject|14|||
126328089|NCT03280056|454496097|FG000|Overall Study|Death|9|||
126328090|NCT03280056|454496098|FG001|Overall Study|Death|2|||
126328091|NCT03280056|454496097|FG000|Overall Study|Adverse Event|1|||
126328092|NCT03280056|454496098|FG001|Overall Study|Adverse Event|3|||
126328093|NCT03280056|454496097|FG000|Overall Study|Lost to Follow-up|1|||
126328094|NCT03280056|454496098|FG001|Overall Study|Lost to Follow-up|1|||
126328095|NCT03280056|454496097|FG000|Overall Study|Physician Decision|0|||
126328096|NCT03280056|454496098|FG001|Overall Study|Physician Decision|1|||
126328097|NCT03280056|454496097|FG000|Overall Study|Early Discontinuation|1|||
126328098|NCT03280056|454496098|FG001|Overall Study|Early Discontinuation|0|||
126328099|NCT02144077|454496099|FG000|Overall Study|Withdrawal by Subject|3|||
126328100|NCT02144077|454496100|FG001|Overall Study|Withdrawal by Subject|3|||
126328101|NCT02144077|454496099|FG000|Overall Study|Adverse Event|2|||
126328102|NCT02144077|454496100|FG001|Overall Study|Adverse Event|3|||
126328103|NCT02144077|454496099|FG000|Overall Study|Lost to Follow-up|2|||
126328104|NCT02144077|454496100|FG001|Overall Study|Lost to Follow-up|2|||
126328105|NCT02144077|454496099|FG000|Overall Study|Protocol Violation|1|||
126328106|NCT02144077|454496100|FG001|Overall Study|Protocol Violation|2|||
126328107|NCT02144077|454496099|FG000|Overall Study|Death|0|||
126328108|NCT02144077|454496100|FG001|Overall Study|Death|1|||
126328109|NCT02144077|454496099|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
126328110|NCT02144077|454496100|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
126328111|NCT00610168|454496101|FG000|Overall Study|Withdrawal by Subject|2|||
126328112|NCT00610168|454496102|FG001|Overall Study|Withdrawal by Subject|0|||
126328113|NCT00943592|454496103|FG000|Overall Study|Death|3|||
126328114|NCT01247350|454496104|FG000|Overall Study|Adverse Event|0|||
126328115|NCT01247350|454496105|FG001|Overall Study|Adverse Event|0|||
126328116|NCT01247350|454496106|FG002|Overall Study|Adverse Event|1|||
126328117|NCT01247350|454496107|FG003|Overall Study|Adverse Event|0|||
126328118|NCT01247350|454496108|FG004|Overall Study|Adverse Event|0|||
126328119|NCT01247350|454496104|FG000|Overall Study|Withdrawal by Subject|0|||
126328120|NCT01247350|454496105|FG001|Overall Study|Withdrawal by Subject|0|||
126328121|NCT01247350|454496106|FG002|Overall Study|Withdrawal by Subject|0|||
126328122|NCT01247350|454496107|FG003|Overall Study|Withdrawal by Subject|1|||
126328123|NCT01247350|454496108|FG004|Overall Study|Withdrawal by Subject|0|||
126328124|NCT01247350|454496104|FG000|Overall Study|Entry criteria not met|0|||
126328125|NCT01247350|454496105|FG001|Overall Study|Entry criteria not met|0|||
126328126|NCT01247350|454496106|FG002|Overall Study|Entry criteria not met|0|||
126328127|NCT01247350|454496107|FG003|Overall Study|Entry criteria not met|0|||
126328128|NCT01247350|454496108|FG004|Overall Study|Entry criteria not met|1|||
126328129|NCT00169104|454496109|FG000|Overall Study|Withdrawal by Subject|2|||
126328130|NCT00169104|454496110|FG001|Overall Study|Withdrawal by Subject|0|||
126328131|NCT00169104|454496109|FG000|Overall Study|Protocol Violation|0|||
126328132|NCT00169104|454496110|FG001|Overall Study|Protocol Violation|1|||
126328133|NCT00169104|454496109|FG000|Overall Study|Physician Decision|0|||
126328134|NCT00169104|454496110|FG001|Overall Study|Physician Decision|1|||
126328135|NCT01540981|454496116|FG000|Overall Study|Withdrawal by Subject|1|||
126328136|NCT01540981|454496117|FG001|Overall Study|Withdrawal by Subject|0|||
126328137|NCT00141518|454496120|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
126328138|NCT00141518|454496121|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
126328139|NCT00141518|454496122|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
126328140|NCT00141518|454496120|FG000|Overall Study|Adverse Event|7|||
126328141|NCT00141518|454496121|FG001|Overall Study|Adverse Event|5|||
126328142|NCT00141518|454496122|FG002|Overall Study|Adverse Event|2|||
126328143|NCT00141518|454496120|FG000|Overall Study|Withdrawal by Subject|2|||
126328144|NCT00141518|454496121|FG001|Overall Study|Withdrawal by Subject|0|||
126328145|NCT00141518|454496122|FG002|Overall Study|Withdrawal by Subject|2|||
126328146|NCT00141518|454496120|FG000|Overall Study|Protocol Violation|1|||
126328147|NCT00141518|454496121|FG001|Overall Study|Protocol Violation|1|||
126328148|NCT00141518|454496122|FG002|Overall Study|Protocol Violation|2|||
126328149|NCT00141518|454496120|FG000|Overall Study|Lack of Efficacy|5|||
126328150|NCT00141518|454496121|FG001|Overall Study|Lack of Efficacy|0|||
126328151|NCT00141518|454496122|FG002|Overall Study|Lack of Efficacy|0|||
126328152|NCT02091414|454496125|FG000|Overall Study|Withdrawal by Subject|2|||
126328153|NCT02091414|454496125|FG000|Overall Study|Death|2|||
126328154|NCT03231306|454496126|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
126328155|NCT03231306|454496126|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
126328156|NCT03231306|454496126|FG000|Overall Study|Treatment delay > 21 days|2|||
126328157|NCT03231306|454496126|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
126328158|NCT03231306|454496126|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
126328159|NCT03231306|454496126|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
126328160|NCT03231306|454496126|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
126328161|NCT03231306|454496126|FG000|Overall Study|More than 1 Reason|2|||
126328162|NCT02306850|454496127|FG000|Overall Study|Lack of Efficacy|2|||
126328163|NCT00237692|454496128|FG000|Overall Study|Lost to Follow-up|9|||
126328164|NCT00237692|454496129|FG001|Overall Study|Lost to Follow-up|3|||
126328165|NCT00237692|454496130|FG002|Overall Study|Lost to Follow-up|5|||
126328166|NCT00237692|454496131|FG003|Overall Study|Lost to Follow-up|3|||
126328167|NCT00237692|454496128|FG000|Overall Study|Death|1|||
126328168|NCT00237692|454496129|FG001|Overall Study|Death|2|||
126328169|NCT00237692|454496130|FG002|Overall Study|Death|2|||
126328170|NCT00237692|454496131|FG003|Overall Study|Death|3|||
126328171|NCT00237692|454496128|FG000|Overall Study|Excluded - did not meet criteria|4|||
126328172|NCT00237692|454496129|FG001|Overall Study|Excluded - did not meet criteria|3|||
126328173|NCT00237692|454496130|FG002|Overall Study|Excluded - did not meet criteria|5|||
126328174|NCT00237692|454496131|FG003|Overall Study|Excluded - did not meet criteria|9|||
126328175|NCT00237692|454496128|FG000|Overall Study|Withdrawal by Subject|4|||
126328176|NCT00237692|454496129|FG001|Overall Study|Withdrawal by Subject|6|||
126328177|NCT00237692|454496130|FG002|Overall Study|Withdrawal by Subject|10|||
126328178|NCT00237692|454496131|FG003|Overall Study|Withdrawal by Subject|4|||
126328179|NCT00685360|454496134|FG000|Overall Study|Lost to Follow-up|0|||
126328180|NCT00685360|454496135|FG001|Overall Study|Lost to Follow-up|1|||
126328181|NCT00685360|454496136|FG002|Overall Study|Lost to Follow-up|2|||
126328182|NCT00685360|454496134|FG000|Overall Study|Adverse Event|4|||
126328183|NCT00685360|454496135|FG001|Overall Study|Adverse Event|6|||
126328184|NCT00685360|454496136|FG002|Overall Study|Adverse Event|4|||
126328185|NCT00685360|454496134|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
126328186|NCT00685360|454496135|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
126328187|NCT00685360|454496136|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
126328188|NCT00685360|454496134|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
126328189|NCT00685360|454496135|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
126328190|NCT00685360|454496136|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
126328191|NCT00685360|454496134|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
126328192|NCT00685360|454496135|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
126328193|NCT00685360|454496136|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
126328194|NCT00685360|454496134|FG000|Overall Study|Protocol Deviation|0|||
126328195|NCT00685360|454496135|FG001|Overall Study|Protocol Deviation|1|||
126328196|NCT00685360|454496136|FG002|Overall Study|Protocol Deviation|1|||
126328197|NCT04865419|454496137|FG000|Overall Study|Other|1|||
126328198|NCT04865419|454496138|FG001|Overall Study|Other|2|||
126328199|NCT04865419|454496139|FG002|Overall Study|Other|2|||
126328200|NCT04865419|454496140|FG003|Overall Study|Other|1|||
126328201|NCT04865419|454496141|FG004|Overall Study|Other|3|||
126328202|NCT04865419|454496142|FG005|Overall Study|Other|0|||
126328203|NCT04865419|454496143|FG006|Overall Study|Other|0|||
126328204|NCT04865419|454496144|FG007|Overall Study|Other|1|||
126328205|NCT04865419|454496145|FG008|Overall Study|Other|0|||
126328206|NCT04865419|454496146|FG009|Overall Study|Other|0|||
126328207|NCT04865419|454496147|FG010|Overall Study|Other|0|||
126328208|NCT04865419|454496137|FG000|Overall Study|Withdrawal by Subject|0|||
126328209|NCT04865419|454496138|FG001|Overall Study|Withdrawal by Subject|1|||
126328210|NCT04865419|454496139|FG002|Overall Study|Withdrawal by Subject|1|||
126328211|NCT04865419|454496140|FG003|Overall Study|Withdrawal by Subject|0|||
126328212|NCT04865419|454496141|FG004|Overall Study|Withdrawal by Subject|0|||
126328213|NCT04865419|454496142|FG005|Overall Study|Withdrawal by Subject|0|||
126328214|NCT04865419|454496143|FG006|Overall Study|Withdrawal by Subject|0|||
126328215|NCT04865419|454496144|FG007|Overall Study|Withdrawal by Subject|1|||
126328216|NCT04865419|454496145|FG008|Overall Study|Withdrawal by Subject|2|||
126328217|NCT04865419|454496146|FG009|Overall Study|Withdrawal by Subject|1|||
126328218|NCT04865419|454496147|FG010|Overall Study|Withdrawal by Subject|0|||
126328219|NCT04865419|454496137|FG000|Overall Study|Study terminated by Sponsor|0|||
126328220|NCT04865419|454496138|FG001|Overall Study|Study terminated by Sponsor|0|||
126328221|NCT04865419|454496139|FG002|Overall Study|Study terminated by Sponsor|0|||
126328222|NCT04865419|454496140|FG003|Overall Study|Study terminated by Sponsor|2|||
126328223|NCT04865419|454496141|FG004|Overall Study|Study terminated by Sponsor|2|||
126328224|NCT04865419|454496142|FG005|Overall Study|Study terminated by Sponsor|0|||
126328225|NCT04865419|454496143|FG006|Overall Study|Study terminated by Sponsor|0|||
126328226|NCT04865419|454496144|FG007|Overall Study|Study terminated by Sponsor|0|||
126328227|NCT04865419|454496145|FG008|Overall Study|Study terminated by Sponsor|0|||
126328228|NCT04865419|454496146|FG009|Overall Study|Study terminated by Sponsor|0|||
126328229|NCT04865419|454496147|FG010|Overall Study|Study terminated by Sponsor|1|||
126328230|NCT04865419|454496137|FG000|Overall Study|Death|3|||
126328231|NCT04865419|454496138|FG001|Overall Study|Death|1|||
126328232|NCT04865419|454496139|FG002|Overall Study|Death|4|||
126328233|NCT04865419|454496140|FG003|Overall Study|Death|2|||
126328234|NCT04865419|454496141|FG004|Overall Study|Death|5|||
126328235|NCT04865419|454496142|FG005|Overall Study|Death|2|||
126328236|NCT04865419|454496143|FG006|Overall Study|Death|1|||
126328237|NCT04865419|454496144|FG007|Overall Study|Death|1|||
126328238|NCT04865419|454496145|FG008|Overall Study|Death|2|||
126328239|NCT04865419|454496146|FG009|Overall Study|Death|2|||
126328240|NCT04865419|454496147|FG010|Overall Study|Death|1|||
126328241|NCT04865419|454496137|FG000|Overall Study|Lost to Follow-up|0|||
126328242|NCT04865419|454496138|FG001|Overall Study|Lost to Follow-up|0|||
126328243|NCT04865419|454496139|FG002|Overall Study|Lost to Follow-up|0|||
126328244|NCT04865419|454496140|FG003|Overall Study|Lost to Follow-up|0|||
126328245|NCT04865419|454496141|FG004|Overall Study|Lost to Follow-up|0|||
126328246|NCT04865419|454496142|FG005|Overall Study|Lost to Follow-up|0|||
126328247|NCT04865419|454496143|FG006|Overall Study|Lost to Follow-up|0|||
126328248|NCT04865419|454496144|FG007|Overall Study|Lost to Follow-up|0|||
126328249|NCT04865419|454496145|FG008|Overall Study|Lost to Follow-up|0|||
126328250|NCT04865419|454496146|FG009|Overall Study|Lost to Follow-up|1|||
126328251|NCT04865419|454496147|FG010|Overall Study|Lost to Follow-up|0|||
126328252|NCT04208412|454496148|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
126328253|NCT04208412|454496149|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
126328254|NCT04208412|454496148|FG000|Overall Study|Withdrawal by Subject|1|||
126328255|NCT04208412|454496149|FG001|Overall Study|Withdrawal by Subject|0|||
126328256|NCT04208412|454496148|FG000|Overall Study|Lost to Follow-up|0|||
126328257|NCT04208412|454496149|FG001|Overall Study|Lost to Follow-up|1|||
126328258|NCT05415462|454496152|FG000|Overall Study|Death|18|||
126328259|NCT05415462|454496153|FG001|Overall Study|Death|10|||
126328260|NCT05415462|454496152|FG000|Overall Study|Lost to Follow-up|72|||
126328261|NCT05415462|454496153|FG001|Overall Study|Lost to Follow-up|64|||
126328262|NCT05415462|454496152|FG000|Overall Study|Physician Decision|5|||
126328263|NCT05415462|454496153|FG001|Overall Study|Physician Decision|5|||
126328264|NCT05415462|454496152|FG000|Overall Study|Protocol Deviation|1|||
126328265|NCT05415462|454496153|FG001|Overall Study|Protocol Deviation|0|||
126328266|NCT05415462|454496152|FG000|Overall Study|Withdrawal by Subject|129|||
126328267|NCT05415462|454496153|FG001|Overall Study|Withdrawal by Subject|101|||
126328268|NCT05415462|454496152|FG000|Overall Study|Other Than Specified|8|||
126328269|NCT05415462|454496153|FG001|Overall Study|Other Than Specified|8|||
126328270|NCT05095311|454496161|FG000|Overall Study|Lost to Follow-up|7|||
126328271|NCT05095311|454496162|FG001|Overall Study|Lost to Follow-up|0|||
126328272|NCT05095311|454496163|FG002|Overall Study|Lost to Follow-up|0|||
126328273|NCT02588664|454496166|FG000|Overall Study|Death|56|||
126328274|NCT02588664|454496167|FG001|Overall Study|Death|55|||
126328275|NCT02588664|454496166|FG000|Overall Study|Lost to Follow-up|1305|||
126328276|NCT02588664|454496167|FG001|Overall Study|Lost to Follow-up|990|||
126328277|NCT01429298|454496168|FG000|Overall Study|Protocol Violation|4|||
126328278|NCT01429298|454496169|FG001|Overall Study|Protocol Violation|6|||
126328279|NCT01124292|454496171|FG000|Overall Study|Lost to Follow-up|2|||
126328280|NCT01124292|454496172|FG001|Overall Study|Lost to Follow-up|4|||
126328281|NCT01124292|454496173|FG002|Overall Study|Lost to Follow-up|3|||
126328282|NCT01124292|454496171|FG000|Overall Study|Physician Decision|0|||
126328283|NCT01124292|454496172|FG001|Overall Study|Physician Decision|3|||
126328284|NCT01124292|454496173|FG002|Overall Study|Physician Decision|2|||
126328285|NCT01124292|454496171|FG000|Overall Study|Withdrawal by Subject|0|||
126328286|NCT01124292|454496172|FG001|Overall Study|Withdrawal by Subject|6|||
126328287|NCT01124292|454496173|FG002|Overall Study|Withdrawal by Subject|2|||
126328288|NCT01124292|454496171|FG000|Overall Study|medical issue unrelated to the study|0|||
126328289|NCT01124292|454496172|FG001|Overall Study|medical issue unrelated to the study|0|||
126328290|NCT01124292|454496173|FG002|Overall Study|medical issue unrelated to the study|2|||
126328291|NCT01124292|454496171|FG000|Overall Study|piercing track closed|0|||
126328292|NCT01124292|454496172|FG001|Overall Study|piercing track closed|2|||
126328293|NCT01124292|454496173|FG002|Overall Study|piercing track closed|1|||
126328294|NCT03373461|454496174|FG000|Part 2|Adverse Event|0|||
126328295|NCT03373461|454496175|FG001|Part 2|Adverse Event|1|||
126328296|NCT03373461|454496176|FG002|Part 2|Adverse Event|0|||
126328297|NCT03373461|454496177|FG003|Part 2|Adverse Event|0|||
126328298|NCT03373461|454496178|FG004|Part 2|Adverse Event|1|||
126328299|NCT03300180|454496179|FG000|Baseline|Withdrawal by Subject|4|||
126328300|NCT03300180|454496180|FG001|Baseline|Withdrawal by Subject|6|||
126328301|NCT03300180|454496181|FG002|Baseline|Withdrawal by Subject|4|||
126328302|NCT03300180|454496179|FG000|6 Month Outcome|Withdrawal by Subject|12|||
126328303|NCT03300180|454496180|FG001|6 Month Outcome|Withdrawal by Subject|12|||
126328304|NCT03300180|454496181|FG002|6 Month Outcome|Withdrawal by Subject|19|||
126328305|NCT03300180|454496179|FG000|6 Month Outcome|Death|2|||
126328306|NCT03300180|454496180|FG001|6 Month Outcome|Death|4|||
126328307|NCT03300180|454496181|FG002|6 Month Outcome|Death|3|||
126328308|NCT03300180|454496179|FG000|6 Month Outcome|Missed Assessment|43|||
126328309|NCT03300180|454496180|FG001|6 Month Outcome|Missed Assessment|52|||
126328310|NCT03300180|454496181|FG002|6 Month Outcome|Missed Assessment|46|||
126328311|NCT03300180|454496179|FG000|12 Month Outcome|Withdrawal by Subject|3|||
126328312|NCT03300180|454496180|FG001|12 Month Outcome|Withdrawal by Subject|6|||
126328313|NCT03300180|454496181|FG002|12 Month Outcome|Withdrawal by Subject|6|||
126328314|NCT03300180|454496179|FG000|12 Month Outcome|Death|9|||
126328315|NCT03300180|454496180|FG001|12 Month Outcome|Death|6|||
126328316|NCT03300180|454496181|FG002|12 Month Outcome|Death|6|||
126328317|NCT03300180|454496179|FG000|12 Month Outcome|Missed Assessment|62|||
126328318|NCT03300180|454496180|FG001|12 Month Outcome|Missed Assessment|59|||
126328319|NCT03300180|454496181|FG002|12 Month Outcome|Missed Assessment|58|||
126328320|NCT03300180|454496179|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
126328321|NCT03300180|454496180|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
126328322|NCT03300180|454496181|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
126328323|NCT03300180|454496179|FG000|18 Month Outcome Assessment|Death|8|||
126328324|NCT03300180|454496180|FG001|18 Month Outcome Assessment|Death|5|||
126328325|NCT03300180|454496181|FG002|18 Month Outcome Assessment|Death|5|||
126328326|NCT03300180|454496179|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
126328327|NCT03300180|454496180|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
126328328|NCT03300180|454496181|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
126328329|NCT03300180|454496179|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
126328330|NCT03300180|454496180|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
126328331|NCT03300180|454496181|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
126328332|NCT03300180|454496179|FG000|24 Month Outcome Assessment|Death|13|||
126328333|NCT03300180|454496180|FG001|24 Month Outcome Assessment|Death|13|||
126328334|NCT03300180|454496181|FG002|24 Month Outcome Assessment|Death|3|||
126328335|NCT03300180|454496179|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
126328336|NCT03300180|454496180|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
126328337|NCT03300180|454496181|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
126328338|NCT00588146|454497866|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
126328339|NCT00588146|454497867|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
126328340|NCT02823470|454497868|FG000|Overall Study|Adverse Event|1|||
126328341|NCT02823470|454497869|FG001|Overall Study|Adverse Event|0|||
126328342|NCT02823470|454497868|FG000|Overall Study|Study terminated by sponsor|8|||
126328343|NCT02823470|454497869|FG001|Overall Study|Study terminated by sponsor|15|||
126328344|NCT00463801|454497872|FG000|Overall Study|Protocol Violation|1|||
126328345|NCT00463801|454497872|FG000|Overall Study|Lack of Efficacy|2|||
126328346|NCT00463801|454497872|FG000|Overall Study|Adverse Event|4|||
126328347|NCT00463801|454497872|FG000|Overall Study|Lost to Follow-up|5|||
126328348|NCT00463801|454497872|FG000|Overall Study|No longer require therapy|1|||
126328349|NCT02315664|454497873|FG000|Overall Study|Lost to Follow-up|1|||
126328350|NCT02315664|454497874|FG001|Overall Study|Lost to Follow-up|1|||
126328351|NCT02315664|454497873|FG000|Overall Study|Withdrawal by Subject|0|||
126328352|NCT02315664|454497874|FG001|Overall Study|Withdrawal by Subject|3|||
126328353|NCT02501161|454497877|FG000|Overall Study|Adverse Event|2|||
126328354|NCT02501161|454497878|FG001|Overall Study|Adverse Event|6|||
126328355|NCT02501161|454497877|FG000|Overall Study|Lost to Follow-up|7|||
126328356|NCT02501161|454497878|FG001|Overall Study|Lost to Follow-up|4|||
126328357|NCT02501161|454497877|FG000|Overall Study|Withdrawal by Subject|10|||
126328358|NCT02501161|454497878|FG001|Overall Study|Withdrawal by Subject|15|||
126328359|NCT02501161|454497877|FG000|Overall Study|Other|3|||
126328360|NCT02501161|454497878|FG001|Overall Study|Other|0|||
126328361|NCT01990573|454497879|FG000|Overall Study|Physician Decision|0|||
126328362|NCT01990573|454497880|FG001|Overall Study|Physician Decision|0|||
126328363|NCT01990573|454497881|FG002|Overall Study|Physician Decision|1|||
126328364|NCT03335813|454497882|FG000|Overall Study|Withdrawal by Subject|1|||
126328365|NCT01957579|454497883|FG000|Overall Study|Withdrawal of concent|0|||
126328366|NCT01957579|454497884|FG001|Overall Study|Withdrawal of concent|1|||
126328367|NCT01957579|454497885|FG002|Overall Study|Withdrawal of concent|0|||
126328368|NCT01957579|454497886|FG003|Overall Study|Withdrawal of concent|0|||
126328369|NCT01957579|454497883|FG000|Overall Study|Death|0|||
126328370|NCT01957579|454497884|FG001|Overall Study|Death|0|||
126328371|NCT01957579|454497885|FG002|Overall Study|Death|2|||
126328372|NCT01957579|454497886|FG003|Overall Study|Death|0|||
126328373|NCT01639144|454497887|FG000|Overall Study|Withdrawal by Subject|4|||
126328374|NCT01639144|454497888|FG001|Overall Study|Withdrawal by Subject|2|||
126328375|NCT01639144|454497887|FG000|Overall Study|Physician Decision|2|||
126328376|NCT01639144|454497888|FG001|Overall Study|Physician Decision|0|||
126328377|NCT01639144|454497887|FG000|Overall Study|Met postoperative exclusion criteria|4|||
126328378|NCT01639144|454497888|FG001|Overall Study|Met postoperative exclusion criteria|3|||
126328379|NCT01000974|454497889|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
126328380|NCT01000974|454497890|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
126328381|NCT01000974|454497891|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
126328382|NCT01000974|454497889|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
126328383|NCT01000974|454497890|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
126328384|NCT01000974|454497891|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
126328385|NCT01000974|454497889|FG000|Primary Vaccination Phase|Protocol Violation|40|||
126328386|NCT01000974|454497890|FG001|Primary Vaccination Phase|Protocol Violation|3|||
126328387|NCT01000974|454497891|FG002|Primary Vaccination Phase|Protocol Violation|2|||
126328388|NCT01000974|454497889|FG000|Primary Vaccination Phase|Adverse Event|14|||
126328389|NCT01000974|454497890|FG001|Primary Vaccination Phase|Adverse Event|2|||
126328390|NCT01000974|454497891|FG002|Primary Vaccination Phase|Adverse Event|2|||
126328391|NCT01000974|454497889|FG000|Primary Vaccination Phase|Other|4|||
126328392|NCT01000974|454497890|FG001|Primary Vaccination Phase|Other|9|||
126328393|NCT01000974|454497891|FG002|Primary Vaccination Phase|Other|12|||
126328394|NCT01000974|454497889|FG000|Booster Vaccination Phase|Protocol Violation|0|||
126328395|NCT01000974|454497890|FG001|Booster Vaccination Phase|Protocol Violation|0|||
126328396|NCT01000974|454497891|FG002|Booster Vaccination Phase|Protocol Violation|2|||
126328397|NCT01000974|454497889|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
126328398|NCT01000974|454497890|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
126328399|NCT01000974|454497891|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
126328400|NCT01000974|454497889|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
126328401|NCT01000974|454497890|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
126328402|NCT01000974|454497891|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
126328403|NCT01000974|454497889|FG000|Booster Vaccination Phase|Other|24|||
126328404|NCT01000974|454497890|FG001|Booster Vaccination Phase|Other|6|||
126328405|NCT01000974|454497891|FG002|Booster Vaccination Phase|Other|4|||
126328406|NCT02750332|454497892|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126328407|NCT02750332|454497893|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126328408|NCT02485483|454497900|FG000|Overall Study|Depression at baseline|15|||
126328409|NCT02485483|454497901|FG001|Overall Study|Depression at baseline|0|||
126328410|NCT02485483|454497900|FG000|Overall Study|Discontinued after baseline|39|||
126328411|NCT02485483|454497901|FG001|Overall Study|Discontinued after baseline|0|||
126328412|NCT00621257|454497902|FG000|Overall Study|Lost to Follow-up|4|||
126328413|NCT00621257|454497903|FG001|Overall Study|Lost to Follow-up|0|||
126328414|NCT00621257|454497904|FG002|Overall Study|Lost to Follow-up|2|||
126328415|NCT00621257|454497905|FG003|Overall Study|Lost to Follow-up|4|||
126328416|NCT00621257|454497906|FG004|Overall Study|Lost to Follow-up|7|||
126328417|NCT00621257|454497902|FG000|Overall Study|Adverse Event|0|||
126328418|NCT00621257|454497903|FG001|Overall Study|Adverse Event|1|||
126328419|NCT00621257|454497904|FG002|Overall Study|Adverse Event|1|||
126328420|NCT00621257|454497905|FG003|Overall Study|Adverse Event|0|||
126328421|NCT00621257|454497906|FG004|Overall Study|Adverse Event|0|||
126328422|NCT00621257|454497902|FG000|Overall Study|Physician Decision|0|||
126328423|NCT00621257|454497903|FG001|Overall Study|Physician Decision|2|||
126328424|NCT00621257|454497904|FG002|Overall Study|Physician Decision|0|||
126328425|NCT00621257|454497905|FG003|Overall Study|Physician Decision|1|||
126328426|NCT00621257|454497906|FG004|Overall Study|Physician Decision|1|||
126328427|NCT00621257|454497902|FG000|Overall Study|Withdrawal by Subject|0|||
126328428|NCT00621257|454497903|FG001|Overall Study|Withdrawal by Subject|0|||
126328429|NCT00621257|454497904|FG002|Overall Study|Withdrawal by Subject|0|||
126328430|NCT00621257|454497905|FG003|Overall Study|Withdrawal by Subject|1|||
126655149|NCT03271021|455695735|FG001|Overall Study|Miscellaneous|8|||
126328431|NCT00621257|454497906|FG004|Overall Study|Withdrawal by Subject|1|||
126328432|NCT01255904|454497907|FG000|Overall Study|Physician Decision|1|||
126328433|NCT01255904|454497908|FG001|Overall Study|Physician Decision|4|||
126328434|NCT00632125|454497913|FG000|Overall Study|Death|82|||
126328435|NCT00632125|454497913|FG000|Overall Study|Withdrawal by Subject|44|||
126328436|NCT00632125|454497913|FG000|Overall Study|Adverse Event|36|||
126328437|NCT00632125|454497913|FG000|Overall Study|Renal transplantation|17|||
126328438|NCT00632125|454497913|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
126328439|NCT00632125|454497913|FG000|Overall Study|Non-compliance|8|||
126328440|NCT00632125|454497913|FG000|Overall Study|Development of uncontrolled hypertension|5|||
126328441|NCT00632125|454497913|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
126328442|NCT02384538|454497914|FG000|Overall Study|Adverse Event|1|||
126328443|NCT02384538|454497915|FG001|Overall Study|Adverse Event|4|||
126328444|NCT02384538|454497914|FG000|Overall Study|Lack of Efficacy|4|||
126328445|NCT02384538|454497915|FG001|Overall Study|Lack of Efficacy|4|||
126328446|NCT02384538|454497914|FG000|Overall Study|Withdrew Consent|0|||
126328447|NCT02384538|454497915|FG001|Overall Study|Withdrew Consent|4|||
126328448|NCT02384538|454497914|FG000|Overall Study|Other|1|||
126328449|NCT02384538|454497915|FG001|Overall Study|Other|3|||
126328450|NCT04446429|454497918|FG000|Overall Study|Lost to Follow-up|6|||
126328451|NCT04446429|454497919|FG001|Overall Study|Lost to Follow-up|0|||
126328452|NCT02256917|454497920|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
126328453|NCT02256917|454497920|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
126328454|NCT02256917|454497920|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
126328455|NCT02256917|454497920|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
126328456|NCT02256917|454497920|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
126328457|NCT00540644|454497921|FG000|Overall Study|Adverse Event|3|||
126328458|NCT00540644|454497922|FG001|Overall Study|Adverse Event|1|||
126328459|NCT00540644|454497921|FG000|Overall Study|Disease Progression|3|||
126328460|NCT00540644|454497922|FG001|Overall Study|Disease Progression|1|||
126328461|NCT00540644|454497921|FG000|Overall Study|Physician Decision|0|||
126328462|NCT00540644|454497922|FG001|Overall Study|Physician Decision|5|||
126328463|NCT00540644|454497921|FG000|Overall Study|Withdrawal by Subject|2|||
126328464|NCT00540644|454497922|FG001|Overall Study|Withdrawal by Subject|2|||
126328465|NCT00540644|454497921|FG000|Overall Study|Noncomplilance|1|||
126328466|NCT00540644|454497922|FG001|Overall Study|Noncomplilance|0|||
126328467|NCT00809094|454497923|FG000|Overall Study|Lost to Follow-up|0|||
126328468|NCT00809094|454497924|FG001|Overall Study|Lost to Follow-up|1|||
126328469|NCT00397189|454497926|FG000|3 Weeks Period|Lost to Follow-up|5|||
126328470|NCT00397189|454497927|FG001|3 Weeks Period|Lost to Follow-up|4|||
126328471|NCT00397189|454497926|FG000|3 Weeks Period|Adverse Event|3|||
126328472|NCT00397189|454497927|FG001|3 Weeks Period|Adverse Event|2|||
126328473|NCT00397189|454497926|FG000|3 Weeks Period|Withdrawal by Subject|13|||
126328474|NCT00397189|454497927|FG001|3 Weeks Period|Withdrawal by Subject|9|||
126328475|NCT00397189|454497926|FG000|3 Weeks Period|Physician Decision|0|||
126328476|NCT00397189|454497927|FG001|3 Weeks Period|Physician Decision|2|||
126328477|NCT00397189|454497926|FG000|3 Weeks Period|Protocol Violation|0|||
126328478|NCT00397189|454497927|FG001|3 Weeks Period|Protocol Violation|3|||
126328479|NCT00397189|454497926|FG000|3 Weeks Period|Other|0|||
126328480|NCT00397189|454497927|FG001|3 Weeks Period|Other|2|||
126328481|NCT01535443|454497928|FG000|Overall Study|Physician Decision|3|||
126328482|NCT00232557|454497931|FG000|Overall Study|Lost to Follow-up|3|||
126328483|NCT00232557|454497932|FG001|Overall Study|Lost to Follow-up|5|||
126328484|NCT01059773|454497933|FG000|Overall Study|Adverse Event|2|||
126328485|NCT01059773|454497934|FG001|Overall Study|Adverse Event|2|||
126328486|NCT01059773|454497933|FG000|Overall Study|Withdrawal by Subject|1|||
126328487|NCT01059773|454497934|FG001|Overall Study|Withdrawal by Subject|5|||
126328488|NCT01059773|454497933|FG000|Overall Study|Lost to Follow-up|1|||
126328489|NCT01059773|454497934|FG001|Overall Study|Lost to Follow-up|1|||
126328490|NCT01059773|454497933|FG000|Overall Study|Pregnancy|1|||
126328491|NCT01059773|454497934|FG001|Overall Study|Pregnancy|1|||
126328492|NCT01059773|454497933|FG000|Overall Study|Protocol Violation|6|||
126328493|NCT01059773|454497934|FG001|Overall Study|Protocol Violation|2|||
126328494|NCT01059773|454497933|FG000|Overall Study|Physician Decision|5|||
126328495|NCT01059773|454497934|FG001|Overall Study|Physician Decision|4|||
126328496|NCT01059773|454497933|FG000|Overall Study|Lack of Efficacy|3|||
126328497|NCT01059773|454497934|FG001|Overall Study|Lack of Efficacy|3|||
126328498|NCT01059773|454497933|FG000|Overall Study|Death|0|||
126328499|NCT01059773|454497934|FG001|Overall Study|Death|1|||
126328500|NCT01059773|454497933|FG000|Overall Study|Malignancy including squamous cell skin|0|||
126328501|NCT01059773|454497934|FG001|Overall Study|Malignancy including squamous cell skin|1|||
126328502|NCT01059773|454497933|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
126328503|NCT01059773|454497934|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
126328504|NCT01059773|454497933|FG000|Overall Study|Other|1|||
126328505|NCT01059773|454497934|FG001|Overall Study|Other|3|||
126328506|NCT01806168|454497937|FG000|Overall Study|Adverse Event|1|||
126328507|NCT01806168|454497938|FG001|Overall Study|Adverse Event|0|||
126328508|NCT01806168|454497939|FG002|Overall Study|Adverse Event|0|||
126328509|NCT01806168|454497937|FG000|Overall Study|Withdrawal by Subject|0|||
126328510|NCT01806168|454497938|FG001|Overall Study|Withdrawal by Subject|1|||
126328511|NCT01806168|454497939|FG002|Overall Study|Withdrawal by Subject|2|||
126328512|NCT01806168|454497937|FG000|Overall Study|Protocol Violation|0|||
126328513|NCT01806168|454497938|FG001|Overall Study|Protocol Violation|0|||
126328514|NCT01806168|454497939|FG002|Overall Study|Protocol Violation|1|||
126328515|NCT01029262|454497942|FG000|Overall Study|Adverse Event|9|||
126328516|NCT01029262|454497943|FG001|Overall Study|Adverse Event|52|||
126328517|NCT01029262|454497942|FG000|Overall Study|Lack of therapeutic effect|57|||
126328518|NCT01029262|454497943|FG001|Overall Study|Lack of therapeutic effect|76|||
126328519|NCT01029262|454497942|FG000|Overall Study|Withdrawal by Subject|10|||
126328520|NCT01029262|454497943|FG001|Overall Study|Withdrawal by Subject|17|||
126328521|NCT01029262|454497942|FG000|Overall Study|Protocol Violation|2|||
126328522|NCT01029262|454497943|FG001|Overall Study|Protocol Violation|3|||
126328523|NCT01029262|454497942|FG000|Overall Study|Miscellaneous|1|||
126328524|NCT01029262|454497943|FG001|Overall Study|Miscellaneous|9|||
126328525|NCT01029262|454497942|FG000|Overall Study|Death|0|||
126328526|NCT01029262|454497943|FG001|Overall Study|Death|3|||
126328527|NCT03410992|454497944|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328528|NCT03410992|454497945|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
126328529|NCT03410992|454497946|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328530|NCT03410992|454497947|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328531|NCT03410992|454497948|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328532|NCT03410992|454497949|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328533|NCT03410992|454497950|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328534|NCT03410992|454497951|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328535|NCT03410992|454497952|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328536|NCT03410992|454497953|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328537|NCT03410992|454497954|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
126328538|NCT03410992|454497944|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
126328539|NCT03410992|454497945|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
126328540|NCT03410992|454497946|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328541|NCT03410992|454497947|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328542|NCT03410992|454497948|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328543|NCT03410992|454497949|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328544|NCT03410992|454497950|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328545|NCT03410992|454497951|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328546|NCT03410992|454497952|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328547|NCT03410992|454497953|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328548|NCT03410992|454497954|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
126328549|NCT03410992|454497944|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
126328550|NCT03410992|454497945|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
126328551|NCT03410992|454497946|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328552|NCT03410992|454497947|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328553|NCT03410992|454497948|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328554|NCT03410992|454497949|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328555|NCT03410992|454497950|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328556|NCT03410992|454497951|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328557|NCT03410992|454497952|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328558|NCT03410992|454497953|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328559|NCT03410992|454497954|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
126328560|NCT03410992|454497944|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
126328561|NCT03410992|454497945|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328562|NCT03410992|454497946|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328563|NCT03410992|454497947|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328564|NCT03410992|454497948|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328565|NCT03410992|454497949|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328566|NCT03410992|454497950|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328567|NCT03410992|454497951|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328568|NCT03410992|454497952|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328569|NCT03410992|454497953|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328570|NCT03410992|454497954|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
126328571|NCT03410992|454497944|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
126328572|NCT03410992|454497945|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
126328573|NCT03410992|454497946|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328574|NCT03410992|454497947|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328575|NCT03410992|454497948|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328576|NCT03410992|454497949|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328577|NCT03410992|454497950|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328578|NCT03410992|454497951|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328579|NCT03410992|454497952|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328580|NCT03410992|454497953|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328581|NCT03410992|454497954|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
126328582|NCT03410992|454497944|FG000|Week 16 Assessment|Incorrect escapers|0|||
126328583|NCT03410992|454497945|FG001|Week 16 Assessment|Incorrect escapers|6|||
126328584|NCT03410992|454497946|FG002|Week 16 Assessment|Incorrect escapers|0|||
126328585|NCT03410992|454497947|FG003|Week 16 Assessment|Incorrect escapers|0|||
126328586|NCT03410992|454497948|FG004|Week 16 Assessment|Incorrect escapers|0|||
126328587|NCT03410992|454497949|FG005|Week 16 Assessment|Incorrect escapers|0|||
126328588|NCT03410992|454497950|FG006|Week 16 Assessment|Incorrect escapers|0|||
126328589|NCT03410992|454497951|FG007|Week 16 Assessment|Incorrect escapers|0|||
126328590|NCT03410992|454497952|FG008|Week 16 Assessment|Incorrect escapers|0|||
126328591|NCT03410992|454497953|FG009|Week 16 Assessment|Incorrect escapers|0|||
126328592|NCT03410992|454497954|FG010|Week 16 Assessment|Incorrect escapers|0|||
126328593|NCT03410992|454497944|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328594|NCT03410992|454497945|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328595|NCT03410992|454497946|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328596|NCT03410992|454497947|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
126328597|NCT03410992|454497948|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
126328598|NCT03410992|454497949|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328599|NCT03410992|454497950|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328600|NCT03410992|454497951|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328601|NCT03410992|454497952|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328602|NCT03410992|454497953|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328603|NCT03410992|454497954|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
126328604|NCT03410992|454497944|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328605|NCT03410992|454497945|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328606|NCT03410992|454497946|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328607|NCT03410992|454497947|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
126328608|NCT03410992|454497948|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
126328609|NCT03410992|454497949|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
126328610|NCT03410992|454497950|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328611|NCT03410992|454497951|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328612|NCT03410992|454497952|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328613|NCT03410992|454497953|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328614|NCT03410992|454497954|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
126328615|NCT03410992|454497944|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328616|NCT03410992|454497945|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328617|NCT03410992|454497946|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328618|NCT03410992|454497947|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328619|NCT03410992|454497948|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328620|NCT03410992|454497949|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
126328621|NCT03410992|454497950|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328622|NCT03410992|454497951|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328623|NCT03410992|454497952|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328624|NCT03410992|454497953|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328625|NCT03410992|454497954|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
126328626|NCT03410992|454497944|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328627|NCT03410992|454497945|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328628|NCT03410992|454497946|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328629|NCT03410992|454497947|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
126328630|NCT03410992|454497948|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
126328631|NCT03410992|454497949|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
126328632|NCT03410992|454497950|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328633|NCT03410992|454497951|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328634|NCT03410992|454497952|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328635|NCT03410992|454497953|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328636|NCT03410992|454497954|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
126328637|NCT03410992|454497944|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328638|NCT03410992|454497945|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328639|NCT03410992|454497946|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328640|NCT03410992|454497947|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328641|NCT03410992|454497948|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328642|NCT03410992|454497949|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328643|NCT03410992|454497950|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328644|NCT03410992|454497951|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
126328645|NCT03410992|454497952|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328646|NCT03410992|454497953|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328647|NCT03410992|454497954|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
126328648|NCT03410992|454497944|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328649|NCT03410992|454497945|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328650|NCT03410992|454497946|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328651|NCT03410992|454497947|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328652|NCT03410992|454497948|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328653|NCT03410992|454497949|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328654|NCT03410992|454497950|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328655|NCT03410992|454497951|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328656|NCT03410992|454497952|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
126328657|NCT03410992|454497953|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328658|NCT03410992|454497954|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
126328659|NCT02438280|454497955|FG000|Overall Study|Physician Decision|1|||
126328660|NCT02438280|454497956|FG001|Overall Study|Physician Decision|0|||
126328661|NCT02260817|454497957|FG000|Overall Study|Lost to Follow-up|0|||
126328662|NCT02260817|454497958|FG001|Overall Study|Lost to Follow-up|14|||
126328663|NCT02260817|454497957|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
126328664|NCT02260817|454497958|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
126328665|NCT02260817|454497957|FG000|Overall Study|Observation, no biopsy|0|||
126328666|NCT02260817|454497958|FG001|Overall Study|Observation, no biopsy|1|||
126328667|NCT02260817|454497957|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
126328668|NCT02260817|454497958|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
126328669|NCT02260817|454497957|FG000|Overall Study|Protocol Violation|0|||
126328670|NCT02260817|454497958|FG001|Overall Study|Protocol Violation|14|||
126328671|NCT03299101|454497959|FG000|Overall Study|Lost to Follow-up|1|||
126328672|NCT03299101|454497959|FG000|Overall Study|Withdrawal by Subject|5|||
126328673|NCT03299101|454497959|FG000|Overall Study|Surgery was changed|3|||
126328674|NCT03299101|454497959|FG000|Overall Study|Not enough time to complete prehab|1|||
126328675|NCT03066778|454497963|FG000|Overall Study|Death|195|||
126328676|NCT03066778|454497964|FG001|Overall Study|Death|205|||
126328677|NCT03066778|454497963|FG000|Overall Study|Withdrawal by Subject|5|||
126328678|NCT03066778|454497964|FG001|Overall Study|Withdrawal by Subject|7|||
126328679|NCT02328937|454497965|FG000|Period 1|Lost to Follow-up|0|||
126328680|NCT02328937|454497966|FG001|Period 1|Lost to Follow-up|0|||
126328681|NCT02328937|454497967|FG002|Period 1|Lost to Follow-up|0|||
126328682|NCT02328937|454497968|FG003|Period 1|Lost to Follow-up|1|||
126328683|NCT02328937|454497969|FG004|Period 1|Lost to Follow-up|0|||
126328684|NCT02328937|454497970|FG005|Period 1|Lost to Follow-up|0|||
126328685|NCT02328937|454497965|FG000|Period 2|Adverse Event|0|||
126328686|NCT02328937|454497966|FG001|Period 2|Adverse Event|0|||
126328687|NCT02328937|454497967|FG002|Period 2|Adverse Event|1|||
126328688|NCT02328937|454497968|FG003|Period 2|Adverse Event|0|||
126328689|NCT02328937|454497969|FG004|Period 2|Adverse Event|0|||
126328690|NCT02328937|454497970|FG005|Period 2|Adverse Event|0|||
126328691|NCT03665077|454497973|FG000|Overall Study|Lost to Follow-up|2|||
126328692|NCT03665077|454497973|FG000|Overall Study|Physician Decision|2|||
126328693|NCT02420262|454497976|FG000|Overall Study|Adverse Event|1|||
126328694|NCT02420262|454497977|FG001|Overall Study|Adverse Event|0|||
126328695|NCT02420262|454497976|FG000|Overall Study|Withdrawal by Subject|1|||
126328696|NCT02420262|454497977|FG001|Overall Study|Withdrawal by Subject|4|||
126328697|NCT02420262|454497976|FG000|Overall Study|Unclassified|0|||
126328698|NCT02420262|454497977|FG001|Overall Study|Unclassified|1|||
126328699|NCT01904032|454497981|FG000|Overall Study|Adverse Event|3|||
126328700|NCT01904032|454497982|FG001|Overall Study|Adverse Event|1|||
126328701|NCT01904032|454497981|FG000|Overall Study|Lost to Follow-up|4|||
126328702|NCT01904032|454497982|FG001|Overall Study|Lost to Follow-up|2|||
126328703|NCT04074330|454497995|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
126328704|NCT04074330|454497996|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
126328705|NCT04074330|454497997|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
126328706|NCT04074330|454497998|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
126328707|NCT04074330|454497999|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
126328708|NCT04074330|454498000|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
126328709|NCT04074330|454498001|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
126328710|NCT04074330|454498002|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
126328711|NCT04074330|454498003|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
126328712|NCT04074330|454498004|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
126328713|NCT04074330|454497995|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
126328714|NCT04074330|454497996|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
126328715|NCT04074330|454497997|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
126328716|NCT04074330|454497998|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
126328717|NCT04074330|454497999|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
126328718|NCT04074330|454498000|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
126328719|NCT04074330|454498001|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
126328720|NCT04074330|454498002|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
126328721|NCT04074330|454498003|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
126328722|NCT04074330|454498004|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
126328723|NCT04074330|454497995|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328724|NCT04074330|454497996|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328725|NCT04074330|454497997|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
126328726|NCT04074330|454497998|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328727|NCT04074330|454497999|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328728|NCT04074330|454498000|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328729|NCT04074330|454498001|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328730|NCT04074330|454498002|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328731|NCT04074330|454498003|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328732|NCT04074330|454498004|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
126328733|NCT04074330|454497995|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328734|NCT04074330|454497996|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328735|NCT04074330|454497997|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328736|NCT04074330|454497998|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328737|NCT04074330|454497999|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328738|NCT04074330|454498000|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
126328739|NCT04074330|454498001|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328740|NCT04074330|454498002|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
126328741|NCT04074330|454498003|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126328742|NCT04074330|454498004|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
126655150|NCT01383499|455695736|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
126655151|NCT01383499|455695737|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126655152|NCT01383499|455695738|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126655153|NCT01383499|455695739|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126328743|NCT04074330|454497995|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
126328744|NCT04074330|454497996|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
126328745|NCT04074330|454497997|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
126328746|NCT04074330|454497998|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
126328747|NCT04074330|454497999|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
126328748|NCT04074330|454498000|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
126328749|NCT04074330|454498001|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
126328750|NCT04074330|454498002|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
126328751|NCT04074330|454498003|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
126328752|NCT04074330|454498004|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
126328753|NCT04074330|454497995|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
126328754|NCT04074330|454497996|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
126328755|NCT04074330|454497997|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
126328756|NCT04074330|454497998|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
126328757|NCT04074330|454497999|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
126328758|NCT04074330|454498000|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
126328759|NCT04074330|454498001|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
126328760|NCT04074330|454498002|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
126328761|NCT04074330|454498003|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
126328762|NCT04074330|454498004|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
126328763|NCT04074330|454497995|FG000|Dose Expansion (up to 42 Months)|Death|0|||
126328764|NCT04074330|454497996|FG001|Dose Expansion (up to 42 Months)|Death|0|||
126328765|NCT04074330|454497997|FG002|Dose Expansion (up to 42 Months)|Death|0|||
126328766|NCT04074330|454497998|FG003|Dose Expansion (up to 42 Months)|Death|0|||
126328767|NCT04074330|454497999|FG004|Dose Expansion (up to 42 Months)|Death|0|||
126328768|NCT04074330|454498000|FG005|Dose Expansion (up to 42 Months)|Death|0|||
126328769|NCT04074330|454498001|FG006|Dose Expansion (up to 42 Months)|Death|0|||
126328770|NCT04074330|454498002|FG007|Dose Expansion (up to 42 Months)|Death|0|||
126328771|NCT04074330|454498003|FG008|Dose Expansion (up to 42 Months)|Death|1|||
126328772|NCT04074330|454498004|FG009|Dose Expansion (up to 42 Months)|Death|0|||
126328773|NCT04074330|454497995|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328774|NCT04074330|454497996|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328775|NCT04074330|454497997|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328776|NCT04074330|454497998|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126655154|NCT04275089|455695742|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
126655155|NCT01079663|455695743|FG000|Overall Study|Adverse Event|0|||
126328777|NCT04074330|454497999|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328778|NCT04074330|454498000|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328779|NCT04074330|454498001|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328780|NCT04074330|454498002|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
126328781|NCT04074330|454498003|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
126328782|NCT04074330|454498004|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
126328783|NCT01903993|454498005|FG000|Overall Study|Death|118|||
126328784|NCT01903993|454498006|FG001|Overall Study|Death|121|||
126328785|NCT01903993|454498005|FG000|Overall Study|Withdrawal by Subject|15|||
126328786|NCT01903993|454498006|FG001|Overall Study|Withdrawal by Subject|4|||
126328787|NCT01903993|454498005|FG000|Overall Study|Lost to Follow-up|2|||
126328788|NCT01903993|454498006|FG001|Overall Study|Lost to Follow-up|3|||
126328789|NCT01903993|454498005|FG000|Overall Study|Study Terminated by Sponsor|8|||
126328790|NCT01903993|454498006|FG001|Overall Study|Study Terminated by Sponsor|14|||
126328791|NCT01903993|454498005|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
126328792|NCT01903993|454498006|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
126328793|NCT00184093|454498007|FG000|Overall Study|Adverse Event|3|||
126328794|NCT00184093|454498007|FG000|Overall Study|Lost to Follow-up|3|||
126328795|NCT00184093|454498007|FG000|Overall Study|Physician Decision|1|||
126328796|NCT00184093|454498007|FG000|Overall Study|Withdrawal by Subject|2|||
126328797|NCT00972283|454498008|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
126328798|NCT00972283|454498009|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
126328799|NCT00972283|454498008|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
126328800|NCT00972283|454498009|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
126328801|NCT00972283|454498008|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
126328802|NCT00972283|454498009|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
126328803|NCT00972283|454498008|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
126328804|NCT00972283|454498009|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
126328805|NCT00972283|454498008|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
126328806|NCT00972283|454498009|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
126328807|NCT00972283|454498008|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
126328808|NCT00972283|454498009|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
126328809|NCT00972283|454498008|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
126328810|NCT00972283|454498009|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
126328811|NCT00972283|454498008|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
126328812|NCT00972283|454498009|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
126328813|NCT00972283|454498008|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
126328814|NCT00972283|454498009|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
126328815|NCT00972283|454498008|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
126655156|NCT01079663|455695744|FG001|Overall Study|Adverse Event|2|||
126655157|NCT01079663|455695743|FG000|Overall Study|Protocol Violation|0|||
126655158|NCT01079663|455695744|FG001|Overall Study|Protocol Violation|2|||
126655159|NCT00297232|455695745|FG000|Overall Study|Lack of Efficacy|7|||
126655160|NCT00297232|455695745|FG000|Overall Study|Lost to Follow-up|10|||
126655161|NCT00297232|455695745|FG000|Overall Study|Adverse Event|63|||
126655162|NCT00297232|455695745|FG000|Overall Study|Voluntary Withdrawal|120|||
126655163|NCT00297232|455695745|FG000|Overall Study|Subject was Noncompliant|9|||
126655164|NCT00297232|455695745|FG000|Overall Study|Death|9|||
126655165|NCT00297232|455695745|FG000|Overall Study|Anti-natalizumab Positive|8|||
126655166|NCT00297232|455695745|FG000|Overall Study|Switched to Commercial Tysabri|22|||
126328816|NCT00972283|454498009|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
126328817|NCT01868165|454498012|FG000|Overall Study|Withdrawal by Subject|36|||
126328818|NCT01868165|454498012|FG000|Overall Study|Physician Decision|2|||
126328819|NCT01868165|454498012|FG000|Overall Study|Lost to Follow-up|3|||
126328820|NCT01868165|454498012|FG000|Overall Study|Death|4|||
126328821|NCT02282163|454498015|FG000|Overall Study|Protocol Violation|1|||
126328822|NCT01603407|454498016|FG000|Overall Study|Adverse Event|1|||
126328823|NCT01603407|454498017|FG001|Overall Study|Adverse Event|1|||
126328824|NCT01603407|454498018|FG002|Overall Study|Adverse Event|1|||
126328825|NCT01603407|454498016|FG000|Overall Study|Protocol Violation|2|||
126328826|NCT01603407|454498017|FG001|Overall Study|Protocol Violation|2|||
126328827|NCT01603407|454498018|FG002|Overall Study|Protocol Violation|0|||
126328828|NCT01603407|454498016|FG000|Overall Study|Withdrawal by Subject|8|||
126328829|NCT01603407|454498017|FG001|Overall Study|Withdrawal by Subject|5|||
126328830|NCT01603407|454498018|FG002|Overall Study|Withdrawal by Subject|7|||
126328831|NCT01603407|454498016|FG000|Overall Study|Lost to Follow-up|0|||
126328832|NCT01603407|454498017|FG001|Overall Study|Lost to Follow-up|3|||
126655167|NCT00297232|455695745|FG000|Overall Study|Disease Progression|8|||
126328833|NCT01603407|454498018|FG002|Overall Study|Lost to Follow-up|2|||
126328834|NCT02500719|454498019|FG000|Overall Study|Lost to Follow-up|2|||
126328835|NCT02500719|454498020|FG001|Overall Study|Lost to Follow-up|3|||
126328836|NCT02500719|454498019|FG000|Overall Study|Trauma history|1|||
126328837|NCT02500719|454498020|FG001|Overall Study|Trauma history|0|||
126655168|NCT00297232|455695745|FG000|Overall Study|Fear of PML|10|||
126328838|NCT02500719|454498019|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
126328839|NCT02500719|454498020|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
126328840|NCT02500719|454498019|FG000|Overall Study|Did not meet criteria for PTSD|0|||
126328841|NCT02500719|454498020|FG001|Overall Study|Did not meet criteria for PTSD|1|||
126328842|NCT02500719|454498019|FG000|Overall Study|Claustrophobia|0|||
126328843|NCT02500719|454498020|FG001|Overall Study|Claustrophobia|1|||
126328844|NCT02500719|454498019|FG000|Overall Study|History of head trauma|0|||
126328845|NCT02500719|454498020|FG001|Overall Study|History of head trauma|1|||
126328846|NCT01990768|454498021|FG000|Intervention Started|Found to be ineligible|14|||
126328847|NCT01990768|454498022|FG001|Intervention Started|Found to be ineligible|13|||
126328848|NCT01990768|454498023|FG002|Intervention Started|Found to be ineligible|11|||
126328849|NCT01990768|454498021|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
126328850|NCT01990768|454498022|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
126328851|NCT01990768|454498023|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
126328852|NCT01990768|454498021|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
126328853|NCT01990768|454498022|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
126328854|NCT01990768|454498023|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
126328855|NCT01990768|454498021|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
126328856|NCT01990768|454498022|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
126328857|NCT01990768|454498023|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
126328858|NCT01990768|454498021|FG000|Intervention Started|Patient care priority|1|||
126328859|NCT01990768|454498022|FG001|Intervention Started|Patient care priority|2|||
126328860|NCT01990768|454498023|FG002|Intervention Started|Patient care priority|3|||
126328861|NCT01990768|454498021|FG000|Intervention Started|IV lost|2|||
126328862|NCT01990768|454498022|FG001|Intervention Started|IV lost|2|||
126328863|NCT01990768|454498023|FG002|Intervention Started|IV lost|2|||
126328864|NCT01990768|454498021|FG000|Intervention Started|Required CPR|1|||
126655169|NCT00297232|455695745|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
126655170|NCT00297232|455695745|FG000|Overall Study|Miscellaneous|5|||
126328865|NCT01990768|454498022|FG001|Intervention Started|Required CPR|1|||
126328866|NCT01990768|454498023|FG002|Intervention Started|Required CPR|0|||
126328867|NCT01990768|454498021|FG000|Intervention Started|Seizure or hx of seizure|0|||
126328868|NCT01990768|454498022|FG001|Intervention Started|Seizure or hx of seizure|0|||
126328869|NCT01990768|454498023|FG002|Intervention Started|Seizure or hx of seizure|2|||
126328870|NCT01990768|454498021|FG000|Intervention Started|Discovered to be pregnant|0|||
126328871|NCT01990768|454498022|FG001|Intervention Started|Discovered to be pregnant|1|||
126328872|NCT01990768|454498023|FG002|Intervention Started|Discovered to be pregnant|0|||
126328873|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
126328874|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
126328875|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
126328876|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
126328877|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
126328878|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
126328879|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
126328880|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
126328881|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
126328882|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
126328883|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
126328884|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
126328885|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Death|3|||
126328886|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Death|1|||
126328887|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Death|1|||
126328888|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Discharged|2|||
126328889|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Discharged|1|||
126328890|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Discharged|0|||
126328891|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
126328892|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
126328893|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
126328894|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
126328895|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
126328896|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
126328897|NCT01990768|454498021|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
126328898|NCT01990768|454498022|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
126328899|NCT01990768|454498023|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
126328900|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
126328901|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
126328902|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
126328903|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
126655171|NCT00297232|455695745|FG000|Overall Study|Sponsor Decision|34|||
126328904|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
126328905|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
126328906|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
126328907|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
126328908|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
126328909|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
126328910|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
126328911|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
126328912|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
126328913|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
126328914|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
126328915|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
126328916|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
126328917|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
126328918|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
126328919|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
126328920|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
126328921|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
126328922|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
126328923|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
126328924|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
126328925|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
126328926|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
126328927|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
126328928|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
126328929|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
126328930|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
126328931|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
126328932|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
126328933|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
126328934|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
126328935|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
126328936|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
126328937|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
126328938|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
126328939|NCT01990768|454498021|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
126328940|NCT01990768|454498022|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
126328941|NCT01990768|454498023|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
126328942|NCT01990768|454498021|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
126328943|NCT01990768|454498022|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
126328944|NCT01990768|454498023|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
126328945|NCT01990768|454498021|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
126328946|NCT01990768|454498022|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
126328947|NCT01990768|454498023|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
126328948|NCT01990768|454498021|FG000|6-Month Follow-up|No contact information|5|||
126328949|NCT01990768|454498022|FG001|6-Month Follow-up|No contact information|6|||
126328950|NCT01990768|454498023|FG002|6-Month Follow-up|No contact information|5|||
126328951|NCT01990768|454498021|FG000|6-Month Follow-up|Homeless|4|||
126328952|NCT01990768|454498022|FG001|6-Month Follow-up|Homeless|3|||
126328953|NCT01990768|454498023|FG002|6-Month Follow-up|Homeless|6|||
126328954|NCT01990768|454498021|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
126328955|NCT01990768|454498022|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
126328956|NCT01990768|454498023|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
126328957|NCT01990768|454498021|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
126328958|NCT01990768|454498022|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
126328959|NCT01990768|454498023|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
126328960|NCT01990768|454498021|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
126328961|NCT01990768|454498022|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
126328962|NCT01990768|454498023|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
126328963|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
126328964|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
126328965|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
126328966|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
126328967|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
126328968|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
126328969|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
126328970|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
126328971|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
126328972|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
126328973|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
126328974|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
126328975|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
126328976|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
126328977|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
126328978|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
126328979|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
126328980|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
126328981|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
126328982|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
126328983|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
126328984|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
126328985|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
126328986|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
126328987|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
126328988|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
126328989|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
126328990|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
126328991|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
126328992|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
126328993|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
126328994|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
126328995|NCT03538691|454498024|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
126328996|NCT03538691|454498025|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
126655172|NCT00297232|455695745|FG000|Overall Study|Subject Relocated|7|||
126655173|NCT00297232|455695745|FG000|Overall Study|Subject Withdrew Consent|37|||
126655174|NCT00297232|455695745|FG000|Overall Study|Persistently Positive Antibodies|11|||
126655175|NCT00297232|455695745|FG000|Overall Study|Investigator Withdrew From Program|19|||
126655176|NCT00297232|455695745|FG000|Overall Study|Did Not Enroll to Week 264|34|||
126655177|NCT00297232|455695745|FG000|Overall Study|Did Not Enroll to Week 480|17|||
126655178|NCT00297232|455695745|FG000|Overall Study|No data available after Week 264|161|||
126655179|NCT00297232|455695745|FG000|Overall Study|Other|1|||
126655180|NCT03038438|455695746|FG000|Overall Study|Death|3|||
126655181|NCT03038438|455695746|FG000|Overall Study|Lost to Follow-up|8|||
126655182|NCT03038438|455695746|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
126328997|NCT03538691|454498026|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
126328998|NCT03538691|454498027|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
126328999|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
126329000|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
126329001|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
126329002|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
126329003|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
126329004|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
126329005|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
126329006|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
126329007|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
126329008|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
126329009|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
126329010|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
126329011|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
126329012|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
126329013|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
126329014|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
126655183|NCT03038438|455695746|FG000|Overall Study|Withdrawal by Subject|5|||
126655184|NCT03038438|455695746|FG000|Overall Study|No 36-Month Follow-Up|18|||
126655185|NCT03625895|455695747|FG000|Overall Study|Protocol Violation|585|||
126329015|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
126655186|NCT02476279|455695748|FG000|Overall Study|Lost to Follow-up|1|||
126655187|NCT02476279|455695749|FG001|Overall Study|Lost to Follow-up|1|||
126655188|NCT00577473|455695750|FG000|Overall Study|Protocol Violation|1|||
126655189|NCT00577473|455695751|FG001|Overall Study|Protocol Violation|4|||
126655190|NCT00577473|455695750|FG000|Overall Study|Adverse Event|8|||
126329016|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
126655191|NCT00577473|455695751|FG001|Overall Study|Adverse Event|5|||
126655192|NCT00577473|455695750|FG000|Overall Study|Withdrawal by Subject|2|||
126655193|NCT00577473|455695751|FG001|Overall Study|Withdrawal by Subject|6|||
126655194|NCT00577473|455695750|FG000|Overall Study|Physician Decision|2|||
126655195|NCT00577473|455695751|FG001|Overall Study|Physician Decision|2|||
126655196|NCT00577473|455695750|FG000|Overall Study|Lack of Efficacy|8|||
126655197|NCT00577473|455695751|FG001|Overall Study|Lack of Efficacy|7|||
126655198|NCT00232544|455695752|FG000|Overall Study|Lost to Follow-up|20|||
126655199|NCT00232544|455695753|FG001|Overall Study|Lost to Follow-up|15|||
126329017|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
126329018|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
126329019|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
126329020|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
126329021|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
126329022|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
126329023|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
126329024|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
126329025|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
126329026|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
126329027|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
126329028|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
126329029|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
126329030|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
126329031|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
126329032|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
126329033|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
126329034|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
126329035|NCT03538691|454498024|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
126329036|NCT03538691|454498025|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
126329037|NCT03538691|454498026|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
126329038|NCT03538691|454498027|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
126329039|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
126329040|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
126329041|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
126329042|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
126329043|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
126329044|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
126329045|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
126329046|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
126329047|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
126329048|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
126329049|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
126329050|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
126329051|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
126329052|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
126329053|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
126329054|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
126329055|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
126329056|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
126329057|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
126329058|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
126329059|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
126329060|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
126329061|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
126329062|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
126329063|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
126329064|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
126329065|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
126329066|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
126329067|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
126655200|NCT00986973|455695754|FG000|Overall Study|Withdrawn by study team|1|||
126655201|NCT01465347|455695755|FG000|Overall Study|Withdrawal by Subject|1|||
126655202|NCT01465347|455695756|FG001|Overall Study|Withdrawal by Subject|1|||
126329068|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
126329069|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
126329070|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
126329071|NCT03538691|454498024|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
126329072|NCT03538691|454498025|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
126329073|NCT03538691|454498026|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
126329074|NCT03538691|454498027|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
126329075|NCT01588405|454498028|FG000|Overall Study|Adverse Event|1|||
126329076|NCT01588405|454498028|FG000|Overall Study|Clinical Worsening|1|||
126329077|NCT02029274|454498030|FG000|Overall Study|Adverse Event|1|||
126329078|NCT02029274|454498031|FG001|Overall Study|Adverse Event|0|||
126329079|NCT02029274|454498032|FG002|Overall Study|Adverse Event|2|||
126329080|NCT02029274|454498033|FG003|Overall Study|Adverse Event|2|||
126329081|NCT03654729|454499979|FG000|Overall Study|Death|9|||
126329082|NCT03654729|454499980|FG001|Overall Study|Death|9|||
126329083|NCT03654729|454499981|FG002|Overall Study|Death|16|||
126329084|NCT03654729|454499979|FG000|Overall Study|Withdrawal by Subject|8|||
126329085|NCT03654729|454499980|FG001|Overall Study|Withdrawal by Subject|6|||
126329086|NCT03654729|454499981|FG002|Overall Study|Withdrawal by Subject|4|||
126329087|NCT03654729|454499979|FG000|Overall Study|Study terminated by Sponsor|3|||
126329088|NCT03654729|454499980|FG001|Overall Study|Study terminated by Sponsor|5|||
126329089|NCT03654729|454499981|FG002|Overall Study|Study terminated by Sponsor|4|||
126329090|NCT03654729|454499979|FG000|Overall Study|Not reported|2|||
126329091|NCT03654729|454499980|FG001|Overall Study|Not reported|4|||
126329092|NCT03654729|454499981|FG002|Overall Study|Not reported|5|||
126329093|NCT03654729|454499979|FG000|Overall Study|Progressive disease|3|||
126329094|NCT03654729|454499980|FG001|Overall Study|Progressive disease|0|||
126329095|NCT03654729|454499981|FG002|Overall Study|Progressive disease|0|||
126329096|NCT03654729|454499979|FG000|Overall Study|Lost to Follow-up|2|||
126329097|NCT03654729|454499980|FG001|Overall Study|Lost to Follow-up|0|||
126329098|NCT03654729|454499981|FG002|Overall Study|Lost to Follow-up|0|||
126329099|NCT03654729|454499979|FG000|Overall Study|Physician Decision|2|||
126329100|NCT03654729|454499980|FG001|Overall Study|Physician Decision|0|||
126329101|NCT03654729|454499981|FG002|Overall Study|Physician Decision|0|||
126329102|NCT03654729|454499979|FG000|Overall Study|Protocol Violation|1|||
126329103|NCT03654729|454499980|FG001|Overall Study|Protocol Violation|1|||
126329104|NCT03654729|454499981|FG002|Overall Study|Protocol Violation|0|||
126329105|NCT03654729|454499979|FG000|Overall Study|Non-compliance with study drug|0|||
126329106|NCT03654729|454499980|FG001|Overall Study|Non-compliance with study drug|1|||
126329107|NCT03654729|454499981|FG002|Overall Study|Non-compliance with study drug|0|||
126329108|NCT03654729|454499979|FG000|Overall Study|Site terminated by Sponsor|1|||
126329109|NCT03654729|454499980|FG001|Overall Study|Site terminated by Sponsor|0|||
126329110|NCT03654729|454499981|FG002|Overall Study|Site terminated by Sponsor|0|||
126329111|NCT01919164|454499989|FG000|Overall Study|Adverse Event|6|||
126329112|NCT01919164|454499990|FG001|Overall Study|Adverse Event|4|||
126329113|NCT01919164|454499991|FG002|Overall Study|Adverse Event|9|||
126329114|NCT01919164|454499992|FG003|Overall Study|Adverse Event|3|||
126329115|NCT01919164|454499993|FG004|Overall Study|Adverse Event|2|||
126329116|NCT01919164|454499989|FG000|Overall Study|Lost to Follow-up|2|||
126329117|NCT01919164|454499990|FG001|Overall Study|Lost to Follow-up|2|||
126329118|NCT01919164|454499991|FG002|Overall Study|Lost to Follow-up|2|||
126329119|NCT01919164|454499992|FG003|Overall Study|Lost to Follow-up|0|||
126329120|NCT01919164|454499993|FG004|Overall Study|Lost to Follow-up|4|||
126329121|NCT01919164|454499989|FG000|Overall Study|Death|1|||
126329122|NCT01919164|454499990|FG001|Overall Study|Death|0|||
126329123|NCT01919164|454499991|FG002|Overall Study|Death|0|||
126329124|NCT01919164|454499992|FG003|Overall Study|Death|0|||
126329125|NCT01919164|454499993|FG004|Overall Study|Death|0|||
126329126|NCT01919164|454499989|FG000|Overall Study|Protocol Violation|6|||
126329127|NCT01919164|454499990|FG001|Overall Study|Protocol Violation|0|||
126329128|NCT01919164|454499991|FG002|Overall Study|Protocol Violation|3|||
126329129|NCT01919164|454499992|FG003|Overall Study|Protocol Violation|2|||
126329130|NCT01919164|454499993|FG004|Overall Study|Protocol Violation|2|||
126329131|NCT01919164|454499989|FG000|Overall Study|Disease progression|2|||
126329132|NCT01919164|454499990|FG001|Overall Study|Disease progression|2|||
126329133|NCT01919164|454499991|FG002|Overall Study|Disease progression|1|||
126329134|NCT01919164|454499992|FG003|Overall Study|Disease progression|2|||
126329135|NCT01919164|454499993|FG004|Overall Study|Disease progression|1|||
126329136|NCT01919164|454499989|FG000|Overall Study|Withdrew consent|13|||
126329137|NCT01919164|454499990|FG001|Overall Study|Withdrew consent|13|||
126329138|NCT01919164|454499991|FG002|Overall Study|Withdrew consent|14|||
126329139|NCT01919164|454499992|FG003|Overall Study|Withdrew consent|14|||
126329140|NCT01919164|454499993|FG004|Overall Study|Withdrew consent|9|||
126329141|NCT01919164|454499989|FG000|Overall Study|Other Un-specified|13|||
126329142|NCT01919164|454499990|FG001|Overall Study|Other Un-specified|9|||
126329143|NCT01919164|454499991|FG002|Overall Study|Other Un-specified|8|||
126329144|NCT01919164|454499992|FG003|Overall Study|Other Un-specified|7|||
126329145|NCT01919164|454499993|FG004|Overall Study|Other Un-specified|15|||
126329146|NCT00667992|454499996|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
126329147|NCT00667992|454499997|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
126329148|NCT00667992|454499996|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
126329149|NCT00667992|454499997|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
126329150|NCT00667992|454499996|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
126329151|NCT00667992|454499997|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
126329152|NCT00667992|454499996|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
126329153|NCT00667992|454499997|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
126329154|NCT00667992|454499996|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
126329155|NCT00667992|454499997|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
126329156|NCT00667992|454499996|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
126329157|NCT00667992|454499997|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
126329158|NCT00667992|454499996|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
126329159|NCT00667992|454499997|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
126329160|NCT00667992|454499996|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
126329161|NCT00667992|454499997|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
126329162|NCT00667992|454499996|FG000|Wash-out|Not within one doubling dilution|4|||
126329163|NCT00667992|454499997|FG001|Wash-out|Not within one doubling dilution|3|||
126329164|NCT00667992|454499996|FG000|Wash-out|Failure to wash-out|2|||
126329165|NCT00667992|454499997|FG001|Wash-out|Failure to wash-out|2|||
126329166|NCT00667992|454499996|FG000|Wash-out|Withdrawal by Subject|1|||
126329167|NCT00667992|454499997|FG001|Wash-out|Withdrawal by Subject|0|||
126329168|NCT00667992|454499996|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
126329169|NCT00667992|454499997|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
126329170|NCT00667992|454499996|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
126329171|NCT00667992|454499997|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
126329172|NCT02748057|454500001|FG000|Overall Study|Adverse Event|1|||
126329173|NCT02748057|454500002|FG001|Overall Study|Adverse Event|0|||
126329174|NCT02748057|454500001|FG000|Overall Study|Physician Decision|0|||
126329175|NCT02748057|454500002|FG001|Overall Study|Physician Decision|1|||
126329176|NCT02748057|454500001|FG000|Overall Study|Protocol Violation|2|||
126329177|NCT02748057|454500002|FG001|Overall Study|Protocol Violation|1|||
126329178|NCT02748057|454500001|FG000|Overall Study|Participant Moved|1|||
126329179|NCT02748057|454500002|FG001|Overall Study|Participant Moved|0|||
126329180|NCT02748057|454500001|FG000|Overall Study|Withdrawal by Subject|1|||
126329181|NCT02748057|454500002|FG001|Overall Study|Withdrawal by Subject|0|||
126329182|NCT00524771|454500017|FG000|Overall Study|Protocol Violation|220|||
126329183|NCT00524771|454500018|FG001|Overall Study|Protocol Violation|585|||
126329184|NCT01266824|454500019|FG000|Overall Study|Study terminated prior to completion|2|||
126329185|NCT01266824|454500020|FG001|Overall Study|Study terminated prior to completion|3|||
126329186|NCT04435808|454500021|FG000|Overall Study|Study stopped by DSMB|0|||
126329187|NCT04435808|454500022|FG001|Overall Study|Study stopped by DSMB|1|||
126329188|NCT02982863|454500023|FG000|Overall Study|Not eligible patients|809|||
126329189|NCT02982863|454500024|FG001|Overall Study|Not eligible patients|4261|||
126329190|NCT02982863|454500025|FG002|Overall Study|Not eligible patients|1852|||
126329191|NCT02982863|454500026|FG003|Overall Study|Not eligible patients|1400|||
126329192|NCT02982863|454500027|FG004|Overall Study|Not eligible patients|492|||
126329193|NCT02457195|454500028|FG000|Overall Study|Adverse Event|3|||
126329194|NCT02457195|454500028|FG000|Overall Study|Protocol Violation|2|||
126329195|NCT02457195|454500028|FG000|Overall Study|Withdrawal by Subject|4|||
126329196|NCT01896193|454500029|FG000|Overall Study|Lack of Efficacy|20|||
126329197|NCT01896193|454500030|FG001|Overall Study|Lack of Efficacy|11|||
126329198|NCT01896193|454500029|FG000|Overall Study|Protocol Violation|0|||
126655203|NCT01465347|455695755|FG000|Overall Study|Physician Decision|0|||
126655204|NCT01465347|455695756|FG001|Overall Study|Physician Decision|1|||
126655205|NCT01465347|455695755|FG000|Overall Study|Admitted to hospice|0|||
126329199|NCT01896193|454500030|FG001|Overall Study|Protocol Violation|1|||
126329200|NCT01896193|454500029|FG000|Overall Study|Withdrew Consent|1|||
126329201|NCT01896193|454500030|FG001|Overall Study|Withdrew Consent|0|||
126329202|NCT01300247|454500032|FG000|Overall Study|Death|1|||
126329203|NCT01300247|454500033|FG001|Overall Study|Death|1|||
126329204|NCT01300247|454500032|FG000|Overall Study|Lost to Follow-up|2|||
126329205|NCT01300247|454500033|FG001|Overall Study|Lost to Follow-up|0|||
126329206|NCT01300247|454500032|FG000|Overall Study|Withdrawal by Subject|1|||
126329207|NCT01300247|454500033|FG001|Overall Study|Withdrawal by Subject|0|||
126329208|NCT01300247|454500032|FG000|Overall Study|Non-Compliance|0|||
126329209|NCT01300247|454500033|FG001|Overall Study|Non-Compliance|1|||
126329210|NCT04819438|454500034|FG000|Overall Study|Withdrawal by Subject|1|||
126329211|NCT04819438|454500035|FG001|Overall Study|Withdrawal by Subject|0|||
126329212|NCT04819438|454500034|FG000|Overall Study|Adverse Event|0|||
126655206|NCT01465347|455695756|FG001|Overall Study|Admitted to hospice|1|||
126655207|NCT01590082|455695757|FG000|Overall Study|Withdrawal by Subject|1|||
126329213|NCT04819438|454500035|FG001|Overall Study|Adverse Event|1|||
126329214|NCT04819438|454500034|FG000|Overall Study|Protocol Violation|0|||
126329215|NCT04819438|454500035|FG001|Overall Study|Protocol Violation|1|||
126329216|NCT03465709|454500037|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
126329217|NCT03465709|454500037|FG000|Overall Study|Withdrawal by Subject|3|||
126329218|NCT05359952|454500038|FG000|Overall Study|Lost to Follow-up|1|||
126329219|NCT05359952|454500039|FG001|Overall Study|Lost to Follow-up|0|||
126329220|NCT04892446|454500040|FG000|Overall Study|Death|4|||
126329221|NCT04892446|454500041|FG001|Overall Study|Death|4|||
126329222|NCT04892446|454500042|FG002|Overall Study|Death|0|||
126329223|NCT04892446|454500040|FG000|Overall Study|Withdrew consent|3|||
126329224|NCT04892446|454500041|FG001|Overall Study|Withdrew consent|0|||
126329225|NCT04892446|454500042|FG002|Overall Study|Withdrew consent|1|||
126329226|NCT04892446|454500040|FG000|Overall Study|Investigator's discretion|1|||
126329227|NCT04892446|454500041|FG001|Overall Study|Investigator's discretion|1|||
126329228|NCT04892446|454500042|FG002|Overall Study|Investigator's discretion|0|||
126329229|NCT04892446|454500040|FG000|Overall Study|Study terminated by sponsor|0|||
126329230|NCT04892446|454500041|FG001|Overall Study|Study terminated by sponsor|0|||
126329231|NCT04892446|454500042|FG002|Overall Study|Study terminated by sponsor|2|||
126329232|NCT03060291|454500043|FG000|3-month Follow-up|Declined to respond|8|||
126329233|NCT03060291|454500044|FG001|3-month Follow-up|Declined to respond|10|||
126329234|NCT03060291|454500045|FG002|3-month Follow-up|Declined to respond|2|||
126329235|NCT03060291|454500043|FG000|6-month Follow-up|Declined to respond|7|||
126329236|NCT03060291|454500044|FG001|6-month Follow-up|Declined to respond|13|||
126329237|NCT03060291|454500045|FG002|6-month Follow-up|Declined to respond|4|||
126329238|NCT03060291|454500043|FG000|12-month Follow-up|Declined to respond|7|||
126329239|NCT03060291|454500044|FG001|12-month Follow-up|Declined to respond|16|||
126329240|NCT03060291|454500045|FG002|12-month Follow-up|Declined to respond|6|||
126329241|NCT01556932|454500046|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
126329242|NCT01556932|454500047|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
126329243|NCT01882803|454500048|FG000|Overall Study|Disease Progression|1|||
126329244|NCT01882803|454500048|FG000|Overall Study|Withdrawal by Subject|9|||
126329245|NCT01882803|454500048|FG000|Overall Study|Death|68|||
126329246|NCT01882803|454500048|FG000|Overall Study|Physician Decision|3|||
126329247|NCT01882803|454500048|FG000|Overall Study|Lost to Follow-up|3|||
126329248|NCT01882803|454500048|FG000|Overall Study|Follow-up Completed|39|||
126329249|NCT01882803|454500048|FG000|Overall Study|Study Terminated by the Sponsor|6|||
126329250|NCT01563913|454500049|FG000|Overall Study|Physician Decision|1|||
126329251|NCT01563913|454500050|FG001|Overall Study|Physician Decision|0|||
126329252|NCT01563913|454500049|FG000|Overall Study|Spouse Passed Away|1|||
126329253|NCT01563913|454500050|FG001|Overall Study|Spouse Passed Away|0|||
126329254|NCT00705341|454500051|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
126329255|NCT00705341|454500052|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
126329256|NCT00705341|454500053|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
126329257|NCT00705341|454500054|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
126329258|NCT00705341|454500051|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
126329259|NCT00705341|454500052|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
126329260|NCT00705341|454500053|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
126329261|NCT00705341|454500054|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
126329262|NCT00791700|454500055|FG000|Overall Study|Insufficient clinical response|1|||
126329263|NCT00791700|454500056|FG001|Overall Study|Insufficient clinical response|4|||
126329264|NCT00791700|454500057|FG002|Overall Study|Insufficient clinical response|1|||
126329265|NCT00791700|454500058|FG003|Overall Study|Insufficient clinical response|8|||
126329266|NCT00791700|454500055|FG000|Overall Study|No longer willing to participate|1|||
126329267|NCT00791700|454500056|FG001|Overall Study|No longer willing to participate|1|||
126329268|NCT00791700|454500057|FG002|Overall Study|No longer willing to participate|0|||
126329269|NCT00791700|454500058|FG003|Overall Study|No longer willing to participate|8|||
126329270|NCT00791700|454500055|FG000|Overall Study|Non-compliance with study treatment|0|||
126329271|NCT00791700|454500056|FG001|Overall Study|Non-compliance with study treatment|2|||
126329272|NCT00791700|454500057|FG002|Overall Study|Non-compliance with study treatment|0|||
126329273|NCT00791700|454500058|FG003|Overall Study|Non-compliance with study treatment|4|||
126329274|NCT00791700|454500055|FG000|Overall Study|Withdrawn due to pregnancy|0|||
126329275|NCT00791700|454500056|FG001|Overall Study|Withdrawn due to pregnancy|0|||
126329276|NCT00791700|454500057|FG002|Overall Study|Withdrawn due to pregnancy|0|||
126329277|NCT00791700|454500058|FG003|Overall Study|Withdrawn due to pregnancy|1|||
126329278|NCT00791700|454500055|FG000|Overall Study|Other|0|||
126329279|NCT00791700|454500056|FG001|Overall Study|Other|1|||
126329280|NCT00791700|454500057|FG002|Overall Study|Other|0|||
126329281|NCT00791700|454500058|FG003|Overall Study|Other|1|||
126329282|NCT00791700|454500055|FG000|Overall Study|Death|0|||
126329283|NCT00791700|454500056|FG001|Overall Study|Death|0|||
126329284|NCT00791700|454500057|FG002|Overall Study|Death|0|||
126329285|NCT00791700|454500058|FG003|Overall Study|Death|1|||
126329286|NCT00791700|454500055|FG000|Overall Study|Lost to Follow-up|4|||
126329287|NCT00791700|454500056|FG001|Overall Study|Lost to Follow-up|3|||
126329288|NCT00791700|454500057|FG002|Overall Study|Lost to Follow-up|4|||
126329289|NCT00791700|454500058|FG003|Overall Study|Lost to Follow-up|6|||
126329290|NCT00791700|454500055|FG000|Overall Study|Adverse Event|0|||
126329291|NCT00791700|454500056|FG001|Overall Study|Adverse Event|0|||
126329292|NCT00791700|454500057|FG002|Overall Study|Adverse Event|1|||
126329293|NCT00791700|454500058|FG003|Overall Study|Adverse Event|1|||
126329294|NCT01720524|454500065|FG000|Part A|Insufficient Clinical Response|2|||
126329295|NCT01720524|454500066|FG001|Part A|Insufficient Clinical Response|4|||
126329296|NCT01720524|454500065|FG000|Part A|Adverse Event|2|||
126329297|NCT01720524|454500066|FG001|Part A|Adverse Event|2|||
126329298|NCT01720524|454500065|FG000|Part A|Death|2|||
126329299|NCT01720524|454500066|FG001|Part A|Death|1|||
126329300|NCT01720524|454500065|FG000|Part A|Lost to Follow-up|0|||
126655208|NCT01590082|455695758|FG001|Overall Study|Withdrawal by Subject|0|||
126655209|NCT01590082|455695757|FG000|Overall Study|Ineligible|1|||
126655210|NCT01590082|455695758|FG001|Overall Study|Ineligible|0|||
126655211|NCT02414932|455695759|FG000|Overall Study|Withdrawal by Subject|2|||
126655212|NCT02414932|455695760|FG001|Overall Study|Withdrawal by Subject|3|||
126655213|NCT02414932|455695759|FG000|Overall Study|Adverse Event|1|||
126655214|NCT02414932|455695760|FG001|Overall Study|Adverse Event|0|||
126655215|NCT01210664|455695762|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
126655216|NCT01210664|455695763|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
126655217|NCT01210664|455695764|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
126655218|NCT01210664|455695765|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
126655219|NCT01210664|455695762|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
126655220|NCT01210664|455695763|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
126655221|NCT01210664|455695764|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
126655222|NCT01210664|455695765|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
126655223|NCT01210664|455695762|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
126329301|NCT01720524|454500066|FG001|Part A|Lost to Follow-up|1|||
126329302|NCT01720524|454500065|FG000|Part A|Missed 28 day follow-up visit|1|||
126329303|NCT01720524|454500066|FG001|Part A|Missed 28 day follow-up visit|1|||
126329304|NCT01720524|454500065|FG000|Part A|Withdrawal by Subject|0|||
126329305|NCT01720524|454500066|FG001|Part A|Withdrawal by Subject|1|||
126329306|NCT01720524|454500065|FG000|Part A|Other|0|||
126329307|NCT01720524|454500066|FG001|Part A|Other|1|||
126329308|NCT01720524|454500065|FG000|Part A|Lost to Follow-up|0|||
126329309|NCT01720524|454500066|FG001|Part A|Lost to Follow-up|1|||
126329310|NCT01720524|454500065|FG000|Part B|No longer willing to participate in study|1|||
126329311|NCT01720524|454500066|FG001|Part B|No longer willing to participate in study|4|||
126329312|NCT01720524|454500065|FG000|Part B|Other|2|||
126329313|NCT01720524|454500066|FG001|Part B|Other|0|||
126329314|NCT01720524|454500065|FG000|Part B|Lost to Follow-up|2|||
126329315|NCT01720524|454500066|FG001|Part B|Lost to Follow-up|3|||
126329316|NCT01720524|454500065|FG000|Part B|Death|0|||
126329317|NCT01720524|454500066|FG001|Part B|Death|2|||
126329318|NCT00996034|454500067|FG000|Overall Study|Lost to Follow-up|2|||
126329319|NCT00996034|454500067|FG000|Overall Study|withdrawn by PI|1|||
126329320|NCT00527826|454500071|FG000|Overall Study|Adverse Event|10|||
126329321|NCT00527826|454500072|FG001|Overall Study|Adverse Event|10|||
126329322|NCT00527826|454500071|FG000|Overall Study|Lost to Follow-up|3|||
126329323|NCT00527826|454500072|FG001|Overall Study|Lost to Follow-up|2|||
126329324|NCT00527826|454500071|FG000|Overall Study|Withdrawal by Subject|5|||
126329325|NCT00527826|454500072|FG001|Overall Study|Withdrawal by Subject|8|||
126329326|NCT00527826|454500071|FG000|Overall Study|Inclusion Criteria Not Met|3|||
126329327|NCT00527826|454500072|FG001|Overall Study|Inclusion Criteria Not Met|3|||
126329328|NCT00527826|454500071|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
126329329|NCT00527826|454500072|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
126329330|NCT00527826|454500071|FG000|Overall Study|Additional Intake of Viani forte|0|||
126329331|NCT00527826|454500072|FG001|Overall Study|Additional Intake of Viani forte|1|||
126329332|NCT00527826|454500071|FG000|Overall Study|Participant moved away|0|||
126329333|NCT00527826|454500072|FG001|Overall Study|Participant moved away|1|||
126329334|NCT00158262|454500073|FG000|Overall Study|Lost to Follow-up|1|||
126329335|NCT00158262|454500074|FG001|Overall Study|Lost to Follow-up|1|||
126329336|NCT02105285|454500077|FG000|Overall Study|Adverse Event|1|||
126329337|NCT02105285|454500078|FG001|Overall Study|Adverse Event|1|||
126329338|NCT02105285|454500079|FG002|Overall Study|Adverse Event|0|||
126329339|NCT02105285|454500077|FG000|Overall Study|Protocol Violation|0|||
126329340|NCT02105285|454500078|FG001|Overall Study|Protocol Violation|1|||
126329341|NCT02105285|454500079|FG002|Overall Study|Protocol Violation|0|||
126329342|NCT02105285|454500077|FG000|Overall Study|Withdrawal by Subject|1|||
126329343|NCT02105285|454500078|FG001|Overall Study|Withdrawal by Subject|0|||
126329344|NCT02105285|454500079|FG002|Overall Study|Withdrawal by Subject|0|||
126329345|NCT01421641|454500080|FG000|Overall Study|Protocol Violation|2|||
126329346|NCT01421641|454500081|FG001|Overall Study|Protocol Violation|2|||
126329347|NCT02959918|454500083|FG000|Overall Study|Adverse Event|1|||
126329348|NCT02959918|454500084|FG001|Overall Study|Adverse Event|1|||
126329349|NCT02959918|454500085|FG002|Overall Study|Adverse Event|2|||
126329350|NCT02959918|454500086|FG003|Overall Study|Adverse Event|0|||
126329351|NCT02959918|454500087|FG004|Overall Study|Adverse Event|0|||
126329352|NCT02959918|454500088|FG005|Overall Study|Adverse Event|2|||
126329353|NCT02959918|454500089|FG006|Overall Study|Adverse Event|2|||
126329354|NCT02959918|454500090|FG007|Overall Study|Adverse Event|1|||
126329355|NCT02959918|454500091|FG008|Overall Study|Adverse Event|2|||
126329356|NCT02959918|454500092|FG009|Overall Study|Adverse Event|1|||
126329357|NCT02959918|454500093|FG010|Overall Study|Adverse Event|1|||
126329358|NCT02959918|454500094|FG011|Overall Study|Adverse Event|3|||
126329359|NCT02959918|454500095|FG012|Overall Study|Adverse Event|2|||
126329360|NCT02959918|454500096|FG013|Overall Study|Adverse Event|4|||
126329361|NCT02959918|454500083|FG000|Overall Study|Lost to Follow-up|0|||
126329362|NCT02959918|454500084|FG001|Overall Study|Lost to Follow-up|0|||
126329363|NCT02959918|454500085|FG002|Overall Study|Lost to Follow-up|0|||
126329364|NCT02959918|454500086|FG003|Overall Study|Lost to Follow-up|0|||
126329365|NCT02959918|454500087|FG004|Overall Study|Lost to Follow-up|0|||
126329366|NCT02959918|454500088|FG005|Overall Study|Lost to Follow-up|0|||
126329367|NCT02959918|454500089|FG006|Overall Study|Lost to Follow-up|0|||
126329368|NCT02959918|454500090|FG007|Overall Study|Lost to Follow-up|0|||
126329369|NCT02959918|454500091|FG008|Overall Study|Lost to Follow-up|0|||
126329370|NCT02959918|454500092|FG009|Overall Study|Lost to Follow-up|1|||
126329371|NCT02959918|454500093|FG010|Overall Study|Lost to Follow-up|0|||
126329372|NCT02959918|454500094|FG011|Overall Study|Lost to Follow-up|0|||
126329373|NCT02959918|454500095|FG012|Overall Study|Lost to Follow-up|1|||
126329374|NCT02959918|454500096|FG013|Overall Study|Lost to Follow-up|0|||
126329375|NCT02959918|454500083|FG000|Overall Study|Withdrawal by Subject|0|||
126329376|NCT02959918|454500084|FG001|Overall Study|Withdrawal by Subject|0|||
126329377|NCT02959918|454500085|FG002|Overall Study|Withdrawal by Subject|1|||
126329378|NCT02959918|454500086|FG003|Overall Study|Withdrawal by Subject|2|||
126329379|NCT02959918|454500087|FG004|Overall Study|Withdrawal by Subject|0|||
126329380|NCT02959918|454500088|FG005|Overall Study|Withdrawal by Subject|0|||
126329381|NCT02959918|454500089|FG006|Overall Study|Withdrawal by Subject|1|||
126329382|NCT02959918|454500090|FG007|Overall Study|Withdrawal by Subject|0|||
126329383|NCT02959918|454500091|FG008|Overall Study|Withdrawal by Subject|1|||
126329384|NCT02959918|454500092|FG009|Overall Study|Withdrawal by Subject|1|||
126329385|NCT02959918|454500093|FG010|Overall Study|Withdrawal by Subject|2|||
126329386|NCT02959918|454500094|FG011|Overall Study|Withdrawal by Subject|3|||
126329387|NCT02959918|454500095|FG012|Overall Study|Withdrawal by Subject|1|||
126329388|NCT02959918|454500096|FG013|Overall Study|Withdrawal by Subject|1|||
126329389|NCT02959918|454500083|FG000|Overall Study|Protocol Violation|0|||
126329390|NCT02959918|454500084|FG001|Overall Study|Protocol Violation|0|||
126329391|NCT02959918|454500085|FG002|Overall Study|Protocol Violation|1|||
126329392|NCT02959918|454500086|FG003|Overall Study|Protocol Violation|0|||
126329393|NCT02959918|454500087|FG004|Overall Study|Protocol Violation|0|||
126329394|NCT02959918|454500088|FG005|Overall Study|Protocol Violation|1|||
126329395|NCT02959918|454500089|FG006|Overall Study|Protocol Violation|0|||
126329396|NCT02959918|454500090|FG007|Overall Study|Protocol Violation|0|||
126329397|NCT02959918|454500091|FG008|Overall Study|Protocol Violation|2|||
126329398|NCT02959918|454500092|FG009|Overall Study|Protocol Violation|1|||
126329399|NCT02959918|454500093|FG010|Overall Study|Protocol Violation|0|||
126329400|NCT02959918|454500094|FG011|Overall Study|Protocol Violation|1|||
126329401|NCT02959918|454500095|FG012|Overall Study|Protocol Violation|1|||
126329402|NCT02959918|454500096|FG013|Overall Study|Protocol Violation|0|||
126329403|NCT02959918|454500083|FG000|Overall Study|Stopping Rule Met|1|||
126329404|NCT02959918|454500084|FG001|Overall Study|Stopping Rule Met|0|||
126329405|NCT02959918|454500085|FG002|Overall Study|Stopping Rule Met|3|||
126329406|NCT02959918|454500086|FG003|Overall Study|Stopping Rule Met|4|||
126329407|NCT02959918|454500087|FG004|Overall Study|Stopping Rule Met|5|||
126329408|NCT02959918|454500088|FG005|Overall Study|Stopping Rule Met|3|||
126329409|NCT02959918|454500089|FG006|Overall Study|Stopping Rule Met|2|||
126329410|NCT02959918|454500090|FG007|Overall Study|Stopping Rule Met|4|||
126329411|NCT02959918|454500091|FG008|Overall Study|Stopping Rule Met|1|||
126329412|NCT02959918|454500092|FG009|Overall Study|Stopping Rule Met|1|||
126329413|NCT02959918|454500093|FG010|Overall Study|Stopping Rule Met|3|||
126329414|NCT02959918|454500094|FG011|Overall Study|Stopping Rule Met|5|||
126655224|NCT01210664|455695763|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
126329415|NCT02959918|454500095|FG012|Overall Study|Stopping Rule Met|2|||
126329416|NCT02959918|454500096|FG013|Overall Study|Stopping Rule Met|1|||
126329417|NCT02959918|454500083|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
126329418|NCT02959918|454500084|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
126329419|NCT02959918|454500085|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
126329420|NCT02959918|454500086|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
126329421|NCT02959918|454500087|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329422|NCT02959918|454500088|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329423|NCT02959918|454500089|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329424|NCT02959918|454500090|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329425|NCT02959918|454500091|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329426|NCT02959918|454500092|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329427|NCT02959918|454500093|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126655225|NCT01210664|455695764|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
126655226|NCT01210664|455695765|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
126655227|NCT01853644|455695766|FG000|Registration and Treatment Start|Did not start treatment|1|||
126655228|NCT01853644|455695766|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
126655229|NCT01853644|455695766|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
126655230|NCT01853644|455695766|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
126329428|NCT02959918|454500094|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329429|NCT02959918|454500095|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329430|NCT02959918|454500096|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
126329431|NCT02959918|454500083|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329432|NCT02959918|454500084|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329433|NCT02959918|454500085|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329434|NCT02959918|454500086|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329435|NCT02959918|454500087|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329436|NCT02959918|454500088|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126655231|NCT01853644|455695766|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
126655232|NCT01853644|455695766|FG000|Continued Treatment After First Response|Adverse Event|2|||
126655233|NCT01853644|455695766|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
126655234|NCT02891408|455695767|FG000|Overall Study|Lost to Follow-up|0|||
126329437|NCT02959918|454500089|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329438|NCT02959918|454500090|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
126329439|NCT02959918|454500091|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329440|NCT02959918|454500092|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329441|NCT02959918|454500093|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329442|NCT02959918|454500094|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329443|NCT02959918|454500095|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329444|NCT02959918|454500096|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
126329445|NCT02959918|454500083|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329446|NCT02959918|454500084|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329447|NCT02959918|454500085|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329448|NCT02959918|454500086|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329449|NCT02959918|454500087|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329450|NCT02959918|454500088|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329451|NCT02959918|454500089|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329452|NCT02959918|454500090|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329453|NCT02959918|454500091|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
126329454|NCT02959918|454500092|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329455|NCT02959918|454500093|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329456|NCT02959918|454500094|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329457|NCT02959918|454500095|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329458|NCT02959918|454500096|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
126329459|NCT02959918|454500083|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329460|NCT02959918|454500084|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126655235|NCT02891408|455695768|FG001|Overall Study|Lost to Follow-up|0|||
126655236|NCT02891408|455695769|FG002|Overall Study|Lost to Follow-up|1|||
126655237|NCT02891408|455695770|FG003|Overall Study|Lost to Follow-up|0|||
126329461|NCT02959918|454500085|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329462|NCT02959918|454500086|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329463|NCT02959918|454500087|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329464|NCT02959918|454500088|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329465|NCT02959918|454500089|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329466|NCT02959918|454500090|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329467|NCT02959918|454500091|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329468|NCT02959918|454500092|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
126329469|NCT02959918|454500093|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126655238|NCT02891408|455695771|FG004|Overall Study|Lost to Follow-up|0|||
126655239|NCT02891408|455695772|FG005|Overall Study|Lost to Follow-up|0|||
126655240|NCT02891408|455695773|FG006|Overall Study|Lost to Follow-up|0|||
126655241|NCT02951767|455695774|FG000|Overall Study|Study Terminated By Sponsor|9|||
126655242|NCT02951767|455695774|FG000|Overall Study|Withdrawal by Subject|11|||
126655243|NCT02951767|455695774|FG000|Overall Study|Death|96|||
126655244|NCT02951767|455695774|FG000|Overall Study|Lost to Follow-up|2|||
126655245|NCT02951767|455695774|FG000|Overall Study|Physician Decision|1|||
126655246|NCT00709852|455695775|FG000|Period 1|Adverse Event|2|||
126655247|NCT00709852|455695776|FG001|Period 1|Adverse Event|0|||
126655248|NCT00709852|455695775|FG000|Period 1|Withdrawal by Subject|4|||
126655249|NCT00709852|455695776|FG001|Period 1|Withdrawal by Subject|2|||
126655250|NCT00709852|455695775|FG000|Period 1|Protocol Violation|1|||
126655251|NCT00709852|455695776|FG001|Period 1|Protocol Violation|0|||
126329470|NCT02959918|454500094|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329471|NCT02959918|454500095|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329472|NCT02959918|454500096|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
126329473|NCT02585713|454500098|FG000|Overall Study|Withdrew prior to treatment|2|||
126329474|NCT02585713|454500099|FG001|Overall Study|Withdrew prior to treatment|7|||
126329475|NCT02585713|454500098|FG000|Overall Study|Other|3|||
126329476|NCT02585713|454500099|FG001|Overall Study|Other|1|||
126329477|NCT03173456|454500104|FG000|Baseline|Medication dispensing system malfunction'|0|||
126329478|NCT03173456|454500105|FG001|Baseline|Medication dispensing system malfunction'|1|||
126329479|NCT03173456|454500106|FG002|Baseline|Medication dispensing system malfunction'|0|||
126329480|NCT03173456|454500107|FG003|Baseline|Medication dispensing system malfunction'|0|||
126329481|NCT03173456|454500108|FG004|Baseline|Medication dispensing system malfunction'|2|||
126329482|NCT03173456|454500104|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
126329483|NCT03173456|454500105|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
126329484|NCT03173456|454500106|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
126329485|NCT03173456|454500107|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
126329486|NCT03173456|454500108|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
126329487|NCT01733121|454500109|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
126329488|NCT01733121|454500110|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
126329489|NCT01733121|454500109|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
126329490|NCT01733121|454500110|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
126329491|NCT01733121|454500109|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
126329492|NCT01733121|454500110|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
126329493|NCT01733121|454500109|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
126329494|NCT01733121|454500110|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
126329495|NCT03061188|454500119|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
126329496|NCT03061188|454500120|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
126329497|NCT03061188|454500121|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
126329498|NCT03061188|454500122|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
126329499|NCT03061188|454500119|FG000|On Follow-up for 3 Years|Death|0|||
126329500|NCT03061188|454500120|FG001|On Follow-up for 3 Years|Death|3|||
126329501|NCT03061188|454500121|FG002|On Follow-up for 3 Years|Death|5|||
126329502|NCT03061188|454500122|FG003|On Follow-up for 3 Years|Death|4|||
126329503|NCT03061188|454500119|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
126329504|NCT03061188|454500120|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
126329505|NCT03061188|454500121|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
126329506|NCT03061188|454500122|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
126329507|NCT04501952|454500123|FG000|Overall Study|Adverse Event|0|||
126329508|NCT04501952|454500124|FG001|Overall Study|Adverse Event|3|||
126329509|NCT04501952|454500123|FG000|Overall Study|Investigator's Discretion|0|||
126329510|NCT04501952|454500124|FG001|Overall Study|Investigator's Discretion|1|||
126329511|NCT04501952|454500123|FG000|Overall Study|Protocol Violation|1|||
126329512|NCT04501952|454500124|FG001|Overall Study|Protocol Violation|1|||
126329513|NCT04501952|454500123|FG000|Overall Study|Withdrew Consent|5|||
126329514|NCT04501952|454500124|FG001|Overall Study|Withdrew Consent|4|||
126329515|NCT04501952|454500123|FG000|Overall Study|Lost to Follow-up|7|||
126329516|NCT04501952|454500124|FG001|Overall Study|Lost to Follow-up|2|||
126329517|NCT04501952|454500123|FG000|Overall Study|Randomized and Never Treated|13|||
126329518|NCT04501952|454500124|FG001|Overall Study|Randomized and Never Treated|9|||
126329519|NCT00436826|454500125|FG000|Double Blind Period (DBP)|Adverse Event|2|||
126329520|NCT00436826|454500126|FG001|Double Blind Period (DBP)|Adverse Event|0|||
126655252|NCT00709852|455695775|FG000|Period 1|Defective scanner|0|||
126655253|NCT00709852|455695776|FG001|Period 1|Defective scanner|1|||
126655254|NCT00709852|455695775|FG000|Period 1|Lost to Follow-up|1|||
126655255|NCT00709852|455695776|FG001|Period 1|Lost to Follow-up|0|||
126655256|NCT00709852|455695775|FG000|Period 2|Protocol Violation|4|||
126655257|NCT00709852|455695776|FG001|Period 2|Protocol Violation|1|||
126655258|NCT00709852|455695775|FG000|Period 2|Adverse Event|1|||
126655259|NCT00709852|455695776|FG001|Period 2|Adverse Event|1|||
126329521|NCT00436826|454500127|FG002|Double Blind Period (DBP)|Adverse Event|0|||
126329522|NCT00436826|454500128|FG003|Double Blind Period (DBP)|Adverse Event|0|||
126329523|NCT00436826|454500129|FG004|Double Blind Period (DBP)|Adverse Event|0|||
126655260|NCT00709852|455695775|FG000|Period 2|Lost to Follow-up|1|||
126655261|NCT00709852|455695776|FG001|Period 2|Lost to Follow-up|0|||
126655262|NCT00709852|455695775|FG000|Period 2|No 72-hour follow-up|3|||
126655263|NCT00709852|455695776|FG001|Period 2|No 72-hour follow-up|0|||
126329524|NCT00436826|454500130|FG005|Double Blind Period (DBP)|Adverse Event|0|||
126329525|NCT00436826|454500125|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
126329526|NCT00436826|454500126|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
126655264|NCT01442779|455695777|FG000|Overall Study|Withdrawal by Subject|3|||
126329527|NCT00436826|454500127|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
126329528|NCT00436826|454500128|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
126329529|NCT00436826|454500129|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
126329530|NCT00436826|454500130|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
126329531|NCT00436826|454500125|FG000|Double Blind Period (DBP)|Other|10|||
126329532|NCT00436826|454500126|FG001|Double Blind Period (DBP)|Other|11|||
126329533|NCT00436826|454500127|FG002|Double Blind Period (DBP)|Other|0|||
126329534|NCT00436826|454500128|FG003|Double Blind Period (DBP)|Other|0|||
126329535|NCT00436826|454500129|FG004|Double Blind Period (DBP)|Other|0|||
126329536|NCT00436826|454500130|FG005|Double Blind Period (DBP)|Other|0|||
126329537|NCT00436826|454500125|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
126329538|NCT00436826|454500126|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
126329539|NCT00436826|454500127|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
126329540|NCT00436826|454500128|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
126329541|NCT00436826|454500129|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
126329542|NCT00436826|454500130|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
126329543|NCT00436826|454500125|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
126329544|NCT00436826|454500126|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
126329545|NCT00436826|454500127|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
126329546|NCT00436826|454500128|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
126329547|NCT00436826|454500129|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
126329548|NCT00436826|454500130|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
126329549|NCT00436826|454500125|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
126329550|NCT00436826|454500126|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
126329551|NCT00436826|454500127|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
126329552|NCT00436826|454500128|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
126329553|NCT00436826|454500129|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
126329554|NCT00436826|454500130|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
126329555|NCT00784719|454500131|FG000|Overall Study|Adverse Event|0|||
126329556|NCT00784719|454500132|FG001|Overall Study|Adverse Event|2|||
126329557|NCT00784719|454500133|FG002|Overall Study|Adverse Event|0|||
126329558|NCT00784719|454500134|FG003|Overall Study|Adverse Event|0|||
126329559|NCT00784719|454500135|FG004|Overall Study|Adverse Event|1|||
126329560|NCT00784719|454500136|FG005|Overall Study|Adverse Event|1|||
126329561|NCT00784719|454500137|FG006|Overall Study|Adverse Event|1|||
126329562|NCT00784719|454500131|FG000|Overall Study|Lost to Follow-up|0|||
126329563|NCT00784719|454500132|FG001|Overall Study|Lost to Follow-up|0|||
126329564|NCT00784719|454500133|FG002|Overall Study|Lost to Follow-up|0|||
126329565|NCT00784719|454500134|FG003|Overall Study|Lost to Follow-up|0|||
126329566|NCT00784719|454500135|FG004|Overall Study|Lost to Follow-up|1|||
126329567|NCT00784719|454500136|FG005|Overall Study|Lost to Follow-up|1|||
126329568|NCT00784719|454500137|FG006|Overall Study|Lost to Follow-up|0|||
126329569|NCT00784719|454500131|FG000|Overall Study|Other|2|||
126329570|NCT00784719|454500132|FG001|Overall Study|Other|1|||
126329571|NCT00784719|454500133|FG002|Overall Study|Other|1|||
126329572|NCT00784719|454500134|FG003|Overall Study|Other|0|||
126329573|NCT00784719|454500135|FG004|Overall Study|Other|2|||
126329574|NCT00784719|454500136|FG005|Overall Study|Other|1|||
126329575|NCT00784719|454500137|FG006|Overall Study|Other|3|||
126329576|NCT00784719|454500131|FG000|Overall Study|Withdrawal by Subject|1|||
126329577|NCT00784719|454500132|FG001|Overall Study|Withdrawal by Subject|0|||
126329578|NCT00784719|454500133|FG002|Overall Study|Withdrawal by Subject|0|||
126329579|NCT00784719|454500134|FG003|Overall Study|Withdrawal by Subject|0|||
126329580|NCT00784719|454500135|FG004|Overall Study|Withdrawal by Subject|2|||
126329581|NCT00784719|454500136|FG005|Overall Study|Withdrawal by Subject|0|||
126329582|NCT00784719|454500137|FG006|Overall Study|Withdrawal by Subject|1|||
126329583|NCT05464420|454500140|FG000|Overall Study|Death|0|||
126329584|NCT05464420|454500141|FG001|Overall Study|Death|0|||
126329585|NCT05464420|454500142|FG002|Overall Study|Death|0|||
126329586|NCT05464420|454500143|FG003|Overall Study|Death|1|||
126329587|NCT05464420|454500140|FG000|Overall Study|Lost to Follow-up|16|||
126329588|NCT05464420|454500141|FG001|Overall Study|Lost to Follow-up|11|||
126329589|NCT05464420|454500142|FG002|Overall Study|Lost to Follow-up|11|||
126329590|NCT05464420|454500143|FG003|Overall Study|Lost to Follow-up|11|||
126329591|NCT05464420|454500140|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
126329592|NCT05464420|454500141|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
126329593|NCT05464420|454500142|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
126329594|NCT05464420|454500143|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
126329595|NCT05464420|454500140|FG000|Overall Study|Withdrawal by Subject|4|||
126329596|NCT05464420|454500141|FG001|Overall Study|Withdrawal by Subject|8|||
126329597|NCT05464420|454500142|FG002|Overall Study|Withdrawal by Subject|3|||
126329598|NCT05464420|454500143|FG003|Overall Study|Withdrawal by Subject|1|||
126329599|NCT05464420|454500140|FG000|Overall Study|Protocol Violation|0|||
126329600|NCT05464420|454500141|FG001|Overall Study|Protocol Violation|0|||
126329601|NCT05464420|454500142|FG002|Overall Study|Protocol Violation|1|||
126329602|NCT05464420|454500143|FG003|Overall Study|Protocol Violation|1|||
126329603|NCT05464420|454500140|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
126329604|NCT05464420|454500141|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
126329605|NCT05464420|454500142|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
126329606|NCT05464420|454500143|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
126329607|NCT01383018|454500144|FG000|Overall Study|Adverse Event|14|||
126329608|NCT01383018|454500144|FG000|Overall Study|Death|10|||
126329609|NCT01383018|454500144|FG000|Overall Study|Lost to Follow-up|5|||
126329610|NCT01383018|454500144|FG000|Overall Study|Physician Decision|5|||
126329611|NCT01383018|454500144|FG000|Overall Study|Withdrawal by Subject|9|||
126329612|NCT01383018|454500144|FG000|Overall Study|Subject not implanted|76|||
126329613|NCT01383018|454500144|FG000|Overall Study|Missed Visit|247|||
126329614|NCT01383018|454500144|FG000|Overall Study|Site closed early-not compliance related|7|||
126329615|NCT01383018|454500144|FG000|Overall Study|Patient moved away from site|1|||
126329616|NCT01383018|454500144|FG000|Overall Study|Subject Incarcerated|1|||
126329617|NCT03131687|454500147|FG000|Overall Study|Adverse Event|0|||
126329618|NCT03131687|454500148|FG001|Overall Study|Adverse Event|1|||
126655265|NCT01442779|455695777|FG000|Overall Study|Death|3|||
126655266|NCT01442779|455695777|FG000|Overall Study|Non-compliance|1|||
126655267|NCT01048671|455695778|FG000|Overall Study|Protocol Violation|0|||
126655268|NCT01048671|455695779|FG001|Overall Study|Protocol Violation|1|||
126655269|NCT01048671|455695780|FG002|Overall Study|Protocol Violation|1|||
126655270|NCT03814187|455695781|FG000|Overall Study|Sponsor's Administrative Decision|0|||
126329619|NCT03131687|454500149|FG002|Overall Study|Adverse Event|0|||
126329620|NCT03131687|454500150|FG003|Overall Study|Adverse Event|1|||
126329621|NCT03131687|454500151|FG004|Overall Study|Adverse Event|2|||
126329622|NCT03131687|454500152|FG005|Overall Study|Adverse Event|2|||
126655271|NCT03814187|455695782|FG001|Overall Study|Sponsor's Administrative Decision|0|||
126655272|NCT03814187|455695783|FG002|Overall Study|Sponsor's Administrative Decision|272|||
126655273|NCT03814187|455695781|FG000|Overall Study|Death|80|||
126329623|NCT03131687|454500147|FG000|Overall Study|Death|1|||
126329624|NCT03131687|454500148|FG001|Overall Study|Death|0|||
126329625|NCT03131687|454500149|FG002|Overall Study|Death|0|||
126655274|NCT03814187|455695782|FG001|Overall Study|Death|81|||
126655275|NCT03814187|455695783|FG002|Overall Study|Death|4|||
126655276|NCT03814187|455695781|FG000|Overall Study|Withdrew Consent|77|||
126655277|NCT03814187|455695782|FG001|Overall Study|Withdrew Consent|78|||
126655278|NCT03814187|455695783|FG002|Overall Study|Withdrew Consent|2|||
126655279|NCT03814187|455695781|FG000|Overall Study|Lost to Follow-up|47|||
126655280|NCT03814187|455695782|FG001|Overall Study|Lost to Follow-up|52|||
126655281|NCT03814187|455695783|FG002|Overall Study|Lost to Follow-up|1|||
126329626|NCT03131687|454500150|FG003|Overall Study|Death|0|||
126329627|NCT03131687|454500151|FG004|Overall Study|Death|0|||
126329628|NCT03131687|454500152|FG005|Overall Study|Death|0|||
126329629|NCT03131687|454500147|FG000|Overall Study|Withdrawal by Subject|3|||
126329630|NCT03131687|454500148|FG001|Overall Study|Withdrawal by Subject|3|||
126329631|NCT03131687|454500149|FG002|Overall Study|Withdrawal by Subject|3|||
126329632|NCT03131687|454500150|FG003|Overall Study|Withdrawal by Subject|1|||
126329633|NCT03131687|454500151|FG004|Overall Study|Withdrawal by Subject|2|||
126329634|NCT03131687|454500152|FG005|Overall Study|Withdrawal by Subject|1|||
126329635|NCT03131687|454500147|FG000|Overall Study|Lost to Follow-up|1|||
126329636|NCT03131687|454500148|FG001|Overall Study|Lost to Follow-up|4|||
126329637|NCT03131687|454500149|FG002|Overall Study|Lost to Follow-up|0|||
126329638|NCT03131687|454500150|FG003|Overall Study|Lost to Follow-up|1|||
126329639|NCT03131687|454500151|FG004|Overall Study|Lost to Follow-up|4|||
126329640|NCT03131687|454500152|FG005|Overall Study|Lost to Follow-up|2|||
126329641|NCT03131687|454500147|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
126329642|NCT03131687|454500148|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
126329643|NCT03131687|454500149|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
126329644|NCT03131687|454500150|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
126329645|NCT03131687|454500151|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
126329646|NCT03131687|454500152|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
126329647|NCT03131687|454500147|FG000|Overall Study|Principle Investigator Decision|0|||
126329648|NCT03131687|454500148|FG001|Overall Study|Principle Investigator Decision|1|||
126329649|NCT03131687|454500149|FG002|Overall Study|Principle Investigator Decision|0|||
126329650|NCT03131687|454500150|FG003|Overall Study|Principle Investigator Decision|0|||
126329651|NCT03131687|454500151|FG004|Overall Study|Principle Investigator Decision|0|||
126329652|NCT03131687|454500152|FG005|Overall Study|Principle Investigator Decision|0|||
126655282|NCT03814187|455695781|FG000|Overall Study|Adverse Event|22|||
126329653|NCT03131687|454500147|FG000|Overall Study|Inadvertent Enrollment|0|||
126329654|NCT03131687|454500148|FG001|Overall Study|Inadvertent Enrollment|0|||
126329655|NCT03131687|454500149|FG002|Overall Study|Inadvertent Enrollment|0|||
126329656|NCT03131687|454500150|FG003|Overall Study|Inadvertent Enrollment|1|||
126655283|NCT03814187|455695782|FG001|Overall Study|Adverse Event|23|||
126655284|NCT03814187|455695783|FG002|Overall Study|Adverse Event|0|||
126655285|NCT03814187|455695781|FG000|Overall Study|Physician Decision|7|||
126655286|NCT03814187|455695782|FG001|Overall Study|Physician Decision|4|||
126655287|NCT03814187|455695783|FG002|Overall Study|Physician Decision|2|||
126655288|NCT03814187|455695781|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
126655289|NCT03814187|455695782|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
126655290|NCT03814187|455695783|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
126329657|NCT03131687|454500151|FG004|Overall Study|Inadvertent Enrollment|0|||
126329658|NCT03131687|454500152|FG005|Overall Study|Inadvertent Enrollment|0|||
126655291|NCT03814187|455695781|FG000|Overall Study|Other reasons|34|||
126655292|NCT03814187|455695782|FG001|Overall Study|Other reasons|40|||
126329659|NCT06597084|454500162|FG000|Overall Study|Withdrawal by Subject|4|||
126329660|NCT06597084|454500163|FG001|Overall Study|Withdrawal by Subject|9|||
126329661|NCT06597084|454500162|FG000|Overall Study|Consent was not given by the patient until V2|0|||
126329662|NCT06597084|454500163|FG001|Overall Study|Consent was not given by the patient until V2|3|||
126329663|NCT06597084|454500162|FG000|Overall Study|Physician Decision|1|||
126329664|NCT06597084|454500163|FG001|Overall Study|Physician Decision|0|||
126329665|NCT06597084|454500162|FG000|Overall Study|Adverse Event|3|||
126329666|NCT06597084|454500163|FG001|Overall Study|Adverse Event|2|||
126329667|NCT06597084|454500162|FG000|Overall Study|Death|4|||
126329668|NCT06597084|454500163|FG001|Overall Study|Death|0|||
126329669|NCT06597084|454500162|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
126329670|NCT06597084|454500163|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
126329671|NCT06597084|454500162|FG000|Overall Study|Lost to Follow-up|4|||
126329672|NCT06597084|454500163|FG001|Overall Study|Lost to Follow-up|2|||
126329673|NCT06597084|454500162|FG000|Overall Study|Other. Not specified|1|||
126329674|NCT06597084|454500163|FG001|Overall Study|Other. Not specified|0|||
126329675|NCT01243177|454500170|FG000|Overall Study|Lack of Efficacy|47|||
126329676|NCT01243177|454500171|FG001|Overall Study|Lack of Efficacy|31|||
126329677|NCT01243177|454500170|FG000|Overall Study|Protocol Violation|11|||
126329678|NCT01243177|454500171|FG001|Overall Study|Protocol Violation|10|||
126329679|NCT01243177|454500170|FG000|Overall Study|Lost to Follow-up|15|||
126329680|NCT01243177|454500171|FG001|Overall Study|Lost to Follow-up|18|||
126329681|NCT01243177|454500170|FG000|Overall Study|Withdrawal by Subject|46|||
126329682|NCT01243177|454500171|FG001|Overall Study|Withdrawal by Subject|38|||
126329683|NCT01243177|454500170|FG000|Overall Study|AE, serious fatal|0|||
126329684|NCT01243177|454500171|FG001|Overall Study|AE, serious fatal|1|||
126329685|NCT01243177|454500170|FG000|Overall Study|SAE, non-fatal|7|||
126329686|NCT01243177|454500171|FG001|Overall Study|SAE, non-fatal|9|||
126329687|NCT01243177|454500170|FG000|Overall Study|AE, non-serious non-fatal|40|||
126329688|NCT01243177|454500171|FG001|Overall Study|AE, non-serious non-fatal|58|||
126329689|NCT01243177|454500170|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
126329690|NCT01243177|454500171|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
126329691|NCT01243177|454500170|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
126329692|NCT01243177|454500171|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
126329693|NCT01243177|454500170|FG000|Overall Study|Other Reason|11|||
126329694|NCT01243177|454500171|FG001|Overall Study|Other Reason|12|||
126329695|NCT05251233|454501666|FG000|Overall Study|Disease progression - did not start treatment|0|||
126329696|NCT05251233|454501667|FG001|Overall Study|Disease progression - did not start treatment|0|||
126329697|NCT05251233|454501668|FG002|Overall Study|Disease progression - did not start treatment|5|||
126329698|NCT05251233|454501666|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
126329699|NCT05251233|454501667|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
126329700|NCT05251233|454501668|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
126329701|NCT05251233|454501666|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
126329702|NCT05251233|454501667|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
126329703|NCT05251233|454501668|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
126329704|NCT05251233|454501666|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
126329705|NCT05251233|454501667|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
126329706|NCT05251233|454501668|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
126329707|NCT05251233|454501666|FG000|Overall Study|Death - did not start treatment|3|||
126329708|NCT05251233|454501667|FG001|Overall Study|Death - did not start treatment|0|||
126329709|NCT05251233|454501668|FG002|Overall Study|Death - did not start treatment|0|||
126329710|NCT05251233|454501666|FG000|Overall Study|Withdrawal by Subject|2|||
126329711|NCT05251233|454501667|FG001|Overall Study|Withdrawal by Subject|2|||
126329712|NCT05251233|454501668|FG002|Overall Study|Withdrawal by Subject|0|||
126329713|NCT05251233|454501666|FG000|Overall Study|Other complicating disease|2|||
126329714|NCT05251233|454501667|FG001|Overall Study|Other complicating disease|1|||
126329715|NCT05251233|454501668|FG002|Overall Study|Other complicating disease|0|||
126329716|NCT05251233|454501666|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
126329717|NCT05251233|454501667|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
126655293|NCT03814187|455695783|FG002|Overall Study|Other reasons|2|||
126329718|NCT05251233|454501668|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
126329719|NCT05251233|454501666|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
126329720|NCT05251233|454501667|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
126329721|NCT05251233|454501668|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
126329722|NCT02781818|454501669|FG000|Overall Study|Lost to Follow-up|4|||
126329723|NCT02781818|454501670|FG001|Overall Study|Lost to Follow-up|2|||
126329724|NCT02781818|454501671|FG002|Overall Study|Lost to Follow-up|1|||
126329725|NCT01223404|454501672|FG000|First Intervention (1 Day)|Adverse Event|0|||
126329726|NCT01223404|454501673|FG001|First Intervention (1 Day)|Adverse Event|0|||
126329727|NCT01223404|454501674|FG002|First Intervention (1 Day)|Adverse Event|0|||
126329728|NCT01223404|454501675|FG003|First Intervention (1 Day)|Adverse Event|1|||
126329729|NCT01223404|454501676|FG004|First Intervention (1 Day)|Adverse Event|0|||
126329730|NCT01223404|454501677|FG005|First Intervention (1 Day)|Adverse Event|0|||
126655294|NCT00196976|455695784|FG000|Primary Study|Migrated from study area|0|||
126329731|NCT01223404|454501672|FG000|Second Intervention (1 Day)|Adverse Event|1|||
126329732|NCT01223404|454501673|FG001|Second Intervention (1 Day)|Adverse Event|0|||
126655295|NCT00196976|455695785|FG001|Primary Study|Migrated from study area|0|||
126329733|NCT01223404|454501674|FG002|Second Intervention (1 Day)|Adverse Event|0|||
126329734|NCT01223404|454501675|FG003|Second Intervention (1 Day)|Adverse Event|0|||
126329735|NCT01223404|454501676|FG004|Second Intervention (1 Day)|Adverse Event|0|||
126329736|NCT01223404|454501677|FG005|Second Intervention (1 Day)|Adverse Event|0|||
126329737|NCT01223404|454501672|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
126329738|NCT01223404|454501673|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
126329739|NCT01223404|454501674|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
126329740|NCT01223404|454501675|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
126329741|NCT01223404|454501676|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
126329742|NCT01223404|454501677|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
126329743|NCT02492165|454501678|FG000|Overall Study|Withdrawal by Subject|0|||
126329744|NCT02492165|454501679|FG001|Overall Study|Withdrawal by Subject|1|||
126655296|NCT00196976|455695786|FG002|Primary Study|Migrated from study area|0|||
126655297|NCT00196976|455695787|FG003|Primary Study|Migrated from study area|0|||
126329745|NCT02492165|454501680|FG002|Overall Study|Withdrawal by Subject|0|||
126329746|NCT02492165|454501681|FG003|Overall Study|Withdrawal by Subject|0|||
126329747|NCT00707057|454501682|FG000|Overall Study|Withdrawal by Subject|8|||
126329748|NCT00707057|454501683|FG001|Overall Study|Withdrawal by Subject|3|||
126329749|NCT00707057|454501682|FG000|Overall Study|Dosed incorrectly|0|||
126329750|NCT00707057|454501683|FG001|Overall Study|Dosed incorrectly|1|||
126329751|NCT02915159|454501689|FG000|Overall Study|Participant no longer meets criteria|2|||
126329752|NCT02915159|454501690|FG001|Overall Study|Participant no longer meets criteria|0|||
126329753|NCT02915159|454501689|FG000|Overall Study|poor/non-compliance|1|||
126655298|NCT00196976|455695788|FG004|Primary Study|Migrated from study area|0|||
126655299|NCT00196976|455695789|FG005|Primary Study|Migrated from study area|0|||
126655300|NCT00196976|455695790|FG006|Primary Study|Migrated from study area|0|||
126655301|NCT00196976|455695791|FG007|Primary Study|Migrated from study area|1|||
126655302|NCT00196976|455695792|FG008|Primary Study|Migrated from study area|0|||
126655303|NCT00196976|455695793|FG009|Primary Study|Migrated from study area|0|||
126655304|NCT00196976|455695794|FG010|Primary Study|Migrated from study area|0|||
126655305|NCT00196976|455695795|FG011|Primary Study|Migrated from study area|0|||
126655306|NCT00196976|455695796|FG012|Primary Study|Migrated from study area|0|||
126655307|NCT00196976|455695797|FG013|Primary Study|Migrated from study area|0|||
126655308|NCT00196976|455695784|FG000|Primary Study|Protocol Violation|0|||
126655309|NCT00196976|455695785|FG001|Primary Study|Protocol Violation|1|||
126329754|NCT02915159|454501690|FG001|Overall Study|poor/non-compliance|0|||
126329755|NCT02915159|454501689|FG000|Overall Study|Participant withdrew consent|5|||
126329756|NCT02915159|454501690|FG001|Overall Study|Participant withdrew consent|1|||
126329757|NCT02915159|454501689|FG000|Overall Study|Request to discontinue treatment|1|||
126329758|NCT02915159|454501690|FG001|Overall Study|Request to discontinue treatment|2|||
126329759|NCT02915159|454501689|FG000|Overall Study|Adverse Event|2|||
126329760|NCT02915159|454501690|FG001|Overall Study|Adverse Event|2|||
126329761|NCT02915159|454501689|FG000|Overall Study|Lack of Efficacy|0|||
126655310|NCT00196976|455695786|FG002|Primary Study|Protocol Violation|1|||
126329762|NCT02915159|454501690|FG001|Overall Study|Lack of Efficacy|3|||
126655311|NCT00196976|455695787|FG003|Primary Study|Protocol Violation|0|||
126329763|NCT02821416|454501693|FG000|Overall Study|Adverse Event|0|||
126329764|NCT02821416|454501694|FG001|Overall Study|Adverse Event|1|||
126329765|NCT02821416|454501693|FG000|Overall Study|Withdrawal by Subject|2|||
126329766|NCT02821416|454501694|FG001|Overall Study|Withdrawal by Subject|0|||
126329767|NCT02821416|454501693|FG000|Overall Study|Lost to Follow-up|1|||
126329768|NCT02821416|454501694|FG001|Overall Study|Lost to Follow-up|0|||
126329769|NCT01001520|454501701|FG000|Medication Period 1|Withdrawal by Subject|2|||
126329770|NCT01001520|454501702|FG001|Medication Period 1|Withdrawal by Subject|2|||
126329771|NCT01001520|454501701|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
126655312|NCT00196976|455695788|FG004|Primary Study|Protocol Violation|0|||
126655313|NCT00196976|455695789|FG005|Primary Study|Protocol Violation|0|||
126655314|NCT00196976|455695790|FG006|Primary Study|Protocol Violation|0|||
126329772|NCT01001520|454501702|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
126655315|NCT00196976|455695791|FG007|Primary Study|Protocol Violation|0|||
126655316|NCT00196976|455695792|FG008|Primary Study|Protocol Violation|0|||
126655317|NCT00196976|455695793|FG009|Primary Study|Protocol Violation|0|||
126655318|NCT00196976|455695794|FG010|Primary Study|Protocol Violation|0|||
126655319|NCT00196976|455695795|FG011|Primary Study|Protocol Violation|0|||
126655320|NCT00196976|455695796|FG012|Primary Study|Protocol Violation|0|||
126655321|NCT00196976|455695797|FG013|Primary Study|Protocol Violation|0|||
126655322|NCT00196976|455695784|FG000|Primary Study|Withdrawal by Subject|1|||
126655323|NCT00196976|455695785|FG001|Primary Study|Withdrawal by Subject|0|||
126655324|NCT00196976|455695786|FG002|Primary Study|Withdrawal by Subject|1|||
126655325|NCT00196976|455695787|FG003|Primary Study|Withdrawal by Subject|1|||
126655326|NCT00196976|455695788|FG004|Primary Study|Withdrawal by Subject|2|||
126655327|NCT00196976|455695789|FG005|Primary Study|Withdrawal by Subject|1|||
126655328|NCT00196976|455695790|FG006|Primary Study|Withdrawal by Subject|0|||
126655329|NCT00196976|455695791|FG007|Primary Study|Withdrawal by Subject|0|||
126655330|NCT00196976|455695792|FG008|Primary Study|Withdrawal by Subject|0|||
126655331|NCT00196976|455695793|FG009|Primary Study|Withdrawal by Subject|1|||
126655332|NCT00196976|455695794|FG010|Primary Study|Withdrawal by Subject|0|||
126655333|NCT00196976|455695795|FG011|Primary Study|Withdrawal by Subject|0|||
126329773|NCT01001520|454501701|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
126329774|NCT01001520|454501702|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
126655334|NCT00196976|455695796|FG012|Primary Study|Withdrawal by Subject|0|||
126655335|NCT00196976|455695797|FG013|Primary Study|Withdrawal by Subject|0|||
126655336|NCT00196976|455695784|FG000|Primary Study|Lost to Follow-up|0|||
126655337|NCT00196976|455695785|FG001|Primary Study|Lost to Follow-up|0|||
126655338|NCT00196976|455695786|FG002|Primary Study|Lost to Follow-up|0|||
126655339|NCT00196976|455695787|FG003|Primary Study|Lost to Follow-up|0|||
126655340|NCT00196976|455695788|FG004|Primary Study|Lost to Follow-up|1|||
126655341|NCT00196976|455695789|FG005|Primary Study|Lost to Follow-up|1|||
126655342|NCT00196976|455695790|FG006|Primary Study|Lost to Follow-up|0|||
126655343|NCT00196976|455695791|FG007|Primary Study|Lost to Follow-up|2|||
126655344|NCT00196976|455695792|FG008|Primary Study|Lost to Follow-up|0|||
126655345|NCT00196976|455695793|FG009|Primary Study|Lost to Follow-up|0|||
126655346|NCT00196976|455695794|FG010|Primary Study|Lost to Follow-up|0|||
126655347|NCT00196976|455695795|FG011|Primary Study|Lost to Follow-up|0|||
126655348|NCT00196976|455695796|FG012|Primary Study|Lost to Follow-up|0|||
126655349|NCT00196976|455695797|FG013|Primary Study|Lost to Follow-up|0|||
126655350|NCT00196976|455695784|FG000|Primary Study|Other|0|||
126655351|NCT00196976|455695785|FG001|Primary Study|Other|0|||
126655352|NCT00196976|455695786|FG002|Primary Study|Other|2|||
126655353|NCT00196976|455695787|FG003|Primary Study|Other|0|||
126655354|NCT00196976|455695788|FG004|Primary Study|Other|0|||
126655355|NCT00196976|455695789|FG005|Primary Study|Other|0|||
126655356|NCT00196976|455695790|FG006|Primary Study|Other|0|||
126655357|NCT00196976|455695791|FG007|Primary Study|Other|0|||
126655358|NCT00196976|455695792|FG008|Primary Study|Other|0|||
126655359|NCT00196976|455695793|FG009|Primary Study|Other|0|||
126655360|NCT00196976|455695794|FG010|Primary Study|Other|0|||
126655361|NCT00196976|455695795|FG011|Primary Study|Other|0|||
126655362|NCT00196976|455695796|FG012|Primary Study|Other|0|||
126655363|NCT00196976|455695797|FG013|Primary Study|Other|0|||
126655364|NCT00196976|455695784|FG000|Booster Study|Withdrawal by Subject|0|||
126329775|NCT01001520|454501701|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
126329776|NCT01001520|454501702|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
126329777|NCT01001520|454501701|FG000|Washout Period|Withdrawal by Subject|2|||
126329778|NCT01001520|454501702|FG001|Washout Period|Withdrawal by Subject|1|||
126329779|NCT01001520|454501701|FG000|Medication Period 2|Withdrawal by Subject|0|||
126655365|NCT00196976|455695785|FG001|Booster Study|Withdrawal by Subject|0|||
126655366|NCT00196976|455695786|FG002|Booster Study|Withdrawal by Subject|0|||
126655367|NCT00196976|455695787|FG003|Booster Study|Withdrawal by Subject|0|||
126655368|NCT00196976|455695788|FG004|Booster Study|Withdrawal by Subject|0|||
126655369|NCT00196976|455695789|FG005|Booster Study|Withdrawal by Subject|0|||
126655370|NCT00196976|455695790|FG006|Booster Study|Withdrawal by Subject|0|||
126655371|NCT00196976|455695791|FG007|Booster Study|Withdrawal by Subject|0|||
126655372|NCT00196976|455695792|FG008|Booster Study|Withdrawal by Subject|0|||
126655373|NCT00196976|455695793|FG009|Booster Study|Withdrawal by Subject|0|||
126655374|NCT00196976|455695794|FG010|Booster Study|Withdrawal by Subject|1|||
126655375|NCT00196976|455695795|FG011|Booster Study|Withdrawal by Subject|0|||
126655376|NCT00196976|455695796|FG012|Booster Study|Withdrawal by Subject|0|||
126655377|NCT00196976|455695797|FG013|Booster Study|Withdrawal by Subject|0|||
126655378|NCT00196976|455695784|FG000|Booster Study|Lost to Follow-up|0|||
126655379|NCT00196976|455695785|FG001|Booster Study|Lost to Follow-up|0|||
126655380|NCT00196976|455695786|FG002|Booster Study|Lost to Follow-up|0|||
126655381|NCT00196976|455695787|FG003|Booster Study|Lost to Follow-up|0|||
126655382|NCT00196976|455695788|FG004|Booster Study|Lost to Follow-up|0|||
126655383|NCT00196976|455695789|FG005|Booster Study|Lost to Follow-up|0|||
126655384|NCT00196976|455695790|FG006|Booster Study|Lost to Follow-up|0|||
126329780|NCT01001520|454501702|FG001|Medication Period 2|Withdrawal by Subject|3|||
126329781|NCT00878800|454501715|FG000|Overall Study|Adverse Event|0|||
126329782|NCT00878800|454501716|FG001|Overall Study|Adverse Event|0|||
126329783|NCT00878800|454501717|FG002|Overall Study|Adverse Event|2|||
126329784|NCT00878800|454501718|FG003|Overall Study|Adverse Event|0|||
126329785|NCT00878800|454501719|FG004|Overall Study|Adverse Event|1|||
126329786|NCT00878800|454501715|FG000|Overall Study|Progressive disease|1|||
126329787|NCT00878800|454501716|FG001|Overall Study|Progressive disease|5|||
126329788|NCT00878800|454501717|FG002|Overall Study|Progressive disease|6|||
126329789|NCT00878800|454501718|FG003|Overall Study|Progressive disease|5|||
126329790|NCT00878800|454501719|FG004|Overall Study|Progressive disease|13|||
126329791|NCT00878800|454501715|FG000|Overall Study|Withdrew consent|1|||
126655385|NCT00196976|455695791|FG007|Booster Study|Lost to Follow-up|0|||
126655386|NCT00196976|455695792|FG008|Booster Study|Lost to Follow-up|0|||
126655387|NCT00196976|455695793|FG009|Booster Study|Lost to Follow-up|0|||
126655388|NCT00196976|455695794|FG010|Booster Study|Lost to Follow-up|1|||
126655389|NCT00196976|455695795|FG011|Booster Study|Lost to Follow-up|2|||
126655390|NCT00196976|455695796|FG012|Booster Study|Lost to Follow-up|0|||
126655391|NCT00196976|455695797|FG013|Booster Study|Lost to Follow-up|0|||
126655392|NCT02689518|455695798|FG000|Overall Study|Withdrawal by Subject|3|||
126655393|NCT00825825|455695803|FG000|First Medication Period (14 Days)|Adverse Event|1|||
126655394|NCT00825825|455695804|FG001|First Medication Period (14 Days)|Adverse Event|0|||
126655395|NCT00825825|455695805|FG002|First Medication Period (14 Days)|Adverse Event|0|||
126655396|NCT00825825|455695806|FG003|First Medication Period (14 Days)|Adverse Event|0|||
126655397|NCT00825825|455695807|FG004|First Medication Period (14 Days)|Adverse Event|0|||
126655398|NCT00825825|455695808|FG005|First Medication Period (14 Days)|Adverse Event|1|||
126655399|NCT00825825|455695803|FG000|First Medication Period (14 Days)|Physician Decision|2|||
126655400|NCT00825825|455695804|FG001|First Medication Period (14 Days)|Physician Decision|0|||
126655401|NCT00825825|455695805|FG002|First Medication Period (14 Days)|Physician Decision|1|||
126655402|NCT00825825|455695806|FG003|First Medication Period (14 Days)|Physician Decision|0|||
126655403|NCT00825825|455695807|FG004|First Medication Period (14 Days)|Physician Decision|0|||
126655404|NCT00825825|455695808|FG005|First Medication Period (14 Days)|Physician Decision|1|||
126655405|NCT00825825|455695803|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
126655406|NCT00825825|455695804|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
126655407|NCT00825825|455695805|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
126655408|NCT00825825|455695806|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
126655409|NCT00825825|455695807|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
126655410|NCT00825825|455695808|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
126655411|NCT00825825|455695803|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
126655412|NCT00825825|455695804|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
126655413|NCT00825825|455695805|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
126655414|NCT00825825|455695806|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
126655415|NCT00825825|455695807|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
126655416|NCT00825825|455695808|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
126655417|NCT00825825|455695803|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
126655418|NCT00825825|455695804|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
126655419|NCT00825825|455695805|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
126655420|NCT00825825|455695806|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
126655421|NCT00825825|455695807|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
126655422|NCT00825825|455695808|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
126655423|NCT00825825|455695803|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
126655424|NCT00825825|455695804|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
126655425|NCT00825825|455695805|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
126655426|NCT00825825|455695806|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
126655427|NCT00825825|455695807|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
126655428|NCT00825825|455695808|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
126655429|NCT00825825|455695803|FG000|Third Medication Period (14 Days)|poor data quality|0|||
126655430|NCT00825825|455695804|FG001|Third Medication Period (14 Days)|poor data quality|1|||
126655431|NCT00825825|455695805|FG002|Third Medication Period (14 Days)|poor data quality|0|||
126655432|NCT00825825|455695806|FG003|Third Medication Period (14 Days)|poor data quality|0|||
126655433|NCT00825825|455695807|FG004|Third Medication Period (14 Days)|poor data quality|0|||
126655434|NCT00825825|455695808|FG005|Third Medication Period (14 Days)|poor data quality|0|||
126655435|NCT01920854|455695812|FG000|Overall Study|Withdrawal by Subject|1|||
126655436|NCT01920854|455695813|FG001|Overall Study|Withdrawal by Subject|0|||
126655437|NCT01920854|455695814|FG002|Overall Study|Withdrawal by Subject|0|||
126655438|NCT01920854|455695815|FG003|Overall Study|Withdrawal by Subject|0|||
126655439|NCT01920854|455695816|FG004|Overall Study|Withdrawal by Subject|1|||
126329792|NCT00878800|454501716|FG001|Overall Study|Withdrew consent|1|||
126655440|NCT01920854|455695817|FG005|Overall Study|Withdrawal by Subject|0|||
126329793|NCT00878800|454501717|FG002|Overall Study|Withdrew consent|0|||
126329794|NCT00878800|454501718|FG003|Overall Study|Withdrew consent|1|||
126655441|NCT01920854|455695818|FG006|Overall Study|Withdrawal by Subject|1|||
126655442|NCT00757783|455695819|FG000|Overall Study|Adverse Event|0|||
126655443|NCT00757783|455695820|FG001|Overall Study|Adverse Event|2|||
126655444|NCT00757783|455695819|FG000|Overall Study|Lost to Follow-up|1|||
126655445|NCT00757783|455695820|FG001|Overall Study|Lost to Follow-up|1|||
126655446|NCT00757783|455695819|FG000|Overall Study|Protocol Violation|1|||
126655447|NCT00757783|455695820|FG001|Overall Study|Protocol Violation|0|||
126655448|NCT00757783|455695819|FG000|Overall Study|Withdrawal by Subject|2|||
126655449|NCT00757783|455695820|FG001|Overall Study|Withdrawal by Subject|1|||
126655450|NCT00757783|455695819|FG000|Overall Study|Other|1|||
126655451|NCT00757783|455695820|FG001|Overall Study|Other|2|||
126655452|NCT02372136|455695825|FG000|Overall Study|Death|3|||
126655453|NCT02372136|455695826|FG001|Overall Study|Death|1|||
126655454|NCT00985946|455695827|FG000|Overall Study|Lost to Follow-up|6|||
126655455|NCT00985946|455695827|FG000|Overall Study|Withdrawal by Subject|1|||
126655456|NCT02471833|455695828|FG000|Overall Study|Lost to Follow-up|1|||
126655457|NCT02471833|455695829|FG001|Overall Study|Lost to Follow-up|0|||
126655458|NCT02471833|455695830|FG002|Overall Study|Lost to Follow-up|0|||
126655459|NCT02471833|455695828|FG000|Overall Study|Withdrawal by Subject|2|||
126655460|NCT02471833|455695829|FG001|Overall Study|Withdrawal by Subject|1|||
126655461|NCT02471833|455695830|FG002|Overall Study|Withdrawal by Subject|5|||
126655462|NCT02673515|455695834|FG000|Overall Study|Lack of motivation|2|||
126655463|NCT02673515|455695835|FG001|Overall Study|Lack of motivation|1|||
126655464|NCT03965351|455695837|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
126655465|NCT03965351|455695838|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
126655466|NCT03965351|455695837|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
126655467|NCT03965351|455695838|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
126655468|NCT00490724|455695839|FG000|Period I|Physician Decision|0|||
126655469|NCT00490724|455695840|FG001|Period I|Physician Decision|0|||
126655470|NCT00490724|455695841|FG002|Period I|Physician Decision|1|||
126329795|NCT00878800|454501719|FG004|Overall Study|Withdrew consent|1|||
126329796|NCT00878800|454501715|FG000|Overall Study|Death|0|||
126329797|NCT00878800|454501716|FG001|Overall Study|Death|0|||
126329798|NCT00878800|454501717|FG002|Overall Study|Death|1|||
126329799|NCT00878800|454501718|FG003|Overall Study|Death|0|||
126329800|NCT00878800|454501719|FG004|Overall Study|Death|0|||
126329801|NCT00878800|454501715|FG000|Overall Study|Other|1|||
126329802|NCT00878800|454501716|FG001|Overall Study|Other|1|||
126329803|NCT00878800|454501717|FG002|Overall Study|Other|0|||
126329804|NCT00878800|454501718|FG003|Overall Study|Other|0|||
126329805|NCT00878800|454501719|FG004|Overall Study|Other|1|||
126329806|NCT00613821|454501720|FG000|Overall Study|Withdrawal by Subject|1|||
126329807|NCT00613821|454501721|FG001|Overall Study|Withdrawal by Subject|0|||
126329808|NCT00613821|454501720|FG000|Overall Study|Physician Decision|1|||
126329809|NCT00613821|454501721|FG001|Overall Study|Physician Decision|1|||
126329810|NCT02302846|454501722|FG000|Overall Study|Withdrawal by Subject|1|||
126329811|NCT00715299|454501724|FG000|Overall Study|Withdrawal by Subject|1|||
126329812|NCT00715299|454501724|FG000|Overall Study|Adverse Event|3|||
126329813|NCT00715299|454501724|FG000|Overall Study|failed the pre-screen exercise test|2|||
126329814|NCT00411450|454501725|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
126329815|NCT00872521|454501726|FG000|Completed PAD Induction|Patient choice|0|||
126329816|NCT00872521|454501727|FG001|Completed PAD Induction|Patient choice|1|||
126329817|NCT00872521|454501728|FG002|Completed PAD Induction|Patient choice|0|||
126329818|NCT00872521|454501726|FG000|Completed PAD Induction|Disease progression|0|||
126329819|NCT00872521|454501727|FG001|Completed PAD Induction|Disease progression|2|||
126329820|NCT00872521|454501728|FG002|Completed PAD Induction|Disease progression|0|||
126329821|NCT00872521|454501726|FG000|Completed PAD Induction|Adverse Event|4|||
126329822|NCT00872521|454501727|FG001|Completed PAD Induction|Adverse Event|0|||
126329823|NCT00872521|454501728|FG002|Completed PAD Induction|Adverse Event|0|||
126329824|NCT00872521|454501726|FG000|Completed PAD Induction|Death|1|||
126329825|NCT00872521|454501727|FG001|Completed PAD Induction|Death|1|||
126329826|NCT00872521|454501728|FG002|Completed PAD Induction|Death|0|||
126329827|NCT00872521|454501726|FG000|Primary Endpoint Analysis|Other|1|||
126329828|NCT00872521|454501727|FG001|Primary Endpoint Analysis|Other|2|||
126329829|NCT00872521|454501728|FG002|Primary Endpoint Analysis|Other|0|||
126655471|NCT00490724|455695839|FG000|Period II|Treatment Discontinuation|3|||
126655472|NCT00490724|455695840|FG001|Period II|Treatment Discontinuation|1|||
126655473|NCT00490724|455695841|FG002|Period II|Treatment Discontinuation|3|||
126655474|NCT00994682|455695842|FG000|Double Bilnd|Withdrawal by Subject|5|||
126655475|NCT00994682|455695843|FG001|Double Bilnd|Withdrawal by Subject|6|||
126655476|NCT00994682|455695842|FG000|Double Bilnd|Lost to Follow-up|3|||
126329830|NCT00872521|454501726|FG000|Primary Endpoint Analysis|Patient choice|0|||
126329831|NCT00872521|454501727|FG001|Primary Endpoint Analysis|Patient choice|1|||
126329832|NCT00872521|454501728|FG002|Primary Endpoint Analysis|Patient choice|0|||
126329833|NCT00872521|454501726|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
126329834|NCT00872521|454501727|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
126329835|NCT00872521|454501728|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
126655477|NCT00994682|455695843|FG001|Double Bilnd|Lost to Follow-up|3|||
126655478|NCT00994682|455695842|FG000|Double Bilnd|Adverse Event|1|||
126655479|NCT00994682|455695843|FG001|Double Bilnd|Adverse Event|0|||
126655480|NCT00994682|455695842|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
126655481|NCT00994682|455695843|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
126655482|NCT00994682|455695842|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
126655483|NCT00994682|455695843|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
126655484|NCT00994682|455695842|FG000|Pioglitazone Open Label|Physician Decision|6|||
126655485|NCT00994682|455695843|FG001|Pioglitazone Open Label|Physician Decision|1|||
126655486|NCT04227704|455695849|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
126655487|NCT04227704|455695850|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
126655488|NCT04227704|455695851|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
126655489|NCT04227704|455695849|FG000|Overall Study|due to C/S being cancelled|1|||
126655490|NCT04227704|455695850|FG001|Overall Study|due to C/S being cancelled|0|||
126655491|NCT04227704|455695851|FG002|Overall Study|due to C/S being cancelled|0|||
126655492|NCT00812331|455697575|FG000|Overall Study|Adverse Event|1|||
126655493|NCT00812331|455697576|FG001|Overall Study|Adverse Event|0|||
126655494|NCT00812331|455697577|FG002|Overall Study|Adverse Event|0|||
126655495|NCT00812331|455697578|FG003|Overall Study|Adverse Event|0|||
126655496|NCT00812331|455697579|FG004|Overall Study|Adverse Event|0|||
126655497|NCT01506453|455697580|FG000|Overall Study|Withdrawal prior to treatment|0|||
126655498|NCT01506453|455697581|FG001|Overall Study|Withdrawal prior to treatment|2|||
126655499|NCT00055601|455697582|FG000|Overall Study|Protocol Violation|1|||
126655500|NCT00055601|455697583|FG001|Overall Study|Protocol Violation|1|||
126655501|NCT00055601|455697582|FG000|Overall Study|No protocol treatment received|1|||
126655502|NCT00055601|455697583|FG001|Overall Study|No protocol treatment received|1|||
126655503|NCT00117845|455697584|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
126655504|NCT00484289|455697585|FG000|Long Term Phase|Adverse Event|1|||
126655505|NCT00484289|455697586|FG001|Long Term Phase|Adverse Event|17|||
126655506|NCT00484289|455697587|FG002|Long Term Phase|Adverse Event|5|||
126655507|NCT00484289|455697585|FG000|Long Term Phase|Withdrawal by Subject|0|||
126655508|NCT00484289|455697586|FG001|Long Term Phase|Withdrawal by Subject|7|||
126655509|NCT00484289|455697587|FG002|Long Term Phase|Withdrawal by Subject|6|||
126655510|NCT00484289|455697585|FG000|Long Term Phase|Inadequate response|2|||
126655511|NCT00484289|455697586|FG001|Long Term Phase|Inadequate response|7|||
126655512|NCT00484289|455697587|FG002|Long Term Phase|Inadequate response|4|||
126655513|NCT00484289|455697585|FG000|Long Term Phase|Other Reason|0|||
126655514|NCT00484289|455697586|FG001|Long Term Phase|Other Reason|5|||
126655515|NCT00484289|455697587|FG002|Long Term Phase|Other Reason|1|||
126655516|NCT00484289|455697585|FG000|Post Marketing Phase|Adverse Event|0|||
126655517|NCT00484289|455697586|FG001|Post Marketing Phase|Adverse Event|1|||
126655518|NCT00484289|455697587|FG002|Post Marketing Phase|Adverse Event|0|||
126655519|NCT02349425|455697588|FG000|Period 1|Adverse Event|1|||
126655520|NCT02349425|455697589|FG001|Period 1|Adverse Event|1|||
126655521|NCT02349425|455697590|FG002|Period 1|Adverse Event|0|||
126655522|NCT02349425|455697591|FG003|Period 1|Adverse Event|0|||
126655523|NCT02349425|455697588|FG000|Period 2|Adverse Event|0|||
126655524|NCT02349425|455697589|FG001|Period 2|Adverse Event|1|||
126655525|NCT02349425|455697590|FG002|Period 2|Adverse Event|1|||
126655526|NCT02349425|455697591|FG003|Period 2|Adverse Event|0|||
126655527|NCT01403610|455697592|FG000|Overall Study|Withdrawal by Subject|2|||
126655528|NCT01403610|455697593|FG001|Overall Study|Withdrawal by Subject|0|||
126655529|NCT01403610|455697594|FG002|Overall Study|Withdrawal by Subject|0|||
126655530|NCT01403610|455697595|FG003|Overall Study|Withdrawal by Subject|0|||
126655531|NCT01403610|455697592|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
126655532|NCT01403610|455697593|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
126655533|NCT01403610|455697594|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
126655534|NCT01403610|455697595|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
126655535|NCT00876928|455697596|FG000|Overall Study|Lost to Follow-up|2|||
126655536|NCT00876928|455697597|FG001|Overall Study|Lost to Follow-up|5|||
126655537|NCT00876928|455697596|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
126655538|NCT00876928|455697597|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
126655539|NCT00686725|455697600|FG000|Overall Study|Adverse Event|1|||
126655540|NCT00686725|455697601|FG001|Overall Study|Adverse Event|1|||
126655541|NCT00686725|455697600|FG000|Overall Study|Progressive Disease|17|||
126655542|NCT00686725|455697601|FG001|Overall Study|Progressive Disease|23|||
126655543|NCT00686725|455697600|FG000|Overall Study|Lost to Follow-up|7|||
126655544|NCT00686725|455697601|FG001|Overall Study|Lost to Follow-up|5|||
126655545|NCT00686725|455697600|FG000|Overall Study|Death|6|||
126655546|NCT00686725|455697601|FG001|Overall Study|Death|3|||
126655547|NCT00686725|455697600|FG000|Overall Study|Withdrawal by Subject|13|||
126655548|NCT00686725|455697601|FG001|Overall Study|Withdrawal by Subject|4|||
126655549|NCT00686725|455697600|FG000|Overall Study|Protocol Violation|1|||
126655550|NCT00686725|455697601|FG001|Overall Study|Protocol Violation|3|||
126655551|NCT00686725|455697600|FG000|Overall Study|Other|1|||
126655552|NCT00686725|455697601|FG001|Overall Study|Other|3|||
126329836|NCT00872521|454501726|FG000|Primary Endpoint Analysis|Patient response missing|0|||
126329837|NCT00872521|454501727|FG001|Primary Endpoint Analysis|Patient response missing|0|||
126329838|NCT00872521|454501728|FG002|Primary Endpoint Analysis|Patient response missing|1|||
126329839|NCT00872521|454501726|FG000|Completed 3-month Follow up|Other|0|||
126329840|NCT00872521|454501727|FG001|Completed 3-month Follow up|Other|2|||
126329841|NCT00872521|454501728|FG002|Completed 3-month Follow up|Other|0|||
126329842|NCT00872521|454501726|FG000|Completed 3-month Follow up|Physician Decision|0|||
126329843|NCT00872521|454501727|FG001|Completed 3-month Follow up|Physician Decision|1|||
126329844|NCT00872521|454501728|FG002|Completed 3-month Follow up|Physician Decision|0|||
126329845|NCT00872521|454501726|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
126329846|NCT00872521|454501727|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
126329847|NCT00872521|454501728|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
126329848|NCT00614874|454501729|FG000|Overall Study|Protocol Violation|1|||
126329849|NCT00614874|454501729|FG000|Overall Study|Withdrawal by Subject|1|||
126329850|NCT01468454|454501730|FG000|Overall Study|Did not have surgery after PET|9|||
126329851|NCT02620787|454501731|FG000|Overall Study|Adverse Event|1|||
126329852|NCT02620787|454501732|FG001|Overall Study|Adverse Event|0|||
126329853|NCT02620787|454501731|FG000|Overall Study|Eligibility Criteria Not Met|1|||
126329854|NCT02620787|454501732|FG001|Overall Study|Eligibility Criteria Not Met|0|||
126329855|NCT00807612|454501734|FG000|Overall Study|Death|8|||
126329856|NCT00807612|454501734|FG000|Overall Study|Study early termination|5|||
126329857|NCT00807612|454501734|FG000|Overall Study|Withdrawal by Subject|1|||
126329858|NCT02028507|454501735|FG000|Overall Study|Progressive Disease|122|||
126329859|NCT02028507|454501736|FG001|Overall Study|Progressive Disease|90|||
126329860|NCT02028507|454501737|FG002|Overall Study|Progressive Disease|102|||
126329861|NCT02028507|454501738|FG003|Overall Study|Progressive Disease|89|||
126329862|NCT02028507|454501735|FG000|Overall Study|Adverse Event|8|||
126329863|NCT02028507|454501736|FG001|Overall Study|Adverse Event|25|||
126329864|NCT02028507|454501737|FG002|Overall Study|Adverse Event|3|||
126329865|NCT02028507|454501738|FG003|Overall Study|Adverse Event|16|||
126329866|NCT02028507|454501735|FG000|Overall Study|Withdrawal by Subject|6|||
126329867|NCT02028507|454501736|FG001|Overall Study|Withdrawal by Subject|8|||
126329868|NCT02028507|454501737|FG002|Overall Study|Withdrawal by Subject|5|||
126655553|NCT03064035|455697604|FG000|Overall Study|Did not receive allocated intervention|4|||
126655554|NCT03064035|455697605|FG001|Overall Study|Did not receive allocated intervention|2|||
126329869|NCT02028507|454501738|FG003|Overall Study|Withdrawal by Subject|9|||
126329870|NCT02028507|454501735|FG000|Overall Study|Protocol Violation|2|||
126329871|NCT02028507|454501736|FG001|Overall Study|Protocol Violation|4|||
126329872|NCT02028507|454501737|FG002|Overall Study|Protocol Violation|1|||
126329873|NCT02028507|454501738|FG003|Overall Study|Protocol Violation|3|||
126329874|NCT02028507|454501735|FG000|Overall Study|Physician Decision|0|||
126329875|NCT02028507|454501736|FG001|Overall Study|Physician Decision|4|||
126329876|NCT02028507|454501737|FG002|Overall Study|Physician Decision|0|||
126329877|NCT02028507|454501738|FG003|Overall Study|Physician Decision|0|||
126329878|NCT02028507|454501735|FG000|Overall Study|Death|1|||
126329879|NCT02028507|454501736|FG001|Overall Study|Death|0|||
126329880|NCT02028507|454501737|FG002|Overall Study|Death|1|||
126329881|NCT02028507|454501738|FG003|Overall Study|Death|3|||
126329882|NCT02028507|454501735|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
126329883|NCT02028507|454501736|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
126329884|NCT02028507|454501737|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
126329885|NCT02028507|454501738|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
126329886|NCT02028507|454501735|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
126329887|NCT02028507|454501736|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
126329888|NCT02028507|454501737|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
126329889|NCT02028507|454501738|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
126329890|NCT02028507|454501735|FG000|Overall Study|Randomized But Not Treated|3|||
126329891|NCT02028507|454501736|FG001|Overall Study|Randomized But Not Treated|6|||
126329892|NCT02028507|454501737|FG002|Overall Study|Randomized But Not Treated|0|||
126329893|NCT02028507|454501738|FG003|Overall Study|Randomized But Not Treated|4|||
126329894|NCT02028507|454501735|FG000|Overall Study|Enzyme defect|0|||
126329895|NCT02028507|454501736|FG001|Overall Study|Enzyme defect|0|||
126329896|NCT02028507|454501737|FG002|Overall Study|Enzyme defect|0|||
126329897|NCT02028507|454501738|FG003|Overall Study|Enzyme defect|1|||
126329898|NCT02028507|454501735|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
126329899|NCT02028507|454501736|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
126329900|NCT02028507|454501737|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
126329901|NCT02028507|454501738|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
126655555|NCT03064035|455697604|FG000|Overall Study|Lost to Follow-up|1|||
126655556|NCT03064035|455697605|FG001|Overall Study|Lost to Follow-up|1|||
126655557|NCT03103763|455697606|FG000|Overall Study|Death|15|||
126655558|NCT03103763|455697607|FG001|Overall Study|Death|5|||
126655559|NCT03103763|455697608|FG002|Overall Study|Death|5|||
126655560|NCT03103763|455697606|FG000|Overall Study|Withdrawal by Subject|0|||
126655561|NCT03103763|455697607|FG001|Overall Study|Withdrawal by Subject|3|||
126655562|NCT03103763|455697608|FG002|Overall Study|Withdrawal by Subject|2|||
126655563|NCT01143038|455697609|FG000|Overall Study|Withdrawal by Subject|4|||
126655564|NCT01143038|455697609|FG000|Overall Study|Requirement for alternative therapy|5|||
126655565|NCT01143038|455697609|FG000|Overall Study|Adverse Event|3|||
126655566|NCT01143038|455697609|FG000|Overall Study|Lost to Follow-up|2|||
126655567|NCT01143038|455697609|FG000|Overall Study|Protocol Deviation|1|||
126655568|NCT01143038|455697609|FG000|Overall Study|Death|1|||
126655569|NCT01970345|455697610|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
126655570|NCT01970345|455697611|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
126655571|NCT01970345|455697610|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
126655572|NCT01970345|455697611|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
126655573|NCT00558259|455697616|FG000|Overall Study|Adverse Event|50|||
126758623|NCT02681094|456066667|FG002|2 - Enrolled Participants Set|Participant decision|9|||
126758624|NCT02681094|456066665|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
126758625|NCT02681094|456066666|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
126758626|NCT02681094|456066667|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
126758627|NCT02681094|456066665|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
126655574|NCT00558259|455697617|FG001|Overall Study|Adverse Event|81|||
126655575|NCT00558259|455697616|FG000|Overall Study|Protocol Violation|9|||
126655576|NCT00558259|455697617|FG001|Overall Study|Protocol Violation|5|||
126655577|NCT00558259|455697616|FG000|Overall Study|Withdrawal by Subject|12|||
126655578|NCT00558259|455697617|FG001|Overall Study|Withdrawal by Subject|13|||
126655579|NCT02874924|455697618|FG000|Overall Study|Adverse Event|2|||
126655580|NCT02874924|455697619|FG001|Overall Study|Adverse Event|0|||
126655581|NCT02874924|455697620|FG002|Overall Study|Adverse Event|0|||
126655582|NCT02874924|455697618|FG000|Overall Study|Withdrawal by Subject|1|||
126655583|NCT02874924|455697619|FG001|Overall Study|Withdrawal by Subject|0|||
126655584|NCT02874924|455697620|FG002|Overall Study|Withdrawal by Subject|0|||
126655585|NCT00321373|455697625|FG000|Overall Study|Adverse Event|0|||
126655586|NCT00321373|455697626|FG001|Overall Study|Adverse Event|0|||
126655587|NCT00321373|455697627|FG002|Overall Study|Adverse Event|1|||
126655588|NCT00321373|455697625|FG000|Overall Study|Lost to Follow-up|1|||
126655589|NCT00321373|455697626|FG001|Overall Study|Lost to Follow-up|0|||
126655590|NCT00321373|455697627|FG002|Overall Study|Lost to Follow-up|1|||
126655591|NCT00321373|455697625|FG000|Overall Study|Withdrawal by Subject|1|||
126655592|NCT00321373|455697626|FG001|Overall Study|Withdrawal by Subject|0|||
126655593|NCT00321373|455697627|FG002|Overall Study|Withdrawal by Subject|0|||
126655594|NCT00321373|455697625|FG000|Overall Study|Other|0|||
126655595|NCT00321373|455697626|FG001|Overall Study|Other|0|||
126655596|NCT00321373|455697627|FG002|Overall Study|Other|1|||
126655597|NCT00552240|455697636|FG000|Overall Study|Adverse Event|9|||
126655598|NCT00552240|455697637|FG001|Overall Study|Adverse Event|9|||
126655599|NCT00552240|455697636|FG000|Overall Study|Protocol Violation|1|||
126655600|NCT00552240|455697637|FG001|Overall Study|Protocol Violation|1|||
126655601|NCT00552240|455697636|FG000|Overall Study|Lost to Follow-up|5|||
126655602|NCT00552240|455697637|FG001|Overall Study|Lost to Follow-up|6|||
126655603|NCT00552240|455697636|FG000|Overall Study|Withdrawal by Subject|2|||
126655604|NCT00552240|455697637|FG001|Overall Study|Withdrawal by Subject|2|||
126655605|NCT00552240|455697636|FG000|Overall Study|Lack of Efficacy|6|||
126655606|NCT00552240|455697637|FG001|Overall Study|Lack of Efficacy|0|||
126655607|NCT00552240|455697636|FG000|Overall Study|Other|1|||
126655608|NCT00552240|455697637|FG001|Overall Study|Other|0|||
126655609|NCT02783768|455697638|FG000|Overall Study|Lost to Follow-up|1|||
126655610|NCT02783768|455697639|FG001|Overall Study|Lost to Follow-up|0|||
126655611|NCT01323647|455697640|FG000|Overall Study|Migrated/moved from study area|2|||
126655612|NCT01323647|455697641|FG001|Overall Study|Migrated/moved from study area|0|||
126655613|NCT01323647|455697640|FG000|Overall Study|Withdrawal by Subject|5|||
126655614|NCT01323647|455697641|FG001|Overall Study|Withdrawal by Subject|0|||
126655615|NCT01323647|455697640|FG000|Overall Study|Lost to Follow-up|2|||
126655616|NCT01323647|455697641|FG001|Overall Study|Lost to Follow-up|0|||
126655617|NCT01236339|455697651|FG000|Overall Study|Termination of study by sponsor|11|||
126655618|NCT01236339|455697652|FG001|Overall Study|Termination of study by sponsor|13|||
126655619|NCT02054741|455697653|FG000|Overall Study|Protocol Violation|13|||
126655620|NCT02054741|455697654|FG001|Overall Study|Protocol Violation|2|||
126655621|NCT02054741|455697653|FG000|Overall Study|Withdrawal by Subject|10|||
126655622|NCT02054741|455697654|FG001|Overall Study|Withdrawal by Subject|5|||
126655623|NCT02054741|455697653|FG000|Overall Study|Death|94|||
126655624|NCT02054741|455697654|FG001|Overall Study|Death|90|||
126655625|NCT02054741|455697653|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
126655626|NCT02054741|455697654|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
126655627|NCT01945060|455697658|FG000|Overall Study|Lost to follow up|1|||
126655628|NCT01945060|455697659|FG001|Overall Study|Lost to follow up|0|||
126655629|NCT01945060|455697658|FG000|Overall Study|Distress related to IV access|0|||
126655630|NCT01945060|455697659|FG001|Overall Study|Distress related to IV access|1|||
126655631|NCT00402597|455697662|FG000|Overall Study|Death|15|||
126655632|NCT00402597|455697663|FG001|Overall Study|Death|7|||
126655633|NCT00402597|455697664|FG002|Overall Study|Death|6|||
126655634|NCT00402597|455697665|FG003|Overall Study|Death|4|||
126655635|NCT00402597|455697666|FG004|Overall Study|Death|6|||
126655636|NCT00402597|455697662|FG000|Overall Study|Adverse Event|81|||
126655637|NCT00402597|455697663|FG001|Overall Study|Adverse Event|18|||
126655638|NCT00402597|455697664|FG002|Overall Study|Adverse Event|106|||
126655639|NCT00402597|455697665|FG003|Overall Study|Adverse Event|39|||
126655640|NCT00402597|455697666|FG004|Overall Study|Adverse Event|71|||
126655641|NCT00402597|455697662|FG000|Overall Study|Lost to Follow-up|8|||
126655642|NCT00402597|455697663|FG001|Overall Study|Lost to Follow-up|1|||
126655643|NCT00402597|455697664|FG002|Overall Study|Lost to Follow-up|8|||
126655644|NCT00402597|455697665|FG003|Overall Study|Lost to Follow-up|2|||
126655645|NCT00402597|455697666|FG004|Overall Study|Lost to Follow-up|3|||
126655646|NCT00402597|455697662|FG000|Overall Study|Withdrawal by Subject|57|||
126655647|NCT00402597|455697663|FG001|Overall Study|Withdrawal by Subject|16|||
126655648|NCT00402597|455697664|FG002|Overall Study|Withdrawal by Subject|65|||
126655649|NCT00402597|455697665|FG003|Overall Study|Withdrawal by Subject|15|||
126655650|NCT00402597|455697666|FG004|Overall Study|Withdrawal by Subject|24|||
126655651|NCT00402597|455697662|FG000|Overall Study|reason not specified|30|||
126655652|NCT00402597|455697663|FG001|Overall Study|reason not specified|4|||
126655653|NCT00402597|455697664|FG002|Overall Study|reason not specified|27|||
126655654|NCT00402597|455697665|FG003|Overall Study|reason not specified|14|||
126655655|NCT00402597|455697666|FG004|Overall Study|reason not specified|20|||
126655656|NCT02319525|455697668|FG000|Overall Study|Withdrawal by Subject|2|||
126655657|NCT02319525|455697669|FG001|Overall Study|Withdrawal by Subject|1|||
126655658|NCT00938860|455697670|FG000|Overall Study|Adverse Event|2|||
126655659|NCT00938860|455697671|FG001|Overall Study|Adverse Event|1|||
126655660|NCT00938860|455697670|FG000|Overall Study|Abnormal laboratory values|2|||
126655661|NCT00938860|455697671|FG001|Overall Study|Abnormal laboratory values|2|||
126655662|NCT00938860|455697670|FG000|Overall Study|Withdrawal by Subject|11|||
126655663|NCT00938860|455697671|FG001|Overall Study|Withdrawal by Subject|8|||
126655664|NCT00938860|455697670|FG000|Overall Study|Lost to Follow-up|4|||
126655665|NCT00938860|455697671|FG001|Overall Study|Lost to Follow-up|4|||
126329902|NCT02028507|454501735|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
126329903|NCT02028507|454501736|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
126655666|NCT00938860|455697670|FG000|Overall Study|Administration problems|2|||
126655667|NCT00938860|455697671|FG001|Overall Study|Administration problems|0|||
126655668|NCT00938860|455697670|FG000|Overall Study|Death|1|||
126655669|NCT00938860|455697671|FG001|Overall Study|Death|1|||
126655670|NCT00938860|455697670|FG000|Overall Study|Protocol Violation|3|||
126655671|NCT00938860|455697671|FG001|Overall Study|Protocol Violation|1|||
126655672|NCT00336895|455697672|FG000|Overall Study|diarrhea|1|||
126655673|NCT00336895|455697672|FG000|Overall Study|nausea and upset stomach|1|||
126655674|NCT00336895|455697672|FG000|Overall Study|Physician Decision|1|||
126655675|NCT00336895|455697672|FG000|Overall Study|screen failed|1|||
126655676|NCT00598273|455697676|FG000|Overall Study|Adverse Event|4|||
126655677|NCT00598273|455697677|FG001|Overall Study|Adverse Event|5|||
126329904|NCT02028507|454501737|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
126329905|NCT02028507|454501738|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
126329906|NCT02258659|454501739|FG000|Overall Study|Withdrawal by Subject|1|||
126329907|NCT00272844|454501740|FG000|Overall Study|Withdrawal by Subject|5|||
126655678|NCT00598273|455697678|FG002|Overall Study|Adverse Event|2|||
126655679|NCT00598273|455697676|FG000|Overall Study|Death|6|||
126655680|NCT00598273|455697677|FG001|Overall Study|Death|12|||
126655681|NCT00598273|455697678|FG002|Overall Study|Death|8|||
126655682|NCT00598273|455697676|FG000|Overall Study|Lost to Follow-up|8|||
126655683|NCT00598273|455697677|FG001|Overall Study|Lost to Follow-up|3|||
126655684|NCT00598273|455697678|FG002|Overall Study|Lost to Follow-up|5|||
126655685|NCT00598273|455697676|FG000|Overall Study|Physician Decision|0|||
126655686|NCT00598273|455697677|FG001|Overall Study|Physician Decision|0|||
126655687|NCT00598273|455697678|FG002|Overall Study|Physician Decision|1|||
126655688|NCT00598273|455697676|FG000|Overall Study|Withdrawal by Subject|12|||
126655689|NCT00598273|455697677|FG001|Overall Study|Withdrawal by Subject|10|||
126655690|NCT00598273|455697678|FG002|Overall Study|Withdrawal by Subject|10|||
126655691|NCT00598273|455697676|FG000|Overall Study|Noncompliance|3|||
126655692|NCT00598273|455697677|FG001|Overall Study|Noncompliance|2|||
126655693|NCT00598273|455697678|FG002|Overall Study|Noncompliance|3|||
126655694|NCT00598273|455697676|FG000|Overall Study|Relocation|0|||
126655695|NCT00598273|455697677|FG001|Overall Study|Relocation|2|||
126655696|NCT00598273|455697678|FG002|Overall Study|Relocation|4|||
126655697|NCT00598273|455697676|FG000|Overall Study|Renal transplant|1|||
126655698|NCT00598273|455697677|FG001|Overall Study|Renal transplant|0|||
126655699|NCT00598273|455697678|FG002|Overall Study|Renal transplant|1|||
126655700|NCT00598273|455697676|FG000|Overall Study|Site elected to close|1|||
126655701|NCT00598273|455697677|FG001|Overall Study|Site elected to close|0|||
126655702|NCT00598273|455697678|FG002|Overall Study|Site elected to close|0|||
126655703|NCT00598273|455697676|FG000|Overall Study|Started dialysis|6|||
126655704|NCT00598273|455697677|FG001|Overall Study|Started dialysis|4|||
126655705|NCT00598273|455697678|FG002|Overall Study|Started dialysis|5|||
126655706|NCT00906945|455697679|FG000|Overall Study|Found to be not eligible|0|||
126655707|NCT00906945|455697680|FG001|Overall Study|Found to be not eligible|0|||
126655708|NCT00906945|455697681|FG002|Overall Study|Found to be not eligible|0|||
126655709|NCT00906945|455697682|FG003|Overall Study|Found to be not eligible|1|||
126655710|NCT00906945|455697683|FG004|Overall Study|Found to be not eligible|1|||
126655711|NCT00906945|455697684|FG005|Overall Study|Found to be not eligible|1|||
126655712|NCT00906945|455697679|FG000|Overall Study|Physician Decision|0|||
126655713|NCT00906945|455697680|FG001|Overall Study|Physician Decision|0|||
126655714|NCT00906945|455697681|FG002|Overall Study|Physician Decision|0|||
126655715|NCT00906945|455697682|FG003|Overall Study|Physician Decision|0|||
126655716|NCT00906945|455697683|FG004|Overall Study|Physician Decision|0|||
126655717|NCT00906945|455697684|FG005|Overall Study|Physician Decision|1|||
126655718|NCT01054170|455697685|FG000|Overall Study|Protocol Violation|1|||
126655719|NCT01054170|455697686|FG001|Overall Study|Protocol Violation|0|||
126655720|NCT01054170|455697685|FG000|Overall Study|Withdrawal by Subject|3|||
126655721|NCT01054170|455697686|FG001|Overall Study|Withdrawal by Subject|2|||
126655722|NCT01054170|455697685|FG000|Overall Study|Adverse Event|0|||
126655723|NCT01054170|455697686|FG001|Overall Study|Adverse Event|4|||
126655724|NCT03426605|455697687|FG000|Overall Study|AML relapse or progression|2|||
126655725|NCT03426605|455697688|FG001|Overall Study|AML relapse or progression|1|||
126655726|NCT03426605|455697689|FG002|Overall Study|AML relapse or progression|2|||
126655727|NCT03426605|455697690|FG003|Overall Study|AML relapse or progression|2|||
126655728|NCT03426605|455697687|FG000|Overall Study|Treatment failure|3|||
126655729|NCT03426605|455697688|FG001|Overall Study|Treatment failure|2|||
126655730|NCT03426605|455697689|FG002|Overall Study|Treatment failure|0|||
126655731|NCT03426605|455697690|FG003|Overall Study|Treatment failure|0|||
126655732|NCT03426605|455697687|FG000|Overall Study|Adverse Event|1|||
126655733|NCT03426605|455697688|FG001|Overall Study|Adverse Event|0|||
126655734|NCT03426605|455697689|FG002|Overall Study|Adverse Event|1|||
126655735|NCT03426605|455697690|FG003|Overall Study|Adverse Event|1|||
126655736|NCT03426605|455697687|FG000|Overall Study|Withdrawal by Subject|0|||
126655737|NCT03426605|455697688|FG001|Overall Study|Withdrawal by Subject|0|||
126655738|NCT03426605|455697689|FG002|Overall Study|Withdrawal by Subject|1|||
126655739|NCT03426605|455697690|FG003|Overall Study|Withdrawal by Subject|1|||
126655740|NCT00513604|455697691|FG000|Overall Study|Not treated|2|||
126655741|NCT00513604|455697692|FG001|Overall Study|Not treated|0|||
126655742|NCT00513604|455697693|FG002|Overall Study|Not treated|1|||
126655743|NCT00513604|455697694|FG003|Overall Study|Not treated|0|||
126655744|NCT00513604|455697695|FG004|Overall Study|Not treated|0|||
126655745|NCT00513604|455697691|FG000|Overall Study|Death during treatment|0|||
126655746|NCT00513604|455697692|FG001|Overall Study|Death during treatment|3|||
126655747|NCT00513604|455697693|FG002|Overall Study|Death during treatment|2|||
126655748|NCT00513604|455697694|FG003|Overall Study|Death during treatment|0|||
126655749|NCT00513604|455697695|FG004|Overall Study|Death during treatment|0|||
126655750|NCT01535560|455697699|FG000|Overall Study|Adverse Event|12|||
126655751|NCT01535560|455697700|FG001|Overall Study|Adverse Event|7|||
126655752|NCT01535560|455697699|FG000|Overall Study|Lost to Follow-up|1|||
126655753|NCT01535560|455697700|FG001|Overall Study|Lost to Follow-up|3|||
126655754|NCT01535560|455697699|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
126655755|NCT01535560|455697700|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
126655756|NCT01535560|455697699|FG000|Overall Study|Treatment Failure|21|||
126655757|NCT01535560|455697700|FG001|Overall Study|Treatment Failure|83|||
126655758|NCT01535560|455697699|FG000|Overall Study|Other|0|||
126655759|NCT01535560|455697700|FG001|Overall Study|Other|1|||
126329908|NCT01502033|454501744|FG000|Overall Study|1 participant had scalp discomfort|1|||
126329909|NCT01502033|454501744|FG000|Overall Study|1 participant had worsening depression|1|||
126329910|NCT01502033|454501744|FG000|Overall Study|1 participant went back to school|1|||
126329911|NCT01808261|454501745|FG000|Overall Study|Physician Decision|0|||
126655760|NCT01535560|455697699|FG000|Overall Study|Randomized in Error|0|||
126655761|NCT01535560|455697700|FG001|Overall Study|Randomized in Error|1|||
126329912|NCT01808261|454501746|FG001|Overall Study|Physician Decision|2|||
126329913|NCT01808261|454501745|FG000|Overall Study|Study Closed/Terminated|25|||
126329914|NCT01808261|454501746|FG001|Overall Study|Study Closed/Terminated|23|||
126329915|NCT01808261|454501745|FG000|Overall Study|Adverse event, non-fatal|2|||
126329916|NCT01808261|454501746|FG001|Overall Study|Adverse event, non-fatal|0|||
126329917|NCT01808261|454501745|FG000|Overall Study|Consent withdrawn by subject|6|||
126329918|NCT01808261|454501746|FG001|Overall Study|Consent withdrawn by subject|7|||
126329919|NCT01808261|454501745|FG000|Overall Study|Lost to Follow-up|3|||
126329920|NCT01808261|454501746|FG001|Overall Study|Lost to Follow-up|1|||
126329921|NCT02609984|454501751|FG000|Overall Study|Death|29|||
126329922|NCT02609984|454501752|FG001|Overall Study|Death|26|||
126329923|NCT02609984|454501751|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
126329924|NCT02609984|454501752|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
126329925|NCT02609984|454501751|FG000|Overall Study|Lost to Follow-up|1|||
126329926|NCT02609984|454501752|FG001|Overall Study|Lost to Follow-up|2|||
126329927|NCT02609984|454501751|FG000|Overall Study|Withdrawal by Subject|0|||
126329928|NCT02609984|454501752|FG001|Overall Study|Withdrawal by Subject|1|||
126329929|NCT02609984|454501751|FG000|Overall Study|Disease Progression|2|||
126329930|NCT02609984|454501752|FG001|Overall Study|Disease Progression|0|||
126329931|NCT02080364|454501753|FG000|Baseline Period|Protocol Violation|2|||
126329932|NCT02080364|454501754|FG001|Baseline Period|Protocol Violation|1|||
126655762|NCT02009761|455697701|FG000|Overall Study|Adverse Event|4|||
126329933|NCT02080364|454501755|FG002|Baseline Period|Protocol Violation|0|||
126329934|NCT02080364|454501756|FG003|Baseline Period|Protocol Violation|0|||
126329935|NCT02080364|454501753|FG000|Baseline Period|Other|0|||
126329936|NCT02080364|454501754|FG001|Baseline Period|Other|1|||
126329937|NCT02080364|454501755|FG002|Baseline Period|Other|1|||
126655763|NCT02054520|455697702|FG000|Overall Study|Adverse Event|1|||
126655764|NCT02054520|455697703|FG001|Overall Study|Adverse Event|4|||
126655765|NCT02054520|455697704|FG002|Overall Study|Adverse Event|2|||
126655766|NCT02054520|455697705|FG003|Overall Study|Adverse Event|1|||
126655767|NCT02054520|455697706|FG004|Overall Study|Adverse Event|1|||
126655768|NCT02054520|455697707|FG005|Overall Study|Adverse Event|0|||
126655769|NCT02054520|455697702|FG000|Overall Study|Lack of Efficacy|7|||
126655770|NCT02054520|455697703|FG001|Overall Study|Lack of Efficacy|0|||
126655771|NCT02054520|455697704|FG002|Overall Study|Lack of Efficacy|2|||
126655772|NCT02054520|455697705|FG003|Overall Study|Lack of Efficacy|1|||
126655773|NCT02054520|455697706|FG004|Overall Study|Lack of Efficacy|3|||
126655774|NCT02054520|455697707|FG005|Overall Study|Lack of Efficacy|2|||
126655775|NCT02054520|455697702|FG000|Overall Study|Withdrawal by Subject|1|||
126655776|NCT02054520|455697703|FG001|Overall Study|Withdrawal by Subject|0|||
126655777|NCT02054520|455697704|FG002|Overall Study|Withdrawal by Subject|0|||
126655778|NCT02054520|455697705|FG003|Overall Study|Withdrawal by Subject|2|||
126655779|NCT02054520|455697706|FG004|Overall Study|Withdrawal by Subject|1|||
126655780|NCT02054520|455697707|FG005|Overall Study|Withdrawal by Subject|0|||
126655781|NCT02054520|455697702|FG000|Overall Study|Physician Decision|0|||
126655782|NCT02054520|455697703|FG001|Overall Study|Physician Decision|1|||
126655783|NCT02054520|455697704|FG002|Overall Study|Physician Decision|0|||
126655784|NCT02054520|455697705|FG003|Overall Study|Physician Decision|1|||
126655785|NCT02054520|455697706|FG004|Overall Study|Physician Decision|0|||
126655786|NCT02054520|455697707|FG005|Overall Study|Physician Decision|1|||
126655787|NCT02054520|455697702|FG000|Overall Study|Study terminated by Sponsor|0|||
126655788|NCT02054520|455697703|FG001|Overall Study|Study terminated by Sponsor|0|||
126655789|NCT02054520|455697704|FG002|Overall Study|Study terminated by Sponsor|2|||
126329938|NCT02080364|454501756|FG003|Baseline Period|Other|0|||
126329939|NCT02080364|454501753|FG000|Treatment Period|Adverse Event|10|||
126329940|NCT02080364|454501754|FG001|Treatment Period|Adverse Event|15|||
126329941|NCT02080364|454501755|FG002|Treatment Period|Adverse Event|11|||
126329942|NCT02080364|454501756|FG003|Treatment Period|Adverse Event|14|||
126329943|NCT02080364|454501753|FG000|Treatment Period|Lost to Follow-up|2|||
126329944|NCT02080364|454501754|FG001|Treatment Period|Lost to Follow-up|3|||
126329945|NCT02080364|454501755|FG002|Treatment Period|Lost to Follow-up|5|||
126329946|NCT02080364|454501756|FG003|Treatment Period|Lost to Follow-up|0|||
126329947|NCT02080364|454501753|FG000|Treatment Period|Protocol Violation|5|||
126655790|NCT02054520|455697705|FG003|Overall Study|Study terminated by Sponsor|1|||
126655791|NCT02054520|455697706|FG004|Overall Study|Study terminated by Sponsor|0|||
126655792|NCT02054520|455697707|FG005|Overall Study|Study terminated by Sponsor|0|||
126655793|NCT03218397|455697708|FG000|Overall Study|Prior positive blood culture|8|||
126655794|NCT03218397|455697709|FG001|Overall Study|Prior positive blood culture|13|||
126655795|NCT03218397|455697708|FG000|Overall Study|Comfort care|8|||
126655796|NCT03218397|455697709|FG001|Overall Study|Comfort care|5|||
126655797|NCT03218397|455697708|FG000|Overall Study|Comfort care and positive blood culture|1|||
126655798|NCT03218397|455697709|FG001|Overall Study|Comfort care and positive blood culture|0|||
126655799|NCT03218397|455697708|FG000|Overall Study|Comfort care and mixed culture|0|||
126655800|NCT03218397|455697709|FG001|Overall Study|Comfort care and mixed culture|1|||
126655801|NCT03218397|455697708|FG000|Overall Study|Mixed culture|2|||
126655802|NCT03218397|455697709|FG001|Overall Study|Mixed culture|2|||
126655803|NCT03218397|455697708|FG000|Overall Study|Inaccessible hospital records|2|||
126655804|NCT03218397|455697709|FG001|Overall Study|Inaccessible hospital records|5|||
126655805|NCT03218397|455697708|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
126655806|NCT03218397|455697709|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
126655807|NCT03218397|455697708|FG000|Overall Study|Randomized during laboratory off hours|2|||
126655808|NCT03218397|455697709|FG001|Overall Study|Randomized during laboratory off hours|1|||
126655809|NCT00943111|455697710|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
126655810|NCT00943111|455697711|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
126655811|NCT00943111|455697712|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
126655812|NCT00943111|455697710|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
126655813|NCT00943111|455697711|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
126655814|NCT00943111|455697712|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
126655815|NCT00943111|455697710|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
126655816|NCT00943111|455697711|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
126655817|NCT00943111|455697712|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
126655818|NCT00943111|455697710|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
126655819|NCT00943111|455697711|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
126655820|NCT00943111|455697712|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
126655821|NCT00943111|455697710|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
126655822|NCT00943111|455697711|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
126655823|NCT00943111|455697712|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
126655824|NCT00943111|455697710|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
126655825|NCT00943111|455697711|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
126655826|NCT00943111|455697712|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
126655827|NCT00943111|455697710|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
126655828|NCT00943111|455697711|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
126655829|NCT00943111|455697712|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
126655830|NCT00943111|455697710|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
126655831|NCT00943111|455697711|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
126655832|NCT00943111|455697712|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
126655833|NCT01796548|455697713|FG000|Overall Study|Lost to Follow-up|1|||
126655834|NCT01796548|455697713|FG000|Overall Study|Other|2|||
126655835|NCT02859324|455697714|FG000|Overall Study|Death|4|||
126655836|NCT02859324|455697715|FG001|Overall Study|Death|6|||
126655837|NCT02859324|455697716|FG002|Overall Study|Death|5|||
126655838|NCT02859324|455697714|FG000|Overall Study|Other reasons|3|||
126655839|NCT02859324|455697715|FG001|Overall Study|Other reasons|3|||
126655840|NCT02859324|455697716|FG002|Overall Study|Other reasons|0|||
126655841|NCT00112047|455697719|FG000|Randomized Phase|Lost to Follow-up|26|||
126655842|NCT00112047|455697720|FG001|Randomized Phase|Lost to Follow-up|33|||
126655843|NCT00112047|455697719|FG000|Randomized Phase|Adverse Event|10|||
126655844|NCT00112047|455697720|FG001|Randomized Phase|Adverse Event|10|||
126655845|NCT00112047|455697719|FG000|Randomized Phase|Withrawal of consent|10|||
126655846|NCT00112047|455697720|FG001|Randomized Phase|Withrawal of consent|18|||
126655847|NCT00112047|455697719|FG000|Randomized Phase|Sub-optimal virological response|3|||
126655848|NCT00112047|455697720|FG001|Randomized Phase|Sub-optimal virological response|13|||
126655849|NCT00112047|455697719|FG000|Randomized Phase|Noncompliance|8|||
126655850|NCT00112047|455697720|FG001|Randomized Phase|Noncompliance|4|||
126655851|NCT00112047|455697719|FG000|Randomized Phase|Protocol Violation|2|||
126655852|NCT00112047|455697720|FG001|Randomized Phase|Protocol Violation|0|||
126655853|NCT00112047|455697719|FG000|Randomized Phase|Pregnancy|3|||
126655854|NCT00112047|455697720|FG001|Randomized Phase|Pregnancy|1|||
126655855|NCT00112047|455697719|FG000|Randomized Phase|Death|1|||
126655856|NCT00112047|455697720|FG001|Randomized Phase|Death|3|||
126655857|NCT00112047|455697719|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
126655858|NCT00112047|455697720|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
126655859|NCT00112047|455697719|FG000|Randomized Phase|Inability to swallow pills|0|||
126655860|NCT00112047|455697720|FG001|Randomized Phase|Inability to swallow pills|1|||
126655861|NCT00112047|455697719|FG000|Randomized Phase|Incarceration|3|||
126655862|NCT00112047|455697720|FG001|Randomized Phase|Incarceration|2|||
126655863|NCT00112047|455697719|FG000|Randomized Phase|Moved out of State|0|||
126655864|NCT00112047|455697720|FG001|Randomized Phase|Moved out of State|1|||
126655865|NCT00112047|455697719|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
126655866|NCT00112047|455697720|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
126655867|NCT00112047|455697719|FG000|Randomized Phase|High Hepatitis B DNA|0|||
126655868|NCT00112047|455697720|FG001|Randomized Phase|High Hepatitis B DNA|1|||
126655869|NCT00112047|455697719|FG000|Atripla Phase|Adverse Event|2|||
126655870|NCT00112047|455697720|FG001|Atripla Phase|Adverse Event|1|||
126655871|NCT00112047|455697719|FG000|Atripla Phase|Lost to Follow-up|5|||
126655872|NCT00112047|455697720|FG001|Atripla Phase|Lost to Follow-up|7|||
126655873|NCT00112047|455697719|FG000|Atripla Phase|Pregnancy|0|||
126655874|NCT00112047|455697720|FG001|Atripla Phase|Pregnancy|1|||
126655875|NCT00112047|455697719|FG000|Atripla Phase|Death|0|||
126655876|NCT00112047|455697720|FG001|Atripla Phase|Death|2|||
126655877|NCT00112047|455697719|FG000|Atripla Phase|Withdrew consent|7|||
126655878|NCT00112047|455697720|FG001|Atripla Phase|Withdrew consent|7|||
126655879|NCT00112047|455697719|FG000|Atripla Phase|Sub-optimal virological response|0|||
126655880|NCT00112047|455697720|FG001|Atripla Phase|Sub-optimal virological response|1|||
126655881|NCT00112047|455697719|FG000|Atripla Phase|Non-compliance|1|||
126655882|NCT00112047|455697720|FG001|Atripla Phase|Non-compliance|0|||
126655883|NCT00112047|455697719|FG000|Atripla Phase|Other|3|||
126655884|NCT00112047|455697720|FG001|Atripla Phase|Other|1|||
126655885|NCT01307579|455697721|FG000|Overall Study|Death|3|||
126655886|NCT01307579|455697722|FG001|Overall Study|Death|6|||
126655887|NCT01307579|455697721|FG000|Overall Study|Physician Decision|26|||
126655888|NCT01307579|455697722|FG001|Overall Study|Physician Decision|29|||
126655889|NCT01307579|455697721|FG000|Overall Study|Withdrawal by Subject|7|||
126655890|NCT01307579|455697722|FG001|Overall Study|Withdrawal by Subject|3|||
126655891|NCT01307579|455697721|FG000|Overall Study|Institutional diagnosis of IFD|21|||
126655892|NCT01307579|455697722|FG001|Overall Study|Institutional diagnosis of IFD|36|||
126655893|NCT01307579|455697721|FG000|Overall Study|Begin conditioning for HSCT|42|||
126655894|NCT01307579|455697722|FG001|Overall Study|Begin conditioning for HSCT|44|||
126655895|NCT01307579|455697721|FG000|Overall Study|Refractory or relapsed AML|38|||
126655896|NCT01307579|455697722|FG001|Overall Study|Refractory or relapsed AML|23|||
126655897|NCT01307579|455697721|FG000|Overall Study|Ineligible|3|||
126655898|NCT01307579|455697722|FG001|Overall Study|Ineligible|4|||
126655899|NCT01022268|455699541|FG000|Overall Study|Withdrawal by Subject|1|||
126655900|NCT01022268|455699542|FG001|Overall Study|Withdrawal by Subject|0|||
126655901|NCT01022268|455699541|FG000|Overall Study|Withdrawal by Subject|1|||
126655902|NCT01022268|455699542|FG001|Overall Study|Withdrawal by Subject|0|||
126655903|NCT00910689|455699543|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
126655904|NCT00910689|455699544|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
126655905|NCT00910689|455699545|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
126655906|NCT00910689|455699546|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
126655907|NCT00910689|455699543|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
126655908|NCT00910689|455699544|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
126655909|NCT00910689|455699545|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
126655910|NCT00910689|455699546|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
126655911|NCT00910689|455699543|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
126655912|NCT00910689|455699544|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
126655913|NCT00910689|455699545|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
126655914|NCT00910689|455699546|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
126655915|NCT00910689|455699543|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
126655916|NCT00910689|455699544|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
126655917|NCT00910689|455699545|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
126655918|NCT00910689|455699546|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
126655919|NCT00910689|455699543|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
126655920|NCT00910689|455699544|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
126655921|NCT00910689|455699545|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
126655922|NCT00910689|455699546|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
126655923|NCT00910689|455699543|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
126655924|NCT00910689|455699544|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
126655925|NCT00910689|455699545|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
126655926|NCT00910689|455699546|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
126655927|NCT00910689|455699543|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
126655928|NCT00910689|455699544|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
126655929|NCT00910689|455699545|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
126655930|NCT00910689|455699546|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
126655931|NCT00910689|455699543|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
126655932|NCT00910689|455699544|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
126655933|NCT00910689|455699545|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
126655934|NCT00910689|455699546|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
126655935|NCT00910689|455699543|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
126655936|NCT00910689|455699544|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
126655937|NCT00910689|455699545|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
126655938|NCT00910689|455699546|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
126655939|NCT00910689|455699543|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
126655940|NCT00910689|455699544|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
126655941|NCT00910689|455699545|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
126655942|NCT00910689|455699546|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
126655943|NCT00910689|455699543|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
126655944|NCT00910689|455699544|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
126655945|NCT00910689|455699545|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
126655946|NCT00910689|455699546|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
126655947|NCT00910689|455699543|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
126655948|NCT00910689|455699544|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
126655949|NCT00910689|455699545|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
126655950|NCT00910689|455699546|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
126655951|NCT00910689|455699543|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
126655952|NCT00910689|455699544|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
126655953|NCT00910689|455699545|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
126655954|NCT00910689|455699546|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
126655955|NCT00910689|455699543|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
126655956|NCT00910689|455699544|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
126655957|NCT00910689|455699545|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
126655958|NCT00910689|455699546|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
126655959|NCT00910689|455699543|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
126655960|NCT00910689|455699544|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
126655961|NCT00910689|455699545|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
126655962|NCT00910689|455699546|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
126655963|NCT00910689|455699543|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
126655964|NCT00910689|455699544|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
126655965|NCT00910689|455699545|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
126655966|NCT00910689|455699546|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
126655967|NCT00910689|455699543|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
126655968|NCT00910689|455699544|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
126655969|NCT00910689|455699545|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
126655970|NCT00910689|455699546|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
126655971|NCT00910689|455699543|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
126655972|NCT00910689|455699544|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
126655973|NCT00910689|455699545|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
126655974|NCT00910689|455699546|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
126655975|NCT00910689|455699543|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
126655976|NCT00910689|455699544|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
126655977|NCT00910689|455699545|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
126655978|NCT00910689|455699546|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
126655979|NCT00910689|455699543|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
126655980|NCT00910689|455699544|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
126655981|NCT00910689|455699545|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
126655982|NCT00910689|455699546|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
126655983|NCT00910689|455699543|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
126655984|NCT00910689|455699544|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
126655985|NCT00910689|455699545|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
126655986|NCT00910689|455699546|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
126655987|NCT00189488|455699547|FG000|Overall Study|Ineligibility determined|1|||
126655988|NCT00189488|455699548|FG001|Overall Study|Ineligibility determined|0|||
126655989|NCT00189488|455699547|FG000|Overall Study|Protocol deviation|2|||
126655990|NCT00189488|455699548|FG001|Overall Study|Protocol deviation|1|||
126655991|NCT00189488|455699547|FG000|Overall Study|Adverse Event|2|||
126655992|NCT00189488|455699548|FG001|Overall Study|Adverse Event|1|||
126655993|NCT00189488|455699547|FG000|Overall Study|Withdrawal by Subject|2|||
126655994|NCT00189488|455699548|FG001|Overall Study|Withdrawal by Subject|6|||
126655995|NCT00189488|455699547|FG000|Overall Study|Disease progression|2|||
126655996|NCT00189488|455699548|FG001|Overall Study|Disease progression|4|||
126655997|NCT00189488|455699547|FG000|Overall Study|Administrative Decision|0|||
126655998|NCT00189488|455699548|FG001|Overall Study|Administrative Decision|2|||
126655999|NCT00189488|455699547|FG000|Overall Study|Death|5|||
126656000|NCT00189488|455699548|FG001|Overall Study|Death|8|||
126656001|NCT00189488|455699547|FG000|Overall Study|Other|1|||
126656002|NCT00189488|455699548|FG001|Overall Study|Other|0|||
126656003|NCT00192647|455699554|FG000|Overall Study|Death|1|||
126656004|NCT00192647|455699555|FG001|Overall Study|Death|1|||
126656005|NCT00192647|455699554|FG000|Overall Study|Adverse Event|35|||
126656006|NCT00192647|455699555|FG001|Overall Study|Adverse Event|29|||
126656007|NCT00192647|455699554|FG000|Overall Study|Laboratory Test Abnormality|4|||
126656008|NCT00192647|455699555|FG001|Overall Study|Laboratory Test Abnormality|2|||
126656009|NCT00192647|455699554|FG000|Overall Study|Insufficient Therapeutic Response|53|||
126656010|NCT00192647|455699555|FG001|Overall Study|Insufficient Therapeutic Response|83|||
126656011|NCT00192647|455699554|FG000|Overall Study|Entry Criteria Violation|6|||
126656012|NCT00192647|455699555|FG001|Overall Study|Entry Criteria Violation|6|||
126656013|NCT00192647|455699554|FG000|Overall Study|Protocol Violation|3|||
126656014|NCT00192647|455699555|FG001|Overall Study|Protocol Violation|1|||
126656015|NCT00192647|455699554|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
126656016|NCT00192647|455699555|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
126656017|NCT00192647|455699554|FG000|Overall Study|Failure to Return|11|||
126656018|NCT00192647|455699555|FG001|Overall Study|Failure to Return|13|||
126656019|NCT00192647|455699554|FG000|Overall Study|Other/Administrative|5|||
126656020|NCT00192647|455699555|FG001|Overall Study|Other/Administrative|3|||
126656021|NCT01828073|455699556|FG000|Overall Study|Lost to Follow-up|1|||
126656022|NCT01828073|455699557|FG001|Overall Study|Lost to Follow-up|2|||
126656023|NCT02915302|455699558|FG000|Overall Study|Adverse Event|3|||
126656024|NCT02915302|455699559|FG001|Overall Study|Adverse Event|0|||
126656025|NCT02915302|455699558|FG000|Overall Study|Protocol Violation|20|||
126656026|NCT02915302|455699559|FG001|Overall Study|Protocol Violation|27|||
126656027|NCT02915302|455699558|FG000|Overall Study|Lost to Follow-up|19|||
126656028|NCT02915302|455699559|FG001|Overall Study|Lost to Follow-up|22|||
126656029|NCT02915302|455699558|FG000|Overall Study|Withdrawal by Subject|22|||
126656030|NCT02915302|455699559|FG001|Overall Study|Withdrawal by Subject|29|||
126656031|NCT02915302|455699558|FG000|Overall Study|Other|1|||
126656032|NCT02915302|455699559|FG001|Overall Study|Other|0|||
126656033|NCT00690443|455699560|FG000|Overall Study|Adverse Event|1|||
126656034|NCT00690443|455699561|FG001|Overall Study|Adverse Event|2|||
126656035|NCT01877837|455699562|FG000|Overall Study|Lost to Follow-up|1|||
126656036|NCT01877837|455699562|FG000|Overall Study|Ineligible|4|||
126656037|NCT00645801|455699564|FG000|Overall Study|unclear if patient took all the medication.|1|||
126656038|NCT00645801|455699565|FG001|Overall Study|unclear if patient took all the medication.|0|||
126656039|NCT00645801|455699564|FG000|Overall Study|Lost to Follow-up|19|||
126656040|NCT00645801|455699565|FG001|Overall Study|Lost to Follow-up|15|||
126656041|NCT00705679|455699566|FG000|Overall Study|Adverse Event|1|||
126656042|NCT00705679|455699567|FG001|Overall Study|Adverse Event|1|||
126656043|NCT00705679|455699568|FG002|Overall Study|Adverse Event|0|||
126656044|NCT00705679|455699569|FG003|Overall Study|Adverse Event|0|||
126656045|NCT00705679|455699570|FG004|Overall Study|Adverse Event|0|||
126656046|NCT00705679|455699566|FG000|Overall Study|Death|0|||
126656047|NCT00705679|455699567|FG001|Overall Study|Death|0|||
126656048|NCT00705679|455699568|FG002|Overall Study|Death|3|||
126656049|NCT00705679|455699569|FG003|Overall Study|Death|2|||
126656050|NCT00705679|455699570|FG004|Overall Study|Death|1|||
126656051|NCT00705679|455699566|FG000|Overall Study|Lost to Follow-up|32|||
126656052|NCT00705679|455699567|FG001|Overall Study|Lost to Follow-up|60|||
126656053|NCT00705679|455699568|FG002|Overall Study|Lost to Follow-up|44|||
126656054|NCT00705679|455699569|FG003|Overall Study|Lost to Follow-up|30|||
126656055|NCT00705679|455699570|FG004|Overall Study|Lost to Follow-up|35|||
126656056|NCT00705679|455699566|FG000|Overall Study|Physician Decision|0|||
126656057|NCT00705679|455699567|FG001|Overall Study|Physician Decision|1|||
126656058|NCT00705679|455699568|FG002|Overall Study|Physician Decision|0|||
126656059|NCT00705679|455699569|FG003|Overall Study|Physician Decision|1|||
126656060|NCT00705679|455699570|FG004|Overall Study|Physician Decision|0|||
126656061|NCT00705679|455699566|FG000|Overall Study|Withdrawal by Subject|32|||
126656062|NCT00705679|455699567|FG001|Overall Study|Withdrawal by Subject|77|||
126656063|NCT00705679|455699568|FG002|Overall Study|Withdrawal by Subject|68|||
126656064|NCT00705679|455699569|FG003|Overall Study|Withdrawal by Subject|47|||
126656065|NCT00705679|455699570|FG004|Overall Study|Withdrawal by Subject|33|||
126656066|NCT00932113|455699571|FG000|Overall Study|Lost to Follow-up|1|||
126656067|NCT00932113|455699572|FG001|Overall Study|Lost to Follow-up|0|||
126656068|NCT01776541|455699576|FG000|Overall Study|Administrative Reason|6|||
126656069|NCT01776541|455699577|FG001|Overall Study|Administrative Reason|2|||
126656070|NCT01776541|455699576|FG000|Overall Study|Death|4|||
126656071|NCT01776541|455699577|FG001|Overall Study|Death|0|||
126656072|NCT01776541|455699576|FG000|Overall Study|Lost to Follow-up|27|||
126656073|NCT01776541|455699577|FG001|Overall Study|Lost to Follow-up|48|||
126656074|NCT01776541|455699576|FG000|Overall Study|Unclassified|5|||
126656075|NCT01776541|455699577|FG001|Overall Study|Unclassified|4|||
126656076|NCT01776541|455699576|FG000|Overall Study|Protocol Violation|2|||
126656077|NCT01776541|455699577|FG001|Overall Study|Protocol Violation|1|||
126656078|NCT01776541|455699576|FG000|Overall Study|Withdrawal by Subject|12|||
126656079|NCT01776541|455699577|FG001|Overall Study|Withdrawal by Subject|20|||
126656080|NCT02090959|455699578|FG000|Overall Study|Withdrawal by Subject|10|||
126656081|NCT02090959|455699578|FG000|Overall Study|Adverse Event|1|||
126656082|NCT02090959|455699578|FG000|Overall Study|Investigator decision|2|||
126656083|NCT02090959|455699578|FG000|Overall Study|Study termination|6|||
126656084|NCT02090959|455699578|FG000|Overall Study|Enrolled but not treated|1|||
126656085|NCT02090959|455699578|FG000|Overall Study|Transfer for compassionate use medicine|4|||
126656086|NCT02090959|455699578|FG000|Overall Study|Move to medical need program|3|||
126656087|NCT02090959|455699578|FG000|Overall Study|Entered in to other study|34|||
126656088|NCT02090959|455699578|FG000|Overall Study|Switched to commercial supply|88|||
126656089|NCT02090959|455699578|FG000|Overall Study|Other than specified|2|||
126656090|NCT00522873|455699581|FG000|Overall Study|Adverse Event|41|||
126656091|NCT00522873|455699582|FG001|Overall Study|Adverse Event|26|||
126329948|NCT02080364|454501754|FG001|Treatment Period|Protocol Violation|3|||
126329949|NCT02080364|454501755|FG002|Treatment Period|Protocol Violation|5|||
126329950|NCT02080364|454501756|FG003|Treatment Period|Protocol Violation|1|||
126329951|NCT02080364|454501753|FG000|Treatment Period|Withdrawal by Subject|16|||
126329952|NCT02080364|454501754|FG001|Treatment Period|Withdrawal by Subject|16|||
126329953|NCT02080364|454501755|FG002|Treatment Period|Withdrawal by Subject|15|||
126329954|NCT02080364|454501756|FG003|Treatment Period|Withdrawal by Subject|10|||
126329955|NCT02080364|454501753|FG000|Treatment Period|Study Terminated by Sponsor|0|||
126329956|NCT02080364|454501754|FG001|Treatment Period|Study Terminated by Sponsor|0|||
126329957|NCT02080364|454501755|FG002|Treatment Period|Study Terminated by Sponsor|180|||
126329958|NCT02080364|454501756|FG003|Treatment Period|Study Terminated by Sponsor|183|||
126329959|NCT02080364|454501753|FG000|Treatment Period|Other|14|||
126329960|NCT02080364|454501754|FG001|Treatment Period|Other|12|||
126329961|NCT02080364|454501755|FG002|Treatment Period|Other|21|||
126329962|NCT02080364|454501756|FG003|Treatment Period|Other|16|||
126329963|NCT02504320|454501757|FG000|Treatment Period 1|Positive Drug Screen|0|||
126329964|NCT02504320|454501758|FG001|Treatment Period 1|Positive Drug Screen|0|||
126329965|NCT02504320|454501759|FG002|Treatment Period 1|Positive Drug Screen|1|||
126329966|NCT02504320|454501760|FG003|Treatment Period 1|Positive Drug Screen|0|||
126329967|NCT02504320|454501757|FG000|Treatment Period 2|Positive Drug Screen|0|||
126329968|NCT02504320|454501758|FG001|Treatment Period 2|Positive Drug Screen|1|||
126329969|NCT02504320|454501759|FG002|Treatment Period 2|Positive Drug Screen|0|||
126656092|NCT00522873|455699581|FG000|Overall Study|Withdrawal by Subject|20|||
126656093|NCT00522873|455699582|FG001|Overall Study|Withdrawal by Subject|9|||
126656094|NCT00522873|455699581|FG000|Overall Study|Protocol Violation|14|||
126656095|NCT00522873|455699582|FG001|Overall Study|Protocol Violation|4|||
126656096|NCT00522873|455699581|FG000|Overall Study|Lost to Follow-up|11|||
126656097|NCT00522873|455699582|FG001|Overall Study|Lost to Follow-up|3|||
126656098|NCT00522873|455699581|FG000|Overall Study|Personal Reasons|8|||
126656099|NCT00522873|455699582|FG001|Overall Study|Personal Reasons|1|||
126656100|NCT00522873|455699581|FG000|Overall Study|Medication Errors|1|||
126656101|NCT00522873|455699582|FG001|Overall Study|Medication Errors|1|||
126656102|NCT00522873|455699581|FG000|Overall Study|Never Received Medication|1|||
126656103|NCT00522873|455699582|FG001|Overall Study|Never Received Medication|0|||
126656104|NCT01248065|455699585|FG000|Overall Study|Lost to Follow-up|3|||
126656105|NCT01248065|455699586|FG001|Overall Study|Lost to Follow-up|5|||
126656106|NCT01248065|455699585|FG000|Overall Study|Withdrawal by Subject|14|||
126656107|NCT01248065|455699586|FG001|Overall Study|Withdrawal by Subject|11|||
126656108|NCT01248065|455699585|FG000|Overall Study|Adverse Event|3|||
126656109|NCT01248065|455699586|FG001|Overall Study|Adverse Event|0|||
126656110|NCT01248065|455699585|FG000|Overall Study|Third treatment failure event|3|||
126656111|NCT01248065|455699586|FG001|Overall Study|Third treatment failure event|1|||
126656112|NCT01248065|455699585|FG000|Overall Study|Other|3|||
126656113|NCT01248065|455699586|FG001|Overall Study|Other|5|||
126656114|NCT03010176|455699590|FG000|Overall Study|Death|21|||
126656115|NCT03010176|455699591|FG001|Overall Study|Death|35|||
126656116|NCT03010176|455699592|FG002|Overall Study|Death|19|||
126656117|NCT03010176|455699593|FG003|Overall Study|Death|19|||
126656118|NCT03010176|455699594|FG004|Overall Study|Death|14|||
126656119|NCT03010176|455699595|FG005|Overall Study|Death|0|||
126656120|NCT03010176|455699590|FG000|Overall Study|Lost to Follow-up|0|||
126656121|NCT03010176|455699591|FG001|Overall Study|Lost to Follow-up|0|||
126656122|NCT03010176|455699592|FG002|Overall Study|Lost to Follow-up|0|||
126656123|NCT03010176|455699593|FG003|Overall Study|Lost to Follow-up|0|||
126656124|NCT03010176|455699594|FG004|Overall Study|Lost to Follow-up|1|||
126656125|NCT03010176|455699595|FG005|Overall Study|Lost to Follow-up|0|||
126656126|NCT03010176|455699590|FG000|Overall Study|Physician Decision|0|||
126656127|NCT03010176|455699591|FG001|Overall Study|Physician Decision|4|||
126656128|NCT03010176|455699592|FG002|Overall Study|Physician Decision|0|||
126656129|NCT03010176|455699593|FG003|Overall Study|Physician Decision|1|||
126656130|NCT03010176|455699594|FG004|Overall Study|Physician Decision|0|||
126656131|NCT03010176|455699595|FG005|Overall Study|Physician Decision|0|||
126656132|NCT03010176|455699590|FG000|Overall Study|Sponsor Decision|0|||
126656133|NCT03010176|455699591|FG001|Overall Study|Sponsor Decision|4|||
126656134|NCT03010176|455699592|FG002|Overall Study|Sponsor Decision|4|||
126329970|NCT02504320|454501760|FG003|Treatment Period 2|Positive Drug Screen|0|||
126329971|NCT02504320|454501757|FG000|Treatment Period 3|Positive Drug Screen|0|||
126329972|NCT02504320|454501758|FG001|Treatment Period 3|Positive Drug Screen|0|||
126656135|NCT03010176|455699593|FG003|Overall Study|Sponsor Decision|1|||
126656136|NCT03010176|455699594|FG004|Overall Study|Sponsor Decision|6|||
126656137|NCT03010176|455699595|FG005|Overall Study|Sponsor Decision|0|||
126656138|NCT03010176|455699590|FG000|Overall Study|Withdrawal by Subject|11|||
126656139|NCT03010176|455699591|FG001|Overall Study|Withdrawal by Subject|9|||
126656140|NCT03010176|455699592|FG002|Overall Study|Withdrawal by Subject|3|||
126656141|NCT03010176|455699593|FG003|Overall Study|Withdrawal by Subject|0|||
126656142|NCT03010176|455699594|FG004|Overall Study|Withdrawal by Subject|4|||
126656143|NCT03010176|455699595|FG005|Overall Study|Withdrawal by Subject|0|||
126329973|NCT02504320|454501759|FG002|Treatment Period 3|Positive Drug Screen|0|||
126656144|NCT04256629|455699596|FG000|Overall Study|Adverse Event|0|||
126656145|NCT04256629|455699597|FG001|Overall Study|Adverse Event|0|||
126656146|NCT04256629|455699598|FG002|Overall Study|Adverse Event|0|||
126656147|NCT04256629|455699599|FG003|Overall Study|Adverse Event|0|||
126656148|NCT04256629|455699600|FG004|Overall Study|Adverse Event|0|||
126656149|NCT04256629|455699601|FG005|Overall Study|Adverse Event|1|||
126656150|NCT04256629|455699596|FG000|Overall Study|Protocol Violation|0|||
126656151|NCT04256629|455699597|FG001|Overall Study|Protocol Violation|1|||
126656152|NCT04256629|455699598|FG002|Overall Study|Protocol Violation|0|||
126656153|NCT04256629|455699599|FG003|Overall Study|Protocol Violation|0|||
126656154|NCT04256629|455699600|FG004|Overall Study|Protocol Violation|0|||
126656155|NCT04256629|455699601|FG005|Overall Study|Protocol Violation|0|||
126656156|NCT01774487|455699602|FG000|Overall Study|Did not tolerate taste|4|||
126656157|NCT01774487|455699603|FG001|Overall Study|Did not tolerate taste|4|||
126656158|NCT04447846|455699604|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
126656159|NCT00461032|455699605|FG000|Overall Study|Adverse Event|5|||
126656160|NCT00461032|455699606|FG001|Overall Study|Adverse Event|6|||
126656161|NCT00461032|455699605|FG000|Overall Study|Lack of Efficacy|5|||
126656162|NCT00461032|455699606|FG001|Overall Study|Lack of Efficacy|1|||
126656163|NCT00461032|455699605|FG000|Overall Study|Lost to Follow-up|7|||
126656164|NCT00461032|455699606|FG001|Overall Study|Lost to Follow-up|12|||
126656165|NCT00461032|455699605|FG000|Overall Study|Protocol Violation|4|||
126656166|NCT00461032|455699606|FG001|Overall Study|Protocol Violation|4|||
126656167|NCT00461032|455699605|FG000|Overall Study|Withdrawal by Subject|7|||
126656168|NCT00461032|455699606|FG001|Overall Study|Withdrawal by Subject|15|||
126656169|NCT00461032|455699605|FG000|Overall Study|Patient Moved or Relocated|2|||
126656170|NCT00461032|455699606|FG001|Overall Study|Patient Moved or Relocated|1|||
126656171|NCT00461032|455699605|FG000|Overall Study|Other|7|||
126656172|NCT00461032|455699606|FG001|Overall Study|Other|5|||
126656173|NCT01878214|455699607|FG000|Overall Study|Withdrawal by Subject|18|||
126656174|NCT01878214|455699608|FG001|Overall Study|Withdrawal by Subject|7|||
126656175|NCT01878214|455699607|FG000|Overall Study|Death|0|||
126656176|NCT01878214|455699608|FG001|Overall Study|Death|1|||
126656177|NCT01878214|455699607|FG000|Overall Study|Lost to Follow-up|35|||
126656178|NCT01878214|455699608|FG001|Overall Study|Lost to Follow-up|36|||
126656179|NCT00946101|455699609|FG000|Overall Study|Lost to Follow-up|2|||
126656180|NCT00946101|455699610|FG001|Overall Study|Lost to Follow-up|1|||
126656181|NCT00946101|455699609|FG000|Overall Study|Withdrawal of consent|2|||
126656182|NCT00946101|455699610|FG001|Overall Study|Withdrawal of consent|0|||
126656183|NCT00946101|455699609|FG000|Overall Study|Physician Decision|0|||
126656184|NCT00946101|455699610|FG001|Overall Study|Physician Decision|1|||
126656185|NCT02647866|455699613|FG000|Overall Study|Adverse Event|0|||
126656186|NCT02647866|455699614|FG001|Overall Study|Adverse Event|0|||
126656187|NCT02647866|455699615|FG002|Overall Study|Adverse Event|2|||
126656188|NCT02647866|455699616|FG003|Overall Study|Adverse Event|2|||
126656189|NCT02647866|455699617|FG004|Overall Study|Adverse Event|1|||
126656190|NCT02647866|455699613|FG000|Overall Study|Disease Worsening|3|||
126656191|NCT02647866|455699614|FG001|Overall Study|Disease Worsening|1|||
126656192|NCT02647866|455699615|FG002|Overall Study|Disease Worsening|0|||
126656193|NCT02647866|455699616|FG003|Overall Study|Disease Worsening|0|||
126656194|NCT02647866|455699617|FG004|Overall Study|Disease Worsening|1|||
126656195|NCT02647866|455699613|FG000|Overall Study|Withdrawal by Subject|1|||
126656196|NCT02647866|455699614|FG001|Overall Study|Withdrawal by Subject|1|||
126656197|NCT02647866|455699615|FG002|Overall Study|Withdrawal by Subject|2|||
126656198|NCT02647866|455699616|FG003|Overall Study|Withdrawal by Subject|4|||
126656199|NCT02647866|455699617|FG004|Overall Study|Withdrawal by Subject|4|||
126656200|NCT02647866|455699613|FG000|Overall Study|Physician Decision|0|||
126656201|NCT02647866|455699614|FG001|Overall Study|Physician Decision|1|||
126656202|NCT02647866|455699615|FG002|Overall Study|Physician Decision|1|||
126656203|NCT02647866|455699616|FG003|Overall Study|Physician Decision|0|||
126656204|NCT02647866|455699617|FG004|Overall Study|Physician Decision|2|||
126656205|NCT02647866|455699613|FG000|Overall Study|Death|0|||
126329974|NCT02504320|454501760|FG003|Treatment Period 3|Positive Drug Screen|1|||
126329975|NCT02504320|454501757|FG000|Treatment Period 3|Adverse Event|0|||
126329976|NCT02504320|454501758|FG001|Treatment Period 3|Adverse Event|0|||
126656206|NCT02647866|455699614|FG001|Overall Study|Death|1|||
126656207|NCT02647866|455699615|FG002|Overall Study|Death|0|||
126656208|NCT02647866|455699616|FG003|Overall Study|Death|0|||
126656209|NCT02647866|455699617|FG004|Overall Study|Death|0|||
126656210|NCT02647866|455699613|FG000|Overall Study|Subject moved to different country|1|||
126656211|NCT02647866|455699614|FG001|Overall Study|Subject moved to different country|0|||
126656212|NCT02647866|455699615|FG002|Overall Study|Subject moved to different country|0|||
126656213|NCT02647866|455699616|FG003|Overall Study|Subject moved to different country|0|||
126656214|NCT02647866|455699617|FG004|Overall Study|Subject moved to different country|0|||
126656215|NCT00069108|455699618|FG000|Overall Study|Withdrawal by Subject|5|||
126656216|NCT00069108|455699619|FG001|Overall Study|Withdrawal by Subject|9|||
126656217|NCT00069108|455699618|FG000|Overall Study|Adverse Event|64|||
126656218|NCT00069108|455699619|FG001|Overall Study|Adverse Event|42|||
126656219|NCT00069108|455699618|FG000|Overall Study|Death|6|||
126656220|NCT00069108|455699619|FG001|Overall Study|Death|6|||
126656221|NCT00069108|455699618|FG000|Overall Study|Administration|15|||
126656222|NCT00069108|455699619|FG001|Overall Study|Administration|4|||
126656223|NCT00069108|455699618|FG000|Overall Study|Insufficient therapy|117|||
126656224|NCT00069108|455699619|FG001|Overall Study|Insufficient therapy|144|||
126656225|NCT00069108|455699618|FG000|Overall Study|Violation criteria|1|||
126656226|NCT00069108|455699619|FG001|Overall Study|Violation criteria|4|||
126656227|NCT00069108|455699618|FG000|Overall Study|Refused treatment|5|||
126656228|NCT00069108|455699619|FG001|Overall Study|Refused treatment|10|||
126656229|NCT01415531|455699621|FG000|Overall Study|Adverse Event|7|||
126656230|NCT01415531|455699622|FG001|Overall Study|Adverse Event|10|||
126656231|NCT01415531|455699621|FG000|Overall Study|Lack of Efficacy|3|||
126656232|NCT01415531|455699622|FG001|Overall Study|Lack of Efficacy|2|||
126656233|NCT01415531|455699621|FG000|Overall Study|Protocol Violation|0|||
126656234|NCT01415531|455699622|FG001|Overall Study|Protocol Violation|1|||
126656235|NCT01415531|455699621|FG000|Overall Study|Withdrawal by Subject|5|||
126656236|NCT01415531|455699622|FG001|Overall Study|Withdrawal by Subject|4|||
126656237|NCT01415531|455699621|FG000|Overall Study|Lost to Follow-up|6|||
126656238|NCT01415531|455699622|FG001|Overall Study|Lost to Follow-up|14|||
126656239|NCT01415531|455699621|FG000|Overall Study|Lack of Compliance|1|||
126656240|NCT01415531|455699622|FG001|Overall Study|Lack of Compliance|4|||
126656241|NCT01415531|455699621|FG000|Overall Study|Other Reasons|3|||
126656242|NCT01415531|455699622|FG001|Overall Study|Other Reasons|2|||
126656243|NCT00394082|455699625|FG000|Overall Study|Unacceptable toxicity|15|||
126656244|NCT00394082|455699625|FG000|Overall Study|Adverse Event|4|||
126656245|NCT00394082|455699625|FG000|Overall Study|Physician Decision|4|||
126656246|NCT00394082|455699625|FG000|Overall Study|Withdrawal by Subject|2|||
126656247|NCT00394082|455699625|FG000|Overall Study|Other|1|||
126656248|NCT02344004|455699627|FG000|Overall Study|Adverse Event|11|||
126656249|NCT02344004|455699628|FG001|Overall Study|Adverse Event|1|||
126656250|NCT02344004|455699627|FG000|Overall Study|Death|9|||
126656251|NCT02344004|455699628|FG001|Overall Study|Death|7|||
126656252|NCT02344004|455699627|FG000|Overall Study|Physician Decision|4|||
126656253|NCT02344004|455699628|FG001|Overall Study|Physician Decision|1|||
126656254|NCT02344004|455699627|FG000|Overall Study|Withdrawal by Subject|22|||
126656255|NCT02344004|455699628|FG001|Overall Study|Withdrawal by Subject|5|||
126656256|NCT02344004|455699627|FG000|Overall Study|Rescue Medication|2|||
126656257|NCT02344004|455699628|FG001|Overall Study|Rescue Medication|0|||
126656258|NCT02344004|455699627|FG000|Overall Study|Other Not Specified|12|||
126656259|NCT02344004|455699628|FG001|Overall Study|Other Not Specified|0|||
126656260|NCT02344004|455699627|FG000|Overall Study|Protocol Violation|1|||
126656261|NCT02344004|455699628|FG001|Overall Study|Protocol Violation|0|||
126656262|NCT02481947|455699632|FG000|Overall Study|Withdrawal by Subject|24|||
126656263|NCT02481947|455699633|FG001|Overall Study|Withdrawal by Subject|10|||
126656264|NCT02481947|455699632|FG000|Overall Study|Lost to Follow-up|11|||
126656265|NCT02481947|455699633|FG001|Overall Study|Lost to Follow-up|5|||
126656266|NCT02481947|455699632|FG000|Overall Study|Adverse Event|6|||
126656267|NCT02481947|455699633|FG001|Overall Study|Adverse Event|11|||
126656268|NCT02481947|455699632|FG000|Overall Study|Physician Decision|4|||
126656269|NCT02481947|455699633|FG001|Overall Study|Physician Decision|5|||
126656270|NCT02481947|455699632|FG000|Overall Study|Protocol Violation|1|||
126656271|NCT02481947|455699633|FG001|Overall Study|Protocol Violation|5|||
126656272|NCT05249829|455699634|FG000|Overall Study|Participant Relocation|0|||
126656273|NCT05249829|455699635|FG001|Overall Study|Participant Relocation|1|||
126656274|NCT05249829|455699636|FG002|Overall Study|Participant Relocation|2|||
126656275|NCT05249829|455699637|FG003|Overall Study|Participant Relocation|2|||
126656276|NCT05249829|455699634|FG000|Overall Study|Withdrawal by Subject|9|||
126656277|NCT05249829|455699635|FG001|Overall Study|Withdrawal by Subject|17|||
126656278|NCT05249829|455699636|FG002|Overall Study|Withdrawal by Subject|40|||
126656279|NCT05249829|455699637|FG003|Overall Study|Withdrawal by Subject|35|||
126329977|NCT02504320|454501759|FG002|Treatment Period 3|Adverse Event|1|||
126329978|NCT02504320|454501760|FG003|Treatment Period 3|Adverse Event|0|||
126329979|NCT01210222|454501761|FG000|Overall Study|Ineligible|2|||
126329980|NCT01210222|454501761|FG000|Overall Study|Never treated|1|||
126329981|NCT00941304|454501762|FG000|Overall Study|Lost to Follow-up|1|||
126329982|NCT00941304|454501763|FG001|Overall Study|Lost to Follow-up|0|||
126329983|NCT00941304|454501764|FG002|Overall Study|Lost to Follow-up|0|||
126329984|NCT00941304|454501765|FG003|Overall Study|Lost to Follow-up|0|||
126329985|NCT00941304|454501766|FG004|Overall Study|Lost to Follow-up|0|||
126656280|NCT05249829|455699634|FG000|Overall Study|Physician Decision|1|||
126656281|NCT05249829|455699635|FG001|Overall Study|Physician Decision|0|||
126656282|NCT05249829|455699636|FG002|Overall Study|Physician Decision|0|||
126656283|NCT05249829|455699637|FG003|Overall Study|Physician Decision|0|||
126656284|NCT05249829|455699634|FG000|Overall Study|Lost to Follow-up|16|||
126656285|NCT05249829|455699635|FG001|Overall Study|Lost to Follow-up|16|||
126656286|NCT05249829|455699636|FG002|Overall Study|Lost to Follow-up|57|||
126656287|NCT05249829|455699637|FG003|Overall Study|Lost to Follow-up|60|||
126656288|NCT05249829|455699634|FG000|Overall Study|Adverse Event|2|||
126656289|NCT05249829|455699635|FG001|Overall Study|Adverse Event|2|||
126329986|NCT03293394|454501767|FG000|Follow-up (6 Months)|Adverse Event|4|||
126329987|NCT03293394|454501768|FG001|Follow-up (6 Months)|Adverse Event|2|||
126656290|NCT05249829|455699636|FG002|Overall Study|Adverse Event|2|||
126329988|NCT01408901|454501771|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
126329989|NCT01408901|454501772|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
126329990|NCT01408901|454501773|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
126329991|NCT01408901|454501774|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
126329992|NCT01408901|454501771|FG000|6-Week Follow-Up|Death|1|||
126329993|NCT01408901|454501772|FG001|6-Week Follow-Up|Death|0|||
126329994|NCT01408901|454501773|FG002|6-Week Follow-Up|Death|0|||
126329995|NCT01408901|454501774|FG003|6-Week Follow-Up|Death|0|||
126329996|NCT01408901|454501771|FG000|6-Week Follow-Up|Cancelled visit|0|||
126329997|NCT01408901|454501772|FG001|6-Week Follow-Up|Cancelled visit|1|||
126545117|NCT00576732|455289219|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
126545118|NCT00576732|455289220|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
126545119|NCT00576732|455289221|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
126545120|NCT00576732|455289222|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
126545121|NCT00576732|455289217|FG000|DOUBLE BLIND|OTHER|0|||
126545122|NCT00576732|455289218|FG001|DOUBLE BLIND|OTHER|2|||
126545123|NCT00576732|455289219|FG002|DOUBLE BLIND|OTHER|1|||
126545124|NCT00576732|455289220|FG003|DOUBLE BLIND|OTHER|0|||
126545125|NCT00576732|455289221|FG004|DOUBLE BLIND|OTHER|0|||
126545126|NCT00576732|455289222|FG005|DOUBLE BLIND|OTHER|0|||
126545127|NCT00576732|455289217|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
126545128|NCT00576732|455289218|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
126545129|NCT00576732|455289219|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
126545130|NCT00576732|455289220|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
126545131|NCT00576732|455289221|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
126545132|NCT00576732|455289222|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
126545133|NCT00576732|455289217|FG000|DOUBLE BLIND|Protocol Violation|1|||
126545134|NCT00576732|455289218|FG001|DOUBLE BLIND|Protocol Violation|0|||
126545135|NCT00576732|455289219|FG002|DOUBLE BLIND|Protocol Violation|0|||
126545136|NCT00576732|455289220|FG003|DOUBLE BLIND|Protocol Violation|0|||
126545137|NCT00576732|455289221|FG004|DOUBLE BLIND|Protocol Violation|0|||
126545138|NCT00576732|455289222|FG005|DOUBLE BLIND|Protocol Violation|0|||
126545139|NCT00576732|455289217|FG000|OPEN LABEL|Adverse Event|0|||
126545140|NCT00576732|455289218|FG001|OPEN LABEL|Adverse Event|0|||
126545141|NCT00576732|455289219|FG002|OPEN LABEL|Adverse Event|0|||
126545142|NCT00576732|455289220|FG003|OPEN LABEL|Adverse Event|4|||
126545143|NCT00576732|455289221|FG004|OPEN LABEL|Adverse Event|0|||
126545144|NCT00576732|455289222|FG005|OPEN LABEL|Adverse Event|1|||
126545145|NCT00576732|455289217|FG000|OPEN LABEL|Lost to Follow-up|0|||
126545146|NCT00576732|455289218|FG001|OPEN LABEL|Lost to Follow-up|0|||
126545147|NCT00576732|455289219|FG002|OPEN LABEL|Lost to Follow-up|0|||
126545148|NCT00576732|455289220|FG003|OPEN LABEL|Lost to Follow-up|2|||
126545149|NCT00576732|455289221|FG004|OPEN LABEL|Lost to Follow-up|1|||
126545150|NCT00576732|455289222|FG005|OPEN LABEL|Lost to Follow-up|1|||
126545151|NCT00576732|455289217|FG000|OPEN LABEL|Withdrawal by Subject|0|||
126545152|NCT00576732|455289218|FG001|OPEN LABEL|Withdrawal by Subject|0|||
126545153|NCT00576732|455289219|FG002|OPEN LABEL|Withdrawal by Subject|0|||
126545154|NCT00576732|455289220|FG003|OPEN LABEL|Withdrawal by Subject|1|||
126545155|NCT00576732|455289221|FG004|OPEN LABEL|Withdrawal by Subject|0|||
126545156|NCT00576732|455289222|FG005|OPEN LABEL|Withdrawal by Subject|1|||
126545157|NCT00576732|455289217|FG000|OPEN LABEL|OTHER|0|||
126545158|NCT00576732|455289218|FG001|OPEN LABEL|OTHER|0|||
126545159|NCT00576732|455289219|FG002|OPEN LABEL|OTHER|0|||
126545160|NCT00576732|455289220|FG003|OPEN LABEL|OTHER|0|||
126545161|NCT00576732|455289221|FG004|OPEN LABEL|OTHER|0|||
126545162|NCT00576732|455289222|FG005|OPEN LABEL|OTHER|2|||
126545163|NCT00576732|455289217|FG000|OPEN LABEL|Lack of Efficacy|0|||
126545164|NCT00576732|455289218|FG001|OPEN LABEL|Lack of Efficacy|0|||
126545165|NCT00576732|455289219|FG002|OPEN LABEL|Lack of Efficacy|0|||
126545166|NCT00576732|455289220|FG003|OPEN LABEL|Lack of Efficacy|2|||
126545167|NCT00576732|455289221|FG004|OPEN LABEL|Lack of Efficacy|2|||
126545168|NCT00576732|455289222|FG005|OPEN LABEL|Lack of Efficacy|3|||
126545169|NCT00576732|455289217|FG000|OPEN LABEL|Protocol Violation|0|||
126545170|NCT00576732|455289218|FG001|OPEN LABEL|Protocol Violation|0|||
126545171|NCT00576732|455289219|FG002|OPEN LABEL|Protocol Violation|0|||
126545172|NCT00576732|455289220|FG003|OPEN LABEL|Protocol Violation|2|||
126545173|NCT00576732|455289221|FG004|OPEN LABEL|Protocol Violation|1|||
126545174|NCT00576732|455289222|FG005|OPEN LABEL|Protocol Violation|0|||
126545175|NCT05096208|455289225|FG000|Overall Study|Lost to Follow-up|3|||
126545176|NCT05096208|455289226|FG001|Overall Study|Lost to Follow-up|5|||
126329998|NCT01408901|454501773|FG002|6-Week Follow-Up|Cancelled visit|0|||
126545177|NCT05096208|455289227|FG002|Overall Study|Lost to Follow-up|5|||
126545178|NCT05096208|455289228|FG003|Overall Study|Lost to Follow-up|2|||
126545179|NCT05096208|455289225|FG000|Overall Study|Withdrawal by Subject|0|||
126545180|NCT05096208|455289226|FG001|Overall Study|Withdrawal by Subject|1|||
126545181|NCT05096208|455289227|FG002|Overall Study|Withdrawal by Subject|2|||
126545182|NCT05096208|455289228|FG003|Overall Study|Withdrawal by Subject|3|||
126545183|NCT05096208|455289225|FG000|Overall Study|No longer met eligibility criteria|1|||
126545184|NCT05096208|455289226|FG001|Overall Study|No longer met eligibility criteria|0|||
126545185|NCT05096208|455289227|FG002|Overall Study|No longer met eligibility criteria|0|||
126545186|NCT05096208|455289228|FG003|Overall Study|No longer met eligibility criteria|0|||
126545187|NCT05096208|455289225|FG000|Overall Study|Other|0|||
126656291|NCT05249829|455699637|FG003|Overall Study|Adverse Event|2|||
126656292|NCT05249829|455699634|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
126656293|NCT05249829|455699635|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
126656294|NCT05249829|455699636|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
126656295|NCT05249829|455699637|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
126656296|NCT05249829|455699634|FG000|Overall Study|Protocol Violation|2|||
126656297|NCT05249829|455699635|FG001|Overall Study|Protocol Violation|0|||
126656298|NCT05249829|455699636|FG002|Overall Study|Protocol Violation|5|||
126656299|NCT05249829|455699637|FG003|Overall Study|Protocol Violation|3|||
126656300|NCT05249829|455699634|FG000|Overall Study|Death|0|||
126656301|NCT05249829|455699635|FG001|Overall Study|Death|1|||
126656302|NCT05249829|455699636|FG002|Overall Study|Death|2|||
126656303|NCT05249829|455699637|FG003|Overall Study|Death|4|||
126656304|NCT02842827|455699639|FG000|Overall Study|Adverse Event|0|||
126656305|NCT02842827|455699640|FG001|Overall Study|Adverse Event|1|||
126656306|NCT02842827|455699641|FG002|Overall Study|Adverse Event|0|||
126656307|NCT02842827|455699642|FG003|Overall Study|Adverse Event|1|||
126656308|NCT02842827|455699643|FG004|Overall Study|Adverse Event|0|||
126656309|NCT02842827|455699644|FG005|Overall Study|Adverse Event|1|||
126656310|NCT02842827|455699645|FG006|Overall Study|Adverse Event|0|||
126656311|NCT02842827|455699646|FG007|Overall Study|Adverse Event|0|||
126656312|NCT02842827|455699639|FG000|Overall Study|Death|1|||
126656313|NCT02842827|455699640|FG001|Overall Study|Death|0|||
126656314|NCT02842827|455699641|FG002|Overall Study|Death|2|||
126656315|NCT02842827|455699642|FG003|Overall Study|Death|3|||
126656316|NCT02842827|455699643|FG004|Overall Study|Death|2|||
126656317|NCT02842827|455699644|FG005|Overall Study|Death|1|||
126656318|NCT02842827|455699645|FG006|Overall Study|Death|0|||
126656319|NCT02842827|455699646|FG007|Overall Study|Death|4|||
126656320|NCT02842827|455699639|FG000|Overall Study|Physician Decision|1|||
126656321|NCT02842827|455699640|FG001|Overall Study|Physician Decision|3|||
126656322|NCT02842827|455699641|FG002|Overall Study|Physician Decision|0|||
126656323|NCT02842827|455699642|FG003|Overall Study|Physician Decision|0|||
126656324|NCT02842827|455699643|FG004|Overall Study|Physician Decision|1|||
126656325|NCT02842827|455699644|FG005|Overall Study|Physician Decision|4|||
126656326|NCT02842827|455699645|FG006|Overall Study|Physician Decision|2|||
126656327|NCT02842827|455699646|FG007|Overall Study|Physician Decision|1|||
126656328|NCT02842827|455699639|FG000|Overall Study|Protocol Defined Disease Progression|0|||
126656329|NCT02842827|455699640|FG001|Overall Study|Protocol Defined Disease Progression|0|||
126656330|NCT02842827|455699641|FG002|Overall Study|Protocol Defined Disease Progression|0|||
126656331|NCT02842827|455699642|FG003|Overall Study|Protocol Defined Disease Progression|0|||
126656332|NCT02842827|455699643|FG004|Overall Study|Protocol Defined Disease Progression|0|||
126656333|NCT02842827|455699644|FG005|Overall Study|Protocol Defined Disease Progression|1|||
126656334|NCT02842827|455699645|FG006|Overall Study|Protocol Defined Disease Progression|0|||
126656335|NCT02842827|455699646|FG007|Overall Study|Protocol Defined Disease Progression|0|||
126656336|NCT02842827|455699639|FG000|Overall Study|Participant Withdrawal of Consent|1|||
126656337|NCT02842827|455699640|FG001|Overall Study|Participant Withdrawal of Consent|2|||
126656338|NCT02842827|455699641|FG002|Overall Study|Participant Withdrawal of Consent|2|||
126656339|NCT02842827|455699642|FG003|Overall Study|Participant Withdrawal of Consent|2|||
126656340|NCT02842827|455699643|FG004|Overall Study|Participant Withdrawal of Consent|2|||
126656341|NCT02842827|455699644|FG005|Overall Study|Participant Withdrawal of Consent|1|||
126656342|NCT02842827|455699645|FG006|Overall Study|Participant Withdrawal of Consent|2|||
126656343|NCT02842827|455699646|FG007|Overall Study|Participant Withdrawal of Consent|1|||
126656344|NCT01815138|455699649|FG000|Overall Study|Withdrawal by Subject|0|||
126656345|NCT01815138|455699650|FG001|Overall Study|Withdrawal by Subject|1|||
126656346|NCT01815138|455699649|FG000|Overall Study|Physician Decision|8|||
126656347|NCT01815138|455699650|FG001|Overall Study|Physician Decision|5|||
126656348|NCT03426267|455699651|FG000|Overall Study|Physician Decision|1|||
126656349|NCT03426267|455699652|FG001|Overall Study|Physician Decision|4|||
126656350|NCT03426267|455699651|FG000|Overall Study|Lost to Follow-up|1|||
126656351|NCT03426267|455699652|FG001|Overall Study|Lost to Follow-up|0|||
126656352|NCT03426267|455699651|FG000|Overall Study|Withdrawal by Subject|4|||
126656353|NCT03426267|455699652|FG001|Overall Study|Withdrawal by Subject|10|||
126656354|NCT03426267|455699651|FG000|Overall Study|Protocol Violation|1|||
126656355|NCT03426267|455699652|FG001|Overall Study|Protocol Violation|3|||
126656356|NCT03426267|455699651|FG000|Overall Study|Adverse Event|9|||
126656357|NCT03426267|455699652|FG001|Overall Study|Adverse Event|27|||
126656358|NCT03426267|455699651|FG000|Overall Study|Prohibited Treatment Intake|2|||
126656359|NCT03426267|455699652|FG001|Overall Study|Prohibited Treatment Intake|3|||
126656360|NCT03426267|455699651|FG000|Overall Study|Lack of Efficacy|0|||
126656361|NCT03426267|455699652|FG001|Overall Study|Lack of Efficacy|25|||
126656362|NCT03426267|455699651|FG000|Overall Study|other|3|||
126656363|NCT03426267|455699652|FG001|Overall Study|other|0|||
126656364|NCT00609765|455699655|FG000|Overall Study|Study ended prior to 12 months|1|||
126656365|NCT02649946|455699662|FG000|Overall Study|Withdrawal by Subject|1|||
126656366|NCT02649946|455699663|FG001|Overall Study|Withdrawal by Subject|1|||
126656367|NCT02649946|455699662|FG000|Overall Study|Death|7|||
126656368|NCT02649946|455699663|FG001|Overall Study|Death|9|||
126656369|NCT02649946|455699662|FG000|Overall Study|Physician Decision|1|||
126656370|NCT02649946|455699663|FG001|Overall Study|Physician Decision|0|||
126656371|NCT02649946|455699662|FG000|Overall Study|Lost to Follow-up|2|||
126656372|NCT02649946|455699663|FG001|Overall Study|Lost to Follow-up|1|||
126656373|NCT02649946|455699662|FG000|Overall Study|Erroneously enrolled|1|||
126656374|NCT02649946|455699663|FG001|Overall Study|Erroneously enrolled|0|||
126656375|NCT02649946|455699662|FG000|Overall Study|Missed 6-month follow-up visit|0|||
126656376|NCT02649946|455699663|FG001|Overall Study|Missed 6-month follow-up visit|4|||
126656377|NCT00950950|455699664|FG000|Overall Study|Adverse Event|1|||
126656378|NCT00950950|455699665|FG001|Overall Study|Adverse Event|0|||
126656379|NCT00950950|455699664|FG000|Overall Study|Withdrawal by Subject|0|||
126656380|NCT00950950|455699665|FG001|Overall Study|Withdrawal by Subject|1|||
126656381|NCT01047293|455699666|FG000|Overall Study|DLT criteria not fulfilled|1|||
126656382|NCT01047293|455699667|FG001|Overall Study|DLT criteria not fulfilled|1|||
126656383|NCT01047293|455699668|FG002|Overall Study|DLT criteria not fulfilled|0|||
126656384|NCT01047293|455699669|FG003|Overall Study|DLT criteria not fulfilled|0|||
126656385|NCT01272804|455699675|FG000|Overall Study|Adverse Event|1|||
126656386|NCT01272804|455699676|FG001|Overall Study|Adverse Event|0|||
126656387|NCT01272804|455699677|FG002|Overall Study|Adverse Event|0|||
126656388|NCT01272804|455699678|FG003|Overall Study|Adverse Event|0|||
126656389|NCT01272804|455699679|FG004|Overall Study|Adverse Event|2|||
126656390|NCT01272804|455699680|FG005|Overall Study|Adverse Event|1|||
126656391|NCT02318797|455699681|FG000|Overall Study|Death|3|||
126656392|NCT02318797|455699682|FG001|Overall Study|Death|6|||
126656393|NCT02318797|455699681|FG000|Overall Study|Lost to Follow-up|85|||
126656394|NCT02318797|455699682|FG001|Overall Study|Lost to Follow-up|96|||
126656395|NCT03432260|455699695|FG000|Overall Study|Lost to Follow-up|1|||
126656396|NCT03432260|455699696|FG001|Overall Study|Lost to Follow-up|1|||
126656397|NCT03432260|455699697|FG002|Overall Study|Lost to Follow-up|0|||
126656398|NCT03432260|455699698|FG003|Overall Study|Lost to Follow-up|0|||
126656399|NCT03432260|455699699|FG004|Overall Study|Lost to Follow-up|1|||
126656400|NCT01775124|455699701|FG000|Core Period|Disease Progression|0|||
126656401|NCT01775124|455699702|FG001|Core Period|Disease Progression|1|||
126656402|NCT01775124|455699701|FG000|Core Period|Physician Decision|1|||
126656403|NCT01775124|455699702|FG001|Core Period|Physician Decision|1|||
126656404|NCT01775124|455699701|FG000|Core Period|Death|0|||
126656405|NCT01775124|455699702|FG001|Core Period|Death|1|||
126656406|NCT01775124|455699701|FG000|Core Period|Administrative problems|1|||
126656407|NCT01775124|455699702|FG001|Core Period|Administrative problems|0|||
126656408|NCT01775124|455699701|FG000|Core Period|Withdrawal by Subject|4|||
126656409|NCT01775124|455699702|FG001|Core Period|Withdrawal by Subject|2|||
126656410|NCT01775124|455699701|FG000|Core Period|Adverse Event|5|||
126656411|NCT01775124|455699702|FG001|Core Period|Adverse Event|5|||
126656412|NCT01775124|455699701|FG000|Extension Period|Adverse Event|3|||
126656413|NCT01775124|455699702|FG001|Extension Period|Adverse Event|2|||
126656414|NCT01775124|455699701|FG000|Extension Period|Physician Decision|0|||
126656415|NCT01775124|455699702|FG001|Extension Period|Physician Decision|2|||
126656416|NCT01775124|455699701|FG000|Extension Period|Administrative problems|0|||
126656417|NCT01775124|455699702|FG001|Extension Period|Administrative problems|1|||
126656418|NCT01775124|455699701|FG000|Extension Period|Lost to Follow-up|0|||
126656419|NCT01775124|455699702|FG001|Extension Period|Lost to Follow-up|1|||
126656420|NCT01775124|455699701|FG000|Extension Period|Withdrawal by Subject|9|||
126656421|NCT01775124|455699702|FG001|Extension Period|Withdrawal by Subject|12|||
126656422|NCT00031551|455701704|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
126656423|NCT00031551|455701705|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
126656424|NCT00409773|455701706|FG000|Overall Study|Adverse Event|3|||
126656425|NCT00409773|455701707|FG001|Overall Study|Adverse Event|4|||
126656426|NCT00409773|455701708|FG002|Overall Study|Adverse Event|4|||
126656427|NCT00409773|455701709|FG003|Overall Study|Adverse Event|2|||
126656428|NCT00409773|455701710|FG004|Overall Study|Adverse Event|6|||
126656429|NCT00409773|455701706|FG000|Overall Study|Lost to Follow-up|6|||
126656430|NCT00409773|455701707|FG001|Overall Study|Lost to Follow-up|1|||
126656431|NCT00409773|455701708|FG002|Overall Study|Lost to Follow-up|2|||
126656432|NCT00409773|455701709|FG003|Overall Study|Lost to Follow-up|3|||
126656433|NCT00409773|455701710|FG004|Overall Study|Lost to Follow-up|1|||
126656434|NCT00409773|455701706|FG000|Overall Study|Physician Decision|0|||
126656435|NCT00409773|455701707|FG001|Overall Study|Physician Decision|0|||
126656436|NCT00409773|455701708|FG002|Overall Study|Physician Decision|0|||
126656437|NCT00409773|455701709|FG003|Overall Study|Physician Decision|2|||
126656438|NCT00409773|455701710|FG004|Overall Study|Physician Decision|0|||
126656439|NCT00409773|455701706|FG000|Overall Study|Protocol Violation|0|||
126656440|NCT00409773|455701707|FG001|Overall Study|Protocol Violation|2|||
126656441|NCT00409773|455701708|FG002|Overall Study|Protocol Violation|3|||
126656442|NCT00409773|455701709|FG003|Overall Study|Protocol Violation|3|||
126656443|NCT00409773|455701710|FG004|Overall Study|Protocol Violation|1|||
126656444|NCT00409773|455701706|FG000|Overall Study|Withdrawal by Subject|0|||
126656445|NCT00409773|455701707|FG001|Overall Study|Withdrawal by Subject|0|||
126656446|NCT00409773|455701708|FG002|Overall Study|Withdrawal by Subject|0|||
126545188|NCT05096208|455289226|FG001|Overall Study|Other|0|||
126545189|NCT05096208|455289227|FG002|Overall Study|Other|1|||
126545190|NCT05096208|455289228|FG003|Overall Study|Other|0|||
126545191|NCT02213328|455289230|FG000|Overall Study|Withdrawal by Subject|10|||
126545192|NCT02213328|455289230|FG000|Overall Study|Physician Decision|2|||
126545193|NCT02213328|455289230|FG000|Overall Study|Lost to Follow-up|16|||
126545194|NCT01279343|455289233|FG000|Overall Study|Did not receive treatment|2|||
126545195|NCT01279343|455289234|FG001|Overall Study|Did not receive treatment|6|||
126545196|NCT02613221|455289240|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
126656447|NCT00409773|455701709|FG003|Overall Study|Withdrawal by Subject|2|||
126656448|NCT00409773|455701710|FG004|Overall Study|Withdrawal by Subject|1|||
126656449|NCT00409773|455701706|FG000|Overall Study|Lack of Eligibility|0|||
126329999|NCT01408901|454501774|FG003|6-Week Follow-Up|Cancelled visit|2|||
126330000|NCT01408901|454501771|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
126330001|NCT01408901|454501772|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
126330002|NCT01408901|454501773|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
126330003|NCT01408901|454501774|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
126330004|NCT01408901|454501771|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
126330005|NCT01408901|454501772|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
126330006|NCT01408901|454501773|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
126330007|NCT01408901|454501774|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
126330008|NCT01408901|454501771|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
126330009|NCT01408901|454501772|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
126330010|NCT01408901|454501773|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
126330011|NCT01408901|454501774|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
126330012|NCT01408901|454501771|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
126330013|NCT01408901|454501772|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
126330014|NCT01408901|454501773|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
126330015|NCT01408901|454501774|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
126330016|NCT01408901|454501771|FG000|26-Week Follow-Up|Death|0|||
126330017|NCT01408901|454501772|FG001|26-Week Follow-Up|Death|1|||
126330018|NCT01408901|454501773|FG002|26-Week Follow-Up|Death|0|||
126330019|NCT01408901|454501774|FG003|26-Week Follow-Up|Death|0|||
126656450|NCT00409773|455701707|FG001|Overall Study|Lack of Eligibility|0|||
126656451|NCT00409773|455701708|FG002|Overall Study|Lack of Eligibility|0|||
126656452|NCT00409773|455701709|FG003|Overall Study|Lack of Eligibility|0|||
126656453|NCT00409773|455701710|FG004|Overall Study|Lack of Eligibility|1|||
126656454|NCT00153062|455701711|FG000|Overall Study|Death|360|||
126656455|NCT00153062|455701712|FG001|Overall Study|Death|352|||
126656456|NCT00153062|455701713|FG002|Overall Study|Death|369|||
126656457|NCT00153062|455701714|FG003|Overall Study|Death|365|||
126656458|NCT00153062|455701711|FG000|Overall Study|Withdrawal by Subject|14|||
126656459|NCT00153062|455701712|FG001|Overall Study|Withdrawal by Subject|30|||
126656460|NCT00153062|455701713|FG002|Overall Study|Withdrawal by Subject|27|||
126656461|NCT00153062|455701714|FG003|Overall Study|Withdrawal by Subject|28|||
126656462|NCT00153062|455701711|FG000|Overall Study|Lost to Follow-up|12|||
126656463|NCT00153062|455701712|FG001|Overall Study|Lost to Follow-up|20|||
126656464|NCT00153062|455701713|FG002|Overall Study|Lost to Follow-up|15|||
126656465|NCT00153062|455701714|FG003|Overall Study|Lost to Follow-up|16|||
126656466|NCT00153062|455701711|FG000|Overall Study|Adverse Event|0|||
126656467|NCT00153062|455701712|FG001|Overall Study|Adverse Event|1|||
126656468|NCT00153062|455701713|FG002|Overall Study|Adverse Event|1|||
126656469|NCT00153062|455701714|FG003|Overall Study|Adverse Event|0|||
126656470|NCT00153062|455701711|FG000|Overall Study|Protocol Violation|0|||
126656471|NCT00153062|455701712|FG001|Overall Study|Protocol Violation|2|||
126656472|NCT00153062|455701713|FG002|Overall Study|Protocol Violation|1|||
126656473|NCT00153062|455701714|FG003|Overall Study|Protocol Violation|1|||
126656474|NCT00153062|455701711|FG000|Overall Study|No disposition data available|1|||
126656475|NCT00153062|455701712|FG001|Overall Study|No disposition data available|1|||
126656476|NCT00153062|455701713|FG002|Overall Study|No disposition data available|1|||
126656477|NCT00153062|455701714|FG003|Overall Study|No disposition data available|1|||
126656478|NCT00153062|455701711|FG000|Overall Study|Other|0|||
126330020|NCT02497404|454501775|FG000|Overall Study|Adverse Event|1|||
126330021|NCT04978337|454501776|FG000|Overall Study|Withdrawal by Subject|0|||
126330022|NCT04978337|454501777|FG001|Overall Study|Withdrawal by Subject|1|||
126330023|NCT01436227|454501783|FG000|Overall Study|Adverse Event|7|||
126330024|NCT01436227|454501783|FG000|Overall Study|Death|1|||
126330025|NCT01436227|454501783|FG000|Overall Study|Lack of Efficacy|1|||
126545197|NCT02613221|455289240|FG000|Overall Study|Adverse Event|2|||
126545198|NCT02613221|455289240|FG000|Overall Study|Voluntary Discontinuation|1|||
126545199|NCT02613221|455289240|FG000|Overall Study|Delayed Treatment|1|||
126656479|NCT00153062|455701712|FG001|Overall Study|Other|0|||
126656480|NCT00153062|455701713|FG002|Overall Study|Other|1|||
126656481|NCT00153062|455701714|FG003|Overall Study|Other|0|||
126656482|NCT02359877|455701715|FG000|Overall Study|Withdrawal by Subject|1|||
126656483|NCT02359877|455701716|FG001|Overall Study|Withdrawal by Subject|0|||
126656484|NCT02359877|455701717|FG002|Overall Study|Withdrawal by Subject|0|||
126656485|NCT02359877|455701718|FG003|Overall Study|Withdrawal by Subject|2|||
126656486|NCT02359877|455701715|FG000|Overall Study|Adverse Event|0|||
126656487|NCT02359877|455701716|FG001|Overall Study|Adverse Event|0|||
126656488|NCT02359877|455701717|FG002|Overall Study|Adverse Event|0|||
126656489|NCT02359877|455701718|FG003|Overall Study|Adverse Event|1|||
126656490|NCT01919814|455701725|FG000|Overall Study|Adverse Event|1|||
126656491|NCT01919814|455701726|FG001|Overall Study|Adverse Event|0|||
126656492|NCT01919814|455701725|FG000|Overall Study|Protocol Violation|1|||
126656493|NCT01919814|455701726|FG001|Overall Study|Protocol Violation|0|||
126656494|NCT01919814|455701725|FG000|Overall Study|Withdrawal by Subject|1|||
126656495|NCT01919814|455701726|FG001|Overall Study|Withdrawal by Subject|0|||
126656496|NCT00275262|455701727|FG000|Overall Study|Adverse Event|2|||
126656497|NCT00275262|455701728|FG001|Overall Study|Adverse Event|0|||
126656498|NCT00275262|455701727|FG000|Overall Study|Disease progression|2|||
126656499|NCT00275262|455701728|FG001|Overall Study|Disease progression|5|||
126656500|NCT00275262|455701727|FG000|Overall Study|Lost to Follow-up|0|||
126656501|NCT00275262|455701728|FG001|Overall Study|Lost to Follow-up|2|||
126656502|NCT00275262|455701727|FG000|Overall Study|Protocol Violation|0|||
126656503|NCT00275262|455701728|FG001|Overall Study|Protocol Violation|2|||
126656504|NCT00275262|455701727|FG000|Overall Study|Death|1|||
126656505|NCT00275262|455701728|FG001|Overall Study|Death|0|||
126656506|NCT00275262|455701727|FG000|Overall Study|Started Chemotherapy|1|||
126656507|NCT00275262|455701728|FG001|Overall Study|Started Chemotherapy|0|||
126656508|NCT02164383|455701731|FG000|Overall Study|Lost to Follow-up|1|||
126656509|NCT02164383|455701732|FG001|Overall Study|Lost to Follow-up|0|||
126656510|NCT01589237|455701743|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
126656511|NCT01589237|455701744|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
126656512|NCT01589237|455701745|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
126656513|NCT01589237|455701746|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
126656514|NCT01589237|455701743|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
126656515|NCT01589237|455701744|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
126656516|NCT01589237|455701745|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
126656517|NCT01589237|455701746|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
126656518|NCT01589237|455701743|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
126656519|NCT01589237|455701744|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
126656520|NCT01589237|455701745|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
126656521|NCT01589237|455701746|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
126656522|NCT01589237|455701743|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
126656523|NCT01589237|455701744|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
126656524|NCT01589237|455701745|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
126656525|NCT01589237|455701746|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
126656526|NCT02594163|455701747|FG000|Treatment Period|Progressive disease|2|||
126656527|NCT02594163|455701748|FG001|Treatment Period|Progressive disease|3|||
126656528|NCT02594163|455701747|FG000|Treatment Period|Adverse Event|1|||
126656529|NCT02594163|455701748|FG001|Treatment Period|Adverse Event|5|||
126656530|NCT02594163|455701747|FG000|Treatment Period|Physician Decision|1|||
126656531|NCT02594163|455701748|FG001|Treatment Period|Physician Decision|3|||
126656532|NCT02594163|455701747|FG000|Treatment Period|Study termination by sponsor|2|||
126656533|NCT02594163|455701748|FG001|Treatment Period|Study termination by sponsor|1|||
126656534|NCT02594163|455701747|FG000|Treatment Period|Other, Non-AE|1|||
126656535|NCT02594163|455701748|FG001|Treatment Period|Other, Non-AE|0|||
126656536|NCT02594163|455701747|FG000|Follow-up Period|Withdrawal by Subject|0|||
126656537|NCT02594163|455701748|FG001|Follow-up Period|Withdrawal by Subject|1|||
126656538|NCT02594163|455701747|FG000|Follow-up Period|Study Termination by Sponsor|6|||
126656539|NCT02594163|455701748|FG001|Follow-up Period|Study Termination by Sponsor|4|||
126656540|NCT02594163|455701747|FG000|Follow-up Period|Lost to Follow-up|1|||
126656541|NCT02594163|455701748|FG001|Follow-up Period|Lost to Follow-up|0|||
126656542|NCT02594163|455701747|FG000|Follow-up Period|Death|2|||
126656543|NCT02594163|455701748|FG001|Follow-up Period|Death|5|||
126656544|NCT02594163|455701747|FG000|Follow-up Period|Adverse Event|0|||
126656545|NCT02594163|455701748|FG001|Follow-up Period|Adverse Event|1|||
126656546|NCT02594163|455701747|FG000|Follow-up Period|Progressive Disease|2|||
126656547|NCT02594163|455701748|FG001|Follow-up Period|Progressive Disease|0|||
126656548|NCT02594163|455701747|FG000|Follow-up Period|Physician Decision|0|||
126656549|NCT02594163|455701748|FG001|Follow-up Period|Physician Decision|1|||
126656550|NCT01290029|455701751|FG000|Overall Study|Other|2|||
126656551|NCT02831387|455701752|FG000|Overall Study|Withdrawal by Subject|1|||
126656552|NCT02831387|455701753|FG001|Overall Study|Withdrawal by Subject|1|||
126656553|NCT02831387|455701752|FG000|Overall Study|Discontinued due to stock recovery|0|||
126656554|NCT02831387|455701753|FG001|Overall Study|Discontinued due to stock recovery|1|||
126656555|NCT02336178|455701757|FG000|Overall Study|Lost to Follow-up|1|||
126656556|NCT02336178|455701757|FG000|Overall Study|Protocol Violation|1|||
126656557|NCT02336178|455701757|FG000|Overall Study|Withdrawal by Subject|1|||
126656558|NCT02336178|455701757|FG000|Overall Study|Other|1|||
126656559|NCT00618982|455701758|FG000|Overall Study|Adverse Event|23|||
126656560|NCT00618982|455701758|FG000|Overall Study|Withdrawal by Subject|1|||
126656561|NCT00618982|455701758|FG000|Overall Study|Protocol Violation|1|||
126656562|NCT00618982|455701758|FG000|Overall Study|ongoing, still treated with study med.|25|||
126656563|NCT00156819|455701761|FG000|Overall Study|Lost to Follow-up|1|||
126656564|NCT00156819|455701762|FG001|Overall Study|Lost to Follow-up|1|||
126656565|NCT00156819|455701763|FG002|Overall Study|Lost to Follow-up|3|||
126656566|NCT00799513|455701764|FG000|Overall Study|Physician Decision|1|||
126656567|NCT00799513|455701764|FG000|Overall Study|Adverse Event|1|||
126656568|NCT00666679|455701767|FG000|First Intervention|Lost to Follow-up|1|||
126656569|NCT00666679|455701768|FG001|First Intervention|Lost to Follow-up|0|||
126656570|NCT00666679|455701767|FG000|First Intervention|Protocol Violation|1|||
126656571|NCT00666679|455701768|FG001|First Intervention|Protocol Violation|0|||
126656572|NCT00666679|455701767|FG000|First Intervention|Withdrawal by Subject|1|||
126656573|NCT00666679|455701768|FG001|First Intervention|Withdrawal by Subject|0|||
126656574|NCT00666679|455701767|FG000|First Intervention|Randomized did not start treatment|1|||
126656575|NCT00666679|455701768|FG001|First Intervention|Randomized did not start treatment|1|||
126656576|NCT00666679|455701767|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
126656577|NCT00666679|455701768|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
126656578|NCT00666679|455701767|FG000|Washout Period of 1 Week|Protocol Violation|0|||
126656579|NCT00666679|455701768|FG001|Washout Period of 1 Week|Protocol Violation|1|||
126656580|NCT00666679|455701767|FG000|Second Intervention|Adverse Event|1|||
126656581|NCT00666679|455701768|FG001|Second Intervention|Adverse Event|0|||
126656582|NCT00666679|455701767|FG000|Second Intervention|Death|0|||
126656583|NCT00666679|455701768|FG001|Second Intervention|Death|1|||
126656584|NCT05062759|455701771|FG000|Overall Study|Death|0|||
126656585|NCT05062759|455701772|FG001|Overall Study|Death|1|||
126656586|NCT05062759|455701771|FG000|Overall Study|Lost to Follow-up|1|||
126656587|NCT05062759|455701772|FG001|Overall Study|Lost to Follow-up|0|||
126656588|NCT02781844|455701773|FG000|Treatment Period 1|Adverse Event|0|||
126656589|NCT02781844|455701774|FG001|Treatment Period 1|Adverse Event|0|||
126656590|NCT02781844|455701775|FG002|Treatment Period 1|Adverse Event|0|||
126656591|NCT02781844|455701776|FG003|Treatment Period 1|Adverse Event|0|||
126656592|NCT02781844|455701777|FG004|Treatment Period 1|Adverse Event|0|||
126656593|NCT02781844|455701778|FG005|Treatment Period 1|Adverse Event|1|||
126656594|NCT02781844|455701779|FG006|Treatment Period 1|Adverse Event|0|||
126656595|NCT02781844|455701780|FG007|Treatment Period 1|Adverse Event|0|||
126656596|NCT02518490|455701783|FG000|Overall Study|Withdrawal by Subject|1|||
126656597|NCT02518490|455701784|FG001|Overall Study|Withdrawal by Subject|1|||
126656598|NCT00346632|455701785|FG000|Overall Study|Progressive Disease|2|||
126656599|NCT00346632|455701786|FG001|Overall Study|Progressive Disease|2|||
126656600|NCT00346632|455701787|FG002|Overall Study|Progressive Disease|4|||
126656601|NCT00346632|455701788|FG003|Overall Study|Progressive Disease|3|||
126656602|NCT00346632|455701789|FG004|Overall Study|Progressive Disease|3|||
126656603|NCT00346632|455701790|FG005|Overall Study|Progressive Disease|1|||
126656604|NCT00346632|455701791|FG006|Overall Study|Progressive Disease|2|||
126656605|NCT00346632|455701792|FG007|Overall Study|Progressive Disease|2|||
126656606|NCT00346632|455701793|FG008|Overall Study|Progressive Disease|2|||
126656607|NCT00346632|455701794|FG009|Overall Study|Progressive Disease|2|||
126656608|NCT00346632|455701785|FG000|Overall Study|Adverse Event|0|||
126656609|NCT00346632|455701786|FG001|Overall Study|Adverse Event|0|||
126656610|NCT00346632|455701787|FG002|Overall Study|Adverse Event|0|||
126656611|NCT00346632|455701788|FG003|Overall Study|Adverse Event|0|||
126656612|NCT00346632|455701789|FG004|Overall Study|Adverse Event|1|||
126656613|NCT00346632|455701790|FG005|Overall Study|Adverse Event|1|||
126656614|NCT00346632|455701791|FG006|Overall Study|Adverse Event|1|||
126656615|NCT00346632|455701792|FG007|Overall Study|Adverse Event|0|||
126656616|NCT00346632|455701793|FG008|Overall Study|Adverse Event|0|||
126656617|NCT00346632|455701794|FG009|Overall Study|Adverse Event|0|||
126656618|NCT00346632|455701785|FG000|Overall Study|Death|0|||
126656619|NCT00346632|455701786|FG001|Overall Study|Death|0|||
126656620|NCT00346632|455701787|FG002|Overall Study|Death|1|||
126656621|NCT00346632|455701788|FG003|Overall Study|Death|0|||
126656622|NCT00346632|455701789|FG004|Overall Study|Death|0|||
126656623|NCT00346632|455701790|FG005|Overall Study|Death|0|||
126656624|NCT00346632|455701791|FG006|Overall Study|Death|0|||
126656625|NCT00346632|455701792|FG007|Overall Study|Death|0|||
126656626|NCT00346632|455701793|FG008|Overall Study|Death|0|||
126330026|NCT01436227|454501783|FG000|Overall Study|Lost to Follow-up|3|||
126656627|NCT00346632|455701794|FG009|Overall Study|Death|0|||
126656628|NCT00346632|455701785|FG000|Overall Study|Protocol Violation|0|||
126656629|NCT00346632|455701786|FG001|Overall Study|Protocol Violation|0|||
126330027|NCT01436227|454501783|FG000|Overall Study|Physician Decision|1|||
126656630|NCT00346632|455701787|FG002|Overall Study|Protocol Violation|0|||
126656631|NCT00346632|455701788|FG003|Overall Study|Protocol Violation|0|||
126656632|NCT00346632|455701789|FG004|Overall Study|Protocol Violation|0|||
126656633|NCT00346632|455701790|FG005|Overall Study|Protocol Violation|0|||
126656634|NCT00346632|455701791|FG006|Overall Study|Protocol Violation|1|||
126656635|NCT00346632|455701792|FG007|Overall Study|Protocol Violation|0|||
126656636|NCT00346632|455701793|FG008|Overall Study|Protocol Violation|0|||
126656637|NCT00346632|455701794|FG009|Overall Study|Protocol Violation|0|||
126656638|NCT00346632|455701785|FG000|Overall Study|Withdrawal by Subject|0|||
126656639|NCT00346632|455701786|FG001|Overall Study|Withdrawal by Subject|0|||
126656640|NCT00346632|455701787|FG002|Overall Study|Withdrawal by Subject|0|||
126656641|NCT00346632|455701788|FG003|Overall Study|Withdrawal by Subject|0|||
126656642|NCT00346632|455701789|FG004|Overall Study|Withdrawal by Subject|0|||
126656643|NCT00346632|455701790|FG005|Overall Study|Withdrawal by Subject|0|||
126656644|NCT00346632|455701791|FG006|Overall Study|Withdrawal by Subject|1|||
126656645|NCT00346632|455701792|FG007|Overall Study|Withdrawal by Subject|0|||
126656646|NCT00346632|455701793|FG008|Overall Study|Withdrawal by Subject|0|||
126656647|NCT00346632|455701794|FG009|Overall Study|Withdrawal by Subject|0|||
126656648|NCT00346632|455701785|FG000|Overall Study|Switched to alternative treatment|0|||
126656649|NCT00346632|455701786|FG001|Overall Study|Switched to alternative treatment|0|||
126656650|NCT00346632|455701787|FG002|Overall Study|Switched to alternative treatment|1|||
126656651|NCT00346632|455701788|FG003|Overall Study|Switched to alternative treatment|0|||
126656652|NCT00346632|455701789|FG004|Overall Study|Switched to alternative treatment|0|||
126656653|NCT00346632|455701790|FG005|Overall Study|Switched to alternative treatment|0|||
126656654|NCT00346632|455701791|FG006|Overall Study|Switched to alternative treatment|0|||
126656655|NCT00346632|455701792|FG007|Overall Study|Switched to alternative treatment|0|||
126656656|NCT00346632|455701793|FG008|Overall Study|Switched to alternative treatment|0|||
126656657|NCT00346632|455701794|FG009|Overall Study|Switched to alternative treatment|0|||
126656658|NCT00346632|455701785|FG000|Overall Study|Not Stated|1|||
126656659|NCT00346632|455701786|FG001|Overall Study|Not Stated|1|||
126656660|NCT00346632|455701787|FG002|Overall Study|Not Stated|0|||
126656661|NCT00346632|455701788|FG003|Overall Study|Not Stated|0|||
126656662|NCT00346632|455701789|FG004|Overall Study|Not Stated|0|||
126656663|NCT00346632|455701790|FG005|Overall Study|Not Stated|0|||
126656664|NCT00346632|455701791|FG006|Overall Study|Not Stated|0|||
126656665|NCT00346632|455701792|FG007|Overall Study|Not Stated|2|||
126656666|NCT00346632|455701793|FG008|Overall Study|Not Stated|2|||
126656667|NCT00346632|455701794|FG009|Overall Study|Not Stated|1|||
126656668|NCT00918580|455701795|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
126656669|NCT00918580|455701795|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
126656670|NCT00918580|455701795|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
126656671|NCT00918580|455701795|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
126656672|NCT00918580|455701795|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
126656673|NCT00918580|455701795|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
126656674|NCT00918580|455701795|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
126656675|NCT03486457|455701799|FG000|Up to Month 3|Adverse Event|2|||
126656676|NCT03486457|455701800|FG001|Up to Month 3|Adverse Event|5|||
126656677|NCT03486457|455701799|FG000|Up to Month 3|Lack of Efficacy|1|||
126656678|NCT03486457|455701800|FG001|Up to Month 3|Lack of Efficacy|0|||
126656679|NCT03486457|455701799|FG000|Up to Month 3|Withdrawal by Subject|1|||
126656680|NCT03486457|455701800|FG001|Up to Month 3|Withdrawal by Subject|0|||
126656681|NCT03486457|455701799|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
126656682|NCT03486457|455701800|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
126656683|NCT03486457|455701799|FG000|Up to Month 3|Other|1|||
126656684|NCT03486457|455701800|FG001|Up to Month 3|Other|0|||
126656685|NCT03486457|455701799|FG000|Month 3 to Month 6|Adverse Event|2|||
126656686|NCT03486457|455701800|FG001|Month 3 to Month 6|Adverse Event|0|||
126656687|NCT03486457|455701799|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
126656688|NCT03486457|455701800|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
126656689|NCT03486457|455701799|FG000|Month 3 to Month 6|Pregnancy|0|||
126656690|NCT03486457|455701800|FG001|Month 3 to Month 6|Pregnancy|1|||
126656691|NCT03486457|455701799|FG000|Month 3 to Month 6|Other|1|||
126656692|NCT03486457|455701800|FG001|Month 3 to Month 6|Other|0|||
126656693|NCT00093808|455701801|FG000|Overall Study|Cancel participation before receiving tx|1|||
126656694|NCT00093808|455701801|FG000|Overall Study|Protocol Violation|1|||
126656695|NCT03235284|455701802|FG000|Overall Study|Adverse Event|1|||
126656696|NCT03235284|455701803|FG001|Overall Study|Adverse Event|2|||
126656697|NCT03235284|455701804|FG002|Overall Study|Adverse Event|1|||
126656698|NCT00262951|455701807|FG000|Overall Study|Progressive disease/relapse|3|||
126656699|NCT00262951|455701807|FG000|Overall Study|Adverse Event|7|||
126656700|NCT00262951|455701807|FG000|Overall Study|Death|1|||
126656701|NCT00262951|455701807|FG000|Overall Study|Withdrawal by Subject|1|||
126656702|NCT00262951|455701807|FG000|Overall Study|Alternative treatment|3|||
126656703|NCT00262951|455701807|FG000|Overall Study|Off treatment for other disease|1|||
126656704|NCT02325557|455701808|FG000|Overall Study|Progressive disease|1|||
126656705|NCT02325557|455701809|FG001|Overall Study|Progressive disease|0|||
126656706|NCT02325557|455701810|FG002|Overall Study|Progressive disease|0|||
126656707|NCT02325557|455701811|FG003|Overall Study|Progressive disease|0|||
126656708|NCT02325557|455701808|FG000|Overall Study|Withdrawal by Subject|4|||
126656709|NCT02325557|455701809|FG001|Overall Study|Withdrawal by Subject|0|||
126656710|NCT02325557|455701810|FG002|Overall Study|Withdrawal by Subject|0|||
126656711|NCT02325557|455701811|FG003|Overall Study|Withdrawal by Subject|15|||
126656712|NCT02325557|455701808|FG000|Overall Study|Death|5|||
126656713|NCT02325557|455701809|FG001|Overall Study|Death|1|||
126656714|NCT02325557|455701810|FG002|Overall Study|Death|1|||
126656715|NCT02325557|455701811|FG003|Overall Study|Death|16|||
126656716|NCT02325557|455701808|FG000|Overall Study|Lost to Follow-up|0|||
126656717|NCT02325557|455701809|FG001|Overall Study|Lost to Follow-up|0|||
126656718|NCT02325557|455701810|FG002|Overall Study|Lost to Follow-up|1|||
126656719|NCT02325557|455701811|FG003|Overall Study|Lost to Follow-up|1|||
126656720|NCT02325557|455701808|FG000|Overall Study|Other|0|||
126656721|NCT02325557|455701809|FG001|Overall Study|Other|0|||
126656722|NCT02325557|455701810|FG002|Overall Study|Other|0|||
126656723|NCT02325557|455701811|FG003|Overall Study|Other|5|||
126656724|NCT01602562|455701814|FG000|Overall Study|Adverse Event|3|||
126656725|NCT01602562|455701815|FG001|Overall Study|Adverse Event|1|||
126656726|NCT01602562|455701814|FG000|Overall Study|Physician Decision|1|||
126656727|NCT01602562|455701815|FG001|Overall Study|Physician Decision|1|||
126656728|NCT01602562|455701814|FG000|Overall Study|Withdrawal by Subject|1|||
126656729|NCT01602562|455701815|FG001|Overall Study|Withdrawal by Subject|1|||
126656730|NCT03881553|455701816|FG000|Overall Study|Discharged prior to participation|1|||
126656731|NCT03881553|455701817|FG001|Overall Study|Discharged prior to participation|1|||
126656732|NCT03881553|455701818|FG002|Overall Study|Discharged prior to participation|0|||
126656733|NCT03881553|455701816|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
126656734|NCT03881553|455701817|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
126656735|NCT03881553|455701818|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
126656736|NCT01959516|455701819|FG000|Epoch 1|Adverse Event|4|||
126656737|NCT01959516|455701820|FG001|Epoch 1|Adverse Event|1|||
126656738|NCT01959516|455701819|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
126656739|NCT01959516|455701820|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
126656740|NCT01959516|455701819|FG000|Epoch 1|Subject withdrew consent|3|||
126656741|NCT01959516|455701820|FG001|Epoch 1|Subject withdrew consent|2|||
126656742|NCT01959516|455701819|FG000|Epoch 1|Administrative problems|1|||
126656743|NCT01959516|455701820|FG001|Epoch 1|Administrative problems|0|||
126656744|NCT01959516|455701819|FG000|Epoch 1|Use of prohibited treatment|1|||
126656745|NCT01959516|455701820|FG001|Epoch 1|Use of prohibited treatment|0|||
126656746|NCT01959516|455701819|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
126656747|NCT01959516|455701820|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
126656748|NCT01959516|455701819|FG000|Epoch 1|Protocol deviation|0|||
126656749|NCT01959516|455701820|FG001|Epoch 1|Protocol deviation|1|||
126656750|NCT01959516|455701819|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
126656751|NCT01959516|455701820|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
126656752|NCT01959516|455701819|FG000|Epoch 2|Subject withdrew consent|1|||
126656753|NCT01959516|455701820|FG001|Epoch 2|Subject withdrew consent|0|||
126656754|NCT01959516|455701819|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
126656755|NCT01959516|455701820|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
126656756|NCT01477333|455701821|FG000|Overall Study|Adverse Event|1|||
126656757|NCT01477333|455701821|FG000|Overall Study|Withdrawal by Subject|1|||
126656758|NCT01477333|455701821|FG000|Overall Study|Clinical Deterioration|1|||
126656759|NCT03801915|455701826|FG000|Overall Study|Screen failure|0|||
126656760|NCT03801915|455701827|FG001|Overall Study|Screen failure|0|||
126656761|NCT03801915|455701828|FG002|Overall Study|Screen failure|1|||
126656762|NCT03801915|455701826|FG000|Overall Study|Ineligible|1|||
126656763|NCT03801915|455701827|FG001|Overall Study|Ineligible|0|||
126656764|NCT03801915|455701828|FG002|Overall Study|Ineligible|0|||
126656765|NCT03801915|455701826|FG000|Overall Study|Physician Decision|2|||
126656766|NCT03801915|455701827|FG001|Overall Study|Physician Decision|1|||
126656767|NCT03801915|455701828|FG002|Overall Study|Physician Decision|0|||
126656768|NCT02308020|455701831|FG000|Overall Study|Lost to Follow-up|1|||
126656769|NCT02308020|455701832|FG001|Overall Study|Lost to Follow-up|7|||
126656770|NCT02308020|455701833|FG002|Overall Study|Lost to Follow-up|0|||
126656771|NCT02308020|455701834|FG003|Overall Study|Lost to Follow-up|0|||
126656772|NCT02308020|455701835|FG004|Overall Study|Lost to Follow-up|1|||
126656773|NCT02308020|455701836|FG005|Overall Study|Lost to Follow-up|2|||
126656774|NCT02308020|455701831|FG000|Overall Study|Sponsor Decision|0|||
126656775|NCT02308020|455701832|FG001|Overall Study|Sponsor Decision|8|||
126656776|NCT02308020|455701833|FG002|Overall Study|Sponsor Decision|0|||
126656777|NCT02308020|455701834|FG003|Overall Study|Sponsor Decision|2|||
126656778|NCT02308020|455701835|FG004|Overall Study|Sponsor Decision|2|||
126656779|NCT02308020|455701836|FG005|Overall Study|Sponsor Decision|1|||
126656780|NCT02308020|455701831|FG000|Overall Study|Withdrawal by Subject|3|||
126656781|NCT02308020|455701832|FG001|Overall Study|Withdrawal by Subject|5|||
126656782|NCT02308020|455701833|FG002|Overall Study|Withdrawal by Subject|3|||
126656783|NCT02308020|455701834|FG003|Overall Study|Withdrawal by Subject|2|||
126656784|NCT02308020|455701835|FG004|Overall Study|Withdrawal by Subject|1|||
126656785|NCT02308020|455701836|FG005|Overall Study|Withdrawal by Subject|2|||
126330028|NCT01436227|454501783|FG000|Overall Study|Withdrawal by Subject|7|||
126656786|NCT01211288|455701837|FG000|Overall Study|Lost to Follow-up|1|||
126656787|NCT01211288|455701838|FG001|Overall Study|Lost to Follow-up|1|||
126656788|NCT03333837|455701840|FG000|Overall Study|Adverse Event|2|||
126656789|NCT03333837|455701841|FG001|Overall Study|Adverse Event|1|||
126656790|NCT03333837|455701842|FG002|Overall Study|Adverse Event|1|||
126656791|NCT03333837|455701843|FG003|Overall Study|Adverse Event|1|||
126656792|NCT03333837|455701844|FG004|Overall Study|Adverse Event|0|||
126656793|NCT03333837|455701840|FG000|Overall Study|Caregiver withdrew|0|||
126656794|NCT03333837|455701841|FG001|Overall Study|Caregiver withdrew|2|||
126656795|NCT03333837|455701842|FG002|Overall Study|Caregiver withdrew|1|||
126656796|NCT03333837|455701843|FG003|Overall Study|Caregiver withdrew|0|||
126656797|NCT03333837|455701844|FG004|Overall Study|Caregiver withdrew|0|||
126656798|NCT03333837|455701840|FG000|Overall Study|Withdrawal by Subject|0|||
126656799|NCT03333837|455701841|FG001|Overall Study|Withdrawal by Subject|0|||
126656800|NCT03333837|455701842|FG002|Overall Study|Withdrawal by Subject|1|||
126656801|NCT03333837|455701843|FG003|Overall Study|Withdrawal by Subject|1|||
126656802|NCT03333837|455701844|FG004|Overall Study|Withdrawal by Subject|3|||
126656803|NCT03333837|455701840|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
126656804|NCT03333837|455701841|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
126656805|NCT03333837|455701842|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
126656806|NCT03333837|455701843|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
126656807|NCT03333837|455701844|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
126656808|NCT04217590|455701846|FG000|Overall Study|Other|1|||
126656809|NCT04217590|455701847|FG001|Overall Study|Other|1|||
126656810|NCT04217590|455701846|FG000|Overall Study|Withdrawal by Subject|3|||
126656811|NCT04217590|455701847|FG001|Overall Study|Withdrawal by Subject|1|||
126656812|NCT04217590|455701846|FG000|Overall Study|Death|0|||
126656813|NCT04217590|455701847|FG001|Overall Study|Death|1|||
126656814|NCT02003573|455701859|FG000|Overall Study|Progressive disease|2|||
126656815|NCT02003573|455701860|FG001|Overall Study|Progressive disease|0|||
126656816|NCT02003573|455701861|FG002|Overall Study|Progressive disease|1|||
126656817|NCT02003573|455701859|FG000|Overall Study|Other Adverse event|0|||
126656818|NCT02003573|455701860|FG001|Overall Study|Other Adverse event|1|||
126656819|NCT02003573|455701861|FG002|Overall Study|Other Adverse event|1|||
126656820|NCT02003573|455701859|FG000|Overall Study|Refuse to take trial medication|0|||
126656821|NCT02003573|455701860|FG001|Overall Study|Refuse to take trial medication|1|||
126656822|NCT02003573|455701861|FG002|Overall Study|Refuse to take trial medication|1|||
126656823|NCT02003573|455701859|FG000|Overall Study|Other than specified|1|||
126656824|NCT02003573|455701860|FG001|Overall Study|Other than specified|2|||
126656825|NCT02003573|455701861|FG002|Overall Study|Other than specified|3|||
126656826|NCT02112708|455701864|FG000|Baseline|Physician Decision|16|||
126656827|NCT02112708|455701865|FG001|Baseline|Physician Decision|11|||
126656828|NCT02112708|455701864|FG000|Baseline|Lost to Follow-up|12|||
126656829|NCT02112708|455701865|FG001|Baseline|Lost to Follow-up|0|||
126656830|NCT02112708|455701864|FG000|4 Month|Death|0|||
126656831|NCT02112708|455701865|FG001|4 Month|Death|1|||
126656832|NCT02112708|455701864|FG000|4 Month|Withdrawal by Subject|12|||
126656833|NCT02112708|455701865|FG001|4 Month|Withdrawal by Subject|0|||
126656834|NCT02232243|455701870|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
126656835|NCT02232243|455701871|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
126656836|NCT02232243|455701872|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
126656837|NCT00704405|455701873|FG000|Overall Study (NC Population)|Adverse Event|1|||
126656838|NCT00704405|455701874|FG001|Overall Study (NC Population)|Adverse Event|0|||
126656839|NCT00704405|455701875|FG002|Overall Study (NC Population)|Adverse Event|0|||
126656840|NCT00704405|455701876|FG003|Overall Study (NC Population)|Adverse Event|0|||
126656841|NCT00704405|455701877|FG004|Overall Study (NC Population)|Adverse Event|0|||
126656842|NCT00704405|455701873|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
126656843|NCT00704405|455701874|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
126656844|NCT00704405|455701875|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
126656845|NCT00704405|455701876|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
126656846|NCT00704405|455701877|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
126656847|NCT00704405|455701873|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
126656848|NCT00704405|455701874|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
126656849|NCT00704405|455701875|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
126656850|NCT00704405|455701876|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
126656851|NCT00704405|455701877|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
126656852|NCT00704405|455701873|FG000|Overall Study (NC Population)|Other|0|||
126656853|NCT00704405|455701874|FG001|Overall Study (NC Population)|Other|0|||
126656854|NCT00704405|455701875|FG002|Overall Study (NC Population)|Other|0|||
126656855|NCT00704405|455701876|FG003|Overall Study (NC Population)|Other|0|||
126656856|NCT00704405|455701877|FG004|Overall Study (NC Population)|Other|1|||
126656857|NCT00704405|455701873|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
126656858|NCT00704405|455701874|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
126656859|NCT00704405|455701875|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
126656860|NCT00704405|455701876|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
126656861|NCT00704405|455701877|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
126656862|NCT00704405|455701873|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
126656863|NCT00704405|455701874|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
126656864|NCT00704405|455701875|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
126656865|NCT00704405|455701876|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
126656866|NCT00704405|455701877|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
126656867|NCT01395888|455701878|FG000|2-week Run-in Period|Adverse Event|2|||
126656868|NCT01395888|455701879|FG001|2-week Run-in Period|Adverse Event|0|||
126656869|NCT01395888|455701880|FG002|2-week Run-in Period|Adverse Event|0|||
126656870|NCT01395888|455701878|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
126656871|NCT01395888|455701879|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
126656872|NCT01395888|455701880|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
126656873|NCT01395888|455701878|FG000|2-week Run-in Period|Lost to Follow-up|1|||
126656874|NCT01395888|455701879|FG001|2-week Run-in Period|Lost to Follow-up|0|||
126656875|NCT01395888|455701880|FG002|2-week Run-in Period|Lost to Follow-up|0|||
126656876|NCT01395888|455701878|FG000|2-week Run-in Period|Protocol Violation|2|||
126656877|NCT01395888|455701879|FG001|2-week Run-in Period|Protocol Violation|0|||
126656878|NCT01395888|455701880|FG002|2-week Run-in Period|Protocol Violation|0|||
126656879|NCT01395888|455701878|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
126656880|NCT01395888|455701879|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126656881|NCT01395888|455701880|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126656882|NCT01395888|455701878|FG000|Treatment Period (TP)|Adverse Event|0|||
126656883|NCT01395888|455701879|FG001|Treatment Period (TP)|Adverse Event|7|||
126656884|NCT01395888|455701880|FG002|Treatment Period (TP)|Adverse Event|6|||
126656885|NCT01395888|455701878|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
126656886|NCT01395888|455701879|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
126656887|NCT01395888|455701880|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
126656888|NCT01395888|455701878|FG000|Treatment Period (TP)|Protocol Violation|0|||
126656889|NCT01395888|455701879|FG001|Treatment Period (TP)|Protocol Violation|1|||
126656890|NCT01395888|455701880|FG002|Treatment Period (TP)|Protocol Violation|5|||
126656891|NCT01395888|455701878|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
126656892|NCT01395888|455701879|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
126656893|NCT01395888|455701880|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
126656894|NCT01395888|455701878|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
126656895|NCT01395888|455701879|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
126656896|NCT01395888|455701880|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
126656897|NCT00928018|455701881|FG000|Overall Study|Withdrawal by Subject|1|||
126656898|NCT00928018|455701882|FG001|Overall Study|Withdrawal by Subject|0|||
126656899|NCT01946438|455701883|FG000|Overall Study|Adverse Event|0|||
126656900|NCT01946438|455701884|FG001|Overall Study|Adverse Event|0|||
126656901|NCT01946438|455701885|FG002|Overall Study|Adverse Event|0|||
126656902|NCT01946438|455701886|FG003|Overall Study|Adverse Event|1|||
126656903|NCT01946438|455701883|FG000|Overall Study|Serious Adverse event|1|||
126656904|NCT01946438|455701884|FG001|Overall Study|Serious Adverse event|0|||
126656905|NCT01946438|455701885|FG002|Overall Study|Serious Adverse event|0|||
126656906|NCT01946438|455701886|FG003|Overall Study|Serious Adverse event|0|||
126656907|NCT01946438|455701883|FG000|Overall Study|Protocol Violation|0|||
126656908|NCT01946438|455701884|FG001|Overall Study|Protocol Violation|0|||
126656909|NCT01946438|455701885|FG002|Overall Study|Protocol Violation|1|||
126656910|NCT01946438|455701886|FG003|Overall Study|Protocol Violation|0|||
126656911|NCT01946438|455701883|FG000|Overall Study|Withdrawal by Subject|1|||
126656912|NCT01946438|455701884|FG001|Overall Study|Withdrawal by Subject|0|||
126656913|NCT01946438|455701885|FG002|Overall Study|Withdrawal by Subject|0|||
126656914|NCT01946438|455701886|FG003|Overall Study|Withdrawal by Subject|0|||
126656915|NCT00126503|455701887|FG000|Overall Study|disease progression|23|||
126656916|NCT00126503|455701888|FG001|Overall Study|disease progression|14|||
126656917|NCT00126503|455701887|FG000|Overall Study|Withdrawal by Subject|0|||
126656918|NCT00126503|455701888|FG001|Overall Study|Withdrawal by Subject|1|||
126656919|NCT00126503|455701887|FG000|Overall Study|alternative therapy|1|||
126656920|NCT00126503|455701888|FG001|Overall Study|alternative therapy|1|||
126656921|NCT00126503|455701887|FG000|Overall Study|other complicating disease|4|||
126656922|NCT00126503|455701888|FG001|Overall Study|other complicating disease|1|||
126656923|NCT00126503|455701887|FG000|Overall Study|Death|3|||
126656924|NCT00126503|455701888|FG001|Overall Study|Death|0|||
126656925|NCT00126503|455701887|FG000|Overall Study|Adverse Event|13|||
126656926|NCT00126503|455701888|FG001|Overall Study|Adverse Event|3|||
126656927|NCT00126503|455701887|FG000|Overall Study|non-compliant|1|||
126656928|NCT00126503|455701888|FG001|Overall Study|non-compliant|0|||
126656929|NCT00126503|455701887|FG000|Overall Study|Physician Decision|2|||
126656930|NCT00126503|455701888|FG001|Overall Study|Physician Decision|1|||
126656931|NCT02457559|455701889|FG000|Overall Study|Progressive Disease|1|||
126656932|NCT02457559|455701890|FG001|Overall Study|Progressive Disease|2|||
126656933|NCT02457559|455701891|FG002|Overall Study|Progressive Disease|3|||
126656934|NCT02457559|455701892|FG003|Overall Study|Progressive Disease|0|||
126656935|NCT02457559|455701893|FG004|Overall Study|Progressive Disease|0|||
126656936|NCT02457559|455701894|FG005|Overall Study|Progressive Disease|2|||
126656937|NCT02457559|455701895|FG006|Overall Study|Progressive Disease|1|||
126656938|NCT02457559|455701896|FG007|Overall Study|Progressive Disease|0|||
126656939|NCT02457559|455701897|FG008|Overall Study|Progressive Disease|1|||
126656940|NCT02457559|455701898|FG009|Overall Study|Progressive Disease|1|||
126656941|NCT02457559|455701899|FG010|Overall Study|Progressive Disease|1|||
126656942|NCT02457559|455701889|FG000|Overall Study|Investigator's Discretion|0|||
126656943|NCT02457559|455701890|FG001|Overall Study|Investigator's Discretion|0|||
126656944|NCT02457559|455701891|FG002|Overall Study|Investigator's Discretion|2|||
126656945|NCT02457559|455701892|FG003|Overall Study|Investigator's Discretion|0|||
126656946|NCT02457559|455701893|FG004|Overall Study|Investigator's Discretion|1|||
126656947|NCT02457559|455701894|FG005|Overall Study|Investigator's Discretion|0|||
126656948|NCT02457559|455701895|FG006|Overall Study|Investigator's Discretion|1|||
126656949|NCT02457559|455701896|FG007|Overall Study|Investigator's Discretion|0|||
126656950|NCT02457559|455701897|FG008|Overall Study|Investigator's Discretion|1|||
126656951|NCT02457559|455701898|FG009|Overall Study|Investigator's Discretion|0|||
126656952|NCT02457559|455701899|FG010|Overall Study|Investigator's Discretion|1|||
126656953|NCT02457559|455701889|FG000|Overall Study|Adverse Event|0|||
126656954|NCT02457559|455701890|FG001|Overall Study|Adverse Event|1|||
126656955|NCT02457559|455701891|FG002|Overall Study|Adverse Event|2|||
126656956|NCT02457559|455701892|FG003|Overall Study|Adverse Event|0|||
126656957|NCT02457559|455701893|FG004|Overall Study|Adverse Event|0|||
126656958|NCT02457559|455701894|FG005|Overall Study|Adverse Event|0|||
126656959|NCT02457559|455701895|FG006|Overall Study|Adverse Event|0|||
126656960|NCT02457559|455701896|FG007|Overall Study|Adverse Event|0|||
126656961|NCT02457559|455701897|FG008|Overall Study|Adverse Event|0|||
126656962|NCT02457559|455701898|FG009|Overall Study|Adverse Event|0|||
126656963|NCT02457559|455701899|FG010|Overall Study|Adverse Event|0|||
126656964|NCT02457559|455701889|FG000|Overall Study|Reason not Specified|1|||
126656965|NCT02457559|455701890|FG001|Overall Study|Reason not Specified|0|||
126656966|NCT02457559|455701891|FG002|Overall Study|Reason not Specified|0|||
126656967|NCT02457559|455701892|FG003|Overall Study|Reason not Specified|0|||
126656968|NCT02457559|455701893|FG004|Overall Study|Reason not Specified|0|||
126656969|NCT02457559|455701894|FG005|Overall Study|Reason not Specified|0|||
126656970|NCT02457559|455701895|FG006|Overall Study|Reason not Specified|0|||
126656971|NCT02457559|455701896|FG007|Overall Study|Reason not Specified|0|||
126656972|NCT02457559|455701897|FG008|Overall Study|Reason not Specified|0|||
126656973|NCT02457559|455701898|FG009|Overall Study|Reason not Specified|2|||
126656974|NCT02457559|455701899|FG010|Overall Study|Reason not Specified|0|||
126656975|NCT02457559|455701889|FG000|Overall Study|Death|0|||
126656976|NCT02457559|455701890|FG001|Overall Study|Death|0|||
126656977|NCT02457559|455701891|FG002|Overall Study|Death|0|||
126656978|NCT02457559|455701892|FG003|Overall Study|Death|0|||
126656979|NCT02457559|455701893|FG004|Overall Study|Death|0|||
126656980|NCT02457559|455701894|FG005|Overall Study|Death|0|||
126656981|NCT02457559|455701895|FG006|Overall Study|Death|0|||
126656982|NCT02457559|455701896|FG007|Overall Study|Death|0|||
126656983|NCT02457559|455701897|FG008|Overall Study|Death|1|||
126656984|NCT02457559|455701898|FG009|Overall Study|Death|1|||
126656985|NCT02457559|455701899|FG010|Overall Study|Death|0|||
126656986|NCT00998335|455701902|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
126656987|NCT00998335|455701903|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
126656988|NCT00790751|455701904|FG000|Overall Study|Protocol non-compliance|16|||
126656989|NCT00790751|455701905|FG001|Overall Study|Protocol non-compliance|16|||
126656990|NCT00790751|455701906|FG002|Overall Study|Protocol non-compliance|10|||
126656991|NCT00790751|455701907|FG003|Overall Study|Protocol non-compliance|11|||
126656992|NCT00790751|455701904|FG000|Overall Study|Lost to Follow-up|4|||
126656993|NCT00790751|455701905|FG001|Overall Study|Lost to Follow-up|9|||
126656994|NCT00790751|455701906|FG002|Overall Study|Lost to Follow-up|4|||
126656995|NCT00790751|455701907|FG003|Overall Study|Lost to Follow-up|5|||
126656996|NCT00790751|455701904|FG000|Overall Study|Adverse Event|5|||
126656997|NCT00790751|455701905|FG001|Overall Study|Adverse Event|3|||
126656998|NCT00790751|455701906|FG002|Overall Study|Adverse Event|5|||
126656999|NCT00790751|455701907|FG003|Overall Study|Adverse Event|4|||
126657000|NCT00790751|455701904|FG000|Overall Study|Requirement for restricted medication|0|||
126657001|NCT00790751|455701905|FG001|Overall Study|Requirement for restricted medication|2|||
126657002|NCT00790751|455701906|FG002|Overall Study|Requirement for restricted medication|0|||
126657003|NCT00790751|455701907|FG003|Overall Study|Requirement for restricted medication|0|||
126657004|NCT00790751|455701904|FG000|Overall Study|Death|0|||
126657005|NCT00790751|455701905|FG001|Overall Study|Death|0|||
126657006|NCT00790751|455701906|FG002|Overall Study|Death|1|||
126657007|NCT00790751|455701907|FG003|Overall Study|Death|0|||
126657008|NCT00790751|455701904|FG000|Overall Study|Physician Decision|0|||
126657009|NCT00790751|455701905|FG001|Overall Study|Physician Decision|0|||
126657010|NCT00790751|455701906|FG002|Overall Study|Physician Decision|0|||
126657011|NCT00790751|455701907|FG003|Overall Study|Physician Decision|1|||
126657012|NCT05330312|455701908|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
126657013|NCT05330312|455701909|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
126657014|NCT05330312|455701910|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
126657015|NCT05330312|455701908|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
126657016|NCT05330312|455701909|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
126657017|NCT05330312|455701910|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
126657018|NCT05330312|455701908|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
126657019|NCT05330312|455701909|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
126657020|NCT05330312|455701910|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
126657021|NCT05330312|455701908|FG000|Pivotal Investigation - Part 2|Death|1|||
126657022|NCT05330312|455701909|FG001|Pivotal Investigation - Part 2|Death|4|||
126657023|NCT05330312|455701910|FG002|Pivotal Investigation - Part 2|Death|0|||
126657024|NCT01078454|455701913|FG000|Overall Study|Adverse Event|1|||
126657025|NCT01078454|455701914|FG001|Overall Study|Adverse Event|1|||
126657026|NCT01078454|455701913|FG000|Overall Study|Death|0|||
126657027|NCT01078454|455701914|FG001|Overall Study|Death|1|||
126657028|NCT00346268|455703668|FG000|Overall Study|Adverse Event|1|||
126657029|NCT00346268|455703669|FG001|Overall Study|Adverse Event|0|||
126657030|NCT00346268|455703668|FG000|Overall Study|Protocol Violation|1|||
126657031|NCT00346268|455703669|FG001|Overall Study|Protocol Violation|0|||
126657032|NCT00346268|455703668|FG000|Overall Study|Participant refused|0|||
126657033|NCT00346268|455703669|FG001|Overall Study|Participant refused|3|||
126657034|NCT02186223|455703673|FG000|Overall Study|Not eligible for device placement|6|||
126657035|NCT02186223|455703673|FG000|Overall Study|Unable to obtain femoral access|3|||
126657036|NCT02186223|455703673|FG000|Overall Study|Death|3|||
126657037|NCT02186223|455703673|FG000|Overall Study|Device in place less than 48 hours|9|||
126657038|NCT00252733|455703674|FG000|Overall Study|Withdrawal by Subject|73|||
126657039|NCT00252733|455703675|FG001|Overall Study|Withdrawal by Subject|67|||
126657040|NCT00252733|455703674|FG000|Overall Study|Death|7|||
126657041|NCT00252733|455703675|FG001|Overall Study|Death|5|||
126657042|NCT00252733|455703674|FG000|Overall Study|Lost to Follow-up|12|||
126657043|NCT00252733|455703675|FG001|Overall Study|Lost to Follow-up|6|||
126657044|NCT00252733|455703674|FG000|Overall Study|Multiple Reasons|14|||
126657045|NCT00252733|455703675|FG001|Overall Study|Multiple Reasons|14|||
126657046|NCT01350336|455703676|FG000|Overall Study|Lost to Follow-up|31|||
126657047|NCT01350336|455703676|FG000|Overall Study|Withdrawal by Subject|14|||
126657048|NCT01350336|455703676|FG000|Overall Study|Physician Decision|8|||
126657049|NCT01350336|455703676|FG000|Overall Study|Death|4|||
126657050|NCT02079610|455703680|FG000|Overall Study|Withdrawal by Subject|1|||
126657051|NCT02079610|455703681|FG001|Overall Study|Withdrawal by Subject|1|||
126657052|NCT01111474|455703682|FG000|Overall Study|Lost to Follow-up|12|||
126657053|NCT01016977|455703683|FG000|Overall Study|Lost to Follow-up|1|||
126657054|NCT01016977|455703684|FG001|Overall Study|Lost to Follow-up|0|||
126657055|NCT01016977|455703683|FG000|Overall Study|Withdrawal by Subject|2|||
126657056|NCT01016977|455703684|FG001|Overall Study|Withdrawal by Subject|2|||
126657057|NCT00824161|455703685|FG000|Overall Study|Withdrawal by Subject|1|||
126657058|NCT00824161|455703685|FG000|Overall Study|Screen Failure|1|||
126657059|NCT04882995|455703686|FG000|Overall Study|Withdrawal by Subject|1|||
126657060|NCT04882995|455703687|FG001|Overall Study|Withdrawal by Subject|2|||
126657061|NCT04882995|455703686|FG000|Overall Study|Protocol Violation|4|||
126657062|NCT04882995|455703687|FG001|Overall Study|Protocol Violation|4|||
126657063|NCT04882995|455703686|FG000|Overall Study|Surgery postponed due to COVID|1|||
126657064|NCT04882995|455703687|FG001|Overall Study|Surgery postponed due to COVID|1|||
126657065|NCT00477334|455703688|FG000|Overall Study|Discontinued prior to taking study drug|106|||
126657066|NCT00477334|455703689|FG001|Overall Study|Discontinued prior to taking study drug|53|||
126657067|NCT00477334|455703688|FG000|Overall Study|Adverse Event|1|||
126657068|NCT00477334|455703689|FG001|Overall Study|Adverse Event|2|||
126657069|NCT00477334|455703688|FG000|Overall Study|Withdrawal by Subject|2|||
126657070|NCT00477334|455703689|FG001|Overall Study|Withdrawal by Subject|1|||
126657071|NCT00477334|455703688|FG000|Overall Study|Lost to Follow-up|15|||
126657072|NCT00477334|455703689|FG001|Overall Study|Lost to Follow-up|4|||
126657073|NCT00477334|455703688|FG000|Overall Study|Administrative Problems|39|||
126657074|NCT00477334|455703689|FG001|Overall Study|Administrative Problems|15|||
126657075|NCT00477334|455703688|FG000|Overall Study|Protocol Violation|7|||
126657076|NCT00477334|455703689|FG001|Overall Study|Protocol Violation|1|||
126657077|NCT03587974|455703693|FG000|Overall Study|caregiver demented, care recipient died|3|||
126657078|NCT03587974|455703694|FG001|Overall Study|caregiver demented, care recipient died|3|||
126657079|NCT03587974|455703693|FG000|Overall Study|Withdrawal by Subject|2|||
126657080|NCT03587974|455703694|FG001|Overall Study|Withdrawal by Subject|1|||
126657081|NCT02354508|455703695|FG000|Period 1: Core Phase|Adverse Event|1|||
126657082|NCT02354508|455703696|FG001|Period 1: Core Phase|Adverse Event|1|||
126657083|NCT02354508|455703697|FG002|Period 1: Core Phase|Adverse Event|2|||
126657084|NCT02354508|455703695|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
126657085|NCT02354508|455703696|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
126657086|NCT02354508|455703697|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
126657087|NCT02354508|455703695|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
126657088|NCT02354508|455703696|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
126657089|NCT02354508|455703697|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
126657090|NCT02354508|455703695|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
126657091|NCT02354508|455703696|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
126657092|NCT02354508|455703697|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
126657093|NCT02354508|455703695|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
126657094|NCT02354508|455703696|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
126657095|NCT02354508|455703697|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
126657096|NCT02354508|455703695|FG000|Period 2: Extension Phase|Physician Decision|5|||
126657097|NCT02354508|455703696|FG001|Period 2: Extension Phase|Physician Decision|0|||
126657098|NCT02354508|455703697|FG002|Period 2: Extension Phase|Physician Decision|1|||
126657099|NCT02354508|455703695|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
126657100|NCT02354508|455703696|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
126657101|NCT02354508|455703697|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
126657102|NCT02354508|455703695|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
126657103|NCT02354508|455703696|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
126657104|NCT02354508|455703697|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
126657105|NCT02354508|455703695|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
126657106|NCT02354508|455703696|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
126657107|NCT02354508|455703697|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
126657108|NCT04371198|455703698|FG000|Overall Study|inadequate sample|4|||
126657109|NCT00372229|455703699|FG000|Study Phase|Graft loss|0|||
126657110|NCT00372229|455703700|FG001|Study Phase|Graft loss|3|||
126657111|NCT00372229|455703699|FG000|Study Phase|Protocol Violation|3|||
126657112|NCT00372229|455703700|FG001|Study Phase|Protocol Violation|4|||
126657113|NCT00372229|455703699|FG000|Study Phase|Consent withdrawn|16|||
126657114|NCT00372229|455703700|FG001|Study Phase|Consent withdrawn|14|||
126657115|NCT00372229|455703699|FG000|Study Phase|Refused treatment/did not cooperate|3|||
126657116|NCT00372229|455703700|FG001|Study Phase|Refused treatment/did not cooperate|1|||
126657117|NCT00372229|455703699|FG000|Study Phase|Death|3|||
126657118|NCT00372229|455703700|FG001|Study Phase|Death|2|||
126657119|NCT00372229|455703699|FG000|Study Phase|Reason not specified|3|||
126657120|NCT00372229|455703700|FG001|Study Phase|Reason not specified|2|||
126657121|NCT00372229|455703699|FG000|Study Phase|Lost to Follow-up|3|||
126657122|NCT00372229|455703700|FG001|Study Phase|Lost to Follow-up|3|||
126657123|NCT00372229|455703699|FG000|Follow-Up Phase|Graft loss|8|||
126657124|NCT00372229|455703700|FG001|Follow-Up Phase|Graft loss|7|||
126657125|NCT00372229|455703699|FG000|Follow-Up Phase|Consent withdrawn|13|||
126657126|NCT00372229|455703700|FG001|Follow-Up Phase|Consent withdrawn|19|||
126657127|NCT00372229|455703699|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
126657128|NCT00372229|455703700|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
126657129|NCT00372229|455703699|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
126657130|NCT00372229|455703700|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
126657131|NCT00372229|455703699|FG000|Follow-Up Phase|Death|9|||
126657132|NCT00372229|455703700|FG001|Follow-Up Phase|Death|12|||
126657133|NCT00372229|455703699|FG000|Follow-Up Phase|Administrative|1|||
126657134|NCT00372229|455703700|FG001|Follow-Up Phase|Administrative|0|||
126657135|NCT00372229|455703699|FG000|Follow-Up Phase|Reason not specified|2|||
126657136|NCT00372229|455703700|FG001|Follow-Up Phase|Reason not specified|3|||
126657137|NCT00372229|455703699|FG000|Follow-Up Phase|Lost to Follow-up|12|||
126657138|NCT00372229|455703700|FG001|Follow-Up Phase|Lost to Follow-up|10|||
126657139|NCT03536143|455703701|FG000|Overall Study|Early termination, Sponsor decision|1|||
126657140|NCT04754477|455703702|FG000|Overall Study|Withdrawal by Subject|1|||
126657141|NCT01347762|455703703|FG000|Overall Study|Lost to Follow-up|0|||
126657142|NCT01347762|455703704|FG001|Overall Study|Lost to Follow-up|1|||
126657143|NCT01347762|455703705|FG002|Overall Study|Lost to Follow-up|6|||
126657144|NCT01347762|455703706|FG003|Overall Study|Lost to Follow-up|5|||
126657145|NCT01347762|455703703|FG000|Overall Study|Withdrawal by Subject|4|||
126657146|NCT01347762|455703704|FG001|Overall Study|Withdrawal by Subject|1|||
126657147|NCT01347762|455703705|FG002|Overall Study|Withdrawal by Subject|3|||
126657148|NCT01347762|455703706|FG003|Overall Study|Withdrawal by Subject|3|||
126657149|NCT03406260|455703707|FG000|Period 1|Adverse Event|0|||
126657150|NCT03406260|455703708|FG001|Period 1|Adverse Event|0|||
126657151|NCT03406260|455703709|FG002|Period 1|Adverse Event|0|||
126657152|NCT03406260|455703710|FG003|Period 1|Adverse Event|0|||
126657153|NCT03406260|455703711|FG004|Period 1|Adverse Event|1|||
126657154|NCT03406260|455703712|FG005|Period 1|Adverse Event|0|||
126657155|NCT00871780|455703713|FG000|Overall Study|Enrolled But Not Treated|6|||
126657156|NCT00871780|455703713|FG000|Overall Study|Withdrawal by Subject|9|||
126657157|NCT00871780|455703713|FG000|Overall Study|Adverse Event|6|||
126657158|NCT00871780|455703713|FG000|Overall Study|Voluntary Discontinuation|4|||
126657159|NCT00871780|455703713|FG000|Overall Study|Death|1|||
126657160|NCT00871780|455703713|FG000|Overall Study|Physician Decision|1|||
126657161|NCT02527343|455703714|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
126657162|NCT02527343|455703715|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
126657163|NCT02527343|455703716|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
126657164|NCT02527343|455703717|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
126657165|NCT02527343|455703718|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
126657166|NCT02527343|455703719|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
126657167|NCT02527343|455703714|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
126657168|NCT02527343|455703715|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
126657169|NCT02527343|455703716|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
126657170|NCT02527343|455703717|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
126657171|NCT02527343|455703718|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
126657172|NCT02527343|455703719|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
126657173|NCT02527343|455703714|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126657174|NCT02527343|455703715|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
126657175|NCT02527343|455703716|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126657176|NCT02527343|455703717|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126657177|NCT02527343|455703718|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126657178|NCT02527343|455703719|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126657179|NCT02527343|455703714|FG000|RT Period: Weeks 1 to 52|Other|4|||
126657180|NCT02527343|455703715|FG001|RT Period: Weeks 1 to 52|Other|3|||
126657181|NCT02527343|455703716|FG002|RT Period: Weeks 1 to 52|Other|0|||
126657182|NCT02527343|455703717|FG003|RT Period: Weeks 1 to 52|Other|0|||
126657183|NCT02527343|455703718|FG004|RT Period: Weeks 1 to 52|Other|0|||
126657184|NCT02527343|455703719|FG005|RT Period: Weeks 1 to 52|Other|0|||
126657185|NCT02527343|455703714|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
126657186|NCT02527343|455703715|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
126657187|NCT02527343|455703716|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
126657188|NCT02527343|455703717|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
126657189|NCT02527343|455703718|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
126657190|NCT02527343|455703719|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
126657191|NCT02527343|455703714|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
126657192|NCT02527343|455703715|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
126657193|NCT02527343|455703716|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
126657194|NCT02527343|455703717|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
126657195|NCT02527343|455703718|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
126657196|NCT02527343|455703719|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
126657197|NCT02527343|455703714|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
126657198|NCT02527343|455703715|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
126657199|NCT02527343|455703716|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
126657200|NCT02527343|455703717|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
126657201|NCT02527343|455703718|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
126657202|NCT02527343|455703719|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
126657203|NCT02527343|455703714|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
126657204|NCT02527343|455703715|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
126657205|NCT02527343|455703716|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
126657206|NCT02527343|455703717|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
126657207|NCT02527343|455703718|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
126657208|NCT02527343|455703719|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
126657209|NCT02527343|455703714|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
126657210|NCT02527343|455703715|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
126657211|NCT02527343|455703716|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
126657212|NCT02527343|455703717|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
126657213|NCT02527343|455703718|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
126657214|NCT02527343|455703719|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
126657215|NCT02527343|455703714|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
126657216|NCT02527343|455703715|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
126657217|NCT02527343|455703716|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
126657218|NCT02527343|455703717|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
126657219|NCT02527343|455703718|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
126657220|NCT02527343|455703719|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
126657221|NCT02527343|455703714|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
126657222|NCT02527343|455703715|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
126657223|NCT02527343|455703716|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
126657224|NCT02527343|455703717|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
126657225|NCT02527343|455703718|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
126657226|NCT02527343|455703719|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
126657227|NCT02527343|455703714|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
126657228|NCT02527343|455703715|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
126657229|NCT02527343|455703716|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
126657230|NCT02527343|455703717|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
126657231|NCT02527343|455703718|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
126330029|NCT01436227|454501783|FG000|Overall Study|Disease progression, relapse|6|||
126657232|NCT02527343|455703719|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
126657233|NCT02527343|455703714|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
126657234|NCT02527343|455703715|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
126657235|NCT02527343|455703716|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
126657236|NCT02527343|455703717|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
126657237|NCT02527343|455703718|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
126657238|NCT02527343|455703719|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
126657239|NCT00701220|455703720|FG000|Overall Study|Withdrawal by Subject|0|||
126657240|NCT00701220|455703721|FG001|Overall Study|Withdrawal by Subject|2|||
126657241|NCT00701220|455703720|FG000|Overall Study|Protocol Violation|2|||
126657242|NCT00701220|455703721|FG001|Overall Study|Protocol Violation|0|||
126657243|NCT01205152|455703722|FG000|Overall Study|Death|1|||
126657244|NCT00249002|455703723|FG000|Overall Study|Adverse Event|2|||
126657245|NCT00249002|455703723|FG000|Overall Study|Study cancellation|3|||
126657246|NCT00249002|455703723|FG000|Overall Study|Other|2|||
126657247|NCT02208999|455703725|FG000|Overall Study|Lost to Follow-up|1|||
126657248|NCT00319839|455703726|FG000|Overall Study|Adverse Event|5|||
126657249|NCT00319839|455703726|FG000|Overall Study|Withdrawal by Subject|1|||
126657250|NCT01577745|455703727|FG000|Overall Study|Withdrawal by Subject|0|||
126657251|NCT01577745|455703728|FG001|Overall Study|Withdrawal by Subject|1|||
126657252|NCT01577745|455703729|FG002|Overall Study|Withdrawal by Subject|0|||
126657253|NCT01577745|455703730|FG003|Overall Study|Withdrawal by Subject|3|||
126657254|NCT01577745|455703731|FG004|Overall Study|Withdrawal by Subject|2|||
126657255|NCT01577745|455703732|FG005|Overall Study|Withdrawal by Subject|0|||
126657256|NCT01577745|455703727|FG000|Overall Study|Death|3|||
126657257|NCT01577745|455703728|FG001|Overall Study|Death|2|||
126657258|NCT01577745|455703729|FG002|Overall Study|Death|2|||
126657259|NCT01577745|455703730|FG003|Overall Study|Death|1|||
126657260|NCT01577745|455703731|FG004|Overall Study|Death|1|||
126657261|NCT01577745|455703732|FG005|Overall Study|Death|3|||
126657262|NCT01577745|455703727|FG000|Overall Study|Physician Decision|0|||
126657263|NCT01577745|455703728|FG001|Overall Study|Physician Decision|0|||
126657264|NCT01577745|455703729|FG002|Overall Study|Physician Decision|0|||
126657265|NCT01577745|455703730|FG003|Overall Study|Physician Decision|1|||
126657266|NCT01577745|455703731|FG004|Overall Study|Physician Decision|1|||
126657267|NCT01577745|455703732|FG005|Overall Study|Physician Decision|0|||
126657268|NCT01577745|455703727|FG000|Overall Study|Lost to Follow-up|0|||
126657269|NCT01577745|455703728|FG001|Overall Study|Lost to Follow-up|0|||
126657270|NCT01577745|455703729|FG002|Overall Study|Lost to Follow-up|0|||
126657271|NCT01577745|455703730|FG003|Overall Study|Lost to Follow-up|0|||
126657272|NCT01577745|455703731|FG004|Overall Study|Lost to Follow-up|0|||
126657273|NCT01577745|455703732|FG005|Overall Study|Lost to Follow-up|1|||
126657274|NCT01577745|455703727|FG000|Overall Study|Alternative Therapy|0|||
126657275|NCT01577745|455703728|FG001|Overall Study|Alternative Therapy|0|||
126657276|NCT01577745|455703729|FG002|Overall Study|Alternative Therapy|0|||
126657277|NCT01577745|455703730|FG003|Overall Study|Alternative Therapy|1|||
126657278|NCT01577745|455703731|FG004|Overall Study|Alternative Therapy|1|||
126657279|NCT01577745|455703732|FG005|Overall Study|Alternative Therapy|0|||
126657280|NCT02483585|455703733|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
126657281|NCT02483585|455703734|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
126657282|NCT02483585|455703733|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
126657283|NCT02483585|455703734|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
126657284|NCT02483585|455703733|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
126657285|NCT02483585|455703734|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
126657286|NCT02483585|455703733|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
126657287|NCT02483585|455703734|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
126657288|NCT02483585|455703733|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
126657289|NCT02483585|455703734|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
126657290|NCT02483585|455703733|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
126657291|NCT02483585|455703734|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
126657292|NCT02483585|455703733|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
126657293|NCT02483585|455703734|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
126657294|NCT01324440|455703739|FG000|Overall Study|Subject moved|0|||
126657295|NCT01324440|455703740|FG001|Overall Study|Subject moved|1|||
126657296|NCT00903630|455703741|FG000|Phase 2|Adverse Event|0|||
126657297|NCT00903630|455703742|FG001|Phase 2|Adverse Event|0|||
126657298|NCT00903630|455703743|FG002|Phase 2|Adverse Event|1|||
126657299|NCT04025580|455703744|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
126657300|NCT04025580|455703745|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
126657301|NCT04025580|455703746|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
126657302|NCT01136772|455703749|FG000|Overall Study|Adverse Event|15|||
126657303|NCT01136772|455703750|FG001|Overall Study|Adverse Event|14|||
126657304|NCT01136772|455703749|FG000|Overall Study|Lack of Efficacy|42|||
126657305|NCT01136772|455703750|FG001|Overall Study|Lack of Efficacy|39|||
126657306|NCT01136772|455703749|FG000|Overall Study|Administrative|14|||
126657307|NCT01136772|455703750|FG001|Overall Study|Administrative|12|||
126657308|NCT01136772|455703749|FG000|Overall Study|Withdrawal by Subject|33|||
126657309|NCT01136772|455703750|FG001|Overall Study|Withdrawal by Subject|36|||
126657310|NCT01136772|455703749|FG000|Overall Study|Did not receive injection|10|||
126657311|NCT01136772|455703750|FG001|Overall Study|Did not receive injection|7|||
126657312|NCT01136772|455703749|FG000|Overall Study|Did not follow up after first injection|2|||
126657313|NCT01136772|455703750|FG001|Overall Study|Did not follow up after first injection|2|||
126657314|NCT00928746|455703751|FG000|Overall Study|Adverse Event|2|||
126657315|NCT00928746|455703751|FG000|Overall Study|Protocol Violation|1|||
126657316|NCT00928746|455703751|FG000|Overall Study|Withdrawal by Subject|1|||
126657317|NCT00928746|455703751|FG000|Overall Study|Other|2|||
126657318|NCT02004353|455703757|FG000|Overall Study|Voluntary participation|1334|||
126657319|NCT02581631|455703758|FG000|Overall Study|Disease progression|29|||
126657320|NCT02581631|455703759|FG001|Overall Study|Disease progression|19|||
126657321|NCT02581631|455703760|FG002|Overall Study|Disease progression|13|||
126657322|NCT02581631|455703761|FG003|Overall Study|Disease progression|5|||
126657323|NCT02581631|455703762|FG004|Overall Study|Disease progression|8|||
126657324|NCT02581631|455703758|FG000|Overall Study|Study drug toxicity|4|||
126657325|NCT02581631|455703759|FG001|Overall Study|Study drug toxicity|6|||
126657326|NCT02581631|455703760|FG002|Overall Study|Study drug toxicity|7|||
126657327|NCT02581631|455703761|FG003|Overall Study|Study drug toxicity|0|||
126657328|NCT02581631|455703762|FG004|Overall Study|Study drug toxicity|3|||
126657329|NCT02581631|455703758|FG000|Overall Study|AE unrelated to study drug|3|||
126657330|NCT02581631|455703759|FG001|Overall Study|AE unrelated to study drug|1|||
126657331|NCT02581631|455703760|FG002|Overall Study|AE unrelated to study drug|1|||
126657332|NCT02581631|455703761|FG003|Overall Study|AE unrelated to study drug|0|||
126657333|NCT02581631|455703762|FG004|Overall Study|AE unrelated to study drug|2|||
126657334|NCT02581631|455703758|FG000|Overall Study|Request to discontinue|1|||
126657335|NCT02581631|455703759|FG001|Overall Study|Request to discontinue|0|||
126657336|NCT02581631|455703760|FG002|Overall Study|Request to discontinue|3|||
126657337|NCT02581631|455703761|FG003|Overall Study|Request to discontinue|0|||
126657338|NCT02581631|455703762|FG004|Overall Study|Request to discontinue|1|||
126657339|NCT02581631|455703758|FG000|Overall Study|participant withdrew consent|3|||
126657340|NCT02581631|455703759|FG001|Overall Study|participant withdrew consent|0|||
126657341|NCT02581631|455703760|FG002|Overall Study|participant withdrew consent|1|||
126657342|NCT02581631|455703761|FG003|Overall Study|participant withdrew consent|0|||
126657343|NCT02581631|455703762|FG004|Overall Study|participant withdrew consent|0|||
126657344|NCT02581631|455703758|FG000|Overall Study|Maximum clinical benefit|1|||
126657345|NCT02581631|455703759|FG001|Overall Study|Maximum clinical benefit|7|||
126657346|NCT02581631|455703760|FG002|Overall Study|Maximum clinical benefit|1|||
126657347|NCT02581631|455703761|FG003|Overall Study|Maximum clinical benefit|3|||
126657348|NCT02581631|455703762|FG004|Overall Study|Maximum clinical benefit|13|||
126657349|NCT02581631|455703758|FG000|Overall Study|Other Reasons|1|||
126657350|NCT02581631|455703759|FG001|Overall Study|Other Reasons|0|||
126657351|NCT02581631|455703760|FG002|Overall Study|Other Reasons|2|||
126657352|NCT02581631|455703761|FG003|Overall Study|Other Reasons|2|||
126657353|NCT02581631|455703762|FG004|Overall Study|Other Reasons|3|||
126657354|NCT02581631|455703758|FG000|Overall Study|Poor/Non-Compliance|0|||
126657355|NCT02581631|455703759|FG001|Overall Study|Poor/Non-Compliance|0|||
126657356|NCT02581631|455703760|FG002|Overall Study|Poor/Non-Compliance|1|||
126657357|NCT02581631|455703761|FG003|Overall Study|Poor/Non-Compliance|0|||
126657358|NCT02581631|455703762|FG004|Overall Study|Poor/Non-Compliance|0|||
126657359|NCT00819390|455703763|FG000|Overall Study|Lost to Follow-up|1|||
126657360|NCT00819390|455703764|FG001|Overall Study|Lost to Follow-up|1|||
126330030|NCT04004260|454501786|FG000|Overall Study|Withdrawal by Subject|7|||
126330031|NCT04004260|454501787|FG001|Overall Study|Withdrawal by Subject|3|||
126330032|NCT04004260|454501786|FG000|Overall Study|Lost to Follow-up|22|||
126330033|NCT04004260|454501787|FG001|Overall Study|Lost to Follow-up|12|||
126657361|NCT00819390|455703765|FG002|Overall Study|Lost to Follow-up|0|||
126657362|NCT00819390|455703766|FG003|Overall Study|Lost to Follow-up|0|||
126657363|NCT00819390|455703763|FG000|Overall Study|Withdrawal by Subject|2|||
126657364|NCT00819390|455703764|FG001|Overall Study|Withdrawal by Subject|0|||
126657365|NCT00819390|455703765|FG002|Overall Study|Withdrawal by Subject|0|||
126657366|NCT00819390|455703766|FG003|Overall Study|Withdrawal by Subject|0|||
126657367|NCT00819390|455703763|FG000|Overall Study|Adverse Event|0|||
126657368|NCT00819390|455703764|FG001|Overall Study|Adverse Event|0|||
126657369|NCT00819390|455703765|FG002|Overall Study|Adverse Event|1|||
126657370|NCT00819390|455703766|FG003|Overall Study|Adverse Event|0|||
126657371|NCT01270971|455703773|FG000|Overall Study|Withdrawal by Subject|24|||
126657372|NCT01270971|455703774|FG001|Overall Study|Withdrawal by Subject|11|||
126657373|NCT01270971|455703773|FG000|Overall Study|Lost to Follow-up|18|||
126657374|NCT01270971|455703774|FG001|Overall Study|Lost to Follow-up|5|||
126657375|NCT01270971|455703773|FG000|Overall Study|Adverse Event|1|||
126657376|NCT01270971|455703774|FG001|Overall Study|Adverse Event|2|||
126657377|NCT01270971|455703773|FG000|Overall Study|Non compliance|2|||
126657378|NCT01270971|455703774|FG001|Overall Study|Non compliance|2|||
126657379|NCT01270971|455703773|FG000|Overall Study|Non-specific|7|||
126657380|NCT01270971|455703774|FG001|Overall Study|Non-specific|3|||
126657381|NCT01242800|455703777|FG000|Overall Study|Patient refusal|0|||
126657382|NCT01242800|455703778|FG001|Overall Study|Patient refusal|10|||
126657383|NCT01242800|455703777|FG000|Overall Study|Physician Decision|0|||
126657384|NCT01242800|455703778|FG001|Overall Study|Physician Decision|1|||
126330034|NCT04004260|454501786|FG000|Overall Study|Did not engage in intervention|13|||
126657385|NCT01242800|455703777|FG000|Overall Study|Disease progression|0|||
126657386|NCT01242800|455703778|FG001|Overall Study|Disease progression|3|||
126657387|NCT01242800|455703777|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
126657388|NCT01242800|455703778|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
126657389|NCT01242800|455703777|FG000|Overall Study|Reasons not reported|0|||
126657390|NCT01242800|455703778|FG001|Overall Study|Reasons not reported|4|||
126657391|NCT02640157|455703780|FG000|Overall Study|Adverse Event|2|||
126657392|NCT02640157|455703781|FG001|Overall Study|Adverse Event|2|||
126657393|NCT02640157|455703782|FG002|Overall Study|Adverse Event|1|||
126657394|NCT02640157|455703780|FG000|Overall Study|Withdrew consent|2|||
126657395|NCT02640157|455703781|FG001|Overall Study|Withdrew consent|0|||
126657396|NCT02640157|455703782|FG002|Overall Study|Withdrew consent|2|||
126657397|NCT02640157|455703780|FG000|Overall Study|Lost to Follow-up|9|||
126657398|NCT02640157|455703781|FG001|Overall Study|Lost to Follow-up|2|||
126657399|NCT02640157|455703782|FG002|Overall Study|Lost to Follow-up|7|||
126657400|NCT02640157|455703780|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
126657401|NCT02640157|455703781|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
126657402|NCT02640157|455703782|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
126657403|NCT01679405|455703784|FG000|Overall Study|Death|2|||
126657404|NCT01679405|455703785|FG001|Overall Study|Death|5|||
126657405|NCT04677179|455703786|FG000|Induction Treatment Period|Adverse Event|1|||
126657406|NCT04677179|455703787|FG001|Induction Treatment Period|Adverse Event|0|||
126657407|NCT04677179|455703788|FG002|Induction Treatment Period|Adverse Event|0|||
126657408|NCT04677179|455703789|FG003|Induction Treatment Period|Adverse Event|0|||
126657409|NCT04677179|455703790|FG004|Induction Treatment Period|Adverse Event|0|||
126657410|NCT04677179|455703791|FG005|Induction Treatment Period|Adverse Event|0|||
126657411|NCT04677179|455703792|FG006|Induction Treatment Period|Adverse Event|0|||
126657412|NCT04677179|455703793|FG007|Induction Treatment Period|Adverse Event|0|||
126657413|NCT04677179|455703794|FG008|Induction Treatment Period|Adverse Event|0|||
126657414|NCT04677179|455703795|FG009|Induction Treatment Period|Adverse Event|0|||
126657415|NCT04677179|455703786|FG000|Induction Treatment Period|Physician Decision|1|||
126657416|NCT04677179|455703787|FG001|Induction Treatment Period|Physician Decision|0|||
126657417|NCT04677179|455703788|FG002|Induction Treatment Period|Physician Decision|1|||
126657418|NCT04677179|455703789|FG003|Induction Treatment Period|Physician Decision|0|||
126657419|NCT04677179|455703790|FG004|Induction Treatment Period|Physician Decision|0|||
126657420|NCT04677179|455703791|FG005|Induction Treatment Period|Physician Decision|0|||
126657421|NCT04677179|455703792|FG006|Induction Treatment Period|Physician Decision|0|||
126657422|NCT04677179|455703793|FG007|Induction Treatment Period|Physician Decision|0|||
126657423|NCT04677179|455703794|FG008|Induction Treatment Period|Physician Decision|0|||
126657424|NCT04677179|455703795|FG009|Induction Treatment Period|Physician Decision|0|||
126657425|NCT04677179|455703786|FG000|Induction Treatment Period|Protocol Violation|0|||
126657426|NCT04677179|455703787|FG001|Induction Treatment Period|Protocol Violation|1|||
126657427|NCT04677179|455703788|FG002|Induction Treatment Period|Protocol Violation|0|||
126657428|NCT04677179|455703789|FG003|Induction Treatment Period|Protocol Violation|0|||
126657429|NCT04677179|455703790|FG004|Induction Treatment Period|Protocol Violation|0|||
126657430|NCT04677179|455703791|FG005|Induction Treatment Period|Protocol Violation|0|||
126657431|NCT04677179|455703792|FG006|Induction Treatment Period|Protocol Violation|0|||
126657432|NCT04677179|455703793|FG007|Induction Treatment Period|Protocol Violation|0|||
126657433|NCT04677179|455703794|FG008|Induction Treatment Period|Protocol Violation|0|||
126657434|NCT04677179|455703795|FG009|Induction Treatment Period|Protocol Violation|0|||
126657435|NCT04677179|455703786|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
126657436|NCT04677179|455703787|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
126657437|NCT04677179|455703788|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
126657438|NCT04677179|455703789|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
126657439|NCT04677179|455703790|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
126657440|NCT04677179|455703791|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
126657441|NCT04677179|455703792|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
126657442|NCT04677179|455703793|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
126657443|NCT04677179|455703794|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
126657444|NCT04677179|455703795|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
126657445|NCT04677179|455703786|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
126657446|NCT04677179|455703787|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
126657447|NCT04677179|455703788|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
126657448|NCT04677179|455703789|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
126657449|NCT04677179|455703790|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
126657450|NCT04677179|455703791|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
126657451|NCT04677179|455703792|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
126657452|NCT04677179|455703793|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
126657453|NCT04677179|455703794|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
126657454|NCT04677179|455703795|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
126330035|NCT04004260|454501787|FG001|Overall Study|Did not engage in intervention|17|||
126657455|NCT04677179|455703786|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
126657456|NCT04677179|455703787|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
126657457|NCT04677179|455703788|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
126657458|NCT04677179|455703789|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
126657459|NCT04677179|455703790|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
126657460|NCT04677179|455703791|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
126657461|NCT04677179|455703792|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
126657462|NCT04677179|455703793|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
126657463|NCT04677179|455703794|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
126657464|NCT04677179|455703795|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
126657465|NCT04677179|455703786|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
126657466|NCT04677179|455703787|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
126657467|NCT04677179|455703788|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
126657468|NCT04677179|455703789|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
126657469|NCT04677179|455703790|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
126657470|NCT04677179|455703791|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
126657471|NCT04677179|455703792|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
126657472|NCT04677179|455703793|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
126657473|NCT04677179|455703794|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
126657474|NCT04677179|455703795|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
126657475|NCT04677179|455703786|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
126657476|NCT04677179|455703787|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
126657477|NCT04677179|455703788|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
126657478|NCT04677179|455703789|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
126657479|NCT04677179|455703790|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
126657480|NCT04677179|455703791|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
126657481|NCT04677179|455703792|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
126657482|NCT04677179|455703793|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
126657483|NCT04677179|455703794|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
126657484|NCT04677179|455703795|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
126657485|NCT04677179|455703786|FG000|Extension Treatment Period|Lack of Efficacy|0|||
126657486|NCT04677179|455703787|FG001|Extension Treatment Period|Lack of Efficacy|0|||
126657487|NCT04677179|455703788|FG002|Extension Treatment Period|Lack of Efficacy|0|||
126657488|NCT04677179|455703789|FG003|Extension Treatment Period|Lack of Efficacy|0|||
126657489|NCT04677179|455703790|FG004|Extension Treatment Period|Lack of Efficacy|0|||
126657490|NCT04677179|455703791|FG005|Extension Treatment Period|Lack of Efficacy|0|||
126657491|NCT04677179|455703792|FG006|Extension Treatment Period|Lack of Efficacy|6|||
126657492|NCT04677179|455703793|FG007|Extension Treatment Period|Lack of Efficacy|0|||
126657493|NCT04677179|455703794|FG008|Extension Treatment Period|Lack of Efficacy|0|||
126657494|NCT04677179|455703795|FG009|Extension Treatment Period|Lack of Efficacy|0|||
126657495|NCT04677179|455703786|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
126657496|NCT04677179|455703787|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
126657497|NCT04677179|455703788|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
126657498|NCT04677179|455703789|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
126657499|NCT04677179|455703790|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
126657500|NCT04677179|455703791|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
126657501|NCT04677179|455703792|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
126657502|NCT04677179|455703793|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
126657503|NCT04677179|455703794|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
126657504|NCT04677179|455703795|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
126657505|NCT04677179|455703786|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
126657506|NCT04677179|455703787|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
126657507|NCT04677179|455703788|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
126657508|NCT04677179|455703789|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
126657509|NCT04677179|455703790|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
126657510|NCT04677179|455703791|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
126657511|NCT04677179|455703792|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
126657512|NCT04677179|455703793|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
126657513|NCT04677179|455703794|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
126657514|NCT04677179|455703795|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
126657515|NCT04677179|455703786|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
126657516|NCT04677179|455703787|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
126657517|NCT04677179|455703788|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
126657518|NCT04677179|455703789|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
126657519|NCT04677179|455703790|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
126657520|NCT04677179|455703791|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
126657521|NCT04677179|455703792|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
126657522|NCT04677179|455703793|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
126330036|NCT01765569|454501792|FG000|Period B|Withdrawal by Subject|1|||
126657523|NCT04677179|455703794|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
126657524|NCT04677179|455703795|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
126657525|NCT04677179|455703786|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126657526|NCT04677179|455703787|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126657527|NCT04677179|455703788|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126657528|NCT04677179|455703789|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126657529|NCT04677179|455703790|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126657530|NCT04677179|455703791|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126657531|NCT04677179|455703792|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126657532|NCT04677179|455703793|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
126657533|NCT04677179|455703794|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
126657534|NCT04677179|455703795|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
126657535|NCT04677179|455703786|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126657536|NCT04677179|455703787|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126657537|NCT04677179|455703788|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126657538|NCT04677179|455703789|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126657539|NCT04677179|455703790|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126657540|NCT04677179|455703791|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126657541|NCT04677179|455703792|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126657542|NCT04677179|455703793|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
126657543|NCT04677179|455703794|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126657544|NCT04677179|455703795|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126657545|NCT04677179|455703786|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126657546|NCT04677179|455703787|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126657547|NCT04677179|455703788|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126657548|NCT04677179|455703789|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126657549|NCT04677179|455703790|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126657550|NCT04677179|455703791|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126657551|NCT04677179|455703792|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126657552|NCT04677179|455703793|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
126657553|NCT04677179|455703794|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
126657554|NCT04677179|455703795|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126657555|NCT04677179|455703786|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126657556|NCT04677179|455703787|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126657557|NCT04677179|455703788|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126657558|NCT04677179|455703789|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126657559|NCT04677179|455703790|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126657560|NCT04677179|455703791|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126657561|NCT04677179|455703792|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
126657562|NCT04677179|455703793|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
126657563|NCT04677179|455703794|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
126657564|NCT04677179|455703795|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
126657565|NCT02374671|455703797|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
126657566|NCT02374671|455703798|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
126657567|NCT02374671|455703799|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
126657568|NCT02374671|455703797|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
126657569|NCT02374671|455703798|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
126657570|NCT02374671|455703799|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
126657571|NCT02374671|455703797|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
126657572|NCT02374671|455703798|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
126657573|NCT02374671|455703799|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
126657574|NCT02374671|455703797|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
126657575|NCT02374671|455703798|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
126657576|NCT02374671|455703799|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
126657577|NCT02374671|455703797|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
126657578|NCT02374671|455703798|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
126657579|NCT02374671|455703799|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
126657580|NCT03866473|455703802|FG000|Phase 1|Death|1|||
126657581|NCT03866473|455703803|FG001|Phase 1|Death|0|||
126657582|NCT03866473|455703802|FG000|Phase 2|Death|0|||
126657583|NCT03866473|455703803|FG001|Phase 2|Death|2|||
126657584|NCT03866473|455703802|FG000|Phase 2|Dropped|1|||
126657585|NCT03866473|455703803|FG001|Phase 2|Dropped|1|||
126657586|NCT03866473|455703802|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
126657587|NCT03866473|455703803|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
126657588|NCT03169101|455703805|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
126330037|NCT01765569|454501792|FG000|Period C|Death|1|||
126330038|NCT03414229|454501793|FG000|Overall Study|Adverse Event|1|||
126657589|NCT03169101|455703806|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
126657590|NCT03169101|455703807|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
126657591|NCT03169101|455703808|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
126657592|NCT02641496|455703809|FG000|Overall Study|Lost to Follow-up|13|||
126657593|NCT02641496|455703810|FG001|Overall Study|Lost to Follow-up|12|||
126657594|NCT02641496|455703809|FG000|Overall Study|Withdrawal by Subject|1|||
126657595|NCT02641496|455703810|FG001|Overall Study|Withdrawal by Subject|0|||
126657596|NCT00600886|455703813|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
126657597|NCT00600886|455703814|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
126657598|NCT00600886|455703813|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
126657599|NCT00600886|455703814|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
126657600|NCT00600886|455703813|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
126657601|NCT00600886|455703814|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
126657602|NCT00600886|455703813|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
126657603|NCT00600886|455703814|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
126657604|NCT00600886|455703813|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
126657605|NCT00600886|455703814|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
126657606|NCT00600886|455703813|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
126657607|NCT00600886|455703814|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
126657608|NCT00600886|455703813|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
126657609|NCT00600886|455703814|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
126657610|NCT00600886|455703813|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
126657611|NCT00600886|455703814|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
126657612|NCT00600886|455703813|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
126657613|NCT00600886|455703814|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
126657614|NCT00600886|455703813|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
126657615|NCT00600886|455703814|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
126657616|NCT00600886|455703813|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
126657617|NCT00600886|455703814|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
126657618|NCT00600886|455703813|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
126657619|NCT00600886|455703814|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
126657620|NCT00600886|455703813|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
126657621|NCT00600886|455703814|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
126657622|NCT00600886|455703813|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
126657623|NCT00600886|455703814|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
126657624|NCT00600886|455703813|FG000|Extension - Same Treatment (FAS)|Death|1|||
126657625|NCT00600886|455703814|FG001|Extension - Same Treatment (FAS)|Death|1|||
126657626|NCT00600886|455703813|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
126657627|NCT00600886|455703814|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
126657628|NCT00600886|455703813|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
126657629|NCT00600886|455703814|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
126657630|NCT00600886|455703813|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
126657631|NCT00600886|455703814|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
126657632|NCT00600886|455703813|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
126657633|NCT00600886|455703814|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
126657634|NCT00600886|455703813|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
126657635|NCT00600886|455703814|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
126657636|NCT00600886|455703813|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
126657637|NCT00600886|455703814|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
126657638|NCT00600886|455703813|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
126657639|NCT00600886|455703814|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
126657640|NCT00600886|455703813|FG000|Extension - After Crossover (CAS)|Death|1|||
126657641|NCT00600886|455703814|FG001|Extension - After Crossover (CAS)|Death|0|||
126657642|NCT03075410|455703815|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
126657643|NCT03075410|455703816|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
126657644|NCT03075410|455703817|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
126657645|NCT03075410|455703818|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
126657646|NCT03075410|455703819|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
126657647|NCT03075410|455703820|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
126657648|NCT03075410|455703821|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
126657649|NCT03075410|455703822|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
126657650|NCT03075410|455703823|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
126657651|NCT03075410|455703815|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
126657652|NCT03075410|455703816|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126657653|NCT03075410|455703817|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126657654|NCT03075410|455703818|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126330039|NCT03414229|454501794|FG001|Overall Study|Adverse Event|0|||
126657655|NCT03075410|455703819|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126657656|NCT03075410|455703820|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126657657|NCT03075410|455703821|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126657658|NCT03075410|455703822|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126657659|NCT03075410|455703823|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
126657660|NCT02523599|455703824|FG000|Overall Study|Adverse Event|1|||
126657661|NCT02523599|455703825|FG001|Overall Study|Adverse Event|0|||
126657662|NCT02523599|455703824|FG000|Overall Study|Physician Decision|1|||
126657663|NCT02523599|455703825|FG001|Overall Study|Physician Decision|0|||
126657664|NCT02523599|455703824|FG000|Overall Study|Lost to Follow-up|4|||
126657665|NCT02523599|455703825|FG001|Overall Study|Lost to Follow-up|1|||
126657666|NCT02523599|455703824|FG000|Overall Study|Did not return for Day 30 visit|2|||
126657667|NCT02523599|455703825|FG001|Overall Study|Did not return for Day 30 visit|0|||
126657668|NCT01427751|455703826|FG000|Overall Study|Adverse Event|18|||
126657669|NCT01427751|455703827|FG001|Overall Study|Adverse Event|2|||
126657670|NCT01427751|455703826|FG000|Overall Study|No further treatment benefit expected|5|||
126657671|NCT01427751|455703827|FG001|Overall Study|No further treatment benefit expected|1|||
126657672|NCT01427751|455703826|FG000|Overall Study|Lost to Follow-up|3|||
126657673|NCT01427751|455703827|FG001|Overall Study|Lost to Follow-up|1|||
126657674|NCT01427751|455703826|FG000|Overall Study|Withdrawal of consent|2|||
126657675|NCT01427751|455703827|FG001|Overall Study|Withdrawal of consent|2|||
126657676|NCT01427751|455703826|FG000|Overall Study|Protocol Violation|6|||
126657677|NCT01427751|455703827|FG001|Overall Study|Protocol Violation|4|||
126657678|NCT01427751|455703826|FG000|Overall Study|Death|2|||
126657679|NCT01427751|455703827|FG001|Overall Study|Death|0|||
126657680|NCT01427751|455703826|FG000|Overall Study|Other miscellaneous reasons|6|||
126657681|NCT01427751|455703827|FG001|Overall Study|Other miscellaneous reasons|4|||
126657682|NCT03319849|455703831|FG000|Overall Study|Adverse Event|1|||
126657683|NCT03319849|455703832|FG001|Overall Study|Adverse Event|0|||
126657684|NCT03319849|455703831|FG000|Overall Study|Physician Decision|0|||
126657685|NCT03319849|455703832|FG001|Overall Study|Physician Decision|1|||
126657686|NCT03319849|455703831|FG000|Overall Study|Withdrawal by Subject|0|||
126657687|NCT03319849|455703832|FG001|Overall Study|Withdrawal by Subject|1|||
126657688|NCT03319849|455703831|FG000|Overall Study|COVID-19|0|||
126657689|NCT03319849|455703832|FG001|Overall Study|COVID-19|1|||
126657690|NCT03319849|455703831|FG000|Overall Study|Other|1|||
126657691|NCT03319849|455703832|FG001|Overall Study|Other|2|||
126657692|NCT03319849|455703831|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
126657693|NCT03319849|455703832|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
126657694|NCT03319849|455703831|FG000|Overall Study|Lost to Follow-up|0|||
126657695|NCT03319849|455703832|FG001|Overall Study|Lost to Follow-up|2|||
126657696|NCT01036763|455705544|FG000|Overall Study|Adverse Event|25|||
126657697|NCT01036763|455705544|FG000|Overall Study|Lost to Follow-up|28|||
126657698|NCT01036763|455705544|FG000|Overall Study|Other reason (not specified)|40|||
126657699|NCT01672723|455705545|FG000|First Intervention|Adverse Event|3|||
126657700|NCT01672723|455705546|FG001|First Intervention|Adverse Event|0|||
126657701|NCT00743275|455705547|FG000|Overall Study|Protocol Violation|0|||
126657702|NCT00743275|455705548|FG001|Overall Study|Protocol Violation|1|||
126657703|NCT03938545|455705552|FG000|Overall Study|Lost to Follow-up|0|||
126657704|NCT03938545|455705553|FG001|Overall Study|Lost to Follow-up|0|||
126657705|NCT03938545|455705554|FG002|Overall Study|Lost to Follow-up|0|||
126657706|NCT03938545|455705555|FG003|Overall Study|Lost to Follow-up|1|||
126657707|NCT03938545|455705552|FG000|Overall Study|Non-compliance with study drug|0|||
126657708|NCT03938545|455705553|FG001|Overall Study|Non-compliance with study drug|0|||
126657709|NCT03938545|455705554|FG002|Overall Study|Non-compliance with study drug|1|||
126657710|NCT03938545|455705555|FG003|Overall Study|Non-compliance with study drug|0|||
126657711|NCT03938545|455705552|FG000|Overall Study|Pregnancy|1|||
126330040|NCT03414229|454501795|FG002|Overall Study|Adverse Event|2|||
126330041|NCT03414229|454501796|FG003|Overall Study|Adverse Event|1|||
126330042|NCT03414229|454501793|FG000|Overall Study|Lack of Efficacy|7|||
126330043|NCT03414229|454501794|FG001|Overall Study|Lack of Efficacy|4|||
126330044|NCT03414229|454501795|FG002|Overall Study|Lack of Efficacy|1|||
126330045|NCT03414229|454501796|FG003|Overall Study|Lack of Efficacy|9|||
126330046|NCT03414229|454501793|FG000|Overall Study|Change in therapy|1|||
126330047|NCT03414229|454501794|FG001|Overall Study|Change in therapy|0|||
126330048|NCT03414229|454501795|FG002|Overall Study|Change in therapy|0|||
126657712|NCT03938545|455705553|FG001|Overall Study|Pregnancy|0|||
126657713|NCT03938545|455705554|FG002|Overall Study|Pregnancy|0|||
126657714|NCT03938545|455705555|FG003|Overall Study|Pregnancy|0|||
126657715|NCT03938545|455705552|FG000|Overall Study|Study terminated by sponsor|6|||
126657716|NCT03938545|455705553|FG001|Overall Study|Study terminated by sponsor|4|||
126657717|NCT03938545|455705554|FG002|Overall Study|Study terminated by sponsor|2|||
126657718|NCT03938545|455705555|FG003|Overall Study|Study terminated by sponsor|4|||
126657719|NCT03938545|455705552|FG000|Overall Study|Withdrawal by Subject|0|||
126657720|NCT03938545|455705553|FG001|Overall Study|Withdrawal by Subject|1|||
126330049|NCT03414229|454501796|FG003|Overall Study|Change in therapy|0|||
126330050|NCT03414229|454501793|FG000|Overall Study|Pregnancy|0|||
126657721|NCT03938545|455705554|FG002|Overall Study|Withdrawal by Subject|0|||
126657722|NCT03938545|455705555|FG003|Overall Study|Withdrawal by Subject|0|||
126657723|NCT03938545|455705552|FG000|Overall Study|Adverse Event|1|||
126657724|NCT03938545|455705553|FG001|Overall Study|Adverse Event|0|||
126657725|NCT03938545|455705554|FG002|Overall Study|Adverse Event|0|||
126657726|NCT03938545|455705555|FG003|Overall Study|Adverse Event|0|||
126657727|NCT01060540|455705556|FG000|Overall Study|Withdrawal by Subject|10|||
126657728|NCT01060540|455705557|FG001|Overall Study|Withdrawal by Subject|20|||
126657729|NCT01060540|455705556|FG000|Overall Study|Lost to Follow-up|52|||
126657730|NCT01060540|455705557|FG001|Overall Study|Lost to Follow-up|43|||
126657731|NCT01060540|455705556|FG000|Overall Study|Death|2|||
126657732|NCT01060540|455705557|FG001|Overall Study|Death|1|||
126657733|NCT01060540|455705556|FG000|Overall Study|Physician Decision|0|||
126657734|NCT01060540|455705557|FG001|Overall Study|Physician Decision|1|||
126657735|NCT02502097|455705562|FG000|Period 1|Adverse Event|0|||
126657736|NCT02502097|455705563|FG001|Period 1|Adverse Event|0|||
126657737|NCT02502097|455705564|FG002|Period 1|Adverse Event|1|||
126657738|NCT02502097|455705565|FG003|Period 1|Adverse Event|0|||
126657739|NCT02502097|455705562|FG000|Wash Out Period|Adverse Event|0|||
126657740|NCT02502097|455705563|FG001|Wash Out Period|Adverse Event|1|||
126657741|NCT02502097|455705564|FG002|Wash Out Period|Adverse Event|1|||
126657742|NCT02502097|455705565|FG003|Wash Out Period|Adverse Event|1|||
126657743|NCT02502097|455705562|FG000|Period 2|Adverse Event|0|||
126657744|NCT02502097|455705563|FG001|Period 2|Adverse Event|0|||
126657745|NCT02502097|455705564|FG002|Period 2|Adverse Event|1|||
126657746|NCT02502097|455705565|FG003|Period 2|Adverse Event|0|||
126657747|NCT01201317|455705566|FG000|Overall Study|Withdrawal by Subject|5|||
126657748|NCT01201317|455705567|FG001|Overall Study|Withdrawal by Subject|0|||
126657749|NCT01201317|455705568|FG002|Overall Study|Withdrawal by Subject|3|||
126657750|NCT01201317|455705566|FG000|Overall Study|Adverse Event|2|||
126657751|NCT01201317|455705567|FG001|Overall Study|Adverse Event|2|||
126657752|NCT01201317|455705568|FG002|Overall Study|Adverse Event|2|||
126657753|NCT01201317|455705566|FG000|Overall Study|Screen failure|1|||
126657754|NCT01201317|455705567|FG001|Overall Study|Screen failure|1|||
126657755|NCT01201317|455705568|FG002|Overall Study|Screen failure|0|||
126657756|NCT01201317|455705566|FG000|Overall Study|Protocol Violation|0|||
126657757|NCT01201317|455705567|FG001|Overall Study|Protocol Violation|1|||
126657758|NCT01201317|455705568|FG002|Overall Study|Protocol Violation|1|||
126657759|NCT01201317|455705566|FG000|Overall Study|Death|0|||
126657760|NCT01201317|455705567|FG001|Overall Study|Death|1|||
126657761|NCT01201317|455705568|FG002|Overall Study|Death|0|||
126657762|NCT01201317|455705566|FG000|Overall Study|Study-specific withdrawal criteria|0|||
126657763|NCT01201317|455705567|FG001|Overall Study|Study-specific withdrawal criteria|0|||
126657764|NCT01201317|455705568|FG002|Overall Study|Study-specific withdrawal criteria|1|||
126657765|NCT01201317|455705566|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
126657766|NCT01201317|455705567|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
126657767|NCT01201317|455705568|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
126657768|NCT01201317|455705566|FG000|Overall Study|Decrease in renal function|0|||
126657769|NCT01201317|455705567|FG001|Overall Study|Decrease in renal function|1|||
126657770|NCT01201317|455705568|FG002|Overall Study|Decrease in renal function|0|||
126657771|NCT01201317|455705566|FG000|Overall Study|Lack of Efficacy|1|||
126657772|NCT01201317|455705567|FG001|Overall Study|Lack of Efficacy|0|||
126657773|NCT01201317|455705568|FG002|Overall Study|Lack of Efficacy|0|||
126657774|NCT01201317|455705566|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
126657775|NCT01201317|455705567|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
126657776|NCT01201317|455705568|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
126657777|NCT01491672|455705569|FG000|Overall Study|Lost to Follow-up|0|||
126657778|NCT01491672|455705570|FG001|Overall Study|Lost to Follow-up|4|||
126657779|NCT01491672|455705571|FG002|Overall Study|Lost to Follow-up|1|||
126657780|NCT01491672|455705569|FG000|Overall Study|Withdrawal by Subject|6|||
126657781|NCT01491672|455705570|FG001|Overall Study|Withdrawal by Subject|7|||
126657782|NCT01491672|455705571|FG002|Overall Study|Withdrawal by Subject|0|||
126657783|NCT01491672|455705569|FG000|Overall Study|Adverse Event|8|||
126657784|NCT01491672|455705570|FG001|Overall Study|Adverse Event|10|||
126657785|NCT01491672|455705571|FG002|Overall Study|Adverse Event|4|||
126657786|NCT01491672|455705569|FG000|Overall Study|Disease progression|42|||
126657787|NCT01491672|455705570|FG001|Overall Study|Disease progression|34|||
126657788|NCT01491672|455705571|FG002|Overall Study|Disease progression|6|||
126657789|NCT01491672|455705569|FG000|Overall Study|Protocol deviation|0|||
126657790|NCT01491672|455705570|FG001|Overall Study|Protocol deviation|1|||
126657791|NCT01491672|455705571|FG002|Overall Study|Protocol deviation|0|||
126657792|NCT01491672|455705569|FG000|Overall Study|Death|0|||
126657793|NCT01491672|455705570|FG001|Overall Study|Death|4|||
126657794|NCT01491672|455705571|FG002|Overall Study|Death|0|||
126657795|NCT03310268|455705572|FG000|Overall Study|(Not specified)|1|||
126657796|NCT03310268|455705573|FG001|Overall Study|(Not specified)|5|||
126657797|NCT03310268|455705574|FG002|Overall Study|(Not specified)|0|||
126657798|NCT00706433|455705577|FG000|Overall Study|Lost to Follow-up|3|||
126657799|NCT00706433|455705578|FG001|Overall Study|Lost to Follow-up|1|||
126657800|NCT00706433|455705579|FG002|Overall Study|Lost to Follow-up|6|||
126330051|NCT03414229|454501794|FG001|Overall Study|Pregnancy|0|||
126330052|NCT03414229|454501795|FG002|Overall Study|Pregnancy|1|||
126330053|NCT03414229|454501796|FG003|Overall Study|Pregnancy|0|||
126330054|NCT03414229|454501793|FG000|Overall Study|Withdrawal by Subject|0|||
126330055|NCT03414229|454501794|FG001|Overall Study|Withdrawal by Subject|1|||
126330056|NCT03414229|454501795|FG002|Overall Study|Withdrawal by Subject|1|||
126330057|NCT03414229|454501796|FG003|Overall Study|Withdrawal by Subject|0|||
126330058|NCT04533438|454501800|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
126330059|NCT04533438|454501801|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
126330060|NCT05568797|454501805|FG000|Overall Study|Adverse Event|0|||
126330061|NCT05568797|454501806|FG001|Overall Study|Adverse Event|8|||
126330062|NCT05568797|454501805|FG000|Overall Study|Lost to Follow-up|2|||
126330063|NCT05568797|454501806|FG001|Overall Study|Lost to Follow-up|3|||
126330064|NCT05568797|454501805|FG000|Overall Study|Withdrawal by Subject|1|||
126545200|NCT02613221|455289240|FG000|Overall Study|Enrolled but Not Treated|1|||
126545201|NCT00399763|455289243|FG000|Overall Study|Lost to Follow-up|2|||
126545202|NCT00399763|455289244|FG001|Overall Study|Lost to Follow-up|3|||
126545203|NCT01657266|455289248|FG000|Overall Study|Lost to Follow-up|2|||
126545204|NCT01657266|455289249|FG001|Overall Study|Lost to Follow-up|2|||
126545205|NCT01657266|455289248|FG000|Overall Study|Adverse Event|2|||
126545206|NCT01657266|455289249|FG001|Overall Study|Adverse Event|3|||
126545207|NCT02234063|455289252|FG000|Overall Study|Lost to Follow-up|235|||
126545208|NCT02234063|455289253|FG001|Overall Study|Lost to Follow-up|42|||
126545209|NCT02234063|455289252|FG000|Overall Study|Withdrawal by Subject|20|||
126545210|NCT02234063|455289253|FG001|Overall Study|Withdrawal by Subject|1|||
126545211|NCT02946918|455289254|FG000|Overall Study|Patient unblinded himself|1|||
126545212|NCT02946918|455289255|FG001|Overall Study|Patient unblinded himself|0|||
126545213|NCT02946918|455289254|FG000|Overall Study|Physician Decision|0|||
126545214|NCT02946918|455289255|FG001|Overall Study|Physician Decision|2|||
126545215|NCT02946918|455289254|FG000|Overall Study|Ran out of study medication|0|||
126545216|NCT02946918|455289255|FG001|Overall Study|Ran out of study medication|1|||
126545217|NCT01125722|455289256|FG000|Overall Study|Withdrawal by Subject|2|||
126545218|NCT01125722|455289257|FG001|Overall Study|Withdrawal by Subject|1|||
126545219|NCT01125722|455289256|FG000|Overall Study|Lost to Follow-up|1|||
126545220|NCT01125722|455289257|FG001|Overall Study|Lost to Follow-up|0|||
126545221|NCT00069784|455289258|FG000|Overall Study|Adverse Event|105|||
126545222|NCT00069784|455289259|FG001|Overall Study|Adverse Event|0|||
126545223|NCT00069784|455289258|FG000|Overall Study|Withdrawal by Subject|1090|||
126545224|NCT00069784|455289259|FG001|Overall Study|Withdrawal by Subject|0|||
126545225|NCT00069784|455289258|FG000|Overall Study|Other|17|||
126545226|NCT00069784|455289259|FG001|Overall Study|Other|0|||
126545227|NCT05648357|455290763|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
126545228|NCT00255346|455290764|FG000|Overall Study|Adverse Event|1|||
126545229|NCT00255346|455290765|FG001|Overall Study|Adverse Event|0|||
126545230|NCT00255346|455290766|FG002|Overall Study|Adverse Event|0|||
126545231|NCT00255346|455290767|FG003|Overall Study|Adverse Event|0|||
126545232|NCT00255346|455290768|FG004|Overall Study|Adverse Event|0|||
126545233|NCT00409786|455290769|FG000|Overall Study|Withdrawal by Subject|3|||
126545234|NCT01077362|455290775|FG000|Overall Study|Lack of Efficacy|13|||
126545235|NCT01077362|455290776|FG001|Overall Study|Lack of Efficacy|8|||
126545236|NCT01077362|455290777|FG002|Overall Study|Lack of Efficacy|10|||
126545237|NCT01077362|455290775|FG000|Overall Study|Lost to Follow-up|1|||
126545238|NCT01077362|455290776|FG001|Overall Study|Lost to Follow-up|0|||
126545239|NCT01077362|455290777|FG002|Overall Study|Lost to Follow-up|3|||
126545240|NCT01077362|455290775|FG000|Overall Study|Adverse Event|12|||
126545241|NCT01077362|455290776|FG001|Overall Study|Adverse Event|7|||
126545242|NCT01077362|455290777|FG002|Overall Study|Adverse Event|4|||
126545243|NCT01077362|455290775|FG000|Overall Study|Withdrawal by Subject|5|||
126545244|NCT01077362|455290776|FG001|Overall Study|Withdrawal by Subject|3|||
126545245|NCT01077362|455290777|FG002|Overall Study|Withdrawal by Subject|5|||
126545246|NCT01077362|455290775|FG000|Overall Study|Other|0|||
126545247|NCT01077362|455290776|FG001|Overall Study|Other|1|||
126545248|NCT01077362|455290777|FG002|Overall Study|Other|2|||
126545249|NCT00301080|455290778|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
126545250|NCT00301080|455290779|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
126545251|NCT00301080|455290780|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
126545252|NCT00301080|455290781|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
126545253|NCT00301080|455290782|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
126545254|NCT01641926|455290783|FG000|Overall Study|Adverse Event|5|||
126545255|NCT01641926|455290784|FG001|Overall Study|Adverse Event|2|||
126545256|NCT01641926|455290785|FG002|Overall Study|Adverse Event|3|||
126545257|NCT01641926|455290786|FG003|Overall Study|Adverse Event|1|||
126545258|NCT01641926|455290783|FG000|Overall Study|Lost to Follow-up|2|||
126545259|NCT01641926|455290784|FG001|Overall Study|Lost to Follow-up|2|||
126545260|NCT01641926|455290785|FG002|Overall Study|Lost to Follow-up|1|||
126545261|NCT01641926|455290786|FG003|Overall Study|Lost to Follow-up|0|||
126545262|NCT01641926|455290783|FG000|Overall Study|Physician Decision|6|||
126545263|NCT01641926|455290784|FG001|Overall Study|Physician Decision|5|||
126657801|NCT00706433|455705580|FG003|Overall Study|Lost to Follow-up|0|||
126657802|NCT00706433|455705577|FG000|Overall Study|Withdrawal by Subject|1|||
126657803|NCT00706433|455705578|FG001|Overall Study|Withdrawal by Subject|2|||
126657804|NCT00706433|455705579|FG002|Overall Study|Withdrawal by Subject|3|||
126657805|NCT00706433|455705580|FG003|Overall Study|Withdrawal by Subject|1|||
126657806|NCT00706433|455705577|FG000|Overall Study|Adverse Event|0|||
126657807|NCT00706433|455705578|FG001|Overall Study|Adverse Event|0|||
126657808|NCT00706433|455705579|FG002|Overall Study|Adverse Event|1|||
126657809|NCT00706433|455705580|FG003|Overall Study|Adverse Event|0|||
126657810|NCT00706433|455705577|FG000|Overall Study|Protocol Violation|1|||
126657811|NCT00706433|455705578|FG001|Overall Study|Protocol Violation|0|||
126657812|NCT00706433|455705579|FG002|Overall Study|Protocol Violation|0|||
126657813|NCT00706433|455705580|FG003|Overall Study|Protocol Violation|0|||
126657814|NCT00706433|455705577|FG000|Overall Study|new job|0|||
126657815|NCT00706433|455705578|FG001|Overall Study|new job|0|||
126657816|NCT00706433|455705579|FG002|Overall Study|new job|0|||
126657817|NCT00706433|455705580|FG003|Overall Study|new job|1|||
126657818|NCT01236365|455705581|FG000|Overall Study|Lost to Follow-up|0|||
126657819|NCT01236365|455705582|FG001|Overall Study|Lost to Follow-up|2|||
126657820|NCT01236365|455705581|FG000|Overall Study|Moved Out of State|1|||
126657821|NCT01236365|455705582|FG001|Overall Study|Moved Out of State|0|||
126657822|NCT01236365|455705581|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
126657823|NCT01236365|455705582|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
126657824|NCT00717067|455705583|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
126657825|NCT00717067|455705584|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
126657826|NCT00717067|455705585|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
126657827|NCT00717067|455705586|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
126657828|NCT00717067|455705587|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
126657829|NCT01689337|455705588|FG000|Overall Study|Study Discontinuation|1|||
126657830|NCT02572882|455705589|FG000|Overall Study|Withdrawal by Subject|1|||
126657831|NCT02572882|455705589|FG000|Overall Study|Participant received kidney transplant|1|||
126657832|NCT01590017|455705590|FG000|Overall Study|Adverse Event|1|||
126657833|NCT01590017|455705590|FG000|Overall Study|Withdrawal by Subject|1|||
126657834|NCT01590017|455705590|FG000|Overall Study|Lack of Efficacy|1|||
126657835|NCT01590017|455705590|FG000|Overall Study|Physician Decision|1|||
126657836|NCT00440999|455705593|FG000|Overall Study|Adverse Event|0|||
126657837|NCT00440999|455705594|FG001|Overall Study|Adverse Event|2|||
126657838|NCT00440999|455705593|FG000|Overall Study|Lack of Efficacy|6|||
126657839|NCT00440999|455705594|FG001|Overall Study|Lack of Efficacy|7|||
126657840|NCT00440999|455705593|FG000|Overall Study|Lost to Follow-up|19|||
126657841|NCT00440999|455705594|FG001|Overall Study|Lost to Follow-up|12|||
126657842|NCT00440999|455705593|FG000|Overall Study|Protocol Violation|1|||
126657843|NCT00440999|455705594|FG001|Overall Study|Protocol Violation|0|||
126657844|NCT00440999|455705593|FG000|Overall Study|Withdrawal by Subject|2|||
126657845|NCT00440999|455705594|FG001|Overall Study|Withdrawal by Subject|5|||
126657846|NCT00440999|455705593|FG000|Overall Study|Subjets missed the visit|1|||
126657847|NCT00440999|455705594|FG001|Overall Study|Subjets missed the visit|0|||
126657848|NCT00440999|455705593|FG000|Overall Study|Mixed infection at entry|1|||
126657849|NCT00440999|455705594|FG001|Overall Study|Mixed infection at entry|0|||
126657850|NCT00440999|455705593|FG000|Overall Study|P. falciparum malaria|5|||
126657851|NCT00440999|455705594|FG001|Overall Study|P. falciparum malaria|14|||
126657852|NCT00440999|455705593|FG000|Overall Study|Subj left hosp without inform staff|0|||
126657853|NCT00440999|455705594|FG001|Overall Study|Subj left hosp without inform staff|1|||
126657854|NCT04745026|455705597|FG000|Overall Study|Physician Decision|1|||
126657855|NCT04745026|455705598|FG001|Overall Study|Physician Decision|0|||
126657856|NCT04745026|455705597|FG000|Overall Study|Adverse Event|2|||
126657857|NCT04745026|455705598|FG001|Overall Study|Adverse Event|2|||
126657858|NCT04745026|455705597|FG000|Overall Study|Protocol Violation|1|||
126657859|NCT04745026|455705598|FG001|Overall Study|Protocol Violation|3|||
126657860|NCT04745026|455705597|FG000|Overall Study|Lost to Follow-up|4|||
126657861|NCT04745026|455705598|FG001|Overall Study|Lost to Follow-up|3|||
126657862|NCT04745026|455705597|FG000|Overall Study|Withdrawal by Subject|5|||
126657863|NCT04745026|455705598|FG001|Overall Study|Withdrawal by Subject|5|||
126657864|NCT05041101|455705599|FG000|Overall Study|Adverse Event|1|||
126657865|NCT05041101|455705600|FG001|Overall Study|Adverse Event|0|||
126657866|NCT05041101|455705601|FG002|Overall Study|Adverse Event|0|||
126657867|NCT05041101|455705599|FG000|Overall Study|Diease Progression|5|||
126657868|NCT05041101|455705600|FG001|Overall Study|Diease Progression|0|||
126657869|NCT05041101|455705601|FG002|Overall Study|Diease Progression|0|||
126657870|NCT04426851|455705602|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
126330065|NCT05568797|454501806|FG001|Overall Study|Withdrawal by Subject|10|||
126657871|NCT04426851|455705603|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
126657872|NCT04426851|455705602|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
126657873|NCT04426851|455705603|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
126657874|NCT03256851|455705604|FG000|Overall Study|Withdrawal by Subject|1|||
126657875|NCT03256851|455705605|FG001|Overall Study|Withdrawal by Subject|0|||
126657876|NCT00986674|455705606|FG000|Overall Study|Lack of Efficacy|28|||
126657877|NCT00986674|455705607|FG001|Overall Study|Lack of Efficacy|25|||
126657878|NCT00986674|455705608|FG002|Overall Study|Lack of Efficacy|23|||
126657879|NCT00986674|455705606|FG000|Overall Study|Adverse Event|4|||
126657880|NCT00986674|455705607|FG001|Overall Study|Adverse Event|8|||
126657881|NCT00986674|455705608|FG002|Overall Study|Adverse Event|9|||
126657882|NCT00986674|455705606|FG000|Overall Study|Death|5|||
126657883|NCT00986674|455705607|FG001|Overall Study|Death|0|||
126657884|NCT00986674|455705608|FG002|Overall Study|Death|4|||
126657885|NCT00986674|455705606|FG000|Overall Study|Withdrawal by Subject|6|||
126657886|NCT00986674|455705607|FG001|Overall Study|Withdrawal by Subject|2|||
126657887|NCT00986674|455705608|FG002|Overall Study|Withdrawal by Subject|1|||
126657888|NCT00986674|455705606|FG000|Overall Study|alternative therapy|0|||
126657889|NCT00986674|455705607|FG001|Overall Study|alternative therapy|0|||
126657890|NCT00986674|455705608|FG002|Overall Study|alternative therapy|1|||
126657891|NCT00986674|455705606|FG000|Overall Study|not start protocol therapy|4|||
126657892|NCT00986674|455705607|FG001|Overall Study|not start protocol therapy|3|||
126657893|NCT00986674|455705608|FG002|Overall Study|not start protocol therapy|1|||
126657894|NCT00986674|455705606|FG000|Overall Study|unknown/not specify|0|||
126657895|NCT00986674|455705607|FG001|Overall Study|unknown/not specify|7|||
126657896|NCT00986674|455705608|FG002|Overall Study|unknown/not specify|9|||
126657897|NCT02128542|455705609|FG000|Overall Study|Lost to Follow-up|3|||
126657898|NCT02128542|455705610|FG001|Overall Study|Lost to Follow-up|0|||
126657899|NCT02128542|455705609|FG000|Overall Study|Withdrew Consent|1|||
126330066|NCT05568797|454501805|FG000|Overall Study|Other|2|||
126657900|NCT02128542|455705610|FG001|Overall Study|Withdrew Consent|0|||
126657901|NCT01853137|455705611|FG000|Overall Study|Lost to Follow-up|4|||
126657902|NCT01853137|455705612|FG001|Overall Study|Lost to Follow-up|1|||
126657903|NCT00825916|455705613|FG000|Overall Study|Lost to Follow-up|4|||
126657904|NCT00825916|455705614|FG001|Overall Study|Lost to Follow-up|2|||
126657905|NCT00825916|455705615|FG002|Overall Study|Lost to Follow-up|1|||
126657906|NCT01990560|455705616|FG000|Overall Study|Withdrawal by Subject|1|||
126657907|NCT01778023|455705617|FG000|Overall Study|Withdrawal by Subject|0|||
126657908|NCT01778023|455705618|FG001|Overall Study|Withdrawal by Subject|3|||
126657909|NCT01098097|455705619|FG000|Overall Study|Adverse Event|17|||
126657910|NCT01098097|455705619|FG000|Overall Study|Lost to Follow-up|18|||
126657911|NCT01098097|455705619|FG000|Overall Study|Status unknown|16|||
126657912|NCT01098097|455705619|FG000|Overall Study|No reason reported|31|||
126657913|NCT01411215|455705620|FG000|Overall Study|Adverse Event|1|||
126657914|NCT01411215|455705621|FG001|Overall Study|Adverse Event|2|||
126657915|NCT01411215|455705620|FG000|Overall Study|Lack of Efficacy|2|||
126657916|NCT01411215|455705621|FG001|Overall Study|Lack of Efficacy|4|||
126657917|NCT01411215|455705620|FG000|Overall Study|Lost to Follow-up|12|||
126657918|NCT01411215|455705621|FG001|Overall Study|Lost to Follow-up|18|||
126657919|NCT01411215|455705620|FG000|Overall Study|Did not meet entrance criteria|0|||
126657920|NCT01411215|455705621|FG001|Overall Study|Did not meet entrance criteria|1|||
126657921|NCT01411215|455705620|FG000|Overall Study|Study terminated by sponsor|2|||
126657922|NCT01411215|455705621|FG001|Overall Study|Study terminated by sponsor|15|||
126657923|NCT01411215|455705620|FG000|Overall Study|Protocol Violation|3|||
126657924|NCT01411215|455705621|FG001|Overall Study|Protocol Violation|5|||
126657925|NCT01411215|455705620|FG000|Overall Study|Withdrawal by Subject|34|||
126657926|NCT01411215|455705621|FG001|Overall Study|Withdrawal by Subject|21|||
126657927|NCT01411215|455705620|FG000|Overall Study|Other|12|||
126657928|NCT01411215|455705621|FG001|Overall Study|Other|17|||
126657929|NCT01411215|455705620|FG000|Overall Study|Screen failure|0|||
126657930|NCT01411215|455705621|FG001|Overall Study|Screen failure|1|||
126657931|NCT00848926|455705622|FG000|Treatment Period|Progressive disease|45|||
126657932|NCT00848926|455705622|FG000|Treatment Period|Adverse Event|20|||
126657933|NCT00848926|455705622|FG000|Treatment Period|Physician Decision|12|||
126657934|NCT00848926|455705622|FG000|Treatment Period|Withdrawal by Subject|7|||
126657935|NCT00848926|455705622|FG000|Follow-up Period|Lost to Follow-up|7|||
126657936|NCT00848926|455705622|FG000|Follow-up Period|Withdrawal by Subject|3|||
126657937|NCT00848926|455705622|FG000|Follow-up Period|Other|2|||
126657938|NCT04507126|455705625|FG000|Overall Study|Withdrawal by Subject|1|||
126657939|NCT04507126|455705625|FG000|Overall Study|Protocol Violation|2|||
126657940|NCT04507126|455705625|FG000|Overall Study|Physician Decision|1|||
126657941|NCT02924064|455705626|FG000|Overall Study|Adverse Event|2|||
126657942|NCT02924064|455705627|FG001|Overall Study|Adverse Event|2|||
126657943|NCT02924064|455705626|FG000|Overall Study|Lost to Follow-up|0|||
126657944|NCT02924064|455705627|FG001|Overall Study|Lost to Follow-up|2|||
126657945|NCT02924064|455705626|FG000|Overall Study|Physician Decision|0|||
126657946|NCT02924064|455705627|FG001|Overall Study|Physician Decision|2|||
126657947|NCT02924064|455705626|FG000|Overall Study|Protocol Violation|1|||
126657948|NCT02924064|455705627|FG001|Overall Study|Protocol Violation|3|||
126657949|NCT02924064|455705626|FG000|Overall Study|Withdrawal by Subject|4|||
126657950|NCT02924064|455705627|FG001|Overall Study|Withdrawal by Subject|5|||
126657951|NCT02924064|455705626|FG000|Overall Study|Other|17|||
126657952|NCT02924064|455705627|FG001|Overall Study|Other|29|||
126657953|NCT00966277|455705630|FG000|Overall Study|Withdrawal by Subject|3|||
126657954|NCT00966277|455705631|FG001|Overall Study|Withdrawal by Subject|0|||
126657955|NCT00966277|455705630|FG000|Overall Study|Ineligible|1|||
126657956|NCT00966277|455705631|FG001|Overall Study|Ineligible|3|||
126657957|NCT00966277|455705630|FG000|Overall Study|Treatment Plan Changed|0|||
126657958|NCT00966277|455705631|FG001|Overall Study|Treatment Plan Changed|1|||
126657959|NCT00138671|455705632|FG000|Overall Study|Death|0|||
126657960|NCT00138671|455705633|FG001|Overall Study|Death|3|||
126657961|NCT00138671|455705632|FG000|Overall Study|Adverse Event|6|||
126657962|NCT00138671|455705633|FG001|Overall Study|Adverse Event|3|||
126657963|NCT00138671|455705632|FG000|Overall Study|Lost to Follow-up|1|||
126657964|NCT00138671|455705633|FG001|Overall Study|Lost to Follow-up|2|||
126657965|NCT00138671|455705632|FG000|Overall Study|Withdrawal by Subject|3|||
126657966|NCT00138671|455705633|FG001|Overall Study|Withdrawal by Subject|5|||
126657967|NCT00138671|455705632|FG000|Overall Study|Other|3|||
126657968|NCT00138671|455705633|FG001|Overall Study|Other|3|||
126657969|NCT01488487|455705634|FG000|Overall Study|Adverse Event|6|||
126657970|NCT01488487|455705634|FG000|Overall Study|Death|1|||
126657971|NCT01488487|455705634|FG000|Overall Study|Withdrawal by Subject|2|||
126657972|NCT01100034|455705635|FG000|Overall Study|Lost to Follow-up|11|||
126657973|NCT01100034|455705635|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
126657974|NCT01100034|455705635|FG000|Overall Study|Withdrawal by Subject|4|||
126657975|NCT01100034|455705635|FG000|Overall Study|Sponsor decision|21|||
126657976|NCT01100034|455705635|FG000|Overall Study|Participated in another clinical trial|1|||
126657977|NCT01100034|455705635|FG000|Overall Study|Participants moved to another hospital|4|||
126657978|NCT01100034|455705635|FG000|Overall Study|Site closed due to non-responsiveness|1|||
126657979|NCT01831856|455705636|FG000|Overall Study|Adverse Event|5|||
126657980|NCT01831856|455705637|FG001|Overall Study|Adverse Event|8|||
126657981|NCT01831856|455705636|FG000|Overall Study|Lack of Efficacy|13|||
126657982|NCT01831856|455705637|FG001|Overall Study|Lack of Efficacy|11|||
126657983|NCT01831856|455705636|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
126657984|NCT01831856|455705637|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
126657985|NCT04620811|455705641|FG000|Overall Study|Withdrawal by Subject|18|||
126657986|NCT04620811|455705642|FG001|Overall Study|Withdrawal by Subject|15|||
126657987|NCT04620811|455705641|FG000|Overall Study|Adverse Event|6|||
126657988|NCT04620811|455705642|FG001|Overall Study|Adverse Event|11|||
126657989|NCT04620811|455705641|FG000|Overall Study|Lost to Follow-up|4|||
126657990|NCT04620811|455705642|FG001|Overall Study|Lost to Follow-up|8|||
126657991|NCT04620811|455705641|FG000|Overall Study|Physician Decision|1|||
126657992|NCT04620811|455705642|FG001|Overall Study|Physician Decision|4|||
126657993|NCT04620811|455705641|FG000|Overall Study|Sponsor Decision|0|||
126657994|NCT04620811|455705642|FG001|Overall Study|Sponsor Decision|1|||
126657995|NCT04620811|455705641|FG000|Overall Study|Elevation of ALT or AST|1|||
126657996|NCT04620811|455705642|FG001|Overall Study|Elevation of ALT or AST|0|||
126657997|NCT04620811|455705641|FG000|Overall Study|Other|3|||
126657998|NCT04620811|455705642|FG001|Overall Study|Other|5|||
126657999|NCT01078675|455705643|FG000|Overall Study|Withdrawal by Subject|7|||
126658000|NCT01078675|455705644|FG001|Overall Study|Withdrawal by Subject|3|||
126658001|NCT01078675|455705643|FG000|Overall Study|Protocol Violation|56|||
126658002|NCT01078675|455705644|FG001|Overall Study|Protocol Violation|0|||
126658003|NCT01078675|455705643|FG000|Overall Study|Provided in CRF for specific reasons|2|||
126658004|NCT01078675|455705644|FG001|Overall Study|Provided in CRF for specific reasons|3|||
126658005|NCT01078675|455705643|FG000|Overall Study|Adverse Event|3|||
126658006|NCT01078675|455705644|FG001|Overall Study|Adverse Event|0|||
126658007|NCT01759368|455705647|FG000|Overall Study|Lost to Follow-up|1|||
126658008|NCT01759368|455705648|FG001|Overall Study|Lost to Follow-up|0|||
126658009|NCT01191268|455705649|FG000|Overall Study|Withdrawal by Subject|19|||
126658010|NCT01191268|455705650|FG001|Overall Study|Withdrawal by Subject|25|||
126658011|NCT01191268|455705651|FG002|Overall Study|Withdrawal by Subject|21|||
126658012|NCT01191268|455705649|FG000|Overall Study|Adverse Event|21|||
126658013|NCT01191268|455705650|FG001|Overall Study|Adverse Event|13|||
126658014|NCT01191268|455705651|FG002|Overall Study|Adverse Event|8|||
126658015|NCT01191268|455705649|FG000|Overall Study|Physician Decision|6|||
126658016|NCT01191268|455705650|FG001|Overall Study|Physician Decision|8|||
126658017|NCT01191268|455705651|FG002|Overall Study|Physician Decision|9|||
126658018|NCT01191268|455705649|FG000|Overall Study|Lost to Follow-up|8|||
126658019|NCT01191268|455705650|FG001|Overall Study|Lost to Follow-up|5|||
126658020|NCT01191268|455705651|FG002|Overall Study|Lost to Follow-up|9|||
126658021|NCT01191268|455705649|FG000|Overall Study|Entry Criteria Not Met|3|||
126658022|NCT01191268|455705650|FG001|Overall Study|Entry Criteria Not Met|1|||
126658023|NCT01191268|455705651|FG002|Overall Study|Entry Criteria Not Met|1|||
126658024|NCT01191268|455705649|FG000|Overall Study|Death|0|||
126658025|NCT01191268|455705650|FG001|Overall Study|Death|1|||
126658026|NCT01191268|455705651|FG002|Overall Study|Death|3|||
126658027|NCT01191268|455705649|FG000|Overall Study|Protocol Violation|1|||
126330067|NCT05568797|454501806|FG001|Overall Study|Other|2|||
126330068|NCT00869128|454501808|FG000|Overall Study|lack of Compliance|6|||
126330069|NCT00869128|454501809|FG001|Overall Study|lack of Compliance|6|||
126658028|NCT01191268|455705650|FG001|Overall Study|Protocol Violation|0|||
126658029|NCT01191268|455705651|FG002|Overall Study|Protocol Violation|1|||
126658030|NCT01191268|455705649|FG000|Overall Study|Sponsor Decision|0|||
126658031|NCT01191268|455705650|FG001|Overall Study|Sponsor Decision|2|||
126658032|NCT01191268|455705651|FG002|Overall Study|Sponsor Decision|0|||
126658033|NCT02294227|455705654|FG000|Overall Study|Death|0|||
126330070|NCT02998996|454501815|FG000|Overall Study|Lost to Follow-up|0|||
126330071|NCT02998996|454501816|FG001|Overall Study|Lost to Follow-up|0|||
126330072|NCT02998996|454501817|FG002|Overall Study|Lost to Follow-up|1|||
126330073|NCT02998996|454501818|FG003|Overall Study|Lost to Follow-up|0|||
126330074|NCT02998996|454501819|FG004|Overall Study|Lost to Follow-up|0|||
126330075|NCT02998996|454501820|FG005|Overall Study|Lost to Follow-up|0|||
126658034|NCT02294227|455705655|FG001|Overall Study|Death|0|||
126658035|NCT02294227|455705656|FG002|Overall Study|Death|1|||
126658036|NCT02294227|455705654|FG000|Overall Study|Subject/Guardian Decision|6|||
126658037|NCT02294227|455705655|FG001|Overall Study|Subject/Guardian Decision|3|||
126658038|NCT02294227|455705656|FG002|Overall Study|Subject/Guardian Decision|7|||
126658039|NCT02294227|455705654|FG000|Overall Study|Physician Decision|1|||
126658040|NCT02294227|455705655|FG001|Overall Study|Physician Decision|2|||
126658041|NCT02294227|455705656|FG002|Overall Study|Physician Decision|1|||
126658042|NCT02294227|455705654|FG000|Overall Study|Lost to Follow-up|1|||
126658043|NCT02294227|455705655|FG001|Overall Study|Lost to Follow-up|0|||
126658044|NCT02294227|455705656|FG002|Overall Study|Lost to Follow-up|0|||
126658045|NCT02294227|455705654|FG000|Overall Study|Lack of Efficacy|11|||
126658046|NCT02294227|455705655|FG001|Overall Study|Lack of Efficacy|12|||
126658047|NCT02294227|455705656|FG002|Overall Study|Lack of Efficacy|8|||
126658048|NCT02294227|455705654|FG000|Overall Study|Adverse Event|6|||
126658049|NCT02294227|455705655|FG001|Overall Study|Adverse Event|8|||
126658050|NCT02294227|455705656|FG002|Overall Study|Adverse Event|2|||
126658051|NCT00899548|455705657|FG000|Overall Study|Physician Decision|3|||
126658052|NCT01636960|455705658|FG000|Induction Phase|Adverse Event|2|||
126658053|NCT01636960|455705658|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
126658054|NCT01636960|455705658|FG000|Maintenance Phase|Adverse Event|3|||
126658055|NCT01636960|455705658|FG000|Maintenance Phase|Progressive disease|1|||
126658056|NCT01209780|455705661|FG000|Overall Study|Adverse Event|0|||
126658057|NCT01209780|455705662|FG001|Overall Study|Adverse Event|1|||
126658058|NCT01209780|455705663|FG002|Overall Study|Adverse Event|0|||
126658059|NCT01209780|455705664|FG003|Overall Study|Adverse Event|0|||
126658060|NCT01209780|455705665|FG004|Overall Study|Adverse Event|0|||
126658061|NCT01209780|455705661|FG000|Overall Study|Withdrawal by Subject|9|||
126658062|NCT01209780|455705662|FG001|Overall Study|Withdrawal by Subject|2|||
126658063|NCT01209780|455705663|FG002|Overall Study|Withdrawal by Subject|1|||
126658064|NCT01209780|455705664|FG003|Overall Study|Withdrawal by Subject|1|||
126658065|NCT01209780|455705665|FG004|Overall Study|Withdrawal by Subject|0|||
126658066|NCT01209780|455705661|FG000|Overall Study|Lost to Follow-up|17|||
126658067|NCT01209780|455705662|FG001|Overall Study|Lost to Follow-up|12|||
126658068|NCT01209780|455705663|FG002|Overall Study|Lost to Follow-up|3|||
126658069|NCT01209780|455705664|FG003|Overall Study|Lost to Follow-up|9|||
126658070|NCT01209780|455705665|FG004|Overall Study|Lost to Follow-up|4|||
126658071|NCT01209780|455705661|FG000|Overall Study|Protocol Violation|0|||
126658072|NCT01209780|455705662|FG001|Overall Study|Protocol Violation|1|||
126658073|NCT01209780|455705663|FG002|Overall Study|Protocol Violation|0|||
126658074|NCT01209780|455705664|FG003|Overall Study|Protocol Violation|0|||
126658075|NCT01209780|455705665|FG004|Overall Study|Protocol Violation|0|||
126658076|NCT01209780|455705661|FG000|Overall Study|Inappropriate enrollment|0|||
126658077|NCT01209780|455705662|FG001|Overall Study|Inappropriate enrollment|2|||
126658078|NCT01209780|455705663|FG002|Overall Study|Inappropriate enrollment|0|||
126658079|NCT01209780|455705664|FG003|Overall Study|Inappropriate enrollment|0|||
126658080|NCT01209780|455705665|FG004|Overall Study|Inappropriate enrollment|1|||
126658081|NCT02709096|455705668|FG000|Overall Study|non-compliance|1|||
126658082|NCT02709096|455705669|FG001|Overall Study|non-compliance|1|||
126658083|NCT00511472|455705670|FG000|Overall Study|Clinical Adverse Event|1|||
126658084|NCT00511472|455705671|FG001|Overall Study|Clinical Adverse Event|2|||
126658085|NCT00511472|455705670|FG000|Overall Study|Laboratory Adverse Event|0|||
126658086|NCT00511472|455705671|FG001|Overall Study|Laboratory Adverse Event|2|||
126658087|NCT00511472|455705670|FG000|Overall Study|Not reported|2|||
126658088|NCT00511472|455705671|FG001|Overall Study|Not reported|2|||
126658089|NCT00505284|455705672|FG000|Overall Study|Adverse Event|3|||
126330076|NCT02998996|454501815|FG000|Overall Study|Pregnancy|0|||
126658090|NCT00505284|455705673|FG001|Overall Study|Adverse Event|7|||
126330077|NCT02998996|454501816|FG001|Overall Study|Pregnancy|1|||
126658091|NCT00505284|455705674|FG002|Overall Study|Adverse Event|9|||
126658092|NCT00505284|455705675|FG003|Overall Study|Adverse Event|14|||
126658093|NCT00505284|455705676|FG004|Overall Study|Adverse Event|22|||
126658094|NCT00505284|455705672|FG000|Overall Study|Protocol Violation|0|||
126658095|NCT00505284|455705673|FG001|Overall Study|Protocol Violation|1|||
126658096|NCT00505284|455705674|FG002|Overall Study|Protocol Violation|1|||
126658097|NCT00505284|455705675|FG003|Overall Study|Protocol Violation|0|||
126658098|NCT00505284|455705676|FG004|Overall Study|Protocol Violation|0|||
126658099|NCT00505284|455705672|FG000|Overall Study|Withdrawal by Subject|2|||
126330078|NCT02998996|454501817|FG002|Overall Study|Pregnancy|0|||
126658100|NCT00505284|455705673|FG001|Overall Study|Withdrawal by Subject|6|||
126658101|NCT00505284|455705674|FG002|Overall Study|Withdrawal by Subject|1|||
126330079|NCT02998996|454501818|FG003|Overall Study|Pregnancy|0|||
126330080|NCT02998996|454501819|FG004|Overall Study|Pregnancy|0|||
126330081|NCT02998996|454501820|FG005|Overall Study|Pregnancy|0|||
126330082|NCT02998996|454501815|FG000|Overall Study|Family reasons|0|||
126330083|NCT02998996|454501816|FG001|Overall Study|Family reasons|0|||
126330084|NCT02998996|454501817|FG002|Overall Study|Family reasons|0|||
126330085|NCT02998996|454501818|FG003|Overall Study|Family reasons|0|||
126330086|NCT02998996|454501819|FG004|Overall Study|Family reasons|1|||
126330087|NCT02998996|454501820|FG005|Overall Study|Family reasons|0|||
126330088|NCT01118663|454501822|FG000|Overall Study|Adverse Event|2|||
126330089|NCT01118663|454501823|FG001|Overall Study|Adverse Event|1|||
126330090|NCT01118663|454501822|FG000|Overall Study|Withdrawal by Subject|0|||
126330091|NCT01118663|454501823|FG001|Overall Study|Withdrawal by Subject|1|||
126330092|NCT03046953|454501824|FG000|Overall Study|Relapse/progressive disease|21|||
126330093|NCT03046953|454501824|FG000|Overall Study|Death|2|||
126330094|NCT03046953|454501824|FG000|Overall Study|Withdrawal by Subject|3|||
126330095|NCT04039204|454501825|FG000|Overall Study|Withdrawal by Subject|0|||
126330096|NCT04039204|454501826|FG001|Overall Study|Withdrawal by Subject|2|||
126330097|NCT01189461|454501827|FG000|Overall Study|Lack of Efficacy|13|||
126330098|NCT01189461|454501827|FG000|Overall Study|Lost to Follow-up|1|||
126330099|NCT01189461|454501827|FG000|Overall Study|Withdrawal by Subject|6|||
126330100|NCT01189461|454501827|FG000|Overall Study|Protocol Violation|1|||
126330101|NCT01189461|454501827|FG000|Overall Study|Adverse Event|2|||
126330102|NCT01189461|454501827|FG000|Overall Study|Did not meet entrance criteria|3|||
126330103|NCT01189461|454501827|FG000|Overall Study|Other|8|||
126330104|NCT02716584|454501828|FG000|Overall Study|Lost to Follow-up|8|||
126330105|NCT02716584|454501829|FG001|Overall Study|Lost to Follow-up|5|||
126330106|NCT05279131|454501831|FG000|Overall Study|Lost to Follow-up|1|||
126330107|NCT05279131|454501831|FG000|Overall Study|Death|1|||
126330108|NCT05279131|454501831|FG000|Overall Study|Physician Decision|1|||
126330109|NCT04530838|454503240|FG000|Overall Study|Other|2|||
126330110|NCT04530838|454503241|FG001|Overall Study|Other|1|||
126330111|NCT04530838|454503242|FG002|Overall Study|Other|0|||
126330112|NCT04530838|454503240|FG000|Overall Study|Physician Decision|0|||
126330113|NCT04530838|454503241|FG001|Overall Study|Physician Decision|0|||
126330114|NCT04530838|454503242|FG002|Overall Study|Physician Decision|1|||
126330115|NCT04530838|454503240|FG000|Overall Study|Death|0|||
126330116|NCT04530838|454503241|FG001|Overall Study|Death|0|||
126330117|NCT04530838|454503242|FG002|Overall Study|Death|1|||
126330118|NCT04530838|454503240|FG000|Overall Study|Adverse Event|0|||
126330119|NCT04530838|454503241|FG001|Overall Study|Adverse Event|1|||
126330120|NCT04530838|454503242|FG002|Overall Study|Adverse Event|0|||
126330121|NCT04530838|454503240|FG000|Overall Study|No longer meets eligibility criteria|1|||
126330122|NCT04530838|454503241|FG001|Overall Study|No longer meets eligibility criteria|0|||
126330123|NCT04530838|454503242|FG002|Overall Study|No longer meets eligibility criteria|2|||
126330124|NCT04530838|454503240|FG000|Overall Study|Withdrawal by parent/guardian|5|||
126330125|NCT04530838|454503241|FG001|Overall Study|Withdrawal by parent/guardian|2|||
126330126|NCT04530838|454503242|FG002|Overall Study|Withdrawal by parent/guardian|2|||
126330127|NCT00803712|454503243|FG000|Overall Study|Noncompliance|3|||
126330128|NCT00803712|454503244|FG001|Overall Study|Noncompliance|0|||
126330129|NCT00803712|454503243|FG000|Overall Study|Adverse Event|5|||
126330130|NCT00803712|454503244|FG001|Overall Study|Adverse Event|0|||
126330131|NCT00803712|454503243|FG000|Overall Study|Death|8|||
126330132|NCT00803712|454503244|FG001|Overall Study|Death|7|||
126330133|NCT00803712|454503243|FG000|Overall Study|Lost to Follow-up|3|||
126330134|NCT00803712|454503244|FG001|Overall Study|Lost to Follow-up|1|||
126330135|NCT00803712|454503243|FG000|Overall Study|Withdrawal by Subject|2|||
126330136|NCT00803712|454503244|FG001|Overall Study|Withdrawal by Subject|4|||
126330137|NCT00803712|454503243|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
126330138|NCT00803712|454503244|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
126330139|NCT00803712|454503243|FG000|Overall Study|Protocol criteria (other)|0|||
126330140|NCT00803712|454503244|FG001|Overall Study|Protocol criteria (other)|2|||
126330141|NCT00803712|454503243|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
126330142|NCT00803712|454503244|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
126330143|NCT00803712|454503243|FG000|Overall Study|Administrative decision|2|||
126330144|NCT00803712|454503244|FG001|Overall Study|Administrative decision|3|||
126330145|NCT00803712|454503243|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
126330146|NCT00803712|454503244|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
126330147|NCT02100839|454503255|FG000|Multiple Ascending Dose|Adverse Event|2|||
126330148|NCT02100839|454503256|FG001|Multiple Ascending Dose|Adverse Event|0|||
126330149|NCT02100839|454503255|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
126330150|NCT02100839|454503256|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
126330151|NCT00669318|454503259|FG000|Overall Study|Withdrawal by Subject|2|||
126330152|NCT01073163|454503260|FG000|Overall Study|Adverse Event|1|||
126330153|NCT01073163|454503260|FG000|Overall Study|Disease Progression|1|||
126330154|NCT01073163|454503260|FG000|Overall Study|Early termination|1|||
126330155|NCT03272347|454503261|FG000|Overall Study|Death|0|||
126330156|NCT03272347|454503262|FG001|Overall Study|Death|0|||
126330157|NCT03272347|454503263|FG002|Overall Study|Death|0|||
126330158|NCT03272347|454503264|FG003|Overall Study|Death|1|||
126658102|NCT00505284|455705675|FG003|Overall Study|Withdrawal by Subject|0|||
126658103|NCT00505284|455705676|FG004|Overall Study|Withdrawal by Subject|6|||
126658104|NCT00505284|455705672|FG000|Overall Study|Lack of Efficacy|0|||
126658105|NCT00505284|455705673|FG001|Overall Study|Lack of Efficacy|1|||
126658106|NCT00505284|455705674|FG002|Overall Study|Lack of Efficacy|1|||
126658107|NCT00505284|455705675|FG003|Overall Study|Lack of Efficacy|1|||
126658108|NCT00505284|455705676|FG004|Overall Study|Lack of Efficacy|1|||
126658109|NCT00505284|455705672|FG000|Overall Study|Physician Decision|0|||
126658110|NCT00505284|455705673|FG001|Overall Study|Physician Decision|1|||
126658111|NCT00505284|455705674|FG002|Overall Study|Physician Decision|0|||
126658112|NCT00505284|455705675|FG003|Overall Study|Physician Decision|0|||
126658113|NCT00505284|455705676|FG004|Overall Study|Physician Decision|0|||
126658114|NCT00505284|455705672|FG000|Overall Study|Other|5|||
126658115|NCT00505284|455705673|FG001|Overall Study|Other|0|||
126658116|NCT00505284|455705674|FG002|Overall Study|Other|0|||
126658117|NCT00505284|455705675|FG003|Overall Study|Other|4|||
126658118|NCT00505284|455705676|FG004|Overall Study|Other|4|||
126658119|NCT00731120|455705677|FG000|Overall Study|Adverse Event|7|||
126658120|NCT00731120|455705678|FG001|Overall Study|Adverse Event|6|||
126658121|NCT00731120|455705679|FG002|Overall Study|Adverse Event|8|||
126658122|NCT00731120|455705677|FG000|Overall Study|Lack of Efficacy|4|||
126658123|NCT00731120|455705678|FG001|Overall Study|Lack of Efficacy|5|||
126658124|NCT00731120|455705679|FG002|Overall Study|Lack of Efficacy|4|||
126658125|NCT00731120|455705677|FG000|Overall Study|Noncompliance with Study Drug|3|||
126658126|NCT00731120|455705678|FG001|Overall Study|Noncompliance with Study Drug|3|||
126658127|NCT00731120|455705679|FG002|Overall Study|Noncompliance with Study Drug|1|||
126658128|NCT00731120|455705677|FG000|Overall Study|Protocol Deviations|1|||
126658129|NCT00731120|455705678|FG001|Overall Study|Protocol Deviations|6|||
126658130|NCT00731120|455705679|FG002|Overall Study|Protocol Deviations|1|||
126658131|NCT00731120|455705677|FG000|Overall Study|Withdrawal of Consent|13|||
126658132|NCT00731120|455705678|FG001|Overall Study|Withdrawal of Consent|8|||
126658133|NCT00731120|455705679|FG002|Overall Study|Withdrawal of Consent|4|||
126658134|NCT00731120|455705677|FG000|Overall Study|Lost to Follow-up|10|||
126658135|NCT00731120|455705678|FG001|Overall Study|Lost to Follow-up|15|||
126658136|NCT00731120|455705679|FG002|Overall Study|Lost to Follow-up|17|||
126658137|NCT00731120|455705677|FG000|Overall Study|Other|4|||
126658138|NCT00731120|455705678|FG001|Overall Study|Other|0|||
126658139|NCT00731120|455705679|FG002|Overall Study|Other|1|||
126658140|NCT01588496|455705683|FG000|Overall Study|Withdrawal by Subject|0|||
126658141|NCT01588496|455705684|FG001|Overall Study|Withdrawal by Subject|1|||
126658142|NCT01588496|455705685|FG002|Overall Study|Withdrawal by Subject|0|||
126658143|NCT01013285|455705686|FG000|Overall Study|Death|48|||
126658144|NCT01013285|455705687|FG001|Overall Study|Death|89|||
126658145|NCT00953745|455705688|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
126658146|NCT00953745|455705689|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
126658147|NCT00953745|455705688|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
126658148|NCT00953745|455705689|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
126658149|NCT00953745|455705688|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
126658150|NCT00953745|455705689|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
126658151|NCT00953745|455705688|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
126658152|NCT00953745|455705689|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
126658153|NCT00953745|455705688|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
126658154|NCT00953745|455705689|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
126658155|NCT00953745|455705688|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
126658156|NCT00953745|455705689|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
126658157|NCT02401867|455707230|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
126658158|NCT02401867|455707230|FG000|Analysis|Cervical assay could not be conducted|9|||
126658159|NCT02795429|455707231|FG000|Overall Study|Adverse Event|1|||
126658160|NCT02795429|455707232|FG001|Overall Study|Adverse Event|2|||
126658161|NCT02795429|455707233|FG002|Overall Study|Adverse Event|1|||
126658162|NCT02795429|455707234|FG003|Overall Study|Adverse Event|2|||
126658163|NCT02795429|455707235|FG004|Overall Study|Adverse Event|1|||
126658164|NCT02795429|455707231|FG000|Overall Study|Death|1|||
126658165|NCT02795429|455707232|FG001|Overall Study|Death|0|||
126658166|NCT02795429|455707233|FG002|Overall Study|Death|1|||
126658167|NCT02795429|455707234|FG003|Overall Study|Death|2|||
126658168|NCT02795429|455707235|FG004|Overall Study|Death|1|||
126658169|NCT02795429|455707231|FG000|Overall Study|Physician Decision|0|||
126658170|NCT02795429|455707232|FG001|Overall Study|Physician Decision|0|||
126658171|NCT02795429|455707233|FG002|Overall Study|Physician Decision|2|||
126658172|NCT02795429|455707234|FG003|Overall Study|Physician Decision|1|||
126658173|NCT02795429|455707235|FG004|Overall Study|Physician Decision|5|||
126330159|NCT03272347|454503261|FG000|Overall Study|Lost to Follow-up|1|||
126658174|NCT02795429|455707231|FG000|Overall Study|Progressive disease|3|||
126658175|NCT02795429|455707232|FG001|Overall Study|Progressive disease|7|||
126658176|NCT02795429|455707233|FG002|Overall Study|Progressive disease|6|||
126658177|NCT02795429|455707234|FG003|Overall Study|Progressive disease|26|||
126658178|NCT02795429|455707235|FG004|Overall Study|Progressive disease|20|||
126330160|NCT03272347|454503262|FG001|Overall Study|Lost to Follow-up|3|||
126330161|NCT03272347|454503263|FG002|Overall Study|Lost to Follow-up|5|||
126330162|NCT03272347|454503264|FG003|Overall Study|Lost to Follow-up|1|||
126330163|NCT03272347|454503261|FG000|Overall Study|Physician Decision|4|||
126330164|NCT03272347|454503262|FG001|Overall Study|Physician Decision|2|||
126330165|NCT03272347|454503263|FG002|Overall Study|Physician Decision|5|||
126330166|NCT03272347|454503264|FG003|Overall Study|Physician Decision|4|||
126330167|NCT03272347|454503261|FG000|Overall Study|Screen Failure|1|||
126330168|NCT03272347|454503262|FG001|Overall Study|Screen Failure|0|||
126330169|NCT03272347|454503263|FG002|Overall Study|Screen Failure|0|||
126330170|NCT03272347|454503264|FG003|Overall Study|Screen Failure|0|||
126330171|NCT03272347|454503261|FG000|Overall Study|Withdrawal by Subject|5|||
126658179|NCT02795429|455707231|FG000|Overall Study|Subject/guardian decision|1|||
126658180|NCT02795429|455707232|FG001|Overall Study|Subject/guardian decision|1|||
126658181|NCT02795429|455707233|FG002|Overall Study|Subject/guardian decision|1|||
126658182|NCT02795429|455707234|FG003|Overall Study|Subject/guardian decision|1|||
126658183|NCT02795429|455707235|FG004|Overall Study|Subject/guardian decision|3|||
126658184|NCT01640054|455707238|FG000|Overall Study|Study-specific disc criteria|1|||
126658185|NCT01640054|455707238|FG000|Overall Study|Lack of Efficacy|3|||
126658186|NCT01640054|455707238|FG000|Overall Study|Adverse Event|2|||
126658187|NCT02080221|455707239|FG000|Overall Study|Withdrawal by Subject|1|||
126658188|NCT02080221|455707239|FG000|Overall Study|Clinical Progression of Disease|1|||
126658189|NCT01386788|455707242|FG000|Overall Study|Lost to Follow-up|2|||
126658190|NCT02808143|455707245|FG000|Maintenance Phase|Disease recurrence|1|||
126658191|NCT02808143|455707246|FG001|Maintenance Phase|Disease recurrence|3|||
126658192|NCT02808143|455707245|FG000|Maintenance Phase|Disease progression|1|||
126658193|NCT02808143|455707246|FG001|Maintenance Phase|Disease progression|2|||
126658194|NCT02808143|455707245|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
126658195|NCT02808143|455707246|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
126658196|NCT02808143|455707245|FG000|Survival Follow-Up|Disease recurrence|0|||
126658197|NCT02808143|455707246|FG001|Survival Follow-Up|Disease recurrence|2|||
126658198|NCT02808143|455707245|FG000|Survival Follow-Up|Adverse Event|0|||
126658199|NCT02808143|455707246|FG001|Survival Follow-Up|Adverse Event|1|||
126658200|NCT02808143|455707245|FG000|Survival Follow-Up|Death|1|||
126658201|NCT02808143|455707246|FG001|Survival Follow-Up|Death|0|||
126658202|NCT04964388|455707247|FG000|Overall Study|Lost to Follow-up|3|||
126658203|NCT04964388|455707248|FG001|Overall Study|Lost to Follow-up|2|||
126658204|NCT00448279|455707250|FG000|Overall Study|Lost to Follow-up|2|||
126658205|NCT00448279|455707251|FG001|Overall Study|Lost to Follow-up|2|||
126658206|NCT00448279|455707250|FG000|Overall Study|Adverse Event|1|||
126658207|NCT00448279|455707251|FG001|Overall Study|Adverse Event|1|||
126658208|NCT00448279|455707250|FG000|Overall Study|Disease progression|16|||
126658209|NCT00448279|455707251|FG001|Overall Study|Disease progression|18|||
126658210|NCT00448279|455707250|FG000|Overall Study|Withdrawal by Subject|4|||
126658211|NCT00448279|455707251|FG001|Overall Study|Withdrawal by Subject|3|||
126658212|NCT00448279|455707250|FG000|Overall Study|Other|6|||
126658213|NCT00448279|455707251|FG001|Overall Study|Other|4|||
126658214|NCT00448279|455707250|FG000|Overall Study|Protocol Violation|0|||
126658215|NCT00448279|455707251|FG001|Overall Study|Protocol Violation|1|||
126658216|NCT03718533|455707252|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
126658217|NCT03718533|455707252|FG000|Overall Study|Protocol deviation|1|||
126658218|NCT03718533|455707252|FG000|Overall Study|Disease progression|1|||
126658219|NCT03718533|455707252|FG000|Overall Study|Relapse|1|||
126658220|NCT03718533|455707252|FG000|Overall Study|Physician Decision|2|||
126658221|NCT03718533|455707252|FG000|Overall Study|Physician Decision and Adverse Event|1|||
126658222|NCT01295034|455707253|FG000|Overall Study|Lost to Follow-up|5|||
126658223|NCT01295034|455707254|FG001|Overall Study|Lost to Follow-up|5|||
126658224|NCT01174160|455707257|FG000|Overall Study|Adverse Event|1|||
126658225|NCT01174160|455707258|FG001|Overall Study|Adverse Event|0|||
126330172|NCT03272347|454503262|FG001|Overall Study|Withdrawal by Subject|1|||
126330173|NCT03272347|454503263|FG002|Overall Study|Withdrawal by Subject|2|||
126330174|NCT03272347|454503264|FG003|Overall Study|Withdrawal by Subject|1|||
126658226|NCT01174160|455707257|FG000|Overall Study|Lost to Follow-up|1|||
126658227|NCT01174160|455707258|FG001|Overall Study|Lost to Follow-up|0|||
126658228|NCT01174160|455707257|FG000|Overall Study|Physician Decision|1|||
126658229|NCT01174160|455707258|FG001|Overall Study|Physician Decision|0|||
126658230|NCT01174160|455707257|FG000|Overall Study|Protocol Violation|4|||
126658231|NCT01174160|455707258|FG001|Overall Study|Protocol Violation|6|||
126330175|NCT00703677|454503265|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
126330176|NCT00940888|454503266|FG000|Overall Study|Unsuccessful Implant|4|||
126330177|NCT00940888|454503266|FG000|Overall Study|Death|461|||
126330178|NCT00940888|454503266|FG000|Overall Study|Withdrawn - Non-Death|364|||
126330179|NCT00940888|454503266|FG000|Overall Study|Lost to Follow-up|6|||
126658232|NCT01174160|455707257|FG000|Overall Study|Withdrawal by Subject|1|||
126658233|NCT01174160|455707258|FG001|Overall Study|Withdrawal by Subject|0|||
126658234|NCT04218084|455707259|FG000|Overall Study|Adverse Event|7|||
126658235|NCT04218084|455707260|FG001|Overall Study|Adverse Event|2|||
126658236|NCT04218084|455707259|FG000|Overall Study|Withdrawal of Consent|4|||
126658237|NCT04218084|455707260|FG001|Overall Study|Withdrawal of Consent|5|||
126658238|NCT04218084|455707259|FG000|Overall Study|Physician Decision|1|||
126330180|NCT04441788|454503269|FG000|Overall Study|Voluntary Withdrawl|0|||
126330181|NCT04441788|454503270|FG001|Overall Study|Voluntary Withdrawl|1|||
126330182|NCT04441788|454503271|FG002|Overall Study|Voluntary Withdrawl|0|||
126330183|NCT04441788|454503269|FG000|Overall Study|Ineligibility|1|||
126330184|NCT04441788|454503270|FG001|Overall Study|Ineligibility|0|||
126330185|NCT04441788|454503271|FG002|Overall Study|Ineligibility|0|||
126330186|NCT04441788|454503269|FG000|Overall Study|Adverse Event|0|||
126330187|NCT04441788|454503270|FG001|Overall Study|Adverse Event|0|||
126330188|NCT04441788|454503271|FG002|Overall Study|Adverse Event|4|||
126330189|NCT04441788|454503269|FG000|Overall Study|Study Terminated by Sponsor|16|||
126330190|NCT04441788|454503270|FG001|Overall Study|Study Terminated by Sponsor|16|||
126330191|NCT04441788|454503271|FG002|Overall Study|Study Terminated by Sponsor|12|||
126330192|NCT03859648|454503278|FG000|Overall Study|Lost to Follow-up|1|||
126330193|NCT03859648|454503278|FG000|Overall Study|Adverse Event|1|||
126330194|NCT01677182|454503279|FG000|Overall Study|Adverse Event|2|||
126658239|NCT04218084|455707260|FG001|Overall Study|Physician Decision|1|||
126658240|NCT04218084|455707259|FG000|Overall Study|Lost to Follow-up|1|||
126658241|NCT04218084|455707260|FG001|Overall Study|Lost to Follow-up|1|||
126658242|NCT04218084|455707259|FG000|Overall Study|Non-compliance with study drug|1|||
126658243|NCT04218084|455707260|FG001|Overall Study|Non-compliance with study drug|1|||
126658244|NCT04218084|455707259|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
126658245|NCT04218084|455707260|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
126658246|NCT04218084|455707259|FG000|Overall Study|Other|0|||
126658247|NCT04218084|455707260|FG001|Overall Study|Other|1|||
126658248|NCT04218084|455707259|FG000|Overall Study|Ongoing at data cut-off date|62|||
126658249|NCT04218084|455707260|FG001|Overall Study|Ongoing at data cut-off date|58|||
126658250|NCT05580588|455707261|FG000|Overall Study|Lack of Efficacy|12|||
126658251|NCT00211185|455707264|FG000|Overall Study|Death|2|||
126658252|NCT00211185|455707264|FG000|Overall Study|Disease progression|7|||
126658253|NCT00211185|455707264|FG000|Overall Study|Withdrawal by Subject|6|||
126658254|NCT00211185|455707264|FG000|Overall Study|Physician Decision|5|||
126658255|NCT00712673|455707265|FG000|Overall Study|Adverse Event|3|||
126658256|NCT00712673|455707266|FG001|Overall Study|Adverse Event|3|||
126658257|NCT00712673|455707267|FG002|Overall Study|Adverse Event|21|||
126658258|NCT00712673|455707268|FG003|Overall Study|Adverse Event|26|||
126658259|NCT00712673|455707265|FG000|Overall Study|Lack of Efficacy|2|||
126658260|NCT00712673|455707266|FG001|Overall Study|Lack of Efficacy|8|||
126658261|NCT00712673|455707267|FG002|Overall Study|Lack of Efficacy|8|||
126658262|NCT00712673|455707268|FG003|Overall Study|Lack of Efficacy|6|||
126658263|NCT00712673|455707265|FG000|Overall Study|Poor Compliance to Protocol|3|||
126658264|NCT00712673|455707266|FG001|Overall Study|Poor Compliance to Protocol|3|||
126658265|NCT00712673|455707267|FG002|Overall Study|Poor Compliance to Protocol|4|||
126658266|NCT00712673|455707268|FG003|Overall Study|Poor Compliance to Protocol|16|||
126658267|NCT00712673|455707265|FG000|Overall Study|Lost to Follow-up|1|||
126658268|NCT00712673|455707266|FG001|Overall Study|Lost to Follow-up|0|||
126658269|NCT00712673|455707267|FG002|Overall Study|Lost to Follow-up|2|||
126658270|NCT00712673|455707268|FG003|Overall Study|Lost to Follow-up|0|||
126658271|NCT00712673|455707265|FG000|Overall Study|Withdrawal by Subject|6|||
126658272|NCT00712673|455707266|FG001|Overall Study|Withdrawal by Subject|7|||
126658273|NCT00712673|455707267|FG002|Overall Study|Withdrawal by Subject|15|||
126658274|NCT00712673|455707268|FG003|Overall Study|Withdrawal by Subject|20|||
126658275|NCT00712673|455707265|FG000|Overall Study|Familial and Personal Reasons|5|||
126658276|NCT00712673|455707266|FG001|Overall Study|Familial and Personal Reasons|0|||
126658277|NCT00712673|455707267|FG002|Overall Study|Familial and Personal Reasons|5|||
126658278|NCT00712673|455707268|FG003|Overall Study|Familial and Personal Reasons|2|||
126658279|NCT00712673|455707265|FG000|Overall Study|Investigator's Decision|1|||
126658280|NCT00712673|455707266|FG001|Overall Study|Investigator's Decision|0|||
126658281|NCT00712673|455707267|FG002|Overall Study|Investigator's Decision|0|||
126658282|NCT00712673|455707268|FG003|Overall Study|Investigator's Decision|0|||
126658283|NCT00712673|455707265|FG000|Overall Study|Protocol Violation|0|||
126658284|NCT00712673|455707266|FG001|Overall Study|Protocol Violation|0|||
126658285|NCT00712673|455707267|FG002|Overall Study|Protocol Violation|2|||
126658286|NCT00712673|455707268|FG003|Overall Study|Protocol Violation|0|||
126658287|NCT01952054|455707269|FG000|Overall Study|Physician Decision|1|||
126658288|NCT05208866|455707270|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
126658289|NCT02070588|455707271|FG000|Overall Study|Withdrawal by Subject|29|||
126658290|NCT02070588|455707272|FG001|Overall Study|Withdrawal by Subject|1|||
126658291|NCT02070588|455707273|FG002|Overall Study|Withdrawal by Subject|0|||
126658292|NCT02070588|455707271|FG000|Overall Study|Writhdrawal due to early termination|9|||
126658293|NCT02070588|455707272|FG001|Overall Study|Writhdrawal due to early termination|0|||
126658294|NCT02070588|455707273|FG002|Overall Study|Writhdrawal due to early termination|0|||
126330195|NCT01677182|454503280|FG001|Overall Study|Adverse Event|1|||
126330196|NCT01677182|454503281|FG002|Overall Study|Adverse Event|8|||
126658295|NCT02070588|455707271|FG000|Overall Study|Adverse Event|1|||
126658296|NCT02070588|455707272|FG001|Overall Study|Adverse Event|0|||
126658297|NCT02070588|455707273|FG002|Overall Study|Adverse Event|0|||
126658298|NCT00836095|455707275|FG000|Overall Study|Physician Decision|0|||
126658299|NCT00836095|455707276|FG001|Overall Study|Physician Decision|3|||
126658300|NCT01718353|455707277|FG000|Overall Study|Lost to Follow-up|0|||
126658301|NCT01718353|455707278|FG001|Overall Study|Lost to Follow-up|1|||
126658302|NCT01718353|455707277|FG000|Overall Study|Principal Investigator's Decision|10|||
126658303|NCT01718353|455707278|FG001|Overall Study|Principal Investigator's Decision|4|||
126658304|NCT01718353|455707277|FG000|Overall Study|Randomized but not treated|2|||
126658305|NCT01718353|455707278|FG001|Overall Study|Randomized but not treated|0|||
126658306|NCT00455325|455707279|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
126658307|NCT00455325|455707280|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
126658308|NCT00455325|455707281|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
126658309|NCT00455325|455707282|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
126658310|NCT00455325|455707279|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
126658311|NCT00455325|455707280|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
126658312|NCT00455325|455707281|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
126658313|NCT00455325|455707282|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
126658314|NCT00455325|455707279|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
126658315|NCT00455325|455707280|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
126658316|NCT00455325|455707281|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
126658317|NCT00455325|455707282|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
126658318|NCT00455325|455707279|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
126658319|NCT00455325|455707280|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
126658320|NCT00455325|455707281|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
126658321|NCT00455325|455707282|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
126658322|NCT00455325|455707279|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
126658323|NCT00455325|455707280|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
126658324|NCT00455325|455707281|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
126658325|NCT00455325|455707282|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
126658326|NCT00455325|455707279|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
126658327|NCT00455325|455707280|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
126658328|NCT00455325|455707281|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
126658329|NCT00455325|455707282|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
126658330|NCT00455325|455707279|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
126658331|NCT00455325|455707280|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
126658332|NCT00455325|455707281|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
126658333|NCT00455325|455707282|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
126658334|NCT02745392|455707288|FG000|Overall Study|Lost to Follow-up|0|||
126658335|NCT02745392|455707289|FG001|Overall Study|Lost to Follow-up|1|||
126658336|NCT02745392|455707290|FG002|Overall Study|Lost to Follow-up|0|||
126658337|NCT02745392|455707291|FG003|Overall Study|Lost to Follow-up|0|||
126658338|NCT01691768|455707292|FG000|Overall Study|Death|0|||
126658339|NCT01691768|455707293|FG001|Overall Study|Death|2|||
126658340|NCT01691768|455707292|FG000|Overall Study|Lost to Follow-up|4|||
126658341|NCT01691768|455707293|FG001|Overall Study|Lost to Follow-up|3|||
126658342|NCT01691768|455707292|FG000|Overall Study|Withdrawal by Subject|10|||
126658343|NCT01691768|455707293|FG001|Overall Study|Withdrawal by Subject|9|||
126658344|NCT01691768|455707292|FG000|Overall Study|Relocated|0|||
126658345|NCT01691768|455707293|FG001|Overall Study|Relocated|1|||
126658346|NCT01691768|455707292|FG000|Overall Study|Investigator decision|1|||
126658347|NCT01691768|455707293|FG001|Overall Study|Investigator decision|1|||
126658348|NCT01959334|455707294|FG000|Second Dose|Adverse Event|1|||
126658349|NCT01959334|455707295|FG001|Second Dose|Adverse Event|0|||
126658350|NCT01959334|455707294|FG000|Third Dose|Adverse Event|0|||
126658351|NCT01959334|455707295|FG001|Third Dose|Adverse Event|1|||
126330197|NCT01677182|454503279|FG000|Overall Study|Protocol Violation|5|||
126330198|NCT01677182|454503280|FG001|Overall Study|Protocol Violation|1|||
126330199|NCT01677182|454503281|FG002|Overall Study|Protocol Violation|4|||
126330200|NCT01677182|454503279|FG000|Overall Study|Lost to Follow-up|4|||
126330201|NCT01677182|454503280|FG001|Overall Study|Lost to Follow-up|0|||
126330202|NCT01677182|454503281|FG002|Overall Study|Lost to Follow-up|3|||
126330203|NCT01677182|454503279|FG000|Overall Study|Withdrawal by Subject|7|||
126330204|NCT01677182|454503280|FG001|Overall Study|Withdrawal by Subject|12|||
126658352|NCT01768637|455707298|FG000|Overall Study|Lost to Follow-up|2|||
126658353|NCT01768637|455707299|FG001|Overall Study|Lost to Follow-up|7|||
126658354|NCT01768637|455707298|FG000|Overall Study|Difficult blood draw|1|||
126658355|NCT01768637|455707299|FG001|Overall Study|Difficult blood draw|0|||
126658356|NCT00887432|455707300|FG000|Overall Study|Start Excluded Therapy|3|||
126658357|NCT00887432|455707301|FG001|Overall Study|Start Excluded Therapy|0|||
126658358|NCT00887432|455707300|FG000|Overall Study|Did not complete treatment|6|||
126658359|NCT00887432|455707301|FG001|Overall Study|Did not complete treatment|8|||
126658360|NCT00887432|455707300|FG000|Overall Study|Protocol Violation|2|||
126658361|NCT00887432|455707301|FG001|Overall Study|Protocol Violation|3|||
126330205|NCT01677182|454503281|FG002|Overall Study|Withdrawal by Subject|10|||
126330206|NCT01677182|454503279|FG000|Overall Study|Study termination|12|||
126658362|NCT00887432|455707300|FG000|Overall Study|Withdrawal by Subject|3|||
126658363|NCT00887432|455707301|FG001|Overall Study|Withdrawal by Subject|2|||
126658364|NCT00887432|455707300|FG000|Overall Study|Lost to Follow-up|1|||
126658365|NCT00887432|455707301|FG001|Overall Study|Lost to Follow-up|0|||
126658366|NCT00887432|455707300|FG000|Overall Study|No reason provided|0|||
126658367|NCT00887432|455707301|FG001|Overall Study|No reason provided|1|||
126658368|NCT04781387|455707302|FG000|Overall Study|Withdrawal by Subject|1|||
126658369|NCT04781387|455707303|FG001|Overall Study|Withdrawal by Subject|0|||
126658370|NCT04781387|455707304|FG002|Overall Study|Withdrawal by Subject|1|||
126658371|NCT04781387|455707302|FG000|Overall Study|Lost to Follow-up|1|||
126658372|NCT04781387|455707303|FG001|Overall Study|Lost to Follow-up|0|||
126658373|NCT04781387|455707304|FG002|Overall Study|Lost to Follow-up|0|||
126658374|NCT01580969|455707305|FG000|Overall Study|Physician Decision|3|||
126658375|NCT01580969|455707306|FG001|Overall Study|Physician Decision|0|||
126658376|NCT01580969|455707307|FG002|Overall Study|Physician Decision|0|||
126658377|NCT01275131|455707311|FG000|Period 1|Withdrawal by Subject|1|||
126658378|NCT01275131|455707312|FG001|Period 1|Withdrawal by Subject|0|||
126658379|NCT01275131|455707313|FG002|Period 1|Withdrawal by Subject|3|||
126658380|NCT01275131|455707314|FG003|Period 1|Withdrawal by Subject|2|||
126658381|NCT01275131|455707311|FG000|Period 1|Physician Decision|1|||
126658382|NCT01275131|455707312|FG001|Period 1|Physician Decision|0|||
126658383|NCT01275131|455707313|FG002|Period 1|Physician Decision|0|||
126658384|NCT01275131|455707314|FG003|Period 1|Physician Decision|0|||
126658385|NCT01275131|455707311|FG000|Period 2 (Crossover)|Adverse Event|0|||
126658386|NCT01275131|455707312|FG001|Period 2 (Crossover)|Adverse Event|1|||
126658387|NCT01275131|455707313|FG002|Period 2 (Crossover)|Adverse Event|0|||
126658388|NCT01275131|455707314|FG003|Period 2 (Crossover)|Adverse Event|0|||
126658389|NCT01275131|455707311|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
126658390|NCT01275131|455707312|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
126658391|NCT01275131|455707313|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
126658392|NCT01275131|455707314|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
126658393|NCT01551212|455707317|FG000|Overall Study|Graft loss/Retransplantation|0|||
126658394|NCT01551212|455707318|FG001|Overall Study|Graft loss/Retransplantation|1|||
126658395|NCT01551212|455707317|FG000|Overall Study|Administrative problems|1|||
126658396|NCT01551212|455707318|FG001|Overall Study|Administrative problems|2|||
126658397|NCT01551212|455707317|FG000|Overall Study|Lost to Follow-up|0|||
126658398|NCT01551212|455707318|FG001|Overall Study|Lost to Follow-up|1|||
126658399|NCT01551212|455707317|FG000|Overall Study|Protocol Violation|0|||
126658400|NCT01551212|455707318|FG001|Overall Study|Protocol Violation|1|||
126658401|NCT01551212|455707317|FG000|Overall Study|Withdrawal by Subject|0|||
126658402|NCT01551212|455707318|FG001|Overall Study|Withdrawal by Subject|7|||
126658403|NCT01551212|455707317|FG000|Overall Study|Death|2|||
126658404|NCT01551212|455707318|FG001|Overall Study|Death|4|||
126658405|NCT01551212|455707317|FG000|Overall Study|Never Received Study Treatment|2|||
126658406|NCT01551212|455707318|FG001|Overall Study|Never Received Study Treatment|4|||
126658407|NCT00705523|455707319|FG000|Overall Study|Lost to Follow-up|2|||
126658408|NCT00705523|455707320|FG001|Overall Study|Lost to Follow-up|3|||
126658409|NCT03110185|455707323|FG000|Overall Study|Death|0|||
126658410|NCT03110185|455707324|FG001|Overall Study|Death|1|||
126330207|NCT01677182|454503280|FG001|Overall Study|Study termination|9|||
126658411|NCT03110185|455707323|FG000|Overall Study|Withdrawal by Subject|2|||
126658412|NCT03110185|455707324|FG001|Overall Study|Withdrawal by Subject|7|||
126658413|NCT03110185|455707323|FG000|Overall Study|Time Constraints|0|||
126658414|NCT03110185|455707324|FG001|Overall Study|Time Constraints|6|||
126658415|NCT03110185|455707323|FG000|Overall Study|Conflict with care|5|||
126658416|NCT03110185|455707324|FG001|Overall Study|Conflict with care|12|||
126658417|NCT03110185|455707323|FG000|Overall Study|Protocol Violation|1|||
126658418|NCT03110185|455707324|FG001|Overall Study|Protocol Violation|4|||
126658419|NCT03110185|455707323|FG000|Overall Study|MRI Incompatible|2|||
126658420|NCT03110185|455707324|FG001|Overall Study|MRI Incompatible|0|||
126658421|NCT03110185|455707323|FG000|Overall Study|Patient Refusal|0|||
126658422|NCT03110185|455707324|FG001|Overall Study|Patient Refusal|1|||
126658423|NCT01575028|455707328|FG000|Overall Study|Physician Decision|0|||
126658424|NCT01575028|455707329|FG001|Overall Study|Physician Decision|1|||
126658425|NCT00529958|455707333|FG000|2-Year Follow-up|Lost to Follow-up|1|||
126658426|NCT00529958|455707334|FG001|2-Year Follow-up|Lost to Follow-up|2|||
126658427|NCT00529958|455707335|FG002|2-Year Follow-up|Lost to Follow-up|2|||
126330208|NCT01677182|454503281|FG002|Overall Study|Study termination|11|||
126658428|NCT00529958|455707333|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
126658429|NCT00529958|455707334|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
126658430|NCT00529958|455707335|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
126658431|NCT00529958|455707333|FG000|5-Year Follow-up|Lost to Follow-up|2|||
126330209|NCT01677182|454503279|FG000|Overall Study|Lack of Efficacy|3|||
126330210|NCT01677182|454503280|FG001|Overall Study|Lack of Efficacy|0|||
126658432|NCT00529958|455707334|FG001|5-Year Follow-up|Lost to Follow-up|3|||
126658433|NCT00529958|455707335|FG002|5-Year Follow-up|Lost to Follow-up|1|||
126658434|NCT00529958|455707333|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
126658435|NCT00529958|455707334|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
126330211|NCT01677182|454503281|FG002|Overall Study|Lack of Efficacy|1|||
126330212|NCT01677182|454503279|FG000|Overall Study|Other reasons|1|||
126658436|NCT00529958|455707335|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
126658437|NCT03534284|455707337|FG000|Overall Study|Death|2|||
126658438|NCT03534284|455707338|FG001|Overall Study|Death|3|||
126658439|NCT03534284|455707339|FG002|Overall Study|Death|3|||
126658440|NCT03534284|455707337|FG000|Overall Study|Withdrawal by Subject|5|||
126658441|NCT03534284|455707338|FG001|Overall Study|Withdrawal by Subject|0|||
126658442|NCT03534284|455707339|FG002|Overall Study|Withdrawal by Subject|0|||
126658443|NCT03316300|455707340|FG000|Overall Study|Withdrawal by Subject|3|||
126658444|NCT03316300|455707341|FG001|Overall Study|Withdrawal by Subject|2|||
126658445|NCT03316300|455707340|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
126658446|NCT03316300|455707341|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
126658447|NCT03316300|455707340|FG000|Overall Study|Adverse Event|1|||
126658448|NCT03316300|455707341|FG001|Overall Study|Adverse Event|0|||
126658449|NCT03316300|455707340|FG000|Overall Study|COVID-19|0|||
126658450|NCT03316300|455707341|FG001|Overall Study|COVID-19|1|||
126658451|NCT04737187|455707343|FG000|Overall Study|Switched to marketed drug|32|||
126658452|NCT04737187|455707344|FG001|Overall Study|Switched to marketed drug|4|||
126658453|NCT04737187|455707343|FG000|Overall Study|Radiological Progressive Disease|145|||
126658454|NCT04737187|455707344|FG001|Overall Study|Radiological Progressive Disease|146|||
126658455|NCT04737187|455707343|FG000|Overall Study|Clinical Progressive Disease|20|||
126658456|NCT04737187|455707344|FG001|Overall Study|Clinical Progressive Disease|20|||
126658457|NCT04737187|455707343|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
126658458|NCT04737187|455707344|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
126658459|NCT04737187|455707343|FG000|Overall Study|Adverse Event|16|||
126658460|NCT04737187|455707344|FG001|Overall Study|Adverse Event|16|||
126658461|NCT04737187|455707343|FG000|Overall Study|Physician Decision|2|||
126658462|NCT04737187|455707344|FG001|Overall Study|Physician Decision|0|||
126658463|NCT04737187|455707343|FG000|Overall Study|Withdrawal by Subject|5|||
126658464|NCT04737187|455707344|FG001|Overall Study|Withdrawal by Subject|8|||
126658465|NCT03756129|455707345|FG000|Overall Study|Adverse Event|1|||
126658466|NCT03756129|455707346|FG001|Overall Study|Adverse Event|1|||
126658467|NCT03756129|455707347|FG002|Overall Study|Adverse Event|0|||
126658468|NCT03756129|455707348|FG003|Overall Study|Adverse Event|2|||
126658469|NCT03756129|455707349|FG004|Overall Study|Adverse Event|0|||
126658470|NCT03756129|455707350|FG005|Overall Study|Adverse Event|0|||
126658471|NCT03756129|455707345|FG000|Overall Study|Withdrawal by Subject|2|||
126658472|NCT03756129|455707346|FG001|Overall Study|Withdrawal by Subject|1|||
126330213|NCT01677182|454503280|FG001|Overall Study|Other reasons|5|||
126330214|NCT01677182|454503281|FG002|Overall Study|Other reasons|2|||
126330215|NCT00762762|454503286|FG000|Overall Study|Did not return for appointments|6|||
126330216|NCT00762762|454503287|FG001|Overall Study|Did not return for appointments|8|||
126330217|NCT02489448|454503288|FG000|Overall Study|Death|3|||
126330218|NCT02489448|454503288|FG000|Overall Study|Withdrawal by Subject|2|||
126330219|NCT00391872|454503290|FG000|Overall Study|Protocol Violation|7|||
126330220|NCT00391872|454503291|FG001|Overall Study|Protocol Violation|2|||
126330221|NCT00391872|454503290|FG000|Overall Study|Withdrawal by Subject|296|||
126330222|NCT00391872|454503291|FG001|Overall Study|Withdrawal by Subject|249|||
126330223|NCT00391872|454503290|FG000|Overall Study|Reason unknown|2|||
126330224|NCT00391872|454503291|FG001|Overall Study|Reason unknown|4|||
126330225|NCT00391872|454503290|FG000|Overall Study|Lost to Follow-up|2|||
126330226|NCT00391872|454503291|FG001|Overall Study|Lost to Follow-up|0|||
126330227|NCT00215644|454503293|FG000|Overall Study|Disease Progression|28|||
126330228|NCT00215644|454503294|FG001|Overall Study|Disease Progression|10|||
126330229|NCT00215644|454503293|FG000|Overall Study|Adverse Event|2|||
126330230|NCT00215644|454503294|FG001|Overall Study|Adverse Event|9|||
126330231|NCT00215644|454503293|FG000|Overall Study|Death|1|||
126330232|NCT00215644|454503294|FG001|Overall Study|Death|2|||
126330233|NCT00215644|454503293|FG000|Overall Study|Withdrawal by Subject|1|||
126330234|NCT00215644|454503294|FG001|Overall Study|Withdrawal by Subject|0|||
126330235|NCT00215644|454503293|FG000|Overall Study|Other|3|||
126330236|NCT00215644|454503294|FG001|Overall Study|Other|15|||
126330237|NCT00215644|454503293|FG000|Overall Study|Randomized but Not Treated|1|||
126658473|NCT03756129|455707347|FG002|Overall Study|Withdrawal by Subject|3|||
126658474|NCT03756129|455707348|FG003|Overall Study|Withdrawal by Subject|1|||
126658475|NCT03756129|455707349|FG004|Overall Study|Withdrawal by Subject|1|||
126658476|NCT03756129|455707350|FG005|Overall Study|Withdrawal by Subject|3|||
126330238|NCT00215644|454503294|FG001|Overall Study|Randomized but Not Treated|0|||
126330239|NCT02861664|454503297|FG000|Overall Study|Withdrawal of Consent|0|||
126330240|NCT02861664|454503298|FG001|Overall Study|Withdrawal of Consent|1|||
126330241|NCT01239394|454503299|FG000|Overall Study|Adverse Event|1|||
126330242|NCT00905632|454503301|FG000|Overall Study|Adverse Event|0|||
126330243|NCT00905632|454503302|FG001|Overall Study|Adverse Event|0|||
126330244|NCT00905632|454503303|FG002|Overall Study|Adverse Event|0|||
126330245|NCT00905632|454503304|FG003|Overall Study|Adverse Event|0|||
126658477|NCT03756129|455707345|FG000|Overall Study|Lost to Follow-up|0|||
126658478|NCT03756129|455707346|FG001|Overall Study|Lost to Follow-up|0|||
126658479|NCT03756129|455707347|FG002|Overall Study|Lost to Follow-up|0|||
126658480|NCT03756129|455707348|FG003|Overall Study|Lost to Follow-up|0|||
126658481|NCT03756129|455707349|FG004|Overall Study|Lost to Follow-up|0|||
126658482|NCT03756129|455707350|FG005|Overall Study|Lost to Follow-up|1|||
126658483|NCT03756129|455707345|FG000|Overall Study|Physician Decision|0|||
126658484|NCT03756129|455707346|FG001|Overall Study|Physician Decision|0|||
126658485|NCT03756129|455707347|FG002|Overall Study|Physician Decision|0|||
126658486|NCT03756129|455707348|FG003|Overall Study|Physician Decision|0|||
126658487|NCT03756129|455707349|FG004|Overall Study|Physician Decision|0|||
126658488|NCT03756129|455707350|FG005|Overall Study|Physician Decision|1|||
126330246|NCT00905632|454503305|FG004|Overall Study|Adverse Event|0|||
126330247|NCT00905632|454503306|FG005|Overall Study|Adverse Event|1|||
126330248|NCT00905632|454503307|FG006|Overall Study|Adverse Event|4|||
126330249|NCT01307891|454503309|FG000|Overall Study|Progressive Disease|3|||
126330250|NCT01307891|454503310|FG001|Overall Study|Progressive Disease|1|||
126330251|NCT02937740|454503311|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
126330252|NCT02937740|454503312|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
126330253|NCT02937740|454503311|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
126330254|NCT02937740|454503312|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
126330255|NCT02937740|454503311|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
126330256|NCT02937740|454503312|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
126330257|NCT02937740|454503311|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
126330258|NCT02937740|454503312|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
126330259|NCT02937740|454503311|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
126330260|NCT02937740|454503312|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
126330261|NCT02937740|454503311|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
126330262|NCT02937740|454503312|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
126330263|NCT00305227|454503317|FG000|Overall Study|Lost to Follow-up|7|||
126330264|NCT00305227|454503318|FG001|Overall Study|Lost to Follow-up|6|||
126330265|NCT04085601|454503319|FG000|Overall Study|Lost to Follow-up|1|||
126330266|NCT04085601|454503320|FG001|Overall Study|Lost to Follow-up|0|||
126330267|NCT04085601|454503319|FG000|Overall Study|Death|1|||
126330268|NCT04085601|454503320|FG001|Overall Study|Death|1|||
126330269|NCT03492437|454503321|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126330270|NCT03492437|454503322|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126330271|NCT04534517|454503324|FG000|Overall Study|Adverse Event|1|||
126330272|NCT04534517|454503324|FG000|Overall Study|Withdrawal by Subject|1|||
126330273|NCT04534517|454503324|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
126330274|NCT04534517|454503324|FG000|Overall Study|COVID-19 Related|1|||
126330275|NCT03872843|454503325|FG000|Overall Study|Lost to Follow-up|5|||
126330276|NCT03872843|454503326|FG001|Overall Study|Lost to Follow-up|7|||
126330277|NCT00823264|454503327|FG000|Overall Study|Protocol Violation|2|||
126330278|NCT00823264|454503328|FG001|Overall Study|Protocol Violation|0|||
126330279|NCT05133323|454503329|FG000|Overall Study|Lack of Efficacy|0|||
126330280|NCT05133323|454503330|FG001|Overall Study|Lack of Efficacy|0|||
126330281|NCT05133323|454503331|FG002|Overall Study|Lack of Efficacy|1|||
126330282|NCT05133323|454503329|FG000|Overall Study|Withdrawal by Subject|2|||
126330283|NCT05133323|454503330|FG001|Overall Study|Withdrawal by Subject|1|||
126330284|NCT05133323|454503331|FG002|Overall Study|Withdrawal by Subject|0|||
126330285|NCT00113295|454503332|FG000|Overall Study|Adverse Event|4|||
126330286|NCT00113295|454503333|FG001|Overall Study|Adverse Event|1|||
126330287|NCT00113295|454503332|FG000|Overall Study|Unrelated Medical Illness|1|||
126330288|NCT00113295|454503333|FG001|Overall Study|Unrelated Medical Illness|0|||
126330289|NCT01714544|454503334|FG000|Overall Study|Lost to Follow-up|1|||
126330290|NCT01714544|454503334|FG000|Overall Study|Physician Decision|1|||
126330291|NCT01714544|454503334|FG000|Overall Study|Withdrawal by Subject|1|||
126330292|NCT00577772|454503343|FG000|Overall Study|Lost to Follow-up|0|||
126330293|NCT00577772|454503344|FG001|Overall Study|Lost to Follow-up|1|||
126330294|NCT00572455|454503345|FG000|Stage I (14 Days)|Adverse Event|0|||
126330295|NCT00572455|454503346|FG001|Stage I (14 Days)|Adverse Event|0|||
126330296|NCT00572455|454503347|FG002|Stage I (14 Days)|Adverse Event|0|||
126330297|NCT00572455|454503348|FG003|Stage I (14 Days)|Adverse Event|0|||
126330298|NCT00572455|454503349|FG004|Stage I (14 Days)|Adverse Event|0|||
126330299|NCT00572455|454503350|FG005|Stage I (14 Days)|Adverse Event|3|||
126330300|NCT00572455|454503351|FG006|Stage I (14 Days)|Adverse Event|0|||
126330301|NCT00572455|454503352|FG007|Stage I (14 Days)|Adverse Event|0|||
126330302|NCT00572455|454503353|FG008|Stage I (14 Days)|Adverse Event|0|||
126330303|NCT00572455|454503354|FG009|Stage I (14 Days)|Adverse Event|0|||
126330304|NCT00572455|454503355|FG010|Stage I (14 Days)|Adverse Event|0|||
126330305|NCT00572455|454503356|FG011|Stage I (14 Days)|Adverse Event|0|||
126658489|NCT01315353|455707351|FG000|Overall Study|Death|2|||
126330306|NCT00572455|454503357|FG012|Stage I (14 Days)|Adverse Event|0|||
126330307|NCT00572455|454503358|FG013|Stage I (14 Days)|Adverse Event|0|||
126330308|NCT00572455|454503345|FG000|Stage I (14 Days)|Other|0|||
126330309|NCT00572455|454503346|FG001|Stage I (14 Days)|Other|0|||
126330310|NCT00572455|454503347|FG002|Stage I (14 Days)|Other|0|||
126330311|NCT00572455|454503348|FG003|Stage I (14 Days)|Other|0|||
126658490|NCT01315353|455707352|FG001|Overall Study|Death|1|||
126330312|NCT00572455|454503349|FG004|Stage I (14 Days)|Other|1|||
126330313|NCT00572455|454503350|FG005|Stage I (14 Days)|Other|0|||
126330314|NCT00572455|454503351|FG006|Stage I (14 Days)|Other|0|||
126330315|NCT00572455|454503352|FG007|Stage I (14 Days)|Other|0|||
126330316|NCT00572455|454503353|FG008|Stage I (14 Days)|Other|0|||
126330317|NCT00572455|454503354|FG009|Stage I (14 Days)|Other|0|||
126330318|NCT00572455|454503355|FG010|Stage I (14 Days)|Other|0|||
126330319|NCT00572455|454503356|FG011|Stage I (14 Days)|Other|0|||
126658491|NCT01315353|455707353|FG002|Overall Study|Death|0|||
126658492|NCT01315353|455707351|FG000|Overall Study|Withdrawal by Subject|2|||
126658493|NCT01315353|455707352|FG001|Overall Study|Withdrawal by Subject|6|||
126658494|NCT01315353|455707353|FG002|Overall Study|Withdrawal by Subject|1|||
126658495|NCT01315353|455707351|FG000|Overall Study|Lost to Follow-up|13|||
126330320|NCT00572455|454503357|FG012|Stage I (14 Days)|Other|0|||
126330321|NCT00572455|454503358|FG013|Stage I (14 Days)|Other|0|||
126330322|NCT00572455|454503345|FG000|Stage II (28 Days)|Adverse Event|0|||
126330323|NCT00572455|454503346|FG001|Stage II (28 Days)|Adverse Event|0|||
126330324|NCT00572455|454503347|FG002|Stage II (28 Days)|Adverse Event|0|||
126330325|NCT00572455|454503348|FG003|Stage II (28 Days)|Adverse Event|0|||
126330326|NCT00572455|454503349|FG004|Stage II (28 Days)|Adverse Event|0|||
126330327|NCT00572455|454503350|FG005|Stage II (28 Days)|Adverse Event|0|||
126330328|NCT00572455|454503351|FG006|Stage II (28 Days)|Adverse Event|0|||
126330329|NCT00572455|454503352|FG007|Stage II (28 Days)|Adverse Event|0|||
126658496|NCT01315353|455707352|FG001|Overall Study|Lost to Follow-up|6|||
126658497|NCT01315353|455707353|FG002|Overall Study|Lost to Follow-up|6|||
126658498|NCT01315353|455707351|FG000|Overall Study|Unwilling to adhere to requirements|5|||
126330330|NCT00572455|454503353|FG008|Stage II (28 Days)|Adverse Event|1|||
126330331|NCT00572455|454503354|FG009|Stage II (28 Days)|Adverse Event|3|||
126330332|NCT00572455|454503355|FG010|Stage II (28 Days)|Adverse Event|3|||
126658499|NCT01315353|455707352|FG001|Overall Study|Unwilling to adhere to requirements|5|||
126658500|NCT01315353|455707353|FG002|Overall Study|Unwilling to adhere to requirements|4|||
126658501|NCT01315353|455707351|FG000|Overall Study|Site closing|7|||
126658502|NCT01315353|455707352|FG001|Overall Study|Site closing|4|||
126658503|NCT01315353|455707353|FG002|Overall Study|Site closing|0|||
126658504|NCT01315353|455707351|FG000|Overall Study|Taken off study by site in error|0|||
126658505|NCT01315353|455707352|FG001|Overall Study|Taken off study by site in error|1|||
126658506|NCT01315353|455707353|FG002|Overall Study|Taken off study by site in error|0|||
126658507|NCT01315353|455707351|FG000|Overall Study|Inadvertent randomization/assignment|0|||
126658508|NCT01315353|455707352|FG001|Overall Study|Inadvertent randomization/assignment|0|||
126658509|NCT01315353|455707353|FG002|Overall Study|Inadvertent randomization/assignment|2|||
126658510|NCT03567434|455707354|FG000|Overall Study|Lost to Follow-up|1|||
126658511|NCT03567434|455707355|FG001|Overall Study|Lost to Follow-up|3|||
126658512|NCT03035201|455707356|FG000|Overall Study|Death|9|||
126658513|NCT03035201|455707357|FG001|Overall Study|Death|12|||
126658514|NCT03035201|455707358|FG002|Overall Study|Death|9|||
126658515|NCT03035201|455707359|FG003|Overall Study|Death|10|||
126658516|NCT03035201|455707356|FG000|Overall Study|Withdrawal by Subject|51|||
126658517|NCT03035201|455707357|FG001|Overall Study|Withdrawal by Subject|49|||
126658518|NCT03035201|455707358|FG002|Overall Study|Withdrawal by Subject|37|||
126658519|NCT03035201|455707359|FG003|Overall Study|Withdrawal by Subject|46|||
126658520|NCT03035201|455707356|FG000|Overall Study|Lost to Follow-up|67|||
126658521|NCT03035201|455707357|FG001|Overall Study|Lost to Follow-up|51|||
126658522|NCT03035201|455707358|FG002|Overall Study|Lost to Follow-up|64|||
126658523|NCT03035201|455707359|FG003|Overall Study|Lost to Follow-up|69|||
126658524|NCT01050790|455707361|FG000|Overall Study|Adverse Event|1|||
126658525|NCT03705832|455707362|FG000|Overall Study|Physician Decision|0|||
126658526|NCT03705832|455707363|FG001|Overall Study|Physician Decision|1|||
126658527|NCT03705832|455707362|FG000|Overall Study|Withdrawal by Subject|1|||
126658528|NCT03705832|455707363|FG001|Overall Study|Withdrawal by Subject|0|||
126658529|NCT01880528|455707364|FG000|Overall Study|Other|1|||
126658530|NCT01880528|455707365|FG001|Overall Study|Other|1|||
126658531|NCT01439360|455707366|FG000|Overall Study|Adverse Event|4|||
126658532|NCT01439360|455707367|FG001|Overall Study|Adverse Event|16|||
126658533|NCT01439360|455707366|FG000|Overall Study|Lost to Follow-up|43|||
126658534|NCT01439360|455707367|FG001|Overall Study|Lost to Follow-up|58|||
126330333|NCT00572455|454503356|FG011|Stage II (28 Days)|Adverse Event|4|||
126330334|NCT00572455|454503357|FG012|Stage II (28 Days)|Adverse Event|5|||
126330335|NCT00572455|454503358|FG013|Stage II (28 Days)|Adverse Event|1|||
126330336|NCT00572455|454503345|FG000|Stage II (28 Days)|Death|0|||
126330337|NCT00572455|454503346|FG001|Stage II (28 Days)|Death|0|||
126330338|NCT00572455|454503347|FG002|Stage II (28 Days)|Death|0|||
126330339|NCT00572455|454503348|FG003|Stage II (28 Days)|Death|0|||
126658535|NCT01439360|455707366|FG000|Overall Study|Others|10|||
126658536|NCT01439360|455707367|FG001|Overall Study|Others|5|||
126330340|NCT00572455|454503349|FG004|Stage II (28 Days)|Death|0|||
126330341|NCT00572455|454503350|FG005|Stage II (28 Days)|Death|0|||
126330342|NCT00572455|454503351|FG006|Stage II (28 Days)|Death|0|||
126330343|NCT00572455|454503352|FG007|Stage II (28 Days)|Death|0|||
126658537|NCT01439360|455707366|FG000|Overall Study|Protocol Violation|1|||
126658538|NCT01439360|455707367|FG001|Overall Study|Protocol Violation|0|||
126658539|NCT01439360|455707366|FG000|Overall Study|Withdrawal by Subject|140|||
126658540|NCT01439360|455707367|FG001|Overall Study|Withdrawal by Subject|129|||
126658541|NCT03727438|455707374|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
126658542|NCT03727438|455707375|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
126658543|NCT03727438|455707374|FG000|Intervention Period|Excluded (health)|1|||
126658544|NCT03727438|455707375|FG001|Intervention Period|Excluded (health)|0|||
126658545|NCT03727438|455707374|FG000|Intervention Period|Withdrawal by Subject|3|||
126658546|NCT03727438|455707375|FG001|Intervention Period|Withdrawal by Subject|1|||
126658547|NCT03727438|455707374|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
126658548|NCT03727438|455707375|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
126658549|NCT03727438|455707374|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
126658550|NCT03727438|455707375|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
126658551|NCT03727438|455707374|FG000|8 Week Assessment|Withdrawal by Subject|6|||
126658552|NCT03727438|455707375|FG001|8 Week Assessment|Withdrawal by Subject|1|||
126658553|NCT03727438|455707374|FG000|6 mo Assessment|did not complete assessment|10|||
126658554|NCT03727438|455707375|FG001|6 mo Assessment|did not complete assessment|11|||
126658555|NCT01912456|455708980|FG000|Period 1|Physician Decision|0|||
126658556|NCT01912456|455708981|FG001|Period 1|Physician Decision|0|||
126658557|NCT01912456|455708982|FG002|Period 1|Physician Decision|1|||
126658558|NCT01912456|455708983|FG003|Period 1|Physician Decision|0|||
126658559|NCT01912456|455708980|FG000|Period 1|non-compliance|1|||
126658560|NCT01912456|455708981|FG001|Period 1|non-compliance|0|||
126658561|NCT01912456|455708982|FG002|Period 1|non-compliance|0|||
126658562|NCT01912456|455708983|FG003|Period 1|non-compliance|1|||
126658563|NCT01912456|455708980|FG000|Period 1|Adverse Event|1|||
126658564|NCT01912456|455708981|FG001|Period 1|Adverse Event|0|||
126658565|NCT01912456|455708982|FG002|Period 1|Adverse Event|0|||
126658566|NCT01912456|455708983|FG003|Period 1|Adverse Event|1|||
126658567|NCT01912456|455708980|FG000|Period 1|Withdrawal by Subject|0|||
126658568|NCT01912456|455708981|FG001|Period 1|Withdrawal by Subject|1|||
126658569|NCT01912456|455708982|FG002|Period 1|Withdrawal by Subject|1|||
126658570|NCT01912456|455708983|FG003|Period 1|Withdrawal by Subject|1|||
126658571|NCT01912456|455708980|FG000|Period 2|Lack of Efficacy|0|||
126658572|NCT01912456|455708981|FG001|Period 2|Lack of Efficacy|2|||
126658573|NCT01912456|455708982|FG002|Period 2|Lack of Efficacy|0|||
126658574|NCT01912456|455708983|FG003|Period 2|Lack of Efficacy|0|||
126658575|NCT01912456|455708980|FG000|Period 2|Adverse Event|0|||
126658576|NCT01912456|455708981|FG001|Period 2|Adverse Event|0|||
126658577|NCT01912456|455708982|FG002|Period 2|Adverse Event|0|||
126658578|NCT01912456|455708983|FG003|Period 2|Adverse Event|1|||
126658579|NCT01201343|455708984|FG000|Overall Study|Adverse Event|6|||
126658580|NCT01201343|455708984|FG000|Overall Study|Withdrawal by Subject|5|||
126658581|NCT01201343|455708984|FG000|Overall Study|Lost to Follow-up|2|||
126658582|NCT01201343|455708984|FG000|Overall Study|Lack of Efficacy|2|||
126658583|NCT01201343|455708984|FG000|Overall Study|Participant wrongly included in trial|1|||
126658584|NCT01201343|455708984|FG000|Overall Study|Randomized, not treated|3|||
126658585|NCT01440374|455708987|FG000|Part 1: Open-label Phase|Adverse Event|5|||
126658586|NCT01440374|455708988|FG001|Part 1: Open-label Phase|Adverse Event|0|||
126658587|NCT01440374|455708989|FG002|Part 1: Open-label Phase|Adverse Event|0|||
126658588|NCT01440374|455708990|FG003|Part 1: Open-label Phase|Adverse Event|0|||
126658589|NCT01440374|455708987|FG000|Part 1: Open-label Phase|Physician Decision|1|||
126658590|NCT01440374|455708988|FG001|Part 1: Open-label Phase|Physician Decision|0|||
126658591|NCT01440374|455708989|FG002|Part 1: Open-label Phase|Physician Decision|0|||
126658592|NCT01440374|455708990|FG003|Part 1: Open-label Phase|Physician Decision|0|||
126658593|NCT01440374|455708987|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
126658594|NCT01440374|455708988|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
126658595|NCT01440374|455708989|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
126658596|NCT01440374|455708990|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
126658597|NCT01440374|455708987|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
126658598|NCT01440374|455708988|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
126658599|NCT01440374|455708989|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
126658600|NCT01440374|455708990|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
126658601|NCT01440374|455708987|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
126658602|NCT01440374|455708988|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
126658603|NCT01440374|455708989|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
126658604|NCT01440374|455708990|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
126658605|NCT01440374|455708987|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
126658606|NCT01440374|455708988|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
126658607|NCT01440374|455708989|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
126658608|NCT01440374|455708990|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
126658609|NCT01440374|455708987|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
126658610|NCT01440374|455708988|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
126658611|NCT01440374|455708989|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
126658612|NCT01440374|455708990|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
126658613|NCT01440374|455708987|FG000|Part 2; Double-blind Phase|Not treated|0|||
126658614|NCT01440374|455708988|FG001|Part 2; Double-blind Phase|Not treated|0|||
126658615|NCT01440374|455708989|FG002|Part 2; Double-blind Phase|Not treated|1|||
126658616|NCT01440374|455708990|FG003|Part 2; Double-blind Phase|Not treated|0|||
126658617|NCT01440374|455708987|FG000|Part 3: Extension|Withdrawal by Subject|0|||
126658618|NCT01440374|455708988|FG001|Part 3: Extension|Withdrawal by Subject|0|||
126658619|NCT01440374|455708989|FG002|Part 3: Extension|Withdrawal by Subject|0|||
126658620|NCT01440374|455708990|FG003|Part 3: Extension|Withdrawal by Subject|5|||
126658621|NCT01440374|455708987|FG000|Part 3: Extension|Adverse Event|0|||
126658622|NCT01440374|455708988|FG001|Part 3: Extension|Adverse Event|0|||
126658623|NCT01440374|455708989|FG002|Part 3: Extension|Adverse Event|0|||
126658624|NCT01440374|455708990|FG003|Part 3: Extension|Adverse Event|13|||
126658625|NCT01440374|455708987|FG000|Part 3: Extension|Physician Decision|0|||
126658626|NCT01440374|455708988|FG001|Part 3: Extension|Physician Decision|0|||
126658627|NCT01440374|455708989|FG002|Part 3: Extension|Physician Decision|0|||
126658628|NCT01440374|455708990|FG003|Part 3: Extension|Physician Decision|14|||
126658629|NCT01177722|455708996|FG000|Overall Study|Serious Adverse Event|0|||
126658630|NCT01177722|455708997|FG001|Overall Study|Serious Adverse Event|0|||
126658631|NCT01177722|455708998|FG002|Overall Study|Serious Adverse Event|1|||
126330344|NCT00572455|454503353|FG008|Stage II (28 Days)|Death|1|||
126330345|NCT00572455|454503354|FG009|Stage II (28 Days)|Death|0|||
126330346|NCT00572455|454503355|FG010|Stage II (28 Days)|Death|0|||
126330347|NCT00572455|454503356|FG011|Stage II (28 Days)|Death|0|||
126330348|NCT00572455|454503357|FG012|Stage II (28 Days)|Death|0|||
126330349|NCT00572455|454503358|FG013|Stage II (28 Days)|Death|0|||
126330350|NCT00572455|454503345|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
126330351|NCT00572455|454503346|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
126658632|NCT01177722|455708999|FG003|Overall Study|Serious Adverse Event|0|||
126658633|NCT01177722|455708996|FG000|Overall Study|Protocol Violation|0|||
126658634|NCT01177722|455708997|FG001|Overall Study|Protocol Violation|0|||
126658635|NCT01177722|455708998|FG002|Overall Study|Protocol Violation|1|||
126658636|NCT01177722|455708999|FG003|Overall Study|Protocol Violation|0|||
126658637|NCT01177722|455708996|FG000|Overall Study|Lost to Follow-up|3|||
126658638|NCT01177722|455708997|FG001|Overall Study|Lost to Follow-up|4|||
126658639|NCT01177722|455708998|FG002|Overall Study|Lost to Follow-up|3|||
126658640|NCT01177722|455708999|FG003|Overall Study|Lost to Follow-up|1|||
126658641|NCT01177722|455708996|FG000|Overall Study|Withdrawal by Subject|10|||
126658642|NCT01177722|455708997|FG001|Overall Study|Withdrawal by Subject|6|||
126658643|NCT01177722|455708998|FG002|Overall Study|Withdrawal by Subject|4|||
126658644|NCT01177722|455708999|FG003|Overall Study|Withdrawal by Subject|6|||
126658645|NCT01222507|455709000|FG000|Overall Study|Physician Decision|1|||
126658646|NCT01222507|455709000|FG000|Overall Study|Withdrawal by Subject|1|||
126658647|NCT02647320|455709001|FG000|Overall Study|Adverse Event|0|||
126658648|NCT02647320|455709002|FG001|Overall Study|Adverse Event|1|||
126658649|NCT02647320|455709003|FG002|Overall Study|Adverse Event|3|||
126658650|NCT02647320|455709004|FG003|Overall Study|Adverse Event|2|||
126658651|NCT02647320|455709005|FG004|Overall Study|Adverse Event|1|||
126658652|NCT02647320|455709001|FG000|Overall Study|Protocol Violation|0|||
126658653|NCT02647320|455709002|FG001|Overall Study|Protocol Violation|0|||
126658654|NCT02647320|455709003|FG002|Overall Study|Protocol Violation|3|||
126658655|NCT02647320|455709004|FG003|Overall Study|Protocol Violation|0|||
126658656|NCT02647320|455709005|FG004|Overall Study|Protocol Violation|0|||
126658657|NCT02647320|455709001|FG000|Overall Study|Withdrawal by Subject|7|||
126658658|NCT02647320|455709002|FG001|Overall Study|Withdrawal by Subject|4|||
126658659|NCT02647320|455709003|FG002|Overall Study|Withdrawal by Subject|2|||
126658660|NCT02647320|455709004|FG003|Overall Study|Withdrawal by Subject|2|||
126658661|NCT02647320|455709005|FG004|Overall Study|Withdrawal by Subject|7|||
126658662|NCT02647320|455709001|FG000|Overall Study|Persistent hyperglycemia|0|||
126658663|NCT02647320|455709002|FG001|Overall Study|Persistent hyperglycemia|1|||
126658664|NCT02647320|455709003|FG002|Overall Study|Persistent hyperglycemia|1|||
126658665|NCT02647320|455709004|FG003|Overall Study|Persistent hyperglycemia|1|||
126658666|NCT02647320|455709005|FG004|Overall Study|Persistent hyperglycemia|1|||
126658667|NCT02647320|455709001|FG000|Overall Study|Study terminated by sponsor|1|||
126658668|NCT02647320|455709002|FG001|Overall Study|Study terminated by sponsor|1|||
126330352|NCT00572455|454503347|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
126330353|NCT00572455|454503348|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
126658669|NCT02647320|455709003|FG002|Overall Study|Study terminated by sponsor|1|||
126658670|NCT02647320|455709004|FG003|Overall Study|Study terminated by sponsor|1|||
126658671|NCT02647320|455709005|FG004|Overall Study|Study terminated by sponsor|2|||
126658672|NCT02647320|455709001|FG000|Overall Study|Reason not provided|0|||
126658673|NCT02647320|455709002|FG001|Overall Study|Reason not provided|0|||
126658674|NCT02647320|455709003|FG002|Overall Study|Reason not provided|1|||
126658675|NCT02647320|455709004|FG003|Overall Study|Reason not provided|0|||
126658676|NCT02647320|455709005|FG004|Overall Study|Reason not provided|2|||
126658677|NCT02647320|455709001|FG000|Overall Study|Lost to Follow-up|1|||
126658678|NCT02647320|455709002|FG001|Overall Study|Lost to Follow-up|1|||
126658679|NCT02647320|455709003|FG002|Overall Study|Lost to Follow-up|0|||
126658680|NCT02647320|455709004|FG003|Overall Study|Lost to Follow-up|0|||
126330354|NCT00572455|454503349|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
126658681|NCT02647320|455709005|FG004|Overall Study|Lost to Follow-up|0|||
126658682|NCT02647320|455709001|FG000|Overall Study|Develop anemia|1|||
126658683|NCT02647320|455709002|FG001|Overall Study|Develop anemia|0|||
126658684|NCT02647320|455709003|FG002|Overall Study|Develop anemia|0|||
126658685|NCT02647320|455709004|FG003|Overall Study|Develop anemia|0|||
126658686|NCT02647320|455709005|FG004|Overall Study|Develop anemia|0|||
126658687|NCT02647320|455709001|FG000|Overall Study|Lack of Efficacy|0|||
126658688|NCT02647320|455709002|FG001|Overall Study|Lack of Efficacy|0|||
126658689|NCT02647320|455709003|FG002|Overall Study|Lack of Efficacy|0|||
126658690|NCT02647320|455709004|FG003|Overall Study|Lack of Efficacy|1|||
126658691|NCT02647320|455709005|FG004|Overall Study|Lack of Efficacy|0|||
126658692|NCT02647320|455709001|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
126658693|NCT02647320|455709002|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
126658694|NCT02647320|455709003|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
126658695|NCT02647320|455709004|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
126658696|NCT02647320|455709005|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
126658697|NCT00596427|455709006|FG000|Overall Study|Withdrawal by Subject|2|||
126658698|NCT00596427|455709007|FG001|Overall Study|Withdrawal by Subject|2|||
126658699|NCT00596427|455709006|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
126658700|NCT00596427|455709007|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
126330355|NCT00572455|454503350|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
126330356|NCT00572455|454503351|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
126330357|NCT00572455|454503352|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
126330358|NCT00572455|454503353|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
126330359|NCT00572455|454503354|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
126330360|NCT00572455|454503355|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
126330361|NCT00572455|454503356|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
126330362|NCT00572455|454503357|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
126330363|NCT00572455|454503358|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
126330364|NCT00572455|454503345|FG000|Stage II (28 Days)|Other|0|||
126330365|NCT00572455|454503346|FG001|Stage II (28 Days)|Other|0|||
126330366|NCT00572455|454503347|FG002|Stage II (28 Days)|Other|0|||
126330367|NCT00572455|454503348|FG003|Stage II (28 Days)|Other|0|||
126330368|NCT00572455|454503349|FG004|Stage II (28 Days)|Other|0|||
126330369|NCT00572455|454503350|FG005|Stage II (28 Days)|Other|0|||
126330370|NCT00572455|454503351|FG006|Stage II (28 Days)|Other|0|||
126330371|NCT00572455|454503352|FG007|Stage II (28 Days)|Other|0|||
126330372|NCT00572455|454503353|FG008|Stage II (28 Days)|Other|1|||
126330373|NCT00572455|454503354|FG009|Stage II (28 Days)|Other|0|||
126330374|NCT00572455|454503355|FG010|Stage II (28 Days)|Other|0|||
126330375|NCT00572455|454503356|FG011|Stage II (28 Days)|Other|0|||
126330376|NCT00572455|454503357|FG012|Stage II (28 Days)|Other|0|||
126330377|NCT00572455|454503358|FG013|Stage II (28 Days)|Other|0|||
126330378|NCT00572455|454503345|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
126330379|NCT00572455|454503346|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
126330380|NCT00572455|454503347|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
126330381|NCT00572455|454503348|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
126330382|NCT00572455|454503349|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
126330383|NCT00572455|454503350|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
126330384|NCT00572455|454503351|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
126330385|NCT00572455|454503352|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
126330386|NCT00572455|454503353|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
126330387|NCT00572455|454503354|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
126330388|NCT00572455|454503355|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
126330389|NCT00572455|454503356|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
126330390|NCT00572455|454503357|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
126330391|NCT00572455|454503358|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
126330392|NCT02824224|454503359|FG000|Overall Study|Discontinued, IUS expulsion|0|||
126330393|NCT02824224|454503360|FG001|Overall Study|Discontinued, IUS expulsion|1|||
126330394|NCT02824224|454503359|FG000|Overall Study|Did not show up for allocation visit|2|||
126330395|NCT02824224|454503360|FG001|Overall Study|Did not show up for allocation visit|0|||
126330396|NCT04152083|454503363|FG000|Overall Study|Lost to Follow-up|2|||
126330397|NCT04152083|454503364|FG001|Overall Study|Lost to Follow-up|1|||
126330398|NCT04152083|454503363|FG000|Overall Study|Adverse Event|1|||
126330399|NCT04152083|454503364|FG001|Overall Study|Adverse Event|0|||
126330400|NCT04152083|454503363|FG000|Overall Study|Randomized but not treated|3|||
126658701|NCT00596427|455709006|FG000|Overall Study|Protocol Violation|1|||
126658702|NCT00596427|455709007|FG001|Overall Study|Protocol Violation|0|||
126330401|NCT04152083|454503364|FG001|Overall Study|Randomized but not treated|2|||
126330402|NCT00856999|454503365|FG000|Overall Study|Withdrawal by Subject|5|||
126330403|NCT02465437|454503370|FG000|Overall Study|Physician Decision|0|||
126330404|NCT02465437|454503371|FG001|Overall Study|Physician Decision|0|||
126658703|NCT00320541|455709008|FG000|Overall Study|Adverse Event|21|||
126658704|NCT00320541|455709009|FG001|Overall Study|Adverse Event|19|||
126330405|NCT02465437|454503372|FG002|Overall Study|Physician Decision|1|||
126330406|NCT02465437|454503373|FG003|Overall Study|Physician Decision|0|||
126330407|NCT02465437|454503370|FG000|Overall Study|Withdrawal by Subject|1|||
126330408|NCT02465437|454503371|FG001|Overall Study|Withdrawal by Subject|0|||
126658705|NCT00320541|455709008|FG000|Overall Study|Protocol Violation|0|||
126658706|NCT00320541|455709009|FG001|Overall Study|Protocol Violation|1|||
126658707|NCT00320541|455709008|FG000|Overall Study|Withdrawal by Subject|12|||
126658708|NCT00320541|455709009|FG001|Overall Study|Withdrawal by Subject|16|||
126658709|NCT00320541|455709008|FG000|Overall Study|Physician Decision|9|||
126658710|NCT00320541|455709009|FG001|Overall Study|Physician Decision|13|||
126658711|NCT00320541|455709008|FG000|Overall Study|Other|3|||
126658712|NCT00320541|455709009|FG001|Overall Study|Other|4|||
126658713|NCT00320541|455709008|FG000|Overall Study|Sponsor Decision|2|||
126658714|NCT00320541|455709009|FG001|Overall Study|Sponsor Decision|1|||
126658715|NCT00320541|455709008|FG000|Overall Study|Death due to Study Disease|1|||
126658716|NCT00320541|455709009|FG001|Overall Study|Death due to Study Disease|3|||
126658717|NCT00320541|455709008|FG000|Overall Study|Death due to Adverse Event(s)|1|||
126658718|NCT00320541|455709009|FG001|Overall Study|Death due to Adverse Event(s)|0|||
126658719|NCT00320541|455709008|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
126658720|NCT00320541|455709009|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
126658721|NCT03057977|455709010|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
126658722|NCT03057977|455709011|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
126658723|NCT03057977|455709010|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
126658724|NCT03057977|455709011|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
126658725|NCT03057977|455709010|FG000|Discontinuation From Treatment|Protocol Violation|6|||
126658726|NCT03057977|455709011|FG001|Discontinuation From Treatment|Protocol Violation|5|||
126658727|NCT03057977|455709010|FG000|Discontinuation From Treatment|Not treated|4|||
126658728|NCT03057977|455709011|FG001|Discontinuation From Treatment|Not treated|0|||
126658729|NCT03057977|455709010|FG000|Discontinuation From Treatment|Adverse Event|343|||
126658730|NCT03057977|455709011|FG001|Discontinuation From Treatment|Adverse Event|337|||
126658731|NCT03057977|455709010|FG000|Discontinuation From Treatment|Reason Unknown|0|||
126658732|NCT03057977|455709011|FG001|Discontinuation From Treatment|Reason Unknown|1|||
126658733|NCT03057977|455709010|FG000|Discontinuation From Treatment|Personal Reasons|1|||
126658734|NCT03057977|455709011|FG001|Discontinuation From Treatment|Personal Reasons|1|||
126658735|NCT03057977|455709010|FG000|Discontinuation From Treatment|Unblinded medication|1|||
126658736|NCT03057977|455709011|FG001|Discontinuation From Treatment|Unblinded medication|0|||
126658737|NCT03057977|455709010|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
126658738|NCT03057977|455709011|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
126658739|NCT03057977|455709010|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
126658740|NCT03057977|455709011|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
126658741|NCT03057977|455709010|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
126658742|NCT03057977|455709011|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
126658743|NCT03057977|455709010|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
126658744|NCT03057977|455709011|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
126658745|NCT03057977|455709010|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
126658746|NCT03057977|455709011|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
126658747|NCT03057977|455709010|FG000|Discontinuation From Treatment|Not attending study visit|3|||
126658748|NCT03057977|455709011|FG001|Discontinuation From Treatment|Not attending study visit|10|||
126658749|NCT03057977|455709010|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
126658750|NCT03057977|455709011|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
126658751|NCT03057977|455709010|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
126658752|NCT03057977|455709011|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
126658753|NCT03057977|455709010|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
126658754|NCT03057977|455709011|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
126658755|NCT03057977|455709010|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
126658756|NCT03057977|455709011|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
126658757|NCT03057977|455709010|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
126658758|NCT03057977|455709011|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
126658759|NCT01650246|455709014|FG000|Overall Study|Adverse Event|23|||
126658760|NCT01650246|455709014|FG000|Overall Study|Protocol Violation|5|||
126658761|NCT01650246|455709014|FG000|Overall Study|Sponsor terminated study|53|||
126658762|NCT01650246|455709014|FG000|Overall Study|Lost to Follow-up|5|||
126658763|NCT01650246|455709014|FG000|Overall Study|Withdrawal by Subject|26|||
126658764|NCT01650246|455709014|FG000|Overall Study|Death|1|||
126658765|NCT01650246|455709014|FG000|Overall Study|Lack of Efficacy|30|||
126658766|NCT00953407|455709015|FG000|Overall Study|Failed inclusion criteria|1|||
126658767|NCT00953407|455709016|FG001|Overall Study|Failed inclusion criteria|1|||
126658768|NCT00953407|455709017|FG002|Overall Study|Failed inclusion criteria|1|||
126330409|NCT02465437|454503372|FG002|Overall Study|Withdrawal by Subject|0|||
126330410|NCT02465437|454503373|FG003|Overall Study|Withdrawal by Subject|1|||
126330411|NCT02465437|454503370|FG000|Overall Study|Adverse Event|0|||
126658769|NCT00953407|455709018|FG003|Overall Study|Failed inclusion criteria|1|||
126658770|NCT00953407|455709019|FG004|Overall Study|Failed inclusion criteria|1|||
126658771|NCT00953407|455709015|FG000|Overall Study|Lost to Follow-up|0|||
126658772|NCT00953407|455709016|FG001|Overall Study|Lost to Follow-up|0|||
126658773|NCT00953407|455709017|FG002|Overall Study|Lost to Follow-up|0|||
126658774|NCT00953407|455709018|FG003|Overall Study|Lost to Follow-up|1|||
126658775|NCT00953407|455709019|FG004|Overall Study|Lost to Follow-up|0|||
126658776|NCT03435497|455709021|FG000|Overall Study|Lost to Follow-up|1|||
126658777|NCT03435497|455709022|FG001|Overall Study|Lost to Follow-up|0|||
126658778|NCT03435497|455709021|FG000|Overall Study|Death|1|||
126658779|NCT03435497|455709022|FG001|Overall Study|Death|0|||
126658780|NCT03435497|455709021|FG000|Overall Study|Withdrawal by Subject|0|||
126658781|NCT03435497|455709022|FG001|Overall Study|Withdrawal by Subject|4|||
126658782|NCT03435497|455709021|FG000|Overall Study|Wrong survey administered|0|||
126658783|NCT03435497|455709022|FG001|Overall Study|Wrong survey administered|2|||
126658784|NCT00701779|455709023|FG000|Overall Study|Adverse Event|6|||
126658785|NCT00701779|455709023|FG000|Overall Study|Lost to Follow-up|1|||
126658786|NCT00701779|455709023|FG000|Overall Study|Withdrawal by Subject|2|||
126658787|NCT05220254|455709025|FG000|Overall Study|Withdrawal by Subject|4|||
126658788|NCT05220254|455709025|FG000|Overall Study|Removed due to ineligibility|1|||
126658789|NCT05220254|455709025|FG000|Overall Study|Lost to Follow-up|7|||
126658790|NCT01557283|455709026|FG000|Overall Study|Lost to Follow-up|7|||
126658791|NCT01557283|455709026|FG000|Overall Study|Non-responder|19|||
126658792|NCT01557283|455709026|FG000|Overall Study|Adverse Event|7|||
126658793|NCT01557283|455709026|FG000|Overall Study|Lack of Efficacy|1|||
126658794|NCT01557283|455709026|FG000|Overall Study|Non-compliance|1|||
126658795|NCT01557283|455709026|FG000|Overall Study|Withdrawal by Subject|1|||
126658796|NCT01557283|455709026|FG000|Overall Study|Participant's weight too high for dose|1|||
126658797|NCT01557283|455709026|FG000|Overall Study|Worsening of psoriasis|1|||
126658798|NCT01557283|455709026|FG000|Overall Study|Other|6|||
126658799|NCT00120406|455709027|FG000|Overall Study|Death|9|||
126658800|NCT00120406|455709028|FG001|Overall Study|Death|4|||
126658801|NCT00120406|455709027|FG000|Overall Study|Withdrawal by Subject|5|||
126658802|NCT00120406|455709028|FG001|Overall Study|Withdrawal by Subject|7|||
126658803|NCT00120406|455709027|FG000|Overall Study|Lost to Follow-up|5|||
126658804|NCT00120406|455709028|FG001|Overall Study|Lost to Follow-up|2|||
126658805|NCT00120406|455709027|FG000|Overall Study|received non-study stent|0|||
126658806|NCT00120406|455709028|FG001|Overall Study|received non-study stent|2|||
126658807|NCT00120406|455709027|FG000|Overall Study|patient moved but has not withdrawn|0|||
126658808|NCT00120406|455709028|FG001|Overall Study|patient moved but has not withdrawn|1|||
126658809|NCT00250679|455709029|FG000|Overall Study|Adverse Event|12|||
126658810|NCT00250679|455709030|FG001|Overall Study|Adverse Event|15|||
126658811|NCT00250679|455709031|FG002|Overall Study|Adverse Event|16|||
126658812|NCT00250679|455709029|FG000|Overall Study|Protocol Violation|2|||
126658813|NCT00250679|455709030|FG001|Overall Study|Protocol Violation|4|||
126658814|NCT00250679|455709031|FG002|Overall Study|Protocol Violation|3|||
126658815|NCT00250679|455709029|FG000|Overall Study|Withdrawal by Subject|15|||
126658816|NCT00250679|455709030|FG001|Overall Study|Withdrawal by Subject|18|||
126658817|NCT00250679|455709031|FG002|Overall Study|Withdrawal by Subject|15|||
126658818|NCT00250679|455709029|FG000|Overall Study|Lost to Follow-up|3|||
126658819|NCT00250679|455709030|FG001|Overall Study|Lost to Follow-up|4|||
126658820|NCT00250679|455709031|FG002|Overall Study|Lost to Follow-up|2|||
126658821|NCT00250679|455709029|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
126658822|NCT00250679|455709030|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
126658823|NCT00250679|455709031|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
126658824|NCT00250679|455709029|FG000|Overall Study|Lack of Efficacy|0|||
126658825|NCT00250679|455709030|FG001|Overall Study|Lack of Efficacy|1|||
126658826|NCT00250679|455709031|FG002|Overall Study|Lack of Efficacy|3|||
126658827|NCT00250679|455709029|FG000|Overall Study|Technical Holter issues|1|||
126658828|NCT00250679|455709030|FG001|Overall Study|Technical Holter issues|0|||
126658829|NCT00250679|455709031|FG002|Overall Study|Technical Holter issues|2|||
126658830|NCT00250679|455709029|FG000|Overall Study|Moved|1|||
126658831|NCT00250679|455709030|FG001|Overall Study|Moved|1|||
126658832|NCT00250679|455709031|FG002|Overall Study|Moved|0|||
126658833|NCT00250679|455709029|FG000|Overall Study|Non-compliance|1|||
126658834|NCT00250679|455709030|FG001|Overall Study|Non-compliance|1|||
126330412|NCT02465437|454503371|FG001|Overall Study|Adverse Event|1|||
126658835|NCT00250679|455709031|FG002|Overall Study|Non-compliance|0|||
126658836|NCT00250679|455709029|FG000|Overall Study|various single events: hip surgery,diary|3|||
126658837|NCT00250679|455709030|FG001|Overall Study|various single events: hip surgery,diary|1|||
126658838|NCT00250679|455709031|FG002|Overall Study|various single events: hip surgery,diary|1|||
126658839|NCT03907410|455709032|FG000|Overall Study|Lost to Follow-up|4|||
126658840|NCT03907410|455709033|FG001|Overall Study|Lost to Follow-up|1|||
126658841|NCT03907410|455709034|FG002|Overall Study|Lost to Follow-up|1|||
126658842|NCT03907410|455709032|FG000|Overall Study|Lost to follow-up and research burden|0|||
126658843|NCT03907410|455709033|FG001|Overall Study|Lost to follow-up and research burden|0|||
126658844|NCT03907410|455709034|FG002|Overall Study|Lost to follow-up and research burden|1|||
126658845|NCT03603028|455709035|FG000|Overall Study|Withdrawal by Subject|1|||
126658846|NCT00842985|455709040|FG000|Screening|Did not meet entrance requirements|27|||
126658847|NCT00842985|455709040|FG000|First Intervention|Withdrawal by Subject|3|||
126658848|NCT00842985|455709040|FG000|First Intervention|Protocol Violation|3|||
126658849|NCT00842985|455709040|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
126658850|NCT00842985|455709040|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
126658851|NCT01037244|455709041|FG000|Overall Study|Adverse Event|3|||
126658852|NCT01037244|455709042|FG001|Overall Study|Adverse Event|2|||
126658853|NCT01037244|455709043|FG002|Overall Study|Adverse Event|6|||
126658854|NCT01037244|455709044|FG003|Overall Study|Adverse Event|3|||
126658855|NCT01037244|455709041|FG000|Overall Study|Lack of Efficacy|1|||
126658856|NCT01037244|455709042|FG001|Overall Study|Lack of Efficacy|1|||
126658857|NCT01037244|455709043|FG002|Overall Study|Lack of Efficacy|0|||
126658858|NCT01037244|455709044|FG003|Overall Study|Lack of Efficacy|1|||
126658859|NCT01037244|455709041|FG000|Overall Study|Lost to Follow-up|3|||
126658860|NCT01037244|455709042|FG001|Overall Study|Lost to Follow-up|3|||
126658861|NCT01037244|455709043|FG002|Overall Study|Lost to Follow-up|4|||
126658862|NCT01037244|455709044|FG003|Overall Study|Lost to Follow-up|4|||
126658863|NCT01037244|455709041|FG000|Overall Study|Withdrawal by Subject|1|||
126658864|NCT01037244|455709042|FG001|Overall Study|Withdrawal by Subject|5|||
126658865|NCT01037244|455709043|FG002|Overall Study|Withdrawal by Subject|3|||
126658866|NCT01037244|455709044|FG003|Overall Study|Withdrawal by Subject|5|||
126658867|NCT01037244|455709041|FG000|Overall Study|Partner Withdrew Consent|2|||
126658868|NCT01037244|455709042|FG001|Overall Study|Partner Withdrew Consent|1|||
126658869|NCT01037244|455709043|FG002|Overall Study|Partner Withdrew Consent|0|||
126658870|NCT01037244|455709044|FG003|Overall Study|Partner Withdrew Consent|0|||
126658871|NCT01037244|455709041|FG000|Overall Study|Various|3|||
126658872|NCT01037244|455709042|FG001|Overall Study|Various|2|||
126658873|NCT01037244|455709043|FG002|Overall Study|Various|1|||
126658874|NCT01037244|455709044|FG003|Overall Study|Various|1|||
126658875|NCT00690820|455709045|FG000|Period 1|Withdrawal by Subject|0|||
126658876|NCT00690820|455709046|FG001|Period 1|Withdrawal by Subject|1|||
126658877|NCT01768117|455709048|FG000|Overall Study|Lost to Follow-up|1|||
126658878|NCT01768117|455709048|FG000|Overall Study|Withdrawal by Subject|2|||
126658879|NCT01768117|455709048|FG000|Overall Study|Protocol Violation|3|||
126658880|NCT01249274|455709051|FG000|Overall Study|Lost to Follow-up|3|||
126658881|NCT01249274|455709052|FG001|Overall Study|Lost to Follow-up|4|||
126658882|NCT01249274|455709051|FG000|Overall Study|Received inpatient substance treatment|1|||
126658883|NCT01249274|455709052|FG001|Overall Study|Received inpatient substance treatment|2|||
126658884|NCT01000636|455709053|FG000|Overall Study|Withdrawal by Subject|1|||
126658885|NCT01000636|455709053|FG000|Overall Study|Adverse Event|1|||
126658886|NCT03451162|455709054|FG000|Overall Study|Lost to Follow-up|1|||
126658887|NCT03451162|455709055|FG001|Overall Study|Lost to Follow-up|0|||
126658888|NCT03451162|455709056|FG002|Overall Study|Lost to Follow-up|0|||
126658889|NCT03451162|455709057|FG003|Overall Study|Lost to Follow-up|0|||
126658890|NCT03451162|455709058|FG004|Overall Study|Lost to Follow-up|0|||
126658891|NCT03451162|455709054|FG000|Overall Study|Physician Decision|0|||
126330413|NCT02465437|454503372|FG002|Overall Study|Adverse Event|0|||
126330414|NCT02465437|454503373|FG003|Overall Study|Adverse Event|0|||
126330415|NCT00003483|454503374|FG000|Overall Study|Not evaluable|1|||
126330416|NCT02401035|454503375|FG000|Overall Study|Withdrawal by Subject|1|||
126330417|NCT02401035|454503376|FG001|Overall Study|Withdrawal by Subject|0|||
126330418|NCT00656175|454503377|FG000|Overall Study|Adverse Event|1|||
126330419|NCT00656175|454503378|FG001|Overall Study|Adverse Event|0|||
126330420|NCT00656175|454503377|FG000|Overall Study|Transportation issues|0|||
126330421|NCT00656175|454503378|FG001|Overall Study|Transportation issues|1|||
126330422|NCT01066871|454503389|FG000|Overall Study|Lost to Follow-up|0|||
126330423|NCT01066871|454503390|FG001|Overall Study|Lost to Follow-up|2|||
126330424|NCT01066871|454503391|FG002|Overall Study|Lost to Follow-up|2|||
126330425|NCT01066871|454503392|FG003|Overall Study|Lost to Follow-up|0|||
126330426|NCT01066871|454503389|FG000|Overall Study|Protocol Violation|1|||
126330427|NCT01066871|454503390|FG001|Overall Study|Protocol Violation|0|||
126330428|NCT01066871|454503391|FG002|Overall Study|Protocol Violation|3|||
126330429|NCT01066871|454503392|FG003|Overall Study|Protocol Violation|2|||
126330430|NCT01066871|454503389|FG000|Overall Study|Lack of Efficacy|0|||
126330431|NCT01066871|454503390|FG001|Overall Study|Lack of Efficacy|0|||
126330432|NCT01066871|454503391|FG002|Overall Study|Lack of Efficacy|0|||
126330433|NCT01066871|454503392|FG003|Overall Study|Lack of Efficacy|1|||
126658892|NCT03451162|455709055|FG001|Overall Study|Physician Decision|1|||
126658893|NCT03451162|455709056|FG002|Overall Study|Physician Decision|0|||
126330434|NCT01066871|454503389|FG000|Overall Study|Withdrawal by Subject|3|||
126330435|NCT01066871|454503390|FG001|Overall Study|Withdrawal by Subject|1|||
126330436|NCT01066871|454503391|FG002|Overall Study|Withdrawal by Subject|0|||
126658894|NCT03451162|455709057|FG003|Overall Study|Physician Decision|0|||
126658895|NCT03451162|455709058|FG004|Overall Study|Physician Decision|0|||
126658896|NCT03451162|455709054|FG000|Overall Study|Withdrawal by Subject|1|||
126658897|NCT03451162|455709055|FG001|Overall Study|Withdrawal by Subject|1|||
126330437|NCT01066871|454503392|FG003|Overall Study|Withdrawal by Subject|0|||
126330438|NCT01066871|454503389|FG000|Overall Study|Other|0|||
126658898|NCT03451162|455709056|FG002|Overall Study|Withdrawal by Subject|0|||
126658899|NCT03451162|455709057|FG003|Overall Study|Withdrawal by Subject|0|||
126658900|NCT03451162|455709058|FG004|Overall Study|Withdrawal by Subject|0|||
126658901|NCT03305731|455709059|FG000|Overall Study|Protocol Violation|1|||
126658902|NCT03658668|455709060|FG000|Overall Study|Time Commitment|1|||
126658903|NCT03658668|455709061|FG001|Overall Study|Time Commitment|1|||
126658904|NCT01127139|455709062|FG000|Overall Study|Adverse Event|40|||
126658905|NCT01127139|455709062|FG000|Overall Study|Incompliance|12|||
126658906|NCT01127139|455709062|FG000|Overall Study|Lack of Efficacy|4|||
126658907|NCT01127139|455709062|FG000|Overall Study|Reason not specified|1|||
126658908|NCT01498653|455709064|FG000|Overall Study|Adverse Event|2|||
126658909|NCT01498653|455709065|FG001|Overall Study|Adverse Event|2|||
126658910|NCT01498653|455709064|FG000|Overall Study|Lack of Efficacy|12|||
126658911|NCT01498653|455709065|FG001|Overall Study|Lack of Efficacy|26|||
126658912|NCT01498653|455709064|FG000|Overall Study|Protocol Violation|0|||
126658913|NCT01498653|455709065|FG001|Overall Study|Protocol Violation|4|||
126658914|NCT01498653|455709064|FG000|Overall Study|Lost to Follow-up|1|||
126658915|NCT01498653|455709065|FG001|Overall Study|Lost to Follow-up|0|||
126658916|NCT01498653|455709064|FG000|Overall Study|Physician Decision|2|||
126658917|NCT01498653|455709065|FG001|Overall Study|Physician Decision|0|||
126658918|NCT01498653|455709064|FG000|Overall Study|Withdrawal by Subject|2|||
126658919|NCT01498653|455709065|FG001|Overall Study|Withdrawal by Subject|3|||
126658920|NCT02216357|455709067|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
126658921|NCT02216357|455709068|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
126658922|NCT04964414|455709070|FG000|Overall Study|Lost to Follow-up|10|||
126658923|NCT04964414|455709071|FG001|Overall Study|Lost to Follow-up|8|||
126658924|NCT04964414|455709070|FG000|Overall Study|Withdrawal by Subject|1|||
126658925|NCT04964414|455709071|FG001|Overall Study|Withdrawal by Subject|1|||
126658926|NCT01079741|455709080|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
126658927|NCT01079741|455709081|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
126658928|NCT01079741|455709082|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
126658929|NCT01079741|455709083|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
126658930|NCT01079741|455709084|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
126658931|NCT01079741|455709080|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
126658932|NCT01079741|455709081|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
126658933|NCT01079741|455709082|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
126658934|NCT01079741|455709083|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
126658935|NCT01079741|455709084|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
126658936|NCT00446992|455709085|FG000|Overall Study|Adverse Event|11|||
126658937|NCT00446992|455709085|FG000|Overall Study|Lost to Follow-up|5|||
126658938|NCT02076178|455709086|FG000|Oral Phase|Adverse Event|0|||
126658939|NCT02076178|455709087|FG001|Oral Phase|Adverse Event|7|||
126658940|NCT02076178|455709086|FG000|Oral Phase|Withdrawal by Subject|0|||
126658941|NCT02076178|455709087|FG001|Oral Phase|Withdrawal by Subject|4|||
126658942|NCT02076178|455709086|FG000|Oral Phase|Physician Decision|0|||
126658943|NCT02076178|455709087|FG001|Oral Phase|Physician Decision|1|||
126658944|NCT02076178|455709086|FG000|Injection Phase|Protocol defined stopping criteria|1|||
126658945|NCT02076178|455709087|FG001|Injection Phase|Protocol defined stopping criteria|0|||
126658946|NCT02076178|455709086|FG000|Injection Phase|Withdrawal by Subject|0|||
126658947|NCT02076178|455709087|FG001|Injection Phase|Withdrawal by Subject|3|||
126658948|NCT02076178|455709086|FG000|Injection Phase|Physician Decision|0|||
126658949|NCT02076178|455709087|FG001|Injection Phase|Physician Decision|3|||
126658950|NCT02076178|455709086|FG000|Injection Phase|Lost to Follow-up|0|||
126658951|NCT02076178|455709087|FG001|Injection Phase|Lost to Follow-up|1|||
126658952|NCT02434939|455709095|FG000|Overall Study|Lack of Efficacy|34|||
126658953|NCT02434939|455709096|FG001|Overall Study|Lack of Efficacy|48|||
126658954|NCT02434939|455709095|FG000|Overall Study|Withdrawal by Subject|3|||
126658955|NCT02434939|455709096|FG001|Overall Study|Withdrawal by Subject|0|||
126658956|NCT02434939|455709095|FG000|Overall Study|Adverse Event|0|||
126658957|NCT02434939|455709096|FG001|Overall Study|Adverse Event|1|||
126658958|NCT00710021|455709097|FG000|Overall Study|Lost to Follow-up|1|||
126658959|NCT00710021|455709098|FG001|Overall Study|Lost to Follow-up|0|||
126658960|NCT00710021|455709099|FG002|Overall Study|Lost to Follow-up|0|||
126330439|NCT01066871|454503390|FG001|Overall Study|Other|2|||
126658961|NCT00710021|455709097|FG000|Overall Study|Subject's Decision|0|||
126658962|NCT00710021|455709098|FG001|Overall Study|Subject's Decision|1|||
126658963|NCT00710021|455709099|FG002|Overall Study|Subject's Decision|0|||
126658964|NCT00710021|455709097|FG000|Overall Study|Subject misrandomized|0|||
126658965|NCT00710021|455709098|FG001|Overall Study|Subject misrandomized|1|||
126658966|NCT00710021|455709099|FG002|Overall Study|Subject misrandomized|1|||
126658967|NCT00710021|455709097|FG000|Overall Study|Physician Decision|0|||
126658968|NCT00710021|455709098|FG001|Overall Study|Physician Decision|1|||
126658969|NCT00710021|455709099|FG002|Overall Study|Physician Decision|0|||
126658970|NCT01536015|455709100|FG000|Overall Study|Adverse Event|1|||
126658971|NCT01536015|455709101|FG001|Overall Study|Adverse Event|4|||
126658972|NCT01536015|455709100|FG000|Overall Study|Lost to Follow-up|0|||
126658973|NCT01536015|455709101|FG001|Overall Study|Lost to Follow-up|1|||
126658974|NCT01536015|455709100|FG000|Overall Study|Inclusion Criterion not met|2|||
126658975|NCT01536015|455709101|FG001|Overall Study|Inclusion Criterion not met|0|||
126658976|NCT01536015|455709100|FG000|Overall Study|Study closure|5|||
126658977|NCT01536015|455709101|FG001|Overall Study|Study closure|5|||
126658978|NCT00001962|455710504|FG000|Overall Study|Lack of Efficacy|18|||
126658979|NCT00001962|455710504|FG000|Overall Study|Lack of Accrual|6|||
126658980|NCT00001962|455710504|FG000|Overall Study|Death|1|||
126658981|NCT00001962|455710504|FG000|Overall Study|Lost to Follow-up|2|||
126658982|NCT00001962|455710504|FG000|Overall Study|Adverse Event|1|||
126658983|NCT03442985|455710508|FG000|Overall Study|Sponsor Request|55|||
126658984|NCT03442985|455710509|FG001|Overall Study|Sponsor Request|60|||
126658985|NCT03442985|455710510|FG002|Overall Study|Sponsor Request|54|||
126658986|NCT03442985|455710508|FG000|Overall Study|Lost to Follow-up|5|||
126658987|NCT03442985|455710509|FG001|Overall Study|Lost to Follow-up|2|||
126658988|NCT03442985|455710510|FG002|Overall Study|Lost to Follow-up|7|||
126658989|NCT03442985|455710508|FG000|Overall Study|Withdrawal by Subject|2|||
126658990|NCT03442985|455710509|FG001|Overall Study|Withdrawal by Subject|3|||
126658991|NCT03442985|455710510|FG002|Overall Study|Withdrawal by Subject|4|||
126658992|NCT03442985|455710508|FG000|Overall Study|Adverse Event|0|||
126658993|NCT03442985|455710509|FG001|Overall Study|Adverse Event|1|||
126658994|NCT03442985|455710510|FG002|Overall Study|Adverse Event|0|||
126658995|NCT01217957|455710511|FG000|Phase 1|Withdrawal by Patient|1|||
126658996|NCT01217957|455710512|FG001|Phase 1|Withdrawal by Patient|0|||
126658997|NCT01217957|455710513|FG002|Phase 1|Withdrawal by Patient|1|||
126658998|NCT01217957|455710514|FG003|Phase 1|Withdrawal by Patient|1|||
126658999|NCT01217957|455710515|FG004|Phase 1|Withdrawal by Patient|0|||
126659000|NCT01217957|455710511|FG000|Phase 2|Withdrawal by Patient|0|||
126659001|NCT01217957|455710512|FG001|Phase 2|Withdrawal by Patient|0|||
126659002|NCT01217957|455710513|FG002|Phase 2|Withdrawal by Patient|0|||
126659003|NCT01217957|455710514|FG003|Phase 2|Withdrawal by Patient|0|||
126659004|NCT01217957|455710515|FG004|Phase 2|Withdrawal by Patient|1|||
126659005|NCT03645057|455710519|FG000|Randomization to Baseline|Lost to Follow-up|1|||
126659006|NCT03645057|455710520|FG001|Randomization to Baseline|Lost to Follow-up|0|||
126659007|NCT03645057|455710521|FG002|Randomization to Baseline|Lost to Follow-up|1|||
126659008|NCT03645057|455710522|FG003|Randomization to Baseline|Lost to Follow-up|0|||
126659009|NCT03645057|455710519|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
126659010|NCT03645057|455710520|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
126659011|NCT03645057|455710521|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
126659012|NCT03645057|455710522|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
126659013|NCT03645057|455710519|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
126659014|NCT03645057|455710520|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
126659015|NCT03645057|455710521|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
126659016|NCT03645057|455710522|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
126659017|NCT03645057|455710519|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
126659018|NCT03645057|455710520|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
126659019|NCT03645057|455710521|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
126659020|NCT03645057|455710522|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
126659021|NCT01873495|455710523|FG000|Overall Study|Withdrawal by Subject|1|||
126659022|NCT01873495|455710523|FG000|Overall Study|Physician Decision|3|||
126659023|NCT01873495|455710523|FG000|Overall Study|Adverse Event|1|||
126659024|NCT01873495|455710523|FG000|Overall Study|Removed for Transplantation|1|||
126659025|NCT01873495|455710523|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
126659026|NCT01206777|455710524|FG000|Overall Study|Death|1|||
126659027|NCT01206777|455710524|FG000|Overall Study|Adverse Event|1|||
126659028|NCT02986334|455710525|FG000|Overall Study|Withdrawal by Subject|0|||
126659029|NCT02986334|455710526|FG001|Overall Study|Withdrawal by Subject|1|||
126659030|NCT02986334|455710527|FG002|Overall Study|Withdrawal by Subject|2|||
126659031|NCT02986334|455710525|FG000|Overall Study|Lost to Follow-up|1|||
126659032|NCT02986334|455710526|FG001|Overall Study|Lost to Follow-up|2|||
126659033|NCT02986334|455710527|FG002|Overall Study|Lost to Follow-up|1|||
126659034|NCT02986334|455710525|FG000|Overall Study|Adverse Event|0|||
126659035|NCT02986334|455710526|FG001|Overall Study|Adverse Event|2|||
126659036|NCT02986334|455710527|FG002|Overall Study|Adverse Event|1|||
126659037|NCT02986334|455710525|FG000|Overall Study|non compliance in phone ratings|2|||
126659038|NCT02986334|455710526|FG001|Overall Study|non compliance in phone ratings|1|||
126659039|NCT02986334|455710527|FG002|Overall Study|non compliance in phone ratings|2|||
126659040|NCT02986334|455710525|FG000|Overall Study|undisclosed comorbidities|0|||
126659041|NCT02986334|455710526|FG001|Overall Study|undisclosed comorbidities|1|||
126659042|NCT02986334|455710527|FG002|Overall Study|undisclosed comorbidities|1|||
126659043|NCT03864146|455710528|FG000|Overall Study|Lost to Follow-up|14|||
126659044|NCT03864146|455710529|FG001|Overall Study|Lost to Follow-up|23|||
126659045|NCT03864146|455710528|FG000|Overall Study|Withdrawal by Subject|3|||
126659046|NCT03864146|455710529|FG001|Overall Study|Withdrawal by Subject|2|||
126659047|NCT01313637|455710533|FG000|Overall Study|Adverse Event|17|||
126659048|NCT01313637|455710534|FG001|Overall Study|Adverse Event|24|||
126659049|NCT01313637|455710535|FG002|Overall Study|Adverse Event|25|||
126659050|NCT01313637|455710536|FG003|Overall Study|Adverse Event|18|||
126659051|NCT01313637|455710533|FG000|Overall Study|Lack of Efficacy|44|||
126659052|NCT01313637|455710534|FG001|Overall Study|Lack of Efficacy|38|||
126659053|NCT01313637|455710535|FG002|Overall Study|Lack of Efficacy|37|||
126659054|NCT01313637|455710536|FG003|Overall Study|Lack of Efficacy|24|||
126659055|NCT01313637|455710533|FG000|Overall Study|Protocol Violation|4|||
126659056|NCT01313637|455710534|FG001|Overall Study|Protocol Violation|3|||
126659057|NCT01313637|455710535|FG002|Overall Study|Protocol Violation|11|||
126659058|NCT01313637|455710536|FG003|Overall Study|Protocol Violation|5|||
126659059|NCT01313637|455710533|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
126659060|NCT01313637|455710534|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
126659061|NCT01313637|455710535|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
126659062|NCT01313637|455710536|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
126659063|NCT01313637|455710533|FG000|Overall Study|Lost to Follow-up|0|||
126659064|NCT01313637|455710534|FG001|Overall Study|Lost to Follow-up|2|||
126659065|NCT01313637|455710535|FG002|Overall Study|Lost to Follow-up|1|||
126659066|NCT01313637|455710536|FG003|Overall Study|Lost to Follow-up|3|||
126659067|NCT01313637|455710533|FG000|Overall Study|Withdrawal by Subject|11|||
126659068|NCT01313637|455710534|FG001|Overall Study|Withdrawal by Subject|13|||
126659069|NCT01313637|455710535|FG002|Overall Study|Withdrawal by Subject|18|||
126659070|NCT01313637|455710536|FG003|Overall Study|Withdrawal by Subject|15|||
126659071|NCT00846391|455710538|FG000|Overall Study|Physician Decision|0|||
126659072|NCT00846391|455710539|FG001|Overall Study|Physician Decision|0|||
126659073|NCT00846391|455710540|FG002|Overall Study|Physician Decision|1|||
126659074|NCT00846391|455710538|FG000|Overall Study|Study Terminated by Sponsor|1|||
126659075|NCT00846391|455710539|FG001|Overall Study|Study Terminated by Sponsor|2|||
126659076|NCT00846391|455710540|FG002|Overall Study|Study Terminated by Sponsor|2|||
126659077|NCT04634825|455710542|FG000|Overall Study|Death|10|||
126659078|NCT04634825|455710543|FG001|Overall Study|Death|3|||
126659079|NCT04634825|455710542|FG000|Overall Study|Lost to Follow-up|1|||
126659080|NCT04634825|455710543|FG001|Overall Study|Lost to Follow-up|0|||
126659081|NCT04634825|455710542|FG000|Overall Study|Study terminated by sponsor|35|||
126659082|NCT04634825|455710543|FG001|Overall Study|Study terminated by sponsor|11|||
126659083|NCT04634825|455710542|FG000|Overall Study|Withdrawal by Subject|2|||
126659084|NCT04634825|455710543|FG001|Overall Study|Withdrawal by Subject|0|||
126659085|NCT01745848|455710549|FG000|Overall Study|Adverse Event|6|||
126659086|NCT00679627|455710550|FG000|Overall Study|Death|41|||
126659087|NCT00679627|455710551|FG001|Overall Study|Death|29|||
126659088|NCT00679627|455710550|FG000|Overall Study|Adverse Event|43|||
126659089|NCT00679627|455710551|FG001|Overall Study|Adverse Event|53|||
126659090|NCT00679627|455710550|FG000|Overall Study|Withdrawal by Subject|168|||
126659091|NCT00679627|455710551|FG001|Overall Study|Withdrawal by Subject|172|||
126659092|NCT00679627|455710550|FG000|Overall Study|Lost to Follow-up|22|||
126659093|NCT00679627|455710551|FG001|Overall Study|Lost to Follow-up|26|||
126659094|NCT00679627|455710550|FG000|Overall Study|Early Study Closure|425|||
126659095|NCT00679627|455710551|FG001|Overall Study|Early Study Closure|405|||
126659096|NCT01886378|455710552|FG000|Overall Study|Adverse Event|1|||
126659097|NCT01886378|455710552|FG000|Overall Study|Withdrawal by Subject|4|||
126659098|NCT03021954|455710556|FG000|Overall Study|Lost to Follow-up|10|||
126659099|NCT03021954|455710557|FG001|Overall Study|Lost to Follow-up|43|||
126659100|NCT03021954|455710556|FG000|Overall Study|Subjects had avulsion trauma|4|||
126659101|NCT03021954|455710557|FG001|Overall Study|Subjects had avulsion trauma|1|||
126659102|NCT00069238|455710558|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
126659103|NCT00069238|455710559|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
126659104|NCT00069238|455710560|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
126659105|NCT00069238|455710558|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
126659106|NCT00069238|455710559|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
126659107|NCT00069238|455710560|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
126659108|NCT00069238|455710558|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
126659109|NCT00069238|455710559|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
126659110|NCT00069238|455710560|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
126659111|NCT01001832|455710561|FG000|Short-term Period|Adverse Event|2|||
126659112|NCT01001832|455710562|FG001|Short-term Period|Adverse Event|3|||
126659113|NCT01001832|455710561|FG000|Long-term Period|Adverse Event|2|||
126659114|NCT01001832|455710562|FG001|Long-term Period|Adverse Event|1|||
126659115|NCT01001832|455710561|FG000|Long-term Period|Withdrawal by Subject|1|||
126659116|NCT01001832|455710562|FG001|Long-term Period|Withdrawal by Subject|0|||
126659117|NCT01001832|455710561|FG000|Long-term Period|Lack of Efficacy|0|||
126659118|NCT01001832|455710562|FG001|Long-term Period|Lack of Efficacy|2|||
126659119|NCT01001832|455710561|FG000|Long-term Period|Other|1|||
126659120|NCT01001832|455710562|FG001|Long-term Period|Other|2|||
126659121|NCT01001832|455710561|FG000|Follow-up Period|Withdrawal by Subject|1|||
126659122|NCT01001832|455710562|FG001|Follow-up Period|Withdrawal by Subject|0|||
126659123|NCT01001832|455710561|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
126659124|NCT01001832|455710562|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
126659125|NCT01001832|455710561|FG000|Follow-up Period|Other|2|||
126659126|NCT01001832|455710562|FG001|Follow-up Period|Other|1|||
126659127|NCT00807235|455710569|FG000|Overall Study|Adverse Event|1|||
126659128|NCT00807235|455710570|FG001|Overall Study|Adverse Event|0|||
126659129|NCT01765179|455710571|FG000|Overall Study|Adverse Event|3|||
126659130|NCT01765179|455710571|FG000|Overall Study|Lost to Follow-up|5|||
126659131|NCT01765179|455710571|FG000|Overall Study|Non-compliance with study drug|2|||
126659132|NCT01765179|455710571|FG000|Overall Study|Protocol Violation|1|||
126659133|NCT01765179|455710571|FG000|Overall Study|Withdrawal by Subject|8|||
126659134|NCT01765179|455710571|FG000|Overall Study|Hematocrit >54%|3|||
126659135|NCT01765179|455710571|FG000|Overall Study|prohibited med|1|||
126659136|NCT01765179|455710571|FG000|Overall Study|Out of country unable to finish study|1|||
126659137|NCT01765179|455710571|FG000|Overall Study|lack of venous access|1|||
126659138|NCT01765179|455710571|FG000|Overall Study|work conflict|1|||
126659139|NCT01765179|455710571|FG000|Overall Study|Ca elevated 10.6|1|||
126659140|NCT03581825|455710573|FG000|Period 1|Lens Discomfort|1|||
126659141|NCT03581825|455710574|FG001|Period 1|Lens Discomfort|0|||
126659142|NCT03581825|455710573|FG000|Period 2|Unsatisfactory Vision to Test|0|||
126659143|NCT03581825|455710574|FG001|Period 2|Unsatisfactory Vision to Test|1|||
126659144|NCT01668667|455710575|FG000|Overall Study|Adverse Event|3|||
126659145|NCT01668667|455710576|FG001|Overall Study|Adverse Event|6|||
126659146|NCT01668667|455710577|FG002|Overall Study|Adverse Event|4|||
126659147|NCT01668667|455710578|FG003|Overall Study|Adverse Event|4|||
126659148|NCT01668667|455710575|FG000|Overall Study|Lack of Efficacy|3|||
126659149|NCT01668667|455710576|FG001|Overall Study|Lack of Efficacy|2|||
126659150|NCT01668667|455710577|FG002|Overall Study|Lack of Efficacy|2|||
126659151|NCT01668667|455710578|FG003|Overall Study|Lack of Efficacy|3|||
126659152|NCT01668667|455710575|FG000|Overall Study|Protocol Violation|6|||
126659153|NCT01668667|455710576|FG001|Overall Study|Protocol Violation|10|||
126659154|NCT01668667|455710577|FG002|Overall Study|Protocol Violation|12|||
126659155|NCT01668667|455710578|FG003|Overall Study|Protocol Violation|5|||
126659156|NCT01668667|455710575|FG000|Overall Study|Lost to Follow-up|9|||
126659157|NCT01668667|455710576|FG001|Overall Study|Lost to Follow-up|4|||
126659158|NCT01668667|455710577|FG002|Overall Study|Lost to Follow-up|7|||
126659159|NCT01668667|455710578|FG003|Overall Study|Lost to Follow-up|6|||
126659160|NCT01668667|455710575|FG000|Overall Study|Physician Decision|3|||
126659161|NCT01668667|455710576|FG001|Overall Study|Physician Decision|0|||
126659162|NCT01668667|455710577|FG002|Overall Study|Physician Decision|1|||
126659163|NCT01668667|455710578|FG003|Overall Study|Physician Decision|0|||
126659164|NCT01668667|455710575|FG000|Overall Study|Withdrawal by Subject|7|||
126659165|NCT01668667|455710576|FG001|Overall Study|Withdrawal by Subject|4|||
126659166|NCT01668667|455710577|FG002|Overall Study|Withdrawal by Subject|5|||
126659167|NCT01668667|455710578|FG003|Overall Study|Withdrawal by Subject|5|||
126659168|NCT00511901|455710579|FG000|Overall Study|Withdrawal by Subject|1|||
126659169|NCT00511901|455710580|FG001|Overall Study|Withdrawal by Subject|3|||
126659170|NCT00178126|455710581|FG000|Overall Study|Lost to Follow-up|21|||
126659171|NCT00178126|455710582|FG001|Overall Study|Lost to Follow-up|21|||
126659172|NCT00178126|455710581|FG000|Overall Study|did not receive intervention|4|||
126659173|NCT00178126|455710582|FG001|Overall Study|did not receive intervention|6|||
126659174|NCT02447172|455710583|FG000|Overall Study|Adverse Event|11|||
126659175|NCT02447172|455710584|FG001|Overall Study|Adverse Event|8|||
126659176|NCT02447172|455710585|FG002|Overall Study|Adverse Event|7|||
126659177|NCT02447172|455710583|FG000|Overall Study|Death|3|||
126659178|NCT02447172|455710584|FG001|Overall Study|Death|1|||
126659179|NCT02447172|455710585|FG002|Overall Study|Death|0|||
126659180|NCT02447172|455710583|FG000|Overall Study|Protocol Violation|2|||
126659181|NCT02447172|455710584|FG001|Overall Study|Protocol Violation|1|||
126659182|NCT02447172|455710585|FG002|Overall Study|Protocol Violation|2|||
126659183|NCT02447172|455710583|FG000|Overall Study|Lost to Follow-up|7|||
126659184|NCT02447172|455710584|FG001|Overall Study|Lost to Follow-up|4|||
126659185|NCT02447172|455710585|FG002|Overall Study|Lost to Follow-up|4|||
126659186|NCT02447172|455710583|FG000|Overall Study|Withdrawal by Subject|5|||
126659187|NCT02447172|455710584|FG001|Overall Study|Withdrawal by Subject|1|||
126659188|NCT02447172|455710585|FG002|Overall Study|Withdrawal by Subject|3|||
126659189|NCT02447172|455710583|FG000|Overall Study|protocol specific treatment unrelated|3|||
126659190|NCT02447172|455710584|FG001|Overall Study|protocol specific treatment unrelated|0|||
126659191|NCT02447172|455710585|FG002|Overall Study|protocol specific treatment unrelated|2|||
126659192|NCT00427895|455710588|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126659193|NCT00427895|455710589|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126659194|NCT00427895|455710590|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126659195|NCT00427895|455710591|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
126659196|NCT00427895|455710592|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126659197|NCT00427895|455710593|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126659198|NCT00427895|455710594|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126659199|NCT00427895|455710595|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
126659200|NCT00427895|455710588|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126659201|NCT00427895|455710589|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126659202|NCT00427895|455710590|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126659203|NCT00427895|455710591|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126659204|NCT00427895|455710592|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126659205|NCT00427895|455710593|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126659206|NCT00427895|455710594|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
126659207|NCT00427895|455710595|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
126659208|NCT00427895|455710588|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
126659209|NCT00427895|455710589|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
126659210|NCT00427895|455710590|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
126659211|NCT00427895|455710591|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
126659212|NCT00427895|455710592|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
126659213|NCT00427895|455710593|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
126659214|NCT00427895|455710594|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
126659215|NCT00427895|455710595|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
126659216|NCT00427895|455710588|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
126659217|NCT00427895|455710589|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
126659218|NCT00427895|455710590|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
126659219|NCT00427895|455710591|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
126659220|NCT00427895|455710592|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
126659221|NCT00427895|455710593|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
126659222|NCT00427895|455710594|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
126659223|NCT00427895|455710595|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
126659224|NCT00427895|455710588|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
126659225|NCT00427895|455710589|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
126659226|NCT00427895|455710590|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
126659227|NCT00427895|455710591|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
126659228|NCT00427895|455710592|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
126659229|NCT00427895|455710593|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
126659230|NCT00427895|455710594|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
126659231|NCT00427895|455710595|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
126659232|NCT00427895|455710588|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
126659233|NCT00427895|455710589|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
126659234|NCT00427895|455710590|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
126659235|NCT00427895|455710591|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
126659236|NCT00427895|455710592|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
126659237|NCT00427895|455710593|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
126659238|NCT00427895|455710594|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
126659239|NCT00427895|455710595|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
126659240|NCT00427895|455710588|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
126659241|NCT00427895|455710589|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
126659242|NCT00427895|455710590|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
126659243|NCT00427895|455710591|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
126659244|NCT00427895|455710592|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
126659245|NCT00427895|455710593|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
126659246|NCT00427895|455710594|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
126659247|NCT00427895|455710595|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
126659248|NCT00427895|455710588|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
126659249|NCT00427895|455710589|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
126659250|NCT00427895|455710590|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
126659251|NCT00427895|455710591|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
126659252|NCT00427895|455710592|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
126659253|NCT00427895|455710593|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
126659254|NCT00427895|455710594|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
126659255|NCT00427895|455710595|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
126659256|NCT00427895|455710588|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126659257|NCT00427895|455710589|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126659258|NCT00427895|455710590|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126659259|NCT00427895|455710591|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
126659260|NCT00427895|455710592|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126659261|NCT00427895|455710593|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126659262|NCT00427895|455710594|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126659263|NCT00427895|455710595|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
126659264|NCT00427895|455710588|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
126659265|NCT00427895|455710589|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
126659266|NCT00427895|455710590|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
126659267|NCT00427895|455710591|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
126659268|NCT00427895|455710592|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
126659269|NCT00427895|455710593|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
126659270|NCT00427895|455710594|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
126659271|NCT00427895|455710595|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
126659272|NCT00427895|455710588|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
126659273|NCT00427895|455710589|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
126659274|NCT00427895|455710590|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
126659275|NCT00427895|455710591|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
126659276|NCT00427895|455710592|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
126659277|NCT00427895|455710593|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
126659278|NCT00427895|455710594|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
126659279|NCT00427895|455710595|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
126659280|NCT00427895|455710588|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
126659281|NCT00427895|455710589|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
126659282|NCT00427895|455710590|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
126659283|NCT00427895|455710591|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
126659284|NCT00427895|455710592|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
126659285|NCT00427895|455710593|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
126659286|NCT00427895|455710594|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
126659287|NCT00427895|455710595|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
126659288|NCT00427895|455710588|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
126659289|NCT00427895|455710589|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
126659290|NCT00427895|455710590|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
126659291|NCT00427895|455710591|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
126659292|NCT00427895|455710592|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
126659293|NCT00427895|455710593|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
126659294|NCT00427895|455710594|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
126659295|NCT00427895|455710595|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
126659296|NCT00427895|455710588|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
126659297|NCT00427895|455710589|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
126659298|NCT00427895|455710590|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
126659299|NCT00427895|455710591|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
126659300|NCT00427895|455710592|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
126659301|NCT00427895|455710593|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
126659302|NCT00427895|455710594|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
126659303|NCT00427895|455710595|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
126659304|NCT00427895|455710588|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126659305|NCT00427895|455710589|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
126659306|NCT00427895|455710590|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126659307|NCT00427895|455710591|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126659308|NCT00427895|455710592|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126659309|NCT00427895|455710593|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126659310|NCT00427895|455710594|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126659311|NCT00427895|455710595|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
126659312|NCT00427895|455710588|FG000|Vax 1/Year 1 Follow-up|Death|1|||
126659313|NCT00427895|455710589|FG001|Vax 1/Year 1 Follow-up|Death|0|||
126659314|NCT00427895|455710590|FG002|Vax 1/Year 1 Follow-up|Death|0|||
126659315|NCT00427895|455710591|FG003|Vax 1/Year 1 Follow-up|Death|0|||
126659316|NCT00427895|455710592|FG004|Vax 1/Year 1 Follow-up|Death|0|||
126659317|NCT00427895|455710593|FG005|Vax 1/Year 1 Follow-up|Death|0|||
126659318|NCT00427895|455710594|FG006|Vax 1/Year 1 Follow-up|Death|0|||
126659319|NCT00427895|455710595|FG007|Vax 1/Year 1 Follow-up|Death|0|||
126659320|NCT00427895|455710588|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
126659321|NCT00427895|455710589|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
126659322|NCT00427895|455710590|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
126659323|NCT00427895|455710591|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
126659324|NCT00427895|455710592|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
126659325|NCT00427895|455710593|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
126659326|NCT00427895|455710594|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
126659327|NCT00427895|455710595|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
126659328|NCT00427895|455710588|FG000|Vax 1/Year 1 Follow-up|Other|0|||
126659329|NCT00427895|455710589|FG001|Vax 1/Year 1 Follow-up|Other|0|||
126659330|NCT00427895|455710590|FG002|Vax 1/Year 1 Follow-up|Other|0|||
126659331|NCT00427895|455710591|FG003|Vax 1/Year 1 Follow-up|Other|2|||
126659332|NCT00427895|455710592|FG004|Vax 1/Year 1 Follow-up|Other|0|||
126659333|NCT00427895|455710593|FG005|Vax 1/Year 1 Follow-up|Other|0|||
126659334|NCT00427895|455710594|FG006|Vax 1/Year 1 Follow-up|Other|0|||
126659335|NCT00427895|455710595|FG007|Vax 1/Year 1 Follow-up|Other|0|||
126659336|NCT00427895|455710588|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
126659337|NCT00427895|455710589|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
126659338|NCT00427895|455710590|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
126659339|NCT00427895|455710591|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
126659340|NCT00427895|455710592|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
126659341|NCT00427895|455710593|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
126659342|NCT00427895|455710594|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
126659343|NCT00427895|455710595|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
126659344|NCT00585195|455710597|FG000|Overall Study|Adverse Event|0|||
126659345|NCT00585195|455710598|FG001|Overall Study|Adverse Event|0|||
126659346|NCT00585195|455710599|FG002|Overall Study|Adverse Event|0|||
126659347|NCT00585195|455710600|FG003|Overall Study|Adverse Event|0|||
126659348|NCT00585195|455710601|FG004|Overall Study|Adverse Event|2|||
126659349|NCT00585195|455710602|FG005|Overall Study|Adverse Event|1|||
126659350|NCT00585195|455710603|FG006|Overall Study|Adverse Event|0|||
126659351|NCT00585195|455710604|FG007|Overall Study|Adverse Event|1|||
126659352|NCT00585195|455710605|FG008|Overall Study|Adverse Event|0|||
126659353|NCT00585195|455710606|FG009|Overall Study|Adverse Event|0|||
126659354|NCT00585195|455710607|FG010|Overall Study|Adverse Event|3|||
126659355|NCT00585195|455710608|FG011|Overall Study|Adverse Event|0|||
126659356|NCT00585195|455710609|FG012|Overall Study|Adverse Event|8|||
126659357|NCT00585195|455710610|FG013|Overall Study|Adverse Event|6|||
126659358|NCT00585195|455710611|FG014|Overall Study|Adverse Event|4|||
126659359|NCT00585195|455710612|FG015|Overall Study|Adverse Event|1|||
126659360|NCT00585195|455710613|FG016|Overall Study|Adverse Event|14|||
126659361|NCT00585195|455710614|FG017|Overall Study|Adverse Event|9|||
126659362|NCT00585195|455710615|FG018|Overall Study|Adverse Event|2|||
126659363|NCT00585195|455710616|FG019|Overall Study|Adverse Event|3|||
126659364|NCT00585195|455710617|FG020|Overall Study|Adverse Event|1|||
126659365|NCT00585195|455710597|FG000|Overall Study|Progressive Disease|2|||
126659366|NCT00585195|455710598|FG001|Overall Study|Progressive Disease|2|||
126659367|NCT00585195|455710599|FG002|Overall Study|Progressive Disease|5|||
126659368|NCT00585195|455710600|FG003|Overall Study|Progressive Disease|4|||
126659369|NCT00585195|455710601|FG004|Overall Study|Progressive Disease|6|||
126659370|NCT00585195|455710602|FG005|Overall Study|Progressive Disease|4|||
126659371|NCT00585195|455710603|FG006|Overall Study|Progressive Disease|6|||
126659372|NCT00585195|455710604|FG007|Overall Study|Progressive Disease|3|||
126659373|NCT00585195|455710605|FG008|Overall Study|Progressive Disease|0|||
126659374|NCT00585195|455710606|FG009|Overall Study|Progressive Disease|5|||
126659375|NCT00585195|455710607|FG010|Overall Study|Progressive Disease|2|||
126659376|NCT00585195|455710608|FG011|Overall Study|Progressive Disease|25|||
126659377|NCT00585195|455710609|FG012|Overall Study|Progressive Disease|29|||
126659378|NCT00585195|455710610|FG013|Overall Study|Progressive Disease|26|||
126659379|NCT00585195|455710611|FG014|Overall Study|Progressive Disease|21|||
126659380|NCT00585195|455710612|FG015|Overall Study|Progressive Disease|12|||
126659381|NCT00585195|455710613|FG016|Overall Study|Progressive Disease|94|||
126659382|NCT00585195|455710614|FG017|Overall Study|Progressive Disease|42|||
126659383|NCT00585195|455710615|FG018|Overall Study|Progressive Disease|4|||
126659384|NCT00585195|455710616|FG019|Overall Study|Progressive Disease|9|||
126659385|NCT00585195|455710617|FG020|Overall Study|Progressive Disease|8|||
126659386|NCT00585195|455710597|FG000|Overall Study|Withdrawal by Subject|1|||
126659387|NCT00585195|455710598|FG001|Overall Study|Withdrawal by Subject|1|||
126659388|NCT00585195|455710599|FG002|Overall Study|Withdrawal by Subject|2|||
126659389|NCT00585195|455710600|FG003|Overall Study|Withdrawal by Subject|2|||
126659390|NCT00585195|455710601|FG004|Overall Study|Withdrawal by Subject|0|||
126659391|NCT00585195|455710602|FG005|Overall Study|Withdrawal by Subject|0|||
126659392|NCT00585195|455710603|FG006|Overall Study|Withdrawal by Subject|0|||
126659393|NCT00585195|455710604|FG007|Overall Study|Withdrawal by Subject|1|||
126659394|NCT00585195|455710605|FG008|Overall Study|Withdrawal by Subject|0|||
126659395|NCT00585195|455710606|FG009|Overall Study|Withdrawal by Subject|0|||
126659396|NCT00585195|455710607|FG010|Overall Study|Withdrawal by Subject|3|||
126659397|NCT00585195|455710608|FG011|Overall Study|Withdrawal by Subject|8|||
126659398|NCT00585195|455710609|FG012|Overall Study|Withdrawal by Subject|15|||
126659399|NCT00585195|455710610|FG013|Overall Study|Withdrawal by Subject|0|||
126659400|NCT00585195|455710611|FG014|Overall Study|Withdrawal by Subject|3|||
126659401|NCT00585195|455710612|FG015|Overall Study|Withdrawal by Subject|0|||
126659402|NCT00585195|455710613|FG016|Overall Study|Withdrawal by Subject|7|||
126659403|NCT00585195|455710614|FG017|Overall Study|Withdrawal by Subject|1|||
126659404|NCT00585195|455710615|FG018|Overall Study|Withdrawal by Subject|2|||
126659405|NCT00585195|455710616|FG019|Overall Study|Withdrawal by Subject|2|||
126659406|NCT00585195|455710617|FG020|Overall Study|Withdrawal by Subject|0|||
126659407|NCT00585195|455710597|FG000|Overall Study|Other|0|||
126659408|NCT00585195|455710598|FG001|Overall Study|Other|1|||
126330440|NCT01066871|454503391|FG002|Overall Study|Other|1|||
126659409|NCT00585195|455710599|FG002|Overall Study|Other|1|||
126659410|NCT00585195|455710600|FG003|Overall Study|Other|1|||
126659411|NCT00585195|455710601|FG004|Overall Study|Other|0|||
126659412|NCT00585195|455710602|FG005|Overall Study|Other|1|||
126659413|NCT00585195|455710603|FG006|Overall Study|Other|0|||
126659414|NCT00585195|455710604|FG007|Overall Study|Other|0|||
126659415|NCT00585195|455710605|FG008|Overall Study|Other|2|||
126659416|NCT00585195|455710606|FG009|Overall Study|Other|1|||
126659417|NCT00585195|455710607|FG010|Overall Study|Other|0|||
126659418|NCT00585195|455710608|FG011|Overall Study|Other|19|||
126659419|NCT00585195|455710609|FG012|Overall Study|Other|24|||
126330441|NCT01066871|454503392|FG003|Overall Study|Other|2|||
126659420|NCT00585195|455710610|FG013|Overall Study|Other|7|||
126659421|NCT00585195|455710611|FG014|Overall Study|Other|11|||
126659422|NCT00585195|455710612|FG015|Overall Study|Other|3|||
126659423|NCT00585195|455710613|FG016|Overall Study|Other|28|||
126659424|NCT00585195|455710614|FG017|Overall Study|Other|12|||
126659425|NCT00585195|455710615|FG018|Overall Study|Other|10|||
126659426|NCT00585195|455710616|FG019|Overall Study|Other|4|||
126659427|NCT00585195|455710617|FG020|Overall Study|Other|2|||
126659428|NCT00585195|455710597|FG000|Overall Study|Randomized not treated|0|||
126659429|NCT00585195|455710598|FG001|Overall Study|Randomized not treated|0|||
126659430|NCT00585195|455710599|FG002|Overall Study|Randomized not treated|1|||
126659431|NCT00585195|455710600|FG003|Overall Study|Randomized not treated|0|||
126659432|NCT00585195|455710601|FG004|Overall Study|Randomized not treated|1|||
126659433|NCT00585195|455710602|FG005|Overall Study|Randomized not treated|0|||
126659434|NCT00585195|455710603|FG006|Overall Study|Randomized not treated|1|||
126659435|NCT00585195|455710604|FG007|Overall Study|Randomized not treated|0|||
126659436|NCT00585195|455710605|FG008|Overall Study|Randomized not treated|0|||
126659437|NCT00585195|455710606|FG009|Overall Study|Randomized not treated|0|||
126659438|NCT00585195|455710607|FG010|Overall Study|Randomized not treated|2|||
126659439|NCT00585195|455710608|FG011|Overall Study|Randomized not treated|0|||
126659440|NCT00585195|455710609|FG012|Overall Study|Randomized not treated|0|||
126659441|NCT00585195|455710610|FG013|Overall Study|Randomized not treated|0|||
126659442|NCT00585195|455710611|FG014|Overall Study|Randomized not treated|0|||
126659443|NCT00585195|455710612|FG015|Overall Study|Randomized not treated|1|||
126659444|NCT00585195|455710613|FG016|Overall Study|Randomized not treated|0|||
126659445|NCT00585195|455710614|FG017|Overall Study|Randomized not treated|1|||
126659446|NCT00585195|455710615|FG018|Overall Study|Randomized not treated|3|||
126659447|NCT00585195|455710616|FG019|Overall Study|Randomized not treated|0|||
126659448|NCT00585195|455710617|FG020|Overall Study|Randomized not treated|2|||
126659449|NCT00585195|455710597|FG000|Overall Study|Death|0|||
126659450|NCT00585195|455710598|FG001|Overall Study|Death|0|||
126659451|NCT00585195|455710599|FG002|Overall Study|Death|0|||
126659452|NCT00585195|455710600|FG003|Overall Study|Death|0|||
126659453|NCT00585195|455710601|FG004|Overall Study|Death|0|||
126659454|NCT00585195|455710602|FG005|Overall Study|Death|0|||
126659455|NCT00585195|455710603|FG006|Overall Study|Death|0|||
126659456|NCT00585195|455710604|FG007|Overall Study|Death|0|||
126659457|NCT00585195|455710605|FG008|Overall Study|Death|1|||
126659458|NCT00585195|455710606|FG009|Overall Study|Death|0|||
126659459|NCT00585195|455710607|FG010|Overall Study|Death|1|||
126659460|NCT00585195|455710608|FG011|Overall Study|Death|1|||
126659461|NCT00585195|455710609|FG012|Overall Study|Death|7|||
126659462|NCT00585195|455710610|FG013|Overall Study|Death|2|||
126659463|NCT00585195|455710611|FG014|Overall Study|Death|8|||
126659464|NCT00585195|455710612|FG015|Overall Study|Death|2|||
126659465|NCT00585195|455710613|FG016|Overall Study|Death|11|||
126659466|NCT00585195|455710614|FG017|Overall Study|Death|0|||
126659467|NCT00585195|455710615|FG018|Overall Study|Death|0|||
126659468|NCT00585195|455710616|FG019|Overall Study|Death|0|||
126659469|NCT00585195|455710617|FG020|Overall Study|Death|1|||
126659470|NCT00585195|455710597|FG000|Overall Study|Lost to Follow-up|0|||
126659471|NCT00585195|455710598|FG001|Overall Study|Lost to Follow-up|0|||
126659472|NCT00585195|455710599|FG002|Overall Study|Lost to Follow-up|0|||
126659473|NCT00585195|455710600|FG003|Overall Study|Lost to Follow-up|0|||
126659474|NCT00585195|455710601|FG004|Overall Study|Lost to Follow-up|0|||
126659475|NCT00585195|455710602|FG005|Overall Study|Lost to Follow-up|0|||
126659476|NCT00585195|455710603|FG006|Overall Study|Lost to Follow-up|0|||
126659477|NCT00585195|455710604|FG007|Overall Study|Lost to Follow-up|0|||
126659478|NCT00585195|455710605|FG008|Overall Study|Lost to Follow-up|0|||
126659479|NCT00585195|455710606|FG009|Overall Study|Lost to Follow-up|0|||
126659480|NCT00585195|455710607|FG010|Overall Study|Lost to Follow-up|0|||
126659481|NCT00585195|455710608|FG011|Overall Study|Lost to Follow-up|0|||
126659482|NCT00585195|455710609|FG012|Overall Study|Lost to Follow-up|1|||
126659483|NCT00585195|455710610|FG013|Overall Study|Lost to Follow-up|0|||
126659484|NCT00585195|455710611|FG014|Overall Study|Lost to Follow-up|0|||
126659485|NCT00585195|455710612|FG015|Overall Study|Lost to Follow-up|0|||
126659486|NCT00585195|455710613|FG016|Overall Study|Lost to Follow-up|0|||
126659487|NCT00585195|455710614|FG017|Overall Study|Lost to Follow-up|2|||
126659488|NCT00585195|455710615|FG018|Overall Study|Lost to Follow-up|0|||
126659489|NCT00585195|455710616|FG019|Overall Study|Lost to Follow-up|0|||
126659490|NCT00585195|455710617|FG020|Overall Study|Lost to Follow-up|0|||
126659491|NCT00585195|455710597|FG000|Overall Study|Site Terminated by Sponsor|0|||
126659492|NCT00585195|455710598|FG001|Overall Study|Site Terminated by Sponsor|0|||
126659493|NCT00585195|455710599|FG002|Overall Study|Site Terminated by Sponsor|0|||
126659494|NCT00585195|455710600|FG003|Overall Study|Site Terminated by Sponsor|0|||
126659495|NCT00585195|455710601|FG004|Overall Study|Site Terminated by Sponsor|0|||
126659496|NCT00585195|455710602|FG005|Overall Study|Site Terminated by Sponsor|0|||
126659497|NCT00585195|455710603|FG006|Overall Study|Site Terminated by Sponsor|0|||
126659498|NCT00585195|455710604|FG007|Overall Study|Site Terminated by Sponsor|0|||
126659499|NCT00585195|455710605|FG008|Overall Study|Site Terminated by Sponsor|0|||
126659500|NCT00585195|455710606|FG009|Overall Study|Site Terminated by Sponsor|0|||
126659501|NCT00585195|455710607|FG010|Overall Study|Site Terminated by Sponsor|0|||
126659502|NCT00585195|455710608|FG011|Overall Study|Site Terminated by Sponsor|0|||
126659503|NCT00585195|455710609|FG012|Overall Study|Site Terminated by Sponsor|1|||
126659504|NCT00585195|455710610|FG013|Overall Study|Site Terminated by Sponsor|0|||
126659505|NCT00585195|455710611|FG014|Overall Study|Site Terminated by Sponsor|0|||
126659506|NCT00585195|455710612|FG015|Overall Study|Site Terminated by Sponsor|0|||
126659507|NCT00585195|455710613|FG016|Overall Study|Site Terminated by Sponsor|0|||
126659508|NCT00585195|455710614|FG017|Overall Study|Site Terminated by Sponsor|0|||
126659509|NCT00585195|455710615|FG018|Overall Study|Site Terminated by Sponsor|0|||
126659510|NCT00585195|455710616|FG019|Overall Study|Site Terminated by Sponsor|0|||
126659511|NCT00585195|455710617|FG020|Overall Study|Site Terminated by Sponsor|0|||
126659512|NCT00585195|455710597|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
126659513|NCT00585195|455710598|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
126659514|NCT00585195|455710599|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
126659515|NCT00585195|455710600|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
126659516|NCT00585195|455710601|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
126659517|NCT00585195|455710602|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
126659518|NCT00585195|455710603|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
126659519|NCT00585195|455710604|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
126659520|NCT00585195|455710605|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
126659521|NCT00585195|455710606|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
126659522|NCT00585195|455710607|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
126659523|NCT00585195|455710608|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
126659524|NCT00585195|455710609|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
126659525|NCT00585195|455710610|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
126659526|NCT00585195|455710611|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
126659527|NCT00585195|455710612|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
126659528|NCT00585195|455710613|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
126659529|NCT00585195|455710614|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
126659530|NCT00585195|455710615|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
126659531|NCT00585195|455710616|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
126659532|NCT00585195|455710617|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
126659533|NCT02796560|455710618|FG000|Overall Study|Adverse Event|2|||
126659534|NCT02796560|455710619|FG001|Overall Study|Adverse Event|0|||
126659535|NCT02796560|455710618|FG000|Overall Study|Withdrawal by Subject|2|||
126659536|NCT02796560|455710619|FG001|Overall Study|Withdrawal by Subject|2|||
126659537|NCT02533570|455710620|FG000|Overall Study|Adverse Event|0|||
126659538|NCT02533570|455710621|FG001|Overall Study|Adverse Event|1|||
126659539|NCT02533570|455710622|FG002|Overall Study|Adverse Event|1|||
126659540|NCT04002401|455710626|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
126659541|NCT04002401|455710626|FG000|Overall Study|Death|10|||
126659542|NCT04002401|455710626|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
126659543|NCT04002401|455710626|FG000|Overall Study|Enrolled but Never Treated|1|||
126659544|NCT04002401|455710626|FG000|Overall Study|Lost to Follow-up|1|||
126659545|NCT00423930|455710627|FG000|Overall Study|Withdrawal by Subject|2|||
126659546|NCT01009580|455710632|FG000|Overall Study|Adverse Event|4|||
126659547|NCT01009580|455710633|FG001|Overall Study|Adverse Event|4|||
126659548|NCT01009580|455710632|FG000|Overall Study|Lack of Efficacy|0|||
126659549|NCT01009580|455710633|FG001|Overall Study|Lack of Efficacy|1|||
126659550|NCT01009580|455710632|FG000|Overall Study|Protocol Violation|2|||
126659551|NCT01009580|455710633|FG001|Overall Study|Protocol Violation|3|||
126659552|NCT01009580|455710632|FG000|Overall Study|Withdrawal Criteria|4|||
126659553|NCT01009580|455710633|FG001|Overall Study|Withdrawal Criteria|6|||
126659554|NCT01009580|455710632|FG000|Overall Study|Unclassified|17|||
126659555|NCT01009580|455710633|FG001|Overall Study|Unclassified|21|||
126659556|NCT02881957|455710639|FG000|Overall Study|Comfort care|0|||
126659557|NCT02881957|455710640|FG001|Overall Study|Comfort care|1|||
126659558|NCT02881957|455710639|FG000|Overall Study|Concurrent trial enrollment|0|||
126659559|NCT02881957|455710640|FG001|Overall Study|Concurrent trial enrollment|1|||
126659560|NCT02881957|455710639|FG000|Overall Study|Discharged within 48 hours|0|||
126659561|NCT02881957|455710640|FG001|Overall Study|Discharged within 48 hours|1|||
126659562|NCT02881957|455710639|FG000|Overall Study|Withdrawal by Subject|2|||
126659563|NCT02881957|455710640|FG001|Overall Study|Withdrawal by Subject|1|||
126659564|NCT02881957|455710639|FG000|Overall Study|Protocol Violation|1|||
126659565|NCT02881957|455710640|FG001|Overall Study|Protocol Violation|0|||
126659566|NCT00081497|455710641|FG000|Overall Study|Adverse Event|2|||
126659567|NCT00081497|455710642|FG001|Overall Study|Adverse Event|0|||
126659568|NCT00081497|455710641|FG000|Overall Study|Death|0|||
126659569|NCT00081497|455710642|FG001|Overall Study|Death|1|||
126330442|NCT04162795|454503393|FG000|Overall Study|Other|16|||
126659570|NCT00081497|455710641|FG000|Overall Study|Withdrawal by Subject|1|||
126659571|NCT00081497|455710642|FG001|Overall Study|Withdrawal by Subject|0|||
126659572|NCT00081497|455710641|FG000|Overall Study|Non-compliance|0|||
126659573|NCT00081497|455710642|FG001|Overall Study|Non-compliance|1|||
126659574|NCT00345293|455710643|FG000|Overall Study|Unable to access line for sample|1|||
126659575|NCT00345293|455710644|FG001|Overall Study|Unable to access line for sample|0|||
126659576|NCT00345293|455710643|FG000|Overall Study|Withdrawal by Subject|1|||
126659577|NCT00345293|455710644|FG001|Overall Study|Withdrawal by Subject|0|||
126659578|NCT02390245|455710645|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
126659579|NCT02390245|455710646|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
126659580|NCT02390245|455710647|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
126659581|NCT02390245|455710645|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
126659582|NCT02390245|455710646|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
126659583|NCT02390245|455710647|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
126659584|NCT01328717|455712017|FG000|Overall Study|Adverse Event|1|||
126659585|NCT03440320|455712018|FG000|Overall Study|Withdrawal by Subject|0|||
126659586|NCT03440320|455712019|FG001|Overall Study|Withdrawal by Subject|1|||
126659587|NCT01786174|455712022|FG000|Overall Study|Discontinued Study Drug|2|||
126659588|NCT01786174|455712023|FG001|Overall Study|Discontinued Study Drug|0|||
126659589|NCT04281004|455712032|FG000|Overall Study|Physician Decision|1|||
126659590|NCT04281004|455712033|FG001|Overall Study|Physician Decision|0|||
126659591|NCT03628898|455712034|FG000|Overall Study|Device deficiency|1|||
126659592|NCT01716117|455712037|FG000|Overall Study|Death|5|||
126659593|NCT01716117|455712038|FG001|Overall Study|Death|2|||
126659594|NCT01716117|455712037|FG000|Overall Study|Withdrawal by Subject|2|||
126659595|NCT01716117|455712038|FG001|Overall Study|Withdrawal by Subject|0|||
126659596|NCT00762970|455712039|FG000|Overall Study|Withdrawal by Subject|7|||
126659597|NCT00762970|455712040|FG001|Overall Study|Withdrawal by Subject|4|||
126659598|NCT00762970|455712041|FG002|Overall Study|Withdrawal by Subject|0|||
126659599|NCT00762970|455712039|FG000|Overall Study|Protocol Violation|3|||
126659600|NCT00762970|455712040|FG001|Overall Study|Protocol Violation|1|||
126659601|NCT00762970|455712041|FG002|Overall Study|Protocol Violation|1|||
126659602|NCT00762970|455712039|FG000|Overall Study|Lost to Follow-up|1|||
126659603|NCT00762970|455712040|FG001|Overall Study|Lost to Follow-up|2|||
126659604|NCT00762970|455712041|FG002|Overall Study|Lost to Follow-up|0|||
126659605|NCT00762970|455712039|FG000|Overall Study|Difficulty of handling lens|1|||
126659606|NCT00762970|455712040|FG001|Overall Study|Difficulty of handling lens|2|||
126659607|NCT00762970|455712041|FG002|Overall Study|Difficulty of handling lens|0|||
126659608|NCT05116046|455712046|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126659609|NCT05116046|455712047|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126659610|NCT05116046|455712048|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126659611|NCT05116046|455712046|FG000|Overall Study|Study terminated by sponsor|14|||
126659612|NCT05116046|455712047|FG001|Overall Study|Study terminated by sponsor|16|||
126659613|NCT05116046|455712048|FG002|Overall Study|Study terminated by sponsor|1|||
126659614|NCT01337115|455712050|FG000|Overall Study|Protocol Violation|2|||
126659615|NCT01337115|455712051|FG001|Overall Study|Protocol Violation|0|||
126659616|NCT02027623|455712057|FG000|Overall Study|Lost to Follow-up|3|||
126659617|NCT02027623|455712058|FG001|Overall Study|Lost to Follow-up|3|||
126659618|NCT02027623|455712057|FG000|Overall Study|Withdrawal by Subject|6|||
126659619|NCT02027623|455712058|FG001|Overall Study|Withdrawal by Subject|9|||
126659620|NCT03513588|455712061|FG000|Overall Study|Lost to Follow-up|0|||
126659621|NCT03513588|455712062|FG001|Overall Study|Lost to Follow-up|1|||
126659622|NCT03513588|455712063|FG002|Overall Study|Lost to Follow-up|1|||
126659623|NCT03513588|455712061|FG000|Overall Study|Study dosing paused by sponsor|1|||
126659624|NCT03513588|455712062|FG001|Overall Study|Study dosing paused by sponsor|1|||
126659625|NCT03513588|455712063|FG002|Overall Study|Study dosing paused by sponsor|0|||
126659626|NCT03513588|455712061|FG000|Overall Study|Death|0|||
126659627|NCT03513588|455712062|FG001|Overall Study|Death|0|||
126659628|NCT03513588|455712063|FG002|Overall Study|Death|1|||
126659629|NCT00940108|455712067|FG000|Overall Study|Adverse Event|2|||
126659630|NCT00940108|455712068|FG001|Overall Study|Adverse Event|4|||
126659631|NCT00940108|455712069|FG002|Overall Study|Adverse Event|0|||
126659632|NCT00940108|455712070|FG003|Overall Study|Adverse Event|2|||
126659633|NCT00940108|455712067|FG000|Overall Study|Withdrew Consent|2|||
126659634|NCT00940108|455712068|FG001|Overall Study|Withdrew Consent|1|||
126659635|NCT00940108|455712069|FG002|Overall Study|Withdrew Consent|0|||
126659636|NCT00940108|455712070|FG003|Overall Study|Withdrew Consent|1|||
126659637|NCT00940108|455712067|FG000|Overall Study|Dose 2 contraindicated|1|||
126659638|NCT00940108|455712068|FG001|Overall Study|Dose 2 contraindicated|1|||
126659639|NCT00940108|455712069|FG002|Overall Study|Dose 2 contraindicated|0|||
126659640|NCT00940108|455712070|FG003|Overall Study|Dose 2 contraindicated|1|||
126659641|NCT00940108|455712067|FG000|Overall Study|Declined further vaccination|0|||
126659642|NCT00940108|455712068|FG001|Overall Study|Declined further vaccination|1|||
126659643|NCT00940108|455712069|FG002|Overall Study|Declined further vaccination|3|||
126659644|NCT00940108|455712070|FG003|Overall Study|Declined further vaccination|0|||
126659645|NCT00940108|455712067|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
126659646|NCT00940108|455712068|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
126659647|NCT00940108|455712069|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
126659648|NCT00940108|455712070|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
126659649|NCT00940108|455712067|FG000|Overall Study|Viral illness after Dose 1|0|||
126659650|NCT00940108|455712068|FG001|Overall Study|Viral illness after Dose 1|1|||
126659651|NCT00940108|455712069|FG002|Overall Study|Viral illness after Dose 1|0|||
126659652|NCT00940108|455712070|FG003|Overall Study|Viral illness after Dose 1|0|||
126659653|NCT00940108|455712067|FG000|Overall Study|Diagnosed with H1N1|0|||
126659654|NCT00940108|455712068|FG001|Overall Study|Diagnosed with H1N1|0|||
126659655|NCT00940108|455712069|FG002|Overall Study|Diagnosed with H1N1|0|||
126659656|NCT00940108|455712070|FG003|Overall Study|Diagnosed with H1N1|1|||
126659657|NCT02075541|455712071|FG000|Overall Study|Serious Adverse Event|1|||
126659658|NCT02075541|455712072|FG001|Overall Study|Serious Adverse Event|4|||
126659659|NCT02075541|455712071|FG000|Overall Study|Protocol Violation|1|||
126659660|NCT02075541|455712072|FG001|Overall Study|Protocol Violation|0|||
126659661|NCT02075541|455712071|FG000|Overall Study|Withdrawal by Subject|1|||
126659662|NCT02075541|455712072|FG001|Overall Study|Withdrawal by Subject|3|||
126659663|NCT02075541|455712071|FG000|Overall Study|Sponsor study termination|0|||
126659664|NCT02075541|455712072|FG001|Overall Study|Sponsor study termination|1|||
126659665|NCT02075541|455712071|FG000|Overall Study|Other- unable to perform study procedure|1|||
126659666|NCT02075541|455712072|FG001|Overall Study|Other- unable to perform study procedure|0|||
126659667|NCT01142596|455712073|FG000|Overall Study|Withdrawal by Subject|9|||
126659668|NCT01142596|455712074|FG001|Overall Study|Withdrawal by Subject|35|||
126659669|NCT01142596|455712073|FG000|Overall Study|Adverse Event|8|||
126659670|NCT01142596|455712074|FG001|Overall Study|Adverse Event|35|||
126659671|NCT01142596|455712073|FG000|Overall Study|Lack of Efficacy|5|||
126659672|NCT01142596|455712074|FG001|Overall Study|Lack of Efficacy|9|||
126659673|NCT01142596|455712073|FG000|Overall Study|Lost to Follow-up|2|||
126659674|NCT01142596|455712074|FG001|Overall Study|Lost to Follow-up|3|||
126659675|NCT01142596|455712073|FG000|Overall Study|Other reason (not specified)|5|||
126659676|NCT01142596|455712074|FG001|Overall Study|Other reason (not specified)|4|||
126659677|NCT01054846|455712075|FG000|Overall Study|Lost to Follow-up|76|||
126659678|NCT01054846|455712076|FG001|Overall Study|Lost to Follow-up|17|||
126659679|NCT02446886|455712077|FG000|Overall Study|Adverse Event|1|||
126659680|NCT02446886|455712078|FG001|Overall Study|Adverse Event|3|||
126659681|NCT02446886|455712077|FG000|Overall Study|Withdrawal by Subject|1|||
126659682|NCT02446886|455712078|FG001|Overall Study|Withdrawal by Subject|1|||
126659683|NCT01259284|455712079|FG000|Overall Study|Study Termination|2|||
126659684|NCT01259284|455712080|FG001|Overall Study|Study Termination|0|||
126659685|NCT01259284|455712081|FG002|Overall Study|Study Termination|0|||
126659686|NCT02988622|455712082|FG000|Overall Study|Lost to Follow-up|17|||
126659687|NCT01204398|455712086|FG000|Overall Study|Adverse Event|1|||
126659688|NCT03562247|455712087|FG000|Overall Study|Lost to Follow-up|3|||
126659689|NCT03562247|455712088|FG001|Overall Study|Lost to Follow-up|1|||
126659690|NCT03562247|455712089|FG002|Overall Study|Lost to Follow-up|1|||
126659691|NCT00983931|455712090|FG000|14 Day Washout Period|Physician Decision|1|||
126659692|NCT01281969|455712093|FG000|Overall Study|not randomized didn't meet criteria|0|||
126659693|NCT01281969|455712094|FG001|Overall Study|not randomized didn't meet criteria|0|||
126659694|NCT01281969|455712095|FG002|Overall Study|not randomized didn't meet criteria|7|||
126659695|NCT01281969|455712093|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
126330443|NCT04162795|454503393|FG000|Overall Study|Screen failures|10|||
126330444|NCT05259163|454505063|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
126330445|NCT05259163|454505064|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
126330446|NCT00103285|454505067|FG000|Induction|Adverse Event|14|||
126330447|NCT00103285|454505068|FG001|Induction|Adverse Event|0|||
126330448|NCT00103285|454505069|FG002|Induction|Adverse Event|0|||
126330449|NCT00103285|454505070|FG003|Induction|Adverse Event|0|||
126330450|NCT00103285|454505071|FG004|Induction|Adverse Event|0|||
126330451|NCT00103285|454505072|FG005|Induction|Adverse Event|0|||
126330452|NCT00103285|454505073|FG006|Induction|Adverse Event|0|||
126330453|NCT00103285|454505074|FG007|Induction|Adverse Event|0|||
126330454|NCT00103285|454505067|FG000|Induction|Death|24|||
126330455|NCT00103285|454505068|FG001|Induction|Death|0|||
126330456|NCT00103285|454505069|FG002|Induction|Death|0|||
126330457|NCT00103285|454505070|FG003|Induction|Death|0|||
126330458|NCT00103285|454505071|FG004|Induction|Death|0|||
126330459|NCT00103285|454505072|FG005|Induction|Death|0|||
126330460|NCT00103285|454505073|FG006|Induction|Death|0|||
126330461|NCT00103285|454505074|FG007|Induction|Death|0|||
126330462|NCT00103285|454505067|FG000|Induction|Physician Decision|103|||
126330463|NCT00103285|454505068|FG001|Induction|Physician Decision|0|||
126330464|NCT00103285|454505069|FG002|Induction|Physician Decision|0|||
126330465|NCT00103285|454505070|FG003|Induction|Physician Decision|0|||
126330466|NCT00103285|454505071|FG004|Induction|Physician Decision|0|||
126330467|NCT00103285|454505072|FG005|Induction|Physician Decision|0|||
126330468|NCT00103285|454505073|FG006|Induction|Physician Decision|0|||
126659696|NCT01281969|455712094|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
126330469|NCT00103285|454505074|FG007|Induction|Physician Decision|0|||
126330470|NCT00103285|454505067|FG000|Induction|Withdrawal by Subject|1|||
126659697|NCT01281969|455712095|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
126659698|NCT01281969|455712093|FG000|Overall Study|not randomized, child consent not given|0|||
126659699|NCT01281969|455712094|FG001|Overall Study|not randomized, child consent not given|0|||
126659700|NCT01281969|455712095|FG002|Overall Study|not randomized, child consent not given|2|||
126330471|NCT00103285|454505068|FG001|Induction|Withdrawal by Subject|0|||
126330472|NCT00103285|454505069|FG002|Induction|Withdrawal by Subject|0|||
126330473|NCT00103285|454505070|FG003|Induction|Withdrawal by Subject|0|||
126330474|NCT00103285|454505071|FG004|Induction|Withdrawal by Subject|0|||
126659701|NCT01201265|455712100|FG000|Overall Study|Death|14|||
126659702|NCT01201265|455712100|FG000|Overall Study|Insufficient Therapeutic Response|3|||
126659703|NCT01201265|455712100|FG000|Overall Study|Lost to Follow-up|10|||
126659704|NCT01201265|455712100|FG000|Overall Study|Withdrawal by Subject|7|||
126659705|NCT01201265|455712100|FG000|Overall Study|Disease Progression|4|||
126659706|NCT04640077|455712101|FG000|Period 1|Withdrawal by Subject|4|||
126659707|NCT04640077|455712102|FG001|Period 1|Withdrawal by Subject|5|||
126659708|NCT04640077|455712103|FG002|Period 1|Withdrawal by Subject|0|||
126659709|NCT04640077|455712101|FG000|Period 1|Adverse Event|1|||
126659710|NCT04640077|455712102|FG001|Period 1|Adverse Event|1|||
126659711|NCT04640077|455712103|FG002|Period 1|Adverse Event|0|||
126659712|NCT04640077|455712101|FG000|Period 1|Screen Failure|2|||
126659713|NCT04640077|455712102|FG001|Period 1|Screen Failure|0|||
126659714|NCT04640077|455712103|FG002|Period 1|Screen Failure|0|||
126659715|NCT04640077|455712101|FG000|Period 2|Withdrawal by Subject|0|||
126659716|NCT04640077|455712102|FG001|Period 2|Withdrawal by Subject|0|||
126659717|NCT04640077|455712103|FG002|Period 2|Withdrawal by Subject|18|||
126659718|NCT04640077|455712101|FG000|Period 2|Adverse Event|0|||
126659719|NCT04640077|455712102|FG001|Period 2|Adverse Event|0|||
126659720|NCT04640077|455712103|FG002|Period 2|Adverse Event|6|||
126659721|NCT04640077|455712101|FG000|Period 2|Lost to Follow-up|0|||
126659722|NCT04640077|455712102|FG001|Period 2|Lost to Follow-up|0|||
126659723|NCT04640077|455712103|FG002|Period 2|Lost to Follow-up|2|||
126659724|NCT04640077|455712101|FG000|Period 2|Death|0|||
126659725|NCT04640077|455712102|FG001|Period 2|Death|0|||
126659726|NCT04640077|455712103|FG002|Period 2|Death|2|||
126659727|NCT04640077|455712101|FG000|Period 2|Progressive Disease|0|||
126659728|NCT04640077|455712102|FG001|Period 2|Progressive Disease|0|||
126659729|NCT04640077|455712103|FG002|Period 2|Progressive Disease|1|||
126659730|NCT04640077|455712101|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
126659731|NCT04640077|455712102|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
126659732|NCT04640077|455712103|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
126659733|NCT01257425|455712104|FG000|Overall Study|Lack of Efficacy|3|||
126659734|NCT01257425|455712105|FG001|Overall Study|Lack of Efficacy|3|||
126659735|NCT01257425|455712104|FG000|Overall Study|Adverse Event|1|||
126659736|NCT01257425|455712105|FG001|Overall Study|Adverse Event|1|||
126659737|NCT01257425|455712104|FG000|Overall Study|Protocol Violation|1|||
126659738|NCT01257425|455712105|FG001|Overall Study|Protocol Violation|1|||
126659739|NCT01257425|455712104|FG000|Overall Study|Withdrawal by Subject|0|||
126659740|NCT01257425|455712105|FG001|Overall Study|Withdrawal by Subject|1|||
126659741|NCT01257425|455712104|FG000|Overall Study|Death|1|||
126659742|NCT01257425|455712105|FG001|Overall Study|Death|0|||
126659743|NCT01182194|455712107|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
126659744|NCT01182194|455712108|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
126659745|NCT03343301|455712109|FG000|Overall Study|Withdrawal by Subject|1|||
126659746|NCT03343301|455712110|FG001|Overall Study|Withdrawal by Subject|1|||
126659747|NCT03343301|455712109|FG000|Overall Study|Death|0|||
126659748|NCT03343301|455712110|FG001|Overall Study|Death|2|||
126659749|NCT03343301|455712109|FG000|Overall Study|Other|0|||
126659750|NCT03343301|455712110|FG001|Overall Study|Other|6|||
126659751|NCT03343301|455712109|FG000|Overall Study|Missing|2|||
126659752|NCT03343301|455712110|FG001|Overall Study|Missing|0|||
126659753|NCT00368992|455712111|FG000|Overall Study|Ineligible|5|||
126659754|NCT00368992|455712111|FG000|Overall Study|Refused treatment|3|||
126659755|NCT00368992|455712111|FG000|Overall Study|Lack of Efficacy|63|||
126659756|NCT00368992|455712111|FG000|Overall Study|Adverse Event|26|||
126659757|NCT00368992|455712111|FG000|Overall Study|Death|4|||
126659758|NCT00368992|455712111|FG000|Overall Study|Other|9|||
126659759|NCT02668185|455712112|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
126659760|NCT02668185|455712113|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
126659761|NCT02668185|455712112|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
126659762|NCT02668185|455712113|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
126659763|NCT02668185|455712112|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
126659764|NCT02668185|455712113|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
126659765|NCT02668185|455712112|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
126659766|NCT02668185|455712113|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
126659767|NCT01013597|455712114|FG000|Overall Study|Withdrawal by Subject|1|||
126659768|NCT00723021|455712119|FG000|Intervention Period 4|Adverse Event|0|||
126659769|NCT00723021|455712120|FG001|Intervention Period 4|Adverse Event|0|||
126659770|NCT00723021|455712121|FG002|Intervention Period 4|Adverse Event|0|||
126659771|NCT00723021|455712122|FG003|Intervention Period 4|Adverse Event|0|||
126659772|NCT00723021|455712123|FG004|Intervention Period 4|Adverse Event|1|||
126659773|NCT00770341|455712124|FG000|Overall Study|Did not meet eligibility criteria|1|||
126659774|NCT00770341|455712125|FG001|Overall Study|Did not meet eligibility criteria|0|||
126659775|NCT00770341|455712126|FG002|Overall Study|Did not meet eligibility criteria|0|||
126659776|NCT00770341|455712124|FG000|Overall Study|Withdrawal by Subject|0|||
126659777|NCT00770341|455712125|FG001|Overall Study|Withdrawal by Subject|1|||
126659778|NCT00770341|455712126|FG002|Overall Study|Withdrawal by Subject|0|||
126659779|NCT00770341|455712124|FG000|Overall Study|Clinical Adverse Event|3|||
126659780|NCT00770341|455712125|FG001|Overall Study|Clinical Adverse Event|1|||
126659781|NCT00770341|455712126|FG002|Overall Study|Clinical Adverse Event|2|||
126659782|NCT00770341|455712124|FG000|Overall Study|Laboratory adverse event|3|||
126659783|NCT00770341|455712125|FG001|Overall Study|Laboratory adverse event|3|||
126659784|NCT00770341|455712126|FG002|Overall Study|Laboratory adverse event|0|||
126659785|NCT00770341|455712124|FG000|Overall Study|Lack of Efficacy|3|||
126659786|NCT00770341|455712125|FG001|Overall Study|Lack of Efficacy|0|||
126659787|NCT00770341|455712126|FG002|Overall Study|Lack of Efficacy|1|||
126659788|NCT00770341|455712124|FG000|Overall Study|Other|1|||
126659789|NCT00770341|455712125|FG001|Overall Study|Other|0|||
126659790|NCT00770341|455712126|FG002|Overall Study|Other|0|||
126659791|NCT00770341|455712124|FG000|Overall Study|Not treated|1|||
126659792|NCT00770341|455712125|FG001|Overall Study|Not treated|0|||
126659793|NCT00770341|455712126|FG002|Overall Study|Not treated|0|||
126659794|NCT00960531|455712132|FG000|Overall Study|Lack of Efficacy|1|||
126659795|NCT00960531|455712133|FG001|Overall Study|Lack of Efficacy|0|||
126659796|NCT00960531|455712134|FG002|Overall Study|Lack of Efficacy|0|||
126659797|NCT00960531|455712135|FG003|Overall Study|Lack of Efficacy|0|||
126659798|NCT00960531|455712136|FG004|Overall Study|Lack of Efficacy|0|||
126659799|NCT00960531|455712137|FG005|Overall Study|Lack of Efficacy|0|||
126659800|NCT00960531|455712138|FG006|Overall Study|Lack of Efficacy|0|||
126659801|NCT00960531|455712139|FG007|Overall Study|Lack of Efficacy|0|||
126659802|NCT00960531|455712140|FG008|Overall Study|Lack of Efficacy|0|||
126659803|NCT00960531|455712141|FG009|Overall Study|Lack of Efficacy|0|||
126659804|NCT00960531|455712132|FG000|Overall Study|Withdrawal by Subject|1|||
126659805|NCT00960531|455712133|FG001|Overall Study|Withdrawal by Subject|0|||
126659806|NCT00960531|455712134|FG002|Overall Study|Withdrawal by Subject|5|||
126659807|NCT00960531|455712135|FG003|Overall Study|Withdrawal by Subject|2|||
126659808|NCT00960531|455712136|FG004|Overall Study|Withdrawal by Subject|0|||
126659809|NCT00960531|455712137|FG005|Overall Study|Withdrawal by Subject|0|||
126659810|NCT00960531|455712138|FG006|Overall Study|Withdrawal by Subject|2|||
126659811|NCT00960531|455712139|FG007|Overall Study|Withdrawal by Subject|0|||
126659812|NCT00960531|455712140|FG008|Overall Study|Withdrawal by Subject|1|||
126659813|NCT00960531|455712141|FG009|Overall Study|Withdrawal by Subject|0|||
126659814|NCT00960531|455712132|FG000|Overall Study|Caregiver Request|2|||
126659815|NCT00960531|455712133|FG001|Overall Study|Caregiver Request|0|||
126659816|NCT00960531|455712134|FG002|Overall Study|Caregiver Request|6|||
126659817|NCT00960531|455712135|FG003|Overall Study|Caregiver Request|5|||
126659818|NCT00960531|455712136|FG004|Overall Study|Caregiver Request|0|||
126659819|NCT00960531|455712137|FG005|Overall Study|Caregiver Request|2|||
126659820|NCT00960531|455712138|FG006|Overall Study|Caregiver Request|3|||
126659821|NCT00960531|455712139|FG007|Overall Study|Caregiver Request|1|||
126659822|NCT00960531|455712140|FG008|Overall Study|Caregiver Request|3|||
126659823|NCT00960531|455712141|FG009|Overall Study|Caregiver Request|0|||
126659824|NCT00960531|455712132|FG000|Overall Study|Investigator Request|0|||
126659825|NCT00960531|455712133|FG001|Overall Study|Investigator Request|0|||
126659826|NCT00960531|455712134|FG002|Overall Study|Investigator Request|1|||
126659827|NCT00960531|455712135|FG003|Overall Study|Investigator Request|0|||
126659828|NCT00960531|455712136|FG004|Overall Study|Investigator Request|0|||
126659829|NCT00960531|455712137|FG005|Overall Study|Investigator Request|0|||
126659830|NCT00960531|455712138|FG006|Overall Study|Investigator Request|0|||
126659831|NCT00960531|455712139|FG007|Overall Study|Investigator Request|0|||
126659832|NCT00960531|455712140|FG008|Overall Study|Investigator Request|0|||
126659833|NCT00960531|455712141|FG009|Overall Study|Investigator Request|0|||
126659834|NCT00960531|455712132|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
126659835|NCT00960531|455712133|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
126659836|NCT00960531|455712134|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
126659837|NCT00960531|455712135|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
126659838|NCT00960531|455712136|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
126659839|NCT00960531|455712137|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
126659840|NCT00960531|455712138|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
126659841|NCT00960531|455712139|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
126659842|NCT00960531|455712140|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
126659843|NCT00960531|455712141|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
126659844|NCT00960531|455712132|FG000|Overall Study|Lost to Follow-up|0|||
126659845|NCT00960531|455712133|FG001|Overall Study|Lost to Follow-up|0|||
126659846|NCT00960531|455712134|FG002|Overall Study|Lost to Follow-up|1|||
126659847|NCT00960531|455712135|FG003|Overall Study|Lost to Follow-up|0|||
126659848|NCT00960531|455712136|FG004|Overall Study|Lost to Follow-up|0|||
126659849|NCT00960531|455712137|FG005|Overall Study|Lost to Follow-up|0|||
126659850|NCT00960531|455712138|FG006|Overall Study|Lost to Follow-up|1|||
126659851|NCT00960531|455712139|FG007|Overall Study|Lost to Follow-up|0|||
126659852|NCT00960531|455712140|FG008|Overall Study|Lost to Follow-up|0|||
126659853|NCT00960531|455712141|FG009|Overall Study|Lost to Follow-up|0|||
126659854|NCT00960531|455712132|FG000|Overall Study|Failed to Return|2|||
126659855|NCT00960531|455712133|FG001|Overall Study|Failed to Return|0|||
126659856|NCT00960531|455712134|FG002|Overall Study|Failed to Return|0|||
126659857|NCT00960531|455712135|FG003|Overall Study|Failed to Return|0|||
126659858|NCT00960531|455712136|FG004|Overall Study|Failed to Return|0|||
126659859|NCT00960531|455712137|FG005|Overall Study|Failed to Return|0|||
126659860|NCT00960531|455712138|FG006|Overall Study|Failed to Return|0|||
126659861|NCT00960531|455712139|FG007|Overall Study|Failed to Return|2|||
126659862|NCT00960531|455712140|FG008|Overall Study|Failed to Return|0|||
126659863|NCT00960531|455712141|FG009|Overall Study|Failed to Return|0|||
126659864|NCT00960531|455712132|FG000|Overall Study|Adverse Event (AE)|2|||
126659865|NCT00960531|455712133|FG001|Overall Study|Adverse Event (AE)|0|||
126659866|NCT00960531|455712134|FG002|Overall Study|Adverse Event (AE)|0|||
126659867|NCT00960531|455712135|FG003|Overall Study|Adverse Event (AE)|0|||
126659868|NCT00960531|455712136|FG004|Overall Study|Adverse Event (AE)|0|||
126659869|NCT00960531|455712137|FG005|Overall Study|Adverse Event (AE)|1|||
126659870|NCT00960531|455712138|FG006|Overall Study|Adverse Event (AE)|2|||
126659871|NCT00960531|455712139|FG007|Overall Study|Adverse Event (AE)|0|||
126659872|NCT00960531|455712140|FG008|Overall Study|Adverse Event (AE)|2|||
126659873|NCT00960531|455712141|FG009|Overall Study|Adverse Event (AE)|0|||
126659874|NCT00960531|455712132|FG000|Overall Study|Reason not Specified|2|||
126659875|NCT00960531|455712133|FG001|Overall Study|Reason not Specified|1|||
126659876|NCT00960531|455712134|FG002|Overall Study|Reason not Specified|13|||
126659877|NCT00960531|455712135|FG003|Overall Study|Reason not Specified|1|||
126659878|NCT00960531|455712136|FG004|Overall Study|Reason not Specified|2|||
126659879|NCT00960531|455712137|FG005|Overall Study|Reason not Specified|0|||
126659880|NCT00960531|455712138|FG006|Overall Study|Reason not Specified|16|||
126659881|NCT00960531|455712139|FG007|Overall Study|Reason not Specified|0|||
126659882|NCT00960531|455712140|FG008|Overall Study|Reason not Specified|8|||
126659883|NCT00960531|455712141|FG009|Overall Study|Reason not Specified|1|||
126659884|NCT01163916|455712142|FG000|Overall Study|Withdrawal by Subject|2|||
126659885|NCT01163916|455712143|FG001|Overall Study|Withdrawal by Subject|0|||
126659886|NCT01163916|455712144|FG002|Overall Study|Withdrawal by Subject|2|||
126659887|NCT01163916|455712142|FG000|Overall Study|Adverse Event|2|||
126659888|NCT01163916|455712143|FG001|Overall Study|Adverse Event|0|||
126659889|NCT01163916|455712144|FG002|Overall Study|Adverse Event|1|||
126659890|NCT01163916|455712142|FG000|Overall Study|Lack of Efficacy|2|||
126659891|NCT01163916|455712143|FG001|Overall Study|Lack of Efficacy|0|||
126659892|NCT01163916|455712144|FG002|Overall Study|Lack of Efficacy|1|||
126659893|NCT01163916|455712142|FG000|Overall Study|Other|24|||
126659894|NCT01163916|455712143|FG001|Overall Study|Other|4|||
126659895|NCT01163916|455712144|FG002|Overall Study|Other|16|||
126659896|NCT00883051|455712145|FG000|Overall Study|Lost to Follow-up|0|||
126659897|NCT00883051|455712146|FG001|Overall Study|Lost to Follow-up|0|||
126659898|NCT00883051|455712147|FG002|Overall Study|Lost to Follow-up|0|||
126659899|NCT00883051|455712148|FG003|Overall Study|Lost to Follow-up|0|||
126659900|NCT00883051|455712149|FG004|Overall Study|Lost to Follow-up|1|||
126659901|NCT00883051|455712145|FG000|Overall Study|Did not use study medication|24|||
126659902|NCT00883051|455712146|FG001|Overall Study|Did not use study medication|22|||
126659903|NCT00883051|455712147|FG002|Overall Study|Did not use study medication|29|||
126659904|NCT00883051|455712148|FG003|Overall Study|Did not use study medication|29|||
126659905|NCT00883051|455712149|FG004|Overall Study|Did not use study medication|17|||
126659906|NCT02337751|455712150|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
126659907|NCT02337751|455712151|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
126659908|NCT02337751|455712150|FG000|Overall Study|Voluntary Withdrawal|6|||
126659909|NCT02337751|455712151|FG001|Overall Study|Voluntary Withdrawal|8|||
126659910|NCT02337751|455712150|FG000|Overall Study|Lack of Efficacy|2|||
126659911|NCT02337751|455712151|FG001|Overall Study|Lack of Efficacy|5|||
126659912|NCT02337751|455712150|FG000|Overall Study|Investigator's Judgement|1|||
126659913|NCT02337751|455712151|FG001|Overall Study|Investigator's Judgement|0|||
126659914|NCT02656823|455712158|FG000|Overall Study|Adverse Event|3|||
126659915|NCT02656823|455712158|FG000|Overall Study|Lost to Follow-up|2|||
126659916|NCT01910181|455712159|FG000|Overall Study|Death|37|||
126659917|NCT01910181|455712159|FG000|Overall Study|Lost to Follow-up|3|||
126659918|NCT01910181|455712159|FG000|Overall Study|Study Terminated by Sponsor|6|||
126659919|NCT05269355|455712160|FG000|Overall Study|Progressive Disease|104|||
126659920|NCT05269355|455712161|FG001|Overall Study|Progressive Disease|68|||
126659921|NCT05269355|455712160|FG000|Overall Study|Study Terminated by Sponsor|87|||
126659922|NCT05269355|455712161|FG001|Overall Study|Study Terminated by Sponsor|29|||
126330475|NCT00103285|454505072|FG005|Induction|Withdrawal by Subject|0|||
126659923|NCT05269355|455712160|FG000|Overall Study|Adverse Event|15|||
126659924|NCT05269355|455712161|FG001|Overall Study|Adverse Event|8|||
126659925|NCT05269355|455712160|FG000|Overall Study|Withdrawal by Subject|18|||
126659926|NCT05269355|455712161|FG001|Overall Study|Withdrawal by Subject|5|||
126659927|NCT05269355|455712160|FG000|Overall Study|Physician Decision|6|||
126659928|NCT05269355|455712161|FG001|Overall Study|Physician Decision|4|||
126659929|NCT05269355|455712160|FG000|Overall Study|Death|3|||
126659930|NCT05269355|455712161|FG001|Overall Study|Death|5|||
126659931|NCT05269355|455712160|FG000|Overall Study|Other Than Specified|5|||
126659932|NCT05269355|455712161|FG001|Overall Study|Other Than Specified|1|||
126659933|NCT05269355|455712160|FG000|Overall Study|Randomized But Not Treated|1|||
126659934|NCT05269355|455712161|FG001|Overall Study|Randomized But Not Treated|0|||
126659935|NCT00959647|455712163|FG000|Overall Study|Adverse Event|2|||
126659936|NCT00959647|455712163|FG000|Overall Study|Progressive disease|6|||
126659937|NCT00959647|455712163|FG000|Overall Study|Study terminated by sponsor|4|||
126659938|NCT00959647|455712163|FG000|Overall Study|Withdrawal by Subject|7|||
126659939|NCT01620255|455714737|FG000|Overall Study|Withdrawal by Subject|4|||
126659940|NCT01620255|455714738|FG001|Overall Study|Withdrawal by Subject|1|||
126659941|NCT01620255|455714739|FG002|Overall Study|Withdrawal by Subject|1|||
126659942|NCT01620255|455714740|FG003|Overall Study|Withdrawal by Subject|2|||
126659943|NCT01620255|455714741|FG004|Overall Study|Withdrawal by Subject|4|||
126659944|NCT01620255|455714737|FG000|Overall Study|Participant underwent fecal transplant|0|||
126659945|NCT01620255|455714738|FG001|Overall Study|Participant underwent fecal transplant|0|||
126659946|NCT01620255|455714739|FG002|Overall Study|Participant underwent fecal transplant|1|||
126659947|NCT01620255|455714740|FG003|Overall Study|Participant underwent fecal transplant|0|||
126659948|NCT01620255|455714741|FG004|Overall Study|Participant underwent fecal transplant|0|||
126659949|NCT01620255|455714737|FG000|Overall Study|Non-compliance|0|||
126659950|NCT01620255|455714738|FG001|Overall Study|Non-compliance|1|||
126659951|NCT01620255|455714739|FG002|Overall Study|Non-compliance|0|||
126659952|NCT01620255|455714740|FG003|Overall Study|Non-compliance|0|||
126659953|NCT01620255|455714741|FG004|Overall Study|Non-compliance|0|||
126659954|NCT01620255|455714737|FG000|Overall Study|Adverse Event|0|||
126659955|NCT01620255|455714738|FG001|Overall Study|Adverse Event|4|||
126659956|NCT01620255|455714739|FG002|Overall Study|Adverse Event|0|||
126659957|NCT01620255|455714740|FG003|Overall Study|Adverse Event|1|||
126659958|NCT01620255|455714741|FG004|Overall Study|Adverse Event|1|||
126659959|NCT01620255|455714737|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
126659960|NCT01620255|455714738|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
126659961|NCT01620255|455714739|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
126659962|NCT01620255|455714740|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
126659963|NCT01620255|455714741|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
126659964|NCT01155375|455714745|FG000|Overall Study|Adverse Event|1|||
126659965|NCT01155375|455714746|FG001|Overall Study|Adverse Event|0|||
126659966|NCT01480674|455714750|FG000|Overall Study|Death|23|||
126659967|NCT01480674|455714750|FG000|Overall Study|Lost to Follow-up|2|||
126659968|NCT01480674|455714750|FG000|Overall Study|visit not done|10|||
126659969|NCT03818204|455714751|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659970|NCT03818204|455714752|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659971|NCT03818204|455714753|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659972|NCT03818204|455714754|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659973|NCT03818204|455714755|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
126659974|NCT03818204|455714756|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659975|NCT03818204|455714757|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659976|NCT03818204|455714758|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659977|NCT03818204|455714759|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659978|NCT03818204|455714760|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659979|NCT03818204|455714761|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659980|NCT03818204|455714762|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659981|NCT03818204|455714763|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659982|NCT03818204|455714764|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
126659983|NCT03818204|455714765|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659984|NCT03818204|455714766|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659985|NCT03818204|455714767|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659986|NCT03818204|455714768|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659987|NCT03818204|455714769|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
126659988|NCT03818204|455714751|FG000|Overall Study|Physician Decision|0|||
126659989|NCT03818204|455714752|FG001|Overall Study|Physician Decision|0|||
126659990|NCT03818204|455714753|FG002|Overall Study|Physician Decision|0|||
126659991|NCT03818204|455714754|FG003|Overall Study|Physician Decision|0|||
126659992|NCT03818204|455714755|FG004|Overall Study|Physician Decision|0|||
126659993|NCT03818204|455714756|FG005|Overall Study|Physician Decision|0|||
126659994|NCT03818204|455714757|FG006|Overall Study|Physician Decision|0|||
126659995|NCT03818204|455714758|FG007|Overall Study|Physician Decision|0|||
126659996|NCT03818204|455714759|FG008|Overall Study|Physician Decision|0|||
126659997|NCT03818204|455714760|FG009|Overall Study|Physician Decision|0|||
126659998|NCT03818204|455714761|FG010|Overall Study|Physician Decision|0|||
126659999|NCT03818204|455714762|FG011|Overall Study|Physician Decision|0|||
126660000|NCT03818204|455714763|FG012|Overall Study|Physician Decision|0|||
126660001|NCT03818204|455714764|FG013|Overall Study|Physician Decision|0|||
126660002|NCT03818204|455714765|FG014|Overall Study|Physician Decision|1|||
126660003|NCT03818204|455714766|FG015|Overall Study|Physician Decision|0|||
126660004|NCT03818204|455714767|FG016|Overall Study|Physician Decision|0|||
126660005|NCT03818204|455714768|FG017|Overall Study|Physician Decision|0|||
126660006|NCT03818204|455714769|FG018|Overall Study|Physician Decision|0|||
126330476|NCT00103285|454505073|FG006|Induction|Withdrawal by Subject|0|||
126660007|NCT00887250|455714770|FG000|Overall Study|Adverse Event|3|||
126660008|NCT00887250|455714771|FG001|Overall Study|Adverse Event|0|||
126660009|NCT00887250|455714772|FG002|Overall Study|Adverse Event|7|||
126660010|NCT00887250|455714770|FG000|Overall Study|Lack of Efficacy|9|||
126660011|NCT00887250|455714771|FG001|Overall Study|Lack of Efficacy|6|||
126660012|NCT00887250|455714772|FG002|Overall Study|Lack of Efficacy|1|||
126660013|NCT00887250|455714770|FG000|Overall Study|Lost to Follow-up|2|||
126660014|NCT00887250|455714771|FG001|Overall Study|Lost to Follow-up|3|||
126660015|NCT00887250|455714772|FG002|Overall Study|Lost to Follow-up|1|||
126660016|NCT00887250|455714770|FG000|Overall Study|Protocol Violation|2|||
126660017|NCT00887250|455714771|FG001|Overall Study|Protocol Violation|2|||
126660018|NCT00887250|455714772|FG002|Overall Study|Protocol Violation|1|||
126660019|NCT00887250|455714770|FG000|Overall Study|Withdrawal by Subject|2|||
126660020|NCT00887250|455714771|FG001|Overall Study|Withdrawal by Subject|1|||
126660021|NCT00887250|455714772|FG002|Overall Study|Withdrawal by Subject|2|||
126660022|NCT00887250|455714770|FG000|Overall Study|Patient uncooperative|0|||
126660023|NCT00887250|455714771|FG001|Overall Study|Patient uncooperative|0|||
126660024|NCT00887250|455714772|FG002|Overall Study|Patient uncooperative|1|||
126660025|NCT01933113|455714773|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
126660026|NCT00879762|455714774|FG000|Overall Study|Lost to Follow-up|3|||
126660027|NCT00879762|455714775|FG001|Overall Study|Lost to Follow-up|1|||
126660028|NCT04981366|455714776|FG000|Overall Study|Withdrawal by Subject|5|||
126660029|NCT04981366|455714777|FG001|Overall Study|Withdrawal by Subject|4|||
126660030|NCT04981366|455714778|FG002|Overall Study|Withdrawal by Subject|8|||
126660031|NCT04981366|455714776|FG000|Overall Study|Health issues unrelated to the trial|1|||
126660032|NCT04981366|455714777|FG001|Overall Study|Health issues unrelated to the trial|2|||
126660033|NCT04981366|455714778|FG002|Overall Study|Health issues unrelated to the trial|0|||
126660034|NCT00881608|455714779|FG000|Overall Study|Study prematurely terminated|11|||
126660035|NCT03214094|455714780|FG000|Overall Study|Case Report Forms Uncollected|14|||
126660036|NCT03214094|455714780|FG000|Overall Study|Protocol Deviation|46|||
126660037|NCT00795951|455714783|FG000|Overall Study|Lost to Follow-up|1|||
126660038|NCT00795951|455714783|FG000|Overall Study|Withdrawal by Subject|1|||
126660039|NCT01122862|455714795|FG000|Period 1|Protocol Violation|0|||
126660040|NCT01122862|455714796|FG001|Period 1|Protocol Violation|1|||
126660041|NCT01122862|455714797|FG002|Period 1|Protocol Violation|0|||
126660042|NCT01122862|455714795|FG000|Period 2|Adverse Event|0|||
126660043|NCT01122862|455714796|FG001|Period 2|Adverse Event|0|||
126660044|NCT01122862|455714797|FG002|Period 2|Adverse Event|1|||
126660045|NCT02699983|455714800|FG000|Overall Study|Withdrawal by Subject|1|||
126660046|NCT02699983|455714801|FG001|Overall Study|Withdrawal by Subject|0|||
126660047|NCT03421431|455714802|FG000|Overall Study|Adverse Event|2|||
126660048|NCT03421431|455714803|FG001|Overall Study|Adverse Event|1|||
126660049|NCT03421431|455714804|FG002|Overall Study|Adverse Event|12|||
126660050|NCT03421431|455714802|FG000|Overall Study|Lost to Follow-up|1|||
126660051|NCT03421431|455714803|FG001|Overall Study|Lost to Follow-up|1|||
126660052|NCT03421431|455714804|FG002|Overall Study|Lost to Follow-up|1|||
126660053|NCT03421431|455714802|FG000|Overall Study|Withdrawal by Subject|3|||
126660054|NCT03421431|455714803|FG001|Overall Study|Withdrawal by Subject|2|||
126660055|NCT03421431|455714804|FG002|Overall Study|Withdrawal by Subject|1|||
126660056|NCT03421431|455714802|FG000|Overall Study|Protocol Violation|0|||
126660057|NCT03421431|455714803|FG001|Overall Study|Protocol Violation|1|||
126660058|NCT03421431|455714804|FG002|Overall Study|Protocol Violation|0|||
126660059|NCT03421431|455714802|FG000|Overall Study|Participant met Stopping Rules|0|||
126660060|NCT03421431|455714803|FG001|Overall Study|Participant met Stopping Rules|1|||
126660061|NCT03421431|455714804|FG002|Overall Study|Participant met Stopping Rules|0|||
126660062|NCT00141726|455714805|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
126660063|NCT00235326|455714813|FG000|Overall Study|Lost to Follow-up|746|||
126660064|NCT00235326|455714814|FG001|Overall Study|Lost to Follow-up|1400|||
126660065|NCT01790126|455714815|FG000|Overall Study|PSA Progression|12|||
126660066|NCT01790126|455714816|FG001|Overall Study|PSA Progression|16|||
126660067|NCT01790126|455714817|FG002|Overall Study|PSA Progression|16|||
126660068|NCT01790126|455714815|FG000|Overall Study|Other|5|||
126660069|NCT01790126|455714816|FG001|Overall Study|Other|4|||
126660070|NCT01790126|455714817|FG002|Overall Study|Other|8|||
126660071|NCT01790126|455714815|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
126660072|NCT01790126|455714816|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
126660073|NCT01790126|455714817|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
126660074|NCT01790126|455714815|FG000|Overall Study|Withdrawal by Physician|1|||
126660075|NCT01790126|455714816|FG001|Overall Study|Withdrawal by Physician|1|||
126660076|NCT01790126|455714817|FG002|Overall Study|Withdrawal by Physician|2|||
126660077|NCT01790126|455714815|FG000|Overall Study|Withdrawal by Subject|3|||
126660078|NCT01790126|455714816|FG001|Overall Study|Withdrawal by Subject|1|||
126660079|NCT01790126|455714817|FG002|Overall Study|Withdrawal by Subject|2|||
126660080|NCT01790126|455714815|FG000|Overall Study|Lost to Follow-up|1|||
126660081|NCT01790126|455714816|FG001|Overall Study|Lost to Follow-up|0|||
126660082|NCT01790126|455714817|FG002|Overall Study|Lost to Follow-up|1|||
126660083|NCT01790126|455714815|FG000|Overall Study|Adverse Event|0|||
126660084|NCT01790126|455714816|FG001|Overall Study|Adverse Event|2|||
126660085|NCT01790126|455714817|FG002|Overall Study|Adverse Event|0|||
126660086|NCT01790126|455714815|FG000|Overall Study|Death|2|||
126660087|NCT01790126|455714816|FG001|Overall Study|Death|0|||
126660088|NCT01790126|455714817|FG002|Overall Study|Death|0|||
126660089|NCT01790126|455714815|FG000|Overall Study|Radiographic Progression|3|||
126660090|NCT01790126|455714816|FG001|Overall Study|Radiographic Progression|1|||
126660091|NCT01790126|455714817|FG002|Overall Study|Radiographic Progression|0|||
126660092|NCT01128738|455714818|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
126660093|NCT01128738|455714819|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
126660094|NCT01128738|455714818|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
126660095|NCT01128738|455714819|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
126660096|NCT01128738|455714818|FG000|Second TP|Lost to Follow-up|0|||
126660097|NCT01128738|455714819|FG001|Second TP|Lost to Follow-up|1|||
126660098|NCT01128738|455714818|FG000|Second TP|Withdrawal by Subject|0|||
126660099|NCT01128738|455714819|FG001|Second TP|Withdrawal by Subject|2|||
126660100|NCT01178671|455714820|FG000|Overall Study|Adverse Event|4|||
126660101|NCT01178671|455714821|FG001|Overall Study|Adverse Event|6|||
126660102|NCT01178671|455714820|FG000|Overall Study|Protocol Violation|1|||
126660103|NCT01178671|455714821|FG001|Overall Study|Protocol Violation|1|||
126660104|NCT01178671|455714820|FG000|Overall Study|Lack of Efficacy|0|||
126660105|NCT01178671|455714821|FG001|Overall Study|Lack of Efficacy|1|||
126660106|NCT01178671|455714820|FG000|Overall Study|Lost to Follow-up|3|||
126660107|NCT01178671|455714821|FG001|Overall Study|Lost to Follow-up|1|||
126660108|NCT01178671|455714820|FG000|Overall Study|Physician Decision|4|||
126660109|NCT01178671|455714821|FG001|Overall Study|Physician Decision|6|||
126660110|NCT01211197|455714825|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126660111|NCT01211197|455714826|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126660112|NCT01211197|455714827|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
126660113|NCT01211197|455714828|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126660114|NCT01211197|455714829|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126660115|NCT01211197|455714830|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126660116|NCT01211197|455714825|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
126660117|NCT01211197|455714826|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
126660118|NCT01211197|455714827|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
126660119|NCT01211197|455714828|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
126660120|NCT01211197|455714829|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
126660121|NCT01211197|455714830|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
126660122|NCT02349451|455714831|FG000|Overall Study|Withdrawal by Subject|0|||
126660123|NCT02349451|455714832|FG001|Overall Study|Withdrawal by Subject|1|||
126660124|NCT02349451|455714833|FG002|Overall Study|Withdrawal by Subject|2|||
126660125|NCT02349451|455714834|FG003|Overall Study|Withdrawal by Subject|1|||
126660126|NCT02683941|455714835|FG000|Double-blind Phase|Adverse Event|0|||
126660127|NCT02683941|455714836|FG001|Double-blind Phase|Adverse Event|1|||
126660128|NCT02683941|455714835|FG000|Double-blind Phase|Withdrawal by Subject|4|||
126660129|NCT02683941|455714836|FG001|Double-blind Phase|Withdrawal by Subject|2|||
126660130|NCT02683941|455714835|FG000|Double-blind Phase|Lost to Follow-up|1|||
126660131|NCT02683941|455714836|FG001|Double-blind Phase|Lost to Follow-up|0|||
126660132|NCT02683941|455714835|FG000|Double-blind Phase|Disease Progression|5|||
126660133|NCT02683941|455714836|FG001|Double-blind Phase|Disease Progression|2|||
126660134|NCT02683941|455714835|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
126660135|NCT02683941|455714836|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
126660136|NCT02683941|455714835|FG000|Open-label Treatment Phase|Disease Progression|1|||
126660137|NCT02683941|455714836|FG001|Open-label Treatment Phase|Disease Progression|2|||
126660138|NCT02683941|455714835|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
126660139|NCT02683941|455714836|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
126660140|NCT02683941|455714835|FG000|Open-label Treatment Phase|Other|1|||
126660141|NCT02683941|455714836|FG001|Open-label Treatment Phase|Other|0|||
126660142|NCT02683941|455714835|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
126660143|NCT02683941|455714836|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
126660144|NCT02683941|455714835|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
126660145|NCT02683941|455714836|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
126660146|NCT02683941|455714835|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
126660147|NCT02683941|455714836|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
126660148|NCT02683941|455714835|FG000|Open-label Follow-up Phase|Other|8|||
126660149|NCT02683941|455714836|FG001|Open-label Follow-up Phase|Other|1|||
126660150|NCT00261846|455714837|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
126660151|NCT00261846|455714838|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
126660152|NCT00261846|455714839|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
126660153|NCT00261846|455714840|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126660154|NCT00261846|455714841|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126660155|NCT00261846|455714842|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126660156|NCT00261846|455714843|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126660157|NCT00261846|455714844|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126660158|NCT00261846|455714845|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126660159|NCT00261846|455714846|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126660160|NCT00261846|455714847|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126660161|NCT00261846|455714848|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
126660162|NCT00261846|455714837|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126660163|NCT00261846|455714838|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126660164|NCT00261846|455714839|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126660165|NCT00261846|455714840|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
126660166|NCT00261846|455714841|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126660167|NCT00261846|455714842|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126660168|NCT00261846|455714843|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126660169|NCT00261846|455714844|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126660170|NCT00261846|455714845|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
126660171|NCT00261846|455714846|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126660172|NCT00261846|455714847|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126660173|NCT00261846|455714848|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
126660174|NCT00261846|455714837|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
126660175|NCT00261846|455714838|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
126660176|NCT00261846|455714839|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
126660177|NCT00261846|455714840|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
126660178|NCT00261846|455714841|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
126660179|NCT00261846|455714842|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
126660180|NCT00261846|455714843|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
126660181|NCT00261846|455714844|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
126660182|NCT00261846|455714845|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
126660183|NCT00261846|455714846|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
126660184|NCT00261846|455714847|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
126660185|NCT00261846|455714848|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
126660186|NCT00261846|455714837|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
126660187|NCT00261846|455714838|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
126660188|NCT00261846|455714839|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
126660189|NCT00261846|455714840|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
126660190|NCT00261846|455714841|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
126660191|NCT00261846|455714842|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
126660192|NCT00261846|455714843|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
126660193|NCT00261846|455714844|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
126660194|NCT00261846|455714845|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
126660195|NCT00261846|455714846|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
126660196|NCT00261846|455714847|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
126660197|NCT00261846|455714848|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
126660198|NCT00261846|455714837|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
126660199|NCT00261846|455714838|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
126660200|NCT00261846|455714839|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
126660201|NCT00261846|455714840|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
126660202|NCT00261846|455714841|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
126660203|NCT00261846|455714842|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
126660204|NCT00261846|455714843|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
126660205|NCT00261846|455714844|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
126660206|NCT00261846|455714845|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
126660207|NCT00261846|455714846|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
126660208|NCT00261846|455714847|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
126660209|NCT00261846|455714848|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
126660210|NCT00261846|455714837|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
126660211|NCT00261846|455714838|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
126330477|NCT00103285|454505074|FG007|Induction|Withdrawal by Subject|0|||
126330478|NCT00103285|454505067|FG000|Induction|Ineligible|43|||
126330479|NCT00103285|454505068|FG001|Induction|Ineligible|0|||
126330480|NCT00103285|454505069|FG002|Induction|Ineligible|0|||
126330481|NCT00103285|454505070|FG003|Induction|Ineligible|0|||
126330482|NCT00103285|454505071|FG004|Induction|Ineligible|0|||
126330483|NCT00103285|454505072|FG005|Induction|Ineligible|0|||
126330484|NCT00103285|454505073|FG006|Induction|Ineligible|0|||
126330485|NCT00103285|454505074|FG007|Induction|Ineligible|0|||
126330486|NCT00103285|454505067|FG000|Induction|Refusal|906|||
126330487|NCT00103285|454505068|FG001|Induction|Refusal|0|||
126330488|NCT00103285|454505069|FG002|Induction|Refusal|0|||
126660212|NCT00261846|455714839|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
126660213|NCT00261846|455714840|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
126660214|NCT00261846|455714841|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
126660215|NCT00261846|455714842|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
126330489|NCT00103285|454505070|FG003|Induction|Refusal|0|||
126330490|NCT00103285|454505071|FG004|Induction|Refusal|0|||
126330491|NCT00103285|454505072|FG005|Induction|Refusal|0|||
126545264|NCT01641926|455290785|FG002|Overall Study|Physician Decision|0|||
126330492|NCT00103285|454505073|FG006|Induction|Refusal|0|||
126660216|NCT00261846|455714843|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
126660217|NCT00261846|455714844|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
126660218|NCT00261846|455714845|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
126660219|NCT00261846|455714846|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
126660220|NCT00261846|455714847|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
126660221|NCT00261846|455714848|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
126660222|NCT00261846|455714837|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
126660223|NCT00261846|455714838|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
126660224|NCT00261846|455714839|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
126660225|NCT00261846|455714840|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
126660226|NCT00261846|455714841|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
126660227|NCT00261846|455714842|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
126660228|NCT00261846|455714843|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
126660229|NCT00261846|455714844|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
126660230|NCT00261846|455714845|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
126660231|NCT00261846|455714846|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
126660232|NCT00261846|455714847|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
126660233|NCT00261846|455714848|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
126660234|NCT01009203|455714849|FG000|Overall Study|Withdrawal by Subject|1|||
126660235|NCT01009203|455714849|FG000|Overall Study|Adverse Event|5|||
126660236|NCT01009203|455714849|FG000|Overall Study|Treatment-unrelated death|1|||
126660237|NCT00892723|455714850|FG000|Overall Study|Lost to Follow-up|1|||
126660238|NCT00892723|455714851|FG001|Overall Study|Lost to Follow-up|3|||
126660239|NCT00892723|455714852|FG002|Overall Study|Lost to Follow-up|1|||
126660240|NCT00892723|455714850|FG000|Overall Study|Withdrawal by Subject|1|||
126660241|NCT00892723|455714851|FG001|Overall Study|Withdrawal by Subject|1|||
126660242|NCT00892723|455714852|FG002|Overall Study|Withdrawal by Subject|1|||
126660243|NCT00150969|455714853|FG000|24 Month Main Study|Adverse Event|3|||
126660244|NCT00150969|455714854|FG001|24 Month Main Study|Adverse Event|4|||
126660245|NCT00150969|455714853|FG000|24 Month Main Study|Death|1|||
126660246|NCT00150969|455714854|FG001|24 Month Main Study|Death|1|||
126660247|NCT00150969|455714853|FG000|24 Month Main Study|Lack of Efficacy|1|||
126660248|NCT00150969|455714854|FG001|24 Month Main Study|Lack of Efficacy|8|||
126660249|NCT00150969|455714853|FG000|24 Month Main Study|Lost to Follow-up|3|||
126660250|NCT00150969|455714854|FG001|24 Month Main Study|Lost to Follow-up|2|||
126660251|NCT00150969|455714853|FG000|24 Month Main Study|Protocol Violation|4|||
126660252|NCT00150969|455714854|FG001|24 Month Main Study|Protocol Violation|2|||
126660253|NCT00150969|455714853|FG000|24 Month Main Study|Withdrawal by Subject|7|||
126660254|NCT00150969|455714854|FG001|24 Month Main Study|Withdrawal by Subject|4|||
126660255|NCT00150969|455714853|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
126660256|NCT00150969|455714854|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
126660257|NCT00150969|455714853|FG000|24-48 Month Extension|Lack of Efficacy|0|||
126660258|NCT00150969|455714854|FG001|24-48 Month Extension|Lack of Efficacy|1|||
126660259|NCT00150969|455714853|FG000|24-48 Month Extension|Adverse Event|1|||
126660260|NCT00150969|455714854|FG001|24-48 Month Extension|Adverse Event|3|||
126660261|NCT00150969|455714853|FG000|24-48 Month Extension|Other Reason|81|||
126660262|NCT00150969|455714854|FG001|24-48 Month Extension|Other Reason|91|||
126660263|NCT00615836|455714855|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
126660264|NCT00615836|455714856|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
126660265|NCT00615836|455714857|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
126660266|NCT00615836|455714858|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
126660267|NCT00615836|455714859|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
126660268|NCT00615836|455714855|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
126660269|NCT00615836|455714856|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
126660270|NCT00615836|455714857|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
126660271|NCT00615836|455714858|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
126660272|NCT00615836|455714859|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
126660273|NCT00615836|455714855|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
126660274|NCT00615836|455714856|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
126660275|NCT00615836|455714857|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
126660276|NCT00615836|455714858|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
126660277|NCT00615836|455714859|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
126660278|NCT00615836|455714855|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
126660279|NCT00615836|455714856|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
126660280|NCT00615836|455714857|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
126660281|NCT00615836|455714858|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
126660282|NCT00615836|455714859|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
126660283|NCT00615836|455714855|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
126660284|NCT00615836|455714856|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
126660285|NCT00615836|455714857|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
126330493|NCT00103285|454505074|FG007|Induction|Refusal|0|||
126660286|NCT00615836|455714858|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
126660287|NCT00615836|455714859|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
126660288|NCT00615836|455714855|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
126660289|NCT00615836|455714856|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
126660290|NCT00615836|455714857|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
126660291|NCT00615836|455714858|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
126660292|NCT00615836|455714859|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
126660293|NCT00615836|455714855|FG000|Extension Study (FE992026 CS31)|Other|10|||
126660294|NCT00615836|455714856|FG001|Extension Study (FE992026 CS31)|Other|7|||
126660295|NCT00615836|455714857|FG002|Extension Study (FE992026 CS31)|Other|8|||
126660296|NCT00615836|455714858|FG003|Extension Study (FE992026 CS31)|Other|8|||
126660297|NCT00615836|455714859|FG004|Extension Study (FE992026 CS31)|Other|0|||
126660298|NCT00615836|455714855|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
126660299|NCT00615836|455714856|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
126660300|NCT00615836|455714857|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
126660301|NCT00615836|455714858|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
126660302|NCT00615836|455714859|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
126660303|NCT00615836|455714855|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
126660304|NCT00615836|455714856|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
126660305|NCT00615836|455714857|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
126660306|NCT00615836|455714858|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
126660307|NCT00615836|455714859|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
126660308|NCT01313689|455714860|FG000|24-Week Randomization 1|Adverse Event|10|||
126660309|NCT01313689|455714861|FG001|24-Week Randomization 1|Adverse Event|5|||
126660310|NCT01313689|455714862|FG002|24-Week Randomization 1|Adverse Event|0|||
126330494|NCT00103285|454505067|FG000|Induction|Other|258|||
126330495|NCT00103285|454505068|FG001|Induction|Other|0|||
126330496|NCT00103285|454505069|FG002|Induction|Other|0|||
126330497|NCT00103285|454505070|FG003|Induction|Other|0|||
126330498|NCT00103285|454505071|FG004|Induction|Other|0|||
126330499|NCT00103285|454505072|FG005|Induction|Other|0|||
126330500|NCT00103285|454505073|FG006|Induction|Other|0|||
126330501|NCT00103285|454505074|FG007|Induction|Other|0|||
126330502|NCT00103285|454505067|FG000|Response Assignment|Adverse Event|0|||
126330503|NCT00103285|454505068|FG001|Response Assignment|Adverse Event|8|||
126330504|NCT00103285|454505069|FG002|Response Assignment|Adverse Event|3|||
126330505|NCT00103285|454505070|FG003|Response Assignment|Adverse Event|2|||
126660311|NCT01313689|455714863|FG003|24-Week Randomization 1|Adverse Event|0|||
126660312|NCT01313689|455714864|FG004|24-Week Randomization 1|Adverse Event|0|||
126660313|NCT01313689|455714860|FG000|24-Week Randomization 1|Physician Decision|4|||
126660314|NCT01313689|455714861|FG001|24-Week Randomization 1|Physician Decision|5|||
126660315|NCT01313689|455714862|FG002|24-Week Randomization 1|Physician Decision|0|||
126660316|NCT01313689|455714863|FG003|24-Week Randomization 1|Physician Decision|0|||
126330506|NCT00103285|454505071|FG004|Response Assignment|Adverse Event|3|||
126660317|NCT01313689|455714864|FG004|24-Week Randomization 1|Physician Decision|0|||
126660318|NCT01313689|455714860|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
126660319|NCT01313689|455714861|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
126660320|NCT01313689|455714862|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
126660321|NCT01313689|455714863|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
126660322|NCT01313689|455714864|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
126660323|NCT01313689|455714860|FG000|24-Week Randomization 2|Adverse Event|0|||
126660324|NCT01313689|455714861|FG001|24-Week Randomization 2|Adverse Event|0|||
126660325|NCT01313689|455714862|FG002|24-Week Randomization 2|Adverse Event|2|||
126660326|NCT01313689|455714863|FG003|24-Week Randomization 2|Adverse Event|0|||
126660327|NCT01313689|455714864|FG004|24-Week Randomization 2|Adverse Event|8|||
126660328|NCT01313689|455714860|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
126660329|NCT01313689|455714861|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
126660330|NCT01313689|455714862|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
126660331|NCT01313689|455714863|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
126330507|NCT00103285|454505072|FG005|Response Assignment|Adverse Event|1|||
126330508|NCT00103285|454505073|FG006|Response Assignment|Adverse Event|1|||
126660332|NCT01313689|455714864|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
126660333|NCT01313689|455714860|FG000|24-Week Randomization 2|Physician Decision|0|||
126660334|NCT01313689|455714861|FG001|24-Week Randomization 2|Physician Decision|0|||
126660335|NCT01313689|455714862|FG002|24-Week Randomization 2|Physician Decision|0|||
126660336|NCT01313689|455714863|FG003|24-Week Randomization 2|Physician Decision|0|||
126660337|NCT01313689|455714864|FG004|24-Week Randomization 2|Physician Decision|4|||
126330509|NCT00103285|454505074|FG007|Response Assignment|Adverse Event|2|||
126330510|NCT00103285|454505067|FG000|Response Assignment|Death|0|||
126330511|NCT00103285|454505068|FG001|Response Assignment|Death|5|||
126545265|NCT01641926|455290786|FG003|Overall Study|Physician Decision|1|||
126545266|NCT01641926|455290783|FG000|Overall Study|Protocol Violation|1|||
126545267|NCT01641926|455290784|FG001|Overall Study|Protocol Violation|0|||
126545268|NCT01641926|455290785|FG002|Overall Study|Protocol Violation|0|||
126545269|NCT01641926|455290786|FG003|Overall Study|Protocol Violation|1|||
126660338|NCT01007448|455714865|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
126660339|NCT01007448|455714866|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
126660340|NCT01007448|455714865|FG000|Overall Study|Staph Skin Infection Flare|1|||
126660341|NCT01007448|455714866|FG001|Overall Study|Staph Skin Infection Flare|0|||
126660342|NCT01007448|455714865|FG000|Overall Study|Participant Leaving the Country|1|||
126660343|NCT01007448|455714866|FG001|Overall Study|Participant Leaving the Country|0|||
126660344|NCT01007448|455714865|FG000|Overall Study|Participant Given Prohibited Medication|1|||
126330512|NCT00103285|454505069|FG002|Response Assignment|Death|2|||
126660345|NCT01007448|455714866|FG001|Overall Study|Participant Given Prohibited Medication|0|||
126660346|NCT01007448|455714865|FG000|Overall Study|Progressive Disease|1|||
126660347|NCT01007448|455714866|FG001|Overall Study|Progressive Disease|2|||
126660348|NCT01007448|455714865|FG000|Overall Study|Lack of Efficacy|2|||
126660349|NCT01007448|455714866|FG001|Overall Study|Lack of Efficacy|0|||
126660350|NCT01007448|455714865|FG000|Overall Study|Withdrawal by Subject|2|||
126660351|NCT01007448|455714866|FG001|Overall Study|Withdrawal by Subject|3|||
126660352|NCT01007448|455714865|FG000|Overall Study|Adverse Event|1|||
126660353|NCT01007448|455714866|FG001|Overall Study|Adverse Event|4|||
126660354|NCT02121834|455714868|FG000|Overall Study|Protocol Violation|0|||
126660355|NCT02121834|455714869|FG001|Overall Study|Protocol Violation|1|||
126660356|NCT02121834|455714870|FG002|Overall Study|Protocol Violation|0|||
126660357|NCT02121834|455714871|FG003|Overall Study|Protocol Violation|0|||
126660358|NCT02121834|455714872|FG004|Overall Study|Protocol Violation|0|||
126660359|NCT02121834|455714873|FG005|Overall Study|Protocol Violation|0|||
126660360|NCT02121834|455714874|FG006|Overall Study|Protocol Violation|0|||
126660361|NCT02121834|455714868|FG000|Overall Study|Withdrawal by Subject|0|||
126660362|NCT02121834|455714869|FG001|Overall Study|Withdrawal by Subject|1|||
126660363|NCT02121834|455714870|FG002|Overall Study|Withdrawal by Subject|1|||
126660364|NCT02121834|455714871|FG003|Overall Study|Withdrawal by Subject|0|||
126660365|NCT02121834|455714872|FG004|Overall Study|Withdrawal by Subject|0|||
126660366|NCT02121834|455714873|FG005|Overall Study|Withdrawal by Subject|0|||
126660367|NCT02121834|455714874|FG006|Overall Study|Withdrawal by Subject|0|||
126660368|NCT02121834|455714868|FG000|Overall Study|Lost to Follow-up|0|||
126660369|NCT02121834|455714869|FG001|Overall Study|Lost to Follow-up|0|||
126660370|NCT02121834|455714870|FG002|Overall Study|Lost to Follow-up|1|||
126660371|NCT02121834|455714871|FG003|Overall Study|Lost to Follow-up|0|||
126660372|NCT02121834|455714872|FG004|Overall Study|Lost to Follow-up|0|||
126660373|NCT02121834|455714873|FG005|Overall Study|Lost to Follow-up|0|||
126660374|NCT02121834|455714874|FG006|Overall Study|Lost to Follow-up|0|||
126660375|NCT00551460|455714875|FG000|Overall Study|Adverse Event|1|||
126660376|NCT00551460|455714875|FG000|Overall Study|Withdrawal by Subject|1|||
126660377|NCT00551460|455714875|FG000|Overall Study|Physician Decision|1|||
126660378|NCT00551460|455714875|FG000|Overall Study|Death|7|||
126660379|NCT00551460|455714875|FG000|Overall Study|Ineligible|4|||
126660380|NCT00551460|455714875|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
126660381|NCT00448123|455714876|FG000|Overall Study|Lost to Follow-up|9|||
126660382|NCT00448123|455714877|FG001|Overall Study|Lost to Follow-up|6|||
126660383|NCT00448123|455714876|FG000|Overall Study|Physician Decision|6|||
126660384|NCT00448123|455714877|FG001|Overall Study|Physician Decision|6|||
126660385|NCT00406653|455714880|FG000|Induction Period|Adverse Event|1|||
126660386|NCT00406653|455714881|FG001|Induction Period|Adverse Event|10|||
126330513|NCT00103285|454505070|FG003|Response Assignment|Death|2|||
126330514|NCT00103285|454505071|FG004|Response Assignment|Death|3|||
126330515|NCT00103285|454505072|FG005|Response Assignment|Death|1|||
126330516|NCT00103285|454505073|FG006|Response Assignment|Death|0|||
126330517|NCT00103285|454505074|FG007|Response Assignment|Death|8|||
126330518|NCT00103285|454505067|FG000|Response Assignment|Lost to Follow-up|0|||
126330519|NCT00103285|454505068|FG001|Response Assignment|Lost to Follow-up|9|||
126330520|NCT00103285|454505069|FG002|Response Assignment|Lost to Follow-up|5|||
126330521|NCT00103285|454505070|FG003|Response Assignment|Lost to Follow-up|5|||
126330522|NCT00103285|454505071|FG004|Response Assignment|Lost to Follow-up|1|||
126330523|NCT00103285|454505072|FG005|Response Assignment|Lost to Follow-up|2|||
126660387|NCT00406653|455714882|FG002|Induction Period|Adverse Event|4|||
126660388|NCT00406653|455714883|FG003|Induction Period|Adverse Event|11|||
126660389|NCT00406653|455714884|FG004|Induction Period|Adverse Event|0|||
126660390|NCT00406653|455714885|FG005|Induction Period|Adverse Event|0|||
126330524|NCT00103285|454505073|FG006|Response Assignment|Lost to Follow-up|2|||
126330525|NCT00103285|454505074|FG007|Response Assignment|Lost to Follow-up|5|||
126660391|NCT00406653|455714886|FG006|Induction Period|Adverse Event|0|||
126660392|NCT00406653|455714880|FG000|Induction Period|Lack of Efficacy|11|||
126660393|NCT00406653|455714881|FG001|Induction Period|Lack of Efficacy|14|||
126330526|NCT00103285|454505067|FG000|Response Assignment|Physician Decision|0|||
126330527|NCT00103285|454505068|FG001|Response Assignment|Physician Decision|13|||
126330528|NCT00103285|454505069|FG002|Response Assignment|Physician Decision|14|||
126660394|NCT00406653|455714882|FG002|Induction Period|Lack of Efficacy|8|||
126660395|NCT00406653|455714883|FG003|Induction Period|Lack of Efficacy|10|||
126660396|NCT00406653|455714884|FG004|Induction Period|Lack of Efficacy|0|||
126660397|NCT00406653|455714885|FG005|Induction Period|Lack of Efficacy|0|||
126660398|NCT00406653|455714886|FG006|Induction Period|Lack of Efficacy|0|||
126660399|NCT00406653|455714880|FG000|Induction Period|Lost to Follow-up|0|||
126660400|NCT00406653|455714881|FG001|Induction Period|Lost to Follow-up|2|||
126660401|NCT00406653|455714882|FG002|Induction Period|Lost to Follow-up|0|||
126660402|NCT00406653|455714883|FG003|Induction Period|Lost to Follow-up|0|||
126660403|NCT00406653|455714884|FG004|Induction Period|Lost to Follow-up|0|||
126660404|NCT00406653|455714885|FG005|Induction Period|Lost to Follow-up|0|||
126660405|NCT00406653|455714886|FG006|Induction Period|Lost to Follow-up|0|||
126660406|NCT00406653|455714880|FG000|Induction Period|Withdrawal of Consent|2|||
126660407|NCT00406653|455714881|FG001|Induction Period|Withdrawal of Consent|5|||
126660408|NCT00406653|455714882|FG002|Induction Period|Withdrawal of Consent|1|||
126660409|NCT00406653|455714883|FG003|Induction Period|Withdrawal of Consent|2|||
126660410|NCT00406653|455714884|FG004|Induction Period|Withdrawal of Consent|0|||
126660411|NCT00406653|455714885|FG005|Induction Period|Withdrawal of Consent|0|||
126660412|NCT00406653|455714886|FG006|Induction Period|Withdrawal of Consent|0|||
126660413|NCT00406653|455714880|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
126660414|NCT00406653|455714881|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
126660415|NCT00406653|455714882|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
126660416|NCT00406653|455714883|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
126660417|NCT00406653|455714884|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
126660418|NCT00406653|455714885|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
126660419|NCT00406653|455714886|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
126660420|NCT00406653|455714880|FG000|Induction Period|Pregnancy|1|||
126660421|NCT00406653|455714881|FG001|Induction Period|Pregnancy|0|||
126660422|NCT00406653|455714882|FG002|Induction Period|Pregnancy|0|||
126660423|NCT00406653|455714883|FG003|Induction Period|Pregnancy|0|||
126660424|NCT00406653|455714884|FG004|Induction Period|Pregnancy|0|||
126660425|NCT00406653|455714885|FG005|Induction Period|Pregnancy|0|||
126660426|NCT00406653|455714886|FG006|Induction Period|Pregnancy|0|||
126660427|NCT00406653|455714880|FG000|Induction Period|Declined participation but followup done|0|||
126660428|NCT00406653|455714881|FG001|Induction Period|Declined participation but followup done|2|||
126660429|NCT00406653|455714882|FG002|Induction Period|Declined participation but followup done|1|||
126660430|NCT00406653|455714883|FG003|Induction Period|Declined participation but followup done|1|||
126660431|NCT00406653|455714884|FG004|Induction Period|Declined participation but followup done|0|||
126660432|NCT00406653|455714885|FG005|Induction Period|Declined participation but followup done|0|||
126660433|NCT00406653|455714886|FG006|Induction Period|Declined participation but followup done|0|||
126660434|NCT00406653|455714880|FG000|Induction Period|Given prohibited drug|0|||
126660435|NCT00406653|455714881|FG001|Induction Period|Given prohibited drug|1|||
126660436|NCT00406653|455714882|FG002|Induction Period|Given prohibited drug|2|||
126660437|NCT00406653|455714883|FG003|Induction Period|Given prohibited drug|0|||
126660438|NCT00406653|455714884|FG004|Induction Period|Given prohibited drug|0|||
126660439|NCT00406653|455714885|FG005|Induction Period|Given prohibited drug|0|||
126660440|NCT00406653|455714886|FG006|Induction Period|Given prohibited drug|0|||
126660441|NCT00406653|455714880|FG000|Induction Period|Incarcerated|0|||
126660442|NCT00406653|455714881|FG001|Induction Period|Incarcerated|0|||
126660443|NCT00406653|455714882|FG002|Induction Period|Incarcerated|1|||
126660444|NCT00406653|455714883|FG003|Induction Period|Incarcerated|0|||
126660445|NCT00406653|455714884|FG004|Induction Period|Incarcerated|0|||
126660446|NCT00406653|455714885|FG005|Induction Period|Incarcerated|0|||
126660447|NCT00406653|455714886|FG006|Induction Period|Incarcerated|0|||
126660448|NCT00406653|455714880|FG000|Induction Period|Patient relocated|0|||
126660449|NCT00406653|455714881|FG001|Induction Period|Patient relocated|0|||
126660450|NCT00406653|455714882|FG002|Induction Period|Patient relocated|1|||
126660451|NCT00406653|455714883|FG003|Induction Period|Patient relocated|0|||
126660452|NCT00406653|455714884|FG004|Induction Period|Patient relocated|0|||
126660453|NCT00406653|455714885|FG005|Induction Period|Patient relocated|0|||
126660454|NCT00406653|455714886|FG006|Induction Period|Patient relocated|0|||
126660455|NCT00406653|455714880|FG000|Maintenance Period|Adverse Event|0|||
126660456|NCT00406653|455714881|FG001|Maintenance Period|Adverse Event|0|||
126660457|NCT00406653|455714882|FG002|Maintenance Period|Adverse Event|0|||
126660458|NCT00406653|455714883|FG003|Maintenance Period|Adverse Event|0|||
126660459|NCT00406653|455714884|FG004|Maintenance Period|Adverse Event|1|||
126660460|NCT00406653|455714885|FG005|Maintenance Period|Adverse Event|1|||
126660461|NCT00406653|455714886|FG006|Maintenance Period|Adverse Event|0|||
126660462|NCT00406653|455714880|FG000|Maintenance Period|Lack of Efficacy|0|||
126660463|NCT00406653|455714881|FG001|Maintenance Period|Lack of Efficacy|0|||
126660464|NCT00406653|455714882|FG002|Maintenance Period|Lack of Efficacy|0|||
126660465|NCT00406653|455714883|FG003|Maintenance Period|Lack of Efficacy|0|||
126660466|NCT00406653|455714884|FG004|Maintenance Period|Lack of Efficacy|20|||
126660467|NCT00406653|455714885|FG005|Maintenance Period|Lack of Efficacy|26|||
126660468|NCT00406653|455714886|FG006|Maintenance Period|Lack of Efficacy|0|||
126660469|NCT00406653|455714880|FG000|Maintenance Period|Lost to Follow-up|0|||
126660470|NCT00406653|455714881|FG001|Maintenance Period|Lost to Follow-up|0|||
126660471|NCT00406653|455714882|FG002|Maintenance Period|Lost to Follow-up|0|||
126660472|NCT00406653|455714883|FG003|Maintenance Period|Lost to Follow-up|0|||
126660473|NCT00406653|455714884|FG004|Maintenance Period|Lost to Follow-up|2|||
126660474|NCT00406653|455714885|FG005|Maintenance Period|Lost to Follow-up|1|||
126660475|NCT00406653|455714886|FG006|Maintenance Period|Lost to Follow-up|0|||
126660476|NCT00406653|455714880|FG000|Maintenance Period|Withdrawal of Consent|0|||
126660477|NCT00406653|455714881|FG001|Maintenance Period|Withdrawal of Consent|0|||
126660478|NCT00406653|455714882|FG002|Maintenance Period|Withdrawal of Consent|0|||
126660479|NCT00406653|455714883|FG003|Maintenance Period|Withdrawal of Consent|0|||
126660480|NCT00406653|455714884|FG004|Maintenance Period|Withdrawal of Consent|2|||
126660481|NCT00406653|455714885|FG005|Maintenance Period|Withdrawal of Consent|0|||
126660482|NCT00406653|455714886|FG006|Maintenance Period|Withdrawal of Consent|0|||
126660483|NCT00406653|455714880|FG000|Maintenance Period|Pregnancy|0|||
126660484|NCT00406653|455714881|FG001|Maintenance Period|Pregnancy|0|||
126660485|NCT00406653|455714882|FG002|Maintenance Period|Pregnancy|0|||
126660486|NCT00406653|455714883|FG003|Maintenance Period|Pregnancy|0|||
126660487|NCT00406653|455714884|FG004|Maintenance Period|Pregnancy|0|||
126660488|NCT00406653|455714885|FG005|Maintenance Period|Pregnancy|1|||
126660489|NCT00406653|455714886|FG006|Maintenance Period|Pregnancy|0|||
126660490|NCT00406653|455714880|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
126660491|NCT00406653|455714881|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
126660492|NCT00406653|455714882|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
126660493|NCT00406653|455714883|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
126660494|NCT00406653|455714884|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
126660495|NCT00406653|455714885|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
126660496|NCT00406653|455714886|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
126660497|NCT00406653|455714880|FG000|Maintenance Period|Error in disease score evaluation|0|||
126660498|NCT00406653|455714881|FG001|Maintenance Period|Error in disease score evaluation|0|||
126660499|NCT00406653|455714882|FG002|Maintenance Period|Error in disease score evaluation|0|||
126660500|NCT00406653|455714883|FG003|Maintenance Period|Error in disease score evaluation|0|||
126660501|NCT00406653|455714884|FG004|Maintenance Period|Error in disease score evaluation|1|||
126660502|NCT00406653|455714885|FG005|Maintenance Period|Error in disease score evaluation|0|||
126660503|NCT00406653|455714886|FG006|Maintenance Period|Error in disease score evaluation|0|||
126660504|NCT00406653|455714880|FG000|Open-Label Period|Death|0|||
126660505|NCT00406653|455714881|FG001|Open-Label Period|Death|0|||
126660506|NCT00406653|455714882|FG002|Open-Label Period|Death|0|||
126660507|NCT00406653|455714883|FG003|Open-Label Period|Death|0|||
126660508|NCT00406653|455714884|FG004|Open-Label Period|Death|0|||
126660509|NCT00406653|455714885|FG005|Open-Label Period|Death|0|||
126660510|NCT00406653|455714886|FG006|Open-Label Period|Death|1|||
126660511|NCT00406653|455714880|FG000|Open-Label Period|Adverse Event|0|||
126660512|NCT00406653|455714881|FG001|Open-Label Period|Adverse Event|0|||
126660513|NCT00406653|455714882|FG002|Open-Label Period|Adverse Event|0|||
126660514|NCT00406653|455714883|FG003|Open-Label Period|Adverse Event|0|||
126660515|NCT00406653|455714884|FG004|Open-Label Period|Adverse Event|0|||
126660516|NCT00406653|455714885|FG005|Open-Label Period|Adverse Event|0|||
126660517|NCT00406653|455714886|FG006|Open-Label Period|Adverse Event|18|||
126660518|NCT00406653|455714880|FG000|Open-Label Period|Lack of Efficacy|0|||
126660519|NCT00406653|455714881|FG001|Open-Label Period|Lack of Efficacy|0|||
126660520|NCT00406653|455714882|FG002|Open-Label Period|Lack of Efficacy|0|||
126660521|NCT00406653|455714883|FG003|Open-Label Period|Lack of Efficacy|0|||
126660522|NCT00406653|455714884|FG004|Open-Label Period|Lack of Efficacy|0|||
126660523|NCT00406653|455714885|FG005|Open-Label Period|Lack of Efficacy|0|||
126660524|NCT00406653|455714886|FG006|Open-Label Period|Lack of Efficacy|160|||
126660525|NCT00406653|455714880|FG000|Open-Label Period|Lost to Follow-up|0|||
126660526|NCT00406653|455714881|FG001|Open-Label Period|Lost to Follow-up|0|||
126660527|NCT00406653|455714882|FG002|Open-Label Period|Lost to Follow-up|0|||
126660528|NCT00406653|455714883|FG003|Open-Label Period|Lost to Follow-up|0|||
126660529|NCT00406653|455714884|FG004|Open-Label Period|Lost to Follow-up|0|||
126660530|NCT00406653|455714885|FG005|Open-Label Period|Lost to Follow-up|0|||
126660531|NCT00406653|455714886|FG006|Open-Label Period|Lost to Follow-up|6|||
126660532|NCT00406653|455714880|FG000|Open-Label Period|Withdrawal of Consent|0|||
126660533|NCT00406653|455714881|FG001|Open-Label Period|Withdrawal of Consent|0|||
126660534|NCT00406653|455714882|FG002|Open-Label Period|Withdrawal of Consent|0|||
126660535|NCT00406653|455714883|FG003|Open-Label Period|Withdrawal of Consent|0|||
126660536|NCT00406653|455714884|FG004|Open-Label Period|Withdrawal of Consent|0|||
126660537|NCT00406653|455714885|FG005|Open-Label Period|Withdrawal of Consent|0|||
126660538|NCT00406653|455714886|FG006|Open-Label Period|Withdrawal of Consent|11|||
126660539|NCT00406653|455714880|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
126660540|NCT00406653|455714881|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
126660541|NCT00406653|455714882|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
126660542|NCT00406653|455714883|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
126660543|NCT00406653|455714884|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
126660544|NCT00406653|455714885|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
126660545|NCT00406653|455714886|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
126660546|NCT00406653|455714880|FG000|Open-Label Period|Pregnancy|0|||
126660547|NCT00406653|455714881|FG001|Open-Label Period|Pregnancy|0|||
126660548|NCT00406653|455714882|FG002|Open-Label Period|Pregnancy|0|||
126660549|NCT00406653|455714883|FG003|Open-Label Period|Pregnancy|0|||
126660550|NCT00406653|455714884|FG004|Open-Label Period|Pregnancy|0|||
126660551|NCT00406653|455714885|FG005|Open-Label Period|Pregnancy|0|||
126660552|NCT00406653|455714886|FG006|Open-Label Period|Pregnancy|2|||
126660553|NCT00406653|455714880|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
126660554|NCT00406653|455714881|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
126660555|NCT00406653|455714882|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
126660556|NCT00406653|455714883|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
126660557|NCT00406653|455714884|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
126660558|NCT00406653|455714885|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
126660559|NCT00406653|455714886|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
126660560|NCT00406653|455714880|FG000|Open-Label Period|Declined participation but followup done|0|||
126660561|NCT00406653|455714881|FG001|Open-Label Period|Declined participation but followup done|0|||
126660562|NCT00406653|455714882|FG002|Open-Label Period|Declined participation but followup done|0|||
126660563|NCT00406653|455714883|FG003|Open-Label Period|Declined participation but followup done|0|||
126660564|NCT00406653|455714884|FG004|Open-Label Period|Declined participation but followup done|0|||
126660565|NCT00406653|455714885|FG005|Open-Label Period|Declined participation but followup done|0|||
126660566|NCT00406653|455714886|FG006|Open-Label Period|Declined participation but followup done|8|||
126660567|NCT00406653|455714880|FG000|Open-Label Period|Discontinued by Sponsor|0|||
126660568|NCT00406653|455714881|FG001|Open-Label Period|Discontinued by Sponsor|0|||
126660569|NCT00406653|455714882|FG002|Open-Label Period|Discontinued by Sponsor|0|||
126660570|NCT00406653|455714883|FG003|Open-Label Period|Discontinued by Sponsor|0|||
126660571|NCT00406653|455714884|FG004|Open-Label Period|Discontinued by Sponsor|0|||
126660572|NCT00406653|455714885|FG005|Open-Label Period|Discontinued by Sponsor|0|||
126660573|NCT00406653|455714886|FG006|Open-Label Period|Discontinued by Sponsor|1|||
126660574|NCT00406653|455714880|FG000|Open-Label Period|Refused followup|0|||
126660575|NCT00406653|455714881|FG001|Open-Label Period|Refused followup|0|||
126660576|NCT00406653|455714882|FG002|Open-Label Period|Refused followup|0|||
126660577|NCT00406653|455714883|FG003|Open-Label Period|Refused followup|0|||
126660578|NCT00406653|455714884|FG004|Open-Label Period|Refused followup|0|||
126660579|NCT00406653|455714885|FG005|Open-Label Period|Refused followup|0|||
126660580|NCT00406653|455714886|FG006|Open-Label Period|Refused followup|1|||
126660581|NCT00818649|455714887|FG000|Overall Study|Declining performance status|2|||
126660582|NCT00818649|455714887|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
126660583|NCT00818649|455714887|FG000|Overall Study|Adverse Event|1|||
126660584|NCT00928447|455714889|FG000|Overall Study|Withdrawal by Subject|1|||
126660585|NCT00928447|455714889|FG000|Overall Study|Investigator's decision|1|||
126660586|NCT01971203|455714890|FG000|Overall Study|Protocol Violation|3|||
126660587|NCT01971203|455714891|FG001|Overall Study|Protocol Violation|2|||
126660588|NCT01971203|455714890|FG000|Overall Study|Withdrawal by Subject|5|||
126660589|NCT01971203|455714891|FG001|Overall Study|Withdrawal by Subject|6|||
126660590|NCT01971203|455714890|FG000|Overall Study|Adverse Event|1|||
126660591|NCT01971203|455714891|FG001|Overall Study|Adverse Event|0|||
126660592|NCT03353350|455714892|FG000|30-week Core Treatment Period|Protocol Violation|1|||
126660593|NCT03353350|455714893|FG001|30-week Core Treatment Period|Protocol Violation|1|||
126660594|NCT03353350|455714894|FG002|30-week Core Treatment Period|Protocol Violation|1|||
126660595|NCT03353350|455714895|FG003|30-week Core Treatment Period|Protocol Violation|0|||
126660596|NCT03353350|455714892|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
126660597|NCT03353350|455714893|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
126660598|NCT03353350|455714894|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
126660599|NCT03353350|455714895|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
126660600|NCT03353350|455714892|FG000|30-week Core Treatment Period|Adverse Event|0|||
126660601|NCT03353350|455714893|FG001|30-week Core Treatment Period|Adverse Event|4|||
126660602|NCT03353350|455714894|FG002|30-week Core Treatment Period|Adverse Event|2|||
126660603|NCT03353350|455714895|FG003|30-week Core Treatment Period|Adverse Event|3|||
126660604|NCT03353350|455714892|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
126660605|NCT03353350|455714893|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
126660606|NCT03353350|455714894|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
126660607|NCT03353350|455714895|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
126660608|NCT03353350|455714892|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
126660609|NCT03353350|455714893|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
126660610|NCT03353350|455714894|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
126660611|NCT03353350|455714895|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
126660612|NCT03353350|455714892|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
126660613|NCT03353350|455714893|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
126660614|NCT03353350|455714894|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
126660615|NCT03353350|455714895|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
126660616|NCT03353350|455714892|FG000|26-week Treatment Extension Period|Adverse Event|1|||
126660617|NCT03353350|455714893|FG001|26-week Treatment Extension Period|Adverse Event|0|||
126660618|NCT03353350|455714894|FG002|26-week Treatment Extension Period|Adverse Event|0|||
126660619|NCT03353350|455714895|FG003|26-week Treatment Extension Period|Adverse Event|1|||
126660620|NCT03353350|455714892|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
126660621|NCT03353350|455714893|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
126660622|NCT03353350|455714894|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
126660623|NCT03353350|455714895|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
126660624|NCT00147823|455714901|FG000|Overall Study|Lost to Follow-up|6|||
126660625|NCT00147823|455714902|FG001|Overall Study|Lost to Follow-up|12|||
126660626|NCT00147823|455714901|FG000|Overall Study|Physician Decision|1|||
126660627|NCT00147823|455714902|FG001|Overall Study|Physician Decision|0|||
126660628|NCT00147823|455714901|FG000|Overall Study|Withdrawal by Subject|0|||
126660629|NCT00147823|455714902|FG001|Overall Study|Withdrawal by Subject|1|||
126660630|NCT00147823|455714901|FG000|Overall Study|Did not receive vitoss due to infection|6|||
126660631|NCT00147823|455714902|FG001|Overall Study|Did not receive vitoss due to infection|2|||
126660632|NCT01012713|455714903|FG000|Overall Study|Lack of Efficacy|3|||
126660633|NCT02571049|455714904|FG000|Screening|Did not meet entry criteria|2|||
126660634|NCT02571049|455714905|FG001|Screening|Did not meet entry criteria|2|||
126660635|NCT02571049|455714904|FG000|Randomization|No migraine attack|0|||
126660636|NCT02571049|455714905|FG001|Randomization|No migraine attack|1|||
126660637|NCT02571049|455714904|FG000|Randomization|Adverse Event|0|||
126660638|NCT02571049|455714905|FG001|Randomization|Adverse Event|1|||
126660639|NCT01055262|455714906|FG000|Overall Study|Adverse Event|5|||
126660640|NCT01055262|455714906|FG000|Overall Study|Protocol Violation|3|||
126660641|NCT01055262|455714906|FG000|Overall Study|Uncooperativeness|1|||
126660642|NCT03370471|455714907|FG000|Overall Study|Withdrawal by Subject|6|||
126660643|NCT03370471|455714908|FG001|Overall Study|Withdrawal by Subject|1|||
126660644|NCT03370471|455714907|FG000|Overall Study|Unable to access veins for blood draw|0|||
126660645|NCT03370471|455714908|FG001|Overall Study|Unable to access veins for blood draw|1|||
126660646|NCT03370471|455714907|FG000|Overall Study|Screen fail|1|||
126660647|NCT03370471|455714908|FG001|Overall Study|Screen fail|0|||
126660648|NCT00561951|455714909|FG000|Overall Study|Adverse Event|11|||
126660649|NCT00561951|455714910|FG001|Overall Study|Adverse Event|14|||
126660650|NCT00561951|455714911|FG002|Overall Study|Adverse Event|14|||
126660651|NCT00561951|455714909|FG000|Overall Study|Lack of Efficacy|5|||
126660652|NCT00561951|455714910|FG001|Overall Study|Lack of Efficacy|3|||
126660653|NCT00561951|455714911|FG002|Overall Study|Lack of Efficacy|2|||
126660654|NCT00561951|455714909|FG000|Overall Study|Lost to Follow-up|1|||
126660655|NCT00561951|455714910|FG001|Overall Study|Lost to Follow-up|1|||
126660656|NCT00561951|455714911|FG002|Overall Study|Lost to Follow-up|0|||
126660657|NCT00561951|455714909|FG000|Overall Study|Withdrawal by Subject|10|||
126660658|NCT00561951|455714910|FG001|Overall Study|Withdrawal by Subject|9|||
126660659|NCT00561951|455714911|FG002|Overall Study|Withdrawal by Subject|10|||
126660660|NCT00561951|455714909|FG000|Overall Study|Protocol Violation|4|||
126660661|NCT00561951|455714910|FG001|Overall Study|Protocol Violation|3|||
126660662|NCT00561951|455714911|FG002|Overall Study|Protocol Violation|4|||
126660663|NCT00561951|455714909|FG000|Overall Study|Physician Decision|1|||
126660664|NCT00561951|455714910|FG001|Overall Study|Physician Decision|0|||
126660665|NCT00561951|455714911|FG002|Overall Study|Physician Decision|0|||
126660666|NCT00561951|455714909|FG000|Overall Study|Pregnancy|0|||
126660667|NCT00561951|455714910|FG001|Overall Study|Pregnancy|1|||
126660668|NCT00561951|455714911|FG002|Overall Study|Pregnancy|0|||
126660669|NCT00561951|455714909|FG000|Overall Study|Meet Withdrawal Criterion|0|||
126660670|NCT00561951|455714910|FG001|Overall Study|Meet Withdrawal Criterion|1|||
126660671|NCT00561951|455714911|FG002|Overall Study|Meet Withdrawal Criterion|1|||
126660672|NCT00561951|455714909|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
126660673|NCT00561951|455714910|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
126660674|NCT00561951|455714911|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
126660675|NCT00392327|455714923|FG000|Overall Study|Death|1|||
126660676|NCT00392327|455714924|FG001|Overall Study|Death|0|||
126660677|NCT00392327|455714925|FG002|Overall Study|Death|1|||
126660678|NCT00392327|455714926|FG003|Overall Study|Death|0|||
126660679|NCT00392327|455714927|FG004|Overall Study|Death|0|||
126660680|NCT00392327|455714928|FG005|Overall Study|Death|0|||
126660681|NCT00392327|455714929|FG006|Overall Study|Death|0|||
126660682|NCT00392327|455714930|FG007|Overall Study|Death|0|||
126660683|NCT00392327|455714923|FG000|Overall Study|Lack of Efficacy|8|||
126660684|NCT00392327|455714924|FG001|Overall Study|Lack of Efficacy|8|||
126660685|NCT00392327|455714925|FG002|Overall Study|Lack of Efficacy|9|||
126660686|NCT00392327|455714926|FG003|Overall Study|Lack of Efficacy|6|||
126660687|NCT00392327|455714927|FG004|Overall Study|Lack of Efficacy|3|||
126660688|NCT00392327|455714928|FG005|Overall Study|Lack of Efficacy|3|||
126660689|NCT00392327|455714929|FG006|Overall Study|Lack of Efficacy|3|||
126660690|NCT00392327|455714930|FG007|Overall Study|Lack of Efficacy|3|||
126660691|NCT00392327|455714923|FG000|Overall Study|Physician Decision|3|||
126660692|NCT00392327|455714924|FG001|Overall Study|Physician Decision|5|||
126660693|NCT00392327|455714925|FG002|Overall Study|Physician Decision|2|||
126660694|NCT00392327|455714926|FG003|Overall Study|Physician Decision|2|||
126660695|NCT00392327|455714927|FG004|Overall Study|Physician Decision|0|||
126660696|NCT00392327|455714928|FG005|Overall Study|Physician Decision|1|||
126660697|NCT00392327|455714929|FG006|Overall Study|Physician Decision|5|||
126660698|NCT00392327|455714930|FG007|Overall Study|Physician Decision|3|||
126660699|NCT00392327|455714923|FG000|Overall Study|Protocol Violation|0|||
126660700|NCT00392327|455714924|FG001|Overall Study|Protocol Violation|0|||
126660701|NCT00392327|455714925|FG002|Overall Study|Protocol Violation|1|||
126660702|NCT00392327|455714926|FG003|Overall Study|Protocol Violation|0|||
126660703|NCT00392327|455714927|FG004|Overall Study|Protocol Violation|0|||
126660704|NCT00392327|455714928|FG005|Overall Study|Protocol Violation|0|||
126660705|NCT00392327|455714929|FG006|Overall Study|Protocol Violation|0|||
126660706|NCT00392327|455714930|FG007|Overall Study|Protocol Violation|0|||
126660707|NCT00392327|455714923|FG000|Overall Study|Withdrawal by Subject|3|||
126660708|NCT00392327|455714924|FG001|Overall Study|Withdrawal by Subject|2|||
126660709|NCT00392327|455714925|FG002|Overall Study|Withdrawal by Subject|4|||
126660710|NCT00392327|455714926|FG003|Overall Study|Withdrawal by Subject|6|||
126660711|NCT00392327|455714927|FG004|Overall Study|Withdrawal by Subject|0|||
126660712|NCT00392327|455714928|FG005|Overall Study|Withdrawal by Subject|1|||
126660713|NCT00392327|455714929|FG006|Overall Study|Withdrawal by Subject|1|||
126660714|NCT00392327|455714930|FG007|Overall Study|Withdrawal by Subject|5|||
126660715|NCT00392327|455714923|FG000|Overall Study|Ineligible|0|||
126660716|NCT00392327|455714924|FG001|Overall Study|Ineligible|4|||
126660717|NCT00392327|455714925|FG002|Overall Study|Ineligible|3|||
126660718|NCT00392327|455714926|FG003|Overall Study|Ineligible|2|||
126660719|NCT00392327|455714927|FG004|Overall Study|Ineligible|0|||
126660720|NCT00392327|455714928|FG005|Overall Study|Ineligible|0|||
126660721|NCT00392327|455714929|FG006|Overall Study|Ineligible|0|||
126660722|NCT00392327|455714930|FG007|Overall Study|Ineligible|0|||
126660723|NCT04508023|455714931|FG000|Overall Study|Withdrawal by Subject|1|||
126660724|NCT04508023|455714932|FG001|Overall Study|Withdrawal by Subject|2|||
126660725|NCT00421707|455714939|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
126660726|NCT00421707|455714940|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
126660727|NCT00421707|455714939|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
126660728|NCT00421707|455714940|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
126660729|NCT00421707|455714939|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
126660730|NCT00421707|455714940|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
126660731|NCT00421707|455714939|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
126660732|NCT00421707|455714940|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
126660733|NCT00421707|455714939|FG000|Period 2: Washout|Adverse Event|1|||
126660734|NCT00421707|455714940|FG001|Period 2: Washout|Adverse Event|1|||
126660735|NCT00421707|455714939|FG000|Period 2: Washout|Withdrawal by Subject|0|||
126660736|NCT00421707|455714940|FG001|Period 2: Washout|Withdrawal by Subject|1|||
126660737|NCT00421707|455714939|FG000|Period 2: Washout|Lost to Follow-up|0|||
126660738|NCT00421707|455714940|FG001|Period 2: Washout|Lost to Follow-up|1|||
126660739|NCT00421707|455714939|FG000|Period 2: Washout|Other: Pregnancy|0|||
126660740|NCT00421707|455714940|FG001|Period 2: Washout|Other: Pregnancy|1|||
126660741|NCT00421707|455714939|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
126660742|NCT00421707|455714940|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
126660743|NCT00421707|455714939|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
126660744|NCT00421707|455714940|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
126660745|NCT00421707|455714939|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
126660746|NCT00421707|455714940|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
126660747|NCT03261700|455714941|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
126660748|NCT03261700|455714942|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
126660749|NCT01723254|455714943|FG000|Overall Study|Conflict with work schedule|0|||
126660750|NCT01723254|455714944|FG001|Overall Study|Conflict with work schedule|0|||
126660751|NCT01723254|455714945|FG002|Overall Study|Conflict with work schedule|0|||
126660752|NCT01723254|455714946|FG003|Overall Study|Conflict with work schedule|0|||
126660753|NCT01723254|455714947|FG004|Overall Study|Conflict with work schedule|0|||
126660754|NCT01723254|455714948|FG005|Overall Study|Conflict with work schedule|0|||
126660755|NCT01723254|455714949|FG006|Overall Study|Conflict with work schedule|0|||
126660756|NCT01723254|455714950|FG007|Overall Study|Conflict with work schedule|1|||
126660757|NCT01723254|455714943|FG000|Overall Study|Personal issues|0|||
126660758|NCT01723254|455714944|FG001|Overall Study|Personal issues|0|||
126660759|NCT01723254|455714945|FG002|Overall Study|Personal issues|0|||
126660760|NCT01723254|455714946|FG003|Overall Study|Personal issues|0|||
126660761|NCT01723254|455714947|FG004|Overall Study|Personal issues|0|||
126660762|NCT01723254|455714948|FG005|Overall Study|Personal issues|1|||
126660763|NCT01723254|455714949|FG006|Overall Study|Personal issues|0|||
126660764|NCT01723254|455714950|FG007|Overall Study|Personal issues|0|||
126660765|NCT01723254|455714943|FG000|Overall Study|No longer have time to participate|0|||
126660766|NCT01723254|455714944|FG001|Overall Study|No longer have time to participate|0|||
126660767|NCT01723254|455714945|FG002|Overall Study|No longer have time to participate|0|||
126660768|NCT01723254|455714946|FG003|Overall Study|No longer have time to participate|1|||
126660769|NCT01723254|455714947|FG004|Overall Study|No longer have time to participate|0|||
126660770|NCT01723254|455714948|FG005|Overall Study|No longer have time to participate|0|||
126660771|NCT01723254|455714949|FG006|Overall Study|No longer have time to participate|0|||
126660772|NCT01723254|455714950|FG007|Overall Study|No longer have time to participate|0|||
126660773|NCT01723254|455714943|FG000|Overall Study|Move/Left to another country/city|0|||
126660774|NCT01723254|455714944|FG001|Overall Study|Move/Left to another country/city|0|||
126660775|NCT01723254|455714945|FG002|Overall Study|Move/Left to another country/city|2|||
126660776|NCT01723254|455714946|FG003|Overall Study|Move/Left to another country/city|1|||
126660777|NCT01723254|455714947|FG004|Overall Study|Move/Left to another country/city|1|||
126660778|NCT01723254|455714948|FG005|Overall Study|Move/Left to another country/city|0|||
126660779|NCT01723254|455714949|FG006|Overall Study|Move/Left to another country/city|0|||
126660780|NCT01723254|455714950|FG007|Overall Study|Move/Left to another country/city|0|||
126660781|NCT01723254|455714943|FG000|Overall Study|Protocol Violation|0|||
126660782|NCT01723254|455714944|FG001|Overall Study|Protocol Violation|1|||
126660783|NCT01723254|455714945|FG002|Overall Study|Protocol Violation|0|||
126660784|NCT01723254|455714946|FG003|Overall Study|Protocol Violation|0|||
126660785|NCT01723254|455714947|FG004|Overall Study|Protocol Violation|0|||
126660786|NCT01723254|455714948|FG005|Overall Study|Protocol Violation|0|||
126660787|NCT01723254|455714949|FG006|Overall Study|Protocol Violation|0|||
126660788|NCT01723254|455714950|FG007|Overall Study|Protocol Violation|0|||
126660789|NCT01723254|455714943|FG000|Overall Study|Withdrawal by Subject|1|||
126660790|NCT01723254|455714944|FG001|Overall Study|Withdrawal by Subject|2|||
126660791|NCT01723254|455714945|FG002|Overall Study|Withdrawal by Subject|1|||
126660792|NCT01723254|455714946|FG003|Overall Study|Withdrawal by Subject|0|||
126660793|NCT01723254|455714947|FG004|Overall Study|Withdrawal by Subject|1|||
126660794|NCT01723254|455714948|FG005|Overall Study|Withdrawal by Subject|1|||
126660795|NCT01723254|455714949|FG006|Overall Study|Withdrawal by Subject|1|||
126660796|NCT01723254|455714950|FG007|Overall Study|Withdrawal by Subject|2|||
126660797|NCT01340196|455716445|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
126660798|NCT00288509|455716447|FG000|Treatment Cycle 1|Adverse Event|1|||
126660799|NCT00288509|455716447|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
126660800|NCT00288509|455716447|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
126660801|NCT00288509|455716447|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
126660802|NCT00288509|455716447|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
126660803|NCT00288509|455716447|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
126660804|NCT00288509|455716447|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
126660805|NCT00288509|455716447|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
126660806|NCT00288509|455716447|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
126660807|NCT00288509|455716447|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
126660808|NCT00288509|455716447|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
126660809|NCT00288509|455716447|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
126660810|NCT00288509|455716447|FG000|Treatment Cycle 4|Physician Decision|4|||
126660811|NCT00288509|455716447|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
126660812|NCT00655486|455716462|FG000|Overall Study|Adverse Event|10|||
126660813|NCT00655486|455716462|FG000|Overall Study|Lack of Efficacy|8|||
126660814|NCT00655486|455716462|FG000|Overall Study|Withdrawal by Subject|4|||
126660815|NCT00655486|455716462|FG000|Overall Study|Protocol Violation|1|||
126660816|NCT00655486|455716462|FG000|Overall Study|Unsatisfactory compliance|2|||
126660817|NCT00655486|455716462|FG000|Overall Study|Other: Pregnancy|1|||
126660818|NCT00655486|455716462|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
126660819|NCT00655486|455716462|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
126660820|NCT03840486|455716463|FG000|Overall Study|Withdrawal by Subject|0|||
126660821|NCT03840486|455716464|FG001|Overall Study|Withdrawal by Subject|1|||
126660822|NCT03840486|455716465|FG002|Overall Study|Withdrawal by Subject|0|||
126660823|NCT03840486|455716466|FG003|Overall Study|Withdrawal by Subject|0|||
126660824|NCT03840486|455716467|FG004|Overall Study|Withdrawal by Subject|0|||
126660825|NCT03840486|455716468|FG005|Overall Study|Withdrawal by Subject|0|||
126660826|NCT03840486|455716469|FG006|Overall Study|Withdrawal by Subject|0|||
126330529|NCT00103285|454505070|FG003|Response Assignment|Physician Decision|9|||
126330530|NCT00103285|454505071|FG004|Response Assignment|Physician Decision|13|||
126330531|NCT00103285|454505072|FG005|Response Assignment|Physician Decision|7|||
126330532|NCT00103285|454505073|FG006|Response Assignment|Physician Decision|4|||
126330533|NCT00103285|454505074|FG007|Response Assignment|Physician Decision|35|||
126330534|NCT00103285|454505067|FG000|Response Assignment|Protocol Violation|0|||
126330535|NCT00103285|454505068|FG001|Response Assignment|Protocol Violation|2|||
126330536|NCT00103285|454505069|FG002|Response Assignment|Protocol Violation|0|||
126330537|NCT00103285|454505070|FG003|Response Assignment|Protocol Violation|0|||
126330538|NCT00103285|454505071|FG004|Response Assignment|Protocol Violation|0|||
126330539|NCT00103285|454505072|FG005|Response Assignment|Protocol Violation|0|||
126660827|NCT03840486|455716470|FG007|Overall Study|Withdrawal by Subject|0|||
126330540|NCT00103285|454505073|FG006|Response Assignment|Protocol Violation|0|||
126660828|NCT03840486|455716471|FG008|Overall Study|Withdrawal by Subject|0|||
126660829|NCT03840486|455716472|FG009|Overall Study|Withdrawal by Subject|0|||
126660830|NCT03840486|455716473|FG010|Overall Study|Withdrawal by Subject|0|||
126660831|NCT03840486|455716474|FG011|Overall Study|Withdrawal by Subject|0|||
126660832|NCT02768870|455716475|FG000|Overall Study|Death|1|||
126660833|NCT02768870|455716475|FG000|Overall Study|Reoperation|6|||
126660834|NCT02768870|455716475|FG000|Overall Study|Lost to Follow-up|1|||
126660835|NCT02768870|455716475|FG000|Overall Study|Exit|4|||
126660836|NCT03401229|455716476|FG000|Overall Study|Lost to Follow-up|2|||
126660837|NCT03401229|455716477|FG001|Overall Study|Lost to Follow-up|1|||
126660838|NCT03401229|455716476|FG000|Overall Study|Other|1|||
126660839|NCT03401229|455716477|FG001|Overall Study|Other|3|||
126660840|NCT03401229|455716476|FG000|Overall Study|Adverse Event|8|||
126660841|NCT03401229|455716477|FG001|Overall Study|Adverse Event|6|||
126660842|NCT03401229|455716476|FG000|Overall Study|Withdrawal by Subject|29|||
126660843|NCT03401229|455716477|FG001|Overall Study|Withdrawal by Subject|26|||
126660844|NCT03401229|455716476|FG000|Overall Study|COVID-19|0|||
126660845|NCT03401229|455716477|FG001|Overall Study|COVID-19|1|||
126660846|NCT01774110|455716478|FG000|Overall Study|Lost to Follow-up|7|||
126660847|NCT00640016|455716479|FG000|Overall Study|Withdrawal by Subject|0|||
126660848|NCT00640016|455716480|FG001|Overall Study|Withdrawal by Subject|1|||
126660849|NCT00640016|455716481|FG002|Overall Study|Withdrawal by Subject|0|||
126660850|NCT00640016|455716482|FG003|Overall Study|Withdrawal by Subject|0|||
126660851|NCT00640016|455716479|FG000|Overall Study|Study termination|2|||
126660852|NCT00640016|455716480|FG001|Overall Study|Study termination|1|||
126660853|NCT00640016|455716481|FG002|Overall Study|Study termination|3|||
126660854|NCT00640016|455716482|FG003|Overall Study|Study termination|2|||
126660855|NCT00640016|455716479|FG000|Overall Study|Adverse Event|0|||
126660856|NCT00640016|455716480|FG001|Overall Study|Adverse Event|0|||
126660857|NCT00640016|455716481|FG002|Overall Study|Adverse Event|0|||
126660858|NCT00640016|455716482|FG003|Overall Study|Adverse Event|1|||
126660859|NCT03575143|455716483|FG000|Overall Study|Lost to Follow-up|0|||
126660860|NCT03575143|455716484|FG001|Overall Study|Lost to Follow-up|0|||
126660861|NCT03575143|455716485|FG002|Overall Study|Lost to Follow-up|4|||
126660862|NCT03575143|455716483|FG000|Overall Study|Withdrawal by Subject|0|||
126660863|NCT03575143|455716484|FG001|Overall Study|Withdrawal by Subject|0|||
126660864|NCT03575143|455716485|FG002|Overall Study|Withdrawal by Subject|5|||
126660865|NCT03575143|455716483|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
126660866|NCT03575143|455716484|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
126660867|NCT03575143|455716485|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
126660868|NCT01287065|455716486|FG000|Treatment Period 1|Adverse Event|0|||
126660869|NCT01287065|455716487|FG001|Treatment Period 1|Adverse Event|0|||
126660870|NCT01287065|455716488|FG002|Treatment Period 1|Adverse Event|0|||
126660871|NCT01287065|455716489|FG003|Treatment Period 1|Adverse Event|0|||
126660872|NCT01287065|455716490|FG004|Treatment Period 1|Adverse Event|1|||
126660873|NCT01287065|455716491|FG005|Treatment Period 1|Adverse Event|0|||
126660874|NCT01287065|455716486|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126660875|NCT01287065|455716487|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126660876|NCT01287065|455716488|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126660877|NCT01287065|455716489|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126660878|NCT01287065|455716490|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126660879|NCT01287065|455716491|FG005|Treatment Period 1|Withdrawal by Subject|1|||
126660880|NCT02875977|455716492|FG000|Overall Study|Lost to Follow-up|42|||
126660881|NCT02875977|455716493|FG001|Overall Study|Lost to Follow-up|29|||
126660882|NCT01259726|455716494|FG000|Overall Study|Death|1|||
126660883|NCT01259726|455716495|FG001|Overall Study|Death|0|||
126660884|NCT01259726|455716496|FG002|Overall Study|Death|0|||
126660885|NCT01259726|455716497|FG003|Overall Study|Death|0|||
126660886|NCT01259726|455716494|FG000|Overall Study|Physician Decision|2|||
126660887|NCT01259726|455716495|FG001|Overall Study|Physician Decision|0|||
126660888|NCT01259726|455716496|FG002|Overall Study|Physician Decision|1|||
126660889|NCT01259726|455716497|FG003|Overall Study|Physician Decision|1|||
126660890|NCT01259726|455716494|FG000|Overall Study|Withdrawal by Subject|1|||
126660891|NCT01259726|455716495|FG001|Overall Study|Withdrawal by Subject|3|||
126660892|NCT01259726|455716496|FG002|Overall Study|Withdrawal by Subject|2|||
126660893|NCT01259726|455716497|FG003|Overall Study|Withdrawal by Subject|1|||
126660894|NCT01259726|455716494|FG000|Overall Study|Lost to Follow-up|1|||
126330541|NCT00103285|454505074|FG007|Response Assignment|Protocol Violation|0|||
126330542|NCT00103285|454505067|FG000|Response Assignment|Withdrawal by Subject|0|||
126330543|NCT00103285|454505068|FG001|Response Assignment|Withdrawal by Subject|4|||
126330544|NCT00103285|454505069|FG002|Response Assignment|Withdrawal by Subject|1|||
126330545|NCT00103285|454505070|FG003|Response Assignment|Withdrawal by Subject|1|||
126330546|NCT00103285|454505071|FG004|Response Assignment|Withdrawal by Subject|2|||
126660895|NCT01259726|455716495|FG001|Overall Study|Lost to Follow-up|1|||
126660896|NCT01259726|455716496|FG002|Overall Study|Lost to Follow-up|1|||
126660897|NCT01259726|455716497|FG003|Overall Study|Lost to Follow-up|3|||
126660898|NCT01978262|455716498|FG000|Overall Study|Withdrawal by Subject|9|||
126660899|NCT01978262|455716498|FG000|Overall Study|Lost to Follow-up|2|||
126660900|NCT02435966|455716506|FG000|Overall Study|Withdrawal by Subject|0|||
126660901|NCT02435966|455716507|FG001|Overall Study|Withdrawal by Subject|1|||
126660902|NCT02435966|455716508|FG002|Overall Study|Withdrawal by Subject|0|||
126660903|NCT02168842|455716510|FG000|Overall Study|Withdrawal by Subject|5|||
126660904|NCT02168842|455716511|FG001|Overall Study|Withdrawal by Subject|3|||
126660905|NCT02168842|455716510|FG000|Overall Study|Lost to Follow-up|0|||
126660906|NCT02168842|455716511|FG001|Overall Study|Lost to Follow-up|2|||
126660907|NCT02168842|455716510|FG000|Overall Study|Death|2|||
126660908|NCT02168842|455716511|FG001|Overall Study|Death|1|||
126660909|NCT02168842|455716510|FG000|Overall Study|Physician Decision|1|||
126660910|NCT02168842|455716511|FG001|Overall Study|Physician Decision|2|||
126660911|NCT00325039|455716512|FG000|Overall Study|Lost to Follow-up|18|||
126660912|NCT00325039|455716513|FG001|Overall Study|Lost to Follow-up|14|||
126660913|NCT02974088|455716514|FG000|Overall Study|Lost to Follow-up|0|||
126660914|NCT02974088|455716515|FG001|Overall Study|Lost to Follow-up|2|||
126660915|NCT02974088|455716514|FG000|Overall Study|Adverse Event|0|||
126660916|NCT02974088|455716515|FG001|Overall Study|Adverse Event|1|||
126660917|NCT00687973|455716521|FG000|Overall Study|Adverse Event|18|||
126660918|NCT00687973|455716522|FG001|Overall Study|Adverse Event|28|||
126660919|NCT00687973|455716521|FG000|Overall Study|Lack of Efficacy|2|||
126660920|NCT00687973|455716522|FG001|Overall Study|Lack of Efficacy|3|||
126660921|NCT00687973|455716521|FG000|Overall Study|Protocol Violation|1|||
126660922|NCT00687973|455716522|FG001|Overall Study|Protocol Violation|2|||
126660923|NCT00687973|455716521|FG000|Overall Study|Administrative Reasons|0|||
126660924|NCT00687973|455716522|FG001|Overall Study|Administrative Reasons|2|||
126660925|NCT00687973|455716521|FG000|Overall Study|Withdrawal by Subject|3|||
126660926|NCT00687973|455716522|FG001|Overall Study|Withdrawal by Subject|3|||
126660927|NCT00343252|455716523|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
126660928|NCT00343252|455716524|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
126660929|NCT00343252|455716523|FG000|6 Months (All Treated Participants)|Death|0|||
126660930|NCT00343252|455716524|FG001|6 Months (All Treated Participants)|Death|2|||
126660931|NCT00343252|455716523|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
126660932|NCT00343252|455716524|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
126660933|NCT00343252|455716523|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
126660934|NCT00343252|455716524|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
126660935|NCT00343252|455716523|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
126660936|NCT00343252|455716524|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
126660937|NCT00343252|455716523|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
126660938|NCT00343252|455716524|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
126660939|NCT00343252|455716523|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
126660940|NCT00343252|455716524|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
126660941|NCT00343252|455716523|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
126660942|NCT00343252|455716524|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
126660943|NCT00343252|455716523|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
126660944|NCT00343252|455716524|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
126660945|NCT00343252|455716523|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
126660946|NCT00343252|455716524|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
126660947|NCT00343252|455716523|FG000|12 Months (All Treated Participants)|Death|3|||
126660948|NCT00343252|455716524|FG001|12 Months (All Treated Participants)|Death|3|||
126660949|NCT00343252|455716523|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
126660950|NCT00343252|455716524|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
126660951|NCT00343252|455716523|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
126660952|NCT00343252|455716524|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
126660953|NCT00343252|455716523|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
126660954|NCT00343252|455716524|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
126660955|NCT00343252|455716523|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
126660956|NCT00343252|455716524|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
126660957|NCT00343252|455716523|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
126660958|NCT00343252|455716524|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
126660959|NCT00343252|455716523|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
126660960|NCT00343252|455716524|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
126660961|NCT00343252|455716523|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
126660962|NCT00343252|455716524|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
126660963|NCT00343252|455716523|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
126660964|NCT00343252|455716524|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
126660965|NCT00343252|455716523|FG000|18 Months (All Treated Participants)|Death|4|||
126660966|NCT00343252|455716524|FG001|18 Months (All Treated Participants)|Death|5|||
126660967|NCT00343252|455716523|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
126660968|NCT00343252|455716524|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
126660969|NCT00343252|455716523|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
126660970|NCT00343252|455716524|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
126660971|NCT00343252|455716523|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
126660972|NCT00343252|455716524|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
126660973|NCT00343252|455716523|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
126660974|NCT00343252|455716524|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
126330547|NCT00103285|454505072|FG005|Response Assignment|Withdrawal by Subject|2|||
126660975|NCT00343252|455716523|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
126660976|NCT00343252|455716524|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
126660977|NCT00343252|455716523|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
126660978|NCT00343252|455716524|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
126660979|NCT00343252|455716523|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
126660980|NCT00343252|455716524|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
126660981|NCT01740323|455716525|FG000|Overall Study|Adverse Event|1|||
126660982|NCT01740323|455716526|FG001|Overall Study|Adverse Event|0|||
126660983|NCT01740323|455716525|FG000|Overall Study|Randomized but did not take study drug|1|||
126660984|NCT01740323|455716526|FG001|Overall Study|Randomized but did not take study drug|0|||
126660985|NCT02019927|455716529|FG000|Overall Study|Lost to Follow-up|2|||
126660986|NCT02019927|455716530|FG001|Overall Study|Lost to Follow-up|4|||
126660987|NCT02019927|455716531|FG002|Overall Study|Lost to Follow-up|1|||
126660988|NCT02019927|455716532|FG003|Overall Study|Lost to Follow-up|2|||
126330548|NCT00103285|454505073|FG006|Response Assignment|Withdrawal by Subject|0|||
126660989|NCT02019927|455716533|FG004|Overall Study|Lost to Follow-up|3|||
126660990|NCT02019927|455716534|FG005|Overall Study|Lost to Follow-up|1|||
126660991|NCT03945825|455716537|FG000|Overall Study|Enrolled but treatment not administered|0|||
126660992|NCT03945825|455716538|FG001|Overall Study|Enrolled but treatment not administered|0|||
126660993|NCT03945825|455716539|FG002|Overall Study|Enrolled but treatment not administered|0|||
126660994|NCT03945825|455716540|FG003|Overall Study|Enrolled but treatment not administered|0|||
126330549|NCT00103285|454505074|FG007|Response Assignment|Withdrawal by Subject|2|||
126330550|NCT00103285|454505067|FG000|Response Assignment|Ineligible|0|||
126330551|NCT00103285|454505068|FG001|Response Assignment|Ineligible|8|||
126330552|NCT00103285|454505069|FG002|Response Assignment|Ineligible|6|||
126330553|NCT00103285|454505070|FG003|Response Assignment|Ineligible|2|||
126330554|NCT00103285|454505071|FG004|Response Assignment|Ineligible|0|||
126330555|NCT00103285|454505072|FG005|Response Assignment|Ineligible|3|||
126330556|NCT00103285|454505073|FG006|Response Assignment|Ineligible|1|||
126330557|NCT00103285|454505074|FG007|Response Assignment|Ineligible|5|||
126330558|NCT00103285|454505067|FG000|Response Assignment|Refusal|0|||
126330559|NCT00103285|454505068|FG001|Response Assignment|Refusal|53|||
126330560|NCT00103285|454505069|FG002|Response Assignment|Refusal|5|||
126330561|NCT00103285|454505070|FG003|Response Assignment|Refusal|3|||
126330562|NCT00103285|454505071|FG004|Response Assignment|Refusal|25|||
126330563|NCT00103285|454505072|FG005|Response Assignment|Refusal|15|||
126330564|NCT00103285|454505073|FG006|Response Assignment|Refusal|30|||
126330565|NCT00103285|454505074|FG007|Response Assignment|Refusal|10|||
126330566|NCT00103285|454505067|FG000|Response Assignment|Other|0|||
126330567|NCT00103285|454505068|FG001|Response Assignment|Other|30|||
126330568|NCT00103285|454505069|FG002|Response Assignment|Other|48|||
126330569|NCT00103285|454505070|FG003|Response Assignment|Other|38|||
126330570|NCT00103285|454505071|FG004|Response Assignment|Other|37|||
126330571|NCT00103285|454505072|FG005|Response Assignment|Other|17|||
126330572|NCT00103285|454505073|FG006|Response Assignment|Other|11|||
126330573|NCT00103285|454505074|FG007|Response Assignment|Other|53|||
126330574|NCT01381926|454505078|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
126330575|NCT01381926|454505079|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
126330576|NCT01381926|454505078|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
126330577|NCT01381926|454505079|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
126330578|NCT02624947|454505080|FG000|Maternal Participants|Adverse Event|5|||
126330579|NCT02624947|454505081|FG001|Maternal Participants|Adverse Event|0|||
126330580|NCT02624947|454505080|FG000|Maternal Participants|Investigator Decision|5|||
126330581|NCT02624947|454505081|FG001|Maternal Participants|Investigator Decision|3|||
126330582|NCT02624947|454505080|FG000|Maternal Participants|Lost to Follow-up|54|||
126330583|NCT02624947|454505081|FG001|Maternal Participants|Lost to Follow-up|24|||
126330584|NCT02624947|454505080|FG000|Maternal Participants|Non Compliance|8|||
126330585|NCT02624947|454505081|FG001|Maternal Participants|Non Compliance|5|||
126330586|NCT02624947|454505080|FG000|Maternal Participants|Sponsor Request|1|||
126330587|NCT02624947|454505081|FG001|Maternal Participants|Sponsor Request|1|||
126330588|NCT02624947|454505080|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
126330589|NCT02624947|454505081|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
126330590|NCT02624947|454505080|FG000|Maternal Participants|Miscellaneous|23|||
126330591|NCT02624947|454505081|FG001|Maternal Participants|Miscellaneous|15|||
126330592|NCT02624947|454505080|FG000|Infant Participants|Adverse Event|18|||
126330593|NCT02624947|454505081|FG001|Infant Participants|Adverse Event|11|||
126330594|NCT02624947|454505080|FG000|Infant Participants|Investigator Decision|5|||
126330595|NCT02624947|454505081|FG001|Infant Participants|Investigator Decision|4|||
126330596|NCT02624947|454505080|FG000|Infant Participants|Lost to Follow-up|93|||
126330597|NCT02624947|454505081|FG001|Infant Participants|Lost to Follow-up|58|||
126330598|NCT02624947|454505080|FG000|Infant Participants|Non Compliance|17|||
126330599|NCT02624947|454505081|FG001|Infant Participants|Non Compliance|7|||
126330600|NCT02624947|454505080|FG000|Infant Participants|Sponsor Request|0|||
126330601|NCT02624947|454505081|FG001|Infant Participants|Sponsor Request|1|||
126330602|NCT02624947|454505080|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
126330603|NCT02624947|454505081|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
126330604|NCT02624947|454505080|FG000|Infant Participants|Miscellaneous|50|||
126330605|NCT02624947|454505081|FG001|Infant Participants|Miscellaneous|26|||
126330606|NCT01971567|454505090|FG000|Overall Study|Withdrawal by Subject|3|||
126330607|NCT01971567|454505091|FG001|Overall Study|Withdrawal by Subject|2|||
126330608|NCT01971567|454505090|FG000|Overall Study|Lost to Follow-up|1|||
126330609|NCT01971567|454505091|FG001|Overall Study|Lost to Follow-up|0|||
126330610|NCT01409915|454505092|FG000|Overall Study|Adverse Event|0|||
126330611|NCT01409915|454505093|FG001|Overall Study|Adverse Event|2|||
126330612|NCT01409915|454505092|FG000|Overall Study|Withdrawal by Subject|0|||
126330613|NCT01409915|454505093|FG001|Overall Study|Withdrawal by Subject|1|||
126330614|NCT01409915|454505092|FG000|Overall Study|Protocol Violation|1|||
126660995|NCT03945825|455716541|FG004|Overall Study|Enrolled but treatment not administered|1|||
126660996|NCT03945825|455716542|FG005|Overall Study|Enrolled but treatment not administered|0|||
126660997|NCT03945825|455716537|FG000|Overall Study|Lost to Follow-up|1|||
126660998|NCT03945825|455716538|FG001|Overall Study|Lost to Follow-up|5|||
126660999|NCT03945825|455716539|FG002|Overall Study|Lost to Follow-up|0|||
126661000|NCT03945825|455716540|FG003|Overall Study|Lost to Follow-up|1|||
126661001|NCT03945825|455716541|FG004|Overall Study|Lost to Follow-up|2|||
126661002|NCT03945825|455716542|FG005|Overall Study|Lost to Follow-up|2|||
126661003|NCT03945825|455716537|FG000|Overall Study|Withdrawal by Subject|1|||
126661004|NCT03945825|455716538|FG001|Overall Study|Withdrawal by Subject|0|||
126661005|NCT03945825|455716539|FG002|Overall Study|Withdrawal by Subject|1|||
126661006|NCT03945825|455716540|FG003|Overall Study|Withdrawal by Subject|1|||
126661007|NCT03945825|455716541|FG004|Overall Study|Withdrawal by Subject|0|||
126661008|NCT03945825|455716542|FG005|Overall Study|Withdrawal by Subject|1|||
126661009|NCT01423253|455716550|FG000|Overall Study|Adverse Event|2|||
126661010|NCT01423253|455716550|FG000|Overall Study|Lack of Efficacy|2|||
126661011|NCT01423253|455716550|FG000|Overall Study|Lost to Follow-up|1|||
126661012|NCT01423253|455716550|FG000|Overall Study|Protocol Violation|2|||
126661013|NCT01423253|455716550|FG000|Overall Study|Withdrawal by Subject|2|||
126661014|NCT00307125|455716551|FG000|Screening Phase|Adverse Event|1|||
126661015|NCT00307125|455716552|FG001|Screening Phase|Adverse Event|0|||
126661016|NCT00307125|455716553|FG002|Screening Phase|Adverse Event|0|||
126661017|NCT00307125|455716551|FG000|Screening Phase|Protocol Violation|27|||
126661018|NCT00307125|455716552|FG001|Screening Phase|Protocol Violation|0|||
126661019|NCT00307125|455716553|FG002|Screening Phase|Protocol Violation|0|||
126661020|NCT00307125|455716551|FG000|Screening Phase|Lost to Follow-up|87|||
126661021|NCT00307125|455716552|FG001|Screening Phase|Lost to Follow-up|0|||
126661022|NCT00307125|455716553|FG002|Screening Phase|Lost to Follow-up|0|||
126661023|NCT00307125|455716551|FG000|Screening Phase|Death|10|||
126661024|NCT00307125|455716552|FG001|Screening Phase|Death|0|||
126661025|NCT00307125|455716553|FG002|Screening Phase|Death|0|||
126661026|NCT00307125|455716551|FG000|Screening Phase|Withdrawal by Subject|77|||
126661027|NCT00307125|455716552|FG001|Screening Phase|Withdrawal by Subject|0|||
126661028|NCT00307125|455716553|FG002|Screening Phase|Withdrawal by Subject|0|||
126661029|NCT00307125|455716551|FG000|Screening Phase|Physician Decision|26|||
126661030|NCT00307125|455716552|FG001|Screening Phase|Physician Decision|0|||
126661031|NCT00307125|455716553|FG002|Screening Phase|Physician Decision|0|||
126661032|NCT00307125|455716551|FG000|Screening Phase|Sponsor Decision|4|||
126661033|NCT00307125|455716552|FG001|Screening Phase|Sponsor Decision|0|||
126661034|NCT00307125|455716553|FG002|Screening Phase|Sponsor Decision|0|||
126661035|NCT00307125|455716551|FG000|Screening Phase|Study Terminated|17|||
126661036|NCT00307125|455716552|FG001|Screening Phase|Study Terminated|0|||
126661037|NCT00307125|455716553|FG002|Screening Phase|Study Terminated|0|||
126661038|NCT00307125|455716551|FG000|Screening Phase|Graft Loss|3|||
126661039|NCT00307125|455716552|FG001|Screening Phase|Graft Loss|0|||
126661040|NCT00307125|455716553|FG002|Screening Phase|Graft Loss|0|||
126661041|NCT00307125|455716551|FG000|Screening Phase|Graft Failure|8|||
126330615|NCT01409915|454505093|FG001|Overall Study|Protocol Violation|0|||
126330616|NCT04826484|454505094|FG000|Overall Study|Lost to Follow-up|2|||
126330617|NCT04826484|454505095|FG001|Overall Study|Lost to Follow-up|0|||
126330618|NCT02250300|454505097|FG000|Expansion Phase|Death|6|||
126330619|NCT02250300|454505098|FG001|Expansion Phase|Death|7|||
126330620|NCT02250300|454505099|FG002|Expansion Phase|Death|0|||
126330621|NCT02250300|454505100|FG003|Expansion Phase|Death|0|||
126330622|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
126330623|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
126330624|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
126661042|NCT00307125|455716552|FG001|Screening Phase|Graft Failure|0|||
126661043|NCT00307125|455716553|FG002|Screening Phase|Graft Failure|0|||
126661044|NCT00307125|455716551|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
126661045|NCT00307125|455716552|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
126661046|NCT00307125|455716553|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
126661047|NCT00307125|455716551|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
126661048|NCT00307125|455716552|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
126661049|NCT00307125|455716553|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
126661050|NCT00307125|455716551|FG000|Screening Phase|Moved or transferred facilities|34|||
126661051|NCT00307125|455716552|FG001|Screening Phase|Moved or transferred facilities|0|||
126661052|NCT00307125|455716553|FG002|Screening Phase|Moved or transferred facilities|0|||
126661053|NCT00307125|455716551|FG000|Screening Phase|Received Pancreas Transplant|8|||
126661054|NCT00307125|455716552|FG001|Screening Phase|Received Pancreas Transplant|0|||
126661055|NCT00307125|455716553|FG002|Screening Phase|Received Pancreas Transplant|0|||
126661056|NCT00307125|455716551|FG000|Screening Phase|Ineligible for pilot|4|||
126661057|NCT00307125|455716552|FG001|Screening Phase|Ineligible for pilot|0|||
126661058|NCT00307125|455716553|FG002|Screening Phase|Ineligible for pilot|0|||
126661059|NCT00307125|455716551|FG000|Screening Phase|Try to get pregnant|1|||
126661060|NCT00307125|455716552|FG001|Screening Phase|Try to get pregnant|0|||
126661061|NCT00307125|455716553|FG002|Screening Phase|Try to get pregnant|0|||
126661062|NCT00307125|455716551|FG000|Screening Phase|Developed acute leukemia|1|||
126661063|NCT00307125|455716552|FG001|Screening Phase|Developed acute leukemia|0|||
126661064|NCT00307125|455716553|FG002|Screening Phase|Developed acute leukemia|0|||
126661065|NCT00307125|455716551|FG000|Screening Phase|Metastatic colon cancer|1|||
126661066|NCT00307125|455716552|FG001|Screening Phase|Metastatic colon cancer|0|||
126661067|NCT00307125|455716553|FG002|Screening Phase|Metastatic colon cancer|0|||
126661068|NCT00307125|455716551|FG000|Screening Phase|Malignancy|1|||
126661069|NCT00307125|455716552|FG001|Screening Phase|Malignancy|0|||
126661070|NCT00307125|455716553|FG002|Screening Phase|Malignancy|0|||
126661071|NCT00307125|455716551|FG000|Screening Phase|PAK|1|||
126661072|NCT00307125|455716552|FG001|Screening Phase|PAK|0|||
126661073|NCT00307125|455716553|FG002|Screening Phase|PAK|0|||
126661074|NCT00307125|455716551|FG000|Screening Phase|Ineligible|1|||
126661075|NCT00307125|455716552|FG001|Screening Phase|Ineligible|0|||
126661076|NCT00307125|455716553|FG002|Screening Phase|Ineligible|0|||
126661077|NCT00307125|455716551|FG000|Screening Phase|Screen Error|1|||
126661078|NCT00307125|455716552|FG001|Screening Phase|Screen Error|0|||
126661079|NCT00307125|455716553|FG002|Screening Phase|Screen Error|0|||
126661080|NCT00307125|455716551|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
126661081|NCT00307125|455716552|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
126661082|NCT00307125|455716553|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
126661083|NCT00307125|455716551|FG000|Screening Phase|AMR and treated with rituximab|1|||
126661084|NCT00307125|455716552|FG001|Screening Phase|AMR and treated with rituximab|0|||
126661085|NCT00307125|455716553|FG002|Screening Phase|AMR and treated with rituximab|0|||
126661086|NCT00307125|455716551|FG000|Screening Phase|Coronary artery bypass|1|||
126661087|NCT00307125|455716552|FG001|Screening Phase|Coronary artery bypass|0|||
126661088|NCT00307125|455716553|FG002|Screening Phase|Coronary artery bypass|0|||
126661089|NCT00307125|455716551|FG000|Pilot Phase|Lost to Follow-up|0|||
126661090|NCT00307125|455716552|FG001|Pilot Phase|Lost to Follow-up|1|||
126661091|NCT00307125|455716553|FG002|Pilot Phase|Lost to Follow-up|0|||
126661092|NCT00307125|455716551|FG000|Pilot Phase|Withdrawal by Subject|0|||
126661093|NCT00307125|455716552|FG001|Pilot Phase|Withdrawal by Subject|1|||
126661094|NCT00307125|455716553|FG002|Pilot Phase|Withdrawal by Subject|1|||
126661095|NCT00051363|455716554|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
126661096|NCT00051363|455716555|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
126661097|NCT00051363|455716554|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
126661098|NCT00051363|455716555|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
126661099|NCT00051363|455716554|FG000|Overall Study|Death|2|||
126661100|NCT00051363|455716555|FG001|Overall Study|Death|2|||
126661101|NCT00051363|455716554|FG000|Overall Study|Excluded Pre-Randomization|2|||
126661102|NCT00051363|455716555|FG001|Overall Study|Excluded Pre-Randomization|5|||
126661103|NCT00985153|455716556|FG000|Overall Study|Lost to Follow-up|16|||
126661104|NCT00985153|455716557|FG001|Overall Study|Lost to Follow-up|19|||
126661105|NCT00985153|455716558|FG002|Overall Study|Lost to Follow-up|17|||
126661106|NCT00985153|455716559|FG003|Overall Study|Lost to Follow-up|20|||
126661107|NCT00985153|455716556|FG000|Overall Study|Protocol Violation|3|||
126661108|NCT00985153|455716557|FG001|Overall Study|Protocol Violation|2|||
126661109|NCT00985153|455716558|FG002|Overall Study|Protocol Violation|4|||
126661110|NCT00985153|455716559|FG003|Overall Study|Protocol Violation|3|||
126661111|NCT00985153|455716556|FG000|Overall Study|Withdrawal by Subject|6|||
126661112|NCT00985153|455716557|FG001|Overall Study|Withdrawal by Subject|11|||
126661113|NCT00985153|455716558|FG002|Overall Study|Withdrawal by Subject|11|||
126661114|NCT00985153|455716559|FG003|Overall Study|Withdrawal by Subject|10|||
126661115|NCT00985153|455716556|FG000|Overall Study|Missed One or More Bleeds|7|||
126661116|NCT00985153|455716557|FG001|Overall Study|Missed One or More Bleeds|7|||
126661117|NCT00985153|455716558|FG002|Overall Study|Missed One or More Bleeds|8|||
126661118|NCT00985153|455716559|FG003|Overall Study|Missed One or More Bleeds|10|||
126661119|NCT00985153|455716556|FG000|Overall Study|Incomplete Safety Follow-up|3|||
126661120|NCT00985153|455716557|FG001|Overall Study|Incomplete Safety Follow-up|5|||
126661121|NCT00985153|455716558|FG002|Overall Study|Incomplete Safety Follow-up|4|||
126661122|NCT00985153|455716559|FG003|Overall Study|Incomplete Safety Follow-up|4|||
126661123|NCT01596621|455716561|FG000|Overall Study|Death|4|||
126661124|NCT01596621|455716561|FG000|Overall Study|Withdrawal by Subject|9|||
126330625|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
126330626|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
126330627|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
126330628|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
126330629|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
126330630|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
126661125|NCT01596621|455716561|FG000|Overall Study|Disease Progression|49|||
126661126|NCT01596621|455716561|FG000|Overall Study|Lost to Follow-up|3|||
126661127|NCT01596621|455716561|FG000|Overall Study|Other than specified|13|||
126661128|NCT01074216|455716564|FG000|Overall Study|Physician Decision|1|||
126661129|NCT01074216|455716564|FG000|Overall Study|Not Treated|12|||
126661130|NCT01323634|455716565|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
126661131|NCT01323634|455716566|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
126661132|NCT01323634|455716567|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
126661133|NCT01323634|455716565|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
126661134|NCT01323634|455716566|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
126661135|NCT01323634|455716567|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
126661136|NCT01323634|455716565|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
126661137|NCT01323634|455716566|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126330631|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
126330632|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
126330633|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
126330634|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
126330635|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
126661138|NCT01323634|455716567|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126661139|NCT01323634|455716565|FG000|2-week Run-in Period|Physician Decision|5|||
126661140|NCT01323634|455716566|FG001|2-week Run-in Period|Physician Decision|0|||
126661141|NCT01323634|455716567|FG002|2-week Run-in Period|Physician Decision|0|||
126661142|NCT01323634|455716565|FG000|2-week Run-in Period|Protocol Violation|1|||
126661143|NCT01323634|455716566|FG001|2-week Run-in Period|Protocol Violation|0|||
126661144|NCT01323634|455716567|FG002|2-week Run-in Period|Protocol Violation|0|||
126661145|NCT01323634|455716565|FG000|2-week Run-in Period|Adverse Event|1|||
126661146|NCT01323634|455716566|FG001|2-week Run-in Period|Adverse Event|0|||
126661147|NCT01323634|455716567|FG002|2-week Run-in Period|Adverse Event|0|||
126661148|NCT01323634|455716565|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126661149|NCT01323634|455716566|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
126661150|NCT01323634|455716567|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
126661151|NCT01323634|455716565|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126661152|NCT01323634|455716566|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126661153|NCT01323634|455716567|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
126661154|NCT01323634|455716565|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126661155|NCT01323634|455716566|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
126661156|NCT01323634|455716567|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
126661157|NCT01323634|455716565|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126661158|NCT01323634|455716566|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
126661159|NCT01323634|455716567|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
126661160|NCT01323634|455716565|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
126661161|NCT01323634|455716566|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
126661162|NCT01323634|455716567|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
126661163|NCT01323634|455716565|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126661164|NCT01323634|455716566|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
126661165|NCT01323634|455716567|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
126661166|NCT01323634|455716565|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
126661167|NCT01323634|455716566|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
126661168|NCT01323634|455716567|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
126661169|NCT05056987|455716568|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
126661170|NCT05056987|455716569|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
126661171|NCT05056987|455716568|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
126661172|NCT05056987|455716569|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
126661173|NCT02678247|455716572|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
126661174|NCT02678247|455716573|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
126661175|NCT02678247|455716572|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
126661176|NCT02678247|455716573|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
126661177|NCT02678247|455716572|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
126661178|NCT02678247|455716573|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
126661179|NCT02678247|455716572|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
126661180|NCT02678247|455716573|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
126661181|NCT02678247|455716572|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
126661182|NCT02678247|455716573|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
126661183|NCT02678247|455716572|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
126661184|NCT02678247|455716573|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
126661185|NCT00753272|455716577|FG000|Overall Study|Adverse Event|878|||
126661186|NCT00753272|455716578|FG001|Overall Study|Adverse Event|869|||
126661187|NCT00753272|455716577|FG000|Overall Study|Protocol Violation|28|||
126661188|NCT00753272|455716578|FG001|Overall Study|Protocol Violation|46|||
126661189|NCT00753272|455716577|FG000|Overall Study|Withdrawal by Subject|2481|||
126661190|NCT00753272|455716578|FG001|Overall Study|Withdrawal by Subject|2407|||
126661191|NCT00753272|455716577|FG000|Overall Study|Lost to Follow-up|491|||
126661192|NCT00753272|455716578|FG001|Overall Study|Lost to Follow-up|497|||
126661193|NCT00753272|455716577|FG000|Overall Study|Other|1104|||
126661194|NCT00753272|455716578|FG001|Overall Study|Other|1088|||
126661195|NCT00971243|455716579|FG000|Double Blind Period|Adverse Event|2|||
126661196|NCT00971243|455716580|FG001|Double Blind Period|Adverse Event|3|||
126661197|NCT00971243|455716581|FG002|Double Blind Period|Adverse Event|2|||
126661198|NCT00971243|455716582|FG003|Double Blind Period|Adverse Event|2|||
126661199|NCT00971243|455716583|FG004|Double Blind Period|Adverse Event|3|||
126661200|NCT00971243|455716579|FG000|Double Blind Period|Lost to Follow-up|0|||
126661201|NCT00971243|455716580|FG001|Double Blind Period|Lost to Follow-up|1|||
126661202|NCT00971243|455716581|FG002|Double Blind Period|Lost to Follow-up|1|||
126661203|NCT00971243|455716582|FG003|Double Blind Period|Lost to Follow-up|0|||
126661204|NCT00971243|455716583|FG004|Double Blind Period|Lost to Follow-up|1|||
126661205|NCT00971243|455716579|FG000|Double Blind Period|Physician Decision|10|||
126661206|NCT00971243|455716580|FG001|Double Blind Period|Physician Decision|6|||
126330636|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
126330637|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
126330638|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
126661207|NCT00971243|455716581|FG002|Double Blind Period|Physician Decision|7|||
126661208|NCT00971243|455716582|FG003|Double Blind Period|Physician Decision|6|||
126661209|NCT00971243|455716583|FG004|Double Blind Period|Physician Decision|7|||
126661210|NCT00971243|455716579|FG000|Double Blind Period|Protocol Violation|2|||
126661211|NCT00971243|455716580|FG001|Double Blind Period|Protocol Violation|0|||
126661212|NCT00971243|455716581|FG002|Double Blind Period|Protocol Violation|3|||
126661213|NCT00971243|455716582|FG003|Double Blind Period|Protocol Violation|2|||
126661214|NCT00971243|455716583|FG004|Double Blind Period|Protocol Violation|2|||
126661215|NCT00971243|455716579|FG000|Double Blind Period|Withdrawal by Subject|4|||
126661216|NCT00971243|455716580|FG001|Double Blind Period|Withdrawal by Subject|1|||
126661217|NCT00971243|455716581|FG002|Double Blind Period|Withdrawal by Subject|4|||
126661218|NCT00971243|455716582|FG003|Double Blind Period|Withdrawal by Subject|4|||
126661219|NCT00971243|455716583|FG004|Double Blind Period|Withdrawal by Subject|4|||
126661220|NCT00971243|455716579|FG000|Double Blind Period|Other reasons|1|||
126661221|NCT00971243|455716580|FG001|Double Blind Period|Other reasons|0|||
126661222|NCT00971243|455716581|FG002|Double Blind Period|Other reasons|2|||
126661223|NCT00971243|455716582|FG003|Double Blind Period|Other reasons|0|||
126661224|NCT00971243|455716583|FG004|Double Blind Period|Other reasons|1|||
126661225|NCT00971243|455716579|FG000|Open-label Period|Adverse Event|1|||
126661226|NCT00971243|455716580|FG001|Open-label Period|Adverse Event|0|||
126661227|NCT00971243|455716581|FG002|Open-label Period|Adverse Event|1|||
126661228|NCT00971243|455716582|FG003|Open-label Period|Adverse Event|1|||
126661229|NCT00971243|455716583|FG004|Open-label Period|Adverse Event|0|||
126661230|NCT00971243|455716579|FG000|Open-label Period|Physician Decision|5|||
126661231|NCT00971243|455716580|FG001|Open-label Period|Physician Decision|9|||
126661232|NCT00971243|455716581|FG002|Open-label Period|Physician Decision|3|||
126661233|NCT00971243|455716582|FG003|Open-label Period|Physician Decision|7|||
126661234|NCT00971243|455716583|FG004|Open-label Period|Physician Decision|2|||
126661235|NCT00971243|455716579|FG000|Open-label Period|Protocol Violation|1|||
126661236|NCT00971243|455716580|FG001|Open-label Period|Protocol Violation|1|||
126661237|NCT00971243|455716581|FG002|Open-label Period|Protocol Violation|1|||
126661238|NCT00971243|455716582|FG003|Open-label Period|Protocol Violation|0|||
126661239|NCT00971243|455716583|FG004|Open-label Period|Protocol Violation|1|||
126661240|NCT00971243|455716579|FG000|Open-label Period|Withdrawal by Subject|1|||
126330639|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
126330640|NCT03569098|454505101|FG000|Double-Blind Treatment Cycle 1|Other|1|||
126330641|NCT03569098|454505102|FG001|Double-Blind Treatment Cycle 1|Other|0|||
126330642|NCT03569098|454505103|FG002|Double-Blind Treatment Cycle 1|Other|1|||
126330643|NCT03569098|454505101|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
126661241|NCT00971243|455716580|FG001|Open-label Period|Withdrawal by Subject|0|||
126661242|NCT00971243|455716581|FG002|Open-label Period|Withdrawal by Subject|0|||
126661243|NCT00971243|455716582|FG003|Open-label Period|Withdrawal by Subject|2|||
126661244|NCT00971243|455716583|FG004|Open-label Period|Withdrawal by Subject|1|||
126661245|NCT00971243|455716579|FG000|Open-label Period|Other reason|0|||
126661246|NCT00971243|455716580|FG001|Open-label Period|Other reason|0|||
126661247|NCT00971243|455716581|FG002|Open-label Period|Other reason|0|||
126661248|NCT00971243|455716582|FG003|Open-label Period|Other reason|0|||
126330644|NCT03569098|454505102|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
126661249|NCT00971243|455716583|FG004|Open-label Period|Other reason|2|||
126661250|NCT03604523|455716586|FG000|Overall Study|Physician Decision|1|||
126661251|NCT03604523|455716587|FG001|Overall Study|Physician Decision|0|||
126661252|NCT04223856|455716593|FG000|Overall Study|Progressive disease|153|||
126661253|NCT04223856|455716594|FG001|Overall Study|Progressive disease|73|||
126661254|NCT04223856|455716593|FG000|Overall Study|Adverse Event|97|||
126661255|NCT04223856|455716594|FG001|Overall Study|Adverse Event|62|||
126661256|NCT04223856|455716593|FG000|Overall Study|Physician Decision|9|||
126661257|NCT04223856|455716594|FG001|Overall Study|Physician Decision|28|||
126661258|NCT04223856|455716593|FG000|Overall Study|Withdrawal by Subject|22|||
126661259|NCT04223856|455716594|FG001|Overall Study|Withdrawal by Subject|24|||
126661260|NCT04223856|455716593|FG000|Overall Study|Other|7|||
126661261|NCT04223856|455716594|FG001|Overall Study|Other|2|||
126661262|NCT04223856|455716593|FG000|Overall Study|Randomized but not treated|2|||
126661263|NCT04223856|455716594|FG001|Overall Study|Randomized but not treated|11|||
126661264|NCT04223856|455716593|FG000|Overall Study|On-treatment|144|||
126661265|NCT04223856|455716594|FG001|Overall Study|On-treatment|0|||
126661266|NCT02903368|455716595|FG000|Part 1|Adverse Event|3|||
126661267|NCT02903368|455716596|FG001|Part 1|Adverse Event|0|||
126661268|NCT02903368|455716597|FG002|Part 1|Adverse Event|0|||
126661269|NCT02903368|455716598|FG003|Part 1|Adverse Event|0|||
126661270|NCT02903368|455716595|FG000|Part 1|Withdrawal by Subject|1|||
126661271|NCT02903368|455716596|FG001|Part 1|Withdrawal by Subject|0|||
126661272|NCT02903368|455716597|FG002|Part 1|Withdrawal by Subject|0|||
126661273|NCT02903368|455716598|FG003|Part 1|Withdrawal by Subject|0|||
126661274|NCT02903368|455716595|FG000|Part 2|Adverse Event|0|||
126661275|NCT02903368|455716596|FG001|Part 2|Adverse Event|0|||
126661276|NCT02903368|455716597|FG002|Part 2|Adverse Event|5|||
126661277|NCT02903368|455716598|FG003|Part 2|Adverse Event|0|||
126661278|NCT02903368|455716595|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
126661279|NCT02903368|455716596|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
126661280|NCT02903368|455716597|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
126661281|NCT02903368|455716598|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
126661282|NCT02903368|455716595|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
126661283|NCT02903368|455716596|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
126661284|NCT02903368|455716597|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
126661285|NCT02903368|455716598|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
126661286|NCT02903368|455716595|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
126661287|NCT02903368|455716596|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
126661288|NCT02903368|455716597|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
126661289|NCT02903368|455716598|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
126661290|NCT00171704|455718014|FG000|Overall Study|Adverse Event|24|||
126661291|NCT00171704|455718015|FG001|Overall Study|Adverse Event|33|||
126661292|NCT00171704|455718014|FG000|Overall Study|Disease Progression|14|||
126661293|NCT00171704|455718015|FG001|Overall Study|Disease Progression|9|||
126661294|NCT00171704|455718014|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
126661295|NCT00171704|455718015|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
126661296|NCT00171704|455718014|FG000|Overall Study|Administrative Problems|2|||
126661297|NCT00171704|455718015|FG001|Overall Study|Administrative Problems|1|||
126661298|NCT00171704|455718014|FG000|Overall Study|Death|2|||
126661299|NCT00171704|455718015|FG001|Overall Study|Death|2|||
126661300|NCT00171704|455718014|FG000|Overall Study|Withdrawal by Subject|1|||
126661301|NCT00171704|455718015|FG001|Overall Study|Withdrawal by Subject|3|||
126661302|NCT00171704|455718014|FG000|Overall Study|Protocol Violation|0|||
126661303|NCT00171704|455718015|FG001|Overall Study|Protocol Violation|1|||
126661304|NCT02141984|455718016|FG000|Overall Study|Lack of Efficacy|2|||
126661305|NCT00816400|455718020|FG000|Overall Study|Death|2|||
126661306|NCT00816400|455718021|FG001|Overall Study|Death|3|||
126661307|NCT00816400|455718022|FG002|Overall Study|Death|3|||
126661308|NCT00816400|455718023|FG003|Overall Study|Death|3|||
126661309|NCT00816400|455718024|FG004|Overall Study|Death|2|||
126661310|NCT00816400|455718025|FG005|Overall Study|Death|3|||
126661311|NCT00816400|455718026|FG006|Overall Study|Death|2|||
126661312|NCT00816400|455718027|FG007|Overall Study|Death|5|||
126661313|NCT00816400|455718028|FG008|Overall Study|Death|6|||
126661314|NCT00816400|455718020|FG000|Overall Study|In hospice care at the end of the study|0|||
126661315|NCT00816400|455718021|FG001|Overall Study|In hospice care at the end of the study|0|||
126661316|NCT00816400|455718022|FG002|Overall Study|In hospice care at the end of the study|2|||
126661317|NCT00816400|455718023|FG003|Overall Study|In hospice care at the end of the study|0|||
126661318|NCT00816400|455718024|FG004|Overall Study|In hospice care at the end of the study|0|||
126661319|NCT00816400|455718025|FG005|Overall Study|In hospice care at the end of the study|0|||
126661320|NCT00816400|455718026|FG006|Overall Study|In hospice care at the end of the study|0|||
126661321|NCT00816400|455718027|FG007|Overall Study|In hospice care at the end of the study|0|||
126661322|NCT00816400|455718028|FG008|Overall Study|In hospice care at the end of the study|0|||
126330645|NCT03569098|454505103|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
126330646|NCT03569098|454505101|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
126330647|NCT03569098|454505102|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
126330648|NCT03569098|454505103|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
126330649|NCT03569098|454505101|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
126330650|NCT03569098|454505102|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
126330651|NCT03569098|454505103|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
126330652|NCT03569098|454505101|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
126330653|NCT03569098|454505102|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
126330654|NCT03569098|454505103|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
126330655|NCT03569098|454505101|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
126661323|NCT00081770|455718029|FG000|Overall Study|Adverse Event|130|||
126661324|NCT00081770|455718030|FG001|Overall Study|Adverse Event|98|||
126661325|NCT00081770|455718031|FG002|Overall Study|Adverse Event|136|||
126661326|NCT00081770|455718029|FG000|Overall Study|Lack of Efficacy|262|||
126661327|NCT00081770|455718030|FG001|Overall Study|Lack of Efficacy|357|||
126661328|NCT00081770|455718031|FG002|Overall Study|Lack of Efficacy|211|||
126661329|NCT00081770|455718029|FG000|Overall Study|Lost to Follow-up|45|||
126661330|NCT00081770|455718030|FG001|Overall Study|Lost to Follow-up|34|||
126661331|NCT00081770|455718031|FG002|Overall Study|Lost to Follow-up|45|||
126661332|NCT00081770|455718029|FG000|Overall Study|Protocol Violation|15|||
126661333|NCT00081770|455718030|FG001|Overall Study|Protocol Violation|10|||
126661334|NCT00081770|455718031|FG002|Overall Study|Protocol Violation|10|||
126661335|NCT00081770|455718029|FG000|Overall Study|Withdrawal by Subject|45|||
126661336|NCT00081770|455718030|FG001|Overall Study|Withdrawal by Subject|40|||
126661337|NCT00081770|455718031|FG002|Overall Study|Withdrawal by Subject|42|||
126661338|NCT00081770|455718029|FG000|Overall Study|Did not meet protocol eligibility|2|||
126661339|NCT00081770|455718030|FG001|Overall Study|Did not meet protocol eligibility|0|||
126661340|NCT00081770|455718031|FG002|Overall Study|Did not meet protocol eligibility|3|||
126661341|NCT00081770|455718029|FG000|Overall Study|Administrative|1|||
126661342|NCT00081770|455718030|FG001|Overall Study|Administrative|0|||
126661343|NCT00081770|455718031|FG002|Overall Study|Administrative|1|||
126661344|NCT00081770|455718029|FG000|Overall Study|Other|2|||
126661345|NCT00081770|455718030|FG001|Overall Study|Other|7|||
126661346|NCT00081770|455718031|FG002|Overall Study|Other|8|||
126661347|NCT00601419|455718032|FG000|Overall Study|Lost to Follow-up|3|||
126661348|NCT00601419|455718032|FG000|Overall Study|Missed Visits|1|||
126661349|NCT01614197|455718033|FG000|Overall Study|Withdrawal by Subject|0|||
126330656|NCT03569098|454505102|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
126330657|NCT03569098|454505103|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
126330658|NCT03569098|454505101|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
126330659|NCT03569098|454505102|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
126330660|NCT03569098|454505103|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
126330661|NCT00758498|454505104|FG000|Overall Study|Adverse Event|2|||
126330662|NCT00758498|454505105|FG001|Overall Study|Adverse Event|2|||
126330663|NCT00758498|454505106|FG002|Overall Study|Adverse Event|3|||
126330664|NCT00758498|454505104|FG000|Overall Study|Subject legally detained out of state|1|||
126330665|NCT00758498|454505105|FG001|Overall Study|Subject legally detained out of state|0|||
126330666|NCT00758498|454505106|FG002|Overall Study|Subject legally detained out of state|0|||
126330667|NCT00758498|454505104|FG000|Overall Study|Withdrawal by Subject|0|||
126330668|NCT00758498|454505105|FG001|Overall Study|Withdrawal by Subject|0|||
126330669|NCT00758498|454505106|FG002|Overall Study|Withdrawal by Subject|1|||
126330670|NCT00758498|454505104|FG000|Overall Study|Noncompliance to study procedures|0|||
126330671|NCT00758498|454505105|FG001|Overall Study|Noncompliance to study procedures|0|||
126330672|NCT00758498|454505106|FG002|Overall Study|Noncompliance to study procedures|1|||
126330673|NCT01516736|454505112|FG000|Overall Study|Withdrawal by Subject|10|||
126330674|NCT01516736|454505113|FG001|Overall Study|Withdrawal by Subject|4|||
126330675|NCT01516736|454505112|FG000|Overall Study|Adverse Event|4|||
126330676|NCT01516736|454505113|FG001|Overall Study|Adverse Event|5|||
126330677|NCT01516736|454505112|FG000|Overall Study|Death|3|||
126330678|NCT01516736|454505113|FG001|Overall Study|Death|1|||
126330679|NCT01516736|454505112|FG000|Overall Study|Physician Decision|2|||
126661350|NCT01614197|455718034|FG001|Overall Study|Withdrawal by Subject|1|||
126661351|NCT01614197|455718035|FG002|Overall Study|Withdrawal by Subject|0|||
126661352|NCT01614197|455718036|FG003|Overall Study|Withdrawal by Subject|0|||
126330680|NCT01516736|454505113|FG001|Overall Study|Physician Decision|1|||
126330681|NCT01516736|454505112|FG000|Overall Study|Lack of Efficacy|1|||
126330682|NCT01516736|454505113|FG001|Overall Study|Lack of Efficacy|0|||
126330683|NCT01516736|454505112|FG000|Overall Study|Protocol Violation|0|||
126330684|NCT01516736|454505113|FG001|Overall Study|Protocol Violation|1|||
126330685|NCT01516736|454505112|FG000|Overall Study|Other (not specified)|0|||
126330686|NCT01516736|454505113|FG001|Overall Study|Other (not specified)|1|||
126330687|NCT01697800|454505114|FG000|Overall Study|Death|0|||
126661353|NCT02245672|455718037|FG000|Overall Study|Adverse Event|4|||
126661354|NCT02245672|455718038|FG001|Overall Study|Adverse Event|4|||
126661355|NCT02245672|455718039|FG002|Overall Study|Adverse Event|4|||
126661356|NCT02245672|455718037|FG000|Overall Study|Lost to Follow-up|3|||
126661357|NCT02245672|455718038|FG001|Overall Study|Lost to Follow-up|5|||
126661358|NCT02245672|455718039|FG002|Overall Study|Lost to Follow-up|1|||
126661359|NCT02245672|455718037|FG000|Overall Study|Withdrawal by Subject|6|||
126661360|NCT02245672|455718038|FG001|Overall Study|Withdrawal by Subject|3|||
126661361|NCT02245672|455718039|FG002|Overall Study|Withdrawal by Subject|0|||
126661362|NCT02245672|455718037|FG000|Overall Study|Randomized in error (not treated)|0|||
126661363|NCT02245672|455718038|FG001|Overall Study|Randomized in error (not treated)|1|||
126661364|NCT02245672|455718039|FG002|Overall Study|Randomized in error (not treated)|0|||
126661365|NCT00971932|455718040|FG000|Overall Study|Withdrawal by Subject|1|||
126661366|NCT00971932|455718040|FG000|Overall Study|Investigator's decision|2|||
126661367|NCT00971932|455718040|FG000|Overall Study|Ongoing|4|||
126661368|NCT01765192|455718043|FG000|Treatment Period 1|Adverse Event|0|||
126661369|NCT01765192|455718044|FG001|Treatment Period 1|Adverse Event|1|||
126661370|NCT01765192|455718043|FG000|Washout Period|Voluntary Withdrawal|1|||
126661371|NCT01765192|455718044|FG001|Washout Period|Voluntary Withdrawal|1|||
126661372|NCT01765192|455718043|FG000|Washout Period|Reason not specified|1|||
126661373|NCT01765192|455718044|FG001|Washout Period|Reason not specified|0|||
126661374|NCT01765192|455718043|FG000|Treatment Period 2|Reason not specified|0|||
126661375|NCT01765192|455718044|FG001|Treatment Period 2|Reason not specified|2|||
126661376|NCT01765192|455718043|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
126661377|NCT01765192|455718044|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
126661378|NCT00876694|455718049|FG000|Overall Study|Adverse Event|10|||
126661379|NCT00876694|455718050|FG001|Overall Study|Adverse Event|7|||
126661380|NCT00876694|455718049|FG000|Overall Study|Subject withdrew consent|6|||
126661381|NCT00876694|455718050|FG001|Overall Study|Subject withdrew consent|4|||
126661382|NCT00876694|455718049|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126661383|NCT00876694|455718050|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126661384|NCT00876694|455718049|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126661385|NCT00876694|455718050|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126661386|NCT00876694|455718049|FG000|Overall Study|Administrative problems|1|||
126661387|NCT00876694|455718050|FG001|Overall Study|Administrative problems|1|||
126661388|NCT00876694|455718049|FG000|Overall Study|Death|1|||
126661389|NCT00876694|455718050|FG001|Overall Study|Death|0|||
126661390|NCT01215422|455718055|FG000|Overall Study|Relocation|1|||
126661391|NCT01215422|455718056|FG001|Overall Study|Relocation|0|||
126661392|NCT01215422|455718057|FG002|Overall Study|Relocation|0|||
126661393|NCT01215422|455718058|FG003|Overall Study|Relocation|0|||
126661394|NCT01215422|455718055|FG000|Overall Study|Failed intubations|0|||
126661395|NCT01215422|455718056|FG001|Overall Study|Failed intubations|0|||
126661396|NCT01215422|455718057|FG002|Overall Study|Failed intubations|3|||
126661397|NCT01215422|455718058|FG003|Overall Study|Failed intubations|8|||
126661398|NCT01215422|455718055|FG000|Overall Study|Did not complete all intubations|7|||
126661399|NCT01215422|455718056|FG001|Overall Study|Did not complete all intubations|0|||
126661400|NCT01215422|455718057|FG002|Overall Study|Did not complete all intubations|0|||
126661401|NCT01215422|455718058|FG003|Overall Study|Did not complete all intubations|0|||
126661402|NCT00294554|455718061|FG000|Overall Study|Lack of Efficacy|0|||
126661403|NCT00294554|455718062|FG001|Overall Study|Lack of Efficacy|1|||
126661404|NCT00294554|455718061|FG000|Overall Study|Physician Decision|0|||
126661405|NCT00294554|455718062|FG001|Overall Study|Physician Decision|1|||
126661406|NCT00462865|455718063|FG000|Overall Study|Adverse Event|1|||
126661407|NCT02864381|455718064|FG000|Overall Study|Death|58|||
126661408|NCT02864381|455718065|FG001|Overall Study|Death|61|||
126661409|NCT02864381|455718064|FG000|Overall Study|Withdrew Consent|5|||
126661410|NCT02864381|455718065|FG001|Overall Study|Withdrew Consent|6|||
126661411|NCT02864381|455718064|FG000|Overall Study|Reason Unknown|7|||
126661412|NCT02864381|455718065|FG001|Overall Study|Reason Unknown|3|||
126661413|NCT02864381|455718064|FG000|Overall Study|Lost to Follow-up|1|||
126661414|NCT02864381|455718065|FG001|Overall Study|Lost to Follow-up|1|||
126661415|NCT02864381|455718064|FG000|Overall Study|Investigator's Discretion|1|||
126661416|NCT02864381|455718065|FG001|Overall Study|Investigator's Discretion|0|||
126661417|NCT02864381|455718064|FG000|Overall Study|Protocol Violation|0|||
126661418|NCT02864381|455718065|FG001|Overall Study|Protocol Violation|1|||
126661419|NCT04142450|455718066|FG000|Overall Study|Screen Failure|1|||
126661420|NCT04142450|455718066|FG000|Overall Study|Lost to Follow-up|1|||
126661421|NCT01146054|455718067|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
126661422|NCT01146054|455718067|FG000|Overall Study|Rapid tumor progression|2|||
126661423|NCT01146054|455718067|FG000|Overall Study|Other illness precluded treatment|2|||
126661424|NCT01146054|455718067|FG000|Overall Study|Lost to Follow-up|1|||
126661425|NCT04335812|455718068|FG000|Overall Study|Withdrawal by Subject|1|||
126661426|NCT04335812|455718069|FG001|Overall Study|Withdrawal by Subject|3|||
126661427|NCT04335812|455718068|FG000|Overall Study|Lost to Follow-up|12|||
126661428|NCT04335812|455718069|FG001|Overall Study|Lost to Follow-up|12|||
126661429|NCT04335812|455718068|FG000|Overall Study|Did not engage in the intervention|22|||
126661430|NCT04335812|455718069|FG001|Overall Study|Did not engage in the intervention|18|||
126661431|NCT03249714|455718080|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
126661432|NCT03249714|455718081|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
126661433|NCT03249714|455718080|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
126661434|NCT03249714|455718081|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
126661435|NCT03249714|455718080|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
126661436|NCT03249714|455718081|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
126661437|NCT03249714|455718080|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
126661438|NCT03249714|455718081|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
126661439|NCT01607554|455718089|FG000|Overall Study|Disease progression|2|||
126661440|NCT01139021|455718090|FG000|Overall Study|Adverse Event|0|||
126661441|NCT01139021|455718091|FG001|Overall Study|Adverse Event|0|||
126661442|NCT01139021|455718092|FG002|Overall Study|Adverse Event|0|||
126661443|NCT01139021|455718093|FG003|Overall Study|Adverse Event|0|||
126661444|NCT01139021|455718094|FG004|Overall Study|Adverse Event|1|||
126661445|NCT01139021|455718095|FG005|Overall Study|Adverse Event|0|||
126661446|NCT01139021|455718090|FG000|Overall Study|Lost to Follow-up|0|||
126661447|NCT01139021|455718091|FG001|Overall Study|Lost to Follow-up|0|||
126661448|NCT01139021|455718092|FG002|Overall Study|Lost to Follow-up|0|||
126661449|NCT01139021|455718093|FG003|Overall Study|Lost to Follow-up|0|||
126661450|NCT01139021|455718094|FG004|Overall Study|Lost to Follow-up|2|||
126661451|NCT01139021|455718095|FG005|Overall Study|Lost to Follow-up|0|||
126661452|NCT01139021|455718090|FG000|Overall Study|Protocol Violation|1|||
126661453|NCT01139021|455718091|FG001|Overall Study|Protocol Violation|0|||
126661454|NCT01139021|455718092|FG002|Overall Study|Protocol Violation|0|||
126661455|NCT01139021|455718093|FG003|Overall Study|Protocol Violation|0|||
126661456|NCT01139021|455718094|FG004|Overall Study|Protocol Violation|2|||
126661457|NCT01139021|455718095|FG005|Overall Study|Protocol Violation|0|||
126661458|NCT01139021|455718090|FG000|Overall Study|Withdrawal by Subject|0|||
126661459|NCT01139021|455718091|FG001|Overall Study|Withdrawal by Subject|0|||
126661460|NCT01139021|455718092|FG002|Overall Study|Withdrawal by Subject|0|||
126661461|NCT01139021|455718093|FG003|Overall Study|Withdrawal by Subject|1|||
126661462|NCT01139021|455718094|FG004|Overall Study|Withdrawal by Subject|4|||
126661463|NCT01139021|455718095|FG005|Overall Study|Withdrawal by Subject|0|||
126661464|NCT02963610|455718096|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
126661465|NCT01294683|455718103|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
126661466|NCT01294683|455718104|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
126661467|NCT01294683|455718103|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
126661468|NCT01294683|455718104|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
126661469|NCT01294683|455718103|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
126661470|NCT01294683|455718104|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
126661471|NCT01294683|455718103|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
126661472|NCT01294683|455718104|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
126661473|NCT01294683|455718103|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
126661474|NCT01294683|455718104|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
126661475|NCT01294683|455718103|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
126661476|NCT01294683|455718104|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
126661477|NCT01294683|455718103|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
126661478|NCT01294683|455718104|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
126661479|NCT01294683|455718103|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
126661480|NCT01294683|455718104|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
126661481|NCT01294683|455718103|FG000|Post Crossover (Period III)|Adverse Event|6|||
126661482|NCT01294683|455718104|FG001|Post Crossover (Period III)|Adverse Event|6|||
126661483|NCT01294683|455718103|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
126661484|NCT01294683|455718104|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
126661485|NCT01294683|455718103|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
126661486|NCT01294683|455718104|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
126661487|NCT01294683|455718103|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
126661488|NCT01294683|455718104|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
126661489|NCT01032382|455718105|FG000|Overall Study|Disease dissemination|1|||
126661490|NCT01032382|455718106|FG001|Overall Study|Disease dissemination|1|||
126661491|NCT01032382|455718105|FG000|Overall Study|Treatment failure|3|||
126661492|NCT01032382|455718106|FG001|Overall Study|Treatment failure|1|||
126661493|NCT01032382|455718105|FG000|Overall Study|Index lesion relapse|1|||
126661494|NCT01032382|455718106|FG001|Overall Study|Index lesion relapse|3|||
126661495|NCT00412971|455718107|FG000|Overall Study|Lost to Follow-up|17|||
126661496|NCT00412971|455718108|FG001|Overall Study|Lost to Follow-up|9|||
126661497|NCT00412971|455718107|FG000|Overall Study|Protocol Violation|13|||
126661498|NCT00412971|455718108|FG001|Overall Study|Protocol Violation|1|||
126661499|NCT02409368|455718109|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
126661500|NCT02409368|455718110|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
126661501|NCT02409368|455718111|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
126661502|NCT02409368|455718112|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
126661503|NCT02409368|455718109|FG000|ECOG Reclassification|Death|1|||
126330688|NCT01697800|454505115|FG001|Overall Study|Death|1|||
126661504|NCT02409368|455718110|FG001|ECOG Reclassification|Death|5|||
126661505|NCT02409368|455718111|FG002|ECOG Reclassification|Death|0|||
126661506|NCT02409368|455718112|FG003|ECOG Reclassification|Death|0|||
126661507|NCT02409368|455718109|FG000|ECOG Reclassification|Disease Progression|113|||
126661508|NCT02409368|455718110|FG001|ECOG Reclassification|Disease Progression|382|||
126661509|NCT02409368|455718111|FG002|ECOG Reclassification|Disease Progression|70|||
126661510|NCT02409368|455718112|FG003|ECOG Reclassification|Disease Progression|1|||
126661511|NCT02409368|455718109|FG000|ECOG Reclassification|Lost to Follow-up|1|||
126661512|NCT02409368|455718110|FG001|ECOG Reclassification|Lost to Follow-up|5|||
126661513|NCT02409368|455718111|FG002|ECOG Reclassification|Lost to Follow-up|0|||
126661514|NCT02409368|455718112|FG003|ECOG Reclassification|Lost to Follow-up|0|||
126661515|NCT02409368|455718109|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
126661516|NCT02409368|455718110|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
126661517|NCT02409368|455718111|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
126661518|NCT02409368|455718112|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
126661519|NCT02409368|455718109|FG000|ECOG Reclassification|Poor/non-compliance|0|||
126661520|NCT02409368|455718110|FG001|ECOG Reclassification|Poor/non-compliance|3|||
126661521|NCT02409368|455718111|FG002|ECOG Reclassification|Poor/non-compliance|2|||
126661522|NCT02409368|455718112|FG003|ECOG Reclassification|Poor/non-compliance|0|||
126661523|NCT02409368|455718109|FG000|ECOG Reclassification|Study drug toxicity|17|||
126661524|NCT02409368|455718110|FG001|ECOG Reclassification|Study drug toxicity|42|||
126661525|NCT02409368|455718111|FG002|ECOG Reclassification|Study drug toxicity|7|||
126661526|NCT02409368|455718112|FG003|ECOG Reclassification|Study drug toxicity|0|||
126661527|NCT02409368|455718109|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
126661528|NCT02409368|455718110|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
126661529|NCT02409368|455718111|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
126661530|NCT02409368|455718112|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
126661531|NCT02409368|455718109|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
126661532|NCT02409368|455718110|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
126661533|NCT02409368|455718111|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
126661534|NCT02409368|455718112|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
126661535|NCT02409368|455718109|FG000|ECOG Reclassification|Participant withdrew consent|2|||
126661536|NCT02409368|455718110|FG001|ECOG Reclassification|Participant withdrew consent|3|||
126661537|NCT02409368|455718111|FG002|ECOG Reclassification|Participant withdrew consent|4|||
126661538|NCT02409368|455718112|FG003|ECOG Reclassification|Participant withdrew consent|0|||
126661539|NCT02409368|455718109|FG000|ECOG Reclassification|Other Reasons|5|||
126661540|NCT02409368|455718110|FG001|ECOG Reclassification|Other Reasons|26|||
126661541|NCT02409368|455718111|FG002|ECOG Reclassification|Other Reasons|2|||
126661542|NCT02409368|455718112|FG003|ECOG Reclassification|Other Reasons|0|||
126661543|NCT02409368|455718109|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
126661544|NCT02409368|455718110|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
126661545|NCT02409368|455718111|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
126661546|NCT02409368|455718112|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
126661547|NCT01296347|455718113|FG000|Allocation|Withdrawal by Subject|1|||
126661548|NCT01296347|455718114|FG001|Allocation|Withdrawal by Subject|2|||
126661549|NCT01296347|455718113|FG000|Allocation|Lack of Efficacy|1|||
126661550|NCT01296347|455718114|FG001|Allocation|Lack of Efficacy|2|||
126661551|NCT01296347|455718113|FG000|Allocation|not received infusion|1|||
126661552|NCT01296347|455718114|FG001|Allocation|not received infusion|0|||
126661553|NCT01296347|455718113|FG000|6 Week Follow up|Death|0|||
126661554|NCT01296347|455718114|FG001|6 Week Follow up|Death|1|||
126661555|NCT01296347|455718113|FG000|3 Month Follow up|Death|1|||
126661556|NCT01296347|455718114|FG001|3 Month Follow up|Death|0|||
126661557|NCT01296347|455718113|FG000|3 Month Follow up|Lost to Follow-up|0|||
126661558|NCT01296347|455718114|FG001|3 Month Follow up|Lost to Follow-up|1|||
126661559|NCT01296347|455718113|FG000|6 Month Follow up|Death|2|||
126661560|NCT01296347|455718114|FG001|6 Month Follow up|Death|1|||
126661561|NCT01296347|455718113|FG000|6 Month Follow up|Lost to Follow-up|0|||
126661562|NCT01296347|455718114|FG001|6 Month Follow up|Lost to Follow-up|1|||
126661563|NCT01296347|455718113|FG000|12 Month Follow up|Lost to Follow-up|3|||
126661564|NCT01296347|455718114|FG001|12 Month Follow up|Lost to Follow-up|1|||
126330689|NCT00954122|454505116|FG000|Overall Study|Withdrawal by Subject|5|||
126330690|NCT00954122|454505116|FG000|Overall Study|Adverse Event|1|||
126330691|NCT00954122|454505116|FG000|Overall Study|Safety Reason|1|||
126330692|NCT03365934|454505123|FG000|Overall Study|Adverse Event|1|||
126661565|NCT01296347|455718113|FG000|12 Month Follow up|Death|1|||
126661566|NCT01296347|455718114|FG001|12 Month Follow up|Death|1|||
126661567|NCT01296347|455718113|FG000|12 Month Follow up|Withdrawal by Subject|0|||
126661568|NCT01296347|455718114|FG001|12 Month Follow up|Withdrawal by Subject|1|||
126330693|NCT03365934|454505123|FG000|Overall Study|Withdrawal by Subject|1|||
126661569|NCT01585987|455718115|FG000|Randomized|Withdrawal by Subject|0|||
126661570|NCT01585987|455718116|FG001|Randomized|Withdrawal by Subject|4|||
126661571|NCT01585987|455718115|FG000|Randomized|No longer met criteria|0|||
126661572|NCT01585987|455718116|FG001|Randomized|No longer met criteria|2|||
126661573|NCT01585987|455718115|FG000|Treated|Disease Progression|39|||
126661574|NCT01585987|455718116|FG001|Treated|Disease Progression|36|||
126661575|NCT01585987|455718115|FG000|Treated|Study Drug Toxicity|9|||
126661576|NCT01585987|455718116|FG001|Treated|Study Drug Toxicity|5|||
126661577|NCT01585987|455718115|FG000|Treated|Adverse Event|3|||
126661578|NCT01585987|455718116|FG001|Treated|Adverse Event|0|||
126661579|NCT01585987|455718115|FG000|Treated|Withdrawal by Subject|1|||
126661580|NCT01585987|455718116|FG001|Treated|Withdrawal by Subject|2|||
126661581|NCT01585987|455718115|FG000|Treated|Death|1|||
126661582|NCT01585987|455718116|FG001|Treated|Death|0|||
126661583|NCT01585987|455718115|FG000|Treated|Lost to Follow-up|0|||
126661584|NCT01585987|455718116|FG001|Treated|Lost to Follow-up|1|||
126661585|NCT01585987|455718115|FG000|Treated|Maximum Clinical Benefit|0|||
126661586|NCT01585987|455718116|FG001|Treated|Maximum Clinical Benefit|1|||
126661587|NCT01585987|455718115|FG000|Treated|Non-Specified|1|||
126330694|NCT04194489|454505124|FG000|Overall Study|Withdrawal by Subject|5|||
126330695|NCT04194489|454505124|FG000|Overall Study|Lost to Follow-up|48|||
126330696|NCT00522548|454505131|FG000|Overall Study|Adverse Event|2|||
126330697|NCT00522548|454505132|FG001|Overall Study|Adverse Event|2|||
126330698|NCT00522548|454505131|FG000|Overall Study|Withdrawal by Subject|0|||
126330699|NCT00522548|454505132|FG001|Overall Study|Withdrawal by Subject|2|||
126330700|NCT02121795|454505133|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
126330701|NCT02121795|454505134|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
126330702|NCT02121795|454505133|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
126330703|NCT02121795|454505134|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
126330704|NCT02121795|454505133|FG000|Double-Blind Phase|Lost to Follow-up|7|||
126330705|NCT02121795|454505134|FG001|Double-Blind Phase|Lost to Follow-up|4|||
126330706|NCT02121795|454505133|FG000|Double-Blind Phase|Physician Decision|2|||
126330707|NCT02121795|454505134|FG001|Double-Blind Phase|Physician Decision|5|||
126330708|NCT02121795|454505133|FG000|Double-Blind Phase|Adverse Event|5|||
126330709|NCT02121795|454505134|FG001|Double-Blind Phase|Adverse Event|0|||
126330710|NCT02121795|454505133|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
126330711|NCT02121795|454505134|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
126330712|NCT02121795|454505133|FG000|Double-Blind Phase|Protocol Violation|0|||
126330713|NCT02121795|454505134|FG001|Double-Blind Phase|Protocol Violation|3|||
126330714|NCT02121795|454505133|FG000|Double-Blind Phase|Death|1|||
126330715|NCT02121795|454505134|FG001|Double-Blind Phase|Death|1|||
126330716|NCT02121795|454505133|FG000|Open-Label Phase|Physician Decision|8|||
126330717|NCT02121795|454505134|FG001|Open-Label Phase|Physician Decision|8|||
126330718|NCT02121795|454505133|FG000|Open-Label Phase|Withdrawal by Subject|3|||
126330719|NCT02121795|454505134|FG001|Open-Label Phase|Withdrawal by Subject|2|||
126330720|NCT02121795|454505133|FG000|Open-Label Phase|Lost to Follow-up|1|||
126330721|NCT02121795|454505134|FG001|Open-Label Phase|Lost to Follow-up|0|||
126330722|NCT00666211|454505135|FG000|Overall Study|Withdrawal by Subject|10|||
126330723|NCT00666211|454505136|FG001|Overall Study|Withdrawal by Subject|13|||
126330724|NCT00666211|454505135|FG000|Overall Study|went off medication, no more pain|1|||
126330725|NCT00666211|454505136|FG001|Overall Study|went off medication, no more pain|0|||
126330726|NCT00666211|454505135|FG000|Overall Study|patient non-compliant|6|||
126330727|NCT00666211|454505136|FG001|Overall Study|patient non-compliant|6|||
126330728|NCT00666211|454505135|FG000|Overall Study|disease progression|1|||
126330729|NCT00666211|454505136|FG001|Overall Study|disease progression|8|||
126330730|NCT00666211|454505135|FG000|Overall Study|Lost to Follow-up|2|||
126330731|NCT00666211|454505136|FG001|Overall Study|Lost to Follow-up|0|||
126330732|NCT00666211|454505135|FG000|Overall Study|toxicity|0|||
126330733|NCT00666211|454505136|FG001|Overall Study|toxicity|2|||
126330734|NCT00666211|454505135|FG000|Overall Study|hospital admission|0|||
126330735|NCT00666211|454505136|FG001|Overall Study|hospital admission|5|||
126330736|NCT00666211|454505135|FG000|Overall Study|Death|0|||
126330737|NCT00666211|454505136|FG001|Overall Study|Death|2|||
126330738|NCT00666211|454505135|FG000|Overall Study|off tx for other complicating disease|0|||
126330739|NCT00666211|454505136|FG001|Overall Study|off tx for other complicating disease|1|||
126330740|NCT00666211|454505135|FG000|Overall Study|Physician Decision|0|||
126330741|NCT00666211|454505136|FG001|Overall Study|Physician Decision|1|||
126330742|NCT02609386|454505141|FG000|Overall Study|Withdrawal by Subject|6|||
126330743|NCT02609386|454505142|FG001|Overall Study|Withdrawal by Subject|1|||
126330744|NCT02609386|454505141|FG000|Overall Study|Lost to Follow-up|3|||
126661588|NCT01585987|455718116|FG001|Treated|Non-Specified|2|||
126330745|NCT02609386|454505142|FG001|Overall Study|Lost to Follow-up|5|||
126330746|NCT02609386|454505141|FG000|Overall Study|Death|19|||
126661589|NCT01585987|455718115|FG000|Treated|Subject Request|0|||
126661590|NCT01585987|455718116|FG001|Treated|Subject Request|1|||
126330747|NCT02609386|454505142|FG001|Overall Study|Death|9|||
126330748|NCT02609386|454505141|FG000|Overall Study|Physician Decision|0|||
126330749|NCT02609386|454505142|FG001|Overall Study|Physician Decision|2|||
126661591|NCT01585987|455718115|FG000|Treated|Poor/Non-Compliance|0|||
126330750|NCT02299388|454505145|FG000|Overall Study|Withdrawal by Subject|0|||
126661592|NCT01585987|455718116|FG001|Treated|Poor/Non-Compliance|1|||
126661593|NCT02041520|455718117|FG000|Overall Study|Adverse Event|2|||
126661594|NCT02041520|455718118|FG001|Overall Study|Adverse Event|1|||
126661595|NCT02041520|455718117|FG000|Overall Study|Withdrawal by Subject|3|||
126661596|NCT02041520|455718118|FG001|Overall Study|Withdrawal by Subject|4|||
126661597|NCT02041520|455718117|FG000|Overall Study|Protocol Violation|1|||
126661598|NCT02041520|455718118|FG001|Overall Study|Protocol Violation|0|||
126661599|NCT02041520|455718117|FG000|Overall Study|Lost to Follow-up|0|||
126661600|NCT02041520|455718118|FG001|Overall Study|Lost to Follow-up|1|||
126661601|NCT02041520|455718117|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
126661602|NCT02041520|455718118|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
126661603|NCT01759407|455718119|FG000|Overall Study|Protocol Violation|0|||
126661604|NCT01759407|455718120|FG001|Overall Study|Protocol Violation|2|||
126661605|NCT03737474|455718121|FG000|Overall Study|Adverse Event|18|||
126661606|NCT03737474|455718122|FG001|Overall Study|Adverse Event|48|||
126661607|NCT03737474|455718121|FG000|Overall Study|Lack of Efficacy|1|||
126661608|NCT03737474|455718122|FG001|Overall Study|Lack of Efficacy|3|||
126661609|NCT03737474|455718121|FG000|Overall Study|Protocol Violation|0|||
126661610|NCT03737474|455718122|FG001|Overall Study|Protocol Violation|8|||
126661611|NCT03737474|455718121|FG000|Overall Study|Withdrawal by Subject|5|||
126661612|NCT03737474|455718122|FG001|Overall Study|Withdrawal by Subject|20|||
126661613|NCT03737474|455718121|FG000|Overall Study|Non-compliance With Study Drug|0|||
126661614|NCT03737474|455718122|FG001|Overall Study|Non-compliance With Study Drug|1|||
126661615|NCT03737474|455718121|FG000|Overall Study|Physician Decision|1|||
126661616|NCT03737474|455718122|FG001|Overall Study|Physician Decision|4|||
126661617|NCT02513745|455718123|FG000|Overall Study|Criteria at time of surgery not met.|3|||
126661618|NCT02513745|455718124|FG001|Overall Study|Criteria at time of surgery not met.|3|||
126661619|NCT01209143|455718125|FG000|Overall Study|Adverse Event|2|||
126661620|NCT01209143|455718126|FG001|Overall Study|Adverse Event|1|||
126661621|NCT01209143|455718125|FG000|Overall Study|Death|0|||
126661622|NCT01209143|455718126|FG001|Overall Study|Death|1|||
126661623|NCT01209143|455718125|FG000|Overall Study|Physician Decision|3|||
126661624|NCT01209143|455718126|FG001|Overall Study|Physician Decision|1|||
126661625|NCT01209143|455718125|FG000|Overall Study|Lost to Follow-up|1|||
126661626|NCT01209143|455718126|FG001|Overall Study|Lost to Follow-up|0|||
126661627|NCT01209143|455718125|FG000|Overall Study|Withdrawal by Subject|2|||
126661628|NCT01209143|455718126|FG001|Overall Study|Withdrawal by Subject|1|||
126661629|NCT01209143|455718125|FG000|Overall Study|Disease progression|11|||
126661630|NCT01209143|455718126|FG001|Overall Study|Disease progression|16|||
126661631|NCT01145755|455718127|FG000|Overall Study|Adverse Event|2|||
126661632|NCT01145755|455718128|FG001|Overall Study|Adverse Event|4|||
126661633|NCT01145755|455718129|FG002|Overall Study|Adverse Event|2|||
126661634|NCT01145755|455718127|FG000|Overall Study|Withdrawal by Subject|2|||
126661635|NCT01145755|455718128|FG001|Overall Study|Withdrawal by Subject|2|||
126661636|NCT01145755|455718129|FG002|Overall Study|Withdrawal by Subject|2|||
126661637|NCT01145755|455718127|FG000|Overall Study|Lost to Follow-up|2|||
126661638|NCT01145755|455718128|FG001|Overall Study|Lost to Follow-up|3|||
126661639|NCT01145755|455718129|FG002|Overall Study|Lost to Follow-up|1|||
126661640|NCT01145755|455718127|FG000|Overall Study|Protocol Violation|0|||
126661641|NCT01145755|455718128|FG001|Overall Study|Protocol Violation|3|||
126661642|NCT01145755|455718129|FG002|Overall Study|Protocol Violation|1|||
126661643|NCT01145755|455718127|FG000|Overall Study|Study Closure|14|||
126661644|NCT01145755|455718128|FG001|Overall Study|Study Closure|14|||
126661645|NCT01145755|455718129|FG002|Overall Study|Study Closure|17|||
126661646|NCT01145755|455718127|FG000|Overall Study|Lack of Efficacy|0|||
126661647|NCT01145755|455718128|FG001|Overall Study|Lack of Efficacy|1|||
126661648|NCT01145755|455718129|FG002|Overall Study|Lack of Efficacy|0|||
126661649|NCT01145755|455718127|FG000|Overall Study|Patient could not swollow medication|0|||
126661650|NCT01145755|455718128|FG001|Overall Study|Patient could not swollow medication|0|||
126661651|NCT01145755|455718129|FG002|Overall Study|Patient could not swollow medication|1|||
126661652|NCT01145755|455718127|FG000|Overall Study|Withdrawal by Subject|0|||
126661653|NCT01145755|455718128|FG001|Overall Study|Withdrawal by Subject|0|||
126661654|NCT01145755|455718129|FG002|Overall Study|Withdrawal by Subject|1|||
126661655|NCT01145755|455718127|FG000|Overall Study|Positive urine ethanol|0|||
126661656|NCT01145755|455718128|FG001|Overall Study|Positive urine ethanol|1|||
126661657|NCT01145755|455718129|FG002|Overall Study|Positive urine ethanol|0|||
126661658|NCT02092220|455718135|FG000|Period 1|Unrelated Illness|0|||
126661659|NCT02092220|455718136|FG001|Period 1|Unrelated Illness|2|||
126661660|NCT02092220|455718135|FG000|Period 2|Severe Hypoglycaemia|1|||
126661661|NCT02092220|455718136|FG001|Period 2|Severe Hypoglycaemia|0|||
126661662|NCT02092220|455718135|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
126661663|NCT02092220|455718136|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
126661664|NCT02739360|455718137|FG000|Overall Study|Adverse Event|1|||
126661665|NCT02739360|455718137|FG000|Overall Study|Study terminated by Sponsor|2|||
126661666|NCT01193920|455718138|FG000|Overall Study|Withdrawal by Subject|1|||
126661667|NCT01193920|455718139|FG001|Overall Study|Withdrawal by Subject|0|||
126661668|NCT01193920|455718140|FG002|Overall Study|Withdrawal by Subject|5|||
126661669|NCT01193920|455718141|FG003|Overall Study|Withdrawal by Subject|1|||
126661670|NCT01193920|455718142|FG004|Overall Study|Withdrawal by Subject|3|||
126661671|NCT01193920|455718143|FG005|Overall Study|Withdrawal by Subject|1|||
126661672|NCT01193920|455718144|FG006|Overall Study|Withdrawal by Subject|3|||
126661673|NCT01193920|455718145|FG007|Overall Study|Withdrawal by Subject|0|||
126661674|NCT01193920|455718146|FG008|Overall Study|Withdrawal by Subject|1|||
126661675|NCT01193920|455718147|FG009|Overall Study|Withdrawal by Subject|0|||
126661676|NCT01193920|455718138|FG000|Overall Study|Lost to Follow-up|1|||
126661677|NCT01193920|455718139|FG001|Overall Study|Lost to Follow-up|0|||
126661678|NCT01193920|455718140|FG002|Overall Study|Lost to Follow-up|1|||
126661679|NCT01193920|455718141|FG003|Overall Study|Lost to Follow-up|1|||
126330751|NCT02299388|454505146|FG001|Overall Study|Withdrawal by Subject|1|||
126330752|NCT03334188|454505150|FG000|Overall Study|Withdrawal by Subject|0|||
126661680|NCT01193920|455718142|FG004|Overall Study|Lost to Follow-up|3|||
126661681|NCT01193920|455718143|FG005|Overall Study|Lost to Follow-up|3|||
126661682|NCT01193920|455718144|FG006|Overall Study|Lost to Follow-up|1|||
126661683|NCT01193920|455718145|FG007|Overall Study|Lost to Follow-up|0|||
126661684|NCT01193920|455718146|FG008|Overall Study|Lost to Follow-up|2|||
126661685|NCT01193920|455718147|FG009|Overall Study|Lost to Follow-up|3|||
126661686|NCT01193920|455718138|FG000|Overall Study|Protocol Violation|1|||
126661687|NCT01193920|455718139|FG001|Overall Study|Protocol Violation|0|||
126661688|NCT01193920|455718140|FG002|Overall Study|Protocol Violation|0|||
126661689|NCT01193920|455718141|FG003|Overall Study|Protocol Violation|0|||
126661690|NCT01193920|455718142|FG004|Overall Study|Protocol Violation|0|||
126661691|NCT01193920|455718143|FG005|Overall Study|Protocol Violation|0|||
126661692|NCT01193920|455718144|FG006|Overall Study|Protocol Violation|0|||
126661693|NCT01193920|455718145|FG007|Overall Study|Protocol Violation|0|||
126661694|NCT01193920|455718146|FG008|Overall Study|Protocol Violation|0|||
126661695|NCT01193920|455718147|FG009|Overall Study|Protocol Violation|0|||
126661696|NCT01193920|455718138|FG000|Overall Study|Death|0|||
126661697|NCT01193920|455718139|FG001|Overall Study|Death|0|||
126661698|NCT01193920|455718140|FG002|Overall Study|Death|0|||
126661699|NCT01193920|455718141|FG003|Overall Study|Death|1|||
126661700|NCT01193920|455718142|FG004|Overall Study|Death|0|||
126661701|NCT01193920|455718143|FG005|Overall Study|Death|0|||
126661702|NCT01193920|455718144|FG006|Overall Study|Death|2|||
126661703|NCT01193920|455718145|FG007|Overall Study|Death|3|||
126661704|NCT01193920|455718146|FG008|Overall Study|Death|2|||
126661705|NCT01193920|455718147|FG009|Overall Study|Death|4|||
126661706|NCT01193920|455718138|FG000|Overall Study|Unable to classify|0|||
126661707|NCT01193920|455718139|FG001|Overall Study|Unable to classify|0|||
126661708|NCT01193920|455718140|FG002|Overall Study|Unable to classify|0|||
126661709|NCT01193920|455718141|FG003|Overall Study|Unable to classify|1|||
126661710|NCT01193920|455718142|FG004|Overall Study|Unable to classify|0|||
126661711|NCT01193920|455718143|FG005|Overall Study|Unable to classify|0|||
126661712|NCT01193920|455718144|FG006|Overall Study|Unable to classify|0|||
126661713|NCT01193920|455718145|FG007|Overall Study|Unable to classify|1|||
126661714|NCT01193920|455718146|FG008|Overall Study|Unable to classify|0|||
126661715|NCT01193920|455718147|FG009|Overall Study|Unable to classify|0|||
126661716|NCT01231516|455718150|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
126661717|NCT01231516|455718151|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
126661718|NCT01231516|455718150|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
126661719|NCT01231516|455718151|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
126661720|NCT01231516|455718150|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
126661721|NCT01231516|455718151|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
126661722|NCT01231516|455718150|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
126661723|NCT01231516|455718151|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
126330753|NCT03334188|454505151|FG001|Overall Study|Withdrawal by Subject|1|||
126330754|NCT03334188|454505150|FG000|Overall Study|Death|1|||
126330755|NCT03334188|454505151|FG001|Overall Study|Death|0|||
126330756|NCT03334188|454505150|FG000|Overall Study|Never had qualifying clinic visit|7|||
126330757|NCT03334188|454505151|FG001|Overall Study|Never had qualifying clinic visit|7|||
126330758|NCT03373760|454505154|FG000|Overall Study|Adverse Event|8|||
126330759|NCT03373760|454505154|FG000|Overall Study|Disease Progression|46|||
126330760|NCT03373760|454505154|FG000|Overall Study|Death|4|||
126330761|NCT01093586|454505155|FG000|Overall Study|Failed to engraft|3|||
126330762|NCT03442088|454505156|FG000|Overall Study|Adverse Event|1|||
126330763|NCT03442088|454505156|FG000|Overall Study|Lack of Efficacy|2|||
126330764|NCT03442088|454505156|FG000|Overall Study|Lost to Follow-up|2|||
126330765|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
126330766|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
126330767|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
126661724|NCT01231516|455718150|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
126661725|NCT01231516|455718151|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
126661726|NCT01231516|455718150|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
126661727|NCT01231516|455718151|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
126661728|NCT01231516|455718150|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
126661729|NCT01231516|455718151|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
126661730|NCT01231516|455718150|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
126661731|NCT01231516|455718151|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
126661732|NCT01231516|455718150|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
126661733|NCT01231516|455718151|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
126661734|NCT01231516|455718150|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
126661735|NCT01231516|455718151|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
126661736|NCT01231516|455718150|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
126661737|NCT01231516|455718151|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
126661738|NCT01231516|455718150|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
126661739|NCT01231516|455718151|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
126661740|NCT01231516|455718150|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
126661741|NCT01231516|455718151|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
126661742|NCT01231516|455718150|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
126661743|NCT01231516|455718151|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
126661744|NCT01231516|455718150|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
126661745|NCT01231516|455718151|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
126661746|NCT01231516|455718150|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
126661747|NCT01231516|455718151|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
126661748|NCT03170154|455718152|FG000|Overall Study|Lost to Follow-up|4|||
126661749|NCT03170154|455718152|FG000|Overall Study|Death|2|||
126661750|NCT03170154|455718152|FG000|Overall Study|Withdrawal by Subject|2|||
126661751|NCT00026208|455718153|FG000|Overall Study|Complications of auto accident|1|||
126661752|NCT00026208|455718154|FG001|Overall Study|Complications of auto accident|0|||
126661753|NCT05266586|455718155|FG000|Overall Study|Adverse Event|2|||
126661754|NCT05266586|455718156|FG001|Overall Study|Adverse Event|2|||
126661755|NCT05266586|455718157|FG002|Overall Study|Adverse Event|1|||
126661756|NCT05266586|455718155|FG000|Overall Study|Withdrawal by Subject|1|||
126661757|NCT05266586|455718156|FG001|Overall Study|Withdrawal by Subject|0|||
126661758|NCT05266586|455718157|FG002|Overall Study|Withdrawal by Subject|1|||
126661759|NCT05266586|455718155|FG000|Overall Study|Non-compliance with study drug|0|||
126661760|NCT05266586|455718156|FG001|Overall Study|Non-compliance with study drug|1|||
126661761|NCT05266586|455718157|FG002|Overall Study|Non-compliance with study drug|0|||
126661762|NCT05266586|455718155|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
126661763|NCT05266586|455718156|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
126661764|NCT05266586|455718157|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
126661765|NCT02225353|455718158|FG000|Overall Study|Lost to Follow-up|0|||
126330768|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
126330769|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
126330770|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
126330771|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
126330772|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
126330773|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
126330774|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
126330775|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
126330776|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
126330777|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
126330778|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
126330779|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Death|1|||
126330780|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Death|0|||
126330781|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
126330782|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
126330783|NCT00105989|454505157|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
126330784|NCT00105989|454505158|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
126330785|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
126330786|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
126330787|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
126330788|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
126330789|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
126330790|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
126330791|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
126330792|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
126330793|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
126330794|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
126330795|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
126330796|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
126330797|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
126661766|NCT02225353|455718159|FG001|Overall Study|Lost to Follow-up|1|||
126330798|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
126330799|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Death|0|||
126330800|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Death|0|||
126330801|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
126661767|NCT02225353|455718160|FG002|Overall Study|Lost to Follow-up|3|||
126661768|NCT02225353|455718158|FG000|Overall Study|Protocol Violation|4|||
126661769|NCT02225353|455718159|FG001|Overall Study|Protocol Violation|5|||
126661770|NCT02225353|455718160|FG002|Overall Study|Protocol Violation|12|||
126661771|NCT01117857|455718161|FG000|Overall Study|Lost to Follow-up|4|||
126661772|NCT01117857|455718161|FG000|Overall Study|Withdrawal by Subject|4|||
126661773|NCT01117857|455718161|FG000|Overall Study|Physician Decision|1|||
126661774|NCT01675479|455718162|FG000|Overall Study|Lost to Follow-up|11|||
126661775|NCT01696942|455718166|FG000|Overall Study|Withdrawal by Subject|1|||
126661776|NCT01696942|455718167|FG001|Overall Study|Withdrawal by Subject|0|||
126661777|NCT01696942|455718166|FG000|Overall Study|Protocol Violation|1|||
126661778|NCT01696942|455718167|FG001|Overall Study|Protocol Violation|2|||
126661779|NCT01696942|455718166|FG000|Overall Study|screen failure|0|||
126661780|NCT01696942|455718167|FG001|Overall Study|screen failure|1|||
126661781|NCT01313117|455718168|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
126661782|NCT01313117|455718168|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
126661783|NCT03226275|455718169|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
126661784|NCT03226275|455718170|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
126661785|NCT03226275|455718171|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
126661786|NCT03226275|455718172|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
126661787|NCT03226275|455718169|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
126661788|NCT03226275|455718170|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
126661789|NCT03226275|455718171|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
126661790|NCT03226275|455718172|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
126661791|NCT03442114|455718173|FG000|Overall Study|Lost to Follow-up|13|||
126661792|NCT03442114|455718174|FG001|Overall Study|Lost to Follow-up|13|||
126661793|NCT03442114|455718173|FG000|Overall Study|Physician Decision|2|||
126661794|NCT03442114|455718174|FG001|Overall Study|Physician Decision|2|||
126661795|NCT03442114|455718173|FG000|Overall Study|Protocol Violation|0|||
126661796|NCT03442114|455718174|FG001|Overall Study|Protocol Violation|2|||
126661797|NCT03442114|455718173|FG000|Overall Study|Withdrawal by Subject|1|||
126661798|NCT03442114|455718174|FG001|Overall Study|Withdrawal by Subject|3|||
126661799|NCT03442114|455718173|FG000|Overall Study|Guardianship Change|0|||
126661800|NCT03442114|455718174|FG001|Overall Study|Guardianship Change|1|||
126661801|NCT01101477|455721164|FG000|Overall Study|Protocol Violation|5|||
126661802|NCT01101477|455721165|FG001|Overall Study|Protocol Violation|3|||
126661803|NCT01101477|455721166|FG002|Overall Study|Protocol Violation|1|||
126661804|NCT02382016|455721167|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
126661805|NCT02382016|455721168|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
126661806|NCT02382016|455721167|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
126661807|NCT02382016|455721168|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
126661808|NCT02382016|455721167|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
126661809|NCT02382016|455721168|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
126661810|NCT02382016|455721167|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
126661811|NCT02382016|455721168|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
126661812|NCT02382016|455721167|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
126661813|NCT02382016|455721168|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
126661814|NCT02382016|455721167|FG000|Open-label (OL) Treatment Period|Death|4|||
126661815|NCT02382016|455721168|FG001|Open-label (OL) Treatment Period|Death|0|||
126661816|NCT02382016|455721167|FG000|OL Extension Period|Physician Decision|3|||
126661817|NCT02382016|455721168|FG001|OL Extension Period|Physician Decision|0|||
126661818|NCT02382016|455721167|FG000|OL Extension Period|Death|2|||
126661819|NCT02382016|455721168|FG001|OL Extension Period|Death|0|||
126661820|NCT02382016|455721167|FG000|OL Extension Period|Withdrawal by Subject|1|||
126330802|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
126330803|NCT00105989|454505157|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
126330804|NCT00105989|454505158|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
126330805|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
126330806|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
126330807|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
126330808|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
126330809|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
126661821|NCT02382016|455721168|FG001|OL Extension Period|Withdrawal by Subject|0|||
126661822|NCT00084266|455721169|FG000|Overall Study|Death|42|||
126661823|NCT00084266|455721170|FG001|Overall Study|Death|39|||
126661824|NCT00084266|455721169|FG000|Overall Study|Adverse Event|8|||
126661825|NCT00084266|455721170|FG001|Overall Study|Adverse Event|5|||
126661826|NCT00084266|455721169|FG000|Overall Study|Lack of Efficacy|2|||
126661827|NCT00084266|455721170|FG001|Overall Study|Lack of Efficacy|4|||
126661828|NCT00084266|455721169|FG000|Overall Study|Lost to Follow-up|5|||
126661829|NCT00084266|455721170|FG001|Overall Study|Lost to Follow-up|3|||
126661830|NCT00084266|455721169|FG000|Overall Study|Participant not willing to participate|3|||
126661831|NCT00084266|455721170|FG001|Overall Study|Participant not willing to participate|8|||
126661832|NCT00084266|455721169|FG000|Overall Study|Other|360|||
126661833|NCT00084266|455721170|FG001|Overall Study|Other|344|||
126661834|NCT00084266|455721169|FG000|Overall Study|Randomized not treated|21|||
126661835|NCT00084266|455721170|FG001|Overall Study|Randomized not treated|20|||
126661836|NCT00730171|455721171|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
126661837|NCT00730171|455721171|FG000|Overall Study|Adverse Event|193|||
126661838|NCT00730171|455721171|FG000|Overall Study|Protocol Violation|48|||
126661839|NCT00730171|455721171|FG000|Overall Study|Withdrawal by Subject|202|||
126661840|NCT00730171|455721171|FG000|Overall Study|Lost to Follow-up|121|||
126661841|NCT00730171|455721171|FG000|Overall Study|Insufficient Therapeutic Response|141|||
126661842|NCT00730171|455721171|FG000|Overall Study|Other|61|||
126661843|NCT01729156|455721172|FG000|Overall Study|Withdrawal by Subject|1|||
126661844|NCT01729156|455721173|FG001|Overall Study|Withdrawal by Subject|0|||
126661845|NCT01729156|455721174|FG002|Overall Study|Withdrawal by Subject|0|||
126661846|NCT02544217|455721175|FG000|Overall Study|Withdrawal by Subject|1|||
126661847|NCT02544217|455721176|FG001|Overall Study|Withdrawal by Subject|1|||
126661848|NCT02544217|455721177|FG002|Overall Study|Withdrawal by Subject|0|||
126661849|NCT02544217|455721178|FG003|Overall Study|Withdrawal by Subject|0|||
126661850|NCT02544217|455721179|FG004|Overall Study|Withdrawal by Subject|0|||
126661851|NCT02544217|455721180|FG005|Overall Study|Withdrawal by Subject|0|||
126661852|NCT02901041|455721183|FG000|Overall Study|Withdrawal by PI|4|||
126661853|NCT02901041|455721184|FG001|Overall Study|Withdrawal by PI|8|||
126661854|NCT02901041|455721183|FG000|Overall Study|Withdrawal by Subject|7|||
126661855|NCT02901041|455721184|FG001|Overall Study|Withdrawal by Subject|3|||
126661856|NCT00975507|455721188|FG000|Overall Study|Adverse Event|1|||
126661857|NCT00975507|455721189|FG001|Overall Study|Adverse Event|0|||
126661858|NCT00975507|455721188|FG000|Overall Study|Lost to Follow-up|7|||
126661859|NCT00975507|455721189|FG001|Overall Study|Lost to Follow-up|1|||
126661860|NCT00975507|455721188|FG000|Overall Study|Protocol Violation|2|||
126661861|NCT00975507|455721189|FG001|Overall Study|Protocol Violation|0|||
126661862|NCT00975507|455721188|FG000|Overall Study|Withdrawal by Subject|10|||
126661863|NCT00975507|455721189|FG001|Overall Study|Withdrawal by Subject|3|||
126661864|NCT01112306|455721192|FG000|Overall Study|Death|175|||
126661865|NCT01112306|455721192|FG000|Overall Study|Lost to Follow-up|9|||
126661866|NCT01112306|455721192|FG000|Overall Study|Withdrawal by Subject|31|||
126661867|NCT01112306|455721192|FG000|Overall Study|Other|70|||
126661868|NCT03952806|455721194|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
126661869|NCT03952806|455721195|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
126330810|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
126330811|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
126330812|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
126330813|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
126330814|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
126330815|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
126330816|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
126330817|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
126330818|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
126330819|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
126330820|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
126330821|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
126330822|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
126330823|NCT00105989|454505157|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
126330824|NCT00105989|454505158|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
126330825|NCT00357877|454505159|FG000|Overall Study|Death|2|||
126330826|NCT00357877|454505160|FG001|Overall Study|Death|1|||
126330827|NCT00357877|454505159|FG000|Overall Study|Lost to Follow-up|20|||
126330828|NCT00357877|454505160|FG001|Overall Study|Lost to Follow-up|23|||
126330829|NCT00357877|454505159|FG000|Overall Study|Withdrawal by Subject|3|||
126330830|NCT00357877|454505160|FG001|Overall Study|Withdrawal by Subject|3|||
126330831|NCT00357877|454505159|FG000|Overall Study|Administrative withdrawal|1|||
126661870|NCT03952806|455721194|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
126661871|NCT03952806|455721195|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
126661872|NCT03952806|455721194|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
126661873|NCT03952806|455721195|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
126661874|NCT03952806|455721194|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
126661875|NCT03952806|455721195|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
126330832|NCT00357877|454505160|FG001|Overall Study|Administrative withdrawal|1|||
126661876|NCT03952806|455721194|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
126661877|NCT03952806|455721195|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
126661878|NCT03952806|455721194|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
126661879|NCT03952806|455721195|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
126661880|NCT03952806|455721194|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
126661881|NCT03952806|455721195|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
126661882|NCT03952806|455721194|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
126661883|NCT03952806|455721195|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
126661884|NCT03952806|455721194|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
126661885|NCT03952806|455721195|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
126661886|NCT03952806|455721194|FG000|OLE Phase (48 Weeks)|Other|16|||
126661887|NCT03952806|455721195|FG001|OLE Phase (48 Weeks)|Other|13|||
126661888|NCT00655863|455721196|FG000|Overall Study|Lost to Follow-up|0|||
126661889|NCT00655863|455721197|FG001|Overall Study|Lost to Follow-up|0|||
126661890|NCT00655863|455721198|FG002|Overall Study|Lost to Follow-up|1|||
126661891|NCT01138007|455721199|FG000|Overall Study|Adverse Event|4|||
126661892|NCT01138007|455721200|FG001|Overall Study|Adverse Event|12|||
126330833|NCT00357877|454505159|FG000|Overall Study|Other|0|||
126330834|NCT00357877|454505160|FG001|Overall Study|Other|2|||
126330835|NCT04668209|454505161|FG000|Overall Study|Withdrawal by Subject|2|||
126330836|NCT04668209|454505162|FG001|Overall Study|Withdrawal by Subject|2|||
126330837|NCT04668209|454505161|FG000|Overall Study|Lost to Follow-up|3|||
126330838|NCT04668209|454505162|FG001|Overall Study|Lost to Follow-up|4|||
126330839|NCT04668209|454505161|FG000|Overall Study|Subject Expired|2|||
126330840|NCT04668209|454505162|FG001|Overall Study|Subject Expired|0|||
126330841|NCT04668209|454505161|FG000|Overall Study|Withdrawn from study|0|||
126330842|NCT04668209|454505162|FG001|Overall Study|Withdrawn from study|1|||
126330843|NCT04668209|454505161|FG000|Overall Study|Adverse Event|0|||
126661893|NCT01138007|455721201|FG002|Overall Study|Adverse Event|9|||
126661894|NCT01138007|455721199|FG000|Overall Study|Lack of Efficacy|2|||
126661895|NCT01138007|455721200|FG001|Overall Study|Lack of Efficacy|0|||
126661896|NCT01138007|455721201|FG002|Overall Study|Lack of Efficacy|6|||
126661897|NCT01138007|455721199|FG000|Overall Study|Protocol Violation|2|||
126661898|NCT01138007|455721200|FG001|Overall Study|Protocol Violation|3|||
126661899|NCT01138007|455721201|FG002|Overall Study|Protocol Violation|2|||
126661900|NCT01138007|455721199|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
126661901|NCT01138007|455721200|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
126661902|NCT01138007|455721201|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
126661903|NCT01138007|455721199|FG000|Overall Study|Lost to Follow-up|3|||
126661904|NCT01138007|455721200|FG001|Overall Study|Lost to Follow-up|3|||
126661905|NCT01138007|455721201|FG002|Overall Study|Lost to Follow-up|5|||
126661906|NCT01138007|455721199|FG000|Overall Study|Physician Decision|0|||
126661907|NCT01138007|455721200|FG001|Overall Study|Physician Decision|5|||
126661908|NCT01138007|455721201|FG002|Overall Study|Physician Decision|3|||
126661909|NCT01138007|455721199|FG000|Overall Study|Withdrawal by Subject|5|||
126661910|NCT01138007|455721200|FG001|Overall Study|Withdrawal by Subject|6|||
126661911|NCT01138007|455721201|FG002|Overall Study|Withdrawal by Subject|15|||
126661912|NCT04661878|455721202|FG000|Overall Study|Lost to Follow-up|6|||
126661913|NCT04661878|455721203|FG001|Overall Study|Lost to Follow-up|5|||
126661914|NCT04442737|455721208|FG000|Overall Study|Lost to Follow-up|1|||
126661915|NCT04442737|455721209|FG001|Overall Study|Lost to Follow-up|3|||
126661916|NCT04442737|455721208|FG000|Overall Study|Withdrawal by Subject|3|||
126661917|NCT04442737|455721209|FG001|Overall Study|Withdrawal by Subject|2|||
126661918|NCT04442737|455721208|FG000|Overall Study|Adverse Event|3|||
126661919|NCT04442737|455721209|FG001|Overall Study|Adverse Event|2|||
126661920|NCT04442737|455721208|FG000|Overall Study|Death|0|||
126661921|NCT04442737|455721209|FG001|Overall Study|Death|1|||
126661922|NCT04442737|455721208|FG000|Overall Study|Protocol Violation|0|||
126661923|NCT04442737|455721209|FG001|Overall Study|Protocol Violation|2|||
126661924|NCT04442737|455721208|FG000|Overall Study|Other|1|||
126661925|NCT04442737|455721209|FG001|Overall Study|Other|1|||
126330844|NCT04668209|454505162|FG001|Overall Study|Adverse Event|1|||
126330845|NCT01869777|454505169|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
126661926|NCT00744523|455721210|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
126330846|NCT00613366|454505172|FG000|Overall Study|Withdrawal by Subject|3|||
126330847|NCT00613366|454505173|FG001|Overall Study|Withdrawal by Subject|2|||
126661927|NCT00744523|455721211|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
126661928|NCT05333224|455721215|FG000|Overall Study - Infants|Lost to Follow-up|1|||
126661929|NCT05333224|455721216|FG001|Overall Study - Infants|Lost to Follow-up|1|||
126661930|NCT00063154|455721217|FG000|Overall Study|Disease progression|27|||
126661931|NCT00063154|455721217|FG000|Overall Study|Adverse Event|2|||
126661932|NCT00063154|455721217|FG000|Overall Study|Physician Decision|10|||
126661933|NCT00063154|455721217|FG000|Overall Study|Death|3|||
126661934|NCT00063154|455721217|FG000|Overall Study|Reason unspecified|1|||
126330848|NCT00766597|454505174|FG000|Overall Study|Unexpected closure of study|4|||
126661935|NCT00063154|455721217|FG000|Overall Study|Did not receive treatment|8|||
126661936|NCT03588728|455721218|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
126661937|NCT03588728|455721219|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
126661938|NCT03588728|455721220|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
126661939|NCT03588728|455721221|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
126661940|NCT03588728|455721218|FG000|Overall Study|Lab shut down due to COVID-19|0|||
126661941|NCT03588728|455721219|FG001|Overall Study|Lab shut down due to COVID-19|0|||
126661942|NCT03588728|455721220|FG002|Overall Study|Lab shut down due to COVID-19|0|||
126661943|NCT03588728|455721221|FG003|Overall Study|Lab shut down due to COVID-19|1|||
126661944|NCT03588728|455721218|FG000|Overall Study|multiple technical issues|1|||
126661945|NCT03588728|455721219|FG001|Overall Study|multiple technical issues|0|||
126661946|NCT03588728|455721220|FG002|Overall Study|multiple technical issues|0|||
126661947|NCT03588728|455721221|FG003|Overall Study|multiple technical issues|0|||
126661948|NCT03588728|455721218|FG000|Overall Study|Hospitalized for COVID|1|||
126661949|NCT03588728|455721219|FG001|Overall Study|Hospitalized for COVID|0|||
126661950|NCT03588728|455721220|FG002|Overall Study|Hospitalized for COVID|0|||
126661951|NCT03588728|455721221|FG003|Overall Study|Hospitalized for COVID|0|||
126661952|NCT03588728|455721218|FG000|Overall Study|Schedule change unable to attend sessions|1|||
126661953|NCT03588728|455721219|FG001|Overall Study|Schedule change unable to attend sessions|0|||
126661954|NCT03588728|455721220|FG002|Overall Study|Schedule change unable to attend sessions|0|||
126661955|NCT03588728|455721221|FG003|Overall Study|Schedule change unable to attend sessions|0|||
126661956|NCT02027701|455721222|FG000|Overall Study|Adverse Event|3|||
126661957|NCT02027701|455721222|FG000|Overall Study|Lack of Efficacy|8|||
126661958|NCT02027701|455721222|FG000|Overall Study|Physician Decision|2|||
126661959|NCT02027701|455721222|FG000|Overall Study|Withdrawal by Subject|3|||
126661960|NCT03285178|455721223|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
126661961|NCT03285178|455721224|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
126661962|NCT03285178|455721225|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
126661963|NCT03285178|455721226|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
126661964|NCT03285178|455721227|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
126661965|NCT03285178|455721228|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
126661966|NCT03285178|455721229|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
126661967|NCT03285178|455721223|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
126661968|NCT03285178|455721224|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
126661969|NCT03285178|455721225|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
126661970|NCT03285178|455721226|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
126661971|NCT03285178|455721227|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
126661972|NCT03285178|455721228|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
126661973|NCT03285178|455721229|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
126661974|NCT03285178|455721223|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
126661975|NCT03285178|455721224|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
126661976|NCT03285178|455721225|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
126661977|NCT03285178|455721226|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
126661978|NCT03285178|455721227|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
126661979|NCT03285178|455721228|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
126661980|NCT03285178|455721229|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
126661981|NCT03285178|455721223|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
126661982|NCT03285178|455721224|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
126661983|NCT03285178|455721225|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
126661984|NCT03285178|455721226|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
126661985|NCT03285178|455721227|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
126661986|NCT03285178|455721228|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
126661987|NCT03285178|455721229|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
126661988|NCT03285178|455721223|FG000|Single-Blind Run-In Period|Physician Decision|2|||
126661989|NCT03285178|455721224|FG001|Single-Blind Run-In Period|Physician Decision|0|||
126661990|NCT03285178|455721225|FG002|Single-Blind Run-In Period|Physician Decision|0|||
126661991|NCT03285178|455721226|FG003|Single-Blind Run-In Period|Physician Decision|0|||
126661992|NCT03285178|455721227|FG004|Single-Blind Run-In Period|Physician Decision|0|||
126661993|NCT03285178|455721228|FG005|Single-Blind Run-In Period|Physician Decision|0|||
126661994|NCT03285178|455721229|FG006|Single-Blind Run-In Period|Physician Decision|0|||
126661995|NCT03285178|455721223|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
126661996|NCT03285178|455721224|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
126661997|NCT03285178|455721225|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
126661998|NCT03285178|455721226|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
126661999|NCT03285178|455721227|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
126662000|NCT03285178|455721228|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
126662001|NCT03285178|455721229|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
126662002|NCT03285178|455721223|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126662003|NCT03285178|455721224|FG001|Double-Blind Treatment Period|Adverse Event|0|||
126662004|NCT03285178|455721225|FG002|Double-Blind Treatment Period|Adverse Event|0|||
126662005|NCT03285178|455721226|FG003|Double-Blind Treatment Period|Adverse Event|0|||
126662006|NCT03285178|455721227|FG004|Double-Blind Treatment Period|Adverse Event|0|||
126662007|NCT03285178|455721228|FG005|Double-Blind Treatment Period|Adverse Event|0|||
126662008|NCT03285178|455721229|FG006|Double-Blind Treatment Period|Adverse Event|2|||
126662009|NCT03285178|455721223|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126662010|NCT03285178|455721224|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
126662011|NCT03285178|455721225|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
126662012|NCT03285178|455721226|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
126662013|NCT03285178|455721227|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
126662014|NCT03285178|455721228|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
126662015|NCT03285178|455721229|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
126662016|NCT03285178|455721223|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126662017|NCT03285178|455721224|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126662018|NCT03285178|455721225|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126662019|NCT03285178|455721226|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126662020|NCT03285178|455721227|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126662021|NCT03285178|455721228|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126662022|NCT03285178|455721229|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126662023|NCT03285178|455721223|FG000|Double-Blind Treatment Period|COVID-19|0|||
126662024|NCT03285178|455721224|FG001|Double-Blind Treatment Period|COVID-19|0|||
126662025|NCT03285178|455721225|FG002|Double-Blind Treatment Period|COVID-19|1|||
126662026|NCT03285178|455721226|FG003|Double-Blind Treatment Period|COVID-19|0|||
126662027|NCT03285178|455721227|FG004|Double-Blind Treatment Period|COVID-19|0|||
126662028|NCT03285178|455721228|FG005|Double-Blind Treatment Period|COVID-19|0|||
126662029|NCT03285178|455721229|FG006|Double-Blind Treatment Period|COVID-19|0|||
126662030|NCT01388790|455721230|FG000|Overall Study|Ongoing at data cut-off date|8|||
126662031|NCT01128894|455721231|FG000|Overall Study|Adverse Event|31|||
126662032|NCT01128894|455721232|FG001|Overall Study|Adverse Event|41|||
126662033|NCT01128894|455721231|FG000|Overall Study|Protocol Violation|2|||
126662034|NCT01128894|455721232|FG001|Overall Study|Protocol Violation|1|||
126662035|NCT01128894|455721231|FG000|Overall Study|Noncompliance|4|||
126662036|NCT01128894|455721232|FG001|Overall Study|Noncompliance|5|||
126662037|NCT01128894|455721231|FG000|Overall Study|Lost to Follow-up|8|||
126662038|NCT01128894|455721232|FG001|Overall Study|Lost to Follow-up|8|||
126662039|NCT01128894|455721231|FG000|Overall Study|Withdrawal by Subject|10|||
126662040|NCT01128894|455721232|FG001|Overall Study|Withdrawal by Subject|12|||
126662041|NCT01128894|455721231|FG000|Overall Study|Physician Decision|2|||
126662042|NCT01128894|455721232|FG001|Overall Study|Physician Decision|1|||
126662043|NCT01128894|455721231|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
126662044|NCT01128894|455721232|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
126662045|NCT00195507|455721233|FG000|Overall Study|Adverse Event|24|||
126662046|NCT00195507|455721234|FG001|Overall Study|Adverse Event|13|||
126662047|NCT00195507|455721233|FG000|Overall Study|Death|0|||
126662048|NCT00195507|455721234|FG001|Overall Study|Death|1|||
126662049|NCT00195507|455721233|FG000|Overall Study|Failed to Return|4|||
126662050|NCT00195507|455721234|FG001|Overall Study|Failed to Return|3|||
126662051|NCT00195507|455721233|FG000|Overall Study|Physician Decision|1|||
126662052|NCT00195507|455721234|FG001|Overall Study|Physician Decision|2|||
126662053|NCT00195507|455721233|FG000|Overall Study|Lost to Follow-up|3|||
126662054|NCT00195507|455721234|FG001|Overall Study|Lost to Follow-up|2|||
126662055|NCT00195507|455721233|FG000|Overall Study|Protocol Violation|5|||
126662056|NCT00195507|455721234|FG001|Overall Study|Protocol Violation|4|||
126662057|NCT00195507|455721233|FG000|Overall Study|Lack of Efficacy|40|||
126662058|NCT00195507|455721234|FG001|Overall Study|Lack of Efficacy|67|||
126662059|NCT00195507|455721233|FG000|Overall Study|Withdrawal by Subject|16|||
126662060|NCT00195507|455721234|FG001|Overall Study|Withdrawal by Subject|23|||
126662061|NCT00195507|455721233|FG000|Overall Study|Protocol Deviation|6|||
126662062|NCT00195507|455721234|FG001|Overall Study|Protocol Deviation|3|||
126662063|NCT00973362|455721235|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
126662064|NCT00973362|455721236|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
126662065|NCT00973362|455721235|FG000|Baseline Evaluation|No colposcopy visit|62|||
126662066|NCT00973362|455721236|FG001|Baseline Evaluation|No colposcopy visit|0|||
126662067|NCT00973362|455721235|FG000|Baseline Evaluation|Inevaluable|686|||
126662068|NCT00973362|455721236|FG001|Baseline Evaluation|Inevaluable|223|||
126662069|NCT00973362|455721235|FG000|3-Year Follow-up|Lost to Follow-up|17|||
126662070|NCT00973362|455721236|FG001|3-Year Follow-up|Lost to Follow-up|0|||
126662071|NCT00887679|455721237|FG000|Overall Study|Withdrawal by Subject|1|||
126662072|NCT00887679|455721237|FG000|Overall Study|Lost to Follow-up|4|||
126330849|NCT00766597|454505174|FG000|Overall Study|Without CCR5-tropic virus|5|||
126330850|NCT01135524|454505178|FG000|Overall Study|Withdrawal by Subject|14|||
126330851|NCT01135524|454505178|FG000|Overall Study|Adverse Event|20|||
126330852|NCT01135524|454505178|FG000|Overall Study|Lost to Follow-up|3|||
126330853|NCT01135524|454505178|FG000|Overall Study|Administrative|151|||
126330854|NCT01135524|454505178|FG000|Overall Study|Lack of Efficacy|8|||
126330855|NCT03318003|454505179|FG000|Overall Study|Withdrawal by Subject|1|||
126662073|NCT00887679|455721237|FG000|Overall Study|Physician Decision|5|||
126662074|NCT01630434|455721244|FG000|Overall Study|Donor lungs turned down|1|||
126662075|NCT01630434|455721245|FG001|Overall Study|Donor lungs turned down|0|||
126662076|NCT01630434|455721244|FG000|Overall Study|Protocol Violation|9|||
126330856|NCT03318003|454505180|FG001|Overall Study|Withdrawal by Subject|1|||
126330857|NCT03318003|454505179|FG000|Overall Study|fetal loss|0|||
126330858|NCT03318003|454505180|FG001|Overall Study|fetal loss|1|||
126330859|NCT02907463|454505182|FG000|Overall Study|Lost to Follow-up|17|||
126330860|NCT02907463|454505182|FG000|Overall Study|Death|10|||
126330861|NCT02907463|454505182|FG000|Overall Study|Withdrawal by Subject|4|||
126330862|NCT02907463|454505182|FG000|Overall Study|MIS Approach was not used|2|||
126330863|NCT02907463|454505182|FG000|Overall Study|Not Implanted with Study Device|2|||
126330864|NCT02907463|454505182|FG000|Overall Study|Device Explanted|1|||
126330865|NCT02907463|454505182|FG000|Overall Study|Missing Exit Form|1|||
126330866|NCT01716663|454505183|FG000|Overall Study|Withdrawn prior to procedure|4|||
126330867|NCT01716663|454505183|FG000|Overall Study|Treated with non-study catheter|2|||
126330868|NCT00511810|454505190|FG000|Overall Study|Lost to Follow-up|1|||
126330869|NCT00511810|454505191|FG001|Overall Study|Lost to Follow-up|2|||
126330870|NCT00511810|454505190|FG000|Overall Study|Lack of Efficacy|0|||
126330871|NCT00511810|454505191|FG001|Overall Study|Lack of Efficacy|2|||
126330872|NCT00511810|454505190|FG000|Overall Study|Refused second scn|0|||
126330873|NCT00511810|454505191|FG001|Overall Study|Refused second scn|1|||
126330874|NCT00452439|454506765|FG000|Overall Study|Lost to Follow-up|1|||
126330875|NCT00452439|454506766|FG001|Overall Study|Lost to Follow-up|1|||
126330876|NCT00452439|454506765|FG000|Overall Study|Refused Treatment|4|||
126330877|NCT00452439|454506766|FG001|Overall Study|Refused Treatment|3|||
126330878|NCT00452439|454506765|FG000|Overall Study|Death|3|||
126330879|NCT00452439|454506766|FG001|Overall Study|Death|1|||
126330880|NCT00452439|454506765|FG000|Overall Study|Bone Marrow Transplant|0|||
126330881|NCT00452439|454506766|FG001|Overall Study|Bone Marrow Transplant|1|||
126330882|NCT00452439|454506765|FG000|Overall Study|Too Ill to Continue|0|||
126330883|NCT00452439|454506766|FG001|Overall Study|Too Ill to Continue|1|||
126330884|NCT00452439|454506765|FG000|Overall Study|Failed to achieve complete response|2|||
126330885|NCT00452439|454506766|FG001|Overall Study|Failed to achieve complete response|0|||
126330886|NCT00452439|454506765|FG000|Overall Study|Relapse|3|||
126662077|NCT01630434|455721245|FG001|Overall Study|Protocol Violation|4|||
126662078|NCT01630434|455721244|FG000|Overall Study|Death|20|||
126662079|NCT01630434|455721245|FG001|Overall Study|Death|26|||
126662080|NCT02578862|455721246|FG000|Overall Study|Withdrawal by Subject|0|||
126662081|NCT02578862|455721247|FG001|Overall Study|Withdrawal by Subject|1|||
126662082|NCT02578862|455721246|FG000|Overall Study|Unplanned unilateral procedure|0|||
126662083|NCT02578862|455721247|FG001|Overall Study|Unplanned unilateral procedure|1|||
126662084|NCT01026454|455721248|FG000|Second Intervention|Pregnancy|1|||
126662085|NCT01026454|455721249|FG001|Second Intervention|Pregnancy|1|||
126662086|NCT02893930|455721250|FG000|Overall Study|Adverse Event|3|||
126662087|NCT02893930|455721250|FG000|Overall Study|Death|1|||
126662088|NCT02893930|455721250|FG000|Overall Study|Disease progression|5|||
126662089|NCT02893930|455721250|FG000|Overall Study|Withdrawal by Subject|2|||
126662090|NCT02893930|455721250|FG000|Overall Study|Physician Decision|1|||
126662091|NCT02893930|455721250|FG000|Overall Study|Ineligible|1|||
126662092|NCT02349360|455721251|FG000|Overall Study|Withdrawal by Subject|0|||
126662093|NCT02349360|455721252|FG001|Overall Study|Withdrawal by Subject|1|||
126662094|NCT00394953|455721253|FG000|First Treatment Period|Adverse Event|1|||
126662095|NCT00394953|455721254|FG001|First Treatment Period|Adverse Event|2|||
126662096|NCT00394953|455721253|FG000|First Treatment Period|Death|6|||
126662097|NCT00394953|455721254|FG001|First Treatment Period|Death|7|||
126330887|NCT00452439|454506766|FG001|Overall Study|Relapse|0|||
126330888|NCT00452439|454506765|FG000|Overall Study|Fracture|1|||
126330889|NCT00452439|454506766|FG001|Overall Study|Fracture|0|||
126330890|NCT00994110|454506773|FG000|Overall Study|Withdrawal by Subject|9|||
126330891|NCT00994110|454506774|FG001|Overall Study|Withdrawal by Subject|9|||
126330892|NCT00994110|454506773|FG000|Overall Study|Not Treated|4|||
126330893|NCT00994110|454506774|FG001|Overall Study|Not Treated|8|||
126330894|NCT00994110|454506773|FG000|Overall Study|Adverse Event|1|||
126662098|NCT00394953|455721253|FG000|First Treatment Period|Lack of Efficacy|1|||
126662099|NCT00394953|455721254|FG001|First Treatment Period|Lack of Efficacy|1|||
126662100|NCT00394953|455721253|FG000|First Treatment Period|Withdrawal by Subject|6|||
126662101|NCT00394953|455721254|FG001|First Treatment Period|Withdrawal by Subject|3|||
126330895|NCT00994110|454506774|FG001|Overall Study|Adverse Event|0|||
126330896|NCT00994110|454506773|FG000|Overall Study|Patient not resected|41|||
126330897|NCT00994110|454506774|FG001|Overall Study|Patient not resected|52|||
126330898|NCT00994110|454506773|FG000|Overall Study|Pt not eligible|10|||
126662102|NCT00394953|455721253|FG000|First Treatment Period|Lost to Follow-up|0|||
126662103|NCT00394953|455721254|FG001|First Treatment Period|Lost to Follow-up|1|||
126662104|NCT00394953|455721253|FG000|First Treatment Period|Renal transplant|11|||
126662105|NCT00394953|455721254|FG001|First Treatment Period|Renal transplant|7|||
126662106|NCT00394953|455721253|FG000|First Treatment Period|Not defined|4|||
126662107|NCT00394953|455721254|FG001|First Treatment Period|Not defined|1|||
126662108|NCT00394953|455721253|FG000|Second Treatment Period|Adverse Event|2|||
126662109|NCT00394953|455721254|FG001|Second Treatment Period|Adverse Event|5|||
126662110|NCT00394953|455721253|FG000|Second Treatment Period|Death|8|||
126662111|NCT00394953|455721254|FG001|Second Treatment Period|Death|4|||
126662112|NCT00394953|455721253|FG000|Second Treatment Period|Lack of Efficacy|9|||
126662113|NCT00394953|455721254|FG001|Second Treatment Period|Lack of Efficacy|47|||
126662114|NCT00394953|455721253|FG000|Second Treatment Period|Withdrawal by Subject|3|||
126662115|NCT00394953|455721254|FG001|Second Treatment Period|Withdrawal by Subject|3|||
126662116|NCT00394953|455721253|FG000|Second Treatment Period|Lost to Follow-up|0|||
126662117|NCT00394953|455721254|FG001|Second Treatment Period|Lost to Follow-up|1|||
126662118|NCT00394953|455721253|FG000|Second Treatment Period|Renal transplant|4|||
126662119|NCT00394953|455721254|FG001|Second Treatment Period|Renal transplant|6|||
126662120|NCT00394953|455721253|FG000|Second Treatment Period|Not defined|3|||
126662121|NCT00394953|455721254|FG001|Second Treatment Period|Not defined|8|||
126662122|NCT01176773|455721255|FG000|Overall Study|Screen Failure|2|||
126662123|NCT01176773|455721255|FG000|Overall Study|Withdrew consent|1|||
126662124|NCT02196714|455721265|FG000|Overall Study|Protocol Violation|0|||
126662125|NCT02196714|455721266|FG001|Overall Study|Protocol Violation|0|||
126662126|NCT02196714|455721267|FG002|Overall Study|Protocol Violation|1|||
126662127|NCT02196714|455721268|FG003|Overall Study|Protocol Violation|0|||
126662128|NCT01592864|455721270|FG000|Overall Study|Withdrawal by Subject|0|||
126662129|NCT01592864|455721271|FG001|Overall Study|Withdrawal by Subject|1|||
126662130|NCT04079803|455721276|FG000|Overall Study|Withdrawal by Subject|0|||
126662131|NCT04079803|455721277|FG001|Overall Study|Withdrawal by Subject|0|||
126662132|NCT04079803|455721278|FG002|Overall Study|Withdrawal by Subject|1|||
126662133|NCT01881750|455721279|FG000|Overall Study|Changes in concomitant therapies|2|||
126662134|NCT01881750|455721280|FG001|Overall Study|Changes in concomitant therapies|3|||
126662135|NCT01881750|455721279|FG000|Overall Study|Lost to Follow-up|0|||
126662136|NCT01881750|455721280|FG001|Overall Study|Lost to Follow-up|1|||
126662137|NCT02804178|455721286|FG000|Overall Study|Adverse Event|1|||
126662138|NCT01290601|455721287|FG000|Overall Study|Adverse Event|0|||
126662139|NCT01290601|455721288|FG001|Overall Study|Adverse Event|2|||
126662140|NCT01290601|455721289|FG002|Overall Study|Adverse Event|0|||
126662141|NCT01290601|455721290|FG003|Overall Study|Adverse Event|0|||
126662142|NCT01290601|455721287|FG000|Overall Study|Lack of Efficacy|2|||
126662143|NCT01290601|455721288|FG001|Overall Study|Lack of Efficacy|1|||
126662144|NCT01290601|455721289|FG002|Overall Study|Lack of Efficacy|0|||
126662145|NCT01290601|455721290|FG003|Overall Study|Lack of Efficacy|0|||
126662146|NCT01290601|455721287|FG000|Overall Study|Lost to Follow-up|7|||
126662147|NCT01290601|455721288|FG001|Overall Study|Lost to Follow-up|2|||
126662148|NCT01290601|455721289|FG002|Overall Study|Lost to Follow-up|0|||
126662149|NCT01290601|455721290|FG003|Overall Study|Lost to Follow-up|0|||
126662150|NCT01290601|455721287|FG000|Overall Study|Other|1|||
126662151|NCT01290601|455721288|FG001|Overall Study|Other|0|||
126662152|NCT01290601|455721289|FG002|Overall Study|Other|0|||
126662153|NCT01290601|455721290|FG003|Overall Study|Other|0|||
126662154|NCT01290601|455721287|FG000|Overall Study|Protocol Violation|1|||
126662155|NCT01290601|455721288|FG001|Overall Study|Protocol Violation|0|||
126662156|NCT01290601|455721289|FG002|Overall Study|Protocol Violation|0|||
126662157|NCT01290601|455721290|FG003|Overall Study|Protocol Violation|0|||
126662158|NCT01749540|455721291|FG000|Overall Study|Protocol Violation|0|||
126662159|NCT01749540|455721292|FG001|Overall Study|Protocol Violation|0|||
126662160|NCT01749540|455721293|FG002|Overall Study|Protocol Violation|0|||
126662161|NCT01749540|455721294|FG003|Overall Study|Protocol Violation|0|||
126662162|NCT01749540|455721295|FG004|Overall Study|Protocol Violation|0|||
126662163|NCT01749540|455721296|FG005|Overall Study|Protocol Violation|1|||
126662164|NCT01749540|455721297|FG006|Overall Study|Protocol Violation|1|||
126330899|NCT00994110|454506774|FG001|Overall Study|Pt not eligible|5|||
126662165|NCT01749540|455721291|FG000|Overall Study|Withdrawal by Subject|0|||
126330900|NCT02683239|454506775|FG000|Overall Study|Protocol Violation|35|||
126662166|NCT01749540|455721292|FG001|Overall Study|Withdrawal by Subject|0|||
126662167|NCT01749540|455721293|FG002|Overall Study|Withdrawal by Subject|0|||
126662168|NCT01749540|455721294|FG003|Overall Study|Withdrawal by Subject|1|||
126662169|NCT01749540|455721295|FG004|Overall Study|Withdrawal by Subject|0|||
126662170|NCT01749540|455721296|FG005|Overall Study|Withdrawal by Subject|0|||
126662171|NCT01749540|455721297|FG006|Overall Study|Withdrawal by Subject|0|||
126662172|NCT01749540|455721291|FG000|Overall Study|Initiated into extension study A536-06|0|||
126662173|NCT01749540|455721292|FG001|Overall Study|Initiated into extension study A536-06|0|||
126662174|NCT01749540|455721293|FG002|Overall Study|Initiated into extension study A536-06|0|||
126662175|NCT01749540|455721294|FG003|Overall Study|Initiated into extension study A536-06|0|||
126662176|NCT01749540|455721295|FG004|Overall Study|Initiated into extension study A536-06|0|||
126662177|NCT01749540|455721296|FG005|Overall Study|Initiated into extension study A536-06|2|||
126662178|NCT01749540|455721297|FG006|Overall Study|Initiated into extension study A536-06|24|||
126662179|NCT02730598|455721300|FG000|Overall Study|Withdrawal by Subject|3|||
126662180|NCT02730598|455721301|FG001|Overall Study|Withdrawal by Subject|3|||
126662181|NCT02730598|455721300|FG000|Overall Study|Protocol Violation|0|||
126662182|NCT02730598|455721301|FG001|Overall Study|Protocol Violation|1|||
126662183|NCT02730598|455721300|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
126662184|NCT02730598|455721301|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
126662185|NCT03282240|455721302|FG000|Overall Study|Adverse Event|2|||
126662186|NCT03282240|455721303|FG001|Overall Study|Adverse Event|2|||
126662187|NCT03282240|455721304|FG002|Overall Study|Adverse Event|0|||
126662188|NCT03282240|455721302|FG000|Overall Study|Lost to Follow-up|3|||
126662189|NCT03282240|455721303|FG001|Overall Study|Lost to Follow-up|0|||
126662190|NCT03282240|455721304|FG002|Overall Study|Lost to Follow-up|0|||
126662191|NCT03282240|455721302|FG000|Overall Study|Protocol Deviation|4|||
126662192|NCT03282240|455721303|FG001|Overall Study|Protocol Deviation|1|||
126662193|NCT03282240|455721304|FG002|Overall Study|Protocol Deviation|2|||
126662194|NCT03282240|455721302|FG000|Overall Study|Withdrawal by Subject|1|||
126662195|NCT03282240|455721303|FG001|Overall Study|Withdrawal by Subject|0|||
126662196|NCT03282240|455721304|FG002|Overall Study|Withdrawal by Subject|1|||
126662197|NCT02910739|455721305|FG000|Overall Study|Adverse Event|1|||
126662198|NCT02910739|455721306|FG001|Overall Study|Adverse Event|0|||
126662199|NCT02910739|455721307|FG002|Overall Study|Adverse Event|0|||
126662200|NCT02910739|455721308|FG003|Overall Study|Adverse Event|0|||
126662201|NCT02146326|455721309|FG000|Overall Study|Lost to Follow-up|3|||
126662202|NCT02146326|455721310|FG001|Overall Study|Lost to Follow-up|3|||
126662203|NCT02146326|455721311|FG002|Overall Study|Lost to Follow-up|11|||
126662204|NCT02146326|455721312|FG003|Overall Study|Lost to Follow-up|19|||
126662205|NCT02146326|455721309|FG000|Overall Study|Withdrawal by Subject|2|||
126662206|NCT02146326|455721310|FG001|Overall Study|Withdrawal by Subject|1|||
126662207|NCT02146326|455721311|FG002|Overall Study|Withdrawal by Subject|15|||
126662208|NCT02146326|455721312|FG003|Overall Study|Withdrawal by Subject|11|||
126662209|NCT02146326|455721309|FG000|Overall Study|Separated from mental health center|23|||
126662210|NCT02146326|455721310|FG001|Overall Study|Separated from mental health center|33|||
126662211|NCT02146326|455721311|FG002|Overall Study|Separated from mental health center|0|||
126662212|NCT02146326|455721312|FG003|Overall Study|Separated from mental health center|0|||
126662213|NCT02146326|455721309|FG000|Overall Study|Incarcerated|0|||
126662214|NCT02146326|455721310|FG001|Overall Study|Incarcerated|0|||
126662215|NCT02146326|455721311|FG002|Overall Study|Incarcerated|3|||
126662216|NCT02146326|455721312|FG003|Overall Study|Incarcerated|8|||
126662217|NCT02146326|455721309|FG000|Overall Study|Death|0|||
126662218|NCT02146326|455721310|FG001|Overall Study|Death|0|||
126662219|NCT02146326|455721311|FG002|Overall Study|Death|4|||
126662220|NCT02146326|455721312|FG003|Overall Study|Death|4|||
126662221|NCT02146326|455721309|FG000|Overall Study|Unable to complete interview|0|||
126662222|NCT02146326|455721310|FG001|Overall Study|Unable to complete interview|0|||
126662223|NCT02146326|455721311|FG002|Overall Study|Unable to complete interview|10|||
126662224|NCT02146326|455721312|FG003|Overall Study|Unable to complete interview|6|||
126662225|NCT01340651|455721313|FG000|Overall Study|Adverse Event|3|||
126662226|NCT01340651|455721313|FG000|Overall Study|Consent Withdrawn|2|||
126662227|NCT01340651|455721313|FG000|Overall Study|Commercial Supply per Sponsor|12|||
126662228|NCT00688103|455721321|FG000|Overall Study|Adverse Event|4|||
126662229|NCT00688103|455721322|FG001|Overall Study|Adverse Event|1|||
126662230|NCT00688103|455721321|FG000|Overall Study|Lack of Efficacy|11|||
126662231|NCT00688103|455721322|FG001|Overall Study|Lack of Efficacy|1|||
126662232|NCT00688103|455721321|FG000|Overall Study|Withdrawal by Subject|4|||
126662233|NCT00688103|455721322|FG001|Overall Study|Withdrawal by Subject|2|||
126662234|NCT00688103|455721321|FG000|Overall Study|complex reasons|11|||
126662235|NCT00688103|455721322|FG001|Overall Study|complex reasons|9|||
126662236|NCT03602261|455721323|FG000|Overall Study|Adverse Event|5|||
126662237|NCT03602261|455721324|FG001|Overall Study|Adverse Event|1|||
126662238|NCT03602261|455721323|FG000|Overall Study|Physician Decision|1|||
126662239|NCT03602261|455721324|FG001|Overall Study|Physician Decision|0|||
126662240|NCT03602261|455721323|FG000|Overall Study|Withdrawal by Subject|1|||
126662241|NCT03602261|455721324|FG001|Overall Study|Withdrawal by Subject|1|||
126662242|NCT03602261|455721323|FG000|Overall Study|Lack of Efficacy|0|||
126662243|NCT03602261|455721324|FG001|Overall Study|Lack of Efficacy|1|||
126662244|NCT03602261|455721323|FG000|Overall Study|Subject moving out of state|1|||
126662245|NCT03602261|455721324|FG001|Overall Study|Subject moving out of state|0|||
126662246|NCT01485354|455722907|FG000|Overall Study|Withdrawal by Subject|5|||
126662247|NCT02101034|455722908|FG000|Overall Study|Enrolled but did not start treatment|0|||
126662248|NCT02101034|455722909|FG001|Overall Study|Enrolled but did not start treatment|0|||
126662249|NCT02101034|455722910|FG002|Overall Study|Enrolled but did not start treatment|1|||
126662250|NCT02101034|455722911|FG003|Overall Study|Enrolled but did not start treatment|0|||
126662251|NCT02101034|455722912|FG004|Overall Study|Enrolled but did not start treatment|0|||
126662252|NCT01103245|455722917|FG000|Overall Study|Withdrawal by Subject|1|||
126662253|NCT01103245|455722918|FG001|Overall Study|Withdrawal by Subject|0|||
126662254|NCT01103245|455722919|FG002|Overall Study|Withdrawal by Subject|3|||
126662255|NCT01103245|455722920|FG003|Overall Study|Withdrawal by Subject|0|||
126662256|NCT01103245|455722917|FG000|Overall Study|Inadequate IV access|1|||
126662257|NCT01103245|455722918|FG001|Overall Study|Inadequate IV access|0|||
126662258|NCT01103245|455722919|FG002|Overall Study|Inadequate IV access|0|||
126662259|NCT01103245|455722920|FG003|Overall Study|Inadequate IV access|0|||
126662260|NCT01103245|455722917|FG000|Overall Study|Adverse Event|0|||
126662261|NCT01103245|455722918|FG001|Overall Study|Adverse Event|2|||
126662262|NCT01103245|455722919|FG002|Overall Study|Adverse Event|1|||
126662263|NCT01103245|455722920|FG003|Overall Study|Adverse Event|0|||
126662264|NCT01103245|455722917|FG000|Overall Study|Physician Decision|1|||
126662265|NCT01103245|455722918|FG001|Overall Study|Physician Decision|0|||
126330901|NCT02683239|454506776|FG001|Overall Study|Protocol Violation|23|||
126330902|NCT02683239|454506777|FG002|Overall Study|Protocol Violation|26|||
126330903|NCT02683239|454506778|FG003|Overall Study|Protocol Violation|4|||
126330904|NCT02683239|454506779|FG004|Overall Study|Protocol Violation|35|||
126330905|NCT02683239|454506780|FG005|Overall Study|Protocol Violation|4|||
126330906|NCT02683239|454506781|FG006|Overall Study|Protocol Violation|5|||
126330907|NCT02683239|454506775|FG000|Overall Study|Adverse Event|64|||
126330908|NCT02683239|454506776|FG001|Overall Study|Adverse Event|39|||
126330909|NCT02683239|454506777|FG002|Overall Study|Adverse Event|42|||
126330910|NCT02683239|454506778|FG003|Overall Study|Adverse Event|16|||
126330911|NCT02683239|454506779|FG004|Overall Study|Adverse Event|189|||
126330912|NCT02683239|454506780|FG005|Overall Study|Adverse Event|9|||
126330913|NCT02683239|454506781|FG006|Overall Study|Adverse Event|9|||
126330914|NCT02683239|454506775|FG000|Overall Study|Physician Decision|38|||
126330915|NCT02683239|454506776|FG001|Overall Study|Physician Decision|19|||
126330916|NCT02683239|454506777|FG002|Overall Study|Physician Decision|14|||
126330917|NCT02683239|454506778|FG003|Overall Study|Physician Decision|73|||
126330918|NCT02683239|454506779|FG004|Overall Study|Physician Decision|143|||
126330919|NCT02683239|454506780|FG005|Overall Study|Physician Decision|14|||
126330920|NCT02683239|454506781|FG006|Overall Study|Physician Decision|15|||
126330921|NCT02683239|454506775|FG000|Overall Study|Withdrawal by Subject|187|||
126330922|NCT02683239|454506776|FG001|Overall Study|Withdrawal by Subject|99|||
126330923|NCT02683239|454506777|FG002|Overall Study|Withdrawal by Subject|91|||
126330924|NCT02683239|454506778|FG003|Overall Study|Withdrawal by Subject|18|||
126330925|NCT02683239|454506779|FG004|Overall Study|Withdrawal by Subject|248|||
126330926|NCT02683239|454506780|FG005|Overall Study|Withdrawal by Subject|22|||
126330927|NCT02683239|454506781|FG006|Overall Study|Withdrawal by Subject|28|||
126330928|NCT02683239|454506775|FG000|Overall Study|Lost to Follow-up|77|||
126330929|NCT02683239|454506776|FG001|Overall Study|Lost to Follow-up|24|||
126330930|NCT02683239|454506777|FG002|Overall Study|Lost to Follow-up|25|||
126330931|NCT02683239|454506778|FG003|Overall Study|Lost to Follow-up|7|||
126330932|NCT02683239|454506779|FG004|Overall Study|Lost to Follow-up|88|||
126330933|NCT02683239|454506780|FG005|Overall Study|Lost to Follow-up|8|||
126330934|NCT02683239|454506781|FG006|Overall Study|Lost to Follow-up|11|||
126330935|NCT02683239|454506775|FG000|Overall Study|Death|9|||
126330936|NCT02683239|454506776|FG001|Overall Study|Death|5|||
126330937|NCT02683239|454506777|FG002|Overall Study|Death|8|||
126330938|NCT02683239|454506778|FG003|Overall Study|Death|0|||
126330939|NCT02683239|454506779|FG004|Overall Study|Death|12|||
126330940|NCT02683239|454506780|FG005|Overall Study|Death|1|||
126330941|NCT02683239|454506781|FG006|Overall Study|Death|0|||
126330942|NCT02683239|454506775|FG000|Overall Study|Lack of Efficacy|50|||
126330943|NCT02683239|454506776|FG001|Overall Study|Lack of Efficacy|23|||
126330944|NCT02683239|454506777|FG002|Overall Study|Lack of Efficacy|12|||
126330945|NCT02683239|454506778|FG003|Overall Study|Lack of Efficacy|2|||
126330946|NCT02683239|454506779|FG004|Overall Study|Lack of Efficacy|29|||
126330947|NCT02683239|454506780|FG005|Overall Study|Lack of Efficacy|2|||
126330948|NCT02683239|454506781|FG006|Overall Study|Lack of Efficacy|3|||
126330949|NCT02683239|454506775|FG000|Overall Study|Missing data|0|||
126330950|NCT02683239|454506776|FG001|Overall Study|Missing data|1|||
126330951|NCT02683239|454506777|FG002|Overall Study|Missing data|1|||
126330952|NCT02683239|454506778|FG003|Overall Study|Missing data|0|||
126330953|NCT02683239|454506779|FG004|Overall Study|Missing data|1|||
126330954|NCT02683239|454506780|FG005|Overall Study|Missing data|0|||
126330955|NCT02683239|454506781|FG006|Overall Study|Missing data|0|||
126330956|NCT04131712|454506782|FG000|Overall Study|COVID related|0|||
126330957|NCT04131712|454506783|FG001|Overall Study|COVID related|0|||
126662266|NCT01103245|455722919|FG002|Overall Study|Physician Decision|0|||
126330958|NCT04131712|454506784|FG002|Overall Study|COVID related|2|||
126330959|NCT04131712|454506785|FG003|Overall Study|COVID related|0|||
126330960|NCT04131712|454506782|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
126330961|NCT04131712|454506783|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
126330962|NCT04131712|454506784|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
126330963|NCT04131712|454506785|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
126330964|NCT00873730|454506786|FG000|Overall Study|Protocol Deviation|5|||
126330965|NCT00873730|454506787|FG001|Overall Study|Protocol Deviation|2|||
126662267|NCT01103245|455722920|FG003|Overall Study|Physician Decision|0|||
126662268|NCT00995020|455722927|FG000|Overall Study|margin analysis not performed|2|||
126662269|NCT00995020|455722928|FG001|Overall Study|margin analysis not performed|5|||
126662270|NCT00995020|455722927|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
126662271|NCT00995020|455722928|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
126662272|NCT00719563|455722936|FG000|Overall Study|Adverse Event|16|||
126662273|NCT00719563|455722937|FG001|Overall Study|Adverse Event|13|||
126662274|NCT00719563|455722936|FG000|Overall Study|Medical condition changed|3|||
126662275|NCT00719563|455722937|FG001|Overall Study|Medical condition changed|5|||
126662276|NCT00719563|455722936|FG000|Overall Study|Lack of Efficacy|3|||
126662277|NCT00719563|455722937|FG001|Overall Study|Lack of Efficacy|7|||
126662278|NCT00719563|455722936|FG000|Overall Study|Personal reasons|6|||
126662279|NCT00719563|455722937|FG001|Overall Study|Personal reasons|7|||
126662280|NCT00719563|455722936|FG000|Overall Study|Unknown reasons|4|||
126662281|NCT00719563|455722937|FG001|Overall Study|Unknown reasons|6|||
126662282|NCT00719563|455722936|FG000|Overall Study|Noncompliant|1|||
126662283|NCT00719563|455722937|FG001|Overall Study|Noncompliant|1|||
126662284|NCT00719563|455722936|FG000|Overall Study|Lost to Follow-up|5|||
126662285|NCT00719563|455722937|FG001|Overall Study|Lost to Follow-up|3|||
126662286|NCT00567268|455722938|FG000|Overall Study|Protocol Violation|7|||
126662287|NCT00567268|455722938|FG000|Overall Study|Lost to Follow-up|36|||
126662288|NCT00567268|455722938|FG000|Overall Study|No Visit After First Day of Treatment|2|||
126662289|NCT00567268|455722938|FG000|Overall Study|No Drug Administration|4|||
126662290|NCT00567268|455722938|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
126662291|NCT00792805|455722939|FG000|Overall Study|Adverse Event|12|||
126662292|NCT00792805|455722940|FG001|Overall Study|Adverse Event|10|||
126662293|NCT00792805|455722941|FG002|Overall Study|Adverse Event|10|||
126662294|NCT00792805|455722939|FG000|Overall Study|Subject withdrew consent|5|||
126662295|NCT00792805|455722940|FG001|Overall Study|Subject withdrew consent|6|||
126662296|NCT00792805|455722941|FG002|Overall Study|Subject withdrew consent|5|||
126662297|NCT00792805|455722939|FG000|Overall Study|Administrative problems|2|||
126662298|NCT00792805|455722940|FG001|Overall Study|Administrative problems|0|||
126662299|NCT00792805|455722941|FG002|Overall Study|Administrative problems|4|||
126662300|NCT00792805|455722939|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126662301|NCT00792805|455722940|FG001|Overall Study|Abnormal test procedure result(s)|2|||
126662302|NCT00792805|455722941|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126662303|NCT00792805|455722939|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126662304|NCT00792805|455722940|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
126662305|NCT00792805|455722941|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
126662306|NCT00792805|455722939|FG000|Overall Study|Lost to Follow-up|1|||
126662307|NCT00792805|455722940|FG001|Overall Study|Lost to Follow-up|1|||
126662308|NCT00792805|455722941|FG002|Overall Study|Lost to Follow-up|6|||
126662309|NCT00792805|455722939|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126662310|NCT00792805|455722940|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126662311|NCT00792805|455722941|FG002|Overall Study|Abnormal laboratory value(s)|1|||
126662312|NCT00792805|455722939|FG000|Overall Study|Protocol deviation|0|||
126662313|NCT00792805|455722940|FG001|Overall Study|Protocol deviation|1|||
126662314|NCT00792805|455722941|FG002|Overall Study|Protocol deviation|1|||
126662315|NCT02120625|455722942|FG000|Overall Study|Physician Decision|2|||
126662316|NCT02952001|455722945|FG000|Overall Study|Adverse Event|3|||
126662317|NCT02952001|455722946|FG001|Overall Study|Adverse Event|0|||
126662318|NCT02952001|455722945|FG000|Overall Study|Prohibited therapy|10|||
126662319|NCT02952001|455722946|FG001|Overall Study|Prohibited therapy|3|||
126662320|NCT02952001|455722945|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
126662321|NCT02952001|455722946|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
126662322|NCT03278106|455722949|FG000|Overall Study|No protocol treatment|1|||
126662323|NCT00820027|455722950|FG000|Overall Study|Adverse Event|15|||
126662324|NCT00820027|455722951|FG001|Overall Study|Adverse Event|8|||
126662325|NCT00820027|455722952|FG002|Overall Study|Adverse Event|10|||
126662326|NCT00820027|455722953|FG003|Overall Study|Adverse Event|5|||
126662327|NCT00820027|455722950|FG000|Overall Study|Lack of Efficacy|2|||
126662328|NCT00820027|455722951|FG001|Overall Study|Lack of Efficacy|1|||
126662329|NCT00820027|455722952|FG002|Overall Study|Lack of Efficacy|2|||
126662330|NCT00820027|455722953|FG003|Overall Study|Lack of Efficacy|2|||
126662331|NCT00820027|455722950|FG000|Overall Study|Physician Decision|0|||
126662332|NCT00820027|455722951|FG001|Overall Study|Physician Decision|1|||
126662333|NCT00820027|455722952|FG002|Overall Study|Physician Decision|1|||
126662334|NCT00820027|455722953|FG003|Overall Study|Physician Decision|0|||
126662335|NCT00820027|455722950|FG000|Overall Study|Protocol Violation|3|||
126662336|NCT00820027|455722951|FG001|Overall Study|Protocol Violation|0|||
126662337|NCT00820027|455722952|FG002|Overall Study|Protocol Violation|4|||
126662338|NCT00820027|455722953|FG003|Overall Study|Protocol Violation|0|||
126662339|NCT00820027|455722950|FG000|Overall Study|Withdrawal by Subject|6|||
126330966|NCT00873730|454506786|FG000|Overall Study|Adverse Event|0|||
126662340|NCT00820027|455722951|FG001|Overall Study|Withdrawal by Subject|4|||
126662341|NCT00820027|455722952|FG002|Overall Study|Withdrawal by Subject|4|||
126662342|NCT00820027|455722953|FG003|Overall Study|Withdrawal by Subject|6|||
126662343|NCT02982187|455722954|FG000|Overall Study|Withdrawal by Subject|0|||
126662344|NCT02982187|455722955|FG001|Overall Study|Withdrawal by Subject|0|||
126662345|NCT02982187|455722956|FG002|Overall Study|Withdrawal by Subject|0|||
126662346|NCT02982187|455722957|FG003|Overall Study|Withdrawal by Subject|0|||
126662347|NCT02982187|455722958|FG004|Overall Study|Withdrawal by Subject|0|||
126662348|NCT02982187|455722959|FG005|Overall Study|Withdrawal by Subject|0|||
126662349|NCT02982187|455722960|FG006|Overall Study|Withdrawal by Subject|1|||
126662350|NCT02982187|455722961|FG007|Overall Study|Withdrawal by Subject|0|||
126662351|NCT02604433|455722962|FG000|Overall Study|Withdrawal by Subject|37|||
126662352|NCT02604433|455722963|FG001|Overall Study|Withdrawal by Subject|16|||
126662353|NCT02604433|455722962|FG000|Overall Study|Adverse Event|4|||
126662354|NCT02604433|455722963|FG001|Overall Study|Adverse Event|0|||
126662355|NCT02604433|455722962|FG000|Overall Study|Other reasons|3|||
126662356|NCT02604433|455722963|FG001|Overall Study|Other reasons|5|||
126662357|NCT02604433|455722962|FG000|Overall Study|Death|4|||
126662358|NCT02604433|455722963|FG001|Overall Study|Death|1|||
126662359|NCT02604433|455722962|FG000|Overall Study|Transition to Rollover Protocol|169|||
126662360|NCT02604433|455722963|FG001|Overall Study|Transition to Rollover Protocol|82|||
126662361|NCT02604433|455722962|FG000|Overall Study|Physician Decision|1|||
126662362|NCT02604433|455722963|FG001|Overall Study|Physician Decision|1|||
126662363|NCT02604433|455722962|FG000|Overall Study|Lack of Efficacy|0|||
126662364|NCT02604433|455722963|FG001|Overall Study|Lack of Efficacy|1|||
126662365|NCT03437278|455722964|FG000|Overall Study|Adverse Event|0|||
126662366|NCT03437278|455722965|FG001|Overall Study|Adverse Event|0|||
126662367|NCT03437278|455722966|FG002|Overall Study|Adverse Event|1|||
126662368|NCT03437278|455722964|FG000|Overall Study|Progressive disease|1|||
126662369|NCT03437278|455722965|FG001|Overall Study|Progressive disease|0|||
126662370|NCT03437278|455722966|FG002|Overall Study|Progressive disease|0|||
126662371|NCT03437278|455722964|FG000|Overall Study|Physician Decision|1|||
126662372|NCT03437278|455722965|FG001|Overall Study|Physician Decision|0|||
126662373|NCT03437278|455722966|FG002|Overall Study|Physician Decision|1|||
126662374|NCT02202551|455722967|FG000|Overall Study|Adverse Event|8|||
126662375|NCT02202551|455722968|FG001|Overall Study|Adverse Event|19|||
126662376|NCT02202551|455722969|FG002|Overall Study|Adverse Event|5|||
126662377|NCT02202551|455722970|FG003|Overall Study|Adverse Event|9|||
126662378|NCT02202551|455722967|FG000|Overall Study|Death|3|||
126662379|NCT02202551|455722968|FG001|Overall Study|Death|2|||
126662380|NCT02202551|455722969|FG002|Overall Study|Death|1|||
126662381|NCT02202551|455722970|FG003|Overall Study|Death|1|||
126662382|NCT02202551|455722967|FG000|Overall Study|Lost to Follow-up|0|||
126662383|NCT02202551|455722968|FG001|Overall Study|Lost to Follow-up|1|||
126662384|NCT02202551|455722969|FG002|Overall Study|Lost to Follow-up|0|||
126662385|NCT02202551|455722970|FG003|Overall Study|Lost to Follow-up|1|||
126662386|NCT02202551|455722967|FG000|Overall Study|Needed to take excluded medication|0|||
126662387|NCT02202551|455722968|FG001|Overall Study|Needed to take excluded medication|2|||
126662388|NCT02202551|455722969|FG002|Overall Study|Needed to take excluded medication|0|||
126662389|NCT02202551|455722970|FG003|Overall Study|Needed to take excluded medication|1|||
126662390|NCT02202551|455722967|FG000|Overall Study|Subject moved away|0|||
126662391|NCT02202551|455722968|FG001|Overall Study|Subject moved away|1|||
126662392|NCT02202551|455722969|FG002|Overall Study|Subject moved away|0|||
126662393|NCT02202551|455722970|FG003|Overall Study|Subject moved away|0|||
126662394|NCT02202551|455722967|FG000|Overall Study|DBS surgery|3|||
126662395|NCT02202551|455722968|FG001|Overall Study|DBS surgery|0|||
126662396|NCT02202551|455722969|FG002|Overall Study|DBS surgery|0|||
126662397|NCT02202551|455722970|FG003|Overall Study|DBS surgery|0|||
126662398|NCT02202551|455722967|FG000|Overall Study|Dyskinesia upon taper|1|||
126662399|NCT02202551|455722968|FG001|Overall Study|Dyskinesia upon taper|0|||
126662400|NCT02202551|455722969|FG002|Overall Study|Dyskinesia upon taper|0|||
126662401|NCT02202551|455722970|FG003|Overall Study|Dyskinesia upon taper|0|||
126662402|NCT02202551|455722967|FG000|Overall Study|Lack of Efficacy|0|||
126662403|NCT02202551|455722968|FG001|Overall Study|Lack of Efficacy|1|||
126662404|NCT02202551|455722969|FG002|Overall Study|Lack of Efficacy|0|||
126662405|NCT02202551|455722970|FG003|Overall Study|Lack of Efficacy|0|||
126662406|NCT02202551|455722967|FG000|Overall Study|Physician Decision|1|||
126662407|NCT02202551|455722968|FG001|Overall Study|Physician Decision|0|||
126662408|NCT02202551|455722969|FG002|Overall Study|Physician Decision|0|||
126662409|NCT02202551|455722970|FG003|Overall Study|Physician Decision|0|||
126662410|NCT02202551|455722967|FG000|Overall Study|Site closure|3|||
126662411|NCT02202551|455722968|FG001|Overall Study|Site closure|0|||
126662412|NCT02202551|455722969|FG002|Overall Study|Site closure|0|||
126662413|NCT02202551|455722970|FG003|Overall Study|Site closure|1|||
126662414|NCT02202551|455722967|FG000|Overall Study|Unable to complete visits per protocol|1|||
126662415|NCT02202551|455722968|FG001|Overall Study|Unable to complete visits per protocol|0|||
126662416|NCT02202551|455722969|FG002|Overall Study|Unable to complete visits per protocol|0|||
126662417|NCT02202551|455722970|FG003|Overall Study|Unable to complete visits per protocol|0|||
126662418|NCT02202551|455722967|FG000|Overall Study|Worsening Dyskinesia|0|||
126662419|NCT02202551|455722968|FG001|Overall Study|Worsening Dyskinesia|0|||
126662420|NCT02202551|455722969|FG002|Overall Study|Worsening Dyskinesia|0|||
126662421|NCT02202551|455722970|FG003|Overall Study|Worsening Dyskinesia|1|||
126662422|NCT02202551|455722967|FG000|Overall Study|Protocol Violation|0|||
126662423|NCT02202551|455722968|FG001|Overall Study|Protocol Violation|1|||
126662424|NCT02202551|455722969|FG002|Overall Study|Protocol Violation|0|||
126662425|NCT02202551|455722970|FG003|Overall Study|Protocol Violation|0|||
126662426|NCT02202551|455722967|FG000|Overall Study|Sponsor's decision|2|||
126662427|NCT02202551|455722968|FG001|Overall Study|Sponsor's decision|0|||
126662428|NCT02202551|455722969|FG002|Overall Study|Sponsor's decision|0|||
126662429|NCT02202551|455722970|FG003|Overall Study|Sponsor's decision|0|||
126662430|NCT02202551|455722967|FG000|Overall Study|Subject unwilling to proceed|1|||
126662431|NCT02202551|455722968|FG001|Overall Study|Subject unwilling to proceed|5|||
126662432|NCT02202551|455722969|FG002|Overall Study|Subject unwilling to proceed|3|||
126662433|NCT02202551|455722970|FG003|Overall Study|Subject unwilling to proceed|5|||
126662434|NCT02202551|455722967|FG000|Overall Study|Subject consent withdrawn|0|||
126662435|NCT02202551|455722968|FG001|Overall Study|Subject consent withdrawn|3|||
126662436|NCT02202551|455722969|FG002|Overall Study|Subject consent withdrawn|1|||
126662437|NCT02202551|455722970|FG003|Overall Study|Subject consent withdrawn|2|||
126662438|NCT02202551|455722967|FG000|Overall Study|eGFR<50mL/min/m2|2|||
126662439|NCT02202551|455722968|FG001|Overall Study|eGFR<50mL/min/m2|2|||
126662440|NCT02202551|455722969|FG002|Overall Study|eGFR<50mL/min/m2|0|||
126662441|NCT02202551|455722970|FG003|Overall Study|eGFR<50mL/min/m2|1|||
126662442|NCT02147353|455722971|FG000|Overall Study|Lost to Follow-up|2|||
126662443|NCT02147353|455722972|FG001|Overall Study|Lost to Follow-up|0|||
126662444|NCT02147353|455722971|FG000|Overall Study|unable to make visits|4|||
126662445|NCT02147353|455722972|FG001|Overall Study|unable to make visits|0|||
126662446|NCT02147353|455722971|FG000|Overall Study|medication noncompliance|3|||
126662447|NCT02147353|455722972|FG001|Overall Study|medication noncompliance|0|||
126662448|NCT01326533|455722985|FG000|Overall Study|Lost to Follow-up|2|||
126662449|NCT01326533|455722986|FG001|Overall Study|Lost to Follow-up|0|||
126662450|NCT01326533|455722985|FG000|Overall Study|Withdrawal by Subject|1|||
126662451|NCT01326533|455722986|FG001|Overall Study|Withdrawal by Subject|0|||
126662452|NCT01326533|455722985|FG000|Overall Study|Adverse Event|1|||
126662453|NCT01326533|455722986|FG001|Overall Study|Adverse Event|0|||
126662454|NCT00926211|455722987|FG000|Overall Study|Lost to Follow-up|1|||
126662455|NCT01106404|455722991|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
126662456|NCT01106404|455722992|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
126662457|NCT01106404|455722991|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
126662458|NCT01106404|455722992|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
126662459|NCT01106404|455722991|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
126662460|NCT01106404|455722992|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
126662461|NCT01106404|455722991|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
126662462|NCT01106404|455722992|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
126662463|NCT00775450|455722993|FG000|Overall Study|Serious Adverse Event|2|||
126662464|NCT00775450|455722994|FG001|Overall Study|Serious Adverse Event|0|||
126662465|NCT00775450|455722995|FG002|Overall Study|Serious Adverse Event|0|||
126662466|NCT00775450|455722996|FG003|Overall Study|Serious Adverse Event|0|||
126662467|NCT00775450|455722997|FG004|Overall Study|Serious Adverse Event|0|||
126662468|NCT00775450|455722993|FG000|Overall Study|Protocol Violation|0|||
126662469|NCT00775450|455722994|FG001|Overall Study|Protocol Violation|0|||
126662470|NCT00775450|455722995|FG002|Overall Study|Protocol Violation|0|||
126662471|NCT00775450|455722996|FG003|Overall Study|Protocol Violation|0|||
126662472|NCT00775450|455722997|FG004|Overall Study|Protocol Violation|1|||
126662473|NCT00775450|455722993|FG000|Overall Study|Withdrawal by Subject|1|||
126662474|NCT00775450|455722994|FG001|Overall Study|Withdrawal by Subject|0|||
126662475|NCT00775450|455722995|FG002|Overall Study|Withdrawal by Subject|0|||
126662476|NCT00775450|455722996|FG003|Overall Study|Withdrawal by Subject|0|||
126662477|NCT00775450|455722997|FG004|Overall Study|Withdrawal by Subject|1|||
126662478|NCT00894686|455723004|FG000|Overall Study|Withdrawal by Subject|50|||
126662479|NCT00894686|455723004|FG000|Overall Study|Physician Decision|1|||
126662480|NCT00894686|455723004|FG000|Overall Study|Other|5|||
126662481|NCT00564018|455723007|FG000|Overall Study|Withdrawal by Subject|2|||
126662482|NCT00564018|455723008|FG001|Overall Study|Withdrawal by Subject|3|||
126662483|NCT00564018|455723009|FG002|Overall Study|Withdrawal by Subject|1|||
126662484|NCT03267940|455723010|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
126662485|NCT03267940|455723011|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
126662486|NCT03267940|455723012|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
126662487|NCT03267940|455723013|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
126662488|NCT03267940|455723014|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
126662489|NCT03267940|455723015|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
126662490|NCT03267940|455723010|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
126662491|NCT03267940|455723011|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
126545270|NCT01641926|455290783|FG000|Overall Study|Withdrawal by Subject|13|||
126662492|NCT03267940|455723012|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
126662493|NCT03267940|455723013|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
126662494|NCT03267940|455723014|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
126662495|NCT03267940|455723015|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
126662496|NCT03267940|455723010|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
126662497|NCT03267940|455723011|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
126662498|NCT03267940|455723012|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
126662499|NCT03267940|455723013|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
126662500|NCT03267940|455723014|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
126662501|NCT03267940|455723015|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
126662502|NCT03267940|455723010|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
126662503|NCT03267940|455723011|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
126662504|NCT03267940|455723012|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
126662505|NCT03267940|455723013|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
126662506|NCT03267940|455723014|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
126662507|NCT03267940|455723015|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
126662508|NCT03267940|455723010|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
126662509|NCT03267940|455723011|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
126662510|NCT03267940|455723012|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
126662511|NCT03267940|455723013|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
126662512|NCT03267940|455723014|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
126662513|NCT03267940|455723015|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
126662514|NCT03267940|455723010|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
126662515|NCT03267940|455723011|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
126662516|NCT03267940|455723012|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
126662517|NCT03267940|455723013|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
126662518|NCT03267940|455723014|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
126662519|NCT03267940|455723015|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
126662520|NCT03267940|455723010|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
126662521|NCT03267940|455723011|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
126662522|NCT03267940|455723012|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
126662523|NCT03267940|455723013|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
126662524|NCT03267940|455723014|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
126662525|NCT03267940|455723015|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
126662526|NCT03267940|455723010|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
126662527|NCT03267940|455723011|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
126662528|NCT03267940|455723012|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
126662529|NCT03267940|455723013|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
126662530|NCT03267940|455723014|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
126662531|NCT03267940|455723015|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
126662532|NCT03267940|455723010|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
126662533|NCT03267940|455723011|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
126662534|NCT03267940|455723012|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
126662535|NCT03267940|455723013|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
126662536|NCT03267940|455723014|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
126662537|NCT03267940|455723015|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
126662538|NCT00388154|455723016|FG000|Overall Study|Withdrawal by Subject|1|||
126330967|NCT00873730|454506787|FG001|Overall Study|Adverse Event|2|||
126330968|NCT00873730|454506786|FG000|Overall Study|Withdrawal by Subject|0|||
126330969|NCT00873730|454506787|FG001|Overall Study|Withdrawal by Subject|1|||
126330970|NCT00873730|454506786|FG000|Overall Study|Sponsor decision|1|||
126330971|NCT00873730|454506787|FG001|Overall Study|Sponsor decision|0|||
126330972|NCT00103662|454506788|FG000|Overall Study|Entered Rescue Procedure|0|||
126330973|NCT00103662|454506789|FG001|Overall Study|Entered Rescue Procedure|7|||
126330974|NCT00103662|454506788|FG000|Overall Study|Death|7|||
126330975|NCT00103662|454506789|FG001|Overall Study|Death|7|||
126330976|NCT00103662|454506788|FG000|Overall Study|Elective Withdrawal|5|||
126330977|NCT00103662|454506789|FG001|Overall Study|Elective Withdrawal|5|||
126330978|NCT00103662|454506788|FG000|Overall Study|Lost to Follow-up|0|||
126330979|NCT00103662|454506789|FG001|Overall Study|Lost to Follow-up|1|||
126330980|NCT00103662|454506788|FG000|Overall Study|Other|6|||
126330981|NCT00103662|454506789|FG001|Overall Study|Other|9|||
126330982|NCT00103662|454506788|FG000|Overall Study|Failed mobilization|0|||
126330983|NCT00103662|454506789|FG001|Overall Study|Failed mobilization|4|||
126330984|NCT00103662|454506788|FG000|Overall Study|Intercurrent illness|1|||
126330985|NCT00103662|454506789|FG001|Overall Study|Intercurrent illness|0|||
126330986|NCT00943397|454506790|FG000|Overall Study|Adverse Event|0|||
126330987|NCT00943397|454506791|FG001|Overall Study|Adverse Event|6|||
126330988|NCT00943397|454506790|FG000|Overall Study|Lost to Follow-up|0|||
126662539|NCT02240693|455723025|FG000|Overall Study|Adverse Event|0|||
126662540|NCT02240693|455723026|FG001|Overall Study|Adverse Event|0|||
126662541|NCT02240693|455723027|FG002|Overall Study|Adverse Event|0|||
126662542|NCT02240693|455723028|FG003|Overall Study|Adverse Event|0|||
126662543|NCT02240693|455723029|FG004|Overall Study|Adverse Event|1|||
126662544|NCT02240693|455723025|FG000|Overall Study|Withdrawal by Subject|0|||
126662545|NCT02240693|455723026|FG001|Overall Study|Withdrawal by Subject|0|||
126662546|NCT02240693|455723027|FG002|Overall Study|Withdrawal by Subject|2|||
126662547|NCT02240693|455723028|FG003|Overall Study|Withdrawal by Subject|1|||
126662548|NCT02240693|455723029|FG004|Overall Study|Withdrawal by Subject|0|||
126662549|NCT02240693|455723025|FG000|Overall Study|Other than specified|0|||
126662550|NCT02240693|455723026|FG001|Overall Study|Other than specified|0|||
126662551|NCT02240693|455723027|FG002|Overall Study|Other than specified|2|||
126662552|NCT02240693|455723028|FG003|Overall Study|Other than specified|0|||
126662553|NCT02240693|455723029|FG004|Overall Study|Other than specified|0|||
126662554|NCT01948908|455723030|FG000|Overall Study|Protocol Violation|1|||
126662555|NCT01948908|455723031|FG001|Overall Study|Protocol Violation|0|||
126662556|NCT01948908|455723032|FG002|Overall Study|Protocol Violation|2|||
126662557|NCT03291587|455723033|FG000|Overall Study|Lost to Follow-up|62|||
126662558|NCT03291587|455723034|FG001|Overall Study|Lost to Follow-up|43|||
126662559|NCT03291587|455723033|FG000|Overall Study|Refused to Answer|5|||
126662560|NCT03291587|455723034|FG001|Overall Study|Refused to Answer|2|||
126662561|NCT03291587|455723033|FG000|Overall Study|Death|2|||
126662562|NCT03291587|455723034|FG001|Overall Study|Death|4|||
126662563|NCT03291587|455723033|FG000|Overall Study|Not interested in participating|8|||
126662564|NCT03291587|455723034|FG001|Overall Study|Not interested in participating|6|||
126662565|NCT03291587|455723033|FG000|Overall Study|Too busy to participate|4|||
126662566|NCT03291587|455723034|FG001|Overall Study|Too busy to participate|2|||
126662567|NCT00796120|455723036|FG000|Overall Study|Death|3|||
126662568|NCT00796120|455723037|FG001|Overall Study|Death|0|||
126662569|NCT00796120|455723036|FG000|Overall Study|Adverse Event|11|||
126662570|NCT00796120|455723037|FG001|Overall Study|Adverse Event|6|||
126662571|NCT00796120|455723036|FG000|Overall Study|Progressive disease|22|||
126662572|NCT00796120|455723037|FG001|Overall Study|Progressive disease|13|||
126662573|NCT00796120|455723036|FG000|Overall Study|Participant refusal|3|||
126662574|NCT00796120|455723037|FG001|Overall Study|Participant refusal|4|||
126330989|NCT00943397|454506791|FG001|Overall Study|Lost to Follow-up|4|||
126330990|NCT00943397|454506790|FG000|Overall Study|Protocol Violation|2|||
126330991|NCT00943397|454506791|FG001|Overall Study|Protocol Violation|5|||
126330992|NCT00943397|454506790|FG000|Overall Study|Withdrawal by Subject|1|||
126330993|NCT00943397|454506791|FG001|Overall Study|Withdrawal by Subject|1|||
126330994|NCT00943397|454506790|FG000|Overall Study|Site terminated and other|12|||
126330995|NCT00943397|454506791|FG001|Overall Study|Site terminated and other|56|||
126330996|NCT04878055|454506792|FG000|Overall Study|Patient transferred in another department|0|||
126330997|NCT04878055|454506793|FG001|Overall Study|Patient transferred in another department|2|||
126330998|NCT04878055|454506792|FG000|Overall Study|Physician Decision|1|||
126330999|NCT04878055|454506793|FG001|Overall Study|Physician Decision|1|||
126331000|NCT04878055|454506792|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
126331001|NCT04878055|454506793|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
126331002|NCT04878055|454506792|FG000|Overall Study|Adverse Event|12|||
126331003|NCT04878055|454506793|FG001|Overall Study|Adverse Event|7|||
126331004|NCT04878055|454506792|FG000|Overall Study|Other|5|||
126331005|NCT04878055|454506793|FG001|Overall Study|Other|0|||
126331006|NCT04878055|454506792|FG000|Overall Study|Withdrawal by Subject|7|||
126331007|NCT04878055|454506793|FG001|Overall Study|Withdrawal by Subject|3|||
126331008|NCT04878055|454506792|FG000|Overall Study|Lost to Follow-up|10|||
126331009|NCT04878055|454506793|FG001|Overall Study|Lost to Follow-up|1|||
126331010|NCT01968811|454506794|FG000|Overall Study|Protocol Violation|4|||
126331011|NCT01968811|454506794|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
126331012|NCT05225558|454506798|FG000|Overall Study|Withdrawal by Subject|4|||
126331013|NCT05225558|454506799|FG001|Overall Study|Withdrawal by Subject|3|||
126331014|NCT05225558|454506798|FG000|Overall Study|Adverse Event|1|||
126331015|NCT05225558|454506799|FG001|Overall Study|Adverse Event|0|||
126662575|NCT00796120|455723036|FG000|Overall Study|Other|6|||
126662576|NCT00796120|455723037|FG001|Overall Study|Other|17|||
126331016|NCT05225558|454506798|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
126331017|NCT05225558|454506799|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
126331018|NCT05225558|454506798|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
126331019|NCT05225558|454506799|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
126331020|NCT03006562|454506800|FG000|Overall Study|Lost to Follow-up|0|||
126331021|NCT03006562|454506801|FG001|Overall Study|Lost to Follow-up|1|||
126545271|NCT01641926|455290784|FG001|Overall Study|Withdrawal by Subject|5|||
126662577|NCT00796120|455723036|FG000|Overall Study|Physician Decision|16|||
126662578|NCT00796120|455723037|FG001|Overall Study|Physician Decision|17|||
126662579|NCT00796120|455723036|FG000|Overall Study|Randomized but not treated|0|||
126662580|NCT00796120|455723037|FG001|Overall Study|Randomized but not treated|3|||
126662581|NCT00413972|455723041|FG000|Overall Study|Adverse Event|2|||
126662582|NCT00413972|455723042|FG001|Overall Study|Adverse Event|1|||
126662583|NCT00413972|455723043|FG002|Overall Study|Adverse Event|0|||
126662584|NCT00413972|455723044|FG003|Overall Study|Adverse Event|0|||
126662585|NCT00413972|455723041|FG000|Overall Study|Lost to Follow-up|1|||
126662586|NCT00413972|455723042|FG001|Overall Study|Lost to Follow-up|2|||
126662587|NCT00413972|455723043|FG002|Overall Study|Lost to Follow-up|1|||
126662588|NCT00413972|455723044|FG003|Overall Study|Lost to Follow-up|0|||
126662589|NCT00413972|455723041|FG000|Overall Study|Withdrawal by Subject|4|||
126662590|NCT00413972|455723042|FG001|Overall Study|Withdrawal by Subject|5|||
126662591|NCT00413972|455723043|FG002|Overall Study|Withdrawal by Subject|7|||
126662592|NCT00413972|455723044|FG003|Overall Study|Withdrawal by Subject|2|||
126662593|NCT00413972|455723041|FG000|Overall Study|Protocol Violation|0|||
126662594|NCT00413972|455723042|FG001|Overall Study|Protocol Violation|0|||
126662595|NCT00413972|455723043|FG002|Overall Study|Protocol Violation|2|||
126662596|NCT00413972|455723044|FG003|Overall Study|Protocol Violation|0|||
126662597|NCT00413972|455723041|FG000|Overall Study|Other|0|||
126662598|NCT00413972|455723042|FG001|Overall Study|Other|0|||
126662599|NCT00413972|455723043|FG002|Overall Study|Other|0|||
126662600|NCT00413972|455723044|FG003|Overall Study|Other|1|||
126662601|NCT01898923|455723045|FG000|Overall Study|Lack of Efficacy|5|||
126662602|NCT01898923|455723046|FG001|Overall Study|Lack of Efficacy|6|||
126662603|NCT01898923|455723045|FG000|Overall Study|Adverse Event|3|||
126662604|NCT01898923|455723046|FG001|Overall Study|Adverse Event|1|||
126662605|NCT01898923|455723045|FG000|Overall Study|Lost to Follow-up|0|||
126662606|NCT01898923|455723046|FG001|Overall Study|Lost to Follow-up|1|||
126331022|NCT02427841|454506803|FG000|Overall Study|Lack of Efficacy|5|||
126331023|NCT02427841|454506803|FG000|Overall Study|Physician Decision|2|||
126331024|NCT02427841|454506803|FG000|Overall Study|Withdrawal by Subject|1|||
126331025|NCT05417412|454506804|FG000|Overall Study|Lost to Follow-up|2|||
126331026|NCT02592447|454506807|FG000|Overall Study|Lost to Follow-up|1|||
126331027|NCT02592447|454506808|FG001|Overall Study|Lost to Follow-up|0|||
126331028|NCT02592447|454506807|FG000|Overall Study|Ineligible after randomization|1|||
126331029|NCT02592447|454506808|FG001|Overall Study|Ineligible after randomization|0|||
126331030|NCT02592447|454506807|FG000|Overall Study|Withdrawal by Subject|0|||
126331031|NCT02592447|454506808|FG001|Overall Study|Withdrawal by Subject|1|||
126331032|NCT01841970|454506809|FG000|Overall Study|Withdrawal by Subject|1|||
126331033|NCT01841970|454506809|FG000|Overall Study|Physician Decision|2|||
126331034|NCT01841970|454506809|FG000|Overall Study|Lost to Follow-up|8|||
126331035|NCT03478371|454506810|FG000|Overall Study|non-compliance|1|||
126331036|NCT03478371|454506810|FG000|Overall Study|Lost to Follow-up|4|||
126331037|NCT02849743|454506815|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
126331038|NCT02849743|454506816|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
126331039|NCT02849743|454506815|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
126331040|NCT02849743|454506816|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
126331041|NCT01048541|454506819|FG000|Overall Study|Withdrawal by Subject|1|||
126331042|NCT01048541|454506820|FG001|Overall Study|Withdrawal by Subject|0|||
126331043|NCT00627497|454506821|FG000|Overall Study|Lost to Follow-up|1|||
126331044|NCT00627497|454506822|FG001|Overall Study|Lost to Follow-up|1|||
126331045|NCT00627497|454506823|FG002|Overall Study|Lost to Follow-up|0|||
126331046|NCT00627497|454506824|FG003|Overall Study|Lost to Follow-up|0|||
126331047|NCT00922116|454506825|FG000|Overall Study|Adverse Event|4|||
126331048|NCT00922116|454506825|FG000|Overall Study|Death|1|||
126331049|NCT00922116|454506825|FG000|Overall Study|Lost to Follow-up|1|||
126331050|NCT00922116|454506825|FG000|Overall Study|Withdrawal by Subject|4|||
126331051|NCT00922116|454506825|FG000|Overall Study|Other|5|||
126331052|NCT04607135|454506826|FG000|Overall Study|Physician Decision|1|||
126331053|NCT04607135|454506826|FG000|Overall Study|Withdrawal by Subject|1|||
126331054|NCT04607135|454506826|FG000|Overall Study|Equipment not working|3|||
126331055|NCT00618826|454506827|FG000|Overall Study|Adverse Event|1|||
126331056|NCT01509664|454506829|FG000|Overall Study|Lost to Follow-up|15|||
126331057|NCT01509664|454506830|FG001|Overall Study|Lost to Follow-up|21|||
126331058|NCT00807885|454506835|FG000|Overall Study|Lost to Follow-up|0|||
126331059|NCT00807885|454506836|FG001|Overall Study|Lost to Follow-up|0|||
126331060|NCT00807885|454506837|FG002|Overall Study|Lost to Follow-up|0|||
126331061|NCT00807885|454506838|FG003|Overall Study|Lost to Follow-up|0|||
126331062|NCT00807885|454506839|FG004|Overall Study|Lost to Follow-up|0|||
126331063|NCT00807885|454506840|FG005|Overall Study|Lost to Follow-up|1|||
126331064|NCT00807885|454506841|FG006|Overall Study|Lost to Follow-up|0|||
126331065|NCT00807885|454506842|FG007|Overall Study|Lost to Follow-up|0|||
126331066|NCT00807885|454506843|FG008|Overall Study|Lost to Follow-up|0|||
126662607|NCT01898923|455723045|FG000|Overall Study|Withdrawal by Subject|4|||
126662608|NCT01898923|455723046|FG001|Overall Study|Withdrawal by Subject|7|||
126331067|NCT02364388|454506844|FG000|Overall Study|Protocol Violation|1|||
126331068|NCT02364388|454506844|FG000|Overall Study|Technical Failure|3|||
126662609|NCT01898923|455723045|FG000|Overall Study|Physician Decision|3|||
126331069|NCT02364388|454506844|FG000|Overall Study|No OA/US data|2|||
126331070|NCT02364388|454506844|FG000|Overall Study|No Biopsy|2|||
126331071|NCT00327717|454506845|FG000|Overall Study|Adverse Event|6|||
126331072|NCT00327717|454506846|FG001|Overall Study|Adverse Event|6|||
126331073|NCT00327717|454506845|FG000|Overall Study|Lack of Efficacy|0|||
126662610|NCT01898923|455723046|FG001|Overall Study|Physician Decision|4|||
126331074|NCT00327717|454506846|FG001|Overall Study|Lack of Efficacy|1|||
126331075|NCT00327717|454506845|FG000|Overall Study|Withdrawal by Subject|3|||
126331076|NCT00327717|454506846|FG001|Overall Study|Withdrawal by Subject|7|||
126662611|NCT01898923|455723045|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
126662612|NCT01898923|455723046|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
126662613|NCT00381303|455723049|FG000|Overall Study|Lost to Follow-up|25|||
126662614|NCT00381303|455723050|FG001|Overall Study|Lost to Follow-up|9|||
126662615|NCT00381303|455723049|FG000|Overall Study|AE/HIV-related event|22|||
126662616|NCT00381303|455723050|FG001|Overall Study|AE/HIV-related event|6|||
126662617|NCT00381303|455723049|FG000|Overall Study|Non-Adherence|13|||
126662618|NCT00381303|455723050|FG001|Overall Study|Non-Adherence|6|||
126662619|NCT00381303|455723049|FG000|Overall Study|Withdrawal by Subject|13|||
126662620|NCT00381303|455723050|FG001|Overall Study|Withdrawal by Subject|6|||
126662621|NCT00381303|455723049|FG000|Overall Study|Virologic failure|6|||
126662622|NCT00381303|455723050|FG001|Overall Study|Virologic failure|4|||
126331077|NCT00905424|454506847|FG000|Overall Study|Lost to Follow-up|3|||
126331078|NCT00905424|454506848|FG001|Overall Study|Lost to Follow-up|3|||
126331079|NCT00905424|454506847|FG000|Overall Study|Withdrawal by Subject|1|||
126331080|NCT00905424|454506848|FG001|Overall Study|Withdrawal by Subject|2|||
126331081|NCT00905424|454506847|FG000|Overall Study|Adverse Event|4|||
126331082|NCT00905424|454506848|FG001|Overall Study|Adverse Event|2|||
126331083|NCT00905424|454506847|FG000|Overall Study|Non-compliance with study medication|2|||
126331084|NCT00905424|454506848|FG001|Overall Study|Non-compliance with study medication|0|||
126331085|NCT00905424|454506847|FG000|Overall Study|Sponsor decision|1|||
126331086|NCT00905424|454506848|FG001|Overall Study|Sponsor decision|0|||
126331087|NCT00905424|454506847|FG000|Overall Study|Positive urine drug screen|0|||
126331088|NCT00905424|454506848|FG001|Overall Study|Positive urine drug screen|1|||
126331089|NCT00905424|454506847|FG000|Overall Study|Non-adherence to visit schedule|0|||
126331090|NCT00905424|454506848|FG001|Overall Study|Non-adherence to visit schedule|1|||
126331091|NCT00426764|454506849|FG000|Overall Study|Protocol Violation|1|||
126331092|NCT00426764|454506849|FG000|Overall Study|Withdrawal by Subject|4|||
126331093|NCT00426764|454506849|FG000|Overall Study|Physician Decision|6|||
126331094|NCT00426764|454506849|FG000|Overall Study|Compassionate Use|1|||
126331095|NCT00426764|454506849|FG000|Overall Study|Progressive Disease|83|||
126331096|NCT00426764|454506849|FG000|Overall Study|Adverse Event|24|||
126331097|NCT00426764|454506849|FG000|Overall Study|Other|1|||
126331098|NCT00426764|454506849|FG000|Overall Study|Death|1|||
126331099|NCT00426764|454506849|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
126331100|NCT01737879|454506850|FG000|Overall Study|Death|1|||
126331101|NCT01737879|454506850|FG000|Overall Study|Sponsor decision|40|||
126331102|NCT05285787|454506851|FG000|Overall Study|Withdrawal by Subject|1|||
126331103|NCT02360280|454506855|FG000|Overall Study|Withdrawal by Subject|2|||
126331104|NCT02360280|454506856|FG001|Overall Study|Withdrawal by Subject|0|||
126331105|NCT02360280|454506855|FG000|Overall Study|Adverse Event|0|||
126331106|NCT02360280|454506856|FG001|Overall Study|Adverse Event|1|||
126331107|NCT02360280|454506855|FG000|Overall Study|Lost to Follow-up|1|||
126331108|NCT02360280|454506856|FG001|Overall Study|Lost to Follow-up|0|||
126331109|NCT02472886|454506857|FG000|Overall Study|Lack of Efficacy|0|||
126331110|NCT02472886|454506858|FG001|Overall Study|Lack of Efficacy|2|||
126331111|NCT02472886|454506859|FG002|Overall Study|Lack of Efficacy|1|||
126331112|NCT00320788|454506860|FG000|Overall Study|Adverse Event|0|||
126331113|NCT00320788|454506861|FG001|Overall Study|Adverse Event|0|||
126331114|NCT00320788|454506862|FG002|Overall Study|Adverse Event|0|||
126331115|NCT00320788|454506863|FG003|Overall Study|Adverse Event|1|||
126331116|NCT00320788|454506864|FG004|Overall Study|Adverse Event|0|||
126331117|NCT00320788|454506860|FG000|Overall Study|Death|0|||
126331118|NCT00320788|454506861|FG001|Overall Study|Death|0|||
126331119|NCT00320788|454506862|FG002|Overall Study|Death|1|||
126331120|NCT00320788|454506863|FG003|Overall Study|Death|0|||
126331121|NCT00320788|454506864|FG004|Overall Study|Death|1|||
126331122|NCT00320788|454506860|FG000|Overall Study|Lost to Follow-up|0|||
126331123|NCT00320788|454506861|FG001|Overall Study|Lost to Follow-up|2|||
126331124|NCT00320788|454506862|FG002|Overall Study|Lost to Follow-up|1|||
126331125|NCT00320788|454506863|FG003|Overall Study|Lost to Follow-up|0|||
126331126|NCT00320788|454506864|FG004|Overall Study|Lost to Follow-up|0|||
126331127|NCT00320788|454506860|FG000|Overall Study|Decision by the Sponsor|1|||
126331128|NCT00320788|454506861|FG001|Overall Study|Decision by the Sponsor|1|||
126331129|NCT00320788|454506862|FG002|Overall Study|Decision by the Sponsor|0|||
126331130|NCT00320788|454506863|FG003|Overall Study|Decision by the Sponsor|0|||
126331131|NCT00320788|454506864|FG004|Overall Study|Decision by the Sponsor|1|||
126331132|NCT00320788|454506860|FG000|Overall Study|Other|1|||
126331133|NCT00320788|454506861|FG001|Overall Study|Other|2|||
126331134|NCT00320788|454506862|FG002|Overall Study|Other|1|||
126331135|NCT00320788|454506863|FG003|Overall Study|Other|1|||
126331136|NCT00320788|454506864|FG004|Overall Study|Other|1|||
126331137|NCT00320788|454506860|FG000|Overall Study|Physician Decision|1|||
126331138|NCT00320788|454506861|FG001|Overall Study|Physician Decision|1|||
126331139|NCT00320788|454506862|FG002|Overall Study|Physician Decision|0|||
126662623|NCT00381303|455723049|FG000|Overall Study|Ineligible to continue the trial|2|||
126662624|NCT00381303|455723050|FG001|Overall Study|Ineligible to continue the trial|1|||
126662625|NCT00381303|455723049|FG000|Overall Study|Pregnancy|2|||
126662626|NCT00381303|455723050|FG001|Overall Study|Pregnancy|0|||
126662627|NCT00381303|455723049|FG000|Overall Study|Physician Decision|1|||
126662628|NCT00381303|455723050|FG001|Overall Study|Physician Decision|0|||
126662629|NCT00381303|455723049|FG000|Overall Study|Physician's decision to close the site|3|||
126662630|NCT00381303|455723050|FG001|Overall Study|Physician's decision to close the site|1|||
126662631|NCT00381303|455723049|FG000|Overall Study|Subject moved out of state|2|||
126662632|NCT00381303|455723050|FG001|Overall Study|Subject moved out of state|0|||
126662633|NCT00381303|455723049|FG000|Overall Study|Subject taking too many different meds|1|||
126662634|NCT00381303|455723050|FG001|Overall Study|Subject taking too many different meds|0|||
126662635|NCT00381303|455723049|FG000|Overall Study|No virologic response by week 12|1|||
126662636|NCT00381303|455723050|FG001|Overall Study|No virologic response by week 12|0|||
126662637|NCT00381303|455723049|FG000|Overall Study|Subject was too busy for appointments|1|||
126662638|NCT00381303|455723050|FG001|Overall Study|Subject was too busy for appointments|0|||
126662639|NCT00381303|455723049|FG000|Overall Study|Subject did not continue visits|1|||
126662640|NCT00381303|455723050|FG001|Overall Study|Subject did not continue visits|0|||
126662641|NCT00381303|455723049|FG000|Overall Study|Subject primary physician's decision|1|||
126662642|NCT00381303|455723050|FG001|Overall Study|Subject primary physician's decision|0|||
126662643|NCT01966471|455723053|FG000|Overall Study|Death|44|||
126662644|NCT01966471|455723054|FG001|Overall Study|Death|56|||
126662645|NCT01966471|455723053|FG000|Overall Study|Lost to Follow-up|46|||
126662646|NCT01966471|455723054|FG001|Overall Study|Lost to Follow-up|39|||
126662647|NCT01966471|455723053|FG000|Overall Study|Various reasons|4|||
126662648|NCT01966471|455723054|FG001|Overall Study|Various reasons|4|||
126662649|NCT01966471|455723053|FG000|Overall Study|Physician Decision|7|||
126662650|NCT01966471|455723054|FG001|Overall Study|Physician Decision|5|||
126662651|NCT01966471|455723053|FG000|Overall Study|Study Terminated By Sponsor|758|||
126662652|NCT01966471|455723054|FG001|Overall Study|Study Terminated By Sponsor|773|||
126662653|NCT01966471|455723053|FG000|Overall Study|Withdrawal by Subject|59|||
126662654|NCT01966471|455723054|FG001|Overall Study|Withdrawal by Subject|51|||
126662655|NCT01030198|455723055|FG000|Overall Study|Could not measure efficacy accurately|0|||
126662656|NCT01030198|455723056|FG001|Overall Study|Could not measure efficacy accurately|7|||
126662657|NCT02370043|455723057|FG000|Overall Study|Withdrawal by Subject|0|||
126662658|NCT02370043|455723058|FG001|Overall Study|Withdrawal by Subject|0|||
126662659|NCT02370043|455723059|FG002|Overall Study|Withdrawal by Subject|0|||
126662660|NCT02370043|455723060|FG003|Overall Study|Withdrawal by Subject|0|||
126662661|NCT02370043|455723061|FG004|Overall Study|Withdrawal by Subject|1|||
126662662|NCT02370043|455723062|FG005|Overall Study|Withdrawal by Subject|1|||
126662663|NCT00688181|455723063|FG000|Overall Study|Lost to Follow-up|17|||
126662664|NCT00688181|455723063|FG000|Overall Study|Unknown Reason|4|||
126662665|NCT00688181|455723063|FG000|Overall Study|Non-clinical Reason|2|||
126662666|NCT01050205|455723064|FG000|Overall Study|Lost to Follow-up|7|||
126662667|NCT01050205|455723065|FG001|Overall Study|Lost to Follow-up|1|||
126662668|NCT01050205|455723064|FG000|Overall Study|Withdrawal by Subject|1|||
126662669|NCT01050205|455723065|FG001|Overall Study|Withdrawal by Subject|1|||
126662670|NCT01050205|455723064|FG000|Overall Study|Relocated from area|1|||
126662671|NCT01050205|455723065|FG001|Overall Study|Relocated from area|2|||
126662672|NCT01050205|455723064|FG000|Overall Study|Discontinued Intervention|2|||
126662673|NCT01050205|455723065|FG001|Overall Study|Discontinued Intervention|0|||
126662674|NCT01119001|455723066|FG000|Overall Study|Withdrawal by Subject|2|||
126662675|NCT00954421|455723067|FG000|Screening|screen failures|3|||
126662676|NCT00954421|455723067|FG000|6 Months of DBS|Withdrawal by Subject|1|||
126662677|NCT00954421|455723067|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
126662678|NCT00633061|455723068|FG000|Overall Study|Study closed|86|||
126662679|NCT00633061|455723069|FG001|Overall Study|Study closed|0|||
126662680|NCT05245097|455723070|FG000|Overall Study|Adverse Event|13|||
126662681|NCT05245097|455723071|FG001|Overall Study|Adverse Event|2|||
126662682|NCT05245097|455723070|FG000|Overall Study|Protocol Violation|8|||
126662683|NCT05245097|455723071|FG001|Overall Study|Protocol Violation|6|||
126662684|NCT05245097|455723070|FG000|Overall Study|Withdrawal by Subject|18|||
126662685|NCT05245097|455723071|FG001|Overall Study|Withdrawal by Subject|0|||
126662686|NCT05245097|455723070|FG000|Overall Study|Death|6|||
126662687|NCT05245097|455723071|FG001|Overall Study|Death|7|||
126662688|NCT05245097|455723070|FG000|Overall Study|Physician Decision|6|||
126545272|NCT01641926|455290785|FG002|Overall Study|Withdrawal by Subject|6|||
126662689|NCT05245097|455723071|FG001|Overall Study|Physician Decision|0|||
126662690|NCT05245097|455723070|FG000|Overall Study|Relocation|4|||
126662691|NCT05245097|455723071|FG001|Overall Study|Relocation|3|||
126662692|NCT00607022|455723079|FG000|Overall Study|Withdrawal by Subject|1|||
126662693|NCT00607022|455723080|FG001|Overall Study|Withdrawal by Subject|0|||
126662694|NCT00607022|455723081|FG002|Overall Study|Withdrawal by Subject|0|||
126662695|NCT00810394|455723082|FG000|Overall Study|Withdrawal by Subject|3|||
126662696|NCT03254485|455723083|FG000|Overall Study|Adverse Event|3|||
126545273|NCT01641926|455290786|FG003|Overall Study|Withdrawal by Subject|1|||
126662697|NCT03254485|455723084|FG001|Overall Study|Adverse Event|0|||
126662698|NCT03254485|455723085|FG002|Overall Study|Adverse Event|0|||
126662699|NCT03254485|455723086|FG003|Overall Study|Adverse Event|6|||
126662700|NCT03254485|455723083|FG000|Overall Study|Protocol Violation|6|||
126662701|NCT03254485|455723084|FG001|Overall Study|Protocol Violation|0|||
126662702|NCT03254485|455723085|FG002|Overall Study|Protocol Violation|0|||
126662703|NCT03254485|455723086|FG003|Overall Study|Protocol Violation|2|||
126662704|NCT03254485|455723083|FG000|Overall Study|Withdrawal by Subject|1|||
126662705|NCT03254485|455723084|FG001|Overall Study|Withdrawal by Subject|0|||
126662706|NCT03254485|455723085|FG002|Overall Study|Withdrawal by Subject|0|||
126662707|NCT03254485|455723086|FG003|Overall Study|Withdrawal by Subject|4|||
126662708|NCT03254485|455723083|FG000|Overall Study|Death|0|||
126662709|NCT03254485|455723084|FG001|Overall Study|Death|0|||
126662710|NCT03254485|455723085|FG002|Overall Study|Death|0|||
126662711|NCT03254485|455723086|FG003|Overall Study|Death|1|||
126662712|NCT03254485|455723083|FG000|Overall Study|Lost to Follow-up|1|||
126662713|NCT03254485|455723084|FG001|Overall Study|Lost to Follow-up|0|||
126662714|NCT03254485|455723085|FG002|Overall Study|Lost to Follow-up|0|||
126662715|NCT03254485|455723086|FG003|Overall Study|Lost to Follow-up|0|||
126662716|NCT03254485|455723083|FG000|Overall Study|Other|1|||
126662717|NCT03254485|455723084|FG001|Overall Study|Other|0|||
126662718|NCT03254485|455723085|FG002|Overall Study|Other|0|||
126662719|NCT03254485|455723086|FG003|Overall Study|Other|2|||
126662720|NCT00777946|455723087|FG000|Overall Study|Adverse Event|11|||
126662721|NCT00777946|455723088|FG001|Overall Study|Adverse Event|1|||
126662722|NCT00777946|455723089|FG002|Overall Study|Adverse Event|3|||
126662723|NCT00777946|455723087|FG000|Overall Study|Lack of Efficacy|0|||
126662724|NCT00777946|455723088|FG001|Overall Study|Lack of Efficacy|0|||
126662725|NCT00777946|455723089|FG002|Overall Study|Lack of Efficacy|9|||
126662726|NCT00777946|455723087|FG000|Overall Study|Condition no longer required study drug|1|||
126662727|NCT00777946|455723088|FG001|Overall Study|Condition no longer required study drug|0|||
126662728|NCT00777946|455723089|FG002|Overall Study|Condition no longer required study drug|0|||
126662729|NCT00777946|455723087|FG000|Overall Study|Patient withdrew consent|3|||
126662730|NCT00777946|455723088|FG001|Overall Study|Patient withdrew consent|2|||
126662731|NCT00777946|455723089|FG002|Overall Study|Patient withdrew consent|3|||
126662732|NCT00777946|455723087|FG000|Overall Study|Lost to Follow-up|3|||
126662733|NCT00777946|455723088|FG001|Overall Study|Lost to Follow-up|1|||
126662734|NCT00777946|455723089|FG002|Overall Study|Lost to Follow-up|0|||
126662735|NCT00777946|455723087|FG000|Overall Study|Protocol deviation|2|||
126662736|NCT00777946|455723088|FG001|Overall Study|Protocol deviation|1|||
126662737|NCT00777946|455723089|FG002|Overall Study|Protocol deviation|1|||
126662738|NCT00777946|455723087|FG000|Overall Study|Randomized in error|1|||
126662739|NCT00777946|455723088|FG001|Overall Study|Randomized in error|1|||
126662740|NCT00777946|455723089|FG002|Overall Study|Randomized in error|0|||
126662741|NCT04675151|455723090|FG000|Overall Study|Protocol Violation|1|||
126662742|NCT04675151|455723091|FG001|Overall Study|Protocol Violation|0|||
126662743|NCT04675151|455723092|FG002|Overall Study|Protocol Violation|0|||
126662744|NCT04675151|455723093|FG003|Overall Study|Protocol Violation|1|||
126662745|NCT01598311|455723095|FG000|Overall Study|Physician Decision|4|||
126662746|NCT01598311|455723096|FG001|Overall Study|Physician Decision|5|||
126662747|NCT01598311|455723095|FG000|Overall Study|Adverse Event|9|||
126662748|NCT01598311|455723096|FG001|Overall Study|Adverse Event|13|||
126662749|NCT01598311|455723095|FG000|Overall Study|Lost to Follow-up|7|||
126662750|NCT01598311|455723096|FG001|Overall Study|Lost to Follow-up|12|||
126662751|NCT01598311|455723095|FG000|Overall Study|Withdrawal by Subject|9|||
126662752|NCT01598311|455723096|FG001|Overall Study|Withdrawal by Subject|13|||
126662753|NCT01598311|455723095|FG000|Overall Study|No reason provided.|0|||
126662754|NCT01598311|455723096|FG001|Overall Study|No reason provided.|5|||
126662755|NCT01598311|455723095|FG000|Overall Study|Randomized but never treated|8|||
126662756|NCT01598311|455723096|FG001|Overall Study|Randomized but never treated|5|||
126662757|NCT01598311|455723095|FG000|Overall Study|Treated but no confirmed CDAD|9|||
126662758|NCT01598311|455723096|FG001|Overall Study|Treated but no confirmed CDAD|8|||
126662759|NCT01598311|455723095|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
126662760|NCT01598311|455723096|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
126662761|NCT05677893|455724732|FG000|Overall Study|Withdrawal by Subject|0|||
126662762|NCT05677893|455724733|FG001|Overall Study|Withdrawal by Subject|0|||
126662763|NCT05677893|455724734|FG002|Overall Study|Withdrawal by Subject|0|||
126662764|NCT05677893|455724735|FG003|Overall Study|Withdrawal by Subject|0|||
126662765|NCT05677893|455724736|FG004|Overall Study|Withdrawal by Subject|1|||
126662766|NCT05677893|455724737|FG005|Overall Study|Withdrawal by Subject|1|||
126662767|NCT05677893|455724738|FG006|Overall Study|Withdrawal by Subject|0|||
126662768|NCT05677893|455724732|FG000|Overall Study|Others|1|||
126662769|NCT05677893|455724733|FG001|Overall Study|Others|0|||
126662770|NCT05677893|455724734|FG002|Overall Study|Others|0|||
126662771|NCT05677893|455724735|FG003|Overall Study|Others|0|||
126662772|NCT05677893|455724736|FG004|Overall Study|Others|0|||
126662773|NCT05677893|455724737|FG005|Overall Study|Others|0|||
126662774|NCT05677893|455724738|FG006|Overall Study|Others|0|||
126662775|NCT00720941|455724739|FG000|Overall Study|Protocol Violation|1|||
126662776|NCT00720941|455724740|FG001|Overall Study|Protocol Violation|2|||
126662777|NCT00720941|455724739|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
126662778|NCT00720941|455724740|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
126662779|NCT00720941|455724739|FG000|Overall Study|Lost to Follow-up|20|||
126662780|NCT00720941|455724740|FG001|Overall Study|Lost to Follow-up|15|||
126662781|NCT00720941|455724739|FG000|Overall Study|Physician Decision|14|||
126662782|NCT00720941|455724740|FG001|Overall Study|Physician Decision|12|||
126662783|NCT00720941|455724739|FG000|Overall Study|Withdrawal by Subject|29|||
126662784|NCT00720941|455724740|FG001|Overall Study|Withdrawal by Subject|36|||
126662785|NCT00604279|455724741|FG000|Overall Study|Lack of Efficacy|22|||
126662786|NCT00604279|455724742|FG001|Overall Study|Lack of Efficacy|9|||
126662787|NCT00604279|455724741|FG000|Overall Study|Lost to Follow-up|9|||
126662788|NCT00604279|455724742|FG001|Overall Study|Lost to Follow-up|14|||
126662789|NCT00604279|455724741|FG000|Overall Study|Pregnancy|2|||
126662790|NCT00604279|455724742|FG001|Overall Study|Pregnancy|0|||
126662791|NCT00604279|455724741|FG000|Overall Study|Protocol Violation|3|||
126662792|NCT00604279|455724742|FG001|Overall Study|Protocol Violation|1|||
126662793|NCT00604279|455724741|FG000|Overall Study|Withdrawal by Subject|16|||
126662794|NCT00604279|455724742|FG001|Overall Study|Withdrawal by Subject|5|||
126662795|NCT00604279|455724741|FG000|Overall Study|Adverse Event|4|||
126662796|NCT00604279|455724742|FG001|Overall Study|Adverse Event|5|||
126662797|NCT00604279|455724741|FG000|Overall Study|Other|8|||
126662798|NCT00604279|455724742|FG001|Overall Study|Other|4|||
126662799|NCT00355056|455724743|FG000|Randomization Period|Early Termination|4|||
126662800|NCT00355056|455724744|FG001|Randomization Period|Early Termination|6|||
126662801|NCT01072877|455724745|FG000|Overall Study|Lost to Follow-up|1|||
126662802|NCT01072877|455724746|FG001|Overall Study|Lost to Follow-up|1|||
126662803|NCT01072877|455724747|FG002|Overall Study|Lost to Follow-up|0|||
126662804|NCT01072877|455724748|FG003|Overall Study|Lost to Follow-up|2|||
126662805|NCT01072877|455724749|FG004|Overall Study|Lost to Follow-up|0|||
126662806|NCT02720536|455724750|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
126662807|NCT02720536|455724750|FG000|Overall Study|PR - pregnancy|2|||
126662808|NCT02720536|455724750|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
126662809|NCT02720536|455724750|FG000|Overall Study|PR - death|1|||
126662810|NCT02720536|455724750|FG000|Overall Study|PR - adverse event|1|||
126662811|NCT02720536|455724750|FG000|Overall Study|PR - abnormal lab value(s)|1|||
126662812|NCT02720536|455724750|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
126662813|NCT01717989|455724753|FG000|Overall Study|Ineligibility determined|6|||
126662814|NCT01717989|455724753|FG000|Overall Study|Protocol deviation|6|||
126662815|NCT01717989|455724753|FG000|Overall Study|Withdrawal by Subject|11|||
126662816|NCT01717989|455724753|FG000|Overall Study|Physician Decision|2|||
126662817|NCT01717989|455724753|FG000|Overall Study|Lost to Follow-up|11|||
126662818|NCT01717989|455724753|FG000|Overall Study|Death|439|||
126662819|NCT01717989|455724753|FG000|Overall Study|Protocol-specified criteria|551|||
126662820|NCT01717989|455724753|FG000|Overall Study|Other|40|||
126662821|NCT03224325|455724754|FG000|Overall Study|Adverse Event|1|||
126662822|NCT03224325|455724755|FG001|Overall Study|Adverse Event|0|||
126662823|NCT03224325|455724756|FG002|Overall Study|Adverse Event|0|||
126662824|NCT03224325|455724757|FG003|Overall Study|Adverse Event|0|||
126662825|NCT03224325|455724758|FG004|Overall Study|Adverse Event|0|||
126662826|NCT03224325|455724759|FG005|Overall Study|Adverse Event|0|||
126662827|NCT03224325|455724760|FG006|Overall Study|Adverse Event|1|||
126662828|NCT03224325|455724754|FG000|Overall Study|Withdrawal by Subject|0|||
126331140|NCT00320788|454506863|FG003|Overall Study|Physician Decision|0|||
126331141|NCT00320788|454506864|FG004|Overall Study|Physician Decision|0|||
126331142|NCT00320788|454506860|FG000|Overall Study|Protocol Violation|0|||
126331143|NCT00320788|454506861|FG001|Overall Study|Protocol Violation|0|||
126331144|NCT00320788|454506862|FG002|Overall Study|Protocol Violation|0|||
126331145|NCT00320788|454506863|FG003|Overall Study|Protocol Violation|0|||
126331146|NCT00320788|454506864|FG004|Overall Study|Protocol Violation|1|||
126331147|NCT00320788|454506860|FG000|Overall Study|Withdrawal by Subject|3|||
126331148|NCT00320788|454506861|FG001|Overall Study|Withdrawal by Subject|0|||
126662829|NCT03224325|455724755|FG001|Overall Study|Withdrawal by Subject|0|||
126662830|NCT03224325|455724756|FG002|Overall Study|Withdrawal by Subject|0|||
126662831|NCT03224325|455724757|FG003|Overall Study|Withdrawal by Subject|1|||
126662832|NCT03224325|455724758|FG004|Overall Study|Withdrawal by Subject|0|||
126662833|NCT03224325|455724759|FG005|Overall Study|Withdrawal by Subject|0|||
126662834|NCT03224325|455724760|FG006|Overall Study|Withdrawal by Subject|0|||
126662835|NCT00937833|455724762|FG000|Overall Study|Protocol Violation|1|||
126662836|NCT00937833|455724763|FG001|Overall Study|Protocol Violation|2|||
126662837|NCT00937833|455724762|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
126662838|NCT00937833|455724763|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
126331149|NCT00320788|454506862|FG002|Overall Study|Withdrawal by Subject|0|||
126331150|NCT00320788|454506863|FG003|Overall Study|Withdrawal by Subject|3|||
126662839|NCT00937833|455724762|FG000|Overall Study|Lost to Follow-up|10|||
126662840|NCT00937833|455724763|FG001|Overall Study|Lost to Follow-up|8|||
126662841|NCT00937833|455724762|FG000|Overall Study|Withdrawal by Subject|4|||
126662842|NCT00937833|455724763|FG001|Overall Study|Withdrawal by Subject|6|||
126662843|NCT00818389|455724765|FG000|Overall Study|Death|1|||
126662844|NCT00818389|455724766|FG001|Overall Study|Death|3|||
126662845|NCT00818389|455724765|FG000|Overall Study|ALS Disease Progression|1|||
126331151|NCT00320788|454506864|FG004|Overall Study|Withdrawal by Subject|1|||
126331152|NCT00627926|454506865|FG000|Overall Study|Adverse Event|26|||
126331153|NCT00627926|454506866|FG001|Overall Study|Adverse Event|37|||
126331154|NCT00627926|454506867|FG002|Overall Study|Adverse Event|36|||
126331155|NCT00627926|454506865|FG000|Overall Study|Death|1|||
126662846|NCT00818389|455724766|FG001|Overall Study|ALS Disease Progression|0|||
126662847|NCT00818389|455724765|FG000|Overall Study|Withdrawal by Subject|2|||
126662848|NCT00818389|455724766|FG001|Overall Study|Withdrawal by Subject|2|||
126662849|NCT00818389|455724765|FG000|Overall Study|Adverse Event|0|||
126331156|NCT00627926|454506866|FG001|Overall Study|Death|0|||
126331157|NCT00627926|454506867|FG002|Overall Study|Death|0|||
126331158|NCT00627926|454506865|FG000|Overall Study|Lost to Follow-up|4|||
126662850|NCT00818389|455724766|FG001|Overall Study|Adverse Event|1|||
126662851|NCT03548987|455724767|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
126662852|NCT03548987|455724768|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
126662853|NCT03548987|455724767|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
126662854|NCT03548987|455724768|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
126662855|NCT03548987|455724767|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
126662856|NCT03548987|455724768|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
126662857|NCT03548987|455724767|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
126662858|NCT03548987|455724768|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
126662859|NCT03548987|455724767|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
126662860|NCT03548987|455724768|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
126662861|NCT03548987|455724767|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
126662862|NCT03548987|455724768|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
126662863|NCT03548987|455724767|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
126662864|NCT03548987|455724768|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
126662865|NCT03548987|455724767|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
126662866|NCT03548987|455724768|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
126662867|NCT03548987|455724767|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
126662868|NCT03548987|455724768|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
126662869|NCT03548987|455724767|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
126662870|NCT03548987|455724768|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
126662871|NCT03548987|455724767|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
126662872|NCT03548987|455724768|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
126662873|NCT03548987|455724767|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
126662874|NCT03548987|455724768|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
126662875|NCT03548987|455724767|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
126662876|NCT03548987|455724768|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
126662877|NCT03548987|455724767|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
126662878|NCT03548987|455724768|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
126662879|NCT00756470|455724773|FG000|Overall Study|Withdrawal by Subject|1|||
126662880|NCT00756470|455724773|FG000|Overall Study|Adverse Event|4|||
126662881|NCT03181451|455724774|FG000|Overall Study|Adverse Event|0|||
126662882|NCT03181451|455724775|FG001|Overall Study|Adverse Event|1|||
126662883|NCT03181451|455724776|FG002|Overall Study|Adverse Event|0|||
126662884|NCT03181451|455724774|FG000|Overall Study|Withdrawal by Subject|0|||
126662885|NCT03181451|455724775|FG001|Overall Study|Withdrawal by Subject|1|||
126662886|NCT03181451|455724776|FG002|Overall Study|Withdrawal by Subject|0|||
126662887|NCT00752622|455724789|FG000|Induction Phase|Adverse Event|3|||
126662888|NCT00752622|455724789|FG000|Induction Phase|Other|3|||
126662889|NCT00752622|455724789|FG000|Induction Phase|Non-responder|14|||
126662890|NCT00752622|455724789|FG000|Induction Phase|Withdrawal by Subject|1|||
126662891|NCT00752622|455724789|FG000|Induction Phase|Premature study termination|14|||
126662892|NCT00752622|455724789|FG000|Observational Phase|Premature Study Termination|36|||
126662893|NCT00752622|455724789|FG000|Observational Phase|Non-responder|2|||
126662894|NCT00752622|455724789|FG000|Observational Phase|Withdrawal by Subject|2|||
126662895|NCT00752622|455724789|FG000|Observational Phase|Adverse Event|1|||
126662896|NCT00752622|455724789|FG000|Observational Phase|Other|2|||
126662897|NCT00752622|455724789|FG000|Interventional Phase|Non-responder|2|||
126662898|NCT00752622|455724789|FG000|Interventional Phase|Physician Decision|1|||
126331159|NCT00627926|454506866|FG001|Overall Study|Lost to Follow-up|3|||
126662899|NCT00752622|455724789|FG000|Interventional Phase|Premature Study Termination|5|||
126662900|NCT00576836|455724790|FG000|Overall Study|Death|0|||
126662901|NCT00576836|455724791|FG001|Overall Study|Death|1|||
126662902|NCT00576836|455724790|FG000|Overall Study|Physician Decision|0|||
126662903|NCT00576836|455724791|FG001|Overall Study|Physician Decision|1|||
126331160|NCT00627926|454506867|FG002|Overall Study|Lost to Follow-up|4|||
126662904|NCT02520284|455724792|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
126662905|NCT02520284|455724793|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
126662906|NCT02520284|455724794|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
126662907|NCT02520284|455724792|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
126662908|NCT02520284|455724793|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
126662909|NCT02520284|455724794|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
126662910|NCT02520284|455724792|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
126662911|NCT02520284|455724793|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
126662912|NCT02520284|455724794|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
126662913|NCT02520284|455724792|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
126662914|NCT02520284|455724793|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
126662915|NCT02520284|455724794|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
126662916|NCT02520284|455724792|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
126662917|NCT02520284|455724793|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
126662918|NCT02520284|455724794|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
126662919|NCT02520284|455724792|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
126662920|NCT02520284|455724793|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
126662921|NCT02520284|455724794|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
126662922|NCT02520284|455724792|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
126662923|NCT02520284|455724793|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
126662924|NCT02520284|455724794|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
126662925|NCT02520284|455724792|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
126662926|NCT02520284|455724793|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
126662927|NCT02520284|455724794|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
126662928|NCT02520284|455724792|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
126662929|NCT02520284|455724793|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
126662930|NCT02520284|455724794|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
126662931|NCT02520284|455724792|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
126662932|NCT02520284|455724793|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
126662933|NCT02520284|455724794|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
126662934|NCT02520284|455724792|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
126662935|NCT02520284|455724793|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
126662936|NCT02520284|455724794|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
126662937|NCT01211522|455724798|FG000|Overall Study|Withdrawal by Subject|3|||
126662938|NCT01211522|455724799|FG001|Overall Study|Withdrawal by Subject|7|||
126662939|NCT01211522|455724800|FG002|Overall Study|Withdrawal by Subject|5|||
126662940|NCT01116882|455724806|FG000|30-day|Lost to Follow-up|50|||
126662941|NCT01116882|455724807|FG001|30-day|Lost to Follow-up|21|||
126662942|NCT01116882|455724806|FG000|30-day|Withdrawal by Subject|2|||
126662943|NCT01116882|455724807|FG001|30-day|Withdrawal by Subject|4|||
126662944|NCT01116882|455724806|FG000|30-day|Other Reasons|16|||
126662945|NCT01116882|455724807|FG001|30-day|Other Reasons|6|||
126662946|NCT01116882|455724806|FG000|12-month|Lost to Follow-up|111|||
126662947|NCT01116882|455724807|FG001|12-month|Lost to Follow-up|42|||
126662948|NCT01116882|455724806|FG000|12-month|Other Reasons|151|||
126662949|NCT01116882|455724807|FG001|12-month|Other Reasons|49|||
126662950|NCT01116882|455724806|FG000|12-month|Withdrawal by Subject|5|||
126662951|NCT01116882|455724807|FG001|12-month|Withdrawal by Subject|8|||
126662952|NCT00547365|455724808|FG000|Overall Study|Physician Decision|1|||
126662953|NCT00547365|455724808|FG000|Overall Study|Lost to Follow-up|1|||
126662954|NCT00547365|455724808|FG000|Overall Study|Protocol Violation|2|||
126662955|NCT00547365|455724808|FG000|Overall Study|death (not related to study)|4|||
126662956|NCT01139658|455724809|FG000|Overall Study|Adverse Event|10|||
126662957|NCT01139658|455724810|FG001|Overall Study|Adverse Event|27|||
126662958|NCT01139658|455724809|FG000|Overall Study|Lack of Efficacy|15|||
126662959|NCT01139658|455724810|FG001|Overall Study|Lack of Efficacy|7|||
126662960|NCT01139658|455724809|FG000|Overall Study|Withdrawal by Subject|2|||
126662961|NCT01139658|455724810|FG001|Overall Study|Withdrawal by Subject|4|||
126662962|NCT01139658|455724809|FG000|Overall Study|No documentation of treatment|1|||
126662963|NCT01139658|455724810|FG001|Overall Study|No documentation of treatment|0|||
126662964|NCT01139658|455724809|FG000|Overall Study|Other|28|||
126662965|NCT01139658|455724810|FG001|Overall Study|Other|75|||
126662966|NCT01777269|455724811|FG000|Overall Study|Adverse Event|24|||
126662967|NCT01777269|455724812|FG001|Overall Study|Adverse Event|33|||
126331161|NCT00627926|454506865|FG000|Overall Study|Withdrawal by Subject|2|||
126331162|NCT00627926|454506866|FG001|Overall Study|Withdrawal by Subject|1|||
126331163|NCT00627926|454506867|FG002|Overall Study|Withdrawal by Subject|0|||
126331164|NCT00627926|454506865|FG000|Overall Study|Lack of Efficacy|118|||
126662968|NCT01777269|455724811|FG000|Overall Study|Lack of Efficacy|8|||
126331165|NCT00627926|454506866|FG001|Overall Study|Lack of Efficacy|40|||
126331166|NCT00627926|454506867|FG002|Overall Study|Lack of Efficacy|38|||
126331167|NCT00627926|454506865|FG000|Overall Study|Noncompliance/unspecified|8|||
126662969|NCT01777269|455724812|FG001|Overall Study|Lack of Efficacy|10|||
126662970|NCT01777269|455724811|FG000|Overall Study|Protocol Violation|4|||
126662971|NCT01777269|455724812|FG001|Overall Study|Protocol Violation|4|||
126662972|NCT01777269|455724811|FG000|Overall Study|Participants reached stopping criteria|1|||
126662973|NCT01777269|455724812|FG001|Overall Study|Participants reached stopping criteria|1|||
126662974|NCT01777269|455724811|FG000|Overall Study|Lost to Follow-up|4|||
126662975|NCT01777269|455724812|FG001|Overall Study|Lost to Follow-up|0|||
126662976|NCT01777269|455724811|FG000|Overall Study|Physician Decision|5|||
126662977|NCT01777269|455724812|FG001|Overall Study|Physician Decision|2|||
126662978|NCT01777269|455724811|FG000|Overall Study|Withdrawal by Subject|9|||
126662979|NCT01777269|455724812|FG001|Overall Study|Withdrawal by Subject|9|||
126662980|NCT00504881|455724813|FG000|Overall Study|Lack of Efficacy|1|||
126662981|NCT00504881|455724814|FG001|Overall Study|Lack of Efficacy|5|||
126662982|NCT00504881|455724813|FG000|Overall Study|Lost to Follow-up|0|||
126662983|NCT00504881|455724814|FG001|Overall Study|Lost to Follow-up|2|||
126662984|NCT00504881|455724813|FG000|Overall Study|Withdrawal by Subject|1|||
126662985|NCT00504881|455724814|FG001|Overall Study|Withdrawal by Subject|4|||
126662986|NCT00504881|455724813|FG000|Overall Study|Non-Compliance|1|||
126662987|NCT00504881|455724814|FG001|Overall Study|Non-Compliance|0|||
126662988|NCT00504881|455724813|FG000|Overall Study|No Birth Control|0|||
126662989|NCT00504881|455724814|FG001|Overall Study|No Birth Control|1|||
126662990|NCT00504881|455724813|FG000|Overall Study|Safety Visit not performed|0|||
126662991|NCT00504881|455724814|FG001|Overall Study|Safety Visit not performed|1|||
126662992|NCT00504881|455724813|FG000|Overall Study|AE, serious fatal|0|||
126662993|NCT00504881|455724814|FG001|Overall Study|AE, serious fatal|1|||
126662994|NCT00504881|455724813|FG000|Overall Study|SAE, non-fatal|2|||
126662995|NCT00504881|455724814|FG001|Overall Study|SAE, non-fatal|6|||
126662996|NCT00504881|455724813|FG000|Overall Study|AE, non-serious non-fatal|4|||
126662997|NCT00504881|455724814|FG001|Overall Study|AE, non-serious non-fatal|14|||
126662998|NCT00504881|455724813|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
126662999|NCT00504881|455724814|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
126663000|NCT00504881|455724813|FG000|Overall Study|AE of unknown type|1|||
126663001|NCT00504881|455724814|FG001|Overall Study|AE of unknown type|0|||
126663002|NCT00593957|455724819|FG000|Overall Study|Physician Decision|0|||
126663003|NCT00593957|455724820|FG001|Overall Study|Physician Decision|1|||
126663004|NCT00593957|455724821|FG002|Overall Study|Physician Decision|2|||
126663005|NCT00494481|455724824|FG000|Overall Study|Condition under investigation worsened|11|||
126663006|NCT00494481|455724825|FG001|Overall Study|Condition under investigation worsened|13|||
126663007|NCT00494481|455724824|FG000|Overall Study|Adverse Event|15|||
126663008|NCT00494481|455724825|FG001|Overall Study|Adverse Event|11|||
126663009|NCT00494481|455724824|FG000|Overall Study|Other|1|||
126663010|NCT00494481|455724825|FG001|Overall Study|Other|0|||
126663011|NCT00494481|455724824|FG000|Overall Study|Never received IP|2|||
126663012|NCT00494481|455724825|FG001|Overall Study|Never received IP|0|||
126663013|NCT00332189|455724826|FG000|Overall Study|Adverse Event|3|||
126663014|NCT00332189|455724826|FG000|Overall Study|Uncooperative/Noncompliant|3|||
126663015|NCT00332189|455724826|FG000|Overall Study|Withdrawal by Subject|9|||
126663016|NCT00332189|455724826|FG000|Overall Study|Lack of Efficacy|4|||
126663017|NCT00332189|455724826|FG000|Overall Study|Moved out of country|2|||
126663018|NCT02279862|455724827|FG000|Overall Study|Study drug toxicity|3|||
126663019|NCT02279862|455724828|FG001|Overall Study|Study drug toxicity|6|||
126663020|NCT02279862|455724827|FG000|Overall Study|No longer meets criteria|0|||
126663021|NCT02279862|455724828|FG001|Overall Study|No longer meets criteria|1|||
126663022|NCT02279862|455724827|FG000|Overall Study|Administrative reason by sponsor|0|||
126663023|NCT02279862|455724828|FG001|Overall Study|Administrative reason by sponsor|1|||
126663024|NCT02279862|455724827|FG000|Overall Study|Disease progression|5|||
126663025|NCT02279862|455724828|FG001|Overall Study|Disease progression|2|||
126663026|NCT02279862|455724827|FG000|Overall Study|Study closed by sponsor|16|||
126663027|NCT02279862|455724828|FG001|Overall Study|Study closed by sponsor|13|||
126663028|NCT02279862|455724827|FG000|Overall Study|Other|1|||
126663029|NCT02279862|455724828|FG001|Overall Study|Other|2|||
126663030|NCT02279862|455724827|FG000|Overall Study|Withdrawal by Subject|1|||
126663031|NCT02279862|455724828|FG001|Overall Study|Withdrawal by Subject|0|||
126663032|NCT01163721|455724829|FG000|Overall Study|Adverse Event|5|||
126663033|NCT01163721|455724830|FG001|Overall Study|Adverse Event|6|||
126663034|NCT01163721|455724829|FG000|Overall Study|Withdrawal by Subject|3|||
126663035|NCT01163721|455724830|FG001|Overall Study|Withdrawal by Subject|4|||
126663036|NCT01163721|455724829|FG000|Overall Study|Lost to Follow-up|0|||
126663037|NCT01163721|455724830|FG001|Overall Study|Lost to Follow-up|1|||
126663038|NCT01163721|455724829|FG000|Overall Study|Physician Decision|0|||
126663039|NCT01163721|455724830|FG001|Overall Study|Physician Decision|1|||
126663040|NCT02511678|455724831|FG000|Overall Study|Withdrawal by Subject|2|||
126663041|NCT02511678|455724831|FG000|Overall Study|Lost to Follow-up|4|||
126663042|NCT02511678|455724831|FG000|Overall Study|Death|19|||
126663043|NCT02511678|455724831|FG000|Overall Study|Adverse Event|1|||
126663044|NCT02511678|455724831|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
126663045|NCT02511678|455724831|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
126663046|NCT02511678|455724831|FG000|Overall Study|Required Radiofrequency Ablation|1|||
126331168|NCT00627926|454506866|FG001|Overall Study|Noncompliance/unspecified|23|||
126331169|NCT00627926|454506867|FG002|Overall Study|Noncompliance/unspecified|17|||
126331170|NCT02797678|454506890|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
126331171|NCT02797678|454506891|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
126663047|NCT02511678|455724831|FG000|Overall Study|Biopsy was Negative|1|||
126663048|NCT02511678|455724831|FG000|Overall Study|Protocol Violation|1|||
126663049|NCT02511678|455724831|FG000|Overall Study|Received Radiation Treatment|1|||
126663050|NCT01295281|455724832|FG000|First Intervention (7 Days)|Death|0|||
126663051|NCT01295281|455724833|FG001|First Intervention (7 Days)|Death|1|||
126663052|NCT01411839|455724835|FG000|Overall Study|Lost to Follow-up|4|||
126663053|NCT01411839|455724836|FG001|Overall Study|Lost to Follow-up|3|||
126663054|NCT05461794|455724839|FG000|Overall Study|Withdrawal by Subject|1|||
126663055|NCT05461794|455724840|FG001|Overall Study|Withdrawal by Subject|1|||
126663056|NCT05461794|455724841|FG002|Overall Study|Withdrawal by Subject|3|||
126663057|NCT05461794|455724839|FG000|Overall Study|Study Terminated By Sponsor|18|||
126663058|NCT05461794|455724840|FG001|Overall Study|Study Terminated By Sponsor|13|||
126663059|NCT05461794|455724841|FG002|Overall Study|Study Terminated By Sponsor|16|||
126663060|NCT05461794|455724839|FG000|Overall Study|Death|20|||
126663061|NCT05461794|455724840|FG001|Overall Study|Death|5|||
126663062|NCT05461794|455724841|FG002|Overall Study|Death|19|||
126663063|NCT00467285|455724842|FG000|Overall Study|Lost to Follow-up|4|||
126663064|NCT00467285|455724843|FG001|Overall Study|Lost to Follow-up|4|||
126663065|NCT02684357|455724844|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
126663066|NCT02684357|455724845|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
126663067|NCT02684357|455724846|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
126663068|NCT02684357|455724847|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
126663069|NCT02684357|455724848|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
126663070|NCT02684357|455724849|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
126663071|NCT02684357|455724844|FG000|Part A|Lost to Follow-up|0|||
126663072|NCT02684357|455724845|FG001|Part A|Lost to Follow-up|2|||
126663073|NCT02684357|455724846|FG002|Part A|Lost to Follow-up|2|||
126663074|NCT02684357|455724847|FG003|Part A|Lost to Follow-up|0|||
126663075|NCT02684357|455724848|FG004|Part A|Lost to Follow-up|0|||
126663076|NCT02684357|455724849|FG005|Part A|Lost to Follow-up|0|||
126663077|NCT02684357|455724844|FG000|Part A|Withdrawal by Subject|3|||
126663078|NCT02684357|455724845|FG001|Part A|Withdrawal by Subject|0|||
126663079|NCT02684357|455724846|FG002|Part A|Withdrawal by Subject|0|||
126663080|NCT02684357|455724847|FG003|Part A|Withdrawal by Subject|0|||
126663081|NCT02684357|455724848|FG004|Part A|Withdrawal by Subject|0|||
126663082|NCT02684357|455724849|FG005|Part A|Withdrawal by Subject|0|||
126663083|NCT02684357|455724844|FG000|Part A|Other|0|||
126663084|NCT02684357|455724845|FG001|Part A|Other|1|||
126663085|NCT02684357|455724846|FG002|Part A|Other|0|||
126663086|NCT02684357|455724847|FG003|Part A|Other|0|||
126663087|NCT02684357|455724848|FG004|Part A|Other|0|||
126663088|NCT02684357|455724849|FG005|Part A|Other|0|||
126663089|NCT02684357|455724844|FG000|Part B|Adverse Event (Other)|0|||
126663090|NCT02684357|455724845|FG001|Part B|Adverse Event (Other)|0|||
126663091|NCT02684357|455724846|FG002|Part B|Adverse Event (Other)|0|||
126663092|NCT02684357|455724847|FG003|Part B|Adverse Event (Other)|1|||
126663093|NCT02684357|455724848|FG004|Part B|Adverse Event (Other)|1|||
126663094|NCT02684357|455724849|FG005|Part B|Adverse Event (Other)|1|||
126663095|NCT02684357|455724844|FG000|Part B|Lost to Follow-up|0|||
126663096|NCT02684357|455724845|FG001|Part B|Lost to Follow-up|0|||
126663097|NCT02684357|455724846|FG002|Part B|Lost to Follow-up|0|||
126663098|NCT02684357|455724847|FG003|Part B|Lost to Follow-up|1|||
126663099|NCT02684357|455724848|FG004|Part B|Lost to Follow-up|1|||
126663100|NCT02684357|455724849|FG005|Part B|Lost to Follow-up|7|||
126663101|NCT02684357|455724844|FG000|Part B|Withdrawal by Subject|0|||
126331172|NCT02797678|454506892|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
126663102|NCT02684357|455724845|FG001|Part B|Withdrawal by Subject|0|||
126663103|NCT02684357|455724846|FG002|Part B|Withdrawal by Subject|0|||
126663104|NCT02684357|455724847|FG003|Part B|Withdrawal by Subject|0|||
126331173|NCT02797678|454506893|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
126663105|NCT02684357|455724848|FG004|Part B|Withdrawal by Subject|2|||
126663106|NCT02684357|455724849|FG005|Part B|Withdrawal by Subject|4|||
126663107|NCT02684357|455724844|FG000|Part B|Other|0|||
126663108|NCT02684357|455724845|FG001|Part B|Other|0|||
126663109|NCT02684357|455724846|FG002|Part B|Other|0|||
126331174|NCT02797678|454506890|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
126663110|NCT02684357|455724847|FG003|Part B|Other|1|||
126663111|NCT02684357|455724848|FG004|Part B|Other|0|||
126663112|NCT02684357|455724849|FG005|Part B|Other|1|||
126663113|NCT01079130|455724850|FG000|Overall Study|Adverse Event|1|||
126663114|NCT01079130|455724851|FG001|Overall Study|Adverse Event|1|||
126663115|NCT01079130|455724852|FG002|Overall Study|Adverse Event|0|||
126663116|NCT01079130|455724853|FG003|Overall Study|Adverse Event|1|||
126663117|NCT01079130|455724854|FG004|Overall Study|Adverse Event|5|||
126663118|NCT01079130|455724855|FG005|Overall Study|Adverse Event|1|||
126663119|NCT01079130|455724850|FG000|Overall Study|Administrative problems|1|||
126663120|NCT01079130|455724851|FG001|Overall Study|Administrative problems|3|||
126663121|NCT01079130|455724852|FG002|Overall Study|Administrative problems|0|||
126663122|NCT01079130|455724853|FG003|Overall Study|Administrative problems|0|||
126663123|NCT01079130|455724854|FG004|Overall Study|Administrative problems|0|||
126663124|NCT01079130|455724855|FG005|Overall Study|Administrative problems|1|||
126663125|NCT01079130|455724850|FG000|Overall Study|Withdrawal by Subject|0|||
126663126|NCT01079130|455724851|FG001|Overall Study|Withdrawal by Subject|1|||
126663127|NCT01079130|455724852|FG002|Overall Study|Withdrawal by Subject|0|||
126663128|NCT01079130|455724853|FG003|Overall Study|Withdrawal by Subject|0|||
126663129|NCT01079130|455724854|FG004|Overall Study|Withdrawal by Subject|1|||
126663130|NCT01079130|455724855|FG005|Overall Study|Withdrawal by Subject|3|||
126663131|NCT01079130|455724850|FG000|Overall Study|Protocol deviation|0|||
126663132|NCT01079130|455724851|FG001|Overall Study|Protocol deviation|2|||
126663133|NCT01079130|455724852|FG002|Overall Study|Protocol deviation|1|||
126663134|NCT01079130|455724853|FG003|Overall Study|Protocol deviation|2|||
126663135|NCT01079130|455724854|FG004|Overall Study|Protocol deviation|0|||
126663136|NCT01079130|455724855|FG005|Overall Study|Protocol deviation|0|||
126663137|NCT01079130|455724850|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126663138|NCT01079130|455724851|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126663139|NCT01079130|455724852|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126663140|NCT01079130|455724853|FG003|Overall Study|Abnormal test procedure result(s)|0|||
126663141|NCT01079130|455724854|FG004|Overall Study|Abnormal test procedure result(s)|1|||
126663142|NCT01079130|455724855|FG005|Overall Study|Abnormal test procedure result(s)|0|||
126663143|NCT01079130|455724850|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126663144|NCT01079130|455724851|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126663145|NCT01079130|455724852|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126663146|NCT01079130|455724853|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
126663147|NCT01079130|455724854|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
126663148|NCT01079130|455724855|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
126663149|NCT01079130|455724850|FG000|Overall Study|Lost to Follow-up|0|||
126663150|NCT01079130|455724851|FG001|Overall Study|Lost to Follow-up|0|||
126663151|NCT01079130|455724852|FG002|Overall Study|Lost to Follow-up|0|||
126663152|NCT01079130|455724853|FG003|Overall Study|Lost to Follow-up|0|||
126663153|NCT01079130|455724854|FG004|Overall Study|Lost to Follow-up|1|||
126663154|NCT01079130|455724855|FG005|Overall Study|Lost to Follow-up|0|||
126663155|NCT01658826|455724873|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
126663156|NCT01658826|455724874|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
126663157|NCT01658826|455724873|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
126663158|NCT01658826|455724874|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
126663159|NCT01658826|455724873|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
126663160|NCT01658826|455724874|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
126663161|NCT01658826|455724873|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
126663162|NCT01658826|455724874|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
126663163|NCT01658826|455724873|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
126663164|NCT01658826|455724874|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
126663165|NCT01658826|455724873|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
126663166|NCT01658826|455724874|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
126663167|NCT01658826|455724873|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
126663168|NCT01658826|455724874|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
126663169|NCT01658826|455724873|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
126663170|NCT01658826|455724874|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
126663171|NCT01658826|455724873|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
126663172|NCT01658826|455724874|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
126663173|NCT00658684|455724875|FG000|Overall Study|Adverse Event|10|||
126663174|NCT00658684|455724876|FG001|Overall Study|Adverse Event|8|||
126663175|NCT00658684|455724877|FG002|Overall Study|Adverse Event|2|||
126663176|NCT00658684|455724878|FG003|Overall Study|Adverse Event|0|||
126663177|NCT00658684|455724875|FG000|Overall Study|Withdrawal by Subject|6|||
126663178|NCT00658684|455724876|FG001|Overall Study|Withdrawal by Subject|4|||
126663179|NCT00658684|455724877|FG002|Overall Study|Withdrawal by Subject|1|||
126663180|NCT00658684|455724878|FG003|Overall Study|Withdrawal by Subject|1|||
126663181|NCT00658684|455724875|FG000|Overall Study|Lack of Efficacy|1|||
126663182|NCT00658684|455724876|FG001|Overall Study|Lack of Efficacy|1|||
126663183|NCT00658684|455724877|FG002|Overall Study|Lack of Efficacy|0|||
126663184|NCT00658684|455724878|FG003|Overall Study|Lack of Efficacy|0|||
126663185|NCT00658684|455724875|FG000|Overall Study|Protocol Violation|1|||
126663186|NCT00658684|455724876|FG001|Overall Study|Protocol Violation|1|||
126663187|NCT00658684|455724877|FG002|Overall Study|Protocol Violation|0|||
126663188|NCT00658684|455724878|FG003|Overall Study|Protocol Violation|0|||
126663189|NCT00658684|455724875|FG000|Overall Study|Pregnancy|1|||
126663190|NCT00658684|455724876|FG001|Overall Study|Pregnancy|1|||
126663191|NCT00658684|455724877|FG002|Overall Study|Pregnancy|0|||
126663192|NCT00658684|455724878|FG003|Overall Study|Pregnancy|0|||
126663193|NCT06515483|455724881|FG000|Overall Study|Subject withdraw due to family issues|1|||
126663194|NCT06515483|455724882|FG001|Overall Study|Subject withdraw due to family issues|0|||
126663195|NCT01390181|455726160|FG000|Overall Study|Lost to Follow-up|1|||
126663196|NCT01390181|455726160|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
126663197|NCT02805725|455726161|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
126663198|NCT02805725|455726162|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
126663199|NCT02805725|455726163|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
126663200|NCT02805725|455726164|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
126663201|NCT02805725|455726165|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
126663202|NCT02805725|455726161|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
126663203|NCT02805725|455726162|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
126663204|NCT02805725|455726163|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
126663205|NCT02805725|455726164|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
126663206|NCT02805725|455726165|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
126663207|NCT02805725|455726161|FG000|Phase II|Protocol Violation|0|||
126663208|NCT02805725|455726162|FG001|Phase II|Protocol Violation|0|||
126663209|NCT02805725|455726163|FG002|Phase II|Protocol Violation|0|||
126663210|NCT02805725|455726164|FG003|Phase II|Protocol Violation|0|||
126663211|NCT02805725|455726165|FG004|Phase II|Protocol Violation|6|||
126663212|NCT01195545|455726166|FG000|Overall Study|Protocol Violation|4|||
126663213|NCT02425644|455726167|FG000|Overall Study|Lost to Follow-up|2|||
126663214|NCT02425644|455726168|FG001|Overall Study|Lost to Follow-up|3|||
126663215|NCT02425644|455726167|FG000|Overall Study|Withdrawal by Subject|41|||
126663216|NCT02425644|455726168|FG001|Overall Study|Withdrawal by Subject|36|||
126663217|NCT02425644|455726167|FG000|Overall Study|Lack of Efficacy|3|||
126663218|NCT02425644|455726168|FG001|Overall Study|Lack of Efficacy|10|||
126663219|NCT02425644|455726167|FG000|Overall Study|Adverse Event|13|||
126663220|NCT02425644|455726168|FG001|Overall Study|Adverse Event|3|||
126663221|NCT02425644|455726167|FG000|Overall Study|Death|0|||
126663222|NCT02425644|455726168|FG001|Overall Study|Death|2|||
126663223|NCT02425644|455726167|FG000|Overall Study|Other|18|||
126663224|NCT02425644|455726168|FG001|Overall Study|Other|17|||
126663225|NCT00909792|455726169|FG000|Period 1|Did not meet inclusion criteria|0|||
126663226|NCT00909792|455726170|FG001|Period 1|Did not meet inclusion criteria|1|||
126663227|NCT00909792|455726169|FG000|Period 2|Biomicroscopy|1|||
126663228|NCT00909792|455726170|FG001|Period 2|Biomicroscopy|0|||
126663229|NCT00909792|455726169|FG000|Period 2|Lost to Follow-up|0|||
126663230|NCT00909792|455726170|FG001|Period 2|Lost to Follow-up|1|||
126663231|NCT00293722|455726173|FG000|Overall Study|Other|427|||
126663232|NCT02824263|455726175|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
126663233|NCT02824263|455726176|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
126663234|NCT02824263|455726175|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
126663235|NCT02824263|455726176|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
126663236|NCT00568321|455726177|FG000|Overall Study|Adverse Event|1|||
126663237|NCT00568321|455726178|FG001|Overall Study|Adverse Event|0|||
126663238|NCT00568321|455726179|FG002|Overall Study|Adverse Event|0|||
126663239|NCT00568321|455726177|FG000|Overall Study|Lack of Efficacy|8|||
126663240|NCT00568321|455726178|FG001|Overall Study|Lack of Efficacy|5|||
126663241|NCT00568321|455726179|FG002|Overall Study|Lack of Efficacy|6|||
126663242|NCT00568321|455726177|FG000|Overall Study|Lost to Follow-up|0|||
126663243|NCT00568321|455726178|FG001|Overall Study|Lost to Follow-up|0|||
126663244|NCT00568321|455726179|FG002|Overall Study|Lost to Follow-up|1|||
126663245|NCT00568321|455726177|FG000|Overall Study|Withdrawal by Subject|2|||
126663246|NCT00568321|455726178|FG001|Overall Study|Withdrawal by Subject|0|||
126663247|NCT00568321|455726179|FG002|Overall Study|Withdrawal by Subject|0|||
126758628|NCT02681094|456066666|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
126331175|NCT02797678|454506891|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
126331176|NCT02797678|454506892|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
126331177|NCT02797678|454506893|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
126331178|NCT02797678|454506890|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
126663248|NCT00568321|455726177|FG000|Overall Study|Protocol Violation|0|||
126663249|NCT00568321|455726178|FG001|Overall Study|Protocol Violation|0|||
126663250|NCT00568321|455726179|FG002|Overall Study|Protocol Violation|1|||
126663251|NCT00568321|455726177|FG000|Overall Study|Randomized, not treated|2|||
126663252|NCT00568321|455726178|FG001|Overall Study|Randomized, not treated|0|||
126663253|NCT00568321|455726179|FG002|Overall Study|Randomized, not treated|1|||
126663254|NCT00221195|455726180|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
126663255|NCT00221195|455726181|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
126663256|NCT00221195|455726180|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
126663257|NCT00221195|455726181|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
126663258|NCT00221195|455726180|FG000|Washout Period (Months 7-9)|Death|0|||
126663259|NCT00221195|455726181|FG001|Washout Period (Months 7-9)|Death|1|||
126663260|NCT00221195|455726180|FG000|Therapy 2 (Months 10-15)|Death|1|||
126663261|NCT00221195|455726181|FG001|Therapy 2 (Months 10-15)|Death|0|||
126663262|NCT00221195|455726180|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
126663263|NCT00221195|455726181|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
126663264|NCT01106014|455726185|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
126663265|NCT01106014|455726186|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
126663266|NCT01106014|455726185|FG000|Overall Study|Adverse Event|78|||
126663267|NCT01106014|455726186|FG001|Overall Study|Adverse Event|42|||
126663268|NCT01106014|455726185|FG000|Overall Study|Withdrawal by Subject|43|||
126663269|NCT01106014|455726186|FG001|Overall Study|Withdrawal by Subject|37|||
126663270|NCT01106014|455726185|FG000|Overall Study|Administrative reason|7|||
126663271|NCT01106014|455726186|FG001|Overall Study|Administrative reason|6|||
126663272|NCT01106014|455726185|FG000|Overall Study|Lost to Follow-up|2|||
126663273|NCT01106014|455726186|FG001|Overall Study|Lost to Follow-up|3|||
126663274|NCT00908232|455726187|FG000|Cycle 1 to 4|Death|5|||
126663275|NCT00908232|455726188|FG001|Cycle 1 to 4|Death|0|||
126663276|NCT00908232|455726189|FG002|Cycle 1 to 4|Death|0|||
126663277|NCT00908232|455726190|FG003|Cycle 1 to 4|Death|0|||
126663278|NCT00908232|455726187|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
126663279|NCT00908232|455726188|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
126663280|NCT00908232|455726189|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
126663281|NCT00908232|455726190|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
126663282|NCT00908232|455726187|FG000|Cycle 1 to 4|Progressive Disease|6|||
126663283|NCT00908232|455726188|FG001|Cycle 1 to 4|Progressive Disease|0|||
126663284|NCT00908232|455726189|FG002|Cycle 1 to 4|Progressive Disease|0|||
126663285|NCT00908232|455726190|FG003|Cycle 1 to 4|Progressive Disease|0|||
126663286|NCT00908232|455726187|FG000|Cycle 1 to 4|Adverse Event|12|||
126663287|NCT00908232|455726188|FG001|Cycle 1 to 4|Adverse Event|0|||
126663288|NCT00908232|455726189|FG002|Cycle 1 to 4|Adverse Event|0|||
126663289|NCT00908232|455726190|FG003|Cycle 1 to 4|Adverse Event|0|||
126663290|NCT00908232|455726187|FG000|Cycle 1 to 4|Other|1|||
126663291|NCT00908232|455726188|FG001|Cycle 1 to 4|Other|0|||
126663292|NCT00908232|455726189|FG002|Cycle 1 to 4|Other|0|||
126663293|NCT00908232|455726190|FG003|Cycle 1 to 4|Other|0|||
126663294|NCT00908232|455726187|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
126663295|NCT00908232|455726188|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
126663296|NCT00908232|455726189|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
126663297|NCT00908232|455726190|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
126663298|NCT00908232|455726187|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
126663299|NCT00908232|455726188|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
126663300|NCT00908232|455726189|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
126663301|NCT00908232|455726190|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
126663302|NCT00908232|455726187|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
126663303|NCT00908232|455726188|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
126663304|NCT00908232|455726189|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
126663305|NCT00908232|455726190|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
126663306|NCT00908232|455726187|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
126663307|NCT00908232|455726188|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
126663308|NCT00908232|455726189|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
126663309|NCT00908232|455726190|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
126663310|NCT00908232|455726187|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
126663311|NCT00908232|455726188|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
126663312|NCT00908232|455726189|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
126663313|NCT00908232|455726190|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
126663314|NCT00908232|455726187|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
126663315|NCT00908232|455726188|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
126663316|NCT00908232|455726189|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
126663317|NCT00908232|455726190|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
126663318|NCT00908232|455726187|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
126663319|NCT00908232|455726188|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
126663320|NCT00908232|455726189|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
126663321|NCT00908232|455726190|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
126663322|NCT00908232|455726187|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
126663323|NCT00908232|455726188|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
126663324|NCT00908232|455726189|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
126663325|NCT00908232|455726190|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
126663326|NCT02260882|455726191|FG000|Overall Study|Protocol Violation|0|||
126663327|NCT02260882|455726192|FG001|Overall Study|Protocol Violation|1|||
126663328|NCT00954174|455726193|FG000|Overall Study|Adverse Event|28|||
126663329|NCT00954174|455726194|FG001|Overall Study|Adverse Event|23|||
126663330|NCT00954174|455726195|FG002|Overall Study|Adverse Event|4|||
126663331|NCT00954174|455726196|FG003|Overall Study|Adverse Event|9|||
126663332|NCT00954174|455726193|FG000|Overall Study|Death|4|||
126663333|NCT00954174|455726194|FG001|Overall Study|Death|2|||
126663334|NCT00954174|455726195|FG002|Overall Study|Death|0|||
126663335|NCT00954174|455726196|FG003|Overall Study|Death|0|||
126663336|NCT00954174|455726193|FG000|Overall Study|Lack of Efficacy|32|||
126331179|NCT02797678|454506891|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
126331180|NCT02797678|454506892|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
126331181|NCT02797678|454506893|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
126331182|NCT03360019|454506895|FG000|Overall Study|Withdrawal by Subject|2|||
126331183|NCT03360019|454506896|FG001|Overall Study|Withdrawal by Subject|0|||
126331184|NCT03360019|454506897|FG002|Overall Study|Withdrawal by Subject|0|||
126331185|NCT03360019|454506895|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
126331186|NCT03360019|454506896|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
126331187|NCT03360019|454506897|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
126331188|NCT01462110|454506898|FG000|Overall Study|Adverse Event|1|||
126331189|NCT01462110|454506899|FG001|Overall Study|Adverse Event|0|||
126331190|NCT02149264|454506905|FG000|Overall Study|Withdrawal by Subject|9|||
126331191|NCT02149264|454506905|FG000|Overall Study|Adverse Event|7|||
126331192|NCT02149264|454506905|FG000|Overall Study|Physician Decision|3|||
126331193|NCT02149264|454506905|FG000|Overall Study|Protocol Violation|1|||
126331194|NCT03283930|454506906|FG000|Overall Study|Scheduling conflict|8|||
126331195|NCT03283930|454506907|FG001|Overall Study|Scheduling conflict|10|||
126331196|NCT03283930|454506906|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
126331197|NCT03283930|454506907|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
126331198|NCT03283930|454506906|FG000|Overall Study|Technical software issue|2|||
126331199|NCT03283930|454506907|FG001|Overall Study|Technical software issue|2|||
126331200|NCT00805129|454506908|FG000|Overall Study|Not treated|1|||
126331201|NCT02499120|454506909|FG000|Overall Study|Death|52|||
126331202|NCT02499120|454506910|FG001|Overall Study|Death|43|||
126331203|NCT02499120|454506909|FG000|Overall Study|Lost to Follow-up|1|||
126331204|NCT02499120|454506910|FG001|Overall Study|Lost to Follow-up|2|||
126331205|NCT02499120|454506909|FG000|Overall Study|Participant refused further follow-up|1|||
126331206|NCT02499120|454506910|FG001|Overall Study|Participant refused further follow-up|0|||
126331207|NCT02499120|454506909|FG000|Overall Study|Withdrawal by Subject|2|||
126331208|NCT02499120|454506910|FG001|Overall Study|Withdrawal by Subject|5|||
126331209|NCT02499120|454506909|FG000|Overall Study|Other|9|||
126331210|NCT02499120|454506910|FG001|Overall Study|Other|10|||
126331211|NCT00964028|454506915|FG000|Overall Study|Withdrawal by Subject|0|||
126331212|NCT00964028|454506916|FG001|Overall Study|Withdrawal by Subject|1|||
126331213|NCT02385110|454506917|FG000|Overall Study|Early Death|1|||
126331214|NCT02385110|454506918|FG001|Overall Study|Early Death|0|||
126331215|NCT03472521|454506919|FG000|Overall Study|Lost to Follow-up|3|||
126331216|NCT03472521|454506920|FG001|Overall Study|Lost to Follow-up|2|||
126331217|NCT03472521|454506919|FG000|Overall Study|Discontinued intervention|3|||
126331218|NCT03472521|454506920|FG001|Overall Study|Discontinued intervention|1|||
126331219|NCT00534638|454506923|FG000|Overall Study|Withdrawal by Subject|3|||
126331220|NCT00534638|454506924|FG001|Overall Study|Withdrawal by Subject|4|||
126331221|NCT00534638|454506923|FG000|Overall Study|Migrated/moved from study area|13|||
126331222|NCT00534638|454506924|FG001|Overall Study|Migrated/moved from study area|11|||
126331223|NCT00534638|454506923|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
126331224|NCT00534638|454506924|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
126331225|NCT00534638|454506923|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
126331226|NCT00534638|454506924|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
126331227|NCT00534638|454506923|FG000|Overall Study|Other|1685|||
126331228|NCT00534638|454506924|FG001|Overall Study|Other|902|||
126331229|NCT01931397|454506931|FG000|Overall Study|Physician Decision|2|||
126331230|NCT01931397|454506931|FG000|Overall Study|Withdrawal by Subject|8|||
126331231|NCT01931397|454506931|FG000|Overall Study|moved out of state|1|||
126331232|NCT00520039|454506932|FG000|Overall Study|Exclusion criteria met at first visit|7|||
126331233|NCT00520039|454506933|FG001|Overall Study|Exclusion criteria met at first visit|5|||
126331234|NCT05176717|454506934|FG000|Overall Study|Sponsor Decision|1|||
126331235|NCT05176717|454506935|FG001|Overall Study|Sponsor Decision|2|||
126331236|NCT05176717|454506936|FG002|Overall Study|Sponsor Decision|2|||
126331237|NCT00765817|454506937|FG000|Overall Study|Adverse Event|13|||
126331238|NCT00765817|454506938|FG001|Overall Study|Adverse Event|1|||
126331239|NCT00765817|454506937|FG000|Overall Study|Death|0|||
126331240|NCT00765817|454506938|FG001|Overall Study|Death|1|||
126331241|NCT00765817|454506937|FG000|Overall Study|Entry criteria not met|2|||
126331242|NCT00765817|454506938|FG001|Overall Study|Entry criteria not met|2|||
126331243|NCT00765817|454506937|FG000|Overall Study|Loss of glucose control|0|||
126331244|NCT00765817|454506938|FG001|Overall Study|Loss of glucose control|2|||
126331245|NCT00765817|454506937|FG000|Overall Study|Lost to Follow-up|1|||
126331246|NCT00765817|454506938|FG001|Overall Study|Lost to Follow-up|3|||
126331247|NCT00765817|454506937|FG000|Overall Study|Physician Decision|2|||
126331248|NCT00765817|454506938|FG001|Overall Study|Physician Decision|1|||
126331249|NCT00765817|454506937|FG000|Overall Study|Protocol Violation|1|||
126331250|NCT00765817|454506938|FG001|Overall Study|Protocol Violation|1|||
126331251|NCT00765817|454506937|FG000|Overall Study|Subject decision|7|||
126663337|NCT00954174|455726194|FG001|Overall Study|Lack of Efficacy|22|||
126663338|NCT00954174|455726195|FG002|Overall Study|Lack of Efficacy|8|||
126663339|NCT00954174|455726196|FG003|Overall Study|Lack of Efficacy|6|||
126663340|NCT00954174|455726193|FG000|Overall Study|Withdrawal by Subject|14|||
126663341|NCT00954174|455726194|FG001|Overall Study|Withdrawal by Subject|10|||
126663342|NCT00954174|455726195|FG002|Overall Study|Withdrawal by Subject|4|||
126663343|NCT00954174|455726196|FG003|Overall Study|Withdrawal by Subject|3|||
126663344|NCT00954174|455726193|FG000|Overall Study|Medical Reason|4|||
126663345|NCT00954174|455726194|FG001|Overall Study|Medical Reason|2|||
126663346|NCT00954174|455726195|FG002|Overall Study|Medical Reason|1|||
126663347|NCT00954174|455726196|FG003|Overall Study|Medical Reason|0|||
126663348|NCT00954174|455726193|FG000|Overall Study|Ineligible|40|||
126663349|NCT00954174|455726194|FG001|Overall Study|Ineligible|47|||
126663350|NCT00954174|455726195|FG002|Overall Study|Ineligible|7|||
126663351|NCT00954174|455726196|FG003|Overall Study|Ineligible|4|||
126663352|NCT00954174|455726193|FG000|Overall Study|Never Treated|4|||
126331252|NCT00765817|454506938|FG001|Overall Study|Subject decision|11|||
126331253|NCT02308228|454506939|FG000|Overall Study|Adverse Event|3|||
126663353|NCT00954174|455726194|FG001|Overall Study|Never Treated|17|||
126663354|NCT00954174|455726195|FG002|Overall Study|Never Treated|0|||
126663355|NCT00954174|455726196|FG003|Overall Study|Never Treated|3|||
126663356|NCT01776424|455726201|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
126663357|NCT01776424|455726202|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
126663358|NCT01776424|455726203|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
126663359|NCT01776424|455726201|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
126331254|NCT02308228|454506940|FG001|Overall Study|Adverse Event|4|||
126331255|NCT02308228|454506939|FG000|Overall Study|Withdrawal by Subject|5|||
126663360|NCT01776424|455726202|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
126663361|NCT01776424|455726203|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
126663362|NCT01776424|455726201|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
126331256|NCT02308228|454506940|FG001|Overall Study|Withdrawal by Subject|3|||
126331257|NCT03999749|454506943|FG000|Overall Study|Toxicity|16|||
126331258|NCT03999749|454506943|FG000|Overall Study|Withdrawal by Subject|3|||
126331259|NCT03999749|454506943|FG000|Overall Study|Disease progression|26|||
126331260|NCT03999749|454506943|FG000|Overall Study|Physician Decision|4|||
126331261|NCT03999749|454506943|FG000|Overall Study|Death|5|||
126331262|NCT03999749|454506943|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
126331263|NCT05219968|454506944|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
126331264|NCT05219968|454506945|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
126331265|NCT05219968|454506946|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
126331266|NCT05219968|454506947|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
126331267|NCT05219968|454506948|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
126331268|NCT05219968|454506944|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
126331269|NCT05219968|454506945|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
126331270|NCT05219968|454506946|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
126331271|NCT05219968|454506947|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
126331272|NCT05219968|454506948|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
126331273|NCT05219968|454506944|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
126331274|NCT05219968|454506945|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
126331275|NCT05219968|454506946|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
126331276|NCT05219968|454506947|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
126331277|NCT05219968|454506948|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
126331278|NCT05219968|454506944|FG000|Week 24 Treatment Period|Adverse Event|3|||
126331279|NCT05219968|454506945|FG001|Week 24 Treatment Period|Adverse Event|0|||
126331280|NCT05219968|454506946|FG002|Week 24 Treatment Period|Adverse Event|0|||
126331281|NCT05219968|454506947|FG003|Week 24 Treatment Period|Adverse Event|0|||
126331282|NCT05219968|454506948|FG004|Week 24 Treatment Period|Adverse Event|0|||
126331283|NCT05219968|454506944|FG000|Week 24 Treatment Period|Physician Decision|0|||
126331284|NCT05219968|454506945|FG001|Week 24 Treatment Period|Physician Decision|1|||
126331285|NCT05219968|454506946|FG002|Week 24 Treatment Period|Physician Decision|0|||
126331286|NCT05219968|454506947|FG003|Week 24 Treatment Period|Physician Decision|0|||
126331287|NCT05219968|454506948|FG004|Week 24 Treatment Period|Physician Decision|0|||
126331288|NCT05219968|454506944|FG000|Week 24 Treatment Period|Other, not specified|3|||
126331289|NCT05219968|454506945|FG001|Week 24 Treatment Period|Other, not specified|0|||
126331290|NCT05219968|454506946|FG002|Week 24 Treatment Period|Other, not specified|0|||
126663363|NCT01776424|455726202|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
126663364|NCT01776424|455726203|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
126663365|NCT01776424|455726201|FG000|LTOLE Part (Open Label)|Refused|5|||
126663366|NCT01776424|455726202|FG001|LTOLE Part (Open Label)|Refused|2|||
126663367|NCT01776424|455726203|FG002|LTOLE Part (Open Label)|Refused|11|||
126663368|NCT01776424|455726201|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
126663369|NCT01776424|455726202|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
126663370|NCT01776424|455726203|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
126663371|NCT00146757|455726204|FG000|Overall Study|Death|1|||
126663372|NCT00146757|455726205|FG001|Overall Study|Death|0|||
126663373|NCT00146757|455726204|FG000|Overall Study|Adverse Event|1|||
126663374|NCT00146757|455726205|FG001|Overall Study|Adverse Event|0|||
126663375|NCT03037619|455726217|FG000|Overall Study|Lost to Follow-up|0|||
126663376|NCT03037619|455726218|FG001|Overall Study|Lost to Follow-up|1|||
126663377|NCT01498289|455726219|FG000|Overall Study|Adverse Event|16|||
126663378|NCT01498289|455726220|FG001|Overall Study|Adverse Event|18|||
126663379|NCT01498289|455726219|FG000|Overall Study|Death|6|||
126663380|NCT01498289|455726220|FG001|Overall Study|Death|8|||
126663381|NCT01498289|455726219|FG000|Overall Study|Withdrawal unrelated to AE|16|||
126663382|NCT01498289|455726220|FG001|Overall Study|Withdrawal unrelated to AE|16|||
126663383|NCT01498289|455726219|FG000|Overall Study|Progression/relapse|53|||
126663384|NCT01498289|455726220|FG001|Overall Study|Progression/relapse|59|||
126663385|NCT01498289|455726219|FG000|Overall Study|Not protocol specified|7|||
126663386|NCT01498289|455726220|FG001|Overall Study|Not protocol specified|2|||
126663387|NCT01498289|455726219|FG000|Overall Study|Reason under review|0|||
126663388|NCT01498289|455726220|FG001|Overall Study|Reason under review|1|||
126663389|NCT03294109|455726221|FG000|Overall Study|Withdrawal by Subject|6|||
126663390|NCT03294109|455726222|FG001|Overall Study|Withdrawal by Subject|5|||
126663391|NCT01794923|455726227|FG000|Overall Study|Adverse Event|0|||
126663392|NCT01794923|455726228|FG001|Overall Study|Adverse Event|0|||
126663393|NCT01794923|455726229|FG002|Overall Study|Adverse Event|1|||
126663394|NCT04744285|455726232|FG000|Overall Study|Withdrawal by Subject|1|||
126663395|NCT04744285|455726233|FG001|Overall Study|Withdrawal by Subject|1|||
126663396|NCT04744285|455726234|FG002|Overall Study|Withdrawal by Subject|2|||
126663397|NCT04744285|455726235|FG003|Overall Study|Withdrawal by Subject|1|||
126663398|NCT02030405|455726239|FG000|Overall Study|Withdrawal by Subject|1|||
126663399|NCT02030405|455726239|FG000|Overall Study|Lost to Follow-up|1|||
126663400|NCT00803270|455726240|FG000|Overall Study|Lost to Follow-up|1|||
126663401|NCT00803270|455726241|FG001|Overall Study|Lost to Follow-up|2|||
126663402|NCT02973048|455726242|FG000|Overall Study|Epidural catheter insertion failure|1|||
126663403|NCT02973048|455726243|FG001|Overall Study|Epidural catheter insertion failure|0|||
126663404|NCT02973048|455726242|FG000|Overall Study|Withdrawal by Subject|0|||
126663405|NCT02973048|455726243|FG001|Overall Study|Withdrawal by Subject|3|||
126663406|NCT03707925|455726246|FG000|Overall Study|Inevaluable|1|||
126663407|NCT03431857|455726248|FG000|Overall Study|Death|6|||
126663408|NCT03431857|455726248|FG000|Overall Study|Lost to Follow-up|41|||
126663409|NCT03431857|455726248|FG000|Overall Study|Adverse Event|6|||
126663410|NCT03431857|455726248|FG000|Overall Study|Withdrawal by Subject|1|||
126663411|NCT00651157|455726250|FG000|Overall Study|Death|1|||
126663412|NCT00651157|455726250|FG000|Overall Study|Protocol Violation|1|||
126663413|NCT00292461|455726254|FG000|Overall Study|Adverse Event|4|||
126663414|NCT00292461|455726255|FG001|Overall Study|Adverse Event|2|||
126663415|NCT00292461|455726254|FG000|Overall Study|Lack of Efficacy|1|||
126663416|NCT00292461|455726255|FG001|Overall Study|Lack of Efficacy|0|||
126663417|NCT00292461|455726254|FG000|Overall Study|Withdrawal by Subject|0|||
126663418|NCT00292461|455726255|FG001|Overall Study|Withdrawal by Subject|1|||
126663419|NCT00292461|455726254|FG000|Overall Study|Protocol Violation|4|||
126663420|NCT00292461|455726255|FG001|Overall Study|Protocol Violation|3|||
126663421|NCT00292461|455726254|FG000|Overall Study|Lost to Follow-up|1|||
126663422|NCT00292461|455726255|FG001|Overall Study|Lost to Follow-up|0|||
126663423|NCT04908189|455726277|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
126663424|NCT04908189|455726278|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
126663425|NCT04908189|455726279|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
126663426|NCT04908189|455726277|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
126663427|NCT04908189|455726278|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
126663428|NCT04908189|455726279|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
126663429|NCT04908189|455726277|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
126663430|NCT04908189|455726278|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
126663431|NCT04908189|455726279|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
126663432|NCT04908189|455726277|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
126663433|NCT04908189|455726278|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
126663434|NCT04908189|455726279|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
126663435|NCT04908189|455726277|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
126663436|NCT04908189|455726278|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
126663437|NCT04908189|455726279|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
126663438|NCT04908189|455726277|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
126663439|NCT04908189|455726278|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
126663440|NCT04908189|455726279|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
126663441|NCT04908189|455726277|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
126663442|NCT04908189|455726278|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
126663443|NCT04908189|455726279|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
126663444|NCT04908189|455726277|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
126663445|NCT04908189|455726278|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
126663446|NCT04908189|455726279|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
126663447|NCT04908189|455726277|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
126663448|NCT04908189|455726278|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
126663449|NCT04908189|455726279|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
126663450|NCT04908189|455726277|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
126663451|NCT04908189|455726278|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
126663452|NCT04908189|455726279|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
126663453|NCT04908189|455726277|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
126663454|NCT04908189|455726278|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
126663455|NCT04908189|455726279|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
126663456|NCT04908189|455726277|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
126663457|NCT04908189|455726278|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
126663458|NCT04908189|455726279|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
126663459|NCT04683731|455726280|FG000|Overall Study|Withdrawal by Subject|1|||
126663460|NCT04683731|455726281|FG001|Overall Study|Withdrawal by Subject|0|||
126663461|NCT04683731|455726282|FG002|Overall Study|Withdrawal by Subject|3|||
126663462|NCT04683731|455726283|FG003|Overall Study|Withdrawal by Subject|2|||
126663463|NCT04683731|455726280|FG000|Overall Study|Determined patient was not eligible|3|||
126663464|NCT04683731|455726281|FG001|Overall Study|Determined patient was not eligible|3|||
126663465|NCT04683731|455726282|FG002|Overall Study|Determined patient was not eligible|12|||
126663466|NCT04683731|455726283|FG003|Overall Study|Determined patient was not eligible|3|||
126663467|NCT01210118|455726286|FG000|Overall Study|Lost to Follow-up|1|||
126663468|NCT01210118|455726287|FG001|Overall Study|Lost to Follow-up|1|||
126663469|NCT01210118|455726286|FG000|Overall Study|Protocol Violation|1|||
126663470|NCT01210118|455726287|FG001|Overall Study|Protocol Violation|1|||
126663471|NCT01210118|455726286|FG000|Overall Study|Spontaneous abortion|1|||
126663472|NCT01210118|455726287|FG001|Overall Study|Spontaneous abortion|3|||
126663473|NCT02958267|455726288|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
126663474|NCT02958267|455726289|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
126663475|NCT02958267|455726288|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
126663476|NCT02958267|455726289|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
126663477|NCT02958267|455726288|FG000|Follow-up Visits|Additional treatment pursued|2|||
126663478|NCT02958267|455726289|FG001|Follow-up Visits|Additional treatment pursued|1|||
126663479|NCT01853982|455726290|FG000|Overall Study|Withdrawal by Subject|1|||
126663480|NCT01853982|455726291|FG001|Overall Study|Withdrawal by Subject|0|||
126663481|NCT01853982|455726290|FG000|Overall Study|Death|1|||
126663482|NCT01853982|455726291|FG001|Overall Study|Death|0|||
126663483|NCT01853982|455726290|FG000|Overall Study|Lost to Follow-up|0|||
126663484|NCT01853982|455726291|FG001|Overall Study|Lost to Follow-up|1|||
126331291|NCT05219968|454506947|FG003|Week 24 Treatment Period|Other, not specified|0|||
126331292|NCT05219968|454506948|FG004|Week 24 Treatment Period|Other, not specified|0|||
126331293|NCT05219968|454506944|FG000|Safety Extension Period|Treatment administration failure|0|||
126331294|NCT05219968|454506945|FG001|Safety Extension Period|Treatment administration failure|0|||
126331295|NCT05219968|454506946|FG002|Safety Extension Period|Treatment administration failure|0|||
126331296|NCT05219968|454506947|FG003|Safety Extension Period|Treatment administration failure|1|||
126331297|NCT05219968|454506948|FG004|Safety Extension Period|Treatment administration failure|4|||
126331298|NCT05219968|454506944|FG000|Safety Extension Period|Bilateral dislodgement|0|||
126331299|NCT05219968|454506945|FG001|Safety Extension Period|Bilateral dislodgement|0|||
126331300|NCT05219968|454506946|FG002|Safety Extension Period|Bilateral dislodgement|4|||
126331301|NCT05219968|454506947|FG003|Safety Extension Period|Bilateral dislodgement|0|||
126331302|NCT05219968|454506948|FG004|Safety Extension Period|Bilateral dislodgement|1|||
126331303|NCT05219968|454506944|FG000|Safety Extension Period|Withdrawal by Subject|0|||
126331304|NCT05219968|454506945|FG001|Safety Extension Period|Withdrawal by Subject|0|||
126331305|NCT05219968|454506946|FG002|Safety Extension Period|Withdrawal by Subject|2|||
126331306|NCT05219968|454506947|FG003|Safety Extension Period|Withdrawal by Subject|0|||
126331307|NCT05219968|454506948|FG004|Safety Extension Period|Withdrawal by Subject|4|||
126331308|NCT05219968|454506944|FG000|Safety Extension Period|Adverse Event|0|||
126331309|NCT05219968|454506945|FG001|Safety Extension Period|Adverse Event|0|||
126331310|NCT05219968|454506946|FG002|Safety Extension Period|Adverse Event|2|||
126331311|NCT05219968|454506947|FG003|Safety Extension Period|Adverse Event|1|||
126331312|NCT05219968|454506948|FG004|Safety Extension Period|Adverse Event|1|||
126331313|NCT05219968|454506944|FG000|Safety Extension Period|Lost to Follow-up|0|||
126331314|NCT05219968|454506945|FG001|Safety Extension Period|Lost to Follow-up|0|||
126331315|NCT05219968|454506946|FG002|Safety Extension Period|Lost to Follow-up|0|||
126331316|NCT05219968|454506947|FG003|Safety Extension Period|Lost to Follow-up|1|||
126331317|NCT05219968|454506948|FG004|Safety Extension Period|Lost to Follow-up|0|||
126331318|NCT04587336|454506949|FG000|Overall Study|Lost to Follow-up|1|||
126331319|NCT04587336|454506950|FG001|Overall Study|Lost to Follow-up|0|||
126663485|NCT01839487|455726292|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
126331320|NCT03512353|454508816|FG000|Overall Study|Sponsor Decision|3|||
126663486|NCT01839487|455726293|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
126663487|NCT01839487|455726294|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
126663488|NCT01839487|455726295|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
126663489|NCT01839487|455726296|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
126663490|NCT01839487|455726297|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
126663491|NCT01839487|455726292|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
126663492|NCT01839487|455726293|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
126663493|NCT01839487|455726294|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
126663494|NCT01839487|455726295|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
126663495|NCT01839487|455726296|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
126663496|NCT01839487|455726297|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
126663497|NCT01839487|455726292|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
126663498|NCT01839487|455726293|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
126663499|NCT01839487|455726294|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
126663500|NCT01839487|455726295|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
126663501|NCT01839487|455726296|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
126663502|NCT01839487|455726297|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
126663503|NCT01839487|455726292|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
126663504|NCT01839487|455726293|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
126663505|NCT01839487|455726294|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
126663506|NCT01839487|455726295|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
126663507|NCT01839487|455726296|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
126663508|NCT01839487|455726297|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
126663509|NCT01839487|455726292|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
126663510|NCT01839487|455726293|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
126663511|NCT01839487|455726294|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
126663512|NCT01839487|455726295|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
126663513|NCT01839487|455726296|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
126663514|NCT01839487|455726297|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
126663515|NCT01839487|455726292|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
126663516|NCT01839487|455726293|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
126663517|NCT01839487|455726294|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
126663518|NCT01839487|455726295|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
126663519|NCT01839487|455726296|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
126663520|NCT01839487|455726297|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
126663521|NCT01839487|455726292|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
126663522|NCT01839487|455726293|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
126663523|NCT01839487|455726294|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
126663524|NCT01839487|455726295|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
126663525|NCT01839487|455726296|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
126663526|NCT01839487|455726297|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
126663527|NCT01839487|455726292|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
126663528|NCT01839487|455726293|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
126663529|NCT01839487|455726294|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
126663530|NCT01839487|455726295|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
126663531|NCT01839487|455726296|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
126663532|NCT01839487|455726297|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
126331321|NCT03512353|454508816|FG000|Overall Study|Death|1|||
126331322|NCT01845597|454508817|FG000|Overall Study|Death|8|||
126331323|NCT01845597|454508817|FG000|Overall Study|Lost to Follow-up|22|||
126331324|NCT02581488|454508820|FG000|Overall Study|Adverse Event|6|||
126331325|NCT02581488|454508821|FG001|Overall Study|Adverse Event|7|||
126331326|NCT02581488|454508820|FG000|Overall Study|Lost to Follow-up|1|||
126331327|NCT02581488|454508821|FG001|Overall Study|Lost to Follow-up|0|||
126331328|NCT02581488|454508820|FG000|Overall Study|Withdrawal by Subject|1|||
126331329|NCT02581488|454508821|FG001|Overall Study|Withdrawal by Subject|0|||
126331330|NCT02581488|454508820|FG000|Overall Study|Non-Compliance|1|||
126331331|NCT02581488|454508821|FG001|Overall Study|Non-Compliance|0|||
126331332|NCT02581488|454508820|FG000|Overall Study|Protocol Violation|0|||
126331333|NCT02581488|454508821|FG001|Overall Study|Protocol Violation|4|||
126331334|NCT01877668|454508822|FG000|Overall Study|Death|0|||
126331335|NCT01877668|454508823|FG001|Overall Study|Death|0|||
126331336|NCT01877668|454508824|FG002|Overall Study|Death|0|||
126663533|NCT01839487|455726292|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
126663534|NCT01839487|455726293|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
126663535|NCT01839487|455726294|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
126331337|NCT01877668|454508825|FG003|Overall Study|Death|1|||
126331338|NCT01877668|454508826|FG004|Overall Study|Death|0|||
126663536|NCT01839487|455726295|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
126663537|NCT01839487|455726296|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
126663538|NCT01839487|455726297|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
126663539|NCT05066724|455726298|FG000|Overall Study|Adverse Event|1|||
126663540|NCT05066724|455726298|FG000|Overall Study|Non-Compliance With Study Drug|5|||
126663541|NCT05066724|455726298|FG000|Overall Study|Withdrawal by Subject|6|||
126663542|NCT05066724|455726298|FG000|Overall Study|Physician Decision|2|||
126663543|NCT00475033|455726299|FG000|Infant Series|Failed to return|3|||
126663544|NCT00475033|455726300|FG001|Infant Series|Failed to return|4|||
126663545|NCT00475033|455726299|FG000|Infant Series|Parent or legal guardian request|1|||
126663546|NCT00475033|455726300|FG001|Infant Series|Parent or legal guardian request|5|||
126663547|NCT00475033|455726299|FG000|Infant Series|Protocol Violation|1|||
126663548|NCT00475033|455726300|FG001|Infant Series|Protocol Violation|2|||
126663549|NCT00475033|455726299|FG000|Infant Series|Lost to Follow-up|2|||
126663550|NCT00475033|455726300|FG001|Infant Series|Lost to Follow-up|0|||
126663551|NCT00475033|455726299|FG000|Infant Series|Adverse Event|0|||
126663552|NCT00475033|455726300|FG001|Infant Series|Adverse Event|2|||
126663553|NCT00475033|455726299|FG000|After the Infant Series|Adverse Event|0|||
126663554|NCT00475033|455726300|FG001|After the Infant Series|Adverse Event|4|||
126663555|NCT00475033|455726299|FG000|After the Infant Series|Parent or legal guardian request|2|||
126663556|NCT00475033|455726300|FG001|After the Infant Series|Parent or legal guardian request|2|||
126663557|NCT00475033|455726299|FG000|After the Infant Series|Failed to return|2|||
126663558|NCT00475033|455726300|FG001|After the Infant Series|Failed to return|1|||
126663559|NCT00475033|455726299|FG000|After the Infant Series|Protocol Violation|1|||
126663560|NCT00475033|455726300|FG001|After the Infant Series|Protocol Violation|0|||
126663561|NCT00475033|455726299|FG000|After the Infant Series|Lost to Follow-up|1|||
126663562|NCT00475033|455726300|FG001|After the Infant Series|Lost to Follow-up|0|||
126663563|NCT00475033|455726299|FG000|After the Infant Series|Other|0|||
126663564|NCT00475033|455726300|FG001|After the Infant Series|Other|1|||
126331339|NCT01877668|454508822|FG000|Overall Study|No longer met study criteria|1|||
126331340|NCT01877668|454508823|FG001|Overall Study|No longer met study criteria|0|||
126331341|NCT01877668|454508824|FG002|Overall Study|No longer met study criteria|1|||
126331342|NCT01877668|454508825|FG003|Overall Study|No longer met study criteria|0|||
126331343|NCT01877668|454508826|FG004|Overall Study|No longer met study criteria|0|||
126663565|NCT00475033|455726299|FG000|Toddler Dose|Parent or legal guardian request|2|||
126663566|NCT00475033|455726300|FG001|Toddler Dose|Parent or legal guardian request|0|||
126331344|NCT01877668|454508822|FG000|Overall Study|Insufficient clinical response|0|||
126331345|NCT01877668|454508823|FG001|Overall Study|Insufficient clinical response|1|||
126331346|NCT01877668|454508824|FG002|Overall Study|Insufficient clinical response|2|||
126331347|NCT01877668|454508825|FG003|Overall Study|Insufficient clinical response|2|||
126331348|NCT01877668|454508826|FG004|Overall Study|Insufficient clinical response|0|||
126331349|NCT01877668|454508822|FG000|Overall Study|Lost to Follow-up|0|||
126331350|NCT01877668|454508823|FG001|Overall Study|Lost to Follow-up|2|||
126331351|NCT01877668|454508824|FG002|Overall Study|Lost to Follow-up|1|||
126331352|NCT01877668|454508825|FG003|Overall Study|Lost to Follow-up|0|||
126331353|NCT01877668|454508826|FG004|Overall Study|Lost to Follow-up|0|||
126331354|NCT01877668|454508822|FG000|Overall Study|Withdrawal by Subject|2|||
126331355|NCT01877668|454508823|FG001|Overall Study|Withdrawal by Subject|0|||
126331356|NCT01877668|454508824|FG002|Overall Study|Withdrawal by Subject|3|||
126331357|NCT01877668|454508825|FG003|Overall Study|Withdrawal by Subject|2|||
126331358|NCT01877668|454508826|FG004|Overall Study|Withdrawal by Subject|2|||
126331359|NCT01877668|454508822|FG000|Overall Study|Other|1|||
126331360|NCT01877668|454508823|FG001|Overall Study|Other|1|||
126331361|NCT01877668|454508824|FG002|Overall Study|Other|1|||
126331362|NCT01877668|454508825|FG003|Overall Study|Other|1|||
126331363|NCT01877668|454508826|FG004|Overall Study|Other|3|||
126331364|NCT01877668|454508822|FG000|Overall Study|Protocol Violation|1|||
126331365|NCT01877668|454508823|FG001|Overall Study|Protocol Violation|1|||
126331366|NCT01877668|454508824|FG002|Overall Study|Protocol Violation|0|||
126331367|NCT01877668|454508825|FG003|Overall Study|Protocol Violation|0|||
126331368|NCT01877668|454508826|FG004|Overall Study|Protocol Violation|3|||
126331369|NCT01877668|454508822|FG000|Overall Study|Adverse event related to study drug|2|||
126331370|NCT01877668|454508823|FG001|Overall Study|Adverse event related to study drug|2|||
126331371|NCT01877668|454508824|FG002|Overall Study|Adverse event related to study drug|2|||
126331372|NCT01877668|454508825|FG003|Overall Study|Adverse event related to study drug|2|||
126331373|NCT01877668|454508826|FG004|Overall Study|Adverse event related to study drug|1|||
126331374|NCT01877668|454508822|FG000|Overall Study|Adverse event unrelated to study drug|4|||
126331375|NCT01877668|454508823|FG001|Overall Study|Adverse event unrelated to study drug|1|||
126545274|NCT01641926|455290783|FG000|Overall Study|Not Treated|1|||
126663567|NCT00475033|455726299|FG000|Toddler Dose|Failed to return|1|||
126663568|NCT00475033|455726300|FG001|Toddler Dose|Failed to return|0|||
126663569|NCT00475033|455726299|FG000|Toddler Dose|Lost to Follow-up|1|||
126663570|NCT00475033|455726300|FG001|Toddler Dose|Lost to Follow-up|0|||
126663571|NCT04821869|455726303|FG000|Overall Study|Adverse Event|4|||
126663572|NCT04821869|455726303|FG000|Overall Study|Withdrawal by Subject|2|||
126663573|NCT04821869|455726303|FG000|Overall Study|Did not meet FEV1 criteria|1|||
126663574|NCT03444324|455726304|FG000|Overall Study|Withdrawal by Subject|0|||
126663575|NCT03444324|455726305|FG001|Overall Study|Withdrawal by Subject|1|||
126663576|NCT03444324|455726304|FG000|Overall Study|Lost to Follow-up|4|||
126663577|NCT03444324|455726305|FG001|Overall Study|Lost to Follow-up|2|||
126663578|NCT03444324|455726304|FG000|Overall Study|Protocol Violation|0|||
126663579|NCT03444324|455726305|FG001|Overall Study|Protocol Violation|1|||
126663580|NCT03444324|455726304|FG000|Overall Study|Lack of Trial Compliance|1|||
126663581|NCT03444324|455726305|FG001|Overall Study|Lack of Trial Compliance|1|||
126663582|NCT03444324|455726304|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
126663583|NCT03444324|455726305|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
126663584|NCT02525861|455727730|FG000|Overall Study|Adverse Event|1|||
126663585|NCT02525861|455727731|FG001|Overall Study|Adverse Event|0|||
126663586|NCT02525861|455727730|FG000|Overall Study|Withdrawal by Subject|0|||
126663587|NCT02525861|455727731|FG001|Overall Study|Withdrawal by Subject|1|||
126663588|NCT02525861|455727730|FG000|Overall Study|Physician Decision|0|||
126663589|NCT02525861|455727731|FG001|Overall Study|Physician Decision|1|||
126663590|NCT01794520|455727732|FG000|Overall Study|Adverse events- related to progression|0|||
126663591|NCT01794520|455727733|FG001|Overall Study|Adverse events- related to progression|0|||
126663592|NCT01794520|455727734|FG002|Overall Study|Adverse events- related to progression|1|||
126663593|NCT01794520|455727735|FG003|Overall Study|Adverse events- related to progression|2|||
126663594|NCT01794520|455727736|FG004|Overall Study|Adverse events- related to progression|0|||
126663595|NCT01794520|455727737|FG005|Overall Study|Adverse events- related to progression|1|||
126663596|NCT01794520|455727738|FG006|Overall Study|Adverse events- related to progression|0|||
126663597|NCT01794520|455727732|FG000|Overall Study|Adverse event- not related to progression|1|||
126663598|NCT01794520|455727733|FG001|Overall Study|Adverse event- not related to progression|1|||
126663599|NCT01794520|455727734|FG002|Overall Study|Adverse event- not related to progression|0|||
126663600|NCT01794520|455727735|FG003|Overall Study|Adverse event- not related to progression|0|||
126663601|NCT01794520|455727736|FG004|Overall Study|Adverse event- not related to progression|2|||
126663602|NCT01794520|455727737|FG005|Overall Study|Adverse event- not related to progression|0|||
126663603|NCT01794520|455727738|FG006|Overall Study|Adverse event- not related to progression|0|||
126663604|NCT01794520|455727732|FG000|Overall Study|Progressive disease|5|||
126663605|NCT01794520|455727733|FG001|Overall Study|Progressive disease|6|||
126663606|NCT01794520|455727734|FG002|Overall Study|Progressive disease|2|||
126663607|NCT01794520|455727735|FG003|Overall Study|Progressive disease|5|||
126663608|NCT01794520|455727736|FG004|Overall Study|Progressive disease|27|||
126663609|NCT01794520|455727737|FG005|Overall Study|Progressive disease|18|||
126663610|NCT01794520|455727738|FG006|Overall Study|Progressive disease|0|||
126663611|NCT01794520|455727732|FG000|Overall Study|Withdrew consent|0|||
126663612|NCT01794520|455727733|FG001|Overall Study|Withdrew consent|0|||
126663613|NCT01794520|455727734|FG002|Overall Study|Withdrew consent|1|||
126663614|NCT01794520|455727735|FG003|Overall Study|Withdrew consent|1|||
126663615|NCT01794520|455727736|FG004|Overall Study|Withdrew consent|0|||
126663616|NCT01794520|455727737|FG005|Overall Study|Withdrew consent|0|||
126663617|NCT01794520|455727738|FG006|Overall Study|Withdrew consent|0|||
126663618|NCT01794520|455727732|FG000|Overall Study|Lost to Follow-up|0|||
126663619|NCT01794520|455727733|FG001|Overall Study|Lost to Follow-up|0|||
126663620|NCT01794520|455727734|FG002|Overall Study|Lost to Follow-up|0|||
126663621|NCT01794520|455727735|FG003|Overall Study|Lost to Follow-up|0|||
126663622|NCT01794520|455727736|FG004|Overall Study|Lost to Follow-up|1|||
126663623|NCT01794520|455727737|FG005|Overall Study|Lost to Follow-up|0|||
126663624|NCT01794520|455727738|FG006|Overall Study|Lost to Follow-up|0|||
126663625|NCT01794520|455727732|FG000|Overall Study|Toxicity|0|||
126663626|NCT01794520|455727733|FG001|Overall Study|Toxicity|2|||
126663627|NCT01794520|455727734|FG002|Overall Study|Toxicity|0|||
126663628|NCT01794520|455727735|FG003|Overall Study|Toxicity|0|||
126663629|NCT01794520|455727736|FG004|Overall Study|Toxicity|0|||
126663630|NCT01794520|455727737|FG005|Overall Study|Toxicity|0|||
126663631|NCT01794520|455727738|FG006|Overall Study|Toxicity|0|||
126663632|NCT01794520|455727732|FG000|Overall Study|Study terminated by sponsor|0|||
126663633|NCT01794520|455727733|FG001|Overall Study|Study terminated by sponsor|0|||
126663634|NCT01794520|455727734|FG002|Overall Study|Study terminated by sponsor|1|||
126663635|NCT01794520|455727735|FG003|Overall Study|Study terminated by sponsor|0|||
126663636|NCT01794520|455727736|FG004|Overall Study|Study terminated by sponsor|1|||
126663637|NCT01794520|455727737|FG005|Overall Study|Study terminated by sponsor|0|||
126663638|NCT01794520|455727738|FG006|Overall Study|Study terminated by sponsor|7|||
126663639|NCT01794520|455727732|FG000|Overall Study|Death|0|||
126663640|NCT01794520|455727733|FG001|Overall Study|Death|0|||
126663641|NCT01794520|455727734|FG002|Overall Study|Death|0|||
126663642|NCT01794520|455727735|FG003|Overall Study|Death|0|||
126663643|NCT01794520|455727736|FG004|Overall Study|Death|1|||
126663644|NCT01794520|455727737|FG005|Overall Study|Death|0|||
126663645|NCT01794520|455727738|FG006|Overall Study|Death|22|||
126663646|NCT01794520|455727732|FG000|Overall Study|Other, not specified|0|||
126663647|NCT01794520|455727733|FG001|Overall Study|Other, not specified|0|||
126663648|NCT01794520|455727734|FG002|Overall Study|Other, not specified|1|||
126663649|NCT01794520|455727735|FG003|Overall Study|Other, not specified|1|||
126663650|NCT01794520|455727736|FG004|Overall Study|Other, not specified|4|||
126663651|NCT01794520|455727737|FG005|Overall Study|Other, not specified|1|||
126663652|NCT01794520|455727738|FG006|Overall Study|Other, not specified|2|||
126663653|NCT04796896|455727739|FG000|Overall Study|Adverse Event|1|||
126663654|NCT04796896|455727740|FG001|Overall Study|Adverse Event|0|||
126663655|NCT04796896|455727741|FG002|Overall Study|Adverse Event|0|||
126663656|NCT04796896|455727742|FG003|Overall Study|Adverse Event|0|||
126663657|NCT04796896|455727743|FG004|Overall Study|Adverse Event|0|||
126663658|NCT04796896|455727744|FG005|Overall Study|Adverse Event|1|||
126663659|NCT04796896|455727745|FG006|Overall Study|Adverse Event|1|||
126663660|NCT04796896|455727746|FG007|Overall Study|Adverse Event|0|||
126663661|NCT04796896|455727747|FG008|Overall Study|Adverse Event|1|||
126663662|NCT04796896|455727748|FG009|Overall Study|Adverse Event|1|||
126663663|NCT04796896|455727749|FG010|Overall Study|Adverse Event|1|||
126663664|NCT04796896|455727750|FG011|Overall Study|Adverse Event|0|||
126663665|NCT04796896|455727739|FG000|Overall Study|Lost to Follow-up|24|||
126663666|NCT04796896|455727740|FG001|Overall Study|Lost to Follow-up|15|||
126663667|NCT04796896|455727741|FG002|Overall Study|Lost to Follow-up|6|||
126663668|NCT04796896|455727742|FG003|Overall Study|Lost to Follow-up|4|||
126663669|NCT04796896|455727743|FG004|Overall Study|Lost to Follow-up|21|||
126663670|NCT04796896|455727744|FG005|Overall Study|Lost to Follow-up|55|||
126663671|NCT04796896|455727745|FG006|Overall Study|Lost to Follow-up|237|||
126663672|NCT04796896|455727746|FG007|Overall Study|Lost to Follow-up|52|||
126663673|NCT04796896|455727747|FG008|Overall Study|Lost to Follow-up|221|||
126663674|NCT04796896|455727748|FG009|Overall Study|Lost to Follow-up|43|||
126663675|NCT04796896|455727749|FG010|Overall Study|Lost to Follow-up|142|||
126663676|NCT04796896|455727750|FG011|Overall Study|Lost to Follow-up|18|||
126663677|NCT04796896|455727739|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
126663678|NCT04796896|455727740|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
126663679|NCT04796896|455727741|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
126663680|NCT04796896|455727742|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
126663681|NCT04796896|455727743|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
126663682|NCT04796896|455727744|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
126663683|NCT04796896|455727745|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
126663684|NCT04796896|455727746|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
126663685|NCT04796896|455727747|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
126663686|NCT04796896|455727748|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
126663687|NCT04796896|455727749|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
126663688|NCT04796896|455727750|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
126663689|NCT04796896|455727739|FG000|Overall Study|Physician Decision|1|||
126663690|NCT04796896|455727740|FG001|Overall Study|Physician Decision|0|||
126663691|NCT04796896|455727741|FG002|Overall Study|Physician Decision|0|||
126663692|NCT04796896|455727742|FG003|Overall Study|Physician Decision|0|||
126663693|NCT04796896|455727743|FG004|Overall Study|Physician Decision|0|||
126663694|NCT04796896|455727744|FG005|Overall Study|Physician Decision|3|||
126663695|NCT04796896|455727745|FG006|Overall Study|Physician Decision|18|||
126663696|NCT04796896|455727746|FG007|Overall Study|Physician Decision|1|||
126663697|NCT04796896|455727747|FG008|Overall Study|Physician Decision|7|||
126663698|NCT04796896|455727748|FG009|Overall Study|Physician Decision|0|||
126663699|NCT04796896|455727749|FG010|Overall Study|Physician Decision|5|||
126663700|NCT04796896|455727750|FG011|Overall Study|Physician Decision|0|||
126663701|NCT04796896|455727739|FG000|Overall Study|Withdrawal by Subject|36|||
126663702|NCT04796896|455727740|FG001|Overall Study|Withdrawal by Subject|31|||
126663703|NCT04796896|455727741|FG002|Overall Study|Withdrawal by Subject|11|||
126663704|NCT04796896|455727742|FG003|Overall Study|Withdrawal by Subject|8|||
126663705|NCT04796896|455727743|FG004|Overall Study|Withdrawal by Subject|16|||
126663706|NCT04796896|455727744|FG005|Overall Study|Withdrawal by Subject|162|||
126663707|NCT04796896|455727745|FG006|Overall Study|Withdrawal by Subject|299|||
126663708|NCT04796896|455727746|FG007|Overall Study|Withdrawal by Subject|149|||
126663709|NCT04796896|455727747|FG008|Overall Study|Withdrawal by Subject|303|||
126663710|NCT04796896|455727748|FG009|Overall Study|Withdrawal by Subject|94|||
126663711|NCT04796896|455727749|FG010|Overall Study|Withdrawal by Subject|192|||
126663712|NCT04796896|455727750|FG011|Overall Study|Withdrawal by Subject|16|||
126663713|NCT04796896|455727739|FG000|Overall Study|Other Than Specified|6|||
126663714|NCT04796896|455727740|FG001|Overall Study|Other Than Specified|5|||
126663715|NCT04796896|455727741|FG002|Overall Study|Other Than Specified|3|||
126331376|NCT01877668|454508824|FG002|Overall Study|Adverse event unrelated to study drug|2|||
126663716|NCT04796896|455727742|FG003|Overall Study|Other Than Specified|2|||
126663717|NCT04796896|455727743|FG004|Overall Study|Other Than Specified|6|||
126663718|NCT04796896|455727744|FG005|Overall Study|Other Than Specified|31|||
126663719|NCT04796896|455727745|FG006|Overall Study|Other Than Specified|86|||
126663720|NCT04796896|455727746|FG007|Overall Study|Other Than Specified|66|||
126663721|NCT04796896|455727747|FG008|Overall Study|Other Than Specified|388|||
126663722|NCT04796896|455727748|FG009|Overall Study|Other Than Specified|48|||
126663723|NCT04796896|455727749|FG010|Overall Study|Other Than Specified|258|||
126663724|NCT04796896|455727750|FG011|Overall Study|Other Than Specified|4|||
126663725|NCT04796896|455727739|FG000|Overall Study|Protocol Deviation|0|||
126663726|NCT04796896|455727740|FG001|Overall Study|Protocol Deviation|0|||
126663727|NCT04796896|455727741|FG002|Overall Study|Protocol Deviation|0|||
126663728|NCT04796896|455727742|FG003|Overall Study|Protocol Deviation|1|||
126663729|NCT04796896|455727743|FG004|Overall Study|Protocol Deviation|1|||
126663730|NCT04796896|455727744|FG005|Overall Study|Protocol Deviation|2|||
126663731|NCT04796896|455727745|FG006|Overall Study|Protocol Deviation|2|||
126663732|NCT04796896|455727746|FG007|Overall Study|Protocol Deviation|2|||
126663733|NCT04796896|455727747|FG008|Overall Study|Protocol Deviation|2|||
126663734|NCT04796896|455727748|FG009|Overall Study|Protocol Deviation|1|||
126663735|NCT04796896|455727749|FG010|Overall Study|Protocol Deviation|0|||
126663736|NCT04796896|455727750|FG011|Overall Study|Protocol Deviation|0|||
126663737|NCT04796896|455727739|FG000|Overall Study|Missing|0|||
126663738|NCT04796896|455727740|FG001|Overall Study|Missing|0|||
126663739|NCT04796896|455727741|FG002|Overall Study|Missing|0|||
126663740|NCT04796896|455727742|FG003|Overall Study|Missing|0|||
126663741|NCT04796896|455727743|FG004|Overall Study|Missing|0|||
126663742|NCT04796896|455727744|FG005|Overall Study|Missing|0|||
126663743|NCT04796896|455727745|FG006|Overall Study|Missing|2|||
126663744|NCT04796896|455727746|FG007|Overall Study|Missing|1|||
126663745|NCT04796896|455727747|FG008|Overall Study|Missing|2|||
126663746|NCT04796896|455727748|FG009|Overall Study|Missing|1|||
126663747|NCT04796896|455727749|FG010|Overall Study|Missing|1|||
126663748|NCT04796896|455727750|FG011|Overall Study|Missing|0|||
126663749|NCT04796896|455727739|FG000|Overall Study|Death|0|||
126663750|NCT04796896|455727740|FG001|Overall Study|Death|0|||
126663751|NCT04796896|455727741|FG002|Overall Study|Death|0|||
126663752|NCT04796896|455727742|FG003|Overall Study|Death|0|||
126663753|NCT04796896|455727743|FG004|Overall Study|Death|0|||
126663754|NCT04796896|455727744|FG005|Overall Study|Death|0|||
126663755|NCT04796896|455727745|FG006|Overall Study|Death|0|||
126663756|NCT04796896|455727746|FG007|Overall Study|Death|0|||
126663757|NCT04796896|455727747|FG008|Overall Study|Death|1|||
126663758|NCT04796896|455727748|FG009|Overall Study|Death|0|||
126663759|NCT04796896|455727749|FG010|Overall Study|Death|0|||
126663760|NCT04796896|455727750|FG011|Overall Study|Death|0|||
126663761|NCT01177787|455727751|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
126663762|NCT01177787|455727751|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
126663763|NCT01177787|455727751|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
126663764|NCT00402363|455727752|FG000|Overall Study|Adverse Event|9|||
126663765|NCT00402363|455727753|FG001|Overall Study|Adverse Event|14|||
126663766|NCT00402363|455727754|FG002|Overall Study|Adverse Event|2|||
126663767|NCT00402363|455727755|FG003|Overall Study|Adverse Event|2|||
126663768|NCT00402363|455727752|FG000|Overall Study|Withdrew Consent|10|||
126663769|NCT00402363|455727753|FG001|Overall Study|Withdrew Consent|5|||
126663770|NCT00402363|455727754|FG002|Overall Study|Withdrew Consent|2|||
126663771|NCT00402363|455727755|FG003|Overall Study|Withdrew Consent|1|||
126663772|NCT00402363|455727752|FG000|Overall Study|Protocol Violation|3|||
126663773|NCT00402363|455727753|FG001|Overall Study|Protocol Violation|5|||
126663774|NCT00402363|455727754|FG002|Overall Study|Protocol Violation|0|||
126331377|NCT01877668|454508825|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126331378|NCT01877668|454508826|FG004|Overall Study|Adverse event unrelated to study drug|1|||
126331379|NCT01302418|454508827|FG000|Overall Study|Protocol Violation|9|||
126331380|NCT01302418|454508827|FG000|Overall Study|Non-evaluable|9|||
126331381|NCT00377637|454508829|FG000|Induction Phase|Adverse Event|12|||
126331382|NCT00377637|454508830|FG001|Induction Phase|Adverse Event|21|||
126331383|NCT00377637|454508831|FG002|Induction Phase|Adverse Event|0|||
126331384|NCT00377637|454508832|FG003|Induction Phase|Adverse Event|0|||
126663775|NCT00402363|455727755|FG003|Overall Study|Protocol Violation|3|||
126663776|NCT00402363|455727752|FG000|Overall Study|Lost to Follow-up|5|||
126663777|NCT00402363|455727753|FG001|Overall Study|Lost to Follow-up|4|||
126663778|NCT00402363|455727754|FG002|Overall Study|Lost to Follow-up|0|||
126663779|NCT00402363|455727755|FG003|Overall Study|Lost to Follow-up|2|||
126663780|NCT00402363|455727752|FG000|Overall Study|"Captured as Other"|6|||
126663781|NCT00402363|455727753|FG001|Overall Study|"Captured as Other"|2|||
126663782|NCT00402363|455727754|FG002|Overall Study|"Captured as Other"|2|||
126663783|NCT00402363|455727755|FG003|Overall Study|"Captured as Other"|2|||
126663784|NCT02634346|455727756|FG000|Overall Study|Withdrawal by Subject|8|||
126663785|NCT02634346|455727757|FG001|Overall Study|Withdrawal by Subject|9|||
126663786|NCT02634346|455727758|FG002|Overall Study|Withdrawal by Subject|8|||
126663787|NCT02634346|455727756|FG000|Overall Study|Adverse Event|2|||
126663788|NCT02634346|455727757|FG001|Overall Study|Adverse Event|2|||
126663789|NCT02634346|455727758|FG002|Overall Study|Adverse Event|7|||
126663790|NCT02634346|455727756|FG000|Overall Study|Lack of Efficacy|1|||
126663791|NCT02634346|455727757|FG001|Overall Study|Lack of Efficacy|2|||
126663792|NCT02634346|455727758|FG002|Overall Study|Lack of Efficacy|8|||
126663793|NCT02634346|455727756|FG000|Overall Study|Lost to Follow-up|1|||
126663794|NCT02634346|455727757|FG001|Overall Study|Lost to Follow-up|0|||
126663795|NCT02634346|455727758|FG002|Overall Study|Lost to Follow-up|0|||
126663796|NCT02634346|455727756|FG000|Overall Study|Protocol Violation|0|||
126663797|NCT02634346|455727757|FG001|Overall Study|Protocol Violation|1|||
126663798|NCT02634346|455727758|FG002|Overall Study|Protocol Violation|0|||
126663799|NCT01676909|455727759|FG000|Overall Study|Withdrawal by Subject|3|||
126663800|NCT01676909|455727760|FG001|Overall Study|Withdrawal by Subject|5|||
126663801|NCT01676909|455727759|FG000|Overall Study|Lost to Follow-up|15|||
126663802|NCT01676909|455727760|FG001|Overall Study|Lost to Follow-up|9|||
126663803|NCT00823901|455727764|FG000|Overall Study|Adverse Event|1|||
126663804|NCT00823901|455727765|FG001|Overall Study|Adverse Event|1|||
126663805|NCT00823901|455727764|FG000|Overall Study|Lack of Efficacy|1|||
126663806|NCT00823901|455727765|FG001|Overall Study|Lack of Efficacy|0|||
126663807|NCT00823901|455727764|FG000|Overall Study|Lost to Follow-up|2|||
126663808|NCT00823901|455727765|FG001|Overall Study|Lost to Follow-up|1|||
126663809|NCT01369511|455727767|FG000|Overall Study|Adverse Event|1|||
126663810|NCT01369511|455727768|FG001|Overall Study|Adverse Event|1|||
126663811|NCT01369511|455727769|FG002|Overall Study|Adverse Event|5|||
126663812|NCT01369511|455727770|FG003|Overall Study|Adverse Event|0|||
126663813|NCT01369511|455727767|FG000|Overall Study|Entry criteria not met|2|||
126663814|NCT01369511|455727768|FG001|Overall Study|Entry criteria not met|0|||
126663815|NCT01369511|455727769|FG002|Overall Study|Entry criteria not met|0|||
126663816|NCT01369511|455727770|FG003|Overall Study|Entry criteria not met|1|||
126663817|NCT01369511|455727767|FG000|Overall Study|Lost to Follow-up|0|||
126663818|NCT01369511|455727768|FG001|Overall Study|Lost to Follow-up|1|||
126663819|NCT01369511|455727769|FG002|Overall Study|Lost to Follow-up|1|||
126663820|NCT01369511|455727770|FG003|Overall Study|Lost to Follow-up|2|||
126663821|NCT01369511|455727767|FG000|Overall Study|Protocol Violation|0|||
126663822|NCT01369511|455727768|FG001|Overall Study|Protocol Violation|1|||
126663823|NCT01369511|455727769|FG002|Overall Study|Protocol Violation|0|||
126663824|NCT01369511|455727770|FG003|Overall Study|Protocol Violation|2|||
126663825|NCT01369511|455727767|FG000|Overall Study|Physician Decision|3|||
126663826|NCT01369511|455727768|FG001|Overall Study|Physician Decision|4|||
126663827|NCT01369511|455727769|FG002|Overall Study|Physician Decision|0|||
126663828|NCT01369511|455727770|FG003|Overall Study|Physician Decision|0|||
126663829|NCT01369511|455727767|FG000|Overall Study|Sponsor decision|2|||
126663830|NCT01369511|455727768|FG001|Overall Study|Sponsor decision|0|||
126663831|NCT01369511|455727769|FG002|Overall Study|Sponsor decision|1|||
126663832|NCT01369511|455727770|FG003|Overall Study|Sponsor decision|0|||
126663833|NCT01369511|455727767|FG000|Overall Study|Withdrawal by Subject|5|||
126663834|NCT01369511|455727768|FG001|Overall Study|Withdrawal by Subject|6|||
126663835|NCT01369511|455727769|FG002|Overall Study|Withdrawal by Subject|4|||
126663836|NCT01369511|455727770|FG003|Overall Study|Withdrawal by Subject|6|||
126663837|NCT01180998|455727771|FG000|Overall Study|Poor Vision|0|||
126663838|NCT01180998|455727772|FG001|Overall Study|Poor Vision|2|||
126663839|NCT01180998|455727773|FG002|Overall Study|Poor Vision|2|||
126663840|NCT01180998|455727771|FG000|Overall Study|Lost to Follow-up|0|||
126663841|NCT01180998|455727772|FG001|Overall Study|Lost to Follow-up|0|||
126663842|NCT01180998|455727773|FG002|Overall Study|Lost to Follow-up|1|||
126663843|NCT01180998|455727771|FG000|Overall Study|Protocol Violation|1|||
126663844|NCT01180998|455727772|FG001|Overall Study|Protocol Violation|2|||
126663845|NCT01180998|455727773|FG002|Overall Study|Protocol Violation|0|||
126663846|NCT01180998|455727771|FG000|Overall Study|Withdrawal by Subject|0|||
126663847|NCT01180998|455727772|FG001|Overall Study|Withdrawal by Subject|0|||
126663848|NCT01180998|455727773|FG002|Overall Study|Withdrawal by Subject|1|||
126663849|NCT01180998|455727771|FG000|Overall Study|Poor comfort|3|||
126663850|NCT01180998|455727772|FG001|Overall Study|Poor comfort|0|||
126663851|NCT01180998|455727773|FG002|Overall Study|Poor comfort|4|||
126663852|NCT01180998|455727771|FG000|Overall Study|Poor lens handling|0|||
126663853|NCT01180998|455727772|FG001|Overall Study|Poor lens handling|0|||
126663854|NCT01180998|455727773|FG002|Overall Study|Poor lens handling|2|||
126663855|NCT01376349|455727774|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
126663856|NCT01376349|455727775|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
126663857|NCT01376349|455727776|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
126663858|NCT01376349|455727774|FG000|Raondomized Treatment|Adverse Event|13|||
126663859|NCT01376349|455727775|FG001|Raondomized Treatment|Adverse Event|17|||
126663860|NCT01376349|455727776|FG002|Raondomized Treatment|Adverse Event|14|||
126663861|NCT01376349|455727774|FG000|Raondomized Treatment|Unkown|1|||
126663862|NCT01376349|455727775|FG001|Raondomized Treatment|Unkown|2|||
126663863|NCT01376349|455727776|FG002|Raondomized Treatment|Unkown|1|||
126663864|NCT01376349|455727774|FG000|Raondomized Treatment|Alternative Treatment|0|||
126663865|NCT01376349|455727775|FG001|Raondomized Treatment|Alternative Treatment|0|||
126663866|NCT01376349|455727776|FG002|Raondomized Treatment|Alternative Treatment|1|||
126663867|NCT00162032|455727777|FG000|Overall Study|Lost to Follow-up|4|||
126663868|NCT00162032|455727778|FG001|Overall Study|Lost to Follow-up|2|||
126663869|NCT00162032|455727777|FG000|Overall Study|Reason not specified|1|||
126663870|NCT00162032|455727778|FG001|Overall Study|Reason not specified|0|||
126663871|NCT01176968|455727779|FG000|Overall Study|Adverse Event|10|||
126663872|NCT01176968|455727780|FG001|Overall Study|Adverse Event|11|||
126663873|NCT01176968|455727779|FG000|Overall Study|Death|2|||
126663874|NCT01176968|455727780|FG001|Overall Study|Death|3|||
126663875|NCT01176968|455727779|FG000|Overall Study|Lack of Efficacy|0|||
126663876|NCT01176968|455727780|FG001|Overall Study|Lack of Efficacy|1|||
126663877|NCT01176968|455727779|FG000|Overall Study|Lost to Follow-up|16|||
126663878|NCT01176968|455727780|FG001|Overall Study|Lost to Follow-up|14|||
126663879|NCT01176968|455727779|FG000|Overall Study|Withdrawal by Subject|48|||
126663880|NCT01176968|455727780|FG001|Overall Study|Withdrawal by Subject|48|||
126663881|NCT01176968|455727779|FG000|Overall Study|Protocol Violation|2|||
126663882|NCT01176968|455727780|FG001|Overall Study|Protocol Violation|1|||
126663883|NCT01176968|455727779|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
126663884|NCT01176968|455727780|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
126663885|NCT01176968|455727779|FG000|Overall Study|Study terminated by sponsor|0|||
126663886|NCT01176968|455727780|FG001|Overall Study|Study terminated by sponsor|1|||
126663887|NCT01176968|455727779|FG000|Overall Study|Reason not defined|5|||
126663888|NCT01176968|455727780|FG001|Overall Study|Reason not defined|3|||
126663889|NCT00833911|455727781|FG000|Titration|Adverse Event|18|||
126663890|NCT00833911|455727781|FG000|Titration|Withdrawal by Subject|3|||
126663891|NCT00833911|455727781|FG000|Maintenance Phase I|Adverse Event|73|||
126663892|NCT00833911|455727781|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
126663893|NCT00833911|455727781|FG000|Maintenance Phase I|Physician Decision|10|||
126663894|NCT00833911|455727781|FG000|Maintenance Phase I|Lack of Efficacy|4|||
126663895|NCT00833911|455727781|FG000|Maintenance Phase II|Adverse Event|6|||
126663896|NCT00833911|455727781|FG000|Maintenance Phase II|Physician Decision|2|||
126663897|NCT00833911|455727781|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
126663898|NCT00833911|455727781|FG000|Maintenance Phase II|Lack of Efficacy|1|||
126663899|NCT00718640|455727782|FG000|Overall Study|Adverse Event|4|||
126663900|NCT00718640|455727782|FG000|Overall Study|Death|1|||
126663901|NCT00718640|455727782|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
126663902|NCT01137955|455727783|FG000|Overall Study|Withdrawal by Subject|5|||
126663903|NCT01137955|455727784|FG001|Overall Study|Withdrawal by Subject|4|||
126663904|NCT01207596|455727785|FG000|Overall Study|Physician Decision|4|||
126663905|NCT01207596|455727785|FG000|Overall Study|Lack of Efficacy|1|||
126663906|NCT01207596|455727785|FG000|Overall Study|Adverse Event|3|||
126663907|NCT01207596|455727785|FG000|Overall Study|Withdrawal by Subject|1|||
126663908|NCT00068588|455727786|FG000|Overall Study|Adverse Event|0|||
126663909|NCT00068588|455727787|FG001|Overall Study|Adverse Event|0|||
126663910|NCT00068588|455727788|FG002|Overall Study|Adverse Event|2|||
126663911|NCT00068588|455727786|FG000|Overall Study|Withdrawal by Subject|0|||
126663912|NCT00068588|455727787|FG001|Overall Study|Withdrawal by Subject|0|||
126663913|NCT00068588|455727788|FG002|Overall Study|Withdrawal by Subject|1|||
126663914|NCT00068588|455727786|FG000|Overall Study|Poor KPS|0|||
126663915|NCT00068588|455727787|FG001|Overall Study|Poor KPS|0|||
126663916|NCT00068588|455727788|FG002|Overall Study|Poor KPS|1|||
126663917|NCT05193500|455727789|FG000|Overall Study|Withdrawal by Subject|7|||
126663918|NCT05193500|455727790|FG001|Overall Study|Withdrawal by Subject|4|||
126663919|NCT05193500|455727791|FG002|Overall Study|Withdrawal by Subject|3|||
126663920|NCT05193500|455727792|FG003|Overall Study|Withdrawal by Subject|5|||
126663921|NCT04098068|455727793|FG000|Overall Study|Disease Progression|7|||
126663922|NCT04098068|455727793|FG000|Overall Study|Withdrawal by Subject|2|||
126663923|NCT04098068|455727793|FG000|Overall Study|New Cancer Diagnosis|1|||
126663924|NCT03871829|455727794|FG000|Overall Study|Lost to Follow-up|0|||
126663925|NCT03871829|455727795|FG001|Overall Study|Lost to Follow-up|1|||
126663926|NCT03871829|455727794|FG000|Overall Study|Withdrawal by Subject|1|||
126663927|NCT03871829|455727795|FG001|Overall Study|Withdrawal by Subject|1|||
126663928|NCT03871829|455727794|FG000|Overall Study|Death|12|||
126663929|NCT03871829|455727795|FG001|Overall Study|Death|8|||
126663930|NCT03871829|455727794|FG000|Overall Study|Study terminated by sponsor|31|||
126663931|NCT03871829|455727795|FG001|Overall Study|Study terminated by sponsor|34|||
126663932|NCT05458479|455727801|FG000|Overall Study|Lost to Follow-up|1|||
126663933|NCT00784693|455727802|FG000|Overall Study|Lost to Follow-up|0|||
126663934|NCT00784693|455727803|FG001|Overall Study|Lost to Follow-up|1|||
126663935|NCT00784693|455727802|FG000|Overall Study|Lack of Efficacy|1|||
126663936|NCT00784693|455727803|FG001|Overall Study|Lack of Efficacy|1|||
126663937|NCT00784693|455727802|FG000|Overall Study|Withdrawal by Subject|0|||
126663938|NCT00784693|455727803|FG001|Overall Study|Withdrawal by Subject|4|||
126663939|NCT00784693|455727802|FG000|Overall Study|Randomized but not Treated|1|||
126663940|NCT00784693|455727803|FG001|Overall Study|Randomized but not Treated|0|||
126663941|NCT00784693|455727802|FG000|Overall Study|Other|1|||
126663942|NCT00784693|455727803|FG001|Overall Study|Other|0|||
126663943|NCT01324323|455727804|FG000|Overall Study|Withdrawal by Subject|1|||
126663944|NCT00993915|455727811|FG000|Overall Study|Insufficient clinical response|3|||
126663945|NCT00993915|455727811|FG000|Overall Study|Withdrawal by Subject|2|||
126663946|NCT00993915|455727811|FG000|Overall Study|Other|1|||
126663947|NCT00993915|455727811|FG000|Overall Study|Ongoing|3|||
126663948|NCT02119325|455727812|FG000|Washout Period 1|Adverse Event|0|||
126663949|NCT02119325|455727813|FG001|Washout Period 1|Adverse Event|1|||
126663950|NCT01386658|455727814|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
126663951|NCT01386658|455727815|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
126663952|NCT01386658|455727814|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
126663953|NCT01386658|455727815|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
126663954|NCT02249767|455727823|FG000|Overall Study|Did not use medication|8|||
126663955|NCT02249767|455727824|FG001|Overall Study|Did not use medication|9|||
126663956|NCT02249767|455727825|FG002|Overall Study|Did not use medication|8|||
126663957|NCT02465463|455727827|FG000|Overall Study|Lost to Follow-up|2|||
126663958|NCT02465463|455727828|FG001|Overall Study|Lost to Follow-up|1|||
126663959|NCT02465463|455727827|FG000|Overall Study|Death|1|||
126663960|NCT02465463|455727828|FG001|Overall Study|Death|0|||
126663961|NCT02465463|455727827|FG000|Overall Study|Protocol Violation|1|||
126663962|NCT02465463|455727828|FG001|Overall Study|Protocol Violation|0|||
126663963|NCT01774084|455727830|FG000|Overall Study|Personal reasons|1|||
126663964|NCT01774084|455727831|FG001|Overall Study|Personal reasons|0|||
126663965|NCT00821431|455727832|FG000|Overall Study|Adverse Event|6|||
126663966|NCT00821431|455727833|FG001|Overall Study|Adverse Event|3|||
126663967|NCT00821431|455727832|FG000|Overall Study|Withdrawal by Subject|5|||
126663968|NCT00821431|455727833|FG001|Overall Study|Withdrawal by Subject|0|||
126663969|NCT00821431|455727832|FG000|Overall Study|Lost to Follow-up|1|||
126663970|NCT00821431|455727833|FG001|Overall Study|Lost to Follow-up|0|||
126663971|NCT00821431|455727832|FG000|Overall Study|Protocol Violation|3|||
126663972|NCT00821431|455727833|FG001|Overall Study|Protocol Violation|1|||
126663973|NCT00821431|455727832|FG000|Overall Study|Physician Decision|0|||
126663974|NCT00821431|455727833|FG001|Overall Study|Physician Decision|1|||
126663975|NCT00986440|455727838|FG000|Overall Study|Progressive disease|27|||
126663976|NCT00986440|455727839|FG001|Overall Study|Progressive disease|37|||
126663977|NCT00986440|455727838|FG000|Overall Study|Serious adverse event or adverse event|9|||
126663978|NCT00986440|455727839|FG001|Overall Study|Serious adverse event or adverse event|2|||
126663979|NCT00986440|455727838|FG000|Overall Study|Withdrawal by Subject|1|||
126663980|NCT00986440|455727839|FG001|Overall Study|Withdrawal by Subject|2|||
126663981|NCT00986440|455727838|FG000|Overall Study|Screen failure (not dosed)|4|||
126663982|NCT00986440|455727839|FG001|Overall Study|Screen failure (not dosed)|2|||
126663983|NCT04526197|455727840|FG000|Period 1|Adverse Event|0|||
126663984|NCT04526197|455727841|FG001|Period 1|Adverse Event|1|||
126663985|NCT04526197|455727840|FG000|Period 1|Withdrawal by Subject|1|||
126663986|NCT04526197|455727841|FG001|Period 1|Withdrawal by Subject|0|||
126663987|NCT04526197|455727840|FG000|Period 2|Adverse Event|0|||
126663988|NCT04526197|455727841|FG001|Period 2|Adverse Event|1|||
126663989|NCT04526197|455727840|FG000|Period 2|Withdrawal by Subject|0|||
126663990|NCT04526197|455727841|FG001|Period 2|Withdrawal by Subject|1|||
126663991|NCT02411578|455727843|FG000|Crossover Trial Phase|Pregnancy|0|||
126663992|NCT02411578|455727844|FG001|Crossover Trial Phase|Pregnancy|1|||
126663993|NCT01323621|455727847|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
126663994|NCT01323621|455727848|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
126663995|NCT01323621|455727849|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
126663996|NCT01323621|455727847|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
126663997|NCT01323621|455727848|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
126663998|NCT01323621|455727849|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
126663999|NCT01323621|455727847|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
126664000|NCT01323621|455727848|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
126664001|NCT01323621|455727849|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
126664002|NCT01323621|455727847|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
126664003|NCT01323621|455727848|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
126664004|NCT01323621|455727849|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
126664005|NCT01323621|455727847|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
126664006|NCT01323621|455727848|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
126664007|NCT01323621|455727849|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
126664008|NCT01323621|455727847|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
126664009|NCT01323621|455727848|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
126664010|NCT01323621|455727849|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
126664011|NCT01323621|455727847|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
126664012|NCT01323621|455727848|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
126664013|NCT01323621|455727849|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
126664014|NCT01323621|455727847|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
126664015|NCT01323621|455727848|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
126664016|NCT01323621|455727849|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
126664017|NCT01323621|455727847|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
126664018|NCT01323621|455727848|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
126664019|NCT01323621|455727849|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
126664020|NCT01323621|455727847|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126664021|NCT01323621|455727848|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
126664022|NCT01323621|455727849|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126664023|NCT01323621|455727847|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
126664024|NCT01323621|455727848|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
126664025|NCT01323621|455727849|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
126664026|NCT01323621|455727847|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126664027|NCT01323621|455727848|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
126664028|NCT01323621|455727849|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
126664029|NCT00364156|455727850|FG000|Overall Study|Withdrawal by Subject|73|||
126664030|NCT00364156|455727851|FG001|Overall Study|Withdrawal by Subject|80|||
126664031|NCT00364156|455727850|FG000|Overall Study|Protocol Violation|6|||
126664032|NCT00364156|455727851|FG001|Overall Study|Protocol Violation|1|||
126664033|NCT01472380|455727852|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
126664034|NCT01472380|455727852|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
126664035|NCT01557348|455727853|FG000|Overall Study|Adverse Event|6|||
126664036|NCT01557348|455727854|FG001|Overall Study|Adverse Event|16|||
126664037|NCT01557348|455727853|FG000|Overall Study|Infusion reaction event|5|||
126664038|NCT01557348|455727854|FG001|Overall Study|Infusion reaction event|5|||
126664039|NCT01557348|455727853|FG000|Overall Study|Death|7|||
126664040|NCT01557348|455727854|FG001|Overall Study|Death|4|||
126664041|NCT01557348|455727853|FG000|Overall Study|Insufficient Therapeutic Response|13|||
126664042|NCT01557348|455727854|FG001|Overall Study|Insufficient Therapeutic Response|28|||
126664043|NCT01557348|455727853|FG000|Overall Study|Withdrawal by Subject|5|||
126664044|NCT01557348|455727854|FG001|Overall Study|Withdrawal by Subject|4|||
126664045|NCT01557348|455727853|FG000|Overall Study|Lost to Follow-up|26|||
126664046|NCT01557348|455727854|FG001|Overall Study|Lost to Follow-up|22|||
126664047|NCT01557348|455727853|FG000|Overall Study|Administrative|18|||
126664048|NCT01557348|455727854|FG001|Overall Study|Administrative|11|||
126664049|NCT01891721|455727855|FG000|Overall Study|Lost to Follow-up|10|||
126664050|NCT01891721|455727856|FG001|Overall Study|Lost to Follow-up|5|||
126664051|NCT01891721|455727857|FG002|Overall Study|Lost to Follow-up|1|||
126664052|NCT05125679|455727862|FG000|Overall Study|Study Terminated by Sponsor|2|||
126664053|NCT05125679|455727863|FG001|Overall Study|Study Terminated by Sponsor|5|||
126664054|NCT04484259|455727864|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
126664055|NCT04484259|455727865|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
126664056|NCT04484259|455727866|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
126664057|NCT04484259|455727867|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
126664058|NCT04484259|455727868|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
126664059|NCT04484259|455727864|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
126664060|NCT04484259|455727865|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
126664061|NCT04484259|455727866|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
126664062|NCT04484259|455727867|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
126664063|NCT04484259|455727868|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
126664064|NCT04484259|455727864|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
126664065|NCT04484259|455727865|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
126664066|NCT04484259|455727866|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
126664067|NCT04484259|455727867|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
126664068|NCT04484259|455727868|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
126664069|NCT04484259|455727864|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
126664070|NCT04484259|455727865|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
126664071|NCT04484259|455727866|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
126664072|NCT04484259|455727867|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
126664073|NCT04484259|455727868|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
126664074|NCT04484259|455727864|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
126664075|NCT04484259|455727865|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
126664076|NCT04484259|455727866|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
126664077|NCT04484259|455727867|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
126664078|NCT04484259|455727868|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
126664079|NCT04484259|455727864|FG000|Randomized Treatment|Withdrawal by Subject|1|||
126664080|NCT04484259|455727865|FG001|Randomized Treatment|Withdrawal by Subject|0|||
126664081|NCT04484259|455727866|FG002|Randomized Treatment|Withdrawal by Subject|0|||
126664082|NCT04484259|455727867|FG003|Randomized Treatment|Withdrawal by Subject|0|||
126664083|NCT04484259|455727868|FG004|Randomized Treatment|Withdrawal by Subject|0|||
126664084|NCT01422850|455727875|FG000|Overall Study|Physician Decision|3|||
126664085|NCT04484831|455727876|FG000|Overall Study|Withdrawal by Subject|1|||
126664086|NCT04484831|455727877|FG001|Overall Study|Withdrawal by Subject|0|||
126664087|NCT02244996|455727878|FG000|Overall Study|Lack of Efficacy|2|||
126664088|NCT02244996|455727879|FG001|Overall Study|Lack of Efficacy|6|||
126664089|NCT01335009|455727880|FG000|Overall Study|Too ill to travel to study sites|1|||
126664090|NCT01335009|455727881|FG001|Overall Study|Too ill to travel to study sites|0|||
126664091|NCT01335009|455727880|FG000|Overall Study|Death|28|||
126664092|NCT01335009|455727881|FG001|Overall Study|Death|32|||
126664093|NCT01335009|455727880|FG000|Overall Study|Withdrawal by Subject|1|||
126664094|NCT01335009|455727881|FG001|Overall Study|Withdrawal by Subject|1|||
126664095|NCT01335009|455727880|FG000|Overall Study|Lost to Follow-up|1|||
126331385|NCT00377637|454508829|FG000|Induction Phase|Deterioration/serum creatinine|2|||
126664096|NCT01335009|455727881|FG001|Overall Study|Lost to Follow-up|0|||
126664097|NCT01128361|455729243|FG000|Overall Study|Lost to Follow-up|0|||
126664098|NCT01128361|455729244|FG001|Overall Study|Lost to Follow-up|1|||
126664099|NCT01128361|455729243|FG000|Overall Study|Withdrawal by Subject|5|||
126664100|NCT01128361|455729244|FG001|Overall Study|Withdrawal by Subject|2|||
126664101|NCT00146328|455729245|FG000|Overall Study|Adverse Event|39|||
126664102|NCT00146328|455729246|FG001|Overall Study|Adverse Event|48|||
126664103|NCT00146328|455729247|FG002|Overall Study|Adverse Event|79|||
126664104|NCT00146328|455729245|FG000|Overall Study|Protocol Violation|11|||
126664105|NCT00146328|455729246|FG001|Overall Study|Protocol Violation|6|||
126664106|NCT00146328|455729247|FG002|Overall Study|Protocol Violation|12|||
126664107|NCT00146328|455729245|FG000|Overall Study|Lost to Follow-up|7|||
126664108|NCT00146328|455729246|FG001|Overall Study|Lost to Follow-up|4|||
126664109|NCT00146328|455729247|FG002|Overall Study|Lost to Follow-up|7|||
126664110|NCT00146328|455729245|FG000|Overall Study|Withdrawal by Subject|16|||
126664111|NCT00146328|455729246|FG001|Overall Study|Withdrawal by Subject|16|||
126664112|NCT00146328|455729247|FG002|Overall Study|Withdrawal by Subject|22|||
126664113|NCT00146328|455729245|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
126664114|NCT00146328|455729246|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
126664115|NCT00146328|455729247|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
126664116|NCT00146328|455729245|FG000|Overall Study|Trial ended/site closed|8|||
126664117|NCT00146328|455729246|FG001|Overall Study|Trial ended/site closed|2|||
126664118|NCT00146328|455729247|FG002|Overall Study|Trial ended/site closed|19|||
126664119|NCT00146328|455729245|FG000|Overall Study|Patient decision to end|0|||
126664120|NCT00146328|455729246|FG001|Overall Study|Patient decision to end|1|||
126664121|NCT00146328|455729247|FG002|Overall Study|Patient decision to end|6|||
126664122|NCT00146328|455729245|FG000|Overall Study|Enroll into other trial|2|||
126664123|NCT00146328|455729246|FG001|Overall Study|Enroll into other trial|4|||
126664124|NCT00146328|455729247|FG002|Overall Study|Enroll into other trial|2|||
126664125|NCT00146328|455729245|FG000|Overall Study|Death|0|||
126664126|NCT00146328|455729246|FG001|Overall Study|Death|1|||
126664127|NCT00146328|455729247|FG002|Overall Study|Death|1|||
126664128|NCT00146328|455729245|FG000|Overall Study|Moved|2|||
126664129|NCT00146328|455729246|FG001|Overall Study|Moved|0|||
126664130|NCT00146328|455729247|FG002|Overall Study|Moved|0|||
126664131|NCT00146328|455729245|FG000|Overall Study|Interaction with other medication|2|||
126664132|NCT00146328|455729246|FG001|Overall Study|Interaction with other medication|0|||
126664133|NCT00146328|455729247|FG002|Overall Study|Interaction with other medication|1|||
126664134|NCT00300781|455729248|FG000|Overall Study|Disease Progression|55|||
126664135|NCT00300781|455729249|FG001|Overall Study|Disease Progression|52|||
126331386|NCT00377637|454508830|FG001|Induction Phase|Deterioration/serum creatinine|0|||
126331387|NCT00377637|454508831|FG002|Induction Phase|Deterioration/serum creatinine|0|||
126331388|NCT00377637|454508832|FG003|Induction Phase|Deterioration/serum creatinine|0|||
126331389|NCT00377637|454508829|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
126331390|NCT00377637|454508830|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
126331391|NCT00377637|454508831|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
126331392|NCT00377637|454508832|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
126331393|NCT00377637|454508829|FG000|Induction Phase|Lost to Follow-up|2|||
126664136|NCT00300781|455729248|FG000|Overall Study|Adverse Event|5|||
126664137|NCT00300781|455729249|FG001|Overall Study|Adverse Event|6|||
126664138|NCT00300781|455729248|FG000|Overall Study|Withdrawal by Subject|1|||
126664139|NCT00300781|455729249|FG001|Overall Study|Withdrawal by Subject|2|||
126664140|NCT00300781|455729248|FG000|Overall Study|Physician Decision|1|||
126664141|NCT00300781|455729249|FG001|Overall Study|Physician Decision|0|||
126664142|NCT00300781|455729248|FG000|Overall Study|Not Recorded|0|||
126664143|NCT00300781|455729249|FG001|Overall Study|Not Recorded|1|||
126664144|NCT00300781|455729248|FG000|Overall Study|Symptomatic Deterioration|1|||
126664145|NCT00300781|455729249|FG001|Overall Study|Symptomatic Deterioration|0|||
126664146|NCT00300781|455729248|FG000|Overall Study|Lost to Follow-up|0|||
126664147|NCT00300781|455729249|FG001|Overall Study|Lost to Follow-up|1|||
126664148|NCT01256658|455729250|FG000|Period 1|Lost to Follow-up|837|||
126664149|NCT01256658|455729251|FG001|Period 1|Lost to Follow-up|661|||
126664150|NCT01256658|455729250|FG000|Period 1|Withdrawal by Subject|35|||
126664151|NCT01256658|455729251|FG001|Period 1|Withdrawal by Subject|43|||
126664152|NCT01256658|455729250|FG000|Period 1|Death|48|||
126664153|NCT01256658|455729251|FG001|Period 1|Death|44|||
126664154|NCT02072434|455729255|FG000|Overall Study|Protocol Violation|10|||
126664155|NCT02072434|455729256|FG001|Overall Study|Protocol Violation|9|||
126664156|NCT02072434|455729255|FG000|Overall Study|Physician Decision|5|||
126664157|NCT02072434|455729256|FG001|Overall Study|Physician Decision|10|||
126664158|NCT02072434|455729255|FG000|Overall Study|Adverse event, serious fatal|1|||
126664159|NCT02072434|455729256|FG001|Overall Study|Adverse event, serious fatal|6|||
126664160|NCT02072434|455729255|FG000|Overall Study|Adverse Event|7|||
126664161|NCT02072434|455729256|FG001|Overall Study|Adverse Event|6|||
126664162|NCT02072434|455729255|FG000|Overall Study|Withdrawal by Subject|17|||
126664163|NCT02072434|455729256|FG001|Overall Study|Withdrawal by Subject|29|||
126664164|NCT02072434|455729255|FG000|Overall Study|Other|14|||
126664165|NCT02072434|455729256|FG001|Overall Study|Other|29|||
126664166|NCT02072434|455729255|FG000|Overall Study|Lost to Follow-up|0|||
126664167|NCT02072434|455729256|FG001|Overall Study|Lost to Follow-up|1|||
126664168|NCT01117454|455729257|FG000|Overall Study|Pregnancy|0|||
126664169|NCT01117454|455729258|FG001|Overall Study|Pregnancy|1|||
126664170|NCT00888433|455729259|FG000|Overall Study|Withdrawal by Subject|1|||
126664171|NCT00888433|455729260|FG001|Overall Study|Withdrawal by Subject|2|||
126664172|NCT00888433|455729259|FG000|Overall Study|Missed Visit|2|||
126664173|NCT00888433|455729260|FG001|Overall Study|Missed Visit|1|||
126664174|NCT04356183|455729266|FG000|Overall Study|Lost to Follow-up|1|||
126664175|NCT04356183|455729267|FG001|Overall Study|Lost to Follow-up|0|||
126664176|NCT04356183|455729266|FG000|Overall Study|Withdrawal by Subject|1|||
126664177|NCT04356183|455729267|FG001|Overall Study|Withdrawal by Subject|1|||
126664178|NCT02170389|455729274|FG000|Overall Study|Study terminated prior to start of treat|1|||
126664179|NCT01008696|455729276|FG000|Overall Study|Participant's evasion of hospital visit|5|||
126664180|NCT01008696|455729277|FG001|Overall Study|Participant's evasion of hospital visit|4|||
126664181|NCT01008696|455729276|FG000|Overall Study|Withdrawal by Subject|2|||
126664182|NCT01008696|455729277|FG001|Overall Study|Withdrawal by Subject|4|||
126664183|NCT01008696|455729276|FG000|Overall Study|Physician Decision|5|||
126664184|NCT01008696|455729277|FG001|Overall Study|Physician Decision|1|||
126664185|NCT01008696|455729276|FG000|Overall Study|Adverse Event|1|||
126664186|NCT01008696|455729277|FG001|Overall Study|Adverse Event|0|||
126664187|NCT01008696|455729276|FG000|Overall Study|Participants' non-cooperation|2|||
126664188|NCT01008696|455729277|FG001|Overall Study|Participants' non-cooperation|3|||
126664189|NCT01008696|455729276|FG000|Overall Study|Other|2|||
126664190|NCT01008696|455729277|FG001|Overall Study|Other|3|||
126664191|NCT01008696|455729276|FG000|Overall Study|Other|0|||
126664192|NCT01008696|455729277|FG001|Overall Study|Other|2|||
126664193|NCT00667355|455729278|FG000|Overall Study|Adverse Event|5|||
126664194|NCT00667355|455729278|FG000|Overall Study|Lost to Follow-up|1|||
126664195|NCT00667355|455729278|FG000|Overall Study|Other reason was not specified|5|||
126664196|NCT02175004|455729280|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
126664197|NCT02175004|455729281|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
126664198|NCT02175004|455729280|FG000|Overall Study|Investigator Judgment|1|||
126664199|NCT02175004|455729281|FG001|Overall Study|Investigator Judgment|4|||
126664200|NCT02175004|455729280|FG000|Overall Study|Voluntary Withdrawal|6|||
126664201|NCT02175004|455729281|FG001|Overall Study|Voluntary Withdrawal|19|||
126664202|NCT02175004|455729280|FG000|Overall Study|Liver Transplant|1|||
126664203|NCT02175004|455729281|FG001|Overall Study|Liver Transplant|0|||
126664204|NCT02175004|455729280|FG000|Overall Study|Disease Progression|1|||
126664205|NCT02175004|455729281|FG001|Overall Study|Disease Progression|0|||
126664206|NCT02175004|455729280|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
126664207|NCT02175004|455729281|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
126664208|NCT02960854|455729282|FG000|Overall Study|Not Disclosed|2|||
126664209|NCT02960854|455729283|FG001|Overall Study|Not Disclosed|2|||
126664210|NCT02960854|455729282|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
126664211|NCT02960854|455729283|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
126664212|NCT02960854|455729282|FG000|Overall Study|Subject Withdrew Consent|0|||
126664213|NCT02960854|455729283|FG001|Overall Study|Subject Withdrew Consent|1|||
126664214|NCT02960854|455729282|FG000|Overall Study|Death|4|||
126664215|NCT02960854|455729283|FG001|Overall Study|Death|6|||
126664216|NCT01383161|455729284|FG000|Overall Study|Adverse Event|5|||
126664217|NCT01383161|455729285|FG001|Overall Study|Adverse Event|1|||
126664218|NCT01383161|455729284|FG000|Overall Study|Withdrawal by Subject|0|||
126664219|NCT01383161|455729285|FG001|Overall Study|Withdrawal by Subject|2|||
126664220|NCT01383161|455729284|FG000|Overall Study|Lack of Efficacy|0|||
126664221|NCT01383161|455729285|FG001|Overall Study|Lack of Efficacy|1|||
126664222|NCT03942406|455729292|FG000|Overall Study|Lost to Follow-up|4|||
126664223|NCT03942406|455729293|FG001|Overall Study|Lost to Follow-up|5|||
126664224|NCT03942406|455729294|FG002|Overall Study|Lost to Follow-up|3|||
126664225|NCT03942406|455729295|FG003|Overall Study|Lost to Follow-up|7|||
126664226|NCT03942406|455729296|FG004|Overall Study|Lost to Follow-up|1|||
126664227|NCT03942406|455729297|FG005|Overall Study|Lost to Follow-up|0|||
126664228|NCT03942406|455729298|FG006|Overall Study|Lost to Follow-up|0|||
126664229|NCT03942406|455729292|FG000|Overall Study|Withdrawal by Subject|3|||
126664230|NCT03942406|455729293|FG001|Overall Study|Withdrawal by Subject|1|||
126664231|NCT03942406|455729294|FG002|Overall Study|Withdrawal by Subject|1|||
126664232|NCT03942406|455729295|FG003|Overall Study|Withdrawal by Subject|3|||
126664233|NCT03942406|455729296|FG004|Overall Study|Withdrawal by Subject|0|||
126664234|NCT03942406|455729297|FG005|Overall Study|Withdrawal by Subject|0|||
126664235|NCT03942406|455729298|FG006|Overall Study|Withdrawal by Subject|0|||
126331394|NCT00377637|454508830|FG001|Induction Phase|Lost to Follow-up|1|||
126664236|NCT03942406|455729292|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
126664237|NCT03942406|455729293|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
126664238|NCT03942406|455729294|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
126664239|NCT03942406|455729295|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
126664240|NCT03942406|455729296|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
126664241|NCT03942406|455729297|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
126664242|NCT03942406|455729298|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
126664243|NCT00216203|455729301|FG000|Overall Study|Withdrawal by Subject|2|||
126664244|NCT04263909|455729302|FG000|Overall Study|Physician Decision|1|||
126664245|NCT04263909|455729303|FG001|Overall Study|Physician Decision|0|||
126664246|NCT04263909|455729304|FG002|Overall Study|Physician Decision|0|||
126664247|NCT04263909|455729302|FG000|Overall Study|Adverse Event|3|||
126664248|NCT04263909|455729303|FG001|Overall Study|Adverse Event|0|||
126664249|NCT04263909|455729304|FG002|Overall Study|Adverse Event|0|||
126664250|NCT04263909|455729302|FG000|Overall Study|Protocol Violation|5|||
126664251|NCT04263909|455729303|FG001|Overall Study|Protocol Violation|0|||
126664252|NCT04263909|455729304|FG002|Overall Study|Protocol Violation|0|||
126664253|NCT04288778|455729305|FG000|Overall Study|Withdrawal by Subject|2|||
126664254|NCT04288778|455729305|FG000|Overall Study|Adverse Event|5|||
126664255|NCT04288778|455729305|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126664256|NCT04288778|455729305|FG000|Overall Study|Other|1|||
126664257|NCT04288778|455729305|FG000|Overall Study|Started but not treated|2|||
126664258|NCT03118674|455729306|FG000|Overall Study|Lost to Follow-up|2|||
126664259|NCT03118674|455729306|FG000|Overall Study|Screen Faliure|8|||
126664260|NCT03118674|455729306|FG000|Overall Study|Withdrawal by Subject|5|||
126664261|NCT03153137|455729307|FG000|Overall Study|Lost to Follow-up|1|||
126664262|NCT03153137|455729308|FG001|Overall Study|Lost to Follow-up|0|||
126664263|NCT03153137|455729307|FG000|Overall Study|Withdrawal by Subject|2|||
126664264|NCT03153137|455729308|FG001|Overall Study|Withdrawal by Subject|1|||
126664265|NCT03153137|455729307|FG000|Overall Study|Physician Decision|0|||
126664266|NCT03153137|455729308|FG001|Overall Study|Physician Decision|3|||
126664267|NCT04209621|455729309|FG000|Overall Study|Death|1|||
126664268|NCT04209621|455729309|FG000|Overall Study|Study Terminated Early|2|||
126664269|NCT01372410|455729310|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
126664270|NCT01372410|455729311|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
126664271|NCT01372410|455729312|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
126664272|NCT01372410|455729313|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
126664273|NCT01372410|455729314|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
126664274|NCT01372410|455729315|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
126664275|NCT01372410|455729316|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
126664276|NCT01372410|455729317|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
126664277|NCT01372410|455729310|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
126664278|NCT01372410|455729311|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
126664279|NCT01372410|455729312|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
126664280|NCT01372410|455729313|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
126664281|NCT01372410|455729314|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
126664282|NCT01372410|455729315|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
126664283|NCT01372410|455729316|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
126664284|NCT01372410|455729317|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
126664285|NCT01372410|455729310|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126664286|NCT01372410|455729311|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126664287|NCT01372410|455729312|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126664288|NCT01372410|455729313|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126664289|NCT01372410|455729314|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
126664290|NCT01372410|455729315|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126664291|NCT01372410|455729316|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126664292|NCT01372410|455729317|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126664293|NCT01372410|455729310|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126664294|NCT01372410|455729311|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126664295|NCT01372410|455729312|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126664296|NCT01372410|455729313|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126664297|NCT01372410|455729314|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126664298|NCT01372410|455729315|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126331395|NCT00377637|454508831|FG002|Induction Phase|Lost to Follow-up|0|||
126331396|NCT00377637|454508832|FG003|Induction Phase|Lost to Follow-up|0|||
126331397|NCT00377637|454508829|FG000|Induction Phase|Death|1|||
126331398|NCT00377637|454508830|FG001|Induction Phase|Death|3|||
126331399|NCT00377637|454508831|FG002|Induction Phase|Death|0|||
126664299|NCT01372410|455729316|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
126664300|NCT01372410|455729317|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
126664301|NCT01372410|455729310|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
126664302|NCT01372410|455729311|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
126664303|NCT01372410|455729312|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
126664304|NCT01372410|455729313|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
126664305|NCT01372410|455729314|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
126664306|NCT01372410|455729315|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
126664307|NCT01372410|455729316|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
126664308|NCT01372410|455729317|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
126331400|NCT00377637|454508832|FG003|Induction Phase|Death|0|||
126331401|NCT00377637|454508829|FG000|Induction Phase|Withdrawal by Subject|5|||
126331402|NCT00377637|454508830|FG001|Induction Phase|Withdrawal by Subject|6|||
126331403|NCT00377637|454508831|FG002|Induction Phase|Withdrawal by Subject|0|||
126331404|NCT00377637|454508832|FG003|Induction Phase|Withdrawal by Subject|0|||
126331405|NCT00377637|454508829|FG000|Induction Phase|Physician Decision|3|||
126331406|NCT00377637|454508830|FG001|Induction Phase|Physician Decision|1|||
126331407|NCT00377637|454508831|FG002|Induction Phase|Physician Decision|0|||
126331408|NCT00377637|454508832|FG003|Induction Phase|Physician Decision|0|||
126331409|NCT00377637|454508829|FG000|Induction Phase|Sponsor decision|1|||
126331410|NCT00377637|454508830|FG001|Induction Phase|Sponsor decision|2|||
126331411|NCT00377637|454508831|FG002|Induction Phase|Sponsor decision|0|||
126331412|NCT00377637|454508832|FG003|Induction Phase|Sponsor decision|0|||
126331413|NCT00377637|454508829|FG000|Induction Phase|Non-Compliance|1|||
126331414|NCT00377637|454508830|FG001|Induction Phase|Non-Compliance|0|||
126331415|NCT00377637|454508831|FG002|Induction Phase|Non-Compliance|0|||
126331416|NCT00377637|454508832|FG003|Induction Phase|Non-Compliance|0|||
126664309|NCT01372410|455729310|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126664310|NCT01372410|455729311|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126664311|NCT01372410|455729312|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126664312|NCT01372410|455729313|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126664313|NCT01372410|455729314|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
126664314|NCT01372410|455729315|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126664315|NCT01372410|455729316|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126664316|NCT01372410|455729317|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
126664317|NCT01372410|455729310|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
126664318|NCT01372410|455729311|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
126664319|NCT01372410|455729312|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
126664320|NCT01372410|455729313|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
126664321|NCT01372410|455729314|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
126664322|NCT01372410|455729315|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
126664323|NCT01372410|455729316|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
126664324|NCT01372410|455729317|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
126664325|NCT01372410|455729310|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126664326|NCT01372410|455729311|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126664327|NCT01372410|455729312|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126664328|NCT01372410|455729313|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126664329|NCT01372410|455729314|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126664330|NCT01372410|455729315|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126664331|NCT01372410|455729316|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
126664332|NCT01372410|455729317|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
126664333|NCT01372410|455729310|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
126664334|NCT01372410|455729311|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
126664335|NCT01372410|455729312|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
126664336|NCT01372410|455729313|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
126664337|NCT01372410|455729314|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
126664338|NCT01372410|455729315|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
126664339|NCT01372410|455729316|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
126664340|NCT01372410|455729317|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
126664341|NCT01372410|455729310|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126664342|NCT01372410|455729311|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126664343|NCT01372410|455729312|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126664344|NCT01372410|455729313|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126664345|NCT01372410|455729314|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126664346|NCT01372410|455729315|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
126664347|NCT01372410|455729316|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126664348|NCT01372410|455729317|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
126664349|NCT04585646|455729318|FG000|First Intervention|Physician Decision|1|||
126664350|NCT04585646|455729319|FG001|First Intervention|Physician Decision|0|||
126664351|NCT04585646|455729318|FG000|First Intervention|Lost to Follow-up|0|||
126664352|NCT04585646|455729319|FG001|First Intervention|Lost to Follow-up|3|||
126664353|NCT04585646|455729318|FG000|First Intervention|Withdrawal by Subject|0|||
126664354|NCT04585646|455729319|FG001|First Intervention|Withdrawal by Subject|1|||
126664355|NCT01067326|455729326|FG000|Overall Study|Adverse Event|0|||
126664356|NCT01067326|455729327|FG001|Overall Study|Adverse Event|2|||
126664357|NCT01067326|455729326|FG000|Overall Study|Withdrawal by Subject|1|||
126664358|NCT01067326|455729327|FG001|Overall Study|Withdrawal by Subject|0|||
126331417|NCT00377637|454508829|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
126331418|NCT00377637|454508830|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
126664359|NCT01067326|455729326|FG000|Overall Study|Early Study Termination|1|||
126664360|NCT01067326|455729327|FG001|Overall Study|Early Study Termination|1|||
126664361|NCT01230788|455729334|FG000|Overall Study|Prescribed exclusion drug|1|||
126664362|NCT00769860|455729335|FG000|Overall Study|Withdrawal by Subject|2|||
126664363|NCT00769860|455729336|FG001|Overall Study|Withdrawal by Subject|0|||
126664364|NCT01603082|455729337|FG000|Overall Study|Adverse Event|0|||
126664365|NCT01603082|455729338|FG001|Overall Study|Adverse Event|1|||
126664366|NCT01603082|455729337|FG000|Overall Study|Withdrawal by Subject|1|||
126664367|NCT01603082|455729338|FG001|Overall Study|Withdrawal by Subject|0|||
126664368|NCT01603082|455729337|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
126664369|NCT01603082|455729338|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
126664370|NCT01019317|455729341|FG000|Overall Study|Not Eligible|4|||
126664371|NCT00372385|455729343|FG000|Overall Study|Adverse Event|6|||
126664372|NCT00372385|455729344|FG001|Overall Study|Adverse Event|11|||
126664373|NCT00372385|455729345|FG002|Overall Study|Adverse Event|9|||
126664374|NCT00372385|455729346|FG003|Overall Study|Adverse Event|7|||
126664375|NCT00372385|455729343|FG000|Overall Study|Noncompliance|0|||
126664376|NCT00372385|455729344|FG001|Overall Study|Noncompliance|1|||
126664377|NCT00372385|455729345|FG002|Overall Study|Noncompliance|1|||
126664378|NCT00372385|455729346|FG003|Overall Study|Noncompliance|1|||
126664379|NCT00372385|455729343|FG000|Overall Study|Physician Decision|1|||
126664380|NCT00372385|455729344|FG001|Overall Study|Physician Decision|0|||
126664381|NCT00372385|455729345|FG002|Overall Study|Physician Decision|0|||
126664382|NCT00372385|455729346|FG003|Overall Study|Physician Decision|0|||
126664383|NCT00372385|455729343|FG000|Overall Study|Lost to Follow-up|2|||
126664384|NCT00372385|455729344|FG001|Overall Study|Lost to Follow-up|0|||
126664385|NCT00372385|455729345|FG002|Overall Study|Lost to Follow-up|0|||
126664386|NCT00372385|455729346|FG003|Overall Study|Lost to Follow-up|0|||
126664387|NCT00372385|455729343|FG000|Overall Study|Withdrawal by Subject|2|||
126664388|NCT00372385|455729344|FG001|Overall Study|Withdrawal by Subject|1|||
126664389|NCT00372385|455729345|FG002|Overall Study|Withdrawal by Subject|0|||
126664390|NCT00372385|455729346|FG003|Overall Study|Withdrawal by Subject|0|||
126664391|NCT00372385|455729343|FG000|Overall Study|Refusal of Treatment|3|||
126664392|NCT00372385|455729344|FG001|Overall Study|Refusal of Treatment|6|||
126664393|NCT00372385|455729345|FG002|Overall Study|Refusal of Treatment|0|||
126664394|NCT00372385|455729346|FG003|Overall Study|Refusal of Treatment|0|||
126664395|NCT00372385|455729343|FG000|Overall Study|No Response|1|||
126664396|NCT00372385|455729344|FG001|Overall Study|No Response|1|||
126664397|NCT00372385|455729345|FG002|Overall Study|No Response|0|||
126664398|NCT00372385|455729346|FG003|Overall Study|No Response|0|||
126664399|NCT00372385|455729343|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
126664400|NCT00372385|455729344|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
126664401|NCT00372385|455729345|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
126664402|NCT00372385|455729346|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
126664403|NCT00372385|455729343|FG000|Overall Study|Virologic Stopping Rule|17|||
126664404|NCT00372385|455729344|FG001|Overall Study|Virologic Stopping Rule|0|||
126664405|NCT00372385|455729345|FG002|Overall Study|Virologic Stopping Rule|0|||
126664406|NCT00372385|455729346|FG003|Overall Study|Virologic Stopping Rule|0|||
126664407|NCT01699789|455729347|FG000|Overall Study|Withdrawal by Subject|18|||
126664408|NCT01699789|455729348|FG001|Overall Study|Withdrawal by Subject|23|||
126664409|NCT01699789|455729347|FG000|Overall Study|Death|1|||
126664410|NCT01699789|455729348|FG001|Overall Study|Death|2|||
126664411|NCT01699789|455729347|FG000|Overall Study|Lost to Follow-up|83|||
126664412|NCT01699789|455729348|FG001|Overall Study|Lost to Follow-up|101|||
126664413|NCT04343248|455729350|FG000|Overall Study|Withdrawal by Subject|5|||
126664414|NCT04343248|455729351|FG001|Overall Study|Withdrawal by Subject|6|||
126664415|NCT04343248|455729350|FG000|Overall Study|Death|1|||
126664416|NCT04343248|455729351|FG001|Overall Study|Death|2|||
126664417|NCT04343248|455729350|FG000|Overall Study|Lost to Follow-up|9|||
126664418|NCT04343248|455729351|FG001|Overall Study|Lost to Follow-up|6|||
126664419|NCT04343248|455729350|FG000|Overall Study|Physician Decision|0|||
126664420|NCT04343248|455729351|FG001|Overall Study|Physician Decision|1|||
126331419|NCT00377637|454508831|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
126545275|NCT01641926|455290784|FG001|Overall Study|Not Treated|1|||
126664421|NCT04343248|455729350|FG000|Overall Study|Adverse Event|1|||
126664422|NCT04343248|455729351|FG001|Overall Study|Adverse Event|0|||
126664423|NCT02708095|455729352|FG000|Overall Study|Adverse Event|4|||
126664424|NCT02708095|455729353|FG001|Overall Study|Adverse Event|10|||
126664425|NCT02708095|455729354|FG002|Overall Study|Adverse Event|11|||
126664426|NCT02708095|455729352|FG000|Overall Study|Lack of Efficacy|9|||
126664427|NCT02708095|455729353|FG001|Overall Study|Lack of Efficacy|3|||
126664428|NCT02708095|455729354|FG002|Overall Study|Lack of Efficacy|0|||
126664429|NCT02708095|455729352|FG000|Overall Study|Lost to Follow-up|2|||
126664430|NCT02708095|455729353|FG001|Overall Study|Lost to Follow-up|0|||
126664431|NCT02708095|455729354|FG002|Overall Study|Lost to Follow-up|0|||
126664432|NCT02708095|455729352|FG000|Overall Study|Physician Decision|2|||
126664433|NCT02708095|455729353|FG001|Overall Study|Physician Decision|3|||
126664434|NCT02708095|455729354|FG002|Overall Study|Physician Decision|2|||
126664435|NCT02708095|455729352|FG000|Overall Study|Protocol Violation|0|||
126664436|NCT02708095|455729353|FG001|Overall Study|Protocol Violation|0|||
126664437|NCT02708095|455729354|FG002|Overall Study|Protocol Violation|1|||
126664438|NCT02708095|455729352|FG000|Overall Study|Withdrawal by Subject|5|||
126664439|NCT02708095|455729353|FG001|Overall Study|Withdrawal by Subject|3|||
126664440|NCT02708095|455729354|FG002|Overall Study|Withdrawal by Subject|4|||
126664441|NCT01313650|455729357|FG000|Overall Study|Adverse Event|9|||
126664442|NCT01313650|455729358|FG001|Overall Study|Adverse Event|34|||
126664443|NCT01313650|455729359|FG002|Overall Study|Adverse Event|24|||
126664444|NCT01313650|455729360|FG003|Overall Study|Adverse Event|23|||
126664445|NCT01313650|455729357|FG000|Overall Study|Lack of Efficacy|37|||
126664446|NCT01313650|455729358|FG001|Overall Study|Lack of Efficacy|20|||
126664447|NCT01313650|455729359|FG002|Overall Study|Lack of Efficacy|32|||
126664448|NCT01313650|455729360|FG003|Overall Study|Lack of Efficacy|20|||
126664449|NCT01313650|455729357|FG000|Overall Study|Lost to Follow-up|1|||
126664450|NCT01313650|455729358|FG001|Overall Study|Lost to Follow-up|0|||
126664451|NCT01313650|455729359|FG002|Overall Study|Lost to Follow-up|3|||
126664452|NCT01313650|455729360|FG003|Overall Study|Lost to Follow-up|2|||
126664453|NCT01313650|455729357|FG000|Overall Study|Withdrawal by Subject|16|||
126664454|NCT01313650|455729358|FG001|Overall Study|Withdrawal by Subject|20|||
126664455|NCT01313650|455729359|FG002|Overall Study|Withdrawal by Subject|15|||
126664456|NCT01313650|455729360|FG003|Overall Study|Withdrawal by Subject|15|||
126664457|NCT01313650|455729357|FG000|Overall Study|Protocol Violation|4|||
126664458|NCT01313650|455729358|FG001|Overall Study|Protocol Violation|7|||
126664459|NCT01313650|455729359|FG002|Overall Study|Protocol Violation|5|||
126331420|NCT00377637|454508832|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
126331421|NCT00377637|454508829|FG000|Maintenance Phase|Adverse Event|0|||
126331422|NCT00377637|454508830|FG001|Maintenance Phase|Adverse Event|0|||
126331423|NCT00377637|454508831|FG002|Maintenance Phase|Adverse Event|29|||
126331424|NCT00377637|454508832|FG003|Maintenance Phase|Adverse Event|43|||
126331425|NCT00377637|454508829|FG000|Maintenance Phase|Physician Decision|0|||
126331426|NCT00377637|454508830|FG001|Maintenance Phase|Physician Decision|0|||
126331427|NCT00377637|454508831|FG002|Maintenance Phase|Physician Decision|5|||
126331428|NCT00377637|454508832|FG003|Maintenance Phase|Physician Decision|4|||
126331429|NCT00377637|454508829|FG000|Maintenance Phase|Lost to Follow-up|0|||
126331430|NCT00377637|454508830|FG001|Maintenance Phase|Lost to Follow-up|0|||
126331431|NCT00377637|454508831|FG002|Maintenance Phase|Lost to Follow-up|3|||
126331432|NCT00377637|454508832|FG003|Maintenance Phase|Lost to Follow-up|1|||
126331433|NCT00377637|454508829|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126331434|NCT00377637|454508830|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126331435|NCT00377637|454508831|FG002|Maintenance Phase|Withdrawal by Subject|3|||
126331436|NCT00377637|454508832|FG003|Maintenance Phase|Withdrawal by Subject|3|||
126331437|NCT00377637|454508829|FG000|Maintenance Phase|Sponsor decision|0|||
126331438|NCT00377637|454508830|FG001|Maintenance Phase|Sponsor decision|0|||
126331439|NCT00377637|454508831|FG002|Maintenance Phase|Sponsor decision|2|||
126331440|NCT00377637|454508832|FG003|Maintenance Phase|Sponsor decision|3|||
126331441|NCT00377637|454508829|FG000|Maintenance Phase|Non-compliance|0|||
126331442|NCT00377637|454508830|FG001|Maintenance Phase|Non-compliance|0|||
126331443|NCT00377637|454508831|FG002|Maintenance Phase|Non-compliance|1|||
126331444|NCT00377637|454508832|FG003|Maintenance Phase|Non-compliance|1|||
126331445|NCT00377637|454508829|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
126331446|NCT00377637|454508830|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
126331447|NCT00377637|454508831|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
126331448|NCT00377637|454508832|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
126331449|NCT00377637|454508829|FG000|Maintenance Phase|Death|0|||
126331450|NCT00377637|454508830|FG001|Maintenance Phase|Death|0|||
126331451|NCT00377637|454508831|FG002|Maintenance Phase|Death|0|||
126331452|NCT00377637|454508832|FG003|Maintenance Phase|Death|1|||
126331453|NCT04147247|454508834|FG000|Overall Study|Progressive disease|3|||
126331454|NCT04147247|454508835|FG001|Overall Study|Progressive disease|3|||
126331455|NCT04147247|454508836|FG002|Overall Study|Progressive disease|4|||
126331456|NCT04147247|454508837|FG003|Overall Study|Progressive disease|4|||
126331457|NCT04147247|454508838|FG004|Overall Study|Progressive disease|3|||
126331458|NCT04147247|454508834|FG000|Overall Study|Physician Decision|0|||
126331459|NCT04147247|454508835|FG001|Overall Study|Physician Decision|1|||
126331460|NCT04147247|454508836|FG002|Overall Study|Physician Decision|0|||
126331461|NCT04147247|454508837|FG003|Overall Study|Physician Decision|0|||
126331462|NCT04147247|454508838|FG004|Overall Study|Physician Decision|0|||
126331463|NCT04147247|454508834|FG000|Overall Study|Clinical Disease Progression|0|||
126331464|NCT04147247|454508835|FG001|Overall Study|Clinical Disease Progression|0|||
126331465|NCT04147247|454508836|FG002|Overall Study|Clinical Disease Progression|0|||
126331466|NCT04147247|454508837|FG003|Overall Study|Clinical Disease Progression|0|||
126664460|NCT01313650|455729360|FG003|Overall Study|Protocol Violation|6|||
126664461|NCT01313650|455729357|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
126664462|NCT01313650|455729358|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
126664463|NCT01313650|455729359|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
126664464|NCT01313650|455729360|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
126664465|NCT05393037|455729361|FG000|Part A|Death|1|||
126664466|NCT05393037|455729362|FG001|Part A|Death|0|||
126664467|NCT05393037|455729361|FG000|Part A|Lost to Follow-up|1|||
126331467|NCT04147247|454508838|FG004|Overall Study|Clinical Disease Progression|1|||
126331468|NCT04147247|454508834|FG000|Overall Study|Adverse Event|0|||
126331469|NCT04147247|454508835|FG001|Overall Study|Adverse Event|0|||
126331470|NCT04147247|454508836|FG002|Overall Study|Adverse Event|1|||
126331471|NCT04147247|454508837|FG003|Overall Study|Adverse Event|0|||
126331472|NCT04147247|454508838|FG004|Overall Study|Adverse Event|1|||
126331473|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
126331474|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
126664468|NCT05393037|455729362|FG001|Part A|Lost to Follow-up|1|||
126664469|NCT05393037|455729361|FG000|Part A|Withdrawal by Subject|2|||
126331475|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
126331476|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
126331477|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
126331478|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
126331479|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
126331480|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
126331481|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
126664470|NCT05393037|455729362|FG001|Part A|Withdrawal by Subject|4|||
126664471|NCT05393037|455729361|FG000|Part B|Lost to Follow-up|1|||
126664472|NCT05393037|455729362|FG001|Part B|Lost to Follow-up|0|||
126664473|NCT01012739|455729363|FG000|Treatment Period 1|Adverse Event|0|||
126664474|NCT01012739|455729364|FG001|Treatment Period 1|Adverse Event|0|||
126664475|NCT01012739|455729365|FG002|Treatment Period 1|Adverse Event|0|||
126664476|NCT01012739|455729366|FG003|Treatment Period 1|Adverse Event|1|||
126664477|NCT01012739|455729363|FG000|Treatment Period 2|Abnormal test procedure results|0|||
126664478|NCT01012739|455729364|FG001|Treatment Period 2|Abnormal test procedure results|0|||
126664479|NCT01012739|455729365|FG002|Treatment Period 2|Abnormal test procedure results|0|||
126664480|NCT01012739|455729366|FG003|Treatment Period 2|Abnormal test procedure results|1|||
126664481|NCT04540133|455729367|FG000|Overall Study|Lost to Follow-up|1|||
126664482|NCT04540133|455729368|FG001|Overall Study|Lost to Follow-up|0|||
126664483|NCT00458341|455729369|FG000|Cycle 1|Adverse Event|1|||
126664484|NCT00458341|455729370|FG001|Cycle 1|Adverse Event|0|||
126664485|NCT03471871|455729372|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
126664486|NCT03471871|455729373|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
126664487|NCT03471871|455729374|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
126664488|NCT03471871|455729375|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
126664489|NCT03471871|455729376|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
126664490|NCT03471871|455729372|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
126664491|NCT03471871|455729373|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
126664492|NCT03471871|455729374|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
126664493|NCT03471871|455729375|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
126664494|NCT03471871|455729376|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
126664495|NCT03471871|455729372|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
126664496|NCT03471871|455729373|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
126664497|NCT03471871|455729374|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
126664498|NCT03471871|455729375|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
126664499|NCT03471871|455729376|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
126664500|NCT03471871|455729372|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
126664501|NCT03471871|455729373|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
126664502|NCT03471871|455729374|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
126664503|NCT03471871|455729375|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
126664504|NCT03471871|455729376|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
126664505|NCT03471871|455729372|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
126664506|NCT03471871|455729373|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
126664507|NCT03471871|455729374|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
126664508|NCT03471871|455729375|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
126664509|NCT03471871|455729376|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
126664510|NCT03040622|455729377|FG000|Overall Study|unable to implant device|3|||
126664511|NCT03971422|455731112|FG000|Overall Study|Lost to Follow-up|0|||
126664512|NCT03971422|455731113|FG001|Overall Study|Lost to Follow-up|1|||
126664513|NCT03971422|455731114|FG002|Overall Study|Lost to Follow-up|0|||
126664514|NCT03971422|455731112|FG000|Overall Study|Lack of Efficacy|5|||
126664515|NCT03971422|455731113|FG001|Overall Study|Lack of Efficacy|1|||
126664516|NCT03971422|455731114|FG002|Overall Study|Lack of Efficacy|1|||
126331482|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
126331483|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
126331484|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
126664517|NCT03971422|455731112|FG000|Overall Study|Adverse event, not fatal|2|||
126664518|NCT03971422|455731113|FG001|Overall Study|Adverse event, not fatal|2|||
126664519|NCT03971422|455731114|FG002|Overall Study|Adverse event, not fatal|5|||
126664520|NCT03971422|455731112|FG000|Overall Study|Worsening of MG Symptoms|1|||
126664521|NCT03971422|455731113|FG001|Overall Study|Worsening of MG Symptoms|4|||
126664522|NCT03971422|455731114|FG002|Overall Study|Worsening of MG Symptoms|2|||
126664523|NCT03971422|455731112|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
126664524|NCT03971422|455731113|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
126664525|NCT03971422|455731114|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
126664526|NCT03971422|455731112|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
126664527|NCT03971422|455731113|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
126664528|NCT03971422|455731114|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
126664529|NCT03971422|455731112|FG000|Overall Study|Due to COVID-19 pandemic|0|||
126664530|NCT03971422|455731113|FG001|Overall Study|Due to COVID-19 pandemic|1|||
126664531|NCT03971422|455731114|FG002|Overall Study|Due to COVID-19 pandemic|1|||
126664532|NCT04751656|455731117|FG000|Overall Study|Lost to Follow-up|1|||
126664533|NCT03566810|455731118|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
126664534|NCT03566810|455731119|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
126664535|NCT03566810|455731120|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
126664536|NCT03566810|455731121|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
126664537|NCT03217266|455731122|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
126664538|NCT03217266|455731123|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
126664539|NCT03217266|455731124|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
126664540|NCT03217266|455731125|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
126664541|NCT03217266|455731122|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
126664542|NCT03217266|455731123|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
126664543|NCT03217266|455731124|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
126664544|NCT03217266|455731125|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
126664545|NCT03217266|455731122|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
126664546|NCT03217266|455731123|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
126664547|NCT03217266|455731124|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
126664548|NCT03217266|455731125|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
126664549|NCT01955122|455731127|FG000|Overall Study|Physician Decision|5|||
126664550|NCT01955122|455731128|FG001|Overall Study|Physician Decision|5|||
126664551|NCT00826111|455731129|FG000|Overall Study|Lost to Follow-up|0|||
126664552|NCT00826111|455731130|FG001|Overall Study|Lost to Follow-up|1|||
126664553|NCT00826111|455731129|FG000|Overall Study|Protocol Violation|1|||
126664554|NCT00826111|455731130|FG001|Overall Study|Protocol Violation|0|||
126664555|NCT00826111|455731129|FG000|Overall Study|Withdrawal by Subject|5|||
126664556|NCT00826111|455731130|FG001|Overall Study|Withdrawal by Subject|0|||
126664557|NCT00826111|455731129|FG000|Overall Study|Physician Decision|1|||
126664558|NCT00826111|455731130|FG001|Overall Study|Physician Decision|1|||
126664559|NCT01672788|455731131|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
126664560|NCT01672788|455731132|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
126664561|NCT01672788|455731133|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
126664562|NCT01672788|455731134|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
126664563|NCT03511053|455731142|FG000|Overall Study|Withdrawal by Subject|1|||
126664564|NCT01929980|455731143|FG000|Overall Study|Physician Decision|1|||
126664565|NCT00985166|455731144|FG000|Overall Study|Lost to Follow-up|3|||
126664566|NCT00985166|455731145|FG001|Overall Study|Lost to Follow-up|2|||
126664567|NCT00985166|455731146|FG002|Overall Study|Lost to Follow-up|2|||
126664568|NCT00985166|455731144|FG000|Overall Study|Withdrawal by Subject|3|||
126664569|NCT00985166|455731145|FG001|Overall Study|Withdrawal by Subject|2|||
126664570|NCT00985166|455731146|FG002|Overall Study|Withdrawal by Subject|0|||
126664571|NCT00985166|455731144|FG000|Overall Study|Test not done|2|||
126664572|NCT00985166|455731145|FG001|Overall Study|Test not done|0|||
126664573|NCT00985166|455731146|FG002|Overall Study|Test not done|4|||
126664574|NCT00985166|455731144|FG000|Overall Study|Other|1|||
126664575|NCT00985166|455731145|FG001|Overall Study|Other|0|||
126664576|NCT00985166|455731146|FG002|Overall Study|Other|1|||
126664577|NCT01028222|455731147|FG000|Overall Study|Protocol deviation|1|||
126664578|NCT01028222|455731148|FG001|Overall Study|Protocol deviation|0|||
126664579|NCT01028222|455731147|FG000|Overall Study|Disease progression|33|||
126664580|NCT01028222|455731148|FG001|Overall Study|Disease progression|9|||
126664581|NCT01028222|455731147|FG000|Overall Study|Administrative problems|1|||
126664582|NCT01028222|455731148|FG001|Overall Study|Administrative problems|1|||
126664583|NCT01028222|455731147|FG000|Overall Study|Lost to Follow-up|0|||
126664584|NCT01028222|455731148|FG001|Overall Study|Lost to Follow-up|1|||
126545276|NCT01641926|455290785|FG002|Overall Study|Not Treated|1|||
126664585|NCT01028222|455731147|FG000|Overall Study|Withdrawal by Subject|1|||
126664586|NCT01028222|455731148|FG001|Overall Study|Withdrawal by Subject|0|||
126664587|NCT01028222|455731147|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
126664588|NCT01028222|455731148|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
126664589|NCT01028222|455731147|FG000|Overall Study|Adverse Event|2|||
126664590|NCT01028222|455731148|FG001|Overall Study|Adverse Event|0|||
126664591|NCT03236246|455731151|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
126664592|NCT03236246|455731152|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
126664593|NCT03236246|455731151|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
126664594|NCT03236246|455731152|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
126664595|NCT03236246|455731151|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
126664596|NCT03236246|455731152|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
126664597|NCT03236246|455731151|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
126664598|NCT03236246|455731152|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
126664599|NCT03236246|455731151|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
126664600|NCT03236246|455731152|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
126664601|NCT03236246|455731151|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
126664602|NCT03236246|455731152|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
126664603|NCT03236246|455731151|FG000|24-Week Dose Titration Period|Death|3|||
126664604|NCT03236246|455731152|FG001|24-Week Dose Titration Period|Death|1|||
126664605|NCT03236246|455731151|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
126664606|NCT03236246|455731152|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
126664607|NCT03236246|455731151|FG000|24-Week Dose Titration Period|Adverse Event|7|||
126664608|NCT03236246|455731152|FG001|24-Week Dose Titration Period|Adverse Event|8|||
126664609|NCT03236246|455731151|FG000|24-Week Dose Titration Period|Captured as Other|1|||
126664610|NCT03236246|455731152|FG001|24-Week Dose Titration Period|Captured as Other|2|||
126664611|NCT03236246|455731151|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
126664612|NCT03236246|455731152|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
126664613|NCT03236246|455731151|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
126664614|NCT03236246|455731152|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
126664615|NCT03236246|455731151|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
126664616|NCT03236246|455731152|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
126664617|NCT03236246|455731151|FG000|24-Week Dose Maintenance Period|Death|0|||
126664618|NCT03236246|455731152|FG001|24-Week Dose Maintenance Period|Death|1|||
126664619|NCT03236246|455731151|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
126664620|NCT03236246|455731152|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
126664621|NCT02598557|455731153|FG000|Overall Study|Withdrawal by Subject|1|||
126664622|NCT02598557|455731154|FG001|Overall Study|Withdrawal by Subject|0|||
126664623|NCT02598557|455731155|FG002|Overall Study|Withdrawal by Subject|1|||
126664624|NCT02598557|455731153|FG000|Overall Study|Participant did not start treatment|2|||
126664625|NCT02598557|455731154|FG001|Overall Study|Participant did not start treatment|1|||
126664626|NCT02598557|455731155|FG002|Overall Study|Participant did not start treatment|1|||
126664627|NCT02598557|455731153|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
126664628|NCT02598557|455731154|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
126664629|NCT02598557|455731155|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
126664630|NCT02598557|455731153|FG000|Overall Study|Adverse Event|1|||
126664631|NCT02598557|455731154|FG001|Overall Study|Adverse Event|1|||
126664632|NCT02598557|455731155|FG002|Overall Study|Adverse Event|0|||
126664633|NCT01681628|455731158|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
126664634|NCT01681628|455731159|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
126664635|NCT01681628|455731158|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
126664636|NCT01681628|455731159|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
126664637|NCT01681628|455731158|FG000|19 Months Follow-up|Death|1|||
126664638|NCT01681628|455731159|FG001|19 Months Follow-up|Death|0|||
126664639|NCT01681628|455731158|FG000|19 Months Follow-up|Lost to Follow-up|61|||
126664640|NCT01681628|455731159|FG001|19 Months Follow-up|Lost to Follow-up|43|||
126664641|NCT01637623|455731164|FG000|Overall Study|Lost to Follow-up|0|||
126664642|NCT01637623|455731165|FG001|Overall Study|Lost to Follow-up|0|||
126664643|NCT01637623|455731166|FG002|Overall Study|Lost to Follow-up|2|||
126664644|NCT01637623|455731164|FG000|Overall Study|Physician Decision|1|||
126664645|NCT01637623|455731165|FG001|Overall Study|Physician Decision|0|||
126664646|NCT01637623|455731166|FG002|Overall Study|Physician Decision|1|||
126664647|NCT05628285|455731171|FG000|Overall Study|Lost to Follow-up|1|||
126664648|NCT02310672|455731175|FG000|Overall Study|Death|1|||
126664649|NCT02310672|455731175|FG000|Overall Study|Lost to Follow-up|1|||
126664650|NCT02310672|455731175|FG000|Overall Study|Withdrawal by Subject|1|||
126664651|NCT02310672|455731175|FG000|Overall Study|Sponsor's decision|12|||
126664652|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
126664653|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
126664654|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
126664655|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
126664656|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
126664657|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
126664658|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
126664659|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
126664660|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Death|1|||
126664661|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Death|1|||
126664662|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
126664663|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
126331485|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
126331486|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
126331487|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
126331488|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
126331489|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
126331490|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
126331491|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
126331492|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
126331493|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
126331494|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
126331495|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
126331496|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
126331497|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
126331498|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
126664664|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
126664665|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
126664666|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
126664667|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
126664668|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
126664669|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
126664670|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
126664671|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
126331499|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
126331500|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
126331501|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
126331502|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
126331503|NCT01111565|454508839|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
126331504|NCT01111565|454508840|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
126331505|NCT01111565|454508841|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
126331506|NCT01111565|454508842|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
126664672|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
126664673|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
126664674|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
126664675|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
126664676|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
126664677|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
126664678|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
126664679|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
126664680|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
126664681|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
126664682|NCT00559585|455731180|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
126664683|NCT00559585|455731181|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
126664684|NCT00559585|455731180|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
126664685|NCT00559585|455731181|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
126664686|NCT00559585|455731180|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
126664687|NCT00559585|455731181|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
126664688|NCT00559585|455731180|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
126664689|NCT00559585|455731181|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
126664690|NCT00559585|455731180|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
126664691|NCT00559585|455731181|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
126664692|NCT00559585|455731180|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
126664693|NCT00559585|455731181|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
126664694|NCT00559585|455731180|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
126664695|NCT00559585|455731181|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
126664696|NCT00559585|455731180|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
126664697|NCT00559585|455731181|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
126664698|NCT00559585|455731180|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
126664699|NCT00559585|455731181|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
126664700|NCT00559585|455731180|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
126664701|NCT00559585|455731181|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
126664702|NCT00559585|455731180|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
126664703|NCT00559585|455731181|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
126664704|NCT00559585|455731180|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
126331507|NCT01111565|454508843|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
126545277|NCT01641926|455290786|FG003|Overall Study|Not Treated|0|||
126664705|NCT00559585|455731181|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
126664706|NCT00559585|455731180|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
126664707|NCT00559585|455731181|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
126664708|NCT04195581|455731182|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
126664709|NCT04195581|455731182|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
126664710|NCT04195581|455731182|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
126664711|NCT04195581|455731182|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
126664712|NCT04195581|455731182|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
126664713|NCT04195581|455731182|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
126664714|NCT01237340|455731183|FG000|Overall Study|Adverse Event|3|||
126664715|NCT01237340|455731183|FG000|Overall Study|Withdrawal by Subject|1|||
126664716|NCT01237340|455731183|FG000|Overall Study|Early termination of the trial|36|||
126664717|NCT02876835|455731186|FG000|Treatment Period (51.1 Month)|Other|1|||
126664718|NCT02876835|455731187|FG001|Treatment Period (51.1 Month)|Other|0|||
126664719|NCT02876835|455731186|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
126664720|NCT02876835|455731187|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
126664721|NCT02876835|455731186|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
126664722|NCT02876835|455731187|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
126664723|NCT02876835|455731186|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
126664724|NCT02876835|455731187|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
126664725|NCT02540538|455731188|FG000|Overall Study|Pregnancy|0|||
126664726|NCT02540538|455731189|FG001|Overall Study|Pregnancy|1|||
126664727|NCT02540538|455731190|FG002|Overall Study|Pregnancy|0|||
126664728|NCT00403754|455731191|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
126664729|NCT00403754|455731192|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
126664730|NCT00403754|455731193|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
126664731|NCT00403754|455731194|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
126664732|NCT00403754|455731191|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
126664733|NCT00403754|455731192|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
126664734|NCT00403754|455731193|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
126664735|NCT00403754|455731194|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
126664736|NCT02000427|455731197|FG000|Overall Study|Death|22|||
126664737|NCT03049735|455731202|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
126664738|NCT03049735|455731203|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
126664739|NCT03049735|455731204|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
126664740|NCT03049735|455731202|FG000|Overall Study|Other|5|||
126664741|NCT03049735|455731203|FG001|Overall Study|Other|3|||
126664742|NCT03049735|455731204|FG002|Overall Study|Other|1|||
126664743|NCT03049735|455731202|FG000|Overall Study|Lack of Efficacy|4|||
126664744|NCT03049735|455731203|FG001|Overall Study|Lack of Efficacy|0|||
126664745|NCT03049735|455731204|FG002|Overall Study|Lack of Efficacy|3|||
126664746|NCT03049735|455731202|FG000|Overall Study|Protocol deviation|1|||
126664747|NCT03049735|455731203|FG001|Overall Study|Protocol deviation|0|||
126664748|NCT03049735|455731204|FG002|Overall Study|Protocol deviation|0|||
126664749|NCT03049735|455731202|FG000|Overall Study|Pregnancy|0|||
126664750|NCT03049735|455731203|FG001|Overall Study|Pregnancy|0|||
126664751|NCT03049735|455731204|FG002|Overall Study|Pregnancy|1|||
126664752|NCT03049735|455731202|FG000|Overall Study|Adverse Event|7|||
126664753|NCT03049735|455731203|FG001|Overall Study|Adverse Event|18|||
126664754|NCT03049735|455731204|FG002|Overall Study|Adverse Event|5|||
126664755|NCT03049735|455731202|FG000|Overall Study|Withdrawal by Subject|10|||
126664756|NCT03049735|455731203|FG001|Overall Study|Withdrawal by Subject|3|||
126664757|NCT03049735|455731204|FG002|Overall Study|Withdrawal by Subject|7|||
126664758|NCT03049735|455731202|FG000|Overall Study|Lost to Follow-up|1|||
126664759|NCT03049735|455731203|FG001|Overall Study|Lost to Follow-up|5|||
126664760|NCT03049735|455731204|FG002|Overall Study|Lost to Follow-up|5|||
126664761|NCT03153111|455731205|FG000|Overall Study|Death|2|||
126664762|NCT03153111|455731206|FG001|Overall Study|Death|5|||
126664763|NCT03153111|455731205|FG000|Overall Study|Lost to Follow-up|1|||
126664764|NCT03153111|455731206|FG001|Overall Study|Lost to Follow-up|0|||
126664765|NCT03153111|455731205|FG000|Overall Study|Physician Decision|5|||
126664766|NCT03153111|455731206|FG001|Overall Study|Physician Decision|1|||
126664767|NCT03153111|455731205|FG000|Overall Study|Withdrawal by Subject|3|||
126664768|NCT03153111|455731206|FG001|Overall Study|Withdrawal by Subject|3|||
126664769|NCT03891524|455731207|FG000|Overall Study|Death|0|||
126664770|NCT03891524|455731208|FG001|Overall Study|Death|0|||
126664771|NCT03891524|455731209|FG002|Overall Study|Death|0|||
126664772|NCT03891524|455731210|FG003|Overall Study|Death|0|||
126664773|NCT03891524|455731211|FG004|Overall Study|Death|0|||
126664774|NCT03891524|455731212|FG005|Overall Study|Death|0|||
126664775|NCT03891524|455731213|FG006|Overall Study|Death|0|||
126664776|NCT03891524|455731214|FG007|Overall Study|Death|1|||
126664777|NCT03891524|455731207|FG000|Overall Study|Withdrawal by Subject|0|||
126664778|NCT03891524|455731208|FG001|Overall Study|Withdrawal by Subject|1|||
126664779|NCT03891524|455731209|FG002|Overall Study|Withdrawal by Subject|2|||
126664780|NCT03891524|455731210|FG003|Overall Study|Withdrawal by Subject|1|||
126664781|NCT03891524|455731211|FG004|Overall Study|Withdrawal by Subject|2|||
126664782|NCT03891524|455731212|FG005|Overall Study|Withdrawal by Subject|2|||
126664783|NCT03891524|455731213|FG006|Overall Study|Withdrawal by Subject|2|||
126664784|NCT03891524|455731214|FG007|Overall Study|Withdrawal by Subject|1|||
126664785|NCT00390910|455731215|FG000|Overall Study|Adverse Event|1|||
126664786|NCT00390910|455731216|FG001|Overall Study|Adverse Event|0|||
126664787|NCT00390910|455731217|FG002|Overall Study|Adverse Event|0|||
126664788|NCT00390910|455731215|FG000|Overall Study|Lost to Follow-up|0|||
126664789|NCT00390910|455731216|FG001|Overall Study|Lost to Follow-up|1|||
126664790|NCT00390910|455731217|FG002|Overall Study|Lost to Follow-up|5|||
126664791|NCT00390910|455731215|FG000|Overall Study|Withdrawal by Subject|1|||
126664792|NCT00390910|455731216|FG001|Overall Study|Withdrawal by Subject|3|||
126664793|NCT00390910|455731217|FG002|Overall Study|Withdrawal by Subject|2|||
126664794|NCT00390910|455731215|FG000|Overall Study|Migrated/moved from study area|0|||
126664795|NCT00390910|455731216|FG001|Overall Study|Migrated/moved from study area|0|||
126664796|NCT00390910|455731217|FG002|Overall Study|Migrated/moved from study area|3|||
126664797|NCT00174265|455731221|FG000|Overall Study|Adverse Event|7|||
126664798|NCT00174265|455731222|FG001|Overall Study|Adverse Event|4|||
126664799|NCT00174265|455731221|FG000|Overall Study|Lack of Efficacy|2|||
126664800|NCT00174265|455731222|FG001|Overall Study|Lack of Efficacy|2|||
126664801|NCT00174265|455731221|FG000|Overall Study|Withdrawal by Subject|3|||
126664802|NCT00174265|455731222|FG001|Overall Study|Withdrawal by Subject|5|||
126664803|NCT00174265|455731221|FG000|Overall Study|Lost to Follow-up|1|||
126664804|NCT00174265|455731222|FG001|Overall Study|Lost to Follow-up|0|||
126664805|NCT00174265|455731221|FG000|Overall Study|Other (Not specified)|16|||
126664806|NCT00174265|455731222|FG001|Overall Study|Other (Not specified)|10|||
126664807|NCT01572922|455731225|FG000|Overall Study|Adverse Event|1|||
126664808|NCT01572922|455731225|FG000|Overall Study|Protocol Violation|1|||
126664809|NCT01572922|455731225|FG000|Overall Study|Death|1|||
126664810|NCT00445068|455731226|FG000|Overall Study|Disease progression|26|||
126664811|NCT00445068|455731226|FG000|Overall Study|Adverse Event|5|||
126664812|NCT00445068|455731226|FG000|Overall Study|Abnormal laboratory value|2|||
126664813|NCT00445068|455731226|FG000|Overall Study|Withdrawal by Subject|2|||
126664814|NCT00445068|455731226|FG000|Overall Study|Death|1|||
126664815|NCT00447382|455731227|FG000|Overall Study|Adverse Event|1|||
126664816|NCT00447382|455731228|FG001|Overall Study|Adverse Event|1|||
126664817|NCT00447382|455731227|FG000|Overall Study|Lack of Efficacy|1|||
126664818|NCT00447382|455731228|FG001|Overall Study|Lack of Efficacy|0|||
126664819|NCT00447382|455731227|FG000|Overall Study|Protocol Violation|2|||
126664820|NCT00447382|455731228|FG001|Overall Study|Protocol Violation|0|||
126664821|NCT00447382|455731227|FG000|Overall Study|Unclassified|2|||
126664822|NCT00447382|455731228|FG001|Overall Study|Unclassified|5|||
126664823|NCT04600336|455731229|FG000|Initial Treatment|Withdrawal by Subject|1|||
126664824|NCT04600336|455731230|FG001|Initial Treatment|Withdrawal by Subject|2|||
126664825|NCT04600336|455731231|FG002|Initial Treatment|Withdrawal by Subject|0|||
126664826|NCT04600336|455731232|FG003|Initial Treatment|Withdrawal by Subject|0|||
126664827|NCT04600336|455731229|FG000|Initial Treatment|Adverse Event|0|||
126664828|NCT04600336|455731230|FG001|Initial Treatment|Adverse Event|2|||
126664829|NCT04600336|455731231|FG002|Initial Treatment|Adverse Event|0|||
126664830|NCT04600336|455731232|FG003|Initial Treatment|Adverse Event|0|||
126664831|NCT04600336|455731229|FG000|Initial Treatment|Other complicating disease|0|||
126664832|NCT04600336|455731230|FG001|Initial Treatment|Other complicating disease|0|||
126664833|NCT04600336|455731231|FG002|Initial Treatment|Other complicating disease|1|||
126664834|NCT04600336|455731232|FG003|Initial Treatment|Other complicating disease|0|||
126664835|NCT04600336|455731229|FG000|Crossover Treatment|Withdrawal by Subject|0|||
126664836|NCT04600336|455731230|FG001|Crossover Treatment|Withdrawal by Subject|0|||
126664837|NCT04600336|455731231|FG002|Crossover Treatment|Withdrawal by Subject|2|||
126664838|NCT04600336|455731232|FG003|Crossover Treatment|Withdrawal by Subject|1|||
126664839|NCT04600336|455731229|FG000|Crossover Treatment|Adverse Event|0|||
126664840|NCT04600336|455731230|FG001|Crossover Treatment|Adverse Event|0|||
126664841|NCT04600336|455731231|FG002|Crossover Treatment|Adverse Event|1|||
126664842|NCT04600336|455731232|FG003|Crossover Treatment|Adverse Event|1|||
126664843|NCT03144804|455731233|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
126664844|NCT04091451|455731236|FG000|Overall Study|Adverse Event|15|||
126664845|NCT04091451|455731237|FG001|Overall Study|Adverse Event|10|||
126664846|NCT04091451|455731236|FG000|Overall Study|Lost to Follow-up|8|||
126664847|NCT04091451|455731237|FG001|Overall Study|Lost to Follow-up|8|||
126664848|NCT04091451|455731236|FG000|Overall Study|Protocol Violation|5|||
126664849|NCT04091451|455731237|FG001|Overall Study|Protocol Violation|4|||
126664850|NCT04091451|455731236|FG000|Overall Study|Withdrawal by Subject|21|||
126664851|NCT04091451|455731237|FG001|Overall Study|Withdrawal by Subject|27|||
126664852|NCT04091451|455731236|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
126664853|NCT04091451|455731237|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
126664854|NCT04091451|455731236|FG000|Overall Study|Migrated/moved from the study area|3|||
126664855|NCT04091451|455731237|FG001|Overall Study|Migrated/moved from the study area|5|||
126664856|NCT04091451|455731236|FG000|Overall Study|Suspected HZ episode|1|||
126664857|NCT04091451|455731237|FG001|Overall Study|Suspected HZ episode|0|||
126664858|NCT03769181|455732863|FG000|Overall Study|Adverse Event|1|||
126331508|NCT01111565|454508839|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126331509|NCT01111565|454508840|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126331510|NCT01111565|454508841|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126331511|NCT01111565|454508842|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
126331512|NCT01111565|454508843|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126331513|NCT01111565|454508839|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126331514|NCT01111565|454508840|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126331515|NCT01111565|454508841|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
126331516|NCT01111565|454508842|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126331517|NCT01111565|454508843|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126331518|NCT01111565|454508839|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
126331519|NCT01111565|454508840|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
126331520|NCT01111565|454508841|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
126331521|NCT01111565|454508842|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
126331522|NCT01111565|454508843|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
126331523|NCT01111565|454508839|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
126331524|NCT01111565|454508840|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
126331525|NCT01111565|454508841|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
126664859|NCT03769181|455732864|FG001|Overall Study|Adverse Event|0|||
126331526|NCT01111565|454508842|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
126331527|NCT01111565|454508843|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
126331528|NCT01111565|454508839|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
126331529|NCT01111565|454508840|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
126331530|NCT01111565|454508841|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
126331531|NCT01111565|454508842|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
126331532|NCT01111565|454508843|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
126331533|NCT00368108|454508844|FG000|Overall Study|Adverse Event|38|||
126331534|NCT00368108|454508845|FG001|Overall Study|Adverse Event|26|||
126331535|NCT00368108|454508846|FG002|Overall Study|Adverse Event|44|||
126331536|NCT00368108|454508844|FG000|Overall Study|Abnormal Laboratory Value|0|||
126331537|NCT00368108|454508845|FG001|Overall Study|Abnormal Laboratory Value|0|||
126331538|NCT00368108|454508846|FG002|Overall Study|Abnormal Laboratory Value|3|||
126331539|NCT00368108|454508844|FG000|Overall Study|Protocol Violation|5|||
126331540|NCT00368108|454508845|FG001|Overall Study|Protocol Violation|9|||
126331541|NCT00368108|454508846|FG002|Overall Study|Protocol Violation|9|||
126331542|NCT00368108|454508844|FG000|Overall Study|Withdrawal by Subject|9|||
126331543|NCT00368108|454508845|FG001|Overall Study|Withdrawal by Subject|3|||
126331544|NCT00368108|454508846|FG002|Overall Study|Withdrawal by Subject|5|||
126331545|NCT00368108|454508844|FG000|Overall Study|Lack of Efficacy|7|||
126331546|NCT00368108|454508845|FG001|Overall Study|Lack of Efficacy|8|||
126331547|NCT00368108|454508846|FG002|Overall Study|Lack of Efficacy|5|||
126331548|NCT00368108|454508844|FG000|Overall Study|Physician Decision|2|||
126331549|NCT00368108|454508845|FG001|Overall Study|Physician Decision|0|||
126331550|NCT00368108|454508846|FG002|Overall Study|Physician Decision|1|||
126331551|NCT00368108|454508844|FG000|Overall Study|Other|3|||
126331552|NCT00368108|454508845|FG001|Overall Study|Other|7|||
126664860|NCT03769181|455732865|FG002|Overall Study|Adverse Event|2|||
126664861|NCT03769181|455732866|FG003|Overall Study|Adverse Event|4|||
126664862|NCT03769181|455732863|FG000|Overall Study|Withdrawal by Subject|1|||
126664863|NCT03769181|455732864|FG001|Overall Study|Withdrawal by Subject|0|||
126664864|NCT03769181|455732865|FG002|Overall Study|Withdrawal by Subject|2|||
126664865|NCT03769181|455732866|FG003|Overall Study|Withdrawal by Subject|1|||
126664866|NCT03769181|455732863|FG000|Overall Study|Progressive disease|9|||
126664867|NCT03769181|455732864|FG001|Overall Study|Progressive disease|7|||
126664868|NCT03769181|455732865|FG002|Overall Study|Progressive disease|13|||
126664869|NCT03769181|455732866|FG003|Overall Study|Progressive disease|6|||
126664870|NCT03769181|455732863|FG000|Overall Study|Other - Unspecified|2|||
126664871|NCT03769181|455732864|FG001|Overall Study|Other - Unspecified|1|||
126664872|NCT03769181|455732865|FG002|Overall Study|Other - Unspecified|0|||
126664873|NCT03769181|455732866|FG003|Overall Study|Other - Unspecified|0|||
126664874|NCT03078907|455732869|FG000|Overall Study|Adverse Event|2|||
126664875|NCT03078907|455732870|FG001|Overall Study|Adverse Event|0|||
126664876|NCT03078907|455732869|FG000|Overall Study|Other|1|||
126664877|NCT03078907|455732870|FG001|Overall Study|Other|0|||
126664878|NCT03078907|455732869|FG000|Overall Study|Protocol Violation|0|||
126664879|NCT03078907|455732870|FG001|Overall Study|Protocol Violation|1|||
126331553|NCT00368108|454508846|FG002|Overall Study|Other|1|||
126331554|NCT02532374|454508862|FG000|Overall Study|Withdrawal by Subject|1|||
126331555|NCT02532374|454508862|FG000|Overall Study|Physician Decision|1|||
126331556|NCT02254772|454508865|FG000|Overall Study|Ineligible|1|||
126664880|NCT03338192|455732871|FG000|Year One to Year Two|High Blood Pressure|7|||
126664881|NCT03338192|455732872|FG001|Year One to Year Two|High Blood Pressure|1|||
126664882|NCT03338192|455732871|FG000|Year One to Year Two|HIV +|1|||
126664883|NCT03338192|455732872|FG001|Year One to Year Two|HIV +|0|||
126664884|NCT03338192|455732871|FG000|Year Two to Year Four|High Blood Pressure|1|||
126664885|NCT03338192|455732872|FG001|Year Two to Year Four|High Blood Pressure|0|||
126664886|NCT03338192|455732871|FG000|Year Two to Year Four|HIV +|2|||
126664887|NCT03338192|455732872|FG001|Year Two to Year Four|HIV +|0|||
126664888|NCT03338192|455732871|FG000|Year Four to Year Six|High Blood Pressure|2|||
126664889|NCT03338192|455732872|FG001|Year Four to Year Six|High Blood Pressure|1|||
126331557|NCT02254772|454508865|FG000|Overall Study|Withdrawal by Subject|1|||
126664890|NCT03808688|455732873|FG000|Overall Study|Adverse Event|13|||
126664891|NCT03808688|455732874|FG001|Overall Study|Adverse Event|17|||
126664892|NCT03808688|455732873|FG000|Overall Study|Lack of Efficacy|2|||
126664893|NCT03808688|455732874|FG001|Overall Study|Lack of Efficacy|0|||
126664894|NCT03808688|455732873|FG000|Overall Study|Lost to Follow-up|0|||
126664895|NCT03808688|455732874|FG001|Overall Study|Lost to Follow-up|2|||
126664896|NCT03808688|455732873|FG000|Overall Study|Withdrawal by Subject|1|||
126664897|NCT03808688|455732874|FG001|Overall Study|Withdrawal by Subject|0|||
126664898|NCT03808688|455732873|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
126664899|NCT03808688|455732874|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
126664900|NCT03808688|455732873|FG000|Overall Study|IOP Too High|1|||
126664901|NCT03808688|455732874|FG001|Overall Study|IOP Too High|1|||
126664902|NCT03808688|455732873|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
126664903|NCT03808688|455732874|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
126664904|NCT03808688|455732873|FG000|Overall Study|Visit Out of Window|0|||
126664905|NCT03808688|455732874|FG001|Overall Study|Visit Out of Window|1|||
126664906|NCT03808688|455732873|FG000|Overall Study|Medication Non-Compliance|0|||
126664907|NCT03808688|455732874|FG001|Overall Study|Medication Non-Compliance|1|||
126664908|NCT03329196|455732875|FG000|Overall Study|Adverse Event|10|||
126664909|NCT03329196|455732876|FG001|Overall Study|Adverse Event|5|||
126664910|NCT03329196|455732875|FG000|Overall Study|Physician Decision|2|||
126664911|NCT03329196|455732876|FG001|Overall Study|Physician Decision|2|||
126664912|NCT03329196|455732875|FG000|Overall Study|Withdrawal by Subject|11|||
126664913|NCT03329196|455732876|FG001|Overall Study|Withdrawal by Subject|3|||
126664914|NCT03329196|455732875|FG000|Overall Study|Hepatic function abnormalities|0|||
126664915|NCT03329196|455732876|FG001|Overall Study|Hepatic function abnormalities|1|||
126664916|NCT03329196|455732875|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
126664917|NCT03329196|455732876|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
126664918|NCT03329196|455732875|FG000|Overall Study|Difficult to control Hb|2|||
126331558|NCT03904420|454508866|FG000|Overall Study|Study terminated|2|||
126331559|NCT03904420|454508867|FG001|Overall Study|Study terminated|2|||
126331560|NCT01089127|454508868|FG000|Overall Study|Adverse Event|5|||
126331561|NCT01089127|454508869|FG001|Overall Study|Adverse Event|1|||
126331562|NCT01089127|454508870|FG002|Overall Study|Adverse Event|1|||
126331563|NCT01089127|454508871|FG003|Overall Study|Adverse Event|0|||
126331564|NCT01089127|454508872|FG004|Overall Study|Adverse Event|0|||
126331565|NCT01089127|454508873|FG005|Overall Study|Adverse Event|1|||
126331566|NCT01089127|454508868|FG000|Overall Study|Subject withdrew consent|0|||
126331567|NCT01089127|454508869|FG001|Overall Study|Subject withdrew consent|1|||
126331568|NCT01089127|454508870|FG002|Overall Study|Subject withdrew consent|1|||
126331569|NCT01089127|454508871|FG003|Overall Study|Subject withdrew consent|1|||
126331570|NCT01089127|454508872|FG004|Overall Study|Subject withdrew consent|0|||
126331571|NCT01089127|454508873|FG005|Overall Study|Subject withdrew consent|2|||
126331572|NCT01089127|454508868|FG000|Overall Study|Abnormal test procedure result(s)|2|||
126331573|NCT01089127|454508869|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126331574|NCT01089127|454508870|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126331575|NCT01089127|454508871|FG003|Overall Study|Abnormal test procedure result(s)|0|||
126331576|NCT01089127|454508872|FG004|Overall Study|Abnormal test procedure result(s)|0|||
126331577|NCT01089127|454508873|FG005|Overall Study|Abnormal test procedure result(s)|0|||
126331578|NCT01089127|454508868|FG000|Overall Study|Lost to Follow-up|1|||
126331579|NCT01089127|454508869|FG001|Overall Study|Lost to Follow-up|1|||
126331580|NCT01089127|454508870|FG002|Overall Study|Lost to Follow-up|0|||
126331581|NCT01089127|454508871|FG003|Overall Study|Lost to Follow-up|0|||
126331582|NCT01089127|454508872|FG004|Overall Study|Lost to Follow-up|1|||
126331583|NCT01089127|454508873|FG005|Overall Study|Lost to Follow-up|0|||
126331584|NCT01089127|454508868|FG000|Overall Study|Protocol deviation|0|||
126331585|NCT01089127|454508869|FG001|Overall Study|Protocol deviation|1|||
126331586|NCT01089127|454508870|FG002|Overall Study|Protocol deviation|0|||
126331587|NCT01089127|454508871|FG003|Overall Study|Protocol deviation|0|||
126331588|NCT01089127|454508872|FG004|Overall Study|Protocol deviation|1|||
126331589|NCT01089127|454508873|FG005|Overall Study|Protocol deviation|0|||
126331590|NCT00716456|454508874|FG000|Overall Study|Adverse Event|0|||
126331591|NCT00716456|454508875|FG001|Overall Study|Adverse Event|2|||
126664919|NCT03329196|455732876|FG001|Overall Study|Difficult to control Hb|3|||
126331592|NCT00716456|454508876|FG002|Overall Study|Adverse Event|0|||
126664920|NCT03329196|455732875|FG000|Overall Study|Dialysis or renal transplant|13|||
126664921|NCT03329196|455732876|FG001|Overall Study|Dialysis or renal transplant|15|||
126664922|NCT04175808|455732877|FG000|Part A|Miscellaneous|2|||
126664923|NCT04175808|455732878|FG001|Part A|Miscellaneous|0|||
126664924|NCT04175808|455732879|FG002|Part A|Miscellaneous|0|||
126664925|NCT04175808|455732880|FG003|Part A|Miscellaneous|0|||
126664926|NCT04175808|455732881|FG004|Part A|Miscellaneous|0|||
126664927|NCT04175808|455732882|FG005|Part A|Miscellaneous|0|||
126664928|NCT04175808|455732883|FG006|Part A|Miscellaneous|0|||
126664929|NCT02076113|455732884|FG000|Overall Study|Lost to Follow-up|4|||
126664930|NCT02076113|455732885|FG001|Overall Study|Lost to Follow-up|1|||
126664931|NCT02076113|455732884|FG000|Overall Study|Withdrawal by Subject|2|||
126664932|NCT02076113|455732885|FG001|Overall Study|Withdrawal by Subject|3|||
126664933|NCT02076113|455732884|FG000|Overall Study|Death|1|||
126664934|NCT02076113|455732885|FG001|Overall Study|Death|3|||
126664935|NCT01054144|455732886|FG000|Overall Study|Death|2|||
126664936|NCT03801902|455732887|FG000|Overall Study|Did not receive protocol treatment.|1|||
126664937|NCT03801902|455732888|FG001|Overall Study|Did not receive protocol treatment.|0|||
126664938|NCT03801902|455732889|FG002|Overall Study|Did not receive protocol treatment.|0|||
126664939|NCT03801902|455732890|FG003|Overall Study|Did not receive protocol treatment.|0|||
126664940|NCT00528866|455732894|FG000|Overall Study|Protocol Violation|6|||
126664941|NCT01601847|455732895|FG000|Overall Study|Death|1|||
126664942|NCT01601847|455732896|FG001|Overall Study|Death|0|||
126664943|NCT01601847|455732895|FG000|Overall Study|Withdrawal by Subject|11|||
126664944|NCT01601847|455732896|FG001|Overall Study|Withdrawal by Subject|7|||
126664945|NCT01601847|455732895|FG000|Overall Study|Lost to Follow-up|1|||
126664946|NCT01601847|455732896|FG001|Overall Study|Lost to Follow-up|3|||
126664947|NCT01284062|455732897|FG000|Overall Study|Adverse Event|4|||
126664948|NCT01284062|455732898|FG001|Overall Study|Adverse Event|5|||
126664949|NCT01284062|455732899|FG002|Overall Study|Adverse Event|0|||
126664950|NCT01284062|455732900|FG003|Overall Study|Adverse Event|5|||
126664951|NCT01284062|455732897|FG000|Overall Study|Lack of Efficacy|3|||
126664952|NCT01284062|455732898|FG001|Overall Study|Lack of Efficacy|2|||
126664953|NCT01284062|455732899|FG002|Overall Study|Lack of Efficacy|2|||
126664954|NCT01284062|455732900|FG003|Overall Study|Lack of Efficacy|1|||
126664955|NCT01284062|455732897|FG000|Overall Study|Medication error without adverse event|0|||
126664956|NCT01284062|455732898|FG001|Overall Study|Medication error without adverse event|0|||
126664957|NCT01284062|455732899|FG002|Overall Study|Medication error without adverse event|1|||
126664958|NCT01284062|455732900|FG003|Overall Study|Medication error without adverse event|0|||
126664959|NCT01284062|455732897|FG000|Overall Study|Protocol Violation|1|||
126664960|NCT01284062|455732898|FG001|Overall Study|Protocol Violation|0|||
126664961|NCT01284062|455732899|FG002|Overall Study|Protocol Violation|0|||
126664962|NCT01284062|455732900|FG003|Overall Study|Protocol Violation|2|||
126664963|NCT01284062|455732897|FG000|Overall Study|Withdrawal by Subject|3|||
126664964|NCT01284062|455732898|FG001|Overall Study|Withdrawal by Subject|1|||
126664965|NCT01284062|455732899|FG002|Overall Study|Withdrawal by Subject|2|||
126664966|NCT01284062|455732900|FG003|Overall Study|Withdrawal by Subject|5|||
126664967|NCT01284062|455732897|FG000|Overall Study|Other|0|||
126664968|NCT01284062|455732898|FG001|Overall Study|Other|0|||
126664969|NCT01284062|455732899|FG002|Overall Study|Other|0|||
126664970|NCT01284062|455732900|FG003|Overall Study|Other|1|||
126664971|NCT01284062|455732897|FG000|Overall Study|Site Closed|0|||
126664972|NCT01284062|455732898|FG001|Overall Study|Site Closed|0|||
126664973|NCT01284062|455732899|FG002|Overall Study|Site Closed|1|||
126664974|NCT01284062|455732900|FG003|Overall Study|Site Closed|0|||
126664975|NCT02234323|455732901|FG000|All Enrolled|Not Treated: Completed study in database|2|||
126664976|NCT02234323|455732901|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
126664977|NCT02234323|455732901|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
126664978|NCT02234323|455732901|FG000|All Treated|Death|1|||
126664979|NCT02234323|455732901|FG000|All Treated|Physician Decision|5|||
126664980|NCT02234323|455732901|FG000|All Treated|Lack of Efficacy|3|||
126664981|NCT02234323|455732901|FG000|All Treated|Exceeded lab value limit|2|||
126664982|NCT02234323|455732901|FG000|All Treated|Other|7|||
126664983|NCT02644941|455732902|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
126664984|NCT02644941|455732903|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
126664985|NCT04614662|455732904|FG000|Overall Study|Withdrawal by Subject|0|||
126664986|NCT04614662|455732905|FG001|Overall Study|Withdrawal by Subject|1|||
126664987|NCT01843218|455732913|FG000|Overall Study|Withdrawal by Subject|5|||
126664988|NCT01906346|455732914|FG000|Overall Study|AEs|1|||
126664989|NCT04226833|455732915|FG000|Overall Study|Death|0|||
126664990|NCT04226833|455732916|FG001|Overall Study|Death|0|||
126664991|NCT04226833|455732917|FG002|Overall Study|Death|1|||
126664992|NCT04226833|455732918|FG003|Overall Study|Death|0|||
126664993|NCT03829319|455732925|FG000|Overall Study|Sponsor's Decision|4|||
126664994|NCT03829319|455732926|FG001|Overall Study|Sponsor's Decision|90|||
126664995|NCT03829319|455732927|FG002|Overall Study|Sponsor's Decision|102|||
126664996|NCT03829319|455732925|FG000|Overall Study|Withdrawal by Subject|1|||
126664997|NCT03829319|455732926|FG001|Overall Study|Withdrawal by Subject|5|||
126664998|NCT03829319|455732927|FG002|Overall Study|Withdrawal by Subject|4|||
126664999|NCT03829319|455732925|FG000|Overall Study|Physician Decision|0|||
126665000|NCT03829319|455732926|FG001|Overall Study|Physician Decision|3|||
126665001|NCT03829319|455732927|FG002|Overall Study|Physician Decision|0|||
126665002|NCT03829319|455732925|FG000|Overall Study|Lost to Follow-up|0|||
126665003|NCT03829319|455732926|FG001|Overall Study|Lost to Follow-up|0|||
126665004|NCT03829319|455732927|FG002|Overall Study|Lost to Follow-up|1|||
126665005|NCT03829319|455732925|FG000|Overall Study|Death|8|||
126665006|NCT03829319|455732926|FG001|Overall Study|Death|277|||
126665007|NCT03829319|455732927|FG002|Overall Study|Death|266|||
126665008|NCT04498832|455732928|FG000|Overall Study|Adverse Event|1|||
126665009|NCT04498832|455732929|FG001|Overall Study|Adverse Event|3|||
126665010|NCT04498832|455732928|FG000|Overall Study|Withdrawal by Subject|0|||
126665011|NCT04498832|455732929|FG001|Overall Study|Withdrawal by Subject|1|||
126665012|NCT03231943|455732933|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126665013|NCT03231943|455732934|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
126665014|NCT03231943|455732935|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
126665015|NCT03231943|455732936|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126665016|NCT03231943|455732937|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126665017|NCT03231943|455732938|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126665018|NCT03231943|455732939|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126665019|NCT03231943|455732940|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126665020|NCT03231943|455732941|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126665021|NCT03231943|455732942|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126665022|NCT03231943|455732943|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126665023|NCT03231943|455732944|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126665024|NCT03231943|455732945|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
126665025|NCT03231943|455732933|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126665026|NCT03231943|455732934|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
126665027|NCT03231943|455732935|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126665028|NCT03231943|455732936|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126665029|NCT03231943|455732937|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126665030|NCT03231943|455732938|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126665031|NCT03231943|455732939|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126665032|NCT03231943|455732940|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126665033|NCT03231943|455732941|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126665034|NCT03231943|455732942|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126665035|NCT03231943|455732943|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126665036|NCT03231943|455732944|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126665037|NCT03231943|455732945|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
126665038|NCT03231943|455732933|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
126665039|NCT03231943|455732934|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126665040|NCT03231943|455732935|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126665041|NCT03231943|455732936|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126665042|NCT03231943|455732937|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126665043|NCT03231943|455732938|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126665044|NCT03231943|455732939|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126665045|NCT03231943|455732940|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126665046|NCT03231943|455732941|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126665047|NCT03231943|455732942|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126665048|NCT03231943|455732943|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126665049|NCT03231943|455732944|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126665050|NCT03231943|455732945|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
126665051|NCT03231943|455732933|FG000|Part 2|Adverse Event|0|||
126665052|NCT03231943|455732934|FG001|Part 2|Adverse Event|0|||
126665053|NCT03231943|455732935|FG002|Part 2|Adverse Event|0|||
126665054|NCT03231943|455732936|FG003|Part 2|Adverse Event|0|||
126665055|NCT03231943|455732937|FG004|Part 2|Adverse Event|0|||
126665056|NCT03231943|455732938|FG005|Part 2|Adverse Event|0|||
126665057|NCT03231943|455732939|FG006|Part 2|Adverse Event|0|||
126665058|NCT03231943|455732940|FG007|Part 2|Adverse Event|0|||
126665059|NCT03231943|455732941|FG008|Part 2|Adverse Event|0|||
126665060|NCT03231943|455732942|FG009|Part 2|Adverse Event|0|||
126331593|NCT00447772|454508877|FG000|Overall Study|Lack of Efficacy|3|||
126331594|NCT00447772|454508877|FG000|Overall Study|Insufficient compliance|6|||
126331595|NCT00447772|454508877|FG000|Overall Study|Discontinuation of drug therapy|1|||
126331596|NCT00447772|454508877|FG000|Overall Study|Lost to Follow-up|9|||
126331597|NCT00447772|454508877|FG000|Overall Study|Withdrawal by Subject|1|||
126331598|NCT00447772|454508877|FG000|Overall Study|Unable to attend all study visits|2|||
126665061|NCT03231943|455732943|FG010|Part 2|Adverse Event|1|||
126665062|NCT03231943|455732944|FG011|Part 2|Adverse Event|0|||
126331599|NCT00447772|454508877|FG000|Overall Study|Adverse Event|1|||
126331600|NCT00447772|454508877|FG000|Overall Study|Patient relocated|1|||
126331601|NCT00447772|454508877|FG000|Overall Study|Incomplete documentation at visit 1|1|||
126331602|NCT00447772|454508877|FG000|Overall Study|Chemotherapy for lung cancer|1|||
126665063|NCT03231943|455732945|FG012|Part 2|Adverse Event|0|||
126665064|NCT03231943|455732933|FG000|Part 2|Withdrawal by Subject|0|||
126665065|NCT03231943|455732934|FG001|Part 2|Withdrawal by Subject|0|||
126545278|NCT01111838|455290787|FG000|Overall Study|Patient Ineligible|2|||
126331603|NCT00447772|454508877|FG000|Overall Study|Premature re-injection required|1|||
126331604|NCT00875563|454508878|FG000|Overall Study|Death|4|||
126665066|NCT03231943|455732935|FG002|Part 2|Withdrawal by Subject|0|||
126665067|NCT03231943|455732936|FG003|Part 2|Withdrawal by Subject|0|||
126665068|NCT03231943|455732937|FG004|Part 2|Withdrawal by Subject|0|||
126665069|NCT03231943|455732938|FG005|Part 2|Withdrawal by Subject|0|||
126665070|NCT03231943|455732939|FG006|Part 2|Withdrawal by Subject|0|||
126665071|NCT03231943|455732940|FG007|Part 2|Withdrawal by Subject|0|||
126665072|NCT03231943|455732941|FG008|Part 2|Withdrawal by Subject|0|||
126665073|NCT03231943|455732942|FG009|Part 2|Withdrawal by Subject|0|||
126665074|NCT03231943|455732943|FG010|Part 2|Withdrawal by Subject|0|||
126665075|NCT03231943|455732944|FG011|Part 2|Withdrawal by Subject|1|||
126665076|NCT03231943|455732945|FG012|Part 2|Withdrawal by Subject|0|||
126665077|NCT04824521|455732948|FG000|Overall Study|Lost to Follow-up|1|||
126665078|NCT04124614|455732951|FG000|Placebo Run-in Period|Not Randomized|34|||
126665079|NCT04124614|455732952|FG001|Placebo Run-in Period|Not Randomized|0|||
126665080|NCT04124614|455732953|FG002|Placebo Run-in Period|Not Randomized|0|||
126665081|NCT04124614|455732951|FG000|Double Blind Treatment Period|Adverse Event|0|||
126665082|NCT04124614|455732952|FG001|Double Blind Treatment Period|Adverse Event|7|||
126665083|NCT04124614|455732953|FG002|Double Blind Treatment Period|Adverse Event|22|||
126665084|NCT04124614|455732951|FG000|Double Blind Treatment Period|Death|0|||
126665085|NCT04124614|455732952|FG001|Double Blind Treatment Period|Death|0|||
126665086|NCT04124614|455732953|FG002|Double Blind Treatment Period|Death|1|||
126665087|NCT04124614|455732951|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
126665088|NCT04124614|455732952|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
126665089|NCT04124614|455732953|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
126331605|NCT00875563|454508878|FG000|Overall Study|Withdrawal by Subject|7|||
126331606|NCT00875563|454508878|FG000|Overall Study|No long-term (3-5 year) consent|6|||
126331607|NCT00875563|454508878|FG000|Overall Study|Still be eligible for follow-up|7|||
126331608|NCT02896569|454508881|FG000|Overall Study|Lost to Follow-up|2|||
126331609|NCT02896569|454508882|FG001|Overall Study|Lost to Follow-up|1|||
126331610|NCT02896569|454508881|FG000|Overall Study|Physician Decision|1|||
126331611|NCT02896569|454508882|FG001|Overall Study|Physician Decision|3|||
126331612|NCT02896569|454508881|FG000|Overall Study|Adverse Event|0|||
126331613|NCT02896569|454508882|FG001|Overall Study|Adverse Event|1|||
126331614|NCT02896569|454508881|FG000|Overall Study|Withdrawal by Subject|1|||
126331615|NCT02896569|454508882|FG001|Overall Study|Withdrawal by Subject|0|||
126331616|NCT03257436|454508883|FG000|Overall Study|Withdrawal by Subject|76|||
126331617|NCT03257436|454508883|FG000|Overall Study|Death|19|||
126331618|NCT03874013|454508890|FG000|Overall Study|Adverse Event|0|||
126331619|NCT03874013|454508891|FG001|Overall Study|Adverse Event|1|||
126331620|NCT06060496|454508893|FG000|Overall Study|Withdrawal by Subject|2|||
126331621|NCT06060496|454508893|FG000|Overall Study|Lost to Follow-up|2|||
126331622|NCT03990051|454508894|FG000|Masked Period|Lost to Follow-up|1|||
126331623|NCT03990051|454508895|FG001|Masked Period|Lost to Follow-up|0|||
126331624|NCT03990051|454508894|FG000|Long Term Period|Death|1|||
126331625|NCT03990051|454508895|FG001|Long Term Period|Death|1|||
126331626|NCT03990051|454508894|FG000|Long Term Period|Lost to Follow-up|7|||
126331627|NCT03990051|454508895|FG001|Long Term Period|Lost to Follow-up|2|||
126331628|NCT01411852|454508896|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
126331629|NCT01411852|454508897|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
126331630|NCT01411852|454508896|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
126331631|NCT01411852|454508897|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
126331632|NCT01411852|454508896|FG000|Prehospital Intervention Phase|Found to be under age|0|||
126331633|NCT01411852|454508897|FG001|Prehospital Intervention Phase|Found to be under age|1|||
126331634|NCT01411852|454508896|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
126331635|NCT01411852|454508897|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
126331636|NCT01411852|454508896|FG000|Hospital Intervention Phase|Severe head injury|5|||
126331637|NCT01411852|454508897|FG001|Hospital Intervention Phase|Severe head injury|4|||
126331638|NCT01411852|454508896|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
126665090|NCT04124614|455732951|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
126665091|NCT04124614|455732952|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
126665092|NCT04124614|455732953|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
126665093|NCT04124614|455732951|FG000|Double Blind Treatment Period|Physician Decision|0|||
126665094|NCT04124614|455732952|FG001|Double Blind Treatment Period|Physician Decision|0|||
126331639|NCT01411852|454508897|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
126331640|NCT01411852|454508896|FG000|Hospital Intervention Phase|Miscommunication error|1|||
126331641|NCT01411852|454508897|FG001|Hospital Intervention Phase|Miscommunication error|2|||
126331642|NCT01411852|454508896|FG000|Hospital Intervention Phase|CPR administered|3|||
126331643|NCT01411852|454508897|FG001|Hospital Intervention Phase|CPR administered|1|||
126331644|NCT01411852|454508896|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
126331645|NCT01411852|454508897|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
126545279|NCT01111838|455290787|FG000|Overall Study|Not Treated|3|||
126331646|NCT01411852|454508896|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
126331647|NCT01411852|454508897|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
126331648|NCT01411852|454508896|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
126331649|NCT01411852|454508897|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
126331650|NCT01411852|454508896|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
126331651|NCT01411852|454508897|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
126665095|NCT04124614|455732953|FG002|Double Blind Treatment Period|Physician Decision|3|||
126665096|NCT04124614|455732951|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
126665097|NCT04124614|455732952|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
126665098|NCT04124614|455732953|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
126665099|NCT04124614|455732951|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
126665100|NCT04124614|455732952|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
126665101|NCT04124614|455732953|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
126665102|NCT04124614|455732951|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
126665103|NCT04124614|455732952|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
126665104|NCT04124614|455732953|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
126665105|NCT01831544|455733983|FG000|Overall Study|Death|1|||
126665106|NCT01831544|455733983|FG000|Overall Study|Still on original MVAD device|2|||
126665107|NCT02021292|455733987|FG000|Overall Study|Physician Decision|0|||
126665108|NCT02021292|455733988|FG001|Overall Study|Physician Decision|1|||
126665109|NCT02021292|455733987|FG000|Overall Study|Lost to Follow-up|0|||
126665110|NCT02021292|455733988|FG001|Overall Study|Lost to Follow-up|1|||
126665111|NCT02021292|455733987|FG000|Overall Study|Death|0|||
126665112|NCT02021292|455733988|FG001|Overall Study|Death|1|||
126665113|NCT04147234|455733989|FG000|Overall Study|Clinical deterioration|0|||
126665114|NCT04147234|455733990|FG001|Overall Study|Clinical deterioration|0|||
126665115|NCT04147234|455733991|FG002|Overall Study|Clinical deterioration|1|||
126665116|NCT04147234|455733992|FG003|Overall Study|Clinical deterioration|0|||
126665117|NCT04147234|455733993|FG004|Overall Study|Clinical deterioration|0|||
126665118|NCT04147234|455733994|FG005|Overall Study|Clinical deterioration|0|||
126665119|NCT04147234|455733995|FG006|Overall Study|Clinical deterioration|0|||
126665120|NCT04147234|455733989|FG000|Overall Study|Withdrawal by Subject|0|||
126665121|NCT04147234|455733990|FG001|Overall Study|Withdrawal by Subject|1|||
126665122|NCT04147234|455733991|FG002|Overall Study|Withdrawal by Subject|1|||
126665123|NCT04147234|455733992|FG003|Overall Study|Withdrawal by Subject|0|||
126665124|NCT04147234|455733993|FG004|Overall Study|Withdrawal by Subject|0|||
126665125|NCT04147234|455733994|FG005|Overall Study|Withdrawal by Subject|0|||
126665126|NCT04147234|455733995|FG006|Overall Study|Withdrawal by Subject|0|||
126665127|NCT04147234|455733989|FG000|Overall Study|Clinical disease progression|1|||
126665128|NCT04147234|455733990|FG001|Overall Study|Clinical disease progression|3|||
126665129|NCT04147234|455733991|FG002|Overall Study|Clinical disease progression|1|||
126665130|NCT04147234|455733992|FG003|Overall Study|Clinical disease progression|1|||
126665131|NCT04147234|455733993|FG004|Overall Study|Clinical disease progression|0|||
126665132|NCT04147234|455733994|FG005|Overall Study|Clinical disease progression|1|||
126665133|NCT04147234|455733995|FG006|Overall Study|Clinical disease progression|0|||
126665134|NCT04147234|455733989|FG000|Overall Study|Objective disease progression|6|||
126665135|NCT04147234|455733990|FG001|Overall Study|Objective disease progression|4|||
126665136|NCT04147234|455733991|FG002|Overall Study|Objective disease progression|3|||
126665137|NCT04147234|455733992|FG003|Overall Study|Objective disease progression|3|||
126665138|NCT04147234|455733993|FG004|Overall Study|Objective disease progression|5|||
126665139|NCT04147234|455733994|FG005|Overall Study|Objective disease progression|2|||
126665140|NCT04147234|455733995|FG006|Overall Study|Objective disease progression|3|||
126665141|NCT04147234|455733989|FG000|Overall Study|Adverse Event|0|||
126665142|NCT04147234|455733990|FG001|Overall Study|Adverse Event|0|||
126665143|NCT04147234|455733991|FG002|Overall Study|Adverse Event|0|||
126665144|NCT04147234|455733992|FG003|Overall Study|Adverse Event|0|||
126665145|NCT04147234|455733993|FG004|Overall Study|Adverse Event|1|||
126665146|NCT04147234|455733994|FG005|Overall Study|Adverse Event|0|||
126665147|NCT04147234|455733995|FG006|Overall Study|Adverse Event|0|||
126665148|NCT05972733|455733996|FG000|Overall Study|Lost to Follow-up|2|||
126665149|NCT05972733|455733996|FG000|Overall Study|Withdrawal by Subject|1|||
126665150|NCT04982588|455733999|FG000|Overall Study|Withdrawal by Subject|2|||
126665151|NCT02366728|455734000|FG000|Overall Study|Death|0|||
126665152|NCT02366728|455734001|FG001|Overall Study|Death|0|||
126665153|NCT02366728|455734002|FG002|Overall Study|Death|1|||
126665154|NCT02366728|455734000|FG000|Overall Study|Adverse Event|1|||
126665155|NCT02366728|455734001|FG001|Overall Study|Adverse Event|0|||
126665156|NCT02366728|455734002|FG002|Overall Study|Adverse Event|0|||
126665157|NCT02366728|455734000|FG000|Overall Study|Screen Failure|2|||
126665158|NCT02366728|455734001|FG001|Overall Study|Screen Failure|1|||
126665159|NCT02366728|455734002|FG002|Overall Study|Screen Failure|0|||
126665160|NCT02366728|455734000|FG000|Overall Study|Only yielded 2 vaccines|1|||
126665161|NCT02366728|455734001|FG001|Overall Study|Only yielded 2 vaccines|0|||
126665162|NCT02366728|455734002|FG002|Overall Study|Only yielded 2 vaccines|0|||
126331652|NCT01411852|454508896|FG000|Hospital Intervention Phase|Other ineligible|2|||
126331653|NCT01411852|454508897|FG001|Hospital Intervention Phase|Other ineligible|2|||
126331654|NCT01411852|454508896|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
126331655|NCT01411852|454508897|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
126331656|NCT01411852|454508896|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
126331657|NCT01411852|454508897|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
126331658|NCT01411852|454508896|FG000|Hospital Intervention Phase|Vascular access failed|1|||
126331659|NCT01411852|454508897|FG001|Hospital Intervention Phase|Vascular access failed|0|||
126331660|NCT03126786|454508902|FG000|Overall Study|Adverse Event|3|||
126331661|NCT03126786|454508903|FG001|Overall Study|Adverse Event|0|||
126331662|NCT03126786|454508902|FG000|Overall Study|Lost to Follow-up|0|||
126331663|NCT03126786|454508903|FG001|Overall Study|Lost to Follow-up|1|||
126331664|NCT03126786|454508902|FG000|Overall Study|Withdrawal by Subject|3|||
126331665|NCT03126786|454508903|FG001|Overall Study|Withdrawal by Subject|1|||
126331666|NCT00991289|454508904|FG000|Overall Study|Adverse Event|1|||
126331667|NCT00991289|454508904|FG000|Overall Study|Physician Decision|2|||
126331668|NCT00991289|454508904|FG000|Overall Study|Withdrawal by Subject|3|||
126331669|NCT00991289|454508904|FG000|Overall Study|Lost to Follow-up|4|||
126331670|NCT00991289|454508904|FG000|Overall Study|Protocol Violation|2|||
126331671|NCT00379899|454508905|FG000|Overall Study|Adverse Event|7|||
126331672|NCT00379899|454508906|FG001|Overall Study|Adverse Event|3|||
126331673|NCT00379899|454508905|FG000|Overall Study|Death|10|||
126665163|NCT00992511|455734004|FG000|Overall Study|Migrated/moved from study area|1|||
126665164|NCT00992511|455734005|FG001|Overall Study|Migrated/moved from study area|0|||
126665165|NCT00992511|455734006|FG002|Overall Study|Migrated/moved from study area|1|||
126665166|NCT00992511|455734007|FG003|Overall Study|Migrated/moved from study area|2|||
126331674|NCT00379899|454508906|FG001|Overall Study|Death|10|||
126331675|NCT00379899|454508905|FG000|Overall Study|Lost to Follow-up|2|||
126331676|NCT00379899|454508906|FG001|Overall Study|Lost to Follow-up|4|||
126331677|NCT00379899|454508905|FG000|Overall Study|Physician Decision|3|||
126331678|NCT00379899|454508906|FG001|Overall Study|Physician Decision|4|||
126331679|NCT00379899|454508905|FG000|Overall Study|Withdrawal by Subject|5|||
126331680|NCT00379899|454508906|FG001|Overall Study|Withdrawal by Subject|5|||
126331681|NCT00379899|454508905|FG000|Overall Study|Ineligibility determined|0|||
126331682|NCT00379899|454508906|FG001|Overall Study|Ineligibility determined|1|||
126331683|NCT00379899|454508905|FG000|Overall Study|Noncompliance|1|||
126331684|NCT00379899|454508906|FG001|Overall Study|Noncompliance|1|||
126331685|NCT00379899|454508905|FG000|Overall Study|Parathyroidectomy|0|||
126331686|NCT00379899|454508906|FG001|Overall Study|Parathyroidectomy|2|||
126331687|NCT00379899|454508905|FG000|Overall Study|Renal transplantation|5|||
126331688|NCT00379899|454508906|FG001|Overall Study|Renal transplantation|4|||
126331689|NCT00379899|454508905|FG000|Overall Study|Coronary artery bypass graft|1|||
126331690|NCT00379899|454508906|FG001|Overall Study|Coronary artery bypass graft|1|||
126331691|NCT00379899|454508905|FG000|Overall Study|Other protocol-specified criteria|3|||
126331692|NCT00379899|454508906|FG001|Overall Study|Other protocol-specified criteria|4|||
126331693|NCT00379899|454508905|FG000|Overall Study|Other|3|||
126331694|NCT00379899|454508906|FG001|Overall Study|Other|1|||
126331695|NCT05225389|454508909|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
126331696|NCT03804268|454508910|FG000|Overall Study|Adverse Event|2|||
126331697|NCT03804268|454508911|FG001|Overall Study|Adverse Event|2|||
126331698|NCT03804268|454508910|FG000|Overall Study|Withdrawal by Subject|2|||
126331699|NCT03804268|454508911|FG001|Overall Study|Withdrawal by Subject|0|||
126331700|NCT03804268|454508910|FG000|Overall Study|Lost to Follow-up|1|||
126331701|NCT03804268|454508911|FG001|Overall Study|Lost to Follow-up|0|||
126331702|NCT03804268|454508910|FG000|Overall Study|Physician Decision|2|||
126331703|NCT03804268|454508911|FG001|Overall Study|Physician Decision|0|||
126331704|NCT02716779|454508912|FG000|Monotherapy|Adverse Event|0|||
126331705|NCT02716779|454508913|FG001|Monotherapy|Adverse Event|1|||
126331706|NCT02716779|454508914|FG002|Monotherapy|Adverse Event|1|||
126331707|NCT02716779|454508912|FG000|Combination Therapy|Adverse Event|0|||
126331708|NCT02716779|454508913|FG001|Combination Therapy|Adverse Event|2|||
126331709|NCT02716779|454508914|FG002|Combination Therapy|Adverse Event|1|||
126331710|NCT01843803|454508917|FG000|Overall Study|not a Veteran, did not see provider|1|||
126331711|NCT01843803|454508918|FG001|Overall Study|not a Veteran, did not see provider|3|||
126331712|NCT03311841|454508919|FG000|14-day Wash-out|Adverse Event|0|||
126331713|NCT03311841|454508920|FG001|14-day Wash-out|Adverse Event|1|||
126331714|NCT03311841|454508921|FG002|14-day Wash-out|Adverse Event|0|||
126331715|NCT03311841|454508922|FG003|14-day Wash-out|Adverse Event|0|||
126665167|NCT00992511|455734004|FG000|Overall Study|Lost to Follow-up|1|||
126331716|NCT03311841|454508923|FG004|14-day Wash-out|Adverse Event|0|||
126331717|NCT03311841|454508919|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
126331718|NCT03311841|454508920|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
126331719|NCT03311841|454508921|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
126331720|NCT03311841|454508922|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
126331721|NCT03311841|454508923|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
126331722|NCT01051817|454508931|FG000|Overall Study|Adverse Event|0|||
126665168|NCT00992511|455734005|FG001|Overall Study|Lost to Follow-up|0|||
126665169|NCT00992511|455734006|FG002|Overall Study|Lost to Follow-up|0|||
126665170|NCT00992511|455734007|FG003|Overall Study|Lost to Follow-up|2|||
126665171|NCT00992511|455734004|FG000|Overall Study|Withdrawal by Subject|0|||
126665172|NCT00992511|455734005|FG001|Overall Study|Withdrawal by Subject|0|||
126665173|NCT00992511|455734006|FG002|Overall Study|Withdrawal by Subject|1|||
126665174|NCT00992511|455734007|FG003|Overall Study|Withdrawal by Subject|1|||
126665175|NCT04498169|455734008|FG000|Study Completion|Adverse Event|1|||
126331723|NCT01051817|454508932|FG001|Overall Study|Adverse Event|2|||
126331724|NCT01051817|454508931|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
126331725|NCT01051817|454508932|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
126665176|NCT04498169|455734009|FG001|Study Completion|Adverse Event|1|||
126665177|NCT04615247|455734010|FG000|Overall Study|Adverse Event|0|||
126665178|NCT04615247|455734011|FG001|Overall Study|Adverse Event|2|||
126665179|NCT04615247|455734010|FG000|Overall Study|Withdrawal by Subject|1|||
126665180|NCT04615247|455734011|FG001|Overall Study|Withdrawal by Subject|1|||
126665181|NCT02596620|455734016|FG000|Overall Study|Lost to Follow-up|1|||
126665182|NCT02596620|455734017|FG001|Overall Study|Lost to Follow-up|1|||
126665183|NCT02993523|455734018|FG000|Overall Study|Withdrew Consent|0|||
126665184|NCT02993523|455734019|FG001|Overall Study|Withdrew Consent|0|||
126665185|NCT02993523|455734020|FG002|Overall Study|Withdrew Consent|2|||
126665186|NCT02993523|455734021|FG003|Overall Study|Withdrew Consent|9|||
126665187|NCT02993523|455734022|FG004|Overall Study|Withdrew Consent|0|||
126665188|NCT02993523|455734018|FG000|Overall Study|Lost to Follow-up|0|||
126665189|NCT02993523|455734019|FG001|Overall Study|Lost to Follow-up|0|||
126665190|NCT02993523|455734020|FG002|Overall Study|Lost to Follow-up|3|||
126665191|NCT02993523|455734021|FG003|Overall Study|Lost to Follow-up|6|||
126665192|NCT02993523|455734022|FG004|Overall Study|Lost to Follow-up|0|||
126331726|NCT01051817|454508931|FG000|Overall Study|Withdrawal by Subject|3|||
126331727|NCT01051817|454508932|FG001|Overall Study|Withdrawal by Subject|5|||
126331728|NCT01051817|454508931|FG000|Overall Study|Protocol Violation|0|||
126331729|NCT01051817|454508932|FG001|Overall Study|Protocol Violation|1|||
126331730|NCT01026948|454508933|FG000|Overall Study|Physician Decision|8|||
126331731|NCT00753675|454508938|FG000|Overall Study|other reason|11|||
126331732|NCT00753675|454508939|FG001|Overall Study|other reason|12|||
126331733|NCT00753675|454508940|FG002|Overall Study|other reason|13|||
126331734|NCT00753675|454508938|FG000|Overall Study|Death|1|||
126331735|NCT00753675|454508939|FG001|Overall Study|Death|2|||
126331736|NCT00753675|454508940|FG002|Overall Study|Death|4|||
126331737|NCT00753675|454508938|FG000|Overall Study|Adverse Event|11|||
126331738|NCT00753675|454508939|FG001|Overall Study|Adverse Event|9|||
126331739|NCT00753675|454508940|FG002|Overall Study|Adverse Event|4|||
126331740|NCT00753675|454508938|FG000|Overall Study|Objective progression of disease|35|||
126331741|NCT00753675|454508939|FG001|Overall Study|Objective progression of disease|35|||
126331742|NCT00753675|454508940|FG002|Overall Study|Objective progression of disease|35|||
126331743|NCT00753675|454508938|FG000|Overall Study|Withdrawal by Subject|0|||
126331744|NCT00753675|454508939|FG001|Overall Study|Withdrawal by Subject|1|||
126331745|NCT00753675|454508940|FG002|Overall Study|Withdrawal by Subject|0|||
126331746|NCT00753675|454508938|FG000|Overall Study|Lost to Follow-up|1|||
126331747|NCT00753675|454508939|FG001|Overall Study|Lost to Follow-up|0|||
126331748|NCT00753675|454508940|FG002|Overall Study|Lost to Follow-up|0|||
126331749|NCT02686164|454508941|FG000|Overall Study|Adverse Event|1|||
126331750|NCT02686164|454508941|FG000|Overall Study|Withdrawal of consent|1|||
126331751|NCT02686164|454508941|FG000|Overall Study|Clinical progression|1|||
126331752|NCT02824627|454508944|FG000|Overall Study|Adverse Event|1|||
126331753|NCT02824627|454508945|FG001|Overall Study|Adverse Event|2|||
126331754|NCT02824627|454508944|FG000|Overall Study|Lost to Follow-up|2|||
126331755|NCT02824627|454508945|FG001|Overall Study|Lost to Follow-up|1|||
126331756|NCT00672633|454508946|FG000|Overall Study|Withdrawal by Subject|0|||
126331757|NCT00672633|454508947|FG001|Overall Study|Withdrawal by Subject|1|||
126331758|NCT00571662|454508959|FG000|Overall Study|Withdrawal by Subject|2|||
126331759|NCT00571662|454508959|FG000|Overall Study|psychiatric instability|1|||
126331760|NCT00571662|454508959|FG000|Overall Study|Adverse Event|5|||
126331761|NCT01839916|454508960|FG000|Overall Study|Death|9|||
126665193|NCT02993523|455734018|FG000|Overall Study|Death|1|||
126331762|NCT01839916|454508960|FG000|Overall Study|Physician Decision|17|||
126331763|NCT01839916|454508960|FG000|Overall Study|Relapse|12|||
126331764|NCT01839916|454508960|FG000|Overall Study|GVHD|2|||
126331765|NCT01839916|454508960|FG000|Overall Study|Graft Failure|1|||
126331766|NCT04235504|454508965|FG000|Study Phase|Withdrawal by Subject|5|||
126331767|NCT04235504|454508966|FG001|Study Phase|Withdrawal by Subject|2|||
126331768|NCT04235504|454508967|FG002|Study Phase|Withdrawal by Subject|0|||
126331769|NCT04235504|454508968|FG003|Study Phase|Withdrawal by Subject|0|||
126331770|NCT04235504|454508965|FG000|Continuation Phase|Withdrawal by Subject|0|||
126665194|NCT02993523|455734019|FG001|Overall Study|Death|1|||
126665195|NCT02993523|455734020|FG002|Overall Study|Death|138|||
126665196|NCT02993523|455734021|FG003|Overall Study|Death|222|||
126665197|NCT02993523|455734022|FG004|Overall Study|Death|6|||
126665198|NCT02993523|455734018|FG000|Overall Study|Reason not Specified|0|||
126665199|NCT02993523|455734019|FG001|Overall Study|Reason not Specified|0|||
126331771|NCT04235504|454508966|FG001|Continuation Phase|Withdrawal by Subject|4|||
126331772|NCT04235504|454508967|FG002|Continuation Phase|Withdrawal by Subject|0|||
126331773|NCT04235504|454508968|FG003|Continuation Phase|Withdrawal by Subject|0|||
126331774|NCT04235504|454508965|FG000|Continuation Phase|Adverse Event|0|||
126331775|NCT04235504|454508966|FG001|Continuation Phase|Adverse Event|1|||
126331776|NCT04235504|454508967|FG002|Continuation Phase|Adverse Event|0|||
126331777|NCT04235504|454508968|FG003|Continuation Phase|Adverse Event|0|||
126331778|NCT04235504|454508965|FG000|Continuation Phase|Physician Decision|1|||
126331779|NCT04235504|454508966|FG001|Continuation Phase|Physician Decision|2|||
126331780|NCT04235504|454508967|FG002|Continuation Phase|Physician Decision|1|||
126331781|NCT04235504|454508968|FG003|Continuation Phase|Physician Decision|0|||
126331782|NCT00181883|454508976|FG000|Overall Study|Lack of Efficacy|2|||
126331783|NCT00181883|454508976|FG000|Overall Study|Treatment Limiting AEs|3|||
126331784|NCT00181883|454508976|FG000|Overall Study|Withdrawal by Subject|4|||
126331785|NCT00181883|454508976|FG000|Overall Study|Lost to Follow-up|1|||
126331786|NCT02106351|454508977|FG000|Treatment Cycle 1|Adverse Event|2|||
126331787|NCT02106351|454508978|FG001|Treatment Cycle 1|Adverse Event|0|||
126331788|NCT02106351|454508979|FG002|Treatment Cycle 1|Adverse Event|0|||
126331789|NCT02106351|454508977|FG000|Treatment Cycle 1|Consent withdrawn|1|||
126331790|NCT02106351|454508978|FG001|Treatment Cycle 1|Consent withdrawn|0|||
126331791|NCT02106351|454508979|FG002|Treatment Cycle 1|Consent withdrawn|2|||
126331792|NCT02106351|454508977|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
126331793|NCT02106351|454508978|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
126331794|NCT02106351|454508979|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
126331795|NCT02106351|454508977|FG000|Treatment Cycle 1|Other|0|||
126331796|NCT02106351|454508978|FG001|Treatment Cycle 1|Other|3|||
126331797|NCT02106351|454508979|FG002|Treatment Cycle 1|Other|1|||
126331798|NCT02106351|454508977|FG000|Treatment Cycle 1|Randomised but not treated|1|||
126331799|NCT02106351|454508978|FG001|Treatment Cycle 1|Randomised but not treated|0|||
126331800|NCT02106351|454508979|FG002|Treatment Cycle 1|Randomised but not treated|1|||
126331801|NCT02106351|454508977|FG000|Treatment Cycle 2|Adverse Event|0|||
126331802|NCT02106351|454508978|FG001|Treatment Cycle 2|Adverse Event|2|||
126331803|NCT02106351|454508979|FG002|Treatment Cycle 2|Adverse Event|0|||
126331804|NCT02106351|454508977|FG000|Treatment Cycle 2|Consent withdrawn|0|||
126331805|NCT02106351|454508978|FG001|Treatment Cycle 2|Consent withdrawn|1|||
126331806|NCT02106351|454508979|FG002|Treatment Cycle 2|Consent withdrawn|1|||
126331807|NCT02106351|454508977|FG000|Treatment Cycle 2|Other|0|||
126331808|NCT02106351|454508978|FG001|Treatment Cycle 2|Other|2|||
126331809|NCT02106351|454508979|FG002|Treatment Cycle 2|Other|2|||
126331810|NCT02106351|454508977|FG000|Treatment Cycle 3|Adverse Event|0|||
126331811|NCT02106351|454508978|FG001|Treatment Cycle 3|Adverse Event|1|||
126331812|NCT02106351|454508979|FG002|Treatment Cycle 3|Adverse Event|0|||
126331813|NCT02106351|454508977|FG000|Treatment Cycle 3|Consent withdrawn|0|||
126331814|NCT02106351|454508978|FG001|Treatment Cycle 3|Consent withdrawn|0|||
126331815|NCT02106351|454508979|FG002|Treatment Cycle 3|Consent withdrawn|2|||
126331816|NCT02106351|454508977|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
126331817|NCT02106351|454508978|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
126331818|NCT02106351|454508979|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
126331819|NCT02106351|454508977|FG000|Treatment Cycle 3|Other|0|||
126331820|NCT02106351|454508978|FG001|Treatment Cycle 3|Other|2|||
126331821|NCT02106351|454508979|FG002|Treatment Cycle 3|Other|3|||
126331822|NCT02106351|454508977|FG000|Treatment Cycle 4|Consent withdrawn|0|||
126331823|NCT02106351|454508978|FG001|Treatment Cycle 4|Consent withdrawn|0|||
126331824|NCT02106351|454508979|FG002|Treatment Cycle 4|Consent withdrawn|2|||
126331825|NCT02106351|454508977|FG000|Treatment Cycle 4|Other|0|||
126331826|NCT02106351|454508978|FG001|Treatment Cycle 4|Other|1|||
126665200|NCT02993523|455734020|FG002|Overall Study|Reason not Specified|1|||
126665201|NCT02993523|455734021|FG003|Overall Study|Reason not Specified|1|||
126665202|NCT02993523|455734022|FG004|Overall Study|Reason not Specified|0|||
126665203|NCT03694418|455734023|FG000|Overall Study|Lost to Follow-up|115|||
126665204|NCT03694418|455734024|FG001|Overall Study|Lost to Follow-up|23|||
126665205|NCT03694418|455734025|FG002|Overall Study|Lost to Follow-up|12|||
126331827|NCT02106351|454508979|FG002|Treatment Cycle 4|Other|0|||
126331828|NCT00101868|454508980|FG000|Overall Study|Death|10|||
126331829|NCT00101868|454508981|FG001|Overall Study|Death|10|||
126331830|NCT00101868|454508980|FG000|Overall Study|Withdrawal by Subject|8|||
126665206|NCT03694418|455734026|FG003|Overall Study|Lost to Follow-up|12|||
126331831|NCT00101868|454508981|FG001|Overall Study|Withdrawal by Subject|9|||
126331832|NCT00101868|454508980|FG000|Overall Study|Protocol Violation|3|||
126331833|NCT00101868|454508981|FG001|Overall Study|Protocol Violation|0|||
126331834|NCT00101868|454508980|FG000|Overall Study|Lost to Follow-up|8|||
126331835|NCT00101868|454508981|FG001|Overall Study|Lost to Follow-up|13|||
126331836|NCT00069823|454508982|FG000|Overall Study|Did not have follow-up diary cards|6|||
126331837|NCT00069823|454508983|FG001|Overall Study|Did not have follow-up diary cards|3|||
126331838|NCT02329327|454508986|FG000|Overall Study|Death|78|||
126331839|NCT02329327|454508987|FG001|Overall Study|Death|0|||
126331840|NCT02329327|454508986|FG000|Overall Study|Withdrawal by Subject|3|||
126665207|NCT03694418|455734027|FG004|Overall Study|Lost to Follow-up|13|||
126331841|NCT02329327|454508987|FG001|Overall Study|Withdrawal by Subject|0|||
126665208|NCT01717768|455734028|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126665209|NCT01717768|455734029|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
126665210|NCT01717768|455734030|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126665211|NCT01717768|455734031|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126665212|NCT01717768|455734032|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126665213|NCT01717768|455734033|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126665214|NCT01717768|455734034|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126665215|NCT01717768|455734035|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126665216|NCT01717768|455734036|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126665217|NCT01717768|455734037|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126665218|NCT01717768|455734038|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126665219|NCT01717768|455734039|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
126665220|NCT01717768|455734028|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126665221|NCT01717768|455734029|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126665222|NCT01717768|455734030|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126665223|NCT01717768|455734031|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126665224|NCT01717768|455734032|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126665225|NCT01717768|455734033|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126665226|NCT01717768|455734034|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126665227|NCT01717768|455734035|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126665228|NCT01717768|455734036|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126665229|NCT01717768|455734037|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126665230|NCT01717768|455734038|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
126665231|NCT01717768|455734039|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
126665232|NCT01717768|455734028|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126665233|NCT01717768|455734029|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126665234|NCT01717768|455734030|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126665235|NCT01717768|455734031|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126665236|NCT01717768|455734032|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126665237|NCT01717768|455734033|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126665238|NCT01717768|455734034|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126665239|NCT01717768|455734035|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
126665240|NCT01717768|455734036|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126665241|NCT01717768|455734037|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126665242|NCT01717768|455734038|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126665243|NCT01717768|455734039|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
126665244|NCT01717768|455734028|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126665245|NCT01717768|455734029|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126665246|NCT01717768|455734030|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126665247|NCT01717768|455734031|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126665248|NCT01717768|455734032|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126665249|NCT01717768|455734033|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126665250|NCT01717768|455734034|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126665251|NCT01717768|455734035|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126665252|NCT01717768|455734036|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126665253|NCT01717768|455734037|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
126665254|NCT01717768|455734038|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126665255|NCT01717768|455734039|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
126665256|NCT01136811|455734044|FG000|Overall Study|Physician Decision|11|||
126665257|NCT01009554|455734045|FG000|Overall Study|Adverse Event|1|||
126665258|NCT01009554|455734046|FG001|Overall Study|Adverse Event|1|||
126665259|NCT01009554|455734045|FG000|Overall Study|Withdrawal by Subject|1|||
126665260|NCT01009554|455734046|FG001|Overall Study|Withdrawal by Subject|3|||
126665261|NCT01009554|455734045|FG000|Overall Study|Noncompliant with Study Product|0|||
126665262|NCT01009554|455734046|FG001|Overall Study|Noncompliant with Study Product|3|||
126665263|NCT01605253|455734047|FG000|Overall Study|Physician Decision|3|||
126665264|NCT01605253|455734048|FG001|Overall Study|Physician Decision|2|||
126665265|NCT01605253|455734047|FG000|Overall Study|Lost to Follow-up|3|||
126665266|NCT01605253|455734048|FG001|Overall Study|Lost to Follow-up|1|||
126665267|NCT05579990|455734063|FG000|Overall Study|Lost to Follow-up|3|||
126665268|NCT05560763|455734065|FG000|Overall Study|Withdrawal by Subject|4|||
126665269|NCT02673619|455734066|FG000|Overall Study|Lost to Follow-up|1|||
126665270|NCT02673619|455734067|FG001|Overall Study|Lost to Follow-up|0|||
126665271|NCT02673619|455734068|FG002|Overall Study|Lost to Follow-up|0|||
126665272|NCT02673619|455734069|FG003|Overall Study|Lost to Follow-up|0|||
126665273|NCT02673619|455734066|FG000|Overall Study|Withdrawal by Subject|1|||
126665274|NCT02673619|455734067|FG001|Overall Study|Withdrawal by Subject|1|||
126331842|NCT02329327|454508986|FG000|Overall Study|Lost to Follow-up|4|||
126331843|NCT02329327|454508987|FG001|Overall Study|Lost to Follow-up|0|||
126331844|NCT03560869|454508988|FG000|Overall Study|Withdrawal by Subject|3|||
126331845|NCT03560869|454508989|FG001|Overall Study|Withdrawal by Subject|4|||
126665275|NCT02673619|455734068|FG002|Overall Study|Withdrawal by Subject|1|||
126665276|NCT02673619|455734069|FG003|Overall Study|Withdrawal by Subject|0|||
126665277|NCT02673619|455734066|FG000|Overall Study|Adverse Event|0|||
126665278|NCT02673619|455734067|FG001|Overall Study|Adverse Event|0|||
126665279|NCT02673619|455734068|FG002|Overall Study|Adverse Event|1|||
126665280|NCT02673619|455734069|FG003|Overall Study|Adverse Event|0|||
126665281|NCT02673619|455734066|FG000|Overall Study|Lack of Efficacy|0|||
126665282|NCT02673619|455734067|FG001|Overall Study|Lack of Efficacy|0|||
126665283|NCT02673619|455734068|FG002|Overall Study|Lack of Efficacy|1|||
126665284|NCT02673619|455734069|FG003|Overall Study|Lack of Efficacy|0|||
126665285|NCT04225806|455734070|FG000|Overall Study|Trial termination|15|||
126665286|NCT02408861|455734073|FG000|Overall Study|Death|0|||
126665287|NCT02408861|455734074|FG001|Overall Study|Death|3|||
126665288|NCT02408861|455734075|FG002|Overall Study|Death|1|||
126665289|NCT02408861|455734076|FG003|Overall Study|Death|2|||
126665290|NCT02408861|455734077|FG004|Overall Study|Death|4|||
126665291|NCT02408861|455734078|FG005|Overall Study|Death|1|||
126665292|NCT02408861|455734079|FG006|Overall Study|Death|0|||
126665293|NCT02408861|455734073|FG000|Overall Study|Lost to Follow-up|0|||
126665294|NCT02408861|455734074|FG001|Overall Study|Lost to Follow-up|0|||
126665295|NCT02408861|455734075|FG002|Overall Study|Lost to Follow-up|1|||
126665296|NCT02408861|455734076|FG003|Overall Study|Lost to Follow-up|1|||
126665297|NCT02408861|455734077|FG004|Overall Study|Lost to Follow-up|4|||
126665298|NCT02408861|455734078|FG005|Overall Study|Lost to Follow-up|2|||
126665299|NCT02408861|455734079|FG006|Overall Study|Lost to Follow-up|1|||
126665300|NCT02408861|455734073|FG000|Overall Study|Disease Progression|0|||
126665301|NCT02408861|455734074|FG001|Overall Study|Disease Progression|0|||
126665302|NCT02408861|455734075|FG002|Overall Study|Disease Progression|1|||
126665303|NCT02408861|455734076|FG003|Overall Study|Disease Progression|0|||
126665304|NCT02408861|455734077|FG004|Overall Study|Disease Progression|3|||
126665305|NCT02408861|455734078|FG005|Overall Study|Disease Progression|1|||
126665306|NCT02408861|455734079|FG006|Overall Study|Disease Progression|1|||
126665307|NCT02408861|455734073|FG000|Overall Study|Adverse Event|1|||
126665308|NCT02408861|455734074|FG001|Overall Study|Adverse Event|0|||
126665309|NCT02408861|455734075|FG002|Overall Study|Adverse Event|1|||
126665310|NCT02408861|455734076|FG003|Overall Study|Adverse Event|0|||
126665311|NCT02408861|455734077|FG004|Overall Study|Adverse Event|2|||
126665312|NCT02408861|455734078|FG005|Overall Study|Adverse Event|0|||
126665313|NCT02408861|455734079|FG006|Overall Study|Adverse Event|0|||
126665314|NCT02408861|455734073|FG000|Overall Study|Physician Decision|1|||
126665315|NCT02408861|455734074|FG001|Overall Study|Physician Decision|1|||
126665316|NCT02408861|455734075|FG002|Overall Study|Physician Decision|1|||
126665317|NCT02408861|455734076|FG003|Overall Study|Physician Decision|0|||
126665318|NCT02408861|455734077|FG004|Overall Study|Physician Decision|0|||
126665319|NCT02408861|455734078|FG005|Overall Study|Physician Decision|1|||
126665320|NCT02408861|455734079|FG006|Overall Study|Physician Decision|0|||
126665321|NCT02408861|455734073|FG000|Overall Study|Protocol Violation|1|||
126665322|NCT02408861|455734074|FG001|Overall Study|Protocol Violation|0|||
126665323|NCT02408861|455734075|FG002|Overall Study|Protocol Violation|0|||
126665324|NCT02408861|455734076|FG003|Overall Study|Protocol Violation|0|||
126665325|NCT02408861|455734077|FG004|Overall Study|Protocol Violation|0|||
126665326|NCT02408861|455734078|FG005|Overall Study|Protocol Violation|0|||
126665327|NCT02408861|455734079|FG006|Overall Study|Protocol Violation|0|||
126665328|NCT02408861|455734073|FG000|Overall Study|Withdrawal by Subject|0|||
126665329|NCT02408861|455734074|FG001|Overall Study|Withdrawal by Subject|0|||
126665330|NCT02408861|455734075|FG002|Overall Study|Withdrawal by Subject|0|||
126665331|NCT02408861|455734076|FG003|Overall Study|Withdrawal by Subject|0|||
126665332|NCT02408861|455734077|FG004|Overall Study|Withdrawal by Subject|1|||
126665333|NCT02408861|455734078|FG005|Overall Study|Withdrawal by Subject|1|||
126665334|NCT02408861|455734079|FG006|Overall Study|Withdrawal by Subject|0|||
126665335|NCT02408861|455734073|FG000|Overall Study|Other Treatment|0|||
126665336|NCT02408861|455734074|FG001|Overall Study|Other Treatment|0|||
126665337|NCT02408861|455734075|FG002|Overall Study|Other Treatment|0|||
126665338|NCT02408861|455734076|FG003|Overall Study|Other Treatment|0|||
126665339|NCT02408861|455734077|FG004|Overall Study|Other Treatment|0|||
126665340|NCT02408861|455734078|FG005|Overall Study|Other Treatment|1|||
126665341|NCT02408861|455734079|FG006|Overall Study|Other Treatment|1|||
126665342|NCT03756350|455735533|FG000|Overall Study|Lost to Follow-up|1|||
126331846|NCT03560869|454508988|FG000|Overall Study|Screening failure|4|||
126665343|NCT01096342|455735535|FG000|Overall Study|Protocol Violation|1|||
126665344|NCT03434353|455735536|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
126665345|NCT03434353|455735537|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
126665346|NCT03434353|455735538|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
126665347|NCT03434353|455735539|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
126665348|NCT03434353|455735540|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
126665349|NCT03434353|455735536|FG000|Overall Study|Withdrew consent|1|||
126665350|NCT03434353|455735537|FG001|Overall Study|Withdrew consent|0|||
126665351|NCT03434353|455735538|FG002|Overall Study|Withdrew consent|3|||
126665352|NCT03434353|455735539|FG003|Overall Study|Withdrew consent|0|||
126665353|NCT03434353|455735540|FG004|Overall Study|Withdrew consent|0|||
126665354|NCT03434353|455735536|FG000|Overall Study|Adverse Event|1|||
126665355|NCT03434353|455735537|FG001|Overall Study|Adverse Event|0|||
126665356|NCT03434353|455735538|FG002|Overall Study|Adverse Event|0|||
126665357|NCT03434353|455735539|FG003|Overall Study|Adverse Event|0|||
126665358|NCT03434353|455735540|FG004|Overall Study|Adverse Event|1|||
126665359|NCT03434353|455735536|FG000|Overall Study|Lost to Follow-up|2|||
126665360|NCT03434353|455735537|FG001|Overall Study|Lost to Follow-up|0|||
126665361|NCT03434353|455735538|FG002|Overall Study|Lost to Follow-up|0|||
126665362|NCT03434353|455735539|FG003|Overall Study|Lost to Follow-up|0|||
126665363|NCT03434353|455735540|FG004|Overall Study|Lost to Follow-up|0|||
126665364|NCT04906616|455735541|FG000|Overall Study|Divorce|3|||
126665365|NCT04906616|455735542|FG001|Overall Study|Divorce|2|||
126665366|NCT02464228|455735543|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
126665367|NCT02464228|455735544|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
126665368|NCT02464228|455735545|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
126665369|NCT02464228|455735546|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
126665370|NCT02464228|455735543|FG000|Overall Study|Physician Decision|2|||
126665371|NCT02464228|455735544|FG001|Overall Study|Physician Decision|0|||
126665372|NCT02464228|455735545|FG002|Overall Study|Physician Decision|1|||
126665373|NCT02464228|455735546|FG003|Overall Study|Physician Decision|0|||
126665374|NCT02464228|455735543|FG000|Overall Study|Miscellaneous|1|||
126665375|NCT02464228|455735544|FG001|Overall Study|Miscellaneous|0|||
126665376|NCT02464228|455735545|FG002|Overall Study|Miscellaneous|1|||
126665377|NCT02464228|455735546|FG003|Overall Study|Miscellaneous|0|||
126665378|NCT02464228|455735543|FG000|Overall Study|Adverse Event|9|||
126665379|NCT02464228|455735544|FG001|Overall Study|Adverse Event|0|||
126665380|NCT02464228|455735545|FG002|Overall Study|Adverse Event|3|||
126665381|NCT02464228|455735546|FG003|Overall Study|Adverse Event|0|||
126665382|NCT02464228|455735543|FG000|Overall Study|Withdrawal by Subject|1|||
126665383|NCT02464228|455735544|FG001|Overall Study|Withdrawal by Subject|1|||
126665384|NCT02464228|455735545|FG002|Overall Study|Withdrawal by Subject|1|||
126665385|NCT02464228|455735546|FG003|Overall Study|Withdrawal by Subject|0|||
126665386|NCT02464228|455735543|FG000|Overall Study|Disease Progression|22|||
126665387|NCT02464228|455735544|FG001|Overall Study|Disease Progression|12|||
126665388|NCT02464228|455735545|FG002|Overall Study|Disease Progression|5|||
126665389|NCT02464228|455735546|FG003|Overall Study|Disease Progression|2|||
126665390|NCT01990534|455735547|FG000|Overall Study|Death|22|||
126665391|NCT01990534|455735547|FG000|Overall Study|Progressive disease|3|||
126665392|NCT01990534|455735547|FG000|Overall Study|Protocol Violation|1|||
126665393|NCT01990534|455735547|FG000|Overall Study|Withdrawal of Informed Consent|2|||
126665394|NCT01990534|455735547|FG000|Overall Study|Symptomatic Deterioration|1|||
126665395|NCT01990534|455735547|FG000|Overall Study|Withdrawal by Subject|3|||
126665396|NCT01990534|455735547|FG000|Overall Study|Reason not Specified|2|||
126665397|NCT01990534|455735547|FG000|Overall Study|Lost to Follow-up|1|||
126665398|NCT00234494|455735548|FG000|Overall Study|Protocol Violation|2|||
126665399|NCT01521897|455735555|FG000|Overall Study|Protocol Violation|18|||
126665400|NCT01521897|455735555|FG000|Overall Study|Lost to Follow-up|5|||
126665401|NCT02194062|455735562|FG000|Overall Study|Lost to Follow-up|2|||
126665402|NCT02194062|455735563|FG001|Overall Study|Lost to Follow-up|2|||
126665403|NCT02194062|455735564|FG002|Overall Study|Lost to Follow-up|5|||
126665404|NCT02276872|455735565|FG000|Overall Study|Adverse Event|1|||
126665405|NCT02276872|455735566|FG001|Overall Study|Adverse Event|0|||
126665406|NCT02276872|455735567|FG002|Overall Study|Adverse Event|0|||
126665407|NCT00448435|455735569|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
126665408|NCT00448435|455735570|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
126331847|NCT03560869|454508989|FG001|Overall Study|Screening failure|4|||
126331848|NCT03560869|454508988|FG000|Overall Study|Withdrawal by PI|0|||
126331849|NCT03560869|454508989|FG001|Overall Study|Withdrawal by PI|1|||
126331850|NCT01801111|454508990|FG000|Overall Study|Adverse Event|12|||
126665409|NCT01387230|455735571|FG000|Overall Study|Adverse Event|0|||
126665410|NCT01387230|455735572|FG001|Overall Study|Adverse Event|1|||
126665411|NCT01387230|455735573|FG002|Overall Study|Adverse Event|3|||
126665412|NCT01387230|455735571|FG000|Overall Study|Lack of Efficacy|8|||
126665413|NCT01387230|455735572|FG001|Overall Study|Lack of Efficacy|5|||
126665414|NCT01387230|455735573|FG002|Overall Study|Lack of Efficacy|4|||
126331851|NCT01801111|454508990|FG000|Overall Study|Death|8|||
126331852|NCT01801111|454508990|FG000|Overall Study|Physician Decision|5|||
126665415|NCT01387230|455735571|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
126665416|NCT01387230|455735572|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
126665417|NCT01387230|455735573|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
126665418|NCT01387230|455735571|FG000|Overall Study|Lost to Follow-up|0|||
126665419|NCT01387230|455735572|FG001|Overall Study|Lost to Follow-up|0|||
126665420|NCT01387230|455735573|FG002|Overall Study|Lost to Follow-up|1|||
126665421|NCT01387230|455735571|FG000|Overall Study|Withdrawal by Subject|4|||
126331853|NCT01801111|454508990|FG000|Overall Study|Other|1|||
126331854|NCT01801111|454508990|FG000|Overall Study|Withdrawal by Subject|4|||
126331855|NCT01801111|454508990|FG000|Overall Study|Study Terminated by Sponsor|27|||
126331856|NCT01801111|454508990|FG000|Overall Study|Progressive Disease|81|||
126331857|NCT01210482|454508991|FG000|Overall Study|Protocol Violation|1|||
126331858|NCT01210482|454508991|FG000|Overall Study|Case Report Forms were not collected|18|||
126331859|NCT01210482|454508991|FG000|Overall Study|Duplicated|2|||
126331860|NCT01210482|454508991|FG000|Overall Study|No Drug Administration|28|||
126331861|NCT01223937|454508992|FG000|Overall Study|Withdrawal by Subject|3|||
126331862|NCT01223937|454508993|FG001|Overall Study|Withdrawal by Subject|2|||
126331863|NCT01223937|454508992|FG000|Overall Study|Lost to Follow-up|1|||
126331864|NCT01223937|454508993|FG001|Overall Study|Lost to Follow-up|4|||
126331865|NCT01223937|454508992|FG000|Overall Study|Adverse Event|1|||
126331866|NCT01223937|454508993|FG001|Overall Study|Adverse Event|4|||
126331867|NCT01223937|454508992|FG000|Overall Study|Protocol Violation|8|||
126331868|NCT01223937|454508993|FG001|Overall Study|Protocol Violation|7|||
126331869|NCT01223937|454508992|FG000|Overall Study|Other|4|||
126331870|NCT01223937|454508993|FG001|Overall Study|Other|1|||
126331871|NCT03284853|454508995|FG000|Overall Study|Adverse Event|40|||
126331872|NCT03284853|454508996|FG001|Overall Study|Adverse Event|4|||
126331873|NCT03284853|454508995|FG000|Overall Study|Withdrawal by Subject|5|||
126331874|NCT03284853|454508996|FG001|Overall Study|Withdrawal by Subject|1|||
126331875|NCT03284853|454508995|FG000|Overall Study|Lost to Follow-up|1|||
126331876|NCT03284853|454508996|FG001|Overall Study|Lost to Follow-up|0|||
126331877|NCT03284853|454508995|FG000|Overall Study|Lack of Efficacy|1|||
126331878|NCT03284853|454508996|FG001|Overall Study|Lack of Efficacy|0|||
126331879|NCT03284853|454508995|FG000|Overall Study|Disallowed Concurrent Medication|1|||
126331880|NCT03284853|454508996|FG001|Overall Study|Disallowed Concurrent Medication|1|||
126331881|NCT03284853|454508995|FG000|Overall Study|Protocol Violation|3|||
126331882|NCT03284853|454508996|FG001|Overall Study|Protocol Violation|3|||
126331883|NCT03284853|454508995|FG000|Overall Study|Death|0|||
126331884|NCT03284853|454508996|FG001|Overall Study|Death|1|||
126331885|NCT03284853|454508995|FG000|Overall Study|Other - Reason not reported in CSR|4|||
126331886|NCT03284853|454508996|FG001|Overall Study|Other - Reason not reported in CSR|3|||
126331887|NCT00255164|454508998|FG000|Overall Study|Adverse Event|10|||
126331888|NCT00255164|454508999|FG001|Overall Study|Adverse Event|6|||
126331889|NCT00255164|454509000|FG002|Overall Study|Adverse Event|9|||
126331890|NCT00255164|454508998|FG000|Overall Study|Lost to Follow-up|4|||
126331891|NCT00255164|454508999|FG001|Overall Study|Lost to Follow-up|3|||
126331892|NCT00255164|454509000|FG002|Overall Study|Lost to Follow-up|4|||
126331893|NCT00255164|454508998|FG000|Overall Study|Withdrawal by Subject|18|||
126331894|NCT00255164|454508999|FG001|Overall Study|Withdrawal by Subject|17|||
126331895|NCT00255164|454509000|FG002|Overall Study|Withdrawal by Subject|8|||
126331896|NCT00255164|454508998|FG000|Overall Study|Noncompliance|0|||
126331897|NCT00255164|454508999|FG001|Overall Study|Noncompliance|1|||
126331898|NCT00255164|454509000|FG002|Overall Study|Noncompliance|2|||
126331899|NCT00255164|454508998|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
126331900|NCT00255164|454508999|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
126665422|NCT01387230|455735572|FG001|Overall Study|Withdrawal by Subject|1|||
126665423|NCT01387230|455735573|FG002|Overall Study|Withdrawal by Subject|0|||
126665424|NCT02066051|455735578|FG000|Overall Study|Subject developed active GVHD|1|||
126665425|NCT03027557|455735582|FG000|Overall Study|Adverse Event|1|||
126665426|NCT03027557|455735583|FG001|Overall Study|Adverse Event|0|||
126665427|NCT03027557|455735584|FG002|Overall Study|Adverse Event|0|||
126665428|NCT01610687|455735585|FG000|Overall Study|Lack of Efficacy|26|||
126665429|NCT01610687|455735585|FG000|Overall Study|Adverse Event|18|||
126665430|NCT01610687|455735585|FG000|Overall Study|Moved out of area|6|||
126665431|NCT01610687|455735585|FG000|Overall Study|Withdrawal by Subject|7|||
126665432|NCT01610687|455735585|FG000|Overall Study|Lost to Follow-up|4|||
126665433|NCT01610687|455735585|FG000|Overall Study|Symptom control without study medication|2|||
126665434|NCT01610687|455735585|FG000|Overall Study|Unable to make journey|1|||
126665435|NCT01610687|455735585|FG000|Overall Study|Death|1|||
126665436|NCT01610687|455735585|FG000|Overall Study|Cannabis affecting job|1|||
126665437|NCT01610687|455735585|FG000|Overall Study|Felt more alter without study medication|1|||
126665438|NCT03836807|455735586|FG000|Overall Study|Physician Decision|1|||
126331901|NCT00255164|454509000|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
126331902|NCT00255164|454508998|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
126331903|NCT00255164|454508999|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
126331904|NCT00255164|454509000|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
126331905|NCT00255164|454508998|FG000|Overall Study|Possible Barrett's Esophagus|1|||
126331906|NCT00255164|454508999|FG001|Overall Study|Possible Barrett's Esophagus|3|||
126331907|NCT00255164|454509000|FG002|Overall Study|Possible Barrett's Esophagus|8|||
126665439|NCT03836807|455735587|FG001|Overall Study|Physician Decision|0|||
126331908|NCT00255164|454508998|FG000|Overall Study|Esophageal Stricture|0|||
126665440|NCT02430051|455735588|FG000|Overall Study|Withdrawal by Subject|6|||
126331909|NCT00255164|454508999|FG001|Overall Study|Esophageal Stricture|0|||
126331910|NCT00255164|454509000|FG002|Overall Study|Esophageal Stricture|1|||
126665441|NCT02430051|455735589|FG001|Overall Study|Withdrawal by Subject|3|||
126665442|NCT02430051|455735588|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
126665443|NCT02430051|455735589|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
126665444|NCT02430051|455735588|FG000|Overall Study|Protocol Violation|1|||
126665445|NCT02430051|455735589|FG001|Overall Study|Protocol Violation|0|||
126665446|NCT01272947|455735590|FG000|Overall Study|Abnormal Laboratory Value|2|||
126665447|NCT01272947|455735591|FG001|Overall Study|Abnormal Laboratory Value|2|||
126665448|NCT02019420|455735593|FG000|Overall Study|Did not receive study drug|2|||
126665449|NCT02019420|455735594|FG001|Overall Study|Did not receive study drug|2|||
126665450|NCT02019420|455735593|FG000|Overall Study|Withdrawal by Subject|1|||
126665451|NCT02019420|455735594|FG001|Overall Study|Withdrawal by Subject|3|||
126665452|NCT02019420|455735593|FG000|Overall Study|At request of sponsor or investigator|0|||
126665453|NCT02019420|455735594|FG001|Overall Study|At request of sponsor or investigator|1|||
126665454|NCT02019420|455735593|FG000|Overall Study|Death|104|||
126665455|NCT02019420|455735594|FG001|Overall Study|Death|99|||
126665456|NCT02019420|455735593|FG000|Overall Study|Transferred to other care facility|1|||
126665457|NCT02019420|455735594|FG001|Overall Study|Transferred to other care facility|1|||
126665458|NCT02510560|455735595|FG000|Overall Study|Discontinued from Treatment|27|||
126665459|NCT02510560|455735596|FG001|Overall Study|Discontinued from Treatment|18|||
126665460|NCT02510560|455735597|FG002|Overall Study|Discontinued from Treatment|19|||
126665461|NCT02510560|455735595|FG000|Overall Study|Other|4|||
126665462|NCT02510560|455735596|FG001|Overall Study|Other|4|||
126665463|NCT02510560|455735597|FG002|Overall Study|Other|3|||
126665464|NCT02554903|455735598|FG000|Overall Study|Death|1|||
126665465|NCT02554903|455735599|FG001|Overall Study|Death|1|||
126665466|NCT02554903|455735598|FG000|Overall Study|Physician Decision|2|||
126665467|NCT02554903|455735599|FG001|Overall Study|Physician Decision|2|||
126665468|NCT02554903|455735598|FG000|Overall Study|Heart Transplant|1|||
126665469|NCT02554903|455735599|FG001|Overall Study|Heart Transplant|2|||
126665470|NCT02742766|455735600|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665471|NCT02742766|455735601|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665472|NCT02742766|455735602|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665473|NCT02742766|455735603|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665474|NCT02742766|455735604|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665475|NCT02742766|455735605|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126331911|NCT00255164|454508998|FG000|Overall Study|Therapeutic Failure|11|||
126331912|NCT00255164|454508999|FG001|Overall Study|Therapeutic Failure|2|||
126331913|NCT00255164|454509000|FG002|Overall Study|Therapeutic Failure|3|||
126331914|NCT00130689|454510825|FG000|Overall Study|Progressive Disease|29|||
126331915|NCT00130689|454510825|FG000|Overall Study|Death|1|||
126331916|NCT00130689|454510825|FG000|Overall Study|Clinical Deterioration|4|||
126331917|NCT00130689|454510825|FG000|Overall Study|Withdrawal by Subject|3|||
126331918|NCT00130689|454510825|FG000|Overall Study|Ineligible|6|||
126331919|NCT01254656|454510826|FG000|Overall Study|Discontinued due to termination of study|40|||
126331920|NCT01254656|454510827|FG001|Overall Study|Discontinued due to termination of study|39|||
126331921|NCT01254656|454510828|FG002|Overall Study|Discontinued due to termination of study|13|||
126331922|NCT01254656|454510826|FG000|Overall Study|Lack of Efficacy|3|||
126331923|NCT01254656|454510827|FG001|Overall Study|Lack of Efficacy|0|||
126331924|NCT01254656|454510828|FG002|Overall Study|Lack of Efficacy|0|||
126331925|NCT01254656|454510826|FG000|Overall Study|Lost to Follow-up|1|||
126331926|NCT01254656|454510827|FG001|Overall Study|Lost to Follow-up|0|||
126331927|NCT01254656|454510828|FG002|Overall Study|Lost to Follow-up|2|||
126331928|NCT01254656|454510826|FG000|Overall Study|Withdrawal by Subject|2|||
126331929|NCT01254656|454510827|FG001|Overall Study|Withdrawal by Subject|2|||
126331930|NCT01254656|454510828|FG002|Overall Study|Withdrawal by Subject|1|||
126331931|NCT01254656|454510826|FG000|Overall Study|Pregnancy|0|||
126331932|NCT01254656|454510827|FG001|Overall Study|Pregnancy|0|||
126331933|NCT01254656|454510828|FG002|Overall Study|Pregnancy|2|||
126331934|NCT01254656|454510826|FG000|Overall Study|Adverse Event|1|||
126331935|NCT01254656|454510827|FG001|Overall Study|Adverse Event|1|||
126331936|NCT01254656|454510828|FG002|Overall Study|Adverse Event|0|||
126331937|NCT01254656|454510826|FG000|Overall Study|Death|0|||
126331938|NCT01254656|454510827|FG001|Overall Study|Death|1|||
126331939|NCT01254656|454510828|FG002|Overall Study|Death|0|||
126331940|NCT03286218|454510838|FG000|Qualification Phase Period 1|Adverse Event|1|||
126331941|NCT03286218|454510839|FG001|Qualification Phase Period 1|Adverse Event|0|||
126331942|NCT03286218|454510840|FG002|Qualification Phase Period 1|Adverse Event|0|||
126331943|NCT03286218|454510841|FG003|Qualification Phase Period 1|Adverse Event|0|||
126331944|NCT03286218|454510842|FG004|Qualification Phase Period 1|Adverse Event|0|||
126331945|NCT03286218|454510843|FG005|Qualification Phase Period 1|Adverse Event|0|||
126331946|NCT03286218|454510844|FG006|Qualification Phase Period 1|Adverse Event|0|||
126665476|NCT02742766|455735606|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665477|NCT02742766|455735607|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665478|NCT02742766|455735608|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665479|NCT02742766|455735609|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665480|NCT02742766|455735610|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126331947|NCT03286218|454510845|FG007|Qualification Phase Period 1|Adverse Event|0|||
126665481|NCT02742766|455735611|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665482|NCT02742766|455735612|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665483|NCT02742766|455735613|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
126665484|NCT02742766|455735614|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126331948|NCT03286218|454510846|FG008|Qualification Phase Period 1|Adverse Event|0|||
126331949|NCT03286218|454510847|FG009|Qualification Phase Period 1|Adverse Event|0|||
126331950|NCT03286218|454510848|FG010|Qualification Phase Period 1|Adverse Event|0|||
126331951|NCT03286218|454510849|FG011|Qualification Phase Period 1|Adverse Event|0|||
126331952|NCT03286218|454510838|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331953|NCT03286218|454510839|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
126331954|NCT03286218|454510840|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331955|NCT03286218|454510841|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331956|NCT03286218|454510842|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331957|NCT03286218|454510843|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331958|NCT03286218|454510844|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331959|NCT03286218|454510845|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331960|NCT03286218|454510846|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331961|NCT03286218|454510847|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331962|NCT03286218|454510848|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331963|NCT03286218|454510849|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
126331964|NCT03286218|454510838|FG000|Qualification Phase Period 2|Adverse Event|0|||
126331965|NCT03286218|454510839|FG001|Qualification Phase Period 2|Adverse Event|1|||
126331966|NCT03286218|454510840|FG002|Qualification Phase Period 2|Adverse Event|0|||
126331967|NCT03286218|454510841|FG003|Qualification Phase Period 2|Adverse Event|0|||
126331968|NCT03286218|454510842|FG004|Qualification Phase Period 2|Adverse Event|0|||
126331969|NCT03286218|454510843|FG005|Qualification Phase Period 2|Adverse Event|0|||
126331970|NCT03286218|454510844|FG006|Qualification Phase Period 2|Adverse Event|0|||
126331971|NCT03286218|454510845|FG007|Qualification Phase Period 2|Adverse Event|0|||
126331972|NCT03286218|454510846|FG008|Qualification Phase Period 2|Adverse Event|0|||
126331973|NCT03286218|454510847|FG009|Qualification Phase Period 2|Adverse Event|0|||
126665485|NCT02742766|455735615|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665486|NCT02742766|455735616|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665487|NCT02742766|455735617|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665488|NCT02742766|455735618|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
126665489|NCT02742766|455735600|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665490|NCT02742766|455735601|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665491|NCT02742766|455735602|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665492|NCT02742766|455735603|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665493|NCT02742766|455735604|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665494|NCT02742766|455735605|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665495|NCT02742766|455735606|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665496|NCT02742766|455735607|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665497|NCT02742766|455735608|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665498|NCT02742766|455735609|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665499|NCT02742766|455735610|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665500|NCT02742766|455735611|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665501|NCT02742766|455735612|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
126665502|NCT02742766|455735613|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
126665503|NCT02742766|455735614|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665504|NCT02742766|455735615|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
126665505|NCT02742766|455735616|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665506|NCT02742766|455735617|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665507|NCT02742766|455735618|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
126665508|NCT04936841|455735621|FG000|Overall Study|Death|1|||
126665509|NCT01395316|455735624|FG000|Overall Study|Lost to Follow-up|2|||
126665510|NCT01395316|455735624|FG000|Overall Study|poor MRI quality|1|||
126665511|NCT03359590|455735626|FG000|First Intervention|Withdrawal by Subject|1|||
126665512|NCT03359590|455735627|FG001|First Intervention|Withdrawal by Subject|1|||
126665513|NCT03359590|455735626|FG000|First Intervention|Protocol Violation|0|||
126665514|NCT03359590|455735627|FG001|First Intervention|Protocol Violation|1|||
126665515|NCT02846532|455735628|FG000|Overall Study|Lost to Follow-up|0|||
126665516|NCT02846532|455735629|FG001|Overall Study|Lost to Follow-up|1|||
126331974|NCT03286218|454510848|FG010|Qualification Phase Period 2|Adverse Event|0|||
126331975|NCT03286218|454510849|FG011|Qualification Phase Period 2|Adverse Event|0|||
126331976|NCT03286218|454510838|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
126331977|NCT03286218|454510839|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
126665517|NCT02846532|455735630|FG002|Overall Study|Lost to Follow-up|1|||
126665518|NCT02846532|455735628|FG000|Overall Study|Withdrawal by Subject|1|||
126665519|NCT02846532|455735629|FG001|Overall Study|Withdrawal by Subject|2|||
126665520|NCT02846532|455735630|FG002|Overall Study|Withdrawal by Subject|0|||
126665521|NCT03951220|455735631|FG000|Overall Study|Withdrawal by Subject|9|||
126665522|NCT03951220|455735632|FG001|Overall Study|Withdrawal by Subject|2|||
126665523|NCT03951220|455735633|FG002|Overall Study|Withdrawal by Subject|0|||
126665524|NCT06132425|455735634|FG000|Overall Study|Withdrawal by Subject|3|||
126665525|NCT06132425|455735635|FG001|Overall Study|Withdrawal by Subject|0|||
126665526|NCT06132425|455735634|FG000|Overall Study|Did not follow study instructions|0|||
126665527|NCT06132425|455735635|FG001|Overall Study|Did not follow study instructions|2|||
126665528|NCT06132425|455735634|FG000|Overall Study|Lost to Follow-up|3|||
126665529|NCT06132425|455735635|FG001|Overall Study|Lost to Follow-up|5|||
126665530|NCT01019980|455735637|FG000|Overall Study|Drug not available.|2|||
126665531|NCT01019980|455735638|FG001|Overall Study|Drug not available.|0|||
126331978|NCT03286218|454510840|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331979|NCT03286218|454510841|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331980|NCT03286218|454510842|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331981|NCT03286218|454510843|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331982|NCT03286218|454510844|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331983|NCT03286218|454510845|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331984|NCT03286218|454510846|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331985|NCT03286218|454510847|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331986|NCT03286218|454510848|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331987|NCT03286218|454510849|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
126331988|NCT03286218|454510838|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
126331989|NCT03286218|454510839|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
126331990|NCT03286218|454510840|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
126331991|NCT03286218|454510841|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
126331992|NCT03286218|454510842|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
126331993|NCT03286218|454510843|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
126331994|NCT03286218|454510844|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
126331995|NCT03286218|454510845|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
126331996|NCT03286218|454510846|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
126665532|NCT02038920|455735639|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
126665533|NCT02038920|455735640|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
126665534|NCT02038920|455735641|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
126665535|NCT02038920|455735642|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
126665536|NCT02038920|455735643|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
126665537|NCT02038920|455735644|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
126665538|NCT02038920|455735639|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
126665539|NCT02038920|455735640|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
126665540|NCT02038920|455735641|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
126665541|NCT02038920|455735642|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
126665542|NCT02038920|455735643|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
126665543|NCT02038920|455735644|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
126665544|NCT02038920|455735639|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
126665545|NCT02038920|455735640|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
126665546|NCT02038920|455735641|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
126665547|NCT02038920|455735642|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
126665548|NCT02038920|455735643|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
126665549|NCT02038920|455735644|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
126665550|NCT02038920|455735639|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
126665551|NCT02038920|455735640|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
126665552|NCT02038920|455735641|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
126665553|NCT02038920|455735642|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
126665554|NCT02038920|455735643|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
126665555|NCT02038920|455735644|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
126665556|NCT02038920|455735639|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
126665557|NCT02038920|455735640|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
126665558|NCT02038920|455735641|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
126665559|NCT02038920|455735642|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
126665560|NCT02038920|455735643|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
126331997|NCT03286218|454510847|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
126331998|NCT03286218|454510848|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
126331999|NCT03286218|454510849|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
126332000|NCT03286218|454510838|FG000|Qualification Phase Period 2|Protocol Violation|2|||
126332001|NCT03286218|454510839|FG001|Qualification Phase Period 2|Protocol Violation|0|||
126665561|NCT02038920|455735644|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
126665562|NCT02038920|455735639|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
126332002|NCT03286218|454510840|FG002|Qualification Phase Period 2|Protocol Violation|0|||
126332003|NCT03286218|454510841|FG003|Qualification Phase Period 2|Protocol Violation|0|||
126332004|NCT03286218|454510842|FG004|Qualification Phase Period 2|Protocol Violation|0|||
126332005|NCT03286218|454510843|FG005|Qualification Phase Period 2|Protocol Violation|0|||
126332006|NCT03286218|454510844|FG006|Qualification Phase Period 2|Protocol Violation|0|||
126332007|NCT03286218|454510845|FG007|Qualification Phase Period 2|Protocol Violation|0|||
126665563|NCT02038920|455735640|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
126665564|NCT02038920|455735641|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
126332008|NCT03286218|454510846|FG008|Qualification Phase Period 2|Protocol Violation|0|||
126332009|NCT03286218|454510847|FG009|Qualification Phase Period 2|Protocol Violation|0|||
126332010|NCT03286218|454510848|FG010|Qualification Phase Period 2|Protocol Violation|0|||
126332011|NCT03286218|454510849|FG011|Qualification Phase Period 2|Protocol Violation|0|||
126332012|NCT03286218|454510838|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
126665565|NCT02038920|455735642|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
126665566|NCT02038920|455735643|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
126665567|NCT02038920|455735644|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
126665568|NCT02038920|455735639|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
126665569|NCT02038920|455735640|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
126665570|NCT02038920|455735641|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
126665571|NCT02038920|455735642|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
126665572|NCT02038920|455735643|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
126665573|NCT02038920|455735644|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
126665574|NCT02038920|455735639|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
126665575|NCT02038920|455735640|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
126665576|NCT02038920|455735641|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
126665577|NCT02038920|455735642|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
126665578|NCT02038920|455735643|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
126665579|NCT02038920|455735644|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
126665580|NCT02038920|455735639|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
126665581|NCT02038920|455735640|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
126665582|NCT02038920|455735641|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
126665583|NCT02038920|455735642|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
126665584|NCT02038920|455735643|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
126665585|NCT02038920|455735644|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
126665586|NCT02038920|455735639|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
126665587|NCT02038920|455735640|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
126665588|NCT02038920|455735641|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
126665589|NCT02038920|455735642|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
126665590|NCT02038920|455735643|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
126665591|NCT02038920|455735644|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
126665592|NCT02038920|455735639|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
126665593|NCT02038920|455735640|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
126665594|NCT02038920|455735641|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
126665595|NCT02038920|455735642|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
126665596|NCT02038920|455735643|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
126665597|NCT02038920|455735644|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
126665598|NCT02038920|455735639|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
126665599|NCT02038920|455735640|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
126665600|NCT02038920|455735641|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
126665601|NCT02038920|455735642|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
126332013|NCT03286218|454510839|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
126332014|NCT03286218|454510840|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332015|NCT03286218|454510841|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332016|NCT03286218|454510842|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332017|NCT03286218|454510843|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332018|NCT03286218|454510844|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332019|NCT03286218|454510845|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332020|NCT03286218|454510846|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332021|NCT03286218|454510847|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332022|NCT03286218|454510848|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332023|NCT03286218|454510849|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
126332024|NCT03286218|454510838|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
126332025|NCT03286218|454510839|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
126665602|NCT02038920|455735643|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
126665603|NCT02038920|455735644|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
126665604|NCT02383589|455735645|FG000|Treatment Period|Adverse Event|1|||
126665605|NCT02383589|455735646|FG001|Treatment Period|Adverse Event|3|||
126665606|NCT02383589|455735645|FG000|Treatment Period|Lost to Follow-up|0|||
126665607|NCT02383589|455735646|FG001|Treatment Period|Lost to Follow-up|1|||
126665608|NCT02383589|455735645|FG000|Treatment Period|Withdrawal by Subject|0|||
126665609|NCT02383589|455735646|FG001|Treatment Period|Withdrawal by Subject|5|||
126665610|NCT02383589|455735645|FG000|Treatment Period|Non-compliance with study drug|0|||
126665611|NCT02383589|455735646|FG001|Treatment Period|Non-compliance with study drug|1|||
126665612|NCT02383589|455735645|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
126665613|NCT02383589|455735646|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
126665614|NCT02383589|455735645|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
126665615|NCT02383589|455735646|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
126665616|NCT02383589|455735645|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
126665617|NCT02383589|455735646|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
126665618|NCT00047320|455735647|FG000|Overall Study|Lack of Efficacy|8|||
126665619|NCT00047320|455735647|FG000|Overall Study|Lost to Follow-up|1|||
126665620|NCT00047320|455735647|FG000|Overall Study|Physician Decision|8|||
126665621|NCT00047320|455735647|FG000|Overall Study|Withdrawal by Subject|9|||
126665622|NCT00047320|455735647|FG000|Overall Study|Ineligible|2|||
126665623|NCT04376060|455735648|FG000|Overall Study|Physician Decision|1|||
126665624|NCT05460273|455735649|FG000|Overall Study|Death|43|||
126665625|NCT05460273|455735650|FG001|Overall Study|Death|9|||
126665626|NCT05460273|455735649|FG000|Overall Study|Lost to Follow-up|7|||
126665627|NCT05460273|455735650|FG001|Overall Study|Lost to Follow-up|0|||
126665628|NCT05460273|455735649|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
126665629|NCT05460273|455735650|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
126665630|NCT04890054|455737085|FG000|Overall Study|Lost to Follow-up|202|||
126665631|NCT04890054|455737086|FG001|Overall Study|Lost to Follow-up|219|||
126665632|NCT01940354|455737087|FG000|Overall Study|Withdrawal by Subject|4|||
126665633|NCT01940354|455737088|FG001|Overall Study|Withdrawal by Subject|2|||
126665634|NCT03872453|455737089|FG000|Overall Study|Adverse Event|1|||
126665635|NCT03872453|455737090|FG001|Overall Study|Adverse Event|1|||
126665636|NCT03872453|455737091|FG002|Overall Study|Adverse Event|0|||
126665637|NCT03872453|455737092|FG003|Overall Study|Adverse Event|0|||
126665638|NCT03872453|455737089|FG000|Overall Study|Lost to Follow-up|8|||
126665639|NCT03872453|455737090|FG001|Overall Study|Lost to Follow-up|7|||
126665640|NCT03872453|455737091|FG002|Overall Study|Lost to Follow-up|4|||
126665641|NCT03872453|455737092|FG003|Overall Study|Lost to Follow-up|4|||
126665642|NCT03872453|455737089|FG000|Overall Study|Never Treated Migraine|19|||
126665643|NCT03872453|455737090|FG001|Overall Study|Never Treated Migraine|17|||
126665644|NCT03872453|455737091|FG002|Overall Study|Never Treated Migraine|13|||
126665645|NCT03872453|455737092|FG003|Overall Study|Never Treated Migraine|12|||
126665646|NCT03872453|455737089|FG000|Overall Study|Pregnancy|1|||
126665647|NCT03872453|455737090|FG001|Overall Study|Pregnancy|0|||
126665648|NCT03872453|455737091|FG002|Overall Study|Pregnancy|0|||
126665649|NCT03872453|455737092|FG003|Overall Study|Pregnancy|0|||
126665650|NCT03872453|455737089|FG000|Overall Study|Protocol Deviation|2|||
126665651|NCT03872453|455737090|FG001|Overall Study|Protocol Deviation|0|||
126665652|NCT03872453|455737091|FG002|Overall Study|Protocol Deviation|0|||
126665653|NCT03872453|455737092|FG003|Overall Study|Protocol Deviation|2|||
126665654|NCT03872453|455737089|FG000|Overall Study|Withdrawal by Subject|0|||
126665655|NCT03872453|455737090|FG001|Overall Study|Withdrawal by Subject|1|||
126665656|NCT03872453|455737091|FG002|Overall Study|Withdrawal by Subject|2|||
126665657|NCT03872453|455737092|FG003|Overall Study|Withdrawal by Subject|0|||
126665658|NCT03872453|455737089|FG000|Overall Study|Other Than Specified|1|||
126665659|NCT03872453|455737090|FG001|Overall Study|Other Than Specified|0|||
126665660|NCT03872453|455737091|FG002|Overall Study|Other Than Specified|0|||
126665661|NCT03872453|455737092|FG003|Overall Study|Other Than Specified|0|||
126665662|NCT00352885|455737093|FG000|Overall Study|Withdrawal by Subject|0|||
126665663|NCT00352885|455737094|FG001|Overall Study|Withdrawal by Subject|3|||
126665664|NCT00352885|455737093|FG000|Overall Study|Development of major depression|0|||
126665665|NCT00352885|455737094|FG001|Overall Study|Development of major depression|1|||
126665666|NCT00352885|455737093|FG000|Overall Study|Progression of metastatic melanoma|5|||
126665667|NCT00352885|455737094|FG001|Overall Study|Progression of metastatic melanoma|3|||
126665668|NCT00352885|455737093|FG000|Overall Study|Side effects of IL-2 administration|1|||
126665669|NCT00352885|455737094|FG001|Overall Study|Side effects of IL-2 administration|0|||
126665670|NCT03873493|455737095|FG000|Overall Study|Withdrawal by Subject|1|||
126665671|NCT03873493|455737095|FG000|Overall Study|Death|9|||
126665672|NCT03873493|455737095|FG000|Overall Study|Lost to Follow-up|1|||
126665673|NCT03873493|455737095|FG000|Overall Study|Study Terminated by Sponsor|1|||
126665674|NCT03873493|455737095|FG000|Overall Study|Other|2|||
126665675|NCT00440700|455737099|FG000|Overall Study|Withdrawal by Subject|8|||
126665676|NCT00440700|455737100|FG001|Overall Study|Withdrawal by Subject|8|||
126665677|NCT00440700|455737101|FG002|Overall Study|Withdrawal by Subject|4|||
126665678|NCT03308942|455737102|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
126665679|NCT03308942|455737103|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
126665680|NCT03308942|455737104|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
126332026|NCT03286218|454510840|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
126332027|NCT03286218|454510841|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
126332028|NCT03286218|454510842|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
126332029|NCT03286218|454510843|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
126332030|NCT03286218|454510844|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
126665681|NCT03308942|455737105|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
126665682|NCT03308942|455737106|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
126665683|NCT03308942|455737102|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
126665684|NCT03308942|455737103|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
126665685|NCT03308942|455737104|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
126665686|NCT03308942|455737105|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
126665687|NCT03308942|455737106|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
126665688|NCT03308942|455737102|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
126665689|NCT03308942|455737103|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
126665690|NCT03308942|455737104|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
126665691|NCT03308942|455737105|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
126665692|NCT03308942|455737106|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
126665693|NCT03308942|455737102|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
126665694|NCT03308942|455737103|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
126665695|NCT03308942|455737104|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
126665696|NCT03308942|455737105|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
126665697|NCT03308942|455737106|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
126665698|NCT03308942|455737102|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
126665699|NCT03308942|455737103|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
126665700|NCT03308942|455737104|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
126665701|NCT03308942|455737105|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
126665702|NCT03308942|455737106|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
126665703|NCT03308942|455737102|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
126665704|NCT03308942|455737103|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
126665705|NCT03308942|455737104|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
126665706|NCT03308942|455737105|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
126665707|NCT03308942|455737106|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
126665708|NCT03308942|455737102|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
126665709|NCT03308942|455737103|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
126665710|NCT03308942|455737104|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
126665711|NCT03308942|455737105|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
126665712|NCT03308942|455737106|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
126665713|NCT01423812|455737109|FG000|Overall Study|Lost to Follow-up|2|||
126665714|NCT01423812|455737110|FG001|Overall Study|Lost to Follow-up|2|||
126665715|NCT01423812|455737109|FG000|Overall Study|Withdrawal by Subject|1|||
126665716|NCT01423812|455737110|FG001|Overall Study|Withdrawal by Subject|2|||
126665717|NCT01179672|455737111|FG000|Overall Study|Adverse Event|17|||
126665718|NCT01179672|455737112|FG001|Overall Study|Adverse Event|8|||
126665719|NCT01179672|455737111|FG000|Overall Study|Withdrawal by Subject|10|||
126665720|NCT01179672|455737112|FG001|Overall Study|Withdrawal by Subject|12|||
126665721|NCT01179672|455737111|FG000|Overall Study|Entry Criteria Not Met|0|||
126665722|NCT01179672|455737112|FG001|Overall Study|Entry Criteria Not Met|2|||
126665723|NCT01179672|455737111|FG000|Overall Study|Lost to Follow-up|0|||
126665724|NCT01179672|455737112|FG001|Overall Study|Lost to Follow-up|1|||
126665725|NCT01179672|455737111|FG000|Overall Study|Protocol Violation|2|||
126665726|NCT01179672|455737112|FG001|Overall Study|Protocol Violation|2|||
126665727|NCT01179672|455737111|FG000|Overall Study|Physician Decision|1|||
126665728|NCT01179672|455737112|FG001|Overall Study|Physician Decision|1|||
126665729|NCT02748018|455737115|FG000|Study Period|Adverse Event|1|||
126665730|NCT02748018|455737116|FG001|Study Period|Adverse Event|3|||
126665731|NCT02748018|455737117|FG002|Study Period|Adverse Event|4|||
126665732|NCT02748018|455737118|FG003|Study Period|Adverse Event|0|||
126665733|NCT02748018|455737119|FG004|Study Period|Adverse Event|3|||
126665734|NCT02748018|455737120|FG005|Study Period|Adverse Event|3|||
126665735|NCT02748018|455737115|FG000|Study Period|Withdrawal by Subject|7|||
126665736|NCT02748018|455737116|FG001|Study Period|Withdrawal by Subject|4|||
126665737|NCT02748018|455737117|FG002|Study Period|Withdrawal by Subject|4|||
126665738|NCT02748018|455737118|FG003|Study Period|Withdrawal by Subject|11|||
126665739|NCT02748018|455737119|FG004|Study Period|Withdrawal by Subject|12|||
126665740|NCT02748018|455737120|FG005|Study Period|Withdrawal by Subject|10|||
126665741|NCT02748018|455737115|FG000|Study Period|Pregnancy|0|||
126665742|NCT02748018|455737116|FG001|Study Period|Pregnancy|1|||
126665743|NCT02748018|455737117|FG002|Study Period|Pregnancy|0|||
126665744|NCT02748018|455737118|FG003|Study Period|Pregnancy|0|||
126665745|NCT02748018|455737119|FG004|Study Period|Pregnancy|1|||
126665746|NCT02748018|455737120|FG005|Study Period|Pregnancy|0|||
126665747|NCT02748018|455737115|FG000|Study Period|Physician Decision|2|||
126665748|NCT02748018|455737116|FG001|Study Period|Physician Decision|2|||
126665749|NCT02748018|455737117|FG002|Study Period|Physician Decision|1|||
126665750|NCT02748018|455737118|FG003|Study Period|Physician Decision|0|||
126665751|NCT02748018|455737119|FG004|Study Period|Physician Decision|2|||
126665752|NCT02748018|455737120|FG005|Study Period|Physician Decision|0|||
126665753|NCT02748018|455737115|FG000|Study Period|Lost to Follow-up|0|||
126665754|NCT02748018|455737116|FG001|Study Period|Lost to Follow-up|0|||
126665755|NCT02748018|455737117|FG002|Study Period|Lost to Follow-up|0|||
126665756|NCT02748018|455737118|FG003|Study Period|Lost to Follow-up|2|||
126665757|NCT02748018|455737119|FG004|Study Period|Lost to Follow-up|0|||
126665758|NCT02748018|455737120|FG005|Study Period|Lost to Follow-up|1|||
126665759|NCT02748018|455737115|FG000|Continuation Period|Adverse Event|2|||
126665760|NCT02748018|455737116|FG001|Continuation Period|Adverse Event|0|||
126665761|NCT02748018|455737117|FG002|Continuation Period|Adverse Event|1|||
126665762|NCT02748018|455737118|FG003|Continuation Period|Adverse Event|1|||
126665763|NCT02748018|455737119|FG004|Continuation Period|Adverse Event|1|||
126665764|NCT02748018|455737120|FG005|Continuation Period|Adverse Event|4|||
126665765|NCT02748018|455737115|FG000|Continuation Period|Withdrawal by Subject|3|||
126665766|NCT02748018|455737116|FG001|Continuation Period|Withdrawal by Subject|5|||
126665767|NCT02748018|455737117|FG002|Continuation Period|Withdrawal by Subject|3|||
126665768|NCT02748018|455737118|FG003|Continuation Period|Withdrawal by Subject|9|||
126665769|NCT02748018|455737119|FG004|Continuation Period|Withdrawal by Subject|11|||
126665770|NCT02748018|455737120|FG005|Continuation Period|Withdrawal by Subject|1|||
126665771|NCT02748018|455737115|FG000|Continuation Period|Lost to Follow-up|0|||
126665772|NCT02748018|455737116|FG001|Continuation Period|Lost to Follow-up|2|||
126665773|NCT02748018|455737117|FG002|Continuation Period|Lost to Follow-up|1|||
126665774|NCT02748018|455737118|FG003|Continuation Period|Lost to Follow-up|0|||
126665775|NCT02748018|455737119|FG004|Continuation Period|Lost to Follow-up|1|||
126665776|NCT02748018|455737120|FG005|Continuation Period|Lost to Follow-up|0|||
126665777|NCT02748018|455737115|FG000|Continuation Period|Pregnancy|1|||
126665778|NCT02748018|455737116|FG001|Continuation Period|Pregnancy|2|||
126665779|NCT02748018|455737117|FG002|Continuation Period|Pregnancy|0|||
126665780|NCT02748018|455737118|FG003|Continuation Period|Pregnancy|0|||
126665781|NCT02748018|455737119|FG004|Continuation Period|Pregnancy|0|||
126665782|NCT02748018|455737120|FG005|Continuation Period|Pregnancy|0|||
126665783|NCT02748018|455737115|FG000|Continuation Period|Physician Decision|0|||
126665784|NCT02748018|455737116|FG001|Continuation Period|Physician Decision|1|||
126665785|NCT02748018|455737117|FG002|Continuation Period|Physician Decision|2|||
126665786|NCT02748018|455737118|FG003|Continuation Period|Physician Decision|0|||
126665787|NCT02748018|455737119|FG004|Continuation Period|Physician Decision|2|||
126665788|NCT02748018|455737120|FG005|Continuation Period|Physician Decision|1|||
126665789|NCT02748018|455737115|FG000|Continuation Period|Protocol Violation|0|||
126665790|NCT02748018|455737116|FG001|Continuation Period|Protocol Violation|1|||
126665791|NCT02748018|455737117|FG002|Continuation Period|Protocol Violation|0|||
126665792|NCT02748018|455737118|FG003|Continuation Period|Protocol Violation|0|||
126665793|NCT02748018|455737119|FG004|Continuation Period|Protocol Violation|0|||
126665794|NCT02748018|455737120|FG005|Continuation Period|Protocol Violation|0|||
126665795|NCT02315898|455737121|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
126665796|NCT02315898|455737122|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
126665797|NCT02315898|455737123|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
126665798|NCT02315898|455737124|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
126665799|NCT00867113|455737134|FG000|Treatment Period|Adverse Event|15|||
126665800|NCT00867113|455737134|FG000|Treatment Period|Death|2|||
126665801|NCT00867113|455737134|FG000|Treatment Period|Withdrawal by Subject|19|||
126665802|NCT00867113|455737134|FG000|Treatment Period|Lost to Follow-up|3|||
126665803|NCT00867113|455737134|FG000|Treatment Period|Administrative problems|1|||
126665804|NCT00867113|455737134|FG000|Treatment Period|Disease progression/relapse|1|||
126665805|NCT00867113|455737134|FG000|Treatment Period|Protocol Violation|4|||
126665806|NCT00867113|455737134|FG000|Post Treatment After Survival Follow-up|Death|1|||
126665807|NCT00867113|455737134|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
126665808|NCT00867113|455737134|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
126665809|NCT00867113|455737134|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
126665810|NCT00578786|455737135|FG000|Overall Study|Adverse Event|27|||
126665811|NCT00578786|455737136|FG001|Overall Study|Adverse Event|37|||
126665812|NCT00578786|455737137|FG002|Overall Study|Adverse Event|17|||
126665813|NCT00578786|455737135|FG000|Overall Study|Lack of Efficacy|2|||
126665814|NCT00578786|455737136|FG001|Overall Study|Lack of Efficacy|5|||
126665815|NCT00578786|455737137|FG002|Overall Study|Lack of Efficacy|2|||
126665816|NCT00578786|455737135|FG000|Overall Study|Early Escape from Prior Study|2|||
126665817|NCT00578786|455737136|FG001|Overall Study|Early Escape from Prior Study|1|||
126665818|NCT00578786|455737137|FG002|Overall Study|Early Escape from Prior Study|2|||
126665819|NCT00578786|455737135|FG000|Overall Study|Withdrawal by Subject|7|||
126665820|NCT00578786|455737136|FG001|Overall Study|Withdrawal by Subject|8|||
126665821|NCT00578786|455737137|FG002|Overall Study|Withdrawal by Subject|5|||
126332031|NCT03286218|454510845|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
126332032|NCT03286218|454510846|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
126332033|NCT03286218|454510847|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
126332034|NCT03286218|454510848|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
126332035|NCT03286218|454510849|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
126332036|NCT03286218|454510838|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332037|NCT03286218|454510839|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332038|NCT03286218|454510840|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332039|NCT03286218|454510841|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332040|NCT03286218|454510842|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332041|NCT03286218|454510843|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
126665822|NCT00578786|455737135|FG000|Overall Study|Protocol Violation|0|||
126665823|NCT00578786|455737136|FG001|Overall Study|Protocol Violation|3|||
126665824|NCT00578786|455737137|FG002|Overall Study|Protocol Violation|1|||
126665825|NCT00578786|455737135|FG000|Overall Study|Physician Decision|1|||
126665826|NCT00578786|455737136|FG001|Overall Study|Physician Decision|0|||
126665827|NCT00578786|455737137|FG002|Overall Study|Physician Decision|1|||
126665828|NCT00578786|455737135|FG000|Overall Study|Sponsor Decision|0|||
126665829|NCT00578786|455737136|FG001|Overall Study|Sponsor Decision|0|||
126665830|NCT00578786|455737137|FG002|Overall Study|Sponsor Decision|1|||
126665831|NCT00578786|455737135|FG000|Overall Study|Lost to Follow-up|0|||
126665832|NCT00578786|455737136|FG001|Overall Study|Lost to Follow-up|4|||
126665833|NCT00578786|455737137|FG002|Overall Study|Lost to Follow-up|0|||
126665834|NCT00578786|455737135|FG000|Overall Study|Pregnancy|0|||
126665835|NCT00578786|455737136|FG001|Overall Study|Pregnancy|1|||
126665836|NCT00578786|455737137|FG002|Overall Study|Pregnancy|0|||
126665837|NCT00578786|455737135|FG000|Overall Study|Not Otherwise Specified|0|||
126665838|NCT00578786|455737136|FG001|Overall Study|Not Otherwise Specified|4|||
126665839|NCT00578786|455737137|FG002|Overall Study|Not Otherwise Specified|1|||
126665840|NCT00578786|455737135|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
126665841|NCT00578786|455737136|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
126665842|NCT00578786|455737137|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
126665843|NCT05105789|455737138|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
126665844|NCT00323297|455737141|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
126665845|NCT00323297|455737142|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
126665846|NCT00323297|455737141|FG000|Part A (Double Blind Randomized)|Death|0|||
126665847|NCT00323297|455737142|FG001|Part A (Double Blind Randomized)|Death|1|||
126665848|NCT00323297|455737141|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
126665849|NCT00323297|455737142|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
126665850|NCT00323297|455737141|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
126665851|NCT00323297|455737142|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
126665852|NCT00323297|455737141|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
126665853|NCT00323297|455737142|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
126665854|NCT00323297|455737141|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
126665855|NCT00323297|455737142|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
126665856|NCT00323297|455737141|FG000|Part B (Open-label)|Death|0|||
126665857|NCT00323297|455737142|FG001|Part B (Open-label)|Death|1|||
126665858|NCT00323297|455737141|FG000|Part B (Open-label)|Reason unspecified|0|||
126665859|NCT00323297|455737142|FG001|Part B (Open-label)|Reason unspecified|1|||
126665860|NCT00323297|455737141|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
126665861|NCT00323297|455737142|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
126665862|NCT00323297|455737141|FG000|Part B (Open-label)|Lack of Efficacy|3|||
126665863|NCT00323297|455737142|FG001|Part B (Open-label)|Lack of Efficacy|1|||
126665864|NCT00323297|455737141|FG000|Part B (Open-label)|Adverse Event|5|||
126665865|NCT00323297|455737142|FG001|Part B (Open-label)|Adverse Event|5|||
126665866|NCT00323297|455737141|FG000|Part B (Open-label)|Protocol Violation|0|||
126665867|NCT00323297|455737142|FG001|Part B (Open-label)|Protocol Violation|1|||
126665868|NCT01003990|455737143|FG000|Overall Study|Adverse Event|8|||
126665869|NCT01003990|455737144|FG001|Overall Study|Adverse Event|5|||
126665870|NCT01003990|455737145|FG002|Overall Study|Adverse Event|11|||
126665871|NCT01003990|455737143|FG000|Overall Study|Death|0|||
126665872|NCT01003990|455737144|FG001|Overall Study|Death|8|||
126665873|NCT01003990|455737145|FG002|Overall Study|Death|1|||
126665874|NCT01003990|455737143|FG000|Overall Study|Lack of Efficacy|10|||
126665875|NCT01003990|455737144|FG001|Overall Study|Lack of Efficacy|2|||
126665876|NCT01003990|455737145|FG002|Overall Study|Lack of Efficacy|3|||
126665877|NCT01003990|455737143|FG000|Overall Study|Lost to Follow-up|30|||
126665878|NCT01003990|455737144|FG001|Overall Study|Lost to Follow-up|12|||
126665879|NCT01003990|455737145|FG002|Overall Study|Lost to Follow-up|7|||
126665880|NCT01003990|455737143|FG000|Overall Study|Reasons Not Identified|14|||
126665881|NCT01003990|455737144|FG001|Overall Study|Reasons Not Identified|13|||
126665882|NCT01003990|455737145|FG002|Overall Study|Reasons Not Identified|8|||
126665883|NCT01003990|455737143|FG000|Overall Study|Poor/Non-compliance|4|||
126665884|NCT01003990|455737144|FG001|Overall Study|Poor/Non-compliance|3|||
126665885|NCT01003990|455737145|FG002|Overall Study|Poor/Non-compliance|2|||
126332042|NCT03286218|454510844|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332043|NCT03286218|454510845|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332044|NCT03286218|454510846|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332045|NCT03286218|454510847|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332046|NCT03286218|454510848|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
126332047|NCT03286218|454510849|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
126332048|NCT01348139|454510850|FG000|Period 1|Adverse Event|1|||
126332049|NCT01348139|454510851|FG001|Period 1|Adverse Event|0|||
126332050|NCT01348139|454510852|FG002|Period 1|Adverse Event|0|||
126332051|NCT01348139|454510853|FG003|Period 1|Adverse Event|0|||
126332052|NCT01348139|454510854|FG004|Period 1|Adverse Event|0|||
126332053|NCT01348139|454510855|FG005|Period 1|Adverse Event|0|||
126332054|NCT02762084|454510858|FG000|Overall Study|Withdrawal by Subject|1|||
126332055|NCT02762084|454510859|FG001|Overall Study|Withdrawal by Subject|0|||
126332056|NCT02762084|454510860|FG002|Overall Study|Withdrawal by Subject|0|||
126332057|NCT02762084|454510858|FG000|Overall Study|Adverse Event|0|||
126332058|NCT02762084|454510859|FG001|Overall Study|Adverse Event|0|||
126332059|NCT02762084|454510860|FG002|Overall Study|Adverse Event|1|||
126332060|NCT01001910|454510863|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
126332061|NCT03200548|454510864|FG000|Overall Study|Withdrawal by Subject|5|||
126332062|NCT03200548|454510865|FG001|Overall Study|Withdrawal by Subject|11|||
126332063|NCT03200548|454510866|FG002|Overall Study|Withdrawal by Subject|7|||
126332064|NCT03200548|454510867|FG003|Overall Study|Withdrawal by Subject|6|||
126332065|NCT01619852|454510872|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
126332066|NCT01619852|454510873|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
126332067|NCT01619852|454510872|FG000|3 Month Follow up|Lost to Follow-up|31|||
126332068|NCT01619852|454510873|FG001|3 Month Follow up|Lost to Follow-up|34|||
126332069|NCT00970489|454510876|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
126332070|NCT00970489|454510877|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
126332071|NCT02168491|454510880|FG000|Overall Study|Withdrawal by Subject|1|||
126332072|NCT01096160|454510881|FG000|Overall Study|Adverse Event|0|||
126332073|NCT01096160|454510882|FG001|Overall Study|Adverse Event|0|||
126332074|NCT01096160|454510883|FG002|Overall Study|Adverse Event|1|||
126332075|NCT01096160|454510884|FG003|Overall Study|Adverse Event|0|||
126332076|NCT01096160|454510885|FG004|Overall Study|Adverse Event|0|||
126332077|NCT01096160|454510886|FG005|Overall Study|Adverse Event|0|||
126332078|NCT01096160|454510887|FG006|Overall Study|Adverse Event|0|||
126332079|NCT01096160|454510888|FG007|Overall Study|Adverse Event|0|||
126332080|NCT01096160|454510889|FG008|Overall Study|Adverse Event|0|||
126332081|NCT01096160|454510890|FG009|Overall Study|Adverse Event|1|||
126332082|NCT01096160|454510881|FG000|Overall Study|Met stopping criteria per protocol|0|||
126332083|NCT01096160|454510882|FG001|Overall Study|Met stopping criteria per protocol|0|||
126332084|NCT01096160|454510883|FG002|Overall Study|Met stopping criteria per protocol|0|||
126332085|NCT01096160|454510884|FG003|Overall Study|Met stopping criteria per protocol|0|||
126332086|NCT01096160|454510885|FG004|Overall Study|Met stopping criteria per protocol|1|||
126332087|NCT01096160|454510886|FG005|Overall Study|Met stopping criteria per protocol|0|||
126665886|NCT01003990|455737143|FG000|Overall Study|Pregnancy|10|||
126665887|NCT01003990|455737144|FG001|Overall Study|Pregnancy|2|||
126332088|NCT01096160|454510887|FG006|Overall Study|Met stopping criteria per protocol|2|||
126332089|NCT01096160|454510888|FG007|Overall Study|Met stopping criteria per protocol|0|||
126332090|NCT01096160|454510889|FG008|Overall Study|Met stopping criteria per protocol|2|||
126332091|NCT01096160|454510890|FG009|Overall Study|Met stopping criteria per protocol|0|||
126332092|NCT01610037|454510891|FG000|All Patients|Adverse Event|27|||
126665888|NCT01003990|455737145|FG002|Overall Study|Pregnancy|4|||
126665889|NCT01003990|455737143|FG000|Overall Study|No Longer Met Study Criteria|4|||
126665890|NCT01003990|455737144|FG001|Overall Study|No Longer Met Study Criteria|1|||
126665891|NCT01003990|455737145|FG002|Overall Study|No Longer Met Study Criteria|0|||
126665892|NCT01003990|455737143|FG000|Overall Study|Subject Withdrew Consent|12|||
126665893|NCT01003990|455737144|FG001|Overall Study|Subject Withdrew Consent|5|||
126665894|NCT01003990|455737145|FG002|Overall Study|Subject Withdrew Consent|7|||
126665895|NCT00634010|455737150|FG000|Overall Study|Adverse Event|2|||
126665896|NCT00634010|455737151|FG001|Overall Study|Adverse Event|5|||
126665897|NCT00634010|455737150|FG000|Overall Study|Withdrawal by Subject|5|||
126665898|NCT00634010|455737151|FG001|Overall Study|Withdrawal by Subject|6|||
126665899|NCT00634010|455737150|FG000|Overall Study|Physician Decision|1|||
126665900|NCT00634010|455737151|FG001|Overall Study|Physician Decision|1|||
126665901|NCT00634010|455737150|FG000|Overall Study|Disease Progression|1|||
126332093|NCT01610037|454510892|FG001|All Patients|Adverse Event|22|||
126332094|NCT01610037|454510893|FG002|All Patients|Adverse Event|26|||
126332095|NCT01610037|454510891|FG000|All Patients|Withdrawal by Subject|12|||
126332096|NCT01610037|454510892|FG001|All Patients|Withdrawal by Subject|10|||
126332097|NCT01610037|454510893|FG002|All Patients|Withdrawal by Subject|20|||
126332098|NCT01610037|454510891|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
126665902|NCT00634010|455737151|FG001|Overall Study|Disease Progression|1|||
126665903|NCT00634010|455737150|FG000|Overall Study|Non-Compliant|1|||
126665904|NCT00634010|455737151|FG001|Overall Study|Non-Compliant|1|||
126665905|NCT01822522|455737157|FG000|Overall Study|Adverse Event|1|||
126665906|NCT01822522|455737158|FG001|Overall Study|Adverse Event|1|||
126665907|NCT01822522|455737159|FG002|Overall Study|Adverse Event|1|||
126665908|NCT01822522|455737160|FG003|Overall Study|Adverse Event|0|||
126665909|NCT01822522|455737161|FG004|Overall Study|Adverse Event|0|||
126665910|NCT01822522|455737162|FG005|Overall Study|Adverse Event|1|||
126665911|NCT01822522|455737157|FG000|Overall Study|Death|3|||
126665912|NCT01822522|455737158|FG001|Overall Study|Death|0|||
126665913|NCT01822522|455737159|FG002|Overall Study|Death|2|||
126665914|NCT01822522|455737160|FG003|Overall Study|Death|0|||
126665915|NCT01822522|455737161|FG004|Overall Study|Death|0|||
126665916|NCT01822522|455737162|FG005|Overall Study|Death|0|||
126665917|NCT01822522|455737157|FG000|Overall Study|Lost to Follow-up|0|||
126665918|NCT01822522|455737158|FG001|Overall Study|Lost to Follow-up|0|||
126665919|NCT01822522|455737159|FG002|Overall Study|Lost to Follow-up|1|||
126665920|NCT01822522|455737160|FG003|Overall Study|Lost to Follow-up|1|||
126665921|NCT01822522|455737161|FG004|Overall Study|Lost to Follow-up|0|||
126665922|NCT01822522|455737162|FG005|Overall Study|Lost to Follow-up|1|||
126665923|NCT01822522|455737157|FG000|Overall Study|Withdrawal by Subject|0|||
126665924|NCT01822522|455737158|FG001|Overall Study|Withdrawal by Subject|0|||
126665925|NCT01822522|455737159|FG002|Overall Study|Withdrawal by Subject|0|||
126665926|NCT01822522|455737160|FG003|Overall Study|Withdrawal by Subject|1|||
126665927|NCT01822522|455737161|FG004|Overall Study|Withdrawal by Subject|0|||
126665928|NCT01822522|455737162|FG005|Overall Study|Withdrawal by Subject|0|||
126665929|NCT01822522|455737157|FG000|Overall Study|Lack of Efficacy|0|||
126665930|NCT01822522|455737158|FG001|Overall Study|Lack of Efficacy|0|||
126665931|NCT01822522|455737159|FG002|Overall Study|Lack of Efficacy|0|||
126665932|NCT01822522|455737160|FG003|Overall Study|Lack of Efficacy|0|||
126665933|NCT01822522|455737161|FG004|Overall Study|Lack of Efficacy|0|||
126665934|NCT01822522|455737162|FG005|Overall Study|Lack of Efficacy|2|||
126665935|NCT00890929|455737163|FG000|Overall Study|Death before treatment|2|||
126665936|NCT00890929|455737163|FG000|Overall Study|Withdrawal by Subject|3|||
126665937|NCT00890929|455737163|FG000|Overall Study|Physician Decision|1|||
126665938|NCT01006265|455737164|FG000|Overall Study|Lost to Follow-up|1|||
126665939|NCT01006265|455737165|FG001|Overall Study|Lost to Follow-up|0|||
126665940|NCT01006265|455737166|FG002|Overall Study|Lost to Follow-up|1|||
126665941|NCT01006265|455737167|FG003|Overall Study|Lost to Follow-up|0|||
126665942|NCT01006265|455737164|FG000|Overall Study|Withdrawal by Subject|4|||
126665943|NCT01006265|455737165|FG001|Overall Study|Withdrawal by Subject|7|||
126665944|NCT01006265|455737166|FG002|Overall Study|Withdrawal by Subject|5|||
126665945|NCT01006265|455737167|FG003|Overall Study|Withdrawal by Subject|5|||
126665946|NCT01006265|455737164|FG000|Overall Study|Administrative reason|1|||
126665947|NCT01006265|455737165|FG001|Overall Study|Administrative reason|2|||
126665948|NCT01006265|455737166|FG002|Overall Study|Administrative reason|3|||
126665949|NCT01006265|455737167|FG003|Overall Study|Administrative reason|0|||
126665950|NCT00132496|455737170|FG000|Overall Study|Withdrawal by Subject|1|||
126665951|NCT00132496|455737171|FG001|Overall Study|Withdrawal by Subject|2|||
126665952|NCT00132496|455737170|FG000|Overall Study|Physician Decision|1|||
126665953|NCT00132496|455737171|FG001|Overall Study|Physician Decision|0|||
126665954|NCT01093625|455737176|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
126665955|NCT01093625|455737177|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
126665956|NCT01093625|455737176|FG000|2-Week Visit|Withdrawal by Subject|1|||
126665957|NCT01093625|455737177|FG001|2-Week Visit|Withdrawal by Subject|0|||
126665958|NCT01093625|455737176|FG000|1-Month Visit|Lost to Follow-up|2|||
126665959|NCT01093625|455737177|FG001|1-Month Visit|Lost to Follow-up|0|||
126665960|NCT01093625|455737176|FG000|3-Month Visit|Lost to Follow-up|2|||
126665961|NCT01093625|455737177|FG001|3-Month Visit|Lost to Follow-up|0|||
126665962|NCT01093625|455737176|FG000|6-Month Visit|Withdrawal by Subject|6|||
126665963|NCT01093625|455737177|FG001|6-Month Visit|Withdrawal by Subject|7|||
126665964|NCT01093625|455737176|FG000|6-Month Visit|Lost to Follow-up|2|||
126665965|NCT01093625|455737177|FG001|6-Month Visit|Lost to Follow-up|2|||
126665966|NCT01093625|455737176|FG000|1-Year Visit|Lost to Follow-up|5|||
126665967|NCT01093625|455737177|FG001|1-Year Visit|Lost to Follow-up|3|||
126665968|NCT02014740|455737178|FG000|Overall Study|Lost to Follow-up|4|||
126665969|NCT02014740|455737179|FG001|Overall Study|Lost to Follow-up|4|||
126665970|NCT02014740|455737178|FG000|Overall Study|Withdrawal by Subject|2|||
126665971|NCT02014740|455737179|FG001|Overall Study|Withdrawal by Subject|1|||
126665972|NCT01431534|455737180|FG000|Treatment Phase|Adverse Event|0|||
126665973|NCT01431534|455737181|FG001|Treatment Phase|Adverse Event|0|||
126665974|NCT01431534|455737182|FG002|Treatment Phase|Adverse Event|1|||
126665975|NCT01431534|455737180|FG000|Treatment Phase|Progressive Disease|4|||
126665976|NCT01431534|455737181|FG001|Treatment Phase|Progressive Disease|3|||
126665977|NCT01431534|455737182|FG002|Treatment Phase|Progressive Disease|10|||
126665978|NCT04427501|455737185|FG000|Overall Study|Death|0|||
126665979|NCT04427501|455737186|FG001|Overall Study|Death|0|||
126665980|NCT04427501|455737187|FG002|Overall Study|Death|0|||
126665981|NCT04427501|455737188|FG003|Overall Study|Death|0|||
126665982|NCT04427501|455737189|FG004|Overall Study|Death|0|||
126665983|NCT04427501|455737190|FG005|Overall Study|Death|15|||
126665984|NCT04427501|455737191|FG006|Overall Study|Death|0|||
126332099|NCT01610037|454510892|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
126332100|NCT01610037|454510893|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
126332101|NCT01610037|454510891|FG000|All Patients|Death|4|||
126332102|NCT01610037|454510892|FG001|All Patients|Death|2|||
126332103|NCT01610037|454510893|FG002|All Patients|Death|1|||
126332104|NCT01610037|454510891|FG000|All Patients|Protocol deviation|4|||
126332105|NCT01610037|454510892|FG001|All Patients|Protocol deviation|3|||
126332106|NCT01610037|454510893|FG002|All Patients|Protocol deviation|3|||
126332107|NCT01610037|454510891|FG000|All Patients|Abnormal laboratory value|1|||
126332108|NCT01610037|454510892|FG001|All Patients|Abnormal laboratory value|1|||
126332109|NCT01610037|454510893|FG002|All Patients|Abnormal laboratory value|0|||
126332110|NCT01610037|454510891|FG000|All Patients|Administrative problems|1|||
126332111|NCT01610037|454510892|FG001|All Patients|Administrative problems|4|||
126332112|NCT01610037|454510893|FG002|All Patients|Administrative problems|4|||
126332113|NCT01610037|454510891|FG000|All Patients|Lost to Follow-up|1|||
126332114|NCT01610037|454510892|FG001|All Patients|Lost to Follow-up|0|||
126332115|NCT01610037|454510893|FG002|All Patients|Lost to Follow-up|0|||
126332116|NCT01610037|454510891|FG000|All Patients|Abnormal test procedure result(s)|0|||
126332117|NCT01610037|454510892|FG001|All Patients|Abnormal test procedure result(s)|1|||
126332118|NCT01610037|454510893|FG002|All Patients|Abnormal test procedure result(s)|3|||
126332119|NCT01610037|454510891|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
126332120|NCT01610037|454510892|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
126332121|NCT01610037|454510893|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
126332122|NCT01610037|454510891|FG000|Treatment and Follow up Period|Death|10|||
126332123|NCT01610037|454510892|FG001|Treatment and Follow up Period|Death|5|||
126332124|NCT01610037|454510893|FG002|Treatment and Follow up Period|Death|4|||
126332125|NCT01610037|454510891|FG000|Treatment and Follow up Period|Administrative problems|1|||
126332126|NCT01610037|454510892|FG001|Treatment and Follow up Period|Administrative problems|3|||
126332127|NCT01610037|454510893|FG002|Treatment and Follow up Period|Administrative problems|2|||
126332128|NCT01610037|454510891|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
126332129|NCT01610037|454510892|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
126332130|NCT01610037|454510893|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
126332131|NCT00705757|454510895|FG000|Overall Study|Lack of Efficacy|5|||
126332132|NCT00705757|454510896|FG001|Overall Study|Lack of Efficacy|1|||
126332133|NCT00705757|454510897|FG002|Overall Study|Lack of Efficacy|3|||
126332134|NCT00705757|454510895|FG000|Overall Study|Lost to Follow-up|7|||
126332135|NCT00705757|454510896|FG001|Overall Study|Lost to Follow-up|6|||
126332136|NCT00705757|454510897|FG002|Overall Study|Lost to Follow-up|6|||
126332137|NCT00705757|454510895|FG000|Overall Study|Withdrawal by Subject|1|||
126332138|NCT00705757|454510896|FG001|Overall Study|Withdrawal by Subject|1|||
126332139|NCT00705757|454510897|FG002|Overall Study|Withdrawal by Subject|2|||
126332140|NCT03193047|454510898|FG000|Overall Study|Physician Decision|1|||
126332141|NCT03193047|454510899|FG001|Overall Study|Physician Decision|0|||
126332142|NCT03193047|454510898|FG000|Overall Study|Participant Left State|1|||
126332143|NCT03193047|454510899|FG001|Overall Study|Participant Left State|0|||
126332144|NCT03743025|454510900|FG000|Overall Study|Surgery was cancelled|2|||
126332145|NCT03743025|454510901|FG001|Overall Study|Surgery was cancelled|1|||
126332146|NCT02420119|454510902|FG000|Overall Study|insufficient laboratory data|5|||
126332147|NCT00149396|454510903|FG000|Overall Study|Death|15|||
126332148|NCT00149396|454510903|FG000|Overall Study|Withdrawal by Subject|1|||
126332149|NCT00149396|454510903|FG000|Overall Study|Subject noncompliance|2|||
126332150|NCT00149396|454510903|FG000|Overall Study|other treatment|5|||
126332151|NCT00186485|454510906|FG000|Overall Study|Lost to Follow-up|3|||
126332152|NCT00227539|454510909|FG000|Overall Study|Protocol Violation|1|||
126332153|NCT01922258|454510910|FG000|Overall Study|Lost to Follow-up|1|||
126332154|NCT01922258|454510911|FG001|Overall Study|Lost to Follow-up|1|||
126332155|NCT01922258|454510910|FG000|Overall Study|Adverse Event|9|||
126332156|NCT01922258|454510911|FG001|Overall Study|Adverse Event|2|||
126332157|NCT01922258|454510910|FG000|Overall Study|Met Withdrawal Criteria|0|||
126332158|NCT01922258|454510911|FG001|Overall Study|Met Withdrawal Criteria|4|||
126332159|NCT01922258|454510910|FG000|Overall Study|Withdrawn by the Investigator|1|||
126332160|NCT01922258|454510911|FG001|Overall Study|Withdrawn by the Investigator|4|||
126332161|NCT01922258|454510910|FG000|Overall Study|Withdrawal by participant|5|||
126332162|NCT01922258|454510911|FG001|Overall Study|Withdrawal by participant|5|||
126332163|NCT00673257|454510912|FG000|Overall Study|Withdrawal by Subject|4|||
126332164|NCT00673257|454510912|FG000|Overall Study|Unable to obtain specimen|1|||
126332165|NCT04552132|454510913|FG000|Overall Study|Lost to Follow-up|4|||
126332166|NCT04552132|454510914|FG001|Overall Study|Lost to Follow-up|3|||
126332167|NCT04552132|454510913|FG000|Overall Study|Protocol Violation|1|||
126332168|NCT04552132|454510914|FG001|Overall Study|Protocol Violation|0|||
126332169|NCT02256839|454510915|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
126332170|NCT02256839|454510916|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
126332171|NCT01951417|454510931|FG000|Overall Study|Withdrawal by Subject|1|||
126332172|NCT01951417|454510931|FG000|Overall Study|Protocol Violation|2|||
126332173|NCT01951417|454510931|FG000|Overall Study|Lost to Follow-up|6|||
126332174|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
126665985|NCT04427501|455737192|FG007|Overall Study|Death|0|||
126665986|NCT04427501|455737193|FG008|Overall Study|Death|0|||
126665987|NCT04427501|455737194|FG009|Overall Study|Death|0|||
126665988|NCT04427501|455737195|FG010|Overall Study|Death|0|||
126665989|NCT04427501|455737196|FG011|Overall Study|Death|0|||
126665990|NCT04427501|455737185|FG000|Overall Study|Lost to Follow-up|5|||
126665991|NCT04427501|455737186|FG001|Overall Study|Lost to Follow-up|1|||
126665992|NCT04427501|455737187|FG002|Overall Study|Lost to Follow-up|2|||
126665993|NCT04427501|455737188|FG003|Overall Study|Lost to Follow-up|0|||
126665994|NCT04427501|455737189|FG004|Overall Study|Lost to Follow-up|2|||
126665995|NCT04427501|455737190|FG005|Overall Study|Lost to Follow-up|11|||
126332175|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
126332176|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Adverse Event|57|||
126332177|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Adverse Event|49|||
126332178|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
126332179|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
126332180|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Site closure|3|||
126332181|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Site closure|2|||
126332182|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
126332183|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
126332184|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Physician Decision|48|||
126332185|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Physician Decision|38|||
126332186|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
126332187|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
126332188|NCT01705977|454510938|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
126332189|NCT01705977|454510939|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
126332190|NCT01705977|454510938|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
126332191|NCT01705977|454510939|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
126332192|NCT01705977|454510938|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
126332193|NCT01705977|454510939|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
126332194|NCT01705977|454510938|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
126332195|NCT01705977|454510939|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
126332196|NCT01705977|454510938|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
126332197|NCT01705977|454510939|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
126332198|NCT00096538|454510941|FG000|Overall Study|Withdrawal by Subject|1|||
126332199|NCT01938846|454510942|FG000|Overall Study|Progressive disease|26|||
126332200|NCT01938846|454510943|FG001|Overall Study|Progressive disease|18|||
126332201|NCT01938846|454510944|FG002|Overall Study|Progressive disease|16|||
126332202|NCT01938846|454510942|FG000|Overall Study|Adverse Event|8|||
126332203|NCT01938846|454510943|FG001|Overall Study|Adverse Event|4|||
126332204|NCT01938846|454510944|FG002|Overall Study|Adverse Event|3|||
126332205|NCT01938846|454510942|FG000|Overall Study|Withdrawal by Subject|2|||
126332206|NCT01938846|454510943|FG001|Overall Study|Withdrawal by Subject|2|||
126332207|NCT01938846|454510944|FG002|Overall Study|Withdrawal by Subject|1|||
126332208|NCT01938846|454510942|FG000|Overall Study|Other than listed|5|||
126332209|NCT01938846|454510943|FG001|Overall Study|Other than listed|1|||
126332210|NCT01938846|454510944|FG002|Overall Study|Other than listed|4|||
126332211|NCT02324361|454510945|FG000|Overall Study|Lost to Follow-up|5|||
126332212|NCT02324361|454510946|FG001|Overall Study|Lost to Follow-up|2|||
126332213|NCT00808067|454510949|FG000|Overall Study|Major/minor bleed|30|||
126332214|NCT00808067|454510950|FG001|Overall Study|Major/minor bleed|44|||
126332215|NCT00808067|454510949|FG000|Overall Study|Outcome event - other|33|||
126332216|NCT00808067|454510950|FG001|Overall Study|Outcome event - other|25|||
126332217|NCT00808067|454510949|FG000|Overall Study|Adverse Event|111|||
126332218|NCT00808067|454510950|FG001|Overall Study|Adverse Event|121|||
126332219|NCT00808067|454510949|FG000|Overall Study|Hospitalization (not including surgery)|18|||
126332220|NCT00808067|454510950|FG001|Overall Study|Hospitalization (not including surgery)|17|||
126332221|NCT00808067|454510949|FG000|Overall Study|Hospitalization due to surgery|37|||
126332222|NCT00808067|454510950|FG001|Overall Study|Hospitalization due to surgery|40|||
126332223|NCT00808067|454510949|FG000|Overall Study|Reduced creatinine clearance|53|||
126332224|NCT00808067|454510950|FG001|Overall Study|Reduced creatinine clearance|55|||
126332225|NCT00808067|454510949|FG000|Overall Study|Elevated LFT results|7|||
126332226|NCT00808067|454510950|FG001|Overall Study|Elevated LFT results|3|||
126665996|NCT04427501|455737191|FG006|Overall Study|Lost to Follow-up|10|||
126665997|NCT04427501|455737192|FG007|Overall Study|Lost to Follow-up|10|||
126665998|NCT04427501|455737193|FG008|Overall Study|Lost to Follow-up|2|||
126332227|NCT00808067|454510949|FG000|Overall Study|Patient refused to take study medication|65|||
126332228|NCT00808067|454510950|FG001|Overall Study|Patient refused to take study medication|76|||
126332229|NCT00808067|454510949|FG000|Overall Study|Missing|1|||
126332230|NCT00808067|454510950|FG001|Overall Study|Missing|0|||
126332231|NCT00808067|454510949|FG000|Overall Study|Death|1|||
126332232|NCT00808067|454510950|FG001|Overall Study|Death|1|||
126332233|NCT00808067|454510949|FG000|Overall Study|Procedure|6|||
126332234|NCT00808067|454510950|FG001|Overall Study|Procedure|7|||
126332235|NCT00808067|454510949|FG000|Overall Study|Withdrawal by Subject|21|||
126332236|NCT00808067|454510950|FG001|Overall Study|Withdrawal by Subject|25|||
126332237|NCT00808067|454510949|FG000|Overall Study|Site closed|4|||
126332238|NCT00808067|454510950|FG001|Overall Study|Site closed|3|||
126332239|NCT00808067|454510949|FG000|Overall Study|Physician Decision|47|||
126332240|NCT00808067|454510950|FG001|Overall Study|Physician Decision|38|||
126332241|NCT00808067|454510949|FG000|Overall Study|Protocol Violation|3|||
126332242|NCT00808067|454510950|FG001|Overall Study|Protocol Violation|11|||
126332243|NCT00808067|454510949|FG000|Overall Study|Patient elected|7|||
126332244|NCT00808067|454510950|FG001|Overall Study|Patient elected|9|||
126332245|NCT00808067|454510949|FG000|Overall Study|Site closed for cause|19|||
126332246|NCT00808067|454510950|FG001|Overall Study|Site closed for cause|19|||
126332247|NCT00808067|454510949|FG000|Overall Study|Other reason not defined above|5|||
126332248|NCT00808067|454510950|FG001|Overall Study|Other reason not defined above|5|||
126332249|NCT00808067|454510949|FG000|Overall Study|Excluded from analysis|13|||
126332250|NCT00808067|454510950|FG001|Overall Study|Excluded from analysis|19|||
126332251|NCT02058589|454510952|FG000|Overall Study|Serious Adverse Event|1|||
126332252|NCT02058589|454510953|FG001|Overall Study|Serious Adverse Event|1|||
126332253|NCT02058589|454510952|FG000|Overall Study|Non-Serious Adverse Event|1|||
126332254|NCT02058589|454510953|FG001|Overall Study|Non-Serious Adverse Event|0|||
126332255|NCT02058589|454510952|FG000|Overall Study|Withdrawal by Subject|0|||
126332256|NCT02058589|454510953|FG001|Overall Study|Withdrawal by Subject|1|||
126332257|NCT02143024|454510955|FG000|Overall Study|Lost to Follow-up|1|||
126332258|NCT02143024|454510956|FG001|Overall Study|Lost to Follow-up|1|||
126332259|NCT02143024|454510955|FG000|Overall Study|Withdrawal by Subject|1|||
126332260|NCT02143024|454510956|FG001|Overall Study|Withdrawal by Subject|0|||
126332261|NCT02532283|454510957|FG000|Overall Study|Adverse Event|0|||
126332262|NCT02532283|454510958|FG001|Overall Study|Adverse Event|1|||
126332263|NCT02532283|454510957|FG000|Overall Study|Death|1|||
126332264|NCT02532283|454510958|FG001|Overall Study|Death|0|||
126332265|NCT02532283|454510957|FG000|Overall Study|Lost to Follow-up|0|||
126332266|NCT02532283|454510958|FG001|Overall Study|Lost to Follow-up|1|||
126332267|NCT02532283|454510957|FG000|Overall Study|Withdrawal by Subject|8|||
126332268|NCT02532283|454510958|FG001|Overall Study|Withdrawal by Subject|3|||
126332269|NCT01945944|454510959|FG000|Overall Study|Adverse Event|0|||
126332270|NCT01945944|454510960|FG001|Overall Study|Adverse Event|2|||
126332271|NCT01945944|454510959|FG000|Overall Study|Physician Decision|1|||
126332272|NCT01945944|454510960|FG001|Overall Study|Physician Decision|0|||
126332273|NCT01945944|454510959|FG000|Overall Study|Withdrawal by Subject|0|||
126332274|NCT01945944|454510960|FG001|Overall Study|Withdrawal by Subject|1|||
126332275|NCT00490971|454510968|FG000|Acute/Continuation|Adverse Event|62|||
126332276|NCT00490971|454510969|FG001|Acute/Continuation|Adverse Event|13|||
126332277|NCT00490971|454510970|FG002|Acute/Continuation|Adverse Event|0|||
126332278|NCT00490971|454510971|FG003|Acute/Continuation|Adverse Event|0|||
126332279|NCT00490971|454510972|FG004|Acute/Continuation|Adverse Event|0|||
126332280|NCT00490971|454510968|FG000|Acute/Continuation|Death|2|||
126332281|NCT00490971|454510969|FG001|Acute/Continuation|Death|0|||
126332282|NCT00490971|454510970|FG002|Acute/Continuation|Death|0|||
126332283|NCT00490971|454510971|FG003|Acute/Continuation|Death|0|||
126332284|NCT00490971|454510972|FG004|Acute/Continuation|Death|0|||
126332285|NCT00490971|454510968|FG000|Acute/Continuation|Lack of Efficacy|106|||
126332286|NCT00490971|454510969|FG001|Acute/Continuation|Lack of Efficacy|12|||
126332287|NCT00490971|454510970|FG002|Acute/Continuation|Lack of Efficacy|0|||
126332288|NCT00490971|454510971|FG003|Acute/Continuation|Lack of Efficacy|0|||
126332289|NCT00490971|454510972|FG004|Acute/Continuation|Lack of Efficacy|0|||
126332290|NCT00490971|454510968|FG000|Acute/Continuation|Lost to Follow-up|23|||
126332291|NCT00490971|454510969|FG001|Acute/Continuation|Lost to Follow-up|7|||
126332292|NCT00490971|454510970|FG002|Acute/Continuation|Lost to Follow-up|0|||
126332293|NCT00490971|454510971|FG003|Acute/Continuation|Lost to Follow-up|0|||
126332294|NCT00490971|454510972|FG004|Acute/Continuation|Lost to Follow-up|0|||
126332295|NCT00490971|454510968|FG000|Acute/Continuation|Protocol Violation|10|||
126332296|NCT00490971|454510969|FG001|Acute/Continuation|Protocol Violation|2|||
126332297|NCT00490971|454510970|FG002|Acute/Continuation|Protocol Violation|0|||
126332298|NCT00490971|454510971|FG003|Acute/Continuation|Protocol Violation|0|||
126332299|NCT00490971|454510972|FG004|Acute/Continuation|Protocol Violation|0|||
126332300|NCT00490971|454510968|FG000|Acute/Continuation|Withdrawal by Subject|92|||
126332301|NCT00490971|454510969|FG001|Acute/Continuation|Withdrawal by Subject|24|||
126332302|NCT00490971|454510970|FG002|Acute/Continuation|Withdrawal by Subject|0|||
126332303|NCT00490971|454510971|FG003|Acute/Continuation|Withdrawal by Subject|0|||
126332304|NCT00490971|454510972|FG004|Acute/Continuation|Withdrawal by Subject|0|||
126332305|NCT00490971|454510968|FG000|Acute/Continuation|Other|11|||
126332306|NCT00490971|454510969|FG001|Acute/Continuation|Other|4|||
126332307|NCT00490971|454510970|FG002|Acute/Continuation|Other|0|||
126332308|NCT00490971|454510971|FG003|Acute/Continuation|Other|0|||
126332309|NCT00490971|454510972|FG004|Acute/Continuation|Other|0|||
126332310|NCT00490971|454510968|FG000|Maintenance|Adverse Event|0|||
126332311|NCT00490971|454510969|FG001|Maintenance|Adverse Event|0|||
126332312|NCT00490971|454510970|FG002|Maintenance|Adverse Event|4|||
126332313|NCT00490971|454510971|FG003|Maintenance|Adverse Event|5|||
126332314|NCT00490971|454510972|FG004|Maintenance|Adverse Event|7|||
126332315|NCT00490971|454510968|FG000|Maintenance|Death|0|||
126332316|NCT00490971|454510969|FG001|Maintenance|Death|0|||
126332317|NCT00490971|454510970|FG002|Maintenance|Death|0|||
126332318|NCT00490971|454510971|FG003|Maintenance|Death|2|||
126332319|NCT00490971|454510972|FG004|Maintenance|Death|0|||
126332320|NCT00490971|454510968|FG000|Maintenance|Lost to Follow-up|0|||
126332321|NCT00490971|454510969|FG001|Maintenance|Lost to Follow-up|0|||
126332322|NCT00490971|454510970|FG002|Maintenance|Lost to Follow-up|5|||
126332323|NCT00490971|454510971|FG003|Maintenance|Lost to Follow-up|8|||
126332324|NCT00490971|454510972|FG004|Maintenance|Lost to Follow-up|10|||
126332325|NCT00490971|454510968|FG000|Maintenance|Pregnancy|0|||
126332326|NCT00490971|454510969|FG001|Maintenance|Pregnancy|0|||
126332327|NCT00490971|454510970|FG002|Maintenance|Pregnancy|1|||
126332328|NCT00490971|454510971|FG003|Maintenance|Pregnancy|0|||
126332329|NCT00490971|454510972|FG004|Maintenance|Pregnancy|0|||
126332330|NCT00490971|454510968|FG000|Maintenance|Protocol Violation|0|||
126332331|NCT00490971|454510969|FG001|Maintenance|Protocol Violation|0|||
126332332|NCT00490971|454510970|FG002|Maintenance|Protocol Violation|4|||
126332333|NCT00490971|454510971|FG003|Maintenance|Protocol Violation|1|||
126332334|NCT00490971|454510972|FG004|Maintenance|Protocol Violation|1|||
126332335|NCT00490971|454510968|FG000|Maintenance|Withdrawal by Subject|0|||
126332336|NCT00490971|454510969|FG001|Maintenance|Withdrawal by Subject|0|||
126332337|NCT00490971|454510970|FG002|Maintenance|Withdrawal by Subject|26|||
126332338|NCT00490971|454510971|FG003|Maintenance|Withdrawal by Subject|28|||
126332339|NCT00490971|454510972|FG004|Maintenance|Withdrawal by Subject|18|||
126332340|NCT00490971|454510968|FG000|Maintenance|Other|0|||
126332341|NCT00490971|454510969|FG001|Maintenance|Other|0|||
126332342|NCT00490971|454510970|FG002|Maintenance|Other|11|||
126332343|NCT00490971|454510971|FG003|Maintenance|Other|9|||
126332344|NCT00490971|454510972|FG004|Maintenance|Other|3|||
126332345|NCT04376515|454510976|FG000|Overall Study|Found to have been vaccinated before study start|6|||
126332346|NCT04376515|454510977|FG001|Overall Study|Found to have been vaccinated before study start|6|||
126332347|NCT01683604|454510979|FG000|Overall Study|Adverse Event|2|||
126332348|NCT01683604|454510979|FG000|Overall Study|Lack of Efficacy|1|||
126332349|NCT01683604|454510979|FG000|Overall Study|Other|2|||
126332350|NCT03430856|454510983|FG000|Overall Study|Adverse Event|0|||
126332351|NCT03430856|454510984|FG001|Overall Study|Adverse Event|1|||
126332352|NCT03430856|454510985|FG002|Overall Study|Adverse Event|0|||
126332353|NCT03430856|454510983|FG000|Overall Study|Rescue criteria|1|||
126332354|NCT03430856|454510984|FG001|Overall Study|Rescue criteria|1|||
126332355|NCT03430856|454510985|FG002|Overall Study|Rescue criteria|0|||
126332356|NCT03430856|454510983|FG000|Overall Study|Voluntary withdrawal of consent|1|||
126332357|NCT03430856|454510984|FG001|Overall Study|Voluntary withdrawal of consent|1|||
126332358|NCT03430856|454510985|FG002|Overall Study|Voluntary withdrawal of consent|1|||
126332359|NCT01949142|454510990|FG000|Overall Study|Withdrawal of consent|1|||
126332360|NCT01949142|454510991|FG001|Overall Study|Withdrawal of consent|0|||
126332361|NCT01949142|454510990|FG000|Overall Study|Lost to Follow-up|1|||
126332362|NCT01949142|454510991|FG001|Overall Study|Lost to Follow-up|1|||
126332363|NCT01949142|454510990|FG000|Overall Study|Parent changed their mind|1|||
126332364|NCT01949142|454510991|FG001|Overall Study|Parent changed their mind|0|||
126332365|NCT04771013|454513121|FG000|Overall Study|Withdrawal by Subject|2|||
126332366|NCT04771013|454513122|FG001|Overall Study|Withdrawal by Subject|0|||
126332367|NCT04771013|454513121|FG000|Overall Study|Death|0|||
126332368|NCT04771013|454513122|FG001|Overall Study|Death|5|||
126332369|NCT04771013|454513121|FG000|Overall Study|Referred to another hospital before day 20|0|||
126332370|NCT04771013|454513122|FG001|Overall Study|Referred to another hospital before day 20|1|||
126332371|NCT00493012|454513123|FG000|Overall Study|Lost to Follow-up|18|||
126332372|NCT00493012|454513124|FG001|Overall Study|Lost to Follow-up|17|||
126332373|NCT01519817|454513126|FG000|Overall Study|Withdrawal by Subject|1|||
126332374|NCT01519817|454513127|FG001|Overall Study|Withdrawal by Subject|0|||
126332375|NCT01519817|454513128|FG002|Overall Study|Withdrawal by Subject|0|||
126332376|NCT01519817|454513129|FG003|Overall Study|Withdrawal by Subject|0|||
126332377|NCT01519817|454513126|FG000|Overall Study|Off study due to infection|0|||
126332378|NCT01519817|454513127|FG001|Overall Study|Off study due to infection|0|||
126332379|NCT01519817|454513128|FG002|Overall Study|Off study due to infection|0|||
126332380|NCT01519817|454513129|FG003|Overall Study|Off study due to infection|1|||
126332381|NCT03234036|454513133|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
126332382|NCT03234036|454513134|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
126332383|NCT03234036|454513135|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
126332384|NCT03234036|454513136|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
126332385|NCT02999789|454513139|FG000|Overall Study|Withdrawal by Subject|0|||
126332386|NCT02999789|454513140|FG001|Overall Study|Withdrawal by Subject|1|||
126332387|NCT02999789|454513139|FG000|Overall Study|Became ineligible|1|||
126545280|NCT01111838|455290787|FG000|Overall Study|Clinical deterioration|1|||
126332388|NCT02999789|454513140|FG001|Overall Study|Became ineligible|2|||
126332389|NCT04547140|454513143|FG000|Overall Study|Adverse Event|0|||
126332390|NCT04547140|454513144|FG001|Overall Study|Adverse Event|1|||
126332391|NCT04547140|454513143|FG000|Overall Study|Withdrawal by Subject|0|||
126332392|NCT04547140|454513144|FG001|Overall Study|Withdrawal by Subject|1|||
126332393|NCT04547140|454513143|FG000|Overall Study|Lost to Follow-up|3|||
126332394|NCT04547140|454513144|FG001|Overall Study|Lost to Follow-up|1|||
126332395|NCT04547140|454513143|FG000|Overall Study|Death|2|||
126332396|NCT04547140|454513144|FG001|Overall Study|Death|1|||
126332397|NCT04547140|454513143|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
126332398|NCT04547140|454513144|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
126332399|NCT04547140|454513143|FG000|Overall Study|Pregnancy|1|||
126332400|NCT04547140|454513144|FG001|Overall Study|Pregnancy|0|||
126332401|NCT04547140|454513143|FG000|Overall Study|Reason Not Specified|4|||
126332402|NCT04547140|454513144|FG001|Overall Study|Reason Not Specified|1|||
126332403|NCT04613739|454513145|FG000|Overall Study|Lost to Follow-up|6|||
126332404|NCT04613739|454513146|FG001|Overall Study|Lost to Follow-up|9|||
126332405|NCT04613739|454513145|FG000|Overall Study|potentially duplicative/fraudulent|1|||
126332406|NCT04613739|454513146|FG001|Overall Study|potentially duplicative/fraudulent|3|||
126332407|NCT00003537|454513147|FG000|Overall Study|Not evalauable|1|||
126332408|NCT00737100|454513158|FG000|Overall Study|Adverse Event|6|||
126332409|NCT00737100|454513159|FG001|Overall Study|Adverse Event|5|||
126332410|NCT00737100|454513160|FG002|Overall Study|Adverse Event|3|||
126332411|NCT00737100|454513158|FG000|Overall Study|Lost to Follow-up|0|||
126332412|NCT00737100|454513159|FG001|Overall Study|Lost to Follow-up|1|||
126332413|NCT00737100|454513160|FG002|Overall Study|Lost to Follow-up|0|||
126332414|NCT00737100|454513158|FG000|Overall Study|Withdrawal by Subject|0|||
126332415|NCT00737100|454513159|FG001|Overall Study|Withdrawal by Subject|0|||
126332416|NCT00737100|454513160|FG002|Overall Study|Withdrawal by Subject|3|||
126332417|NCT00737100|454513158|FG000|Overall Study|Reason discontinued not explained above|1|||
126332418|NCT00737100|454513159|FG001|Overall Study|Reason discontinued not explained above|1|||
126332419|NCT00737100|454513160|FG002|Overall Study|Reason discontinued not explained above|1|||
126332420|NCT01265394|454513163|FG000|Overall Study|Subjects withdrawn|37|||
126332421|NCT00735943|454513164|FG000|Overall Study|Lost to Follow-up|1|||
126332422|NCT00735943|454513164|FG000|Overall Study|Adverse Event|1|||
126332423|NCT01719380|454513169|FG000|Overall Study|Adverse Event|0|||
126332424|NCT01719380|454513170|FG001|Overall Study|Adverse Event|0|||
126332425|NCT01719380|454513171|FG002|Overall Study|Adverse Event|1|||
126332426|NCT01719380|454513172|FG003|Overall Study|Adverse Event|2|||
126332427|NCT01719380|454513173|FG004|Overall Study|Adverse Event|0|||
126332428|NCT01719380|454513174|FG005|Overall Study|Adverse Event|1|||
126332429|NCT01719380|454513175|FG006|Overall Study|Adverse Event|0|||
126332430|NCT01719380|454513176|FG007|Overall Study|Adverse Event|1|||
126332431|NCT01719380|454513177|FG008|Overall Study|Adverse Event|4|||
126332432|NCT01719380|454513178|FG009|Overall Study|Adverse Event|3|||
126332433|NCT01719380|454513169|FG000|Overall Study|Death|0|||
126332434|NCT01719380|454513170|FG001|Overall Study|Death|1|||
126332435|NCT01719380|454513171|FG002|Overall Study|Death|0|||
126332436|NCT01719380|454513172|FG003|Overall Study|Death|0|||
126332437|NCT01719380|454513173|FG004|Overall Study|Death|0|||
126332438|NCT01719380|454513174|FG005|Overall Study|Death|0|||
126332439|NCT01719380|454513175|FG006|Overall Study|Death|0|||
126332440|NCT01719380|454513176|FG007|Overall Study|Death|0|||
126332441|NCT01719380|454513177|FG008|Overall Study|Death|3|||
126332442|NCT01719380|454513178|FG009|Overall Study|Death|3|||
126332443|NCT01719380|454513169|FG000|Overall Study|Participant/Guardian Decision|0|||
126332444|NCT01719380|454513170|FG001|Overall Study|Participant/Guardian Decision|0|||
126332445|NCT01719380|454513171|FG002|Overall Study|Participant/Guardian Decision|1|||
126332446|NCT01719380|454513172|FG003|Overall Study|Participant/Guardian Decision|0|||
126332447|NCT01719380|454513173|FG004|Overall Study|Participant/Guardian Decision|0|||
126332448|NCT01719380|454513174|FG005|Overall Study|Participant/Guardian Decision|0|||
126332449|NCT01719380|454513175|FG006|Overall Study|Participant/Guardian Decision|0|||
126332450|NCT01719380|454513176|FG007|Overall Study|Participant/Guardian Decision|0|||
126332451|NCT01719380|454513177|FG008|Overall Study|Participant/Guardian Decision|2|||
126332452|NCT01719380|454513178|FG009|Overall Study|Participant/Guardian Decision|2|||
126332453|NCT01719380|454513169|FG000|Overall Study|Physician Decision|0|||
126332454|NCT01719380|454513170|FG001|Overall Study|Physician Decision|0|||
126332455|NCT01719380|454513171|FG002|Overall Study|Physician Decision|2|||
126332456|NCT01719380|454513172|FG003|Overall Study|Physician Decision|0|||
126332457|NCT01719380|454513173|FG004|Overall Study|Physician Decision|0|||
126332458|NCT01719380|454513174|FG005|Overall Study|Physician Decision|0|||
126332459|NCT01719380|454513175|FG006|Overall Study|Physician Decision|0|||
126332460|NCT01719380|454513176|FG007|Overall Study|Physician Decision|0|||
126332461|NCT01719380|454513177|FG008|Overall Study|Physician Decision|1|||
126332462|NCT01719380|454513178|FG009|Overall Study|Physician Decision|1|||
126332463|NCT01719380|454513169|FG000|Overall Study|Lack of Efficacy|2|||
126332464|NCT01719380|454513170|FG001|Overall Study|Lack of Efficacy|6|||
126332465|NCT01719380|454513171|FG002|Overall Study|Lack of Efficacy|5|||
126332466|NCT01719380|454513172|FG003|Overall Study|Lack of Efficacy|6|||
126332467|NCT01719380|454513173|FG004|Overall Study|Lack of Efficacy|3|||
126332468|NCT01719380|454513174|FG005|Overall Study|Lack of Efficacy|7|||
126332469|NCT01719380|454513175|FG006|Overall Study|Lack of Efficacy|10|||
126332470|NCT01719380|454513176|FG007|Overall Study|Lack of Efficacy|6|||
126332471|NCT01719380|454513177|FG008|Overall Study|Lack of Efficacy|39|||
126332472|NCT01719380|454513178|FG009|Overall Study|Lack of Efficacy|42|||
126665999|NCT04427501|455737194|FG009|Overall Study|Lost to Follow-up|5|||
126666000|NCT04427501|455737195|FG010|Overall Study|Lost to Follow-up|2|||
126666001|NCT04427501|455737196|FG011|Overall Study|Lost to Follow-up|0|||
126666002|NCT04427501|455737185|FG000|Overall Study|Physician Decision|0|||
126332473|NCT01719380|454513169|FG000|Overall Study|Progressive Disease|0|||
126332474|NCT01719380|454513170|FG001|Overall Study|Progressive Disease|0|||
126332475|NCT01719380|454513171|FG002|Overall Study|Progressive Disease|0|||
126332476|NCT01719380|454513172|FG003|Overall Study|Progressive Disease|0|||
126332477|NCT01719380|454513173|FG004|Overall Study|Progressive Disease|0|||
126332478|NCT01719380|454513174|FG005|Overall Study|Progressive Disease|0|||
126332479|NCT01719380|454513175|FG006|Overall Study|Progressive Disease|0|||
126332480|NCT01719380|454513176|FG007|Overall Study|Progressive Disease|0|||
126332481|NCT01719380|454513177|FG008|Overall Study|Progressive Disease|1|||
126332482|NCT01719380|454513178|FG009|Overall Study|Progressive Disease|0|||
126332483|NCT01064414|454513179|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
126332484|NCT01064414|454513180|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
126332485|NCT01064414|454513181|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
126332486|NCT01064414|454513179|FG000|Core Period: Baseline to Week 26|Death|0|||
126332487|NCT01064414|454513180|FG001|Core Period: Baseline to Week 26|Death|1|||
126332488|NCT01064414|454513181|FG002|Core Period: Baseline to Week 26|Death|0|||
126332489|NCT01064414|454513179|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
126332490|NCT01064414|454513180|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
126332491|NCT01064414|454513181|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
126332492|NCT01064414|454513179|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
126332493|NCT01064414|454513180|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
126332494|NCT01064414|454513181|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
126332495|NCT01064414|454513179|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126332496|NCT01064414|454513180|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
126332497|NCT01064414|454513181|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126332498|NCT01064414|454513179|FG000|Core Period: Baseline to Week 26|Other|4|||
126332499|NCT01064414|454513180|FG001|Core Period: Baseline to Week 26|Other|7|||
126332500|NCT01064414|454513181|FG002|Core Period: Baseline to Week 26|Other|2|||
126332501|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
126332502|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
126332503|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
126332504|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Death|0|||
126332505|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Death|1|||
126332506|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Death|0|||
126332507|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
126332508|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126332509|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126332510|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
126332511|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126332512|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126332513|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126332514|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
126332515|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126332516|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
126332517|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
126332518|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
126332519|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
126332520|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
126332521|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
126332522|NCT01064414|454513179|FG000|Extension Period: Week 26 to Week 52|Other|5|||
126332523|NCT01064414|454513180|FG001|Extension Period: Week 26 to Week 52|Other|2|||
126332524|NCT01064414|454513181|FG002|Extension Period: Week 26 to Week 52|Other|1|||
126332525|NCT00249873|454513182|FG000|Overall Study|Not treated|7|||
126332526|NCT00249873|454513183|FG001|Overall Study|Not treated|8|||
126332527|NCT00249873|454513182|FG000|Overall Study|Significant thrombocytopenia|9|||
126332528|NCT00249873|454513183|FG001|Overall Study|Significant thrombocytopenia|8|||
126332529|NCT00249873|454513182|FG000|Overall Study|Severe allergic reaction|8|||
126332530|NCT00249873|454513183|FG001|Overall Study|Severe allergic reaction|1|||
126332531|NCT00249873|454513182|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
126332532|NCT00249873|454513183|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
126332533|NCT00249873|454513182|FG000|Overall Study|Other Serious Adverse Event|86|||
126332534|NCT00249873|454513183|FG001|Overall Study|Other Serious Adverse Event|97|||
126332535|NCT00249873|454513182|FG000|Overall Study|Qualifying condition not present|20|||
126332536|NCT00249873|454513183|FG001|Overall Study|Qualifying condition not present|23|||
126332537|NCT00249873|454513182|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
126332538|NCT00249873|454513183|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
126332539|NCT00249873|454513182|FG000|Overall Study|Withdrawal by Subject|504|||
126332540|NCT00249873|454513183|FG001|Overall Study|Withdrawal by Subject|466|||
126332541|NCT00249873|454513182|FG000|Overall Study|Lost to Follow-up|4|||
126332542|NCT00249873|454513183|FG001|Overall Study|Lost to Follow-up|7|||
126332543|NCT00249873|454513182|FG000|Overall Study|Minor bleeding|99|||
126332544|NCT00249873|454513183|FG001|Overall Study|Minor bleeding|37|||
126332545|NCT00249873|454513182|FG000|Overall Study|Non-compliance|41|||
126332546|NCT00249873|454513183|FG001|Overall Study|Non-compliance|46|||
126332547|NCT00249873|454513182|FG000|Overall Study|Other non serious Adverse Event|112|||
126332548|NCT00249873|454513183|FG001|Overall Study|Other non serious Adverse Event|108|||
126332549|NCT00249873|454513182|FG000|Overall Study|Other contraindicated medication|1|||
126332550|NCT00249873|454513183|FG001|Overall Study|Other contraindicated medication|0|||
126332551|NCT00249873|454513182|FG000|Overall Study|Patient not wish to continue after May08|3|||
126332552|NCT00249873|454513183|FG001|Overall Study|Patient not wish to continue after May08|4|||
126332553|NCT00249873|454513182|FG000|Overall Study|Physician withdrew consent|59|||
126332554|NCT00249873|454513183|FG001|Overall Study|Physician withdrew consent|60|||
126332555|NCT00249873|454513182|FG000|Overall Study|Open label clopidogrel required|31|||
126332556|NCT00249873|454513183|FG001|Overall Study|Open label clopidogrel required|42|||
126332557|NCT00249873|454513182|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
126332558|NCT00249873|454513183|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
126332559|NCT00249873|454513182|FG000|Overall Study|Oral anticoagulant required|159|||
126332560|NCT00249873|454513183|FG001|Overall Study|Oral anticoagulant required|157|||
126332561|NCT00249873|454513182|FG000|Overall Study|Study drug intolerance|5|||
126332562|NCT00249873|454513183|FG001|Overall Study|Study drug intolerance|0|||
126332563|NCT00249873|454513182|FG000|Overall Study|Surgery/ procedure|9|||
126332564|NCT00249873|454513183|FG001|Overall Study|Surgery/ procedure|9|||
126332565|NCT00249873|454513182|FG000|Overall Study|Event related to cardiac condition|12|||
126332566|NCT00249873|454513183|FG001|Overall Study|Event related to cardiac condition|21|||
126332567|NCT00249873|454513182|FG000|Overall Study|Thromboembolic/outcome event|82|||
126666003|NCT04427501|455737186|FG001|Overall Study|Physician Decision|3|||
126332568|NCT00249873|454513183|FG001|Overall Study|Thromboembolic/outcome event|122|||
126666004|NCT04427501|455737187|FG002|Overall Study|Physician Decision|0|||
126666005|NCT04427501|455737188|FG003|Overall Study|Physician Decision|0|||
126666006|NCT04427501|455737189|FG004|Overall Study|Physician Decision|0|||
126666007|NCT04427501|455737190|FG005|Overall Study|Physician Decision|0|||
126666008|NCT04427501|455737191|FG006|Overall Study|Physician Decision|2|||
126666009|NCT04427501|455737192|FG007|Overall Study|Physician Decision|0|||
126666010|NCT04427501|455737193|FG008|Overall Study|Physician Decision|0|||
126666011|NCT04427501|455737194|FG009|Overall Study|Physician Decision|0|||
126332569|NCT03131167|454513184|FG000|Overall Study|Other (Unspecified)|0|||
126332570|NCT03131167|454513185|FG001|Overall Study|Other (Unspecified)|0|||
126332571|NCT03131167|454513186|FG002|Overall Study|Other (Unspecified)|0|||
126332572|NCT03131167|454513187|FG003|Overall Study|Other (Unspecified)|0|||
126332573|NCT03131167|454513188|FG004|Overall Study|Other (Unspecified)|0|||
126332574|NCT03131167|454513189|FG005|Overall Study|Other (Unspecified)|1|||
126332575|NCT03131167|454513190|FG006|Overall Study|Other (Unspecified)|0|||
126332576|NCT03131167|454513191|FG007|Overall Study|Other (Unspecified)|0|||
126332577|NCT03131167|454513192|FG008|Overall Study|Other (Unspecified)|0|||
126332578|NCT03131167|454513193|FG009|Overall Study|Other (Unspecified)|0|||
126332579|NCT03131167|454513194|FG010|Overall Study|Other (Unspecified)|0|||
126332580|NCT03131167|454513195|FG011|Overall Study|Other (Unspecified)|0|||
126332581|NCT03131167|454513196|FG012|Overall Study|Other (Unspecified)|0|||
126332582|NCT00165503|454513197|FG000|Overall Study|Death|1|||
126332583|NCT00165503|454513197|FG000|Overall Study|Lost to Follow-up|12|||
126332584|NCT00165503|454513197|FG000|Overall Study|Unresectable|3|||
126332585|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Death|20|||
126332586|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Death|26|||
126332587|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
126332588|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
126332589|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
126332590|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
126332591|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
126332592|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
126332593|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
126332594|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
126332595|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
126332596|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
126332597|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
126666012|NCT04427501|455737195|FG010|Overall Study|Physician Decision|0|||
126666013|NCT04427501|455737196|FG011|Overall Study|Physician Decision|0|||
126666014|NCT04427501|455737185|FG000|Overall Study|Withdrawal by Subject|9|||
126666015|NCT04427501|455737186|FG001|Overall Study|Withdrawal by Subject|2|||
126666016|NCT04427501|455737187|FG002|Overall Study|Withdrawal by Subject|2|||
126666017|NCT04427501|455737188|FG003|Overall Study|Withdrawal by Subject|3|||
126332598|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
126332599|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
126332600|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
126332601|NCT00643201|454513198|FG000|Randomized, Completed 6 Months of Study|Other|107|||
126332602|NCT00643201|454513199|FG001|Randomized, Completed 6 Months of Study|Other|107|||
126332603|NCT00643201|454513198|FG000|Completed Study Follow Up|Death|28|||
126332604|NCT00643201|454513199|FG001|Completed Study Follow Up|Death|34|||
126332605|NCT00643201|454513198|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
126332606|NCT00643201|454513199|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
126332607|NCT00643201|454513198|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
126332608|NCT00643201|454513199|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
126332609|NCT00643201|454513198|FG000|Completed Study Follow Up|non-specified|1|||
126332610|NCT00643201|454513199|FG001|Completed Study Follow Up|non-specified|0|||
126332611|NCT02346708|454513200|FG000|Overall Study|Adverse Event|2|||
126332612|NCT02346708|454513201|FG001|Overall Study|Adverse Event|0|||
126332613|NCT02346708|454513200|FG000|Overall Study|Protocol Violation|0|||
126332614|NCT02346708|454513201|FG001|Overall Study|Protocol Violation|1|||
126332615|NCT02976519|454513202|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
126332616|NCT02976519|454513203|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
126332617|NCT02976519|454513204|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
126332618|NCT02976519|454513205|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
126332619|NCT02976519|454513206|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
126332620|NCT02976519|454513207|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
126332621|NCT02976519|454513208|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
126332622|NCT02976519|454513202|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
126332623|NCT02976519|454513203|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
126332624|NCT02976519|454513204|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
126332625|NCT02976519|454513205|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
126332626|NCT02976519|454513206|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
126332627|NCT02976519|454513207|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
126332628|NCT02976519|454513208|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
126332629|NCT02976519|454513202|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
126332630|NCT02976519|454513203|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
126332631|NCT02976519|454513204|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
126332632|NCT02976519|454513205|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
126332633|NCT02976519|454513206|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
126332634|NCT02976519|454513207|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
126332635|NCT02976519|454513208|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
126332636|NCT02976519|454513202|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
126332637|NCT02976519|454513203|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
126332638|NCT02976519|454513204|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
126332639|NCT02976519|454513205|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
126332640|NCT02976519|454513206|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
126332641|NCT02976519|454513207|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
126332642|NCT02976519|454513208|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
126332643|NCT02976519|454513202|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
126332644|NCT02976519|454513203|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
126332645|NCT02976519|454513204|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
126666018|NCT04427501|455737189|FG004|Overall Study|Withdrawal by Subject|7|||
126666019|NCT04427501|455737190|FG005|Overall Study|Withdrawal by Subject|25|||
126666020|NCT04427501|455737191|FG006|Overall Study|Withdrawal by Subject|15|||
126666021|NCT04427501|455737192|FG007|Overall Study|Withdrawal by Subject|7|||
126666022|NCT04427501|455737193|FG008|Overall Study|Withdrawal by Subject|4|||
126666023|NCT04427501|455737194|FG009|Overall Study|Withdrawal by Subject|1|||
126666024|NCT04427501|455737195|FG010|Overall Study|Withdrawal by Subject|4|||
126666025|NCT04427501|455737196|FG011|Overall Study|Withdrawal by Subject|0|||
126666026|NCT04427501|455737185|FG000|Overall Study|Other - as reported by the investigator|1|||
126666027|NCT04427501|455737186|FG001|Overall Study|Other - as reported by the investigator|0|||
126666028|NCT04427501|455737187|FG002|Overall Study|Other - as reported by the investigator|0|||
126666029|NCT04427501|455737188|FG003|Overall Study|Other - as reported by the investigator|0|||
126666030|NCT04427501|455737189|FG004|Overall Study|Other - as reported by the investigator|0|||
126666031|NCT04427501|455737190|FG005|Overall Study|Other - as reported by the investigator|6|||
126666032|NCT04427501|455737191|FG006|Overall Study|Other - as reported by the investigator|6|||
126666033|NCT04427501|455737192|FG007|Overall Study|Other - as reported by the investigator|0|||
126666034|NCT04427501|455737193|FG008|Overall Study|Other - as reported by the investigator|0|||
126666035|NCT04427501|455737194|FG009|Overall Study|Other - as reported by the investigator|0|||
126332646|NCT02976519|454513205|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
126666036|NCT04427501|455737195|FG010|Overall Study|Other - as reported by the investigator|0|||
126666037|NCT04427501|455737196|FG011|Overall Study|Other - as reported by the investigator|0|||
126666038|NCT04427501|455737185|FG000|Overall Study|Other|0|||
126666039|NCT04427501|455737186|FG001|Overall Study|Other|0|||
126666040|NCT04427501|455737187|FG002|Overall Study|Other|0|||
126666041|NCT04427501|455737188|FG003|Overall Study|Other|0|||
126666042|NCT04427501|455737189|FG004|Overall Study|Other|0|||
126666043|NCT04427501|455737190|FG005|Overall Study|Other|0|||
126666044|NCT04427501|455737191|FG006|Overall Study|Other|0|||
126666045|NCT04427501|455737192|FG007|Overall Study|Other|0|||
126666046|NCT04427501|455737193|FG008|Overall Study|Other|0|||
126666047|NCT04427501|455737194|FG009|Overall Study|Other|0|||
126666048|NCT04427501|455737195|FG010|Overall Study|Other|0|||
126666049|NCT04427501|455737196|FG011|Overall Study|Other|1|||
126666050|NCT00999713|455737197|FG000|Overall Study|Physician Decision|2|||
126666051|NCT00999713|455737198|FG001|Overall Study|Physician Decision|0|||
126332647|NCT02976519|454513206|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
126332648|NCT02976519|454513207|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
126332649|NCT02976519|454513208|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
126332650|NCT01781962|454513211|FG000|Overall Study|Other Miscellaneous Reasons|5|||
126332651|NCT00928434|454513212|FG000|Overall Study|Adverse Event|14|||
126332652|NCT00928434|454513213|FG001|Overall Study|Adverse Event|5|||
126332653|NCT00928434|454513214|FG002|Overall Study|Adverse Event|18|||
126332654|NCT00928434|454513212|FG000|Overall Study|Protocol Violation|5|||
126332655|NCT00928434|454513213|FG001|Overall Study|Protocol Violation|0|||
126332656|NCT00928434|454513214|FG002|Overall Study|Protocol Violation|8|||
126332657|NCT00928434|454513212|FG000|Overall Study|Physician Decision|2|||
126332658|NCT00928434|454513213|FG001|Overall Study|Physician Decision|0|||
126332659|NCT00928434|454513214|FG002|Overall Study|Physician Decision|3|||
126332660|NCT00928434|454513212|FG000|Overall Study|Lost to Follow-up|1|||
126332661|NCT00928434|454513213|FG001|Overall Study|Lost to Follow-up|0|||
126332662|NCT00928434|454513214|FG002|Overall Study|Lost to Follow-up|3|||
126332663|NCT00928434|454513212|FG000|Overall Study|Withdrawal by Subject|5|||
126332664|NCT00928434|454513213|FG001|Overall Study|Withdrawal by Subject|3|||
126332665|NCT00928434|454513214|FG002|Overall Study|Withdrawal by Subject|2|||
126332666|NCT00928434|454513212|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
126332667|NCT00928434|454513213|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
126332668|NCT00928434|454513214|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
126332669|NCT00928434|454513212|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
126332670|NCT00928434|454513213|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
126332671|NCT00928434|454513214|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
126332672|NCT00928434|454513212|FG000|Overall Study|Other (not meeting above criteria)|5|||
126332673|NCT00928434|454513213|FG001|Overall Study|Other (not meeting above criteria)|1|||
126332674|NCT00928434|454513214|FG002|Overall Study|Other (not meeting above criteria)|2|||
126332675|NCT01278342|454513217|FG000|Overall Study|Physician Decision|0|||
126332676|NCT01278342|454513218|FG001|Overall Study|Physician Decision|1|||
126332677|NCT01278342|454513219|FG002|Overall Study|Physician Decision|0|||
126332678|NCT01278342|454513217|FG000|Overall Study|Lost to Follow-up|1|||
126332679|NCT01278342|454513218|FG001|Overall Study|Lost to Follow-up|0|||
126332680|NCT01278342|454513219|FG002|Overall Study|Lost to Follow-up|0|||
126332681|NCT01278342|454513217|FG000|Overall Study|Administrative problems|2|||
126332682|NCT01278342|454513218|FG001|Overall Study|Administrative problems|0|||
126332683|NCT01278342|454513219|FG002|Overall Study|Administrative problems|0|||
126332684|NCT01278342|454513217|FG000|Overall Study|Other|1|||
126332685|NCT01278342|454513218|FG001|Overall Study|Other|0|||
126666052|NCT00639223|455737199|FG000|Overall Study|Lost to Follow-up|0|||
126666053|NCT00639223|455737200|FG001|Overall Study|Lost to Follow-up|2|||
126666054|NCT03739437|455737201|FG000|Overall Study|Lost to Follow-up|2|||
126666055|NCT03739437|455737202|FG001|Overall Study|Lost to Follow-up|5|||
126666056|NCT04598477|455737203|FG000|Overall Study|Adverse Event|2|||
126666057|NCT04598477|455737204|FG001|Overall Study|Adverse Event|0|||
126666058|NCT04598477|455737203|FG000|Overall Study|Death|0|||
126666059|NCT04598477|455737204|FG001|Overall Study|Death|1|||
126666060|NCT04598477|455737203|FG000|Overall Study|Lost to Follow-up|1|||
126666061|NCT04598477|455737204|FG001|Overall Study|Lost to Follow-up|0|||
126332686|NCT01278342|454513219|FG002|Overall Study|Other|0|||
126332687|NCT00313846|454513225|FG000|Overall Study|Withdrawal by Subject|2|||
126332688|NCT00313846|454513226|FG001|Overall Study|Withdrawal by Subject|0|||
126332689|NCT00313846|454513225|FG000|Overall Study|Adverse Event|1|||
126332690|NCT00313846|454513226|FG001|Overall Study|Adverse Event|8|||
126666062|NCT04598477|455737203|FG000|Overall Study|Physician Decision|7|||
126332691|NCT00313846|454513225|FG000|Overall Study|Administrative|2|||
126332692|NCT00313846|454513226|FG001|Overall Study|Administrative|3|||
126332693|NCT01462630|454513228|FG000|Overall Study|Did not initiate therapy|3|||
126332694|NCT01462630|454513228|FG000|Overall Study|Death|1|||
126332695|NCT01462630|454513228|FG000|Overall Study|Protocol Violation|2|||
126332696|NCT01462630|454513228|FG000|Overall Study|Adverse Event|1|||
126666063|NCT04598477|455737204|FG001|Overall Study|Physician Decision|2|||
126666064|NCT04598477|455737203|FG000|Overall Study|Pregnancy|0|||
126666065|NCT04598477|455737204|FG001|Overall Study|Pregnancy|1|||
126332697|NCT01765296|454513229|FG000|Overall Study|Protocol Violation|0|||
126332698|NCT01765296|454513230|FG001|Overall Study|Protocol Violation|5|||
126332699|NCT01765296|454513231|FG002|Overall Study|Protocol Violation|4|||
126332700|NCT01765296|454513229|FG000|Overall Study|Withdrawal by Subject|4|||
126332701|NCT01765296|454513230|FG001|Overall Study|Withdrawal by Subject|2|||
126332702|NCT01765296|454513231|FG002|Overall Study|Withdrawal by Subject|2|||
126332703|NCT01765296|454513229|FG000|Overall Study|Adverse Event|1|||
126332704|NCT01765296|454513230|FG001|Overall Study|Adverse Event|13|||
126332705|NCT01765296|454513231|FG002|Overall Study|Adverse Event|5|||
126332706|NCT01765296|454513229|FG000|Overall Study|Lack of Efficacy|0|||
126332707|NCT01765296|454513230|FG001|Overall Study|Lack of Efficacy|0|||
126332708|NCT01765296|454513231|FG002|Overall Study|Lack of Efficacy|2|||
126332709|NCT03933449|454513232|FG000|Overall Study|Adverse Event|6|||
126332710|NCT03933449|454513233|FG001|Overall Study|Adverse Event|4|||
126332711|NCT03933449|454513232|FG000|Overall Study|Death|55|||
126332712|NCT03933449|454513233|FG001|Overall Study|Death|57|||
126332713|NCT03933449|454513232|FG000|Overall Study|Sponsor Decision|1|||
126332714|NCT03933449|454513233|FG001|Overall Study|Sponsor Decision|0|||
126332715|NCT02659943|454513234|FG000|Overall Study|Switched to alternative treatment|1|||
126332716|NCT02659943|454513235|FG001|Overall Study|Switched to alternative treatment|1|||
126332717|NCT02659943|454513236|FG002|Overall Study|Switched to alternative treatment|0|||
126332718|NCT02659943|454513237|FG003|Overall Study|Switched to alternative treatment|2|||
126332719|NCT02659943|454513238|FG004|Overall Study|Switched to alternative treatment|1|||
126332720|NCT02659943|454513239|FG005|Overall Study|Switched to alternative treatment|0|||
126332721|NCT02659943|454513240|FG006|Overall Study|Switched to alternative treatment|1|||
126332722|NCT02659943|454513234|FG000|Overall Study|Disease progression on study|0|||
126332723|NCT02659943|454513235|FG001|Overall Study|Disease progression on study|1|||
126332724|NCT02659943|454513236|FG002|Overall Study|Disease progression on study|1|||
126332725|NCT02659943|454513237|FG003|Overall Study|Disease progression on study|1|||
126332726|NCT02659943|454513238|FG004|Overall Study|Disease progression on study|1|||
126332727|NCT02659943|454513239|FG005|Overall Study|Disease progression on study|4|||
126332728|NCT02659943|454513240|FG006|Overall Study|Disease progression on study|0|||
126332729|NCT02659943|454513234|FG000|Overall Study|Patient's condition per principal investigator|0|||
126332730|NCT02659943|454513235|FG001|Overall Study|Patient's condition per principal investigator|0|||
126332731|NCT02659943|454513236|FG002|Overall Study|Patient's condition per principal investigator|0|||
126332732|NCT02659943|454513237|FG003|Overall Study|Patient's condition per principal investigator|0|||
126332733|NCT02659943|454513238|FG004|Overall Study|Patient's condition per principal investigator|0|||
126332734|NCT02659943|454513239|FG005|Overall Study|Patient's condition per principal investigator|1|||
126332735|NCT02659943|454513240|FG006|Overall Study|Patient's condition per principal investigator|0|||
126332736|NCT02659943|454513234|FG000|Overall Study|Ineligible|0|||
126332737|NCT02659943|454513235|FG001|Overall Study|Ineligible|0|||
126332738|NCT02659943|454513236|FG002|Overall Study|Ineligible|0|||
126332739|NCT02659943|454513237|FG003|Overall Study|Ineligible|0|||
126332740|NCT02659943|454513238|FG004|Overall Study|Ineligible|0|||
126332741|NCT02659943|454513239|FG005|Overall Study|Ineligible|0|||
126332742|NCT02659943|454513240|FG006|Overall Study|Ineligible|1|||
126332743|NCT02659943|454513234|FG000|Overall Study|No longer meets eligibility|0|||
126332744|NCT02659943|454513235|FG001|Overall Study|No longer meets eligibility|0|||
126332745|NCT02659943|454513236|FG002|Overall Study|No longer meets eligibility|0|||
126332746|NCT02659943|454513237|FG003|Overall Study|No longer meets eligibility|0|||
126332747|NCT02659943|454513238|FG004|Overall Study|No longer meets eligibility|0|||
126332748|NCT02659943|454513239|FG005|Overall Study|No longer meets eligibility|0|||
126332749|NCT02659943|454513240|FG006|Overall Study|No longer meets eligibility|1|||
126332750|NCT02659943|454513234|FG000|Overall Study|No treatment, per protocol|0|||
126332751|NCT02659943|454513235|FG001|Overall Study|No treatment, per protocol|0|||
126332752|NCT02659943|454513236|FG002|Overall Study|No treatment, per protocol|0|||
126332753|NCT02659943|454513237|FG003|Overall Study|No treatment, per protocol|0|||
126332754|NCT02659943|454513238|FG004|Overall Study|No treatment, per protocol|0|||
126332755|NCT02659943|454513239|FG005|Overall Study|No treatment, per protocol|0|||
126332756|NCT02659943|454513240|FG006|Overall Study|No treatment, per protocol|3|||
126332757|NCT01576575|454513241|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
126666066|NCT04598477|455737203|FG000|Overall Study|Requires Prohibited Medication|0|||
126666067|NCT04598477|455737204|FG001|Overall Study|Requires Prohibited Medication|1|||
126666068|NCT04598477|455737203|FG000|Overall Study|Study Terminated by Sponsor|18|||
126332758|NCT01576575|454513241|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
126666069|NCT04598477|455737204|FG001|Overall Study|Study Terminated by Sponsor|12|||
126332759|NCT01576575|454513241|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
126332760|NCT01723072|454513242|FG000|Overall Study|Withdrawal by Subject|7|||
126332761|NCT01723072|454513243|FG001|Overall Study|Withdrawal by Subject|13|||
126332762|NCT01723072|454513242|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
126332763|NCT01723072|454513243|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
126332764|NCT01723072|454513242|FG000|Overall Study|Other|4|||
126332765|NCT01723072|454513243|FG001|Overall Study|Other|3|||
126332766|NCT03428100|454513244|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
126666070|NCT04598477|455737203|FG000|Overall Study|Withdrawal by Subject|16|||
126666071|NCT04598477|455737204|FG001|Overall Study|Withdrawal by Subject|12|||
126666072|NCT04598477|455737203|FG000|Overall Study|Other|15|||
126666073|NCT04598477|455737204|FG001|Overall Study|Other|8|||
126666074|NCT02499770|455737207|FG000|Overall Study|Death|17|||
126666075|NCT02499770|455737208|FG001|Overall Study|Death|56|||
126666076|NCT02499770|455737207|FG000|Overall Study|Study completion|1|||
126666077|NCT02499770|455737208|FG001|Overall Study|Study completion|10|||
126666078|NCT02499770|455737207|FG000|Overall Study|Withdrawal by Subject|0|||
126666079|NCT02499770|455737208|FG001|Overall Study|Withdrawal by Subject|7|||
126666080|NCT02499770|455737207|FG000|Overall Study|Lost to Follow-up|0|||
126666081|NCT02499770|455737208|FG001|Overall Study|Lost to Follow-up|2|||
126666082|NCT02499770|455737207|FG000|Overall Study|Subject declined further treatment|1|||
126666083|NCT02499770|455737208|FG001|Overall Study|Subject declined further treatment|0|||
126666084|NCT02499770|455737207|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
126666085|NCT02499770|455737208|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
126666086|NCT02499770|455737207|FG000|Overall Study|Randomized but not enrolled|0|||
126666087|NCT02499770|455737208|FG001|Overall Study|Randomized but not enrolled|1|||
126666088|NCT01298518|455737211|FG000|Overall Study|Withdrawal by Subject|0|||
126666089|NCT01298518|455737212|FG001|Overall Study|Withdrawal by Subject|0|||
126666090|NCT01298518|455737213|FG002|Overall Study|Withdrawal by Subject|1|||
126666091|NCT00866697|455737229|FG000|Overall Study|Study closed/terminated|156|||
126666092|NCT00866697|455737230|FG001|Overall Study|Study closed/terminated|138|||
126666093|NCT00866697|455737229|FG000|Overall Study|Lost to Follow-up|22|||
126666094|NCT00866697|455737230|FG001|Overall Study|Lost to Follow-up|28|||
126666095|NCT00866697|455737229|FG000|Overall Study|Physician Decision|3|||
126666096|NCT00866697|455737230|FG001|Overall Study|Physician Decision|5|||
126666097|NCT00866697|455737229|FG000|Overall Study|Withdrawal by Subject|33|||
126666098|NCT00866697|455737230|FG001|Overall Study|Withdrawal by Subject|57|||
126666099|NCT02906787|455737233|FG000|Overall Study|Withdrawal by Subject|12|||
126666100|NCT02906787|455737234|FG001|Overall Study|Withdrawal by Subject|10|||
126666101|NCT02906787|455737233|FG000|Overall Study|Missed|24|||
126666102|NCT02906787|455737234|FG001|Overall Study|Missed|22|||
126666103|NCT02818920|455737235|FG000|Overall Study|Unresectable|4|||
126666104|NCT02818920|455737235|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
126666105|NCT02818920|455737235|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
126666106|NCT02818920|455737235|FG000|Overall Study|Adverse Event|3|||
126666107|NCT02818920|455737235|FG000|Overall Study|Developed Other Disease|1|||
126666108|NCT02818920|455737235|FG000|Overall Study|Refused Further Treatment|1|||
126666109|NCT04275297|455737236|FG000|Overall Study|Lost to Follow-up|1|||
126666110|NCT04275297|455737237|FG001|Overall Study|Lost to Follow-up|1|||
126666111|NCT07052682|455737240|FG000|Overall Study|Withdrawal by Subject|4|||
126666112|NCT01310803|455739303|FG000|Overall Study|Subject terminated by Sponsor|1|||
126666113|NCT01310803|455739304|FG001|Overall Study|Subject terminated by Sponsor|0|||
126666114|NCT01306890|455739305|FG000|Overall Study|Adverse Event|2|||
126666115|NCT01306890|455739305|FG000|Overall Study|Death|1223|||
126666116|NCT01306890|455739305|FG000|Overall Study|Lost to Follow-up|58|||
126666117|NCT01306890|455739305|FG000|Overall Study|Withdrawal by Subject|88|||
126666118|NCT01306890|455739305|FG000|Overall Study|Unspecified reasons|104|||
126666119|NCT01306890|455739305|FG000|Overall Study|Study Termination|3|||
126666120|NCT01306890|455739305|FG000|Overall Study|No discontinuation documentation|41|||
126332767|NCT03428100|454513245|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332768|NCT03428100|454513246|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
126332769|NCT03428100|454513247|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
126332770|NCT03428100|454513248|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332771|NCT03428100|454513249|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332772|NCT03428100|454513250|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332773|NCT03428100|454513251|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332774|NCT03428100|454513252|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332775|NCT03428100|454513253|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332776|NCT03428100|454513254|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126666121|NCT03739762|455739310|FG000|Overall Study|Lost to Follow-up|1|||
126666122|NCT03739762|455739311|FG001|Overall Study|Lost to Follow-up|1|||
126666123|NCT03739762|455739310|FG000|Overall Study|Withdrawal by Subject|2|||
126666124|NCT03739762|455739311|FG001|Overall Study|Withdrawal by Subject|6|||
126666125|NCT01131351|455739313|FG000|Overall Study|Adverse Event|0|||
126666126|NCT01131351|455739314|FG001|Overall Study|Adverse Event|2|||
126666127|NCT01131351|455739313|FG000|Overall Study|Protocol Deviation|0|||
126666128|NCT01131351|455739314|FG001|Overall Study|Protocol Deviation|1|||
126666129|NCT02294682|455739315|FG000|Overall Study|Could not swallow pills|1|||
126666130|NCT02294682|455739316|FG001|Overall Study|Could not swallow pills|0|||
126666131|NCT03422172|455739319|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
126666132|NCT03422172|455739319|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
126666133|NCT03422172|455739319|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
126666134|NCT03383289|455739320|FG000|Overall Study|Death|83|||
126332777|NCT03428100|454513255|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332778|NCT03428100|454513256|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332779|NCT03428100|454513257|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332780|NCT03428100|454513258|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332781|NCT03428100|454513259|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332782|NCT03428100|454513260|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332783|NCT03428100|454513261|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332784|NCT03428100|454513262|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
126332785|NCT03428100|454513244|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
126332786|NCT03428100|454513245|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
126332787|NCT03428100|454513246|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
126332788|NCT03428100|454513247|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
126332789|NCT03428100|454513248|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332790|NCT03428100|454513249|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332791|NCT03428100|454513250|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332792|NCT03428100|454513251|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332793|NCT03428100|454513252|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332794|NCT03428100|454513253|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332795|NCT03428100|454513254|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332796|NCT03428100|454513255|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332797|NCT03428100|454513256|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332798|NCT03428100|454513257|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332799|NCT03428100|454513258|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332800|NCT03428100|454513259|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332801|NCT03428100|454513260|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332802|NCT03428100|454513261|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332803|NCT03428100|454513262|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
126332804|NCT03428100|454513244|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332805|NCT03428100|454513245|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
126332806|NCT03428100|454513246|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
126332807|NCT03428100|454513247|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332808|NCT03428100|454513248|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332809|NCT03428100|454513249|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332810|NCT03428100|454513250|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332811|NCT03428100|454513251|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332812|NCT03428100|454513252|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332813|NCT03428100|454513253|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332814|NCT03428100|454513254|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332815|NCT03428100|454513255|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332816|NCT03428100|454513256|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332817|NCT03428100|454513257|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332818|NCT03428100|454513258|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332819|NCT03428100|454513259|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332820|NCT03428100|454513260|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332821|NCT03428100|454513261|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332822|NCT03428100|454513262|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
126332823|NCT03428100|454513244|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
126332824|NCT03428100|454513245|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332825|NCT03428100|454513246|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332826|NCT03428100|454513247|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332827|NCT03428100|454513248|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332828|NCT03428100|454513249|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332829|NCT03428100|454513250|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332830|NCT03428100|454513251|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332831|NCT03428100|454513252|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332832|NCT03428100|454513253|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332833|NCT03428100|454513254|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332834|NCT03428100|454513255|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332835|NCT03428100|454513256|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332836|NCT03428100|454513257|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332837|NCT03428100|454513258|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332838|NCT03428100|454513259|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332839|NCT03428100|454513260|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332840|NCT03428100|454513261|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332841|NCT03428100|454513262|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
126332842|NCT03428100|454513244|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332843|NCT03428100|454513245|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
126332844|NCT03428100|454513246|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332845|NCT03428100|454513247|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332846|NCT03428100|454513248|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332847|NCT03428100|454513249|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332848|NCT03428100|454513250|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332849|NCT03428100|454513251|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332850|NCT03428100|454513252|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332851|NCT03428100|454513253|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332852|NCT03428100|454513254|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332853|NCT03428100|454513255|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332854|NCT03428100|454513256|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332855|NCT03428100|454513257|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332856|NCT03428100|454513258|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332857|NCT03428100|454513259|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332858|NCT03428100|454513260|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332859|NCT03428100|454513261|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332860|NCT03428100|454513262|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
126332861|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332862|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332863|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332864|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332865|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332866|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
126332867|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
126332868|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
126332869|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
126332870|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332871|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
126332872|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332873|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
126332874|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
126332875|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
126332876|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
126332877|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
126332878|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332879|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
126332880|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
126332881|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
126332882|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
126332883|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
126332884|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
126332885|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
126666135|NCT03383289|455739321|FG001|Overall Study|Death|78|||
126666136|NCT03383289|455739320|FG000|Overall Study|discharge from facility|84|||
126666137|NCT03383289|455739321|FG001|Overall Study|discharge from facility|84|||
126666138|NCT03383289|455739320|FG000|Overall Study|Withdrawal by Subject|4|||
126666139|NCT03383289|455739321|FG001|Overall Study|Withdrawal by Subject|1|||
126666140|NCT00059839|455739324|FG000|Overall Study|Death|1|||
126666141|NCT00059839|455739325|FG001|Overall Study|Death|1|||
126666142|NCT00059839|455739324|FG000|Overall Study|Lack of Efficacy|6|||
126666143|NCT00059839|455739325|FG001|Overall Study|Lack of Efficacy|5|||
126666144|NCT00059839|455739324|FG000|Overall Study|Lost to Follow-up|2|||
126666145|NCT00059839|455739325|FG001|Overall Study|Lost to Follow-up|0|||
126666146|NCT00059839|455739324|FG000|Overall Study|Physician Decision|1|||
126666147|NCT00059839|455739325|FG001|Overall Study|Physician Decision|2|||
126666148|NCT00059839|455739324|FG000|Overall Study|Withdrawal by Subject|1|||
126666149|NCT00059839|455739325|FG001|Overall Study|Withdrawal by Subject|6|||
126666150|NCT00059839|455739324|FG000|Overall Study|Ineligible|1|||
126666151|NCT00059839|455739325|FG001|Overall Study|Ineligible|3|||
126666152|NCT00129623|455739326|FG000|Overall Study|Adverse Event|3|||
126666153|NCT00129623|455739327|FG001|Overall Study|Adverse Event|7|||
126666154|NCT00129623|455739326|FG000|Overall Study|Refused Treatment|5|||
126666155|NCT00129623|455739327|FG001|Overall Study|Refused Treatment|3|||
126666156|NCT00129623|455739326|FG000|Overall Study|Failure to Return|1|||
126666157|NCT00129623|455739327|FG001|Overall Study|Failure to Return|1|||
126332886|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
126332887|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
126332888|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
126332889|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
126332890|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
126332891|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
126332892|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
126332893|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
126332894|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
126332895|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
126332896|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
126332897|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
126332898|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
126332899|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
126332900|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
126332901|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
126332902|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
126332903|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
126332904|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
126332905|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
126332906|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
126332907|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
126332908|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
126332909|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
126332910|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
126332911|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
126332912|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
126332913|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
126332914|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
126332915|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
126332916|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
126332917|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
126332918|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332919|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332920|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332921|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126666158|NCT00129623|455739326|FG000|Overall Study|Relocated job out of state|1|||
126666159|NCT00129623|455739327|FG001|Overall Study|Relocated job out of state|0|||
126666160|NCT00129623|455739326|FG000|Overall Study|Uncertainty to return|0|||
126666161|NCT00129623|455739327|FG001|Overall Study|Uncertainty to return|1|||
126666162|NCT03155373|455739328|FG000|Overall Study|No longer required surgery|1|||
126666163|NCT03155373|455739328|FG000|Overall Study|Protocol Violation|1|||
126666164|NCT03155373|455739328|FG000|Overall Study|Death|2|||
126666165|NCT03155373|455739328|FG000|Overall Study|Withdrawal by Subject|3|||
126666166|NCT05352048|455739333|FG000|Overall Study|Lost to Follow-up|1|||
126666167|NCT05352048|455739333|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
126666168|NCT01214187|455739334|FG000|Overall Study|Adverse Event|6|||
126666169|NCT01214187|455739335|FG001|Overall Study|Adverse Event|2|||
126666170|NCT01214187|455739334|FG000|Overall Study|Death|1|||
126666171|NCT01214187|455739335|FG001|Overall Study|Death|1|||
126666172|NCT01214187|455739334|FG000|Overall Study|Withdrawal by Subject|0|||
126666173|NCT01214187|455739335|FG001|Overall Study|Withdrawal by Subject|3|||
126666174|NCT01233869|455739343|FG000|Initial Treatment Period (24 Months)|Death|1|||
126666175|NCT01233869|455739344|FG001|Initial Treatment Period (24 Months)|Death|0|||
126666176|NCT01233869|455739345|FG002|Initial Treatment Period (24 Months)|Death|0|||
126666177|NCT01233869|455739346|FG003|Initial Treatment Period (24 Months)|Death|0|||
126666178|NCT01233869|455739343|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
126666179|NCT01233869|455739344|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
126666180|NCT01233869|455739345|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
126666181|NCT01233869|455739346|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
126666182|NCT01233869|455739343|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
126666183|NCT01233869|455739344|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
126666184|NCT01233869|455739345|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
126332922|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332923|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332924|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332925|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
126332926|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126666185|NCT01233869|455739346|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
126332927|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332928|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332929|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
126332930|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
126332931|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332932|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
126332933|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332934|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332935|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
126332936|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
126332937|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
126332938|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
126332939|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
126332940|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
126332941|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
126332942|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
126332943|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
126332944|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
126332945|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
126332946|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
126332947|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
126332948|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
126332949|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
126332950|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
126332951|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
126332952|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
126666186|NCT01233869|455739343|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
126666187|NCT01233869|455739344|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
126666188|NCT01233869|455739345|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
126666189|NCT01233869|455739346|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
126666190|NCT01233869|455739343|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
126666191|NCT01233869|455739344|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
126666192|NCT01233869|455739345|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
126666193|NCT01233869|455739346|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
126666194|NCT01233869|455739343|FG000|Extended Treatment Period (46 Months)|Other|3|||
126666195|NCT01233869|455739344|FG001|Extended Treatment Period (46 Months)|Other|0|||
126666196|NCT01233869|455739345|FG002|Extended Treatment Period (46 Months)|Other|0|||
126332953|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
126332954|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
126332955|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
126666197|NCT01233869|455739346|FG003|Extended Treatment Period (46 Months)|Other|3|||
126332956|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126666198|NCT01233869|455739343|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
126666199|NCT01233869|455739344|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
126666200|NCT01233869|455739345|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
126666201|NCT01233869|455739346|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
126666202|NCT03678103|455739347|FG000|Overall Study|Withdrawn prior to completion|4|||
126666203|NCT00537485|455739348|FG000|Overall Study|Adverse Event|10|||
126666204|NCT00537485|455739349|FG001|Overall Study|Adverse Event|5|||
126666205|NCT00537485|455739348|FG000|Overall Study|Withdrawal by Subject|3|||
126666206|NCT00537485|455739349|FG001|Overall Study|Withdrawal by Subject|2|||
126666207|NCT00537485|455739348|FG000|Overall Study|Withdrawal by Subject|1|||
126666208|NCT00537485|455739349|FG001|Overall Study|Withdrawal by Subject|3|||
126666209|NCT00537485|455739348|FG000|Overall Study|Physician Decision|1|||
126666210|NCT00537485|455739349|FG001|Overall Study|Physician Decision|0|||
126666211|NCT01241552|455739355|FG000|Overall Study|Lack of Efficacy|1|||
126666212|NCT01241552|455739356|FG001|Overall Study|Lack of Efficacy|0|||
126666213|NCT01241552|455739357|FG002|Overall Study|Lack of Efficacy|0|||
126666214|NCT01241552|455739358|FG003|Overall Study|Lack of Efficacy|0|||
126666215|NCT01241552|455739355|FG000|Overall Study|Death|26|||
126332957|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332958|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332959|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126666216|NCT01241552|455739356|FG001|Overall Study|Death|30|||
126666217|NCT01241552|455739357|FG002|Overall Study|Death|20|||
126666218|NCT01241552|455739358|FG003|Overall Study|Death|25|||
126666219|NCT01241552|455739355|FG000|Overall Study|Adverse Event|1|||
126666220|NCT01241552|455739356|FG001|Overall Study|Adverse Event|1|||
126666221|NCT01241552|455739357|FG002|Overall Study|Adverse Event|0|||
126332960|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126666222|NCT01241552|455739358|FG003|Overall Study|Adverse Event|0|||
126332961|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332962|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
126332963|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332964|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332965|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332966|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332967|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332968|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332969|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332970|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332971|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332972|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332973|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
126332974|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
126332975|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
126332976|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
126332977|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
126332978|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
126332979|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
126332980|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
126332981|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
126332982|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
126332983|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
126332984|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
126332985|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
126332986|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
126332987|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
126332988|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
126332989|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
126332990|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
126332991|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
126332992|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
126332993|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
126332994|NCT03428100|454513244|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126332995|NCT03428100|454513245|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126332996|NCT03428100|454513246|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126332997|NCT03428100|454513247|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126332998|NCT03428100|454513248|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
126332999|NCT03428100|454513249|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126333000|NCT03428100|454513250|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
126333001|NCT03428100|454513251|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
126333002|NCT03428100|454513252|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126333003|NCT03428100|454513253|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
126333004|NCT03428100|454513254|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
126333005|NCT03428100|454513255|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
126333006|NCT03428100|454513256|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
126666223|NCT01241552|455739355|FG000|Overall Study|Technical Problems|2|||
126666224|NCT01241552|455739356|FG001|Overall Study|Technical Problems|0|||
126666225|NCT01241552|455739357|FG002|Overall Study|Technical Problems|2|||
126666226|NCT01241552|455739358|FG003|Overall Study|Technical Problems|2|||
126666227|NCT01241552|455739355|FG000|Overall Study|Progressive Disease|0|||
126666228|NCT01241552|455739356|FG001|Overall Study|Progressive Disease|0|||
126666229|NCT01241552|455739357|FG002|Overall Study|Progressive Disease|1|||
126666230|NCT01241552|455739358|FG003|Overall Study|Progressive Disease|2|||
126666231|NCT01241552|455739355|FG000|Overall Study|Protocol Violation|0|||
126666232|NCT01241552|455739356|FG001|Overall Study|Protocol Violation|2|||
126666233|NCT01241552|455739357|FG002|Overall Study|Protocol Violation|6|||
126666234|NCT01241552|455739358|FG003|Overall Study|Protocol Violation|1|||
126666235|NCT01241552|455739355|FG000|Overall Study|Withdrawal by Subject|7|||
126666236|NCT01241552|455739356|FG001|Overall Study|Withdrawal by Subject|15|||
126333007|NCT03428100|454513257|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
126666237|NCT01241552|455739357|FG002|Overall Study|Withdrawal by Subject|14|||
126666238|NCT01241552|455739358|FG003|Overall Study|Withdrawal by Subject|15|||
126333008|NCT03428100|454513258|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
126333009|NCT03428100|454513259|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126333010|NCT03428100|454513260|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
126333011|NCT03428100|454513261|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
126333012|NCT03428100|454513262|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
126333013|NCT04556760|454513263|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
126333014|NCT04556760|454513264|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
126333015|NCT04556760|454513265|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
126333016|NCT04556760|454513266|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
126333017|NCT04556760|454513267|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
126333018|NCT04556760|454513268|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
126333019|NCT04556760|454513263|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
126333020|NCT04556760|454513264|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
126333021|NCT04556760|454513265|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
126333022|NCT04556760|454513266|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
126333023|NCT04556760|454513267|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
126333024|NCT04556760|454513268|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
126333025|NCT02221648|454513275|FG000|Overall Study|Withdrawal by Subject|3|||
126333026|NCT02221648|454513276|FG001|Overall Study|Withdrawal by Subject|3|||
126333027|NCT03489343|454513280|FG000|Overall Study|Documented progressive disease|1|||
126333028|NCT03489343|454513281|FG001|Overall Study|Documented progressive disease|0|||
126333029|NCT03489343|454513282|FG002|Overall Study|Documented progressive disease|3|||
126333030|NCT03489343|454513283|FG003|Overall Study|Documented progressive disease|1|||
126333031|NCT03489343|454513284|FG004|Overall Study|Documented progressive disease|3|||
126333032|NCT03489343|454513285|FG005|Overall Study|Documented progressive disease|5|||
126333033|NCT03489343|454513286|FG006|Overall Study|Documented progressive disease|4|||
126333034|NCT03489343|454513280|FG000|Overall Study|Adverse Event|0|||
126333035|NCT03489343|454513281|FG001|Overall Study|Adverse Event|1|||
126333036|NCT03489343|454513282|FG002|Overall Study|Adverse Event|0|||
126333037|NCT03489343|454513283|FG003|Overall Study|Adverse Event|0|||
126333038|NCT03489343|454513284|FG004|Overall Study|Adverse Event|0|||
126333039|NCT03489343|454513285|FG005|Overall Study|Adverse Event|1|||
126333040|NCT03489343|454513286|FG006|Overall Study|Adverse Event|0|||
126333041|NCT03489343|454513280|FG000|Overall Study|Withdrawal by Subject|0|||
126333042|NCT03489343|454513281|FG001|Overall Study|Withdrawal by Subject|0|||
126333043|NCT03489343|454513282|FG002|Overall Study|Withdrawal by Subject|0|||
126333044|NCT03489343|454513283|FG003|Overall Study|Withdrawal by Subject|1|||
126333045|NCT03489343|454513284|FG004|Overall Study|Withdrawal by Subject|0|||
126333046|NCT03489343|454513285|FG005|Overall Study|Withdrawal by Subject|1|||
126333047|NCT03489343|454513286|FG006|Overall Study|Withdrawal by Subject|1|||
126333048|NCT03489343|454513280|FG000|Overall Study|Clinical progression|0|||
126333049|NCT03489343|454513281|FG001|Overall Study|Clinical progression|0|||
126333050|NCT03489343|454513282|FG002|Overall Study|Clinical progression|0|||
126333051|NCT03489343|454513283|FG003|Overall Study|Clinical progression|1|||
126333052|NCT03489343|454513284|FG004|Overall Study|Clinical progression|0|||
126333053|NCT03489343|454513285|FG005|Overall Study|Clinical progression|0|||
126333054|NCT03489343|454513286|FG006|Overall Study|Clinical progression|1|||
126333055|NCT00565604|454513290|FG000|Overall Study|Failure to treat|2|||
126333056|NCT00565604|454513290|FG000|Overall Study|Lost to Follow-up|2|||
126333057|NCT05027815|454513291|FG000|Overall Study|Death|2|||
126333058|NCT05027815|454513292|FG001|Overall Study|Death|1|||
126333059|NCT01395810|454513295|FG000|Overall Study|Adverse Event|0|||
126333060|NCT01395810|454513296|FG001|Overall Study|Adverse Event|1|||
126333061|NCT01395810|454513297|FG002|Overall Study|Adverse Event|0|||
126333062|NCT01395810|454513298|FG003|Overall Study|Adverse Event|0|||
126333063|NCT01395810|454513295|FG000|Overall Study|Lack of Efficacy|0|||
126333064|NCT01395810|454513296|FG001|Overall Study|Lack of Efficacy|1|||
126333065|NCT01395810|454513297|FG002|Overall Study|Lack of Efficacy|0|||
126333066|NCT01395810|454513298|FG003|Overall Study|Lack of Efficacy|0|||
126333067|NCT01395810|454513295|FG000|Overall Study|Withdrawal criteria|0|||
126333068|NCT01395810|454513296|FG001|Overall Study|Withdrawal criteria|2|||
126333069|NCT01395810|454513297|FG002|Overall Study|Withdrawal criteria|0|||
126333070|NCT01395810|454513298|FG003|Overall Study|Withdrawal criteria|0|||
126333071|NCT01395810|454513295|FG000|Overall Study|Unclassified|2|||
126333072|NCT01395810|454513296|FG001|Overall Study|Unclassified|0|||
126333073|NCT01395810|454513297|FG002|Overall Study|Unclassified|0|||
126333074|NCT01395810|454513298|FG003|Overall Study|Unclassified|0|||
126333075|NCT03677869|454513302|FG000|Overall Study|Withdrawal by Subject|1|||
126333076|NCT04265261|454513304|FG000|Overall Study|Adverse Event|2|||
126333077|NCT04265261|454513305|FG001|Overall Study|Adverse Event|0|||
126333078|NCT04265261|454513306|FG002|Overall Study|Adverse Event|0|||
126333079|NCT04265261|454513304|FG000|Overall Study|Death|1|||
126333080|NCT04265261|454513305|FG001|Overall Study|Death|0|||
126333081|NCT04265261|454513306|FG002|Overall Study|Death|0|||
126666239|NCT01241552|455739355|FG000|Overall Study|Physician Decision|2|||
126333082|NCT04265261|454513304|FG000|Overall Study|Lost to Follow-up|4|||
126333083|NCT04265261|454513305|FG001|Overall Study|Lost to Follow-up|1|||
126333084|NCT04265261|454513306|FG002|Overall Study|Lost to Follow-up|3|||
126333085|NCT04265261|454513304|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126333086|NCT04265261|454513305|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126333087|NCT04265261|454513306|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126333088|NCT04265261|454513304|FG000|Overall Study|Physician Decision|0|||
126333089|NCT04265261|454513305|FG001|Overall Study|Physician Decision|0|||
126333090|NCT04265261|454513306|FG002|Overall Study|Physician Decision|1|||
126333091|NCT04265261|454513304|FG000|Overall Study|Protocol Deviation|0|||
126333092|NCT04265261|454513305|FG001|Overall Study|Protocol Deviation|2|||
126333093|NCT04265261|454513306|FG002|Overall Study|Protocol Deviation|0|||
126333094|NCT04265261|454513304|FG000|Overall Study|Withdrawal by Subject|2|||
126333095|NCT04265261|454513305|FG001|Overall Study|Withdrawal by Subject|1|||
126333096|NCT04265261|454513306|FG002|Overall Study|Withdrawal by Subject|4|||
126333097|NCT03877224|454513307|FG000|Overall Study|Death|3|||
126333098|NCT03877224|454513308|FG001|Overall Study|Death|2|||
126333099|NCT03877224|454513307|FG000|Overall Study|Withdrawal by Subject|1|||
126666240|NCT01241552|455739356|FG001|Overall Study|Physician Decision|4|||
126666241|NCT01241552|455739357|FG002|Overall Study|Physician Decision|2|||
126666242|NCT01241552|455739358|FG003|Overall Study|Physician Decision|3|||
126333100|NCT03877224|454513308|FG001|Overall Study|Withdrawal by Subject|6|||
126333101|NCT03877224|454513307|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
126333102|NCT03877224|454513308|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
126333103|NCT01212094|454515011|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
126333104|NCT01212094|454515012|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
126333105|NCT01212094|454515013|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
126333106|NCT01212094|454515011|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
126333107|NCT01212094|454515012|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
126333108|NCT01212094|454515013|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
126333109|NCT01212094|454515011|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
126333110|NCT01212094|454515012|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
126333111|NCT01212094|454515013|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
126333112|NCT01212094|454515011|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
126333113|NCT01212094|454515012|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
126333114|NCT01212094|454515013|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
126333115|NCT01212094|454515011|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
126333116|NCT01212094|454515012|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
126333117|NCT01212094|454515013|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
126333118|NCT01212094|454515011|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
126333119|NCT01212094|454515012|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
126333120|NCT01212094|454515013|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
126333121|NCT02019550|454515015|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
126333122|NCT02019550|454515016|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
126333123|NCT00823134|454515018|FG000|Overall Study|Invalid measurement|1|||
126333124|NCT02291029|454515019|FG000|Overall Study|Withdrawal by Subject|0|||
126333125|NCT02291029|454515020|FG001|Overall Study|Withdrawal by Subject|0|||
126333126|NCT02291029|454515021|FG002|Overall Study|Withdrawal by Subject|1|||
126333127|NCT02291029|454515022|FG003|Overall Study|Withdrawal by Subject|0|||
126333128|NCT02291029|454515023|FG004|Overall Study|Withdrawal by Subject|0|||
126333129|NCT02291029|454515024|FG005|Overall Study|Withdrawal by Subject|0|||
126333130|NCT02291029|454515019|FG000|Overall Study|Adverse Event|0|||
126333131|NCT02291029|454515020|FG001|Overall Study|Adverse Event|1|||
126333132|NCT02291029|454515021|FG002|Overall Study|Adverse Event|0|||
126333133|NCT02291029|454515022|FG003|Overall Study|Adverse Event|0|||
126333134|NCT02291029|454515023|FG004|Overall Study|Adverse Event|0|||
126333135|NCT02291029|454515024|FG005|Overall Study|Adverse Event|0|||
126333136|NCT02922153|454515028|FG000|Overall Study|Death|8|||
126333137|NCT02922153|454515029|FG001|Overall Study|Death|1|||
126333138|NCT02922153|454515028|FG000|Overall Study|Lost to Follow-up|1|||
126333139|NCT02922153|454515029|FG001|Overall Study|Lost to Follow-up|0|||
126333140|NCT02922153|454515028|FG000|Overall Study|Physician Decision|1|||
126333141|NCT02922153|454515029|FG001|Overall Study|Physician Decision|1|||
126666243|NCT01241552|455739355|FG000|Overall Study|Lost to Follow-up|2|||
126333142|NCT02692586|454515032|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
126333143|NCT02692586|454515032|FG000|Overall Study|Received adjunctive thrombolytics|2|||
126333144|NCT01051557|454515034|FG000|Overall Study|Physician Decision|1|||
126333145|NCT01051557|454515035|FG001|Overall Study|Physician Decision|0|||
126333146|NCT01051557|454515036|FG002|Overall Study|Physician Decision|0|||
126333147|NCT01051557|454515037|FG003|Overall Study|Physician Decision|0|||
126333148|NCT01051557|454515038|FG004|Overall Study|Physician Decision|0|||
126666244|NCT01241552|455739356|FG001|Overall Study|Lost to Follow-up|11|||
126666245|NCT01241552|455739357|FG002|Overall Study|Lost to Follow-up|15|||
126666246|NCT01241552|455739358|FG003|Overall Study|Lost to Follow-up|16|||
126666247|NCT01296035|455739360|FG000|Overall Study|Withdrawal by Subject|1|||
126666248|NCT05696236|455739365|FG000|Overall Study|Lost to Follow-up|1|||
126666249|NCT05696236|455739366|FG001|Overall Study|Lost to Follow-up|0|||
126666250|NCT05696236|455739365|FG000|Overall Study|Later determined to not be eligible for participation|0|||
126666251|NCT05696236|455739366|FG001|Overall Study|Later determined to not be eligible for participation|1|||
126666252|NCT05696236|455739365|FG000|Overall Study|Withdrawal by Subject|2|||
126666253|NCT05696236|455739366|FG001|Overall Study|Withdrawal by Subject|2|||
126666254|NCT01145495|455739369|FG000|Overall Study|Adverse Event|6|||
126666255|NCT01145495|455739369|FG000|Overall Study|Withdrawal by Subject|6|||
126666256|NCT01145495|455739369|FG000|Overall Study|Disease progression after respone|2|||
126666257|NCT01886313|455739370|FG000|Overall Study|Adverse Event|1|||
126666258|NCT01886313|455739371|FG001|Overall Study|Adverse Event|1|||
126666259|NCT02378220|455739372|FG000|Overall Study|Death|6|||
126666260|NCT02378220|455739373|FG001|Overall Study|Death|1|||
126666261|NCT00312221|455739374|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
126666262|NCT00312221|455739375|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
126666263|NCT00312221|455739376|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
126666264|NCT00312221|455739377|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
126666265|NCT00312221|455739374|FG000|Open-label Run-in Period|Adverse Event|74|||
126666266|NCT00312221|455739375|FG001|Open-label Run-in Period|Adverse Event|0|||
126666267|NCT00312221|455739376|FG002|Open-label Run-in Period|Adverse Event|0|||
126666268|NCT00312221|455739377|FG003|Open-label Run-in Period|Adverse Event|0|||
126666269|NCT00312221|455739374|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
126666270|NCT00312221|455739375|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
126666271|NCT00312221|455739376|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
126666272|NCT00312221|455739377|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
126666273|NCT00312221|455739374|FG000|Open-label Run-in Period|Administrative|42|||
126666274|NCT00312221|455739375|FG001|Open-label Run-in Period|Administrative|0|||
126666275|NCT00312221|455739376|FG002|Open-label Run-in Period|Administrative|0|||
126333149|NCT01051557|454515039|FG005|Overall Study|Physician Decision|0|||
126333150|NCT01051557|454515040|FG006|Overall Study|Physician Decision|0|||
126333151|NCT01051557|454515034|FG000|Overall Study|disease progression|3|||
126333152|NCT01051557|454515035|FG001|Overall Study|disease progression|3|||
126333153|NCT01051557|454515036|FG002|Overall Study|disease progression|5|||
126333154|NCT01051557|454515037|FG003|Overall Study|disease progression|2|||
126333155|NCT01051557|454515038|FG004|Overall Study|disease progression|4|||
126333156|NCT01051557|454515039|FG005|Overall Study|disease progression|3|||
126333157|NCT01051557|454515040|FG006|Overall Study|disease progression|1|||
126333158|NCT01051557|454515034|FG000|Overall Study|Withdrawal by Subject|0|||
126333159|NCT01051557|454515035|FG001|Overall Study|Withdrawal by Subject|0|||
126333160|NCT01051557|454515036|FG002|Overall Study|Withdrawal by Subject|1|||
126333161|NCT01051557|454515037|FG003|Overall Study|Withdrawal by Subject|0|||
126333162|NCT01051557|454515038|FG004|Overall Study|Withdrawal by Subject|2|||
126333163|NCT01051557|454515039|FG005|Overall Study|Withdrawal by Subject|0|||
126333164|NCT01051557|454515040|FG006|Overall Study|Withdrawal by Subject|1|||
126333165|NCT01051557|454515034|FG000|Overall Study|Adverse Event|0|||
126333166|NCT01051557|454515035|FG001|Overall Study|Adverse Event|0|||
126333167|NCT01051557|454515036|FG002|Overall Study|Adverse Event|0|||
126333168|NCT01051557|454515037|FG003|Overall Study|Adverse Event|1|||
126333169|NCT01051557|454515038|FG004|Overall Study|Adverse Event|1|||
126333170|NCT01051557|454515039|FG005|Overall Study|Adverse Event|3|||
126333171|NCT01051557|454515040|FG006|Overall Study|Adverse Event|4|||
126333172|NCT04110314|454515041|FG000|Overall Study|Did not meet inclusion criteria|35255|||
126333173|NCT04110314|454515042|FG001|Overall Study|Did not meet inclusion criteria|35104|||
126333174|NCT04110314|454515043|FG002|Overall Study|Did not meet inclusion criteria|35636|||
126333175|NCT04110314|454515044|FG003|Overall Study|Did not meet inclusion criteria|35135|||
126333176|NCT04110314|454515045|FG004|Overall Study|Did not meet inclusion criteria|35247|||
126333177|NCT04110314|454515046|FG005|Overall Study|Did not meet inclusion criteria|35727|||
126333178|NCT01178125|454515055|FG000|Overall Study|Lost to Follow-up|397|||
126333179|NCT01178125|454515055|FG000|Overall Study|Adverse Event|244|||
126333180|NCT01178125|454515055|FG000|Overall Study|Withdrawal by Subject|209|||
126333181|NCT01178125|454515055|FG000|Overall Study|Noncompliance|184|||
126666276|NCT00312221|455739377|FG003|Open-label Run-in Period|Administrative|0|||
126666277|NCT00312221|455739374|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
126666278|NCT00312221|455739375|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
126666279|NCT00312221|455739376|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
126666280|NCT00312221|455739377|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
126333182|NCT01178125|454515055|FG000|Overall Study|Pregnancy|55|||
126333183|NCT01178125|454515055|FG000|Overall Study|Other Reason|39|||
126333184|NCT01178125|454515055|FG000|Overall Study|Sponsor Decision|28|||
126333185|NCT01178125|454515055|FG000|Overall Study|Protocol Violation|17|||
126333186|NCT01178125|454515055|FG000|Overall Study|Investigator Decision|5|||
126333187|NCT02948829|454515056|FG000|Overall Study|Lost to Follow-up|2|||
126333188|NCT02948829|454515056|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
126666281|NCT00312221|455739374|FG000|Open-label Run-in Period|Did not qualify|5|||
126666282|NCT00312221|455739375|FG001|Open-label Run-in Period|Did not qualify|0|||
126666283|NCT00312221|455739376|FG002|Open-label Run-in Period|Did not qualify|0|||
126666284|NCT00312221|455739377|FG003|Open-label Run-in Period|Did not qualify|0|||
126666285|NCT00312221|455739374|FG000|Double-blind Phase|Withdrawal by Subject|0|||
126666286|NCT00312221|455739375|FG001|Double-blind Phase|Withdrawal by Subject|6|||
126666287|NCT00312221|455739376|FG002|Double-blind Phase|Withdrawal by Subject|8|||
126666288|NCT00312221|455739377|FG003|Double-blind Phase|Withdrawal by Subject|7|||
126666289|NCT00312221|455739374|FG000|Double-blind Phase|Adverse Event|0|||
126666290|NCT00312221|455739375|FG001|Double-blind Phase|Adverse Event|10|||
126333189|NCT02948829|454515056|FG000|Overall Study|Pregnancy|1|||
126333190|NCT02948829|454515056|FG000|Overall Study|Other: Reason not Specified|8|||
126333191|NCT01004978|454515057|FG000|Overall Study|Disease progression|31|||
126333192|NCT01004978|454515058|FG001|Overall Study|Disease progression|48|||
126333193|NCT01004978|454515057|FG000|Overall Study|Adverse Event|42|||
126333194|NCT01004978|454515058|FG001|Overall Study|Adverse Event|22|||
126666291|NCT00312221|455739376|FG002|Double-blind Phase|Adverse Event|19|||
126666292|NCT00312221|455739377|FG003|Double-blind Phase|Adverse Event|18|||
126666293|NCT00312221|455739374|FG000|Double-blind Phase|Lost to Follow-up|0|||
126666294|NCT00312221|455739375|FG001|Double-blind Phase|Lost to Follow-up|0|||
126666295|NCT00312221|455739376|FG002|Double-blind Phase|Lost to Follow-up|2|||
126666296|NCT00312221|455739377|FG003|Double-blind Phase|Lost to Follow-up|2|||
126666297|NCT00312221|455739374|FG000|Double-blind Phase|Administrative|0|||
126666298|NCT00312221|455739375|FG001|Double-blind Phase|Administrative|26|||
126666299|NCT00312221|455739376|FG002|Double-blind Phase|Administrative|37|||
126666300|NCT00312221|455739377|FG003|Double-blind Phase|Administrative|33|||
126666301|NCT00312221|455739374|FG000|Double-blind Phase|Lack of Efficacy|0|||
126666302|NCT00312221|455739375|FG001|Double-blind Phase|Lack of Efficacy|17|||
126666303|NCT00312221|455739376|FG002|Double-blind Phase|Lack of Efficacy|6|||
126666304|NCT00312221|455739377|FG003|Double-blind Phase|Lack of Efficacy|10|||
126666305|NCT02060721|455739378|FG000|Overall Study|Lost to Follow-up|1|||
126666306|NCT02060721|455739378|FG000|Overall Study|Physician Decision|2|||
126666307|NCT02060721|455739378|FG000|Overall Study|Death|14|||
126666308|NCT02060721|455739378|FG000|Overall Study|Withdrawal by Subject|2|||
126666309|NCT02060721|455739378|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
126666310|NCT00117507|455739379|FG000|Overall Study|Adverse Event|4|||
126666311|NCT00117507|455739379|FG000|Overall Study|Abnormal laboratory values|3|||
126666312|NCT00117507|455739379|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126666313|NCT00117507|455739379|FG000|Overall Study|Patient withdrew consent|4|||
126666314|NCT00117507|455739379|FG000|Overall Study|Death|3|||
126666315|NCT00866723|455739380|FG000|Overall Study|Withdrawal by Subject|1|||
126666316|NCT00866723|455739380|FG000|Overall Study|Disease Progression|4|||
126666317|NCT01271803|455739381|FG000|Overall Study|Progressive disease|0|||
126666318|NCT01271803|455739382|FG001|Overall Study|Progressive disease|0|||
126666319|NCT01271803|455739383|FG002|Overall Study|Progressive disease|2|||
126666320|NCT01271803|455739381|FG000|Overall Study|Death|53|||
126666321|NCT01271803|455739382|FG001|Overall Study|Death|34|||
126666322|NCT01271803|455739383|FG002|Overall Study|Death|0|||
126666323|NCT01271803|455739381|FG000|Overall Study|Withdrawal by Subject|1|||
126666324|NCT01271803|455739382|FG001|Overall Study|Withdrawal by Subject|5|||
126666325|NCT01271803|455739383|FG002|Overall Study|Withdrawal by Subject|0|||
126666326|NCT01271803|455739381|FG000|Overall Study|Lost to Follow-up|1|||
126666327|NCT01271803|455739382|FG001|Overall Study|Lost to Follow-up|0|||
126666328|NCT01271803|455739383|FG002|Overall Study|Lost to Follow-up|0|||
126666329|NCT01862640|455739387|FG000|Overall Study|Adverse Event|4|||
126666330|NCT01862640|455739388|FG001|Overall Study|Adverse Event|10|||
126666331|NCT01862640|455739389|FG002|Overall Study|Adverse Event|6|||
126666332|NCT01862640|455739390|FG003|Overall Study|Adverse Event|8|||
126666333|NCT01862640|455739387|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
126666334|NCT01862640|455739388|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
126666335|NCT01862640|455739389|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
126666336|NCT01862640|455739390|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
126666337|NCT01862640|455739387|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
126666338|NCT01862640|455739388|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
126666339|NCT01862640|455739389|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
126666340|NCT01862640|455739390|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
126666341|NCT01862640|455739387|FG000|Overall Study|Withdrawal by Subject|2|||
126666342|NCT01862640|455739388|FG001|Overall Study|Withdrawal by Subject|4|||
126666343|NCT01862640|455739389|FG002|Overall Study|Withdrawal by Subject|8|||
126333195|NCT01004978|454515057|FG000|Overall Study|Death|3|||
126333196|NCT01004978|454515058|FG001|Overall Study|Death|2|||
126333197|NCT01004978|454515057|FG000|Overall Study|Withdrawal by Subject|16|||
126666344|NCT01862640|455739390|FG003|Overall Study|Withdrawal by Subject|5|||
126666345|NCT01862640|455739387|FG000|Overall Study|Protocol Deviation|0|||
126666346|NCT01862640|455739388|FG001|Overall Study|Protocol Deviation|0|||
126666347|NCT01862640|455739389|FG002|Overall Study|Protocol Deviation|1|||
126666348|NCT01862640|455739390|FG003|Overall Study|Protocol Deviation|0|||
126333198|NCT01004978|454515058|FG001|Overall Study|Withdrawal by Subject|16|||
126333199|NCT01004978|454515057|FG000|Overall Study|Alternative therapy|4|||
126333200|NCT01004978|454515058|FG001|Overall Study|Alternative therapy|8|||
126333201|NCT01004978|454515057|FG000|Overall Study|Physician Decision|6|||
126333202|NCT01004978|454515058|FG001|Overall Study|Physician Decision|3|||
126333203|NCT01004978|454515057|FG000|Overall Study|Other complicating disease|2|||
126333204|NCT01004978|454515058|FG001|Overall Study|Other complicating disease|2|||
126333205|NCT01004978|454515057|FG000|Overall Study|Protocol Violation|2|||
126333206|NCT01004978|454515058|FG001|Overall Study|Protocol Violation|3|||
126333207|NCT01004978|454515057|FG000|Overall Study|Non-compliance|3|||
126333208|NCT01004978|454515058|FG001|Overall Study|Non-compliance|2|||
126333209|NCT01004978|454515057|FG000|Overall Study|Ineligible|1|||
126333210|NCT01004978|454515058|FG001|Overall Study|Ineligible|0|||
126333211|NCT01004978|454515057|FG000|Overall Study|Unblinded|0|||
126333212|NCT01004978|454515058|FG001|Overall Study|Unblinded|1|||
126333213|NCT01004978|454515057|FG000|Overall Study|Performance status worsening|0|||
126333214|NCT01004978|454515058|FG001|Overall Study|Performance status worsening|1|||
126333215|NCT01004978|454515057|FG000|Overall Study|Never started treatment|8|||
126666349|NCT02178553|455739393|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
126666350|NCT02178553|455739394|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
126666351|NCT02178553|455739393|FG000|Overall Study|Physician Decision|0|||
126333216|NCT01004978|454515058|FG001|Overall Study|Never started treatment|9|||
126333217|NCT00369915|454515059|FG000|Overall Study|expected side effects|2|||
126333218|NCT00369915|454515060|FG001|Overall Study|expected side effects|1|||
126333219|NCT00369915|454515059|FG000|Overall Study|Withdrawal by Subject|4|||
126333220|NCT00369915|454515060|FG001|Overall Study|Withdrawal by Subject|1|||
126333221|NCT00369915|454515059|FG000|Overall Study|W/drawl by investigators|0|||
126333222|NCT00369915|454515060|FG001|Overall Study|W/drawl by investigators|1|||
126333223|NCT01711983|454515061|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
126333224|NCT01711983|454515061|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
126333225|NCT01711983|454515061|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
126333226|NCT01711983|454515061|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
126333227|NCT01447407|454515062|FG000|Overall Study|Withdrawal by Subject|2|||
126333228|NCT01447407|454515063|FG001|Overall Study|Withdrawal by Subject|0|||
126333229|NCT01447407|454515064|FG002|Overall Study|Withdrawal by Subject|0|||
126333230|NCT01447407|454515065|FG003|Overall Study|Withdrawal by Subject|1|||
126333231|NCT01447407|454515062|FG000|Overall Study|Physician Decision|0|||
126333232|NCT01447407|454515063|FG001|Overall Study|Physician Decision|0|||
126333233|NCT01447407|454515064|FG002|Overall Study|Physician Decision|1|||
126333234|NCT01447407|454515065|FG003|Overall Study|Physician Decision|1|||
126333235|NCT00268983|454515066|FG000|Overall Study|Death|3|||
126333236|NCT00268983|454515067|FG001|Overall Study|Death|0|||
126333237|NCT00321906|454515074|FG000|Overall Study|Adverse Event|36|||
126333238|NCT00321906|454515075|FG001|Overall Study|Adverse Event|44|||
126333239|NCT00321906|454515074|FG000|Overall Study|Death|9|||
126333240|NCT00321906|454515075|FG001|Overall Study|Death|6|||
126333241|NCT00321906|454515074|FG000|Overall Study|Lost to Follow-up|1|||
126333242|NCT00321906|454515075|FG001|Overall Study|Lost to Follow-up|2|||
126333243|NCT00321906|454515074|FG000|Overall Study|Withdrawal by Subject|0|||
126333244|NCT00321906|454515075|FG001|Overall Study|Withdrawal by Subject|4|||
126333245|NCT01272908|454515076|FG000|Initial Treatment Period|Adverse Event|1|||
126333246|NCT01272908|454515076|FG000|Initial Treatment Period|Lack of Efficacy|5|||
126333247|NCT01272908|454515076|FG000|Initial Treatment Period|Protocol Violation|1|||
126333248|NCT01272908|454515076|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
126333249|NCT01272908|454515076|FG000|Re-Treatment Period|Adverse Event|2|||
126333250|NCT01272908|454515076|FG000|Re-Treatment Period|Lack of Efficacy|3|||
126333251|NCT01272908|454515076|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
126333252|NCT01158261|454515077|FG000|Overall Study|Lost to Follow-up|9|||
126333253|NCT01158261|454515077|FG000|Overall Study|Death|7|||
126333254|NCT01158261|454515077|FG000|Overall Study|Withdrawal by Subject|1|||
126333255|NCT03143101|454515078|FG000|Overall Study|Withdrawal by Subject|0|||
126333256|NCT03143101|454515079|FG001|Overall Study|Withdrawal by Subject|1|||
126333257|NCT03143101|454515080|FG002|Overall Study|Withdrawal by Subject|0|||
126333258|NCT03143101|454515078|FG000|Overall Study|Lost to Follow-up|2|||
126333259|NCT03143101|454515079|FG001|Overall Study|Lost to Follow-up|2|||
126666352|NCT02178553|455739394|FG001|Overall Study|Physician Decision|4|||
126333260|NCT03143101|454515080|FG002|Overall Study|Lost to Follow-up|0|||
126333261|NCT01630135|454515082|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
126333262|NCT01630135|454515083|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
126333263|NCT03243305|454515086|FG000|Overall Study|Lost to Follow-up|250|||
126333264|NCT03243305|454515086|FG000|Overall Study|Withdrawal by Subject|170|||
126333265|NCT03243305|454515086|FG000|Overall Study|Pregnancy|104|||
126333266|NCT03243305|454515086|FG000|Overall Study|Non-Compliance with Study Drug|38|||
126333267|NCT03243305|454515086|FG000|Overall Study|Adverse Event|23|||
126333268|NCT03243305|454515086|FG000|Overall Study|No sexually active|26|||
126333269|NCT03243305|454515086|FG000|Overall Study|Physician Decision|22|||
126666353|NCT02178553|455739393|FG000|Overall Study|Technical problem with injection|1|||
126666354|NCT02178553|455739394|FG001|Overall Study|Technical problem with injection|3|||
126666355|NCT01641809|455739395|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
126666356|NCT01641809|455739396|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
126666357|NCT01641809|455739397|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
126666358|NCT01641809|455739398|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
126666359|NCT01641809|455739395|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
126666360|NCT01641809|455739396|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
126666361|NCT01641809|455739397|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
126333270|NCT03243305|454515086|FG000|Overall Study|Protocol Violation|22|||
126666362|NCT01641809|455739398|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
126666363|NCT01641809|455739395|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
126666364|NCT01641809|455739396|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
126666365|NCT01641809|455739397|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
126666366|NCT01641809|455739398|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
126666367|NCT01641809|455739395|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
126666368|NCT01641809|455739396|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
126666369|NCT01641809|455739397|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
126666370|NCT01641809|455739398|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
126666371|NCT01641809|455739395|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
126666372|NCT01641809|455739396|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
126666373|NCT01641809|455739397|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
126666374|NCT01641809|455739398|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
126666375|NCT01641809|455739395|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
126666376|NCT01641809|455739396|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
126666377|NCT01641809|455739397|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
126666378|NCT01641809|455739398|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
126666379|NCT01641809|455739395|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
126666380|NCT01641809|455739396|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
126666381|NCT01641809|455739397|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
126666382|NCT01641809|455739398|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
126666383|NCT01641809|455739395|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
126666384|NCT01641809|455739396|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
126666385|NCT01641809|455739397|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
126666386|NCT01641809|455739398|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
126666387|NCT01641809|455739395|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
126333271|NCT03243305|454515086|FG000|Overall Study|Study method no longer primary method|12|||
126333272|NCT03243305|454515086|FG000|Overall Study|Study Terminated by Sponsor|1|||
126333273|NCT03243305|454515086|FG000|Overall Study|Early terminations|267|||
126333274|NCT01166750|454515088|FG000|Overall Study|Lost to Follow-up|1|||
126333275|NCT01166750|454515089|FG001|Overall Study|Lost to Follow-up|0|||
126333276|NCT01585246|454515090|FG000|Overall Study|Lost to Follow-up|0|||
126333277|NCT01585246|454515091|FG001|Overall Study|Lost to Follow-up|0|||
126333278|NCT01585246|454515092|FG002|Overall Study|Lost to Follow-up|2|||
126333279|NCT01585246|454515093|FG003|Overall Study|Lost to Follow-up|1|||
126333280|NCT01585246|454515094|FG004|Overall Study|Lost to Follow-up|0|||
126333281|NCT01585246|454515090|FG000|Overall Study|Protocol Violation|0|||
126333282|NCT01585246|454515091|FG001|Overall Study|Protocol Violation|0|||
126333283|NCT01585246|454515092|FG002|Overall Study|Protocol Violation|0|||
126333284|NCT01585246|454515093|FG003|Overall Study|Protocol Violation|0|||
126333285|NCT01585246|454515094|FG004|Overall Study|Protocol Violation|1|||
126333286|NCT01585246|454515090|FG000|Overall Study|Withdrawal by Subject|0|||
126333287|NCT01585246|454515091|FG001|Overall Study|Withdrawal by Subject|0|||
126333288|NCT01585246|454515092|FG002|Overall Study|Withdrawal by Subject|1|||
126333289|NCT01585246|454515093|FG003|Overall Study|Withdrawal by Subject|2|||
126333290|NCT01585246|454515094|FG004|Overall Study|Withdrawal by Subject|1|||
126333291|NCT01585246|454515090|FG000|Overall Study|Other|0|||
126333292|NCT01585246|454515091|FG001|Overall Study|Other|1|||
126333293|NCT01585246|454515092|FG002|Overall Study|Other|1|||
126333294|NCT01585246|454515093|FG003|Overall Study|Other|1|||
126333295|NCT01585246|454515094|FG004|Overall Study|Other|0|||
126333296|NCT04396626|454515095|FG000|Overall Study|Premature termination of study|975|||
126333297|NCT02111174|454515098|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
126333298|NCT02111174|454515099|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
126333299|NCT02111174|454515098|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
126333300|NCT02111174|454515099|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
126333301|NCT02111174|454515098|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
126333302|NCT02111174|454515099|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
126333303|NCT02111174|454515098|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
126333304|NCT02111174|454515099|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
126333305|NCT00838097|454515102|FG000|Overall Study|Ineligibility determined|6|||
126333306|NCT00838097|454515102|FG000|Overall Study|Adverse Event|2|||
126333307|NCT00838097|454515102|FG000|Overall Study|Withdrawal by Subject|3|||
126333308|NCT00838097|454515102|FG000|Overall Study|Requirement for alternative therapy|2|||
126333309|NCT00838097|454515102|FG000|Overall Study|Physician Decision|4|||
126333310|NCT00838097|454515102|FG000|Overall Study|Lost to Follow-up|11|||
126333311|NCT00838097|454515102|FG000|Overall Study|Death|6|||
126333312|NCT00838097|454515102|FG000|Overall Study|Protocol-specified criteria|142|||
126333313|NCT00871234|454515103|FG000|Overall Study|Adverse Event|2|||
126333314|NCT00871234|454515103|FG000|Overall Study|Lost to Follow-up|3|||
126333315|NCT03380377|454515106|FG000|Overall Study|Physician Decision|1|||
126666388|NCT01641809|455739396|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
126333316|NCT03380377|454515106|FG000|Overall Study|Withdrawal by Subject|1|||
126333317|NCT02600923|454515109|FG000|Overall Study|Death|10|||
126333318|NCT02600923|454515109|FG000|Overall Study|Adverse Event|3|||
126333319|NCT02600923|454515109|FG000|Overall Study|Global deterioration of health status|2|||
126333320|NCT02600923|454515109|FG000|Overall Study|Insufficient clinical response|6|||
126333321|NCT02600923|454515109|FG000|Overall Study|Lost to Follow-up|1|||
126333322|NCT02600923|454515109|FG000|Overall Study|Withdrawal by Subject|5|||
126333323|NCT02600923|454515109|FG000|Overall Study|Objective progression or relapse|50|||
126333324|NCT02600923|454515109|FG000|Overall Study|Study terminated by Sponsor|53|||
126333325|NCT02600923|454515109|FG000|Overall Study|Not treated|1|||
126333326|NCT00792909|454515110|FG000|Overall Study|Withdrawal by Subject|0|||
126333327|NCT00792909|454515111|FG001|Overall Study|Withdrawal by Subject|1|||
126333328|NCT00792909|454515112|FG002|Overall Study|Withdrawal by Subject|0|||
126333329|NCT00128661|454515115|FG000|Overall Study|Adverse Event|14|||
126333330|NCT00128661|454515116|FG001|Overall Study|Adverse Event|11|||
126333331|NCT00128661|454515115|FG000|Overall Study|Lost to Follow-up|10|||
126333332|NCT00128661|454515116|FG001|Overall Study|Lost to Follow-up|7|||
126333333|NCT00128661|454515115|FG000|Overall Study|Withdrawal by Subject|243|||
126333334|NCT00128661|454515116|FG001|Overall Study|Withdrawal by Subject|232|||
126333335|NCT00128661|454515115|FG000|Overall Study|Other|7|||
126333336|NCT00128661|454515116|FG001|Overall Study|Other|8|||
126333337|NCT01261390|454515118|FG000|Overall Study|Significant Concurrent Illness|1|||
126333338|NCT01261390|454515119|FG001|Overall Study|Significant Concurrent Illness|0|||
126333339|NCT01261390|454515120|FG002|Overall Study|Significant Concurrent Illness|1|||
126333340|NCT01261390|454515121|FG003|Overall Study|Significant Concurrent Illness|0|||
126333341|NCT01261390|454515118|FG000|Overall Study|Dissatisfaction with Treatment|2|||
126333342|NCT01261390|454515119|FG001|Overall Study|Dissatisfaction with Treatment|1|||
126333343|NCT01261390|454515120|FG002|Overall Study|Dissatisfaction with Treatment|1|||
126333344|NCT01261390|454515121|FG003|Overall Study|Dissatisfaction with Treatment|2|||
126333345|NCT01261390|454515118|FG000|Overall Study|Relocation|0|||
126333346|NCT01261390|454515119|FG001|Overall Study|Relocation|1|||
126333347|NCT01261390|454515120|FG002|Overall Study|Relocation|0|||
126333348|NCT01261390|454515121|FG003|Overall Study|Relocation|0|||
126333349|NCT01261390|454515118|FG000|Overall Study|Loss of Interest in the Study|3|||
126333350|NCT01261390|454515119|FG001|Overall Study|Loss of Interest in the Study|1|||
126333351|NCT01261390|454515120|FG002|Overall Study|Loss of Interest in the Study|0|||
126333352|NCT01261390|454515121|FG003|Overall Study|Loss of Interest in the Study|0|||
126333353|NCT01261390|454515118|FG000|Overall Study|Lost to Follow-up|1|||
126333354|NCT01261390|454515119|FG001|Overall Study|Lost to Follow-up|6|||
126333355|NCT01261390|454515120|FG002|Overall Study|Lost to Follow-up|5|||
126333356|NCT01261390|454515121|FG003|Overall Study|Lost to Follow-up|6|||
126333357|NCT00977613|454515126|FG000|Overall Study|Lost to Follow-up|16|||
126333358|NCT01497067|454515127|FG000|Overall Study|Lost to Follow-up|56|||
126333359|NCT01497067|454515127|FG000|Overall Study|Adverse Event|3|||
126333360|NCT01497067|454515127|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
126333361|NCT01497067|454515127|FG000|Overall Study|Other|13|||
126333362|NCT01598610|454515130|FG000|Overall Study|Adverse Event|1|||
126333363|NCT04346199|454515131|FG000|Overall Study|Death|8|||
126333364|NCT04346199|454515132|FG001|Overall Study|Death|9|||
126666389|NCT01641809|455739397|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
126666390|NCT01641809|455739398|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
126666391|NCT01641809|455739395|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
126666392|NCT01641809|455739396|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
126666393|NCT01641809|455739397|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
126333365|NCT04346199|454515131|FG000|Overall Study|Lost to Follow-up|0|||
126333366|NCT04346199|454515132|FG001|Overall Study|Lost to Follow-up|1|||
126333367|NCT04346199|454515131|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
126333368|NCT04346199|454515132|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
126333369|NCT04346199|454515131|FG000|Overall Study|Withdrawal by Subject|5|||
126333370|NCT04346199|454515132|FG001|Overall Study|Withdrawal by Subject|1|||
126333371|NCT03066830|454515133|FG000|Overall Study|At the Participant's own Request|16|||
126333372|NCT03066830|454515134|FG001|Overall Study|At the Participant's own Request|17|||
126333373|NCT03066830|454515133|FG000|Overall Study|Other|3|||
126333374|NCT03066830|454515134|FG001|Overall Study|Other|0|||
126333375|NCT03066830|454515133|FG000|Overall Study|Poor Compliance to Protocol|1|||
126333376|NCT03066830|454515134|FG001|Overall Study|Poor Compliance to Protocol|0|||
126333377|NCT03066830|454515133|FG000|Overall Study|Adverse Event|2|||
126333378|NCT03066830|454515134|FG001|Overall Study|Adverse Event|2|||
126333379|NCT03066830|454515133|FG000|Overall Study|Lost to Follow-up|11|||
126666394|NCT01641809|455739398|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
126333380|NCT03066830|454515134|FG001|Overall Study|Lost to Follow-up|3|||
126333381|NCT02989402|454515135|FG000|Overall Study|Adverse event, or serious adverse event|4|||
126333382|NCT02989402|454515135|FG000|Overall Study|Death|2|||
126333383|NCT02989402|454515135|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
126333384|NCT02989402|454515135|FG000|Overall Study|Lost to Follow-up|8|||
126333385|NCT02989402|454515135|FG000|Overall Study|Patient no longer on monotherapy|1|||
126333386|NCT02989402|454515135|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
126333387|NCT02989402|454515135|FG000|Overall Study|Withdrawal by Subject|7|||
126333388|NCT02989402|454515135|FG000|Overall Study|Other|2|||
126333389|NCT02039778|454515136|FG000|Overall Study|Death|2|||
126333390|NCT02039778|454515136|FG000|Overall Study|Withdrawal by Subject|1|||
126333391|NCT02039778|454515136|FG000|Overall Study|Never started the protocol treatment|1|||
126333392|NCT04001803|454515144|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
126333393|NCT04001803|454515144|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
126333394|NCT04001803|454515144|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
126333395|NCT04001803|454515144|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
126333396|NCT04001803|454515144|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
126333397|NCT04001803|454515144|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
126333398|NCT04001803|454515144|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
126333399|NCT04001803|454515144|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
126333400|NCT04001803|454515144|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
126333401|NCT04001803|454515144|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
126333402|NCT05404711|454515145|FG000|Completed Study Visit|Withdrawal by Subject|1|||
126333403|NCT05404711|454515145|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
126333404|NCT05404711|454515145|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
126333405|NCT05404711|454515145|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
126333406|NCT05404711|454515145|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
126333407|NCT05404711|454515145|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
126333408|NCT02346877|454515148|FG000|Overall Study|Adverse Event|1|||
126333409|NCT02346877|454515149|FG001|Overall Study|Adverse Event|0|||
126333410|NCT02346877|454515148|FG000|Overall Study|Administrative Decision|1|||
126333411|NCT02346877|454515149|FG001|Overall Study|Administrative Decision|0|||
126333412|NCT02346877|454515148|FG000|Overall Study|Sponsor Decision|12|||
126333413|NCT02346877|454515149|FG001|Overall Study|Sponsor Decision|0|||
126333414|NCT02346877|454515148|FG000|Overall Study|Missing|5|||
126333415|NCT02346877|454515149|FG001|Overall Study|Missing|0|||
126333416|NCT00447902|454515150|FG000|Overall Study|Adverse Event|0|||
126333417|NCT00447902|454515151|FG001|Overall Study|Adverse Event|3|||
126333418|NCT00447902|454515150|FG000|Overall Study|Protocol Violation|1|||
126333419|NCT00447902|454515151|FG001|Overall Study|Protocol Violation|0|||
126333420|NCT00447902|454515150|FG000|Overall Study|Withdrawal by Subject|0|||
126333421|NCT00447902|454515151|FG001|Overall Study|Withdrawal by Subject|1|||
126333422|NCT00447902|454515150|FG000|Overall Study|included patients who discontinued|1|||
126333423|NCT00447902|454515151|FG001|Overall Study|included patients who discontinued|1|||
126333424|NCT00447902|454515150|FG000|Overall Study|Lack of Efficacy|2|||
126333425|NCT00447902|454515151|FG001|Overall Study|Lack of Efficacy|1|||
126333426|NCT04754542|454515152|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
126333427|NCT04754542|454515153|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
126333428|NCT00419757|454516875|FG000|Overall Study|Adverse Event|1|||
126333429|NCT00419757|454516876|FG001|Overall Study|Adverse Event|4|||
126333430|NCT00419757|454516875|FG000|Overall Study|Lost to Follow-up|1|||
126333431|NCT00419757|454516876|FG001|Overall Study|Lost to Follow-up|4|||
126333432|NCT00419757|454516875|FG000|Overall Study|Withdrawal by Subject|7|||
126333433|NCT00419757|454516876|FG001|Overall Study|Withdrawal by Subject|1|||
126333434|NCT00419757|454516875|FG000|Overall Study|Protocol Violation|2|||
126333435|NCT00419757|454516876|FG001|Overall Study|Protocol Violation|3|||
126333436|NCT00419757|454516875|FG000|Overall Study|Study specific discontinuation criteria|4|||
126333437|NCT00419757|454516876|FG001|Overall Study|Study specific discontinuation criteria|8|||
126333438|NCT00419757|454516875|FG000|Overall Study|Multiple reasons|3|||
126333439|NCT00419757|454516876|FG001|Overall Study|Multiple reasons|1|||
126666395|NCT01641809|455739395|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
126666396|NCT01641809|455739396|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
126666397|NCT01641809|455739397|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
126666398|NCT01641809|455739398|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
126666399|NCT01641809|455739395|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
126666400|NCT01641809|455739396|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
126666401|NCT01641809|455739397|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
126666402|NCT01641809|455739398|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
126333440|NCT00327340|454516877|FG000|Overall Study|Withdrawal by Subject|1|||
126333441|NCT00327340|454516878|FG001|Overall Study|Withdrawal by Subject|5|||
126333442|NCT00327340|454516877|FG000|Overall Study|Physician Decision|1|||
126333443|NCT00327340|454516878|FG001|Overall Study|Physician Decision|1|||
126666403|NCT01641809|455739395|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
126666404|NCT01641809|455739396|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
126333444|NCT00327340|454516877|FG000|Overall Study|Disease Progression|10|||
126333445|NCT00327340|454516878|FG001|Overall Study|Disease Progression|19|||
126333446|NCT00327340|454516877|FG000|Overall Study|Symptomatic Disease|0|||
126333447|NCT00327340|454516878|FG001|Overall Study|Symptomatic Disease|2|||
126333448|NCT00327340|454516877|FG000|Overall Study|Adverse Event|3|||
126333449|NCT00327340|454516878|FG001|Overall Study|Adverse Event|3|||
126333450|NCT03316586|454516883|FG000|Overall Study|Adverse Event|2|||
126333451|NCT03316586|454516883|FG000|Overall Study|Physician Decision|3|||
126333452|NCT03316586|454516883|FG000|Overall Study|Lack of Efficacy|10|||
126333453|NCT03316586|454516883|FG000|Overall Study|still on treatment|1|||
126333454|NCT03316586|454516883|FG000|Overall Study|Patient needed radiation therapy|1|||
126333455|NCT03316586|454516883|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
126333456|NCT01396083|454516884|FG000|Overall Study|Adverse Event|2|||
126333457|NCT01396083|454516885|FG001|Overall Study|Adverse Event|28|||
126333458|NCT01396083|454516884|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126666405|NCT01641809|455739397|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
126666406|NCT01641809|455739398|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
126666407|NCT01641809|455739395|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
126333459|NCT01396083|454516885|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
126333460|NCT01396083|454516884|FG000|Overall Study|Consent withdrawn|4|||
126333461|NCT01396083|454516885|FG001|Overall Study|Consent withdrawn|5|||
126333462|NCT01396083|454516884|FG000|Overall Study|Protocol deviation(s)|0|||
126333463|NCT01396083|454516885|FG001|Overall Study|Protocol deviation(s)|1|||
126333464|NCT01396083|454516884|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126333465|NCT01396083|454516885|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126333466|NCT01396083|454516884|FG000|Overall Study|Administrative problems|1|||
126333467|NCT01396083|454516885|FG001|Overall Study|Administrative problems|0|||
126333468|NCT01396083|454516884|FG000|Overall Study|Lost to Follow-up|1|||
126333469|NCT01396083|454516885|FG001|Overall Study|Lost to Follow-up|0|||
126333470|NCT02806713|454516886|FG000|Overall Study|Urethral injury during procedure|1|||
126666408|NCT01641809|455739396|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
126666409|NCT01641809|455739397|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
126666410|NCT01641809|455739398|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
126666411|NCT01641809|455739395|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
126666412|NCT01641809|455739396|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
126666413|NCT01641809|455739397|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
126666414|NCT01641809|455739398|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
126666415|NCT01641809|455739395|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
126666416|NCT01641809|455739396|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
126666417|NCT01641809|455739397|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
126666418|NCT01641809|455739398|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
126666419|NCT01641809|455739395|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
126666420|NCT01641809|455739396|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
126666421|NCT01641809|455739397|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
126666422|NCT01641809|455739398|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
126666423|NCT01641809|455739395|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
126666424|NCT01641809|455739396|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
126666425|NCT01641809|455739397|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
126666426|NCT01641809|455739398|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
126666427|NCT03690141|455739401|FG000|Overall Study|Adverse Event|5|||
126666428|NCT03690141|455739401|FG000|Overall Study|Withdrawal by Subject|3|||
126666429|NCT03690141|455739401|FG000|Overall Study|Physician Decision|4|||
126666430|NCT03690141|455739401|FG000|Overall Study|Disease progression|4|||
126666431|NCT01251120|455739402|FG000|Overall Study|Lack of Efficacy|0|||
126666432|NCT01251120|455739403|FG001|Overall Study|Lack of Efficacy|1|||
126666433|NCT01807923|455739404|FG000|Overall Study|Adverse Event|2|||
126333471|NCT02806713|454516887|FG001|Overall Study|Urethral injury during procedure|0|||
126333472|NCT02806713|454516886|FG000|Overall Study|cancelled surgery|1|||
126333473|NCT02806713|454516887|FG001|Overall Study|cancelled surgery|2|||
126333474|NCT00735709|454516888|FG000|Overall Study|Adverse Event|2|||
126333475|NCT00735709|454516889|FG001|Overall Study|Adverse Event|3|||
126333476|NCT00735709|454516890|FG002|Overall Study|Adverse Event|1|||
126333477|NCT00735709|454516891|FG003|Overall Study|Adverse Event|5|||
126333478|NCT00735709|454516888|FG000|Overall Study|Lack of Efficacy|8|||
126333479|NCT00735709|454516889|FG001|Overall Study|Lack of Efficacy|4|||
126666434|NCT01807923|455739405|FG001|Overall Study|Adverse Event|1|||
126333480|NCT00735709|454516890|FG002|Overall Study|Lack of Efficacy|2|||
126333481|NCT00735709|454516891|FG003|Overall Study|Lack of Efficacy|3|||
126333482|NCT00735709|454516888|FG000|Overall Study|Noncompliance|0|||
126333483|NCT00735709|454516889|FG001|Overall Study|Noncompliance|0|||
126333484|NCT00735709|454516890|FG002|Overall Study|Noncompliance|1|||
126666435|NCT01807923|455739406|FG002|Overall Study|Adverse Event|2|||
126666436|NCT01807923|455739404|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
126666437|NCT01807923|455739405|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
126666438|NCT01807923|455739406|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
126666439|NCT01807923|455739404|FG000|Overall Study|Physician Decision|0|||
126666440|NCT01807923|455739405|FG001|Overall Study|Physician Decision|0|||
126666441|NCT01807923|455739406|FG002|Overall Study|Physician Decision|1|||
126666442|NCT01807923|455739404|FG000|Overall Study|Not Eligible (Genotype)|0|||
126666443|NCT01807923|455739405|FG001|Overall Study|Not Eligible (Genotype)|0|||
126666444|NCT01807923|455739406|FG002|Overall Study|Not Eligible (Genotype)|1|||
126666445|NCT01807923|455739404|FG000|Overall Study|Randomized But Not Treated|3|||
126666446|NCT01807923|455739405|FG001|Overall Study|Randomized But Not Treated|2|||
126666447|NCT01807923|455739406|FG002|Overall Study|Randomized But Not Treated|5|||
126666448|NCT02558231|455739408|FG000|Overall Study|Death|4|||
126666449|NCT02558231|455739409|FG001|Overall Study|Death|12|||
126666450|NCT02558231|455739408|FG000|Overall Study|Lost to Follow-up|7|||
126666451|NCT02558231|455739409|FG001|Overall Study|Lost to Follow-up|4|||
126666452|NCT02558231|455739408|FG000|Overall Study|Withdrawal by Subject|7|||
126666453|NCT02558231|455739409|FG001|Overall Study|Withdrawal by Subject|4|||
126666454|NCT02558231|455739408|FG000|Overall Study|Physician Decision|7|||
126666455|NCT02558231|455739409|FG001|Overall Study|Physician Decision|5|||
126666456|NCT02558231|455739408|FG000|Overall Study|Sponsor Decision|0|||
126666457|NCT02558231|455739409|FG001|Overall Study|Sponsor Decision|1|||
126666458|NCT04233164|455739412|FG000|Overall Study|Unable to obtain specimen|0|||
126333485|NCT00735709|454516891|FG003|Overall Study|Noncompliance|0|||
126333486|NCT00735709|454516888|FG000|Overall Study|Protocol deviations|1|||
126333487|NCT00735709|454516889|FG001|Overall Study|Protocol deviations|2|||
126333488|NCT00735709|454516890|FG002|Overall Study|Protocol deviations|1|||
126333489|NCT00735709|454516891|FG003|Overall Study|Protocol deviations|1|||
126333490|NCT00735709|454516888|FG000|Overall Study|Voluntary Withdrawal|1|||
126333491|NCT00735709|454516889|FG001|Overall Study|Voluntary Withdrawal|3|||
126333492|NCT00735709|454516890|FG002|Overall Study|Voluntary Withdrawal|5|||
126333493|NCT00735709|454516891|FG003|Overall Study|Voluntary Withdrawal|7|||
126333494|NCT00735709|454516888|FG000|Overall Study|Lost to Follow-up|0|||
126333495|NCT00735709|454516889|FG001|Overall Study|Lost to Follow-up|1|||
126333496|NCT00735709|454516890|FG002|Overall Study|Lost to Follow-up|1|||
126333497|NCT00735709|454516891|FG003|Overall Study|Lost to Follow-up|1|||
126333498|NCT00735709|454516888|FG000|Overall Study|Excluded medication|1|||
126333499|NCT00735709|454516889|FG001|Overall Study|Excluded medication|0|||
126333500|NCT00735709|454516890|FG002|Overall Study|Excluded medication|0|||
126333501|NCT00735709|454516891|FG003|Overall Study|Excluded medication|1|||
126333502|NCT01165307|454516893|FG000|Overall Study|Lost to Follow-up|11|||
126333503|NCT01165307|454516894|FG001|Overall Study|Lost to Follow-up|3|||
126333504|NCT01165307|454516893|FG000|Overall Study|Withdrawal by Subject|2|||
126333505|NCT01165307|454516894|FG001|Overall Study|Withdrawal by Subject|0|||
126333506|NCT01165307|454516893|FG000|Overall Study|Subject not available for contact|1|||
126333507|NCT01165307|454516894|FG001|Overall Study|Subject not available for contact|0|||
126333508|NCT00521365|454516898|FG000|Overall Study|Adverse Event|3|||
126333509|NCT00521365|454516898|FG000|Overall Study|Lost to Follow-up|6|||
126333510|NCT00521365|454516898|FG000|Overall Study|Protocol deviation|2|||
126333511|NCT00521365|454516898|FG000|Overall Study|Drug compliance|3|||
126333512|NCT00521365|454516898|FG000|Overall Study|Usage of not allowed drugs|6|||
126333513|NCT03627832|454516899|FG000|Overall Study|Withdrawal by Subject|10|||
126333514|NCT03627832|454516900|FG001|Overall Study|Withdrawal by Subject|1|||
126333515|NCT03150082|454516901|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
126333516|NCT03150082|454516902|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
126333517|NCT01718483|454516903|FG000|Overall Study|Withdrawal by Subject|14|||
126333518|NCT01718483|454516904|FG001|Overall Study|Withdrawal by Subject|12|||
126333519|NCT01718483|454516903|FG000|Overall Study|Adverse Event|5|||
126333520|NCT01718483|454516904|FG001|Overall Study|Adverse Event|12|||
126333521|NCT01718483|454516903|FG000|Overall Study|Lost to Follow-up|8|||
126333522|NCT01718483|454516904|FG001|Overall Study|Lost to Follow-up|3|||
126333523|NCT01718483|454516903|FG000|Overall Study|Protocol Violation|4|||
126333524|NCT01718483|454516904|FG001|Overall Study|Protocol Violation|2|||
126333525|NCT01718483|454516903|FG000|Overall Study|Other|1|||
126333526|NCT01718483|454516904|FG001|Overall Study|Other|4|||
126333527|NCT01718483|454516903|FG000|Overall Study|Pregnancy|1|||
126333528|NCT01718483|454516904|FG001|Overall Study|Pregnancy|1|||
126333529|NCT01718483|454516903|FG000|Overall Study|Lack of Efficacy|1|||
126333530|NCT01718483|454516904|FG001|Overall Study|Lack of Efficacy|0|||
126333531|NCT00536510|454516907|FG000|Overall Study|Adverse Event|27|||
126333532|NCT00536510|454516908|FG001|Overall Study|Adverse Event|4|||
126333533|NCT00536510|454516907|FG000|Overall Study|Lost to Follow-up|11|||
126333534|NCT00536510|454516908|FG001|Overall Study|Lost to Follow-up|8|||
126333535|NCT00536510|454516907|FG000|Overall Study|Protocol Violation|4|||
126333536|NCT00536510|454516908|FG001|Overall Study|Protocol Violation|5|||
126333537|NCT00536510|454516907|FG000|Overall Study|Withdrawal by Subject|16|||
126333538|NCT00536510|454516908|FG001|Overall Study|Withdrawal by Subject|9|||
126333539|NCT00536510|454516907|FG000|Overall Study|Flushing with Product|20|||
126666459|NCT04233164|455739413|FG001|Overall Study|Unable to obtain specimen|1|||
126666460|NCT01840605|455739414|FG000|Overall Study|Adverse Event|0|||
126666461|NCT01840605|455739415|FG001|Overall Study|Adverse Event|1|||
126666462|NCT01840605|455739414|FG000|Overall Study|Physician Decision|2|||
126333540|NCT00536510|454516908|FG001|Overall Study|Flushing with Product|0|||
126333541|NCT00536510|454516907|FG000|Overall Study|Laboratory Adverse Event|2|||
126333542|NCT00536510|454516908|FG001|Overall Study|Laboratory Adverse Event|1|||
126333543|NCT00536510|454516907|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
126333544|NCT00536510|454516908|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
126333545|NCT00809445|454516909|FG000|1 Month Follow-up|Lost contact|1|||
126333546|NCT00809445|454516910|FG001|1 Month Follow-up|Lost contact|2|||
126333547|NCT00809445|454516911|FG002|1 Month Follow-up|Lost contact|1|||
126333548|NCT00809445|454516909|FG000|1 Month Follow-up|Withdrew consent|1|||
126333549|NCT00809445|454516910|FG001|1 Month Follow-up|Withdrew consent|1|||
126333550|NCT00809445|454516911|FG002|1 Month Follow-up|Withdrew consent|1|||
126333551|NCT00809445|454516909|FG000|1 Month Follow-up|Death|0|||
126333552|NCT00809445|454516910|FG001|1 Month Follow-up|Death|1|||
126333553|NCT00809445|454516911|FG002|1 Month Follow-up|Death|1|||
126333554|NCT00809445|454516909|FG000|1 Month Follow-up|Incarcerated|0|||
126333555|NCT00809445|454516910|FG001|1 Month Follow-up|Incarcerated|0|||
126333556|NCT00809445|454516911|FG002|1 Month Follow-up|Incarcerated|1|||
126333557|NCT00809445|454516909|FG000|6 Month Follow-up|Lost contact|16|||
126333558|NCT00809445|454516910|FG001|6 Month Follow-up|Lost contact|14|||
126333559|NCT00809445|454516911|FG002|6 Month Follow-up|Lost contact|14|||
126333560|NCT00809445|454516909|FG000|6 Month Follow-up|Death|2|||
126333561|NCT00809445|454516910|FG001|6 Month Follow-up|Death|1|||
126333562|NCT00809445|454516911|FG002|6 Month Follow-up|Death|1|||
126333563|NCT00809445|454516909|FG000|6 Month Follow-up|Incarcerated|6|||
126333564|NCT00809445|454516910|FG001|6 Month Follow-up|Incarcerated|8|||
126333565|NCT00809445|454516911|FG002|6 Month Follow-up|Incarcerated|8|||
126333566|NCT00809445|454516909|FG000|6 Month Follow-up|Withdrew consent|0|||
126333567|NCT00809445|454516910|FG001|6 Month Follow-up|Withdrew consent|0|||
126333568|NCT00809445|454516911|FG002|6 Month Follow-up|Withdrew consent|1|||
126333569|NCT00676403|454516912|FG000|Overall Study|Adverse Event|1|||
126333570|NCT00676403|454516913|FG001|Overall Study|Adverse Event|2|||
126333571|NCT00676403|454516914|FG002|Overall Study|Adverse Event|0|||
126333572|NCT00676403|454516915|FG003|Overall Study|Adverse Event|5|||
126333573|NCT00676403|454516916|FG004|Overall Study|Adverse Event|1|||
126333574|NCT00676403|454516917|FG005|Overall Study|Adverse Event|2|||
126333575|NCT00676403|454516912|FG000|Overall Study|Lost to Follow-up|0|||
126333576|NCT00676403|454516913|FG001|Overall Study|Lost to Follow-up|0|||
126333577|NCT00676403|454516914|FG002|Overall Study|Lost to Follow-up|0|||
126333578|NCT00676403|454516915|FG003|Overall Study|Lost to Follow-up|0|||
126333579|NCT00676403|454516916|FG004|Overall Study|Lost to Follow-up|0|||
126333580|NCT00676403|454516917|FG005|Overall Study|Lost to Follow-up|1|||
126333581|NCT00676403|454516912|FG000|Overall Study|Reason Unspecified|1|||
126333582|NCT00676403|454516913|FG001|Overall Study|Reason Unspecified|0|||
126333583|NCT00676403|454516914|FG002|Overall Study|Reason Unspecified|1|||
126333584|NCT00676403|454516915|FG003|Overall Study|Reason Unspecified|0|||
126333585|NCT00676403|454516916|FG004|Overall Study|Reason Unspecified|0|||
126333586|NCT00676403|454516917|FG005|Overall Study|Reason Unspecified|1|||
126333587|NCT00676403|454516912|FG000|Overall Study|Withdrawal by Subject|0|||
126333588|NCT00676403|454516913|FG001|Overall Study|Withdrawal by Subject|0|||
126333589|NCT00676403|454516914|FG002|Overall Study|Withdrawal by Subject|0|||
126333590|NCT00676403|454516915|FG003|Overall Study|Withdrawal by Subject|0|||
126333591|NCT00676403|454516916|FG004|Overall Study|Withdrawal by Subject|0|||
126333592|NCT00676403|454516917|FG005|Overall Study|Withdrawal by Subject|1|||
126333593|NCT02048722|454516918|FG000|2 Cycles of Treatment|Adverse Event|2|||
126333594|NCT02048722|454516918|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
126333595|NCT02048722|454516918|FG000|2 Cycles of Treatment|Progressive Disease|2|||
126333596|NCT02048722|454516918|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
126333597|NCT02048722|454516918|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
126333598|NCT02048722|454516918|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
126333599|NCT04073303|454516919|FG000|Overall Study|Adverse Event|0|||
126666463|NCT01840605|455739415|FG001|Overall Study|Physician Decision|1|||
126666464|NCT04029961|455739416|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
126333600|NCT04073303|454516920|FG001|Overall Study|Adverse Event|2|||
126333601|NCT04073303|454516919|FG000|Overall Study|Withdrawal by Subject|16|||
126333602|NCT04073303|454516920|FG001|Overall Study|Withdrawal by Subject|36|||
126333603|NCT04073303|454516919|FG000|Overall Study|Lost to Follow-up|6|||
126333604|NCT04073303|454516920|FG001|Overall Study|Lost to Follow-up|1|||
126333605|NCT04073303|454516919|FG000|Overall Study|Protocol Deviation|0|||
126333606|NCT04073303|454516920|FG001|Overall Study|Protocol Deviation|4|||
126333607|NCT04073303|454516919|FG000|Overall Study|Other|1|||
126333608|NCT04073303|454516920|FG001|Overall Study|Other|1|||
126333609|NCT02899065|454516923|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
126333610|NCT02899065|454516924|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
126333611|NCT02899065|454516923|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
126333612|NCT02899065|454516924|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
126333613|NCT02899065|454516923|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
126333614|NCT02899065|454516924|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
126333615|NCT05227118|454516927|FG000|Overall Study|Adverse Event|0|||
126666465|NCT04029961|455739417|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
126333616|NCT05227118|454516928|FG001|Overall Study|Adverse Event|0|||
126333617|NCT05227118|454516929|FG002|Overall Study|Adverse Event|1|||
126333618|NCT05227118|454516930|FG003|Overall Study|Adverse Event|0|||
126333619|NCT05227118|454516927|FG000|Overall Study|Withdrawal by Subject|0|||
126333620|NCT05227118|454516928|FG001|Overall Study|Withdrawal by Subject|0|||
126333621|NCT05227118|454516929|FG002|Overall Study|Withdrawal by Subject|2|||
126333622|NCT05227118|454516930|FG003|Overall Study|Withdrawal by Subject|0|||
126333623|NCT02689804|454516931|FG000|Overall Study|Withdrawal by Subject|2|||
126333624|NCT02689804|454516932|FG001|Overall Study|Withdrawal by Subject|0|||
126333625|NCT02417753|454516933|FG000|Overall Study|Death|1|||
126333626|NCT03113968|454516936|FG000|Overall Study|Withdrawal by Subject|31|||
126333627|NCT03113968|454516937|FG001|Overall Study|Withdrawal by Subject|4|||
126333628|NCT04805671|454516938|FG000|Overall Study|Death|2|||
126333629|NCT04805671|454516939|FG001|Overall Study|Death|7|||
126333630|NCT04805671|454516938|FG000|Overall Study|Lost to Follow-up|1|||
126333631|NCT04805671|454516939|FG001|Overall Study|Lost to Follow-up|0|||
126333632|NCT04805671|454516938|FG000|Overall Study|Withdrawal by Subject|9|||
126333633|NCT04805671|454516939|FG001|Overall Study|Withdrawal by Subject|7|||
126333634|NCT04805671|454516938|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
126333635|NCT04805671|454516939|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
126333636|NCT01657162|454516946|FG000|Overall Study|Adverse Event|26|||
126333637|NCT01657162|454516947|FG001|Overall Study|Adverse Event|36|||
126333638|NCT01657162|454516946|FG000|Overall Study|Withdrawal by Subject|13|||
126333639|NCT01657162|454516947|FG001|Overall Study|Withdrawal by Subject|13|||
126333640|NCT01657162|454516946|FG000|Overall Study|Continuing Significant Deterioration|9|||
126333641|NCT01657162|454516947|FG001|Overall Study|Continuing Significant Deterioration|3|||
126333642|NCT01657162|454516946|FG000|Overall Study|Refusal of Treatment|4|||
126333643|NCT01657162|454516947|FG001|Overall Study|Refusal of Treatment|6|||
126333644|NCT01657162|454516946|FG000|Overall Study|Lost to Follow-up|3|||
126333645|NCT01657162|454516947|FG001|Overall Study|Lost to Follow-up|4|||
126333646|NCT01657162|454516946|FG000|Overall Study|Death|2|||
126333647|NCT01657162|454516947|FG001|Overall Study|Death|3|||
126333648|NCT01657162|454516946|FG000|Overall Study|Inability to Complete Study Procedures|1|||
126333649|NCT01657162|454516947|FG001|Overall Study|Inability to Complete Study Procedures|7|||
126333650|NCT01657162|454516946|FG000|Overall Study|Protocol Violation|1|||
126333651|NCT01657162|454516947|FG001|Overall Study|Protocol Violation|0|||
126333652|NCT01657162|454516946|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
126333653|NCT01657162|454516947|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
126333654|NCT01657162|454516946|FG000|Overall Study|Other than Specified|0|||
126333655|NCT01657162|454516947|FG001|Overall Study|Other than Specified|2|||
126333656|NCT00901342|454516948|FG000|Overall Study|Adverse Event|1|||
126333657|NCT00901342|454516948|FG000|Overall Study|Death|4|||
126333658|NCT00901342|454516948|FG000|Overall Study|Disease progression|1|||
126333659|NCT00901342|454516948|FG000|Overall Study|Withdrawal by Subject|9|||
126333660|NCT02782741|454516950|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
126333661|NCT02782741|454516951|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
126333662|NCT02782741|454516952|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
126333663|NCT02782741|454516950|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
126333664|NCT02782741|454516951|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
126333665|NCT02782741|454516952|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
126333666|NCT02782741|454516950|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
126333667|NCT02782741|454516951|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
126333668|NCT02782741|454516952|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
126333669|NCT02782741|454516950|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
126333670|NCT02782741|454516951|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
126333671|NCT02782741|454516952|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
126333672|NCT02782741|454516950|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
126333673|NCT02782741|454516951|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
126333674|NCT02782741|454516952|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
126333675|NCT04058028|454516953|FG000|Overall Study|Withdrawal of Consent from Study|12|||
126333676|NCT04058028|454516954|FG001|Overall Study|Withdrawal of Consent from Study|8|||
126333677|NCT04058028|454516955|FG002|Overall Study|Withdrawal of Consent from Study|6|||
126333678|NCT04058028|454516956|FG003|Overall Study|Withdrawal of Consent from Study|7|||
126333679|NCT04058028|454516953|FG000|Overall Study|Decision by Sponsor|13|||
126333680|NCT04058028|454516954|FG001|Overall Study|Decision by Sponsor|4|||
126333681|NCT04058028|454516955|FG002|Overall Study|Decision by Sponsor|1|||
126333682|NCT04058028|454516956|FG003|Overall Study|Decision by Sponsor|35|||
126333683|NCT04058028|454516953|FG000|Overall Study|Lost to Follow-up|1|||
126333684|NCT04058028|454516954|FG001|Overall Study|Lost to Follow-up|1|||
126333685|NCT04058028|454516955|FG002|Overall Study|Lost to Follow-up|1|||
126333686|NCT04058028|454516956|FG003|Overall Study|Lost to Follow-up|0|||
126333687|NCT04058028|454516953|FG000|Overall Study|Death|0|||
126333688|NCT04058028|454516954|FG001|Overall Study|Death|1|||
126333689|NCT04058028|454516955|FG002|Overall Study|Death|0|||
126333690|NCT04058028|454516956|FG003|Overall Study|Death|0|||
126333691|NCT00485069|454516957|FG000|Overall Study|Adverse Event|10|||
126333692|NCT00485069|454516958|FG001|Overall Study|Adverse Event|4|||
126333693|NCT00485069|454516957|FG000|Overall Study|Lack of Efficacy|2|||
126333694|NCT00485069|454516958|FG001|Overall Study|Lack of Efficacy|1|||
126333695|NCT00485069|454516957|FG000|Overall Study|Protocol Violation|0|||
126333696|NCT00485069|454516958|FG001|Overall Study|Protocol Violation|1|||
126333697|NCT00485069|454516957|FG000|Overall Study|Withdrawal by Subject|6|||
126333698|NCT00485069|454516958|FG001|Overall Study|Withdrawal by Subject|6|||
126333699|NCT00992017|454516970|FG000|Overall Study|Lost to Follow-up|2|||
126333700|NCT00992017|454516970|FG000|Overall Study|Withdrawal by Subject|2|||
126333701|NCT00992017|454516970|FG000|Overall Study|Unable to get to clinic|5|||
126333702|NCT00992017|454516970|FG000|Overall Study|Not adhere to study requirements|1|||
126333703|NCT01691378|454516981|FG000|Overall Study|Withdrawal by Subject|2|||
126333704|NCT01691378|454516982|FG001|Overall Study|Withdrawal by Subject|0|||
126333705|NCT01691378|454516981|FG000|Overall Study|Lost to Follow-up|5|||
126333706|NCT01691378|454516982|FG001|Overall Study|Lost to Follow-up|2|||
126333707|NCT01827592|454516983|FG000|Overall Study|Adverse Event|11|||
126333708|NCT01827592|454516984|FG001|Overall Study|Adverse Event|9|||
126333709|NCT01827592|454516985|FG002|Overall Study|Adverse Event|2|||
126333710|NCT01827592|454516983|FG000|Overall Study|Physician Decision|0|||
126333711|NCT01827592|454516984|FG001|Overall Study|Physician Decision|2|||
126333712|NCT01827592|454516985|FG002|Overall Study|Physician Decision|1|||
126333713|NCT01827592|454516983|FG000|Overall Study|Protocol Violation|2|||
126333714|NCT01827592|454516984|FG001|Overall Study|Protocol Violation|1|||
126333715|NCT01827592|454516985|FG002|Overall Study|Protocol Violation|0|||
126333716|NCT01827592|454516983|FG000|Overall Study|Lost to Follow-up|1|||
126333717|NCT01827592|454516984|FG001|Overall Study|Lost to Follow-up|2|||
126333718|NCT01827592|454516985|FG002|Overall Study|Lost to Follow-up|2|||
126333719|NCT01827592|454516983|FG000|Overall Study|Withdrawal by Subject|12|||
126333720|NCT01827592|454516984|FG001|Overall Study|Withdrawal by Subject|11|||
126333721|NCT01827592|454516985|FG002|Overall Study|Withdrawal by Subject|11|||
126333722|NCT01827592|454516983|FG000|Overall Study|Patient's substantial non-compliance|1|||
126333723|NCT01827592|454516984|FG001|Overall Study|Patient's substantial non-compliance|1|||
126333724|NCT01827592|454516985|FG002|Overall Study|Patient's substantial non-compliance|6|||
126333725|NCT01827592|454516983|FG000|Overall Study|Trial terminated by Sponsor|47|||
126333726|NCT01827592|454516984|FG001|Overall Study|Trial terminated by Sponsor|53|||
126333727|NCT01827592|454516985|FG002|Overall Study|Trial terminated by Sponsor|51|||
126333728|NCT01827592|454516983|FG000|Overall Study|Others|0|||
126333729|NCT01827592|454516984|FG001|Overall Study|Others|1|||
126333730|NCT01827592|454516985|FG002|Overall Study|Others|3|||
126333731|NCT02155985|454516986|FG000|Overall Study|Withdrawal by Subject|0|||
126333732|NCT02155985|454516987|FG001|Overall Study|Withdrawal by Subject|0|||
126333733|NCT02155985|454516988|FG002|Overall Study|Withdrawal by Subject|1|||
126333734|NCT02155985|454516986|FG000|Overall Study|Lost to Follow-up|1|||
126333735|NCT02155985|454516987|FG001|Overall Study|Lost to Follow-up|0|||
126333736|NCT02155985|454516988|FG002|Overall Study|Lost to Follow-up|0|||
126333737|NCT02998151|454516991|FG000|Overall Study|Withdrawal by Subject|3|||
126333738|NCT02998151|454516991|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
126333739|NCT02998151|454516991|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
126333740|NCT02573259|454516992|FG000|Overall Study|Death|1|||
126333741|NCT02573259|454516993|FG001|Overall Study|Death|6|||
126333742|NCT02573259|454516994|FG002|Overall Study|Death|5|||
126333743|NCT02573259|454516995|FG003|Overall Study|Death|6|||
126666466|NCT04029961|455739416|FG000|Overall Study|Change in Treatment Course|0|||
126666467|NCT04029961|455739417|FG001|Overall Study|Change in Treatment Course|1|||
126666468|NCT05975840|455739418|FG000|Overall Study|Other|1|||
126333744|NCT02573259|454516996|FG004|Overall Study|Death|9|||
126333745|NCT02573259|454516997|FG005|Overall Study|Death|32|||
126333746|NCT02573259|454516998|FG006|Overall Study|Death|21|||
126333747|NCT02573259|454516992|FG000|Overall Study|Lost to Follow-up|0|||
126333748|NCT02573259|454516993|FG001|Overall Study|Lost to Follow-up|0|||
126333749|NCT02573259|454516994|FG002|Overall Study|Lost to Follow-up|0|||
126333750|NCT02573259|454516995|FG003|Overall Study|Lost to Follow-up|0|||
126333751|NCT02573259|454516996|FG004|Overall Study|Lost to Follow-up|0|||
126333752|NCT02573259|454516997|FG005|Overall Study|Lost to Follow-up|2|||
126333753|NCT02573259|454516998|FG006|Overall Study|Lost to Follow-up|1|||
126666469|NCT05975840|455739419|FG001|Overall Study|Other|0|||
126333754|NCT02573259|454516992|FG000|Overall Study|Participant refused further follow-up|0|||
126333755|NCT02573259|454516993|FG001|Overall Study|Participant refused further follow-up|2|||
126333756|NCT02573259|454516994|FG002|Overall Study|Participant refused further follow-up|1|||
126333757|NCT02573259|454516995|FG003|Overall Study|Participant refused further follow-up|0|||
126333758|NCT02573259|454516996|FG004|Overall Study|Participant refused further follow-up|3|||
126666470|NCT05975840|455739420|FG002|Overall Study|Other|0|||
126666471|NCT05975840|455739421|FG003|Overall Study|Other|0|||
126666472|NCT05975840|455739422|FG004|Overall Study|Other|1|||
126666473|NCT05975840|455739423|FG005|Overall Study|Other|0|||
126666474|NCT05975840|455739424|FG006|Overall Study|Other|0|||
126666475|NCT05975840|455739425|FG007|Overall Study|Other|0|||
126666476|NCT05975840|455739418|FG000|Overall Study|Lost to Follow-up|3|||
126666477|NCT05975840|455739419|FG001|Overall Study|Lost to Follow-up|6|||
126666478|NCT05975840|455739420|FG002|Overall Study|Lost to Follow-up|3|||
126666479|NCT05975840|455739421|FG003|Overall Study|Lost to Follow-up|1|||
126333759|NCT02573259|454516997|FG005|Overall Study|Participant refused further follow-up|20|||
126333760|NCT02573259|454516998|FG006|Overall Study|Participant refused further follow-up|7|||
126333761|NCT02573259|454516992|FG000|Overall Study|Other|0|||
126333762|NCT02573259|454516993|FG001|Overall Study|Other|0|||
126333763|NCT02573259|454516994|FG002|Overall Study|Other|0|||
126333764|NCT02573259|454516995|FG003|Overall Study|Other|0|||
126333765|NCT02573259|454516996|FG004|Overall Study|Other|1|||
126333766|NCT02573259|454516997|FG005|Overall Study|Other|4|||
126333767|NCT02573259|454516998|FG006|Overall Study|Other|5|||
126333768|NCT00751140|454516999|FG000|Overall Study|benign angioma excluded from analysis|1|||
126333769|NCT02493517|454517005|FG000|Overall Study|Protocol Violation|1|||
126333770|NCT02493517|454517006|FG001|Overall Study|Protocol Violation|2|||
126333771|NCT02493517|454517005|FG000|Overall Study|Withdrawal by Subject|1|||
126333772|NCT02493517|454517006|FG001|Overall Study|Withdrawal by Subject|2|||
126333773|NCT02493517|454517005|FG000|Overall Study|Adverse Event|0|||
126333774|NCT02493517|454517006|FG001|Overall Study|Adverse Event|2|||
126333775|NCT02493517|454517005|FG000|Overall Study|Missed study visit|0|||
126333776|NCT02493517|454517006|FG001|Overall Study|Missed study visit|1|||
126333777|NCT03718429|454517008|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
126333778|NCT03718429|454517009|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
126333779|NCT03718429|454517010|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
126333780|NCT03718429|454517011|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
126333781|NCT04632225|454517013|FG000|Overall Study|Withdrawal by Subject|2|||
126333782|NCT04632225|454517014|FG001|Overall Study|Withdrawal by Subject|2|||
126333783|NCT00325819|454517015|FG000|Overall Study|Study product lost in mail|2|||
126333784|NCT00325819|454517016|FG001|Overall Study|Study product lost in mail|1|||
126333785|NCT00325819|454517015|FG000|Overall Study|Did not take a dose of study product|4|||
126333786|NCT00325819|454517016|FG001|Overall Study|Did not take a dose of study product|9|||
126333787|NCT00325819|454517015|FG000|Overall Study|Lost to Follow-up|3|||
126333788|NCT00325819|454517016|FG001|Overall Study|Lost to Follow-up|3|||
126333789|NCT01817075|454517017|FG000|Overall Study|Adverse Event|7|||
126333790|NCT01817075|454517018|FG001|Overall Study|Adverse Event|5|||
126333791|NCT01817075|454517017|FG000|Overall Study|Physician Decision|9|||
126333792|NCT01817075|454517018|FG001|Overall Study|Physician Decision|12|||
126333793|NCT01817075|454517017|FG000|Overall Study|Withdrawal by Subject|31|||
126333794|NCT01817075|454517018|FG001|Overall Study|Withdrawal by Subject|15|||
126333795|NCT01817075|454517017|FG000|Overall Study|Received Sorafenib after enrollment|0|||
126333796|NCT01817075|454517018|FG001|Overall Study|Received Sorafenib after enrollment|1|||
126333797|NCT01817075|454517017|FG000|Overall Study|Ineligible|0|||
126333798|NCT01817075|454517018|FG001|Overall Study|Ineligible|2|||
126333799|NCT05212168|454517019|FG000|Overall Study|Lost to Follow-up|0|||
126333800|NCT05212168|454517020|FG001|Overall Study|Lost to Follow-up|3|||
126333801|NCT05212168|454517019|FG000|Overall Study|Study terminated by sponsor|30|||
126333802|NCT05212168|454517020|FG001|Overall Study|Study terminated by sponsor|27|||
126333803|NCT05212168|454517019|FG000|Overall Study|Other|4|||
126333804|NCT05212168|454517020|FG001|Overall Study|Other|7|||
126333805|NCT03811821|454517021|FG000|Overall Study|Adverse Event|1|||
126333806|NCT03811821|454517022|FG001|Overall Study|Adverse Event|1|||
126333807|NCT03811821|454517021|FG000|Overall Study|Withdrawal by Subject|5|||
126333808|NCT03811821|454517022|FG001|Overall Study|Withdrawal by Subject|4|||
126333809|NCT03811821|454517021|FG000|Overall Study|Lost to Follow-up|2|||
126333810|NCT03811821|454517022|FG001|Overall Study|Lost to Follow-up|2|||
126333811|NCT03811821|454517021|FG000|Overall Study|Contraindication for treatment|0|||
126333812|NCT03811821|454517022|FG001|Overall Study|Contraindication for treatment|1|||
126333813|NCT03811821|454517021|FG000|Overall Study|Tolerability|0|||
126333814|NCT03811821|454517022|FG001|Overall Study|Tolerability|3|||
126333815|NCT03811821|454517021|FG000|Overall Study|Comorbidities|0|||
126333816|NCT03811821|454517022|FG001|Overall Study|Comorbidities|2|||
126333817|NCT04888494|454517025|FG000|Overall Study|Lost to Follow-up|2|||
126666480|NCT05975840|455739422|FG004|Overall Study|Lost to Follow-up|4|||
126666481|NCT05975840|455739423|FG005|Overall Study|Lost to Follow-up|1|||
126666482|NCT05975840|455739424|FG006|Overall Study|Lost to Follow-up|2|||
126333818|NCT04888494|454517026|FG001|Overall Study|Lost to Follow-up|3|||
126333819|NCT04888494|454517025|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
126333820|NCT04888494|454517026|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
126333821|NCT02317991|454518521|FG000|Overall Study|Adverse Event|12|||
126333822|NCT02317991|454518521|FG000|Overall Study|Death|4|||
126666483|NCT05975840|455739425|FG007|Overall Study|Lost to Follow-up|4|||
126333823|NCT02317991|454518521|FG000|Overall Study|Withdrawal by Subject|8|||
126333824|NCT02317991|454518521|FG000|Overall Study|Progressive Disease|41|||
126333825|NCT01325350|454518522|FG000|Overall Study|Adverse Event|3|||
126333826|NCT01325350|454518523|FG001|Overall Study|Adverse Event|3|||
126333827|NCT01325350|454518524|FG002|Overall Study|Adverse Event|3|||
126333828|NCT01325350|454518525|FG003|Overall Study|Adverse Event|1|||
126333829|NCT01325350|454518526|FG004|Overall Study|Adverse Event|2|||
126666484|NCT05975840|455739418|FG000|Overall Study|Migrated/moved from the study area|1|||
126666485|NCT05975840|455739419|FG001|Overall Study|Migrated/moved from the study area|0|||
126666486|NCT05975840|455739420|FG002|Overall Study|Migrated/moved from the study area|0|||
126666487|NCT05975840|455739421|FG003|Overall Study|Migrated/moved from the study area|0|||
126666488|NCT05975840|455739422|FG004|Overall Study|Migrated/moved from the study area|0|||
126666489|NCT05975840|455739423|FG005|Overall Study|Migrated/moved from the study area|0|||
126666490|NCT05975840|455739424|FG006|Overall Study|Migrated/moved from the study area|0|||
126666491|NCT05975840|455739425|FG007|Overall Study|Migrated/moved from the study area|0|||
126666492|NCT05975840|455739418|FG000|Overall Study|Withdrawal by Subject|0|||
126666493|NCT05975840|455739419|FG001|Overall Study|Withdrawal by Subject|5|||
126666494|NCT05975840|455739420|FG002|Overall Study|Withdrawal by Subject|2|||
126666495|NCT05975840|455739421|FG003|Overall Study|Withdrawal by Subject|2|||
126666496|NCT05975840|455739422|FG004|Overall Study|Withdrawal by Subject|0|||
126666497|NCT05975840|455739423|FG005|Overall Study|Withdrawal by Subject|2|||
126666498|NCT05975840|455739424|FG006|Overall Study|Withdrawal by Subject|2|||
126666499|NCT05975840|455739425|FG007|Overall Study|Withdrawal by Subject|1|||
126666500|NCT05975840|455739418|FG000|Overall Study|Protocol Violation|0|||
126666501|NCT05975840|455739419|FG001|Overall Study|Protocol Violation|1|||
126666502|NCT05975840|455739420|FG002|Overall Study|Protocol Violation|0|||
126666503|NCT05975840|455739421|FG003|Overall Study|Protocol Violation|0|||
126666504|NCT05975840|455739422|FG004|Overall Study|Protocol Violation|0|||
126666505|NCT05975840|455739423|FG005|Overall Study|Protocol Violation|0|||
126666506|NCT05975840|455739424|FG006|Overall Study|Protocol Violation|0|||
126666507|NCT05975840|455739425|FG007|Overall Study|Protocol Violation|0|||
126666508|NCT05975840|455739418|FG000|Overall Study|Adverse Event|0|||
126666509|NCT05975840|455739419|FG001|Overall Study|Adverse Event|0|||
126666510|NCT05975840|455739420|FG002|Overall Study|Adverse Event|0|||
126666511|NCT05975840|455739421|FG003|Overall Study|Adverse Event|1|||
126666512|NCT05975840|455739422|FG004|Overall Study|Adverse Event|0|||
126666513|NCT05975840|455739423|FG005|Overall Study|Adverse Event|0|||
126666514|NCT05975840|455739424|FG006|Overall Study|Adverse Event|0|||
126666515|NCT05975840|455739425|FG007|Overall Study|Adverse Event|0|||
126666516|NCT05975840|455739418|FG000|Overall Study|Death|0|||
126666517|NCT05975840|455739419|FG001|Overall Study|Death|1|||
126666518|NCT05975840|455739420|FG002|Overall Study|Death|0|||
126666519|NCT05975840|455739421|FG003|Overall Study|Death|0|||
126666520|NCT05975840|455739422|FG004|Overall Study|Death|0|||
126666521|NCT05975840|455739423|FG005|Overall Study|Death|0|||
126666522|NCT05975840|455739424|FG006|Overall Study|Death|0|||
126666523|NCT05975840|455739425|FG007|Overall Study|Death|1|||
126666524|NCT01130051|455739426|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
126666525|NCT01130051|455739427|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
126666526|NCT01130051|455739426|FG000|Washout Period of 14 Days|Protocol Violation|1|||
126666527|NCT01130051|455739427|FG001|Washout Period of 14 Days|Protocol Violation|1|||
126666528|NCT04252287|455739428|FG000|Overall Study|Death|5|||
126666529|NCT04252287|455739429|FG001|Overall Study|Death|3|||
126666530|NCT04252287|455739428|FG000|Overall Study|Lost to Follow-up|4|||
126666531|NCT04252287|455739429|FG001|Overall Study|Lost to Follow-up|6|||
126666532|NCT04252287|455739428|FG000|Overall Study|Withdrawal by Subject|19|||
126666533|NCT04252287|455739429|FG001|Overall Study|Withdrawal by Subject|16|||
126666534|NCT04252287|455739428|FG000|Overall Study|Protocol Violation|3|||
126666535|NCT04252287|455739429|FG001|Overall Study|Protocol Violation|4|||
126666536|NCT02273726|455739434|FG000|Overall Study|Death|70|||
126666537|NCT02273726|455739435|FG001|Overall Study|Death|62|||
126666538|NCT02273726|455739434|FG000|Overall Study|Withdrawal by Subject|41|||
126666539|NCT02273726|455739435|FG001|Overall Study|Withdrawal by Subject|29|||
126666540|NCT02273726|455739434|FG000|Overall Study|Kidney transplant|31|||
126666541|NCT02273726|455739435|FG001|Overall Study|Kidney transplant|39|||
126666542|NCT02273726|455739434|FG000|Overall Study|Physician Decision|30|||
126666543|NCT02273726|455739435|FG001|Overall Study|Physician Decision|15|||
126545281|NCT01111838|455290787|FG000|Overall Study|Other Complicating Disease|1|||
126666544|NCT02273726|455739434|FG000|Overall Study|Adverse Event|27|||
126666545|NCT02273726|455739435|FG001|Overall Study|Adverse Event|9|||
126666546|NCT02273726|455739434|FG000|Overall Study|Lost to Follow-up|6|||
126666547|NCT02273726|455739435|FG001|Overall Study|Lost to Follow-up|3|||
126666548|NCT02273726|455739434|FG000|Overall Study|Lack of Efficacy|6|||
126666549|NCT02273726|455739435|FG001|Overall Study|Lack of Efficacy|1|||
126666550|NCT02273726|455739434|FG000|Overall Study|Protocol Violation|4|||
126333830|NCT01325350|454518522|FG000|Overall Study|Pregnancy|0|||
126666551|NCT02273726|455739435|FG001|Overall Study|Protocol Violation|0|||
126666552|NCT02273726|455739434|FG000|Overall Study|Other than specified|28|||
126666553|NCT02273726|455739435|FG001|Overall Study|Other than specified|30|||
126666554|NCT02129205|455739436|FG000|Overall Study|Withdrawal by Subject|0|||
126666555|NCT02129205|455739437|FG001|Overall Study|Withdrawal by Subject|0|||
126666556|NCT02129205|455739438|FG002|Overall Study|Withdrawal by Subject|0|||
126666557|NCT02129205|455739439|FG003|Overall Study|Withdrawal by Subject|0|||
126666558|NCT02129205|455739440|FG004|Overall Study|Withdrawal by Subject|1|||
126666559|NCT02129205|455739441|FG005|Overall Study|Withdrawal by Subject|1|||
126666560|NCT02129205|455739442|FG006|Overall Study|Withdrawal by Subject|1|||
126666561|NCT02129205|455739443|FG007|Overall Study|Withdrawal by Subject|0|||
126666562|NCT02129205|455739444|FG008|Overall Study|Withdrawal by Subject|1|||
126666563|NCT02129205|455739445|FG009|Overall Study|Withdrawal by Subject|0|||
126666564|NCT02129205|455739436|FG000|Overall Study|Other|1|||
126666565|NCT02129205|455739437|FG001|Overall Study|Other|0|||
126666566|NCT02129205|455739438|FG002|Overall Study|Other|0|||
126666567|NCT02129205|455739439|FG003|Overall Study|Other|0|||
126666568|NCT02129205|455739440|FG004|Overall Study|Other|2|||
126666569|NCT02129205|455739441|FG005|Overall Study|Other|3|||
126666570|NCT02129205|455739442|FG006|Overall Study|Other|3|||
126666571|NCT02129205|455739443|FG007|Overall Study|Other|2|||
126666572|NCT02129205|455739444|FG008|Overall Study|Other|1|||
126666573|NCT02129205|455739445|FG009|Overall Study|Other|0|||
126666574|NCT02877927|455739446|FG000|Overall Study|Adverse Event|1|||
126666575|NCT02877927|455739447|FG001|Overall Study|Adverse Event|0|||
126666576|NCT02877927|455739446|FG000|Overall Study|Lost to Follow-up|37|||
126666577|NCT02877927|455739447|FG001|Overall Study|Lost to Follow-up|38|||
126666578|NCT02877927|455739446|FG000|Overall Study|Withdrawal by Subject|11|||
126666579|NCT02877927|455739447|FG001|Overall Study|Withdrawal by Subject|12|||
126666580|NCT02877927|455739446|FG000|Overall Study|Physician Decision|0|||
126333831|NCT01325350|454518523|FG001|Overall Study|Pregnancy|0|||
126666581|NCT02877927|455739447|FG001|Overall Study|Physician Decision|1|||
126666582|NCT02877927|455739446|FG000|Overall Study|Missed EOT/PTE Visit|5|||
126666583|NCT02877927|455739447|FG001|Overall Study|Missed EOT/PTE Visit|6|||
126666584|NCT04435782|455739449|FG000|Overall Study|Study terminated by sponsor|4|||
126666585|NCT03672461|455739450|FG000|Overall Study|COVID Related|4|||
126666586|NCT03672461|455739451|FG001|Overall Study|COVID Related|2|||
126666587|NCT03672461|455739450|FG000|Overall Study|Adverse Event|2|||
126666588|NCT03672461|455739451|FG001|Overall Study|Adverse Event|0|||
126666589|NCT03672461|455739450|FG000|Overall Study|Serious Adverse Event|0|||
126666590|NCT03672461|455739451|FG001|Overall Study|Serious Adverse Event|1|||
126666591|NCT03672461|455739450|FG000|Overall Study|Too Busy|3|||
126666592|NCT03672461|455739451|FG001|Overall Study|Too Busy|1|||
126666593|NCT03672461|455739450|FG000|Overall Study|Lost to Follow-up|1|||
126666594|NCT03672461|455739451|FG001|Overall Study|Lost to Follow-up|2|||
126333832|NCT01325350|454518524|FG002|Overall Study|Pregnancy|1|||
126333833|NCT01325350|454518525|FG003|Overall Study|Pregnancy|0|||
126333834|NCT01325350|454518526|FG004|Overall Study|Pregnancy|1|||
126333835|NCT01325350|454518522|FG000|Overall Study|Lost to Follow-up|1|||
126333836|NCT01325350|454518523|FG001|Overall Study|Lost to Follow-up|0|||
126333837|NCT01325350|454518524|FG002|Overall Study|Lost to Follow-up|5|||
126333838|NCT01325350|454518525|FG003|Overall Study|Lost to Follow-up|1|||
126333839|NCT01325350|454518526|FG004|Overall Study|Lost to Follow-up|5|||
126333840|NCT01325350|454518522|FG000|Overall Study|Personal Reasons|2|||
126333841|NCT01325350|454518523|FG001|Overall Study|Personal Reasons|1|||
126333842|NCT01325350|454518524|FG002|Overall Study|Personal Reasons|6|||
126333843|NCT01325350|454518525|FG003|Overall Study|Personal Reasons|5|||
126333844|NCT01325350|454518526|FG004|Overall Study|Personal Reasons|3|||
126333845|NCT01325350|454518522|FG000|Overall Study|Protocol Violation|0|||
126333846|NCT01325350|454518523|FG001|Overall Study|Protocol Violation|0|||
126333847|NCT01325350|454518524|FG002|Overall Study|Protocol Violation|0|||
126333848|NCT01325350|454518525|FG003|Overall Study|Protocol Violation|1|||
126333849|NCT01325350|454518526|FG004|Overall Study|Protocol Violation|0|||
126333850|NCT01325350|454518522|FG000|Overall Study|Withdrawal by Subject|0|||
126333851|NCT01325350|454518523|FG001|Overall Study|Withdrawal by Subject|0|||
126666595|NCT03672461|455739450|FG000|Overall Study|Family|2|||
126666596|NCT03672461|455739451|FG001|Overall Study|Family|2|||
126666597|NCT03672461|455739450|FG000|Overall Study|No remote technology access|0|||
126666598|NCT03672461|455739451|FG001|Overall Study|No remote technology access|1|||
126666599|NCT03672461|455739450|FG000|Overall Study|Withdrawal by Subject|1|||
126666600|NCT03672461|455739451|FG001|Overall Study|Withdrawal by Subject|0|||
126666601|NCT03672461|455739450|FG000|Overall Study|Cannot tolerate intervention|1|||
126333852|NCT01325350|454518524|FG002|Overall Study|Withdrawal by Subject|1|||
126333853|NCT01325350|454518525|FG003|Overall Study|Withdrawal by Subject|1|||
126333854|NCT01325350|454518526|FG004|Overall Study|Withdrawal by Subject|0|||
126666602|NCT03672461|455739451|FG001|Overall Study|Cannot tolerate intervention|0|||
126333855|NCT01325350|454518522|FG000|Overall Study|Did Not Receive Treatment|0|||
126333856|NCT01325350|454518523|FG001|Overall Study|Did Not Receive Treatment|1|||
126333857|NCT01325350|454518524|FG002|Overall Study|Did Not Receive Treatment|1|||
126666603|NCT03672461|455739450|FG000|Overall Study|Incomplete outcome data|6|||
126666604|NCT03672461|455739451|FG001|Overall Study|Incomplete outcome data|1|||
126666605|NCT01444651|455741068|FG000|Overall Study|Adverse Event|3|||
126666606|NCT01444651|455741069|FG001|Overall Study|Adverse Event|2|||
126666607|NCT01444651|455741068|FG000|Overall Study|Lost to Follow-up|5|||
126666608|NCT01444651|455741069|FG001|Overall Study|Lost to Follow-up|5|||
126333858|NCT01325350|454518525|FG003|Overall Study|Did Not Receive Treatment|0|||
126333859|NCT01325350|454518526|FG004|Overall Study|Did Not Receive Treatment|1|||
126333860|NCT01716806|454518527|FG000|Overall Study|Patient withdrawal of consent|4|||
126333861|NCT01716806|454518528|FG001|Overall Study|Patient withdrawal of consent|2|||
126333862|NCT01716806|454518529|FG002|Overall Study|Patient withdrawal of consent|4|||
126333863|NCT01716806|454518530|FG003|Overall Study|Patient withdrawal of consent|3|||
126333864|NCT01716806|454518531|FG004|Overall Study|Patient withdrawal of consent|2|||
126333865|NCT01716806|454518532|FG005|Overall Study|Patient withdrawal of consent|0|||
126333866|NCT01716806|454518527|FG000|Overall Study|Lost to Follow-up|3|||
126333867|NCT01716806|454518528|FG001|Overall Study|Lost to Follow-up|3|||
126333868|NCT01716806|454518529|FG002|Overall Study|Lost to Follow-up|0|||
126333869|NCT01716806|454518530|FG003|Overall Study|Lost to Follow-up|2|||
126333870|NCT01716806|454518531|FG004|Overall Study|Lost to Follow-up|1|||
126333871|NCT01716806|454518532|FG005|Overall Study|Lost to Follow-up|0|||
126333872|NCT01716806|454518527|FG000|Overall Study|Death|13|||
126333873|NCT01716806|454518528|FG001|Overall Study|Death|9|||
126333874|NCT01716806|454518529|FG002|Overall Study|Death|12|||
126333875|NCT01716806|454518530|FG003|Overall Study|Death|4|||
126333876|NCT01716806|454518531|FG004|Overall Study|Death|10|||
126333877|NCT01716806|454518532|FG005|Overall Study|Death|5|||
126333878|NCT01716806|454518527|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
126333879|NCT01716806|454518528|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
126333880|NCT01716806|454518529|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
126333881|NCT01716806|454518530|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
126333882|NCT01716806|454518531|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
126333883|NCT01716806|454518532|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
126333884|NCT01716806|454518527|FG000|Overall Study|PI decision|0|||
126333885|NCT01716806|454518528|FG001|Overall Study|PI decision|0|||
126333886|NCT01716806|454518529|FG002|Overall Study|PI decision|0|||
126333887|NCT01716806|454518530|FG003|Overall Study|PI decision|0|||
126333888|NCT01716806|454518531|FG004|Overall Study|PI decision|1|||
126333889|NCT01716806|454518532|FG005|Overall Study|PI decision|0|||
126333890|NCT01716806|454518527|FG000|Overall Study|Change in performance status|1|||
126333891|NCT01716806|454518528|FG001|Overall Study|Change in performance status|0|||
126333892|NCT01716806|454518529|FG002|Overall Study|Change in performance status|0|||
126333893|NCT01716806|454518530|FG003|Overall Study|Change in performance status|0|||
126333894|NCT01716806|454518531|FG004|Overall Study|Change in performance status|0|||
126333895|NCT01716806|454518532|FG005|Overall Study|Change in performance status|0|||
126333896|NCT01716806|454518527|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
126333897|NCT01716806|454518528|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
126333898|NCT01716806|454518529|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
126333899|NCT01716806|454518530|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
126333900|NCT01716806|454518531|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
126333901|NCT01716806|454518532|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
126333902|NCT01716806|454518527|FG000|Overall Study|Sponsor direction|7|||
126333903|NCT01716806|454518528|FG001|Overall Study|Sponsor direction|8|||
126333904|NCT01716806|454518529|FG002|Overall Study|Sponsor direction|5|||
126333905|NCT01716806|454518530|FG003|Overall Study|Sponsor direction|12|||
126333906|NCT01716806|454518531|FG004|Overall Study|Sponsor direction|16|||
126333907|NCT01716806|454518532|FG005|Overall Study|Sponsor direction|1|||
126333908|NCT00956839|454518533|FG000|Overall Study|Lost to Follow-up|3|||
126333909|NCT00956839|454518534|FG001|Overall Study|Lost to Follow-up|0|||
126333910|NCT00956839|454518535|FG002|Overall Study|Lost to Follow-up|3|||
126333911|NCT03506438|454518536|FG000|Overall Study|Lost to Follow-up|8|||
126333912|NCT03506438|454518537|FG001|Overall Study|Lost to Follow-up|7|||
126333913|NCT03506438|454518538|FG002|Overall Study|Lost to Follow-up|8|||
126333914|NCT03506438|454518539|FG003|Overall Study|Lost to Follow-up|7|||
126333915|NCT03506438|454518540|FG004|Overall Study|Lost to Follow-up|0|||
126333916|NCT03506438|454518541|FG005|Overall Study|Lost to Follow-up|0|||
126333917|NCT03527277|454518542|FG000|Overall Study|Withdrawal by Subject|5|||
126333918|NCT03527277|454518543|FG001|Overall Study|Withdrawal by Subject|0|||
126333919|NCT03527277|454518542|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
126333920|NCT03527277|454518543|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
126666609|NCT01444651|455741068|FG000|Overall Study|Non-fasting|2|||
126333921|NCT03527277|454518542|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
126333922|NCT03527277|454518543|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
126666610|NCT01444651|455741069|FG001|Overall Study|Non-fasting|1|||
126666611|NCT01444651|455741068|FG000|Overall Study|Missing data|1|||
126333923|NCT01128296|454518544|FG000|Overall Study|Physician Decision|0|||
126333924|NCT01128296|454518545|FG001|Overall Study|Physician Decision|0|||
126333925|NCT01128296|454518546|FG002|Overall Study|Physician Decision|0|||
126666612|NCT01444651|455741069|FG001|Overall Study|Missing data|1|||
126333926|NCT01128296|454518547|FG003|Overall Study|Physician Decision|0|||
126333927|NCT01128296|454518548|FG004|Overall Study|Physician Decision|0|||
126333928|NCT01128296|454518549|FG005|Overall Study|Physician Decision|3|||
126333929|NCT01128296|454518544|FG000|Overall Study|Withdrawal by Subject|0|||
126333930|NCT01128296|454518545|FG001|Overall Study|Withdrawal by Subject|0|||
126333931|NCT01128296|454518546|FG002|Overall Study|Withdrawal by Subject|0|||
126333932|NCT01128296|454518547|FG003|Overall Study|Withdrawal by Subject|0|||
126333933|NCT01128296|454518548|FG004|Overall Study|Withdrawal by Subject|0|||
126333934|NCT01128296|454518549|FG005|Overall Study|Withdrawal by Subject|2|||
126333935|NCT04155463|454518550|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
126333936|NCT04155463|454518551|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
126333937|NCT01914393|454518556|FG000|Overall Study|Protocol Violation|11|||
126333938|NCT01914393|454518557|FG001|Overall Study|Protocol Violation|3|||
126333939|NCT01914393|454518558|FG002|Overall Study|Protocol Violation|19|||
126333940|NCT01914393|454518556|FG000|Overall Study|Lack of Efficacy|11|||
126333941|NCT01914393|454518557|FG001|Overall Study|Lack of Efficacy|16|||
126333942|NCT01914393|454518558|FG002|Overall Study|Lack of Efficacy|5|||
126333943|NCT01914393|454518556|FG000|Overall Study|no reason given|14|||
126333944|NCT01914393|454518557|FG001|Overall Study|no reason given|8|||
126333945|NCT01914393|454518558|FG002|Overall Study|no reason given|16|||
126333946|NCT01914393|454518556|FG000|Overall Study|Adverse Event|29|||
126333947|NCT01914393|454518557|FG001|Overall Study|Adverse Event|18|||
126333948|NCT01914393|454518558|FG002|Overall Study|Adverse Event|31|||
126333949|NCT01914393|454518556|FG000|Overall Study|Withdrawal by Subject|38|||
126333950|NCT01914393|454518557|FG001|Overall Study|Withdrawal by Subject|20|||
126333951|NCT01914393|454518558|FG002|Overall Study|Withdrawal by Subject|47|||
126333952|NCT01914393|454518556|FG000|Overall Study|Lost to Follow-up|12|||
126333953|NCT01914393|454518557|FG001|Overall Study|Lost to Follow-up|6|||
126333954|NCT01914393|454518558|FG002|Overall Study|Lost to Follow-up|19|||
126333955|NCT01914393|454518556|FG000|Overall Study|subject never dosed|0|||
126333956|NCT01914393|454518557|FG001|Overall Study|subject never dosed|0|||
126333957|NCT01914393|454518558|FG002|Overall Study|subject never dosed|1|||
126333958|NCT01831427|454518559|FG000|Overall Study|Adverse Event|0|||
126333959|NCT01831427|454518560|FG001|Overall Study|Adverse Event|1|||
126333960|NCT01831427|454518561|FG002|Overall Study|Adverse Event|0|||
126333961|NCT01831427|454518562|FG003|Overall Study|Adverse Event|0|||
126333962|NCT01831427|454518563|FG004|Overall Study|Adverse Event|0|||
126333963|NCT01831427|454518564|FG005|Overall Study|Adverse Event|1|||
126333964|NCT01831427|454518565|FG006|Overall Study|Adverse Event|0|||
126333965|NCT01831427|454518566|FG007|Overall Study|Adverse Event|1|||
126333966|NCT01831427|454518567|FG008|Overall Study|Adverse Event|0|||
126333967|NCT01831427|454518568|FG009|Overall Study|Adverse Event|0|||
126333968|NCT01831427|454518569|FG010|Overall Study|Adverse Event|2|||
126333969|NCT01831427|454518559|FG000|Overall Study|Investigator's Discretion|0|||
126333970|NCT01831427|454518560|FG001|Overall Study|Investigator's Discretion|0|||
126333971|NCT01831427|454518561|FG002|Overall Study|Investigator's Discretion|0|||
126333972|NCT01831427|454518562|FG003|Overall Study|Investigator's Discretion|1|||
126333973|NCT01831427|454518563|FG004|Overall Study|Investigator's Discretion|0|||
126333974|NCT01831427|454518564|FG005|Overall Study|Investigator's Discretion|0|||
126333975|NCT01831427|454518565|FG006|Overall Study|Investigator's Discretion|0|||
126333976|NCT01831427|454518566|FG007|Overall Study|Investigator's Discretion|0|||
126333977|NCT01831427|454518567|FG008|Overall Study|Investigator's Discretion|0|||
126333978|NCT01831427|454518568|FG009|Overall Study|Investigator's Discretion|0|||
126333979|NCT01831427|454518569|FG010|Overall Study|Investigator's Discretion|0|||
126666613|NCT03047551|455741070|FG000|Overall Study|Did not receive TAS|1|||
126666614|NCT03047551|455741071|FG001|Overall Study|Did not receive TAS|0|||
126666615|NCT03047551|455741070|FG000|Overall Study|Physician Decision|1|||
126666616|NCT03047551|455741071|FG001|Overall Study|Physician Decision|0|||
126666617|NCT03047551|455741070|FG000|Overall Study|Withdrawal by Subject|0|||
126666618|NCT03047551|455741071|FG001|Overall Study|Withdrawal by Subject|1|||
126333980|NCT01831427|454518559|FG000|Overall Study|Withdrew Consent|0|||
126333981|NCT01831427|454518560|FG001|Overall Study|Withdrew Consent|0|||
126333982|NCT01831427|454518561|FG002|Overall Study|Withdrew Consent|0|||
126333983|NCT01831427|454518562|FG003|Overall Study|Withdrew Consent|0|||
126333984|NCT01831427|454518563|FG004|Overall Study|Withdrew Consent|0|||
126333985|NCT01831427|454518564|FG005|Overall Study|Withdrew Consent|0|||
126333986|NCT01831427|454518565|FG006|Overall Study|Withdrew Consent|2|||
126333987|NCT01831427|454518566|FG007|Overall Study|Withdrew Consent|0|||
126333988|NCT01831427|454518567|FG008|Overall Study|Withdrew Consent|0|||
126333989|NCT01831427|454518568|FG009|Overall Study|Withdrew Consent|1|||
126333990|NCT01831427|454518569|FG010|Overall Study|Withdrew Consent|1|||
126333991|NCT02169505|454518570|FG000|Overall Study|Withdrawal by Subject|1|||
126333992|NCT05137717|454518571|FG000|Overall Study|Death|2|||
126333993|NCT05137717|454518571|FG000|Overall Study|Withdrawal by Subject|6|||
126333994|NCT02035553|454518572|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
126333995|NCT02035553|454518573|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
126666619|NCT03047551|455741070|FG000|Overall Study|Probe malfunction|0|||
126666620|NCT03047551|455741071|FG001|Overall Study|Probe malfunction|1|||
126666621|NCT03047551|455741070|FG000|Overall Study|Ineligible|0|||
126666622|NCT03047551|455741071|FG001|Overall Study|Ineligible|1|||
126666623|NCT00726622|455741072|FG000|Overall Study|Withdrawal by Subject|16|||
126666624|NCT00726622|455741073|FG001|Overall Study|Withdrawal by Subject|2|||
126666625|NCT00726622|455741072|FG000|Overall Study|Physician Decision|0|||
126666626|NCT00726622|455741073|FG001|Overall Study|Physician Decision|1|||
126666627|NCT00726622|455741072|FG000|Overall Study|Metastasis|2|||
126666628|NCT00726622|455741073|FG001|Overall Study|Metastasis|0|||
126666629|NCT02462928|455741074|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
126666630|NCT02462928|455741075|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
126666631|NCT02462928|455741076|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
126666632|NCT02462928|455741074|FG000|Overall Study|Adverse Event|47|||
126333996|NCT02035553|454518572|FG000|Overall Study|Adverse Event|10|||
126333997|NCT02035553|454518573|FG001|Overall Study|Adverse Event|6|||
126666633|NCT02462928|455741075|FG001|Overall Study|Adverse Event|51|||
126666634|NCT02462928|455741076|FG002|Overall Study|Adverse Event|25|||
126666635|NCT02462928|455741074|FG000|Overall Study|Lack of Efficacy|3|||
126666636|NCT02462928|455741075|FG001|Overall Study|Lack of Efficacy|8|||
126666637|NCT02462928|455741076|FG002|Overall Study|Lack of Efficacy|3|||
126666638|NCT02462928|455741074|FG000|Overall Study|Lost to Follow-up|4|||
126666639|NCT02462928|455741075|FG001|Overall Study|Lost to Follow-up|4|||
126666640|NCT02462928|455741076|FG002|Overall Study|Lost to Follow-up|1|||
126666641|NCT02462928|455741074|FG000|Overall Study|Withdrawal by Patient|31|||
126666642|NCT02462928|455741075|FG001|Overall Study|Withdrawal by Patient|21|||
126666643|NCT02462928|455741076|FG002|Overall Study|Withdrawal by Patient|21|||
126666644|NCT02462928|455741074|FG000|Overall Study|Protocol Violation|0|||
126666645|NCT02462928|455741075|FG001|Overall Study|Protocol Violation|1|||
126666646|NCT02462928|455741076|FG002|Overall Study|Protocol Violation|0|||
126666647|NCT02462928|455741074|FG000|Overall Study|Reason not Specified|4|||
126666648|NCT02462928|455741075|FG001|Overall Study|Reason not Specified|6|||
126666649|NCT02462928|455741076|FG002|Overall Study|Reason not Specified|5|||
126666650|NCT01493557|455741077|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
126666651|NCT01493557|455741078|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
126666652|NCT01493557|455741079|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
126666653|NCT01493557|455741077|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
126666654|NCT01493557|455741078|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
126666655|NCT01493557|455741079|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
126666656|NCT01493557|455741077|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
126666657|NCT01493557|455741078|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
126666658|NCT01493557|455741079|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
126666659|NCT01493557|455741077|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
126666660|NCT01493557|455741078|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
126666661|NCT01493557|455741079|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
126666662|NCT01493557|455741077|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
126666663|NCT01493557|455741078|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
126666664|NCT01493557|455741079|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
126666665|NCT01493557|455741077|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
126666666|NCT01493557|455741078|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
126666667|NCT01493557|455741079|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
126666668|NCT01493557|455741077|FG000|Not Randomized to Management Strategies|Early termination|0|||
126333998|NCT02035553|454518572|FG000|Overall Study|Physician Decision|3|||
126333999|NCT02035553|454518573|FG001|Overall Study|Physician Decision|2|||
126334000|NCT02035553|454518572|FG000|Overall Study|Lack of Efficacy|1|||
126334001|NCT02035553|454518573|FG001|Overall Study|Lack of Efficacy|1|||
126334002|NCT02035553|454518572|FG000|Overall Study|Withdrawal by Subject|4|||
126334003|NCT02035553|454518573|FG001|Overall Study|Withdrawal by Subject|7|||
126666669|NCT01493557|455741078|FG001|Not Randomized to Management Strategies|Early termination|0|||
126666670|NCT01493557|455741079|FG002|Not Randomized to Management Strategies|Early termination|34|||
126666671|NCT01493557|455741077|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
126666672|NCT01493557|455741078|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
126666673|NCT01493557|455741079|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
126666674|NCT01493557|455741077|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
126666675|NCT01493557|455741078|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
126666676|NCT01493557|455741079|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
126666677|NCT01493557|455741077|FG000|Randomized to Management Strategies|Other adverse event|8|||
126666678|NCT01493557|455741078|FG001|Randomized to Management Strategies|Other adverse event|5|||
126666679|NCT01493557|455741079|FG002|Randomized to Management Strategies|Other adverse event|0|||
126334004|NCT02035553|454518572|FG000|Overall Study|Non-compliance with Study Drug|0|||
126334005|NCT02035553|454518573|FG001|Overall Study|Non-compliance with Study Drug|1|||
126334006|NCT02035553|454518572|FG000|Overall Study|Lost to Follow-up|0|||
126334007|NCT02035553|454518573|FG001|Overall Study|Lost to Follow-up|1|||
126334008|NCT02035553|454518572|FG000|Overall Study|Other Reason|0|||
126334009|NCT02035553|454518573|FG001|Overall Study|Other Reason|4|||
126334010|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334011|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
126334012|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
126334013|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334014|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334015|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334016|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334017|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334018|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334019|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334020|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334021|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334022|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334023|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334024|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126334025|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
126334026|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
126334027|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334028|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334029|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334030|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334031|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334032|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334033|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334034|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334035|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334036|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334037|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334038|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334039|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
126334040|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
126334041|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
126334042|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
126334043|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334044|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334045|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334046|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334047|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334048|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334049|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334050|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334051|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334052|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334053|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334054|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126334055|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334056|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334057|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
126334058|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334059|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334060|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334061|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334062|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334063|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334064|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334065|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334066|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334067|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334068|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334069|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
126334070|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334071|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334072|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
126334073|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334074|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334075|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334076|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334077|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126666680|NCT01493557|455741077|FG000|Randomized to Management Strategies|Protocol Violation|3|||
126666681|NCT01493557|455741078|FG001|Randomized to Management Strategies|Protocol Violation|0|||
126666682|NCT01493557|455741079|FG002|Randomized to Management Strategies|Protocol Violation|0|||
126666683|NCT01493557|455741077|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
126666684|NCT01493557|455741078|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
126666685|NCT01493557|455741079|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
126666686|NCT01493557|455741077|FG000|Randomized to Management Strategies|Other than stated above|1|||
126666687|NCT01493557|455741078|FG001|Randomized to Management Strategies|Other than stated above|3|||
126666688|NCT01493557|455741079|FG002|Randomized to Management Strategies|Other than stated above|0|||
126666689|NCT01493557|455741077|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
126666690|NCT01493557|455741078|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
126666691|NCT01493557|455741079|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
126666692|NCT01493557|455741077|FG000|Adding the Second Strategy|Other adverse event|1|||
126666693|NCT01493557|455741078|FG001|Adding the Second Strategy|Other adverse event|2|||
126666694|NCT01493557|455741079|FG002|Adding the Second Strategy|Other adverse event|0|||
126666695|NCT01493557|455741077|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
126666696|NCT01493557|455741078|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
126666697|NCT01493557|455741079|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
126666698|NCT01890148|455741089|FG000|Overall Study|Adverse Event|1|||
126666699|NCT01170039|455741092|FG000|Overall Study|Withdrawal by Subject|5|||
126666700|NCT01170039|455741093|FG001|Overall Study|Withdrawal by Subject|3|||
126666701|NCT01170039|455741092|FG000|Overall Study|Lack of funding, drug not available|3|||
126666702|NCT01170039|455741093|FG001|Overall Study|Lack of funding, drug not available|3|||
126666703|NCT00727649|455741094|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
126666704|NCT00727649|455741095|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
126666705|NCT00727649|455741094|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
126666706|NCT00727649|455741095|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
126666707|NCT00727649|455741094|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
126666708|NCT00727649|455741095|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
126666709|NCT00727649|455741094|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
126666710|NCT00727649|455741095|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
126666711|NCT00727649|455741094|FG000|Second Intervention (4-weeks)|Death|1|||
126666712|NCT00727649|455741095|FG001|Second Intervention (4-weeks)|Death|0|||
126666713|NCT00727649|455741094|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
126666714|NCT00727649|455741095|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
126666715|NCT00727649|455741094|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
126334078|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126666716|NCT00727649|455741095|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
126666717|NCT00832117|455741098|FG000|Overall Study|Death|1|||
126666718|NCT00832117|455741098|FG000|Overall Study|Disease Progression|11|||
126666719|NCT00404066|455741099|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
126666720|NCT00404066|455741099|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
126666721|NCT01524133|455741102|FG000|Treatment Phase|Withdrawal by Subject|13|||
126666722|NCT01524133|455741103|FG001|Treatment Phase|Withdrawal by Subject|28|||
126666723|NCT01524133|455741104|FG002|Treatment Phase|Withdrawal by Subject|31|||
126666724|NCT01524133|455741102|FG000|Treatment Phase|Physician Decision|6|||
126666725|NCT01524133|455741103|FG001|Treatment Phase|Physician Decision|3|||
126666726|NCT01524133|455741104|FG002|Treatment Phase|Physician Decision|3|||
126666727|NCT01524133|455741102|FG000|Treatment Phase|Lost to Follow-up|0|||
126666728|NCT01524133|455741103|FG001|Treatment Phase|Lost to Follow-up|1|||
126666729|NCT01524133|455741104|FG002|Treatment Phase|Lost to Follow-up|2|||
126666730|NCT01524133|455741102|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
126666731|NCT01524133|455741103|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
126334079|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126666732|NCT01524133|455741104|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
126666733|NCT01524133|455741102|FG000|Overall Study 52 Weeks|Physician Decision|1|||
126666734|NCT01524133|455741103|FG001|Overall Study 52 Weeks|Physician Decision|0|||
126666735|NCT01524133|455741104|FG002|Overall Study 52 Weeks|Physician Decision|2|||
126666736|NCT01524133|455741102|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
126666737|NCT01524133|455741103|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
126666738|NCT01524133|455741104|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
126666739|NCT03842163|455741109|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
126666740|NCT03842163|455741109|FG000|Overall Study|Scintigraphy was not performed|44|||
126666741|NCT03829241|455741110|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
126666742|NCT03829241|455741111|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
126666743|NCT03829241|455741110|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
126666744|NCT03829241|455741111|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
126666745|NCT03829241|455741110|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
126666746|NCT03829241|455741111|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
126666747|NCT03829241|455741110|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
126666748|NCT03829241|455741111|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
126334080|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334081|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334082|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334083|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334084|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
126334085|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334086|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334087|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
126334088|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334089|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334090|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334091|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334092|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334093|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334094|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334095|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334096|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334097|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334098|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334099|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
126334100|NCT02326272|454518574|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334101|NCT02326272|454518575|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334102|NCT02326272|454518576|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
126334103|NCT02326272|454518577|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334104|NCT02326272|454518578|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334105|NCT02326272|454518579|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334106|NCT02326272|454518580|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334107|NCT02326272|454518581|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334108|NCT02326272|454518582|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334109|NCT02326272|454518583|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334110|NCT02326272|454518584|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334111|NCT02326272|454518585|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334112|NCT02326272|454518586|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334113|NCT02326272|454518587|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334114|NCT02326272|454518588|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
126334115|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334116|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334117|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334118|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334119|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
126334120|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
126334121|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
126334122|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
126334123|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
126334124|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334125|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334126|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334127|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334128|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126334129|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126545282|NCT03303469|455290792|FG000|Overall Study|Lost to Follow-up|2|||
126758629|NCT02681094|456066667|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
126758630|NCT02681094|456066665|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
126334130|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334131|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334132|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334133|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334134|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334135|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
126334136|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
126334137|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334138|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
126334139|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
126334140|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334141|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334142|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334143|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334144|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126334145|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334146|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334147|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334148|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334149|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334150|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
126334151|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334152|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
126334153|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334154|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334155|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334156|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334157|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334158|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334159|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126334160|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334161|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334162|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334163|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126334164|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334165|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
126334166|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126334167|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126334168|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334169|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126334170|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334171|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334172|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334173|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334174|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126334175|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334176|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334177|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334178|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334179|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334180|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334181|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334182|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
126334183|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334184|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334185|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334186|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334187|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334188|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334189|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
126334190|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334191|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334192|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126666749|NCT03829241|455741110|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
126666750|NCT03829241|455741111|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
126666751|NCT03829241|455741110|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
126666752|NCT03829241|455741111|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
126666753|NCT03829241|455741110|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
126666754|NCT03829241|455741111|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
126666755|NCT03829241|455741110|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
126666756|NCT03829241|455741111|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
126666757|NCT03829241|455741110|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
126666758|NCT03829241|455741111|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
126666759|NCT03829241|455741110|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
126666760|NCT03829241|455741111|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
126666761|NCT03829241|455741110|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
126666762|NCT03829241|455741111|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
126666763|NCT03829241|455741110|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
126666764|NCT03829241|455741111|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
126666765|NCT03829241|455741110|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
126666766|NCT03829241|455741111|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
126666767|NCT03829241|455741110|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
126666768|NCT03829241|455741111|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
126666769|NCT00698451|455741112|FG000|Overall Study|Adverse Event|22|||
126666770|NCT00698451|455741112|FG000|Overall Study|Physician Decision|2|||
126666771|NCT00698451|455741112|FG000|Overall Study|Protocol Violation|6|||
126666772|NCT00698451|455741112|FG000|Overall Study|Withdrawal by Subject|6|||
126666773|NCT00698451|455741112|FG000|Overall Study|Disease progression|3|||
126666774|NCT02224599|455741113|FG000|Overall Study|Physician Decision|1|||
126666775|NCT02224599|455741113|FG000|Overall Study|Progression of Disease|1|||
126666776|NCT01187550|455741114|FG000|Overall Study|Protocol Violation|3|||
126666777|NCT01187550|455741115|FG001|Overall Study|Protocol Violation|1|||
126666778|NCT01187550|455741114|FG000|Overall Study|Other|3|||
126666779|NCT01187550|455741115|FG001|Overall Study|Other|0|||
126666780|NCT01187550|455741114|FG000|Overall Study|Randomized but not treated|8|||
126666781|NCT01187550|455741115|FG001|Overall Study|Randomized but not treated|0|||
126666782|NCT00733304|455741116|FG000|Overall Study|Adverse Event|3|||
126666783|NCT00733304|455741117|FG001|Overall Study|Adverse Event|0|||
126666784|NCT00733304|455741118|FG002|Overall Study|Adverse Event|0|||
126666785|NCT00733304|455741116|FG000|Overall Study|Lack of Efficacy|0|||
126666786|NCT00733304|455741117|FG001|Overall Study|Lack of Efficacy|0|||
126666787|NCT00733304|455741118|FG002|Overall Study|Lack of Efficacy|2|||
126666788|NCT00733304|455741116|FG000|Overall Study|Lost to Follow-up|0|||
126666789|NCT00733304|455741117|FG001|Overall Study|Lost to Follow-up|1|||
126666790|NCT00733304|455741118|FG002|Overall Study|Lost to Follow-up|0|||
126666791|NCT00733304|455741116|FG000|Overall Study|Physician Decision|3|||
126666792|NCT00733304|455741117|FG001|Overall Study|Physician Decision|1|||
126666793|NCT00733304|455741118|FG002|Overall Study|Physician Decision|3|||
126666794|NCT00733304|455741116|FG000|Overall Study|Withdrawal by Subject|1|||
126666795|NCT00733304|455741117|FG001|Overall Study|Withdrawal by Subject|1|||
126666796|NCT00733304|455741118|FG002|Overall Study|Withdrawal by Subject|0|||
126666797|NCT02616614|455741128|FG000|Overall Study|Withdrawal by Subject|10|||
126666798|NCT02616614|455741129|FG001|Overall Study|Withdrawal by Subject|5|||
126666799|NCT02616614|455741130|FG002|Overall Study|Withdrawal by Subject|6|||
126666800|NCT02616614|455741128|FG000|Overall Study|Physician Decision|2|||
126666801|NCT02616614|455741129|FG001|Overall Study|Physician Decision|1|||
126666802|NCT02616614|455741130|FG002|Overall Study|Physician Decision|0|||
126666803|NCT02616614|455741128|FG000|Overall Study|Adverse Event|1|||
126666804|NCT02616614|455741129|FG001|Overall Study|Adverse Event|4|||
126666805|NCT02616614|455741130|FG002|Overall Study|Adverse Event|1|||
126666806|NCT02616614|455741128|FG000|Overall Study|Protocol Violation|0|||
126666807|NCT02616614|455741129|FG001|Overall Study|Protocol Violation|3|||
126666808|NCT02616614|455741130|FG002|Overall Study|Protocol Violation|1|||
126666809|NCT02616614|455741128|FG000|Overall Study|Prohibited Medication|12|||
126666810|NCT02616614|455741129|FG001|Overall Study|Prohibited Medication|9|||
126666811|NCT02616614|455741130|FG002|Overall Study|Prohibited Medication|5|||
126666812|NCT02616614|455741128|FG000|Overall Study|More than 3 applications missed|6|||
126666813|NCT02616614|455741129|FG001|Overall Study|More than 3 applications missed|8|||
126666814|NCT02616614|455741130|FG002|Overall Study|More than 3 applications missed|1|||
126666815|NCT02616614|455741128|FG000|Overall Study|Lost to Follow-up|31|||
126666816|NCT02616614|455741129|FG001|Overall Study|Lost to Follow-up|28|||
126666817|NCT02616614|455741130|FG002|Overall Study|Lost to Follow-up|13|||
126666818|NCT02616614|455741128|FG000|Overall Study|Pregnancy|2|||
126545283|NCT02567825|455290795|FG000|Overall Study|No follow-up post-randomization|5|||
126666819|NCT02616614|455741129|FG001|Overall Study|Pregnancy|0|||
126666820|NCT02616614|455741130|FG002|Overall Study|Pregnancy|1|||
126666821|NCT02616614|455741128|FG000|Overall Study|Other|1|||
126666822|NCT02616614|455741129|FG001|Overall Study|Other|2|||
126334193|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334194|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334195|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334196|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
126334197|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334198|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334199|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334200|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334201|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334202|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334203|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334204|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
126334205|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334206|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334207|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334208|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334209|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334210|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334211|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334212|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334213|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
126334214|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334215|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334216|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334217|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334218|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334219|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
126334220|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334221|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334222|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334223|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334224|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334225|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
126334226|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
126334227|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
126334228|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
126334229|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334230|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334231|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334232|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334233|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334234|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126334235|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334236|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334237|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334238|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334239|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334240|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
126334241|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334242|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334243|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334244|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334245|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334246|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334247|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334248|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334249|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
126334250|NCT02326272|454518574|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126666823|NCT02616614|455741130|FG002|Overall Study|Other|1|||
126666824|NCT00596934|455741131|FG000|Overall Study|Protocol Violation|1|||
126666825|NCT00596934|455741131|FG000|Overall Study|Withdrawal by Subject|1|||
126666826|NCT02445755|455741132|FG000|Overall Study|Withdrawal by Subject|2|||
126666827|NCT02445755|455741132|FG000|Overall Study|Protocol Violation|6|||
126666828|NCT02445755|455741132|FG000|Overall Study|Screen Failure|5|||
126666829|NCT03239483|455741133|FG000|Overall Study|Lost to Follow-up|1|||
126666830|NCT03239483|455741134|FG001|Overall Study|Lost to Follow-up|0|||
126666831|NCT03239483|455741133|FG000|Overall Study|Withdrawal by Subject|1|||
126666832|NCT03239483|455741134|FG001|Overall Study|Withdrawal by Subject|0|||
126666833|NCT04464265|455741135|FG000|Overall Study|Physician Decision|2|||
126666834|NCT00974090|455741140|FG000|Period 1: Double Blind Period|Adverse Event|2|||
126666835|NCT00974090|455741141|FG001|Period 1: Double Blind Period|Adverse Event|1|||
126666836|NCT00974090|455741140|FG000|Period 1: Double Blind Period|Physician Decision|1|||
126666837|NCT00974090|455741141|FG001|Period 1: Double Blind Period|Physician Decision|0|||
126666838|NCT00974090|455741140|FG000|Period 2: Open-label Period|Adverse Event|4|||
126666839|NCT00974090|455741141|FG001|Period 2: Open-label Period|Adverse Event|6|||
126666840|NCT00974090|455741140|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
126666841|NCT00974090|455741141|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
126666842|NCT00974090|455741140|FG000|Period 2: Open-label Period|Physician Decision|0|||
126666843|NCT00974090|455741141|FG001|Period 2: Open-label Period|Physician Decision|3|||
126666844|NCT00974090|455741140|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
126666845|NCT00974090|455741141|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
126666846|NCT03189862|455741142|FG000|Overall Study|Withdrawal by Subject|1|||
126666847|NCT03189862|455741143|FG001|Overall Study|Withdrawal by Subject|0|||
126666848|NCT03189862|455741142|FG000|Overall Study|Lost to Follow-up|54|||
126666849|NCT03189862|455741143|FG001|Overall Study|Lost to Follow-up|62|||
126666850|NCT01829360|455741144|FG000|Overall Study|Protocol Violation|0|||
126666851|NCT01829360|455741145|FG001|Overall Study|Protocol Violation|0|||
126666852|NCT01829360|455741146|FG002|Overall Study|Protocol Violation|1|||
126666853|NCT01829360|455741147|FG003|Overall Study|Protocol Violation|0|||
126666854|NCT03838198|455741152|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
126666855|NCT03838198|455741153|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
126666856|NCT03838198|455741154|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
126666857|NCT03838198|455741155|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
126666858|NCT03838198|455741152|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
126666859|NCT03838198|455741153|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
126666860|NCT03838198|455741154|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
126666861|NCT03838198|455741155|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
126666862|NCT05211739|455741156|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
126666863|NCT05211739|455741157|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
126666864|NCT05211739|455741156|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
126666865|NCT05211739|455741157|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
126666866|NCT05211739|455741156|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
126666867|NCT05211739|455741157|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
126666868|NCT05211739|455741156|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
126666869|NCT05211739|455741157|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
126666870|NCT01975428|455741158|FG000|Overall Study|Lost to Follow-up|17|||
126666871|NCT01975428|455741159|FG001|Overall Study|Lost to Follow-up|4|||
126666872|NCT01975428|455741158|FG000|Overall Study|Withdrawal by Subject|3|||
126666873|NCT01975428|455741159|FG001|Overall Study|Withdrawal by Subject|10|||
126666874|NCT02187809|455741160|FG000|Overall Study|The study was terminated|3|||
126666875|NCT05085665|455741161|FG000|Overall Study|Physician Decision|2|||
126666876|NCT00778622|455741162|FG000|Overall Study|Adverse Event|5|||
126666877|NCT00778622|455741163|FG001|Overall Study|Adverse Event|4|||
126666878|NCT00778622|455741164|FG002|Overall Study|Adverse Event|7|||
126666879|NCT00778622|455741162|FG000|Overall Study|Withdrawal by Subject|4|||
126666880|NCT00778622|455741163|FG001|Overall Study|Withdrawal by Subject|5|||
126666881|NCT00778622|455741164|FG002|Overall Study|Withdrawal by Subject|5|||
126666882|NCT00778622|455741162|FG000|Overall Study|Lost to Follow-up|3|||
126666883|NCT00778622|455741163|FG001|Overall Study|Lost to Follow-up|3|||
126666884|NCT00778622|455741164|FG002|Overall Study|Lost to Follow-up|2|||
126666885|NCT00778622|455741162|FG000|Overall Study|Protocol Violation|0|||
126666886|NCT00778622|455741163|FG001|Overall Study|Protocol Violation|3|||
126666887|NCT00778622|455741164|FG002|Overall Study|Protocol Violation|0|||
126666888|NCT00778622|455741162|FG000|Overall Study|Lack of Efficacy|2|||
126666889|NCT00778622|455741163|FG001|Overall Study|Lack of Efficacy|0|||
126666890|NCT00778622|455741164|FG002|Overall Study|Lack of Efficacy|0|||
126666891|NCT00778622|455741162|FG000|Overall Study|immigration|1|||
126666892|NCT00778622|455741163|FG001|Overall Study|immigration|0|||
126666893|NCT00778622|455741164|FG002|Overall Study|immigration|0|||
126666894|NCT00778622|455741162|FG000|Overall Study|Other|1|||
126666895|NCT00778622|455741163|FG001|Overall Study|Other|0|||
126666896|NCT00778622|455741164|FG002|Overall Study|Other|1|||
126334251|NCT02326272|454518575|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334252|NCT02326272|454518576|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334253|NCT02326272|454518577|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334254|NCT02326272|454518578|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334255|NCT02326272|454518579|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334256|NCT02326272|454518580|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
126334257|NCT02326272|454518581|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334258|NCT02326272|454518582|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334259|NCT02326272|454518583|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334260|NCT02326272|454518584|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334261|NCT02326272|454518585|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334262|NCT02326272|454518586|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334263|NCT02326272|454518587|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334264|NCT02326272|454518588|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
126334265|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
126334266|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
126334267|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
126334268|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
126334269|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
126334270|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
126334271|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
126334272|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
126334273|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
126334274|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
126334275|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
126334276|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
126334277|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
126334278|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
126334279|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
126334280|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334281|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334282|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334283|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334284|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334285|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334286|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334287|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334288|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334289|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334290|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
126334291|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
126334292|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
126334293|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
126334294|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
126334295|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334296|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334297|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334298|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334299|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334300|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334301|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126666897|NCT01130974|455741171|FG000|Overall Study|Protocol Violation|10|||
126666898|NCT01130974|455741172|FG001|Overall Study|Protocol Violation|10|||
126334302|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334303|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126666899|NCT01130974|455741171|FG000|Overall Study|Withdrawal by Subject|0|||
126666900|NCT01130974|455741172|FG001|Overall Study|Withdrawal by Subject|1|||
126666901|NCT01130974|455741171|FG000|Overall Study|Ineligibility criteria|5|||
126666902|NCT01130974|455741172|FG001|Overall Study|Ineligibility criteria|2|||
126666903|NCT02536755|455741173|FG000|Overall Study|Adverse Event|4|||
126666904|NCT02301936|455741174|FG000|Overall Study|Lost to Follow-up|1|||
126666905|NCT02301936|455741175|FG001|Overall Study|Lost to Follow-up|0|||
126666906|NCT03065023|455741177|FG000|Overall Study|Progressive Disease|0|||
126666907|NCT03065023|455741178|FG001|Overall Study|Progressive Disease|1|||
126666908|NCT03065023|455741179|FG002|Overall Study|Progressive Disease|0|||
126666909|NCT03065023|455741180|FG003|Overall Study|Progressive Disease|0|||
126666910|NCT03065023|455741181|FG004|Overall Study|Progressive Disease|0|||
126666911|NCT03065023|455741177|FG000|Overall Study|Death|2|||
126666912|NCT03065023|455741178|FG001|Overall Study|Death|0|||
126666913|NCT03065023|455741179|FG002|Overall Study|Death|1|||
126666914|NCT03065023|455741180|FG003|Overall Study|Death|1|||
126666915|NCT03065023|455741181|FG004|Overall Study|Death|0|||
126666916|NCT03065023|455741177|FG000|Overall Study|Lost to Follow-up|0|||
126666917|NCT03065023|455741178|FG001|Overall Study|Lost to Follow-up|1|||
126666918|NCT03065023|455741179|FG002|Overall Study|Lost to Follow-up|0|||
126666919|NCT03065023|455741180|FG003|Overall Study|Lost to Follow-up|0|||
126666920|NCT03065023|455741181|FG004|Overall Study|Lost to Follow-up|0|||
126666921|NCT03065023|455741177|FG000|Overall Study|Participant Decision|0|||
126666922|NCT03065023|455741178|FG001|Overall Study|Participant Decision|0|||
126666923|NCT03065023|455741179|FG002|Overall Study|Participant Decision|0|||
126666924|NCT03065023|455741180|FG003|Overall Study|Participant Decision|1|||
126666925|NCT03065023|455741181|FG004|Overall Study|Participant Decision|0|||
126666926|NCT03065023|455741177|FG000|Overall Study|Withdrawal by Subject|0|||
126666927|NCT03065023|455741178|FG001|Overall Study|Withdrawal by Subject|0|||
126334304|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334305|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
126334306|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334307|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
126334308|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334309|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126334310|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334311|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334312|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334313|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126666928|NCT03065023|455741179|FG002|Overall Study|Withdrawal by Subject|0|||
126666929|NCT03065023|455741180|FG003|Overall Study|Withdrawal by Subject|1|||
126666930|NCT03065023|455741181|FG004|Overall Study|Withdrawal by Subject|0|||
126666931|NCT03427125|455741182|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
126666932|NCT03427125|455741183|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
126666933|NCT03427125|455741184|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
126666934|NCT04014361|455741187|FG000|Period 2|Physician Decision|0|||
126666935|NCT04014361|455741188|FG001|Period 2|Physician Decision|0|||
126666936|NCT04014361|455741189|FG002|Period 2|Physician Decision|0|||
126666937|NCT04014361|455741190|FG003|Period 2|Physician Decision|1|||
126666938|NCT04014361|455741191|FG004|Period 2|Physician Decision|0|||
126666939|NCT04014361|455741192|FG005|Period 2|Physician Decision|0|||
126666940|NCT04014361|455741193|FG006|Period 2|Physician Decision|0|||
126666941|NCT04014361|455741194|FG007|Period 2|Physician Decision|0|||
126666942|NCT03610165|455741200|FG000|Overall Study|Device didn't work|0|||
126666943|NCT03610165|455741201|FG001|Overall Study|Device didn't work|1|||
126666944|NCT01810016|455741202|FG000|Overall Study|Progressive disease|1|||
126666945|NCT01810016|455741203|FG001|Overall Study|Progressive disease|1|||
126666946|NCT01810016|455741204|FG002|Overall Study|Progressive disease|0|||
126666947|NCT01810016|455741202|FG000|Overall Study|Death|0|||
126666948|NCT01810016|455741203|FG001|Overall Study|Death|0|||
126666949|NCT01810016|455741204|FG002|Overall Study|Death|1|||
126666950|NCT00708175|455741205|FG000|Overall Study|Adverse Event|4|||
126666951|NCT00708175|455741206|FG001|Overall Study|Adverse Event|5|||
126666952|NCT00708175|455741205|FG000|Overall Study|Protocol Violation|2|||
126666953|NCT00708175|455741206|FG001|Overall Study|Protocol Violation|3|||
126666954|NCT00708175|455741205|FG000|Overall Study|Lost to Follow-up|5|||
126666955|NCT00708175|455741206|FG001|Overall Study|Lost to Follow-up|3|||
126666956|NCT00708175|455741205|FG000|Overall Study|Withdrawal by Subject|5|||
126666957|NCT00708175|455741206|FG001|Overall Study|Withdrawal by Subject|7|||
126666958|NCT00708175|455741205|FG000|Overall Study|BMD loss >7%|2|||
126666959|NCT00708175|455741206|FG001|Overall Study|BMD loss >7%|3|||
126666960|NCT03828292|455741210|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
126666961|NCT03828292|455741211|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
126666962|NCT03828292|455741212|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
126666963|NCT03828292|455741213|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
126666964|NCT03828292|455741214|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
126666965|NCT03828292|455741215|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
126666966|NCT03828292|455741210|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
126666967|NCT03828292|455741211|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
126666968|NCT03828292|455741212|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
126666969|NCT03828292|455741213|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
126666970|NCT03828292|455741214|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
126666971|NCT03828292|455741215|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
126666972|NCT03828292|455741210|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
126666973|NCT03828292|455741211|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
126666974|NCT03828292|455741212|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
126666975|NCT03828292|455741213|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
126334314|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334315|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334316|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334317|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126666976|NCT03828292|455741214|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
126334318|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334319|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334320|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334321|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
126334322|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334323|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334324|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
126334325|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334326|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334327|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334328|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334329|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334330|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334331|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334332|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334333|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334334|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334335|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
126334336|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334337|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
126334338|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126334339|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
126334340|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334341|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334342|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334343|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334344|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334345|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334346|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334347|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334348|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334349|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334350|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334351|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
126334352|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334353|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126334354|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
126334355|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334356|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334357|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334358|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334359|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334360|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334361|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334362|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334363|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334364|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334365|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334366|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
126334367|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
126334368|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
126334369|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
126334370|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334371|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334372|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126666977|NCT03828292|455741215|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
126666978|NCT03828292|455741210|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
126666979|NCT03828292|455741211|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
126666980|NCT03828292|455741212|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
126666981|NCT03828292|455741213|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
126666982|NCT03828292|455741214|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
126666983|NCT03828292|455741215|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
126666984|NCT03828292|455741210|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
126666985|NCT03828292|455741211|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
126666986|NCT03828292|455741212|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
126666987|NCT03828292|455741213|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
126666988|NCT03828292|455741214|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
126666989|NCT03828292|455741215|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
126666990|NCT04667247|455741218|FG000|Overall Study|Withdrawal by Subject|0|||
126666991|NCT04667247|455741219|FG001|Overall Study|Withdrawal by Subject|1|||
126666992|NCT06950879|455741220|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
126666993|NCT01436071|455742893|FG000|Overall Study|Adverse Event|1|||
126666994|NCT01436071|455742894|FG001|Overall Study|Adverse Event|0|||
126666995|NCT01436071|455742893|FG000|Overall Study|Lack of Efficacy|16|||
126666996|NCT01436071|455742894|FG001|Overall Study|Lack of Efficacy|7|||
126666997|NCT01436071|455742893|FG000|Overall Study|Protocol Violation|0|||
126334373|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126666998|NCT01436071|455742894|FG001|Overall Study|Protocol Violation|1|||
126666999|NCT01436071|455742893|FG000|Overall Study|Lost to Follow-up|3|||
126667000|NCT01436071|455742894|FG001|Overall Study|Lost to Follow-up|1|||
126667001|NCT01436071|455742893|FG000|Overall Study|Physician Decision|1|||
126667002|NCT01436071|455742894|FG001|Overall Study|Physician Decision|0|||
126667003|NCT01436071|455742893|FG000|Overall Study|Withdrawal by Subject|2|||
126667004|NCT01436071|455742894|FG001|Overall Study|Withdrawal by Subject|2|||
126667005|NCT01436071|455742893|FG000|Overall Study|Did Not Receive Trial Medication|3|||
126667006|NCT01436071|455742894|FG001|Overall Study|Did Not Receive Trial Medication|3|||
126667007|NCT01215175|455742903|FG000|Overall Study|Lost to Follow-up|0|||
126667008|NCT01215175|455742904|FG001|Overall Study|Lost to Follow-up|1|||
126667009|NCT01215175|455742905|FG002|Overall Study|Lost to Follow-up|0|||
126667010|NCT01215175|455742906|FG003|Overall Study|Lost to Follow-up|1|||
126334374|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334375|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334376|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126667011|NCT01215175|455742907|FG004|Overall Study|Lost to Follow-up|0|||
126667012|NCT01678209|455742908|FG000|Overall Study|could not scan twice|1|||
126334377|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334378|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334379|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334380|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334381|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
126334382|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334383|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334384|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
126334385|NCT02326272|454518574|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334386|NCT02326272|454518575|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334387|NCT02326272|454518576|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334388|NCT02326272|454518577|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334389|NCT02326272|454518578|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334390|NCT02326272|454518579|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334391|NCT02326272|454518580|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334392|NCT02326272|454518581|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334393|NCT02326272|454518582|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334394|NCT02326272|454518583|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334395|NCT02326272|454518584|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334396|NCT02326272|454518585|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334397|NCT02326272|454518586|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
126334398|NCT02326272|454518587|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126334399|NCT02326272|454518588|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
126667013|NCT01678209|455742909|FG001|Overall Study|could not scan twice|1|||
126667014|NCT01678209|455742910|FG002|Overall Study|could not scan twice|1|||
126667015|NCT01678209|455742908|FG000|Overall Study|scheduling conflicts|0|||
126667016|NCT01678209|455742909|FG001|Overall Study|scheduling conflicts|0|||
126667017|NCT01678209|455742910|FG002|Overall Study|scheduling conflicts|1|||
126667018|NCT01678209|455742908|FG000|Overall Study|screen fail|16|||
126667019|NCT01678209|455742909|FG001|Overall Study|screen fail|17|||
126667020|NCT01678209|455742910|FG002|Overall Study|screen fail|16|||
126667021|NCT00702845|455742911|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
126334400|NCT03713684|454518589|FG000|Overall Study|Adverse Event|1|||
126667022|NCT00702845|455742912|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
126334401|NCT03713684|454518590|FG001|Overall Study|Adverse Event|3|||
126334402|NCT03713684|454518591|FG002|Overall Study|Adverse Event|1|||
126334403|NCT03713684|454518592|FG003|Overall Study|Adverse Event|0|||
126334404|NCT03713684|454518589|FG000|Overall Study|Poor compliance to protocol|2|||
126334405|NCT03713684|454518590|FG001|Overall Study|Poor compliance to protocol|1|||
126334406|NCT03713684|454518591|FG002|Overall Study|Poor compliance to protocol|0|||
126334407|NCT03713684|454518592|FG003|Overall Study|Poor compliance to protocol|1|||
126334408|NCT03713684|454518589|FG000|Overall Study|Withdrawal by Subject|14|||
126334409|NCT03713684|454518590|FG001|Overall Study|Withdrawal by Subject|6|||
126334410|NCT03713684|454518591|FG002|Overall Study|Withdrawal by Subject|14|||
126334411|NCT03713684|454518592|FG003|Overall Study|Withdrawal by Subject|16|||
126334412|NCT03713684|454518589|FG000|Overall Study|Other than specified|69|||
126334413|NCT03713684|454518590|FG001|Overall Study|Other than specified|77|||
126334414|NCT03713684|454518591|FG002|Overall Study|Other than specified|73|||
126334415|NCT03713684|454518592|FG003|Overall Study|Other than specified|70|||
126334416|NCT02185417|454518593|FG000|Overall Study|Death|448|||
126334417|NCT02185417|454518594|FG001|Overall Study|Death|446|||
126334418|NCT02185417|454518595|FG002|Overall Study|Death|0|||
126334419|NCT02185417|454518593|FG000|Overall Study|Withdrawal by Subject|7|||
126334420|NCT02185417|454518594|FG001|Overall Study|Withdrawal by Subject|12|||
126334421|NCT02185417|454518595|FG002|Overall Study|Withdrawal by Subject|0|||
126334422|NCT02595502|454518596|FG000|Period 1|Adverse Event|0|||
126334423|NCT02595502|454518597|FG001|Period 1|Adverse Event|1|||
126334424|NCT02595502|454518596|FG000|Period 1|Withdrawal by Subject|1|||
126334425|NCT02595502|454518597|FG001|Period 1|Withdrawal by Subject|0|||
126334426|NCT02595502|454518596|FG000|Period 1|Lost to Follow-up|0|||
126334427|NCT02595502|454518597|FG001|Period 1|Lost to Follow-up|1|||
126334428|NCT02595502|454518596|FG000|Period 2|Adverse Event|1|||
126334429|NCT02595502|454518597|FG001|Period 2|Adverse Event|1|||
126334430|NCT02595502|454518596|FG000|Period 2|Received incorrect lens at Period 1|0|||
126334431|NCT02595502|454518597|FG001|Period 2|Received incorrect lens at Period 1|1|||
126334432|NCT02595502|454518596|FG000|Period 3|Protocol Violation|0|||
126334433|NCT02595502|454518597|FG001|Period 3|Protocol Violation|1|||
126334434|NCT02595502|454518596|FG000|Period 3|Lost to Follow-up|1|||
126334435|NCT02595502|454518597|FG001|Period 3|Lost to Follow-up|0|||
126334436|NCT02595502|454518596|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
126334437|NCT02595502|454518597|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
126334438|NCT05556148|454518598|FG000|Overall Study|Early Termination|29|||
126334439|NCT05556148|454518598|FG000|Overall Study|Baseline Tasks Expired|4|||
126334440|NCT05556148|454518598|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
126334441|NCT05556148|454518598|FG000|Overall Study|No Longer Wished to Participate|1|||
126334442|NCT05556148|454518598|FG000|Overall Study|Bacterial Conjunctivitis|1|||
126334443|NCT00458003|454518604|FG000|Overall Study|Non protocol spinal anesthesia|1|||
126334444|NCT00458003|454518605|FG001|Overall Study|Non protocol spinal anesthesia|1|||
126334445|NCT00468585|454518608|FG000|Overall Study|Patient not treated|1|||
126334446|NCT00468585|454518609|FG001|Overall Study|Patient not treated|0|||
126334447|NCT00468585|454518610|FG002|Overall Study|Patient not treated|1|||
126334448|NCT00468585|454518611|FG003|Overall Study|Patient not treated|0|||
126334449|NCT00468585|454518608|FG000|Overall Study|Patient found to be ineligible|0|||
126334450|NCT00468585|454518609|FG001|Overall Study|Patient found to be ineligible|0|||
126334451|NCT00468585|454518610|FG002|Overall Study|Patient found to be ineligible|1|||
126334452|NCT00468585|454518611|FG003|Overall Study|Patient found to be ineligible|0|||
126334453|NCT00468585|454518608|FG000|Overall Study|Adverse Event|0|||
126334454|NCT00468585|454518609|FG001|Overall Study|Adverse Event|0|||
126334455|NCT00468585|454518610|FG002|Overall Study|Adverse Event|1|||
126334456|NCT00468585|454518611|FG003|Overall Study|Adverse Event|0|||
126334457|NCT00468585|454518608|FG000|Overall Study|Withdrawal by Subject|0|||
126334458|NCT00468585|454518609|FG001|Overall Study|Withdrawal by Subject|0|||
126334459|NCT00468585|454518610|FG002|Overall Study|Withdrawal by Subject|2|||
126334460|NCT00468585|454518611|FG003|Overall Study|Withdrawal by Subject|1|||
126334461|NCT02154139|454518612|FG000|Overall Study|Injection not administered|2|||
126334462|NCT02154139|454518612|FG000|Overall Study|Other|2|||
126334463|NCT02154139|454518612|FG000|Overall Study|Investigator transferred|3|||
126334464|NCT01529606|454518616|FG000|Overall Study|Lost to Follow-up|21|||
126334465|NCT01529606|454518617|FG001|Overall Study|Lost to Follow-up|18|||
126334466|NCT01746862|454518618|FG000|Overall Study|Withdrawal by Subject|1|||
126334467|NCT01746862|454518619|FG001|Overall Study|Withdrawal by Subject|1|||
126334468|NCT01746862|454518618|FG000|Overall Study|Protocol Violation|1|||
126334469|NCT01746862|454518619|FG001|Overall Study|Protocol Violation|0|||
126334470|NCT01746862|454518618|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
126334471|NCT01746862|454518619|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
126334472|NCT01746862|454518618|FG000|Overall Study|Entered puberty during the study|1|||
126334473|NCT01746862|454518619|FG001|Overall Study|Entered puberty during the study|0|||
126334474|NCT04742673|454518620|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
126334475|NCT04742673|454518621|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
126334476|NCT01900444|454518622|FG000|Overall Study|Protocol Violation|2|||
126334477|NCT01900444|454518622|FG000|Overall Study|Lost to Follow-up|1|||
126667023|NCT00702845|455742911|FG000|Overall Study|Too high ovarian response|5|||
126334478|NCT01825200|454518626|FG000|Overall Study|Lost to Follow-up|5|||
126667024|NCT00702845|455742912|FG001|Overall Study|Too high ovarian response|1|||
126667025|NCT00702845|455742911|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
126667026|NCT00702845|455742912|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
126667027|NCT00702845|455742911|FG000|Overall Study|Insufficient ovarian response|1|||
126667028|NCT00702845|455742912|FG001|Overall Study|Insufficient ovarian response|0|||
126334479|NCT01825200|454518627|FG001|Overall Study|Lost to Follow-up|6|||
126334480|NCT01825200|454518626|FG000|Overall Study|Withdrawal by Subject|0|||
126334481|NCT01825200|454518627|FG001|Overall Study|Withdrawal by Subject|1|||
126667029|NCT00702845|455742911|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
126667030|NCT00702845|455742912|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
126667031|NCT00702845|455742911|FG000|Overall Study|No or abnormal fertilization|4|||
126667032|NCT00702845|455742912|FG001|Overall Study|No or abnormal fertilization|2|||
126334482|NCT06058390|454518631|FG000|Overall Study|Lost to Follow-up|0|||
126334483|NCT06058390|454518632|FG001|Overall Study|Lost to Follow-up|0|||
126334484|NCT06058390|454518633|FG002|Overall Study|Lost to Follow-up|2|||
126334485|NCT06058390|454518634|FG003|Overall Study|Lost to Follow-up|1|||
126334486|NCT06058390|454518631|FG000|Overall Study|Physician Decision|0|||
126334487|NCT06058390|454518632|FG001|Overall Study|Physician Decision|0|||
126334488|NCT06058390|454518633|FG002|Overall Study|Physician Decision|0|||
126334489|NCT06058390|454518634|FG003|Overall Study|Physician Decision|1|||
126334490|NCT06058390|454518631|FG000|Overall Study|Participants did not receive any study intervention|0|||
126334491|NCT06058390|454518632|FG001|Overall Study|Participants did not receive any study intervention|0|||
126334492|NCT06058390|454518633|FG002|Overall Study|Participants did not receive any study intervention|0|||
126334493|NCT06058390|454518634|FG003|Overall Study|Participants did not receive any study intervention|1|||
126334494|NCT03361306|454518635|FG000|Overall Study|Death|6|||
126334495|NCT02131064|454518637|FG000|Overall Study|Death|5|||
126334496|NCT02131064|454518638|FG001|Overall Study|Death|6|||
126334497|NCT02131064|454518637|FG000|Overall Study|Lost to Follow-up|4|||
126334498|NCT02131064|454518638|FG001|Overall Study|Lost to Follow-up|8|||
126334499|NCT02131064|454518637|FG000|Overall Study|Withdrawal by Subject|14|||
126334500|NCT02131064|454518638|FG001|Overall Study|Withdrawal by Subject|18|||
126334501|NCT02131064|454518637|FG000|Overall Study|Other|2|||
126334502|NCT02131064|454518638|FG001|Overall Study|Other|2|||
126334503|NCT00810069|454518641|FG000|Lead-in Period I|Adverse Event|43|||
126334504|NCT00810069|454518642|FG001|Lead-in Period I|Adverse Event|0|||
126334505|NCT00810069|454518643|FG002|Lead-in Period I|Adverse Event|0|||
126334506|NCT00810069|454518641|FG000|Lead-in Period I|Lack of Efficacy|1|||
126334507|NCT00810069|454518642|FG001|Lead-in Period I|Lack of Efficacy|0|||
126334508|NCT00810069|454518643|FG002|Lead-in Period I|Lack of Efficacy|0|||
126334509|NCT00810069|454518641|FG000|Lead-in Period I|Lost to Follow-up|19|||
126334510|NCT00810069|454518642|FG001|Lead-in Period I|Lost to Follow-up|0|||
126334511|NCT00810069|454518643|FG002|Lead-in Period I|Lost to Follow-up|0|||
126334512|NCT00810069|454518641|FG000|Lead-in Period I|Physician Decision|1|||
126334513|NCT00810069|454518642|FG001|Lead-in Period I|Physician Decision|0|||
126334514|NCT00810069|454518643|FG002|Lead-in Period I|Physician Decision|0|||
126334515|NCT00810069|454518641|FG000|Lead-in Period I|Protocol Violation|1|||
126334516|NCT00810069|454518642|FG001|Lead-in Period I|Protocol Violation|0|||
126334517|NCT00810069|454518643|FG002|Lead-in Period I|Protocol Violation|0|||
126334518|NCT00810069|454518641|FG000|Lead-in Period I|Withdrawal by Subject|46|||
126334519|NCT00810069|454518642|FG001|Lead-in Period I|Withdrawal by Subject|0|||
126334520|NCT00810069|454518643|FG002|Lead-in Period I|Withdrawal by Subject|0|||
126334521|NCT00810069|454518641|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
126334522|NCT00810069|454518642|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
126334523|NCT00810069|454518643|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
126334524|NCT00810069|454518641|FG000|Lead-in Period I|Randomization criteria not met|158|||
126334525|NCT00810069|454518642|FG001|Lead-in Period I|Randomization criteria not met|0|||
126334526|NCT00810069|454518643|FG002|Lead-in Period I|Randomization criteria not met|0|||
126334527|NCT00810069|454518641|FG000|Double-Blind Period II|Adverse Event|0|||
126334528|NCT00810069|454518642|FG001|Double-Blind Period II|Adverse Event|9|||
126334529|NCT00810069|454518643|FG002|Double-Blind Period II|Adverse Event|8|||
126334530|NCT00810069|454518641|FG000|Double-Blind Period II|Lack of Efficacy|0|||
126334531|NCT00810069|454518642|FG001|Double-Blind Period II|Lack of Efficacy|7|||
126334532|NCT00810069|454518643|FG002|Double-Blind Period II|Lack of Efficacy|12|||
126667033|NCT00702845|455742911|FG000|Overall Study|Patient's decision|2|||
126667034|NCT00702845|455742912|FG001|Overall Study|Patient's decision|1|||
126667035|NCT00702845|455742911|FG000|Overall Study|Not randomized|0|||
126334533|NCT00810069|454518641|FG000|Double-Blind Period II|Lost to Follow-up|0|||
126334534|NCT00810069|454518642|FG001|Double-Blind Period II|Lost to Follow-up|9|||
126334535|NCT00810069|454518643|FG002|Double-Blind Period II|Lost to Follow-up|9|||
126334536|NCT00810069|454518641|FG000|Double-Blind Period II|Physician Decision|0|||
126334537|NCT00810069|454518642|FG001|Double-Blind Period II|Physician Decision|0|||
126334538|NCT00810069|454518643|FG002|Double-Blind Period II|Physician Decision|1|||
126334539|NCT00810069|454518641|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
126334540|NCT00810069|454518642|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
126334541|NCT00810069|454518643|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
126334542|NCT00810069|454518641|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
126334543|NCT00810069|454518642|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
126334544|NCT00810069|454518643|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
126334545|NCT00810069|454518641|FG000|Double-Blind Period II|Clinical relapse|0|||
126334546|NCT00810069|454518642|FG001|Double-Blind Period II|Clinical relapse|3|||
126334547|NCT00810069|454518643|FG002|Double-Blind Period II|Clinical relapse|0|||
126334548|NCT00810069|454518641|FG000|Double-Blind Period II|Protocol Violation|0|||
126334549|NCT00810069|454518642|FG001|Double-Blind Period II|Protocol Violation|7|||
126334550|NCT00810069|454518643|FG002|Double-Blind Period II|Protocol Violation|6|||
126334551|NCT00971867|454518647|FG000|Overall Study|Adverse Event|4|||
126334552|NCT00971867|454518647|FG000|Overall Study|Participant Withdrew Consent|1|||
126334553|NCT00971867|454518647|FG000|Overall Study|Disease Progression|6|||
126334554|NCT04767373|454518648|FG000|Overall Study|Death|6|||
126334555|NCT04767373|454518649|FG001|Overall Study|Death|3|||
126334556|NCT04767373|454518648|FG000|Overall Study|Lost to Follow-up|67|||
126334557|NCT04767373|454518649|FG001|Overall Study|Lost to Follow-up|35|||
126334558|NCT04767373|454518648|FG000|Overall Study|Physician Decision|15|||
126334559|NCT04767373|454518649|FG001|Overall Study|Physician Decision|4|||
126334560|NCT04767373|454518648|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126334561|NCT04767373|454518649|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126334562|NCT04767373|454518648|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
126334563|NCT04767373|454518649|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
126334564|NCT04767373|454518648|FG000|Overall Study|Other|1|||
126334565|NCT04767373|454518649|FG001|Overall Study|Other|2|||
126334566|NCT02983045|454518651|FG000|Overall Study|Withdrawal by Subject|0|||
126334567|NCT02983045|454518652|FG001|Overall Study|Withdrawal by Subject|1|||
126334568|NCT02983045|454518653|FG002|Overall Study|Withdrawal by Subject|0|||
126334569|NCT02983045|454518654|FG003|Overall Study|Withdrawal by Subject|5|||
126334570|NCT02983045|454518655|FG004|Overall Study|Withdrawal by Subject|0|||
126334571|NCT02983045|454518656|FG005|Overall Study|Withdrawal by Subject|72|||
126334572|NCT02983045|454518657|FG006|Overall Study|Withdrawal by Subject|0|||
126334573|NCT02983045|454518658|FG007|Overall Study|Withdrawal by Subject|0|||
126334574|NCT02983045|454518659|FG008|Overall Study|Withdrawal by Subject|0|||
126334575|NCT02983045|454518660|FG009|Overall Study|Withdrawal by Subject|2|||
126334576|NCT02983045|454518651|FG000|Overall Study|Lost to Follow-up|0|||
126334577|NCT02983045|454518652|FG001|Overall Study|Lost to Follow-up|0|||
126334578|NCT02983045|454518653|FG002|Overall Study|Lost to Follow-up|0|||
126334579|NCT02983045|454518654|FG003|Overall Study|Lost to Follow-up|0|||
126334580|NCT02983045|454518655|FG004|Overall Study|Lost to Follow-up|0|||
126334581|NCT02983045|454518656|FG005|Overall Study|Lost to Follow-up|10|||
126334582|NCT02983045|454518657|FG006|Overall Study|Lost to Follow-up|0|||
126334583|NCT02983045|454518658|FG007|Overall Study|Lost to Follow-up|0|||
126334584|NCT02983045|454518659|FG008|Overall Study|Lost to Follow-up|0|||
126334585|NCT02983045|454518660|FG009|Overall Study|Lost to Follow-up|0|||
126334586|NCT00593918|454518661|FG000|Overall Study|Withdrawal by Subject|5|||
126334587|NCT00593918|454518662|FG001|Overall Study|Withdrawal by Subject|24|||
126334588|NCT02658669|454518663|FG000|Overall Study|Lost to Follow-up|7|||
126334589|NCT02658669|454518664|FG001|Overall Study|Lost to Follow-up|5|||
126334590|NCT03727841|454518665|FG000|Overall Study|Physician Decision|3|||
126334591|NCT03727841|454518666|FG001|Overall Study|Physician Decision|1|||
126334592|NCT01601496|454518667|FG000|Overall Study|Physician Decision|1|||
126334593|NCT01601496|454518667|FG000|Overall Study|Withdrawal by Subject|1|||
126334594|NCT01601496|454518667|FG000|Overall Study|Lost to Follow-up|6|||
126334595|NCT01601496|454518667|FG000|Overall Study|Death|4|||
126334596|NCT01601496|454518667|FG000|Overall Study|Other: patient refusal to continue|3|||
126334597|NCT03421379|454518675|FG000|Period 1|Withdrawal by Subject|0|||
126334598|NCT03421379|454518676|FG001|Period 1|Withdrawal by Subject|1|||
126334599|NCT03421379|454518675|FG000|Period 1|Physician Decision|1|||
126334600|NCT03421379|454518676|FG001|Period 1|Physician Decision|1|||
126334601|NCT03421379|454518675|FG000|Period 1|Did not receive treatment|1|||
126334602|NCT03421379|454518676|FG001|Period 1|Did not receive treatment|2|||
126334603|NCT04157088|454518677|FG000|Overall Study|Study terminated by sponsor|23|||
126334604|NCT04157088|454518677|FG000|Overall Study|Withdrawal by Subject|4|||
126334605|NCT04157088|454518677|FG000|Overall Study|Lost to Follow-up|2|||
126334606|NCT04157088|454518677|FG000|Overall Study|Death|1|||
126334607|NCT02421419|454518678|FG000|Overall Study|Physician Decision|0|||
126334608|NCT02421419|454518679|FG001|Overall Study|Physician Decision|0|||
126334609|NCT02421419|454518680|FG002|Overall Study|Physician Decision|1|||
126334610|NCT00196105|454518686|FG000|Overall Study|Lost to Follow-up|4|||
126334611|NCT00196105|454518687|FG001|Overall Study|Lost to Follow-up|5|||
126334612|NCT00196105|454518688|FG002|Overall Study|Lost to Follow-up|7|||
126334613|NCT04863872|454518689|FG000|Overall Study|Withdrawal by Subject|4|||
126334614|NCT04863872|454518690|FG001|Overall Study|Withdrawal by Subject|15|||
126334615|NCT04863872|454518689|FG000|Overall Study|Death|5|||
126334616|NCT04863872|454518690|FG001|Overall Study|Death|2|||
126334617|NCT04863872|454518689|FG000|Overall Study|Lost to Follow-up|2|||
126334618|NCT04863872|454518690|FG001|Overall Study|Lost to Follow-up|1|||
126334619|NCT03771963|454518691|FG000|Overall Study|Lost to Follow-up|22|||
126334620|NCT03771963|454518691|FG000|Overall Study|Withdrawal of Consent|10|||
126334621|NCT03014206|454518692|FG000|Overall Study|Registration Violation|12|||
126667036|NCT00702845|455742912|FG001|Overall Study|Not randomized|1|||
126667037|NCT02973425|455742913|FG000|Overall Study|Lost to Follow-up|49|||
126667038|NCT02973425|455742914|FG001|Overall Study|Lost to Follow-up|53|||
126667039|NCT03876171|455742915|FG000|Overall Study|Withdrawal by Subject|3|||
126667040|NCT03876171|455742916|FG001|Overall Study|Withdrawal by Subject|3|||
126667041|NCT03876171|455742915|FG000|Overall Study|Re-arrest|0|||
126667042|NCT03876171|455742916|FG001|Overall Study|Re-arrest|4|||
126667043|NCT03503513|455742921|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
126667044|NCT03503513|455742921|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
126667045|NCT03503513|455742921|FG000|Overall Study|Physician Decision|3|||
126667046|NCT03503513|455742921|FG000|Overall Study|Withdrawal by Subject|2|||
126667047|NCT03503513|455742921|FG000|Overall Study|Lost to Follow-up|1|||
126667048|NCT00929656|455742922|FG000|Overall Study|Lost to Follow-up|0|||
126667049|NCT00929656|455742923|FG001|Overall Study|Lost to Follow-up|1|||
126667050|NCT00607880|455742924|FG000|Overall Study|Unable to place port due to occlusion|1|||
126667051|NCT00607880|455742925|FG001|Overall Study|Unable to place port due to occlusion|0|||
126667052|NCT00908583|455742926|FG000|Phase 1|Withdrawal by Subject|1|||
126667053|NCT00908583|455742926|FG000|Phase 1|Adverse Event|4|||
126667054|NCT00908583|455742926|FG000|Phase 2|Physician Decision|1|||
126667055|NCT00908583|455742926|FG000|Phase 2|Adverse Event|1|||
126667056|NCT00908583|455742926|FG000|Phase 3|Adverse Event|2|||
126667057|NCT00908583|455742926|FG000|Phase 4|Adverse Event|1|||
126667058|NCT00908583|455742926|FG000|Phase 4|Physician Decision|1|||
126667059|NCT00908583|455742926|FG000|Phase 5|Adverse Event|3|||
126667060|NCT00993954|455742927|FG000|Overall Study|Protocol Violation|21|||
126667061|NCT00993954|455742928|FG001|Overall Study|Protocol Violation|2|||
126667062|NCT00860951|455742929|FG000|Overall Study|Withdrawal by Subject|2|||
126667063|NCT00860951|455742929|FG000|Overall Study|Lost to Follow-up|5|||
126667064|NCT03627767|455742930|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
126667065|NCT03627767|455742931|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
126667066|NCT03627767|455742932|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
126667067|NCT03627767|455742933|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
126667068|NCT03627767|455742934|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
126667069|NCT03627767|455742930|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
126667070|NCT03627767|455742931|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
126667071|NCT03627767|455742932|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
126667072|NCT03627767|455742933|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
126667073|NCT03627767|455742934|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
126667074|NCT03627767|455742930|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
126667075|NCT03627767|455742931|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
126667076|NCT03627767|455742932|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
126667077|NCT03627767|455742933|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
126667078|NCT03627767|455742934|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
126667079|NCT03627767|455742930|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
126667080|NCT03627767|455742931|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
126667081|NCT03627767|455742932|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
126667082|NCT03627767|455742933|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
126667083|NCT03627767|455742934|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
126667084|NCT03627767|455742930|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
126667085|NCT03627767|455742931|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
126667086|NCT03627767|455742932|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
126667087|NCT03627767|455742933|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
126667088|NCT03627767|455742934|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
126667089|NCT03627767|455742930|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
126667090|NCT03627767|455742931|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
126667091|NCT03627767|455742932|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
126667092|NCT03627767|455742933|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
126667093|NCT03627767|455742934|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
126667094|NCT03627767|455742930|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
126334622|NCT02864407|454518694|FG000|Overall Study|Protocol Violation|3|||
126667095|NCT03627767|455742931|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
126667096|NCT03627767|455742932|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
126334623|NCT02864407|454518694|FG000|Overall Study|Lost to Follow-up|115|||
126667097|NCT03627767|455742933|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
126667098|NCT03627767|455742934|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
126334624|NCT02864407|454518694|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
126334625|NCT02864407|454518694|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
126334626|NCT02864407|454518694|FG000|Overall Study|Consent prior to the contract date|1|||
126334627|NCT05502302|454518696|FG000|Overall Study|Lost to Follow-up|6|||
126334628|NCT05502302|454518696|FG000|Overall Study|Death|2|||
126334629|NCT02849080|454518697|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
126334630|NCT02849080|454518698|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
126334631|NCT02849080|454518699|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
126334632|NCT02849080|454518700|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
126334633|NCT02849080|454518697|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
126334634|NCT02849080|454518698|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
126334635|NCT02849080|454518699|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
126334636|NCT02849080|454518700|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
126334637|NCT02849080|454518697|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
126334638|NCT02849080|454518698|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
126334639|NCT02849080|454518699|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
126334640|NCT02849080|454518700|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
126334641|NCT02849080|454518697|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
126334642|NCT02849080|454518698|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
126334643|NCT02849080|454518699|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
126334644|NCT02849080|454518700|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
126334645|NCT02849080|454518697|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
126334646|NCT02849080|454518698|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
126334647|NCT02849080|454518699|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
126334648|NCT02849080|454518700|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
126334649|NCT02849080|454518697|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
126334650|NCT02849080|454518698|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
126334651|NCT02849080|454518699|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
126334652|NCT02849080|454518700|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
126334653|NCT01819727|454518701|FG000|Overall Study|Adverse Event|8|||
126334654|NCT01819727|454518702|FG001|Overall Study|Adverse Event|9|||
126334655|NCT01819727|454518701|FG000|Overall Study|Death|1|||
126334656|NCT01819727|454518702|FG001|Overall Study|Death|0|||
126334657|NCT01819727|454518701|FG000|Overall Study|Lost to Follow-up|1|||
126334658|NCT01819727|454518702|FG001|Overall Study|Lost to Follow-up|1|||
126334659|NCT01819727|454518701|FG000|Overall Study|Physician Decision|3|||
126334660|NCT01819727|454518702|FG001|Overall Study|Physician Decision|2|||
126334661|NCT01819727|454518701|FG000|Overall Study|Pregnancy|1|||
126334662|NCT01819727|454518702|FG001|Overall Study|Pregnancy|0|||
126334663|NCT01819727|454518701|FG000|Overall Study|Protocol Violation|0|||
126334664|NCT01819727|454518702|FG001|Overall Study|Protocol Violation|2|||
126334665|NCT01819727|454518701|FG000|Overall Study|Study Terminated by Sponsor|0|||
126334666|NCT01819727|454518702|FG001|Overall Study|Study Terminated by Sponsor|1|||
126334667|NCT01819727|454518701|FG000|Overall Study|Withdrawal by Subject|6|||
126334668|NCT01819727|454518702|FG001|Overall Study|Withdrawal by Subject|11|||
126334669|NCT01819727|454518701|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
126334670|NCT01819727|454518702|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
126334671|NCT01819727|454518701|FG000|Overall Study|Quit due to lack of health benifits|0|||
126334672|NCT01819727|454518702|FG001|Overall Study|Quit due to lack of health benifits|1|||
126334673|NCT00611806|454520452|FG000|Overall Study|Withdrawal by Subject|8|||
126334674|NCT00611806|454520453|FG001|Overall Study|Withdrawal by Subject|2|||
126334675|NCT00611806|454520452|FG000|Overall Study|Adverse Event|2|||
126334676|NCT00611806|454520453|FG001|Overall Study|Adverse Event|1|||
126334677|NCT00611806|454520452|FG000|Overall Study|Lost to Follow-up|6|||
126334678|NCT00611806|454520453|FG001|Overall Study|Lost to Follow-up|0|||
126334679|NCT01921517|454520454|FG000|Overall Study|Lost to Follow-up|5|||
126334680|NCT01921517|454520455|FG001|Overall Study|Lost to Follow-up|0|||
126334681|NCT01921517|454520454|FG000|Overall Study|Newly diagnosed health concern|2|||
126334682|NCT01921517|454520455|FG001|Overall Study|Newly diagnosed health concern|0|||
126334683|NCT01921517|454520454|FG000|Overall Study|Physician Decision|0|||
126667099|NCT03627767|455742930|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
126334684|NCT01921517|454520455|FG001|Overall Study|Physician Decision|2|||
126334685|NCT01921517|454520454|FG000|Overall Study|Withdrawal by Subject|7|||
126334686|NCT01921517|454520455|FG001|Overall Study|Withdrawal by Subject|3|||
126334687|NCT01921517|454520454|FG000|Overall Study|Subject missed final imaging|1|||
126334688|NCT01921517|454520455|FG001|Overall Study|Subject missed final imaging|4|||
126334689|NCT00643760|454520456|FG000|Overall Study|Adverse Event|11|||
126334690|NCT00643760|454520457|FG001|Overall Study|Adverse Event|5|||
126334691|NCT00643760|454520458|FG002|Overall Study|Adverse Event|12|||
126334692|NCT00643760|454520459|FG003|Overall Study|Adverse Event|21|||
126334693|NCT00643760|454520460|FG004|Overall Study|Adverse Event|6|||
126667100|NCT03627767|455742931|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
126667101|NCT03627767|455742932|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
126667102|NCT03627767|455742933|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
126667103|NCT03627767|455742934|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
126334694|NCT00643760|454520456|FG000|Overall Study|Lack of Efficacy|3|||
126334695|NCT00643760|454520457|FG001|Overall Study|Lack of Efficacy|1|||
126334696|NCT00643760|454520458|FG002|Overall Study|Lack of Efficacy|0|||
126334697|NCT00643760|454520459|FG003|Overall Study|Lack of Efficacy|4|||
126334698|NCT00643760|454520460|FG004|Overall Study|Lack of Efficacy|3|||
126334699|NCT00643760|454520456|FG000|Overall Study|Protocol Violation|7|||
126334700|NCT00643760|454520457|FG001|Overall Study|Protocol Violation|6|||
126334701|NCT00643760|454520458|FG002|Overall Study|Protocol Violation|4|||
126334702|NCT00643760|454520459|FG003|Overall Study|Protocol Violation|4|||
126334703|NCT00643760|454520460|FG004|Overall Study|Protocol Violation|6|||
126334704|NCT00643760|454520456|FG000|Overall Study|Lost to Follow-up|6|||
126334705|NCT00643760|454520457|FG001|Overall Study|Lost to Follow-up|2|||
126334706|NCT00643760|454520458|FG002|Overall Study|Lost to Follow-up|1|||
126334707|NCT00643760|454520459|FG003|Overall Study|Lost to Follow-up|3|||
126334708|NCT00643760|454520460|FG004|Overall Study|Lost to Follow-up|3|||
126334709|NCT00643760|454520456|FG000|Overall Study|Investigator Discretion|0|||
126334710|NCT00643760|454520457|FG001|Overall Study|Investigator Discretion|0|||
126334711|NCT00643760|454520458|FG002|Overall Study|Investigator Discretion|0|||
126334712|NCT00643760|454520459|FG003|Overall Study|Investigator Discretion|2|||
126334713|NCT00643760|454520460|FG004|Overall Study|Investigator Discretion|0|||
126334714|NCT00643760|454520456|FG000|Overall Study|Withdrawal by Subject|3|||
126334715|NCT00643760|454520457|FG001|Overall Study|Withdrawal by Subject|1|||
126334716|NCT00643760|454520458|FG002|Overall Study|Withdrawal by Subject|2|||
126334717|NCT00643760|454520459|FG003|Overall Study|Withdrawal by Subject|4|||
126334718|NCT00643760|454520460|FG004|Overall Study|Withdrawal by Subject|1|||
126334719|NCT03934216|454520461|FG000|Overall Study|Other Reasons|5|||
126334720|NCT03934216|454520462|FG001|Overall Study|Other Reasons|5|||
126334721|NCT03934216|454520461|FG000|Overall Study|Adverse Event|22|||
126334722|NCT03934216|454520462|FG001|Overall Study|Adverse Event|11|||
126334723|NCT03934216|454520461|FG000|Overall Study|Lack of Efficacy|8|||
126334724|NCT03934216|454520462|FG001|Overall Study|Lack of Efficacy|7|||
126334725|NCT03934216|454520461|FG000|Overall Study|Lost to Follow-up|2|||
126334726|NCT03934216|454520462|FG001|Overall Study|Lost to Follow-up|0|||
126334727|NCT03934216|454520461|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126334728|NCT03934216|454520462|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126334729|NCT03934216|454520461|FG000|Overall Study|Pregnancy|1|||
126334730|NCT03934216|454520462|FG001|Overall Study|Pregnancy|0|||
126334731|NCT03934216|454520461|FG000|Overall Study|Withdrawal by Subject|18|||
126334732|NCT03934216|454520462|FG001|Overall Study|Withdrawal by Subject|6|||
126334733|NCT03934216|454520461|FG000|Overall Study|Randomized but not treated|1|||
126334734|NCT03934216|454520462|FG001|Overall Study|Randomized but not treated|1|||
126334735|NCT01063855|454520463|FG000|Overall Study|Adverse Event|4|||
126334736|NCT01063855|454520464|FG001|Overall Study|Adverse Event|4|||
126334737|NCT01063855|454520463|FG000|Overall Study|Death|0|||
126334738|NCT01063855|454520464|FG001|Overall Study|Death|1|||
126334739|NCT01063855|454520463|FG000|Overall Study|Lost to Follow-up|8|||
126334740|NCT01063855|454520464|FG001|Overall Study|Lost to Follow-up|4|||
126334741|NCT01063855|454520463|FG000|Overall Study|Pregnancy|1|||
126334742|NCT01063855|454520464|FG001|Overall Study|Pregnancy|0|||
126334743|NCT01063855|454520463|FG000|Overall Study|Lack of Efficacy|0|||
126334744|NCT01063855|454520464|FG001|Overall Study|Lack of Efficacy|1|||
126334745|NCT01063855|454520463|FG000|Overall Study|Withdrawal by Subject|11|||
126334746|NCT01063855|454520464|FG001|Overall Study|Withdrawal by Subject|8|||
126334747|NCT01063855|454520463|FG000|Overall Study|Reason not specified|13|||
126334748|NCT01063855|454520464|FG001|Overall Study|Reason not specified|11|||
126667104|NCT03627767|455742930|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
126667105|NCT03627767|455742931|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
126667106|NCT03627767|455742932|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
126334749|NCT02163395|454520467|FG000|Overall Study|Withdrawal by Subject|1|||
126334750|NCT02163395|454520467|FG000|Overall Study|Lost to Follow-up|3|||
126334751|NCT02163395|454520467|FG000|Overall Study|Adverse Event|1|||
126334752|NCT00048035|454520490|FG000|Core Period|Early Withdrawals|4|||
126334753|NCT00048035|454520491|FG001|Core Period|Early Withdrawals|2|||
126334754|NCT00048035|454520492|FG002|Core Period|Early Withdrawals|1|||
126334755|NCT00048035|454520493|FG003|Core Period|Early Withdrawals|1|||
126334756|NCT00048035|454520494|FG004|Core Period|Early Withdrawals|1|||
126334757|NCT00048035|454520495|FG005|Core Period|Early Withdrawals|1|||
126334758|NCT00048035|454520496|FG006|Core Period|Early Withdrawals|0|||
126334759|NCT00048035|454520497|FG007|Core Period|Early Withdrawals|0|||
126334760|NCT00048035|454520490|FG000|Extension Year 1|Early Withdrawals|0|||
126334761|NCT00048035|454520491|FG001|Extension Year 1|Early Withdrawals|0|||
126334762|NCT00048035|454520492|FG002|Extension Year 1|Early Withdrawals|0|||
126334763|NCT00048035|454520493|FG003|Extension Year 1|Early Withdrawals|0|||
126334764|NCT00048035|454520494|FG004|Extension Year 1|Early Withdrawals|0|||
126334765|NCT00048035|454520495|FG005|Extension Year 1|Early Withdrawals|0|||
126334766|NCT00048035|454520496|FG006|Extension Year 1|Early Withdrawals|11|||
126334767|NCT00048035|454520497|FG007|Extension Year 1|Early Withdrawals|11|||
126334768|NCT00048035|454520490|FG000|Extension Year 2|Early Withdrawals|0|||
126334769|NCT00048035|454520491|FG001|Extension Year 2|Early Withdrawals|0|||
126334770|NCT00048035|454520492|FG002|Extension Year 2|Early Withdrawals|0|||
126334771|NCT00048035|454520493|FG003|Extension Year 2|Early Withdrawals|0|||
126334772|NCT00048035|454520494|FG004|Extension Year 2|Early Withdrawals|0|||
126334773|NCT00048035|454520495|FG005|Extension Year 2|Early Withdrawals|0|||
126334774|NCT00048035|454520496|FG006|Extension Year 2|Early Withdrawals|3|||
126334775|NCT00048035|454520497|FG007|Extension Year 2|Early Withdrawals|3|||
126334776|NCT02619617|454520498|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
126334777|NCT02619617|454520499|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
126334778|NCT02619617|454520498|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
126334779|NCT02619617|454520499|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
126334780|NCT02735980|454520500|FG000|Overall Study|Adverse Event|0|||
126334781|NCT02735980|454520501|FG001|Overall Study|Adverse Event|4|||
126334782|NCT02735980|454520502|FG002|Overall Study|Adverse Event|1|||
126667107|NCT03627767|455742933|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
126334783|NCT02735980|454520500|FG000|Overall Study|Death|5|||
126334784|NCT02735980|454520501|FG001|Overall Study|Death|4|||
126334785|NCT02735980|454520502|FG002|Overall Study|Death|0|||
126334786|NCT02735980|454520500|FG000|Overall Study|Physician Decision|3|||
126334787|NCT02735980|454520501|FG001|Overall Study|Physician Decision|1|||
126334788|NCT02735980|454520502|FG002|Overall Study|Physician Decision|0|||
126334789|NCT02735980|454520500|FG000|Overall Study|Screen failure|1|||
126334790|NCT02735980|454520501|FG001|Overall Study|Screen failure|0|||
126334791|NCT02735980|454520502|FG002|Overall Study|Screen failure|0|||
126334792|NCT02735980|454520500|FG000|Overall Study|Withdrawal by Subject|1|||
126334793|NCT02735980|454520501|FG001|Overall Study|Withdrawal by Subject|2|||
126334794|NCT02735980|454520502|FG002|Overall Study|Withdrawal by Subject|0|||
126334795|NCT00509899|454520503|FG000|Overall Study|Progressive disease|1|||
126334796|NCT00509899|454520504|FG001|Overall Study|Progressive disease|3|||
126334797|NCT00509899|454520505|FG002|Overall Study|Progressive disease|5|||
126334798|NCT00509899|454520506|FG003|Overall Study|Progressive disease|1|||
126334799|NCT00509899|454520507|FG004|Overall Study|Progressive disease|0|||
126334800|NCT00509899|454520508|FG005|Overall Study|Progressive disease|1|||
126334801|NCT00509899|454520509|FG006|Overall Study|Progressive disease|0|||
126334802|NCT00509899|454520510|FG007|Overall Study|Progressive disease|0|||
126334803|NCT00509899|454520503|FG000|Overall Study|Unacceptable Toxicity|1|||
126334804|NCT00509899|454520504|FG001|Overall Study|Unacceptable Toxicity|0|||
126334805|NCT00509899|454520505|FG002|Overall Study|Unacceptable Toxicity|0|||
126334806|NCT00509899|454520506|FG003|Overall Study|Unacceptable Toxicity|2|||
126334807|NCT00509899|454520507|FG004|Overall Study|Unacceptable Toxicity|0|||
126334808|NCT00509899|454520508|FG005|Overall Study|Unacceptable Toxicity|0|||
126334809|NCT00509899|454520509|FG006|Overall Study|Unacceptable Toxicity|0|||
126334810|NCT00509899|454520510|FG007|Overall Study|Unacceptable Toxicity|0|||
126334811|NCT00509899|454520503|FG000|Overall Study|Withdrawal by Subject|6|||
126334812|NCT00509899|454520504|FG001|Overall Study|Withdrawal by Subject|2|||
126334813|NCT00509899|454520505|FG002|Overall Study|Withdrawal by Subject|3|||
126334814|NCT00509899|454520506|FG003|Overall Study|Withdrawal by Subject|0|||
126334815|NCT00509899|454520507|FG004|Overall Study|Withdrawal by Subject|3|||
126334816|NCT00509899|454520508|FG005|Overall Study|Withdrawal by Subject|2|||
126334817|NCT00509899|454520509|FG006|Overall Study|Withdrawal by Subject|0|||
126334818|NCT00509899|454520510|FG007|Overall Study|Withdrawal by Subject|0|||
126334819|NCT00509899|454520503|FG000|Overall Study|Physician Decision|4|||
126667108|NCT03627767|455742934|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
126667109|NCT03627767|455742930|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
126667110|NCT03627767|455742931|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
126667111|NCT03627767|455742932|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
126667112|NCT03627767|455742933|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
126667113|NCT03627767|455742934|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
126334820|NCT00509899|454520504|FG001|Overall Study|Physician Decision|2|||
126334821|NCT00509899|454520505|FG002|Overall Study|Physician Decision|7|||
126334822|NCT00509899|454520506|FG003|Overall Study|Physician Decision|0|||
126334823|NCT00509899|454520507|FG004|Overall Study|Physician Decision|1|||
126334824|NCT00509899|454520508|FG005|Overall Study|Physician Decision|4|||
126334825|NCT00509899|454520509|FG006|Overall Study|Physician Decision|0|||
126334826|NCT00509899|454520510|FG007|Overall Study|Physician Decision|0|||
126334827|NCT00509899|454520503|FG000|Overall Study|Intercurrent Illness|1|||
126334828|NCT00509899|454520504|FG001|Overall Study|Intercurrent Illness|0|||
126334829|NCT00509899|454520505|FG002|Overall Study|Intercurrent Illness|0|||
126334830|NCT00509899|454520506|FG003|Overall Study|Intercurrent Illness|1|||
126334831|NCT00509899|454520507|FG004|Overall Study|Intercurrent Illness|0|||
126667114|NCT03627767|455742930|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
126667115|NCT03627767|455742931|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
126667116|NCT03627767|455742932|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
126667117|NCT03627767|455742933|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
126667118|NCT03627767|455742934|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
126667119|NCT03627767|455742930|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
126667120|NCT03627767|455742931|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
126667121|NCT03627767|455742932|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
126334832|NCT00509899|454520508|FG005|Overall Study|Intercurrent Illness|1|||
126334833|NCT00509899|454520509|FG006|Overall Study|Intercurrent Illness|0|||
126334834|NCT00509899|454520510|FG007|Overall Study|Intercurrent Illness|0|||
126334835|NCT00509899|454520503|FG000|Overall Study|Death|2|||
126334836|NCT00509899|454520504|FG001|Overall Study|Death|2|||
126334837|NCT00509899|454520505|FG002|Overall Study|Death|3|||
126334838|NCT00509899|454520506|FG003|Overall Study|Death|0|||
126334839|NCT00509899|454520507|FG004|Overall Study|Death|1|||
126334840|NCT00509899|454520508|FG005|Overall Study|Death|1|||
126334841|NCT00509899|454520509|FG006|Overall Study|Death|1|||
126334842|NCT00509899|454520510|FG007|Overall Study|Death|1|||
126334843|NCT00509899|454520503|FG000|Overall Study|Lack of Efficacy|1|||
126334844|NCT00509899|454520504|FG001|Overall Study|Lack of Efficacy|0|||
126334845|NCT00509899|454520505|FG002|Overall Study|Lack of Efficacy|2|||
126334846|NCT00509899|454520506|FG003|Overall Study|Lack of Efficacy|0|||
126334847|NCT00509899|454520507|FG004|Overall Study|Lack of Efficacy|0|||
126334848|NCT00509899|454520508|FG005|Overall Study|Lack of Efficacy|1|||
126334849|NCT00509899|454520509|FG006|Overall Study|Lack of Efficacy|0|||
126334850|NCT00509899|454520510|FG007|Overall Study|Lack of Efficacy|0|||
126334851|NCT01854697|454520511|FG000|Overall Study|Adverse Event|1|||
126334852|NCT01854697|454520512|FG001|Overall Study|Adverse Event|0|||
126334853|NCT01854697|454520513|FG002|Overall Study|Adverse Event|0|||
126334854|NCT01854697|454520514|FG003|Overall Study|Adverse Event|0|||
126334855|NCT01854697|454520515|FG004|Overall Study|Adverse Event|1|||
126334856|NCT01854697|454520511|FG000|Overall Study|Lost to Follow-up|4|||
126334857|NCT01854697|454520512|FG001|Overall Study|Lost to Follow-up|1|||
126334858|NCT01854697|454520513|FG002|Overall Study|Lost to Follow-up|1|||
126334859|NCT01854697|454520514|FG003|Overall Study|Lost to Follow-up|2|||
126334860|NCT01854697|454520515|FG004|Overall Study|Lost to Follow-up|0|||
126334861|NCT01854697|454520511|FG000|Overall Study|To enter another AbbVie study|1|||
126334862|NCT01854697|454520512|FG001|Overall Study|To enter another AbbVie study|0|||
126334863|NCT01854697|454520513|FG002|Overall Study|To enter another AbbVie study|0|||
126334864|NCT01854697|454520514|FG003|Overall Study|To enter another AbbVie study|0|||
126334865|NCT01854697|454520515|FG004|Overall Study|To enter another AbbVie study|1|||
126334866|NCT01854697|454520511|FG000|Overall Study|Withdrew Consent|0|||
126334867|NCT01854697|454520512|FG001|Overall Study|Withdrew Consent|1|||
126334868|NCT01854697|454520513|FG002|Overall Study|Withdrew Consent|0|||
126334869|NCT01854697|454520514|FG003|Overall Study|Withdrew Consent|1|||
126334870|NCT01854697|454520515|FG004|Overall Study|Withdrew Consent|0|||
126334871|NCT01854697|454520511|FG000|Overall Study|Other|0|||
126334872|NCT01854697|454520512|FG001|Overall Study|Other|1|||
126334873|NCT01854697|454520513|FG002|Overall Study|Other|1|||
126334874|NCT01854697|454520514|FG003|Overall Study|Other|0|||
126334875|NCT01854697|454520515|FG004|Overall Study|Other|0|||
126334876|NCT00974311|454520516|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
126334877|NCT00974311|454520517|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
126334878|NCT00974311|454520516|FG000|DB Phase (up to 24 Months)|Death|561|||
126334879|NCT00974311|454520517|FG001|DB Phase (up to 24 Months)|Death|298|||
126334880|NCT00974311|454520516|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
126334881|NCT00974311|454520517|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
126334882|NCT00974311|454520516|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
126334883|NCT00974311|454520517|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
126334884|NCT00974311|454520516|FG000|DB Phase (up to 24 Months)|Other|1|||
126334885|NCT00974311|454520517|FG001|DB Phase (up to 24 Months)|Other|0|||
126334886|NCT00974311|454520516|FG000|OLE Phase (up to 77 Months)|Death|14|||
126334887|NCT00974311|454520517|FG001|OLE Phase (up to 77 Months)|Death|21|||
126334888|NCT00974311|454520516|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
126334889|NCT00974311|454520517|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
126334890|NCT00974311|454520516|FG000|OLE Phase (up to 77 Months)|Other|15|||
126334891|NCT00974311|454520517|FG001|OLE Phase (up to 77 Months)|Other|2|||
126334892|NCT00974311|454520516|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
126334893|NCT00974311|454520517|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
126334894|NCT02087774|454520520|FG000|Overall Study|Were absent day of data collection|8|||
126334895|NCT02087774|454520521|FG001|Overall Study|Were absent day of data collection|20|||
126334896|NCT02157519|454520528|FG000|Overall Study|Death|3|||
126334897|NCT02157519|454520529|FG001|Overall Study|Death|1|||
126334898|NCT02157519|454520528|FG000|Overall Study|Withdrawal by Subject|7|||
126334899|NCT02157519|454520529|FG001|Overall Study|Withdrawal by Subject|0|||
126334900|NCT02157519|454520528|FG000|Overall Study|Lost to Follow-up|1|||
126334901|NCT02157519|454520529|FG001|Overall Study|Lost to Follow-up|0|||
126334902|NCT01656395|454520530|FG000|Overall Study|Adverse Event|1|||
126334903|NCT01656395|454520531|FG001|Overall Study|Adverse Event|14|||
126334904|NCT01656395|454520532|FG002|Overall Study|Adverse Event|5|||
126334905|NCT01656395|454520533|FG003|Overall Study|Adverse Event|4|||
126334906|NCT01656395|454520534|FG004|Overall Study|Adverse Event|5|||
126334907|NCT01656395|454520535|FG005|Overall Study|Adverse Event|7|||
126334908|NCT01656395|454520536|FG006|Overall Study|Adverse Event|0|||
126334909|NCT01656395|454520537|FG007|Overall Study|Adverse Event|0|||
126334910|NCT01656395|454520530|FG000|Overall Study|Lack of Efficacy|1|||
126334911|NCT01656395|454520531|FG001|Overall Study|Lack of Efficacy|8|||
126334912|NCT01656395|454520532|FG002|Overall Study|Lack of Efficacy|6|||
126334913|NCT01656395|454520533|FG003|Overall Study|Lack of Efficacy|1|||
126334914|NCT01656395|454520534|FG004|Overall Study|Lack of Efficacy|1|||
126334915|NCT01656395|454520535|FG005|Overall Study|Lack of Efficacy|6|||
126334916|NCT01656395|454520536|FG006|Overall Study|Lack of Efficacy|0|||
126334917|NCT01656395|454520537|FG007|Overall Study|Lack of Efficacy|0|||
126334918|NCT01656395|454520530|FG000|Overall Study|Lost to Follow-up|1|||
126334919|NCT01656395|454520531|FG001|Overall Study|Lost to Follow-up|0|||
126334920|NCT01656395|454520532|FG002|Overall Study|Lost to Follow-up|0|||
126334921|NCT01656395|454520533|FG003|Overall Study|Lost to Follow-up|0|||
126334922|NCT01656395|454520534|FG004|Overall Study|Lost to Follow-up|0|||
126334923|NCT01656395|454520535|FG005|Overall Study|Lost to Follow-up|0|||
126334924|NCT01656395|454520536|FG006|Overall Study|Lost to Follow-up|0|||
126334925|NCT01656395|454520537|FG007|Overall Study|Lost to Follow-up|0|||
126334926|NCT01656395|454520530|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126334927|NCT01656395|454520531|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126334928|NCT01656395|454520532|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126334929|NCT01656395|454520533|FG003|Overall Study|Non-Compliance with Study Drug|0|||
126334930|NCT01656395|454520534|FG004|Overall Study|Non-Compliance with Study Drug|1|||
126334931|NCT01656395|454520535|FG005|Overall Study|Non-Compliance with Study Drug|1|||
126334932|NCT01656395|454520536|FG006|Overall Study|Non-Compliance with Study Drug|0|||
126334933|NCT01656395|454520537|FG007|Overall Study|Non-Compliance with Study Drug|0|||
126667122|NCT03627767|455742933|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
126667123|NCT03627767|455742934|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
126667124|NCT03627767|455742930|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
126667125|NCT03627767|455742931|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
126667126|NCT03627767|455742932|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
126667127|NCT03627767|455742933|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
126667128|NCT03627767|455742934|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
126667129|NCT03627767|455742930|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
126667130|NCT03627767|455742931|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
126667131|NCT03627767|455742932|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
126667132|NCT03627767|455742933|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
126667133|NCT03627767|455742934|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
126667134|NCT03627767|455742930|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
126667135|NCT03627767|455742931|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
126667136|NCT03627767|455742932|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
126667137|NCT03627767|455742933|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
126667138|NCT03627767|455742934|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
126667139|NCT03627767|455742930|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
126667140|NCT03627767|455742931|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
126667141|NCT03627767|455742932|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
126667142|NCT03627767|455742933|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
126667143|NCT03627767|455742934|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
126667144|NCT03627767|455742930|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
126667145|NCT03627767|455742931|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
126667146|NCT03627767|455742932|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
126667147|NCT03627767|455742933|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
126667148|NCT03627767|455742934|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
126667149|NCT03627767|455742930|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
126667150|NCT03627767|455742931|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
126667151|NCT03627767|455742932|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
126667152|NCT03627767|455742933|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
126667153|NCT03627767|455742934|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
126667154|NCT03627767|455742930|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
126667155|NCT03627767|455742931|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
126334934|NCT01656395|454520530|FG000|Overall Study|Other|0|||
126334935|NCT01656395|454520531|FG001|Overall Study|Other|0|||
126334936|NCT01656395|454520532|FG002|Overall Study|Other|1|||
126334937|NCT01656395|454520533|FG003|Overall Study|Other|0|||
126667156|NCT03627767|455742932|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
126334938|NCT01656395|454520534|FG004|Overall Study|Other|0|||
126334939|NCT01656395|454520535|FG005|Overall Study|Other|1|||
126334940|NCT01656395|454520536|FG006|Overall Study|Other|0|||
126334941|NCT01656395|454520537|FG007|Overall Study|Other|0|||
126334942|NCT01656395|454520530|FG000|Overall Study|Physician Decision|2|||
126334943|NCT01656395|454520531|FG001|Overall Study|Physician Decision|3|||
126334944|NCT01656395|454520532|FG002|Overall Study|Physician Decision|3|||
126334945|NCT01656395|454520533|FG003|Overall Study|Physician Decision|2|||
126334946|NCT01656395|454520534|FG004|Overall Study|Physician Decision|3|||
126334947|NCT01656395|454520535|FG005|Overall Study|Physician Decision|3|||
126334948|NCT01656395|454520536|FG006|Overall Study|Physician Decision|0|||
126334949|NCT01656395|454520537|FG007|Overall Study|Physician Decision|0|||
126334950|NCT01656395|454520530|FG000|Overall Study|Pregnancy|0|||
126334951|NCT01656395|454520531|FG001|Overall Study|Pregnancy|0|||
126334952|NCT01656395|454520532|FG002|Overall Study|Pregnancy|1|||
126334953|NCT01656395|454520533|FG003|Overall Study|Pregnancy|0|||
126334954|NCT01656395|454520534|FG004|Overall Study|Pregnancy|0|||
126334955|NCT01656395|454520535|FG005|Overall Study|Pregnancy|0|||
126334956|NCT01656395|454520536|FG006|Overall Study|Pregnancy|0|||
126334957|NCT01656395|454520537|FG007|Overall Study|Pregnancy|0|||
126334958|NCT01656395|454520530|FG000|Overall Study|Progressive Disease|0|||
126334959|NCT01656395|454520531|FG001|Overall Study|Progressive Disease|0|||
126334960|NCT01656395|454520532|FG002|Overall Study|Progressive Disease|0|||
126334961|NCT01656395|454520533|FG003|Overall Study|Progressive Disease|0|||
126667157|NCT03627767|455742933|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
126667158|NCT03627767|455742934|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
126667159|NCT03627767|455742930|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
126667160|NCT03627767|455742931|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
126667161|NCT03627767|455742932|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
126667162|NCT03627767|455742933|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
126667163|NCT03627767|455742934|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
126667164|NCT01873417|455742935|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
126667165|NCT01873417|455742935|FG000|Overall Study|Adverse Event|24|||
126667166|NCT01873417|455742935|FG000|Overall Study|Lost to Follow-up|2|||
126667167|NCT01873417|455742935|FG000|Overall Study|Withdrawal by Subject|2|||
126667168|NCT01873417|455742935|FG000|Overall Study|Physician Decision|3|||
126667169|NCT00385203|455742936|FG000|Overall Study|Adverse Event|5|||
126667170|NCT00385203|455742937|FG001|Overall Study|Adverse Event|4|||
126667171|NCT00385203|455742936|FG000|Overall Study|Death|1|||
126667172|NCT00385203|455742937|FG001|Overall Study|Death|0|||
126667173|NCT00385203|455742936|FG000|Overall Study|Condition under investigation worsened|18|||
126667174|NCT00385203|455742937|FG001|Overall Study|Condition under investigation worsened|3|||
126667175|NCT00385203|455742936|FG000|Overall Study|Incorrect enrollment|2|||
126667176|NCT00385203|455742937|FG001|Overall Study|Incorrect enrollment|0|||
126667177|NCT01798992|455742938|FG000|Overall Study|Administrative withdrawal|0|||
126667178|NCT01798992|455742939|FG001|Overall Study|Administrative withdrawal|1|||
126667179|NCT01798992|455742940|FG002|Overall Study|Administrative withdrawal|0|||
126667180|NCT01798992|455742941|FG003|Overall Study|Administrative withdrawal|1|||
126667181|NCT01798992|455742938|FG000|Overall Study|Lost to Follow-up|0|||
126667182|NCT01798992|455742939|FG001|Overall Study|Lost to Follow-up|1|||
126667183|NCT01798992|455742940|FG002|Overall Study|Lost to Follow-up|1|||
126667184|NCT01798992|455742941|FG003|Overall Study|Lost to Follow-up|0|||
126667185|NCT01798992|455742938|FG000|Overall Study|Insufficient biopsy tissue|0|||
126667186|NCT01798992|455742939|FG001|Overall Study|Insufficient biopsy tissue|0|||
126667187|NCT01798992|455742940|FG002|Overall Study|Insufficient biopsy tissue|1|||
126667188|NCT01798992|455742941|FG003|Overall Study|Insufficient biopsy tissue|0|||
126667189|NCT03823404|455742942|FG000|Overall Study|Lost to Follow-up|1|||
126667190|NCT03823404|455742943|FG001|Overall Study|Lost to Follow-up|2|||
126667191|NCT03823404|455742944|FG002|Overall Study|Lost to Follow-up|3|||
126667192|NCT03823404|455742942|FG000|Overall Study|Protocol Violation|2|||
126667193|NCT03823404|455742943|FG001|Overall Study|Protocol Violation|0|||
126667194|NCT03823404|455742944|FG002|Overall Study|Protocol Violation|2|||
126667195|NCT03823404|455742942|FG000|Overall Study|Adverse Event|35|||
126667196|NCT03823404|455742943|FG001|Overall Study|Adverse Event|38|||
126667197|NCT03823404|455742944|FG002|Overall Study|Adverse Event|8|||
126667198|NCT03823404|455742942|FG000|Overall Study|Withdrawal by Subject|38|||
126667199|NCT03823404|455742943|FG001|Overall Study|Withdrawal by Subject|40|||
126334962|NCT01656395|454520534|FG004|Overall Study|Progressive Disease|0|||
126334963|NCT01656395|454520535|FG005|Overall Study|Progressive Disease|1|||
126334964|NCT01656395|454520536|FG006|Overall Study|Progressive Disease|0|||
126667200|NCT03823404|455742944|FG002|Overall Study|Withdrawal by Subject|35|||
126667201|NCT03823404|455742942|FG000|Overall Study|Death|4|||
126667202|NCT03823404|455742943|FG001|Overall Study|Death|0|||
126667203|NCT03823404|455742944|FG002|Overall Study|Death|0|||
126334965|NCT01656395|454520537|FG007|Overall Study|Progressive Disease|0|||
126334966|NCT01656395|454520530|FG000|Overall Study|Protocol Violation|6|||
126334967|NCT01656395|454520531|FG001|Overall Study|Protocol Violation|6|||
126334968|NCT01656395|454520532|FG002|Overall Study|Protocol Violation|9|||
126667204|NCT03823404|455742942|FG000|Overall Study|Other: Various reasons provided|5|||
126334969|NCT01656395|454520533|FG003|Overall Study|Protocol Violation|2|||
126334970|NCT01656395|454520534|FG004|Overall Study|Protocol Violation|4|||
126334971|NCT01656395|454520535|FG005|Overall Study|Protocol Violation|10|||
126334972|NCT01656395|454520536|FG006|Overall Study|Protocol Violation|0|||
126334973|NCT01656395|454520537|FG007|Overall Study|Protocol Violation|0|||
126334974|NCT01656395|454520530|FG000|Overall Study|Screen Failure|2|||
126334975|NCT01656395|454520531|FG001|Overall Study|Screen Failure|1|||
126334976|NCT01656395|454520532|FG002|Overall Study|Screen Failure|7|||
126334977|NCT01656395|454520533|FG003|Overall Study|Screen Failure|1|||
126334978|NCT01656395|454520534|FG004|Overall Study|Screen Failure|0|||
126334979|NCT01656395|454520535|FG005|Overall Study|Screen Failure|8|||
126334980|NCT01656395|454520536|FG006|Overall Study|Screen Failure|0|||
126334981|NCT01656395|454520537|FG007|Overall Study|Screen Failure|0|||
126334982|NCT01656395|454520530|FG000|Overall Study|Withdrawal by Subject|3|||
126334983|NCT01656395|454520531|FG001|Overall Study|Withdrawal by Subject|1|||
126334984|NCT01656395|454520532|FG002|Overall Study|Withdrawal by Subject|4|||
126334985|NCT01656395|454520533|FG003|Overall Study|Withdrawal by Subject|2|||
126334986|NCT01656395|454520534|FG004|Overall Study|Withdrawal by Subject|0|||
126334987|NCT01656395|454520535|FG005|Overall Study|Withdrawal by Subject|3|||
126334988|NCT01656395|454520536|FG006|Overall Study|Withdrawal by Subject|0|||
126334989|NCT01656395|454520537|FG007|Overall Study|Withdrawal by Subject|0|||
126334990|NCT03075267|454520538|FG000|Overall Study|Protocol Violation|1|||
126334991|NCT03075267|454520539|FG001|Overall Study|Protocol Violation|0|||
126334992|NCT03075267|454520540|FG002|Overall Study|Protocol Violation|0|||
126334993|NCT00661089|454520544|FG000|Overall Study|1 subject withdrawal|0|||
126334994|NCT00661089|454520545|FG001|Overall Study|1 subject withdrawal|1|||
126334995|NCT00661089|454520544|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
126334996|NCT00661089|454520545|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
126334997|NCT00274742|454520546|FG000|Overall Study|Adverse Event|0|||
126334998|NCT00274742|454520547|FG001|Overall Study|Adverse Event|4|||
126334999|NCT00274742|454520548|FG002|Overall Study|Adverse Event|1|||
126335000|NCT00274742|454520549|FG003|Overall Study|Adverse Event|4|||
126335001|NCT00274742|454520550|FG004|Overall Study|Adverse Event|12|||
126335002|NCT00274742|454520551|FG005|Overall Study|Adverse Event|3|||
126335003|NCT00274742|454520546|FG000|Overall Study|Lost to Follow-up|0|||
126335004|NCT00274742|454520547|FG001|Overall Study|Lost to Follow-up|0|||
126335005|NCT00274742|454520548|FG002|Overall Study|Lost to Follow-up|0|||
126335006|NCT00274742|454520549|FG003|Overall Study|Lost to Follow-up|0|||
126335007|NCT00274742|454520550|FG004|Overall Study|Lost to Follow-up|1|||
126335008|NCT00274742|454520551|FG005|Overall Study|Lost to Follow-up|0|||
126335009|NCT00274742|454520546|FG000|Overall Study|End of Study|0|||
126335010|NCT00274742|454520547|FG001|Overall Study|End of Study|0|||
126335011|NCT00274742|454520548|FG002|Overall Study|End of Study|0|||
126335012|NCT00274742|454520549|FG003|Overall Study|End of Study|1|||
126335013|NCT00274742|454520550|FG004|Overall Study|End of Study|0|||
126335014|NCT00274742|454520551|FG005|Overall Study|End of Study|0|||
126335015|NCT00274742|454520546|FG000|Overall Study|Disease Progression|0|||
126335016|NCT00274742|454520547|FG001|Overall Study|Disease Progression|1|||
126335017|NCT00274742|454520548|FG002|Overall Study|Disease Progression|1|||
126335018|NCT00274742|454520549|FG003|Overall Study|Disease Progression|0|||
126335019|NCT00274742|454520550|FG004|Overall Study|Disease Progression|1|||
126335020|NCT00274742|454520551|FG005|Overall Study|Disease Progression|0|||
126335021|NCT00274742|454520546|FG000|Overall Study|Other|0|||
126335022|NCT00274742|454520547|FG001|Overall Study|Other|3|||
126335023|NCT00274742|454520548|FG002|Overall Study|Other|0|||
126335024|NCT00274742|454520549|FG003|Overall Study|Other|0|||
126335025|NCT00274742|454520550|FG004|Overall Study|Other|2|||
126335026|NCT00274742|454520551|FG005|Overall Study|Other|0|||
126335027|NCT00072384|454520560|FG000|Overall Study|Physician Decision|1|||
126335028|NCT00072384|454520560|FG000|Overall Study|Ineligible|8|||
126335029|NCT00490035|454520561|FG000|Overall Study|AE, non-serious non-fatal|3|||
126335030|NCT00490035|454520562|FG001|Overall Study|AE, non-serious non-fatal|4|||
126335031|NCT00490035|454520563|FG002|Overall Study|AE, non-serious non-fatal|4|||
126667205|NCT03823404|455742943|FG001|Overall Study|Other: Various reasons provided|5|||
126667206|NCT03823404|455742944|FG002|Overall Study|Other: Various reasons provided|6|||
126335032|NCT00490035|454520564|FG003|Overall Study|AE, non-serious non-fatal|5|||
126335033|NCT00490035|454520561|FG000|Overall Study|Lost to Follow-up|2|||
126335034|NCT00490035|454520562|FG001|Overall Study|Lost to Follow-up|0|||
126335035|NCT00490035|454520563|FG002|Overall Study|Lost to Follow-up|1|||
126335036|NCT00490035|454520564|FG003|Overall Study|Lost to Follow-up|0|||
126335037|NCT00490035|454520561|FG000|Overall Study|Withdrawal by Subject|2|||
126335038|NCT00490035|454520562|FG001|Overall Study|Withdrawal by Subject|1|||
126335039|NCT00490035|454520563|FG002|Overall Study|Withdrawal by Subject|1|||
126335040|NCT00490035|454520564|FG003|Overall Study|Withdrawal by Subject|0|||
126335041|NCT00490035|454520561|FG000|Overall Study|Other reason|0|||
126335042|NCT00490035|454520562|FG001|Overall Study|Other reason|1|||
126335043|NCT00490035|454520563|FG002|Overall Study|Other reason|3|||
126335044|NCT00490035|454520564|FG003|Overall Study|Other reason|1|||
126335045|NCT00490035|454520561|FG000|Overall Study|AE, serious fatal|1|||
126335046|NCT00490035|454520562|FG001|Overall Study|AE, serious fatal|0|||
126335047|NCT00490035|454520563|FG002|Overall Study|AE, serious fatal|0|||
126335048|NCT00490035|454520564|FG003|Overall Study|AE, serious fatal|0|||
126335049|NCT00490035|454520561|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
126335050|NCT00490035|454520562|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
126335051|NCT00490035|454520563|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
126335052|NCT00490035|454520564|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
126335053|NCT00490035|454520561|FG000|Overall Study|AE of unknown type|0|||
126335054|NCT00490035|454520562|FG001|Overall Study|AE of unknown type|0|||
126335055|NCT00490035|454520563|FG002|Overall Study|AE of unknown type|2|||
126335056|NCT00490035|454520564|FG003|Overall Study|AE of unknown type|0|||
126335057|NCT05209880|454520567|FG000|1-Month Follow-up|Spoke with Doctor|5|||
126335058|NCT05209880|454520568|FG001|1-Month Follow-up|Spoke with Doctor|5|||
126335059|NCT05209880|454520567|FG000|1-Month Follow-up|Lost to Follow-up|7|||
126335060|NCT05209880|454520568|FG001|1-Month Follow-up|Lost to Follow-up|9|||
126335061|NCT05209880|454520567|FG000|1-Month Follow-up|Discontinued|0|||
126335062|NCT05209880|454520568|FG001|1-Month Follow-up|Discontinued|1|||
126335063|NCT05209880|454520567|FG000|3-Month Follow-up|Spoke with Doctor|17|||
126335064|NCT05209880|454520568|FG001|3-Month Follow-up|Spoke with Doctor|7|||
126335065|NCT05209880|454520567|FG000|3-Month Follow-up|Lost to Follow-up|8|||
126335066|NCT05209880|454520568|FG001|3-Month Follow-up|Lost to Follow-up|10|||
126335067|NCT05209880|454520567|FG000|3-Month Follow-up|Discontinued|1|||
126335068|NCT05209880|454520568|FG001|3-Month Follow-up|Discontinued|3|||
126335069|NCT05209880|454520567|FG000|6-Month Follow-up|Spoke with Doctor|25|||
126335070|NCT05209880|454520568|FG001|6-Month Follow-up|Spoke with Doctor|14|||
126335071|NCT05209880|454520567|FG000|6-Month Follow-up|Lost to Follow-up|9|||
126335072|NCT05209880|454520568|FG001|6-Month Follow-up|Lost to Follow-up|14|||
126335073|NCT05209880|454520567|FG000|6-Month Follow-up|Discontinued|1|||
126335074|NCT05209880|454520568|FG001|6-Month Follow-up|Discontinued|3|||
126335075|NCT04144322|454520571|FG000|Overall Study|Lack of Efficacy|2|||
126335076|NCT04144322|454520572|FG001|Overall Study|Lack of Efficacy|2|||
126335077|NCT04817332|454520573|FG000|Overall Study|Lost to Follow-up|3|||
126335078|NCT04817332|454520574|FG001|Overall Study|Lost to Follow-up|3|||
126335079|NCT04817332|454520573|FG000|Overall Study|Protocol Violation|2|||
126335080|NCT04817332|454520574|FG001|Overall Study|Protocol Violation|0|||
126335081|NCT04795466|454520580|FG000|Overall Study|Adverse Event|3|||
126335082|NCT04795466|454520581|FG001|Overall Study|Adverse Event|1|||
126335083|NCT04795466|454520580|FG000|Overall Study|Physician Decision|1|||
126335084|NCT04795466|454520581|FG001|Overall Study|Physician Decision|0|||
126335085|NCT04795466|454520580|FG000|Overall Study|Withdrawal by Subject|2|||
126335086|NCT04795466|454520581|FG001|Overall Study|Withdrawal by Subject|1|||
126335087|NCT05635045|454520582|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
126335088|NCT05635045|454520583|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
126335089|NCT05635045|454520584|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
126335090|NCT05635045|454520585|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
126335091|NCT04577794|454520591|FG000|Overall Study|Adverse Event|1|||
126335092|NCT04577794|454520592|FG001|Overall Study|Adverse Event|1|||
126335093|NCT01628848|454520593|FG000|Overall Study|Adverse Event|9|||
126335094|NCT01628848|454520594|FG001|Overall Study|Adverse Event|7|||
126335095|NCT01628848|454520593|FG000|Overall Study|Lack of Efficacy|0|||
126335096|NCT01628848|454520594|FG001|Overall Study|Lack of Efficacy|4|||
126335097|NCT01628848|454520593|FG000|Overall Study|Withdrawal by Subject|0|||
126335098|NCT01628848|454520594|FG001|Overall Study|Withdrawal by Subject|2|||
126335099|NCT01628848|454520593|FG000|Overall Study|Physician Decision|3|||
126335100|NCT01628848|454520594|FG001|Overall Study|Physician Decision|1|||
126335101|NCT00003471|454520595|FG000|Overall Study|Not evaluable|4|||
126667207|NCT02308007|455742945|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
126667208|NCT02308007|455742946|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
126667209|NCT02308007|455742947|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
126335102|NCT02104895|454520596|FG000|Overall Study|Withdrawal by Subject|0|||
126335103|NCT02104895|454520597|FG001|Overall Study|Withdrawal by Subject|14|||
126335104|NCT01107925|454520599|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
126335105|NCT01107925|454520600|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
126335106|NCT01107925|454520601|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
126335107|NCT01107925|454520602|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
126335108|NCT01107925|454520603|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
126335109|NCT01107925|454520604|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
126335110|NCT01107925|454520599|FG000|Period 2|Withdrawal by Subject|0|||
126335111|NCT01107925|454520600|FG001|Period 2|Withdrawal by Subject|1|||
126335112|NCT01107925|454520601|FG002|Period 2|Withdrawal by Subject|0|||
126335113|NCT01107925|454520602|FG003|Period 2|Withdrawal by Subject|0|||
126335114|NCT01107925|454520603|FG004|Period 2|Withdrawal by Subject|0|||
126335115|NCT01107925|454520604|FG005|Period 2|Withdrawal by Subject|1|||
126335116|NCT03311945|454520605|FG000|Overall Study|Adverse Event|2|||
126335117|NCT03311945|454520605|FG000|Overall Study|Lack of Efficacy|1|||
126335118|NCT04877990|454520606|FG000|Treatment|Other reasons|3|||
126335119|NCT04877990|454520607|FG001|Treatment|Other reasons|1|||
126335120|NCT04877990|454520606|FG000|Treatment|Administrative reasons by sponsor|17|||
126335121|NCT04877990|454520607|FG001|Treatment|Administrative reasons by sponsor|33|||
126335122|NCT04877990|454520606|FG000|Treatment|Withdrawal by Subject|2|||
126335123|NCT04877990|454520607|FG001|Treatment|Withdrawal by Subject|6|||
126335124|NCT04877990|454520606|FG000|Treatment|Adverse Event|2|||
126335125|NCT04877990|454520607|FG001|Treatment|Adverse Event|1|||
126335126|NCT03839394|454520608|FG000|Overall Study|Lost to Follow-up|6|||
126335127|NCT03839394|454520609|FG001|Overall Study|Lost to Follow-up|8|||
126335128|NCT03839394|454520608|FG000|Overall Study|Withdrawal by Subject|0|||
126335129|NCT03839394|454520609|FG001|Overall Study|Withdrawal by Subject|2|||
126335130|NCT01619878|454520610|FG000|6 Week Follow-up Phase|Adverse Event|1|||
126335131|NCT01619878|454520610|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
126667210|NCT02308007|455742945|FG000|Overall Study|Positive for STD at Baseline|7|||
126667211|NCT02308007|455742946|FG001|Overall Study|Positive for STD at Baseline|11|||
126667212|NCT02308007|455742947|FG002|Overall Study|Positive for STD at Baseline|7|||
126667213|NCT02308007|455742945|FG000|Overall Study|Lost to Follow-up|3|||
126667214|NCT02308007|455742946|FG001|Overall Study|Lost to Follow-up|0|||
126667215|NCT02308007|455742947|FG002|Overall Study|Lost to Follow-up|1|||
126667216|NCT00528567|455742952|FG000|Overall Study|Death|4|||
126667217|NCT00528567|455742953|FG001|Overall Study|Death|5|||
126667218|NCT00528567|455742952|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
126667219|NCT00528567|455742953|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
126667220|NCT00528567|455742952|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
126667221|NCT00528567|455742953|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
126667222|NCT00528567|455742952|FG000|Overall Study|Violation Criteria at Entry|3|||
126667223|NCT00528567|455742953|FG001|Overall Study|Violation Criteria at Entry|17|||
126667224|NCT00528567|455742952|FG000|Overall Study|Withdrew Consent|59|||
126667225|NCT00528567|455742953|FG001|Overall Study|Withdrew Consent|55|||
126667226|NCT00528567|455742952|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
126335132|NCT01619878|454520610|FG000|Follow-up at 12 Months of Age|Death|2|||
126667227|NCT00528567|455742953|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
126667228|NCT00528567|455742952|FG000|Overall Study|Failure to Return|1|||
126667229|NCT00528567|455742953|FG001|Overall Study|Failure to Return|4|||
126667230|NCT00528567|455742952|FG000|Overall Study|Other Protocol Violation|5|||
126667231|NCT00528567|455742953|FG001|Overall Study|Other Protocol Violation|21|||
126667232|NCT00528567|455742952|FG000|Overall Study|Administrative/Other|22|||
126667233|NCT00528567|455742953|FG001|Overall Study|Administrative/Other|75|||
126667234|NCT03085758|455742958|FG000|Overall Study|Death|26|||
126667235|NCT03085758|455742959|FG001|Overall Study|Death|24|||
126667236|NCT03085758|455742960|FG002|Overall Study|Death|53|||
126667237|NCT03085758|455742958|FG000|Overall Study|Lost to Follow-up|1|||
126667238|NCT03085758|455742959|FG001|Overall Study|Lost to Follow-up|1|||
126667239|NCT03085758|455742960|FG002|Overall Study|Lost to Follow-up|1|||
126335133|NCT02895295|454520613|FG000|Overall Study|Survey Non-response|71|||
126335134|NCT02895295|454520614|FG001|Overall Study|Survey Non-response|94|||
126335135|NCT02895295|454520615|FG002|Overall Study|Survey Non-response|92|||
126335136|NCT01367249|454520616|FG000|Overall Study|Withdrawal by Subject|6|||
126335137|NCT01367249|454520617|FG001|Overall Study|Withdrawal by Subject|6|||
126335138|NCT01367249|454520616|FG000|Overall Study|Other|3|||
126335139|NCT01367249|454520617|FG001|Overall Study|Other|10|||
126335140|NCT04821830|454520620|FG000|Overall Study|Withdrawal by Subject|1|||
126335141|NCT04821830|454520621|FG001|Overall Study|Withdrawal by Subject|0|||
126335142|NCT00960804|454520627|FG000|Overall Study|Adverse Event|1|||
126335143|NCT00960804|454520628|FG001|Overall Study|Adverse Event|0|||
126335144|NCT00960804|454520629|FG002|Overall Study|Adverse Event|0|||
126335145|NCT00960804|454520627|FG000|Overall Study|Withdrawal by Subject|1|||
126335146|NCT00960804|454520628|FG001|Overall Study|Withdrawal by Subject|0|||
126335147|NCT00960804|454520629|FG002|Overall Study|Withdrawal by Subject|0|||
126667240|NCT03085758|455742958|FG000|Overall Study|Withdrawal by Subject|2|||
126667241|NCT03085758|455742959|FG001|Overall Study|Withdrawal by Subject|2|||
126335148|NCT00960804|454520627|FG000|Overall Study|Study terminated by the sponsor|5|||
126335149|NCT00960804|454520628|FG001|Overall Study|Study terminated by the sponsor|4|||
126667242|NCT03085758|455742960|FG002|Overall Study|Withdrawal by Subject|1|||
126335150|NCT00960804|454520629|FG002|Overall Study|Study terminated by the sponsor|10|||
126335151|NCT00490919|454520630|FG000|Open-label Run-in Period|Adverse Event|239|||
126335152|NCT00490919|454520631|FG001|Open-label Run-in Period|Adverse Event|0|||
126335153|NCT00490919|454520632|FG002|Open-label Run-in Period|Adverse Event|0|||
126335154|NCT00490919|454520630|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
126335155|NCT00490919|454520631|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
126335156|NCT00490919|454520632|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
126667243|NCT03085758|455742958|FG000|Overall Study|Refusal to recall it up to day 90|0|||
126667244|NCT03085758|455742959|FG001|Overall Study|Refusal to recall it up to day 90|0|||
126667245|NCT03085758|455742960|FG002|Overall Study|Refusal to recall it up to day 90|1|||
126667246|NCT03085758|455742958|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
126667247|NCT03085758|455742959|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
126667248|NCT03085758|455742960|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
126667249|NCT04004429|455742961|FG000|Overall Study|Protocol Violation|1|||
126667250|NCT04004429|455742962|FG001|Overall Study|Protocol Violation|0|||
126667251|NCT04004429|455742963|FG002|Overall Study|Protocol Violation|0|||
126667252|NCT04004429|455742961|FG000|Overall Study|Physician Decision|0|||
126667253|NCT04004429|455742962|FG001|Overall Study|Physician Decision|1|||
126667254|NCT04004429|455742963|FG002|Overall Study|Physician Decision|1|||
126667255|NCT04004429|455742961|FG000|Overall Study|Withdrawal by Subject|1|||
126667256|NCT04004429|455742962|FG001|Overall Study|Withdrawal by Subject|1|||
126667257|NCT04004429|455742963|FG002|Overall Study|Withdrawal by Subject|1|||
126667258|NCT00631189|455742964|FG000|Initial Phase|Protocol Violation|347|||
126667259|NCT00631189|455742965|FG001|Initial Phase|Protocol Violation|0|||
126667260|NCT00631189|455742966|FG002|Initial Phase|Protocol Violation|0|||
126667261|NCT00631189|455742967|FG003|Initial Phase|Protocol Violation|0|||
126667262|NCT00631189|455742964|FG000|Initial Phase|Withdrawal by Subject|4|||
126667263|NCT00631189|455742965|FG001|Initial Phase|Withdrawal by Subject|0|||
126667264|NCT00631189|455742966|FG002|Initial Phase|Withdrawal by Subject|0|||
126667265|NCT00631189|455742967|FG003|Initial Phase|Withdrawal by Subject|0|||
126667266|NCT00631189|455742964|FG000|Treatment Phase|Withdrawal by Subject|0|||
126667267|NCT00631189|455742965|FG001|Treatment Phase|Withdrawal by Subject|2|||
126667268|NCT00631189|455742966|FG002|Treatment Phase|Withdrawal by Subject|1|||
126667269|NCT00631189|455742967|FG003|Treatment Phase|Withdrawal by Subject|1|||
126667270|NCT00631189|455742964|FG000|Treatment Phase|Protocol Violation|0|||
126667271|NCT00631189|455742965|FG001|Treatment Phase|Protocol Violation|1|||
126667272|NCT00631189|455742966|FG002|Treatment Phase|Protocol Violation|6|||
126667273|NCT00631189|455742967|FG003|Treatment Phase|Protocol Violation|2|||
126667274|NCT00631189|455742964|FG000|Treatment Phase|Adverse Event|0|||
126667275|NCT00631189|455742965|FG001|Treatment Phase|Adverse Event|3|||
126667276|NCT00631189|455742966|FG002|Treatment Phase|Adverse Event|2|||
126667277|NCT00631189|455742967|FG003|Treatment Phase|Adverse Event|4|||
126667278|NCT00631189|455742964|FG000|Treatment Phase|Lost to Follow-up|0|||
126667279|NCT00631189|455742965|FG001|Treatment Phase|Lost to Follow-up|1|||
126667280|NCT00631189|455742966|FG002|Treatment Phase|Lost to Follow-up|0|||
126667281|NCT00631189|455742967|FG003|Treatment Phase|Lost to Follow-up|0|||
126667282|NCT00631189|455742964|FG000|Treatment Phase|Pregnancy|0|||
126667283|NCT00631189|455742965|FG001|Treatment Phase|Pregnancy|0|||
126667284|NCT00631189|455742966|FG002|Treatment Phase|Pregnancy|1|||
126667285|NCT00631189|455742967|FG003|Treatment Phase|Pregnancy|0|||
126667286|NCT00631189|455742964|FG000|Treatment Phase|patient did not take pravastatin|0|||
126667287|NCT00631189|455742965|FG001|Treatment Phase|patient did not take pravastatin|0|||
126667288|NCT00631189|455742966|FG002|Treatment Phase|patient did not take pravastatin|1|||
126667289|NCT00631189|455742967|FG003|Treatment Phase|patient did not take pravastatin|0|||
126667290|NCT00056862|455742968|FG000|Overall Study|Protocol Violation|1|||
126667291|NCT00056862|455742969|FG001|Overall Study|Protocol Violation|0|||
126667292|NCT02252536|455742970|FG000|Overall Study|Lost to Follow-up|5|||
126667293|NCT02252536|455742971|FG001|Overall Study|Lost to Follow-up|3|||
126667294|NCT01438151|455742974|FG000|Overall Study|study terminated|8|||
126667295|NCT00006392|455742981|FG000|Overall Study|Ineligible|11|||
126667296|NCT00006392|455742982|FG001|Overall Study|Ineligible|3|||
126667297|NCT00006392|455742983|FG002|Overall Study|Ineligible|5|||
126667298|NCT00006392|455742984|FG003|Overall Study|Ineligible|5|||
126667299|NCT00006392|455742981|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
126667300|NCT00006392|455742982|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
126335157|NCT00490919|454520630|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
126335158|NCT00490919|454520631|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
126335159|NCT00490919|454520632|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
126335160|NCT00490919|454520630|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
126335161|NCT00490919|454520631|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
126335162|NCT00490919|454520632|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
126335163|NCT00490919|454520630|FG000|Open-label Run-in Period|Administrative|40|||
126335164|NCT00490919|454520631|FG001|Open-label Run-in Period|Administrative|0|||
126335165|NCT00490919|454520632|FG002|Open-label Run-in Period|Administrative|0|||
126335166|NCT00490919|454520630|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
126667301|NCT00006392|455742983|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
126335167|NCT00490919|454520631|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
126667302|NCT00006392|455742984|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
126667303|NCT00728481|455742986|FG000|Overall Study|Withdrawal by Subject|0|||
126667304|NCT00728481|455742987|FG001|Overall Study|Withdrawal by Subject|1|||
126667305|NCT00728481|455742986|FG000|Overall Study|Adverse Event|0|||
126667306|NCT00728481|455742987|FG001|Overall Study|Adverse Event|1|||
126667307|NCT00728481|455742986|FG000|Overall Study|Study medication non-compliance|0|||
126667308|NCT00728481|455742987|FG001|Overall Study|Study medication non-compliance|2|||
126335168|NCT00490919|454520632|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
126667309|NCT00728481|455742986|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
126667310|NCT00728481|455742987|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
126667311|NCT02545322|455742988|FG000|Overall Study|Withdrawal by Subject|3|||
126667312|NCT01505010|455742989|FG000|Overall Study|Protocol Violation|0|||
126667313|NCT01505010|455742990|FG001|Overall Study|Protocol Violation|1|||
126667314|NCT01505010|455742989|FG000|Overall Study|Lost to Follow-up|0|||
126667315|NCT01505010|455742990|FG001|Overall Study|Lost to Follow-up|1|||
126667316|NCT00108069|455742993|FG000|Overall Study|Never rec'd study drug|0|||
126667317|NCT00108069|455742994|FG001|Overall Study|Never rec'd study drug|1|||
126667318|NCT00108069|455742993|FG000|Overall Study|Adverse Event|1|||
126667319|NCT00108069|455742994|FG001|Overall Study|Adverse Event|1|||
126667320|NCT00108069|455742993|FG000|Overall Study|Withdrawal by Subject|1|||
126667321|NCT00108069|455742994|FG001|Overall Study|Withdrawal by Subject|0|||
126667322|NCT00108069|455742993|FG000|Overall Study|Death|1|||
126667323|NCT00108069|455742994|FG001|Overall Study|Death|0|||
126667324|NCT00108069|455742993|FG000|Overall Study|Progessive disease|27|||
126667325|NCT00108069|455742994|FG001|Overall Study|Progessive disease|11|||
126667326|NCT00995007|455742995|FG000|Overall Study|Withdrew consent|1|||
126667327|NCT00995007|455742996|FG001|Overall Study|Withdrew consent|0|||
126667328|NCT00995007|455742995|FG000|Overall Study|Refused further treatment|8|||
126667329|NCT00995007|455742996|FG001|Overall Study|Refused further treatment|2|||
126335169|NCT00490919|454520630|FG000|Double-blind Phase|Adverse Event|0|||
126335170|NCT00490919|454520631|FG001|Double-blind Phase|Adverse Event|40|||
126335171|NCT00490919|454520632|FG002|Double-blind Phase|Adverse Event|20|||
126335172|NCT00490919|454520630|FG000|Double-blind Phase|Withdrawal by Subject|0|||
126335173|NCT00490919|454520631|FG001|Double-blind Phase|Withdrawal by Subject|10|||
126335174|NCT00490919|454520632|FG002|Double-blind Phase|Withdrawal by Subject|11|||
126335175|NCT00490919|454520630|FG000|Double-blind Phase|Lost to Follow-up|0|||
126335176|NCT00490919|454520631|FG001|Double-blind Phase|Lost to Follow-up|8|||
126335177|NCT00490919|454520632|FG002|Double-blind Phase|Lost to Follow-up|11|||
126335178|NCT00490919|454520630|FG000|Double-blind Phase|Lack of Efficacy|0|||
126335179|NCT00490919|454520631|FG001|Double-blind Phase|Lack of Efficacy|22|||
126335180|NCT00490919|454520632|FG002|Double-blind Phase|Lack of Efficacy|36|||
126335181|NCT00490919|454520630|FG000|Double-blind Phase|Administrative|0|||
126335182|NCT00490919|454520631|FG001|Double-blind Phase|Administrative|6|||
126335183|NCT00490919|454520632|FG002|Double-blind Phase|Administrative|6|||
126335184|NCT02358031|454522356|FG000|Overall Study|Death|253|||
126335185|NCT02358031|454522357|FG001|Overall Study|Death|237|||
126335186|NCT02358031|454522358|FG002|Overall Study|Death|266|||
126335187|NCT02358031|454522356|FG000|Overall Study|Lost to Follow-up|1|||
126335188|NCT02358031|454522357|FG001|Overall Study|Lost to Follow-up|1|||
126335189|NCT02358031|454522358|FG002|Overall Study|Lost to Follow-up|0|||
126335190|NCT02358031|454522356|FG000|Overall Study|Withdrawal by Subject|19|||
126335191|NCT02358031|454522357|FG001|Overall Study|Withdrawal by Subject|14|||
126335192|NCT02358031|454522358|FG002|Overall Study|Withdrawal by Subject|18|||
126335193|NCT02358031|454522356|FG000|Overall Study|Sponsor Decision|26|||
126335194|NCT02358031|454522357|FG001|Overall Study|Sponsor Decision|28|||
126335195|NCT02358031|454522358|FG002|Overall Study|Sponsor Decision|16|||
126335196|NCT05664581|454522359|FG000|Overall Study|Withdrawal by Subject|2|||
126335197|NCT03101150|454522360|FG000|Overall Study|Lost to Follow-up|2|||
126335198|NCT03101150|454522361|FG001|Overall Study|Lost to Follow-up|4|||
126335199|NCT03101150|454522360|FG000|Overall Study|Miscarriage|3|||
126335200|NCT03101150|454522361|FG001|Overall Study|Miscarriage|6|||
126335201|NCT03163446|454522364|FG000|Overall Study|Unable to return for Day 180 visit|2|||
126335202|NCT03163446|454522365|FG001|Overall Study|Unable to return for Day 180 visit|0|||
126335203|NCT03163446|454522364|FG000|Overall Study|Withdrawal by Subject|2|||
126335204|NCT03163446|454522365|FG001|Overall Study|Withdrawal by Subject|6|||
126335205|NCT03163446|454522364|FG000|Overall Study|Death|16|||
126335206|NCT03163446|454522365|FG001|Overall Study|Death|5|||
126335207|NCT03163446|454522364|FG000|Overall Study|Lost to Follow-up|6|||
126335208|NCT03163446|454522365|FG001|Overall Study|Lost to Follow-up|5|||
126335209|NCT03163446|454522364|FG000|Overall Study|Physician Decision|1|||
126335210|NCT03163446|454522365|FG001|Overall Study|Physician Decision|1|||
126335211|NCT03163446|454522364|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
126335212|NCT03163446|454522365|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
126335213|NCT01317641|454522366|FG000|Overall Study|Not treated|0|||
126335214|NCT01317641|454522367|FG001|Overall Study|Not treated|0|||
126335215|NCT01317641|454522368|FG002|Overall Study|Not treated|0|||
126335216|NCT01317641|454522369|FG003|Overall Study|Not treated|0|||
126335217|NCT01317641|454522370|FG004|Overall Study|Not treated|0|||
126335218|NCT01317641|454522371|FG005|Overall Study|Not treated|0|||
126335219|NCT01317641|454522372|FG006|Overall Study|Not treated|0|||
126335220|NCT01317641|454522373|FG007|Overall Study|Not treated|1|||
126667330|NCT00995007|455742995|FG000|Overall Study|Toxicity|8|||
126667331|NCT00995007|455742996|FG001|Overall Study|Toxicity|0|||
126667332|NCT01910116|455742997|FG000|Overall Study|Adverse Event|0|||
126667333|NCT01910116|455742998|FG001|Overall Study|Adverse Event|3|||
126335221|NCT01317641|454522374|FG008|Overall Study|Not treated|1|||
126335222|NCT01317641|454522366|FG000|Overall Study|Adverse Event|0|||
126335223|NCT01317641|454522367|FG001|Overall Study|Adverse Event|1|||
126335224|NCT01317641|454522368|FG002|Overall Study|Adverse Event|0|||
126667334|NCT01910116|455742997|FG000|Overall Study|Lack of Efficacy|3|||
126667335|NCT01910116|455742998|FG001|Overall Study|Lack of Efficacy|4|||
126667336|NCT01910116|455742997|FG000|Overall Study|Lost to Follow-up|1|||
126667337|NCT01910116|455742998|FG001|Overall Study|Lost to Follow-up|0|||
126667338|NCT01910116|455742997|FG000|Overall Study|Protocol Violation|1|||
126667339|NCT01910116|455742998|FG001|Overall Study|Protocol Violation|2|||
126667340|NCT01910116|455742997|FG000|Overall Study|Withdrawal by Subject|8|||
126667341|NCT01910116|455742998|FG001|Overall Study|Withdrawal by Subject|3|||
126335225|NCT01317641|454522369|FG003|Overall Study|Adverse Event|1|||
126335226|NCT01317641|454522370|FG004|Overall Study|Adverse Event|0|||
126335227|NCT01317641|454522371|FG005|Overall Study|Adverse Event|0|||
126335228|NCT01317641|454522372|FG006|Overall Study|Adverse Event|2|||
126335229|NCT01317641|454522373|FG007|Overall Study|Adverse Event|1|||
126335230|NCT01317641|454522374|FG008|Overall Study|Adverse Event|0|||
126335231|NCT01317641|454522366|FG000|Overall Study|Protocol Violation|1|||
126335232|NCT01317641|454522367|FG001|Overall Study|Protocol Violation|0|||
126335233|NCT01317641|454522368|FG002|Overall Study|Protocol Violation|0|||
126335234|NCT01317641|454522369|FG003|Overall Study|Protocol Violation|0|||
126335235|NCT01317641|454522370|FG004|Overall Study|Protocol Violation|0|||
126335236|NCT01317641|454522371|FG005|Overall Study|Protocol Violation|0|||
126335237|NCT01317641|454522372|FG006|Overall Study|Protocol Violation|0|||
126335238|NCT01317641|454522373|FG007|Overall Study|Protocol Violation|0|||
126335239|NCT01317641|454522374|FG008|Overall Study|Protocol Violation|0|||
126335240|NCT01317641|454522366|FG000|Overall Study|Disease progression|0|||
126335241|NCT01317641|454522367|FG001|Overall Study|Disease progression|0|||
126335242|NCT01317641|454522368|FG002|Overall Study|Disease progression|0|||
126335243|NCT01317641|454522369|FG003|Overall Study|Disease progression|0|||
126335244|NCT01317641|454522370|FG004|Overall Study|Disease progression|0|||
126335245|NCT01317641|454522371|FG005|Overall Study|Disease progression|0|||
126335246|NCT01317641|454522372|FG006|Overall Study|Disease progression|0|||
126335247|NCT01317641|454522373|FG007|Overall Study|Disease progression|3|||
126335248|NCT01317641|454522374|FG008|Overall Study|Disease progression|4|||
126335249|NCT01317641|454522366|FG000|Overall Study|Withdrawal by Subject|0|||
126335250|NCT01317641|454522367|FG001|Overall Study|Withdrawal by Subject|0|||
126335251|NCT01317641|454522368|FG002|Overall Study|Withdrawal by Subject|0|||
126335252|NCT01317641|454522369|FG003|Overall Study|Withdrawal by Subject|0|||
126335253|NCT01317641|454522370|FG004|Overall Study|Withdrawal by Subject|0|||
126335254|NCT01317641|454522371|FG005|Overall Study|Withdrawal by Subject|0|||
126335255|NCT01317641|454522372|FG006|Overall Study|Withdrawal by Subject|1|||
126335256|NCT01317641|454522373|FG007|Overall Study|Withdrawal by Subject|0|||
126335257|NCT01317641|454522374|FG008|Overall Study|Withdrawal by Subject|0|||
126335258|NCT01228591|454522375|FG000|Baseline|Lack of Efficacy|1|||
126335259|NCT01228591|454522376|FG001|Baseline|Lack of Efficacy|2|||
126335260|NCT02787304|454522377|FG000|Overall Study|Adverse Event|9|||
126335261|NCT02787304|454522378|FG001|Overall Study|Adverse Event|3|||
126335262|NCT02787304|454522379|FG002|Overall Study|Adverse Event|8|||
126335263|NCT02787304|454522380|FG003|Overall Study|Adverse Event|1|||
126335264|NCT02787304|454522377|FG000|Overall Study|Withdrawal by Subject|1|||
126335265|NCT02787304|454522378|FG001|Overall Study|Withdrawal by Subject|4|||
126335266|NCT02787304|454522379|FG002|Overall Study|Withdrawal by Subject|0|||
126335267|NCT02787304|454522380|FG003|Overall Study|Withdrawal by Subject|0|||
126335268|NCT02787304|454522377|FG000|Overall Study|Lost to Follow-up|1|||
126335269|NCT02787304|454522378|FG001|Overall Study|Lost to Follow-up|0|||
126335270|NCT02787304|454522379|FG002|Overall Study|Lost to Follow-up|0|||
126335271|NCT02787304|454522380|FG003|Overall Study|Lost to Follow-up|1|||
126335272|NCT02787304|454522377|FG000|Overall Study|Noncompliance with study drug|0|||
126335273|NCT02787304|454522378|FG001|Overall Study|Noncompliance with study drug|0|||
126335274|NCT02787304|454522379|FG002|Overall Study|Noncompliance with study drug|1|||
126667342|NCT01910116|455742997|FG000|Overall Study|uncertain allocation|1|||
126667343|NCT01910116|455742998|FG001|Overall Study|uncertain allocation|3|||
126335275|NCT02787304|454522380|FG003|Overall Study|Noncompliance with study drug|0|||
126335276|NCT02787304|454522377|FG000|Overall Study|Physician Decision|0|||
126335277|NCT02787304|454522378|FG001|Overall Study|Physician Decision|0|||
126335278|NCT02787304|454522379|FG002|Overall Study|Physician Decision|1|||
126335279|NCT02787304|454522380|FG003|Overall Study|Physician Decision|0|||
126335280|NCT02787304|454522377|FG000|Overall Study|Study terminated by sponsor|25|||
126335281|NCT02787304|454522378|FG001|Overall Study|Study terminated by sponsor|31|||
126335282|NCT02787304|454522379|FG002|Overall Study|Study terminated by sponsor|31|||
126335283|NCT02787304|454522380|FG003|Overall Study|Study terminated by sponsor|32|||
126335284|NCT03110354|454522386|FG000|Overall Study|Death|1|||
126335285|NCT03110354|454522387|FG001|Overall Study|Death|0|||
126667344|NCT01910116|455742997|FG000|Overall Study|incomplete data|0|||
126667345|NCT01910116|455742998|FG001|Overall Study|incomplete data|1|||
126758631|NCT02681094|456066666|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
126335286|NCT03110354|454522388|FG002|Overall Study|Death|0|||
126335287|NCT03110354|454522389|FG003|Overall Study|Death|1|||
126335288|NCT03110354|454522390|FG004|Overall Study|Death|0|||
126335289|NCT03110354|454522386|FG000|Overall Study|Start of new therapy|0|||
126335290|NCT03110354|454522387|FG001|Overall Study|Start of new therapy|0|||
126335291|NCT03110354|454522388|FG002|Overall Study|Start of new therapy|0|||
126335292|NCT03110354|454522389|FG003|Overall Study|Start of new therapy|0|||
126335293|NCT03110354|454522390|FG004|Overall Study|Start of new therapy|1|||
126335294|NCT03110354|454522386|FG000|Overall Study|Failure to achieve response|2|||
126335295|NCT03110354|454522387|FG001|Overall Study|Failure to achieve response|3|||
126335296|NCT03110354|454522388|FG002|Overall Study|Failure to achieve response|0|||
126335297|NCT03110354|454522389|FG003|Overall Study|Failure to achieve response|2|||
126667346|NCT03606980|455742999|FG000|Overall Study|Lost to Follow-up|3|||
126667347|NCT03606980|455743000|FG001|Overall Study|Lost to Follow-up|2|||
126667348|NCT03606980|455743001|FG002|Overall Study|Lost to Follow-up|3|||
126667349|NCT03606980|455742999|FG000|Overall Study|Withdrawal by Subject|1|||
126667350|NCT03606980|455743000|FG001|Overall Study|Withdrawal by Subject|0|||
126667351|NCT03606980|455743001|FG002|Overall Study|Withdrawal by Subject|4|||
126667352|NCT02469896|455743004|FG000|Overall Study|Withdrawal by Subject|2|||
126667353|NCT02469896|455743005|FG001|Overall Study|Withdrawal by Subject|0|||
126667354|NCT01294150|455743006|FG000|Overall Study|Physician Decision|2|||
126667355|NCT01294150|455743007|FG001|Overall Study|Physician Decision|2|||
126667356|NCT03675776|455743008|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
126667357|NCT03675776|455743009|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
126667358|NCT03675776|455743010|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
126667359|NCT03675776|455743008|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
126667360|NCT03675776|455743009|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
126667361|NCT03675776|455743010|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
126667362|NCT01351623|455743012|FG000|Overall Study|Protocol Violation|2|||
126667363|NCT01351623|455743012|FG000|Overall Study|Adverse Event|4|||
126667364|NCT01351623|455743012|FG000|Overall Study|Withdrawal by Subject|1|||
126667365|NCT01351623|455743012|FG000|Overall Study|Death|2|||
126667366|NCT01184053|455743013|FG000|Overall Study|progression while on treatment|3|||
126667367|NCT04399122|455743014|FG000|Overall Study|Lost to Follow-up|2|||
126667368|NCT04399122|455743015|FG001|Overall Study|Lost to Follow-up|0|||
126667369|NCT04399122|455743014|FG000|Overall Study|Withdrawal by Subject|1|||
126667370|NCT04399122|455743015|FG001|Overall Study|Withdrawal by Subject|0|||
126667371|NCT01174238|455743018|FG000|Overall Study|Lost to Follow-up|2|||
126667372|NCT01102803|455743019|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
126667373|NCT01102803|455743020|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
126667374|NCT01102803|455743019|FG000|Post to Follow-Up|Lost to Follow-up|1|||
126667375|NCT01102803|455743020|FG001|Post to Follow-Up|Lost to Follow-up|3|||
126667376|NCT02733185|455743023|FG000|Overall Study|Withdrawal by Subject|12|||
126667377|NCT02733185|455743024|FG001|Overall Study|Withdrawal by Subject|10|||
126667378|NCT02733185|455743025|FG002|Overall Study|Withdrawal by Subject|17|||
126667379|NCT02733185|455743026|FG003|Overall Study|Withdrawal by Subject|21|||
126667380|NCT02733185|455743023|FG000|Overall Study|Death|46|||
126667381|NCT02733185|455743024|FG001|Overall Study|Death|34|||
126667382|NCT02733185|455743025|FG002|Overall Study|Death|35|||
126667383|NCT02733185|455743026|FG003|Overall Study|Death|43|||
126667384|NCT02733185|455743023|FG000|Overall Study|Lost to Follow-up|17|||
126667385|NCT02733185|455743024|FG001|Overall Study|Lost to Follow-up|18|||
126667386|NCT02733185|455743025|FG002|Overall Study|Lost to Follow-up|16|||
126667387|NCT02733185|455743026|FG003|Overall Study|Lost to Follow-up|11|||
126667388|NCT02593786|455743027|FG000|Overall Study|Disease progression|12|||
126667389|NCT02593786|455743028|FG001|Overall Study|Disease progression|16|||
126667390|NCT02593786|455743029|FG002|Overall Study|Disease progression|10|||
126667391|NCT02593786|455743030|FG003|Overall Study|Disease progression|7|||
126667392|NCT02593786|455743027|FG000|Overall Study|Study drug toxicity|1|||
126335298|NCT03110354|454522390|FG004|Overall Study|Failure to achieve response|1|||
126335299|NCT03110354|454522386|FG000|Overall Study|Progressive disease|1|||
126335300|NCT03110354|454522387|FG001|Overall Study|Progressive disease|1|||
126335301|NCT03110354|454522388|FG002|Overall Study|Progressive disease|3|||
126335302|NCT03110354|454522389|FG003|Overall Study|Progressive disease|4|||
126335303|NCT03110354|454522390|FG004|Overall Study|Progressive disease|2|||
126335304|NCT03110354|454522386|FG000|Overall Study|Adverse Event|0|||
126335305|NCT03110354|454522387|FG001|Overall Study|Adverse Event|0|||
126335306|NCT03110354|454522388|FG002|Overall Study|Adverse Event|0|||
126335307|NCT03110354|454522389|FG003|Overall Study|Adverse Event|2|||
126335308|NCT03110354|454522390|FG004|Overall Study|Adverse Event|2|||
126335309|NCT03110354|454522386|FG000|Overall Study|Other|0|||
126335310|NCT03110354|454522387|FG001|Overall Study|Other|0|||
126335311|NCT03110354|454522388|FG002|Overall Study|Other|0|||
126335312|NCT03110354|454522389|FG003|Overall Study|Other|1|||
126335313|NCT03110354|454522390|FG004|Overall Study|Other|1|||
126667393|NCT02593786|455743028|FG001|Overall Study|Study drug toxicity|0|||
126667394|NCT02593786|455743029|FG002|Overall Study|Study drug toxicity|0|||
126667395|NCT02593786|455743030|FG003|Overall Study|Study drug toxicity|0|||
126667396|NCT02593786|455743027|FG000|Overall Study|Adverse event unrelated to study drug|1|||
126667397|NCT02593786|455743028|FG001|Overall Study|Adverse event unrelated to study drug|1|||
126667398|NCT02593786|455743029|FG002|Overall Study|Adverse event unrelated to study drug|1|||
126667399|NCT02593786|455743030|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126667400|NCT02593786|455743027|FG000|Overall Study|Participant request to discontinue study therapy|0|||
126667401|NCT02593786|455743028|FG001|Overall Study|Participant request to discontinue study therapy|2|||
126667402|NCT02593786|455743029|FG002|Overall Study|Participant request to discontinue study therapy|0|||
126667403|NCT02593786|455743030|FG003|Overall Study|Participant request to discontinue study therapy|0|||
126667404|NCT02593786|455743027|FG000|Overall Study|Other reasons|1|||
126667405|NCT02593786|455743028|FG001|Overall Study|Other reasons|1|||
126667406|NCT02593786|455743029|FG002|Overall Study|Other reasons|0|||
126667407|NCT02593786|455743030|FG003|Overall Study|Other reasons|5|||
126667408|NCT00835120|455743031|FG000|Overall Study|Lack of Efficacy|1|||
126667409|NCT00835120|455743031|FG000|Overall Study|Lost to Follow-up|3|||
126667410|NCT00835120|455743031|FG000|Overall Study|Adverse Event|2|||
126667411|NCT00835120|455743031|FG000|Overall Study|Withdrawal by Subject|2|||
126667412|NCT01624259|455743032|FG000|Overall Study|Adverse Event|18|||
126667413|NCT01624259|455743033|FG001|Overall Study|Adverse Event|18|||
126667414|NCT01624259|455743032|FG000|Overall Study|Protocol Violation|1|||
126667415|NCT01624259|455743033|FG001|Overall Study|Protocol Violation|2|||
126667416|NCT01624259|455743032|FG000|Overall Study|Withdrawal by Subject|5|||
126667417|NCT01624259|455743033|FG001|Overall Study|Withdrawal by Subject|7|||
126667418|NCT01624259|455743032|FG000|Overall Study|Physician Decision|1|||
126667419|NCT01624259|455743033|FG001|Overall Study|Physician Decision|1|||
126667420|NCT01624259|455743032|FG000|Overall Study|Lost to Follow-up|2|||
126667421|NCT01624259|455743033|FG001|Overall Study|Lost to Follow-up|3|||
126667422|NCT01624259|455743032|FG000|Overall Study|Abnormal laboratory measure|3|||
126667423|NCT01624259|455743033|FG001|Overall Study|Abnormal laboratory measure|0|||
126667424|NCT00671554|455743037|FG000|Overall Study|Disease progression|3|||
126667425|NCT01479829|455743038|FG000|Overall Study|Withdrawal by Subject|8|||
126667426|NCT01479829|455743039|FG001|Overall Study|Withdrawal by Subject|10|||
126667427|NCT00601250|455743040|FG000|Overall Study|Adverse Event|3|||
126667428|NCT00601250|455743041|FG001|Overall Study|Adverse Event|9|||
126667429|NCT00601250|455743040|FG000|Overall Study|Protocol Violation|3|||
126667430|NCT00601250|455743041|FG001|Overall Study|Protocol Violation|2|||
126667431|NCT00601250|455743040|FG000|Overall Study|Lost to Follow-up|2|||
126667432|NCT00601250|455743041|FG001|Overall Study|Lost to Follow-up|6|||
126667433|NCT00601250|455743040|FG000|Overall Study|Withdrawal by Subject|4|||
126667434|NCT00601250|455743041|FG001|Overall Study|Withdrawal by Subject|13|||
126667435|NCT00601250|455743040|FG000|Overall Study|Other incl. lack of efficacy|2|||
126667436|NCT00601250|455743041|FG001|Overall Study|Other incl. lack of efficacy|9|||
126667437|NCT01791803|455743043|FG000|Overall Study|Withdrawal by Subject|0|||
126667438|NCT01791803|455743044|FG001|Overall Study|Withdrawal by Subject|0|||
126667439|NCT01791803|455743045|FG002|Overall Study|Withdrawal by Subject|0|||
126667440|NCT01791803|455743046|FG003|Overall Study|Withdrawal by Subject|2|||
126667441|NCT01791803|455743043|FG000|Overall Study|Physician Decision|0|||
126667442|NCT01791803|455743044|FG001|Overall Study|Physician Decision|2|||
126667443|NCT01791803|455743045|FG002|Overall Study|Physician Decision|0|||
126667444|NCT01791803|455743046|FG003|Overall Study|Physician Decision|1|||
126667445|NCT01791803|455743043|FG000|Overall Study|Death|0|||
126667446|NCT01791803|455743044|FG001|Overall Study|Death|0|||
126667447|NCT01791803|455743045|FG002|Overall Study|Death|2|||
126667448|NCT01791803|455743046|FG003|Overall Study|Death|2|||
126667449|NCT04752475|455744729|FG000|Overall Study|Withdrawal by Subject|1|||
126667450|NCT04752475|455744730|FG001|Overall Study|Withdrawal by Subject|1|||
126667451|NCT00594516|455744733|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
126667452|NCT00594516|455744734|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
126667453|NCT00594516|455744735|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
126667454|NCT00594516|455744733|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
126667455|NCT00594516|455744734|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
126667456|NCT00594516|455744735|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
126667457|NCT00594516|455744733|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
126667458|NCT00594516|455744734|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
126667459|NCT00594516|455744735|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
126667460|NCT00594516|455744733|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
126667461|NCT00594516|455744734|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
126667462|NCT00594516|455744735|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
126667463|NCT00594516|455744733|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
126667464|NCT00594516|455744734|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
126667465|NCT00594516|455744735|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
126667466|NCT00594516|455744733|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
126667467|NCT00594516|455744734|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
126667468|NCT00594516|455744735|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
126667469|NCT00594516|455744733|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
126667470|NCT00594516|455744734|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
126667471|NCT00594516|455744735|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
126335314|NCT00379834|454522391|FG000|Overall Study|Time constraints|2|||
126335315|NCT01298700|454522393|FG000|Overall Study|Adverse Event|50|||
126335316|NCT01298700|454522394|FG001|Overall Study|Adverse Event|51|||
126335317|NCT01298700|454522393|FG000|Overall Study|Lack of Efficacy|9|||
126335318|NCT01298700|454522394|FG001|Overall Study|Lack of Efficacy|14|||
126335319|NCT01298700|454522393|FG000|Overall Study|Lost to Follow-up|5|||
126335320|NCT01298700|454522394|FG001|Overall Study|Lost to Follow-up|2|||
126335321|NCT01298700|454522393|FG000|Overall Study|Withdrawal by Subject|12|||
126335322|NCT01298700|454522394|FG001|Overall Study|Withdrawal by Subject|9|||
126335323|NCT01298700|454522393|FG000|Overall Study|Protocol Violation|6|||
126335324|NCT01298700|454522394|FG001|Overall Study|Protocol Violation|4|||
126335325|NCT01298700|454522393|FG000|Overall Study|Other Miscellaneous Reasons|16|||
126335326|NCT01298700|454522394|FG001|Overall Study|Other Miscellaneous Reasons|15|||
126335327|NCT01298700|454522393|FG000|Overall Study|Did not Receive Study Drug|3|||
126335328|NCT01298700|454522394|FG001|Overall Study|Did not Receive Study Drug|5|||
126335329|NCT01001429|454522397|FG000|Overall Study|surgery cancelled|0|||
126335330|NCT01001429|454522398|FG001|Overall Study|surgery cancelled|1|||
126335331|NCT01053741|454522405|FG000|2nd Study Intervention|Physician Decision|0|||
126335332|NCT01053741|454522406|FG001|2nd Study Intervention|Physician Decision|1|||
126335333|NCT02063672|454522407|FG000|Overall Study|Ongoing Follow-up|27|||
126335334|NCT02063672|454522408|FG001|Overall Study|Ongoing Follow-up|14|||
126335335|NCT02063672|454522407|FG000|Overall Study|Death|5|||
126335336|NCT02063672|454522408|FG001|Overall Study|Death|3|||
126335337|NCT02063672|454522407|FG000|Overall Study|Lost to Follow-up|1|||
126335338|NCT02063672|454522408|FG001|Overall Study|Lost to Follow-up|3|||
126335339|NCT02063672|454522407|FG000|Overall Study|Withdrawal by Subject|2|||
126335340|NCT02063672|454522408|FG001|Overall Study|Withdrawal by Subject|2|||
126335341|NCT00619827|454522410|FG000|Overall Study|Adverse Event|1|||
126335342|NCT00619827|454522411|FG001|Overall Study|Adverse Event|2|||
126335343|NCT00619827|454522410|FG000|Overall Study|Withdrawal by Subject|2|||
126335344|NCT00619827|454522411|FG001|Overall Study|Withdrawal by Subject|2|||
126335345|NCT00104052|454522412|FG000|Overall Study|Adverse Event|1|||
126335346|NCT00104052|454522412|FG000|Overall Study|Lack of Efficacy|26|||
126335347|NCT00104052|454522412|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
126335348|NCT02498678|454522413|FG000|Overall Study|interference from the surgical team|0|||
126335349|NCT02498678|454522414|FG001|Overall Study|interference from the surgical team|2|||
126335350|NCT00239720|454522420|FG000|Overall Study|Adverse Event|1|||
126335351|NCT00239720|454522421|FG001|Overall Study|Adverse Event|0|||
126335352|NCT00239720|454522420|FG000|Overall Study|Lost to Follow-up|0|||
126335353|NCT00239720|454522421|FG001|Overall Study|Lost to Follow-up|1|||
126335354|NCT01484951|454522423|FG000|Overall Study|Adverse Event|3|||
126335355|NCT01484951|454522423|FG000|Overall Study|Personal Reasons|1|||
126335356|NCT01484951|454522423|FG000|Overall Study|Non-Compliance|1|||
126335357|NCT00917124|454522428|FG000|Overall Study|Protocol Violation|4|||
126335358|NCT00917124|454522429|FG001|Overall Study|Protocol Violation|6|||
126335359|NCT00115778|454522430|FG000|Overall Study|Withdrawal by Subject|0|||
126335360|NCT00115778|454522431|FG001|Overall Study|Withdrawal by Subject|1|||
126335361|NCT00528424|454522434|FG000|Overall Study|Lost to Follow-up|13|||
126335362|NCT00528424|454522434|FG000|Overall Study|Withdrew consent|2|||
126335363|NCT00528424|454522434|FG000|Overall Study|Administrative reason|2|||
126335364|NCT00528424|454522434|FG000|Overall Study|Other|12|||
126335365|NCT02515630|454522435|FG000|Overall Study|Withdrawal by Subject|5|||
126335366|NCT02515630|454522435|FG000|Overall Study|Adverse Event|4|||
126335367|NCT02515630|454522435|FG000|Overall Study|Physician Decision|4|||
126335368|NCT02515630|454522435|FG000|Overall Study|Death|2|||
126335369|NCT02515630|454522435|FG000|Overall Study|Disease Progression|1|||
126335370|NCT00483652|454522436|FG000|Double-blind Treatment Period|Protocol Violation|2|||
126335371|NCT00483652|454522437|FG001|Double-blind Treatment Period|Protocol Violation|1|||
126335372|NCT00483652|454522436|FG000|Double-blind Treatment Period|Adverse Event|3|||
126335373|NCT00483652|454522437|FG001|Double-blind Treatment Period|Adverse Event|4|||
126335374|NCT00483652|454522436|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
126667472|NCT00594516|455744733|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
126667473|NCT00594516|455744734|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
126335375|NCT00483652|454522437|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
126335376|NCT00483652|454522436|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
126335377|NCT00483652|454522437|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
126335378|NCT00473655|454522444|FG000|Overall Study|Lost to Follow-up|9|||
126335379|NCT00473655|454522445|FG001|Overall Study|Lost to Follow-up|5|||
126335380|NCT00473655|454522446|FG002|Overall Study|Lost to Follow-up|8|||
126335381|NCT05081388|454522447|FG000|Overall Study|Adverse Event|1|||
126335382|NCT05081388|454522448|FG001|Overall Study|Adverse Event|0|||
126335383|NCT05081388|454522449|FG002|Overall Study|Adverse Event|0|||
126335384|NCT05081388|454522450|FG003|Overall Study|Adverse Event|0|||
126335385|NCT05081388|454522451|FG004|Overall Study|Adverse Event|0|||
126335386|NCT05081388|454522447|FG000|Overall Study|Lost to Follow-up|0|||
126335387|NCT05081388|454522448|FG001|Overall Study|Lost to Follow-up|1|||
126335388|NCT05081388|454522449|FG002|Overall Study|Lost to Follow-up|0|||
126335389|NCT05081388|454522450|FG003|Overall Study|Lost to Follow-up|0|||
126335390|NCT05081388|454522451|FG004|Overall Study|Lost to Follow-up|0|||
126335391|NCT05081388|454522447|FG000|Overall Study|Subject decision|0|||
126335392|NCT05081388|454522448|FG001|Overall Study|Subject decision|0|||
126335393|NCT05081388|454522449|FG002|Overall Study|Subject decision|0|||
126335394|NCT05081388|454522450|FG003|Overall Study|Subject decision|1|||
126335395|NCT05081388|454522451|FG004|Overall Study|Subject decision|0|||
126335396|NCT04176939|454522452|FG000|Overall Study|Withdrawal by Subject|5|||
126335397|NCT04176939|454522452|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
126335398|NCT04176939|454522452|FG000|Overall Study|Lost to Follow-up|2|||
126335399|NCT04176939|454522452|FG000|Overall Study|Unspecified reason|4|||
126335400|NCT04176939|454522452|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
126335401|NCT02219685|454522455|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
126335402|NCT02219685|454522456|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
126335403|NCT02219685|454522455|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
126335404|NCT02219685|454522456|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
126335405|NCT02869789|454522457|FG000|Overall Study|Disease progression|184|||
126335406|NCT02869789|454522458|FG001|Overall Study|Disease progression|109|||
126335407|NCT02869789|454522459|FG002|Overall Study|Disease progression|260|||
126335408|NCT02869789|454522460|FG003|Overall Study|Disease progression|19|||
126335409|NCT02869789|454522457|FG000|Overall Study|Study drug toxicity|90|||
126335410|NCT02869789|454522458|FG001|Overall Study|Study drug toxicity|32|||
126335411|NCT02869789|454522459|FG002|Overall Study|Study drug toxicity|55|||
126335412|NCT02869789|454522460|FG003|Overall Study|Study drug toxicity|14|||
126335413|NCT02869789|454522457|FG000|Overall Study|Death|7|||
126335414|NCT02869789|454522458|FG001|Overall Study|Death|3|||
126335415|NCT02869789|454522459|FG002|Overall Study|Death|5|||
126335416|NCT02869789|454522460|FG003|Overall Study|Death|1|||
126335417|NCT02869789|454522457|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
126335418|NCT02869789|454522458|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
126335419|NCT02869789|454522459|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
126335420|NCT02869789|454522460|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
126335421|NCT02869789|454522457|FG000|Overall Study|Participant request to discontinue study treatment|10|||
126335422|NCT02869789|454522458|FG001|Overall Study|Participant request to discontinue study treatment|5|||
126335423|NCT02869789|454522459|FG002|Overall Study|Participant request to discontinue study treatment|5|||
126335424|NCT02869789|454522460|FG003|Overall Study|Participant request to discontinue study treatment|3|||
126335425|NCT02869789|454522457|FG000|Overall Study|Withdrawal by Subject|5|||
126335426|NCT02869789|454522458|FG001|Overall Study|Withdrawal by Subject|2|||
126335427|NCT02869789|454522459|FG002|Overall Study|Withdrawal by Subject|7|||
126335428|NCT02869789|454522460|FG003|Overall Study|Withdrawal by Subject|2|||
126335429|NCT02869789|454522457|FG000|Overall Study|Lost to Follow-up|0|||
126335430|NCT02869789|454522458|FG001|Overall Study|Lost to Follow-up|0|||
126335431|NCT02869789|454522459|FG002|Overall Study|Lost to Follow-up|2|||
126335432|NCT02869789|454522460|FG003|Overall Study|Lost to Follow-up|0|||
126335433|NCT02869789|454522457|FG000|Overall Study|Maximum clinical benefit|5|||
126335434|NCT02869789|454522458|FG001|Overall Study|Maximum clinical benefit|2|||
126335435|NCT02869789|454522459|FG002|Overall Study|Maximum clinical benefit|1|||
126335436|NCT02869789|454522460|FG003|Overall Study|Maximum clinical benefit|0|||
126335437|NCT02869789|454522457|FG000|Overall Study|Poor/Non-compliance|0|||
126335438|NCT02869789|454522458|FG001|Overall Study|Poor/Non-compliance|2|||
126335439|NCT02869789|454522459|FG002|Overall Study|Poor/Non-compliance|1|||
126335440|NCT02869789|454522460|FG003|Overall Study|Poor/Non-compliance|0|||
126335441|NCT02869789|454522457|FG000|Overall Study|Participant no longer meets study criteria|0|||
126335442|NCT02869789|454522458|FG001|Overall Study|Participant no longer meets study criteria|1|||
126335443|NCT02869789|454522459|FG002|Overall Study|Participant no longer meets study criteria|1|||
126335444|NCT02869789|454522460|FG003|Overall Study|Participant no longer meets study criteria|0|||
126335445|NCT02869789|454522457|FG000|Overall Study|Administrative reason by sponsor|0|||
126335446|NCT02869789|454522458|FG001|Overall Study|Administrative reason by sponsor|0|||
126335447|NCT02869789|454522459|FG002|Overall Study|Administrative reason by sponsor|1|||
126335448|NCT02869789|454522460|FG003|Overall Study|Administrative reason by sponsor|0|||
126335449|NCT02869789|454522457|FG000|Overall Study|Other reasons|4|||
126335450|NCT02869789|454522458|FG001|Overall Study|Other reasons|8|||
126335451|NCT02869789|454522459|FG002|Overall Study|Other reasons|6|||
126667474|NCT00594516|455744735|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
126335452|NCT02869789|454522460|FG003|Overall Study|Other reasons|0|||
126335453|NCT01566604|454522463|FG000|Overall Study|Patient's inability to use the device|1|||
126335454|NCT01566604|454522464|FG001|Overall Study|Patient's inability to use the device|0|||
126335455|NCT01566604|454522463|FG000|Overall Study|Administrative problems|1|||
126335456|NCT01566604|454522464|FG001|Overall Study|Administrative problems|0|||
126335457|NCT01566604|454522463|FG000|Overall Study|Lack of Efficacy|1|||
126335458|NCT01566604|454522464|FG001|Overall Study|Lack of Efficacy|2|||
126335459|NCT01566604|454522463|FG000|Overall Study|Protocol deviation|2|||
126335460|NCT01566604|454522464|FG001|Overall Study|Protocol deviation|0|||
126335461|NCT01566604|454522463|FG000|Overall Study|Abnormal laboratory value|2|||
126335462|NCT01566604|454522464|FG001|Overall Study|Abnormal laboratory value|0|||
126667475|NCT00594516|455744733|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
126667476|NCT00594516|455744734|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
126667477|NCT00594516|455744735|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
126667478|NCT01448213|455744741|FG000|Overall Study|Lost to Follow-up|12|||
126667479|NCT01448213|455744742|FG001|Overall Study|Lost to Follow-up|10|||
126667480|NCT01448213|455744741|FG000|Overall Study|Adverse Event|4|||
126667481|NCT01448213|455744742|FG001|Overall Study|Adverse Event|10|||
126667482|NCT01448213|455744741|FG000|Overall Study|Protocol Violation|1|||
126667483|NCT01448213|455744742|FG001|Overall Study|Protocol Violation|2|||
126667484|NCT00659529|455744743|FG000|Overall Study|Withdrawal by Subject|4|||
126667485|NCT00659529|455744743|FG000|Overall Study|Protocol Violation|3|||
126667486|NCT00659529|455744743|FG000|Overall Study|Screen failure|9|||
126667487|NCT00785044|455744744|FG000|Overall Study|Dosed at non-participating sites|152|||
126667488|NCT00785044|455744744|FG000|Overall Study|Death|77|||
126667489|NCT00785044|455744744|FG000|Overall Study|Lost to Follow-up|266|||
126667490|NCT00785044|455744744|FG000|Overall Study|Withdrawal by Subject|1|||
126335463|NCT01566604|454522463|FG000|Overall Study|Death|4|||
126335464|NCT01566604|454522464|FG001|Overall Study|Death|1|||
126335465|NCT01566604|454522463|FG000|Overall Study|Adverse Event|4|||
126335466|NCT01566604|454522464|FG001|Overall Study|Adverse Event|2|||
126335467|NCT01566604|454522463|FG000|Overall Study|Withdrawal by Subject|9|||
126335468|NCT01566604|454522464|FG001|Overall Study|Withdrawal by Subject|6|||
126335469|NCT03225170|454522465|FG000|Overall Study|Lost to Follow-up|4|||
126667491|NCT00763971|455744745|FG000|Overall Study|Adverse Event|5|||
126667492|NCT00763971|455744746|FG001|Overall Study|Adverse Event|2|||
126667493|NCT00763971|455744747|FG002|Overall Study|Adverse Event|4|||
126335470|NCT03225170|454522466|FG001|Overall Study|Lost to Follow-up|4|||
126335471|NCT03225170|454522467|FG002|Overall Study|Lost to Follow-up|0|||
126335472|NCT03225170|454522465|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
126335473|NCT03225170|454522466|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
126335474|NCT03225170|454522467|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
126335475|NCT00385918|454522486|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
126335476|NCT00385918|454522487|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
126335477|NCT00385918|454522488|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
126335478|NCT00385918|454522486|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
126335479|NCT00385918|454522487|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
126335480|NCT00385918|454522488|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
126335481|NCT00385918|454522486|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
126335482|NCT00385918|454522487|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
126335483|NCT00385918|454522488|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
126335484|NCT00385918|454522486|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
126335485|NCT00385918|454522487|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
126335486|NCT00385918|454522488|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
126335487|NCT00385918|454522486|FG000|Intervention Phase After Randomization|Physician Decision|1|||
126335488|NCT00385918|454522487|FG001|Intervention Phase After Randomization|Physician Decision|0|||
126335489|NCT00385918|454522488|FG002|Intervention Phase After Randomization|Physician Decision|0|||
126335490|NCT00385918|454522486|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
126335491|NCT00385918|454522487|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
126335492|NCT00385918|454522488|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
126335493|NCT01676701|454522489|FG000|Overall Study|Protocol Violation|1|||
126335494|NCT01676701|454522490|FG001|Overall Study|Protocol Violation|0|||
126335495|NCT01676701|454522489|FG000|Overall Study|Sponsor Decision|3|||
126335496|NCT01676701|454522490|FG001|Overall Study|Sponsor Decision|4|||
126335497|NCT02227784|454522495|FG000|Double-Blind Phase|Adverse Event|3|||
126335498|NCT02227784|454522496|FG001|Double-Blind Phase|Adverse Event|2|||
126335499|NCT02227784|454522497|FG002|Double-Blind Phase|Adverse Event|1|||
126335500|NCT02227784|454522498|FG003|Double-Blind Phase|Adverse Event|3|||
126335501|NCT02227784|454522499|FG004|Double-Blind Phase|Adverse Event|0|||
126335502|NCT02227784|454522495|FG000|Double-Blind Phase|Physician Decision|1|||
126335503|NCT02227784|454522496|FG001|Double-Blind Phase|Physician Decision|0|||
126335504|NCT02227784|454522497|FG002|Double-Blind Phase|Physician Decision|0|||
126335505|NCT02227784|454522498|FG003|Double-Blind Phase|Physician Decision|1|||
126335506|NCT02227784|454522499|FG004|Double-Blind Phase|Physician Decision|0|||
126335507|NCT02227784|454522495|FG000|Double-Blind Phase|Protocol Violation|0|||
126335508|NCT02227784|454522496|FG001|Double-Blind Phase|Protocol Violation|0|||
126335509|NCT02227784|454522497|FG002|Double-Blind Phase|Protocol Violation|1|||
126667494|NCT00763971|455744745|FG000|Overall Study|Protocol Violation|3|||
126667495|NCT00763971|455744746|FG001|Overall Study|Protocol Violation|3|||
126667496|NCT00763971|455744747|FG002|Overall Study|Protocol Violation|2|||
126335510|NCT02227784|454522498|FG003|Double-Blind Phase|Protocol Violation|1|||
126335511|NCT02227784|454522499|FG004|Double-Blind Phase|Protocol Violation|0|||
126335512|NCT02227784|454522495|FG000|Double-Blind Phase|Sponsor Decision|34|||
126667497|NCT00763971|455744745|FG000|Overall Study|Withdrawal by Subject|4|||
126335513|NCT02227784|454522496|FG001|Double-Blind Phase|Sponsor Decision|15|||
126335514|NCT02227784|454522497|FG002|Double-Blind Phase|Sponsor Decision|14|||
126335515|NCT02227784|454522498|FG003|Double-Blind Phase|Sponsor Decision|32|||
126335516|NCT02227784|454522499|FG004|Double-Blind Phase|Sponsor Decision|0|||
126335517|NCT02227784|454522495|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
126335518|NCT02227784|454522496|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
126335519|NCT02227784|454522497|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
126335520|NCT02227784|454522498|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
126335521|NCT02227784|454522499|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
126335522|NCT02227784|454522495|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
126335523|NCT02227784|454522496|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
126335524|NCT02227784|454522497|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
126335525|NCT02227784|454522498|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
126335526|NCT02227784|454522499|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
126335527|NCT02227784|454522495|FG000|Open-Label Extension Phase (OLE)|Death|0|||
126335528|NCT02227784|454522496|FG001|Open-Label Extension Phase (OLE)|Death|0|||
126335529|NCT02227784|454522497|FG002|Open-Label Extension Phase (OLE)|Death|0|||
126335530|NCT02227784|454522498|FG003|Open-Label Extension Phase (OLE)|Death|0|||
126335531|NCT02227784|454522499|FG004|Open-Label Extension Phase (OLE)|Death|1|||
126335532|NCT02227784|454522495|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
126667498|NCT00763971|455744746|FG001|Overall Study|Withdrawal by Subject|5|||
126667499|NCT00763971|455744747|FG002|Overall Study|Withdrawal by Subject|5|||
126667500|NCT00763971|455744745|FG000|Overall Study|Lost to Follow-up|0|||
126667501|NCT00763971|455744746|FG001|Overall Study|Lost to Follow-up|1|||
126667502|NCT00763971|455744747|FG002|Overall Study|Lost to Follow-up|0|||
126667503|NCT00763971|455744745|FG000|Overall Study|Lack of Efficacy|11|||
126667504|NCT00763971|455744746|FG001|Overall Study|Lack of Efficacy|22|||
126667505|NCT00763971|455744747|FG002|Overall Study|Lack of Efficacy|54|||
126667506|NCT00763971|455744745|FG000|Overall Study|Unable to swallow capsule|2|||
126667507|NCT00763971|455744746|FG001|Overall Study|Unable to swallow capsule|1|||
126667508|NCT00763971|455744747|FG002|Overall Study|Unable to swallow capsule|1|||
126667509|NCT00763971|455744745|FG000|Overall Study|Personal reason|3|||
126667510|NCT00763971|455744746|FG001|Overall Study|Personal reason|0|||
126667511|NCT00763971|455744747|FG002|Overall Study|Personal reason|0|||
126667512|NCT00763971|455744745|FG000|Overall Study|Exclusion criteria met|1|||
126667513|NCT00763971|455744746|FG001|Overall Study|Exclusion criteria met|0|||
126667514|NCT00763971|455744747|FG002|Overall Study|Exclusion criteria met|0|||
126667515|NCT00763971|455744745|FG000|Overall Study|Sponsor decision|1|||
126667516|NCT00763971|455744746|FG001|Overall Study|Sponsor decision|0|||
126667517|NCT00763971|455744747|FG002|Overall Study|Sponsor decision|0|||
126667518|NCT00763971|455744745|FG000|Overall Study|Due to holiday season|2|||
126667519|NCT00763971|455744746|FG001|Overall Study|Due to holiday season|0|||
126667520|NCT00763971|455744747|FG002|Overall Study|Due to holiday season|1|||
126667521|NCT00763971|455744745|FG000|Overall Study|Randomization error|0|||
126667522|NCT00763971|455744746|FG001|Overall Study|Randomization error|0|||
126667523|NCT00763971|455744747|FG002|Overall Study|Randomization error|1|||
126667524|NCT00763971|455744745|FG000|Overall Study|Medical monitor decision|0|||
126667525|NCT00763971|455744746|FG001|Overall Study|Medical monitor decision|0|||
126667526|NCT00763971|455744747|FG002|Overall Study|Medical monitor decision|1|||
126667527|NCT00763971|455744745|FG000|Overall Study|Moved to another country|0|||
126667528|NCT00763971|455744746|FG001|Overall Study|Moved to another country|1|||
126667529|NCT00763971|455744747|FG002|Overall Study|Moved to another country|0|||
126667530|NCT00763971|455744745|FG000|Overall Study|Subject wanted dose reduction|0|||
126667531|NCT00763971|455744746|FG001|Overall Study|Subject wanted dose reduction|1|||
126667532|NCT00763971|455744747|FG002|Overall Study|Subject wanted dose reduction|0|||
126667533|NCT00763971|455744745|FG000|Overall Study|Lack of availability|0|||
126667534|NCT00763971|455744746|FG001|Overall Study|Lack of availability|1|||
126667535|NCT00763971|455744747|FG002|Overall Study|Lack of availability|0|||
126667536|NCT00763971|455744745|FG000|Overall Study|Performed final visit on phone|0|||
126667537|NCT00763971|455744746|FG001|Overall Study|Performed final visit on phone|1|||
126667538|NCT00763971|455744747|FG002|Overall Study|Performed final visit on phone|0|||
126335533|NCT02227784|454522496|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
126335534|NCT02227784|454522497|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
126335535|NCT02227784|454522498|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
126667539|NCT00763971|455744745|FG000|Overall Study|Participation in 489-326 required|1|||
126667540|NCT00763971|455744746|FG001|Overall Study|Participation in 489-326 required|0|||
126667541|NCT00763971|455744747|FG002|Overall Study|Participation in 489-326 required|0|||
126667542|NCT04439071|455744748|FG000|Overall Study|Lost to Follow-up|0|||
126667543|NCT04439071|455744749|FG001|Overall Study|Lost to Follow-up|3|||
126335536|NCT02227784|454522499|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
126335537|NCT02227784|454522495|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
126335538|NCT02227784|454522496|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
126667544|NCT04439071|455744748|FG000|Overall Study|Withdrawal by Subject|3|||
126667545|NCT04439071|455744749|FG001|Overall Study|Withdrawal by Subject|8|||
126667546|NCT04439071|455744748|FG000|Overall Study|Death|6|||
126335539|NCT02227784|454522497|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
126335540|NCT02227784|454522498|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
126335541|NCT02227784|454522499|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
126335542|NCT02155699|454522500|FG000|Overall Study|Withdrawal by Subject|0|||
126335543|NCT02155699|454522501|FG001|Overall Study|Withdrawal by Subject|3|||
126335544|NCT02155699|454522502|FG002|Overall Study|Withdrawal by Subject|6|||
126335545|NCT02155699|454522503|FG003|Overall Study|Withdrawal by Subject|1|||
126335546|NCT02155699|454522500|FG000|Overall Study|Lost to Follow-up|0|||
126335547|NCT02155699|454522501|FG001|Overall Study|Lost to Follow-up|0|||
126335548|NCT02155699|454522502|FG002|Overall Study|Lost to Follow-up|0|||
126335549|NCT02155699|454522503|FG003|Overall Study|Lost to Follow-up|3|||
126335550|NCT02155699|454522500|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
126335551|NCT02155699|454522501|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
126335552|NCT02155699|454522502|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
126335553|NCT02155699|454522503|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
126335554|NCT00715559|454524728|FG000|Overall Study|medication not tolerated - nausea|1|||
126335555|NCT02699996|454524729|FG000|Overall Study|Withdrawal by Subject|5|||
126335556|NCT02699996|454524730|FG001|Overall Study|Withdrawal by Subject|2|||
126335557|NCT01095835|454524733|FG000|Overall Study|Adverse Event|8|||
126335558|NCT01095835|454524734|FG001|Overall Study|Adverse Event|6|||
126335559|NCT01095835|454524735|FG002|Overall Study|Adverse Event|6|||
126335560|NCT01095835|454524733|FG000|Overall Study|Lack of Efficacy|0|||
126335561|NCT01095835|454524734|FG001|Overall Study|Lack of Efficacy|1|||
126335562|NCT01095835|454524735|FG002|Overall Study|Lack of Efficacy|0|||
126335563|NCT01095835|454524733|FG000|Overall Study|Physician Decision|0|||
126335564|NCT01095835|454524734|FG001|Overall Study|Physician Decision|0|||
126335565|NCT01095835|454524735|FG002|Overall Study|Physician Decision|1|||
126335566|NCT01095835|454524733|FG000|Overall Study|Withdrawal by Subject|1|||
126335567|NCT01095835|454524734|FG001|Overall Study|Withdrawal by Subject|3|||
126335568|NCT01095835|454524735|FG002|Overall Study|Withdrawal by Subject|0|||
126335569|NCT01095835|454524733|FG000|Overall Study|Non study compliance|0|||
126335570|NCT01095835|454524734|FG001|Overall Study|Non study compliance|0|||
126335571|NCT01095835|454524735|FG002|Overall Study|Non study compliance|1|||
126335572|NCT01095835|454524733|FG000|Overall Study|Protocol Violation|1|||
126335573|NCT01095835|454524734|FG001|Overall Study|Protocol Violation|2|||
126335574|NCT01095835|454524735|FG002|Overall Study|Protocol Violation|0|||
126335575|NCT01051921|454524736|FG000|Overall Study|Physician Decision|9|||
126335576|NCT01051921|454524736|FG000|Overall Study|Adverse Event|8|||
126335577|NCT01051921|454524736|FG000|Overall Study|Withdrawal by Subject|7|||
126335578|NCT01051921|454524736|FG000|Overall Study|Lost to Follow-up|4|||
126335579|NCT01051921|454524736|FG000|Overall Study|virological failure|1|||
126335580|NCT01051921|454524736|FG000|Overall Study|patient moved|1|||
126335581|NCT00116688|454524741|FG000|Overall Study|Protocol deviation|1|||
126335582|NCT00116688|454524742|FG001|Overall Study|Protocol deviation|0|||
126335583|NCT00116688|454524741|FG000|Overall Study|Noncompliance|3|||
126335584|NCT00116688|454524742|FG001|Overall Study|Noncompliance|1|||
126335585|NCT00116688|454524741|FG000|Overall Study|Adverse Event|11|||
126667547|NCT04439071|455744749|FG001|Overall Study|Death|4|||
126667548|NCT04439071|455744748|FG000|Overall Study|Other than specified|3|||
126667549|NCT04439071|455744749|FG001|Overall Study|Other than specified|3|||
126667550|NCT04439071|455744748|FG000|Overall Study|Randomized but not treated|2|||
126667551|NCT04439071|455744749|FG001|Overall Study|Randomized but not treated|0|||
126667552|NCT01122576|455744750|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
126667553|NCT01122576|455744751|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
126667554|NCT01122576|455744752|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
126667555|NCT01122576|455744750|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
126667556|NCT01122576|455744751|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
126667557|NCT01122576|455744752|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
126667558|NCT01122576|455744750|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
126667559|NCT01122576|455744751|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
126667560|NCT01122576|455744752|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
126667561|NCT00381563|455744757|FG000|Overall Study|Withdrawal by Subject|5|||
126667562|NCT00381563|455744758|FG001|Overall Study|Withdrawal by Subject|5|||
126667563|NCT00381563|455744757|FG000|Overall Study|Lost to Follow-up|2|||
126667564|NCT00381563|455744758|FG001|Overall Study|Lost to Follow-up|0|||
126335586|NCT00116688|454524742|FG001|Overall Study|Adverse Event|0|||
126335587|NCT00116688|454524741|FG000|Overall Study|Withdrawal by Subject|26|||
126335588|NCT00116688|454524742|FG001|Overall Study|Withdrawal by Subject|2|||
126335589|NCT00116688|454524741|FG000|Overall Study|Requirement for alternative therapy|11|||
126667565|NCT00381563|455744757|FG000|Overall Study|Protocol Violation|0|||
126335590|NCT00116688|454524742|FG001|Overall Study|Requirement for alternative therapy|1|||
126667566|NCT00381563|455744758|FG001|Overall Study|Protocol Violation|1|||
126335591|NCT00116688|454524741|FG000|Overall Study|Physician Decision|7|||
126335592|NCT00116688|454524742|FG001|Overall Study|Physician Decision|0|||
126335593|NCT00116688|454524741|FG000|Overall Study|Lost to Follow-up|3|||
126335594|NCT00116688|454524742|FG001|Overall Study|Lost to Follow-up|0|||
126335595|NCT00116688|454524741|FG000|Overall Study|Death|15|||
126335596|NCT00116688|454524742|FG001|Overall Study|Death|0|||
126335597|NCT00116688|454524741|FG000|Overall Study|Protocol-specified criteria|3|||
126335598|NCT00116688|454524742|FG001|Overall Study|Protocol-specified criteria|0|||
126335599|NCT00116688|454524741|FG000|Overall Study|Pregnancy|1|||
126335600|NCT00116688|454524742|FG001|Overall Study|Pregnancy|0|||
126335601|NCT00116688|454524741|FG000|Overall Study|Other|11|||
126335602|NCT00116688|454524742|FG001|Overall Study|Other|0|||
126335603|NCT01775670|454524747|FG000|Overall Study|Lost to Follow-up|1|||
126335604|NCT01775670|454524748|FG001|Overall Study|Lost to Follow-up|1|||
126335605|NCT04006145|454524749|FG000|Overall Study|Lost to Follow-up|0|||
126335606|NCT04006145|454524750|FG001|Overall Study|Lost to Follow-up|1|||
126335607|NCT04006145|454524749|FG000|Overall Study|Other|1|||
126335608|NCT04006145|454524750|FG001|Overall Study|Other|2|||
126335609|NCT00010257|454524753|FG000|Overall Study|Withdrawal by Subject|1|||
126335610|NCT00010257|454524754|FG001|Overall Study|Withdrawal by Subject|0|||
126335611|NCT01249417|454524760|FG000|Randomised Population|Study treatment not received|0|||
126335612|NCT01249417|454524761|FG001|Randomised Population|Study treatment not received|0|||
126335613|NCT01249417|454524762|FG002|Randomised Population|Study treatment not received|2|||
126667567|NCT00931944|455744760|FG000|Overall Study|Adverse Event|4|||
126667568|NCT00931944|455744760|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
126667569|NCT00931944|455744760|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
126667570|NCT00931944|455744760|FG000|Overall Study|Death|28|||
126667571|NCT00931944|455744760|FG000|Overall Study|Other|2|||
126667572|NCT01109173|455744761|FG000|Overall Study|Adverse Event|15|||
126667573|NCT01109173|455744762|FG001|Overall Study|Adverse Event|17|||
126667574|NCT01109173|455744763|FG002|Overall Study|Adverse Event|9|||
126667575|NCT01109173|455744764|FG003|Overall Study|Adverse Event|6|||
126667576|NCT01109173|455744761|FG000|Overall Study|Lost to Follow-up|0|||
126667577|NCT01109173|455744762|FG001|Overall Study|Lost to Follow-up|1|||
126667578|NCT01109173|455744763|FG002|Overall Study|Lost to Follow-up|0|||
126667579|NCT01109173|455744764|FG003|Overall Study|Lost to Follow-up|0|||
126667580|NCT01109173|455744761|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
126667581|NCT01109173|455744762|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
126667582|NCT01109173|455744763|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
126667583|NCT01109173|455744764|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
126335614|NCT01249417|454524760|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
126335615|NCT01249417|454524761|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
126335616|NCT01249417|454524762|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
126335617|NCT01249417|454524760|FG000|Treatment Phase - ITT Population|Other|0|||
126335618|NCT01249417|454524761|FG001|Treatment Phase - ITT Population|Other|0|||
126335619|NCT01249417|454524762|FG002|Treatment Phase - ITT Population|Other|1|||
126335620|NCT01249417|454524760|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
126335621|NCT01249417|454524761|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
126335622|NCT01249417|454524762|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
126335623|NCT01249417|454524760|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
126335624|NCT01249417|454524761|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
126335625|NCT01249417|454524762|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
126335626|NCT01249417|454524760|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
126335627|NCT01249417|454524761|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
126335628|NCT01249417|454524762|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
126335629|NCT00126594|454524764|FG000|Overall Study|Ineligible|2|||
126335630|NCT00126594|454524765|FG001|Overall Study|Ineligible|0|||
126335631|NCT00126594|454524764|FG000|Overall Study|Withdrawal by Subject|0|||
126335632|NCT00126594|454524765|FG001|Overall Study|Withdrawal by Subject|4|||
126335633|NCT00126594|454524764|FG000|Overall Study|Physician Decision|1|||
126335634|NCT00126594|454524765|FG001|Overall Study|Physician Decision|3|||
126335635|NCT00126594|454524764|FG000|Overall Study|Adverse Event|7|||
126335636|NCT00126594|454524765|FG001|Overall Study|Adverse Event|5|||
126335637|NCT00126594|454524764|FG000|Overall Study|Non-compliance|0|||
126335638|NCT00126594|454524765|FG001|Overall Study|Non-compliance|1|||
126335639|NCT00126594|454524764|FG000|Overall Study|Disease Progression|29|||
126335640|NCT00126594|454524765|FG001|Overall Study|Disease Progression|24|||
126667584|NCT01109173|455744761|FG000|Overall Study|Noncompliance|0|||
126667585|NCT01109173|455744762|FG001|Overall Study|Noncompliance|1|||
126335641|NCT03769649|454524766|FG000|Overall Study|Lost to Follow-up|4|||
126335642|NCT01290718|454524769|FG000|Overall Study|Early termination of the study|4|||
126335643|NCT00243919|454524770|FG000|Overall Study|Death|3|||
126335644|NCT00243919|454524771|FG001|Overall Study|Death|4|||
126335645|NCT00243919|454524772|FG002|Overall Study|Death|6|||
126335646|NCT00243919|454524770|FG000|Overall Study|Withdrawal by Subject|6|||
126335647|NCT00243919|454524771|FG001|Overall Study|Withdrawal by Subject|6|||
126335648|NCT00243919|454524772|FG002|Overall Study|Withdrawal by Subject|2|||
126335649|NCT00243919|454524770|FG000|Overall Study|Lost to Follow-up|6|||
126667586|NCT01109173|455744763|FG002|Overall Study|Noncompliance|0|||
126335650|NCT00243919|454524771|FG001|Overall Study|Lost to Follow-up|7|||
126335651|NCT00243919|454524772|FG002|Overall Study|Lost to Follow-up|3|||
126335652|NCT00243919|454524770|FG000|Overall Study|Administrative Error|1|||
126335653|NCT00243919|454524771|FG001|Overall Study|Administrative Error|0|||
126335654|NCT00243919|454524772|FG002|Overall Study|Administrative Error|0|||
126335655|NCT00243919|454524770|FG000|Overall Study|Physician Decision|1|||
126335656|NCT00243919|454524771|FG001|Overall Study|Physician Decision|1|||
126335657|NCT00243919|454524772|FG002|Overall Study|Physician Decision|0|||
126335658|NCT02059239|454524775|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
126335659|NCT02059239|454524776|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
126335660|NCT02059239|454524775|FG000|Overall Study|Physician Decision|1|||
126335661|NCT02059239|454524776|FG001|Overall Study|Physician Decision|0|||
126335662|NCT01268267|454524777|FG000|Overall Study|Protocol Violation|1|||
126335663|NCT04919317|454524782|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
126335664|NCT04919317|454524783|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
126335665|NCT04919317|454524782|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
126335666|NCT04919317|454524783|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
126335667|NCT00230048|454524784|FG000|Overall Study|Lost to Follow-up|13|||
126335668|NCT00230048|454524785|FG001|Overall Study|Lost to Follow-up|18|||
126335669|NCT00731822|454524794|FG000|Overall Study|Adverse Event|2|||
126335670|NCT00731822|454524795|FG001|Overall Study|Adverse Event|1|||
126335671|NCT00731822|454524794|FG000|Overall Study|Protocol Violation|1|||
126335672|NCT00731822|454524795|FG001|Overall Study|Protocol Violation|0|||
126335673|NCT00731822|454524794|FG000|Overall Study|Lost to Follow-up|1|||
126335674|NCT00731822|454524795|FG001|Overall Study|Lost to Follow-up|0|||
126335675|NCT02127658|454524797|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
126335676|NCT02127658|454524798|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
126335677|NCT02127658|454524797|FG000|Overall Study|Withdrawal by Subject|0|||
126335678|NCT02127658|454524798|FG001|Overall Study|Withdrawal by Subject|2|||
126335679|NCT02127658|454524797|FG000|Overall Study|Physician Decision|0|||
126335680|NCT02127658|454524798|FG001|Overall Study|Physician Decision|1|||
126335681|NCT01443858|454524799|FG000|Overall Study|Withdrawal by Subject|9|||
126335682|NCT01443858|454524800|FG001|Overall Study|Withdrawal by Subject|8|||
126335683|NCT01443858|454524801|FG002|Overall Study|Withdrawal by Subject|5|||
126335684|NCT01443858|454524799|FG000|Overall Study|Lack of Efficacy|1|||
126335685|NCT01443858|454524800|FG001|Overall Study|Lack of Efficacy|0|||
126335686|NCT01443858|454524801|FG002|Overall Study|Lack of Efficacy|0|||
126335687|NCT01443858|454524799|FG000|Overall Study|Lost to Follow-up|5|||
126335688|NCT01443858|454524800|FG001|Overall Study|Lost to Follow-up|5|||
126335689|NCT01443858|454524801|FG002|Overall Study|Lost to Follow-up|2|||
126335690|NCT03589807|454524802|FG000|Overall Study|Lost to Follow-up|0|||
126335691|NCT03589807|454524803|FG001|Overall Study|Lost to Follow-up|2|||
126667587|NCT01109173|455744764|FG003|Overall Study|Noncompliance|0|||
126667588|NCT01109173|455744761|FG000|Overall Study|Treatment Failure|25|||
126667589|NCT01109173|455744762|FG001|Overall Study|Treatment Failure|32|||
126667590|NCT01109173|455744763|FG002|Overall Study|Treatment Failure|69|||
126667591|NCT01109173|455744764|FG003|Overall Study|Treatment Failure|64|||
126667592|NCT01109173|455744761|FG000|Overall Study|Protocol Violation|4|||
126667593|NCT01109173|455744762|FG001|Overall Study|Protocol Violation|5|||
126667594|NCT01109173|455744763|FG002|Overall Study|Protocol Violation|1|||
126667595|NCT01109173|455744764|FG003|Overall Study|Protocol Violation|2|||
126667596|NCT01109173|455744761|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
126667597|NCT01109173|455744762|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
126667598|NCT01109173|455744763|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
126667599|NCT01109173|455744764|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
126667600|NCT01109173|455744761|FG000|Overall Study|Not Specifiied|5|||
126667601|NCT01109173|455744762|FG001|Overall Study|Not Specifiied|4|||
126667602|NCT01109173|455744763|FG002|Overall Study|Not Specifiied|9|||
126667603|NCT01109173|455744764|FG003|Overall Study|Not Specifiied|14|||
126667604|NCT01132612|455744765|FG000|Overall Study|Death|0|||
126667605|NCT01132612|455744766|FG001|Overall Study|Death|0|||
126667606|NCT01132612|455744767|FG002|Overall Study|Death|1|||
126667607|NCT01132612|455744765|FG000|Overall Study|Protocol deviation|0|||
126667608|NCT01132612|455744766|FG001|Overall Study|Protocol deviation|0|||
126335692|NCT03589807|454524804|FG002|Overall Study|Lost to Follow-up|2|||
126335693|NCT03589807|454524805|FG003|Overall Study|Lost to Follow-up|3|||
126335694|NCT03589807|454524806|FG004|Overall Study|Lost to Follow-up|1|||
126335695|NCT03589807|454524807|FG005|Overall Study|Lost to Follow-up|1|||
126335696|NCT03589807|454524802|FG000|Overall Study|Withdrawal by Subject|0|||
126335697|NCT03589807|454524803|FG001|Overall Study|Withdrawal by Subject|5|||
126335698|NCT03589807|454524804|FG002|Overall Study|Withdrawal by Subject|0|||
126335699|NCT03589807|454524805|FG003|Overall Study|Withdrawal by Subject|0|||
126335700|NCT03589807|454524806|FG004|Overall Study|Withdrawal by Subject|0|||
126667609|NCT01132612|455744767|FG002|Overall Study|Protocol deviation|3|||
126667610|NCT01132612|455744765|FG000|Overall Study|Lost to Follow-up|2|||
126667611|NCT01132612|455744766|FG001|Overall Study|Lost to Follow-up|2|||
126667612|NCT01132612|455744767|FG002|Overall Study|Lost to Follow-up|7|||
126667613|NCT01132612|455744765|FG000|Overall Study|Adverse Event|5|||
126667614|NCT01132612|455744766|FG001|Overall Study|Adverse Event|2|||
126667615|NCT01132612|455744767|FG002|Overall Study|Adverse Event|15|||
126335701|NCT03589807|454524807|FG005|Overall Study|Withdrawal by Subject|0|||
126335702|NCT03589807|454524802|FG000|Overall Study|Protocol Violation|0|||
126335703|NCT03589807|454524803|FG001|Overall Study|Protocol Violation|0|||
126335704|NCT03589807|454524804|FG002|Overall Study|Protocol Violation|0|||
126335705|NCT03589807|454524805|FG003|Overall Study|Protocol Violation|1|||
126335706|NCT03589807|454524806|FG004|Overall Study|Protocol Violation|0|||
126335707|NCT03589807|454524807|FG005|Overall Study|Protocol Violation|0|||
126335708|NCT03589807|454524802|FG000|Overall Study|Enrolled but treatment not administered|0|||
126335709|NCT03589807|454524803|FG001|Overall Study|Enrolled but treatment not administered|0|||
126335710|NCT03589807|454524804|FG002|Overall Study|Enrolled but treatment not administered|0|||
126335711|NCT03589807|454524805|FG003|Overall Study|Enrolled but treatment not administered|0|||
126335712|NCT03589807|454524806|FG004|Overall Study|Enrolled but treatment not administered|1|||
126335713|NCT03589807|454524807|FG005|Overall Study|Enrolled but treatment not administered|0|||
126335714|NCT01435759|454524809|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
126335715|NCT01435759|454524810|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
126335716|NCT01435759|454524811|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
126335717|NCT01435759|454524812|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
126335718|NCT01435759|454524813|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
126335719|NCT01435759|454524814|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
126335720|NCT01435759|454524809|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
126335721|NCT01435759|454524810|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
126667616|NCT01132612|455744765|FG000|Overall Study|Withdrawal by Subject|5|||
126667617|NCT01132612|455744766|FG001|Overall Study|Withdrawal by Subject|8|||
126667618|NCT01132612|455744767|FG002|Overall Study|Withdrawal by Subject|19|||
126667619|NCT01132612|455744765|FG000|Overall Study|Administrative problems|5|||
126667620|NCT01132612|455744766|FG001|Overall Study|Administrative problems|1|||
126667621|NCT01132612|455744767|FG002|Overall Study|Administrative problems|52|||
126667622|NCT01132612|455744765|FG000|Overall Study|Lack of Efficacy|23|||
126667623|NCT01132612|455744766|FG001|Overall Study|Lack of Efficacy|22|||
126667624|NCT01132612|455744767|FG002|Overall Study|Lack of Efficacy|73|||
126667625|NCT01186796|455744774|FG000|Overall Study|Adverse Event|3|||
126667626|NCT01186796|455744775|FG001|Overall Study|Adverse Event|0|||
126667627|NCT01186796|455744774|FG000|Overall Study|Withdrawal by Subject|1|||
126667628|NCT01186796|455744775|FG001|Overall Study|Withdrawal by Subject|1|||
126667629|NCT01186796|455744774|FG000|Overall Study|Protocol Violation|0|||
126667630|NCT01186796|455744775|FG001|Overall Study|Protocol Violation|1|||
126667631|NCT02459769|455744776|FG000|Overall Study|Withdrawal by Subject|7|||
126667632|NCT02459769|455744777|FG001|Overall Study|Withdrawal by Subject|4|||
126667633|NCT02459769|455744778|FG002|Overall Study|Withdrawal by Subject|8|||
126667634|NCT02459769|455744779|FG003|Overall Study|Withdrawal by Subject|5|||
126667635|NCT02459769|455744776|FG000|Overall Study|Lost to Follow-up|1|||
126667636|NCT02459769|455744777|FG001|Overall Study|Lost to Follow-up|0|||
126667637|NCT02459769|455744778|FG002|Overall Study|Lost to Follow-up|1|||
126667638|NCT02459769|455744779|FG003|Overall Study|Lost to Follow-up|0|||
126667639|NCT01287364|455744780|FG000|Overall Study|Adverse Event|0|||
126667640|NCT01287364|455744781|FG001|Overall Study|Adverse Event|3|||
126667641|NCT01287364|455744780|FG000|Overall Study|Protocol Violation|5|||
126667642|NCT01287364|455744781|FG001|Overall Study|Protocol Violation|5|||
126667643|NCT01287364|455744780|FG000|Overall Study|Other Reason|4|||
126667644|NCT01287364|455744781|FG001|Overall Study|Other Reason|2|||
126667645|NCT00962390|455744786|FG000|Overall Study|Adverse Event|0|||
126667646|NCT00962390|455744787|FG001|Overall Study|Adverse Event|0|||
126667647|NCT00962390|455744788|FG002|Overall Study|Adverse Event|3|||
126667648|NCT00962390|455744789|FG003|Overall Study|Adverse Event|1|||
126667649|NCT00962390|455744786|FG000|Overall Study|Lost to Follow-up|2|||
126667650|NCT00962390|455744787|FG001|Overall Study|Lost to Follow-up|2|||
126667651|NCT00962390|455744788|FG002|Overall Study|Lost to Follow-up|0|||
126667652|NCT00962390|455744789|FG003|Overall Study|Lost to Follow-up|0|||
126667653|NCT00962390|455744786|FG000|Overall Study|Protocol Violation|1|||
126667654|NCT00962390|455744787|FG001|Overall Study|Protocol Violation|0|||
126667655|NCT00962390|455744788|FG002|Overall Study|Protocol Violation|0|||
126667656|NCT00962390|455744789|FG003|Overall Study|Protocol Violation|0|||
126667657|NCT00962390|455744786|FG000|Overall Study|Withdrawal by Subject|1|||
126335722|NCT01435759|454524811|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
126335723|NCT01435759|454524812|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
126335724|NCT01435759|454524813|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
126335725|NCT01435759|454524814|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
126667658|NCT00962390|455744787|FG001|Overall Study|Withdrawal by Subject|1|||
126667659|NCT00962390|455744788|FG002|Overall Study|Withdrawal by Subject|1|||
126667660|NCT00962390|455744789|FG003|Overall Study|Withdrawal by Subject|0|||
126667661|NCT03740997|455744797|FG000|Overall Study|Withdrawal by Subject|1|||
126667662|NCT03740997|455744798|FG001|Overall Study|Withdrawal by Subject|0|||
126667663|NCT03740997|455744797|FG000|Overall Study|Participant was unable to complete study procedures|1|||
126667664|NCT03740997|455744798|FG001|Overall Study|Participant was unable to complete study procedures|0|||
126667665|NCT01026142|455744799|FG000|Overall Study|Death|136|||
126667666|NCT01026142|455744800|FG001|Overall Study|Death|134|||
126667667|NCT01026142|455744799|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
126667668|NCT01026142|455744800|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
126667669|NCT01829425|455744801|FG000|Overall Study|Withdrawal by Subject|4|||
126667670|NCT01829425|455744802|FG001|Overall Study|Withdrawal by Subject|3|||
126667671|NCT01829425|455744801|FG000|Overall Study|Lost to Follow-up|2|||
126667672|NCT01829425|455744802|FG001|Overall Study|Lost to Follow-up|1|||
126667673|NCT04178967|455744803|FG000|Induction Period|Adverse Event|4|||
126667674|NCT04178967|455744804|FG001|Induction Period|Adverse Event|6|||
126667675|NCT04178967|455744805|FG002|Induction Period|Adverse Event|0|||
126667676|NCT04178967|455744806|FG003|Induction Period|Adverse Event|0|||
126667677|NCT04178967|455744807|FG004|Induction Period|Adverse Event|0|||
126667678|NCT04178967|455744808|FG005|Induction Period|Adverse Event|0|||
126667679|NCT04178967|455744809|FG006|Induction Period|Adverse Event|0|||
126667680|NCT04178967|455744810|FG007|Induction Period|Adverse Event|0|||
126667681|NCT04178967|455744811|FG008|Induction Period|Adverse Event|0|||
126667682|NCT04178967|455744812|FG009|Induction Period|Adverse Event|0|||
126335726|NCT01435759|454524809|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
126335727|NCT01435759|454524810|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
126335728|NCT01435759|454524811|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
126335729|NCT01435759|454524812|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
126335730|NCT01435759|454524813|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
126335731|NCT01435759|454524814|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
126335732|NCT01435759|454524809|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
126335733|NCT01435759|454524810|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
126335734|NCT01435759|454524811|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
126335735|NCT01435759|454524812|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
126335736|NCT01435759|454524813|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
126335737|NCT01435759|454524814|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
126335738|NCT01435759|454524809|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
126335739|NCT01435759|454524810|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335740|NCT01435759|454524811|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335741|NCT01435759|454524812|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335742|NCT01435759|454524813|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335743|NCT01435759|454524814|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335744|NCT01435759|454524809|FG000|Antidepressant Lead-in Phase|Other|119|||
126335745|NCT01435759|454524810|FG001|Antidepressant Lead-in Phase|Other|0|||
126335746|NCT01435759|454524811|FG002|Antidepressant Lead-in Phase|Other|0|||
126335747|NCT01435759|454524812|FG003|Antidepressant Lead-in Phase|Other|0|||
126335748|NCT01435759|454524813|FG004|Antidepressant Lead-in Phase|Other|0|||
126335749|NCT01435759|454524814|FG005|Antidepressant Lead-in Phase|Other|0|||
126335750|NCT01435759|454524809|FG000|Double-blind Phase|Adverse Event|7|||
126335751|NCT01435759|454524810|FG001|Double-blind Phase|Adverse Event|0|||
126335752|NCT01435759|454524811|FG002|Double-blind Phase|Adverse Event|1|||
126335753|NCT01435759|454524812|FG003|Double-blind Phase|Adverse Event|1|||
126335754|NCT01435759|454524813|FG004|Double-blind Phase|Adverse Event|1|||
126335755|NCT01435759|454524814|FG005|Double-blind Phase|Adverse Event|3|||
126335756|NCT01435759|454524809|FG000|Double-blind Phase|Protocol Violation|2|||
126335757|NCT01435759|454524810|FG001|Double-blind Phase|Protocol Violation|0|||
126335758|NCT01435759|454524811|FG002|Double-blind Phase|Protocol Violation|1|||
126335759|NCT01435759|454524812|FG003|Double-blind Phase|Protocol Violation|2|||
126335760|NCT01435759|454524813|FG004|Double-blind Phase|Protocol Violation|0|||
126335761|NCT01435759|454524814|FG005|Double-blind Phase|Protocol Violation|1|||
126335762|NCT01435759|454524809|FG000|Double-blind Phase|Withdrawal by Subject|17|||
126335763|NCT01435759|454524810|FG001|Double-blind Phase|Withdrawal by Subject|4|||
126335764|NCT01435759|454524811|FG002|Double-blind Phase|Withdrawal by Subject|3|||
126335765|NCT01435759|454524812|FG003|Double-blind Phase|Withdrawal by Subject|4|||
126335766|NCT01435759|454524813|FG004|Double-blind Phase|Withdrawal by Subject|2|||
126335767|NCT01435759|454524814|FG005|Double-blind Phase|Withdrawal by Subject|2|||
126335768|NCT01435759|454524809|FG000|Double-blind Phase|Lost to Follow-up|31|||
126335769|NCT01435759|454524810|FG001|Double-blind Phase|Lost to Follow-up|1|||
126335770|NCT01435759|454524811|FG002|Double-blind Phase|Lost to Follow-up|2|||
126335771|NCT01435759|454524812|FG003|Double-blind Phase|Lost to Follow-up|0|||
126335772|NCT01435759|454524813|FG004|Double-blind Phase|Lost to Follow-up|3|||
126335773|NCT01435759|454524814|FG005|Double-blind Phase|Lost to Follow-up|3|||
126335774|NCT01435759|454524809|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
126335775|NCT01435759|454524810|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
126667683|NCT04178967|455744813|FG010|Induction Period|Adverse Event|0|||
126335776|NCT01435759|454524811|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
126667684|NCT04178967|455744803|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
126667685|NCT04178967|455744804|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
126335777|NCT01435759|454524812|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335778|NCT01435759|454524813|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
126335779|NCT01435759|454524814|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
126335780|NCT01435759|454524809|FG000|Double-blind Phase|Other|8|||
126335781|NCT01435759|454524810|FG001|Double-blind Phase|Other|2|||
126335782|NCT01435759|454524811|FG002|Double-blind Phase|Other|0|||
126335783|NCT01435759|454524812|FG003|Double-blind Phase|Other|2|||
126335784|NCT01435759|454524813|FG004|Double-blind Phase|Other|0|||
126335785|NCT01435759|454524814|FG005|Double-blind Phase|Other|0|||
126335786|NCT02849587|454524817|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
126335787|NCT02849587|454524818|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
126335788|NCT02849587|454524819|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
126335789|NCT02849587|454524817|FG000|Overall Study|Withdrawal by Subject|0|||
126335790|NCT02849587|454524818|FG001|Overall Study|Withdrawal by Subject|1|||
126335791|NCT02849587|454524819|FG002|Overall Study|Withdrawal by Subject|0|||
126335792|NCT00549549|454524833|FG000|Overall Study|Adverse Event|5|||
126335793|NCT00549549|454524834|FG001|Overall Study|Adverse Event|3|||
126335794|NCT00549549|454524835|FG002|Overall Study|Adverse Event|1|||
126335795|NCT00549549|454524836|FG003|Overall Study|Adverse Event|9|||
126335796|NCT00549549|454524833|FG000|Overall Study|Lack of Efficacy|9|||
126335797|NCT00549549|454524834|FG001|Overall Study|Lack of Efficacy|6|||
126335798|NCT00549549|454524835|FG002|Overall Study|Lack of Efficacy|4|||
126335799|NCT00549549|454524836|FG003|Overall Study|Lack of Efficacy|2|||
126335800|NCT00549549|454524833|FG000|Overall Study|Lost to Follow-up|1|||
126335801|NCT00549549|454524834|FG001|Overall Study|Lost to Follow-up|0|||
126335802|NCT00549549|454524835|FG002|Overall Study|Lost to Follow-up|1|||
126667686|NCT04178967|455744805|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
126667687|NCT04178967|455744806|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
126667688|NCT04178967|455744807|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
126667689|NCT04178967|455744808|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
126667690|NCT04178967|455744809|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
126667691|NCT04178967|455744810|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
126667692|NCT04178967|455744811|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
126667693|NCT04178967|455744812|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
126667694|NCT04178967|455744813|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
126667695|NCT04178967|455744803|FG000|Induction Period|Lack of Efficacy|4|||
126667696|NCT04178967|455744804|FG001|Induction Period|Lack of Efficacy|1|||
126667697|NCT04178967|455744805|FG002|Induction Period|Lack of Efficacy|0|||
126667698|NCT04178967|455744806|FG003|Induction Period|Lack of Efficacy|0|||
126667699|NCT04178967|455744807|FG004|Induction Period|Lack of Efficacy|0|||
126667700|NCT04178967|455744808|FG005|Induction Period|Lack of Efficacy|0|||
126667701|NCT04178967|455744809|FG006|Induction Period|Lack of Efficacy|0|||
126667702|NCT04178967|455744810|FG007|Induction Period|Lack of Efficacy|0|||
126667703|NCT04178967|455744811|FG008|Induction Period|Lack of Efficacy|0|||
126667704|NCT04178967|455744812|FG009|Induction Period|Lack of Efficacy|0|||
126667705|NCT04178967|455744813|FG010|Induction Period|Lack of Efficacy|0|||
126667706|NCT04178967|455744803|FG000|Induction Period|Protocol Violation|0|||
126667707|NCT04178967|455744804|FG001|Induction Period|Protocol Violation|6|||
126667708|NCT04178967|455744805|FG002|Induction Period|Protocol Violation|0|||
126667709|NCT04178967|455744806|FG003|Induction Period|Protocol Violation|0|||
126667710|NCT04178967|455744807|FG004|Induction Period|Protocol Violation|0|||
126667711|NCT04178967|455744808|FG005|Induction Period|Protocol Violation|0|||
126667712|NCT04178967|455744809|FG006|Induction Period|Protocol Violation|0|||
126667713|NCT04178967|455744810|FG007|Induction Period|Protocol Violation|0|||
126667714|NCT04178967|455744811|FG008|Induction Period|Protocol Violation|0|||
126667715|NCT04178967|455744812|FG009|Induction Period|Protocol Violation|0|||
126667716|NCT04178967|455744813|FG010|Induction Period|Protocol Violation|0|||
126667717|NCT04178967|455744803|FG000|Induction Period|Withdrawal by Subject|6|||
126667718|NCT04178967|455744804|FG001|Induction Period|Withdrawal by Subject|4|||
126667719|NCT04178967|455744805|FG002|Induction Period|Withdrawal by Subject|0|||
126667720|NCT04178967|455744806|FG003|Induction Period|Withdrawal by Subject|0|||
126667721|NCT04178967|455744807|FG004|Induction Period|Withdrawal by Subject|0|||
126667722|NCT04178967|455744808|FG005|Induction Period|Withdrawal by Subject|0|||
126667723|NCT04178967|455744809|FG006|Induction Period|Withdrawal by Subject|0|||
126667724|NCT04178967|455744810|FG007|Induction Period|Withdrawal by Subject|0|||
126335803|NCT00549549|454524836|FG003|Overall Study|Lost to Follow-up|2|||
126667725|NCT04178967|455744811|FG008|Induction Period|Withdrawal by Subject|0|||
126667726|NCT04178967|455744812|FG009|Induction Period|Withdrawal by Subject|0|||
126667727|NCT04178967|455744813|FG010|Induction Period|Withdrawal by Subject|0|||
126667728|NCT04178967|455744803|FG000|Induction Period|Lost to Follow-up|2|||
126667729|NCT04178967|455744804|FG001|Induction Period|Lost to Follow-up|0|||
126667730|NCT04178967|455744805|FG002|Induction Period|Lost to Follow-up|0|||
126667731|NCT04178967|455744806|FG003|Induction Period|Lost to Follow-up|0|||
126335804|NCT00549549|454524833|FG000|Overall Study|Withdrawal by Subject|0|||
126335805|NCT00549549|454524834|FG001|Overall Study|Withdrawal by Subject|4|||
126335806|NCT00549549|454524835|FG002|Overall Study|Withdrawal by Subject|1|||
126335807|NCT00549549|454524836|FG003|Overall Study|Withdrawal by Subject|0|||
126335808|NCT00549549|454524833|FG000|Overall Study|Other|9|||
126335809|NCT00549549|454524834|FG001|Overall Study|Other|9|||
126335810|NCT00549549|454524835|FG002|Overall Study|Other|9|||
126335811|NCT00549549|454524836|FG003|Overall Study|Other|11|||
126335812|NCT00549549|454524833|FG000|Overall Study|Randomized but not treated|0|||
126335813|NCT00549549|454524834|FG001|Overall Study|Randomized but not treated|0|||
126335814|NCT00549549|454524835|FG002|Overall Study|Randomized but not treated|1|||
126335815|NCT00549549|454524836|FG003|Overall Study|Randomized but not treated|1|||
126335816|NCT00102596|454524840|FG000|Part A|Screen failures|6|||
126335817|NCT00102596|454524841|FG001|Part A|Screen failures|0|||
126335818|NCT00102596|454524840|FG000|Part A|Adverse Event|1|||
126335819|NCT00102596|454524841|FG001|Part A|Adverse Event|0|||
126335820|NCT02688933|454524846|FG000|Overall Study|Adverse Event|3|||
126335821|NCT02688933|454524847|FG001|Overall Study|Adverse Event|1|||
126335822|NCT02688933|454524846|FG000|Overall Study|Lack of Efficacy|2|||
126335823|NCT02688933|454524847|FG001|Overall Study|Lack of Efficacy|2|||
126335824|NCT02688933|454524846|FG000|Overall Study|Poor compliance to protocol|7|||
126335825|NCT02688933|454524847|FG001|Overall Study|Poor compliance to protocol|4|||
126335826|NCT02688933|454524846|FG000|Overall Study|Hypoglycemia|2|||
126335827|NCT02688933|454524847|FG001|Overall Study|Hypoglycemia|0|||
126335828|NCT02688933|454524846|FG000|Overall Study|Other than Specified|14|||
126335829|NCT02688933|454524847|FG001|Overall Study|Other than Specified|25|||
126335830|NCT02688933|454524846|FG000|Overall Study|Lost to Follow-up|1|||
126335831|NCT02688933|454524847|FG001|Overall Study|Lost to Follow-up|5|||
126335832|NCT00248651|454524848|FG000|Overall Study|Withdrawal by Subject|28|||
126335833|NCT00248651|454524849|FG001|Overall Study|Withdrawal by Subject|40|||
126335834|NCT00248651|454524850|FG002|Overall Study|Withdrawal by Subject|32|||
126335835|NCT01275144|454524851|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
126335836|NCT01275144|454524852|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
126335837|NCT00828113|454524853|FG000|Overall Study|Withdrawal by Subject|27|||
126335838|NCT00828113|454524854|FG001|Overall Study|Withdrawal by Subject|26|||
126335839|NCT00828113|454524853|FG000|Overall Study|Lost to Follow-up|3|||
126335840|NCT00828113|454524854|FG001|Overall Study|Lost to Follow-up|5|||
126335841|NCT01365130|454524855|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
126335842|NCT05547386|454524858|FG000|Overall Study|Withdrawal by Subject|7|||
126335843|NCT04622969|454524859|FG000|Overall Study|Withdrawal by Subject|2|||
126335844|NCT04622969|454524860|FG001|Overall Study|Withdrawal by Subject|3|||
126335845|NCT05607576|454524861|FG000|Overall Study|immediate sensor error|2|||
126335846|NCT05607576|454524861|FG000|Overall Study|Physician Decision|2|||
126335847|NCT04467515|454524862|FG000|Overall Study|Lost to Follow-up|1|||
126335848|NCT04467515|454524863|FG001|Overall Study|Lost to Follow-up|0|||
126335849|NCT04467515|454524864|FG002|Overall Study|Lost to Follow-up|0|||
126335850|NCT04467515|454524862|FG000|Overall Study|Withdrawal by Subject|1|||
126335851|NCT04467515|454524863|FG001|Overall Study|Withdrawal by Subject|0|||
126335852|NCT04467515|454524864|FG002|Overall Study|Withdrawal by Subject|1|||
126335853|NCT04467515|454524862|FG000|Overall Study|Progressive Disease|0|||
126335854|NCT04467515|454524863|FG001|Overall Study|Progressive Disease|1|||
126335855|NCT04467515|454524864|FG002|Overall Study|Progressive Disease|3|||
126335856|NCT04467515|454524862|FG000|Overall Study|Death|0|||
126335857|NCT04467515|454524863|FG001|Overall Study|Death|1|||
126335858|NCT04467515|454524864|FG002|Overall Study|Death|0|||
126335859|NCT03834506|454524867|FG000|Overall Study|Death|336|||
126335860|NCT03834506|454524868|FG001|Overall Study|Death|326|||
126335861|NCT03834506|454524867|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126335862|NCT03834506|454524868|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126335863|NCT03834506|454524867|FG000|Overall Study|Withdrawal by Subject|10|||
126335864|NCT03834506|454524868|FG001|Overall Study|Withdrawal by Subject|8|||
126335865|NCT03834506|454524867|FG000|Overall Study|Sponsor decision|165|||
126335866|NCT03834506|454524868|FG001|Overall Study|Sponsor decision|178|||
126335867|NCT03834506|454524867|FG000|Overall Study|Physician Decision|3|||
126335868|NCT03834506|454524868|FG001|Overall Study|Physician Decision|1|||
126335869|NCT03834506|454524867|FG000|Overall Study|Lost to Follow-up|0|||
126335870|NCT03834506|454524868|FG001|Overall Study|Lost to Follow-up|1|||
126335871|NCT05067972|454524869|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
126335872|NCT05067972|454524870|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
126335873|NCT05067972|454524871|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
126335874|NCT05067972|454524872|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
126335875|NCT05067972|454524873|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
126335876|NCT05067972|454524874|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
126335877|NCT05067972|454524875|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
126335878|NCT05067972|454524869|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
126335879|NCT05067972|454524870|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
126335880|NCT05067972|454524871|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
126335881|NCT05067972|454524872|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
126335882|NCT05067972|454524873|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
126335883|NCT05067972|454524874|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
126335884|NCT05067972|454524875|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
126335885|NCT05067972|454524869|FG000|Part 1: Treatment|Progressive Disease|3|||
126335886|NCT05067972|454524870|FG001|Part 1: Treatment|Progressive Disease|3|||
126335887|NCT05067972|454524871|FG002|Part 1: Treatment|Progressive Disease|4|||
126335888|NCT05067972|454524872|FG003|Part 1: Treatment|Progressive Disease|2|||
126335889|NCT05067972|454524873|FG004|Part 1: Treatment|Progressive Disease|3|||
126335890|NCT05067972|454524874|FG005|Part 1: Treatment|Progressive Disease|0|||
126335891|NCT05067972|454524875|FG006|Part 1: Treatment|Progressive Disease|2|||
126335892|NCT05067972|454524869|FG000|Part 1: Treatment|Physician Decision|0|||
126335893|NCT05067972|454524870|FG001|Part 1: Treatment|Physician Decision|0|||
126335894|NCT05067972|454524871|FG002|Part 1: Treatment|Physician Decision|0|||
126335895|NCT05067972|454524872|FG003|Part 1: Treatment|Physician Decision|1|||
126335896|NCT05067972|454524873|FG004|Part 1: Treatment|Physician Decision|0|||
126335897|NCT05067972|454524874|FG005|Part 1: Treatment|Physician Decision|0|||
126667732|NCT04178967|455744807|FG004|Induction Period|Lost to Follow-up|0|||
126667733|NCT04178967|455744808|FG005|Induction Period|Lost to Follow-up|0|||
126335898|NCT05067972|454524875|FG006|Part 1: Treatment|Physician Decision|0|||
126335899|NCT05067972|454524869|FG000|Part 1: Treatment|Death|0|||
126335900|NCT05067972|454524870|FG001|Part 1: Treatment|Death|0|||
126335901|NCT05067972|454524871|FG002|Part 1: Treatment|Death|0|||
126335902|NCT05067972|454524872|FG003|Part 1: Treatment|Death|2|||
126335903|NCT05067972|454524873|FG004|Part 1: Treatment|Death|0|||
126335904|NCT05067972|454524874|FG005|Part 1: Treatment|Death|0|||
126335905|NCT05067972|454524875|FG006|Part 1: Treatment|Death|0|||
126335906|NCT05067972|454524869|FG000|Part 1: Treatment|Adverse Event|0|||
126335907|NCT05067972|454524870|FG001|Part 1: Treatment|Adverse Event|0|||
126335908|NCT05067972|454524871|FG002|Part 1: Treatment|Adverse Event|0|||
126335909|NCT05067972|454524872|FG003|Part 1: Treatment|Adverse Event|0|||
126335910|NCT05067972|454524873|FG004|Part 1: Treatment|Adverse Event|0|||
126335911|NCT05067972|454524874|FG005|Part 1: Treatment|Adverse Event|2|||
126335912|NCT05067972|454524875|FG006|Part 1: Treatment|Adverse Event|1|||
126335913|NCT05067972|454524869|FG000|Part 1: Follow-up|Adverse Event|0|||
126335914|NCT05067972|454524870|FG001|Part 1: Follow-up|Adverse Event|0|||
126335915|NCT05067972|454524871|FG002|Part 1: Follow-up|Adverse Event|0|||
126335916|NCT05067972|454524872|FG003|Part 1: Follow-up|Adverse Event|0|||
126335917|NCT05067972|454524873|FG004|Part 1: Follow-up|Adverse Event|0|||
126335918|NCT05067972|454524874|FG005|Part 1: Follow-up|Adverse Event|1|||
126335919|NCT05067972|454524875|FG006|Part 1: Follow-up|Adverse Event|0|||
126335920|NCT05067972|454524869|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
126335921|NCT05067972|454524870|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
126667734|NCT04178967|455744809|FG006|Induction Period|Lost to Follow-up|0|||
126667735|NCT04178967|455744810|FG007|Induction Period|Lost to Follow-up|0|||
126667736|NCT04178967|455744811|FG008|Induction Period|Lost to Follow-up|0|||
126667737|NCT04178967|455744812|FG009|Induction Period|Lost to Follow-up|0|||
126667738|NCT04178967|455744813|FG010|Induction Period|Lost to Follow-up|0|||
126667739|NCT04178967|455744803|FG000|Induction Period|Participant Missed Study Visits|0|||
126667740|NCT04178967|455744804|FG001|Induction Period|Participant Missed Study Visits|1|||
126667741|NCT04178967|455744805|FG002|Induction Period|Participant Missed Study Visits|0|||
126667742|NCT04178967|455744806|FG003|Induction Period|Participant Missed Study Visits|0|||
126667743|NCT04178967|455744807|FG004|Induction Period|Participant Missed Study Visits|0|||
126667744|NCT04178967|455744808|FG005|Induction Period|Participant Missed Study Visits|0|||
126667745|NCT04178967|455744809|FG006|Induction Period|Participant Missed Study Visits|0|||
126667746|NCT04178967|455744810|FG007|Induction Period|Participant Missed Study Visits|0|||
126667747|NCT04178967|455744811|FG008|Induction Period|Participant Missed Study Visits|0|||
126667748|NCT04178967|455744812|FG009|Induction Period|Participant Missed Study Visits|0|||
126667749|NCT04178967|455744813|FG010|Induction Period|Participant Missed Study Visits|0|||
126667750|NCT04178967|455744803|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
126667751|NCT04178967|455744804|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
126667752|NCT04178967|455744805|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
126667753|NCT04178967|455744806|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
126667754|NCT04178967|455744807|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
126667755|NCT04178967|455744808|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
126667756|NCT04178967|455744809|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
126335922|NCT05067972|454524871|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
126335923|NCT05067972|454524872|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
126335924|NCT05067972|454524873|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
126335925|NCT05067972|454524874|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
126335926|NCT05067972|454524875|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
126335927|NCT05067972|454524869|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
126335928|NCT05067972|454524870|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
126335929|NCT05067972|454524871|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
126335930|NCT05067972|454524872|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
126667757|NCT04178967|455744810|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
126335931|NCT05067972|454524873|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
126335932|NCT05067972|454524874|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
126335933|NCT05067972|454524875|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
126335934|NCT05067972|454524869|FG000|Part 1: Follow-up|Physician Decision|0|||
126335935|NCT05067972|454524870|FG001|Part 1: Follow-up|Physician Decision|0|||
126335936|NCT05067972|454524871|FG002|Part 1: Follow-up|Physician Decision|0|||
126335937|NCT05067972|454524872|FG003|Part 1: Follow-up|Physician Decision|1|||
126335938|NCT05067972|454524873|FG004|Part 1: Follow-up|Physician Decision|0|||
126335939|NCT05067972|454524874|FG005|Part 1: Follow-up|Physician Decision|0|||
126335940|NCT05067972|454524875|FG006|Part 1: Follow-up|Physician Decision|0|||
126335941|NCT05067972|454524869|FG000|Part 1: Follow-up|Death|1|||
126335942|NCT05067972|454524870|FG001|Part 1: Follow-up|Death|2|||
126335943|NCT05067972|454524871|FG002|Part 1: Follow-up|Death|1|||
126335944|NCT05067972|454524872|FG003|Part 1: Follow-up|Death|0|||
126335945|NCT05067972|454524873|FG004|Part 1: Follow-up|Death|1|||
126335946|NCT05067972|454524874|FG005|Part 1: Follow-up|Death|0|||
126335947|NCT05067972|454524875|FG006|Part 1: Follow-up|Death|1|||
126335948|NCT04391842|454524876|FG000|Overall Study|Withdrawal by Subject|2|||
126335949|NCT00810199|454524877|FG000|Overall Study|Adverse Event|24|||
126335950|NCT00810199|454524878|FG001|Overall Study|Adverse Event|26|||
126335951|NCT00810199|454524877|FG000|Overall Study|Death|4|||
126335952|NCT00810199|454524878|FG001|Overall Study|Death|6|||
126335953|NCT00810199|454524877|FG000|Overall Study|Withdrew consent|9|||
126335954|NCT00810199|454524878|FG001|Overall Study|Withdrew consent|12|||
126335955|NCT00810199|454524877|FG000|Overall Study|Insufficient therapeutic response|5|||
126335956|NCT00810199|454524878|FG001|Overall Study|Insufficient therapeutic response|14|||
126335957|NCT00810199|454524877|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
126335958|NCT00810199|454524878|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
126335959|NCT00810199|454524877|FG000|Overall Study|Administrative/Other|5|||
126335960|NCT00810199|454524878|FG001|Overall Study|Administrative/Other|6|||
126335961|NCT00810199|454524877|FG000|Overall Study|Protocol Violation|2|||
126335962|NCT00810199|454524878|FG001|Overall Study|Protocol Violation|6|||
126335963|NCT00810199|454524877|FG000|Overall Study|Failure to return|1|||
126335964|NCT00810199|454524878|FG001|Overall Study|Failure to return|4|||
126335965|NCT00810199|454524877|FG000|Overall Study|Did not receive study drug|2|||
126335966|NCT00810199|454524878|FG001|Overall Study|Did not receive study drug|1|||
126335967|NCT01091246|454524879|FG000|Overall Study|Lost to Follow-up|23|||
126335968|NCT01091246|454524880|FG001|Overall Study|Lost to Follow-up|11|||
126335969|NCT01091246|454524881|FG002|Overall Study|Lost to Follow-up|7|||
126335970|NCT01091246|454524879|FG000|Overall Study|Adverse Event|1|||
126335971|NCT01091246|454524880|FG001|Overall Study|Adverse Event|0|||
126335972|NCT01091246|454524881|FG002|Overall Study|Adverse Event|1|||
126335973|NCT01091246|454524879|FG000|Overall Study|Withdrawal by Subject|9|||
126335974|NCT01091246|454524880|FG001|Overall Study|Withdrawal by Subject|5|||
126335975|NCT01091246|454524881|FG002|Overall Study|Withdrawal by Subject|4|||
126335976|NCT01091246|454524879|FG000|Overall Study|Subject not dosed|2|||
126335977|NCT01091246|454524880|FG001|Overall Study|Subject not dosed|0|||
126335978|NCT01091246|454524881|FG002|Overall Study|Subject not dosed|1|||
126335979|NCT02287038|454524882|FG000|Overall Study|Stopped attending appointments|3|||
126335980|NCT02287038|454524883|FG001|Overall Study|Stopped attending appointments|2|||
126335981|NCT02287038|454524882|FG000|Overall Study|Anxiety after starting medication|0|||
126335982|NCT02287038|454524883|FG001|Overall Study|Anxiety after starting medication|1|||
126335983|NCT02287038|454524882|FG000|Overall Study|Nausea after starting medication|1|||
126335984|NCT02287038|454524883|FG001|Overall Study|Nausea after starting medication|0|||
126335985|NCT02287038|454524882|FG000|Overall Study|Abnormal ECG after starting medication|1|||
126335986|NCT02287038|454524883|FG001|Overall Study|Abnormal ECG after starting medication|0|||
126335987|NCT01676012|454524889|FG000|Overall Study|Adverse Event|2|||
126335988|NCT01676012|454524889|FG000|Overall Study|incomplete set of videos|1|||
126335989|NCT02667301|454524904|FG000|Overall Study|Adverse Event|1|||
126335990|NCT02667301|454524904|FG000|Overall Study|Lack of Efficacy|1|||
126335991|NCT02283658|454524905|FG000|Overall Study|Withdrawal by Subject|1|||
126335992|NCT03528551|454524907|FG000|Overall Study|Lost to Follow-up|0|||
126335993|NCT03528551|454524908|FG001|Overall Study|Lost to Follow-up|1|||
126335994|NCT03528551|454524909|FG002|Overall Study|Lost to Follow-up|0|||
126335995|NCT03528551|454524907|FG000|Overall Study|Transferred to other arm/group|2|||
126335996|NCT03528551|454524908|FG001|Overall Study|Transferred to other arm/group|3|||
126335997|NCT03528551|454524909|FG002|Overall Study|Transferred to other arm/group|0|||
126335998|NCT03528551|454524907|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126335999|NCT03528551|454524908|FG001|Overall Study|Withdrawal by parent/guardian|5|||
126336000|NCT03528551|454524909|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126336001|NCT03528551|454524907|FG000|Overall Study|Protocol Violation|0|||
126336002|NCT03528551|454524908|FG001|Overall Study|Protocol Violation|3|||
126336003|NCT03528551|454524909|FG002|Overall Study|Protocol Violation|0|||
126336004|NCT03528551|454524907|FG000|Overall Study|Withdrawal by Subject|0|||
126336005|NCT03528551|454524908|FG001|Overall Study|Withdrawal by Subject|7|||
126336006|NCT03528551|454524909|FG002|Overall Study|Withdrawal by Subject|0|||
126336007|NCT00846586|454524910|FG000|Overall Study|Adverse Event|20|||
126336008|NCT00846586|454524911|FG001|Overall Study|Adverse Event|10|||
126336009|NCT00846586|454524910|FG000|Overall Study|Subject withdrew consent|8|||
126336010|NCT00846586|454524911|FG001|Overall Study|Subject withdrew consent|10|||
126336011|NCT00846586|454524910|FG000|Overall Study|Administrative problems|5|||
126336012|NCT00846586|454524911|FG001|Overall Study|Administrative problems|4|||
126336013|NCT00846586|454524910|FG000|Overall Study|Death|2|||
126336014|NCT00846586|454524911|FG001|Overall Study|Death|0|||
126336015|NCT00846586|454524910|FG000|Overall Study|Protocol deviation|2|||
126336016|NCT00846586|454524911|FG001|Overall Study|Protocol deviation|6|||
126336017|NCT00846586|454524910|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126336018|NCT00846586|454524911|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126336019|NCT00846586|454524910|FG000|Overall Study|Lost to Follow-up|1|||
126336020|NCT00846586|454524911|FG001|Overall Study|Lost to Follow-up|4|||
126336021|NCT00846586|454524910|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126336022|NCT00846586|454524911|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126336023|NCT00689338|454524912|FG000|Overall Study|Death|65|||
126336024|NCT00689338|454524912|FG000|Overall Study|Adverse Event|13|||
126336025|NCT00689338|454524912|FG000|Overall Study|Insufficient Clinical Response|1|||
126336026|NCT00689338|454524912|FG000|Overall Study|Lack of Efficacy|6|||
126336027|NCT00689338|454524912|FG000|Overall Study|Other|8|||
126336028|NCT00689338|454524912|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
126336029|NCT00689338|454524912|FG000|Overall Study|Lost to Follow-up|5|||
126667758|NCT04178967|455744811|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
126667759|NCT04178967|455744812|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
126336030|NCT00689338|454524912|FG000|Overall Study|Withdrawal by Subject|3|||
126336031|NCT00689338|454524912|FG000|Overall Study|Protocol Violation|15|||
126336032|NCT00735007|454524913|FG000|Overall Study|Adverse Event|4|||
126336033|NCT00735007|454524913|FG000|Overall Study|Protocol Violation|1|||
126336034|NCT01061606|454524914|FG000|Overall Study|Adverse Event|1|||
126336035|NCT01061606|454524914|FG000|Overall Study|Death|1|||
126336036|NCT01061606|454524914|FG000|Overall Study|Disease Progression|4|||
126336037|NCT01061606|454524914|FG000|Overall Study|alternative therapy|2|||
126336038|NCT01789047|454524915|FG000|Overall Study|Adverse Event|3|||
126336039|NCT01789047|454524916|FG001|Overall Study|Adverse Event|2|||
126336040|NCT01789047|454524915|FG000|Overall Study|Withdrawal by Subject|1|||
126336041|NCT01789047|454524916|FG001|Overall Study|Withdrawal by Subject|2|||
126336042|NCT00715403|454524917|FG000|Overall Study|Progressive disease|0|||
126336043|NCT00715403|454524918|FG001|Overall Study|Progressive disease|1|||
126336044|NCT00715403|454524919|FG002|Overall Study|Progressive disease|3|||
126336045|NCT00715403|454524920|FG003|Overall Study|Progressive disease|9|||
126336046|NCT00715403|454524921|FG004|Overall Study|Progressive disease|5|||
126667760|NCT04178967|455744813|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
126667761|NCT04178967|455744803|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126667762|NCT04178967|455744804|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126667763|NCT04178967|455744805|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126667764|NCT04178967|455744806|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126667765|NCT04178967|455744807|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126667766|NCT04178967|455744808|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
126667767|NCT04178967|455744809|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126667768|NCT04178967|455744810|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126667769|NCT04178967|455744811|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126667770|NCT04178967|455744812|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126667771|NCT04178967|455744813|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126667772|NCT04178967|455744803|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126667773|NCT04178967|455744804|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126667774|NCT04178967|455744805|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126667775|NCT04178967|455744806|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
126336047|NCT00715403|454524922|FG005|Overall Study|Progressive disease|14|||
126336048|NCT00715403|454524923|FG006|Overall Study|Progressive disease|1|||
126336049|NCT00715403|454524917|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
126336050|NCT00715403|454524918|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
126336051|NCT00715403|454524919|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
126336052|NCT00715403|454524920|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
126336053|NCT00715403|454524921|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
126336054|NCT00715403|454524922|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
126336055|NCT00715403|454524923|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
126336056|NCT00715403|454524917|FG000|Overall Study|Other Adverse Event than DLT|1|||
126336057|NCT00715403|454524918|FG001|Overall Study|Other Adverse Event than DLT|0|||
126336058|NCT00715403|454524919|FG002|Overall Study|Other Adverse Event than DLT|0|||
126336059|NCT00715403|454524920|FG003|Overall Study|Other Adverse Event than DLT|0|||
126336060|NCT00715403|454524921|FG004|Overall Study|Other Adverse Event than DLT|0|||
126336061|NCT00715403|454524922|FG005|Overall Study|Other Adverse Event than DLT|2|||
126667776|NCT04178967|455744807|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126667777|NCT04178967|455744808|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126336062|NCT00715403|454524923|FG006|Overall Study|Other Adverse Event than DLT|0|||
126667778|NCT04178967|455744809|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126667779|NCT04178967|455744810|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126667780|NCT04178967|455744811|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126667781|NCT04178967|455744812|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126667782|NCT04178967|455744813|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126667783|NCT04178967|455744803|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
126667784|NCT04178967|455744804|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
126667785|NCT04178967|455744805|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
126667786|NCT04178967|455744806|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
126667787|NCT04178967|455744807|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
126667788|NCT04178967|455744808|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
126667789|NCT04178967|455744809|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
126667790|NCT04178967|455744810|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
126667791|NCT04178967|455744811|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
126667792|NCT04178967|455744812|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
126667793|NCT04178967|455744813|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
126667794|NCT04178967|455744803|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126667795|NCT04178967|455744804|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126667796|NCT04178967|455744805|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126667797|NCT04178967|455744806|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126667798|NCT04178967|455744807|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
126667799|NCT04178967|455744808|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
126667800|NCT04178967|455744809|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126667801|NCT04178967|455744810|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
126667802|NCT04178967|455744811|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126667803|NCT04178967|455744812|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126667804|NCT04178967|455744813|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126667805|NCT04178967|455744803|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
126667806|NCT04178967|455744804|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
126667807|NCT04178967|455744805|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
126667808|NCT04178967|455744806|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
126667809|NCT04178967|455744807|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
126667810|NCT04178967|455744808|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
126667811|NCT04178967|455744809|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
126667812|NCT04178967|455744810|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
126667813|NCT04178967|455744811|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
126667814|NCT04178967|455744812|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
126336063|NCT00715403|454524917|FG000|Overall Study|Protocol Violation|0|||
126336064|NCT00715403|454524918|FG001|Overall Study|Protocol Violation|0|||
126336065|NCT00715403|454524919|FG002|Overall Study|Protocol Violation|0|||
126336066|NCT00715403|454524920|FG003|Overall Study|Protocol Violation|0|||
126336067|NCT00715403|454524921|FG004|Overall Study|Protocol Violation|0|||
126336068|NCT00715403|454524922|FG005|Overall Study|Protocol Violation|1|||
126336069|NCT00715403|454524923|FG006|Overall Study|Protocol Violation|0|||
126336070|NCT00715403|454524917|FG000|Overall Study|Other reason not defined above|0|||
126336071|NCT00715403|454524918|FG001|Overall Study|Other reason not defined above|0|||
126336072|NCT00715403|454524919|FG002|Overall Study|Other reason not defined above|1|||
126336073|NCT00715403|454524920|FG003|Overall Study|Other reason not defined above|0|||
126336074|NCT00715403|454524921|FG004|Overall Study|Other reason not defined above|1|||
126336075|NCT00715403|454524922|FG005|Overall Study|Other reason not defined above|1|||
126336076|NCT00715403|454524923|FG006|Overall Study|Other reason not defined above|0|||
126336077|NCT03644017|454524924|FG000|Overall Study|Access Abandonment|5|||
126336078|NCT03644017|454524924|FG000|Overall Study|Kidney Transplant|2|||
126336079|NCT02700048|454524925|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
126336080|NCT02700048|454524926|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
126336081|NCT02175225|454524929|FG000|Overall Study|Withdrawal by Subject|1|||
126336082|NCT02175225|454524930|FG001|Overall Study|Withdrawal by Subject|2|||
126336083|NCT02175225|454524929|FG000|Overall Study|Lost to Follow-up|6|||
126336084|NCT02175225|454524930|FG001|Overall Study|Lost to Follow-up|7|||
126336085|NCT02175225|454524929|FG000|Overall Study|Study drug not administered|1|||
126336086|NCT02175225|454524930|FG001|Overall Study|Study drug not administered|2|||
126336087|NCT02340000|454524931|FG000|Time Period 1|Withdrawal by Subject|6|||
126336088|NCT02340000|454524932|FG001|Time Period 1|Withdrawal by Subject|8|||
126336089|NCT02340000|454524931|FG000|Time Period 1|Lost to Follow-up|6|||
126336090|NCT02340000|454524932|FG001|Time Period 1|Lost to Follow-up|7|||
126336091|NCT02340000|454524931|FG000|Time Period 2|Withdrawal by Subject|9|||
126336092|NCT02340000|454524932|FG001|Time Period 2|Withdrawal by Subject|7|||
126336093|NCT02340000|454524931|FG000|Time Period 2|Lost to Follow-up|10|||
126336094|NCT02340000|454524932|FG001|Time Period 2|Lost to Follow-up|8|||
126336095|NCT01883895|454524933|FG000|Overall Study|Lost to Follow-up|2|||
126336096|NCT02481050|454526800|FG000|Overall Study|Adverse Event|1|||
126336097|NCT02481050|454526800|FG000|Overall Study|Disease Progression|47|||
126336098|NCT02481050|454526800|FG000|Overall Study|Withdrawal by Subject|7|||
126336099|NCT02481050|454526800|FG000|Overall Study|Other|3|||
126336100|NCT01386606|454526801|FG000|Overall Study|Adverse Event|0|||
126336101|NCT01386606|454526802|FG001|Overall Study|Adverse Event|1|||
126336102|NCT01386606|454526803|FG002|Overall Study|Adverse Event|0|||
126336103|NCT01386606|454526804|FG003|Overall Study|Adverse Event|0|||
126336104|NCT01386606|454526801|FG000|Overall Study|Withdrawal by Subject|0|||
126667815|NCT04178967|455744813|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
126667816|NCT04178967|455744803|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126667817|NCT04178967|455744804|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126667818|NCT04178967|455744805|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126667819|NCT04178967|455744806|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
126336105|NCT01386606|454526802|FG001|Overall Study|Withdrawal by Subject|1|||
126336106|NCT01386606|454526803|FG002|Overall Study|Withdrawal by Subject|1|||
126336107|NCT01386606|454526804|FG003|Overall Study|Withdrawal by Subject|0|||
126336108|NCT01386606|454526801|FG000|Overall Study|Protocol Violation|1|||
126336109|NCT01386606|454526802|FG001|Overall Study|Protocol Violation|0|||
126336110|NCT01386606|454526803|FG002|Overall Study|Protocol Violation|1|||
126336111|NCT01386606|454526804|FG003|Overall Study|Protocol Violation|1|||
126336112|NCT01386606|454526801|FG000|Overall Study|Lost to Follow-up|2|||
126336113|NCT01386606|454526802|FG001|Overall Study|Lost to Follow-up|0|||
126336114|NCT01386606|454526803|FG002|Overall Study|Lost to Follow-up|0|||
126336115|NCT01386606|454526804|FG003|Overall Study|Lost to Follow-up|0|||
126336116|NCT01386606|454526801|FG000|Overall Study|Subject incarcerated|0|||
126336117|NCT01386606|454526802|FG001|Overall Study|Subject incarcerated|1|||
126336118|NCT01386606|454526803|FG002|Overall Study|Subject incarcerated|0|||
126336119|NCT01386606|454526804|FG003|Overall Study|Subject incarcerated|0|||
126336120|NCT01386606|454526801|FG000|Overall Study|Unable to draw PK|1|||
126336121|NCT01386606|454526802|FG001|Overall Study|Unable to draw PK|0|||
126336122|NCT01386606|454526803|FG002|Overall Study|Unable to draw PK|0|||
126667820|NCT04178967|455744807|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126667821|NCT04178967|455744808|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
126667822|NCT04178967|455744809|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
126667823|NCT04178967|455744810|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
126667824|NCT04178967|455744811|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126667825|NCT04178967|455744812|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126667826|NCT04178967|455744813|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126667827|NCT04178967|455744803|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
126667828|NCT04178967|455744804|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
126667829|NCT04178967|455744805|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
126667830|NCT04178967|455744806|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
126667831|NCT04178967|455744807|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
126667832|NCT04178967|455744808|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
126667833|NCT04178967|455744809|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
126667834|NCT04178967|455744810|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
126667835|NCT04178967|455744811|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
126667836|NCT04178967|455744812|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
126667837|NCT04178967|455744813|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
126667838|NCT04178967|455744803|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126667839|NCT04178967|455744804|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126667840|NCT04178967|455744805|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126336123|NCT01386606|454526804|FG003|Overall Study|Unable to draw PK|0|||
126336124|NCT01386606|454526801|FG000|Overall Study|T levels too high|0|||
126336125|NCT01386606|454526802|FG001|Overall Study|T levels too high|1|||
126336126|NCT01386606|454526803|FG002|Overall Study|T levels too high|1|||
126336127|NCT01386606|454526804|FG003|Overall Study|T levels too high|0|||
126336128|NCT01022203|454526811|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
126336129|NCT01022203|454526812|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
126336130|NCT01022203|454526811|FG000|Post Treatment Assessment|Physician Decision|2|||
126667841|NCT04178967|455744806|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126336131|NCT01022203|454526812|FG001|Post Treatment Assessment|Physician Decision|0|||
126336132|NCT01022203|454526811|FG000|Post Treatment Assessment|Adverse Event|0|||
126336133|NCT01022203|454526812|FG001|Post Treatment Assessment|Adverse Event|2|||
126336134|NCT01022203|454526811|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
126336135|NCT01022203|454526812|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
126336136|NCT01094288|454526814|FG000|Overall Study|Adverse Event|0|||
126336137|NCT01094288|454526815|FG001|Overall Study|Adverse Event|3|||
126336138|NCT01094288|454526816|FG002|Overall Study|Adverse Event|1|||
126336139|NCT01094288|454526817|FG003|Overall Study|Adverse Event|1|||
126667842|NCT04178967|455744807|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126336140|NCT01094288|454526818|FG004|Overall Study|Adverse Event|0|||
126336141|NCT01094288|454526819|FG005|Overall Study|Adverse Event|0|||
126336142|NCT01094288|454526820|FG006|Overall Study|Adverse Event|0|||
126336143|NCT01094288|454526821|FG007|Overall Study|Adverse Event|0|||
126336144|NCT01094288|454526814|FG000|Overall Study|Withdrawal by Subject|0|||
126336145|NCT01094288|454526815|FG001|Overall Study|Withdrawal by Subject|1|||
126336146|NCT01094288|454526816|FG002|Overall Study|Withdrawal by Subject|2|||
126336147|NCT01094288|454526817|FG003|Overall Study|Withdrawal by Subject|0|||
126336148|NCT01094288|454526818|FG004|Overall Study|Withdrawal by Subject|0|||
126336149|NCT01094288|454526819|FG005|Overall Study|Withdrawal by Subject|0|||
126336150|NCT01094288|454526820|FG006|Overall Study|Withdrawal by Subject|0|||
126336151|NCT01094288|454526821|FG007|Overall Study|Withdrawal by Subject|2|||
126336152|NCT01094288|454526814|FG000|Overall Study|Initiation of Alternative Therapy|0|||
126336153|NCT01094288|454526815|FG001|Overall Study|Initiation of Alternative Therapy|0|||
126336154|NCT01094288|454526816|FG002|Overall Study|Initiation of Alternative Therapy|1|||
126336155|NCT01094288|454526817|FG003|Overall Study|Initiation of Alternative Therapy|0|||
126336156|NCT01094288|454526818|FG004|Overall Study|Initiation of Alternative Therapy|0|||
126336157|NCT01094288|454526819|FG005|Overall Study|Initiation of Alternative Therapy|0|||
126336158|NCT01094288|454526820|FG006|Overall Study|Initiation of Alternative Therapy|0|||
126336159|NCT01094288|454526821|FG007|Overall Study|Initiation of Alternative Therapy|0|||
126336160|NCT01094288|454526814|FG000|Overall Study|Reason not Specified|2|||
126336161|NCT01094288|454526815|FG001|Overall Study|Reason not Specified|3|||
126336162|NCT01094288|454526816|FG002|Overall Study|Reason not Specified|0|||
126336163|NCT01094288|454526817|FG003|Overall Study|Reason not Specified|1|||
126336164|NCT01094288|454526818|FG004|Overall Study|Reason not Specified|0|||
126336165|NCT01094288|454526819|FG005|Overall Study|Reason not Specified|0|||
126336166|NCT01094288|454526820|FG006|Overall Study|Reason not Specified|0|||
126336167|NCT01094288|454526821|FG007|Overall Study|Reason not Specified|0|||
126336168|NCT01094288|454526814|FG000|Overall Study|Ongoing Participants|0|||
126336169|NCT01094288|454526815|FG001|Overall Study|Ongoing Participants|3|||
126336170|NCT01094288|454526816|FG002|Overall Study|Ongoing Participants|0|||
126336171|NCT01094288|454526817|FG003|Overall Study|Ongoing Participants|0|||
126336172|NCT01094288|454526818|FG004|Overall Study|Ongoing Participants|0|||
126336173|NCT01094288|454526819|FG005|Overall Study|Ongoing Participants|0|||
126336174|NCT01094288|454526820|FG006|Overall Study|Ongoing Participants|0|||
126336175|NCT01094288|454526821|FG007|Overall Study|Ongoing Participants|0|||
126336176|NCT02611882|454526822|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
126336177|NCT02611882|454526823|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
126336178|NCT02611882|454526824|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
126336179|NCT01317940|454526825|FG000|Overall Study|Death|1|||
126336180|NCT01317940|454526826|FG001|Overall Study|Death|0|||
126336181|NCT01317940|454526827|FG002|Overall Study|Death|1|||
126336182|NCT01317940|454526828|FG003|Overall Study|Death|0|||
126336183|NCT01317940|454526829|FG004|Overall Study|Death|0|||
126336184|NCT01317940|454526830|FG005|Overall Study|Death|0|||
126336185|NCT01317940|454526825|FG000|Overall Study|Lost to Follow-up|0|||
126336186|NCT01317940|454526826|FG001|Overall Study|Lost to Follow-up|0|||
126336187|NCT01317940|454526827|FG002|Overall Study|Lost to Follow-up|1|||
126336188|NCT01317940|454526828|FG003|Overall Study|Lost to Follow-up|1|||
126336189|NCT01317940|454526829|FG004|Overall Study|Lost to Follow-up|1|||
126336190|NCT01317940|454526830|FG005|Overall Study|Lost to Follow-up|0|||
126336191|NCT01317940|454526825|FG000|Overall Study|Change in therapy plan|0|||
126336192|NCT01317940|454526826|FG001|Overall Study|Change in therapy plan|0|||
126336193|NCT01317940|454526827|FG002|Overall Study|Change in therapy plan|3|||
126336194|NCT01317940|454526828|FG003|Overall Study|Change in therapy plan|0|||
126336195|NCT01317940|454526829|FG004|Overall Study|Change in therapy plan|0|||
126667843|NCT04178967|455744808|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126667844|NCT04178967|455744809|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126667845|NCT04178967|455744810|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126667846|NCT04178967|455744811|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
126667847|NCT04178967|455744812|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
126667848|NCT04178967|455744813|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
126667849|NCT04178967|455744803|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126667850|NCT04178967|455744804|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126667851|NCT04178967|455744805|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126667852|NCT04178967|455744806|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126667853|NCT04178967|455744807|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126667854|NCT04178967|455744808|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126667855|NCT04178967|455744809|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126336196|NCT01317940|454526830|FG005|Overall Study|Change in therapy plan|0|||
126336197|NCT04152200|454526832|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
126336198|NCT04152200|454526833|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
126667856|NCT04178967|455744810|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126667857|NCT04178967|455744811|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126667858|NCT04178967|455744812|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
126667859|NCT04178967|455744813|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126667860|NCT04178967|455744803|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126667861|NCT04178967|455744804|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126667862|NCT04178967|455744805|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126667863|NCT04178967|455744806|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126667864|NCT04178967|455744807|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126667865|NCT04178967|455744808|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126667866|NCT04178967|455744809|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126667867|NCT04178967|455744810|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126667868|NCT04178967|455744811|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
126667869|NCT04178967|455744812|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
126667870|NCT04178967|455744813|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
126667871|NCT04178967|455744803|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126667872|NCT04178967|455744804|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126667873|NCT04178967|455744805|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126667874|NCT04178967|455744806|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126667875|NCT04178967|455744807|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126667876|NCT04178967|455744808|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126336199|NCT04980014|454526834|FG000|Overall Study|Participants who are Duplicated|1|||
126336200|NCT04980014|454526834|FG000|Overall Study|Follow-up Failure|13|||
126336201|NCT04980014|454526834|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
126336202|NCT04980014|454526834|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
126336203|NCT04980014|454526834|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
126336204|NCT00593814|454526835|FG000|Overall Study|Death|7|||
126336205|NCT00593814|454526836|FG001|Overall Study|Death|0|||
126336206|NCT00593814|454526835|FG000|Overall Study|Withdrawal by Subject|7|||
126336207|NCT00593814|454526836|FG001|Overall Study|Withdrawal by Subject|0|||
126336208|NCT00593814|454526835|FG000|Overall Study|Lost to Follow-up|7|||
126336209|NCT00593814|454526836|FG001|Overall Study|Lost to Follow-up|0|||
126336210|NCT00593814|454526835|FG000|Overall Study|Physician Decision|3|||
126336211|NCT00593814|454526836|FG001|Overall Study|Physician Decision|0|||
126336212|NCT04069715|454526837|FG000|Overall Study|Lost to Follow-up|1|||
126336213|NCT04069715|454526838|FG001|Overall Study|Lost to Follow-up|1|||
126336214|NCT04069715|454526837|FG000|Overall Study|Physician Decision|1|||
126336215|NCT04069715|454526838|FG001|Overall Study|Physician Decision|1|||
126336216|NCT04069715|454526837|FG000|Overall Study|Withdrawal by Subject|3|||
126336217|NCT04069715|454526838|FG001|Overall Study|Withdrawal by Subject|3|||
126336218|NCT02723188|454526839|FG000|Overall Study|Withdrawal by Subject|1|||
126336219|NCT02723188|454526840|FG001|Overall Study|Withdrawal by Subject|0|||
126336220|NCT02723188|454526841|FG002|Overall Study|Withdrawal by Subject|0|||
126336221|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
126336222|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
126336223|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
126336224|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
126336225|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
126336226|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
126336227|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
126336228|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
126336229|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
126336230|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
126336231|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
126336232|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
126336233|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
126336234|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
126336235|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
126336236|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
126336237|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
126336238|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
126336239|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
126336240|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
126667877|NCT04178967|455744809|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126667878|NCT04178967|455744810|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126336241|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
126336242|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
126336243|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
126336244|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
126336245|NCT01198002|454526844|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
126336246|NCT01198002|454526845|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
126336247|NCT01198002|454526846|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
126336248|NCT01198002|454526844|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
126336249|NCT01198002|454526845|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
126336250|NCT01198002|454526846|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
126336251|NCT01198002|454526844|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
126336252|NCT01198002|454526845|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
126336253|NCT01198002|454526846|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
126336254|NCT01198002|454526844|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
126336255|NCT01198002|454526845|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
126336256|NCT01198002|454526846|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
126336257|NCT01198002|454526844|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
126336258|NCT01198002|454526845|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
126336259|NCT01198002|454526846|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
126336260|NCT01198002|454526844|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
126336261|NCT01198002|454526845|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
126336262|NCT01198002|454526846|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
126336263|NCT01198002|454526844|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
126336264|NCT01198002|454526845|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
126336265|NCT01198002|454526846|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
126336266|NCT03652818|454526854|FG000|Overall Study|Adverse Event|1|||
126336267|NCT03652818|454526855|FG001|Overall Study|Adverse Event|0|||
126336268|NCT03652818|454526856|FG002|Overall Study|Adverse Event|0|||
126336269|NCT03652818|454526857|FG003|Overall Study|Adverse Event|0|||
126336270|NCT03652818|454526858|FG004|Overall Study|Adverse Event|0|||
126336271|NCT03652818|454526854|FG000|Overall Study|Physician Decision|1|||
126336272|NCT03652818|454526855|FG001|Overall Study|Physician Decision|0|||
126336273|NCT03652818|454526856|FG002|Overall Study|Physician Decision|0|||
126336274|NCT03652818|454526857|FG003|Overall Study|Physician Decision|0|||
126336275|NCT03652818|454526858|FG004|Overall Study|Physician Decision|0|||
126336276|NCT03652818|454526854|FG000|Overall Study|Lost to Follow-up|0|||
126336277|NCT03652818|454526855|FG001|Overall Study|Lost to Follow-up|1|||
126336278|NCT03652818|454526856|FG002|Overall Study|Lost to Follow-up|2|||
126336279|NCT03652818|454526857|FG003|Overall Study|Lost to Follow-up|1|||
126336280|NCT03652818|454526858|FG004|Overall Study|Lost to Follow-up|1|||
126336281|NCT01241279|454526859|FG000|Overall Study|Lost to Follow-up|0|||
126336282|NCT01241279|454526860|FG001|Overall Study|Lost to Follow-up|1|||
126336283|NCT00301834|454526863|FG000|Overall Study|Death|1|||
126336284|NCT01811732|454526864|FG000|Overall Study|Lost to Follow-up|24|||
126336285|NCT01811732|454526865|FG001|Overall Study|Lost to Follow-up|30|||
126336286|NCT01811732|454526864|FG000|Overall Study|Withdrawal by Subject|16|||
126336287|NCT01811732|454526865|FG001|Overall Study|Withdrawal by Subject|10|||
126336288|NCT01811732|454526864|FG000|Overall Study|Adverse Event|3|||
126336289|NCT01811732|454526865|FG001|Overall Study|Adverse Event|9|||
126336290|NCT01811732|454526864|FG000|Overall Study|Lack of Efficacy|3|||
126336291|NCT01811732|454526865|FG001|Overall Study|Lack of Efficacy|1|||
126336292|NCT01811732|454526864|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
126336293|NCT01811732|454526865|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
126336294|NCT01811732|454526864|FG000|Overall Study|Physician Decision|2|||
126336295|NCT01811732|454526865|FG001|Overall Study|Physician Decision|0|||
126336296|NCT01811732|454526864|FG000|Overall Study|Death|1|||
126336297|NCT01811732|454526865|FG001|Overall Study|Death|1|||
126336298|NCT01811732|454526864|FG000|Overall Study|Insufficient venous access|0|||
126336299|NCT01811732|454526865|FG001|Overall Study|Insufficient venous access|1|||
126336300|NCT01811732|454526864|FG000|Overall Study|Protocol Violation|0|||
126336301|NCT01811732|454526865|FG001|Overall Study|Protocol Violation|1|||
126336302|NCT01811732|454526864|FG000|Overall Study|Subject incarcerated|1|||
126336303|NCT01811732|454526865|FG001|Overall Study|Subject incarcerated|2|||
126336304|NCT01811732|454526864|FG000|Overall Study|Admitted to another facility|1|||
126336305|NCT01811732|454526865|FG001|Overall Study|Admitted to another facility|0|||
126336306|NCT01811732|454526864|FG000|Overall Study|Correct study drug not available on site|1|||
126336307|NCT01811732|454526865|FG001|Overall Study|Correct study drug not available on site|0|||
126336308|NCT01607593|454526866|FG000|Overall Study|Adverse Event|15|||
126336309|NCT01607593|454526866|FG000|Overall Study|Lack of Efficacy|16|||
126336310|NCT01607593|454526866|FG000|Overall Study|Lost to Follow-up|25|||
126336311|NCT01607593|454526866|FG000|Overall Study|Continuation|33|||
126336312|NCT01607593|454526866|FG000|Overall Study|Other|4|||
126336313|NCT01867008|454526867|FG000|Overall Study|Withdrawal by Subject|1|||
126336314|NCT01534273|454526868|FG000|Period 1|Physician Decision|0|||
126336315|NCT01534273|454526869|FG001|Period 1|Physician Decision|0|||
126336316|NCT01534273|454526870|FG002|Period 1|Physician Decision|0|||
126336317|NCT01534273|454526871|FG003|Period 1|Physician Decision|1|||
126336318|NCT01534273|454526872|FG004|Period 1|Physician Decision|0|||
126336319|NCT01534273|454526873|FG005|Period 1|Physician Decision|0|||
126667879|NCT04178967|455744811|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126667880|NCT04178967|455744812|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
126667881|NCT04178967|455744813|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
126667882|NCT04178967|455744803|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126667883|NCT04178967|455744804|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126667884|NCT04178967|455744805|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126336320|NCT01534273|454526874|FG006|Period 1|Physician Decision|0|||
126336321|NCT03586050|454526875|FG000|Overall Study|Death|3|||
126336322|NCT03586050|454526875|FG000|Overall Study|Withdrawal by Subject|2|||
126336323|NCT01211145|454526876|FG000|Overall Study|Reason not specified|3|||
126336324|NCT01211145|454526877|FG001|Overall Study|Reason not specified|2|||
126336325|NCT01211145|454526878|FG002|Overall Study|Reason not specified|2|||
126336326|NCT01211145|454526879|FG003|Overall Study|Reason not specified|1|||
126336327|NCT01211145|454526876|FG000|Overall Study|Lost to Follow-up|3|||
126336328|NCT01211145|454526877|FG001|Overall Study|Lost to Follow-up|2|||
126336329|NCT01211145|454526878|FG002|Overall Study|Lost to Follow-up|1|||
126336330|NCT01211145|454526879|FG003|Overall Study|Lost to Follow-up|2|||
126336331|NCT01211145|454526876|FG000|Overall Study|Study-specific withdrawal criteria|1|||
126336332|NCT01211145|454526877|FG001|Overall Study|Study-specific withdrawal criteria|0|||
126336333|NCT01211145|454526878|FG002|Overall Study|Study-specific withdrawal criteria|0|||
126336334|NCT01211145|454526879|FG003|Overall Study|Study-specific withdrawal criteria|0|||
126336335|NCT01211145|454526876|FG000|Overall Study|Severe noncompliance to protocol|1|||
126336336|NCT01211145|454526877|FG001|Overall Study|Severe noncompliance to protocol|0|||
126336337|NCT01211145|454526878|FG002|Overall Study|Severe noncompliance to protocol|0|||
126336338|NCT01211145|454526879|FG003|Overall Study|Severe noncompliance to protocol|0|||
126336339|NCT01211145|454526876|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
126336340|NCT01211145|454526877|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
126336341|NCT01211145|454526878|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
126336342|NCT01211145|454526879|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
126336343|NCT01211145|454526876|FG000|Overall Study|Patient decision|2|||
126336344|NCT01211145|454526877|FG001|Overall Study|Patient decision|1|||
126336345|NCT01211145|454526878|FG002|Overall Study|Patient decision|0|||
126336346|NCT01211145|454526879|FG003|Overall Study|Patient decision|2|||
126336347|NCT00570401|454526880|FG000|Overall Study|Adverse Event|2|||
126336348|NCT04202497|454526881|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
126336349|NCT04202497|454526882|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
126336350|NCT04202497|454526883|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
126336351|NCT04202497|454526884|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
126336352|NCT02115607|454526885|FG000|Overall Study|Withdrawal by Subject|1|||
126336353|NCT00069264|454526886|FG000|Overall Study|Adverse Event|3|||
126336354|NCT00069264|454526886|FG000|Overall Study|Progressive Disease|23|||
126336355|NCT00069264|454526886|FG000|Overall Study|Withdrawal by Subject|3|||
126336356|NCT00069264|454526886|FG000|Overall Study|Discon Therapy|3|||
126336357|NCT05616013|454526887|FG000|Overall Study|Adverse Event|6|||
126336358|NCT05616013|454526888|FG001|Overall Study|Adverse Event|12|||
126336359|NCT05616013|454526889|FG002|Overall Study|Adverse Event|8|||
126336360|NCT05616013|454526890|FG003|Overall Study|Adverse Event|4|||
126336361|NCT05616013|454526891|FG004|Overall Study|Adverse Event|6|||
126336362|NCT05616013|454526892|FG005|Overall Study|Adverse Event|8|||
126336363|NCT05616013|454526893|FG006|Overall Study|Adverse Event|3|||
126336364|NCT05616013|454526894|FG007|Overall Study|Adverse Event|6|||
126336365|NCT05616013|454526895|FG008|Overall Study|Adverse Event|1|||
126336366|NCT05616013|454526887|FG000|Overall Study|Lost to Follow-up|5|||
126336367|NCT05616013|454526888|FG001|Overall Study|Lost to Follow-up|4|||
126336368|NCT05616013|454526889|FG002|Overall Study|Lost to Follow-up|3|||
126336369|NCT05616013|454526890|FG003|Overall Study|Lost to Follow-up|2|||
126336370|NCT05616013|454526891|FG004|Overall Study|Lost to Follow-up|0|||
126336371|NCT05616013|454526892|FG005|Overall Study|Lost to Follow-up|5|||
126336372|NCT05616013|454526893|FG006|Overall Study|Lost to Follow-up|2|||
126336373|NCT05616013|454526894|FG007|Overall Study|Lost to Follow-up|1|||
126336374|NCT05616013|454526895|FG008|Overall Study|Lost to Follow-up|2|||
126336375|NCT05616013|454526887|FG000|Overall Study|Non-compliance with study requirements|2|||
126336376|NCT05616013|454526888|FG001|Overall Study|Non-compliance with study requirements|2|||
126336377|NCT05616013|454526889|FG002|Overall Study|Non-compliance with study requirements|2|||
126336378|NCT05616013|454526890|FG003|Overall Study|Non-compliance with study requirements|3|||
126336379|NCT05616013|454526891|FG004|Overall Study|Non-compliance with study requirements|0|||
126336380|NCT05616013|454526892|FG005|Overall Study|Non-compliance with study requirements|2|||
126336381|NCT05616013|454526893|FG006|Overall Study|Non-compliance with study requirements|1|||
126336382|NCT05616013|454526894|FG007|Overall Study|Non-compliance with study requirements|1|||
126336383|NCT05616013|454526895|FG008|Overall Study|Non-compliance with study requirements|4|||
126336384|NCT05616013|454526887|FG000|Overall Study|Withdrawal by Subject|11|||
126336385|NCT05616013|454526888|FG001|Overall Study|Withdrawal by Subject|9|||
126336386|NCT05616013|454526889|FG002|Overall Study|Withdrawal by Subject|8|||
126336387|NCT05616013|454526890|FG003|Overall Study|Withdrawal by Subject|6|||
126336388|NCT05616013|454526891|FG004|Overall Study|Withdrawal by Subject|3|||
126336389|NCT05616013|454526892|FG005|Overall Study|Withdrawal by Subject|4|||
126336390|NCT05616013|454526893|FG006|Overall Study|Withdrawal by Subject|6|||
126336391|NCT05616013|454526894|FG007|Overall Study|Withdrawal by Subject|5|||
126336392|NCT05616013|454526895|FG008|Overall Study|Withdrawal by Subject|4|||
126336393|NCT05616013|454526887|FG000|Overall Study|Physician Decision|0|||
126336394|NCT05616013|454526888|FG001|Overall Study|Physician Decision|0|||
126336395|NCT05616013|454526889|FG002|Overall Study|Physician Decision|1|||
126336396|NCT05616013|454526890|FG003|Overall Study|Physician Decision|0|||
126336397|NCT05616013|454526891|FG004|Overall Study|Physician Decision|0|||
126336398|NCT05616013|454526892|FG005|Overall Study|Physician Decision|1|||
126336399|NCT05616013|454526893|FG006|Overall Study|Physician Decision|3|||
126336400|NCT05616013|454526894|FG007|Overall Study|Physician Decision|0|||
126336401|NCT05616013|454526895|FG008|Overall Study|Physician Decision|0|||
126336402|NCT05616013|454526887|FG000|Overall Study|Protocol Violation|0|||
126336403|NCT05616013|454526888|FG001|Overall Study|Protocol Violation|0|||
126336404|NCT05616013|454526889|FG002|Overall Study|Protocol Violation|0|||
126336405|NCT05616013|454526890|FG003|Overall Study|Protocol Violation|0|||
126336406|NCT05616013|454526891|FG004|Overall Study|Protocol Violation|0|||
126336407|NCT05616013|454526892|FG005|Overall Study|Protocol Violation|0|||
126336408|NCT05616013|454526893|FG006|Overall Study|Protocol Violation|1|||
126336409|NCT05616013|454526894|FG007|Overall Study|Protocol Violation|0|||
126336410|NCT05616013|454526895|FG008|Overall Study|Protocol Violation|2|||
126336411|NCT05616013|454526887|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
126336412|NCT05616013|454526888|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336413|NCT05616013|454526889|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336414|NCT05616013|454526890|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336415|NCT05616013|454526891|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336416|NCT05616013|454526892|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336417|NCT05616013|454526893|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336418|NCT05616013|454526894|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336419|NCT05616013|454526895|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
126336420|NCT05616013|454526887|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
126336421|NCT05616013|454526888|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336422|NCT05616013|454526889|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336423|NCT05616013|454526890|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336424|NCT05616013|454526891|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336425|NCT05616013|454526892|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336426|NCT05616013|454526893|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336427|NCT05616013|454526894|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336428|NCT05616013|454526895|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
126336429|NCT05616013|454526887|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
126336430|NCT05616013|454526888|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336431|NCT05616013|454526889|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336432|NCT05616013|454526890|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336433|NCT05616013|454526891|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336434|NCT05616013|454526892|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336435|NCT05616013|454526893|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336436|NCT05616013|454526894|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126336437|NCT05616013|454526895|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
126667885|NCT04178967|455744806|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126667886|NCT04178967|455744807|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126336438|NCT05616013|454526887|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126336439|NCT05616013|454526888|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
126336440|NCT05616013|454526889|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126667887|NCT04178967|455744808|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126667888|NCT04178967|455744809|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126667889|NCT04178967|455744810|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126667890|NCT04178967|455744811|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126667891|NCT04178967|455744812|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
126336441|NCT05616013|454526890|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126336442|NCT05616013|454526891|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126336443|NCT05616013|454526892|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126336444|NCT05616013|454526893|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126336445|NCT05616013|454526894|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126336446|NCT05616013|454526895|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
126336447|NCT05616013|454526887|FG000|Overall Study|Participant Decision, Time Constraints|0|||
126336448|NCT05616013|454526888|FG001|Overall Study|Participant Decision, Time Constraints|1|||
126336449|NCT05616013|454526889|FG002|Overall Study|Participant Decision, Time Constraints|0|||
126336450|NCT05616013|454526890|FG003|Overall Study|Participant Decision, Time Constraints|0|||
126336451|NCT05616013|454526891|FG004|Overall Study|Participant Decision, Time Constraints|0|||
126336452|NCT05616013|454526892|FG005|Overall Study|Participant Decision, Time Constraints|0|||
126336453|NCT05616013|454526893|FG006|Overall Study|Participant Decision, Time Constraints|0|||
126336454|NCT05616013|454526894|FG007|Overall Study|Participant Decision, Time Constraints|0|||
126336455|NCT05616013|454526895|FG008|Overall Study|Participant Decision, Time Constraints|0|||
126336456|NCT05616013|454526887|FG000|Overall Study|Prohibited Concomitant Medication|0|||
126336457|NCT05616013|454526888|FG001|Overall Study|Prohibited Concomitant Medication|0|||
126336458|NCT05616013|454526889|FG002|Overall Study|Prohibited Concomitant Medication|1|||
126336459|NCT05616013|454526890|FG003|Overall Study|Prohibited Concomitant Medication|0|||
126336460|NCT05616013|454526891|FG004|Overall Study|Prohibited Concomitant Medication|0|||
126336461|NCT05616013|454526892|FG005|Overall Study|Prohibited Concomitant Medication|0|||
126336462|NCT05616013|454526893|FG006|Overall Study|Prohibited Concomitant Medication|0|||
126336463|NCT05616013|454526894|FG007|Overall Study|Prohibited Concomitant Medication|0|||
126336464|NCT05616013|454526895|FG008|Overall Study|Prohibited Concomitant Medication|0|||
126336465|NCT05616013|454526887|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336466|NCT05616013|454526888|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336467|NCT05616013|454526889|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
126336468|NCT05616013|454526890|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336469|NCT05616013|454526891|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336470|NCT05616013|454526892|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336471|NCT05616013|454526893|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336472|NCT05616013|454526894|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336473|NCT05616013|454526895|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
126336474|NCT05616013|454526887|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336475|NCT05616013|454526888|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336476|NCT05616013|454526889|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336477|NCT05616013|454526890|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
126336478|NCT05616013|454526891|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336479|NCT05616013|454526892|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336480|NCT05616013|454526893|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336481|NCT05616013|454526894|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336482|NCT05616013|454526895|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
126336483|NCT05616013|454526887|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336484|NCT05616013|454526888|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336485|NCT05616013|454526889|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336486|NCT05616013|454526890|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336487|NCT05616013|454526891|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336488|NCT05616013|454526892|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336489|NCT05616013|454526893|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
126336490|NCT05616013|454526894|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336491|NCT05616013|454526895|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
126336492|NCT05616013|454526887|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336493|NCT05616013|454526888|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336494|NCT05616013|454526889|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336495|NCT05616013|454526890|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336496|NCT05616013|454526891|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336497|NCT05616013|454526892|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336498|NCT05616013|454526893|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336499|NCT05616013|454526894|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
126336500|NCT05616013|454526895|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
126336501|NCT05616013|454526887|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336502|NCT05616013|454526888|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336503|NCT05616013|454526889|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336504|NCT05616013|454526890|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
126667892|NCT04178967|455744813|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
126667893|NCT03681951|455744814|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
126667894|NCT03681951|455744815|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126667895|NCT03681951|455744816|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126667896|NCT03681951|455744817|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126667897|NCT03681951|455744818|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126667898|NCT03681951|455744819|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126667899|NCT03681951|455744820|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126667900|NCT03681951|455744821|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
126667901|NCT03681951|455744814|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
126667902|NCT03681951|455744815|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126667903|NCT03681951|455744816|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126667904|NCT03681951|455744817|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126667905|NCT03681951|455744818|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126667906|NCT03681951|455744819|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126667907|NCT03681951|455744820|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126667908|NCT03681951|455744821|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
126667909|NCT03681951|455744814|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
126336505|NCT05616013|454526891|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336506|NCT05616013|454526892|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336507|NCT05616013|454526893|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336508|NCT05616013|454526894|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
126336509|NCT05616013|454526895|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
126336510|NCT05116202|454526896|FG000|Overall Study|Study Terminated by Sponsor|21|||
126336511|NCT05116202|454526897|FG001|Overall Study|Study Terminated by Sponsor|38|||
126336512|NCT05116202|454526898|FG002|Overall Study|Study Terminated by Sponsor|17|||
126336513|NCT05116202|454526899|FG003|Overall Study|Study Terminated by Sponsor|18|||
126336514|NCT05116202|454526900|FG004|Overall Study|Study Terminated by Sponsor|0|||
126336515|NCT05116202|454526896|FG000|Overall Study|Withdrawal by Subject|0|||
126336516|NCT05116202|454526897|FG001|Overall Study|Withdrawal by Subject|1|||
126336517|NCT05116202|454526898|FG002|Overall Study|Withdrawal by Subject|1|||
126336518|NCT05116202|454526899|FG003|Overall Study|Withdrawal by Subject|1|||
126336519|NCT05116202|454526900|FG004|Overall Study|Withdrawal by Subject|1|||
126336520|NCT05116202|454526896|FG000|Overall Study|Lost to Follow-up|0|||
126336521|NCT05116202|454526897|FG001|Overall Study|Lost to Follow-up|0|||
126336522|NCT05116202|454526898|FG002|Overall Study|Lost to Follow-up|0|||
126336523|NCT05116202|454526899|FG003|Overall Study|Lost to Follow-up|0|||
126336524|NCT05116202|454526900|FG004|Overall Study|Lost to Follow-up|2|||
126336525|NCT05116202|454526896|FG000|Overall Study|Death|1|||
126336526|NCT05116202|454526897|FG001|Overall Study|Death|1|||
126336527|NCT05116202|454526898|FG002|Overall Study|Death|2|||
126336528|NCT05116202|454526899|FG003|Overall Study|Death|1|||
126336529|NCT05116202|454526900|FG004|Overall Study|Death|5|||
126336530|NCT02668640|454526913|FG000|Overall Study|Lost to Follow-up|13|||
126336531|NCT02668640|454526913|FG000|Overall Study|Other, not specified|1|||
126336532|NCT03669588|454526914|FG000|Overall Study|Adverse Event|1|||
126336533|NCT03669588|454526915|FG001|Overall Study|Adverse Event|0|||
126336534|NCT03669588|454526914|FG000|Overall Study|Physician Decision|0|||
126336535|NCT03669588|454526915|FG001|Overall Study|Physician Decision|1|||
126336536|NCT03669588|454526914|FG000|Overall Study|Protocol Violation|1|||
126336537|NCT03669588|454526915|FG001|Overall Study|Protocol Violation|0|||
126336538|NCT03669588|454526914|FG000|Overall Study|Sponsor Decision|1|||
126336539|NCT03669588|454526915|FG001|Overall Study|Sponsor Decision|1|||
126336540|NCT03669588|454526914|FG000|Overall Study|Withdrawal by Subject|1|||
126336541|NCT03669588|454526915|FG001|Overall Study|Withdrawal by Subject|4|||
126336542|NCT03669588|454526914|FG000|Overall Study|Rescue Therapy Needed|0|||
126336543|NCT03669588|454526915|FG001|Overall Study|Rescue Therapy Needed|1|||
126336544|NCT00369343|454526917|FG000|Double-blind Phase|Adverse Event|19|||
126336545|NCT00369343|454526918|FG001|Double-blind Phase|Adverse Event|4|||
126336546|NCT00369343|454526917|FG000|Double-blind Phase|Failed to return|2|||
126336547|NCT00369343|454526918|FG001|Double-blind Phase|Failed to return|0|||
126336548|NCT00369343|454526917|FG000|Double-blind Phase|Lost to Follow-up|9|||
126336549|NCT00369343|454526918|FG001|Double-blind Phase|Lost to Follow-up|2|||
126336550|NCT00369343|454526917|FG000|Double-blind Phase|Protocol Violation|2|||
126336551|NCT00369343|454526918|FG001|Double-blind Phase|Protocol Violation|0|||
126336552|NCT00369343|454526917|FG000|Double-blind Phase|Withdrawal by Subject|8|||
126336553|NCT00369343|454526918|FG001|Double-blind Phase|Withdrawal by Subject|6|||
126336554|NCT00369343|454526917|FG000|Double-blind Phase|Lack of Efficacy|0|||
126336555|NCT00369343|454526918|FG001|Double-blind Phase|Lack of Efficacy|4|||
126336556|NCT00369343|454526917|FG000|Double-blind Phase|Protocol deviation|4|||
126336557|NCT00369343|454526918|FG001|Double-blind Phase|Protocol deviation|0|||
126336558|NCT00369343|454526917|FG000|Open-label Phase|Adverse Event|19|||
126336559|NCT00369343|454526918|FG001|Open-label Phase|Adverse Event|7|||
126336560|NCT00369343|454526917|FG000|Open-label Phase|Failed to return|4|||
126336561|NCT00369343|454526918|FG001|Open-label Phase|Failed to return|0|||
126336562|NCT00369343|454526917|FG000|Open-label Phase|Physician Decision|2|||
126336563|NCT00369343|454526918|FG001|Open-label Phase|Physician Decision|0|||
126336564|NCT00369343|454526917|FG000|Open-label Phase|Lost to Follow-up|5|||
126336565|NCT00369343|454526918|FG001|Open-label Phase|Lost to Follow-up|3|||
126336566|NCT00369343|454526917|FG000|Open-label Phase|inadvertently reported study completers|3|||
126336567|NCT00369343|454526918|FG001|Open-label Phase|inadvertently reported study completers|2|||
126336568|NCT00369343|454526917|FG000|Open-label Phase|Protocol Violation|1|||
126336569|NCT00369343|454526918|FG001|Open-label Phase|Protocol Violation|3|||
126336570|NCT00369343|454526917|FG000|Open-label Phase|Withdrawal by Subject|15|||
126336571|NCT00369343|454526918|FG001|Open-label Phase|Withdrawal by Subject|6|||
126336572|NCT00369343|454526917|FG000|Open-label Phase|Lack of Efficacy|4|||
126336573|NCT00369343|454526918|FG001|Open-label Phase|Lack of Efficacy|3|||
126336574|NCT00369343|454526917|FG000|Open-label Phase|Lack of continuance tolerability|3|||
126336575|NCT00369343|454526918|FG001|Open-label Phase|Lack of continuance tolerability|4|||
126336576|NCT00369343|454526917|FG000|Open-label Phase|did not take study drug|1|||
126336577|NCT00369343|454526918|FG001|Open-label Phase|did not take study drug|2|||
126336578|NCT01100502|454526919|FG000|Overall Study|Withdrawal by Subject|18|||
126336579|NCT01100502|454526920|FG001|Overall Study|Withdrawal by Subject|25|||
126336580|NCT01100502|454526919|FG000|Overall Study|Lost to Follow-up|13|||
126336581|NCT01100502|454526920|FG001|Overall Study|Lost to Follow-up|28|||
126336582|NCT01100502|454526919|FG000|Overall Study|Site request to end participation in study|0|||
126336583|NCT01100502|454526920|FG001|Overall Study|Site request to end participation in study|1|||
126336584|NCT01100502|454526919|FG000|Overall Study|Death|45|||
126336585|NCT01100502|454526920|FG001|Overall Study|Death|40|||
126336586|NCT02322749|454526921|FG000|Period 2|Adverse Event|0|||
126336587|NCT02322749|454526922|FG001|Period 2|Adverse Event|0|||
126336588|NCT02322749|454526923|FG002|Period 2|Adverse Event|0|||
126336589|NCT02322749|454526924|FG003|Period 2|Adverse Event|1|||
126336590|NCT02322749|454526925|FG004|Period 2|Adverse Event|0|||
126336591|NCT02322749|454526926|FG005|Period 2|Adverse Event|0|||
126336592|NCT02322749|454526921|FG000|Period 2|Withdrawal by Subject|0|||
126336593|NCT02322749|454526922|FG001|Period 2|Withdrawal by Subject|0|||
126336594|NCT02322749|454526923|FG002|Period 2|Withdrawal by Subject|0|||
126336595|NCT02322749|454526924|FG003|Period 2|Withdrawal by Subject|1|||
126336596|NCT02322749|454526925|FG004|Period 2|Withdrawal by Subject|0|||
126336597|NCT02322749|454526926|FG005|Period 2|Withdrawal by Subject|0|||
126336598|NCT02322749|454526921|FG000|Period 3|Withdrawal by Subject|0|||
126336599|NCT02322749|454526922|FG001|Period 3|Withdrawal by Subject|0|||
126336600|NCT02322749|454526923|FG002|Period 3|Withdrawal by Subject|1|||
126336601|NCT02322749|454526924|FG003|Period 3|Withdrawal by Subject|0|||
126336602|NCT02322749|454526925|FG004|Period 3|Withdrawal by Subject|0|||
126667910|NCT03681951|455744815|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126667911|NCT03681951|455744816|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126667912|NCT03681951|455744817|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126667913|NCT03681951|455744818|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126667914|NCT03681951|455744819|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126667915|NCT03681951|455744820|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126667916|NCT03681951|455744821|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
126667917|NCT00628251|455744822|FG000|Randomised Part|Withdrawal by Subject|0|||
126667918|NCT00628251|455744823|FG001|Randomised Part|Withdrawal by Subject|0|||
126667919|NCT00628251|455744824|FG002|Randomised Part|Withdrawal by Subject|1|||
126667920|NCT00628251|455744822|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
126667921|NCT00628251|455744823|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
126667922|NCT00628251|455744824|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
126667923|NCT00628251|455744822|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
126667924|NCT00628251|455744823|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
126667925|NCT00628251|455744824|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
126667926|NCT00628251|455744822|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
126667927|NCT00628251|455744823|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
126667928|NCT00628251|455744824|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
126667929|NCT00628251|455744822|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
126336603|NCT02322749|454526926|FG005|Period 3|Withdrawal by Subject|0|||
126336604|NCT00073918|454526931|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
126336605|NCT00073918|454526931|FG000|Overall Study|Rapid disease progression|2|||
126336606|NCT00073918|454526931|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
126336607|NCT01190813|454526932|FG000|Overall Study|Lost to Follow-up|1|||
126336608|NCT01190813|454526933|FG001|Overall Study|Lost to Follow-up|2|||
126336609|NCT01190813|454526932|FG000|Overall Study|Withdrawal by Subject|2|||
126336610|NCT01190813|454526933|FG001|Overall Study|Withdrawal by Subject|1|||
126336611|NCT01190813|454526932|FG000|Overall Study|Refused study treatment after randomized|1|||
126336612|NCT01190813|454526933|FG001|Overall Study|Refused study treatment after randomized|0|||
126336613|NCT01190813|454526932|FG000|Overall Study|Adverse Event|0|||
126336614|NCT01190813|454526933|FG001|Overall Study|Adverse Event|1|||
126336615|NCT05158140|454526940|FG000|Overall Study|Death|0|||
126336616|NCT05158140|454526941|FG001|Overall Study|Death|0|||
126336617|NCT05158140|454526942|FG002|Overall Study|Death|0|||
126336618|NCT05158140|454526943|FG003|Overall Study|Death|1|||
126336619|NCT05158140|454526940|FG000|Overall Study|Lost to Follow-up|3|||
126336620|NCT05158140|454526941|FG001|Overall Study|Lost to Follow-up|6|||
126336621|NCT05158140|454526942|FG002|Overall Study|Lost to Follow-up|4|||
126336622|NCT05158140|454526943|FG003|Overall Study|Lost to Follow-up|3|||
126336623|NCT05158140|454526940|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126336624|NCT05158140|454526941|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126336625|NCT05158140|454526942|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
126336626|NCT05158140|454526943|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126336627|NCT05158140|454526940|FG000|Overall Study|Withdrawal by Subject|3|||
126336628|NCT05158140|454526941|FG001|Overall Study|Withdrawal by Subject|7|||
126336629|NCT05158140|454526942|FG002|Overall Study|Withdrawal by Subject|3|||
126336630|NCT05158140|454526943|FG003|Overall Study|Withdrawal by Subject|7|||
126336631|NCT04414787|454526948|FG000|Overall Study|Patient Death|18|||
126336632|NCT04414787|454526949|FG001|Overall Study|Patient Death|18|||
126336633|NCT04414787|454526950|FG002|Overall Study|Patient Death|15|||
126336634|NCT04414787|454526951|FG003|Overall Study|Patient Death|15|||
126336635|NCT04414787|454526948|FG000|Overall Study|Patient Hospitalization|1|||
126336636|NCT04414787|454526949|FG001|Overall Study|Patient Hospitalization|1|||
126336637|NCT04414787|454526950|FG002|Overall Study|Patient Hospitalization|2|||
126336638|NCT04414787|454526951|FG003|Overall Study|Patient Hospitalization|2|||
126336639|NCT04414787|454526948|FG000|Overall Study|Lost to Follow-up|7|||
126336640|NCT04414787|454526949|FG001|Overall Study|Lost to Follow-up|7|||
126336641|NCT04414787|454526950|FG002|Overall Study|Lost to Follow-up|5|||
126336642|NCT04414787|454526951|FG003|Overall Study|Lost to Follow-up|5|||
126336643|NCT04414787|454526948|FG000|Overall Study|Residence in post-acute care facility|3|||
126336644|NCT04414787|454526949|FG001|Overall Study|Residence in post-acute care facility|3|||
126336645|NCT04414787|454526950|FG002|Overall Study|Residence in post-acute care facility|5|||
126336646|NCT04414787|454526951|FG003|Overall Study|Residence in post-acute care facility|5|||
126336647|NCT00807365|454526952|FG000|Overall Study|Study Terminated|5|||
126336648|NCT00919633|454526953|FG000|Overall Study|Adverse Event|1|||
126336649|NCT00919633|454526954|FG001|Overall Study|Adverse Event|9|||
126336650|NCT00919633|454526955|FG002|Overall Study|Adverse Event|12|||
126336651|NCT00919633|454526956|FG003|Overall Study|Adverse Event|10|||
126336652|NCT00919633|454526953|FG000|Overall Study|Death|0|||
126336653|NCT00919633|454526954|FG001|Overall Study|Death|0|||
126336654|NCT00919633|454526955|FG002|Overall Study|Death|2|||
126336655|NCT00919633|454526956|FG003|Overall Study|Death|0|||
126336656|NCT00919633|454526953|FG000|Overall Study|Lack of Efficacy|17|||
126336657|NCT00919633|454526954|FG001|Overall Study|Lack of Efficacy|3|||
126336658|NCT00919633|454526955|FG002|Overall Study|Lack of Efficacy|2|||
126336659|NCT00919633|454526956|FG003|Overall Study|Lack of Efficacy|3|||
126336660|NCT00919633|454526953|FG000|Overall Study|Withdrawal by Subject|1|||
126336661|NCT00919633|454526954|FG001|Overall Study|Withdrawal by Subject|2|||
126336662|NCT00919633|454526955|FG002|Overall Study|Withdrawal by Subject|4|||
126336663|NCT00919633|454526956|FG003|Overall Study|Withdrawal by Subject|3|||
126336664|NCT00919633|454526953|FG000|Overall Study|Lost to Follow-up|3|||
126336665|NCT00919633|454526954|FG001|Overall Study|Lost to Follow-up|1|||
126336666|NCT00919633|454526955|FG002|Overall Study|Lost to Follow-up|0|||
126336667|NCT00919633|454526956|FG003|Overall Study|Lost to Follow-up|2|||
126336668|NCT00919633|454526953|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
126336669|NCT00919633|454526954|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
126336670|NCT00919633|454526955|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
126336671|NCT00919633|454526956|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
126336672|NCT00919633|454526953|FG000|Overall Study|Protocol Violation|0|||
126336673|NCT00919633|454526954|FG001|Overall Study|Protocol Violation|0|||
126336674|NCT00919633|454526955|FG002|Overall Study|Protocol Violation|0|||
126336675|NCT00919633|454526956|FG003|Overall Study|Protocol Violation|1|||
126336676|NCT00919633|454526953|FG000|Overall Study|Physician Decision|0|||
126336677|NCT00919633|454526954|FG001|Overall Study|Physician Decision|0|||
126336678|NCT00919633|454526955|FG002|Overall Study|Physician Decision|0|||
126336679|NCT00919633|454526956|FG003|Overall Study|Physician Decision|1|||
126336680|NCT00919633|454526953|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
126336681|NCT00919633|454526954|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
126336682|NCT00919633|454526955|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
126336683|NCT00919633|454526956|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
126336684|NCT00919633|454526953|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
126336685|NCT00919633|454526954|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
126336686|NCT00919633|454526955|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
126336687|NCT00919633|454526956|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
126667930|NCT00628251|455744823|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
126667931|NCT00628251|455744824|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
126667932|NCT00628251|455744822|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
126667933|NCT00628251|455744823|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
126667934|NCT00628251|455744824|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
126667935|NCT01020448|455744825|FG000|Pre-assignment|Adverse Event|6|||
126667936|NCT01020448|455744825|FG000|Pre-assignment|Withdrawal by Subject|5|||
126667937|NCT01020448|455744825|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
126667938|NCT01020448|455744825|FG000|Treatment|Adverse Event|11|||
126667939|NCT01020448|455744825|FG000|Treatment|Consent Withdrawn|3|||
126667940|NCT01020448|455744825|FG000|Treatment|Disease Progression|2|||
126667941|NCT01020448|455744825|FG000|Treatment|Lack of Efficacy|8|||
126667942|NCT01020448|455744825|FG000|Treatment|Lost to Follow-up|2|||
126667943|NCT00041067|455744826|FG000|Overall Study|Adverse Event|20|||
126667944|NCT00041067|455744826|FG000|Overall Study|Progression|19|||
126667945|NCT00041067|455744826|FG000|Overall Study|Patient refusal|12|||
126667946|NCT00041067|455744826|FG000|Overall Study|Other reasons|23|||
126667947|NCT00041067|455744826|FG000|Overall Study|Ineligible|2|||
126667948|NCT01968070|455744828|FG000|Period 1|Withdrawal by Subject|0|||
126667949|NCT01968070|455744829|FG001|Period 1|Withdrawal by Subject|1|||
126667950|NCT01968070|455744830|FG002|Period 1|Withdrawal by Subject|0|||
126667951|NCT01968070|455744831|FG003|Period 1|Withdrawal by Subject|0|||
126667952|NCT01968070|455744832|FG004|Period 1|Withdrawal by Subject|0|||
126336688|NCT01526785|454526957|FG000|Overall Study|Study Terminated by Sponsor|8|||
126336689|NCT01526785|454526957|FG000|Overall Study|Death|2|||
126336690|NCT01526785|454526957|FG000|Overall Study|Physician Decision|1|||
126336691|NCT01526785|454526957|FG000|Overall Study|Withdrawal by Subject|2|||
126336692|NCT01121263|454526960|FG000|Overall Study|Death|3|||
126336693|NCT01121263|454526961|FG001|Overall Study|Death|2|||
126336694|NCT01121263|454526960|FG000|Overall Study|Lost to Follow-up|22|||
126336695|NCT01121263|454526961|FG001|Overall Study|Lost to Follow-up|12|||
126336696|NCT01121263|454526960|FG000|Overall Study|Withdrawal by Subject|0|||
126336697|NCT01121263|454526961|FG001|Overall Study|Withdrawal by Subject|1|||
126336698|NCT02007720|454526962|FG000|Overall Study|Withdrawal by Subject|9|||
126336699|NCT02007720|454526963|FG001|Overall Study|Withdrawal by Subject|11|||
126336700|NCT02007720|454526962|FG000|Overall Study|study terminated by sponsor|58|||
126336701|NCT02007720|454526963|FG001|Overall Study|study terminated by sponsor|54|||
126336702|NCT02007720|454526962|FG000|Overall Study|technical problem|4|||
126336703|NCT02007720|454526963|FG001|Overall Study|technical problem|2|||
126667953|NCT01968070|455744833|FG005|Period 1|Withdrawal by Subject|0|||
126667954|NCT01968070|455744834|FG006|Period 1|Withdrawal by Subject|1|||
126667955|NCT01968070|455744835|FG007|Period 1|Withdrawal by Subject|0|||
126667956|NCT01968070|455744836|FG008|Period 1|Withdrawal by Subject|0|||
126667957|NCT01968070|455744837|FG009|Period 1|Withdrawal by Subject|0|||
126667958|NCT01968070|455744838|FG010|Period 1|Withdrawal by Subject|0|||
126667959|NCT01968070|455744839|FG011|Period 1|Withdrawal by Subject|0|||
126667960|NCT01968070|455744840|FG012|Period 1|Withdrawal by Subject|0|||
126667961|NCT01968070|455744841|FG013|Period 1|Withdrawal by Subject|0|||
126667962|NCT01968070|455744842|FG014|Period 1|Withdrawal by Subject|0|||
126667963|NCT01968070|455744843|FG015|Period 1|Withdrawal by Subject|1|||
126667964|NCT01968070|455744844|FG016|Period 1|Withdrawal by Subject|0|||
126667965|NCT01968070|455744845|FG017|Period 1|Withdrawal by Subject|0|||
126667966|NCT01968070|455744828|FG000|Period 1|Protocol Violation|0|||
126667967|NCT01968070|455744829|FG001|Period 1|Protocol Violation|0|||
126667968|NCT01968070|455744830|FG002|Period 1|Protocol Violation|0|||
126667969|NCT01968070|455744831|FG003|Period 1|Protocol Violation|1|||
126667970|NCT01968070|455744832|FG004|Period 1|Protocol Violation|1|||
126667971|NCT01968070|455744833|FG005|Period 1|Protocol Violation|0|||
126667972|NCT01968070|455744834|FG006|Period 1|Protocol Violation|0|||
126667973|NCT01968070|455744835|FG007|Period 1|Protocol Violation|0|||
126336704|NCT02007720|454526962|FG000|Overall Study|patient followd less than 165 days|11|||
126336705|NCT02007720|454526963|FG001|Overall Study|patient followd less than 165 days|5|||
126667974|NCT01968070|455744836|FG008|Period 1|Protocol Violation|0|||
126667975|NCT01968070|455744837|FG009|Period 1|Protocol Violation|0|||
126667976|NCT01968070|455744838|FG010|Period 1|Protocol Violation|0|||
126667977|NCT01968070|455744839|FG011|Period 1|Protocol Violation|0|||
126667978|NCT01968070|455744840|FG012|Period 1|Protocol Violation|0|||
126667979|NCT01968070|455744841|FG013|Period 1|Protocol Violation|0|||
126667980|NCT01968070|455744842|FG014|Period 1|Protocol Violation|0|||
126667981|NCT01968070|455744843|FG015|Period 1|Protocol Violation|0|||
126667982|NCT01968070|455744844|FG016|Period 1|Protocol Violation|0|||
126667983|NCT01968070|455744845|FG017|Period 1|Protocol Violation|0|||
126667984|NCT01968070|455744828|FG000|Period 1|Lost to Follow-up|0|||
126667985|NCT01968070|455744829|FG001|Period 1|Lost to Follow-up|0|||
126336706|NCT03810456|454526964|FG000|Treatment|Urgent Family Matters|3|||
126336707|NCT03810456|454526965|FG001|Treatment|Urgent Family Matters|0|||
126336708|NCT03810456|454526966|FG002|Treatment|Urgent Family Matters|0|||
126336709|NCT03810456|454526964|FG000|Treatment|Scheduling Conflicts|0|||
126336710|NCT03810456|454526965|FG001|Treatment|Scheduling Conflicts|11|||
126667986|NCT01968070|455744830|FG002|Period 1|Lost to Follow-up|0|||
126667987|NCT01968070|455744831|FG003|Period 1|Lost to Follow-up|1|||
126667988|NCT01968070|455744832|FG004|Period 1|Lost to Follow-up|0|||
126667989|NCT01968070|455744833|FG005|Period 1|Lost to Follow-up|0|||
126667990|NCT01968070|455744834|FG006|Period 1|Lost to Follow-up|0|||
126667991|NCT01968070|455744835|FG007|Period 1|Lost to Follow-up|0|||
126667992|NCT01968070|455744836|FG008|Period 1|Lost to Follow-up|0|||
126667993|NCT01968070|455744837|FG009|Period 1|Lost to Follow-up|0|||
126667994|NCT01968070|455744838|FG010|Period 1|Lost to Follow-up|0|||
126667995|NCT01968070|455744839|FG011|Period 1|Lost to Follow-up|0|||
126667996|NCT01968070|455744840|FG012|Period 1|Lost to Follow-up|0|||
126667997|NCT01968070|455744841|FG013|Period 1|Lost to Follow-up|0|||
126667998|NCT01968070|455744842|FG014|Period 1|Lost to Follow-up|0|||
126667999|NCT01968070|455744843|FG015|Period 1|Lost to Follow-up|0|||
126668000|NCT01968070|455744844|FG016|Period 1|Lost to Follow-up|0|||
126668001|NCT01968070|455744845|FG017|Period 1|Lost to Follow-up|0|||
126668002|NCT01968070|455744828|FG000|Period 1|Adverse Event|0|||
126668003|NCT01968070|455744829|FG001|Period 1|Adverse Event|0|||
126668004|NCT01968070|455744830|FG002|Period 1|Adverse Event|0|||
126668005|NCT01968070|455744831|FG003|Period 1|Adverse Event|0|||
126668006|NCT01968070|455744832|FG004|Period 1|Adverse Event|0|||
126668007|NCT01968070|455744833|FG005|Period 1|Adverse Event|0|||
126668008|NCT01968070|455744834|FG006|Period 1|Adverse Event|1|||
126668009|NCT01968070|455744835|FG007|Period 1|Adverse Event|0|||
126668010|NCT01968070|455744836|FG008|Period 1|Adverse Event|0|||
126668011|NCT01968070|455744837|FG009|Period 1|Adverse Event|0|||
126668012|NCT01968070|455744838|FG010|Period 1|Adverse Event|0|||
126668013|NCT01968070|455744839|FG011|Period 1|Adverse Event|0|||
126668014|NCT01968070|455744840|FG012|Period 1|Adverse Event|0|||
126668015|NCT01968070|455744841|FG013|Period 1|Adverse Event|0|||
126668016|NCT01968070|455744842|FG014|Period 1|Adverse Event|0|||
126668017|NCT01968070|455744843|FG015|Period 1|Adverse Event|0|||
126668018|NCT01968070|455744844|FG016|Period 1|Adverse Event|0|||
126668019|NCT01968070|455744845|FG017|Period 1|Adverse Event|0|||
126668020|NCT01968070|455744828|FG000|Period 1|Physician Decision|0|||
126668021|NCT01968070|455744829|FG001|Period 1|Physician Decision|0|||
126668022|NCT01968070|455744830|FG002|Period 1|Physician Decision|0|||
126668023|NCT01968070|455744831|FG003|Period 1|Physician Decision|0|||
126668024|NCT01968070|455744832|FG004|Period 1|Physician Decision|0|||
126668025|NCT01968070|455744833|FG005|Period 1|Physician Decision|0|||
126668026|NCT01968070|455744834|FG006|Period 1|Physician Decision|0|||
126668027|NCT01968070|455744835|FG007|Period 1|Physician Decision|0|||
126668028|NCT01968070|455744836|FG008|Period 1|Physician Decision|0|||
126668029|NCT01968070|455744837|FG009|Period 1|Physician Decision|0|||
126668030|NCT01968070|455744838|FG010|Period 1|Physician Decision|0|||
126668031|NCT01968070|455744839|FG011|Period 1|Physician Decision|1|||
126668032|NCT01968070|455744840|FG012|Period 1|Physician Decision|0|||
126668033|NCT01968070|455744841|FG013|Period 1|Physician Decision|0|||
126668034|NCT01968070|455744842|FG014|Period 1|Physician Decision|0|||
126668035|NCT01968070|455744843|FG015|Period 1|Physician Decision|0|||
126668036|NCT01968070|455744844|FG016|Period 1|Physician Decision|0|||
126668037|NCT01968070|455744845|FG017|Period 1|Physician Decision|0|||
126668038|NCT01968070|455744828|FG000|Period 2|Withdrawal by Subject|0|||
126668039|NCT01968070|455744829|FG001|Period 2|Withdrawal by Subject|0|||
126668040|NCT01968070|455744830|FG002|Period 2|Withdrawal by Subject|0|||
126668041|NCT01968070|455744831|FG003|Period 2|Withdrawal by Subject|0|||
126668042|NCT01968070|455744832|FG004|Period 2|Withdrawal by Subject|1|||
126668043|NCT01968070|455744833|FG005|Period 2|Withdrawal by Subject|0|||
126668044|NCT01968070|455744834|FG006|Period 2|Withdrawal by Subject|0|||
126668045|NCT01968070|455744835|FG007|Period 2|Withdrawal by Subject|0|||
126668046|NCT01968070|455744836|FG008|Period 2|Withdrawal by Subject|0|||
126668047|NCT01968070|455744837|FG009|Period 2|Withdrawal by Subject|0|||
126668048|NCT01968070|455744838|FG010|Period 2|Withdrawal by Subject|0|||
126668049|NCT01968070|455744839|FG011|Period 2|Withdrawal by Subject|0|||
126668050|NCT01968070|455744840|FG012|Period 2|Withdrawal by Subject|0|||
126668051|NCT01968070|455744841|FG013|Period 2|Withdrawal by Subject|0|||
126668052|NCT01968070|455744842|FG014|Period 2|Withdrawal by Subject|0|||
126668053|NCT01968070|455744843|FG015|Period 2|Withdrawal by Subject|0|||
126668054|NCT01968070|455744844|FG016|Period 2|Withdrawal by Subject|0|||
126668055|NCT01968070|455744845|FG017|Period 2|Withdrawal by Subject|0|||
126668056|NCT02401412|455744849|FG000|Overall Study|Lost to Follow-up|1|||
126668057|NCT02401412|455744850|FG001|Overall Study|Lost to Follow-up|0|||
126668058|NCT02401412|455744849|FG000|Overall Study|Discontinued Intervention|15|||
126668059|NCT02401412|455744850|FG001|Overall Study|Discontinued Intervention|21|||
126668060|NCT02401412|455744849|FG000|Overall Study|Withdrawal by Subject|4|||
126668061|NCT02401412|455744850|FG001|Overall Study|Withdrawal by Subject|4|||
126668062|NCT02401412|455744849|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
126668063|NCT02401412|455744850|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
126668064|NCT02401412|455744849|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
126668065|NCT02401412|455744850|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
126668066|NCT00882310|455744851|FG000|Overall Study|Screen Failure|10|||
126668067|NCT00882310|455744851|FG000|Overall Study|Never received treatment|1|||
126668068|NCT00882310|455744851|FG000|Overall Study|Death|6|||
126668069|NCT00882310|455744851|FG000|Overall Study|Progression of disease|4|||
126668070|NCT00882310|455744851|FG000|Overall Study|Adverse Event|1|||
126668071|NCT04246801|455744854|FG000|Overall Study|Adverse Event|1|||
126668072|NCT04246801|455744855|FG001|Overall Study|Adverse Event|1|||
126668073|NCT04246801|455744854|FG000|Overall Study|Protocol Violation|1|||
126668074|NCT04246801|455744855|FG001|Overall Study|Protocol Violation|1|||
126668075|NCT04246801|455744854|FG000|Overall Study|Lack of Efficacy|0|||
126668076|NCT04246801|455744855|FG001|Overall Study|Lack of Efficacy|2|||
126668077|NCT04246801|455744854|FG000|Overall Study|Lost to Follow-up|1|||
126668078|NCT04246801|455744855|FG001|Overall Study|Lost to Follow-up|1|||
126668079|NCT04246801|455744854|FG000|Overall Study|Withdrawal by Subject|2|||
126668080|NCT04246801|455744855|FG001|Overall Study|Withdrawal by Subject|1|||
126668081|NCT03684642|455744856|FG000|Overall Study|Adverse Event|6|||
126668082|NCT03684642|455744857|FG001|Overall Study|Adverse Event|15|||
126668083|NCT03684642|455744858|FG002|Overall Study|Adverse Event|11|||
126668084|NCT03684642|455744856|FG000|Overall Study|Withdrawal by Subject|35|||
126668085|NCT03684642|455744857|FG001|Overall Study|Withdrawal by Subject|53|||
126668086|NCT03684642|455744858|FG002|Overall Study|Withdrawal by Subject|23|||
126668087|NCT03684642|455744856|FG000|Overall Study|Lack of Efficacy|0|||
126668088|NCT03684642|455744857|FG001|Overall Study|Lack of Efficacy|0|||
126668089|NCT03684642|455744858|FG002|Overall Study|Lack of Efficacy|1|||
126668090|NCT03684642|455744856|FG000|Overall Study|Poor compliance to protocol|0|||
126668091|NCT03684642|455744857|FG001|Overall Study|Poor compliance to protocol|4|||
126668092|NCT03684642|455744858|FG002|Overall Study|Poor compliance to protocol|1|||
126668093|NCT03684642|455744856|FG000|Overall Study|Other than specified|62|||
126668094|NCT03684642|455744857|FG001|Overall Study|Other than specified|60|||
126668095|NCT03684642|455744858|FG002|Overall Study|Other than specified|67|||
126668096|NCT03684642|455744856|FG000|Overall Study|Randomized and not treated|0|||
126668097|NCT03684642|455744857|FG001|Overall Study|Randomized and not treated|0|||
126668098|NCT03684642|455744858|FG002|Overall Study|Randomized and not treated|1|||
126668099|NCT03684642|455744856|FG000|Overall Study|Missing completion status but alive at last contact|0|||
126668100|NCT03684642|455744857|FG001|Overall Study|Missing completion status but alive at last contact|1|||
126668101|NCT03684642|455744858|FG002|Overall Study|Missing completion status but alive at last contact|2|||
126668102|NCT04201821|455744867|FG000|Overall Study|Withdrawal by Subject|2|||
126668103|NCT00387764|455744868|FG000|Overall Study|Adverse Event|12|||
126668104|NCT00387764|455744868|FG000|Overall Study|Withdrawal by Subject|8|||
126668105|NCT00387764|455744868|FG000|Overall Study|Sponsor Terminated Study|1|||
126668106|NCT00387764|455744868|FG000|Overall Study|Physician Decision|1|||
126668107|NCT00387764|455744868|FG000|Overall Study|Other|2|||
126668108|NCT00387764|455744868|FG000|Overall Study|Death|7|||
126668109|NCT01326728|455744869|FG000|Overall Study|Death|13|||
126668110|NCT01326728|455744870|FG001|Overall Study|Death|0|||
126668111|NCT01326728|455744869|FG000|Overall Study|Early closure of study|34|||
126668112|NCT01326728|455744870|FG001|Overall Study|Early closure of study|9|||
126668113|NCT03785678|455744871|FG000|Overall Study|Death|44|||
126668114|NCT03785678|455744872|FG001|Overall Study|Death|42|||
126668115|NCT03785678|455744871|FG000|Overall Study|Lost to Follow-up|4|||
126668116|NCT03785678|455744872|FG001|Overall Study|Lost to Follow-up|2|||
126668117|NCT03785678|455744871|FG000|Overall Study|Physician Decision|0|||
126668118|NCT03785678|455744872|FG001|Overall Study|Physician Decision|2|||
126668119|NCT03785678|455744871|FG000|Overall Study|Withdrawal by Subject|5|||
126668120|NCT03785678|455744872|FG001|Overall Study|Withdrawal by Subject|3|||
126668121|NCT02374021|455744876|FG000|Overall Study|Adverse Event|1|||
126668122|NCT02374021|455744877|FG001|Overall Study|Adverse Event|0|||
126668123|NCT02374021|455744876|FG000|Overall Study|Lost to Follow-up|3|||
126668124|NCT02374021|455744877|FG001|Overall Study|Lost to Follow-up|2|||
126668125|NCT02374021|455744876|FG000|Overall Study|Physician Decision|0|||
126336711|NCT03810456|454526966|FG002|Treatment|Scheduling Conflicts|0|||
126336712|NCT03810456|454526964|FG000|Treatment|No Longer Interested|0|||
126336713|NCT03810456|454526965|FG001|Treatment|No Longer Interested|12|||
126668126|NCT02374021|455744877|FG001|Overall Study|Physician Decision|3|||
126668127|NCT02374021|455744876|FG000|Overall Study|Withdrawal by Subject|6|||
126668128|NCT02374021|455744877|FG001|Overall Study|Withdrawal by Subject|5|||
126668129|NCT02374021|455744876|FG000|Overall Study|Poor Adherence|0|||
126668130|NCT02374021|455744877|FG001|Overall Study|Poor Adherence|1|||
126668131|NCT02374021|455744876|FG000|Overall Study|Scan protocol not followed|0|||
126668132|NCT02374021|455744877|FG001|Overall Study|Scan protocol not followed|1|||
126668133|NCT02374021|455744876|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
126668134|NCT02374021|455744877|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
126668135|NCT01667107|455744878|FG000|Overall Study|Adverse Event|4|||
126668136|NCT01667107|455744879|FG001|Overall Study|Adverse Event|3|||
126668137|NCT01667107|455744878|FG000|Overall Study|Tolerability issues|0|||
126668138|NCT01667107|455744879|FG001|Overall Study|Tolerability issues|2|||
126668139|NCT01667107|455744878|FG000|Overall Study|Protocol Violation|0|||
126668140|NCT01667107|455744879|FG001|Overall Study|Protocol Violation|1|||
126668141|NCT01667107|455744878|FG000|Overall Study|Lack of Efficacy|0|||
126336714|NCT03810456|454526966|FG002|Treatment|No Longer Interested|0|||
126668142|NCT01667107|455744879|FG001|Overall Study|Lack of Efficacy|1|||
126668143|NCT02684279|455744880|FG000|Overall Study|Adverse Event|87|||
126668144|NCT02684279|455744880|FG000|Overall Study|Lack of Efficacy|4|||
126668145|NCT02684279|455744880|FG000|Overall Study|Lost to Follow-up|61|||
126668146|NCT02684279|455744880|FG000|Overall Study|Protocol Violation|6|||
126668147|NCT02684279|455744880|FG000|Overall Study|Pregnancy|8|||
126668148|NCT02684279|455744880|FG000|Overall Study|Withdrawal by Subject|92|||
126336715|NCT03810456|454526964|FG000|Treatment|Transportation Issues|0|||
126336716|NCT03810456|454526965|FG001|Treatment|Transportation Issues|1|||
126336717|NCT03810456|454526966|FG002|Treatment|Transportation Issues|0|||
126336718|NCT03810456|454526964|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
126336719|NCT03810456|454526965|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
126336720|NCT03810456|454526966|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
126336721|NCT03810456|454526964|FG000|1 Month Follow-Up|Relocated to Different State|1|||
126668149|NCT02684279|455744880|FG000|Overall Study|non-compliance with study drug|9|||
126668150|NCT02684279|455744880|FG000|Overall Study|non compliance with study visits|2|||
126668151|NCT02684279|455744880|FG000|Overall Study|subject to have surgery|1|||
126668152|NCT02684279|455744880|FG000|Overall Study|family emergency|1|||
126668153|NCT02684279|455744880|FG000|Overall Study|Site closures|7|||
126668154|NCT02684279|455744880|FG000|Overall Study|Physician Decision|1|||
126668155|NCT01162239|455744881|FG000|Treatment Phase|Withdrawal by Subject|1|||
126668156|NCT01162239|455744882|FG001|Treatment Phase|Withdrawal by Subject|3|||
126668157|NCT01162239|455744883|FG002|Treatment Phase|Withdrawal by Subject|2|||
126668158|NCT01162239|455744884|FG003|Treatment Phase|Withdrawal by Subject|3|||
126668159|NCT01162239|455744881|FG000|Treatment Phase|Death|0|||
126668160|NCT01162239|455744882|FG001|Treatment Phase|Death|0|||
126668161|NCT01162239|455744883|FG002|Treatment Phase|Death|0|||
126668162|NCT01162239|455744884|FG003|Treatment Phase|Death|1|||
126668163|NCT01162239|455744881|FG000|Treatment Phase|Lost to Follow-up|5|||
126668164|NCT01162239|455744882|FG001|Treatment Phase|Lost to Follow-up|4|||
126668165|NCT01162239|455744883|FG002|Treatment Phase|Lost to Follow-up|2|||
126668166|NCT01162239|455744884|FG003|Treatment Phase|Lost to Follow-up|1|||
126668167|NCT01162239|455744881|FG000|Extended Follow-up|Lost to Follow-up|8|||
126668168|NCT01162239|455744882|FG001|Extended Follow-up|Lost to Follow-up|13|||
126668169|NCT01162239|455744883|FG002|Extended Follow-up|Lost to Follow-up|8|||
126668170|NCT01162239|455744884|FG003|Extended Follow-up|Lost to Follow-up|6|||
126668171|NCT00228566|455744885|FG000|Overall Study|Adverse Event|31|||
126668172|NCT00228566|455744885|FG000|Overall Study|Lack of Efficacy|14|||
126668173|NCT00228566|455744885|FG000|Overall Study|Lost to Follow-up|16|||
126668174|NCT00228566|455744885|FG000|Overall Study|Physician Decision|5|||
126668175|NCT00228566|455744885|FG000|Overall Study|Withdrawal by Subject|4|||
126668176|NCT00228566|455744885|FG000|Overall Study|Miscellaneous|1|||
126668177|NCT04448756|455744886|FG000|Overall Study|Adverse Event|0|||
126668178|NCT04448756|455744887|FG001|Overall Study|Adverse Event|1|||
126668179|NCT04448756|455744888|FG002|Overall Study|Adverse Event|0|||
126668180|NCT04448756|455744886|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
126668181|NCT04448756|455744887|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
126668182|NCT04448756|455744888|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
126336722|NCT03810456|454526965|FG001|1 Month Follow-Up|Relocated to Different State|0|||
126336723|NCT03810456|454526966|FG002|1 Month Follow-Up|Relocated to Different State|1|||
126336724|NCT03810456|454526964|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
126336725|NCT03810456|454526965|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
126336726|NCT03810456|454526966|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
126336727|NCT03810456|454526964|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
126336728|NCT03810456|454526965|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
126336729|NCT03810456|454526966|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
126336730|NCT03810456|454526964|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
126336731|NCT03810456|454526965|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
126668183|NCT04448756|455744886|FG000|Overall Study|Withdrawal by Subject|0|||
126668184|NCT04448756|455744887|FG001|Overall Study|Withdrawal by Subject|3|||
126668185|NCT04448756|455744888|FG002|Overall Study|Withdrawal by Subject|1|||
126668186|NCT04448756|455744886|FG000|Overall Study|Death|2|||
126668187|NCT04448756|455744887|FG001|Overall Study|Death|1|||
126668188|NCT04448756|455744888|FG002|Overall Study|Death|0|||
126668189|NCT00232141|455744889|FG000|Overall Study|Adverse Event|9|||
126668190|NCT00232141|455744890|FG001|Overall Study|Adverse Event|4|||
126668191|NCT00232141|455744889|FG000|Overall Study|Lack of Efficacy|0|||
126668192|NCT00232141|455744890|FG001|Overall Study|Lack of Efficacy|3|||
126668193|NCT00232141|455744889|FG000|Overall Study|Lost to Follow-up|9|||
126336732|NCT03810456|454526966|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
126336733|NCT03810456|454526964|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
126336734|NCT03810456|454526965|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
126336735|NCT03810456|454526966|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
126668194|NCT00232141|455744890|FG001|Overall Study|Lost to Follow-up|6|||
126668195|NCT00232141|455744889|FG000|Overall Study|Other|8|||
126668196|NCT00232141|455744890|FG001|Overall Study|Other|10|||
126668197|NCT00232141|455744889|FG000|Overall Study|Withdrawal by Subject|5|||
126336736|NCT03810456|454526964|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
126668198|NCT00232141|455744890|FG001|Overall Study|Withdrawal by Subject|3|||
126668199|NCT04572854|455744891|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
126668200|NCT04572854|455744892|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
126668201|NCT04572854|455744893|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
126336737|NCT03810456|454526965|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
126336738|NCT03810456|454526966|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
126668202|NCT04572854|455744894|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
126668203|NCT04572854|455744891|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
126668204|NCT04572854|455744892|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
126668205|NCT04572854|455744893|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
126336739|NCT04194814|454526971|FG000|Overall Study|Physician Decision|3|||
126336740|NCT04194814|454526972|FG001|Overall Study|Physician Decision|0|||
126336741|NCT04194814|454526971|FG000|Overall Study|Withdrawal by Subject|0|||
126668206|NCT04572854|455744894|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
126668207|NCT01093326|455744896|FG000|Overall Study|Death|0|||
126668208|NCT01093326|455744897|FG001|Overall Study|Death|1|||
126668209|NCT01093326|455744898|FG002|Overall Study|Death|0|||
126668210|NCT01093326|455744896|FG000|Overall Study|Lack of Efficacy|7|||
126668211|NCT01093326|455744897|FG001|Overall Study|Lack of Efficacy|6|||
126668212|NCT01093326|455744898|FG002|Overall Study|Lack of Efficacy|3|||
126668213|NCT01093326|455744896|FG000|Overall Study|Lost to Follow-up|2|||
126668214|NCT01093326|455744897|FG001|Overall Study|Lost to Follow-up|5|||
126668215|NCT01093326|455744898|FG002|Overall Study|Lost to Follow-up|4|||
126668216|NCT01093326|455744896|FG000|Overall Study|Physician Decision|3|||
126668217|NCT01093326|455744897|FG001|Overall Study|Physician Decision|1|||
126668218|NCT01093326|455744898|FG002|Overall Study|Physician Decision|3|||
126668219|NCT01093326|455744896|FG000|Overall Study|Withdrawal by Subject|30|||
126668220|NCT01093326|455744897|FG001|Overall Study|Withdrawal by Subject|27|||
126668221|NCT01093326|455744898|FG002|Overall Study|Withdrawal by Subject|26|||
126668222|NCT01093326|455744896|FG000|Overall Study|Adverse Event|2|||
126668223|NCT01093326|455744897|FG001|Overall Study|Adverse Event|1|||
126668224|NCT01093326|455744898|FG002|Overall Study|Adverse Event|4|||
126668225|NCT01093326|455744896|FG000|Overall Study|Other|0|||
126668226|NCT01093326|455744897|FG001|Overall Study|Other|0|||
126668227|NCT01093326|455744898|FG002|Overall Study|Other|1|||
126668228|NCT01444456|455744899|FG000|Overall Study|Withdrawal by Subject|21|||
126668229|NCT01444456|455744899|FG000|Overall Study|Physician Decision|9|||
126668230|NCT01444456|455744899|FG000|Overall Study|Lost to Follow-up|37|||
126668231|NCT01444456|455744899|FG000|Overall Study|Death|73|||
126668232|NCT01444456|455744899|FG000|Overall Study|Ineligibility determined|23|||
126668233|NCT01444456|455744899|FG000|Overall Study|Other|18|||
126668234|NCT01444456|455744899|FG000|Overall Study|Not treated|104|||
126668235|NCT04263896|455744900|FG000|Overall Study|Withdrawal by Subject|2|||
126668236|NCT04263896|455744901|FG001|Overall Study|Withdrawal by Subject|4|||
126668237|NCT04263896|455744900|FG000|Overall Study|converted to open procedure|0|||
126668238|NCT04263896|455744901|FG001|Overall Study|converted to open procedure|1|||
126668239|NCT04263896|455744900|FG000|Overall Study|Lost to Follow-up|9|||
126668240|NCT04263896|455744901|FG001|Overall Study|Lost to Follow-up|11|||
126668241|NCT04263896|455744900|FG000|Overall Study|surveys lost in mail|5|||
126668242|NCT04263896|455744901|FG001|Overall Study|surveys lost in mail|3|||
126668243|NCT04263896|455744900|FG000|Overall Study|excluded from analysis|1|||
126668244|NCT04263896|455744901|FG001|Overall Study|excluded from analysis|0|||
126668245|NCT04313153|455746159|FG000|Overall Study|Adverse Event (includes Death)|14|||
126668246|NCT04313153|455746160|FG001|Overall Study|Adverse Event (includes Death)|19|||
126668247|NCT04313153|455746161|FG002|Overall Study|Adverse Event (includes Death)|10|||
126668248|NCT04313153|455746159|FG000|Overall Study|Physician Decision|4|||
126668249|NCT04313153|455746160|FG001|Overall Study|Physician Decision|2|||
126668250|NCT04313153|455746161|FG002|Overall Study|Physician Decision|1|||
126668251|NCT04313153|455746159|FG000|Overall Study|Withdrawal by Subject|7|||
126668252|NCT04313153|455746160|FG001|Overall Study|Withdrawal by Subject|6|||
126668253|NCT04313153|455746161|FG002|Overall Study|Withdrawal by Subject|2|||
126668254|NCT04313153|455746159|FG000|Overall Study|Lack of Efficacy|3|||
126668255|NCT04313153|455746160|FG001|Overall Study|Lack of Efficacy|3|||
126336742|NCT04194814|454526972|FG001|Overall Study|Withdrawal by Subject|2|||
126336743|NCT03246347|454528363|FG000|Overall Study|On Study|23|||
126336744|NCT00329108|454528364|FG000|Overall Study|Adverse Event|2|||
126668256|NCT04313153|455746161|FG002|Overall Study|Lack of Efficacy|0|||
126668257|NCT04313153|455746159|FG000|Overall Study|Lost to Follow-up|1|||
126668258|NCT04313153|455746160|FG001|Overall Study|Lost to Follow-up|0|||
126668259|NCT04313153|455746161|FG002|Overall Study|Lost to Follow-up|2|||
126668260|NCT04313153|455746159|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
126668261|NCT04313153|455746160|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
126668262|NCT04313153|455746161|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
126668263|NCT04313153|455746159|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
126668264|NCT04313153|455746160|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
126668265|NCT04313153|455746161|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
126668266|NCT04313153|455746159|FG000|Overall Study|Change in Dialysis Modality|0|||
126668267|NCT04313153|455746160|FG001|Overall Study|Change in Dialysis Modality|1|||
126668268|NCT04313153|455746161|FG002|Overall Study|Change in Dialysis Modality|2|||
126668269|NCT04313153|455746159|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
126668270|NCT04313153|455746160|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
126668271|NCT04313153|455746161|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
126668272|NCT04313153|455746159|FG000|Overall Study|Other|5|||
126668273|NCT04313153|455746160|FG001|Overall Study|Other|3|||
126668274|NCT04313153|455746161|FG002|Overall Study|Other|2|||
126668275|NCT05586269|455746162|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
126668276|NCT05586269|455746163|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
126668277|NCT05586269|455746164|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
126668278|NCT05586269|455746165|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
126668279|NCT05586269|455746162|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
126668280|NCT05586269|455746163|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
126668281|NCT05586269|455746164|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
126668282|NCT05586269|455746165|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
126668283|NCT02113579|455746168|FG000|Overall Study|Adverse Event|1|||
126668284|NCT02113579|455746169|FG001|Overall Study|Adverse Event|0|||
126668285|NCT02113579|455746168|FG000|Overall Study|Withdrawal by Subject|3|||
126668286|NCT02113579|455746169|FG001|Overall Study|Withdrawal by Subject|2|||
126668287|NCT02113579|455746168|FG000|Overall Study|Lost to Follow-up|6|||
126668288|NCT02113579|455746169|FG001|Overall Study|Lost to Follow-up|2|||
126668289|NCT00088907|455746170|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
126668290|NCT00088907|455746171|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
126668291|NCT00088907|455746170|FG000|Randomized Study (Step 1)|Adverse Event|14|||
126668292|NCT00088907|455746171|FG001|Randomized Study (Step 1)|Adverse Event|19|||
126668293|NCT00088907|455746170|FG000|Randomized Study (Step 1)|Death|11|||
126668294|NCT00088907|455746171|FG001|Randomized Study (Step 1)|Death|12|||
126668295|NCT00088907|455746170|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
126668296|NCT00088907|455746171|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
126668297|NCT00088907|455746170|FG000|Randomized Study (Step 1)|complicating disease|3|||
126668298|NCT00088907|455746171|FG001|Randomized Study (Step 1)|complicating disease|1|||
126668299|NCT00088907|455746170|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
126668300|NCT00088907|455746171|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
126668301|NCT00088907|455746170|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
126668302|NCT00088907|455746171|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
126668303|NCT00088907|455746170|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
126668304|NCT00088907|455746171|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
126668305|NCT00088907|455746170|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
126668306|NCT00088907|455746171|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
126668307|NCT00088907|455746170|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
126668308|NCT00088907|455746171|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
126668309|NCT00088907|455746170|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
126668310|NCT00088907|455746171|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
126668311|NCT03426787|455746176|FG000|Overall Study|Withdrawal by Subject|6|||
126668312|NCT03426787|455746176|FG000|Overall Study|Lost to Follow-up|7|||
126668313|NCT03426787|455746176|FG000|Overall Study|Unrelated to intervention death|1|||
126668314|NCT02217436|455746177|FG000|Overall Study|Protocol Violation|1|||
126668315|NCT02217436|455746178|FG001|Overall Study|Protocol Violation|1|||
126668316|NCT02217436|455746177|FG000|Overall Study|Incomplete data|0|||
126668317|NCT02217436|455746178|FG001|Overall Study|Incomplete data|1|||
126668318|NCT04641299|455746181|FG000|Overall Study|Adverse Event|0|||
126668319|NCT04641299|455746182|FG001|Overall Study|Adverse Event|0|||
126668320|NCT04641299|455746183|FG002|Overall Study|Adverse Event|2|||
126668321|NCT04641299|455746184|FG003|Overall Study|Adverse Event|0|||
126668322|NCT04641299|455746181|FG000|Overall Study|Lost to Follow-up|0|||
126668323|NCT04641299|455746182|FG001|Overall Study|Lost to Follow-up|1|||
126668324|NCT04641299|455746183|FG002|Overall Study|Lost to Follow-up|0|||
126668325|NCT04641299|455746184|FG003|Overall Study|Lost to Follow-up|0|||
126668326|NCT04641299|455746181|FG000|Overall Study|Withdrawal by Subject|1|||
126668327|NCT04641299|455746182|FG001|Overall Study|Withdrawal by Subject|0|||
126668328|NCT04641299|455746183|FG002|Overall Study|Withdrawal by Subject|0|||
126668329|NCT04641299|455746184|FG003|Overall Study|Withdrawal by Subject|0|||
126336745|NCT00329108|454528365|FG001|Overall Study|Adverse Event|2|||
126668330|NCT04641299|455746181|FG000|Overall Study|Reason not given|1|||
126668331|NCT04641299|455746182|FG001|Overall Study|Reason not given|0|||
126668332|NCT04641299|455746183|FG002|Overall Study|Reason not given|0|||
126668333|NCT04641299|455746184|FG003|Overall Study|Reason not given|0|||
126668334|NCT01016964|455746185|FG000|Overall Study|Lost to Follow-up|3|||
126668335|NCT01016964|455746186|FG001|Overall Study|Lost to Follow-up|3|||
126668336|NCT01920594|455746187|FG000|Overall Study|Adverse Event|4|||
126668337|NCT01920594|455746188|FG001|Overall Study|Adverse Event|2|||
126668338|NCT01920594|455746187|FG000|Overall Study|Lost to Follow-up|1|||
126668339|NCT01920594|455746188|FG001|Overall Study|Lost to Follow-up|0|||
126668340|NCT01920594|455746187|FG000|Overall Study|Recovery|2|||
126668341|NCT01920594|455746188|FG001|Overall Study|Recovery|0|||
126668342|NCT01920594|455746187|FG000|Overall Study|Investigator discretion|0|||
126668343|NCT01920594|455746188|FG001|Overall Study|Investigator discretion|1|||
126668344|NCT00928564|455746189|FG000|Overall Study|Lost to Follow-up|6|||
126668345|NCT00928564|455746190|FG001|Overall Study|Lost to Follow-up|0|||
126668346|NCT02460497|455746194|FG000|Overall Study|Participant Requested Withdrawal|4|||
126668347|NCT02460497|455746194|FG000|Overall Study|Non-Compliance|1|||
126668348|NCT02460497|455746194|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
126668349|NCT02460497|455746194|FG000|Overall Study|Lost to Follow-up|2|||
126668350|NCT02460497|455746194|FG000|Overall Study|Investigator Decision|1|||
126668351|NCT02012296|455746199|FG000|Overall Study|Lack of Efficacy|0|||
126668352|NCT02012296|455746200|FG001|Overall Study|Lack of Efficacy|0|||
126668353|NCT02012296|455746201|FG002|Overall Study|Lack of Efficacy|15|||
126668354|NCT02012296|455746199|FG000|Overall Study|Adverse Event|0|||
126668355|NCT02012296|455746200|FG001|Overall Study|Adverse Event|0|||
126668356|NCT02012296|455746201|FG002|Overall Study|Adverse Event|2|||
126668357|NCT02012296|455746199|FG000|Overall Study|Early study closure|0|||
126668358|NCT02012296|455746200|FG001|Overall Study|Early study closure|0|||
126668359|NCT02012296|455746201|FG002|Overall Study|Early study closure|5|||
126668360|NCT02012296|455746199|FG000|Overall Study|Protocol Violation|0|||
126668361|NCT02012296|455746200|FG001|Overall Study|Protocol Violation|1|||
126668362|NCT02012296|455746201|FG002|Overall Study|Protocol Violation|0|||
126668363|NCT01330914|455746202|FG000|Overall Study|Withdrawal by Subject|4|||
126668364|NCT01330914|455746202|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
126668365|NCT02615470|455746203|FG000|Overall Study|Lost to Follow-up|21|||
126668366|NCT02615470|455746204|FG001|Overall Study|Lost to Follow-up|32|||
126668367|NCT01650285|455746208|FG000|Overall Study|Adverse Event|1|||
126668368|NCT00907257|455746215|FG000|Overall Study|Adverse Event|0|||
126668369|NCT00907257|455746216|FG001|Overall Study|Adverse Event|4|||
126668370|NCT00907257|455746215|FG000|Overall Study|Protocol Violation|1|||
126668371|NCT00907257|455746216|FG001|Overall Study|Protocol Violation|2|||
126668372|NCT00907257|455746215|FG000|Overall Study|Lost to Follow-up|3|||
126668373|NCT00907257|455746216|FG001|Overall Study|Lost to Follow-up|3|||
126668374|NCT00907257|455746215|FG000|Overall Study|Withdrawal by Subject|1|||
126668375|NCT00907257|455746216|FG001|Overall Study|Withdrawal by Subject|2|||
126668376|NCT00907257|455746215|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
126336746|NCT00329108|454528364|FG000|Overall Study|Lack of Efficacy|3|||
126336747|NCT00329108|454528365|FG001|Overall Study|Lack of Efficacy|3|||
126336748|NCT00329108|454528364|FG000|Overall Study|Withdrawal by Subject|0|||
126336749|NCT00329108|454528365|FG001|Overall Study|Withdrawal by Subject|2|||
126336750|NCT00329108|454528364|FG000|Overall Study|symptomatic deterioration|1|||
126336751|NCT00329108|454528365|FG001|Overall Study|symptomatic deterioration|1|||
126336752|NCT00329108|454528364|FG000|Overall Study|Subject no longer willing to participate|2|||
126336753|NCT00329108|454528365|FG001|Overall Study|Subject no longer willing to participate|2|||
126336754|NCT00329108|454528364|FG000|Overall Study|study terminated by sponsor|1|||
126336755|NCT00329108|454528365|FG001|Overall Study|study terminated by sponsor|0|||
126336756|NCT00329108|454528364|FG000|Overall Study|withdrew patient after SAE resolved|1|||
126336757|NCT00329108|454528365|FG001|Overall Study|withdrew patient after SAE resolved|0|||
126336758|NCT00329108|454528364|FG000|Overall Study|Protocol Violation|0|||
126336759|NCT00329108|454528365|FG001|Overall Study|Protocol Violation|2|||
126336760|NCT00903201|454528366|FG000|Overall Study|Adverse Event|1|||
126336761|NCT00903201|454528367|FG001|Overall Study|Adverse Event|4|||
126336762|NCT00903201|454528368|FG002|Overall Study|Adverse Event|0|||
126336763|NCT00903201|454528366|FG000|Overall Study|Protocol Violation|2|||
126336764|NCT00903201|454528367|FG001|Overall Study|Protocol Violation|1|||
126336765|NCT00903201|454528368|FG002|Overall Study|Protocol Violation|0|||
126336766|NCT00903201|454528366|FG000|Overall Study|Lost to Follow-up|0|||
126336767|NCT00903201|454528367|FG001|Overall Study|Lost to Follow-up|1|||
126668377|NCT00907257|455746216|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
126668378|NCT00907257|455746215|FG000|Overall Study|Moved|1|||
126336768|NCT00903201|454528368|FG002|Overall Study|Lost to Follow-up|0|||
126668379|NCT00907257|455746216|FG001|Overall Study|Moved|0|||
126668380|NCT00907257|455746215|FG000|Overall Study|Personal Reasons|6|||
126668381|NCT00907257|455746216|FG001|Overall Study|Personal Reasons|1|||
126668382|NCT04163900|455746217|FG000|Overall Study|Radiological disease progression|112|||
126668383|NCT04163900|455746218|FG001|Overall Study|Radiological disease progression|127|||
126668384|NCT04163900|455746217|FG000|Overall Study|Study closure|98|||
126668385|NCT04163900|455746218|FG001|Overall Study|Study closure|133|||
126336769|NCT00903201|454528366|FG000|Overall Study|Physician Decision|1|||
126668386|NCT04163900|455746217|FG000|Overall Study|Adverse Event|78|||
126668387|NCT04163900|455746218|FG001|Overall Study|Adverse Event|32|||
126336770|NCT00903201|454528367|FG001|Overall Study|Physician Decision|0|||
126668388|NCT04163900|455746217|FG000|Overall Study|Withdrawal by Subject|37|||
126668389|NCT04163900|455746218|FG001|Overall Study|Withdrawal by Subject|34|||
126668390|NCT04163900|455746217|FG000|Overall Study|Death|29|||
126668391|NCT04163900|455746218|FG001|Overall Study|Death|16|||
126668392|NCT04163900|455746217|FG000|Overall Study|Physician Decision|17|||
126668393|NCT04163900|455746218|FG001|Overall Study|Physician Decision|25|||
126668394|NCT04163900|455746217|FG000|Overall Study|Clinical disease progression|14|||
126668395|NCT04163900|455746218|FG001|Overall Study|Clinical disease progression|13|||
126668396|NCT04163900|455746217|FG000|Overall Study|Protocol Violation|3|||
126668397|NCT04163900|455746218|FG001|Overall Study|Protocol Violation|4|||
126668398|NCT04163900|455746217|FG000|Overall Study|Lost to Follow-up|0|||
126336771|NCT00903201|454528368|FG002|Overall Study|Physician Decision|1|||
126336772|NCT00903201|454528366|FG000|Overall Study|Withdrawal by Subject|1|||
126668399|NCT04163900|455746218|FG001|Overall Study|Lost to Follow-up|1|||
126668400|NCT00283049|455746219|FG000|Overall Study|Adverse Event|6|||
126668401|NCT00283049|455746220|FG001|Overall Study|Adverse Event|1|||
126668402|NCT00283049|455746221|FG002|Overall Study|Adverse Event|4|||
126668403|NCT00283049|455746219|FG000|Overall Study|Protocol Violation|3|||
126668404|NCT00283049|455746220|FG001|Overall Study|Protocol Violation|0|||
126668405|NCT00283049|455746221|FG002|Overall Study|Protocol Violation|3|||
126668406|NCT00283049|455746219|FG000|Overall Study|Death|1|||
126668407|NCT00283049|455746220|FG001|Overall Study|Death|1|||
126668408|NCT00283049|455746221|FG002|Overall Study|Death|1|||
126668409|NCT00283049|455746219|FG000|Overall Study|Lack of Efficacy|0|||
126668410|NCT00283049|455746220|FG001|Overall Study|Lack of Efficacy|1|||
126668411|NCT00283049|455746221|FG002|Overall Study|Lack of Efficacy|1|||
126668412|NCT00283049|455746219|FG000|Overall Study|Lost to Follow-up|4|||
126668413|NCT00283049|455746220|FG001|Overall Study|Lost to Follow-up|2|||
126668414|NCT00283049|455746221|FG002|Overall Study|Lost to Follow-up|5|||
126668415|NCT00283049|455746219|FG000|Overall Study|Withdrawal by Subject|26|||
126668416|NCT00283049|455746220|FG001|Overall Study|Withdrawal by Subject|24|||
126668417|NCT00283049|455746221|FG002|Overall Study|Withdrawal by Subject|19|||
126668418|NCT00283049|455746219|FG000|Overall Study|Discontinuation of Study|18|||
126336773|NCT00903201|454528367|FG001|Overall Study|Withdrawal by Subject|0|||
126336774|NCT00903201|454528368|FG002|Overall Study|Withdrawal by Subject|1|||
126336775|NCT01389232|454528369|FG000|Overall Study|Had scaffold removed|15|||
126336776|NCT01389232|454528369|FG000|Overall Study|Personal reasons|2|||
126336777|NCT01389232|454528369|FG000|Overall Study|Adverse Event|1|||
126336778|NCT01389232|454528369|FG000|Overall Study|Death|1|||
126336779|NCT03205150|454528370|FG000|Overall Study|Protocol deviation|1|||
126336780|NCT03205150|454528371|FG001|Overall Study|Protocol deviation|3|||
126336781|NCT03205150|454528372|FG002|Overall Study|Protocol deviation|0|||
126336782|NCT03205150|454528370|FG000|Overall Study|Patient/guardian decision|0|||
126336783|NCT03205150|454528371|FG001|Overall Study|Patient/guardian decision|3|||
126336784|NCT03205150|454528372|FG002|Overall Study|Patient/guardian decision|0|||
126336785|NCT03205150|454528370|FG000|Overall Study|Adverse Event|1|||
126336786|NCT03205150|454528371|FG001|Overall Study|Adverse Event|1|||
126336787|NCT03205150|454528372|FG002|Overall Study|Adverse Event|1|||
126336788|NCT03205150|454528370|FG000|Overall Study|Lost to Follow-up|0|||
126336789|NCT03205150|454528371|FG001|Overall Study|Lost to Follow-up|0|||
126336790|NCT03205150|454528372|FG002|Overall Study|Lost to Follow-up|1|||
126336791|NCT00789321|454528377|FG000|Overall Study|Adverse Event|0|||
126336792|NCT00789321|454528378|FG001|Overall Study|Adverse Event|1|||
126336793|NCT01162343|454528379|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
126336794|NCT01162343|454528379|FG000|Overall Study|Refused psychiatrist assessment|12|||
126336795|NCT03964207|454528381|FG000|First Treatment|Withdrawal by Subject|1|||
126336796|NCT03964207|454528382|FG001|First Treatment|Withdrawal by Subject|2|||
126336797|NCT03964207|454528381|FG000|First Treatment|Protocol Violation|1|||
126336798|NCT03964207|454528382|FG001|First Treatment|Protocol Violation|0|||
126336799|NCT03964207|454528381|FG000|First Treatment|Lost to Follow-up|1|||
126336800|NCT03964207|454528382|FG001|First Treatment|Lost to Follow-up|0|||
126336801|NCT03964207|454528381|FG000|Second Treatment|Lost to Follow-up|0|||
126336802|NCT03964207|454528382|FG001|Second Treatment|Lost to Follow-up|1|||
126336803|NCT03964207|454528381|FG000|Second Treatment|Adverse Event|1|||
126336804|NCT03964207|454528382|FG001|Second Treatment|Adverse Event|2|||
126336805|NCT01930539|454528384|FG000|Overall Study|Withdrawal by Subject|2|||
126336806|NCT01930539|454528385|FG001|Overall Study|Withdrawal by Subject|2|||
126336807|NCT01405560|454528390|FG000|Overall Study|Physician Decision|1|||
126336808|NCT02119299|454528392|FG000|Overall Study|Withdrawal by Subject|7|||
126336809|NCT02119299|454528392|FG000|Overall Study|Lack of Efficacy|1|||
126336810|NCT02119299|454528392|FG000|Overall Study|Pregnancy|1|||
126668419|NCT00283049|455746220|FG001|Overall Study|Discontinuation of Study|16|||
126668420|NCT00283049|455746221|FG002|Overall Study|Discontinuation of Study|20|||
126668421|NCT00283049|455746219|FG000|Overall Study|No longer requires study treatment|0|||
126668422|NCT00283049|455746220|FG001|Overall Study|No longer requires study treatment|0|||
126668423|NCT00283049|455746221|FG002|Overall Study|No longer requires study treatment|1|||
126668424|NCT01830855|455746222|FG000|Overall Study|Other|7|||
126336811|NCT00744939|454528393|FG000|Overall Study|Withdrawal by Subject|9|||
126336812|NCT00744939|454528393|FG000|Overall Study|Protocol Violation|13|||
126668425|NCT01830855|455746223|FG001|Overall Study|Other|1|||
126668426|NCT01830855|455746224|FG002|Overall Study|Other|4|||
126336813|NCT00744939|454528393|FG000|Overall Study|Death|24|||
126336814|NCT00744939|454528393|FG000|Overall Study|distance|4|||
126336815|NCT00744939|454528393|FG000|Overall Study|Lost to Follow-up|12|||
126336816|NCT00744939|454528393|FG000|Overall Study|Medical history exclusionary|1|||
126336817|NCT00744939|454528393|FG000|Overall Study|Did not receive Magnevist|7|||
126336818|NCT00744939|454528393|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
126336819|NCT00744939|454528393|FG000|Overall Study|coma|1|||
126336820|NCT00744939|454528393|FG000|Overall Study|incorrect race|1|||
126336821|NCT02452047|454528394|FG000|Overall Study|Adverse Event|0|||
126336822|NCT02452047|454528395|FG001|Overall Study|Adverse Event|1|||
126336823|NCT02452047|454528396|FG002|Overall Study|Adverse Event|1|||
126336824|NCT02452047|454528394|FG000|Overall Study|Death|1|||
126336825|NCT02452047|454528395|FG001|Overall Study|Death|3|||
126336826|NCT02452047|454528396|FG002|Overall Study|Death|1|||
126336827|NCT02452047|454528394|FG000|Overall Study|Physician Decision|1|||
126336828|NCT02452047|454528395|FG001|Overall Study|Physician Decision|0|||
126336829|NCT02452047|454528396|FG002|Overall Study|Physician Decision|0|||
126336830|NCT02452047|454528394|FG000|Overall Study|Lost to Follow-up|1|||
126336831|NCT02452047|454528395|FG001|Overall Study|Lost to Follow-up|1|||
126668427|NCT01830855|455746225|FG003|Overall Study|Other|4|||
126336832|NCT02452047|454528396|FG002|Overall Study|Lost to Follow-up|0|||
126336833|NCT02452047|454528394|FG000|Overall Study|Withdrawal by Subject|1|||
126336834|NCT02452047|454528395|FG001|Overall Study|Withdrawal by Subject|0|||
126336835|NCT02452047|454528396|FG002|Overall Study|Withdrawal by Subject|0|||
126336836|NCT00288912|454528397|FG000|Overall Study|Developed exclusion criterion|4|||
126336837|NCT00288912|454528398|FG001|Overall Study|Developed exclusion criterion|6|||
126336838|NCT00288912|454528399|FG002|Overall Study|Developed exclusion criterion|7|||
126336839|NCT00288912|454528397|FG000|Overall Study|Lost to Follow-up|9|||
126336840|NCT00288912|454528398|FG001|Overall Study|Lost to Follow-up|6|||
126336841|NCT00288912|454528399|FG002|Overall Study|Lost to Follow-up|9|||
126336842|NCT00288912|454528397|FG000|Overall Study|Withdrawal by Subject|4|||
126336843|NCT00288912|454528398|FG001|Overall Study|Withdrawal by Subject|5|||
126336844|NCT00288912|454528399|FG002|Overall Study|Withdrawal by Subject|12|||
126336845|NCT02026141|454528403|FG000|Overall Study|Protocol Violation|0|||
126336846|NCT02026141|454528404|FG001|Overall Study|Protocol Violation|1|||
126336847|NCT01783743|454528409|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
126336848|NCT01783743|454528410|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
126336849|NCT01783743|454528409|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
126336850|NCT01783743|454528410|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
126336851|NCT01783743|454528409|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
126336852|NCT01783743|454528410|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
126336853|NCT02771275|454528411|FG000|Overall Study|Reoperation|3|||
126336854|NCT02771275|454528411|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
126336855|NCT00728494|454528424|FG000|Overall Study|Adverse Event|7|||
126336856|NCT00728494|454528425|FG001|Overall Study|Adverse Event|0|||
126336857|NCT00728494|454528424|FG000|Overall Study|Withdrawal by Subject|0|||
126336858|NCT00728494|454528425|FG001|Overall Study|Withdrawal by Subject|2|||
126336859|NCT00728494|454528424|FG000|Overall Study|Lack of Efficacy|2|||
126336860|NCT00728494|454528425|FG001|Overall Study|Lack of Efficacy|4|||
126336861|NCT00728494|454528424|FG000|Overall Study|No data available|0|||
126336862|NCT00728494|454528425|FG001|Overall Study|No data available|1|||
126336863|NCT03439137|454528426|FG000|Overall Study|Adverse Event|16|||
126336864|NCT03439137|454528427|FG001|Overall Study|Adverse Event|12|||
126668428|NCT01830855|455746222|FG000|Overall Study|Medication error without associated AE|1|||
126668429|NCT01830855|455746223|FG001|Overall Study|Medication error without associated AE|0|||
126668430|NCT01830855|455746224|FG002|Overall Study|Medication error without associated AE|0|||
126668431|NCT01830855|455746225|FG003|Overall Study|Medication error without associated AE|1|||
126668432|NCT01830855|455746222|FG000|Overall Study|Pregnancy|3|||
126668433|NCT01830855|455746223|FG001|Overall Study|Pregnancy|1|||
126668434|NCT01830855|455746224|FG002|Overall Study|Pregnancy|2|||
126668435|NCT01830855|455746225|FG003|Overall Study|Pregnancy|1|||
126668436|NCT01830855|455746222|FG000|Overall Study|No longer meets eligibility criteria|11|||
126668437|NCT01830855|455746223|FG001|Overall Study|No longer meets eligibility criteria|2|||
126336865|NCT03439137|454528426|FG000|Overall Study|Physician Decision|0|||
126336866|NCT03439137|454528427|FG001|Overall Study|Physician Decision|5|||
126336867|NCT03439137|454528426|FG000|Overall Study|Withdrawal by Subject|14|||
126336868|NCT03439137|454528427|FG001|Overall Study|Withdrawal by Subject|4|||
126336869|NCT03439137|454528426|FG000|Overall Study|Conducting rescue therapy|2|||
126336870|NCT03439137|454528427|FG001|Overall Study|Conducting rescue therapy|1|||
126336871|NCT03439137|454528426|FG000|Overall Study|Difficult to control Hb|10|||
126336872|NCT03439137|454528427|FG001|Overall Study|Difficult to control Hb|2|||
126336873|NCT03439137|454528426|FG000|Overall Study|Initiation of a renal transplant|0|||
126336874|NCT03439137|454528427|FG001|Overall Study|Initiation of a renal transplant|2|||
126668438|NCT01830855|455746224|FG002|Overall Study|No longer meets eligibility criteria|3|||
126336875|NCT00748241|454528428|FG000|Overall Study|Implant failure|1|||
126668439|NCT01830855|455746225|FG003|Overall Study|No longer meets eligibility criteria|5|||
126668440|NCT01830855|455746222|FG000|Overall Study|Adverse Event|11|||
126668441|NCT01830855|455746223|FG001|Overall Study|Adverse Event|5|||
126668442|NCT01830855|455746224|FG002|Overall Study|Adverse Event|6|||
126668443|NCT01830855|455746225|FG003|Overall Study|Adverse Event|3|||
126668444|NCT01830855|455746222|FG000|Overall Study|Protocol deviation|10|||
126336876|NCT00748241|454528428|FG000|Overall Study|Lost to Follow-up|5|||
126336877|NCT00748241|454528428|FG000|Overall Study|Death|2|||
126336878|NCT01240382|454528429|FG000|Overall Study|Adverse Event|2|||
126336879|NCT01240382|454528430|FG001|Overall Study|Adverse Event|1|||
126336880|NCT01240382|454528429|FG000|Overall Study|Lack of Efficacy|0|||
126336881|NCT01240382|454528430|FG001|Overall Study|Lack of Efficacy|2|||
126336882|NCT01240382|454528429|FG000|Overall Study|Fear of adverse events|0|||
126336883|NCT01240382|454528430|FG001|Overall Study|Fear of adverse events|1|||
126336884|NCT02456727|454528438|FG000|Overall Study|Lost to Follow-up|63|||
126336885|NCT02456727|454528439|FG001|Overall Study|Lost to Follow-up|65|||
126336886|NCT02456727|454528438|FG000|Overall Study|Death|2|||
126336887|NCT02456727|454528439|FG001|Overall Study|Death|1|||
126336888|NCT02456727|454528438|FG000|Overall Study|Withdrawal by Subject|1|||
126336889|NCT02456727|454528439|FG001|Overall Study|Withdrawal by Subject|10|||
126336890|NCT02456727|454528438|FG000|Overall Study|Never Initiated Treatment|43|||
126336891|NCT02456727|454528439|FG001|Overall Study|Never Initiated Treatment|30|||
126336892|NCT02643693|454528440|FG000|Overall Study|Physician Decision|0|||
126336893|NCT02643693|454528441|FG001|Overall Study|Physician Decision|1|||
126336894|NCT02643693|454528442|FG002|Overall Study|Physician Decision|0|||
126336895|NCT02643693|454528443|FG003|Overall Study|Physician Decision|0|||
126336896|NCT02643693|454528444|FG004|Overall Study|Physician Decision|0|||
126336897|NCT02643693|454528445|FG005|Overall Study|Physician Decision|0|||
126336898|NCT02643693|454528440|FG000|Overall Study|Withdrawal by Subject|0|||
126336899|NCT02643693|454528441|FG001|Overall Study|Withdrawal by Subject|1|||
126336900|NCT02643693|454528442|FG002|Overall Study|Withdrawal by Subject|0|||
126336901|NCT02643693|454528443|FG003|Overall Study|Withdrawal by Subject|0|||
126336902|NCT02643693|454528444|FG004|Overall Study|Withdrawal by Subject|0|||
126336903|NCT02643693|454528445|FG005|Overall Study|Withdrawal by Subject|0|||
126336904|NCT02643693|454528440|FG000|Overall Study|Protocol Adherence Issues|2|||
126336905|NCT02643693|454528441|FG001|Overall Study|Protocol Adherence Issues|0|||
126336906|NCT02643693|454528442|FG002|Overall Study|Protocol Adherence Issues|1|||
126336907|NCT02643693|454528443|FG003|Overall Study|Protocol Adherence Issues|0|||
126336908|NCT02643693|454528444|FG004|Overall Study|Protocol Adherence Issues|0|||
126336909|NCT02643693|454528445|FG005|Overall Study|Protocol Adherence Issues|1|||
126336910|NCT01408706|454528446|FG000|Overall Study|Physician Decision|1|||
126336911|NCT01408706|454528447|FG001|Overall Study|Physician Decision|0|||
126336912|NCT03669549|454528450|FG000|Overall Study|Adverse Event|4|||
126336913|NCT03669549|454528450|FG000|Overall Study|Withdrawal by Subject|1|||
126336914|NCT03669549|454528450|FG000|Overall Study|Study terminated by the Sponsor|1|||
126336915|NCT00698815|454528451|FG000|Overall Study|Death|1|||
126336916|NCT00698815|454528452|FG001|Overall Study|Death|2|||
126336917|NCT00698815|454528453|FG002|Overall Study|Death|4|||
126336918|NCT00698815|454528451|FG000|Overall Study|Withdrawal by Subject|6|||
126336919|NCT00698815|454528452|FG001|Overall Study|Withdrawal by Subject|3|||
126336920|NCT00698815|454528453|FG002|Overall Study|Withdrawal by Subject|2|||
126336921|NCT00698815|454528451|FG000|Overall Study|MD discretion|2|||
126336922|NCT00698815|454528452|FG001|Overall Study|MD discretion|7|||
126336923|NCT00698815|454528453|FG002|Overall Study|MD discretion|2|||
126336924|NCT00698815|454528451|FG000|Overall Study|Did not receive protocol treatment|1|||
126336925|NCT00698815|454528452|FG001|Overall Study|Did not receive protocol treatment|2|||
126336926|NCT00698815|454528453|FG002|Overall Study|Did not receive protocol treatment|2|||
126336927|NCT02974868|454528454|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
126336928|NCT02974868|454528455|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
126336929|NCT02974868|454528456|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
126668445|NCT01830855|455746223|FG001|Overall Study|Protocol deviation|5|||
126668446|NCT01830855|455746224|FG002|Overall Study|Protocol deviation|6|||
126336930|NCT02974868|454528457|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
126336931|NCT02974868|454528454|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
126336932|NCT02974868|454528455|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
126336933|NCT02974868|454528456|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
126336934|NCT02974868|454528457|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
126336935|NCT02974868|454528454|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
126336936|NCT02974868|454528455|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
126336937|NCT02974868|454528456|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
126336938|NCT02974868|454528457|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
126336939|NCT02974868|454528454|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
126336940|NCT02974868|454528455|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
126668447|NCT01830855|455746225|FG003|Overall Study|Protocol deviation|6|||
126668448|NCT01830855|455746222|FG000|Overall Study|Withdrawal by Subject|33|||
126668449|NCT01830855|455746223|FG001|Overall Study|Withdrawal by Subject|14|||
126668450|NCT01830855|455746224|FG002|Overall Study|Withdrawal by Subject|10|||
126668451|NCT01830855|455746225|FG003|Overall Study|Withdrawal by Subject|12|||
126668452|NCT01830855|455746222|FG000|Overall Study|No longer willing to participate|32|||
126668453|NCT01830855|455746223|FG001|Overall Study|No longer willing to participate|13|||
126668454|NCT01830855|455746224|FG002|Overall Study|No longer willing to participate|12|||
126668455|NCT01830855|455746225|FG003|Overall Study|No longer willing to participate|17|||
126668456|NCT01830855|455746222|FG000|Overall Study|Lost to Follow-up|47|||
126668457|NCT01830855|455746223|FG001|Overall Study|Lost to Follow-up|20|||
126668458|NCT01830855|455746224|FG002|Overall Study|Lost to Follow-up|23|||
126668459|NCT01830855|455746225|FG003|Overall Study|Lost to Follow-up|33|||
126668460|NCT01667081|455746226|FG000|Overall Study|Death|43|||
126668461|NCT01667081|455746227|FG001|Overall Study|Death|3|||
126668462|NCT01667081|455746226|FG000|Overall Study|Lost to Follow-up|99|||
126668463|NCT01667081|455746227|FG001|Overall Study|Lost to Follow-up|48|||
126668464|NCT01667081|455746226|FG000|Overall Study|Physician Decision|16|||
126668465|NCT01667081|455746227|FG001|Overall Study|Physician Decision|2|||
126668466|NCT01667081|455746226|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
126668467|NCT01667081|455746227|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
126668468|NCT01667081|455746226|FG000|Overall Study|Withdrawal by Subject|90|||
126668469|NCT01667081|455746227|FG001|Overall Study|Withdrawal by Subject|35|||
126668470|NCT00930722|455746228|FG000|Overall Study|Lost to Follow-up|16|||
126668471|NCT00930722|455746228|FG000|Overall Study|No longer willing to participate|9|||
126668472|NCT00930722|455746228|FG000|Overall Study|Study terminated by sponsor|2|||
126668473|NCT03034460|455746229|FG000|Overall Study|Adverse Event|0|||
126668474|NCT03034460|455746230|FG001|Overall Study|Adverse Event|1|||
126668475|NCT03034460|455746229|FG000|Overall Study|Withdrawal by Subject|2|||
126668476|NCT03034460|455746230|FG001|Overall Study|Withdrawal by Subject|2|||
126668477|NCT03034460|455746229|FG000|Overall Study|Personal Reasons|1|||
126336941|NCT02974868|454528456|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
126336942|NCT02974868|454528457|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
126336943|NCT00297648|454528460|FG000|Overall Study|Adverse Event|13|||
126336944|NCT00297648|454528460|FG000|Overall Study|Lack of Efficacy|18|||
126336945|NCT00297648|454528460|FG000|Overall Study|Lost to Follow-up|1|||
126336946|NCT00297648|454528460|FG000|Overall Study|Withdrawal by Subject|3|||
126336947|NCT00297648|454528460|FG000|Overall Study|Other: Incompliance|1|||
126336948|NCT03575702|454528461|FG000|Overall Study|Withdrawal by Subject|1|||
126336949|NCT03575702|454528462|FG001|Overall Study|Withdrawal by Subject|1|||
126336950|NCT03575702|454528461|FG000|Overall Study|Lost to Follow-up|1|||
126336951|NCT03575702|454528462|FG001|Overall Study|Lost to Follow-up|2|||
126336952|NCT03575702|454528461|FG000|Overall Study|Protocol Violation|0|||
126336953|NCT03575702|454528462|FG001|Overall Study|Protocol Violation|1|||
126336954|NCT03575702|454528461|FG000|Overall Study|Patient non compliance|4|||
126336955|NCT03575702|454528462|FG001|Overall Study|Patient non compliance|0|||
126336956|NCT03903172|454528463|FG000|Overall Study|screen fail|4|||
126336957|NCT03903172|454528464|FG001|Overall Study|screen fail|1|||
126336958|NCT01545388|454528465|FG000|Overall Study|Adverse Event|2|||
126336959|NCT01545388|454528466|FG001|Overall Study|Adverse Event|4|||
126336960|NCT01545388|454528467|FG002|Overall Study|Adverse Event|1|||
126336961|NCT01545388|454528465|FG000|Overall Study|Lack of Efficacy|3|||
126336962|NCT01545388|454528466|FG001|Overall Study|Lack of Efficacy|2|||
126336963|NCT01545388|454528467|FG002|Overall Study|Lack of Efficacy|5|||
126336964|NCT01545388|454528465|FG000|Overall Study|Participant moved or relocated|1|||
126336965|NCT01545388|454528466|FG001|Overall Study|Participant moved or relocated|0|||
126336966|NCT01545388|454528467|FG002|Overall Study|Participant moved or relocated|0|||
126336967|NCT01545388|454528465|FG000|Overall Study|Withdrawal by Subject|1|||
126336968|NCT01545388|454528466|FG001|Overall Study|Withdrawal by Subject|4|||
126336969|NCT01545388|454528467|FG002|Overall Study|Withdrawal by Subject|2|||
126336970|NCT01545388|454528465|FG000|Overall Study|Other|1|||
126336971|NCT01545388|454528466|FG001|Overall Study|Other|1|||
126336972|NCT01545388|454528467|FG002|Overall Study|Other|0|||
126336973|NCT01255163|454528468|FG000|Overall Study|Withdrawal by Subject|1|||
126336974|NCT01255163|454528469|FG001|Overall Study|Withdrawal by Subject|0|||
126336975|NCT01255163|454528468|FG000|Overall Study|Lost to Follow-up|2|||
126336976|NCT01255163|454528469|FG001|Overall Study|Lost to Follow-up|0|||
126336977|NCT01255163|454528468|FG000|Overall Study|Adverse Event|0|||
126668478|NCT03034460|455746230|FG001|Overall Study|Personal Reasons|0|||
126668479|NCT00295633|455746231|FG000|Overall Study|Lack of Efficacy|19|||
126668480|NCT00295633|455746232|FG001|Overall Study|Lack of Efficacy|7|||
126668481|NCT00295633|455746233|FG002|Overall Study|Lack of Efficacy|16|||
126336978|NCT01255163|454528469|FG001|Overall Study|Adverse Event|2|||
126336979|NCT01255163|454528468|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
126336980|NCT01255163|454528469|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
126336981|NCT02495389|454528470|FG000|Overall Study|Withdrawal by Subject|40|||
126668482|NCT00295633|455746231|FG000|Overall Study|Withdrawal of consent by subject|16|||
126668483|NCT00295633|455746232|FG001|Overall Study|Withdrawal of consent by subject|16|||
126668484|NCT00295633|455746233|FG002|Overall Study|Withdrawal of consent by subject|26|||
126336982|NCT01802385|454528474|FG000|Overall Study|Death|106|||
126336983|NCT01802385|454528475|FG001|Overall Study|Death|120|||
126336984|NCT03834493|454528476|FG000|Overall Study|Participants Ongoing|311|||
126336985|NCT03834493|454528477|FG001|Overall Study|Participants Ongoing|324|||
126336986|NCT03834493|454528476|FG000|Overall Study|Withdrawal by Subject|20|||
126336987|NCT03834493|454528477|FG001|Overall Study|Withdrawal by Subject|17|||
126336988|NCT03834493|454528476|FG000|Overall Study|Physician Decision|1|||
126336989|NCT03834493|454528477|FG001|Overall Study|Physician Decision|0|||
126336990|NCT03834493|454528476|FG000|Overall Study|Death|289|||
126668485|NCT00295633|455746231|FG000|Overall Study|Adverse Event|9|||
126668486|NCT00295633|455746232|FG001|Overall Study|Adverse Event|17|||
126668487|NCT00295633|455746233|FG002|Overall Study|Adverse Event|9|||
126668488|NCT00295633|455746231|FG000|Overall Study|Lost to Follow-up|6|||
126668489|NCT00295633|455746232|FG001|Overall Study|Lost to Follow-up|11|||
126668490|NCT00295633|455746233|FG002|Overall Study|Lost to Follow-up|7|||
126668491|NCT00295633|455746231|FG000|Overall Study|Physician Decision|9|||
126668492|NCT00295633|455746232|FG001|Overall Study|Physician Decision|10|||
126668493|NCT00295633|455746233|FG002|Overall Study|Physician Decision|8|||
126668494|NCT00295633|455746231|FG000|Overall Study|Poor/Noncompliance|2|||
126668495|NCT00295633|455746232|FG001|Overall Study|Poor/Noncompliance|2|||
126668496|NCT00295633|455746233|FG002|Overall Study|Poor/Noncompliance|6|||
126668497|NCT00295633|455746231|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
126668498|NCT00295633|455746232|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
126668499|NCT00295633|455746233|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
126668500|NCT00295633|455746231|FG000|Overall Study|Death|1|||
126668501|NCT00295633|455746232|FG001|Overall Study|Death|1|||
126668502|NCT00295633|455746233|FG002|Overall Study|Death|0|||
126336991|NCT03834493|454528477|FG001|Overall Study|Death|282|||
126336992|NCT05559905|454528478|FG000|Overall Study|Withdrawal by Subject|1|||
126668503|NCT00295633|455746231|FG000|Overall Study|Administrative reason by sponsor|0|||
126668504|NCT00295633|455746232|FG001|Overall Study|Administrative reason by sponsor|0|||
126668505|NCT00295633|455746233|FG002|Overall Study|Administrative reason by sponsor|1|||
126668506|NCT00419120|455746234|FG000|Long Term Follow up Period|study ongoing|10|||
126668507|NCT01754857|455746246|FG000|Overall Study|Adverse Event|7|||
126668508|NCT01754857|455746246|FG000|Overall Study|Disease progression|3|||
126668509|NCT01754857|455746246|FG000|Overall Study|Physician Decision|2|||
126668510|NCT01754857|455746246|FG000|Overall Study|Withdrawal by Subject|3|||
126668511|NCT01754857|455746246|FG000|Overall Study|other complicating disease|1|||
126668512|NCT01754857|455746246|FG000|Overall Study|ineligible to continue onto maintenance|1|||
126668513|NCT01754857|455746246|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
126668514|NCT01754857|455746246|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
126668515|NCT01509079|455746247|FG000|Overall Study|Lack of Efficacy|0|||
126668516|NCT01509079|455746248|FG001|Overall Study|Lack of Efficacy|2|||
126668517|NCT01509079|455746247|FG000|Overall Study|started an excluded medication|0|||
126668518|NCT01509079|455746248|FG001|Overall Study|started an excluded medication|1|||
126668519|NCT01399190|455746251|FG000|Overall Study|Not Eligible for Final Analysis|5|||
126668520|NCT01399190|455746251|FG000|Overall Study|Adverse Event|8|||
126668521|NCT01399190|455746251|FG000|Overall Study|Participant's Request|5|||
126668522|NCT01399190|455746251|FG000|Overall Study|Physician Decision|2|||
126668523|NCT00436618|455746255|FG000|Overall Study|Withdrawal by Subject|5|||
126668524|NCT00436618|455746256|FG001|Overall Study|Withdrawal by Subject|8|||
126336993|NCT05559905|454528479|FG001|Overall Study|Withdrawal by Subject|0|||
126668525|NCT00436618|455746257|FG002|Overall Study|Withdrawal by Subject|11|||
126668526|NCT00436618|455746255|FG000|Overall Study|Adverse Event|8|||
126668527|NCT00436618|455746256|FG001|Overall Study|Adverse Event|8|||
126668528|NCT00436618|455746257|FG002|Overall Study|Adverse Event|9|||
126336994|NCT05559905|454528480|FG002|Overall Study|Withdrawal by Subject|0|||
126336995|NCT05559905|454528478|FG000|Overall Study|Not Reported|1|||
126336996|NCT05559905|454528479|FG001|Overall Study|Not Reported|0|||
126336997|NCT05559905|454528480|FG002|Overall Study|Not Reported|0|||
126336998|NCT04003103|454528481|FG000|Overall Study|Death|1|||
126336999|NCT04003103|454528482|FG001|Overall Study|Death|0|||
126337000|NCT04003103|454528483|FG002|Overall Study|Death|0|||
126337001|NCT04003103|454528481|FG000|Overall Study|Lost to Follow-up|4|||
126337002|NCT04003103|454528482|FG001|Overall Study|Lost to Follow-up|3|||
126337003|NCT04003103|454528483|FG002|Overall Study|Lost to Follow-up|2|||
126337004|NCT04003103|454528481|FG000|Overall Study|Withdrawal by Subject|10|||
126337005|NCT04003103|454528482|FG001|Overall Study|Withdrawal by Subject|1|||
126337006|NCT04003103|454528483|FG002|Overall Study|Withdrawal by Subject|1|||
126337007|NCT04003103|454528481|FG000|Overall Study|Status not recorded|0|||
126337008|NCT04003103|454528482|FG001|Overall Study|Status not recorded|2|||
126337009|NCT04003103|454528483|FG002|Overall Study|Status not recorded|0|||
126337010|NCT03829462|454528488|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
126337011|NCT03829462|454528489|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
126337012|NCT03829462|454528488|FG000|Overall Study|No treatment due to progression disease|0|||
126337013|NCT03829462|454528489|FG001|Overall Study|No treatment due to progression disease|1|||
126337014|NCT04613518|454528491|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
126337015|NCT04613518|454528492|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
126337016|NCT04613518|454528493|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
126337017|NCT04613518|454528491|FG000|Double-Blind Treatment Period|Adverse Event|2|||
126337018|NCT04613518|454528492|FG001|Double-Blind Treatment Period|Adverse Event|0|||
126337019|NCT04613518|454528493|FG002|Double-Blind Treatment Period|Adverse Event|1|||
126337020|NCT04613518|454528491|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
126337021|NCT04613518|454528492|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
126337022|NCT04613518|454528493|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
126337023|NCT04613518|454528491|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
126337024|NCT04613518|454528492|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
126337025|NCT04613518|454528493|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
126668529|NCT00436618|455746255|FG000|Overall Study|Alternate Treatment|3|||
126668530|NCT00436618|455746256|FG001|Overall Study|Alternate Treatment|4|||
126668531|NCT00436618|455746257|FG002|Overall Study|Alternate Treatment|12|||
126337026|NCT04613518|454528491|FG000|Double-Blind Treatment Period|Other Reasons|2|||
126337027|NCT04613518|454528492|FG001|Double-Blind Treatment Period|Other Reasons|0|||
126668532|NCT00436618|455746255|FG000|Overall Study|Other Medical Problems|3|||
126668533|NCT00436618|455746256|FG001|Overall Study|Other Medical Problems|1|||
126668534|NCT00436618|455746257|FG002|Overall Study|Other Medical Problems|7|||
126668535|NCT00436618|455746255|FG000|Overall Study|Death|4|||
126668536|NCT00436618|455746256|FG001|Overall Study|Death|2|||
126668537|NCT00436618|455746257|FG002|Overall Study|Death|3|||
126668538|NCT00436618|455746255|FG000|Overall Study|New Primary or Other Reasons|6|||
126668539|NCT00436618|455746256|FG001|Overall Study|New Primary or Other Reasons|2|||
126668540|NCT00436618|455746257|FG002|Overall Study|New Primary or Other Reasons|12|||
126668541|NCT00436618|455746255|FG000|Overall Study|Still on treatment|1|||
126668542|NCT00436618|455746256|FG001|Overall Study|Still on treatment|2|||
126668543|NCT00436618|455746257|FG002|Overall Study|Still on treatment|7|||
126668544|NCT00698204|455746258|FG000|Overall Study|Withdrawal by Subject|1|||
126668545|NCT00698204|455746259|FG001|Overall Study|Withdrawal by Subject|0|||
126668546|NCT00314249|455746260|FG000|Overall Study|Adverse Event|73|||
126668547|NCT00314249|455746261|FG001|Overall Study|Adverse Event|94|||
126668548|NCT00314249|455746260|FG000|Overall Study|Lack of Efficacy|33|||
126668549|NCT00314249|455746261|FG001|Overall Study|Lack of Efficacy|24|||
126668550|NCT00314249|455746260|FG000|Overall Study|Withdrawal by Subject|21|||
126668551|NCT00314249|455746261|FG001|Overall Study|Withdrawal by Subject|28|||
126668552|NCT00314249|455746260|FG000|Overall Study|Lost to Follow-up|15|||
126668553|NCT00314249|455746261|FG001|Overall Study|Lost to Follow-up|9|||
126668554|NCT00314249|455746260|FG000|Overall Study|Physician Decision|1|||
126668555|NCT00314249|455746261|FG001|Overall Study|Physician Decision|1|||
126668556|NCT00314249|455746260|FG000|Overall Study|Withdrawn for other reasons|4|||
126668557|NCT00314249|455746261|FG001|Overall Study|Withdrawn for other reasons|1|||
126668558|NCT00314249|455746260|FG000|Overall Study|Non-Compliant|5|||
126668559|NCT00314249|455746261|FG001|Overall Study|Non-Compliant|6|||
126668560|NCT01949155|455746262|FG000|Overall Study|Lost to Follow-up|1|||
126668561|NCT01949155|455746263|FG001|Overall Study|Lost to Follow-up|0|||
126337028|NCT04613518|454528493|FG002|Double-Blind Treatment Period|Other Reasons|0|||
126337029|NCT04613518|454528491|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
126337030|NCT04613518|454528492|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
126337031|NCT04613518|454528493|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
126337032|NCT04613518|454528491|FG000|Open-Label Treatment Period|Adverse Event|1|||
126668562|NCT01949155|455746262|FG000|Overall Study|Protocol Violation|1|||
126668563|NCT01949155|455746263|FG001|Overall Study|Protocol Violation|0|||
126668564|NCT00210184|455746264|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
126668565|NCT01118325|455746267|FG000|Overall Study|Adverse Event|1|||
126668566|NCT01118325|455746268|FG001|Overall Study|Adverse Event|0|||
126668567|NCT01118325|455746269|FG002|Overall Study|Adverse Event|1|||
126668568|NCT03334409|455746270|FG000|Overall Study|Did not meet inclusion criteria|1|||
126668569|NCT03334409|455746271|FG001|Overall Study|Did not meet inclusion criteria|0|||
126337033|NCT04613518|454528492|FG001|Open-Label Treatment Period|Adverse Event|0|||
126337034|NCT04613518|454528493|FG002|Open-Label Treatment Period|Adverse Event|3|||
126337035|NCT04613518|454528491|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
126337036|NCT04613518|454528492|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
126337037|NCT04613518|454528493|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
126337038|NCT04613518|454528491|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
126337039|NCT04613518|454528492|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
126337040|NCT04613518|454528493|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
126337041|NCT04613518|454528491|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
126337042|NCT04613518|454528492|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
126337043|NCT04613518|454528493|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
126337044|NCT04613518|454528491|FG000|Open-Label Treatment Period|Other reasons|1|||
126337045|NCT04613518|454528492|FG001|Open-Label Treatment Period|Other reasons|0|||
126337046|NCT04613518|454528493|FG002|Open-Label Treatment Period|Other reasons|0|||
126337047|NCT04113694|454530831|FG000|Overall Study|Adverse Event|2|||
126337048|NCT04113694|454530831|FG000|Overall Study|Lost to Follow-up|2|||
126337049|NCT04113694|454530831|FG000|Overall Study|Withdrawal by Subject|6|||
126337050|NCT04113694|454530831|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
126337051|NCT03638128|454530836|FG000|Overall Study|Withdrawal by Subject|1|||
126337052|NCT03638128|454530837|FG001|Overall Study|Withdrawal by Subject|7|||
126337053|NCT03638128|454530838|FG002|Overall Study|Withdrawal by Subject|6|||
126337054|NCT03638128|454530836|FG000|Overall Study|Sponsor Decision|15|||
126337055|NCT03638128|454530837|FG001|Overall Study|Sponsor Decision|12|||
126337056|NCT03638128|454530838|FG002|Overall Study|Sponsor Decision|19|||
126337057|NCT03638128|454530836|FG000|Overall Study|Lost to Follow-up|0|||
126337058|NCT03638128|454530837|FG001|Overall Study|Lost to Follow-up|0|||
126337059|NCT03638128|454530838|FG002|Overall Study|Lost to Follow-up|1|||
126337060|NCT01307787|454530840|FG000|Overall Study|Withdrawal by Subject|2|||
126337061|NCT01307787|454530841|FG001|Overall Study|Withdrawal by Subject|0|||
126337062|NCT01965327|454530847|FG000|Overall Study|Physician Decision|2|||
126337063|NCT02579629|454530865|FG000|Overall Study|Withdrawal by Subject|0|||
126337064|NCT02579629|454530866|FG001|Overall Study|Withdrawal by Subject|1|||
126337065|NCT02579629|454530867|FG002|Overall Study|Withdrawal by Subject|0|||
126337066|NCT02579629|454530865|FG000|Overall Study|Screen Failure|2|||
126337067|NCT02579629|454530866|FG001|Overall Study|Screen Failure|0|||
126337068|NCT02579629|454530867|FG002|Overall Study|Screen Failure|2|||
126337069|NCT00830219|454530868|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
126337070|NCT00830219|454530869|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
126337071|NCT01294423|454530870|FG000|Overall Study|Adverse Event|1|||
126337072|NCT01294423|454530871|FG001|Overall Study|Adverse Event|2|||
126337073|NCT01294423|454530872|FG002|Overall Study|Adverse Event|3|||
126337074|NCT01294423|454530870|FG000|Overall Study|Withdrawal by Subject|1|||
126337075|NCT01294423|454530871|FG001|Overall Study|Withdrawal by Subject|2|||
126337076|NCT01294423|454530872|FG002|Overall Study|Withdrawal by Subject|2|||
126337077|NCT01294423|454530870|FG000|Overall Study|subject no longer meets study criteria|2|||
126337078|NCT01294423|454530871|FG001|Overall Study|subject no longer meets study criteria|5|||
126337079|NCT01294423|454530872|FG002|Overall Study|subject no longer meets study criteria|2|||
126337080|NCT01294423|454530870|FG000|Overall Study|poor/non-compliance|1|||
126337081|NCT01294423|454530871|FG001|Overall Study|poor/non-compliance|0|||
126337082|NCT01294423|454530872|FG002|Overall Study|poor/non-compliance|1|||
126337083|NCT01145482|454530873|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
126337084|NCT01145482|454530874|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
126337085|NCT01699750|454530875|FG000|Overall Study|Withdrew Consent|0|||
126337086|NCT01699750|454530876|FG001|Overall Study|Withdrew Consent|1|||
126337087|NCT01699750|454530875|FG000|Overall Study|Other|0|||
126337088|NCT01699750|454530876|FG001|Overall Study|Other|2|||
126337089|NCT04635839|454530877|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
126337090|NCT04635839|454530878|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
126337091|NCT02737358|454530879|FG000|Overall Study|Withdrawal by Subject|7|||
126668570|NCT00975715|455746272|FG000|Titration Period|Adverse Event|6|||
126668571|NCT00975715|455746273|FG001|Titration Period|Adverse Event|0|||
126337092|NCT02737358|454530880|FG001|Overall Study|Withdrawal by Subject|12|||
126337093|NCT02737358|454530879|FG000|Overall Study|Lost to Follow-up|2|||
126337094|NCT02737358|454530880|FG001|Overall Study|Lost to Follow-up|3|||
126337095|NCT00896493|454530881|FG000|Overall Study|Early disease relapse|3|||
126337096|NCT02870868|454530882|FG000|Overall Study|Withdrawal by Subject|2|||
126337097|NCT02870868|454530883|FG001|Overall Study|Withdrawal by Subject|1|||
126337098|NCT01739335|454530884|FG000|Overall Study|Lost to Follow-up|7|||
126668572|NCT00975715|455746272|FG000|Titration Period|Protocol Violation|1|||
126668573|NCT00975715|455746273|FG001|Titration Period|Protocol Violation|0|||
126337099|NCT01739335|454530885|FG001|Overall Study|Lost to Follow-up|4|||
126668574|NCT00975715|455746272|FG000|Maintenance Period|Adverse Event|2|||
126668575|NCT00975715|455746273|FG001|Maintenance Period|Adverse Event|1|||
126668576|NCT01674712|455746275|FG000|Overall Study|Adverse Event|5|||
126668577|NCT01674712|455746276|FG001|Overall Study|Adverse Event|6|||
126668578|NCT01674712|455746277|FG002|Overall Study|Adverse Event|3|||
126668579|NCT01674712|455746278|FG003|Overall Study|Adverse Event|4|||
126668580|NCT01674712|455746279|FG004|Overall Study|Adverse Event|6|||
126668581|NCT01674712|455746275|FG000|Overall Study|Lost to Follow-up|1|||
126668582|NCT01674712|455746276|FG001|Overall Study|Lost to Follow-up|0|||
126668583|NCT01674712|455746277|FG002|Overall Study|Lost to Follow-up|0|||
126668584|NCT01674712|455746278|FG003|Overall Study|Lost to Follow-up|0|||
126668585|NCT01674712|455746279|FG004|Overall Study|Lost to Follow-up|0|||
126668586|NCT01674712|455746275|FG000|Overall Study|Protocol Violation|2|||
126668587|NCT01674712|455746276|FG001|Overall Study|Protocol Violation|0|||
126668588|NCT01674712|455746277|FG002|Overall Study|Protocol Violation|0|||
126668589|NCT01674712|455746278|FG003|Overall Study|Protocol Violation|0|||
126668590|NCT01674712|455746279|FG004|Overall Study|Protocol Violation|0|||
126668591|NCT01674712|455746275|FG000|Overall Study|Withdrawal by Subject|2|||
126668592|NCT01674712|455746276|FG001|Overall Study|Withdrawal by Subject|2|||
126668593|NCT01674712|455746277|FG002|Overall Study|Withdrawal by Subject|5|||
126668594|NCT01674712|455746278|FG003|Overall Study|Withdrawal by Subject|4|||
126668595|NCT01674712|455746279|FG004|Overall Study|Withdrawal by Subject|3|||
126668596|NCT01674712|455746275|FG000|Overall Study|Administrative|0|||
126668597|NCT01674712|455746276|FG001|Overall Study|Administrative|1|||
126668598|NCT01674712|455746277|FG002|Overall Study|Administrative|0|||
126668599|NCT01674712|455746278|FG003|Overall Study|Administrative|0|||
126668600|NCT01674712|455746279|FG004|Overall Study|Administrative|1|||
126668601|NCT01674712|455746275|FG000|Overall Study|Lack of Efficacy|0|||
126668602|NCT01674712|455746276|FG001|Overall Study|Lack of Efficacy|0|||
126668603|NCT01674712|455746277|FG002|Overall Study|Lack of Efficacy|1|||
126668604|NCT01674712|455746278|FG003|Overall Study|Lack of Efficacy|0|||
126668605|NCT01674712|455746279|FG004|Overall Study|Lack of Efficacy|1|||
126668606|NCT03974334|455746280|FG000|Overall Study|Lost to Follow-up|1|||
126668607|NCT00024167|455746281|FG000|Overall Study|Death|53|||
126668608|NCT00024167|455746282|FG001|Overall Study|Death|47|||
126668609|NCT01379573|455746292|FG000|Overall Study|Lost to Follow-up|1|||
126668610|NCT01379573|455746292|FG000|Overall Study|Screen Failure|10|||
126668611|NCT00770770|455746297|FG000|Overall Study|Lost to Follow-up|1|||
126668612|NCT00770770|455746298|FG001|Overall Study|Lost to Follow-up|0|||
126668613|NCT00770770|455746297|FG000|Overall Study|Withdrawal by Subject|1|||
126668614|NCT00770770|455746298|FG001|Overall Study|Withdrawal by Subject|0|||
126668615|NCT00770770|455746297|FG000|Overall Study|Death|0|||
126668616|NCT00770770|455746298|FG001|Overall Study|Death|1|||
126668617|NCT00770770|455746297|FG000|Overall Study|Study Terminated|8|||
126668618|NCT00770770|455746298|FG001|Overall Study|Study Terminated|0|||
126668619|NCT05372653|455746300|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
126668620|NCT05372653|455746301|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
126668621|NCT05372653|455746300|FG000|Overall Study|Adverse Event|0|||
126668622|NCT05372653|455746301|FG001|Overall Study|Adverse Event|1|||
126668623|NCT00711529|455746308|FG000|Overall Study|Protocol Violation|2|||
126668624|NCT00711529|455746309|FG001|Overall Study|Protocol Violation|0|||
126337100|NCT01739335|454530884|FG000|Overall Study|Ineligible patient randomized|0|||
126337101|NCT01739335|454530885|FG001|Overall Study|Ineligible patient randomized|1|||
126337102|NCT01868646|454530888|FG000|Overall Study|Do not meet inclusion criteria|3|||
126337103|NCT01868646|454530889|FG001|Overall Study|Do not meet inclusion criteria|5|||
126337104|NCT03191799|454530892|FG000|Overall Study|Withdrawal by Subject|4|||
126337105|NCT03191799|454530892|FG000|Overall Study|Physician Decision|2|||
126668625|NCT00711529|455746308|FG000|Overall Study|Withdrawal by Subject|2|||
126668626|NCT00711529|455746309|FG001|Overall Study|Withdrawal by Subject|6|||
126668627|NCT01230554|455746314|FG000|Overall Study|Lost to Follow-up|2|||
126668628|NCT01230554|455746314|FG000|Overall Study|Inability to maintain visit schedule|1|||
126668629|NCT00685685|455746315|FG000|Washout Period of 7 Days|Adverse Event|2|||
126668630|NCT00685685|455746316|FG001|Washout Period of 7 Days|Adverse Event|0|||
126668631|NCT00685685|455746315|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
126668632|NCT00685685|455746316|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126668633|NCT00523718|455747259|FG000|Overall Study|Withdrawal by Subject|1|||
126668634|NCT00523718|455747260|FG001|Overall Study|Withdrawal by Subject|0|||
126668635|NCT00523718|455747259|FG000|Overall Study|Protocol Violation|2|||
126337106|NCT03191799|454530892|FG000|Overall Study|Lost to Follow-up|1|||
126337107|NCT03191799|454530892|FG000|Overall Study|Death|2|||
126668636|NCT00523718|455747260|FG001|Overall Study|Protocol Violation|0|||
126337108|NCT00853762|454530900|FG000|Overall Study|Premature Termination|16|||
126668637|NCT02060383|455747261|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
126668638|NCT02060383|455747262|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
126668639|NCT02060383|455747263|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
126668640|NCT02060383|455747264|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
126668641|NCT02060383|455747265|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
126668642|NCT02060383|455747261|FG000|Core Phase|Adverse Event|2|||
126668643|NCT02060383|455747262|FG001|Core Phase|Adverse Event|0|||
126668644|NCT02060383|455747263|FG002|Core Phase|Adverse Event|0|||
126668645|NCT02060383|455747264|FG003|Core Phase|Adverse Event|2|||
126668646|NCT02060383|455747265|FG004|Core Phase|Adverse Event|6|||
126668647|NCT02060383|455747261|FG000|Core Phase|Administrative problems|0|||
126668648|NCT02060383|455747262|FG001|Core Phase|Administrative problems|1|||
126668649|NCT02060383|455747263|FG002|Core Phase|Administrative problems|0|||
126668650|NCT02060383|455747264|FG003|Core Phase|Administrative problems|0|||
126668651|NCT02060383|455747265|FG004|Core Phase|Administrative problems|0|||
126668652|NCT02060383|455747261|FG000|Core Phase|Protocol Violation|0|||
126668653|NCT02060383|455747262|FG001|Core Phase|Protocol Violation|0|||
126668654|NCT02060383|455747263|FG002|Core Phase|Protocol Violation|0|||
126668655|NCT02060383|455747264|FG003|Core Phase|Protocol Violation|1|||
126668656|NCT02060383|455747265|FG004|Core Phase|Protocol Violation|0|||
126668657|NCT02060383|455747261|FG000|Core Phase|Withdrawal by Subject|0|||
126668658|NCT02060383|455747262|FG001|Core Phase|Withdrawal by Subject|0|||
126668659|NCT02060383|455747263|FG002|Core Phase|Withdrawal by Subject|0|||
126668660|NCT02060383|455747264|FG003|Core Phase|Withdrawal by Subject|4|||
126668661|NCT02060383|455747265|FG004|Core Phase|Withdrawal by Subject|2|||
126668662|NCT02060383|455747261|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
126668663|NCT02060383|455747262|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
126668664|NCT02060383|455747263|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
126668665|NCT02060383|455747264|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
126668666|NCT02060383|455747265|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
126668667|NCT02060383|455747261|FG000|Extension Phase|Adverse Event|1|||
126337109|NCT00853762|454530901|FG001|Overall Study|Premature Termination|15|||
126337110|NCT00853762|454530902|FG002|Overall Study|Premature Termination|14|||
126668668|NCT02060383|455747262|FG001|Extension Phase|Adverse Event|1|||
126668669|NCT02060383|455747263|FG002|Extension Phase|Adverse Event|2|||
126668670|NCT02060383|455747264|FG003|Extension Phase|Adverse Event|0|||
126668671|NCT02060383|455747265|FG004|Extension Phase|Adverse Event|1|||
126668672|NCT02060383|455747261|FG000|Extension Phase|Withdrawal by Subject|0|||
126668673|NCT02060383|455747262|FG001|Extension Phase|Withdrawal by Subject|1|||
126668674|NCT02060383|455747263|FG002|Extension Phase|Withdrawal by Subject|0|||
126668675|NCT02060383|455747264|FG003|Extension Phase|Withdrawal by Subject|0|||
126668676|NCT02060383|455747265|FG004|Extension Phase|Withdrawal by Subject|2|||
126668677|NCT02060383|455747261|FG000|Extension Phase|Administrative problems|1|||
126668678|NCT02060383|455747262|FG001|Extension Phase|Administrative problems|0|||
126668679|NCT02060383|455747263|FG002|Extension Phase|Administrative problems|0|||
126668680|NCT02060383|455747264|FG003|Extension Phase|Administrative problems|0|||
126668681|NCT02060383|455747265|FG004|Extension Phase|Administrative problems|0|||
126668682|NCT02060383|455747261|FG000|Extension Phase|Death|0|||
126668683|NCT02060383|455747262|FG001|Extension Phase|Death|0|||
126668684|NCT02060383|455747263|FG002|Extension Phase|Death|1|||
126668685|NCT02060383|455747264|FG003|Extension Phase|Death|0|||
126668686|NCT02060383|455747265|FG004|Extension Phase|Death|1|||
126668687|NCT02060383|455747261|FG000|Extension Phase|Protocol Violation|0|||
126668688|NCT02060383|455747262|FG001|Extension Phase|Protocol Violation|0|||
126668689|NCT02060383|455747263|FG002|Extension Phase|Protocol Violation|0|||
126668690|NCT02060383|455747264|FG003|Extension Phase|Protocol Violation|0|||
126668691|NCT02060383|455747265|FG004|Extension Phase|Protocol Violation|1|||
126668692|NCT00332839|455747266|FG000|Core (Months 0 - 12)|Administrative problems|1|||
126668693|NCT00332839|455747267|FG001|Core (Months 0 - 12)|Administrative problems|1|||
126668694|NCT00332839|455747266|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
126668695|NCT00332839|455747267|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
126668696|NCT00332839|455747266|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
126668697|NCT00332839|455747267|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
126668698|NCT00332839|455747266|FG000|Core (Months 0 - 12)|Adverse Event|5|||
126337111|NCT00853762|454530903|FG003|Overall Study|Premature Termination|21|||
126337112|NCT00853762|454530900|FG000|Overall Study|Protocol Violation|0|||
126337113|NCT00853762|454530901|FG001|Overall Study|Protocol Violation|0|||
126668699|NCT00332839|455747267|FG001|Core (Months 0 - 12)|Adverse Event|15|||
126668700|NCT00332839|455747266|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
126668701|NCT00332839|455747267|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
126668702|NCT00332839|455747266|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
126668703|NCT00332839|455747267|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
126668704|NCT00332839|455747266|FG000|Follow-up (Months 12 - 60)|Death|1|||
126337114|NCT00853762|454530902|FG002|Overall Study|Protocol Violation|0|||
126668705|NCT00332839|455747267|FG001|Follow-up (Months 12 - 60)|Death|1|||
126337115|NCT00853762|454530903|FG003|Overall Study|Protocol Violation|1|||
126668706|NCT02020863|455747269|FG000|Overall Study|Discovery of Metastatic disease|4|||
126337116|NCT00853762|454530900|FG000|Overall Study|Withdrawal by Subject|0|||
126668707|NCT02020863|455747269|FG000|Overall Study|Team chose not to place an a line|1|||
126668708|NCT03523728|455747273|FG000|Stage 1 (24 Months)|Adverse Event|2|||
126337117|NCT00853762|454530901|FG001|Overall Study|Withdrawal by Subject|0|||
126337118|NCT00853762|454530902|FG002|Overall Study|Withdrawal by Subject|1|||
126337119|NCT00853762|454530903|FG003|Overall Study|Withdrawal by Subject|0|||
126337120|NCT00853762|454530900|FG000|Overall Study|Other|0|||
126337121|NCT00853762|454530901|FG001|Overall Study|Other|2|||
126337122|NCT00853762|454530902|FG002|Overall Study|Other|0|||
126337123|NCT00853762|454530903|FG003|Overall Study|Other|0|||
126337124|NCT00853762|454530900|FG000|Overall Study|Randomised but not Treated|0|||
126337125|NCT00853762|454530901|FG001|Overall Study|Randomised but not Treated|2|||
126337126|NCT00853762|454530902|FG002|Overall Study|Randomised but not Treated|2|||
126337127|NCT00853762|454530903|FG003|Overall Study|Randomised but not Treated|0|||
126337128|NCT02000921|454530905|FG000|Overall Study|Withdrawal by Subject|3|||
126337129|NCT02000921|454530906|FG001|Overall Study|Withdrawal by Subject|10|||
126337130|NCT02000921|454530907|FG002|Overall Study|Withdrawal by Subject|5|||
126337131|NCT02000921|454530905|FG000|Overall Study|Lost to Follow-up|2|||
126337132|NCT02000921|454530906|FG001|Overall Study|Lost to Follow-up|4|||
126337133|NCT02000921|454530907|FG002|Overall Study|Lost to Follow-up|5|||
126668709|NCT03523728|455747274|FG001|Stage 1 (24 Months)|Adverse Event|2|||
126668710|NCT03523728|455747275|FG002|Stage 1 (24 Months)|Adverse Event|4|||
126668711|NCT03523728|455747276|FG003|Stage 1 (24 Months)|Adverse Event|0|||
126668712|NCT03523728|455747277|FG004|Stage 1 (24 Months)|Adverse Event|0|||
126337134|NCT02000921|454530905|FG000|Overall Study|Physician Decision|0|||
126337135|NCT02000921|454530906|FG001|Overall Study|Physician Decision|2|||
126337136|NCT02000921|454530907|FG002|Overall Study|Physician Decision|0|||
126337137|NCT02051296|454530912|FG000|Overall Study|Lost to Follow-up|1|||
126337138|NCT02051296|454530913|FG001|Overall Study|Lost to Follow-up|2|||
126337139|NCT02051296|454530912|FG000|Overall Study|withdraw prior to treatment|7|||
126337140|NCT02051296|454530913|FG001|Overall Study|withdraw prior to treatment|7|||
126337141|NCT02631941|454530916|FG000|Overall Study|Physician Decision|0|||
126337142|NCT02631941|454530917|FG001|Overall Study|Physician Decision|1|||
126337143|NCT02631941|454530918|FG002|Overall Study|Physician Decision|0|||
126337144|NCT02631941|454530919|FG003|Overall Study|Physician Decision|0|||
126337145|NCT02631941|454530920|FG004|Overall Study|Physician Decision|0|||
126337146|NCT02631941|454530921|FG005|Overall Study|Physician Decision|0|||
126337147|NCT02631941|454530922|FG006|Overall Study|Physician Decision|0|||
126337148|NCT02631941|454530923|FG007|Overall Study|Physician Decision|0|||
126337149|NCT02631941|454530924|FG008|Overall Study|Physician Decision|0|||
126337150|NCT02631941|454530925|FG009|Overall Study|Physician Decision|0|||
126337151|NCT02631941|454530916|FG000|Overall Study|Adverse Event|0|||
126337152|NCT02631941|454530917|FG001|Overall Study|Adverse Event|1|||
126337153|NCT02631941|454530918|FG002|Overall Study|Adverse Event|0|||
126337154|NCT02631941|454530919|FG003|Overall Study|Adverse Event|0|||
126337155|NCT02631941|454530920|FG004|Overall Study|Adverse Event|0|||
126337156|NCT02631941|454530921|FG005|Overall Study|Adverse Event|0|||
126337157|NCT02631941|454530922|FG006|Overall Study|Adverse Event|0|||
126337158|NCT02631941|454530923|FG007|Overall Study|Adverse Event|0|||
126337159|NCT02631941|454530924|FG008|Overall Study|Adverse Event|0|||
126668713|NCT03523728|455747273|FG000|Stage 1 (24 Months)|Progressive disease|0|||
126668714|NCT03523728|455747274|FG001|Stage 1 (24 Months)|Progressive disease|0|||
126668715|NCT03523728|455747275|FG002|Stage 1 (24 Months)|Progressive disease|1|||
126668716|NCT03523728|455747276|FG003|Stage 1 (24 Months)|Progressive disease|0|||
126668717|NCT03523728|455747277|FG004|Stage 1 (24 Months)|Progressive disease|0|||
126668718|NCT03523728|455747273|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
126668719|NCT03523728|455747274|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
126668720|NCT03523728|455747275|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
126668721|NCT03523728|455747276|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
126668722|NCT03523728|455747277|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
126668723|NCT03523728|455747273|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
126668724|NCT03523728|455747274|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
126668725|NCT03523728|455747275|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
126668726|NCT03523728|455747276|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
126668727|NCT03523728|455747277|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
126668728|NCT03523728|455747273|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
126668729|NCT03523728|455747274|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
126668730|NCT03523728|455747275|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
126668731|NCT03523728|455747276|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
126668732|NCT03523728|455747277|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
126337160|NCT02631941|454530925|FG009|Overall Study|Adverse Event|0|||
126337161|NCT02631941|454530916|FG000|Overall Study|Withdrawal by Subject|0|||
126337162|NCT02631941|454530917|FG001|Overall Study|Withdrawal by Subject|0|||
126337163|NCT02631941|454530918|FG002|Overall Study|Withdrawal by Subject|0|||
126337164|NCT02631941|454530919|FG003|Overall Study|Withdrawal by Subject|0|||
126337165|NCT02631941|454530920|FG004|Overall Study|Withdrawal by Subject|1|||
126337166|NCT02631941|454530921|FG005|Overall Study|Withdrawal by Subject|0|||
126337167|NCT02631941|454530922|FG006|Overall Study|Withdrawal by Subject|0|||
126337168|NCT02631941|454530923|FG007|Overall Study|Withdrawal by Subject|1|||
126337169|NCT02631941|454530924|FG008|Overall Study|Withdrawal by Subject|0|||
126668733|NCT03523728|455747273|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
126668734|NCT03523728|455747274|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
126668735|NCT03523728|455747275|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
126668736|NCT03523728|455747276|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
126668737|NCT03523728|455747277|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
126668738|NCT03523728|455747273|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
126668739|NCT03523728|455747274|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
126668740|NCT03523728|455747275|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
126668741|NCT03523728|455747276|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
126668742|NCT03523728|455747277|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
126668743|NCT03523728|455747273|FG000|Stage 2 (24 Months)|Adverse Event|0|||
126668744|NCT03523728|455747274|FG001|Stage 2 (24 Months)|Adverse Event|0|||
126668745|NCT03523728|455747275|FG002|Stage 2 (24 Months)|Adverse Event|0|||
126668746|NCT03523728|455747276|FG003|Stage 2 (24 Months)|Adverse Event|1|||
126668747|NCT03523728|455747277|FG004|Stage 2 (24 Months)|Adverse Event|2|||
126668748|NCT03523728|455747273|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
126668749|NCT03523728|455747274|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
126668750|NCT03523728|455747275|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
126668751|NCT03523728|455747276|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
126668752|NCT03523728|455747277|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
126668753|NCT03523728|455747273|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
126668754|NCT03523728|455747274|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
126668755|NCT03523728|455747275|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
126668756|NCT03523728|455747276|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
126337170|NCT02631941|454530925|FG009|Overall Study|Withdrawal by Subject|0|||
126337171|NCT02631941|454530916|FG000|Overall Study|Lost to Follow-up|0|||
126337172|NCT02631941|454530917|FG001|Overall Study|Lost to Follow-up|0|||
126337173|NCT02631941|454530918|FG002|Overall Study|Lost to Follow-up|0|||
126337174|NCT02631941|454530919|FG003|Overall Study|Lost to Follow-up|0|||
126337175|NCT02631941|454530920|FG004|Overall Study|Lost to Follow-up|0|||
126337176|NCT02631941|454530921|FG005|Overall Study|Lost to Follow-up|0|||
126337177|NCT02631941|454530922|FG006|Overall Study|Lost to Follow-up|0|||
126337178|NCT02631941|454530923|FG007|Overall Study|Lost to Follow-up|0|||
126337179|NCT02631941|454530924|FG008|Overall Study|Lost to Follow-up|1|||
126337180|NCT02631941|454530925|FG009|Overall Study|Lost to Follow-up|0|||
126337181|NCT02858401|454530927|FG000|Overall Study|Withdrew Consent|0|||
126337182|NCT02858401|454530928|FG001|Overall Study|Withdrew Consent|0|||
126337183|NCT02858401|454530929|FG002|Overall Study|Withdrew Consent|0|||
126337184|NCT02858401|454530930|FG003|Overall Study|Withdrew Consent|0|||
126337185|NCT02858401|454530931|FG004|Overall Study|Withdrew Consent|0|||
126337186|NCT02858401|454530932|FG005|Overall Study|Withdrew Consent|1|||
126337187|NCT02858401|454530933|FG006|Overall Study|Withdrew Consent|0|||
126337188|NCT02858401|454530927|FG000|Overall Study|Lost to Follow-up|0|||
126337189|NCT02858401|454530928|FG001|Overall Study|Lost to Follow-up|1|||
126337190|NCT02858401|454530929|FG002|Overall Study|Lost to Follow-up|0|||
126337191|NCT02858401|454530930|FG003|Overall Study|Lost to Follow-up|0|||
126337192|NCT02858401|454530931|FG004|Overall Study|Lost to Follow-up|0|||
126337193|NCT02858401|454530932|FG005|Overall Study|Lost to Follow-up|0|||
126337194|NCT02858401|454530933|FG006|Overall Study|Lost to Follow-up|0|||
126337195|NCT02513550|454530934|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
126337196|NCT02513550|454530935|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
126337197|NCT02513550|454530936|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
126337198|NCT02513550|454530937|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
126337199|NCT02513550|454530938|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
126337200|NCT02513550|454530939|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
126337201|NCT02513550|454530934|FG000|Double Blind Treatment Period|Adverse Event|5|||
126337202|NCT02513550|454530935|FG001|Double Blind Treatment Period|Adverse Event|13|||
126337203|NCT02513550|454530936|FG002|Double Blind Treatment Period|Adverse Event|17|||
126337204|NCT02513550|454530937|FG003|Double Blind Treatment Period|Adverse Event|0|||
126337205|NCT02513550|454530938|FG004|Double Blind Treatment Period|Adverse Event|1|||
126668757|NCT03523728|455747277|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
126668758|NCT03523728|455747273|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
126668759|NCT03523728|455747274|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
126668760|NCT03523728|455747275|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
126337206|NCT02513550|454530939|FG005|Double Blind Treatment Period|Adverse Event|0|||
126337207|NCT02513550|454530934|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
126337208|NCT02513550|454530935|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
126337209|NCT02513550|454530936|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
126337210|NCT02513550|454530937|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
126337211|NCT02513550|454530938|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
126337212|NCT02513550|454530939|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
126337213|NCT02513550|454530934|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
126337214|NCT02513550|454530935|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
126337215|NCT02513550|454530936|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
126668761|NCT03523728|455747276|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
126668762|NCT03523728|455747277|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
126668763|NCT03523728|455747273|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
126668764|NCT03523728|455747274|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
126668765|NCT03523728|455747275|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
126668766|NCT03523728|455747276|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
126668767|NCT03523728|455747277|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
126668768|NCT00621751|455747278|FG000|Overall Study|Adverse Event|0|||
126668769|NCT00621751|455747279|FG001|Overall Study|Adverse Event|1|||
126668770|NCT01950247|455747281|FG000|Overall Study|Withdrawal by Subject|28|||
126668771|NCT01950247|455747282|FG001|Overall Study|Withdrawal by Subject|13|||
126668772|NCT01950247|455747281|FG000|Overall Study|Lost to Follow-up|18|||
126668773|NCT01950247|455747282|FG001|Overall Study|Lost to Follow-up|16|||
126668774|NCT01950247|455747281|FG000|Overall Study|Physician Decision|3|||
126668775|NCT01950247|455747282|FG001|Overall Study|Physician Decision|4|||
126668776|NCT01950247|455747281|FG000|Overall Study|Adverse Event|3|||
126668777|NCT01950247|455747282|FG001|Overall Study|Adverse Event|2|||
126668778|NCT01950247|455747281|FG000|Overall Study|Death|1|||
126668779|NCT01950247|455747282|FG001|Overall Study|Death|1|||
126668780|NCT01950247|455747281|FG000|Overall Study|Not Defined|4|||
126668781|NCT01950247|455747282|FG001|Overall Study|Not Defined|10|||
126668782|NCT00710879|455747285|FG000|Overall Study|Lost to Follow-up|2|||
126668783|NCT00710879|455747286|FG001|Overall Study|Lost to Follow-up|1|||
126668784|NCT00710879|455747285|FG000|Overall Study|Protocol Violation|0|||
126668785|NCT00710879|455747286|FG001|Overall Study|Protocol Violation|3|||
126668786|NCT01809132|455747287|FG000|Overall Study|Withdrawal by Subject|0|||
126668787|NCT01809132|455747288|FG001|Overall Study|Withdrawal by Subject|0|||
126668788|NCT01809132|455747289|FG002|Overall Study|Withdrawal by Subject|1|||
126668789|NCT03349775|455747290|FG000|Overall Study|Side Effects|1|||
126668790|NCT03349775|455747291|FG001|Overall Study|Side Effects|2|||
126668791|NCT03349775|455747290|FG000|Overall Study|Withdrawal by Subject|1|||
126668792|NCT03349775|455747291|FG001|Overall Study|Withdrawal by Subject|1|||
126668793|NCT03349775|455747290|FG000|Overall Study|No primary outcome measurements|0|||
126668794|NCT03349775|455747291|FG001|Overall Study|No primary outcome measurements|1|||
126668795|NCT01516970|455747292|FG000|Overall Study|Lost to Follow-up|7|||
126668796|NCT01516970|455747293|FG001|Overall Study|Lost to Follow-up|8|||
126668797|NCT01516970|455747292|FG000|Overall Study|Adverse Event|1|||
126668798|NCT01516970|455747293|FG001|Overall Study|Adverse Event|5|||
126668799|NCT01516970|455747292|FG000|Overall Study|Withdrawal by Subject|1|||
126668800|NCT01516970|455747293|FG001|Overall Study|Withdrawal by Subject|1|||
126668801|NCT01516970|455747292|FG000|Overall Study|Other|9|||
126668802|NCT01516970|455747293|FG001|Overall Study|Other|7|||
126668803|NCT00434421|455747294|FG000|Overall Study|Withdrawal by Subject|1|||
126668804|NCT00434421|455747294|FG000|Overall Study|Non-compliance with study treatment|1|||
126668805|NCT01756040|455747295|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
126668806|NCT01756040|455747295|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
126668807|NCT01756040|455747295|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
126668808|NCT01688466|455747296|FG000|Overall Study|Withdrawal by Subject|2|||
126668809|NCT01688466|455747297|FG001|Overall Study|Withdrawal by Subject|1|||
126668810|NCT01688466|455747296|FG000|Overall Study|Death|0|||
126668811|NCT01688466|455747297|FG001|Overall Study|Death|1|||
126668812|NCT01688466|455747296|FG000|Overall Study|Adverse Event|0|||
126668813|NCT01688466|455747297|FG001|Overall Study|Adverse Event|4|||
126668814|NCT01688466|455747296|FG000|Overall Study|Not evaluable|0|||
126668815|NCT01688466|455747297|FG001|Overall Study|Not evaluable|1|||
126668816|NCT03631667|455747298|FG000|Overall Study|Withdrawal by Subject|3|||
126668817|NCT00892177|455747299|FG000|Phase II|Ineligible|0|||
126668818|NCT00892177|455747300|FG001|Phase II|Ineligible|0|||
126668819|NCT00892177|455747301|FG002|Phase II|Ineligible|0|||
126668820|NCT00892177|455747302|FG003|Phase II|Ineligible|0|||
126668821|NCT00892177|455747303|FG004|Phase II|Ineligible|1|||
126668822|NCT00892177|455747304|FG005|Phase II|Ineligible|1|||
126668823|NCT00892177|455747299|FG000|Phase II|Withdrawal by Subject|0|||
126668824|NCT00892177|455747300|FG001|Phase II|Withdrawal by Subject|0|||
126668825|NCT00892177|455747301|FG002|Phase II|Withdrawal by Subject|0|||
126668826|NCT00892177|455747302|FG003|Phase II|Withdrawal by Subject|0|||
126668827|NCT00892177|455747303|FG004|Phase II|Withdrawal by Subject|4|||
126668828|NCT00892177|455747304|FG005|Phase II|Withdrawal by Subject|1|||
126668829|NCT01446016|455747305|FG000|Overall Study|Lost to Follow-up|3|||
126668830|NCT01446016|455747305|FG000|Overall Study|Withdrawal by Subject|1|||
126668831|NCT01446016|455747305|FG000|Overall Study|Toxicity|3|||
126668832|NCT01087957|455747315|FG000|Overall Study|Death|2|||
126668833|NCT01087957|455747316|FG001|Overall Study|Death|2|||
126668834|NCT01087957|455747315|FG000|Overall Study|Lost to Follow-up|3|||
126668835|NCT01087957|455747316|FG001|Overall Study|Lost to Follow-up|4|||
126668836|NCT01087957|455747315|FG000|Overall Study|Protocol Violation|13|||
126668837|NCT01087957|455747316|FG001|Overall Study|Protocol Violation|25|||
126668838|NCT01087957|455747315|FG000|Overall Study|Withdrawal by Subject|18|||
126668839|NCT01087957|455747316|FG001|Overall Study|Withdrawal by Subject|15|||
126668840|NCT01087957|455747315|FG000|Overall Study|Physician Decision|5|||
126668841|NCT01087957|455747316|FG001|Overall Study|Physician Decision|9|||
126668842|NCT01186939|455747317|FG000|Overall Study|Death|7|||
126668843|NCT01186939|455747317|FG000|Overall Study|Withdrawal by Subject|2|||
126668844|NCT01186939|455747317|FG000|Overall Study|No longer receiving clinical benefit|17|||
126668845|NCT01186939|455747317|FG000|Overall Study|Program closed|5|||
126668846|NCT01186939|455747317|FG000|Overall Study|Sponsor decision|4|||
126668847|NCT01186939|455747317|FG000|Overall Study|Started additional treatment|1|||
126668848|NCT01186939|455747317|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
126668849|NCT01186939|455747317|FG000|Overall Study|Myocardial infarction|1|||
126668850|NCT01186939|455747317|FG000|Overall Study|Bone marrow transplant|1|||
126668851|NCT01186939|455747317|FG000|Overall Study|Transformation to AML|1|||
126668852|NCT00616434|455747318|FG000|Overall Study|Adverse Event|5|||
126668853|NCT00616434|455747319|FG001|Overall Study|Adverse Event|2|||
126668854|NCT00616434|455747318|FG000|Overall Study|Physician Decision|0|||
126668855|NCT00616434|455747319|FG001|Overall Study|Physician Decision|4|||
126668856|NCT00616434|455747318|FG000|Overall Study|Withdrawal by Subject|1|||
126668857|NCT00616434|455747319|FG001|Overall Study|Withdrawal by Subject|1|||
126668858|NCT00616434|455747318|FG000|Overall Study|Protocol deviation|0|||
126668859|NCT00616434|455747319|FG001|Overall Study|Protocol deviation|1|||
126668860|NCT03933397|455747323|FG000|Overall Study|No emergency department visit|65|||
126668861|NCT03933397|455747324|FG001|Overall Study|No emergency department visit|71|||
126668862|NCT03933397|455747323|FG000|Overall Study|Missed emergency department visit|25|||
126668863|NCT03933397|455747324|FG001|Overall Study|Missed emergency department visit|30|||
126668864|NCT03933397|455747323|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
126668865|NCT03933397|455747324|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
126668866|NCT03933397|455747323|FG000|Overall Study|Withdrawal by Subject|1|||
126668867|NCT03933397|455747324|FG001|Overall Study|Withdrawal by Subject|0|||
126668868|NCT03933397|455747323|FG000|Overall Study|Physician Decision|1|||
126668869|NCT03933397|455747324|FG001|Overall Study|Physician Decision|1|||
126668870|NCT03933397|455747323|FG000|Overall Study|missing pain score|1|||
126668871|NCT03933397|455747324|FG001|Overall Study|missing pain score|1|||
126668872|NCT03933397|455747323|FG000|Overall Study|Confirmed COVID-19|1|||
126668873|NCT03933397|455747324|FG001|Overall Study|Confirmed COVID-19|2|||
126668874|NCT04029116|455747325|FG000|Overall Study|Adverse Event|0|||
126668875|NCT04029116|455747326|FG001|Overall Study|Adverse Event|2|||
126668876|NCT04029116|455747325|FG000|Overall Study|Lost to Follow-up|3|||
126668877|NCT04029116|455747326|FG001|Overall Study|Lost to Follow-up|5|||
126668878|NCT04029116|455747325|FG000|Overall Study|Physician Decision|2|||
126668879|NCT04029116|455747326|FG001|Overall Study|Physician Decision|0|||
126668880|NCT04029116|455747325|FG000|Overall Study|Pregnancy|1|||
126668881|NCT04029116|455747326|FG001|Overall Study|Pregnancy|2|||
126668882|NCT04029116|455747325|FG000|Overall Study|Withdrawal by Subject|4|||
126668883|NCT04029116|455747326|FG001|Overall Study|Withdrawal by Subject|6|||
126668884|NCT04029116|455747325|FG000|Overall Study|Other|2|||
126668885|NCT04029116|455747326|FG001|Overall Study|Other|1|||
126668886|NCT04513665|455747327|FG000|Overall Study|Adverse Event|2|||
126668887|NCT04513665|455747328|FG001|Overall Study|Adverse Event|0|||
126668888|NCT04513665|455747327|FG000|Overall Study|Lack of Efficacy|14|||
126668889|NCT04513665|455747328|FG001|Overall Study|Lack of Efficacy|0|||
126668890|NCT02608879|455747330|FG000|Overall Study|Lost to Follow-up|1|||
126668891|NCT02608879|455747331|FG001|Overall Study|Lost to Follow-up|0|||
126668892|NCT02608879|455747332|FG002|Overall Study|Lost to Follow-up|0|||
126668893|NCT02608879|455747330|FG000|Overall Study|Did not meet continuation criteria|0|||
126668894|NCT02608879|455747331|FG001|Overall Study|Did not meet continuation criteria|0|||
126668895|NCT02608879|455747332|FG002|Overall Study|Did not meet continuation criteria|3|||
126668896|NCT00760669|455747333|FG000|Overall Study|Not assessed for overall improvement|18|||
126668897|NCT00760669|455747333|FG000|Overall Study|Participants missing efficacy assessment|6|||
126668898|NCT00760669|455747333|FG000|Overall Study|Participants with overlapping cases|1|||
126668899|NCT00760669|455747333|FG000|Overall Study|Took drug before entering in contract|5|||
126668900|NCT01572675|455747334|FG000|Overall Study|End of prescribed treatment|140|||
126668901|NCT01572675|455747335|FG001|Overall Study|End of prescribed treatment|118|||
126668902|NCT01572675|455747334|FG000|Overall Study|Recovery|16|||
126668903|NCT01572675|455747335|FG001|Overall Study|Recovery|23|||
126668904|NCT01572675|455747334|FG000|Overall Study|Lack of Efficacy|31|||
126668905|NCT01572675|455747335|FG001|Overall Study|Lack of Efficacy|31|||
126668906|NCT01572675|455747334|FG000|Overall Study|Intolerance|6|||
126337216|NCT02513550|454530937|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
126668907|NCT01572675|455747335|FG001|Overall Study|Intolerance|5|||
126668908|NCT01572675|455747334|FG000|Overall Study|Improved symptoms|8|||
126668909|NCT01572675|455747335|FG001|Overall Study|Improved symptoms|2|||
126668910|NCT01572675|455747334|FG000|Overall Study|Surgical intervention|3|||
126668911|NCT01572675|455747335|FG001|Overall Study|Surgical intervention|6|||
126668912|NCT01572675|455747334|FG000|Overall Study|Withdrawal by Subject|5|||
126668913|NCT01572675|455747335|FG001|Overall Study|Withdrawal by Subject|1|||
126668914|NCT01572675|455747334|FG000|Overall Study|Physician Decision|2|||
126668915|NCT01572675|455747335|FG001|Overall Study|Physician Decision|2|||
126337217|NCT02513550|454530938|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
126668916|NCT01572675|455747334|FG000|Overall Study|Death unrelated to coxibs|1|||
126668917|NCT01572675|455747335|FG001|Overall Study|Death unrelated to coxibs|1|||
126668918|NCT01572675|455747334|FG000|Overall Study|Other disease detected|1|||
126668919|NCT01572675|455747335|FG001|Overall Study|Other disease detected|1|||
126668920|NCT01572675|455747334|FG000|Overall Study|Unknown reason|1|||
126668921|NCT01572675|455747335|FG001|Overall Study|Unknown reason|1|||
126668922|NCT01572675|455747334|FG000|Overall Study|Rheumatologist new evaluation|0|||
126668923|NCT01572675|455747335|FG001|Overall Study|Rheumatologist new evaluation|1|||
126668924|NCT01572675|455747334|FG000|Overall Study|Missing data|1|||
126668925|NCT01572675|455747335|FG001|Overall Study|Missing data|4|||
126668926|NCT01572675|455747334|FG000|Overall Study|Lost to Follow-up|22|||
126668927|NCT01572675|455747335|FG001|Overall Study|Lost to Follow-up|27|||
126668928|NCT02966223|455747336|FG000|Overall Study|Physician Decision|3|||
126668929|NCT02966223|455747336|FG000|Overall Study|Withdrawal by Subject|11|||
126668930|NCT02966223|455747336|FG000|Overall Study|Lost to Follow-up|1|||
126668931|NCT02003014|455747337|FG000|Overall Study|Case report forms uncollected|9|||
126668932|NCT02003014|455747337|FG000|Overall Study|Treatment started after contract period|1|||
126668933|NCT02003014|455747337|FG000|Overall Study|Patient did not visit the study site|5|||
126668934|NCT02003014|455747337|FG000|Overall Study|Investigator's transfer|4|||
126668935|NCT01660451|455747340|FG000|Overall Study|Protocol Violation|0|||
126668936|NCT01660451|455747341|FG001|Overall Study|Protocol Violation|1|||
126668937|NCT01660451|455747342|FG002|Overall Study|Protocol Violation|1|||
126668938|NCT01660451|455747340|FG000|Overall Study|AE not associated with clinical disease progression|13|||
126668939|NCT01660451|455747341|FG001|Overall Study|AE not associated with clinical disease progression|10|||
126668940|NCT01660451|455747342|FG002|Overall Study|AE not associated with clinical disease progression|40|||
126668941|NCT01660451|455747340|FG000|Overall Study|AE associated with clinical disease progression|1|||
126668942|NCT01660451|455747341|FG001|Overall Study|AE associated with clinical disease progression|3|||
126668943|NCT01660451|455747342|FG002|Overall Study|AE associated with clinical disease progression|11|||
126668944|NCT01660451|455747340|FG000|Overall Study|Sponsor Decision|0|||
126668945|NCT01660451|455747341|FG001|Overall Study|Sponsor Decision|0|||
126668946|NCT01660451|455747342|FG002|Overall Study|Sponsor Decision|1|||
126668947|NCT01660451|455747340|FG000|Overall Study|Protocol Deviation|0|||
126668948|NCT01660451|455747341|FG001|Overall Study|Protocol Deviation|0|||
126668949|NCT01660451|455747342|FG002|Overall Study|Protocol Deviation|1|||
126668950|NCT01660451|455747340|FG000|Overall Study|Physician Decision|1|||
126668951|NCT01660451|455747341|FG001|Overall Study|Physician Decision|2|||
126668952|NCT01660451|455747342|FG002|Overall Study|Physician Decision|5|||
126668953|NCT01660451|455747340|FG000|Overall Study|Withdrawal by Subject|1|||
126668954|NCT01660451|455747341|FG001|Overall Study|Withdrawal by Subject|1|||
126668955|NCT01660451|455747342|FG002|Overall Study|Withdrawal by Subject|20|||
126668956|NCT01660451|455747340|FG000|Overall Study|Trial closure.|0|||
126668957|NCT01660451|455747341|FG001|Overall Study|Trial closure.|0|||
126668958|NCT01660451|455747342|FG002|Overall Study|Trial closure.|1|||
126668959|NCT01660451|455747340|FG000|Overall Study|Switching to other therapy|0|||
126668960|NCT01660451|455747341|FG001|Overall Study|Switching to other therapy|1|||
126337218|NCT02513550|454530939|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
126337219|NCT02513550|454530934|FG000|Double Blind Treatment Period|Protocol Violation|1|||
126337220|NCT02513550|454530935|FG001|Double Blind Treatment Period|Protocol Violation|1|||
126337221|NCT02513550|454530936|FG002|Double Blind Treatment Period|Protocol Violation|4|||
126337222|NCT02513550|454530937|FG003|Double Blind Treatment Period|Protocol Violation|0|||
126337223|NCT02513550|454530938|FG004|Double Blind Treatment Period|Protocol Violation|0|||
126337224|NCT02513550|454530939|FG005|Double Blind Treatment Period|Protocol Violation|0|||
126337225|NCT02513550|454530934|FG000|Double Blind Treatment Period|Physician Decision|2|||
126337226|NCT02513550|454530935|FG001|Double Blind Treatment Period|Physician Decision|0|||
126337227|NCT02513550|454530936|FG002|Double Blind Treatment Period|Physician Decision|4|||
126337228|NCT02513550|454530937|FG003|Double Blind Treatment Period|Physician Decision|0|||
126337229|NCT02513550|454530938|FG004|Double Blind Treatment Period|Physician Decision|0|||
126337230|NCT02513550|454530939|FG005|Double Blind Treatment Period|Physician Decision|0|||
126337231|NCT02513550|454530934|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
126337232|NCT02513550|454530935|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
126337233|NCT02513550|454530936|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
126337234|NCT02513550|454530937|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
126337235|NCT02513550|454530938|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
126337236|NCT02513550|454530939|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
126337237|NCT02513550|454530934|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
126337238|NCT02513550|454530935|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
126668961|NCT01660451|455747342|FG002|Overall Study|Switching to other therapy|1|||
126668962|NCT01660451|455747340|FG000|Overall Study|Progressive disease - clinical progression|4|||
126668963|NCT01660451|455747341|FG001|Overall Study|Progressive disease - clinical progression|10|||
126337239|NCT02513550|454530936|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
126337240|NCT02513550|454530937|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
126337241|NCT02513550|454530938|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
126668964|NCT01660451|455747342|FG002|Overall Study|Progressive disease - clinical progression|9|||
126668965|NCT01660451|455747340|FG000|Overall Study|Progressive disease - radiological progression|12|||
126668966|NCT01660451|455747341|FG001|Overall Study|Progressive disease - radiological progression|23|||
126668967|NCT01660451|455747342|FG002|Overall Study|Progressive disease - radiological progression|50|||
126668968|NCT01660451|455747340|FG000|Overall Study|Death|1|||
126668969|NCT01660451|455747341|FG001|Overall Study|Death|0|||
126668970|NCT01660451|455747342|FG002|Overall Study|Death|1|||
126668971|NCT01660451|455747340|FG000|Overall Study|Other|0|||
126668972|NCT01660451|455747341|FG001|Overall Study|Other|0|||
126668973|NCT01660451|455747342|FG002|Overall Study|Other|1|||
126668974|NCT00805025|455747344|FG000|Overall Study|Screened but not enrolled/treated|42|||
126668975|NCT00805025|455747344|FG000|Overall Study|Adverse Event|4|||
126668976|NCT00805025|455747344|FG000|Overall Study|Withdrawal by Subject|2|||
126668977|NCT00805025|455747344|FG000|Overall Study|Physician Decision|1|||
126668978|NCT00375219|455747345|FG000|Overall Study|Failure to achieve a response|16|||
126668979|NCT00375219|455747346|FG001|Overall Study|Failure to achieve a response|2|||
126668980|NCT00375219|455747347|FG002|Overall Study|Failure to achieve a response|0|||
126668981|NCT00375219|455747345|FG000|Overall Study|Adverse Event|8|||
126668982|NCT00375219|455747346|FG001|Overall Study|Adverse Event|2|||
126668983|NCT00375219|455747347|FG002|Overall Study|Adverse Event|1|||
126668984|NCT00375219|455747345|FG000|Overall Study|Protocol Violation|1|||
126668985|NCT00375219|455747346|FG001|Overall Study|Protocol Violation|0|||
126668986|NCT00375219|455747347|FG002|Overall Study|Protocol Violation|1|||
126668987|NCT00375219|455747345|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
126668988|NCT00375219|455747346|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
126668989|NCT00375219|455747347|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
126668990|NCT00375219|455747345|FG000|Overall Study|Lost to Follow-up|1|||
126668991|NCT00375219|455747346|FG001|Overall Study|Lost to Follow-up|1|||
126668992|NCT00375219|455747347|FG002|Overall Study|Lost to Follow-up|0|||
126668993|NCT00375219|455747345|FG000|Overall Study|Disease progression|18|||
126668994|NCT00375219|455747346|FG001|Overall Study|Disease progression|9|||
126668995|NCT00375219|455747347|FG002|Overall Study|Disease progression|12|||
126668996|NCT00375219|455747345|FG000|Overall Study|Death|4|||
126668997|NCT00375219|455747346|FG001|Overall Study|Death|3|||
126668998|NCT00375219|455747347|FG002|Overall Study|Death|7|||
126668999|NCT00375219|455747345|FG000|Overall Study|Hematologic resistance|1|||
126669000|NCT00375219|455747346|FG001|Overall Study|Hematologic resistance|0|||
126669001|NCT00375219|455747347|FG002|Overall Study|Hematologic resistance|0|||
126669002|NCT00375219|455747345|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
126669003|NCT00375219|455747346|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
126669004|NCT00375219|455747347|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
126669005|NCT00375219|455747345|FG000|Overall Study|Allograft|2|||
126669006|NCT00375219|455747346|FG001|Overall Study|Allograft|0|||
126669007|NCT00375219|455747347|FG002|Overall Study|Allograft|0|||
126669008|NCT00375219|455747345|FG000|Overall Study|Cord blood transplantation|1|||
126669009|NCT00375219|455747346|FG001|Overall Study|Cord blood transplantation|0|||
126669010|NCT00375219|455747347|FG002|Overall Study|Cord blood transplantation|0|||
126669011|NCT00375219|455747345|FG000|Overall Study|Withdrawal by Subject|1|||
126669012|NCT00375219|455747346|FG001|Overall Study|Withdrawal by Subject|0|||
126669013|NCT00375219|455747347|FG002|Overall Study|Withdrawal by Subject|0|||
126337242|NCT02513550|454530939|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
126337243|NCT02513550|454530934|FG000|Double Blind Treatment Period|Due to personal business|2|||
126337244|NCT02513550|454530935|FG001|Double Blind Treatment Period|Due to personal business|0|||
126337245|NCT02513550|454530936|FG002|Double Blind Treatment Period|Due to personal business|1|||
126337246|NCT02513550|454530937|FG003|Double Blind Treatment Period|Due to personal business|0|||
126337247|NCT02513550|454530938|FG004|Double Blind Treatment Period|Due to personal business|0|||
126337248|NCT02513550|454530939|FG005|Double Blind Treatment Period|Due to personal business|0|||
126337249|NCT02513550|454530934|FG000|Double Blind Treatment Period|Death|1|||
126337250|NCT02513550|454530935|FG001|Double Blind Treatment Period|Death|0|||
126337251|NCT02513550|454530936|FG002|Double Blind Treatment Period|Death|2|||
126337252|NCT02513550|454530937|FG003|Double Blind Treatment Period|Death|0|||
126337253|NCT02513550|454530938|FG004|Double Blind Treatment Period|Death|0|||
126337254|NCT02513550|454530939|FG005|Double Blind Treatment Period|Death|0|||
126337255|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
126337256|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
126337257|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
126337258|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126669014|NCT02281357|455747348|FG000|Overall Study|Adverse Event|2|||
126337259|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126337260|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
126337261|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
126669015|NCT02281357|455747349|FG001|Overall Study|Adverse Event|1|||
126669016|NCT02281357|455747348|FG000|Overall Study|Lost to Follow-up|1|||
126669017|NCT02281357|455747349|FG001|Overall Study|Lost to Follow-up|0|||
126669018|NCT02281357|455747348|FG000|Overall Study|Withdrawal by Subject|4|||
126337262|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
126337263|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
126337264|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
126337265|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
126337266|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
126337267|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
126337268|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
126337269|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
126337270|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126337271|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126337272|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
126337273|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
126337274|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
126337275|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
126337276|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
126337277|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
126337278|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
126337279|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
126337280|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
126337281|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
126337282|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
126337283|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
126337284|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
126337285|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Death|0|||
126337286|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Death|0|||
126337287|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Death|1|||
126337288|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Death|0|||
126337289|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Death|0|||
126337290|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Death|0|||
126337291|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
126669019|NCT02281357|455747349|FG001|Overall Study|Withdrawal by Subject|3|||
126669020|NCT00482703|455747354|FG000|Overall Study|Poor compliance|1|||
126669021|NCT00482703|455747355|FG001|Overall Study|Poor compliance|0|||
126669022|NCT00972777|455747362|FG000|Overall Study|Adverse Event|3|||
126669023|NCT00972777|455747363|FG001|Overall Study|Adverse Event|2|||
126669024|NCT00972777|455747362|FG000|Overall Study|Lost to Follow-up|0|||
126669025|NCT00972777|455747363|FG001|Overall Study|Lost to Follow-up|4|||
126669026|NCT00972777|455747362|FG000|Overall Study|Withdrawal by Subject|4|||
126669027|NCT00972777|455747363|FG001|Overall Study|Withdrawal by Subject|5|||
126669028|NCT00972777|455747362|FG000|Overall Study|Physician Decision|4|||
126669029|NCT00972777|455747363|FG001|Overall Study|Physician Decision|0|||
126669030|NCT00972777|455747362|FG000|Overall Study|Protocol Violation|0|||
126669031|NCT00972777|455747363|FG001|Overall Study|Protocol Violation|2|||
126669032|NCT00972777|455747362|FG000|Overall Study|Screening Failure|2|||
126669033|NCT00972777|455747363|FG001|Overall Study|Screening Failure|1|||
126669034|NCT00972777|455747362|FG000|Overall Study|Missed visit|1|||
126337292|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
126337293|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
126337294|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
126337295|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
126337296|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
126337297|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
126337298|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
126337299|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
126337300|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
126337301|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
126337302|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
126337303|NCT02513550|454530934|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
126337304|NCT02513550|454530935|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
126337305|NCT02513550|454530936|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
126337306|NCT02513550|454530937|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
126337307|NCT02513550|454530938|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
126669035|NCT00972777|455747363|FG001|Overall Study|Missed visit|0|||
126337308|NCT02513550|454530939|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
126337309|NCT00492297|454530943|FG000|Treatment|Death|2|||
126337310|NCT00492297|454530943|FG000|Treatment|Study terminated by sponsor|3|||
126669036|NCT00729378|455749163|FG000|Baseline|Did not complete study measurements|72|||
126669037|NCT00729378|455749164|FG001|Baseline|Did not complete study measurements|33|||
126669038|NCT00729378|455749163|FG000|Baseline|Withdrawal by Subject|66|||
126669039|NCT00729378|455749164|FG001|Baseline|Withdrawal by Subject|59|||
126669040|NCT00729378|455749163|FG000|12-months|Lost to Follow-up|100|||
126669041|NCT00729378|455749164|FG001|12-months|Lost to Follow-up|65|||
126669042|NCT00729378|455749163|FG000|24-months|Lost to Follow-up|72|||
126669043|NCT00729378|455749164|FG001|24-months|Lost to Follow-up|51|||
126669044|NCT00729378|455749163|FG000|36-months|Lost to Follow-up|15|||
126669045|NCT00729378|455749164|FG001|36-months|Lost to Follow-up|6|||
126669046|NCT02246582|455749167|FG000|Overall Study|Withdrawal by Subject|3|||
126669047|NCT02246582|455749168|FG001|Overall Study|Withdrawal by Subject|4|||
126669048|NCT03441334|455749170|FG000|Overall Study|Withdrawal by Subject|1|||
126669049|NCT03441334|455749171|FG001|Overall Study|Withdrawal by Subject|0|||
126669050|NCT00395863|455749172|FG000|Overall Study|Patients did not complete both exams|2|||
126669051|NCT00395863|455749173|FG001|Overall Study|Patients did not complete both exams|3|||
126669052|NCT02592551|455749176|FG000|Overall Study|Not evaluable|1|||
126669053|NCT02592551|455749177|FG001|Overall Study|Not evaluable|3|||
126669054|NCT02592551|455749178|FG002|Overall Study|Not evaluable|0|||
126337311|NCT00492297|454530943|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
126337312|NCT00492297|454530943|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
126337313|NCT00492297|454530943|FG000|Survival Only Follow-up|Death|46|||
126337314|NCT00492297|454530943|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
126337315|NCT00492297|454530943|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
126337316|NCT00888654|454530946|FG000|Overall Study|Problems swallowing oral meds.|1|||
126337317|NCT00888654|454530946|FG000|Overall Study|Not enough oral meds before surgery|3|||
126337318|NCT00888654|454530946|FG000|Overall Study|Surgery aborted|2|||
126337319|NCT00888654|454530946|FG000|Overall Study|Withdrawal by Subject|1|||
126337320|NCT00888654|454530946|FG000|Overall Study|Inelig. due to contraindication of med|1|||
126337321|NCT00888654|454530946|FG000|Overall Study|Change in surg date|1|||
126337322|NCT00888654|454530946|FG000|Overall Study|Stopped meds due to headaches|1|||
126337323|NCT02204917|454530947|FG000|Overall Study|Protocol Violation|1|||
126337324|NCT01663402|454530950|FG000|Overall Study|Randomized but not treated|19|||
126337325|NCT01663402|454530951|FG001|Overall Study|Randomized but not treated|11|||
126337326|NCT01663402|454530950|FG000|Overall Study|Adverse Event|347|||
126337327|NCT01663402|454530951|FG001|Overall Study|Adverse Event|362|||
126337328|NCT01663402|454530950|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
126337329|NCT01663402|454530951|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
126337330|NCT01663402|454530950|FG000|Overall Study|Poor compliance to protocol|529|||
126337331|NCT01663402|454530951|FG001|Overall Study|Poor compliance to protocol|454|||
126337332|NCT01663402|454530950|FG000|Overall Study|Physician Decision|77|||
126337333|NCT01663402|454530951|FG001|Overall Study|Physician Decision|62|||
126337334|NCT01663402|454530950|FG000|Overall Study|Site terminated by sponsor|1|||
126337335|NCT01663402|454530951|FG001|Overall Study|Site terminated by sponsor|3|||
126337336|NCT01663402|454530950|FG000|Overall Study|Participant moved|139|||
126337337|NCT01663402|454530951|FG001|Overall Study|Participant moved|104|||
126337338|NCT01663402|454530950|FG000|Overall Study|Withdrawal by Subject|118|||
126337339|NCT01663402|454530951|FG001|Overall Study|Withdrawal by Subject|91|||
126337340|NCT01663402|454530950|FG000|Overall Study|Related to study drug administration|96|||
126337341|NCT01663402|454530951|FG001|Overall Study|Related to study drug administration|105|||
126337342|NCT01663402|454530950|FG000|Overall Study|Lost to Follow-up|17|||
126337343|NCT01663402|454530951|FG001|Overall Study|Lost to Follow-up|15|||
126337344|NCT01663402|454530950|FG000|Overall Study|Other than specified above|172|||
126337345|NCT01663402|454530951|FG001|Overall Study|Other than specified above|147|||
126337346|NCT01701245|454530957|FG000|Overall Study|Protocol Violation|1|||
126337347|NCT01701245|454530958|FG001|Overall Study|Protocol Violation|3|||
126337348|NCT01701245|454530957|FG000|Overall Study|Did not complete the open label period|11|||
126337349|NCT01701245|454530958|FG001|Overall Study|Did not complete the open label period|12|||
126337350|NCT02277028|454530959|FG000|Overall Study|Lost to Follow-up|1|||
126337351|NCT02277028|454530960|FG001|Overall Study|Lost to Follow-up|0|||
126337352|NCT02277028|454530959|FG000|Overall Study|Withdrawal by Subject|0|||
126337353|NCT02277028|454530960|FG001|Overall Study|Withdrawal by Subject|1|||
126337354|NCT05002972|454530961|FG000|Overall Study|Withdrawal by Subject|2|||
126337355|NCT05518539|454530965|FG000|Overall Study|Lost to Follow-up|6|||
126337356|NCT02053493|454530968|FG000|Overall Study|Withdrawal by Subject|1|||
126337357|NCT02053493|454530969|FG001|Overall Study|Withdrawal by Subject|1|||
126337358|NCT01619865|454530974|FG000|Overall Study|Adverse Event|1|||
126337359|NCT01619865|454530974|FG000|Overall Study|Death|2|||
126337360|NCT01619865|454530974|FG000|Overall Study|subject not able to comply|1|||
126337361|NCT01494818|454530975|FG000|Overall Study|Relocation|1|||
126337362|NCT01494818|454530976|FG001|Overall Study|Relocation|2|||
126337363|NCT01494818|454530975|FG000|Overall Study|Lost to Follow-up|1|||
126337364|NCT01494818|454530976|FG001|Overall Study|Lost to Follow-up|0|||
126337365|NCT00791999|454530977|FG000|Overall Study|Protocol planed withdrawal|14|||
126337366|NCT00791999|454530978|FG001|Overall Study|Protocol planed withdrawal|11|||
126669055|NCT01876251|455749179|FG000|Overall Study|Clinical progression|1|||
126669056|NCT01876251|455749180|FG001|Overall Study|Clinical progression|0|||
126669057|NCT01876251|455749181|FG002|Overall Study|Clinical progression|0|||
126669058|NCT01876251|455749179|FG000|Overall Study|Death|2|||
126669059|NCT01876251|455749180|FG001|Overall Study|Death|0|||
126669060|NCT01876251|455749181|FG002|Overall Study|Death|1|||
126669061|NCT01876251|455749179|FG000|Overall Study|Participant started new treatment|1|||
126669062|NCT01876251|455749180|FG001|Overall Study|Participant started new treatment|0|||
126669063|NCT01876251|455749181|FG002|Overall Study|Participant started new treatment|1|||
126669064|NCT01876251|455749179|FG000|Overall Study|Participant refused further follow-up|0|||
126337367|NCT00791999|454530979|FG002|Overall Study|Protocol planed withdrawal|11|||
126337368|NCT00791999|454530980|FG003|Overall Study|Protocol planed withdrawal|45|||
126337369|NCT00791999|454530977|FG000|Overall Study|Withdrawal by Subject|0|||
126669065|NCT01876251|455749180|FG001|Overall Study|Participant refused further follow-up|0|||
126669066|NCT01876251|455749181|FG002|Overall Study|Participant refused further follow-up|1|||
126669067|NCT01876251|455749179|FG000|Overall Study|Study terminated|1|||
126669068|NCT01876251|455749180|FG001|Overall Study|Study terminated|0|||
126669069|NCT01876251|455749181|FG002|Overall Study|Study terminated|0|||
126669070|NCT01876251|455749179|FG000|Overall Study|Objective progression or relapse|10|||
126669071|NCT01876251|455749180|FG001|Overall Study|Objective progression or relapse|3|||
126669072|NCT01876251|455749181|FG002|Overall Study|Objective progression or relapse|8|||
126669073|NCT00268437|455749182|FG000|Overall Study|Ineligible|1|||
126669074|NCT01628107|455749186|FG000|Overall Study|Withdrawal by Subject|17|||
126669075|NCT01628107|455749186|FG000|Overall Study|Lost to Follow-up|4|||
126669076|NCT01628107|455749186|FG000|Overall Study|Adverse Event|33|||
126669077|NCT01628107|455749186|FG000|Overall Study|Physician Decision|2|||
126669078|NCT01628107|455749186|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
126669079|NCT01628107|455749186|FG000|Overall Study|Non-compliant with Study Procedures|10|||
126669080|NCT01628107|455749186|FG000|Overall Study|Not Treated|8|||
126669081|NCT01628107|455749186|FG000|Overall Study|Sponsor Decision|11|||
126669082|NCT01628107|455749186|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
126669083|NCT01628107|455749186|FG000|Overall Study|Relocated|8|||
126669084|NCT01628107|455749186|FG000|Overall Study|Kidney Transplant|9|||
126669085|NCT01628107|455749186|FG000|Overall Study|Use of Standard of Care|9|||
126669086|NCT01086410|455749187|FG000|Overall Study|Adverse Event|1|||
126669087|NCT01086410|455749188|FG001|Overall Study|Adverse Event|0|||
126669088|NCT01086410|455749189|FG002|Overall Study|Adverse Event|0|||
126669089|NCT01086410|455749190|FG003|Overall Study|Adverse Event|2|||
126669090|NCT01086410|455749187|FG000|Overall Study|Lack of Efficacy|1|||
126669091|NCT01086410|455749188|FG001|Overall Study|Lack of Efficacy|1|||
126669092|NCT01086410|455749189|FG002|Overall Study|Lack of Efficacy|0|||
126669093|NCT01086410|455749190|FG003|Overall Study|Lack of Efficacy|0|||
126669094|NCT01086410|455749187|FG000|Overall Study|Protocol Violation|1|||
126669095|NCT01086410|455749188|FG001|Overall Study|Protocol Violation|1|||
126669096|NCT01086410|455749189|FG002|Overall Study|Protocol Violation|0|||
126669097|NCT01086410|455749190|FG003|Overall Study|Protocol Violation|0|||
126669098|NCT01086410|455749187|FG000|Overall Study|Lost to Follow-up|0|||
126669099|NCT01086410|455749188|FG001|Overall Study|Lost to Follow-up|0|||
126669100|NCT01086410|455749189|FG002|Overall Study|Lost to Follow-up|1|||
126669101|NCT01086410|455749190|FG003|Overall Study|Lost to Follow-up|0|||
126669102|NCT02953639|455749191|FG000|Overall Study|Adverse Event|2|||
126669103|NCT02953639|455749192|FG001|Overall Study|Adverse Event|0|||
126669104|NCT02953639|455749193|FG002|Overall Study|Adverse Event|1|||
126669105|NCT02953639|455749191|FG000|Overall Study|Lost to Follow-up|8|||
126669106|NCT02953639|455749192|FG001|Overall Study|Lost to Follow-up|4|||
126669107|NCT02953639|455749193|FG002|Overall Study|Lost to Follow-up|3|||
126669108|NCT02953639|455749191|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126669109|NCT02953639|455749192|FG001|Overall Study|Non-Compliance With Study Drug|2|||
126669110|NCT02953639|455749193|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126669111|NCT02953639|455749191|FG000|Overall Study|Multiple Reasons|1|||
126669112|NCT02953639|455749192|FG001|Overall Study|Multiple Reasons|0|||
126669113|NCT02953639|455749193|FG002|Overall Study|Multiple Reasons|1|||
126337370|NCT00791999|454530978|FG001|Overall Study|Withdrawal by Subject|1|||
126337371|NCT00791999|454530979|FG002|Overall Study|Withdrawal by Subject|0|||
126337372|NCT00791999|454530980|FG003|Overall Study|Withdrawal by Subject|2|||
126337373|NCT00791999|454530977|FG000|Overall Study|Protocol Violation|3|||
126669114|NCT02953639|455749191|FG000|Overall Study|Physician Decision|1|||
126337374|NCT00791999|454530978|FG001|Overall Study|Protocol Violation|0|||
126669115|NCT02953639|455749192|FG001|Overall Study|Physician Decision|0|||
126669116|NCT02953639|455749193|FG002|Overall Study|Physician Decision|0|||
126669117|NCT02953639|455749191|FG000|Overall Study|Withdrawal by Subject|7|||
126669118|NCT02953639|455749192|FG001|Overall Study|Withdrawal by Subject|8|||
126669119|NCT02953639|455749193|FG002|Overall Study|Withdrawal by Subject|10|||
126669120|NCT02953639|455749191|FG000|Overall Study|Completed or Discontinued information is missing|1|||
126669121|NCT02953639|455749192|FG001|Overall Study|Completed or Discontinued information is missing|0|||
126669122|NCT02953639|455749193|FG002|Overall Study|Completed or Discontinued information is missing|0|||
126669123|NCT04196803|455749194|FG000|Overall Study|Withdrawal by Subject|1|||
126669124|NCT04196803|455749195|FG001|Overall Study|Withdrawal by Subject|3|||
126669125|NCT04196803|455749194|FG000|Overall Study|Adverse Event|4|||
126669126|NCT04196803|455749195|FG001|Overall Study|Adverse Event|2|||
126669127|NCT04196803|455749194|FG000|Overall Study|Lost to Follow-up|0|||
126669128|NCT04196803|455749195|FG001|Overall Study|Lost to Follow-up|1|||
126669129|NCT01022996|455749196|FG000|Overall Study|Adverse Event|14|||
126669130|NCT01022996|455749196|FG000|Overall Study|Withdrawal by Subject|3|||
126669131|NCT01022996|455749196|FG000|Overall Study|Lost to Follow-up|1|||
126669132|NCT01022996|455749196|FG000|Overall Study|Administrative problems|6|||
126669133|NCT01022996|455749196|FG000|Overall Study|Disease Progression|32|||
126669134|NCT01022996|455749196|FG000|Overall Study|Protocol Violation|1|||
126669135|NCT01069120|455749197|FG000|Overall Study|Study prematurely terminated|27|||
126669136|NCT01205438|455749198|FG000|Overall Study|Adverse Event|19|||
126669137|NCT01205438|455749199|FG001|Overall Study|Adverse Event|17|||
126669138|NCT01205438|455749200|FG002|Overall Study|Adverse Event|24|||
126669139|NCT01205438|455749198|FG000|Overall Study|Death|1|||
126669140|NCT01205438|455749199|FG001|Overall Study|Death|1|||
126669141|NCT01205438|455749200|FG002|Overall Study|Death|3|||
126669142|NCT01205438|455749198|FG000|Overall Study|Entry Criteria Not Met|16|||
126669143|NCT01205438|455749199|FG001|Overall Study|Entry Criteria Not Met|15|||
126669144|NCT01205438|455749200|FG002|Overall Study|Entry Criteria Not Met|13|||
126669145|NCT01205438|455749198|FG000|Overall Study|Lack of Efficacy|14|||
126669146|NCT01205438|455749199|FG001|Overall Study|Lack of Efficacy|11|||
126669147|NCT01205438|455749200|FG002|Overall Study|Lack of Efficacy|14|||
126669148|NCT01205438|455749198|FG000|Overall Study|Lost to Follow-up|6|||
126669149|NCT01205438|455749199|FG001|Overall Study|Lost to Follow-up|7|||
126669150|NCT01205438|455749200|FG002|Overall Study|Lost to Follow-up|8|||
126669151|NCT01205438|455749198|FG000|Overall Study|Withdrawal by Subject|19|||
126669152|NCT01205438|455749199|FG001|Overall Study|Withdrawal by Subject|25|||
126669153|NCT01205438|455749200|FG002|Overall Study|Withdrawal by Subject|19|||
126669154|NCT01205438|455749198|FG000|Overall Study|Physician Decision|0|||
126669155|NCT01205438|455749199|FG001|Overall Study|Physician Decision|3|||
126669156|NCT01205438|455749200|FG002|Overall Study|Physician Decision|2|||
126669157|NCT01205438|455749198|FG000|Overall Study|Protocol Violation|2|||
126669158|NCT01205438|455749199|FG001|Overall Study|Protocol Violation|7|||
126669159|NCT01205438|455749200|FG002|Overall Study|Protocol Violation|4|||
126669160|NCT01205438|455749198|FG000|Overall Study|Sponsor Decision|0|||
126669161|NCT01205438|455749199|FG001|Overall Study|Sponsor Decision|1|||
126669162|NCT01205438|455749200|FG002|Overall Study|Sponsor Decision|1|||
126669163|NCT03083847|455749205|FG000|Main|Physician Decision|0|||
126669164|NCT03083847|455749206|FG001|Main|Physician Decision|0|||
126669165|NCT03083847|455749207|FG002|Main|Physician Decision|0|||
126669166|NCT03083847|455749208|FG003|Main|Physician Decision|0|||
126669167|NCT03083847|455749209|FG004|Main|Physician Decision|0|||
126669168|NCT03083847|455749210|FG005|Main|Physician Decision|1|||
126669169|NCT03083847|455749211|FG006|Main|Physician Decision|0|||
126669170|NCT03083847|455749212|FG007|Main|Physician Decision|0|||
126669171|NCT03083847|455749213|FG008|Main|Physician Decision|0|||
126669172|NCT03083847|455749214|FG009|Main|Physician Decision|0|||
126669173|NCT03083847|455749205|FG000|Main|Pregnancy|0|||
126669174|NCT03083847|455749206|FG001|Main|Pregnancy|0|||
126669175|NCT03083847|455749207|FG002|Main|Pregnancy|0|||
126669176|NCT03083847|455749208|FG003|Main|Pregnancy|0|||
126669177|NCT03083847|455749209|FG004|Main|Pregnancy|0|||
126669178|NCT03083847|455749210|FG005|Main|Pregnancy|0|||
126669179|NCT03083847|455749211|FG006|Main|Pregnancy|0|||
126669180|NCT03083847|455749212|FG007|Main|Pregnancy|1|||
126669181|NCT03083847|455749213|FG008|Main|Pregnancy|0|||
126669182|NCT03083847|455749214|FG009|Main|Pregnancy|0|||
126669183|NCT03083847|455749205|FG000|Main|Adverse Event|0|||
126669184|NCT03083847|455749206|FG001|Main|Adverse Event|0|||
126669185|NCT03083847|455749207|FG002|Main|Adverse Event|0|||
126669186|NCT03083847|455749208|FG003|Main|Adverse Event|0|||
126337375|NCT00791999|454530979|FG002|Overall Study|Protocol Violation|1|||
126337376|NCT00791999|454530980|FG003|Overall Study|Protocol Violation|0|||
126337377|NCT00791999|454530977|FG000|Overall Study|Adverse Event|3|||
126337378|NCT00791999|454530978|FG001|Overall Study|Adverse Event|3|||
126337379|NCT00791999|454530979|FG002|Overall Study|Adverse Event|7|||
126337380|NCT00791999|454530980|FG003|Overall Study|Adverse Event|3|||
126669187|NCT03083847|455749209|FG004|Main|Adverse Event|0|||
126669188|NCT03083847|455749210|FG005|Main|Adverse Event|0|||
126669189|NCT03083847|455749211|FG006|Main|Adverse Event|0|||
126669190|NCT03083847|455749212|FG007|Main|Adverse Event|2|||
126669191|NCT03083847|455749213|FG008|Main|Adverse Event|0|||
126669192|NCT03083847|455749214|FG009|Main|Adverse Event|0|||
126669193|NCT03083847|455749205|FG000|Main|Withdrawal by Subject|0|||
126669194|NCT03083847|455749206|FG001|Main|Withdrawal by Subject|0|||
126669195|NCT03083847|455749207|FG002|Main|Withdrawal by Subject|0|||
126669196|NCT03083847|455749208|FG003|Main|Withdrawal by Subject|0|||
126669197|NCT03083847|455749209|FG004|Main|Withdrawal by Subject|0|||
126669198|NCT03083847|455749210|FG005|Main|Withdrawal by Subject|0|||
126669199|NCT03083847|455749211|FG006|Main|Withdrawal by Subject|1|||
126669200|NCT03083847|455749212|FG007|Main|Withdrawal by Subject|1|||
126669201|NCT03083847|455749213|FG008|Main|Withdrawal by Subject|0|||
126669202|NCT03083847|455749214|FG009|Main|Withdrawal by Subject|0|||
126669203|NCT00058552|455749216|FG000|Overall Study|Died prior to receiving treatment|4|||
126669204|NCT00058552|455749217|FG001|Overall Study|Died prior to receiving treatment|2|||
126669205|NCT00058552|455749216|FG000|Overall Study|Disease progression|52|||
126669206|NCT00058552|455749217|FG001|Overall Study|Disease progression|44|||
126669207|NCT00058552|455749216|FG000|Overall Study|Adverse Event|4|||
126669208|NCT00058552|455749217|FG001|Overall Study|Adverse Event|2|||
126669209|NCT00058552|455749216|FG000|Overall Study|Withdrawal by Subject|3|||
126669210|NCT00058552|455749217|FG001|Overall Study|Withdrawal by Subject|5|||
126669211|NCT00058552|455749216|FG000|Overall Study|Physician Decision|2|||
126669212|NCT00058552|455749217|FG001|Overall Study|Physician Decision|5|||
126669213|NCT00058552|455749216|FG000|Overall Study|Clinical disease progression|0|||
126669214|NCT00058552|455749217|FG001|Overall Study|Clinical disease progression|4|||
126669215|NCT02319668|455749218|FG000|Overall Study|Other (Not specified)|0|||
126669216|NCT02319668|455749219|FG001|Overall Study|Other (Not specified)|2|||
126669217|NCT02316340|455749222|FG000|First Progression|Clinical progression|2|||
126337381|NCT00791999|454530977|FG000|Overall Study|Lack of Efficacy|0|||
126669218|NCT02316340|455749223|FG001|First Progression|Clinical progression|1|||
126669219|NCT02316340|455749222|FG000|First Progression|Withdrawal by Subject|1|||
126669220|NCT02316340|455749223|FG001|First Progression|Withdrawal by Subject|0|||
126669221|NCT01986920|455749224|FG000|A- 101 25%|Withdrawal by Subject|1|||
126669222|NCT01986920|455749225|FG001|A- 101 25%|Withdrawal by Subject|0|||
126669223|NCT01986920|455749226|FG002|A- 101 25%|Withdrawal by Subject|0|||
126669224|NCT01986920|455749227|FG003|A- 101 25%|Withdrawal by Subject|0|||
126669225|NCT01986920|455749224|FG000|A-101 32.5%|Withdrawal by Subject|0|||
126669226|NCT01986920|455749225|FG001|A-101 32.5%|Withdrawal by Subject|1|||
126669227|NCT01986920|455749226|FG002|A-101 32.5%|Withdrawal by Subject|0|||
126669228|NCT01986920|455749227|FG003|A-101 32.5%|Withdrawal by Subject|0|||
126669229|NCT01986920|455749224|FG000|A-101 40%|Withdrawal by Subject|0|||
126669230|NCT01986920|455749225|FG001|A-101 40%|Withdrawal by Subject|0|||
126669231|NCT01986920|455749226|FG002|A-101 40%|Withdrawal by Subject|1|||
126669232|NCT01986920|455749227|FG003|A-101 40%|Withdrawal by Subject|0|||
126669233|NCT01986920|455749224|FG000|Placebo|Withdrawal by Subject|0|||
126669234|NCT01986920|455749225|FG001|Placebo|Withdrawal by Subject|0|||
126669235|NCT01986920|455749226|FG002|Placebo|Withdrawal by Subject|0|||
126669236|NCT01986920|455749227|FG003|Placebo|Withdrawal by Subject|1|||
126669237|NCT03781323|455749228|FG000|Overall Study|Withdrawal by Subject|1|||
126669238|NCT01338415|455749229|FG000|Core + Extension|Adverse Event|8|||
126669239|NCT01338415|455749230|FG001|Core + Extension|Adverse Event|6|||
126669240|NCT01338415|455749231|FG002|Core + Extension|Adverse Event|0|||
126669241|NCT01338415|455749229|FG000|Core + Extension|Withdrawal by Subject|1|||
126669242|NCT01338415|455749230|FG001|Core + Extension|Withdrawal by Subject|1|||
126669243|NCT01338415|455749231|FG002|Core + Extension|Withdrawal by Subject|0|||
126669244|NCT01338415|455749229|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
126669245|NCT01338415|455749230|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
126669246|NCT01338415|455749231|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
126669247|NCT01338415|455749229|FG000|Core + Extension|Other (administrative reason)|1|||
126669248|NCT01338415|455749230|FG001|Core + Extension|Other (administrative reason)|0|||
126669249|NCT01338415|455749231|FG002|Core + Extension|Other (administrative reason)|0|||
126669250|NCT01338415|455749229|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
126669251|NCT01338415|455749230|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
126669252|NCT01338415|455749231|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
126669253|NCT01338415|455749229|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
126337382|NCT00791999|454530978|FG001|Overall Study|Lack of Efficacy|1|||
126669254|NCT01338415|455749230|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
126669255|NCT01338415|455749231|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
126669256|NCT01338415|455749229|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
126669257|NCT01338415|455749230|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
126669258|NCT01338415|455749231|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
126669259|NCT01338415|455749229|FG000|Exceptional Use Treatment Period|Death|0|||
126669260|NCT01338415|455749230|FG001|Exceptional Use Treatment Period|Death|0|||
126669261|NCT01338415|455749231|FG002|Exceptional Use Treatment Period|Death|1|||
126669262|NCT00874770|455749236|FG000|Overall Study|Lack of Efficacy|2|||
126669263|NCT00874770|455749237|FG001|Overall Study|Lack of Efficacy|0|||
126337383|NCT00791999|454530979|FG002|Overall Study|Lack of Efficacy|0|||
126337384|NCT00791999|454530980|FG003|Overall Study|Lack of Efficacy|2|||
126669264|NCT00874770|455749238|FG002|Overall Study|Lack of Efficacy|0|||
126669265|NCT00874770|455749239|FG003|Overall Study|Lack of Efficacy|2|||
126669266|NCT00874770|455749236|FG000|Overall Study|Adverse Event|1|||
126669267|NCT00874770|455749237|FG001|Overall Study|Adverse Event|1|||
126669268|NCT00874770|455749238|FG002|Overall Study|Adverse Event|4|||
126669269|NCT00874770|455749239|FG003|Overall Study|Adverse Event|2|||
126669270|NCT00874770|455749236|FG000|Overall Study|Lost to Follow-up|1|||
126669271|NCT00874770|455749237|FG001|Overall Study|Lost to Follow-up|0|||
126669272|NCT00874770|455749238|FG002|Overall Study|Lost to Follow-up|0|||
126669273|NCT00874770|455749239|FG003|Overall Study|Lost to Follow-up|1|||
126337385|NCT00791999|454530977|FG000|Overall Study|Reason other than those above|1|||
126669274|NCT00874770|455749236|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
126669275|NCT00874770|455749237|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
126669276|NCT00874770|455749238|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
126669277|NCT00874770|455749239|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
126669278|NCT04880447|455749241|FG000|Overall Study|No vaccination information|1|||
126669279|NCT04880447|455749241|FG000|Overall Study|No adverse event information (missing information)|1|||
126669280|NCT04880447|455749241|FG000|Overall Study|Disease not covered in this study|35|||
126669281|NCT05395104|455749242|FG000|Overall Study|Met Liver Stopping Criteria|1|||
126669282|NCT05395104|455749242|FG000|Overall Study|Withdrawal by Subject|1|||
126669283|NCT01970488|455749243|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
126669284|NCT01970488|455749244|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
126669285|NCT01970488|455749245|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
126669286|NCT01970488|455749246|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
126669287|NCT01970488|455749247|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
126669288|NCT01970488|455749243|FG000|Part 1: Through Week 16|Protocol Violation|1|||
126669289|NCT01970488|455749244|FG001|Part 1: Through Week 16|Protocol Violation|2|||
126669290|NCT01970488|455749245|FG002|Part 1: Through Week 16|Protocol Violation|0|||
126669291|NCT01970488|455749246|FG003|Part 1: Through Week 16|Protocol Violation|0|||
126669292|NCT01970488|455749247|FG004|Part 1: Through Week 16|Protocol Violation|0|||
126669293|NCT01970488|455749243|FG000|Part 1: Through Week 16|Adverse Event|6|||
126669294|NCT01970488|455749244|FG001|Part 1: Through Week 16|Adverse Event|5|||
126669295|NCT01970488|455749245|FG002|Part 1: Through Week 16|Adverse Event|0|||
126669296|NCT01970488|455749246|FG003|Part 1: Through Week 16|Adverse Event|0|||
126669297|NCT01970488|455749247|FG004|Part 1: Through Week 16|Adverse Event|0|||
126669298|NCT01970488|455749243|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
126669299|NCT01970488|455749244|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
126669300|NCT01970488|455749245|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
126669301|NCT01970488|455749246|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
126669302|NCT01970488|455749247|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
126669303|NCT01970488|455749243|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
126669304|NCT01970488|455749244|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
126669305|NCT01970488|455749245|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
126669306|NCT01970488|455749246|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
126669307|NCT01970488|455749247|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
126669308|NCT01970488|455749243|FG000|Part 2: Post Week 16|Physician Decision|0|||
126669309|NCT01970488|455749244|FG001|Part 2: Post Week 16|Physician Decision|0|||
126669310|NCT01970488|455749245|FG002|Part 2: Post Week 16|Physician Decision|0|||
126669311|NCT01970488|455749246|FG003|Part 2: Post Week 16|Physician Decision|0|||
126669312|NCT01970488|455749247|FG004|Part 2: Post Week 16|Physician Decision|1|||
126669313|NCT01970488|455749243|FG000|Part 2: Post Week 16|Non-compliance|0|||
126669314|NCT01970488|455749244|FG001|Part 2: Post Week 16|Non-compliance|0|||
126669315|NCT01970488|455749245|FG002|Part 2: Post Week 16|Non-compliance|1|||
126669316|NCT01970488|455749246|FG003|Part 2: Post Week 16|Non-compliance|0|||
126669317|NCT01970488|455749247|FG004|Part 2: Post Week 16|Non-compliance|0|||
126669318|NCT01970488|455749243|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
126669319|NCT01970488|455749244|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
126669320|NCT01970488|455749245|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
126669321|NCT01970488|455749246|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
126669322|NCT01970488|455749247|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
126669323|NCT01970488|455749243|FG000|Part 2: Post Week 16|Adverse Event|0|||
126669324|NCT01970488|455749244|FG001|Part 2: Post Week 16|Adverse Event|0|||
126669325|NCT01970488|455749245|FG002|Part 2: Post Week 16|Adverse Event|5|||
126669326|NCT01970488|455749246|FG003|Part 2: Post Week 16|Adverse Event|1|||
126669327|NCT01970488|455749247|FG004|Part 2: Post Week 16|Adverse Event|1|||
126669328|NCT01970488|455749243|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
126669329|NCT01970488|455749244|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
126669330|NCT01970488|455749245|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
126669331|NCT01970488|455749246|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
126669332|NCT01970488|455749247|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
126669333|NCT01970488|455749243|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
126669334|NCT01970488|455749244|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
126669335|NCT01970488|455749245|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
126669336|NCT01970488|455749246|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
126669337|NCT01970488|455749247|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
126669338|NCT02613884|455749256|FG000|Overall Study|Death|1|||
126669339|NCT02613884|455749256|FG000|Overall Study|Lost to Follow-up|1|||
126669340|NCT02486653|455749257|FG000|Overall Study|Withdrawal by Subject|1|||
126669341|NCT02486653|455749258|FG001|Overall Study|Withdrawal by Subject|3|||
126669342|NCT02486653|455749257|FG000|Overall Study|Protocol Violation|1|||
126669343|NCT02486653|455749258|FG001|Overall Study|Protocol Violation|0|||
126669344|NCT02486653|455749257|FG000|Overall Study|surgery cancelled|4|||
126669345|NCT02486653|455749258|FG001|Overall Study|surgery cancelled|1|||
126669346|NCT01848353|455749259|FG000|Phase 1|Withdrawal by Subject|3|||
126669347|NCT01848353|455749260|FG001|Phase 1|Withdrawal by Subject|1|||
126337386|NCT00791999|454530978|FG001|Overall Study|Reason other than those above|0|||
126337387|NCT00791999|454530979|FG002|Overall Study|Reason other than those above|1|||
126337388|NCT00791999|454530980|FG003|Overall Study|Reason other than those above|0|||
126337389|NCT01077323|454530981|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
126337390|NCT01077323|454530982|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
126337391|NCT01077323|454530983|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
126337392|NCT01077323|454530981|FG000|Overall Study|Dispensing of drug in baseline period|0|||
126337393|NCT01077323|454530982|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
126337394|NCT01077323|454530983|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
126337395|NCT01077323|454530981|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
126337396|NCT01077323|454530982|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
126669348|NCT01848353|455749261|FG002|Phase 1|Withdrawal by Subject|0|||
126669349|NCT01848353|455749262|FG003|Phase 1|Withdrawal by Subject|0|||
126669350|NCT01848353|455749259|FG000|Phase 2|Withdrawal by Subject|3|||
126669351|NCT01848353|455749260|FG001|Phase 2|Withdrawal by Subject|2|||
126669352|NCT01848353|455749261|FG002|Phase 2|Withdrawal by Subject|0|||
126669353|NCT01848353|455749262|FG003|Phase 2|Withdrawal by Subject|0|||
126669354|NCT01848353|455749259|FG000|Phase 3|Withdrawal by Subject|1|||
126669355|NCT01848353|455749260|FG001|Phase 3|Withdrawal by Subject|1|||
126669356|NCT01848353|455749261|FG002|Phase 3|Withdrawal by Subject|0|||
126669357|NCT01848353|455749262|FG003|Phase 3|Withdrawal by Subject|0|||
126669358|NCT01514136|455749266|FG000|Test Period 1; Test A|Protocol Violation|1|||
126669359|NCT01514136|455749267|FG001|Test Period 1; Test A|Protocol Violation|0|||
126669360|NCT01514136|455749268|FG002|Test Period 1; Test A|Protocol Violation|0|||
126669361|NCT01514136|455749269|FG003|Test Period 1; Test A|Protocol Violation|0|||
126669362|NCT01514136|455749270|FG004|Test Period 1; Test A|Protocol Violation|0|||
126669363|NCT01514136|455749271|FG005|Test Period 1; Test A|Protocol Violation|0|||
126669364|NCT01514136|455749272|FG006|Test Period 1; Test A|Protocol Violation|0|||
126669365|NCT01514136|455749273|FG007|Test Period 1; Test A|Protocol Violation|0|||
126669366|NCT01514136|455749266|FG000|Test Period 1; Test A|Break from study holiday|2|||
126669367|NCT01514136|455749267|FG001|Test Period 1; Test A|Break from study holiday|0|||
126669368|NCT01514136|455749268|FG002|Test Period 1; Test A|Break from study holiday|0|||
126669369|NCT01514136|455749269|FG003|Test Period 1; Test A|Break from study holiday|0|||
126669370|NCT01514136|455749270|FG004|Test Period 1; Test A|Break from study holiday|0|||
126669371|NCT01514136|455749271|FG005|Test Period 1; Test A|Break from study holiday|0|||
126669372|NCT01514136|455749272|FG006|Test Period 1; Test A|Break from study holiday|0|||
126669373|NCT01514136|455749273|FG007|Test Period 1; Test A|Break from study holiday|0|||
126669374|NCT01514136|455749266|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
126669375|NCT01514136|455749267|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
126337397|NCT01077323|454530983|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
126337398|NCT01710020|454530984|FG000|Period 1|Protocol Violation|1|||
126337399|NCT00427908|454530985|FG000|Primary Phase|Lost to Follow-up|4|||
126669376|NCT01514136|455749268|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
126669377|NCT01514136|455749269|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
126669378|NCT01514136|455749270|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
126669379|NCT01514136|455749271|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
126669380|NCT01514136|455749272|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
126669381|NCT01514136|455749273|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
126669382|NCT01514136|455749266|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
126669383|NCT01514136|455749267|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
126669384|NCT01514136|455749268|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
126669385|NCT01514136|455749269|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
126669386|NCT01514136|455749270|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
126669387|NCT01514136|455749271|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
126337400|NCT00427908|454530986|FG001|Primary Phase|Lost to Follow-up|0|||
126337401|NCT00427908|454530987|FG002|Primary Phase|Lost to Follow-up|2|||
126337402|NCT00427908|454530988|FG003|Primary Phase|Lost to Follow-up|0|||
126669388|NCT01514136|455749272|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
126669389|NCT01514136|455749273|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
126669390|NCT01514136|455749266|FG000|Test Period 2; Test A*|Adverse Event|0|||
126669391|NCT01514136|455749267|FG001|Test Period 2; Test A*|Adverse Event|0|||
126669392|NCT01514136|455749268|FG002|Test Period 2; Test A*|Adverse Event|0|||
126337403|NCT00427908|454530985|FG000|Primary Phase|Withdrawal by Subject|1|||
126669393|NCT01514136|455749269|FG003|Test Period 2; Test A*|Adverse Event|0|||
126669394|NCT01514136|455749270|FG004|Test Period 2; Test A*|Adverse Event|1|||
126669395|NCT01514136|455749271|FG005|Test Period 2; Test A*|Adverse Event|0|||
126337404|NCT00427908|454530986|FG001|Primary Phase|Withdrawal by Subject|2|||
126669396|NCT01514136|455749272|FG006|Test Period 2; Test A*|Adverse Event|0|||
126669397|NCT01514136|455749273|FG007|Test Period 2; Test A*|Adverse Event|0|||
126337405|NCT00427908|454530987|FG002|Primary Phase|Withdrawal by Subject|1|||
126337406|NCT00427908|454530988|FG003|Primary Phase|Withdrawal by Subject|0|||
126669398|NCT01514136|455749266|FG000|Test Period 2; Test A*|Holiday|0|||
126669399|NCT01514136|455749267|FG001|Test Period 2; Test A*|Holiday|0|||
126669400|NCT01514136|455749268|FG002|Test Period 2; Test A*|Holiday|0|||
126669401|NCT01514136|455749269|FG003|Test Period 2; Test A*|Holiday|0|||
126669402|NCT01514136|455749270|FG004|Test Period 2; Test A*|Holiday|1|||
126669403|NCT01514136|455749271|FG005|Test Period 2; Test A*|Holiday|0|||
126669404|NCT01514136|455749272|FG006|Test Period 2; Test A*|Holiday|0|||
126669405|NCT01514136|455749273|FG007|Test Period 2; Test A*|Holiday|0|||
126669406|NCT01514136|455749266|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
126669407|NCT01514136|455749267|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
126669408|NCT01514136|455749268|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
126669409|NCT01514136|455749269|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
126669410|NCT01514136|455749270|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
126669411|NCT01514136|455749271|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
126669412|NCT01514136|455749272|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
126669413|NCT01514136|455749273|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
126669414|NCT01514136|455749266|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
126669415|NCT01514136|455749267|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
126669416|NCT01514136|455749268|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
126669417|NCT01514136|455749269|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
126669418|NCT01514136|455749270|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
126669419|NCT01514136|455749271|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
126669420|NCT01514136|455749272|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
126669421|NCT01514136|455749273|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
126669422|NCT01514136|455749266|FG000|Test Period 2; Test C*|holiday|0|||
126669423|NCT01514136|455749267|FG001|Test Period 2; Test C*|holiday|0|||
126669424|NCT01514136|455749268|FG002|Test Period 2; Test C*|holiday|0|||
126669425|NCT01514136|455749269|FG003|Test Period 2; Test C*|holiday|0|||
126669426|NCT01514136|455749270|FG004|Test Period 2; Test C*|holiday|0|||
126669427|NCT01514136|455749271|FG005|Test Period 2; Test C*|holiday|0|||
126669428|NCT01514136|455749272|FG006|Test Period 2; Test C*|holiday|1|||
126669429|NCT01514136|455749273|FG007|Test Period 2; Test C*|holiday|0|||
126669430|NCT01514136|455749266|FG000|Test Period 2; Test C*|Protocol Violation|0|||
126669431|NCT01514136|455749267|FG001|Test Period 2; Test C*|Protocol Violation|0|||
126669432|NCT01514136|455749268|FG002|Test Period 2; Test C*|Protocol Violation|0|||
126669433|NCT01514136|455749269|FG003|Test Period 2; Test C*|Protocol Violation|0|||
126669434|NCT01514136|455749270|FG004|Test Period 2; Test C*|Protocol Violation|0|||
126669435|NCT01514136|455749271|FG005|Test Period 2; Test C*|Protocol Violation|0|||
126669436|NCT01514136|455749272|FG006|Test Period 2; Test C*|Protocol Violation|1|||
126669437|NCT01514136|455749273|FG007|Test Period 2; Test C*|Protocol Violation|0|||
126669438|NCT02941926|455749274|FG000|Core Phase|Progressive disease|1109|||
126669439|NCT02941926|455749274|FG000|Core Phase|Adverse Event|504|||
126669440|NCT02941926|455749274|FG000|Core Phase|Subject/guardian decision|127|||
126669441|NCT02941926|455749274|FG000|Core Phase|Physician Decision|112|||
126669442|NCT02941926|455749274|FG000|Core Phase|Death|46|||
126669443|NCT02941926|455749274|FG000|Core Phase|Protocol deviation|34|||
126669444|NCT02941926|455749274|FG000|Core Phase|Lost to Follow-up|8|||
126669445|NCT02941926|455749274|FG000|Core Phase|Technical problems|5|||
126669446|NCT02941926|455749274|FG000|Extension Phase|Physician Decision|155|||
126669447|NCT02941926|455749274|FG000|Extension Phase|Progressive disease|115|||
126669448|NCT02941926|455749274|FG000|Extension Phase|Adverse Event|13|||
126669449|NCT02941926|455749274|FG000|Extension Phase|Subject/Guardian decision|12|||
126669450|NCT02941926|455749274|FG000|Extension Phase|Death|6|||
126669451|NCT02729740|455749275|FG000|Overall Study|Early Termination|130|||
126669452|NCT02729740|455749275|FG000|Overall Study|Other|1|||
126669453|NCT00307333|455749276|FG000|Overall Study|Lost to Follow-up|11|||
126669454|NCT00307333|455749277|FG001|Overall Study|Lost to Follow-up|3|||
126669455|NCT00601705|455749281|FG000|Overall Study|Withdrawal by Subject|1|||
126669456|NCT03044249|455749297|FG000|Overall Study|Adverse Event|4|||
126669457|NCT03044249|455749298|FG001|Overall Study|Adverse Event|9|||
126669458|NCT03044249|455749297|FG000|Overall Study|Lost to Follow-up|1|||
126669459|NCT03044249|455749298|FG001|Overall Study|Lost to Follow-up|0|||
126669460|NCT03044249|455749297|FG000|Overall Study|Non-compliance with Study Drug|1|||
126669461|NCT03044249|455749298|FG001|Overall Study|Non-compliance with Study Drug|0|||
126669462|NCT03044249|455749297|FG000|Overall Study|Study Terminated by Sponsor|2|||
126669463|NCT03044249|455749298|FG001|Overall Study|Study Terminated by Sponsor|0|||
126669464|NCT03044249|455749297|FG000|Overall Study|Withdrawal by Subject|2|||
126669465|NCT03044249|455749298|FG001|Overall Study|Withdrawal by Subject|5|||
126337407|NCT00427908|454530985|FG000|Primary Phase|Adverse Event|0|||
126669466|NCT02101021|455749299|FG000|Overall Study|Death|4|||
126669467|NCT02101021|455749300|FG001|Overall Study|Death|3|||
126669468|NCT02101021|455749301|FG002|Overall Study|Death|6|||
126669469|NCT02101021|455749302|FG003|Overall Study|Death|0|||
126337408|NCT00427908|454530986|FG001|Primary Phase|Adverse Event|1|||
126669470|NCT02101021|455749303|FG004|Overall Study|Death|3|||
126669471|NCT02101021|455749299|FG000|Overall Study|Withdrew Consent from study|1|||
126669472|NCT02101021|455749300|FG001|Overall Study|Withdrew Consent from study|1|||
126669473|NCT02101021|455749301|FG002|Overall Study|Withdrew Consent from study|0|||
126669474|NCT02101021|455749302|FG003|Overall Study|Withdrew Consent from study|2|||
126669475|NCT02101021|455749303|FG004|Overall Study|Withdrew Consent from study|0|||
126669476|NCT02101021|455749299|FG000|Overall Study|Lost to Follow-up|1|||
126669477|NCT02101021|455749300|FG001|Overall Study|Lost to Follow-up|0|||
126669478|NCT02101021|455749301|FG002|Overall Study|Lost to Follow-up|0|||
126669479|NCT02101021|455749302|FG003|Overall Study|Lost to Follow-up|0|||
126669480|NCT02101021|455749303|FG004|Overall Study|Lost to Follow-up|0|||
126669481|NCT02101021|455749299|FG000|Overall Study|Study Terminated by Sponsor|1|||
126669482|NCT02101021|455749300|FG001|Overall Study|Study Terminated by Sponsor|0|||
126669483|NCT02101021|455749301|FG002|Overall Study|Study Terminated by Sponsor|1|||
126669484|NCT02101021|455749302|FG003|Overall Study|Study Terminated by Sponsor|1|||
126669485|NCT02101021|455749303|FG004|Overall Study|Study Terminated by Sponsor|1|||
126669486|NCT01621542|455749304|FG000|Overall Study|Adverse Event|0|||
126669487|NCT01621542|455749305|FG001|Overall Study|Adverse Event|0|||
126669488|NCT01621542|455749306|FG002|Overall Study|Adverse Event|1|||
126669489|NCT01621542|455749307|FG003|Overall Study|Adverse Event|3|||
126669490|NCT01621542|455749308|FG004|Overall Study|Adverse Event|0|||
126669491|NCT01621542|455749309|FG005|Overall Study|Adverse Event|0|||
126669492|NCT01621542|455749304|FG000|Overall Study|Death|0|||
126669493|NCT01621542|455749305|FG001|Overall Study|Death|1|||
126669494|NCT01621542|455749306|FG002|Overall Study|Death|0|||
126669495|NCT01621542|455749307|FG003|Overall Study|Death|0|||
126669496|NCT01621542|455749308|FG004|Overall Study|Death|0|||
126669497|NCT01621542|455749309|FG005|Overall Study|Death|0|||
126669498|NCT01621542|455749304|FG000|Overall Study|Physician Decision|1|||
126669499|NCT01621542|455749305|FG001|Overall Study|Physician Decision|0|||
126669500|NCT01621542|455749306|FG002|Overall Study|Physician Decision|1|||
126669501|NCT01621542|455749307|FG003|Overall Study|Physician Decision|13|||
126669502|NCT01621542|455749308|FG004|Overall Study|Physician Decision|3|||
126669503|NCT01621542|455749309|FG005|Overall Study|Physician Decision|1|||
126669504|NCT01621542|455749304|FG000|Overall Study|Withdrawal by Subject|2|||
126669505|NCT01621542|455749305|FG001|Overall Study|Withdrawal by Subject|0|||
126669506|NCT01621542|455749306|FG002|Overall Study|Withdrawal by Subject|1|||
126669507|NCT01621542|455749307|FG003|Overall Study|Withdrawal by Subject|3|||
126669508|NCT01621542|455749308|FG004|Overall Study|Withdrawal by Subject|3|||
126669509|NCT01621542|455749309|FG005|Overall Study|Withdrawal by Subject|3|||
126669510|NCT01621542|455749304|FG000|Overall Study|progression/treatment failure|2|||
126669511|NCT01621542|455749305|FG001|Overall Study|progression/treatment failure|4|||
126669512|NCT01621542|455749306|FG002|Overall Study|progression/treatment failure|3|||
126669513|NCT01621542|455749307|FG003|Overall Study|progression/treatment failure|7|||
126669514|NCT01621542|455749308|FG004|Overall Study|progression/treatment failure|3|||
126669515|NCT01621542|455749309|FG005|Overall Study|progression/treatment failure|5|||
126669516|NCT01621542|455749304|FG000|Overall Study|Protocol Violation|0|||
126669517|NCT01621542|455749305|FG001|Overall Study|Protocol Violation|0|||
126669518|NCT01621542|455749306|FG002|Overall Study|Protocol Violation|0|||
126669519|NCT01621542|455749307|FG003|Overall Study|Protocol Violation|1|||
126669520|NCT01621542|455749308|FG004|Overall Study|Protocol Violation|0|||
126337409|NCT00427908|454530987|FG002|Primary Phase|Adverse Event|0|||
126337410|NCT00427908|454530988|FG003|Primary Phase|Adverse Event|0|||
126337411|NCT02984982|454530989|FG000|Overall Study|Adverse Event|2|||
126337412|NCT02984982|454530990|FG001|Overall Study|Adverse Event|5|||
126337413|NCT02984982|454530989|FG000|Overall Study|Poor Compliance to Protocol|4|||
126337414|NCT02984982|454530990|FG001|Overall Study|Poor Compliance to Protocol|4|||
126337415|NCT02984982|454530989|FG000|Overall Study|Withdrawal by Subject|2|||
126337416|NCT02984982|454530990|FG001|Overall Study|Withdrawal by Subject|0|||
126337417|NCT02984982|454530989|FG000|Overall Study|Randomized but not treated|0|||
126337418|NCT02984982|454530990|FG001|Overall Study|Randomized but not treated|1|||
126337419|NCT02153918|454530991|FG000|Overall Study|Refused further treatment|1|||
126337420|NCT02616783|454530992|FG000|Overall Study|Randomized but Not Treated|1|||
126337421|NCT02616783|454530993|FG001|Overall Study|Randomized but Not Treated|0|||
126337422|NCT02616783|454530992|FG000|Overall Study|Adverse Event|1|||
126337423|NCT02616783|454530993|FG001|Overall Study|Adverse Event|0|||
126337424|NCT02616783|454530992|FG000|Overall Study|Death|1|||
126337425|NCT02616783|454530993|FG001|Overall Study|Death|0|||
126337426|NCT02616783|454530992|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126337427|NCT02616783|454530993|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126337428|NCT02616783|454530992|FG000|Overall Study|Protocol Violation|1|||
126337429|NCT02616783|454530993|FG001|Overall Study|Protocol Violation|1|||
126669521|NCT01621542|455749309|FG005|Overall Study|Protocol Violation|0|||
126669522|NCT01621542|455749304|FG000|Overall Study|study stopped by sponsor|0|||
126669523|NCT01621542|455749305|FG001|Overall Study|study stopped by sponsor|0|||
126669524|NCT01621542|455749306|FG002|Overall Study|study stopped by sponsor|0|||
126669525|NCT01621542|455749307|FG003|Overall Study|study stopped by sponsor|1|||
126337430|NCT02616783|454530992|FG000|Overall Study|Withdrew Consent|1|||
126337431|NCT02616783|454530993|FG001|Overall Study|Withdrew Consent|1|||
126337432|NCT04344301|454530994|FG000|Overall Study|Withdrawal by Subject|1|||
126669526|NCT01621542|455749308|FG004|Overall Study|study stopped by sponsor|0|||
126337433|NCT04344301|454530995|FG001|Overall Study|Withdrawal by Subject|0|||
126337434|NCT04344301|454530994|FG000|Overall Study|Death|0|||
126337435|NCT04344301|454530995|FG001|Overall Study|Death|1|||
126337436|NCT01747499|454530996|FG000|Overall Study|Steroid refractory aGvHD|1|||
126337437|NCT01747499|454530997|FG001|Overall Study|Steroid refractory aGvHD|0|||
126337438|NCT01747499|454530998|FG002|Overall Study|Steroid refractory aGvHD|0|||
126337439|NCT01747499|454530999|FG003|Overall Study|Steroid refractory aGvHD|1|||
126337440|NCT01747499|454531000|FG004|Overall Study|Steroid refractory aGvHD|4|||
126337441|NCT01747499|454530996|FG000|Overall Study|Physician Decision|0|||
126337442|NCT01747499|454530997|FG001|Overall Study|Physician Decision|1|||
126337443|NCT01747499|454530998|FG002|Overall Study|Physician Decision|0|||
126337444|NCT01747499|454530999|FG003|Overall Study|Physician Decision|0|||
126337445|NCT01747499|454531000|FG004|Overall Study|Physician Decision|2|||
126337446|NCT01747499|454530996|FG000|Overall Study|Death|0|||
126337447|NCT01747499|454530997|FG001|Overall Study|Death|0|||
126337448|NCT01747499|454530998|FG002|Overall Study|Death|0|||
126337449|NCT01747499|454530999|FG003|Overall Study|Death|1|||
126337450|NCT01747499|454531000|FG004|Overall Study|Death|1|||
126337451|NCT01747499|454530996|FG000|Overall Study|Withdrawal by Subject|0|||
126337452|NCT01747499|454530997|FG001|Overall Study|Withdrawal by Subject|0|||
126669527|NCT01621542|455749309|FG005|Overall Study|study stopped by sponsor|0|||
126669528|NCT01368042|455749310|FG000|Overall Study|Death|14|||
126669529|NCT01368042|455749310|FG000|Overall Study|Protocol Violation|11|||
126669530|NCT01368042|455749310|FG000|Overall Study|Lost to Follow-up|4|||
126669531|NCT01368042|455749310|FG000|Overall Study|Transplanted|1|||
126669532|NCT00955279|455749311|FG000|Overall Study|Other|0|||
126669533|NCT00955279|455749312|FG001|Overall Study|Other|0|||
126669534|NCT00955279|455749313|FG002|Overall Study|Other|3|||
126669535|NCT00955279|455749311|FG000|Overall Study|Death|1|||
126669536|NCT00955279|455749312|FG001|Overall Study|Death|1|||
126669537|NCT00955279|455749313|FG002|Overall Study|Death|1|||
126669538|NCT00955279|455749311|FG000|Overall Study|Lost to Follow-up|0|||
126669539|NCT00955279|455749312|FG001|Overall Study|Lost to Follow-up|3|||
126669540|NCT00955279|455749313|FG002|Overall Study|Lost to Follow-up|1|||
126669541|NCT00955279|455749311|FG000|Overall Study|Withdrawal by Subject|2|||
126669542|NCT00955279|455749312|FG001|Overall Study|Withdrawal by Subject|0|||
126669543|NCT00955279|455749313|FG002|Overall Study|Withdrawal by Subject|3|||
126669544|NCT02632721|455749315|FG000|Overall Study|Adverse Event|0|||
126669545|NCT02632721|455749316|FG001|Overall Study|Adverse Event|0|||
126669546|NCT02632721|455749317|FG002|Overall Study|Adverse Event|2|||
126669547|NCT02632721|455749318|FG003|Overall Study|Adverse Event|5|||
126669548|NCT02632721|455749319|FG004|Overall Study|Adverse Event|3|||
126669549|NCT02632721|455749315|FG000|Overall Study|Dose limiting toxicity|0|||
126669550|NCT02632721|455749316|FG001|Overall Study|Dose limiting toxicity|0|||
126669551|NCT02632721|455749317|FG002|Overall Study|Dose limiting toxicity|0|||
126669552|NCT02632721|455749318|FG003|Overall Study|Dose limiting toxicity|1|||
126669553|NCT02632721|455749319|FG004|Overall Study|Dose limiting toxicity|0|||
126669554|NCT02632721|455749315|FG000|Overall Study|Progressive disease|3|||
126669555|NCT02632721|455749316|FG001|Overall Study|Progressive disease|0|||
126669556|NCT02632721|455749317|FG002|Overall Study|Progressive disease|4|||
126669557|NCT02632721|455749318|FG003|Overall Study|Progressive disease|6|||
126669558|NCT02632721|455749319|FG004|Overall Study|Progressive disease|5|||
126669559|NCT02632721|455749315|FG000|Overall Study|Refused to continue taking trial medication|0|||
126669560|NCT02632721|455749316|FG001|Overall Study|Refused to continue taking trial medication|1|||
126669561|NCT02632721|455749317|FG002|Overall Study|Refused to continue taking trial medication|1|||
126669562|NCT02632721|455749318|FG003|Overall Study|Refused to continue taking trial medication|1|||
126669563|NCT02632721|455749319|FG004|Overall Study|Refused to continue taking trial medication|2|||
126669564|NCT02632721|455749315|FG000|Overall Study|Inadequate clinical condition|0|||
126669565|NCT02632721|455749316|FG001|Overall Study|Inadequate clinical condition|0|||
126669566|NCT02632721|455749317|FG002|Overall Study|Inadequate clinical condition|0|||
126669567|NCT02632721|455749318|FG003|Overall Study|Inadequate clinical condition|0|||
126669568|NCT02632721|455749319|FG004|Overall Study|Inadequate clinical condition|1|||
126669569|NCT02632721|455749315|FG000|Overall Study|No meet eligibility|0|||
126669570|NCT02632721|455749316|FG001|Overall Study|No meet eligibility|0|||
126669571|NCT02632721|455749317|FG002|Overall Study|No meet eligibility|0|||
126669572|NCT02632721|455749318|FG003|Overall Study|No meet eligibility|0|||
126669573|NCT02632721|455749319|FG004|Overall Study|No meet eligibility|1|||
126669574|NCT02632721|455749315|FG000|Overall Study|Allergic reaction|0|||
126669575|NCT02632721|455749316|FG001|Overall Study|Allergic reaction|0|||
126669576|NCT02632721|455749317|FG002|Overall Study|Allergic reaction|0|||
126669577|NCT02632721|455749318|FG003|Overall Study|Allergic reaction|1|||
126669578|NCT02632721|455749319|FG004|Overall Study|Allergic reaction|0|||
126669579|NCT02632721|455749315|FG000|Overall Study|Receiving Decitabine locally|0|||
126669580|NCT02632721|455749316|FG001|Overall Study|Receiving Decitabine locally|0|||
126337453|NCT01747499|454530998|FG002|Overall Study|Withdrawal by Subject|0|||
126337454|NCT01747499|454530999|FG003|Overall Study|Withdrawal by Subject|0|||
126337455|NCT01747499|454531000|FG004|Overall Study|Withdrawal by Subject|6|||
126337456|NCT01747499|454530996|FG000|Overall Study|Developed AML and death|0|||
126337457|NCT01747499|454530997|FG001|Overall Study|Developed AML and death|0|||
126669581|NCT02632721|455749317|FG002|Overall Study|Receiving Decitabine locally|1|||
126669582|NCT02632721|455749318|FG003|Overall Study|Receiving Decitabine locally|0|||
126669583|NCT02632721|455749319|FG004|Overall Study|Receiving Decitabine locally|0|||
126669584|NCT02632721|455749315|FG000|Overall Study|No benefit from study treatment|1|||
126669585|NCT02632721|455749316|FG001|Overall Study|No benefit from study treatment|1|||
126669586|NCT02632721|455749317|FG002|Overall Study|No benefit from study treatment|0|||
126669587|NCT02632721|455749318|FG003|Overall Study|No benefit from study treatment|0|||
126669588|NCT02632721|455749319|FG004|Overall Study|No benefit from study treatment|1|||
126669589|NCT02632721|455749315|FG000|Overall Study|Patient wish for other treatment|0|||
126669590|NCT02632721|455749316|FG001|Overall Study|Patient wish for other treatment|1|||
126669591|NCT02632721|455749317|FG002|Overall Study|Patient wish for other treatment|0|||
126669592|NCT02632721|455749318|FG003|Overall Study|Patient wish for other treatment|0|||
126669593|NCT02632721|455749319|FG004|Overall Study|Patient wish for other treatment|0|||
126669594|NCT02632721|455749315|FG000|Overall Study|Relapsed Pneumonia|0|||
126669595|NCT02632721|455749316|FG001|Overall Study|Relapsed Pneumonia|0|||
126669596|NCT02632721|455749317|FG002|Overall Study|Relapsed Pneumonia|0|||
126669597|NCT02632721|455749318|FG003|Overall Study|Relapsed Pneumonia|0|||
126669598|NCT02632721|455749319|FG004|Overall Study|Relapsed Pneumonia|1|||
126669599|NCT02632721|455749315|FG000|Overall Study|Therapy refractory AML|0|||
126669600|NCT02632721|455749316|FG001|Overall Study|Therapy refractory AML|0|||
126669601|NCT02632721|455749317|FG002|Overall Study|Therapy refractory AML|0|||
126669602|NCT02632721|455749318|FG003|Overall Study|Therapy refractory AML|0|||
126669603|NCT02632721|455749319|FG004|Overall Study|Therapy refractory AML|1|||
126669604|NCT02632721|455749315|FG000|Overall Study|Increase of white blood cell count|0|||
126669605|NCT02632721|455749316|FG001|Overall Study|Increase of white blood cell count|0|||
126669606|NCT02632721|455749317|FG002|Overall Study|Increase of white blood cell count|0|||
126669607|NCT02632721|455749318|FG003|Overall Study|Increase of white blood cell count|0|||
126669608|NCT02632721|455749319|FG004|Overall Study|Increase of white blood cell count|1|||
126669609|NCT02632721|455749315|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
126669610|NCT02632721|455749316|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
126669611|NCT02632721|455749317|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
126669612|NCT02632721|455749318|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
126669613|NCT02632721|455749319|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
126669614|NCT00544648|455749325|FG000|Overall Study|Withdrawal by Subject|1|||
126669615|NCT00544648|455749326|FG001|Overall Study|Withdrawal by Subject|0|||
126669616|NCT00544648|455749325|FG000|Overall Study|Adverse Event|1|||
126669617|NCT00544648|455749326|FG001|Overall Study|Adverse Event|1|||
126669618|NCT00544648|455749325|FG000|Overall Study|progression of disease|1|||
126669619|NCT00544648|455749326|FG001|Overall Study|progression of disease|0|||
126669620|NCT02663271|455749327|FG000|Overall Study|Withdrawal by Subject|5|||
126669621|NCT02663271|455749327|FG000|Overall Study|Lack of Efficacy|1|||
126669622|NCT01235793|455749328|FG000|Overall Study|Death|6|||
126669623|NCT03346057|455749330|FG000|Overall Study|Death|1|||
126669624|NCT03346057|455749331|FG001|Overall Study|Death|2|||
126669625|NCT03346057|455749332|FG002|Overall Study|Death|0|||
126669626|NCT03346057|455749333|FG003|Overall Study|Death|0|||
126669627|NCT03346057|455749330|FG000|Overall Study|Lost to Follow-up|0|||
126669628|NCT03346057|455749331|FG001|Overall Study|Lost to Follow-up|2|||
126669629|NCT03346057|455749332|FG002|Overall Study|Lost to Follow-up|1|||
126669630|NCT03346057|455749333|FG003|Overall Study|Lost to Follow-up|0|||
126669631|NCT03346057|455749330|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
126669632|NCT03346057|455749331|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
126669633|NCT03346057|455749332|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
126669634|NCT03346057|455749333|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
126669635|NCT03346057|455749330|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
126669636|NCT03346057|455749331|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
126669637|NCT03346057|455749332|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
126669638|NCT03346057|455749333|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
126669639|NCT03346057|455749330|FG000|Overall Study|Physician Decision|3|||
126669640|NCT03346057|455749331|FG001|Overall Study|Physician Decision|2|||
126337458|NCT01747499|454530998|FG002|Overall Study|Developed AML and death|0|||
126337459|NCT01747499|454530999|FG003|Overall Study|Developed AML and death|0|||
126337460|NCT01747499|454531000|FG004|Overall Study|Developed AML and death|1|||
126337461|NCT01747499|454530996|FG000|Overall Study|Determined not to be eligible|0|||
126337462|NCT01747499|454530997|FG001|Overall Study|Determined not to be eligible|0|||
126337463|NCT01747499|454530998|FG002|Overall Study|Determined not to be eligible|0|||
126669641|NCT03346057|455749332|FG002|Overall Study|Physician Decision|0|||
126669642|NCT03346057|455749333|FG003|Overall Study|Physician Decision|2|||
126669643|NCT03346057|455749330|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
126669644|NCT03346057|455749331|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
126669645|NCT03346057|455749332|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
126669646|NCT03346057|455749333|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
126669647|NCT03346057|455749330|FG000|Overall Study|Withdrawal by Subject|1|||
126669648|NCT03346057|455749331|FG001|Overall Study|Withdrawal by Subject|0|||
126669649|NCT03346057|455749332|FG002|Overall Study|Withdrawal by Subject|0|||
126669650|NCT03346057|455749333|FG003|Overall Study|Withdrawal by Subject|0|||
126669651|NCT01159912|455749334|FG000|Overall Study|Adverse Event|2|||
126669652|NCT01159912|455749335|FG001|Overall Study|Adverse Event|2|||
126669653|NCT01159912|455749336|FG002|Overall Study|Adverse Event|3|||
126669654|NCT01159912|455749334|FG000|Overall Study|Lack of Efficacy|23|||
126669655|NCT01159912|455749335|FG001|Overall Study|Lack of Efficacy|15|||
126669656|NCT01159912|455749336|FG002|Overall Study|Lack of Efficacy|14|||
126669657|NCT01159912|455749334|FG000|Overall Study|Protocol Violation|1|||
126669658|NCT01159912|455749335|FG001|Overall Study|Protocol Violation|2|||
126669659|NCT01159912|455749336|FG002|Overall Study|Protocol Violation|3|||
126669660|NCT01159912|455749334|FG000|Overall Study|Lost to Follow-up|4|||
126669661|NCT01159912|455749335|FG001|Overall Study|Lost to Follow-up|0|||
126669662|NCT01159912|455749336|FG002|Overall Study|Lost to Follow-up|0|||
126669663|NCT01159912|455749334|FG000|Overall Study|Physician Decision|0|||
126669664|NCT01159912|455749335|FG001|Overall Study|Physician Decision|0|||
126669665|NCT01159912|455749336|FG002|Overall Study|Physician Decision|3|||
126669666|NCT01159912|455749334|FG000|Overall Study|Withdrawal by Subject|10|||
126669667|NCT01159912|455749335|FG001|Overall Study|Withdrawal by Subject|3|||
126669668|NCT01159912|455749336|FG002|Overall Study|Withdrawal by Subject|3|||
126669669|NCT02456662|455749337|FG000|Overall Study|Lost to Follow-up|2|||
126669670|NCT02456662|455749338|FG001|Overall Study|Lost to Follow-up|1|||
126669671|NCT03519867|455749342|FG000|Overall Study|Adverse Event|1|||
126669672|NCT03519867|455749343|FG001|Overall Study|Adverse Event|1|||
126669673|NCT03519867|455749344|FG002|Overall Study|Adverse Event|0|||
126669674|NCT03519867|455749345|FG003|Overall Study|Adverse Event|0|||
126669675|NCT03519867|455749346|FG004|Overall Study|Adverse Event|0|||
126669676|NCT03519867|455749347|FG005|Overall Study|Adverse Event|0|||
126669677|NCT03519867|455749348|FG006|Overall Study|Adverse Event|0|||
126669678|NCT03519867|455749349|FG007|Overall Study|Adverse Event|0|||
126669679|NCT03519867|455749350|FG008|Overall Study|Adverse Event|0|||
126669680|NCT03519867|455749351|FG009|Overall Study|Adverse Event|0|||
126669681|NCT03519867|455749342|FG000|Overall Study|Protocol Violation|0|||
126669682|NCT03519867|455749343|FG001|Overall Study|Protocol Violation|0|||
126669683|NCT03519867|455749344|FG002|Overall Study|Protocol Violation|0|||
126669684|NCT03519867|455749345|FG003|Overall Study|Protocol Violation|0|||
126669685|NCT03519867|455749346|FG004|Overall Study|Protocol Violation|0|||
126669686|NCT03519867|455749347|FG005|Overall Study|Protocol Violation|1|||
126669687|NCT03519867|455749348|FG006|Overall Study|Protocol Violation|0|||
126669688|NCT03519867|455749349|FG007|Overall Study|Protocol Violation|0|||
126669689|NCT03519867|455749350|FG008|Overall Study|Protocol Violation|0|||
126669690|NCT03519867|455749351|FG009|Overall Study|Protocol Violation|0|||
126669691|NCT03519867|455749342|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126669692|NCT03519867|455749343|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126669693|NCT03519867|455749344|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126669694|NCT03519867|455749345|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126669695|NCT03519867|455749346|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126669696|NCT03519867|455749347|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126669697|NCT03519867|455749348|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
126669698|NCT03519867|455749349|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126669699|NCT03519867|455749350|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126669700|NCT03519867|455749351|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
126669701|NCT03519867|455749342|FG000|Overall Study|Admin. of other reversal agent|1|||
126669702|NCT03519867|455749343|FG001|Overall Study|Admin. of other reversal agent|1|||
126669703|NCT03519867|455749344|FG002|Overall Study|Admin. of other reversal agent|0|||
126669704|NCT03519867|455749345|FG003|Overall Study|Admin. of other reversal agent|0|||
126669705|NCT03519867|455749346|FG004|Overall Study|Admin. of other reversal agent|0|||
126669706|NCT03519867|455749347|FG005|Overall Study|Admin. of other reversal agent|1|||
126669707|NCT03519867|455749348|FG006|Overall Study|Admin. of other reversal agent|0|||
126669708|NCT03519867|455749349|FG007|Overall Study|Admin. of other reversal agent|0|||
126669709|NCT03519867|455749350|FG008|Overall Study|Admin. of other reversal agent|0|||
126669710|NCT03519867|455749351|FG009|Overall Study|Admin. of other reversal agent|0|||
126669711|NCT03519867|455749342|FG000|Overall Study|Reason not provided|1|||
126669712|NCT03519867|455749343|FG001|Overall Study|Reason not provided|1|||
126669713|NCT03519867|455749344|FG002|Overall Study|Reason not provided|1|||
126669714|NCT03519867|455749345|FG003|Overall Study|Reason not provided|1|||
126669715|NCT03519867|455749346|FG004|Overall Study|Reason not provided|0|||
126669716|NCT03519867|455749347|FG005|Overall Study|Reason not provided|1|||
126669717|NCT03519867|455749348|FG006|Overall Study|Reason not provided|0|||
126669718|NCT03519867|455749349|FG007|Overall Study|Reason not provided|1|||
126669719|NCT03519867|455749350|FG008|Overall Study|Reason not provided|1|||
126669720|NCT03519867|455749351|FG009|Overall Study|Reason not provided|0|||
126669721|NCT03007979|455749352|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
126669722|NCT01428661|455749353|FG000|Double-Masked Phase|Protocol Violation|9|||
126669723|NCT01428661|455749354|FG001|Double-Masked Phase|Protocol Violation|4|||
126669724|NCT01428661|455749355|FG002|Double-Masked Phase|Protocol Violation|0|||
126669725|NCT01428661|455749353|FG000|Double-Masked Phase|Adverse Event|13|||
126669726|NCT01428661|455749354|FG001|Double-Masked Phase|Adverse Event|4|||
126669727|NCT01428661|455749355|FG002|Double-Masked Phase|Adverse Event|0|||
126669728|NCT01428661|455749353|FG000|Double-Masked Phase|Lost to Follow-up|14|||
126669729|NCT01428661|455749354|FG001|Double-Masked Phase|Lost to Follow-up|14|||
126669730|NCT01428661|455749355|FG002|Double-Masked Phase|Lost to Follow-up|0|||
126669731|NCT01428661|455749353|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
126669732|NCT01428661|455749354|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
126669733|NCT01428661|455749355|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
126669734|NCT01428661|455749353|FG000|Double-Masked Phase|Lack of Efficacy|2|||
126337464|NCT01747499|454530999|FG003|Overall Study|Determined not to be eligible|0|||
126337465|NCT01747499|454531000|FG004|Overall Study|Determined not to be eligible|1|||
126337466|NCT05214118|454531003|FG000|Overall Study|Lost to Follow-up|0|||
126337467|NCT05214118|454531004|FG001|Overall Study|Lost to Follow-up|2|||
126337468|NCT05214118|454531003|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
126337469|NCT05214118|454531004|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
126669735|NCT01428661|455749354|FG001|Double-Masked Phase|Lack of Efficacy|1|||
126669736|NCT01428661|455749355|FG002|Double-Masked Phase|Lack of Efficacy|0|||
126669737|NCT01428661|455749353|FG000|Double-Masked Phase|*Various|1|||
126669738|NCT01428661|455749354|FG001|Double-Masked Phase|*Various|6|||
126669739|NCT01428661|455749355|FG002|Double-Masked Phase|*Various|0|||
126669740|NCT01428661|455749353|FG000|Open Label Extension|Protocol Violation|0|||
126669741|NCT01428661|455749354|FG001|Open Label Extension|Protocol Violation|0|||
126669742|NCT01428661|455749355|FG002|Open Label Extension|Protocol Violation|9|||
126669743|NCT01428661|455749353|FG000|Open Label Extension|Adverse Event|0|||
126669744|NCT01428661|455749354|FG001|Open Label Extension|Adverse Event|0|||
126669745|NCT01428661|455749355|FG002|Open Label Extension|Adverse Event|15|||
126669746|NCT01428661|455749353|FG000|Open Label Extension|Lost to Follow-up|0|||
126669747|NCT01428661|455749354|FG001|Open Label Extension|Lost to Follow-up|0|||
126669748|NCT01428661|455749355|FG002|Open Label Extension|Lost to Follow-up|38|||
126669749|NCT01428661|455749353|FG000|Open Label Extension|Withdrawal by Subject|0|||
126669750|NCT01428661|455749354|FG001|Open Label Extension|Withdrawal by Subject|0|||
126669751|NCT01428661|455749355|FG002|Open Label Extension|Withdrawal by Subject|49|||
126669752|NCT01428661|455749353|FG000|Open Label Extension|Lack of Efficacy|0|||
126669753|NCT01428661|455749354|FG001|Open Label Extension|Lack of Efficacy|0|||
126669754|NCT01428661|455749355|FG002|Open Label Extension|Lack of Efficacy|24|||
126669755|NCT01428661|455749353|FG000|Open Label Extension|**Various|0|||
126669756|NCT01428661|455749354|FG001|Open Label Extension|**Various|0|||
126669757|NCT01428661|455749355|FG002|Open Label Extension|**Various|185|||
126669758|NCT04223791|455749357|FG000|Overall Study|Lost to Follow-up|0|||
126669759|NCT04223791|455749358|FG001|Overall Study|Lost to Follow-up|4|||
126669760|NCT04223791|455749357|FG000|Overall Study|Physician Decision|5|||
126337470|NCT05214118|454531003|FG000|Overall Study|moved|1|||
126337471|NCT05214118|454531004|FG001|Overall Study|moved|0|||
126337472|NCT04010461|454531005|FG000|Overall Study|COVID based withdrawal|5|||
126337473|NCT04010461|454531005|FG000|Overall Study|Withdrawal by Subject|5|||
126337474|NCT04010461|454531005|FG000|Overall Study|Adverse Event|1|||
126337475|NCT04010461|454531005|FG000|Overall Study|No Motor Threshold obtainable|1|||
126337476|NCT04010461|454531005|FG000|Overall Study|Physician Decision|1|||
126337477|NCT03797898|454531006|FG000|Overall Study|Lost to Follow-up|60|||
126337478|NCT03797898|454531007|FG001|Overall Study|Lost to Follow-up|69|||
126337479|NCT03797898|454531006|FG000|Overall Study|Withdrawal by Subject|9|||
126337480|NCT03797898|454531007|FG001|Overall Study|Withdrawal by Subject|7|||
126337481|NCT03797898|454531006|FG000|Overall Study|Became ineligible|5|||
126337482|NCT03797898|454531007|FG001|Overall Study|Became ineligible|2|||
126337483|NCT00086190|454531008|FG000|Overall Study|Adverse Event|6|||
126337484|NCT00086190|454531009|FG001|Overall Study|Adverse Event|2|||
126337485|NCT00086190|454531010|FG002|Overall Study|Adverse Event|2|||
126337486|NCT00086190|454531008|FG000|Overall Study|Withdrawal by Subject|0|||
126337487|NCT00086190|454531009|FG001|Overall Study|Withdrawal by Subject|2|||
126337488|NCT00086190|454531010|FG002|Overall Study|Withdrawal by Subject|2|||
126337489|NCT00086190|454531008|FG000|Overall Study|Protocol Violation|1|||
126337490|NCT00086190|454531009|FG001|Overall Study|Protocol Violation|0|||
126337491|NCT00086190|454531010|FG002|Overall Study|Protocol Violation|0|||
126337492|NCT00086190|454531008|FG000|Overall Study|Moved|1|||
126337493|NCT00086190|454531009|FG001|Overall Study|Moved|0|||
126337494|NCT00086190|454531010|FG002|Overall Study|Moved|0|||
126669761|NCT04223791|455749358|FG001|Overall Study|Physician Decision|1|||
126669762|NCT04223791|455749357|FG000|Overall Study|Protocol Violation|1|||
126337495|NCT00086190|454531008|FG000|Overall Study|Worsening depression|0|||
126337496|NCT00086190|454531009|FG001|Overall Study|Worsening depression|0|||
126337497|NCT00086190|454531010|FG002|Overall Study|Worsening depression|2|||
126337498|NCT03902613|454531011|FG000|Overall Study|Physician Decision|1|||
126337499|NCT02027025|454531015|FG000|Overall Study|Adverse Event|0|||
126669763|NCT04223791|455749358|FG001|Overall Study|Protocol Violation|1|||
126669764|NCT04223791|455749357|FG000|Overall Study|Withdrawal by Subject|10|||
126669765|NCT04223791|455749358|FG001|Overall Study|Withdrawal by Subject|12|||
126669766|NCT04223791|455749357|FG000|Overall Study|Pregnancy|1|||
126669767|NCT04223791|455749358|FG001|Overall Study|Pregnancy|1|||
126669768|NCT04223791|455749357|FG000|Overall Study|Ongoing in Study|305|||
126669769|NCT04223791|455749358|FG001|Overall Study|Ongoing in Study|302|||
126669770|NCT00884325|455751384|FG000|Overall Study|Lost to Follow-up|1|||
126669771|NCT00884325|455751385|FG001|Overall Study|Lost to Follow-up|2|||
126669772|NCT00884325|455751384|FG000|Overall Study|Lack of Efficacy|0|||
126669773|NCT00884325|455751385|FG001|Overall Study|Lack of Efficacy|1|||
126669774|NCT00884325|455751384|FG000|Overall Study|Withdrawal by Subject|1|||
126669775|NCT00884325|455751385|FG001|Overall Study|Withdrawal by Subject|1|||
126669776|NCT00884325|455751384|FG000|Overall Study|Not provided|1|||
126669777|NCT00884325|455751385|FG001|Overall Study|Not provided|0|||
126669778|NCT05097716|455751409|FG000|Period 1|Adverse Event|1|||
126669779|NCT05097716|455751409|FG000|Period 1|Close contact with highly-transmissible infection|1|||
126669780|NCT03945591|455751412|FG000|Overall Study|Participant not transplanted|1|||
126669781|NCT03945591|455751412|FG000|Overall Study|Change in treatment plan|3|||
126669782|NCT03945591|455751412|FG000|Overall Study|Adverse Event|1|||
126669783|NCT01372150|455751413|FG000|Overall Study|Lack of Efficacy|3|||
126669784|NCT01372150|455751414|FG001|Overall Study|Lack of Efficacy|0|||
126669785|NCT01372150|455751415|FG002|Overall Study|Lack of Efficacy|1|||
126669786|NCT01372150|455751413|FG000|Overall Study|Lost to Follow-up|4|||
126669787|NCT01372150|455751414|FG001|Overall Study|Lost to Follow-up|5|||
126669788|NCT01372150|455751415|FG002|Overall Study|Lost to Follow-up|6|||
126669789|NCT01372150|455751413|FG000|Overall Study|Protocol Violation|1|||
126669790|NCT01372150|455751414|FG001|Overall Study|Protocol Violation|0|||
126669791|NCT01372150|455751415|FG002|Overall Study|Protocol Violation|3|||
126669792|NCT01372150|455751413|FG000|Overall Study|Withdrawal by Subject|2|||
126669793|NCT01372150|455751414|FG001|Overall Study|Withdrawal by Subject|7|||
126669794|NCT01372150|455751415|FG002|Overall Study|Withdrawal by Subject|2|||
126669795|NCT01372150|455751413|FG000|Overall Study|Other|1|||
126669796|NCT01372150|455751414|FG001|Overall Study|Other|0|||
126669797|NCT01372150|455751415|FG002|Overall Study|Other|2|||
126669798|NCT01372150|455751413|FG000|Overall Study|Adverse Event|2|||
126669799|NCT01372150|455751414|FG001|Overall Study|Adverse Event|1|||
126669800|NCT01372150|455751415|FG002|Overall Study|Adverse Event|2|||
126669801|NCT01372150|455751413|FG000|Overall Study|Randomized but not treated|0|||
126669802|NCT01372150|455751414|FG001|Overall Study|Randomized but not treated|1|||
126669803|NCT01372150|455751415|FG002|Overall Study|Randomized but not treated|0|||
126669804|NCT01526551|455751416|FG000|Overall Study|Lack of returned parental consent form|424|||
126669805|NCT05215262|455751417|FG000|Overall Study|Lost to Follow-up|12|||
126669806|NCT05215262|455751418|FG001|Overall Study|Lost to Follow-up|0|||
126669807|NCT00718549|455751423|FG000|Induction Phase|Disease Progression|1|||
126669808|NCT00718549|455751424|FG001|Induction Phase|Disease Progression|0|||
126669809|NCT00718549|455751425|FG002|Induction Phase|Disease Progression|0|||
126669810|NCT00718549|455751423|FG000|Induction Phase|Eligibility Criteria Violation|2|||
126669811|NCT00718549|455751424|FG001|Induction Phase|Eligibility Criteria Violation|0|||
126669812|NCT00718549|455751425|FG002|Induction Phase|Eligibility Criteria Violation|0|||
126669813|NCT00718549|455751423|FG000|Induction Phase|Early Termination - No Additional Info|59|||
126669814|NCT00718549|455751424|FG001|Induction Phase|Early Termination - No Additional Info|0|||
126669815|NCT00718549|455751425|FG002|Induction Phase|Early Termination - No Additional Info|0|||
126337500|NCT02027025|454531016|FG001|Overall Study|Adverse Event|1|||
126337501|NCT02027025|454531017|FG002|Overall Study|Adverse Event|1|||
126337502|NCT02027025|454531015|FG000|Overall Study|Protocol Violation|1|||
126337503|NCT02027025|454531016|FG001|Overall Study|Protocol Violation|0|||
126337504|NCT02027025|454531017|FG002|Overall Study|Protocol Violation|0|||
126337505|NCT02027025|454531015|FG000|Overall Study|Lost to Follow-up|0|||
126337506|NCT02027025|454531016|FG001|Overall Study|Lost to Follow-up|2|||
126337507|NCT02027025|454531017|FG002|Overall Study|Lost to Follow-up|0|||
126337508|NCT02027025|454531015|FG000|Overall Study|Withdrawal by Subject|0|||
126337509|NCT02027025|454531016|FG001|Overall Study|Withdrawal by Subject|1|||
126337510|NCT02027025|454531017|FG002|Overall Study|Withdrawal by Subject|0|||
126337511|NCT02027025|454531015|FG000|Overall Study|Sponsor's decision|0|||
126669816|NCT00718549|455751423|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
126669817|NCT00718549|455751424|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
126669818|NCT00718549|455751425|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
126669819|NCT00718549|455751423|FG000|Maintenance/ Observation Phase|Death|0|||
126669820|NCT00718549|455751424|FG001|Maintenance/ Observation Phase|Death|1|||
126669821|NCT00718549|455751425|FG002|Maintenance/ Observation Phase|Death|2|||
126669822|NCT00718549|455751423|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
126337512|NCT02027025|454531016|FG001|Overall Study|Sponsor's decision|1|||
126337513|NCT02027025|454531017|FG002|Overall Study|Sponsor's decision|0|||
126669823|NCT00718549|455751424|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
126669824|NCT00718549|455751425|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
126669825|NCT00718549|455751423|FG000|Maintenance/ Observation Phase|Progression|0|||
126669826|NCT00718549|455751424|FG001|Maintenance/ Observation Phase|Progression|5|||
126669827|NCT00718549|455751425|FG002|Maintenance/ Observation Phase|Progression|14|||
126669828|NCT00718549|455751423|FG000|Maintenance/ Observation Phase|Relapse|0|||
126669829|NCT00718549|455751424|FG001|Maintenance/ Observation Phase|Relapse|3|||
126669830|NCT00718549|455751425|FG002|Maintenance/ Observation Phase|Relapse|2|||
126669831|NCT01353508|455751426|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
126669832|NCT01353508|455751427|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
126669833|NCT01353508|455751428|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
126669834|NCT01353508|455751429|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
126669835|NCT01353508|455751426|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
126669836|NCT01353508|455751427|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
126669837|NCT01353508|455751428|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
126669838|NCT01353508|455751429|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
126337514|NCT01939314|454531020|FG000|Overall Study|Withdrawal by Subject|3|||
126337515|NCT01939314|454531021|FG001|Overall Study|Withdrawal by Subject|1|||
126337516|NCT01939314|454531020|FG000|Overall Study|Protocol Violation|1|||
126337517|NCT01939314|454531021|FG001|Overall Study|Protocol Violation|0|||
126337518|NCT01939314|454531020|FG000|Overall Study|Pregnancy|0|||
126337519|NCT01939314|454531021|FG001|Overall Study|Pregnancy|1|||
126337520|NCT01939314|454531020|FG000|Overall Study|Lost to Follow-up|5|||
126337521|NCT01939314|454531021|FG001|Overall Study|Lost to Follow-up|6|||
126337522|NCT04350827|454531026|FG000|Overall Study|Lost to Follow-up|1|||
126337523|NCT04350827|454531027|FG001|Overall Study|Lost to Follow-up|2|||
126337524|NCT02357459|454532865|FG000|Overall Study|Adverse Event|0|||
126337525|NCT02357459|454532866|FG001|Overall Study|Adverse Event|1|||
126337526|NCT02357459|454532867|FG002|Overall Study|Adverse Event|1|||
126669839|NCT02448225|455751432|FG000|Overall Study|Withdrawal by Subject|1|||
126669840|NCT02448225|455751432|FG000|Overall Study|Did not get FSPG scan|18|||
126669841|NCT02448225|455751432|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
126669842|NCT00851682|455751433|FG000|Overall Study|screen failure|5|||
126669843|NCT00851682|455751434|FG001|Overall Study|screen failure|0|||
126669844|NCT04060563|455751435|FG000|Overall Study|Lost to Follow-up|1|||
126669845|NCT04060563|455751436|FG001|Overall Study|Lost to Follow-up|1|||
126669846|NCT04060563|455751435|FG000|Overall Study|Physician Decision|0|||
126669847|NCT04060563|455751436|FG001|Overall Study|Physician Decision|1|||
126669848|NCT00433914|455751440|FG000|Overall Study|Withdrawal by Subject|0|||
126669849|NCT00433914|455751441|FG001|Overall Study|Withdrawal by Subject|2|||
126669850|NCT00433914|455751440|FG000|Overall Study|Lost to Follow-up|0|||
126669851|NCT00433914|455751441|FG001|Overall Study|Lost to Follow-up|1|||
126669852|NCT00935272|455751452|FG000|Overall Study|Lost to Follow-up|10|||
126669853|NCT00935272|455751453|FG001|Overall Study|Lost to Follow-up|3|||
126669854|NCT00935272|455751452|FG000|Overall Study|Withdrawal by Subject|8|||
126669855|NCT00935272|455751453|FG001|Overall Study|Withdrawal by Subject|2|||
126669856|NCT00935272|455751452|FG000|Overall Study|Physician Decision|1|||
126669857|NCT00935272|455751453|FG001|Overall Study|Physician Decision|0|||
126669858|NCT00935272|455751452|FG000|Overall Study|Protocol Violation|0|||
126669859|NCT00935272|455751453|FG001|Overall Study|Protocol Violation|1|||
126669860|NCT01478360|455751462|FG000|Overall Study|Lost to Follow-up|1|||
126669861|NCT01478360|455751463|FG001|Overall Study|Lost to Follow-up|0|||
126669862|NCT01478360|455751462|FG000|Overall Study|Adverse Event|0|||
126669863|NCT01478360|455751463|FG001|Overall Study|Adverse Event|1|||
126669864|NCT01478360|455751462|FG000|Overall Study|Administrative problems|1|||
126669865|NCT01478360|455751463|FG001|Overall Study|Administrative problems|2|||
126669866|NCT02289352|455751464|FG000|Overall Study|Withdrawal by Subject|1|||
126669867|NCT02289352|455751465|FG001|Overall Study|Withdrawal by Subject|1|||
126669868|NCT02289352|455751466|FG002|Overall Study|Withdrawal by Subject|0|||
126669869|NCT01177384|455751467|FG000|Overall Study|Adverse Event|6|||
126669870|NCT01177384|455751468|FG001|Overall Study|Adverse Event|4|||
126669871|NCT01177384|455751467|FG000|Overall Study|Lack of Efficacy|0|||
126669872|NCT01177384|455751468|FG001|Overall Study|Lack of Efficacy|1|||
126669873|NCT01177384|455751467|FG000|Overall Study|Lost to Follow-up|3|||
126337527|NCT02357459|454532865|FG000|Overall Study|Withdrawal by Subject|5|||
126337528|NCT02357459|454532866|FG001|Overall Study|Withdrawal by Subject|3|||
126337529|NCT02357459|454532867|FG002|Overall Study|Withdrawal by Subject|3|||
126669874|NCT01177384|455751468|FG001|Overall Study|Lost to Follow-up|4|||
126669875|NCT01177384|455751467|FG000|Overall Study|Physician Decision|0|||
126669876|NCT01177384|455751468|FG001|Overall Study|Physician Decision|3|||
126669877|NCT01177384|455751467|FG000|Overall Study|Protocol Violation|0|||
126669878|NCT01177384|455751468|FG001|Overall Study|Protocol Violation|2|||
126669879|NCT01177384|455751467|FG000|Overall Study|Withdrawal by Subject|5|||
126669880|NCT01177384|455751468|FG001|Overall Study|Withdrawal by Subject|12|||
126669881|NCT01849497|455751469|FG000|Overall Study|Withdrawal by Subject|1|||
126337530|NCT02357459|454532865|FG000|Overall Study|Physician Decision|0|||
126337531|NCT02357459|454532866|FG001|Overall Study|Physician Decision|2|||
126337532|NCT02357459|454532867|FG002|Overall Study|Physician Decision|0|||
126337533|NCT02357459|454532865|FG000|Overall Study|Protocol Violation|1|||
126669882|NCT01849497|455751470|FG001|Overall Study|Withdrawal by Subject|2|||
126669883|NCT01849497|455751469|FG000|Overall Study|Sponsor Decision|0|||
126337534|NCT02357459|454532866|FG001|Overall Study|Protocol Violation|1|||
126337535|NCT02357459|454532867|FG002|Overall Study|Protocol Violation|0|||
126337536|NCT02357459|454532865|FG000|Overall Study|Lost to Follow-up|1|||
126669884|NCT01849497|455751470|FG001|Overall Study|Sponsor Decision|1|||
126669885|NCT01849497|455751469|FG000|Overall Study|Lost to Follow-up|0|||
126669886|NCT01849497|455751470|FG001|Overall Study|Lost to Follow-up|1|||
126669887|NCT00911625|455751496|FG000|Overall Study|Lost to Follow-up|7|||
126669888|NCT00911625|455751497|FG001|Overall Study|Lost to Follow-up|0|||
126669889|NCT00529451|455751498|FG000|Overall Study|Subject withdrew consent|16|||
126669890|NCT00529451|455751499|FG001|Overall Study|Subject withdrew consent|21|||
126669891|NCT00529451|455751500|FG002|Overall Study|Subject withdrew consent|13|||
126669892|NCT00529451|455751501|FG003|Overall Study|Subject withdrew consent|12|||
126669893|NCT00529451|455751498|FG000|Overall Study|Adverse Event|9|||
126669894|NCT00529451|455751499|FG001|Overall Study|Adverse Event|16|||
126669895|NCT00529451|455751500|FG002|Overall Study|Adverse Event|14|||
126669896|NCT00529451|455751501|FG003|Overall Study|Adverse Event|8|||
126669897|NCT00529451|455751498|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
126669898|NCT00529451|455751499|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
126669899|NCT00529451|455751500|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
126669900|NCT00529451|455751501|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
126669901|NCT00529451|455751498|FG000|Overall Study|Lost to Follow-up|4|||
126669902|NCT00529451|455751499|FG001|Overall Study|Lost to Follow-up|7|||
126669903|NCT00529451|455751500|FG002|Overall Study|Lost to Follow-up|4|||
126669904|NCT00529451|455751501|FG003|Overall Study|Lost to Follow-up|4|||
126669905|NCT00529451|455751498|FG000|Overall Study|Protocol deviation|1|||
126669906|NCT00529451|455751499|FG001|Overall Study|Protocol deviation|1|||
126669907|NCT00529451|455751500|FG002|Overall Study|Protocol deviation|4|||
126669908|NCT00529451|455751501|FG003|Overall Study|Protocol deviation|1|||
126669909|NCT00529451|455751498|FG000|Overall Study|Administrative problems|1|||
126669910|NCT00529451|455751499|FG001|Overall Study|Administrative problems|1|||
126669911|NCT00529451|455751500|FG002|Overall Study|Administrative problems|0|||
126669912|NCT00529451|455751501|FG003|Overall Study|Administrative problems|2|||
126669913|NCT00698932|455751504|FG000|Overall Study|Adverse Event|0|||
126669914|NCT00698932|455751505|FG001|Overall Study|Adverse Event|2|||
126669915|NCT00698932|455751504|FG000|Overall Study|Incorrect enrollment|0|||
126669916|NCT00698932|455751505|FG001|Overall Study|Incorrect enrollment|2|||
126669917|NCT00698932|455751504|FG000|Overall Study|Study specific discontinuation criteria|3|||
126669918|NCT00698932|455751505|FG001|Overall Study|Study specific discontinuation criteria|4|||
126669919|NCT00698932|455751504|FG000|Overall Study|Withdrawal by Subject|11|||
126669920|NCT00698932|455751505|FG001|Overall Study|Withdrawal by Subject|23|||
126669921|NCT00698932|455751504|FG000|Overall Study|Lost to Follow-up|6|||
126669922|NCT00698932|455751505|FG001|Overall Study|Lost to Follow-up|1|||
126669923|NCT00698932|455751504|FG000|Overall Study|Severe non-compliance to protocol|1|||
126669924|NCT00698932|455751505|FG001|Overall Study|Severe non-compliance to protocol|2|||
126669925|NCT00698932|455751504|FG000|Overall Study|Safety reasons|0|||
126669926|NCT00698932|455751505|FG001|Overall Study|Safety reasons|2|||
126669927|NCT00698932|455751504|FG000|Overall Study|Death|1|||
126669928|NCT00698932|455751505|FG001|Overall Study|Death|0|||
126669929|NCT01245387|455751506|FG000|Overall Study|Lost to Follow-up|106|||
126669930|NCT01245387|455751506|FG000|Overall Study|Lack of Efficacy|195|||
126669931|NCT01245387|455751506|FG000|Overall Study|Adverse Event|9|||
126669932|NCT01245387|455751506|FG000|Overall Study|Death|3|||
126669933|NCT01245387|455751506|FG000|Overall Study|Other|131|||
126669934|NCT01245387|455751506|FG000|Overall Study|Missing discontinuation status|369|||
126669935|NCT02146599|455751509|FG000|Overall Study|Failed to meet inclusion criteria|5|||
126669936|NCT03061175|455751515|FG000|Baseline|Participant was deemed ineligible|1|||
126669937|NCT03061175|455751516|FG001|Baseline|Participant was deemed ineligible|0|||
126669938|NCT03061175|455751515|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
126669939|NCT03061175|455751516|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
126669940|NCT03061175|455751515|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
126669941|NCT03061175|455751516|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
126669942|NCT03061175|455751515|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
126669943|NCT03061175|455751516|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
126669944|NCT02243865|455751517|FG000|Overall Study|Protocol Violation|1|||
126669945|NCT02243865|455751518|FG001|Overall Study|Protocol Violation|3|||
126669946|NCT02243865|455751517|FG000|Overall Study|Lost to Follow-up|1|||
126669947|NCT02243865|455751518|FG001|Overall Study|Lost to Follow-up|1|||
126669948|NCT02243865|455751517|FG000|Overall Study|Withdrawal by Subject|1|||
126669949|NCT02243865|455751518|FG001|Overall Study|Withdrawal by Subject|0|||
126337537|NCT02357459|454532866|FG001|Overall Study|Lost to Follow-up|3|||
126669950|NCT02243865|455751517|FG000|Overall Study|Adverse Event|1|||
126669951|NCT02243865|455751518|FG001|Overall Study|Adverse Event|1|||
126669952|NCT04166383|455751526|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
126669953|NCT04166383|455751526|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
126337538|NCT02357459|454532867|FG002|Overall Study|Lost to Follow-up|0|||
126669954|NCT04166383|455751526|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
126669955|NCT03044886|455751528|FG000|Overall Study|Lost to Follow-up|15|||
126669956|NCT03044886|455751529|FG001|Overall Study|Lost to Follow-up|10|||
126669957|NCT03044886|455751530|FG002|Overall Study|Lost to Follow-up|12|||
126669958|NCT02054325|455751541|FG000|Overall Study|Lost to Follow-up|8|||
126669959|NCT02054325|455751542|FG001|Overall Study|Lost to Follow-up|5|||
126669960|NCT00504153|455751549|FG000|Overall Study|Withdrawal by Subject|1|||
126669961|NCT00504153|455751549|FG000|Overall Study|Adverse Event|4|||
126669962|NCT00504153|455751549|FG000|Overall Study|Death|1|||
126669963|NCT00074581|455751551|FG000|Overall Study|Death|15|||
126669964|NCT00074581|455751552|FG001|Overall Study|Death|16|||
126669965|NCT00074581|455751551|FG000|Overall Study|Withdrawal by Subject|50|||
126669966|NCT00074581|455751552|FG001|Overall Study|Withdrawal by Subject|49|||
126669967|NCT00074581|455751551|FG000|Overall Study|Unable to adhere to visit schedule|13|||
126669968|NCT00074581|455751552|FG001|Overall Study|Unable to adhere to visit schedule|14|||
126669969|NCT00074581|455751551|FG000|Overall Study|Relocated|14|||
126669970|NCT00074581|455751552|FG001|Overall Study|Relocated|9|||
126669971|NCT00074581|455751551|FG000|Overall Study|Were withdrawn by investigator|5|||
126669972|NCT00074581|455751552|FG001|Overall Study|Were withdrawn by investigator|2|||
126669973|NCT00074581|455751551|FG000|Overall Study|Lost to Follow-up|16|||
126669974|NCT00074581|455751552|FG001|Overall Study|Lost to Follow-up|11|||
126669975|NCT00074581|455751551|FG000|Overall Study|Ended relationship w. index participant|117|||
126669976|NCT00074581|455751552|FG001|Overall Study|Ended relationship w. index participant|106|||
126669977|NCT00074581|455751551|FG000|Overall Study|Other|14|||
126669978|NCT00074581|455751552|FG001|Overall Study|Other|19|||
126669979|NCT02322229|455751554|FG000|Overall Study|Physician Decision|2|||
126669980|NCT03250832|455751555|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
126669981|NCT03250832|455751556|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
126669982|NCT03250832|455751557|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
126669983|NCT03250832|455751558|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
126669984|NCT03250832|455751559|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
126669985|NCT03250832|455751560|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
126669986|NCT03250832|455751561|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
126669987|NCT03250832|455751562|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
126669988|NCT03250832|455751563|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
126669989|NCT03250832|455751564|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
126669990|NCT03250832|455751565|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
126669991|NCT03250832|455751566|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
126669992|NCT03250832|455751555|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
126669993|NCT03250832|455751556|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
126669994|NCT03250832|455751557|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
126669995|NCT03250832|455751558|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
126669996|NCT03250832|455751559|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
126669997|NCT03250832|455751560|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
126669998|NCT03250832|455751561|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
126669999|NCT03250832|455751562|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
126670000|NCT03250832|455751563|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
126670001|NCT03250832|455751564|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
126670002|NCT03250832|455751565|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
126670003|NCT03250832|455751566|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
126670004|NCT03250832|455751555|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126670005|NCT03250832|455751556|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126670006|NCT03250832|455751557|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
126670007|NCT03250832|455751558|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126670008|NCT03250832|455751559|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126670009|NCT03250832|455751560|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126670010|NCT03250832|455751561|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126670011|NCT03250832|455751562|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126670012|NCT03250832|455751563|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126670013|NCT03250832|455751564|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126670014|NCT03250832|455751565|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126670015|NCT03250832|455751566|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
126670016|NCT03250832|455751555|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
126670017|NCT03250832|455751556|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
126337539|NCT02357459|454532865|FG000|Overall Study|Lack of Efficacy|7|||
126337540|NCT02357459|454532866|FG001|Overall Study|Lack of Efficacy|4|||
126337541|NCT02357459|454532867|FG002|Overall Study|Lack of Efficacy|4|||
126670018|NCT03250832|455751557|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
126337542|NCT02357459|454532865|FG000|Overall Study|Patient Relocated|2|||
126337543|NCT02357459|454532866|FG001|Overall Study|Patient Relocated|0|||
126670019|NCT03250832|455751558|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
126670020|NCT03250832|455751559|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
126670021|NCT03250832|455751560|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
126670022|NCT03250832|455751561|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
126670023|NCT03250832|455751562|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
126670024|NCT03250832|455751563|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
126670025|NCT03250832|455751564|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
126670026|NCT03250832|455751565|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
126670027|NCT03250832|455751566|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
126670028|NCT03250832|455751555|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126670029|NCT03250832|455751556|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126670030|NCT03250832|455751557|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126670031|NCT03250832|455751558|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126670032|NCT03250832|455751559|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126670033|NCT03250832|455751560|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126670034|NCT03250832|455751561|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126670035|NCT03250832|455751562|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
126670036|NCT03250832|455751563|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126670037|NCT03250832|455751564|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126670038|NCT03250832|455751565|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126670039|NCT03250832|455751566|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
126670040|NCT03250832|455751555|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126670041|NCT03250832|455751556|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126670042|NCT03250832|455751557|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126670043|NCT03250832|455751558|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126670044|NCT03250832|455751559|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126670045|NCT03250832|455751560|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126670046|NCT03250832|455751561|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126670047|NCT03250832|455751562|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
126670048|NCT03250832|455751563|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126670049|NCT03250832|455751564|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126670050|NCT03250832|455751565|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126670051|NCT03250832|455751566|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
126670052|NCT03250832|455751555|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126670053|NCT03250832|455751556|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126670054|NCT03250832|455751557|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126670055|NCT03250832|455751558|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126670056|NCT03250832|455751559|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126670057|NCT03250832|455751560|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126670058|NCT03250832|455751561|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126670059|NCT03250832|455751562|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
126670060|NCT03250832|455751563|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126670061|NCT03250832|455751564|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126670062|NCT03250832|455751565|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126670063|NCT03250832|455751566|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
126670064|NCT03250832|455751555|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
126670065|NCT03250832|455751556|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
126670066|NCT03250832|455751557|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
126670067|NCT03250832|455751558|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
126670068|NCT03250832|455751559|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
126670069|NCT03250832|455751560|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
126670070|NCT03250832|455751561|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
126670071|NCT03250832|455751562|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
126670072|NCT03250832|455751563|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
126670073|NCT03250832|455751564|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
126670074|NCT03250832|455751565|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
126670075|NCT03250832|455751566|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
126670076|NCT03250832|455751555|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
126670077|NCT03250832|455751556|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
126670078|NCT03250832|455751557|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
126670079|NCT03250832|455751558|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
126337544|NCT02357459|454532867|FG002|Overall Study|Patient Relocated|0|||
126670080|NCT03250832|455751559|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
126670081|NCT03250832|455751560|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
126670082|NCT03250832|455751561|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
126670083|NCT03250832|455751562|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
126670084|NCT03250832|455751563|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
126670085|NCT03250832|455751564|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
126670086|NCT03250832|455751565|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
126670087|NCT03250832|455751566|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
126670088|NCT03250832|455751555|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126670089|NCT03250832|455751556|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126670090|NCT03250832|455751557|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126670091|NCT03250832|455751558|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126670092|NCT03250832|455751559|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126670093|NCT03250832|455751560|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126670094|NCT03250832|455751561|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126670095|NCT03250832|455751562|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126670096|NCT03250832|455751563|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
126670097|NCT03250832|455751564|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
126670098|NCT03250832|455751565|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126670099|NCT03250832|455751566|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
126670100|NCT03250832|455751555|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126670101|NCT03250832|455751556|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126670102|NCT03250832|455751557|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126670103|NCT03250832|455751558|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126670104|NCT03250832|455751559|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126670105|NCT03250832|455751560|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126670106|NCT03250832|455751561|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126670107|NCT03250832|455751562|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126670108|NCT03250832|455751563|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
126670109|NCT03250832|455751564|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
126670110|NCT03250832|455751565|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126670111|NCT03250832|455751566|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
126670112|NCT03250832|455751555|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126670113|NCT03250832|455751556|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126670114|NCT03250832|455751557|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126670115|NCT03250832|455751558|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126670116|NCT03250832|455751559|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126670117|NCT03250832|455751560|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126670118|NCT03250832|455751561|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126670119|NCT03250832|455751562|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126670120|NCT03250832|455751563|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126670121|NCT03250832|455751564|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126670122|NCT03250832|455751565|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
126670123|NCT03250832|455751566|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
126670124|NCT00617604|455751567|FG000|Overall Study|Death|2|||
126670125|NCT00617604|455751568|FG001|Overall Study|Death|1|||
126670126|NCT00617604|455751567|FG000|Overall Study|Lost to Follow-up|1|||
126670127|NCT00617604|455751568|FG001|Overall Study|Lost to Follow-up|0|||
126670128|NCT00617604|455751567|FG000|Overall Study|Miscellaneous Reasons|8|||
126670129|NCT00617604|455751568|FG001|Overall Study|Miscellaneous Reasons|10|||
126670130|NCT00617604|455751567|FG000|Overall Study|Withdrawal by Subject|4|||
126670131|NCT00617604|455751568|FG001|Overall Study|Withdrawal by Subject|6|||
126670132|NCT00617604|455751567|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
126670133|NCT00617604|455751568|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
126670134|NCT02303704|455751569|FG000|Overall Study|Protocol Violation|5|||
126670135|NCT02303704|455751570|FG001|Overall Study|Protocol Violation|9|||
126670136|NCT00705432|455751573|FG000|Treatment Period|Adverse Event|45|||
126670137|NCT00705432|455751574|FG001|Treatment Period|Adverse Event|37|||
126670138|NCT00705432|455751575|FG002|Treatment Period|Adverse Event|51|||
126670139|NCT00705432|455751576|FG003|Treatment Period|Adverse Event|12|||
126670140|NCT00705432|455751577|FG004|Treatment Period|Adverse Event|8|||
126670141|NCT00705432|455751578|FG005|Treatment Period|Adverse Event|9|||
126670142|NCT00705432|455751573|FG000|Treatment Period|Treatment failure|92|||
126670143|NCT00705432|455751574|FG001|Treatment Period|Treatment failure|42|||
126670144|NCT00705432|455751575|FG002|Treatment Period|Treatment failure|33|||
126670145|NCT00705432|455751576|FG003|Treatment Period|Treatment failure|25|||
126670146|NCT00705432|455751577|FG004|Treatment Period|Treatment failure|13|||
126670147|NCT00705432|455751578|FG005|Treatment Period|Treatment failure|14|||
126670148|NCT00705432|455751573|FG000|Treatment Period|Non medical reason|26|||
126670149|NCT00705432|455751574|FG001|Treatment Period|Non medical reason|32|||
126670150|NCT00705432|455751575|FG002|Treatment Period|Non medical reason|37|||
126670151|NCT00705432|455751576|FG003|Treatment Period|Non medical reason|4|||
126337545|NCT02357459|454532865|FG000|Overall Study|Instruction from PCP|1|||
126337546|NCT02357459|454532866|FG001|Overall Study|Instruction from PCP|0|||
126337547|NCT02357459|454532867|FG002|Overall Study|Instruction from PCP|0|||
126670152|NCT00705432|455751577|FG004|Treatment Period|Non medical reason|7|||
126670153|NCT00705432|455751578|FG005|Treatment Period|Non medical reason|7|||
126670154|NCT00705432|455751573|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
126670155|NCT00705432|455751574|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
126670156|NCT00705432|455751575|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
126670157|NCT00705432|455751576|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
126670158|NCT00705432|455751577|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
126670159|NCT00705432|455751578|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
126670160|NCT00705432|455751573|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
126670161|NCT00705432|455751574|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
126670162|NCT00705432|455751575|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
126670163|NCT00705432|455751576|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
126670164|NCT00705432|455751577|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
126670165|NCT00705432|455751578|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
126670166|NCT04411628|455751579|FG000|Overall Study|Withdrawal by Subject|1|||
126337548|NCT02357459|454532865|FG000|Overall Study|Incarceration|0|||
126337549|NCT02357459|454532866|FG001|Overall Study|Incarceration|0|||
126337550|NCT02357459|454532867|FG002|Overall Study|Incarceration|1|||
126337551|NCT02357459|454532865|FG000|Overall Study|Pre-planned Knee surgery|0|||
126670167|NCT04411628|455751580|FG001|Overall Study|Withdrawal by Subject|1|||
126670168|NCT04411628|455751581|FG002|Overall Study|Withdrawal by Subject|2|||
126670169|NCT04411628|455751582|FG003|Overall Study|Withdrawal by Subject|0|||
126670170|NCT04411628|455751579|FG000|Overall Study|Lost to Follow-up|0|||
126670171|NCT04411628|455751580|FG001|Overall Study|Lost to Follow-up|1|||
126670172|NCT04411628|455751581|FG002|Overall Study|Lost to Follow-up|0|||
126670173|NCT04411628|455751582|FG003|Overall Study|Lost to Follow-up|0|||
126670174|NCT00521053|455751583|FG000|Observation Phase|Disease Progression|55|||
126670175|NCT00521053|455751583|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
126670176|NCT00521053|455751583|FG000|Observation Phase|Death|2|||
126670177|NCT00521053|455751583|FG000|Observation Phase|Adverse Event|1|||
126670178|NCT00521053|455751583|FG000|Observation Phase|Other non-study melanoma treatment|1|||
126670179|NCT00521053|455751583|FG000|Observation Phase|Physician Decision|1|||
126670180|NCT00732251|455751584|FG000|Overall Study|Lost to Follow-up|3|||
126670181|NCT00732251|455751584|FG000|Overall Study|Withdrawal by Subject|3|||
126670182|NCT00732251|455751584|FG000|Overall Study|Early Term due to Site Closure|1|||
126670183|NCT01034540|455751585|FG000|Overall Study|Adverse Event|0|||
126670184|NCT01034540|455751586|FG001|Overall Study|Adverse Event|1|||
126670185|NCT01252810|455751589|FG000|Overall Study|Withdrawal by Subject|4|||
126670186|NCT01252810|455751590|FG001|Overall Study|Withdrawal by Subject|1|||
126670187|NCT01252810|455751589|FG000|Overall Study|Lost to Follow-up|0|||
126670188|NCT01252810|455751590|FG001|Overall Study|Lost to Follow-up|1|||
126670189|NCT01252810|455751589|FG000|Overall Study|Physician Decision|2|||
126670190|NCT01252810|455751590|FG001|Overall Study|Physician Decision|1|||
126670191|NCT01252810|455751589|FG000|Overall Study|Various reasons|8|||
126670192|NCT01252810|455751590|FG001|Overall Study|Various reasons|0|||
126670193|NCT05162027|455753434|FG000|Overall Study|Adverse Event|1|||
126670194|NCT05162027|455753435|FG001|Overall Study|Adverse Event|0|||
126670195|NCT02767323|455753439|FG000|Overall Study|Withdrawal by Subject|17|||
126670196|NCT02767323|455753440|FG001|Overall Study|Withdrawal by Subject|5|||
126670197|NCT02767323|455753441|FG002|Overall Study|Withdrawal by Subject|13|||
126670198|NCT02767323|455753442|FG003|Overall Study|Withdrawal by Subject|0|||
126670199|NCT02767323|455753439|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
126670200|NCT02767323|455753440|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
126670201|NCT02767323|455753441|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
126670202|NCT02767323|455753442|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
126670203|NCT01641237|455753444|FG000|Period II|Withdrawal by Subject|1|||
126670204|NCT01641237|455753445|FG001|Period II|Withdrawal by Subject|0|||
126337552|NCT02357459|454532866|FG001|Overall Study|Pre-planned Knee surgery|0|||
126337553|NCT02357459|454532867|FG002|Overall Study|Pre-planned Knee surgery|2|||
126337554|NCT02357459|454532865|FG000|Overall Study|Job Commitments|0|||
126337555|NCT02357459|454532866|FG001|Overall Study|Job Commitments|0|||
126337556|NCT02357459|454532867|FG002|Overall Study|Job Commitments|1|||
126337557|NCT02188160|454532868|FG000|Overall Study|Adverse Event|1|||
126337558|NCT02188160|454532869|FG001|Overall Study|Adverse Event|0|||
126337559|NCT02188160|454532868|FG000|Overall Study|Use of an excluded medication|0|||
126670205|NCT01641237|455753446|FG002|Period II|Withdrawal by Subject|0|||
126670206|NCT01641237|455753447|FG003|Period II|Withdrawal by Subject|0|||
126670207|NCT01641237|455753444|FG000|Period III|Lost to Follow-up|1|||
126670208|NCT01641237|455753445|FG001|Period III|Lost to Follow-up|0|||
126670209|NCT01641237|455753446|FG002|Period III|Lost to Follow-up|0|||
126670210|NCT01641237|455753447|FG003|Period III|Lost to Follow-up|0|||
126670211|NCT03593850|455753452|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
126337560|NCT02188160|454532869|FG001|Overall Study|Use of an excluded medication|1|||
126337561|NCT01655901|454532872|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
126670212|NCT03593850|455753453|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
126670213|NCT01735279|455753454|FG000|Overall Study|Lost to Follow-up|11|||
126670214|NCT01735279|455753455|FG001|Overall Study|Lost to Follow-up|8|||
126670215|NCT01195090|455753461|FG000|Overall Study|Adverse Event|1|||
126670216|NCT01195090|455753462|FG001|Overall Study|Adverse Event|2|||
126670217|NCT01195090|455753461|FG000|Overall Study|Lost to Follow-up|2|||
126670218|NCT01195090|455753462|FG001|Overall Study|Lost to Follow-up|2|||
126670219|NCT01195090|455753461|FG000|Overall Study|Protocol Violation|3|||
126670220|NCT01195090|455753462|FG001|Overall Study|Protocol Violation|4|||
126670221|NCT05111041|455753463|FG000|Overall Study|Lost to Follow-up|6|||
126670222|NCT05111041|455753464|FG001|Overall Study|Lost to Follow-up|7|||
126670223|NCT05111041|455753463|FG000|Overall Study|Withdrawal by Subject|1|||
126670224|NCT05111041|455753464|FG001|Overall Study|Withdrawal by Subject|0|||
126670225|NCT01205230|455753465|FG000|Overall Study|Adverse Event|4|||
126670226|NCT01205230|455753466|FG001|Overall Study|Adverse Event|0|||
126670227|NCT01205230|455753465|FG000|Overall Study|Physician Decision|1|||
126670228|NCT01205230|455753466|FG001|Overall Study|Physician Decision|0|||
126670229|NCT00791258|455753467|FG000|Overall Study|Adverse Event|87|||
126670230|NCT00791258|455753467|FG000|Overall Study|Lost to Follow-up|18|||
126670231|NCT00791258|455753467|FG000|Overall Study|Protocol Violation|109|||
126670232|NCT00791258|455753467|FG000|Overall Study|Withdrawal by Subject|40|||
126670233|NCT00791258|455753467|FG000|Overall Study|Did not take medication for >3 days|1|||
126670234|NCT00791258|455753467|FG000|Overall Study|subject left area|2|||
126670235|NCT00791258|455753467|FG000|Overall Study|non-compliance|3|||
126670236|NCT00791258|455753467|FG000|Overall Study|Subject incarcerated|1|||
126670237|NCT00791258|455753467|FG000|Overall Study|Subject required restricted medication|1|||
126670238|NCT00791258|455753467|FG000|Overall Study|Lack of Efficacy|1|||
126670239|NCT00922480|455753468|FG000|Main Study|Protocol Violation|3|||
126670240|NCT00922480|455753469|FG001|Main Study|Protocol Violation|6|||
126670241|NCT00922480|455753468|FG000|Main Study|Adverse Event|6|||
126670242|NCT00922480|455753469|FG001|Main Study|Adverse Event|7|||
126670243|NCT00922480|455753468|FG000|Main Study|Lack of Efficacy|3|||
126670244|NCT00922480|455753469|FG001|Main Study|Lack of Efficacy|0|||
126670245|NCT00922480|455753468|FG000|Main Study|Withdrawal by Subject|20|||
126670246|NCT00922480|455753469|FG001|Main Study|Withdrawal by Subject|15|||
126670247|NCT00922480|455753468|FG000|Main Study|Lost to Follow-up|5|||
126670248|NCT00922480|455753469|FG001|Main Study|Lost to Follow-up|0|||
126670249|NCT00922480|455753468|FG000|Main Study|Physician Decision|0|||
126670250|NCT00922480|455753469|FG001|Main Study|Physician Decision|1|||
126670251|NCT00922480|455753468|FG000|Extension Study|Protocol Violation|3|||
126670252|NCT00922480|455753469|FG001|Extension Study|Protocol Violation|0|||
126670253|NCT00922480|455753468|FG000|Extension Study|Adverse Event|1|||
126670254|NCT00922480|455753469|FG001|Extension Study|Adverse Event|1|||
126670255|NCT00922480|455753468|FG000|Extension Study|Withdrawal by Subject|1|||
126670256|NCT00922480|455753469|FG001|Extension Study|Withdrawal by Subject|1|||
126670257|NCT00922480|455753468|FG000|Extension Study|Others|0|||
126670258|NCT00922480|455753469|FG001|Extension Study|Others|1|||
126670259|NCT04784897|455753470|FG000|Overall Study|Death|4|||
126670260|NCT04784897|455753471|FG001|Overall Study|Death|2|||
126670261|NCT04784897|455753472|FG002|Overall Study|Death|1|||
126670262|NCT04784897|455753470|FG000|Overall Study|Withdrawal by Subject|0|||
126670263|NCT04784897|455753471|FG001|Overall Study|Withdrawal by Subject|0|||
126670264|NCT04784897|455753472|FG002|Overall Study|Withdrawal by Subject|1|||
126670265|NCT04667377|455753473|FG000|Dose Escalation Period|Other not specified below|3|||
126670266|NCT04667377|455753474|FG001|Dose Escalation Period|Other not specified below|3|||
126670267|NCT04667377|455753475|FG002|Dose Escalation Period|Other not specified below|2|||
126670268|NCT04667377|455753476|FG003|Dose Escalation Period|Other not specified below|1|||
126670269|NCT04667377|455753477|FG004|Dose Escalation Period|Other not specified below|3|||
126670270|NCT04667377|455753473|FG000|Dose Escalation Period|Protocol Violation|2|||
126670271|NCT04667377|455753474|FG001|Dose Escalation Period|Protocol Violation|2|||
126670272|NCT04667377|455753475|FG002|Dose Escalation Period|Protocol Violation|0|||
126670273|NCT04667377|455753476|FG003|Dose Escalation Period|Protocol Violation|2|||
126670274|NCT04667377|455753477|FG004|Dose Escalation Period|Protocol Violation|1|||
126337562|NCT01655901|454532873|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
126337563|NCT01655901|454532874|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
126337564|NCT01655901|454532875|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
126670275|NCT04667377|455753473|FG000|Dose Escalation Period|Burden of study procedures|2|||
126670276|NCT04667377|455753474|FG001|Dose Escalation Period|Burden of study procedures|1|||
126670277|NCT04667377|455753475|FG002|Dose Escalation Period|Burden of study procedures|1|||
126670278|NCT04667377|455753476|FG003|Dose Escalation Period|Burden of study procedures|1|||
126670279|NCT04667377|455753477|FG004|Dose Escalation Period|Burden of study procedures|5|||
126670280|NCT04667377|455753473|FG000|Dose Escalation Period|Change of residence|0|||
126670281|NCT04667377|455753474|FG001|Dose Escalation Period|Change of residence|0|||
126670282|NCT04667377|455753475|FG002|Dose Escalation Period|Change of residence|1|||
126670283|NCT04667377|455753476|FG003|Dose Escalation Period|Change of residence|0|||
126337565|NCT01655901|454532876|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
126670284|NCT04667377|455753477|FG004|Dose Escalation Period|Change of residence|0|||
126670285|NCT04667377|455753473|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
126670286|NCT04667377|455753474|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
126670287|NCT04667377|455753475|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
126670288|NCT04667377|455753476|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
126670289|NCT04667377|455753477|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
126670290|NCT04667377|455753473|FG000|Dose Escalation Period|Adverse Event|9|||
126670291|NCT04667377|455753474|FG001|Dose Escalation Period|Adverse Event|10|||
126670292|NCT04667377|455753475|FG002|Dose Escalation Period|Adverse Event|12|||
126670293|NCT04667377|455753476|FG003|Dose Escalation Period|Adverse Event|17|||
126670294|NCT04667377|455753477|FG004|Dose Escalation Period|Adverse Event|3|||
126670295|NCT04667377|455753473|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
126670296|NCT04667377|455753474|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
126670297|NCT04667377|455753475|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
126670298|NCT04667377|455753476|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
126670299|NCT04667377|455753477|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
126670300|NCT04667377|455753473|FG000|Dose Escalation Period|Not treated|1|||
126670301|NCT04667377|455753474|FG001|Dose Escalation Period|Not treated|0|||
126670302|NCT04667377|455753475|FG002|Dose Escalation Period|Not treated|0|||
126670303|NCT04667377|455753476|FG003|Dose Escalation Period|Not treated|0|||
126670304|NCT04667377|455753477|FG004|Dose Escalation Period|Not treated|0|||
126670305|NCT04667377|455753473|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
126670306|NCT04667377|455753474|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
126670307|NCT04667377|455753475|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
126670308|NCT04667377|455753476|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
126670309|NCT04667377|455753477|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
126670310|NCT04667377|455753473|FG000|Dose Escalation Period|Lost to Follow-up|0|||
126670311|NCT04667377|455753474|FG001|Dose Escalation Period|Lost to Follow-up|1|||
126670312|NCT04667377|455753475|FG002|Dose Escalation Period|Lost to Follow-up|0|||
126670313|NCT04667377|455753476|FG003|Dose Escalation Period|Lost to Follow-up|0|||
126670314|NCT04667377|455753477|FG004|Dose Escalation Period|Lost to Follow-up|0|||
126670315|NCT04667377|455753473|FG000|Maintenance Period|Perceived lack of efficacy|0|||
126670316|NCT04667377|455753474|FG001|Maintenance Period|Perceived lack of efficacy|2|||
126670317|NCT04667377|455753475|FG002|Maintenance Period|Perceived lack of efficacy|1|||
126670318|NCT04667377|455753476|FG003|Maintenance Period|Perceived lack of efficacy|0|||
126670319|NCT04667377|455753477|FG004|Maintenance Period|Perceived lack of efficacy|1|||
126670320|NCT04667377|455753473|FG000|Maintenance Period|Adverse Event|2|||
126670321|NCT04667377|455753474|FG001|Maintenance Period|Adverse Event|8|||
126670322|NCT04667377|455753475|FG002|Maintenance Period|Adverse Event|5|||
126670323|NCT04667377|455753476|FG003|Maintenance Period|Adverse Event|4|||
126670324|NCT04667377|455753477|FG004|Maintenance Period|Adverse Event|1|||
126670325|NCT04667377|455753473|FG000|Maintenance Period|Adverse event: COVID infection|0|||
126670326|NCT04667377|455753474|FG001|Maintenance Period|Adverse event: COVID infection|1|||
126670327|NCT04667377|455753475|FG002|Maintenance Period|Adverse event: COVID infection|0|||
126670328|NCT04667377|455753476|FG003|Maintenance Period|Adverse event: COVID infection|0|||
126670329|NCT04667377|455753477|FG004|Maintenance Period|Adverse event: COVID infection|0|||
126670330|NCT04667377|455753473|FG000|Maintenance Period|COVID-related|0|||
126670331|NCT04667377|455753474|FG001|Maintenance Period|COVID-related|0|||
126670332|NCT04667377|455753475|FG002|Maintenance Period|COVID-related|1|||
126670333|NCT04667377|455753476|FG003|Maintenance Period|COVID-related|1|||
126670334|NCT04667377|455753477|FG004|Maintenance Period|COVID-related|0|||
126670335|NCT04667377|455753473|FG000|Maintenance Period|Protocol Violation|1|||
126670336|NCT04667377|455753474|FG001|Maintenance Period|Protocol Violation|0|||
126670337|NCT04667377|455753475|FG002|Maintenance Period|Protocol Violation|0|||
126670338|NCT04667377|455753476|FG003|Maintenance Period|Protocol Violation|0|||
126670339|NCT04667377|455753477|FG004|Maintenance Period|Protocol Violation|1|||
126670340|NCT04667377|455753473|FG000|Maintenance Period|Burden of study procedures|1|||
126670341|NCT04667377|455753474|FG001|Maintenance Period|Burden of study procedures|2|||
126670342|NCT04667377|455753475|FG002|Maintenance Period|Burden of study procedures|0|||
126670343|NCT04667377|455753476|FG003|Maintenance Period|Burden of study procedures|1|||
126670344|NCT04667377|455753477|FG004|Maintenance Period|Burden of study procedures|0|||
126670345|NCT04667377|455753473|FG000|Maintenance Period|Change of residence|0|||
126670346|NCT04667377|455753474|FG001|Maintenance Period|Change of residence|1|||
126670347|NCT04667377|455753475|FG002|Maintenance Period|Change of residence|0|||
126337566|NCT01655901|454532877|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
126337567|NCT00945243|454532880|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
126337568|NCT03256578|454532881|FG000|Overall Study|Excluded Post Randomization|66|||
126670348|NCT04667377|455753476|FG003|Maintenance Period|Change of residence|0|||
126337569|NCT03256578|454532882|FG001|Overall Study|Excluded Post Randomization|56|||
126337570|NCT02371616|454532883|FG000|Overall Study|Protocol Violation|2|||
126670349|NCT04667377|455753477|FG004|Maintenance Period|Change of residence|1|||
126670350|NCT04667377|455753473|FG000|Maintenance Period|Missing|1|||
126670351|NCT04667377|455753474|FG001|Maintenance Period|Missing|0|||
126670352|NCT04667377|455753475|FG002|Maintenance Period|Missing|0|||
126670353|NCT04667377|455753476|FG003|Maintenance Period|Missing|0|||
126670354|NCT04667377|455753477|FG004|Maintenance Period|Missing|0|||
126670355|NCT04667377|455753473|FG000|Maintenance Period|Other than listed above|2|||
126670356|NCT04667377|455753474|FG001|Maintenance Period|Other than listed above|0|||
126670357|NCT04667377|455753475|FG002|Maintenance Period|Other than listed above|3|||
126670358|NCT04667377|455753476|FG003|Maintenance Period|Other than listed above|2|||
126670359|NCT04667377|455753477|FG004|Maintenance Period|Other than listed above|6|||
126670360|NCT04667377|455753473|FG000|Maintenance Period|Withdrawal by Subject|0|||
126670361|NCT04667377|455753474|FG001|Maintenance Period|Withdrawal by Subject|1|||
126670362|NCT04667377|455753475|FG002|Maintenance Period|Withdrawal by Subject|0|||
126670363|NCT04667377|455753476|FG003|Maintenance Period|Withdrawal by Subject|0|||
126670364|NCT04667377|455753477|FG004|Maintenance Period|Withdrawal by Subject|0|||
126670365|NCT04667377|455753473|FG000|Maintenance Period|Lost to Follow-up|1|||
126670366|NCT04667377|455753474|FG001|Maintenance Period|Lost to Follow-up|0|||
126670367|NCT04667377|455753475|FG002|Maintenance Period|Lost to Follow-up|1|||
126670368|NCT04667377|455753476|FG003|Maintenance Period|Lost to Follow-up|0|||
126670369|NCT04667377|455753477|FG004|Maintenance Period|Lost to Follow-up|1|||
126670370|NCT01011439|455753478|FG000|Overall Study|Death|37|||
126670371|NCT01011439|455753478|FG000|Overall Study|Lost to Follow-up|4|||
126670372|NCT01011439|455753478|FG000|Overall Study|Withdrawal by Subject|1|||
126670373|NCT01011439|455753478|FG000|Overall Study|Sponsor's decision|15|||
126670374|NCT02428855|455753479|FG000|Overall Study|Withdrawal by Subject|2|||
126670375|NCT02066311|455753480|FG000|Overall Study|Adverse Event|4|||
126670376|NCT02066311|455753480|FG000|Overall Study|Withdrawal by Subject|1|||
126670377|NCT03198520|455753485|FG000|Overall Study|Physician Decision|2|||
126670378|NCT03198520|455753485|FG000|Overall Study|Protocol Violation|2|||
126670379|NCT03198520|455753485|FG000|Overall Study|Withdrawal by Subject|1|||
126670380|NCT03198520|455753485|FG000|Overall Study|Study Ended|1|||
126670381|NCT01670539|455753486|FG000|Overall Study|Death|3|||
126670382|NCT01670539|455753487|FG001|Overall Study|Death|5|||
126670383|NCT01670539|455753486|FG000|Overall Study|Withdrawal by Subject|3|||
126670384|NCT01670539|455753487|FG001|Overall Study|Withdrawal by Subject|0|||
126670385|NCT00536809|455753488|FG000|Phase II|Adverse Event|1|||
126337571|NCT02371616|454532884|FG001|Overall Study|Protocol Violation|1|||
126670386|NCT00536809|455753488|FG000|Phase II|Referred for surgical resection|1|||
126670387|NCT02606461|455753489|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
126670388|NCT02606461|455753490|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
126670389|NCT02606461|455753491|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
126670390|NCT02606461|455753492|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
126670391|NCT02606461|455753493|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
126670392|NCT02606461|455753494|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
126670393|NCT02092350|455753499|FG000|Overall Study|Adverse Event|0|||
126670394|NCT02092350|455753500|FG001|Overall Study|Adverse Event|3|||
126670395|NCT02092350|455753499|FG000|Overall Study|Death|2|||
126670396|NCT02092350|455753500|FG001|Overall Study|Death|5|||
126670397|NCT02092350|455753499|FG000|Overall Study|Lost to Follow-up|3|||
126670398|NCT02092350|455753500|FG001|Overall Study|Lost to Follow-up|1|||
126337572|NCT02371616|454532883|FG000|Overall Study|Adverse Event|0|||
126337573|NCT02371616|454532884|FG001|Overall Study|Adverse Event|1|||
126337574|NCT02371616|454532883|FG000|Overall Study|Withdrawal of Consent|1|||
126337575|NCT02371616|454532884|FG001|Overall Study|Withdrawal of Consent|0|||
126337576|NCT02371616|454532883|FG000|Overall Study|Other (Not specified)|1|||
126337577|NCT02371616|454532884|FG001|Overall Study|Other (Not specified)|5|||
126337578|NCT02990000|454532885|FG000|Overall Study|Failed to provide data beyond baseline|36|||
126337579|NCT02990000|454532886|FG001|Overall Study|Failed to provide data beyond baseline|34|||
126337580|NCT00754741|454532887|FG000|Overall Study|Died or disenrolled|57|||
126337581|NCT00754741|454532888|FG001|Overall Study|Died or disenrolled|69|||
126337582|NCT00754741|454532889|FG002|Overall Study|Died or disenrolled|54|||
126337583|NCT00922636|454532890|FG000|Overall Study|Adverse Event|3|||
126337584|NCT00922636|454532891|FG001|Overall Study|Adverse Event|3|||
126337585|NCT00922636|454532892|FG002|Overall Study|Adverse Event|2|||
126337586|NCT00922636|454532893|FG003|Overall Study|Adverse Event|3|||
126337587|NCT00922636|454532894|FG004|Overall Study|Adverse Event|2|||
126337588|NCT00922636|454532890|FG000|Overall Study|Lack of Efficacy|1|||
126670399|NCT02092350|455753499|FG000|Overall Study|Protocol Violation|1|||
126670400|NCT02092350|455753500|FG001|Overall Study|Protocol Violation|0|||
126670401|NCT02092350|455753499|FG000|Overall Study|Physician Decision|1|||
126670402|NCT02092350|455753500|FG001|Overall Study|Physician Decision|1|||
126670403|NCT02092350|455753499|FG000|Overall Study|Screen Failure|1|||
126670404|NCT02092350|455753500|FG001|Overall Study|Screen Failure|0|||
126670405|NCT02092350|455753499|FG000|Overall Study|Withdrawal by Subject|2|||
126670406|NCT02092350|455753500|FG001|Overall Study|Withdrawal by Subject|2|||
126337589|NCT00922636|454532891|FG001|Overall Study|Lack of Efficacy|7|||
126337590|NCT00922636|454532892|FG002|Overall Study|Lack of Efficacy|3|||
126337591|NCT00922636|454532893|FG003|Overall Study|Lack of Efficacy|2|||
126670407|NCT00239226|455753501|FG000|Overall Study|permAF during stabilization period|0|||
126670408|NCT00239226|455753502|FG001|Overall Study|permAF during stabilization period|0|||
126670409|NCT00239226|455753503|FG002|Overall Study|permAF during stabilization period|0|||
126670410|NCT00239226|455753504|FG003|Overall Study|permAF during stabilization period|3|||
126670411|NCT00239226|455753501|FG000|Overall Study|Lost to Follow-up|1|||
126670412|NCT00239226|455753502|FG001|Overall Study|Lost to Follow-up|0|||
126670413|NCT00239226|455753503|FG002|Overall Study|Lost to Follow-up|1|||
126670414|NCT00239226|455753504|FG003|Overall Study|Lost to Follow-up|0|||
126670415|NCT00646906|455753506|FG000|Crossover Period 1|Withdrawal by Subject|1|||
126670416|NCT00646906|455753507|FG001|Crossover Period 1|Withdrawal by Subject|0|||
126670417|NCT00646906|455753508|FG002|Crossover Period 1|Withdrawal by Subject|0|||
126670418|NCT00646906|455753509|FG003|Crossover Period 1|Withdrawal by Subject|0|||
126670419|NCT00646906|455753510|FG004|Crossover Period 1|Withdrawal by Subject|0|||
126337592|NCT00922636|454532894|FG004|Overall Study|Lack of Efficacy|4|||
126337593|NCT00922636|454532890|FG000|Overall Study|Sponsor Decision|0|||
126337594|NCT00922636|454532891|FG001|Overall Study|Sponsor Decision|0|||
126337595|NCT00922636|454532892|FG002|Overall Study|Sponsor Decision|2|||
126337596|NCT00922636|454532893|FG003|Overall Study|Sponsor Decision|0|||
126337597|NCT00922636|454532894|FG004|Overall Study|Sponsor Decision|0|||
126337598|NCT00922636|454532890|FG000|Overall Study|Withdrawal by Subject|0|||
126337599|NCT00922636|454532891|FG001|Overall Study|Withdrawal by Subject|0|||
126337600|NCT00922636|454532892|FG002|Overall Study|Withdrawal by Subject|5|||
126337601|NCT00922636|454532893|FG003|Overall Study|Withdrawal by Subject|2|||
126337602|NCT00922636|454532894|FG004|Overall Study|Withdrawal by Subject|4|||
126337603|NCT00922636|454532890|FG000|Overall Study|Protocol Violation|0|||
126337604|NCT00922636|454532891|FG001|Overall Study|Protocol Violation|0|||
126337605|NCT00922636|454532892|FG002|Overall Study|Protocol Violation|2|||
126337606|NCT00922636|454532893|FG003|Overall Study|Protocol Violation|2|||
126337607|NCT00922636|454532894|FG004|Overall Study|Protocol Violation|0|||
126337608|NCT00922636|454532890|FG000|Overall Study|Entry Criteria Not Met|0|||
126337609|NCT00922636|454532891|FG001|Overall Study|Entry Criteria Not Met|0|||
126337610|NCT00922636|454532892|FG002|Overall Study|Entry Criteria Not Met|1|||
126337611|NCT00922636|454532893|FG003|Overall Study|Entry Criteria Not Met|1|||
126337612|NCT00922636|454532894|FG004|Overall Study|Entry Criteria Not Met|0|||
126337613|NCT00922636|454532890|FG000|Overall Study|Parent/Caregiver Decision|2|||
126337614|NCT00922636|454532891|FG001|Overall Study|Parent/Caregiver Decision|4|||
126337615|NCT00922636|454532892|FG002|Overall Study|Parent/Caregiver Decision|3|||
126337616|NCT00922636|454532893|FG003|Overall Study|Parent/Caregiver Decision|5|||
126337617|NCT00922636|454532894|FG004|Overall Study|Parent/Caregiver Decision|2|||
126337618|NCT00922636|454532890|FG000|Overall Study|Lost to Follow-up|1|||
126337619|NCT00922636|454532891|FG001|Overall Study|Lost to Follow-up|2|||
126337620|NCT00922636|454532892|FG002|Overall Study|Lost to Follow-up|2|||
126337621|NCT00922636|454532893|FG003|Overall Study|Lost to Follow-up|2|||
126337622|NCT00922636|454532894|FG004|Overall Study|Lost to Follow-up|4|||
126337623|NCT04969289|454532895|FG000|Overall Study|Lost to Follow-up|13|||
126337624|NCT04969289|454532896|FG001|Overall Study|Lost to Follow-up|9|||
126337625|NCT00557466|454532897|FG000|Overall Study|Adverse Event|3|||
126337626|NCT00557466|454532898|FG001|Overall Study|Adverse Event|1|||
126337627|NCT00557466|454532899|FG002|Overall Study|Adverse Event|4|||
126337628|NCT00557466|454532900|FG003|Overall Study|Adverse Event|1|||
126337629|NCT00557466|454532901|FG004|Overall Study|Adverse Event|2|||
126337630|NCT00557466|454532902|FG005|Overall Study|Adverse Event|4|||
126337631|NCT00557466|454532897|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126337632|NCT00557466|454532898|FG001|Overall Study|Abnormal laboratory value(s)|2|||
126337633|NCT00557466|454532899|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126337634|NCT00557466|454532900|FG003|Overall Study|Abnormal laboratory value(s)|0|||
126337635|NCT00557466|454532901|FG004|Overall Study|Abnormal laboratory value(s)|0|||
126337636|NCT00557466|454532902|FG005|Overall Study|Abnormal laboratory value(s)|0|||
126337637|NCT00557466|454532897|FG000|Overall Study|Protocol deviation|0|||
126337638|NCT00557466|454532898|FG001|Overall Study|Protocol deviation|1|||
126337639|NCT00557466|454532899|FG002|Overall Study|Protocol deviation|0|||
126337640|NCT00557466|454532900|FG003|Overall Study|Protocol deviation|2|||
126337641|NCT00557466|454532901|FG004|Overall Study|Protocol deviation|0|||
126337642|NCT00557466|454532902|FG005|Overall Study|Protocol deviation|0|||
126337643|NCT00557466|454532897|FG000|Overall Study|Subject withdrew consent|0|||
126337644|NCT00557466|454532898|FG001|Overall Study|Subject withdrew consent|0|||
126337645|NCT00557466|454532899|FG002|Overall Study|Subject withdrew consent|0|||
126337646|NCT00557466|454532900|FG003|Overall Study|Subject withdrew consent|0|||
126337647|NCT00557466|454532901|FG004|Overall Study|Subject withdrew consent|1|||
126337648|NCT00557466|454532902|FG005|Overall Study|Subject withdrew consent|2|||
126337649|NCT00557466|454532897|FG000|Overall Study|Administrative problems|0|||
126337650|NCT00557466|454532898|FG001|Overall Study|Administrative problems|1|||
126670420|NCT00646906|455753511|FG005|Crossover Period 1|Withdrawal by Subject|1|||
126337651|NCT00557466|454532899|FG002|Overall Study|Administrative problems|1|||
126337652|NCT00557466|454532900|FG003|Overall Study|Administrative problems|0|||
126337653|NCT00557466|454532901|FG004|Overall Study|Administrative problems|0|||
126337654|NCT00557466|454532902|FG005|Overall Study|Administrative problems|0|||
126670421|NCT00646906|455753512|FG006|Crossover Period 1|Withdrawal by Subject|0|||
126670422|NCT00646906|455753506|FG000|Crossover Period 2|Withdrawal by Subject|0|||
126670423|NCT00646906|455753507|FG001|Crossover Period 2|Withdrawal by Subject|1|||
126670424|NCT00646906|455753508|FG002|Crossover Period 2|Withdrawal by Subject|2|||
126670425|NCT00646906|455753509|FG003|Crossover Period 2|Withdrawal by Subject|1|||
126670426|NCT00646906|455753510|FG004|Crossover Period 2|Withdrawal by Subject|0|||
126670427|NCT00646906|455753511|FG005|Crossover Period 2|Withdrawal by Subject|0|||
126670428|NCT00646906|455753512|FG006|Crossover Period 2|Withdrawal by Subject|0|||
126670429|NCT00646906|455753506|FG000|Crossover Period 2|Physician Decision|0|||
126670430|NCT00646906|455753507|FG001|Crossover Period 2|Physician Decision|0|||
126670431|NCT00646906|455753508|FG002|Crossover Period 2|Physician Decision|0|||
126670432|NCT00646906|455753509|FG003|Crossover Period 2|Physician Decision|0|||
126670433|NCT00646906|455753510|FG004|Crossover Period 2|Physician Decision|0|||
126670434|NCT00646906|455753511|FG005|Crossover Period 2|Physician Decision|0|||
126670435|NCT00646906|455753512|FG006|Crossover Period 2|Physician Decision|1|||
126670436|NCT01303965|455753513|FG000|Overall Study|Adverse Event|1|||
126670437|NCT01303965|455753514|FG001|Overall Study|Adverse Event|1|||
126670438|NCT01303965|455753513|FG000|Overall Study|Death|0|||
126670439|NCT01303965|455753514|FG001|Overall Study|Death|3|||
126670440|NCT01303965|455753513|FG000|Overall Study|Withdrawal by Subject|1|||
126337655|NCT00557466|454532897|FG000|Overall Study|Abnormal test procedure results|0|||
126337656|NCT00557466|454532898|FG001|Overall Study|Abnormal test procedure results|0|||
126337657|NCT00557466|454532899|FG002|Overall Study|Abnormal test procedure results|1|||
126337658|NCT00557466|454532900|FG003|Overall Study|Abnormal test procedure results|0|||
126337659|NCT00557466|454532901|FG004|Overall Study|Abnormal test procedure results|0|||
126670441|NCT01303965|455753514|FG001|Overall Study|Withdrawal by Subject|0|||
126670442|NCT01303965|455753513|FG000|Overall Study|Disease Progression|1|||
126670443|NCT01303965|455753514|FG001|Overall Study|Disease Progression|6|||
126670444|NCT02844920|455753518|FG000|Overall Study|Lost to Follow-up|2|||
126670445|NCT00800436|455753523|FG000|Overall Study|Withdrawal by Subject|0|||
126670446|NCT00800436|455753524|FG001|Overall Study|Withdrawal by Subject|0|||
126670447|NCT00800436|455753525|FG002|Overall Study|Withdrawal by Subject|1|||
126670448|NCT00800436|455753526|FG003|Overall Study|Withdrawal by Subject|1|||
126670449|NCT00800436|455753527|FG004|Overall Study|Withdrawal by Subject|0|||
126670450|NCT00800436|455753528|FG005|Overall Study|Withdrawal by Subject|0|||
126670451|NCT00800436|455753529|FG006|Overall Study|Withdrawal by Subject|0|||
126670452|NCT00766090|455753530|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126670453|NCT00766090|455753531|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126670454|NCT00766090|455753532|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126670455|NCT00766090|455753533|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126670456|NCT00766090|455753534|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126670457|NCT00766090|455753535|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126670458|NCT00766090|455753536|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126670459|NCT00766090|455753537|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126670460|NCT00766090|455753538|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
126337660|NCT00557466|454532902|FG005|Overall Study|Abnormal test procedure results|0|||
126337661|NCT00557466|454532897|FG000|Overall Study|Lost to Follow-up|0|||
126337662|NCT00557466|454532898|FG001|Overall Study|Lost to Follow-up|0|||
126670461|NCT00766090|455753539|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126670462|NCT00766090|455753540|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126337663|NCT00557466|454532899|FG002|Overall Study|Lost to Follow-up|0|||
126337664|NCT00557466|454532900|FG003|Overall Study|Lost to Follow-up|1|||
126337665|NCT00557466|454532901|FG004|Overall Study|Lost to Follow-up|0|||
126337666|NCT00557466|454532902|FG005|Overall Study|Lost to Follow-up|0|||
126337667|NCT01251952|454532905|FG000|Overall Study|Adverse Event|1|||
126337668|NCT03028142|454532906|FG000|Overall Study|Adverse Event|1|||
126337669|NCT03028142|454532907|FG001|Overall Study|Adverse Event|1|||
126337670|NCT03028142|454532908|FG002|Overall Study|Adverse Event|0|||
126337671|NCT03028142|454532909|FG003|Overall Study|Adverse Event|0|||
126337672|NCT03028142|454532910|FG004|Overall Study|Adverse Event|0|||
126337673|NCT03028142|454532911|FG005|Overall Study|Adverse Event|1|||
126337674|NCT03028142|454532906|FG000|Overall Study|Withdrawal by Subject|0|||
126337675|NCT03028142|454532907|FG001|Overall Study|Withdrawal by Subject|0|||
126337676|NCT03028142|454532908|FG002|Overall Study|Withdrawal by Subject|0|||
126337677|NCT03028142|454532909|FG003|Overall Study|Withdrawal by Subject|0|||
126670463|NCT00766090|455753541|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126670464|NCT00766090|455753530|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
126670465|NCT00766090|455753531|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126670466|NCT00766090|455753532|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126337678|NCT03028142|454532910|FG004|Overall Study|Withdrawal by Subject|1|||
126337679|NCT03028142|454532911|FG005|Overall Study|Withdrawal by Subject|0|||
126337680|NCT02810418|454532912|FG000|Arm A Dose Escalation|Adverse Event|2|||
126670467|NCT00766090|455753533|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126670468|NCT00766090|455753534|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126670469|NCT00766090|455753535|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126670470|NCT00766090|455753536|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126670471|NCT00766090|455753537|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126670472|NCT00766090|455753538|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126670473|NCT00766090|455753539|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126670474|NCT00766090|455753540|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126670475|NCT00766090|455753541|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
126670476|NCT00766090|455753530|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
126670477|NCT00766090|455753531|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126670478|NCT00766090|455753532|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126670479|NCT00766090|455753533|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
126670480|NCT00766090|455753534|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126670481|NCT00766090|455753535|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126670482|NCT00766090|455753536|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126670483|NCT00766090|455753537|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126670484|NCT00766090|455753538|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126670485|NCT00766090|455753539|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126670486|NCT00766090|455753540|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126670487|NCT00766090|455753541|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126670488|NCT00766090|455753530|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
126670489|NCT00766090|455753531|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
126670490|NCT00766090|455753532|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
126670491|NCT00766090|455753533|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
126670492|NCT00766090|455753534|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
126670493|NCT00766090|455753535|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
126670494|NCT00766090|455753536|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
126670495|NCT00766090|455753537|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
126670496|NCT00766090|455753538|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
126670497|NCT00766090|455753539|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
126670498|NCT00766090|455753540|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
126670499|NCT00766090|455753541|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
126670500|NCT00766090|455753530|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126670501|NCT00766090|455753531|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126670502|NCT00766090|455753532|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126670503|NCT00766090|455753533|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126670504|NCT00766090|455753534|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
126670505|NCT00766090|455753535|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126670506|NCT00766090|455753536|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126670507|NCT00766090|455753537|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126670508|NCT00766090|455753538|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126670509|NCT00766090|455753539|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126670510|NCT00766090|455753540|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126670511|NCT00766090|455753541|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126670512|NCT00766090|455753530|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126670513|NCT00766090|455753531|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126670514|NCT00766090|455753532|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
126670515|NCT00766090|455753533|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126670516|NCT00766090|455753534|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126670517|NCT00766090|455753535|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126670518|NCT00766090|455753536|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126670519|NCT00766090|455753537|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126670520|NCT00766090|455753538|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126670521|NCT00766090|455753539|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126670522|NCT00766090|455753540|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126670523|NCT00766090|455753541|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
126670524|NCT00766090|455753530|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
126670525|NCT00766090|455753531|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
126670526|NCT00766090|455753532|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
126670527|NCT00766090|455753533|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
126670528|NCT00766090|455753534|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
126670529|NCT00766090|455753535|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
126670530|NCT00766090|455753536|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
126670531|NCT00766090|455753537|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
126670532|NCT00766090|455753538|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
126670533|NCT00766090|455753539|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
126670534|NCT00766090|455753540|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
126670535|NCT00766090|455753541|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
126670536|NCT00766090|455753530|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126670537|NCT00766090|455753531|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126670538|NCT00766090|455753532|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126670539|NCT00766090|455753533|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126670540|NCT00766090|455753534|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126670541|NCT00766090|455753535|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
126670542|NCT00766090|455753536|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126670543|NCT00766090|455753537|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126670544|NCT00766090|455753538|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126670545|NCT00766090|455753539|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126670546|NCT00766090|455753540|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126670547|NCT00766090|455753541|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
126670548|NCT00766090|455753530|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126670549|NCT00766090|455753531|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
126670550|NCT00766090|455753532|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126670551|NCT00766090|455753533|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
126670552|NCT00766090|455753534|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126670553|NCT00766090|455753535|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126670554|NCT00766090|455753536|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126670555|NCT00766090|455753537|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126670556|NCT00766090|455753538|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126337681|NCT02810418|454532913|FG001|Arm A Dose Escalation|Adverse Event|1|||
126337682|NCT02810418|454532914|FG002|Arm A Dose Escalation|Adverse Event|0|||
126337683|NCT02810418|454532915|FG003|Arm A Dose Escalation|Adverse Event|0|||
126670557|NCT00766090|455753539|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126670558|NCT00766090|455753540|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
126670559|NCT00766090|455753541|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
126670560|NCT00766090|455753530|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126670561|NCT00766090|455753531|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126670562|NCT00766090|455753532|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126670563|NCT00766090|455753533|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126670564|NCT00766090|455753534|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
126670565|NCT00766090|455753535|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126670566|NCT00766090|455753536|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126670567|NCT00766090|455753537|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126670568|NCT00766090|455753538|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126670569|NCT00766090|455753539|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126670570|NCT00766090|455753540|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126670571|NCT00766090|455753541|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
126670572|NCT01106027|455753546|FG000|Overall Study|Lost graft early, discontinued|1|||
126670573|NCT02871778|455753547|FG000|Part A: Treatment Period 1|Adverse Event|1|||
126670574|NCT02871778|455753548|FG001|Part A: Treatment Period 1|Adverse Event|1|||
126670575|NCT02871778|455753549|FG002|Part A: Treatment Period 1|Adverse Event|1|||
126670576|NCT02871778|455753550|FG003|Part A: Treatment Period 1|Adverse Event|0|||
126670577|NCT02871778|455753551|FG004|Part A: Treatment Period 1|Adverse Event|0|||
126670578|NCT02871778|455753552|FG005|Part A: Treatment Period 1|Adverse Event|0|||
126670579|NCT02871778|455753553|FG006|Part A: Treatment Period 1|Adverse Event|0|||
126670580|NCT02871778|455753554|FG007|Part A: Treatment Period 1|Adverse Event|0|||
126670581|NCT02871778|455753547|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
126670582|NCT02871778|455753548|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
126670583|NCT02871778|455753549|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
126670584|NCT02871778|455753550|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
126670585|NCT02871778|455753551|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
126670586|NCT02871778|455753552|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
126670587|NCT02871778|455753553|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
126670588|NCT02871778|455753554|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
126670589|NCT02871778|455753547|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126670590|NCT02871778|455753548|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126670591|NCT02871778|455753549|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
126670592|NCT02871778|455753550|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126670593|NCT02871778|455753551|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126670594|NCT02871778|455753552|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126670595|NCT02871778|455753553|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126670596|NCT02871778|455753554|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
126670597|NCT02871778|455753547|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126670598|NCT02871778|455753548|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126670599|NCT02871778|455753549|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
126670600|NCT02871778|455753550|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126337684|NCT02810418|454532916|FG004|Arm A Dose Escalation|Adverse Event|0|||
126337685|NCT02810418|454532917|FG005|Arm A Dose Escalation|Adverse Event|0|||
126337686|NCT02810418|454532918|FG006|Arm A Dose Escalation|Adverse Event|0|||
126337687|NCT02810418|454532912|FG000|Dose Expansion|Adverse Event|0|||
126337688|NCT02810418|454532913|FG001|Dose Expansion|Adverse Event|1|||
126337689|NCT02810418|454532914|FG002|Dose Expansion|Adverse Event|1|||
126337690|NCT02810418|454532915|FG003|Dose Expansion|Adverse Event|0|||
126337691|NCT02810418|454532916|FG004|Dose Expansion|Adverse Event|0|||
126337692|NCT02810418|454532917|FG005|Dose Expansion|Adverse Event|0|||
126337693|NCT02810418|454532918|FG006|Dose Expansion|Adverse Event|0|||
126337694|NCT02810418|454532912|FG000|Dose Expansion|Physician Decision|0|||
126337695|NCT02810418|454532913|FG001|Dose Expansion|Physician Decision|0|||
126337696|NCT02810418|454532914|FG002|Dose Expansion|Physician Decision|2|||
126337697|NCT02810418|454532915|FG003|Dose Expansion|Physician Decision|0|||
126337698|NCT02810418|454532916|FG004|Dose Expansion|Physician Decision|0|||
126337699|NCT02810418|454532917|FG005|Dose Expansion|Physician Decision|0|||
126337700|NCT02810418|454532918|FG006|Dose Expansion|Physician Decision|0|||
126337701|NCT02810418|454532912|FG000|Arm B Dose Escalation|Adverse Event|0|||
126337702|NCT02810418|454532913|FG001|Arm B Dose Escalation|Adverse Event|0|||
126337703|NCT02810418|454532914|FG002|Arm B Dose Escalation|Adverse Event|0|||
126337704|NCT02810418|454532915|FG003|Arm B Dose Escalation|Adverse Event|0|||
126670601|NCT02871778|455753551|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126670602|NCT02871778|455753552|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126670603|NCT02871778|455753553|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126670604|NCT02871778|455753554|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
126670605|NCT02871778|455753547|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
126670606|NCT02871778|455753548|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
126670607|NCT02871778|455753549|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
126670608|NCT02871778|455753550|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
126670609|NCT02871778|455753551|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
126670610|NCT02871778|455753552|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
126670611|NCT02871778|455753553|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
126670612|NCT02871778|455753554|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
126670613|NCT02871778|455753547|FG000|Part A: Treatment Period 2|Adverse Event|2|||
126670614|NCT02871778|455753548|FG001|Part A: Treatment Period 2|Adverse Event|2|||
126670615|NCT02871778|455753549|FG002|Part A: Treatment Period 2|Adverse Event|0|||
126670616|NCT02871778|455753550|FG003|Part A: Treatment Period 2|Adverse Event|0|||
126670617|NCT02871778|455753551|FG004|Part A: Treatment Period 2|Adverse Event|0|||
126670618|NCT02871778|455753552|FG005|Part A: Treatment Period 2|Adverse Event|0|||
126670619|NCT02871778|455753553|FG006|Part A: Treatment Period 2|Adverse Event|0|||
126670620|NCT02871778|455753554|FG007|Part A: Treatment Period 2|Adverse Event|0|||
126670621|NCT02871778|455753547|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
126670622|NCT02871778|455753548|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
126670623|NCT02871778|455753549|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
126670624|NCT02871778|455753550|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
126670625|NCT02871778|455753551|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
126670626|NCT02871778|455753552|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
126670627|NCT02871778|455753553|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
126670628|NCT02871778|455753554|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
126670629|NCT02871778|455753547|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
126670630|NCT02871778|455753548|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
126670631|NCT02871778|455753549|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
126670632|NCT02871778|455753550|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
126670633|NCT02871778|455753551|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
126670634|NCT02871778|455753552|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
126670635|NCT02871778|455753553|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
126670636|NCT02871778|455753554|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
126670637|NCT02871778|455753547|FG000|Part B: Treatment Period 3|Adverse Event|0|||
126670638|NCT02871778|455753548|FG001|Part B: Treatment Period 3|Adverse Event|0|||
126670639|NCT02871778|455753549|FG002|Part B: Treatment Period 3|Adverse Event|0|||
126670640|NCT02871778|455753550|FG003|Part B: Treatment Period 3|Adverse Event|0|||
126670641|NCT02871778|455753551|FG004|Part B: Treatment Period 3|Adverse Event|1|||
126670642|NCT02871778|455753552|FG005|Part B: Treatment Period 3|Adverse Event|1|||
126670643|NCT02871778|455753553|FG006|Part B: Treatment Period 3|Adverse Event|1|||
126670644|NCT02871778|455753554|FG007|Part B: Treatment Period 3|Adverse Event|0|||
126670645|NCT02653300|455753555|FG000|Overall Study|Withdrawal by Subject|2|||
126670646|NCT02170779|455753556|FG000|Overall Study|Withdrawal by Subject|1|||
126337705|NCT02810418|454532916|FG004|Arm B Dose Escalation|Adverse Event|1|||
126337706|NCT02810418|454532917|FG005|Arm B Dose Escalation|Adverse Event|2|||
126670647|NCT02170779|455753557|FG001|Overall Study|Withdrawal by Subject|0|||
126670648|NCT02170779|455753556|FG000|Overall Study|Lost to Follow-up|0|||
126670649|NCT02170779|455753557|FG001|Overall Study|Lost to Follow-up|1|||
126670650|NCT00369785|455753569|FG000|Overall Study|Physician Decision|3|||
126670651|NCT00369785|455753570|FG001|Overall Study|Physician Decision|2|||
126337707|NCT02810418|454532918|FG006|Arm B Dose Escalation|Adverse Event|0|||
126337708|NCT01573000|454532919|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
126670652|NCT00369785|455753569|FG000|Overall Study|Death|1|||
126670653|NCT00369785|455753570|FG001|Overall Study|Death|2|||
126670654|NCT00369785|455753569|FG000|Overall Study|Withdrawal by Subject|7|||
126670655|NCT00369785|455753570|FG001|Overall Study|Withdrawal by Subject|6|||
126670656|NCT00369785|455753569|FG000|Overall Study|Toxicity|6|||
126670657|NCT00369785|455753570|FG001|Overall Study|Toxicity|4|||
126670658|NCT00369785|455753569|FG000|Overall Study|Never started|0|||
126670659|NCT00369785|455753570|FG001|Overall Study|Never started|2|||
126670660|NCT00369785|455753569|FG000|Overall Study|Progression|4|||
126670661|NCT00369785|455753570|FG001|Overall Study|Progression|4|||
126670662|NCT00369785|455753569|FG000|Overall Study|Multiple reasons|6|||
126670663|NCT00369785|455753570|FG001|Overall Study|Multiple reasons|5|||
126670664|NCT00800683|455753571|FG000|Overall Study|Adverse Event|11|||
126670665|NCT00800683|455753572|FG001|Overall Study|Adverse Event|8|||
126670666|NCT00800683|455753571|FG000|Overall Study|Lost to Follow-up|3|||
126670667|NCT00800683|455753572|FG001|Overall Study|Lost to Follow-up|1|||
126670668|NCT00800683|455753571|FG000|Overall Study|Withdrawal by Subject|1|||
126670669|NCT00800683|455753572|FG001|Overall Study|Withdrawal by Subject|7|||
126670670|NCT00800683|455753571|FG000|Overall Study|Lack of Efficacy|1|||
126670671|NCT00800683|455753572|FG001|Overall Study|Lack of Efficacy|1|||
126670672|NCT00800683|455753571|FG000|Overall Study|Other|1|||
126670673|NCT00800683|455753572|FG001|Overall Study|Other|2|||
126670674|NCT02678416|455753577|FG000|Part 1|Withdrawal by Subject|1|||
126670675|NCT02678416|455753577|FG000|Part 2|Adverse Event|2|||
126670676|NCT02678416|455753577|FG000|Part 2|Withdrawal by Subject|1|||
126670677|NCT04556136|455753578|FG000|Overall Study|Lost to Follow-up|6|||
126670678|NCT04556136|455753579|FG001|Overall Study|Lost to Follow-up|6|||
126670679|NCT04556136|455753578|FG000|Overall Study|Physician Decision|2|||
126670680|NCT04556136|455753579|FG001|Overall Study|Physician Decision|1|||
126670681|NCT04556136|455753578|FG000|Overall Study|Withdrawal by Subject|2|||
126670682|NCT04556136|455753579|FG001|Overall Study|Withdrawal by Subject|1|||
126670683|NCT03492554|455753583|FG000|Overall Study|Protocol Violation|0|||
126670684|NCT03492554|455753584|FG001|Overall Study|Protocol Violation|14|||
126670685|NCT04340557|455753585|FG000|Overall Study|Transferred to ICU and/or death|1|||
126670686|NCT04340557|455753586|FG001|Overall Study|Transferred to ICU and/or death|2|||
126670687|NCT01289821|455753589|FG000|Treatment Period|Withdrawal by Subject|1|||
126670688|NCT01289821|455753589|FG000|Treatment Period|Physician Decision|3|||
126670689|NCT01289821|455753589|FG000|Treatment Period|Adverse Event|4|||
126670690|NCT01289821|455753589|FG000|Treatment Period|Radiological Progression|43|||
126670691|NCT01289821|455753589|FG000|Treatment Period|Clinical Progression|2|||
126670692|NCT01289821|455753589|FG000|Treatment Period|Therapeutic procedure required|1|||
126670693|NCT01289821|455753589|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
126670694|NCT01289821|455753589|FG000|Safety Follow-up Period|Protocol Violation|3|||
126670695|NCT01289821|455753589|FG000|Safety Follow-up Period|Unspecified reason|1|||
126670696|NCT01289821|455753589|FG000|Survival Follow-up Period|Protocol Violation|1|||
126670697|NCT01289821|455753589|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
126670698|NCT01289821|455753589|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
126670699|NCT00773136|455753595|FG000|Overall Study|Physician Decision|2|||
126670700|NCT01010633|455753598|FG000|Overall Study|Adverse Event|1|||
126670701|NCT01010633|455753599|FG001|Overall Study|Adverse Event|1|||
126670702|NCT01010633|455753598|FG000|Overall Study|Protocol Violation|1|||
126670703|NCT01010633|455753599|FG001|Overall Study|Protocol Violation|2|||
126670704|NCT01010633|455753598|FG000|Overall Study|Withdrawal by Subject|2|||
126670705|NCT01010633|455753599|FG001|Overall Study|Withdrawal by Subject|1|||
126670706|NCT01010633|455753598|FG000|Overall Study|Investigator decision|0|||
126670707|NCT01010633|455753599|FG001|Overall Study|Investigator decision|1|||
126670708|NCT02463071|455753602|FG000|Overall Study|Adverse Event|3|||
126670709|NCT02463071|455753603|FG001|Overall Study|Adverse Event|5|||
126670710|NCT02463071|455753604|FG002|Overall Study|Adverse Event|1|||
126670711|NCT02463071|455753602|FG000|Overall Study|Death|1|||
126670712|NCT02463071|455753603|FG001|Overall Study|Death|0|||
126670713|NCT02463071|455753604|FG002|Overall Study|Death|0|||
126670714|NCT02463071|455753602|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
126670715|NCT02463071|455753603|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126670716|NCT02463071|455753604|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
126670717|NCT02463071|455753602|FG000|Overall Study|Reason not specified|7|||
126670718|NCT02463071|455753603|FG001|Overall Study|Reason not specified|9|||
126670719|NCT02463071|455753604|FG002|Overall Study|Reason not specified|4|||
126670720|NCT02463071|455753602|FG000|Overall Study|Protocol Violation|0|||
126670721|NCT02463071|455753603|FG001|Overall Study|Protocol Violation|2|||
126670722|NCT02463071|455753604|FG002|Overall Study|Protocol Violation|0|||
126670723|NCT02463071|455753602|FG000|Overall Study|Lost to Follow-up|0|||
126670724|NCT02463071|455753603|FG001|Overall Study|Lost to Follow-up|0|||
126670725|NCT02463071|455753604|FG002|Overall Study|Lost to Follow-up|1|||
126670726|NCT00888381|455753607|FG000|Overall Study|Lost to Follow-up|0|||
126670727|NCT00888381|455753608|FG001|Overall Study|Lost to Follow-up|1|||
126670728|NCT00097773|455753609|FG000|Overall Study|Lost to Follow-up|2|||
126670729|NCT00097773|455753610|FG001|Overall Study|Lost to Follow-up|2|||
126670730|NCT00097773|455753611|FG002|Overall Study|Lost to Follow-up|0|||
126670731|NCT00097773|455753612|FG003|Overall Study|Lost to Follow-up|1|||
126670732|NCT00097773|455753609|FG000|Overall Study|Physician Decision|2|||
126670733|NCT00097773|455753610|FG001|Overall Study|Physician Decision|2|||
126670734|NCT00097773|455753611|FG002|Overall Study|Physician Decision|3|||
126670735|NCT00097773|455753612|FG003|Overall Study|Physician Decision|1|||
126670736|NCT00097773|455753609|FG000|Overall Study|Withdrawal by Subject|3|||
126670737|NCT00097773|455753610|FG001|Overall Study|Withdrawal by Subject|3|||
126670738|NCT00097773|455753611|FG002|Overall Study|Withdrawal by Subject|3|||
126670739|NCT00097773|455753612|FG003|Overall Study|Withdrawal by Subject|1|||
126670740|NCT00097773|455753609|FG000|Overall Study|Adverse Event|0|||
126670741|NCT00097773|455753610|FG001|Overall Study|Adverse Event|1|||
126670742|NCT00097773|455753611|FG002|Overall Study|Adverse Event|0|||
126670743|NCT00097773|455753612|FG003|Overall Study|Adverse Event|0|||
126670744|NCT00097773|455753609|FG000|Overall Study|Other|1|||
126670745|NCT00097773|455753610|FG001|Overall Study|Other|0|||
126670746|NCT00097773|455753611|FG002|Overall Study|Other|2|||
126670747|NCT00097773|455753612|FG003|Overall Study|Other|0|||
126670748|NCT00003702|455753613|FG000|Overall Study|Ineligible cell types|2|||
126670749|NCT00003702|455753614|FG001|Overall Study|Ineligible cell types|2|||
126670750|NCT00003702|455753613|FG000|Overall Study|Did not meet criteria for persistence|8|||
126670751|NCT00003702|455753614|FG001|Overall Study|Did not meet criteria for persistence|5|||
126670752|NCT00003702|455753613|FG000|Overall Study|WHO score > 6|2|||
126670753|NCT00003702|455753614|FG001|Overall Study|WHO score > 6|1|||
126670754|NCT00003702|455753613|FG000|Overall Study|Inadequate documentation of disease|1|||
126670755|NCT00003702|455753614|FG001|Overall Study|Inadequate documentation of disease|3|||
126670756|NCT01009034|455753615|FG000|Overall Study|Lost to Follow-up|2|||
126670757|NCT01009034|455753615|FG000|Overall Study|Withdrawal by Subject|2|||
126670758|NCT01494350|455753616|FG000|Overall Study|Worsening of lesion|1|||
126670759|NCT00757003|455753617|FG000|Overall Study|Death|33|||
126670760|NCT00757003|455753617|FG000|Overall Study|Lost to Follow-up|9|||
126670761|NCT00757003|455753617|FG000|Overall Study|Withdrawal by Subject|4|||
126670762|NCT00757003|455753617|FG000|Overall Study|Surgically explanted|2|||
126670763|NCT00757003|455753617|FG000|Overall Study|Not implanted|1|||
126670764|NCT02921269|455753618|FG000|Overall Study|Did not complete DLT period|1|||
126670765|NCT00761306|455755515|FG000|Overall Study|Adverse Event|5|||
126670766|NCT00761306|455755515|FG000|Overall Study|Lack of Efficacy|4|||
126670767|NCT00761306|455755515|FG000|Overall Study|Protocol Violation|2|||
126670768|NCT00761306|455755515|FG000|Overall Study|Withdrawal of Consent|3|||
126670769|NCT00761306|455755515|FG000|Overall Study|Lost to Follow-up|1|||
126670770|NCT00761306|455755515|FG000|Overall Study|Administrative or Other Reasons|5|||
126670771|NCT04042740|455755518|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
126670772|NCT04042740|455755518|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
126670773|NCT03713034|455755519|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
126670774|NCT03713034|455755520|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
126670775|NCT02982239|455755523|FG000|Overall Study|Lost to Follow-up|3|||
126670776|NCT02982239|455755524|FG001|Overall Study|Lost to Follow-up|2|||
126670777|NCT00880555|455755531|FG000|Overall Study|Physician Decision|0|||
126670778|NCT00880555|455755532|FG001|Overall Study|Physician Decision|8|||
126670779|NCT00880555|455755533|FG002|Overall Study|Physician Decision|0|||
126670780|NCT00880555|455755534|FG003|Overall Study|Physician Decision|2|||
126670781|NCT00880555|455755535|FG004|Overall Study|Physician Decision|1|||
126670782|NCT00880555|455755536|FG005|Overall Study|Physician Decision|0|||
126670783|NCT00880555|455755531|FG000|Overall Study|Withdrawal by Subject|1|||
126670784|NCT00880555|455755532|FG001|Overall Study|Withdrawal by Subject|1|||
126670785|NCT00880555|455755533|FG002|Overall Study|Withdrawal by Subject|0|||
126670786|NCT00880555|455755534|FG003|Overall Study|Withdrawal by Subject|0|||
126670787|NCT00880555|455755535|FG004|Overall Study|Withdrawal by Subject|0|||
126670788|NCT00880555|455755536|FG005|Overall Study|Withdrawal by Subject|0|||
126670789|NCT00880555|455755531|FG000|Overall Study|Lack of resources (hired rater)|9|||
126670790|NCT00880555|455755532|FG001|Overall Study|Lack of resources (hired rater)|7|||
126670791|NCT00880555|455755533|FG002|Overall Study|Lack of resources (hired rater)|5|||
126670792|NCT00880555|455755534|FG003|Overall Study|Lack of resources (hired rater)|0|||
126670793|NCT00880555|455755535|FG004|Overall Study|Lack of resources (hired rater)|0|||
126670794|NCT00880555|455755536|FG005|Overall Study|Lack of resources (hired rater)|0|||
126670795|NCT00880555|455755531|FG000|Overall Study|Death|0|||
126670796|NCT00880555|455755532|FG001|Overall Study|Death|0|||
126670797|NCT00880555|455755533|FG002|Overall Study|Death|0|||
126670798|NCT00880555|455755534|FG003|Overall Study|Death|0|||
126670799|NCT00880555|455755535|FG004|Overall Study|Death|0|||
126670800|NCT00880555|455755536|FG005|Overall Study|Death|1|||
126670801|NCT00880555|455755531|FG000|Overall Study|Lost to Follow-up|0|||
126670802|NCT00880555|455755532|FG001|Overall Study|Lost to Follow-up|1|||
126670803|NCT00880555|455755533|FG002|Overall Study|Lost to Follow-up|0|||
126670804|NCT00880555|455755534|FG003|Overall Study|Lost to Follow-up|0|||
126670805|NCT00880555|455755535|FG004|Overall Study|Lost to Follow-up|0|||
126670806|NCT00880555|455755536|FG005|Overall Study|Lost to Follow-up|0|||
126670807|NCT02982590|455755538|FG000|Overall Study|Lost to Follow-up|0|||
126670808|NCT02982590|455755539|FG001|Overall Study|Lost to Follow-up|1|||
126670809|NCT02982590|455755538|FG000|Overall Study|Death|4|||
126670810|NCT02982590|455755539|FG001|Overall Study|Death|0|||
126670811|NCT01168973|455755540|FG000|Overall Study|Progressive Disease|341|||
126670812|NCT01168973|455755541|FG001|Overall Study|Progressive Disease|429|||
126670813|NCT01168973|455755540|FG000|Overall Study|Adverse Event|94|||
126670814|NCT01168973|455755541|FG001|Overall Study|Adverse Event|55|||
126670815|NCT01168973|455755540|FG000|Overall Study|Withdrawal by Subject|90|||
126670816|NCT01168973|455755541|FG001|Overall Study|Withdrawal by Subject|53|||
126670817|NCT01168973|455755540|FG000|Overall Study|Death|42|||
126670818|NCT01168973|455755541|FG001|Overall Study|Death|45|||
126670819|NCT01168973|455755540|FG000|Overall Study|Physician Decision|37|||
126670820|NCT01168973|455755541|FG001|Overall Study|Physician Decision|19|||
126670821|NCT01168973|455755540|FG000|Overall Study|Sponsor Decision|2|||
126670822|NCT01168973|455755541|FG001|Overall Study|Sponsor Decision|1|||
126670823|NCT01168973|455755540|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
126670824|NCT01168973|455755541|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
126670825|NCT00388505|455755546|FG000|Overall Study|Adverse Event or Death|43|||
126670826|NCT00388505|455755547|FG001|Overall Study|Adverse Event or Death|17|||
126670827|NCT00388505|455755546|FG000|Overall Study|Withdrawal by Subject|24|||
126670828|NCT00388505|455755547|FG001|Overall Study|Withdrawal by Subject|9|||
126670829|NCT00388505|455755546|FG000|Overall Study|Lost to Follow-up|5|||
126670830|NCT00388505|455755547|FG001|Overall Study|Lost to Follow-up|3|||
126670831|NCT00388505|455755546|FG000|Overall Study|Inappropriate Enrollment|0|||
126670832|NCT00388505|455755547|FG001|Overall Study|Inappropriate Enrollment|1|||
126670833|NCT00388505|455755546|FG000|Overall Study|Administrative Reason|1|||
126670834|NCT00388505|455755547|FG001|Overall Study|Administrative Reason|0|||
126670835|NCT00388505|455755546|FG000|Overall Study|Protocol Violation|6|||
126670836|NCT00388505|455755547|FG001|Overall Study|Protocol Violation|5|||
126670837|NCT00388505|455755546|FG000|Overall Study|Unable to classify|4|||
126670838|NCT00388505|455755547|FG001|Overall Study|Unable to classify|3|||
126670839|NCT04479436|455755551|FG000|Overall Study|Progressive disease|26|||
126670840|NCT04479436|455755552|FG001|Overall Study|Progressive disease|1|||
126670841|NCT04479436|455755551|FG000|Overall Study|Adverse Event|6|||
126670842|NCT04479436|455755552|FG001|Overall Study|Adverse Event|0|||
126670843|NCT04479436|455755551|FG000|Overall Study|Withdrawal by Subject|5|||
126670844|NCT04479436|455755552|FG001|Overall Study|Withdrawal by Subject|0|||
126670845|NCT04479436|455755551|FG000|Overall Study|Clinical progression|1|||
126670846|NCT04479436|455755552|FG001|Overall Study|Clinical progression|0|||
126670847|NCT04479436|455755551|FG000|Overall Study|Physician Decision|1|||
126670848|NCT04479436|455755552|FG001|Overall Study|Physician Decision|0|||
126670849|NCT01480284|455755555|FG000|Overall Study|Withdrawal by Subject|2|||
126670850|NCT01480284|455755556|FG001|Overall Study|Withdrawal by Subject|0|||
126670851|NCT01480284|455755555|FG000|Overall Study|Adverse Event|1|||
126670852|NCT01480284|455755556|FG001|Overall Study|Adverse Event|0|||
126670853|NCT01480284|455755555|FG000|Overall Study|Study closed/terminated|3|||
126670854|NCT01480284|455755556|FG001|Overall Study|Study closed/terminated|0|||
126670855|NCT01480284|455755555|FG000|Overall Study|Lost to Follow-up|1|||
126670856|NCT01480284|455755556|FG001|Overall Study|Lost to Follow-up|0|||
126670857|NCT01480284|455755555|FG000|Overall Study|Physician Decision|1|||
126670858|NCT01480284|455755556|FG001|Overall Study|Physician Decision|0|||
126670859|NCT02357134|455755557|FG000|Overall Study|Lost to Follow-up|1|||
126670860|NCT02357134|455755558|FG001|Overall Study|Lost to Follow-up|0|||
126670861|NCT02357134|455755559|FG002|Overall Study|Lost to Follow-up|0|||
126670862|NCT02357134|455755560|FG003|Overall Study|Lost to Follow-up|0|||
126670863|NCT00709111|455755561|FG000|Overall Study|Withdrawal by Subject|1|||
126670864|NCT00709111|455755561|FG000|Overall Study|Unable to attend clinic visits|1|||
126670865|NCT02716675|455755562|FG000|Overall Study|Death|2|||
126670866|NCT02716675|455755563|FG001|Overall Study|Death|3|||
126670867|NCT02716675|455755564|FG002|Overall Study|Death|0|||
126670868|NCT02716675|455755562|FG000|Overall Study|Physician Decision|2|||
126670869|NCT02716675|455755563|FG001|Overall Study|Physician Decision|1|||
126670870|NCT02716675|455755564|FG002|Overall Study|Physician Decision|1|||
126670871|NCT02716675|455755562|FG000|Overall Study|Lost to Follow-up|100|||
126670872|NCT02716675|455755563|FG001|Overall Study|Lost to Follow-up|87|||
126670873|NCT02716675|455755564|FG002|Overall Study|Lost to Follow-up|99|||
126670874|NCT02716675|455755562|FG000|Overall Study|Withdrawal by Subject|22|||
126670875|NCT02716675|455755563|FG001|Overall Study|Withdrawal by Subject|25|||
126670876|NCT02716675|455755564|FG002|Overall Study|Withdrawal by Subject|20|||
126670877|NCT02716675|455755562|FG000|Overall Study|Protocol Violation|0|||
126670878|NCT02716675|455755563|FG001|Overall Study|Protocol Violation|3|||
126670879|NCT02716675|455755564|FG002|Overall Study|Protocol Violation|1|||
126670880|NCT02716675|455755562|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
126670881|NCT02716675|455755563|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
126670882|NCT02716675|455755564|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
126670883|NCT02716675|455755562|FG000|Overall Study|Other|38|||
126670884|NCT02716675|455755563|FG001|Overall Study|Other|47|||
126670885|NCT02716675|455755564|FG002|Overall Study|Other|48|||
126670886|NCT01301456|455755565|FG000|Stage 1|Withdrawal by Subject|0|||
126670887|NCT01301456|455755566|FG001|Stage 1|Withdrawal by Subject|0|||
126670888|NCT01301456|455755567|FG002|Stage 1|Withdrawal by Subject|1|||
126670889|NCT01301456|455755568|FG003|Stage 1|Withdrawal by Subject|0|||
126670890|NCT01301456|455755569|FG004|Stage 1|Withdrawal by Subject|1|||
126670891|NCT01301456|455755570|FG005|Stage 1|Withdrawal by Subject|0|||
126670892|NCT01301456|455755571|FG006|Stage 1|Withdrawal by Subject|0|||
126670893|NCT01301456|455755572|FG007|Stage 1|Withdrawal by Subject|0|||
126670894|NCT01301456|455755573|FG008|Stage 1|Withdrawal by Subject|0|||
126670895|NCT01301456|455755574|FG009|Stage 1|Withdrawal by Subject|0|||
126670896|NCT01301456|455755575|FG010|Stage 1|Withdrawal by Subject|0|||
126670897|NCT01301456|455755576|FG011|Stage 1|Withdrawal by Subject|0|||
126670898|NCT01301456|455755565|FG000|Stage 1|Randomized but not treated|0|||
126670899|NCT01301456|455755566|FG001|Stage 1|Randomized but not treated|0|||
126670900|NCT01301456|455755567|FG002|Stage 1|Randomized but not treated|0|||
126670901|NCT01301456|455755568|FG003|Stage 1|Randomized but not treated|0|||
126670902|NCT01301456|455755569|FG004|Stage 1|Randomized but not treated|0|||
126670903|NCT01301456|455755570|FG005|Stage 1|Randomized but not treated|0|||
126670904|NCT01301456|455755571|FG006|Stage 1|Randomized but not treated|1|||
126670905|NCT01301456|455755572|FG007|Stage 1|Randomized but not treated|0|||
126670906|NCT01301456|455755573|FG008|Stage 1|Randomized but not treated|0|||
126670907|NCT01301456|455755574|FG009|Stage 1|Randomized but not treated|0|||
126670908|NCT01301456|455755575|FG010|Stage 1|Randomized but not treated|0|||
126670909|NCT01301456|455755576|FG011|Stage 1|Randomized but not treated|0|||
126670910|NCT01301456|455755565|FG000|Stage 2|Adverse Event|0|||
126670911|NCT01301456|455755566|FG001|Stage 2|Adverse Event|0|||
126670912|NCT01301456|455755567|FG002|Stage 2|Adverse Event|0|||
126670913|NCT01301456|455755568|FG003|Stage 2|Adverse Event|0|||
126670914|NCT01301456|455755569|FG004|Stage 2|Adverse Event|0|||
126670915|NCT01301456|455755570|FG005|Stage 2|Adverse Event|0|||
126670916|NCT01301456|455755571|FG006|Stage 2|Adverse Event|0|||
126670917|NCT01301456|455755572|FG007|Stage 2|Adverse Event|0|||
126670918|NCT01301456|455755573|FG008|Stage 2|Adverse Event|0|||
126670919|NCT01301456|455755574|FG009|Stage 2|Adverse Event|0|||
126670920|NCT01301456|455755575|FG010|Stage 2|Adverse Event|1|||
126670921|NCT01301456|455755576|FG011|Stage 2|Adverse Event|0|||
126670922|NCT00915772|455755577|FG000|Overall Study|Adverse Event|12|||
126670923|NCT00915772|455755578|FG001|Overall Study|Adverse Event|13|||
126670924|NCT00915772|455755579|FG002|Overall Study|Adverse Event|11|||
126670925|NCT00915772|455755577|FG000|Overall Study|Protocol Violation|4|||
126670926|NCT00915772|455755578|FG001|Overall Study|Protocol Violation|1|||
126670927|NCT00915772|455755579|FG002|Overall Study|Protocol Violation|2|||
126670928|NCT00915772|455755577|FG000|Overall Study|Lost to Follow-up|1|||
126670929|NCT00915772|455755578|FG001|Overall Study|Lost to Follow-up|2|||
126670930|NCT00915772|455755579|FG002|Overall Study|Lost to Follow-up|2|||
126670931|NCT00915772|455755577|FG000|Overall Study|Lack of Efficacy|9|||
126670932|NCT00915772|455755578|FG001|Overall Study|Lack of Efficacy|15|||
126670933|NCT00915772|455755579|FG002|Overall Study|Lack of Efficacy|3|||
126670934|NCT00915772|455755577|FG000|Overall Study|Refused to continue trial medication|6|||
126670935|NCT00915772|455755578|FG001|Overall Study|Refused to continue trial medication|8|||
126670936|NCT00915772|455755579|FG002|Overall Study|Refused to continue trial medication|4|||
126670937|NCT00915772|455755577|FG000|Overall Study|Any other reason|4|||
126670938|NCT00915772|455755578|FG001|Overall Study|Any other reason|7|||
126670939|NCT00915772|455755579|FG002|Overall Study|Any other reason|7|||
126670940|NCT03583450|455755580|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
126670941|NCT03583450|455755581|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
126670942|NCT03374995|455755582|FG000|Overall Study|Withdrawal by Subject|0|||
126670943|NCT03374995|455755583|FG001|Overall Study|Withdrawal by Subject|1|||
126670944|NCT01383096|455755584|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
126670945|NCT01383096|455755585|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
126670946|NCT01383096|455755586|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
126670947|NCT01383096|455755584|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
126670948|NCT01383096|455755585|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
126670949|NCT01383096|455755586|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
126670950|NCT01383096|455755584|FG000|Third Intervention (8 Days)|Elevated AST|0|||
126670951|NCT01383096|455755585|FG001|Third Intervention (8 Days)|Elevated AST|1|||
126670952|NCT01383096|455755586|FG002|Third Intervention (8 Days)|Elevated AST|0|||
126670953|NCT01383096|455755584|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
126670954|NCT01383096|455755585|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
126670955|NCT01383096|455755586|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
126670956|NCT01383096|455755584|FG000|Third Intervention (8 Days)|Adverse Event|1|||
126670957|NCT01383096|455755585|FG001|Third Intervention (8 Days)|Adverse Event|0|||
126670958|NCT01383096|455755586|FG002|Third Intervention (8 Days)|Adverse Event|0|||
126670959|NCT01383096|455755584|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
126670960|NCT01383096|455755585|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
126670961|NCT01383096|455755586|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
126670962|NCT01383096|455755584|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
126670963|NCT01383096|455755585|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
126670964|NCT01383096|455755586|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
126670965|NCT01383096|455755584|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
126670966|NCT01383096|455755585|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
126670967|NCT01383096|455755586|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
126670968|NCT01383096|455755584|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
126670969|NCT01383096|455755585|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
126670970|NCT01383096|455755586|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
126670971|NCT01383096|455755584|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
126670972|NCT01383096|455755585|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
126670973|NCT01383096|455755586|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
126670974|NCT01383096|455755584|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
126670975|NCT01383096|455755585|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
126670976|NCT01383096|455755586|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
126670977|NCT01211535|455755587|FG000|Overall Study|Adverse Event|0|||
126670978|NCT01211535|455755588|FG001|Overall Study|Adverse Event|1|||
126670979|NCT01380730|455755589|FG000|Overall Study|Death|0|||
126670980|NCT01380730|455755590|FG001|Overall Study|Death|0|||
126670981|NCT01380730|455755591|FG002|Overall Study|Death|0|||
126670982|NCT01380730|455755592|FG003|Overall Study|Death|0|||
126670983|NCT01380730|455755593|FG004|Overall Study|Death|1|||
126670984|NCT01380730|455755594|FG005|Overall Study|Death|0|||
126670985|NCT01380730|455755595|FG006|Overall Study|Death|0|||
126670986|NCT01380730|455755596|FG007|Overall Study|Death|0|||
126670987|NCT00467779|455755597|FG000|Stage 1|Adverse Event|1|||
126670988|NCT00467779|455755598|FG001|Stage 1|Adverse Event|0|||
126670989|NCT00467779|455755599|FG002|Stage 1|Adverse Event|0|||
126670990|NCT00467779|455755600|FG003|Stage 1|Adverse Event|0|||
126670991|NCT00467779|455755601|FG004|Stage 1|Adverse Event|0|||
126670992|NCT00467779|455755602|FG005|Stage 1|Adverse Event|1|||
126670993|NCT00467779|455755603|FG006|Stage 1|Adverse Event|2|||
126670994|NCT00467779|455755604|FG007|Stage 1|Adverse Event|1|||
126670995|NCT00467779|455755605|FG008|Stage 1|Adverse Event|0|||
126670996|NCT00467779|455755606|FG009|Stage 1|Adverse Event|0|||
126670997|NCT00467779|455755607|FG010|Stage 1|Adverse Event|0|||
126670998|NCT00467779|455755608|FG011|Stage 1|Adverse Event|0|||
126670999|NCT00467779|455755609|FG012|Stage 1|Adverse Event|0|||
126671000|NCT00467779|455755610|FG013|Stage 1|Adverse Event|0|||
126671001|NCT00467779|455755611|FG014|Stage 1|Adverse Event|0|||
126671002|NCT00467779|455755597|FG000|Stage 1|Disease Progression|2|||
126671003|NCT00467779|455755598|FG001|Stage 1|Disease Progression|2|||
126671004|NCT00467779|455755599|FG002|Stage 1|Disease Progression|2|||
126671005|NCT00467779|455755600|FG003|Stage 1|Disease Progression|3|||
126671006|NCT00467779|455755601|FG004|Stage 1|Disease Progression|2|||
126671007|NCT00467779|455755602|FG005|Stage 1|Disease Progression|2|||
126671008|NCT00467779|455755603|FG006|Stage 1|Disease Progression|4|||
126671009|NCT00467779|455755604|FG007|Stage 1|Disease Progression|5|||
126671010|NCT00467779|455755605|FG008|Stage 1|Disease Progression|0|||
126671011|NCT00467779|455755606|FG009|Stage 1|Disease Progression|0|||
126671012|NCT00467779|455755607|FG010|Stage 1|Disease Progression|0|||
126671013|NCT00467779|455755608|FG011|Stage 1|Disease Progression|0|||
126671014|NCT00467779|455755609|FG012|Stage 1|Disease Progression|0|||
126671015|NCT00467779|455755610|FG013|Stage 1|Disease Progression|0|||
126671016|NCT00467779|455755611|FG014|Stage 1|Disease Progression|0|||
126671017|NCT00467779|455755597|FG000|Stage 1|Unspecified Reason|1|||
126671018|NCT00467779|455755598|FG001|Stage 1|Unspecified Reason|0|||
126671019|NCT00467779|455755599|FG002|Stage 1|Unspecified Reason|1|||
126671020|NCT00467779|455755600|FG003|Stage 1|Unspecified Reason|0|||
126671021|NCT00467779|455755601|FG004|Stage 1|Unspecified Reason|1|||
126671022|NCT00467779|455755602|FG005|Stage 1|Unspecified Reason|2|||
126671023|NCT00467779|455755603|FG006|Stage 1|Unspecified Reason|0|||
126671024|NCT00467779|455755604|FG007|Stage 1|Unspecified Reason|0|||
126671025|NCT00467779|455755605|FG008|Stage 1|Unspecified Reason|0|||
126671026|NCT00467779|455755606|FG009|Stage 1|Unspecified Reason|0|||
126671027|NCT00467779|455755607|FG010|Stage 1|Unspecified Reason|0|||
126671028|NCT00467779|455755608|FG011|Stage 1|Unspecified Reason|0|||
126671029|NCT00467779|455755609|FG012|Stage 1|Unspecified Reason|0|||
126671030|NCT00467779|455755610|FG013|Stage 1|Unspecified Reason|0|||
126671031|NCT00467779|455755611|FG014|Stage 1|Unspecified Reason|0|||
126671032|NCT00467779|455755597|FG000|Stage 1|Physician Decision|0|||
126671033|NCT00467779|455755598|FG001|Stage 1|Physician Decision|1|||
126671034|NCT00467779|455755599|FG002|Stage 1|Physician Decision|0|||
126671035|NCT00467779|455755600|FG003|Stage 1|Physician Decision|0|||
126671036|NCT00467779|455755601|FG004|Stage 1|Physician Decision|0|||
126671037|NCT00467779|455755602|FG005|Stage 1|Physician Decision|0|||
126671038|NCT00467779|455755603|FG006|Stage 1|Physician Decision|0|||
126671039|NCT00467779|455755604|FG007|Stage 1|Physician Decision|0|||
126671040|NCT00467779|455755605|FG008|Stage 1|Physician Decision|0|||
126671041|NCT00467779|455755606|FG009|Stage 1|Physician Decision|0|||
126671042|NCT00467779|455755607|FG010|Stage 1|Physician Decision|0|||
126671043|NCT00467779|455755608|FG011|Stage 1|Physician Decision|0|||
126671044|NCT00467779|455755609|FG012|Stage 1|Physician Decision|0|||
126671045|NCT00467779|455755610|FG013|Stage 1|Physician Decision|0|||
126671046|NCT00467779|455755611|FG014|Stage 1|Physician Decision|0|||
126671047|NCT00467779|455755597|FG000|Stage 1|Withdrawal by Subject|0|||
126671048|NCT00467779|455755598|FG001|Stage 1|Withdrawal by Subject|0|||
126671049|NCT00467779|455755599|FG002|Stage 1|Withdrawal by Subject|0|||
126671050|NCT00467779|455755600|FG003|Stage 1|Withdrawal by Subject|0|||
126671051|NCT00467779|455755601|FG004|Stage 1|Withdrawal by Subject|0|||
126671052|NCT00467779|455755602|FG005|Stage 1|Withdrawal by Subject|0|||
126671053|NCT00467779|455755603|FG006|Stage 1|Withdrawal by Subject|1|||
126671054|NCT00467779|455755604|FG007|Stage 1|Withdrawal by Subject|1|||
126671055|NCT00467779|455755605|FG008|Stage 1|Withdrawal by Subject|0|||
126671056|NCT00467779|455755606|FG009|Stage 1|Withdrawal by Subject|0|||
126671057|NCT00467779|455755607|FG010|Stage 1|Withdrawal by Subject|0|||
126671058|NCT00467779|455755608|FG011|Stage 1|Withdrawal by Subject|0|||
126671059|NCT00467779|455755609|FG012|Stage 1|Withdrawal by Subject|0|||
126671060|NCT00467779|455755610|FG013|Stage 1|Withdrawal by Subject|0|||
126671061|NCT00467779|455755611|FG014|Stage 1|Withdrawal by Subject|0|||
126671062|NCT00467779|455755597|FG000|Stage 1A|Adverse Event|0|||
126671063|NCT00467779|455755598|FG001|Stage 1A|Adverse Event|0|||
126671064|NCT00467779|455755599|FG002|Stage 1A|Adverse Event|0|||
126671065|NCT00467779|455755600|FG003|Stage 1A|Adverse Event|0|||
126671066|NCT00467779|455755601|FG004|Stage 1A|Adverse Event|0|||
126671067|NCT00467779|455755602|FG005|Stage 1A|Adverse Event|0|||
126671068|NCT00467779|455755603|FG006|Stage 1A|Adverse Event|0|||
126671069|NCT00467779|455755604|FG007|Stage 1A|Adverse Event|0|||
126671070|NCT00467779|455755605|FG008|Stage 1A|Adverse Event|0|||
126671071|NCT00467779|455755606|FG009|Stage 1A|Adverse Event|0|||
126671072|NCT00467779|455755607|FG010|Stage 1A|Adverse Event|0|||
126671073|NCT00467779|455755608|FG011|Stage 1A|Adverse Event|0|||
126671074|NCT00467779|455755609|FG012|Stage 1A|Adverse Event|1|||
126671075|NCT00467779|455755610|FG013|Stage 1A|Adverse Event|0|||
126671076|NCT00467779|455755611|FG014|Stage 1A|Adverse Event|0|||
126671077|NCT00467779|455755597|FG000|Stage 1A|Death|0|||
126671078|NCT00467779|455755598|FG001|Stage 1A|Death|0|||
126671079|NCT00467779|455755599|FG002|Stage 1A|Death|0|||
126671080|NCT00467779|455755600|FG003|Stage 1A|Death|0|||
126671081|NCT00467779|455755601|FG004|Stage 1A|Death|0|||
126671082|NCT00467779|455755602|FG005|Stage 1A|Death|0|||
126671083|NCT00467779|455755603|FG006|Stage 1A|Death|0|||
126671084|NCT00467779|455755604|FG007|Stage 1A|Death|0|||
126671085|NCT00467779|455755605|FG008|Stage 1A|Death|0|||
126671086|NCT00467779|455755606|FG009|Stage 1A|Death|0|||
126671087|NCT00467779|455755607|FG010|Stage 1A|Death|0|||
126671088|NCT00467779|455755608|FG011|Stage 1A|Death|1|||
126671089|NCT00467779|455755609|FG012|Stage 1A|Death|1|||
126671090|NCT00467779|455755610|FG013|Stage 1A|Death|0|||
126671091|NCT00467779|455755611|FG014|Stage 1A|Death|0|||
126671092|NCT00467779|455755597|FG000|Stage 1A|Disease Progression|0|||
126671093|NCT00467779|455755598|FG001|Stage 1A|Disease Progression|0|||
126671094|NCT00467779|455755599|FG002|Stage 1A|Disease Progression|0|||
126671095|NCT00467779|455755600|FG003|Stage 1A|Disease Progression|0|||
126671096|NCT00467779|455755601|FG004|Stage 1A|Disease Progression|0|||
126671097|NCT00467779|455755602|FG005|Stage 1A|Disease Progression|0|||
126671098|NCT00467779|455755603|FG006|Stage 1A|Disease Progression|0|||
126671099|NCT00467779|455755604|FG007|Stage 1A|Disease Progression|0|||
126671100|NCT00467779|455755605|FG008|Stage 1A|Disease Progression|0|||
126671101|NCT00467779|455755606|FG009|Stage 1A|Disease Progression|2|||
126671102|NCT00467779|455755607|FG010|Stage 1A|Disease Progression|2|||
126671103|NCT00467779|455755608|FG011|Stage 1A|Disease Progression|5|||
126337709|NCT01573000|454532920|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
126337710|NCT01573000|454532919|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
126671104|NCT00467779|455755609|FG012|Stage 1A|Disease Progression|2|||
126337711|NCT01573000|454532920|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
126671105|NCT00467779|455755610|FG013|Stage 1A|Disease Progression|0|||
126671106|NCT00467779|455755611|FG014|Stage 1A|Disease Progression|0|||
126671107|NCT00467779|455755597|FG000|Stage 1A|Physician Decision|0|||
126671108|NCT00467779|455755598|FG001|Stage 1A|Physician Decision|0|||
126671109|NCT00467779|455755599|FG002|Stage 1A|Physician Decision|0|||
126671110|NCT00467779|455755600|FG003|Stage 1A|Physician Decision|0|||
126671111|NCT00467779|455755601|FG004|Stage 1A|Physician Decision|0|||
126671112|NCT00467779|455755602|FG005|Stage 1A|Physician Decision|0|||
126671113|NCT00467779|455755603|FG006|Stage 1A|Physician Decision|0|||
126671114|NCT00467779|455755604|FG007|Stage 1A|Physician Decision|0|||
126671115|NCT00467779|455755605|FG008|Stage 1A|Physician Decision|0|||
126671116|NCT00467779|455755606|FG009|Stage 1A|Physician Decision|1|||
126671117|NCT00467779|455755607|FG010|Stage 1A|Physician Decision|0|||
126671118|NCT00467779|455755608|FG011|Stage 1A|Physician Decision|0|||
126671119|NCT00467779|455755609|FG012|Stage 1A|Physician Decision|0|||
126671120|NCT00467779|455755610|FG013|Stage 1A|Physician Decision|0|||
126671121|NCT00467779|455755611|FG014|Stage 1A|Physician Decision|0|||
126671122|NCT00467779|455755597|FG000|Stage 1A|Withdrawal by Subject|0|||
126671123|NCT00467779|455755598|FG001|Stage 1A|Withdrawal by Subject|0|||
126671124|NCT00467779|455755599|FG002|Stage 1A|Withdrawal by Subject|0|||
126671125|NCT00467779|455755600|FG003|Stage 1A|Withdrawal by Subject|0|||
126671126|NCT00467779|455755601|FG004|Stage 1A|Withdrawal by Subject|0|||
126671127|NCT00467779|455755602|FG005|Stage 1A|Withdrawal by Subject|0|||
126671128|NCT00467779|455755603|FG006|Stage 1A|Withdrawal by Subject|0|||
126671129|NCT00467779|455755604|FG007|Stage 1A|Withdrawal by Subject|0|||
126671130|NCT00467779|455755605|FG008|Stage 1A|Withdrawal by Subject|0|||
126671131|NCT00467779|455755606|FG009|Stage 1A|Withdrawal by Subject|0|||
126671132|NCT00467779|455755607|FG010|Stage 1A|Withdrawal by Subject|1|||
126671133|NCT00467779|455755608|FG011|Stage 1A|Withdrawal by Subject|1|||
126671134|NCT00467779|455755609|FG012|Stage 1A|Withdrawal by Subject|1|||
126671135|NCT00467779|455755610|FG013|Stage 1A|Withdrawal by Subject|0|||
126671136|NCT00467779|455755611|FG014|Stage 1A|Withdrawal by Subject|0|||
126671137|NCT00467779|455755597|FG000|Stage 1A|Unspecified Reason|0|||
126671138|NCT00467779|455755598|FG001|Stage 1A|Unspecified Reason|0|||
126671139|NCT00467779|455755599|FG002|Stage 1A|Unspecified Reason|0|||
126671140|NCT00467779|455755600|FG003|Stage 1A|Unspecified Reason|0|||
126671141|NCT00467779|455755601|FG004|Stage 1A|Unspecified Reason|0|||
126671142|NCT00467779|455755602|FG005|Stage 1A|Unspecified Reason|0|||
126671143|NCT00467779|455755603|FG006|Stage 1A|Unspecified Reason|0|||
126671144|NCT00467779|455755604|FG007|Stage 1A|Unspecified Reason|0|||
126671145|NCT00467779|455755605|FG008|Stage 1A|Unspecified Reason|0|||
126671146|NCT00467779|455755606|FG009|Stage 1A|Unspecified Reason|0|||
126671147|NCT00467779|455755607|FG010|Stage 1A|Unspecified Reason|0|||
126671148|NCT00467779|455755608|FG011|Stage 1A|Unspecified Reason|1|||
126671149|NCT00467779|455755609|FG012|Stage 1A|Unspecified Reason|1|||
126671150|NCT00467779|455755610|FG013|Stage 1A|Unspecified Reason|0|||
126671151|NCT00467779|455755611|FG014|Stage 1A|Unspecified Reason|0|||
126671152|NCT00467779|455755597|FG000|Stage 2|Adverse Event|0|||
126671153|NCT00467779|455755598|FG001|Stage 2|Adverse Event|0|||
126671154|NCT00467779|455755599|FG002|Stage 2|Adverse Event|0|||
126671155|NCT00467779|455755600|FG003|Stage 2|Adverse Event|0|||
126671156|NCT00467779|455755601|FG004|Stage 2|Adverse Event|0|||
126671157|NCT00467779|455755602|FG005|Stage 2|Adverse Event|0|||
126671158|NCT00467779|455755603|FG006|Stage 2|Adverse Event|0|||
126671159|NCT00467779|455755604|FG007|Stage 2|Adverse Event|0|||
126671160|NCT00467779|455755605|FG008|Stage 2|Adverse Event|1|||
126671161|NCT00467779|455755606|FG009|Stage 2|Adverse Event|0|||
126671162|NCT00467779|455755607|FG010|Stage 2|Adverse Event|0|||
126671163|NCT00467779|455755608|FG011|Stage 2|Adverse Event|0|||
126671164|NCT00467779|455755609|FG012|Stage 2|Adverse Event|0|||
126671165|NCT00467779|455755610|FG013|Stage 2|Adverse Event|0|||
126671166|NCT00467779|455755611|FG014|Stage 2|Adverse Event|0|||
126671167|NCT00467779|455755597|FG000|Stage 2|Death|0|||
126337712|NCT01573000|454532919|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
126337713|NCT01573000|454532920|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
126337714|NCT01573000|454532919|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
126337715|NCT01573000|454532920|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
126337716|NCT01573000|454532919|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
126337717|NCT01573000|454532920|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
126337718|NCT01573000|454532919|FG000|Crossover Phase|Lack of Efficacy|0|||
126337719|NCT01573000|454532920|FG001|Crossover Phase|Lack of Efficacy|13|||
126337720|NCT01573000|454532919|FG000|Crossover Phase|Lost to Follow-up|0|||
126337721|NCT01573000|454532920|FG001|Crossover Phase|Lost to Follow-up|2|||
126337722|NCT01573000|454532919|FG000|Crossover Phase|Death|0|||
126337723|NCT01573000|454532920|FG001|Crossover Phase|Death|3|||
126337724|NCT01573000|454532919|FG000|Long-Term Follow-Up|Death|3|||
126337725|NCT01573000|454532920|FG001|Long-Term Follow-Up|Death|0|||
126337726|NCT01573000|454532919|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
126337727|NCT01573000|454532920|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
126337728|NCT03353792|454532921|FG000|Overall Study|Lost to Follow-up|1|||
126671168|NCT00467779|455755598|FG001|Stage 2|Death|0|||
126671169|NCT00467779|455755599|FG002|Stage 2|Death|0|||
126671170|NCT00467779|455755600|FG003|Stage 2|Death|0|||
126671171|NCT00467779|455755601|FG004|Stage 2|Death|0|||
126671172|NCT00467779|455755602|FG005|Stage 2|Death|0|||
126671173|NCT00467779|455755603|FG006|Stage 2|Death|0|||
126671174|NCT00467779|455755604|FG007|Stage 2|Death|0|||
126671175|NCT00467779|455755605|FG008|Stage 2|Death|1|||
126671176|NCT00467779|455755606|FG009|Stage 2|Death|0|||
126671177|NCT00467779|455755607|FG010|Stage 2|Death|0|||
126671178|NCT00467779|455755608|FG011|Stage 2|Death|0|||
126671179|NCT00467779|455755609|FG012|Stage 2|Death|0|||
126671180|NCT00467779|455755610|FG013|Stage 2|Death|0|||
126671181|NCT00467779|455755611|FG014|Stage 2|Death|0|||
126337729|NCT03353792|454532922|FG001|Overall Study|Lost to Follow-up|0|||
126671182|NCT00467779|455755597|FG000|Stage 2|Disease Progression|0|||
126671183|NCT00467779|455755598|FG001|Stage 2|Disease Progression|0|||
126671184|NCT00467779|455755599|FG002|Stage 2|Disease Progression|0|||
126671185|NCT00467779|455755600|FG003|Stage 2|Disease Progression|0|||
126671186|NCT00467779|455755601|FG004|Stage 2|Disease Progression|0|||
126671187|NCT00467779|455755602|FG005|Stage 2|Disease Progression|0|||
126671188|NCT00467779|455755603|FG006|Stage 2|Disease Progression|0|||
126671189|NCT00467779|455755604|FG007|Stage 2|Disease Progression|0|||
126671190|NCT00467779|455755605|FG008|Stage 2|Disease Progression|16|||
126671191|NCT00467779|455755606|FG009|Stage 2|Disease Progression|0|||
126671192|NCT00467779|455755607|FG010|Stage 2|Disease Progression|0|||
126671193|NCT00467779|455755608|FG011|Stage 2|Disease Progression|0|||
126671194|NCT00467779|455755609|FG012|Stage 2|Disease Progression|0|||
126671195|NCT00467779|455755610|FG013|Stage 2|Disease Progression|0|||
126671196|NCT00467779|455755611|FG014|Stage 2|Disease Progression|0|||
126671197|NCT00467779|455755597|FG000|Stage 2|Unspecified Reason|0|||
126671198|NCT00467779|455755598|FG001|Stage 2|Unspecified Reason|0|||
126671199|NCT00467779|455755599|FG002|Stage 2|Unspecified Reason|0|||
126671200|NCT00467779|455755600|FG003|Stage 2|Unspecified Reason|0|||
126671201|NCT00467779|455755601|FG004|Stage 2|Unspecified Reason|0|||
126671202|NCT00467779|455755602|FG005|Stage 2|Unspecified Reason|0|||
126671203|NCT00467779|455755603|FG006|Stage 2|Unspecified Reason|0|||
126671204|NCT00467779|455755604|FG007|Stage 2|Unspecified Reason|0|||
126671205|NCT00467779|455755605|FG008|Stage 2|Unspecified Reason|3|||
126671206|NCT00467779|455755606|FG009|Stage 2|Unspecified Reason|0|||
126671207|NCT00467779|455755607|FG010|Stage 2|Unspecified Reason|0|||
126671208|NCT00467779|455755608|FG011|Stage 2|Unspecified Reason|0|||
126671209|NCT00467779|455755609|FG012|Stage 2|Unspecified Reason|0|||
126671210|NCT00467779|455755610|FG013|Stage 2|Unspecified Reason|0|||
126671211|NCT00467779|455755611|FG014|Stage 2|Unspecified Reason|0|||
126671212|NCT00467779|455755597|FG000|Stage 2A|Adverse Event|0|||
126671213|NCT00467779|455755598|FG001|Stage 2A|Adverse Event|0|||
126671214|NCT00467779|455755599|FG002|Stage 2A|Adverse Event|0|||
126671215|NCT00467779|455755600|FG003|Stage 2A|Adverse Event|0|||
126671216|NCT00467779|455755601|FG004|Stage 2A|Adverse Event|0|||
126671217|NCT00467779|455755602|FG005|Stage 2A|Adverse Event|0|||
126671218|NCT00467779|455755603|FG006|Stage 2A|Adverse Event|0|||
126671219|NCT00467779|455755604|FG007|Stage 2A|Adverse Event|0|||
126671220|NCT00467779|455755605|FG008|Stage 2A|Adverse Event|0|||
126671221|NCT00467779|455755606|FG009|Stage 2A|Adverse Event|0|||
126671222|NCT00467779|455755607|FG010|Stage 2A|Adverse Event|0|||
126671223|NCT00467779|455755608|FG011|Stage 2A|Adverse Event|0|||
126671224|NCT00467779|455755609|FG012|Stage 2A|Adverse Event|0|||
126671225|NCT00467779|455755610|FG013|Stage 2A|Adverse Event|2|||
126671226|NCT00467779|455755611|FG014|Stage 2A|Adverse Event|0|||
126671227|NCT00467779|455755597|FG000|Stage 2A|Death|0|||
126671228|NCT00467779|455755598|FG001|Stage 2A|Death|0|||
126671229|NCT00467779|455755599|FG002|Stage 2A|Death|0|||
126671230|NCT00467779|455755600|FG003|Stage 2A|Death|0|||
126671231|NCT00467779|455755601|FG004|Stage 2A|Death|0|||
126671232|NCT00467779|455755602|FG005|Stage 2A|Death|0|||
126671233|NCT00467779|455755603|FG006|Stage 2A|Death|0|||
126671234|NCT00467779|455755604|FG007|Stage 2A|Death|0|||
126671235|NCT00467779|455755605|FG008|Stage 2A|Death|0|||
126671236|NCT00467779|455755606|FG009|Stage 2A|Death|0|||
126671237|NCT00467779|455755607|FG010|Stage 2A|Death|0|||
126671238|NCT00467779|455755608|FG011|Stage 2A|Death|0|||
126671239|NCT00467779|455755609|FG012|Stage 2A|Death|0|||
126671240|NCT00467779|455755610|FG013|Stage 2A|Death|1|||
126671241|NCT00467779|455755611|FG014|Stage 2A|Death|0|||
126671242|NCT00467779|455755597|FG000|Stage 2A|Disease Progression|0|||
126671243|NCT00467779|455755598|FG001|Stage 2A|Disease Progression|0|||
126671244|NCT00467779|455755599|FG002|Stage 2A|Disease Progression|0|||
126671245|NCT00467779|455755600|FG003|Stage 2A|Disease Progression|0|||
126671246|NCT00467779|455755601|FG004|Stage 2A|Disease Progression|0|||
126671247|NCT00467779|455755602|FG005|Stage 2A|Disease Progression|0|||
126671248|NCT00467779|455755603|FG006|Stage 2A|Disease Progression|0|||
126671249|NCT00467779|455755604|FG007|Stage 2A|Disease Progression|0|||
126671250|NCT00467779|455755605|FG008|Stage 2A|Disease Progression|0|||
126671251|NCT00467779|455755606|FG009|Stage 2A|Disease Progression|0|||
126671252|NCT00467779|455755607|FG010|Stage 2A|Disease Progression|0|||
126671253|NCT00467779|455755608|FG011|Stage 2A|Disease Progression|0|||
126671254|NCT00467779|455755609|FG012|Stage 2A|Disease Progression|0|||
126671255|NCT00467779|455755610|FG013|Stage 2A|Disease Progression|10|||
126671256|NCT00467779|455755611|FG014|Stage 2A|Disease Progression|0|||
126671257|NCT00467779|455755597|FG000|Stage 2A|Unspecified Reason|0|||
126671258|NCT00467779|455755598|FG001|Stage 2A|Unspecified Reason|0|||
126671259|NCT00467779|455755599|FG002|Stage 2A|Unspecified Reason|0|||
126671260|NCT00467779|455755600|FG003|Stage 2A|Unspecified Reason|0|||
126671261|NCT00467779|455755601|FG004|Stage 2A|Unspecified Reason|0|||
126671262|NCT00467779|455755602|FG005|Stage 2A|Unspecified Reason|0|||
126671263|NCT00467779|455755603|FG006|Stage 2A|Unspecified Reason|0|||
126671264|NCT00467779|455755604|FG007|Stage 2A|Unspecified Reason|0|||
126671265|NCT00467779|455755605|FG008|Stage 2A|Unspecified Reason|0|||
126671266|NCT00467779|455755606|FG009|Stage 2A|Unspecified Reason|0|||
126671267|NCT00467779|455755607|FG010|Stage 2A|Unspecified Reason|0|||
126671268|NCT00467779|455755608|FG011|Stage 2A|Unspecified Reason|0|||
126671269|NCT00467779|455755609|FG012|Stage 2A|Unspecified Reason|0|||
126671270|NCT00467779|455755610|FG013|Stage 2A|Unspecified Reason|7|||
126671271|NCT00467779|455755611|FG014|Stage 2A|Unspecified Reason|0|||
126671272|NCT00467779|455755597|FG000|Stage 2A|Withdrawal by Subject|0|||
126671273|NCT00467779|455755598|FG001|Stage 2A|Withdrawal by Subject|0|||
126671274|NCT00467779|455755599|FG002|Stage 2A|Withdrawal by Subject|0|||
126671275|NCT00467779|455755600|FG003|Stage 2A|Withdrawal by Subject|0|||
126671276|NCT00467779|455755601|FG004|Stage 2A|Withdrawal by Subject|0|||
126671277|NCT00467779|455755602|FG005|Stage 2A|Withdrawal by Subject|0|||
126671278|NCT00467779|455755603|FG006|Stage 2A|Withdrawal by Subject|0|||
126671279|NCT00467779|455755604|FG007|Stage 2A|Withdrawal by Subject|0|||
126671280|NCT00467779|455755605|FG008|Stage 2A|Withdrawal by Subject|0|||
126671281|NCT00467779|455755606|FG009|Stage 2A|Withdrawal by Subject|0|||
126671282|NCT00467779|455755607|FG010|Stage 2A|Withdrawal by Subject|0|||
126671283|NCT00467779|455755608|FG011|Stage 2A|Withdrawal by Subject|0|||
126671284|NCT00467779|455755609|FG012|Stage 2A|Withdrawal by Subject|0|||
126671285|NCT00467779|455755610|FG013|Stage 2A|Withdrawal by Subject|1|||
126671286|NCT00467779|455755611|FG014|Stage 2A|Withdrawal by Subject|0|||
126671287|NCT00467779|455755597|FG000|Stage 3|Adverse Event|0|||
126671288|NCT00467779|455755598|FG001|Stage 3|Adverse Event|0|||
126671289|NCT00467779|455755599|FG002|Stage 3|Adverse Event|0|||
126671290|NCT00467779|455755600|FG003|Stage 3|Adverse Event|0|||
126671291|NCT00467779|455755601|FG004|Stage 3|Adverse Event|0|||
126671292|NCT00467779|455755602|FG005|Stage 3|Adverse Event|0|||
126671293|NCT00467779|455755603|FG006|Stage 3|Adverse Event|0|||
126671294|NCT00467779|455755604|FG007|Stage 3|Adverse Event|0|||
126671295|NCT00467779|455755605|FG008|Stage 3|Adverse Event|0|||
126671296|NCT00467779|455755606|FG009|Stage 3|Adverse Event|0|||
126671297|NCT00467779|455755607|FG010|Stage 3|Adverse Event|0|||
126671298|NCT00467779|455755608|FG011|Stage 3|Adverse Event|0|||
126671299|NCT00467779|455755609|FG012|Stage 3|Adverse Event|0|||
126671300|NCT00467779|455755610|FG013|Stage 3|Adverse Event|0|||
126671301|NCT00467779|455755611|FG014|Stage 3|Adverse Event|2|||
126671302|NCT00467779|455755597|FG000|Stage 3|Death|0|||
126671303|NCT00467779|455755598|FG001|Stage 3|Death|0|||
126671304|NCT00467779|455755599|FG002|Stage 3|Death|0|||
126671305|NCT00467779|455755600|FG003|Stage 3|Death|0|||
126671306|NCT00467779|455755601|FG004|Stage 3|Death|0|||
126671307|NCT00467779|455755602|FG005|Stage 3|Death|0|||
126671308|NCT00467779|455755603|FG006|Stage 3|Death|0|||
126337730|NCT03353792|454532921|FG000|Overall Study|Participant Unable to Manage Device|1|||
126337731|NCT03353792|454532922|FG001|Overall Study|Participant Unable to Manage Device|0|||
126337732|NCT03342001|454532924|FG000|Overall Study|Adverse Event|1|||
126337733|NCT03342001|454532924|FG000|Overall Study|Lost to Follow-up|1|||
126337734|NCT04161391|454532928|FG000|Overall Study|Adverse Event|0|||
126337735|NCT04161391|454532929|FG001|Overall Study|Adverse Event|1|||
126337736|NCT04161391|454532930|FG002|Overall Study|Adverse Event|0|||
126337737|NCT04161391|454532931|FG003|Overall Study|Adverse Event|1|||
126671309|NCT00467779|455755604|FG007|Stage 3|Death|0|||
126671310|NCT00467779|455755605|FG008|Stage 3|Death|0|||
126671311|NCT00467779|455755606|FG009|Stage 3|Death|0|||
126671312|NCT00467779|455755607|FG010|Stage 3|Death|0|||
126671313|NCT00467779|455755608|FG011|Stage 3|Death|0|||
126671314|NCT00467779|455755609|FG012|Stage 3|Death|0|||
126671315|NCT00467779|455755610|FG013|Stage 3|Death|0|||
126671316|NCT00467779|455755611|FG014|Stage 3|Death|1|||
126671317|NCT00467779|455755597|FG000|Stage 3|Disease Progression|0|||
126671318|NCT00467779|455755598|FG001|Stage 3|Disease Progression|0|||
126671319|NCT00467779|455755599|FG002|Stage 3|Disease Progression|0|||
126671320|NCT00467779|455755600|FG003|Stage 3|Disease Progression|0|||
126671321|NCT00467779|455755601|FG004|Stage 3|Disease Progression|0|||
126671322|NCT00467779|455755602|FG005|Stage 3|Disease Progression|0|||
126671323|NCT00467779|455755603|FG006|Stage 3|Disease Progression|0|||
126671324|NCT00467779|455755604|FG007|Stage 3|Disease Progression|0|||
126671325|NCT00467779|455755605|FG008|Stage 3|Disease Progression|0|||
126671326|NCT00467779|455755606|FG009|Stage 3|Disease Progression|0|||
126671327|NCT00467779|455755607|FG010|Stage 3|Disease Progression|0|||
126671328|NCT00467779|455755608|FG011|Stage 3|Disease Progression|0|||
126671329|NCT00467779|455755609|FG012|Stage 3|Disease Progression|0|||
126671330|NCT00467779|455755610|FG013|Stage 3|Disease Progression|0|||
126337738|NCT04161391|454532932|FG004|Overall Study|Adverse Event|0|||
126337739|NCT04161391|454532933|FG005|Overall Study|Adverse Event|0|||
126671331|NCT00467779|455755611|FG014|Stage 3|Disease Progression|9|||
126671332|NCT00467779|455755597|FG000|Stage 3|Unspecified Reason|0|||
126671333|NCT00467779|455755598|FG001|Stage 3|Unspecified Reason|0|||
126671334|NCT00467779|455755599|FG002|Stage 3|Unspecified Reason|0|||
126671335|NCT00467779|455755600|FG003|Stage 3|Unspecified Reason|0|||
126671336|NCT00467779|455755601|FG004|Stage 3|Unspecified Reason|0|||
126671337|NCT00467779|455755602|FG005|Stage 3|Unspecified Reason|0|||
126337740|NCT04161391|454532934|FG006|Overall Study|Adverse Event|0|||
126671338|NCT00467779|455755603|FG006|Stage 3|Unspecified Reason|0|||
126671339|NCT00467779|455755604|FG007|Stage 3|Unspecified Reason|0|||
126671340|NCT00467779|455755605|FG008|Stage 3|Unspecified Reason|0|||
126671341|NCT00467779|455755606|FG009|Stage 3|Unspecified Reason|0|||
126671342|NCT00467779|455755607|FG010|Stage 3|Unspecified Reason|0|||
126671343|NCT00467779|455755608|FG011|Stage 3|Unspecified Reason|0|||
126671344|NCT00467779|455755609|FG012|Stage 3|Unspecified Reason|0|||
126671345|NCT00467779|455755610|FG013|Stage 3|Unspecified Reason|0|||
126671346|NCT00467779|455755611|FG014|Stage 3|Unspecified Reason|5|||
126671347|NCT00041080|455755614|FG000|Overall Study|Adverse Event|21|||
126671348|NCT00041080|455755615|FG001|Overall Study|Adverse Event|1|||
126671349|NCT00041080|455755614|FG000|Overall Study|Withdrawal by Subject|6|||
126671350|NCT00041080|455755615|FG001|Overall Study|Withdrawal by Subject|6|||
126671351|NCT00041080|455755614|FG000|Overall Study|Concommitant Illness/Other|1|||
126671352|NCT00041080|455755615|FG001|Overall Study|Concommitant Illness/Other|2|||
126671353|NCT00041080|455755614|FG000|Overall Study|Did not start therapy|1|||
126671354|NCT00041080|455755615|FG001|Overall Study|Did not start therapy|1|||
126671355|NCT00041080|455755614|FG000|Overall Study|Ineligible|1|||
126671356|NCT00041080|455755615|FG001|Overall Study|Ineligible|0|||
126671357|NCT04353596|455755618|FG000|Overall Study|Protocol Violation|4|||
126671358|NCT04353596|455755619|FG001|Overall Study|Protocol Violation|4|||
126671359|NCT04353596|455755618|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
126671360|NCT04353596|455755619|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
126671361|NCT00823823|455755620|FG000|Overall Study|Lost to Follow-up|3|||
126671362|NCT00823823|455755621|FG001|Overall Study|Lost to Follow-up|1|||
126671363|NCT00823823|455755620|FG000|Overall Study|Protocol Violation|5|||
126671364|NCT00823823|455755621|FG001|Overall Study|Protocol Violation|5|||
126671365|NCT04422990|455755625|FG000|Overall Study|Withdrawal by Subject|0|||
126671366|NCT04422990|455755626|FG001|Overall Study|Withdrawal by Subject|1|||
126671367|NCT04422990|455755625|FG000|Overall Study|Travel|3|||
126671368|NCT04422990|455755626|FG001|Overall Study|Travel|0|||
126671369|NCT01490814|455755627|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
126671370|NCT01490814|455755628|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
126671371|NCT01490814|455755627|FG000|Overall Study|Physician Decision|1|||
126671372|NCT01490814|455755628|FG001|Overall Study|Physician Decision|0|||
126671373|NCT01490814|455755627|FG000|Overall Study|Withdrawal by Subject|0|||
126671374|NCT01490814|455755628|FG001|Overall Study|Withdrawal by Subject|5|||
126671375|NCT03024970|455755640|FG000|First Intervention|Adverse Event|1|||
126671376|NCT03024970|455755641|FG001|First Intervention|Adverse Event|0|||
126671377|NCT03024970|455755640|FG000|Second Intervention|Lost to Follow-up|1|||
126671378|NCT03024970|455755641|FG001|Second Intervention|Lost to Follow-up|0|||
126671379|NCT01221727|455755645|FG000|Overall Study|Physician Decision|2|||
126671380|NCT01221727|455755646|FG001|Overall Study|Physician Decision|0|||
126671381|NCT01221727|455755645|FG000|Overall Study|Withdrawal by Subject|1|||
126671382|NCT01221727|455755646|FG001|Overall Study|Withdrawal by Subject|1|||
126671383|NCT00590044|455755647|FG000|Overall Study|Withdrawal by Subject|2|||
126671384|NCT00590044|455755648|FG001|Overall Study|Withdrawal by Subject|2|||
126671385|NCT00590044|455755647|FG000|Overall Study|wrong insulin arm assigned|1|||
126671386|NCT00590044|455755648|FG001|Overall Study|wrong insulin arm assigned|0|||
126671387|NCT00590044|455755647|FG000|Overall Study|Protocol Violation|1|||
126671388|NCT00590044|455755648|FG001|Overall Study|Protocol Violation|0|||
126671389|NCT02790138|455755649|FG000|Overall Study|Adverse Event|5|||
126671390|NCT02790138|455755650|FG001|Overall Study|Adverse Event|2|||
126671391|NCT02790138|455755649|FG000|Overall Study|Significant Protocol Deviation|0|||
126671392|NCT02790138|455755650|FG001|Overall Study|Significant Protocol Deviation|1|||
126671393|NCT02790138|455755649|FG000|Overall Study|Lost to Follow-up|1|||
126671394|NCT02790138|455755650|FG001|Overall Study|Lost to Follow-up|0|||
126671395|NCT02790138|455755649|FG000|Overall Study|Voluntary Withdrawal|8|||
126671396|NCT02790138|455755650|FG001|Overall Study|Voluntary Withdrawal|9|||
126671397|NCT02790138|455755649|FG000|Overall Study|Lack of Efficacy|6|||
126671398|NCT02790138|455755650|FG001|Overall Study|Lack of Efficacy|7|||
126671399|NCT02790138|455755649|FG000|Overall Study|Reason not Specified|1|||
126671400|NCT02790138|455755650|FG001|Overall Study|Reason not Specified|0|||
126671401|NCT01786603|455755651|FG000|Overall Study|Death|5|||
126671402|NCT01786603|455755652|FG001|Overall Study|Death|1|||
126671403|NCT01786603|455755651|FG000|Overall Study|Adverse Event|6|||
126671404|NCT01786603|455755652|FG001|Overall Study|Adverse Event|2|||
126671405|NCT01786603|455755651|FG000|Overall Study|Physician decision to withdraw|6|||
126671406|NCT01786603|455755652|FG001|Overall Study|Physician decision to withdraw|7|||
126671407|NCT01786603|455755651|FG000|Overall Study|Lost to Follow-up|1|||
126671408|NCT01786603|455755652|FG001|Overall Study|Lost to Follow-up|2|||
126671409|NCT01226459|455755653|FG000|Overall Study|Adverse Event|2|||
126671410|NCT01226459|455755654|FG001|Overall Study|Adverse Event|8|||
126671411|NCT01226459|455755653|FG000|Overall Study|Protocol Violation|4|||
126671412|NCT01226459|455755654|FG001|Overall Study|Protocol Violation|3|||
126671413|NCT01226459|455755653|FG000|Overall Study|Withdrawal by Subject|10|||
126671414|NCT01226459|455755654|FG001|Overall Study|Withdrawal by Subject|13|||
126671415|NCT01226459|455755653|FG000|Overall Study|Lost to Follow-up|4|||
126671416|NCT01226459|455755654|FG001|Overall Study|Lost to Follow-up|8|||
126671417|NCT01226459|455755653|FG000|Overall Study|Pregnancy|1|||
126671418|NCT01226459|455755654|FG001|Overall Study|Pregnancy|0|||
126671419|NCT00474708|455755655|FG000|Overall Study|Lack of Efficacy|11|||
126671420|NCT00474708|455755656|FG001|Overall Study|Lack of Efficacy|5|||
126671421|NCT00474708|455755655|FG000|Overall Study|Suicide ideation/behavior|0|||
126671422|NCT00474708|455755656|FG001|Overall Study|Suicide ideation/behavior|1|||
126671423|NCT00474708|455755655|FG000|Overall Study|Withdrawal by Subject|7|||
126671424|NCT00474708|455755656|FG001|Overall Study|Withdrawal by Subject|0|||
126671425|NCT00474708|455755655|FG000|Overall Study|Lack of compliance|12|||
126671426|NCT00474708|455755656|FG001|Overall Study|Lack of compliance|4|||
126337741|NCT04161391|454532935|FG007|Overall Study|Adverse Event|3|||
126337742|NCT04161391|454532936|FG008|Overall Study|Adverse Event|0|||
126671427|NCT00474708|455755655|FG000|Overall Study|Lost to Follow-up|18|||
126671428|NCT00474708|455755656|FG001|Overall Study|Lost to Follow-up|9|||
126671429|NCT00474708|455755655|FG000|Overall Study|Physician Decision|9|||
126671430|NCT00474708|455755656|FG001|Overall Study|Physician Decision|6|||
126671431|NCT03700320|455755657|FG000|Overall Study|Adverse Event|5|||
126671432|NCT03700320|455755658|FG001|Overall Study|Adverse Event|31|||
126671433|NCT03700320|455755657|FG000|Overall Study|Lack of Efficacy|2|||
126671434|NCT03700320|455755658|FG001|Overall Study|Lack of Efficacy|5|||
126671435|NCT03700320|455755657|FG000|Overall Study|Withdrawal by Subject|29|||
126671436|NCT03700320|455755658|FG001|Overall Study|Withdrawal by Subject|75|||
126671437|NCT03700320|455755657|FG000|Overall Study|Lost to Follow-up|16|||
126671438|NCT03700320|455755658|FG001|Overall Study|Lost to Follow-up|23|||
126671439|NCT03700320|455755657|FG000|Overall Study|Pregnancy|2|||
126671440|NCT03700320|455755658|FG001|Overall Study|Pregnancy|4|||
126671441|NCT03700320|455755657|FG000|Overall Study|Protocol Deviation|7|||
126671442|NCT03700320|455755658|FG001|Overall Study|Protocol Deviation|31|||
126671443|NCT03700320|455755657|FG000|Overall Study|Non-compliance with Study Drug|1|||
126671444|NCT03700320|455755658|FG001|Overall Study|Non-compliance with Study Drug|3|||
126671445|NCT03700320|455755657|FG000|Overall Study|Reason not Specified|0|||
126671446|NCT03700320|455755658|FG001|Overall Study|Reason not Specified|1|||
126671447|NCT00175877|455755662|FG000|Overall Study|Adverse Event|136|||
126671448|NCT00175877|455755662|FG000|Overall Study|Withdrawal by Subject|141|||
126671449|NCT00175877|455755662|FG000|Overall Study|Lost to Follow-up|9|||
126671450|NCT00175877|455755662|FG000|Overall Study|Lack of Efficacy|26|||
126671451|NCT00175877|455755662|FG000|Overall Study|Protocol Violation|15|||
126671452|NCT00175877|455755662|FG000|Overall Study|Other Reason|20|||
126671453|NCT00175877|455755662|FG000|Overall Study|AE & Other|1|||
126671454|NCT00175877|455755662|FG000|Overall Study|Withdrawal by subject & Other|1|||
126671455|NCT01092143|455755665|FG000|Overall Study|Adverse Event|10|||
126671456|NCT01092143|455755666|FG001|Overall Study|Adverse Event|5|||
126671457|NCT01092143|455755667|FG002|Overall Study|Adverse Event|1|||
126671458|NCT01092143|455755668|FG003|Overall Study|Adverse Event|4|||
126671459|NCT01092143|455755669|FG004|Overall Study|Adverse Event|3|||
126671460|NCT01092143|455755665|FG000|Overall Study|Lost to Follow-up|1|||
126671461|NCT01092143|455755666|FG001|Overall Study|Lost to Follow-up|0|||
126671462|NCT01092143|455755667|FG002|Overall Study|Lost to Follow-up|1|||
126671463|NCT01092143|455755668|FG003|Overall Study|Lost to Follow-up|0|||
126671464|NCT01092143|455755669|FG004|Overall Study|Lost to Follow-up|0|||
126671465|NCT01092143|455755665|FG000|Overall Study|Consent withdrawn|2|||
126671466|NCT01092143|455755666|FG001|Overall Study|Consent withdrawn|1|||
126671467|NCT01092143|455755667|FG002|Overall Study|Consent withdrawn|0|||
126671468|NCT01092143|455755668|FG003|Overall Study|Consent withdrawn|1|||
126671469|NCT01092143|455755669|FG004|Overall Study|Consent withdrawn|3|||
126671470|NCT01092143|455755665|FG000|Overall Study|Not treated|0|||
126671471|NCT01092143|455755666|FG001|Overall Study|Not treated|0|||
126671472|NCT01092143|455755667|FG002|Overall Study|Not treated|1|||
126671473|NCT01092143|455755668|FG003|Overall Study|Not treated|0|||
126671474|NCT01092143|455755669|FG004|Overall Study|Not treated|0|||
126671475|NCT01092143|455755665|FG000|Overall Study|did not reversibility criteria|0|||
126671476|NCT01092143|455755666|FG001|Overall Study|did not reversibility criteria|0|||
126671477|NCT01092143|455755667|FG002|Overall Study|did not reversibility criteria|1|||
126671478|NCT01092143|455755668|FG003|Overall Study|did not reversibility criteria|0|||
126671479|NCT01092143|455755669|FG004|Overall Study|did not reversibility criteria|0|||
126671480|NCT01092143|455755665|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
126671481|NCT01092143|455755666|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
126671482|NCT01092143|455755667|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
126671483|NCT01092143|455755668|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
126337743|NCT04161391|454532928|FG000|Overall Study|Death|0|||
126671484|NCT01092143|455755669|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
126671485|NCT01092143|455755665|FG000|Overall Study|Ineligible patient|1|||
126671486|NCT01092143|455755666|FG001|Overall Study|Ineligible patient|0|||
126671487|NCT01092143|455755667|FG002|Overall Study|Ineligible patient|0|||
126337744|NCT04161391|454532929|FG001|Overall Study|Death|0|||
126337745|NCT04161391|454532930|FG002|Overall Study|Death|0|||
126671488|NCT01092143|455755668|FG003|Overall Study|Ineligible patient|0|||
126671489|NCT01092143|455755669|FG004|Overall Study|Ineligible patient|0|||
126671490|NCT01092143|455755665|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
126671491|NCT01092143|455755666|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
126671492|NCT01092143|455755667|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
126671493|NCT01092143|455755668|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
126671494|NCT01092143|455755669|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
126671495|NCT01092143|455755665|FG000|Overall Study|Patient travel|0|||
126671496|NCT01092143|455755666|FG001|Overall Study|Patient travel|0|||
126671497|NCT01092143|455755667|FG002|Overall Study|Patient travel|0|||
126337746|NCT04161391|454532931|FG003|Overall Study|Death|0|||
126671498|NCT01092143|455755668|FG003|Overall Study|Patient travel|0|||
126337747|NCT04161391|454532932|FG004|Overall Study|Death|0|||
126337748|NCT04161391|454532933|FG005|Overall Study|Death|0|||
126671499|NCT01092143|455755669|FG004|Overall Study|Patient travel|1|||
126671500|NCT01092143|455755665|FG000|Overall Study|Non compliance with study medication|0|||
126337749|NCT04161391|454532934|FG006|Overall Study|Death|0|||
126337750|NCT04161391|454532935|FG007|Overall Study|Death|1|||
126337751|NCT04161391|454532936|FG008|Overall Study|Death|0|||
126337752|NCT04161391|454532928|FG000|Overall Study|Physician Decision|0|||
126337753|NCT04161391|454532929|FG001|Overall Study|Physician Decision|0|||
126337754|NCT04161391|454532930|FG002|Overall Study|Physician Decision|1|||
126337755|NCT04161391|454532931|FG003|Overall Study|Physician Decision|2|||
126337756|NCT04161391|454532932|FG004|Overall Study|Physician Decision|0|||
126337757|NCT04161391|454532933|FG005|Overall Study|Physician Decision|0|||
126337758|NCT04161391|454532934|FG006|Overall Study|Physician Decision|2|||
126337759|NCT04161391|454532935|FG007|Overall Study|Physician Decision|0|||
126337760|NCT04161391|454532936|FG008|Overall Study|Physician Decision|0|||
126337761|NCT04161391|454532928|FG000|Overall Study|Progressive Disease|4|||
126337762|NCT04161391|454532929|FG001|Overall Study|Progressive Disease|3|||
126337763|NCT04161391|454532930|FG002|Overall Study|Progressive Disease|3|||
126337764|NCT04161391|454532931|FG003|Overall Study|Progressive Disease|5|||
126337765|NCT04161391|454532932|FG004|Overall Study|Progressive Disease|3|||
126671501|NCT01092143|455755666|FG001|Overall Study|Non compliance with study medication|0|||
126671502|NCT01092143|455755667|FG002|Overall Study|Non compliance with study medication|0|||
126671503|NCT01092143|455755668|FG003|Overall Study|Non compliance with study medication|0|||
126671504|NCT01092143|455755669|FG004|Overall Study|Non compliance with study medication|1|||
126671505|NCT01092143|455755665|FG000|Overall Study|Randomized by mistake|0|||
126671506|NCT01092143|455755666|FG001|Overall Study|Randomized by mistake|0|||
126671507|NCT01092143|455755667|FG002|Overall Study|Randomized by mistake|0|||
126671508|NCT01092143|455755668|FG003|Overall Study|Randomized by mistake|1|||
126671509|NCT01092143|455755669|FG004|Overall Study|Randomized by mistake|0|||
126671510|NCT01092143|455755665|FG000|Overall Study|Pregnancy|0|||
126671511|NCT01092143|455755666|FG001|Overall Study|Pregnancy|0|||
126671512|NCT01092143|455755667|FG002|Overall Study|Pregnancy|0|||
126671513|NCT01092143|455755668|FG003|Overall Study|Pregnancy|1|||
126671514|NCT01092143|455755669|FG004|Overall Study|Pregnancy|0|||
126671515|NCT03986866|455755670|FG000|Overall Study|Withdrawal by Subject|0|||
126671516|NCT03986866|455755671|FG001|Overall Study|Withdrawal by Subject|3|||
126671517|NCT03986866|455755670|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
126671518|NCT03986866|455755671|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
126671519|NCT05093322|455755674|FG000|Overall Study|Death|6|||
126671520|NCT05093322|455755675|FG001|Overall Study|Death|2|||
126671521|NCT05093322|455755674|FG000|Overall Study|Other|4|||
126671522|NCT05093322|455755675|FG001|Overall Study|Other|1|||
126671523|NCT00397033|455755681|FG000|Overall Study|Adverse Event|7|||
126671524|NCT00397033|455755682|FG001|Overall Study|Adverse Event|10|||
126671525|NCT00397033|455755683|FG002|Overall Study|Adverse Event|4|||
126671526|NCT00397033|455755681|FG000|Overall Study|Lack of Efficacy|22|||
126671527|NCT00397033|455755682|FG001|Overall Study|Lack of Efficacy|12|||
126671528|NCT00397033|455755683|FG002|Overall Study|Lack of Efficacy|9|||
126671529|NCT00397033|455755681|FG000|Overall Study|Lost to Follow-up|3|||
126671530|NCT00397033|455755682|FG001|Overall Study|Lost to Follow-up|3|||
126671531|NCT00397033|455755683|FG002|Overall Study|Lost to Follow-up|3|||
126671532|NCT00397033|455755681|FG000|Overall Study|Withdrawal by Subject|12|||
126671533|NCT00397033|455755682|FG001|Overall Study|Withdrawal by Subject|7|||
126671534|NCT00397033|455755683|FG002|Overall Study|Withdrawal by Subject|5|||
126671535|NCT00397033|455755681|FG000|Overall Study|Other|0|||
126671536|NCT00397033|455755682|FG001|Overall Study|Other|5|||
126671537|NCT00397033|455755683|FG002|Overall Study|Other|2|||
126671538|NCT01984164|455755684|FG000|Overall Study|Withdrawal by Subject|4|||
126671539|NCT01984164|455755685|FG001|Overall Study|Withdrawal by Subject|3|||
126671540|NCT01984164|455755684|FG000|Overall Study|Adverse Event|5|||
126671541|NCT01984164|455755685|FG001|Overall Study|Adverse Event|19|||
126337766|NCT04161391|454532933|FG005|Overall Study|Progressive Disease|3|||
126337767|NCT04161391|454532934|FG006|Overall Study|Progressive Disease|5|||
126671542|NCT01984164|455755684|FG000|Overall Study|Lost to Follow-up|1|||
126671543|NCT01984164|455755685|FG001|Overall Study|Lost to Follow-up|3|||
126671544|NCT05293743|455755686|FG000|Overall Study|Withdrawal by Subject|1|||
126337768|NCT04161391|454532935|FG007|Overall Study|Progressive Disease|2|||
126337769|NCT04161391|454532936|FG008|Overall Study|Progressive Disease|2|||
126671545|NCT05293743|455755687|FG001|Overall Study|Withdrawal by Subject|0|||
126671546|NCT00667823|455755688|FG000|Overall Study|Lost to Follow-up|5|||
126671547|NCT00667823|455755688|FG000|Overall Study|Adverse Event|7|||
126671548|NCT00667823|455755688|FG000|Overall Study|Death|182|||
126671549|NCT00667823|455755688|FG000|Overall Study|Withdrawal by Subject|12|||
126671550|NCT00667823|455755688|FG000|Overall Study|Other|8|||
126671551|NCT00667823|455755688|FG000|Overall Study|Missing (completion page missing)|2|||
126337770|NCT02351934|454532937|FG000|Allocation|POD weight<pre-op weight|3|||
126337771|NCT02351934|454532938|FG001|Allocation|POD weight<pre-op weight|0|||
126337772|NCT02351934|454532937|FG000|Allocation|Hypotension preventing administration|2|||
126337773|NCT02351934|454532938|FG001|Allocation|Hypotension preventing administration|0|||
126337774|NCT02351934|454532937|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
126337775|NCT02351934|454532938|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
126337776|NCT02351934|454532937|FG000|Follow-Up|POD weight<pre-op weight|3|||
126337777|NCT02351934|454532938|FG001|Follow-Up|POD weight<pre-op weight|0|||
126337778|NCT02351934|454532937|FG000|Follow-Up|Acute Kidney Injury|1|||
126337779|NCT02351934|454532938|FG001|Follow-Up|Acute Kidney Injury|0|||
126337780|NCT02351934|454532937|FG000|Follow-Up|Early dismissal|3|||
126337781|NCT02351934|454532938|FG001|Follow-Up|Early dismissal|0|||
126337782|NCT02351934|454532937|FG000|Follow-Up|Hypotension|3|||
126337783|NCT02351934|454532938|FG001|Follow-Up|Hypotension|0|||
126337784|NCT02351934|454532937|FG000|Follow-Up|No documentation|2|||
126337785|NCT02351934|454532938|FG001|Follow-Up|No documentation|0|||
126337786|NCT02351934|454532937|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
126337787|NCT02351934|454532938|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
126337788|NCT02351934|454532937|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
126337789|NCT02351934|454532938|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
126337790|NCT00785356|454532945|FG000|Overall Study|Study prematurely terminated|8|||
126337791|NCT03238417|454532947|FG000|Overall|non-response|955|||
126337792|NCT03238417|454532948|FG001|Overall|non-response|1920|||
126337793|NCT03238417|454532947|FG000|Overall|partial completion|48|||
126337794|NCT03238417|454532948|FG001|Overall|partial completion|68|||
126337795|NCT03238417|454532947|FG000|Baseline|Partial completion|17|||
126337796|NCT03238417|454532948|FG001|Baseline|Partial completion|48|||
126337797|NCT03238417|454532947|FG000|Baseline|non-response|372|||
126337798|NCT03238417|454532948|FG001|Baseline|non-response|669|||
126337799|NCT03238417|454532947|FG000|12-month|non-response|296|||
126337800|NCT03238417|454532948|FG001|12-month|non-response|669|||
126671552|NCT00583024|455755689|FG000|Overall Study|Lost to Follow-up|4|||
126671553|NCT04376827|455755695|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
126671554|NCT04376827|455755696|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
126671555|NCT04376827|455755695|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
126671556|NCT04376827|455755696|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
126671557|NCT04376827|455755695|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
126671558|NCT04376827|455755696|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
126671559|NCT04376827|455755695|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
126671560|NCT04376827|455755696|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
126671561|NCT04376827|455755695|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
126671562|NCT04376827|455755696|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
126671563|NCT00574145|455757305|FG000|Overall Study|Withdrawal by Subject|2|||
126671564|NCT00574145|455757306|FG001|Overall Study|Withdrawal by Subject|1|||
126671565|NCT03227471|455757307|FG000|Overall Study|Withdrawal by Subject|0|||
126671566|NCT03227471|455757308|FG001|Overall Study|Withdrawal by Subject|0|||
126671567|NCT03227471|455757309|FG002|Overall Study|Withdrawal by Subject|0|||
126671568|NCT03227471|455757310|FG003|Overall Study|Withdrawal by Subject|0|||
126671569|NCT03227471|455757311|FG004|Overall Study|Withdrawal by Subject|1|||
126671570|NCT03227471|455757312|FG005|Overall Study|Withdrawal by Subject|0|||
126671571|NCT03227471|455757313|FG006|Overall Study|Withdrawal by Subject|0|||
126671572|NCT03227471|455757314|FG007|Overall Study|Withdrawal by Subject|0|||
126671573|NCT03227471|455757315|FG008|Overall Study|Withdrawal by Subject|0|||
126671574|NCT03227471|455757316|FG009|Overall Study|Withdrawal by Subject|0|||
126671575|NCT03227471|455757317|FG010|Overall Study|Withdrawal by Subject|0|||
126671576|NCT03227471|455757318|FG011|Overall Study|Withdrawal by Subject|0|||
126671577|NCT03227471|455757319|FG012|Overall Study|Withdrawal by Subject|1|||
126671578|NCT03227471|455757320|FG013|Overall Study|Withdrawal by Subject|0|||
126671579|NCT03227471|455757321|FG014|Overall Study|Withdrawal by Subject|0|||
126671580|NCT03227471|455757307|FG000|Overall Study|Randomized, Never Dosed|0|||
126671581|NCT03227471|455757308|FG001|Overall Study|Randomized, Never Dosed|0|||
126671582|NCT03227471|455757309|FG002|Overall Study|Randomized, Never Dosed|0|||
126671583|NCT03227471|455757310|FG003|Overall Study|Randomized, Never Dosed|0|||
126671584|NCT03227471|455757311|FG004|Overall Study|Randomized, Never Dosed|0|||
126671585|NCT03227471|455757312|FG005|Overall Study|Randomized, Never Dosed|0|||
126671586|NCT03227471|455757313|FG006|Overall Study|Randomized, Never Dosed|0|||
126671587|NCT03227471|455757314|FG007|Overall Study|Randomized, Never Dosed|0|||
126337801|NCT03238417|454532947|FG000|12-month|partial completion|23|||
126337802|NCT03238417|454532948|FG001|12-month|partial completion|37|||
126337803|NCT03238417|454532947|FG000|24-month|non-response|287|||
126337804|NCT03238417|454532948|FG001|24-month|non-response|594|||
126337805|NCT03238417|454532947|FG000|24-month|partial completion|8|||
126337806|NCT03238417|454532948|FG001|24-month|partial completion|31|||
126337807|NCT01232790|454532949|FG000|Randomization|Withdrawal by Subject|2|||
126337808|NCT01232790|454532950|FG001|Randomization|Withdrawal by Subject|0|||
126337809|NCT01232790|454532949|FG000|Randomization|Protocol Violation|0|||
126337810|NCT01232790|454532950|FG001|Randomization|Protocol Violation|1|||
126337811|NCT01232790|454532949|FG000|Randomization|Physician Decision|0|||
126337812|NCT01232790|454532950|FG001|Randomization|Physician Decision|1|||
126337813|NCT01232790|454532949|FG000|Initial Assessment|Withdrawal by Subject|0|||
126337814|NCT01232790|454532950|FG001|Initial Assessment|Withdrawal by Subject|1|||
126337815|NCT01232790|454532949|FG000|First Crossover|Withdrawal by Subject|1|||
126337816|NCT01232790|454532950|FG001|First Crossover|Withdrawal by Subject|0|||
126337817|NCT01232790|454532949|FG000|Second Crossover|Withdrawal by Subject|1|||
126337818|NCT01232790|454532950|FG001|Second Crossover|Withdrawal by Subject|2|||
126337819|NCT00083915|454532951|FG000|Overall Study|Death|6|||
126337820|NCT00083915|454532952|FG001|Overall Study|Death|3|||
126337821|NCT00083915|454532951|FG000|Overall Study|Physician Decision|11|||
126337822|NCT00083915|454532952|FG001|Overall Study|Physician Decision|6|||
126337823|NCT00083915|454532951|FG000|Overall Study|Withdrawal by Subject|8|||
126337824|NCT00083915|454532952|FG001|Overall Study|Withdrawal by Subject|3|||
126337825|NCT00083915|454532951|FG000|Overall Study|disease progression|18|||
126337826|NCT00083915|454532952|FG001|Overall Study|disease progression|23|||
126337827|NCT00083915|454532951|FG000|Overall Study|Failure to collect|3|||
126337828|NCT00083915|454532952|FG001|Overall Study|Failure to collect|0|||
126337829|NCT00083915|454532951|FG000|Overall Study|No response|3|||
126337830|NCT00083915|454532952|FG001|Overall Study|No response|1|||
126337831|NCT00083915|454532951|FG000|Overall Study|Insurance issues|1|||
126337832|NCT00083915|454532952|FG001|Overall Study|Insurance issues|1|||
126337833|NCT01239797|454532953|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
126337834|NCT01239797|454532954|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
126337835|NCT01239797|454532953|FG000|Randomized Participants|Participant withdrew consent|1|||
126337836|NCT01239797|454532954|FG001|Randomized Participants|Participant withdrew consent|7|||
126337837|NCT01239797|454532953|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
126337838|NCT01239797|454532954|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
126337839|NCT01239797|454532953|FG000|Treated Participants|Disease progression|185|||
126337840|NCT01239797|454532954|FG001|Treated Participants|Disease progression|185|||
126337841|NCT01239797|454532953|FG000|Treated Participants|Study drug toxicity|39|||
126337842|NCT01239797|454532954|FG001|Treated Participants|Study drug toxicity|45|||
126337843|NCT01239797|454532953|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
126337844|NCT01239797|454532954|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
126337845|NCT01239797|454532953|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
126337846|NCT01239797|454532954|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
126337847|NCT01239797|454532953|FG000|Treated Participants|Administrative reason by sponsor|13|||
126337848|NCT01239797|454532954|FG001|Treated Participants|Administrative reason by sponsor|4|||
126337849|NCT01239797|454532953|FG000|Treated Participants|Other reasons|14|||
126337850|NCT01239797|454532954|FG001|Treated Participants|Other reasons|14|||
126337851|NCT01239797|454532953|FG000|Treated Participants|Participant withdrew consent|6|||
126337852|NCT01239797|454532954|FG001|Treated Participants|Participant withdrew consent|11|||
126337853|NCT01239797|454532953|FG000|Treated Participants|Death|1|||
126337854|NCT01239797|454532954|FG001|Treated Participants|Death|1|||
126337855|NCT01239797|454532953|FG000|Treated Participants|Participant no longer meets study criteria|1|||
126337856|NCT01239797|454532954|FG001|Treated Participants|Participant no longer meets study criteria|1|||
126337857|NCT01239797|454532953|FG000|Treated Participants|Poor/non-compliance|0|||
126671588|NCT03227471|455757315|FG008|Overall Study|Randomized, Never Dosed|0|||
126671589|NCT03227471|455757316|FG009|Overall Study|Randomized, Never Dosed|0|||
126671590|NCT03227471|455757317|FG010|Overall Study|Randomized, Never Dosed|0|||
126671591|NCT03227471|455757318|FG011|Overall Study|Randomized, Never Dosed|0|||
126671592|NCT03227471|455757319|FG012|Overall Study|Randomized, Never Dosed|0|||
126671593|NCT03227471|455757320|FG013|Overall Study|Randomized, Never Dosed|0|||
126671594|NCT03227471|455757321|FG014|Overall Study|Randomized, Never Dosed|1|||
126671595|NCT00682448|455757322|FG000|Overall Study|Adverse Event|1|||
126671596|NCT00682448|455757323|FG001|Overall Study|Adverse Event|2|||
126671597|NCT00682448|455757322|FG000|Overall Study|Lack of Efficacy|1|||
126671598|NCT00682448|455757323|FG001|Overall Study|Lack of Efficacy|0|||
126671599|NCT00682448|455757322|FG000|Overall Study|Lost to Follow-up|1|||
126671600|NCT00682448|455757323|FG001|Overall Study|Lost to Follow-up|3|||
126671601|NCT00682448|455757322|FG000|Overall Study|Pregnancy|0|||
126671602|NCT00682448|455757323|FG001|Overall Study|Pregnancy|1|||
126671603|NCT00682448|455757322|FG000|Overall Study|Withdrawal by Subject|2|||
126671604|NCT00682448|455757323|FG001|Overall Study|Withdrawal by Subject|0|||
126671605|NCT02737852|455757326|FG000|Overall Study|Withdrawal by Subject|2|||
126671606|NCT03335163|455757333|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
126337858|NCT01239797|454532954|FG001|Treated Participants|Poor/non-compliance|1|||
126671607|NCT03335163|455757333|FG000|Overall Study|Withdrawal by Subject|18|||
126671608|NCT00525044|455757334|FG000|Overall Study|Lost to Follow-up|0|||
126671609|NCT00525044|455757335|FG001|Overall Study|Lost to Follow-up|1|||
126671610|NCT02553265|455757337|FG000|Enrollment|Death|0|||
126671611|NCT02553265|455757338|FG001|Enrollment|Death|0|||
126671612|NCT02553265|455757339|FG002|Enrollment|Death|1|||
126671613|NCT02553265|455757337|FG000|First Intervention (28 Days)|Adverse Event|1|||
126671614|NCT02553265|455757338|FG001|First Intervention (28 Days)|Adverse Event|0|||
126671615|NCT02553265|455757339|FG002|First Intervention (28 Days)|Adverse Event|0|||
126337859|NCT01225549|454532957|FG000|Period 4 - Washout|Disallowed medication|0|||
126337860|NCT01225549|454532958|FG001|Period 4 - Washout|Disallowed medication|1|||
126337861|NCT01225549|454532959|FG002|Period 4 - Washout|Disallowed medication|0|||
126337862|NCT01225549|454532960|FG003|Period 4 - Washout|Disallowed medication|0|||
126337863|NCT01225549|454532961|FG004|Period 4 - Washout|Disallowed medication|0|||
126337864|NCT01225549|454532962|FG005|Period 4 - Washout|Disallowed medication|0|||
126337865|NCT01225549|454532963|FG006|Period 4 - Washout|Disallowed medication|0|||
126337866|NCT01225549|454532964|FG007|Period 4 - Washout|Disallowed medication|0|||
126337867|NCT01225549|454532965|FG008|Period 4 - Washout|Disallowed medication|0|||
126337868|NCT01225549|454532966|FG009|Period 4 - Washout|Disallowed medication|0|||
126337869|NCT01225549|454532957|FG000|Period 6 - Washout|Disallowed medication|0|||
126337870|NCT01225549|454532958|FG001|Period 6 - Washout|Disallowed medication|0|||
126337871|NCT01225549|454532959|FG002|Period 6 - Washout|Disallowed medication|0|||
126337872|NCT01225549|454532960|FG003|Period 6 - Washout|Disallowed medication|1|||
126337873|NCT01225549|454532961|FG004|Period 6 - Washout|Disallowed medication|0|||
126337874|NCT01225549|454532962|FG005|Period 6 - Washout|Disallowed medication|0|||
126337875|NCT01225549|454532963|FG006|Period 6 - Washout|Disallowed medication|0|||
126671616|NCT02553265|455757337|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
126671617|NCT02553265|455757338|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
126671618|NCT02553265|455757339|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
126671619|NCT02553265|455757337|FG000|Second Intervention (28 Days)|Adverse Event|1|||
126671620|NCT02553265|455757338|FG001|Second Intervention (28 Days)|Adverse Event|0|||
126671621|NCT02553265|455757339|FG002|Second Intervention (28 Days)|Adverse Event|0|||
126671622|NCT02553265|455757337|FG000|Third Intervention (28 Days)|Adverse Event|1|||
126671623|NCT02553265|455757338|FG001|Third Intervention (28 Days)|Adverse Event|0|||
126671624|NCT02553265|455757339|FG002|Third Intervention (28 Days)|Adverse Event|0|||
126671625|NCT02553265|455757337|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
126671626|NCT02553265|455757338|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
126337876|NCT01225549|454532964|FG007|Period 6 - Washout|Disallowed medication|0|||
126337877|NCT01225549|454532965|FG008|Period 6 - Washout|Disallowed medication|0|||
126337878|NCT01225549|454532966|FG009|Period 6 - Washout|Disallowed medication|0|||
126337879|NCT00891813|454532968|FG000|Overall Study|Adverse Event|3|||
126337880|NCT00891813|454532968|FG000|Overall Study|Withdrawal by Subject|1|||
126337881|NCT00891813|454532968|FG000|Overall Study|Patient Noncompliance|6|||
126337882|NCT00891813|454532968|FG000|Overall Study|Protocol Violation|2|||
126337883|NCT03722576|454532969|FG000|Overall Study|Withdrawal by Subject|3|||
126337884|NCT03722576|454532969|FG000|Overall Study|Adverse Event|2|||
126337885|NCT03722576|454532969|FG000|Overall Study|Physician Decision|1|||
126337886|NCT03722576|454532969|FG000|Overall Study|Lost to Follow-up|1|||
126337887|NCT00192114|454532972|FG000|Overall Study|Objective Tumor Progression|19|||
126337888|NCT00192114|454532972|FG000|Overall Study|Adverse Event|2|||
126337889|NCT00192114|454532972|FG000|Overall Study|Clinical Progression|2|||
126337890|NCT00192114|454532972|FG000|Overall Study|Death|1|||
126337891|NCT00749398|454532973|FG000|Overall Study|Lack of Efficacy|7|||
126337892|NCT00749398|454532973|FG000|Overall Study|Adverse Event|4|||
126337893|NCT00749398|454532973|FG000|Overall Study|Serious adverse event|11|||
126337894|NCT00749398|454532973|FG000|Overall Study|Withdrawal by Subject|17|||
126337895|NCT00749398|454532973|FG000|Overall Study|Lost to Follow-up|11|||
126337896|NCT00749398|454532973|FG000|Overall Study|Reason not specified|2|||
126337897|NCT00749398|454532973|FG000|Overall Study|Unknown reason|1|||
126337898|NCT02718911|454532976|FG000|Overall Study|Adverse Event|0|||
126337899|NCT02718911|454532977|FG001|Overall Study|Adverse Event|0|||
126337900|NCT02718911|454532978|FG002|Overall Study|Adverse Event|0|||
126337901|NCT02718911|454532979|FG003|Overall Study|Adverse Event|0|||
126337902|NCT02718911|454532980|FG004|Overall Study|Adverse Event|0|||
126337903|NCT02718911|454532981|FG005|Overall Study|Adverse Event|0|||
126337904|NCT02718911|454532982|FG006|Overall Study|Adverse Event|0|||
126337905|NCT02718911|454532983|FG007|Overall Study|Adverse Event|0|||
126337906|NCT02718911|454532984|FG008|Overall Study|Adverse Event|0|||
126337907|NCT02718911|454532985|FG009|Overall Study|Adverse Event|2|||
126337908|NCT02718911|454532976|FG000|Overall Study|Death|2|||
126337909|NCT02718911|454532977|FG001|Overall Study|Death|3|||
126337910|NCT02718911|454532978|FG002|Overall Study|Death|1|||
126337911|NCT02718911|454532979|FG003|Overall Study|Death|0|||
126337912|NCT02718911|454532980|FG004|Overall Study|Death|1|||
126337913|NCT02718911|454532981|FG005|Overall Study|Death|3|||
126337914|NCT02718911|454532982|FG006|Overall Study|Death|1|||
126337915|NCT02718911|454532983|FG007|Overall Study|Death|1|||
126337916|NCT02718911|454532984|FG008|Overall Study|Death|4|||
126337917|NCT02718911|454532985|FG009|Overall Study|Death|3|||
126337918|NCT02718911|454532976|FG000|Overall Study|Lost to Follow-up|0|||
126337919|NCT02718911|454532977|FG001|Overall Study|Lost to Follow-up|0|||
126337920|NCT02718911|454532978|FG002|Overall Study|Lost to Follow-up|0|||
126337921|NCT02718911|454532979|FG003|Overall Study|Lost to Follow-up|0|||
126671627|NCT02553265|455757339|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
126671628|NCT02023242|455757340|FG000|Overall Study|Lost to Follow-up|3|||
126671629|NCT02023242|455757341|FG001|Overall Study|Lost to Follow-up|1|||
126671630|NCT02023242|455757340|FG000|Overall Study|Death|0|||
126671631|NCT02023242|455757341|FG001|Overall Study|Death|1|||
126671632|NCT04854434|455757348|FG000|Overall Study|Death|1|||
126671633|NCT04854434|455757349|FG001|Overall Study|Death|3|||
126671634|NCT04854434|455757350|FG002|Overall Study|Death|4|||
126671635|NCT04854434|455757348|FG000|Overall Study|Study Terminated by Sponsor|2|||
126671636|NCT04854434|455757349|FG001|Overall Study|Study Terminated by Sponsor|0|||
126671637|NCT04854434|455757350|FG002|Overall Study|Study Terminated by Sponsor|0|||
126671638|NCT04854434|455757348|FG000|Overall Study|Other|1|||
126671639|NCT04854434|455757349|FG001|Overall Study|Other|1|||
126671640|NCT04854434|455757350|FG002|Overall Study|Other|0|||
126671641|NCT02667275|455757351|FG000|Overall Study|Protocol Violation|11|||
126671642|NCT02667275|455757352|FG001|Overall Study|Protocol Violation|7|||
126671643|NCT02667275|455757351|FG000|Overall Study|Lost to Follow-up|0|||
126671644|NCT02667275|455757352|FG001|Overall Study|Lost to Follow-up|2|||
126671645|NCT02667275|455757351|FG000|Overall Study|Withdrawal by Subject|0|||
126671646|NCT02667275|455757352|FG001|Overall Study|Withdrawal by Subject|5|||
126671647|NCT02667275|455757351|FG000|Overall Study|Discontinued early without completing|0|||
126671648|NCT02667275|455757352|FG001|Overall Study|Discontinued early without completing|1|||
126671649|NCT01274715|455757353|FG000|Overall Study|Lost to Follow-up|1|||
126671650|NCT01274715|455757353|FG000|Overall Study|After consent, met exclusion criteria.|1|||
126671651|NCT01274715|455757353|FG000|Overall Study|After consent, met exclusion criteria.|1|||
126671652|NCT01274715|455757353|FG000|Overall Study|After consent, met exclusion criteria.|1|||
126671653|NCT02285920|455757354|FG000|Overall Study|Kidney transplantation|2|||
126671654|NCT02285920|455757355|FG001|Overall Study|Kidney transplantation|2|||
126671655|NCT02285920|455757356|FG002|Overall Study|Kidney transplantation|2|||
126671656|NCT02285920|455757357|FG003|Overall Study|Kidney transplantation|0|||
126671657|NCT02285920|455757354|FG000|Overall Study|Change to peritoneal dialysis|0|||
126671658|NCT02285920|455757355|FG001|Overall Study|Change to peritoneal dialysis|0|||
126671659|NCT02285920|455757356|FG002|Overall Study|Change to peritoneal dialysis|1|||
126671660|NCT02285920|455757357|FG003|Overall Study|Change to peritoneal dialysis|0|||
126671661|NCT02285920|455757354|FG000|Overall Study|Transfer to non-participating unit|0|||
126671662|NCT02285920|455757355|FG001|Overall Study|Transfer to non-participating unit|1|||
126671663|NCT02285920|455757356|FG002|Overall Study|Transfer to non-participating unit|0|||
126671664|NCT02285920|455757357|FG003|Overall Study|Transfer to non-participating unit|0|||
126671665|NCT02285920|455757354|FG000|Overall Study|Dialysis discontinuation|0|||
126671666|NCT02285920|455757355|FG001|Overall Study|Dialysis discontinuation|1|||
126671667|NCT02285920|455757356|FG002|Overall Study|Dialysis discontinuation|0|||
126671668|NCT02285920|455757357|FG003|Overall Study|Dialysis discontinuation|0|||
126671669|NCT02285920|455757354|FG000|Overall Study|Death|2|||
126671670|NCT02285920|455757355|FG001|Overall Study|Death|0|||
126671671|NCT02285920|455757356|FG002|Overall Study|Death|2|||
126671672|NCT02285920|455757357|FG003|Overall Study|Death|1|||
126671673|NCT05418673|455757358|FG000|Overall Study|Study Terminated by Sponsor|2|||
126671674|NCT05418673|455757359|FG001|Overall Study|Study Terminated by Sponsor|4|||
126671675|NCT05418673|455757358|FG000|Overall Study|Lost to Follow-up|1|||
126671676|NCT05418673|455757359|FG001|Overall Study|Lost to Follow-up|0|||
126671677|NCT02665052|455757362|FG000|Overall Study|Lost to Follow-up|1|||
126671678|NCT02665052|455757363|FG001|Overall Study|Lost to Follow-up|0|||
126671679|NCT02665052|455757364|FG002|Overall Study|Lost to Follow-up|0|||
126671680|NCT02665052|455757365|FG003|Overall Study|Lost to Follow-up|0|||
126337922|NCT02718911|454532980|FG004|Overall Study|Lost to Follow-up|0|||
126337923|NCT02718911|454532981|FG005|Overall Study|Lost to Follow-up|0|||
126337924|NCT02718911|454532982|FG006|Overall Study|Lost to Follow-up|0|||
126337925|NCT02718911|454532983|FG007|Overall Study|Lost to Follow-up|0|||
126337926|NCT02718911|454532984|FG008|Overall Study|Lost to Follow-up|1|||
126337927|NCT02718911|454532985|FG009|Overall Study|Lost to Follow-up|0|||
126337928|NCT02718911|454532976|FG000|Overall Study|Physician Decision|2|||
126337929|NCT02718911|454532977|FG001|Overall Study|Physician Decision|0|||
126337930|NCT02718911|454532978|FG002|Overall Study|Physician Decision|1|||
126337931|NCT02718911|454532979|FG003|Overall Study|Physician Decision|1|||
126337932|NCT02718911|454532980|FG004|Overall Study|Physician Decision|0|||
126671681|NCT02665052|455757362|FG000|Overall Study|Withdrawal by Subject|1|||
126671682|NCT02665052|455757363|FG001|Overall Study|Withdrawal by Subject|1|||
126671683|NCT02665052|455757364|FG002|Overall Study|Withdrawal by Subject|0|||
126671684|NCT02665052|455757365|FG003|Overall Study|Withdrawal by Subject|5|||
126671685|NCT02665052|455757362|FG000|Overall Study|Adverse Event|1|||
126671686|NCT02665052|455757363|FG001|Overall Study|Adverse Event|1|||
126671687|NCT02665052|455757364|FG002|Overall Study|Adverse Event|0|||
126671688|NCT02665052|455757365|FG003|Overall Study|Adverse Event|0|||
126671689|NCT02234284|455757366|FG000|Overall Study|Death|4|||
126671690|NCT02234284|455757367|FG001|Overall Study|Death|2|||
126671691|NCT02234284|455757366|FG000|Overall Study|Withdrawal by Subject|1|||
126671692|NCT02234284|455757367|FG001|Overall Study|Withdrawal by Subject|0|||
126337933|NCT02718911|454532981|FG005|Overall Study|Physician Decision|0|||
126671693|NCT02234284|455757366|FG000|Overall Study|Lost to Follow-up|20|||
126671694|NCT02234284|455757367|FG001|Overall Study|Lost to Follow-up|7|||
126671695|NCT00233363|455757369|FG000|Overall Study|Adverse Event|1|||
126671696|NCT00233363|455757370|FG001|Overall Study|Adverse Event|2|||
126671697|NCT00233363|455757369|FG000|Overall Study|Lack of Efficacy|0|||
126671698|NCT00233363|455757370|FG001|Overall Study|Lack of Efficacy|2|||
126671699|NCT00233363|455757369|FG000|Overall Study|Withdrawal by Subject|1|||
126671700|NCT00233363|455757370|FG001|Overall Study|Withdrawal by Subject|1|||
126671701|NCT00233363|455757369|FG000|Overall Study|Aggravation of complication|1|||
126671702|NCT00233363|455757370|FG001|Overall Study|Aggravation of complication|0|||
126671703|NCT00873366|455757374|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
126671704|NCT00873366|455757374|FG000|Overall Study|Off tamoxifen due to side effects|2|||
126671705|NCT00873366|455757374|FG000|Overall Study|Refused to continue DM-BT testing|3|||
126671706|NCT01576172|455757375|FG000|Overall Study|Ineligible|2|||
126671707|NCT01576172|455757376|FG001|Overall Study|Ineligible|1|||
126671708|NCT01576172|455757375|FG000|Overall Study|Withdrawal by Subject|2|||
126671709|NCT01576172|455757376|FG001|Overall Study|Withdrawal by Subject|0|||
126671710|NCT01576172|455757375|FG000|Overall Study|Insurance issue|1|||
126671711|NCT01576172|455757376|FG001|Overall Study|Insurance issue|0|||
126671712|NCT03199040|455757380|FG000|Overall Study|Lack of Efficacy|2|||
126671713|NCT03199040|455757381|FG001|Overall Study|Lack of Efficacy|0|||
126671714|NCT03199040|455757380|FG000|Overall Study|Withdrawal by Subject|2|||
126671715|NCT03199040|455757381|FG001|Overall Study|Withdrawal by Subject|0|||
126671716|NCT03199040|455757380|FG000|Overall Study|Adverse Event|0|||
126671717|NCT03199040|455757381|FG001|Overall Study|Adverse Event|1|||
126671718|NCT03199040|455757380|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
126671719|NCT03199040|455757381|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
126671720|NCT00199836|455757384|FG000|Overall Study|Progressive Disease|5|||
126671721|NCT00199836|455757384|FG000|Overall Study|Death|1|||
126671722|NCT01708291|455757385|FG000|Overall Study|fighting|2|||
126671723|NCT01708291|455757386|FG001|Overall Study|fighting|1|||
126671724|NCT01843972|455757387|FG000|Overall Study|Withdrawal by Subject|0|||
126671725|NCT01843972|455757388|FG001|Overall Study|Withdrawal by Subject|0|||
126671726|NCT01843972|455757389|FG002|Overall Study|Withdrawal by Subject|0|||
126671727|NCT01843972|455757390|FG003|Overall Study|Withdrawal by Subject|0|||
126671728|NCT01843972|455757391|FG004|Overall Study|Withdrawal by Subject|1|||
126671729|NCT01843972|455757392|FG005|Overall Study|Withdrawal by Subject|0|||
126671730|NCT01843972|455757393|FG006|Overall Study|Withdrawal by Subject|0|||
126671731|NCT01843972|455757394|FG007|Overall Study|Withdrawal by Subject|0|||
126671732|NCT01843972|455757395|FG008|Overall Study|Withdrawal by Subject|0|||
126671733|NCT01843972|455757396|FG009|Overall Study|Withdrawal by Subject|0|||
126671734|NCT00932425|455757400|FG000|Overall Study|Lost to Follow-up|0|||
126671735|NCT00932425|455757401|FG001|Overall Study|Lost to Follow-up|1|||
126671736|NCT00932425|455757400|FG000|Overall Study|Withdrawal by Subject|0|||
126671737|NCT00932425|455757401|FG001|Overall Study|Withdrawal by Subject|1|||
126671738|NCT01854645|455757404|FG000|Overall Study|Protocol-Specified Criteria|13|||
126671739|NCT01854645|455757405|FG001|Overall Study|Protocol-Specified Criteria|10|||
126671740|NCT01854645|455757406|FG002|Overall Study|Protocol-Specified Criteria|8|||
126671741|NCT01854645|455757407|FG003|Overall Study|Protocol-Specified Criteria|5|||
126671742|NCT01854645|455757408|FG004|Overall Study|Protocol-Specified Criteria|7|||
126671743|NCT01854645|455757404|FG000|Overall Study|Administrative Reasons / Missing|0|||
126671744|NCT01854645|455757405|FG001|Overall Study|Administrative Reasons / Missing|0|||
126671745|NCT01854645|455757406|FG002|Overall Study|Administrative Reasons / Missing|0|||
126671746|NCT01854645|455757407|FG003|Overall Study|Administrative Reasons / Missing|1|||
126337934|NCT02718911|454532982|FG006|Overall Study|Physician Decision|0|||
126671747|NCT01854645|455757408|FG004|Overall Study|Administrative Reasons / Missing|1|||
126671748|NCT01854645|455757404|FG000|Overall Study|Protocol Violation|3|||
126671749|NCT01854645|455757405|FG001|Overall Study|Protocol Violation|0|||
126671750|NCT01854645|455757406|FG002|Overall Study|Protocol Violation|5|||
126671751|NCT01854645|455757407|FG003|Overall Study|Protocol Violation|4|||
126671752|NCT01854645|455757408|FG004|Overall Study|Protocol Violation|1|||
126337935|NCT02718911|454532983|FG007|Overall Study|Physician Decision|1|||
126337936|NCT02718911|454532984|FG008|Overall Study|Physician Decision|2|||
126337937|NCT02718911|454532985|FG009|Overall Study|Physician Decision|1|||
126337938|NCT02718911|454532976|FG000|Overall Study|Withdrawal by Subject|0|||
126671753|NCT01854645|455757404|FG000|Overall Study|Lost to Follow-up|10|||
126671754|NCT01854645|455757405|FG001|Overall Study|Lost to Follow-up|7|||
126671755|NCT01854645|455757406|FG002|Overall Study|Lost to Follow-up|8|||
126671756|NCT01854645|455757407|FG003|Overall Study|Lost to Follow-up|5|||
126671757|NCT01854645|455757408|FG004|Overall Study|Lost to Follow-up|0|||
126671758|NCT01854645|455757404|FG000|Overall Study|Physician Decision|1|||
126671759|NCT01854645|455757405|FG001|Overall Study|Physician Decision|5|||
126671760|NCT01854645|455757406|FG002|Overall Study|Physician Decision|3|||
126671761|NCT01854645|455757407|FG003|Overall Study|Physician Decision|3|||
126671762|NCT01854645|455757408|FG004|Overall Study|Physician Decision|7|||
126671763|NCT01854645|455757404|FG000|Overall Study|Withdrawal by Subject|31|||
126671764|NCT01854645|455757405|FG001|Overall Study|Withdrawal by Subject|41|||
126671765|NCT01854645|455757406|FG002|Overall Study|Withdrawal by Subject|30|||
126337939|NCT02718911|454532977|FG001|Overall Study|Withdrawal by Subject|0|||
126337940|NCT02718911|454532978|FG002|Overall Study|Withdrawal by Subject|0|||
126337941|NCT02718911|454532979|FG003|Overall Study|Withdrawal by Subject|0|||
126337942|NCT02718911|454532980|FG004|Overall Study|Withdrawal by Subject|1|||
126337943|NCT02718911|454532981|FG005|Overall Study|Withdrawal by Subject|0|||
126337944|NCT02718911|454532982|FG006|Overall Study|Withdrawal by Subject|0|||
126337945|NCT02718911|454532983|FG007|Overall Study|Withdrawal by Subject|0|||
126337946|NCT02718911|454532984|FG008|Overall Study|Withdrawal by Subject|1|||
126337947|NCT02718911|454532985|FG009|Overall Study|Withdrawal by Subject|4|||
126337948|NCT02718911|454532976|FG000|Overall Study|Reason Not Collected|0|||
126337949|NCT02718911|454532977|FG001|Overall Study|Reason Not Collected|0|||
126337950|NCT02718911|454532978|FG002|Overall Study|Reason Not Collected|1|||
126671766|NCT01854645|455757407|FG003|Overall Study|Withdrawal by Subject|21|||
126671767|NCT01854645|455757408|FG004|Overall Study|Withdrawal by Subject|24|||
126671768|NCT01854645|455757404|FG000|Overall Study|Lack of Efficacy|7|||
126671769|NCT01854645|455757405|FG001|Overall Study|Lack of Efficacy|12|||
126671770|NCT01854645|455757406|FG002|Overall Study|Lack of Efficacy|9|||
126671771|NCT01854645|455757407|FG003|Overall Study|Lack of Efficacy|3|||
126671772|NCT01854645|455757408|FG004|Overall Study|Lack of Efficacy|9|||
126671773|NCT01854645|455757404|FG000|Overall Study|Adverse Event|33|||
126671774|NCT01854645|455757405|FG001|Overall Study|Adverse Event|31|||
126671775|NCT01854645|455757406|FG002|Overall Study|Adverse Event|19|||
126671776|NCT01854645|455757407|FG003|Overall Study|Adverse Event|20|||
126671777|NCT01854645|455757408|FG004|Overall Study|Adverse Event|11|||
126671778|NCT00430482|455757409|FG000|Completed Treatment|Insufficient Treatment|7|||
126671779|NCT00430482|455757410|FG001|Completed Treatment|Insufficient Treatment|11|||
126671780|NCT00555477|455757411|FG000|Overall Study|Adverse Event|0|||
126671781|NCT00555477|455757412|FG001|Overall Study|Adverse Event|9|||
126671782|NCT00555477|455757411|FG000|Overall Study|Withdrawal by Subject|1|||
126671783|NCT00555477|455757412|FG001|Overall Study|Withdrawal by Subject|2|||
126671784|NCT00555477|455757411|FG000|Overall Study|Physician Decision|1|||
126671785|NCT00555477|455757412|FG001|Overall Study|Physician Decision|2|||
126671786|NCT00545402|455757413|FG000|Overall Study|Discontinuation of treatment|17|||
126671787|NCT00545402|455757414|FG001|Overall Study|Discontinuation of treatment|9|||
126671788|NCT00545402|455757413|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
126671789|NCT00545402|455757414|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
126671790|NCT00545402|455757413|FG000|Overall Study|Death|5|||
126671791|NCT00545402|455757414|FG001|Overall Study|Death|7|||
126671792|NCT00545402|455757413|FG000|Overall Study|Graft loss|2|||
126671793|NCT00545402|455757414|FG001|Overall Study|Graft loss|4|||
126671794|NCT00545402|455757413|FG000|Overall Study|Withdrawal by Subject|0|||
126671795|NCT00545402|455757414|FG001|Overall Study|Withdrawal by Subject|1|||
126671796|NCT00545402|455757413|FG000|Overall Study|Protocol Violation|1|||
126671797|NCT00545402|455757414|FG001|Overall Study|Protocol Violation|0|||
126671798|NCT00545402|455757413|FG000|Overall Study|Reason not specified|1|||
126671799|NCT00545402|455757414|FG001|Overall Study|Reason not specified|1|||
126671800|NCT01721876|455757415|FG000|Overall Study|Not treated|1|||
126671801|NCT01721876|455757416|FG001|Overall Study|Not treated|4|||
126671802|NCT01721876|455757415|FG000|Overall Study|Disease progression / relapse|123|||
126671803|NCT01721876|455757416|FG001|Overall Study|Disease progression / relapse|156|||
126671804|NCT01721876|455757415|FG000|Overall Study|Death|6|||
126671805|NCT01721876|455757416|FG001|Overall Study|Death|13|||
126671806|NCT01721876|455757415|FG000|Overall Study|Adverse Event|41|||
126671807|NCT01721876|455757416|FG001|Overall Study|Adverse Event|165|||
126671808|NCT01721876|455757415|FG000|Overall Study|Protocol Violation|2|||
126671809|NCT01721876|455757416|FG001|Overall Study|Protocol Violation|1|||
126671810|NCT01721876|455757415|FG000|Overall Study|Withdrawal by Subject|15|||
126671811|NCT01721876|455757416|FG001|Overall Study|Withdrawal by Subject|38|||
126671812|NCT01721876|455757415|FG000|Overall Study|Reason not listed|34|||
126671813|NCT01721876|455757416|FG001|Overall Study|Reason not listed|63|||
126337951|NCT02718911|454532979|FG003|Overall Study|Reason Not Collected|0|||
126671814|NCT01721876|455757415|FG000|Overall Study|Sponsor terminated trial|0|||
126671815|NCT01721876|455757416|FG001|Overall Study|Sponsor terminated trial|4|||
126671816|NCT01721057|455757419|FG000|Treatment Period|Withdrawal by Subject|11|||
126671817|NCT01721057|455757420|FG001|Treatment Period|Withdrawal by Subject|5|||
126671818|NCT01721057|455757421|FG002|Treatment Period|Withdrawal by Subject|8|||
126671819|NCT01721057|455757422|FG003|Treatment Period|Withdrawal by Subject|0|||
126337952|NCT02718911|454532980|FG004|Overall Study|Reason Not Collected|0|||
126671820|NCT01721057|455757423|FG004|Treatment Period|Withdrawal by Subject|0|||
126671821|NCT01721057|455757424|FG005|Treatment Period|Withdrawal by Subject|0|||
126671822|NCT01721057|455757425|FG006|Treatment Period|Withdrawal by Subject|0|||
126337953|NCT02718911|454532981|FG005|Overall Study|Reason Not Collected|0|||
126671823|NCT01721057|455757419|FG000|Treatment Period|Adverse Event|7|||
126671824|NCT01721057|455757420|FG001|Treatment Period|Adverse Event|10|||
126671825|NCT01721057|455757421|FG002|Treatment Period|Adverse Event|12|||
126671826|NCT01721057|455757422|FG003|Treatment Period|Adverse Event|0|||
126671827|NCT01721057|455757423|FG004|Treatment Period|Adverse Event|0|||
126671828|NCT01721057|455757424|FG005|Treatment Period|Adverse Event|0|||
126671829|NCT01721057|455757425|FG006|Treatment Period|Adverse Event|0|||
126671830|NCT01721057|455757419|FG000|Treatment Period|Lack of Efficacy|7|||
126671831|NCT01721057|455757420|FG001|Treatment Period|Lack of Efficacy|3|||
126671832|NCT01721057|455757421|FG002|Treatment Period|Lack of Efficacy|0|||
126671833|NCT01721057|455757422|FG003|Treatment Period|Lack of Efficacy|0|||
126671834|NCT01721057|455757423|FG004|Treatment Period|Lack of Efficacy|0|||
126671835|NCT01721057|455757424|FG005|Treatment Period|Lack of Efficacy|0|||
126671836|NCT01721057|455757425|FG006|Treatment Period|Lack of Efficacy|0|||
126671837|NCT01721057|455757419|FG000|Treatment Period|Lost to Follow-up|1|||
126671838|NCT01721057|455757420|FG001|Treatment Period|Lost to Follow-up|0|||
126671839|NCT01721057|455757421|FG002|Treatment Period|Lost to Follow-up|0|||
126671840|NCT01721057|455757422|FG003|Treatment Period|Lost to Follow-up|0|||
126671841|NCT01721057|455757423|FG004|Treatment Period|Lost to Follow-up|0|||
126671842|NCT01721057|455757424|FG005|Treatment Period|Lost to Follow-up|0|||
126671843|NCT01721057|455757425|FG006|Treatment Period|Lost to Follow-up|0|||
126671844|NCT01721057|455757419|FG000|Treatment Period|Physician Decision|0|||
126671845|NCT01721057|455757420|FG001|Treatment Period|Physician Decision|1|||
126671846|NCT01721057|455757421|FG002|Treatment Period|Physician Decision|3|||
126671847|NCT01721057|455757422|FG003|Treatment Period|Physician Decision|0|||
126671848|NCT01721057|455757423|FG004|Treatment Period|Physician Decision|0|||
126671849|NCT01721057|455757424|FG005|Treatment Period|Physician Decision|0|||
126671850|NCT01721057|455757425|FG006|Treatment Period|Physician Decision|0|||
126671851|NCT01721057|455757419|FG000|Treatment Period|Death|2|||
126671852|NCT01721057|455757420|FG001|Treatment Period|Death|0|||
126671853|NCT01721057|455757421|FG002|Treatment Period|Death|0|||
126337954|NCT02718911|454532982|FG006|Overall Study|Reason Not Collected|2|||
126337955|NCT02718911|454532983|FG007|Overall Study|Reason Not Collected|1|||
126337956|NCT02718911|454532984|FG008|Overall Study|Reason Not Collected|4|||
126337957|NCT02718911|454532985|FG009|Overall Study|Reason Not Collected|9|||
126337958|NCT01172873|454532988|FG000|Overall Study|Withdrawal by Subject|3|||
126337959|NCT01172873|454532989|FG001|Overall Study|Withdrawal by Subject|2|||
126337960|NCT00983372|454532990|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
126337961|NCT00983372|454532990|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
126337962|NCT00983372|454532990|FG000|Diltiazem ER Alone|Adverse Event|1|||
126337963|NCT00617357|454532997|FG000|Overall Study|Lost to Follow-up|7|||
126337964|NCT00617357|454532997|FG000|Overall Study|Death|5|||
126337965|NCT00617357|454532997|FG000|Overall Study|insurance concerns|2|||
126337966|NCT00617357|454532997|FG000|Overall Study|Withdrawal by Subject|1|||
126337967|NCT00617357|454532997|FG000|Overall Study|Physician Decision|1|||
126337968|NCT01764841|454532998|FG000|Overall Study|Logistical Difficulties|0|||
126337969|NCT01764841|454532999|FG001|Overall Study|Logistical Difficulties|1|||
126337970|NCT01764841|454533000|FG002|Overall Study|Logistical Difficulties|0|||
126337971|NCT01764841|454533001|FG003|Overall Study|Logistical Difficulties|0|||
126337972|NCT01764841|454532998|FG000|Overall Study|Death|3|||
126337973|NCT01764841|454532999|FG001|Overall Study|Death|0|||
126337974|NCT01764841|454533000|FG002|Overall Study|Death|1|||
126337975|NCT01764841|454533001|FG003|Overall Study|Death|4|||
126337976|NCT01764841|454532998|FG000|Overall Study|No Follow Up|1|||
126337977|NCT01764841|454532999|FG001|Overall Study|No Follow Up|0|||
126337978|NCT01764841|454533000|FG002|Overall Study|No Follow Up|1|||
126337979|NCT01764841|454533001|FG003|Overall Study|No Follow Up|0|||
126337980|NCT01764841|454532998|FG000|Overall Study|Protocol Violation|0|||
126337981|NCT01764841|454532999|FG001|Overall Study|Protocol Violation|1|||
126337982|NCT01764841|454533000|FG002|Overall Study|Protocol Violation|0|||
126337983|NCT01764841|454533001|FG003|Overall Study|Protocol Violation|0|||
126337984|NCT01764841|454532998|FG000|Overall Study|Withdrawal by Subject|16|||
126337985|NCT01764841|454532999|FG001|Overall Study|Withdrawal by Subject|24|||
126337986|NCT01764841|454533000|FG002|Overall Study|Withdrawal by Subject|11|||
126337987|NCT01764841|454533001|FG003|Overall Study|Withdrawal by Subject|15|||
126337988|NCT01764841|454532998|FG000|Overall Study|Lost to Follow-up|3|||
126337989|NCT01764841|454532999|FG001|Overall Study|Lost to Follow-up|0|||
126337990|NCT01764841|454533000|FG002|Overall Study|Lost to Follow-up|1|||
126671854|NCT01721057|455757422|FG003|Treatment Period|Death|0|||
126671855|NCT01721057|455757423|FG004|Treatment Period|Death|0|||
126671856|NCT01721057|455757424|FG005|Treatment Period|Death|0|||
126337991|NCT01764841|454533001|FG003|Overall Study|Lost to Follow-up|0|||
126671857|NCT01721057|455757425|FG006|Treatment Period|Death|0|||
126337992|NCT01103323|454533003|FG000|Without/Before Drug Switch|Adverse Event|50|||
126337993|NCT01103323|454533004|FG001|Without/Before Drug Switch|Adverse Event|7|||
126337994|NCT01103323|454533003|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
126337995|NCT01103323|454533004|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
126337996|NCT01103323|454533003|FG000|Without/Before Drug Switch|Protocol Violation|2|||
126671858|NCT01721057|455757419|FG000|Rescue Period|Adverse Event|0|||
126671859|NCT01721057|455757420|FG001|Rescue Period|Adverse Event|0|||
126337997|NCT01103323|454533004|FG001|Without/Before Drug Switch|Protocol Violation|0|||
126671860|NCT01721057|455757421|FG002|Rescue Period|Adverse Event|0|||
126671861|NCT01721057|455757422|FG003|Rescue Period|Adverse Event|1|||
126671862|NCT01721057|455757423|FG004|Rescue Period|Adverse Event|0|||
126671863|NCT01721057|455757424|FG005|Rescue Period|Adverse Event|0|||
126671864|NCT01721057|455757425|FG006|Rescue Period|Adverse Event|0|||
126671865|NCT01721057|455757419|FG000|Rescue Period|Lack of Efficacy|0|||
126671866|NCT01721057|455757420|FG001|Rescue Period|Lack of Efficacy|0|||
126671867|NCT01721057|455757421|FG002|Rescue Period|Lack of Efficacy|0|||
126671868|NCT01721057|455757422|FG003|Rescue Period|Lack of Efficacy|2|||
126671869|NCT01721057|455757423|FG004|Rescue Period|Lack of Efficacy|0|||
126671870|NCT01721057|455757424|FG005|Rescue Period|Lack of Efficacy|0|||
126671871|NCT01721057|455757425|FG006|Rescue Period|Lack of Efficacy|0|||
126671872|NCT01202279|455757426|FG000|Overall Study|Adverse Event|8|||
126671873|NCT01202279|455757427|FG001|Overall Study|Adverse Event|6|||
126671874|NCT01202279|455757426|FG000|Overall Study|Withdrawal by Subject|13|||
126671875|NCT01202279|455757427|FG001|Overall Study|Withdrawal by Subject|10|||
126671876|NCT01202279|455757426|FG000|Overall Study|Physician Decision|0|||
126671877|NCT01202279|455757427|FG001|Overall Study|Physician Decision|1|||
126671878|NCT01202279|455757426|FG000|Overall Study|Lost to Follow-up|10|||
126671879|NCT01202279|455757427|FG001|Overall Study|Lost to Follow-up|7|||
126671880|NCT01202279|455757426|FG000|Overall Study|Protocol Violation|1|||
126671881|NCT01202279|455757427|FG001|Overall Study|Protocol Violation|1|||
126671882|NCT01202279|455757426|FG000|Overall Study|study compliance|5|||
126671883|NCT01202279|455757427|FG001|Overall Study|study compliance|2|||
126671884|NCT02546765|455757430|FG000|Overall Study|Withdrawal by Subject|0|||
126671885|NCT02546765|455757431|FG001|Overall Study|Withdrawal by Subject|1|||
126671886|NCT02546765|455757432|FG002|Overall Study|Withdrawal by Subject|0|||
126671887|NCT02546765|455757433|FG003|Overall Study|Withdrawal by Subject|0|||
126671888|NCT00475722|455757434|FG000|Overall Study|Withdrawal by Subject|12|||
126671889|NCT00475722|455757435|FG001|Overall Study|Withdrawal by Subject|12|||
126671890|NCT00475722|455757434|FG000|Overall Study|Protocol Violation|3|||
126671891|NCT00475722|455757435|FG001|Overall Study|Protocol Violation|0|||
126671892|NCT00916279|455757436|FG000|Overall Study|Death|2|||
126671893|NCT00916279|455757436|FG000|Overall Study|Lost to Follow-up|2|||
126671894|NCT02064920|455757437|FG000|Overall Study|Adverse Event|0|||
126671895|NCT02064920|455757438|FG001|Overall Study|Adverse Event|4|||
126671896|NCT02064920|455757437|FG000|Overall Study|Physician Decision|0|||
126671897|NCT02064920|455757438|FG001|Overall Study|Physician Decision|1|||
126671898|NCT02064920|455757437|FG000|Overall Study|Technical Problems|0|||
126671899|NCT02064920|455757438|FG001|Overall Study|Technical Problems|1|||
126671900|NCT02064920|455757437|FG000|Overall Study|Withdrawal by Subject|1|||
126671901|NCT02064920|455757438|FG001|Overall Study|Withdrawal by Subject|3|||
126337998|NCT01103323|454533003|FG000|Without/Before Drug Switch|Physician Decision|2|||
126337999|NCT01103323|454533004|FG001|Without/Before Drug Switch|Physician Decision|0|||
126338000|NCT01103323|454533003|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
126338001|NCT01103323|454533004|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
126338002|NCT01103323|454533003|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
126338003|NCT01103323|454533004|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
126671902|NCT00310804|455757439|FG000|Overall Study|Lost to Follow-up|2|||
126671903|NCT00310804|455757440|FG001|Overall Study|Lost to Follow-up|0|||
126671904|NCT00310804|455757439|FG000|Overall Study|Withdrawal by Subject|3|||
126671905|NCT00310804|455757440|FG001|Overall Study|Withdrawal by Subject|0|||
126671906|NCT02109562|455757441|FG000|Overall Study|Insufficient clinical response|2|||
126671907|NCT02109562|455757442|FG001|Overall Study|Insufficient clinical response|0|||
126671908|NCT02109562|455757443|FG002|Overall Study|Insufficient clinical response|4|||
126671909|NCT02109562|455757441|FG000|Overall Study|Adverse Event|0|||
126671910|NCT02109562|455757442|FG001|Overall Study|Adverse Event|2|||
126671911|NCT02109562|455757443|FG002|Overall Study|Adverse Event|3|||
126671912|NCT02109562|455757441|FG000|Overall Study|Lost to Follow-up|1|||
126671913|NCT02109562|455757442|FG001|Overall Study|Lost to Follow-up|0|||
126671914|NCT02109562|455757443|FG002|Overall Study|Lost to Follow-up|1|||
126671915|NCT02109562|455757441|FG000|Overall Study|Protocol Violation|0|||
126338004|NCT01103323|454533003|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
126338005|NCT01103323|454533004|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
126671916|NCT02109562|455757442|FG001|Overall Study|Protocol Violation|3|||
126671917|NCT02109562|455757443|FG002|Overall Study|Protocol Violation|1|||
126671918|NCT02109562|455757441|FG000|Overall Study|Withdrawal by Subject|20|||
126671919|NCT02109562|455757442|FG001|Overall Study|Withdrawal by Subject|25|||
126671920|NCT02109562|455757443|FG002|Overall Study|Withdrawal by Subject|21|||
126671921|NCT02109562|455757441|FG000|Overall Study|Physician Decision|3|||
126671922|NCT02109562|455757442|FG001|Overall Study|Physician Decision|4|||
126671923|NCT02109562|455757443|FG002|Overall Study|Physician Decision|5|||
126671924|NCT00688155|455757444|FG000|Overall Study|Withdrawal by Subject|2|||
126671925|NCT00688155|455757445|FG001|Overall Study|Withdrawal by Subject|2|||
126671926|NCT00688155|455757446|FG002|Overall Study|Withdrawal by Subject|1|||
126671927|NCT00688155|455757447|FG003|Overall Study|Withdrawal by Subject|1|||
126671928|NCT01129921|455757452|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
126671929|NCT01129921|455757453|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
126671930|NCT01129921|455757452|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
126671931|NCT01129921|455757453|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
126338006|NCT00732069|454533005|FG000|Washout After First Study Drug|Adverse Event|1|||
126338007|NCT00732069|454533006|FG001|Washout After First Study Drug|Adverse Event|0|||
126338008|NCT00732069|454533007|FG002|Washout After First Study Drug|Adverse Event|0|||
126671932|NCT01129921|455757452|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
126671933|NCT01129921|455757453|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
126671934|NCT01129921|455757452|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
126671935|NCT01129921|455757453|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
126671936|NCT05050318|455758723|FG000|Overall Study|Protocol Deviation|1|||
126671937|NCT05050318|455758724|FG001|Overall Study|Protocol Deviation|0|||
126671938|NCT05050318|455758725|FG002|Overall Study|Protocol Deviation|0|||
126671939|NCT02229539|455758730|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
126671940|NCT02229539|455758731|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
126671941|NCT02229539|455758732|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
126671942|NCT02229539|455758730|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
126671943|NCT02229539|455758731|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
126671944|NCT02229539|455758732|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
126671945|NCT02229539|455758730|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
126671946|NCT02229539|455758731|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
126671947|NCT02229539|455758732|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
126671948|NCT02229539|455758730|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
126671949|NCT02229539|455758731|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
126671950|NCT02229539|455758732|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
126671951|NCT02229539|455758730|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
126671952|NCT02229539|455758731|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
126671953|NCT02229539|455758732|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
126671954|NCT02229539|455758730|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
126671955|NCT02229539|455758731|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
126671956|NCT02229539|455758732|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
126671957|NCT00382720|455758736|FG000|Overall Study|Adverse Event|21|||
126671958|NCT00382720|455758737|FG001|Overall Study|Adverse Event|23|||
126671959|NCT00382720|455758738|FG002|Overall Study|Adverse Event|15|||
126671960|NCT00382720|455758736|FG000|Overall Study|Protocol Violation|2|||
126671961|NCT00382720|455758737|FG001|Overall Study|Protocol Violation|5|||
126671962|NCT00382720|455758738|FG002|Overall Study|Protocol Violation|1|||
126671963|NCT00382720|455758736|FG000|Overall Study|Death|0|||
126671964|NCT00382720|455758737|FG001|Overall Study|Death|1|||
126671965|NCT00382720|455758738|FG002|Overall Study|Death|2|||
126671966|NCT00382720|455758736|FG000|Overall Study|Progressive disease|37|||
126671967|NCT00382720|455758737|FG001|Overall Study|Progressive disease|28|||
126671968|NCT00382720|455758738|FG002|Overall Study|Progressive disease|38|||
126671969|NCT00382720|455758736|FG000|Overall Study|Withdrew consent|1|||
126671970|NCT00382720|455758737|FG001|Overall Study|Withdrew consent|1|||
126671971|NCT00382720|455758738|FG002|Overall Study|Withdrew consent|2|||
126671972|NCT00382720|455758736|FG000|Overall Study|Withdrawal by Subject|11|||
126671973|NCT00382720|455758737|FG001|Overall Study|Withdrawal by Subject|20|||
126671974|NCT00382720|455758738|FG002|Overall Study|Withdrawal by Subject|12|||
126671975|NCT00382720|455758736|FG000|Overall Study|Surgery|1|||
126671976|NCT00382720|455758737|FG001|Overall Study|Surgery|1|||
126671977|NCT00382720|455758738|FG002|Overall Study|Surgery|4|||
126671978|NCT00382720|455758736|FG000|Overall Study|Patient did not receive study medication|1|||
126671979|NCT00382720|455758737|FG001|Overall Study|Patient did not receive study medication|1|||
126671980|NCT00382720|455758738|FG002|Overall Study|Patient did not receive study medication|4|||
126671981|NCT00382720|455758736|FG000|Overall Study|Clinically progressive disease|0|||
126671982|NCT00382720|455758737|FG001|Overall Study|Clinically progressive disease|1|||
126671983|NCT00382720|455758738|FG002|Overall Study|Clinically progressive disease|0|||
126671984|NCT00382720|455758736|FG000|Overall Study|Good prognosis|0|||
126671985|NCT00382720|455758737|FG001|Overall Study|Good prognosis|1|||
126671986|NCT00382720|455758738|FG002|Overall Study|Good prognosis|0|||
126671987|NCT00382720|455758736|FG000|Overall Study|Investigator/Clinical decision|5|||
126671988|NCT00382720|455758737|FG001|Overall Study|Investigator/Clinical decision|6|||
126671989|NCT00382720|455758738|FG002|Overall Study|Investigator/Clinical decision|6|||
126671990|NCT00382720|455758736|FG000|Overall Study|Discontinued at end of study|0|||
126671991|NCT00382720|455758737|FG001|Overall Study|Discontinued at end of study|1|||
126671992|NCT00382720|455758738|FG002|Overall Study|Discontinued at end of study|2|||
126671993|NCT00257166|455758742|FG000|Overall Study|Adverse Event|18|||
126671994|NCT00257166|455758743|FG001|Overall Study|Adverse Event|13|||
126671995|NCT00257166|455758742|FG000|Overall Study|Laboratory abnormality|1|||
126671996|NCT00257166|455758743|FG001|Overall Study|Laboratory abnormality|0|||
126671997|NCT00257166|455758742|FG000|Overall Study|Lost to Follow-up|8|||
126671998|NCT00257166|455758743|FG001|Overall Study|Lost to Follow-up|1|||
126671999|NCT00257166|455758742|FG000|Overall Study|Withdrawal by Subject|9|||
126672000|NCT00257166|455758743|FG001|Overall Study|Withdrawal by Subject|2|||
126672001|NCT00257166|455758742|FG000|Overall Study|Other|16|||
126672002|NCT00257166|455758743|FG001|Overall Study|Other|21|||
126672003|NCT00257166|455758742|FG000|Overall Study|Randomized, but not treated|1|||
126672004|NCT00257166|455758743|FG001|Overall Study|Randomized, but not treated|0|||
126672005|NCT04050670|455758746|FG000|Period 3|Physician Decision|0|||
126672006|NCT04050670|455758747|FG001|Period 3|Physician Decision|1|||
126672007|NCT04050670|455758748|FG002|Period 3|Physician Decision|0|||
126672008|NCT02230254|455758749|FG000|Overall Study|Lost to Follow-up|3|||
126672009|NCT00066742|455758752|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
126672010|NCT00066742|455758752|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
126672011|NCT00066742|455758752|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
126672012|NCT00066742|455758752|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
126672013|NCT00066742|455758752|FG000|Induction Chemoradiotherapy|Ineligible|3|||
126672014|NCT00066742|455758752|FG000|Consolidation Chemotherapy|not protocol specified|1|||
126672015|NCT00066742|455758752|FG000|Consolidation Chemotherapy|Ineligible|2|||
126672016|NCT01994382|455758758|FG000|Overall Study|Informed consent withdrawn|0|||
126672017|NCT01994382|455758759|FG001|Overall Study|Informed consent withdrawn|0|||
126672018|NCT01994382|455758760|FG002|Overall Study|Informed consent withdrawn|0|||
126672019|NCT01994382|455758761|FG003|Overall Study|Informed consent withdrawn|0|||
126672020|NCT01994382|455758762|FG004|Overall Study|Informed consent withdrawn|0|||
126672021|NCT01994382|455758763|FG005|Overall Study|Informed consent withdrawn|0|||
126672022|NCT01994382|455758764|FG006|Overall Study|Informed consent withdrawn|1|||
126672023|NCT01994382|455758765|FG007|Overall Study|Informed consent withdrawn|0|||
126672024|NCT01994382|455758766|FG008|Overall Study|Informed consent withdrawn|0|||
126672025|NCT01994382|455758767|FG009|Overall Study|Informed consent withdrawn|0|||
126672026|NCT01994382|455758768|FG010|Overall Study|Informed consent withdrawn|0|||
126672027|NCT01994382|455758769|FG011|Overall Study|Informed consent withdrawn|0|||
126672028|NCT01994382|455758770|FG012|Overall Study|Informed consent withdrawn|0|||
126672029|NCT01994382|455758771|FG013|Overall Study|Informed consent withdrawn|0|||
126672030|NCT01994382|455758772|FG014|Overall Study|Informed consent withdrawn|0|||
126672031|NCT01994382|455758773|FG015|Overall Study|Informed consent withdrawn|0|||
126672032|NCT01994382|455758774|FG016|Overall Study|Informed consent withdrawn|0|||
126672033|NCT01994382|455758758|FG000|Overall Study|Progressive disease|3|||
126672034|NCT01994382|455758759|FG001|Overall Study|Progressive disease|4|||
126672035|NCT01994382|455758760|FG002|Overall Study|Progressive disease|4|||
126672036|NCT01994382|455758761|FG003|Overall Study|Progressive disease|3|||
126672037|NCT01994382|455758762|FG004|Overall Study|Progressive disease|2|||
126672038|NCT01994382|455758763|FG005|Overall Study|Progressive disease|3|||
126672039|NCT01994382|455758764|FG006|Overall Study|Progressive disease|3|||
126672040|NCT01994382|455758765|FG007|Overall Study|Progressive disease|6|||
126672041|NCT01994382|455758766|FG008|Overall Study|Progressive disease|2|||
126672042|NCT01994382|455758767|FG009|Overall Study|Progressive disease|2|||
126672043|NCT01994382|455758768|FG010|Overall Study|Progressive disease|13|||
126672044|NCT01994382|455758769|FG011|Overall Study|Progressive disease|8|||
126672045|NCT01994382|455758770|FG012|Overall Study|Progressive disease|7|||
126672046|NCT01994382|455758771|FG013|Overall Study|Progressive disease|3|||
126672047|NCT01994382|455758772|FG014|Overall Study|Progressive disease|6|||
126672048|NCT01994382|455758773|FG015|Overall Study|Progressive disease|44|||
126672049|NCT01994382|455758774|FG016|Overall Study|Progressive disease|28|||
126672050|NCT01994382|455758758|FG000|Overall Study|Physician Decision|0|||
126672051|NCT01994382|455758759|FG001|Overall Study|Physician Decision|1|||
126672052|NCT01994382|455758760|FG002|Overall Study|Physician Decision|0|||
126672053|NCT01994382|455758761|FG003|Overall Study|Physician Decision|0|||
126672054|NCT01994382|455758762|FG004|Overall Study|Physician Decision|0|||
126672055|NCT01994382|455758763|FG005|Overall Study|Physician Decision|0|||
126672056|NCT01994382|455758764|FG006|Overall Study|Physician Decision|0|||
126672057|NCT01994382|455758765|FG007|Overall Study|Physician Decision|0|||
126672058|NCT01994382|455758766|FG008|Overall Study|Physician Decision|0|||
126672059|NCT01994382|455758767|FG009|Overall Study|Physician Decision|0|||
126672060|NCT01994382|455758768|FG010|Overall Study|Physician Decision|3|||
126672061|NCT01994382|455758769|FG011|Overall Study|Physician Decision|1|||
126672062|NCT01994382|455758770|FG012|Overall Study|Physician Decision|1|||
126672063|NCT01994382|455758771|FG013|Overall Study|Physician Decision|0|||
126672064|NCT01994382|455758772|FG014|Overall Study|Physician Decision|1|||
126672065|NCT01994382|455758773|FG015|Overall Study|Physician Decision|4|||
126672066|NCT01994382|455758774|FG016|Overall Study|Physician Decision|2|||
126672067|NCT01994382|455758758|FG000|Overall Study|Death|0|||
126672068|NCT01994382|455758759|FG001|Overall Study|Death|0|||
126672069|NCT01994382|455758760|FG002|Overall Study|Death|0|||
126672070|NCT01994382|455758761|FG003|Overall Study|Death|0|||
126672071|NCT01994382|455758762|FG004|Overall Study|Death|1|||
126672072|NCT01994382|455758763|FG005|Overall Study|Death|0|||
126672073|NCT01994382|455758764|FG006|Overall Study|Death|0|||
126672074|NCT01994382|455758765|FG007|Overall Study|Death|0|||
126672075|NCT01994382|455758766|FG008|Overall Study|Death|1|||
126672076|NCT01994382|455758767|FG009|Overall Study|Death|1|||
126672077|NCT01994382|455758768|FG010|Overall Study|Death|0|||
126672078|NCT01994382|455758769|FG011|Overall Study|Death|0|||
126672079|NCT01994382|455758770|FG012|Overall Study|Death|0|||
126672080|NCT01994382|455758771|FG013|Overall Study|Death|0|||
126672081|NCT01994382|455758772|FG014|Overall Study|Death|0|||
126672082|NCT01994382|455758773|FG015|Overall Study|Death|1|||
126672083|NCT01994382|455758774|FG016|Overall Study|Death|0|||
126672084|NCT01994382|455758758|FG000|Overall Study|Adverse Event|0|||
126672085|NCT01994382|455758759|FG001|Overall Study|Adverse Event|1|||
126672086|NCT01994382|455758760|FG002|Overall Study|Adverse Event|2|||
126672087|NCT01994382|455758761|FG003|Overall Study|Adverse Event|0|||
126672088|NCT01994382|455758762|FG004|Overall Study|Adverse Event|0|||
126672089|NCT01994382|455758763|FG005|Overall Study|Adverse Event|0|||
126672090|NCT01994382|455758764|FG006|Overall Study|Adverse Event|0|||
126672091|NCT01994382|455758765|FG007|Overall Study|Adverse Event|0|||
126672092|NCT01994382|455758766|FG008|Overall Study|Adverse Event|0|||
126672093|NCT01994382|455758767|FG009|Overall Study|Adverse Event|0|||
126672094|NCT01994382|455758768|FG010|Overall Study|Adverse Event|15|||
126672095|NCT01994382|455758769|FG011|Overall Study|Adverse Event|2|||
126672096|NCT01994382|455758770|FG012|Overall Study|Adverse Event|7|||
126672097|NCT01994382|455758771|FG013|Overall Study|Adverse Event|3|||
126672098|NCT01994382|455758772|FG014|Overall Study|Adverse Event|17|||
126672099|NCT01994382|455758773|FG015|Overall Study|Adverse Event|6|||
126672100|NCT01994382|455758774|FG016|Overall Study|Adverse Event|3|||
126672101|NCT01994382|455758758|FG000|Overall Study|Other than specified|0|||
126672102|NCT01994382|455758759|FG001|Overall Study|Other than specified|0|||
126672103|NCT01994382|455758760|FG002|Overall Study|Other than specified|0|||
126672104|NCT01994382|455758761|FG003|Overall Study|Other than specified|0|||
126672105|NCT01994382|455758762|FG004|Overall Study|Other than specified|0|||
126672106|NCT01994382|455758763|FG005|Overall Study|Other than specified|0|||
126672107|NCT01994382|455758764|FG006|Overall Study|Other than specified|0|||
126672108|NCT01994382|455758765|FG007|Overall Study|Other than specified|0|||
126672109|NCT01994382|455758766|FG008|Overall Study|Other than specified|0|||
126672110|NCT01994382|455758767|FG009|Overall Study|Other than specified|0|||
126672111|NCT01994382|455758768|FG010|Overall Study|Other than specified|2|||
126672112|NCT01994382|455758769|FG011|Overall Study|Other than specified|0|||
126672113|NCT01994382|455758770|FG012|Overall Study|Other than specified|2|||
126672114|NCT01994382|455758771|FG013|Overall Study|Other than specified|0|||
126672115|NCT01994382|455758772|FG014|Overall Study|Other than specified|0|||
126672116|NCT01994382|455758773|FG015|Overall Study|Other than specified|4|||
126672117|NCT01994382|455758774|FG016|Overall Study|Other than specified|4|||
126672118|NCT01994382|455758758|FG000|Overall Study|Withdrawal by Subject|0|||
126672119|NCT01994382|455758759|FG001|Overall Study|Withdrawal by Subject|0|||
126672120|NCT01994382|455758760|FG002|Overall Study|Withdrawal by Subject|0|||
126672121|NCT01994382|455758761|FG003|Overall Study|Withdrawal by Subject|0|||
126672122|NCT01994382|455758762|FG004|Overall Study|Withdrawal by Subject|0|||
126672123|NCT01994382|455758763|FG005|Overall Study|Withdrawal by Subject|0|||
126672124|NCT01994382|455758764|FG006|Overall Study|Withdrawal by Subject|0|||
126672125|NCT01994382|455758765|FG007|Overall Study|Withdrawal by Subject|0|||
126672126|NCT01994382|455758766|FG008|Overall Study|Withdrawal by Subject|0|||
126672127|NCT01994382|455758767|FG009|Overall Study|Withdrawal by Subject|0|||
126672128|NCT01994382|455758768|FG010|Overall Study|Withdrawal by Subject|6|||
126672129|NCT01994382|455758769|FG011|Overall Study|Withdrawal by Subject|0|||
126672130|NCT01994382|455758770|FG012|Overall Study|Withdrawal by Subject|2|||
126672131|NCT01994382|455758771|FG013|Overall Study|Withdrawal by Subject|0|||
126672132|NCT01994382|455758772|FG014|Overall Study|Withdrawal by Subject|4|||
126672133|NCT01994382|455758773|FG015|Overall Study|Withdrawal by Subject|3|||
126338009|NCT00732069|454533008|FG003|Washout After First Study Drug|Adverse Event|0|||
126672134|NCT01994382|455758774|FG016|Overall Study|Withdrawal by Subject|0|||
126672135|NCT01994382|455758758|FG000|Overall Study|Lost to Follow-up|0|||
126672136|NCT01994382|455758759|FG001|Overall Study|Lost to Follow-up|0|||
126672137|NCT01994382|455758760|FG002|Overall Study|Lost to Follow-up|0|||
126672138|NCT01994382|455758761|FG003|Overall Study|Lost to Follow-up|0|||
126672139|NCT01994382|455758762|FG004|Overall Study|Lost to Follow-up|0|||
126672140|NCT01994382|455758763|FG005|Overall Study|Lost to Follow-up|0|||
126672141|NCT01994382|455758764|FG006|Overall Study|Lost to Follow-up|0|||
126672142|NCT01994382|455758765|FG007|Overall Study|Lost to Follow-up|0|||
126672143|NCT01994382|455758766|FG008|Overall Study|Lost to Follow-up|0|||
126338010|NCT00732069|454533009|FG004|Washout After First Study Drug|Adverse Event|0|||
126338011|NCT00732069|454533010|FG005|Washout After First Study Drug|Adverse Event|0|||
126338012|NCT04460326|454533011|FG000|Completed at Least 4 Meals|Early discharge|5|||
126672144|NCT01994382|455758767|FG009|Overall Study|Lost to Follow-up|0|||
126672145|NCT01994382|455758768|FG010|Overall Study|Lost to Follow-up|1|||
126672146|NCT01994382|455758769|FG011|Overall Study|Lost to Follow-up|0|||
126672147|NCT01994382|455758770|FG012|Overall Study|Lost to Follow-up|0|||
126672148|NCT01994382|455758771|FG013|Overall Study|Lost to Follow-up|0|||
126672149|NCT01994382|455758772|FG014|Overall Study|Lost to Follow-up|0|||
126672150|NCT01994382|455758773|FG015|Overall Study|Lost to Follow-up|0|||
126672151|NCT01994382|455758774|FG016|Overall Study|Lost to Follow-up|0|||
126672152|NCT01994382|455758758|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672153|NCT01994382|455758759|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672154|NCT01994382|455758760|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672155|NCT01994382|455758761|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672156|NCT01994382|455758762|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672157|NCT01994382|455758763|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672158|NCT01994382|455758764|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672159|NCT01994382|455758765|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672160|NCT01994382|455758766|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672161|NCT01994382|455758767|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672162|NCT01994382|455758768|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
126672163|NCT01994382|455758769|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672164|NCT01994382|455758770|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
126672165|NCT01994382|455758771|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672166|NCT01994382|455758772|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
126672167|NCT01994382|455758773|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
126672168|NCT01994382|455758774|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
126672169|NCT01994382|455758758|FG000|Overall Study|Protocol violation/noncompliance|0|||
126672170|NCT01994382|455758759|FG001|Overall Study|Protocol violation/noncompliance|0|||
126672171|NCT01994382|455758760|FG002|Overall Study|Protocol violation/noncompliance|0|||
126672172|NCT01994382|455758761|FG003|Overall Study|Protocol violation/noncompliance|0|||
126672173|NCT01994382|455758762|FG004|Overall Study|Protocol violation/noncompliance|0|||
126672174|NCT01994382|455758763|FG005|Overall Study|Protocol violation/noncompliance|0|||
126672175|NCT01994382|455758764|FG006|Overall Study|Protocol violation/noncompliance|0|||
126672176|NCT01994382|455758765|FG007|Overall Study|Protocol violation/noncompliance|0|||
126672177|NCT01994382|455758766|FG008|Overall Study|Protocol violation/noncompliance|0|||
126672178|NCT01994382|455758767|FG009|Overall Study|Protocol violation/noncompliance|0|||
126672179|NCT01994382|455758768|FG010|Overall Study|Protocol violation/noncompliance|0|||
126672180|NCT01994382|455758769|FG011|Overall Study|Protocol violation/noncompliance|1|||
126672181|NCT01994382|455758770|FG012|Overall Study|Protocol violation/noncompliance|0|||
126672182|NCT01994382|455758771|FG013|Overall Study|Protocol violation/noncompliance|0|||
126672183|NCT01994382|455758772|FG014|Overall Study|Protocol violation/noncompliance|0|||
126672184|NCT01994382|455758773|FG015|Overall Study|Protocol violation/noncompliance|0|||
126672185|NCT01994382|455758774|FG016|Overall Study|Protocol violation/noncompliance|2|||
126672186|NCT01994382|455758758|FG000|Overall Study|Rolled over to Phase 2a|0|||
126672187|NCT01994382|455758759|FG001|Overall Study|Rolled over to Phase 2a|0|||
126672188|NCT01994382|455758760|FG002|Overall Study|Rolled over to Phase 2a|1|||
126672189|NCT01994382|455758761|FG003|Overall Study|Rolled over to Phase 2a|0|||
126672190|NCT01994382|455758762|FG004|Overall Study|Rolled over to Phase 2a|0|||
126672191|NCT01994382|455758763|FG005|Overall Study|Rolled over to Phase 2a|0|||
126672192|NCT01994382|455758764|FG006|Overall Study|Rolled over to Phase 2a|0|||
126672193|NCT01994382|455758765|FG007|Overall Study|Rolled over to Phase 2a|0|||
126672194|NCT01994382|455758766|FG008|Overall Study|Rolled over to Phase 2a|0|||
126672195|NCT01994382|455758767|FG009|Overall Study|Rolled over to Phase 2a|2|||
126672196|NCT01994382|455758768|FG010|Overall Study|Rolled over to Phase 2a|0|||
126672197|NCT01994382|455758769|FG011|Overall Study|Rolled over to Phase 2a|0|||
126672198|NCT01994382|455758770|FG012|Overall Study|Rolled over to Phase 2a|0|||
126672199|NCT01994382|455758771|FG013|Overall Study|Rolled over to Phase 2a|0|||
126672200|NCT01994382|455758772|FG014|Overall Study|Rolled over to Phase 2a|0|||
126672201|NCT01994382|455758773|FG015|Overall Study|Rolled over to Phase 2a|0|||
126672202|NCT01994382|455758774|FG016|Overall Study|Rolled over to Phase 2a|0|||
126672203|NCT01537198|455758783|FG000|Overall Study|RSV infection|2|||
126672204|NCT01537198|455758783|FG000|Overall Study|Adverse Event|4|||
126672205|NCT01537198|455758783|FG000|Overall Study|No Further Visits to the Clinic|37|||
126672206|NCT01537198|455758783|FG000|Overall Study|Other|111|||
126338013|NCT04460326|454533012|FG001|Completed at Least 4 Meals|Early discharge|5|||
126338014|NCT04460326|454533011|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
126338015|NCT04460326|454533012|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
126672207|NCT01231659|455758784|FG000|Overall Study|Adverse Event|9|||
126672208|NCT01231659|455758784|FG000|Overall Study|Disease Progression|48|||
126338016|NCT04460326|454533011|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
126338017|NCT04460326|454533012|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
126672209|NCT01231659|455758784|FG000|Overall Study|Death|2|||
126672210|NCT01231659|455758784|FG000|Overall Study|Patient refused to complete study visit|1|||
126672211|NCT01231659|455758784|FG000|Overall Study|Other protocol defined criteria|12|||
126672212|NCT02247960|455758785|FG000|Patient Consent and Randomization|Physician Decision|2|||
126672213|NCT02247960|455758786|FG001|Patient Consent and Randomization|Physician Decision|2|||
126338018|NCT04460326|454533011|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
126338019|NCT04460326|454533012|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
126338020|NCT04460326|454533011|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
126338021|NCT04460326|454533012|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
126672214|NCT02247960|455758785|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
126672215|NCT02247960|455758786|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
126672216|NCT02247960|455758785|FG000|Catheter Removed|Lost to Follow-up|7|||
126672217|NCT02247960|455758786|FG001|Catheter Removed|Lost to Follow-up|10|||
126672218|NCT01390272|455758787|FG000|Overall Study|Death|3|||
126672219|NCT01390272|455758788|FG001|Overall Study|Death|2|||
126672220|NCT01390272|455758787|FG000|Overall Study|Withdrawal by Subject|9|||
126672221|NCT01390272|455758788|FG001|Overall Study|Withdrawal by Subject|5|||
126672222|NCT01390272|455758787|FG000|Overall Study|Patient moved, no longer eligible|5|||
126672223|NCT01390272|455758788|FG001|Overall Study|Patient moved, no longer eligible|8|||
126672224|NCT03086057|455758790|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
126672225|NCT03086057|455758791|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
126672226|NCT03086057|455758792|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
126672227|NCT03086057|455758793|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
126672228|NCT03086057|455758790|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
126672229|NCT03086057|455758791|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
126672230|NCT03086057|455758792|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
126672231|NCT03086057|455758793|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
126672232|NCT03086057|455758790|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
126672233|NCT03086057|455758791|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
126672234|NCT03086057|455758792|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
126672235|NCT03086057|455758793|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
126672236|NCT03086057|455758790|FG000|Stage 1: PrEP Uptake|Death|1|||
126672237|NCT03086057|455758791|FG001|Stage 1: PrEP Uptake|Death|0|||
126672238|NCT03086057|455758792|FG002|Stage 1: PrEP Uptake|Death|0|||
126672239|NCT03086057|455758793|FG003|Stage 1: PrEP Uptake|Death|0|||
126672240|NCT03086057|455758790|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
126672241|NCT03086057|455758791|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
126672242|NCT03086057|455758792|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
126672243|NCT03086057|455758793|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
126672244|NCT03086057|455758790|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
126672245|NCT03086057|455758791|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
126672246|NCT03086057|455758792|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
126672247|NCT03086057|455758793|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
126672248|NCT03086057|455758790|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
126672249|NCT03086057|455758791|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
126672250|NCT03086057|455758792|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
126672251|NCT03086057|455758793|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
126672252|NCT04305275|455758796|FG000|Overall Study|Adverse Event|4|||
126672253|NCT04305275|455758797|FG001|Overall Study|Adverse Event|0|||
126672254|NCT04305275|455758796|FG000|Overall Study|Lost to Follow-up|1|||
126672255|NCT04305275|455758797|FG001|Overall Study|Lost to Follow-up|1|||
126672256|NCT04305275|455758796|FG000|Overall Study|Withdrawal by Participant|8|||
126672257|NCT04305275|455758797|FG001|Overall Study|Withdrawal by Participant|1|||
126672258|NCT00117598|455758798|FG000|Prior to Treatment Cross Over|Death|40|||
126672259|NCT00117598|455758799|FG001|Prior to Treatment Cross Over|Death|41|||
126672260|NCT00117598|455758800|FG002|Prior to Treatment Cross Over|Death|37|||
126672261|NCT00117598|455758801|FG003|Prior to Treatment Cross Over|Death|0|||
126672262|NCT00117598|455758802|FG004|Prior to Treatment Cross Over|Death|0|||
126672263|NCT00117598|455758798|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
126672264|NCT00117598|455758799|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
126672265|NCT00117598|455758800|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
126672266|NCT00117598|455758801|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
126672267|NCT00117598|455758802|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
126672268|NCT00117598|455758798|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
126672269|NCT00117598|455758799|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
126338022|NCT04460326|454533011|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
126338023|NCT04460326|454533012|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
126672270|NCT00117598|455758800|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
126672271|NCT00117598|455758801|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
126672272|NCT00117598|455758802|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
126338024|NCT00577317|454533013|FG000|Overall Study|Study Terminated|0|||
126338025|NCT00577317|454533014|FG001|Overall Study|Study Terminated|2|||
126338026|NCT03160716|454533015|FG000|Overall Study|Lost to Follow-up|1|||
126338027|NCT04794751|454533017|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
126672273|NCT00117598|455758798|FG000|Prior to Treatment Cross Over|Other|15|||
126672274|NCT00117598|455758799|FG001|Prior to Treatment Cross Over|Other|9|||
126672275|NCT00117598|455758800|FG002|Prior to Treatment Cross Over|Other|9|||
126672276|NCT00117598|455758801|FG003|Prior to Treatment Cross Over|Other|0|||
126672277|NCT00117598|455758802|FG004|Prior to Treatment Cross Over|Other|0|||
126672278|NCT00117598|455758798|FG000|After Treament Cross Over|Death|0|||
126672279|NCT00117598|455758799|FG001|After Treament Cross Over|Death|0|||
126672280|NCT00117598|455758800|FG002|After Treament Cross Over|Death|0|||
126672281|NCT00117598|455758801|FG003|After Treament Cross Over|Death|1|||
126672282|NCT00117598|455758802|FG004|After Treament Cross Over|Death|2|||
126672283|NCT00117598|455758798|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
126672284|NCT00117598|455758799|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
126672285|NCT00117598|455758800|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
126672286|NCT00117598|455758801|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
126672287|NCT00117598|455758802|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
126672288|NCT00117598|455758798|FG000|After Treament Cross Over|Other|0|||
126672289|NCT00117598|455758799|FG001|After Treament Cross Over|Other|0|||
126672290|NCT00117598|455758800|FG002|After Treament Cross Over|Other|0|||
126672291|NCT00117598|455758801|FG003|After Treament Cross Over|Other|1|||
126672292|NCT00117598|455758802|FG004|After Treament Cross Over|Other|2|||
126672293|NCT01536951|455758803|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126672294|NCT01536951|455758804|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126672295|NCT01536951|455758805|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
126672296|NCT01536951|455758806|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126672297|NCT01536951|455758807|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126672298|NCT01536951|455758808|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126672299|NCT01536951|455758809|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126672300|NCT01536951|455758810|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126672301|NCT01536951|455758811|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
126672302|NCT01536951|455758803|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
126672303|NCT01536951|455758804|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
126672304|NCT01536951|455758805|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
126672305|NCT01536951|455758806|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
126672306|NCT01536951|455758807|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
126672307|NCT01536951|455758808|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
126672308|NCT01536951|455758809|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
126672309|NCT01536951|455758810|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
126672310|NCT01536951|455758811|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
126672311|NCT03805750|455758812|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
126672312|NCT03805750|455758813|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
126672313|NCT01177683|455758814|FG000|Study Treatment|Disease Progressions during treatment|2|||
126672314|NCT01177683|455758815|FG001|Study Treatment|Disease Progressions during treatment|0|||
126672315|NCT01177683|455758816|FG002|Study Treatment|Disease Progressions during treatment|3|||
126672316|NCT01177683|455758814|FG000|Study Treatment|Adverse Event|0|||
126672317|NCT01177683|455758815|FG001|Study Treatment|Adverse Event|1|||
126672318|NCT01177683|455758816|FG002|Study Treatment|Adverse Event|12|||
126672319|NCT01177683|455758814|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
126672320|NCT01177683|455758815|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
126672321|NCT01177683|455758816|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
126672322|NCT01177683|455758814|FG000|Study Treatment|Alternative therapy|0|||
126672323|NCT01177683|455758815|FG001|Study Treatment|Alternative therapy|0|||
126672324|NCT01177683|455758816|FG002|Study Treatment|Alternative therapy|4|||
126672325|NCT01177683|455758814|FG000|Study Treatment|Physician Decision|1|||
126672326|NCT01177683|455758815|FG001|Study Treatment|Physician Decision|0|||
126672327|NCT01177683|455758816|FG002|Study Treatment|Physician Decision|1|||
126672328|NCT01177683|455758814|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
126672329|NCT01177683|455758815|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
126672330|NCT01177683|455758816|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
126672331|NCT01177683|455758814|FG000|Study Treatment|Symptomatic Deterioration|0|||
126672332|NCT01177683|455758815|FG001|Study Treatment|Symptomatic Deterioration|0|||
126672333|NCT01177683|455758816|FG002|Study Treatment|Symptomatic Deterioration|1|||
126672334|NCT01177683|455758814|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
126672335|NCT01177683|455758815|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
126672336|NCT01177683|455758816|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
126672337|NCT01177683|455758814|FG000|Follow up|Patient lost to follow up|0|||
126672338|NCT01177683|455758815|FG001|Follow up|Patient lost to follow up|0|||
126672339|NCT01177683|455758816|FG002|Follow up|Patient lost to follow up|2|||
126672340|NCT01177683|455758814|FG000|Follow up|Death|2|||
126672341|NCT01177683|455758815|FG001|Follow up|Death|1|||
126672342|NCT01177683|455758816|FG002|Follow up|Death|7|||
126672343|NCT01177683|455758814|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
126672344|NCT01177683|455758815|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
126672345|NCT01177683|455758816|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
126672346|NCT01889238|455758823|FG000|Overall Study|Death|1|||
126672347|NCT01889238|455758823|FG000|Overall Study|Withdrawal by Subject|1|||
126672348|NCT01889238|455758823|FG000|Overall Study|Adverse Event|6|||
126672349|NCT01889238|455758823|FG000|Overall Study|Disease Progression|104|||
126672350|NCT01889238|455758823|FG000|Overall Study|Other|6|||
126672351|NCT04136184|455758824|FG000|Overall Study|Lost to Follow-up|0|||
126672352|NCT04136184|455758825|FG001|Overall Study|Lost to Follow-up|3|||
126672353|NCT04136184|455758824|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
126672354|NCT04136184|455758825|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
126672355|NCT03318978|455758829|FG000|Overall Study|Withdrawal by Subject|1|||
126672356|NCT02844816|455758830|FG000|Overall Study|No protocol treatment received|5|||
126672357|NCT02844816|455758831|FG001|Overall Study|No protocol treatment received|1|||
126672358|NCT02844816|455758830|FG000|Overall Study|Ineligible|22|||
126672359|NCT02844816|455758831|FG001|Overall Study|Ineligible|15|||
126672360|NCT02844816|455758830|FG000|Overall Study|Participant refusal|5|||
126672361|NCT02844816|455758831|FG001|Overall Study|Participant refusal|5|||
126672362|NCT02844816|455758830|FG000|Overall Study|Adverse Event|5|||
126672363|NCT02844816|455758831|FG001|Overall Study|Adverse Event|4|||
126672364|NCT02844816|455758830|FG000|Overall Study|Death|0|||
126672365|NCT02844816|455758831|FG001|Overall Study|Death|1|||
126672366|NCT02844816|455758830|FG000|Overall Study|Disease progression/recurrence|50|||
126672367|NCT02844816|455758831|FG001|Overall Study|Disease progression/recurrence|24|||
126672368|NCT02844816|455758830|FG000|Overall Study|Physician Decision|1|||
126672369|NCT02844816|455758831|FG001|Overall Study|Physician Decision|1|||
126672370|NCT01200238|455758833|FG000|Overall Study|Adverse Event|2|||
126672371|NCT01200238|455758834|FG001|Overall Study|Adverse Event|1|||
126672372|NCT01200238|455758833|FG000|Overall Study|Progressive Disease|5|||
126672373|NCT01200238|455758834|FG001|Overall Study|Progressive Disease|8|||
126672374|NCT01200238|455758833|FG000|Overall Study|Withdrawal by Subject|0|||
126672375|NCT01200238|455758834|FG001|Overall Study|Withdrawal by Subject|1|||
126672376|NCT02717754|455758835|FG000|Overall Study|Incorrect Infusion Duration|0|||
126672377|NCT02717754|455758836|FG001|Overall Study|Incorrect Infusion Duration|0|||
126672378|NCT02717754|455758837|FG002|Overall Study|Incorrect Infusion Duration|0|||
126672379|NCT02717754|455758838|FG003|Overall Study|Incorrect Infusion Duration|10|||
126672380|NCT02717754|455758839|FG004|Overall Study|Incorrect Infusion Duration|20|||
126672381|NCT02717754|455758840|FG005|Overall Study|Incorrect Infusion Duration|20|||
126672382|NCT03734016|455758842|FG000|Overall Study|Sponsor Ended Study|225|||
126672383|NCT03734016|455758843|FG001|Overall Study|Sponsor Ended Study|200|||
126672384|NCT03734016|455758842|FG000|Overall Study|Death|69|||
126672385|NCT03734016|455758843|FG001|Overall Study|Death|83|||
126672386|NCT03734016|455758842|FG000|Overall Study|Withdrawal by Subject|21|||
126672387|NCT03734016|455758843|FG001|Overall Study|Withdrawal by Subject|27|||
126672388|NCT03734016|455758842|FG000|Overall Study|Physician Decision|1|||
126672389|NCT03734016|455758843|FG001|Overall Study|Physician Decision|12|||
126672390|NCT03734016|455758842|FG000|Overall Study|Lost to Follow-up|6|||
126672391|NCT03734016|455758843|FG001|Overall Study|Lost to Follow-up|2|||
126672392|NCT03734016|455758842|FG000|Overall Study|Miscellaneous|5|||
126672393|NCT03734016|455758843|FG001|Overall Study|Miscellaneous|1|||
126672394|NCT01979835|455758844|FG000|Primary Outcome SA Measurment|failed insertion|18|||
126672395|NCT01979835|455758844|FG000|Follow-up|Lost to Follow-up|32|||
126672396|NCT02592018|455758847|FG000|Overall Study|Adverse Event|1|||
126672397|NCT02592018|455758847|FG000|Overall Study|Lost to Follow-up|1|||
126672398|NCT02710136|455758850|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
126672399|NCT02710136|455758851|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
126672400|NCT00418665|455758852|FG000|Treatment Period|Ineligibility determined|1|||
126672401|NCT00418665|455758853|FG001|Treatment Period|Ineligibility determined|1|||
126672402|NCT00418665|455758854|FG002|Treatment Period|Ineligibility determined|0|||
126672403|NCT00418665|455758852|FG000|Treatment Period|Adverse Event|2|||
126672404|NCT00418665|455758853|FG001|Treatment Period|Adverse Event|2|||
126672405|NCT00418665|455758854|FG002|Treatment Period|Adverse Event|0|||
126672406|NCT00418665|455758852|FG000|Treatment Period|Withdrawal by Subject|0|||
126672407|NCT00418665|455758853|FG001|Treatment Period|Withdrawal by Subject|3|||
126672408|NCT00418665|455758854|FG002|Treatment Period|Withdrawal by Subject|1|||
126672409|NCT00418665|455758852|FG000|Treatment Period|Requirement for alternative therapy|1|||
126672410|NCT00418665|455758853|FG001|Treatment Period|Requirement for alternative therapy|0|||
126672411|NCT00418665|455758854|FG002|Treatment Period|Requirement for alternative therapy|0|||
126672412|NCT00418665|455758852|FG000|Treatment Period|Physician Decision|1|||
126672413|NCT00418665|455758853|FG001|Treatment Period|Physician Decision|0|||
126672414|NCT00418665|455758854|FG002|Treatment Period|Physician Decision|3|||
126672415|NCT00418665|455758852|FG000|Treatment Extension|Adverse Event|1|||
126672416|NCT00418665|455758853|FG001|Treatment Extension|Adverse Event|0|||
126672417|NCT00418665|455758854|FG002|Treatment Extension|Adverse Event|0|||
126672418|NCT00418665|455758852|FG000|Treatment Extension|Withdrawal by Subject|1|||
126672419|NCT00418665|455758853|FG001|Treatment Extension|Withdrawal by Subject|0|||
126672420|NCT00418665|455758854|FG002|Treatment Extension|Withdrawal by Subject|0|||
126672421|NCT00418665|455758852|FG000|Treatment Extension|Requirement for alternative therapy|2|||
126672422|NCT00418665|455758853|FG001|Treatment Extension|Requirement for alternative therapy|2|||
126672423|NCT00418665|455758854|FG002|Treatment Extension|Requirement for alternative therapy|0|||
126672424|NCT00418665|455758852|FG000|Treatment Extension|Physician Decision|2|||
126672425|NCT00418665|455758853|FG001|Treatment Extension|Physician Decision|2|||
126672426|NCT00418665|455758854|FG002|Treatment Extension|Physician Decision|1|||
126672427|NCT00418665|455758852|FG000|Treatment Extension|Death|0|||
126672428|NCT00418665|455758853|FG001|Treatment Extension|Death|0|||
126672429|NCT00418665|455758854|FG002|Treatment Extension|Death|1|||
126672430|NCT01133379|455758857|FG000|Overall Study|Withdrawal by Subject|0|||
126672431|NCT01133379|455758858|FG001|Overall Study|Withdrawal by Subject|1|||
126672432|NCT01133379|455758859|FG002|Overall Study|Withdrawal by Subject|1|||
126672433|NCT01133379|455758857|FG000|Overall Study|Lost to Follow-up|1|||
126338028|NCT04794751|454533018|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
126338029|NCT04794751|454533017|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
126338030|NCT04794751|454533018|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
126338031|NCT04794751|454533017|FG000|Period 1|Protocol Violation|0|||
126338032|NCT04794751|454533018|FG001|Period 1|Protocol Violation|2|||
126338033|NCT04794751|454533017|FG000|Period 1|Withdrawal by Subject|0|||
126672434|NCT01133379|455758858|FG001|Overall Study|Lost to Follow-up|1|||
126672435|NCT01133379|455758859|FG002|Overall Study|Lost to Follow-up|1|||
126672436|NCT00591214|455758862|FG000|Overall Study|Physician Decision|7|||
126672437|NCT00591214|455758862|FG000|Overall Study|Withdrawal by Subject|1|||
126672438|NCT02142738|455760487|FG000|Overall Study|Adverse Event|13|||
126672439|NCT02142738|455760488|FG001|Overall Study|Adverse Event|9|||
126672440|NCT02142738|455760487|FG000|Overall Study|Death|92|||
126672441|NCT02142738|455760488|FG001|Overall Study|Death|112|||
126672442|NCT02142738|455760487|FG000|Overall Study|Lost to Follow-up|0|||
126672443|NCT02142738|455760488|FG001|Overall Study|Lost to Follow-up|3|||
126672444|NCT02142738|455760487|FG000|Overall Study|Withdrawal by Subject|6|||
126672445|NCT02142738|455760488|FG001|Overall Study|Withdrawal by Subject|7|||
126672446|NCT02142738|455760487|FG000|Overall Study|Follow up ended by sponsor|43|||
126672447|NCT02142738|455760488|FG001|Overall Study|Follow up ended by sponsor|20|||
126672448|NCT03688880|455760489|FG000|Overall Study|Withdrawal by Subject|0|||
126672449|NCT03688880|455760490|FG001|Overall Study|Withdrawal by Subject|2|||
126672450|NCT03688880|455760489|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
126672451|NCT03688880|455760490|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
126672452|NCT03688880|455760489|FG000|Overall Study|Lost to Follow-up|4|||
126672453|NCT03688880|455760490|FG001|Overall Study|Lost to Follow-up|7|||
126672454|NCT03688880|455760489|FG000|Overall Study|Adverse Event|0|||
126672455|NCT03688880|455760490|FG001|Overall Study|Adverse Event|2|||
126672456|NCT03688880|455760489|FG000|Overall Study|Device deficiencies|0|||
126672457|NCT03688880|455760490|FG001|Overall Study|Device deficiencies|2|||
126672458|NCT03688880|455760489|FG000|Overall Study|Other|10|||
126672459|NCT03688880|455760490|FG001|Overall Study|Other|16|||
126672460|NCT04490395|455760491|FG000|Overall Study|Lost to Follow-up|0|||
126672461|NCT04490395|455760492|FG001|Overall Study|Lost to Follow-up|1|||
126672462|NCT01942148|455760493|FG000|Overall Study|Adverse Event|4|||
126672463|NCT01942148|455760493|FG000|Overall Study|Lack of Efficacy|2|||
126672464|NCT01942148|455760493|FG000|Overall Study|Physician Decision|11|||
126672465|NCT01942148|455760493|FG000|Overall Study|Protocol Violation|1|||
126672466|NCT01942148|455760493|FG000|Overall Study|Withdrawal by Subject|8|||
126672467|NCT01942148|455760493|FG000|Overall Study|Use of the prohibition medicine|1|||
126672468|NCT00257725|455760495|FG000|Overall Study|Adverse Event|3|||
126672469|NCT01858532|455760496|FG000|Overall Study|Adverse Event|58|||
126672470|NCT01858532|455760497|FG001|Overall Study|Adverse Event|50|||
126672471|NCT01858532|455760498|FG002|Overall Study|Adverse Event|23|||
126672472|NCT01858532|455760499|FG003|Overall Study|Adverse Event|28|||
126672473|NCT01858532|455760496|FG000|Overall Study|Withdrew consent|71|||
126672474|NCT01858532|455760497|FG001|Overall Study|Withdrew consent|93|||
126672475|NCT01858532|455760498|FG002|Overall Study|Withdrew consent|46|||
126672476|NCT01858532|455760499|FG003|Overall Study|Withdrew consent|27|||
126672477|NCT01858532|455760496|FG000|Overall Study|Lost to Follow-up|17|||
126672478|NCT01858532|455760497|FG001|Overall Study|Lost to Follow-up|26|||
126672479|NCT01858532|455760498|FG002|Overall Study|Lost to Follow-up|11|||
126672480|NCT01858532|455760499|FG003|Overall Study|Lost to Follow-up|14|||
126338034|NCT04794751|454533018|FG001|Period 1|Withdrawal by Subject|1|||
126672481|NCT01858532|455760496|FG000|Overall Study|Deterioration of medical status|3|||
126672482|NCT01858532|455760497|FG001|Overall Study|Deterioration of medical status|4|||
126672483|NCT01858532|455760498|FG002|Overall Study|Deterioration of medical status|3|||
126672484|NCT01858532|455760499|FG003|Overall Study|Deterioration of medical status|7|||
126672485|NCT01858532|455760496|FG000|Overall Study|Investigator request|3|||
126672486|NCT01858532|455760497|FG001|Overall Study|Investigator request|4|||
126672487|NCT01858532|455760498|FG002|Overall Study|Investigator request|2|||
126672488|NCT01858532|455760499|FG003|Overall Study|Investigator request|6|||
126672489|NCT01858532|455760496|FG000|Overall Study|Other, not specified|29|||
126672490|NCT01858532|455760497|FG001|Overall Study|Other, not specified|15|||
126672491|NCT01858532|455760498|FG002|Overall Study|Other, not specified|13|||
126672492|NCT01858532|455760499|FG003|Overall Study|Other, not specified|11|||
126672493|NCT00514514|455760500|FG000|Pre-phase|Death|10|||
126672494|NCT00514514|455760501|FG001|Pre-phase|Death|0|||
126672495|NCT00514514|455760502|FG002|Pre-phase|Death|0|||
126672496|NCT00514514|455760500|FG000|Pre-phase|administrative problems|2|||
126672497|NCT00514514|455760501|FG001|Pre-phase|administrative problems|0|||
126672498|NCT00514514|455760502|FG002|Pre-phase|administrative problems|0|||
126672499|NCT00514514|455760500|FG000|Pre-phase|Protocol Violation|6|||
126672500|NCT00514514|455760501|FG001|Pre-phase|Protocol Violation|0|||
126672501|NCT00514514|455760502|FG002|Pre-phase|Protocol Violation|0|||
126672502|NCT00514514|455760500|FG000|Pre-phase|condition no longer requires study drug|7|||
126672503|NCT00514514|455760501|FG001|Pre-phase|condition no longer requires study drug|0|||
126672504|NCT00514514|455760502|FG002|Pre-phase|condition no longer requires study drug|0|||
126672505|NCT00514514|455760500|FG000|Pre-phase|abnormal test procedure results|15|||
126672506|NCT00514514|455760501|FG001|Pre-phase|abnormal test procedure results|0|||
126672507|NCT00514514|455760502|FG002|Pre-phase|abnormal test procedure results|0|||
126672508|NCT00514514|455760500|FG000|Pre-phase|Lost to Follow-up|2|||
126672509|NCT00514514|455760501|FG001|Pre-phase|Lost to Follow-up|0|||
126672510|NCT00514514|455760502|FG002|Pre-phase|Lost to Follow-up|0|||
126672511|NCT00514514|455760500|FG000|Pre-phase|abnormal lab values|23|||
126672512|NCT00514514|455760501|FG001|Pre-phase|abnormal lab values|0|||
126672513|NCT00514514|455760502|FG002|Pre-phase|abnormal lab values|0|||
126672514|NCT00514514|455760500|FG000|Pre-phase|Lack of Efficacy|35|||
126672515|NCT00514514|455760501|FG001|Pre-phase|Lack of Efficacy|0|||
126672516|NCT00514514|455760502|FG002|Pre-phase|Lack of Efficacy|0|||
126672517|NCT00514514|455760500|FG000|Pre-phase|Adverse Event|137|||
126672518|NCT00514514|455760501|FG001|Pre-phase|Adverse Event|0|||
126672519|NCT00514514|455760502|FG002|Pre-phase|Adverse Event|0|||
126672520|NCT00514514|455760500|FG000|Pre-phase|Withdrawal by Subject|66|||
126672521|NCT00514514|455760501|FG001|Pre-phase|Withdrawal by Subject|0|||
126672522|NCT00514514|455760502|FG002|Pre-phase|Withdrawal by Subject|0|||
126672523|NCT00514514|455760500|FG000|Randomized - 9 Month|Death|3|||
126672524|NCT00514514|455760501|FG001|Randomized - 9 Month|Death|2|||
126672525|NCT00514514|455760502|FG002|Randomized - 9 Month|Death|2|||
126672526|NCT00514514|455760500|FG000|Randomized - 9 Month|Administrative problems|1|||
126672527|NCT00514514|455760501|FG001|Randomized - 9 Month|Administrative problems|1|||
126672528|NCT00514514|455760502|FG002|Randomized - 9 Month|Administrative problems|2|||
126672529|NCT00514514|455760500|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
126672530|NCT00514514|455760501|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
126672531|NCT00514514|455760502|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
126672532|NCT00514514|455760500|FG000|Randomized - 9 Month|Protocol Violation|1|||
126672533|NCT00514514|455760501|FG001|Randomized - 9 Month|Protocol Violation|1|||
126672534|NCT00514514|455760502|FG002|Randomized - 9 Month|Protocol Violation|0|||
126672535|NCT00514514|455760500|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
126672536|NCT00514514|455760501|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
126672537|NCT00514514|455760502|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
126338035|NCT04794751|454533017|FG000|Period 2|Withdrawal by Subject|0|||
126338036|NCT04794751|454533018|FG001|Period 2|Withdrawal by Subject|1|||
126338037|NCT04794751|454533017|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
126338038|NCT04794751|454533018|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
126338039|NCT04794751|454533017|FG000|Period 2|Protocol Violation|1|||
126338040|NCT04794751|454533018|FG001|Period 2|Protocol Violation|0|||
126338041|NCT00875810|454533022|FG000|Overall Study|Withdrawal by Subject|1|||
126338042|NCT00875810|454533022|FG000|Overall Study|Physician Decision|3|||
126338043|NCT00875810|454533022|FG000|Overall Study|Lost to Follow-up|39|||
126338044|NCT00875810|454533022|FG000|Overall Study|Patient enroled but not implanted|2|||
126338045|NCT00875810|454533022|FG000|Overall Study|Device explanted|1|||
126338046|NCT00780975|454533025|FG000|Overall Study|Progressive disease|3|||
126338047|NCT00780975|454533025|FG000|Overall Study|Toxicity|5|||
126338048|NCT03044314|454533027|FG000|Overall Study|Physician Decision|2|||
126338049|NCT03044314|454533027|FG000|Overall Study|Withdrawal by Subject|1|||
126338050|NCT03044314|454533027|FG000|Overall Study|Connector tubing not available|1|||
126338051|NCT00969228|454533030|FG000|Overall Study|Adverse Event|1|||
126338052|NCT00969228|454533031|FG001|Overall Study|Adverse Event|0|||
126338053|NCT00969228|454533030|FG000|Overall Study|Withdrawal by Subject|4|||
126338054|NCT00969228|454533031|FG001|Overall Study|Withdrawal by Subject|0|||
126338055|NCT00969228|454533030|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
126338056|NCT00969228|454533031|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
126338057|NCT02563899|454533032|FG000|Overall Study|Protocol Violation|1|||
126338058|NCT02563899|454533033|FG001|Overall Study|Protocol Violation|0|||
126338059|NCT02563899|454533034|FG002|Overall Study|Protocol Violation|0|||
126338060|NCT02563899|454533035|FG003|Overall Study|Protocol Violation|0|||
126338061|NCT02563899|454533032|FG000|Overall Study|Withdrawal by Subject|0|||
126338062|NCT02563899|454533033|FG001|Overall Study|Withdrawal by Subject|0|||
126338063|NCT02563899|454533034|FG002|Overall Study|Withdrawal by Subject|1|||
126672538|NCT00514514|455760500|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
126672539|NCT00514514|455760501|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
126338064|NCT02563899|454533035|FG003|Overall Study|Withdrawal by Subject|0|||
126672540|NCT00514514|455760502|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
126672541|NCT00514514|455760500|FG000|Randomized - 9 Month|Adverse Event|25|||
126338065|NCT00794664|454533041|FG000|Treatment Period|Withdrawal by Subject|0|||
126338066|NCT00794664|454533042|FG001|Treatment Period|Withdrawal by Subject|2|||
126338067|NCT00794664|454533041|FG000|Treatment Period|Protocol non-compliance|0|||
126338068|NCT00794664|454533042|FG001|Treatment Period|Protocol non-compliance|1|||
126338069|NCT00794664|454533041|FG000|Treatment Period|Other|0|||
126338070|NCT00794664|454533042|FG001|Treatment Period|Other|1|||
126338071|NCT00794664|454533041|FG000|Treatment Period|Adverse Event|1|||
126338072|NCT00794664|454533042|FG001|Treatment Period|Adverse Event|8|||
126338073|NCT00794664|454533041|FG000|Follow-up Period|Other|1|||
126338074|NCT00794664|454533042|FG001|Follow-up Period|Other|2|||
126338075|NCT00794664|454533041|FG000|Follow-up Period|Withdrawal by Subject|0|||
126338076|NCT00794664|454533042|FG001|Follow-up Period|Withdrawal by Subject|2|||
126338077|NCT00794664|454533041|FG000|Follow-up Period|Protocol non-compliance|0|||
126338078|NCT00794664|454533042|FG001|Follow-up Period|Protocol non-compliance|1|||
126338079|NCT01305564|454533047|FG000|Overall Study|Death|21|||
126338080|NCT01305564|454533047|FG000|Overall Study|Lost to Follow-up|12|||
126338081|NCT01305564|454533047|FG000|Overall Study|Withdrawal by Subject|1|||
126338082|NCT01305564|454533047|FG000|Overall Study|Physician Decision|3|||
126338083|NCT02370511|454533048|FG000|Overall Study|Death|10|||
126338084|NCT02370511|454533049|FG001|Overall Study|Death|7|||
126338085|NCT02370511|454533050|FG002|Overall Study|Death|1|||
126338086|NCT02370511|454533048|FG000|Overall Study|Withdrawal by Subject|2|||
126338087|NCT02370511|454533049|FG001|Overall Study|Withdrawal by Subject|0|||
126338088|NCT02370511|454533050|FG002|Overall Study|Withdrawal by Subject|0|||
126338089|NCT02370511|454533048|FG000|Overall Study|Lost to Follow-up|0|||
126338090|NCT02370511|454533049|FG001|Overall Study|Lost to Follow-up|4|||
126338091|NCT02370511|454533050|FG002|Overall Study|Lost to Follow-up|0|||
126338092|NCT03882918|454533051|FG000|Overall Study|Study terminated by sponsor|98|||
126338093|NCT03882918|454533051|FG000|Overall Study|Protocol Violation|1|||
126338094|NCT03882918|454533051|FG000|Overall Study|Other|9|||
126338095|NCT03882918|454533051|FG000|Overall Study|Lack of Efficacy|14|||
126338096|NCT03882918|454533051|FG000|Overall Study|Adverse Event|13|||
126338097|NCT03882918|454533051|FG000|Overall Study|Withdrawal by Subject|5|||
126338098|NCT00916578|454534693|FG000|Overall Study|Physician Decision|2|||
126338099|NCT00916578|454534693|FG000|Overall Study|Withdrawal by Subject|3|||
126338100|NCT00916578|454534693|FG000|Overall Study|Insurance Denial|2|||
126338101|NCT00496769|454534696|FG000|Double Blind|>=1 reason assigned per patient|558|||
126338102|NCT00496769|454534697|FG001|Double Blind|>=1 reason assigned per patient|649|||
126338103|NCT00496769|454534698|FG002|Double Blind|>=1 reason assigned per patient|0|||
126338104|NCT00496769|454534696|FG000|Open Label|>=1 reason assigned per patient|0|||
126338105|NCT00496769|454534697|FG001|Open Label|>=1 reason assigned per patient|0|||
126338106|NCT00496769|454534698|FG002|Open Label|>=1 reason assigned per patient|1011|||
126338107|NCT02486692|454534699|FG000|Overall Study|did not login for randomization|4|||
126338108|NCT02486692|454534700|FG001|Overall Study|did not login for randomization|7|||
126338109|NCT02224625|454534703|FG000|Irritation|Adverse Event|6|||
126338110|NCT02224625|454534703|FG000|Sensitization|Adverse Event|55|||
126338111|NCT02812186|454534704|FG000|Period 1|Post randomization screen failure|5|||
126338112|NCT02812186|454534705|FG001|Period 1|Post randomization screen failure|9|||
126338113|NCT02812186|454534704|FG000|Period 1|nonevaluable data sets|6|||
126338114|NCT02812186|454534705|FG001|Period 1|nonevaluable data sets|6|||
126338115|NCT01433159|454534710|FG000|Overall Study|Adverse Event|1|||
126338116|NCT01433159|454534711|FG001|Overall Study|Adverse Event|0|||
126338117|NCT01433159|454534710|FG000|Overall Study|Physician Decision|1|||
126338118|NCT01433159|454534711|FG001|Overall Study|Physician Decision|0|||
126338119|NCT01433159|454534710|FG000|Overall Study|Protocol Violation|0|||
126338120|NCT01433159|454534711|FG001|Overall Study|Protocol Violation|1|||
126338121|NCT01100853|454534712|FG000|Overall Study|Lost to Follow-up|11|||
126338122|NCT01100853|454534713|FG001|Overall Study|Lost to Follow-up|6|||
126338123|NCT01100853|454534712|FG000|Overall Study|Received <4 study injections|10|||
126338124|NCT01100853|454534713|FG001|Overall Study|Received <4 study injections|13|||
126338125|NCT01100853|454534712|FG000|Overall Study|Withdrawal by Subject|6|||
126338126|NCT01100853|454534713|FG001|Overall Study|Withdrawal by Subject|4|||
126338127|NCT01190891|454534714|FG000|Overall Study|Protocol Violation|1|||
126338128|NCT01190891|454534715|FG001|Overall Study|Protocol Violation|0|||
126338129|NCT01190891|454534714|FG000|Overall Study|Withdrawal by Subject|5|||
126338130|NCT01190891|454534715|FG001|Overall Study|Withdrawal by Subject|0|||
126338131|NCT00266708|454534716|FG000|Overall Study|No renal function|1|||
126338132|NCT00266708|454534717|FG001|Overall Study|No renal function|1|||
126338133|NCT00266708|454534716|FG000|Overall Study|Refused biopsy|3|||
126338134|NCT00266708|454534717|FG001|Overall Study|Refused biopsy|6|||
126338135|NCT00266708|454534716|FG000|Overall Study|Asthma|0|||
126338136|NCT00266708|454534717|FG001|Overall Study|Asthma|2|||
126338137|NCT01926028|454534718|FG000|Overall Study|Lost to Follow-up|7|||
126338138|NCT01926028|454534719|FG001|Overall Study|Lost to Follow-up|6|||
126338139|NCT01926028|454534720|FG002|Overall Study|Lost to Follow-up|0|||
126338140|NCT01926028|454534718|FG000|Overall Study|Physician Decision|1|||
126338141|NCT01926028|454534719|FG001|Overall Study|Physician Decision|5|||
126338142|NCT01926028|454534720|FG002|Overall Study|Physician Decision|0|||
126338143|NCT01926028|454534718|FG000|Overall Study|Withdrawal by Subject|9|||
126338144|NCT01926028|454534719|FG001|Overall Study|Withdrawal by Subject|9|||
126338145|NCT01926028|454534720|FG002|Overall Study|Withdrawal by Subject|2|||
126338146|NCT01926028|454534718|FG000|Overall Study|Non compliance or other reasons|4|||
126338147|NCT01926028|454534719|FG001|Overall Study|Non compliance or other reasons|2|||
126338148|NCT01926028|454534720|FG002|Overall Study|Non compliance or other reasons|0|||
126338149|NCT01130272|454534721|FG000|Overall Study|Adverse Event|2|||
126338150|NCT01130272|454534722|FG001|Overall Study|Adverse Event|5|||
126338151|NCT01130272|454534723|FG002|Overall Study|Adverse Event|6|||
126338152|NCT01130272|454534724|FG003|Overall Study|Adverse Event|22|||
126338153|NCT01130272|454534725|FG004|Overall Study|Adverse Event|7|||
126338154|NCT01130272|454534721|FG000|Overall Study|IVRS-confirmed constipation|0|||
126338155|NCT01130272|454534722|FG001|Overall Study|IVRS-confirmed constipation|1|||
126338156|NCT01130272|454534723|FG002|Overall Study|IVRS-confirmed constipation|1|||
126338157|NCT01130272|454534724|FG003|Overall Study|IVRS-confirmed constipation|2|||
126338158|NCT01130272|454534725|FG004|Overall Study|IVRS-confirmed constipation|0|||
126338159|NCT01130272|454534721|FG000|Overall Study|Rescue medications due to diarrhea|3|||
126338160|NCT01130272|454534722|FG001|Overall Study|Rescue medications due to diarrhea|5|||
126338161|NCT01130272|454534723|FG002|Overall Study|Rescue medications due to diarrhea|8|||
126338162|NCT01130272|454534724|FG003|Overall Study|Rescue medications due to diarrhea|8|||
126338163|NCT01130272|454534725|FG004|Overall Study|Rescue medications due to diarrhea|6|||
126338164|NCT01130272|454534721|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
126338165|NCT01130272|454534722|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
126338166|NCT01130272|454534723|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
126338167|NCT01130272|454534724|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
126338168|NCT01130272|454534725|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
126338169|NCT01130272|454534721|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
126338170|NCT01130272|454534722|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
126338171|NCT01130272|454534723|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
126338172|NCT01130272|454534724|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
126338173|NCT01130272|454534725|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
126338174|NCT01130272|454534721|FG000|Overall Study|Protocol Violation|0|||
126338175|NCT01130272|454534722|FG001|Overall Study|Protocol Violation|0|||
126338176|NCT01130272|454534723|FG002|Overall Study|Protocol Violation|3|||
126338177|NCT01130272|454534724|FG003|Overall Study|Protocol Violation|5|||
126338178|NCT01130272|454534725|FG004|Overall Study|Protocol Violation|5|||
126338179|NCT01130272|454534721|FG000|Overall Study|Lost to Follow-up|4|||
126338180|NCT01130272|454534722|FG001|Overall Study|Lost to Follow-up|3|||
126338181|NCT01130272|454534723|FG002|Overall Study|Lost to Follow-up|4|||
126338182|NCT01130272|454534724|FG003|Overall Study|Lost to Follow-up|7|||
126338183|NCT01130272|454534725|FG004|Overall Study|Lost to Follow-up|6|||
126338184|NCT01130272|454534721|FG000|Overall Study|Withdrawal by Subject|4|||
126338185|NCT01130272|454534722|FG001|Overall Study|Withdrawal by Subject|11|||
126338186|NCT01130272|454534723|FG002|Overall Study|Withdrawal by Subject|10|||
126338187|NCT01130272|454534724|FG003|Overall Study|Withdrawal by Subject|9|||
126338188|NCT01130272|454534725|FG004|Overall Study|Withdrawal by Subject|8|||
126338189|NCT01130272|454534721|FG000|Overall Study|Physician Decision|1|||
126338190|NCT01130272|454534722|FG001|Overall Study|Physician Decision|1|||
126338191|NCT01130272|454534723|FG002|Overall Study|Physician Decision|0|||
126338192|NCT01130272|454534724|FG003|Overall Study|Physician Decision|1|||
126338193|NCT01130272|454534725|FG004|Overall Study|Physician Decision|2|||
126338194|NCT01130272|454534721|FG000|Overall Study|Sponsor decision|6|||
126338195|NCT01130272|454534722|FG001|Overall Study|Sponsor decision|15|||
126338196|NCT01130272|454534723|FG002|Overall Study|Sponsor decision|16|||
126338197|NCT01130272|454534724|FG003|Overall Study|Sponsor decision|13|||
126338198|NCT01130272|454534725|FG004|Overall Study|Sponsor decision|16|||
126338199|NCT01130272|454534721|FG000|Overall Study|Study arm discontinued|38|||
126338200|NCT01130272|454534722|FG001|Overall Study|Study arm discontinued|0|||
126338201|NCT01130272|454534723|FG002|Overall Study|Study arm discontinued|0|||
126338202|NCT01130272|454534724|FG003|Overall Study|Study arm discontinued|0|||
126338203|NCT01130272|454534725|FG004|Overall Study|Study arm discontinued|0|||
126338204|NCT01548404|454534726|FG000|Overall Study|Adverse Event|3|||
126338205|NCT01548404|454534727|FG001|Overall Study|Adverse Event|1|||
126338206|NCT01548404|454534726|FG000|Overall Study|Physician Decision|2|||
126338207|NCT01548404|454534727|FG001|Overall Study|Physician Decision|1|||
126338208|NCT01548404|454534726|FG000|Overall Study|Inadequate response to study treatment|23|||
126338209|NCT01548404|454534727|FG001|Overall Study|Inadequate response to study treatment|7|||
126338210|NCT01548404|454534726|FG000|Overall Study|Lost to Follow-up|2|||
126338211|NCT01548404|454534727|FG001|Overall Study|Lost to Follow-up|0|||
126338212|NCT01548404|454534726|FG000|Overall Study|Withdrawal by Subject|0|||
126338213|NCT01548404|454534727|FG001|Overall Study|Withdrawal by Subject|3|||
126338214|NCT01548404|454534726|FG000|Overall Study|Other than specified above|0|||
126338215|NCT01548404|454534727|FG001|Overall Study|Other than specified above|2|||
126338216|NCT00737048|454534728|FG000|Overall Study|Physician Decision|0|||
126338217|NCT00737048|454534729|FG001|Overall Study|Physician Decision|0|||
126338218|NCT00737048|454534730|FG002|Overall Study|Physician Decision|1|||
126338219|NCT00737048|454534728|FG000|Overall Study|Adverse Event|0|||
126338220|NCT00737048|454534729|FG001|Overall Study|Adverse Event|1|||
126338221|NCT00737048|454534730|FG002|Overall Study|Adverse Event|0|||
126338222|NCT00737048|454534728|FG000|Overall Study|Worsening of the symptoms|3|||
126338223|NCT00737048|454534729|FG001|Overall Study|Worsening of the symptoms|5|||
126338224|NCT00737048|454534730|FG002|Overall Study|Worsening of the symptoms|3|||
126338225|NCT00641056|454534731|FG000|Overall Study|Adverse Event|12|||
126338226|NCT00641056|454534732|FG001|Overall Study|Adverse Event|2|||
126338227|NCT00641056|454534731|FG000|Overall Study|Lost to Follow-up|2|||
126338228|NCT00641056|454534732|FG001|Overall Study|Lost to Follow-up|1|||
126338229|NCT00641056|454534731|FG000|Overall Study|Physician Decision|3|||
126338230|NCT00641056|454534732|FG001|Overall Study|Physician Decision|1|||
126338231|NCT00641056|454534731|FG000|Overall Study|Protocol Violation|2|||
126338232|NCT00641056|454534732|FG001|Overall Study|Protocol Violation|0|||
126338233|NCT00641056|454534731|FG000|Overall Study|Entry Criteria Not Met|3|||
126338234|NCT00641056|454534732|FG001|Overall Study|Entry Criteria Not Met|0|||
126338235|NCT00641056|454534731|FG000|Overall Study|Subject Decision|6|||
126338236|NCT00641056|454534732|FG001|Overall Study|Subject Decision|19|||
126338237|NCT00641056|454534731|FG000|Overall Study|Sponsor Decision|1|||
126338238|NCT00641056|454534732|FG001|Overall Study|Sponsor Decision|2|||
126338239|NCT04040439|454534734|FG000|Overall Study|Invalid registration|11|||
126338240|NCT04040439|454534734|FG000|Overall Study|No IC* on publication of study results|2|||
126338241|NCT01309386|454534735|FG000|Overall Study|Other|2|||
126338242|NCT01309386|454534736|FG001|Overall Study|Other|0|||
126338243|NCT01309386|454534735|FG000|Overall Study|Withdrawal by Subject|2|||
126338244|NCT01309386|454534736|FG001|Overall Study|Withdrawal by Subject|0|||
126338245|NCT01309386|454534735|FG000|Overall Study|Progressive disease|9|||
126338246|NCT01309386|454534736|FG001|Overall Study|Progressive disease|11|||
126338247|NCT01309386|454534735|FG000|Overall Study|Physician Decision|1|||
126338248|NCT01309386|454534736|FG001|Overall Study|Physician Decision|1|||
126338249|NCT01309386|454534735|FG000|Overall Study|Lack of Efficacy|3|||
126338250|NCT01309386|454534736|FG001|Overall Study|Lack of Efficacy|1|||
126338251|NCT01309386|454534735|FG000|Overall Study|Adverse Event|5|||
126338252|NCT01309386|454534736|FG001|Overall Study|Adverse Event|8|||
126338253|NCT02062437|454534737|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
126338254|NCT02062437|454534737|FG000|Overall Study|Patient not available for the 2y visit|18|||
126338255|NCT02062437|454534737|FG000|Overall Study|Death|2|||
126338256|NCT02062437|454534737|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
126338257|NCT01674725|454534738|FG000|Overall Study|Adverse Event|1|||
126338258|NCT01674725|454534739|FG001|Overall Study|Adverse Event|0|||
126338259|NCT01674725|454534738|FG000|Overall Study|Did not receive study drug|1|||
126338260|NCT01674725|454534739|FG001|Overall Study|Did not receive study drug|0|||
126338261|NCT01674725|454534738|FG000|Overall Study|Withdrawal by Subject|1|||
126338262|NCT01674725|454534739|FG001|Overall Study|Withdrawal by Subject|0|||
126338263|NCT01674725|454534738|FG000|Overall Study|Lost to Follow-up|0|||
126338264|NCT01674725|454534739|FG001|Overall Study|Lost to Follow-up|1|||
126338265|NCT02900352|454534740|FG000|Overall Study|Lost to Follow-up|28|||
126338266|NCT02900352|454534741|FG001|Overall Study|Lost to Follow-up|17|||
126338267|NCT03074695|454534742|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
126338268|NCT03074695|454534743|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
126338269|NCT03074695|454534742|FG000|Overall Study|Research staff not available|1|||
126338270|NCT03074695|454534743|FG001|Overall Study|Research staff not available|2|||
126338271|NCT03074695|454534742|FG000|Overall Study|Did not receive neuraxial block|2|||
126338272|NCT03074695|454534743|FG001|Overall Study|Did not receive neuraxial block|2|||
126338273|NCT01774981|454534744|FG000|Overall Study|Adverse Event|0|||
126338274|NCT01774981|454534745|FG001|Overall Study|Adverse Event|0|||
126338275|NCT01774981|454534746|FG002|Overall Study|Adverse Event|0|||
126338276|NCT01774981|454534747|FG003|Overall Study|Adverse Event|0|||
126338277|NCT01774981|454534748|FG004|Overall Study|Adverse Event|0|||
126338278|NCT01774981|454534749|FG005|Overall Study|Adverse Event|1|||
126338279|NCT01774981|454534750|FG006|Overall Study|Adverse Event|0|||
126338280|NCT01774981|454534751|FG007|Overall Study|Adverse Event|0|||
126338281|NCT01774981|454534744|FG000|Overall Study|Withdrawal by Subject|0|||
126338282|NCT01774981|454534745|FG001|Overall Study|Withdrawal by Subject|0|||
126338283|NCT01774981|454534746|FG002|Overall Study|Withdrawal by Subject|0|||
126338284|NCT01774981|454534747|FG003|Overall Study|Withdrawal by Subject|0|||
126338285|NCT01774981|454534748|FG004|Overall Study|Withdrawal by Subject|0|||
126338286|NCT01774981|454534749|FG005|Overall Study|Withdrawal by Subject|0|||
126338287|NCT01774981|454534750|FG006|Overall Study|Withdrawal by Subject|0|||
126338288|NCT01774981|454534751|FG007|Overall Study|Withdrawal by Subject|1|||
126338289|NCT01774981|454534744|FG000|Overall Study|Death|0|||
126338290|NCT01774981|454534745|FG001|Overall Study|Death|0|||
126338291|NCT01774981|454534746|FG002|Overall Study|Death|0|||
126338292|NCT01774981|454534747|FG003|Overall Study|Death|0|||
126338293|NCT01774981|454534748|FG004|Overall Study|Death|1|||
126338294|NCT01774981|454534749|FG005|Overall Study|Death|0|||
126338295|NCT01774981|454534750|FG006|Overall Study|Death|0|||
126338296|NCT01774981|454534751|FG007|Overall Study|Death|0|||
126338297|NCT00960193|454534752|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
126338298|NCT01324102|454534753|FG000|Overall Study|illness|1|||
126338299|NCT01324102|454534754|FG001|Overall Study|illness|6|||
126338300|NCT00386334|454534759|FG000|Double Blind Period|Adverse Event|9|||
126338301|NCT00386334|454534760|FG001|Double Blind Period|Adverse Event|14|||
126338302|NCT00386334|454534759|FG000|Double Blind Period|Protocol Violation|1|||
126338303|NCT00386334|454534760|FG001|Double Blind Period|Protocol Violation|1|||
126338304|NCT00386334|454534759|FG000|Double Blind Period|Withdrawal by Subject|9|||
126338305|NCT00386334|454534760|FG001|Double Blind Period|Withdrawal by Subject|13|||
126338306|NCT00386334|454534759|FG000|Double Blind Period|Lack of Efficacy|20|||
126338307|NCT00386334|454534760|FG001|Double Blind Period|Lack of Efficacy|11|||
126338308|NCT00386334|454534759|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
126338309|NCT00386334|454534760|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
126338310|NCT00386334|454534759|FG000|Double Blind Period|Other|3|||
126338311|NCT00386334|454534760|FG001|Double Blind Period|Other|3|||
126338312|NCT00386334|454534759|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
126338313|NCT00386334|454534760|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
126338314|NCT00902577|454534761|FG000|Overall Study|Withdrawal by Subject|6|||
126338315|NCT00902577|454534761|FG000|Overall Study|FMISO production failure|2|||
126338316|NCT00106002|454534762|FG000|Overall Study|Did not take any study drug|1|||
126338317|NCT00106002|454534762|FG000|Overall Study|Ineligible after Registration|1|||
126338318|NCT01245101|454534765|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
126338319|NCT01245101|454534766|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
126338320|NCT01245101|454534765|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
126338321|NCT01245101|454534766|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
126338322|NCT01245101|454534765|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
126338323|NCT01245101|454534766|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
126338324|NCT04456686|454534769|FG000|Overall Study|Adverse Event|2|||
126338325|NCT04456686|454534770|FG001|Overall Study|Adverse Event|1|||
126338326|NCT04456686|454534769|FG000|Overall Study|Lack of Efficacy|3|||
126338327|NCT04456686|454534770|FG001|Overall Study|Lack of Efficacy|1|||
126338328|NCT04456686|454534769|FG000|Overall Study|Withdrew consent|3|||
126338329|NCT04456686|454534770|FG001|Overall Study|Withdrew consent|1|||
126338330|NCT04456686|454534769|FG000|Overall Study|Physician Decision|2|||
126338331|NCT04456686|454534770|FG001|Overall Study|Physician Decision|2|||
126338332|NCT04456686|454534769|FG000|Overall Study|Withdrawal by Subject|5|||
126338333|NCT04456686|454534770|FG001|Overall Study|Withdrawal by Subject|1|||
126338334|NCT04456686|454534769|FG000|Overall Study|Protocol Violation|0|||
126338335|NCT04456686|454534770|FG001|Overall Study|Protocol Violation|1|||
126338336|NCT00473083|454534775|FG000|Overall Study|Adverse Event|1|||
126338337|NCT00473083|454534776|FG001|Overall Study|Adverse Event|0|||
126338338|NCT00473083|454534777|FG002|Overall Study|Adverse Event|0|||
126338339|NCT02915835|454534778|FG000|Overall Study|Physician Decision|1|||
126338340|NCT02915835|454534779|FG001|Overall Study|Physician Decision|0|||
126338341|NCT02915835|454534778|FG000|Overall Study|Withdrawal by Subject|0|||
126338342|NCT02915835|454534779|FG001|Overall Study|Withdrawal by Subject|1|||
126338343|NCT00113607|454534780|FG000|Overall Study|Adverse Event|40|||
126338344|NCT00113607|454534781|FG001|Overall Study|Adverse Event|71|||
126338345|NCT00113607|454534780|FG000|Overall Study|Death|8|||
126338346|NCT00113607|454534781|FG001|Overall Study|Death|8|||
126338347|NCT00113607|454534780|FG000|Overall Study|Withdrawal by Subject|50|||
126338348|NCT00113607|454534781|FG001|Overall Study|Withdrawal by Subject|58|||
126338349|NCT00113607|454534780|FG000|Overall Study|Lost to Follow-up|0|||
126338350|NCT00113607|454534781|FG001|Overall Study|Lost to Follow-up|2|||
126338351|NCT00113607|454534780|FG000|Overall Study|Disease Progression|180|||
126338352|NCT00113607|454534781|FG001|Overall Study|Disease Progression|142|||
126338353|NCT00113607|454534780|FG000|Overall Study|Complete Response (Confirmed)|14|||
126338354|NCT00113607|454534781|FG001|Overall Study|Complete Response (Confirmed)|24|||
126338355|NCT00113607|454534780|FG000|Overall Study|Other|43|||
126338356|NCT00113607|454534781|FG001|Overall Study|Other|32|||
126338357|NCT01222104|454534782|FG000|Overall Study|Lost to Follow-up|37|||
126338358|NCT01222104|454534782|FG000|Overall Study|Death|10|||
126338359|NCT01418339|454534783|FG000|Overall Study|Adverse Event|5|||
126338360|NCT01418339|454534784|FG001|Overall Study|Adverse Event|2|||
126338361|NCT01418339|454534783|FG000|Overall Study|Subject Withdrew Consent|1|||
126338362|NCT01418339|454534784|FG001|Overall Study|Subject Withdrew Consent|2|||
126338363|NCT01418339|454534783|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
126338364|NCT01418339|454534784|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
126338365|NCT03885908|454534785|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
126338366|NCT03885908|454534786|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
126338367|NCT03885908|454534785|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
126338368|NCT03885908|454534786|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
126338369|NCT03885908|454534785|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
126338370|NCT03885908|454534786|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
126338371|NCT03885908|454534785|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
126338372|NCT03885908|454534786|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
126672542|NCT00514514|455760501|FG001|Randomized - 9 Month|Adverse Event|44|||
126338373|NCT00909844|454534787|FG000|Overall Study|Adverse Event|1|||
126338374|NCT00909844|454534787|FG000|Overall Study|Withdrawal by Subject|1|||
126338375|NCT00909844|454534787|FG000|Overall Study|Lost to Follow-up|2|||
126338376|NCT00706004|454534788|FG000|Overall Study|Did not meet eligibility criteria|2|||
126338377|NCT01064479|454534789|FG000|Overall Study|Death|10|||
126338378|NCT01064479|454534790|FG001|Overall Study|Death|11|||
126338379|NCT01064479|454534789|FG000|Overall Study|Withdrawal by Subject|2|||
126338380|NCT01064479|454534790|FG001|Overall Study|Withdrawal by Subject|2|||
126338381|NCT01064479|454534789|FG000|Overall Study|Disease progression|1|||
126338382|NCT01064479|454534790|FG001|Overall Study|Disease progression|1|||
126338383|NCT01064479|454534789|FG000|Overall Study|Toxicity|1|||
126338384|NCT01064479|454534790|FG001|Overall Study|Toxicity|1|||
126338385|NCT01064479|454534789|FG000|Overall Study|Other|1|||
126338386|NCT01064479|454534790|FG001|Overall Study|Other|2|||
126338387|NCT03093181|454534793|FG000|Overall Study|Withdrawal by Subject|2|||
126338388|NCT03093181|454534794|FG001|Overall Study|Withdrawal by Subject|1|||
126338389|NCT03093181|454534795|FG002|Overall Study|Withdrawal by Subject|2|||
126338390|NCT03093181|454534793|FG000|Overall Study|Other (Not specified)|1|||
126338391|NCT03093181|454534794|FG001|Overall Study|Other (Not specified)|0|||
126338392|NCT03093181|454534795|FG002|Overall Study|Other (Not specified)|0|||
126338393|NCT03093181|454534793|FG000|Overall Study|Adverse Event|0|||
126338394|NCT03093181|454534794|FG001|Overall Study|Adverse Event|1|||
126338395|NCT03093181|454534795|FG002|Overall Study|Adverse Event|0|||
126338396|NCT03093181|454534793|FG000|Overall Study|Other (Protocol violation)|0|||
126338397|NCT03093181|454534794|FG001|Overall Study|Other (Protocol violation)|0|||
126338398|NCT03093181|454534795|FG002|Overall Study|Other (Protocol violation)|1|||
126338399|NCT04210986|454534796|FG000|Overall Study|Lost to Follow-up|5|||
126338400|NCT04210986|454534797|FG001|Overall Study|Lost to Follow-up|2|||
126338401|NCT04210986|454534796|FG000|Overall Study|Withdrawal by Subject|3|||
126338402|NCT04210986|454534797|FG001|Overall Study|Withdrawal by Subject|1|||
126338403|NCT04210986|454534796|FG000|Overall Study|Protocol Violation|1|||
126338404|NCT04210986|454534797|FG001|Overall Study|Protocol Violation|1|||
126338405|NCT04210986|454534796|FG000|Overall Study|Physician Decision|0|||
126338406|NCT04210986|454534797|FG001|Overall Study|Physician Decision|1|||
126338407|NCT02378662|454534798|FG000|Overall Study|Early Discontinuation|2|||
126338408|NCT02378662|454534799|FG001|Overall Study|Early Discontinuation|0|||
126338409|NCT01159574|454534800|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
126338410|NCT01159574|454534800|FG000|Treatment Phase|Adverse Event|3|||
126338411|NCT01159574|454534800|FG000|Treatment Phase|Death|6|||
126338412|NCT01159574|454534800|FG000|Treatment Phase|Physician Decision|2|||
126338413|NCT01159574|454534800|FG000|Treatment Phase|Withdrawal by Subject|7|||
126338414|NCT01159574|454534800|FG000|Treatment Phase|still on treatment|2|||
126338415|NCT01159574|454534800|FG000|Follow Up Phase|Lost to Follow-up|2|||
126338416|NCT01159574|454534800|FG000|Follow Up Phase|still being followed for overall surviva|18|||
126338417|NCT02666222|454534802|FG000|Overall Study|Death|2|||
126338418|NCT01474486|454534804|FG000|Overall Study|Death|2|||
126338419|NCT01474486|454534804|FG000|Overall Study|Withdrawal by Subject|4|||
126338420|NCT01474486|454534804|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
126338421|NCT03504917|454534805|FG000|Blinded Treatment Period|Protocol Violation|1|||
126338422|NCT03504917|454534806|FG001|Blinded Treatment Period|Protocol Violation|0|||
126338423|NCT03504917|454534805|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
126338424|NCT03504917|454534806|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
126338425|NCT03504917|454534805|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
126338426|NCT03504917|454534806|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
126338427|NCT03504917|454534805|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
126338428|NCT03504917|454534806|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
126338429|NCT03504917|454534805|FG000|Blinded Treatment Period|Adverse Event|4|||
126338430|NCT03504917|454534806|FG001|Blinded Treatment Period|Adverse Event|4|||
126338431|NCT03504917|454534805|FG000|Blinded Treatment Period|Physician Decision|1|||
126338432|NCT03504917|454534806|FG001|Blinded Treatment Period|Physician Decision|0|||
126338433|NCT03504917|454534805|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
126338434|NCT03504917|454534806|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
126338435|NCT03504917|454534805|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
126338436|NCT03504917|454534806|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
126338437|NCT03504917|454534805|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
126338438|NCT03504917|454534806|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
126338439|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
126338440|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
126338441|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
126338442|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
126338443|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
126338444|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
126338445|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
126338446|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
126338447|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
126338448|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
126338449|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
126338450|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
126338451|NCT03504917|454534805|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
126338452|NCT03504917|454534806|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
126338453|NCT04219189|454534807|FG000|Overall Study|Withdrawal by Subject|1|||
126338454|NCT04219189|454534808|FG001|Overall Study|Withdrawal by Subject|2|||
126338455|NCT04219189|454534807|FG000|Overall Study|Protocol Violation|0|||
126338456|NCT04219189|454534808|FG001|Overall Study|Protocol Violation|1|||
126338457|NCT04219189|454534807|FG000|Overall Study|Lost to Follow-up|0|||
126338458|NCT04219189|454534808|FG001|Overall Study|Lost to Follow-up|1|||
126338459|NCT04219189|454534807|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
126338460|NCT04219189|454534808|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
126338461|NCT03101020|454534809|FG000|Overall Study|Lack of time to participate|1|||
126338462|NCT03101020|454534810|FG001|Overall Study|Lack of time to participate|0|||
126338463|NCT03101020|454534809|FG000|Overall Study|Ran over by a car|0|||
126338464|NCT03101020|454534810|FG001|Overall Study|Ran over by a car|1|||
126338465|NCT03101020|454534809|FG000|Overall Study|Withdrawal by Subject|0|||
126338466|NCT03101020|454534810|FG001|Overall Study|Withdrawal by Subject|2|||
126338467|NCT04233879|454534811|FG000|Overall Study|Death|2|||
126338468|NCT04233879|454534812|FG001|Overall Study|Death|0|||
126338469|NCT04233879|454534811|FG000|Overall Study|Lost to Follow-up|3|||
126338470|NCT04233879|454534812|FG001|Overall Study|Lost to Follow-up|8|||
126338471|NCT04233879|454534811|FG000|Overall Study|Physician Decision|4|||
126338472|NCT04233879|454534812|FG001|Overall Study|Physician Decision|4|||
126338473|NCT04233879|454534811|FG000|Overall Study|Withdrawal by Subject|7|||
126338474|NCT04233879|454534812|FG001|Overall Study|Withdrawal by Subject|10|||
126338475|NCT04233879|454534811|FG000|Overall Study|Other|281|||
126338476|NCT04233879|454534812|FG001|Overall Study|Other|279|||
126338477|NCT03585270|454534815|FG000|Overall Study|Withdrawal by Subject|2|||
126338478|NCT03585270|454534816|FG001|Overall Study|Withdrawal by Subject|6|||
126338479|NCT03585270|454534815|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
126338480|NCT03585270|454534816|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
126338481|NCT03585270|454534815|FG000|Overall Study|Adverse Event|5|||
126338482|NCT03585270|454534816|FG001|Overall Study|Adverse Event|2|||
126338483|NCT03585270|454534815|FG000|Overall Study|Lost to Follow-up|1|||
126338484|NCT03585270|454534816|FG001|Overall Study|Lost to Follow-up|4|||
126338485|NCT03585270|454534815|FG000|Overall Study|Death|5|||
126338486|NCT03585270|454534816|FG001|Overall Study|Death|3|||
126338487|NCT03585270|454534815|FG000|Overall Study|Other reasons|2|||
126338488|NCT03585270|454534816|FG001|Overall Study|Other reasons|2|||
126338489|NCT03292016|454534817|FG000|Second Washout|Adverse Event|0|||
126338490|NCT03292016|454534818|FG001|Second Washout|Adverse Event|1|||
126338491|NCT03292016|454534819|FG002|Second Washout|Adverse Event|0|||
126338492|NCT03292016|454534820|FG003|Second Washout|Adverse Event|0|||
126338493|NCT03292016|454534821|FG004|Second Washout|Adverse Event|0|||
126338494|NCT03292016|454534822|FG005|Second Washout|Adverse Event|0|||
126338495|NCT01791985|454534827|FG000|Overall Study|Adverse Event|7|||
126338496|NCT01791985|454534827|FG000|Overall Study|Withdrawal by Subject|1|||
126338497|NCT00372424|454534828|FG000|Overall Study|Adverse Event|2|||
126338498|NCT00372424|454534828|FG000|Overall Study|Withdrawal by Subject|1|||
126338499|NCT00372424|454534828|FG000|Overall Study|Death|1|||
126338500|NCT00372424|454534828|FG000|Overall Study|Objective Progression or Relapse|14|||
126338501|NCT00372424|454534828|FG000|Overall Study|Other|7|||
126338502|NCT00372424|454534828|FG000|Overall Study|Enrolled, Not Treated|1|||
126338503|NCT00072410|454534829|FG000|Overall Study|Progressive disease|0|||
126338504|NCT00072410|454534830|FG001|Overall Study|Progressive disease|3|||
126338505|NCT02314728|454534836|FG000|Overall Study|Protocol Violation|1|||
126338506|NCT02314728|454534837|FG001|Overall Study|Protocol Violation|0|||
126338507|NCT02314728|454534836|FG000|Overall Study|Lost to Follow-up|0|||
126338508|NCT02314728|454534837|FG001|Overall Study|Lost to Follow-up|1|||
126338509|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
126338510|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
126338511|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
126338512|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
126338513|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
126338514|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
126338515|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
126338516|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
126338517|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
126338518|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
126338519|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
126338520|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
126338521|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
126338522|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
126338523|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
126338524|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
126338525|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
126338526|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
126338527|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
126338528|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
126338529|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
126338530|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
126338531|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
126338532|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
126338533|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
126338534|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
126338535|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
126338536|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
126338537|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
126338538|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
126338539|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
126338540|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
126338541|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
126338542|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
126338543|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
126338544|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
126338545|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
126338546|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
126338547|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
126338548|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
126338549|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
126338550|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
126338551|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
126338552|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
126338553|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
126338554|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
126338555|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
126338556|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
126338557|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
126338558|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
126338559|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
126338560|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
126338561|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
126338562|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
126338563|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
126338564|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
126338565|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
126338566|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
126338567|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
126338568|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
126338569|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
126338570|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
126338571|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
126338572|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
126338573|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
126338574|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
126338575|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
126338576|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
126338577|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
126338578|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
126338579|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
126338580|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
126338581|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
126338582|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
126338583|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
126338584|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
126338585|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
126338586|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
126338587|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
126338588|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
126338589|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
126338590|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
126338591|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
126338592|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
126338593|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
126338594|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
126338595|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
126338596|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
126338597|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
126338598|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
126338599|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
126338600|NCT01791595|454534838|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
126338601|NCT01791595|454534839|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
126338602|NCT01791595|454534840|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
126338603|NCT01791595|454534841|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
126338604|NCT01791595|454534842|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
126338605|NCT01791595|454534843|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
126338606|NCT01791595|454534844|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
126338607|NCT01791595|454534838|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
126338608|NCT01791595|454534839|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
126338609|NCT01791595|454534840|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
126338610|NCT01791595|454534841|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
126338611|NCT01791595|454534842|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
126338612|NCT01791595|454534843|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
126338613|NCT01791595|454534844|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
126338614|NCT01791595|454534838|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
126338615|NCT01791595|454534839|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
126338616|NCT01791595|454534840|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
126338617|NCT01791595|454534841|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
126338618|NCT01791595|454534842|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
126338619|NCT01791595|454534843|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
126338620|NCT01791595|454534844|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
126338621|NCT01791595|454534838|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
126338622|NCT01791595|454534839|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
126338623|NCT01791595|454534840|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
126338624|NCT01791595|454534841|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
126338625|NCT01791595|454534842|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
126338626|NCT01791595|454534843|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
126338627|NCT01791595|454534844|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
126338628|NCT01791595|454534838|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
126338629|NCT01791595|454534839|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
126338630|NCT01791595|454534840|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
126338631|NCT01791595|454534841|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
126338632|NCT01791595|454534842|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
126338633|NCT01791595|454534843|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
126338634|NCT01791595|454534844|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
126338635|NCT03118934|454534845|FG000|Overall Study|Adverse Event|0|||
126338636|NCT03118934|454534846|FG001|Overall Study|Adverse Event|0|||
126338637|NCT03118934|454534847|FG002|Overall Study|Adverse Event|0|||
126338638|NCT03118934|454534848|FG003|Overall Study|Adverse Event|0|||
126338639|NCT03118934|454534849|FG004|Overall Study|Adverse Event|0|||
126338640|NCT03118934|454534850|FG005|Overall Study|Adverse Event|1|||
126338641|NCT03118934|454534845|FG000|Overall Study|Physician Decision|0|||
126338642|NCT03118934|454534846|FG001|Overall Study|Physician Decision|0|||
126338643|NCT03118934|454534847|FG002|Overall Study|Physician Decision|0|||
126338644|NCT03118934|454534848|FG003|Overall Study|Physician Decision|0|||
126338645|NCT03118934|454534849|FG004|Overall Study|Physician Decision|0|||
126338646|NCT03118934|454534850|FG005|Overall Study|Physician Decision|1|||
126338647|NCT03118934|454534845|FG000|Overall Study|Discontinued prior to exposure|0|||
126338648|NCT03118934|454534846|FG001|Overall Study|Discontinued prior to exposure|1|||
126338649|NCT03118934|454534847|FG002|Overall Study|Discontinued prior to exposure|1|||
126338650|NCT03118934|454534848|FG003|Overall Study|Discontinued prior to exposure|1|||
126338651|NCT03118934|454534849|FG004|Overall Study|Discontinued prior to exposure|2|||
126338652|NCT03118934|454534850|FG005|Overall Study|Discontinued prior to exposure|0|||
126338653|NCT01419314|454534855|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
126338654|NCT01419314|454534856|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
126338655|NCT01419314|454534855|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
126338656|NCT01419314|454534856|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
126338657|NCT01419314|454534855|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
126338658|NCT01419314|454534856|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
126338659|NCT01814007|454534861|FG000|Overall Study|Withdrawal by Subject|1|||
126338660|NCT02100124|454534863|FG000|Overall Study|Lost to Follow-up|5|||
126338661|NCT02100124|454534864|FG001|Overall Study|Lost to Follow-up|11|||
126338662|NCT02100124|454534865|FG002|Overall Study|Lost to Follow-up|3|||
126338663|NCT02100124|454534863|FG000|Overall Study|Withdrawal by Subject|1|||
126338664|NCT02100124|454534864|FG001|Overall Study|Withdrawal by Subject|0|||
126338665|NCT02100124|454534865|FG002|Overall Study|Withdrawal by Subject|0|||
126338666|NCT01548599|454536277|FG000|Overall Study|Lost to Follow-up|0|||
126338667|NCT01548599|454536278|FG001|Overall Study|Lost to Follow-up|1|||
126338668|NCT01548599|454536277|FG000|Overall Study|Withdrawal by Subject|4|||
126338669|NCT01548599|454536278|FG001|Overall Study|Withdrawal by Subject|0|||
126338670|NCT01548599|454536277|FG000|Overall Study|Death|2|||
126338671|NCT01548599|454536278|FG001|Overall Study|Death|1|||
126338672|NCT05630196|454536279|FG000|Overall Study|Adverse Event|2|||
126338673|NCT05630196|454536280|FG001|Overall Study|Adverse Event|1|||
126338674|NCT05630196|454536279|FG000|Overall Study|Lost to Follow-up|1|||
126338675|NCT05630196|454536280|FG001|Overall Study|Lost to Follow-up|1|||
126338676|NCT05630196|454536279|FG000|Overall Study|Protocol Violation|2|||
126338677|NCT05630196|454536280|FG001|Overall Study|Protocol Violation|3|||
126338678|NCT05630196|454536279|FG000|Overall Study|Physician Decision|1|||
126338679|NCT05630196|454536280|FG001|Overall Study|Physician Decision|0|||
126338680|NCT05630196|454536279|FG000|Overall Study|Withdrawal by Subject|3|||
126338681|NCT05630196|454536280|FG001|Overall Study|Withdrawal by Subject|4|||
126338682|NCT00352118|454536282|FG000|Overall Study|Physician Decision|4|||
126338683|NCT02308046|454536283|FG000|Overall Study|Negative yeast culture at Baseline|32|||
126338684|NCT02308046|454536284|FG001|Overall Study|Negative yeast culture at Baseline|33|||
126338685|NCT02308046|454536283|FG000|Overall Study|Positive for STD at Baseline|1|||
126338686|NCT02308046|454536284|FG001|Overall Study|Positive for STD at Baseline|2|||
126338687|NCT02308046|454536283|FG000|Overall Study|Lost to Follow-up|1|||
126338688|NCT02308046|454536284|FG001|Overall Study|Lost to Follow-up|3|||
126338689|NCT01587885|454536285|FG000|Treatment Period 1|Failure to Return|0|||
126338690|NCT01587885|454536286|FG001|Treatment Period 1|Failure to Return|1|||
126338691|NCT01587885|454536285|FG000|Treatment Period 1|Protocol Violation|0|||
126338692|NCT01587885|454536286|FG001|Treatment Period 1|Protocol Violation|2|||
126338693|NCT00752089|454536291|FG000|Overall Study|Adverse Event|1|||
126338694|NCT00752089|454536291|FG000|Overall Study|Protocol Deviation|2|||
126338695|NCT00752089|454536291|FG000|Overall Study|Could not attend visit 9|1|||
126338696|NCT00752089|454536291|FG000|Overall Study|Not capable of wearing partial denture|1|||
126338697|NCT00752089|454536291|FG000|Overall Study|Cannot continue the study|1|||
126338698|NCT00001566|454536292|FG000|Overall Study|patients' choice to discontinue protocol|3|||
126338699|NCT00001566|454536292|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
126338700|NCT00001566|454536292|FG000|Overall Study|Death|13|||
126338701|NCT00001566|454536292|FG000|Overall Study|Lost to Follow-up|1|||
126338702|NCT00001566|454536292|FG000|Overall Study|unable to complete initial apheresis|1|||
126338703|NCT02914834|454536293|FG000|Overall Study|Study halted due to COVID|1|||
126338704|NCT02914834|454536294|FG001|Overall Study|Study halted due to COVID|1|||
126338705|NCT02914834|454536293|FG000|Overall Study|1 subject withdrew|0|||
126338706|NCT02914834|454536294|FG001|Overall Study|1 subject withdrew|1|||
126338707|NCT00975416|454536297|FG000|Overall Study|early discharge from tx|3|||
126338708|NCT00975416|454536298|FG001|Overall Study|early discharge from tx|5|||
126338709|NCT01249131|454536303|FG000|Washout Period of 10 Days|Adverse Event|0|||
126338710|NCT01249131|454536304|FG001|Washout Period of 10 Days|Adverse Event|0|||
126338711|NCT01249131|454536305|FG002|Washout Period of 10 Days|Adverse Event|0|||
126338712|NCT01249131|454536306|FG003|Washout Period of 10 Days|Adverse Event|0|||
126338713|NCT01249131|454536307|FG004|Washout Period of 10 Days|Adverse Event|1|||
126338714|NCT01249131|454536308|FG005|Washout Period of 10 Days|Adverse Event|0|||
126338715|NCT03555149|454536313|FG000|Overall Study|Death|18|||
126338716|NCT03555149|454536314|FG001|Overall Study|Death|15|||
126338717|NCT03555149|454536315|FG002|Overall Study|Death|15|||
126338718|NCT03555149|454536316|FG003|Overall Study|Death|4|||
126338719|NCT03555149|454536317|FG004|Overall Study|Death|4|||
126338720|NCT03555149|454536318|FG005|Overall Study|Death|11|||
126338721|NCT03555149|454536319|FG006|Overall Study|Death|12|||
126338722|NCT03555149|454536320|FG007|Overall Study|Death|1|||
126338723|NCT03555149|454536313|FG000|Overall Study|Lost to Follow-up|1|||
126338724|NCT03555149|454536314|FG001|Overall Study|Lost to Follow-up|0|||
126338725|NCT03555149|454536315|FG002|Overall Study|Lost to Follow-up|0|||
126338726|NCT03555149|454536316|FG003|Overall Study|Lost to Follow-up|0|||
126338727|NCT03555149|454536317|FG004|Overall Study|Lost to Follow-up|0|||
126338728|NCT03555149|454536318|FG005|Overall Study|Lost to Follow-up|1|||
126338729|NCT03555149|454536319|FG006|Overall Study|Lost to Follow-up|0|||
126338730|NCT03555149|454536320|FG007|Overall Study|Lost to Follow-up|0|||
126338731|NCT03555149|454536313|FG000|Overall Study|Physician Decision|1|||
126338732|NCT03555149|454536314|FG001|Overall Study|Physician Decision|0|||
126338733|NCT03555149|454536315|FG002|Overall Study|Physician Decision|0|||
126338734|NCT03555149|454536316|FG003|Overall Study|Physician Decision|0|||
126338735|NCT03555149|454536317|FG004|Overall Study|Physician Decision|0|||
126338736|NCT03555149|454536318|FG005|Overall Study|Physician Decision|0|||
126338737|NCT03555149|454536319|FG006|Overall Study|Physician Decision|0|||
126338738|NCT03555149|454536320|FG007|Overall Study|Physician Decision|0|||
126338739|NCT03555149|454536313|FG000|Overall Study|Study Terminated By Sponsor|1|||
126338740|NCT03555149|454536314|FG001|Overall Study|Study Terminated By Sponsor|0|||
126338741|NCT03555149|454536315|FG002|Overall Study|Study Terminated By Sponsor|0|||
126338742|NCT03555149|454536316|FG003|Overall Study|Study Terminated By Sponsor|0|||
126338743|NCT03555149|454536317|FG004|Overall Study|Study Terminated By Sponsor|0|||
126338744|NCT03555149|454536318|FG005|Overall Study|Study Terminated By Sponsor|2|||
126338745|NCT03555149|454536319|FG006|Overall Study|Study Terminated By Sponsor|3|||
126338746|NCT03555149|454536320|FG007|Overall Study|Study Terminated By Sponsor|1|||
126338747|NCT03555149|454536313|FG000|Overall Study|Withdrawal by Subject|3|||
126338748|NCT03555149|454536314|FG001|Overall Study|Withdrawal by Subject|0|||
126338749|NCT03555149|454536315|FG002|Overall Study|Withdrawal by Subject|0|||
126338750|NCT03555149|454536316|FG003|Overall Study|Withdrawal by Subject|2|||
126423996|NCT02222558|454849254|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
126423997|NCT02222558|454849255|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
126423998|NCT02222558|454849256|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
126423999|NCT02222558|454849257|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
126424000|NCT02222558|454849258|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
126424001|NCT02222558|454849259|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
126424002|NCT02222558|454849254|FG000|Period 3|Withdrawal by Subject|0|||
126424003|NCT02222558|454849255|FG001|Period 3|Withdrawal by Subject|0|||
126424004|NCT02222558|454849256|FG002|Period 3|Withdrawal by Subject|0|||
126424005|NCT02222558|454849257|FG003|Period 3|Withdrawal by Subject|0|||
126424006|NCT02222558|454849258|FG004|Period 3|Withdrawal by Subject|0|||
126424007|NCT02222558|454849259|FG005|Period 3|Withdrawal by Subject|1|||
126424008|NCT03400852|454849260|FG000|Blinded Treatment Period|Physician Decision|0|||
126424009|NCT03400852|454849261|FG001|Blinded Treatment Period|Physician Decision|1|||
126424010|NCT03400852|454849262|FG002|Blinded Treatment Period|Physician Decision|0|||
126424011|NCT03400852|454849260|FG000|Blinded Treatment Period|Adverse Event|1|||
126424012|NCT03400852|454849261|FG001|Blinded Treatment Period|Adverse Event|1|||
126424013|NCT03400852|454849262|FG002|Blinded Treatment Period|Adverse Event|0|||
126424014|NCT03400852|454849260|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
126424015|NCT03400852|454849261|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
126424016|NCT03400852|454849262|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
126424017|NCT03400852|454849260|FG000|Open Label Period|Physician Decision|0|||
126424018|NCT03400852|454849261|FG001|Open Label Period|Physician Decision|0|||
126424019|NCT03400852|454849262|FG002|Open Label Period|Physician Decision|1|||
126424020|NCT03400852|454849260|FG000|Open Label Period|Study terminated by sponsor|0|||
126424021|NCT03400852|454849261|FG001|Open Label Period|Study terminated by sponsor|0|||
126338751|NCT03555149|454536317|FG004|Overall Study|Withdrawal by Subject|0|||
126338752|NCT03555149|454536318|FG005|Overall Study|Withdrawal by Subject|1|||
126338753|NCT03555149|454536319|FG006|Overall Study|Withdrawal by Subject|0|||
126338754|NCT03555149|454536320|FG007|Overall Study|Withdrawal by Subject|0|||
126338755|NCT03863353|454536324|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
126338756|NCT03863353|454536325|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
126338757|NCT05817669|454536326|FG000|Overall Study|Prohibited medication used|1|||
126338758|NCT05817669|454536327|FG001|Overall Study|Prohibited medication used|2|||
126338759|NCT05817669|454536326|FG000|Overall Study|Adverse Event|1|||
126338760|NCT05817669|454536327|FG001|Overall Study|Adverse Event|0|||
126338761|NCT05817669|454536326|FG000|Overall Study|Withdrawal by Subject|1|||
126338762|NCT05817669|454536327|FG001|Overall Study|Withdrawal by Subject|2|||
126424022|NCT03400852|454849262|FG002|Open Label Period|Study terminated by sponsor|21|||
126338763|NCT03810183|454536328|FG000|Overall Study|Study terminated by Sponsor|2|||
126338764|NCT03810183|454536329|FG001|Overall Study|Study terminated by Sponsor|1|||
126338765|NCT00323063|454536331|FG000|Overall Study|Adverse Event|1|||
126338766|NCT00323063|454536332|FG001|Overall Study|Adverse Event|0|||
126338767|NCT00323063|454536331|FG000|Overall Study|brain mets discovered prior to treatment|1|||
126338768|NCT00323063|454536332|FG001|Overall Study|brain mets discovered prior to treatment|0|||
126338769|NCT03786380|454536333|FG000|Overall Study|Adverse Event|1|||
126338770|NCT03786380|454536334|FG001|Overall Study|Adverse Event|0|||
126338771|NCT03786380|454536335|FG002|Overall Study|Adverse Event|0|||
126338772|NCT03786380|454536336|FG003|Overall Study|Adverse Event|3|||
126338773|NCT03786380|454536337|FG004|Overall Study|Adverse Event|1|||
126338774|NCT03786380|454536333|FG000|Overall Study|Lack of Efficacy|0|||
126338775|NCT03786380|454536334|FG001|Overall Study|Lack of Efficacy|0|||
126338776|NCT03786380|454536335|FG002|Overall Study|Lack of Efficacy|0|||
126338777|NCT03786380|454536336|FG003|Overall Study|Lack of Efficacy|0|||
126338778|NCT03786380|454536337|FG004|Overall Study|Lack of Efficacy|1|||
126338779|NCT03786380|454536333|FG000|Overall Study|Withdrawal by Subject|1|||
126338780|NCT03786380|454536334|FG001|Overall Study|Withdrawal by Subject|2|||
126338781|NCT03786380|454536335|FG002|Overall Study|Withdrawal by Subject|2|||
126338782|NCT03786380|454536336|FG003|Overall Study|Withdrawal by Subject|1|||
126338783|NCT03786380|454536337|FG004|Overall Study|Withdrawal by Subject|2|||
126338784|NCT03786380|454536333|FG000|Overall Study|Lost to Follow-up|3|||
126338785|NCT03786380|454536334|FG001|Overall Study|Lost to Follow-up|0|||
126338786|NCT03786380|454536335|FG002|Overall Study|Lost to Follow-up|1|||
126338787|NCT03786380|454536336|FG003|Overall Study|Lost to Follow-up|2|||
126338788|NCT03786380|454536337|FG004|Overall Study|Lost to Follow-up|0|||
126338789|NCT03786380|454536333|FG000|Overall Study|Physician Decision|0|||
126338790|NCT03786380|454536334|FG001|Overall Study|Physician Decision|0|||
126338791|NCT03786380|454536335|FG002|Overall Study|Physician Decision|1|||
126338792|NCT03786380|454536336|FG003|Overall Study|Physician Decision|0|||
126338793|NCT03786380|454536337|FG004|Overall Study|Physician Decision|0|||
126338794|NCT03786380|454536333|FG000|Overall Study|Study Terminated by the Sponsor|30|||
126338795|NCT03786380|454536334|FG001|Overall Study|Study Terminated by the Sponsor|20|||
126338796|NCT03786380|454536335|FG002|Overall Study|Study Terminated by the Sponsor|50|||
126338797|NCT03786380|454536336|FG003|Overall Study|Study Terminated by the Sponsor|57|||
126338798|NCT03786380|454536337|FG004|Overall Study|Study Terminated by the Sponsor|23|||
126338799|NCT03786380|454536333|FG000|Overall Study|Reason Not Specified|0|||
126338800|NCT03786380|454536334|FG001|Overall Study|Reason Not Specified|0|||
126338801|NCT03786380|454536335|FG002|Overall Study|Reason Not Specified|0|||
126338802|NCT03786380|454536336|FG003|Overall Study|Reason Not Specified|0|||
126338803|NCT03786380|454536337|FG004|Overall Study|Reason Not Specified|1|||
126338804|NCT01664091|454536338|FG000|Overall Study|Death|1|||
126338805|NCT01664091|454536338|FG000|Overall Study|Disease Progression|2|||
126338806|NCT01664091|454536338|FG000|Overall Study|Lost to Follow-up|2|||
126338807|NCT01664091|454536338|FG000|Overall Study|Withdrawal by Subject|1|||
126338808|NCT01038687|454536339|FG000|Overall Study|Adverse Event|0|||
126338809|NCT01038687|454536340|FG001|Overall Study|Adverse Event|2|||
126338810|NCT01038687|454536341|FG002|Overall Study|Adverse Event|1|||
126338811|NCT01076543|454536343|FG000|Overall Study|Withdrawal by Subject|2|||
126338812|NCT01076543|454536344|FG001|Overall Study|Withdrawal by Subject|0|||
126338813|NCT01076543|454536345|FG002|Overall Study|Withdrawal by Subject|0|||
126338814|NCT01076543|454536346|FG003|Overall Study|Withdrawal by Subject|0|||
126338815|NCT01076543|454536347|FG004|Overall Study|Withdrawal by Subject|0|||
126338816|NCT01076543|454536348|FG005|Overall Study|Withdrawal by Subject|0|||
126338817|NCT00338741|454536349|FG000|Overall Study|Lost to Follow-up|2|||
126338818|NCT00338741|454536350|FG001|Overall Study|Lost to Follow-up|0|||
126338819|NCT05222880|454536351|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
126338820|NCT05222880|454536351|FG000|Overall Study|Withdrew Consent during Study|1|||
126338821|NCT05222880|454536351|FG000|Overall Study|COVID-19 Related|1|||
126338822|NCT02895347|454536365|FG000|Overall Study|Withdrawal by Subject|3|||
126338823|NCT02895347|454536366|FG001|Overall Study|Withdrawal by Subject|1|||
126338824|NCT01673178|454536367|FG000|Overall Study|Lost to Follow-up|0|||
126338825|NCT01673178|454536368|FG001|Overall Study|Lost to Follow-up|1|||
126338826|NCT01673178|454536369|FG002|Overall Study|Lost to Follow-up|0|||
126338827|NCT01673178|454536370|FG003|Overall Study|Lost to Follow-up|0|||
126338828|NCT01673178|454536371|FG004|Overall Study|Lost to Follow-up|0|||
126338829|NCT01673178|454536367|FG000|Overall Study|Withdrawal by Subject|0|||
126338830|NCT01673178|454536368|FG001|Overall Study|Withdrawal by Subject|0|||
126338831|NCT01673178|454536369|FG002|Overall Study|Withdrawal by Subject|1|||
126338832|NCT01673178|454536370|FG003|Overall Study|Withdrawal by Subject|4|||
126338833|NCT01673178|454536371|FG004|Overall Study|Withdrawal by Subject|2|||
126338834|NCT01673178|454536367|FG000|Overall Study|Protocol Violation|1|||
126338835|NCT01673178|454536368|FG001|Overall Study|Protocol Violation|1|||
126338836|NCT01673178|454536369|FG002|Overall Study|Protocol Violation|0|||
126424023|NCT00936702|454849263|FG000|Overall Study|Disease progression|34|||
126424024|NCT00936702|454849263|FG000|Overall Study|Adverse Event|8|||
126424025|NCT00936702|454849263|FG000|Overall Study|Withdrawal by Subject|2|||
126424026|NCT00936702|454849263|FG000|Overall Study|Alternative Treatment|1|||
126424027|NCT00936702|454849263|FG000|Overall Study|Other|1|||
126424028|NCT02532465|454849264|FG000|Overall Study|Protocol Violation|1|||
126424029|NCT02532465|454849265|FG001|Overall Study|Protocol Violation|0|||
126424030|NCT02532465|454849264|FG000|Overall Study|Lack of Efficacy|0|||
126424031|NCT02532465|454849265|FG001|Overall Study|Lack of Efficacy|1|||
126338837|NCT01673178|454536370|FG003|Overall Study|Protocol Violation|1|||
126338838|NCT01673178|454536371|FG004|Overall Study|Protocol Violation|0|||
126338839|NCT01673178|454536367|FG000|Overall Study|Adverse Event|1|||
126338840|NCT01673178|454536368|FG001|Overall Study|Adverse Event|0|||
126338841|NCT01673178|454536369|FG002|Overall Study|Adverse Event|0|||
126338842|NCT01673178|454536370|FG003|Overall Study|Adverse Event|2|||
126424032|NCT00622505|454849271|FG000|Overall Study|Adverse Event|9|||
126424033|NCT00622505|454849272|FG001|Overall Study|Adverse Event|7|||
126424034|NCT00622505|454849271|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
126424035|NCT00622505|454849272|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
126424036|NCT00622505|454849271|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
126424037|NCT00622505|454849272|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
126424038|NCT00622505|454849271|FG000|Overall Study|Withdrawal by Subject|12|||
126424039|NCT00622505|454849272|FG001|Overall Study|Withdrawal by Subject|5|||
126424040|NCT00622505|454849271|FG000|Overall Study|Administrative Problems|2|||
126424041|NCT00622505|454849272|FG001|Overall Study|Administrative Problems|4|||
126424042|NCT00622505|454849271|FG000|Overall Study|Death|2|||
126424043|NCT00622505|454849272|FG001|Overall Study|Death|2|||
126424044|NCT01544920|454849273|FG000|Overall Study|Adverse Event|0|||
126424045|NCT01544920|454849274|FG001|Overall Study|Adverse Event|3|||
126424046|NCT01544920|454849273|FG000|Overall Study|Death|0|||
126424047|NCT01544920|454849274|FG001|Overall Study|Death|1|||
126424048|NCT01544920|454849273|FG000|Overall Study|Lost to Follow-up|11|||
126424049|NCT01544920|454849274|FG001|Overall Study|Lost to Follow-up|12|||
126424050|NCT01544920|454849273|FG000|Overall Study|Protocol Violation|0|||
126424051|NCT01544920|454849274|FG001|Overall Study|Protocol Violation|2|||
126424052|NCT01544920|454849273|FG000|Overall Study|Physician Decision|4|||
126424053|NCT01544920|454849274|FG001|Overall Study|Physician Decision|1|||
126424054|NCT01544920|454849273|FG000|Overall Study|Withdrawal by Subject|4|||
126338843|NCT01673178|454536371|FG004|Overall Study|Adverse Event|0|||
126338844|NCT01673178|454536367|FG000|Overall Study|Other|1|||
126338845|NCT01673178|454536368|FG001|Overall Study|Other|0|||
126338846|NCT01673178|454536369|FG002|Overall Study|Other|2|||
126338847|NCT01673178|454536370|FG003|Overall Study|Other|1|||
126338848|NCT01673178|454536371|FG004|Overall Study|Other|0|||
126338849|NCT03177148|454536372|FG000|Overall Study|Lost to Follow-up|50|||
126338850|NCT03177148|454536373|FG001|Overall Study|Lost to Follow-up|1|||
126338851|NCT03177148|454536372|FG000|Overall Study|Death|1|||
126338852|NCT03177148|454536373|FG001|Overall Study|Death|0|||
126338853|NCT00887484|454536385|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
126338854|NCT00887484|454536385|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
126338855|NCT00887484|454536385|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
126338856|NCT01204671|454536386|FG000|Overall Study|Adverse Event|4|||
126338857|NCT01204671|454536387|FG001|Overall Study|Adverse Event|3|||
126338858|NCT01204671|454536388|FG002|Overall Study|Adverse Event|3|||
126338859|NCT01204671|454536389|FG003|Overall Study|Adverse Event|3|||
126338860|NCT01204671|454536390|FG004|Overall Study|Adverse Event|1|||
126338861|NCT01204671|454536386|FG000|Overall Study|Withdrawal by Subject|2|||
126338862|NCT01204671|454536387|FG001|Overall Study|Withdrawal by Subject|3|||
126338863|NCT01204671|454536388|FG002|Overall Study|Withdrawal by Subject|4|||
126338864|NCT01204671|454536389|FG003|Overall Study|Withdrawal by Subject|5|||
126338865|NCT01204671|454536390|FG004|Overall Study|Withdrawal by Subject|3|||
126338866|NCT01204671|454536386|FG000|Overall Study|Lost to Follow-up|7|||
126338867|NCT01204671|454536387|FG001|Overall Study|Lost to Follow-up|8|||
126338868|NCT01204671|454536388|FG002|Overall Study|Lost to Follow-up|6|||
126338869|NCT01204671|454536389|FG003|Overall Study|Lost to Follow-up|4|||
126338870|NCT01204671|454536390|FG004|Overall Study|Lost to Follow-up|0|||
126338871|NCT01204671|454536386|FG000|Overall Study|Unknown Completion Status|1|||
126338872|NCT01204671|454536387|FG001|Overall Study|Unknown Completion Status|1|||
126338873|NCT01204671|454536388|FG002|Overall Study|Unknown Completion Status|0|||
126338874|NCT01204671|454536389|FG003|Overall Study|Unknown Completion Status|0|||
126338875|NCT01204671|454536390|FG004|Overall Study|Unknown Completion Status|0|||
126338876|NCT01204671|454536386|FG000|Overall Study|Physician Decision|0|||
126338877|NCT01204671|454536387|FG001|Overall Study|Physician Decision|0|||
126338878|NCT01204671|454536388|FG002|Overall Study|Physician Decision|0|||
126338879|NCT01204671|454536389|FG003|Overall Study|Physician Decision|1|||
126338880|NCT01204671|454536390|FG004|Overall Study|Physician Decision|0|||
126338881|NCT01316224|454536391|FG000|Overall Study|Protocol Violation|3|||
126338882|NCT01316224|454536391|FG000|Overall Study|Adverse Event|3|||
126338883|NCT01316224|454536391|FG000|Overall Study|Lack of Efficacy|1|||
126338884|NCT01316224|454536391|FG000|Overall Study|Withdrawal by Subject|1|||
126338885|NCT01316224|454536391|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
126338886|NCT01316224|454536391|FG000|Overall Study|Other|1|||
126338887|NCT03106077|454536392|FG000|Overall Study|Screen Failure|94|||
126338888|NCT03106077|454536393|FG001|Overall Study|Screen Failure|0|||
126338889|NCT00606307|454536396|FG000|Overall Study|Adverse Event|2|||
126338890|NCT00606307|454536396|FG000|Overall Study|Withdrawal by Subject|2|||
126338891|NCT00606307|454536396|FG000|Overall Study|Disease progression|6|||
126338892|NCT00606307|454536396|FG000|Overall Study|QTc prolongation|1|||
126338893|NCT01274533|454536397|FG000|Overall Study|Withdrawal by Subject|1|||
126338894|NCT01274533|454536397|FG000|Overall Study|Non-compliance|1|||
126338895|NCT01274533|454536397|FG000|Overall Study|Disease progression|2|||
126338896|NCT02008526|454536406|FG000|Overall Study|Death|0|||
126338897|NCT02008526|454536407|FG001|Overall Study|Death|2|||
126338898|NCT02008526|454536408|FG002|Overall Study|Death|1|||
126338899|NCT02008526|454536406|FG000|Overall Study|Withdrawal by Subject|3|||
126424055|NCT01544920|454849274|FG001|Overall Study|Withdrawal by Subject|4|||
126338900|NCT02008526|454536407|FG001|Overall Study|Withdrawal by Subject|3|||
126338901|NCT02008526|454536408|FG002|Overall Study|Withdrawal by Subject|2|||
126338902|NCT02008526|454536406|FG000|Overall Study|Lost to Follow-up|5|||
126338903|NCT02008526|454536407|FG001|Overall Study|Lost to Follow-up|9|||
126338904|NCT02008526|454536408|FG002|Overall Study|Lost to Follow-up|6|||
126338905|NCT01118052|454536409|FG000|Overall Study|Never treated|2|||
126338906|NCT02949947|454536410|FG000|Overall Study|Non Compliance|0|||
126338907|NCT02949947|454536411|FG001|Overall Study|Non Compliance|1|||
126338908|NCT02949947|454536410|FG000|Overall Study|Insurance change|1|||
126338909|NCT02949947|454536411|FG001|Overall Study|Insurance change|0|||
126338910|NCT00492726|454536413|FG000|Overall Study|Adverse Event|10|||
126338911|NCT00492726|454536414|FG001|Overall Study|Adverse Event|6|||
126338912|NCT00492726|454536413|FG000|Overall Study|Death|7|||
126338913|NCT00492726|454536414|FG001|Overall Study|Death|2|||
126338914|NCT00492726|454536413|FG000|Overall Study|Lack of Efficacy|0|||
126338915|NCT00492726|454536414|FG001|Overall Study|Lack of Efficacy|2|||
126338916|NCT00492726|454536413|FG000|Overall Study|Lost to Follow-up|27|||
126338917|NCT00492726|454536414|FG001|Overall Study|Lost to Follow-up|19|||
126338918|NCT00492726|454536413|FG000|Overall Study|Physician Decision|0|||
126338919|NCT00492726|454536414|FG001|Overall Study|Physician Decision|1|||
126338920|NCT00492726|454536413|FG000|Overall Study|Withdrawal by Subject|6|||
126338921|NCT00492726|454536414|FG001|Overall Study|Withdrawal by Subject|3|||
126338922|NCT00492726|454536413|FG000|Overall Study|Non compliant with study medication|0|||
126338923|NCT00492726|454536414|FG001|Overall Study|Non compliant with study medication|3|||
126338924|NCT04386902|454536415|FG000|Overall Study|Withdrawal by Subject|5|||
126338925|NCT04386902|454536415|FG000|Overall Study|Technical problems in the recording|5|||
126338926|NCT00828711|454536416|FG000|Overall Study|Lost to Follow-up|1|||
126338927|NCT00828711|454536417|FG001|Overall Study|Lost to Follow-up|0|||
126338928|NCT00828711|454536418|FG002|Overall Study|Lost to Follow-up|0|||
126338929|NCT02230891|454536419|FG000|Baseline|Did not meet inclusion|0|||
126338930|NCT02230891|454536420|FG001|Baseline|Did not meet inclusion|1|||
126338931|NCT02230891|454536421|FG002|Baseline|Did not meet inclusion|1|||
126338932|NCT02230891|454536419|FG000|2 Week|Withdrawal by Subject|2|||
126338933|NCT02230891|454536420|FG001|2 Week|Withdrawal by Subject|2|||
126338934|NCT02230891|454536421|FG002|2 Week|Withdrawal by Subject|0|||
126338935|NCT02230891|454536419|FG000|2 Week|Consent withdrawn|1|||
126338936|NCT02230891|454536420|FG001|2 Week|Consent withdrawn|0|||
126338937|NCT02230891|454536421|FG002|2 Week|Consent withdrawn|0|||
126338938|NCT02230891|454536419|FG000|6 Month|Withdrawal by Subject|1|||
126338939|NCT02230891|454536420|FG001|6 Month|Withdrawal by Subject|1|||
126338940|NCT02230891|454536421|FG002|6 Month|Withdrawal by Subject|1|||
126338941|NCT02230891|454536419|FG000|6 Month|Physician Decision|0|||
126338942|NCT02230891|454536420|FG001|6 Month|Physician Decision|2|||
126338943|NCT02230891|454536421|FG002|6 Month|Physician Decision|0|||
126338944|NCT02230891|454536419|FG000|12 Month|Death|1|||
126338945|NCT02230891|454536420|FG001|12 Month|Death|0|||
126338946|NCT02230891|454536421|FG002|12 Month|Death|0|||
126338947|NCT02230891|454536419|FG000|12 Month|Lost to Follow-up|0|||
126338948|NCT02230891|454536420|FG001|12 Month|Lost to Follow-up|1|||
126338949|NCT02230891|454536421|FG002|12 Month|Lost to Follow-up|0|||
126338950|NCT02230891|454536419|FG000|12 Month|Withdrawal by Subject|0|||
126338951|NCT02230891|454536420|FG001|12 Month|Withdrawal by Subject|2|||
126338952|NCT02230891|454536421|FG002|12 Month|Withdrawal by Subject|0|||
126338953|NCT02230891|454536419|FG000|18 Month End of Study|Death|0|||
126338954|NCT02230891|454536420|FG001|18 Month End of Study|Death|0|||
126338955|NCT02230891|454536421|FG002|18 Month End of Study|Death|1|||
126338956|NCT02230891|454536419|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
126338957|NCT02230891|454536420|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
126338958|NCT02230891|454536421|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
126338959|NCT02404545|454536422|FG000|Overall Study|Sponsor Termination|6|||
126338960|NCT02404545|454536423|FG001|Overall Study|Sponsor Termination|6|||
126338961|NCT02033759|454536425|FG000|Overall Study|Withdrawal by Subject|2|||
126338962|NCT02033759|454536426|FG001|Overall Study|Withdrawal by Subject|1|||
126338963|NCT02033759|454536425|FG000|Overall Study|Protocol Violation|1|||
126338964|NCT02033759|454536426|FG001|Overall Study|Protocol Violation|1|||
126338965|NCT01419535|454536436|FG000|Overall Study|could not maintain iv line|1|||
126338966|NCT01419535|454536437|FG001|Overall Study|could not maintain iv line|1|||
126338967|NCT01419535|454536436|FG000|Overall Study|Withdrawal by Subject|0|||
126338968|NCT01419535|454536437|FG001|Overall Study|Withdrawal by Subject|1|||
126338969|NCT01712516|454538398|FG000|Overall Study|Technical problems|0|||
126338970|NCT01712516|454538399|FG001|Overall Study|Technical problems|0|||
126338971|NCT01712516|454538400|FG002|Overall Study|Technical problems|0|||
126338972|NCT01712516|454538401|FG003|Overall Study|Technical problems|2|||
126338973|NCT01712516|454538398|FG000|Overall Study|Lost to Follow-up|0|||
126338974|NCT01712516|454538399|FG001|Overall Study|Lost to Follow-up|0|||
126338975|NCT01712516|454538400|FG002|Overall Study|Lost to Follow-up|2|||
126338976|NCT01712516|454538401|FG003|Overall Study|Lost to Follow-up|1|||
126338977|NCT01712516|454538398|FG000|Overall Study|Death|0|||
126338978|NCT01712516|454538399|FG001|Overall Study|Death|1|||
126338979|NCT01712516|454538400|FG002|Overall Study|Death|0|||
126338980|NCT01712516|454538401|FG003|Overall Study|Death|0|||
126338981|NCT01712516|454538398|FG000|Overall Study|Protocol deviation|1|||
126338982|NCT01712516|454538399|FG001|Overall Study|Protocol deviation|0|||
126338983|NCT01712516|454538400|FG002|Overall Study|Protocol deviation|1|||
126338984|NCT01712516|454538401|FG003|Overall Study|Protocol deviation|0|||
126338985|NCT01712516|454538398|FG000|Overall Study|Physician Decision|2|||
126338986|NCT01712516|454538399|FG001|Overall Study|Physician Decision|0|||
126424056|NCT00466440|454849275|FG000|Overall Study|Adverse Event|0|||
126424057|NCT00466440|454849276|FG001|Overall Study|Adverse Event|3|||
126424058|NCT00466440|454849277|FG002|Overall Study|Adverse Event|1|||
126424059|NCT00466440|454849275|FG000|Overall Study|Death|1|||
126338987|NCT01712516|454538400|FG002|Overall Study|Physician Decision|0|||
126338988|NCT01712516|454538401|FG003|Overall Study|Physician Decision|1|||
126338989|NCT01712516|454538398|FG000|Overall Study|Withdrawal by Subject|3|||
126338990|NCT01712516|454538399|FG001|Overall Study|Withdrawal by Subject|9|||
126338991|NCT01712516|454538400|FG002|Overall Study|Withdrawal by Subject|3|||
126338992|NCT01712516|454538401|FG003|Overall Study|Withdrawal by Subject|9|||
126338993|NCT01181167|454538405|FG000|Overall Study|Adverse Event|11|||
126338994|NCT01181167|454538406|FG001|Overall Study|Adverse Event|21|||
126338995|NCT01181167|454538405|FG000|Overall Study|Lost to Follow-up|1|||
126338996|NCT01181167|454538406|FG001|Overall Study|Lost to Follow-up|0|||
126338997|NCT01181167|454538405|FG000|Overall Study|Physician Decision|2|||
126338998|NCT01181167|454538406|FG001|Overall Study|Physician Decision|3|||
126338999|NCT01181167|454538405|FG000|Overall Study|Protocol Violation|3|||
126339000|NCT01181167|454538406|FG001|Overall Study|Protocol Violation|0|||
126339001|NCT01181167|454538405|FG000|Overall Study|Withdrawal by Subject|6|||
126339002|NCT01181167|454538406|FG001|Overall Study|Withdrawal by Subject|8|||
126339003|NCT00161213|454538407|FG000|Overall Study|Withdrawal by Subject|1|||
126339004|NCT00161213|454538407|FG000|Overall Study|Evaluable for toxicity but not response|1|||
126339005|NCT03103503|454538408|FG000|Overall Study|Death|64|||
126339006|NCT03103503|454538408|FG000|Overall Study|Physician Decision|57|||
126339007|NCT03103503|454538408|FG000|Overall Study|Withdrawal by Subject|10|||
126339008|NCT03103503|454538408|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
126339009|NCT03103503|454538408|FG000|Overall Study|Lost to Follow-up|3|||
126339010|NCT03103503|454538408|FG000|Overall Study|Study Closure|757|||
126339011|NCT01384877|454538409|FG000|Treatment 2|Lost to Follow-up|2|||
126339012|NCT01384877|454538410|FG001|Treatment 2|Lost to Follow-up|2|||
126339013|NCT03630393|454538411|FG000|Overall Study|Death|1|||
126339014|NCT03630393|454538412|FG001|Overall Study|Death|0|||
126339015|NCT00408499|454538413|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
126339016|NCT00408499|454538414|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
126339017|NCT00408499|454538415|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
126339018|NCT00408499|454538416|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
126339019|NCT00408499|454538417|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
126339020|NCT00408499|454538413|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
126339021|NCT00408499|454538414|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
126339022|NCT00408499|454538415|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
126339023|NCT00408499|454538416|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
126339024|NCT00408499|454538417|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
126339025|NCT00408499|454538413|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
126339026|NCT00408499|454538414|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
126339027|NCT00408499|454538415|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
126339028|NCT00408499|454538416|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
126339029|NCT00408499|454538417|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
126339030|NCT00408499|454538413|FG000|Phase II- MTD Expansion|Adverse Event|0|||
126339031|NCT00408499|454538414|FG001|Phase II- MTD Expansion|Adverse Event|0|||
126339032|NCT00408499|454538415|FG002|Phase II- MTD Expansion|Adverse Event|0|||
126339033|NCT00408499|454538416|FG003|Phase II- MTD Expansion|Adverse Event|0|||
126339034|NCT00408499|454538417|FG004|Phase II- MTD Expansion|Adverse Event|9|||
126339035|NCT00408499|454538413|FG000|Phase II- MTD Expansion|Death|0|||
126339036|NCT00408499|454538414|FG001|Phase II- MTD Expansion|Death|0|||
126339037|NCT00408499|454538415|FG002|Phase II- MTD Expansion|Death|0|||
126339038|NCT00408499|454538416|FG003|Phase II- MTD Expansion|Death|0|||
126424060|NCT00466440|454849276|FG001|Overall Study|Death|1|||
126424061|NCT00466440|454849277|FG002|Overall Study|Death|0|||
126424062|NCT00466440|454849275|FG000|Overall Study|Progressive disease|13|||
126339039|NCT00408499|454538417|FG004|Phase II- MTD Expansion|Death|2|||
126339040|NCT00408499|454538413|FG000|Phase II- MTD Expansion|Physician Decision|0|||
126424063|NCT00466440|454849276|FG001|Overall Study|Progressive disease|5|||
126424064|NCT00466440|454849277|FG002|Overall Study|Progressive disease|4|||
126424065|NCT00466440|454849275|FG000|Overall Study|Lost to Follow-up|0|||
126424066|NCT00466440|454849276|FG001|Overall Study|Lost to Follow-up|1|||
126424067|NCT00466440|454849277|FG002|Overall Study|Lost to Follow-up|0|||
126424068|NCT00466440|454849275|FG000|Overall Study|Physician Decision|0|||
126424069|NCT00466440|454849276|FG001|Overall Study|Physician Decision|1|||
126424070|NCT00466440|454849277|FG002|Overall Study|Physician Decision|2|||
126339041|NCT00408499|454538414|FG001|Phase II- MTD Expansion|Physician Decision|0|||
126424071|NCT00466440|454849275|FG000|Overall Study|Protocol entry criteria not met|0|||
126339042|NCT00408499|454538415|FG002|Phase II- MTD Expansion|Physician Decision|0|||
126339043|NCT00408499|454538416|FG003|Phase II- MTD Expansion|Physician Decision|0|||
126339044|NCT00408499|454538417|FG004|Phase II- MTD Expansion|Physician Decision|1|||
126339045|NCT00408499|454538413|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
126339046|NCT00408499|454538414|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
126339047|NCT00408499|454538415|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
126339048|NCT00408499|454538416|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
126339049|NCT00408499|454538417|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
126339050|NCT00408499|454538413|FG000|Phase II- MTD Expansion|treatment delay|0|||
126339051|NCT00408499|454538414|FG001|Phase II- MTD Expansion|treatment delay|0|||
126339052|NCT00408499|454538415|FG002|Phase II- MTD Expansion|treatment delay|0|||
126339053|NCT00408499|454538416|FG003|Phase II- MTD Expansion|treatment delay|0|||
126339054|NCT00408499|454538417|FG004|Phase II- MTD Expansion|treatment delay|3|||
126339055|NCT00997334|454538419|FG000|Overall Study|still on therapy|12|||
126339056|NCT00997334|454538419|FG000|Overall Study|Adverse Event|3|||
126339057|NCT00997334|454538419|FG000|Overall Study|Patient non-compliance|1|||
126339058|NCT00997334|454538419|FG000|Overall Study|Withdrawal by Subject|3|||
126339059|NCT00997334|454538419|FG000|Overall Study|Death|2|||
126339060|NCT00997334|454538419|FG000|Overall Study|Urgent Palliative Care|2|||
126339061|NCT00997334|454538419|FG000|Overall Study|No lesion amenable|1|||
126339062|NCT00997334|454538419|FG000|Overall Study|Ineligible|1|||
126424072|NCT00466440|454849276|FG001|Overall Study|Protocol entry criteria not met|0|||
126424073|NCT00466440|454849277|FG002|Overall Study|Protocol entry criteria not met|4|||
126424074|NCT00466440|454849275|FG000|Overall Study|Withdrawal by Subject|0|||
126424075|NCT00466440|454849276|FG001|Overall Study|Withdrawal by Subject|1|||
126339063|NCT01586195|454538420|FG000|Overall Study|Death|11|||
126339064|NCT01586195|454538420|FG000|Overall Study|Withdrawal of Consent|5|||
126339065|NCT01586195|454538420|FG000|Overall Study|Started new anti-melanoma therapy|1|||
126339066|NCT01586195|454538420|FG000|Overall Study|Reason not specified|9|||
126339067|NCT02683109|454538424|FG000|Overall Study|Adverse Event|1|||
126339068|NCT02683109|454538425|FG001|Overall Study|Adverse Event|0|||
126339069|NCT00183430|454538426|FG000|Overall Study|Adverse Event|1|||
126339070|NCT00183430|454538427|FG001|Overall Study|Adverse Event|0|||
126339071|NCT00183430|454538426|FG000|Overall Study|Lost to Follow-up|3|||
126339072|NCT00183430|454538427|FG001|Overall Study|Lost to Follow-up|0|||
126339073|NCT00183430|454538426|FG000|Overall Study|did not meet inclusion criteria|1|||
126339074|NCT00183430|454538427|FG001|Overall Study|did not meet inclusion criteria|0|||
126339075|NCT00183430|454538426|FG000|Overall Study|Withdrawal by Subject|1|||
126339076|NCT00183430|454538427|FG001|Overall Study|Withdrawal by Subject|0|||
126339077|NCT00883181|454538430|FG000|Overall Study|Hematological Adverse Event|26|||
126339078|NCT00883181|454538430|FG000|Overall Study|Non-hematological Adverse Event|55|||
126339079|NCT00883181|454538430|FG000|Overall Study|Disease Progression|94|||
126339080|NCT00883181|454538430|FG000|Overall Study|Administrative Reason|24|||
126339081|NCT00883181|454538430|FG000|Overall Study|Withdrawal by Subject|4|||
126339082|NCT00883181|454538430|FG000|Overall Study|Death|31|||
126339083|NCT00883181|454538430|FG000|Overall Study|Other|38|||
126339084|NCT00883181|454538430|FG000|Overall Study|Protocol Deviation|3|||
126339085|NCT00883181|454538430|FG000|Overall Study|Noncompliance|3|||
126339086|NCT00426270|454538435|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
126339087|NCT00426270|454538435|FG000|Overall Study|Adverse Event|5|||
126339088|NCT00958074|454538436|FG000|Overall Study|Withdrawal by Subject|0|||
126339089|NCT00958074|454538437|FG001|Overall Study|Withdrawal by Subject|1|||
126339090|NCT03102762|454538438|FG000|Overall Study|Lost to Follow-up|1|||
126339091|NCT03102762|454538439|FG001|Overall Study|Lost to Follow-up|0|||
126339092|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
126339093|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
126339094|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
126339095|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
126339096|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
126339097|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
126339098|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
126339099|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
126339100|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
126339101|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
126339102|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
126339103|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
126339104|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
126339105|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
126339106|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
126339107|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
126339108|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
126339109|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
126339110|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
126339111|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
126339112|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
126339113|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
126339114|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
126339115|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
126339116|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
126339117|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
126339118|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
126339119|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
126339120|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
126339121|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
126339122|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
126339123|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
126339124|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
126339125|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
126339126|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
126339127|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
126339128|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
126339129|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
126339130|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
126339131|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
126339132|NCT02709746|454538440|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
126339133|NCT02709746|454538441|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
126339134|NCT02709746|454538442|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
126339135|NCT02709746|454538443|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
126339136|NCT02709746|454538444|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
126339137|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
126339138|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
126339139|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
126339140|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
126339141|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
126339142|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
126339143|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
126339144|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
126339145|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
126339146|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
126339147|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
126339148|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
126339149|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
126339150|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
126339151|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
126339152|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
126339153|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
126339154|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
126424076|NCT00466440|454849277|FG002|Overall Study|Withdrawal by Subject|0|||
126424077|NCT00466440|454849275|FG000|Overall Study|Sponsor decision|0|||
126424078|NCT00466440|454849276|FG001|Overall Study|Sponsor decision|0|||
126424079|NCT00466440|454849277|FG002|Overall Study|Sponsor decision|1|||
126424080|NCT00965081|454849282|FG000|Overall Study|Adverse Event|14|||
126424081|NCT00965081|454849283|FG001|Overall Study|Adverse Event|9|||
126424082|NCT00965081|454849282|FG000|Overall Study|Lack of Efficacy|2|||
126424083|NCT00965081|454849283|FG001|Overall Study|Lack of Efficacy|5|||
126424084|NCT00965081|454849282|FG000|Overall Study|Lost to Follow-up|4|||
126424085|NCT00965081|454849283|FG001|Overall Study|Lost to Follow-up|5|||
126424086|NCT00965081|454849282|FG000|Overall Study|Physician Decision|2|||
126424087|NCT00965081|454849283|FG001|Overall Study|Physician Decision|0|||
126424088|NCT00965081|454849282|FG000|Overall Study|Protocol Violation|2|||
126424089|NCT00965081|454849283|FG001|Overall Study|Protocol Violation|5|||
126424090|NCT00965081|454849282|FG000|Overall Study|Sponsor Decision|1|||
126424091|NCT00965081|454849283|FG001|Overall Study|Sponsor Decision|0|||
126424092|NCT00965081|454849282|FG000|Overall Study|Withdrawal by Subject|4|||
126424093|NCT00965081|454849283|FG001|Overall Study|Withdrawal by Subject|7|||
126424094|NCT00965081|454849282|FG000|Overall Study|Switched to Rescue Arm|5|||
126424095|NCT00965081|454849283|FG001|Overall Study|Switched to Rescue Arm|12|||
126424096|NCT02159066|454849288|FG000|Part I|Adverse Event|7|||
126424097|NCT02159066|454849289|FG001|Part I|Adverse Event|5|||
126424098|NCT02159066|454849290|FG002|Part I|Adverse Event|0|||
126424099|NCT02159066|454849291|FG003|Part I|Adverse Event|0|||
126424100|NCT02159066|454849292|FG004|Part I|Adverse Event|0|||
126424101|NCT02159066|454849293|FG005|Part I|Adverse Event|0|||
126424102|NCT02159066|454849288|FG000|Part I|Death|11|||
126424103|NCT02159066|454849289|FG001|Part I|Death|9|||
126424104|NCT02159066|454849290|FG002|Part I|Death|0|||
126424105|NCT02159066|454849291|FG003|Part I|Death|0|||
126424106|NCT02159066|454849292|FG004|Part I|Death|0|||
126424107|NCT02159066|454849293|FG005|Part I|Death|0|||
126424108|NCT02159066|454849288|FG000|Part I|Progressive Disease|37|||
126424109|NCT02159066|454849289|FG001|Part I|Progressive Disease|46|||
126424110|NCT02159066|454849290|FG002|Part I|Progressive Disease|0|||
126424111|NCT02159066|454849291|FG003|Part I|Progressive Disease|0|||
126424112|NCT02159066|454849292|FG004|Part I|Progressive Disease|0|||
126424113|NCT02159066|454849293|FG005|Part I|Progressive Disease|0|||
126424114|NCT02159066|454849288|FG000|Part I|New Therapy for Study Indication|5|||
126424115|NCT02159066|454849289|FG001|Part I|New Therapy for Study Indication|4|||
126424116|NCT02159066|454849290|FG002|Part I|New Therapy for Study Indication|0|||
126424117|NCT02159066|454849291|FG003|Part I|New Therapy for Study Indication|0|||
126424118|NCT02159066|454849292|FG004|Part I|New Therapy for Study Indication|0|||
126424119|NCT02159066|454849293|FG005|Part I|New Therapy for Study Indication|0|||
126424120|NCT02159066|454849288|FG000|Part I|Termination of participants from the study|3|||
126424121|NCT02159066|454849289|FG001|Part I|Termination of participants from the study|3|||
126424122|NCT02159066|454849290|FG002|Part I|Termination of participants from the study|0|||
126424123|NCT02159066|454849291|FG003|Part I|Termination of participants from the study|0|||
126424124|NCT02159066|454849292|FG004|Part I|Termination of participants from the study|0|||
126424125|NCT02159066|454849293|FG005|Part I|Termination of participants from the study|0|||
126424126|NCT02159066|454849288|FG000|Part I|Physician Decision|2|||
126424127|NCT02159066|454849289|FG001|Part I|Physician Decision|9|||
126424128|NCT02159066|454849290|FG002|Part I|Physician Decision|0|||
126424129|NCT02159066|454849291|FG003|Part I|Physician Decision|0|||
126424130|NCT02159066|454849292|FG004|Part I|Physician Decision|0|||
126424131|NCT02159066|454849293|FG005|Part I|Physician Decision|0|||
126424132|NCT02159066|454849288|FG000|Part I|Participant/Guardian Decision|9|||
126424133|NCT02159066|454849289|FG001|Part I|Participant/Guardian Decision|3|||
126424134|NCT02159066|454849290|FG002|Part I|Participant/Guardian Decision|0|||
126424135|NCT02159066|454849291|FG003|Part I|Participant/Guardian Decision|0|||
126424136|NCT02159066|454849292|FG004|Part I|Participant/Guardian Decision|0|||
126424137|NCT02159066|454849293|FG005|Part I|Participant/Guardian Decision|0|||
126424138|NCT02159066|454849288|FG000|Part I|Missing Data|1|||
126424139|NCT02159066|454849289|FG001|Part I|Missing Data|0|||
126424140|NCT02159066|454849290|FG002|Part I|Missing Data|0|||
126424141|NCT02159066|454849291|FG003|Part I|Missing Data|0|||
126424142|NCT02159066|454849292|FG004|Part I|Missing Data|0|||
126424143|NCT02159066|454849293|FG005|Part I|Missing Data|0|||
126424144|NCT02159066|454849288|FG000|Part II|Adverse Event|0|||
126424145|NCT02159066|454849289|FG001|Part II|Adverse Event|0|||
126424146|NCT02159066|454849290|FG002|Part II|Adverse Event|1|||
126424147|NCT02159066|454849291|FG003|Part II|Adverse Event|0|||
126424148|NCT02159066|454849292|FG004|Part II|Adverse Event|1|||
126424149|NCT02159066|454849293|FG005|Part II|Adverse Event|1|||
126424150|NCT02159066|454849288|FG000|Part II|Death|0|||
126424151|NCT02159066|454849289|FG001|Part II|Death|0|||
126424152|NCT02159066|454849290|FG002|Part II|Death|1|||
126424153|NCT02159066|454849291|FG003|Part II|Death|0|||
126424154|NCT02159066|454849292|FG004|Part II|Death|2|||
126424155|NCT02159066|454849293|FG005|Part II|Death|1|||
126424156|NCT02159066|454849288|FG000|Part II|Progressive Disease|0|||
126424157|NCT02159066|454849289|FG001|Part II|Progressive Disease|0|||
126424158|NCT02159066|454849290|FG002|Part II|Progressive Disease|35|||
126424159|NCT02159066|454849291|FG003|Part II|Progressive Disease|1|||
126424160|NCT02159066|454849292|FG004|Part II|Progressive Disease|7|||
126424161|NCT02159066|454849293|FG005|Part II|Progressive Disease|4|||
126424162|NCT02159066|454849288|FG000|Part II|New Therapy for Study Indication|0|||
126424163|NCT02159066|454849289|FG001|Part II|New Therapy for Study Indication|0|||
126424164|NCT02159066|454849290|FG002|Part II|New Therapy for Study Indication|0|||
126424165|NCT02159066|454849291|FG003|Part II|New Therapy for Study Indication|0|||
126424166|NCT02159066|454849292|FG004|Part II|New Therapy for Study Indication|1|||
126424167|NCT02159066|454849293|FG005|Part II|New Therapy for Study Indication|0|||
126424168|NCT02159066|454849288|FG000|Part II|Physician Decision|0|||
126424169|NCT02159066|454849289|FG001|Part II|Physician Decision|0|||
126424170|NCT02159066|454849290|FG002|Part II|Physician Decision|1|||
126424171|NCT02159066|454849291|FG003|Part II|Physician Decision|0|||
126424172|NCT02159066|454849292|FG004|Part II|Physician Decision|0|||
126424173|NCT02159066|454849293|FG005|Part II|Physician Decision|0|||
126424174|NCT02159066|454849288|FG000|Part II|Participant/Guardian Decision|0|||
126424175|NCT02159066|454849289|FG001|Part II|Participant/Guardian Decision|0|||
126424176|NCT02159066|454849290|FG002|Part II|Participant/Guardian Decision|0|||
126424177|NCT02159066|454849291|FG003|Part II|Participant/Guardian Decision|0|||
126424178|NCT02159066|454849292|FG004|Part II|Participant/Guardian Decision|2|||
126339155|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
126424179|NCT02159066|454849293|FG005|Part II|Participant/Guardian Decision|0|||
126424180|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
126424181|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
126424182|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
126424183|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424184|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424185|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424186|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424187|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424188|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424189|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424190|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424191|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424192|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
126424193|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424194|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
126424195|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424196|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
126424197|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424198|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424199|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
126424200|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
126424201|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
126424202|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
126424203|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424204|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
126424205|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424206|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424207|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
126424208|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
126424209|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
126424210|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
126424211|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
126424212|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
126424213|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
126424214|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
126424215|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
126424216|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
126424217|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
126424218|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
126424219|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
126424220|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
126424221|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
126424222|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
126424223|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
126424224|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
126424225|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
126424226|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424227|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424228|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
126424229|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424230|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424231|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424232|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424233|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424234|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424235|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
126424236|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424237|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424238|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126424239|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
126339156|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
126339157|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
126339158|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
126339159|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
126339160|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
126339161|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
126339162|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
126339163|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
126339164|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
126339165|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
126339166|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
126339167|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
126339168|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
126339169|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
126339170|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
126339171|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
126339172|NCT02709746|454538440|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
126339173|NCT02709746|454538441|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
126339174|NCT02709746|454538442|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
126339175|NCT02709746|454538443|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
126339176|NCT02709746|454538444|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
126339177|NCT00551369|454538445|FG000|Overall Study|Protocol Violation|5|||
126339178|NCT00551369|454538445|FG000|Overall Study|Withdrawal by Subject|1|||
126339179|NCT00551369|454538445|FG000|Overall Study|Not treated per protocol and re|1|||
126339180|NCT00719901|454538446|FG000|Overall Study|Adverse Event|5|||
126339181|NCT00719901|454538446|FG000|Overall Study|Withdrawal by Subject|1|||
126339182|NCT00719901|454538446|FG000|Overall Study|Alternate Treatment|1|||
126339183|NCT00719901|454538446|FG000|Overall Study|Disease Progression|3|||
126339184|NCT00719901|454538446|FG000|Overall Study|Availability of Study Drug|1|||
126424240|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424241|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424242|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424243|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424244|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
126424245|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
126672543|NCT00514514|455760502|FG002|Randomized - 9 Month|Adverse Event|27|||
126672544|NCT00514514|455760500|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
126672545|NCT00514514|455760501|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
126672546|NCT00514514|455760502|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
126672547|NCT00514514|455760500|FG000|Extension - 4 Years|Lost to Follow-up|12|||
126672548|NCT00514514|455760501|FG001|Extension - 4 Years|Lost to Follow-up|10|||
126672549|NCT00514514|455760502|FG002|Extension - 4 Years|Lost to Follow-up|9|||
126672550|NCT00514514|455760500|FG000|Extension - 4 Years|Administrative problems|3|||
126672551|NCT00514514|455760501|FG001|Extension - 4 Years|Administrative problems|1|||
126672552|NCT00514514|455760502|FG002|Extension - 4 Years|Administrative problems|1|||
126672553|NCT00514514|455760500|FG000|Extension - 4 Years|Death|8|||
126672554|NCT00514514|455760501|FG001|Extension - 4 Years|Death|3|||
126672555|NCT00514514|455760502|FG002|Extension - 4 Years|Death|6|||
126672556|NCT00514514|455760500|FG000|Extension - 4 Years|Adverse Event|9|||
126672557|NCT00514514|455760501|FG001|Extension - 4 Years|Adverse Event|6|||
126672558|NCT00514514|455760502|FG002|Extension - 4 Years|Adverse Event|3|||
126672559|NCT03785925|455760504|FG000|Overall Study|Withdrawal by Subject|15|||
126672560|NCT03785925|455760504|FG000|Overall Study|Lost to Follow-up|1|||
126672561|NCT01101438|455760508|FG000|Overall Study|Withdrawal by Subject|8|||
126672562|NCT01101438|455760509|FG001|Overall Study|Withdrawal by Subject|9|||
126672563|NCT02713542|455760510|FG000|Overall Study|Use of prohibited medication|14|||
126672564|NCT02713542|455760511|FG001|Overall Study|Use of prohibited medication|5|||
126672565|NCT02713542|455760510|FG000|Overall Study|Withdrawal by Subject|4|||
126672566|NCT02713542|455760511|FG001|Overall Study|Withdrawal by Subject|1|||
126672567|NCT03794583|455760514|FG000|Overall Study|Death|8|||
126672568|NCT03794583|455760514|FG000|Overall Study|Study Terminated by Sponsor|24|||
126672569|NCT03794583|455760514|FG000|Overall Study|Withdrawal by Subject|9|||
126672570|NCT00806195|455760517|FG000|Overall Study|Death|6|||
126672571|NCT00806195|455760518|FG001|Overall Study|Death|0|||
126672572|NCT00806195|455760519|FG002|Overall Study|Death|1|||
126672573|NCT00806195|455760520|FG003|Overall Study|Death|0|||
126672574|NCT00806195|455760517|FG000|Overall Study|Adverse Event|25|||
126672575|NCT00806195|455760518|FG001|Overall Study|Adverse Event|5|||
126672576|NCT00806195|455760519|FG002|Overall Study|Adverse Event|11|||
126672577|NCT00806195|455760520|FG003|Overall Study|Adverse Event|2|||
126672578|NCT00806195|455760517|FG000|Overall Study|Withdrawal by Subject|119|||
126672579|NCT00806195|455760518|FG001|Overall Study|Withdrawal by Subject|31|||
126672580|NCT00806195|455760519|FG002|Overall Study|Withdrawal by Subject|76|||
126672581|NCT00806195|455760520|FG003|Overall Study|Withdrawal by Subject|35|||
126672582|NCT00806195|455760517|FG000|Overall Study|Lost to Follow-up|217|||
126672583|NCT00806195|455760518|FG001|Overall Study|Lost to Follow-up|66|||
126672584|NCT00806195|455760519|FG002|Overall Study|Lost to Follow-up|90|||
126672585|NCT00806195|455760520|FG003|Overall Study|Lost to Follow-up|34|||
126672586|NCT00806195|455760517|FG000|Overall Study|Inappropriate Enrollment|0|||
126672587|NCT00806195|455760518|FG001|Overall Study|Inappropriate Enrollment|1|||
126672588|NCT00806195|455760519|FG002|Overall Study|Inappropriate Enrollment|0|||
126672589|NCT00806195|455760520|FG003|Overall Study|Inappropriate Enrollment|0|||
126672590|NCT00806195|455760517|FG000|Overall Study|Administrative Reason|113|||
126672591|NCT00806195|455760518|FG001|Overall Study|Administrative Reason|35|||
126672592|NCT00806195|455760519|FG002|Overall Study|Administrative Reason|66|||
126672593|NCT00806195|455760520|FG003|Overall Study|Administrative Reason|26|||
126672594|NCT00806195|455760517|FG000|Overall Study|Protocol Violation|34|||
126672595|NCT00806195|455760518|FG001|Overall Study|Protocol Violation|24|||
126672596|NCT00806195|455760519|FG002|Overall Study|Protocol Violation|26|||
126672597|NCT00806195|455760520|FG003|Overall Study|Protocol Violation|9|||
126672598|NCT02490475|455760521|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
126672599|NCT02490475|455760522|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
126672600|NCT02490475|455760523|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
126672601|NCT02490475|455760524|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
126672602|NCT02490475|455760521|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
126672603|NCT02490475|455760522|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
126672604|NCT02490475|455760523|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
126672605|NCT02490475|455760524|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
126672606|NCT02490475|455760521|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
126672607|NCT02490475|455760522|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
126672608|NCT02490475|455760523|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
126672609|NCT02490475|455760524|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
126672610|NCT02490475|455760521|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
126672611|NCT02490475|455760522|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
126672612|NCT02490475|455760523|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
126672613|NCT02490475|455760524|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
126672614|NCT02490475|455760521|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
126672615|NCT02490475|455760522|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
126672616|NCT02490475|455760523|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
126672617|NCT02490475|455760524|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
126672618|NCT02490475|455760521|FG000|Period 2: Extension Phase|Refused Treatment|0|||
126672619|NCT02490475|455760522|FG001|Period 2: Extension Phase|Refused Treatment|0|||
126672620|NCT02490475|455760523|FG002|Period 2: Extension Phase|Refused Treatment|0|||
126672621|NCT02490475|455760524|FG003|Period 2: Extension Phase|Refused Treatment|1|||
126672622|NCT02490475|455760521|FG000|Period 2: Extension Phase|Adverse Event|0|||
126672623|NCT02490475|455760522|FG001|Period 2: Extension Phase|Adverse Event|0|||
126672624|NCT02490475|455760523|FG002|Period 2: Extension Phase|Adverse Event|1|||
126672625|NCT02490475|455760524|FG003|Period 2: Extension Phase|Adverse Event|0|||
126672626|NCT00139776|455760525|FG000|Period I|Did not enter Period II|575|||
126672627|NCT00139776|455760526|FG001|Period I|Did not enter Period II|0|||
126672628|NCT00139776|455760527|FG002|Period I|Did not enter Period II|0|||
126672629|NCT00139776|455760528|FG003|Period I|Did not enter Period II|0|||
126672630|NCT00139776|455760525|FG000|Period II|Not Randomized into Period III|0|||
126672631|NCT00139776|455760526|FG001|Period II|Not Randomized into Period III|322|||
126672632|NCT00139776|455760527|FG002|Period II|Not Randomized into Period III|0|||
126672633|NCT00139776|455760528|FG003|Period II|Not Randomized into Period III|0|||
126672634|NCT00139776|455760525|FG000|Period III|Adverse Event|0|||
126672635|NCT00139776|455760526|FG001|Period III|Adverse Event|0|||
126672636|NCT00139776|455760527|FG002|Period III|Adverse Event|22|||
126672637|NCT00139776|455760528|FG003|Period III|Adverse Event|23|||
126672638|NCT00139776|455760525|FG000|Period III|Other|0|||
126672639|NCT00139776|455760526|FG001|Period III|Other|0|||
126672640|NCT00139776|455760527|FG002|Period III|Other|23|||
126672641|NCT00139776|455760528|FG003|Period III|Other|34|||
126672642|NCT00139776|455760525|FG000|Period III|Lack of Efficacy|0|||
126672643|NCT00139776|455760526|FG001|Period III|Lack of Efficacy|0|||
126672644|NCT00139776|455760527|FG002|Period III|Lack of Efficacy|10|||
126672645|NCT00139776|455760528|FG003|Period III|Lack of Efficacy|24|||
126672646|NCT00139776|455760525|FG000|Period III|Lost to Follow-up|0|||
126672647|NCT00139776|455760526|FG001|Period III|Lost to Follow-up|0|||
126672648|NCT00139776|455760527|FG002|Period III|Lost to Follow-up|5|||
126672649|NCT00139776|455760528|FG003|Period III|Lost to Follow-up|4|||
126672650|NCT00139776|455760525|FG000|Period III|Withdrawal by Subject|0|||
126672651|NCT00139776|455760526|FG001|Period III|Withdrawal by Subject|0|||
126672652|NCT00139776|455760527|FG002|Period III|Withdrawal by Subject|16|||
126672653|NCT00139776|455760528|FG003|Period III|Withdrawal by Subject|21|||
126672654|NCT01519934|455760535|FG000|Overall Study|Lost to Follow-up|3|||
126672655|NCT01368536|455760538|FG000|Overall Study|Adverse Event|5|||
126672656|NCT01368536|455760539|FG001|Overall Study|Adverse Event|6|||
126672657|NCT01368536|455760540|FG002|Overall Study|Adverse Event|8|||
126672658|NCT01368536|455760538|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126672659|NCT01368536|455760539|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126672660|NCT01368536|455760540|FG002|Overall Study|Abnormal laboratory value(s)|2|||
126672661|NCT01368536|455760538|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126672662|NCT01368536|455760539|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126672663|NCT01368536|455760540|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126672664|NCT01368536|455760538|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
126672665|NCT01368536|455760539|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126672666|NCT01368536|455760540|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126672667|NCT01368536|455760538|FG000|Overall Study|No longer required study medication|0|||
126672668|NCT01368536|455760539|FG001|Overall Study|No longer required study medication|0|||
126672669|NCT01368536|455760540|FG002|Overall Study|No longer required study medication|1|||
126672670|NCT01368536|455760538|FG000|Overall Study|Withdrawal by Subject|2|||
126672671|NCT01368536|455760539|FG001|Overall Study|Withdrawal by Subject|5|||
126672672|NCT01368536|455760540|FG002|Overall Study|Withdrawal by Subject|4|||
126672673|NCT01368536|455760538|FG000|Overall Study|Lost to Follow-up|3|||
126672674|NCT01368536|455760539|FG001|Overall Study|Lost to Follow-up|3|||
126672675|NCT01368536|455760540|FG002|Overall Study|Lost to Follow-up|5|||
126672676|NCT01368536|455760538|FG000|Overall Study|Administrative problems|34|||
126672677|NCT01368536|455760539|FG001|Overall Study|Administrative problems|39|||
126672678|NCT01368536|455760540|FG002|Overall Study|Administrative problems|35|||
126672679|NCT01368536|455760538|FG000|Overall Study|Protocol deviation|0|||
126672680|NCT01368536|455760539|FG001|Overall Study|Protocol deviation|3|||
126672681|NCT01368536|455760540|FG002|Overall Study|Protocol deviation|1|||
126672682|NCT00359021|455760541|FG000|Overall Study|Adverse Event|26|||
126672683|NCT00359021|455760542|FG001|Overall Study|Adverse Event|8|||
126672684|NCT00359021|455760541|FG000|Overall Study|Subject Non-Compliant|1|||
126672685|NCT00359021|455760542|FG001|Overall Study|Subject Non-Compliant|2|||
126672686|NCT00359021|455760541|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
126672687|NCT00359021|455760542|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
126672688|NCT00359021|455760541|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
126672689|NCT00359021|455760542|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
126672690|NCT00359021|455760541|FG000|Overall Study|Withdrawal by Subject|2|||
126672691|NCT00359021|455760542|FG001|Overall Study|Withdrawal by Subject|9|||
126672692|NCT00359021|455760541|FG000|Overall Study|Lost to Follow-up|1|||
126672693|NCT00359021|455760542|FG001|Overall Study|Lost to Follow-up|0|||
126672694|NCT00359021|455760541|FG000|Overall Study|Other|4|||
126672695|NCT00359021|455760542|FG001|Overall Study|Other|1|||
126672696|NCT00359021|455760541|FG000|Overall Study|Pregnancy|1|||
126672697|NCT00359021|455760542|FG001|Overall Study|Pregnancy|0|||
126672698|NCT03861936|455760543|FG000|Overall Study|Withdrawal by Subject|4|||
126672699|NCT03861936|455760544|FG001|Overall Study|Withdrawal by Subject|1|||
126672700|NCT03861936|455760545|FG002|Overall Study|Withdrawal by Subject|3|||
126672701|NCT03861936|455760543|FG000|Overall Study|Lost to Follow-up|5|||
126672702|NCT03861936|455760544|FG001|Overall Study|Lost to Follow-up|3|||
126672703|NCT03861936|455760545|FG002|Overall Study|Lost to Follow-up|3|||
126672704|NCT03861936|455760543|FG000|Overall Study|Physician Decision|0|||
126672705|NCT03861936|455760544|FG001|Overall Study|Physician Decision|1|||
126672706|NCT03861936|455760545|FG002|Overall Study|Physician Decision|0|||
126672707|NCT03861936|455760543|FG000|Overall Study|Protocol Deviation|0|||
126672708|NCT03861936|455760544|FG001|Overall Study|Protocol Deviation|0|||
126672709|NCT03861936|455760545|FG002|Overall Study|Protocol Deviation|1|||
126672710|NCT03861936|455760543|FG000|Overall Study|Reason not Specified|5|||
126672711|NCT03861936|455760544|FG001|Overall Study|Reason not Specified|5|||
126672712|NCT03861936|455760545|FG002|Overall Study|Reason not Specified|3|||
126672713|NCT01835015|455760549|FG000|Overall Study|Adverse Event|0|||
126672714|NCT01835015|455760550|FG001|Overall Study|Adverse Event|0|||
126339185|NCT01122173|454538447|FG000|Overall Study|Lost to Follow-up|3|||
126339186|NCT01122173|454538447|FG000|Overall Study|Withdrawal by Subject|3|||
126339187|NCT01122173|454538447|FG000|Overall Study|Left study for other reasons|3|||
126339188|NCT01184872|454538448|FG000|Overall Study|Adverse Event|3|||
126339189|NCT01184872|454538449|FG001|Overall Study|Adverse Event|4|||
126339190|NCT01184872|454538448|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
126339191|NCT01184872|454538449|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126339192|NCT01184872|454538448|FG000|Overall Study|Withdrawal by Subject|2|||
126339193|NCT01184872|454538449|FG001|Overall Study|Withdrawal by Subject|0|||
126339194|NCT01184872|454538448|FG000|Overall Study|Lost to Follow-up|0|||
126339195|NCT01184872|454538449|FG001|Overall Study|Lost to Follow-up|1|||
126339196|NCT01184872|454538448|FG000|Overall Study|Administrative problems|1|||
126672715|NCT01835015|455760551|FG002|Overall Study|Adverse Event|1|||
126672716|NCT01835015|455760552|FG003|Overall Study|Adverse Event|0|||
126672717|NCT01835015|455760553|FG004|Overall Study|Adverse Event|0|||
126672718|NCT04569032|455760558|FG000|Overall Study|Death|10|||
126672719|NCT04569032|455760559|FG001|Overall Study|Death|13|||
126672720|NCT04569032|455760558|FG000|Overall Study|Withdrawal by Subject|2|||
126339197|NCT01184872|454538449|FG001|Overall Study|Administrative problems|1|||
126672721|NCT04569032|455760559|FG001|Overall Study|Withdrawal by Subject|0|||
126339198|NCT01184872|454538448|FG000|Overall Study|Protocol deviation|1|||
126672722|NCT04569032|455760558|FG000|Overall Study|Lost to Follow-up|0|||
126672723|NCT04569032|455760559|FG001|Overall Study|Lost to Follow-up|1|||
126672724|NCT04569032|455760558|FG000|Overall Study|In long term follow up|22|||
126672725|NCT04569032|455760559|FG001|Overall Study|In long term follow up|34|||
126672726|NCT00701090|455760561|FG000|Overall Study|Adverse Event|11|||
126672727|NCT00701090|455760562|FG001|Overall Study|Adverse Event|2|||
126672728|NCT00701090|455760561|FG000|Overall Study|Death|0|||
126672729|NCT00701090|455760562|FG001|Overall Study|Death|1|||
126672730|NCT00701090|455760561|FG000|Overall Study|Lack of Efficacy|5|||
126672731|NCT00701090|455760562|FG001|Overall Study|Lack of Efficacy|4|||
126672732|NCT00701090|455760561|FG000|Overall Study|Lost to Follow-up|9|||
126672733|NCT00701090|455760562|FG001|Overall Study|Lost to Follow-up|9|||
126672734|NCT00701090|455760561|FG000|Overall Study|Physician Decision|3|||
126672735|NCT00701090|455760562|FG001|Overall Study|Physician Decision|4|||
126672736|NCT00701090|455760561|FG000|Overall Study|Protocol Violation|2|||
126672737|NCT00701090|455760562|FG001|Overall Study|Protocol Violation|3|||
126672738|NCT00701090|455760561|FG000|Overall Study|Withdrawal by Subject|11|||
126672739|NCT00701090|455760562|FG001|Overall Study|Withdrawal by Subject|16|||
126672740|NCT00701090|455760561|FG000|Overall Study|Other|7|||
126672741|NCT00701090|455760562|FG001|Overall Study|Other|12|||
126672742|NCT04534491|455760569|FG000|Overall Study|Not completed end-of-study interview|24|||
126339199|NCT01184872|454538449|FG001|Overall Study|Protocol deviation|0|||
126339200|NCT03426345|454538450|FG000|Overall Study|Adverse Event|4|||
126672743|NCT04534491|455760569|FG000|Overall Study|Non-users|70|||
126672744|NCT04534491|455760569|FG000|Overall Study|Non-verifiable users|58|||
126672745|NCT00113074|455760571|FG000|Overall Study|Lost to Follow-up|10|||
126672746|NCT00113074|455760572|FG001|Overall Study|Lost to Follow-up|10|||
126672747|NCT00113074|455760573|FG002|Overall Study|Lost to Follow-up|14|||
126672748|NCT02114268|455760574|FG000|Overall Study|Lost to Follow-up|4|||
126672749|NCT02114268|455760575|FG001|Overall Study|Lost to Follow-up|1|||
126672750|NCT02114268|455760576|FG002|Overall Study|Lost to Follow-up|1|||
126672751|NCT02114268|455760577|FG003|Overall Study|Lost to Follow-up|0|||
126672752|NCT02114268|455760578|FG004|Overall Study|Lost to Follow-up|0|||
126672753|NCT02114268|455760579|FG005|Overall Study|Lost to Follow-up|2|||
126672754|NCT02114268|455760574|FG000|Overall Study|Withdrawal by Subject|1|||
126672755|NCT02114268|455760575|FG001|Overall Study|Withdrawal by Subject|0|||
126672756|NCT02114268|455760576|FG002|Overall Study|Withdrawal by Subject|0|||
126672757|NCT02114268|455760577|FG003|Overall Study|Withdrawal by Subject|0|||
126672758|NCT02114268|455760578|FG004|Overall Study|Withdrawal by Subject|0|||
126672759|NCT02114268|455760579|FG005|Overall Study|Withdrawal by Subject|1|||
126672760|NCT02114268|455760574|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
126672761|NCT02114268|455760575|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
126672762|NCT02114268|455760576|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
126672763|NCT02114268|455760577|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
126672764|NCT02114268|455760578|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
126672765|NCT02114268|455760579|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
126672766|NCT03962738|455760580|FG000|Overall Study|Protocol Deviation|3|||
126672767|NCT03962738|455760581|FG001|Overall Study|Protocol Deviation|0|||
126672768|NCT03962738|455760582|FG002|Overall Study|Protocol Deviation|1|||
126672769|NCT03962738|455760583|FG003|Overall Study|Protocol Deviation|1|||
126672770|NCT03962738|455760580|FG000|Overall Study|Withdrawal by Subject|4|||
126672771|NCT03962738|455760581|FG001|Overall Study|Withdrawal by Subject|0|||
126672772|NCT03962738|455760582|FG002|Overall Study|Withdrawal by Subject|0|||
126672773|NCT03962738|455760583|FG003|Overall Study|Withdrawal by Subject|0|||
126672774|NCT03962738|455760580|FG000|Overall Study|Lost to Follow-up|0|||
126339201|NCT03426345|454538451|FG001|Overall Study|Adverse Event|4|||
126339202|NCT03426345|454538450|FG000|Overall Study|Lack of Efficacy|1|||
126339203|NCT03426345|454538451|FG001|Overall Study|Lack of Efficacy|0|||
126339204|NCT03426345|454538450|FG000|Overall Study|Withdrawal by Subject|5|||
126339205|NCT03426345|454538451|FG001|Overall Study|Withdrawal by Subject|6|||
126339206|NCT03426345|454538450|FG000|Overall Study|Lost to Follow-up|3|||
126339207|NCT03426345|454538451|FG001|Overall Study|Lost to Follow-up|1|||
126339208|NCT03426345|454538450|FG000|Overall Study|Protocol Deviation|3|||
126339209|NCT03426345|454538451|FG001|Overall Study|Protocol Deviation|4|||
126339210|NCT03426345|454538450|FG000|Overall Study|Reason Not Specified|1|||
126339211|NCT03426345|454538451|FG001|Overall Study|Reason Not Specified|2|||
126672775|NCT03962738|455760581|FG001|Overall Study|Lost to Follow-up|0|||
126672776|NCT03962738|455760582|FG002|Overall Study|Lost to Follow-up|1|||
126672777|NCT03962738|455760583|FG003|Overall Study|Lost to Follow-up|0|||
126339212|NCT03426345|454538450|FG000|Overall Study|Missing Completion Status|1|||
126339213|NCT03426345|454538451|FG001|Overall Study|Missing Completion Status|0|||
126339214|NCT00116142|454538452|FG000|Overall Study|Adverse Event|8|||
126339215|NCT00116142|454538453|FG001|Overall Study|Adverse Event|7|||
126672778|NCT00509067|455760584|FG000|Overall Study|Lost to Follow-up|1|||
126672779|NCT00509067|455760585|FG001|Overall Study|Lost to Follow-up|1|||
126672780|NCT00509067|455760584|FG000|Overall Study|Adverse Event|3|||
126672781|NCT00509067|455760585|FG001|Overall Study|Adverse Event|1|||
126672782|NCT00509067|455760584|FG000|Overall Study|Protocol Violation|0|||
126672783|NCT00509067|455760585|FG001|Overall Study|Protocol Violation|3|||
126672784|NCT00131469|455760586|FG000|Overall Study|Withdrawal by Subject|3|||
126424246|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424247|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
126424248|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424249|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
126424250|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424251|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
126424252|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424253|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
126424254|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
126424255|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424256|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424257|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424258|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
126424259|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424260|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424261|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424262|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424263|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126672785|NCT00131469|455760587|FG001|Overall Study|Withdrawal by Subject|4|||
126672786|NCT00131469|455760586|FG000|Overall Study|Protocol Violation|3|||
126672787|NCT00131469|455760587|FG001|Overall Study|Protocol Violation|1|||
126672788|NCT00131469|455760586|FG000|Overall Study|Death|0|||
126672789|NCT00131469|455760587|FG001|Overall Study|Death|1|||
126672790|NCT00131469|455760586|FG000|Overall Study|Lost to Follow-up|0|||
126672791|NCT00131469|455760587|FG001|Overall Study|Lost to Follow-up|1|||
126672792|NCT00131469|455760586|FG000|Overall Study|scan not analyzable|3|||
126672793|NCT00131469|455760587|FG001|Overall Study|scan not analyzable|6|||
126672794|NCT00356889|455760589|FG000|Overall Study|Protocol Violation|2|||
126672795|NCT00356889|455760589|FG000|Overall Study|Adverse Event|1|||
126672796|NCT00702325|455760590|FG000|Overall Study|Adverse Event|1|||
126672797|NCT00702325|455760591|FG001|Overall Study|Adverse Event|0|||
126672798|NCT00702325|455760590|FG000|Overall Study|Withdrawal by Subject|7|||
126672799|NCT00702325|455760591|FG001|Overall Study|Withdrawal by Subject|7|||
126672800|NCT00702325|455760590|FG000|Overall Study|Lost to Follow-up|3|||
126672801|NCT00702325|455760591|FG001|Overall Study|Lost to Follow-up|4|||
126672802|NCT00702325|455760590|FG000|Overall Study|Incorrect enrollment|5|||
126672803|NCT00702325|455760591|FG001|Overall Study|Incorrect enrollment|7|||
126672804|NCT00702325|455760590|FG000|Overall Study|Developed study discontinuation criteria|18|||
126672805|NCT00702325|455760591|FG001|Overall Study|Developed study discontinuation criteria|28|||
126672806|NCT00702325|455760590|FG000|Overall Study|Severe noncompliance to protocol|3|||
126672807|NCT00702325|455760591|FG001|Overall Study|Severe noncompliance to protocol|3|||
126672808|NCT00702325|455760590|FG000|Overall Study|Termination due to lab results|1|||
126672809|NCT00702325|455760591|FG001|Overall Study|Termination due to lab results|0|||
126672810|NCT00702325|455760590|FG000|Overall Study|Didn't follow study medication dosage|0|||
126672811|NCT00702325|455760591|FG001|Overall Study|Didn't follow study medication dosage|2|||
126672812|NCT00702325|455760590|FG000|Overall Study|Withdrew consent|0|||
126672813|NCT00702325|455760591|FG001|Overall Study|Withdrew consent|1|||
126672814|NCT00702325|455760590|FG000|Overall Study|Incorrectly Discontinued|0|||
126672815|NCT00702325|455760591|FG001|Overall Study|Incorrectly Discontinued|1|||
126672816|NCT00736034|455760594|FG000|Overall Study|Adverse Event|2|||
126672817|NCT01022502|455760598|FG000|Overall Study|Adverse Event|1|||
126672818|NCT01022502|455760598|FG000|Overall Study|employment related reasons|1|||
126672819|NCT01022502|455760598|FG000|Overall Study|Withdrawal by Subject|1|||
126672820|NCT03716050|455760599|FG000|Overall Study|Lost to Follow-up|0|||
126672821|NCT03716050|455760600|FG001|Overall Study|Lost to Follow-up|0|||
126672822|NCT03716050|455760601|FG002|Overall Study|Lost to Follow-up|1|||
126672823|NCT03716050|455760602|FG003|Overall Study|Lost to Follow-up|0|||
126672824|NCT03716050|455760603|FG004|Overall Study|Lost to Follow-up|0|||
126672825|NCT03716050|455760604|FG005|Overall Study|Lost to Follow-up|0|||
126672826|NCT03716050|455760605|FG006|Overall Study|Lost to Follow-up|0|||
126672827|NCT03716050|455760606|FG007|Overall Study|Lost to Follow-up|0|||
126672828|NCT03716050|455760599|FG000|Overall Study|Physician Decision|0|||
126672829|NCT03716050|455760600|FG001|Overall Study|Physician Decision|0|||
126672830|NCT03716050|455760601|FG002|Overall Study|Physician Decision|0|||
126672831|NCT03716050|455760602|FG003|Overall Study|Physician Decision|1|||
126672832|NCT03716050|455760603|FG004|Overall Study|Physician Decision|0|||
126672833|NCT03716050|455760604|FG005|Overall Study|Physician Decision|0|||
126672834|NCT03716050|455760605|FG006|Overall Study|Physician Decision|0|||
126672835|NCT03716050|455760606|FG007|Overall Study|Physician Decision|0|||
126672836|NCT03716050|455760599|FG000|Overall Study|Protocol Violation|0|||
126672837|NCT03716050|455760600|FG001|Overall Study|Protocol Violation|0|||
126672838|NCT03716050|455760601|FG002|Overall Study|Protocol Violation|0|||
126672839|NCT03716050|455760602|FG003|Overall Study|Protocol Violation|1|||
126672840|NCT03716050|455760603|FG004|Overall Study|Protocol Violation|0|||
126672841|NCT03716050|455760604|FG005|Overall Study|Protocol Violation|0|||
126424264|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126672842|NCT03716050|455760605|FG006|Overall Study|Protocol Violation|0|||
126672843|NCT03716050|455760606|FG007|Overall Study|Protocol Violation|2|||
126672844|NCT03123250|455760607|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
126672845|NCT02566577|455760608|FG000|Overall Study|Withdrawal by Subject|1|||
126672846|NCT02566577|455760609|FG001|Overall Study|Withdrawal by Subject|1|||
126672847|NCT02566577|455760608|FG000|Overall Study|Equipment failure|1|||
126672848|NCT02566577|455760609|FG001|Overall Study|Equipment failure|1|||
126672849|NCT02566577|455760608|FG000|Overall Study|Physical limitation|1|||
126339216|NCT00116142|454538452|FG000|Overall Study|Protocol Violation|2|||
126339217|NCT00116142|454538453|FG001|Overall Study|Protocol Violation|1|||
126339218|NCT00116142|454538452|FG000|Overall Study|Withdrawal by Subject|5|||
126339219|NCT00116142|454538453|FG001|Overall Study|Withdrawal by Subject|5|||
126339220|NCT00116142|454538452|FG000|Overall Study|Physician Decision|3|||
126339221|NCT00116142|454538453|FG001|Overall Study|Physician Decision|1|||
126339222|NCT00116142|454538452|FG000|Overall Study|Delayed Radiation Therapy|1|||
126339223|NCT00116142|454538453|FG001|Overall Study|Delayed Radiation Therapy|0|||
126339224|NCT00116142|454538452|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
126339225|NCT00116142|454538453|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
126339226|NCT00116142|454538452|FG000|Overall Study|Patient stopped due to depression|0|||
126339227|NCT00116142|454538453|FG001|Overall Study|Patient stopped due to depression|1|||
126339228|NCT00116142|454538452|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
126339229|NCT00116142|454538453|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
126339230|NCT00116142|454538452|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
126339231|NCT00116142|454538453|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
126339232|NCT00116142|454538452|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
126339233|NCT00116142|454538453|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
126339234|NCT00644059|454538454|FG000|Overall Study|Lost to Follow-up|37|||
126339235|NCT00644059|454538455|FG001|Overall Study|Lost to Follow-up|34|||
126339236|NCT00644059|454538456|FG002|Overall Study|Lost to Follow-up|16|||
126339237|NCT00644059|454538454|FG000|Overall Study|Withdrawal by Subject|52|||
126339238|NCT00644059|454538455|FG001|Overall Study|Withdrawal by Subject|60|||
126339239|NCT00644059|454538456|FG002|Overall Study|Withdrawal by Subject|30|||
126339240|NCT00644059|454538454|FG000|Overall Study|Adverse Event|8|||
126339241|NCT00644059|454538455|FG001|Overall Study|Adverse Event|5|||
126339242|NCT00644059|454538456|FG002|Overall Study|Adverse Event|1|||
126339243|NCT00644059|454538454|FG000|Overall Study|Inappropriate Enrollment|1|||
126339244|NCT00644059|454538455|FG001|Overall Study|Inappropriate Enrollment|3|||
126339245|NCT00644059|454538456|FG002|Overall Study|Inappropriate Enrollment|0|||
126339246|NCT00644059|454538454|FG000|Overall Study|Protocol Deviation/violation|20|||
126339247|NCT00644059|454538455|FG001|Overall Study|Protocol Deviation/violation|19|||
126339248|NCT00644059|454538456|FG002|Overall Study|Protocol Deviation/violation|15|||
126339249|NCT00644059|454538454|FG000|Overall Study|Unable to classify|6|||
126339250|NCT00644059|454538455|FG001|Overall Study|Unable to classify|2|||
126339251|NCT00644059|454538456|FG002|Overall Study|Unable to classify|3|||
126339252|NCT02133508|454538457|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
126339253|NCT02133508|454538457|FG000|Overall Study|Death|12|||
126339254|NCT02133508|454538457|FG000|Overall Study|Lost to Follow-up|2|||
126339255|NCT02497469|454538464|FG000|Overall Study|Randomized but not Treated|0|||
126339256|NCT02497469|454538465|FG001|Overall Study|Randomized but not Treated|2|||
126339257|NCT02497469|454538464|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
126339258|NCT02497469|454538465|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
126339259|NCT02497469|454538464|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
126339260|NCT02497469|454538465|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
126339261|NCT02497469|454538464|FG000|Overall Study|Significant Protocol Deviation|4|||
126339262|NCT02497469|454538465|FG001|Overall Study|Significant Protocol Deviation|5|||
126339263|NCT02497469|454538464|FG000|Overall Study|Lost to Follow-up|14|||
126339264|NCT02497469|454538465|FG001|Overall Study|Lost to Follow-up|4|||
126339265|NCT02497469|454538464|FG000|Overall Study|Voluntary Withdrawal|39|||
126339266|NCT02497469|454538465|FG001|Overall Study|Voluntary Withdrawal|41|||
126339267|NCT02497469|454538464|FG000|Overall Study|Pregnancy|1|||
126339268|NCT02497469|454538465|FG001|Overall Study|Pregnancy|1|||
126339269|NCT02497469|454538464|FG000|Overall Study|Lack of Efficacy|86|||
126339270|NCT02497469|454538465|FG001|Overall Study|Lack of Efficacy|40|||
126339271|NCT02497469|454538464|FG000|Overall Study|Reason not Specified|6|||
126339272|NCT02497469|454538465|FG001|Overall Study|Reason not Specified|6|||
126339273|NCT04076917|454538467|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
126339274|NCT04076917|454538467|FG000|Overall Study|Study closure|13|||
126339275|NCT04076917|454538467|FG000|Overall Study|Physician Decision|3|||
126339276|NCT04076917|454538467|FG000|Overall Study|Death|1|||
126672850|NCT02566577|455760609|FG001|Overall Study|Physical limitation|0|||
126339277|NCT04076917|454538467|FG000|Overall Study|Lost to Follow-up|1|||
126339278|NCT04076917|454538467|FG000|Overall Study|Withdrawal by Subject|1|||
126339279|NCT04076917|454538467|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
126424265|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
126424266|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424267|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424268|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424269|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
126424270|NCT01147666|454849294|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424271|NCT01147666|454849295|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424272|NCT01147666|454849296|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126672851|NCT00073528|455760617|FG000|Overall Study|Death|488|||
126672852|NCT00073528|455760618|FG001|Overall Study|Death|473|||
126672853|NCT00073528|455760617|FG000|Overall Study|Lost to Follow-up|52|||
126672854|NCT00073528|455760618|FG001|Overall Study|Lost to Follow-up|45|||
126672855|NCT00073528|455760617|FG000|Overall Study|Withdrawal by Subject|50|||
126672856|NCT00073528|455760618|FG001|Overall Study|Withdrawal by Subject|45|||
126672857|NCT00073528|455760617|FG000|Overall Study|Study terminated by Sponsor|10|||
126672858|NCT00073528|455760618|FG001|Overall Study|Study terminated by Sponsor|29|||
126672859|NCT00073528|455760617|FG000|Overall Study|Other|18|||
126672860|NCT00073528|455760618|FG001|Overall Study|Other|19|||
126672861|NCT00073528|455760617|FG000|Overall Study|Other|9|||
126672862|NCT00073528|455760618|FG001|Overall Study|Other|12|||
126672863|NCT00073528|455760617|FG000|Overall Study|Protocol Violation|3|||
126672864|NCT00073528|455760618|FG001|Overall Study|Protocol Violation|5|||
126672865|NCT03654976|455760622|FG000|Overall Study|Withdrawal by Subject|12|||
126672866|NCT03654976|455760623|FG001|Overall Study|Withdrawal by Subject|11|||
126672867|NCT03654976|455760622|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
126672868|NCT03654976|455760623|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
126672869|NCT03654976|455760622|FG000|Overall Study|Adverse Event|5|||
126672870|NCT03654976|455760623|FG001|Overall Study|Adverse Event|0|||
126672871|NCT03654976|455760622|FG000|Overall Study|Lost to Follow-up|2|||
126672872|NCT03654976|455760623|FG001|Overall Study|Lost to Follow-up|0|||
126672873|NCT03654976|455760622|FG000|Overall Study|Lack of Efficacy|0|||
126672874|NCT03654976|455760623|FG001|Overall Study|Lack of Efficacy|1|||
126672875|NCT03098836|455760629|FG000|Overall Study|Adverse Event|1|||
126672876|NCT03098836|455760630|FG001|Overall Study|Adverse Event|3|||
126672877|NCT03098836|455760629|FG000|Overall Study|Lack of Efficacy|30|||
126672878|NCT03098836|455760630|FG001|Overall Study|Lack of Efficacy|15|||
126672879|NCT03098836|455760629|FG000|Overall Study|Physician Decision|2|||
126672880|NCT03098836|455760630|FG001|Overall Study|Physician Decision|1|||
126672881|NCT03098836|455760629|FG000|Overall Study|Withdrawal by Subject|3|||
126672882|NCT03098836|455760630|FG001|Overall Study|Withdrawal by Subject|2|||
126672883|NCT04688775|455760633|FG000|Placebo-controlled Period|Randomized, not treated|1|||
126672884|NCT04688775|455760634|FG001|Placebo-controlled Period|Randomized, not treated|1|||
126672885|NCT04688775|455760635|FG002|Placebo-controlled Period|Randomized, not treated|0|||
126672886|NCT04688775|455760636|FG003|Placebo-controlled Period|Randomized, not treated|0|||
126672887|NCT04688775|455760633|FG000|Placebo-controlled Period|Adverse Event|2|||
126672888|NCT04688775|455760634|FG001|Placebo-controlled Period|Adverse Event|0|||
126672889|NCT04688775|455760635|FG002|Placebo-controlled Period|Adverse Event|0|||
126672890|NCT04688775|455760636|FG003|Placebo-controlled Period|Adverse Event|0|||
126672891|NCT04688775|455760633|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
126672892|NCT04688775|455760634|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
126672893|NCT04688775|455760635|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
126672894|NCT04688775|455760636|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
126672895|NCT04688775|455760633|FG000|Placebo-controlled Period|Protocol Violation|0|||
126672896|NCT04688775|455760634|FG001|Placebo-controlled Period|Protocol Violation|1|||
126672897|NCT04688775|455760635|FG002|Placebo-controlled Period|Protocol Violation|0|||
126672898|NCT04688775|455760636|FG003|Placebo-controlled Period|Protocol Violation|0|||
126672899|NCT04688775|455760633|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
126672900|NCT04688775|455760634|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
126672901|NCT04688775|455760635|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
126672902|NCT04688775|455760636|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
126672903|NCT04688775|455760633|FG000|Placebo-controlled Period|Other reasons|0|||
126672904|NCT04688775|455760634|FG001|Placebo-controlled Period|Other reasons|1|||
126672905|NCT04688775|455760635|FG002|Placebo-controlled Period|Other reasons|0|||
126672906|NCT04688775|455760636|FG003|Placebo-controlled Period|Other reasons|0|||
126672907|NCT04688775|455760633|FG000|Delayed Start Period|Adverse Event|0|||
126672908|NCT04688775|455760634|FG001|Delayed Start Period|Adverse Event|0|||
126672909|NCT04688775|455760635|FG002|Delayed Start Period|Adverse Event|1|||
126672910|NCT04688775|455760636|FG003|Delayed Start Period|Adverse Event|0|||
126672911|NCT04688775|455760633|FG000|Delayed Start Period|Lack of Efficacy|0|||
126672912|NCT04688775|455760634|FG001|Delayed Start Period|Lack of Efficacy|0|||
126672913|NCT04688775|455760635|FG002|Delayed Start Period|Lack of Efficacy|0|||
126672914|NCT04688775|455760636|FG003|Delayed Start Period|Lack of Efficacy|3|||
126672915|NCT04688775|455760633|FG000|Delayed Start Period|Withdrawal by Subject|0|||
126672916|NCT04688775|455760634|FG001|Delayed Start Period|Withdrawal by Subject|0|||
126672917|NCT04688775|455760635|FG002|Delayed Start Period|Withdrawal by Subject|2|||
126672918|NCT04688775|455760636|FG003|Delayed Start Period|Withdrawal by Subject|4|||
126672919|NCT04688775|455760633|FG000|Delayed Start Period|Lost to Follow-up|0|||
126672920|NCT04688775|455760634|FG001|Delayed Start Period|Lost to Follow-up|0|||
126672921|NCT04688775|455760635|FG002|Delayed Start Period|Lost to Follow-up|2|||
126672922|NCT04688775|455760636|FG003|Delayed Start Period|Lost to Follow-up|1|||
126672923|NCT04688775|455760633|FG000|Delayed Start Period|other reasons|0|||
126672924|NCT04688775|455760634|FG001|Delayed Start Period|other reasons|0|||
126672925|NCT04688775|455760635|FG002|Delayed Start Period|other reasons|1|||
126672926|NCT04688775|455760636|FG003|Delayed Start Period|other reasons|0|||
126672927|NCT01770912|455760637|FG000|Overall Study|Lost to Follow-up|2|||
126672928|NCT01770912|455760638|FG001|Overall Study|Lost to Follow-up|0|||
126672929|NCT01817751|455760643|FG000|Overall Study|Physician Decision|1|||
126672930|NCT00382018|455760644|FG000|Overall Study|Progression|0|||
126672931|NCT00382018|455760645|FG001|Overall Study|Progression|136|||
126672932|NCT00382018|455760646|FG002|Overall Study|Progression|51|||
126672933|NCT00382018|455760647|FG003|Overall Study|Progression|43|||
126672934|NCT00382018|455760644|FG000|Overall Study|Death|0|||
126672935|NCT00382018|455760645|FG001|Overall Study|Death|9|||
126672936|NCT00382018|455760646|FG002|Overall Study|Death|7|||
126672937|NCT00382018|455760647|FG003|Overall Study|Death|11|||
126672938|NCT00382018|455760644|FG000|Overall Study|Withdrawal by Subject|0|||
126672939|NCT00382018|455760645|FG001|Overall Study|Withdrawal by Subject|4|||
126672940|NCT00382018|455760646|FG002|Overall Study|Withdrawal by Subject|3|||
126672941|NCT00382018|455760647|FG003|Overall Study|Withdrawal by Subject|4|||
126672942|NCT00382018|455760644|FG000|Overall Study|Other, not protocol specified|0|||
126672943|NCT00382018|455760645|FG001|Overall Study|Other, not protocol specified|16|||
126672944|NCT00382018|455760646|FG002|Overall Study|Other, not protocol specified|3|||
126672945|NCT00382018|455760647|FG003|Overall Study|Other, not protocol specified|1|||
126672946|NCT00789880|455760648|FG000|Overall Study|Adverse Event|0|||
126672947|NCT00789880|455760649|FG001|Overall Study|Adverse Event|0|||
126672948|NCT00789880|455760650|FG002|Overall Study|Adverse Event|0|||
126672949|NCT00789880|455760651|FG003|Overall Study|Adverse Event|0|||
126672950|NCT00789880|455760652|FG004|Overall Study|Adverse Event|1|||
126672951|NCT00789880|455760653|FG005|Overall Study|Adverse Event|0|||
126672952|NCT00789880|455760648|FG000|Overall Study|Protocol Violation|0|||
126672953|NCT00789880|455760649|FG001|Overall Study|Protocol Violation|1|||
126672954|NCT00789880|455760650|FG002|Overall Study|Protocol Violation|0|||
126672955|NCT00789880|455760651|FG003|Overall Study|Protocol Violation|1|||
126672956|NCT00789880|455760652|FG004|Overall Study|Protocol Violation|0|||
126672957|NCT00789880|455760653|FG005|Overall Study|Protocol Violation|0|||
126672958|NCT00789880|455760648|FG000|Overall Study|Withdrawal by Subject|1|||
126672959|NCT00789880|455760649|FG001|Overall Study|Withdrawal by Subject|0|||
126672960|NCT00789880|455760650|FG002|Overall Study|Withdrawal by Subject|0|||
126672961|NCT00789880|455760651|FG003|Overall Study|Withdrawal by Subject|0|||
126672962|NCT00789880|455760652|FG004|Overall Study|Withdrawal by Subject|2|||
126672963|NCT00789880|455760653|FG005|Overall Study|Withdrawal by Subject|0|||
126672964|NCT01977820|455760657|FG000|Overall Study|Sponsor terminated the study|1|||
126672965|NCT01977820|455760658|FG001|Overall Study|Sponsor terminated the study|1|||
126672966|NCT00493220|455760659|FG000|Third Intervention|Withdrawal by Subject|1|||
126672967|NCT00493220|455760660|FG001|Third Intervention|Withdrawal by Subject|0|||
126672968|NCT00493220|455760661|FG002|Third Intervention|Withdrawal by Subject|0|||
126672969|NCT00493220|455760662|FG003|Third Intervention|Withdrawal by Subject|0|||
126672970|NCT00493220|455760663|FG004|Third Intervention|Withdrawal by Subject|0|||
126672971|NCT00493220|455760664|FG005|Third Intervention|Withdrawal by Subject|0|||
126672972|NCT02568475|455760665|FG000|Overall Study|Lost to Follow-up|40|||
126672973|NCT02568475|455760666|FG001|Overall Study|Lost to Follow-up|39|||
126672974|NCT02568475|455760665|FG000|Overall Study|Withdrawal by Subject|2|||
126672975|NCT02568475|455760666|FG001|Overall Study|Withdrawal by Subject|0|||
126672976|NCT02568475|455760665|FG000|Overall Study|Discharged home|4|||
126672977|NCT02568475|455760666|FG001|Overall Study|Discharged home|4|||
126672978|NCT02568475|455760665|FG000|Overall Study|Short-term: Discharge location unknown|4|||
126672979|NCT02568475|455760666|FG001|Overall Study|Short-term: Discharge location unknown|0|||
126339280|NCT01774591|454538470|FG000|Overall Study|Physician Decision|1|||
126339281|NCT01774591|454538471|FG001|Overall Study|Physician Decision|1|||
126339282|NCT01774591|454538470|FG000|Overall Study|Withdrawal by Subject|0|||
126339283|NCT01774591|454538471|FG001|Overall Study|Withdrawal by Subject|1|||
126339284|NCT01774591|454538470|FG000|Overall Study|Adverse Event|0|||
126672980|NCT02568475|455760665|FG000|Overall Study|Transferred to another facility|1|||
126672981|NCT02568475|455760666|FG001|Overall Study|Transferred to another facility|0|||
126672982|NCT02625233|455760667|FG000|Overall Study|Adverse Event|2|||
126672983|NCT02625233|455760668|FG001|Overall Study|Adverse Event|0|||
126672984|NCT01704287|455762012|FG000|Initial Treatment Period|Death|139|||
126672985|NCT01704287|455762013|FG001|Initial Treatment Period|Death|129|||
126672986|NCT01704287|455762014|FG002|Initial Treatment Period|Death|71|||
126672987|NCT01704287|455762015|FG003|Initial Treatment Period|Death|0|||
126672988|NCT01704287|455762016|FG004|Initial Treatment Period|Death|0|||
126672989|NCT01704287|455762012|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
126672990|NCT01704287|455762013|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
126672991|NCT01704287|455762014|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
126672992|NCT01704287|455762015|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
126672993|NCT01704287|455762016|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
126672994|NCT01704287|455762012|FG000|Initial Treatment Period|Lost to Follow-up|5|||
126672995|NCT01704287|455762013|FG001|Initial Treatment Period|Lost to Follow-up|3|||
126672996|NCT01704287|455762014|FG002|Initial Treatment Period|Lost to Follow-up|0|||
126672997|NCT01704287|455762015|FG003|Initial Treatment Period|Lost to Follow-up|0|||
126672998|NCT01704287|455762016|FG004|Initial Treatment Period|Lost to Follow-up|0|||
126672999|NCT01704287|455762012|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
126673000|NCT01704287|455762013|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
126673001|NCT01704287|455762014|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
126673002|NCT01704287|455762015|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
126673003|NCT01704287|455762016|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
126673004|NCT01704287|455762012|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
126673005|NCT01704287|455762013|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
126673006|NCT01704287|455762014|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
126673007|NCT01704287|455762015|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
126673008|NCT01704287|455762016|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
126673009|NCT01704287|455762012|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
126673010|NCT01704287|455762013|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
126673011|NCT01704287|455762014|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
126673012|NCT01704287|455762015|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
126673013|NCT01704287|455762016|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
126673014|NCT01704287|455762012|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
126339285|NCT01774591|454538471|FG001|Overall Study|Adverse Event|2|||
126339286|NCT01787552|454538472|FG000|Overall Study|Withdrawal by Subject|2|||
126339287|NCT01787552|454538473|FG001|Overall Study|Withdrawal by Subject|0|||
126339288|NCT01787552|454538474|FG002|Overall Study|Withdrawal by Subject|0|||
126339289|NCT01787552|454538475|FG003|Overall Study|Withdrawal by Subject|4|||
126339290|NCT01787552|454538472|FG000|Overall Study|Physician Decision|2|||
126339291|NCT01787552|454538473|FG001|Overall Study|Physician Decision|2|||
126339292|NCT01787552|454538474|FG002|Overall Study|Physician Decision|1|||
126339293|NCT01787552|454538475|FG003|Overall Study|Physician Decision|2|||
126339294|NCT01787552|454538472|FG000|Overall Study|Death|0|||
126339295|NCT01787552|454538473|FG001|Overall Study|Death|0|||
126339296|NCT01787552|454538474|FG002|Overall Study|Death|0|||
126339297|NCT01787552|454538475|FG003|Overall Study|Death|1|||
126339298|NCT01787552|454538472|FG000|Overall Study|Adverse Event|2|||
126339299|NCT01787552|454538473|FG001|Overall Study|Adverse Event|5|||
126339300|NCT01787552|454538474|FG002|Overall Study|Adverse Event|2|||
126339301|NCT01787552|454538475|FG003|Overall Study|Adverse Event|16|||
126339302|NCT01787552|454538472|FG000|Overall Study|Study terminated by Sponsor|0|||
126339303|NCT01787552|454538473|FG001|Overall Study|Study terminated by Sponsor|0|||
126339304|NCT01787552|454538474|FG002|Overall Study|Study terminated by Sponsor|1|||
126339305|NCT01787552|454538475|FG003|Overall Study|Study terminated by Sponsor|3|||
126339306|NCT01787552|454538472|FG000|Overall Study|Progressive Disease|2|||
126339307|NCT01787552|454538473|FG001|Overall Study|Progressive Disease|2|||
126339308|NCT01787552|454538474|FG002|Overall Study|Progressive Disease|1|||
126339309|NCT01787552|454538475|FG003|Overall Study|Progressive Disease|1|||
126339310|NCT03055936|454538481|FG000|Overall Study|Adverse Event|0|||
126339311|NCT03055936|454538482|FG001|Overall Study|Adverse Event|1|||
126339312|NCT03055936|454538483|FG002|Overall Study|Adverse Event|1|||
126339313|NCT03055936|454538484|FG003|Overall Study|Adverse Event|1|||
126339314|NCT03055936|454538481|FG000|Overall Study|Personal reason|2|||
126339315|NCT03055936|454538482|FG001|Overall Study|Personal reason|0|||
126339316|NCT03055936|454538483|FG002|Overall Study|Personal reason|1|||
126339317|NCT03055936|454538484|FG003|Overall Study|Personal reason|0|||
126339318|NCT03167242|454538485|FG000|Overall Study|Patient/Guardian Decision|0|||
126339319|NCT03167242|454538486|FG001|Overall Study|Patient/Guardian Decision|1|||
126339320|NCT03167242|454538487|FG002|Overall Study|Patient/Guardian Decision|2|||
126339321|NCT03167242|454538488|FG003|Overall Study|Patient/Guardian Decision|1|||
126339322|NCT03167242|454538489|FG004|Overall Study|Patient/Guardian Decision|1|||
126339323|NCT03167242|454538490|FG005|Overall Study|Patient/Guardian Decision|1|||
126339324|NCT03167242|454538491|FG006|Overall Study|Patient/Guardian Decision|0|||
126339325|NCT03167242|454538492|FG007|Overall Study|Patient/Guardian Decision|0|||
126673015|NCT01704287|455762013|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
126339326|NCT03167242|454538493|FG008|Overall Study|Patient/Guardian Decision|0|||
126339327|NCT03167242|454538494|FG009|Overall Study|Patient/Guardian Decision|0|||
126339328|NCT03167242|454538495|FG010|Overall Study|Patient/Guardian Decision|1|||
126339329|NCT03167242|454538496|FG011|Overall Study|Patient/Guardian Decision|0|||
126339330|NCT03167242|454538485|FG000|Overall Study|Lost to Follow-up|0|||
126339331|NCT03167242|454538486|FG001|Overall Study|Lost to Follow-up|0|||
126673016|NCT01704287|455762014|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
126673017|NCT01704287|455762015|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
126673018|NCT01704287|455762016|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
126673019|NCT00938717|455762017|FG000|Overall Study|Adverse Event|10|||
126673020|NCT00938717|455762018|FG001|Overall Study|Adverse Event|41|||
126673021|NCT00938717|455762017|FG000|Overall Study|Protocol Violation|11|||
126673022|NCT00938717|455762018|FG001|Overall Study|Protocol Violation|8|||
126673023|NCT00938717|455762017|FG000|Overall Study|Withdrawal by Subject|26|||
126673024|NCT00938717|455762018|FG001|Overall Study|Withdrawal by Subject|24|||
126673025|NCT00938717|455762017|FG000|Overall Study|Lost to Follow-up|13|||
126673026|NCT00938717|455762018|FG001|Overall Study|Lost to Follow-up|18|||
126673027|NCT00938717|455762017|FG000|Overall Study|Lack of Efficacy|33|||
126673028|NCT00938717|455762018|FG001|Overall Study|Lack of Efficacy|15|||
126673029|NCT00938717|455762017|FG000|Overall Study|Other reason|5|||
126673030|NCT00938717|455762018|FG001|Overall Study|Other reason|2|||
126673031|NCT01462435|455762021|FG000|Overall Study|Lack of Efficacy|1|||
126673032|NCT01462435|455762022|FG001|Overall Study|Lack of Efficacy|0|||
126673033|NCT01462435|455762023|FG002|Overall Study|Lack of Efficacy|0|||
126673034|NCT01462435|455762024|FG003|Overall Study|Lack of Efficacy|3|||
126673035|NCT01462435|455762021|FG000|Overall Study|Physician Decision|0|||
126673036|NCT01462435|455762022|FG001|Overall Study|Physician Decision|0|||
126673037|NCT01462435|455762023|FG002|Overall Study|Physician Decision|1|||
126673038|NCT01462435|455762024|FG003|Overall Study|Physician Decision|0|||
126673039|NCT01462435|455762021|FG000|Overall Study|Withdrawal by Subject|0|||
126673040|NCT01462435|455762022|FG001|Overall Study|Withdrawal by Subject|0|||
126673041|NCT01462435|455762023|FG002|Overall Study|Withdrawal by Subject|0|||
126673042|NCT01462435|455762024|FG003|Overall Study|Withdrawal by Subject|1|||
126673043|NCT01462435|455762021|FG000|Overall Study|Lost to Follow-up|0|||
126673044|NCT01462435|455762022|FG001|Overall Study|Lost to Follow-up|0|||
126673045|NCT01462435|455762023|FG002|Overall Study|Lost to Follow-up|0|||
126673046|NCT01462435|455762024|FG003|Overall Study|Lost to Follow-up|1|||
126673047|NCT05092919|455762025|FG000|Overall Study|Lost to Follow-up|7|||
126673048|NCT05092919|455762025|FG000|Overall Study|Withdrawal by Subject|2|||
126673049|NCT02248259|455762027|FG000|Treatment Period 1|Adverse Event|0|||
126673050|NCT02248259|455762028|FG001|Treatment Period 1|Adverse Event|0|||
126673051|NCT02248259|455762029|FG002|Treatment Period 1|Adverse Event|1|||
126673052|NCT02248259|455762030|FG003|Treatment Period 1|Adverse Event|0|||
126673053|NCT02573870|455762031|FG000|Overall Study|Adverse Event|0|||
126673054|NCT02573870|455762032|FG001|Overall Study|Adverse Event|2|||
126673055|NCT02573870|455762031|FG000|Overall Study|Lack of Efficacy|0|||
126673056|NCT02573870|455762032|FG001|Overall Study|Lack of Efficacy|1|||
126673057|NCT02573870|455762031|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
126673058|NCT02573870|455762032|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
126673059|NCT02573870|455762031|FG000|Overall Study|Lost to Follow-up|0|||
126673060|NCT02573870|455762032|FG001|Overall Study|Lost to Follow-up|1|||
126673061|NCT02573870|455762031|FG000|Overall Study|Other: Fail to Meet Visit|0|||
126673062|NCT02573870|455762032|FG001|Overall Study|Other: Fail to Meet Visit|2|||
126673063|NCT01848288|455762036|FG000|Overall Study|Death|1|||
126673064|NCT01848288|455762036|FG000|Overall Study|Protocol Violation|1|||
126673065|NCT01848288|455762036|FG000|Overall Study|Withdrawal by Subject|1|||
126673066|NCT00677820|455762038|FG000|Overall Study|Lost to Follow-up|1|||
126673067|NCT00677820|455762039|FG001|Overall Study|Lost to Follow-up|0|||
126673068|NCT00290290|455762059|FG000|Overall Study|Death|3|||
126673069|NCT00290290|455762060|FG001|Overall Study|Death|4|||
126673070|NCT00290290|455762059|FG000|Overall Study|Withdrawal by Subject|2|||
126673071|NCT00290290|455762060|FG001|Overall Study|Withdrawal by Subject|2|||
126339332|NCT03167242|454538487|FG002|Overall Study|Lost to Follow-up|1|||
126673072|NCT00290290|455762059|FG000|Overall Study|Underwent clean surgical procedure|13|||
126673073|NCT00290290|455762060|FG001|Overall Study|Underwent clean surgical procedure|12|||
126673074|NCT00003895|455762064|FG000|Overall Study|Adverse Event|4|||
126339333|NCT03167242|454538488|FG003|Overall Study|Lost to Follow-up|0|||
126339334|NCT03167242|454538489|FG004|Overall Study|Lost to Follow-up|0|||
126339335|NCT03167242|454538490|FG005|Overall Study|Lost to Follow-up|1|||
126339336|NCT03167242|454538491|FG006|Overall Study|Lost to Follow-up|2|||
126339337|NCT03167242|454538492|FG007|Overall Study|Lost to Follow-up|1|||
126339338|NCT03167242|454538493|FG008|Overall Study|Lost to Follow-up|0|||
126673075|NCT00003895|455762065|FG001|Overall Study|Adverse Event|0|||
126673076|NCT00003895|455762064|FG000|Overall Study|Lack of Efficacy|1|||
126339339|NCT03167242|454538494|FG009|Overall Study|Lost to Follow-up|0|||
126673077|NCT00003895|455762065|FG001|Overall Study|Lack of Efficacy|1|||
126673078|NCT00003895|455762064|FG000|Overall Study|Patient Vacation|2|||
126673079|NCT00003895|455762065|FG001|Overall Study|Patient Vacation|0|||
126673080|NCT00003895|455762064|FG000|Overall Study|Withdrawal by Subject|0|||
126339340|NCT03167242|454538495|FG010|Overall Study|Lost to Follow-up|1|||
126673081|NCT00003895|455762065|FG001|Overall Study|Withdrawal by Subject|3|||
126673082|NCT04912245|455762068|FG000|Overall Study|Withdrawal by Subject|21|||
126673083|NCT04912245|455762069|FG001|Overall Study|Withdrawal by Subject|4|||
126339341|NCT03167242|454538496|FG011|Overall Study|Lost to Follow-up|1|||
126424273|NCT01147666|454849297|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424274|NCT01147666|454849298|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424275|NCT01147666|454849299|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424276|NCT01147666|454849300|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424277|NCT01147666|454849301|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424278|NCT01147666|454849302|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424279|NCT01147666|454849303|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424280|NCT01147666|454849304|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126424281|NCT01147666|454849305|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
126424282|NCT01147666|454849306|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
126424283|NCT01147666|454849307|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
126673084|NCT04912245|455762068|FG000|Overall Study|Lost to Follow-up|5|||
126673085|NCT04912245|455762069|FG001|Overall Study|Lost to Follow-up|11|||
126673086|NCT01134614|455762070|FG000|Overall Study|Still on treatment as of March 2013|21|||
126673087|NCT01134614|455762071|FG001|Overall Study|Still on treatment as of March 2013|13|||
126673088|NCT01134614|455762070|FG000|Overall Study|Progressive disease|60|||
126673089|NCT01134614|455762071|FG001|Overall Study|Progressive disease|54|||
126673090|NCT01134614|455762070|FG000|Overall Study|Adverse Event|26|||
126673091|NCT01134614|455762071|FG001|Overall Study|Adverse Event|39|||
126673092|NCT01134614|455762070|FG000|Overall Study|Death|5|||
126673093|NCT01134614|455762071|FG001|Overall Study|Death|8|||
126673094|NCT01134614|455762070|FG000|Overall Study|Withdrawal by Subject|3|||
126673095|NCT01134614|455762071|FG001|Overall Study|Withdrawal by Subject|2|||
126673096|NCT01134614|455762070|FG000|Overall Study|Alternative therapy|2|||
126673097|NCT01134614|455762071|FG001|Overall Study|Alternative therapy|0|||
126673098|NCT01134614|455762070|FG000|Overall Study|Complicating disease|2|||
126673099|NCT01134614|455762071|FG001|Overall Study|Complicating disease|1|||
126673100|NCT01134614|455762070|FG000|Overall Study|Physician's decision|0|||
126673101|NCT01134614|455762071|FG001|Overall Study|Physician's decision|1|||
126673102|NCT01134614|455762070|FG000|Overall Study|Never started treatment|4|||
126673103|NCT01134614|455762071|FG001|Overall Study|Never started treatment|1|||
126673104|NCT01134614|455762070|FG000|Overall Study|Pt received tx not allowed on study|0|||
126673105|NCT01134614|455762071|FG001|Overall Study|Pt received tx not allowed on study|1|||
126673106|NCT01134614|455762070|FG000|Overall Study|Symptomatic deterioration|0|||
126673107|NCT01134614|455762071|FG001|Overall Study|Symptomatic deterioration|1|||
126673108|NCT01134614|455762070|FG000|Overall Study|Patient in hospice care|0|||
126673109|NCT01134614|455762071|FG001|Overall Study|Patient in hospice care|1|||
126673110|NCT02752035|455762072|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
126673111|NCT02752035|455762073|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
126673112|NCT02752035|455762074|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
126673113|NCT02752035|455762075|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
126673114|NCT02752035|455762072|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
126673115|NCT02752035|455762073|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
126673116|NCT02752035|455762074|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
126673117|NCT02752035|455762075|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
126673118|NCT02752035|455762072|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
126673119|NCT02752035|455762073|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
126673120|NCT02752035|455762074|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
126673121|NCT02752035|455762075|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
126673122|NCT02752035|455762072|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
126673123|NCT02752035|455762073|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
126673124|NCT02752035|455762074|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
126673125|NCT02752035|455762075|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
126673126|NCT02752035|455762072|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
126673127|NCT02752035|455762073|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
126673128|NCT02752035|455762074|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
126673129|NCT02752035|455762075|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
126673130|NCT02752035|455762072|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
126673131|NCT02752035|455762073|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
126673132|NCT02752035|455762074|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
126673133|NCT02752035|455762075|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
126673134|NCT02752035|455762072|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
126673135|NCT02752035|455762073|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
126673136|NCT02752035|455762074|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
126673137|NCT02752035|455762075|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
126673138|NCT02752035|455762072|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
126673139|NCT02752035|455762073|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
126673140|NCT02752035|455762074|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
126673141|NCT02752035|455762075|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
126424284|NCT01147666|454849308|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
126424285|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
126424286|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
126673142|NCT02752035|455762072|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
126673143|NCT02752035|455762073|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
126673144|NCT02752035|455762074|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
126673145|NCT02752035|455762075|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
126673146|NCT02752035|455762072|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
126673147|NCT02752035|455762073|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
126673148|NCT02752035|455762074|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
126673149|NCT02752035|455762075|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
126673150|NCT02752035|455762072|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
126673151|NCT02752035|455762073|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
126673152|NCT02752035|455762074|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
126673153|NCT02752035|455762075|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
126673154|NCT02752035|455762072|FG000|Randomization: Approximately 3 Years|Death|0|||
126673155|NCT02752035|455762073|FG001|Randomization: Approximately 3 Years|Death|25|||
126673156|NCT02752035|455762074|FG002|Randomization: Approximately 3 Years|Death|13|||
126673157|NCT02752035|455762075|FG003|Randomization: Approximately 3 Years|Death|4|||
126673158|NCT02752035|455762072|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
126673159|NCT02752035|455762073|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
126673160|NCT02752035|455762074|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
126673161|NCT02752035|455762075|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
126673162|NCT02752035|455762072|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
126673163|NCT02752035|455762073|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
126673164|NCT02752035|455762074|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
126673165|NCT02752035|455762075|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
126673166|NCT02752035|455762072|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
126673167|NCT02752035|455762073|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
126673168|NCT02752035|455762074|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
126673169|NCT02752035|455762075|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
126673170|NCT02752035|455762072|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
126673171|NCT02752035|455762073|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
126673172|NCT02752035|455762074|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
126673173|NCT02752035|455762075|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
126673174|NCT02752035|455762072|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
126673175|NCT02752035|455762073|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
126673176|NCT02752035|455762074|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
126673177|NCT02752035|455762075|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
126673178|NCT01161043|455762078|FG000|Overall Study|Withdrawal by Subject|3|||
126673179|NCT01236573|455762079|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126673180|NCT01236573|455762080|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126673181|NCT01236573|455762081|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126673182|NCT01236573|455762082|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126673183|NCT01236573|455762083|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126673184|NCT01236573|455762084|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126673185|NCT01236573|455762085|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
126673186|NCT01236573|455762086|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126673187|NCT01236573|455762087|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
126673188|NCT01236573|455762088|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
126673189|NCT01236573|455762089|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
126673190|NCT01236573|455762079|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126673191|NCT01236573|455762080|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126673192|NCT01236573|455762081|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126673193|NCT01236573|455762082|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126673194|NCT01236573|455762083|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126673195|NCT01236573|455762084|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126673196|NCT01236573|455762085|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126673197|NCT01236573|455762086|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126673198|NCT01236573|455762087|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
126424287|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
126673199|NCT01236573|455762088|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126673200|NCT01236573|455762089|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
126673201|NCT01236573|455762079|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126424288|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
126424289|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
126424290|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
126673202|NCT01236573|455762080|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126673203|NCT01236573|455762081|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126673204|NCT01236573|455762082|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126673205|NCT01236573|455762083|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126673206|NCT01236573|455762084|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126673207|NCT01236573|455762085|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126673208|NCT01236573|455762086|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126673209|NCT01236573|455762087|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126673210|NCT01236573|455762088|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
126673211|NCT01236573|455762089|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
126673212|NCT02164929|455762092|FG000|Overall Study|Converted to open procedure|1|||
126673213|NCT02164929|455762093|FG001|Overall Study|Converted to open procedure|0|||
126673214|NCT02164929|455762094|FG002|Overall Study|Converted to open procedure|0|||
126673215|NCT02164929|455762095|FG003|Overall Study|Converted to open procedure|2|||
126673216|NCT02164929|455762092|FG000|Overall Study|Failed regional block|0|||
126673217|NCT02164929|455762093|FG001|Overall Study|Failed regional block|0|||
126673218|NCT02164929|455762094|FG002|Overall Study|Failed regional block|1|||
126673219|NCT02164929|455762095|FG003|Overall Study|Failed regional block|0|||
126673220|NCT00971178|455762096|FG000|Overall Study|Lost to Follow-up|2|||
126673221|NCT00971178|455762097|FG001|Overall Study|Lost to Follow-up|2|||
126673222|NCT00971178|455762098|FG002|Overall Study|Lost to Follow-up|2|||
126673223|NCT02161575|455762100|FG000|Overall Study|Protocol Violation|8|||
126673224|NCT02161575|455762100|FG000|Overall Study|Lack of Efficacy|1|||
126673225|NCT02161575|455762100|FG000|Overall Study|Adverse Event|2|||
126673226|NCT00424749|455762102|FG000|Overall Study|Withdrawal by Subject|1|||
126673227|NCT04109222|455762103|FG000|Overall Study|Adverse Event|1|||
126673228|NCT04109222|455762104|FG001|Overall Study|Adverse Event|0|||
126673229|NCT04109222|455762105|FG002|Overall Study|Adverse Event|0|||
126673230|NCT03023059|455762106|FG000|Overall Study|Withdrawal by Subject|5|||
126673231|NCT02138617|455762107|FG000|Overall Study|Death|1|||
126673232|NCT02138617|455762108|FG001|Overall Study|Death|2|||
126673233|NCT02138617|455762109|FG002|Overall Study|Death|2|||
126673234|NCT02138617|455762107|FG000|Overall Study|Adverse Event|8|||
126339342|NCT03167242|454538485|FG000|Overall Study|Reason not provided|0|||
126673235|NCT02138617|455762108|FG001|Overall Study|Adverse Event|5|||
126673236|NCT02138617|455762109|FG002|Overall Study|Adverse Event|2|||
126673237|NCT02138617|455762107|FG000|Overall Study|Disease Progression|20|||
126673238|NCT02138617|455762108|FG001|Overall Study|Disease Progression|13|||
126673239|NCT02138617|455762109|FG002|Overall Study|Disease Progression|4|||
126673240|NCT02138617|455762107|FG000|Overall Study|Withdrawal by Subject|7|||
126673241|NCT02138617|455762108|FG001|Overall Study|Withdrawal by Subject|10|||
126673242|NCT02138617|455762109|FG002|Overall Study|Withdrawal by Subject|2|||
126673243|NCT02138617|455762107|FG000|Overall Study|other complicating disease|0|||
126673244|NCT02138617|455762108|FG001|Overall Study|other complicating disease|2|||
126673245|NCT02138617|455762109|FG002|Overall Study|other complicating disease|0|||
126673246|NCT02138617|455762107|FG000|Overall Study|Protocol Violation|1|||
126673247|NCT02138617|455762108|FG001|Overall Study|Protocol Violation|0|||
126673248|NCT02138617|455762109|FG002|Overall Study|Protocol Violation|0|||
126673249|NCT02138617|455762107|FG000|Overall Study|Physician Decision|7|||
126673250|NCT02138617|455762108|FG001|Overall Study|Physician Decision|6|||
126673251|NCT02138617|455762109|FG002|Overall Study|Physician Decision|0|||
126673252|NCT02138617|455762107|FG000|Overall Study|financial reason|0|||
126673253|NCT02138617|455762108|FG001|Overall Study|financial reason|1|||
126673254|NCT02138617|455762109|FG002|Overall Study|financial reason|0|||
126673255|NCT02138617|455762107|FG000|Overall Study|other therapy|3|||
126673256|NCT02138617|455762108|FG001|Overall Study|other therapy|4|||
126673257|NCT02138617|455762109|FG002|Overall Study|other therapy|0|||
126673258|NCT00596947|455762114|FG000|Overall Study|study halted due to low enrollment|5|||
126673259|NCT00596947|455762115|FG001|Overall Study|study halted due to low enrollment|3|||
126673260|NCT00596947|455762114|FG000|Overall Study|Lost to Follow-up|1|||
126673261|NCT00596947|455762115|FG001|Overall Study|Lost to Follow-up|0|||
126673262|NCT00496730|455762116|FG000|Overall Study|Lost to Follow-up|4|||
126673263|NCT00496730|455762117|FG001|Overall Study|Lost to Follow-up|3|||
126673264|NCT00496730|455762116|FG000|Overall Study|Withdrawal by Subject|2|||
126673265|NCT00496730|455762117|FG001|Overall Study|Withdrawal by Subject|2|||
126673266|NCT00574288|455762118|FG000|Overall Study|Adverse Event|2|||
126673267|NCT00574288|455762119|FG001|Overall Study|Adverse Event|0|||
126673268|NCT00574288|455762120|FG002|Overall Study|Adverse Event|0|||
126673269|NCT00574288|455762121|FG003|Overall Study|Adverse Event|0|||
126339343|NCT03167242|454538486|FG001|Overall Study|Reason not provided|0|||
126339344|NCT03167242|454538487|FG002|Overall Study|Reason not provided|0|||
126339345|NCT03167242|454538488|FG003|Overall Study|Reason not provided|0|||
126673270|NCT00574288|455762122|FG004|Overall Study|Adverse Event|1|||
126673271|NCT00574288|455762123|FG005|Overall Study|Adverse Event|0|||
126673272|NCT00574288|455762124|FG006|Overall Study|Adverse Event|0|||
126339346|NCT03167242|454538489|FG004|Overall Study|Reason not provided|0|||
126673273|NCT00574288|455762118|FG000|Overall Study|Death|0|||
126673274|NCT00574288|455762119|FG001|Overall Study|Death|0|||
126673275|NCT00574288|455762120|FG002|Overall Study|Death|0|||
126673276|NCT00574288|455762121|FG003|Overall Study|Death|0|||
126673277|NCT00574288|455762122|FG004|Overall Study|Death|0|||
126673278|NCT00574288|455762123|FG005|Overall Study|Death|25|||
126673279|NCT00574288|455762124|FG006|Overall Study|Death|21|||
126673280|NCT00574288|455762118|FG000|Overall Study|Lost to Follow-up|0|||
126673281|NCT00574288|455762119|FG001|Overall Study|Lost to Follow-up|0|||
126673282|NCT00574288|455762120|FG002|Overall Study|Lost to Follow-up|0|||
126673283|NCT00574288|455762121|FG003|Overall Study|Lost to Follow-up|0|||
126673284|NCT00574288|455762122|FG004|Overall Study|Lost to Follow-up|0|||
126673285|NCT00574288|455762123|FG005|Overall Study|Lost to Follow-up|1|||
126673286|NCT00574288|455762124|FG006|Overall Study|Lost to Follow-up|2|||
126673287|NCT00574288|455762118|FG000|Overall Study|Study Terminated By Sponsor|0|||
126673288|NCT00574288|455762119|FG001|Overall Study|Study Terminated By Sponsor|0|||
126673289|NCT00574288|455762120|FG002|Overall Study|Study Terminated By Sponsor|0|||
126673290|NCT00574288|455762121|FG003|Overall Study|Study Terminated By Sponsor|0|||
126673291|NCT00574288|455762122|FG004|Overall Study|Study Terminated By Sponsor|0|||
126673292|NCT00574288|455762123|FG005|Overall Study|Study Terminated By Sponsor|0|||
126673293|NCT00574288|455762124|FG006|Overall Study|Study Terminated By Sponsor|5|||
126673294|NCT00574288|455762118|FG000|Overall Study|Progressive Disease|17|||
126673295|NCT00574288|455762119|FG001|Overall Study|Progressive Disease|2|||
126673296|NCT00574288|455762120|FG002|Overall Study|Progressive Disease|3|||
126673297|NCT00574288|455762121|FG003|Overall Study|Progressive Disease|2|||
126673298|NCT00574288|455762122|FG004|Overall Study|Progressive Disease|1|||
126673299|NCT00574288|455762123|FG005|Overall Study|Progressive Disease|0|||
126673300|NCT00574288|455762124|FG006|Overall Study|Progressive Disease|0|||
126673301|NCT00574288|455762118|FG000|Overall Study|Other|1|||
126673302|NCT00574288|455762119|FG001|Overall Study|Other|1|||
126673303|NCT00574288|455762120|FG002|Overall Study|Other|0|||
126673304|NCT00574288|455762121|FG003|Overall Study|Other|0|||
126673305|NCT00574288|455762122|FG004|Overall Study|Other|0|||
126673306|NCT00574288|455762123|FG005|Overall Study|Other|0|||
126673307|NCT00574288|455762124|FG006|Overall Study|Other|0|||
126673308|NCT02361944|455762125|FG000|Overall Study|surgery cancellation|0|||
126673309|NCT02361944|455762126|FG001|Overall Study|surgery cancellation|1|||
126673310|NCT02811549|455762127|FG000|Overall Study|Lost to Follow-up|1|||
126673311|NCT02811549|455762127|FG000|Overall Study|Withdrawal by Subject|3|||
126673312|NCT02811549|455762127|FG000|Overall Study|Subject screen failed|4|||
126673313|NCT02811549|455762127|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
126673314|NCT03472924|455762129|FG000|Overall Study|Adverse Event|1|||
126673315|NCT03472924|455762130|FG001|Overall Study|Adverse Event|0|||
126673316|NCT00427349|455762132|FG000|Overall Study|Lack of Efficacy|23|||
126673317|NCT00427349|455762132|FG000|Overall Study|Adverse Event|14|||
126673318|NCT00427349|455762132|FG000|Overall Study|Death|1|||
126673319|NCT00427349|455762132|FG000|Overall Study|Withdrawal by Subject|3|||
126673320|NCT00427349|455762132|FG000|Overall Study|Alternative therapy|1|||
126673321|NCT00427349|455762132|FG000|Overall Study|Other|2|||
126673322|NCT00427349|455762132|FG000|Overall Study|Ineligible|1|||
126673323|NCT00427349|455762132|FG000|Overall Study|Never started therapy|1|||
126673324|NCT05082376|455762134|FG000|Overall Study|Lost to Follow-up|2|||
126673325|NCT04425720|455762142|FG000|Overall Study|Withdrawal by Subject|0|||
126673326|NCT04425720|455762143|FG001|Overall Study|Withdrawal by Subject|20|||
126673327|NCT00290186|455762144|FG000|Overall Study|Adverse Event|1|||
126673328|NCT00290186|455762145|FG001|Overall Study|Adverse Event|1|||
126673329|NCT00290186|455762144|FG000|Overall Study|Lost to Follow-up|3|||
126673330|NCT00290186|455762145|FG001|Overall Study|Lost to Follow-up|2|||
126673331|NCT00290186|455762144|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
126673332|NCT00290186|455762145|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
126673333|NCT00290186|455762144|FG000|Overall Study|Withdrawal by Subject|0|||
126673334|NCT00290186|455762145|FG001|Overall Study|Withdrawal by Subject|1|||
126673335|NCT00445224|455762146|FG000|Specific Exercises|Withdrawal by Subject|3|||
126673336|NCT00445224|455762147|FG001|Specific Exercises|Withdrawal by Subject|3|||
126673337|NCT00445224|455762146|FG000|Specific Exercises|Withdrawal by Subject|1|||
126673338|NCT00445224|455762147|FG001|Specific Exercises|Withdrawal by Subject|0|||
126673339|NCT04085523|455762152|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
126339347|NCT03167242|454538490|FG005|Overall Study|Reason not provided|0|||
126673340|NCT04085523|455762153|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
126673341|NCT04085523|455762154|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
126673342|NCT04085523|455762155|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
126673343|NCT04085523|455762156|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
126673344|NCT04085523|455762157|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
126673345|NCT01877915|455762160|FG000|Overall Study|Lost to Follow-up|10|||
126673346|NCT01877915|455762161|FG001|Overall Study|Lost to Follow-up|9|||
126673347|NCT01877915|455762160|FG000|Overall Study|Withdrawal by Subject|42|||
126673348|NCT01877915|455762161|FG001|Overall Study|Withdrawal by Subject|55|||
126673349|NCT01877915|455762160|FG000|Overall Study|Other|2|||
126673350|NCT01877915|455762161|FG001|Overall Study|Other|4|||
126424291|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
126424292|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
126424293|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
126424294|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
126424295|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
126424296|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
126424297|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
126424298|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
126424299|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
126424300|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126673351|NCT03520959|455762162|FG000|Overall Study|Study terminated by Sponsor|0|||
126673352|NCT03520959|455762163|FG001|Overall Study|Study terminated by Sponsor|1|||
126673353|NCT01449461|455762164|FG000|Overall Study|Adverse Event|0|||
126673354|NCT01449461|455762165|FG001|Overall Study|Adverse Event|3|||
126673355|NCT01449461|455762166|FG002|Overall Study|Adverse Event|2|||
126673356|NCT01449461|455762167|FG003|Overall Study|Adverse Event|3|||
126673357|NCT01449461|455762168|FG004|Overall Study|Adverse Event|4|||
126673358|NCT01449461|455762169|FG005|Overall Study|Adverse Event|4|||
126673359|NCT01449461|455762164|FG000|Overall Study|Death|0|||
126673360|NCT01449461|455762165|FG001|Overall Study|Death|2|||
126673361|NCT01449461|455762166|FG002|Overall Study|Death|0|||
126673362|NCT01449461|455762167|FG003|Overall Study|Death|0|||
126673363|NCT01449461|455762168|FG004|Overall Study|Death|7|||
126673364|NCT01449461|455762169|FG005|Overall Study|Death|1|||
126673365|NCT01449461|455762164|FG000|Overall Study|Physician Decision|0|||
126673366|NCT01449461|455762165|FG001|Overall Study|Physician Decision|1|||
126673367|NCT01449461|455762166|FG002|Overall Study|Physician Decision|0|||
126673368|NCT01449461|455762167|FG003|Overall Study|Physician Decision|4|||
126673369|NCT01449461|455762168|FG004|Overall Study|Physician Decision|1|||
126673370|NCT01449461|455762169|FG005|Overall Study|Physician Decision|0|||
126673371|NCT01449461|455762164|FG000|Overall Study|Documented Progressive Disease|4|||
126673372|NCT01449461|455762165|FG001|Overall Study|Documented Progressive Disease|7|||
126673373|NCT01449461|455762166|FG002|Overall Study|Documented Progressive Disease|14|||
126673374|NCT01449461|455762167|FG003|Overall Study|Documented Progressive Disease|15|||
126673375|NCT01449461|455762168|FG004|Overall Study|Documented Progressive Disease|24|||
126673376|NCT01449461|455762169|FG005|Overall Study|Documented Progressive Disease|5|||
126673377|NCT01449461|455762164|FG000|Overall Study|Clinical Progressive Disease|2|||
126673378|NCT01449461|455762165|FG001|Overall Study|Clinical Progressive Disease|2|||
126673379|NCT01449461|455762166|FG002|Overall Study|Clinical Progressive Disease|0|||
126673380|NCT01449461|455762167|FG003|Overall Study|Clinical Progressive Disease|3|||
126673381|NCT01449461|455762168|FG004|Overall Study|Clinical Progressive Disease|4|||
126673382|NCT01449461|455762169|FG005|Overall Study|Clinical Progressive Disease|2|||
126673383|NCT01449461|455762164|FG000|Overall Study|Protocol Violation|0|||
126673384|NCT01449461|455762165|FG001|Overall Study|Protocol Violation|0|||
126673385|NCT01449461|455762166|FG002|Overall Study|Protocol Violation|0|||
126673386|NCT01449461|455762167|FG003|Overall Study|Protocol Violation|1|||
126673387|NCT01449461|455762168|FG004|Overall Study|Protocol Violation|0|||
126673388|NCT01449461|455762169|FG005|Overall Study|Protocol Violation|0|||
126673389|NCT01449461|455762164|FG000|Overall Study|Site Terminated by Sponsor|0|||
126673390|NCT01449461|455762165|FG001|Overall Study|Site Terminated by Sponsor|1|||
126673391|NCT01449461|455762166|FG002|Overall Study|Site Terminated by Sponsor|2|||
126673392|NCT01449461|455762167|FG003|Overall Study|Site Terminated by Sponsor|3|||
126673393|NCT01449461|455762168|FG004|Overall Study|Site Terminated by Sponsor|4|||
126673394|NCT01449461|455762169|FG005|Overall Study|Site Terminated by Sponsor|1|||
126673395|NCT01449461|455762164|FG000|Overall Study|Withdrawal by Subject|0|||
126673396|NCT01449461|455762165|FG001|Overall Study|Withdrawal by Subject|1|||
126673397|NCT01449461|455762166|FG002|Overall Study|Withdrawal by Subject|0|||
126673398|NCT01449461|455762167|FG003|Overall Study|Withdrawal by Subject|0|||
126673399|NCT01449461|455762168|FG004|Overall Study|Withdrawal by Subject|2|||
126673400|NCT01449461|455762169|FG005|Overall Study|Withdrawal by Subject|1|||
126673401|NCT01449461|455762164|FG000|Overall Study|Reason not Specified|0|||
126673402|NCT01449461|455762165|FG001|Overall Study|Reason not Specified|1|||
126673403|NCT01449461|455762166|FG002|Overall Study|Reason not Specified|0|||
126673404|NCT01449461|455762167|FG003|Overall Study|Reason not Specified|3|||
126673405|NCT01449461|455762168|FG004|Overall Study|Reason not Specified|2|||
126673406|NCT01449461|455762169|FG005|Overall Study|Reason not Specified|1|||
126673407|NCT01357577|455762170|FG000|Overall Study|Lost to Follow-up|20|||
126424301|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126424302|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126673408|NCT01357577|455762171|FG001|Overall Study|Lost to Follow-up|16|||
126673409|NCT01357577|455762170|FG000|Overall Study|Withdrawal by Subject|16|||
126673410|NCT01357577|455762171|FG001|Overall Study|Withdrawal by Subject|8|||
126673411|NCT01357577|455762170|FG000|Overall Study|look at data in database?|1|||
126673412|NCT01357577|455762171|FG001|Overall Study|look at data in database?|2|||
126673413|NCT01502709|455763136|FG000|Overall Study|Lost to Follow-up|4|||
126673414|NCT01502709|455763137|FG001|Overall Study|Lost to Follow-up|0|||
126673415|NCT00937937|455763139|FG000|Overall Study|Adverse Event|6|||
126673416|NCT00937937|455763139|FG000|Overall Study|Withdrawal by Subject|2|||
126673417|NCT00937937|455763139|FG000|Overall Study|Progression/relapse|61|||
126673418|NCT00937937|455763139|FG000|Overall Study|Death|1|||
126673419|NCT00937937|455763139|FG000|Overall Study|Other|2|||
126673420|NCT04024228|455763141|FG000|Overall Study|Adverse Event|1|||
126673421|NCT04024228|455763142|FG001|Overall Study|Adverse Event|0|||
126673422|NCT04024228|455763141|FG000|Overall Study|Protocol Deviation|0|||
126673423|NCT04024228|455763142|FG001|Overall Study|Protocol Deviation|2|||
126673424|NCT04024228|455763141|FG000|Overall Study|Withdrawal by Subject|3|||
126673425|NCT04024228|455763142|FG001|Overall Study|Withdrawal by Subject|4|||
126339348|NCT03167242|454538491|FG006|Overall Study|Reason not provided|0|||
126339349|NCT03167242|454538492|FG007|Overall Study|Reason not provided|0|||
126339350|NCT03167242|454538493|FG008|Overall Study|Reason not provided|1|||
126339351|NCT03167242|454538494|FG009|Overall Study|Reason not provided|0|||
126339352|NCT03167242|454538495|FG010|Overall Study|Reason not provided|0|||
126339353|NCT03167242|454538496|FG011|Overall Study|Reason not provided|0|||
126339354|NCT00726609|454538499|FG000|Overall Study|Adverse Event|10|||
126339355|NCT00726609|454538499|FG000|Overall Study|Withdrawal by Subject|2|||
126339356|NCT00726609|454538499|FG000|Overall Study|Lack of Efficacy|25|||
126339357|NCT00726609|454538499|FG000|Overall Study|Other|16|||
126339358|NCT00726609|454538499|FG000|Overall Study|Missing|42|||
126339359|NCT00726609|454538499|FG000|Overall Study|Other|3|||
126339360|NCT02144701|454538505|FG000|Overall Study|development of relapse, GVHD or death|9|||
126339361|NCT02144701|454538506|FG001|Overall Study|development of relapse, GVHD or death|3|||
126339362|NCT03327324|454538508|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339363|NCT03327324|454538509|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
126339364|NCT03327324|454538510|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339365|NCT03327324|454538511|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
126339366|NCT03327324|454538512|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339367|NCT03327324|454538513|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
126339368|NCT03327324|454538508|FG000|Baseline (Month 0-Month 3)|Refused|0|||
126339369|NCT03327324|454538509|FG001|Baseline (Month 0-Month 3)|Refused|0|||
126339370|NCT03327324|454538510|FG002|Baseline (Month 0-Month 3)|Refused|0|||
126339371|NCT03327324|454538511|FG003|Baseline (Month 0-Month 3)|Refused|0|||
126339372|NCT03327324|454538512|FG004|Baseline (Month 0-Month 3)|Refused|1|||
126339373|NCT03327324|454538513|FG005|Baseline (Month 0-Month 3)|Refused|0|||
126339374|NCT03327324|454538508|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
126339375|NCT03327324|454538509|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
126339376|NCT03327324|454538510|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
126339377|NCT03327324|454538511|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
126339378|NCT03327324|454538512|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
126339379|NCT03327324|454538513|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
126339380|NCT03327324|454538508|FG000|Baseline (Month 0-Month 3)|Death|0|||
126339381|NCT03327324|454538509|FG001|Baseline (Month 0-Month 3)|Death|0|||
126339382|NCT03327324|454538510|FG002|Baseline (Month 0-Month 3)|Death|0|||
126339383|NCT03327324|454538511|FG003|Baseline (Month 0-Month 3)|Death|0|||
126339384|NCT03327324|454538512|FG004|Baseline (Month 0-Month 3)|Death|1|||
126339385|NCT03327324|454538513|FG005|Baseline (Month 0-Month 3)|Death|0|||
126339386|NCT03327324|454538508|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339387|NCT03327324|454538509|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339388|NCT03327324|454538510|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339389|NCT03327324|454538511|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339390|NCT03327324|454538512|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339391|NCT03327324|454538513|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
126339392|NCT03327324|454538508|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339393|NCT03327324|454538509|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339394|NCT03327324|454538510|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
126339395|NCT03327324|454538511|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339396|NCT03327324|454538512|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126673426|NCT02932410|455763143|FG000|Overall Study|Death|7|||
126673427|NCT02932410|455763144|FG001|Overall Study|Death|6|||
126673428|NCT02932410|455763145|FG002|Overall Study|Death|0|||
126673429|NCT02932410|455763146|FG003|Overall Study|Death|0|||
126673430|NCT02932410|455763143|FG000|Overall Study|Lost to Follow-up|1|||
126673431|NCT02932410|455763144|FG001|Overall Study|Lost to Follow-up|2|||
126673432|NCT02932410|455763145|FG002|Overall Study|Lost to Follow-up|0|||
126673433|NCT02932410|455763146|FG003|Overall Study|Lost to Follow-up|0|||
126673434|NCT02932410|455763143|FG000|Overall Study|Parent/Subjects decision|6|||
126339397|NCT03327324|454538513|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339398|NCT03327324|454538508|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
126339399|NCT03327324|454538509|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
126339400|NCT03327324|454538510|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
126339401|NCT03327324|454538511|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
126339402|NCT03327324|454538512|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
126339403|NCT03327324|454538513|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
126339404|NCT03327324|454538508|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
126339405|NCT03327324|454538509|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
126339406|NCT03327324|454538510|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
126339407|NCT03327324|454538511|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
126339408|NCT03327324|454538512|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
126339409|NCT03327324|454538513|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
126339410|NCT03327324|454538508|FG000|Intervention (Month 3-Month 6)|Death|1|||
126339411|NCT03327324|454538509|FG001|Intervention (Month 3-Month 6)|Death|0|||
126339412|NCT03327324|454538510|FG002|Intervention (Month 3-Month 6)|Death|1|||
126339413|NCT03327324|454538511|FG003|Intervention (Month 3-Month 6)|Death|1|||
126339414|NCT03327324|454538512|FG004|Intervention (Month 3-Month 6)|Death|1|||
126339415|NCT03327324|454538513|FG005|Intervention (Month 3-Month 6)|Death|0|||
126339416|NCT03327324|454538508|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339417|NCT03327324|454538509|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339418|NCT03327324|454538510|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339419|NCT03327324|454538511|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339420|NCT03327324|454538512|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339421|NCT03327324|454538513|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
126339422|NCT03327324|454538508|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
126339423|NCT03327324|454538509|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339424|NCT03327324|454538510|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339425|NCT03327324|454538511|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339426|NCT03327324|454538512|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339427|NCT03327324|454538513|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
126339428|NCT03327324|454538508|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
126339429|NCT03327324|454538509|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
126339430|NCT03327324|454538510|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
126339431|NCT03327324|454538511|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
126339432|NCT03327324|454538512|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
126339433|NCT03327324|454538513|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
126339434|NCT03327324|454538508|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
126339435|NCT03327324|454538509|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
126339436|NCT03327324|454538510|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
126339437|NCT03327324|454538511|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
126339438|NCT03327324|454538512|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
126339439|NCT03327324|454538513|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
126339440|NCT03327324|454538508|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339441|NCT03327324|454538509|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339442|NCT03327324|454538510|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339443|NCT03327324|454538511|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
126339444|NCT03327324|454538512|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
126339445|NCT03327324|454538513|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
126339446|NCT03327324|454538508|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
126339447|NCT03327324|454538509|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
126339448|NCT03327324|454538510|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
126673435|NCT02932410|455763144|FG001|Overall Study|Parent/Subjects decision|6|||
126673436|NCT02932410|455763145|FG002|Overall Study|Parent/Subjects decision|1|||
126424303|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126424304|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
126424305|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
126424306|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
126424307|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
126424308|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126424309|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
126424310|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126424311|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126424312|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
126424313|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
126424314|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
126424315|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424316|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424317|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424318|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
126424319|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424320|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424321|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424322|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424323|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424324|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424325|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424326|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424327|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424328|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424329|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
126424330|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424331|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424332|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424333|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424334|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
126424335|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
126424336|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424337|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
126424338|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424339|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
126424340|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424341|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424342|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424343|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
126424344|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
126424345|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424346|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424347|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424348|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
126424349|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424350|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424351|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424352|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126673437|NCT02932410|455763146|FG003|Overall Study|Parent/Subjects decision|0|||
126673438|NCT02932410|455763143|FG000|Overall Study|Physician Decision|0|||
126673439|NCT02932410|455763144|FG001|Overall Study|Physician Decision|1|||
126673440|NCT02932410|455763145|FG002|Overall Study|Physician Decision|0|||
126673441|NCT02932410|455763146|FG003|Overall Study|Physician Decision|0|||
126673442|NCT01007032|455763152|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
126673443|NCT01007032|455763153|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
126673444|NCT01007032|455763154|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
126673445|NCT01007032|455763155|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
126673446|NCT01007032|455763152|FG000|Overall Study|Withdrawal by Subject|0|||
126673447|NCT01007032|455763153|FG001|Overall Study|Withdrawal by Subject|0|||
126673448|NCT01007032|455763154|FG002|Overall Study|Withdrawal by Subject|0|||
126673449|NCT01007032|455763155|FG003|Overall Study|Withdrawal by Subject|1|||
126673450|NCT01841749|455763156|FG000|Overall Study|Protocol Violation|1|||
126673451|NCT02865018|455763161|FG000|Overall Study|Withdrawal by Subject|1|||
126673452|NCT00549939|455763169|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
126673453|NCT00549939|455763170|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
126673454|NCT00549939|455763171|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
126673455|NCT00549939|455763169|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
126673456|NCT00549939|455763170|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
126673457|NCT00549939|455763171|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
126339449|NCT03327324|454538511|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
126339450|NCT03327324|454538512|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
126339451|NCT03327324|454538513|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
126339452|NCT03327324|454538508|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
126339453|NCT03327324|454538509|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
126339454|NCT03327324|454538510|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
126339455|NCT03327324|454538511|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
126339456|NCT03327324|454538512|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
126339457|NCT03327324|454538513|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
126339458|NCT01614470|454538516|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
126339459|NCT01614470|454538517|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126339460|NCT01614470|454538518|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126339461|NCT01614470|454538516|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
126339462|NCT01614470|454538517|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
126339463|NCT01614470|454538518|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
126339464|NCT03217591|454538519|FG000|Overall Study|Adverse Event|1|||
126339465|NCT03217591|454538520|FG001|Overall Study|Adverse Event|2|||
126339466|NCT03217591|454538521|FG002|Overall Study|Adverse Event|6|||
126339467|NCT03217591|454538519|FG000|Overall Study|Withdrawal by Subject|0|||
126339468|NCT03217591|454538520|FG001|Overall Study|Withdrawal by Subject|1|||
126339469|NCT03217591|454538521|FG002|Overall Study|Withdrawal by Subject|3|||
126339470|NCT03217591|454538519|FG000|Overall Study|Lost to Follow-up|1|||
126339471|NCT03217591|454538520|FG001|Overall Study|Lost to Follow-up|0|||
126339472|NCT03217591|454538521|FG002|Overall Study|Lost to Follow-up|0|||
126339473|NCT03217591|454538519|FG000|Overall Study|Protocol Violation|1|||
126339474|NCT03217591|454538520|FG001|Overall Study|Protocol Violation|0|||
126339475|NCT03217591|454538521|FG002|Overall Study|Protocol Violation|1|||
126339476|NCT00249834|454538522|FG000|Overall Study|Ovarian stimulation failed|1|||
126339477|NCT00249834|454538523|FG001|Overall Study|Ovarian stimulation failed|0|||
126339478|NCT00249834|454538524|FG002|Overall Study|Ovarian stimulation failed|0|||
126339479|NCT00249834|454538525|FG003|Overall Study|Ovarian stimulation failed|0|||
126339480|NCT00249834|454538526|FG004|Overall Study|Ovarian stimulation failed|0|||
126339481|NCT00249834|454538527|FG005|Overall Study|Ovarian stimulation failed|0|||
126339482|NCT00249834|454538528|FG006|Overall Study|Ovarian stimulation failed|0|||
126339483|NCT00249834|454538529|FG007|Overall Study|Ovarian stimulation failed|0|||
126339484|NCT00249834|454538522|FG000|Overall Study|Failure of down-regulation|0|||
126339485|NCT00249834|454538523|FG001|Overall Study|Failure of down-regulation|0|||
126339486|NCT00249834|454538524|FG002|Overall Study|Failure of down-regulation|0|||
126339487|NCT00249834|454538525|FG003|Overall Study|Failure of down-regulation|0|||
126339488|NCT00249834|454538526|FG004|Overall Study|Failure of down-regulation|0|||
126339489|NCT00249834|454538527|FG005|Overall Study|Failure of down-regulation|0|||
126339490|NCT00249834|454538528|FG006|Overall Study|Failure of down-regulation|1|||
126339491|NCT00249834|454538529|FG007|Overall Study|Failure of down-regulation|0|||
126339492|NCT00249834|454538522|FG000|Overall Study|Protocol Violation|0|||
126339493|NCT00249834|454538523|FG001|Overall Study|Protocol Violation|19|||
126339494|NCT00249834|454538524|FG002|Overall Study|Protocol Violation|14|||
126339495|NCT00249834|454538525|FG003|Overall Study|Protocol Violation|8|||
126339496|NCT00249834|454538526|FG004|Overall Study|Protocol Violation|5|||
126339497|NCT00249834|454538527|FG005|Overall Study|Protocol Violation|2|||
126339498|NCT00249834|454538528|FG006|Overall Study|Protocol Violation|0|||
126339499|NCT00249834|454538529|FG007|Overall Study|Protocol Violation|0|||
126339500|NCT00269152|454538531|FG000|Overall Study|Adverse Event|9|||
126339501|NCT00269152|454538532|FG001|Overall Study|Adverse Event|3|||
126339502|NCT00269152|454538531|FG000|Overall Study|Withdrawal by Subject|7|||
126339503|NCT00269152|454538532|FG001|Overall Study|Withdrawal by Subject|3|||
126339504|NCT00269152|454538531|FG000|Overall Study|Physician Decision|2|||
126339505|NCT00269152|454538532|FG001|Overall Study|Physician Decision|3|||
126339506|NCT00269152|454538531|FG000|Overall Study|Protocol Violation|0|||
126339507|NCT00269152|454538532|FG001|Overall Study|Protocol Violation|1|||
126339508|NCT04249427|454538533|FG000|Overall Study|Adverse Event|3|||
126339509|NCT04249427|454538534|FG001|Overall Study|Adverse Event|1|||
126339510|NCT04249427|454538533|FG000|Overall Study|Lack of Efficacy|0|||
126339511|NCT04249427|454538534|FG001|Overall Study|Lack of Efficacy|1|||
126339512|NCT04249427|454538533|FG000|Overall Study|Withdrawal by Subject|1|||
126339513|NCT04249427|454538534|FG001|Overall Study|Withdrawal by Subject|2|||
126339514|NCT02557399|454538535|FG000|Overall Study|Adverse Event|6|||
126339515|NCT02557399|454538536|FG001|Overall Study|Adverse Event|5|||
126339516|NCT02557399|454538535|FG000|Overall Study|Protocol Violation|0|||
126339517|NCT02557399|454538536|FG001|Overall Study|Protocol Violation|1|||
126673458|NCT00549939|455763169|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
126673459|NCT00549939|455763170|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
126673460|NCT00549939|455763171|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
126673461|NCT00549939|455763169|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
126673462|NCT00549939|455763170|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
126673463|NCT00549939|455763171|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
126673464|NCT00549939|455763169|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
126673465|NCT00549939|455763170|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
126673466|NCT00549939|455763171|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
126673467|NCT00549939|455763169|FG000|40-week Open Label Treatment Period|Other|0|||
126673468|NCT00549939|455763170|FG001|40-week Open Label Treatment Period|Other|1|||
126673469|NCT00549939|455763171|FG002|40-week Open Label Treatment Period|Other|4|||
126673470|NCT03677596|455763172|FG000|Overall Study|Adverse Event|0|||
126673471|NCT03677596|455763173|FG001|Overall Study|Adverse Event|1|||
126673472|NCT03677596|455763172|FG000|Overall Study|Death|10|||
126673473|NCT03677596|455763173|FG001|Overall Study|Death|6|||
126673474|NCT03677596|455763172|FG000|Overall Study|Lost to Follow-up|0|||
126673475|NCT03677596|455763173|FG001|Overall Study|Lost to Follow-up|1|||
126673476|NCT03677596|455763172|FG000|Overall Study|Progressive Disease|8|||
126673477|NCT03677596|455763173|FG001|Overall Study|Progressive Disease|8|||
126673478|NCT03677596|455763172|FG000|Overall Study|Withdrawal by Subject|3|||
126673479|NCT03677596|455763173|FG001|Overall Study|Withdrawal by Subject|0|||
126673480|NCT03677596|455763172|FG000|Overall Study|Disease Relapse|2|||
126339518|NCT02557399|454538535|FG000|Overall Study|Protocol-defined stopping criteria|0|||
126339519|NCT02557399|454538536|FG001|Overall Study|Protocol-defined stopping criteria|1|||
126339520|NCT02557399|454538535|FG000|Overall Study|Withdrawal by Subject|1|||
126339521|NCT02557399|454538536|FG001|Overall Study|Withdrawal by Subject|1|||
126339522|NCT02848664|454538537|FG000|Overall Study|Withdrawal by Subject|2|||
126339523|NCT02848664|454538537|FG000|Overall Study|Adverse Event|1|||
126339524|NCT02848664|454538537|FG000|Overall Study|no assistance for device training|1|||
126339525|NCT00402727|454538538|FG000|Overall Study|Adverse Event|10|||
126339526|NCT00402727|454538539|FG001|Overall Study|Adverse Event|6|||
126339527|NCT00402727|454538538|FG000|Overall Study|Death|1|||
126339528|NCT00402727|454538539|FG001|Overall Study|Death|0|||
126339529|NCT00402727|454538538|FG000|Overall Study|Lack of Efficacy|1|||
126339530|NCT00402727|454538539|FG001|Overall Study|Lack of Efficacy|3|||
126339531|NCT00402727|454538538|FG000|Overall Study|Lost to Follow-up|24|||
126339532|NCT00402727|454538539|FG001|Overall Study|Lost to Follow-up|11|||
126339533|NCT00402727|454538538|FG000|Overall Study|Physician Decision|1|||
126339534|NCT00402727|454538539|FG001|Overall Study|Physician Decision|1|||
126339535|NCT00402727|454538538|FG000|Overall Study|Protocol Violation|0|||
126339536|NCT00402727|454538539|FG001|Overall Study|Protocol Violation|4|||
126339537|NCT00402727|454538538|FG000|Overall Study|Withdrawal by Subject|3|||
126339538|NCT00402727|454538539|FG001|Overall Study|Withdrawal by Subject|7|||
126339539|NCT00402727|454538538|FG000|Overall Study|supply problems|2|||
126339540|NCT00402727|454538539|FG001|Overall Study|supply problems|1|||
126339541|NCT00402727|454538538|FG000|Overall Study|non-compliance|0|||
126339542|NCT00402727|454538539|FG001|Overall Study|non-compliance|1|||
126339543|NCT03188055|454538540|FG000|Overall Study|Unavailable for training|0|||
126339544|NCT03188055|454538541|FG001|Overall Study|Unavailable for training|0|||
126339545|NCT03188055|454538542|FG002|Overall Study|Unavailable for training|19|||
126339546|NCT03188055|454538543|FG003|Overall Study|Unavailable for training|0|||
126339547|NCT03188055|454538544|FG004|Overall Study|Unavailable for training|0|||
126339548|NCT03188055|454538545|FG005|Overall Study|Unavailable for training|0|||
126339549|NCT03188055|454538540|FG000|Overall Study|Lost to Follow-up|0|||
126339550|NCT03188055|454538541|FG001|Overall Study|Lost to Follow-up|18|||
126339551|NCT03188055|454538542|FG002|Overall Study|Lost to Follow-up|0|||
126339552|NCT03188055|454538543|FG003|Overall Study|Lost to Follow-up|11|||
126339553|NCT03188055|454538544|FG004|Overall Study|Lost to Follow-up|0|||
126339554|NCT03188055|454538545|FG005|Overall Study|Lost to Follow-up|0|||
126339555|NCT03188055|454538540|FG000|Overall Study|Withdrawal by Subject|0|||
126339556|NCT03188055|454538541|FG001|Overall Study|Withdrawal by Subject|1|||
126339557|NCT03188055|454538542|FG002|Overall Study|Withdrawal by Subject|0|||
126339558|NCT03188055|454538543|FG003|Overall Study|Withdrawal by Subject|1|||
126339559|NCT03188055|454538544|FG004|Overall Study|Withdrawal by Subject|0|||
126339560|NCT03188055|454538545|FG005|Overall Study|Withdrawal by Subject|0|||
126339561|NCT01405898|454538546|FG000|Overall Study|Withdrawal by Subject|2|||
126339562|NCT01405898|454538547|FG001|Overall Study|Withdrawal by Subject|2|||
126339563|NCT00264147|454538550|FG000|Treatment I Period|Adverse Event|3|||
126339564|NCT00264147|454538551|FG001|Treatment I Period|Adverse Event|6|||
126673481|NCT03677596|455763173|FG001|Overall Study|Disease Relapse|2|||
126673482|NCT03677596|455763172|FG000|Overall Study|Other|0|||
126339565|NCT00264147|454538552|FG002|Treatment I Period|Adverse Event|3|||
126339566|NCT00264147|454538553|FG003|Treatment I Period|Adverse Event|5|||
126339567|NCT00264147|454538554|FG004|Treatment I Period|Adverse Event|7|||
126339568|NCT00264147|454538555|FG005|Treatment I Period|Adverse Event|0|||
126673483|NCT03677596|455763173|FG001|Overall Study|Other|1|||
126673484|NCT05197049|455763174|FG000|Overall Study|Death|0|||
126673485|NCT05197049|455763175|FG001|Overall Study|Death|1|||
126673486|NCT05197049|455763176|FG002|Overall Study|Death|0|||
126673487|NCT05197049|455763174|FG000|Overall Study|Lost to Follow-up|3|||
126673488|NCT05197049|455763175|FG001|Overall Study|Lost to Follow-up|1|||
126673489|NCT05197049|455763176|FG002|Overall Study|Lost to Follow-up|0|||
126673490|NCT05197049|455763174|FG000|Overall Study|Withdrawal by Subject|15|||
126673491|NCT05197049|455763175|FG001|Overall Study|Withdrawal by Subject|3|||
126673492|NCT05197049|455763176|FG002|Overall Study|Withdrawal by Subject|1|||
126673493|NCT05197049|455763174|FG000|Overall Study|GCP non-compliance|1|||
126673494|NCT05197049|455763175|FG001|Overall Study|GCP non-compliance|2|||
126673495|NCT05197049|455763176|FG002|Overall Study|GCP non-compliance|0|||
126673496|NCT02577406|455763183|FG000|Randomized Period|Death|1|||
126673497|NCT02577406|455763184|FG001|Randomized Period|Death|0|||
126673498|NCT02577406|455763183|FG000|Randomized Period|Other reasons|0|||
126673499|NCT02577406|455763184|FG001|Randomized Period|Other reasons|20|||
126673500|NCT02577406|455763183|FG000|Treatment Period|Death|38|||
126673501|NCT02577406|455763184|FG001|Treatment Period|Death|23|||
126673502|NCT02577406|455763183|FG000|Treatment Period|Adverse Event|17|||
126673503|NCT02577406|455763184|FG001|Treatment Period|Adverse Event|12|||
126673504|NCT02577406|455763183|FG000|Treatment Period|Progressive Disease|53|||
126673505|NCT02577406|455763184|FG001|Treatment Period|Progressive Disease|37|||
126673506|NCT02577406|455763183|FG000|Treatment Period|Withdrawal by Subject|10|||
126673507|NCT02577406|455763184|FG001|Treatment Period|Withdrawal by Subject|24|||
126673508|NCT02577406|455763183|FG000|Treatment Period|Lost to Follow-up|0|||
126673509|NCT02577406|455763184|FG001|Treatment Period|Lost to Follow-up|1|||
126673510|NCT02577406|455763183|FG000|Treatment Period|Transition to commercially available treatment|1|||
126673511|NCT02577406|455763184|FG001|Treatment Period|Transition to commercially available treatment|1|||
126673512|NCT02577406|455763183|FG000|Treatment Period|Physician Decision|1|||
126673513|NCT02577406|455763184|FG001|Treatment Period|Physician Decision|0|||
126673514|NCT02577406|455763183|FG000|Treatment Period|Disease Relapse|28|||
126673515|NCT02577406|455763184|FG001|Treatment Period|Disease Relapse|1|||
126673516|NCT02577406|455763183|FG000|Treatment Period|Protocol Violation|0|||
126673517|NCT02577406|455763184|FG001|Treatment Period|Protocol Violation|1|||
126673518|NCT02577406|455763183|FG000|Treatment Period|Other Reasons|3|||
126673519|NCT02577406|455763184|FG001|Treatment Period|Other Reasons|39|||
126673520|NCT02577406|455763183|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
126673521|NCT02577406|455763184|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
126673522|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
126673523|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
126673524|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126673525|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126673526|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126673527|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
126673528|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
126673529|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126673530|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126339569|NCT00264147|454538550|FG000|Treatment I Period|Laboratory Adverse Event|0|||
126339570|NCT00264147|454538551|FG001|Treatment I Period|Laboratory Adverse Event|0|||
126339571|NCT00264147|454538552|FG002|Treatment I Period|Laboratory Adverse Event|0|||
126339572|NCT00264147|454538553|FG003|Treatment I Period|Laboratory Adverse Event|1|||
126339573|NCT00264147|454538554|FG004|Treatment I Period|Laboratory Adverse Event|0|||
126339574|NCT00264147|454538555|FG005|Treatment I Period|Laboratory Adverse Event|0|||
126339575|NCT00264147|454538550|FG000|Treatment I Period|Lack of Efficacy|6|||
126339576|NCT00264147|454538551|FG001|Treatment I Period|Lack of Efficacy|2|||
126339577|NCT00264147|454538552|FG002|Treatment I Period|Lack of Efficacy|8|||
126339578|NCT00264147|454538553|FG003|Treatment I Period|Lack of Efficacy|0|||
126339579|NCT00264147|454538554|FG004|Treatment I Period|Lack of Efficacy|1|||
126339580|NCT00264147|454538555|FG005|Treatment I Period|Lack of Efficacy|0|||
126339581|NCT00264147|454538550|FG000|Treatment I Period|Lost to Follow-up|1|||
126339582|NCT00264147|454538551|FG001|Treatment I Period|Lost to Follow-up|0|||
126339583|NCT00264147|454538552|FG002|Treatment I Period|Lost to Follow-up|0|||
126339584|NCT00264147|454538553|FG003|Treatment I Period|Lost to Follow-up|1|||
126339585|NCT00264147|454538554|FG004|Treatment I Period|Lost to Follow-up|1|||
126673531|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126673532|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126673533|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126673534|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126673535|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
126673536|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126339586|NCT00264147|454538555|FG005|Treatment I Period|Lost to Follow-up|0|||
126339587|NCT00264147|454538550|FG000|Treatment I Period|Protocol Violation|2|||
126673537|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126673538|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126673539|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126673540|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126673541|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
126673542|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
126673543|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126673544|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126673545|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126673546|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126673547|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126673548|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126673549|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
126673550|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
126673551|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126673552|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126673553|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126673554|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126673555|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126673556|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
126673557|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126673558|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126673559|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126673560|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126673561|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126673562|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126673563|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
126673564|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126673565|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126673566|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126673567|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126673568|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126673569|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
126673570|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
126673571|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126673572|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126673573|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126673574|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126673575|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126673576|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126673577|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
126673578|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126339588|NCT00264147|454538551|FG001|Treatment I Period|Protocol Violation|2|||
126339589|NCT00264147|454538552|FG002|Treatment I Period|Protocol Violation|0|||
126339590|NCT00264147|454538553|FG003|Treatment I Period|Protocol Violation|0|||
126339591|NCT00264147|454538554|FG004|Treatment I Period|Protocol Violation|0|||
126339592|NCT00264147|454538555|FG005|Treatment I Period|Protocol Violation|0|||
126339593|NCT00264147|454538550|FG000|Treatment I Period|Withdrawal by Subject|2|||
126339594|NCT00264147|454538551|FG001|Treatment I Period|Withdrawal by Subject|0|||
126339595|NCT00264147|454538552|FG002|Treatment I Period|Withdrawal by Subject|0|||
126339596|NCT00264147|454538553|FG003|Treatment I Period|Withdrawal by Subject|2|||
126339597|NCT00264147|454538554|FG004|Treatment I Period|Withdrawal by Subject|2|||
126339598|NCT00264147|454538555|FG005|Treatment I Period|Withdrawal by Subject|0|||
126339599|NCT00264147|454538550|FG000|Treatment I Period|Patient out of town for an extended time|0|||
126339600|NCT00264147|454538551|FG001|Treatment I Period|Patient out of town for an extended time|1|||
126339601|NCT00264147|454538552|FG002|Treatment I Period|Patient out of town for an extended time|0|||
126339602|NCT00264147|454538553|FG003|Treatment I Period|Patient out of town for an extended time|0|||
126339603|NCT00264147|454538554|FG004|Treatment I Period|Patient out of town for an extended time|0|||
126339604|NCT00264147|454538555|FG005|Treatment I Period|Patient out of town for an extended time|0|||
126339605|NCT00264147|454538550|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
126673579|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126673580|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126673581|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126673582|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126673583|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126673584|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
126673585|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126673586|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126673587|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126339606|NCT00264147|454538551|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
126673588|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126673589|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126673590|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126673591|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
126673592|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
126673593|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
126673594|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
126673595|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126673596|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126673597|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
126673598|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
126673599|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126673600|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126673601|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126673602|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126673603|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126673604|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126673605|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
126673606|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126673607|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
126673608|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126673609|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126673610|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126673611|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
126673612|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126673613|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126673614|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126673615|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126673616|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126673617|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126673618|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126673619|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
126673620|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
126673621|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126673622|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126673623|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126339607|NCT00264147|454538552|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
126339608|NCT00264147|454538553|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
126339609|NCT00264147|454538554|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
126339610|NCT00264147|454538555|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
126339611|NCT00264147|454538550|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
126339612|NCT00264147|454538551|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
126339613|NCT00264147|454538552|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
126339614|NCT00264147|454538553|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
126339615|NCT00264147|454538554|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
126339616|NCT00264147|454538555|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
126339617|NCT00264147|454538550|FG000|Treatment II Period|Adverse Event|0|||
126339618|NCT00264147|454538551|FG001|Treatment II Period|Adverse Event|0|||
126339619|NCT00264147|454538552|FG002|Treatment II Period|Adverse Event|0|||
126339620|NCT00264147|454538553|FG003|Treatment II Period|Adverse Event|0|||
126339621|NCT00264147|454538554|FG004|Treatment II Period|Adverse Event|9|||
126339622|NCT00264147|454538555|FG005|Treatment II Period|Adverse Event|9|||
126339623|NCT00264147|454538550|FG000|Treatment II Period|Laboratory Adverse Event|0|||
126339624|NCT00264147|454538551|FG001|Treatment II Period|Laboratory Adverse Event|0|||
126339625|NCT00264147|454538552|FG002|Treatment II Period|Laboratory Adverse Event|0|||
126339626|NCT00264147|454538553|FG003|Treatment II Period|Laboratory Adverse Event|0|||
126339627|NCT00264147|454538554|FG004|Treatment II Period|Laboratory Adverse Event|0|||
126339628|NCT00264147|454538555|FG005|Treatment II Period|Laboratory Adverse Event|1|||
126339629|NCT00264147|454538550|FG000|Treatment II Period|Lack of Efficacy|0|||
126339630|NCT00264147|454538551|FG001|Treatment II Period|Lack of Efficacy|0|||
126339631|NCT00264147|454538552|FG002|Treatment II Period|Lack of Efficacy|0|||
126339632|NCT00264147|454538553|FG003|Treatment II Period|Lack of Efficacy|0|||
126339633|NCT00264147|454538554|FG004|Treatment II Period|Lack of Efficacy|20|||
126339634|NCT00264147|454538555|FG005|Treatment II Period|Lack of Efficacy|19|||
126339635|NCT00264147|454538550|FG000|Treatment II Period|Lost to Follow-up|0|||
126339636|NCT00264147|454538551|FG001|Treatment II Period|Lost to Follow-up|0|||
126339637|NCT00264147|454538552|FG002|Treatment II Period|Lost to Follow-up|0|||
126673624|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126673625|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
126673626|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126673627|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126673628|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126673629|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126673630|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126673631|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126673632|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126673633|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
126673634|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126673635|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126424353|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424354|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424355|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
126424356|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424357|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424358|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424359|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
126424360|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424361|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424362|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424363|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424364|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424365|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424366|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424367|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424368|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424369|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424370|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424371|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424372|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
126424373|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424374|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
126424375|NCT01147666|454849294|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424376|NCT01147666|454849295|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424377|NCT01147666|454849296|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424378|NCT01147666|454849297|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424379|NCT01147666|454849298|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424380|NCT01147666|454849299|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424381|NCT01147666|454849300|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424382|NCT01147666|454849301|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126339638|NCT00264147|454538553|FG003|Treatment II Period|Lost to Follow-up|0|||
126339639|NCT00264147|454538554|FG004|Treatment II Period|Lost to Follow-up|1|||
126339640|NCT00264147|454538555|FG005|Treatment II Period|Lost to Follow-up|1|||
126339641|NCT00264147|454538550|FG000|Treatment II Period|Withdrawal by Subject|0|||
126339642|NCT00264147|454538551|FG001|Treatment II Period|Withdrawal by Subject|0|||
126339643|NCT00264147|454538552|FG002|Treatment II Period|Withdrawal by Subject|0|||
126339644|NCT00264147|454538553|FG003|Treatment II Period|Withdrawal by Subject|0|||
126339645|NCT00264147|454538554|FG004|Treatment II Period|Withdrawal by Subject|3|||
126339646|NCT00264147|454538555|FG005|Treatment II Period|Withdrawal by Subject|2|||
126339647|NCT00264147|454538550|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
126339648|NCT00264147|454538551|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
126339649|NCT00264147|454538552|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
126339650|NCT00264147|454538553|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
126339651|NCT00264147|454538554|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
126339652|NCT00264147|454538555|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
126339653|NCT03234465|454538556|FG000|Overall Study|Adverse Event|4|||
126339654|NCT03234465|454538557|FG001|Overall Study|Adverse Event|2|||
126339655|NCT03234465|454538556|FG000|Overall Study|Death|0|||
126339656|NCT03234465|454538557|FG001|Overall Study|Death|1|||
126339657|NCT03234465|454538556|FG000|Overall Study|Lost to Follow-up|1|||
126424383|NCT01147666|454849302|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424384|NCT01147666|454849303|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126339658|NCT03234465|454538557|FG001|Overall Study|Lost to Follow-up|1|||
126339659|NCT03234465|454538556|FG000|Overall Study|Withdrawal by Subject|12|||
126339660|NCT03234465|454538557|FG001|Overall Study|Withdrawal by Subject|27|||
126339661|NCT03234465|454538556|FG000|Overall Study|Symptomatic deterioration|0|||
126339662|NCT03234465|454538557|FG001|Overall Study|Symptomatic deterioration|1|||
126339663|NCT03234465|454538556|FG000|Overall Study|Non-compliance|2|||
126339664|NCT03234465|454538557|FG001|Overall Study|Non-compliance|0|||
126339665|NCT03234465|454538556|FG000|Overall Study|Other|14|||
126339666|NCT03234465|454538557|FG001|Overall Study|Other|8|||
126339667|NCT00449163|454538558|FG000|Overall Study|Physician Decision|3|||
126339668|NCT02247466|454538559|FG000|Overall Study|Procedure changed to open surgery|0|||
126339669|NCT02247466|454538560|FG001|Overall Study|Procedure changed to open surgery|3|||
126339670|NCT01618968|454538561|FG000|Overall Study|Adverse Event|1|||
126339671|NCT01618968|454538562|FG001|Overall Study|Adverse Event|0|||
126339672|NCT01618968|454538563|FG002|Overall Study|Adverse Event|0|||
126339673|NCT01618968|454538564|FG003|Overall Study|Adverse Event|0|||
126339674|NCT01618968|454538561|FG000|Overall Study|Death|0|||
126339675|NCT01618968|454538562|FG001|Overall Study|Death|0|||
126339676|NCT01618968|454538563|FG002|Overall Study|Death|0|||
126339677|NCT01618968|454538564|FG003|Overall Study|Death|1|||
126339678|NCT00721799|454538565|FG000|Overall Study|Withdrawal by Subject|7|||
126339679|NCT00721799|454538565|FG000|Overall Study|withdraw by subject after scan 1|1|||
126339680|NCT04356937|454538568|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
126339681|NCT04356937|454538569|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
126339682|NCT03141359|454538570|FG000|Overall Study|Death|32|||
126339683|NCT03141359|454538570|FG000|Overall Study|Still On Study (in follow up)|29|||
126339684|NCT01081626|454538571|FG000|Overall Study|Dosing error|1|||
126339685|NCT01081626|454538572|FG001|Overall Study|Dosing error|1|||
126339686|NCT01081626|454538571|FG000|Overall Study|Missing Estradiol|25|||
126339687|NCT01081626|454538572|FG001|Overall Study|Missing Estradiol|28|||
126339688|NCT01081626|454538571|FG000|Overall Study|Low antral follicle count|1|||
126339689|NCT01081626|454538572|FG001|Overall Study|Low antral follicle count|0|||
126339690|NCT01081626|454538571|FG000|Overall Study|Overstimulation|0|||
126339691|NCT01081626|454538572|FG001|Overall Study|Overstimulation|1|||
126339692|NCT01081626|454538571|FG000|Overall Study|Lost to Follow-up|0|||
126339693|NCT01081626|454538572|FG001|Overall Study|Lost to Follow-up|1|||
126339694|NCT01081626|454538571|FG000|Overall Study|Other|33|||
126339695|NCT01081626|454538572|FG001|Overall Study|Other|30|||
126339696|NCT04158219|454538573|FG000|Overall Study|Lost to Follow-up|1|||
126339697|NCT05965752|454538574|FG000|Overall Study|Adverse Event|0|||
126339698|NCT05965752|454538575|FG001|Overall Study|Adverse Event|1|||
126339699|NCT05965752|454538576|FG002|Overall Study|Adverse Event|0|||
126339700|NCT05965752|454538577|FG003|Overall Study|Adverse Event|1|||
126339701|NCT05965752|454538578|FG004|Overall Study|Adverse Event|3|||
126339702|NCT05965752|454538574|FG000|Overall Study|Lost to Follow-up|2|||
126339703|NCT05965752|454538575|FG001|Overall Study|Lost to Follow-up|0|||
126339704|NCT05965752|454538576|FG002|Overall Study|Lost to Follow-up|1|||
126339705|NCT05965752|454538577|FG003|Overall Study|Lost to Follow-up|1|||
126339706|NCT05965752|454538578|FG004|Overall Study|Lost to Follow-up|1|||
126339707|NCT05965752|454538574|FG000|Overall Study|Withdrawal by Subject|2|||
126339708|NCT05965752|454538575|FG001|Overall Study|Withdrawal by Subject|2|||
126339709|NCT05965752|454538576|FG002|Overall Study|Withdrawal by Subject|1|||
126339710|NCT05965752|454538577|FG003|Overall Study|Withdrawal by Subject|5|||
126339711|NCT05965752|454538578|FG004|Overall Study|Withdrawal by Subject|0|||
126339712|NCT05965752|454538574|FG000|Overall Study|Disease Relapse|1|||
126339713|NCT05965752|454538575|FG001|Overall Study|Disease Relapse|0|||
126339714|NCT05965752|454538576|FG002|Overall Study|Disease Relapse|1|||
126339715|NCT05965752|454538577|FG003|Overall Study|Disease Relapse|0|||
126339716|NCT05965752|454538578|FG004|Overall Study|Disease Relapse|0|||
126339717|NCT05965752|454538574|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
126339718|NCT05965752|454538575|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
126339719|NCT05965752|454538576|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
126339720|NCT05965752|454538577|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
126339721|NCT05965752|454538578|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
126339722|NCT05965752|454538574|FG000|Overall Study|Unable to Return for Study Visits|0|||
126339723|NCT05965752|454538575|FG001|Overall Study|Unable to Return for Study Visits|1|||
126339724|NCT05965752|454538576|FG002|Overall Study|Unable to Return for Study Visits|0|||
126339725|NCT05965752|454538577|FG003|Overall Study|Unable to Return for Study Visits|3|||
126339726|NCT05965752|454538578|FG004|Overall Study|Unable to Return for Study Visits|1|||
126339727|NCT05965752|454538574|FG000|Overall Study|Early Termination|0|||
126339728|NCT05965752|454538575|FG001|Overall Study|Early Termination|0|||
126339729|NCT05965752|454538576|FG002|Overall Study|Early Termination|1|||
126424385|NCT01147666|454849304|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126339730|NCT05965752|454538577|FG003|Overall Study|Early Termination|0|||
126339731|NCT05965752|454538578|FG004|Overall Study|Early Termination|0|||
126339732|NCT05965752|454538574|FG000|Overall Study|Reported Unwanted Symptoms|0|||
126339733|NCT05965752|454538575|FG001|Overall Study|Reported Unwanted Symptoms|0|||
126339734|NCT05965752|454538576|FG002|Overall Study|Reported Unwanted Symptoms|0|||
126339735|NCT05965752|454538577|FG003|Overall Study|Reported Unwanted Symptoms|0|||
126339736|NCT05965752|454538578|FG004|Overall Study|Reported Unwanted Symptoms|1|||
126339737|NCT05965752|454538574|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
126339738|NCT05965752|454538575|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
126339739|NCT05965752|454538576|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
126339740|NCT05965752|454538577|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
126339741|NCT05965752|454538578|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
126339742|NCT02074514|454538579|FG000|Overall Study|Lack of Efficacy|3|||
126339743|NCT02074514|454538580|FG001|Overall Study|Lack of Efficacy|2|||
126339744|NCT02074514|454538579|FG000|Overall Study|Lost to Follow-up|0|||
126339745|NCT02074514|454538580|FG001|Overall Study|Lost to Follow-up|1|||
126339746|NCT02074514|454538579|FG000|Overall Study|Withdrew Consent|0|||
126339747|NCT02074514|454538580|FG001|Overall Study|Withdrew Consent|1|||
126369331|NCT01153516|454648203|FG000|Overall Study|Both subjects refused surgery|2|||
126369332|NCT01153516|454648204|FG001|Overall Study|Both subjects refused surgery|0|||
126369333|NCT03502200|454648207|FG000|Overall Study|Adverse Event|1|||
126369334|NCT03502200|454648208|FG001|Overall Study|Adverse Event|0|||
126369335|NCT03502200|454648207|FG000|Overall Study|Lost to Follow-up|36|||
126369336|NCT03502200|454648208|FG001|Overall Study|Lost to Follow-up|38|||
126369337|NCT03502200|454648207|FG000|Overall Study|Study Team Decision|1|||
126369338|NCT03502200|454648208|FG001|Overall Study|Study Team Decision|1|||
126369339|NCT03502200|454648207|FG000|Overall Study|Withdrawal by Subject|5|||
126369340|NCT03502200|454648208|FG001|Overall Study|Withdrawal by Subject|7|||
126369341|NCT03502200|454648207|FG000|Overall Study|Death|0|||
126369342|NCT03502200|454648208|FG001|Overall Study|Death|2|||
126369343|NCT04380142|454648212|FG000|LD/CD Stabilization Period|Adverse Event|3|||
126369344|NCT04380142|454648213|FG001|LD/CD Stabilization Period|Adverse Event|0|||
126369345|NCT04380142|454648214|FG002|LD/CD Stabilization Period|Adverse Event|0|||
126369346|NCT04380142|454648212|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
126369347|NCT04380142|454648213|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
126369348|NCT04380142|454648214|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
126369349|NCT04380142|454648212|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
126369350|NCT04380142|454648213|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
126369351|NCT04380142|454648214|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
126369352|NCT04380142|454648212|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
126369353|NCT04380142|454648213|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
126369354|NCT04380142|454648214|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
126369355|NCT04380142|454648212|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
126369356|NCT04380142|454648213|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
126369357|NCT04380142|454648214|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
126369358|NCT04380142|454648212|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
126369359|NCT04380142|454648213|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
126369360|NCT04380142|454648214|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
126369361|NCT04380142|454648212|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126369362|NCT04380142|454648213|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126369363|NCT04380142|454648214|FG002|Double-Blind Treatment Period|Adverse Event|14|||
126369364|NCT04380142|454648212|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
126369365|NCT04380142|454648213|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
126369366|NCT04380142|454648214|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
126369367|NCT04380142|454648212|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
126369368|NCT04380142|454648213|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
126369369|NCT04380142|454648214|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
126369370|NCT04380142|454648212|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
126369371|NCT04380142|454648213|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
126369372|NCT04380142|454648214|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
126369373|NCT04380142|454648212|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
126369374|NCT04380142|454648213|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
126424386|NCT01147666|454849305|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424387|NCT01147666|454849306|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
126424388|NCT01147666|454849307|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
126424389|NCT01147666|454849308|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
126424390|NCT00474955|454849309|FG000|Overall Study|Adverse Event|2|||
126424391|NCT00474955|454849309|FG000|Overall Study|Drug unavailability|1|||
126424392|NCT00474955|454849309|FG000|Overall Study|Personal reasons|5|||
126424393|NCT01135134|454849310|FG000|Overall Study|Adverse Event|1|||
126424394|NCT01135134|454849311|FG001|Overall Study|Adverse Event|1|||
126424395|NCT01135134|454849310|FG000|Overall Study|Did not meet protocol eligibility|1|||
126424396|NCT01135134|454849311|FG001|Overall Study|Did not meet protocol eligibility|0|||
126424397|NCT00256724|454849322|FG000|Overall Study|Physician Decision|2|||
126424398|NCT00256724|454849323|FG001|Overall Study|Physician Decision|5|||
126424399|NCT00256724|454849322|FG000|Overall Study|Protocol Violation|3|||
126424400|NCT00256724|454849323|FG001|Overall Study|Protocol Violation|3|||
126424401|NCT01217463|454849324|FG000|Overall Study|Adverse Event|8|||
126424402|NCT01217463|454849325|FG001|Overall Study|Adverse Event|5|||
126424403|NCT01217463|454849324|FG000|Overall Study|Physician Decision|0|||
126424404|NCT01217463|454849325|FG001|Overall Study|Physician Decision|1|||
126424405|NCT01217463|454849324|FG000|Overall Study|Withdrawal by Subject|3|||
126424406|NCT01217463|454849325|FG001|Overall Study|Withdrawal by Subject|0|||
126424407|NCT01217463|454849324|FG000|Overall Study|Surgery on the Target Limb|0|||
126424408|NCT01217463|454849325|FG001|Overall Study|Surgery on the Target Limb|1|||
126424409|NCT01217463|454849324|FG000|Overall Study|Patient Non-compliant|1|||
126424410|NCT01217463|454849325|FG001|Overall Study|Patient Non-compliant|0|||
126424411|NCT01217463|454849324|FG000|Overall Study|Other|1|||
126424412|NCT01217463|454849325|FG001|Overall Study|Other|1|||
126424413|NCT01569841|454849334|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
126424414|NCT01569841|454849335|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
126424415|NCT01859923|454849336|FG000|Overall Study|Adverse Event|0|||
126424416|NCT01859923|454849337|FG001|Overall Study|Adverse Event|0|||
126424417|NCT01859923|454849338|FG002|Overall Study|Adverse Event|1|||
126424418|NCT01859923|454849339|FG003|Overall Study|Adverse Event|1|||
126424419|NCT03634085|454849343|FG000|Overall Study|Adverse Event|1|||
126424420|NCT03634085|454849344|FG001|Overall Study|Adverse Event|0|||
126424421|NCT03634085|454849343|FG000|Overall Study|Withdrawal by Subject|0|||
126424422|NCT03634085|454849344|FG001|Overall Study|Withdrawal by Subject|2|||
126424423|NCT01517750|454851272|FG000|Overall Study|Lost to Follow-up|1|||
126424424|NCT01517750|454851273|FG001|Overall Study|Lost to Follow-up|2|||
126424425|NCT01517750|454851274|FG002|Overall Study|Lost to Follow-up|4|||
126424426|NCT01517750|454851275|FG003|Overall Study|Lost to Follow-up|1|||
126424427|NCT00248495|454851276|FG000|Overall Study|Withdrawal by Subject|1|||
126424428|NCT03812380|454851277|FG000|Overall Study|Protocol Violation|3|||
126424429|NCT03812380|454851278|FG001|Overall Study|Protocol Violation|3|||
126424430|NCT03812380|454851277|FG000|Overall Study|Withdrawal by Subject|5|||
126424431|NCT03812380|454851278|FG001|Overall Study|Withdrawal by Subject|4|||
126424432|NCT03812380|454851277|FG000|Overall Study|Early termination of study|14|||
126424433|NCT03812380|454851278|FG001|Overall Study|Early termination of study|14|||
126424434|NCT01285401|454851279|FG000|Overall Study|Prematurely withdrawn from the study|17|||
126424435|NCT01285401|454851280|FG001|Overall Study|Prematurely withdrawn from the study|29|||
126424436|NCT02366312|454851290|FG000|Overall Study|Lost to Follow-up|0|||
126424437|NCT02366312|454851291|FG001|Overall Study|Lost to Follow-up|1|||
126424438|NCT00354679|454851292|FG000|Overall Study|Patient Not Treated|1|||
126424439|NCT03719131|454851293|FG000|Overall Study|Death|1|||
126424440|NCT03719131|454851294|FG001|Overall Study|Death|2|||
126424441|NCT03294590|454851295|FG000|Overall Study|Lost to Follow-up|105|||
126424442|NCT03294590|454851296|FG001|Overall Study|Lost to Follow-up|107|||
126424443|NCT02420093|454851299|FG000|Overall Study|Withdrawal by Subject|1|||
126424444|NCT02420093|454851300|FG001|Overall Study|Withdrawal by Subject|1|||
126424445|NCT03244917|454851302|FG000|Overall Study|Lost to Follow-up|2|||
126424446|NCT03244917|454851303|FG001|Overall Study|Lost to Follow-up|2|||
126673636|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126673637|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
126673638|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
126673639|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126424447|NCT01272232|454851304|FG000|Weeks 0-56|Adverse Event|39|||
126673640|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126673641|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
126673642|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
126673643|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126673644|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126673645|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126673646|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126673647|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
126673648|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126673649|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126673650|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126673651|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126673652|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126424448|NCT01272232|454851305|FG001|Weeks 0-56|Adverse Event|18|||
126424449|NCT01272232|454851306|FG002|Weeks 0-56|Adverse Event|7|||
126424450|NCT01272232|454851304|FG000|Weeks 0-56|Lack of Efficacy|0|||
126424451|NCT01272232|454851305|FG001|Weeks 0-56|Lack of Efficacy|0|||
126673653|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126424452|NCT01272232|454851306|FG002|Weeks 0-56|Lack of Efficacy|3|||
126424453|NCT01272232|454851304|FG000|Weeks 0-56|Protocol Violation|12|||
126424454|NCT01272232|454851305|FG001|Weeks 0-56|Protocol Violation|8|||
126424455|NCT01272232|454851306|FG002|Weeks 0-56|Protocol Violation|13|||
126424456|NCT01272232|454851304|FG000|Weeks 0-56|Withdrawal criteria|32|||
126424457|NCT01272232|454851305|FG001|Weeks 0-56|Withdrawal criteria|14|||
126424458|NCT01272232|454851306|FG002|Weeks 0-56|Withdrawal criteria|37|||
126424459|NCT01272232|454851304|FG000|Weeks 0-56|Unclassified|16|||
126673654|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126673655|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
126673656|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
126673657|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126673658|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126673659|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126673660|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126673661|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
126673662|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126673663|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126673664|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126673665|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126673666|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126673667|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126673668|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126673669|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126673670|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
126673671|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126673672|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126424460|NCT01272232|454851305|FG001|Weeks 0-56|Unclassified|7|||
126339748|NCT00870727|454540617|FG000|Overall Study|Lost to Follow-up|0|||
126339749|NCT00870727|454540618|FG001|Overall Study|Lost to Follow-up|1|||
126339750|NCT00870727|454540617|FG000|Overall Study|Lack of Efficacy|1|||
126339751|NCT00870727|454540618|FG001|Overall Study|Lack of Efficacy|3|||
126339752|NCT00870727|454540617|FG000|Overall Study|Adverse Event|0|||
126339753|NCT00870727|454540618|FG001|Overall Study|Adverse Event|1|||
126339754|NCT00720278|454540619|FG000|Overall Study|Adverse Event|5|||
126339755|NCT00720278|454540620|FG001|Overall Study|Adverse Event|3|||
126339756|NCT00720278|454540621|FG002|Overall Study|Adverse Event|4|||
126339757|NCT00720278|454540619|FG000|Overall Study|Withdrawal by Subject|0|||
126339758|NCT00720278|454540620|FG001|Overall Study|Withdrawal by Subject|1|||
126339759|NCT00720278|454540621|FG002|Overall Study|Withdrawal by Subject|0|||
126339760|NCT00720278|454540619|FG000|Overall Study|Lost to Follow-up|0|||
126339761|NCT00720278|454540620|FG001|Overall Study|Lost to Follow-up|0|||
126339762|NCT00720278|454540621|FG002|Overall Study|Lost to Follow-up|1|||
126339763|NCT00720278|454540619|FG000|Overall Study|Non-compliance|1|||
126339764|NCT00720278|454540620|FG001|Overall Study|Non-compliance|0|||
126339765|NCT00720278|454540621|FG002|Overall Study|Non-compliance|0|||
126339766|NCT00720278|454540619|FG000|Overall Study|eligibility criteria violation|1|||
126339767|NCT00720278|454540620|FG001|Overall Study|eligibility criteria violation|0|||
126339768|NCT00720278|454540621|FG002|Overall Study|eligibility criteria violation|1|||
126339769|NCT03312738|454540624|FG000|Overall Study|Progressive disease|58|||
126339770|NCT03312738|454540625|FG001|Overall Study|Progressive disease|67|||
126339771|NCT03312738|454540624|FG000|Overall Study|Patient/guardian decision|13|||
126339772|NCT03312738|454540625|FG001|Overall Study|Patient/guardian decision|5|||
126339773|NCT03312738|454540624|FG000|Overall Study|Adverse Event|5|||
126339774|NCT03312738|454540625|FG001|Overall Study|Adverse Event|3|||
126339775|NCT03312738|454540624|FG000|Overall Study|Protocol deviation|2|||
126339776|NCT03312738|454540625|FG001|Overall Study|Protocol deviation|0|||
126339777|NCT03312738|454540624|FG000|Overall Study|Technical problems|0|||
126339778|NCT03312738|454540625|FG001|Overall Study|Technical problems|1|||
126339779|NCT03312738|454540624|FG000|Overall Study|Physician Decision|2|||
126339780|NCT03312738|454540625|FG001|Overall Study|Physician Decision|3|||
126339781|NCT02466399|454540632|FG000|Overall Study|Adverse Event|1|||
126339782|NCT02466399|454540633|FG001|Overall Study|Adverse Event|0|||
126339783|NCT02466399|454540632|FG000|Overall Study|Early exit due to family emergency|1|||
126339784|NCT02466399|454540633|FG001|Overall Study|Early exit due to family emergency|0|||
126339785|NCT03408899|454540634|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
126339786|NCT00606008|454540635|FG000|Overall Study|Adverse Event|1|||
126339787|NCT00606008|454540635|FG000|Overall Study|Withdrawal by Subject|4|||
126339788|NCT01863771|454540636|FG000|Induction Phase|Adverse Event|9|||
126339789|NCT01863771|454540637|FG001|Induction Phase|Adverse Event|0|||
126339790|NCT01863771|454540638|FG002|Induction Phase|Adverse Event|0|||
126339791|NCT01863771|454540639|FG003|Induction Phase|Adverse Event|0|||
126339792|NCT01863771|454540636|FG000|Induction Phase|Lack of Efficacy|10|||
126339793|NCT01863771|454540637|FG001|Induction Phase|Lack of Efficacy|0|||
126339794|NCT01863771|454540638|FG002|Induction Phase|Lack of Efficacy|0|||
126424461|NCT01272232|454851306|FG002|Weeks 0-56|Unclassified|12|||
126339795|NCT01863771|454540639|FG003|Induction Phase|Lack of Efficacy|0|||
126339796|NCT01863771|454540636|FG000|Induction Phase|Withdrawal by Subject|2|||
126339797|NCT01863771|454540637|FG001|Induction Phase|Withdrawal by Subject|0|||
126339798|NCT01863771|454540638|FG002|Induction Phase|Withdrawal by Subject|0|||
126339799|NCT01863771|454540639|FG003|Induction Phase|Withdrawal by Subject|0|||
126424462|NCT01272232|454851304|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
126673673|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126673674|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126673675|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
126673676|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126673677|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126339800|NCT01863771|454540636|FG000|Maintenance Phase|Adverse Event|0|||
126339801|NCT01863771|454540637|FG001|Maintenance Phase|Adverse Event|0|||
126339802|NCT01863771|454540638|FG002|Maintenance Phase|Adverse Event|1|||
126339803|NCT01863771|454540639|FG003|Maintenance Phase|Adverse Event|1|||
126339804|NCT01863771|454540636|FG000|Maintenance Phase|Lack of Efficacy|0|||
126339805|NCT01863771|454540637|FG001|Maintenance Phase|Lack of Efficacy|3|||
126339806|NCT01863771|454540638|FG002|Maintenance Phase|Lack of Efficacy|7|||
126339807|NCT01863771|454540639|FG003|Maintenance Phase|Lack of Efficacy|38|||
126339808|NCT01863771|454540636|FG000|Maintenance Phase|Physician Decision|0|||
126339809|NCT01863771|454540637|FG001|Maintenance Phase|Physician Decision|0|||
126339810|NCT01863771|454540638|FG002|Maintenance Phase|Physician Decision|2|||
126339811|NCT01863771|454540639|FG003|Maintenance Phase|Physician Decision|1|||
126339812|NCT01863771|454540636|FG000|Maintenance Phase|Pregnancy|0|||
126339813|NCT01863771|454540637|FG001|Maintenance Phase|Pregnancy|1|||
126339814|NCT01863771|454540638|FG002|Maintenance Phase|Pregnancy|0|||
126339815|NCT01863771|454540639|FG003|Maintenance Phase|Pregnancy|0|||
126339816|NCT01863771|454540636|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126339817|NCT01863771|454540637|FG001|Maintenance Phase|Withdrawal by Subject|1|||
126339818|NCT01863771|454540638|FG002|Maintenance Phase|Withdrawal by Subject|2|||
126339819|NCT01863771|454540639|FG003|Maintenance Phase|Withdrawal by Subject|3|||
126339820|NCT02014272|454540640|FG000|Intervention Period 1|Withdrawal by Subject|1|||
126339821|NCT02014272|454540641|FG001|Intervention Period 1|Withdrawal by Subject|0|||
126339822|NCT02014272|454540640|FG000|Intervention Period 1|Adverse Event|0|||
126339823|NCT02014272|454540641|FG001|Intervention Period 1|Adverse Event|1|||
126339824|NCT01218308|454540642|FG000|Overall Study|Adverse Event|1|||
126339825|NCT01218308|454540643|FG001|Overall Study|Adverse Event|2|||
126339826|NCT01218308|454540642|FG000|Overall Study|Protocol Violation|0|||
126339827|NCT01218308|454540643|FG001|Overall Study|Protocol Violation|2|||
126339828|NCT01218308|454540642|FG000|Overall Study|Withdrawal by Subject|61|||
126339829|NCT01218308|454540643|FG001|Overall Study|Withdrawal by Subject|64|||
126339830|NCT01218308|454540642|FG000|Overall Study|Lost to Follow-up|27|||
126339831|NCT01218308|454540643|FG001|Overall Study|Lost to Follow-up|31|||
126339832|NCT01218308|454540642|FG000|Overall Study|Other|14|||
126339833|NCT01218308|454540643|FG001|Overall Study|Other|21|||
126339834|NCT00547339|454540644|FG000|Overall Study|Physician Decision|0|||
126339835|NCT00547339|454540645|FG001|Overall Study|Physician Decision|0|||
126339836|NCT00547339|454540646|FG002|Overall Study|Physician Decision|1|||
126339837|NCT00547339|454540647|FG003|Overall Study|Physician Decision|0|||
126339838|NCT01248455|454540648|FG000|Overall Study|switched to alternate treatment|1|||
126339839|NCT01117870|454540649|FG000|Overall Study|Inability to place needle|1|||
126339840|NCT01117870|454540650|FG001|Overall Study|Inability to place needle|0|||
126339841|NCT01450813|454540651|FG000|Overall Study|Physician Decision|1|||
126339842|NCT01450813|454540652|FG001|Overall Study|Physician Decision|1|||
126339843|NCT01450813|454540653|FG002|Overall Study|Physician Decision|0|||
126339844|NCT01450813|454540654|FG003|Overall Study|Physician Decision|3|||
126339845|NCT01483118|454540657|FG000|Overall Study|Lost to Follow-up|12|||
126339846|NCT01483118|454540658|FG001|Overall Study|Lost to Follow-up|16|||
126339847|NCT03322293|454540664|FG000|Overall Study|Lost to Follow-up|0|||
126339848|NCT03322293|454540665|FG001|Overall Study|Lost to Follow-up|0|||
126339849|NCT03322293|454540666|FG002|Overall Study|Lost to Follow-up|1|||
126339850|NCT01178294|454540667|FG000|Overall Study|Adverse Event|4|||
126339851|NCT01178294|454540667|FG000|Overall Study|Lost to Follow-up|2|||
126339852|NCT01178294|454540667|FG000|Overall Study|Lack of Efficacy|1|||
126339853|NCT01178294|454540667|FG000|Overall Study|Death|1|||
126339854|NCT01178294|454540667|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
126339855|NCT01178294|454540667|FG000|Overall Study|Subject status is terminal|1|||
126339856|NCT01178294|454540667|FG000|Overall Study|Completion status could not be verified|1|||
126339857|NCT03435055|454540668|FG000|Screening|Physician Decision|2|||
126339858|NCT03435055|454540668|FG000|Received Intervention|Did not complete nitrous administration|3|||
126339859|NCT02089347|454540669|FG000|Overall Study|Protocol Violation|1|||
126339860|NCT02089347|454540670|FG001|Overall Study|Protocol Violation|0|||
126339861|NCT02783066|454540671|FG000|Overall Study|Withdrawal by Subject|13|||
126339862|NCT03712280|454540673|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
126339863|NCT03712280|454540674|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
126339864|NCT03712280|454540675|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
126339865|NCT03712280|454540676|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
126339866|NCT03712280|454540673|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
126339867|NCT03712280|454540674|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
126339868|NCT03712280|454540675|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
126339869|NCT03712280|454540676|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
126424463|NCT01272232|454851305|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
126424464|NCT01272232|454851306|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
126424465|NCT01272232|454851304|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
126424466|NCT01272232|454851305|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
126424467|NCT01272232|454851306|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
126424468|NCT01272232|454851304|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
126424469|NCT01272232|454851305|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
126424470|NCT01272232|454851306|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
126424471|NCT01272232|454851304|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
126424472|NCT01272232|454851305|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
126424473|NCT01272232|454851306|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
126424474|NCT01272232|454851304|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
126424475|NCT01272232|454851305|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
126424476|NCT01272232|454851306|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
126424477|NCT00255190|454851310|FG000|Overall Study|Adverse Event|17|||
126424478|NCT00255190|454851311|FG001|Overall Study|Adverse Event|36|||
126424479|NCT00255190|454851310|FG000|Overall Study|Protocol Violation|2|||
126424480|NCT00255190|454851311|FG001|Overall Study|Protocol Violation|2|||
126673678|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126673679|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
126673680|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126339870|NCT03712280|454540673|FG000|Overall Study|Adverse Event|0|||
126339871|NCT03712280|454540674|FG001|Overall Study|Adverse Event|0|||
126339872|NCT03712280|454540675|FG002|Overall Study|Adverse Event|1|||
126339873|NCT03712280|454540676|FG003|Overall Study|Adverse Event|0|||
126339874|NCT05379920|454540677|FG000|Overall Study|Lost to Follow-up|0|||
126339875|NCT05379920|454540678|FG001|Overall Study|Lost to Follow-up|5|||
126339876|NCT05379920|454540679|FG002|Overall Study|Lost to Follow-up|0|||
126339877|NCT05379920|454540680|FG003|Overall Study|Lost to Follow-up|0|||
126339878|NCT03176771|454540683|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
126339879|NCT03176771|454540684|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
126339880|NCT03176771|454540685|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
126339881|NCT03176771|454540686|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
126339882|NCT03176771|454540687|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
126339883|NCT03176771|454540683|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
126339884|NCT03176771|454540684|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
126339885|NCT03176771|454540685|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
126339886|NCT03176771|454540686|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
126339887|NCT03176771|454540687|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
126339888|NCT03176771|454540683|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
126339889|NCT03176771|454540684|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
126339890|NCT03176771|454540685|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
126339891|NCT03176771|454540686|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
126339892|NCT03176771|454540687|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
126339893|NCT03176771|454540683|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
126339894|NCT03176771|454540684|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
126339895|NCT03176771|454540685|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
126339896|NCT03176771|454540686|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
126339897|NCT03176771|454540687|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
126339898|NCT03176771|454540683|FG000|Double-Blind Extension Period|Adverse Event|0|||
126339899|NCT03176771|454540684|FG001|Double-Blind Extension Period|Adverse Event|0|||
126339900|NCT03176771|454540685|FG002|Double-Blind Extension Period|Adverse Event|0|||
126339901|NCT03176771|454540686|FG003|Double-Blind Extension Period|Adverse Event|15|||
126339902|NCT03176771|454540687|FG004|Double-Blind Extension Period|Adverse Event|18|||
126339903|NCT03176771|454540683|FG000|Double-Blind Extension Period|Death|0|||
126339904|NCT03176771|454540684|FG001|Double-Blind Extension Period|Death|0|||
126339905|NCT03176771|454540685|FG002|Double-Blind Extension Period|Death|0|||
126339906|NCT03176771|454540686|FG003|Double-Blind Extension Period|Death|3|||
126339907|NCT03176771|454540687|FG004|Double-Blind Extension Period|Death|4|||
126339908|NCT03176771|454540683|FG000|Double-Blind Extension Period|Physician Decision|0|||
126339909|NCT03176771|454540684|FG001|Double-Blind Extension Period|Physician Decision|0|||
126339910|NCT03176771|454540685|FG002|Double-Blind Extension Period|Physician Decision|0|||
126339911|NCT03176771|454540686|FG003|Double-Blind Extension Period|Physician Decision|3|||
126339912|NCT03176771|454540687|FG004|Double-Blind Extension Period|Physician Decision|1|||
126424481|NCT00255190|454851310|FG000|Overall Study|Lost to Follow-up|10|||
126339913|NCT03176771|454540683|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
126339914|NCT03176771|454540684|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
126424482|NCT00255190|454851311|FG001|Overall Study|Lost to Follow-up|27|||
126424483|NCT00255190|454851310|FG000|Overall Study|Withdrew Consent|17|||
126424484|NCT00255190|454851311|FG001|Overall Study|Withdrew Consent|48|||
126424485|NCT00255190|454851310|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
126424486|NCT00255190|454851311|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
126424487|NCT00255190|454851310|FG000|Overall Study|Erosive esophagitis not healed|0|||
126424488|NCT00255190|454851311|FG001|Overall Study|Erosive esophagitis not healed|20|||
126424489|NCT00255190|454851310|FG000|Overall Study|Various|4|||
126424490|NCT00255190|454851311|FG001|Overall Study|Various|23|||
126424491|NCT00628030|454851312|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
126424492|NCT00628030|454851313|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
126424493|NCT00628030|454851312|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
126424494|NCT00628030|454851313|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
126424495|NCT00628030|454851312|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
126424496|NCT00628030|454851313|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
126424497|NCT03367858|454851315|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
126424498|NCT03367858|454851316|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
126424499|NCT03367858|454851315|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
126424500|NCT03367858|454851316|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
126424501|NCT03367858|454851315|FG000|3 Month Follow Up|Lost to Follow-up|8|||
126424502|NCT03367858|454851316|FG001|3 Month Follow Up|Lost to Follow-up|3|||
126424503|NCT03367858|454851315|FG000|3 Month Follow Up|Moved out of study area|2|||
126424504|NCT03367858|454851316|FG001|3 Month Follow Up|Moved out of study area|6|||
126424505|NCT03367858|454851315|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
126424506|NCT03367858|454851316|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
126424507|NCT03367858|454851315|FG000|3 Month Follow Up|MRI contraindication|2|||
126424508|NCT03367858|454851316|FG001|3 Month Follow Up|MRI contraindication|1|||
126424509|NCT03367858|454851315|FG000|3 Month Follow Up|Incarcerated|0|||
126424510|NCT03367858|454851316|FG001|3 Month Follow Up|Incarcerated|1|||
126424511|NCT03367858|454851315|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
126424512|NCT03367858|454851316|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
126424513|NCT03367858|454851315|FG000|6 Month Follow Up|Lost to Follow-up|5|||
126424514|NCT03367858|454851316|FG001|6 Month Follow Up|Lost to Follow-up|2|||
126424515|NCT03367858|454851315|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
126424516|NCT03367858|454851316|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
126424517|NCT03367858|454851315|FG000|12 Month Follow Up|Lost to Follow-up|3|||
126424518|NCT03367858|454851316|FG001|12 Month Follow Up|Lost to Follow-up|3|||
126424519|NCT03367858|454851315|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
126424520|NCT03367858|454851316|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
126424521|NCT03827655|454851317|FG000|Overall Study|Death|0|||
126424522|NCT03827655|454851318|FG001|Overall Study|Death|0|||
126424523|NCT03827655|454851319|FG002|Overall Study|Death|0|||
126424524|NCT03827655|454851320|FG003|Overall Study|Death|0|||
126424525|NCT03827655|454851321|FG004|Overall Study|Death|1|||
126424526|NCT03827655|454851317|FG000|Overall Study|Protocol Deviation|1|||
126424527|NCT03827655|454851318|FG001|Overall Study|Protocol Deviation|0|||
126424528|NCT03827655|454851319|FG002|Overall Study|Protocol Deviation|1|||
126424529|NCT03827655|454851320|FG003|Overall Study|Protocol Deviation|1|||
126424530|NCT03827655|454851321|FG004|Overall Study|Protocol Deviation|0|||
126424531|NCT03827655|454851317|FG000|Overall Study|Withdrawal by Subject|3|||
126424532|NCT03827655|454851318|FG001|Overall Study|Withdrawal by Subject|2|||
126424533|NCT03827655|454851319|FG002|Overall Study|Withdrawal by Subject|2|||
126424534|NCT03827655|454851320|FG003|Overall Study|Withdrawal by Subject|0|||
126424535|NCT03827655|454851321|FG004|Overall Study|Withdrawal by Subject|1|||
126424536|NCT03827655|454851317|FG000|Overall Study|Reason not Specified|3|||
126424537|NCT03827655|454851318|FG001|Overall Study|Reason not Specified|1|||
126424538|NCT03827655|454851319|FG002|Overall Study|Reason not Specified|1|||
126424539|NCT03827655|454851320|FG003|Overall Study|Reason not Specified|1|||
126424540|NCT03827655|454851321|FG004|Overall Study|Reason not Specified|1|||
126424541|NCT01721161|454851323|FG000|Overall Study|Adverse Event|2|||
126424542|NCT01721161|454851324|FG001|Overall Study|Adverse Event|3|||
126424543|NCT01721161|454851323|FG000|Overall Study|Lost to Follow-up|1|||
126424544|NCT01721161|454851324|FG001|Overall Study|Lost to Follow-up|2|||
126424545|NCT01721161|454851323|FG000|Overall Study|Withdrawal by Subject|1|||
126424546|NCT01721161|454851324|FG001|Overall Study|Withdrawal by Subject|1|||
126424547|NCT01721161|454851323|FG000|Overall Study|Other|0|||
126673681|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126424548|NCT01721161|454851324|FG001|Overall Study|Other|1|||
126424549|NCT01216202|454851325|FG000|Overall Study|Withdrawal by Subject|8|||
126424550|NCT01216202|454851326|FG001|Overall Study|Withdrawal by Subject|0|||
126424551|NCT01216202|454851325|FG000|Overall Study|Death|0|||
126424552|NCT01216202|454851326|FG001|Overall Study|Death|2|||
126424553|NCT01216202|454851325|FG000|Overall Study|Lost to Follow-up|14|||
126673682|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126424554|NCT01216202|454851326|FG001|Overall Study|Lost to Follow-up|0|||
126424555|NCT01091675|454851331|FG000|Overall Study|Adverse Event|7|||
126424556|NCT01091675|454851331|FG000|Overall Study|Lack of Efficacy|27|||
126424557|NCT02888106|454851338|FG000|Overall Study|Withdrawal by Subject|1|||
126673683|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126673684|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126339915|NCT03176771|454540685|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
126339916|NCT03176771|454540686|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
126339917|NCT03176771|454540687|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
126339918|NCT02732639|454540688|FG000|Overall Study|Lost to Follow-up|1|||
126339919|NCT02662569|454540690|FG000|Overall Study|Withdrawal by Subject|6|||
126339920|NCT02662569|454540691|FG001|Overall Study|Withdrawal by Subject|1|||
126339921|NCT02662569|454540692|FG002|Overall Study|Withdrawal by Subject|6|||
126339922|NCT02662569|454540693|FG003|Overall Study|Withdrawal by Subject|4|||
126339923|NCT02662569|454540690|FG000|Overall Study|Lost to Follow-up|1|||
126339924|NCT02662569|454540691|FG001|Overall Study|Lost to Follow-up|0|||
126339925|NCT02662569|454540692|FG002|Overall Study|Lost to Follow-up|0|||
126339926|NCT02662569|454540693|FG003|Overall Study|Lost to Follow-up|0|||
126339927|NCT00630916|454540697|FG000|Overall Study|Death|110|||
126339928|NCT00630916|454540697|FG000|Overall Study|Explant|8|||
126339929|NCT00630916|454540697|FG000|Overall Study|Lost to Follow-up|5|||
126339930|NCT00630916|454540697|FG000|Overall Study|Withdrawal by Subject|30|||
126339931|NCT00630916|454540697|FG000|Overall Study|Protocol Violation|7|||
126339932|NCT00630916|454540697|FG000|Overall Study|Physician Decision|47|||
126339933|NCT00630916|454540697|FG000|Overall Study|Lack of Efficacy|3|||
126339934|NCT01299584|454540704|FG000|Overall Study|Protocol Violation|9|||
126339935|NCT04079790|454540705|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
126339936|NCT04079790|454540706|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
126339937|NCT04079790|454540707|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
126339938|NCT04079790|454540708|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
126339939|NCT04079790|454540705|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
126339940|NCT04079790|454540706|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
126339941|NCT04079790|454540707|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
126339942|NCT04079790|454540708|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
126339943|NCT04079790|454540705|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
126339944|NCT04079790|454540706|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
126339945|NCT04079790|454540707|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
126339946|NCT04079790|454540708|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
126339947|NCT00390689|454540709|FG000|Overall Study|Adverse Event|2|||
126339948|NCT00390689|454540710|FG001|Overall Study|Adverse Event|5|||
126339949|NCT00390689|454540711|FG002|Overall Study|Adverse Event|2|||
126339950|NCT00390689|454540709|FG000|Overall Study|Lack of Efficacy|0|||
126339951|NCT00390689|454540710|FG001|Overall Study|Lack of Efficacy|0|||
126339952|NCT00390689|454540711|FG002|Overall Study|Lack of Efficacy|1|||
126339953|NCT00390689|454540709|FG000|Overall Study|Protocol Violation|1|||
126339954|NCT00390689|454540710|FG001|Overall Study|Protocol Violation|0|||
126339955|NCT00390689|454540711|FG002|Overall Study|Protocol Violation|0|||
126339956|NCT00390689|454540709|FG000|Overall Study|Investigator's judgement|2|||
126339957|NCT00390689|454540710|FG001|Overall Study|Investigator's judgement|0|||
126339958|NCT00390689|454540711|FG002|Overall Study|Investigator's judgement|0|||
126339959|NCT01253161|454540712|FG000|Overall Study|Adverse Event|1|||
126339960|NCT01924533|454540714|FG000|Overall Study|Death|181|||
126339961|NCT01924533|454540715|FG001|Overall Study|Death|200|||
126339962|NCT01924533|454540714|FG000|Overall Study|Lost to Follow-up|0|||
126339963|NCT01924533|454540715|FG001|Overall Study|Lost to Follow-up|1|||
126339964|NCT01924533|454540714|FG000|Overall Study|Withdrawal by Subject|7|||
126339965|NCT01924533|454540715|FG001|Overall Study|Withdrawal by Subject|3|||
126339966|NCT01924533|454540714|FG000|Overall Study|Other Eligibility criteria|1|||
126339967|NCT01924533|454540715|FG001|Overall Study|Other Eligibility criteria|1|||
126339968|NCT02747927|454540716|FG000|Overall Study|Adverse Event|5|||
126339969|NCT02747927|454540717|FG001|Overall Study|Adverse Event|14|||
126339970|NCT02747927|454540716|FG000|Overall Study|Lost to Follow-up|22|||
126339971|NCT02747927|454540717|FG001|Overall Study|Lost to Follow-up|43|||
126339972|NCT02747927|454540716|FG000|Overall Study|Pregnancy|34|||
126339973|NCT02747927|454540717|FG001|Overall Study|Pregnancy|66|||
126339974|NCT02747927|454540716|FG000|Overall Study|Protocol Violation|2|||
126339975|NCT02747927|454540717|FG001|Overall Study|Protocol Violation|4|||
126339976|NCT02747927|454540716|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
126339977|NCT02747927|454540717|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
126339978|NCT02747927|454540716|FG000|Overall Study|Reason not Specified|11|||
126339979|NCT02747927|454540717|FG001|Overall Study|Reason not Specified|27|||
126339980|NCT05412134|454540718|FG000|Overall Study|Lost to Follow-up|2|||
126339981|NCT05412134|454540719|FG001|Overall Study|Lost to Follow-up|0|||
126339982|NCT04275336|454540721|FG000|Overall Study|First venipuncture failed|4|||
126339983|NCT04275336|454540722|FG001|Overall Study|First venipuncture failed|6|||
126339984|NCT04275336|454540723|FG002|Overall Study|First venipuncture failed|5|||
126339985|NCT04275336|454540721|FG000|Overall Study|Unscheduled venipuncture|9|||
126339986|NCT04275336|454540722|FG001|Overall Study|Unscheduled venipuncture|13|||
126339987|NCT04275336|454540723|FG002|Overall Study|Unscheduled venipuncture|7|||
126424558|NCT02888106|454851339|FG001|Overall Study|Withdrawal by Subject|2|||
126424559|NCT02888106|454851340|FG002|Overall Study|Withdrawal by Subject|0|||
126424560|NCT02888106|454851341|FG003|Overall Study|Withdrawal by Subject|1|||
126424561|NCT02888106|454851342|FG004|Overall Study|Withdrawal by Subject|0|||
126673685|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126673686|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126673687|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126673688|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126673689|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
126673690|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126673691|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126673692|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126673693|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126673694|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126339988|NCT04275336|454540721|FG000|Overall Study|Failed specimen of saliva|4|||
126339989|NCT04275336|454540722|FG001|Overall Study|Failed specimen of saliva|3|||
126339990|NCT04275336|454540723|FG002|Overall Study|Failed specimen of saliva|4|||
126339991|NCT00423046|454540730|FG000|Overall Study|Other|340|||
126339992|NCT00423046|454540731|FG001|Overall Study|Other|345|||
126339993|NCT01909804|454540732|FG000|Overall Study|Randomized but Never Treated|0|||
126339994|NCT01909804|454540733|FG001|Overall Study|Randomized but Never Treated|0|||
126339995|NCT01909804|454540734|FG002|Overall Study|Randomized but Never Treated|0|||
126339996|NCT01909804|454540735|FG003|Overall Study|Randomized but Never Treated|0|||
126339997|NCT01909804|454540736|FG004|Overall Study|Randomized but Never Treated|0|||
126339998|NCT01909804|454540737|FG005|Overall Study|Randomized but Never Treated|0|||
126339999|NCT01909804|454540738|FG006|Overall Study|Randomized but Never Treated|1|||
126340000|NCT01909804|454540739|FG007|Overall Study|Randomized but Never Treated|0|||
126340001|NCT01909804|454540740|FG008|Overall Study|Randomized but Never Treated|0|||
126340002|NCT01909804|454540741|FG009|Overall Study|Randomized but Never Treated|0|||
126340003|NCT01909804|454540742|FG010|Overall Study|Randomized but Never Treated|0|||
126340004|NCT01909804|454540743|FG011|Overall Study|Randomized but Never Treated|1|||
126340005|NCT01909804|454540732|FG000|Overall Study|Death|0|||
126340006|NCT01909804|454540733|FG001|Overall Study|Death|0|||
126340007|NCT01909804|454540734|FG002|Overall Study|Death|0|||
126340008|NCT01909804|454540735|FG003|Overall Study|Death|0|||
126340009|NCT01909804|454540736|FG004|Overall Study|Death|0|||
126340010|NCT01909804|454540737|FG005|Overall Study|Death|0|||
126340011|NCT01909804|454540738|FG006|Overall Study|Death|0|||
126340012|NCT01909804|454540739|FG007|Overall Study|Death|0|||
126340013|NCT01909804|454540740|FG008|Overall Study|Death|0|||
126340014|NCT01909804|454540741|FG009|Overall Study|Death|0|||
126340015|NCT01909804|454540742|FG010|Overall Study|Death|1|||
126340016|NCT01909804|454540743|FG011|Overall Study|Death|0|||
126340017|NCT01909804|454540732|FG000|Overall Study|Lack of Efficacy|4|||
126340018|NCT01909804|454540733|FG001|Overall Study|Lack of Efficacy|1|||
126340019|NCT01909804|454540734|FG002|Overall Study|Lack of Efficacy|0|||
126340020|NCT01909804|454540735|FG003|Overall Study|Lack of Efficacy|0|||
126340021|NCT01909804|454540736|FG004|Overall Study|Lack of Efficacy|7|||
126340022|NCT01909804|454540737|FG005|Overall Study|Lack of Efficacy|3|||
126340023|NCT01909804|454540738|FG006|Overall Study|Lack of Efficacy|1|||
126340024|NCT01909804|454540739|FG007|Overall Study|Lack of Efficacy|1|||
126340025|NCT01909804|454540740|FG008|Overall Study|Lack of Efficacy|0|||
126340026|NCT01909804|454540741|FG009|Overall Study|Lack of Efficacy|1|||
126340027|NCT01909804|454540742|FG010|Overall Study|Lack of Efficacy|0|||
126340028|NCT01909804|454540743|FG011|Overall Study|Lack of Efficacy|1|||
126340029|NCT01909804|454540732|FG000|Overall Study|Withdrew Consent|0|||
126340030|NCT01909804|454540733|FG001|Overall Study|Withdrew Consent|0|||
126340031|NCT01909804|454540734|FG002|Overall Study|Withdrew Consent|0|||
126340032|NCT01909804|454540735|FG003|Overall Study|Withdrew Consent|0|||
126340033|NCT01909804|454540736|FG004|Overall Study|Withdrew Consent|1|||
126340034|NCT01909804|454540737|FG005|Overall Study|Withdrew Consent|1|||
126340035|NCT01909804|454540738|FG006|Overall Study|Withdrew Consent|0|||
126340036|NCT01909804|454540739|FG007|Overall Study|Withdrew Consent|0|||
126340037|NCT01909804|454540740|FG008|Overall Study|Withdrew Consent|0|||
126424562|NCT02888106|454851343|FG005|Overall Study|Withdrawal by Subject|0|||
126673695|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126340038|NCT01909804|454540741|FG009|Overall Study|Withdrew Consent|0|||
126340039|NCT01909804|454540742|FG010|Overall Study|Withdrew Consent|0|||
126424563|NCT02888106|454851338|FG000|Overall Study|Lost to Follow-up|1|||
126340040|NCT01909804|454540743|FG011|Overall Study|Withdrew Consent|0|||
126340041|NCT01909804|454540732|FG000|Overall Study|Protocol Violation|0|||
126340042|NCT01909804|454540733|FG001|Overall Study|Protocol Violation|0|||
126340043|NCT01909804|454540734|FG002|Overall Study|Protocol Violation|0|||
126340044|NCT01909804|454540735|FG003|Overall Study|Protocol Violation|0|||
126340045|NCT01909804|454540736|FG004|Overall Study|Protocol Violation|0|||
126340046|NCT01909804|454540737|FG005|Overall Study|Protocol Violation|0|||
126424564|NCT02888106|454851339|FG001|Overall Study|Lost to Follow-up|0|||
126424565|NCT02888106|454851340|FG002|Overall Study|Lost to Follow-up|0|||
126424566|NCT02888106|454851341|FG003|Overall Study|Lost to Follow-up|1|||
126424567|NCT02888106|454851342|FG004|Overall Study|Lost to Follow-up|0|||
126424568|NCT02888106|454851343|FG005|Overall Study|Lost to Follow-up|1|||
126424569|NCT02888106|454851338|FG000|Overall Study|Adverse Event|2|||
126424570|NCT02888106|454851339|FG001|Overall Study|Adverse Event|0|||
126424571|NCT02888106|454851340|FG002|Overall Study|Adverse Event|0|||
126424572|NCT02888106|454851341|FG003|Overall Study|Adverse Event|0|||
126424573|NCT02888106|454851342|FG004|Overall Study|Adverse Event|0|||
126424574|NCT02888106|454851343|FG005|Overall Study|Adverse Event|0|||
126424575|NCT02888106|454851338|FG000|Overall Study|Withdrawal of consent|0|||
126424576|NCT02888106|454851339|FG001|Overall Study|Withdrawal of consent|0|||
126424577|NCT02888106|454851340|FG002|Overall Study|Withdrawal of consent|0|||
126424578|NCT02888106|454851341|FG003|Overall Study|Withdrawal of consent|0|||
126424579|NCT02888106|454851342|FG004|Overall Study|Withdrawal of consent|1|||
126424580|NCT02888106|454851343|FG005|Overall Study|Withdrawal of consent|0|||
126424581|NCT02888106|454851338|FG000|Overall Study|Pregnancy|1|||
126424582|NCT02888106|454851339|FG001|Overall Study|Pregnancy|0|||
126424583|NCT02888106|454851340|FG002|Overall Study|Pregnancy|0|||
126424584|NCT02888106|454851341|FG003|Overall Study|Pregnancy|0|||
126424585|NCT02888106|454851342|FG004|Overall Study|Pregnancy|0|||
126424586|NCT02888106|454851343|FG005|Overall Study|Pregnancy|0|||
126424587|NCT01894607|454851350|FG000|Overall Study|Ineligible|1|||
126424588|NCT03259555|454851369|FG000|Overall Study|Adverse Event|6|||
126424589|NCT03259555|454851370|FG001|Overall Study|Adverse Event|4|||
126424590|NCT03259555|454851369|FG000|Overall Study|Lack of Efficacy|6|||
126424591|NCT03259555|454851370|FG001|Overall Study|Lack of Efficacy|4|||
126424592|NCT03259555|454851369|FG000|Overall Study|Lost to Follow-up|0|||
126424593|NCT03259555|454851370|FG001|Overall Study|Lost to Follow-up|2|||
126424594|NCT03259555|454851369|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126424595|NCT03259555|454851370|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126424596|NCT03259555|454851369|FG000|Overall Study|Progressive Disease|0|||
126424597|NCT03259555|454851370|FG001|Overall Study|Progressive Disease|2|||
126424598|NCT03259555|454851369|FG000|Overall Study|Withdrawal by Subject|19|||
126424599|NCT03259555|454851370|FG001|Overall Study|Withdrawal by Subject|16|||
126424600|NCT03259555|454851369|FG000|Overall Study|Physician Decision|1|||
126424601|NCT03259555|454851370|FG001|Overall Study|Physician Decision|2|||
126424602|NCT03259555|454851369|FG000|Overall Study|Other|1|||
126424603|NCT03259555|454851370|FG001|Overall Study|Other|0|||
126424604|NCT04393493|454851371|FG000|First 4 Days of Intervention|Early improvement|5|||
126424605|NCT04393493|454851372|FG001|First 4 Days of Intervention|Early improvement|7|||
126424606|NCT01125800|454851373|FG000|Phase I|Protocol Violation|0|||
126424607|NCT01125800|454851374|FG001|Phase I|Protocol Violation|3|||
126424608|NCT01125800|454851375|FG002|Phase I|Protocol Violation|1|||
126424609|NCT01125800|454851376|FG003|Phase I|Protocol Violation|1|||
126424610|NCT01125800|454851377|FG004|Phase I|Protocol Violation|0|||
126424611|NCT01125800|454851373|FG000|Phase I|Adverse Event|2|||
126424612|NCT01125800|454851374|FG001|Phase I|Adverse Event|2|||
126424613|NCT01125800|454851375|FG002|Phase I|Adverse Event|1|||
126424614|NCT01125800|454851376|FG003|Phase I|Adverse Event|7|||
126424615|NCT01125800|454851377|FG004|Phase I|Adverse Event|0|||
126424616|NCT01125800|454851373|FG000|Phase I|Administrative problems|1|||
126424617|NCT01125800|454851374|FG001|Phase I|Administrative problems|0|||
126424618|NCT01125800|454851375|FG002|Phase I|Administrative problems|0|||
126424619|NCT01125800|454851376|FG003|Phase I|Administrative problems|0|||
126424620|NCT01125800|454851377|FG004|Phase I|Administrative problems|0|||
126424621|NCT01125800|454851373|FG000|Phase I|Withdrawal by Subject|0|||
126424622|NCT01125800|454851374|FG001|Phase I|Withdrawal by Subject|0|||
126424623|NCT01125800|454851375|FG002|Phase I|Withdrawal by Subject|1|||
126424624|NCT01125800|454851376|FG003|Phase I|Withdrawal by Subject|0|||
126424625|NCT01125800|454851377|FG004|Phase I|Withdrawal by Subject|0|||
126424626|NCT01125800|454851373|FG000|Phase I|Disease progression|5|||
126424627|NCT01125800|454851374|FG001|Phase I|Disease progression|4|||
126424628|NCT01125800|454851375|FG002|Phase I|Disease progression|1|||
126424629|NCT01125800|454851376|FG003|Phase I|Disease progression|3|||
126424630|NCT01125800|454851377|FG004|Phase I|Disease progression|0|||
126424631|NCT01125800|454851373|FG000|Phase II|Protocol Violation|0|||
126424632|NCT01125800|454851374|FG001|Phase II|Protocol Violation|0|||
126424633|NCT01125800|454851375|FG002|Phase II|Protocol Violation|0|||
126424634|NCT01125800|454851376|FG003|Phase II|Protocol Violation|0|||
126424635|NCT01125800|454851377|FG004|Phase II|Protocol Violation|1|||
126424636|NCT01125800|454851373|FG000|Phase II|Adverse Event|0|||
126424637|NCT01125800|454851374|FG001|Phase II|Adverse Event|0|||
126424638|NCT01125800|454851375|FG002|Phase II|Adverse Event|0|||
126424639|NCT01125800|454851376|FG003|Phase II|Adverse Event|0|||
126424640|NCT01125800|454851377|FG004|Phase II|Adverse Event|2|||
126340047|NCT01909804|454540738|FG006|Overall Study|Protocol Violation|0|||
126424641|NCT01125800|454851373|FG000|Phase II|Disease progression|0|||
126424642|NCT01125800|454851374|FG001|Phase II|Disease progression|0|||
126424643|NCT01125800|454851375|FG002|Phase II|Disease progression|0|||
126424644|NCT01125800|454851376|FG003|Phase II|Disease progression|1|||
126424645|NCT01125800|454851377|FG004|Phase II|Disease progression|8|||
126424646|NCT04332107|454851384|FG000|Day 3|Lost to Follow-up|23|||
126424647|NCT04332107|454851385|FG001|Day 3|Lost to Follow-up|14|||
126424648|NCT04332107|454851384|FG000|Day 3|Missing outcome data|3|||
126424649|NCT04332107|454851385|FG001|Day 3|Missing outcome data|6|||
126424650|NCT04332107|454851384|FG000|Day 14|Lost to Follow-up|13|||
126424651|NCT04332107|454851385|FG001|Day 14|Lost to Follow-up|4|||
126424652|NCT04332107|454851384|FG000|Day 14|Missing outcome data|4|||
126424653|NCT04332107|454851385|FG001|Day 14|Missing outcome data|4|||
126424654|NCT04332107|454851384|FG000|Day 21|Lost to Follow-up|10|||
126424655|NCT04332107|454851385|FG001|Day 21|Lost to Follow-up|2|||
126424656|NCT03370718|454851390|FG000|Overall Study|Withdrawal by Subject|1|||
126424657|NCT01670721|454851393|FG000|Overall Study|Participant's decision|15|||
126424658|NCT01670721|454851393|FG000|Overall Study|Other than specified above|38|||
126424659|NCT03863509|454851396|FG000|Overall Study|COVID-19 shutdown period|0|||
126424660|NCT03863509|454851397|FG001|Overall Study|COVID-19 shutdown period|4|||
126424661|NCT03863509|454851398|FG002|Overall Study|COVID-19 shutdown period|0|||
126424662|NCT03863509|454851396|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
126424663|NCT03863509|454851397|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
126424664|NCT03863509|454851398|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
126424665|NCT03863509|454851396|FG000|Overall Study|Lost to Follow-up|8|||
126424666|NCT03863509|454851397|FG001|Overall Study|Lost to Follow-up|0|||
126424667|NCT03863509|454851398|FG002|Overall Study|Lost to Follow-up|2|||
126424668|NCT03863509|454851396|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
126424669|NCT03863509|454851397|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
126424670|NCT03863509|454851398|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
126424671|NCT03863509|454851396|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
126424672|NCT03863509|454851397|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
126424673|NCT03863509|454851398|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
126424674|NCT04970654|454851399|FG000|Overall Study|Withdrawal by parents/guardian|1|||
126424675|NCT04970654|454851400|FG001|Overall Study|Withdrawal by parents/guardian|2|||
126424676|NCT04970654|454851399|FG000|Overall Study|Unclassified|2|||
126424677|NCT04970654|454851400|FG001|Overall Study|Unclassified|1|||
126424678|NCT04970654|454851399|FG000|Overall Study|Lost to Follow-up|1|||
126424679|NCT04970654|454851400|FG001|Overall Study|Lost to Follow-up|0|||
126424680|NCT01572480|454851403|FG000|Participants Enrolled|Withdrawal by Subject|1|||
126424681|NCT01572480|454851403|FG000|Drug Administration|Discontinued drug/Off Study|1|||
126424682|NCT01572480|454851403|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
126424683|NCT01572480|454851403|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
126424684|NCT06172348|454851404|FG000|Treatment Period 2|Adverse Event|0|||
126424685|NCT06172348|454851405|FG001|Treatment Period 2|Adverse Event|0|||
126424686|NCT06172348|454851406|FG002|Treatment Period 2|Adverse Event|1|||
126424687|NCT06172348|454851407|FG003|Treatment Period 2|Adverse Event|0|||
126424688|NCT06172348|454851408|FG004|Treatment Period 2|Adverse Event|0|||
126424689|NCT06172348|454851409|FG005|Treatment Period 2|Adverse Event|0|||
126424690|NCT00191334|454851410|FG000|Overall Study|Adverse Event|4|||
126424691|NCT00191334|454851410|FG000|Overall Study|Disease Progression or Relapse|8|||
126340048|NCT01909804|454540739|FG007|Overall Study|Protocol Violation|0|||
126340049|NCT01909804|454540740|FG008|Overall Study|Protocol Violation|0|||
126340050|NCT01909804|454540741|FG009|Overall Study|Protocol Violation|0|||
126340051|NCT01909804|454540742|FG010|Overall Study|Protocol Violation|0|||
126340052|NCT01909804|454540743|FG011|Overall Study|Protocol Violation|1|||
126340053|NCT00830128|454540745|FG000|Overall Study|Adverse Event|5|||
126340054|NCT00830128|454540745|FG000|Overall Study|Lack of Efficacy|7|||
126340055|NCT00830128|454540745|FG000|Overall Study|Protocol Violation|1|||
126340056|NCT00830128|454540745|FG000|Overall Study|Withdrawal by Subject|2|||
126340057|NCT00830128|454540745|FG000|Overall Study|Family obligation|1|||
126340058|NCT00830128|454540745|FG000|Overall Study|Relocation|1|||
126424692|NCT00191334|454851410|FG000|Overall Study|Physician Decision|1|||
126424693|NCT00191334|454851410|FG000|Overall Study|Withdrawal by Subject|4|||
126424694|NCT05579977|454851418|FG000|Treatment Phase|Other|0|||
126424695|NCT05579977|454851419|FG001|Treatment Phase|Other|0|||
126424696|NCT05579977|454851420|FG002|Treatment Phase|Other|0|||
126424697|NCT05579977|454851421|FG003|Treatment Phase|Other|2|||
126424698|NCT05579977|454851422|FG004|Treatment Phase|Other|1|||
126424699|NCT05579977|454851423|FG005|Treatment Phase|Other|2|||
126424700|NCT05579977|454851424|FG006|Treatment Phase|Other|1|||
126424701|NCT05579977|454851425|FG007|Treatment Phase|Other|2|||
126424702|NCT05579977|454851426|FG008|Treatment Phase|Other|2|||
126424703|NCT05579977|454851427|FG009|Treatment Phase|Other|1|||
126424704|NCT05579977|454851428|FG010|Treatment Phase|Other|0|||
126424705|NCT05579977|454851429|FG011|Treatment Phase|Other|0|||
126424706|NCT05579977|454851430|FG012|Treatment Phase|Other|3|||
126424707|NCT05579977|454851418|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
126424708|NCT05579977|454851419|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
126424709|NCT05579977|454851420|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
126424710|NCT05579977|454851421|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
126424711|NCT05579977|454851422|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
126424712|NCT05579977|454851423|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
126424713|NCT05579977|454851424|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
126424714|NCT05579977|454851425|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
126424715|NCT05579977|454851426|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
126424716|NCT05579977|454851427|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
126424717|NCT05579977|454851428|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
126424718|NCT05579977|454851429|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
126424719|NCT05579977|454851430|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
126424720|NCT05579977|454851418|FG000|Treatment Phase|Withdrawal by Subject|2|||
126424721|NCT05579977|454851419|FG001|Treatment Phase|Withdrawal by Subject|0|||
126424722|NCT05579977|454851420|FG002|Treatment Phase|Withdrawal by Subject|0|||
126424723|NCT05579977|454851421|FG003|Treatment Phase|Withdrawal by Subject|1|||
126424724|NCT05579977|454851422|FG004|Treatment Phase|Withdrawal by Subject|2|||
126424725|NCT05579977|454851423|FG005|Treatment Phase|Withdrawal by Subject|0|||
126424726|NCT05579977|454851424|FG006|Treatment Phase|Withdrawal by Subject|1|||
126673696|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126673697|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
126424727|NCT05579977|454851425|FG007|Treatment Phase|Withdrawal by Subject|8|||
126424728|NCT05579977|454851426|FG008|Treatment Phase|Withdrawal by Subject|3|||
126424729|NCT05579977|454851427|FG009|Treatment Phase|Withdrawal by Subject|3|||
126424730|NCT05579977|454851428|FG010|Treatment Phase|Withdrawal by Subject|5|||
126424731|NCT05579977|454851429|FG011|Treatment Phase|Withdrawal by Subject|1|||
126424732|NCT05579977|454851430|FG012|Treatment Phase|Withdrawal by Subject|3|||
126424733|NCT05579977|454851418|FG000|Treatment Phase|Study terminated by sponsor|70|||
126424734|NCT05579977|454851419|FG001|Treatment Phase|Study terminated by sponsor|70|||
126424735|NCT05579977|454851420|FG002|Treatment Phase|Study terminated by sponsor|61|||
126424736|NCT05579977|454851421|FG003|Treatment Phase|Study terminated by sponsor|59|||
126424737|NCT05579977|454851422|FG004|Treatment Phase|Study terminated by sponsor|63|||
126424738|NCT05579977|454851423|FG005|Treatment Phase|Study terminated by sponsor|53|||
126424739|NCT05579977|454851424|FG006|Treatment Phase|Study terminated by sponsor|66|||
126424740|NCT05579977|454851425|FG007|Treatment Phase|Study terminated by sponsor|48|||
126424741|NCT05579977|454851426|FG008|Treatment Phase|Study terminated by sponsor|47|||
126424742|NCT05579977|454851427|FG009|Treatment Phase|Study terminated by sponsor|37|||
126424743|NCT05579977|454851428|FG010|Treatment Phase|Study terminated by sponsor|44|||
126424744|NCT05579977|454851429|FG011|Treatment Phase|Study terminated by sponsor|36|||
126424745|NCT05579977|454851430|FG012|Treatment Phase|Study terminated by sponsor|32|||
126424746|NCT05579977|454851418|FG000|Treatment Phase|Pregnancy|0|||
126424747|NCT05579977|454851419|FG001|Treatment Phase|Pregnancy|0|||
126424748|NCT05579977|454851420|FG002|Treatment Phase|Pregnancy|0|||
126424749|NCT05579977|454851421|FG003|Treatment Phase|Pregnancy|0|||
126424750|NCT05579977|454851422|FG004|Treatment Phase|Pregnancy|0|||
126424751|NCT05579977|454851423|FG005|Treatment Phase|Pregnancy|0|||
126424752|NCT05579977|454851424|FG006|Treatment Phase|Pregnancy|0|||
126424753|NCT05579977|454851425|FG007|Treatment Phase|Pregnancy|0|||
126424754|NCT05579977|454851426|FG008|Treatment Phase|Pregnancy|0|||
126424755|NCT05579977|454851427|FG009|Treatment Phase|Pregnancy|1|||
126424756|NCT05579977|454851428|FG010|Treatment Phase|Pregnancy|0|||
126424757|NCT05579977|454851429|FG011|Treatment Phase|Pregnancy|0|||
126424758|NCT05579977|454851430|FG012|Treatment Phase|Pregnancy|0|||
126673698|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
126673699|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126673700|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126673701|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126673702|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126424759|NCT05579977|454851418|FG000|Treatment Phase|Physician Decision|0|||
126424760|NCT05579977|454851419|FG001|Treatment Phase|Physician Decision|0|||
126424761|NCT05579977|454851420|FG002|Treatment Phase|Physician Decision|0|||
126424762|NCT05579977|454851421|FG003|Treatment Phase|Physician Decision|0|||
126424763|NCT05579977|454851422|FG004|Treatment Phase|Physician Decision|0|||
126424764|NCT05579977|454851423|FG005|Treatment Phase|Physician Decision|0|||
126424765|NCT05579977|454851424|FG006|Treatment Phase|Physician Decision|0|||
126424766|NCT05579977|454851425|FG007|Treatment Phase|Physician Decision|0|||
126424767|NCT05579977|454851426|FG008|Treatment Phase|Physician Decision|0|||
126424768|NCT05579977|454851427|FG009|Treatment Phase|Physician Decision|0|||
126424769|NCT05579977|454851428|FG010|Treatment Phase|Physician Decision|0|||
126424770|NCT05579977|454851429|FG011|Treatment Phase|Physician Decision|1|||
126424771|NCT05579977|454851430|FG012|Treatment Phase|Physician Decision|0|||
126424772|NCT05579977|454851418|FG000|Treatment Phase|Lost to Follow-up|0|||
126424773|NCT05579977|454851419|FG001|Treatment Phase|Lost to Follow-up|0|||
126424774|NCT05579977|454851420|FG002|Treatment Phase|Lost to Follow-up|0|||
126424775|NCT05579977|454851421|FG003|Treatment Phase|Lost to Follow-up|1|||
126424776|NCT05579977|454851422|FG004|Treatment Phase|Lost to Follow-up|1|||
126424777|NCT05579977|454851423|FG005|Treatment Phase|Lost to Follow-up|1|||
126424778|NCT05579977|454851424|FG006|Treatment Phase|Lost to Follow-up|0|||
126424779|NCT05579977|454851425|FG007|Treatment Phase|Lost to Follow-up|1|||
126424780|NCT05579977|454851426|FG008|Treatment Phase|Lost to Follow-up|2|||
126424781|NCT05579977|454851427|FG009|Treatment Phase|Lost to Follow-up|2|||
126424782|NCT05579977|454851428|FG010|Treatment Phase|Lost to Follow-up|1|||
126424783|NCT05579977|454851429|FG011|Treatment Phase|Lost to Follow-up|4|||
126424784|NCT05579977|454851430|FG012|Treatment Phase|Lost to Follow-up|3|||
126424785|NCT05579977|454851418|FG000|Treatment Phase|Death|1|||
126424786|NCT05579977|454851419|FG001|Treatment Phase|Death|0|||
126424787|NCT05579977|454851420|FG002|Treatment Phase|Death|0|||
126424788|NCT05579977|454851421|FG003|Treatment Phase|Death|0|||
126424789|NCT05579977|454851422|FG004|Treatment Phase|Death|0|||
126424790|NCT05579977|454851423|FG005|Treatment Phase|Death|0|||
126424791|NCT05579977|454851424|FG006|Treatment Phase|Death|0|||
126424792|NCT05579977|454851425|FG007|Treatment Phase|Death|0|||
126424793|NCT05579977|454851426|FG008|Treatment Phase|Death|0|||
126424794|NCT05579977|454851427|FG009|Treatment Phase|Death|0|||
126424795|NCT05579977|454851428|FG010|Treatment Phase|Death|0|||
126424796|NCT05579977|454851429|FG011|Treatment Phase|Death|0|||
126424797|NCT05579977|454851430|FG012|Treatment Phase|Death|0|||
126424798|NCT05579977|454851418|FG000|Treatment Phase|Adverse Event|0|||
126424799|NCT05579977|454851419|FG001|Treatment Phase|Adverse Event|3|||
126424800|NCT05579977|454851420|FG002|Treatment Phase|Adverse Event|11|||
126424801|NCT05579977|454851421|FG003|Treatment Phase|Adverse Event|10|||
126424802|NCT05579977|454851422|FG004|Treatment Phase|Adverse Event|5|||
126424803|NCT05579977|454851423|FG005|Treatment Phase|Adverse Event|17|||
126424804|NCT05579977|454851424|FG006|Treatment Phase|Adverse Event|5|||
126424805|NCT05579977|454851425|FG007|Treatment Phase|Adverse Event|5|||
126424806|NCT05579977|454851426|FG008|Treatment Phase|Adverse Event|12|||
126424807|NCT05579977|454851427|FG009|Treatment Phase|Adverse Event|20|||
126424808|NCT05579977|454851428|FG010|Treatment Phase|Adverse Event|15|||
126424809|NCT05579977|454851429|FG011|Treatment Phase|Adverse Event|24|||
126424810|NCT05579977|454851430|FG012|Treatment Phase|Adverse Event|23|||
126424811|NCT05579977|454851418|FG000|Treatment Phase|Randomized not treated|0|||
126424812|NCT05579977|454851419|FG001|Treatment Phase|Randomized not treated|0|||
126424813|NCT05579977|454851420|FG002|Treatment Phase|Randomized not treated|0|||
126424814|NCT05579977|454851421|FG003|Treatment Phase|Randomized not treated|0|||
126424815|NCT05579977|454851422|FG004|Treatment Phase|Randomized not treated|1|||
126424816|NCT05579977|454851423|FG005|Treatment Phase|Randomized not treated|0|||
126424817|NCT05579977|454851424|FG006|Treatment Phase|Randomized not treated|0|||
126424818|NCT05579977|454851425|FG007|Treatment Phase|Randomized not treated|0|||
126424819|NCT05579977|454851426|FG008|Treatment Phase|Randomized not treated|0|||
126424820|NCT05579977|454851427|FG009|Treatment Phase|Randomized not treated|0|||
126424821|NCT05579977|454851428|FG010|Treatment Phase|Randomized not treated|0|||
126424822|NCT05579977|454851429|FG011|Treatment Phase|Randomized not treated|0|||
126424823|NCT05579977|454851430|FG012|Treatment Phase|Randomized not treated|0|||
126424824|NCT05579977|454851418|FG000|Follow up|Death|1|||
126673703|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
126673704|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126673705|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126673706|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126673707|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126673708|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126673709|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126424825|NCT05579977|454851419|FG001|Follow up|Death|0|||
126424826|NCT05579977|454851420|FG002|Follow up|Death|0|||
126424827|NCT05579977|454851421|FG003|Follow up|Death|0|||
126424828|NCT05579977|454851422|FG004|Follow up|Death|0|||
126424829|NCT05579977|454851423|FG005|Follow up|Death|0|||
126424830|NCT05579977|454851424|FG006|Follow up|Death|0|||
126424831|NCT05579977|454851425|FG007|Follow up|Death|0|||
126424832|NCT05579977|454851426|FG008|Follow up|Death|0|||
126424833|NCT05579977|454851427|FG009|Follow up|Death|0|||
126424834|NCT05579977|454851428|FG010|Follow up|Death|0|||
126424835|NCT05579977|454851429|FG011|Follow up|Death|0|||
126424836|NCT05579977|454851430|FG012|Follow up|Death|0|||
126424837|NCT05579977|454851418|FG000|Follow up|Lost to Follow-up|0|||
126424838|NCT05579977|454851419|FG001|Follow up|Lost to Follow-up|0|||
126424839|NCT05579977|454851420|FG002|Follow up|Lost to Follow-up|0|||
126673710|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126340059|NCT00830128|454540745|FG000|Overall Study|Work obligation|1|||
126340060|NCT00830128|454540745|FG000|Overall Study|Operating a vehicle|1|||
126340061|NCT05401565|454540746|FG000|Overall Study|Lost to Follow-up|1|||
126340062|NCT05401565|454540747|FG001|Overall Study|Lost to Follow-up|0|||
126340063|NCT05401565|454540746|FG000|Overall Study|Adverse Event|2|||
126340064|NCT05401565|454540747|FG001|Overall Study|Adverse Event|0|||
126340065|NCT01218802|454540756|FG000|Overall Study|Lost to Follow-up|5|||
126340066|NCT01218802|454540757|FG001|Overall Study|Lost to Follow-up|6|||
126340067|NCT01218802|454540756|FG000|Overall Study|Withdrawal by Subject|3|||
126340068|NCT01218802|454540757|FG001|Overall Study|Withdrawal by Subject|10|||
126340069|NCT01218802|454540756|FG000|Overall Study|Adverse Event|0|||
126340070|NCT01218802|454540757|FG001|Overall Study|Adverse Event|2|||
126340071|NCT01218802|454540756|FG000|Overall Study|Incarcerated|2|||
126340072|NCT01218802|454540757|FG001|Overall Study|Incarcerated|0|||
126340073|NCT03080935|454540758|FG000|Overall Study|Death|34|||
126340074|NCT03080935|454540759|FG001|Overall Study|Death|50|||
126340075|NCT03080935|454540758|FG000|Overall Study|Lost to Follow-up|5|||
126340076|NCT03080935|454540759|FG001|Overall Study|Lost to Follow-up|4|||
126340077|NCT03080935|454540758|FG000|Overall Study|Withdrawal by Subject|11|||
126340078|NCT03080935|454540759|FG001|Overall Study|Withdrawal by Subject|15|||
126340079|NCT02175121|454540760|FG000|Overall Study|Lack of Efficacy|1|||
126340080|NCT02175121|454540761|FG001|Overall Study|Lack of Efficacy|0|||
126340081|NCT02175121|454540762|FG002|Overall Study|Lack of Efficacy|0|||
126340082|NCT02175121|454540763|FG003|Overall Study|Lack of Efficacy|0|||
126340083|NCT02175121|454540764|FG004|Overall Study|Lack of Efficacy|0|||
126340084|NCT02175121|454540760|FG000|Overall Study|Lost to Follow-up|0|||
126340085|NCT02175121|454540761|FG001|Overall Study|Lost to Follow-up|1|||
126340086|NCT02175121|454540762|FG002|Overall Study|Lost to Follow-up|0|||
126340087|NCT02175121|454540763|FG003|Overall Study|Lost to Follow-up|1|||
126340088|NCT02175121|454540764|FG004|Overall Study|Lost to Follow-up|0|||
126340089|NCT02175121|454540760|FG000|Overall Study|Personal emergency|0|||
126340090|NCT02175121|454540761|FG001|Overall Study|Personal emergency|0|||
126340091|NCT02175121|454540762|FG002|Overall Study|Personal emergency|0|||
126340092|NCT02175121|454540763|FG003|Overall Study|Personal emergency|0|||
126340093|NCT02175121|454540764|FG004|Overall Study|Personal emergency|1|||
126340094|NCT02175121|454540760|FG000|Overall Study|Schedule conflict|0|||
126340095|NCT02175121|454540761|FG001|Overall Study|Schedule conflict|0|||
126340096|NCT02175121|454540762|FG002|Overall Study|Schedule conflict|1|||
126340097|NCT02175121|454540763|FG003|Overall Study|Schedule conflict|0|||
126340098|NCT02175121|454540764|FG004|Overall Study|Schedule conflict|0|||
126340099|NCT02175121|454540760|FG000|Overall Study|Time issues|0|||
126340100|NCT02175121|454540761|FG001|Overall Study|Time issues|0|||
126340101|NCT02175121|454540762|FG002|Overall Study|Time issues|1|||
126340102|NCT02175121|454540763|FG003|Overall Study|Time issues|0|||
126340103|NCT02175121|454540764|FG004|Overall Study|Time issues|0|||
126340104|NCT03329885|454540765|FG000|Overall Study|Sponsor discontinued the study early|0|||
126340105|NCT03329885|454540766|FG001|Overall Study|Sponsor discontinued the study early|0|||
126340106|NCT03329885|454540767|FG002|Overall Study|Sponsor discontinued the study early|0|||
126340107|NCT03329885|454540768|FG003|Overall Study|Sponsor discontinued the study early|0|||
126340108|NCT03329885|454540769|FG004|Overall Study|Sponsor discontinued the study early|0|||
126340109|NCT03329885|454540770|FG005|Overall Study|Sponsor discontinued the study early|0|||
126340110|NCT03329885|454540771|FG006|Overall Study|Sponsor discontinued the study early|1|||
126340111|NCT03329885|454540772|FG007|Overall Study|Sponsor discontinued the study early|1|||
126340112|NCT03329885|454540773|FG008|Overall Study|Sponsor discontinued the study early|0|||
126340113|NCT03886272|454540780|FG000|Period 1|Withdrawal by Subject|0|||
126340114|NCT03886272|454540781|FG001|Period 1|Withdrawal by Subject|0|||
126340115|NCT03886272|454540782|FG002|Period 1|Withdrawal by Subject|0|||
126340116|NCT03886272|454540783|FG003|Period 1|Withdrawal by Subject|0|||
126340117|NCT03886272|454540784|FG004|Period 1|Withdrawal by Subject|0|||
126340118|NCT03886272|454540785|FG005|Period 1|Withdrawal by Subject|1|||
126340119|NCT03886272|454540786|FG006|Period 1|Withdrawal by Subject|0|||
126340120|NCT00931632|454540787|FG000|Overall Study|Withdrawal by Subject|2|||
126340121|NCT00931632|454540788|FG001|Overall Study|Withdrawal by Subject|3|||
126340122|NCT00931632|454540787|FG000|Overall Study|Adverse Event|19|||
126340123|NCT00931632|454540788|FG001|Overall Study|Adverse Event|15|||
126673711|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
126340124|NCT03372798|454540791|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
126340125|NCT03372798|454540792|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
126424840|NCT05579977|454851421|FG003|Follow up|Lost to Follow-up|1|||
126424841|NCT05579977|454851422|FG004|Follow up|Lost to Follow-up|1|||
126340126|NCT03372798|454540791|FG000|Overall Study|Failure of imaging probe|0|||
126340127|NCT03372798|454540792|FG001|Overall Study|Failure of imaging probe|1|||
126340128|NCT01687218|454540793|FG000|Overall Study|Withdrawal by Subject|2|||
126340129|NCT01687218|454540794|FG001|Overall Study|Withdrawal by Subject|3|||
126340130|NCT01687218|454540795|FG002|Overall Study|Withdrawal by Subject|0|||
126340131|NCT01687218|454540796|FG003|Overall Study|Withdrawal by Subject|1|||
126424842|NCT05579977|454851423|FG005|Follow up|Lost to Follow-up|2|||
126424843|NCT05579977|454851424|FG006|Follow up|Lost to Follow-up|1|||
126424844|NCT05579977|454851425|FG007|Follow up|Lost to Follow-up|1|||
126424845|NCT05579977|454851426|FG008|Follow up|Lost to Follow-up|3|||
126424846|NCT05579977|454851427|FG009|Follow up|Lost to Follow-up|2|||
126424847|NCT05579977|454851428|FG010|Follow up|Lost to Follow-up|2|||
126424848|NCT05579977|454851429|FG011|Follow up|Lost to Follow-up|4|||
126424849|NCT05579977|454851430|FG012|Follow up|Lost to Follow-up|4|||
126424850|NCT05579977|454851418|FG000|Follow up|Withdrawal by Subject|2|||
126424851|NCT05579977|454851419|FG001|Follow up|Withdrawal by Subject|0|||
126424852|NCT05579977|454851420|FG002|Follow up|Withdrawal by Subject|0|||
126424853|NCT05579977|454851421|FG003|Follow up|Withdrawal by Subject|0|||
126424854|NCT05579977|454851422|FG004|Follow up|Withdrawal by Subject|1|||
126424855|NCT05579977|454851423|FG005|Follow up|Withdrawal by Subject|0|||
126424856|NCT05579977|454851424|FG006|Follow up|Withdrawal by Subject|1|||
126424857|NCT05579977|454851425|FG007|Follow up|Withdrawal by Subject|4|||
126424858|NCT05579977|454851426|FG008|Follow up|Withdrawal by Subject|2|||
126424859|NCT05579977|454851427|FG009|Follow up|Withdrawal by Subject|3|||
126424860|NCT05579977|454851428|FG010|Follow up|Withdrawal by Subject|3|||
126424861|NCT05579977|454851429|FG011|Follow up|Withdrawal by Subject|1|||
126424862|NCT05579977|454851430|FG012|Follow up|Withdrawal by Subject|3|||
126424863|NCT00350844|454851431|FG000|Overall Study|Lost to Follow-up|1|||
126424864|NCT01420926|454851432|FG000|Overall Study|Adverse Event|6|||
126424865|NCT01420926|454851433|FG001|Overall Study|Adverse Event|4|||
126424866|NCT01420926|454851432|FG000|Overall Study|Death|18|||
126424867|NCT01420926|454851433|FG001|Overall Study|Death|17|||
126424868|NCT01420926|454851432|FG000|Overall Study|Withdrawal by Subject|11|||
126424869|NCT01420926|454851433|FG001|Overall Study|Withdrawal by Subject|17|||
126424870|NCT01420926|454851432|FG000|Overall Study|Non-protocol treatment|17|||
126424871|NCT01420926|454851433|FG001|Overall Study|Non-protocol treatment|20|||
126424872|NCT01420926|454851432|FG000|Overall Study|Physician Decision|8|||
126424873|NCT01420926|454851433|FG001|Overall Study|Physician Decision|5|||
126424874|NCT02775916|454851436|FG000|Overall Study|Adverse Event|1|||
126424875|NCT02775916|454851437|FG001|Overall Study|Adverse Event|0|||
126424876|NCT02775916|454851436|FG000|Overall Study|Subject/Guardian Decision|2|||
126424877|NCT02775916|454851437|FG001|Overall Study|Subject/Guardian Decision|0|||
126424878|NCT01232868|454853750|FG000|Overall Study|Lost to Follow-up|2|||
126424879|NCT01232868|454853751|FG001|Overall Study|Lost to Follow-up|4|||
126424880|NCT02539797|454853752|FG000|Overall Study|Lost to Follow-up|0|||
126424881|NCT02539797|454853753|FG001|Overall Study|Lost to Follow-up|1|||
126424882|NCT02539797|454853754|FG002|Overall Study|Lost to Follow-up|0|||
126424883|NCT04002960|454853756|FG000|Overall Study|Withdrawn prior to Completion|2|||
126424884|NCT00865345|454853759|FG000|Overall Study|Withdrawal by Subject|2|||
126424885|NCT00383786|454853760|FG000|Overall Study|Protocol Violation|2|||
126424886|NCT00383786|454853761|FG001|Overall Study|Protocol Violation|6|||
126424887|NCT00383786|454853760|FG000|Overall Study|Withdrawal by Subject|2|||
126424888|NCT00383786|454853761|FG001|Overall Study|Withdrawal by Subject|5|||
126424889|NCT00383786|454853760|FG000|Overall Study|Physician Decision|0|||
126424890|NCT00383786|454853761|FG001|Overall Study|Physician Decision|1|||
126424891|NCT02723773|454853764|FG000|Overall Study|Adverse Event|934|||
126424892|NCT02723773|454853765|FG001|Overall Study|Adverse Event|3|||
126424893|NCT02723773|454853766|FG002|Overall Study|Adverse Event|1|||
126424894|NCT02723773|454853767|FG003|Overall Study|Adverse Event|9|||
126424895|NCT02723773|454853764|FG000|Overall Study|Protocol Violation|1|||
126424896|NCT02723773|454853765|FG001|Overall Study|Protocol Violation|0|||
126424897|NCT02723773|454853766|FG002|Overall Study|Protocol Violation|0|||
126424898|NCT02723773|454853767|FG003|Overall Study|Protocol Violation|0|||
126424899|NCT02723773|454853764|FG000|Overall Study|Withdrawal by Subject|360|||
126424900|NCT02723773|454853765|FG001|Overall Study|Withdrawal by Subject|5|||
126424901|NCT02723773|454853766|FG002|Overall Study|Withdrawal by Subject|6|||
126424902|NCT02723773|454853767|FG003|Overall Study|Withdrawal by Subject|10|||
126424903|NCT02723773|454853764|FG000|Overall Study|Migrated/moved from study area|37|||
126424904|NCT02723773|454853765|FG001|Overall Study|Migrated/moved from study area|0|||
126424905|NCT02723773|454853766|FG002|Overall Study|Migrated/moved from study area|0|||
126424906|NCT02723773|454853767|FG003|Overall Study|Migrated/moved from study area|1|||
126424907|NCT02723773|454853764|FG000|Overall Study|Lost to Follow-up|198|||
126424908|NCT02723773|454853765|FG001|Overall Study|Lost to Follow-up|0|||
126424909|NCT02723773|454853766|FG002|Overall Study|Lost to Follow-up|0|||
126424910|NCT02723773|454853767|FG003|Overall Study|Lost to Follow-up|0|||
126424911|NCT02723773|454853764|FG000|Overall Study|Other|189|||
126424912|NCT02723773|454853765|FG001|Overall Study|Other|1|||
126424913|NCT02723773|454853766|FG002|Overall Study|Other|2|||
126424914|NCT02723773|454853767|FG003|Overall Study|Other|2|||
126424915|NCT03629886|454853768|FG000|Overall Study|Migrated / moved from the study area|0|||
126424916|NCT03629886|454853769|FG001|Overall Study|Migrated / moved from the study area|55|||
126424917|NCT03629886|454853768|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
126424918|NCT03629886|454853769|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
126424919|NCT03629886|454853768|FG000|Overall Study|Study vaccine not administrated|0|||
126673712|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126673713|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126673714|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126673715|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126673716|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126673717|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
126673718|NCT04033445|455763185|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126673719|NCT04033445|455763186|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126673720|NCT04033445|455763187|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126673721|NCT04033445|455763188|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126673722|NCT04033445|455763189|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126673723|NCT04033445|455763190|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126673724|NCT04033445|455763191|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126340132|NCT01687218|454540797|FG004|Overall Study|Withdrawal by Subject|1|||
126340133|NCT01687218|454540798|FG005|Overall Study|Withdrawal by Subject|0|||
126340134|NCT01687218|454540793|FG000|Overall Study|Relocated, no follow-up planned|1|||
126340135|NCT01687218|454540794|FG001|Overall Study|Relocated, no follow-up planned|0|||
126340136|NCT01687218|454540795|FG002|Overall Study|Relocated, no follow-up planned|1|||
126340137|NCT01687218|454540796|FG003|Overall Study|Relocated, no follow-up planned|1|||
126340138|NCT01687218|454540797|FG004|Overall Study|Relocated, no follow-up planned|0|||
126340139|NCT01687218|454540798|FG005|Overall Study|Relocated, no follow-up planned|0|||
126340140|NCT03139552|454540804|FG000|Overall Study|unable to attend tasting due to schedule|3|||
126340141|NCT03368807|454540813|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
126340142|NCT03368807|454540813|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
126340143|NCT03368807|454540813|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
126340144|NCT03368807|454540813|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
126340145|NCT01973218|454540814|FG000|Overall Study|Adverse Event|1|||
126340146|NCT01973218|454540815|FG001|Overall Study|Adverse Event|0|||
126340147|NCT01973218|454540814|FG000|Overall Study|Withdrawal by Subject|1|||
126340148|NCT01973218|454540815|FG001|Overall Study|Withdrawal by Subject|0|||
126340149|NCT03533751|454540816|FG000|Overall Study|Withdrawal by Subject|12|||
126340150|NCT03533751|454540817|FG001|Overall Study|Withdrawal by Subject|6|||
126340151|NCT03533751|454540818|FG002|Overall Study|Withdrawal by Subject|11|||
126340152|NCT03533751|454540819|FG003|Overall Study|Withdrawal by Subject|9|||
126340153|NCT03533751|454540820|FG004|Overall Study|Withdrawal by Subject|10|||
126340154|NCT03533751|454540816|FG000|Overall Study|Adverse Event|4|||
126340155|NCT03533751|454540817|FG001|Overall Study|Adverse Event|7|||
126340156|NCT03533751|454540818|FG002|Overall Study|Adverse Event|2|||
126340157|NCT03533751|454540819|FG003|Overall Study|Adverse Event|4|||
126340158|NCT03533751|454540820|FG004|Overall Study|Adverse Event|5|||
126340159|NCT03533751|454540816|FG000|Overall Study|Physician Decision|0|||
126340160|NCT03533751|454540817|FG001|Overall Study|Physician Decision|2|||
126340161|NCT03533751|454540818|FG002|Overall Study|Physician Decision|1|||
126340162|NCT03533751|454540819|FG003|Overall Study|Physician Decision|2|||
126340163|NCT03533751|454540820|FG004|Overall Study|Physician Decision|1|||
126340164|NCT03533751|454540816|FG000|Overall Study|Sponsor Decision|0|||
126340165|NCT03533751|454540817|FG001|Overall Study|Sponsor Decision|0|||
126340166|NCT03533751|454540818|FG002|Overall Study|Sponsor Decision|1|||
126340167|NCT03533751|454540819|FG003|Overall Study|Sponsor Decision|1|||
126340168|NCT03533751|454540820|FG004|Overall Study|Sponsor Decision|0|||
126340169|NCT03533751|454540816|FG000|Overall Study|Lost to Follow-up|3|||
126340170|NCT03533751|454540817|FG001|Overall Study|Lost to Follow-up|7|||
126340171|NCT03533751|454540818|FG002|Overall Study|Lost to Follow-up|6|||
126340172|NCT03533751|454540819|FG003|Overall Study|Lost to Follow-up|4|||
126340173|NCT03533751|454540820|FG004|Overall Study|Lost to Follow-up|3|||
126340174|NCT03533751|454540816|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
126340175|NCT03533751|454540817|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
126340176|NCT03533751|454540818|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
126340177|NCT03533751|454540819|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
126340178|NCT03533751|454540820|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
126340179|NCT03533751|454540816|FG000|Overall Study|Other|0|||
126340180|NCT03533751|454540817|FG001|Overall Study|Other|2|||
126340181|NCT03533751|454540818|FG002|Overall Study|Other|1|||
126340182|NCT03533751|454540819|FG003|Overall Study|Other|0|||
126424920|NCT03629886|454853769|FG001|Overall Study|Study vaccine not administrated|3|||
126424921|NCT03629886|454853768|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
126340183|NCT03533751|454540820|FG004|Overall Study|Other|3|||
126340184|NCT05117060|454540821|FG000|Overall Study|Adverse Event|3|||
126340185|NCT05117060|454540822|FG001|Overall Study|Adverse Event|5|||
126340186|NCT05117060|454540823|FG002|Overall Study|Adverse Event|6|||
126340187|NCT05117060|454540824|FG003|Overall Study|Adverse Event|1|||
126340188|NCT05117060|454540821|FG000|Overall Study|Lost to Follow-up|0|||
126340189|NCT05117060|454540822|FG001|Overall Study|Lost to Follow-up|0|||
126340190|NCT05117060|454540823|FG002|Overall Study|Lost to Follow-up|0|||
126424922|NCT03629886|454853769|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
126424923|NCT03629886|454853768|FG000|Overall Study|Refused vaccination step of the study|0|||
126424924|NCT03629886|454853769|FG001|Overall Study|Refused vaccination step of the study|44|||
126424925|NCT00404651|454853770|FG000|Overall Study|Serious Adverse Event|0|||
126424926|NCT00404651|454853771|FG001|Overall Study|Serious Adverse Event|0|||
126424927|NCT00404651|454853772|FG002|Overall Study|Serious Adverse Event|2|||
126424928|NCT00404651|454853773|FG003|Overall Study|Serious Adverse Event|0|||
126424929|NCT00404651|454853770|FG000|Overall Study|Protocol Violation|10|||
126424930|NCT00404651|454853771|FG001|Overall Study|Protocol Violation|5|||
126424931|NCT00404651|454853772|FG002|Overall Study|Protocol Violation|14|||
126424932|NCT00404651|454853773|FG003|Overall Study|Protocol Violation|5|||
126424933|NCT00404651|454853770|FG000|Overall Study|Lost to Follow-up|15|||
126424934|NCT00404651|454853771|FG001|Overall Study|Lost to Follow-up|11|||
126424935|NCT00404651|454853772|FG002|Overall Study|Lost to Follow-up|13|||
126424936|NCT00404651|454853773|FG003|Overall Study|Lost to Follow-up|10|||
126424937|NCT00404651|454853770|FG000|Overall Study|Withdrawal by Subject|14|||
126424938|NCT00404651|454853771|FG001|Overall Study|Withdrawal by Subject|12|||
126424939|NCT00404651|454853772|FG002|Overall Study|Withdrawal by Subject|16|||
126424940|NCT00404651|454853773|FG003|Overall Study|Withdrawal by Subject|6|||
126424941|NCT01702844|454853788|FG000|Overall Study|Adverse Event|9|||
126424942|NCT01702844|454853788|FG000|Overall Study|Death|1|||
126424943|NCT01702844|454853788|FG000|Overall Study|Withdrawal by Subject|3|||
126424944|NCT01702844|454853788|FG000|Overall Study|Physician Decision|6|||
126424945|NCT02123134|454853789|FG000|Overall Study|Withdrawal of consent|3|||
126424946|NCT02123134|454853790|FG001|Overall Study|Withdrawal of consent|2|||
126424947|NCT02123134|454853789|FG000|Overall Study|Administrative decision|0|||
126424948|NCT02123134|454853790|FG001|Overall Study|Administrative decision|1|||
126424949|NCT03431441|454853791|FG000|Overall Study|Withdrawal by Subject|2|||
126424950|NCT03431441|454853791|FG000|Overall Study|Adverse Event|2|||
126424951|NCT03431441|454853791|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
126424952|NCT00346216|454853792|FG000|Overall Study|Other|181|||
126424953|NCT00346216|454853793|FG001|Overall Study|Other|231|||
126424954|NCT00346216|454853794|FG002|Overall Study|Other|205|||
126424955|NCT00346216|454853792|FG000|Overall Study|No longer willing to participate|600|||
126424956|NCT00346216|454853793|FG001|Overall Study|No longer willing to participate|606|||
126424957|NCT00346216|454853794|FG002|Overall Study|No longer willing to participate|585|||
126424958|NCT00346216|454853792|FG000|Overall Study|Withdrawal by Subject|661|||
126424959|NCT00346216|454853793|FG001|Overall Study|Withdrawal by Subject|692|||
126424960|NCT00346216|454853794|FG002|Overall Study|Withdrawal by Subject|651|||
126424961|NCT00346216|454853792|FG000|Overall Study|Lost to Follow-up|611|||
126424962|NCT00346216|454853793|FG001|Overall Study|Lost to Follow-up|588|||
126424963|NCT00346216|454853794|FG002|Overall Study|Lost to Follow-up|542|||
126424964|NCT00346216|454853792|FG000|Overall Study|Physician Decision|80|||
126424965|NCT00346216|454853793|FG001|Overall Study|Physician Decision|76|||
126424966|NCT00346216|454853794|FG002|Overall Study|Physician Decision|59|||
126424967|NCT00346216|454853792|FG000|Overall Study|Does not meet entrance criteria|13|||
126424968|NCT00346216|454853793|FG001|Overall Study|Does not meet entrance criteria|10|||
126424969|NCT00346216|454853794|FG002|Overall Study|Does not meet entrance criteria|8|||
126424970|NCT00346216|454853792|FG000|Overall Study|Death|189|||
126424971|NCT00346216|454853793|FG001|Overall Study|Death|192|||
126424972|NCT00346216|454853794|FG002|Overall Study|Death|228|||
126424973|NCT00346216|454853792|FG000|Overall Study|Study terminated by sponsor|11|||
126424974|NCT00346216|454853793|FG001|Overall Study|Study terminated by sponsor|4|||
126424975|NCT00346216|454853794|FG002|Overall Study|Study terminated by sponsor|8|||
126424976|NCT00346216|454853792|FG000|Overall Study|Missing Subject Summary Status|62|||
126424977|NCT00346216|454853793|FG001|Overall Study|Missing Subject Summary Status|61|||
126424978|NCT00346216|454853794|FG002|Overall Study|Missing Subject Summary Status|62|||
126424979|NCT02648204|454853805|FG000|Overall Study|Withdrawal by Subject|12|||
126424980|NCT02648204|454853806|FG001|Overall Study|Withdrawal by Subject|8|||
126424981|NCT02648204|454853807|FG002|Overall Study|Withdrawal by Subject|2|||
126424982|NCT02648204|454853808|FG003|Overall Study|Withdrawal by Subject|6|||
126424983|NCT02648204|454853805|FG000|Overall Study|Lost to Follow-up|5|||
126424984|NCT02648204|454853806|FG001|Overall Study|Lost to Follow-up|8|||
126424985|NCT02648204|454853807|FG002|Overall Study|Lost to Follow-up|4|||
126424986|NCT02648204|454853808|FG003|Overall Study|Lost to Follow-up|6|||
126715079|NCT02116972|455908673|FG002|Overall Study|scheduling conflicts and relocation|6|||
126424987|NCT02648204|454853805|FG000|Overall Study|Missing follow-up information|4|||
126424988|NCT02648204|454853806|FG001|Overall Study|Missing follow-up information|4|||
126424989|NCT02648204|454853807|FG002|Overall Study|Missing follow-up information|4|||
126424990|NCT02648204|454853808|FG003|Overall Study|Missing follow-up information|2|||
126424991|NCT02648204|454853805|FG000|Overall Study|Death|1|||
126424992|NCT02648204|454853806|FG001|Overall Study|Death|1|||
126424993|NCT02648204|454853807|FG002|Overall Study|Death|2|||
126424994|NCT02648204|454853808|FG003|Overall Study|Death|2|||
126424995|NCT02648204|454853805|FG000|Overall Study|Adverse Event|0|||
126424996|NCT02648204|454853806|FG001|Overall Study|Adverse Event|0|||
126424997|NCT02648204|454853807|FG002|Overall Study|Adverse Event|1|||
126673725|NCT04033445|455763192|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
126673726|NCT04033445|455763193|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126673727|NCT04033445|455763194|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126673728|NCT04033445|455763195|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126673729|NCT04033445|455763196|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126673730|NCT04033445|455763197|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126673731|NCT04033445|455763198|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
126673732|NCT04033445|455763185|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126673733|NCT04033445|455763186|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126673734|NCT04033445|455763187|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126673735|NCT04033445|455763188|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126673736|NCT04033445|455763189|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126673737|NCT04033445|455763190|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126340191|NCT05117060|454540824|FG003|Overall Study|Lost to Follow-up|1|||
126340192|NCT05117060|454540821|FG000|Overall Study|Lack of Efficacy|4|||
126340193|NCT05117060|454540822|FG001|Overall Study|Lack of Efficacy|5|||
126340194|NCT05117060|454540823|FG002|Overall Study|Lack of Efficacy|2|||
126340195|NCT05117060|454540824|FG003|Overall Study|Lack of Efficacy|6|||
126340196|NCT05117060|454540821|FG000|Overall Study|Withdrawal by Subject|8|||
126340197|NCT05117060|454540822|FG001|Overall Study|Withdrawal by Subject|5|||
126340198|NCT05117060|454540823|FG002|Overall Study|Withdrawal by Subject|5|||
126340199|NCT05117060|454540824|FG003|Overall Study|Withdrawal by Subject|6|||
126340200|NCT05117060|454540821|FG000|Overall Study|Other|2|||
126340201|NCT05117060|454540822|FG001|Overall Study|Other|1|||
126340202|NCT05117060|454540823|FG002|Overall Study|Other|3|||
126340203|NCT05117060|454540824|FG003|Overall Study|Other|1|||
126340204|NCT00368251|454542189|FG000|Overall Study|SAE, non-fatal|1|||
126340205|NCT00368251|454542190|FG001|Overall Study|SAE, non-fatal|0|||
126340206|NCT00368251|454542191|FG002|Overall Study|SAE, non-fatal|0|||
126340207|NCT00368251|454542189|FG000|Overall Study|AE, non-serious non-fatal|0|||
126340208|NCT00368251|454542190|FG001|Overall Study|AE, non-serious non-fatal|0|||
126340209|NCT00368251|454542191|FG002|Overall Study|AE, non-serious non-fatal|1|||
126340210|NCT00607893|454542193|FG000|Overall Study|Lost to Follow-up|4|||
126340211|NCT00607893|454542194|FG001|Overall Study|Lost to Follow-up|0|||
126340212|NCT00607893|454542193|FG000|Overall Study|withdrew due to loss of interest|0|||
126340213|NCT00607893|454542194|FG001|Overall Study|withdrew due to loss of interest|1|||
126340214|NCT00607893|454542193|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
126340215|NCT00607893|454542194|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
126340216|NCT00607893|454542193|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
126340217|NCT00607893|454542194|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
126340218|NCT00607893|454542193|FG000|Overall Study|Declined to be treated|1|||
126340219|NCT00607893|454542194|FG001|Overall Study|Declined to be treated|0|||
126340220|NCT00607893|454542193|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
126340221|NCT00607893|454542194|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
126340222|NCT02669849|454542195|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
126340223|NCT02669849|454542196|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
126340224|NCT02669849|454542197|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
126340225|NCT02669849|454542195|FG000|Overall Study|Lost to Follow-up|1|||
126340226|NCT02669849|454542196|FG001|Overall Study|Lost to Follow-up|0|||
126340227|NCT02669849|454542197|FG002|Overall Study|Lost to Follow-up|3|||
126340228|NCT02669849|454542195|FG000|Overall Study|Death|1|||
126340229|NCT02669849|454542196|FG001|Overall Study|Death|1|||
126340230|NCT02669849|454542197|FG002|Overall Study|Death|2|||
126340231|NCT02669849|454542195|FG000|Overall Study|Study terminated by sponsor|16|||
126340232|NCT02669849|454542196|FG001|Overall Study|Study terminated by sponsor|1|||
126340233|NCT02669849|454542197|FG002|Overall Study|Study terminated by sponsor|14|||
126340234|NCT02669849|454542195|FG000|Overall Study|Other|0|||
126340235|NCT02669849|454542196|FG001|Overall Study|Other|0|||
126340236|NCT02669849|454542197|FG002|Overall Study|Other|2|||
126340237|NCT04745351|454542200|FG000|Overall Study|Death|51|||
126340238|NCT04745351|454542201|FG001|Overall Study|Death|25|||
126673738|NCT04033445|455763191|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126673739|NCT04033445|455763192|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126715080|NCT01400971|455908674|FG000|Overall Study|Death|82|||
126340239|NCT04745351|454542200|FG000|Overall Study|Lost to Follow-up|9|||
126340240|NCT04745351|454542201|FG001|Overall Study|Lost to Follow-up|3|||
126340241|NCT04745351|454542200|FG000|Overall Study|Randomized but Never Treated|3|||
126340242|NCT04745351|454542201|FG001|Overall Study|Randomized but Never Treated|3|||
126340243|NCT04745351|454542200|FG000|Overall Study|Adverse Event|4|||
126340244|NCT04745351|454542201|FG001|Overall Study|Adverse Event|0|||
126340245|NCT04745351|454542200|FG000|Overall Study|Withdrew Consent|1|||
126340246|NCT04745351|454542201|FG001|Overall Study|Withdrew Consent|2|||
126340247|NCT04745351|454542200|FG000|Overall Study|Investigator's Discretion|2|||
126340248|NCT04745351|454542201|FG001|Overall Study|Investigator's Discretion|0|||
126673740|NCT04033445|455763193|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
126673741|NCT04033445|455763194|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
126673742|NCT04033445|455763195|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
126673743|NCT04033445|455763196|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
126673744|NCT04033445|455763197|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
126673745|NCT04033445|455763198|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
126673746|NCT04033445|455763185|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126673747|NCT04033445|455763186|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126673748|NCT04033445|455763187|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126673749|NCT04033445|455763188|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126673750|NCT04033445|455763189|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126673751|NCT04033445|455763190|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126673752|NCT04033445|455763191|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126673753|NCT04033445|455763192|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126673754|NCT04033445|455763193|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
126673755|NCT04033445|455763194|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
126673756|NCT04033445|455763195|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
126673757|NCT04033445|455763196|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
126673758|NCT04033445|455763197|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
126673759|NCT04033445|455763198|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
126673760|NCT04033445|455763185|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126424998|NCT02648204|454853808|FG003|Overall Study|Adverse Event|0|||
126424999|NCT01220167|454853809|FG000|Period 3|Urine positive for substance abuse|0|||
126425000|NCT01220167|454853810|FG001|Period 3|Urine positive for substance abuse|1|||
126425001|NCT01220167|454853811|FG002|Period 3|Urine positive for substance abuse|0|||
126425002|NCT05789745|454853817|FG000|Overall Study|Withdrawal by Subject|0|||
126425003|NCT05789745|454853818|FG001|Overall Study|Withdrawal by Subject|0|||
126425004|NCT05789745|454853819|FG002|Overall Study|Withdrawal by Subject|0|||
126425005|NCT05789745|454853820|FG003|Overall Study|Withdrawal by Subject|0|||
126425006|NCT05789745|454853821|FG004|Overall Study|Withdrawal by Subject|1|||
126673761|NCT04033445|455763186|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126673762|NCT04033445|455763187|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126673763|NCT04033445|455763188|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126673764|NCT04033445|455763189|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126673765|NCT04033445|455763190|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126673766|NCT04033445|455763191|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126425007|NCT00619515|454853822|FG000|Overall Study|Study Termination by IRB|73|||
126425008|NCT04862065|454853828|FG000|Screening|Protocol Violation|54|||
126425009|NCT04862065|454853829|FG001|Screening|Protocol Violation|0|||
126425010|NCT04862065|454853830|FG002|Screening|Protocol Violation|0|||
126425011|NCT04862065|454853828|FG000|Screening|Insufficient Sample|1|||
126425012|NCT04862065|454853829|FG001|Screening|Insufficient Sample|0|||
126425013|NCT04862065|454853830|FG002|Screening|Insufficient Sample|0|||
126425014|NCT04862065|454853828|FG000|Follow-Up|Lost to Follow-up|3|||
126425015|NCT04862065|454853829|FG001|Follow-Up|Lost to Follow-up|0|||
126425016|NCT04862065|454853830|FG002|Follow-Up|Lost to Follow-up|0|||
126425017|NCT02634333|454853831|FG000|Overall Study|Completed out of Window|3|||
126425018|NCT02634333|454853832|FG001|Overall Study|Completed out of Window|2|||
126425019|NCT02634333|454853831|FG000|Overall Study|Missed Visit|5|||
126425020|NCT02634333|454853832|FG001|Overall Study|Missed Visit|2|||
126425021|NCT02634333|454853831|FG000|Overall Study|Lost to Follow-up|12|||
126425022|NCT02634333|454853832|FG001|Overall Study|Lost to Follow-up|7|||
126425023|NCT02634333|454853831|FG000|Overall Study|Withdrawal by Subject|9|||
126425024|NCT02634333|454853832|FG001|Overall Study|Withdrawal by Subject|13|||
126425025|NCT02634333|454853831|FG000|Overall Study|Death|11|||
126425026|NCT02634333|454853832|FG001|Overall Study|Death|8|||
126425027|NCT03001557|454853835|FG000|Core Phase|Randomized but not treated|0|||
126425028|NCT03001557|454853836|FG001|Core Phase|Randomized but not treated|0|||
126425029|NCT03001557|454853837|FG002|Core Phase|Randomized but not treated|1|||
126425030|NCT03001557|454853838|FG003|Core Phase|Randomized but not treated|0|||
126425031|NCT03001557|454853839|FG004|Core Phase|Randomized but not treated|0|||
126425032|NCT03001557|454853840|FG005|Core Phase|Randomized but not treated|0|||
126425033|NCT03001557|454853841|FG006|Core Phase|Randomized but not treated|0|||
126425034|NCT03001557|454853842|FG007|Core Phase|Randomized but not treated|0|||
126673767|NCT04033445|455763192|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126715081|NCT01400971|455908674|FG000|Overall Study|Lost to Follow-up|196|||
126425035|NCT03001557|454853835|FG000|Extension Phase|Adverse Event|0|||
126425036|NCT03001557|454853836|FG001|Extension Phase|Adverse Event|0|||
126425037|NCT03001557|454853837|FG002|Extension Phase|Adverse Event|0|||
126425038|NCT03001557|454853838|FG003|Extension Phase|Adverse Event|0|||
126425039|NCT03001557|454853839|FG004|Extension Phase|Adverse Event|0|||
126425040|NCT03001557|454853840|FG005|Extension Phase|Adverse Event|2|||
126425041|NCT03001557|454853841|FG006|Extension Phase|Adverse Event|0|||
126673768|NCT04033445|455763193|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126673769|NCT04033445|455763194|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126673770|NCT04033445|455763195|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
126673771|NCT04033445|455763196|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
126673772|NCT04033445|455763197|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
126673773|NCT04033445|455763198|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
126673774|NCT04033445|455763185|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126673775|NCT04033445|455763186|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126673776|NCT04033445|455763187|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126673777|NCT04033445|455763188|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126673778|NCT04033445|455763189|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126673779|NCT04033445|455763190|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126340249|NCT04745351|454542200|FG000|Overall Study|Protocol Violation|1|||
126340250|NCT04745351|454542201|FG001|Overall Study|Protocol Violation|0|||
126340251|NCT03499795|454542207|FG000|Overall Study|Adverse Event|1|||
126340252|NCT03499795|454542207|FG000|Overall Study|Lost to Follow-up|1|||
126340253|NCT03636256|454542210|FG000|Overall Study|Lost to Follow-up|3|||
126340254|NCT03636256|454542211|FG001|Overall Study|Lost to Follow-up|0|||
126340255|NCT03636256|454542212|FG002|Overall Study|Lost to Follow-up|2|||
126340256|NCT03636256|454542213|FG003|Overall Study|Lost to Follow-up|1|||
126340257|NCT03636256|454542214|FG004|Overall Study|Lost to Follow-up|0|||
126340258|NCT03636256|454542215|FG005|Overall Study|Lost to Follow-up|4|||
126340259|NCT03636256|454542216|FG006|Overall Study|Lost to Follow-up|2|||
126340260|NCT03636256|454542217|FG007|Overall Study|Lost to Follow-up|0|||
126340261|NCT03636256|454542218|FG008|Overall Study|Lost to Follow-up|4|||
126340262|NCT03636256|454542210|FG000|Overall Study|Withdrawal by Subject|0|||
126340263|NCT03636256|454542211|FG001|Overall Study|Withdrawal by Subject|0|||
126340264|NCT03636256|454542212|FG002|Overall Study|Withdrawal by Subject|0|||
126340265|NCT03636256|454542213|FG003|Overall Study|Withdrawal by Subject|0|||
126340266|NCT03636256|454542214|FG004|Overall Study|Withdrawal by Subject|0|||
126340267|NCT03636256|454542215|FG005|Overall Study|Withdrawal by Subject|0|||
126340268|NCT03636256|454542216|FG006|Overall Study|Withdrawal by Subject|0|||
126340269|NCT03636256|454542217|FG007|Overall Study|Withdrawal by Subject|0|||
126340270|NCT03636256|454542218|FG008|Overall Study|Withdrawal by Subject|1|||
126340271|NCT01516216|454542221|FG000|Overall Study|Adverse Event|2|||
126340272|NCT01516216|454542222|FG001|Overall Study|Adverse Event|4|||
126340273|NCT01516216|454542221|FG000|Overall Study|Disease Progression|38|||
126340274|NCT01516216|454542222|FG001|Overall Study|Disease Progression|34|||
126340275|NCT01516216|454542221|FG000|Overall Study|Withdrawal by Subject|9|||
126340276|NCT01516216|454542222|FG001|Overall Study|Withdrawal by Subject|11|||
126340277|NCT01516216|454542221|FG000|Overall Study|Potentially Curative Resection|6|||
126340278|NCT01516216|454542222|FG001|Overall Study|Potentially Curative Resection|12|||
126340279|NCT01516216|454542221|FG000|Overall Study|Nonadherence|2|||
126340280|NCT01516216|454542222|FG001|Overall Study|Nonadherence|3|||
126340281|NCT01516216|454542221|FG000|Overall Study|Physician Decision|6|||
126340282|NCT01516216|454542222|FG001|Overall Study|Physician Decision|3|||
126340283|NCT01516216|454542221|FG000|Overall Study|Prolonged Treatment Delay|5|||
126340284|NCT01516216|454542222|FG001|Overall Study|Prolonged Treatment Delay|1|||
126340285|NCT01516216|454542221|FG000|Overall Study|Intercurrent Illness|1|||
126340286|NCT01516216|454542222|FG001|Overall Study|Intercurrent Illness|0|||
126340287|NCT01516216|454542221|FG000|Overall Study|Death|1|||
126340288|NCT01516216|454542222|FG001|Overall Study|Death|1|||
126340289|NCT01603602|454542225|FG000|Overall Study|Adverse Event|1|||
126340290|NCT01603602|454542226|FG001|Overall Study|Adverse Event|0|||
126340291|NCT01603602|454542227|FG002|Overall Study|Adverse Event|0|||
126340292|NCT01603602|454542225|FG000|Overall Study|Personal Reasons|1|||
126340293|NCT01603602|454542226|FG001|Overall Study|Personal Reasons|0|||
126340294|NCT01603602|454542227|FG002|Overall Study|Personal Reasons|1|||
126340295|NCT04748718|454542231|FG000|Overall Study|Lost to Follow-up|50|||
126340296|NCT01065818|454542232|FG000|Overall Study|Withdrawal by Subject|1|||
126340297|NCT01065818|454542232|FG000|Overall Study|Not a candidate for surgery|1|||
126340298|NCT01935089|454542233|FG000|Overall Study|Adverse Event|2|||
126340299|NCT01935089|454542233|FG000|Overall Study|Withdrawal by Subject|1|||
126340300|NCT02337491|454542237|FG000|Overall Study|Death|1|||
126340301|NCT02337491|454542238|FG001|Overall Study|Death|1|||
126340302|NCT02337491|454542237|FG000|Overall Study|Adverse Event|0|||
126340303|NCT02337491|454542238|FG001|Overall Study|Adverse Event|1|||
126340304|NCT02337491|454542237|FG000|Overall Study|Withdrawal by Subject|3|||
126340305|NCT02337491|454542238|FG001|Overall Study|Withdrawal by Subject|0|||
126340306|NCT02337491|454542237|FG000|Overall Study|Progressive Disease|44|||
126340307|NCT02337491|454542238|FG001|Overall Study|Progressive Disease|28|||
126340308|NCT02337491|454542237|FG000|Overall Study|On Treatment|2|||
126340309|NCT02337491|454542238|FG001|Overall Study|On Treatment|0|||
126340310|NCT00723229|454542239|FG000|First Intervention|Lost to Follow-up|7|||
126340311|NCT00723229|454542240|FG001|First Intervention|Lost to Follow-up|3|||
126340312|NCT01079780|454542244|FG000|Overall Study|Disease progression|43|||
126673780|NCT04033445|455763191|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126673781|NCT04033445|455763192|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126673782|NCT04033445|455763193|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126673783|NCT04033445|455763194|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
126673784|NCT04033445|455763195|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
126673785|NCT04033445|455763196|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
126673786|NCT04033445|455763197|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
126673787|NCT04033445|455763198|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
126673788|NCT04033445|455763185|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126673789|NCT04033445|455763186|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126673790|NCT04033445|455763187|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126673791|NCT04033445|455763188|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126673792|NCT04033445|455763189|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126673793|NCT04033445|455763190|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126673794|NCT04033445|455763191|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126673795|NCT04033445|455763192|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126673796|NCT04033445|455763193|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
126673797|NCT04033445|455763194|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
126673798|NCT04033445|455763195|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
126673799|NCT04033445|455763196|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
126673800|NCT04033445|455763197|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
126673801|NCT04033445|455763198|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
126673802|NCT04033445|455763185|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126673803|NCT04033445|455763186|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126673804|NCT04033445|455763187|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126673805|NCT04033445|455763188|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126673806|NCT04033445|455763189|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126673807|NCT04033445|455763190|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126673808|NCT04033445|455763191|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126673809|NCT04033445|455763192|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126425042|NCT03001557|454853842|FG007|Extension Phase|Adverse Event|0|||
126425043|NCT03001557|454853835|FG000|Extension Phase|Withdrawal by Subject|0|||
126425044|NCT03001557|454853836|FG001|Extension Phase|Withdrawal by Subject|0|||
126425045|NCT03001557|454853837|FG002|Extension Phase|Withdrawal by Subject|0|||
126425046|NCT03001557|454853838|FG003|Extension Phase|Withdrawal by Subject|0|||
126425047|NCT03001557|454853839|FG004|Extension Phase|Withdrawal by Subject|0|||
126425048|NCT03001557|454853840|FG005|Extension Phase|Withdrawal by Subject|1|||
126425049|NCT03001557|454853841|FG006|Extension Phase|Withdrawal by Subject|5|||
126425050|NCT03001557|454853842|FG007|Extension Phase|Withdrawal by Subject|2|||
126425051|NCT03001557|454853835|FG000|Extension Phase|Lost to Follow-up|0|||
126425052|NCT03001557|454853836|FG001|Extension Phase|Lost to Follow-up|0|||
126425053|NCT03001557|454853837|FG002|Extension Phase|Lost to Follow-up|0|||
126425054|NCT03001557|454853838|FG003|Extension Phase|Lost to Follow-up|0|||
126425055|NCT03001557|454853839|FG004|Extension Phase|Lost to Follow-up|0|||
126425056|NCT03001557|454853840|FG005|Extension Phase|Lost to Follow-up|0|||
126425057|NCT03001557|454853841|FG006|Extension Phase|Lost to Follow-up|2|||
126425058|NCT03001557|454853842|FG007|Extension Phase|Lost to Follow-up|1|||
126425059|NCT03001557|454853835|FG000|Extension Phase|Administrative Reason|0|||
126425060|NCT03001557|454853836|FG001|Extension Phase|Administrative Reason|0|||
126425061|NCT03001557|454853837|FG002|Extension Phase|Administrative Reason|0|||
126425062|NCT03001557|454853838|FG003|Extension Phase|Administrative Reason|0|||
126425063|NCT03001557|454853839|FG004|Extension Phase|Administrative Reason|0|||
126425064|NCT03001557|454853840|FG005|Extension Phase|Administrative Reason|1|||
126425065|NCT03001557|454853841|FG006|Extension Phase|Administrative Reason|3|||
126425066|NCT03001557|454853842|FG007|Extension Phase|Administrative Reason|3|||
126425067|NCT03001557|454853835|FG000|Extension Phase|Loss of caregiver|0|||
126425068|NCT03001557|454853836|FG001|Extension Phase|Loss of caregiver|0|||
126425069|NCT03001557|454853837|FG002|Extension Phase|Loss of caregiver|0|||
126425070|NCT03001557|454853838|FG003|Extension Phase|Loss of caregiver|0|||
126425071|NCT03001557|454853839|FG004|Extension Phase|Loss of caregiver|0|||
126425072|NCT03001557|454853840|FG005|Extension Phase|Loss of caregiver|0|||
126425073|NCT03001557|454853841|FG006|Extension Phase|Loss of caregiver|1|||
126425074|NCT03001557|454853842|FG007|Extension Phase|Loss of caregiver|0|||
126425075|NCT03001557|454853835|FG000|Extension Phase|Others|0|||
126425076|NCT03001557|454853836|FG001|Extension Phase|Others|0|||
126425077|NCT03001557|454853837|FG002|Extension Phase|Others|0|||
126425078|NCT03001557|454853838|FG003|Extension Phase|Others|0|||
126425079|NCT03001557|454853839|FG004|Extension Phase|Others|0|||
126673810|NCT04033445|455763193|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126425080|NCT03001557|454853840|FG005|Extension Phase|Others|1|||
126425081|NCT03001557|454853841|FG006|Extension Phase|Others|3|||
126425082|NCT03001557|454853842|FG007|Extension Phase|Others|0|||
126425083|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
126425084|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
126425085|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Death|1|||
126425086|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Death|2|||
126425087|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
126425088|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
126425089|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
126425090|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
126425091|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
126425092|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
126425093|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
126425094|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
126425095|NCT01794000|454853843|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
126425096|NCT01794000|454853844|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
126425097|NCT01794000|454853843|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
126425098|NCT01794000|454853844|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
126425099|NCT01960140|454853846|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
126425100|NCT01156480|454853847|FG000|Overall Study|change in diagnosis|0|||
126425101|NCT01156480|454853848|FG001|Overall Study|change in diagnosis|1|||
126425102|NCT05470387|454853849|FG000|Overall Study|Protocol Violation|0|||
126425103|NCT05470387|454853850|FG001|Overall Study|Protocol Violation|3|||
126425104|NCT01255423|454853851|FG000|Overall Study|Abnormal Laboratory value|3|||
126425105|NCT01255423|454853852|FG001|Overall Study|Abnormal Laboratory value|2|||
126425106|NCT01255423|454853851|FG000|Overall Study|Use of prohibited medications|0|||
126425107|NCT01255423|454853852|FG001|Overall Study|Use of prohibited medications|1|||
126425108|NCT00657046|454853853|FG000|Overall Study|Adverse Event|1|||
126425109|NCT00657046|454853854|FG001|Overall Study|Adverse Event|1|||
126425110|NCT00657046|454853855|FG002|Overall Study|Adverse Event|0|||
126425111|NCT00657046|454853853|FG000|Overall Study|Protocol Violation|2|||
126425112|NCT00657046|454853854|FG001|Overall Study|Protocol Violation|2|||
126425113|NCT00657046|454853855|FG002|Overall Study|Protocol Violation|0|||
126425114|NCT00657046|454853853|FG000|Overall Study|Withdrawal by Subject|1|||
126425115|NCT00657046|454853854|FG001|Overall Study|Withdrawal by Subject|0|||
126425116|NCT00657046|454853855|FG002|Overall Study|Withdrawal by Subject|0|||
126425117|NCT00657046|454853853|FG000|Overall Study|Death|0|||
126425118|NCT00657046|454853854|FG001|Overall Study|Death|0|||
126425119|NCT00657046|454853855|FG002|Overall Study|Death|1|||
126425120|NCT00657046|454853853|FG000|Overall Study|Surgery|0|||
126425121|NCT00657046|454853854|FG001|Overall Study|Surgery|0|||
126425122|NCT00657046|454853855|FG002|Overall Study|Surgery|1|||
126425123|NCT01176058|454853856|FG000|Overall Study|Adverse Event|1|||
126425124|NCT01176058|454853857|FG001|Overall Study|Adverse Event|0|||
126425125|NCT01176058|454853856|FG000|Overall Study|Insufficient clinical response|2|||
126425126|NCT01176058|454853857|FG001|Overall Study|Insufficient clinical response|2|||
126425127|NCT01176058|454853856|FG000|Overall Study|Insufficient mycological response|0|||
126425128|NCT01176058|454853857|FG001|Overall Study|Insufficient mycological response|1|||
126425129|NCT01176058|454853856|FG000|Overall Study|Withdrawal by Subject|1|||
126425130|NCT01176058|454853857|FG001|Overall Study|Withdrawal by Subject|0|||
126425131|NCT03480152|454853863|FG000|Phase I|Signed consent. Died before treatment.|1|||
126425132|NCT03480152|454853864|FG001|Phase I|Signed consent. Died before treatment.|0|||
126425133|NCT03480152|454853865|FG002|Phase I|Signed consent. Died before treatment.|0|||
126673811|NCT04033445|455763194|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126673812|NCT04033445|455763195|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126673813|NCT04033445|455763196|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126673814|NCT04033445|455763197|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
126673815|NCT04033445|455763198|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
126673816|NCT04033445|455763185|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
126673817|NCT04033445|455763186|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
126673818|NCT04033445|455763187|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
126673819|NCT04033445|455763188|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
126425134|NCT04276233|454853866|FG000|Overall Study|Adverse Event|1|||
126425135|NCT04276233|454853866|FG000|Overall Study|Lost to Follow-up|3|||
126425136|NCT04276233|454853866|FG000|Overall Study|Physician Decision|4|||
126425137|NCT04276233|454853866|FG000|Overall Study|Withdrawal by Subject|2|||
126425138|NCT01946139|454853867|FG000|Overall Study|Withdrawal by Subject|8|||
126425139|NCT01946139|454853867|FG000|Overall Study|ineligible|8|||
126425140|NCT01946139|454853867|FG000|Overall Study|Specimens not available|4|||
126425141|NCT02525471|454853874|FG000|Overall Study|Screen Failure|6|||
126425142|NCT02525471|454853874|FG000|Overall Study|Withdrawal by Subject|4|||
126425143|NCT02525471|454853874|FG000|Overall Study|Death|1|||
126673820|NCT04033445|455763189|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
126673821|NCT04033445|455763190|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
126673822|NCT04033445|455763191|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
126673823|NCT04033445|455763192|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
126673824|NCT04033445|455763193|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
126673825|NCT04033445|455763194|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
126673826|NCT04033445|455763195|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
126673827|NCT04033445|455763196|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
126673828|NCT04033445|455763197|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
126673829|NCT04033445|455763198|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
126673830|NCT04033445|455763185|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126673831|NCT04033445|455763186|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126673832|NCT04033445|455763187|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126673833|NCT04033445|455763188|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126673834|NCT04033445|455763189|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126673835|NCT04033445|455763190|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126425144|NCT03275740|454853875|FG000|Overall Study|Adverse Event|0|||
126425145|NCT03275740|454853876|FG001|Overall Study|Adverse Event|0|||
126425146|NCT03275740|454853877|FG002|Overall Study|Adverse Event|0|||
126425147|NCT03275740|454853878|FG003|Overall Study|Adverse Event|0|||
126425148|NCT03275740|454853879|FG004|Overall Study|Adverse Event|1|||
126425149|NCT03275740|454853880|FG005|Overall Study|Adverse Event|0|||
126425150|NCT03275740|454853881|FG006|Overall Study|Adverse Event|0|||
126425151|NCT03275740|454853882|FG007|Overall Study|Adverse Event|0|||
126425152|NCT03275740|454853883|FG008|Overall Study|Adverse Event|0|||
126425153|NCT03275740|454853884|FG009|Overall Study|Adverse Event|0|||
126425154|NCT03275740|454853885|FG010|Overall Study|Adverse Event|0|||
126425155|NCT03275740|454853886|FG011|Overall Study|Adverse Event|0|||
126425156|NCT03275740|454853875|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425157|NCT03275740|454853876|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425158|NCT03275740|454853877|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425159|NCT03275740|454853878|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425160|NCT03275740|454853879|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425161|NCT03275740|454853880|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
126425162|NCT03275740|454853881|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425163|NCT03275740|454853882|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425164|NCT03275740|454853883|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425165|NCT03275740|454853884|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425166|NCT03275740|454853885|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425167|NCT03275740|454853886|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
126425168|NCT03275740|454853875|FG000|Overall Study|Withdrawal by Subject|0|||
126425169|NCT03275740|454853876|FG001|Overall Study|Withdrawal by Subject|0|||
126425170|NCT03275740|454853877|FG002|Overall Study|Withdrawal by Subject|0|||
126425171|NCT03275740|454853878|FG003|Overall Study|Withdrawal by Subject|0|||
126425172|NCT03275740|454853879|FG004|Overall Study|Withdrawal by Subject|0|||
126425173|NCT03275740|454853880|FG005|Overall Study|Withdrawal by Subject|0|||
126425174|NCT03275740|454853881|FG006|Overall Study|Withdrawal by Subject|0|||
126425175|NCT03275740|454853882|FG007|Overall Study|Withdrawal by Subject|0|||
126425176|NCT03275740|454853883|FG008|Overall Study|Withdrawal by Subject|1|||
126425177|NCT03275740|454853884|FG009|Overall Study|Withdrawal by Subject|1|||
126425178|NCT03275740|454853885|FG010|Overall Study|Withdrawal by Subject|0|||
126425179|NCT03275740|454853886|FG011|Overall Study|Withdrawal by Subject|0|||
126425180|NCT00890825|454853887|FG000|Overall Study|Withdrawal by Subject|1|||
126425181|NCT00890825|454853888|FG001|Overall Study|Withdrawal by Subject|0|||
126425182|NCT00890825|454853887|FG000|Overall Study|Alive at data cut off (DCO)|13|||
126425183|NCT00890825|454853888|FG001|Overall Study|Alive at data cut off (DCO)|14|||
126425184|NCT02336607|454853890|FG000|Overall Study|Physician Decision|1|||
126425185|NCT02336607|454853891|FG001|Overall Study|Physician Decision|4|||
126425186|NCT02336607|454853892|FG002|Overall Study|Physician Decision|3|||
126425187|NCT02336607|454853893|FG003|Overall Study|Physician Decision|15|||
126425188|NCT02336607|454853890|FG000|Overall Study|Lack of Efficacy|1|||
126673836|NCT04033445|455763191|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126673837|NCT04033445|455763192|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126673838|NCT04033445|455763193|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126425189|NCT02336607|454853891|FG001|Overall Study|Lack of Efficacy|0|||
126425190|NCT02336607|454853892|FG002|Overall Study|Lack of Efficacy|0|||
126425191|NCT02336607|454853893|FG003|Overall Study|Lack of Efficacy|2|||
126425192|NCT02336607|454853890|FG000|Overall Study|Lost to Follow-up|2|||
126425193|NCT02336607|454853891|FG001|Overall Study|Lost to Follow-up|1|||
126425194|NCT02336607|454853892|FG002|Overall Study|Lost to Follow-up|0|||
126425195|NCT02336607|454853893|FG003|Overall Study|Lost to Follow-up|21|||
126673839|NCT04033445|455763194|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
126673840|NCT04033445|455763195|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126673841|NCT04033445|455763196|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
126673842|NCT04033445|455763197|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
126673843|NCT04033445|455763198|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
126673844|NCT04754802|455763204|FG000|Overall Study|Lost to Follow-up|0|||
126673845|NCT04754802|455763205|FG001|Overall Study|Lost to Follow-up|2|||
126673846|NCT04754802|455763204|FG000|Overall Study|Withdrawal by Subject|2|||
126673847|NCT04754802|455763205|FG001|Overall Study|Withdrawal by Subject|0|||
126673848|NCT04451161|455763206|FG000|Overall Study|Lost to Follow-up|28|||
126673849|NCT04451161|455763207|FG001|Overall Study|Lost to Follow-up|37|||
126673850|NCT04451161|455763208|FG002|Overall Study|Lost to Follow-up|22|||
126673851|NCT04451161|455763209|FG003|Overall Study|Lost to Follow-up|13|||
126673852|NCT04451161|455763210|FG004|Overall Study|Lost to Follow-up|11|||
126673853|NCT04451161|455763211|FG005|Overall Study|Lost to Follow-up|14|||
126673854|NCT04451161|455763206|FG000|Overall Study|Withdrawal by Subject|3|||
126673855|NCT04451161|455763207|FG001|Overall Study|Withdrawal by Subject|0|||
126673856|NCT04451161|455763208|FG002|Overall Study|Withdrawal by Subject|0|||
126673857|NCT04451161|455763209|FG003|Overall Study|Withdrawal by Subject|0|||
126425196|NCT02336607|454853890|FG000|Overall Study|Protocol Violation|0|||
126425197|NCT02336607|454853891|FG001|Overall Study|Protocol Violation|1|||
126425198|NCT02336607|454853892|FG002|Overall Study|Protocol Violation|1|||
126425199|NCT02336607|454853893|FG003|Overall Study|Protocol Violation|3|||
126425200|NCT02336607|454853890|FG000|Overall Study|Adverse Event|0|||
126425201|NCT02336607|454853891|FG001|Overall Study|Adverse Event|2|||
126425202|NCT02336607|454853892|FG002|Overall Study|Adverse Event|2|||
126425203|NCT02336607|454853893|FG003|Overall Study|Adverse Event|26|||
126425204|NCT02336607|454853890|FG000|Overall Study|Withdrawal by Subject|0|||
126425205|NCT02336607|454853891|FG001|Overall Study|Withdrawal by Subject|2|||
126425206|NCT02336607|454853892|FG002|Overall Study|Withdrawal by Subject|0|||
126425207|NCT02336607|454853893|FG003|Overall Study|Withdrawal by Subject|20|||
126425208|NCT02552966|454853896|FG000|Overall Study|Lost to Follow-up|2|||
126425209|NCT02552966|454853896|FG000|Overall Study|Withdrawal by Subject|3|||
126425210|NCT00614380|454853900|FG000|Overall Study|Adverse Event|14|||
126425211|NCT00614380|454853901|FG001|Overall Study|Adverse Event|4|||
126425212|NCT00614380|454853902|FG002|Overall Study|Adverse Event|0|||
126425213|NCT00614380|454853903|FG003|Overall Study|Adverse Event|0|||
126425214|NCT00614380|454853900|FG000|Overall Study|Lost to Follow-up|6|||
126425215|NCT00614380|454853901|FG001|Overall Study|Lost to Follow-up|1|||
126425216|NCT00614380|454853902|FG002|Overall Study|Lost to Follow-up|0|||
126425217|NCT00614380|454853903|FG003|Overall Study|Lost to Follow-up|0|||
126425218|NCT00614380|454853900|FG000|Overall Study|Non compliant with the protocol|12|||
126425219|NCT00614380|454853901|FG001|Overall Study|Non compliant with the protocol|2|||
126425220|NCT00614380|454853902|FG002|Overall Study|Non compliant with the protocol|1|||
126425221|NCT00614380|454853903|FG003|Overall Study|Non compliant with the protocol|2|||
126425222|NCT00614380|454853900|FG000|Overall Study|Consent withdrawn|3|||
126425223|NCT00614380|454853901|FG001|Overall Study|Consent withdrawn|1|||
126425224|NCT00614380|454853902|FG002|Overall Study|Consent withdrawn|0|||
126425225|NCT00614380|454853903|FG003|Overall Study|Consent withdrawn|0|||
126425226|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126425227|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126425228|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126425229|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
126425230|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126673858|NCT04451161|455763210|FG004|Overall Study|Withdrawal by Subject|2|||
126673859|NCT04451161|455763211|FG005|Overall Study|Withdrawal by Subject|4|||
126673860|NCT05525689|455763212|FG000|Overall Study|Lost to Follow-up|1|||
126673861|NCT05525689|455763213|FG001|Overall Study|Lost to Follow-up|0|||
126673862|NCT01671111|455763214|FG000|Overall Study|Adverse Event|2|||
126673863|NCT01671111|455763214|FG000|Overall Study|Lack of Efficacy|1|||
126673864|NCT01671111|455763214|FG000|Overall Study|Withdrawal by Subject|2|||
126673865|NCT01671111|455763214|FG000|Overall Study|Physician Decision|1|||
126673866|NCT01671111|455763214|FG000|Overall Study|Other|24|||
126673867|NCT03680911|455763215|FG000|At Home Treatment|Study Termination|3|||
126673868|NCT03680911|455763216|FG001|At Home Treatment|Study Termination|0|||
126673869|NCT03680911|455763215|FG000|At Home Treatment|Lost to Follow-up|0|||
126673870|NCT03680911|455763216|FG001|At Home Treatment|Lost to Follow-up|1|||
126673871|NCT03680911|455763215|FG000|At Home Treatment|Withdrawal by Subject|0|||
126425231|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126425232|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126673872|NCT03680911|455763216|FG001|At Home Treatment|Withdrawal by Subject|2|||
126673873|NCT03680911|455763215|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
126673874|NCT03680911|455763216|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
126673875|NCT00898443|455763221|FG000|Overall Study|Withdrawal by Subject|1|||
126673876|NCT00898443|455763222|FG001|Overall Study|Withdrawal by Subject|0|||
126673877|NCT04695392|455763223|FG000|Overall Study|Withdrawn by parent/guardian|0|||
126673878|NCT04695392|455763224|FG001|Overall Study|Withdrawn by parent/guardian|1|||
126673879|NCT04695392|455763223|FG000|Overall Study|Withdrawn by physician|0|||
126673880|NCT04695392|455763224|FG001|Overall Study|Withdrawn by physician|1|||
126673881|NCT04702737|455763231|FG000|Overall Study|Decision by Sponsor|1|||
126673882|NCT04702737|455763231|FG000|Overall Study|Withdrawal of Consent from Study|3|||
126673883|NCT04702737|455763231|FG000|Overall Study|Lost to Follow-up|1|||
126673884|NCT04702737|455763231|FG000|Overall Study|Death|35|||
126673885|NCT00698997|455763232|FG000|Overall Study|Lost to Follow-up|3|||
126673886|NCT00698997|455763233|FG001|Overall Study|Lost to Follow-up|0|||
126673887|NCT00698997|455763232|FG000|Overall Study|Withdrawal by Subject|7|||
126673888|NCT00698997|455763233|FG001|Overall Study|Withdrawal by Subject|27|||
126673889|NCT01436084|455763236|FG000|Overall Study|Disease Progression|2|||
126673890|NCT01436084|455763236|FG000|Overall Study|Withdrawal by Subject|1|||
126673891|NCT01436084|455763236|FG000|Overall Study|Early Closure of Study|1|||
126673892|NCT04814823|455763238|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
126673893|NCT00943579|455763243|FG000|Overall Study|Adverse Event|4|||
126673894|NCT00943579|455763244|FG001|Overall Study|Adverse Event|3|||
126673895|NCT00943579|455763243|FG000|Overall Study|Lack of Efficacy|2|||
126673896|NCT00943579|455763244|FG001|Overall Study|Lack of Efficacy|2|||
126715082|NCT01400971|455908674|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
126715083|NCT01400971|455908674|FG000|Overall Study|Physician Decision|57|||
126715084|NCT01400971|455908674|FG000|Overall Study|Withdrawal by Subject|158|||
126715085|NCT01400971|455908674|FG000|Overall Study|Other|422|||
126715086|NCT01921270|455908679|FG000|Overall Study|Withdrawal by Subject|1|||
126715087|NCT00789477|455908680|FG000|Overall Study|Withdrawal by Subject|2|||
126715088|NCT00789477|455908681|FG001|Overall Study|Withdrawal by Subject|1|||
126715089|NCT00789477|455908682|FG002|Overall Study|Withdrawal by Subject|3|||
126715090|NCT00789477|455908683|FG003|Overall Study|Withdrawal by Subject|2|||
126715091|NCT00789477|455908684|FG004|Overall Study|Withdrawal by Subject|3|||
126715092|NCT00789477|455908680|FG000|Overall Study|Protocol Violation|1|||
126715093|NCT00789477|455908681|FG001|Overall Study|Protocol Violation|0|||
126715094|NCT00789477|455908682|FG002|Overall Study|Protocol Violation|0|||
126715095|NCT00789477|455908683|FG003|Overall Study|Protocol Violation|1|||
126715096|NCT00789477|455908684|FG004|Overall Study|Protocol Violation|0|||
126715097|NCT00789477|455908680|FG000|Overall Study|Adverse Event|3|||
126715098|NCT00789477|455908681|FG001|Overall Study|Adverse Event|3|||
126715099|NCT00789477|455908682|FG002|Overall Study|Adverse Event|1|||
126715100|NCT00789477|455908683|FG003|Overall Study|Adverse Event|0|||
126715101|NCT00789477|455908684|FG004|Overall Study|Adverse Event|0|||
126715102|NCT00789477|455908680|FG000|Overall Study|Death|1|||
126715103|NCT00789477|455908681|FG001|Overall Study|Death|1|||
126715104|NCT00789477|455908682|FG002|Overall Study|Death|2|||
126715105|NCT00789477|455908683|FG003|Overall Study|Death|2|||
126715106|NCT00789477|455908684|FG004|Overall Study|Death|0|||
126715107|NCT00789477|455908680|FG000|Overall Study|Lost to Follow-up|0|||
126715108|NCT00789477|455908681|FG001|Overall Study|Lost to Follow-up|1|||
126715109|NCT00789477|455908682|FG002|Overall Study|Lost to Follow-up|4|||
126715110|NCT00789477|455908683|FG003|Overall Study|Lost to Follow-up|2|||
126715111|NCT00789477|455908684|FG004|Overall Study|Lost to Follow-up|4|||
126715112|NCT00789477|455908680|FG000|Overall Study|Lack of Efficacy|2|||
126715113|NCT00789477|455908681|FG001|Overall Study|Lack of Efficacy|0|||
126715114|NCT00789477|455908682|FG002|Overall Study|Lack of Efficacy|0|||
126715115|NCT00789477|455908683|FG003|Overall Study|Lack of Efficacy|0|||
126715116|NCT00789477|455908684|FG004|Overall Study|Lack of Efficacy|0|||
126715117|NCT00789477|455908680|FG000|Overall Study|Other|2|||
126715118|NCT00789477|455908681|FG001|Overall Study|Other|0|||
126715119|NCT00789477|455908682|FG002|Overall Study|Other|1|||
126715120|NCT00789477|455908683|FG003|Overall Study|Other|3|||
126715121|NCT00789477|455908684|FG004|Overall Study|Other|0|||
126715122|NCT00455858|455908685|FG000|Overall Study|Lost to Follow-up|2|||
126715123|NCT00455858|455908685|FG000|Overall Study|Protocol Violation|1|||
126715124|NCT00455858|455908685|FG000|Overall Study|Lack of Efficacy|1|||
126715125|NCT00455858|455908685|FG000|Overall Study|Well controlled FPG without insulin|1|||
126715126|NCT00455858|455908685|FG000|Overall Study|Withdrawal|1|||
126715127|NCT02092389|455908687|FG000|Overall Study|Adverse Event|1|||
126715128|NCT02092389|455908687|FG000|Overall Study|Other|5|||
126715129|NCT01242020|455908688|FG000|Overall Study|Withdrawal by Subject|2|||
126715130|NCT01242020|455908689|FG001|Overall Study|Withdrawal by Subject|0|||
126715131|NCT01242020|455908688|FG000|Overall Study|Failed screening|1|||
126715132|NCT01242020|455908689|FG001|Overall Study|Failed screening|0|||
126715133|NCT01595646|455908690|FG000|Overall Study|Withdrawal by Subject|1|||
126715134|NCT01595646|455908691|FG001|Overall Study|Withdrawal by Subject|0|||
126715135|NCT01595646|455908692|FG002|Overall Study|Withdrawal by Subject|0|||
126715136|NCT01161524|455908694|FG000|Core Study (23 Weeks)|Adverse Event|3|||
126715137|NCT01161524|455908695|FG001|Core Study (23 Weeks)|Adverse Event|0|||
126715138|NCT01161524|455908696|FG002|Core Study (23 Weeks)|Adverse Event|0|||
126673897|NCT03697720|455764441|FG000|Overall Study|Lost to Follow-up|7|||
126673898|NCT03496012|455764448|FG000|Overall Study|Withdrawal by Subject|2|||
126340313|NCT01079780|454542245|FG001|Overall Study|Disease progression|7|||
126340314|NCT01079780|454542246|FG002|Overall Study|Disease progression|31|||
126340315|NCT01079780|454542244|FG000|Overall Study|Adverse Event|13|||
126340316|NCT01079780|454542245|FG001|Overall Study|Adverse Event|5|||
126340317|NCT01079780|454542246|FG002|Overall Study|Adverse Event|7|||
126340318|NCT01079780|454542244|FG000|Overall Study|Death|2|||
126340319|NCT01079780|454542245|FG001|Overall Study|Death|0|||
126340320|NCT01079780|454542246|FG002|Overall Study|Death|2|||
126340321|NCT01079780|454542244|FG000|Overall Study|Withdrawal by Subject|6|||
126340322|NCT01079780|454542245|FG001|Overall Study|Withdrawal by Subject|4|||
126340323|NCT01079780|454542246|FG002|Overall Study|Withdrawal by Subject|4|||
126340324|NCT01079780|454542244|FG000|Overall Study|Alternative therapy|2|||
126340325|NCT01079780|454542245|FG001|Overall Study|Alternative therapy|0|||
126340326|NCT01079780|454542246|FG002|Overall Study|Alternative therapy|2|||
126340327|NCT01079780|454542244|FG000|Overall Study|Physician Decision|1|||
126340328|NCT01079780|454542245|FG001|Overall Study|Physician Decision|0|||
126340329|NCT01079780|454542246|FG002|Overall Study|Physician Decision|1|||
126340330|NCT01079780|454542244|FG000|Overall Study|Error made in lesion measurement|1|||
126340331|NCT01079780|454542245|FG001|Overall Study|Error made in lesion measurement|0|||
126340332|NCT01079780|454542246|FG002|Overall Study|Error made in lesion measurement|0|||
126340333|NCT01079780|454542244|FG000|Overall Study|Patient had surgery|1|||
126340334|NCT01079780|454542245|FG001|Overall Study|Patient had surgery|0|||
126340335|NCT01079780|454542246|FG002|Overall Study|Patient had surgery|0|||
126340336|NCT01079780|454542244|FG000|Overall Study|Treatment cycle delay|0|||
126340337|NCT01079780|454542245|FG001|Overall Study|Treatment cycle delay|0|||
126340338|NCT01079780|454542246|FG002|Overall Study|Treatment cycle delay|1|||
126340339|NCT01079780|454542244|FG000|Overall Study|Never started treatment|1|||
126340340|NCT01079780|454542245|FG001|Overall Study|Never started treatment|0|||
126340341|NCT01079780|454542246|FG002|Overall Study|Never started treatment|2|||
126340342|NCT03530293|454542254|FG000|Pre-randomization|Adverse Event|12|||
126340343|NCT03530293|454542255|FG001|Pre-randomization|Adverse Event|0|||
126340344|NCT03530293|454542256|FG002|Pre-randomization|Adverse Event|0|||
126340345|NCT03530293|454542254|FG000|Pre-randomization|Protocol Violation|2|||
126340346|NCT03530293|454542255|FG001|Pre-randomization|Protocol Violation|0|||
126340347|NCT03530293|454542256|FG002|Pre-randomization|Protocol Violation|0|||
126340348|NCT03530293|454542254|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
126340349|NCT03530293|454542255|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
126340350|NCT03530293|454542256|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
126340351|NCT03530293|454542254|FG000|Pre-randomization|Withdrawal by Subject|5|||
126340352|NCT03530293|454542255|FG001|Pre-randomization|Withdrawal by Subject|0|||
126340353|NCT03530293|454542256|FG002|Pre-randomization|Withdrawal by Subject|0|||
126340354|NCT03530293|454542254|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
126340355|NCT03530293|454542255|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
126340356|NCT03530293|454542256|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
126340357|NCT03530293|454542254|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
126340358|NCT03530293|454542255|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
126340359|NCT03530293|454542256|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
126340360|NCT03530293|454542254|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
126340361|NCT03530293|454542255|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
126340362|NCT03530293|454542256|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
126340363|NCT03530293|454542254|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
126340364|NCT03530293|454542255|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
126340365|NCT03530293|454542256|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
126340366|NCT03530293|454542254|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
126340367|NCT03530293|454542255|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
126340368|NCT03530293|454542256|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
126340369|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
126340370|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
126340371|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
126340372|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
126340373|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
126340374|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
126340375|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
126340376|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
126340377|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
126340378|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
126425233|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126673899|NCT03496012|455764449|FG001|Overall Study|Withdrawal by Subject|0|||
126340379|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
126340380|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
126425234|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126425235|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
126425236|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
126425237|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
126425238|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
126425239|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
126425240|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
126425241|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
126425242|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
126425243|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
126425244|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
126425245|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
126425246|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
126425247|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
126425248|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
126425249|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
126425250|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
126425251|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
126425252|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
126425253|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
126425254|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
126425255|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
126425256|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
126425257|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
126425258|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
126425259|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
126673900|NCT03496012|455764450|FG002|Overall Study|Withdrawal by Subject|2|||
126673901|NCT03496012|455764448|FG000|Overall Study|Adverse Event|0|||
126425260|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
126425261|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
126425262|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
126425263|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
126425264|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
126425265|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
126425266|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
126425267|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425268|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
126425269|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425270|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
126425271|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425272|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425273|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425274|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425275|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
126425276|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
126425277|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126425278|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126425279|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126425280|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
126425281|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
126425282|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126673902|NCT03496012|455764449|FG001|Overall Study|Adverse Event|0|||
126673903|NCT03496012|455764450|FG002|Overall Study|Adverse Event|1|||
126673904|NCT03496012|455764448|FG000|Overall Study|Reason Not Specified|2|||
126673905|NCT03496012|455764449|FG001|Overall Study|Reason Not Specified|0|||
126673906|NCT03496012|455764450|FG002|Overall Study|Reason Not Specified|1|||
126673907|NCT02322125|455764451|FG000|Overall Study|Withdrawal by Subject|2|||
126673908|NCT04183790|455764455|FG000|Overall Study|Participants did not rollover to Part B|12|||
126425283|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126425284|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126425285|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
126425286|NCT02365649|454853904|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425287|NCT02365649|454853905|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425288|NCT02365649|454853906|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
126673909|NCT04183790|455764456|FG001|Overall Study|Participants did not rollover to Part B|0|||
126673910|NCT04183790|455764455|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
126673911|NCT04183790|455764456|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
126673912|NCT04183790|455764455|FG000|Overall Study|Commercial drug is available for participant|6|||
126673913|NCT04183790|455764456|FG001|Overall Study|Commercial drug is available for participant|0|||
126673914|NCT04183790|455764455|FG000|Overall Study|Adverse Event|1|||
126673915|NCT04183790|455764456|FG001|Overall Study|Adverse Event|0|||
126673916|NCT04183790|455764455|FG000|Overall Study|Not enrolled in 107 study|0|||
126340381|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
126340382|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
126340383|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
126340384|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
126340385|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
126340386|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
126340387|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
126340388|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
126340389|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
126340390|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
126340391|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
126340392|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
126340393|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
126340394|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
126340395|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
126340396|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
126340397|NCT01668797|454542258|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
126340398|NCT01668797|454542259|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
126340399|NCT01668797|454542260|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
126340400|NCT01668797|454542261|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
126340401|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
126340402|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
126340403|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
126340404|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
126340405|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
126340406|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
126340407|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
126340408|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
126340409|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
126340410|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
126340411|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
126340412|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
126340413|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
126340414|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
126340415|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
126340416|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
126340417|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
126340418|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
126340419|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
126340420|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
126340421|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
126340422|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
126340423|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
126340424|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
126340425|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
126340426|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
126340427|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
126340428|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
126340429|NCT01668797|454542258|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
126340430|NCT01668797|454542259|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
126340431|NCT01668797|454542260|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
126340432|NCT01668797|454542261|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
126340433|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
126340434|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
126340435|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
126340436|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
126340437|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
126340438|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
126340439|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
126673917|NCT04183790|455764456|FG001|Overall Study|Not enrolled in 107 study|2|||
126673918|NCT01251653|455764457|FG000|Overall Study|Progressive Disease|1|||
126673919|NCT01251653|455764458|FG001|Overall Study|Progressive Disease|7|||
126425289|NCT02365649|454853907|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425290|NCT02365649|454853908|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425291|NCT02365649|454853909|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425292|NCT02365649|454853910|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425293|NCT02365649|454853911|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425294|NCT02365649|454853912|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425295|NCT02365649|454853913|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
126425296|NCT02365649|454853904|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425297|NCT02365649|454853905|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425298|NCT02365649|454853906|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425299|NCT02365649|454853907|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425300|NCT02365649|454853908|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425301|NCT02365649|454853909|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425302|NCT02365649|454853910|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
126425303|NCT02365649|454853911|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425304|NCT02365649|454853912|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425305|NCT02365649|454853913|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
126425306|NCT02365649|454853904|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425307|NCT02365649|454853905|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425308|NCT02365649|454853906|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425309|NCT02365649|454853907|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425310|NCT02365649|454853908|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425311|NCT02365649|454853909|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425312|NCT02365649|454853910|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
126425313|NCT02365649|454853911|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
126425314|NCT02365649|454853912|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
126425315|NCT02365649|454853913|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
126425316|NCT02365649|454853904|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
126425317|NCT02365649|454853905|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
126425318|NCT02365649|454853906|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
126425319|NCT02365649|454853907|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
126425320|NCT02365649|454853908|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
126425321|NCT02365649|454853909|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
126425322|NCT02365649|454853910|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
126425323|NCT02365649|454853911|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
126425324|NCT02365649|454853912|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
126425325|NCT02365649|454853913|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
126425326|NCT02365649|454853904|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425327|NCT02365649|454853905|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425328|NCT02365649|454853906|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425329|NCT02365649|454853907|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425330|NCT02365649|454853908|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425331|NCT02365649|454853909|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425332|NCT02365649|454853910|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
126425333|NCT02365649|454853911|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
126425334|NCT02365649|454853912|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
126425335|NCT02365649|454853913|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
126425336|NCT02365649|454853904|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425337|NCT02365649|454853905|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425338|NCT02365649|454853906|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425339|NCT02365649|454853907|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425340|NCT02365649|454853908|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425341|NCT02365649|454853909|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425342|NCT02365649|454853910|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
126425343|NCT02365649|454853911|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425344|NCT02365649|454853912|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
126425345|NCT02365649|454853913|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
126425346|NCT01188772|454853922|FG000|Overall Study|Randomized but Not Treated|0|||
126425347|NCT01188772|454853923|FG001|Overall Study|Randomized but Not Treated|1|||
126425348|NCT01188772|454853924|FG002|Overall Study|Randomized but Not Treated|0|||
126425349|NCT01188772|454853925|FG003|Overall Study|Randomized but Not Treated|0|||
126673920|NCT01251653|455764459|FG002|Overall Study|Progressive Disease|16|||
126673921|NCT01251653|455764460|FG003|Overall Study|Progressive Disease|4|||
126673922|NCT01251653|455764461|FG004|Overall Study|Progressive Disease|0|||
126673923|NCT01251653|455764462|FG005|Overall Study|Progressive Disease|17|||
126673924|NCT01251653|455764463|FG006|Overall Study|Progressive Disease|14|||
126673925|NCT01251653|455764464|FG007|Overall Study|Progressive Disease|7|||
126673926|NCT01251653|455764465|FG008|Overall Study|Progressive Disease|5|||
126673927|NCT01251653|455764457|FG000|Overall Study|Dose-limiting toxicity|0|||
126340440|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
126340441|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
126340442|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
126340443|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
126340444|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
126340445|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
126340446|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
126340447|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
126340448|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
126340449|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
126340450|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
126340451|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
126340452|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
126340453|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
126340454|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
126340455|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
126340456|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
126340457|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
126340458|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
126340459|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
126340460|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
126340461|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
126340462|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
126340463|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
126340464|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
126340465|NCT01668797|454542258|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
126340466|NCT01668797|454542259|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
126340467|NCT01668797|454542260|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
126340468|NCT01668797|454542261|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
126340469|NCT02530385|454542262|FG000|Overall Study|Withdrawal by Subject|0|||
126340470|NCT02530385|454542263|FG001|Overall Study|Withdrawal by Subject|1|||
126340471|NCT01569022|454542265|FG000|First Intervention|Lost to Follow-up|2|||
126340472|NCT01569022|454542266|FG001|First Intervention|Lost to Follow-up|1|||
126340473|NCT01569022|454542265|FG000|Second Intervention|Lost to Follow-up|2|||
126340474|NCT01569022|454542266|FG001|Second Intervention|Lost to Follow-up|2|||
126340475|NCT00433836|454542271|FG000|Overall Study|Adverse Event|7|||
126340476|NCT00433836|454542272|FG001|Overall Study|Adverse Event|0|||
126340477|NCT00433836|454542271|FG000|Overall Study|Lost to Follow-up|3|||
126340478|NCT00433836|454542272|FG001|Overall Study|Lost to Follow-up|0|||
126340479|NCT00433836|454542271|FG000|Overall Study|Withdrawal by Subject|2|||
126340480|NCT00433836|454542272|FG001|Overall Study|Withdrawal by Subject|1|||
126340481|NCT00433836|454542271|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126340482|NCT00433836|454542272|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126340483|NCT00433836|454542271|FG000|Overall Study|Protocol Violation|0|||
126340484|NCT00433836|454542272|FG001|Overall Study|Protocol Violation|2|||
126340485|NCT00433836|454542271|FG000|Overall Study|Condition no longer requires study drug|0|||
126340486|NCT00433836|454542272|FG001|Overall Study|Condition no longer requires study drug|1|||
126340487|NCT00433836|454542271|FG000|Overall Study|Abnormal laboratory values|0|||
126340488|NCT00433836|454542272|FG001|Overall Study|Abnormal laboratory values|1|||
126340489|NCT02446691|454542273|FG000|Overall Study|Withdrawal by Subject|2|||
126340490|NCT02446691|454542273|FG000|Overall Study|Lost to Follow-up|8|||
126340491|NCT02446691|454542273|FG000|Overall Study|Protocol Violation|1|||
126340492|NCT00472420|454542274|FG000|Induction Treatment Period|Physician Decision|9|||
126340493|NCT00472420|454542274|FG000|Induction Treatment Period|Adverse Event|3|||
126340494|NCT00472420|454542274|FG000|Induction Treatment Period|Non-compliance|1|||
126340495|NCT00472420|454542274|FG000|Induction Treatment Period|Death|3|||
126340496|NCT00472420|454542274|FG000|Follow-up Period|Death|5|||
126340497|NCT00472420|454542274|FG000|Follow-up Period|Physician Decision|9|||
126340498|NCT00472420|454542274|FG000|Follow-up Period|Lost to Follow-up|2|||
126340499|NCT00472420|454542274|FG000|Follow-up Period|Protocol Violation|1|||
126340500|NCT02674516|454542277|FG000|Overall Study|Lost to Follow-up|3|||
126340501|NCT02674516|454542278|FG001|Overall Study|Lost to Follow-up|0|||
126340502|NCT02674516|454542277|FG000|Overall Study|Protocol Violation|0|||
126673928|NCT01251653|455764458|FG001|Overall Study|Dose-limiting toxicity|1|||
126425350|NCT01188772|454853922|FG000|Overall Study|Adverse Event|0|||
126425351|NCT01188772|454853923|FG001|Overall Study|Adverse Event|1|||
126425352|NCT01188772|454853924|FG002|Overall Study|Adverse Event|2|||
126425353|NCT01188772|454853925|FG003|Overall Study|Adverse Event|0|||
126425354|NCT01188772|454853922|FG000|Overall Study|Lost to Follow-up|4|||
126425355|NCT01188772|454853923|FG001|Overall Study|Lost to Follow-up|1|||
126425356|NCT01188772|454853924|FG002|Overall Study|Lost to Follow-up|1|||
126425357|NCT01188772|454853925|FG003|Overall Study|Lost to Follow-up|1|||
126425358|NCT01188772|454853922|FG000|Overall Study|Non-responder|0|||
126425359|NCT01188772|454853923|FG001|Overall Study|Non-responder|0|||
126425360|NCT01188772|454853924|FG002|Overall Study|Non-responder|3|||
126425361|NCT01188772|454853925|FG003|Overall Study|Non-responder|0|||
126425362|NCT01188772|454853922|FG000|Overall Study|Physician Decision|0|||
126425363|NCT01188772|454853923|FG001|Overall Study|Physician Decision|0|||
126425364|NCT01188772|454853924|FG002|Overall Study|Physician Decision|1|||
126425365|NCT01188772|454853925|FG003|Overall Study|Physician Decision|0|||
126425366|NCT01188772|454853922|FG000|Overall Study|Terminated by Sponsor|0|||
126425367|NCT01188772|454853923|FG001|Overall Study|Terminated by Sponsor|0|||
126425368|NCT01188772|454853924|FG002|Overall Study|Terminated by Sponsor|1|||
126425369|NCT01188772|454853925|FG003|Overall Study|Terminated by Sponsor|0|||
126425370|NCT01188772|454853922|FG000|Overall Study|Treatment Failure|0|||
126425371|NCT01188772|454853923|FG001|Overall Study|Treatment Failure|0|||
126425372|NCT01188772|454853924|FG002|Overall Study|Treatment Failure|1|||
126425373|NCT01188772|454853925|FG003|Overall Study|Treatment Failure|0|||
126425374|NCT01188772|454853922|FG000|Overall Study|Virologic Failure|1|||
126673929|NCT01251653|455764459|FG002|Overall Study|Dose-limiting toxicity|1|||
126673930|NCT01251653|455764460|FG003|Overall Study|Dose-limiting toxicity|1|||
126673931|NCT01251653|455764461|FG004|Overall Study|Dose-limiting toxicity|0|||
126673932|NCT01251653|455764462|FG005|Overall Study|Dose-limiting toxicity|0|||
126673933|NCT01251653|455764463|FG006|Overall Study|Dose-limiting toxicity|2|||
126340503|NCT02674516|454542278|FG001|Overall Study|Protocol Violation|4|||
126340504|NCT02674516|454542277|FG000|Overall Study|Knowledge of study hypothesis|1|||
126340505|NCT02674516|454542278|FG001|Overall Study|Knowledge of study hypothesis|0|||
126340506|NCT01026493|454542279|FG000|Overall Study|Protocol Violation|0|||
126340507|NCT01026493|454542280|FG001|Overall Study|Protocol Violation|1|||
126340508|NCT01026493|454542281|FG002|Overall Study|Protocol Violation|0|||
126340509|NCT01026493|454542282|FG003|Overall Study|Protocol Violation|0|||
126340510|NCT01026493|454542283|FG004|Overall Study|Protocol Violation|2|||
126340511|NCT01026493|454542284|FG005|Overall Study|Protocol Violation|3|||
126340512|NCT01026493|454542285|FG006|Overall Study|Protocol Violation|4|||
126340513|NCT01026493|454542286|FG007|Overall Study|Protocol Violation|1|||
126340514|NCT02295644|454542289|FG000|Overall Study|Did not meet inclusion criterion|0|||
126340515|NCT02295644|454542290|FG001|Overall Study|Did not meet inclusion criterion|0|||
126340516|NCT02295644|454542291|FG002|Overall Study|Did not meet inclusion criterion|1|||
126340517|NCT02295644|454542292|FG003|Overall Study|Did not meet inclusion criterion|2|||
126340518|NCT00324155|454542293|FG000|Enrolled and Randomized|No longer met study criteria|3|||
126340519|NCT00324155|454542294|FG001|Enrolled and Randomized|No longer met study criteria|0|||
126340520|NCT00324155|454542293|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
126340521|NCT00324155|454542294|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
126340522|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
126340523|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
126340524|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
126340525|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
126340526|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Death|8|||
126340527|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Death|15|||
126340528|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
126340529|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
126340530|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
126340531|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
126340532|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
126340533|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
126340534|NCT00324155|454542293|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
126340535|NCT00324155|454542294|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
126340536|NCT00324155|454542293|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
126340537|NCT00324155|454542294|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
126340538|NCT00324155|454542293|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
126425375|NCT01188772|454853923|FG001|Overall Study|Virologic Failure|0|||
126425376|NCT01188772|454853924|FG002|Overall Study|Virologic Failure|0|||
126673934|NCT01251653|455764464|FG007|Overall Study|Dose-limiting toxicity|0|||
126340539|NCT00324155|454542294|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
126425377|NCT01188772|454853925|FG003|Overall Study|Virologic Failure|0|||
126425378|NCT01188772|454853922|FG000|Overall Study|Withdrawal by Subject|0|||
126425379|NCT01188772|454853923|FG001|Overall Study|Withdrawal by Subject|0|||
126425380|NCT01188772|454853924|FG002|Overall Study|Withdrawal by Subject|2|||
126425381|NCT01188772|454853925|FG003|Overall Study|Withdrawal by Subject|0|||
126425382|NCT02910466|454853926|FG000|Overall Study|Adverse Event|1|||
126425383|NCT02910466|454853926|FG000|Overall Study|Withdrawal by Subject|3|||
126425384|NCT02910466|454853926|FG000|Overall Study|Lost to Follow-up|5|||
126425385|NCT02910466|454853926|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
126425386|NCT02910466|454853926|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
126425387|NCT01808196|454853933|FG000|Overall Study|Lost to Follow-up|1|||
126425388|NCT00479713|454853934|FG000|Overall Study|Adverse Event|8|||
126425389|NCT00479713|454853935|FG001|Overall Study|Adverse Event|6|||
126425390|NCT00479713|454853934|FG000|Overall Study|Death|1|||
126425391|NCT00479713|454853935|FG001|Overall Study|Death|0|||
126425392|NCT00479713|454853934|FG000|Overall Study|Lost to Follow-up|0|||
126425393|NCT00479713|454853935|FG001|Overall Study|Lost to Follow-up|1|||
126425394|NCT00479713|454853934|FG000|Overall Study|Protocol Violation|0|||
126673935|NCT01251653|455764465|FG008|Overall Study|Dose-limiting toxicity|0|||
126673936|NCT01251653|455764457|FG000|Overall Study|Adverse Event|1|||
126340540|NCT00324155|454542293|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
126340541|NCT00324155|454542294|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
126340542|NCT00324155|454542293|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
126340543|NCT00324155|454542294|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
126340544|NCT00324155|454542293|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
126340545|NCT00324155|454542294|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
126340546|NCT00324155|454542293|FG000|Follow-up Phase|On-going participants still on drug|11|||
126340547|NCT00324155|454542294|FG001|Follow-up Phase|On-going participants still on drug|6|||
126340548|NCT03307174|454542295|FG000|Overall Study|Unplanned ICU Administrion|5|||
126340549|NCT03307174|454542296|FG001|Overall Study|Unplanned ICU Administrion|3|||
126340550|NCT03307174|454542295|FG000|Overall Study|Aborted Surgery|1|||
126340551|NCT03307174|454542296|FG001|Overall Study|Aborted Surgery|2|||
126340552|NCT03307174|454542295|FG000|Overall Study|Hypotension|6|||
126340553|NCT03307174|454542296|FG001|Overall Study|Hypotension|0|||
126340554|NCT03307174|454542295|FG000|Overall Study|Nonfunctional epidural|1|||
126340555|NCT03307174|454542296|FG001|Overall Study|Nonfunctional epidural|1|||
126340556|NCT03307174|454542295|FG000|Overall Study|Planned epidural removal|1|||
126340557|NCT03307174|454542296|FG001|Overall Study|Planned epidural removal|0|||
126340558|NCT03307174|454542295|FG000|Overall Study|Intrathecal catheter placement|0|||
126340559|NCT03307174|454542296|FG001|Overall Study|Intrathecal catheter placement|1|||
126340560|NCT00846053|454542297|FG000|Overall Study|Physician Decision|3|||
126340561|NCT00846053|454542298|FG001|Overall Study|Physician Decision|0|||
126340562|NCT00111761|454542299|FG000|Part 1|Physician Decision|0|||
126340563|NCT00111761|454542300|FG001|Part 1|Physician Decision|1|||
126340564|NCT00111761|454542299|FG000|Part 1|Death|0|||
126340565|NCT00111761|454542300|FG001|Part 1|Death|2|||
126340566|NCT00111761|454542299|FG000|Part 1|Other|0|||
126340567|NCT00111761|454542300|FG001|Part 1|Other|1|||
126340568|NCT00111761|454542299|FG000|Part 1|Withdrawal by Subject|0|||
126340569|NCT00111761|454542300|FG001|Part 1|Withdrawal by Subject|1|||
126340570|NCT00111761|454542299|FG000|Part 2|Adverse Event|1|||
126340571|NCT00111761|454542300|FG001|Part 2|Adverse Event|0|||
126340572|NCT00111761|454542299|FG000|Part 2|Physician Decision|1|||
126340573|NCT00111761|454542300|FG001|Part 2|Physician Decision|0|||
126340574|NCT00111761|454542299|FG000|Part 2|Death|1|||
126340575|NCT00111761|454542300|FG001|Part 2|Death|0|||
126340576|NCT00111761|454542299|FG000|Part 2|Disease progression|3|||
126340577|NCT00111761|454542300|FG001|Part 2|Disease progression|0|||
126340578|NCT00111761|454542299|FG000|Part 2|Protocol-specified criteria|1|||
126340579|NCT00111761|454542300|FG001|Part 2|Protocol-specified criteria|0|||
126340580|NCT00111761|454542299|FG000|Part 2|Other|1|||
126673937|NCT01251653|455764458|FG001|Overall Study|Adverse Event|0|||
126673938|NCT01251653|455764459|FG002|Overall Study|Adverse Event|2|||
126673939|NCT01251653|455764460|FG003|Overall Study|Adverse Event|1|||
126673940|NCT01251653|455764461|FG004|Overall Study|Adverse Event|1|||
126673941|NCT01251653|455764462|FG005|Overall Study|Adverse Event|0|||
126673942|NCT01251653|455764463|FG006|Overall Study|Adverse Event|2|||
126673943|NCT01251653|455764464|FG007|Overall Study|Adverse Event|2|||
126673944|NCT01251653|455764465|FG008|Overall Study|Adverse Event|1|||
126340581|NCT00111761|454542300|FG001|Part 2|Other|0|||
126340582|NCT00746551|454542301|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
126425395|NCT00479713|454853935|FG001|Overall Study|Protocol Violation|1|||
126425396|NCT00479713|454853934|FG000|Overall Study|Withdrawal by Subject|4|||
126340583|NCT00746551|454542302|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
126340584|NCT00746551|454542301|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
126340585|NCT00746551|454542302|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
126340586|NCT00746551|454542301|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
126340587|NCT00746551|454542302|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
126340588|NCT00843492|454542306|FG000|Overall Study|Adverse Event|0|||
126340589|NCT00843492|454542307|FG001|Overall Study|Adverse Event|3|||
126425397|NCT00479713|454853935|FG001|Overall Study|Withdrawal by Subject|1|||
126425398|NCT00141102|454853936|FG000|Overall Study|Adverse Event|233|||
126425399|NCT00141102|454853937|FG001|Overall Study|Adverse Event|305|||
126425400|NCT00141102|454853936|FG000|Overall Study|Laboratory Abnormality|9|||
126425401|NCT00141102|454853937|FG001|Overall Study|Laboratory Abnormality|33|||
126425402|NCT00141102|454853936|FG000|Overall Study|Lack of Efficacy|21|||
126425403|NCT00141102|454853937|FG001|Overall Study|Lack of Efficacy|26|||
126425404|NCT00141102|454853936|FG000|Overall Study|Lost to Follow-up|29|||
126425405|NCT00141102|454853937|FG001|Overall Study|Lost to Follow-up|32|||
126425406|NCT00141102|454853936|FG000|Overall Study|Other|87|||
126425407|NCT00141102|454853937|FG001|Overall Study|Other|76|||
126425408|NCT00141102|454853936|FG000|Overall Study|Withdrawal by Subject|112|||
126425409|NCT00141102|454853937|FG001|Overall Study|Withdrawal by Subject|142|||
126425410|NCT00141102|454853936|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
126425411|NCT00141102|454853937|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
126425412|NCT00141102|454853936|FG000|Overall Study|Death|2|||
126425413|NCT00141102|454853937|FG001|Overall Study|Death|2|||
126673945|NCT01251653|455764457|FG000|Overall Study|Withdrawal by Subject|1|||
126673946|NCT01251653|455764458|FG001|Overall Study|Withdrawal by Subject|0|||
126673947|NCT01251653|455764459|FG002|Overall Study|Withdrawal by Subject|1|||
126673948|NCT01251653|455764460|FG003|Overall Study|Withdrawal by Subject|0|||
126673949|NCT01251653|455764461|FG004|Overall Study|Withdrawal by Subject|1|||
126673950|NCT01251653|455764462|FG005|Overall Study|Withdrawal by Subject|1|||
126673951|NCT01251653|455764463|FG006|Overall Study|Withdrawal by Subject|0|||
126673952|NCT01251653|455764464|FG007|Overall Study|Withdrawal by Subject|1|||
126673953|NCT01251653|455764465|FG008|Overall Study|Withdrawal by Subject|0|||
126673954|NCT01251653|455764457|FG000|Overall Study|Other reason not mentioned above|0|||
126673955|NCT01251653|455764458|FG001|Overall Study|Other reason not mentioned above|0|||
126673956|NCT01251653|455764459|FG002|Overall Study|Other reason not mentioned above|0|||
126673957|NCT01251653|455764460|FG003|Overall Study|Other reason not mentioned above|0|||
126673958|NCT01251653|455764461|FG004|Overall Study|Other reason not mentioned above|0|||
126673959|NCT01251653|455764462|FG005|Overall Study|Other reason not mentioned above|0|||
126673960|NCT01251653|455764463|FG006|Overall Study|Other reason not mentioned above|0|||
126673961|NCT01251653|455764464|FG007|Overall Study|Other reason not mentioned above|2|||
126673962|NCT01251653|455764465|FG008|Overall Study|Other reason not mentioned above|0|||
126673963|NCT01439282|455764466|FG000|Overall Study|Adverse Event|5|||
126673964|NCT01439282|455764467|FG001|Overall Study|Adverse Event|0|||
126673965|NCT01439282|455764466|FG000|Overall Study|Withdrawal by Subject|2|||
126673966|NCT01439282|455764467|FG001|Overall Study|Withdrawal by Subject|0|||
126673967|NCT01439282|455764466|FG000|Overall Study|Other|1|||
126673968|NCT01439282|455764467|FG001|Overall Study|Other|1|||
126673969|NCT00885703|455764470|FG000|Overall Study|Death|9|||
126673970|NCT00885703|455764471|FG001|Overall Study|Death|7|||
126673971|NCT00885703|455764472|FG002|Overall Study|Death|8|||
126673972|NCT00885703|455764473|FG003|Overall Study|Death|7|||
126673973|NCT00885703|455764474|FG004|Overall Study|Death|7|||
126673974|NCT00885703|455764475|FG005|Overall Study|Death|8|||
126673975|NCT00885703|455764476|FG006|Overall Study|Death|4|||
126673976|NCT00885703|455764470|FG000|Overall Study|Lost to Follow-up|0|||
126673977|NCT00885703|455764471|FG001|Overall Study|Lost to Follow-up|0|||
126673978|NCT00885703|455764472|FG002|Overall Study|Lost to Follow-up|1|||
126673979|NCT00885703|455764473|FG003|Overall Study|Lost to Follow-up|0|||
126673980|NCT00885703|455764474|FG004|Overall Study|Lost to Follow-up|0|||
126673981|NCT00885703|455764475|FG005|Overall Study|Lost to Follow-up|1|||
126673982|NCT00885703|455764476|FG006|Overall Study|Lost to Follow-up|0|||
126673983|NCT00885703|455764470|FG000|Overall Study|Withdrawal by Subject|0|||
126673984|NCT00885703|455764471|FG001|Overall Study|Withdrawal by Subject|0|||
126673985|NCT00885703|455764472|FG002|Overall Study|Withdrawal by Subject|0|||
126673986|NCT00885703|455764473|FG003|Overall Study|Withdrawal by Subject|1|||
126673987|NCT00885703|455764474|FG004|Overall Study|Withdrawal by Subject|3|||
126673988|NCT00885703|455764475|FG005|Overall Study|Withdrawal by Subject|1|||
126673989|NCT00885703|455764476|FG006|Overall Study|Withdrawal by Subject|1|||
126673990|NCT00885703|455764470|FG000|Overall Study|Ineligible (no CM)|1|||
126673991|NCT00885703|455764471|FG001|Overall Study|Ineligible (no CM)|3|||
126673992|NCT00885703|455764472|FG002|Overall Study|Ineligible (no CM)|2|||
126673993|NCT00885703|455764473|FG003|Overall Study|Ineligible (no CM)|1|||
126673994|NCT00885703|455764474|FG004|Overall Study|Ineligible (no CM)|2|||
126673995|NCT00885703|455764475|FG005|Overall Study|Ineligible (no CM)|3|||
126673996|NCT00885703|455764476|FG006|Overall Study|Ineligible (no CM)|1|||
126425414|NCT00866814|454853938|FG000|Overall Study|Lost to Follow-up|12|||
126425415|NCT00866814|454853938|FG000|Overall Study|Adverse Event|2|||
126425416|NCT00866814|454853938|FG000|Overall Study|Physician Decision|1|||
126425417|NCT00866814|454853938|FG000|Overall Study|Death|1|||
126425418|NCT00866814|454853938|FG000|Overall Study|No longer wished to participate|1|||
126425419|NCT00866814|454853938|FG000|Overall Study|Unable to meet follow-up requirements|2|||
126425420|NCT00866814|454853938|FG000|Overall Study|Moved to area without study site|1|||
126673997|NCT01183143|455764477|FG000|Overall Study|Protocol Violation|115|||
126673998|NCT01183143|455764477|FG000|Overall Study|Withdrawal by Subject|19|||
126425421|NCT01063153|454853939|FG000|Overall Study|Found Ineligible During Screening|2|||
126425422|NCT01063153|454853940|FG001|Overall Study|Found Ineligible During Screening|0|||
126425423|NCT01063153|454853939|FG000|Overall Study|Lost to Follow-up|0|||
126425424|NCT01063153|454853940|FG001|Overall Study|Lost to Follow-up|7|||
126673999|NCT01183143|455764477|FG000|Overall Study|Subject Questionnaires not returned|5|||
126674000|NCT01183143|455764477|FG000|Overall Study|Subjects enrolled, but not treated|11|||
126674001|NCT04096274|455764480|FG000|Phase I|Lost to Follow-up|5|||
126674002|NCT04096274|455764481|FG001|Phase I|Lost to Follow-up|5|||
126674003|NCT04096274|455764480|FG000|Phase II|Lost to Follow-up|11|||
126674004|NCT04096274|455764481|FG001|Phase II|Lost to Follow-up|11|||
126674005|NCT02807480|455764482|FG000|Overall Study|Withdrawal by Subject|14|||
126674006|NCT02807480|455764483|FG001|Overall Study|Withdrawal by Subject|10|||
126674007|NCT02163187|455764484|FG000|Overall Study|Device removed|1|||
126674008|NCT02163187|455764485|FG001|Overall Study|Device removed|0|||
126674009|NCT02163187|455764484|FG000|Overall Study|Progressive disease|1|||
126674010|NCT02163187|455764485|FG001|Overall Study|Progressive disease|0|||
126674011|NCT02369848|455764486|FG000|Overall Study|Death|1|||
126674012|NCT02369848|455764486|FG000|Overall Study|Withdrawal by Subject|2|||
126674013|NCT02369848|455764486|FG000|Overall Study|Lost to Follow-up|1|||
126674014|NCT03281668|455764488|FG000|Overall Study|Physician Decision|1|||
126674015|NCT03281668|455764488|FG000|Overall Study|scheduling conflict, family circumstance|2|||
126674016|NCT03281668|455764488|FG000|Overall Study|Withdrawal by Subject|4|||
126674017|NCT03281668|455764488|FG000|Overall Study|Lost to Follow-up|1|||
126674018|NCT01543152|455764489|FG000|Overall Study|Withdrawal by Subject|0|||
126425425|NCT01063153|454853939|FG000|Overall Study|Withdrawal by Subject|0|||
126425426|NCT01063153|454853940|FG001|Overall Study|Withdrawal by Subject|1|||
126425427|NCT01063153|454853939|FG000|Overall Study|Physician Decision|0|||
126425428|NCT01063153|454853940|FG001|Overall Study|Physician Decision|4|||
126425429|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
126425430|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
126425431|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
126425432|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
126425433|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
126425434|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
126425435|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
126425436|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
126425437|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
126425438|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
126425439|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
126425440|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
126425441|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
126425442|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
126425443|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
126425444|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
126425445|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
126425446|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
126425447|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
126425448|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
126425449|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
126425450|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
126425451|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
126425452|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
126425453|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
126425454|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
126425455|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
126425456|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
126425457|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
126425458|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
126425459|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
126674019|NCT01543152|455764490|FG001|Overall Study|Withdrawal by Subject|2|||
126674020|NCT01543152|455764491|FG002|Overall Study|Withdrawal by Subject|0|||
126674021|NCT01543152|455764492|FG003|Overall Study|Withdrawal by Subject|0|||
126674022|NCT01543152|455764493|FG004|Overall Study|Withdrawal by Subject|0|||
126674023|NCT00762892|455764495|FG000|Overall Study|Lost to Follow-up|2|||
126674024|NCT00762892|455764496|FG001|Overall Study|Lost to Follow-up|5|||
126425460|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
126674025|NCT00762892|455764495|FG000|Overall Study|Withdrawal by Subject|0|||
126674026|NCT00762892|455764496|FG001|Overall Study|Withdrawal by Subject|1|||
126674027|NCT00762892|455764495|FG000|Overall Study|Death|1|||
126674028|NCT00762892|455764496|FG001|Overall Study|Death|0|||
126674029|NCT00762892|455764495|FG000|Overall Study|Pregnancy|1|||
126674030|NCT00762892|455764496|FG001|Overall Study|Pregnancy|0|||
126674031|NCT00762892|455764495|FG000|Overall Study|Incarceration|1|||
126674032|NCT00762892|455764496|FG001|Overall Study|Incarceration|0|||
126674033|NCT05500274|455764501|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
126674034|NCT05500274|455764502|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
126674035|NCT05500274|455764501|FG000|Overall Study|Lost to Follow-up|76|||
126674036|NCT05500274|455764502|FG001|Overall Study|Lost to Follow-up|51|||
126674037|NCT05807464|455764503|FG000|Overall Study|Adverse Event|1|||
126674038|NCT01555151|455764504|FG000|Overall Study|Withdrawal by Subject|6|||
126674039|NCT01555151|455764505|FG001|Overall Study|Withdrawal by Subject|2|||
126674040|NCT01555151|455764506|FG002|Overall Study|Withdrawal by Subject|0|||
126674041|NCT01555151|455764507|FG003|Overall Study|Withdrawal by Subject|2|||
126425461|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
126425462|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
126425463|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
126425464|NCT02831764|454856123|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
126425465|NCT02831764|454856124|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
126425466|NCT02831764|454856125|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
126425467|NCT02831764|454856126|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
126425468|NCT02831764|454856127|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
126425469|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
126425470|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
126425471|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
126425472|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
126425473|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
126425474|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126425475|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126425476|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
126425477|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126425478|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126425479|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126425480|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126425481|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
126425482|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
126425483|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126425484|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
126425485|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
126425486|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
126425487|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
126425488|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
126425489|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
126425490|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
126425491|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
126425492|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
126425493|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
126425494|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
126425495|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
126425496|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
126425497|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
126425498|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
126425499|NCT02831764|454856123|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
126425500|NCT02831764|454856124|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
126425501|NCT02831764|454856125|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
126425502|NCT02831764|454856126|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
126425503|NCT02831764|454856127|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
126425504|NCT02831764|454856123|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126425505|NCT02831764|454856124|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126425506|NCT02831764|454856125|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126425507|NCT02831764|454856126|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126425508|NCT02831764|454856127|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
126674042|NCT01555151|455764504|FG000|Overall Study|Administrative|3|||
126674043|NCT01555151|455764505|FG001|Overall Study|Administrative|1|||
126674044|NCT01555151|455764506|FG002|Overall Study|Administrative|2|||
126674045|NCT01555151|455764507|FG003|Overall Study|Administrative|0|||
126674046|NCT01555151|455764504|FG000|Overall Study|Protocol Violation|3|||
126425509|NCT02831764|454856123|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126425510|NCT02831764|454856124|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126425511|NCT02831764|454856125|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126425512|NCT02831764|454856126|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126425513|NCT02831764|454856127|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
126425514|NCT02831764|454856123|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126425515|NCT02831764|454856124|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126425516|NCT02831764|454856125|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126425517|NCT02831764|454856126|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126425518|NCT02831764|454856127|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
126425519|NCT02831764|454856123|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126425520|NCT02831764|454856124|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126425521|NCT02831764|454856125|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126425522|NCT02831764|454856126|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126425523|NCT02831764|454856127|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
126425524|NCT04564846|454856128|FG000|Overall Study|Withdrawal by Subject|2|||
126425525|NCT04564846|454856129|FG001|Overall Study|Withdrawal by Subject|1|||
126425526|NCT04564846|454856128|FG000|Overall Study|Physician Decision|0|||
126425527|NCT04564846|454856129|FG001|Overall Study|Physician Decision|1|||
126425528|NCT04564846|454856128|FG000|Overall Study|Lost to Follow-up|0|||
126425529|NCT04564846|454856129|FG001|Overall Study|Lost to Follow-up|1|||
126425530|NCT04564846|454856128|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
126425531|NCT04564846|454856129|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
126425532|NCT04564846|454856128|FG000|Overall Study|Subject non-compliance|1|||
126425533|NCT04564846|454856129|FG001|Overall Study|Subject non-compliance|0|||
126425534|NCT02173769|454856130|FG000|Overall Study|Protocol Violation|4|||
126425535|NCT02735239|454856131|FG000|Overall Study|Adverse Event|0|||
126425536|NCT02735239|454856132|FG001|Overall Study|Adverse Event|0|||
126425537|NCT02735239|454856133|FG002|Overall Study|Adverse Event|4|||
126425538|NCT02735239|454856134|FG003|Overall Study|Adverse Event|0|||
126425539|NCT02735239|454856135|FG004|Overall Study|Adverse Event|0|||
126425540|NCT02735239|454856136|FG005|Overall Study|Adverse Event|0|||
126425541|NCT02735239|454856131|FG000|Overall Study|Death|1|||
126425542|NCT02735239|454856132|FG001|Overall Study|Death|1|||
126425543|NCT02735239|454856133|FG002|Overall Study|Death|0|||
126425544|NCT02735239|454856134|FG003|Overall Study|Death|0|||
126425545|NCT02735239|454856135|FG004|Overall Study|Death|0|||
126425546|NCT02735239|454856136|FG005|Overall Study|Death|0|||
126425547|NCT02735239|454856131|FG000|Overall Study|Physician Decision|0|||
126425548|NCT02735239|454856132|FG001|Overall Study|Physician Decision|0|||
126425549|NCT02735239|454856133|FG002|Overall Study|Physician Decision|1|||
126425550|NCT02735239|454856134|FG003|Overall Study|Physician Decision|0|||
126425551|NCT02735239|454856135|FG004|Overall Study|Physician Decision|0|||
126425552|NCT02735239|454856136|FG005|Overall Study|Physician Decision|0|||
126425553|NCT02735239|454856131|FG000|Overall Study|Progressive disease|3|||
126425554|NCT02735239|454856132|FG001|Overall Study|Progressive disease|1|||
126425555|NCT02735239|454856133|FG002|Overall Study|Progressive disease|3|||
126425556|NCT02735239|454856134|FG003|Overall Study|Progressive disease|0|||
126425557|NCT02735239|454856135|FG004|Overall Study|Progressive disease|0|||
126425558|NCT02735239|454856136|FG005|Overall Study|Progressive disease|2|||
126425559|NCT02735239|454856131|FG000|Overall Study|Withdrawal by Subject|0|||
126425560|NCT02735239|454856132|FG001|Overall Study|Withdrawal by Subject|1|||
126425561|NCT02735239|454856133|FG002|Overall Study|Withdrawal by Subject|0|||
126425562|NCT02735239|454856134|FG003|Overall Study|Withdrawal by Subject|0|||
126425563|NCT02735239|454856135|FG004|Overall Study|Withdrawal by Subject|0|||
126674047|NCT01555151|455764505|FG001|Overall Study|Protocol Violation|3|||
126674048|NCT01555151|455764506|FG002|Overall Study|Protocol Violation|3|||
126674049|NCT01555151|455764507|FG003|Overall Study|Protocol Violation|5|||
126674050|NCT01555151|455764504|FG000|Overall Study|Adverse Event|1|||
126674051|NCT01555151|455764505|FG001|Overall Study|Adverse Event|2|||
126674052|NCT01555151|455764506|FG002|Overall Study|Adverse Event|1|||
126674053|NCT01555151|455764507|FG003|Overall Study|Adverse Event|2|||
126674054|NCT01555151|455764504|FG000|Overall Study|Lost to Follow-up|0|||
126674055|NCT01555151|455764505|FG001|Overall Study|Lost to Follow-up|0|||
126674056|NCT01555151|455764506|FG002|Overall Study|Lost to Follow-up|0|||
126674057|NCT01555151|455764507|FG003|Overall Study|Lost to Follow-up|1|||
126674058|NCT03596866|455764508|FG000|Overall Study|Site terminated by Sponsor|64|||
126425564|NCT02735239|454856136|FG005|Overall Study|Withdrawal by Subject|0|||
126425565|NCT00387881|454856142|FG000|Overall Study|Lost to Follow-up|23|||
126425566|NCT00387881|454856143|FG001|Overall Study|Lost to Follow-up|23|||
126425567|NCT00387881|454856142|FG000|Overall Study|Protocol Violation|2|||
126425568|NCT00387881|454856143|FG001|Overall Study|Protocol Violation|12|||
126674059|NCT03596866|455764509|FG001|Overall Study|Site terminated by Sponsor|65|||
126674060|NCT03596866|455764508|FG000|Overall Study|Death|37|||
126674061|NCT03596866|455764509|FG001|Overall Study|Death|24|||
126674062|NCT03596866|455764508|FG000|Overall Study|Withdrawal by Subject|4|||
126674063|NCT03596866|455764509|FG001|Overall Study|Withdrawal by Subject|6|||
126674064|NCT03596866|455764508|FG000|Overall Study|Missing|0|||
126674065|NCT03596866|455764509|FG001|Overall Study|Missing|6|||
126674066|NCT03596866|455764508|FG000|Overall Study|Lost to Follow-up|2|||
126674067|NCT03596866|455764509|FG001|Overall Study|Lost to Follow-up|3|||
126674068|NCT03596866|455764508|FG000|Overall Study|Protocol Violation|1|||
126674069|NCT03596866|455764509|FG001|Overall Study|Protocol Violation|0|||
126674070|NCT03596866|455764508|FG000|Overall Study|Reason Not Specified|14|||
126674071|NCT03596866|455764509|FG001|Overall Study|Reason Not Specified|13|||
126340590|NCT00843492|454542306|FG000|Overall Study|Lost to Follow-up|4|||
126340591|NCT00843492|454542307|FG001|Overall Study|Lost to Follow-up|4|||
126340592|NCT00843492|454542306|FG000|Overall Study|Withdrawal by Subject|0|||
126340593|NCT00843492|454542307|FG001|Overall Study|Withdrawal by Subject|4|||
126340594|NCT00843492|454542306|FG000|Overall Study|Immobilization Stopped|1|||
126340595|NCT00843492|454542307|FG001|Overall Study|Immobilization Stopped|0|||
126340596|NCT00843492|454542306|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
126340597|NCT00843492|454542307|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
126340598|NCT00843492|454542306|FG000|Overall Study|Orthopedic Surgery|0|||
126340599|NCT00843492|454542307|FG001|Overall Study|Orthopedic Surgery|2|||
126340600|NCT00843492|454542306|FG000|Overall Study|Visit Not Performed|1|||
126340601|NCT00843492|454542307|FG001|Overall Study|Visit Not Performed|0|||
126340602|NCT00843492|454542306|FG000|Overall Study|Deep-vein Thrombosis|1|||
126340603|NCT00843492|454542307|FG001|Overall Study|Deep-vein Thrombosis|0|||
126340604|NCT01677741|454542309|FG000|Overall Study|Death|0|||
126340605|NCT01677741|454542310|FG001|Overall Study|Death|0|||
126340606|NCT01677741|454542311|FG002|Overall Study|Death|0|||
126340607|NCT01677741|454542312|FG003|Overall Study|Death|1|||
126340608|NCT01677741|454542313|FG004|Overall Study|Death|0|||
126340609|NCT01677741|454542314|FG005|Overall Study|Death|1|||
126340610|NCT01677741|454542315|FG006|Overall Study|Death|0|||
126340611|NCT01677741|454542316|FG007|Overall Study|Death|0|||
126340612|NCT01677741|454542309|FG000|Overall Study|Withdrawal by Subject|2|||
126340613|NCT01677741|454542310|FG001|Overall Study|Withdrawal by Subject|7|||
126340614|NCT01677741|454542311|FG002|Overall Study|Withdrawal by Subject|5|||
126340615|NCT01677741|454542312|FG003|Overall Study|Withdrawal by Subject|4|||
126340616|NCT01677741|454542313|FG004|Overall Study|Withdrawal by Subject|11|||
126340617|NCT01677741|454542314|FG005|Overall Study|Withdrawal by Subject|20|||
126340618|NCT01677741|454542315|FG006|Overall Study|Withdrawal by Subject|4|||
126340619|NCT01677741|454542316|FG007|Overall Study|Withdrawal by Subject|2|||
126340620|NCT01677741|454542309|FG000|Overall Study|Enrolled in a rollover study|0|||
126340621|NCT01677741|454542310|FG001|Overall Study|Enrolled in a rollover study|3|||
126340622|NCT01677741|454542311|FG002|Overall Study|Enrolled in a rollover study|2|||
126340623|NCT01677741|454542312|FG003|Overall Study|Enrolled in a rollover study|1|||
126340624|NCT01677741|454542313|FG004|Overall Study|Enrolled in a rollover study|6|||
126340625|NCT01677741|454542314|FG005|Overall Study|Enrolled in a rollover study|6|||
126340626|NCT01677741|454542315|FG006|Overall Study|Enrolled in a rollover study|7|||
126340627|NCT01677741|454542316|FG007|Overall Study|Enrolled in a rollover study|0|||
126340628|NCT01677741|454542309|FG000|Overall Study|Progressive disease|1|||
126340629|NCT01677741|454542310|FG001|Overall Study|Progressive disease|0|||
126340630|NCT01677741|454542311|FG002|Overall Study|Progressive disease|1|||
126340631|NCT01677741|454542312|FG003|Overall Study|Progressive disease|0|||
126340632|NCT01677741|454542313|FG004|Overall Study|Progressive disease|0|||
126340633|NCT01677741|454542314|FG005|Overall Study|Progressive disease|1|||
126340634|NCT01677741|454542315|FG006|Overall Study|Progressive disease|0|||
126340635|NCT01677741|454542316|FG007|Overall Study|Progressive disease|0|||
126340636|NCT00720499|454542317|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
126340637|NCT00720499|454542318|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
126340638|NCT00720499|454542317|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
126340639|NCT00720499|454542318|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
126340640|NCT00720499|454542317|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
126340641|NCT00720499|454542318|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
126340642|NCT01441973|454542326|FG000|Overall Study|Disease progression|8|||
126674072|NCT03159091|455764514|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
126674073|NCT03159091|455764515|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
126715139|NCT01161524|455908694|FG000|Core Study (23 Weeks)|Other|1|||
126340643|NCT01441973|454542327|FG001|Overall Study|Disease progression|6|||
126340644|NCT01441973|454542326|FG000|Overall Study|Adverse event unrelated to study drug|3|||
126340645|NCT01441973|454542327|FG001|Overall Study|Adverse event unrelated to study drug|2|||
126340646|NCT01441973|454542326|FG000|Overall Study|Participant request to discontinue|1|||
126340647|NCT01441973|454542327|FG001|Overall Study|Participant request to discontinue|1|||
126340648|NCT01441973|454542326|FG000|Overall Study|Poor compliance/noncompliance|0|||
126340649|NCT01441973|454542327|FG001|Overall Study|Poor compliance/noncompliance|1|||
126340650|NCT01441973|454542326|FG000|Overall Study|Administrative reason by sponsor|3|||
126340651|NCT01441973|454542327|FG001|Overall Study|Administrative reason by sponsor|5|||
126340652|NCT01441973|454542326|FG000|Overall Study|Participant withdrew consent|0|||
126674074|NCT03159091|455764514|FG000|Overall Study|Patient has taken no dose of study drug|0|||
126674075|NCT03159091|455764515|FG001|Overall Study|Patient has taken no dose of study drug|1|||
126674076|NCT00262522|455764516|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
126674077|NCT00262522|455764517|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
126674078|NCT00262522|455764518|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
126674079|NCT00262522|455764519|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
126674080|NCT00262522|455764516|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
126674081|NCT00262522|455764517|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
126674082|NCT00262522|455764518|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
126674083|NCT00262522|455764519|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
126674084|NCT00262522|455764516|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
126674085|NCT00262522|455764517|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
126674086|NCT00262522|455764518|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
126674087|NCT00262522|455764519|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
126674088|NCT00262522|455764516|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
126674089|NCT00262522|455764517|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
126674090|NCT00262522|455764518|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
126340653|NCT01441973|454542327|FG001|Overall Study|Participant withdrew consent|1|||
126340654|NCT04030598|454542328|FG000|Overall Study|Voluntary Withdrawal|0|||
126340655|NCT04030598|454542329|FG001|Overall Study|Voluntary Withdrawal|1|||
126340656|NCT04030598|454542330|FG002|Overall Study|Voluntary Withdrawal|0|||
126340657|NCT05079321|454542331|FG000|Overall Study|Withdrawal by Subject|2|||
126340658|NCT05079321|454542332|FG001|Overall Study|Withdrawal by Subject|2|||
126340659|NCT05079321|454542331|FG000|Overall Study|Lost to Follow-up|0|||
126340660|NCT05079321|454542332|FG001|Overall Study|Lost to Follow-up|1|||
126340661|NCT02003144|454542333|FG000|Open Label Maintenance Phase|Other than specified|2|||
126340662|NCT02003144|454542334|FG001|Open Label Maintenance Phase|Other than specified|4|||
126340663|NCT02003144|454542333|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
126340664|NCT02003144|454542334|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
126340665|NCT02003144|454542333|FG000|Open Label Maintenance Phase|Pregnancy|0|||
126340666|NCT02003144|454542334|FG001|Open Label Maintenance Phase|Pregnancy|2|||
126340667|NCT02003144|454542333|FG000|Open Label Maintenance Phase|Physician Decision|1|||
126340668|NCT02003144|454542334|FG001|Open Label Maintenance Phase|Physician Decision|1|||
126340669|NCT02003144|454542333|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
126340670|NCT02003144|454542334|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
126340671|NCT02003144|454542333|FG000|Open Label Maintenance Phase|Adverse Event|2|||
126340672|NCT02003144|454542334|FG001|Open Label Maintenance Phase|Adverse Event|1|||
126340673|NCT01324947|454542338|FG000|Overall Study|Adverse Event|7|||
126340674|NCT01324947|454542338|FG000|Overall Study|Death|10|||
126340675|NCT01324947|454542338|FG000|Overall Study|Other|3|||
126340676|NCT01324947|454542338|FG000|Overall Study|Progressive Disease|50|||
126340677|NCT01324947|454542338|FG000|Overall Study|Withdrawal by Subject|3|||
126340678|NCT01324947|454542338|FG000|Overall Study|1 discontinued before starting drug|1|||
126340679|NCT01274351|454542339|FG000|Overall Study|Lost to Follow-up|1|||
126340680|NCT01274351|454542339|FG000|Overall Study|patient not compliant with the protocol|1|||
126340681|NCT01274351|454542339|FG000|Overall Study|Pregnancy|1|||
126340682|NCT01274351|454542339|FG000|Overall Study|Death|2|||
126340683|NCT01274351|454542339|FG000|Overall Study|Withdrawal by Subject|3|||
126340684|NCT01274351|454542339|FG000|Overall Study|Adverse Event|8|||
126340685|NCT01274351|454542339|FG000|Overall Study|progression of disease|3|||
126340686|NCT01274351|454542339|FG000|Overall Study|hospitalization|1|||
126340687|NCT02873689|454544339|FG000|Overall Study|Lack of Efficacy|1|||
126340688|NCT02873689|454544340|FG001|Overall Study|Lack of Efficacy|0|||
126340689|NCT02873689|454544339|FG000|Overall Study|Withdrawal by Subject|2|||
126340690|NCT02873689|454544340|FG001|Overall Study|Withdrawal by Subject|2|||
126340691|NCT02873689|454544339|FG000|Overall Study|Protocol Violation|1|||
126340692|NCT02873689|454544340|FG001|Overall Study|Protocol Violation|0|||
126340693|NCT02873689|454544339|FG000|Overall Study|Adverse Event|2|||
126340694|NCT02873689|454544340|FG001|Overall Study|Adverse Event|2|||
126340695|NCT02873689|454544339|FG000|Overall Study|Randomized but not Treated|1|||
126340696|NCT02873689|454544340|FG001|Overall Study|Randomized but not Treated|1|||
126340697|NCT00350545|454544341|FG000|Overall Study|Withdrawal by Subject|2|||
126340698|NCT02997163|454544352|FG000|Overall Study|Adverse Event|1|||
126340699|NCT02997163|454544353|FG001|Overall Study|Adverse Event|0|||
126340700|NCT02997163|454544354|FG002|Overall Study|Adverse Event|0|||
126340701|NCT02997163|454544355|FG003|Overall Study|Adverse Event|1|||
126340702|NCT02337764|454544356|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
126340703|NCT02337764|454544356|FG000|Overall Study|Voluntary Withdrawal|12|||
126340704|NCT02337764|454544356|FG000|Overall Study|Lack of Efficacy|2|||
126340705|NCT01855958|454544376|FG000|Overall Study|Withdrawal by Subject|1|||
126340706|NCT01855958|454544377|FG001|Overall Study|Withdrawal by Subject|0|||
126340707|NCT00903968|454544378|FG000|Overall Study|Adverse Event|0|||
126340708|NCT00903968|454544379|FG001|Overall Study|Adverse Event|0|||
126340709|NCT00903968|454544380|FG002|Overall Study|Adverse Event|0|||
126674091|NCT00262522|455764519|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
126425569|NCT00387881|454856142|FG000|Overall Study|Withdrawal by Subject|15|||
126425570|NCT00387881|454856143|FG001|Overall Study|Withdrawal by Subject|18|||
126425571|NCT00387881|454856142|FG000|Overall Study|Sponsor terminated Study|0|||
126425572|NCT00387881|454856143|FG001|Overall Study|Sponsor terminated Study|1|||
126425573|NCT00387881|454856142|FG000|Overall Study|Not eligible|6|||
126425574|NCT00387881|454856143|FG001|Overall Study|Not eligible|7|||
126425575|NCT00387881|454856142|FG000|Overall Study|No opportunity to treat headache|32|||
126425576|NCT00387881|454856143|FG001|Overall Study|No opportunity to treat headache|34|||
126425577|NCT00387881|454856142|FG000|Overall Study|Not otherwise specified|11|||
126425578|NCT00387881|454856143|FG001|Overall Study|Not otherwise specified|7|||
126425579|NCT02038153|454856144|FG000|Overall Study|Withdrawal by Subject|1|||
126425580|NCT03016312|454856145|FG000|Overall Study|discontinued before the treatment started|0|||
126425581|NCT03016312|454856146|FG001|Overall Study|discontinued before the treatment started|1|||
126425582|NCT03016312|454856145|FG000|Overall Study|Withdrawal by Subject|37|||
126425583|NCT03016312|454856146|FG001|Overall Study|Withdrawal by Subject|44|||
126425584|NCT03016312|454856145|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
126425585|NCT03016312|454856146|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
126425586|NCT03016312|454856145|FG000|Overall Study|Physician Decision|1|||
126425587|NCT03016312|454856146|FG001|Overall Study|Physician Decision|3|||
126425588|NCT03016312|454856145|FG000|Overall Study|Lost to Follow-up|12|||
126425589|NCT03016312|454856146|FG001|Overall Study|Lost to Follow-up|12|||
126425590|NCT03016312|454856145|FG000|Overall Study|Death|210|||
126425591|NCT03016312|454856146|FG001|Overall Study|Death|184|||
126425592|NCT03016312|454856145|FG000|Overall Study|loss to contact|1|||
126425593|NCT03016312|454856146|FG001|Overall Study|loss to contact|0|||
126425594|NCT03016312|454856145|FG000|Overall Study|started a new cancer therapy|1|||
126425595|NCT03016312|454856146|FG001|Overall Study|started a new cancer therapy|0|||
126425596|NCT01050634|454856147|FG000|Overall Study|Enrolled, but Not Treated|56|||
126425597|NCT01050634|454856147|FG000|Overall Study|Death|2|||
126425598|NCT01050634|454856147|FG000|Overall Study|Adverse Event|42|||
126425599|NCT01050634|454856147|FG000|Overall Study|Lost to Follow-up|2|||
126425600|NCT01050634|454856147|FG000|Overall Study|Other|21|||
126425601|NCT01050634|454856147|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
126425602|NCT00496015|454856148|FG000|Overall Study|Other|1|||
126425603|NCT00496015|454856149|FG001|Overall Study|Other|0|||
126425604|NCT00496015|454856150|FG002|Overall Study|Other|0|||
126425605|NCT00496015|454856151|FG003|Overall Study|Other|1|||
126425606|NCT00496015|454856152|FG004|Overall Study|Other|0|||
126425607|NCT00527735|454856153|FG000|Overall Study|Disease progression|47|||
126425608|NCT00527735|454856154|FG001|Overall Study|Disease progression|61|||
126425609|NCT00527735|454856155|FG002|Overall Study|Disease progression|53|||
126425610|NCT00527735|454856153|FG000|Overall Study|Death|23|||
126425611|NCT00527735|454856154|FG001|Overall Study|Death|13|||
126425612|NCT00527735|454856155|FG002|Overall Study|Death|15|||
126425613|NCT00527735|454856153|FG000|Overall Study|Completed treatment in treatment phase|14|||
126425614|NCT00527735|454856154|FG001|Overall Study|Completed treatment in treatment phase|13|||
126425615|NCT00527735|454856155|FG002|Overall Study|Completed treatment in treatment phase|18|||
126425616|NCT00527735|454856153|FG000|Overall Study|Adverse Event|10|||
126425617|NCT00527735|454856154|FG001|Overall Study|Adverse Event|6|||
126425618|NCT00527735|454856155|FG002|Overall Study|Adverse Event|7|||
126425619|NCT00527735|454856153|FG000|Overall Study|Not identified|5|||
126425620|NCT00527735|454856154|FG001|Overall Study|Not identified|5|||
126425621|NCT00527735|454856155|FG002|Overall Study|Not identified|5|||
126425622|NCT00527735|454856153|FG000|Overall Study|Withdrawal by Subject|5|||
126425623|NCT00527735|454856154|FG001|Overall Study|Withdrawal by Subject|4|||
126425624|NCT00527735|454856155|FG002|Overall Study|Withdrawal by Subject|3|||
126425625|NCT00527735|454856153|FG000|Overall Study|No longer met study criteria|2|||
126425626|NCT00527735|454856154|FG001|Overall Study|No longer met study criteria|2|||
126425627|NCT00527735|454856155|FG002|Overall Study|No longer met study criteria|1|||
126674092|NCT00262522|455764516|FG000|Study Start Through 8 Weeks|Death|1|||
126674093|NCT00262522|455764517|FG001|Study Start Through 8 Weeks|Death|0|||
126674094|NCT00262522|455764518|FG002|Study Start Through 8 Weeks|Death|0|||
126674095|NCT00262522|455764519|FG003|Study Start Through 8 Weeks|Death|0|||
126674096|NCT00262522|455764516|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
126674097|NCT00262522|455764517|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
126674098|NCT00262522|455764518|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
126425628|NCT00527735|454856153|FG000|Overall Study|Lost to Follow-up|0|||
126425629|NCT00527735|454856154|FG001|Overall Study|Lost to Follow-up|0|||
126425630|NCT00527735|454856155|FG002|Overall Study|Lost to Follow-up|3|||
126425631|NCT00527735|454856153|FG000|Overall Study|Poor compliance or noncompliance|0|||
126425632|NCT00527735|454856154|FG001|Overall Study|Poor compliance or noncompliance|1|||
126425633|NCT00527735|454856155|FG002|Overall Study|Poor compliance or noncompliance|1|||
126425634|NCT00527735|454856153|FG000|Overall Study|Completed treatment during maintenance|2|||
126425635|NCT00527735|454856154|FG001|Overall Study|Completed treatment during maintenance|2|||
126425636|NCT00527735|454856155|FG002|Overall Study|Completed treatment during maintenance|1|||
126674099|NCT00262522|455764519|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
126425637|NCT01535807|454856156|FG000|Overall Study|Withdrawal by Subject|1|||
126425638|NCT01535807|454856157|FG001|Overall Study|Withdrawal by Subject|1|||
126425639|NCT01535807|454856156|FG000|Overall Study|Data collection error|1|||
126425640|NCT01535807|454856157|FG001|Overall Study|Data collection error|1|||
126425641|NCT02730728|454856160|FG000|Overall Study|Withdrawal by Subject|0|||
126425642|NCT02730728|454856161|FG001|Overall Study|Withdrawal by Subject|1|||
126425643|NCT02730728|454856162|FG002|Overall Study|Withdrawal by Subject|0|||
126425644|NCT02730728|454856160|FG000|Overall Study|Lack of Efficacy|0|||
126425645|NCT02730728|454856161|FG001|Overall Study|Lack of Efficacy|1|||
126425646|NCT02730728|454856162|FG002|Overall Study|Lack of Efficacy|1|||
126425647|NCT01855412|454856163|FG000|Overall Study|Death|77|||
126425648|NCT01855412|454856164|FG001|Overall Study|Death|123|||
126425649|NCT01855412|454856165|FG002|Overall Study|Death|30|||
126425650|NCT01855412|454856163|FG000|Overall Study|Lost to Follow-up|28|||
126425651|NCT01855412|454856164|FG001|Overall Study|Lost to Follow-up|46|||
126425652|NCT01855412|454856165|FG002|Overall Study|Lost to Follow-up|15|||
126425653|NCT01855412|454856163|FG000|Overall Study|Withdrawal by Subject|77|||
126425654|NCT01855412|454856164|FG001|Overall Study|Withdrawal by Subject|123|||
126425655|NCT01855412|454856165|FG002|Overall Study|Withdrawal by Subject|24|||
126425656|NCT01855412|454856163|FG000|Overall Study|Physician Decision|25|||
126425657|NCT01855412|454856164|FG001|Overall Study|Physician Decision|31|||
126425658|NCT01855412|454856165|FG002|Overall Study|Physician Decision|3|||
126425659|NCT01855412|454856163|FG000|Overall Study|Site Closure|4|||
126425660|NCT01855412|454856164|FG001|Overall Study|Site Closure|18|||
126425661|NCT01855412|454856165|FG002|Overall Study|Site Closure|1|||
126425662|NCT01855412|454856163|FG000|Overall Study|Reason not Specified|1|||
126425663|NCT01855412|454856164|FG001|Overall Study|Reason not Specified|2|||
126425664|NCT01855412|454856165|FG002|Overall Study|Reason not Specified|3|||
126425665|NCT00764699|454856175|FG000|Overall Study|PI left and study terminated|3|||
126425666|NCT03985761|454856177|FG000|Overall Study|Withdrawal by Subject|2|||
126425667|NCT03985761|454856178|FG001|Overall Study|Withdrawal by Subject|3|||
126425668|NCT01755234|454856179|FG000|Overall Study|Lost to Follow-up|11|||
126425669|NCT01755234|454856180|FG001|Overall Study|Lost to Follow-up|6|||
126425670|NCT01755234|454856179|FG000|Overall Study|Change in surgical case|2|||
126425671|NCT01755234|454856180|FG001|Overall Study|Change in surgical case|1|||
126425672|NCT01755234|454856179|FG000|Overall Study|case cancelled|1|||
126425673|NCT01755234|454856180|FG001|Overall Study|case cancelled|0|||
126425674|NCT01755234|454856179|FG000|Overall Study|Withdrawal by Subject|0|||
126425675|NCT01755234|454856180|FG001|Overall Study|Withdrawal by Subject|1|||
126425676|NCT01755234|454856179|FG000|Overall Study|unblinded|1|||
126425677|NCT01755234|454856180|FG001|Overall Study|unblinded|0|||
126425678|NCT02322281|454856183|FG000|Overall Study|Progressive Disease|42|||
126425679|NCT02322281|454856184|FG001|Overall Study|Progressive Disease|14|||
126425680|NCT02322281|454856185|FG002|Overall Study|Progressive Disease|49|||
126425681|NCT02322281|454856183|FG000|Overall Study|Adverse Event|3|||
126425682|NCT02322281|454856184|FG001|Overall Study|Adverse Event|4|||
126425683|NCT02322281|454856185|FG002|Overall Study|Adverse Event|6|||
126425684|NCT02322281|454856183|FG000|Overall Study|Death|3|||
126425685|NCT02322281|454856184|FG001|Overall Study|Death|3|||
126425686|NCT02322281|454856185|FG002|Overall Study|Death|3|||
126425687|NCT02322281|454856183|FG000|Overall Study|Withdrawal by Subject|1|||
126425688|NCT02322281|454856184|FG001|Overall Study|Withdrawal by Subject|1|||
126425689|NCT02322281|454856185|FG002|Overall Study|Withdrawal by Subject|6|||
126425690|NCT02322281|454856183|FG000|Overall Study|Physician Decision|2|||
126425691|NCT02322281|454856184|FG001|Overall Study|Physician Decision|0|||
126425692|NCT02322281|454856185|FG002|Overall Study|Physician Decision|5|||
126425693|NCT02322281|454856183|FG000|Overall Study|Study Terminated by Sponsor|2|||
126425694|NCT02322281|454856184|FG001|Overall Study|Study Terminated by Sponsor|0|||
126425695|NCT02322281|454856185|FG002|Overall Study|Study Terminated by Sponsor|0|||
126425696|NCT02322281|454856183|FG000|Overall Study|Missing|0|||
126425697|NCT02322281|454856184|FG001|Overall Study|Missing|0|||
126425698|NCT02322281|454856185|FG002|Overall Study|Missing|1|||
126425699|NCT02322281|454856183|FG000|Overall Study|Miscellaneous|0|||
126425700|NCT02322281|454856184|FG001|Overall Study|Miscellaneous|0|||
126425701|NCT02322281|454856185|FG002|Overall Study|Miscellaneous|4|||
126425702|NCT04537793|454856187|FG000|Part B (24 Weeks)|Adverse Event|0|||
126425703|NCT04537793|454856188|FG001|Part B (24 Weeks)|Adverse Event|1|||
126425704|NCT01858363|454856190|FG000|Overall Study|Death|35|||
126425705|NCT01858363|454856191|FG001|Overall Study|Death|9|||
126425706|NCT01858363|454856190|FG000|Overall Study|Withdrawal by Subject|28|||
126425707|NCT01858363|454856191|FG001|Overall Study|Withdrawal by Subject|14|||
126425708|NCT01858363|454856190|FG000|Overall Study|Lost to Follow-up|13|||
126425709|NCT01858363|454856191|FG001|Overall Study|Lost to Follow-up|3|||
126425710|NCT00101686|454856196|FG000|Overall Study|Progressive Disease|37|||
126425711|NCT00101686|454856197|FG001|Overall Study|Progressive Disease|28|||
126425712|NCT00101686|454856198|FG002|Overall Study|Progressive Disease|37|||
126425713|NCT00101686|454856199|FG003|Overall Study|Progressive Disease|38|||
126425714|NCT00101686|454856200|FG004|Overall Study|Progressive Disease|28|||
126425715|NCT00101686|454856201|FG005|Overall Study|Progressive Disease|25|||
126425716|NCT00101686|454856202|FG006|Overall Study|Progressive Disease|5|||
126425717|NCT00101686|454856203|FG007|Overall Study|Progressive Disease|7|||
126425718|NCT00101686|454856204|FG008|Overall Study|Progressive Disease|10|||
126425719|NCT00101686|454856205|FG009|Overall Study|Progressive Disease|8|||
126425720|NCT00101686|454856196|FG000|Overall Study|initiation other anti-cancer treatment|4|||
126425721|NCT00101686|454856197|FG001|Overall Study|initiation other anti-cancer treatment|3|||
126425722|NCT00101686|454856198|FG002|Overall Study|initiation other anti-cancer treatment|4|||
126425723|NCT00101686|454856199|FG003|Overall Study|initiation other anti-cancer treatment|3|||
126425724|NCT00101686|454856200|FG004|Overall Study|initiation other anti-cancer treatment|1|||
126425725|NCT00101686|454856201|FG005|Overall Study|initiation other anti-cancer treatment|1|||
126425726|NCT00101686|454856202|FG006|Overall Study|initiation other anti-cancer treatment|2|||
126425727|NCT00101686|454856203|FG007|Overall Study|initiation other anti-cancer treatment|2|||
126425728|NCT00101686|454856204|FG008|Overall Study|initiation other anti-cancer treatment|3|||
126425729|NCT00101686|454856205|FG009|Overall Study|initiation other anti-cancer treatment|3|||
126425730|NCT00101686|454856196|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
126425731|NCT00101686|454856197|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
126425732|NCT00101686|454856198|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
126425733|NCT00101686|454856199|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
126425734|NCT00101686|454856200|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
126425735|NCT00101686|454856201|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
126425736|NCT00101686|454856202|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
126425737|NCT00101686|454856203|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
126425738|NCT00101686|454856204|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
126425739|NCT00101686|454856205|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
126425740|NCT00101686|454856196|FG000|Overall Study|unacceptable toxicity|3|||
126425741|NCT00101686|454856197|FG001|Overall Study|unacceptable toxicity|9|||
126425742|NCT00101686|454856198|FG002|Overall Study|unacceptable toxicity|10|||
126425743|NCT00101686|454856199|FG003|Overall Study|unacceptable toxicity|6|||
126425744|NCT00101686|454856200|FG004|Overall Study|unacceptable toxicity|16|||
126425745|NCT00101686|454856201|FG005|Overall Study|unacceptable toxicity|10|||
126425746|NCT00101686|454856202|FG006|Overall Study|unacceptable toxicity|4|||
126425747|NCT00101686|454856203|FG007|Overall Study|unacceptable toxicity|2|||
126425748|NCT00101686|454856204|FG008|Overall Study|unacceptable toxicity|1|||
126425749|NCT00101686|454856205|FG009|Overall Study|unacceptable toxicity|4|||
126425750|NCT00101686|454856196|FG000|Overall Study|Randomized but did not receive treament|1|||
126425751|NCT00101686|454856197|FG001|Overall Study|Randomized but did not receive treament|6|||
126425752|NCT00101686|454856198|FG002|Overall Study|Randomized but did not receive treament|2|||
126425753|NCT00101686|454856199|FG003|Overall Study|Randomized but did not receive treament|2|||
126425754|NCT00101686|454856200|FG004|Overall Study|Randomized but did not receive treament|2|||
126425755|NCT00101686|454856201|FG005|Overall Study|Randomized but did not receive treament|2|||
126425756|NCT00101686|454856202|FG006|Overall Study|Randomized but did not receive treament|0|||
126425757|NCT00101686|454856203|FG007|Overall Study|Randomized but did not receive treament|1|||
126425758|NCT00101686|454856204|FG008|Overall Study|Randomized but did not receive treament|0|||
126425759|NCT00101686|454856205|FG009|Overall Study|Randomized but did not receive treament|1|||
126425760|NCT00101686|454856196|FG000|Overall Study|intercurrent non-cancer related illness|0|||
126425761|NCT00101686|454856197|FG001|Overall Study|intercurrent non-cancer related illness|0|||
126425762|NCT00101686|454856198|FG002|Overall Study|intercurrent non-cancer related illness|2|||
126425763|NCT00101686|454856199|FG003|Overall Study|intercurrent non-cancer related illness|0|||
126425764|NCT00101686|454856200|FG004|Overall Study|intercurrent non-cancer related illness|1|||
126425765|NCT00101686|454856201|FG005|Overall Study|intercurrent non-cancer related illness|3|||
126425766|NCT00101686|454856202|FG006|Overall Study|intercurrent non-cancer related illness|1|||
126674100|NCT00262522|455764516|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
126674101|NCT00262522|455764517|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
126674102|NCT00262522|455764518|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
126674103|NCT00262522|455764519|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
126674104|NCT00262522|455764516|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
126674105|NCT00262522|455764517|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
126674106|NCT00262522|455764518|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
126674107|NCT00262522|455764519|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
126674108|NCT00262522|455764516|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
126674109|NCT00262522|455764517|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
126674110|NCT00262522|455764518|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
126674111|NCT00262522|455764519|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
126425767|NCT00101686|454856203|FG007|Overall Study|intercurrent non-cancer related illness|0|||
126674112|NCT00262522|455764516|FG000|Study Start Through 48 Weeks|Death|2|||
126425768|NCT00101686|454856204|FG008|Overall Study|intercurrent non-cancer related illness|1|||
126425769|NCT00101686|454856205|FG009|Overall Study|intercurrent non-cancer related illness|1|||
126425770|NCT00101686|454856196|FG000|Overall Study|Physician Decision|10|||
126674113|NCT00262522|455764517|FG001|Study Start Through 48 Weeks|Death|0|||
126674114|NCT00262522|455764518|FG002|Study Start Through 48 Weeks|Death|1|||
126674115|NCT00262522|455764519|FG003|Study Start Through 48 Weeks|Death|0|||
126674116|NCT00262522|455764516|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
126674117|NCT00262522|455764517|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
126674118|NCT00262522|455764518|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
126674119|NCT00262522|455764519|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
126674120|NCT00262522|455764516|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
126674121|NCT00262522|455764517|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
126674122|NCT00262522|455764518|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
126340710|NCT00903968|454544381|FG003|Overall Study|Adverse Event|0|||
126340711|NCT00903968|454544382|FG004|Overall Study|Adverse Event|0|||
126340712|NCT00903968|454544383|FG005|Overall Study|Adverse Event|0|||
126340713|NCT00903968|454544384|FG006|Overall Study|Adverse Event|1|||
126340714|NCT00903968|454544385|FG007|Overall Study|Adverse Event|8|||
126340715|NCT00903968|454544378|FG000|Overall Study|DLT|0|||
126340716|NCT00903968|454544379|FG001|Overall Study|DLT|0|||
126340717|NCT00903968|454544380|FG002|Overall Study|DLT|0|||
126340718|NCT00903968|454544381|FG003|Overall Study|DLT|0|||
126340719|NCT00903968|454544382|FG004|Overall Study|DLT|0|||
126340720|NCT00903968|454544383|FG005|Overall Study|DLT|0|||
126340721|NCT00903968|454544384|FG006|Overall Study|DLT|2|||
126340722|NCT00903968|454544385|FG007|Overall Study|DLT|0|||
126340723|NCT00903968|454544378|FG000|Overall Study|Withdrawal by Subject|1|||
126340724|NCT00903968|454544379|FG001|Overall Study|Withdrawal by Subject|0|||
126340725|NCT00903968|454544380|FG002|Overall Study|Withdrawal by Subject|1|||
126340726|NCT00903968|454544381|FG003|Overall Study|Withdrawal by Subject|0|||
126340727|NCT00903968|454544382|FG004|Overall Study|Withdrawal by Subject|1|||
126340728|NCT00903968|454544383|FG005|Overall Study|Withdrawal by Subject|1|||
126340729|NCT00903968|454544384|FG006|Overall Study|Withdrawal by Subject|0|||
126340730|NCT00903968|454544385|FG007|Overall Study|Withdrawal by Subject|4|||
126340731|NCT00903968|454544378|FG000|Overall Study|Non-Compliance|0|||
126340732|NCT00903968|454544379|FG001|Overall Study|Non-Compliance|0|||
126340733|NCT00903968|454544380|FG002|Overall Study|Non-Compliance|0|||
126340734|NCT00903968|454544381|FG003|Overall Study|Non-Compliance|0|||
126340735|NCT00903968|454544382|FG004|Overall Study|Non-Compliance|0|||
126340736|NCT00903968|454544383|FG005|Overall Study|Non-Compliance|1|||
126340737|NCT00903968|454544384|FG006|Overall Study|Non-Compliance|0|||
126340738|NCT00903968|454544385|FG007|Overall Study|Non-Compliance|0|||
126340739|NCT00903968|454544378|FG000|Overall Study|Physician Decision|0|||
126340740|NCT00903968|454544379|FG001|Overall Study|Physician Decision|0|||
126340741|NCT00903968|454544380|FG002|Overall Study|Physician Decision|0|||
126340742|NCT00903968|454544381|FG003|Overall Study|Physician Decision|0|||
126340743|NCT00903968|454544382|FG004|Overall Study|Physician Decision|0|||
126340744|NCT00903968|454544383|FG005|Overall Study|Physician Decision|1|||
126340745|NCT00903968|454544384|FG006|Overall Study|Physician Decision|0|||
126340746|NCT00903968|454544385|FG007|Overall Study|Physician Decision|0|||
126340747|NCT00903968|454544378|FG000|Overall Study|Progressive Disease|2|||
126340748|NCT00903968|454544379|FG001|Overall Study|Progressive Disease|3|||
126340749|NCT00903968|454544380|FG002|Overall Study|Progressive Disease|2|||
126340750|NCT00903968|454544381|FG003|Overall Study|Progressive Disease|3|||
126340751|NCT00903968|454544382|FG004|Overall Study|Progressive Disease|3|||
126340752|NCT00903968|454544383|FG005|Overall Study|Progressive Disease|3|||
126340753|NCT00903968|454544384|FG006|Overall Study|Progressive Disease|0|||
126340754|NCT00903968|454544385|FG007|Overall Study|Progressive Disease|18|||
126340755|NCT00903968|454544378|FG000|Overall Study|Lack of Efficacy|0|||
126340756|NCT00903968|454544379|FG001|Overall Study|Lack of Efficacy|0|||
126340757|NCT00903968|454544380|FG002|Overall Study|Lack of Efficacy|0|||
126340758|NCT00903968|454544381|FG003|Overall Study|Lack of Efficacy|0|||
126340759|NCT00903968|454544382|FG004|Overall Study|Lack of Efficacy|0|||
126340760|NCT00903968|454544383|FG005|Overall Study|Lack of Efficacy|0|||
126340761|NCT00903968|454544384|FG006|Overall Study|Lack of Efficacy|0|||
126340762|NCT00903968|454544385|FG007|Overall Study|Lack of Efficacy|3|||
126340763|NCT00095979|454544386|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
126340764|NCT01663623|454544387|FG000|Overall Study|Adverse Event|3|||
126340765|NCT01663623|454544388|FG001|Overall Study|Adverse Event|7|||
126340766|NCT01663623|454544387|FG000|Overall Study|Lack of Efficacy|5|||
126340767|NCT01663623|454544388|FG001|Overall Study|Lack of Efficacy|6|||
126340768|NCT01663623|454544387|FG000|Overall Study|Protocol Violation|0|||
126340769|NCT01663623|454544388|FG001|Overall Study|Protocol Violation|1|||
126340770|NCT01663623|454544387|FG000|Overall Study|Other-Study closed/terminated|1|||
126340771|NCT01663623|454544388|FG001|Overall Study|Other-Study closed/terminated|1|||
126340772|NCT01663623|454544387|FG000|Overall Study|Physician Decision|1|||
126340773|NCT01663623|454544388|FG001|Overall Study|Physician Decision|4|||
126340774|NCT01663623|454544387|FG000|Overall Study|Withdrawal by Subject|2|||
126340775|NCT01663623|454544388|FG001|Overall Study|Withdrawal by Subject|1|||
126340776|NCT02251275|454544389|FG000|Overall Study|Adverse Event|23|||
126340777|NCT02251275|454544390|FG001|Overall Study|Adverse Event|60|||
126340778|NCT02251275|454544391|FG002|Overall Study|Adverse Event|28|||
126425771|NCT00101686|454856197|FG001|Overall Study|Physician Decision|13|||
126425772|NCT00101686|454856198|FG002|Overall Study|Physician Decision|6|||
126425773|NCT00101686|454856199|FG003|Overall Study|Physician Decision|7|||
126425774|NCT00101686|454856200|FG004|Overall Study|Physician Decision|8|||
126425775|NCT00101686|454856201|FG005|Overall Study|Physician Decision|9|||
126425776|NCT00101686|454856202|FG006|Overall Study|Physician Decision|5|||
126425777|NCT00101686|454856203|FG007|Overall Study|Physician Decision|5|||
126425778|NCT00101686|454856204|FG008|Overall Study|Physician Decision|1|||
126425779|NCT00101686|454856205|FG009|Overall Study|Physician Decision|1|||
126425780|NCT00101686|454856196|FG000|Overall Study|Other|1|||
126425781|NCT00101686|454856197|FG001|Overall Study|Other|4|||
126425782|NCT00101686|454856198|FG002|Overall Study|Other|1|||
126425783|NCT00101686|454856199|FG003|Overall Study|Other|6|||
126425784|NCT00101686|454856200|FG004|Overall Study|Other|2|||
126425785|NCT00101686|454856201|FG005|Overall Study|Other|12|||
126425786|NCT00101686|454856202|FG006|Overall Study|Other|1|||
126425787|NCT00101686|454856203|FG007|Overall Study|Other|5|||
126425788|NCT00101686|454856204|FG008|Overall Study|Other|3|||
126674123|NCT00262522|455764519|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
126674124|NCT00262522|455764516|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
126674125|NCT00262522|455764517|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
126674126|NCT00262522|455764518|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
126674127|NCT00262522|455764519|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
126674128|NCT00262522|455764516|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
126674129|NCT00262522|455764517|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
126674130|NCT00262522|455764518|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
126674131|NCT00262522|455764519|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
126674132|NCT00262522|455764516|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
126674133|NCT00262522|455764517|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
126674134|NCT00262522|455764518|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
126674135|NCT00262522|455764519|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
126674136|NCT00262522|455764516|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
126674137|NCT00262522|455764517|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
126425789|NCT00101686|454856205|FG009|Overall Study|Other|3|||
126425790|NCT00101686|454856196|FG000|Overall Study|Withdrawal by Subject|9|||
126425791|NCT00101686|454856197|FG001|Overall Study|Withdrawal by Subject|8|||
126425792|NCT00101686|454856198|FG002|Overall Study|Withdrawal by Subject|6|||
126425793|NCT00101686|454856199|FG003|Overall Study|Withdrawal by Subject|8|||
126425794|NCT00101686|454856200|FG004|Overall Study|Withdrawal by Subject|8|||
126425795|NCT00101686|454856201|FG005|Overall Study|Withdrawal by Subject|7|||
126425796|NCT00101686|454856202|FG006|Overall Study|Withdrawal by Subject|7|||
126425797|NCT00101686|454856203|FG007|Overall Study|Withdrawal by Subject|7|||
126425798|NCT00101686|454856204|FG008|Overall Study|Withdrawal by Subject|8|||
126425799|NCT00101686|454856205|FG009|Overall Study|Withdrawal by Subject|9|||
126425800|NCT00687401|454856206|FG000|Overall Study|Protocol Violation|7|||
126425801|NCT00687401|454856206|FG000|Overall Study|Adverse Event|6|||
126425802|NCT00687401|454856206|FG000|Overall Study|Lack of Efficacy|6|||
126425803|NCT00687401|454856206|FG000|Overall Study|Withdrawal by Subject|4|||
126425804|NCT00687401|454856206|FG000|Overall Study|Did not return for visit|3|||
126674138|NCT00262522|455764518|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
126674139|NCT00262522|455764519|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
126674140|NCT00262522|455764516|FG000|Study Start Through 96 Weeks|Death|2|||
126674141|NCT00262522|455764517|FG001|Study Start Through 96 Weeks|Death|0|||
126674142|NCT00262522|455764518|FG002|Study Start Through 96 Weeks|Death|2|||
126674143|NCT00262522|455764519|FG003|Study Start Through 96 Weeks|Death|0|||
126674144|NCT00262522|455764516|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
126674145|NCT00262522|455764517|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
126425805|NCT00687401|454856206|FG000|Overall Study|For reasons different from those above|4|||
126425806|NCT02920892|454856207|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
126674146|NCT00262522|455764518|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
126674147|NCT00262522|455764519|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
126674148|NCT00262522|455764516|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
126674149|NCT00262522|455764517|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
126674150|NCT00262522|455764518|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
126425807|NCT02920892|454856208|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
126425808|NCT02920892|454856209|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
126674151|NCT00262522|455764519|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
126674152|NCT03740165|455764520|FG000|Overall Study|Death|232|||
126425809|NCT02920892|454856207|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
126425810|NCT02920892|454856208|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
126425811|NCT02920892|454856209|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
126425812|NCT02920892|454856207|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
126425813|NCT02920892|454856208|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
126425814|NCT02920892|454856209|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
126674153|NCT03740165|455764521|FG001|Overall Study|Death|242|||
126674154|NCT03740165|455764522|FG002|Overall Study|Death|229|||
126674155|NCT03740165|455764520|FG000|Overall Study|Lost to Follow-up|0|||
126674156|NCT03740165|455764521|FG001|Overall Study|Lost to Follow-up|0|||
126674157|NCT03740165|455764522|FG002|Overall Study|Lost to Follow-up|1|||
126674158|NCT03740165|455764520|FG000|Overall Study|Withdrawal by Subject|7|||
126674159|NCT03740165|455764521|FG001|Overall Study|Withdrawal by Subject|4|||
126674160|NCT03740165|455764522|FG002|Overall Study|Withdrawal by Subject|3|||
126674161|NCT03740165|455764520|FG000|Overall Study|Ongoing in Study|216|||
126674162|NCT03740165|455764521|FG001|Overall Study|Ongoing in Study|212|||
126674163|NCT03740165|455764522|FG002|Overall Study|Ongoing in Study|221|||
126674164|NCT02044133|455764523|FG000|Overall Study|Lost to Follow-up|1|||
126674165|NCT02044133|455764524|FG001|Overall Study|Lost to Follow-up|1|||
126674166|NCT02044133|455764523|FG000|Overall Study|Death|1|||
126674167|NCT02044133|455764524|FG001|Overall Study|Death|0|||
126674168|NCT02044133|455764523|FG000|Overall Study|Release|3|||
126674169|NCT02044133|455764524|FG001|Overall Study|Release|4|||
126674170|NCT02044133|455764523|FG000|Overall Study|Transfer|1|||
126674171|NCT02044133|455764524|FG001|Overall Study|Transfer|0|||
126674172|NCT02044133|455764523|FG000|Overall Study|refusal of blood sampling|0|||
126674173|NCT02044133|455764524|FG001|Overall Study|refusal of blood sampling|1|||
126674174|NCT05318937|455764525|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126674175|NCT05318937|455764526|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126674176|NCT05318937|455764525|FG000|Overall Study|Lost to Follow-up|0|||
126425815|NCT02920892|454856207|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
126425816|NCT02920892|454856208|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
126425817|NCT02920892|454856209|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
126425818|NCT02920892|454856207|FG000|Placebo-Controlled Period|Physician Decision|0|||
126425819|NCT02920892|454856208|FG001|Placebo-Controlled Period|Physician Decision|0|||
126674177|NCT05318937|455764526|FG001|Overall Study|Lost to Follow-up|1|||
126674178|NCT05318937|455764525|FG000|Overall Study|Withdrawal by Subject|0|||
126674179|NCT05318937|455764526|FG001|Overall Study|Withdrawal by Subject|2|||
126425820|NCT02920892|454856209|FG002|Placebo-Controlled Period|Physician Decision|1|||
126425821|NCT02920892|454856207|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
126425822|NCT02920892|454856208|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
126425823|NCT02920892|454856209|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
126425824|NCT02920892|454856207|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126425825|NCT02920892|454856208|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
126425826|NCT02920892|454856209|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
126425827|NCT02920892|454856207|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
126425828|NCT02920892|454856208|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
126425829|NCT02920892|454856209|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
126425830|NCT04486235|454856210|FG000|Overall Study|Pregnancy|1|||
126425831|NCT04486235|454856211|FG001|Overall Study|Pregnancy|0|||
126425832|NCT04486235|454856210|FG000|Overall Study|Lost to Follow-up|1|||
126425833|NCT04486235|454856211|FG001|Overall Study|Lost to Follow-up|0|||
126425834|NCT03935126|454856212|FG000|Overall Study|Study termination by sponsor|3|||
126425835|NCT03649217|454856213|FG000|Overall Study|subject had severe ataxia not initially found|1|||
126425836|NCT03649217|454856213|FG000|Overall Study|subject had cognitive issues not initially found|1|||
126425837|NCT01092728|454856214|FG000|Overall Study|Withdrawal by Subject|2|||
126425838|NCT01092728|454856215|FG001|Overall Study|Withdrawal by Subject|0|||
126425839|NCT01092728|454856214|FG000|Overall Study|Adverse Event|0|||
126425840|NCT01092728|454856215|FG001|Overall Study|Adverse Event|1|||
126425841|NCT01092728|454856214|FG000|Overall Study|Disease Progression|1|||
126425842|NCT01092728|454856215|FG001|Overall Study|Disease Progression|13|||
126425843|NCT01092728|454856214|FG000|Overall Study|Prohibited Concomitant Medications|1|||
126425844|NCT01092728|454856215|FG001|Overall Study|Prohibited Concomitant Medications|0|||
126425845|NCT02520726|454856216|FG000|Overall Study|Lost to Follow-up|3|||
126425846|NCT02520726|454856217|FG001|Overall Study|Lost to Follow-up|2|||
126674180|NCT05318937|455764525|FG000|Overall Study|Protocol Violation|0|||
126674181|NCT05318937|455764526|FG001|Overall Study|Protocol Violation|1|||
126674182|NCT05678257|455764532|FG000|Overall Study|Withdrawal by Subject|2|||
126674183|NCT05678257|455764533|FG001|Overall Study|Withdrawal by Subject|0|||
126674184|NCT05678257|455764534|FG002|Overall Study|Withdrawal by Subject|5|||
126674185|NCT05678257|455764532|FG000|Overall Study|Physician Decision|1|||
126425847|NCT00721396|454856218|FG000|Overall Study|Adverse Event|4|||
126425848|NCT00721396|454856219|FG001|Overall Study|Adverse Event|7|||
126425849|NCT00721396|454856220|FG002|Overall Study|Adverse Event|2|||
126425850|NCT00721396|454856221|FG003|Overall Study|Adverse Event|0|||
126425851|NCT00721396|454856218|FG000|Overall Study|Withdrawal by Subject|12|||
126425852|NCT00721396|454856219|FG001|Overall Study|Withdrawal by Subject|15|||
126674186|NCT05678257|455764533|FG001|Overall Study|Physician Decision|0|||
126674187|NCT05678257|455764534|FG002|Overall Study|Physician Decision|1|||
126674188|NCT05678257|455764532|FG000|Overall Study|Adverse Event|1|||
126674189|NCT05678257|455764533|FG001|Overall Study|Adverse Event|3|||
126674190|NCT05678257|455764534|FG002|Overall Study|Adverse Event|1|||
126674191|NCT05678257|455764532|FG000|Overall Study|Progressive disease|11|||
126674192|NCT05678257|455764533|FG001|Overall Study|Progressive disease|18|||
126674193|NCT05678257|455764534|FG002|Overall Study|Progressive disease|7|||
126674194|NCT05678257|455764532|FG000|Overall Study|No longer clinically benefitting|2|||
126674195|NCT05678257|455764533|FG001|Overall Study|No longer clinically benefitting|1|||
126674196|NCT05678257|455764534|FG002|Overall Study|No longer clinically benefitting|0|||
126674197|NCT05678257|455764532|FG000|Overall Study|Sponsor decision|5|||
126674198|NCT05678257|455764533|FG001|Overall Study|Sponsor decision|9|||
126674199|NCT05678257|455764534|FG002|Overall Study|Sponsor decision|8|||
126425853|NCT00721396|454856220|FG002|Overall Study|Withdrawal by Subject|3|||
126425854|NCT00721396|454856221|FG003|Overall Study|Withdrawal by Subject|7|||
126425855|NCT00721396|454856218|FG000|Overall Study|Lost to Follow-up|7|||
126425856|NCT00721396|454856219|FG001|Overall Study|Lost to Follow-up|9|||
126425857|NCT00721396|454856220|FG002|Overall Study|Lost to Follow-up|3|||
126425858|NCT00721396|454856221|FG003|Overall Study|Lost to Follow-up|3|||
126425859|NCT00721396|454856218|FG000|Overall Study|Protocol Violation|4|||
126425860|NCT00721396|454856219|FG001|Overall Study|Protocol Violation|3|||
126425861|NCT00721396|454856220|FG002|Overall Study|Protocol Violation|1|||
126425862|NCT00721396|454856221|FG003|Overall Study|Protocol Violation|0|||
126425863|NCT00721396|454856218|FG000|Overall Study|Inappropriate enrollment|0|||
126425864|NCT00721396|454856219|FG001|Overall Study|Inappropriate enrollment|2|||
126425865|NCT00721396|454856220|FG002|Overall Study|Inappropriate enrollment|0|||
126425866|NCT00721396|454856221|FG003|Overall Study|Inappropriate enrollment|0|||
126425867|NCT00721396|454856218|FG000|Overall Study|Administrative reason|3|||
126425868|NCT00721396|454856219|FG001|Overall Study|Administrative reason|0|||
126425869|NCT00721396|454856220|FG002|Overall Study|Administrative reason|1|||
126425870|NCT00721396|454856221|FG003|Overall Study|Administrative reason|0|||
126425871|NCT02021565|454856228|FG000|Baseline Through Intervention|Death|0|||
126425872|NCT02021565|454856229|FG001|Baseline Through Intervention|Death|1|||
126425873|NCT02021565|454856228|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
126425874|NCT02021565|454856229|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
126425875|NCT02021565|454856228|FG000|Baseline Through Intervention|Protocol Violation|0|||
126425876|NCT02021565|454856229|FG001|Baseline Through Intervention|Protocol Violation|7|||
126425877|NCT02021565|454856228|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
126425878|NCT02021565|454856229|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
126425879|NCT02021565|454856228|FG000|3-month Follow-up|Death|3|||
126425880|NCT02021565|454856229|FG001|3-month Follow-up|Death|0|||
126425881|NCT02021565|454856228|FG000|3-month Follow-up|Withdrawal by Subject|4|||
126425882|NCT02021565|454856229|FG001|3-month Follow-up|Withdrawal by Subject|0|||
126425883|NCT02021565|454856228|FG000|3-month Follow-up|Protocol Violation|3|||
126425884|NCT02021565|454856229|FG001|3-month Follow-up|Protocol Violation|2|||
126425885|NCT03318549|454856230|FG000|Overall Study|Withdrawal by Subject|5|||
126425886|NCT03318549|454856231|FG001|Overall Study|Withdrawal by Subject|19|||
126425887|NCT03318549|454856232|FG002|Overall Study|Withdrawal by Subject|2|||
126425888|NCT03318549|454856233|FG003|Overall Study|Withdrawal by Subject|0|||
126425889|NCT03318549|454856234|FG004|Overall Study|Withdrawal by Subject|0|||
126425890|NCT03318549|454856235|FG005|Overall Study|Withdrawal by Subject|0|||
126425891|NCT03318549|454856236|FG006|Overall Study|Withdrawal by Subject|0|||
126425892|NCT03318549|454856230|FG000|Overall Study|Physician Decision|0|||
126425893|NCT03318549|454856231|FG001|Overall Study|Physician Decision|4|||
126425894|NCT03318549|454856232|FG002|Overall Study|Physician Decision|1|||
126425895|NCT03318549|454856233|FG003|Overall Study|Physician Decision|0|||
126425896|NCT03318549|454856234|FG004|Overall Study|Physician Decision|0|||
126425897|NCT03318549|454856235|FG005|Overall Study|Physician Decision|0|||
126425898|NCT03318549|454856236|FG006|Overall Study|Physician Decision|0|||
126425899|NCT03318549|454856230|FG000|Overall Study|Lost to Follow-up|0|||
126425900|NCT03318549|454856231|FG001|Overall Study|Lost to Follow-up|3|||
126425901|NCT03318549|454856232|FG002|Overall Study|Lost to Follow-up|3|||
126425902|NCT03318549|454856233|FG003|Overall Study|Lost to Follow-up|0|||
126425903|NCT03318549|454856234|FG004|Overall Study|Lost to Follow-up|0|||
126425904|NCT03318549|454856235|FG005|Overall Study|Lost to Follow-up|0|||
126425905|NCT03318549|454856236|FG006|Overall Study|Lost to Follow-up|0|||
126425906|NCT00510835|454856239|FG000|Overall Study|Withdrawal by Subject|6|||
126425907|NCT00510835|454856240|FG001|Overall Study|Withdrawal by Subject|2|||
126674200|NCT05678257|455764532|FG000|Overall Study|Protocol Violation|0|||
126674201|NCT05678257|455764533|FG001|Overall Study|Protocol Violation|0|||
126674202|NCT05678257|455764534|FG002|Overall Study|Protocol Violation|1|||
126674203|NCT05678257|455764532|FG000|Overall Study|Patient non-compliance|0|||
126425908|NCT00510835|454856241|FG002|Overall Study|Withdrawal by Subject|2|||
126425909|NCT00607087|454856245|FG000|Overall Study|Withdrawal by Subject|9|||
126425910|NCT00607087|454856246|FG001|Overall Study|Withdrawal by Subject|4|||
126425911|NCT00607087|454856247|FG002|Overall Study|Withdrawal by Subject|4|||
126425912|NCT00607087|454856245|FG000|Overall Study|Adverse Event|3|||
126425913|NCT00607087|454856246|FG001|Overall Study|Adverse Event|2|||
126425914|NCT00607087|454856247|FG002|Overall Study|Adverse Event|3|||
126425915|NCT00607087|454856245|FG000|Overall Study|Other reason|1|||
126674204|NCT05678257|455764533|FG001|Overall Study|Patient non-compliance|0|||
126674205|NCT05678257|455764534|FG002|Overall Study|Patient non-compliance|3|||
126425916|NCT00607087|454856246|FG001|Overall Study|Other reason|5|||
126425917|NCT00607087|454856247|FG002|Overall Study|Other reason|2|||
126674206|NCT05314517|455764535|FG000|Double-blind Period|Adverse Event|4|||
126674207|NCT05314517|455764536|FG001|Double-blind Period|Adverse Event|0|||
126674208|NCT05314517|455764537|FG002|Double-blind Period|Adverse Event|0|||
126674209|NCT05314517|455764538|FG003|Double-blind Period|Adverse Event|0|||
126425918|NCT00607087|454856245|FG000|Overall Study|Poor compliance to protocol|1|||
126425919|NCT00607087|454856246|FG001|Overall Study|Poor compliance to protocol|0|||
126425920|NCT00607087|454856247|FG002|Overall Study|Poor compliance to protocol|1|||
126674210|NCT05314517|455764535|FG000|Double-blind Period|Noncompliance|0|||
126674211|NCT05314517|455764536|FG001|Double-blind Period|Noncompliance|1|||
126674212|NCT05314517|455764537|FG002|Double-blind Period|Noncompliance|0|||
126674213|NCT05314517|455764538|FG003|Double-blind Period|Noncompliance|0|||
126674214|NCT05314517|455764535|FG000|Double-blind Period|Randomized, not treated|1|||
126674215|NCT05314517|455764536|FG001|Double-blind Period|Randomized, not treated|0|||
126674216|NCT05314517|455764537|FG002|Double-blind Period|Randomized, not treated|0|||
126674217|NCT05314517|455764538|FG003|Double-blind Period|Randomized, not treated|0|||
126674218|NCT05314517|455764535|FG000|Open-label Extension|Adverse Event|0|||
126674219|NCT05314517|455764536|FG001|Open-label Extension|Adverse Event|0|||
126674220|NCT05314517|455764537|FG002|Open-label Extension|Adverse Event|1|||
126674221|NCT05314517|455764538|FG003|Open-label Extension|Adverse Event|2|||
126674222|NCT05314517|455764535|FG000|Open-label Extension|Investigator decision|0|||
126425921|NCT00607087|454856245|FG000|Overall Study|Lost to Follow-up|1|||
126425922|NCT00607087|454856246|FG001|Overall Study|Lost to Follow-up|0|||
126425923|NCT00607087|454856247|FG002|Overall Study|Lost to Follow-up|0|||
126425924|NCT00607087|454856245|FG000|Period 1|Withdrawal by Subject|7|||
126425925|NCT00607087|454856246|FG001|Period 1|Withdrawal by Subject|2|||
126425926|NCT00607087|454856247|FG002|Period 1|Withdrawal by Subject|3|||
126425927|NCT00607087|454856245|FG000|Period 1|Adverse Event|3|||
126425928|NCT00607087|454856246|FG001|Period 1|Adverse Event|0|||
126425929|NCT00607087|454856247|FG002|Period 1|Adverse Event|0|||
126425930|NCT00607087|454856245|FG000|Period 1|Poor compliance to protocol|1|||
126425931|NCT00607087|454856246|FG001|Period 1|Poor compliance to protocol|0|||
126425932|NCT00607087|454856247|FG002|Period 1|Poor compliance to protocol|0|||
126425933|NCT00607087|454856245|FG000|Period 1|Lost to Follow-up|1|||
126425934|NCT00607087|454856246|FG001|Period 1|Lost to Follow-up|0|||
126425935|NCT00607087|454856247|FG002|Period 1|Lost to Follow-up|0|||
126425936|NCT00607087|454856245|FG000|Period 1|Other reason|0|||
126425937|NCT00607087|454856246|FG001|Period 1|Other reason|4|||
126425938|NCT00607087|454856247|FG002|Period 1|Other reason|2|||
126425939|NCT00607087|454856245|FG000|Period 2|Withdrawal by Subject|0|||
126425940|NCT00607087|454856246|FG001|Period 2|Withdrawal by Subject|1|||
126425941|NCT00607087|454856247|FG002|Period 2|Withdrawal by Subject|1|||
126425942|NCT00607087|454856245|FG000|Period 2|Other reason|1|||
126425943|NCT00607087|454856246|FG001|Period 2|Other reason|1|||
126425944|NCT00607087|454856247|FG002|Period 2|Other reason|0|||
126425945|NCT00607087|454856245|FG000|Period 2|Adverse Event|0|||
126425946|NCT00607087|454856246|FG001|Period 2|Adverse Event|1|||
126425947|NCT00607087|454856247|FG002|Period 2|Adverse Event|3|||
126425948|NCT00607087|454856245|FG000|Period 2|Poor compliance to protocol|0|||
126425949|NCT00607087|454856246|FG001|Period 2|Poor compliance to protocol|0|||
126425950|NCT00607087|454856247|FG002|Period 2|Poor compliance to protocol|1|||
126425951|NCT00607087|454856245|FG000|Period 3|Withdrawal by Subject|2|||
126425952|NCT00607087|454856246|FG001|Period 3|Withdrawal by Subject|1|||
126425953|NCT00607087|454856247|FG002|Period 3|Withdrawal by Subject|0|||
126425954|NCT00607087|454856245|FG000|Period 3|Adverse Event|0|||
126425955|NCT00607087|454856246|FG001|Period 3|Adverse Event|1|||
126425956|NCT00607087|454856247|FG002|Period 3|Adverse Event|0|||
126425957|NCT00650767|454856249|FG000|Overall Study|Adverse Event|0|||
126425958|NCT00650767|454856250|FG001|Overall Study|Adverse Event|3|||
126425959|NCT00650767|454856251|FG002|Overall Study|Adverse Event|10|||
126425960|NCT00650767|454856252|FG003|Overall Study|Adverse Event|8|||
126425961|NCT00650767|454856249|FG000|Overall Study|Death|1|||
126425962|NCT00650767|454856250|FG001|Overall Study|Death|0|||
126425963|NCT00650767|454856251|FG002|Overall Study|Death|0|||
126425964|NCT00650767|454856252|FG003|Overall Study|Death|0|||
126425965|NCT00650767|454856249|FG000|Overall Study|Withdrawal by Subject|2|||
126674223|NCT05314517|455764536|FG001|Open-label Extension|Investigator decision|0|||
126674224|NCT05314517|455764537|FG002|Open-label Extension|Investigator decision|1|||
126674225|NCT05314517|455764538|FG003|Open-label Extension|Investigator decision|0|||
126674226|NCT05314517|455764535|FG000|Open-label Extension|Lost to Follow-up|0|||
126425966|NCT00650767|454856250|FG001|Overall Study|Withdrawal by Subject|4|||
126425967|NCT00650767|454856251|FG002|Overall Study|Withdrawal by Subject|3|||
126425968|NCT00650767|454856252|FG003|Overall Study|Withdrawal by Subject|3|||
126425969|NCT00650767|454856249|FG000|Overall Study|Lost to Follow-up|1|||
126425970|NCT00650767|454856250|FG001|Overall Study|Lost to Follow-up|1|||
126425971|NCT00650767|454856251|FG002|Overall Study|Lost to Follow-up|1|||
126425972|NCT00650767|454856252|FG003|Overall Study|Lost to Follow-up|0|||
126425973|NCT00650767|454856249|FG000|Overall Study|Other|1|||
126425974|NCT00650767|454856250|FG001|Overall Study|Other|1|||
126674227|NCT05314517|455764536|FG001|Open-label Extension|Lost to Follow-up|0|||
126674228|NCT05314517|455764537|FG002|Open-label Extension|Lost to Follow-up|0|||
126674229|NCT05314517|455764538|FG003|Open-label Extension|Lost to Follow-up|1|||
126674230|NCT05314517|455764535|FG000|Open-label Extension|Withdrawal by Subject|0|||
126674231|NCT05314517|455764536|FG001|Open-label Extension|Withdrawal by Subject|0|||
126674232|NCT05314517|455764537|FG002|Open-label Extension|Withdrawal by Subject|1|||
126674233|NCT05314517|455764538|FG003|Open-label Extension|Withdrawal by Subject|2|||
126674234|NCT05314517|455764535|FG000|Open-label Extension|Use of prohibited medication|0|||
126674235|NCT05314517|455764536|FG001|Open-label Extension|Use of prohibited medication|0|||
126674236|NCT05314517|455764537|FG002|Open-label Extension|Use of prohibited medication|1|||
126674237|NCT05314517|455764538|FG003|Open-label Extension|Use of prohibited medication|0|||
126674238|NCT05314517|455764535|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
126674239|NCT05314517|455764536|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
126674240|NCT05314517|455764537|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
126674241|NCT05314517|455764538|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
126674242|NCT04969276|455764539|FG000|Overall Study|Protocol Deviation|0|||
126674243|NCT04969276|455764540|FG001|Overall Study|Protocol Deviation|1|||
126674244|NCT04969276|455764541|FG002|Overall Study|Protocol Deviation|0|||
126674245|NCT04969276|455764539|FG000|Overall Study|Withdrawal by Subject|1|||
126674246|NCT04969276|455764540|FG001|Overall Study|Withdrawal by Subject|10|||
126674247|NCT04969276|455764541|FG002|Overall Study|Withdrawal by Subject|0|||
126674248|NCT04969276|455764539|FG000|Overall Study|Lost to Follow-up|0|||
126674249|NCT04969276|455764540|FG001|Overall Study|Lost to Follow-up|1|||
126674250|NCT04969276|455764541|FG002|Overall Study|Lost to Follow-up|0|||
126674251|NCT04655144|455764545|FG000|Overall Study|Consumed THC|1|||
126674252|NCT04655144|455764546|FG001|Overall Study|Consumed THC|0|||
126674253|NCT04655144|455764545|FG000|Overall Study|Unilateral embolization|0|||
126674254|NCT04655144|455764546|FG001|Overall Study|Unilateral embolization|1|||
126674255|NCT04490018|455764547|FG000|Overall Study|Protocol Violation|0|||
126674256|NCT04490018|455764548|FG001|Overall Study|Protocol Violation|2|||
126674257|NCT04490018|455764549|FG002|Overall Study|Protocol Violation|1|||
126674258|NCT04490018|455764547|FG000|Overall Study|Lost to Follow-up|2|||
126674259|NCT04490018|455764548|FG001|Overall Study|Lost to Follow-up|2|||
126674260|NCT04490018|455764549|FG002|Overall Study|Lost to Follow-up|0|||
126674261|NCT04490018|455764547|FG000|Overall Study|Withdrawal by Subject|2|||
126674262|NCT04490018|455764548|FG001|Overall Study|Withdrawal by Subject|1|||
126674263|NCT04490018|455764549|FG002|Overall Study|Withdrawal by Subject|0|||
126674264|NCT04490018|455764547|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126674265|NCT04490018|455764548|FG001|Overall Study|Withdrawal by parent/guardian|3|||
126674266|NCT04490018|455764549|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126674267|NCT00282295|455764551|FG000|Overall Study|Adverse Event|0|||
126674268|NCT00282295|455764552|FG001|Overall Study|Adverse Event|1|||
126674269|NCT00282295|455764553|FG002|Overall Study|Adverse Event|0|||
126674270|NCT00282295|455764551|FG000|Overall Study|Serious Adverse Events|0|||
126674271|NCT00282295|455764552|FG001|Overall Study|Serious Adverse Events|0|||
126674272|NCT00282295|455764553|FG002|Overall Study|Serious Adverse Events|1|||
126674273|NCT00282295|455764551|FG000|Overall Study|Protocol Violation|0|||
126674274|NCT00282295|455764552|FG001|Overall Study|Protocol Violation|2|||
126674275|NCT00282295|455764553|FG002|Overall Study|Protocol Violation|1|||
126674276|NCT00282295|455764551|FG000|Overall Study|Withdrawal by Subject|2|||
126674277|NCT00282295|455764552|FG001|Overall Study|Withdrawal by Subject|6|||
126674278|NCT00282295|455764553|FG002|Overall Study|Withdrawal by Subject|4|||
126674279|NCT00282295|455764551|FG000|Overall Study|Lost to Follow-up|1|||
126674280|NCT00282295|455764552|FG001|Overall Study|Lost to Follow-up|7|||
126674281|NCT00282295|455764553|FG002|Overall Study|Lost to Follow-up|2|||
126674282|NCT00282295|455764551|FG000|Overall Study|Other|0|||
126674283|NCT00282295|455764552|FG001|Overall Study|Other|1|||
126674284|NCT00282295|455764553|FG002|Overall Study|Other|0|||
126674285|NCT03337542|455764554|FG000|Overall Study|Withdrew Consent|17|||
126340779|NCT02251275|454544392|FG003|Overall Study|Adverse Event|0|||
126340780|NCT02251275|454544393|FG004|Overall Study|Adverse Event|0|||
126340781|NCT02251275|454544389|FG000|Overall Study|Lost to Follow-up|5|||
126340782|NCT02251275|454544390|FG001|Overall Study|Lost to Follow-up|6|||
126674286|NCT03337542|455764554|FG000|Overall Study|Allergic Adverse Event|1|||
126674287|NCT03337542|455764554|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
126674288|NCT03337542|455764554|FG000|Overall Study|Lost to Follow-up|1|||
126674289|NCT03337542|455764554|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
126674290|NCT01401842|455764555|FG000|Overall Study|Withdrawal by Subject|3|||
126674291|NCT01401842|455764556|FG001|Overall Study|Withdrawal by Subject|2|||
126340783|NCT02251275|454544391|FG002|Overall Study|Lost to Follow-up|4|||
126674292|NCT01401842|455764555|FG000|Overall Study|academic reason|4|||
126674293|NCT01401842|455764556|FG001|Overall Study|academic reason|1|||
126674294|NCT01401842|455764555|FG000|Overall Study|changed companies|20|||
126674295|NCT01401842|455764556|FG001|Overall Study|changed companies|34|||
126674296|NCT01401842|455764555|FG000|Overall Study|discharged from US Army|3|||
126340784|NCT02251275|454544392|FG003|Overall Study|Lost to Follow-up|0|||
126425975|NCT00650767|454856251|FG002|Overall Study|Other|0|||
126425976|NCT00650767|454856252|FG003|Overall Study|Other|0|||
126425977|NCT01774799|454856253|FG000|Overall Study|Lost to Follow-up|1|||
126425978|NCT01774799|454856254|FG001|Overall Study|Lost to Follow-up|1|||
126425979|NCT01774799|454856255|FG002|Overall Study|Lost to Follow-up|0|||
126425980|NCT01774799|454856256|FG003|Overall Study|Lost to Follow-up|0|||
126425981|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
126425982|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
126425983|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
126425984|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
126425985|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
126425986|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
126425987|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
126425988|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
126425989|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
126425990|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
126425991|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
126425992|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
126425993|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
126425994|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
126425995|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
126425996|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
126425997|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
126425998|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
126425999|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
126426000|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
126426001|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
126426002|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
126426003|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
126426004|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
126426005|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
126426006|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
126426007|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
126426008|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
126426009|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
126426010|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
126426011|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
126426012|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
126426013|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
126426014|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
126426015|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
126426016|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
126426017|NCT02586623|454856257|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
126426018|NCT02586623|454856258|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
126426019|NCT02586623|454856259|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
126426020|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
126426021|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
126426022|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
126426023|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
126426024|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
126426025|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
126426026|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
126426027|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
126426028|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
126426029|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
126426030|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
126426031|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
126426032|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
126426033|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
126426034|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
126426035|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
126426036|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
126426037|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
126426038|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
126426039|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
126426040|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
126426041|NCT02586623|454856257|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
126426042|NCT02586623|454856258|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
126426043|NCT02586623|454856259|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
126426044|NCT03064490|454856264|FG000|Overall Study|Physician Decision|5|||
126426045|NCT04158583|454856268|FG000|Overall Study|Withdrawal by Subject|1|||
126426046|NCT04158583|454856269|FG001|Overall Study|Withdrawal by Subject|1|||
126426047|NCT04158583|454856270|FG002|Overall Study|Withdrawal by Subject|0|||
126426048|NCT04158583|454856271|FG003|Overall Study|Withdrawal by Subject|0|||
126426049|NCT04158583|454856272|FG004|Overall Study|Withdrawal by Subject|1|||
126426050|NCT04158583|454856273|FG005|Overall Study|Withdrawal by Subject|0|||
126426051|NCT04158583|454856274|FG006|Overall Study|Withdrawal by Subject|0|||
126426052|NCT04158583|454856275|FG007|Overall Study|Withdrawal by Subject|0|||
126426053|NCT04158583|454856276|FG008|Overall Study|Withdrawal by Subject|2|||
126426054|NCT04158583|454856277|FG009|Overall Study|Withdrawal by Subject|0|||
126426055|NCT04158583|454856268|FG000|Overall Study|Study Terminated by Sponsor|0|||
126426056|NCT04158583|454856269|FG001|Overall Study|Study Terminated by Sponsor|0|||
126426057|NCT04158583|454856270|FG002|Overall Study|Study Terminated by Sponsor|0|||
126426058|NCT04158583|454856271|FG003|Overall Study|Study Terminated by Sponsor|1|||
126426059|NCT04158583|454856272|FG004|Overall Study|Study Terminated by Sponsor|0|||
126426060|NCT04158583|454856273|FG005|Overall Study|Study Terminated by Sponsor|0|||
126426061|NCT04158583|454856274|FG006|Overall Study|Study Terminated by Sponsor|0|||
126426062|NCT04158583|454856275|FG007|Overall Study|Study Terminated by Sponsor|0|||
126426063|NCT04158583|454856276|FG008|Overall Study|Study Terminated by Sponsor|0|||
126426064|NCT04158583|454856277|FG009|Overall Study|Study Terminated by Sponsor|0|||
126426065|NCT04158583|454856268|FG000|Overall Study|Progressive Disease|1|||
126426066|NCT04158583|454856269|FG001|Overall Study|Progressive Disease|0|||
126426067|NCT04158583|454856270|FG002|Overall Study|Progressive Disease|3|||
126426068|NCT04158583|454856271|FG003|Overall Study|Progressive Disease|5|||
126426069|NCT04158583|454856272|FG004|Overall Study|Progressive Disease|0|||
126426070|NCT04158583|454856273|FG005|Overall Study|Progressive Disease|1|||
126426071|NCT04158583|454856274|FG006|Overall Study|Progressive Disease|6|||
126426072|NCT04158583|454856275|FG007|Overall Study|Progressive Disease|2|||
126426073|NCT04158583|454856276|FG008|Overall Study|Progressive Disease|1|||
126426074|NCT04158583|454856277|FG009|Overall Study|Progressive Disease|2|||
126426075|NCT04158583|454856268|FG000|Overall Study|Lost to Follow-up|0|||
126426076|NCT04158583|454856269|FG001|Overall Study|Lost to Follow-up|0|||
126426077|NCT04158583|454856270|FG002|Overall Study|Lost to Follow-up|1|||
126426078|NCT04158583|454856271|FG003|Overall Study|Lost to Follow-up|1|||
126426079|NCT04158583|454856272|FG004|Overall Study|Lost to Follow-up|1|||
126426080|NCT04158583|454856273|FG005|Overall Study|Lost to Follow-up|0|||
126426081|NCT04158583|454856274|FG006|Overall Study|Lost to Follow-up|0|||
126426082|NCT04158583|454856275|FG007|Overall Study|Lost to Follow-up|0|||
126426083|NCT04158583|454856276|FG008|Overall Study|Lost to Follow-up|0|||
126426084|NCT04158583|454856277|FG009|Overall Study|Lost to Follow-up|0|||
126426085|NCT04158583|454856268|FG000|Overall Study|Due To Patient Status|0|||
126426086|NCT04158583|454856269|FG001|Overall Study|Due To Patient Status|0|||
126426087|NCT04158583|454856270|FG002|Overall Study|Due To Patient Status|0|||
126426088|NCT04158583|454856271|FG003|Overall Study|Due To Patient Status|0|||
126426089|NCT04158583|454856272|FG004|Overall Study|Due To Patient Status|0|||
126426090|NCT04158583|454856273|FG005|Overall Study|Due To Patient Status|0|||
126426091|NCT04158583|454856274|FG006|Overall Study|Due To Patient Status|0|||
126426092|NCT04158583|454856275|FG007|Overall Study|Due To Patient Status|0|||
126426093|NCT04158583|454856276|FG008|Overall Study|Due To Patient Status|1|||
126426094|NCT04158583|454856277|FG009|Overall Study|Due To Patient Status|0|||
126426095|NCT04158583|454856268|FG000|Overall Study|Death|3|||
126426096|NCT04158583|454856269|FG001|Overall Study|Death|4|||
126426097|NCT04158583|454856270|FG002|Overall Study|Death|2|||
126426098|NCT04158583|454856271|FG003|Overall Study|Death|2|||
126426099|NCT04158583|454856272|FG004|Overall Study|Death|4|||
126426100|NCT04158583|454856273|FG005|Overall Study|Death|3|||
126426101|NCT04158583|454856274|FG006|Overall Study|Death|5|||
126426102|NCT04158583|454856275|FG007|Overall Study|Death|2|||
126426103|NCT04158583|454856276|FG008|Overall Study|Death|0|||
126426104|NCT04158583|454856277|FG009|Overall Study|Death|1|||
126426105|NCT04158583|454856268|FG000|Overall Study|Clinical Progression Disease|0|||
126426106|NCT04158583|454856269|FG001|Overall Study|Clinical Progression Disease|0|||
126426107|NCT04158583|454856270|FG002|Overall Study|Clinical Progression Disease|0|||
126426108|NCT04158583|454856271|FG003|Overall Study|Clinical Progression Disease|1|||
126426109|NCT04158583|454856272|FG004|Overall Study|Clinical Progression Disease|0|||
126426110|NCT04158583|454856273|FG005|Overall Study|Clinical Progression Disease|0|||
126426111|NCT04158583|454856274|FG006|Overall Study|Clinical Progression Disease|0|||
126426112|NCT04158583|454856275|FG007|Overall Study|Clinical Progression Disease|0|||
126426113|NCT04158583|454856276|FG008|Overall Study|Clinical Progression Disease|0|||
126426114|NCT04158583|454856277|FG009|Overall Study|Clinical Progression Disease|0|||
126426115|NCT04158583|454856268|FG000|Overall Study|Clinical Progression|0|||
126426116|NCT04158583|454856269|FG001|Overall Study|Clinical Progression|0|||
126426117|NCT04158583|454856270|FG002|Overall Study|Clinical Progression|0|||
126426118|NCT04158583|454856271|FG003|Overall Study|Clinical Progression|0|||
126340785|NCT02251275|454544393|FG004|Overall Study|Lost to Follow-up|0|||
126340786|NCT02251275|454544389|FG000|Overall Study|Physician Decision|19|||
126340787|NCT02251275|454544390|FG001|Overall Study|Physician Decision|30|||
126340788|NCT02251275|454544391|FG002|Overall Study|Physician Decision|26|||
126340789|NCT02251275|454544392|FG003|Overall Study|Physician Decision|0|||
126340790|NCT02251275|454544393|FG004|Overall Study|Physician Decision|1|||
126340791|NCT02251275|454544389|FG000|Overall Study|Protocol Deviation|0|||
126340792|NCT02251275|454544390|FG001|Overall Study|Protocol Deviation|0|||
126340793|NCT02251275|454544391|FG002|Overall Study|Protocol Deviation|1|||
126340794|NCT02251275|454544392|FG003|Overall Study|Protocol Deviation|0|||
126340795|NCT02251275|454544393|FG004|Overall Study|Protocol Deviation|0|||
126340796|NCT02251275|454544389|FG000|Overall Study|Withdrawal by Subject|25|||
126340797|NCT02251275|454544390|FG001|Overall Study|Withdrawal by Subject|51|||
126340798|NCT02251275|454544391|FG002|Overall Study|Withdrawal by Subject|35|||
126340799|NCT02251275|454544392|FG003|Overall Study|Withdrawal by Subject|1|||
126340800|NCT02251275|454544393|FG004|Overall Study|Withdrawal by Subject|0|||
126340801|NCT00856180|454544399|FG000|Overall Study|Adverse Event|4|||
126340802|NCT00856180|454544399|FG000|Overall Study|Progressive Disease|16|||
126340803|NCT02265510|454544400|FG000|Overall Study|Withdrawal by Subject|1|||
126340804|NCT02265510|454544401|FG001|Overall Study|Withdrawal by Subject|1|||
126340805|NCT02265510|454544402|FG002|Overall Study|Withdrawal by Subject|2|||
126340806|NCT02265510|454544403|FG003|Overall Study|Withdrawal by Subject|1|||
126340807|NCT02265510|454544404|FG004|Overall Study|Withdrawal by Subject|0|||
126340808|NCT02265510|454544405|FG005|Overall Study|Withdrawal by Subject|2|||
126340809|NCT02265510|454544406|FG006|Overall Study|Withdrawal by Subject|0|||
126340810|NCT02265510|454544407|FG007|Overall Study|Withdrawal by Subject|2|||
126340811|NCT02265510|454544408|FG008|Overall Study|Withdrawal by Subject|0|||
126340812|NCT02265510|454544409|FG009|Overall Study|Withdrawal by Subject|0|||
126340813|NCT02265510|454544410|FG010|Overall Study|Withdrawal by Subject|0|||
126340814|NCT02265510|454544411|FG011|Overall Study|Withdrawal by Subject|0|||
126340815|NCT02265510|454544412|FG012|Overall Study|Withdrawal by Subject|1|||
126340816|NCT02265510|454544413|FG013|Overall Study|Withdrawal by Subject|0|||
126340817|NCT02265510|454544400|FG000|Overall Study|Disease Progression|0|||
126340818|NCT02265510|454544401|FG001|Overall Study|Disease Progression|1|||
126340819|NCT02265510|454544402|FG002|Overall Study|Disease Progression|2|||
126340820|NCT02265510|454544403|FG003|Overall Study|Disease Progression|1|||
126340821|NCT02265510|454544404|FG004|Overall Study|Disease Progression|1|||
126340822|NCT02265510|454544405|FG005|Overall Study|Disease Progression|0|||
126340823|NCT02265510|454544406|FG006|Overall Study|Disease Progression|0|||
126340824|NCT02265510|454544407|FG007|Overall Study|Disease Progression|0|||
126340825|NCT02265510|454544408|FG008|Overall Study|Disease Progression|0|||
126340826|NCT02265510|454544409|FG009|Overall Study|Disease Progression|0|||
126340827|NCT02265510|454544410|FG010|Overall Study|Disease Progression|0|||
126340828|NCT02265510|454544411|FG011|Overall Study|Disease Progression|0|||
126340829|NCT02265510|454544412|FG012|Overall Study|Disease Progression|0|||
126340830|NCT02265510|454544413|FG013|Overall Study|Disease Progression|0|||
126340831|NCT02265510|454544400|FG000|Overall Study|Death|2|||
126340832|NCT02265510|454544401|FG001|Overall Study|Death|0|||
126340833|NCT02265510|454544402|FG002|Overall Study|Death|2|||
126340834|NCT02265510|454544403|FG003|Overall Study|Death|2|||
126340835|NCT02265510|454544404|FG004|Overall Study|Death|1|||
126340836|NCT02265510|454544405|FG005|Overall Study|Death|3|||
126340837|NCT02265510|454544406|FG006|Overall Study|Death|2|||
126340838|NCT02265510|454544407|FG007|Overall Study|Death|1|||
126340839|NCT02265510|454544408|FG008|Overall Study|Death|3|||
126340840|NCT02265510|454544409|FG009|Overall Study|Death|3|||
126340841|NCT02265510|454544410|FG010|Overall Study|Death|4|||
126340842|NCT02265510|454544411|FG011|Overall Study|Death|12|||
126340843|NCT02265510|454544412|FG012|Overall Study|Death|7|||
126340844|NCT02265510|454544413|FG013|Overall Study|Death|6|||
126340845|NCT02265510|454544400|FG000|Overall Study|Lost to Follow-up|0|||
126340846|NCT02265510|454544401|FG001|Overall Study|Lost to Follow-up|0|||
126340847|NCT02265510|454544402|FG002|Overall Study|Lost to Follow-up|0|||
126340848|NCT02265510|454544403|FG003|Overall Study|Lost to Follow-up|0|||
126340849|NCT02265510|454544404|FG004|Overall Study|Lost to Follow-up|1|||
126340850|NCT02265510|454544405|FG005|Overall Study|Lost to Follow-up|0|||
126340851|NCT02265510|454544406|FG006|Overall Study|Lost to Follow-up|0|||
126340852|NCT02265510|454544407|FG007|Overall Study|Lost to Follow-up|0|||
126426119|NCT04158583|454856272|FG004|Overall Study|Clinical Progression|1|||
126340853|NCT02265510|454544408|FG008|Overall Study|Lost to Follow-up|0|||
126340854|NCT02265510|454544409|FG009|Overall Study|Lost to Follow-up|2|||
126340855|NCT02265510|454544410|FG010|Overall Study|Lost to Follow-up|0|||
126340856|NCT02265510|454544411|FG011|Overall Study|Lost to Follow-up|0|||
126340857|NCT02265510|454544412|FG012|Overall Study|Lost to Follow-up|0|||
126340858|NCT02265510|454544413|FG013|Overall Study|Lost to Follow-up|2|||
126340859|NCT02265510|454544400|FG000|Overall Study|Other|0|||
126340860|NCT02265510|454544401|FG001|Overall Study|Other|1|||
126340861|NCT02265510|454544402|FG002|Overall Study|Other|0|||
126340862|NCT02265510|454544403|FG003|Overall Study|Other|0|||
126340863|NCT02265510|454544404|FG004|Overall Study|Other|0|||
126426120|NCT04158583|454856273|FG005|Overall Study|Clinical Progression|0|||
126426121|NCT04158583|454856274|FG006|Overall Study|Clinical Progression|2|||
126426122|NCT04158583|454856275|FG007|Overall Study|Clinical Progression|0|||
126426123|NCT04158583|454856276|FG008|Overall Study|Clinical Progression|0|||
126426124|NCT04158583|454856277|FG009|Overall Study|Clinical Progression|0|||
126426125|NCT04158583|454856268|FG000|Overall Study|Clinical Deterioration|0|||
126426126|NCT04158583|454856269|FG001|Overall Study|Clinical Deterioration|0|||
126426127|NCT04158583|454856270|FG002|Overall Study|Clinical Deterioration|0|||
126426128|NCT04158583|454856271|FG003|Overall Study|Clinical Deterioration|1|||
126426129|NCT04158583|454856272|FG004|Overall Study|Clinical Deterioration|0|||
126426130|NCT04158583|454856273|FG005|Overall Study|Clinical Deterioration|0|||
126426131|NCT04158583|454856274|FG006|Overall Study|Clinical Deterioration|0|||
126426132|NCT04158583|454856275|FG007|Overall Study|Clinical Deterioration|0|||
126426133|NCT04158583|454856276|FG008|Overall Study|Clinical Deterioration|0|||
126426134|NCT04158583|454856277|FG009|Overall Study|Clinical Deterioration|1|||
126426135|NCT01871519|454856278|FG000|Overall Study|Death|26|||
126426136|NCT01871519|454856278|FG000|Overall Study|Lost to Follow-up|15|||
126426137|NCT01871519|454856278|FG000|Overall Study|Withdrawal by Subject|49|||
126426138|NCT00320515|454856279|FG000|Overall Study|Death|33|||
126426139|NCT00320515|454856279|FG000|Overall Study|Lost to Follow-up|6|||
126426140|NCT00320515|454856279|FG000|Overall Study|Physician Decision|2|||
126426141|NCT00320515|454856279|FG000|Overall Study|Withdrawal by Subject|8|||
126426142|NCT00794950|454856280|FG000|BCG Induction|Withdrawal by Subject|2|||
126426143|NCT00794950|454856280|FG000|BCG Induction|ineligible|3|||
126426144|NCT00794950|454856280|FG000|BCG Induction|noncompliant w. BCG|1|||
126426145|NCT00794950|454856280|FG000|BCG Induction|Adverse Event|1|||
126426146|NCT00794950|454856280|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
126426147|NCT00794950|454856280|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
126426148|NCT00794950|454856280|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
126426149|NCT00794950|454856280|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
126426150|NCT02485704|454856281|FG000|Overall Study|Lost to Follow-up|4|||
126426151|NCT02485704|454856282|FG001|Overall Study|Lost to Follow-up|5|||
126426152|NCT02485704|454856281|FG000|Overall Study|Withdrawal by Subject|0|||
126426153|NCT02485704|454856282|FG001|Overall Study|Withdrawal by Subject|3|||
126426154|NCT02485704|454856281|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
126426155|NCT02485704|454856282|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
126426156|NCT01777776|454856283|FG000|Overall Study|Adverse Event|2|||
126426157|NCT01777776|454856284|FG001|Overall Study|Adverse Event|4|||
126426158|NCT01777776|454856285|FG002|Overall Study|Adverse Event|0|||
126426159|NCT01777776|454856286|FG003|Overall Study|Adverse Event|0|||
126426160|NCT01777776|454856283|FG000|Overall Study|Disease Progression|4|||
126426161|NCT01777776|454856284|FG001|Overall Study|Disease Progression|8|||
126426162|NCT01777776|454856285|FG002|Overall Study|Disease Progression|6|||
126426163|NCT01777776|454856286|FG003|Overall Study|Disease Progression|3|||
126426164|NCT01777776|454856283|FG000|Overall Study|Withdrawal by Subject|0|||
126426165|NCT01777776|454856284|FG001|Overall Study|Withdrawal by Subject|0|||
126426166|NCT01777776|454856285|FG002|Overall Study|Withdrawal by Subject|0|||
126426167|NCT01777776|454856286|FG003|Overall Study|Withdrawal by Subject|1|||
126426168|NCT04481243|454857773|FG000|Overall Study|Withdrawal by Subject|4|||
126426169|NCT03737123|454857774|FG000|Study Treatment|Adverse Event|2|||
126426170|NCT03737123|454857775|FG001|Study Treatment|Adverse Event|0|||
126426171|NCT03737123|454857774|FG000|Study Treatment|Disease Progression|2|||
126426172|NCT03737123|454857775|FG001|Study Treatment|Disease Progression|0|||
126426173|NCT03737123|454857774|FG000|Study Treatment|Withdrawal by Subject|2|||
126426174|NCT03737123|454857775|FG001|Study Treatment|Withdrawal by Subject|0|||
126426175|NCT03737123|454857774|FG000|Follow up|Death|1|||
126426176|NCT03737123|454857775|FG001|Follow up|Death|0|||
126426177|NCT03737123|454857774|FG000|Follow up|Withdrawal by Subject|1|||
126426178|NCT03737123|454857775|FG001|Follow up|Withdrawal by Subject|0|||
126426179|NCT03737123|454857774|FG000|Follow up|Termination of study|4|||
126426180|NCT03737123|454857775|FG001|Follow up|Termination of study|0|||
126426181|NCT04388111|454857777|FG000|Overall Study|Lost to Follow-up|5|||
126426182|NCT04388111|454857778|FG001|Overall Study|Lost to Follow-up|3|||
126426183|NCT04388111|454857777|FG000|Overall Study|Adverse Event|1|||
126426184|NCT04388111|454857778|FG001|Overall Study|Adverse Event|1|||
126426185|NCT04388111|454857777|FG000|Overall Study|Protocol Violation|2|||
126426186|NCT04388111|454857778|FG001|Overall Study|Protocol Violation|4|||
126426187|NCT04388111|454857777|FG000|Overall Study|Withdrawal by Subject|1|||
126426188|NCT04388111|454857778|FG001|Overall Study|Withdrawal by Subject|0|||
126426189|NCT00928486|454857779|FG000|Overall Study|Adverse Event|2|||
126426190|NCT00928486|454857779|FG000|Overall Study|Disease Progression|7|||
126426191|NCT00928486|454857779|FG000|Overall Study|Withdrawal by Subject|1|||
126426192|NCT01342913|454857780|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
126426193|NCT01342913|454857781|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
126426194|NCT01342913|454857782|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
126426195|NCT01342913|454857780|FG000|2-week Run-in Period|Physician Decision|6|||
126426196|NCT01342913|454857781|FG001|2-week Run-in Period|Physician Decision|0|||
126426197|NCT01342913|454857782|FG002|2-week Run-in Period|Physician Decision|0|||
126426198|NCT01342913|454857780|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
126426199|NCT01342913|454857781|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126426200|NCT01342913|454857782|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126426201|NCT01342913|454857780|FG000|2-week Run-in Period|Adverse Event|2|||
126426202|NCT01342913|454857781|FG001|2-week Run-in Period|Adverse Event|0|||
126426203|NCT01342913|454857782|FG002|2-week Run-in Period|Adverse Event|0|||
126426204|NCT01342913|454857780|FG000|2-week Run-in Period|Protocol Violation|5|||
126426205|NCT01342913|454857781|FG001|2-week Run-in Period|Protocol Violation|0|||
126426206|NCT01342913|454857782|FG002|2-week Run-in Period|Protocol Violation|0|||
126426207|NCT01342913|454857780|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
126426208|NCT01342913|454857781|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
126426209|NCT01342913|454857782|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
126426210|NCT01342913|454857780|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126426211|NCT01342913|454857781|FG001|Double-Blind Treatment Period|Adverse Event|3|||
126426212|NCT01342913|454857782|FG002|Double-Blind Treatment Period|Adverse Event|6|||
126426213|NCT01342913|454857780|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
126426214|NCT01342913|454857781|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
126426215|NCT01342913|454857782|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
126426216|NCT01342913|454857780|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
126426217|NCT01342913|454857781|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
126426218|NCT01342913|454857782|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
126426219|NCT01342913|454857780|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126426220|NCT01342913|454857781|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
126426221|NCT01342913|454857782|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
126426222|NCT01342913|454857780|FG000|Double-Blind Treatment Period|Physician Decision|0|||
126426223|NCT01342913|454857781|FG001|Double-Blind Treatment Period|Physician Decision|2|||
126426224|NCT01342913|454857782|FG002|Double-Blind Treatment Period|Physician Decision|0|||
126426225|NCT01342913|454857780|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126426226|NCT01342913|454857781|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126426227|NCT01342913|454857782|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126426228|NCT04024891|454857789|FG000|Overall Study|Pregnancy|0|||
126426229|NCT04024891|454857790|FG001|Overall Study|Pregnancy|1|||
126426230|NCT00453154|454857792|FG000|Double BIind Maintenance|Adverse Event|0|||
126426231|NCT00453154|454857793|FG001|Double BIind Maintenance|Adverse Event|0|||
126426232|NCT00453154|454857794|FG002|Double BIind Maintenance|Adverse Event|3|||
126426233|NCT00453154|454857795|FG003|Double BIind Maintenance|Adverse Event|12|||
126426234|NCT00453154|454857792|FG000|Double BIind Maintenance|Death|0|||
126426235|NCT00453154|454857793|FG001|Double BIind Maintenance|Death|0|||
126426236|NCT00453154|454857794|FG002|Double BIind Maintenance|Death|2|||
126426237|NCT00453154|454857795|FG003|Double BIind Maintenance|Death|1|||
126426238|NCT00453154|454857792|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
126426239|NCT00453154|454857793|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
126426240|NCT00453154|454857794|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
126426241|NCT00453154|454857795|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
126426242|NCT00453154|454857792|FG000|Double BIind Maintenance|Progression|0|||
126426243|NCT00453154|454857793|FG001|Double BIind Maintenance|Progression|0|||
126426244|NCT00453154|454857794|FG002|Double BIind Maintenance|Progression|29|||
126426245|NCT00453154|454857795|FG003|Double BIind Maintenance|Progression|26|||
126426246|NCT00453154|454857792|FG000|Double BIind Maintenance|Medical Issues|0|||
126426247|NCT00453154|454857793|FG001|Double BIind Maintenance|Medical Issues|0|||
126426248|NCT00453154|454857794|FG002|Double BIind Maintenance|Medical Issues|3|||
126426249|NCT00453154|454857795|FG003|Double BIind Maintenance|Medical Issues|1|||
126426250|NCT00453154|454857792|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
126426251|NCT00453154|454857793|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
126426252|NCT00453154|454857794|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
126426253|NCT00453154|454857795|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
126426254|NCT01790594|454857797|FG000|Overall Study|Death|1|||
126426255|NCT01790594|454857798|FG001|Overall Study|Death|0|||
126426256|NCT01790594|454857799|FG002|Overall Study|Death|0|||
126426257|NCT01790594|454857797|FG000|Overall Study|Physician Decision|2|||
126674297|NCT01401842|455764556|FG001|Overall Study|discharged from US Army|4|||
126674298|NCT01401842|455764555|FG000|Overall Study|invalid follow-up strength data|1|||
126674299|NCT01401842|455764556|FG001|Overall Study|invalid follow-up strength data|4|||
126674300|NCT01401842|455764555|FG000|Overall Study|on profile|9|||
126426258|NCT01790594|454857798|FG001|Overall Study|Physician Decision|1|||
126426259|NCT01790594|454857799|FG002|Overall Study|Physician Decision|0|||
126674301|NCT01401842|455764556|FG001|Overall Study|on profile|5|||
126426260|NCT01790594|454857797|FG000|Overall Study|Withdrawal by Subject|2|||
126426261|NCT01790594|454857798|FG001|Overall Study|Withdrawal by Subject|0|||
126426262|NCT01790594|454857799|FG002|Overall Study|Withdrawal by Subject|0|||
126674302|NCT01401842|455764555|FG000|Overall Study|other/unknown|28|||
126426263|NCT01790594|454857797|FG000|Overall Study|Transplant was not done|0|||
126426264|NCT01790594|454857798|FG001|Overall Study|Transplant was not done|0|||
126426265|NCT01790594|454857799|FG002|Overall Study|Transplant was not done|3|||
126426266|NCT01790594|454857797|FG000|Overall Study|Terminated prior to week 76|0|||
126426267|NCT01790594|454857798|FG001|Overall Study|Terminated prior to week 76|2|||
126426268|NCT01790594|454857799|FG002|Overall Study|Terminated prior to week 76|0|||
126426269|NCT03291067|454857801|FG000|Overall Study|Adverse Event|0|||
126426270|NCT03291067|454857802|FG001|Overall Study|Adverse Event|2|||
126426271|NCT03291067|454857803|FG002|Overall Study|Adverse Event|17|||
126426272|NCT03291067|454857804|FG003|Overall Study|Adverse Event|3|||
126426273|NCT03291067|454857801|FG000|Overall Study|Lost to Follow-up|2|||
126426274|NCT03291067|454857802|FG001|Overall Study|Lost to Follow-up|1|||
126426275|NCT03291067|454857803|FG002|Overall Study|Lost to Follow-up|0|||
126426276|NCT03291067|454857804|FG003|Overall Study|Lost to Follow-up|1|||
126426277|NCT03291067|454857801|FG000|Overall Study|Physician Decision|0|||
126426278|NCT03291067|454857802|FG001|Overall Study|Physician Decision|0|||
126426279|NCT03291067|454857803|FG002|Overall Study|Physician Decision|1|||
126426280|NCT03291067|454857804|FG003|Overall Study|Physician Decision|0|||
126426281|NCT03291067|454857801|FG000|Overall Study|Protocol Violation|5|||
126426282|NCT03291067|454857802|FG001|Overall Study|Protocol Violation|3|||
126426283|NCT03291067|454857803|FG002|Overall Study|Protocol Violation|4|||
126426284|NCT03291067|454857804|FG003|Overall Study|Protocol Violation|2|||
126426285|NCT03291067|454857801|FG000|Overall Study|Withdrawal by Subject|3|||
126426286|NCT03291067|454857802|FG001|Overall Study|Withdrawal by Subject|4|||
126426287|NCT03291067|454857803|FG002|Overall Study|Withdrawal by Subject|7|||
126426288|NCT03291067|454857804|FG003|Overall Study|Withdrawal by Subject|5|||
126426289|NCT03291067|454857801|FG000|Overall Study|Other|0|||
126426290|NCT03291067|454857802|FG001|Overall Study|Other|4|||
126426291|NCT03291067|454857803|FG002|Overall Study|Other|4|||
126426292|NCT03291067|454857804|FG003|Overall Study|Other|6|||
126426293|NCT02152631|454857805|FG000|Overall Study|Adverse Event|32|||
126426294|NCT02152631|454857806|FG001|Overall Study|Adverse Event|4|||
126426295|NCT02152631|454857805|FG000|Overall Study|Withdrawal by Subject|13|||
126426296|NCT02152631|454857806|FG001|Overall Study|Withdrawal by Subject|16|||
126426297|NCT02152631|454857805|FG000|Overall Study|Noncompliance with study drug|1|||
126426298|NCT02152631|454857806|FG001|Overall Study|Noncompliance with study drug|0|||
126426299|NCT02152631|454857805|FG000|Overall Study|Physician Decision|1|||
126426300|NCT02152631|454857806|FG001|Overall Study|Physician Decision|2|||
126426301|NCT02152631|454857805|FG000|Overall Study|Lost to Follow-up|0|||
126426302|NCT02152631|454857806|FG001|Overall Study|Lost to Follow-up|1|||
126426303|NCT02152631|454857805|FG000|Overall Study|On Treatment|19|||
126426304|NCT02152631|454857806|FG001|Overall Study|On Treatment|3|||
126426305|NCT05473026|454857807|FG000|Overall Study|Lost to Follow-up|5|||
126426306|NCT05473026|454857808|FG001|Overall Study|Lost to Follow-up|2|||
126426307|NCT03683173|454857819|FG000|Completed Follow-up|Unavailable|235|||
126426308|NCT03683173|454857820|FG001|Completed Follow-up|Unavailable|217|||
126426309|NCT03683173|454857819|FG000|Completed Follow-up|Refused|69|||
126426310|NCT03683173|454857820|FG001|Completed Follow-up|Refused|59|||
126426311|NCT03683173|454857819|FG000|Completed Follow-up|Disconnected phone|65|||
126426312|NCT03683173|454857820|FG001|Completed Follow-up|Disconnected phone|95|||
126426313|NCT03683173|454857819|FG000|Completed Follow-up|Health issue/deceased|10|||
126426314|NCT03683173|454857820|FG001|Completed Follow-up|Health issue/deceased|4|||
126426315|NCT03683173|454857819|FG000|Completed Follow-up|Moved away|8|||
126426316|NCT03683173|454857820|FG001|Completed Follow-up|Moved away|1|||
126426317|NCT02210000|454857821|FG000|Overall Study|Study Terminated|11|||
126426318|NCT02210000|454857822|FG001|Overall Study|Study Terminated|12|||
126426319|NCT02210000|454857821|FG000|Overall Study|Withdrawal by Subject|7|||
126426320|NCT02210000|454857822|FG001|Overall Study|Withdrawal by Subject|1|||
126426321|NCT02210000|454857821|FG000|Overall Study|Adverse Event|1|||
126426322|NCT02210000|454857822|FG001|Overall Study|Adverse Event|5|||
126426323|NCT02210000|454857821|FG000|Overall Study|Lost to Follow-up|0|||
126426324|NCT02210000|454857822|FG001|Overall Study|Lost to Follow-up|2|||
126426325|NCT02210000|454857821|FG000|Overall Study|Physician Decision|0|||
126426326|NCT02210000|454857822|FG001|Overall Study|Physician Decision|1|||
126426327|NCT01329263|454857825|FG000|Overall Study|Lost to Follow-up|4|||
126426328|NCT01329263|454857826|FG001|Overall Study|Lost to Follow-up|21|||
126426329|NCT01329263|454857825|FG000|Overall Study|Withdrawal by Subject|1|||
126426330|NCT01329263|454857826|FG001|Overall Study|Withdrawal by Subject|2|||
126426331|NCT01421017|454857828|FG000|Overall Study|Withdrawal by Subject|2|||
126426332|NCT01421017|454857829|FG001|Overall Study|Withdrawal by Subject|0|||
126426333|NCT01421017|454857830|FG002|Overall Study|Withdrawal by Subject|0|||
126426334|NCT01421017|454857828|FG000|Overall Study|POD|0|||
126426335|NCT01421017|454857829|FG001|Overall Study|POD|6|||
126426336|NCT01421017|454857830|FG002|Overall Study|POD|3|||
126426337|NCT00308139|454857831|FG000|Overall Study|Adverse Event|20|||
126426338|NCT00308139|454857832|FG001|Overall Study|Adverse Event|14|||
126426339|NCT00308139|454857831|FG000|Overall Study|Lost to Follow-up|13|||
126426340|NCT00308139|454857832|FG001|Overall Study|Lost to Follow-up|8|||
126426341|NCT00308139|454857831|FG000|Overall Study|Protocol Violation|3|||
126426342|NCT00308139|454857832|FG001|Overall Study|Protocol Violation|2|||
126426343|NCT00308139|454857831|FG000|Overall Study|Withdrawal of Consent|40|||
126426344|NCT00308139|454857832|FG001|Overall Study|Withdrawal of Consent|42|||
126426345|NCT00308139|454857831|FG000|Overall Study|Investigator Decision|11|||
126426346|NCT00308139|454857832|FG001|Overall Study|Investigator Decision|10|||
126426347|NCT00308139|454857831|FG000|Overall Study|Loss of Glucose Control|5|||
126426348|NCT00308139|454857832|FG001|Overall Study|Loss of Glucose Control|7|||
126426349|NCT00308139|454857831|FG000|Overall Study|Administrative|1|||
126426350|NCT00308139|454857832|FG001|Overall Study|Administrative|4|||
126426351|NCT00308139|454857831|FG000|Overall Study|Other|1|||
126674303|NCT01401842|455764556|FG001|Overall Study|other/unknown|17|||
126674304|NCT00121108|455764559|FG000|Overall Study|Lost to Follow-up|10|||
126674305|NCT00121108|455764560|FG001|Overall Study|Lost to Follow-up|22|||
126674306|NCT00121108|455764559|FG000|Overall Study|Withdrawal by Subject|106|||
126674307|NCT00121108|455764560|FG001|Overall Study|Withdrawal by Subject|195|||
126674308|NCT00121108|455764559|FG000|Overall Study|Death|5|||
126674309|NCT00121108|455764560|FG001|Overall Study|Death|8|||
126674310|NCT01380379|455764561|FG000|Overall Study|Pregnancy|1|||
126426352|NCT00308139|454857832|FG001|Overall Study|Other|0|||
126426353|NCT00833040|454857835|FG000|Overall Study|Adverse Event|0|||
126674311|NCT03977974|455764566|FG000|Period 2|Adverse Event|0|||
126674312|NCT03977974|455764567|FG001|Period 2|Adverse Event|0|||
126674313|NCT03977974|455764568|FG002|Period 2|Adverse Event|0|||
126674314|NCT03977974|455764569|FG003|Period 2|Adverse Event|0|||
126426354|NCT00833040|454857836|FG001|Overall Study|Adverse Event|0|||
126426355|NCT00833040|454857837|FG002|Overall Study|Adverse Event|0|||
126426356|NCT00833040|454857838|FG003|Overall Study|Adverse Event|0|||
126426357|NCT00833040|454857839|FG004|Overall Study|Adverse Event|0|||
126426358|NCT00833040|454857840|FG005|Overall Study|Adverse Event|1|||
126426359|NCT02313766|454857841|FG000|Overall Study|surgery cancelled|1|||
126426360|NCT02313766|454857842|FG001|Overall Study|surgery cancelled|0|||
126426361|NCT02313766|454857843|FG002|Overall Study|surgery cancelled|0|||
126426362|NCT02313766|454857841|FG000|Overall Study|Lost to Follow-up|0|||
126426363|NCT02313766|454857842|FG001|Overall Study|Lost to Follow-up|2|||
126426364|NCT02313766|454857843|FG002|Overall Study|Lost to Follow-up|0|||
126426365|NCT02313766|454857841|FG000|Overall Study|Adverse Event|0|||
126426366|NCT02313766|454857842|FG001|Overall Study|Adverse Event|1|||
126426367|NCT02313766|454857843|FG002|Overall Study|Adverse Event|0|||
126426368|NCT02193776|454857845|FG000|Overall Study|Consent withdrawn|1|||
126426369|NCT02193776|454857846|FG001|Overall Study|Consent withdrawn|0|||
126426370|NCT02193776|454857847|FG002|Overall Study|Consent withdrawn|0|||
126426371|NCT02193776|454857848|FG003|Overall Study|Consent withdrawn|0|||
126426372|NCT02193776|454857845|FG000|Overall Study|Failure to comply with protocol|0|||
126426373|NCT02193776|454857846|FG001|Overall Study|Failure to comply with protocol|1|||
126426374|NCT02193776|454857847|FG002|Overall Study|Failure to comply with protocol|0|||
126426375|NCT02193776|454857848|FG003|Overall Study|Failure to comply with protocol|0|||
126426376|NCT02193776|454857845|FG000|Overall Study|Investigator/Sponsor decision|1|||
126426377|NCT02193776|454857846|FG001|Overall Study|Investigator/Sponsor decision|1|||
126426378|NCT02193776|454857847|FG002|Overall Study|Investigator/Sponsor decision|0|||
126426379|NCT02193776|454857848|FG003|Overall Study|Investigator/Sponsor decision|0|||
126426380|NCT02193776|454857845|FG000|Overall Study|Death|1|||
126426381|NCT02193776|454857846|FG001|Overall Study|Death|0|||
126426382|NCT02193776|454857847|FG002|Overall Study|Death|0|||
126426383|NCT02193776|454857848|FG003|Overall Study|Death|0|||
126426384|NCT02193776|454857845|FG000|Overall Study|Adverse event/Specific toxicity|5|||
126426385|NCT02193776|454857846|FG001|Overall Study|Adverse event/Specific toxicity|5|||
126426386|NCT02193776|454857847|FG002|Overall Study|Adverse event/Specific toxicity|2|||
126426387|NCT02193776|454857848|FG003|Overall Study|Adverse event/Specific toxicity|2|||
126426388|NCT01458639|454857849|FG000|Overall Study|Physician Decision|4|||
126426389|NCT01458639|454857849|FG000|Overall Study|Equipment issue|1|||
126426390|NCT01458639|454857849|FG000|Overall Study|Inability to obtain subject blood sample|1|||
126674315|NCT03977974|455764570|FG004|Period 2|Adverse Event|1|||
126674316|NCT03977974|455764571|FG005|Period 2|Adverse Event|0|||
126674317|NCT03977974|455764572|FG006|Period 2|Adverse Event|0|||
126426391|NCT01884077|454857850|FG000|Overall Study|screen fail|0|||
126426392|NCT01884077|454857851|FG001|Overall Study|screen fail|2|||
126426393|NCT01884077|454857850|FG000|Overall Study|canceled surgery|2|||
126426394|NCT01884077|454857851|FG001|Overall Study|canceled surgery|0|||
126426395|NCT01884077|454857850|FG000|Overall Study|Lost to Follow-up|0|||
126426396|NCT01884077|454857851|FG001|Overall Study|Lost to Follow-up|4|||
126426397|NCT01884077|454857850|FG000|Overall Study|study closed|6|||
126426398|NCT01884077|454857851|FG001|Overall Study|study closed|4|||
126426399|NCT00981149|454857852|FG000|Overall Study|Lost to Follow-up|1|||
126426400|NCT00981149|454857853|FG001|Overall Study|Lost to Follow-up|2|||
126426401|NCT00981149|454857852|FG000|Overall Study|Withdrawal by Subject|1|||
126426402|NCT00981149|454857853|FG001|Overall Study|Withdrawal by Subject|1|||
126426403|NCT02748863|454857854|FG000|Treatment Period 1|Adverse Event|0|||
126426404|NCT02748863|454857855|FG001|Treatment Period 1|Adverse Event|1|||
126426405|NCT02748863|454857856|FG002|Treatment Period 1|Adverse Event|0|||
126426406|NCT02748863|454857857|FG003|Treatment Period 1|Adverse Event|0|||
126426407|NCT02748863|454857858|FG004|Treatment Period 1|Adverse Event|0|||
126426408|NCT02748863|454857854|FG000|Treatment Period 1|Lack of Efficacy|0|||
126426409|NCT02748863|454857855|FG001|Treatment Period 1|Lack of Efficacy|0|||
126426410|NCT02748863|454857856|FG002|Treatment Period 1|Lack of Efficacy|1|||
126426411|NCT02748863|454857857|FG003|Treatment Period 1|Lack of Efficacy|0|||
126426412|NCT02748863|454857858|FG004|Treatment Period 1|Lack of Efficacy|0|||
126426413|NCT02748863|454857854|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126426414|NCT02748863|454857855|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126426415|NCT02748863|454857856|FG002|Treatment Period 1|Withdrawal by Subject|1|||
126426416|NCT02748863|454857857|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126426417|NCT02748863|454857858|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126426418|NCT02748863|454857854|FG000|Treatment Period 2|Lost to Follow-up|2|||
126426419|NCT02748863|454857855|FG001|Treatment Period 2|Lost to Follow-up|0|||
126426420|NCT02748863|454857856|FG002|Treatment Period 2|Lost to Follow-up|0|||
126426421|NCT02748863|454857857|FG003|Treatment Period 2|Lost to Follow-up|0|||
126340864|NCT02265510|454544405|FG005|Overall Study|Other|0|||
126340865|NCT02265510|454544406|FG006|Overall Study|Other|0|||
126340866|NCT02265510|454544407|FG007|Overall Study|Other|0|||
126340867|NCT02265510|454544408|FG008|Overall Study|Other|0|||
126340868|NCT02265510|454544409|FG009|Overall Study|Other|0|||
126340869|NCT02265510|454544410|FG010|Overall Study|Other|0|||
126340870|NCT02265510|454544411|FG011|Overall Study|Other|0|||
126340871|NCT02265510|454544412|FG012|Overall Study|Other|0|||
126340872|NCT02265510|454544413|FG013|Overall Study|Other|0|||
126340873|NCT02265510|454544400|FG000|Overall Study|Study Terminated by Sponsor|0|||
126340874|NCT02265510|454544401|FG001|Overall Study|Study Terminated by Sponsor|0|||
126340875|NCT02265510|454544402|FG002|Overall Study|Study Terminated by Sponsor|0|||
126340876|NCT02265510|454544403|FG003|Overall Study|Study Terminated by Sponsor|0|||
126340877|NCT02265510|454544404|FG004|Overall Study|Study Terminated by Sponsor|0|||
126340878|NCT02265510|454544405|FG005|Overall Study|Study Terminated by Sponsor|1|||
126340879|NCT02265510|454544406|FG006|Overall Study|Study Terminated by Sponsor|1|||
126340880|NCT02265510|454544407|FG007|Overall Study|Study Terminated by Sponsor|1|||
126340881|NCT02265510|454544408|FG008|Overall Study|Study Terminated by Sponsor|1|||
126340882|NCT02265510|454544409|FG009|Overall Study|Study Terminated by Sponsor|2|||
126340883|NCT02265510|454544410|FG010|Overall Study|Study Terminated by Sponsor|1|||
126340884|NCT02265510|454544411|FG011|Overall Study|Study Terminated by Sponsor|4|||
126340885|NCT02265510|454544412|FG012|Overall Study|Study Terminated by Sponsor|1|||
126340886|NCT02265510|454544413|FG013|Overall Study|Study Terminated by Sponsor|2|||
126340887|NCT01004614|454544414|FG000|Washout|Withdrawal by Subject|0|||
126340888|NCT01004614|454544415|FG001|Washout|Withdrawal by Subject|1|||
126340889|NCT01004614|454544416|FG002|Washout|Withdrawal by Subject|0|||
126340890|NCT01004614|454544417|FG003|Washout|Withdrawal by Subject|0|||
126340891|NCT02111083|454544418|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
126340892|NCT02111083|454544419|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
126340893|NCT00686972|454544420|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
126340894|NCT00368550|454544421|FG000|Overall Study|Adverse Event|7|||
126340895|NCT00368550|454544422|FG001|Overall Study|Adverse Event|4|||
126340896|NCT00368550|454544421|FG000|Overall Study|Lack of Efficacy|4|||
126340897|NCT00368550|454544422|FG001|Overall Study|Lack of Efficacy|9|||
126340898|NCT00368550|454544421|FG000|Overall Study|Withdrawal by Subject|17|||
126340899|NCT00368550|454544422|FG001|Overall Study|Withdrawal by Subject|10|||
126340900|NCT00486044|454544423|FG000|Overall Study|Withdrawal by Subject|2|||
126340901|NCT00486044|454544424|FG001|Overall Study|Withdrawal by Subject|1|||
126340902|NCT00486044|454544423|FG000|Overall Study|Adverse Event|0|||
126340903|NCT00486044|454544424|FG001|Overall Study|Adverse Event|1|||
126340904|NCT00486044|454544423|FG000|Overall Study|Lost to Follow-up|0|||
126340905|NCT00486044|454544424|FG001|Overall Study|Lost to Follow-up|1|||
126340906|NCT01670292|454544429|FG000|Overall Study|Lost to Follow-up|14|||
126340907|NCT03154086|454544433|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340908|NCT03154086|454544434|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340909|NCT03154086|454544435|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340910|NCT03154086|454544436|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
126340911|NCT03154086|454544437|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340912|NCT03154086|454544438|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340913|NCT03154086|454544439|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340914|NCT03154086|454544440|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340915|NCT03154086|454544441|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340916|NCT03154086|454544442|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340917|NCT03154086|454544443|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340918|NCT03154086|454544444|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340919|NCT03154086|454544445|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340920|NCT03154086|454544446|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126426422|NCT02748863|454857858|FG004|Treatment Period 2|Lost to Follow-up|0|||
126426423|NCT02748863|454857854|FG000|Treatment Period 2|Adverse Event|3|||
126426424|NCT02748863|454857855|FG001|Treatment Period 2|Adverse Event|2|||
126426425|NCT02748863|454857856|FG002|Treatment Period 2|Adverse Event|0|||
126426426|NCT02748863|454857857|FG003|Treatment Period 2|Adverse Event|2|||
126426427|NCT02748863|454857858|FG004|Treatment Period 2|Adverse Event|0|||
126426428|NCT02748863|454857854|FG000|Treatment Period 2|Lack of Efficacy|0|||
126426429|NCT02748863|454857855|FG001|Treatment Period 2|Lack of Efficacy|1|||
126426430|NCT02748863|454857856|FG002|Treatment Period 2|Lack of Efficacy|0|||
126426431|NCT02748863|454857857|FG003|Treatment Period 2|Lack of Efficacy|0|||
126426432|NCT02748863|454857858|FG004|Treatment Period 2|Lack of Efficacy|0|||
126426433|NCT02748863|454857854|FG000|Treatment Period 2|Pregnancy|0|||
126426434|NCT02748863|454857855|FG001|Treatment Period 2|Pregnancy|0|||
126426435|NCT02748863|454857856|FG002|Treatment Period 2|Pregnancy|0|||
126426436|NCT02748863|454857857|FG003|Treatment Period 2|Pregnancy|0|||
126426437|NCT02748863|454857858|FG004|Treatment Period 2|Pregnancy|1|||
126426438|NCT00867165|454857859|FG000|Overall Study|Adverse Event|3|||
126426439|NCT00867165|454857860|FG001|Overall Study|Adverse Event|0|||
126426440|NCT00867165|454857859|FG000|Overall Study|Withdrawal by Subject|1|||
126426441|NCT00867165|454857860|FG001|Overall Study|Withdrawal by Subject|0|||
126426442|NCT01054456|454857861|FG000|Overall Study|Other|1|||
126426443|NCT02738008|454857862|FG000|Overall Study|Study Terminated by Sponsor|1|||
126426444|NCT02738008|454857863|FG001|Overall Study|Study Terminated by Sponsor|5|||
126426445|NCT02738008|454857864|FG002|Overall Study|Study Terminated by Sponsor|3|||
126426446|NCT02738008|454857862|FG000|Overall Study|Adverse Event|0|||
126426447|NCT02738008|454857863|FG001|Overall Study|Adverse Event|1|||
126426448|NCT02738008|454857864|FG002|Overall Study|Adverse Event|2|||
126426449|NCT03550378|454857867|FG000|Overall Study|Death|0|||
126426450|NCT03550378|454857868|FG001|Overall Study|Death|1|||
126426451|NCT00468299|454857869|FG000|Overall Study|Withdrawal by Subject|0|||
126426452|NCT00468299|454857870|FG001|Overall Study|Withdrawal by Subject|1|||
126426453|NCT03546621|454857871|FG000|Overall Study|Withdrawal by Subject|0|||
126426454|NCT03546621|454857872|FG001|Overall Study|Withdrawal by Subject|1|||
126426455|NCT03546621|454857873|FG002|Overall Study|Withdrawal by Subject|2|||
126426456|NCT03546621|454857874|FG003|Overall Study|Withdrawal by Subject|1|||
126426457|NCT03546621|454857871|FG000|Overall Study|Lost to Follow-up|0|||
126426458|NCT03546621|454857872|FG001|Overall Study|Lost to Follow-up|1|||
126426459|NCT03546621|454857873|FG002|Overall Study|Lost to Follow-up|0|||
126426460|NCT03546621|454857874|FG003|Overall Study|Lost to Follow-up|0|||
126426461|NCT03546621|454857871|FG000|Overall Study|Adverse Event|0|||
126426462|NCT03546621|454857872|FG001|Overall Study|Adverse Event|1|||
126426463|NCT03546621|454857873|FG002|Overall Study|Adverse Event|0|||
126426464|NCT03546621|454857874|FG003|Overall Study|Adverse Event|1|||
126426465|NCT03546621|454857871|FG000|Overall Study|Progressive disease|0|||
126426466|NCT03546621|454857872|FG001|Overall Study|Progressive disease|0|||
126426467|NCT03546621|454857873|FG002|Overall Study|Progressive disease|0|||
126426468|NCT03546621|454857874|FG003|Overall Study|Progressive disease|1|||
126426469|NCT00377520|454857879|FG000|Overall Study|Ineligible (Prior radiation)|1|||
126426470|NCT03040141|454857886|FG000|Overall Study|Death|1|||
126426471|NCT03040141|454857887|FG001|Overall Study|Death|2|||
126426472|NCT03040141|454857888|FG002|Overall Study|Death|3|||
126426473|NCT03040141|454857886|FG000|Overall Study|Withdrawal by Subject|3|||
126426474|NCT03040141|454857887|FG001|Overall Study|Withdrawal by Subject|1|||
126426475|NCT03040141|454857888|FG002|Overall Study|Withdrawal by Subject|1|||
126426476|NCT03040141|454857886|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
126426477|NCT03040141|454857887|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
126426478|NCT03040141|454857888|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
126426479|NCT03040141|454857886|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
126426480|NCT03040141|454857887|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
126426481|NCT03040141|454857888|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
126426482|NCT00462306|454857889|FG000|Overall Study|insufficient data|0|||
126426483|NCT00462306|454857890|FG001|Overall Study|insufficient data|13|||
126426484|NCT03515824|454857891|FG000|Overall Study|Death|3|||
126426485|NCT03515824|454857892|FG001|Overall Study|Death|2|||
126674318|NCT03977974|455764573|FG007|Period 2|Adverse Event|0|||
126674319|NCT03977974|455764574|FG008|Period 2|Adverse Event|0|||
126426486|NCT03515824|454857893|FG002|Overall Study|Death|6|||
126426487|NCT03515824|454857894|FG003|Overall Study|Death|0|||
126426488|NCT03515824|454857891|FG000|Overall Study|Lost to Follow-up|0|||
126426489|NCT03515824|454857892|FG001|Overall Study|Lost to Follow-up|1|||
126426490|NCT03515824|454857893|FG002|Overall Study|Lost to Follow-up|1|||
126426491|NCT03515824|454857894|FG003|Overall Study|Lost to Follow-up|0|||
126426492|NCT03515824|454857891|FG000|Overall Study|Study terminated by sponsor|0|||
126426493|NCT03515824|454857892|FG001|Overall Study|Study terminated by sponsor|1|||
126674320|NCT03977974|455764575|FG009|Period 2|Adverse Event|0|||
126674321|NCT03977974|455764576|FG010|Period 2|Adverse Event|0|||
126674322|NCT03977974|455764577|FG011|Period 2|Adverse Event|0|||
126674323|NCT03977974|455764578|FG012|Period 2|Adverse Event|0|||
126426494|NCT03515824|454857893|FG002|Overall Study|Study terminated by sponsor|6|||
126426495|NCT03515824|454857894|FG003|Overall Study|Study terminated by sponsor|0|||
126674324|NCT00766038|455765925|FG000|Overall Study|Lost to Follow-up|15|||
126674325|NCT00766038|455765926|FG001|Overall Study|Lost to Follow-up|14|||
126674326|NCT00449670|455765927|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
126674327|NCT00449670|455765928|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
126674328|NCT00449670|455765927|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
126674329|NCT00449670|455765928|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
126340921|NCT03154086|454544447|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
126340922|NCT03154086|454544433|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340923|NCT03154086|454544434|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
126340924|NCT03154086|454544435|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340925|NCT03154086|454544436|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340926|NCT03154086|454544437|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340927|NCT03154086|454544438|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340928|NCT03154086|454544439|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340929|NCT03154086|454544440|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340930|NCT03154086|454544441|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340931|NCT03154086|454544442|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340932|NCT03154086|454544443|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340933|NCT03154086|454544444|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340934|NCT03154086|454544445|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340935|NCT03154086|454544446|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340936|NCT03154086|454544447|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
126340937|NCT03154086|454544433|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340938|NCT03154086|454544434|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340939|NCT03154086|454544435|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
126340940|NCT03154086|454544436|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340941|NCT03154086|454544437|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340942|NCT03154086|454544438|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340943|NCT03154086|454544439|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340944|NCT03154086|454544440|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340945|NCT03154086|454544441|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340946|NCT03154086|454544442|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340947|NCT03154086|454544443|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340948|NCT03154086|454544444|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340949|NCT03154086|454544445|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340950|NCT03154086|454544446|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340951|NCT03154086|454544447|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
126340952|NCT03154086|454544433|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
126340953|NCT03154086|454544434|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340954|NCT03154086|454544435|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340955|NCT03154086|454544436|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340956|NCT03154086|454544437|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340957|NCT03154086|454544438|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340958|NCT03154086|454544439|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340959|NCT03154086|454544440|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340960|NCT03154086|454544441|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340961|NCT03154086|454544442|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340962|NCT03154086|454544443|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340963|NCT03154086|454544444|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340964|NCT03154086|454544445|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340965|NCT03154086|454544446|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340966|NCT03154086|454544447|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
126340967|NCT03154086|454544433|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340968|NCT03154086|454544434|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340969|NCT03154086|454544435|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340970|NCT03154086|454544436|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340971|NCT03154086|454544437|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340972|NCT03154086|454544438|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340973|NCT03154086|454544439|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340974|NCT03154086|454544440|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340975|NCT03154086|454544441|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
126340976|NCT03154086|454544442|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340977|NCT03154086|454544443|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340978|NCT03154086|454544444|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340979|NCT03154086|454544445|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126674330|NCT00449670|455765927|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
126674331|NCT00449670|455765928|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
126674332|NCT00449670|455765927|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
126674333|NCT00449670|455765928|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
126674334|NCT00449670|455765927|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
126674335|NCT00449670|455765928|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
126674336|NCT00449670|455765927|FG000|Booster Phase (Study no.109873)|Other|0|||
126674337|NCT00449670|455765928|FG001|Booster Phase (Study no.109873)|Other|2|||
126674338|NCT00847145|455765933|FG000|Overall Study|AE or Death|0|||
126674339|NCT00847145|455765934|FG001|Overall Study|AE or Death|1|||
126674340|NCT00847145|455765935|FG002|Overall Study|AE or Death|1|||
126674341|NCT00847145|455765936|FG003|Overall Study|AE or Death|0|||
126674342|NCT00847145|455765937|FG004|Overall Study|AE or Death|0|||
126674343|NCT00847145|455765938|FG005|Overall Study|AE or Death|0|||
126674344|NCT00847145|455765939|FG006|Overall Study|AE or Death|0|||
126674345|NCT00847145|455765940|FG007|Overall Study|AE or Death|0|||
126674346|NCT00847145|455765933|FG000|Overall Study|Withdrawal by Subject|3|||
126674347|NCT00847145|455765934|FG001|Overall Study|Withdrawal by Subject|4|||
126674348|NCT00847145|455765935|FG002|Overall Study|Withdrawal by Subject|6|||
126674349|NCT00847145|455765936|FG003|Overall Study|Withdrawal by Subject|1|||
126674350|NCT00847145|455765937|FG004|Overall Study|Withdrawal by Subject|0|||
126674351|NCT00847145|455765938|FG005|Overall Study|Withdrawal by Subject|0|||
126674352|NCT00847145|455765939|FG006|Overall Study|Withdrawal by Subject|1|||
126674353|NCT00847145|455765940|FG007|Overall Study|Withdrawal by Subject|1|||
126674354|NCT00847145|455765933|FG000|Overall Study|Lost to Follow-up|3|||
126674355|NCT00847145|455765934|FG001|Overall Study|Lost to Follow-up|1|||
126674356|NCT00847145|455765935|FG002|Overall Study|Lost to Follow-up|1|||
126674357|NCT00847145|455765936|FG003|Overall Study|Lost to Follow-up|0|||
126674358|NCT00847145|455765937|FG004|Overall Study|Lost to Follow-up|4|||
126674359|NCT00847145|455765938|FG005|Overall Study|Lost to Follow-up|4|||
126674360|NCT00847145|455765939|FG006|Overall Study|Lost to Follow-up|8|||
126674361|NCT00847145|455765940|FG007|Overall Study|Lost to Follow-up|2|||
126674362|NCT00847145|455765933|FG000|Overall Study|Inappropriate enrollment|0|||
126674363|NCT00847145|455765934|FG001|Overall Study|Inappropriate enrollment|0|||
126674364|NCT00847145|455765935|FG002|Overall Study|Inappropriate enrollment|0|||
126674365|NCT00847145|455765936|FG003|Overall Study|Inappropriate enrollment|0|||
126674366|NCT00847145|455765937|FG004|Overall Study|Inappropriate enrollment|1|||
126674367|NCT00847145|455765938|FG005|Overall Study|Inappropriate enrollment|0|||
126674368|NCT00847145|455765939|FG006|Overall Study|Inappropriate enrollment|0|||
126340980|NCT03154086|454544446|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340981|NCT03154086|454544447|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
126340982|NCT03154086|454544433|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340983|NCT03154086|454544434|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340984|NCT03154086|454544435|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340985|NCT03154086|454544436|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340986|NCT03154086|454544437|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340987|NCT03154086|454544438|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340988|NCT03154086|454544439|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340989|NCT03154086|454544440|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
126340990|NCT03154086|454544441|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340991|NCT03154086|454544442|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340992|NCT03154086|454544443|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340993|NCT03154086|454544444|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340994|NCT03154086|454544445|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340995|NCT03154086|454544446|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340996|NCT03154086|454544447|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
126340997|NCT03154086|454544433|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
126340998|NCT03154086|454544434|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
126340999|NCT03154086|454544435|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
126341000|NCT03154086|454544436|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
126341001|NCT03154086|454544437|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
126341002|NCT03154086|454544438|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
126341003|NCT03154086|454544439|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
126341004|NCT03154086|454544440|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
126341005|NCT03154086|454544441|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
126341006|NCT03154086|454544442|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
126341007|NCT03154086|454544443|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
126341008|NCT03154086|454544444|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
126341009|NCT03154086|454544445|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
126341010|NCT03154086|454544446|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
126341011|NCT03154086|454544447|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
126341012|NCT01603277|454544448|FG000|Overall Study|Adverse Event|1|||
126341013|NCT01603277|454544449|FG001|Overall Study|Adverse Event|2|||
126674369|NCT00847145|455765940|FG007|Overall Study|Inappropriate enrollment|0|||
126674370|NCT00847145|455765933|FG000|Overall Study|Protocol Violation|0|||
126674371|NCT00847145|455765934|FG001|Overall Study|Protocol Violation|0|||
126426496|NCT03515824|454857891|FG000|Overall Study|Status not recorded|0|||
126674372|NCT00847145|455765935|FG002|Overall Study|Protocol Violation|3|||
126674373|NCT00847145|455765936|FG003|Overall Study|Protocol Violation|0|||
126674374|NCT00847145|455765937|FG004|Overall Study|Protocol Violation|1|||
126674375|NCT00847145|455765938|FG005|Overall Study|Protocol Violation|0|||
126674376|NCT00847145|455765939|FG006|Overall Study|Protocol Violation|0|||
126674377|NCT00847145|455765940|FG007|Overall Study|Protocol Violation|1|||
126674378|NCT02833974|455765942|FG000|Overall Study|Lost to Follow-up|1|||
126674379|NCT02833974|455765943|FG001|Overall Study|Lost to Follow-up|0|||
126674380|NCT02833974|455765942|FG000|Overall Study|Adverse Event|0|||
126674381|NCT02833974|455765943|FG001|Overall Study|Adverse Event|3|||
126674382|NCT01524198|455765944|FG000|Overall Study|Protocol Violation|8|||
126674383|NCT01524198|455765945|FG001|Overall Study|Protocol Violation|6|||
126674384|NCT01524198|455765944|FG000|Overall Study|Withdrawal by Subject|15|||
126674385|NCT01524198|455765945|FG001|Overall Study|Withdrawal by Subject|10|||
126674386|NCT04419610|455765946|FG000|Overall Study|Withdrawal by Subject|3|||
126674387|NCT04419610|455765947|FG001|Overall Study|Withdrawal by Subject|1|||
126674388|NCT04419610|455765946|FG000|Overall Study|Adverse Event|1|||
126674389|NCT04419610|455765947|FG001|Overall Study|Adverse Event|0|||
126674390|NCT04419610|455765946|FG000|Overall Study|discharged early|1|||
126674391|NCT04419610|455765947|FG001|Overall Study|discharged early|1|||
126674392|NCT02232802|455765948|FG000|Period 1|Sponsor request|1|||
126674393|NCT02232802|455765949|FG001|Period 1|Sponsor request|0|||
126674394|NCT02232802|455765948|FG000|Period 1|Adverse Event|1|||
126674395|NCT02232802|455765949|FG001|Period 1|Adverse Event|1|||
126674396|NCT01490450|455765956|FG000|Period 1|Lack of Efficacy|2|||
126674397|NCT01490450|455765957|FG001|Period 1|Lack of Efficacy|0|||
126674398|NCT01490450|455765958|FG002|Period 1|Lack of Efficacy|3|||
126674399|NCT01490450|455765959|FG003|Period 1|Lack of Efficacy|0|||
126674400|NCT01490450|455765956|FG000|Period 1|Adverse Event|0|||
126674401|NCT01490450|455765957|FG001|Period 1|Adverse Event|0|||
126674402|NCT01490450|455765958|FG002|Period 1|Adverse Event|0|||
126674403|NCT01490450|455765959|FG003|Period 1|Adverse Event|5|||
126426497|NCT03515824|454857892|FG001|Overall Study|Status not recorded|0|||
126426498|NCT03515824|454857893|FG002|Overall Study|Status not recorded|2|||
126426499|NCT03515824|454857894|FG003|Overall Study|Status not recorded|0|||
126426500|NCT01384734|454857896|FG000|Overall Study|Adverse Event|0|||
126674404|NCT01490450|455765956|FG000|Period 1|Request to discontinue treatment|1|||
126674405|NCT01490450|455765957|FG001|Period 1|Request to discontinue treatment|0|||
126426501|NCT01384734|454857897|FG001|Overall Study|Adverse Event|3|||
126426502|NCT01384734|454857898|FG002|Overall Study|Adverse Event|0|||
126426503|NCT01384734|454857899|FG003|Overall Study|Adverse Event|2|||
126426504|NCT01384734|454857900|FG004|Overall Study|Adverse Event|7|||
126426505|NCT01384734|454857896|FG000|Overall Study|Death|1|||
126426506|NCT01384734|454857897|FG001|Overall Study|Death|0|||
126426507|NCT01384734|454857898|FG002|Overall Study|Death|1|||
126426508|NCT01384734|454857899|FG003|Overall Study|Death|0|||
126426509|NCT01384734|454857900|FG004|Overall Study|Death|0|||
126426510|NCT01384734|454857896|FG000|Overall Study|Continuation criteria not met|0|||
126426511|NCT01384734|454857897|FG001|Overall Study|Continuation criteria not met|0|||
126426512|NCT01384734|454857898|FG002|Overall Study|Continuation criteria not met|1|||
126426513|NCT01384734|454857899|FG003|Overall Study|Continuation criteria not met|1|||
126426514|NCT01384734|454857900|FG004|Overall Study|Continuation criteria not met|0|||
126426515|NCT01384734|454857896|FG000|Overall Study|Lack of Efficacy|3|||
126426516|NCT01384734|454857897|FG001|Overall Study|Lack of Efficacy|7|||
126426517|NCT01384734|454857898|FG002|Overall Study|Lack of Efficacy|4|||
126426518|NCT01384734|454857899|FG003|Overall Study|Lack of Efficacy|4|||
126426519|NCT01384734|454857900|FG004|Overall Study|Lack of Efficacy|2|||
126426520|NCT01384734|454857896|FG000|Overall Study|Lost to Follow-up|5|||
126426521|NCT01384734|454857897|FG001|Overall Study|Lost to Follow-up|3|||
126426522|NCT01384734|454857898|FG002|Overall Study|Lost to Follow-up|3|||
126426523|NCT01384734|454857899|FG003|Overall Study|Lost to Follow-up|8|||
126426524|NCT01384734|454857900|FG004|Overall Study|Lost to Follow-up|5|||
126674406|NCT01490450|455765958|FG002|Period 1|Request to discontinue treatment|0|||
126674407|NCT01490450|455765959|FG003|Period 1|Request to discontinue treatment|0|||
126674408|NCT01490450|455765956|FG000|Period 1|Withdrawal by Subject|0|||
126674409|NCT01490450|455765957|FG001|Period 1|Withdrawal by Subject|0|||
126426525|NCT01384734|454857896|FG000|Overall Study|Non-compliance with study drug|1|||
126426526|NCT01384734|454857897|FG001|Overall Study|Non-compliance with study drug|2|||
126674410|NCT01490450|455765958|FG002|Period 1|Withdrawal by Subject|0|||
126674411|NCT01490450|455765959|FG003|Period 1|Withdrawal by Subject|3|||
126674412|NCT01490450|455765956|FG000|Period 1|No longer met study criteria|0|||
126426527|NCT01384734|454857898|FG002|Overall Study|Non-compliance with study drug|6|||
126426528|NCT01384734|454857899|FG003|Overall Study|Non-compliance with study drug|0|||
126426529|NCT01384734|454857900|FG004|Overall Study|Non-compliance with study drug|2|||
126426530|NCT01384734|454857896|FG000|Overall Study|Pregnancy|0|||
126674413|NCT01490450|455765957|FG001|Period 1|No longer met study criteria|1|||
126674414|NCT01490450|455765958|FG002|Period 1|No longer met study criteria|1|||
126674415|NCT01490450|455765959|FG003|Period 1|No longer met study criteria|0|||
126674416|NCT01490450|455765956|FG000|Period 2|Lack of Efficacy|0|||
126674417|NCT01490450|455765957|FG001|Period 2|Lack of Efficacy|0|||
126674418|NCT01490450|455765958|FG002|Period 2|Lack of Efficacy|0|||
126674419|NCT01490450|455765959|FG003|Period 2|Lack of Efficacy|1|||
126674420|NCT01490450|455765956|FG000|Period 2|Adverse Event|1|||
126674421|NCT01490450|455765957|FG001|Period 2|Adverse Event|1|||
126674422|NCT01490450|455765958|FG002|Period 2|Adverse Event|0|||
126674423|NCT01490450|455765959|FG003|Period 2|Adverse Event|1|||
126674424|NCT01490450|455765956|FG000|Period 2|Withdrawal by Subject|1|||
126674425|NCT01490450|455765957|FG001|Period 2|Withdrawal by Subject|0|||
126674426|NCT01490450|455765958|FG002|Period 2|Withdrawal by Subject|0|||
126674427|NCT01490450|455765959|FG003|Period 2|Withdrawal by Subject|0|||
126674428|NCT01490450|455765956|FG000|Period 2|Lost to Follow-up|0|||
126674429|NCT01490450|455765957|FG001|Period 2|Lost to Follow-up|0|||
126674430|NCT01490450|455765958|FG002|Period 2|Lost to Follow-up|0|||
126674431|NCT01490450|455765959|FG003|Period 2|Lost to Follow-up|2|||
126674432|NCT03197493|455765960|FG000|Overall Study|Withdrawal by Subject|5|||
126674433|NCT00054704|455765963|FG000|Overall Study|Lack of Efficacy|2|||
126674434|NCT00054704|455765964|FG001|Overall Study|Lack of Efficacy|3|||
126674435|NCT00054704|455765963|FG000|Overall Study|Adverse Event|3|||
126674436|NCT00054704|455765964|FG001|Overall Study|Adverse Event|1|||
126674437|NCT00054704|455765963|FG000|Overall Study|Lost to Follow-up|0|||
126674438|NCT00054704|455765964|FG001|Overall Study|Lost to Follow-up|1|||
126674439|NCT00362414|455765965|FG000|Overall Study|Death|2|||
126674440|NCT00362414|455765965|FG000|Overall Study|Adverse Event|1|||
126674441|NCT02053168|455765966|FG000|Overall Study|Withdrawal by Subject|1|||
126674442|NCT02053168|455765966|FG000|Overall Study|Physician Decision|1|||
126674443|NCT02053168|455765966|FG000|Overall Study|Lost to Follow-up|1|||
126674444|NCT00636675|455765967|FG000|Overall Study|Lost to Follow-up|121|||
126674445|NCT00636675|455765968|FG001|Overall Study|Lost to Follow-up|31|||
126674446|NCT00636675|455765967|FG000|Overall Study|Withdrawal by Subject|19|||
126674447|NCT00636675|455765968|FG001|Overall Study|Withdrawal by Subject|10|||
126674448|NCT04053868|455765969|FG000|Overall Study|Withdrawal by Subject|1|||
126674449|NCT04053868|455765970|FG001|Overall Study|Withdrawal by Subject|0|||
126674450|NCT00833053|455765971|FG000|Overall Study|Adverse Event|4|||
126674451|NCT00833053|455765972|FG001|Overall Study|Adverse Event|0|||
126674452|NCT00833053|455765971|FG000|Overall Study|Treatment Failure|3|||
126674453|NCT00833053|455765972|FG001|Overall Study|Treatment Failure|1|||
126674454|NCT00833053|455765971|FG000|Overall Study|Withdrawal by Subject|0|||
126674455|NCT00833053|455765972|FG001|Overall Study|Withdrawal by Subject|1|||
126674456|NCT00833053|455765971|FG000|Overall Study|Protocol Violation|2|||
126674457|NCT00833053|455765972|FG001|Overall Study|Protocol Violation|1|||
126674458|NCT02187471|455765974|FG000|Overall Study|Protocol Violation|4|||
126674459|NCT02187471|455765975|FG001|Overall Study|Protocol Violation|5|||
126674460|NCT02187471|455765976|FG002|Overall Study|Protocol Violation|4|||
126674461|NCT02187471|455765977|FG003|Overall Study|Protocol Violation|4|||
126674462|NCT02187471|455765974|FG000|Overall Study|Missing|0|||
126674463|NCT02187471|455765975|FG001|Overall Study|Missing|0|||
126674464|NCT02187471|455765976|FG002|Overall Study|Missing|0|||
126674465|NCT02187471|455765977|FG003|Overall Study|Missing|1|||
126426531|NCT01384734|454857897|FG001|Overall Study|Pregnancy|1|||
126426532|NCT01384734|454857898|FG002|Overall Study|Pregnancy|0|||
126426533|NCT01384734|454857899|FG003|Overall Study|Pregnancy|0|||
126426534|NCT01384734|454857900|FG004|Overall Study|Pregnancy|1|||
126426535|NCT01384734|454857896|FG000|Overall Study|Sponsor terminated|0|||
126426536|NCT01384734|454857897|FG001|Overall Study|Sponsor terminated|0|||
126674466|NCT02187471|455765974|FG000|Overall Study|Lack of Efficacy|18|||
126674467|NCT02187471|455765975|FG001|Overall Study|Lack of Efficacy|9|||
126674468|NCT02187471|455765976|FG002|Overall Study|Lack of Efficacy|13|||
126674469|NCT02187471|455765977|FG003|Overall Study|Lack of Efficacy|11|||
126674470|NCT02187471|455765974|FG000|Overall Study|Adverse Event|24|||
126674471|NCT02187471|455765975|FG001|Overall Study|Adverse Event|34|||
126674472|NCT02187471|455765976|FG002|Overall Study|Adverse Event|44|||
126674473|NCT02187471|455765977|FG003|Overall Study|Adverse Event|36|||
126674474|NCT02187471|455765974|FG000|Overall Study|Withdrawal by Subject|23|||
126674475|NCT02187471|455765975|FG001|Overall Study|Withdrawal by Subject|29|||
126674476|NCT02187471|455765976|FG002|Overall Study|Withdrawal by Subject|22|||
126674477|NCT02187471|455765977|FG003|Overall Study|Withdrawal by Subject|24|||
126674478|NCT02187471|455765974|FG000|Overall Study|Other|7|||
126674479|NCT02187471|455765975|FG001|Overall Study|Other|5|||
126426537|NCT01384734|454857898|FG002|Overall Study|Sponsor terminated|0|||
126426538|NCT01384734|454857899|FG003|Overall Study|Sponsor terminated|0|||
126674480|NCT02187471|455765976|FG002|Overall Study|Other|3|||
126674481|NCT02187471|455765977|FG003|Overall Study|Other|4|||
126674482|NCT02236520|455765978|FG000|Overall Study|Physician Decision|0|||
126674483|NCT02236520|455765979|FG001|Overall Study|Physician Decision|5|||
126674484|NCT02236520|455765980|FG002|Overall Study|Physician Decision|0|||
126674485|NCT02236520|455765981|FG003|Overall Study|Physician Decision|0|||
126674486|NCT02236520|455765978|FG000|Overall Study|Withdrawal by Subject|1|||
126674487|NCT02236520|455765979|FG001|Overall Study|Withdrawal by Subject|0|||
126674488|NCT02236520|455765980|FG002|Overall Study|Withdrawal by Subject|0|||
126674489|NCT02236520|455765981|FG003|Overall Study|Withdrawal by Subject|1|||
126674490|NCT02236520|455765978|FG000|Overall Study|Pregnancy|1|||
126674491|NCT02236520|455765979|FG001|Overall Study|Pregnancy|0|||
126674492|NCT02236520|455765980|FG002|Overall Study|Pregnancy|0|||
126674493|NCT02236520|455765981|FG003|Overall Study|Pregnancy|0|||
126341014|NCT01603277|454544448|FG000|Overall Study|Physician Decision|0|||
126341015|NCT01603277|454544449|FG001|Overall Study|Physician Decision|1|||
126341016|NCT01603277|454544448|FG000|Overall Study|Protocol Violation|6|||
126341017|NCT01603277|454544449|FG001|Overall Study|Protocol Violation|10|||
126341018|NCT01603277|454544448|FG000|Overall Study|Withdrawal by Subject|5|||
126341019|NCT01603277|454544449|FG001|Overall Study|Withdrawal by Subject|4|||
126341020|NCT01603277|454544448|FG000|Overall Study|Non-Compliance|2|||
126341021|NCT01603277|454544449|FG001|Overall Study|Non-Compliance|1|||
126341022|NCT04494646|454544454|FG000|Overall Study|Adverse Event|0|||
126341023|NCT04494646|454544455|FG001|Overall Study|Adverse Event|1|||
126341024|NCT04494646|454544454|FG000|Overall Study|Withdrawal by Subject|0|||
126341025|NCT04494646|454544455|FG001|Overall Study|Withdrawal by Subject|1|||
126341026|NCT02785939|454544458|FG000|Overall Study|Progression|25|||
126341027|NCT02785939|454544459|FG001|Overall Study|Progression|8|||
126341028|NCT02785939|454544458|FG000|Overall Study|Adverse Event|3|||
126341029|NCT02785939|454544459|FG001|Overall Study|Adverse Event|1|||
126341030|NCT02785939|454544458|FG000|Overall Study|Death|1|||
126341031|NCT02785939|454544459|FG001|Overall Study|Death|0|||
126341032|NCT02785939|454544458|FG000|Overall Study|Refusal|1|||
126341033|NCT02785939|454544459|FG001|Overall Study|Refusal|0|||
126341034|NCT02785939|454544458|FG000|Overall Study|Deteriorating health|1|||
126341035|NCT02785939|454544459|FG001|Overall Study|Deteriorating health|0|||
126341036|NCT02785939|454544458|FG000|Overall Study|Not protocol specified|0|||
126341037|NCT02785939|454544459|FG001|Overall Study|Not protocol specified|1|||
126341038|NCT02391337|454544463|FG000|6 Months Follow-up|Death|5|||
126341039|NCT02391337|454544464|FG001|6 Months Follow-up|Death|4|||
126341040|NCT02391337|454544463|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
126341041|NCT02391337|454544464|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
126341042|NCT02391337|454544463|FG000|12 Months Follow-up|Death|2|||
126341043|NCT02391337|454544464|FG001|12 Months Follow-up|Death|0|||
126341044|NCT02391337|454544463|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
126341045|NCT02391337|454544464|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
126341046|NCT02391337|454544463|FG000|12 Months Follow-up|Lost to Follow-up|0|||
126341047|NCT02391337|454544464|FG001|12 Months Follow-up|Lost to Follow-up|2|||
126341048|NCT03122171|454544481|FG000|Overall Study|Withdrawal by Subject|1|||
126341049|NCT01326871|454544491|FG000|Overall Study|Major surgery|0|||
126341050|NCT01326871|454544492|FG001|Overall Study|Major surgery|1|||
126341051|NCT01326871|454544493|FG002|Overall Study|Major surgery|0|||
126341052|NCT01326871|454544491|FG000|Overall Study|SAE and death|0|||
126341053|NCT01326871|454544492|FG001|Overall Study|SAE and death|2|||
126341054|NCT01326871|454544493|FG002|Overall Study|SAE and death|0|||
126341055|NCT01326871|454544491|FG000|Overall Study|Physician decision and decreased performance status|0|||
126341056|NCT01326871|454544492|FG001|Overall Study|Physician decision and decreased performance status|1|||
126341057|NCT01326871|454544493|FG002|Overall Study|Physician decision and decreased performance status|0|||
126341058|NCT01326871|454544491|FG000|Overall Study|Disease progression|0|||
126341059|NCT01326871|454544492|FG001|Overall Study|Disease progression|11|||
126341060|NCT01326871|454544493|FG002|Overall Study|Disease progression|5|||
126341061|NCT01326871|454544491|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
126341062|NCT01326871|454544492|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
126341063|NCT01326871|454544493|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
126341064|NCT01326871|454544491|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
126341065|NCT01326871|454544492|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
126341066|NCT01326871|454544493|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
126341067|NCT01326871|454544491|FG000|Overall Study|Withdrawal by Subject|0|||
126341068|NCT01326871|454544492|FG001|Overall Study|Withdrawal by Subject|1|||
126341069|NCT01326871|454544493|FG002|Overall Study|Withdrawal by Subject|0|||
126341070|NCT01326871|454544491|FG000|Overall Study|DLT|0|||
126341071|NCT01326871|454544492|FG001|Overall Study|DLT|2|||
126341072|NCT01326871|454544493|FG002|Overall Study|DLT|0|||
126341073|NCT01326871|454544491|FG000|Overall Study|SAE, disease progression and subject decision|0|||
126341074|NCT01326871|454544492|FG001|Overall Study|SAE, disease progression and subject decision|1|||
126341075|NCT01326871|454544493|FG002|Overall Study|SAE, disease progression and subject decision|0|||
126341076|NCT01326871|454544491|FG000|Overall Study|Death|0|||
126341077|NCT01326871|454544492|FG001|Overall Study|Death|1|||
126341078|NCT01326871|454544493|FG002|Overall Study|Death|0|||
126674494|NCT01785160|455765982|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
126341079|NCT01326871|454544491|FG000|Overall Study|Other|0|||
126341080|NCT01326871|454544492|FG001|Overall Study|Other|3|||
126341081|NCT01326871|454544493|FG002|Overall Study|Other|0|||
126341082|NCT01326871|454544491|FG000|Overall Study|SAE and disease progression|0|||
126341083|NCT01326871|454544492|FG001|Overall Study|SAE and disease progression|0|||
126426539|NCT01384734|454857900|FG004|Overall Study|Sponsor terminated|1|||
126426540|NCT01384734|454857896|FG000|Overall Study|Withdrawal by Subject|5|||
126426541|NCT01384734|454857897|FG001|Overall Study|Withdrawal by Subject|5|||
126426542|NCT01384734|454857898|FG002|Overall Study|Withdrawal by Subject|6|||
126426543|NCT01384734|454857899|FG003|Overall Study|Withdrawal by Subject|7|||
126426544|NCT01384734|454857900|FG004|Overall Study|Withdrawal by Subject|9|||
126426545|NCT01384734|454857896|FG000|Overall Study|Investigator relocating|0|||
126426546|NCT01384734|454857897|FG001|Overall Study|Investigator relocating|2|||
126426547|NCT01384734|454857898|FG002|Overall Study|Investigator relocating|0|||
126426548|NCT01384734|454857899|FG003|Overall Study|Investigator relocating|3|||
126426549|NCT01384734|454857900|FG004|Overall Study|Investigator relocating|1|||
126426550|NCT01384734|454857896|FG000|Overall Study|Unable to come back for visit|1|||
126426551|NCT01384734|454857897|FG001|Overall Study|Unable to come back for visit|0|||
126426552|NCT01384734|454857898|FG002|Overall Study|Unable to come back for visit|1|||
126426553|NCT01384734|454857899|FG003|Overall Study|Unable to come back for visit|1|||
126426554|NCT01384734|454857900|FG004|Overall Study|Unable to come back for visit|0|||
126426555|NCT01384734|454857896|FG000|Overall Study|Prison|0|||
126426556|NCT01384734|454857897|FG001|Overall Study|Prison|0|||
126426557|NCT01384734|454857898|FG002|Overall Study|Prison|1|||
126426558|NCT01384734|454857899|FG003|Overall Study|Prison|0|||
126426559|NCT01384734|454857900|FG004|Overall Study|Prison|0|||
126426560|NCT01384734|454857896|FG000|Overall Study|As per Exclusion criteria|0|||
126426561|NCT01384734|454857897|FG001|Overall Study|As per Exclusion criteria|1|||
126426562|NCT01384734|454857898|FG002|Overall Study|As per Exclusion criteria|0|||
126426563|NCT01384734|454857899|FG003|Overall Study|As per Exclusion criteria|0|||
126426564|NCT01384734|454857900|FG004|Overall Study|As per Exclusion criteria|0|||
126426565|NCT01384734|454857896|FG000|Overall Study|Missed End of treatment visit|0|||
126426566|NCT01384734|454857897|FG001|Overall Study|Missed End of treatment visit|0|||
126426567|NCT01384734|454857898|FG002|Overall Study|Missed End of treatment visit|0|||
126426568|NCT01384734|454857899|FG003|Overall Study|Missed End of treatment visit|1|||
126426569|NCT01384734|454857900|FG004|Overall Study|Missed End of treatment visit|0|||
126426570|NCT01384734|454857896|FG000|Overall Study|Adhesion problem|0|||
126426571|NCT01384734|454857897|FG001|Overall Study|Adhesion problem|0|||
126426572|NCT01384734|454857898|FG002|Overall Study|Adhesion problem|0|||
126426573|NCT01384734|454857899|FG003|Overall Study|Adhesion problem|1|||
126426574|NCT01384734|454857900|FG004|Overall Study|Adhesion problem|0|||
126426575|NCT01384734|454857896|FG000|Overall Study|Early termination|0|||
126426576|NCT01384734|454857897|FG001|Overall Study|Early termination|0|||
126426577|NCT01384734|454857898|FG002|Overall Study|Early termination|0|||
126426578|NCT01384734|454857899|FG003|Overall Study|Early termination|0|||
126426579|NCT01384734|454857900|FG004|Overall Study|Early termination|1|||
126426580|NCT01384734|454857896|FG000|Overall Study|Physician Decision|1|||
126426581|NCT01384734|454857897|FG001|Overall Study|Physician Decision|0|||
126426582|NCT01384734|454857898|FG002|Overall Study|Physician Decision|0|||
126426583|NCT01384734|454857899|FG003|Overall Study|Physician Decision|0|||
126426584|NCT01384734|454857900|FG004|Overall Study|Physician Decision|0|||
126426585|NCT00154297|454857901|FG000|Overall Study|Death|5|||
126426586|NCT00154297|454857902|FG001|Overall Study|Death|2|||
126426587|NCT00154297|454857901|FG000|Overall Study|Withdrawal by Subject|0|||
126426588|NCT00154297|454857902|FG001|Overall Study|Withdrawal by Subject|5|||
126426589|NCT00154297|454857901|FG000|Overall Study|Lost to Follow-up|3|||
126426590|NCT00154297|454857902|FG001|Overall Study|Lost to Follow-up|0|||
126426591|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
126426592|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
126426593|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
126674495|NCT01785160|455765982|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
126426594|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
126426595|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
126426596|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
126426597|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
126426598|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
126674496|NCT00957528|455765983|FG000|Overall Study|Protocol Violation|0|||
126674497|NCT00957528|455765984|FG001|Overall Study|Protocol Violation|1|||
126426599|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
126426600|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
126426601|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
126426602|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
126426603|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
126674498|NCT00957528|455765985|FG002|Overall Study|Protocol Violation|0|||
126426604|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
126426605|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
126426606|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
126426607|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
126426608|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
126674499|NCT00957528|455765983|FG000|Overall Study|Withdrawal by Subject|0|||
126426609|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
126426610|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
126426611|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
126426612|NCT00550407|454857904|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
126426613|NCT00550407|454857905|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
126426614|NCT00550407|454857906|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
126426615|NCT00550407|454857904|FG000|26-Week Randomized Phase|Adverse Event|0|||
126426616|NCT00550407|454857905|FG001|26-Week Randomized Phase|Adverse Event|5|||
126426617|NCT00550407|454857906|FG002|26-Week Randomized Phase|Adverse Event|2|||
126426618|NCT00550407|454857904|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
126426619|NCT00550407|454857905|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
126426620|NCT00550407|454857906|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
126426621|NCT00550407|454857904|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
126426622|NCT00550407|454857905|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
126426623|NCT00550407|454857906|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
126426624|NCT00550407|454857904|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
126426625|NCT00550407|454857905|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
126426626|NCT00550407|454857906|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
126426627|NCT05051579|454857907|FG000|Overall Study|Withdrawal by Subject|3|||
126426628|NCT05051579|454857908|FG001|Overall Study|Withdrawal by Subject|5|||
126426629|NCT05051579|454857909|FG002|Overall Study|Withdrawal by Subject|2|||
126426630|NCT05051579|454857910|FG003|Overall Study|Withdrawal by Subject|1|||
126426631|NCT05051579|454857911|FG004|Overall Study|Withdrawal by Subject|4|||
126426632|NCT05051579|454857912|FG005|Overall Study|Withdrawal by Subject|0|||
126426633|NCT05051579|454857913|FG006|Overall Study|Withdrawal by Subject|4|||
126426634|NCT05051579|454857907|FG000|Overall Study|Lost to Follow-up|1|||
126426635|NCT05051579|454857908|FG001|Overall Study|Lost to Follow-up|0|||
126426636|NCT05051579|454857909|FG002|Overall Study|Lost to Follow-up|0|||
126426637|NCT05051579|454857910|FG003|Overall Study|Lost to Follow-up|0|||
126426638|NCT05051579|454857911|FG004|Overall Study|Lost to Follow-up|1|||
126426639|NCT05051579|454857912|FG005|Overall Study|Lost to Follow-up|0|||
126426640|NCT05051579|454857913|FG006|Overall Study|Lost to Follow-up|1|||
126426641|NCT05051579|454857907|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
126426642|NCT05051579|454857908|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
126426643|NCT05051579|454857909|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
126426644|NCT05051579|454857910|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
126426645|NCT05051579|454857911|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
126426646|NCT05051579|454857912|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
126426647|NCT05051579|454857913|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
126426648|NCT05051579|454857907|FG000|Overall Study|Adverse Event|2|||
126426649|NCT05051579|454857908|FG001|Overall Study|Adverse Event|1|||
126426650|NCT05051579|454857909|FG002|Overall Study|Adverse Event|0|||
126426651|NCT05051579|454857910|FG003|Overall Study|Adverse Event|4|||
126426652|NCT05051579|454857911|FG004|Overall Study|Adverse Event|1|||
126426653|NCT05051579|454857912|FG005|Overall Study|Adverse Event|2|||
126426654|NCT05051579|454857913|FG006|Overall Study|Adverse Event|0|||
126426655|NCT05051579|454857907|FG000|Overall Study|Inadvertent Enrollment|0|||
126426656|NCT05051579|454857908|FG001|Overall Study|Inadvertent Enrollment|0|||
126426657|NCT05051579|454857909|FG002|Overall Study|Inadvertent Enrollment|0|||
126426658|NCT05051579|454857910|FG003|Overall Study|Inadvertent Enrollment|0|||
126426659|NCT05051579|454857911|FG004|Overall Study|Inadvertent Enrollment|0|||
126426660|NCT05051579|454857912|FG005|Overall Study|Inadvertent Enrollment|0|||
126426661|NCT05051579|454857913|FG006|Overall Study|Inadvertent Enrollment|1|||
126426662|NCT05051579|454857907|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
126426663|NCT05051579|454857908|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
126426664|NCT05051579|454857909|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
126426665|NCT05051579|454857910|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
126426666|NCT05051579|454857911|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
126426667|NCT05051579|454857912|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
126426668|NCT05051579|454857913|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
126426669|NCT05051579|454857907|FG000|Overall Study|Sponsor Decision|0|||
126674500|NCT00957528|455765984|FG001|Overall Study|Withdrawal by Subject|0|||
126674501|NCT00957528|455765985|FG002|Overall Study|Withdrawal by Subject|1|||
126674502|NCT02234479|455765990|FG000|Overall Study|Withdrawal by Subject|1|||
126426670|NCT05051579|454857908|FG001|Overall Study|Sponsor Decision|0|||
126674503|NCT02234479|455765991|FG001|Overall Study|Withdrawal by Subject|3|||
126674504|NCT02318667|455765992|FG000|Overall Study|Adverse Event|1|||
126674505|NCT02318667|455765992|FG000|Overall Study|Lack of Efficacy|6|||
126341084|NCT01326871|454544493|FG002|Overall Study|SAE and disease progression|1|||
126341085|NCT01326871|454544491|FG000|Overall Study|SAE and physician decision|0|||
126341086|NCT01326871|454544492|FG001|Overall Study|SAE and physician decision|0|||
126341087|NCT01326871|454544493|FG002|Overall Study|SAE and physician decision|1|||
126341088|NCT01326871|454544491|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
126341089|NCT01326871|454544492|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
126341090|NCT01326871|454544493|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
126341091|NCT01326871|454544491|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
126341092|NCT01326871|454544492|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
126341093|NCT01326871|454544493|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
126341094|NCT01326871|454544491|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
126341095|NCT01326871|454544492|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
126341096|NCT01326871|454544493|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
126341097|NCT01326871|454544491|FG000|Overall Study|Physician Decision|0|||
126341098|NCT01326871|454544492|FG001|Overall Study|Physician Decision|0|||
126341099|NCT01326871|454544493|FG002|Overall Study|Physician Decision|1|||
126341100|NCT01326871|454544491|FG000|Overall Study|SAE|0|||
126341101|NCT01326871|454544492|FG001|Overall Study|SAE|0|||
126341102|NCT01326871|454544493|FG002|Overall Study|SAE|1|||
126341103|NCT01326871|454544491|FG000|Overall Study|Disease progression and death|0|||
126341104|NCT01326871|454544492|FG001|Overall Study|Disease progression and death|0|||
126341105|NCT01326871|454544493|FG002|Overall Study|Disease progression and death|1|||
126341106|NCT01326871|454544491|FG000|Overall Study|Subject decision|0|||
126341107|NCT01326871|454544492|FG001|Overall Study|Subject decision|0|||
126341108|NCT01326871|454544493|FG002|Overall Study|Subject decision|1|||
126341109|NCT01200329|454544498|FG000|Overall Study|Lack of financial coverage|2|||
126341110|NCT01200329|454544498|FG000|Overall Study|Progressive disease|1|||
126341111|NCT03641508|454544501|FG000|First Injection|Lost to Follow-up|2|||
126341112|NCT03641508|454544502|FG001|First Injection|Lost to Follow-up|0|||
126341113|NCT03642990|454544503|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
126341114|NCT03642990|454544503|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
126341115|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
126341116|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
126341117|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
126341118|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
126341119|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
126341120|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
126341121|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
126341122|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
126426671|NCT05051579|454857909|FG002|Overall Study|Sponsor Decision|0|||
126426672|NCT05051579|454857910|FG003|Overall Study|Sponsor Decision|0|||
126426673|NCT05051579|454857911|FG004|Overall Study|Sponsor Decision|1|||
126426674|NCT05051579|454857912|FG005|Overall Study|Sponsor Decision|0|||
126426675|NCT05051579|454857913|FG006|Overall Study|Sponsor Decision|0|||
126426676|NCT05051579|454857907|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
126426677|NCT05051579|454857908|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
126426678|NCT05051579|454857909|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
126426679|NCT05051579|454857910|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
126426680|NCT05051579|454857911|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
126674506|NCT02318667|455765992|FG000|Overall Study|Protocol Violation|2|||
126715140|NCT01161524|455908695|FG001|Core Study (23 Weeks)|Other|0|||
126341123|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
126341124|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
126341125|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
126341126|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
126341127|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
126341128|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
126341129|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
126341130|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
126341131|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
126341132|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
126341133|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
126341134|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
126341135|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
126341136|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
126341137|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
126426681|NCT05051579|454857912|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
126426682|NCT05051579|454857913|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
126426683|NCT00717249|454857914|FG000|Overall Study|Lens Discomfort|4|||
126426684|NCT00717249|454857915|FG001|Overall Study|Lens Discomfort|1|||
126426685|NCT00717249|454857914|FG000|Overall Study|Unsatisfactory visual Response|0|||
126426686|NCT00717249|454857915|FG001|Overall Study|Unsatisfactory visual Response|2|||
126426687|NCT00717249|454857914|FG000|Overall Study|Adverse Event|4|||
126426688|NCT00717249|454857915|FG001|Overall Study|Adverse Event|2|||
126426689|NCT00717249|454857914|FG000|Overall Study|Lost to Follow-up|2|||
126426690|NCT00717249|454857915|FG001|Overall Study|Lost to Follow-up|0|||
126426691|NCT00717249|454857914|FG000|Overall Study|Withdrawal by Subject|1|||
126426692|NCT00717249|454857915|FG001|Overall Study|Withdrawal by Subject|2|||
126426693|NCT00717249|454857914|FG000|Overall Study|Pregnancy|6|||
126426694|NCT00717249|454857915|FG001|Overall Study|Pregnancy|3|||
126426695|NCT00717249|454857914|FG000|Overall Study|Protocol Violation|0|||
126426696|NCT00717249|454857915|FG001|Overall Study|Protocol Violation|2|||
126426697|NCT00717249|454857914|FG000|Overall Study|Subject became Ineligible|1|||
126426698|NCT00717249|454857915|FG001|Overall Study|Subject became Ineligible|1|||
126426699|NCT00717249|454857914|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
126426700|NCT00717249|454857915|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
126426701|NCT00717249|454857914|FG000|Overall Study|Gastric Surgery|0|||
126426702|NCT00717249|454857915|FG001|Overall Study|Gastric Surgery|1|||
126426703|NCT00717249|454857914|FG000|Overall Study|Diagnosed with Diabetes|1|||
126426704|NCT00717249|454857915|FG001|Overall Study|Diagnosed with Diabetes|0|||
126426705|NCT00717249|454857914|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
126426706|NCT00717249|454857915|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
126426707|NCT00717249|454857914|FG000|Overall Study|Subject relocated|1|||
126426708|NCT00717249|454857915|FG001|Overall Study|Subject relocated|0|||
126426709|NCT00717249|454857914|FG000|Overall Study|Headaches|1|||
126426710|NCT00717249|454857915|FG001|Overall Study|Headaches|0|||
126426711|NCT00360412|454857916|FG000|Overall Study|Adverse Event|37|||
126426712|NCT00360412|454857917|FG001|Overall Study|Adverse Event|65|||
126426713|NCT00360412|454857916|FG000|Overall Study|Protocol Violation|2|||
126426714|NCT00360412|454857917|FG001|Overall Study|Protocol Violation|5|||
126426715|NCT00360412|454857916|FG000|Overall Study|Patient withdrew consent|27|||
126426716|NCT00360412|454857917|FG001|Overall Study|Patient withdrew consent|52|||
126426717|NCT00360412|454857916|FG000|Overall Study|Lack of therapeutic efficacy|46|||
126426718|NCT00360412|454857917|FG001|Overall Study|Lack of therapeutic efficacy|61|||
126426719|NCT00360412|454857916|FG000|Overall Study|Physician Decision|2|||
126426720|NCT00360412|454857917|FG001|Overall Study|Physician Decision|4|||
126426721|NCT00360412|454857916|FG000|Overall Study|Other|5|||
126426722|NCT00360412|454857917|FG001|Overall Study|Other|6|||
126426723|NCT00360412|454857916|FG000|Overall Study|Study termination by Sponsor|214|||
126426724|NCT00360412|454857917|FG001|Overall Study|Study termination by Sponsor|469|||
126426725|NCT00871871|454857918|FG000|Part I|Adverse Event|0|||
126426726|NCT00871871|454857919|FG001|Part I|Adverse Event|2|||
126426727|NCT00871871|454857920|FG002|Part I|Adverse Event|0|||
126426728|NCT00871871|454857921|FG003|Part I|Adverse Event|0|||
126426729|NCT00871871|454857918|FG000|Part I|Withdrawal by Subject|3|||
126426730|NCT00871871|454857919|FG001|Part I|Withdrawal by Subject|0|||
126426731|NCT00871871|454857920|FG002|Part I|Withdrawal by Subject|0|||
126426732|NCT00871871|454857921|FG003|Part I|Withdrawal by Subject|0|||
126426733|NCT00871871|454857918|FG000|Part I|Laboratory abnormality|0|||
126426734|NCT00871871|454857919|FG001|Part I|Laboratory abnormality|1|||
126426735|NCT00871871|454857920|FG002|Part I|Laboratory abnormality|0|||
126426736|NCT00871871|454857921|FG003|Part I|Laboratory abnormality|0|||
126426737|NCT00871871|454857918|FG000|Part II|Lack of Efficacy|0|||
126426738|NCT00871871|454857919|FG001|Part II|Lack of Efficacy|0|||
126426739|NCT00871871|454857920|FG002|Part II|Lack of Efficacy|1|||
126426740|NCT00871871|454857921|FG003|Part II|Lack of Efficacy|0|||
126426741|NCT00871871|454857918|FG000|Part II|Withdrawal by Subject|0|||
126426742|NCT00871871|454857919|FG001|Part II|Withdrawal by Subject|0|||
126426743|NCT00871871|454857920|FG002|Part II|Withdrawal by Subject|2|||
126426744|NCT00871871|454857921|FG003|Part II|Withdrawal by Subject|1|||
126426745|NCT00871871|454857918|FG000|Part II|Adverse Event|0|||
126426746|NCT00871871|454857919|FG001|Part II|Adverse Event|0|||
126426747|NCT00871871|454857920|FG002|Part II|Adverse Event|1|||
126426748|NCT00871871|454857921|FG003|Part II|Adverse Event|2|||
126426749|NCT00871871|454857918|FG000|Part II|Protocol Violation|0|||
126426750|NCT00871871|454857919|FG001|Part II|Protocol Violation|0|||
126426751|NCT00871871|454857920|FG002|Part II|Protocol Violation|0|||
126426752|NCT00871871|454857921|FG003|Part II|Protocol Violation|1|||
126426753|NCT00990106|454857925|FG000|Overall Study|"too busy to continue"|1|||
126426754|NCT00990106|454857926|FG001|Overall Study|"too busy to continue"|2|||
126426755|NCT00990106|454857925|FG000|Overall Study|Lost to Follow-up|1|||
126426756|NCT00990106|454857926|FG001|Overall Study|Lost to Follow-up|3|||
126426757|NCT00990106|454857925|FG000|Overall Study|Withdrawal by Subject|2|||
126426758|NCT00990106|454857926|FG001|Overall Study|Withdrawal by Subject|1|||
126674507|NCT02289742|455765993|FG000|First Wear Period|Adverse event prior to treatment|0|||
126674508|NCT02289742|455765994|FG001|First Wear Period|Adverse event prior to treatment|1|||
126674509|NCT02289742|455765995|FG002|First Wear Period|Adverse event prior to treatment|0|||
126674510|NCT02289742|455765996|FG003|First Wear Period|Adverse event prior to treatment|0|||
126341138|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
126341139|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
126341140|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
126341141|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
126341142|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
126341143|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
126341144|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
126341145|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
126341146|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
126341147|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
126341148|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
126341149|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
126341150|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
126341151|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
126341152|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
126341153|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
126341154|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
126341155|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
126341156|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
126341157|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
126341158|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
126341159|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
126341160|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
126341161|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
126341162|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
126341163|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
126341164|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
126341165|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
126341166|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
126341167|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
126341168|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
126341169|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
126341170|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
126341171|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
126341172|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
126341173|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
126341174|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
126341175|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
126341176|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
126341177|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
126341178|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
126341179|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
126341180|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
126341181|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
126341182|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
126341183|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
126341184|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
126341185|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
126341186|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
126341187|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
126341188|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
126341189|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
126341190|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
126341191|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
126341192|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
126341193|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
126674511|NCT02289742|455765993|FG000|First Wear Period|Adverse Event|0|||
126674512|NCT02289742|455765994|FG001|First Wear Period|Adverse Event|0|||
126674513|NCT02289742|455765995|FG002|First Wear Period|Adverse Event|1|||
126674514|NCT02289742|455765996|FG003|First Wear Period|Adverse Event|0|||
126674515|NCT02289742|455765993|FG000|First Wear Period|Other prior to treatment|0|||
126674516|NCT02289742|455765994|FG001|First Wear Period|Other prior to treatment|0|||
126674517|NCT02289742|455765995|FG002|First Wear Period|Other prior to treatment|0|||
126674518|NCT02289742|455765996|FG003|First Wear Period|Other prior to treatment|1|||
126674519|NCT02289742|455765993|FG000|Third Wear Period|Adverse Event|0|||
126674520|NCT02289742|455765994|FG001|Third Wear Period|Adverse Event|1|||
126341194|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
126341195|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
126341196|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
126341197|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
126341198|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
126341199|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
126341200|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
126341201|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
126341202|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
126341203|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
126341204|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
126341205|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
126341206|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
126341207|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
126341208|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
126341209|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
126341210|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
126341211|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
126341212|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
126341213|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
126341214|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
126341215|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
126341216|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
126341217|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
126341218|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
126341219|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
126341220|NCT02717195|454544505|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
126341221|NCT02717195|454544506|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
126341222|NCT02717195|454544507|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
126341223|NCT02717195|454544508|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
126341224|NCT02717195|454544509|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
126341225|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
126341226|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
126341227|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
126341228|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
126341229|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
126341230|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
126341231|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
126341232|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
126341233|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
126341234|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
126341235|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
126341236|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
126341237|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
126341238|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
126341239|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
126341240|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
126341241|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
126341242|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
126341243|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
126341244|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
126341245|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
126341246|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
126341247|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
126341248|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
126674521|NCT02289742|455765995|FG002|Third Wear Period|Adverse Event|0|||
126674522|NCT02289742|455765996|FG003|Third Wear Period|Adverse Event|0|||
126674523|NCT02289742|455765993|FG000|Third Wear Period|Reason not given|0|||
126674524|NCT02289742|455765994|FG001|Third Wear Period|Reason not given|0|||
126674525|NCT02289742|455765995|FG002|Third Wear Period|Reason not given|0|||
126674526|NCT02289742|455765996|FG003|Third Wear Period|Reason not given|1|||
126674527|NCT01365039|455765997|FG000|Overall Study|Study related symptoms and complaints|1|||
126674528|NCT01365039|455765998|FG001|Overall Study|Study related symptoms and complaints|0|||
126674529|NCT00253643|455766003|FG000|Overall Study|Withdrawal by Subject|0|||
126674530|NCT00253643|455766004|FG001|Overall Study|Withdrawal by Subject|0|||
126674531|NCT00253643|455766005|FG002|Overall Study|Withdrawal by Subject|1|||
126674532|NCT00253643|455766006|FG003|Overall Study|Withdrawal by Subject|1|||
126674533|NCT00253643|455766003|FG000|Overall Study|Non-Compliance|0|||
126674534|NCT00253643|455766004|FG001|Overall Study|Non-Compliance|0|||
126674535|NCT00253643|455766005|FG002|Overall Study|Non-Compliance|0|||
126674536|NCT00253643|455766006|FG003|Overall Study|Non-Compliance|2|||
126674537|NCT00383084|455766007|FG000|Overall Study|Withdrawal by Subject|12|||
126674538|NCT00383084|455766008|FG001|Overall Study|Withdrawal by Subject|10|||
126674539|NCT02636582|455766009|FG000|Overall Study|Surgical Pathology|1|||
126674540|NCT02636582|455766010|FG001|Overall Study|Surgical Pathology|0|||
126674541|NCT01263483|455766011|FG000|Overall Study|Adverse Event|4|||
126674542|NCT01263483|455766012|FG001|Overall Study|Adverse Event|0|||
126674543|NCT01263483|455766013|FG002|Overall Study|Adverse Event|3|||
126674544|NCT01263483|455766011|FG000|Overall Study|Withdrawal by Subject|1|||
126674545|NCT01263483|455766012|FG001|Overall Study|Withdrawal by Subject|0|||
126674546|NCT01263483|455766013|FG002|Overall Study|Withdrawal by Subject|0|||
126674547|NCT01263483|455766011|FG000|Overall Study|Lack of Efficacy|2|||
126674548|NCT01263483|455766012|FG001|Overall Study|Lack of Efficacy|0|||
126674549|NCT01263483|455766013|FG002|Overall Study|Lack of Efficacy|0|||
126674550|NCT01263483|455766011|FG000|Overall Study|Protocol Violation|0|||
126674551|NCT01263483|455766012|FG001|Overall Study|Protocol Violation|1|||
126674552|NCT01263483|455766013|FG002|Overall Study|Protocol Violation|1|||
126674553|NCT01263483|455766011|FG000|Overall Study|Participant Unavailability|0|||
126674554|NCT01263483|455766012|FG001|Overall Study|Participant Unavailability|1|||
126674555|NCT01263483|455766013|FG002|Overall Study|Participant Unavailability|1|||
126674556|NCT00326209|455766014|FG000|Overall Study|Adverse Event|28|||
126674557|NCT00326209|455766014|FG000|Overall Study|Withdrawal by Subject|22|||
126674558|NCT00326209|455766014|FG000|Overall Study|Lack of Efficacy|31|||
126674559|NCT00326209|455766014|FG000|Overall Study|Lost to Follow-up|18|||
126674560|NCT00326209|455766014|FG000|Overall Study|Participant non-compliant|6|||
126674561|NCT00326209|455766014|FG000|Overall Study|Sponsor closed study|173|||
126674562|NCT00326209|455766014|FG000|Overall Study|Prohibited medication use|1|||
126674563|NCT00326209|455766014|FG000|Overall Study|Violation of entry criteria|1|||
126674564|NCT00326209|455766014|FG000|Overall Study|Withdrawn in error|1|||
126341249|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
126341250|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
126341251|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
126341252|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
126674565|NCT00326209|455766014|FG000|Overall Study|Pregnancy|1|||
126674566|NCT00714285|455766015|FG000|Overall Study|Lost to Follow-up|0|||
126674567|NCT00714285|455766016|FG001|Overall Study|Lost to Follow-up|2|||
126674568|NCT00714285|455766017|FG002|Overall Study|Lost to Follow-up|0|||
126674569|NCT00714285|455766018|FG003|Overall Study|Lost to Follow-up|1|||
126674570|NCT00714285|455766015|FG000|Overall Study|Migrated/moved from study area|0|||
126341253|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
126341254|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
126341255|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
126341256|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
126341257|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
126341258|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
126341259|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
126341260|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
126341261|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
126341262|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
126341263|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
126341264|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
126674571|NCT00714285|455766016|FG001|Overall Study|Migrated/moved from study area|1|||
126674572|NCT00714285|455766017|FG002|Overall Study|Migrated/moved from study area|0|||
126674573|NCT00714285|455766018|FG003|Overall Study|Migrated/moved from study area|0|||
126674574|NCT01372384|455766019|FG000|Overall Study|Progression of disease|3|||
126674575|NCT01131676|455766024|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
126674576|NCT01131676|455766025|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
126674577|NCT01131676|455766026|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
126674578|NCT01131676|455766024|FG000|Discontinuation From Treatment|Not treated|4|||
126674579|NCT01131676|455766025|FG001|Discontinuation From Treatment|Not treated|2|||
126674580|NCT01131676|455766026|FG002|Discontinuation From Treatment|Not treated|2|||
126674581|NCT01131676|455766024|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
126674582|NCT01131676|455766025|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
126674583|NCT01131676|455766026|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
126341265|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
126341266|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
126341267|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
126341268|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
126341269|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
126341270|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
126341271|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
126341272|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
126341273|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
126341274|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
126341275|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
126341276|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
126341277|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
126341278|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
126341279|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
126341280|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
126341281|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
126341282|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
126341283|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
126341284|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
126341285|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
126341286|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
126341287|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
126341288|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
126341289|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
126341290|NCT02717195|454544505|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
126341291|NCT02717195|454544506|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
126341292|NCT02717195|454544507|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
126341293|NCT02717195|454544508|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
126341294|NCT02717195|454544509|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
126341295|NCT00855218|454544510|FG000|Overall Study|Adverse Event|43|||
126341296|NCT00855218|454544511|FG001|Overall Study|Adverse Event|27|||
126341297|NCT00855218|454544510|FG000|Overall Study|Withdrawal by Subject|10|||
126341298|NCT00855218|454544511|FG001|Overall Study|Withdrawal by Subject|6|||
126341299|NCT00855218|454544510|FG000|Overall Study|Physician Decision|18|||
126341300|NCT00855218|454544511|FG001|Overall Study|Physician Decision|11|||
126341301|NCT00855218|454544510|FG000|Overall Study|Lost to Follow-up|0|||
126341302|NCT00855218|454544511|FG001|Overall Study|Lost to Follow-up|1|||
126341303|NCT00855218|454544510|FG000|Overall Study|Protocol Violation|5|||
126341304|NCT00855218|454544511|FG001|Overall Study|Protocol Violation|9|||
126341305|NCT00855218|454544510|FG000|Overall Study|non-compliant with study drug|3|||
126341306|NCT00855218|454544511|FG001|Overall Study|non-compliant with study drug|1|||
126341307|NCT00855218|454544510|FG000|Overall Study|patient convenience|2|||
126341308|NCT00855218|454544511|FG001|Overall Study|patient convenience|0|||
126341309|NCT00855218|454544510|FG000|Overall Study|technical problems|2|||
126341310|NCT00855218|454544511|FG001|Overall Study|technical problems|1|||
126341311|NCT00855218|454544510|FG000|Overall Study|Still treated with study medication|0|||
126341312|NCT00855218|454544511|FG001|Overall Study|Still treated with study medication|1|||
126341313|NCT00855218|454544510|FG000|Overall Study|Untreatable disease progression|54|||
126341314|NCT00855218|454544511|FG001|Overall Study|Untreatable disease progression|67|||
126341315|NCT00855218|454544510|FG000|Overall Study|Second malignancy|0|||
126341316|NCT00855218|454544511|FG001|Overall Study|Second malignancy|1|||
126341317|NCT00855218|454544510|FG000|Overall Study|Progression measurement proven|7|||
126341318|NCT00855218|454544511|FG001|Overall Study|Progression measurement proven|15|||
126341319|NCT00855218|454544510|FG000|Overall Study|Clinical endpoint reached|10|||
126341320|NCT00855218|454544511|FG001|Overall Study|Clinical endpoint reached|13|||
126341321|NCT00764790|454544512|FG000|Overall Study|Protocol Violation|0|||
126341322|NCT00764790|454544513|FG001|Overall Study|Protocol Violation|0|||
126341323|NCT00764790|454544514|FG002|Overall Study|Protocol Violation|1|||
126341324|NCT00764790|454544512|FG000|Overall Study|Withdrawal by Subject|10|||
126341325|NCT00764790|454544513|FG001|Overall Study|Withdrawal by Subject|12|||
126341326|NCT00764790|454544514|FG002|Overall Study|Withdrawal by Subject|6|||
126341327|NCT00764790|454544512|FG000|Overall Study|Lost to Follow-up|28|||
126674584|NCT01131676|455766024|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
126341328|NCT00764790|454544513|FG001|Overall Study|Lost to Follow-up|29|||
126341329|NCT00764790|454544514|FG002|Overall Study|Lost to Follow-up|23|||
126674585|NCT01131676|455766025|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
126674586|NCT01131676|455766026|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
126674587|NCT01131676|455766024|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
126674588|NCT01131676|455766025|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
126674589|NCT01131676|455766026|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
126674590|NCT01131676|455766024|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
126674591|NCT01131676|455766025|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
126674592|NCT01131676|455766026|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
126674593|NCT01131676|455766024|FG000|Discontinuation From Treatment|Other than those specified|162|||
126674594|NCT01131676|455766025|FG001|Discontinuation From Treatment|Other than those specified|142|||
126674595|NCT01131676|455766026|FG002|Discontinuation From Treatment|Other than those specified|125|||
126674596|NCT01131676|455766024|FG000|Discontinuation From Treatment|Adverse Event|303|||
126674597|NCT01131676|455766025|FG001|Discontinuation From Treatment|Adverse Event|267|||
126341330|NCT03191552|454544515|FG000|Overall Study|Lost to Follow-up|1|||
126341331|NCT03191552|454544516|FG001|Overall Study|Lost to Follow-up|0|||
126426759|NCT00990106|454857925|FG000|Overall Study|opted for open label prazosin|1|||
126426760|NCT00990106|454857926|FG001|Overall Study|opted for open label prazosin|1|||
126426761|NCT00990106|454857925|FG000|Overall Study|relocation/deployment|4|||
126341332|NCT03191552|454544517|FG002|Overall Study|Lost to Follow-up|0|||
126341333|NCT03191552|454544515|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
126341334|NCT03191552|454544516|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
126341335|NCT03191552|454544517|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
126341336|NCT01149655|454544518|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
126341337|NCT01149655|454544519|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
126341338|NCT01149655|454544520|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
126341339|NCT01149655|454544521|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
126341340|NCT01149655|454544518|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
126341341|NCT01149655|454544519|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
126341342|NCT01149655|454544520|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
126341343|NCT01149655|454544521|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
126341344|NCT01149655|454544518|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
126341345|NCT01149655|454544519|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
126341346|NCT01149655|454544520|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
126341347|NCT01149655|454544521|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
126341348|NCT01149655|454544518|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
126341349|NCT01149655|454544519|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
126341350|NCT01149655|454544520|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
126341351|NCT01149655|454544521|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
126341352|NCT01149655|454544518|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
126341353|NCT01149655|454544519|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
126341354|NCT01149655|454544520|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
126341355|NCT01149655|454544521|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
126341356|NCT01149655|454544518|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
126341357|NCT01149655|454544519|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
126341358|NCT01149655|454544520|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
126341359|NCT01149655|454544521|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
126341360|NCT01149655|454544518|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
126341361|NCT01149655|454544519|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
126341362|NCT01149655|454544520|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
126341363|NCT01149655|454544521|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
126341364|NCT01149655|454544518|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
126341365|NCT01149655|454544519|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
126341366|NCT01149655|454544520|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
126341367|NCT01149655|454544521|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
126341368|NCT01149655|454544518|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
126341369|NCT01149655|454544519|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
126341370|NCT01149655|454544520|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
126341371|NCT01149655|454544521|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
126341372|NCT01149655|454544518|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
126341373|NCT01149655|454544519|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
126341374|NCT01149655|454544520|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
126341375|NCT01149655|454544521|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
126341376|NCT01149655|454544518|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
126426762|NCT00990106|454857926|FG001|Overall Study|relocation/deployment|1|||
126674598|NCT01131676|455766026|FG002|Discontinuation From Treatment|Adverse Event|273|||
126674599|NCT01131676|455766024|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
126674600|NCT01131676|455766025|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
126674601|NCT01131676|455766026|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
126674602|NCT01131676|455766024|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
126674603|NCT01131676|455766025|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
126674604|NCT01131676|455766026|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
126674605|NCT01131676|455766024|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
126674606|NCT01131676|455766025|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
126674607|NCT01131676|455766026|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
126674608|NCT01131676|455766024|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
126674609|NCT01131676|455766025|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
126674610|NCT01131676|455766026|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
126674611|NCT01131676|455766024|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
126674612|NCT01131676|455766025|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
126674613|NCT01131676|455766026|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
126426763|NCT00990106|454857925|FG000|Overall Study|started exclusionary medication|0|||
126426764|NCT00990106|454857926|FG001|Overall Study|started exclusionary medication|1|||
126426765|NCT00990106|454857925|FG000|Overall Study|planned major surgery|0|||
126426766|NCT00990106|454857926|FG001|Overall Study|planned major surgery|1|||
126426767|NCT00990106|454857925|FG000|Overall Study|scheduling conflicts|0|||
126426768|NCT00990106|454857926|FG001|Overall Study|scheduling conflicts|2|||
126426769|NCT00410956|454857928|FG000|Overall Study|Adverse Event|1|||
126426770|NCT00410956|454857928|FG000|Overall Study|Death|2|||
126426771|NCT00410956|454857928|FG000|Overall Study|Lack of Efficacy|10|||
126426772|NCT00410956|454857928|FG000|Overall Study|Physician Decision|6|||
126426773|NCT01650194|454857929|FG000|Overall Study|Progressive Disease (PD)|35|||
126426774|NCT01650194|454857929|FG000|Overall Study|Withdrawal by Subject|2|||
126426775|NCT01650194|454857929|FG000|Overall Study|Miscellaneous|10|||
126426776|NCT00880698|454857933|FG000|Overall Study|Death|0|||
126426777|NCT00880698|454857934|FG001|Overall Study|Death|0|||
126426778|NCT00880698|454857935|FG002|Overall Study|Death|1|||
126426779|NCT00880698|454857936|FG003|Overall Study|Death|2|||
126426780|NCT00880698|454857933|FG000|Overall Study|Lost to Follow-up|1|||
126426781|NCT00880698|454857934|FG001|Overall Study|Lost to Follow-up|3|||
126426782|NCT00880698|454857935|FG002|Overall Study|Lost to Follow-up|0|||
126426783|NCT00880698|454857936|FG003|Overall Study|Lost to Follow-up|1|||
126426784|NCT00851786|454857938|FG000|Overall Study|Withdrawal by Subject|0|||
126426785|NCT00851786|454857939|FG001|Overall Study|Withdrawal by Subject|1|||
126426786|NCT00851786|454857938|FG000|Overall Study|Protocol Violation|0|||
126426787|NCT00851786|454857939|FG001|Overall Study|Protocol Violation|1|||
126426788|NCT00851786|454857938|FG000|Overall Study|Lost to Follow-up|1|||
126426789|NCT00851786|454857939|FG001|Overall Study|Lost to Follow-up|0|||
126426790|NCT00851786|454857938|FG000|Overall Study|Incarceration|1|||
126426791|NCT00851786|454857939|FG001|Overall Study|Incarceration|0|||
126426792|NCT00851786|454857938|FG000|Overall Study|Site Closure|1|||
126426793|NCT00851786|454857939|FG001|Overall Study|Site Closure|0|||
126426794|NCT00851786|454857938|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
126674614|NCT01131676|455766024|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
126674615|NCT01131676|455766025|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
126674616|NCT01131676|455766026|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
126674617|NCT00829179|455766029|FG000|Overall Study|Withdrawal by Subject|1|||
126674618|NCT03000179|455766030|FG000|Overall Study|Lost to Follow-up|2|||
126674619|NCT01075412|455766031|FG000|Overall Study|Withdrawal by Subject|0|||
126674620|NCT01075412|455766032|FG001|Overall Study|Withdrawal by Subject|1|||
126674621|NCT00865904|455766033|FG000|Overall Study|Randomized but not Treated|2|||
126674622|NCT00865904|455766034|FG001|Overall Study|Randomized but not Treated|0|||
126674623|NCT00865904|455766035|FG002|Overall Study|Randomized but not Treated|0|||
126674624|NCT00865904|455766036|FG003|Overall Study|Randomized but not Treated|1|||
126674625|NCT00865904|455766037|FG004|Overall Study|Randomized but not Treated|1|||
126341377|NCT01149655|454544519|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
126341378|NCT01149655|454544520|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
126341379|NCT01149655|454544521|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
126341380|NCT01149655|454544518|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
126341381|NCT01149655|454544519|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
126341382|NCT01149655|454544520|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
126341383|NCT01149655|454544521|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
126341384|NCT01149655|454544518|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
126426795|NCT00851786|454857939|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
126426796|NCT03858049|454860320|FG000|Overall Study|Adverse Event|16|||
126426797|NCT03858049|454860321|FG001|Overall Study|Adverse Event|9|||
126426798|NCT03858049|454860320|FG000|Overall Study|Other|1|||
126426799|NCT03858049|454860321|FG001|Overall Study|Other|1|||
126341385|NCT01149655|454544519|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
126341386|NCT01149655|454544520|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
126341387|NCT01149655|454544521|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
126341388|NCT01149655|454544518|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
126341389|NCT01149655|454544519|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
126341390|NCT01149655|454544520|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
126341391|NCT01149655|454544521|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
126341392|NCT01149655|454544518|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
126341393|NCT01149655|454544519|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
126341394|NCT01149655|454544520|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
126341395|NCT01149655|454544521|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
126341396|NCT01149655|454544518|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
126341397|NCT01149655|454544519|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
126341398|NCT01149655|454544520|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
126341399|NCT01149655|454544521|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
126341400|NCT01265498|454544522|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
126341401|NCT01265498|454544523|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
126341402|NCT00921024|454544524|FG000|Overall Study|Lost to Follow-up|2|||
126341403|NCT00921024|454544525|FG001|Overall Study|Lost to Follow-up|0|||
126341404|NCT00921024|454544524|FG000|Overall Study|Received concomittant therapy|2|||
126341405|NCT00921024|454544525|FG001|Overall Study|Received concomittant therapy|0|||
126341406|NCT00921024|454544524|FG000|Overall Study|Withdrawal by Subject|0|||
126341407|NCT00921024|454544525|FG001|Overall Study|Withdrawal by Subject|3|||
126341408|NCT03225287|454544526|FG000|Overall Study|Adverse Event|0|||
126341409|NCT03225287|454544527|FG001|Overall Study|Adverse Event|0|||
126341410|NCT03225287|454544528|FG002|Overall Study|Adverse Event|1|||
126341411|NCT03225287|454544526|FG000|Overall Study|Protocol non-compliance|0|||
126341412|NCT03225287|454544527|FG001|Overall Study|Protocol non-compliance|0|||
126341413|NCT03225287|454544528|FG002|Overall Study|Protocol non-compliance|1|||
126341414|NCT03225287|454544526|FG000|Overall Study|Subject withdraws consent|3|||
126341415|NCT03225287|454544527|FG001|Overall Study|Subject withdraws consent|0|||
126341416|NCT03225287|454544528|FG002|Overall Study|Subject withdraws consent|0|||
126341417|NCT03225287|454544526|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
126341418|NCT03225287|454544527|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
126341419|NCT03225287|454544528|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
126341420|NCT03225287|454544526|FG000|Overall Study|Trial drug not effective|0|||
126341421|NCT03225287|454544527|FG001|Overall Study|Trial drug not effective|1|||
126341422|NCT03225287|454544528|FG002|Overall Study|Trial drug not effective|0|||
126341423|NCT03225287|454544526|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
126341424|NCT03225287|454544527|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
126341425|NCT03225287|454544528|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
126341426|NCT03225287|454544526|FG000|Overall Study|Stem cell transplantation|0|||
126341427|NCT03225287|454544527|FG001|Overall Study|Stem cell transplantation|1|||
126341428|NCT03225287|454544528|FG002|Overall Study|Stem cell transplantation|0|||
126341429|NCT01296412|454544530|FG000|Overall Study|Adverse Event|8|||
126341430|NCT01296412|454544531|FG001|Overall Study|Adverse Event|29|||
126341431|NCT01296412|454544530|FG000|Overall Study|Lack of Efficacy|1|||
126341432|NCT01296412|454544531|FG001|Overall Study|Lack of Efficacy|0|||
126341433|NCT01296412|454544530|FG000|Overall Study|Lost to Follow-up|10|||
126341434|NCT01296412|454544531|FG001|Overall Study|Lost to Follow-up|7|||
126341435|NCT01296412|454544530|FG000|Overall Study|Non-compliance with study drug|1|||
126341436|NCT01296412|454544531|FG001|Overall Study|Non-compliance with study drug|2|||
126341437|NCT01296412|454544530|FG000|Overall Study|Other reason not specified|20|||
126341438|NCT01296412|454544531|FG001|Overall Study|Other reason not specified|15|||
126341439|NCT01296412|454544530|FG000|Overall Study|Physician Decision|1|||
126341440|NCT01296412|454544531|FG001|Overall Study|Physician Decision|3|||
126341441|NCT01296412|454544530|FG000|Overall Study|Pregnancy|0|||
126341442|NCT01296412|454544531|FG001|Overall Study|Pregnancy|1|||
126341443|NCT01296412|454544530|FG000|Overall Study|Withdrawal by Subject|10|||
126341444|NCT01296412|454544531|FG001|Overall Study|Withdrawal by Subject|13|||
126341445|NCT02160626|454544532|FG000|Overall Study|Adverse Event|1|||
126341446|NCT02160626|454544533|FG001|Overall Study|Adverse Event|0|||
126341447|NCT02160626|454544534|FG002|Overall Study|Adverse Event|0|||
126341448|NCT02160626|454544532|FG000|Overall Study|Schedule not conducive to study visits|0|||
126341449|NCT02160626|454544533|FG001|Overall Study|Schedule not conducive to study visits|0|||
126341450|NCT02160626|454544534|FG002|Overall Study|Schedule not conducive to study visits|1|||
126341451|NCT02160626|454544532|FG000|Overall Study|Withdrawal by Subject|0|||
126341452|NCT02160626|454544533|FG001|Overall Study|Withdrawal by Subject|1|||
126341453|NCT02160626|454544534|FG002|Overall Study|Withdrawal by Subject|0|||
126341454|NCT04239924|454544535|FG000|Overall Study|Lost to Follow-up|2|||
126341455|NCT00296244|454546589|FG000|Overall Study|Underwent retransplant|0|||
126341456|NCT00296244|454546590|FG001|Overall Study|Underwent retransplant|1|||
126341457|NCT00427934|454546591|FG000|Overall Study|Adverse Event|1|||
126426800|NCT04617782|454860322|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
126426801|NCT04617782|454860322|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
126426802|NCT04617782|454860322|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
126426803|NCT04617782|454860322|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
126426804|NCT04617782|454860322|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
126426805|NCT04617782|454860322|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
126426806|NCT04233801|454860331|FG000|Overall Study|Other than listed|0|||
126426807|NCT04233801|454860332|FG001|Overall Study|Other than listed|0|||
126426808|NCT04233801|454860333|FG002|Overall Study|Other than listed|1|||
126426809|NCT04233801|454860331|FG000|Overall Study|Withdrawal by Subject|0|||
126426810|NCT04233801|454860332|FG001|Overall Study|Withdrawal by Subject|2|||
126426811|NCT04233801|454860333|FG002|Overall Study|Withdrawal by Subject|3|||
126426812|NCT01690052|454860338|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
126426813|NCT01690052|454860339|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
126426814|NCT02421172|454860340|FG000|Period 1|Adverse Event|1|||
126426815|NCT02421172|454860341|FG001|Period 1|Adverse Event|0|||
126426816|NCT02421172|454860342|FG002|Period 1|Adverse Event|0|||
126426817|NCT02421172|454860343|FG003|Period 1|Adverse Event|0|||
126426818|NCT02421172|454860344|FG004|Period 1|Adverse Event|0|||
126426819|NCT02421172|454860340|FG000|Period 1|Lost to Follow-up|3|||
126426820|NCT02421172|454860341|FG001|Period 1|Lost to Follow-up|1|||
126426821|NCT02421172|454860342|FG002|Period 1|Lost to Follow-up|0|||
126426822|NCT02421172|454860343|FG003|Period 1|Lost to Follow-up|0|||
126426823|NCT02421172|454860344|FG004|Period 1|Lost to Follow-up|0|||
126426824|NCT02421172|454860340|FG000|Period 1|Patient/guardian decision|0|||
126426825|NCT02421172|454860341|FG001|Period 1|Patient/guardian decision|1|||
126426826|NCT02421172|454860342|FG002|Period 1|Patient/guardian decision|0|||
126426827|NCT02421172|454860343|FG003|Period 1|Patient/guardian decision|0|||
126426828|NCT02421172|454860344|FG004|Period 1|Patient/guardian decision|0|||
126426829|NCT02421172|454860340|FG000|Period 2|Adverse Event|0|||
126426830|NCT02421172|454860341|FG001|Period 2|Adverse Event|0|||
126426831|NCT02421172|454860342|FG002|Period 2|Adverse Event|4|||
126426832|NCT02421172|454860343|FG003|Period 2|Adverse Event|0|||
126426833|NCT02421172|454860344|FG004|Period 2|Adverse Event|0|||
126426834|NCT02421172|454860340|FG000|Period 2|Lost to Follow-up|0|||
126426835|NCT02421172|454860341|FG001|Period 2|Lost to Follow-up|0|||
126426836|NCT02421172|454860342|FG002|Period 2|Lost to Follow-up|0|||
126426837|NCT02421172|454860343|FG003|Period 2|Lost to Follow-up|1|||
126426838|NCT02421172|454860344|FG004|Period 2|Lost to Follow-up|0|||
126426839|NCT02421172|454860340|FG000|Period 2|Patient/guardian decision|0|||
126426840|NCT02421172|454860341|FG001|Period 2|Patient/guardian decision|0|||
126426841|NCT02421172|454860342|FG002|Period 2|Patient/guardian decision|3|||
126426842|NCT02421172|454860343|FG003|Period 2|Patient/guardian decision|2|||
126426843|NCT02421172|454860344|FG004|Period 2|Patient/guardian decision|1|||
126426844|NCT00683878|454860345|FG000|Overall Study|Lack of Efficacy|3|||
126426845|NCT00683878|454860346|FG001|Overall Study|Lack of Efficacy|0|||
126426846|NCT00683878|454860347|FG002|Overall Study|Lack of Efficacy|1|||
126426847|NCT00683878|454860345|FG000|Overall Study|Adverse Event|4|||
126426848|NCT00683878|454860346|FG001|Overall Study|Adverse Event|3|||
126426849|NCT00683878|454860347|FG002|Overall Study|Adverse Event|3|||
126426850|NCT00683878|454860345|FG000|Overall Study|Withdrawal by Subject|9|||
126426851|NCT00683878|454860346|FG001|Overall Study|Withdrawal by Subject|8|||
126426852|NCT00683878|454860347|FG002|Overall Study|Withdrawal by Subject|6|||
126426853|NCT00683878|454860345|FG000|Overall Study|Death|0|||
126426854|NCT00683878|454860346|FG001|Overall Study|Death|1|||
126426855|NCT00683878|454860347|FG002|Overall Study|Death|0|||
126426856|NCT00683878|454860345|FG000|Overall Study|Lost to Follow-up|4|||
126426857|NCT00683878|454860346|FG001|Overall Study|Lost to Follow-up|2|||
126426858|NCT00683878|454860347|FG002|Overall Study|Lost to Follow-up|4|||
126426859|NCT00683878|454860345|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
126426860|NCT00683878|454860346|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
126426861|NCT00683878|454860347|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
126426862|NCT02869633|454860348|FG000|Overall Study|Death|2|||
126426863|NCT02869633|454860349|FG001|Overall Study|Death|1|||
126674626|NCT03625687|455766038|FG000|Overall Study|Death|1|||
126674627|NCT00916149|455766043|FG000|Overall Study|Lost to Follow-up|3|||
126426864|NCT02869633|454860348|FG000|Overall Study|Patient refused follow-up|1|||
126426865|NCT02869633|454860349|FG001|Overall Study|Patient refused follow-up|0|||
126426866|NCT02869633|454860348|FG000|Overall Study|Provider discretion|1|||
126426867|NCT02869633|454860349|FG001|Overall Study|Provider discretion|0|||
126426868|NCT02869633|454860348|FG000|Overall Study|Investigator decision|1|||
126426869|NCT02869633|454860349|FG001|Overall Study|Investigator decision|0|||
126426870|NCT02869633|454860348|FG000|Overall Study|Lost to Follow-up|0|||
126426871|NCT02869633|454860349|FG001|Overall Study|Lost to Follow-up|1|||
126426872|NCT02869633|454860348|FG000|Overall Study|Not eligible|6|||
126426873|NCT02869633|454860349|FG001|Overall Study|Not eligible|1|||
126426874|NCT02869633|454860348|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
126426875|NCT02869633|454860349|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
126426876|NCT02869633|454860348|FG000|Overall Study|Withdrawal by Subject|0|||
126426877|NCT02869633|454860349|FG001|Overall Study|Withdrawal by Subject|1|||
126426878|NCT01474317|454860357|FG000|Overall Study|Adverse Event|1|||
126426879|NCT01474317|454860357|FG000|Overall Study|Subject ineligible for study|1|||
126426880|NCT01693029|454860360|FG000|Overall Study|Withdrawal by Subject|15|||
126426881|NCT01693029|454860361|FG001|Overall Study|Withdrawal by Subject|22|||
126426882|NCT01693029|454860360|FG000|Overall Study|Kidney transplantation|7|||
126426883|NCT01693029|454860361|FG001|Overall Study|Kidney transplantation|7|||
126426884|NCT01693029|454860360|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
126426885|NCT01693029|454860361|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
126426886|NCT01693029|454860360|FG000|Overall Study|Protocol Violation|6|||
126426887|NCT01693029|454860361|FG001|Overall Study|Protocol Violation|7|||
126426888|NCT01693029|454860360|FG000|Overall Study|Change in dialysis modality|2|||
126426889|NCT01693029|454860361|FG001|Overall Study|Change in dialysis modality|1|||
126426890|NCT01693029|454860360|FG000|Overall Study|Physician Decision|0|||
126426891|NCT01693029|454860361|FG001|Overall Study|Physician Decision|2|||
126426892|NCT01693029|454860360|FG000|Overall Study|Lost to Follow-up|0|||
126426893|NCT01693029|454860361|FG001|Overall Study|Lost to Follow-up|1|||
126426894|NCT01693029|454860360|FG000|Overall Study|Adverse Event|1|||
126426895|NCT01693029|454860361|FG001|Overall Study|Adverse Event|6|||
126426896|NCT01693029|454860360|FG000|Overall Study|Death|5|||
126426897|NCT01693029|454860361|FG001|Overall Study|Death|8|||
126426898|NCT01693029|454860360|FG000|Overall Study|Non-compliance|2|||
126426899|NCT01693029|454860361|FG001|Overall Study|Non-compliance|1|||
126426900|NCT02647281|454860362|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426901|NCT02647281|454860363|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426902|NCT02647281|454860364|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426903|NCT02647281|454860365|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426904|NCT02647281|454860366|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426905|NCT02647281|454860367|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426906|NCT02647281|454860368|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426907|NCT02647281|454860369|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
126426908|NCT02647281|454860370|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
126426909|NCT05801991|454860371|FG000|Overall Study|Lost to Follow-up|1|||
126426910|NCT05801991|454860372|FG001|Overall Study|Lost to Follow-up|0|||
126426911|NCT03489863|454860373|FG000|Overall Study|Withdrawal by Subject|0|||
126426912|NCT03489863|454860374|FG001|Overall Study|Withdrawal by Subject|1|||
126426913|NCT00962208|454860376|FG000|Overall Study|Could not achieve good vision|9|||
126426914|NCT00962208|454860377|FG001|Overall Study|Could not achieve good vision|0|||
126426915|NCT00962208|454860376|FG000|Overall Study|Contraindicated to continue study|5|||
126426916|NCT00962208|454860377|FG001|Overall Study|Contraindicated to continue study|1|||
126426917|NCT00962208|454860376|FG000|Overall Study|Lost to Follow-up|0|||
126426918|NCT00962208|454860377|FG001|Overall Study|Lost to Follow-up|9|||
126426919|NCT00791388|454860378|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
126426920|NCT00791388|454860379|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
126426921|NCT00791388|454860380|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
126426922|NCT00791388|454860381|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
126426923|NCT00791388|454860382|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
126674628|NCT00916149|455766044|FG001|Overall Study|Lost to Follow-up|2|||
126674629|NCT00916149|455766045|FG002|Overall Study|Lost to Follow-up|0|||
126674630|NCT00916149|455766043|FG000|Overall Study|Unable to place scalp EEG leads|1|||
126426924|NCT00791388|454860378|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
126426925|NCT00791388|454860379|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
126426926|NCT00791388|454860380|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
126426927|NCT00791388|454860381|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
126426928|NCT00791388|454860382|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
126426929|NCT00791388|454860378|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
126426930|NCT00791388|454860379|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
126426931|NCT00791388|454860380|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
126426932|NCT00791388|454860381|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
126426933|NCT00791388|454860382|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
126426934|NCT02995980|454860383|FG000|Overall Study|Lost to Follow-up|14|||
126674631|NCT00916149|455766044|FG001|Overall Study|Unable to place scalp EEG leads|0|||
126426935|NCT00657540|454860385|FG000|Overall Study|Lost to Follow-up|1|||
126426936|NCT00657540|454860386|FG001|Overall Study|Lost to Follow-up|4|||
126674632|NCT00916149|455766045|FG002|Overall Study|Unable to place scalp EEG leads|0|||
126426937|NCT01169103|454860388|FG000|Overall Study|Lost to Follow-up|3|||
126426938|NCT01169103|454860389|FG001|Overall Study|Lost to Follow-up|3|||
126674633|NCT00589420|455766046|FG000|Overall Study|screen failure|1|||
126426939|NCT01169103|454860388|FG000|Overall Study|Withdrawal by Subject|3|||
126674634|NCT01940471|455766047|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
126426940|NCT01169103|454860389|FG001|Overall Study|Withdrawal by Subject|1|||
126674635|NCT01940471|455766048|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
126426941|NCT03010527|454860390|FG000|Overall Study|Death|0|||
126674636|NCT01940471|455766049|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
126341458|NCT00427934|454546592|FG001|Overall Study|Adverse Event|0|||
126341459|NCT00427934|454546593|FG002|Overall Study|Adverse Event|5|||
126341460|NCT00427934|454546594|FG003|Overall Study|Adverse Event|4|||
126341461|NCT00427934|454546591|FG000|Overall Study|Lack of Efficacy|0|||
126341462|NCT00427934|454546592|FG001|Overall Study|Lack of Efficacy|0|||
126341463|NCT00427934|454546593|FG002|Overall Study|Lack of Efficacy|5|||
126341464|NCT00427934|454546594|FG003|Overall Study|Lack of Efficacy|2|||
126341465|NCT00427934|454546591|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
126341466|NCT00427934|454546592|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
126341467|NCT00427934|454546593|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
126341468|NCT00427934|454546594|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
126341469|NCT00427934|454546591|FG000|Overall Study|Other|0|||
126341470|NCT00427934|454546592|FG001|Overall Study|Other|0|||
126341471|NCT00427934|454546593|FG002|Overall Study|Other|11|||
126341472|NCT00427934|454546594|FG003|Overall Study|Other|5|||
126341473|NCT00427934|454546591|FG000|Overall Study|Withdrawal by Subject|0|||
126341474|NCT00427934|454546592|FG001|Overall Study|Withdrawal by Subject|0|||
126341475|NCT00427934|454546593|FG002|Overall Study|Withdrawal by Subject|1|||
126341476|NCT00427934|454546594|FG003|Overall Study|Withdrawal by Subject|3|||
126341477|NCT00499122|454546595|FG000|Overall Study|Withdrawal by Subject|2|||
126341478|NCT04539275|454546598|FG000|Overall Study|Death|2|||
126341479|NCT04539275|454546599|FG001|Overall Study|Death|4|||
126341480|NCT04539275|454546598|FG000|Overall Study|Lost to Follow-up|1|||
126341481|NCT04539275|454546599|FG001|Overall Study|Lost to Follow-up|1|||
126341482|NCT04539275|454546598|FG000|Overall Study|Withdrawal by Subject|3|||
126341483|NCT04539275|454546599|FG001|Overall Study|Withdrawal by Subject|0|||
126341484|NCT01373164|454546604|FG000|Overall Study|Lost to Follow-up|0|||
126341485|NCT01373164|454546605|FG001|Overall Study|Lost to Follow-up|0|||
126341486|NCT01373164|454546606|FG002|Overall Study|Lost to Follow-up|1|||
126341487|NCT01373164|454546607|FG003|Overall Study|Lost to Follow-up|2|||
126341488|NCT01373164|454546608|FG004|Overall Study|Lost to Follow-up|0|||
126341489|NCT01373164|454546604|FG000|Overall Study|Withdrawal by Subject|0|||
126341490|NCT01373164|454546605|FG001|Overall Study|Withdrawal by Subject|1|||
126341491|NCT01373164|454546606|FG002|Overall Study|Withdrawal by Subject|0|||
126341492|NCT01373164|454546607|FG003|Overall Study|Withdrawal by Subject|10|||
126341493|NCT01373164|454546608|FG004|Overall Study|Withdrawal by Subject|2|||
126341494|NCT01799941|454546609|FG000|Overall Study|Adverse Event|34|||
126341495|NCT01799941|454546609|FG000|Overall Study|Withdrawal by Subject|21|||
126341496|NCT01799941|454546609|FG000|Overall Study|Death|2|||
126341497|NCT01799941|454546609|FG000|Overall Study|Investigator Decision|4|||
126341498|NCT01799941|454546609|FG000|Overall Study|Lack of Efficacy|3|||
126341499|NCT01799941|454546609|FG000|Overall Study|Lost to Follow-up|17|||
126341500|NCT01799941|454546609|FG000|Overall Study|Other|15|||
126341501|NCT00420745|454546616|FG000|Overall Study|Adverse Event|2|||
126341502|NCT00420745|454546617|FG001|Overall Study|Adverse Event|2|||
126341503|NCT00420745|454546616|FG000|Overall Study|Lost to Follow-up|10|||
126341504|NCT00420745|454546617|FG001|Overall Study|Lost to Follow-up|2|||
126341505|NCT00420745|454546616|FG000|Overall Study|Protocol Violation|1|||
126341506|NCT00420745|454546617|FG001|Overall Study|Protocol Violation|0|||
126341507|NCT00420745|454546616|FG000|Overall Study|Physician Decision|1|||
126341508|NCT00420745|454546617|FG001|Overall Study|Physician Decision|1|||
126341509|NCT00420745|454546616|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
126341510|NCT00420745|454546617|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
126341511|NCT00420745|454546616|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
126341512|NCT00420745|454546617|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
126341513|NCT03736967|454546620|FG000|Overall Study|Withdrawal by Subject|26|||
126426942|NCT03010527|454860391|FG001|Overall Study|Death|0|||
126426943|NCT03010527|454860392|FG002|Overall Study|Death|1|||
126341514|NCT03736967|454546621|FG001|Overall Study|Withdrawal by Subject|25|||
126341515|NCT03736967|454546622|FG002|Overall Study|Withdrawal by Subject|23|||
126341516|NCT03736967|454546623|FG003|Overall Study|Withdrawal by Subject|26|||
126341517|NCT03736967|454546620|FG000|Overall Study|Lost to Follow-up|3|||
126341518|NCT03736967|454546621|FG001|Overall Study|Lost to Follow-up|2|||
126341519|NCT03736967|454546622|FG002|Overall Study|Lost to Follow-up|1|||
126341520|NCT03736967|454546623|FG003|Overall Study|Lost to Follow-up|1|||
126341521|NCT03736967|454546620|FG000|Overall Study|Physician Decision|1|||
126341522|NCT03736967|454546621|FG001|Overall Study|Physician Decision|0|||
126341523|NCT03736967|454546622|FG002|Overall Study|Physician Decision|0|||
126341524|NCT03736967|454546623|FG003|Overall Study|Physician Decision|1|||
126341525|NCT03736967|454546620|FG000|Overall Study|Adverse Event|0|||
126341526|NCT03736967|454546621|FG001|Overall Study|Adverse Event|1|||
126341527|NCT03736967|454546622|FG002|Overall Study|Adverse Event|0|||
126341528|NCT03736967|454546623|FG003|Overall Study|Adverse Event|1|||
126341529|NCT03736967|454546620|FG000|Overall Study|Death|0|||
126341530|NCT03736967|454546621|FG001|Overall Study|Death|0|||
126426944|NCT03010527|454860390|FG000|Overall Study|Adverse Event|0|||
126341531|NCT03736967|454546622|FG002|Overall Study|Death|0|||
126426945|NCT03010527|454860391|FG001|Overall Study|Adverse Event|4|||
126426946|NCT03010527|454860392|FG002|Overall Study|Adverse Event|2|||
126426947|NCT03010527|454860390|FG000|Overall Study|Protocol Violation|0|||
126426948|NCT03010527|454860391|FG001|Overall Study|Protocol Violation|1|||
126426949|NCT03010527|454860392|FG002|Overall Study|Protocol Violation|0|||
126426950|NCT03010527|454860390|FG000|Overall Study|Lost to Follow-up|0|||
126426951|NCT03010527|454860391|FG001|Overall Study|Lost to Follow-up|2|||
126426952|NCT03010527|454860392|FG002|Overall Study|Lost to Follow-up|1|||
126426953|NCT03010527|454860390|FG000|Overall Study|Withdrawal by Subject|0|||
126426954|NCT03010527|454860391|FG001|Overall Study|Withdrawal by Subject|3|||
126426955|NCT03010527|454860392|FG002|Overall Study|Withdrawal by Subject|4|||
126426956|NCT03010527|454860390|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
126426957|NCT03010527|454860391|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
126426958|NCT03010527|454860392|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
126426959|NCT03010527|454860390|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
126426960|NCT03010527|454860391|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
126426961|NCT03010527|454860392|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
126426962|NCT03010527|454860390|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
126426963|NCT03010527|454860391|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
126426964|NCT03010527|454860392|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
126426965|NCT02656017|454860393|FG000|Overall Study|Study burden|3|||
126426966|NCT02656017|454860394|FG001|Overall Study|Study burden|3|||
126426967|NCT02656017|454860393|FG000|Overall Study|Adverse Event|2|||
126426968|NCT02656017|454860394|FG001|Overall Study|Adverse Event|1|||
126426969|NCT02656017|454860393|FG000|Overall Study|Unable/unwilling to take study medication|2|||
126426970|NCT02656017|454860394|FG001|Overall Study|Unable/unwilling to take study medication|1|||
126426971|NCT02656017|454860393|FG000|Overall Study|Began Tolvaptan|1|||
126426972|NCT02656017|454860394|FG001|Overall Study|Began Tolvaptan|1|||
126674637|NCT01940471|455766050|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
126426973|NCT02656017|454860393|FG000|Overall Study|Withdrawal by Subject|1|||
126426974|NCT02656017|454860394|FG001|Overall Study|Withdrawal by Subject|0|||
126426975|NCT02792231|454860399|FG000|Overall Study|Patient/guardian decision|32|||
126426976|NCT02792231|454860400|FG001|Overall Study|Patient/guardian decision|42|||
126426977|NCT02792231|454860399|FG000|Overall Study|Adverse Event|15|||
126426978|NCT02792231|454860400|FG001|Overall Study|Adverse Event|11|||
126426979|NCT02792231|454860399|FG000|Overall Study|Physician Decision|14|||
126426980|NCT02792231|454860400|FG001|Overall Study|Physician Decision|12|||
126426981|NCT02792231|454860399|FG000|Overall Study|Lack of Efficacy|7|||
126426982|NCT02792231|454860400|FG001|Overall Study|Lack of Efficacy|9|||
126674638|NCT01940471|455766047|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
126674639|NCT01940471|455766048|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
126674640|NCT01940471|455766049|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
126674641|NCT01940471|455766050|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
126674642|NCT01940471|455766047|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
126674643|NCT01940471|455766048|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
126674644|NCT01940471|455766049|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
126426983|NCT02792231|454860399|FG000|Overall Study|Lost to Follow-up|9|||
126426984|NCT02792231|454860400|FG001|Overall Study|Lost to Follow-up|5|||
126674645|NCT01940471|455766050|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
126674646|NCT01940471|455766047|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
126674647|NCT01940471|455766048|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
126674648|NCT01940471|455766049|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
126674649|NCT01940471|455766050|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
126426985|NCT02792231|454860399|FG000|Overall Study|Pregnancy|1|||
126426986|NCT02792231|454860400|FG001|Overall Study|Pregnancy|3|||
126426987|NCT02792231|454860399|FG000|Overall Study|Non-compliance with study treatment|2|||
126426988|NCT02792231|454860400|FG001|Overall Study|Non-compliance with study treatment|1|||
126426989|NCT02792231|454860399|FG000|Overall Study|Protocol deviation|2|||
126426990|NCT02792231|454860400|FG001|Overall Study|Protocol deviation|0|||
126426991|NCT02792231|454860399|FG000|Overall Study|Technical problems|0|||
126674650|NCT01940471|455766047|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
126674651|NCT01940471|455766048|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
126674652|NCT01940471|455766049|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
126674653|NCT01940471|455766050|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
126426992|NCT02792231|454860400|FG001|Overall Study|Technical problems|1|||
126426993|NCT05196828|454860401|FG000|Overall Study|Withdrawal by Subject|2|||
126674654|NCT01940471|455766047|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
126426994|NCT05196828|454860402|FG001|Overall Study|Withdrawal by Subject|0|||
126426995|NCT05196828|454860401|FG000|Overall Study|Lost to Follow-up|0|||
126426996|NCT05196828|454860402|FG001|Overall Study|Lost to Follow-up|4|||
126426997|NCT05196828|454860401|FG000|Overall Study|Adverse Event|1|||
126426998|NCT05196828|454860402|FG001|Overall Study|Adverse Event|0|||
126426999|NCT02469623|454860403|FG000|Overall Study|Not consented for long-term follow-up|4|||
126427000|NCT02469623|454860403|FG000|Overall Study|Lost to Follow-up|4|||
126427001|NCT02469623|454860403|FG000|Overall Study|Withdrawal by Subject|2|||
126341532|NCT03736967|454546623|FG003|Overall Study|Death|1|||
126341533|NCT03736967|454546620|FG000|Overall Study|Randomized but never treated|1|||
126341534|NCT03736967|454546621|FG001|Overall Study|Randomized but never treated|0|||
126341535|NCT03736967|454546622|FG002|Overall Study|Randomized but never treated|0|||
126341536|NCT03736967|454546623|FG003|Overall Study|Randomized but never treated|0|||
126341537|NCT02419807|454546624|FG000|Overall Study|Withdrawal by Subject|4|||
126341538|NCT02419807|454546624|FG000|Overall Study|Physician Decision|1|||
126341539|NCT02419807|454546624|FG000|Overall Study|Protocol Violation|5|||
126341540|NCT01458587|454546625|FG000|Overall Study|Withdrawal by Subject|1|||
126341541|NCT01458587|454546626|FG001|Overall Study|Withdrawal by Subject|0|||
126341542|NCT02932943|454546628|FG000|Overall Study|Lost to Follow-up|0|||
126341543|NCT02932943|454546629|FG001|Overall Study|Lost to Follow-up|2|||
126341544|NCT02932943|454546628|FG000|Overall Study|Adverse Event|2|||
126341545|NCT02932943|454546629|FG001|Overall Study|Adverse Event|2|||
126341546|NCT02932943|454546628|FG000|Overall Study|Withdrawal by Subject|3|||
126341547|NCT02932943|454546629|FG001|Overall Study|Withdrawal by Subject|3|||
126341548|NCT01454284|454546630|FG000|Overall Study|Adverse Event|20|||
126341549|NCT01454284|454546631|FG001|Overall Study|Adverse Event|7|||
126341550|NCT01454284|454546630|FG000|Overall Study|Death|0|||
126341551|NCT01454284|454546631|FG001|Overall Study|Death|3|||
126341552|NCT01454284|454546630|FG000|Overall Study|Lost to Follow-up|13|||
126341553|NCT01454284|454546631|FG001|Overall Study|Lost to Follow-up|8|||
126341554|NCT01454284|454546630|FG000|Overall Study|Protocol Violation|9|||
126341555|NCT01454284|454546631|FG001|Overall Study|Protocol Violation|6|||
126341556|NCT01454284|454546630|FG000|Overall Study|Withdrawal by Subject|58|||
126341557|NCT01454284|454546631|FG001|Overall Study|Withdrawal by Subject|36|||
126341558|NCT01454284|454546630|FG000|Overall Study|Physician Decision|16|||
126341559|NCT01454284|454546631|FG001|Overall Study|Physician Decision|11|||
126341560|NCT01454284|454546630|FG000|Overall Study|Sponsor Decision|0|||
126341561|NCT01454284|454546631|FG001|Overall Study|Sponsor Decision|2|||
126341562|NCT03248037|454546634|FG000|Overall Study|Withdrawal by Subject|6|||
126341563|NCT03248037|454546635|FG001|Overall Study|Withdrawal by Subject|9|||
126341564|NCT03248037|454546634|FG000|Overall Study|Adverse Event|15|||
126341565|NCT03248037|454546635|FG001|Overall Study|Adverse Event|0|||
126341566|NCT04018066|454546636|FG000|Overall Study|participants started taking medications during the study period|3|||
126341567|NCT04018066|454546636|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
126341568|NCT01462942|454546645|FG000|Overall Study|Adverse Event|7|||
126341569|NCT01462942|454546646|FG001|Overall Study|Adverse Event|12|||
126341570|NCT01462942|454546647|FG002|Overall Study|Adverse Event|10|||
126341571|NCT01462942|454546648|FG003|Overall Study|Adverse Event|11|||
126341572|NCT01462942|454546649|FG004|Overall Study|Adverse Event|11|||
126341573|NCT01462942|454546645|FG000|Overall Study|Other, including COPD exacerbation|3|||
126341574|NCT01462942|454546646|FG001|Overall Study|Other, including COPD exacerbation|5|||
126341575|NCT01462942|454546647|FG002|Overall Study|Other, including COPD exacerbation|2|||
126341576|NCT01462942|454546648|FG003|Overall Study|Other, including COPD exacerbation|8|||
126341577|NCT01462942|454546649|FG004|Overall Study|Other, including COPD exacerbation|5|||
126341578|NCT01462942|454546645|FG000|Overall Study|Withdrawal by Subject|14|||
126341579|NCT01462942|454546646|FG001|Overall Study|Withdrawal by Subject|10|||
126341580|NCT01462942|454546647|FG002|Overall Study|Withdrawal by Subject|14|||
126341581|NCT01462942|454546648|FG003|Overall Study|Withdrawal by Subject|16|||
126341582|NCT01462942|454546649|FG004|Overall Study|Withdrawal by Subject|19|||
126341583|NCT01462942|454546645|FG000|Overall Study|Lack of Efficacy|6|||
126341584|NCT01462942|454546646|FG001|Overall Study|Lack of Efficacy|0|||
126341585|NCT01462942|454546647|FG002|Overall Study|Lack of Efficacy|4|||
126341586|NCT01462942|454546648|FG003|Overall Study|Lack of Efficacy|5|||
126341587|NCT01462942|454546649|FG004|Overall Study|Lack of Efficacy|3|||
126341588|NCT01462942|454546645|FG000|Overall Study|Lost to Follow-up|0|||
126341589|NCT01462942|454546646|FG001|Overall Study|Lost to Follow-up|1|||
126341590|NCT01462942|454546647|FG002|Overall Study|Lost to Follow-up|1|||
126341591|NCT01462942|454546648|FG003|Overall Study|Lost to Follow-up|1|||
126341592|NCT01462942|454546649|FG004|Overall Study|Lost to Follow-up|1|||
126341593|NCT01462942|454546645|FG000|Overall Study|Protocol Violation|4|||
126341594|NCT01462942|454546646|FG001|Overall Study|Protocol Violation|6|||
126341595|NCT01462942|454546647|FG002|Overall Study|Protocol Violation|9|||
126341596|NCT01462942|454546648|FG003|Overall Study|Protocol Violation|9|||
126341597|NCT01462942|454546649|FG004|Overall Study|Protocol Violation|6|||
126341598|NCT01027845|454546650|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
126341599|NCT01027845|454546651|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
126341600|NCT01027845|454546652|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
126341601|NCT01027845|454546653|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
126341602|NCT01027845|454546650|FG000|Primary Vaccination Phase|Adverse Event|1|||
126341603|NCT01027845|454546651|FG001|Primary Vaccination Phase|Adverse Event|0|||
126341604|NCT01027845|454546652|FG002|Primary Vaccination Phase|Adverse Event|0|||
126341605|NCT01027845|454546653|FG003|Primary Vaccination Phase|Adverse Event|0|||
126341606|NCT01027845|454546650|FG000|Primary Vaccination Phase|Protocol Violation|1|||
126341607|NCT01027845|454546651|FG001|Primary Vaccination Phase|Protocol Violation|0|||
126341608|NCT01027845|454546652|FG002|Primary Vaccination Phase|Protocol Violation|0|||
126674655|NCT01940471|455766048|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
126674656|NCT01940471|455766049|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
126674657|NCT01940471|455766050|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
126674658|NCT01940471|455766047|FG000|Period 1: Double-blind Phase|Death|2|||
126674659|NCT01940471|455766048|FG001|Period 1: Double-blind Phase|Death|1|||
126674660|NCT01940471|455766049|FG002|Period 1: Double-blind Phase|Death|0|||
126674661|NCT01940471|455766050|FG003|Period 1: Double-blind Phase|Death|0|||
126674662|NCT01940471|455766047|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
126674663|NCT01940471|455766048|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
126674664|NCT01940471|455766049|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
126674665|NCT01940471|455766050|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
126674666|NCT01940471|455766047|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
126674667|NCT01940471|455766048|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
126674668|NCT01940471|455766049|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
126674669|NCT01940471|455766050|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
126674670|NCT01940471|455766047|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
126674671|NCT01940471|455766048|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
126674672|NCT01940471|455766049|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
126674673|NCT01940471|455766050|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
126674674|NCT01940471|455766047|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
126674675|NCT01940471|455766048|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
126674676|NCT01940471|455766049|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
126674677|NCT01940471|455766050|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
126674678|NCT01940471|455766047|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
126674679|NCT01940471|455766048|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
126674680|NCT01940471|455766049|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
126674681|NCT01940471|455766050|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
126674682|NCT01940471|455766047|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
126674683|NCT01940471|455766048|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
126674684|NCT01940471|455766049|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
126674685|NCT01940471|455766050|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
126674686|NCT01940471|455766047|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
126674687|NCT01940471|455766048|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
126674688|NCT01940471|455766049|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
126674689|NCT01940471|455766050|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
126674690|NCT01940471|455766047|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
126674691|NCT01940471|455766048|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
126674692|NCT01940471|455766049|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
126674693|NCT01940471|455766050|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
126674694|NCT01940471|455766047|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
126674695|NCT01940471|455766048|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
126674696|NCT01940471|455766049|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
126674697|NCT01940471|455766050|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
126674698|NCT01940471|455766047|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
126674699|NCT01940471|455766048|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
126674700|NCT01940471|455766049|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
126674701|NCT01940471|455766050|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
126674702|NCT01940471|455766047|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
126674703|NCT01940471|455766048|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
126674704|NCT01940471|455766049|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
126674705|NCT01940471|455766050|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
126674706|NCT01940471|455766047|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
126674707|NCT01940471|455766048|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
126674708|NCT01940471|455766049|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
126674709|NCT01940471|455766050|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
126674710|NCT01940471|455766047|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
126674711|NCT01940471|455766048|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
126674712|NCT01940471|455766049|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
126674713|NCT01940471|455766050|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
126674714|NCT01940471|455766047|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
126674715|NCT01940471|455766048|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
126341609|NCT01027845|454546653|FG003|Primary Vaccination Phase|Protocol Violation|0|||
126341610|NCT01027845|454546650|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
126341611|NCT01027845|454546651|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
126427002|NCT02469623|454860403|FG000|Overall Study|Death|3|||
126427003|NCT04073186|454860404|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
126674716|NCT01940471|455766049|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
126674717|NCT01940471|455766050|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
126674718|NCT01846624|455766051|FG000|Overall Study|Died during induction, no midostaurin|1|||
126674719|NCT03574753|455766052|FG000|Overall Study|Adverse Event|3|||
126674720|NCT03574753|455766052|FG000|Overall Study|Progression/relapse|19|||
126674721|NCT03574753|455766052|FG000|Overall Study|Death|1|||
126674722|NCT03462719|455766055|FG000|Overall Study|Withdrawal by Subject|4|||
126674723|NCT03462719|455766056|FG001|Overall Study|Withdrawal by Subject|3|||
126674724|NCT03462719|455766055|FG000|Overall Study|Ongoing|87|||
126674725|NCT03462719|455766056|FG001|Overall Study|Ongoing|72|||
126674726|NCT03451851|455766059|FG000|PCP: Week 0 -16|Adverse Event|1|||
126674727|NCT03451851|455766060|FG001|PCP: Week 0 -16|Adverse Event|0|||
126674728|NCT03451851|455766061|FG002|PCP: Week 0 -16|Adverse Event|0|||
126674729|NCT03451851|455766062|FG003|PCP: Week 0 -16|Adverse Event|0|||
126674730|NCT03451851|455766063|FG004|PCP: Week 0 -16|Adverse Event|0|||
126674731|NCT03451851|455766064|FG005|PCP: Week 0 -16|Adverse Event|0|||
126674732|NCT03451851|455766065|FG006|PCP: Week 0 -16|Adverse Event|1|||
126674733|NCT03451851|455766066|FG007|PCP: Week 0 -16|Adverse Event|0|||
126674734|NCT03451851|455766059|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
126674735|NCT03451851|455766060|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
126674736|NCT03451851|455766061|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
126674737|NCT03451851|455766062|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
126674738|NCT03451851|455766063|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
126674739|NCT03451851|455766064|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
126674740|NCT03451851|455766065|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
126674741|NCT03451851|455766066|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
126674742|NCT03451851|455766059|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126427004|NCT04073186|454860404|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
126427005|NCT04073186|454860404|FG000|First Wearing Cycle|Protocol Violation|1|||
126427006|NCT04073186|454860404|FG000|First Wearing Cycle|Lens Discomfort|2|||
126427007|NCT04073186|454860404|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
126427008|NCT04073186|454860404|FG000|Second Wearing Cycle|Adverse Event|1|||
126427009|NCT03309878|454860405|FG000|Overall Study|Adverse Event|1|||
126427010|NCT03309878|454860406|FG001|Overall Study|Adverse Event|0|||
126427011|NCT03309878|454860407|FG002|Overall Study|Adverse Event|0|||
126427012|NCT03309878|454860408|FG003|Overall Study|Adverse Event|0|||
126427013|NCT03309878|454860405|FG000|Overall Study|Did not maintain eligibility|2|||
126427014|NCT03309878|454860406|FG001|Overall Study|Did not maintain eligibility|1|||
126674743|NCT03451851|455766060|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126674744|NCT03451851|455766061|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
126674745|NCT03451851|455766062|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126674746|NCT03451851|455766063|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126674747|NCT03451851|455766064|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126674748|NCT03451851|455766065|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126674749|NCT03451851|455766066|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
126674750|NCT03451851|455766059|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
126674751|NCT03451851|455766060|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
126674752|NCT03451851|455766061|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
126674753|NCT03451851|455766062|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
126674754|NCT03451851|455766063|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
126674755|NCT03451851|455766064|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
126674756|NCT03451851|455766065|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
126674757|NCT03451851|455766066|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
126674758|NCT03451851|455766059|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126674759|NCT03451851|455766060|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126674760|NCT03451851|455766061|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126674761|NCT03451851|455766062|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126674762|NCT03451851|455766063|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
126674763|NCT03451851|455766064|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126674764|NCT03451851|455766065|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126674765|NCT03451851|455766066|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
126674766|NCT03451851|455766059|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126674767|NCT03451851|455766060|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126674768|NCT03451851|455766061|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126674769|NCT03451851|455766062|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126674770|NCT03451851|455766063|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
126674771|NCT03451851|455766064|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126674772|NCT03451851|455766065|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126674773|NCT03451851|455766066|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
126674774|NCT05885737|455766067|FG000|DB Period|Adverse Event|4|||
126674775|NCT05885737|455766068|FG001|DB Period|Adverse Event|4|||
126674776|NCT05885737|455766067|FG000|DB Period|Lost to Follow-up|0|||
126674777|NCT05885737|455766068|FG001|DB Period|Lost to Follow-up|1|||
126674778|NCT05885737|455766067|FG000|DB Period|Physician Decision|2|||
126674779|NCT05885737|455766068|FG001|DB Period|Physician Decision|0|||
126674780|NCT05885737|455766067|FG000|DB Period|Withdrawal by Subject|12|||
126674781|NCT05885737|455766068|FG001|DB Period|Withdrawal by Subject|6|||
126674782|NCT05885737|455766067|FG000|DB Period|Other: Unspecified|2|||
126674783|NCT05885737|455766068|FG001|DB Period|Other: Unspecified|2|||
126674784|NCT05885737|455766067|FG000|OLE Period|Adverse Event|3|||
126674785|NCT05885737|455766068|FG001|OLE Period|Adverse Event|2|||
126674786|NCT05885737|455766067|FG000|OLE Period|Physician Decision|1|||
126674787|NCT05885737|455766068|FG001|OLE Period|Physician Decision|0|||
126674788|NCT05885737|455766067|FG000|OLE Period|Withdrawal by Subject|5|||
126674789|NCT05885737|455766068|FG001|OLE Period|Withdrawal by Subject|5|||
126674790|NCT05885737|455766067|FG000|OLE Period|Other: Unspecified|2|||
126674791|NCT05885737|455766068|FG001|OLE Period|Other: Unspecified|1|||
126674792|NCT00307151|455767003|FG000|Overall Study|Death|4|||
126674793|NCT00307151|455767004|FG001|Overall Study|Death|3|||
126674794|NCT00307151|455767005|FG002|Overall Study|Death|10|||
126674795|NCT00307151|455767006|FG003|Overall Study|Death|3|||
126674796|NCT00307151|455767003|FG000|Overall Study|Severe debilitation, unable to continue|1|||
126674797|NCT00307151|455767004|FG001|Overall Study|Severe debilitation, unable to continue|0|||
126674798|NCT00307151|455767005|FG002|Overall Study|Severe debilitation, unable to continue|0|||
126674799|NCT00307151|455767006|FG003|Overall Study|Severe debilitation, unable to continue|0|||
126674800|NCT00307151|455767003|FG000|Overall Study|Subject unable to get to clinic|1|||
126674801|NCT00307151|455767004|FG001|Overall Study|Subject unable to get to clinic|0|||
126674802|NCT00307151|455767005|FG002|Overall Study|Subject unable to get to clinic|6|||
126674803|NCT00307151|455767006|FG003|Overall Study|Subject unable to get to clinic|2|||
126674804|NCT00307151|455767003|FG000|Overall Study|Withdrew consent|0|||
126674805|NCT00307151|455767004|FG001|Overall Study|Withdrew consent|1|||
126674806|NCT00307151|455767005|FG002|Overall Study|Withdrew consent|1|||
126674807|NCT00307151|455767006|FG003|Overall Study|Withdrew consent|3|||
126674808|NCT00307151|455767003|FG000|Overall Study|Not willing to adhere to study reqs|2|||
126674809|NCT00307151|455767004|FG001|Overall Study|Not willing to adhere to study reqs|0|||
126674810|NCT00307151|455767005|FG002|Overall Study|Not willing to adhere to study reqs|2|||
126674811|NCT00307151|455767006|FG003|Overall Study|Not willing to adhere to study reqs|2|||
126674812|NCT00307151|455767003|FG000|Overall Study|Clinic unable to contact subject|3|||
126674813|NCT00307151|455767004|FG001|Overall Study|Clinic unable to contact subject|3|||
126674814|NCT00307151|455767005|FG002|Overall Study|Clinic unable to contact subject|1|||
126674815|NCT00307151|455767006|FG003|Overall Study|Clinic unable to contact subject|1|||
126674816|NCT00516048|455767010|FG000|Overall Study|Death|0|||
126674817|NCT00516048|455767011|FG001|Overall Study|Death|0|||
126674818|NCT00516048|455767012|FG002|Overall Study|Death|1|||
126674819|NCT00516048|455767010|FG000|Overall Study|Subject Decision|0|||
126674820|NCT00516048|455767011|FG001|Overall Study|Subject Decision|2|||
126674821|NCT00516048|455767012|FG002|Overall Study|Subject Decision|0|||
126674822|NCT00096785|455767013|FG000|Overall Study|Lost to Follow-up|1|||
126674823|NCT00096785|455767014|FG001|Overall Study|Lost to Follow-up|0|||
126674824|NCT00096785|455767013|FG000|Overall Study|Withdrawal by Subject|0|||
126674825|NCT00096785|455767014|FG001|Overall Study|Withdrawal by Subject|1|||
126674826|NCT00096785|455767013|FG000|Overall Study|Relocated|1|||
126674827|NCT00096785|455767014|FG001|Overall Study|Relocated|0|||
126674828|NCT02081534|455767018|FG000|Overall Study|Adverse Event|5|||
126674829|NCT02081534|455767019|FG001|Overall Study|Adverse Event|4|||
126674830|NCT02081534|455767020|FG002|Overall Study|Adverse Event|3|||
126674831|NCT02081534|455767021|FG003|Overall Study|Adverse Event|10|||
126674832|NCT02081534|455767022|FG004|Overall Study|Adverse Event|2|||
126674833|NCT02081534|455767023|FG005|Overall Study|Adverse Event|8|||
126674834|NCT02081534|455767024|FG006|Overall Study|Adverse Event|2|||
126674835|NCT02081534|455767018|FG000|Overall Study|Withdrawal by Subject|0|||
126674836|NCT02081534|455767019|FG001|Overall Study|Withdrawal by Subject|1|||
126674837|NCT02081534|455767020|FG002|Overall Study|Withdrawal by Subject|1|||
126674838|NCT02081534|455767021|FG003|Overall Study|Withdrawal by Subject|1|||
126674839|NCT02081534|455767022|FG004|Overall Study|Withdrawal by Subject|1|||
126674840|NCT02081534|455767023|FG005|Overall Study|Withdrawal by Subject|0|||
126674841|NCT02081534|455767024|FG006|Overall Study|Withdrawal by Subject|1|||
126674842|NCT02081534|455767018|FG000|Overall Study|Protocol Violation|0|||
126674843|NCT02081534|455767019|FG001|Overall Study|Protocol Violation|3|||
126674844|NCT02081534|455767020|FG002|Overall Study|Protocol Violation|0|||
126674845|NCT02081534|455767021|FG003|Overall Study|Protocol Violation|0|||
126674846|NCT02081534|455767022|FG004|Overall Study|Protocol Violation|0|||
126674847|NCT02081534|455767023|FG005|Overall Study|Protocol Violation|0|||
126674848|NCT02081534|455767024|FG006|Overall Study|Protocol Violation|1|||
126674849|NCT02081534|455767018|FG000|Overall Study|Lost to Follow-up|0|||
126674850|NCT02081534|455767019|FG001|Overall Study|Lost to Follow-up|0|||
126674851|NCT02081534|455767020|FG002|Overall Study|Lost to Follow-up|0|||
126674852|NCT02081534|455767021|FG003|Overall Study|Lost to Follow-up|2|||
126674853|NCT02081534|455767022|FG004|Overall Study|Lost to Follow-up|1|||
126674854|NCT02081534|455767023|FG005|Overall Study|Lost to Follow-up|1|||
126674855|NCT02081534|455767024|FG006|Overall Study|Lost to Follow-up|0|||
126674856|NCT00003535|455767025|FG000|Overall Study|Not evaluable|5|||
126674857|NCT02181816|455767026|FG000|Overall Study|Case Report Forms Uncollected|38|||
126674858|NCT02181816|455767026|FG000|Overall Study|Protocol Deviation|21|||
126674859|NCT03807349|455767029|FG000|Overall Study|Early Study Termination|9|||
126674860|NCT00294060|455767030|FG000|Overall Study|Death|225|||
126674861|NCT00294060|455767030|FG000|Overall Study|Other|59|||
126674862|NCT00294060|455767030|FG000|Overall Study|Lost to Follow-up|55|||
126674863|NCT00294060|455767030|FG000|Overall Study|Withdrawal by Subject|11|||
126674864|NCT00294060|455767030|FG000|Overall Study|Physician Decision|797|||
126674865|NCT00294060|455767030|FG000|Overall Study|Medical condition|3|||
126674866|NCT00294060|455767030|FG000|Overall Study|Device explanted/not replaced|23|||
126674867|NCT01360554|455767031|FG000|Overall Study|Death|359|||
126674868|NCT01360554|455767032|FG001|Overall Study|Death|371|||
126674869|NCT01360554|455767031|FG000|Overall Study|Lost to Follow-up|4|||
126674870|NCT01360554|455767032|FG001|Overall Study|Lost to Follow-up|4|||
126674871|NCT01360554|455767031|FG000|Overall Study|Withdrawal by Subject|23|||
126341612|NCT01027845|454546652|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
126341613|NCT01027845|454546653|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
126341614|NCT01027845|454546650|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
126341615|NCT01027845|454546651|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
126341616|NCT01027845|454546652|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
126341617|NCT01027845|454546653|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
126341618|NCT01027845|454546650|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
126341619|NCT01027845|454546651|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
126341620|NCT01027845|454546652|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
126341621|NCT01027845|454546653|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
126341622|NCT00087178|454546656|FG000|Overall Study|No follow up data|5|||
126341623|NCT00087178|454546657|FG001|Overall Study|No follow up data|15|||
126341624|NCT00087178|454546656|FG000|Overall Study|No clinical assessment|1|||
126341625|NCT00087178|454546657|FG001|Overall Study|No clinical assessment|2|||
126341626|NCT00087178|454546656|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
126341627|NCT00087178|454546657|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
126341628|NCT04465422|454546658|FG000|Overall Study|Lost to Follow-up|0|||
126341629|NCT04465422|454546659|FG001|Overall Study|Lost to Follow-up|2|||
126341630|NCT01692119|454546662|FG000|Overall Study|Protocol Violation|3|||
126341631|NCT01692119|454546663|FG001|Overall Study|Protocol Violation|1|||
126341632|NCT01692119|454546662|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
126341633|NCT01692119|454546663|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
126341634|NCT00997893|454546664|FG000|Overall Study|Adverse Event|1|||
126341635|NCT00997893|454546665|FG001|Overall Study|Adverse Event|0|||
126341636|NCT00997893|454546666|FG002|Overall Study|Adverse Event|0|||
126341637|NCT00997893|454546664|FG000|Overall Study|Unable to meet study timelines|1|||
126341638|NCT00997893|454546665|FG001|Overall Study|Unable to meet study timelines|0|||
126341639|NCT00997893|454546666|FG002|Overall Study|Unable to meet study timelines|0|||
126341640|NCT00997893|454546664|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
126341641|NCT00997893|454546665|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
126341642|NCT00997893|454546666|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
126341643|NCT03444584|454546667|FG000|Overall Study|Withdrawal by Subject|0|||
126341644|NCT03444584|454546668|FG001|Overall Study|Withdrawal by Subject|1|||
126341645|NCT03444584|454546667|FG000|Overall Study|Other|0|||
126341646|NCT03444584|454546668|FG001|Overall Study|Other|1|||
126341647|NCT01142336|454546669|FG000|Overall Study|Adverse Event|1|||
126341648|NCT01142336|454546670|FG001|Overall Study|Adverse Event|1|||
126341649|NCT01142336|454546669|FG000|Overall Study|Lost to Follow-up|0|||
126341650|NCT01142336|454546670|FG001|Overall Study|Lost to Follow-up|1|||
126341651|NCT01704261|454546671|FG000|Overall Study|Withdrawal by Subject|12|||
126341652|NCT01704261|454546672|FG001|Overall Study|Withdrawal by Subject|15|||
126341653|NCT01704261|454546671|FG000|Overall Study|Lost to Follow-up|1|||
126341654|NCT01704261|454546672|FG001|Overall Study|Lost to Follow-up|0|||
126341655|NCT02722967|454546673|FG000|Overall Study|Adverse Event|1|||
126341656|NCT02722967|454546674|FG001|Overall Study|Adverse Event|0|||
126341657|NCT02722967|454546675|FG002|Overall Study|Adverse Event|0|||
126341658|NCT02722967|454546673|FG000|Overall Study|Lost to Follow-up|0|||
126341659|NCT02722967|454546674|FG001|Overall Study|Lost to Follow-up|1|||
126341660|NCT02722967|454546675|FG002|Overall Study|Lost to Follow-up|0|||
126674872|NCT01360554|455767032|FG001|Overall Study|Withdrawal by Subject|24|||
126341661|NCT02722967|454546673|FG000|Overall Study|Non-compliance with patch wearing|2|||
126341662|NCT02722967|454546674|FG001|Overall Study|Non-compliance with patch wearing|1|||
126341663|NCT02722967|454546675|FG002|Overall Study|Non-compliance with patch wearing|1|||
126674873|NCT01360554|455767031|FG000|Overall Study|Study terminated by sponsor|49|||
126341664|NCT02722967|454546673|FG000|Overall Study|Withdrawal by Subject|1|||
126341665|NCT02722967|454546674|FG001|Overall Study|Withdrawal by Subject|0|||
126341666|NCT02722967|454546675|FG002|Overall Study|Withdrawal by Subject|1|||
126341667|NCT02722967|454546673|FG000|Overall Study|Physician Decision|1|||
126341668|NCT02722967|454546674|FG001|Overall Study|Physician Decision|0|||
126341669|NCT02722967|454546675|FG002|Overall Study|Physician Decision|0|||
126341670|NCT02722967|454546673|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
126341671|NCT02722967|454546674|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
126341672|NCT02722967|454546675|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
126341673|NCT00071981|454546678|FG000|Overall Study|Lack of Efficacy|37|||
126341674|NCT00071981|454546679|FG001|Overall Study|Lack of Efficacy|29|||
126341675|NCT00071981|454546680|FG002|Overall Study|Lack of Efficacy|30|||
126341676|NCT00071981|454546681|FG003|Overall Study|Lack of Efficacy|43|||
126341677|NCT00071981|454546678|FG000|Overall Study|Adverse Event|4|||
126341678|NCT00071981|454546679|FG001|Overall Study|Adverse Event|4|||
126341679|NCT00071981|454546680|FG002|Overall Study|Adverse Event|3|||
126341680|NCT00071981|454546681|FG003|Overall Study|Adverse Event|1|||
126341681|NCT00071981|454546678|FG000|Overall Study|Death|0|||
126341682|NCT00071981|454546679|FG001|Overall Study|Death|0|||
126341683|NCT00071981|454546680|FG002|Overall Study|Death|1|||
126341684|NCT00071981|454546681|FG003|Overall Study|Death|1|||
126341685|NCT00071981|454546678|FG000|Overall Study|Withdrawal by Subject|3|||
126341686|NCT00071981|454546679|FG001|Overall Study|Withdrawal by Subject|1|||
126341687|NCT00071981|454546680|FG002|Overall Study|Withdrawal by Subject|0|||
126341688|NCT00071981|454546681|FG003|Overall Study|Withdrawal by Subject|0|||
126341689|NCT00071981|454546678|FG000|Overall Study|No protocol therapy|2|||
126341690|NCT00071981|454546679|FG001|Overall Study|No protocol therapy|5|||
126341691|NCT00071981|454546680|FG002|Overall Study|No protocol therapy|1|||
126341692|NCT00071981|454546681|FG003|Overall Study|No protocol therapy|0|||
126341693|NCT00071981|454546678|FG000|Overall Study|others (not specified in the study)|0|||
126341694|NCT00071981|454546679|FG001|Overall Study|others (not specified in the study)|2|||
126341695|NCT00071981|454546680|FG002|Overall Study|others (not specified in the study)|2|||
126341696|NCT00071981|454546681|FG003|Overall Study|others (not specified in the study)|0|||
126341697|NCT00467519|454546682|FG000|Overall Study|Protocol Violation|8|||
126341698|NCT00467519|454546683|FG001|Overall Study|Protocol Violation|4|||
126341699|NCT00467519|454546682|FG000|Overall Study|Lost to Follow-up|2|||
126341700|NCT00467519|454546683|FG001|Overall Study|Lost to Follow-up|9|||
126341701|NCT00467519|454546682|FG000|Overall Study|Withdrawal by Subject|4|||
126341702|NCT00467519|454546683|FG001|Overall Study|Withdrawal by Subject|10|||
126341703|NCT01123655|454546686|FG000|Overall Study|Medication for RA had to be changed|1|||
126341704|NCT01123655|454546687|FG001|Overall Study|Medication for RA had to be changed|0|||
126341705|NCT01123655|454546688|FG002|Overall Study|Medication for RA had to be changed|0|||
126341706|NCT01123655|454546686|FG000|Overall Study|new illness|0|||
126341707|NCT01123655|454546687|FG001|Overall Study|new illness|1|||
126341708|NCT01123655|454546688|FG002|Overall Study|new illness|0|||
126341709|NCT01123655|454546686|FG000|Overall Study|began prohibitive drug|0|||
126341710|NCT01123655|454546687|FG001|Overall Study|began prohibitive drug|0|||
126341711|NCT01123655|454546688|FG002|Overall Study|began prohibitive drug|1|||
126341712|NCT00062166|454546689|FG000|Overall Study|Withdrawal by Subject|6|||
126341713|NCT00833755|454546690|FG000|Overall Study|Physician Decision|4|||
126341714|NCT00833755|454546691|FG001|Overall Study|Physician Decision|4|||
126341715|NCT00833755|454546692|FG002|Overall Study|Physician Decision|2|||
126341716|NCT00833755|454546693|FG003|Overall Study|Physician Decision|6|||
126341717|NCT00833755|454546690|FG000|Overall Study|Subject had scheduling issues|0|||
126341718|NCT00833755|454546691|FG001|Overall Study|Subject had scheduling issues|1|||
126341719|NCT00833755|454546692|FG002|Overall Study|Subject had scheduling issues|0|||
126341720|NCT00833755|454546693|FG003|Overall Study|Subject had scheduling issues|0|||
126341721|NCT01776554|454546697|FG000|Overall Study|Adverse Event|1|||
126341722|NCT01776554|454546698|FG001|Overall Study|Adverse Event|0|||
126341723|NCT01776554|454546697|FG000|Overall Study|Withdrawal by Subject|3|||
126341724|NCT01776554|454546698|FG001|Overall Study|Withdrawal by Subject|8|||
126341725|NCT01776554|454546697|FG000|Overall Study|Lost to Follow-up|6|||
126341726|NCT01776554|454546698|FG001|Overall Study|Lost to Follow-up|9|||
126341727|NCT01776554|454546697|FG000|Overall Study|Administrative Reason|2|||
126341728|NCT01776554|454546698|FG001|Overall Study|Administrative Reason|5|||
126341729|NCT01776554|454546697|FG000|Overall Study|Protocol Violation|1|||
126341730|NCT01776554|454546698|FG001|Overall Study|Protocol Violation|0|||
126341731|NCT01776554|454546697|FG000|Overall Study|Unclassified|4|||
126341732|NCT01776554|454546698|FG001|Overall Study|Unclassified|1|||
126341733|NCT00171249|454546699|FG000|Overall Study|Withdrawal by Subject|2|||
126341734|NCT00171249|454546700|FG001|Overall Study|Withdrawal by Subject|0|||
126341735|NCT00171249|454546701|FG002|Overall Study|Withdrawal by Subject|0|||
126341736|NCT00171249|454546702|FG003|Overall Study|Withdrawal by Subject|6|||
126341737|NCT00171249|454546703|FG004|Overall Study|Withdrawal by Subject|0|||
126341738|NCT00171249|454546704|FG005|Overall Study|Withdrawal by Subject|0|||
126341739|NCT00171249|454546705|FG006|Overall Study|Withdrawal by Subject|0|||
126341740|NCT00171249|454546699|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
126674874|NCT01360554|455767032|FG001|Overall Study|Study terminated by sponsor|37|||
126674875|NCT01360554|455767031|FG000|Overall Study|Other, not specified|1|||
126674876|NCT01360554|455767032|FG001|Overall Study|Other, not specified|0|||
126674877|NCT01360554|455767031|FG000|Overall Study|Randomized but not treated.|3|||
126674878|NCT01360554|455767032|FG001|Overall Study|Randomized but not treated.|3|||
126674879|NCT00187096|455767034|FG000|Overall Study|unacceptable toxicity|0|||
126674880|NCT00187096|455767035|FG001|Overall Study|unacceptable toxicity|0|||
126674881|NCT00187096|455767036|FG002|Overall Study|unacceptable toxicity|1|||
126674882|NCT02113436|455767037|FG000|Period 1: 8 Weeks|Adverse Event|1|||
126674883|NCT02113436|455767038|FG001|Period 1: 8 Weeks|Adverse Event|0|||
126674884|NCT02113436|455767039|FG002|Period 1: 8 Weeks|Adverse Event|0|||
126674885|NCT02113436|455767040|FG003|Period 1: 8 Weeks|Adverse Event|0|||
126674886|NCT02113436|455767037|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
126674887|NCT02113436|455767038|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
126674888|NCT02113436|455767039|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
126341741|NCT00171249|454546700|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126341742|NCT00171249|454546701|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
126341743|NCT00171249|454546702|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
126341744|NCT00171249|454546703|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126341745|NCT00171249|454546704|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
126341746|NCT00171249|454546705|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
126341747|NCT00171249|454546699|FG000|Overall Study|Death|7|||
126341748|NCT00171249|454546700|FG001|Overall Study|Death|1|||
126341749|NCT00171249|454546701|FG002|Overall Study|Death|0|||
126341750|NCT00171249|454546702|FG003|Overall Study|Death|4|||
126341751|NCT00171249|454546703|FG004|Overall Study|Death|0|||
126341752|NCT00171249|454546704|FG005|Overall Study|Death|3|||
126341753|NCT00171249|454546705|FG006|Overall Study|Death|1|||
126341754|NCT00171249|454546699|FG000|Overall Study|Other|10|||
126341755|NCT00171249|454546700|FG001|Overall Study|Other|0|||
126341756|NCT00171249|454546701|FG002|Overall Study|Other|0|||
126341757|NCT00171249|454546702|FG003|Overall Study|Other|43|||
126341758|NCT00171249|454546703|FG004|Overall Study|Other|0|||
126341759|NCT00171249|454546704|FG005|Overall Study|Other|2|||
126341760|NCT00171249|454546705|FG006|Overall Study|Other|0|||
126341761|NCT00171249|454546699|FG000|Overall Study|No Longer Requires Study Drug|4|||
126341762|NCT00171249|454546700|FG001|Overall Study|No Longer Requires Study Drug|0|||
126341763|NCT00171249|454546701|FG002|Overall Study|No Longer Requires Study Drug|0|||
126341764|NCT00171249|454546702|FG003|Overall Study|No Longer Requires Study Drug|3|||
126341765|NCT00171249|454546703|FG004|Overall Study|No Longer Requires Study Drug|0|||
126341766|NCT00171249|454546704|FG005|Overall Study|No Longer Requires Study Drug|5|||
126341767|NCT00171249|454546705|FG006|Overall Study|No Longer Requires Study Drug|0|||
126341768|NCT00171249|454546699|FG000|Overall Study|Administrative Problems|1|||
126341769|NCT00171249|454546700|FG001|Overall Study|Administrative Problems|0|||
126341770|NCT00171249|454546701|FG002|Overall Study|Administrative Problems|0|||
126341771|NCT00171249|454546702|FG003|Overall Study|Administrative Problems|2|||
126341772|NCT00171249|454546703|FG004|Overall Study|Administrative Problems|0|||
126341773|NCT00171249|454546704|FG005|Overall Study|Administrative Problems|0|||
126341774|NCT00171249|454546705|FG006|Overall Study|Administrative Problems|0|||
126341775|NCT00171249|454546699|FG000|Overall Study|Adverse Event|3|||
126341776|NCT00171249|454546700|FG001|Overall Study|Adverse Event|1|||
126341777|NCT00171249|454546701|FG002|Overall Study|Adverse Event|0|||
126341778|NCT00171249|454546702|FG003|Overall Study|Adverse Event|15|||
126341779|NCT00171249|454546703|FG004|Overall Study|Adverse Event|0|||
126341780|NCT00171249|454546704|FG005|Overall Study|Adverse Event|2|||
126341781|NCT00171249|454546705|FG006|Overall Study|Adverse Event|0|||
126341782|NCT00171249|454546699|FG000|Overall Study|Lost to Follow-up|5|||
126341783|NCT00171249|454546700|FG001|Overall Study|Lost to Follow-up|0|||
126341784|NCT00171249|454546701|FG002|Overall Study|Lost to Follow-up|0|||
126341785|NCT00171249|454546702|FG003|Overall Study|Lost to Follow-up|9|||
126341786|NCT00171249|454546703|FG004|Overall Study|Lost to Follow-up|0|||
126341787|NCT00171249|454546704|FG005|Overall Study|Lost to Follow-up|0|||
126674889|NCT02113436|455767040|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
126674890|NCT02113436|455767037|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
126674891|NCT02113436|455767038|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
126674892|NCT02113436|455767039|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
126341788|NCT00171249|454546705|FG006|Overall Study|Lost to Follow-up|0|||
126341789|NCT02475369|454546706|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
126341790|NCT02475369|454546707|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
126341791|NCT03608826|454546711|FG000|Overall Study|Death|3|||
126341792|NCT03608826|454546711|FG000|Overall Study|Heart Transplant|3|||
126341793|NCT03608826|454546711|FG000|Overall Study|Physician Decision|4|||
126341794|NCT03087058|454546724|FG000|Overall Study|Withdrawal by Subject|2|||
126341795|NCT03087058|454546725|FG001|Overall Study|Withdrawal by Subject|0|||
126341796|NCT03087058|454546726|FG002|Overall Study|Withdrawal by Subject|0|||
126341797|NCT02577029|454546727|FG000|Overall Study|Adverse Event|1|||
126341798|NCT02577029|454546728|FG001|Overall Study|Adverse Event|0|||
126674893|NCT02113436|455767040|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
126674894|NCT02113436|455767037|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
126674895|NCT02113436|455767038|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
126674896|NCT02113436|455767039|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
126674897|NCT02113436|455767040|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
126674898|NCT02113436|455767037|FG000|Period 2: 16 Weeks|Adverse Event|0|||
126674899|NCT02113436|455767038|FG001|Period 2: 16 Weeks|Adverse Event|0|||
126674900|NCT02113436|455767039|FG002|Period 2: 16 Weeks|Adverse Event|4|||
126674901|NCT02113436|455767040|FG003|Period 2: 16 Weeks|Adverse Event|5|||
126674902|NCT02113436|455767037|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
126674903|NCT02113436|455767038|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
126674904|NCT02113436|455767039|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
126674905|NCT02113436|455767040|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
126674906|NCT02113436|455767037|FG000|Period 2: 16 Weeks|Physician Decision|0|||
126674907|NCT02113436|455767038|FG001|Period 2: 16 Weeks|Physician Decision|0|||
126674908|NCT02113436|455767039|FG002|Period 2: 16 Weeks|Physician Decision|2|||
126674909|NCT02113436|455767040|FG003|Period 2: 16 Weeks|Physician Decision|0|||
126674910|NCT02113436|455767037|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
126674911|NCT02113436|455767038|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
126674912|NCT02113436|455767039|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
126674913|NCT02113436|455767040|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
126674914|NCT02159729|455767041|FG000|Overall Study|Adverse Event|0|||
126674915|NCT02159729|455767042|FG001|Overall Study|Adverse Event|1|||
126674916|NCT02159729|455767041|FG000|Overall Study|Subject's Request|13|||
126674917|NCT02159729|455767042|FG001|Overall Study|Subject's Request|10|||
126674918|NCT02159729|455767041|FG000|Overall Study|Lost to Follow-up|24|||
126674919|NCT02159729|455767042|FG001|Overall Study|Lost to Follow-up|9|||
126674920|NCT02159729|455767041|FG000|Overall Study|Non compliance|2|||
126674921|NCT02159729|455767042|FG001|Overall Study|Non compliance|0|||
126674922|NCT02159729|455767041|FG000|Overall Study|Other Unspecified|3|||
126674923|NCT02159729|455767042|FG001|Overall Study|Other Unspecified|1|||
126674924|NCT01111851|455767045|FG000|Overall Study|All planned PET scans were not obtained.|2|||
126674925|NCT01111851|455767046|FG001|Overall Study|All planned PET scans were not obtained.|0|||
126674926|NCT01816061|455767047|FG000|Overall Study|Lost to Follow-up|13|||
126674927|NCT01816061|455767048|FG001|Overall Study|Lost to Follow-up|24|||
126674928|NCT01961349|455767049|FG000|Overall Study|Withdrawal by Subject|1|||
126674929|NCT01961349|455767050|FG001|Overall Study|Withdrawal by Subject|4|||
126674930|NCT01961349|455767051|FG002|Overall Study|Withdrawal by Subject|0|||
126674931|NCT01961349|455767049|FG000|Overall Study|Adverse Event|0|||
126674932|NCT01961349|455767050|FG001|Overall Study|Adverse Event|0|||
126674933|NCT01961349|455767051|FG002|Overall Study|Adverse Event|1|||
126674934|NCT01961349|455767049|FG000|Overall Study|registration error, personal reason etc|2|||
126674935|NCT01961349|455767050|FG001|Overall Study|registration error, personal reason etc|2|||
126674936|NCT01961349|455767051|FG002|Overall Study|registration error, personal reason etc|1|||
126674937|NCT02576444|455767053|FG000|Overall Study|Death|1|||
126674938|NCT02576444|455767054|FG001|Overall Study|Death|1|||
126674939|NCT02576444|455767055|FG002|Overall Study|Death|0|||
126674940|NCT02576444|455767056|FG003|Overall Study|Death|0|||
126674941|NCT02576444|455767053|FG000|Overall Study|Withdrawal by Subject|0|||
126674942|NCT02576444|455767054|FG001|Overall Study|Withdrawal by Subject|0|||
126674943|NCT02576444|455767055|FG002|Overall Study|Withdrawal by Subject|2|||
126674944|NCT02576444|455767056|FG003|Overall Study|Withdrawal by Subject|0|||
126674945|NCT02576444|455767053|FG000|Overall Study|Adverse Event|0|||
126674946|NCT02576444|455767054|FG001|Overall Study|Adverse Event|0|||
126674947|NCT02576444|455767055|FG002|Overall Study|Adverse Event|1|||
126674948|NCT02576444|455767056|FG003|Overall Study|Adverse Event|0|||
126674949|NCT02576444|455767053|FG000|Overall Study|Physician Decision|0|||
126341799|NCT02577029|454546729|FG002|Overall Study|Adverse Event|2|||
126341800|NCT02577029|454546730|FG003|Overall Study|Adverse Event|0|||
126341801|NCT02577029|454546731|FG004|Overall Study|Adverse Event|1|||
126341802|NCT02577029|454546732|FG005|Overall Study|Adverse Event|0|||
126341803|NCT02577029|454546733|FG006|Overall Study|Adverse Event|0|||
126341804|NCT02577029|454546734|FG007|Overall Study|Adverse Event|0|||
126341805|NCT02577029|454546727|FG000|Overall Study|Withdrawal by Subject|0|||
126674950|NCT02576444|455767054|FG001|Overall Study|Physician Decision|0|||
126674951|NCT02576444|455767055|FG002|Overall Study|Physician Decision|1|||
126674952|NCT02576444|455767056|FG003|Overall Study|Physician Decision|0|||
126674953|NCT01299376|455767058|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
126674954|NCT01299376|455767059|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
126674955|NCT01299376|455767058|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
126674956|NCT01299376|455767059|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
126674957|NCT01299376|455767058|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
126674958|NCT01299376|455767059|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
126674959|NCT01299376|455767058|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
126674960|NCT01299376|455767059|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
126715141|NCT01161524|455908696|FG002|Core Study (23 Weeks)|Other|0|||
126427015|NCT03309878|454860407|FG002|Overall Study|Did not maintain eligibility|0|||
126427016|NCT03309878|454860408|FG003|Overall Study|Did not maintain eligibility|0|||
126427017|NCT03309878|454860405|FG000|Overall Study|Withdrawal by Subject|0|||
126427018|NCT03309878|454860406|FG001|Overall Study|Withdrawal by Subject|1|||
126427019|NCT03309878|454860407|FG002|Overall Study|Withdrawal by Subject|0|||
126427020|NCT03309878|454860408|FG003|Overall Study|Withdrawal by Subject|0|||
126674961|NCT01299376|455767058|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
126674962|NCT01299376|455767059|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
126674963|NCT01299376|455767058|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
126674964|NCT01299376|455767059|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
126674965|NCT01299376|455767058|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
126674966|NCT01299376|455767059|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
126674967|NCT01299376|455767058|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
126674968|NCT01299376|455767059|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
126674969|NCT01299376|455767058|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
126674970|NCT01299376|455767059|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
126674971|NCT01299376|455767058|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
126674972|NCT01299376|455767059|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
126674973|NCT01299376|455767058|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
126674974|NCT01299376|455767059|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
126674975|NCT02343159|455767062|FG000|Overall Study|Early Study Termination|16|||
126674976|NCT02343159|455767063|FG001|Overall Study|Early Study Termination|19|||
126674977|NCT02343159|455767064|FG002|Overall Study|Early Study Termination|23|||
126674978|NCT02343159|455767062|FG000|Overall Study|Physician Decision|2|||
126674979|NCT02343159|455767063|FG001|Overall Study|Physician Decision|0|||
126674980|NCT02343159|455767064|FG002|Overall Study|Physician Decision|1|||
126674981|NCT02343159|455767062|FG000|Overall Study|Withdrawal by Subject|3|||
126674982|NCT02343159|455767063|FG001|Overall Study|Withdrawal by Subject|0|||
126674983|NCT02343159|455767064|FG002|Overall Study|Withdrawal by Subject|2|||
126674984|NCT02343159|455767062|FG000|Overall Study|Lost to Follow-up|0|||
126674985|NCT02343159|455767063|FG001|Overall Study|Lost to Follow-up|2|||
126674986|NCT02343159|455767064|FG002|Overall Study|Lost to Follow-up|2|||
126674987|NCT02343159|455767062|FG000|Overall Study|Adverse Event|4|||
126674988|NCT02343159|455767063|FG001|Overall Study|Adverse Event|4|||
126674989|NCT02343159|455767064|FG002|Overall Study|Adverse Event|2|||
126674990|NCT02343159|455767062|FG000|Overall Study|Sponsor Decision|0|||
126674991|NCT02343159|455767063|FG001|Overall Study|Sponsor Decision|1|||
126674992|NCT02343159|455767064|FG002|Overall Study|Sponsor Decision|0|||
126674993|NCT02343159|455767062|FG000|Overall Study|Enrollment Error|1|||
126341806|NCT02577029|454546728|FG001|Overall Study|Withdrawal by Subject|0|||
126341807|NCT02577029|454546729|FG002|Overall Study|Withdrawal by Subject|0|||
126341808|NCT02577029|454546730|FG003|Overall Study|Withdrawal by Subject|0|||
126341809|NCT02577029|454546731|FG004|Overall Study|Withdrawal by Subject|0|||
126341810|NCT02577029|454546732|FG005|Overall Study|Withdrawal by Subject|1|||
126341811|NCT02577029|454546733|FG006|Overall Study|Withdrawal by Subject|0|||
126341812|NCT02577029|454546734|FG007|Overall Study|Withdrawal by Subject|0|||
126341813|NCT02577029|454546727|FG000|Overall Study|Sponsor Termination of the Study|9|||
126341814|NCT02577029|454546728|FG001|Overall Study|Sponsor Termination of the Study|2|||
126341815|NCT02577029|454546729|FG002|Overall Study|Sponsor Termination of the Study|5|||
126341816|NCT02577029|454546730|FG003|Overall Study|Sponsor Termination of the Study|12|||
126341817|NCT02577029|454546731|FG004|Overall Study|Sponsor Termination of the Study|10|||
126341818|NCT02577029|454546732|FG005|Overall Study|Sponsor Termination of the Study|12|||
126341819|NCT02577029|454546733|FG006|Overall Study|Sponsor Termination of the Study|12|||
126341820|NCT02577029|454546734|FG007|Overall Study|Sponsor Termination of the Study|12|||
126341821|NCT02078817|454546735|FG000|Overall Study|Withdrawal by Subject|1|||
126341822|NCT01420536|454546736|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
126341823|NCT01420536|454546737|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
126341824|NCT03054428|454546738|FG000|Overall Study|Physician Decision|0|||
126341825|NCT03054428|454546739|FG001|Overall Study|Physician Decision|1|||
126341826|NCT03054428|454546740|FG002|Overall Study|Physician Decision|1|||
126341827|NCT03054428|454546738|FG000|Overall Study|Lack of Efficacy|3|||
126341828|NCT03054428|454546739|FG001|Overall Study|Lack of Efficacy|1|||
126341829|NCT03054428|454546740|FG002|Overall Study|Lack of Efficacy|0|||
126341830|NCT03054428|454546738|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
126674994|NCT02343159|455767063|FG001|Overall Study|Enrollment Error|0|||
126674995|NCT02343159|455767064|FG002|Overall Study|Enrollment Error|0|||
126341831|NCT03054428|454546739|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
126341832|NCT03054428|454546740|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
126427021|NCT01096316|454860409|FG000|Overall Study|Lost to Follow-up|15|||
126427022|NCT01096316|454860410|FG001|Overall Study|Lost to Follow-up|9|||
126674996|NCT01431274|455767070|FG000|Overall Study|Adverse Event|51|||
126674997|NCT01431274|455767071|FG001|Overall Study|Adverse Event|37|||
126341833|NCT03054428|454546738|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
126341834|NCT03054428|454546739|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
126674998|NCT01431274|455767072|FG002|Overall Study|Adverse Event|43|||
126674999|NCT01431274|455767073|FG003|Overall Study|Adverse Event|30|||
126675000|NCT01431274|455767074|FG004|Overall Study|Adverse Event|37|||
126675001|NCT01431274|455767070|FG000|Overall Study|Consent withdrawn not due to AE|29|||
126675002|NCT01431274|455767071|FG001|Overall Study|Consent withdrawn not due to AE|20|||
126675003|NCT01431274|455767072|FG002|Overall Study|Consent withdrawn not due to AE|17|||
126675004|NCT01431274|455767073|FG003|Overall Study|Consent withdrawn not due to AE|20|||
126427023|NCT02763644|454860411|FG000|Overall Study|Patient/guardian decision|1|||
126427024|NCT02763644|454860412|FG001|Overall Study|Patient/guardian decision|0|||
126427025|NCT02763644|454860411|FG000|Overall Study|Death|1|||
126427026|NCT02763644|454860412|FG001|Overall Study|Death|1|||
126427027|NCT02763644|454860411|FG000|Overall Study|Adverse Event|1|||
126427028|NCT02763644|454860412|FG001|Overall Study|Adverse Event|1|||
126427029|NCT02836652|454860413|FG000|Overall Study|Death|3|||
126427030|NCT02836652|454860414|FG001|Overall Study|Death|3|||
126427031|NCT02836652|454860413|FG000|Overall Study|Transplant/Explant|3|||
126427032|NCT02836652|454860414|FG001|Overall Study|Transplant/Explant|4|||
126427033|NCT02836652|454860413|FG000|Overall Study|Withdrawn|9|||
126427034|NCT02836652|454860414|FG001|Overall Study|Withdrawn|9|||
126427035|NCT02836652|454860413|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
126427036|NCT02836652|454860414|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
126427037|NCT00473434|454860415|FG000|Overall Study|Physician Decision|3|||
126427038|NCT00473434|454860415|FG000|Overall Study|Withdrawal by Subject|9|||
126427039|NCT00473434|454860415|FG000|Overall Study|Compliance|3|||
126427040|NCT00473434|454860415|FG000|Overall Study|Lack of Efficacy|3|||
126427041|NCT00473434|454860415|FG000|Overall Study|Adverse Event|3|||
126427042|NCT00473434|454860415|FG000|Overall Study|Patient was selling medication to others|1|||
126427043|NCT00473434|454860415|FG000|Overall Study|Safety evaluation|1|||
126427044|NCT00473434|454860415|FG000|Overall Study|Reason not specified|6|||
126427045|NCT00473434|454860415|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
126427046|NCT00473434|454860415|FG000|Overall Study|Switching to trial medication|1|||
126427047|NCT00473434|454860415|FG000|Overall Study|No longer required|1|||
126427048|NCT02349633|454860416|FG000|Overall Study|Death|0|||
126427049|NCT02349633|454860417|FG001|Overall Study|Death|1|||
126427050|NCT02349633|454860418|FG002|Overall Study|Death|0|||
126427051|NCT02349633|454860419|FG003|Overall Study|Death|0|||
126427052|NCT02349633|454860420|FG004|Overall Study|Death|0|||
126427053|NCT02349633|454860421|FG005|Overall Study|Death|1|||
126427054|NCT02349633|454860422|FG006|Overall Study|Death|1|||
126427055|NCT02349633|454860423|FG007|Overall Study|Death|1|||
126675005|NCT01431274|455767074|FG004|Overall Study|Consent withdrawn not due to AE|11|||
126675006|NCT01431274|455767070|FG000|Overall Study|Non compliant with protocol|5|||
126675007|NCT01431274|455767071|FG001|Overall Study|Non compliant with protocol|8|||
126675008|NCT01431274|455767072|FG002|Overall Study|Non compliant with protocol|4|||
126675009|NCT01431274|455767073|FG003|Overall Study|Non compliant with protocol|4|||
126675010|NCT01431274|455767074|FG004|Overall Study|Non compliant with protocol|4|||
126675011|NCT01431274|455767070|FG000|Overall Study|Lost to Follow-up|6|||
126675012|NCT01431274|455767071|FG001|Overall Study|Lost to Follow-up|7|||
126675013|NCT01431274|455767072|FG002|Overall Study|Lost to Follow-up|1|||
126675014|NCT01431274|455767073|FG003|Overall Study|Lost to Follow-up|4|||
126427056|NCT02349633|454860424|FG008|Overall Study|Death|0|||
126427057|NCT02349633|454860425|FG009|Overall Study|Death|1|||
126427058|NCT02349633|454860426|FG010|Overall Study|Death|0|||
126427059|NCT02349633|454860427|FG011|Overall Study|Death|0|||
126427060|NCT02349633|454860428|FG012|Overall Study|Death|0|||
126427061|NCT02349633|454860429|FG013|Overall Study|Death|0|||
126427062|NCT02349633|454860416|FG000|Overall Study|Withdrawal by Subject|0|||
126427063|NCT02349633|454860417|FG001|Overall Study|Withdrawal by Subject|0|||
126427064|NCT02349633|454860418|FG002|Overall Study|Withdrawal by Subject|0|||
126427065|NCT02349633|454860419|FG003|Overall Study|Withdrawal by Subject|1|||
126427066|NCT02349633|454860420|FG004|Overall Study|Withdrawal by Subject|0|||
126427067|NCT02349633|454860421|FG005|Overall Study|Withdrawal by Subject|0|||
126675015|NCT01431274|455767074|FG004|Overall Study|Lost to Follow-up|0|||
126675016|NCT01431274|455767070|FG000|Overall Study|Other reason not stated above|6|||
126427068|NCT02349633|454860422|FG006|Overall Study|Withdrawal by Subject|0|||
126427069|NCT02349633|454860423|FG007|Overall Study|Withdrawal by Subject|2|||
126675017|NCT01431274|455767071|FG001|Overall Study|Other reason not stated above|5|||
126675018|NCT01431274|455767072|FG002|Overall Study|Other reason not stated above|7|||
126427070|NCT02349633|454860424|FG008|Overall Study|Withdrawal by Subject|2|||
126675019|NCT01431274|455767073|FG003|Overall Study|Other reason not stated above|2|||
126675020|NCT01431274|455767074|FG004|Overall Study|Other reason not stated above|4|||
126675021|NCT00711425|455767075|FG000|Overall Study|Protocol Violation|1|||
126675022|NCT00711425|455767075|FG000|Overall Study|Death|2|||
126427071|NCT02349633|454860425|FG009|Overall Study|Withdrawal by Subject|1|||
126427072|NCT02349633|454860426|FG010|Overall Study|Withdrawal by Subject|0|||
126427073|NCT02349633|454860427|FG011|Overall Study|Withdrawal by Subject|0|||
126427074|NCT02349633|454860428|FG012|Overall Study|Withdrawal by Subject|0|||
126427075|NCT02349633|454860429|FG013|Overall Study|Withdrawal by Subject|0|||
126675023|NCT00711425|455767075|FG000|Overall Study|Lost to Follow-up|1|||
126675024|NCT04607148|455767078|FG000|Overall Study|Withdrawal by Subject|0|||
126675025|NCT04607148|455767079|FG001|Overall Study|Withdrawal by Subject|4|||
126675026|NCT04607148|455767080|FG002|Overall Study|Withdrawal by Subject|2|||
126675027|NCT04607148|455767081|FG003|Overall Study|Withdrawal by Subject|8|||
126675028|NCT04607148|455767078|FG000|Overall Study|Study Terminated by Sponsor|14|||
126675029|NCT04607148|455767079|FG001|Overall Study|Study Terminated by Sponsor|59|||
126675030|NCT04607148|455767080|FG002|Overall Study|Study Terminated by Sponsor|9|||
126675031|NCT04607148|455767081|FG003|Overall Study|Study Terminated by Sponsor|39|||
126675032|NCT04607148|455767078|FG000|Overall Study|Sponsor Decision|0|||
126675033|NCT04607148|455767079|FG001|Overall Study|Sponsor Decision|0|||
126675034|NCT04607148|455767080|FG002|Overall Study|Sponsor Decision|1|||
126675035|NCT04607148|455767081|FG003|Overall Study|Sponsor Decision|0|||
126675036|NCT04607148|455767078|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126675037|NCT04607148|455767079|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126675038|NCT04607148|455767080|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126675039|NCT04607148|455767081|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126675040|NCT04607148|455767078|FG000|Overall Study|Lost to Follow-up|0|||
126675041|NCT04607148|455767079|FG001|Overall Study|Lost to Follow-up|2|||
126675042|NCT04607148|455767080|FG002|Overall Study|Lost to Follow-up|0|||
126675043|NCT04607148|455767081|FG003|Overall Study|Lost to Follow-up|0|||
126341835|NCT03054428|454546740|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
126341836|NCT03054428|454546738|FG000|Overall Study|Transitioned to OLE study|76|||
126341837|NCT03054428|454546739|FG001|Overall Study|Transitioned to OLE study|76|||
126341838|NCT03054428|454546740|FG002|Overall Study|Transitioned to OLE study|73|||
126341839|NCT03054428|454546738|FG000|Overall Study|Withdrawal by Subject|3|||
126341840|NCT03054428|454546739|FG001|Overall Study|Withdrawal by Subject|2|||
126341841|NCT03054428|454546740|FG002|Overall Study|Withdrawal by Subject|3|||
126341842|NCT03054428|454546738|FG000|Overall Study|Lost to Follow-up|0|||
126341843|NCT03054428|454546739|FG001|Overall Study|Lost to Follow-up|0|||
126341844|NCT03054428|454546740|FG002|Overall Study|Lost to Follow-up|1|||
126341845|NCT01652690|454546742|FG000|Overall Study|Withdrawal by Subject|16|||
126341846|NCT01652690|454546743|FG001|Overall Study|Withdrawal by Subject|4|||
126341847|NCT01652690|454546742|FG000|Overall Study|Other|8|||
126341848|NCT01652690|454546743|FG001|Overall Study|Other|9|||
126341849|NCT01652690|454546742|FG000|Overall Study|Lost to Follow-up|6|||
126341850|NCT01652690|454546743|FG001|Overall Study|Lost to Follow-up|6|||
126341851|NCT01652690|454546742|FG000|Overall Study|Death|5|||
126341852|NCT01652690|454546743|FG001|Overall Study|Death|2|||
126341853|NCT00617279|454546744|FG000|Overall Study|Study terminated by Sponsor|10|||
126341854|NCT00617279|454546745|FG001|Overall Study|Study terminated by Sponsor|15|||
126341855|NCT00617279|454546744|FG000|Overall Study|Graft abandonment|2|||
126341856|NCT00617279|454546745|FG001|Overall Study|Graft abandonment|0|||
126341857|NCT00617279|454546744|FG000|Overall Study|Lost to Follow-up|1|||
126341858|NCT00617279|454546745|FG001|Overall Study|Lost to Follow-up|0|||
126341859|NCT00617279|454546744|FG000|Overall Study|Death|1|||
126341860|NCT00617279|454546745|FG001|Overall Study|Death|2|||
126341861|NCT03415178|454546752|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
126341862|NCT03415178|454546753|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
126341863|NCT03415178|454546752|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
126341864|NCT03415178|454546753|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
126341865|NCT01093846|454546755|FG000|Overall Study|Adverse Event|0|||
126341866|NCT01093846|454546756|FG001|Overall Study|Adverse Event|0|||
126341867|NCT01093846|454546757|FG002|Overall Study|Adverse Event|1|||
126341868|NCT01093846|454546755|FG000|Overall Study|Lack of Efficacy|0|||
126341869|NCT01093846|454546756|FG001|Overall Study|Lack of Efficacy|0|||
126341870|NCT01093846|454546757|FG002|Overall Study|Lack of Efficacy|4|||
126341871|NCT01093846|454546755|FG000|Overall Study|Condition no longer required study drug|1|||
126341872|NCT01093846|454546756|FG001|Overall Study|Condition no longer required study drug|1|||
126341873|NCT01093846|454546757|FG002|Overall Study|Condition no longer required study drug|1|||
126341874|NCT01093846|454546755|FG000|Overall Study|Administrative Problems|18|||
126341875|NCT01093846|454546756|FG001|Overall Study|Administrative Problems|17|||
126341876|NCT01093846|454546757|FG002|Overall Study|Administrative Problems|15|||
126341877|NCT01416571|454546758|FG000|Overall Study|Lost to Follow-up|2|||
126341878|NCT00753519|454548688|FG000|Overall Study|Withdrawal by Subject|0|||
126341879|NCT00753519|454548689|FG001|Overall Study|Withdrawal by Subject|2|||
126675044|NCT04607148|455767078|FG000|Overall Study|Death|0|||
126341880|NCT00959751|454548690|FG000|Overall Study|Lost to Follow-up|2|||
126341881|NCT00959751|454548691|FG001|Overall Study|Lost to Follow-up|3|||
126341882|NCT00959751|454548690|FG000|Overall Study|Consent Withdrawn|0|||
126675045|NCT04607148|455767079|FG001|Overall Study|Death|3|||
126675046|NCT04607148|455767080|FG002|Overall Study|Death|0|||
126341883|NCT00959751|454548691|FG001|Overall Study|Consent Withdrawn|1|||
126341884|NCT00959751|454548690|FG000|Overall Study|Non-compliance to Study Procedures|0|||
126341885|NCT00959751|454548691|FG001|Overall Study|Non-compliance to Study Procedures|1|||
126675047|NCT04607148|455767081|FG003|Overall Study|Death|1|||
126675048|NCT04607148|455767078|FG000|Overall Study|Adverse Event|0|||
126675049|NCT04607148|455767079|FG001|Overall Study|Adverse Event|1|||
126675050|NCT04607148|455767080|FG002|Overall Study|Adverse Event|0|||
126675051|NCT04607148|455767081|FG003|Overall Study|Adverse Event|0|||
126675052|NCT00912028|455767082|FG000|Overall Study|Lost to Follow-up|2|||
126675053|NCT00912028|455767083|FG001|Overall Study|Lost to Follow-up|3|||
126675054|NCT00912028|455767084|FG002|Overall Study|Lost to Follow-up|0|||
126675055|NCT00912028|455767085|FG003|Overall Study|Lost to Follow-up|1|||
126675056|NCT00912028|455767086|FG004|Overall Study|Lost to Follow-up|3|||
126675057|NCT00912028|455767082|FG000|Overall Study|Withdrawal by Subject|3|||
126675058|NCT00912028|455767083|FG001|Overall Study|Withdrawal by Subject|0|||
126675059|NCT00912028|455767084|FG002|Overall Study|Withdrawal by Subject|0|||
126675060|NCT00912028|455767085|FG003|Overall Study|Withdrawal by Subject|0|||
126675061|NCT00912028|455767086|FG004|Overall Study|Withdrawal by Subject|0|||
126675062|NCT01744665|455767091|FG000|Monitoring Phase|Adverse Event|4|||
126675063|NCT01744665|455767091|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
126675064|NCT01744665|455767091|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
126675065|NCT01744665|455767091|FG000|Monitoring Phase|Withdrawal by Subject|5|||
126675066|NCT01744665|455767091|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
126675067|NCT01744665|455767091|FG000|Consolidation Phase|Adverse Event|2|||
126675068|NCT01744665|455767091|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
126675069|NCT01744665|455767091|FG000|Consolidation Phase|Withdrawal by Subject|4|||
126675070|NCT01744665|455767091|FG000|Consolidation Phase|Administrative problems|9|||
126675071|NCT01744665|455767091|FG000|Re-initiation Phase|Administrative problems|10|||
126675072|NCT01744665|455767091|FG000|Re-initiation Phase|Adverse Event|1|||
126675073|NCT01744665|455767091|FG000|Re-initiation Phase|No longer required treatment|1|||
126675074|NCT01744665|455767091|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
126675075|NCT03184077|455767093|FG000|Overall Study|Lost to Follow-up|21|||
126675076|NCT03184077|455767094|FG001|Overall Study|Lost to Follow-up|21|||
126675077|NCT02046096|455767100|FG000|Overall Study|Death|28|||
126675078|NCT02046096|455767101|FG001|Overall Study|Death|45|||
126675079|NCT02046096|455767100|FG000|Overall Study|Lost to Follow-up|9|||
126675080|NCT02046096|455767101|FG001|Overall Study|Lost to Follow-up|20|||
126675081|NCT02046096|455767100|FG000|Overall Study|Withdrawal by Subject|5|||
126675082|NCT02046096|455767101|FG001|Overall Study|Withdrawal by Subject|17|||
126675083|NCT02046096|455767100|FG000|Overall Study|Other endpoint|2|||
126675084|NCT02046096|455767101|FG001|Overall Study|Other endpoint|19|||
126675085|NCT01045798|455767102|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
126675086|NCT01045798|455767103|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
126675087|NCT01045798|455767102|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
126675088|NCT01045798|455767103|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
126675089|NCT01045798|455767102|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
126675090|NCT01045798|455767103|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
126675091|NCT01045798|455767102|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
126675092|NCT01045798|455767103|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
126675093|NCT06156215|455767109|FG000|Overall Study|Withdrawal by Subject|2|||
126675094|NCT06156215|455767110|FG001|Overall Study|Withdrawal by Subject|4|||
126675095|NCT06156215|455767111|FG002|Overall Study|Withdrawal by Subject|4|||
126675096|NCT06156215|455767112|FG003|Overall Study|Withdrawal by Subject|0|||
126675097|NCT06156215|455767113|FG004|Overall Study|Withdrawal by Subject|2|||
126675098|NCT06156215|455767114|FG005|Overall Study|Withdrawal by Subject|2|||
126675099|NCT06156215|455767109|FG000|Overall Study|Left ED without completing study|9|||
126675100|NCT06156215|455767110|FG001|Overall Study|Left ED without completing study|3|||
126675101|NCT06156215|455767111|FG002|Overall Study|Left ED without completing study|9|||
126675102|NCT06156215|455767112|FG003|Overall Study|Left ED without completing study|0|||
126675103|NCT06156215|455767113|FG004|Overall Study|Left ED without completing study|8|||
126675104|NCT06156215|455767114|FG005|Overall Study|Left ED without completing study|16|||
126675105|NCT06156215|455767109|FG000|Overall Study|Physician Decision|1|||
126675106|NCT06156215|455767110|FG001|Overall Study|Physician Decision|0|||
126675107|NCT06156215|455767111|FG002|Overall Study|Physician Decision|0|||
126675108|NCT06156215|455767112|FG003|Overall Study|Physician Decision|0|||
126675109|NCT06156215|455767113|FG004|Overall Study|Physician Decision|0|||
126675110|NCT06156215|455767114|FG005|Overall Study|Physician Decision|0|||
126675111|NCT06156215|455767109|FG000|Overall Study|Became or found ineligible|2|||
126675112|NCT06156215|455767110|FG001|Overall Study|Became or found ineligible|0|||
126675113|NCT06156215|455767111|FG002|Overall Study|Became or found ineligible|2|||
126675114|NCT06156215|455767112|FG003|Overall Study|Became or found ineligible|0|||
126675115|NCT06156215|455767113|FG004|Overall Study|Became or found ineligible|1|||
126675116|NCT06156215|455767114|FG005|Overall Study|Became or found ineligible|2|||
126675117|NCT00597753|455767119|FG000|Overall Study|Adverse Event|6|||
126675118|NCT00597753|455767120|FG001|Overall Study|Adverse Event|2|||
126675119|NCT00597753|455767119|FG000|Overall Study|Death|55|||
126675120|NCT00597753|455767120|FG001|Overall Study|Death|29|||
126675121|NCT00597753|455767119|FG000|Overall Study|Lack of Efficacy|2|||
126675122|NCT00597753|455767120|FG001|Overall Study|Lack of Efficacy|0|||
126675123|NCT00597753|455767119|FG000|Overall Study|Lost to Follow-up|10|||
126675124|NCT00597753|455767120|FG001|Overall Study|Lost to Follow-up|3|||
126427076|NCT02349633|454860416|FG000|Overall Study|Withdrawal of informed consent|0|||
126427077|NCT02349633|454860417|FG001|Overall Study|Withdrawal of informed consent|0|||
126427078|NCT02349633|454860418|FG002|Overall Study|Withdrawal of informed consent|0|||
126427079|NCT02349633|454860419|FG003|Overall Study|Withdrawal of informed consent|1|||
126427080|NCT02349633|454860420|FG004|Overall Study|Withdrawal of informed consent|1|||
126427081|NCT02349633|454860421|FG005|Overall Study|Withdrawal of informed consent|0|||
126427082|NCT02349633|454860422|FG006|Overall Study|Withdrawal of informed consent|0|||
126427083|NCT02349633|454860423|FG007|Overall Study|Withdrawal of informed consent|3|||
126427084|NCT02349633|454860424|FG008|Overall Study|Withdrawal of informed consent|0|||
126427085|NCT02349633|454860425|FG009|Overall Study|Withdrawal of informed consent|0|||
126427086|NCT02349633|454860426|FG010|Overall Study|Withdrawal of informed consent|0|||
126427087|NCT02349633|454860427|FG011|Overall Study|Withdrawal of informed consent|0|||
126427088|NCT02349633|454860428|FG012|Overall Study|Withdrawal of informed consent|0|||
126427089|NCT02349633|454860429|FG013|Overall Study|Withdrawal of informed consent|0|||
126427090|NCT02349633|454860416|FG000|Overall Study|Transition to compassionate use|0|||
126427091|NCT02349633|454860417|FG001|Overall Study|Transition to compassionate use|0|||
126427092|NCT02349633|454860418|FG002|Overall Study|Transition to compassionate use|0|||
126427093|NCT02349633|454860419|FG003|Overall Study|Transition to compassionate use|0|||
126427094|NCT02349633|454860420|FG004|Overall Study|Transition to compassionate use|1|||
126675125|NCT00597753|455767119|FG000|Overall Study|Physician Decision|5|||
126341886|NCT00959751|454548690|FG000|Overall Study|No migraine headache without aura|7|||
126341887|NCT00959751|454548691|FG001|Overall Study|No migraine headache without aura|7|||
126341888|NCT00434252|454548692|FG000|Overall Study|Lack of Efficacy|50|||
126341889|NCT00434252|454548693|FG001|Overall Study|Lack of Efficacy|100|||
126341890|NCT00434252|454548692|FG000|Overall Study|Adverse Event|6|||
126341891|NCT00434252|454548693|FG001|Overall Study|Adverse Event|13|||
126341892|NCT00434252|454548692|FG000|Overall Study|Death|1|||
126341893|NCT00434252|454548693|FG001|Overall Study|Death|2|||
126341894|NCT00434252|454548692|FG000|Overall Study|Lost to Follow-up|0|||
126341895|NCT00434252|454548693|FG001|Overall Study|Lost to Follow-up|1|||
126341896|NCT00434252|454548692|FG000|Overall Study|Physician Decision|4|||
126341897|NCT00434252|454548693|FG001|Overall Study|Physician Decision|8|||
126341898|NCT00434252|454548692|FG000|Overall Study|Withdrawal by Subject|3|||
126341899|NCT00434252|454548693|FG001|Overall Study|Withdrawal by Subject|7|||
126341900|NCT02807259|454548694|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
126341901|NCT02807259|454548695|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
126341902|NCT02807259|454548694|FG000|Midline (3 Months)|migration, refusal, not available|30|||
126341903|NCT02807259|454548695|FG001|Midline (3 Months)|migration, refusal, not available|34|||
126341904|NCT02807259|454548694|FG000|Endline (3 Months)|migration, refusal, not available|35|||
126341905|NCT02807259|454548695|FG001|Endline (3 Months)|migration, refusal, not available|87|||
126341906|NCT03861039|454548696|FG000|Overall Study|Adverse Event|2|||
126341907|NCT03861039|454548697|FG001|Overall Study|Adverse Event|5|||
126341908|NCT03861039|454548698|FG002|Overall Study|Adverse Event|11|||
126341909|NCT03861039|454548696|FG000|Overall Study|Withdrawal by Subject|1|||
126341910|NCT03861039|454548697|FG001|Overall Study|Withdrawal by Subject|3|||
126341911|NCT03861039|454548698|FG002|Overall Study|Withdrawal by Subject|4|||
126341912|NCT01125930|454548706|FG000|Overall Study|Adverse Event|0|||
126341913|NCT01125930|454548707|FG001|Overall Study|Adverse Event|1|||
126341914|NCT01125930|454548706|FG000|Overall Study|Withdrawal by Subject|1|||
126341915|NCT01125930|454548707|FG001|Overall Study|Withdrawal by Subject|6|||
126341916|NCT01125930|454548706|FG000|Overall Study|Protocol Violation|0|||
126341917|NCT01125930|454548707|FG001|Overall Study|Protocol Violation|1|||
126341918|NCT01125930|454548706|FG000|Overall Study|Lost to Follow-up|0|||
126341919|NCT01125930|454548707|FG001|Overall Study|Lost to Follow-up|2|||
126341920|NCT01715831|454548708|FG000|Overall Study|Adverse Event|1|||
126341921|NCT00900562|454548709|FG000|Overall Study|Progressive disease|9|||
126341922|NCT00900562|454548710|FG001|Overall Study|Progressive disease|5|||
126341923|NCT00900562|454548709|FG000|Overall Study|Toxicity|1|||
126341924|NCT00900562|454548710|FG001|Overall Study|Toxicity|0|||
126341925|NCT00900562|454548709|FG000|Overall Study|Death|1|||
126341926|NCT00900562|454548710|FG001|Overall Study|Death|1|||
126341927|NCT00900562|454548709|FG000|Overall Study|Withdrawal by Subject|0|||
126341928|NCT00900562|454548710|FG001|Overall Study|Withdrawal by Subject|1|||
126341929|NCT00900562|454548709|FG000|Overall Study|Unrelated adverse event|1|||
126341930|NCT00900562|454548710|FG001|Overall Study|Unrelated adverse event|0|||
126341931|NCT03098979|454548711|FG000|Overall Study|Adverse Event|1|||
126341932|NCT03098979|454548712|FG001|Overall Study|Adverse Event|0|||
126341933|NCT03098979|454548713|FG002|Overall Study|Adverse Event|1|||
126427095|NCT02349633|454860421|FG005|Overall Study|Transition to compassionate use|0|||
126675126|NCT00597753|455767120|FG001|Overall Study|Physician Decision|1|||
126427096|NCT02349633|454860422|FG006|Overall Study|Transition to compassionate use|0|||
126675127|NCT00597753|455767119|FG000|Overall Study|Pregnancy|1|||
126341934|NCT03098979|454548714|FG003|Overall Study|Adverse Event|4|||
126341935|NCT03098979|454548715|FG004|Overall Study|Adverse Event|6|||
126341936|NCT03098979|454548716|FG005|Overall Study|Adverse Event|1|||
126341937|NCT03098979|454548711|FG000|Overall Study|Withdrawal by Subject|2|||
126675128|NCT00597753|455767120|FG001|Overall Study|Pregnancy|0|||
126675129|NCT00597753|455767119|FG000|Overall Study|Withdrawal by Subject|35|||
126675130|NCT00597753|455767120|FG001|Overall Study|Withdrawal by Subject|12|||
126675131|NCT00597753|455767119|FG000|Overall Study|Discontinued Dialysis|0|||
126675132|NCT00597753|455767120|FG001|Overall Study|Discontinued Dialysis|1|||
126675133|NCT00597753|455767119|FG000|Overall Study|Never dosed|2|||
126675134|NCT00597753|455767120|FG001|Overall Study|Never dosed|0|||
126675135|NCT00597753|455767119|FG000|Overall Study|Noncompliance|2|||
126675136|NCT00597753|455767120|FG001|Overall Study|Noncompliance|1|||
126675137|NCT00597753|455767119|FG000|Overall Study|Relocation|17|||
126675138|NCT00597753|455767120|FG001|Overall Study|Relocation|6|||
126675139|NCT00597753|455767119|FG000|Overall Study|Renal transplant|10|||
126675140|NCT00597753|455767120|FG001|Overall Study|Renal transplant|3|||
126675141|NCT00597753|455767119|FG000|Overall Study|Site closed by sponsor|19|||
126675142|NCT00597753|455767120|FG001|Overall Study|Site closed by sponsor|7|||
126675143|NCT00597753|455767119|FG000|Overall Study|Site elected to close|2|||
126675144|NCT00597753|455767120|FG001|Overall Study|Site elected to close|4|||
126675145|NCT02966509|455768972|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
126675146|NCT02966509|455768973|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
126675147|NCT02966509|455768972|FG000|Baseline Satisfaction Survey|Death|0|||
126675148|NCT02966509|455768973|FG001|Baseline Satisfaction Survey|Death|1|||
126675149|NCT02966509|455768972|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
126675150|NCT02966509|455768973|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
126675151|NCT02966509|455768972|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
126675152|NCT02966509|455768973|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
126675153|NCT02966509|455768972|FG000|6 Month Satisfaction Decision Survey|Death|22|||
126675154|NCT02966509|455768973|FG001|6 Month Satisfaction Decision Survey|Death|25|||
126675155|NCT02966509|455768972|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
126675156|NCT02966509|455768973|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
126675157|NCT02966509|455768972|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
126675158|NCT02966509|455768973|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
126675159|NCT02966509|455768972|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
126675160|NCT02966509|455768973|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
126675161|NCT02966509|455768972|FG000|6 Month Satisfaction Survey|Death|36|||
126675162|NCT02966509|455768973|FG001|6 Month Satisfaction Survey|Death|33|||
126675163|NCT02966509|455768972|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
126675164|NCT02966509|455768973|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
126675165|NCT02966509|455768972|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
126675166|NCT02966509|455768973|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
126675167|NCT02966509|455768972|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
126675168|NCT02966509|455768973|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
126675169|NCT02966509|455768972|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
126675170|NCT02966509|455768973|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
126675171|NCT02966509|455768972|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
126675172|NCT02966509|455768973|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
126675173|NCT01469182|455768978|FG000|Overall Study|Adverse Event|21|||
126675174|NCT01469182|455768979|FG001|Overall Study|Adverse Event|3|||
126675175|NCT01469182|455768978|FG000|Overall Study|Lost to Follow-up|3|||
126675176|NCT01469182|455768979|FG001|Overall Study|Lost to Follow-up|0|||
126675177|NCT01469182|455768978|FG000|Overall Study|Withdrawal by Subject|4|||
126675178|NCT01469182|455768979|FG001|Overall Study|Withdrawal by Subject|1|||
126675179|NCT01469182|455768978|FG000|Overall Study|Protocol Violation|4|||
126675180|NCT01469182|455768979|FG001|Overall Study|Protocol Violation|2|||
126675181|NCT01469182|455768978|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
126675182|NCT01469182|455768979|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
126675183|NCT02687542|455768980|FG000|Overall Study|Medication error without associated AEs|0|||
126675184|NCT02687542|455768981|FG001|Overall Study|Medication error without associated AEs|0|||
126675185|NCT02687542|455768982|FG002|Overall Study|Medication error without associated AEs|0|||
126675186|NCT02687542|455768983|FG003|Overall Study|Medication error without associated AEs|0|||
126675187|NCT02687542|455768984|FG004|Overall Study|Medication error without associated AEs|1|||
126675188|NCT02687542|455768980|FG000|Overall Study|Lost to Follow-up|0|||
126675189|NCT02687542|455768981|FG001|Overall Study|Lost to Follow-up|0|||
126675190|NCT02687542|455768982|FG002|Overall Study|Lost to Follow-up|0|||
126675191|NCT02687542|455768983|FG003|Overall Study|Lost to Follow-up|0|||
126675192|NCT02687542|455768984|FG004|Overall Study|Lost to Follow-up|1|||
126675193|NCT02687542|455768980|FG000|Overall Study|Protocol Violation|0|||
126675194|NCT02687542|455768981|FG001|Overall Study|Protocol Violation|1|||
126675195|NCT02687542|455768982|FG002|Overall Study|Protocol Violation|0|||
126675196|NCT02687542|455768983|FG003|Overall Study|Protocol Violation|0|||
126675197|NCT02687542|455768984|FG004|Overall Study|Protocol Violation|0|||
126675198|NCT02687542|455768980|FG000|Overall Study|Other|5|||
126675199|NCT02687542|455768981|FG001|Overall Study|Other|9|||
126675200|NCT02687542|455768982|FG002|Overall Study|Other|10|||
126675201|NCT02687542|455768983|FG003|Overall Study|Other|6|||
126675202|NCT02687542|455768984|FG004|Overall Study|Other|5|||
126675203|NCT02687542|455768980|FG000|Overall Study|Adverse Event|3|||
126675204|NCT02687542|455768981|FG001|Overall Study|Adverse Event|1|||
126675205|NCT02687542|455768982|FG002|Overall Study|Adverse Event|3|||
126675206|NCT02687542|455768983|FG003|Overall Study|Adverse Event|2|||
126675207|NCT02687542|455768984|FG004|Overall Study|Adverse Event|9|||
126675208|NCT02687542|455768980|FG000|Overall Study|Withdrawal by Subject|0|||
126675209|NCT02687542|455768981|FG001|Overall Study|Withdrawal by Subject|1|||
126675210|NCT02687542|455768982|FG002|Overall Study|Withdrawal by Subject|1|||
126675211|NCT02687542|455768983|FG003|Overall Study|Withdrawal by Subject|2|||
126675212|NCT02687542|455768984|FG004|Overall Study|Withdrawal by Subject|4|||
126675213|NCT01838616|455768987|FG000|Titration Period|Adverse Event|18|||
126675214|NCT01838616|455768988|FG001|Titration Period|Adverse Event|48|||
126675215|NCT01838616|455768987|FG000|Titration Period|Lack of Efficacy|5|||
126675216|NCT01838616|455768988|FG001|Titration Period|Lack of Efficacy|12|||
126675217|NCT01838616|455768987|FG000|Titration Period|Withdrawal by Subject|5|||
126675218|NCT01838616|455768988|FG001|Titration Period|Withdrawal by Subject|5|||
126675219|NCT01838616|455768987|FG000|Titration Period|Technical problems|1|||
126675220|NCT01838616|455768988|FG001|Titration Period|Technical problems|0|||
126675221|NCT01838616|455768987|FG000|Titration Period|Other|1|||
126675222|NCT01838616|455768988|FG001|Titration Period|Other|0|||
126427097|NCT02349633|454860423|FG007|Overall Study|Transition to compassionate use|3|||
126427098|NCT02349633|454860424|FG008|Overall Study|Transition to compassionate use|0|||
126427099|NCT02349633|454860425|FG009|Overall Study|Transition to compassionate use|1|||
126427100|NCT02349633|454860426|FG010|Overall Study|Transition to compassionate use|0|||
126427101|NCT02349633|454860427|FG011|Overall Study|Transition to compassionate use|0|||
126675223|NCT01838616|455768987|FG000|Titration Period|Protocol Violation|0|||
126675224|NCT01838616|455768988|FG001|Titration Period|Protocol Violation|1|||
126427102|NCT02349633|454860428|FG012|Overall Study|Transition to compassionate use|0|||
126427103|NCT02349633|454860429|FG013|Overall Study|Transition to compassionate use|0|||
126427104|NCT02349633|454860416|FG000|Overall Study|Early termination of survival follow-up|0|||
126427105|NCT02349633|454860417|FG001|Overall Study|Early termination of survival follow-up|0|||
126675225|NCT01838616|455768987|FG000|Continuation Period|Lack of Efficacy|3|||
126427106|NCT02349633|454860418|FG002|Overall Study|Early termination of survival follow-up|0|||
126427107|NCT02349633|454860419|FG003|Overall Study|Early termination of survival follow-up|0|||
126427108|NCT02349633|454860420|FG004|Overall Study|Early termination of survival follow-up|0|||
126427109|NCT02349633|454860421|FG005|Overall Study|Early termination of survival follow-up|0|||
126427110|NCT02349633|454860422|FG006|Overall Study|Early termination of survival follow-up|0|||
126427111|NCT02349633|454860423|FG007|Overall Study|Early termination of survival follow-up|4|||
126427112|NCT02349633|454860424|FG008|Overall Study|Early termination of survival follow-up|0|||
126427113|NCT02349633|454860425|FG009|Overall Study|Early termination of survival follow-up|0|||
126427114|NCT02349633|454860426|FG010|Overall Study|Early termination of survival follow-up|0|||
126427115|NCT02349633|454860427|FG011|Overall Study|Early termination of survival follow-up|0|||
126427116|NCT02349633|454860428|FG012|Overall Study|Early termination of survival follow-up|0|||
126427117|NCT02349633|454860429|FG013|Overall Study|Early termination of survival follow-up|0|||
126427118|NCT02349633|454860416|FG000|Overall Study|Termination by sponsor|0|||
126675226|NCT01838616|455768988|FG001|Continuation Period|Lack of Efficacy|5|||
126675227|NCT01838616|455768987|FG000|Continuation Period|Adverse Event|8|||
126675228|NCT01838616|455768988|FG001|Continuation Period|Adverse Event|4|||
126675229|NCT01838616|455768987|FG000|Continuation Period|Protocol Violation|2|||
126675230|NCT01838616|455768988|FG001|Continuation Period|Protocol Violation|0|||
126427119|NCT02349633|454860417|FG001|Overall Study|Termination by sponsor|0|||
126427120|NCT02349633|454860418|FG002|Overall Study|Termination by sponsor|0|||
126427121|NCT02349633|454860419|FG003|Overall Study|Termination by sponsor|0|||
126427122|NCT02349633|454860420|FG004|Overall Study|Termination by sponsor|0|||
126427123|NCT02349633|454860421|FG005|Overall Study|Termination by sponsor|0|||
126675231|NCT01838616|455768987|FG000|Continuation Period|Lost to Follow-up|1|||
126675232|NCT01838616|455768988|FG001|Continuation Period|Lost to Follow-up|0|||
126675233|NCT01838616|455768987|FG000|Continuation Period|Withdrawal by Subject|0|||
126675234|NCT01838616|455768988|FG001|Continuation Period|Withdrawal by Subject|4|||
126675235|NCT01838616|455768987|FG000|Continuation Period|Technical problems|0|||
126675236|NCT01838616|455768988|FG001|Continuation Period|Technical problems|1|||
126675237|NCT01838616|455768987|FG000|Pick-up Arm|Lack of Efficacy|4|||
126675238|NCT01838616|455768988|FG001|Pick-up Arm|Lack of Efficacy|0|||
126675239|NCT01838616|455768987|FG000|Pick-up Arm|Adverse Event|9|||
126675240|NCT01838616|455768988|FG001|Pick-up Arm|Adverse Event|0|||
126675241|NCT01838616|455768987|FG000|Pick-up Arm|Withdrawal by Subject|1|||
126675242|NCT01838616|455768988|FG001|Pick-up Arm|Withdrawal by Subject|0|||
126675243|NCT01838616|455768987|FG000|Pick-up Arm|Technical problems|1|||
126427124|NCT02349633|454860422|FG006|Overall Study|Termination by sponsor|0|||
126427125|NCT02349633|454860423|FG007|Overall Study|Termination by sponsor|1|||
126427126|NCT02349633|454860424|FG008|Overall Study|Termination by sponsor|0|||
126675244|NCT01838616|455768988|FG001|Pick-up Arm|Technical problems|0|||
126675245|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
126675246|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
126675247|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
126675248|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
126675249|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
126675250|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
126675251|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
126675252|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
126675253|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
126675254|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
126675255|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
126675256|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
126675257|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
126675258|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
126675259|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
126675260|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
126675261|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
126675262|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
126675263|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
126675264|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
126675265|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
126675266|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
126675267|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
126675268|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
126675269|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
126675270|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
126675271|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
126675272|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
126427127|NCT02349633|454860425|FG009|Overall Study|Termination by sponsor|2|||
126427128|NCT02349633|454860426|FG010|Overall Study|Termination by sponsor|0|||
126427129|NCT02349633|454860427|FG011|Overall Study|Termination by sponsor|0|||
126427130|NCT02349633|454860428|FG012|Overall Study|Termination by sponsor|0|||
126427131|NCT02349633|454860429|FG013|Overall Study|Termination by sponsor|0|||
126427132|NCT02349633|454860416|FG000|Overall Study|Other|0|||
126427133|NCT02349633|454860417|FG001|Overall Study|Other|0|||
126427134|NCT02349633|454860418|FG002|Overall Study|Other|0|||
126427135|NCT02349633|454860419|FG003|Overall Study|Other|0|||
126427136|NCT02349633|454860420|FG004|Overall Study|Other|0|||
126427137|NCT02349633|454860421|FG005|Overall Study|Other|0|||
126427138|NCT02349633|454860422|FG006|Overall Study|Other|0|||
126427139|NCT02349633|454860423|FG007|Overall Study|Other|2|||
126427140|NCT02349633|454860424|FG008|Overall Study|Other|0|||
126427141|NCT02349633|454860425|FG009|Overall Study|Other|0|||
126427142|NCT02349633|454860426|FG010|Overall Study|Other|0|||
126427143|NCT02349633|454860427|FG011|Overall Study|Other|0|||
126427144|NCT02349633|454860428|FG012|Overall Study|Other|0|||
126427145|NCT02349633|454860429|FG013|Overall Study|Other|0|||
126427146|NCT01008943|454860432|FG000|Overall Study|Withdrawal by Subject|1|||
126427147|NCT00667628|454860435|FG000|Overall Study|Lost to Follow-up|1|||
126427148|NCT00667628|454860436|FG001|Overall Study|Lost to Follow-up|0|||
126427149|NCT00667628|454860435|FG000|Overall Study|Death|6|||
126427150|NCT00667628|454860436|FG001|Overall Study|Death|6|||
126427151|NCT00667628|454860435|FG000|Overall Study|Investigator Considers in Best Interest|1|||
126427152|NCT00667628|454860436|FG001|Overall Study|Investigator Considers in Best Interest|0|||
126427153|NCT00667628|454860435|FG000|Overall Study|Sponsor Terminated Study|17|||
126427154|NCT00667628|454860436|FG001|Overall Study|Sponsor Terminated Study|21|||
126427155|NCT04244253|454860437|FG000|Overall Study|Adverse Event|2|||
126427156|NCT04244253|454860438|FG001|Overall Study|Adverse Event|2|||
126427157|NCT04244253|454860439|FG002|Overall Study|Adverse Event|4|||
126427158|NCT04244253|454860437|FG000|Overall Study|Protocol Violation|1|||
126427159|NCT04244253|454860438|FG001|Overall Study|Protocol Violation|2|||
126427160|NCT04244253|454860439|FG002|Overall Study|Protocol Violation|1|||
126427161|NCT04244253|454860437|FG000|Overall Study|Withdrawal by Subject|0|||
126427162|NCT04244253|454860438|FG001|Overall Study|Withdrawal by Subject|1|||
126427163|NCT04244253|454860439|FG002|Overall Study|Withdrawal by Subject|6|||
126675273|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
126675274|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
126675275|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126675276|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
126675277|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
126427164|NCT04244253|454860437|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126427165|NCT04244253|454860438|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126427166|NCT04244253|454860439|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126427167|NCT04663321|454860440|FG000|Overall Study|Study terminated by Sponsor|2|||
126341938|NCT03098979|454548712|FG001|Overall Study|Withdrawal by Subject|1|||
126341939|NCT03098979|454548713|FG002|Overall Study|Withdrawal by Subject|1|||
126341940|NCT03098979|454548714|FG003|Overall Study|Withdrawal by Subject|1|||
126341941|NCT03098979|454548715|FG004|Overall Study|Withdrawal by Subject|2|||
126341942|NCT03098979|454548716|FG005|Overall Study|Withdrawal by Subject|1|||
126341943|NCT03098979|454548711|FG000|Overall Study|Death|1|||
126341944|NCT03098979|454548712|FG001|Overall Study|Death|0|||
126341945|NCT03098979|454548713|FG002|Overall Study|Death|2|||
126341946|NCT03098979|454548714|FG003|Overall Study|Death|0|||
126341947|NCT03098979|454548715|FG004|Overall Study|Death|1|||
126341948|NCT03098979|454548716|FG005|Overall Study|Death|0|||
126341949|NCT03098979|454548711|FG000|Overall Study|Physician Decision|2|||
126341950|NCT03098979|454548712|FG001|Overall Study|Physician Decision|1|||
126341951|NCT03098979|454548713|FG002|Overall Study|Physician Decision|0|||
126341952|NCT03098979|454548714|FG003|Overall Study|Physician Decision|0|||
126341953|NCT03098979|454548715|FG004|Overall Study|Physician Decision|0|||
126341954|NCT03098979|454548716|FG005|Overall Study|Physician Decision|0|||
126341955|NCT03098979|454548711|FG000|Overall Study|Non-compliance|0|||
126341956|NCT03098979|454548712|FG001|Overall Study|Non-compliance|0|||
126341957|NCT03098979|454548713|FG002|Overall Study|Non-compliance|0|||
126341958|NCT03098979|454548714|FG003|Overall Study|Non-compliance|0|||
126341959|NCT03098979|454548715|FG004|Overall Study|Non-compliance|0|||
126341960|NCT03098979|454548716|FG005|Overall Study|Non-compliance|1|||
126341961|NCT03098979|454548711|FG000|Overall Study|Protocol Violation|0|||
126341962|NCT03098979|454548712|FG001|Overall Study|Protocol Violation|0|||
126341963|NCT03098979|454548713|FG002|Overall Study|Protocol Violation|0|||
126341964|NCT03098979|454548714|FG003|Overall Study|Protocol Violation|0|||
126341965|NCT03098979|454548715|FG004|Overall Study|Protocol Violation|0|||
126341966|NCT03098979|454548716|FG005|Overall Study|Protocol Violation|1|||
126341967|NCT02426684|454548717|FG000|Overall Study|Physician Decision|1|||
126341968|NCT02369653|454548718|FG000|Overall Study|Lost to Follow-up|0|||
126341969|NCT02369653|454548719|FG001|Overall Study|Lost to Follow-up|1|||
126341970|NCT02369653|454548718|FG000|Overall Study|Administrative reason by sponsor|0|||
126341971|NCT02369653|454548719|FG001|Overall Study|Administrative reason by sponsor|1|||
126341972|NCT02369653|454548718|FG000|Overall Study|Death|1|||
126341973|NCT02369653|454548719|FG001|Overall Study|Death|2|||
126341974|NCT02369653|454548718|FG000|Overall Study|Participant withdrew consent|13|||
126341975|NCT02369653|454548719|FG001|Overall Study|Participant withdrew consent|3|||
126341976|NCT03587636|454548720|FG000|Overall Study|Lost to Follow-up|2|||
126341977|NCT03587636|454548721|FG001|Overall Study|Lost to Follow-up|5|||
126341978|NCT01006629|454548722|FG000|Overall Study|Adverse Event|1|||
126341979|NCT01006629|454548722|FG000|Overall Study|Parent refused to continue participation|1|||
126341980|NCT01006629|454548722|FG000|Overall Study|Parent unable to perform site visit|4|||
126341981|NCT01118299|454548723|FG000|Overall Study|Death|7|||
126341982|NCT01118299|454548724|FG001|Overall Study|Death|5|||
126341983|NCT01118299|454548723|FG000|Overall Study|Withdrawal by Subject|8|||
126341984|NCT01118299|454548724|FG001|Overall Study|Withdrawal by Subject|8|||
126341985|NCT01118299|454548723|FG000|Overall Study|Lost to Follow-up|2|||
126341986|NCT01118299|454548724|FG001|Overall Study|Lost to Follow-up|1|||
126341987|NCT01118299|454548723|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
126675278|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
126675279|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126675280|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
126675281|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
126675282|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
126675283|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
126675284|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
126675285|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
126675286|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
126675287|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
126675288|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
126675289|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
126675290|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
126341988|NCT01118299|454548724|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
126341989|NCT04459338|454548725|FG000|Overall Study|Loss of IV during study|1|||
126341990|NCT04459338|454548726|FG001|Overall Study|Loss of IV during study|0|||
126341991|NCT03157089|454548727|FG000|Overall Study|Treated only with pembrolizumab|1|||
126341992|NCT03157089|454548728|FG001|Overall Study|Treated only with pembrolizumab|0|||
126341993|NCT03157089|454548727|FG000|Overall Study|Adverse Event|5|||
126341994|NCT03157089|454548728|FG001|Overall Study|Adverse Event|4|||
126341995|NCT03157089|454548727|FG000|Overall Study|Progressive disease|6|||
126341996|NCT03157089|454548728|FG001|Overall Study|Progressive disease|8|||
126341997|NCT02665117|454548729|FG000|Overall Study|Physician Decision|1|||
126341998|NCT02665117|454548730|FG001|Overall Study|Physician Decision|0|||
126341999|NCT02300610|454548731|FG000|Overall Study|Withdrawal by Subject|1|||
126675291|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
126675292|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
126675293|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
126675294|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
126675295|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
126675296|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
126675297|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
126675298|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
126675299|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
126675300|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
126675301|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
126675302|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
126675303|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
126675304|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
126675305|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
126675306|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
126675307|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
126675308|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
126675309|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
126675310|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
126675311|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
126675312|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
126675313|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
126675314|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
126675315|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
126675316|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
126675317|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
126675318|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
126675319|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
126675320|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
126675321|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
126675322|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
126675323|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
126675324|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
126675325|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
126675326|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
126342000|NCT02300610|454548732|FG001|Overall Study|Withdrawal by Subject|0|||
126342001|NCT02300610|454548733|FG002|Overall Study|Withdrawal by Subject|1|||
126342002|NCT03743194|454548735|FG000|Overall Study|Protocol Violation|7|||
126342003|NCT03743194|454548736|FG001|Overall Study|Protocol Violation|7|||
126342004|NCT03743194|454548735|FG000|Overall Study|Physician Decision|0|||
126342005|NCT03743194|454548736|FG001|Overall Study|Physician Decision|2|||
126342006|NCT01829347|454548740|FG000|VTI-210|Death|5|||
126342007|NCT01829347|454548741|FG001|VTI-210|Death|3|||
126342008|NCT01829347|454548740|FG000|VTI-210|Withdrawal by Subject|1|||
126342009|NCT01829347|454548741|FG001|VTI-210|Withdrawal by Subject|0|||
126342010|NCT01829347|454548740|FG000|VTI-210E|Death|2|||
126342011|NCT01829347|454548741|FG001|VTI-210E|Death|1|||
126342012|NCT01829347|454548740|FG000|VTI-210E|Study terminated prematurely|1|||
126342013|NCT01829347|454548741|FG001|VTI-210E|Study terminated prematurely|5|||
126342014|NCT03817528|454548743|FG000|Overall Study|Withdrawal by Subject|1|||
126342015|NCT03817528|454548743|FG000|Overall Study|Adverse Event|2|||
126342016|NCT01259245|454548757|FG000|Overall Study|Withdrawal by Subject|27|||
126342017|NCT01259245|454548758|FG001|Overall Study|Withdrawal by Subject|24|||
126342018|NCT01259245|454548757|FG000|Overall Study|Death|1|||
126342019|NCT01259245|454548758|FG001|Overall Study|Death|2|||
126342020|NCT02152007|454548759|FG000|Overall Study|Withdrawal by Subject|1|||
126342021|NCT01302899|454548766|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
126342022|NCT01302899|454548767|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
126342023|NCT01302899|454548766|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
126342024|NCT01302899|454548767|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
126342025|NCT02834975|454548768|FG000|Overall Study|Physician Decision|2|||
126342026|NCT02834975|454548768|FG000|Overall Study|Adverse Event|1|||
126342027|NCT02834975|454548768|FG000|Overall Study|Withdrawal by Subject|1|||
126342028|NCT02834975|454548768|FG000|Overall Study|Lack of Efficacy|1|||
126342029|NCT03558516|454548770|FG000|Overall Study|Protocol Violation|2|||
126342030|NCT03558516|454548771|FG001|Overall Study|Protocol Violation|2|||
126675327|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
126675328|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
126675329|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
126675330|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
126675331|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
126675332|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
126675333|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
126675334|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
126675335|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
126675336|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
126675337|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
126675338|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
126675339|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
126675340|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
126675341|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
126675342|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
126675343|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
126675344|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
126675345|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
126675346|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
126675347|NCT00111800|455768989|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
126675348|NCT00111800|455768990|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
126675349|NCT00111800|455768991|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
126675350|NCT00111800|455768992|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
126675351|NCT00111800|455768993|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
126675352|NCT00111800|455768994|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
126675353|NCT00111800|455768989|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
126675354|NCT00111800|455768990|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
126675355|NCT00111800|455768991|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
126675356|NCT00111800|455768992|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
126675357|NCT00111800|455768993|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
126675358|NCT00111800|455768994|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
126675359|NCT00111800|455768989|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
126675360|NCT00111800|455768990|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
126675361|NCT00111800|455768991|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
126675362|NCT00111800|455768992|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
126675363|NCT00111800|455768993|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
126675364|NCT00111800|455768994|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
126675365|NCT00111800|455768989|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
126675366|NCT00111800|455768990|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
126675367|NCT00111800|455768991|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
126675368|NCT00111800|455768992|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
126675369|NCT00111800|455768993|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
126675370|NCT00111800|455768994|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
126675371|NCT00111800|455768989|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
126675372|NCT00111800|455768990|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
126675373|NCT00111800|455768991|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
126675374|NCT00111800|455768992|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
126675375|NCT00111800|455768993|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
126675376|NCT00111800|455768994|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
126675377|NCT00111800|455768989|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126675378|NCT00111800|455768990|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126675379|NCT00111800|455768991|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
126675380|NCT00111800|455768992|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126675381|NCT00111800|455768993|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126675382|NCT00111800|455768994|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
126675383|NCT00111800|455768989|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
126675384|NCT00111800|455768990|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
126675385|NCT00111800|455768991|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
126675386|NCT00111800|455768992|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
126675387|NCT00111800|455768993|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
126675388|NCT00111800|455768994|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
126427168|NCT04663321|454860441|FG001|Overall Study|Study terminated by Sponsor|1|||
126427169|NCT04663321|454860442|FG002|Overall Study|Study terminated by Sponsor|2|||
126427170|NCT04663321|454860440|FG000|Overall Study|Withdrawal by Subject|10|||
126427171|NCT04663321|454860441|FG001|Overall Study|Withdrawal by Subject|3|||
126427172|NCT04663321|454860442|FG002|Overall Study|Withdrawal by Subject|2|||
126427173|NCT04663321|454860440|FG000|Overall Study|Not provided|0|||
126427174|NCT04663321|454860441|FG001|Overall Study|Not provided|0|||
126427175|NCT04663321|454860442|FG002|Overall Study|Not provided|1|||
126427176|NCT01453140|454860443|FG000|Overall Study|Adverse Event|3|||
126427177|NCT02611479|454860444|FG000|Baseline Enrollment|Exited study|13|||
126675389|NCT00111800|455768989|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
126675390|NCT00111800|455768990|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
126675391|NCT00111800|455768991|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
126675392|NCT00111800|455768992|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
126675393|NCT00111800|455768993|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
126675394|NCT00111800|455768994|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
126675395|NCT00111800|455768989|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
126675396|NCT00111800|455768990|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
126675397|NCT00111800|455768991|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
126675398|NCT00111800|455768992|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
126675399|NCT00111800|455768993|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
126675400|NCT00111800|455768994|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
126675401|NCT01549275|455768995|FG000|Overall Study|Lost to Follow-up|1|||
126675402|NCT01549275|455768996|FG001|Overall Study|Lost to Follow-up|0|||
126675403|NCT03668600|455769001|FG000|Overall Study|Study Terminated by the Sponsor|157|||
126675404|NCT03668600|455769001|FG000|Overall Study|Protocol Violation|1|||
126675405|NCT03668600|455769001|FG000|Overall Study|Pregnancy|1|||
126675406|NCT03668600|455769001|FG000|Overall Study|Lost to Follow-up|7|||
126675407|NCT03668600|455769001|FG000|Overall Study|Withdrawal by Subject|56|||
126675408|NCT03668600|455769001|FG000|Overall Study|Lack of Efficacy|7|||
126675409|NCT03668600|455769001|FG000|Overall Study|Adverse Event|1|||
126675410|NCT01471015|455769002|FG000|Overall Study|Death|0|||
126675411|NCT01471015|455769003|FG001|Overall Study|Death|1|||
126675412|NCT01471015|455769004|FG002|Overall Study|Death|1|||
126675413|NCT01843842|455769005|FG000|Overall Study|Do not meet inclusion criteria|1|||
126675414|NCT01843842|455769006|FG001|Overall Study|Do not meet inclusion criteria|1|||
126675415|NCT01376778|455769007|FG000|Overall Study|Lost to Follow-up|3|||
126675416|NCT01376778|455769008|FG001|Overall Study|Lost to Follow-up|2|||
126675417|NCT00928889|455769009|FG000|Overall Study|Lost to Follow-up|3|||
126675418|NCT00928889|455769010|FG001|Overall Study|Lost to Follow-up|1|||
126675419|NCT00928889|455769009|FG000|Overall Study|Protocol Violation|0|||
126675420|NCT00928889|455769010|FG001|Overall Study|Protocol Violation|1|||
126675421|NCT00928889|455769009|FG000|Overall Study|Adverse Event|1|||
126675422|NCT00928889|455769010|FG001|Overall Study|Adverse Event|0|||
126675423|NCT00928889|455769009|FG000|Overall Study|Other|1|||
126675424|NCT00928889|455769010|FG001|Overall Study|Other|0|||
126675425|NCT04712110|455769011|FG000|Overall Study|Lost to Follow-up|0|||
126675426|NCT04712110|455769012|FG001|Overall Study|Lost to Follow-up|1|||
126675427|NCT04712110|455769011|FG000|Overall Study|Withdrawal by Subject|0|||
126675428|NCT04712110|455769012|FG001|Overall Study|Withdrawal by Subject|4|||
126675429|NCT04712110|455769011|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
126675430|NCT04712110|455769012|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
126675431|NCT01517893|455769013|FG000|Overall Study|Withdrawal by Subject|3|||
126675432|NCT01517893|455769014|FG001|Overall Study|Withdrawal by Subject|0|||
126675433|NCT01309659|455769015|FG000|Overall Study|Protocol Violation|0|||
126675434|NCT01309659|455769016|FG001|Overall Study|Protocol Violation|1|||
126675435|NCT03462576|455769017|FG000|Overall Study|Protocol Violation|5|||
126675436|NCT03462576|455769018|FG001|Overall Study|Protocol Violation|11|||
126675437|NCT03462576|455769019|FG002|Overall Study|Protocol Violation|7|||
126675438|NCT03462576|455769017|FG000|Overall Study|Device Malfunction|0|||
126675439|NCT03462576|455769018|FG001|Overall Study|Device Malfunction|0|||
126675440|NCT03462576|455769019|FG002|Overall Study|Device Malfunction|1|||
126675441|NCT02285777|455769023|FG000|Overall Study|Withdrawal by Subject|1|||
126675442|NCT02285777|455769024|FG001|Overall Study|Withdrawal by Subject|1|||
126675443|NCT02285777|455769023|FG000|Overall Study|Lost to Follow-up|4|||
126675444|NCT02285777|455769024|FG001|Overall Study|Lost to Follow-up|2|||
126675445|NCT03962101|455769028|FG000|Overall Study|Adverse Event|1|||
126675446|NCT03962101|455769028|FG000|Overall Study|Physician Decision|2|||
126675447|NCT03962101|455769028|FG000|Overall Study|Not related to medical events|1|||
126675448|NCT00271596|455769035|FG000|Overall Study|Protocol Violation|1|||
126675449|NCT00271596|455769036|FG001|Overall Study|Protocol Violation|0|||
126675450|NCT00271596|455769035|FG000|Overall Study|Withdrawal by Subject|0|||
126675451|NCT00271596|455769036|FG001|Overall Study|Withdrawal by Subject|1|||
126675452|NCT01069172|455769041|FG000|Overall Study|Withdrawal by Subject|1|||
126675453|NCT01069172|455769042|FG001|Overall Study|Withdrawal by Subject|0|||
126675454|NCT04206605|455769043|FG000|Overall Study|Adverse Event|0|||
126675455|NCT04206605|455769044|FG001|Overall Study|Adverse Event|1|||
126675456|NCT04206605|455769043|FG000|Overall Study|Withdrawal by Subject|1|||
126675457|NCT04206605|455769044|FG001|Overall Study|Withdrawal by Subject|0|||
126427178|NCT02611479|454860444|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
126427179|NCT02611479|454860444|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
126427180|NCT02611479|454860444|FG000|Data Cleaning|No baseline function or pain metrics|2|||
126427181|NCT00743249|454860445|FG000|Overall Study|Adverse Event|0|||
126427182|NCT00743249|454860446|FG001|Overall Study|Adverse Event|4|||
126427183|NCT00743249|454860445|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
126427184|NCT00743249|454860446|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
126427185|NCT00743249|454860445|FG000|Overall Study|Unsuccessful insertion of stent|2|||
126427186|NCT00743249|454860446|FG001|Overall Study|Unsuccessful insertion of stent|1|||
126427187|NCT00423657|454860450|FG000|Overall Study|Withdrew consent|10|||
126427188|NCT00423657|454860451|FG001|Overall Study|Withdrew consent|8|||
126427189|NCT00423657|454860450|FG000|Overall Study|Non-compliance|0|||
126427190|NCT00423657|454860451|FG001|Overall Study|Non-compliance|1|||
126427191|NCT00423657|454860450|FG000|Overall Study|Other|15|||
126427192|NCT00423657|454860451|FG001|Overall Study|Other|16|||
126427193|NCT00423657|454860450|FG000|Overall Study|Request of sponsor/investigator|1|||
126427194|NCT00423657|454860451|FG001|Overall Study|Request of sponsor/investigator|0|||
126427195|NCT02422498|454860455|FG000|Overall Study|Inevaluable|4|||
126427196|NCT02653326|454860456|FG000|Overall Study|Lost to Follow-up|10|||
126427197|NCT02653326|454860457|FG001|Overall Study|Lost to Follow-up|7|||
126427198|NCT03206216|454860458|FG000|Overall Study|Withdrawal by Subject|0|||
126427199|NCT03206216|454860459|FG001|Overall Study|Withdrawal by Subject|1|||
126427200|NCT04621448|454860462|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
126427201|NCT04621448|454860463|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
126427202|NCT04621448|454860464|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
126427203|NCT04621448|454860465|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
126427204|NCT04621448|454860462|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
126427205|NCT04621448|454860463|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
126427206|NCT04621448|454860464|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
126427207|NCT04621448|454860465|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
126427208|NCT04621448|454860462|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
126427209|NCT04621448|454860463|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
126675458|NCT04315181|455769045|FG000|Overall Study|Non-responsive to drug conditions.|1|||
126675459|NCT05879107|455769048|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
126675460|NCT05879107|455769049|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
126342031|NCT03363906|454548772|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
126342032|NCT03363906|454548773|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
126342033|NCT03363906|454548772|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
126342034|NCT03363906|454548773|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
126342035|NCT03363906|454548772|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
126342036|NCT03363906|454548773|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
126342037|NCT03363906|454548772|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
126342038|NCT03363906|454548773|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
126342039|NCT00676143|454548774|FG000|Overall Study|Adverse Event|34|||
126342040|NCT00676143|454548775|FG001|Overall Study|Adverse Event|60|||
126342041|NCT00676143|454548774|FG000|Overall Study|Death|4|||
126342042|NCT00676143|454548775|FG001|Overall Study|Death|4|||
126342043|NCT00676143|454548774|FG000|Overall Study|Lack of Efficacy|0|||
126342044|NCT00676143|454548775|FG001|Overall Study|Lack of Efficacy|6|||
126342045|NCT00676143|454548774|FG000|Overall Study|Lost to Follow-up|0|||
126342046|NCT00676143|454548775|FG001|Overall Study|Lost to Follow-up|13|||
126342047|NCT00676143|454548774|FG000|Overall Study|Physician Decision|5|||
126342048|NCT00676143|454548775|FG001|Overall Study|Physician Decision|8|||
126342049|NCT00676143|454548774|FG000|Overall Study|Protocol Violation|4|||
126342050|NCT00676143|454548775|FG001|Overall Study|Protocol Violation|8|||
126342051|NCT00676143|454548774|FG000|Overall Study|Withdrawal by Subject|24|||
126342052|NCT00676143|454548775|FG001|Overall Study|Withdrawal by Subject|42|||
126342053|NCT00676143|454548774|FG000|Overall Study|Discontinuation of study by sponsor|65|||
126342054|NCT00676143|454548775|FG001|Overall Study|Discontinuation of study by sponsor|88|||
126342055|NCT00676143|454548774|FG000|Overall Study|Failed to return|2|||
126342056|NCT00676143|454548775|FG001|Overall Study|Failed to return|1|||
126342057|NCT00676143|454548774|FG000|Overall Study|Loss of caregiver|5|||
126342058|NCT00676143|454548775|FG001|Overall Study|Loss of caregiver|3|||
126342059|NCT00676143|454548774|FG000|Overall Study|Other|11|||
126342060|NCT00676143|454548775|FG001|Overall Study|Other|20|||
126342061|NCT00676143|454548774|FG000|Overall Study|Participant participation unknown|1|||
126342062|NCT00676143|454548775|FG001|Overall Study|Participant participation unknown|4|||
126427210|NCT04621448|454860464|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
126342063|NCT00676143|454548774|FG000|Overall Study|Vasogenic edema recurrence|1|||
126675461|NCT05879107|455769048|FG000|Overall Study|Migrated / moved from the study area|1|||
126675462|NCT05879107|455769049|FG001|Overall Study|Migrated / moved from the study area|1|||
126675463|NCT05879107|455769048|FG000|Overall Study|Lost to Follow-up|8|||
126675464|NCT05879107|455769049|FG001|Overall Study|Lost to Follow-up|13|||
126675465|NCT05879107|455769048|FG000|Overall Study|Death|0|||
126675466|NCT05879107|455769049|FG001|Overall Study|Death|2|||
126675467|NCT05879107|455769048|FG000|Overall Study|Other|0|||
126675468|NCT05879107|455769049|FG001|Overall Study|Other|3|||
126675469|NCT03901079|455769050|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
126675470|NCT00843518|455769051|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
126675471|NCT00843518|455769052|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
126675472|NCT00843518|455769051|FG000|Period 2 (Double-blind Treatment)|Death|0|||
126675473|NCT00843518|455769052|FG001|Period 2 (Double-blind Treatment)|Death|1|||
126675474|NCT00843518|455769051|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
126675475|NCT00843518|455769052|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
126675476|NCT00843518|455769051|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
126675477|NCT00843518|455769052|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
126675478|NCT00843518|455769051|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
126675479|NCT00843518|455769052|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
126675480|NCT00843518|455769051|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
126675481|NCT00843518|455769052|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
126675482|NCT00843518|455769051|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
126675483|NCT00843518|455769052|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
126675484|NCT00827606|455769055|FG000|Overall Study|Protocol Violation|4|||
126675485|NCT00827606|455769056|FG001|Overall Study|Protocol Violation|3|||
126675486|NCT00827606|455769055|FG000|Overall Study|Lost to Follow-up|3|||
126675487|NCT00827606|455769056|FG001|Overall Study|Lost to Follow-up|1|||
126675488|NCT00827606|455769055|FG000|Overall Study|Withdrawal by Subject|7|||
126675489|NCT00827606|455769056|FG001|Overall Study|Withdrawal by Subject|6|||
126675490|NCT00827606|455769055|FG000|Overall Study|Pregnancy|0|||
126675491|NCT00827606|455769056|FG001|Overall Study|Pregnancy|1|||
126675492|NCT00827606|455769055|FG000|Overall Study|Other|5|||
126675493|NCT00827606|455769056|FG001|Overall Study|Other|13|||
126675494|NCT00827606|455769055|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
126675495|NCT00827606|455769056|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
126675496|NCT00827606|455769055|FG000|Overall Study|Adverse Event|4|||
126675497|NCT00827606|455769056|FG001|Overall Study|Adverse Event|2|||
126675498|NCT04037748|455769059|FG000|Treatment Period 1|Withdrawal by Subject|3|||
126675499|NCT04037748|455769060|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126675500|NCT04037748|455769059|FG000|Treatment Period 1|Adverse Event|1|||
126675501|NCT04037748|455769060|FG001|Treatment Period 1|Adverse Event|1|||
126675502|NCT04037748|455769059|FG000|Treatment Period 1|Protocol Violation|4|||
126675503|NCT04037748|455769060|FG001|Treatment Period 1|Protocol Violation|5|||
126675504|NCT04037748|455769059|FG000|Treatment Period 2|Adverse Event|0|||
126675505|NCT04037748|455769060|FG001|Treatment Period 2|Adverse Event|1|||
126675506|NCT04037748|455769059|FG000|Treatment Period 2|Protocol Violation|2|||
126675507|NCT04037748|455769060|FG001|Treatment Period 2|Protocol Violation|0|||
126675508|NCT04544475|455769065|FG000|Overall Study|Withdrawal by Subject|1|||
126675509|NCT04544475|455769066|FG001|Overall Study|Withdrawal by Subject|3|||
126675510|NCT01378858|455769067|FG000|Overall Study|Withdrawal by Subject|4|||
126675511|NCT01378858|455769068|FG001|Overall Study|Withdrawal by Subject|4|||
126675512|NCT00942175|455769069|FG000|Overall Study|Adverse Event|2|||
126675513|NCT00942175|455769070|FG001|Overall Study|Adverse Event|1|||
126675514|NCT00942175|455769071|FG002|Overall Study|Adverse Event|0|||
126675515|NCT00942175|455769072|FG003|Overall Study|Adverse Event|0|||
126675516|NCT00942175|455769069|FG000|Overall Study|Protocol Violation|0|||
126675517|NCT00942175|455769070|FG001|Overall Study|Protocol Violation|1|||
126675518|NCT00942175|455769071|FG002|Overall Study|Protocol Violation|2|||
126675519|NCT00942175|455769072|FG003|Overall Study|Protocol Violation|0|||
126675520|NCT00942175|455769069|FG000|Overall Study|Pregnancy|0|||
126675521|NCT00942175|455769070|FG001|Overall Study|Pregnancy|0|||
126675522|NCT00942175|455769071|FG002|Overall Study|Pregnancy|0|||
126675523|NCT00942175|455769072|FG003|Overall Study|Pregnancy|1|||
126675524|NCT00942175|455769069|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
126675525|NCT00942175|455769070|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
126675526|NCT00942175|455769071|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
126675527|NCT00942175|455769072|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
126675528|NCT00942175|455769069|FG000|Overall Study|Low Platelet Count|0|||
126675529|NCT00942175|455769070|FG001|Overall Study|Low Platelet Count|2|||
126675530|NCT00942175|455769071|FG002|Overall Study|Low Platelet Count|0|||
126675531|NCT00942175|455769072|FG003|Overall Study|Low Platelet Count|0|||
126675532|NCT02664272|455769073|FG000|Overall Study|Fluoroscopic images not made available|2|||
126675533|NCT03073980|455769074|FG000|Overall Study|Lost to Follow-up|10|||
126675534|NCT03073980|455769075|FG001|Overall Study|Lost to Follow-up|2|||
126675535|NCT03073980|455769076|FG002|Overall Study|Lost to Follow-up|9|||
126675536|NCT03073980|455769074|FG000|Overall Study|No post-procedure data|0|||
126675537|NCT03073980|455769075|FG001|Overall Study|No post-procedure data|0|||
126427211|NCT04621448|454860465|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
126427212|NCT04621448|454860462|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
126427213|NCT04621448|454860463|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
126427214|NCT04621448|454860464|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
126427215|NCT04621448|454860465|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
126427216|NCT04590014|454860468|FG000|Overall Study|Withdrawal by Subject|1|||
126427217|NCT04590014|454860469|FG001|Overall Study|Withdrawal by Subject|0|||
126427218|NCT01506271|454860470|FG000|Overall Study|Progressive disease|0|||
126427219|NCT01506271|454860471|FG001|Overall Study|Progressive disease|1|||
126427220|NCT01506271|454860472|FG002|Overall Study|Progressive disease|0|||
126427221|NCT01506271|454860470|FG000|Overall Study|Protocol Violation|3|||
126427222|NCT01506271|454860471|FG001|Overall Study|Protocol Violation|1|||
126342064|NCT00676143|454548775|FG001|Overall Study|Vasogenic edema recurrence|3|||
126342065|NCT00929669|454548777|FG000|Overall Study|elevated glucose levels|1|||
126342066|NCT02714153|454548778|FG000|Overall Study|Death|1|||
126342067|NCT02065557|454548782|FG000|Induction Period|Withdrawal by Subject|2|||
126342068|NCT02065557|454548783|FG001|Induction Period|Withdrawal by Subject|1|||
126342069|NCT02065557|454548784|FG002|Induction Period|Withdrawal by Subject|0|||
126342070|NCT02065557|454548785|FG003|Induction Period|Withdrawal by Subject|0|||
126342071|NCT02065557|454548786|FG004|Induction Period|Withdrawal by Subject|0|||
126342072|NCT02065557|454548787|FG005|Induction Period|Withdrawal by Subject|0|||
126342073|NCT02065557|454548782|FG000|Induction Period|Lack of Efficacy|2|||
126427223|NCT01506271|454860472|FG002|Overall Study|Protocol Violation|0|||
126427224|NCT01506271|454860470|FG000|Overall Study|Death|0|||
126427225|NCT01506271|454860471|FG001|Overall Study|Death|1|||
126427226|NCT01506271|454860472|FG002|Overall Study|Death|0|||
126427227|NCT01506271|454860470|FG000|Overall Study|Adverse Event|0|||
126427228|NCT01506271|454860471|FG001|Overall Study|Adverse Event|2|||
126427229|NCT01506271|454860472|FG002|Overall Study|Adverse Event|0|||
126427230|NCT01506271|454860470|FG000|Overall Study|Insufficient supply of study drug|1|||
126427231|NCT01506271|454860471|FG001|Overall Study|Insufficient supply of study drug|0|||
126427232|NCT01506271|454860472|FG002|Overall Study|Insufficient supply of study drug|0|||
126427233|NCT01506271|454860470|FG000|Overall Study|Withdrawal by Subject|0|||
126427234|NCT01506271|454860471|FG001|Overall Study|Withdrawal by Subject|1|||
126427235|NCT01506271|454860472|FG002|Overall Study|Withdrawal by Subject|1|||
126427236|NCT01506271|454860470|FG000|Overall Study|Lost to Follow-up|0|||
126427237|NCT01506271|454860471|FG001|Overall Study|Lost to Follow-up|1|||
126427238|NCT01506271|454860472|FG002|Overall Study|Lost to Follow-up|2|||
126427239|NCT01391663|454860473|FG000|Overall Study|Withdrawal by Subject|0|||
126427240|NCT01391663|454860474|FG001|Overall Study|Withdrawal by Subject|0|||
126675538|NCT03073980|455769076|FG002|Overall Study|No post-procedure data|2|||
126342074|NCT02065557|454548783|FG001|Induction Period|Lack of Efficacy|1|||
126342075|NCT02065557|454548784|FG002|Induction Period|Lack of Efficacy|1|||
126342076|NCT02065557|454548785|FG003|Induction Period|Lack of Efficacy|0|||
126342077|NCT02065557|454548786|FG004|Induction Period|Lack of Efficacy|0|||
126342078|NCT02065557|454548787|FG005|Induction Period|Lack of Efficacy|0|||
126342079|NCT02065557|454548782|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
126342080|NCT02065557|454548783|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
126342081|NCT02065557|454548784|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
126342082|NCT02065557|454548785|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
126342083|NCT02065557|454548786|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
126342084|NCT02065557|454548787|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
126342085|NCT02065557|454548782|FG000|Induction Period|Non-Responder at Week 8|4|||
126342086|NCT02065557|454548783|FG001|Induction Period|Non-Responder at Week 8|4|||
126342087|NCT02065557|454548784|FG002|Induction Period|Non-Responder at Week 8|0|||
126342088|NCT02065557|454548785|FG003|Induction Period|Non-Responder at Week 8|0|||
126342089|NCT02065557|454548786|FG004|Induction Period|Non-Responder at Week 8|0|||
126342090|NCT02065557|454548787|FG005|Induction Period|Non-Responder at Week 8|0|||
126342091|NCT02065557|454548782|FG000|Induction Period|Adverse Event|1|||
126427241|NCT01391663|454860475|FG002|Overall Study|Withdrawal by Subject|1|||
126675539|NCT00501007|455769077|FG000|Overall Study|Inclusion criteria not met.|29|||
126675540|NCT00501007|455769078|FG001|Overall Study|Inclusion criteria not met.|25|||
126675541|NCT00545064|455769079|FG000|Overall Study|Lost to Follow-up|3|||
126675542|NCT00545064|455769079|FG000|Overall Study|Withdrawal by Subject|2|||
126675543|NCT00545064|455769079|FG000|Overall Study|did not complete course of treatment|1|||
126675544|NCT00545064|455769079|FG000|Overall Study|cancel all appointments, no rebooking|1|||
126342092|NCT02065557|454548783|FG001|Induction Period|Adverse Event|1|||
126342093|NCT02065557|454548784|FG002|Induction Period|Adverse Event|0|||
126342094|NCT02065557|454548785|FG003|Induction Period|Adverse Event|0|||
126342095|NCT02065557|454548786|FG004|Induction Period|Adverse Event|0|||
126342096|NCT02065557|454548787|FG005|Induction Period|Adverse Event|0|||
126427242|NCT01391663|454860476|FG003|Overall Study|Withdrawal by Subject|0|||
126427243|NCT00920855|454860477|FG000|Overall Study|Adverse Event|1|||
126427244|NCT00920855|454860478|FG001|Overall Study|Adverse Event|1|||
126427245|NCT00920855|454860479|FG002|Overall Study|Adverse Event|4|||
126427246|NCT00920855|454860477|FG000|Overall Study|Withdrawal by Subject|2|||
126675545|NCT00545064|455769079|FG000|Overall Study|inclement weather|1|||
126342097|NCT02065557|454548782|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
126342098|NCT02065557|454548783|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
126342099|NCT02065557|454548784|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
126342100|NCT02065557|454548785|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
126342101|NCT02065557|454548786|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
126342102|NCT02065557|454548787|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
126342103|NCT02065557|454548782|FG000|Maintenance Period|Withdrawal by Subject|0|||
126342104|NCT02065557|454548783|FG001|Maintenance Period|Withdrawal by Subject|0|||
126342105|NCT02065557|454548784|FG002|Maintenance Period|Withdrawal by Subject|0|||
126342106|NCT02065557|454548785|FG003|Maintenance Period|Withdrawal by Subject|0|||
126342107|NCT02065557|454548786|FG004|Maintenance Period|Withdrawal by Subject|2|||
126342108|NCT02065557|454548787|FG005|Maintenance Period|Withdrawal by Subject|1|||
126342109|NCT02065557|454548782|FG000|Maintenance Period|Lack of Efficacy|0|||
126342110|NCT02065557|454548783|FG001|Maintenance Period|Lack of Efficacy|0|||
126342111|NCT02065557|454548784|FG002|Maintenance Period|Lack of Efficacy|0|||
126342112|NCT02065557|454548785|FG003|Maintenance Period|Lack of Efficacy|0|||
126342113|NCT02065557|454548786|FG004|Maintenance Period|Lack of Efficacy|5|||
126342114|NCT02065557|454548787|FG005|Maintenance Period|Lack of Efficacy|2|||
126342115|NCT02065557|454548782|FG000|Maintenance Period|Subject Non-Compliance|0|||
126342116|NCT02065557|454548783|FG001|Maintenance Period|Subject Non-Compliance|0|||
126342117|NCT02065557|454548784|FG002|Maintenance Period|Subject Non-Compliance|0|||
126675546|NCT00258674|455769082|FG000|Overall Study|Death|32|||
126675547|NCT00258674|455769083|FG001|Overall Study|Death|53|||
126675548|NCT00258674|455769084|FG002|Overall Study|Death|34|||
126675549|NCT03715153|455769085|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
126675550|NCT03715153|455769086|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
126675551|NCT03715153|455769085|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
126675552|NCT03715153|455769086|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
126675553|NCT03715153|455769085|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
126675554|NCT03715153|455769086|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
126675555|NCT03715153|455769085|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
126675556|NCT03715153|455769086|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
126675557|NCT03715153|455769085|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
126675558|NCT03715153|455769086|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
126675559|NCT03715153|455769085|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
126675560|NCT03715153|455769086|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
126675561|NCT02973087|455769089|FG000|Overall Study|Withdrawal by Subject|2|||
126675562|NCT02973087|455769090|FG001|Overall Study|Withdrawal by Subject|1|||
126675563|NCT02973087|455769089|FG000|Overall Study|Adverse Event|1|||
126675564|NCT02973087|455769090|FG001|Overall Study|Adverse Event|0|||
126675565|NCT02973087|455769089|FG000|Overall Study|other|1|||
126675566|NCT02973087|455769090|FG001|Overall Study|other|1|||
126675567|NCT01358760|455769093|FG000|Overall Study|Adverse Event|3|||
126675568|NCT01358760|455769094|FG001|Overall Study|Adverse Event|4|||
126675569|NCT01358760|455769095|FG002|Overall Study|Adverse Event|3|||
126675570|NCT01358760|455769093|FG000|Overall Study|Lost to Follow-up|1|||
126675571|NCT01358760|455769094|FG001|Overall Study|Lost to Follow-up|1|||
126675572|NCT01358760|455769095|FG002|Overall Study|Lost to Follow-up|3|||
126675573|NCT01358760|455769093|FG000|Overall Study|Withdrawal by Subject|5|||
126675574|NCT01358760|455769094|FG001|Overall Study|Withdrawal by Subject|3|||
126675575|NCT01358760|455769095|FG002|Overall Study|Withdrawal by Subject|2|||
126675576|NCT01358760|455769093|FG000|Overall Study|Physician Decision|1|||
126675577|NCT01358760|455769094|FG001|Overall Study|Physician Decision|0|||
126675578|NCT01358760|455769095|FG002|Overall Study|Physician Decision|1|||
126675579|NCT01358760|455769093|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
126675580|NCT01358760|455769094|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
126675581|NCT01358760|455769095|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
126675582|NCT01506960|455769096|FG000|Overall Study|Did not meet angiographic criteria|47|||
126675583|NCT00450723|455769098|FG000|Overall Study|Physician Decision|5|||
126675584|NCT00932360|455769099|FG000|Washout (One Week)|Withdrawal by Subject|0|||
126675585|NCT00932360|455769100|FG001|Washout (One Week)|Withdrawal by Subject|0|||
126675586|NCT00932360|455769101|FG002|Washout (One Week)|Withdrawal by Subject|0|||
126675587|NCT00932360|455769102|FG003|Washout (One Week)|Withdrawal by Subject|0|||
126342118|NCT02065557|454548785|FG003|Maintenance Period|Subject Non-Compliance|0|||
126342119|NCT02065557|454548786|FG004|Maintenance Period|Subject Non-Compliance|0|||
126675588|NCT00932360|455769103|FG004|Washout (One Week)|Withdrawal by Subject|2|||
126675589|NCT00932360|455769104|FG005|Washout (One Week)|Withdrawal by Subject|0|||
126675590|NCT01924182|455769105|FG000|Overall Study|Withdrawal by Subject|1|||
126675591|NCT01924182|455769106|FG001|Overall Study|Withdrawal by Subject|0|||
126675592|NCT04143009|455769107|FG000|Pilot Trial|Lost to Follow-up|0|||
126675593|NCT04143009|455769108|FG001|Pilot Trial|Lost to Follow-up|1|||
126675594|NCT04143009|455769109|FG002|Pilot Trial|Lost to Follow-up|1|||
126427247|NCT00920855|454860478|FG001|Overall Study|Withdrawal by Subject|1|||
126427248|NCT00920855|454860479|FG002|Overall Study|Withdrawal by Subject|6|||
126427249|NCT00920855|454860477|FG000|Overall Study|Disease progression|2|||
126427250|NCT00920855|454860478|FG001|Overall Study|Disease progression|1|||
126427251|NCT00920855|454860479|FG002|Overall Study|Disease progression|10|||
126427252|NCT00920855|454860477|FG000|Overall Study|Noncompliance to study medication|0|||
126427253|NCT00920855|454860478|FG001|Overall Study|Noncompliance to study medication|0|||
126427254|NCT00920855|454860479|FG002|Overall Study|Noncompliance to study medication|1|||
126427255|NCT00920855|454860477|FG000|Overall Study|Response plateau; started maintenance|0|||
126427256|NCT00920855|454860478|FG001|Overall Study|Response plateau; started maintenance|0|||
126427257|NCT00920855|454860479|FG002|Overall Study|Response plateau; started maintenance|1|||
126427258|NCT01290523|454860480|FG000|Overall Study|Death|3|||
126427259|NCT00539994|454860481|FG000|Overall Study|Lost to Follow-up|2|||
126427260|NCT00539994|454860482|FG001|Overall Study|Lost to Follow-up|1|||
126427261|NCT00539994|454860483|FG002|Overall Study|Lost to Follow-up|0|||
126427262|NCT00539994|454860481|FG000|Overall Study|Withdrawal by Subject|1|||
126427263|NCT00539994|454860482|FG001|Overall Study|Withdrawal by Subject|0|||
126427264|NCT00539994|454860483|FG002|Overall Study|Withdrawal by Subject|1|||
126427265|NCT00539994|454860481|FG000|Overall Study|Physician Decision|0|||
126427266|NCT00539994|454860482|FG001|Overall Study|Physician Decision|0|||
126427267|NCT00539994|454860483|FG002|Overall Study|Physician Decision|1|||
126427268|NCT03071263|454860484|FG000|Overall Study|Adverse Event|1|||
126427269|NCT03071263|454860485|FG001|Overall Study|Adverse Event|3|||
126427270|NCT03071263|454860484|FG000|Overall Study|Withdrawal by Subject|1|||
126427271|NCT03071263|454860485|FG001|Overall Study|Withdrawal by Subject|3|||
126427272|NCT03071263|454860484|FG000|Overall Study|Physician Decision|1|||
126427273|NCT03071263|454860485|FG001|Overall Study|Physician Decision|0|||
126427274|NCT03071263|454860484|FG000|Overall Study|Participant moved to another city|0|||
126427275|NCT03071263|454860485|FG001|Overall Study|Participant moved to another city|1|||
126427276|NCT03084796|454860486|FG000|Overall Study|Adverse Event|4|||
126427277|NCT03084796|454860487|FG001|Overall Study|Adverse Event|5|||
126427278|NCT03084796|454860488|FG002|Overall Study|Adverse Event|6|||
126427279|NCT03084796|454860489|FG003|Overall Study|Adverse Event|2|||
126427280|NCT03084796|454860490|FG004|Overall Study|Adverse Event|3|||
126427281|NCT03084796|454860491|FG005|Overall Study|Adverse Event|5|||
126427282|NCT03084796|454860486|FG000|Overall Study|Withdrawal by Subject|3|||
126427283|NCT03084796|454860487|FG001|Overall Study|Withdrawal by Subject|5|||
126427284|NCT03084796|454860488|FG002|Overall Study|Withdrawal by Subject|2|||
126427285|NCT03084796|454860489|FG003|Overall Study|Withdrawal by Subject|1|||
126427286|NCT03084796|454860490|FG004|Overall Study|Withdrawal by Subject|3|||
126427287|NCT03084796|454860491|FG005|Overall Study|Withdrawal by Subject|0|||
126427288|NCT03084796|454860486|FG000|Overall Study|Protocol Violation|0|||
126427289|NCT03084796|454860487|FG001|Overall Study|Protocol Violation|0|||
126675595|NCT00993265|455769110|FG000|Overall Study|Adverse Event|1|||
126675596|NCT00993265|455769111|FG001|Overall Study|Adverse Event|0|||
126675597|NCT00993265|455769110|FG000|Overall Study|Changed dose of concomitant drug|2|||
126675598|NCT00993265|455769111|FG001|Overall Study|Changed dose of concomitant drug|0|||
126675599|NCT00993265|455769110|FG000|Overall Study|Non-compliant with study medication|1|||
126675600|NCT00993265|455769111|FG001|Overall Study|Non-compliant with study medication|0|||
126675601|NCT05003622|455769112|FG000|Overall Study|Progressive disease|2|||
126675602|NCT05003622|455769112|FG000|Overall Study|Withdrawal by Subject|1|||
126675603|NCT00609986|455769113|FG000|Overall Study|Did not receive transplant or treatment|8|||
126675604|NCT00609986|455769114|FG001|Overall Study|Did not receive transplant or treatment|3|||
126675605|NCT02090413|455769118|FG000|Overall Study|Adverse Event|11|||
126675606|NCT02090413|455769119|FG001|Overall Study|Adverse Event|15|||
126675607|NCT02090413|455769120|FG002|Overall Study|Adverse Event|20|||
126675608|NCT02090413|455769118|FG000|Overall Study|Flushing event|2|||
126675609|NCT02090413|455769119|FG001|Overall Study|Flushing event|0|||
126675610|NCT02090413|455769120|FG002|Overall Study|Flushing event|1|||
126675611|NCT02090413|455769118|FG000|Overall Study|Withdrawal by Subject|2|||
126675612|NCT02090413|455769119|FG001|Overall Study|Withdrawal by Subject|2|||
126427290|NCT03084796|454860488|FG002|Overall Study|Protocol Violation|1|||
126427291|NCT03084796|454860489|FG003|Overall Study|Protocol Violation|0|||
126427292|NCT03084796|454860490|FG004|Overall Study|Protocol Violation|1|||
126675613|NCT02090413|455769120|FG002|Overall Study|Withdrawal by Subject|2|||
126427293|NCT03084796|454860491|FG005|Overall Study|Protocol Violation|1|||
126427294|NCT03084796|454860486|FG000|Overall Study|Lack of Efficacy|0|||
126427295|NCT03084796|454860487|FG001|Overall Study|Lack of Efficacy|0|||
126427296|NCT03084796|454860488|FG002|Overall Study|Lack of Efficacy|1|||
126427297|NCT03084796|454860489|FG003|Overall Study|Lack of Efficacy|0|||
126427298|NCT03084796|454860490|FG004|Overall Study|Lack of Efficacy|1|||
126427299|NCT03084796|454860491|FG005|Overall Study|Lack of Efficacy|0|||
126427300|NCT03084796|454860486|FG000|Overall Study|Lost to Follow-up|0|||
126427301|NCT03084796|454860487|FG001|Overall Study|Lost to Follow-up|0|||
126427302|NCT03084796|454860488|FG002|Overall Study|Lost to Follow-up|1|||
126342120|NCT02065557|454548787|FG005|Maintenance Period|Subject Non-Compliance|1|||
126342121|NCT00250588|454548788|FG000|Overall Study|Withdrawal by Subject|3|||
126342122|NCT00250588|454548789|FG001|Overall Study|Withdrawal by Subject|6|||
126342123|NCT00250588|454548790|FG002|Overall Study|Withdrawal by Subject|0|||
126342124|NCT00250588|454548788|FG000|Overall Study|Lost to Follow-up|6|||
126342125|NCT00250588|454548789|FG001|Overall Study|Lost to Follow-up|13|||
126342126|NCT00250588|454548790|FG002|Overall Study|Lost to Follow-up|13|||
126342127|NCT00706797|454548791|FG000|Overall Study|Lack of Efficacy|3|||
126342128|NCT00706797|454548792|FG001|Overall Study|Lack of Efficacy|0|||
126342129|NCT00706797|454548791|FG000|Overall Study|Adverse Event|0|||
126342130|NCT00706797|454548792|FG001|Overall Study|Adverse Event|3|||
126675614|NCT02090413|455769118|FG000|Overall Study|Investigator Decision|1|||
126675615|NCT02090413|455769119|FG001|Overall Study|Investigator Decision|1|||
126675616|NCT02090413|455769120|FG002|Overall Study|Investigator Decision|0|||
126675617|NCT02090413|455769118|FG000|Overall Study|Other|2|||
126342131|NCT00706797|454548791|FG000|Overall Study|Withdrawal by Subject|8|||
126342132|NCT00706797|454548792|FG001|Overall Study|Withdrawal by Subject|1|||
126342133|NCT00706797|454548791|FG000|Overall Study|Death|1|||
126342134|NCT00706797|454548792|FG001|Overall Study|Death|0|||
126342135|NCT00706797|454548791|FG000|Overall Study|Discontinuation of study by sponsor|52|||
126342136|NCT00706797|454548792|FG001|Overall Study|Discontinuation of study by sponsor|63|||
126342137|NCT00706797|454548791|FG000|Overall Study|Protocol Violation|3|||
126342138|NCT00706797|454548792|FG001|Overall Study|Protocol Violation|2|||
126342139|NCT00706797|454548791|FG000|Overall Study|Lost to Follow-up|1|||
126342140|NCT00706797|454548792|FG001|Overall Study|Lost to Follow-up|2|||
126342141|NCT00706797|454548791|FG000|Overall Study|Other|1|||
126342142|NCT00706797|454548792|FG001|Overall Study|Other|0|||
126342143|NCT00485303|454548796|FG000|Overall Study|Adverse Event|5|||
126342144|NCT00485303|454548796|FG000|Overall Study|Progressive Disease|44|||
126342145|NCT00485303|454548796|FG000|Overall Study|Other|3|||
126342146|NCT00485303|454548796|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
126342147|NCT00485303|454548796|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
126342148|NCT02147626|454548798|FG000|Overall Study|Lost to Follow-up|4|||
126342149|NCT02147626|454548799|FG001|Overall Study|Lost to Follow-up|4|||
126342150|NCT02147626|454548798|FG000|Overall Study|Pregnancy|1|||
126342151|NCT02147626|454548799|FG001|Overall Study|Pregnancy|2|||
126342152|NCT02147626|454548798|FG000|Overall Study|Withdrawal by Subject|0|||
126342153|NCT02147626|454548799|FG001|Overall Study|Withdrawal by Subject|1|||
126342154|NCT00572832|454548801|FG000|Overall Study|Lost to Follow-up|0|||
126342155|NCT00572832|454548802|FG001|Overall Study|Lost to Follow-up|11|||
126342156|NCT00572832|454548801|FG000|Overall Study|Pregnancy|0|||
126342157|NCT00572832|454548802|FG001|Overall Study|Pregnancy|1|||
126342158|NCT03704064|454548807|FG000|Overall Study|Lost to Follow-up|8|||
126342159|NCT03704064|454548808|FG001|Overall Study|Lost to Follow-up|4|||
126342160|NCT03704064|454548807|FG000|Overall Study|Withdrawal by Subject|1|||
126342161|NCT03704064|454548808|FG001|Overall Study|Withdrawal by Subject|1|||
126342162|NCT03704064|454548807|FG000|Overall Study|No longer available for study visits|0|||
126342163|NCT03704064|454548808|FG001|Overall Study|No longer available for study visits|1|||
126342164|NCT03704064|454548807|FG000|Overall Study|Censoring event|1|||
126342165|NCT03704064|454548808|FG001|Overall Study|Censoring event|0|||
126675618|NCT02090413|455769119|FG001|Overall Study|Other|1|||
126675619|NCT02090413|455769120|FG002|Overall Study|Other|0|||
126675620|NCT02090413|455769118|FG000|Overall Study|Lost to Follow-up|1|||
126675621|NCT02090413|455769119|FG001|Overall Study|Lost to Follow-up|1|||
126675622|NCT02090413|455769120|FG002|Overall Study|Lost to Follow-up|0|||
126675623|NCT05321069|455769124|FG000|Overall Study|Adverse Event|52|||
126675624|NCT05321069|455769125|FG001|Overall Study|Adverse Event|52|||
126675625|NCT05321069|455769126|FG002|Overall Study|Adverse Event|64|||
126342166|NCT00289276|454548811|FG000|Second Part of FAST Study (Expansion)|Death|0|||
126342167|NCT00289276|454548812|FG001|Second Part of FAST Study (Expansion)|Death|2|||
126342168|NCT00289276|454548811|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
126342169|NCT00289276|454548812|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
126342170|NCT02029417|454548813|FG000|Overall Study|Death|1|||
126342171|NCT02029417|454548813|FG000|Overall Study|Adverse Event|1|||
126342172|NCT02783911|454548814|FG000|Overall Study|Lost to Follow-up|3|||
126342173|NCT02783911|454548815|FG001|Overall Study|Lost to Follow-up|32|||
126342174|NCT01041859|454548818|FG000|Open-Label Titration|Adverse Event|69|||
126342175|NCT01041859|454548819|FG001|Open-Label Titration|Adverse Event|0|||
126342176|NCT01041859|454548820|FG002|Open-Label Titration|Adverse Event|0|||
126342177|NCT01041859|454548818|FG000|Open-Label Titration|Lack of Efficacy|3|||
126342178|NCT01041859|454548819|FG001|Open-Label Titration|Lack of Efficacy|0|||
126675626|NCT05321069|455769124|FG000|Overall Study|Protocol Violation|1|||
126675627|NCT05321069|455769125|FG001|Overall Study|Protocol Violation|1|||
126342179|NCT01041859|454548820|FG002|Open-Label Titration|Lack of Efficacy|0|||
126675628|NCT05321069|455769126|FG002|Overall Study|Protocol Violation|0|||
126342180|NCT01041859|454548818|FG000|Open-Label Titration|Lost to Follow-up|1|||
126342181|NCT01041859|454548819|FG001|Open-Label Titration|Lost to Follow-up|0|||
126675629|NCT05321069|455769124|FG000|Overall Study|Withdrawal by Subject|23|||
126427303|NCT03084796|454860489|FG003|Overall Study|Lost to Follow-up|1|||
126427304|NCT03084796|454860490|FG004|Overall Study|Lost to Follow-up|3|||
126427305|NCT03084796|454860491|FG005|Overall Study|Lost to Follow-up|1|||
126427306|NCT03084796|454860486|FG000|Overall Study|Randomization error|0|||
126427307|NCT03084796|454860487|FG001|Overall Study|Randomization error|0|||
126427308|NCT03084796|454860488|FG002|Overall Study|Randomization error|1|||
126427309|NCT03084796|454860489|FG003|Overall Study|Randomization error|0|||
126427310|NCT03084796|454860490|FG004|Overall Study|Randomization error|0|||
126427311|NCT03084796|454860491|FG005|Overall Study|Randomization error|0|||
126427312|NCT05470985|454860492|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
126427313|NCT05470985|454860493|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
126427314|NCT05470985|454860492|FG000|Double Blind Treatment Period|Physician Decision|0|||
126427315|NCT05470985|454860493|FG001|Double Blind Treatment Period|Physician Decision|1|||
126427316|NCT05470985|454860492|FG000|Long Term Extension|Adverse Event|0|||
126427317|NCT05470985|454860493|FG001|Long Term Extension|Adverse Event|1|||
126427318|NCT05470985|454860492|FG000|Long Term Extension|Study terminated by sponsor|2|||
126427319|NCT05470985|454860493|FG001|Long Term Extension|Study terminated by sponsor|0|||
126427320|NCT01917747|454860494|FG000|Overall Study|Withdrawal by Subject|1|||
126427321|NCT01917747|454860495|FG001|Overall Study|Withdrawal by Subject|2|||
126427322|NCT01917747|454860494|FG000|Overall Study|Lost to Follow-up|18|||
126427323|NCT01917747|454860495|FG001|Overall Study|Lost to Follow-up|9|||
126427324|NCT02741245|454860496|FG000|Overall Study|Adverse Event|0|||
126427325|NCT02741245|454860497|FG001|Overall Study|Adverse Event|0|||
126427326|NCT02741245|454860498|FG002|Overall Study|Adverse Event|0|||
126427327|NCT02741245|454860499|FG003|Overall Study|Adverse Event|2|||
126427328|NCT02741245|454860500|FG004|Overall Study|Adverse Event|2|||
126427329|NCT02741245|454860496|FG000|Overall Study|Protocol Violation|0|||
126427330|NCT02741245|454860497|FG001|Overall Study|Protocol Violation|1|||
126427331|NCT02741245|454860498|FG002|Overall Study|Protocol Violation|0|||
126427332|NCT02741245|454860499|FG003|Overall Study|Protocol Violation|1|||
126427333|NCT02741245|454860500|FG004|Overall Study|Protocol Violation|0|||
126427334|NCT02741245|454860496|FG000|Overall Study|Withdrawal by Subject|0|||
126427335|NCT02741245|454860497|FG001|Overall Study|Withdrawal by Subject|0|||
126427336|NCT02741245|454860498|FG002|Overall Study|Withdrawal by Subject|0|||
126427337|NCT02741245|454860499|FG003|Overall Study|Withdrawal by Subject|1|||
126427338|NCT02741245|454860500|FG004|Overall Study|Withdrawal by Subject|0|||
126427339|NCT00152503|454860503|FG000|Overall Study|Adverse Event|4|||
126427340|NCT02922725|454860504|FG000|Overall Study|Withdrawal by Subject|1|||
126427341|NCT02922725|454860505|FG001|Overall Study|Withdrawal by Subject|0|||
126427342|NCT02922725|454860506|FG002|Overall Study|Withdrawal by Subject|0|||
126427343|NCT01300234|454860507|FG000|Overall Study|Adverse Event|1|||
126427344|NCT01300234|454860508|FG001|Overall Study|Adverse Event|1|||
126427345|NCT01300234|454860507|FG000|Overall Study|Protocol Violation|2|||
126427346|NCT01300234|454860508|FG001|Overall Study|Protocol Violation|3|||
126427347|NCT01300234|454860507|FG000|Overall Study|Withdrawal by Subject|5|||
126427348|NCT01300234|454860508|FG001|Overall Study|Withdrawal by Subject|9|||
126427349|NCT01300234|454860507|FG000|Overall Study|Lost to Follow-up|14|||
126427350|NCT01300234|454860508|FG001|Overall Study|Lost to Follow-up|12|||
126427351|NCT01300234|454860507|FG000|Overall Study|Pregnancy|2|||
126427352|NCT01300234|454860508|FG001|Overall Study|Pregnancy|1|||
126427353|NCT01300234|454860507|FG000|Overall Study|Participant reached stopping critera|2|||
126427354|NCT01300234|454860508|FG001|Overall Study|Participant reached stopping critera|0|||
126427355|NCT01300234|454860507|FG000|Overall Study|Participant stopped medication|1|||
126427356|NCT01300234|454860508|FG001|Overall Study|Participant stopped medication|1|||
126427357|NCT01300234|454860507|FG000|Overall Study|Participant refused return to hospital|1|||
126427358|NCT01300234|454860508|FG001|Overall Study|Participant refused return to hospital|0|||
126427359|NCT03253679|454860509|FG000|Overall Study|Screen Failure|1|||
126427360|NCT04816214|454860510|FG000|Overall Study|Progressive Disease|4|||
126427361|NCT04816214|454860511|FG001|Overall Study|Progressive Disease|0|||
126675630|NCT05321069|455769125|FG001|Overall Study|Withdrawal by Subject|18|||
126675631|NCT05321069|455769126|FG002|Overall Study|Withdrawal by Subject|12|||
126675632|NCT05321069|455769124|FG000|Overall Study|Lost to Follow-up|1|||
126675633|NCT05321069|455769125|FG001|Overall Study|Lost to Follow-up|0|||
126427362|NCT04816214|454860512|FG002|Overall Study|Progressive Disease|0|||
126427363|NCT04816214|454860510|FG000|Overall Study|Death|1|||
126427364|NCT04816214|454860511|FG001|Overall Study|Death|0|||
126427365|NCT04816214|454860512|FG002|Overall Study|Death|0|||
126427366|NCT04816214|454860510|FG000|Overall Study|Study Terminated by Sponsor|1|||
126427367|NCT04816214|454860511|FG001|Overall Study|Study Terminated by Sponsor|0|||
126427368|NCT04816214|454860512|FG002|Overall Study|Study Terminated by Sponsor|0|||
126427369|NCT00584415|454860513|FG000|Overall Study|Adverse Event|7|||
126427370|NCT01928927|454860514|FG000|Overall Study|Lost to Follow-up|1|||
126427371|NCT01928927|454860515|FG001|Overall Study|Lost to Follow-up|0|||
126427372|NCT01928927|454860514|FG000|Overall Study|Withdrawal by Subject|1|||
126427373|NCT01928927|454860515|FG001|Overall Study|Withdrawal by Subject|1|||
126675634|NCT05321069|455769126|FG002|Overall Study|Lost to Follow-up|1|||
126675635|NCT05321069|455769124|FG000|Overall Study|No reason stated by the participants|23|||
126675636|NCT05321069|455769125|FG001|Overall Study|No reason stated by the participants|22|||
126675637|NCT05321069|455769126|FG002|Overall Study|No reason stated by the participants|16|||
126675638|NCT05321069|455769124|FG000|Overall Study|Lack of Efficacy|1|||
126675639|NCT05321069|455769125|FG001|Overall Study|Lack of Efficacy|1|||
126675640|NCT05321069|455769126|FG002|Overall Study|Lack of Efficacy|0|||
126675641|NCT00736255|455770490|FG000|Overall Study|Adverse Event|1|||
126675642|NCT00736255|455770491|FG001|Overall Study|Adverse Event|0|||
126675643|NCT00736255|455770490|FG000|Overall Study|Physician Decision|1|||
126675644|NCT00736255|455770491|FG001|Overall Study|Physician Decision|0|||
126675645|NCT00736255|455770490|FG000|Overall Study|Non-compliance|1|||
126675646|NCT00736255|455770491|FG001|Overall Study|Non-compliance|1|||
126675647|NCT01717287|455770496|FG000|Overall Study|Lost to Follow-up|0|||
126675648|NCT01717287|455770497|FG001|Overall Study|Lost to Follow-up|2|||
126675649|NCT01717287|455770496|FG000|Overall Study|Protocol Violation|0|||
126675650|NCT01717287|455770497|FG001|Overall Study|Protocol Violation|1|||
126675651|NCT00404820|455770498|FG000|Overall Study|Adverse Event|4|||
126675652|NCT00404820|455770499|FG001|Overall Study|Adverse Event|16|||
126675653|NCT00404820|455770498|FG000|Overall Study|Withdrawal by Subject|5|||
126675654|NCT00404820|455770499|FG001|Overall Study|Withdrawal by Subject|3|||
126675655|NCT00404820|455770498|FG000|Overall Study|Lost to Follow-up|7|||
126675656|NCT00404820|455770499|FG001|Overall Study|Lost to Follow-up|3|||
126675657|NCT00404820|455770498|FG000|Overall Study|Administrative problems|2|||
126675658|NCT00404820|455770499|FG001|Overall Study|Administrative problems|0|||
126675659|NCT00404820|455770498|FG000|Overall Study|Death|1|||
126675660|NCT00404820|455770499|FG001|Overall Study|Death|0|||
126675661|NCT00404820|455770498|FG000|Overall Study|Other|0|||
126675662|NCT00404820|455770499|FG001|Overall Study|Other|2|||
126675663|NCT00840086|455770500|FG000|Overall Study|Adverse Event|1|||
126675664|NCT00840086|455770500|FG000|Overall Study|Protocol Violation|2|||
126675665|NCT00840086|455770500|FG000|Overall Study|Lost to Follow-up|1|||
126675666|NCT03332498|455770501|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
126675667|NCT03332498|455770502|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
126675668|NCT03332498|455770503|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
126675669|NCT01566773|455770504|FG000|Overall Study|Protocol specified criteria|4|||
126675670|NCT01566773|455770504|FG000|Overall Study|Protocol Violation|4|||
126675671|NCT01566773|455770504|FG000|Overall Study|Withdrawal by Subject|9|||
126675672|NCT01566773|455770504|FG000|Overall Study|Administrative reason|1|||
126675673|NCT01566773|455770504|FG000|Overall Study|Adverse Event|10|||
126675674|NCT01566773|455770504|FG000|Overall Study|Physician Decision|2|||
126427404|NCT02079740|454862183|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
126427405|NCT02079740|454862184|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
126427406|NCT02079740|454862185|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
126427407|NCT02079740|454862186|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
126427408|NCT02079740|454862187|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
126427409|NCT02079740|454862188|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
126427410|NCT02079740|454862189|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
126675675|NCT04036708|455770505|FG000|Overall Study|Lost to Follow-up|14|||
126427411|NCT02079740|454862190|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
126427412|NCT02079740|454862191|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
126427413|NCT02079740|454862192|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
126427414|NCT02079740|454862193|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
126427415|NCT02079740|454862194|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
126427416|NCT02079740|454862195|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
126427417|NCT02079740|454862183|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
126427418|NCT02079740|454862184|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
126427419|NCT02079740|454862185|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
126427420|NCT02079740|454862186|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
126427421|NCT02079740|454862187|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
126427422|NCT02079740|454862188|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
126427423|NCT02079740|454862189|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
126427424|NCT02079740|454862190|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
126427425|NCT02079740|454862191|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
126427426|NCT02079740|454862192|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
126427427|NCT02079740|454862193|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
126427428|NCT02079740|454862194|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
126427429|NCT02079740|454862195|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
126427430|NCT02079740|454862183|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427431|NCT02079740|454862184|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427432|NCT02079740|454862185|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427433|NCT02079740|454862186|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427434|NCT02079740|454862187|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427435|NCT02079740|454862188|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427436|NCT02079740|454862189|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427437|NCT02079740|454862190|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
126427438|NCT02079740|454862191|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427439|NCT02079740|454862192|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427440|NCT02079740|454862193|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427441|NCT02079740|454862194|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427442|NCT02079740|454862195|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
126427443|NCT02079740|454862183|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427444|NCT02079740|454862184|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427445|NCT02079740|454862185|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427446|NCT02079740|454862186|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427447|NCT02079740|454862187|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427448|NCT02079740|454862188|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427449|NCT02079740|454862189|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427450|NCT02079740|454862190|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
126427451|NCT02079740|454862191|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427452|NCT02079740|454862192|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427453|NCT02079740|454862193|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427454|NCT02079740|454862194|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427455|NCT02079740|454862195|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
126427456|NCT02079740|454862183|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427457|NCT02079740|454862184|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427458|NCT02079740|454862185|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427459|NCT02079740|454862186|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126675676|NCT04036708|455770506|FG001|Overall Study|Lost to Follow-up|4|||
126427460|NCT02079740|454862187|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427461|NCT02079740|454862188|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427462|NCT02079740|454862189|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427463|NCT02079740|454862190|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427464|NCT02079740|454862191|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427465|NCT02079740|454862192|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
126675677|NCT04036708|455770507|FG002|Overall Study|Lost to Follow-up|14|||
126675678|NCT04036708|455770508|FG003|Overall Study|Lost to Follow-up|4|||
126675679|NCT01033734|455770509|FG000|Overall Study|Withdrawal by Subject|1|||
126427466|NCT02079740|454862193|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
126427467|NCT02079740|454862194|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
126427468|NCT02079740|454862195|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
126675680|NCT01444742|455770512|FG000|Overall Study|Death|1|||
126427471|NCT03493945|454862199|FG000|Phase I Dose Escalation|Ineligible|0|||
126427472|NCT03493945|454862200|FG001|Phase I Dose Escalation|Ineligible|0|||
126427473|NCT03493945|454862201|FG002|Phase I Dose Escalation|Ineligible|1|||
126427474|NCT03493945|454862202|FG003|Phase I Dose Escalation|Ineligible|0|||
126675681|NCT02349048|455770514|FG000|Overall Study|Withdrawal by Subject|4|||
126675682|NCT02349048|455770515|FG001|Overall Study|Withdrawal by Subject|0|||
126675683|NCT02349048|455770514|FG000|Overall Study|Lost to Follow-up|1|||
126675684|NCT02349048|455770515|FG001|Overall Study|Lost to Follow-up|0|||
126675685|NCT00094770|455770518|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
126675686|NCT00094770|455770519|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
126675687|NCT00094770|455770518|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
126675688|NCT00094770|455770519|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
126675689|NCT00094770|455770518|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
126675690|NCT00094770|455770519|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
126675691|NCT00094770|455770518|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
126675692|NCT00094770|455770519|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
126675693|NCT00094770|455770518|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
126675694|NCT00094770|455770519|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
126675695|NCT00094770|455770518|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
126675696|NCT00094770|455770519|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
126342182|NCT01041859|454548820|FG002|Open-Label Titration|Lost to Follow-up|0|||
126342183|NCT01041859|454548818|FG000|Open-Label Titration|Physician Decision|1|||
126342184|NCT01041859|454548819|FG001|Open-Label Titration|Physician Decision|0|||
126342185|NCT01041859|454548820|FG002|Open-Label Titration|Physician Decision|0|||
126342186|NCT01041859|454548818|FG000|Open-Label Titration|Protocol Violation|1|||
126342187|NCT01041859|454548819|FG001|Open-Label Titration|Protocol Violation|0|||
126342188|NCT01041859|454548820|FG002|Open-Label Titration|Protocol Violation|0|||
126342189|NCT01041859|454548818|FG000|Open-Label Titration|Other|7|||
126342190|NCT01041859|454548819|FG001|Open-Label Titration|Other|0|||
126342191|NCT01041859|454548820|FG002|Open-Label Titration|Other|0|||
126342192|NCT01041859|454548818|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
126342193|NCT01041859|454548819|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
126342194|NCT01041859|454548820|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
126342195|NCT01041859|454548818|FG000|Open-Label Titration|Withdrawal by Subject|11|||
126342196|NCT01041859|454548819|FG001|Open-Label Titration|Withdrawal by Subject|0|||
126342197|NCT01041859|454548820|FG002|Open-Label Titration|Withdrawal by Subject|0|||
126342198|NCT01041859|454548818|FG000|Double-Blind Maintenance|Adverse Event|0|||
126342199|NCT01041859|454548819|FG001|Double-Blind Maintenance|Adverse Event|23|||
126342200|NCT01041859|454548820|FG002|Double-Blind Maintenance|Adverse Event|13|||
126342201|NCT01041859|454548818|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
126342202|NCT01041859|454548819|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
126342203|NCT01041859|454548820|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
126342204|NCT01041859|454548818|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
126342205|NCT01041859|454548819|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
126342206|NCT01041859|454548820|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
126342207|NCT01041859|454548818|FG000|Double-Blind Maintenance|Physician Decision|0|||
126342208|NCT01041859|454548819|FG001|Double-Blind Maintenance|Physician Decision|2|||
126342209|NCT01041859|454548820|FG002|Double-Blind Maintenance|Physician Decision|1|||
126342210|NCT01041859|454548818|FG000|Double-Blind Maintenance|Protocol Violation|0|||
126342211|NCT01041859|454548819|FG001|Double-Blind Maintenance|Protocol Violation|1|||
126342212|NCT01041859|454548820|FG002|Double-Blind Maintenance|Protocol Violation|3|||
126342213|NCT01041859|454548818|FG000|Double-Blind Maintenance|Other|0|||
126342214|NCT01041859|454548819|FG001|Double-Blind Maintenance|Other|6|||
126342215|NCT01041859|454548820|FG002|Double-Blind Maintenance|Other|2|||
126342216|NCT01041859|454548818|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
126342217|NCT01041859|454548819|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
126342218|NCT01041859|454548820|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
126342219|NCT01041859|454548818|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
126342220|NCT01041859|454548819|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
126342221|NCT01041859|454548820|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
126342222|NCT02908347|454548826|FG000|Overall Study|Adverse Event|0|||
126342223|NCT02908347|454548827|FG001|Overall Study|Adverse Event|1|||
126342224|NCT02908347|454548826|FG000|Overall Study|Lost to Follow-up|1|||
126342225|NCT02908347|454548827|FG001|Overall Study|Lost to Follow-up|0|||
126342226|NCT00885118|454548828|FG000|Overall Study|Adverse Event|1|||
126342227|NCT00885118|454548829|FG001|Overall Study|Adverse Event|0|||
126342228|NCT00885118|454548830|FG002|Overall Study|Adverse Event|0|||
126342229|NCT00885118|454548831|FG003|Overall Study|Adverse Event|0|||
126342230|NCT00885118|454548832|FG004|Overall Study|Adverse Event|0|||
126342231|NCT00885118|454548828|FG000|Overall Study|Withdrawal by Subject|0|||
126342232|NCT00885118|454548829|FG001|Overall Study|Withdrawal by Subject|0|||
126342233|NCT00885118|454548830|FG002|Overall Study|Withdrawal by Subject|0|||
126342234|NCT00885118|454548831|FG003|Overall Study|Withdrawal by Subject|0|||
126342235|NCT00885118|454548832|FG004|Overall Study|Withdrawal by Subject|1|||
126342236|NCT00885118|454548828|FG000|Overall Study|Other reason not defined above|0|||
126675697|NCT00094770|455770518|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
126675698|NCT00094770|455770519|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
126427475|NCT03493945|454862203|FG004|Phase I Dose Escalation|Ineligible|0|||
126427476|NCT03493945|454862204|FG005|Phase I Dose Escalation|Ineligible|0|||
126427477|NCT03493945|454862205|FG006|Phase I Dose Escalation|Ineligible|0|||
126427478|NCT03493945|454862199|FG000|Phase I Dose Escalation|New therapy|0|||
126427479|NCT03493945|454862200|FG001|Phase I Dose Escalation|New therapy|1|||
126427480|NCT03493945|454862201|FG002|Phase I Dose Escalation|New therapy|0|||
126427481|NCT03493945|454862202|FG003|Phase I Dose Escalation|New therapy|0|||
126427482|NCT03493945|454862203|FG004|Phase I Dose Escalation|New therapy|0|||
126427483|NCT03493945|454862204|FG005|Phase I Dose Escalation|New therapy|0|||
126675699|NCT00094770|455770518|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
126675700|NCT00094770|455770519|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
126675701|NCT00094770|455770518|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
126675702|NCT00094770|455770519|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
126675703|NCT00094770|455770518|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
126675704|NCT00094770|455770519|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
126675705|NCT00094770|455770518|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
126675706|NCT00094770|455770519|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
126675707|NCT00094770|455770518|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
126427484|NCT03493945|454862205|FG006|Phase I Dose Escalation|New therapy|0|||
126427485|NCT03493945|454862199|FG000|Phase II Dose Expansion|Refused further treatment|0|||
126427486|NCT03493945|454862200|FG001|Phase II Dose Expansion|Refused further treatment|0|||
126427487|NCT03493945|454862201|FG002|Phase II Dose Expansion|Refused further treatment|0|||
126427488|NCT03493945|454862202|FG003|Phase II Dose Expansion|Refused further treatment|0|||
126427489|NCT03493945|454862203|FG004|Phase II Dose Expansion|Refused further treatment|1|||
126427490|NCT03493945|454862204|FG005|Phase II Dose Expansion|Refused further treatment|1|||
126427491|NCT03493945|454862205|FG006|Phase II Dose Expansion|Refused further treatment|0|||
126675708|NCT00094770|455770519|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
126675709|NCT00094770|455770518|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
126675710|NCT00094770|455770519|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
126675711|NCT00094770|455770518|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
126675712|NCT00094770|455770519|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
126675713|NCT00094770|455770518|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
126675714|NCT00094770|455770519|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
126675715|NCT00094770|455770518|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
126675716|NCT00094770|455770519|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
126675717|NCT00094770|455770518|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
126675718|NCT00094770|455770519|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
126675719|NCT00094770|455770518|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
126675720|NCT00094770|455770519|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
126675721|NCT01648790|455770520|FG000|Treatment 3|Withdrawal by Subject|0|||
126675722|NCT01648790|455770521|FG001|Treatment 3|Withdrawal by Subject|0|||
126675723|NCT01648790|455770522|FG002|Treatment 3|Withdrawal by Subject|0|||
126675724|NCT01648790|455770523|FG003|Treatment 3|Withdrawal by Subject|1|||
126675725|NCT01648790|455770524|FG004|Treatment 3|Withdrawal by Subject|0|||
126675726|NCT02969187|455770525|FG000|Overall Study|Physician Decision|12|||
126675727|NCT02969187|455770526|FG001|Overall Study|Physician Decision|13|||
126675728|NCT01486927|455770527|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
126675729|NCT01486927|455770527|FG000|Overall Study|Physician Decision|1|||
126675730|NCT01486927|455770527|FG000|Overall Study|50 Exposure days not reached|2|||
126675731|NCT01486927|455770527|FG000|Overall Study|Withdrawal by Subject|8|||
126675732|NCT01486927|455770527|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
126675733|NCT00365456|455770528|FG000|Trial Period I (12 Months)|Adverse Event|84|||
126675734|NCT00365456|455770529|FG001|Trial Period I (12 Months)|Adverse Event|0|||
126675735|NCT00365456|455770528|FG000|Trial Period I (12 Months)|Non-compliance|3|||
126675736|NCT00365456|455770529|FG001|Trial Period I (12 Months)|Non-compliance|0|||
126675737|NCT00365456|455770528|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
126675738|NCT00365456|455770529|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
126675739|NCT00365456|455770528|FG000|Trial Period I (12 Months)|Other|11|||
126675740|NCT00365456|455770529|FG001|Trial Period I (12 Months)|Other|0|||
126675741|NCT00365456|455770528|FG000|Trial Period II (12 Months)|Adverse Event|0|||
126675742|NCT00365456|455770529|FG001|Trial Period II (12 Months)|Adverse Event|6|||
126675743|NCT00365456|455770528|FG000|Trial Period II (12 Months)|Non-compliance|0|||
126675744|NCT00365456|455770529|FG001|Trial Period II (12 Months)|Non-compliance|2|||
126675745|NCT00365456|455770528|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
126675746|NCT00365456|455770529|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
126675747|NCT00365456|455770528|FG000|Trial Period II (12 Months)|Other|0|||
126675748|NCT00365456|455770529|FG001|Trial Period II (12 Months)|Other|1|||
126675749|NCT00365456|455770528|FG000|Trial Period III (12 Months)|Adverse Event|13|||
126675750|NCT00365456|455770529|FG001|Trial Period III (12 Months)|Adverse Event|3|||
126427492|NCT03493945|454862199|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
126427493|NCT03493945|454862200|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
126427494|NCT03493945|454862201|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
126427495|NCT03493945|454862202|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
126675751|NCT00365456|455770528|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
126675752|NCT00365456|455770529|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
126675753|NCT00365456|455770528|FG000|Trial Period III (12 Months)|Other|1|||
126675754|NCT00365456|455770529|FG001|Trial Period III (12 Months)|Other|1|||
126675755|NCT01476475|455770531|FG000|Overall Study|Adverse Event|6|||
126675756|NCT01476475|455770532|FG001|Overall Study|Adverse Event|0|||
126675757|NCT01476475|455770531|FG000|Overall Study|Poor compliance to protocol|1|||
126675758|NCT01476475|455770532|FG001|Overall Study|Poor compliance to protocol|1|||
126675759|NCT01476475|455770531|FG000|Overall Study|Other reasons|4|||
126675760|NCT01476475|455770532|FG001|Overall Study|Other reasons|2|||
126675761|NCT01278745|455770533|FG000|Overall Study|Death|2|||
126675762|NCT01278745|455770534|FG001|Overall Study|Death|5|||
126675763|NCT01278745|455770535|FG002|Overall Study|Death|7|||
126675764|NCT01278745|455770536|FG003|Overall Study|Death|0|||
126675765|NCT01278745|455770533|FG000|Overall Study|Physician Decision|1|||
126675766|NCT01278745|455770534|FG001|Overall Study|Physician Decision|0|||
126675767|NCT01278745|455770535|FG002|Overall Study|Physician Decision|0|||
126675768|NCT01278745|455770536|FG003|Overall Study|Physician Decision|9|||
126675769|NCT01278745|455770533|FG000|Overall Study|Withdrawal by Subject|1|||
126675770|NCT01278745|455770534|FG001|Overall Study|Withdrawal by Subject|1|||
126675771|NCT01278745|455770535|FG002|Overall Study|Withdrawal by Subject|5|||
126675772|NCT01278745|455770536|FG003|Overall Study|Withdrawal by Subject|1|||
126675773|NCT01278745|455770533|FG000|Overall Study|Sponsor Decision|1|||
126675774|NCT01278745|455770534|FG001|Overall Study|Sponsor Decision|0|||
126675775|NCT01278745|455770535|FG002|Overall Study|Sponsor Decision|62|||
126675776|NCT01278745|455770536|FG003|Overall Study|Sponsor Decision|6|||
126675777|NCT01278745|455770533|FG000|Overall Study|Ineligible|0|||
126675778|NCT01278745|455770534|FG001|Overall Study|Ineligible|0|||
126675779|NCT01278745|455770535|FG002|Overall Study|Ineligible|42|||
126675780|NCT01278745|455770536|FG003|Overall Study|Ineligible|61|||
126675781|NCT01278745|455770533|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
126675782|NCT01278745|455770534|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
126675783|NCT01278745|455770535|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
126675784|NCT01278745|455770536|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
126675785|NCT01265615|455770537|FG000|Overall Study|Protocol Violation|2|||
126675786|NCT01265615|455770538|FG001|Overall Study|Protocol Violation|2|||
126675787|NCT01265615|455770539|FG002|Overall Study|Protocol Violation|4|||
126675788|NCT01265615|455770540|FG003|Overall Study|Protocol Violation|3|||
126675789|NCT02953340|455770545|FG000|Overall Study|Death|0|||
126675790|NCT02953340|455770546|FG001|Overall Study|Death|1|||
126675791|NCT02953340|455770545|FG000|Overall Study|Investigator Decision|3|||
126675792|NCT02953340|455770546|FG001|Overall Study|Investigator Decision|3|||
126675793|NCT02953340|455770545|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
126675794|NCT02953340|455770546|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
126675795|NCT02953340|455770545|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
126675796|NCT02953340|455770546|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
126675797|NCT02953340|455770545|FG000|Overall Study|Withdrawal by Subject|9|||
126675798|NCT02953340|455770546|FG001|Overall Study|Withdrawal by Subject|9|||
126675799|NCT02953340|455770545|FG000|Overall Study|Sponsor decision|0|||
126675800|NCT02953340|455770546|FG001|Overall Study|Sponsor decision|2|||
126675801|NCT02953340|455770545|FG000|Overall Study|Lost to Follow-up|3|||
126675802|NCT02953340|455770546|FG001|Overall Study|Lost to Follow-up|2|||
126675803|NCT02953340|455770545|FG000|Overall Study|Reason not specified|2|||
126675804|NCT02953340|455770546|FG001|Overall Study|Reason not specified|2|||
126675805|NCT00454857|455770547|FG000|Overall Study|Withdrawal by Subject|15|||
126675806|NCT00454857|455770547|FG000|Overall Study|Lost to Follow-up|16|||
126675807|NCT00454857|455770547|FG000|Overall Study|Noncompliance|6|||
126675808|NCT00454857|455770547|FG000|Overall Study|Death|5|||
126675809|NCT00454857|455770547|FG000|Overall Study|Other|11|||
126675810|NCT00454857|455770547|FG000|Overall Study|Reason unknown|1|||
126675811|NCT04206020|455770550|FG000|Overall Study|Adverse Event|1|||
126675812|NCT04206020|455770551|FG001|Overall Study|Adverse Event|4|||
126675813|NCT04206020|455770550|FG000|Overall Study|Protocol Violation|2|||
126675814|NCT04206020|455770551|FG001|Overall Study|Protocol Violation|0|||
126675815|NCT04206020|455770550|FG000|Overall Study|Withdrawal by Subject|2|||
126675816|NCT04206020|455770551|FG001|Overall Study|Withdrawal by Subject|0|||
126342237|NCT00885118|454548829|FG001|Overall Study|Other reason not defined above|0|||
126342238|NCT00885118|454548830|FG002|Overall Study|Other reason not defined above|1|||
126342239|NCT00885118|454548831|FG003|Overall Study|Other reason not defined above|0|||
126675817|NCT04206020|455770550|FG000|Overall Study|Lost to Follow-up|2|||
126675818|NCT04206020|455770551|FG001|Overall Study|Lost to Follow-up|0|||
126342240|NCT00885118|454548832|FG004|Overall Study|Other reason not defined above|0|||
126675819|NCT04206020|455770550|FG000|Overall Study|Pregnancy|0|||
126675820|NCT04206020|455770551|FG001|Overall Study|Pregnancy|1|||
126675821|NCT04206020|455770550|FG000|Overall Study|Unable to attend visits|1|||
126675822|NCT04206020|455770551|FG001|Overall Study|Unable to attend visits|2|||
126675823|NCT02375724|455770557|FG000|Overall Study|Lack of Efficacy|1|||
126675824|NCT02375724|455770558|FG001|Overall Study|Lack of Efficacy|1|||
126675825|NCT02375724|455770557|FG000|Overall Study|Withdrawal by Subject|1|||
126675826|NCT02375724|455770558|FG001|Overall Study|Withdrawal by Subject|1|||
126675827|NCT02375724|455770557|FG000|Overall Study|Lost to Follow-up|1|||
126675828|NCT02375724|455770558|FG001|Overall Study|Lost to Follow-up|0|||
126675829|NCT02375724|455770557|FG000|Overall Study|Protocol Violation|1|||
126675830|NCT02375724|455770558|FG001|Overall Study|Protocol Violation|0|||
126675831|NCT02375724|455770557|FG000|Overall Study|Adverse Event|2|||
126675832|NCT02375724|455770558|FG001|Overall Study|Adverse Event|4|||
126675833|NCT01197521|455770563|FG000|Overall Study|Not reported|24|||
126675834|NCT01197521|455770564|FG001|Overall Study|Not reported|25|||
126675835|NCT01197521|455770565|FG002|Overall Study|Not reported|21|||
126675836|NCT01197521|455770563|FG000|Overall Study|Enrolment in long term extension|42|||
126675837|NCT01197521|455770564|FG001|Overall Study|Enrolment in long term extension|36|||
126675838|NCT01197521|455770565|FG002|Overall Study|Enrolment in long term extension|87|||
126675839|NCT01197521|455770563|FG000|Overall Study|Severe non-compliance to protocol|1|||
126675840|NCT01197521|455770564|FG001|Overall Study|Severe non-compliance to protocol|3|||
126675841|NCT01197521|455770565|FG002|Overall Study|Severe non-compliance to protocol|3|||
126675842|NCT01197521|455770563|FG000|Overall Study|Lack of therapeutic response|2|||
126675843|NCT01197521|455770564|FG001|Overall Study|Lack of therapeutic response|3|||
126675844|NCT01197521|455770565|FG002|Overall Study|Lack of therapeutic response|4|||
126675845|NCT01197521|455770563|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
126675846|NCT01197521|455770564|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
126675847|NCT01197521|455770565|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
126675848|NCT01197521|455770563|FG000|Overall Study|Lost to Follow-up|3|||
126675849|NCT01197521|455770564|FG001|Overall Study|Lost to Follow-up|2|||
126675850|NCT01197521|455770565|FG002|Overall Study|Lost to Follow-up|2|||
126675851|NCT01197521|455770563|FG000|Overall Study|Adverse Event|25|||
126675852|NCT01197521|455770564|FG001|Overall Study|Adverse Event|28|||
126675853|NCT01197521|455770565|FG002|Overall Study|Adverse Event|24|||
126675854|NCT00552175|455770566|FG000|Overall Study|Lack of Efficacy|2|||
126675855|NCT00552175|455770567|FG001|Overall Study|Lack of Efficacy|0|||
126675856|NCT00552175|455770568|FG002|Overall Study|Lack of Efficacy|1|||
126675857|NCT00552175|455770566|FG000|Overall Study|Adverse Event|9|||
126675858|NCT00552175|455770567|FG001|Overall Study|Adverse Event|9|||
126675859|NCT00552175|455770568|FG002|Overall Study|Adverse Event|10|||
126675860|NCT00552175|455770566|FG000|Overall Study|Withdrawal by Subject|2|||
126675861|NCT00552175|455770567|FG001|Overall Study|Withdrawal by Subject|2|||
126675862|NCT00552175|455770568|FG002|Overall Study|Withdrawal by Subject|1|||
126675863|NCT00552175|455770566|FG000|Overall Study|Lost to Follow-up|0|||
126675864|NCT00552175|455770567|FG001|Overall Study|Lost to Follow-up|0|||
126675865|NCT00552175|455770568|FG002|Overall Study|Lost to Follow-up|1|||
126675866|NCT00552175|455770566|FG000|Overall Study|Entry Criteria Not Met|1|||
126675867|NCT00552175|455770567|FG001|Overall Study|Entry Criteria Not Met|1|||
126675868|NCT00552175|455770568|FG002|Overall Study|Entry Criteria Not Met|0|||
126675869|NCT00552175|455770566|FG000|Overall Study|Reason Not Specified|3|||
126675870|NCT00552175|455770567|FG001|Overall Study|Reason Not Specified|1|||
126675871|NCT00552175|455770568|FG002|Overall Study|Reason Not Specified|1|||
126675872|NCT00078325|455770571|FG000|Overall Study|Adverse Event|15|||
126675873|NCT00078325|455770572|FG001|Overall Study|Adverse Event|10|||
126675874|NCT00078325|455770573|FG002|Overall Study|Adverse Event|5|||
126675875|NCT00078325|455770571|FG000|Overall Study|Protocol Violation|2|||
126675876|NCT00078325|455770572|FG001|Overall Study|Protocol Violation|2|||
126675877|NCT00078325|455770573|FG002|Overall Study|Protocol Violation|0|||
126675878|NCT00078325|455770571|FG000|Overall Study|Withdrawal by Subject|1|||
126675879|NCT00078325|455770572|FG001|Overall Study|Withdrawal by Subject|5|||
126675880|NCT00078325|455770573|FG002|Overall Study|Withdrawal by Subject|3|||
126675881|NCT00078325|455770571|FG000|Overall Study|Lost to Follow-up|0|||
126675882|NCT00078325|455770572|FG001|Overall Study|Lost to Follow-up|1|||
126675883|NCT00078325|455770573|FG002|Overall Study|Lost to Follow-up|1|||
126675884|NCT00078325|455770571|FG000|Overall Study|Physician Decision|2|||
126675885|NCT00078325|455770572|FG001|Overall Study|Physician Decision|0|||
126675886|NCT00078325|455770573|FG002|Overall Study|Physician Decision|1|||
126675887|NCT00078325|455770571|FG000|Overall Study|Miscellaneous|1|||
126675888|NCT00078325|455770572|FG001|Overall Study|Miscellaneous|1|||
126675889|NCT00078325|455770573|FG002|Overall Study|Miscellaneous|1|||
126675890|NCT00578136|455770574|FG000|Overall Study|Not given intervention|1|||
126675891|NCT00578136|455770575|FG001|Overall Study|Not given intervention|1|||
126675892|NCT02047253|455770576|FG000|Overall Study|Lost to Follow-up|8|||
126675893|NCT01987960|455770578|FG000|Period 1|Adverse Event|24|||
126675894|NCT01987960|455770579|FG001|Period 1|Adverse Event|0|||
126675895|NCT01987960|455770580|FG002|Period 1|Adverse Event|0|||
126675896|NCT01987960|455770581|FG003|Period 1|Adverse Event|0|||
126675897|NCT01987960|455770578|FG000|Period 1|Lack of Efficacy|4|||
126675898|NCT01987960|455770579|FG001|Period 1|Lack of Efficacy|0|||
126675899|NCT01987960|455770580|FG002|Period 1|Lack of Efficacy|0|||
126675900|NCT01987960|455770581|FG003|Period 1|Lack of Efficacy|0|||
126675901|NCT01987960|455770578|FG000|Period 1|Non-compliance with IMP|6|||
126675902|NCT01987960|455770579|FG001|Period 1|Non-compliance with IMP|0|||
126427496|NCT03493945|454862203|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
126427497|NCT03493945|454862204|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
126427498|NCT03493945|454862205|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
126427499|NCT04319198|454862218|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
126427500|NCT04319198|454862219|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
126427501|NCT04319198|454862220|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
126427502|NCT04319198|454862218|FG000|Overall Study|Death|0|||
126427503|NCT04319198|454862219|FG001|Overall Study|Death|3|||
126427504|NCT04319198|454862220|FG002|Overall Study|Death|3|||
126427505|NCT04319198|454862218|FG000|Overall Study|Reason Not Specified|0|||
126427506|NCT04319198|454862219|FG001|Overall Study|Reason Not Specified|2|||
126427507|NCT04319198|454862220|FG002|Overall Study|Reason Not Specified|4|||
126427508|NCT04319198|454862218|FG000|Overall Study|Withdrawal of Consent|0|||
126427509|NCT04319198|454862219|FG001|Overall Study|Withdrawal of Consent|0|||
126427510|NCT04319198|454862220|FG002|Overall Study|Withdrawal of Consent|5|||
126427511|NCT04319198|454862218|FG000|Overall Study|Site Terminated by Sponsor|0|||
126427512|NCT04319198|454862219|FG001|Overall Study|Site Terminated by Sponsor|1|||
126427513|NCT04319198|454862220|FG002|Overall Study|Site Terminated by Sponsor|0|||
126675903|NCT01987960|455770580|FG002|Period 1|Non-compliance with IMP|0|||
126675904|NCT01987960|455770581|FG003|Period 1|Non-compliance with IMP|0|||
126675905|NCT01987960|455770578|FG000|Period 1|Protocol Violation|12|||
126675906|NCT01987960|455770579|FG001|Period 1|Protocol Violation|0|||
126675907|NCT01987960|455770580|FG002|Period 1|Protocol Violation|0|||
126675908|NCT01987960|455770581|FG003|Period 1|Protocol Violation|0|||
126675909|NCT01987960|455770578|FG000|Period 1|Withdrawal by Subject|21|||
126675910|NCT01987960|455770579|FG001|Period 1|Withdrawal by Subject|0|||
126675911|NCT01987960|455770580|FG002|Period 1|Withdrawal by Subject|0|||
126675912|NCT01987960|455770581|FG003|Period 1|Withdrawal by Subject|0|||
126675913|NCT01987960|455770578|FG000|Period 1|Lost to Follow-up|40|||
126675914|NCT01987960|455770579|FG001|Period 1|Lost to Follow-up|0|||
126675915|NCT01987960|455770580|FG002|Period 1|Lost to Follow-up|0|||
126675916|NCT01987960|455770581|FG003|Period 1|Lost to Follow-up|0|||
126675917|NCT01987960|455770578|FG000|Period 1|administrative or other reason|75|||
126675918|NCT01987960|455770579|FG001|Period 1|administrative or other reason|0|||
126675919|NCT01987960|455770580|FG002|Period 1|administrative or other reason|0|||
126675920|NCT01987960|455770581|FG003|Period 1|administrative or other reason|0|||
126675921|NCT01987960|455770578|FG000|Period 1|Withdrawal of consent before treatment|4|||
126675922|NCT01987960|455770579|FG001|Period 1|Withdrawal of consent before treatment|0|||
126675923|NCT01987960|455770580|FG002|Period 1|Withdrawal of consent before treatment|0|||
126675924|NCT01987960|455770581|FG003|Period 1|Withdrawal of consent before treatment|0|||
126675925|NCT01987960|455770578|FG000|Period 2|Adverse Event|0|||
126675926|NCT01987960|455770579|FG001|Period 2|Adverse Event|0|||
126675927|NCT01987960|455770580|FG002|Period 2|Adverse Event|1|||
126675928|NCT01987960|455770581|FG003|Period 2|Adverse Event|0|||
126675929|NCT01987960|455770578|FG000|Period 2|Withdrawal by Subject|0|||
126675930|NCT01987960|455770579|FG001|Period 2|Withdrawal by Subject|0|||
126675931|NCT01987960|455770580|FG002|Period 2|Withdrawal by Subject|1|||
126675932|NCT01987960|455770581|FG003|Period 2|Withdrawal by Subject|0|||
126675933|NCT01987960|455770578|FG000|Period 2|Administrative or other reason|0|||
126675934|NCT01987960|455770579|FG001|Period 2|Administrative or other reason|5|||
126675935|NCT01987960|455770580|FG002|Period 2|Administrative or other reason|7|||
126675936|NCT01987960|455770581|FG003|Period 2|Administrative or other reason|0|||
126675937|NCT01987960|455770578|FG000|Period 3|Adverse Event|0|||
126675938|NCT01987960|455770579|FG001|Period 3|Adverse Event|0|||
126675939|NCT01987960|455770580|FG002|Period 3|Adverse Event|0|||
126675940|NCT01987960|455770581|FG003|Period 3|Adverse Event|7|||
126675941|NCT01987960|455770578|FG000|Period 3|Non-compliance with IMP|0|||
126675942|NCT01987960|455770579|FG001|Period 3|Non-compliance with IMP|0|||
126675943|NCT01987960|455770580|FG002|Period 3|Non-compliance with IMP|0|||
126675944|NCT01987960|455770581|FG003|Period 3|Non-compliance with IMP|1|||
126675945|NCT01987960|455770578|FG000|Period 3|Protocol Violation|0|||
126675946|NCT01987960|455770579|FG001|Period 3|Protocol Violation|0|||
126675947|NCT01987960|455770580|FG002|Period 3|Protocol Violation|0|||
126675948|NCT01987960|455770581|FG003|Period 3|Protocol Violation|6|||
126675949|NCT01987960|455770578|FG000|Period 3|Withdrawal by Subject|0|||
126675950|NCT01987960|455770579|FG001|Period 3|Withdrawal by Subject|0|||
126675951|NCT01987960|455770580|FG002|Period 3|Withdrawal by Subject|0|||
126675952|NCT01987960|455770581|FG003|Period 3|Withdrawal by Subject|9|||
126675953|NCT01987960|455770578|FG000|Period 3|Lost to Follow-up|0|||
126675954|NCT01987960|455770579|FG001|Period 3|Lost to Follow-up|0|||
126675955|NCT01987960|455770580|FG002|Period 3|Lost to Follow-up|0|||
126675956|NCT01987960|455770581|FG003|Period 3|Lost to Follow-up|5|||
126675957|NCT01987960|455770578|FG000|Period 3|Administrative or other reason|0|||
126675958|NCT01987960|455770579|FG001|Period 3|Administrative or other reason|0|||
126675959|NCT01987960|455770580|FG002|Period 3|Administrative or other reason|0|||
126675960|NCT01987960|455770581|FG003|Period 3|Administrative or other reason|43|||
126675961|NCT01357655|455770588|FG000|Overall Study|Administrative Reason by Sponsor|45|||
126675962|NCT01357655|455770589|FG001|Overall Study|Administrative Reason by Sponsor|0|||
126675963|NCT01357655|455770588|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
126675964|NCT01357655|455770589|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126675965|NCT01357655|455770588|FG000|Overall Study|Disease Progression|1|||
126675966|NCT01357655|455770589|FG001|Overall Study|Disease Progression|0|||
126675967|NCT01357655|455770588|FG000|Overall Study|Lost to Follow-up|2|||
126675968|NCT01357655|455770589|FG001|Overall Study|Lost to Follow-up|0|||
126675969|NCT01357655|455770588|FG000|Overall Study|Maximum Clinical Benefit|2|||
126675970|NCT01357655|455770589|FG001|Overall Study|Maximum Clinical Benefit|0|||
126675971|NCT01357655|455770588|FG000|Overall Study|Reason Unspecified|1|||
126675972|NCT01357655|455770589|FG001|Overall Study|Reason Unspecified|0|||
126675973|NCT01357655|455770588|FG000|Overall Study|Study Drug Toxicity|11|||
126675974|NCT01357655|455770589|FG001|Overall Study|Study Drug Toxicity|0|||
126675975|NCT01357655|455770588|FG000|Overall Study|Subject Withdrew Consent|1|||
126675976|NCT01357655|455770589|FG001|Overall Study|Subject Withdrew Consent|0|||
126675977|NCT04722042|455770590|FG000|Overall Study|Withdrawal by Subject|2|||
126675978|NCT04722042|455770591|FG001|Overall Study|Withdrawal by Subject|1|||
126675979|NCT04722042|455770592|FG002|Overall Study|Withdrawal by Subject|0|||
126675980|NCT02321930|455770595|FG000|Overall Study|Lost to Follow-up|1|||
126675981|NCT01293968|455770596|FG000|Overall Study|non-cooperation|3|||
126675982|NCT01293968|455770597|FG001|Overall Study|non-cooperation|3|||
126675983|NCT00853749|455770598|FG000|Overall Study|Lost to Follow-up|0|||
126675984|NCT00853749|455770599|FG001|Overall Study|Lost to Follow-up|1|||
126675985|NCT02269787|455770602|FG000|Overall Study|Lost to Follow-up|20|||
126675986|NCT02269787|455770603|FG001|Overall Study|Lost to Follow-up|6|||
126675987|NCT02269787|455770602|FG000|Overall Study|Death|2|||
126675988|NCT02269787|455770603|FG001|Overall Study|Death|3|||
126675989|NCT02269787|455770602|FG000|Overall Study|Incapacitated|0|||
126675990|NCT02269787|455770603|FG001|Overall Study|Incapacitated|1|||
126675991|NCT00687440|455770604|FG000|Overall Study|Adverse Event|3|||
126675992|NCT00687440|455770604|FG000|Overall Study|Lost to Follow-up|3|||
126675993|NCT00687440|455770604|FG000|Overall Study|Lack of Efficacy|2|||
126675994|NCT00687440|455770604|FG000|Overall Study|Death|2|||
126675995|NCT00687440|455770604|FG000|Overall Study|Other|1|||
126675996|NCT00687440|455770604|FG000|Overall Study|Missing|1|||
126675997|NCT02228720|455770605|FG000|Open Label - Day 30|Lost to Follow-up|1|||
126675998|NCT01392677|455770610|FG000|Overall Study|Adverse Event|3|||
126675999|NCT01392677|455770611|FG001|Overall Study|Adverse Event|1|||
126676000|NCT01392677|455770610|FG000|Overall Study|Withdrawal by Subject|0|||
126676001|NCT01392677|455770611|FG001|Overall Study|Withdrawal by Subject|2|||
126676002|NCT01392677|455770610|FG000|Overall Study|Incorrect enrollment|2|||
126676003|NCT01392677|455770611|FG001|Overall Study|Incorrect enrollment|3|||
126676004|NCT01392677|455770610|FG000|Overall Study|Other reason|3|||
126676005|NCT01392677|455770611|FG001|Overall Study|Other reason|2|||
126676006|NCT03996876|455770612|FG000|Overall Study|Incomplete Data|2|||
126676007|NCT03996876|455770613|FG001|Overall Study|Incomplete Data|4|||
126676008|NCT05264740|455770618|FG000|Baseline|Withdrawal by Subject|0|||
126676009|NCT05264740|455770619|FG001|Baseline|Withdrawal by Subject|1|||
126676010|NCT05264740|455770618|FG000|Follow Up 1|Lost to Follow-up|1|||
126676011|NCT05264740|455770619|FG001|Follow Up 1|Lost to Follow-up|1|||
126676012|NCT05264740|455770618|FG000|Follow Up 1|Withdrawal by Subject|0|||
126676013|NCT05264740|455770619|FG001|Follow Up 1|Withdrawal by Subject|1|||
126676014|NCT05264740|455770618|FG000|Follow Up 2|Lost to Follow-up|1|||
126676015|NCT05264740|455770619|FG001|Follow Up 2|Lost to Follow-up|4|||
126676016|NCT05264740|455770618|FG000|Follow Up 3|Lost to Follow-up|7|||
126676017|NCT05264740|455770619|FG001|Follow Up 3|Lost to Follow-up|4|||
126676018|NCT01538628|455770620|FG000|Overall Study|Withdrawal by Subject|1|||
126676019|NCT01538628|455770621|FG001|Overall Study|Withdrawal by Subject|1|||
126676020|NCT01538628|455770620|FG000|Overall Study|Lost to Follow-up|0|||
126676021|NCT01538628|455770621|FG001|Overall Study|Lost to Follow-up|1|||
126676022|NCT03080883|455770622|FG000|Overall Study|Withdrawal by Subject|11|||
126676023|NCT03080883|455770623|FG001|Overall Study|Withdrawal by Subject|15|||
126676024|NCT03080883|455770622|FG000|Overall Study|Adverse Event|22|||
126676025|NCT03080883|455770623|FG001|Overall Study|Adverse Event|22|||
126676026|NCT03080883|455770622|FG000|Overall Study|Alternative Therapy|0|||
126676027|NCT03080883|455770623|FG001|Overall Study|Alternative Therapy|3|||
126676028|NCT03080883|455770622|FG000|Overall Study|Other Complicating Disease|9|||
126676029|NCT03080883|455770623|FG001|Overall Study|Other Complicating Disease|5|||
126676030|NCT03080883|455770622|FG000|Overall Study|Death|21|||
126676031|NCT03080883|455770623|FG001|Overall Study|Death|16|||
126676032|NCT03080883|455770622|FG000|Overall Study|Physician Decision|2|||
126676033|NCT03080883|455770623|FG001|Overall Study|Physician Decision|2|||
126676034|NCT03080883|455770622|FG000|Overall Study|Disease Progression|2|||
126676035|NCT03080883|455770623|FG001|Overall Study|Disease Progression|8|||
126676036|NCT03080883|455770622|FG000|Overall Study|Lost to Follow-up|1|||
126676037|NCT03080883|455770623|FG001|Overall Study|Lost to Follow-up|1|||
126676038|NCT04360551|455771878|FG000|Overall Study|Withdrawal by Subject|1|||
126342241|NCT01884597|454548835|FG000|Overall Study|Adverse Event|0|||
126342242|NCT01884597|454548836|FG001|Overall Study|Adverse Event|0|||
126342243|NCT01884597|454548837|FG002|Overall Study|Adverse Event|1|||
126342244|NCT01884597|454548835|FG000|Overall Study|Lack of Efficacy|1|||
126342245|NCT01884597|454548836|FG001|Overall Study|Lack of Efficacy|0|||
126342246|NCT01884597|454548837|FG002|Overall Study|Lack of Efficacy|0|||
126342247|NCT01884597|454548835|FG000|Overall Study|Death|0|||
126342248|NCT01884597|454548836|FG001|Overall Study|Death|1|||
126676039|NCT04360551|455771879|FG001|Overall Study|Withdrawal by Subject|0|||
126676040|NCT00388973|455771884|FG000|Overall Study|Adverse Event|16|||
126676041|NCT00388973|455771885|FG001|Overall Study|Adverse Event|6|||
126676042|NCT00388973|455771884|FG000|Overall Study|Lack of Efficacy|1|||
126676043|NCT00388973|455771885|FG001|Overall Study|Lack of Efficacy|12|||
126342249|NCT01884597|454548837|FG002|Overall Study|Death|0|||
126342250|NCT02097823|454548838|FG000|Overall Study|Withdrawal by Subject|1|||
126342251|NCT02097823|454548839|FG001|Overall Study|Withdrawal by Subject|1|||
126676044|NCT00388973|455771884|FG000|Overall Study|Protocol Violation|3|||
126676045|NCT00388973|455771885|FG001|Overall Study|Protocol Violation|0|||
126676046|NCT00388973|455771884|FG000|Overall Study|Withdrawal by Subject|14|||
126342252|NCT03082729|454548840|FG000|Overall Study|Lost to Follow-up|7|||
126676047|NCT00388973|455771885|FG001|Overall Study|Withdrawal by Subject|17|||
126676048|NCT00388973|455771884|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
126676049|NCT00388973|455771885|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
126427660|NCT06039579|454862258|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427661|NCT06039579|454862259|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427662|NCT06039579|454862260|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427663|NCT06039579|454862261|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427664|NCT06039579|454862262|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427665|NCT06039579|454862263|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427666|NCT06039579|454862264|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
126427667|NCT06039579|454862265|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
126427672|NCT02356159|454862273|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
126427673|NCT02356159|454862274|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
126427674|NCT02356159|454862275|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
126427675|NCT02356159|454862276|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
126427676|NCT02356159|454862277|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
126427677|NCT02356159|454862278|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
126427678|NCT00861705|454862279|FG000|Overall Study|Never Began Treatment|7|||
126676050|NCT00388973|455771884|FG000|Overall Study|Did not complete 61 days of treatment|5|||
126676051|NCT00388973|455771885|FG001|Overall Study|Did not complete 61 days of treatment|4|||
126676052|NCT00388973|455771884|FG000|Overall Study|Left region|0|||
126676053|NCT00388973|455771885|FG001|Overall Study|Left region|1|||
126342253|NCT03082729|454548840|FG000|Overall Study|Physician Decision|2|||
126342254|NCT03082729|454548840|FG000|Overall Study|Withdrawal by Subject|1|||
126342255|NCT03082729|454548840|FG000|Overall Study|Lack of Efficacy|9|||
126342256|NCT03082729|454548840|FG000|Overall Study|Adverse Event|4|||
126342257|NCT03082729|454548840|FG000|Overall Study|Protocol Violation|6|||
126342258|NCT03082729|454548840|FG000|Overall Study|Fear of study procedure|1|||
126342259|NCT03082729|454548840|FG000|Overall Study|Scheduling conflict|1|||
126342260|NCT02934178|454550431|FG000|Received Vaccination 2|Death|0|||
126342261|NCT02934178|454550432|FG001|Received Vaccination 2|Death|1|||
126342262|NCT02934178|454550431|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
126342263|NCT02934178|454550432|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
126342264|NCT01898078|454550435|FG000|Overall Study|Progressive Disease|1|||
126342265|NCT01898078|454550436|FG001|Overall Study|Progressive Disease|5|||
126342266|NCT01898078|454550435|FG000|Overall Study|Adverse Event|2|||
126342267|NCT01898078|454550436|FG001|Overall Study|Adverse Event|1|||
126342268|NCT01898078|454550435|FG000|Overall Study|Withdrawal by Subject|1|||
126342269|NCT01898078|454550436|FG001|Overall Study|Withdrawal by Subject|1|||
126342270|NCT01898078|454550435|FG000|Overall Study|Symptomatic Deterioration|2|||
126342271|NCT01898078|454550436|FG001|Overall Study|Symptomatic Deterioration|0|||
126342272|NCT01898078|454550435|FG000|Overall Study|Reason not Specified|0|||
126342273|NCT01898078|454550436|FG001|Overall Study|Reason not Specified|1|||
126342274|NCT01140906|454550438|FG000|Overall Study|Adverse Event|7|||
126342275|NCT01140906|454550439|FG001|Overall Study|Adverse Event|10|||
126342276|NCT01140906|454550440|FG002|Overall Study|Adverse Event|17|||
126342277|NCT01140906|454550441|FG003|Overall Study|Adverse Event|7|||
126342278|NCT01140906|454550438|FG000|Overall Study|Lack of Efficacy|6|||
126342279|NCT01140906|454550439|FG001|Overall Study|Lack of Efficacy|8|||
126342280|NCT01140906|454550440|FG002|Overall Study|Lack of Efficacy|2|||
126342281|NCT01140906|454550441|FG003|Overall Study|Lack of Efficacy|1|||
126342282|NCT01140906|454550438|FG000|Overall Study|Non-compliance|0|||
126342283|NCT01140906|454550439|FG001|Overall Study|Non-compliance|1|||
126342284|NCT01140906|454550440|FG002|Overall Study|Non-compliance|0|||
126342285|NCT01140906|454550441|FG003|Overall Study|Non-compliance|1|||
126342286|NCT01140906|454550438|FG000|Overall Study|Protocol Violation|5|||
126342287|NCT01140906|454550439|FG001|Overall Study|Protocol Violation|3|||
126342288|NCT01140906|454550440|FG002|Overall Study|Protocol Violation|2|||
126342289|NCT01140906|454550441|FG003|Overall Study|Protocol Violation|1|||
126342290|NCT01140906|454550438|FG000|Overall Study|Withdrawal of consent|6|||
126342291|NCT01140906|454550439|FG001|Overall Study|Withdrawal of consent|6|||
126342292|NCT01140906|454550440|FG002|Overall Study|Withdrawal of consent|2|||
126342293|NCT01140906|454550441|FG003|Overall Study|Withdrawal of consent|2|||
126342294|NCT01140906|454550438|FG000|Overall Study|Lost to Follow-up|1|||
126342295|NCT01140906|454550439|FG001|Overall Study|Lost to Follow-up|1|||
126342296|NCT01140906|454550440|FG002|Overall Study|Lost to Follow-up|0|||
126676054|NCT00388973|455771884|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
126676055|NCT00388973|455771885|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
126676056|NCT04179734|455771900|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
126676057|NCT04179734|455771901|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
126715142|NCT01161524|455908694|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
126342297|NCT01140906|454550441|FG003|Overall Study|Lost to Follow-up|2|||
126342298|NCT01140906|454550438|FG000|Overall Study|Administrative or other reason|0|||
126342299|NCT01140906|454550439|FG001|Overall Study|Administrative or other reason|5|||
126342300|NCT01140906|454550440|FG002|Overall Study|Administrative or other reason|3|||
126342301|NCT01140906|454550441|FG003|Overall Study|Administrative or other reason|2|||
126342302|NCT00703534|454550442|FG000|Overall Study|Adverse Event|14|||
126342303|NCT00703534|454550443|FG001|Overall Study|Adverse Event|3|||
126342304|NCT00703534|454550442|FG000|Overall Study|Withdrawal by Subject|8|||
126342305|NCT00703534|454550443|FG001|Overall Study|Withdrawal by Subject|7|||
126342306|NCT00703534|454550442|FG000|Overall Study|Incorrect Enrollment|6|||
126342307|NCT00703534|454550443|FG001|Overall Study|Incorrect Enrollment|6|||
126342308|NCT00703534|454550442|FG000|Overall Study|Lost to Follow-up|1|||
126342309|NCT00703534|454550443|FG001|Overall Study|Lost to Follow-up|4|||
126342310|NCT00703534|454550442|FG000|Overall Study|Severe Non Compliance|1|||
126342311|NCT00703534|454550443|FG001|Overall Study|Severe Non Compliance|5|||
126342312|NCT02791269|454550444|FG000|Overall Study|Lost to Follow-up|0|||
126342313|NCT02791269|454550445|FG001|Overall Study|Lost to Follow-up|1|||
126342314|NCT01648764|454550446|FG000|Overall Study|Progressive Disease|0|||
126342315|NCT01648764|454550447|FG001|Overall Study|Progressive Disease|1|||
126342316|NCT01648764|454550448|FG002|Overall Study|Progressive Disease|0|||
126342317|NCT01648764|454550449|FG003|Overall Study|Progressive Disease|0|||
126342318|NCT01648764|454550450|FG004|Overall Study|Progressive Disease|0|||
126342319|NCT01648764|454550451|FG005|Overall Study|Progressive Disease|1|||
126342320|NCT01648764|454550452|FG006|Overall Study|Progressive Disease|1|||
126342321|NCT01648764|454550453|FG007|Overall Study|Progressive Disease|0|||
126342322|NCT01648764|454550454|FG008|Overall Study|Progressive Disease|0|||
126342323|NCT01648764|454550455|FG009|Overall Study|Progressive Disease|2|||
126342324|NCT01648764|454550456|FG010|Overall Study|Progressive Disease|0|||
126342325|NCT01648764|454550457|FG011|Overall Study|Progressive Disease|1|||
126342326|NCT01648764|454550458|FG012|Overall Study|Progressive Disease|2|||
126342327|NCT01648764|454550459|FG013|Overall Study|Progressive Disease|1|||
126342328|NCT01648764|454550446|FG000|Overall Study|Adverse Event|0|||
126342329|NCT01648764|454550447|FG001|Overall Study|Adverse Event|0|||
126342330|NCT01648764|454550448|FG002|Overall Study|Adverse Event|0|||
126342331|NCT01648764|454550449|FG003|Overall Study|Adverse Event|0|||
126342332|NCT01648764|454550450|FG004|Overall Study|Adverse Event|0|||
126342333|NCT01648764|454550451|FG005|Overall Study|Adverse Event|1|||
126342334|NCT01648764|454550452|FG006|Overall Study|Adverse Event|0|||
126342335|NCT01648764|454550453|FG007|Overall Study|Adverse Event|0|||
126342336|NCT01648764|454550454|FG008|Overall Study|Adverse Event|0|||
126342337|NCT01648764|454550455|FG009|Overall Study|Adverse Event|1|||
126342338|NCT01648764|454550456|FG010|Overall Study|Adverse Event|0|||
126342339|NCT01648764|454550457|FG011|Overall Study|Adverse Event|3|||
126342340|NCT01648764|454550458|FG012|Overall Study|Adverse Event|1|||
126342341|NCT01648764|454550459|FG013|Overall Study|Adverse Event|1|||
126342342|NCT01648764|454550446|FG000|Overall Study|Death|0|||
126342343|NCT01648764|454550447|FG001|Overall Study|Death|0|||
126342344|NCT01648764|454550448|FG002|Overall Study|Death|0|||
126342345|NCT01648764|454550449|FG003|Overall Study|Death|0|||
126342346|NCT01648764|454550450|FG004|Overall Study|Death|0|||
126342347|NCT01648764|454550451|FG005|Overall Study|Death|0|||
126342348|NCT01648764|454550452|FG006|Overall Study|Death|1|||
126342349|NCT01648764|454550453|FG007|Overall Study|Death|0|||
126342350|NCT01648764|454550454|FG008|Overall Study|Death|0|||
126342351|NCT01648764|454550455|FG009|Overall Study|Death|0|||
126342352|NCT01648764|454550456|FG010|Overall Study|Death|0|||
126342353|NCT01648764|454550457|FG011|Overall Study|Death|0|||
126342354|NCT01648764|454550458|FG012|Overall Study|Death|0|||
126342355|NCT01648764|454550459|FG013|Overall Study|Death|1|||
126342356|NCT01648764|454550446|FG000|Overall Study|Withdrawal by Subject|0|||
126342357|NCT01648764|454550447|FG001|Overall Study|Withdrawal by Subject|0|||
126342358|NCT01648764|454550448|FG002|Overall Study|Withdrawal by Subject|0|||
126342359|NCT01648764|454550449|FG003|Overall Study|Withdrawal by Subject|0|||
126342360|NCT01648764|454550450|FG004|Overall Study|Withdrawal by Subject|0|||
126342361|NCT01648764|454550451|FG005|Overall Study|Withdrawal by Subject|0|||
126342362|NCT01648764|454550452|FG006|Overall Study|Withdrawal by Subject|2|||
126342363|NCT01648764|454550453|FG007|Overall Study|Withdrawal by Subject|0|||
126342364|NCT01648764|454550454|FG008|Overall Study|Withdrawal by Subject|0|||
126342365|NCT01648764|454550455|FG009|Overall Study|Withdrawal by Subject|0|||
126342366|NCT01648764|454550456|FG010|Overall Study|Withdrawal by Subject|0|||
126342367|NCT01648764|454550457|FG011|Overall Study|Withdrawal by Subject|0|||
126342368|NCT01648764|454550458|FG012|Overall Study|Withdrawal by Subject|1|||
126342369|NCT01648764|454550459|FG013|Overall Study|Withdrawal by Subject|0|||
126342370|NCT01648764|454550446|FG000|Overall Study|Investigator Decision|0|||
126342371|NCT01648764|454550447|FG001|Overall Study|Investigator Decision|0|||
126676058|NCT04179734|455771900|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
126676059|NCT04179734|455771901|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
126676060|NCT01761292|455771903|FG000|Part 1|Adverse Event|1|||
126676061|NCT01761292|455771903|FG000|Part 1|not receiving treatment in Part 1|1|||
126676062|NCT01761292|455771903|FG000|Extension 1|Withdrawal by Subject|1|||
126676063|NCT02535715|455771904|FG000|Overall Study|Withdrawal by Subject|0|||
126676064|NCT02535715|455771905|FG001|Overall Study|Withdrawal by Subject|0|||
126676065|NCT02535715|455771906|FG002|Overall Study|Withdrawal by Subject|1|||
126676066|NCT00909181|455771907|FG000|Overall Study|Lost to Follow-up|39|||
126676067|NCT00909181|455771908|FG001|Overall Study|Lost to Follow-up|18|||
126676068|NCT00909181|455771909|FG002|Overall Study|Lost to Follow-up|33|||
126676069|NCT00914927|455771911|FG000|Overall Study|Adverse Event|0|||
126676070|NCT00914927|455771912|FG001|Overall Study|Adverse Event|0|||
126676071|NCT00914927|455771913|FG002|Overall Study|Adverse Event|0|||
126676072|NCT00914927|455771914|FG003|Overall Study|Adverse Event|0|||
126676073|NCT00914927|455771915|FG004|Overall Study|Adverse Event|1|||
126676074|NCT00914927|455771916|FG005|Overall Study|Adverse Event|0|||
126676075|NCT00914927|455771917|FG006|Overall Study|Adverse Event|0|||
126676076|NCT00914927|455771911|FG000|Overall Study|Withdrawal by Subject|0|||
126676077|NCT00914927|455771912|FG001|Overall Study|Withdrawal by Subject|1|||
126676078|NCT00914927|455771913|FG002|Overall Study|Withdrawal by Subject|0|||
126676079|NCT00914927|455771914|FG003|Overall Study|Withdrawal by Subject|1|||
126676080|NCT00914927|455771915|FG004|Overall Study|Withdrawal by Subject|0|||
126676081|NCT00914927|455771916|FG005|Overall Study|Withdrawal by Subject|0|||
126676082|NCT00914927|455771917|FG006|Overall Study|Withdrawal by Subject|0|||
126676083|NCT00914927|455771911|FG000|Overall Study|Lost to Follow-up|0|||
126676084|NCT00914927|455771912|FG001|Overall Study|Lost to Follow-up|0|||
126676085|NCT00914927|455771913|FG002|Overall Study|Lost to Follow-up|0|||
126676086|NCT00914927|455771914|FG003|Overall Study|Lost to Follow-up|1|||
126676087|NCT00914927|455771915|FG004|Overall Study|Lost to Follow-up|0|||
126342372|NCT01648764|454550448|FG002|Overall Study|Investigator Decision|0|||
126342373|NCT01648764|454550449|FG003|Overall Study|Investigator Decision|0|||
126342374|NCT01648764|454550450|FG004|Overall Study|Investigator Decision|0|||
126342375|NCT01648764|454550451|FG005|Overall Study|Investigator Decision|0|||
126342376|NCT01648764|454550452|FG006|Overall Study|Investigator Decision|1|||
126342377|NCT01648764|454550453|FG007|Overall Study|Investigator Decision|0|||
126342378|NCT01648764|454550454|FG008|Overall Study|Investigator Decision|0|||
126342379|NCT01648764|454550455|FG009|Overall Study|Investigator Decision|0|||
126342380|NCT01648764|454550456|FG010|Overall Study|Investigator Decision|0|||
126342381|NCT01648764|454550457|FG011|Overall Study|Investigator Decision|1|||
126342382|NCT01648764|454550458|FG012|Overall Study|Investigator Decision|0|||
126342383|NCT01648764|454550459|FG013|Overall Study|Investigator Decision|0|||
126342384|NCT00715208|454550460|FG000|Overall Study|Withdrawal by Subject|1|||
126342385|NCT00715208|454550461|FG001|Overall Study|Withdrawal by Subject|1|||
126342386|NCT00715208|454550460|FG000|Overall Study|Adverse Event|0|||
126342387|NCT00715208|454550461|FG001|Overall Study|Adverse Event|6|||
126342388|NCT00715208|454550460|FG000|Overall Study|Lack of Efficacy|0|||
126342389|NCT00715208|454550461|FG001|Overall Study|Lack of Efficacy|2|||
126342390|NCT04889040|454550462|FG000|Overall Study|Withdrawal by Subject|3|||
126342391|NCT04889040|454550463|FG001|Overall Study|Withdrawal by Subject|3|||
126342392|NCT04889040|454550462|FG000|Overall Study|Lost to Follow-up|0|||
126342393|NCT04889040|454550463|FG001|Overall Study|Lost to Follow-up|1|||
126342394|NCT04889040|454550462|FG000|Overall Study|Adverse Event|2|||
126342395|NCT04889040|454550463|FG001|Overall Study|Adverse Event|1|||
126342396|NCT02058095|454550464|FG000|Overall Study|Adverse Event|1|||
126342397|NCT02058095|454550465|FG001|Overall Study|Adverse Event|0|||
126342398|NCT00316004|454550468|FG000|Overall Study|Subject was not given study fluid.|14|||
126342399|NCT00316004|454550469|FG001|Overall Study|Subject was not given study fluid.|14|||
126342400|NCT00316004|454550470|FG002|Overall Study|Subject was not given study fluid.|21|||
126342401|NCT00977197|454550473|FG000|Overall Study|Withdrawal by Subject|3|||
126342402|NCT00977197|454550474|FG001|Overall Study|Withdrawal by Subject|4|||
126342403|NCT00977197|454550473|FG000|Overall Study|Adverse Event|3|||
126342404|NCT00977197|454550474|FG001|Overall Study|Adverse Event|1|||
126342405|NCT00977197|454550473|FG000|Overall Study|Lack of Efficacy|1|||
126342406|NCT00977197|454550474|FG001|Overall Study|Lack of Efficacy|0|||
126342407|NCT00977197|454550473|FG000|Overall Study|Lost to Follow-up|1|||
126342408|NCT00977197|454550474|FG001|Overall Study|Lost to Follow-up|3|||
126342409|NCT00977197|454550473|FG000|Overall Study|Nonadherence|1|||
126342410|NCT00977197|454550474|FG001|Overall Study|Nonadherence|1|||
126342411|NCT00784875|454550475|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
126342412|NCT00784875|454550476|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
126342413|NCT00784875|454550477|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
126427679|NCT00861705|454862280|FG001|Overall Study|Never Began Treatment|3|||
126676088|NCT00914927|455771916|FG005|Overall Study|Lost to Follow-up|0|||
126676089|NCT00914927|455771917|FG006|Overall Study|Lost to Follow-up|0|||
126676090|NCT00914927|455771911|FG000|Overall Study|Administrative/Other|2|||
126676091|NCT00914927|455771912|FG001|Overall Study|Administrative/Other|1|||
126427680|NCT00861705|454862281|FG002|Overall Study|Never Began Treatment|0|||
126427681|NCT00861705|454862282|FG003|Overall Study|Never Began Treatment|1|||
126427682|NCT06418152|454862284|FG000|Overall Study|Frequent DBS setting changes|1|||
126427683|NCT06418152|454862284|FG000|Overall Study|Withdrawal by Subject|2|||
126427698|NCT03360682|454862294|FG000|Overall Study|Adverse Event|3|||
126676092|NCT00914927|455771913|FG002|Overall Study|Administrative/Other|0|||
126676093|NCT00914927|455771914|FG003|Overall Study|Administrative/Other|0|||
126676094|NCT00914927|455771915|FG004|Overall Study|Administrative/Other|1|||
126676095|NCT00914927|455771916|FG005|Overall Study|Administrative/Other|0|||
126676096|NCT00914927|455771917|FG006|Overall Study|Administrative/Other|0|||
126676097|NCT04773106|455771918|FG000|Overall Study|Withdrawal by Subject|3|||
126676098|NCT04773106|455771918|FG000|Overall Study|Death|1|||
126676099|NCT01349465|455771919|FG000|Overall Study|Adverse Event|1|||
126676100|NCT01349465|455771920|FG001|Overall Study|Adverse Event|0|||
126676101|NCT01349465|455771919|FG000|Overall Study|Death|3|||
126676102|NCT01349465|455771920|FG001|Overall Study|Death|0|||
126676103|NCT01349465|455771919|FG000|Overall Study|Lost to Follow-up|10|||
126676104|NCT01349465|455771920|FG001|Overall Study|Lost to Follow-up|1|||
126676105|NCT01349465|455771919|FG000|Overall Study|Withdrawal by Subject|4|||
126676106|NCT01349465|455771920|FG001|Overall Study|Withdrawal by Subject|2|||
126676107|NCT01349465|455771919|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
126676108|NCT01349465|455771920|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
126676109|NCT03370120|455771923|FG000|Overall Study|Adverse event, non-fatal|24|||
126676110|NCT03370120|455771923|FG000|Overall Study|Withdrawal by Subject|6|||
126676111|NCT03370120|455771923|FG000|Overall Study|Lost to Follow-up|1|||
126676112|NCT03370120|455771923|FG000|Overall Study|Lack of Efficacy|37|||
126676113|NCT03370120|455771923|FG000|Overall Study|Per sponsor's instructions|1|||
126676114|NCT03370120|455771923|FG000|Overall Study|Study was terminated by parent company UCB|2|||
126676115|NCT03370120|455771923|FG000|Overall Study|The study was ended by the promoter|3|||
126676116|NCT03370120|455771923|FG000|Overall Study|Discontinuation of drug development|3|||
126676117|NCT03370120|455771923|FG000|Overall Study|End of project|2|||
126676118|NCT03370120|455771923|FG000|Overall Study|Premature study closure|2|||
126676119|NCT03370120|455771923|FG000|Overall Study|Premature program termination|1|||
126676120|NCT03370120|455771923|FG000|Overall Study|Premature study termination|7|||
126676121|NCT03370120|455771923|FG000|Overall Study|Trial terminated by sponsor|2|||
126676122|NCT03370120|455771923|FG000|Overall Study|Trial discontinued by sponsor|2|||
126676123|NCT03370120|455771923|FG000|Overall Study|Study ended|15|||
126676124|NCT03370120|455771923|FG000|Overall Study|Clinical trial has been cancelled|1|||
126676125|NCT03370120|455771923|FG000|Overall Study|End of study per sponsor decision|2|||
126676126|NCT03370120|455771923|FG000|Overall Study|Promoter's decision|2|||
126676127|NCT03370120|455771923|FG000|Overall Study|The trial has been suspended|3|||
126676128|NCT03370120|455771923|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
126676129|NCT03370120|455771923|FG000|Overall Study|Early termination by order of sponsor|2|||
126676130|NCT03370120|455771923|FG000|Overall Study|Discontinuation of the study|5|||
126676131|NCT03370120|455771923|FG000|Overall Study|End of clinical trial discontinuation|1|||
126676132|NCT03370120|455771923|FG000|Overall Study|Because the clinical trial ended halfway|4|||
126676133|NCT03370120|455771923|FG000|Overall Study|Development discontinued|5|||
126676134|NCT03370120|455771923|FG000|Overall Study|Padsenovil program closed|3|||
126676135|NCT03370120|455771923|FG000|Overall Study|End of project|2|||
126676136|NCT03370120|455771923|FG000|Overall Study|Termination of project|1|||
126676137|NCT03370120|455771923|FG000|Overall Study|The study was interrupted by sponsor|4|||
126676138|NCT03370120|455771923|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
126676139|NCT03370120|455771923|FG000|Overall Study|End of sponsor decision|1|||
126676140|NCT03370120|455771923|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
126676141|NCT03370120|455771923|FG000|Overall Study|Early termination of studies|5|||
126676142|NCT03370120|455771923|FG000|Overall Study|This study is ended early|1|||
126676143|NCT03370120|455771923|FG000|Overall Study|End of padsevonil program|2|||
126676144|NCT03370120|455771923|FG000|Overall Study|Decision of sponsor|6|||
126676145|NCT03370120|455771923|FG000|Overall Study|Asked by the sponsor|3|||
126676146|NCT03370120|455771923|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
126676147|NCT03370120|455771923|FG000|Overall Study|PI decision poor compliance from participant|1|||
126676148|NCT03370120|455771923|FG000|Overall Study|Promoter ended the study|3|||
126676149|NCT03370120|455771923|FG000|Overall Study|Premature study close by sponsor's decision|4|||
126676150|NCT03370120|455771923|FG000|Overall Study|Study terminated by sponsor|33|||
126676151|NCT03370120|455771923|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
126676152|NCT03370120|455771923|FG000|Overall Study|Sponsor decision to terminate study|63|||
126676153|NCT03370120|455771923|FG000|Overall Study|Program closure|3|||
126676154|NCT03370120|455771923|FG000|Overall Study|Study ended prematurely|1|||
126676155|NCT03370120|455771923|FG000|Overall Study|Study stopped by sponsor|2|||
126676156|NCT03370120|455771923|FG000|Overall Study|Program termination|55|||
126676157|NCT03370120|455771923|FG000|Overall Study|Sponsor decision|62|||
126676158|NCT03370120|455771923|FG000|Overall Study|Sponsor study closure|10|||
126676159|NCT02700412|455771925|FG000|Overall Study|Adverse Event|6|||
126676160|NCT02700412|455771925|FG000|Overall Study|Death|1|||
126676161|NCT02700412|455771925|FG000|Overall Study|Lack of Efficacy|19|||
126676162|NCT02700412|455771925|FG000|Overall Study|Protocol Violation|5|||
126676163|NCT02700412|455771925|FG000|Overall Study|Withdrawal by Subject|2|||
126676164|NCT00632099|455771926|FG000|Overall Study|Lost to Follow-up|3|||
126676165|NCT00632099|455771927|FG001|Overall Study|Lost to Follow-up|3|||
126676166|NCT03374189|455771928|FG000|Overall Study|Lost to Follow-up|1|||
126676167|NCT03374189|455771929|FG001|Overall Study|Lost to Follow-up|0|||
126676168|NCT01543828|455771931|FG000|Treatment 2|Lost to Follow-up|1|||
126676169|NCT01543828|455771932|FG001|Treatment 2|Lost to Follow-up|0|||
126676170|NCT03975920|455771933|FG000|Overall Study|Lost to Follow-up|1|||
126676171|NCT03975920|455771934|FG001|Overall Study|Lost to Follow-up|2|||
126676172|NCT03975920|455771933|FG000|Overall Study|Protocol Violation|1|||
126676173|NCT03975920|455771934|FG001|Overall Study|Protocol Violation|1|||
126676174|NCT03975920|455771933|FG000|Overall Study|Did not complete survey|2|||
126676175|NCT03975920|455771934|FG001|Overall Study|Did not complete survey|1|||
126676176|NCT00884273|455771937|FG000|Overall Study|Adverse Event|0|||
126676177|NCT00884273|455771938|FG001|Overall Study|Adverse Event|2|||
126676178|NCT00884273|455771937|FG000|Overall Study|Protocol Violation|1|||
126676179|NCT00884273|455771938|FG001|Overall Study|Protocol Violation|3|||
126676180|NCT00884273|455771937|FG000|Overall Study|Practical reasons|1|||
126676181|NCT00884273|455771938|FG001|Overall Study|Practical reasons|0|||
126676182|NCT03710486|455771944|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
126676183|NCT03710486|455771945|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
126676184|NCT03710486|455771944|FG000|Overall Study|Missing|0|||
126676185|NCT03710486|455771945|FG001|Overall Study|Missing|2|||
126427783|NCT05767021|454862315|FG000|Overall Study|Adverse Event|2|||
126427784|NCT05767021|454862315|FG000|Overall Study|Protocol Deviation|1|||
126427785|NCT05767021|454862315|FG000|Overall Study|Withdrawal by Subject|1|||
126427786|NCT05767021|454862315|FG000|Overall Study|Physician Decision|1|||
126427787|NCT05767021|454862315|FG000|Overall Study|Lack of Efficacy|11|||
126427788|NCT05767021|454862315|FG000|Overall Study|Assigned Treatment by Mistake|1|||
126676186|NCT01147744|455771950|FG000|Overall Study|Protocol Violation|1|||
126676187|NCT01147744|455771951|FG001|Overall Study|Protocol Violation|0|||
126676188|NCT01147744|455771952|FG002|Overall Study|Protocol Violation|1|||
126676189|NCT01147744|455771953|FG003|Overall Study|Protocol Violation|0|||
126676190|NCT01147744|455771954|FG004|Overall Study|Protocol Violation|1|||
126676191|NCT01147744|455771955|FG005|Overall Study|Protocol Violation|3|||
126676192|NCT01147744|455771956|FG006|Overall Study|Protocol Violation|1|||
126676193|NCT01147744|455771950|FG000|Overall Study|Physician Decision|0|||
126342414|NCT00784875|454550478|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
126342415|NCT00784875|454550475|FG000|Period A - Baseline|Adverse Event|0|||
126342416|NCT00784875|454550476|FG001|Period A - Baseline|Adverse Event|0|||
126342417|NCT00784875|454550477|FG002|Period A - Baseline|Adverse Event|0|||
126342418|NCT00784875|454550478|FG003|Period A - Baseline|Adverse Event|8|||
126342419|NCT00784875|454550475|FG000|Period A - Baseline|Protocol Violation|0|||
126342420|NCT00784875|454550476|FG001|Period A - Baseline|Protocol Violation|0|||
126342421|NCT00784875|454550477|FG002|Period A - Baseline|Protocol Violation|0|||
126342422|NCT00784875|454550478|FG003|Period A - Baseline|Protocol Violation|25|||
126342423|NCT00784875|454550475|FG000|Period A - Baseline|Withdrawal by Subject|0|||
126342424|NCT00784875|454550476|FG001|Period A - Baseline|Withdrawal by Subject|0|||
126342425|NCT00784875|454550477|FG002|Period A - Baseline|Withdrawal by Subject|0|||
126342426|NCT00784875|454550478|FG003|Period A - Baseline|Withdrawal by Subject|27|||
126342427|NCT00784875|454550475|FG000|Period A - Baseline|Physician Decision|0|||
126342428|NCT00784875|454550476|FG001|Period A - Baseline|Physician Decision|0|||
126342429|NCT00784875|454550477|FG002|Period A - Baseline|Physician Decision|0|||
126342430|NCT00784875|454550478|FG003|Period A - Baseline|Physician Decision|2|||
126342431|NCT00784875|454550475|FG000|Period A - Baseline|Sponsor Decision|0|||
126342432|NCT00784875|454550476|FG001|Period A - Baseline|Sponsor Decision|0|||
126342433|NCT00784875|454550477|FG002|Period A - Baseline|Sponsor Decision|0|||
126342434|NCT00784875|454550478|FG003|Period A - Baseline|Sponsor Decision|113|||
126342435|NCT00784875|454550475|FG000|Period A - Baseline|Lost to Follow-up|0|||
126342436|NCT00784875|454550476|FG001|Period A - Baseline|Lost to Follow-up|0|||
126342437|NCT00784875|454550477|FG002|Period A - Baseline|Lost to Follow-up|0|||
126342438|NCT00784875|454550478|FG003|Period A - Baseline|Lost to Follow-up|2|||
126342439|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
126342440|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
126342441|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
126342442|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
126342443|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
126342444|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
126342445|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
126342446|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
126342447|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
126342448|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
126342449|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
126342450|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
126342451|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
126342452|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
126342453|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
126342454|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
126342455|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
126342456|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
126342457|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
126342458|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
126342459|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
126342460|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
126342461|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
126342462|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
126342463|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
126342464|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
126342465|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
126342466|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
126342467|NCT00784875|454550475|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
126342468|NCT00784875|454550476|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
126342469|NCT00784875|454550477|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
126342470|NCT00784875|454550478|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
126342471|NCT00784875|454550475|FG000|Period C|Adverse Event|1|||
126342472|NCT00784875|454550476|FG001|Period C|Adverse Event|0|||
126342473|NCT00784875|454550477|FG002|Period C|Adverse Event|4|||
126342474|NCT00784875|454550478|FG003|Period C|Adverse Event|2|||
126342475|NCT00784875|454550475|FG000|Period C|Protocol Violation|0|||
126342476|NCT00784875|454550476|FG001|Period C|Protocol Violation|0|||
126342477|NCT00784875|454550477|FG002|Period C|Protocol Violation|1|||
126342478|NCT00784875|454550478|FG003|Period C|Protocol Violation|2|||
126342479|NCT00784875|454550475|FG000|Period C|Lack of Efficacy|0|||
126342480|NCT00784875|454550476|FG001|Period C|Lack of Efficacy|0|||
126342481|NCT00784875|454550477|FG002|Period C|Lack of Efficacy|1|||
126342482|NCT00784875|454550478|FG003|Period C|Lack of Efficacy|0|||
126342483|NCT00784875|454550475|FG000|Period C|Withdrawal by Subject|1|||
126342484|NCT00784875|454550476|FG001|Period C|Withdrawal by Subject|1|||
126342485|NCT00784875|454550477|FG002|Period C|Withdrawal by Subject|2|||
126342486|NCT00784875|454550478|FG003|Period C|Withdrawal by Subject|0|||
126676194|NCT01147744|455771951|FG001|Overall Study|Physician Decision|1|||
126676195|NCT01147744|455771952|FG002|Overall Study|Physician Decision|1|||
126676196|NCT01147744|455771953|FG003|Overall Study|Physician Decision|0|||
126676197|NCT01147744|455771954|FG004|Overall Study|Physician Decision|0|||
126676198|NCT01147744|455771955|FG005|Overall Study|Physician Decision|0|||
126676199|NCT01147744|455771956|FG006|Overall Study|Physician Decision|1|||
126676200|NCT01147744|455771950|FG000|Overall Study|Lack of Efficacy|11|||
126676201|NCT01147744|455771951|FG001|Overall Study|Lack of Efficacy|11|||
126676202|NCT01147744|455771952|FG002|Overall Study|Lack of Efficacy|9|||
126676203|NCT01147744|455771953|FG003|Overall Study|Lack of Efficacy|11|||
126676204|NCT01147744|455771954|FG004|Overall Study|Lack of Efficacy|13|||
126676205|NCT01147744|455771955|FG005|Overall Study|Lack of Efficacy|8|||
126676206|NCT01147744|455771956|FG006|Overall Study|Lack of Efficacy|7|||
126676207|NCT01147744|455771950|FG000|Overall Study|Adverse Event|1|||
126676208|NCT01147744|455771951|FG001|Overall Study|Adverse Event|2|||
126676209|NCT01147744|455771952|FG002|Overall Study|Adverse Event|3|||
126676210|NCT01147744|455771953|FG003|Overall Study|Adverse Event|0|||
126676211|NCT01147744|455771954|FG004|Overall Study|Adverse Event|2|||
126676212|NCT01147744|455771955|FG005|Overall Study|Adverse Event|1|||
126676213|NCT01147744|455771956|FG006|Overall Study|Adverse Event|2|||
126676214|NCT01147744|455771950|FG000|Overall Study|Withdrawal by Subject|8|||
126676215|NCT01147744|455771951|FG001|Overall Study|Withdrawal by Subject|4|||
126676216|NCT01147744|455771952|FG002|Overall Study|Withdrawal by Subject|2|||
126676217|NCT01147744|455771953|FG003|Overall Study|Withdrawal by Subject|2|||
126676218|NCT01147744|455771954|FG004|Overall Study|Withdrawal by Subject|2|||
126676219|NCT01147744|455771955|FG005|Overall Study|Withdrawal by Subject|5|||
126676220|NCT01147744|455771956|FG006|Overall Study|Withdrawal by Subject|2|||
126676221|NCT01147744|455771950|FG000|Overall Study|Lost to Follow-up|0|||
126676222|NCT01147744|455771951|FG001|Overall Study|Lost to Follow-up|1|||
126676223|NCT01147744|455771952|FG002|Overall Study|Lost to Follow-up|0|||
126676224|NCT01147744|455771953|FG003|Overall Study|Lost to Follow-up|0|||
126676225|NCT01147744|455771954|FG004|Overall Study|Lost to Follow-up|0|||
126676226|NCT01147744|455771955|FG005|Overall Study|Lost to Follow-up|0|||
126676227|NCT01147744|455771956|FG006|Overall Study|Lost to Follow-up|0|||
126342487|NCT00784875|454550475|FG000|Period C|Physician Decision|0|||
126342488|NCT00784875|454550476|FG001|Period C|Physician Decision|0|||
126342489|NCT00784875|454550477|FG002|Period C|Physician Decision|1|||
126342490|NCT00784875|454550478|FG003|Period C|Physician Decision|1|||
126758632|NCT02681094|456066667|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
126758633|NCT02681094|456066665|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
126758634|NCT02681094|456066666|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
126342491|NCT00784875|454550475|FG000|Period C|Sponsor Decision|5|||
126342492|NCT00784875|454550476|FG001|Period C|Sponsor Decision|5|||
126342493|NCT00784875|454550477|FG002|Period C|Sponsor Decision|4|||
126342494|NCT00784875|454550478|FG003|Period C|Sponsor Decision|2|||
126342495|NCT00784875|454550475|FG000|Period D|Adverse Event|0|||
126342496|NCT00784875|454550476|FG001|Period D|Adverse Event|2|||
126342497|NCT00784875|454550477|FG002|Period D|Adverse Event|2|||
126342498|NCT00784875|454550478|FG003|Period D|Adverse Event|0|||
126676228|NCT01147744|455771950|FG000|Overall Study|Sponsor decision to amend protocol|7|||
126342499|NCT00784875|454550475|FG000|Period D|Protocol Violation|1|||
126342500|NCT00784875|454550476|FG001|Period D|Protocol Violation|0|||
126342501|NCT00784875|454550477|FG002|Period D|Protocol Violation|0|||
126342502|NCT00784875|454550478|FG003|Period D|Protocol Violation|0|||
126676229|NCT01147744|455771951|FG001|Overall Study|Sponsor decision to amend protocol|4|||
126676230|NCT01147744|455771952|FG002|Overall Study|Sponsor decision to amend protocol|2|||
126676231|NCT01147744|455771953|FG003|Overall Study|Sponsor decision to amend protocol|5|||
126676232|NCT01147744|455771954|FG004|Overall Study|Sponsor decision to amend protocol|7|||
126676233|NCT01147744|455771955|FG005|Overall Study|Sponsor decision to amend protocol|2|||
126676234|NCT01147744|455771956|FG006|Overall Study|Sponsor decision to amend protocol|6|||
126676235|NCT01147744|455771950|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126676236|NCT01147744|455771951|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126676237|NCT01147744|455771952|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126342503|NCT00784875|454550475|FG000|Period D|Withdrawal by Subject|2|||
126342504|NCT00784875|454550476|FG001|Period D|Withdrawal by Subject|0|||
126676238|NCT01147744|455771953|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126676239|NCT01147744|455771954|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126676240|NCT01147744|455771955|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126676241|NCT01147744|455771956|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126676242|NCT02536313|455771957|FG000|Overall Study|Lack of Efficacy|0|||
126676243|NCT02536313|455771958|FG001|Overall Study|Lack of Efficacy|1|||
126676244|NCT02437864|455771968|FG000|Overall Study|Protocol Violation|4|||
126676245|NCT02437864|455771969|FG001|Overall Study|Protocol Violation|0|||
126676246|NCT01892163|455771970|FG000|Overall Study|Death|1|||
126676247|NCT01892163|455771971|FG001|Overall Study|Death|1|||
126676248|NCT01892163|455771970|FG000|Overall Study|Lost to Follow-up|1|||
126676249|NCT01892163|455771971|FG001|Overall Study|Lost to Follow-up|0|||
126676250|NCT03302975|455771972|FG000|Overall Study|Lost to Follow-up|4|||
126342505|NCT00784875|454550477|FG002|Period D|Withdrawal by Subject|2|||
126342506|NCT00784875|454550478|FG003|Period D|Withdrawal by Subject|0|||
126342507|NCT00784875|454550475|FG000|Period D|Physician Decision|0|||
126342508|NCT00784875|454550476|FG001|Period D|Physician Decision|1|||
126342509|NCT00784875|454550477|FG002|Period D|Physician Decision|0|||
126342510|NCT00784875|454550478|FG003|Period D|Physician Decision|0|||
126342511|NCT00784875|454550475|FG000|Period D|Sponsor Decision|1|||
126342512|NCT00784875|454550476|FG001|Period D|Sponsor Decision|1|||
126342513|NCT00784875|454550477|FG002|Period D|Sponsor Decision|1|||
126342514|NCT00784875|454550478|FG003|Period D|Sponsor Decision|0|||
126342515|NCT00784875|454550475|FG000|Period D|Lost to Follow-up|1|||
126342516|NCT00784875|454550476|FG001|Period D|Lost to Follow-up|0|||
126342517|NCT00784875|454550477|FG002|Period D|Lost to Follow-up|1|||
126342518|NCT00784875|454550478|FG003|Period D|Lost to Follow-up|1|||
126342519|NCT02842866|454550479|FG000|Overall Study|Serious Adverse Event|0|||
126342520|NCT02842866|454550480|FG001|Overall Study|Serious Adverse Event|1|||
126342521|NCT02842866|454550479|FG000|Overall Study|Protocol Violation|4|||
126342522|NCT02842866|454550480|FG001|Overall Study|Protocol Violation|2|||
126342523|NCT02842866|454550479|FG000|Overall Study|Lost to Follow-up|2|||
126342524|NCT02842866|454550480|FG001|Overall Study|Lost to Follow-up|0|||
126342525|NCT02842866|454550479|FG000|Overall Study|Withdrawal by Subject|1|||
126342526|NCT02842866|454550480|FG001|Overall Study|Withdrawal by Subject|0|||
126342527|NCT02897349|454550485|FG000|Overall Study|Lost to Follow-up|2|||
126342528|NCT02897349|454550486|FG001|Overall Study|Lost to Follow-up|2|||
126342529|NCT02897349|454550485|FG000|Overall Study|Adverse Event|3|||
126342530|NCT02897349|454550486|FG001|Overall Study|Adverse Event|3|||
126342531|NCT02897349|454550485|FG000|Overall Study|Other than listed above|0|||
126342532|NCT02897349|454550486|FG001|Overall Study|Other than listed above|1|||
126342533|NCT01027949|454550492|FG000|Overall Study|Death|174|||
126342534|NCT01027949|454550492|FG000|Overall Study|Progressive Disease|163|||
126342535|NCT01027949|454550492|FG000|Overall Study|Adverse Event|172|||
126342536|NCT01027949|454550492|FG000|Overall Study|Withdrawal by Subject|113|||
126342537|NCT01027949|454550492|FG000|Overall Study|Lost to Follow-up|17|||
126342538|NCT01027949|454550492|FG000|Overall Study|Protocol Violation|13|||
126342539|NCT01027949|454550492|FG000|Overall Study|PI Decision|8|||
126342540|NCT01027949|454550492|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
126342541|NCT01027949|454550492|FG000|Overall Study|Non-compliance with Study Procedures|7|||
126342542|NCT01027949|454550492|FG000|Overall Study|Lung Transplant|5|||
126342543|NCT01027949|454550492|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
126342544|NCT01027949|454550492|FG000|Overall Study|Use of Excluded Medication|2|||
126342545|NCT01027949|454550492|FG000|Overall Study|Patient Self-discontinuation|1|||
126342546|NCT01027949|454550492|FG000|Overall Study|Pregnancy|1|||
126342547|NCT01027949|454550492|FG000|Overall Study|Surgery|1|||
126676251|NCT00807742|455771974|FG000|Overall Study|Death|9|||
126676252|NCT00807742|455771975|FG001|Overall Study|Death|2|||
126676253|NCT00807742|455771974|FG000|Overall Study|Withdrawal by Subject|2|||
126676254|NCT00807742|455771975|FG001|Overall Study|Withdrawal by Subject|1|||
126676255|NCT00807742|455771974|FG000|Overall Study|Lost to Follow-up|35|||
126342548|NCT00671749|454550495|FG000|Overall Study|Adverse Event|2|||
126342549|NCT00671749|454550495|FG000|Overall Study|Withdrawal by Subject|4|||
126342550|NCT00671749|454550495|FG000|Overall Study|Protocol Violation|1|||
126342551|NCT00671749|454550495|FG000|Overall Study|Lost to Follow-up|1|||
126342552|NCT02515227|454550496|FG000|Overall Study|Adverse Event|0|||
126342553|NCT02515227|454550497|FG001|Overall Study|Adverse Event|2|||
126342554|NCT02515227|454550496|FG000|Overall Study|Progressive disease|2|||
126342555|NCT02515227|454550497|FG001|Overall Study|Progressive disease|9|||
126342556|NCT03451071|454550498|FG000|First Vaccine|Withdrawal by Subject|1|||
126342557|NCT03451071|454550498|FG000|Second Vaccine|Lost to Follow-up|19|||
126342558|NCT03451071|454550498|FG000|Third Vaccine|Lost to Follow-up|22|||
126342559|NCT03451071|454550498|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
126676256|NCT00807742|455771975|FG001|Overall Study|Lost to Follow-up|51|||
126676257|NCT00492752|455771976|FG000|Double Blind Treatment|Death|13|||
126676258|NCT00492752|455771977|FG001|Double Blind Treatment|Death|0|||
126342560|NCT01901185|454550499|FG000|Overall Study|Withdrawal by Subject|2|||
126342561|NCT03502798|454550500|FG000|Overall Study|equipment failure|0|||
126342562|NCT03502798|454550501|FG001|Overall Study|equipment failure|7|||
126676259|NCT00492752|455771978|FG002|Double Blind Treatment|Death|2|||
126676260|NCT00492752|455771979|FG003|Double Blind Treatment|Death|0|||
126676261|NCT00492752|455771976|FG000|Double Blind Treatment|Adverse Event|1|||
126676262|NCT00492752|455771977|FG001|Double Blind Treatment|Adverse Event|0|||
126676263|NCT00492752|455771978|FG002|Double Blind Treatment|Adverse Event|0|||
126676264|NCT00492752|455771979|FG003|Double Blind Treatment|Adverse Event|0|||
126676265|NCT00492752|455771976|FG000|Double Blind Treatment|Protocol Violation|0|||
126676266|NCT00492752|455771977|FG001|Double Blind Treatment|Protocol Violation|0|||
126676267|NCT00492752|455771978|FG002|Double Blind Treatment|Protocol Violation|1|||
126676268|NCT00492752|455771979|FG003|Double Blind Treatment|Protocol Violation|0|||
126676269|NCT00492752|455771976|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
126676270|NCT00492752|455771977|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
126676271|NCT00492752|455771978|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
126676272|NCT00492752|455771979|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
126676273|NCT00492752|455771976|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
126676274|NCT00492752|455771977|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
126676275|NCT00492752|455771978|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
126676276|NCT00492752|455771979|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
126676277|NCT00492752|455771976|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
126676278|NCT00492752|455771977|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
126676279|NCT00492752|455771978|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
126676280|NCT00492752|455771979|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
126676281|NCT00492752|455771976|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
126676282|NCT00492752|455771977|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
126676283|NCT00492752|455771978|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
126676284|NCT00492752|455771979|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
126676285|NCT00492752|455771976|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
126676286|NCT00492752|455771977|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
126676287|NCT00492752|455771978|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
126676288|NCT00492752|455771979|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
126676289|NCT00492752|455771976|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
126676290|NCT00492752|455771977|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
126676291|NCT00492752|455771978|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
126676292|NCT00492752|455771979|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
126676293|NCT00492752|455771976|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
126676294|NCT00492752|455771977|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
126676295|NCT00492752|455771978|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
126676296|NCT00492752|455771979|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
126676297|NCT00492752|455771976|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
126676298|NCT00492752|455771977|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
126676299|NCT00492752|455771978|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
126676300|NCT00492752|455771979|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
126676301|NCT00219284|455771980|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
126676302|NCT00219284|455771981|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
126676303|NCT00219284|455771980|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
126676304|NCT00219284|455771981|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
126676305|NCT00219284|455771980|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
126676306|NCT00219284|455771981|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
126676307|NCT00219284|455771980|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
126676308|NCT00219284|455771981|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
126676309|NCT00219284|455771980|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
126676310|NCT00219284|455771981|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
126676311|NCT00219284|455771980|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
126676312|NCT00219284|455771981|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
126676313|NCT00219284|455771980|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
126676314|NCT00219284|455771981|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
126676315|NCT00219284|455771980|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
126676316|NCT00219284|455771981|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
126676317|NCT00219284|455771980|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
126676318|NCT00219284|455771981|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
126676319|NCT02258451|455771982|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
126676320|NCT02258451|455771983|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
126676321|NCT02258451|455771982|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
126676322|NCT02258451|455771983|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
126427897|NCT04154943|454862336|FG000|Overall Study|Study Ongoing|68|||
126427898|NCT04154943|454862336|FG000|Overall Study|Lost to Follow-up|1|||
126427899|NCT04154943|454862336|FG000|Overall Study|Decision by the Investigator|1|||
126427900|NCT04154943|454862336|FG000|Overall Study|Death|5|||
126427901|NCT04154943|454862336|FG000|Overall Study|Withdrawal by Subject|4|||
126676323|NCT02258451|455771982|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
126676324|NCT02258451|455771983|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
126676325|NCT02258451|455771982|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
126676326|NCT02258451|455771983|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
126427990|NCT01239381|454862357|FG000|Overall Study|Protocol Violation|1|||
126427991|NCT01239381|454862357|FG000|Overall Study|Withdrawal by Subject|1|||
126427992|NCT06237049|454862358|FG000|Overall Study|Death|0|||
126427993|NCT06237049|454862359|FG001|Overall Study|Death|0|||
126427994|NCT06237049|454862360|FG002|Overall Study|Death|0|||
126676327|NCT02258451|455771982|FG000|Overall Study|Discontinuation all treatment due to death|4|||
126676328|NCT02258451|455771983|FG001|Overall Study|Discontinuation all treatment due to death|3|||
126676329|NCT02258451|455771982|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
126427995|NCT06237049|454862361|FG003|Overall Study|Death|1|||
126427996|NCT06237049|454862358|FG000|Overall Study|Lost to Follow-up|11|||
126427997|NCT06237049|454862359|FG001|Overall Study|Lost to Follow-up|5|||
126427998|NCT06237049|454862360|FG002|Overall Study|Lost to Follow-up|8|||
126427999|NCT06237049|454862361|FG003|Overall Study|Lost to Follow-up|8|||
126428000|NCT06237049|454862358|FG000|Overall Study|Protocol Violation|0|||
126428001|NCT06237049|454862359|FG001|Overall Study|Protocol Violation|1|||
126428002|NCT06237049|454862360|FG002|Overall Study|Protocol Violation|0|||
126428003|NCT06237049|454862361|FG003|Overall Study|Protocol Violation|1|||
126428004|NCT06237049|454862358|FG000|Overall Study|Withdrawal by Subject|4|||
126428005|NCT06237049|454862359|FG001|Overall Study|Withdrawal by Subject|2|||
126428006|NCT06237049|454862360|FG002|Overall Study|Withdrawal by Subject|1|||
126428007|NCT06237049|454862361|FG003|Overall Study|Withdrawal by Subject|0|||
126676330|NCT02258451|455771983|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
126676331|NCT02258451|455771982|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
126676332|NCT02258451|455771983|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
126676333|NCT02258451|455771982|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
126676334|NCT02258451|455771983|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
126676335|NCT02258451|455771982|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
126676336|NCT02258451|455771983|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
126676337|NCT02258451|455771982|FG000|Overall Study|Other reason|1|||
126676338|NCT02258451|455771983|FG001|Overall Study|Other reason|1|||
126676339|NCT02258451|455771982|FG000|Overall Study|Never treated|2|||
126676340|NCT02258451|455771983|FG001|Overall Study|Never treated|3|||
126676341|NCT05419128|455771988|FG000|Overall Study|Withdrawal by Subject|1|||
126676342|NCT05419128|455771989|FG001|Overall Study|Withdrawal by Subject|1|||
126676343|NCT05419128|455771990|FG002|Overall Study|Withdrawal by Subject|0|||
126676344|NCT05419128|455771991|FG003|Overall Study|Withdrawal by Subject|1|||
126676345|NCT05419128|455771992|FG004|Overall Study|Withdrawal by Subject|1|||
126676346|NCT05419128|455771993|FG005|Overall Study|Withdrawal by Subject|0|||
126676347|NCT05419128|455771988|FG000|Overall Study|Lost to Follow-up|0|||
126676348|NCT05419128|455771989|FG001|Overall Study|Lost to Follow-up|0|||
126676349|NCT05419128|455771990|FG002|Overall Study|Lost to Follow-up|1|||
126676350|NCT05419128|455771991|FG003|Overall Study|Lost to Follow-up|0|||
126676351|NCT05419128|455771992|FG004|Overall Study|Lost to Follow-up|0|||
126676352|NCT05419128|455771993|FG005|Overall Study|Lost to Follow-up|1|||
126676353|NCT03834519|455771994|FG000|Overall Study|Lost to Follow-up|2|||
126676354|NCT03834519|455771995|FG001|Overall Study|Lost to Follow-up|1|||
126676355|NCT03834519|455771994|FG000|Overall Study|Withdrawal by Subject|5|||
126676356|NCT03834519|455771995|FG001|Overall Study|Withdrawal by Subject|8|||
126676357|NCT03834519|455771994|FG000|Overall Study|Death|368|||
126676358|NCT03834519|455771995|FG001|Overall Study|Death|174|||
126676359|NCT03834519|455771994|FG000|Overall Study|Physician Decision|5|||
126676360|NCT03834519|455771995|FG001|Overall Study|Physician Decision|1|||
126676361|NCT03834519|455771994|FG000|Overall Study|Sponsor decision|149|||
126676362|NCT03834519|455771995|FG001|Overall Study|Sponsor decision|80|||
126676363|NCT04066491|455771996|FG000|Overall Study|Randomized, not treated|0|||
126676364|NCT04066491|455771997|FG001|Overall Study|Randomized, not treated|0|||
126676365|NCT04066491|455771998|FG002|Overall Study|Randomized, not treated|2|||
126676366|NCT04506086|455771999|FG000|Overall Study|Withdrawal by Subject|2|||
126676367|NCT00517751|455772000|FG000|Overall Study|Death|3|||
126676368|NCT00517751|455772000|FG000|Overall Study|Withdrawal by Subject|37|||
126676369|NCT00517751|455772000|FG000|Overall Study|Lost to Follow-up|4|||
126676370|NCT00517751|455772000|FG000|Overall Study|patient not over due|6|||
126676371|NCT00517751|455772000|FG000|Overall Study|Patient not due for visit|76|||
126676372|NCT00517751|455772000|FG000|Overall Study|Missing|3|||
126676373|NCT01484977|455772005|FG000|Overall Study|Adverse Event|8|||
126676374|NCT01484977|455772005|FG000|Overall Study|Lack of Efficacy|4|||
126676375|NCT01484977|455772005|FG000|Overall Study|Protocol Violation|6|||
126676376|NCT01484977|455772005|FG000|Overall Study|Lost to Follow-up|1|||
126676377|NCT01484977|455772005|FG000|Overall Study|Withdrawal by Subject|4|||
126676378|NCT01484977|455772005|FG000|Overall Study|Subject Protocol Non-compliant|1|||
126676379|NCT01484977|455772005|FG000|Overall Study|Moving Overseas|1|||
126676380|NCT01484977|455772005|FG000|Overall Study|Low White Blood Cell Count|1|||
126676381|NCT01484977|455772005|FG000|Overall Study|Lack of Compliance|1|||
126676382|NCT00495820|455772006|FG000|Overall Study|Adverse Event|1|||
126676383|NCT00495820|455772007|FG001|Overall Study|Adverse Event|1|||
126676384|NCT04857996|455772008|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
126676385|NCT04857996|455772009|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
126676386|NCT04857996|455772008|FG000|Overall Study|Lost to Follow-up|1|||
126676387|NCT04857996|455772009|FG001|Overall Study|Lost to Follow-up|3|||
126676388|NCT04857996|455772008|FG000|Overall Study|Site Closure|1|||
126676389|NCT04857996|455772009|FG001|Overall Study|Site Closure|0|||
126676390|NCT04857996|455772008|FG000|Overall Study|Withdrawal by Subject|1|||
126676391|NCT04857996|455772009|FG001|Overall Study|Withdrawal by Subject|0|||
126676392|NCT00820950|455772010|FG000|Overall Study|Scheduling Conflict|0|||
126676393|NCT00820950|455772011|FG001|Overall Study|Scheduling Conflict|0|||
126676394|NCT00820950|455772012|FG002|Overall Study|Scheduling Conflict|0|||
126676395|NCT00820950|455772013|FG003|Overall Study|Scheduling Conflict|0|||
126676396|NCT00820950|455772014|FG004|Overall Study|Scheduling Conflict|0|||
126676397|NCT00820950|455772015|FG005|Overall Study|Scheduling Conflict|0|||
126676398|NCT00820950|455772016|FG006|Overall Study|Scheduling Conflict|1|||
126676399|NCT00820950|455772017|FG007|Overall Study|Scheduling Conflict|1|||
126676400|NCT00820950|455772018|FG008|Overall Study|Scheduling Conflict|0|||
126676401|NCT00820950|455772019|FG009|Overall Study|Scheduling Conflict|0|||
126676402|NCT00820950|455772010|FG000|Overall Study|Protocol Violation|1|||
126676403|NCT00820950|455772011|FG001|Overall Study|Protocol Violation|1|||
126676404|NCT00820950|455772012|FG002|Overall Study|Protocol Violation|0|||
126676405|NCT00820950|455772013|FG003|Overall Study|Protocol Violation|0|||
126676406|NCT00820950|455772014|FG004|Overall Study|Protocol Violation|0|||
126676407|NCT00820950|455772015|FG005|Overall Study|Protocol Violation|0|||
126676408|NCT00820950|455772016|FG006|Overall Study|Protocol Violation|0|||
126676409|NCT00820950|455772017|FG007|Overall Study|Protocol Violation|0|||
126676410|NCT00820950|455772018|FG008|Overall Study|Protocol Violation|0|||
126676411|NCT00820950|455772019|FG009|Overall Study|Protocol Violation|0|||
126676412|NCT00798135|455772020|FG000|Overall Study|Disease progression, relapse|11|||
126676413|NCT00798135|455772020|FG000|Overall Study|Disease progression, refractory|1|||
126676414|NCT00798135|455772020|FG000|Overall Study|Physician Decision|1|||
126676415|NCT00346073|455773643|FG000|Overall Study|Serious Adverse Event|2|||
126676416|NCT00346073|455773644|FG001|Overall Study|Serious Adverse Event|0|||
126676417|NCT00346073|455773643|FG000|Overall Study|Lost to Follow-up|39|||
126676418|NCT00346073|455773644|FG001|Overall Study|Lost to Follow-up|24|||
126676419|NCT01617460|455773645|FG000|Overall Study|Adverse Event|10|||
126676420|NCT01617460|455773645|FG000|Overall Study|Physician Decision|16|||
126676421|NCT01617460|455773645|FG000|Overall Study|Protocol Violation|5|||
126676422|NCT01617460|455773645|FG000|Overall Study|Withdrawal by Subject|9|||
126676423|NCT03703882|455773646|FG000|Overall Study|Adverse Event|1|||
126676424|NCT03703882|455773647|FG001|Overall Study|Adverse Event|0|||
126676425|NCT03703882|455773646|FG000|Overall Study|Lost to Follow-up|0|||
126676426|NCT03703882|455773647|FG001|Overall Study|Lost to Follow-up|2|||
126676427|NCT03703882|455773646|FG000|Overall Study|Non-compliance with study drug|0|||
126676428|NCT03703882|455773647|FG001|Overall Study|Non-compliance with study drug|1|||
126676429|NCT03703882|455773646|FG000|Overall Study|Physician Decision|0|||
126676430|NCT03703882|455773647|FG001|Overall Study|Physician Decision|1|||
126676431|NCT03703882|455773646|FG000|Overall Study|Progressive disease|1|||
126676432|NCT03703882|455773647|FG001|Overall Study|Progressive disease|0|||
126676433|NCT03703882|455773646|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126676434|NCT03703882|455773647|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126676435|NCT03703882|455773646|FG000|Overall Study|Starting another treatment|0|||
126676436|NCT03703882|455773647|FG001|Overall Study|Starting another treatment|1|||
126676437|NCT03703882|455773646|FG000|Overall Study|noncompliance with study procedures|0|||
126676438|NCT03703882|455773647|FG001|Overall Study|noncompliance with study procedures|1|||
126676439|NCT02263079|455773653|FG000|Overall Study|Physician Decision|1|||
126676440|NCT02263079|455773654|FG001|Overall Study|Physician Decision|0|||
126676441|NCT02263079|455773655|FG002|Overall Study|Physician Decision|0|||
126676442|NCT02263079|455773653|FG000|Overall Study|Withdrawal by Subject|2|||
126676443|NCT02263079|455773654|FG001|Overall Study|Withdrawal by Subject|8|||
126676444|NCT02263079|455773655|FG002|Overall Study|Withdrawal by Subject|0|||
126676445|NCT02603120|455773656|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
126676446|NCT02603120|455773657|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
126676447|NCT02603120|455773656|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
126676448|NCT02603120|455773657|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
126676449|NCT02603120|455773656|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
126676450|NCT02603120|455773657|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
126676451|NCT02603120|455773656|FG000|Double-Blind Treatment Phase|Death|2|||
126676452|NCT02603120|455773657|FG001|Double-Blind Treatment Phase|Death|0|||
126676453|NCT02603120|455773656|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
126676454|NCT02603120|455773657|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
126676455|NCT02603120|455773656|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
126676456|NCT02603120|455773657|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
126676457|NCT02603120|455773656|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
126676458|NCT02603120|455773657|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
126676459|NCT02603120|455773656|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
126676460|NCT02603120|455773657|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
126676461|NCT02603120|455773656|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
126676462|NCT02603120|455773657|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
126676463|NCT02603120|455773656|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
126676464|NCT02603120|455773657|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
126676465|NCT02603120|455773656|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
126676466|NCT02603120|455773657|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
126676467|NCT02603120|455773656|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
126676468|NCT02603120|455773657|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
126676469|NCT02603120|455773656|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
126676470|NCT02603120|455773657|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
126676471|NCT02603120|455773656|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
126676472|NCT02603120|455773657|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
126676473|NCT01199042|455773660|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
126676474|NCT01199042|455773660|FG000|At Home (3 Months)|Lost to Follow-up|1|||
126676475|NCT00176605|455773663|FG000|Overall Study|Withdrawal by Subject|2|||
126676476|NCT01321710|455773666|FG000|Overall Study|Lost to Follow-up|4|||
126676477|NCT01321710|455773667|FG001|Overall Study|Lost to Follow-up|5|||
126676478|NCT01321710|455773668|FG002|Overall Study|Lost to Follow-up|0|||
126676479|NCT01227187|455773669|FG000|Overall Study|Physician Decision|0|||
126676480|NCT01227187|455773670|FG001|Overall Study|Physician Decision|0|||
126676481|NCT01227187|455773671|FG002|Overall Study|Physician Decision|0|||
126676482|NCT01227187|455773672|FG003|Overall Study|Physician Decision|1|||
126676483|NCT02463409|455773673|FG000|Overall Study|Withdrawal by Subject|1|||
126676484|NCT02463409|455773673|FG000|Overall Study|Screen failure|1|||
126676485|NCT03577730|455773675|FG000|Overall Study|Physician Decision|3|||
126676486|NCT03577730|455773676|FG001|Overall Study|Physician Decision|1|||
126676487|NCT03577730|455773675|FG000|Overall Study|Did not receive allocated intervention|1|||
126676488|NCT03577730|455773676|FG001|Overall Study|Did not receive allocated intervention|0|||
126676489|NCT00880399|455773677|FG000|Overall Study|Adverse Event|4|||
126676490|NCT00880399|455773678|FG001|Overall Study|Adverse Event|6|||
126676491|NCT00880399|455773679|FG002|Overall Study|Adverse Event|5|||
126676492|NCT00880399|455773677|FG000|Overall Study|Lack of Efficacy|1|||
126676493|NCT00880399|455773678|FG001|Overall Study|Lack of Efficacy|4|||
126676494|NCT00880399|455773679|FG002|Overall Study|Lack of Efficacy|2|||
126676495|NCT00880399|455773677|FG000|Overall Study|Protocol Violation|4|||
126676496|NCT00880399|455773678|FG001|Overall Study|Protocol Violation|4|||
126676497|NCT00880399|455773679|FG002|Overall Study|Protocol Violation|6|||
126676498|NCT00880399|455773677|FG000|Overall Study|Study closed/terminated|3|||
126676499|NCT00880399|455773678|FG001|Overall Study|Study closed/terminated|7|||
126676500|NCT00880399|455773679|FG002|Overall Study|Study closed/terminated|4|||
126676501|NCT00880399|455773677|FG000|Overall Study|Lost to Follow-up|8|||
126676502|NCT00880399|455773678|FG001|Overall Study|Lost to Follow-up|5|||
126676503|NCT00880399|455773679|FG002|Overall Study|Lost to Follow-up|3|||
126676504|NCT00880399|455773677|FG000|Overall Study|Physician Decision|5|||
126676505|NCT00880399|455773678|FG001|Overall Study|Physician Decision|0|||
126676506|NCT00880399|455773679|FG002|Overall Study|Physician Decision|3|||
126676507|NCT00880399|455773677|FG000|Overall Study|Withdrawal by Subject|6|||
126676508|NCT00880399|455773678|FG001|Overall Study|Withdrawal by Subject|3|||
126676509|NCT00880399|455773679|FG002|Overall Study|Withdrawal by Subject|3|||
126676510|NCT01911442|455773680|FG000|Overall Study|Adverse Event|2|||
126676511|NCT01911442|455773681|FG001|Overall Study|Adverse Event|2|||
126676512|NCT01911442|455773682|FG002|Overall Study|Adverse Event|4|||
126676513|NCT01911442|455773680|FG000|Overall Study|Lack of Efficacy|1|||
126676514|NCT01911442|455773681|FG001|Overall Study|Lack of Efficacy|1|||
126676515|NCT01911442|455773682|FG002|Overall Study|Lack of Efficacy|1|||
126676516|NCT01911442|455773680|FG000|Overall Study|Lost to Follow-up|2|||
126676517|NCT01911442|455773681|FG001|Overall Study|Lost to Follow-up|0|||
126676518|NCT01911442|455773682|FG002|Overall Study|Lost to Follow-up|1|||
126676519|NCT01911442|455773680|FG000|Overall Study|Withdrawal by Subject|1|||
126676520|NCT01911442|455773681|FG001|Overall Study|Withdrawal by Subject|0|||
126676521|NCT01911442|455773682|FG002|Overall Study|Withdrawal by Subject|6|||
126676522|NCT01911442|455773680|FG000|Overall Study|Mother's Work Schedule|0|||
126676523|NCT01911442|455773681|FG001|Overall Study|Mother's Work Schedule|1|||
126676524|NCT01911442|455773682|FG002|Overall Study|Mother's Work Schedule|0|||
126676525|NCT00122681|455773686|FG000|Overall Study|Adverse Event|20|||
126676526|NCT00122681|455773687|FG001|Overall Study|Adverse Event|16|||
126676527|NCT00122681|455773686|FG000|Overall Study|Lost to Follow-up|1080|||
126676528|NCT00122681|455773687|FG001|Overall Study|Lost to Follow-up|1097|||
126676529|NCT00122681|455773686|FG000|Overall Study|Protocol Violation|7|||
126676530|NCT00122681|455773687|FG001|Overall Study|Protocol Violation|10|||
126676531|NCT00122681|455773686|FG000|Overall Study|Withdrawal by Subject|257|||
126676532|NCT00122681|455773687|FG001|Overall Study|Withdrawal by Subject|251|||
126676533|NCT00122681|455773686|FG000|Overall Study|Personal reasons|150|||
126676534|NCT00122681|455773687|FG001|Overall Study|Personal reasons|147|||
126676535|NCT02819635|455773689|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
126676536|NCT02819635|455773690|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
126676537|NCT02819635|455773691|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
126676538|NCT02819635|455773692|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
126428232|NCT04908397|454863901|FG000|Overall Study|Withdrawal by Subject|2|||
126428233|NCT04264442|454863902|FG000|Overall Study|Lack of Efficacy|6|||
126428234|NCT04264442|454863902|FG000|Overall Study|Lost to Follow-up|2|||
126428235|NCT04264442|454863902|FG000|Overall Study|Sponsor Decision|23|||
126428236|NCT04264442|454863902|FG000|Overall Study|Withdrawal by Subject|11|||
126428237|NCT04264442|454863902|FG000|Overall Study|Study Termination|5|||
126676539|NCT02819635|455773693|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
126676540|NCT02819635|455773694|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
126676541|NCT02819635|455773695|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
126676542|NCT02819635|455773696|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
126676543|NCT02819635|455773697|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
126676544|NCT02819635|455773698|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
126676545|NCT02819635|455773699|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
126676546|NCT02819635|455773700|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
126676547|NCT02819635|455773689|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126676548|NCT02819635|455773690|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126676549|NCT02819635|455773691|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126676550|NCT02819635|455773692|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126676551|NCT02819635|455773693|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
126676552|NCT02819635|455773694|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
126676553|NCT02819635|455773695|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
126676554|NCT02819635|455773696|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126676555|NCT02819635|455773697|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126676556|NCT02819635|455773698|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126676557|NCT02819635|455773699|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126676558|NCT02819635|455773700|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
126676559|NCT02819635|455773689|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126676560|NCT02819635|455773690|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126676561|NCT02819635|455773691|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126676562|NCT02819635|455773692|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126676563|NCT02819635|455773693|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126676564|NCT02819635|455773694|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
126676565|NCT02819635|455773695|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
126676566|NCT02819635|455773696|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126676567|NCT02819635|455773697|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126676568|NCT02819635|455773698|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126676569|NCT02819635|455773699|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126676570|NCT02819635|455773700|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
126676571|NCT02819635|455773689|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126676572|NCT02819635|455773690|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126676573|NCT02819635|455773691|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126676574|NCT02819635|455773692|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126676575|NCT02819635|455773693|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126676576|NCT02819635|455773694|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126676577|NCT02819635|455773695|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
126676578|NCT02819635|455773696|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126676579|NCT02819635|455773697|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126676580|NCT02819635|455773698|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126676581|NCT02819635|455773699|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126676582|NCT02819635|455773700|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
126676583|NCT02819635|455773689|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
126676584|NCT02819635|455773690|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
126676585|NCT02819635|455773691|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
126676586|NCT02819635|455773692|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
126676587|NCT02819635|455773693|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
126676588|NCT02819635|455773694|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
126676589|NCT02819635|455773695|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
126676590|NCT02819635|455773696|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
126676591|NCT02819635|455773697|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
126676592|NCT02819635|455773698|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
126676593|NCT02819635|455773699|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
126676594|NCT02819635|455773700|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
126676595|NCT02819635|455773689|FG000|Substudy 2, Part 2|Adverse Event|0|||
126676596|NCT02819635|455773690|FG001|Substudy 2, Part 2|Adverse Event|0|||
126676597|NCT02819635|455773691|FG002|Substudy 2, Part 2|Adverse Event|0|||
126676598|NCT02819635|455773692|FG003|Substudy 2, Part 2|Adverse Event|0|||
126676599|NCT02819635|455773693|FG004|Substudy 2, Part 2|Adverse Event|0|||
126676600|NCT02819635|455773694|FG005|Substudy 2, Part 2|Adverse Event|4|||
126676601|NCT02819635|455773695|FG006|Substudy 2, Part 2|Adverse Event|0|||
126676602|NCT02819635|455773696|FG007|Substudy 2, Part 2|Adverse Event|0|||
126676603|NCT02819635|455773697|FG008|Substudy 2, Part 2|Adverse Event|0|||
126676604|NCT02819635|455773698|FG009|Substudy 2, Part 2|Adverse Event|0|||
126676605|NCT02819635|455773699|FG010|Substudy 2, Part 2|Adverse Event|0|||
126676606|NCT02819635|455773700|FG011|Substudy 2, Part 2|Adverse Event|0|||
126676607|NCT02819635|455773689|FG000|Substudy 2, Part 2|Withdrew consent|0|||
126676608|NCT02819635|455773690|FG001|Substudy 2, Part 2|Withdrew consent|0|||
126676609|NCT02819635|455773691|FG002|Substudy 2, Part 2|Withdrew consent|0|||
126676610|NCT02819635|455773692|FG003|Substudy 2, Part 2|Withdrew consent|0|||
126676611|NCT02819635|455773693|FG004|Substudy 2, Part 2|Withdrew consent|0|||
126676612|NCT02819635|455773694|FG005|Substudy 2, Part 2|Withdrew consent|3|||
126676613|NCT02819635|455773695|FG006|Substudy 2, Part 2|Withdrew consent|1|||
126676614|NCT02819635|455773696|FG007|Substudy 2, Part 2|Withdrew consent|0|||
126676615|NCT02819635|455773697|FG008|Substudy 2, Part 2|Withdrew consent|0|||
126676616|NCT02819635|455773698|FG009|Substudy 2, Part 2|Withdrew consent|0|||
126676617|NCT02819635|455773699|FG010|Substudy 2, Part 2|Withdrew consent|0|||
126676618|NCT02819635|455773700|FG011|Substudy 2, Part 2|Withdrew consent|0|||
126676619|NCT02819635|455773689|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
126676620|NCT02819635|455773690|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
126676621|NCT02819635|455773691|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
126676622|NCT02819635|455773692|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
126676623|NCT02819635|455773693|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
126676624|NCT02819635|455773694|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
126676625|NCT02819635|455773695|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
126676626|NCT02819635|455773696|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
126676627|NCT02819635|455773697|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
126676628|NCT02819635|455773698|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
126676629|NCT02819635|455773699|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
126676630|NCT02819635|455773700|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
126676631|NCT02819635|455773689|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126676632|NCT02819635|455773690|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126676633|NCT02819635|455773691|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126676634|NCT02819635|455773692|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126676635|NCT02819635|455773693|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126676636|NCT02819635|455773694|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126676637|NCT02819635|455773695|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
126342563|NCT00296335|454550502|FG000|Overall Study|Recurrence|3|||
126342564|NCT00296335|454550503|FG001|Overall Study|Recurrence|51|||
126342565|NCT00296335|454550502|FG000|Overall Study|Adverse Event|17|||
126342566|NCT00296335|454550503|FG001|Overall Study|Adverse Event|27|||
126342567|NCT00296335|454550502|FG000|Overall Study|Lost to Follow-up|7|||
126342568|NCT00296335|454550503|FG001|Overall Study|Lost to Follow-up|33|||
126342569|NCT00296335|454550502|FG000|Overall Study|Physician Decision|3|||
126342570|NCT00296335|454550503|FG001|Overall Study|Physician Decision|11|||
126342571|NCT01401322|454550504|FG000|Overall Study|Withdrawal by Subject|1|||
126342572|NCT01401322|454550504|FG000|Overall Study|Physician Decision|1|||
126342573|NCT02737722|454550505|FG000|Overall Study|Physician Decision|0|||
126342574|NCT02737722|454550506|FG001|Overall Study|Physician Decision|0|||
126342575|NCT02737722|454550507|FG002|Overall Study|Physician Decision|1|||
126342576|NCT02737722|454550508|FG003|Overall Study|Physician Decision|0|||
126342577|NCT00112957|454550523|FG000|Overall Study|Progressive disease|18|||
126342578|NCT00112957|454550523|FG000|Overall Study|Physician Decision|1|||
126342579|NCT02309359|454550526|FG000|Overall Study|Adverse Event|4|||
126342580|NCT02309359|454550527|FG001|Overall Study|Adverse Event|5|||
126342581|NCT02309359|454550528|FG002|Overall Study|Adverse Event|5|||
126342582|NCT02309359|454550529|FG003|Overall Study|Adverse Event|4|||
126342583|NCT02309359|454550530|FG004|Overall Study|Adverse Event|4|||
126342584|NCT02309359|454550526|FG000|Overall Study|Death|1|||
126342585|NCT02309359|454550527|FG001|Overall Study|Death|0|||
126342586|NCT02309359|454550528|FG002|Overall Study|Death|0|||
126342587|NCT02309359|454550529|FG003|Overall Study|Death|0|||
126342588|NCT02309359|454550530|FG004|Overall Study|Death|0|||
126342589|NCT02309359|454550526|FG000|Overall Study|Withdrawal by Subject|2|||
126342590|NCT02309359|454550527|FG001|Overall Study|Withdrawal by Subject|2|||
126342591|NCT02309359|454550528|FG002|Overall Study|Withdrawal by Subject|4|||
126342592|NCT02309359|454550529|FG003|Overall Study|Withdrawal by Subject|4|||
126342593|NCT02309359|454550530|FG004|Overall Study|Withdrawal by Subject|0|||
126342594|NCT02309359|454550526|FG000|Overall Study|Lack of Efficacy|3|||
126342595|NCT02309359|454550527|FG001|Overall Study|Lack of Efficacy|1|||
126342596|NCT02309359|454550528|FG002|Overall Study|Lack of Efficacy|0|||
126342597|NCT02309359|454550529|FG003|Overall Study|Lack of Efficacy|0|||
126342598|NCT02309359|454550530|FG004|Overall Study|Lack of Efficacy|3|||
126342599|NCT02309359|454550526|FG000|Overall Study|Lost to Follow-up|0|||
126342600|NCT02309359|454550527|FG001|Overall Study|Lost to Follow-up|0|||
126342601|NCT02309359|454550528|FG002|Overall Study|Lost to Follow-up|0|||
126342602|NCT02309359|454550529|FG003|Overall Study|Lost to Follow-up|1|||
126342603|NCT02309359|454550530|FG004|Overall Study|Lost to Follow-up|0|||
126342604|NCT02309359|454550526|FG000|Overall Study|Other|2|||
126342605|NCT02309359|454550527|FG001|Overall Study|Other|0|||
126342606|NCT02309359|454550528|FG002|Overall Study|Other|2|||
126342607|NCT02309359|454550529|FG003|Overall Study|Other|3|||
126342608|NCT02309359|454550530|FG004|Overall Study|Other|2|||
126342609|NCT00284856|454550531|FG000|Overall Study|Adverse Event|3|||
126342610|NCT00284856|454550532|FG001|Overall Study|Adverse Event|3|||
126342611|NCT00284856|454550533|FG002|Overall Study|Adverse Event|3|||
126342612|NCT00284856|454550531|FG000|Overall Study|Lack of Efficacy|2|||
126342613|NCT00284856|454550532|FG001|Overall Study|Lack of Efficacy|1|||
126342614|NCT00284856|454550533|FG002|Overall Study|Lack of Efficacy|8|||
126342615|NCT00284856|454550531|FG000|Overall Study|Lost to Follow-up|25|||
126342616|NCT00284856|454550532|FG001|Overall Study|Lost to Follow-up|21|||
126342617|NCT00284856|454550533|FG002|Overall Study|Lost to Follow-up|22|||
126342618|NCT00284856|454550531|FG000|Overall Study|Protocol Violation|5|||
126342619|NCT00284856|454550532|FG001|Overall Study|Protocol Violation|4|||
126342620|NCT00284856|454550533|FG002|Overall Study|Protocol Violation|5|||
126342621|NCT00284856|454550531|FG000|Overall Study|Withdrawal by Subject|12|||
126342622|NCT00284856|454550532|FG001|Overall Study|Withdrawal by Subject|16|||
126342623|NCT00284856|454550533|FG002|Overall Study|Withdrawal by Subject|18|||
126342624|NCT00284856|454550531|FG000|Overall Study|Other|4|||
126342625|NCT00284856|454550532|FG001|Overall Study|Other|5|||
126342626|NCT00284856|454550533|FG002|Overall Study|Other|4|||
126342627|NCT03451045|454550535|FG000|Overall Study|Lack of Efficacy|3|||
126342628|NCT03451045|454550536|FG001|Overall Study|Lack of Efficacy|2|||
126342629|NCT03451045|454550537|FG002|Overall Study|Lack of Efficacy|2|||
126342630|NCT03451045|454550535|FG000|Overall Study|Physician Decision|1|||
126342631|NCT03451045|454550536|FG001|Overall Study|Physician Decision|1|||
126342632|NCT03451045|454550537|FG002|Overall Study|Physician Decision|1|||
126342633|NCT03451045|454550535|FG000|Overall Study|Withdrawal by Subject|4|||
126342634|NCT03451045|454550536|FG001|Overall Study|Withdrawal by Subject|0|||
126342635|NCT03451045|454550537|FG002|Overall Study|Withdrawal by Subject|5|||
126342636|NCT03451045|454550535|FG000|Overall Study|Pregnancy|0|||
126342637|NCT03451045|454550536|FG001|Overall Study|Pregnancy|0|||
126342638|NCT03451045|454550537|FG002|Overall Study|Pregnancy|2|||
126342639|NCT03451045|454550535|FG000|Overall Study|Adverse Event|7|||
126342640|NCT03451045|454550536|FG001|Overall Study|Adverse Event|1|||
126342641|NCT03451045|454550537|FG002|Overall Study|Adverse Event|3|||
126342642|NCT03451045|454550535|FG000|Overall Study|Non-compliance with study|2|||
126342643|NCT03451045|454550536|FG001|Overall Study|Non-compliance with study|0|||
126676638|NCT02819635|455773696|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126676639|NCT02819635|455773697|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126676640|NCT02819635|455773698|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126676641|NCT02819635|455773699|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126676642|NCT02819635|455773700|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
126676643|NCT02819635|455773689|FG000|Substudy 2, Part 2|Other, not specified|0|||
126676644|NCT02819635|455773690|FG001|Substudy 2, Part 2|Other, not specified|0|||
126676645|NCT02819635|455773691|FG002|Substudy 2, Part 2|Other, not specified|0|||
126676646|NCT02819635|455773692|FG003|Substudy 2, Part 2|Other, not specified|0|||
126676647|NCT02819635|455773693|FG004|Substudy 2, Part 2|Other, not specified|0|||
126342644|NCT03451045|454550537|FG002|Overall Study|Non-compliance with study|1|||
126342645|NCT03451045|454550535|FG000|Overall Study|any other reason|10|||
126342646|NCT03451045|454550536|FG001|Overall Study|any other reason|2|||
126342647|NCT03451045|454550537|FG002|Overall Study|any other reason|13|||
126342648|NCT00863707|454550538|FG000|Overall Study|Randomized, but drug not received|4|||
126676648|NCT02819635|455773694|FG005|Substudy 2, Part 2|Other, not specified|4|||
126342649|NCT00863707|454550539|FG001|Overall Study|Randomized, but drug not received|3|||
126342650|NCT04142242|454550540|FG000|Stage I|Non-compliance with the protocol|1|||
126342651|NCT04142242|454550541|FG001|Stage I|Non-compliance with the protocol|0|||
126342652|NCT04142242|454550542|FG002|Stage I|Non-compliance with the protocol|0|||
126676649|NCT02819635|455773695|FG006|Substudy 2, Part 2|Other, not specified|8|||
126676650|NCT02819635|455773696|FG007|Substudy 2, Part 2|Other, not specified|0|||
126676651|NCT02819635|455773697|FG008|Substudy 2, Part 2|Other, not specified|0|||
126676652|NCT02819635|455773698|FG009|Substudy 2, Part 2|Other, not specified|0|||
126676653|NCT02819635|455773699|FG010|Substudy 2, Part 2|Other, not specified|0|||
126676654|NCT02819635|455773700|FG011|Substudy 2, Part 2|Other, not specified|0|||
126676655|NCT02819635|455773689|FG000|Substudy 3|Adverse Event|0|||
126676656|NCT02819635|455773690|FG001|Substudy 3|Adverse Event|0|||
126676657|NCT02819635|455773691|FG002|Substudy 3|Adverse Event|0|||
126676658|NCT02819635|455773692|FG003|Substudy 3|Adverse Event|0|||
126676659|NCT02819635|455773693|FG004|Substudy 3|Adverse Event|0|||
126676660|NCT02819635|455773694|FG005|Substudy 3|Adverse Event|0|||
126676661|NCT02819635|455773695|FG006|Substudy 3|Adverse Event|0|||
126676662|NCT02819635|455773696|FG007|Substudy 3|Adverse Event|0|||
126676663|NCT02819635|455773697|FG008|Substudy 3|Adverse Event|32|||
126676664|NCT02819635|455773698|FG009|Substudy 3|Adverse Event|3|||
126676665|NCT02819635|455773699|FG010|Substudy 3|Adverse Event|12|||
126676666|NCT02819635|455773700|FG011|Substudy 3|Adverse Event|18|||
126676667|NCT02819635|455773689|FG000|Substudy 3|Withdrew consent|0|||
126676668|NCT02819635|455773690|FG001|Substudy 3|Withdrew consent|0|||
126676669|NCT02819635|455773691|FG002|Substudy 3|Withdrew consent|0|||
126676670|NCT02819635|455773692|FG003|Substudy 3|Withdrew consent|0|||
126676671|NCT02819635|455773693|FG004|Substudy 3|Withdrew consent|0|||
126676672|NCT02819635|455773694|FG005|Substudy 3|Withdrew consent|0|||
126676673|NCT02819635|455773695|FG006|Substudy 3|Withdrew consent|0|||
126676674|NCT02819635|455773696|FG007|Substudy 3|Withdrew consent|0|||
126676675|NCT02819635|455773697|FG008|Substudy 3|Withdrew consent|11|||
126676676|NCT02819635|455773698|FG009|Substudy 3|Withdrew consent|1|||
126676677|NCT02819635|455773699|FG010|Substudy 3|Withdrew consent|4|||
126676678|NCT02819635|455773700|FG011|Substudy 3|Withdrew consent|9|||
126676679|NCT02819635|455773689|FG000|Substudy 3|Lost to Follow-up|0|||
126676680|NCT02819635|455773690|FG001|Substudy 3|Lost to Follow-up|0|||
126676681|NCT02819635|455773691|FG002|Substudy 3|Lost to Follow-up|0|||
126676682|NCT02819635|455773692|FG003|Substudy 3|Lost to Follow-up|0|||
126676683|NCT02819635|455773693|FG004|Substudy 3|Lost to Follow-up|0|||
126676684|NCT02819635|455773694|FG005|Substudy 3|Lost to Follow-up|0|||
126676685|NCT02819635|455773695|FG006|Substudy 3|Lost to Follow-up|0|||
126676686|NCT02819635|455773696|FG007|Substudy 3|Lost to Follow-up|0|||
126676687|NCT02819635|455773697|FG008|Substudy 3|Lost to Follow-up|1|||
126676688|NCT02819635|455773698|FG009|Substudy 3|Lost to Follow-up|0|||
126676689|NCT02819635|455773699|FG010|Substudy 3|Lost to Follow-up|1|||
126676690|NCT02819635|455773700|FG011|Substudy 3|Lost to Follow-up|1|||
126676691|NCT02819635|455773689|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
126676692|NCT02819635|455773690|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
126676693|NCT02819635|455773691|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
126676694|NCT02819635|455773692|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
126676695|NCT02819635|455773693|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
126676696|NCT02819635|455773694|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
126676697|NCT02819635|455773695|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
126676698|NCT02819635|455773696|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
126676699|NCT02819635|455773697|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
126676700|NCT02819635|455773698|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
126676701|NCT02819635|455773699|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
126676702|NCT02819635|455773700|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
126676703|NCT02819635|455773689|FG000|Substudy 3|Other, not specified|0|||
126676704|NCT02819635|455773690|FG001|Substudy 3|Other, not specified|0|||
126676705|NCT02819635|455773691|FG002|Substudy 3|Other, not specified|0|||
126676706|NCT02819635|455773692|FG003|Substudy 3|Other, not specified|0|||
126676707|NCT02819635|455773693|FG004|Substudy 3|Other, not specified|0|||
126676708|NCT02819635|455773694|FG005|Substudy 3|Other, not specified|0|||
126676709|NCT02819635|455773695|FG006|Substudy 3|Other, not specified|0|||
126676710|NCT02819635|455773696|FG007|Substudy 3|Other, not specified|0|||
126676711|NCT02819635|455773697|FG008|Substudy 3|Other, not specified|202|||
126676712|NCT02819635|455773698|FG009|Substudy 3|Other, not specified|5|||
126676713|NCT02819635|455773699|FG010|Substudy 3|Other, not specified|89|||
126676714|NCT02819635|455773700|FG011|Substudy 3|Other, not specified|39|||
126676715|NCT03179891|455773701|FG000|First Intervention|Withdrawal by Subject|1|||
126676716|NCT03179891|455773702|FG001|First Intervention|Withdrawal by Subject|1|||
126676717|NCT03179891|455773701|FG000|First Intervention|Unspecified reason|1|||
126676718|NCT03179891|455773702|FG001|First Intervention|Unspecified reason|0|||
126676719|NCT03179891|455773701|FG000|First Intervention|Protocol Violation|0|||
126676720|NCT03179891|455773702|FG001|First Intervention|Protocol Violation|1|||
126676721|NCT04416555|455773704|FG000|Overall Study|Withdrawal by Subject|0|||
126676722|NCT04416555|455773705|FG001|Overall Study|Withdrawal by Subject|3|||
126676723|NCT02004262|455773716|FG000|Overall Study|Death|67|||
126676724|NCT02004262|455773717|FG001|Overall Study|Death|64|||
126676725|NCT02004262|455773718|FG002|Overall Study|Death|66|||
126676726|NCT02004262|455773719|FG003|Overall Study|Death|28|||
126676727|NCT02004262|455773720|FG004|Overall Study|Death|29|||
126676728|NCT02004262|455773721|FG005|Overall Study|Death|22|||
126676729|NCT02004262|455773716|FG000|Overall Study|Withdrawal by Subject|1|||
126676730|NCT02004262|455773717|FG001|Overall Study|Withdrawal by Subject|0|||
126676731|NCT02004262|455773718|FG002|Overall Study|Withdrawal by Subject|4|||
126428430|NCT04879628|454863939|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
126428431|NCT04879628|454863940|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
126428432|NCT04879628|454863941|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
126428433|NCT04879628|454863942|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
126428434|NCT04879628|454863939|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
126428435|NCT04879628|454863940|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
126428436|NCT04879628|454863941|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
126428437|NCT04879628|454863942|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
126428438|NCT04879628|454863939|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
126428439|NCT04879628|454863940|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
126428440|NCT04879628|454863941|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
126428441|NCT04879628|454863942|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
126428442|NCT04879628|454863939|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
126428443|NCT04879628|454863940|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
126428444|NCT04879628|454863941|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
126428445|NCT04879628|454863942|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
126676732|NCT02004262|455773719|FG003|Overall Study|Withdrawal by Subject|0|||
126676733|NCT02004262|455773720|FG004|Overall Study|Withdrawal by Subject|1|||
126676734|NCT02004262|455773721|FG005|Overall Study|Withdrawal by Subject|3|||
126676735|NCT02004262|455773716|FG000|Overall Study|Lost to Follow-up|1|||
126676736|NCT02004262|455773717|FG001|Overall Study|Lost to Follow-up|1|||
126676737|NCT02004262|455773718|FG002|Overall Study|Lost to Follow-up|0|||
126676738|NCT02004262|455773719|FG003|Overall Study|Lost to Follow-up|0|||
126676739|NCT02004262|455773720|FG004|Overall Study|Lost to Follow-up|0|||
126676740|NCT02004262|455773721|FG005|Overall Study|Lost to Follow-up|0|||
126676741|NCT02004262|455773716|FG000|Overall Study|Study Terminated by Sponsor|4|||
126676742|NCT02004262|455773717|FG001|Overall Study|Study Terminated by Sponsor|3|||
126676743|NCT02004262|455773718|FG002|Overall Study|Study Terminated by Sponsor|2|||
126676744|NCT02004262|455773719|FG003|Overall Study|Study Terminated by Sponsor|1|||
126676745|NCT02004262|455773720|FG004|Overall Study|Study Terminated by Sponsor|1|||
126676746|NCT02004262|455773721|FG005|Overall Study|Study Terminated by Sponsor|5|||
126676747|NCT01923285|455773722|FG000|Overall Study|Withdrawal by Subject|7|||
126676748|NCT01923285|455773723|FG001|Overall Study|Withdrawal by Subject|6|||
126676749|NCT03200366|455773724|FG000|Patient Navigation Intervention Given|Death|0|||
126676750|NCT03200366|455773725|FG001|Patient Navigation Intervention Given|Death|2|||
126676751|NCT03200366|455773726|FG002|Patient Navigation Intervention Given|Death|0|||
126676752|NCT03200366|455773724|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
126676753|NCT03200366|455773725|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
126676754|NCT03200366|455773726|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
126676755|NCT03200366|455773724|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
126676756|NCT03200366|455773725|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
126676757|NCT03200366|455773726|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
126676758|NCT03200366|455773724|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
126676759|NCT03200366|455773725|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
126676760|NCT03200366|455773726|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
126676761|NCT03200366|455773724|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
126676762|NCT03200366|455773725|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
126676763|NCT03200366|455773726|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
126676764|NCT03200366|455773724|FG000|6 Month Post-Baseline Interview|Death|1|||
126676765|NCT03200366|455773725|FG001|6 Month Post-Baseline Interview|Death|1|||
126676766|NCT03200366|455773726|FG002|6 Month Post-Baseline Interview|Death|1|||
126676767|NCT03200366|455773724|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
126676768|NCT03200366|455773725|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
126676769|NCT03200366|455773726|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
126676770|NCT03200366|455773724|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
126676771|NCT03200366|455773725|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
126676772|NCT03200366|455773726|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
126676773|NCT03200366|455773724|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
126676774|NCT03200366|455773725|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
126676775|NCT03200366|455773726|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
126676776|NCT03200366|455773724|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
126676777|NCT03200366|455773725|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
126676778|NCT03200366|455773726|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
126676779|NCT03200366|455773724|FG000|9 Month Post-Baseline Interview|Death|1|||
126676780|NCT03200366|455773725|FG001|9 Month Post-Baseline Interview|Death|1|||
126676781|NCT03200366|455773726|FG002|9 Month Post-Baseline Interview|Death|1|||
126676782|NCT03200366|455773724|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
126676783|NCT03200366|455773725|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
126676784|NCT03200366|455773726|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
126676785|NCT03200366|455773724|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
126676786|NCT03200366|455773725|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
126676787|NCT03200366|455773726|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
126676788|NCT03200366|455773724|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
126676789|NCT03200366|455773725|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
126676790|NCT03200366|455773726|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
126676791|NCT03201458|455773727|FG000|Overall Study|No longer eligible|2|||
126676792|NCT03201458|455773728|FG001|Overall Study|No longer eligible|5|||
126676793|NCT03201458|455773727|FG000|Overall Study|Health event before starting|1|||
126676794|NCT03201458|455773728|FG001|Overall Study|Health event before starting|0|||
126676795|NCT03201458|455773727|FG000|Overall Study|Physician Decision|1|||
126676796|NCT03201458|455773728|FG001|Overall Study|Physician Decision|0|||
126676797|NCT00750737|455773731|FG000|Overall Study|Withdrawal by Subject|3|||
126676798|NCT00750737|455773732|FG001|Overall Study|Withdrawal by Subject|3|||
126676799|NCT04707157|455773733|FG000|Overall Study|Adverse Event|12|||
126676800|NCT04707157|455773734|FG001|Overall Study|Adverse Event|3|||
126676801|NCT04707157|455773733|FG000|Overall Study|Lost to Follow-up|2|||
126676802|NCT04707157|455773734|FG001|Overall Study|Lost to Follow-up|0|||
126428522|NCT04875195|454863971|FG000|Overall Study|Death|9|||
126676803|NCT04707157|455773733|FG000|Overall Study|Sponsor's decision|1|||
126676804|NCT04707157|455773734|FG001|Overall Study|Sponsor's decision|0|||
126676805|NCT04707157|455773733|FG000|Overall Study|Physician Decision|8|||
126676806|NCT04707157|455773734|FG001|Overall Study|Physician Decision|5|||
126428523|NCT04875195|454863972|FG001|Overall Study|Death|3|||
126428524|NCT04875195|454863971|FG000|Overall Study|Withdrawal by Subject|2|||
126428525|NCT04875195|454863972|FG001|Overall Study|Withdrawal by Subject|1|||
126676807|NCT04707157|455773733|FG000|Overall Study|Protocol Deviation|1|||
126676808|NCT04707157|455773734|FG001|Overall Study|Protocol Deviation|0|||
126676809|NCT04707157|455773733|FG000|Overall Study|Withdrawal by Subject|1|||
126676810|NCT04707157|455773734|FG001|Overall Study|Withdrawal by Subject|1|||
126676811|NCT00804570|455773735|FG000|Overall Study|Adverse Event|14|||
126676812|NCT00804570|455773736|FG001|Overall Study|Adverse Event|7|||
126676813|NCT00804570|455773735|FG000|Overall Study|Lack of Efficacy|0|||
126676814|NCT00804570|455773736|FG001|Overall Study|Lack of Efficacy|1|||
126676815|NCT00804570|455773735|FG000|Overall Study|Lost to Follow-up|18|||
126676816|NCT00804570|455773736|FG001|Overall Study|Lost to Follow-up|21|||
126676817|NCT00804570|455773735|FG000|Overall Study|Entry criteria not met|5|||
126676818|NCT00804570|455773736|FG001|Overall Study|Entry criteria not met|5|||
126676819|NCT00804570|455773735|FG000|Overall Study|Protocol Violation|12|||
126676820|NCT00804570|455773736|FG001|Overall Study|Protocol Violation|16|||
126676821|NCT00804570|455773735|FG000|Overall Study|Physician Decision|1|||
126676822|NCT00804570|455773736|FG001|Overall Study|Physician Decision|2|||
126676823|NCT00804570|455773735|FG000|Overall Study|Sponsor decision|1|||
126676824|NCT00804570|455773736|FG001|Overall Study|Sponsor decision|4|||
126676825|NCT00804570|455773735|FG000|Overall Study|Withdrawal by Subject|21|||
126676826|NCT00804570|455773736|FG001|Overall Study|Withdrawal by Subject|38|||
126428526|NCT04875195|454863971|FG000|Overall Study|Ongoing in study|49|||
126428527|NCT04875195|454863972|FG001|Overall Study|Ongoing in study|2|||
126428528|NCT05190120|454863973|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
126428529|NCT05190120|454863974|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
126428530|NCT05190120|454863975|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
126428531|NCT05190120|454863976|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
126428532|NCT05190120|454863973|FG000|Overall Study|Lost to Follow-up|5|||
126428533|NCT05190120|454863974|FG001|Overall Study|Lost to Follow-up|0|||
126428534|NCT05190120|454863975|FG002|Overall Study|Lost to Follow-up|2|||
126676827|NCT00290342|455773737|FG000|Overall Study|Other|0|||
126342653|NCT04142242|454550543|FG003|Stage I|Non-compliance with the protocol|0|||
126342654|NCT04142242|454550544|FG004|Stage I|Non-compliance with the protocol|0|||
126342655|NCT04142242|454550545|FG005|Stage I|Non-compliance with the protocol|1|||
126342656|NCT04142242|454550540|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
126342657|NCT04142242|454550541|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
126342658|NCT04142242|454550542|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
126342659|NCT04142242|454550543|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
126428535|NCT05190120|454863976|FG003|Overall Study|Lost to Follow-up|3|||
126676828|NCT00290342|455773738|FG001|Overall Study|Other|1|||
126676829|NCT00290342|455773737|FG000|Overall Study|Withdrawal by Subject|6|||
126676830|NCT00290342|455773738|FG001|Overall Study|Withdrawal by Subject|4|||
126676831|NCT00290342|455773737|FG000|Overall Study|Lost to Follow-up|1|||
126676832|NCT00290342|455773738|FG001|Overall Study|Lost to Follow-up|0|||
126676833|NCT01056510|455773741|FG000|Overall Study|Dropout Before Start of Treatment|1|||
126676834|NCT01056510|455773742|FG001|Overall Study|Dropout Before Start of Treatment|1|||
126676835|NCT01056510|455773741|FG000|Overall Study|Withdrawal by Subject|4|||
126676836|NCT01056510|455773742|FG001|Overall Study|Withdrawal by Subject|2|||
126676837|NCT01056510|455773741|FG000|Overall Study|Death|29|||
126676838|NCT01056510|455773742|FG001|Overall Study|Death|34|||
126676839|NCT01056510|455773741|FG000|Overall Study|Noncompliance|1|||
126676840|NCT01056510|455773742|FG001|Overall Study|Noncompliance|3|||
126676841|NCT01056510|455773741|FG000|Overall Study|Physician Decision|4|||
126676842|NCT01056510|455773742|FG001|Overall Study|Physician Decision|5|||
126676843|NCT01056510|455773741|FG000|Overall Study|Lost to Follow-up|5|||
126676844|NCT01056510|455773742|FG001|Overall Study|Lost to Follow-up|6|||
126676845|NCT01056510|455773741|FG000|Overall Study|Other|10|||
126676846|NCT01056510|455773742|FG001|Overall Study|Other|12|||
126676847|NCT01056510|455773741|FG000|Overall Study|Missing|0|||
126676848|NCT01056510|455773742|FG001|Overall Study|Missing|1|||
126676849|NCT00243386|455773743|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
126676850|NCT00243386|455773744|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
126676851|NCT00243386|455773745|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
126676852|NCT00243386|455773743|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
126676853|NCT00243386|455773744|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
126676854|NCT00243386|455773745|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
126676855|NCT00243386|455773743|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
126676856|NCT00243386|455773744|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
126676857|NCT00243386|455773745|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
126676858|NCT00243386|455773743|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
126676859|NCT00243386|455773744|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
126676860|NCT00243386|455773745|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
126676861|NCT00243386|455773743|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
126676862|NCT00243386|455773744|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
126676863|NCT00243386|455773745|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
126676864|NCT00243386|455773743|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
126676865|NCT00243386|455773744|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
126676866|NCT00243386|455773745|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
126676867|NCT00243386|455773743|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
126676868|NCT00243386|455773744|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
126676869|NCT00243386|455773745|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
126676870|NCT00243386|455773743|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
126676871|NCT00243386|455773744|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
126676872|NCT00243386|455773745|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
126676873|NCT02285998|455773746|FG000|Overall Study|Adverse Event|9|||
126676874|NCT02285998|455773747|FG001|Overall Study|Adverse Event|8|||
126676875|NCT02285998|455773746|FG000|Overall Study|Physician Decision|1|||
126676876|NCT02285998|455773747|FG001|Overall Study|Physician Decision|2|||
126676877|NCT02285998|455773746|FG000|Overall Study|Lost to Follow-up|176|||
126676878|NCT02285998|455773747|FG001|Overall Study|Lost to Follow-up|172|||
126676879|NCT02285998|455773746|FG000|Overall Study|Withdrawal by Subject|53|||
126676880|NCT02285998|455773747|FG001|Overall Study|Withdrawal by Subject|61|||
126676881|NCT02285998|455773746|FG000|Overall Study|Other Reasons|7|||
126676882|NCT02285998|455773747|FG001|Overall Study|Other Reasons|10|||
126676883|NCT00545298|455773748|FG000|Overall Study|Issues with Standard of Care|2|||
126676884|NCT00545298|455773749|FG001|Overall Study|Issues with Standard of Care|0|||
126676885|NCT00545298|455773750|FG002|Overall Study|Issues with Standard of Care|1|||
126676886|NCT01820364|455773754|FG000|Part I: LGX818|Death|1|||
126676887|NCT01820364|455773755|FG001|Part I: LGX818|Death|0|||
126676888|NCT01820364|455773754|FG000|Part I: LGX818|Administrative Problems|3|||
126676889|NCT01820364|455773755|FG001|Part I: LGX818|Administrative Problems|0|||
126676890|NCT01820364|455773754|FG000|Part I: LGX818|Adverse Event|6|||
126676891|NCT01820364|455773755|FG001|Part I: LGX818|Adverse Event|0|||
126676892|NCT01820364|455773754|FG000|Part I: LGX818|Disease Progression|4|||
126676893|NCT01820364|455773755|FG001|Part I: LGX818|Disease Progression|0|||
126428577|NCT03069352|454863987|FG000|Overall Study|Ongoing|12|||
126428578|NCT03069352|454863988|FG001|Overall Study|Ongoing|40|||
126428579|NCT02621424|454863989|FG000|Overall Study|Withdrawal by Subject|1|||
126428580|NCT02621424|454863990|FG001|Overall Study|Withdrawal by Subject|2|||
126676894|NCT01820364|455773754|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
126676895|NCT01820364|455773755|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
126676896|NCT01793142|455773758|FG000|Overall Study|Randomized not treated|7|||
126676897|NCT03451084|455773761|FG000|Overall Study|Withdrawal by Subject|2|||
126676898|NCT03451084|455773762|FG001|Overall Study|Withdrawal by Subject|1|||
126676899|NCT03451084|455773763|FG002|Overall Study|Withdrawal by Subject|2|||
126676900|NCT03451084|455773764|FG003|Overall Study|Withdrawal by Subject|1|||
126676901|NCT03451084|455773761|FG000|Overall Study|Disease recurrence|0|||
126676902|NCT03451084|455773762|FG001|Overall Study|Disease recurrence|2|||
126676903|NCT03451084|455773763|FG002|Overall Study|Disease recurrence|0|||
126676904|NCT03451084|455773764|FG003|Overall Study|Disease recurrence|0|||
126676905|NCT03451084|455773761|FG000|Overall Study|Lack of Efficacy|0|||
126676906|NCT03451084|455773762|FG001|Overall Study|Lack of Efficacy|3|||
126676907|NCT03451084|455773763|FG002|Overall Study|Lack of Efficacy|0|||
126676908|NCT03451084|455773764|FG003|Overall Study|Lack of Efficacy|1|||
126676909|NCT03451084|455773761|FG000|Overall Study|Death|1|||
126676910|NCT03451084|455773762|FG001|Overall Study|Death|0|||
126676911|NCT03451084|455773763|FG002|Overall Study|Death|2|||
126428596|NCT05148234|454864001|FG000|Phase I|Ineligible|0|||
126428597|NCT05148234|454864002|FG001|Phase I|Ineligible|0|||
126428598|NCT05148234|454864003|FG002|Phase I|Ineligible|0|||
126428599|NCT05148234|454864004|FG003|Phase I|Ineligible|0|||
126428600|NCT05148234|454864005|FG004|Phase I|Ineligible|0|||
126676912|NCT03451084|455773764|FG003|Overall Study|Death|0|||
126676913|NCT03451084|455773761|FG000|Overall Study|Physician Decision|0|||
126676914|NCT03451084|455773762|FG001|Overall Study|Physician Decision|0|||
126676915|NCT03451084|455773763|FG002|Overall Study|Physician Decision|2|||
126428601|NCT05148234|454864006|FG005|Phase I|Ineligible|0|||
126428602|NCT05148234|454864007|FG006|Phase I|Ineligible|0|||
126676916|NCT03451084|455773764|FG003|Overall Study|Physician Decision|2|||
126676917|NCT03451084|455773761|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
126676918|NCT03451084|455773762|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
126676919|NCT03451084|455773763|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
126676920|NCT03451084|455773764|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
126676921|NCT04995055|455773770|FG000|Period 1|COVID-19 Related|1|||
126676922|NCT04995055|455773771|FG001|Period 1|COVID-19 Related|0|||
126676923|NCT04995055|455773770|FG000|Period 1|Withdrawal by Subject|0|||
126676924|NCT04995055|455773771|FG001|Period 1|Withdrawal by Subject|1|||
126676925|NCT04995055|455773770|FG000|Period 1|Subject discontinued due to timing|4|||
126676926|NCT04995055|455773771|FG001|Period 1|Subject discontinued due to timing|4|||
126676927|NCT03418129|455773774|FG000|Overall Study|Lost to Follow-up|11|||
126676928|NCT03418129|455773775|FG001|Overall Study|Lost to Follow-up|20|||
126676929|NCT03418129|455773776|FG002|Overall Study|Lost to Follow-up|15|||
126676930|NCT03418129|455773774|FG000|Overall Study|Withdrawal by Subject|3|||
126676931|NCT03418129|455773775|FG001|Overall Study|Withdrawal by Subject|6|||
126676932|NCT03418129|455773776|FG002|Overall Study|Withdrawal by Subject|4|||
126676933|NCT01066585|455773784|FG000|Overall Study|Protocol Violation|1|||
126676934|NCT01066585|455773785|FG001|Overall Study|Protocol Violation|0|||
126676935|NCT01066585|455773784|FG000|Overall Study|Withdrawal by Subject|0|||
126676936|NCT01066585|455773785|FG001|Overall Study|Withdrawal by Subject|3|||
126676937|NCT04126083|455773786|FG000|Overall Study|Withdrawal by Subject|1|||
126676938|NCT01279850|455773787|FG000|Overall Study|Protocol Violation|50|||
126676939|NCT01279850|455773787|FG000|Overall Study|No Drug Administration Information|7|||
126676940|NCT01279850|455773787|FG000|Overall Study|No Visit After Treatment|34|||
126676941|NCT01131520|455773788|FG000|Overall Study|Computer problem|1|||
126676942|NCT01131520|455773789|FG001|Overall Study|Computer problem|0|||
126676943|NCT01131520|455773788|FG000|Overall Study|Counselor not available|0|||
126676944|NCT01131520|455773789|FG001|Overall Study|Counselor not available|3|||
126676945|NCT01131520|455773788|FG000|Overall Study|Subject changed history after enrollment|0|||
126676946|NCT01131520|455773789|FG001|Overall Study|Subject changed history after enrollment|1|||
126676947|NCT02186847|455773790|FG000|Overall Study|Protocol Violation|3|||
126676948|NCT02186847|455773791|FG001|Overall Study|Protocol Violation|0|||
126676949|NCT01423851|455773793|FG000|Whole Study|Disease progression|2|||
126676950|NCT01423851|455773794|FG001|Whole Study|Disease progression|1|||
126676951|NCT01423851|455773795|FG002|Whole Study|Disease progression|1|||
126676952|NCT01423851|455773796|FG003|Whole Study|Disease progression|4|||
126676953|NCT01423851|455773797|FG004|Whole Study|Disease progression|1|||
126676954|NCT01423851|455773798|FG005|Whole Study|Disease progression|3|||
126676955|NCT01423851|455773799|FG006|Whole Study|Disease progression|1|||
126676956|NCT01423851|455773800|FG007|Whole Study|Disease progression|4|||
126676957|NCT01423851|455773801|FG008|Whole Study|Disease progression|0|||
126676958|NCT01423851|455773802|FG009|Whole Study|Disease progression|2|||
126676959|NCT01423851|455773803|FG010|Whole Study|Disease progression|10|||
126676960|NCT01423851|455773793|FG000|Whole Study|Physician Decision|0|||
126676961|NCT01423851|455773794|FG001|Whole Study|Physician Decision|1|||
126676962|NCT01423851|455773795|FG002|Whole Study|Physician Decision|2|||
126676963|NCT01423851|455773796|FG003|Whole Study|Physician Decision|0|||
126676964|NCT01423851|455773797|FG004|Whole Study|Physician Decision|2|||
126676965|NCT01423851|455773798|FG005|Whole Study|Physician Decision|0|||
126676966|NCT01423851|455773799|FG006|Whole Study|Physician Decision|2|||
126676967|NCT01423851|455773800|FG007|Whole Study|Physician Decision|1|||
126676968|NCT01423851|455773801|FG008|Whole Study|Physician Decision|3|||
126676969|NCT01423851|455773802|FG009|Whole Study|Physician Decision|4|||
126676970|NCT01423851|455773803|FG010|Whole Study|Physician Decision|12|||
126676971|NCT01423851|455773793|FG000|Whole Study|Withdrawal by Subject|1|||
126676972|NCT01423851|455773794|FG001|Whole Study|Withdrawal by Subject|1|||
126676973|NCT01423851|455773795|FG002|Whole Study|Withdrawal by Subject|0|||
126676974|NCT01423851|455773796|FG003|Whole Study|Withdrawal by Subject|0|||
126676975|NCT01423851|455773797|FG004|Whole Study|Withdrawal by Subject|0|||
126676976|NCT01423851|455773798|FG005|Whole Study|Withdrawal by Subject|0|||
126676977|NCT01423851|455773799|FG006|Whole Study|Withdrawal by Subject|0|||
126676978|NCT01423851|455773800|FG007|Whole Study|Withdrawal by Subject|0|||
126676979|NCT01423851|455773801|FG008|Whole Study|Withdrawal by Subject|2|||
126676980|NCT01423851|455773802|FG009|Whole Study|Withdrawal by Subject|0|||
126676981|NCT01423851|455773803|FG010|Whole Study|Withdrawal by Subject|4|||
126676982|NCT01423851|455773793|FG000|Whole Study|Adverse Event|0|||
126676983|NCT01423851|455773794|FG001|Whole Study|Adverse Event|0|||
126676984|NCT01423851|455773795|FG002|Whole Study|Adverse Event|0|||
126676985|NCT01423851|455773796|FG003|Whole Study|Adverse Event|2|||
126676986|NCT01423851|455773797|FG004|Whole Study|Adverse Event|0|||
126676987|NCT01423851|455773798|FG005|Whole Study|Adverse Event|0|||
126676988|NCT01423851|455773799|FG006|Whole Study|Adverse Event|0|||
126676989|NCT01423851|455773800|FG007|Whole Study|Adverse Event|3|||
126676990|NCT01423851|455773801|FG008|Whole Study|Adverse Event|3|||
126676991|NCT01423851|455773802|FG009|Whole Study|Adverse Event|2|||
126676992|NCT01423851|455773803|FG010|Whole Study|Adverse Event|3|||
126676993|NCT03416153|455773804|FG000|Overall Study|Physician Decision|1|||
126676994|NCT03416153|455773805|FG001|Overall Study|Physician Decision|1|||
126676995|NCT03416153|455773804|FG000|Overall Study|Withdrawal by Subject|1|||
126428603|NCT05148234|454864008|FG007|Phase I|Ineligible|1|||
126428604|NCT05148234|454864001|FG000|Phase I|Company closed the trial.|0|||
126428605|NCT05148234|454864002|FG001|Phase I|Company closed the trial.|1|||
126428606|NCT05148234|454864003|FG002|Phase I|Company closed the trial.|0|||
126428607|NCT05148234|454864004|FG003|Phase I|Company closed the trial.|0|||
126428608|NCT05148234|454864005|FG004|Phase I|Company closed the trial.|0|||
126428609|NCT05148234|454864006|FG005|Phase I|Company closed the trial.|0|||
126428610|NCT05148234|454864007|FG006|Phase I|Company closed the trial.|0|||
126428611|NCT05148234|454864008|FG007|Phase I|Company closed the trial.|0|||
126428612|NCT03061201|454864010|FG000|Overall Study|Participants Terminated at Month 36|0|||
126428613|NCT03061201|454864011|FG001|Overall Study|Participants Terminated at Month 36|1|||
126428614|NCT03061201|454864012|FG002|Overall Study|Participants Terminated at Month 36|0|||
126428615|NCT03061201|454864013|FG003|Overall Study|Participants Terminated at Month 36|1|||
126428616|NCT03061201|454864010|FG000|Overall Study|Lost to Follow-up|1|||
126428617|NCT03061201|454864011|FG001|Overall Study|Lost to Follow-up|0|||
126428618|NCT03061201|454864012|FG002|Overall Study|Lost to Follow-up|0|||
126428619|NCT03061201|454864013|FG003|Overall Study|Lost to Follow-up|0|||
126428658|NCT03062358|454864020|FG000|Overall Study|Death|269|||
126428659|NCT03062358|454864021|FG001|Overall Study|Death|145|||
126428660|NCT03062358|454864020|FG000|Overall Study|Withdrawal by Subject|2|||
126428661|NCT03062358|454864021|FG001|Overall Study|Withdrawal by Subject|1|||
126428662|NCT03062358|454864020|FG000|Overall Study|Sponsor Decision|29|||
126428663|NCT03062358|454864021|FG001|Overall Study|Sponsor Decision|7|||
126428664|NCT03861273|454864022|FG000|Screening Phase (3 Weeks)|Other|1|||
126428665|NCT03861273|454864022|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
126428666|NCT03861273|454864022|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
126428667|NCT03861273|454864022|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
126428668|NCT03861273|454864022|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
126676996|NCT03416153|455773805|FG001|Overall Study|Withdrawal by Subject|0|||
126676997|NCT00075023|455775237|FG000|Pilot Study|Physician Decision|1|||
126676998|NCT00075023|455775238|FG001|Pilot Study|Physician Decision|2|||
126676999|NCT00075023|455775237|FG000|Pilot Study|Withdrawal by Subject|1|||
126677000|NCT00075023|455775238|FG001|Pilot Study|Withdrawal by Subject|0|||
126677001|NCT03670953|455775239|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
126677002|NCT03670953|455775240|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
126677003|NCT03670953|455775241|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
126677004|NCT03670953|455775242|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
126677005|NCT03670953|455775239|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
126677006|NCT03670953|455775240|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
126677007|NCT03670953|455775241|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
126677008|NCT03670953|455775242|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
126677009|NCT03670953|455775239|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
126677010|NCT03670953|455775240|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
126677011|NCT03670953|455775241|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
126677012|NCT03670953|455775242|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
126677013|NCT03670953|455775239|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
126677014|NCT03670953|455775240|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
126677015|NCT03670953|455775241|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
126677016|NCT03670953|455775242|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
126677017|NCT03670953|455775239|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
126677018|NCT03670953|455775240|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
126677019|NCT03670953|455775241|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
126677020|NCT03670953|455775242|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
126677021|NCT03670953|455775239|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
126677022|NCT03670953|455775240|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
126677023|NCT03670953|455775241|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
126677024|NCT03670953|455775242|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
126677025|NCT03670953|455775239|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
126677026|NCT03670953|455775240|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
126677027|NCT03670953|455775241|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
126677028|NCT03670953|455775242|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
126677029|NCT03670953|455775239|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
126677030|NCT03670953|455775240|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
126677031|NCT03670953|455775241|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
126677032|NCT03670953|455775242|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
126428679|NCT03799341|454864027|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
126428680|NCT03799341|454864028|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
126428681|NCT03799341|454864029|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
126428682|NCT03799341|454864027|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
126428683|NCT03799341|454864028|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
126428684|NCT03799341|454864029|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
126428685|NCT03799341|454864027|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
126428686|NCT03799341|454864028|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
126428687|NCT03799341|454864029|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
126428688|NCT03799341|454864027|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
126428689|NCT03799341|454864028|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
126428690|NCT03799341|454864029|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
126428691|NCT03799341|454864027|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
126428692|NCT03799341|454864028|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
126428693|NCT03799341|454864029|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
126428694|NCT03799341|454864027|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
126428695|NCT03799341|454864028|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
126428696|NCT03799341|454864029|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
126677033|NCT03670953|455775239|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
126677034|NCT03670953|455775240|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
126677035|NCT03670953|455775241|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
126677036|NCT03670953|455775242|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
126677037|NCT03670953|455775239|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
126677038|NCT03670953|455775240|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
126677039|NCT03670953|455775241|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
126677040|NCT03670953|455775242|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
126677041|NCT03670953|455775239|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
126677042|NCT03670953|455775240|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
126677043|NCT03670953|455775241|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
126677044|NCT03670953|455775242|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
126677045|NCT03670953|455775239|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
126428710|NCT01116648|454864037|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
126428711|NCT01116648|454864038|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
126428712|NCT01116648|454864039|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
126428713|NCT01116648|454864040|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
126428714|NCT01116648|454864041|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
126428715|NCT01116648|454864042|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
126428716|NCT01116648|454864043|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
126428717|NCT01116648|454864044|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
126428718|NCT01116648|454864045|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
126428719|NCT01116648|454864046|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
126428720|NCT01116648|454864047|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
126428721|NCT01116648|454864048|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
126428722|NCT01116648|454864049|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
126428723|NCT01116648|454864050|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
126428724|NCT01116648|454864051|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
126428725|NCT04539938|454864052|FG000|Overall Study|Death|30|||
126428726|NCT04539938|454864052|FG000|Overall Study|Withdrawal by Subject|4|||
126428727|NCT03100149|454864666|FG000|Overall Study|Adverse Event|0|||
126428728|NCT03100149|454864667|FG001|Overall Study|Adverse Event|1|||
126428729|NCT03100149|454864668|FG002|Overall Study|Adverse Event|0|||
126428730|NCT03100149|454864666|FG000|Overall Study|Participant Moved out of Country|0|||
126428731|NCT03100149|454864667|FG001|Overall Study|Participant Moved out of Country|0|||
126428732|NCT03100149|454864668|FG002|Overall Study|Participant Moved out of Country|1|||
126428733|NCT03100149|454864666|FG000|Overall Study|Withdrawal by Subject|0|||
126428734|NCT03100149|454864667|FG001|Overall Study|Withdrawal by Subject|3|||
126428735|NCT03100149|454864668|FG002|Overall Study|Withdrawal by Subject|1|||
126677046|NCT03670953|455775240|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
126677047|NCT03670953|455775241|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
126677048|NCT03670953|455775242|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
126677049|NCT03670953|455775239|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
126677050|NCT03670953|455775240|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
126677051|NCT03670953|455775241|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
126677052|NCT03670953|455775242|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
126677053|NCT03670953|455775239|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
126677054|NCT03670953|455775240|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
126677055|NCT03670953|455775241|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
126677056|NCT03670953|455775242|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
126677057|NCT03670953|455775239|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
126677058|NCT03670953|455775240|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
126677059|NCT03670953|455775241|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
126677060|NCT03670953|455775242|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
126677061|NCT03670953|455775239|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
126677062|NCT03670953|455775240|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
126677063|NCT03670953|455775241|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
126677064|NCT03670953|455775242|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
126677065|NCT03670953|455775239|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
126677066|NCT03670953|455775240|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
126677067|NCT03670953|455775241|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
126677068|NCT03670953|455775242|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
126677069|NCT03670953|455775239|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
126677070|NCT03670953|455775240|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
126677071|NCT03670953|455775241|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
126677072|NCT03670953|455775242|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
126677073|NCT04342871|455775243|FG000|Overall Study|Death|4|||
126677074|NCT04342871|455775243|FG000|Overall Study|Clinical deterioration/illness progression|2|||
126677075|NCT04342871|455775243|FG000|Overall Study|Did not complete baseline assessments|5|||
126677076|NCT04342871|455775243|FG000|Overall Study|Lost to Follow-up|13|||
126677077|NCT00666458|455775245|FG000|Overall Study|Adverse Event|8|||
126342660|NCT04142242|454550544|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
126342661|NCT04142242|454550545|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
126342662|NCT04142242|454550540|FG000|Stage II|Non-compliance with the protocol|0|||
126342663|NCT04142242|454550541|FG001|Stage II|Non-compliance with the protocol|0|||
126342664|NCT04142242|454550542|FG002|Stage II|Non-compliance with the protocol|0|||
126342665|NCT04142242|454550543|FG003|Stage II|Non-compliance with the protocol|2|||
126342666|NCT04142242|454550544|FG004|Stage II|Non-compliance with the protocol|0|||
126342667|NCT04142242|454550545|FG005|Stage II|Non-compliance with the protocol|0|||
126342668|NCT04142242|454550540|FG000|Stage II|Lost to Follow-up|0|||
126342669|NCT04142242|454550541|FG001|Stage II|Lost to Follow-up|0|||
126342670|NCT04142242|454550542|FG002|Stage II|Lost to Follow-up|1|||
126342671|NCT04142242|454550543|FG003|Stage II|Lost to Follow-up|2|||
126342672|NCT04142242|454550544|FG004|Stage II|Lost to Follow-up|0|||
126342673|NCT04142242|454550545|FG005|Stage II|Lost to Follow-up|0|||
126342674|NCT04142242|454550540|FG000|Stage II|Withdrawal by Subject|0|||
126342675|NCT04142242|454550541|FG001|Stage II|Withdrawal by Subject|0|||
126342676|NCT04142242|454550542|FG002|Stage II|Withdrawal by Subject|5|||
126342677|NCT04142242|454550543|FG003|Stage II|Withdrawal by Subject|9|||
126342678|NCT04142242|454550544|FG004|Stage II|Withdrawal by Subject|0|||
126342679|NCT04142242|454550545|FG005|Stage II|Withdrawal by Subject|0|||
126342680|NCT03040726|454550546|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
126342681|NCT03040726|454550547|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
126342682|NCT03040726|454550546|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
126342683|NCT03040726|454550547|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
126342684|NCT03040726|454550546|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
126342685|NCT03040726|454550547|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
126342686|NCT03040726|454550546|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
126342687|NCT03040726|454550547|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
126342688|NCT03040726|454550546|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
126342689|NCT03040726|454550547|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
126342690|NCT05219162|454550550|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
126342691|NCT05219162|454550550|FG000|Overall Study|Withdrawal by Subject|23|||
126342692|NCT00666237|454550570|FG000|Overall Study|Death|5|||
126342693|NCT00666237|454550571|FG001|Overall Study|Death|5|||
126342694|NCT00666237|454550570|FG000|Overall Study|Lost to Follow-up|29|||
126342695|NCT00666237|454550571|FG001|Overall Study|Lost to Follow-up|25|||
126677078|NCT00666458|455775246|FG001|Overall Study|Adverse Event|7|||
126677079|NCT00666458|455775245|FG000|Overall Study|Withdrawal by Subject|5|||
126677080|NCT00666458|455775246|FG001|Overall Study|Withdrawal by Subject|4|||
126677081|NCT00666458|455775245|FG000|Overall Study|Lost to Follow-up|0|||
126677082|NCT00666458|455775246|FG001|Overall Study|Lost to Follow-up|3|||
126677083|NCT00666458|455775245|FG000|Overall Study|Administrative reason by sponsor|1|||
126677084|NCT00666458|455775246|FG001|Overall Study|Administrative reason by sponsor|1|||
126677085|NCT00666458|455775245|FG000|Overall Study|Incorrect enrollment|7|||
126677086|NCT00666458|455775246|FG001|Overall Study|Incorrect enrollment|1|||
126677087|NCT00666458|455775245|FG000|Overall Study|Study specific discontinuation criteria|14|||
126677088|NCT00666458|455775246|FG001|Overall Study|Study specific discontinuation criteria|7|||
126677089|NCT00666458|455775245|FG000|Overall Study|Severe non-compliance to the protocol|1|||
126677090|NCT00666458|455775246|FG001|Overall Study|Severe non-compliance to the protocol|1|||
126677091|NCT00666458|455775245|FG000|Overall Study|Safety reasons|1|||
126677092|NCT00666458|455775246|FG001|Overall Study|Safety reasons|0|||
126677093|NCT00666458|455775245|FG000|Overall Study|Medical history of anemia|1|||
126677094|NCT00666458|455775246|FG001|Overall Study|Medical history of anemia|0|||
126677095|NCT02222207|455775247|FG000|Overall Study|Death|1|||
126677096|NCT02222207|455775247|FG000|Overall Study|Other reasons|2|||
126677097|NCT02222207|455775247|FG000|Overall Study|Adverse Event|1|||
126677098|NCT02982954|455775248|FG000|Overall Study|Death|55|||
126677099|NCT02982954|455775249|FG001|Overall Study|Death|29|||
126677100|NCT02982954|455775250|FG002|Overall Study|Death|15|||
126677101|NCT02982954|455775251|FG003|Overall Study|Death|20|||
126677102|NCT02982954|455775248|FG000|Overall Study|Lost to Follow-up|2|||
126677103|NCT02982954|455775249|FG001|Overall Study|Lost to Follow-up|1|||
126677104|NCT02982954|455775250|FG002|Overall Study|Lost to Follow-up|0|||
126677105|NCT02982954|455775251|FG003|Overall Study|Lost to Follow-up|0|||
126677106|NCT02982954|455775248|FG000|Overall Study|Participant withdrew consent|7|||
126677107|NCT02982954|455775249|FG001|Overall Study|Participant withdrew consent|5|||
126677108|NCT02982954|455775250|FG002|Overall Study|Participant withdrew consent|1|||
126677109|NCT02982954|455775251|FG003|Overall Study|Participant withdrew consent|1|||
126677110|NCT02982954|455775248|FG000|Overall Study|Other reasons|42|||
126677111|NCT02982954|455775249|FG001|Overall Study|Other reasons|17|||
126677112|NCT02982954|455775250|FG002|Overall Study|Other reasons|12|||
126677113|NCT02982954|455775251|FG003|Overall Study|Other reasons|3|||
126677114|NCT02982954|455775248|FG000|Overall Study|Premature site closure|0|||
126677115|NCT02982954|455775249|FG001|Overall Study|Premature site closure|0|||
126677116|NCT02982954|455775250|FG002|Overall Study|Premature site closure|0|||
126677117|NCT02982954|455775251|FG003|Overall Study|Premature site closure|1|||
126677118|NCT01429584|455775252|FG000|Overall Study|Withdrawal by Subject|1|||
126677119|NCT01429584|455775253|FG001|Overall Study|Withdrawal by Subject|0|||
126677120|NCT01429584|455775252|FG000|Overall Study|Protocol Violation|0|||
126677121|NCT01429584|455775253|FG001|Overall Study|Protocol Violation|1|||
126677122|NCT00747643|455775257|FG000|Overall Study|Withdrawal by Subject|36|||
126677123|NCT00747643|455775258|FG001|Overall Study|Withdrawal by Subject|27|||
126677124|NCT00750698|455775259|FG000|Overall Study|Withdrawal by Subject|1|||
126677125|NCT00750698|455775260|FG001|Overall Study|Withdrawal by Subject|0|||
126677126|NCT00750698|455775259|FG000|Overall Study|Progressive disease|5|||
126677127|NCT00750698|455775260|FG001|Overall Study|Progressive disease|2|||
126677128|NCT04353284|455775261|FG000|Overall Study|Adverse Event|1|||
126677129|NCT04353284|455775262|FG001|Overall Study|Adverse Event|1|||
126677130|NCT04353284|455775261|FG000|Overall Study|Lost to Follow-up|1|||
126677131|NCT04353284|455775262|FG001|Overall Study|Lost to Follow-up|0|||
126677132|NCT00751400|455775265|FG000|Overall Study|Lost to Follow-up|10|||
126677133|NCT00441974|455775270|FG000|Overall Study|Adverse Event|6|||
126677134|NCT00441974|455775270|FG000|Overall Study|Consent Withdrawn|35|||
126677135|NCT00441974|455775270|FG000|Overall Study|Lost to Follow-up|80|||
126677136|NCT00441974|455775270|FG000|Overall Study|Protocol Violation|7|||
126677137|NCT02770547|455775271|FG000|Overall Study|Patient non-compliant|1|||
126677138|NCT02770547|455775272|FG001|Overall Study|Patient non-compliant|0|||
126677139|NCT02770547|455775271|FG000|Overall Study|Adverse Event|0|||
126677140|NCT02770547|455775272|FG001|Overall Study|Adverse Event|1|||
126677141|NCT01148537|455775273|FG000|Overall Study|Withdrawal by Subject|1|||
126677142|NCT01148537|455775274|FG001|Overall Study|Withdrawal by Subject|0|||
126677143|NCT01148537|455775275|FG002|Overall Study|Withdrawal by Subject|2|||
126677144|NCT01148537|455775273|FG000|Overall Study|Adverse Event|2|||
126677145|NCT01148537|455775274|FG001|Overall Study|Adverse Event|0|||
126677146|NCT01148537|455775275|FG002|Overall Study|Adverse Event|1|||
126677147|NCT00393887|455775276|FG000|Overall Study|Physician Decision|5|||
126677148|NCT00393887|455775277|FG001|Overall Study|Physician Decision|0|||
126677149|NCT00393887|455775276|FG000|Overall Study|Lost to Follow-up|11|||
126677150|NCT00393887|455775277|FG001|Overall Study|Lost to Follow-up|9|||
126677151|NCT02055820|455775285|FG000|Phase I: Dose-Finding|Death|1|||
126677152|NCT02055820|455775286|FG001|Phase I: Dose-Finding|Death|0|||
126677153|NCT02055820|455775287|FG002|Phase I: Dose-Finding|Death|1|||
126677154|NCT02055820|455775288|FG003|Phase I: Dose-Finding|Death|2|||
126677155|NCT02055820|455775289|FG004|Phase I: Dose-Finding|Death|0|||
126677156|NCT02055820|455775290|FG005|Phase I: Dose-Finding|Death|1|||
126677157|NCT02055820|455775291|FG006|Phase I: Dose-Finding|Death|1|||
126677158|NCT02055820|455775292|FG007|Phase I: Dose-Finding|Death|0|||
126677159|NCT02055820|455775293|FG008|Phase I: Dose-Finding|Death|0|||
126677160|NCT02055820|455775294|FG009|Phase I: Dose-Finding|Death|0|||
126677161|NCT02055820|455775285|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126677162|NCT02055820|455775286|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126677163|NCT02055820|455775287|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126677164|NCT02055820|455775288|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126677165|NCT02055820|455775289|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126677166|NCT02055820|455775290|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
126677167|NCT02055820|455775291|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126677168|NCT02055820|455775292|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126677169|NCT02055820|455775293|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126677170|NCT02055820|455775294|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
126677171|NCT02055820|455775285|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
126677172|NCT02055820|455775286|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
126677173|NCT02055820|455775287|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
126677174|NCT02055820|455775288|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
126677175|NCT02055820|455775289|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
126677176|NCT02055820|455775290|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
126677177|NCT02055820|455775291|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
126677178|NCT02055820|455775292|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
126677179|NCT02055820|455775293|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
126677180|NCT02055820|455775294|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
126677181|NCT02055820|455775285|FG000|Phase II: Expansion|Death|0|||
126677182|NCT02055820|455775286|FG001|Phase II: Expansion|Death|0|||
126677183|NCT02055820|455775287|FG002|Phase II: Expansion|Death|0|||
126677184|NCT02055820|455775288|FG003|Phase II: Expansion|Death|0|||
126677185|NCT02055820|455775289|FG004|Phase II: Expansion|Death|33|||
126677186|NCT02055820|455775290|FG005|Phase II: Expansion|Death|0|||
126677187|NCT02055820|455775291|FG006|Phase II: Expansion|Death|0|||
126677188|NCT02055820|455775292|FG007|Phase II: Expansion|Death|0|||
126677189|NCT02055820|455775293|FG008|Phase II: Expansion|Death|0|||
126677190|NCT02055820|455775294|FG009|Phase II: Expansion|Death|0|||
126677191|NCT02055820|455775285|FG000|Phase II: Expansion|Lost to Follow-up|0|||
126677192|NCT02055820|455775286|FG001|Phase II: Expansion|Lost to Follow-up|0|||
126342696|NCT03321721|454550572|FG000|Overall Study|Lost to Follow-up|4|||
126342697|NCT03321721|454550573|FG001|Overall Study|Lost to Follow-up|8|||
126342698|NCT03321721|454550574|FG002|Overall Study|Lost to Follow-up|11|||
126342699|NCT03353220|454550575|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
126342700|NCT03353220|454550576|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
126342701|NCT01673386|454552003|FG000|Overall Study|Study terminated by sponsor|16|||
126342702|NCT01673386|454552004|FG001|Overall Study|Study terminated by sponsor|22|||
126342703|NCT01673386|454552003|FG000|Overall Study|Adverse Event|5|||
126342704|NCT01673386|454552004|FG001|Overall Study|Adverse Event|2|||
126342705|NCT01673386|454552003|FG000|Overall Study|Progressive disease|4|||
126342706|NCT01673386|454552004|FG001|Overall Study|Progressive disease|1|||
126342707|NCT01673386|454552003|FG000|Overall Study|Withdrawal by Subject|0|||
126342708|NCT01673386|454552004|FG001|Overall Study|Withdrawal by Subject|2|||
126342709|NCT01075048|454552005|FG000|Overall Study|Death|4|||
126342710|NCT01075048|454552006|FG001|Overall Study|Death|17|||
126342711|NCT01075048|454552007|FG002|Overall Study|Death|12|||
126342712|NCT01075048|454552005|FG000|Overall Study|Start of other or new therapy|4|||
126342713|NCT01075048|454552006|FG001|Overall Study|Start of other or new therapy|36|||
126342714|NCT01075048|454552007|FG002|Overall Study|Start of other or new therapy|46|||
126342715|NCT01075048|454552005|FG000|Overall Study|Withdrawal by Subject|1|||
126342716|NCT01075048|454552006|FG001|Overall Study|Withdrawal by Subject|6|||
126342717|NCT01075048|454552007|FG002|Overall Study|Withdrawal by Subject|3|||
126342718|NCT01075048|454552005|FG000|Overall Study|Lost to Follow-up|0|||
126342719|NCT01075048|454552006|FG001|Overall Study|Lost to Follow-up|1|||
126342720|NCT01075048|454552007|FG002|Overall Study|Lost to Follow-up|1|||
126342721|NCT01287936|454552011|FG000|Overall Study|Lost to Follow-up|0|||
126342722|NCT01287936|454552012|FG001|Overall Study|Lost to Follow-up|1|||
126342723|NCT01287936|454552013|FG002|Overall Study|Lost to Follow-up|1|||
126342724|NCT00336544|454552014|FG000|Overall Study|Lack of Efficacy|8|||
126342725|NCT00336544|454552015|FG001|Overall Study|Lack of Efficacy|5|||
126342726|NCT00336544|454552014|FG000|Overall Study|Adverse Event|4|||
126342727|NCT00336544|454552015|FG001|Overall Study|Adverse Event|9|||
126342728|NCT00336544|454552014|FG000|Overall Study|Withdrawal by Subject|4|||
126342729|NCT00336544|454552015|FG001|Overall Study|Withdrawal by Subject|3|||
126342730|NCT00336544|454552014|FG000|Overall Study|Other|3|||
126342731|NCT00336544|454552015|FG001|Overall Study|Other|5|||
126342732|NCT01649765|454552016|FG000|Overall Study|Adverse Event|5|||
126677193|NCT02055820|455775287|FG002|Phase II: Expansion|Lost to Follow-up|0|||
126677194|NCT02055820|455775288|FG003|Phase II: Expansion|Lost to Follow-up|0|||
126677195|NCT02055820|455775289|FG004|Phase II: Expansion|Lost to Follow-up|4|||
126677196|NCT02055820|455775290|FG005|Phase II: Expansion|Lost to Follow-up|0|||
126677197|NCT02055820|455775291|FG006|Phase II: Expansion|Lost to Follow-up|0|||
126677198|NCT02055820|455775292|FG007|Phase II: Expansion|Lost to Follow-up|0|||
126677199|NCT02055820|455775293|FG008|Phase II: Expansion|Lost to Follow-up|0|||
126677200|NCT02055820|455775294|FG009|Phase II: Expansion|Lost to Follow-up|0|||
126677201|NCT02055820|455775285|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
126677202|NCT02055820|455775286|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
126677203|NCT02055820|455775287|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
126677204|NCT02055820|455775288|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
126677205|NCT02055820|455775289|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
126677206|NCT02055820|455775290|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
126677207|NCT02055820|455775291|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
126677208|NCT02055820|455775292|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
126677209|NCT02055820|455775293|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
126677210|NCT02055820|455775294|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
126677211|NCT02018822|455775295|FG000|Overall Study|filling replaced by crown|0|||
126677212|NCT02018822|455775296|FG001|Overall Study|filling replaced by crown|1|||
126677213|NCT02018822|455775297|FG002|Overall Study|filling replaced by crown|0|||
126677214|NCT02018822|455775295|FG000|Overall Study|Physician Decision|0|||
126677215|NCT02018822|455775296|FG001|Overall Study|Physician Decision|1|||
126677216|NCT02018822|455775297|FG002|Overall Study|Physician Decision|1|||
126677217|NCT02018822|455775295|FG000|Overall Study|Lost to Follow-up|6|||
126677218|NCT02018822|455775296|FG001|Overall Study|Lost to Follow-up|6|||
126677219|NCT02018822|455775297|FG002|Overall Study|Lost to Follow-up|5|||
126677220|NCT00715026|455775298|FG000|Overall Study|Withdrawal by Subject|5|||
126677221|NCT00715026|455775298|FG000|Overall Study|Lost to Follow-up|3|||
126677222|NCT00715026|455775298|FG000|Overall Study|Protocol Violation|1|||
126677223|NCT00715026|455775298|FG000|Overall Study|Surgery done on non-study consented hip|1|||
126677224|NCT01389752|455775301|FG000|Study Period 1|Sponsor decision|0|||
126677225|NCT01389752|455775302|FG001|Study Period 1|Sponsor decision|2|||
126677226|NCT01389752|455775301|FG000|Study Period 2|Sponsor decision|1|||
126677227|NCT01389752|455775302|FG001|Study Period 2|Sponsor decision|0|||
126677228|NCT04251910|455775310|FG000|Overall Study|Covid 19 lockdown|0|||
126677229|NCT04251910|455775311|FG001|Overall Study|Covid 19 lockdown|5|||
126677230|NCT04251910|455775312|FG002|Overall Study|Covid 19 lockdown|0|||
126677231|NCT04251910|455775313|FG003|Overall Study|Covid 19 lockdown|4|||
126677232|NCT04251910|455775314|FG004|Overall Study|Covid 19 lockdown|0|||
126677233|NCT04251910|455775315|FG005|Overall Study|Covid 19 lockdown|0|||
126677234|NCT04251910|455775310|FG000|Overall Study|Assisted living facility was closed|0|||
126677235|NCT04251910|455775311|FG001|Overall Study|Assisted living facility was closed|0|||
126677236|NCT04251910|455775312|FG002|Overall Study|Assisted living facility was closed|0|||
126677237|NCT04251910|455775313|FG003|Overall Study|Assisted living facility was closed|0|||
126677238|NCT04251910|455775314|FG004|Overall Study|Assisted living facility was closed|1|||
126677239|NCT04251910|455775315|FG005|Overall Study|Assisted living facility was closed|0|||
126677240|NCT00841568|455775318|FG000|Overall Study|Adverse Event|1|||
126677241|NCT00841568|455775318|FG000|Overall Study|Death|1|||
126677242|NCT00841568|455775318|FG000|Overall Study|Withdrawal by Subject|2|||
126677243|NCT00841568|455775318|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
126677244|NCT00133991|455775319|FG000|Overall Study|Death|4|||
126677245|NCT03002155|455775320|FG000|Overall Study|Lost to Follow-up|1|||
126677246|NCT03002155|455775321|FG001|Overall Study|Lost to Follow-up|2|||
126677247|NCT03002155|455775320|FG000|Overall Study|Withdrawal by Subject|1|||
126677248|NCT03002155|455775321|FG001|Overall Study|Withdrawal by Subject|0|||
126677249|NCT03002155|455775320|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
126677250|NCT03002155|455775321|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
126677251|NCT00978029|455775322|FG000|Overall Study|Adverse Event|1|||
126677252|NCT00978029|455775323|FG001|Overall Study|Adverse Event|2|||
126677253|NCT00978029|455775324|FG002|Overall Study|Adverse Event|5|||
126677254|NCT00978029|455775322|FG000|Overall Study|Withdrawal by Subject|0|||
126677255|NCT00978029|455775323|FG001|Overall Study|Withdrawal by Subject|0|||
126677256|NCT00978029|455775324|FG002|Overall Study|Withdrawal by Subject|1|||
126677257|NCT00978029|455775322|FG000|Overall Study|Protocol Violation|0|||
126677258|NCT00978029|455775323|FG001|Overall Study|Protocol Violation|1|||
126677259|NCT00978029|455775324|FG002|Overall Study|Protocol Violation|0|||
126677260|NCT01553188|455775326|FG000|Overall Study|Patient choice|1|||
126677261|NCT01553188|455775327|FG001|Overall Study|Patient choice|0|||
126677262|NCT01553188|455775328|FG002|Overall Study|Patient choice|0|||
126677263|NCT01553188|455775329|FG003|Overall Study|Patient choice|0|||
126677264|NCT01553188|455775326|FG000|Overall Study|Intercurrent illness and adverse event|0|||
126677265|NCT01553188|455775327|FG001|Overall Study|Intercurrent illness and adverse event|1|||
126677266|NCT01553188|455775328|FG002|Overall Study|Intercurrent illness and adverse event|2|||
126677267|NCT01553188|455775329|FG003|Overall Study|Intercurrent illness and adverse event|0|||
126428809|NCT04972162|454864699|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
126428810|NCT04972162|454864700|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
126428816|NCT00336024|454864702|FG000|Overall Study|Death|2|||
126428817|NCT00336024|454864703|FG001|Overall Study|Death|1|||
126428818|NCT00336024|454864702|FG000|Overall Study|Physician Decision|4|||
126428819|NCT00336024|454864703|FG001|Overall Study|Physician Decision|1|||
126428820|NCT00336024|454864702|FG000|Overall Study|Protocol Violation|1|||
126428821|NCT00336024|454864703|FG001|Overall Study|Protocol Violation|0|||
126428822|NCT00336024|454864702|FG000|Overall Study|Withdrawal by Subject|1|||
126428823|NCT00336024|454864703|FG001|Overall Study|Withdrawal by Subject|2|||
126428824|NCT00336024|454864702|FG000|Overall Study|Failure to fulfill consolidation|1|||
126428825|NCT00336024|454864703|FG001|Overall Study|Failure to fulfill consolidation|1|||
126428826|NCT00336024|454864702|FG000|Overall Study|Progressive Disease|4|||
126428827|NCT00336024|454864703|FG001|Overall Study|Progressive Disease|7|||
126428828|NCT00336024|454864702|FG000|Overall Study|Ineligible|7|||
126428829|NCT00336024|454864703|FG001|Overall Study|Ineligible|7|||
126677268|NCT04744207|455775331|FG000|Treatment|Withdrawal by Subject|2|||
126677269|NCT04744207|455775332|FG001|Treatment|Withdrawal by Subject|0|||
126677270|NCT04744207|455775331|FG000|Treatment|Adverse Event|1|||
126463788|NCT00423670|455000237|FG006|Follow-up Period|Non-compliance with protocol|3|||
126677271|NCT04744207|455775332|FG001|Treatment|Adverse Event|2|||
126428848|NCT04245111|454866501|FG000|Overall Study|Lost to Follow-up|5|||
126428849|NCT04245111|454866502|FG001|Overall Study|Lost to Follow-up|1|||
126428850|NCT04245111|454866503|FG002|Overall Study|Lost to Follow-up|1|||
126428851|NCT03192176|454866504|FG000|Overall Study|Adverse Event|1|||
126428852|NCT03192176|454866505|FG001|Overall Study|Adverse Event|0|||
126428853|NCT03192176|454866506|FG002|Overall Study|Adverse Event|4|||
126428854|NCT03192176|454866507|FG003|Overall Study|Adverse Event|5|||
126428855|NCT03192176|454866508|FG004|Overall Study|Adverse Event|3|||
126428856|NCT03192176|454866509|FG005|Overall Study|Adverse Event|2|||
126428857|NCT03192176|454866510|FG006|Overall Study|Adverse Event|3|||
126428858|NCT03192176|454866511|FG007|Overall Study|Adverse Event|3|||
126428859|NCT03192176|454866504|FG000|Overall Study|Lost to Follow-up|0|||
126428860|NCT03192176|454866505|FG001|Overall Study|Lost to Follow-up|0|||
126428861|NCT03192176|454866506|FG002|Overall Study|Lost to Follow-up|1|||
126428862|NCT03192176|454866507|FG003|Overall Study|Lost to Follow-up|2|||
126428863|NCT03192176|454866508|FG004|Overall Study|Lost to Follow-up|3|||
126428864|NCT03192176|454866509|FG005|Overall Study|Lost to Follow-up|1|||
126428865|NCT03192176|454866510|FG006|Overall Study|Lost to Follow-up|1|||
126428866|NCT03192176|454866511|FG007|Overall Study|Lost to Follow-up|1|||
126428867|NCT03192176|454866504|FG000|Overall Study|Physician Decision|1|||
126428868|NCT03192176|454866505|FG001|Overall Study|Physician Decision|0|||
126428869|NCT03192176|454866506|FG002|Overall Study|Physician Decision|0|||
126428870|NCT03192176|454866507|FG003|Overall Study|Physician Decision|0|||
126677272|NCT05289570|455775337|FG000|Overall Study|Physician Decision|1|||
126677273|NCT01617070|455775339|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
126677274|NCT00777101|455775340|FG000|Overall Study|Death|48|||
126428871|NCT03192176|454866508|FG004|Overall Study|Physician Decision|0|||
126428872|NCT03192176|454866509|FG005|Overall Study|Physician Decision|2|||
126428873|NCT03192176|454866510|FG006|Overall Study|Physician Decision|1|||
126428874|NCT03192176|454866511|FG007|Overall Study|Physician Decision|0|||
126428875|NCT03192176|454866504|FG000|Overall Study|Protocol Deviation|1|||
126428876|NCT03192176|454866505|FG001|Overall Study|Protocol Deviation|1|||
126428877|NCT03192176|454866506|FG002|Overall Study|Protocol Deviation|0|||
126428878|NCT03192176|454866507|FG003|Overall Study|Protocol Deviation|0|||
126428879|NCT03192176|454866508|FG004|Overall Study|Protocol Deviation|2|||
126428880|NCT03192176|454866509|FG005|Overall Study|Protocol Deviation|0|||
126428881|NCT03192176|454866510|FG006|Overall Study|Protocol Deviation|0|||
126428882|NCT03192176|454866511|FG007|Overall Study|Protocol Deviation|0|||
126428883|NCT03192176|454866504|FG000|Overall Study|Withdrawal by Subject|3|||
126428884|NCT03192176|454866505|FG001|Overall Study|Withdrawal by Subject|4|||
126428885|NCT03192176|454866506|FG002|Overall Study|Withdrawal by Subject|0|||
126428886|NCT03192176|454866507|FG003|Overall Study|Withdrawal by Subject|4|||
126428887|NCT03192176|454866508|FG004|Overall Study|Withdrawal by Subject|3|||
126428888|NCT03192176|454866509|FG005|Overall Study|Withdrawal by Subject|4|||
126428889|NCT03192176|454866510|FG006|Overall Study|Withdrawal by Subject|4|||
126428890|NCT03192176|454866511|FG007|Overall Study|Withdrawal by Subject|2|||
126428891|NCT03192176|454866504|FG000|Overall Study|Miscellaneous|1|||
126428892|NCT03192176|454866505|FG001|Overall Study|Miscellaneous|0|||
126428893|NCT03192176|454866506|FG002|Overall Study|Miscellaneous|1|||
126428894|NCT03192176|454866507|FG003|Overall Study|Miscellaneous|1|||
126428895|NCT03192176|454866508|FG004|Overall Study|Miscellaneous|1|||
126428896|NCT03192176|454866509|FG005|Overall Study|Miscellaneous|2|||
126428897|NCT03192176|454866510|FG006|Overall Study|Miscellaneous|0|||
126428898|NCT03192176|454866511|FG007|Overall Study|Miscellaneous|1|||
126428899|NCT03532542|454866514|FG000|Overall Study|Death|1|||
126677275|NCT00777101|455775341|FG001|Overall Study|Death|43|||
126677276|NCT00777101|455775340|FG000|Overall Study|Withdrawal by Subject|11|||
126677277|NCT00777101|455775341|FG001|Overall Study|Withdrawal by Subject|6|||
126677278|NCT00777101|455775340|FG000|Overall Study|Lost to Follow-up|2|||
126677279|NCT00777101|455775341|FG001|Overall Study|Lost to Follow-up|1|||
126428900|NCT03532542|454866515|FG001|Overall Study|Death|0|||
126428901|NCT03532542|454866514|FG000|Overall Study|Study Terminated by Sponsor|41|||
126428902|NCT03532542|454866515|FG001|Overall Study|Study Terminated by Sponsor|65|||
126428903|NCT03532542|454866514|FG000|Overall Study|Withdrawal by Subject|6|||
126428904|NCT03532542|454866515|FG001|Overall Study|Withdrawal by Subject|5|||
126428905|NCT01962441|454866516|FG000|Randomized Period|Randomized but Never Treated|4|||
126677280|NCT00777101|455775340|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
126677281|NCT00777101|455775341|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
126677282|NCT00777101|455775340|FG000|Overall Study|Failed to Return|0|||
126677283|NCT00777101|455775341|FG001|Overall Study|Failed to Return|1|||
126428906|NCT01962441|454866517|FG001|Randomized Period|Randomized but Never Treated|2|||
126428907|NCT01962441|454866518|FG002|Randomized Period|Randomized but Never Treated|3|||
126428908|NCT01962441|454866516|FG000|Randomized Period|Lost to Follow-up|2|||
126428909|NCT01962441|454866517|FG001|Randomized Period|Lost to Follow-up|4|||
126428910|NCT01962441|454866518|FG002|Randomized Period|Lost to Follow-up|4|||
126428911|NCT01962441|454866516|FG000|Randomized Period|Withdrew Consent|3|||
126428912|NCT01962441|454866517|FG001|Randomized Period|Withdrew Consent|3|||
126428913|NCT01962441|454866518|FG002|Randomized Period|Withdrew Consent|2|||
126677284|NCT02230384|455775342|FG000|Phase 1|Lost to Follow-up|1|||
126677285|NCT02230384|455775343|FG001|Phase 1|Lost to Follow-up|0|||
126677286|NCT02230384|455775342|FG000|Phase 1|Physician Decision|0|||
126677287|NCT02230384|455775343|FG001|Phase 1|Physician Decision|1|||
126677288|NCT02230384|455775342|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
126677289|NCT02230384|455775343|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
126677290|NCT02230384|455775342|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
126677291|NCT02230384|455775343|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
126677292|NCT02230384|455775342|FG000|Phase 2 - Switch|Adverse Event|2|||
126677293|NCT02230384|455775343|FG001|Phase 2 - Switch|Adverse Event|0|||
126677294|NCT00808236|455775344|FG000|Overall Study|Was not resuscitated|50|||
126677295|NCT00808236|455775345|FG001|Overall Study|Was not resuscitated|56|||
126677296|NCT00808236|455775344|FG000|Overall Study|Pre-defined exclusion|13|||
126677297|NCT00808236|455775345|FG001|Overall Study|Pre-defined exclusion|3|||
126677298|NCT00808236|455775344|FG000|Overall Study|Lost to Follow-up|1|||
126677299|NCT00808236|455775345|FG001|Overall Study|Lost to Follow-up|1|||
126677300|NCT00808236|455775344|FG000|Overall Study|Physician Decision|0|||
126677301|NCT00808236|455775345|FG001|Overall Study|Physician Decision|1|||
126677302|NCT00808236|455775344|FG000|Overall Study|Death|18|||
126677303|NCT00808236|455775345|FG001|Overall Study|Death|30|||
126677304|NCT00961220|455775346|FG000|Overall Study|Adverse Event|3|||
126677305|NCT00961220|455775346|FG000|Overall Study|Lack of Efficacy|1|||
126677306|NCT00961220|455775346|FG000|Overall Study|No IV access for O6BG|1|||
126677307|NCT00961220|455775346|FG000|Overall Study|O6BG no longer supplied|1|||
126677308|NCT00961220|455775346|FG000|Overall Study|Complete Response prior to 12 courses|1|||
126677309|NCT05376215|455775347|FG000|Overall Study|Withdrawal by Subject|2|||
126677310|NCT05376215|455775348|FG001|Overall Study|Withdrawal by Subject|1|||
126677311|NCT05376215|455775347|FG000|Overall Study|Lost to Follow-up|0|||
126677312|NCT05376215|455775348|FG001|Overall Study|Lost to Follow-up|1|||
126677313|NCT01301950|455775355|FG000|Overall Study|Surgery was cancelled by patient|0|||
126677314|NCT01301950|455775356|FG001|Overall Study|Surgery was cancelled by patient|1|||
126677315|NCT00786565|455775366|FG000|Enrollment Prior to Surgery|Site Closed|3|||
126677316|NCT00786565|455775366|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
126677317|NCT00786565|455775366|FG000|Post Surgery|Abnormal macular pucker|1|||
126677318|NCT00786565|455775366|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
126677319|NCT05248295|455775372|FG000|Overall Study|found ineligible|4|||
126677320|NCT05248295|455775373|FG001|Overall Study|found ineligible|1|||
126677321|NCT05248295|455775372|FG000|Overall Study|Withdrawal by Subject|0|||
126677322|NCT05248295|455775373|FG001|Overall Study|Withdrawal by Subject|1|||
126677323|NCT05248295|455775372|FG000|Overall Study|Data loss: audio recording error|1|||
126677324|NCT05248295|455775373|FG001|Overall Study|Data loss: audio recording error|1|||
126677325|NCT03021499|455775374|FG000|Overall Study|Adverse Event|1|||
126677326|NCT03021499|455775375|FG001|Overall Study|Adverse Event|0|||
126677327|NCT03021499|455775374|FG000|Overall Study|Death|1|||
126677328|NCT03021499|455775375|FG001|Overall Study|Death|5|||
126677329|NCT03021499|455775374|FG000|Overall Study|Lack of Efficacy|0|||
126677330|NCT03021499|455775375|FG001|Overall Study|Lack of Efficacy|1|||
126677331|NCT03021499|455775374|FG000|Overall Study|Lost to Follow-up|1|||
126677332|NCT03021499|455775375|FG001|Overall Study|Lost to Follow-up|3|||
126677333|NCT03021499|455775374|FG000|Overall Study|Physician Decision|2|||
126677334|NCT03021499|455775375|FG001|Overall Study|Physician Decision|3|||
126677335|NCT03021499|455775374|FG000|Overall Study|Pregnancy|1|||
126677336|NCT03021499|455775375|FG001|Overall Study|Pregnancy|0|||
126677337|NCT03021499|455775374|FG000|Overall Study|Withdrawal by Subject|7|||
126677338|NCT03021499|455775375|FG001|Overall Study|Withdrawal by Subject|14|||
126677339|NCT03021499|455775374|FG000|Overall Study|Prohibited medication required|1|||
126677340|NCT03021499|455775375|FG001|Overall Study|Prohibited medication required|0|||
126677341|NCT03021499|455775374|FG000|Overall Study|Protocol non-compliance|1|||
126677342|NCT03021499|455775375|FG001|Overall Study|Protocol non-compliance|1|||
126677343|NCT03021499|455775374|FG000|Overall Study|None of the above|0|||
126677344|NCT03021499|455775375|FG001|Overall Study|None of the above|4|||
126677345|NCT03021499|455775374|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
126677346|NCT03021499|455775375|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
126677347|NCT01210690|455775376|FG000|Overall Study|Adverse Event|7|||
126677348|NCT01210690|455775376|FG000|Overall Study|Lack of Efficacy|12|||
126677349|NCT01210690|455775376|FG000|Overall Study|Lost to Follow-up|3|||
126677350|NCT01210690|455775376|FG000|Overall Study|Disease Remission|1|||
126677351|NCT01210690|455775376|FG000|Overall Study|Withdrawal by Subject|1|||
126677352|NCT01210690|455775376|FG000|Overall Study|Patient refused to swallow|1|||
126677353|NCT01210690|455775376|FG000|Overall Study|Patient could not take glucose|1|||
126677354|NCT00470054|455775377|FG000|Overall Study|Ineligible|1|||
126677355|NCT04869345|455775384|FG000|Overall Study|Lost to Follow-up|8|||
126677356|NCT04869345|455775385|FG001|Overall Study|Lost to Follow-up|3|||
126677357|NCT00528021|455775389|FG000|Overall Study|Lack of Efficacy|17|||
126677358|NCT00528021|455775390|FG001|Overall Study|Lack of Efficacy|13|||
126677359|NCT00528021|455775391|FG002|Overall Study|Lack of Efficacy|7|||
126677360|NCT00528021|455775392|FG003|Overall Study|Lack of Efficacy|9|||
126677361|NCT04050982|455775393|FG000|Overall Study|Did not meet eligibility criteria|0|||
126677362|NCT04050982|455775394|FG001|Overall Study|Did not meet eligibility criteria|1|||
126677363|NCT04050982|455775395|FG002|Overall Study|Did not meet eligibility criteria|0|||
126677364|NCT04050982|455775393|FG000|Overall Study|Withdrawal by Subject|1|||
126677365|NCT04050982|455775394|FG001|Overall Study|Withdrawal by Subject|0|||
126677366|NCT04050982|455775395|FG002|Overall Study|Withdrawal by Subject|0|||
126677367|NCT04050982|455775393|FG000|Overall Study|Unable to enroll on platform|1|||
126677368|NCT04050982|455775394|FG001|Overall Study|Unable to enroll on platform|0|||
126677369|NCT04050982|455775395|FG002|Overall Study|Unable to enroll on platform|0|||
126677370|NCT05054114|455775396|FG000|Overall Study|Protocol Violation|13|||
126677371|NCT05054114|455775397|FG001|Overall Study|Protocol Violation|1|||
126677372|NCT05054114|455775396|FG000|Overall Study|Pregnancy|0|||
126677373|NCT05054114|455775397|FG001|Overall Study|Pregnancy|1|||
126677374|NCT00733954|455775398|FG000|Overall Study|Lost to Follow-up|5|||
126677375|NCT00733954|455775399|FG001|Overall Study|Lost to Follow-up|2|||
126677376|NCT00733954|455775398|FG000|Overall Study|Protocol Violation|1|||
126677377|NCT00733954|455775399|FG001|Overall Study|Protocol Violation|0|||
126677378|NCT00733954|455775398|FG000|Overall Study|Withdrawal by Subject|2|||
126677379|NCT00733954|455775399|FG001|Overall Study|Withdrawal by Subject|0|||
126677380|NCT02663453|455775400|FG000|Overall Study|Death|4|||
126677381|NCT02663453|455775401|FG001|Overall Study|Death|4|||
126677382|NCT02663453|455775400|FG000|Overall Study|Withdrawal by Subject|1|||
126677383|NCT02663453|455775401|FG001|Overall Study|Withdrawal by Subject|0|||
126677384|NCT03557281|455777330|FG000|Overall Study|Investigator discretion|0|||
126677385|NCT03557281|455777331|FG001|Overall Study|Investigator discretion|0|||
126677386|NCT03557281|455777332|FG002|Overall Study|Investigator discretion|1|||
126677387|NCT03557281|455777333|FG003|Overall Study|Investigator discretion|0|||
126677388|NCT03557281|455777334|FG004|Overall Study|Investigator discretion|0|||
126677389|NCT03557281|455777330|FG000|Overall Study|Withdrawal by Subject|0|||
126677390|NCT03557281|455777331|FG001|Overall Study|Withdrawal by Subject|1|||
126677391|NCT03557281|455777332|FG002|Overall Study|Withdrawal by Subject|1|||
126677392|NCT03557281|455777333|FG003|Overall Study|Withdrawal by Subject|1|||
126677393|NCT03557281|455777334|FG004|Overall Study|Withdrawal by Subject|2|||
126677394|NCT03557281|455777330|FG000|Overall Study|Randomized, but did not receive treatment|0|||
126677395|NCT03557281|455777331|FG001|Overall Study|Randomized, but did not receive treatment|0|||
126677396|NCT03557281|455777332|FG002|Overall Study|Randomized, but did not receive treatment|0|||
126677397|NCT03557281|455777333|FG003|Overall Study|Randomized, but did not receive treatment|0|||
126677398|NCT03557281|455777334|FG004|Overall Study|Randomized, but did not receive treatment|1|||
126677399|NCT00402649|455777335|FG000|Overall Study|Lost to Follow-up|1|||
126677400|NCT00402649|455777335|FG000|Overall Study|Withdrawal by Subject|1|||
126677401|NCT01999465|455777336|FG000|Overall Study|Lost to Follow-up|0|||
126677402|NCT01999465|455777337|FG001|Overall Study|Lost to Follow-up|2|||
126677403|NCT01999465|455777336|FG000|Overall Study|Protocol Violation|0|||
126677404|NCT01999465|455777337|FG001|Overall Study|Protocol Violation|1|||
126677405|NCT01611974|455777346|FG000|Overall Study|Death|10|||
126677406|NCT01611974|455777347|FG001|Overall Study|Death|12|||
126677407|NCT01611974|455777348|FG002|Overall Study|Death|10|||
126342733|NCT01649765|454552017|FG001|Overall Study|Adverse Event|3|||
126342734|NCT01649765|454552016|FG000|Overall Study|Lack of Efficacy|1|||
126342735|NCT01649765|454552017|FG001|Overall Study|Lack of Efficacy|1|||
126342736|NCT01649765|454552016|FG000|Overall Study|Physician Decision|0|||
126342737|NCT01649765|454552017|FG001|Overall Study|Physician Decision|3|||
126342738|NCT01649765|454552016|FG000|Overall Study|Protocol Violation|1|||
126342739|NCT01649765|454552017|FG001|Overall Study|Protocol Violation|0|||
126342740|NCT01649765|454552016|FG000|Overall Study|Withdrawal by Subject|2|||
126342741|NCT01649765|454552017|FG001|Overall Study|Withdrawal by Subject|1|||
126342742|NCT01316614|454552018|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
126342743|NCT01316614|454552018|FG000|Overall Study|Cytology slides not available for review|4|||
126342744|NCT01316614|454552018|FG000|Overall Study|Cystic lesion|5|||
126342745|NCT01316614|454552018|FG000|Overall Study|Inadequate number of passes|2|||
126342746|NCT01316614|454552018|FG000|Overall Study|Medically unstable|1|||
126342747|NCT03427411|454552019|FG000|Overall Study|Screen failure - platelets too low|0|||
126342748|NCT03427411|454552020|FG001|Overall Study|Screen failure - platelets too low|1|||
126342749|NCT00076570|454552021|FG000|Overall Study|Drug intolerance|8|||
126342750|NCT00076570|454552022|FG001|Overall Study|Drug intolerance|8|||
126342751|NCT00998946|454552023|FG000|Overall Study|Lost to Follow-up|1|||
126342752|NCT00998946|454552023|FG000|Overall Study|Withdrawal by Subject|1|||
126342753|NCT00998946|454552023|FG000|Overall Study|Death|2|||
126342754|NCT00998946|454552023|FG000|Overall Study|Reason Unspecified|3|||
126342755|NCT00998946|454552023|FG000|Overall Study|Enrolled but not Dosed|2|||
126342756|NCT00701363|454552030|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
126342757|NCT00701363|454552031|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
126342758|NCT00701363|454552032|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
126342759|NCT00701363|454552033|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
126342760|NCT00701363|454552030|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
126342761|NCT00701363|454552031|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
126677408|NCT01611974|455777346|FG000|Overall Study|Lost to Follow-up|0|||
126677409|NCT01611974|455777347|FG001|Overall Study|Lost to Follow-up|1|||
126677410|NCT01611974|455777348|FG002|Overall Study|Lost to Follow-up|0|||
126677411|NCT01611974|455777346|FG000|Overall Study|Physician Decision|5|||
126677412|NCT01611974|455777347|FG001|Overall Study|Physician Decision|1|||
126677413|NCT01611974|455777348|FG002|Overall Study|Physician Decision|2|||
126677414|NCT01611974|455777346|FG000|Overall Study|Withdrawal by Subject|0|||
126677415|NCT01611974|455777347|FG001|Overall Study|Withdrawal by Subject|1|||
126677416|NCT01611974|455777348|FG002|Overall Study|Withdrawal by Subject|4|||
126677417|NCT02554019|455777349|FG000|Overall Study|Withdrawal by Subject|1|||
126677418|NCT02554019|455777350|FG001|Overall Study|Withdrawal by Subject|0|||
126677419|NCT02554019|455777351|FG002|Overall Study|Withdrawal by Subject|2|||
126677420|NCT02554019|455777349|FG000|Overall Study|Adverse Event|1|||
126677421|NCT02554019|455777350|FG001|Overall Study|Adverse Event|0|||
126677422|NCT02554019|455777351|FG002|Overall Study|Adverse Event|0|||
126677423|NCT00916357|455777352|FG000|Period 1|Withdrawal by Subject|1|||
126677424|NCT00916357|455777353|FG001|Period 1|Withdrawal by Subject|0|||
126677425|NCT00916357|455777354|FG002|Period 1|Withdrawal by Subject|0|||
126677426|NCT00916357|455777355|FG003|Period 1|Withdrawal by Subject|0|||
126677427|NCT00916357|455777356|FG004|Period 1|Withdrawal by Subject|0|||
126677428|NCT00916357|455777357|FG005|Period 1|Withdrawal by Subject|0|||
126677429|NCT00916357|455777352|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
126677430|NCT00916357|455777353|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
126677431|NCT00916357|455777354|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
126428914|NCT01962441|454866516|FG000|Randomized Period|Adverse Event|1|||
126428915|NCT01962441|454866517|FG001|Randomized Period|Adverse Event|1|||
126428916|NCT01962441|454866518|FG002|Randomized Period|Adverse Event|0|||
126428917|NCT01962441|454866516|FG000|Randomized Period|Death|0|||
126428918|NCT01962441|454866517|FG001|Randomized Period|Death|0|||
126428919|NCT01962441|454866518|FG002|Randomized Period|Death|2|||
126677432|NCT00916357|455777355|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
126677433|NCT00916357|455777356|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
126677434|NCT00916357|455777357|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
126677435|NCT01308008|455777358|FG000|4 Weeks|Illness, disinterest, time|9|||
126677436|NCT01308008|455777359|FG001|4 Weeks|Illness, disinterest, time|2|||
126677437|NCT01417195|455777360|FG000|Overall Study|Stimulation failure|1|||
126677438|NCT01417195|455777361|FG001|Overall Study|Stimulation failure|0|||
126677439|NCT01417195|455777360|FG000|Overall Study|No embryos for transfer|0|||
126677440|NCT01417195|455777361|FG001|Overall Study|No embryos for transfer|1|||
126677441|NCT01417195|455777360|FG000|Overall Study|No transfer due to risk of OHSS|1|||
126677442|NCT01417195|455777361|FG001|Overall Study|No transfer due to risk of OHSS|0|||
126677443|NCT01417195|455777360|FG000|Overall Study|No transfer due to elevated progesterone|1|||
126677444|NCT01417195|455777361|FG001|Overall Study|No transfer due to elevated progesterone|0|||
126677445|NCT03357731|455777362|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
126677446|NCT03357731|455777363|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
126677447|NCT03357731|455777364|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
126677448|NCT03357731|455777365|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
126677449|NCT03357731|455777366|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
126677450|NCT03357731|455777367|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
126677451|NCT03357731|455777362|FG000|Overall Study|Acute bradycardia and hypotension|0|||
126677452|NCT03357731|455777363|FG001|Overall Study|Acute bradycardia and hypotension|0|||
126677453|NCT03357731|455777364|FG002|Overall Study|Acute bradycardia and hypotension|0|||
126677454|NCT03357731|455777365|FG003|Overall Study|Acute bradycardia and hypotension|1|||
126677455|NCT03357731|455777366|FG004|Overall Study|Acute bradycardia and hypotension|0|||
126677456|NCT03357731|455777367|FG005|Overall Study|Acute bradycardia and hypotension|0|||
126677457|NCT03357731|455777362|FG000|Overall Study|Adverse Event|0|||
126677458|NCT03357731|455777363|FG001|Overall Study|Adverse Event|0|||
126677459|NCT03357731|455777364|FG002|Overall Study|Adverse Event|0|||
126677460|NCT03357731|455777365|FG003|Overall Study|Adverse Event|0|||
126677461|NCT03357731|455777366|FG004|Overall Study|Adverse Event|0|||
126677462|NCT03357731|455777367|FG005|Overall Study|Adverse Event|1|||
126677463|NCT03357731|455777362|FG000|Overall Study|Hypotension|0|||
126677464|NCT03357731|455777363|FG001|Overall Study|Hypotension|0|||
126677465|NCT03357731|455777364|FG002|Overall Study|Hypotension|1|||
126677466|NCT03357731|455777365|FG003|Overall Study|Hypotension|1|||
126677467|NCT03357731|455777366|FG004|Overall Study|Hypotension|0|||
126677468|NCT03357731|455777367|FG005|Overall Study|Hypotension|0|||
126677469|NCT03357731|455777362|FG000|Overall Study|Lost to Follow-up|0|||
126677470|NCT03357731|455777363|FG001|Overall Study|Lost to Follow-up|0|||
126677471|NCT03357731|455777364|FG002|Overall Study|Lost to Follow-up|0|||
126677472|NCT03357731|455777365|FG003|Overall Study|Lost to Follow-up|1|||
126677473|NCT03357731|455777366|FG004|Overall Study|Lost to Follow-up|0|||
126677474|NCT03357731|455777367|FG005|Overall Study|Lost to Follow-up|0|||
126677475|NCT00772954|455777368|FG000|Overall Study|Adverse Event|0|||
126677476|NCT00772954|455777369|FG001|Overall Study|Adverse Event|0|||
126428920|NCT01962441|454866516|FG000|Randomized Period|Protocol Violation|0|||
126428921|NCT01962441|454866517|FG001|Randomized Period|Protocol Violation|1|||
126677477|NCT00772954|455777370|FG002|Overall Study|Adverse Event|1|||
126677478|NCT01773109|455777371|FG000|Overall Study|Symptomatic Progression|2|||
126428922|NCT01962441|454866518|FG002|Randomized Period|Protocol Violation|0|||
126428923|NCT01962441|454866516|FG000|Retreatment Substudy|Lack of Efficacy|1|||
126428924|NCT01962441|454866517|FG001|Retreatment Substudy|Lack of Efficacy|0|||
126428925|NCT01962441|454866518|FG002|Retreatment Substudy|Lack of Efficacy|0|||
126428926|NCT01962441|454866516|FG000|Retreatment Substudy|Lost to Follow-up|1|||
126428927|NCT01962441|454866517|FG001|Retreatment Substudy|Lost to Follow-up|0|||
126428928|NCT01962441|454866518|FG002|Retreatment Substudy|Lost to Follow-up|0|||
126428929|NCT02055898|454866519|FG000|First Intervention (5 Days)|Physician Decision|2|||
126428930|NCT02055898|454866520|FG001|First Intervention (5 Days)|Physician Decision|0|||
126428931|NCT02055898|454866519|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
126428932|NCT02055898|454866520|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
126428933|NCT02314052|454866524|FG000|Cycle One|Adverse Event|0|||
126428934|NCT02314052|454866525|FG001|Cycle One|Adverse Event|0|||
126428935|NCT02314052|454866526|FG002|Cycle One|Adverse Event|0|||
126428936|NCT02314052|454866527|FG003|Cycle One|Adverse Event|1|||
126428937|NCT02314052|454866528|FG004|Cycle One|Adverse Event|0|||
126428938|NCT02314052|454866529|FG005|Cycle One|Adverse Event|0|||
126428939|NCT00117637|454866530|FG000|First Intervention (Period 1)|Adverse Event|11|||
126428940|NCT00117637|454866531|FG001|First Intervention (Period 1)|Adverse Event|16|||
126428941|NCT00117637|454866530|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
126428942|NCT00117637|454866531|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
126428943|NCT00117637|454866530|FG000|First Intervention (Period 1)|Protocol Violation|1|||
126428944|NCT00117637|454866531|FG001|First Intervention (Period 1)|Protocol Violation|0|||
126428945|NCT00117637|454866530|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
126428946|NCT00117637|454866531|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
126428947|NCT00117637|454866530|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
126428948|NCT00117637|454866531|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
126428949|NCT00117637|454866530|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
126428950|NCT00117637|454866531|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
126428951|NCT00117637|454866530|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
126677479|NCT01773109|455777371|FG000|Overall Study|Death|1|||
126677480|NCT01239342|455777372|FG000|Overall Study|Adverse Event|1|||
126677481|NCT01239342|455777373|FG001|Overall Study|Adverse Event|0|||
126677482|NCT01239342|455777372|FG000|Overall Study|Withdrawal by Subject|1|||
126677483|NCT01239342|455777373|FG001|Overall Study|Withdrawal by Subject|5|||
126677484|NCT01239342|455777372|FG000|Overall Study|Reason Unknown|1|||
126677485|NCT01239342|455777373|FG001|Overall Study|Reason Unknown|1|||
126677486|NCT02495844|455777374|FG000|Overall Study|Lack of Efficacy|1|||
126677487|NCT02495844|455777375|FG001|Overall Study|Lack of Efficacy|2|||
126677488|NCT02495844|455777374|FG000|Overall Study|AE, non-fatal|0|||
126677489|NCT02495844|455777375|FG001|Overall Study|AE, non-fatal|1|||
126677490|NCT02495844|455777374|FG000|Overall Study|Hepatitis Positivity|0|||
126677491|NCT02495844|455777375|FG001|Overall Study|Hepatitis Positivity|1|||
126677492|NCT02325219|455777378|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
126677493|NCT02325219|455777379|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
126677494|NCT02325219|455777380|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
126677495|NCT02325219|455777381|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
126677496|NCT02325219|455777382|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
126677497|NCT02325219|455777378|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
126677498|NCT02325219|455777379|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
126677499|NCT02325219|455777380|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126677500|NCT02325219|455777381|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126677501|NCT02325219|455777382|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126677502|NCT02325219|455777378|FG000|Controlled Period (Week 0 - 16)|Other|0|||
126677503|NCT02325219|455777379|FG001|Controlled Period (Week 0 - 16)|Other|0|||
126677504|NCT02325219|455777380|FG002|Controlled Period (Week 0 - 16)|Other|1|||
126677505|NCT02325219|455777381|FG003|Controlled Period (Week 0 - 16)|Other|0|||
126677506|NCT02325219|455777382|FG004|Controlled Period (Week 0 - 16)|Other|0|||
126677507|NCT02325219|455777378|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
126677508|NCT02325219|455777379|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
126677509|NCT02325219|455777380|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
126677510|NCT02325219|455777381|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
126428952|NCT00117637|454866531|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
126428953|NCT00117637|454866530|FG000|First Intervention (Period 1)|reason not reported|0|||
126428954|NCT00117637|454866531|FG001|First Intervention (Period 1)|reason not reported|1|||
126428955|NCT00117637|454866530|FG000|Second Intervention (Period 2)|Adverse Event|0|||
126428956|NCT00117637|454866531|FG001|Second Intervention (Period 2)|Adverse Event|9|||
126428957|NCT00117637|454866530|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
126677511|NCT02325219|455777382|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
126677512|NCT02325219|455777378|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
126677513|NCT02325219|455777379|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
126428958|NCT00117637|454866531|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
126428959|NCT00117637|454866530|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
126428960|NCT00117637|454866531|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
126428961|NCT00117637|454866530|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
126428962|NCT00117637|454866531|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
126428963|NCT00117637|454866530|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
126428964|NCT00117637|454866531|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
126428965|NCT00117637|454866530|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
126428966|NCT00117637|454866531|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
126428967|NCT00117637|454866530|FG000|Second Intervention (Period 2)|reason not reported|1|||
126428968|NCT00117637|454866531|FG001|Second Intervention (Period 2)|reason not reported|0|||
126428969|NCT01620060|454866532|FG000|Overall Study|Adverse Event|9|||
126428970|NCT01620060|454866532|FG000|Overall Study|Protocol Violation|1|||
126428971|NCT01620060|454866532|FG000|Overall Study|Withdrawal by Subject|1|||
126428972|NCT01620060|454866532|FG000|Overall Study|Did not comply with Study Produre|1|||
126428973|NCT01620060|454866532|FG000|Overall Study|Family emergency|1|||
126428974|NCT01620060|454866532|FG000|Overall Study|Per Sponsor Decision|2|||
126428975|NCT01582061|454866533|FG000|Overall Study|Lack of Efficacy|3|||
126428976|NCT01582061|454866534|FG001|Overall Study|Lack of Efficacy|23|||
126428977|NCT01582061|454866533|FG000|Overall Study|Adverse Event|12|||
126428978|NCT01582061|454866534|FG001|Overall Study|Adverse Event|8|||
126428979|NCT01582061|454866533|FG000|Overall Study|Withdrawal by Subject|10|||
126428980|NCT01582061|454866534|FG001|Overall Study|Withdrawal by Subject|4|||
126428981|NCT01582061|454866533|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126428982|NCT01582061|454866534|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126428983|NCT01582061|454866533|FG000|Overall Study|Death|0|||
126428984|NCT01582061|454866534|FG001|Overall Study|Death|1|||
126428985|NCT01582061|454866533|FG000|Overall Study|condition no longer requires study drug|1|||
126428986|NCT01582061|454866534|FG001|Overall Study|condition no longer requires study drug|0|||
126428987|NCT01582061|454866533|FG000|Overall Study|Lost to Follow-up|1|||
126428988|NCT01582061|454866534|FG001|Overall Study|Lost to Follow-up|0|||
126428989|NCT00231777|454866535|FG000|Overall Study|Lost to Follow-up|3|||
126428990|NCT00231777|454866536|FG001|Overall Study|Lost to Follow-up|0|||
126428991|NCT00231777|454866535|FG000|Overall Study|Other|3|||
126428992|NCT00231777|454866536|FG001|Overall Study|Other|2|||
126428993|NCT04551989|454866539|FG000|Overall Study|Adverse Event|4|||
126428994|NCT04551989|454866539|FG000|Overall Study|Protocol Violation|3|||
126428995|NCT04551989|454866539|FG000|Overall Study|Lost to Follow-up|1|||
126428996|NCT04551989|454866539|FG000|Overall Study|Physician Decision|3|||
126428997|NCT04698343|454866540|FG000|Overall Study|Withdrawal by Subject|6|||
126428998|NCT04698343|454866540|FG000|Overall Study|Physician Decision|2|||
126428999|NCT04698343|454866540|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
126429000|NCT04698343|454866540|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
126429001|NCT04698343|454866540|FG000|Overall Study|Personal reasons|3|||
126429002|NCT04698343|454866540|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
126429003|NCT02756338|454866541|FG000|Overall Study|Withdrawn by Investigator|1|||
126429004|NCT02756338|454866541|FG000|Overall Study|Device Replaced with Pacemaker|4|||
126429005|NCT00088530|454866544|FG000|Overall Study|Progressive/Relapsed Disease|28|||
126429006|NCT00088530|454866545|FG001|Overall Study|Progressive/Relapsed Disease|39|||
126429007|NCT00088530|454866544|FG000|Overall Study|Adverse Event|15|||
126429008|NCT00088530|454866545|FG001|Overall Study|Adverse Event|9|||
126429009|NCT00088530|454866544|FG000|Overall Study|Withdrawal by Subject|2|||
126429010|NCT00088530|454866545|FG001|Overall Study|Withdrawal by Subject|5|||
126429011|NCT00088530|454866544|FG000|Overall Study|Lost to Follow-up|2|||
126429012|NCT00088530|454866545|FG001|Overall Study|Lost to Follow-up|0|||
126429013|NCT00088530|454866544|FG000|Overall Study|Physician Decision|2|||
126429014|NCT00088530|454866545|FG001|Overall Study|Physician Decision|0|||
126429015|NCT00088530|454866544|FG000|Overall Study|Sponsor decision|0|||
126429016|NCT00088530|454866545|FG001|Overall Study|Sponsor decision|1|||
126429017|NCT00088530|454866544|FG000|Overall Study|Patient never treated|1|||
126429018|NCT00088530|454866545|FG001|Overall Study|Patient never treated|0|||
126677514|NCT02325219|455777380|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
126677515|NCT02325219|455777381|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
126677516|NCT02325219|455777382|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
126342762|NCT00701363|454552032|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
126342763|NCT00701363|454552033|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
126342764|NCT00701363|454552030|FG000|Treatment Phase 1|Adverse Event|7|||
126342765|NCT00701363|454552031|FG001|Treatment Phase 1|Adverse Event|0|||
126342766|NCT00701363|454552032|FG002|Treatment Phase 1|Adverse Event|0|||
126342767|NCT00701363|454552033|FG003|Treatment Phase 1|Adverse Event|0|||
126342768|NCT00701363|454552030|FG000|Treatment Phase 1|Protocol Violation|1|||
126342769|NCT00701363|454552031|FG001|Treatment Phase 1|Protocol Violation|0|||
126342770|NCT00701363|454552032|FG002|Treatment Phase 1|Protocol Violation|0|||
126429019|NCT00300755|454866548|FG000|Overall Study|Adverse Event|1|||
126429020|NCT00300755|454866549|FG001|Overall Study|Adverse Event|2|||
126429021|NCT00300755|454866550|FG002|Overall Study|Adverse Event|1|||
126429022|NCT00300755|454866548|FG000|Overall Study|Withdrawal by Subject|0|||
126429023|NCT00300755|454866549|FG001|Overall Study|Withdrawal by Subject|2|||
126429024|NCT00300755|454866550|FG002|Overall Study|Withdrawal by Subject|0|||
126429025|NCT00300755|454866548|FG000|Overall Study|Protocol Violation|0|||
126429026|NCT00300755|454866549|FG001|Overall Study|Protocol Violation|0|||
126429027|NCT00300755|454866550|FG002|Overall Study|Protocol Violation|1|||
126429028|NCT02694744|454866554|FG000|Overall Study|Adverse Event|2|||
126429029|NCT02694744|454866555|FG001|Overall Study|Adverse Event|1|||
126429030|NCT02694744|454866554|FG000|Overall Study|Withdrawal by Subject|2|||
126429031|NCT02694744|454866555|FG001|Overall Study|Withdrawal by Subject|1|||
126429032|NCT02694744|454866554|FG000|Overall Study|Physician Decision|1|||
126429033|NCT02694744|454866555|FG001|Overall Study|Physician Decision|2|||
126429034|NCT02694744|454866554|FG000|Overall Study|Lost to Follow-up|1|||
126429035|NCT02694744|454866555|FG001|Overall Study|Lost to Follow-up|0|||
126429036|NCT02694744|454866554|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
126429037|NCT02694744|454866555|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
126429038|NCT00686777|454866556|FG000|Overall Study|Adverse Event|2|||
126429039|NCT00686777|454866556|FG000|Overall Study|Pregnancy|1|||
126429040|NCT00686777|454866556|FG000|Overall Study|Withdrawal by Subject|2|||
126429041|NCT00686777|454866556|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
126429042|NCT00686777|454866556|FG000|Overall Study|No Visit|1|||
126429043|NCT01945021|454866557|FG000|Overall Study|Adverse Event|1|||
126429044|NCT01945021|454866557|FG000|Overall Study|Withdrawal of consent|12|||
126429045|NCT01945021|454866557|FG000|Overall Study|Lost to Follow-up|5|||
126429046|NCT01945021|454866557|FG000|Overall Study|Death|65|||
126429047|NCT03582215|454866558|FG000|Overall Study|Adverse Event|1|||
126429048|NCT03582215|454866559|FG001|Overall Study|Adverse Event|0|||
126429049|NCT03582215|454866560|FG002|Overall Study|Adverse Event|0|||
126429050|NCT03582215|454866561|FG003|Overall Study|Adverse Event|0|||
126429051|NCT03582215|454866562|FG004|Overall Study|Adverse Event|0|||
126429052|NCT03582215|454866563|FG005|Overall Study|Adverse Event|0|||
126429053|NCT03582215|454866564|FG006|Overall Study|Adverse Event|2|||
126429054|NCT03582215|454866565|FG007|Overall Study|Adverse Event|2|||
126429055|NCT02163902|454866566|FG000|Overall Study|Subject's Request|3|||
126429056|NCT02163902|454866567|FG001|Overall Study|Subject's Request|4|||
126429057|NCT02163902|454866566|FG000|Overall Study|Lost to Follow-up|6|||
126429058|NCT02163902|454866567|FG001|Overall Study|Lost to Follow-up|7|||
126429059|NCT02163902|454866566|FG000|Overall Study|Administrative Decision|2|||
126429060|NCT02163902|454866567|FG001|Overall Study|Administrative Decision|2|||
126429061|NCT02174731|454866568|FG000|Overall Study|Participant decision|67|||
126429062|NCT02174731|454866569|FG001|Overall Study|Participant decision|64|||
126429063|NCT02174731|454866568|FG000|Overall Study|Incorrect enrolment before randomization|0|||
126429064|NCT02174731|454866569|FG001|Overall Study|Incorrect enrolment before randomization|1|||
126429065|NCT02174731|454866568|FG000|Overall Study|Missing|2|||
126429066|NCT02174731|454866569|FG001|Overall Study|Missing|0|||
126429067|NCT03119259|454866570|FG000|Overall Study|Withdrawn as no longer eligible|1|||
126429068|NCT03119259|454866571|FG001|Overall Study|Withdrawn as no longer eligible|0|||
126429069|NCT03119259|454866570|FG000|Overall Study|Withdrawal by Subject|4|||
126429070|NCT03119259|454866571|FG001|Overall Study|Withdrawal by Subject|2|||
126429071|NCT03119259|454866570|FG000|Overall Study|Lost to Follow-up|0|||
126429072|NCT03119259|454866571|FG001|Overall Study|Lost to Follow-up|1|||
126429073|NCT00739401|454866576|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
126429074|NCT00739401|454866576|FG000|Overall Study|Death|3|||
126429075|NCT00739401|454866576|FG000|Overall Study|Withdrawal by Subject|4|||
126429076|NCT04575155|454866577|FG000|2 Month|Withdrawal by Subject|1|||
126429077|NCT04575155|454866578|FG001|2 Month|Withdrawal by Subject|1|||
126429078|NCT04575155|454866577|FG000|2 Month|Lost to Follow-up|5|||
126429079|NCT04575155|454866578|FG001|2 Month|Lost to Follow-up|3|||
126429080|NCT04575155|454866577|FG000|2 Month|Ineligible|1|||
126429081|NCT04575155|454866578|FG001|2 Month|Ineligible|0|||
126429082|NCT02903160|454866581|FG000|Overall Study|Adverse Event|2|||
126429083|NCT02903160|454866581|FG000|Overall Study|Death|1|||
126429084|NCT02903160|454866581|FG000|Overall Study|Lost to Follow-up|2|||
126429085|NCT02903160|454866581|FG000|Overall Study|Withdrawal by Subject|1|||
126429086|NCT02903160|454866581|FG000|Overall Study|Medical Insurance Barriers|1|||
126429087|NCT01664910|454866584|FG000|Overall Study|Adverse Event|0|||
126429088|NCT01664910|454866585|FG001|Overall Study|Adverse Event|0|||
126429089|NCT01664910|454866586|FG002|Overall Study|Adverse Event|1|||
126429090|NCT00730158|454866590|FG000|Overall Study|Withdrawal by Subject|1|||
126429091|NCT00730158|454866591|FG001|Overall Study|Withdrawal by Subject|1|||
126429092|NCT04678115|454866592|FG000|Overall Study|Lost to Follow-up|1|||
126429093|NCT04678115|454866593|FG001|Overall Study|Lost to Follow-up|0|||
126429094|NCT01168349|454866594|FG000|Overall Study|Death|157|||
126429095|NCT01168349|454866594|FG000|Overall Study|Lost to Follow-up|34|||
126429096|NCT01168349|454866594|FG000|Overall Study|Withdrawal by Subject|9|||
126429097|NCT01168349|454866594|FG000|Overall Study|Kidney transplantation|3|||
126677517|NCT02325219|455777378|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126677518|NCT02325219|455777379|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
126342771|NCT00701363|454552033|FG003|Treatment Phase 1|Protocol Violation|0|||
126342772|NCT00701363|454552030|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
126342773|NCT00701363|454552031|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
126342774|NCT00701363|454552032|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
126342775|NCT00701363|454552033|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
126342776|NCT00701363|454552030|FG000|Treatment Phase 1|Lack of Efficacy|1|||
126342777|NCT00701363|454552031|FG001|Treatment Phase 1|Lack of Efficacy|0|||
126342778|NCT00701363|454552032|FG002|Treatment Phase 1|Lack of Efficacy|0|||
126342779|NCT00701363|454552033|FG003|Treatment Phase 1|Lack of Efficacy|0|||
126342780|NCT00701363|454552030|FG000|Treatment Phase 2|Adverse Event|0|||
126342781|NCT00701363|454552031|FG001|Treatment Phase 2|Adverse Event|0|||
126342782|NCT00701363|454552032|FG002|Treatment Phase 2|Adverse Event|1|||
126342783|NCT00701363|454552033|FG003|Treatment Phase 2|Adverse Event|0|||
126342784|NCT00701363|454552030|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
126342785|NCT00701363|454552031|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
126342786|NCT00701363|454552032|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
126342787|NCT00701363|454552033|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
126342788|NCT01192815|454552034|FG000|Overall Study|Withdrawal by Subject|1|||
126342789|NCT01192815|454552034|FG000|Overall Study|Lack of Efficacy|1|||
126342790|NCT01286129|454552038|FG000|Overall Study|Withdrawal by Subject|4|||
126342791|NCT01286129|454552039|FG001|Overall Study|Withdrawal by Subject|1|||
126342792|NCT01286129|454552038|FG000|Overall Study|Could not comply with study requirements|4|||
126342793|NCT01286129|454552039|FG001|Overall Study|Could not comply with study requirements|4|||
126342794|NCT00869960|454552040|FG000|Overall Study|Lost to Follow-up|2|||
126342795|NCT01394276|454552042|FG000|Overall Study|Related Adverse event (AEs)|15|||
126342796|NCT01394276|454552042|FG000|Overall Study|Not related AEs|9|||
126342797|NCT01394276|454552042|FG000|Overall Study|Remission of disease|2|||
126342798|NCT01394276|454552042|FG000|Overall Study|Insufficient therapeutic effect|17|||
126342799|NCT01394276|454552042|FG000|Overall Study|Insufficient compliance|9|||
126342800|NCT01394276|454552042|FG000|Overall Study|Lost to Follow-up|5|||
126342801|NCT01394276|454552042|FG000|Overall Study|Participant moved to another site|1|||
126342802|NCT01394276|454552042|FG000|Overall Study|Pregnancy|1|||
126342803|NCT01394276|454552042|FG000|Overall Study|unavailability of drug at the Hospital|2|||
126342804|NCT01394276|454552042|FG000|Overall Study|Symptoms of concurrent diseases|1|||
126342805|NCT00465179|454552043|FG000|Overall Study|Adverse Event|4|||
126342806|NCT00465179|454552043|FG000|Overall Study|Withdrawal by Subject|2|||
126342807|NCT00465179|454552043|FG000|Overall Study|Progression of Disease|47|||
126342808|NCT00262925|454552047|FG000|Overall Study|Lack of Efficacy|3|||
126342809|NCT00262925|454552047|FG000|Overall Study|Adverse Event|4|||
126342810|NCT00262925|454552047|FG000|Overall Study|Death|2|||
126342811|NCT00262925|454552047|FG000|Overall Study|alternative therapy|1|||
126342812|NCT00262925|454552047|FG000|Overall Study|Other|1|||
126342813|NCT04682301|454552049|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
126342814|NCT04682301|454552049|FG000|Overall Study|Death|2|||
126342815|NCT02187783|454552050|FG000|Overall Study|Adverse Event|8|||
126342816|NCT02187783|454552050|FG000|Overall Study|Death|3|||
126342817|NCT02187783|454552050|FG000|Overall Study|Progressive disease|80|||
126342818|NCT02187783|454552050|FG000|Overall Study|Protocol Violation|3|||
126342819|NCT02187783|454552050|FG000|Overall Study|Physician Decision|2|||
126342820|NCT02187783|454552050|FG000|Overall Study|Withdrawal by Subject|9|||
126342821|NCT02187783|454552050|FG000|Overall Study|Study terminated by sponsor|1|||
126342822|NCT00471497|454552051|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
126342823|NCT00471497|454552052|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
126342824|NCT00471497|454552053|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
126342825|NCT00471497|454552051|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
126342826|NCT00471497|454552052|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
126342827|NCT00471497|454552053|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
126342828|NCT00471497|454552051|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
126342829|NCT00471497|454552052|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
126342830|NCT00471497|454552053|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
126342831|NCT00471497|454552051|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
126677519|NCT02325219|455777380|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126342832|NCT00471497|454552052|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
126342833|NCT00471497|454552053|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
126342834|NCT00471497|454552051|FG000|Core Treatment Phase|Lost to Follow-up|6|||
126342835|NCT00471497|454552052|FG001|Core Treatment Phase|Lost to Follow-up|6|||
126342836|NCT00471497|454552053|FG002|Core Treatment Phase|Lost to Follow-up|3|||
126342837|NCT00471497|454552051|FG000|Core Treatment Phase|Death|3|||
126677520|NCT02325219|455777381|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126342838|NCT00471497|454552052|FG001|Core Treatment Phase|Death|9|||
126342839|NCT00471497|454552053|FG002|Core Treatment Phase|Death|3|||
126342840|NCT00471497|454552051|FG000|Core Treatment Phase|Disease Progression|10|||
126342841|NCT00471497|454552052|FG001|Core Treatment Phase|Disease Progression|2|||
126429098|NCT01168349|454866594|FG000|Overall Study|Other|22|||
126429099|NCT01168349|454866594|FG000|Overall Study|Protocol Violation|76|||
126429100|NCT03535974|454866595|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
126429101|NCT03535974|454866596|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
126429102|NCT03535974|454866597|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
126429103|NCT03535974|454866595|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
126429104|NCT03535974|454866596|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
126429105|NCT03535974|454866597|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
126429106|NCT00844376|454866598|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
126429107|NCT00844376|454866599|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
126429108|NCT04059549|454866600|FG000|Overall Study|Withdrawal by Subject|2|||
126429109|NCT04059549|454866601|FG001|Overall Study|Withdrawal by Subject|0|||
126429110|NCT02678351|454866603|FG000|Overall Study|Withdrawal by Subject|1|||
126429111|NCT00988884|454866604|FG000|Overall Study|Adverse Event|0|||
126429112|NCT00988884|454866605|FG001|Overall Study|Adverse Event|1|||
126429113|NCT00988884|454866604|FG000|Overall Study|Lost to Follow-up|20|||
126429114|NCT00988884|454866605|FG001|Overall Study|Lost to Follow-up|16|||
126429115|NCT00988884|454866604|FG000|Overall Study|Protocol Violation|0|||
126429116|NCT00988884|454866605|FG001|Overall Study|Protocol Violation|1|||
126429117|NCT00988884|454866604|FG000|Overall Study|Withdrawal by Subject|15|||
126429118|NCT00988884|454866605|FG001|Overall Study|Withdrawal by Subject|18|||
126429119|NCT01919229|454866606|FG000|Overall Study|Subject/guardian decision|0|||
126429120|NCT01919229|454866607|FG001|Overall Study|Subject/guardian decision|0|||
126429121|NCT01919229|454866608|FG002|Overall Study|Subject/guardian decision|1|||
126429122|NCT01632020|454866609|FG000|Overall Study|Withdrawal by Subject|1|||
126429123|NCT01632020|454866610|FG001|Overall Study|Withdrawal by Subject|0|||
126429124|NCT01632020|454866609|FG000|Overall Study|Adverse Event|1|||
126429125|NCT01632020|454866610|FG001|Overall Study|Adverse Event|0|||
126429126|NCT00549640|454866612|FG000|Overall Study|Withdrawal by Subject|6|||
126429127|NCT00549640|454866613|FG001|Overall Study|Withdrawal by Subject|12|||
126429128|NCT00549640|454866612|FG000|Overall Study|Adverse Event|5|||
126429129|NCT00549640|454866613|FG001|Overall Study|Adverse Event|0|||
126429130|NCT00549640|454866612|FG000|Overall Study|Lost to Follow-up|7|||
126429131|NCT00549640|454866613|FG001|Overall Study|Lost to Follow-up|4|||
126429132|NCT01362348|454866614|FG000|Overall Study|Protocol-defined stopping criteria|9|||
126429133|NCT01362348|454866614|FG000|Overall Study|Study closed/terminated|5|||
126429134|NCT00399516|454866615|FG000|Overall Study|Lost to Follow-up|2|||
126429135|NCT00660192|454866618|FG000|Overall Study|Lost to Follow-up|2|||
126429136|NCT00660192|454866619|FG001|Overall Study|Lost to Follow-up|3|||
126429137|NCT02734693|454866620|FG000|Overall Study|Adverse Event|1|||
126429138|NCT02734693|454866621|FG001|Overall Study|Adverse Event|3|||
126429139|NCT02734693|454866622|FG002|Overall Study|Adverse Event|3|||
126429140|NCT02734693|454866620|FG000|Overall Study|Lack of Efficacy|1|||
126429141|NCT02734693|454866621|FG001|Overall Study|Lack of Efficacy|0|||
126429142|NCT02734693|454866622|FG002|Overall Study|Lack of Efficacy|0|||
126429143|NCT02734693|454866620|FG000|Overall Study|Lost to Follow-up|2|||
126429144|NCT02734693|454866621|FG001|Overall Study|Lost to Follow-up|0|||
126429145|NCT02734693|454866622|FG002|Overall Study|Lost to Follow-up|0|||
126429146|NCT02734693|454866620|FG000|Overall Study|Protocol Violation|1|||
126429147|NCT02734693|454866621|FG001|Overall Study|Protocol Violation|0|||
126429148|NCT02734693|454866622|FG002|Overall Study|Protocol Violation|0|||
126429149|NCT02734693|454866620|FG000|Overall Study|Withdrawal by Subject|1|||
126429150|NCT02734693|454866621|FG001|Overall Study|Withdrawal by Subject|0|||
126429151|NCT02734693|454866622|FG002|Overall Study|Withdrawal by Subject|0|||
126429152|NCT00982735|454866623|FG000|Overall Study|Lost to Follow-up|6|||
126429153|NCT00982735|454866623|FG000|Overall Study|Patient ineligible for trial|224|||
126429154|NCT02898454|454866631|FG000|Overall Study|Adverse Event|4|||
126429155|NCT02898454|454866632|FG001|Overall Study|Adverse Event|1|||
126429156|NCT02898454|454866633|FG002|Overall Study|Adverse Event|2|||
126429157|NCT02898454|454866631|FG000|Overall Study|Protocol Violation|1|||
126429158|NCT02898454|454866632|FG001|Overall Study|Protocol Violation|0|||
126429159|NCT02898454|454866633|FG002|Overall Study|Protocol Violation|1|||
126429160|NCT02898454|454866631|FG000|Overall Study|Lack of Efficacy|4|||
126429161|NCT02898454|454866632|FG001|Overall Study|Lack of Efficacy|1|||
126429162|NCT02898454|454866633|FG002|Overall Study|Lack of Efficacy|0|||
126429163|NCT02898454|454866631|FG000|Overall Study|Withdrawal by Subject|6|||
126429164|NCT02898454|454866632|FG001|Overall Study|Withdrawal by Subject|3|||
126429165|NCT02898454|454866633|FG002|Overall Study|Withdrawal by Subject|3|||
126429166|NCT02898454|454866631|FG000|Overall Study|Lost to Follow-up|1|||
126429167|NCT02898454|454866632|FG001|Overall Study|Lost to Follow-up|0|||
126429168|NCT02898454|454866633|FG002|Overall Study|Lost to Follow-up|0|||
126429169|NCT02898454|454866631|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
126429170|NCT02898454|454866632|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
126429171|NCT02898454|454866633|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
126429172|NCT01601535|454866634|FG000|Phase 1|Adverse Event|1|||
126429173|NCT01601535|454866635|FG001|Phase 1|Adverse Event|0|||
126429174|NCT01601535|454866636|FG002|Phase 1|Adverse Event|2|||
126429175|NCT01601535|454866637|FG003|Phase 1|Adverse Event|1|||
126429176|NCT01601535|454866638|FG004|Phase 1|Adverse Event|0|||
126429177|NCT01601535|454866639|FG005|Phase 1|Adverse Event|0|||
126429178|NCT01601535|454866634|FG000|Phase 1|Withdrawal by Subject|2|||
126429179|NCT01601535|454866635|FG001|Phase 1|Withdrawal by Subject|1|||
126429180|NCT01601535|454866636|FG002|Phase 1|Withdrawal by Subject|1|||
126429181|NCT01601535|454866637|FG003|Phase 1|Withdrawal by Subject|2|||
126429182|NCT01601535|454866638|FG004|Phase 1|Withdrawal by Subject|0|||
126429183|NCT01601535|454866639|FG005|Phase 1|Withdrawal by Subject|0|||
126429184|NCT01601535|454866634|FG000|Phase 1|Progressive Disease|2|||
126429185|NCT01601535|454866635|FG001|Phase 1|Progressive Disease|3|||
126677521|NCT02325219|455777382|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126677522|NCT02918864|455777383|FG000|Overall Study|Withdrawal by Subject|1|||
126677523|NCT02918864|455777384|FG001|Overall Study|Withdrawal by Subject|1|||
126677524|NCT02918864|455777383|FG000|Overall Study|Lost to Follow-up|3|||
126677525|NCT02918864|455777384|FG001|Overall Study|Lost to Follow-up|2|||
126677526|NCT02634151|455777388|FG000|Overall Study|Withdrawal by Subject|1|||
126677527|NCT02634151|455777389|FG001|Overall Study|Withdrawal by Subject|0|||
126677528|NCT02634151|455777388|FG000|Overall Study|Non-Compliance|0|||
126677529|NCT02634151|455777389|FG001|Overall Study|Non-Compliance|1|||
126677530|NCT02634151|455777388|FG000|Overall Study|Other|0|||
126677531|NCT02634151|455777389|FG001|Overall Study|Other|1|||
126677532|NCT04640272|455777390|FG000|Overall Study|Subject moved out of area|1|||
126677533|NCT00573430|455777400|FG000|Overall Study|Incorrect enrollment of randomization|0|||
126677534|NCT00573430|455777401|FG001|Overall Study|Incorrect enrollment of randomization|4|||
126677535|NCT00573430|455777402|FG002|Overall Study|Incorrect enrollment of randomization|3|||
126677536|NCT00573430|455777400|FG000|Overall Study|Adverse Event|0|||
126677537|NCT00573430|455777401|FG001|Overall Study|Adverse Event|0|||
126677538|NCT00573430|455777402|FG002|Overall Study|Adverse Event|2|||
126677539|NCT00573430|455777400|FG000|Overall Study|Withdrawal by Subject|1|||
126677540|NCT00573430|455777401|FG001|Overall Study|Withdrawal by Subject|0|||
126677541|NCT00573430|455777402|FG002|Overall Study|Withdrawal by Subject|1|||
126677542|NCT00573430|455777400|FG000|Overall Study|Protocol Violation|0|||
126677543|NCT00573430|455777401|FG001|Overall Study|Protocol Violation|1|||
126677544|NCT00573430|455777402|FG002|Overall Study|Protocol Violation|1|||
126429186|NCT01601535|454866636|FG002|Phase 1|Progressive Disease|2|||
126429187|NCT01601535|454866637|FG003|Phase 1|Progressive Disease|1|||
126429188|NCT01601535|454866638|FG004|Phase 1|Progressive Disease|0|||
126429189|NCT01601535|454866639|FG005|Phase 1|Progressive Disease|0|||
126429190|NCT01601535|454866634|FG000|Phase 1|Started Another Treatment|1|||
126429191|NCT01601535|454866635|FG001|Phase 1|Started Another Treatment|2|||
126429192|NCT01601535|454866636|FG002|Phase 1|Started Another Treatment|0|||
126429193|NCT01601535|454866637|FG003|Phase 1|Started Another Treatment|0|||
126429194|NCT01601535|454866638|FG004|Phase 1|Started Another Treatment|0|||
126429195|NCT01601535|454866639|FG005|Phase 1|Started Another Treatment|0|||
126429196|NCT01601535|454866634|FG000|Phase 2|Adverse Event|0|||
126429197|NCT01601535|454866635|FG001|Phase 2|Adverse Event|0|||
126429198|NCT01601535|454866636|FG002|Phase 2|Adverse Event|0|||
126429199|NCT01601535|454866637|FG003|Phase 2|Adverse Event|0|||
126429200|NCT01601535|454866638|FG004|Phase 2|Adverse Event|5|||
126429201|NCT01601535|454866639|FG005|Phase 2|Adverse Event|1|||
126429202|NCT01601535|454866634|FG000|Phase 2|Withdrawal by Subject|0|||
126429203|NCT01601535|454866635|FG001|Phase 2|Withdrawal by Subject|0|||
126429204|NCT01601535|454866636|FG002|Phase 2|Withdrawal by Subject|0|||
126429205|NCT01601535|454866637|FG003|Phase 2|Withdrawal by Subject|0|||
126429206|NCT01601535|454866638|FG004|Phase 2|Withdrawal by Subject|8|||
126429207|NCT01601535|454866639|FG005|Phase 2|Withdrawal by Subject|2|||
126429208|NCT01601535|454866634|FG000|Phase 2|Progressive Disease|0|||
126429209|NCT01601535|454866635|FG001|Phase 2|Progressive Disease|0|||
126429210|NCT01601535|454866636|FG002|Phase 2|Progressive Disease|0|||
126429211|NCT01601535|454866637|FG003|Phase 2|Progressive Disease|0|||
126429212|NCT01601535|454866638|FG004|Phase 2|Progressive Disease|5|||
126429213|NCT01601535|454866639|FG005|Phase 2|Progressive Disease|7|||
126429214|NCT01601535|454866634|FG000|Phase 2|Started Another Treatment|0|||
126429215|NCT01601535|454866635|FG001|Phase 2|Started Another Treatment|0|||
126429216|NCT01601535|454866636|FG002|Phase 2|Started Another Treatment|0|||
126429217|NCT01601535|454866637|FG003|Phase 2|Started Another Treatment|0|||
126429218|NCT01601535|454866638|FG004|Phase 2|Started Another Treatment|1|||
126429219|NCT01601535|454866639|FG005|Phase 2|Started Another Treatment|2|||
126429220|NCT00647296|454866640|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
126429221|NCT00647296|454866641|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
126429222|NCT00647296|454866642|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
126677545|NCT00573430|455777400|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126677546|NCT00573430|455777401|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126677547|NCT00573430|455777402|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
126677548|NCT03134599|455777404|FG000|Week 1|Lost to Follow-up|0|||
126677549|NCT03134599|455777405|FG001|Week 1|Lost to Follow-up|0|||
126677550|NCT03134599|455777406|FG002|Week 1|Lost to Follow-up|0|||
126677551|NCT03134599|455777407|FG003|Week 1|Lost to Follow-up|0|||
126677552|NCT03134599|455777408|FG004|Week 1|Lost to Follow-up|1|||
126342842|NCT00471497|454552053|FG002|Core Treatment Phase|Disease Progression|4|||
126342843|NCT00471497|454552051|FG000|Core Treatment Phase|Protocol Violation|6|||
126342844|NCT00471497|454552052|FG001|Core Treatment Phase|Protocol Violation|15|||
126342845|NCT00471497|454552053|FG002|Core Treatment Phase|Protocol Violation|11|||
126342846|NCT00471497|454552051|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
126342847|NCT00471497|454552052|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
126342848|NCT00471497|454552053|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
126342849|NCT00471497|454552051|FG000|Core Treatment Phase|Administrative problems|14|||
126342850|NCT00471497|454552052|FG001|Core Treatment Phase|Administrative problems|14|||
126342851|NCT00471497|454552053|FG002|Core Treatment Phase|Administrative problems|12|||
126342852|NCT00471497|454552051|FG000|Core Treatment Phase|Adverse Event|43|||
126342853|NCT00471497|454552052|FG001|Core Treatment Phase|Adverse Event|53|||
126342854|NCT00471497|454552053|FG002|Core Treatment Phase|Adverse Event|89|||
126342855|NCT00471497|454552051|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
126342856|NCT00471497|454552052|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
126342857|NCT00471497|454552053|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
126342858|NCT00471497|454552051|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
126342859|NCT00471497|454552052|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
126342860|NCT00471497|454552053|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
126342861|NCT00471497|454552051|FG000|Extension Phase|Adverse Event|9|||
126342862|NCT00471497|454552052|FG001|Extension Phase|Adverse Event|5|||
126342863|NCT00471497|454552053|FG002|Extension Phase|Adverse Event|1|||
126342864|NCT00471497|454552051|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
126342865|NCT00471497|454552052|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
126342866|NCT00471497|454552053|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
126342867|NCT00471497|454552051|FG000|Extension Phase|Withdrawal by Subject|3|||
126342868|NCT00471497|454552052|FG001|Extension Phase|Withdrawal by Subject|1|||
126342869|NCT00471497|454552053|FG002|Extension Phase|Withdrawal by Subject|0|||
126342870|NCT00471497|454552051|FG000|Extension Phase|Lost to Follow-up|2|||
126342871|NCT00471497|454552052|FG001|Extension Phase|Lost to Follow-up|0|||
126342872|NCT00471497|454552053|FG002|Extension Phase|Lost to Follow-up|0|||
126342873|NCT00471497|454552051|FG000|Extension Phase|Death|1|||
126342874|NCT00471497|454552052|FG001|Extension Phase|Death|0|||
126342875|NCT00471497|454552053|FG002|Extension Phase|Death|0|||
126342876|NCT00471497|454552051|FG000|Extension Phase|Disease progression|2|||
126342877|NCT00471497|454552052|FG001|Extension Phase|Disease progression|0|||
126342878|NCT00471497|454552053|FG002|Extension Phase|Disease progression|0|||
126342879|NCT00471497|454552051|FG000|Extension Phase|Protocol Violation|2|||
126342880|NCT00471497|454552052|FG001|Extension Phase|Protocol Violation|2|||
126342881|NCT00471497|454552053|FG002|Extension Phase|Protocol Violation|0|||
126342882|NCT01654276|454552054|FG000|Overall Study|Lack of Efficacy|1|||
126342883|NCT01654276|454552054|FG000|Overall Study|Lost to Follow-up|4|||
126342884|NCT01654276|454552054|FG000|Overall Study|Withdrawal by Subject|1|||
126342885|NCT03344757|454552055|FG000|Overall Study|Withdrawal by Subject|18|||
126342886|NCT03344757|454552056|FG001|Overall Study|Withdrawal by Subject|16|||
126342887|NCT03344757|454552055|FG000|Overall Study|Lost to Follow-up|0|||
126342888|NCT03344757|454552056|FG001|Overall Study|Lost to Follow-up|2|||
126342889|NCT04609514|454552057|FG000|Overall Study|Lost to Follow-up|5|||
126342890|NCT04609514|454552058|FG001|Overall Study|Lost to Follow-up|4|||
126342891|NCT04609514|454552057|FG000|Overall Study|Withdrawal by PI|0|||
126342892|NCT04609514|454552058|FG001|Overall Study|Withdrawal by PI|2|||
126342893|NCT00909870|454552059|FG000|Overall Study|Adverse Event|13|||
126342894|NCT00909870|454552060|FG001|Overall Study|Adverse Event|7|||
126342895|NCT00909870|454552059|FG000|Overall Study|Protocol Violation|1|||
126342896|NCT00909870|454552060|FG001|Overall Study|Protocol Violation|2|||
126342897|NCT00909870|454552059|FG000|Overall Study|Withdrawal by Subject|5|||
126342898|NCT00909870|454552060|FG001|Overall Study|Withdrawal by Subject|8|||
126342899|NCT00909870|454552059|FG000|Overall Study|Lost to Follow-up|3|||
126342900|NCT00909870|454552060|FG001|Overall Study|Lost to Follow-up|3|||
126342901|NCT00909870|454552059|FG000|Overall Study|Physician Decision|0|||
126342902|NCT00909870|454552060|FG001|Overall Study|Physician Decision|2|||
126342903|NCT00909870|454552059|FG000|Overall Study|Other|1|||
126342904|NCT00909870|454552060|FG001|Overall Study|Other|5|||
126342905|NCT01316575|454552063|FG000|Overall Study|Withdrawal by Subject|2|||
126342906|NCT01316575|454552064|FG001|Overall Study|Withdrawal by Subject|0|||
126342907|NCT01316575|454552063|FG000|Overall Study|Required alternate treatment|0|||
126342908|NCT01316575|454552064|FG001|Overall Study|Required alternate treatment|1|||
126342909|NCT00402831|454552065|FG000|Overall Study|Lost to Follow-up|1|||
126342910|NCT00402831|454552066|FG001|Overall Study|Lost to Follow-up|2|||
126342911|NCT00402831|454552065|FG000|Overall Study|Non-compliance with protocol|0|||
126342912|NCT00402831|454552066|FG001|Overall Study|Non-compliance with protocol|1|||
126342913|NCT01114724|454552071|FG000|Overall Study|Death|8|||
126342914|NCT01114724|454552071|FG000|Overall Study|Lost to Follow-up|1|||
126342915|NCT01114724|454552071|FG000|Overall Study|Withdrawal by Subject|1|||
126342916|NCT02814526|454552072|FG000|Overall Study|Adverse Event|4|||
126342917|NCT02814526|454552073|FG001|Overall Study|Adverse Event|3|||
126429223|NCT00647296|454866643|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
126429224|NCT00647296|454866640|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
126429225|NCT00647296|454866641|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
126429226|NCT00647296|454866642|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
126429227|NCT00647296|454866643|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
126429228|NCT00647296|454866640|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
126429229|NCT00647296|454866641|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
126429230|NCT00647296|454866642|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
126429231|NCT00647296|454866643|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
126429232|NCT00647296|454866640|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
126429233|NCT00647296|454866641|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
126429234|NCT00647296|454866642|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
126429235|NCT00647296|454866643|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
126429236|NCT00647296|454866640|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
126429237|NCT00647296|454866641|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
126429238|NCT00647296|454866642|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
126429239|NCT00647296|454866643|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
126429240|NCT00647296|454866640|FG000|Part 2: 4-week Placebo Washout|Death|3|||
126429241|NCT00647296|454866641|FG001|Part 2: 4-week Placebo Washout|Death|0|||
126429242|NCT00647296|454866642|FG002|Part 2: 4-week Placebo Washout|Death|0|||
126429243|NCT00647296|454866643|FG003|Part 2: 4-week Placebo Washout|Death|0|||
126429244|NCT00647296|454866640|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
126429245|NCT00647296|454866641|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
126429246|NCT00647296|454866642|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
126429247|NCT00647296|454866643|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
126429248|NCT00647296|454866640|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
126429249|NCT00647296|454866641|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
126429250|NCT00647296|454866642|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
126429251|NCT00647296|454866643|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
126429252|NCT00647296|454866640|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
126429253|NCT00647296|454866641|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
126429254|NCT00647296|454866642|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
126429255|NCT00647296|454866643|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
126429256|NCT00647296|454866640|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
126429257|NCT00647296|454866641|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
126429258|NCT00647296|454866642|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
126429259|NCT00647296|454866643|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
126429260|NCT00647296|454866640|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
126429261|NCT00647296|454866641|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
126429262|NCT00647296|454866642|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
126429263|NCT00647296|454866643|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
126429264|NCT01787461|454866644|FG000|Overall Study|Adverse Event|4|||
126429265|NCT01787461|454866645|FG001|Overall Study|Adverse Event|3|||
126429266|NCT01787461|454866644|FG000|Overall Study|Lost to Follow-up|3|||
126429267|NCT01787461|454866645|FG001|Overall Study|Lost to Follow-up|2|||
126429268|NCT01787461|454866644|FG000|Overall Study|No longer met eligibility criteria|1|||
126429269|NCT01787461|454866645|FG001|Overall Study|No longer met eligibility criteria|0|||
126429270|NCT01787461|454866644|FG000|Overall Study|Withdrawal by Subject|3|||
126429271|NCT01787461|454866645|FG001|Overall Study|Withdrawal by Subject|4|||
126429272|NCT01787461|454866644|FG000|Overall Study|Protocol Violation|3|||
126429273|NCT01787461|454866645|FG001|Overall Study|Protocol Violation|0|||
126429274|NCT03649074|454866646|FG000|Overall Study|Lost to Follow-up|2|||
126429275|NCT03649074|454866647|FG001|Overall Study|Lost to Follow-up|1|||
126429276|NCT03649074|454866646|FG000|Overall Study|Adverse Event|1|||
126429277|NCT03649074|454866647|FG001|Overall Study|Adverse Event|0|||
126429278|NCT03649074|454866646|FG000|Overall Study|Physician Decision|1|||
126429279|NCT03649074|454866647|FG001|Overall Study|Physician Decision|0|||
126429280|NCT03649074|454866646|FG000|Overall Study|Withdrawal by Subject|0|||
126429281|NCT03649074|454866647|FG001|Overall Study|Withdrawal by Subject|2|||
126429282|NCT03649074|454866646|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
126429283|NCT03649074|454866647|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
126677553|NCT03134599|455777409|FG005|Week 1|Lost to Follow-up|0|||
126677554|NCT03134599|455777404|FG000|Week 2|Lost to Follow-up|1|||
126677555|NCT03134599|455777405|FG001|Week 2|Lost to Follow-up|0|||
126677556|NCT03134599|455777406|FG002|Week 2|Lost to Follow-up|0|||
126677557|NCT03134599|455777407|FG003|Week 2|Lost to Follow-up|1|||
126677558|NCT03134599|455777408|FG004|Week 2|Lost to Follow-up|1|||
126677559|NCT03134599|455777409|FG005|Week 2|Lost to Follow-up|0|||
126677560|NCT03134599|455777404|FG000|Week 3|Lost to Follow-up|0|||
126677561|NCT03134599|455777405|FG001|Week 3|Lost to Follow-up|0|||
126677562|NCT03134599|455777406|FG002|Week 3|Lost to Follow-up|0|||
126677563|NCT03134599|455777407|FG003|Week 3|Lost to Follow-up|1|||
126677564|NCT03134599|455777408|FG004|Week 3|Lost to Follow-up|0|||
126677565|NCT03134599|455777409|FG005|Week 3|Lost to Follow-up|1|||
126677566|NCT04962022|455777410|FG000|Period 1|Withdrawal by Subject|1|||
126677567|NCT04962022|455777411|FG001|Period 1|Withdrawal by Subject|0|||
126677568|NCT01146873|455777414|FG000|Overall Study|Transfer out|0|||
126677569|NCT01146873|455777415|FG001|Overall Study|Transfer out|6|||
126677570|NCT01967628|455777416|FG000|Overall Study|Withdrawal by Subject|2|||
126677571|NCT01967628|455777417|FG001|Overall Study|Withdrawal by Subject|0|||
126677572|NCT01967628|455777416|FG000|Overall Study|Unable to complete bronchoscopy|4|||
126677573|NCT01967628|455777417|FG001|Overall Study|Unable to complete bronchoscopy|6|||
126342918|NCT02814526|454552072|FG000|Overall Study|Death|1|||
126342919|NCT02814526|454552073|FG001|Overall Study|Death|1|||
126342920|NCT02814526|454552072|FG000|Overall Study|Lost to Follow-up|3|||
126342921|NCT02814526|454552073|FG001|Overall Study|Lost to Follow-up|4|||
126342922|NCT02814526|454552072|FG000|Overall Study|non site physician decision|1|||
126342923|NCT02814526|454552073|FG001|Overall Study|non site physician decision|0|||
126342924|NCT02814526|454552072|FG000|Overall Study|participant noncompliance|1|||
126342925|NCT02814526|454552073|FG001|Overall Study|participant noncompliance|1|||
126342926|NCT02814526|454552072|FG000|Overall Study|Withdrawal by Subject|20|||
126342927|NCT02814526|454552073|FG001|Overall Study|Withdrawal by Subject|14|||
126342928|NCT02814526|454552072|FG000|Overall Study|safety risk|2|||
126342929|NCT02814526|454552073|FG001|Overall Study|safety risk|1|||
126342930|NCT02814526|454552072|FG000|Overall Study|early termination-study terminated|1|||
126342931|NCT02814526|454552073|FG001|Overall Study|early termination-study terminated|2|||
126342932|NCT02814526|454552072|FG000|Overall Study|Other|0|||
126342933|NCT02814526|454552073|FG001|Overall Study|Other|4|||
126342934|NCT03883386|454552074|FG000|First Assignment|Lost to Follow-up|1|||
126342935|NCT03883386|454552075|FG001|First Assignment|Lost to Follow-up|0|||
126342936|NCT03883386|454552074|FG000|First Assignment|Withdrawal by Subject|1|||
126342937|NCT03883386|454552075|FG001|First Assignment|Withdrawal by Subject|1|||
126342938|NCT00251758|454552076|FG000|Overall Study|Adverse Event|7|||
126342939|NCT00251758|454552077|FG001|Overall Study|Adverse Event|9|||
126342940|NCT00251758|454552078|FG002|Overall Study|Adverse Event|11|||
126342941|NCT00251758|454552076|FG000|Overall Study|Lost to Follow-up|4|||
126342942|NCT00251758|454552077|FG001|Overall Study|Lost to Follow-up|2|||
126342943|NCT00251758|454552078|FG002|Overall Study|Lost to Follow-up|5|||
126342944|NCT00251758|454552076|FG000|Overall Study|Withdrawal by Subject|13|||
126342945|NCT00251758|454552077|FG001|Overall Study|Withdrawal by Subject|7|||
126342946|NCT00251758|454552078|FG002|Overall Study|Withdrawal by Subject|3|||
126342947|NCT00251758|454552076|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
126342948|NCT00251758|454552077|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
126342949|NCT00251758|454552078|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
126342950|NCT00251758|454552076|FG000|Overall Study|Lack of Efficacy|3|||
126342951|NCT00251758|454552077|FG001|Overall Study|Lack of Efficacy|0|||
126342952|NCT00251758|454552078|FG002|Overall Study|Lack of Efficacy|0|||
126342953|NCT00251758|454552076|FG000|Overall Study|Noncompliant|0|||
126342954|NCT00251758|454552077|FG001|Overall Study|Noncompliant|2|||
126342955|NCT00251758|454552078|FG002|Overall Study|Noncompliant|2|||
126342956|NCT00251758|454552076|FG000|Overall Study|Pregnancy|0|||
126342957|NCT00251758|454552077|FG001|Overall Study|Pregnancy|1|||
126342958|NCT00251758|454552078|FG002|Overall Study|Pregnancy|0|||
126342959|NCT00251758|454552076|FG000|Overall Study|Per Subject Request|0|||
126342960|NCT00251758|454552077|FG001|Overall Study|Per Subject Request|0|||
126342961|NCT00251758|454552078|FG002|Overall Study|Per Subject Request|1|||
126342962|NCT00251758|454552076|FG000|Overall Study|Per Investigator Request|1|||
126342963|NCT00251758|454552077|FG001|Overall Study|Per Investigator Request|0|||
126342964|NCT00251758|454552078|FG002|Overall Study|Per Investigator Request|0|||
126342965|NCT01387269|454552079|FG000|Overall Study|Death|38|||
126342966|NCT01387269|454552080|FG001|Overall Study|Death|20|||
126342967|NCT01387269|454552079|FG000|Overall Study|Other|8|||
126342968|NCT01387269|454552080|FG001|Overall Study|Other|7|||
126677574|NCT01967628|455777416|FG000|Overall Study|Lost to Follow-up|1|||
126342969|NCT01387269|454552079|FG000|Overall Study|Unrelated AE|12|||
126342970|NCT01387269|454552080|FG001|Overall Study|Unrelated AE|3|||
126342971|NCT01387269|454552079|FG000|Overall Study|Withdrawal by patient|32|||
126677575|NCT01967628|455777417|FG001|Overall Study|Lost to Follow-up|0|||
126677576|NCT01967628|455777416|FG000|Overall Study|Low protein concentration in sample|20|||
126677577|NCT01967628|455777417|FG001|Overall Study|Low protein concentration in sample|25|||
126342972|NCT01387269|454552080|FG001|Overall Study|Withdrawal by patient|10|||
126342973|NCT01387269|454552079|FG000|Overall Study|Study drug-related AE|1|||
126342974|NCT01387269|454552080|FG001|Overall Study|Study drug-related AE|0|||
126342975|NCT01387269|454552079|FG000|Overall Study|Lost to Follow-up|1|||
126342976|NCT01387269|454552080|FG001|Overall Study|Lost to Follow-up|0|||
126342977|NCT01981616|454552086|FG000|Overall Study|Adverse Event|0|||
126342978|NCT01981616|454552087|FG001|Overall Study|Adverse Event|1|||
126342979|NCT01981616|454552086|FG000|Overall Study|Protocol Violation|1|||
126342980|NCT01981616|454552087|FG001|Overall Study|Protocol Violation|0|||
126342981|NCT01020123|454552088|FG000|Main Period|Withdrawal by Subject|6|||
126429284|NCT03649074|454866646|FG000|Overall Study|Other|1|||
126429285|NCT03649074|454866647|FG001|Overall Study|Other|0|||
126429286|NCT00556894|454866648|FG000|Overall Study|Adverse Event|2|||
126429287|NCT00556894|454866649|FG001|Overall Study|Adverse Event|3|||
126429288|NCT00556894|454866650|FG002|Overall Study|Adverse Event|3|||
126429289|NCT00556894|454866648|FG000|Overall Study|Death|1|||
126429290|NCT00556894|454866649|FG001|Overall Study|Death|0|||
126429291|NCT00556894|454866650|FG002|Overall Study|Death|0|||
126429292|NCT00556894|454866648|FG000|Overall Study|regulatory decision in Bulgaria|10|||
126429293|NCT00556894|454866649|FG001|Overall Study|regulatory decision in Bulgaria|14|||
126429294|NCT00556894|454866650|FG002|Overall Study|regulatory decision in Bulgaria|13|||
126429295|NCT00556894|454866648|FG000|Overall Study|Change in therapy|2|||
126429296|NCT00556894|454866649|FG001|Overall Study|Change in therapy|1|||
126429297|NCT00556894|454866650|FG002|Overall Study|Change in therapy|2|||
126429298|NCT00556894|454866648|FG000|Overall Study|Withdrawal by Subject|1|||
126429299|NCT00556894|454866649|FG001|Overall Study|Withdrawal by Subject|1|||
126429300|NCT00556894|454866650|FG002|Overall Study|Withdrawal by Subject|1|||
126429301|NCT04750642|454866654|FG000|Overall Study|Adverse Event|1|||
126429302|NCT04750642|454866655|FG001|Overall Study|Adverse Event|0|||
126429303|NCT04750642|454866654|FG000|Overall Study|Withdrawal by Subject|0|||
126429304|NCT04750642|454866655|FG001|Overall Study|Withdrawal by Subject|1|||
126429305|NCT04750642|454866654|FG000|Overall Study|Protocol Violation|0|||
126429306|NCT04750642|454866655|FG001|Overall Study|Protocol Violation|1|||
126429307|NCT01519323|454868037|FG000|Overall Study|Death|3|||
126429308|NCT01519323|454868038|FG001|Overall Study|Death|2|||
126429309|NCT01519323|454868037|FG000|Overall Study|Study terminated by sponsor|0|||
126429310|NCT01519323|454868038|FG001|Overall Study|Study terminated by sponsor|1|||
126429311|NCT00445549|454868039|FG000|Overall Study|progressive disease|12|||
126429312|NCT00383552|454868042|FG000|Overall Study|Adverse Event|7|||
126429313|NCT00383552|454868043|FG001|Overall Study|Adverse Event|6|||
126429314|NCT00383552|454868044|FG002|Overall Study|Adverse Event|9|||
126429315|NCT00383552|454868045|FG003|Overall Study|Adverse Event|6|||
126429316|NCT00383552|454868042|FG000|Overall Study|Lack of Efficacy|4|||
126429317|NCT00383552|454868043|FG001|Overall Study|Lack of Efficacy|13|||
126429318|NCT00383552|454868044|FG002|Overall Study|Lack of Efficacy|29|||
126677578|NCT01356407|455777418|FG000|Overall Study|Lost to Follow-up|2|||
126677579|NCT01356407|455777419|FG001|Overall Study|Lost to Follow-up|0|||
126677580|NCT01356407|455777418|FG000|Overall Study|Patient Withdrew Consent|2|||
126677581|NCT01356407|455777419|FG001|Overall Study|Patient Withdrew Consent|1|||
126677582|NCT01356407|455777418|FG000|Overall Study|Could not afford IMP administration|0|||
126677583|NCT01356407|455777419|FG001|Overall Study|Could not afford IMP administration|1|||
126677584|NCT01356407|455777418|FG000|Overall Study|Not complete Endoscopy|2|||
126677585|NCT01356407|455777419|FG001|Overall Study|Not complete Endoscopy|2|||
126677586|NCT01157364|455777420|FG000|Overall Study|Other Reasons|1|||
126677587|NCT01157364|455777421|FG001|Overall Study|Other Reasons|1|||
126677588|NCT01157364|455777422|FG002|Overall Study|Other Reasons|2|||
126677589|NCT01157364|455777423|FG003|Overall Study|Other Reasons|1|||
126677590|NCT01157364|455777424|FG004|Overall Study|Other Reasons|0|||
126677591|NCT01157364|455777425|FG005|Overall Study|Other Reasons|0|||
126677592|NCT01157364|455777420|FG000|Overall Study|Personal Reasons|0|||
126677593|NCT01157364|455777421|FG001|Overall Study|Personal Reasons|2|||
126677594|NCT01157364|455777422|FG002|Overall Study|Personal Reasons|0|||
126677595|NCT01157364|455777423|FG003|Overall Study|Personal Reasons|0|||
126677596|NCT01157364|455777424|FG004|Overall Study|Personal Reasons|1|||
126677597|NCT01157364|455777425|FG005|Overall Study|Personal Reasons|1|||
126677598|NCT01157364|455777420|FG000|Overall Study|Lost to Follow-up|1|||
126677599|NCT01157364|455777421|FG001|Overall Study|Lost to Follow-up|0|||
126677600|NCT01157364|455777422|FG002|Overall Study|Lost to Follow-up|1|||
126677601|NCT01157364|455777423|FG003|Overall Study|Lost to Follow-up|0|||
126677602|NCT01157364|455777424|FG004|Overall Study|Lost to Follow-up|0|||
126677603|NCT01157364|455777425|FG005|Overall Study|Lost to Follow-up|0|||
126677604|NCT01157364|455777420|FG000|Overall Study|Lack of Efficacy|0|||
126677605|NCT01157364|455777421|FG001|Overall Study|Lack of Efficacy|0|||
126677606|NCT01157364|455777422|FG002|Overall Study|Lack of Efficacy|0|||
126677607|NCT01157364|455777423|FG003|Overall Study|Lack of Efficacy|1|||
126677608|NCT01157364|455777424|FG004|Overall Study|Lack of Efficacy|0|||
126429319|NCT00383552|454868045|FG003|Overall Study|Lack of Efficacy|42|||
126429320|NCT00383552|454868042|FG000|Overall Study|Lost to Follow-up|0|||
126429321|NCT00383552|454868043|FG001|Overall Study|Lost to Follow-up|1|||
126677609|NCT01157364|455777425|FG005|Overall Study|Lack of Efficacy|0|||
126677610|NCT01157364|455777420|FG000|Overall Study|Adverse Event|0|||
126677611|NCT01157364|455777421|FG001|Overall Study|Adverse Event|1|||
126677612|NCT01157364|455777422|FG002|Overall Study|Adverse Event|1|||
126677613|NCT01157364|455777423|FG003|Overall Study|Adverse Event|0|||
126677614|NCT01157364|455777424|FG004|Overall Study|Adverse Event|1|||
126429322|NCT00383552|454868044|FG002|Overall Study|Lost to Follow-up|5|||
126429323|NCT00383552|454868045|FG003|Overall Study|Lost to Follow-up|1|||
126429324|NCT00383552|454868042|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
126429325|NCT00383552|454868043|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
126677615|NCT01157364|455777425|FG005|Overall Study|Adverse Event|0|||
126429326|NCT00383552|454868044|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
126429327|NCT00383552|454868045|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
126429328|NCT00383552|454868042|FG000|Overall Study|Did not wish to continue (related)|1|||
126429329|NCT00383552|454868043|FG001|Overall Study|Did not wish to continue (related)|0|||
126429330|NCT00383552|454868044|FG002|Overall Study|Did not wish to continue (related)|2|||
126429331|NCT00383552|454868045|FG003|Overall Study|Did not wish to continue (related)|3|||
126429332|NCT00383552|454868042|FG000|Overall Study|Noncompliance with the protocol|11|||
126429333|NCT00383552|454868043|FG001|Overall Study|Noncompliance with the protocol|6|||
126429334|NCT00383552|454868044|FG002|Overall Study|Noncompliance with the protocol|8|||
126429335|NCT00383552|454868045|FG003|Overall Study|Noncompliance with the protocol|10|||
126429336|NCT00383552|454868042|FG000|Overall Study|Did not meet protocol eligibility|8|||
126429337|NCT00383552|454868043|FG001|Overall Study|Did not meet protocol eligibility|6|||
126429338|NCT00383552|454868044|FG002|Overall Study|Did not meet protocol eligibility|2|||
126429339|NCT00383552|454868045|FG003|Overall Study|Did not meet protocol eligibility|3|||
126429340|NCT00383552|454868042|FG000|Overall Study|Administrative|1|||
126429341|NCT00383552|454868043|FG001|Overall Study|Administrative|0|||
126429342|NCT00383552|454868044|FG002|Overall Study|Administrative|1|||
126429343|NCT00383552|454868045|FG003|Overall Study|Administrative|1|||
126429344|NCT03096834|454868046|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
126429345|NCT03096834|454868047|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
126429346|NCT03096834|454868048|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
126429347|NCT03096834|454868049|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
126429348|NCT03096834|454868046|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
126429349|NCT03096834|454868047|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
126429350|NCT03096834|454868048|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
126429351|NCT03096834|454868049|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
126429352|NCT03096834|454868046|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
126429353|NCT03096834|454868047|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
126429354|NCT03096834|454868048|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
126429355|NCT03096834|454868049|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
126429356|NCT03096834|454868046|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
126429357|NCT03096834|454868047|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
126429358|NCT03096834|454868048|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
126429359|NCT03096834|454868049|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
126429360|NCT03096834|454868046|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
126429361|NCT03096834|454868047|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
126429362|NCT03096834|454868048|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
126429363|NCT03096834|454868049|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
126429364|NCT03096834|454868046|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
126429365|NCT03096834|454868047|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
126429366|NCT03096834|454868048|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
126429367|NCT03096834|454868049|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
126429368|NCT03096834|454868046|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
126429369|NCT03096834|454868047|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
126429370|NCT03096834|454868048|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
126429371|NCT03096834|454868049|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
126429372|NCT03096834|454868046|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
126429373|NCT03096834|454868047|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
126429374|NCT03096834|454868048|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
126429375|NCT03096834|454868049|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
126429376|NCT03096834|454868046|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
126429377|NCT03096834|454868047|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
126429378|NCT03096834|454868048|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
126429379|NCT03096834|454868049|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
126429380|NCT03096834|454868046|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
126429381|NCT03096834|454868047|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
126429382|NCT03096834|454868048|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
126429383|NCT03096834|454868049|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
126429384|NCT03096834|454868046|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
126677616|NCT01087775|455777436|FG000|Overall Study|failed inclusion criteria|2|||
126677617|NCT00825162|455777444|FG000|Overall Study|Withdrawal by Subject|11|||
126677618|NCT00825162|455777445|FG001|Overall Study|Withdrawal by Subject|13|||
126677619|NCT00825162|455777446|FG002|Overall Study|Withdrawal by Subject|3|||
126677620|NCT00825162|455777444|FG000|Overall Study|Lost to Follow-up|9|||
126677621|NCT00825162|455777445|FG001|Overall Study|Lost to Follow-up|6|||
126429385|NCT03096834|454868047|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
126429386|NCT03096834|454868048|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
126429387|NCT03096834|454868049|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
126429388|NCT03096834|454868046|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
126429389|NCT03096834|454868047|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
126677622|NCT00825162|455777446|FG002|Overall Study|Lost to Follow-up|3|||
126429390|NCT03096834|454868048|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
126429391|NCT03096834|454868049|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
126429392|NCT00966654|454868050|FG000|Overall Study|Study was terminated,PI left institution|12|||
126429393|NCT04416204|454868053|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
126429394|NCT04416204|454868054|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
126429395|NCT04416204|454868055|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
126429396|NCT04416204|454868056|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
126429397|NCT04456504|454868057|FG000|Overall Study|Lost to Follow-up|2|||
126429398|NCT01405768|454868058|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
126429399|NCT01405768|454868059|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
126429400|NCT01381016|454868064|FG000|Overall Study|Lost to Follow-up|1|||
126429401|NCT01381016|454868065|FG001|Overall Study|Lost to Follow-up|1|||
126429402|NCT01381016|454868064|FG000|Overall Study|Screen Failure|2|||
126429403|NCT01381016|454868065|FG001|Overall Study|Screen Failure|2|||
126429404|NCT01381016|454868064|FG000|Overall Study|Withdrawal by Subject|0|||
126429405|NCT01381016|454868065|FG001|Overall Study|Withdrawal by Subject|1|||
126429406|NCT01381016|454868064|FG000|Overall Study|Physician Decision|0|||
126429407|NCT01381016|454868065|FG001|Overall Study|Physician Decision|2|||
126429408|NCT01451723|454868067|FG000|Overall Study|study halted|6|||
126429409|NCT01451723|454868068|FG001|Overall Study|study halted|5|||
126429410|NCT01631435|454868069|FG000|Overall Study|Adverse Event|2|||
126429411|NCT01631435|454868069|FG000|Overall Study|Withdrawal by Subject|2|||
126429412|NCT01631435|454868069|FG000|Overall Study|incomplete study procedure|5|||
126429413|NCT01005251|454868078|FG000|Overall Study|Withdrawal by Subject|2|||
126429414|NCT01005251|454868079|FG001|Overall Study|Withdrawal by Subject|5|||
126429415|NCT01005251|454868080|FG002|Overall Study|Withdrawal by Subject|3|||
126429416|NCT01005251|454868081|FG003|Overall Study|Withdrawal by Subject|4|||
126429417|NCT01005251|454868082|FG004|Overall Study|Withdrawal by Subject|9|||
126429418|NCT01005251|454868078|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
126429419|NCT01005251|454868079|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126429420|NCT01005251|454868080|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
126429421|NCT01005251|454868081|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
126429422|NCT01005251|454868082|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
126429423|NCT01005251|454868078|FG000|Overall Study|Adverse Event|2|||
126429424|NCT01005251|454868079|FG001|Overall Study|Adverse Event|6|||
126429425|NCT01005251|454868080|FG002|Overall Study|Adverse Event|8|||
126429426|NCT01005251|454868081|FG003|Overall Study|Adverse Event|5|||
126429427|NCT01005251|454868082|FG004|Overall Study|Adverse Event|4|||
126429428|NCT01005251|454868078|FG000|Overall Study|Protocol Violation|1|||
126429429|NCT01005251|454868079|FG001|Overall Study|Protocol Violation|0|||
126429430|NCT01005251|454868080|FG002|Overall Study|Protocol Violation|0|||
126429431|NCT01005251|454868081|FG003|Overall Study|Protocol Violation|0|||
126429432|NCT01005251|454868082|FG004|Overall Study|Protocol Violation|2|||
126429433|NCT01005251|454868078|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
126429434|NCT01005251|454868079|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
126429435|NCT01005251|454868080|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
126677623|NCT00825162|455777444|FG000|Overall Study|Physician Decision|2|||
126677624|NCT00825162|455777445|FG001|Overall Study|Physician Decision|0|||
126677625|NCT00825162|455777446|FG002|Overall Study|Physician Decision|0|||
126677626|NCT00825162|455777444|FG000|Overall Study|Move away from the study area|1|||
126677627|NCT00825162|455777445|FG001|Overall Study|Move away from the study area|0|||
126677628|NCT00825162|455777446|FG002|Overall Study|Move away from the study area|0|||
126677629|NCT00825162|455777444|FG000|Overall Study|Unable to attend the study visit|5|||
126677630|NCT00825162|455777445|FG001|Overall Study|Unable to attend the study visit|2|||
126677631|NCT00825162|455777446|FG002|Overall Study|Unable to attend the study visit|0|||
126677632|NCT00964743|455777447|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
126677633|NCT00781911|455777448|FG000|Overall Study|Adverse Event|4|||
126677634|NCT00781911|455777449|FG001|Overall Study|Adverse Event|4|||
126677635|NCT00781911|455777448|FG000|Overall Study|Withdrawal by Subject|1|||
126677636|NCT00781911|455777449|FG001|Overall Study|Withdrawal by Subject|2|||
126677637|NCT00781911|455777448|FG000|Overall Study|Physician Decision|0|||
126677638|NCT00781911|455777449|FG001|Overall Study|Physician Decision|2|||
126677639|NCT00781911|455777448|FG000|Overall Study|Sponsor Decision|1|||
126677640|NCT00781911|455777449|FG001|Overall Study|Sponsor Decision|0|||
126677641|NCT03317795|455777450|FG000|Overall Study|IUD Expulsion|1|||
126677642|NCT03317795|455777451|FG001|Overall Study|IUD Expulsion|0|||
126429436|NCT01005251|454868081|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
126429437|NCT01005251|454868082|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
126429438|NCT01005251|454868078|FG000|Overall Study|Lost to Follow-up|1|||
126429439|NCT01005251|454868079|FG001|Overall Study|Lost to Follow-up|4|||
126429440|NCT01005251|454868080|FG002|Overall Study|Lost to Follow-up|2|||
126429441|NCT01005251|454868081|FG003|Overall Study|Lost to Follow-up|0|||
126429442|NCT01005251|454868082|FG004|Overall Study|Lost to Follow-up|0|||
126429443|NCT01005251|454868078|FG000|Overall Study|Physician Decision|0|||
126677643|NCT03317795|455777450|FG000|Overall Study|Lost to Follow-up|1|||
126677644|NCT03317795|455777451|FG001|Overall Study|Lost to Follow-up|3|||
126677645|NCT03317795|455777450|FG000|Overall Study|Treatment change|0|||
126677646|NCT03317795|455777451|FG001|Overall Study|Treatment change|3|||
126677647|NCT03317795|455777450|FG000|Overall Study|Intolerance of medication|0|||
126677648|NCT03317795|455777451|FG001|Overall Study|Intolerance of medication|1|||
126677649|NCT01549002|455777457|FG000|Overall Study|Excessive pain|0|||
126677650|NCT01549002|455777458|FG001|Overall Study|Excessive pain|2|||
126677651|NCT01549002|455777457|FG000|Overall Study|Moderate sedation required|0|||
126677652|NCT01549002|455777458|FG001|Overall Study|Moderate sedation required|2|||
126677653|NCT01251367|455777463|FG000|Overall Study|Protocol Violation|1|||
126677654|NCT01251367|455777463|FG000|Overall Study|Lack of Efficacy|2|||
126677655|NCT01251367|455777463|FG000|Overall Study|Adverse Event|19|||
126677656|NCT01251367|455777463|FG000|Overall Study|Withdrawal by Subject|36|||
126677657|NCT01251367|455777463|FG000|Overall Study|Lost to Follow-up|5|||
126677658|NCT01251367|455777463|FG000|Overall Study|Subject Required Alternative Treatment|7|||
126429444|NCT01005251|454868079|FG001|Overall Study|Physician Decision|0|||
126429445|NCT01005251|454868080|FG002|Overall Study|Physician Decision|0|||
126429446|NCT01005251|454868081|FG003|Overall Study|Physician Decision|0|||
126677659|NCT01251367|455777463|FG000|Overall Study|No Study Drug Available|1|||
126342982|NCT01020123|454552089|FG001|Main Period|Withdrawal by Subject|5|||
126342983|NCT01020123|454552090|FG002|Main Period|Withdrawal by Subject|3|||
126342984|NCT01020123|454552091|FG003|Main Period|Withdrawal by Subject|1|||
126342985|NCT01020123|454552092|FG004|Main Period|Withdrawal by Subject|6|||
126342986|NCT01020123|454552093|FG005|Main Period|Withdrawal by Subject|3|||
126342987|NCT01020123|454552094|FG006|Main Period|Withdrawal by Subject|2|||
126342988|NCT01020123|454552088|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
126342989|NCT01020123|454552089|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
126342990|NCT01020123|454552090|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
126342991|NCT01020123|454552091|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
126342992|NCT01020123|454552092|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
126342993|NCT01020123|454552093|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
126342994|NCT01020123|454552094|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
126342995|NCT01020123|454552088|FG000|Main Period|Adverse Event|5|||
126342996|NCT01020123|454552089|FG001|Main Period|Adverse Event|2|||
126342997|NCT01020123|454552090|FG002|Main Period|Adverse Event|2|||
126342998|NCT01020123|454552091|FG003|Main Period|Adverse Event|1|||
126342999|NCT01020123|454552092|FG004|Main Period|Adverse Event|1|||
126343000|NCT01020123|454552093|FG005|Main Period|Adverse Event|2|||
126343001|NCT01020123|454552094|FG006|Main Period|Adverse Event|1|||
126343002|NCT01020123|454552088|FG000|Main Period|Protocol Violation|4|||
126343003|NCT01020123|454552089|FG001|Main Period|Protocol Violation|4|||
126343004|NCT01020123|454552090|FG002|Main Period|Protocol Violation|2|||
126343005|NCT01020123|454552091|FG003|Main Period|Protocol Violation|5|||
126343006|NCT01020123|454552092|FG004|Main Period|Protocol Violation|2|||
126343007|NCT01020123|454552093|FG005|Main Period|Protocol Violation|3|||
126343008|NCT01020123|454552094|FG006|Main Period|Protocol Violation|2|||
126343009|NCT01020123|454552088|FG000|Main Period|Lost to Follow-up|0|||
126343010|NCT01020123|454552089|FG001|Main Period|Lost to Follow-up|2|||
126343011|NCT01020123|454552090|FG002|Main Period|Lost to Follow-up|0|||
126343012|NCT01020123|454552091|FG003|Main Period|Lost to Follow-up|0|||
126343013|NCT01020123|454552092|FG004|Main Period|Lost to Follow-up|0|||
126343014|NCT01020123|454552093|FG005|Main Period|Lost to Follow-up|0|||
126343015|NCT01020123|454552094|FG006|Main Period|Lost to Follow-up|0|||
126343016|NCT01020123|454552088|FG000|Main Period|Unclasified|2|||
126343017|NCT01020123|454552089|FG001|Main Period|Unclasified|0|||
126343018|NCT01020123|454552090|FG002|Main Period|Unclasified|1|||
126343019|NCT01020123|454552091|FG003|Main Period|Unclasified|0|||
126343020|NCT01020123|454552092|FG004|Main Period|Unclasified|1|||
126343021|NCT01020123|454552093|FG005|Main Period|Unclasified|3|||
126343022|NCT01020123|454552094|FG006|Main Period|Unclasified|6|||
126343023|NCT01020123|454552088|FG000|Extention Period|Withdrawal by Subject|2|||
126343024|NCT01020123|454552089|FG001|Extention Period|Withdrawal by Subject|1|||
126343025|NCT01020123|454552090|FG002|Extention Period|Withdrawal by Subject|1|||
126343026|NCT01020123|454552091|FG003|Extention Period|Withdrawal by Subject|0|||
126343027|NCT01020123|454552092|FG004|Extention Period|Withdrawal by Subject|0|||
126343028|NCT01020123|454552093|FG005|Extention Period|Withdrawal by Subject|0|||
126343029|NCT01020123|454552094|FG006|Extention Period|Withdrawal by Subject|0|||
126343030|NCT01020123|454552088|FG000|Extention Period|Adverse Event|0|||
126343031|NCT01020123|454552089|FG001|Extention Period|Adverse Event|0|||
126343032|NCT01020123|454552090|FG002|Extention Period|Adverse Event|0|||
126343033|NCT01020123|454552091|FG003|Extention Period|Adverse Event|1|||
126343034|NCT01020123|454552092|FG004|Extention Period|Adverse Event|0|||
126343035|NCT01020123|454552093|FG005|Extention Period|Adverse Event|0|||
126343036|NCT01020123|454552094|FG006|Extention Period|Adverse Event|0|||
126343037|NCT01020123|454552088|FG000|Extention Period|Protocol Violation|1|||
126343038|NCT01020123|454552089|FG001|Extention Period|Protocol Violation|1|||
126343039|NCT01020123|454552090|FG002|Extention Period|Protocol Violation|1|||
126429447|NCT01005251|454868082|FG004|Overall Study|Physician Decision|2|||
126677660|NCT01251367|455777463|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
126677661|NCT01251367|455777463|FG000|Overall Study|End of Study Visit Performed in Error|1|||
126677662|NCT02016820|455777466|FG000|Overall Study|Lost to Follow-up|2|||
126677663|NCT02016820|455777467|FG001|Overall Study|Lost to Follow-up|4|||
126677664|NCT01227044|455777468|FG000|Overall Study|Lost to Follow-up|5|||
126677665|NCT01227044|455777469|FG001|Overall Study|Lost to Follow-up|7|||
126677666|NCT01227044|455777468|FG000|Overall Study|Discontinued Intervention|1|||
126677667|NCT01227044|455777469|FG001|Overall Study|Discontinued Intervention|2|||
126677668|NCT02424253|455777470|FG000|Overall Study|Other, unspecified|1|||
126677669|NCT02424253|455777471|FG001|Overall Study|Other, unspecified|0|||
126677670|NCT02424253|455777470|FG000|Overall Study|Compliance problems|1|||
126677671|NCT02424253|455777471|FG001|Overall Study|Compliance problems|0|||
126677672|NCT02424253|455777470|FG000|Overall Study|Physician Decision|2|||
126677673|NCT02424253|455777471|FG001|Overall Study|Physician Decision|0|||
126677674|NCT02424253|455777470|FG000|Overall Study|Lack of Efficacy|0|||
126677675|NCT02424253|455777471|FG001|Overall Study|Lack of Efficacy|7|||
126677676|NCT02424253|455777470|FG000|Overall Study|Adverse Event|2|||
126677677|NCT02424253|455777471|FG001|Overall Study|Adverse Event|0|||
126677678|NCT02424253|455777470|FG000|Overall Study|Consent withdrawn by subject|4|||
126677679|NCT02424253|455777471|FG001|Overall Study|Consent withdrawn by subject|1|||
126677680|NCT02424253|455777470|FG000|Overall Study|Lost to Follow-up|1|||
126677681|NCT02424253|455777471|FG001|Overall Study|Lost to Follow-up|1|||
126677682|NCT00583362|455777472|FG000|Overall Study|Adverse Event|44|||
126677683|NCT00583362|455777472|FG000|Overall Study|Lack of Efficacy|22|||
126677684|NCT00583362|455777472|FG000|Overall Study|Lost to Follow-up|4|||
126677685|NCT00583362|455777472|FG000|Overall Study|Non-compliance with study drug|28|||
126677686|NCT00583362|455777472|FG000|Overall Study|Pregnancy|7|||
126677687|NCT00583362|455777472|FG000|Overall Study|Miscommunication of visit window|5|||
126677688|NCT00583362|455777472|FG000|Overall Study|Current site closed|7|||
126677689|NCT00583362|455777472|FG000|Overall Study|Subject not dosed in LBSL99|1|||
126677690|NCT00583362|455777472|FG000|Overall Study|Subject moved out of the country/state|2|||
126677691|NCT00583362|455777472|FG000|Overall Study|Missed visits due to staff changes|1|||
126677692|NCT00583362|455777472|FG000|Overall Study|Misunderstanding of protocol|1|||
126677693|NCT00583362|455777472|FG000|Overall Study|Behavioral problems and non-compliance|1|||
126677694|NCT00583362|455777472|FG000|Overall Study|Sponsor request due to missed doses|1|||
126677695|NCT00583362|455777472|FG000|Overall Study|Physician Decision|19|||
126677696|NCT00583362|455777472|FG000|Overall Study|Protocol Violation|2|||
126677697|NCT00583362|455777472|FG000|Overall Study|Withdrawal by Subject|57|||
126677698|NCT02290873|455777475|FG000|Overall Study|Withdrawal by Subject|0|||
126677699|NCT02290873|455777476|FG001|Overall Study|Withdrawal by Subject|1|||
126429448|NCT01005251|454868078|FG000|Overall Study|Patient moved|1|||
126429449|NCT01005251|454868079|FG001|Overall Study|Patient moved|0|||
126429450|NCT01005251|454868080|FG002|Overall Study|Patient moved|0|||
126429451|NCT01005251|454868081|FG003|Overall Study|Patient moved|0|||
126429452|NCT01005251|454868082|FG004|Overall Study|Patient moved|0|||
126429453|NCT01005251|454868078|FG000|Overall Study|Wrong drug dispensed|0|||
126429454|NCT01005251|454868079|FG001|Overall Study|Wrong drug dispensed|1|||
126429455|NCT01005251|454868080|FG002|Overall Study|Wrong drug dispensed|0|||
126429456|NCT01005251|454868081|FG003|Overall Study|Wrong drug dispensed|0|||
126429457|NCT01005251|454868082|FG004|Overall Study|Wrong drug dispensed|0|||
126429458|NCT01005251|454868078|FG000|Overall Study|Randomized in error|0|||
126429459|NCT01005251|454868079|FG001|Overall Study|Randomized in error|0|||
126429460|NCT01005251|454868080|FG002|Overall Study|Randomized in error|1|||
126429461|NCT01005251|454868081|FG003|Overall Study|Randomized in error|1|||
126429462|NCT01005251|454868082|FG004|Overall Study|Randomized in error|0|||
126429463|NCT01005251|454868078|FG000|Overall Study|Lack of Efficacy|0|||
126429464|NCT01005251|454868079|FG001|Overall Study|Lack of Efficacy|0|||
126429465|NCT01005251|454868080|FG002|Overall Study|Lack of Efficacy|1|||
126429466|NCT01005251|454868081|FG003|Overall Study|Lack of Efficacy|1|||
126429467|NCT01005251|454868082|FG004|Overall Study|Lack of Efficacy|0|||
126429468|NCT00768989|454868085|FG000|Prior to Week 24|Withdrawal by Subject|1|||
126429469|NCT00768989|454868086|FG001|Prior to Week 24|Withdrawal by Subject|0|||
126429470|NCT00768989|454868085|FG000|Prior to Week 24|Adverse Event|3|||
126429471|NCT00768989|454868086|FG001|Prior to Week 24|Adverse Event|0|||
126429472|NCT00768989|454868085|FG000|Prior to Week 24|Lost to Follow-up|0|||
126677700|NCT02290873|455777477|FG002|Overall Study|Withdrawal by Subject|1|||
126677701|NCT02290873|455777475|FG000|Overall Study|Nellcor device error|1|||
126677702|NCT02290873|455777476|FG001|Overall Study|Nellcor device error|0|||
126429473|NCT00768989|454868086|FG001|Prior to Week 24|Lost to Follow-up|1|||
126429474|NCT00768989|454868085|FG000|Prior to Week 24|Protocol Violation|0|||
126429475|NCT00768989|454868086|FG001|Prior to Week 24|Protocol Violation|2|||
126429476|NCT00768989|454868085|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
126429477|NCT00768989|454868086|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
126429478|NCT00768989|454868085|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
126429479|NCT00768989|454868086|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
126677703|NCT02290873|455777477|FG002|Overall Study|Nellcor device error|0|||
126677704|NCT02290873|455777475|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
126677705|NCT02290873|455777476|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
126677706|NCT02290873|455777477|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
126677707|NCT02290873|455777475|FG000|Overall Study|Protocol Violation|0|||
126677708|NCT02290873|455777476|FG001|Overall Study|Protocol Violation|0|||
126677709|NCT02290873|455777477|FG002|Overall Study|Protocol Violation|1|||
126677710|NCT01378104|455777481|FG000|Overall Study|Adverse Event|8|||
126677711|NCT01378104|455777482|FG001|Overall Study|Adverse Event|8|||
126677712|NCT01378104|455777481|FG000|Overall Study|Lack of Efficacy|7|||
126677713|NCT01378104|455777482|FG001|Overall Study|Lack of Efficacy|5|||
126677714|NCT01378104|455777481|FG000|Overall Study|Withdrawal by Subject|12|||
126677715|NCT01378104|455777482|FG001|Overall Study|Withdrawal by Subject|13|||
126677716|NCT02700997|455777483|FG000|Overall Study|Did not undergo CT imaging|1|||
126677717|NCT02700997|455777483|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
126677718|NCT03610724|455777484|FG000|Overall Study|Death|17|||
126677719|NCT03610724|455777484|FG000|Overall Study|Lost to Follow-up|1|||
126677720|NCT03610724|455777484|FG000|Overall Study|Physician Decision|1|||
126677721|NCT03610724|455777484|FG000|Overall Study|Died prior to infusion|1|||
126677722|NCT01519765|455777485|FG000|Overall Study|Adverse Event|0|||
126677723|NCT01519765|455777486|FG001|Overall Study|Adverse Event|1|||
126343040|NCT01020123|454552091|FG003|Extention Period|Protocol Violation|0|||
126343041|NCT01020123|454552092|FG004|Extention Period|Protocol Violation|0|||
126343042|NCT01020123|454552093|FG005|Extention Period|Protocol Violation|0|||
126343043|NCT01020123|454552094|FG006|Extention Period|Protocol Violation|1|||
126343044|NCT01020123|454552088|FG000|Extention Period|Lost to Follow-up|0|||
126343045|NCT01020123|454552089|FG001|Extention Period|Lost to Follow-up|0|||
126343046|NCT01020123|454552090|FG002|Extention Period|Lost to Follow-up|0|||
126343047|NCT01020123|454552091|FG003|Extention Period|Lost to Follow-up|0|||
126343048|NCT01020123|454552092|FG004|Extention Period|Lost to Follow-up|0|||
126343049|NCT01020123|454552093|FG005|Extention Period|Lost to Follow-up|2|||
126343050|NCT01020123|454552094|FG006|Extention Period|Lost to Follow-up|0|||
126343051|NCT04711005|454552099|FG000|Overall Study|Withdrawal by Subject|0|||
126343052|NCT04711005|454552100|FG001|Overall Study|Withdrawal by Subject|0|||
126343053|NCT04711005|454552101|FG002|Overall Study|Withdrawal by Subject|0|||
126343054|NCT04711005|454552102|FG003|Overall Study|Withdrawal by Subject|0|||
126343055|NCT04711005|454552103|FG004|Overall Study|Withdrawal by Subject|0|||
126343056|NCT04711005|454552104|FG005|Overall Study|Withdrawal by Subject|0|||
126343057|NCT04711005|454552105|FG006|Overall Study|Withdrawal by Subject|0|||
126343058|NCT04711005|454552106|FG007|Overall Study|Withdrawal by Subject|1|||
126343059|NCT04711005|454552107|FG008|Overall Study|Withdrawal by Subject|0|||
126343060|NCT04711005|454552108|FG009|Overall Study|Withdrawal by Subject|0|||
126343061|NCT04711005|454552099|FG000|Overall Study|Physician Decision|0|||
126343062|NCT04711005|454552100|FG001|Overall Study|Physician Decision|0|||
126343063|NCT04711005|454552101|FG002|Overall Study|Physician Decision|0|||
126343064|NCT04711005|454552102|FG003|Overall Study|Physician Decision|0|||
126343065|NCT04711005|454552103|FG004|Overall Study|Physician Decision|0|||
126343066|NCT04711005|454552104|FG005|Overall Study|Physician Decision|0|||
126343067|NCT04711005|454552105|FG006|Overall Study|Physician Decision|0|||
126343068|NCT04711005|454552106|FG007|Overall Study|Physician Decision|2|||
126343069|NCT04711005|454552107|FG008|Overall Study|Physician Decision|1|||
126343070|NCT04711005|454552108|FG009|Overall Study|Physician Decision|0|||
126343071|NCT03824561|454552116|FG000|Overall Study|Protocol Violation|19|||
126343072|NCT03573297|454552118|FG000|Open Label Treatment Period|Adverse Event|67|||
126343073|NCT03573297|454552119|FG001|Open Label Treatment Period|Adverse Event|0|||
126343074|NCT03573297|454552120|FG002|Open Label Treatment Period|Adverse Event|0|||
126343075|NCT03573297|454552121|FG003|Open Label Treatment Period|Adverse Event|0|||
126343076|NCT03573297|454552118|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
126343077|NCT03573297|454552119|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
126343078|NCT03573297|454552120|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
126343079|NCT03573297|454552121|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
126343080|NCT03573297|454552118|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
126343081|NCT03573297|454552119|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
126343082|NCT03573297|454552120|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
126343083|NCT03573297|454552121|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
126343084|NCT03573297|454552118|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
126343085|NCT03573297|454552119|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
126343086|NCT03573297|454552120|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
126343087|NCT03573297|454552121|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
126343088|NCT03573297|454552118|FG000|Open Label Treatment Period|Pregnancy|1|||
126343089|NCT03573297|454552119|FG001|Open Label Treatment Period|Pregnancy|0|||
126343090|NCT03573297|454552120|FG002|Open Label Treatment Period|Pregnancy|0|||
126343091|NCT03573297|454552121|FG003|Open Label Treatment Period|Pregnancy|0|||
126343092|NCT03573297|454552118|FG000|Open Label Treatment Period|Protocol Violation|17|||
126343093|NCT03573297|454552119|FG001|Open Label Treatment Period|Protocol Violation|0|||
126677724|NCT01519765|455777485|FG000|Overall Study|Lack of Efficacy|2|||
126677725|NCT01519765|455777486|FG001|Overall Study|Lack of Efficacy|0|||
126677726|NCT01519765|455777485|FG000|Overall Study|Protocol Violation|1|||
126343094|NCT03573297|454552120|FG002|Open Label Treatment Period|Protocol Violation|0|||
126677727|NCT01519765|455777486|FG001|Overall Study|Protocol Violation|0|||
126429480|NCT00768989|454868085|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
126429481|NCT00768989|454868086|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
126429482|NCT00768989|454868085|FG000|On or After Week 36|Lack of Efficacy|1|||
126429483|NCT00768989|454868086|FG001|On or After Week 36|Lack of Efficacy|0|||
126429484|NCT00768989|454868085|FG000|On or After Week 36|Adverse Event|0|||
126429485|NCT00768989|454868086|FG001|On or After Week 36|Adverse Event|1|||
126429486|NCT00768989|454868085|FG000|On or After Week 36|Lost to Follow-up|1|||
126429487|NCT00768989|454868086|FG001|On or After Week 36|Lost to Follow-up|0|||
126429488|NCT00768989|454868085|FG000|On or After Week 36|Poor Compliance|1|||
126429489|NCT00768989|454868086|FG001|On or After Week 36|Poor Compliance|0|||
126429490|NCT00768989|454868085|FG000|On or After Week 36|Protocol Violation|1|||
126429491|NCT00768989|454868086|FG001|On or After Week 36|Protocol Violation|0|||
126429492|NCT00768989|454868085|FG000|On or After Week 36|Did not attend termination visit|2|||
126429493|NCT00768989|454868086|FG001|On or After Week 36|Did not attend termination visit|0|||
126429494|NCT00768989|454868085|FG000|On or After Week 36|Sponsor Termination|45|||
126429495|NCT00768989|454868086|FG001|On or After Week 36|Sponsor Termination|26|||
126429496|NCT00443040|454868087|FG000|Overall Study|Withdrawal by Subject|1|||
126429497|NCT00443040|454868088|FG001|Overall Study|Withdrawal by Subject|0|||
126429498|NCT00443040|454868089|FG002|Overall Study|Withdrawal by Subject|0|||
126429499|NCT00443040|454868087|FG000|Overall Study|Converted to an open laparotomy|3|||
126429500|NCT00443040|454868088|FG001|Overall Study|Converted to an open laparotomy|0|||
126429501|NCT00443040|454868089|FG002|Overall Study|Converted to an open laparotomy|1|||
126429502|NCT00435409|454868093|FG000|Overall Study|Protocol Violation|1|||
126429503|NCT00435409|454868094|FG001|Overall Study|Protocol Violation|2|||
126429504|NCT00435409|454868095|FG002|Overall Study|Protocol Violation|0|||
126429505|NCT00435409|454868093|FG000|Overall Study|Lost to Follow-up|1|||
126429506|NCT00435409|454868094|FG001|Overall Study|Lost to Follow-up|2|||
126429507|NCT00435409|454868095|FG002|Overall Study|Lost to Follow-up|0|||
126429508|NCT00435409|454868093|FG000|Overall Study|Death|8|||
126429509|NCT00435409|454868094|FG001|Overall Study|Death|6|||
126429510|NCT00435409|454868095|FG002|Overall Study|Death|6|||
126429511|NCT00435409|454868093|FG000|Overall Study|Objective progression or relapse|158|||
126429512|NCT00435409|454868094|FG001|Overall Study|Objective progression or relapse|93|||
126429513|NCT00435409|454868095|FG002|Overall Study|Objective progression or relapse|58|||
126429514|NCT00435409|454868093|FG000|Overall Study|Global deterioration of health status|0|||
126429515|NCT00435409|454868094|FG001|Overall Study|Global deterioration of health status|0|||
126429516|NCT00435409|454868095|FG002|Overall Study|Global deterioration of health status|4|||
126429517|NCT00435409|454868093|FG000|Overall Study|Withdrawal by Subject|8|||
126429518|NCT00435409|454868094|FG001|Overall Study|Withdrawal by Subject|7|||
126429519|NCT00435409|454868095|FG002|Overall Study|Withdrawal by Subject|1|||
126429520|NCT00435409|454868093|FG000|Overall Study|Other|45|||
126429521|NCT00435409|454868094|FG001|Overall Study|Other|30|||
126429522|NCT00435409|454868095|FG002|Overall Study|Other|1|||
126429523|NCT00435409|454868093|FG000|Overall Study|Adverse Event|0|||
126429524|NCT00435409|454868094|FG001|Overall Study|Adverse Event|0|||
126429525|NCT00435409|454868095|FG002|Overall Study|Adverse Event|8|||
126429526|NCT00435409|454868093|FG000|Overall Study|Sponsor decision|0|||
126429527|NCT00435409|454868094|FG001|Overall Study|Sponsor decision|3|||
126429528|NCT00435409|454868095|FG002|Overall Study|Sponsor decision|0|||
126677728|NCT01519765|455777485|FG000|Overall Study|Withdrawal by Subject|0|||
126429529|NCT03661723|454868099|FG000|Overall Study|Disease Progression|4|||
126429530|NCT03661723|454868100|FG001|Overall Study|Disease Progression|24|||
126429531|NCT03661723|454868101|FG002|Overall Study|Disease Progression|4|||
126429532|NCT03661723|454868102|FG003|Overall Study|Disease Progression|19|||
126677729|NCT01519765|455777486|FG001|Overall Study|Withdrawal by Subject|1|||
126677730|NCT01473563|455777487|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
126677731|NCT02354222|455777488|FG000|Overall Study|Adverse Event|0|||
126429533|NCT03661723|454868099|FG000|Overall Study|Withdrawal by Subject|1|||
126429534|NCT03661723|454868100|FG001|Overall Study|Withdrawal by Subject|0|||
126429535|NCT03661723|454868101|FG002|Overall Study|Withdrawal by Subject|2|||
126429536|NCT03661723|454868102|FG003|Overall Study|Withdrawal by Subject|4|||
126429537|NCT03661723|454868099|FG000|Overall Study|Physician Decision|1|||
126677732|NCT02354222|455777489|FG001|Overall Study|Adverse Event|3|||
126677733|NCT02354222|455777488|FG000|Overall Study|Physician Decision|1|||
126677734|NCT02354222|455777489|FG001|Overall Study|Physician Decision|1|||
126429538|NCT03661723|454868100|FG001|Overall Study|Physician Decision|0|||
126429539|NCT03661723|454868101|FG002|Overall Study|Physician Decision|0|||
126429540|NCT03661723|454868102|FG003|Overall Study|Physician Decision|0|||
126429541|NCT03661723|454868099|FG000|Overall Study|Clinical Deterioration|0|||
126429542|NCT03661723|454868100|FG001|Overall Study|Clinical Deterioration|0|||
126429543|NCT03661723|454868101|FG002|Overall Study|Clinical Deterioration|0|||
126429544|NCT03661723|454868102|FG003|Overall Study|Clinical Deterioration|1|||
126429545|NCT00718510|454868105|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
126429546|NCT00718510|454868106|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126677735|NCT02354222|455777488|FG000|Overall Study|Pregnancy|1|||
126677736|NCT02354222|455777489|FG001|Overall Study|Pregnancy|0|||
126677737|NCT02354222|455777488|FG000|Overall Study|Withdrawal by Subject|2|||
126343095|NCT03573297|454552121|FG003|Open Label Treatment Period|Protocol Violation|0|||
126343096|NCT03573297|454552118|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
126343097|NCT03573297|454552119|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
126343098|NCT03573297|454552120|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
126343099|NCT03573297|454552121|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
126343100|NCT03573297|454552118|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
126343101|NCT03573297|454552119|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
126343102|NCT03573297|454552120|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
126343103|NCT03573297|454552121|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
126343104|NCT03573297|454552118|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
126343105|NCT03573297|454552119|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
126343106|NCT03573297|454552120|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
126343107|NCT03573297|454552121|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
126343108|NCT03573297|454552118|FG000|Open Label Treatment Period|Other, Not Specified|7|||
126343109|NCT03573297|454552119|FG001|Open Label Treatment Period|Other, Not Specified|0|||
126343110|NCT03573297|454552120|FG002|Open Label Treatment Period|Other, Not Specified|0|||
126343111|NCT03573297|454552121|FG003|Open Label Treatment Period|Other, Not Specified|0|||
126343112|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
126343113|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
126343114|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
126343115|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
126343116|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126343117|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126343118|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Adverse Event|5|||
126343119|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Adverse Event|1|||
126343120|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
126343121|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
126343122|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
126343123|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
126343124|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126343125|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
126343126|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
126343127|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
126343128|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126343129|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
126343130|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
126343131|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
126343132|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
126343133|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
126343134|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
126343135|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
126343136|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
126343137|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
126343138|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
126343139|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
126343140|NCT03573297|454552118|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
126343141|NCT03573297|454552119|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
126343142|NCT03573297|454552120|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
126343143|NCT03573297|454552121|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
126343144|NCT01499810|454552122|FG000|Overall Study|Lost to Follow-up|10|||
126343145|NCT01499810|454552122|FG000|Overall Study|Protocol Violation|1|||
126343146|NCT01499810|454552122|FG000|Overall Study|Withdrawal by Subject|1|||
126343147|NCT06996301|454552123|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
126343148|NCT06996301|454552124|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
126343149|NCT06996301|454552123|FG000|Overall Study|Patients with discordant diagnostic results|107|||
126343150|NCT06996301|454552124|FG001|Overall Study|Patients with discordant diagnostic results|90|||
126343151|NCT06996301|454552123|FG000|Overall Study|Lost to Follow-up|31|||
126343152|NCT06996301|454552124|FG001|Overall Study|Lost to Follow-up|56|||
126343153|NCT06996301|454552123|FG000|Overall Study|Withdrawal by Subject|12|||
126343154|NCT06996301|454552124|FG001|Overall Study|Withdrawal by Subject|7|||
126343155|NCT02273167|454552128|FG000|Overall Study|Adverse Event|1|||
126343156|NCT02273167|454552129|FG001|Overall Study|Adverse Event|0|||
126677738|NCT02354222|455777489|FG001|Overall Study|Withdrawal by Subject|3|||
126677739|NCT02354222|455777488|FG000|Overall Study|Conflict with the stopping criteria|0|||
126677740|NCT02354222|455777489|FG001|Overall Study|Conflict with the stopping criteria|4|||
126677741|NCT01342484|455777494|FG000|Overall Study|Other Reasons|1|||
126677742|NCT01342484|455777495|FG001|Overall Study|Other Reasons|0|||
126429547|NCT00718510|454868105|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
126429548|NCT00718510|454868106|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
126429549|NCT00667888|454868107|FG000|Overall Study|Death|1|||
126429550|NCT00667888|454868108|FG001|Overall Study|Death|1|||
126429551|NCT00667888|454868107|FG000|Overall Study|Withdrawal by Subject|6|||
126429552|NCT00667888|454868108|FG001|Overall Study|Withdrawal by Subject|3|||
126429553|NCT00667888|454868107|FG000|Overall Study|Proceed with other treatment|3|||
126429554|NCT00667888|454868108|FG001|Overall Study|Proceed with other treatment|3|||
126429555|NCT00667888|454868107|FG000|Overall Study|Ineligible after SIM|0|||
126429556|NCT00667888|454868108|FG001|Overall Study|Ineligible after SIM|2|||
126429557|NCT00883779|454868109|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
126429558|NCT00883779|454868110|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
126429559|NCT00883779|454868109|FG000|Primary Study Treatment Phase|Disease progression|75|||
126429560|NCT00883779|454868110|FG001|Primary Study Treatment Phase|Disease progression|59|||
126429561|NCT00883779|454868109|FG000|Primary Study Treatment Phase|Adverse Event|16|||
126429562|NCT00883779|454868110|FG001|Primary Study Treatment Phase|Adverse Event|16|||
126429563|NCT00883779|454868109|FG000|Primary Study Treatment Phase|Death|2|||
126429564|NCT00883779|454868110|FG001|Primary Study Treatment Phase|Death|3|||
126429565|NCT00883779|454868109|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
126429566|NCT00883779|454868110|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
126429567|NCT00883779|454868109|FG000|Primary Study Treatment Phase|Other|3|||
126429568|NCT00883779|454868110|FG001|Primary Study Treatment Phase|Other|0|||
126429569|NCT00883779|454868109|FG000|Post-Study Treatment Phase|Adverse Event|2|||
126429570|NCT00883779|454868110|FG001|Post-Study Treatment Phase|Adverse Event|3|||
126429571|NCT00883779|454868109|FG000|Post-Study Treatment Phase|Death|1|||
126429572|NCT00883779|454868110|FG001|Post-Study Treatment Phase|Death|3|||
126429573|NCT00883779|454868109|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
126429574|NCT00883779|454868110|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
126429575|NCT00883779|454868109|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
126429576|NCT00883779|454868110|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
126429577|NCT00883779|454868109|FG000|Post-Study Treatment Phase|Disease progression|103|||
126429578|NCT00883779|454868110|FG001|Post-Study Treatment Phase|Disease progression|122|||
126429579|NCT00883779|454868109|FG000|Post-Study Treatment Phase|Other|3|||
126429580|NCT00883779|454868110|FG001|Post-Study Treatment Phase|Other|0|||
126429581|NCT00883779|454868109|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
126429582|NCT00883779|454868110|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
126429583|NCT00883779|454868109|FG000|Off-study Phase|Death|185|||
126429584|NCT00883779|454868110|FG001|Off-study Phase|Death|174|||
126429585|NCT00883779|454868109|FG000|Off-study Phase|Refused treatment|1|||
126429586|NCT00883779|454868110|FG001|Off-study Phase|Refused treatment|1|||
126429587|NCT00883779|454868109|FG000|Off-study Phase|Failure to return|5|||
126429588|NCT00883779|454868110|FG001|Off-study Phase|Failure to return|6|||
126429589|NCT00883779|454868109|FG000|Off-study Phase|Other|18|||
126429590|NCT00883779|454868110|FG001|Off-study Phase|Other|21|||
126429591|NCT00499681|454868111|FG000|Overall Study|toxicity|0|||
126429592|NCT00499681|454868112|FG001|Overall Study|toxicity|1|||
126429593|NCT00499681|454868111|FG000|Overall Study|disease progression|0|||
126429594|NCT00499681|454868112|FG001|Overall Study|disease progression|1|||
126429595|NCT00659061|454868113|FG000|Overall Study|Migration due to political unrest|21|||
126429596|NCT00659061|454868114|FG001|Overall Study|Migration due to political unrest|15|||
126429597|NCT00079040|454868115|FG000|Overall Study|Withdrew before treatment|1|||
126429598|NCT00079040|454868115|FG000|Overall Study|Ineligible|1|||
126429599|NCT01277744|454868116|FG000|Overall Study|Physician Decision|2|||
126429600|NCT00325897|454868117|FG000|Overall Study|Lost to Follow-up|12|||
126429601|NCT00325897|454868118|FG001|Overall Study|Lost to Follow-up|13|||
126429602|NCT03915717|454868119|FG000|Overall Study|EchoMark Not Implanted|6|||
126429603|NCT00467740|454868124|FG000|Overall Study|Adverse Event|0|||
126429604|NCT00467740|454868125|FG001|Overall Study|Adverse Event|0|||
126429605|NCT00467740|454868126|FG002|Overall Study|Adverse Event|1|||
126429606|NCT00467740|454868127|FG003|Overall Study|Adverse Event|0|||
126429607|NCT00467740|454868128|FG004|Overall Study|Adverse Event|0|||
126429608|NCT00467740|454868124|FG000|Overall Study|Protocol Violation|0|||
126429609|NCT00467740|454868125|FG001|Overall Study|Protocol Violation|0|||
126429610|NCT00467740|454868126|FG002|Overall Study|Protocol Violation|1|||
126429611|NCT00467740|454868127|FG003|Overall Study|Protocol Violation|0|||
126429612|NCT00467740|454868128|FG004|Overall Study|Protocol Violation|0|||
126429613|NCT00467740|454868124|FG000|Overall Study|Lost to Follow-up|0|||
126429614|NCT00467740|454868125|FG001|Overall Study|Lost to Follow-up|1|||
126429615|NCT00467740|454868126|FG002|Overall Study|Lost to Follow-up|0|||
126677743|NCT01342484|455777496|FG002|Overall Study|Other Reasons|0|||
126429616|NCT00467740|454868127|FG003|Overall Study|Lost to Follow-up|0|||
126429617|NCT00467740|454868128|FG004|Overall Study|Lost to Follow-up|0|||
126429618|NCT00467740|454868124|FG000|Overall Study|Withdrawal by Subject|1|||
126429619|NCT00467740|454868125|FG001|Overall Study|Withdrawal by Subject|1|||
126429620|NCT00467740|454868126|FG002|Overall Study|Withdrawal by Subject|0|||
126429621|NCT00467740|454868127|FG003|Overall Study|Withdrawal by Subject|1|||
126429622|NCT00467740|454868128|FG004|Overall Study|Withdrawal by Subject|0|||
126429623|NCT00467740|454868124|FG000|Overall Study|Lack of Efficacy|0|||
126429624|NCT00467740|454868125|FG001|Overall Study|Lack of Efficacy|1|||
126429625|NCT00467740|454868126|FG002|Overall Study|Lack of Efficacy|0|||
126429626|NCT00467740|454868127|FG003|Overall Study|Lack of Efficacy|0|||
126429627|NCT00467740|454868128|FG004|Overall Study|Lack of Efficacy|0|||
126429628|NCT04999839|454868138|FG000|Overall Study|Adverse Event|1|||
126429629|NCT04999839|454868139|FG001|Overall Study|Adverse Event|1|||
126429630|NCT04999839|454868140|FG002|Overall Study|Adverse Event|1|||
126429631|NCT04999839|454868141|FG003|Overall Study|Adverse Event|1|||
126429632|NCT04999839|454868142|FG004|Overall Study|Adverse Event|1|||
126429633|NCT04999839|454868138|FG000|Overall Study|Lost to Follow-up|2|||
126429634|NCT04999839|454868139|FG001|Overall Study|Lost to Follow-up|0|||
126429635|NCT04999839|454868140|FG002|Overall Study|Lost to Follow-up|2|||
126429636|NCT04999839|454868141|FG003|Overall Study|Lost to Follow-up|4|||
126429637|NCT04999839|454868142|FG004|Overall Study|Lost to Follow-up|1|||
126429638|NCT04999839|454868138|FG000|Overall Study|Withdrawal by Subject|6|||
126677744|NCT01342484|455777494|FG000|Overall Study|Protocol Violation|0|||
126677745|NCT01342484|455777495|FG001|Overall Study|Protocol Violation|0|||
126677746|NCT01342484|455777496|FG002|Overall Study|Protocol Violation|1|||
126429639|NCT04999839|454868139|FG001|Overall Study|Withdrawal by Subject|5|||
126429640|NCT04999839|454868140|FG002|Overall Study|Withdrawal by Subject|3|||
126429641|NCT04999839|454868141|FG003|Overall Study|Withdrawal by Subject|2|||
126429642|NCT04999839|454868142|FG004|Overall Study|Withdrawal by Subject|2|||
126429643|NCT04999839|454868138|FG000|Overall Study|Lack of Efficacy|0|||
126429644|NCT04999839|454868139|FG001|Overall Study|Lack of Efficacy|1|||
126429645|NCT04999839|454868140|FG002|Overall Study|Lack of Efficacy|0|||
126429646|NCT04999839|454868141|FG003|Overall Study|Lack of Efficacy|0|||
126429647|NCT04999839|454868142|FG004|Overall Study|Lack of Efficacy|0|||
126429648|NCT04999839|454868138|FG000|Overall Study|Physician Decision|0|||
126429649|NCT04999839|454868139|FG001|Overall Study|Physician Decision|0|||
126429650|NCT04999839|454868140|FG002|Overall Study|Physician Decision|0|||
126429651|NCT04999839|454868141|FG003|Overall Study|Physician Decision|0|||
126429652|NCT04999839|454868142|FG004|Overall Study|Physician Decision|1|||
126429653|NCT04999839|454868138|FG000|Overall Study|Sponsor request|0|||
126429654|NCT04999839|454868139|FG001|Overall Study|Sponsor request|1|||
126429655|NCT04999839|454868140|FG002|Overall Study|Sponsor request|0|||
126429656|NCT04999839|454868141|FG003|Overall Study|Sponsor request|0|||
126429657|NCT04999839|454868142|FG004|Overall Study|Sponsor request|0|||
126429658|NCT04999839|454868138|FG000|Overall Study|Other|0|||
126429659|NCT04999839|454868139|FG001|Overall Study|Other|0|||
126429660|NCT04999839|454868140|FG002|Overall Study|Other|1|||
126429661|NCT04999839|454868141|FG003|Overall Study|Other|0|||
126429662|NCT04999839|454868142|FG004|Overall Study|Other|0|||
126429663|NCT03740048|454868144|FG000|Overall Study|Withdrawal by Subject|1|||
126429664|NCT03740048|454868145|FG001|Overall Study|Withdrawal by Subject|1|||
126429665|NCT03740048|454868144|FG000|Overall Study|Death|1|||
126429666|NCT03740048|454868145|FG001|Overall Study|Death|6|||
126429667|NCT03740048|454868144|FG000|Overall Study|Switched to thrice-weekly HD|2|||
126429668|NCT03740048|454868145|FG001|Overall Study|Switched to thrice-weekly HD|0|||
126429669|NCT03740048|454868144|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
126429670|NCT03740048|454868145|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
126429671|NCT03740048|454868144|FG000|Overall Study|Lost to Follow-up|0|||
126429672|NCT03740048|454868145|FG001|Overall Study|Lost to Follow-up|1|||
126429673|NCT03740048|454868144|FG000|Overall Study|Non-compliance with HD|0|||
126429674|NCT03740048|454868145|FG001|Overall Study|Non-compliance with HD|1|||
126429675|NCT02675907|454868148|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
126429676|NCT02675907|454868149|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
126429677|NCT02675907|454868148|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
126429678|NCT02675907|454868149|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
126677747|NCT01342484|455777494|FG000|Overall Study|Withdrawal by Subject|1|||
126677748|NCT01342484|455777495|FG001|Overall Study|Withdrawal by Subject|0|||
126677749|NCT01342484|455777496|FG002|Overall Study|Withdrawal by Subject|0|||
126429679|NCT02675907|454868148|FG000|Study Overall|Lack of Efficacy|1|||
126429680|NCT02675907|454868149|FG001|Study Overall|Lack of Efficacy|0|||
126429681|NCT02675907|454868148|FG000|Study Overall|Withdrawal by Subject|2|||
126429682|NCT02675907|454868149|FG001|Study Overall|Withdrawal by Subject|2|||
126429683|NCT02675907|454868148|FG000|Study Overall|Lost to Follow-up|0|||
126429684|NCT02675907|454868149|FG001|Study Overall|Lost to Follow-up|2|||
126429685|NCT00539981|454868150|FG000|Overall Study|Adverse events (AE)|3|||
126429686|NCT00539981|454868151|FG001|Overall Study|Adverse events (AE)|3|||
126429687|NCT00539981|454868150|FG000|Overall Study|Lost to Follow-up|260|||
126429688|NCT00539981|454868151|FG001|Overall Study|Lost to Follow-up|251|||
126429689|NCT00539981|454868150|FG000|Overall Study|Withdrew consent|22|||
126429690|NCT00539981|454868151|FG001|Overall Study|Withdrew consent|14|||
126429691|NCT00539981|454868150|FG000|Overall Study|Death|1|||
126429692|NCT00539981|454868151|FG001|Overall Study|Death|1|||
126429693|NCT00539981|454868150|FG000|Overall Study|Other reason-unspecified|9|||
126429694|NCT00539981|454868151|FG001|Overall Study|Other reason-unspecified|13|||
126677750|NCT01840579|455777497|FG000|Overall Study|Status not recorded|0|||
126677751|NCT01840579|455777498|FG001|Overall Study|Status not recorded|0|||
126677752|NCT01840579|455777499|FG002|Overall Study|Status not recorded|2|||
126677753|NCT01840579|455777500|FG003|Overall Study|Status not recorded|3|||
126677754|NCT01840579|455777501|FG004|Overall Study|Status not recorded|4|||
126677755|NCT01840579|455777502|FG005|Overall Study|Status not recorded|3|||
126677756|NCT01840579|455777503|FG006|Overall Study|Status not recorded|0|||
126677757|NCT01840579|455777504|FG007|Overall Study|Status not recorded|3|||
126677758|NCT01840579|455777505|FG008|Overall Study|Status not recorded|3|||
126677759|NCT01840579|455777506|FG009|Overall Study|Status not recorded|3|||
126677760|NCT01840579|455777497|FG000|Overall Study|Progressive disease|3|||
126343157|NCT02273167|454552130|FG002|Overall Study|Adverse Event|0|||
126343158|NCT02273167|454552128|FG000|Overall Study|Protocol Violation|3|||
126343159|NCT02273167|454552129|FG001|Overall Study|Protocol Violation|1|||
126343160|NCT02273167|454552130|FG002|Overall Study|Protocol Violation|1|||
126343161|NCT02273167|454552128|FG000|Overall Study|Lost to Follow-up|0|||
126343162|NCT02273167|454552129|FG001|Overall Study|Lost to Follow-up|1|||
126343163|NCT02273167|454552130|FG002|Overall Study|Lost to Follow-up|1|||
126343164|NCT02273167|454552128|FG000|Overall Study|Withdrawal by Subject|10|||
126343165|NCT02273167|454552129|FG001|Overall Study|Withdrawal by Subject|12|||
126343166|NCT02273167|454552130|FG002|Overall Study|Withdrawal by Subject|11|||
126343167|NCT02273167|454552128|FG000|Overall Study|Various|10|||
126343168|NCT02273167|454552129|FG001|Overall Study|Various|9|||
126343169|NCT02273167|454552130|FG002|Overall Study|Various|8|||
126343170|NCT02781324|454552135|FG000|Overall Study|Withdrawal by Subject|1|||
126343171|NCT02781324|454552136|FG001|Overall Study|Withdrawal by Subject|0|||
126343172|NCT02781324|454552135|FG000|Overall Study|Physician Decision|1|||
126343173|NCT02781324|454552136|FG001|Overall Study|Physician Decision|2|||
126343174|NCT00834041|454552137|FG000|Overall Study|Withdrawal by Subject|1|||
126343175|NCT00834041|454552138|FG001|Overall Study|Withdrawal by Subject|0|||
126343176|NCT00834041|454552137|FG000|Overall Study|Lost to Follow-up|0|||
126343177|NCT00834041|454552138|FG001|Overall Study|Lost to Follow-up|1|||
126343178|NCT00661388|454552139|FG000|Overall Study|Adverse Event|14|||
126343179|NCT00661388|454552139|FG000|Overall Study|Protocol Violation|7|||
126343180|NCT00661388|454552139|FG000|Overall Study|Renal transplantation|1|||
126343181|NCT00661388|454552139|FG000|Overall Study|Dialysis initiation|1|||
126343182|NCT00661388|454552139|FG000|Overall Study|Administrative reasons|1|||
126343183|NCT03370172|454554023|FG000|Overall Study|Withdrawal by Subject|0|||
126343184|NCT03370172|454554024|FG001|Overall Study|Withdrawal by Subject|1|||
126343185|NCT01171534|454554031|FG000|Overall Study|Lost to Follow-up|0|||
126343186|NCT01171534|454554032|FG001|Overall Study|Lost to Follow-up|2|||
126343187|NCT01171534|454554031|FG000|Overall Study|screen failure|0|||
126343188|NCT01171534|454554032|FG001|Overall Study|screen failure|1|||
126343189|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
126343190|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
126343191|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
126343192|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
126343193|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
126343194|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
126343195|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
126343196|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
126343197|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
126343198|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
126343199|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
126343200|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
126343201|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
126343202|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
126343203|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
126343204|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
126343205|NCT00849056|454554033|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
126343206|NCT00849056|454554034|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
126343207|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
126429695|NCT01611792|454868152|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
126677761|NCT01840579|455777498|FG001|Overall Study|Progressive disease|5|||
126677762|NCT01840579|455777499|FG002|Overall Study|Progressive disease|0|||
126343208|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
126343209|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
126343210|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
126343211|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
126343212|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
126343213|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
126343214|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
126677763|NCT01840579|455777500|FG003|Overall Study|Progressive disease|0|||
126677764|NCT01840579|455777501|FG004|Overall Study|Progressive disease|0|||
126429696|NCT01611792|454868153|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
126429697|NCT01611792|454868152|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
126429698|NCT01611792|454868153|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
126429699|NCT03289208|454868156|FG000|Overall Study|Adverse Event|1|||
126429700|NCT03289208|454868157|FG001|Overall Study|Adverse Event|0|||
126429701|NCT03289208|454868158|FG002|Overall Study|Adverse Event|0|||
126429702|NCT03353675|454868162|FG000|Overall Study|Adverse Event|4|||
126429703|NCT02025179|454868163|FG000|Overall Study|Lost to Follow-up|0|||
126429704|NCT02025179|454868164|FG001|Overall Study|Lost to Follow-up|0|||
126429705|NCT02025179|454868165|FG002|Overall Study|Lost to Follow-up|1|||
126429706|NCT02362724|454868166|FG000|Overall Study|Withdrawal by Subject|3|||
126429707|NCT02362724|454868167|FG001|Overall Study|Withdrawal by Subject|1|||
126429708|NCT02362724|454868166|FG000|Overall Study|Adverse Event|3|||
126429709|NCT02362724|454868167|FG001|Overall Study|Adverse Event|0|||
126429710|NCT00395746|454868168|FG000|Overall Study|Adverse Event|5|||
126429711|NCT00395746|454868169|FG001|Overall Study|Adverse Event|2|||
126429712|NCT00395746|454868170|FG002|Overall Study|Adverse Event|2|||
126429713|NCT00395746|454868168|FG000|Overall Study|Protocol Violation|0|||
126429714|NCT00395746|454868169|FG001|Overall Study|Protocol Violation|1|||
126429715|NCT00395746|454868170|FG002|Overall Study|Protocol Violation|0|||
126429716|NCT00395746|454868168|FG000|Overall Study|Lack of Efficacy|2|||
126429717|NCT00395746|454868169|FG001|Overall Study|Lack of Efficacy|0|||
126429718|NCT00395746|454868170|FG002|Overall Study|Lack of Efficacy|17|||
126429719|NCT00395746|454868168|FG000|Overall Study|Hypoglycaemia|2|||
126429720|NCT00395746|454868169|FG001|Overall Study|Hypoglycaemia|1|||
126429721|NCT00395746|454868170|FG002|Overall Study|Hypoglycaemia|0|||
126429722|NCT00395746|454868168|FG000|Overall Study|Subject decision|0|||
126429723|NCT00395746|454868169|FG001|Overall Study|Subject decision|0|||
126429724|NCT00395746|454868170|FG002|Overall Study|Subject decision|1|||
126429725|NCT00395746|454868168|FG000|Overall Study|Withdrawal of consent|0|||
126429726|NCT00395746|454868169|FG001|Overall Study|Withdrawal of consent|0|||
126429727|NCT00395746|454868170|FG002|Overall Study|Withdrawal of consent|1|||
126429728|NCT00395746|454868168|FG000|Overall Study|Difficultulty in use of device|0|||
126429729|NCT00395746|454868169|FG001|Overall Study|Difficultulty in use of device|0|||
126429730|NCT00395746|454868170|FG002|Overall Study|Difficultulty in use of device|1|||
126429731|NCT00395746|454868168|FG000|Overall Study|Unable to visit site on schedule|1|||
126429732|NCT00395746|454868169|FG001|Overall Study|Unable to visit site on schedule|0|||
126429733|NCT00395746|454868170|FG002|Overall Study|Unable to visit site on schedule|0|||
126429734|NCT03137992|454868175|FG000|Washout Period 1|Adverse Event|1|||
126429735|NCT03137992|454868176|FG001|Washout Period 1|Adverse Event|1|||
126429736|NCT03137992|454868177|FG002|Washout Period 1|Adverse Event|0|||
126429737|NCT03137992|454868178|FG003|Washout Period 1|Adverse Event|0|||
126429738|NCT03137992|454868179|FG004|Washout Period 1|Adverse Event|0|||
126429739|NCT03137992|454868180|FG005|Washout Period 1|Adverse Event|1|||
126429740|NCT03137992|454868175|FG000|Washout Period 1|Withdrawal by Subject|0|||
126429741|NCT03137992|454868176|FG001|Washout Period 1|Withdrawal by Subject|1|||
126429742|NCT03137992|454868177|FG002|Washout Period 1|Withdrawal by Subject|1|||
126429743|NCT03137992|454868178|FG003|Washout Period 1|Withdrawal by Subject|0|||
126429744|NCT03137992|454868179|FG004|Washout Period 1|Withdrawal by Subject|0|||
126429745|NCT03137992|454868180|FG005|Washout Period 1|Withdrawal by Subject|0|||
126429746|NCT03137992|454868175|FG000|Washout Period 1|Principal Investigator Discretion|0|||
126429747|NCT03137992|454868176|FG001|Washout Period 1|Principal Investigator Discretion|1|||
126429748|NCT03137992|454868177|FG002|Washout Period 1|Principal Investigator Discretion|0|||
126429749|NCT03137992|454868178|FG003|Washout Period 1|Principal Investigator Discretion|0|||
126429750|NCT03137992|454868179|FG004|Washout Period 1|Principal Investigator Discretion|0|||
126677765|NCT01840579|455777502|FG005|Overall Study|Progressive disease|0|||
126677766|NCT01840579|455777503|FG006|Overall Study|Progressive disease|0|||
126677767|NCT01840579|455777504|FG007|Overall Study|Progressive disease|0|||
126677768|NCT01840579|455777505|FG008|Overall Study|Progressive disease|0|||
126677769|NCT01840579|455777506|FG009|Overall Study|Progressive disease|0|||
126677770|NCT01840579|455777497|FG000|Overall Study|Ongoing in study|0|||
126677771|NCT01840579|455777498|FG001|Overall Study|Ongoing in study|1|||
126677772|NCT01840579|455777499|FG002|Overall Study|Ongoing in study|0|||
126677773|NCT01840579|455777500|FG003|Overall Study|Ongoing in study|0|||
126677774|NCT01840579|455777501|FG004|Overall Study|Ongoing in study|0|||
126677775|NCT01840579|455777502|FG005|Overall Study|Ongoing in study|0|||
126677776|NCT01840579|455777503|FG006|Overall Study|Ongoing in study|0|||
126429751|NCT03137992|454868180|FG005|Washout Period 1|Principal Investigator Discretion|0|||
126429752|NCT03137992|454868175|FG000|Washout Period 1|COPD Exacerbation|1|||
126429753|NCT03137992|454868176|FG001|Washout Period 1|COPD Exacerbation|1|||
126429754|NCT03137992|454868177|FG002|Washout Period 1|COPD Exacerbation|1|||
126429755|NCT03137992|454868178|FG003|Washout Period 1|COPD Exacerbation|0|||
126429756|NCT03137992|454868179|FG004|Washout Period 1|COPD Exacerbation|1|||
126429757|NCT03137992|454868180|FG005|Washout Period 1|COPD Exacerbation|1|||
126429758|NCT03137992|454868175|FG000|Washout Period 1|Subject Noncompliance|1|||
126677777|NCT01840579|455777504|FG007|Overall Study|Ongoing in study|0|||
126677778|NCT01840579|455777505|FG008|Overall Study|Ongoing in study|0|||
126677779|NCT01840579|455777506|FG009|Overall Study|Ongoing in study|0|||
126677780|NCT01840579|455777497|FG000|Overall Study|Death|0|||
126677781|NCT01840579|455777498|FG001|Overall Study|Death|0|||
126677782|NCT01840579|455777499|FG002|Overall Study|Death|0|||
126677783|NCT01840579|455777500|FG003|Overall Study|Death|0|||
126677784|NCT01840579|455777501|FG004|Overall Study|Death|0|||
126677785|NCT01840579|455777502|FG005|Overall Study|Death|1|||
126677786|NCT01840579|455777503|FG006|Overall Study|Death|0|||
126677787|NCT01840579|455777504|FG007|Overall Study|Death|0|||
126677788|NCT01840579|455777505|FG008|Overall Study|Death|0|||
126677789|NCT01840579|455777506|FG009|Overall Study|Death|0|||
126677790|NCT01840579|455777497|FG000|Overall Study|Adverse Event|0|||
126677791|NCT01840579|455777498|FG001|Overall Study|Adverse Event|1|||
126677792|NCT01840579|455777499|FG002|Overall Study|Adverse Event|0|||
126677793|NCT01840579|455777500|FG003|Overall Study|Adverse Event|0|||
126677794|NCT01840579|455777501|FG004|Overall Study|Adverse Event|0|||
126677795|NCT01840579|455777502|FG005|Overall Study|Adverse Event|0|||
126677796|NCT01840579|455777503|FG006|Overall Study|Adverse Event|0|||
126677797|NCT01840579|455777504|FG007|Overall Study|Adverse Event|0|||
126677798|NCT01840579|455777505|FG008|Overall Study|Adverse Event|0|||
126677799|NCT01840579|455777506|FG009|Overall Study|Adverse Event|0|||
126677800|NCT01840579|455777497|FG000|Overall Study|Follow-up ended by Sponsor|0|||
126677801|NCT01840579|455777498|FG001|Overall Study|Follow-up ended by Sponsor|0|||
126677802|NCT01840579|455777499|FG002|Overall Study|Follow-up ended by Sponsor|0|||
126677803|NCT01840579|455777500|FG003|Overall Study|Follow-up ended by Sponsor|0|||
126677804|NCT01840579|455777501|FG004|Overall Study|Follow-up ended by Sponsor|0|||
126677805|NCT01840579|455777502|FG005|Overall Study|Follow-up ended by Sponsor|0|||
126677806|NCT01840579|455777503|FG006|Overall Study|Follow-up ended by Sponsor|2|||
126677807|NCT01840579|455777504|FG007|Overall Study|Follow-up ended by Sponsor|0|||
126677808|NCT01840579|455777505|FG008|Overall Study|Follow-up ended by Sponsor|0|||
126677809|NCT01840579|455777506|FG009|Overall Study|Follow-up ended by Sponsor|0|||
126677810|NCT00432042|455777507|FG000|Overall Study|Protocol Violation|2|||
126677811|NCT00432042|455777508|FG001|Overall Study|Protocol Violation|0|||
126677812|NCT00432042|455777509|FG002|Overall Study|Protocol Violation|0|||
126677813|NCT00432042|455777507|FG000|Overall Study|Withdrawal by Subject|0|||
126677814|NCT00432042|455777508|FG001|Overall Study|Withdrawal by Subject|0|||
126677815|NCT00432042|455777509|FG002|Overall Study|Withdrawal by Subject|2|||
126677816|NCT00432042|455777507|FG000|Overall Study|Lost to Follow-up|5|||
126677817|NCT00432042|455777508|FG001|Overall Study|Lost to Follow-up|1|||
126677818|NCT00432042|455777509|FG002|Overall Study|Lost to Follow-up|0|||
126677819|NCT04013529|455777513|FG000|Overall Study|Withdrawal by Subject|1|||
126343215|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
126343216|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
126343217|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
126343218|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
126343219|NCT00849056|454554033|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
126343220|NCT00849056|454554034|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
126343221|NCT02711137|454554035|FG000|Overall Study|Death|1|||
126343222|NCT02711137|454554036|FG001|Overall Study|Death|4|||
126343223|NCT02711137|454554037|FG002|Overall Study|Death|5|||
126343224|NCT02711137|454554038|FG003|Overall Study|Death|5|||
126343225|NCT02711137|454554039|FG004|Overall Study|Death|3|||
126343226|NCT02711137|454554040|FG005|Overall Study|Death|1|||
126343227|NCT02711137|454554041|FG006|Overall Study|Death|61|||
126343228|NCT02711137|454554042|FG007|Overall Study|Death|3|||
126343229|NCT02711137|454554043|FG008|Overall Study|Death|0|||
126343230|NCT02711137|454554044|FG009|Overall Study|Death|1|||
126343231|NCT02711137|454554045|FG010|Overall Study|Death|1|||
126343232|NCT02711137|454554046|FG011|Overall Study|Death|1|||
126343233|NCT02711137|454554047|FG012|Overall Study|Death|0|||
126343234|NCT02711137|454554048|FG013|Overall Study|Death|0|||
126343235|NCT02711137|454554049|FG014|Overall Study|Death|0|||
126343236|NCT02711137|454554035|FG000|Overall Study|Study Terminated by Sponsor|0|||
126343237|NCT02711137|454554036|FG001|Overall Study|Study Terminated by Sponsor|0|||
126343238|NCT02711137|454554037|FG002|Overall Study|Study Terminated by Sponsor|1|||
126677820|NCT04013529|455777514|FG001|Overall Study|Withdrawal by Subject|1|||
126677821|NCT03116698|455777515|FG000|Overall Study|Adverse Event|1|||
126677822|NCT03116698|455777516|FG001|Overall Study|Adverse Event|1|||
126677823|NCT03116698|455777517|FG002|Overall Study|Adverse Event|1|||
126677824|NCT03116698|455777518|FG003|Overall Study|Adverse Event|0|||
126677825|NCT03116698|455777515|FG000|Overall Study|Withdrawal by Subject|1|||
126677826|NCT03116698|455777516|FG001|Overall Study|Withdrawal by Subject|4|||
126343239|NCT02711137|454554038|FG003|Overall Study|Study Terminated by Sponsor|0|||
126343240|NCT02711137|454554039|FG004|Overall Study|Study Terminated by Sponsor|0|||
126343241|NCT02711137|454554040|FG005|Overall Study|Study Terminated by Sponsor|0|||
126343242|NCT02711137|454554041|FG006|Overall Study|Study Terminated by Sponsor|1|||
126677827|NCT03116698|455777517|FG002|Overall Study|Withdrawal by Subject|5|||
126677828|NCT03116698|455777518|FG003|Overall Study|Withdrawal by Subject|2|||
126677829|NCT03116698|455777515|FG000|Overall Study|Lost to Follow-up|2|||
126677830|NCT03116698|455777516|FG001|Overall Study|Lost to Follow-up|0|||
126429759|NCT03137992|454868176|FG001|Washout Period 1|Subject Noncompliance|0|||
126677831|NCT03116698|455777517|FG002|Overall Study|Lost to Follow-up|0|||
126677832|NCT03116698|455777518|FG003|Overall Study|Lost to Follow-up|0|||
126677833|NCT03116698|455777515|FG000|Overall Study|Physician Decision|1|||
126429760|NCT03137992|454868177|FG002|Washout Period 1|Subject Noncompliance|0|||
126429761|NCT03137992|454868178|FG003|Washout Period 1|Subject Noncompliance|0|||
126429762|NCT03137992|454868179|FG004|Washout Period 1|Subject Noncompliance|1|||
126429763|NCT03137992|454868180|FG005|Washout Period 1|Subject Noncompliance|0|||
126429764|NCT03137992|454868175|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
126429765|NCT03137992|454868176|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
126429766|NCT03137992|454868177|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
126429767|NCT03137992|454868178|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
126429768|NCT03137992|454868179|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
126429769|NCT03137992|454868180|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
126429770|NCT03137992|454868175|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
126429771|NCT03137992|454868176|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
126429772|NCT03137992|454868177|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
126429773|NCT03137992|454868178|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
126429774|NCT03137992|454868179|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
126429775|NCT03137992|454868180|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
126429776|NCT03137992|454868175|FG000|Period 2 (Visit 3)|Adverse Event|0|||
126429777|NCT03137992|454868176|FG001|Period 2 (Visit 3)|Adverse Event|1|||
126429778|NCT03137992|454868177|FG002|Period 2 (Visit 3)|Adverse Event|0|||
126429779|NCT03137992|454868178|FG003|Period 2 (Visit 3)|Adverse Event|0|||
126429780|NCT03137992|454868179|FG004|Period 2 (Visit 3)|Adverse Event|0|||
126429781|NCT03137992|454868180|FG005|Period 2 (Visit 3)|Adverse Event|0|||
126429782|NCT03137992|454868175|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
126429783|NCT03137992|454868176|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
126429784|NCT03137992|454868177|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
126429785|NCT03137992|454868178|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
126429786|NCT03137992|454868179|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
126429787|NCT03137992|454868180|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
126429788|NCT03137992|454868175|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
126429789|NCT03137992|454868176|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
126429790|NCT03137992|454868177|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
126429791|NCT03137992|454868178|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
126429792|NCT03137992|454868179|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
126429793|NCT03137992|454868180|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
126429794|NCT03137992|454868175|FG000|Washout Period 2|COPD Exacerbation|1|||
126429795|NCT03137992|454868176|FG001|Washout Period 2|COPD Exacerbation|1|||
126429796|NCT03137992|454868177|FG002|Washout Period 2|COPD Exacerbation|0|||
126429797|NCT03137992|454868178|FG003|Washout Period 2|COPD Exacerbation|0|||
126429798|NCT03137992|454868179|FG004|Washout Period 2|COPD Exacerbation|1|||
126429799|NCT03137992|454868180|FG005|Washout Period 2|COPD Exacerbation|0|||
126429800|NCT03137992|454868175|FG000|Washout Period 2|Subject Non-compliance|0|||
126429801|NCT03137992|454868176|FG001|Washout Period 2|Subject Non-compliance|1|||
126429802|NCT03137992|454868177|FG002|Washout Period 2|Subject Non-compliance|0|||
126429803|NCT03137992|454868178|FG003|Washout Period 2|Subject Non-compliance|0|||
126429804|NCT03137992|454868179|FG004|Washout Period 2|Subject Non-compliance|0|||
126429805|NCT03137992|454868180|FG005|Washout Period 2|Subject Non-compliance|0|||
126429806|NCT03137992|454868175|FG000|Washout Period 2|Adverse Event|0|||
126677834|NCT03116698|455777516|FG001|Overall Study|Physician Decision|1|||
126677835|NCT03116698|455777517|FG002|Overall Study|Physician Decision|0|||
126677836|NCT03116698|455777518|FG003|Overall Study|Physician Decision|0|||
126677837|NCT03116698|455777515|FG000|Overall Study|Protocol Violation|1|||
126677838|NCT03116698|455777516|FG001|Overall Study|Protocol Violation|0|||
126677839|NCT03116698|455777517|FG002|Overall Study|Protocol Violation|0|||
126677840|NCT03116698|455777518|FG003|Overall Study|Protocol Violation|0|||
126429807|NCT03137992|454868176|FG001|Washout Period 2|Adverse Event|0|||
126677841|NCT03116698|455777515|FG000|Overall Study|Death|0|||
126677842|NCT03116698|455777516|FG001|Overall Study|Death|0|||
126677843|NCT03116698|455777517|FG002|Overall Study|Death|2|||
126429808|NCT03137992|454868177|FG002|Washout Period 2|Adverse Event|0|||
126429809|NCT03137992|454868178|FG003|Washout Period 2|Adverse Event|1|||
126429810|NCT03137992|454868179|FG004|Washout Period 2|Adverse Event|1|||
126429811|NCT03137992|454868180|FG005|Washout Period 2|Adverse Event|0|||
126429812|NCT03137992|454868175|FG000|Washout Period 2|Withdrawal by Subject|1|||
126429813|NCT03137992|454868176|FG001|Washout Period 2|Withdrawal by Subject|0|||
126429814|NCT03137992|454868177|FG002|Washout Period 2|Withdrawal by Subject|0|||
126429815|NCT03137992|454868178|FG003|Washout Period 2|Withdrawal by Subject|0|||
126429816|NCT03137992|454868179|FG004|Washout Period 2|Withdrawal by Subject|1|||
126677844|NCT03116698|455777518|FG003|Overall Study|Death|0|||
126677845|NCT00788372|455777519|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
126677846|NCT00788372|455777519|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
126677847|NCT00788372|455777519|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
126677848|NCT00788372|455777519|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
126677849|NCT00788372|455777519|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
126677850|NCT00788372|455777519|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
126677851|NCT00788372|455777519|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
126677852|NCT04766021|455778972|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
126677853|NCT04766021|455778972|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
126677854|NCT00789529|455778973|FG000|Overall Study|Withdrawal by Subject|0|||
126677855|NCT00789529|455778974|FG001|Overall Study|Withdrawal by Subject|1|||
126677856|NCT00789529|455778973|FG000|Overall Study|Other Reason|1|||
126677857|NCT00789529|455778974|FG001|Overall Study|Other Reason|0|||
126677858|NCT01849874|455778975|FG000|Overall Study|Death|89|||
126677859|NCT01849874|455778976|FG001|Overall Study|Death|42|||
126677860|NCT01849874|455778975|FG000|Overall Study|Withdrawal by Subject|17|||
126677861|NCT01849874|455778976|FG001|Overall Study|Withdrawal by Subject|16|||
126677862|NCT01849874|455778975|FG000|Overall Study|Lost to Follow-up|3|||
126677863|NCT01849874|455778976|FG001|Overall Study|Lost to Follow-up|2|||
126677864|NCT01849874|455778975|FG000|Overall Study|Study Termination By Sponsor|93|||
126677865|NCT01849874|455778976|FG001|Overall Study|Study Termination By Sponsor|48|||
126677866|NCT01849874|455778975|FG000|Overall Study|Completed as per protocol amendment 6|3|||
126343243|NCT02711137|454554042|FG007|Overall Study|Study Terminated by Sponsor|0|||
126343244|NCT02711137|454554043|FG008|Overall Study|Study Terminated by Sponsor|0|||
126343245|NCT02711137|454554044|FG009|Overall Study|Study Terminated by Sponsor|0|||
126343246|NCT02711137|454554045|FG010|Overall Study|Study Terminated by Sponsor|0|||
126343247|NCT02711137|454554046|FG011|Overall Study|Study Terminated by Sponsor|0|||
126343248|NCT02711137|454554047|FG012|Overall Study|Study Terminated by Sponsor|0|||
126343249|NCT02711137|454554048|FG013|Overall Study|Study Terminated by Sponsor|0|||
126343250|NCT02711137|454554049|FG014|Overall Study|Study Terminated by Sponsor|0|||
126343251|NCT02711137|454554035|FG000|Overall Study|Physician Decision|1|||
126343252|NCT02711137|454554036|FG001|Overall Study|Physician Decision|0|||
126343253|NCT02711137|454554037|FG002|Overall Study|Physician Decision|2|||
126343254|NCT02711137|454554038|FG003|Overall Study|Physician Decision|1|||
126343255|NCT02711137|454554039|FG004|Overall Study|Physician Decision|1|||
126343256|NCT02711137|454554040|FG005|Overall Study|Physician Decision|0|||
126343257|NCT02711137|454554041|FG006|Overall Study|Physician Decision|12|||
126343258|NCT02711137|454554042|FG007|Overall Study|Physician Decision|2|||
126343259|NCT02711137|454554043|FG008|Overall Study|Physician Decision|1|||
126343260|NCT02711137|454554044|FG009|Overall Study|Physician Decision|1|||
126343261|NCT02711137|454554045|FG010|Overall Study|Physician Decision|3|||
126343262|NCT02711137|454554046|FG011|Overall Study|Physician Decision|2|||
126343263|NCT02711137|454554047|FG012|Overall Study|Physician Decision|1|||
126343264|NCT02711137|454554048|FG013|Overall Study|Physician Decision|1|||
126343265|NCT02711137|454554049|FG014|Overall Study|Physician Decision|2|||
126343266|NCT02711137|454554035|FG000|Overall Study|Other|0|||
126343267|NCT02711137|454554036|FG001|Overall Study|Other|1|||
126343268|NCT02711137|454554037|FG002|Overall Study|Other|0|||
126343269|NCT02711137|454554038|FG003|Overall Study|Other|0|||
126343270|NCT02711137|454554039|FG004|Overall Study|Other|0|||
126343271|NCT02711137|454554040|FG005|Overall Study|Other|0|||
126343272|NCT02711137|454554041|FG006|Overall Study|Other|3|||
126343273|NCT02711137|454554042|FG007|Overall Study|Other|0|||
126343274|NCT02711137|454554043|FG008|Overall Study|Other|0|||
126343275|NCT02711137|454554044|FG009|Overall Study|Other|0|||
126343276|NCT02711137|454554045|FG010|Overall Study|Other|0|||
126343277|NCT02711137|454554046|FG011|Overall Study|Other|0|||
126343278|NCT02711137|454554047|FG012|Overall Study|Other|0|||
126343279|NCT02711137|454554048|FG013|Overall Study|Other|0|||
126343280|NCT02711137|454554049|FG014|Overall Study|Other|1|||
126343281|NCT02711137|454554035|FG000|Overall Study|Withdrawal by Subject|1|||
126343282|NCT02711137|454554036|FG001|Overall Study|Withdrawal by Subject|0|||
126343283|NCT02711137|454554037|FG002|Overall Study|Withdrawal by Subject|0|||
126343284|NCT02711137|454554038|FG003|Overall Study|Withdrawal by Subject|1|||
126343285|NCT02711137|454554039|FG004|Overall Study|Withdrawal by Subject|1|||
126343286|NCT02711137|454554040|FG005|Overall Study|Withdrawal by Subject|0|||
126343287|NCT02711137|454554041|FG006|Overall Study|Withdrawal by Subject|7|||
126343288|NCT02711137|454554042|FG007|Overall Study|Withdrawal by Subject|0|||
126343289|NCT02711137|454554043|FG008|Overall Study|Withdrawal by Subject|0|||
126343290|NCT02711137|454554044|FG009|Overall Study|Withdrawal by Subject|0|||
126677867|NCT01849874|455778976|FG001|Overall Study|Completed as per protocol amendment 6|0|||
126677868|NCT01849874|455778975|FG000|Overall Study|Physician Decision|7|||
126677869|NCT01849874|455778976|FG001|Overall Study|Physician Decision|1|||
126343291|NCT02711137|454554045|FG010|Overall Study|Withdrawal by Subject|0|||
126343292|NCT02711137|454554046|FG011|Overall Study|Withdrawal by Subject|0|||
126343293|NCT02711137|454554047|FG012|Overall Study|Withdrawal by Subject|0|||
126343294|NCT02711137|454554048|FG013|Overall Study|Withdrawal by Subject|1|||
126343295|NCT02711137|454554049|FG014|Overall Study|Withdrawal by Subject|0|||
126343296|NCT02711137|454554035|FG000|Overall Study|Lost to Follow-up|1|||
126677870|NCT01849874|455778975|FG000|Overall Study|Other|16|||
126677871|NCT01849874|455778976|FG001|Overall Study|Other|4|||
126677872|NCT02347098|455778977|FG000|Overall Study|Death|1|||
126343297|NCT02711137|454554036|FG001|Overall Study|Lost to Follow-up|0|||
126343298|NCT02711137|454554037|FG002|Overall Study|Lost to Follow-up|0|||
126343299|NCT02711137|454554038|FG003|Overall Study|Lost to Follow-up|0|||
126343300|NCT02711137|454554039|FG004|Overall Study|Lost to Follow-up|0|||
126343301|NCT02711137|454554040|FG005|Overall Study|Lost to Follow-up|0|||
126343302|NCT02711137|454554041|FG006|Overall Study|Lost to Follow-up|2|||
126343303|NCT02711137|454554042|FG007|Overall Study|Lost to Follow-up|0|||
126343304|NCT02711137|454554043|FG008|Overall Study|Lost to Follow-up|0|||
126343305|NCT02711137|454554044|FG009|Overall Study|Lost to Follow-up|0|||
126343306|NCT02711137|454554045|FG010|Overall Study|Lost to Follow-up|0|||
126343307|NCT02711137|454554046|FG011|Overall Study|Lost to Follow-up|0|||
126343308|NCT02711137|454554047|FG012|Overall Study|Lost to Follow-up|0|||
126343309|NCT02711137|454554048|FG013|Overall Study|Lost to Follow-up|0|||
126343310|NCT02711137|454554049|FG014|Overall Study|Lost to Follow-up|0|||
126343311|NCT03427892|454554050|FG000|Overall Study|Lost to Follow-up|2|||
126343312|NCT00548327|454554051|FG000|Overall Study|Adverse Event|0|||
126343313|NCT00548327|454554052|FG001|Overall Study|Adverse Event|1|||
126343314|NCT00274456|454554053|FG000|Overall Study|Still on treatment|2|||
126343315|NCT00274456|454554054|FG001|Overall Study|Still on treatment|3|||
126343316|NCT00274456|454554055|FG002|Overall Study|Still on treatment|5|||
126343317|NCT00274456|454554056|FG003|Overall Study|Still on treatment|1|||
126343318|NCT00274456|454554053|FG000|Overall Study|Unacceptable toxicity|10|||
126343319|NCT00274456|454554054|FG001|Overall Study|Unacceptable toxicity|5|||
126343320|NCT00274456|454554055|FG002|Overall Study|Unacceptable toxicity|12|||
126343321|NCT00274456|454554056|FG003|Overall Study|Unacceptable toxicity|16|||
126343322|NCT00274456|454554053|FG000|Overall Study|Adverse Event|0|||
126343323|NCT00274456|454554054|FG001|Overall Study|Adverse Event|1|||
126343324|NCT00274456|454554055|FG002|Overall Study|Adverse Event|2|||
126343325|NCT00274456|454554056|FG003|Overall Study|Adverse Event|2|||
126677873|NCT02347098|455778978|FG001|Overall Study|Death|0|||
126677874|NCT02347098|455778977|FG000|Overall Study|Withdrawal by Subject|1|||
126677875|NCT02347098|455778978|FG001|Overall Study|Withdrawal by Subject|0|||
126677876|NCT02347098|455778977|FG000|Overall Study|Lost to Follow-up|2|||
126677877|NCT02347098|455778978|FG001|Overall Study|Lost to Follow-up|2|||
126677878|NCT02347098|455778977|FG000|Overall Study|Refuse Follow-up Visit|1|||
126677879|NCT02347098|455778978|FG001|Overall Study|Refuse Follow-up Visit|5|||
126677880|NCT02347098|455778977|FG000|Overall Study|no visit due to illness|2|||
126677881|NCT02347098|455778978|FG001|Overall Study|no visit due to illness|1|||
126677882|NCT02187172|455778979|FG000|Overall Study|Lost to Follow-up|1|||
126677883|NCT02187172|455778980|FG001|Overall Study|Lost to Follow-up|2|||
126677884|NCT02187172|455778979|FG000|Overall Study|Lack of Efficacy|1|||
126677885|NCT02187172|455778980|FG001|Overall Study|Lack of Efficacy|2|||
126677886|NCT02187172|455778979|FG000|Overall Study|Adverse Event|0|||
126677887|NCT02187172|455778980|FG001|Overall Study|Adverse Event|1|||
126677888|NCT02187172|455778979|FG000|Overall Study|Physician Decision|1|||
126677889|NCT02187172|455778980|FG001|Overall Study|Physician Decision|1|||
126677890|NCT01230242|455778985|FG000|Overall Study|Physician Decision|2|||
126677891|NCT01230242|455778985|FG000|Overall Study|Withdrawal by Subject|1|||
126677892|NCT04329702|455778989|FG000|Overall Study|illness|3|||
126677893|NCT04329702|455778990|FG001|Overall Study|illness|4|||
126677894|NCT04329702|455778991|FG002|Overall Study|illness|0|||
126677895|NCT04329702|455778989|FG000|Overall Study|Lost to Follow-up|0|||
126677896|NCT04329702|455778990|FG001|Overall Study|Lost to Follow-up|0|||
126677897|NCT04329702|455778991|FG002|Overall Study|Lost to Follow-up|2|||
126677898|NCT04329702|455778989|FG000|Overall Study|Death|0|||
126677899|NCT04329702|455778990|FG001|Overall Study|Death|2|||
126677900|NCT04329702|455778991|FG002|Overall Study|Death|0|||
126677901|NCT00766532|455778992|FG000|Overall Study|Protocol Violation|2|||
126677902|NCT01438489|455778993|FG000|Overall Study|Lost to Follow-up|4|||
126677903|NCT01438489|455778994|FG001|Overall Study|Lost to Follow-up|2|||
126677904|NCT01438489|455778995|FG002|Overall Study|Lost to Follow-up|2|||
126677905|NCT01438489|455778993|FG000|Overall Study|Withdrawal by Subject|11|||
126677906|NCT01438489|455778994|FG001|Overall Study|Withdrawal by Subject|3|||
126677907|NCT01438489|455778995|FG002|Overall Study|Withdrawal by Subject|8|||
126677908|NCT01438489|455778993|FG000|Overall Study|Death|0|||
126677909|NCT01438489|455778994|FG001|Overall Study|Death|0|||
126677910|NCT01438489|455778995|FG002|Overall Study|Death|1|||
126343326|NCT00274456|454554053|FG000|Overall Study|Physician Decision|7|||
126343327|NCT00274456|454554054|FG001|Overall Study|Physician Decision|5|||
126343328|NCT00274456|454554055|FG002|Overall Study|Physician Decision|6|||
126343329|NCT00274456|454554056|FG003|Overall Study|Physician Decision|13|||
126677911|NCT01438489|455778993|FG000|Overall Study|Sponsor decision|4|||
126677912|NCT01438489|455778994|FG001|Overall Study|Sponsor decision|1|||
126677913|NCT01438489|455778995|FG002|Overall Study|Sponsor decision|4|||
126677914|NCT01438489|455778993|FG000|Overall Study|Subject choice/Subject moved|2|||
126677915|NCT01438489|455778994|FG001|Overall Study|Subject choice/Subject moved|1|||
126677916|NCT01438489|455778995|FG002|Overall Study|Subject choice/Subject moved|1|||
126677917|NCT01438489|455778993|FG000|Overall Study|Investigator decision|0|||
126343330|NCT00274456|454554053|FG000|Overall Study|Lost to Follow-up|0|||
126343331|NCT00274456|454554054|FG001|Overall Study|Lost to Follow-up|0|||
126677918|NCT01438489|455778994|FG001|Overall Study|Investigator decision|1|||
126677919|NCT01438489|455778995|FG002|Overall Study|Investigator decision|0|||
126677920|NCT01438489|455778993|FG000|Overall Study|AE/SAEs|2|||
126677921|NCT01438489|455778994|FG001|Overall Study|AE/SAEs|1|||
126677922|NCT01438489|455778995|FG002|Overall Study|AE/SAEs|1|||
126429817|NCT03137992|454868180|FG005|Washout Period 2|Withdrawal by Subject|0|||
126429818|NCT03137992|454868175|FG000|Washout Period 2|Sponsor Decision|0|||
126429819|NCT03137992|454868176|FG001|Washout Period 2|Sponsor Decision|0|||
126429820|NCT03137992|454868177|FG002|Washout Period 2|Sponsor Decision|0|||
126429821|NCT03137992|454868178|FG003|Washout Period 2|Sponsor Decision|0|||
126429822|NCT03137992|454868179|FG004|Washout Period 2|Sponsor Decision|0|||
126429823|NCT03137992|454868180|FG005|Washout Period 2|Sponsor Decision|1|||
126429824|NCT03137992|454868175|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
126429825|NCT03137992|454868176|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
126429826|NCT03137992|454868177|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
126429827|NCT03137992|454868178|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
126677923|NCT01438489|455778993|FG000|Overall Study|Received prohibited medication|1|||
126677924|NCT01438489|455778994|FG001|Overall Study|Received prohibited medication|0|||
126343332|NCT00274456|454554055|FG002|Overall Study|Lost to Follow-up|1|||
126343333|NCT00274456|454554056|FG003|Overall Study|Lost to Follow-up|0|||
126343334|NCT00274456|454554053|FG000|Overall Study|Withdrawal by Subject|18|||
126343335|NCT00274456|454554054|FG001|Overall Study|Withdrawal by Subject|13|||
126343336|NCT00274456|454554055|FG002|Overall Study|Withdrawal by Subject|9|||
126343337|NCT00274456|454554056|FG003|Overall Study|Withdrawal by Subject|13|||
126343338|NCT03255187|454554057|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
126343339|NCT03255187|454554058|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
126343340|NCT03255187|454554057|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
126343341|NCT03255187|454554058|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
126343342|NCT02034006|454554059|FG000|Overall Study|Withdrawal by Subject|7|||
126343343|NCT02034006|454554059|FG000|Overall Study|Lost to Follow-up|5|||
126343344|NCT02034006|454554059|FG000|Overall Study|Death|1|||
126343345|NCT02034006|454554059|FG000|Overall Study|Pregnancy|1|||
126343346|NCT00109343|454554060|FG000|Overall Study|Adverse Event|1|||
126343347|NCT00109343|454554061|FG001|Overall Study|Adverse Event|0|||
126343348|NCT00109343|454554062|FG002|Overall Study|Adverse Event|2|||
126343349|NCT00109343|454554060|FG000|Overall Study|Lack of Efficacy|1|||
126343350|NCT00109343|454554061|FG001|Overall Study|Lack of Efficacy|0|||
126343351|NCT00109343|454554062|FG002|Overall Study|Lack of Efficacy|0|||
126343352|NCT00109343|454554060|FG000|Overall Study|Lost to Follow-up|35|||
126343353|NCT00109343|454554061|FG001|Overall Study|Lost to Follow-up|20|||
126343354|NCT00109343|454554062|FG002|Overall Study|Lost to Follow-up|14|||
126343355|NCT00109343|454554060|FG000|Overall Study|Protocol Violation|1|||
126343356|NCT00109343|454554061|FG001|Overall Study|Protocol Violation|2|||
126343357|NCT00109343|454554062|FG002|Overall Study|Protocol Violation|2|||
126343358|NCT00109343|454554060|FG000|Overall Study|Withdrawal by Subject|15|||
126343359|NCT00109343|454554061|FG001|Overall Study|Withdrawal by Subject|11|||
126343360|NCT00109343|454554062|FG002|Overall Study|Withdrawal by Subject|10|||
126343361|NCT00109343|454554060|FG000|Overall Study|Subject Moved|6|||
126343362|NCT00109343|454554061|FG001|Overall Study|Subject Moved|2|||
126343363|NCT00109343|454554062|FG002|Overall Study|Subject Moved|1|||
126343364|NCT00109343|454554060|FG000|Overall Study|Other|5|||
126343365|NCT00109343|454554061|FG001|Overall Study|Other|2|||
126343366|NCT00109343|454554062|FG002|Overall Study|Other|1|||
126343367|NCT01799889|454554063|FG000|Overall Study|Adverse Event|4|||
126343368|NCT01799889|454554064|FG001|Overall Study|Adverse Event|4|||
126343369|NCT01799889|454554065|FG002|Overall Study|Adverse Event|5|||
126343370|NCT01799889|454554066|FG003|Overall Study|Adverse Event|1|||
126343371|NCT01799889|454554067|FG004|Overall Study|Adverse Event|11|||
126343372|NCT01799889|454554068|FG005|Overall Study|Adverse Event|1|||
126343373|NCT01799889|454554069|FG006|Overall Study|Adverse Event|5|||
126343374|NCT01799889|454554070|FG007|Overall Study|Adverse Event|2|||
126343375|NCT01799889|454554071|FG008|Overall Study|Adverse Event|3|||
126343376|NCT01799889|454554072|FG009|Overall Study|Adverse Event|1|||
126343377|NCT01799889|454554073|FG010|Overall Study|Adverse Event|1|||
126677925|NCT01438489|455778995|FG002|Overall Study|Received prohibited medication|0|||
126677926|NCT01438489|455778993|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
126677927|NCT01438489|455778994|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
126677928|NCT01438489|455778995|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
126677929|NCT01438489|455778993|FG000|Overall Study|Inadequate venous access|0|||
126343378|NCT01799889|454554074|FG011|Overall Study|Adverse Event|0|||
126343379|NCT01799889|454554063|FG000|Overall Study|Death|1|||
126343380|NCT01799889|454554064|FG001|Overall Study|Death|0|||
126343381|NCT01799889|454554065|FG002|Overall Study|Death|5|||
126343382|NCT01799889|454554066|FG003|Overall Study|Death|3|||
126343383|NCT01799889|454554067|FG004|Overall Study|Death|1|||
126343384|NCT01799889|454554068|FG005|Overall Study|Death|0|||
126429828|NCT03137992|454868179|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
126429829|NCT03137992|454868180|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
126429830|NCT03137992|454868175|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
126429831|NCT03137992|454868176|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
126429832|NCT03137992|454868177|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
126429833|NCT03137992|454868178|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
126429834|NCT03137992|454868179|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
126429835|NCT03137992|454868180|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
126429836|NCT03137992|454868175|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
126429837|NCT03137992|454868176|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
126429838|NCT03137992|454868177|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
126429839|NCT03137992|454868178|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
126429840|NCT03137992|454868179|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
126429841|NCT03137992|454868180|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
126429842|NCT03137992|454868175|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
126429843|NCT03137992|454868176|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
126429844|NCT03137992|454868177|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
126429845|NCT03137992|454868178|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
126429846|NCT03137992|454868179|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
126429847|NCT03137992|454868180|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
126429848|NCT03137992|454868175|FG000|Part 2 (Open-label Extension)|Per study team|1|||
126429849|NCT03137992|454868176|FG001|Part 2 (Open-label Extension)|Per study team|0|||
126429850|NCT03137992|454868177|FG002|Part 2 (Open-label Extension)|Per study team|0|||
126429851|NCT03137992|454868178|FG003|Part 2 (Open-label Extension)|Per study team|0|||
126429852|NCT03137992|454868179|FG004|Part 2 (Open-label Extension)|Per study team|0|||
126429853|NCT03137992|454868180|FG005|Part 2 (Open-label Extension)|Per study team|0|||
126429854|NCT03137992|454868175|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
126429855|NCT03137992|454868176|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
126429856|NCT03137992|454868177|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
126429857|NCT03137992|454868178|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
126429858|NCT03137992|454868179|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
126429859|NCT03137992|454868180|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
126429860|NCT02370420|454868181|FG000|Overall Study|Physician Decision|3|||
126429861|NCT02370420|454868182|FG001|Overall Study|Physician Decision|3|||
126429862|NCT02370420|454868181|FG000|Overall Study|Lost to Follow-up|11|||
126429863|NCT02370420|454868182|FG001|Overall Study|Lost to Follow-up|9|||
126429864|NCT03077542|454868183|FG000|Overall Study|Death|4|||
126429865|NCT03077542|454868184|FG001|Overall Study|Death|0|||
126429866|NCT03077542|454868183|FG000|Overall Study|Physician Decision|6|||
126429867|NCT03077542|454868184|FG001|Overall Study|Physician Decision|1|||
126429868|NCT03077542|454868183|FG000|Overall Study|Withdrawal by Subject|0|||
126429869|NCT03077542|454868184|FG001|Overall Study|Withdrawal by Subject|1|||
126429870|NCT00795704|454868185|FG000|Overall Study|Withdrawal by Subject|3|||
126429871|NCT00795704|454868186|FG001|Overall Study|Withdrawal by Subject|2|||
126429872|NCT00795704|454868185|FG000|Overall Study|Adverse Event|1|||
126429873|NCT00795704|454868186|FG001|Overall Study|Adverse Event|1|||
126429874|NCT03980730|454868187|FG000|Overall Study|Study Terminated by Sponsor|0|||
126429875|NCT03980730|454868188|FG001|Overall Study|Study Terminated by Sponsor|3|||
126429876|NCT03980730|454868187|FG000|Overall Study|Adverse Event|2|||
126429877|NCT03980730|454868188|FG001|Overall Study|Adverse Event|0|||
126429878|NCT03980730|454868187|FG000|Overall Study|Sponsor Request|0|||
126429879|NCT03980730|454868188|FG001|Overall Study|Sponsor Request|1|||
126429880|NCT01300728|454868189|FG000|Overall Study|Withdrawal by Subject|1|||
126429881|NCT01300728|454868190|FG001|Overall Study|Withdrawal by Subject|1|||
126429882|NCT01300728|454868189|FG000|Overall Study|Physician Decision|1|||
126429883|NCT01300728|454868190|FG001|Overall Study|Physician Decision|0|||
126429884|NCT00880620|454868193|FG000|Overall Study|Adverse Event|4|||
126429885|NCT00880620|454868194|FG001|Overall Study|Adverse Event|5|||
126429886|NCT00880620|454868195|FG002|Overall Study|Adverse Event|15|||
126429887|NCT00880620|454868196|FG003|Overall Study|Adverse Event|15|||
126429888|NCT00880620|454868193|FG000|Overall Study|Death|0|||
126429889|NCT00880620|454868194|FG001|Overall Study|Death|0|||
126429890|NCT00880620|454868195|FG002|Overall Study|Death|1|||
126677930|NCT01438489|455778994|FG001|Overall Study|Inadequate venous access|2|||
126677931|NCT01438489|455778995|FG002|Overall Study|Inadequate venous access|0|||
126677932|NCT02037295|455778999|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
126677933|NCT02037295|455779000|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
126677934|NCT02037295|455779001|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
126429891|NCT00880620|454868196|FG003|Overall Study|Death|0|||
126429892|NCT00880620|454868193|FG000|Overall Study|Lack of Efficacy|12|||
126429893|NCT00880620|454868194|FG001|Overall Study|Lack of Efficacy|4|||
126429894|NCT00880620|454868195|FG002|Overall Study|Lack of Efficacy|0|||
126429895|NCT00880620|454868196|FG003|Overall Study|Lack of Efficacy|1|||
126429896|NCT00880620|454868193|FG000|Overall Study|Lost to Follow-up|0|||
126429897|NCT00880620|454868194|FG001|Overall Study|Lost to Follow-up|1|||
126429898|NCT00880620|454868195|FG002|Overall Study|Lost to Follow-up|1|||
126429899|NCT00880620|454868196|FG003|Overall Study|Lost to Follow-up|0|||
126343385|NCT01799889|454554069|FG006|Overall Study|Death|0|||
126343386|NCT01799889|454554070|FG007|Overall Study|Death|0|||
126343387|NCT01799889|454554071|FG008|Overall Study|Death|1|||
126343388|NCT01799889|454554072|FG009|Overall Study|Death|0|||
126343389|NCT01799889|454554073|FG010|Overall Study|Death|1|||
126343390|NCT01799889|454554074|FG011|Overall Study|Death|0|||
126343391|NCT01799889|454554063|FG000|Overall Study|Lack of Efficacy|1|||
126343392|NCT01799889|454554064|FG001|Overall Study|Lack of Efficacy|1|||
126343393|NCT01799889|454554065|FG002|Overall Study|Lack of Efficacy|0|||
126343394|NCT01799889|454554066|FG003|Overall Study|Lack of Efficacy|1|||
126343395|NCT01799889|454554067|FG004|Overall Study|Lack of Efficacy|2|||
126343396|NCT01799889|454554068|FG005|Overall Study|Lack of Efficacy|2|||
126343397|NCT01799889|454554069|FG006|Overall Study|Lack of Efficacy|0|||
126343398|NCT01799889|454554070|FG007|Overall Study|Lack of Efficacy|0|||
126343399|NCT01799889|454554071|FG008|Overall Study|Lack of Efficacy|2|||
126343400|NCT01799889|454554072|FG009|Overall Study|Lack of Efficacy|0|||
126343401|NCT01799889|454554073|FG010|Overall Study|Lack of Efficacy|1|||
126343402|NCT01799889|454554074|FG011|Overall Study|Lack of Efficacy|0|||
126343403|NCT01799889|454554063|FG000|Overall Study|Lost to Follow-up|0|||
126343404|NCT01799889|454554064|FG001|Overall Study|Lost to Follow-up|1|||
126343405|NCT01799889|454554065|FG002|Overall Study|Lost to Follow-up|0|||
126343406|NCT01799889|454554066|FG003|Overall Study|Lost to Follow-up|0|||
126343407|NCT01799889|454554067|FG004|Overall Study|Lost to Follow-up|0|||
126343408|NCT01799889|454554068|FG005|Overall Study|Lost to Follow-up|0|||
126343409|NCT01799889|454554069|FG006|Overall Study|Lost to Follow-up|0|||
126343410|NCT01799889|454554070|FG007|Overall Study|Lost to Follow-up|0|||
126343411|NCT01799889|454554071|FG008|Overall Study|Lost to Follow-up|0|||
126343412|NCT01799889|454554072|FG009|Overall Study|Lost to Follow-up|0|||
126343413|NCT01799889|454554073|FG010|Overall Study|Lost to Follow-up|0|||
126343414|NCT01799889|454554074|FG011|Overall Study|Lost to Follow-up|0|||
126343415|NCT01799889|454554063|FG000|Overall Study|Physician Decision|3|||
126343416|NCT01799889|454554064|FG001|Overall Study|Physician Decision|2|||
126343417|NCT01799889|454554065|FG002|Overall Study|Physician Decision|4|||
126343418|NCT01799889|454554066|FG003|Overall Study|Physician Decision|4|||
126343419|NCT01799889|454554067|FG004|Overall Study|Physician Decision|5|||
126343420|NCT01799889|454554068|FG005|Overall Study|Physician Decision|5|||
126343421|NCT01799889|454554069|FG006|Overall Study|Physician Decision|5|||
126343422|NCT01799889|454554070|FG007|Overall Study|Physician Decision|2|||
126343423|NCT01799889|454554071|FG008|Overall Study|Physician Decision|6|||
126343424|NCT01799889|454554072|FG009|Overall Study|Physician Decision|0|||
126343425|NCT01799889|454554073|FG010|Overall Study|Physician Decision|0|||
126343426|NCT01799889|454554074|FG011|Overall Study|Physician Decision|1|||
126343427|NCT01799889|454554063|FG000|Overall Study|Progressive Disease|30|||
126343428|NCT01799889|454554064|FG001|Overall Study|Progressive Disease|26|||
126343429|NCT01799889|454554065|FG002|Overall Study|Progressive Disease|25|||
126343430|NCT01799889|454554066|FG003|Overall Study|Progressive Disease|30|||
126343431|NCT01799889|454554067|FG004|Overall Study|Progressive Disease|23|||
126343432|NCT01799889|454554068|FG005|Overall Study|Progressive Disease|9|||
126343433|NCT01799889|454554069|FG006|Overall Study|Progressive Disease|8|||
126343434|NCT01799889|454554070|FG007|Overall Study|Progressive Disease|13|||
126343435|NCT01799889|454554071|FG008|Overall Study|Progressive Disease|18|||
126343436|NCT01799889|454554072|FG009|Overall Study|Progressive Disease|5|||
126343437|NCT01799889|454554073|FG010|Overall Study|Progressive Disease|3|||
126343438|NCT01799889|454554074|FG011|Overall Study|Progressive Disease|1|||
126343439|NCT01799889|454554063|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
126343440|NCT01799889|454554064|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
126343441|NCT01799889|454554065|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
126343442|NCT01799889|454554066|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
126343443|NCT01799889|454554067|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
126343444|NCT01799889|454554068|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
126343445|NCT01799889|454554069|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
126343446|NCT01799889|454554070|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
126343447|NCT01799889|454554071|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
126343448|NCT01799889|454554072|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
126343449|NCT01799889|454554073|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
126343450|NCT01799889|454554074|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
126343451|NCT01799889|454554063|FG000|Overall Study|Study Terminated By Sponsor|1|||
126343452|NCT01799889|454554064|FG001|Overall Study|Study Terminated By Sponsor|0|||
126343453|NCT01799889|454554065|FG002|Overall Study|Study Terminated By Sponsor|0|||
126343454|NCT01799889|454554066|FG003|Overall Study|Study Terminated By Sponsor|0|||
126343455|NCT01799889|454554067|FG004|Overall Study|Study Terminated By Sponsor|2|||
126343456|NCT01799889|454554068|FG005|Overall Study|Study Terminated By Sponsor|1|||
126343457|NCT01799889|454554069|FG006|Overall Study|Study Terminated By Sponsor|0|||
126343458|NCT01799889|454554070|FG007|Overall Study|Study Terminated By Sponsor|2|||
126343459|NCT01799889|454554071|FG008|Overall Study|Study Terminated By Sponsor|1|||
126343460|NCT01799889|454554072|FG009|Overall Study|Study Terminated By Sponsor|1|||
126343461|NCT01799889|454554073|FG010|Overall Study|Study Terminated By Sponsor|0|||
126343462|NCT01799889|454554074|FG011|Overall Study|Study Terminated By Sponsor|0|||
126343463|NCT01799889|454554063|FG000|Overall Study|Withdrawal by Subject|1|||
126429900|NCT00880620|454868193|FG000|Overall Study|Protocol Violation|0|||
126429901|NCT00880620|454868194|FG001|Overall Study|Protocol Violation|1|||
126429902|NCT00880620|454868195|FG002|Overall Study|Protocol Violation|0|||
126429903|NCT00880620|454868196|FG003|Overall Study|Protocol Violation|2|||
126429904|NCT00880620|454868193|FG000|Overall Study|Withdrawal by Subject|4|||
126429905|NCT00880620|454868194|FG001|Overall Study|Withdrawal by Subject|3|||
126429906|NCT00880620|454868195|FG002|Overall Study|Withdrawal by Subject|1|||
126429907|NCT00880620|454868196|FG003|Overall Study|Withdrawal by Subject|3|||
126429908|NCT00880620|454868193|FG000|Overall Study|Noncompliance|0|||
126429909|NCT00880620|454868194|FG001|Overall Study|Noncompliance|0|||
126429910|NCT00880620|454868195|FG002|Overall Study|Noncompliance|1|||
126429911|NCT00880620|454868196|FG003|Overall Study|Noncompliance|1|||
126429912|NCT00880620|454868193|FG000|Overall Study|Other|1|||
126429913|NCT00880620|454868194|FG001|Overall Study|Other|1|||
126429914|NCT00880620|454868195|FG002|Overall Study|Other|2|||
126429915|NCT00880620|454868196|FG003|Overall Study|Other|2|||
126429916|NCT03883581|454868198|FG000|Overall Study|Withdrawal by Subject|4|||
126429917|NCT04612725|454868199|FG000|Overall Study|Adverse Event|1|||
126429918|NCT04612725|454868200|FG001|Overall Study|Adverse Event|3|||
126429919|NCT04612725|454868201|FG002|Overall Study|Adverse Event|1|||
126429920|NCT04612725|454868202|FG003|Overall Study|Adverse Event|0|||
126429921|NCT04612725|454868203|FG004|Overall Study|Adverse Event|1|||
126429922|NCT04612725|454868199|FG000|Overall Study|Lost to Follow-up|0|||
126429923|NCT04612725|454868200|FG001|Overall Study|Lost to Follow-up|1|||
126429924|NCT04612725|454868201|FG002|Overall Study|Lost to Follow-up|0|||
126429925|NCT04612725|454868202|FG003|Overall Study|Lost to Follow-up|0|||
126429926|NCT04612725|454868203|FG004|Overall Study|Lost to Follow-up|0|||
126429927|NCT04612725|454868199|FG000|Overall Study|Physician Decision|2|||
126429928|NCT04612725|454868200|FG001|Overall Study|Physician Decision|0|||
126429929|NCT04612725|454868201|FG002|Overall Study|Physician Decision|0|||
126429930|NCT04612725|454868202|FG003|Overall Study|Physician Decision|0|||
126429931|NCT04612725|454868203|FG004|Overall Study|Physician Decision|0|||
126429932|NCT04612725|454868199|FG000|Overall Study|Study terminated by sponsor|3|||
126429933|NCT04612725|454868200|FG001|Overall Study|Study terminated by sponsor|1|||
126429934|NCT04612725|454868201|FG002|Overall Study|Study terminated by sponsor|2|||
126429935|NCT04612725|454868202|FG003|Overall Study|Study terminated by sponsor|4|||
126429936|NCT04612725|454868203|FG004|Overall Study|Study terminated by sponsor|5|||
126429937|NCT04612725|454868199|FG000|Overall Study|Withdrawal by Subject|8|||
126429938|NCT04612725|454868200|FG001|Overall Study|Withdrawal by Subject|3|||
126429939|NCT04612725|454868201|FG002|Overall Study|Withdrawal by Subject|5|||
126429940|NCT04612725|454868202|FG003|Overall Study|Withdrawal by Subject|1|||
126429941|NCT04612725|454868203|FG004|Overall Study|Withdrawal by Subject|9|||
126429942|NCT04612725|454868199|FG000|Overall Study|Other|0|||
126429943|NCT04612725|454868200|FG001|Overall Study|Other|0|||
126429944|NCT04612725|454868201|FG002|Overall Study|Other|0|||
126429945|NCT04612725|454868202|FG003|Overall Study|Other|0|||
126429946|NCT04612725|454868203|FG004|Overall Study|Other|1|||
126429947|NCT02354235|454868204|FG000|Overall Study|Adverse Event|2|||
126429948|NCT02354235|454868205|FG001|Overall Study|Adverse Event|2|||
126429949|NCT02354235|454868204|FG000|Overall Study|Physician Decision|0|||
126429950|NCT02354235|454868205|FG001|Overall Study|Physician Decision|1|||
126429951|NCT02354235|454868204|FG000|Overall Study|Withdrawal by Subject|1|||
126429952|NCT02354235|454868205|FG001|Overall Study|Withdrawal by Subject|3|||
126429953|NCT02354235|454868204|FG000|Overall Study|Conflict with the stopping criteria|0|||
126429954|NCT02354235|454868205|FG001|Overall Study|Conflict with the stopping criteria|1|||
126429955|NCT02926638|454868208|FG000|Overall Study|Progression|2|||
126429956|NCT02926638|454868209|FG001|Overall Study|Progression|5|||
126429957|NCT02926638|454868208|FG000|Overall Study|Ineligible|1|||
126429958|NCT02926638|454868209|FG001|Overall Study|Ineligible|0|||
126429959|NCT02926638|454868208|FG000|Overall Study|Not protocol specified|1|||
126429960|NCT02926638|454868209|FG001|Overall Study|Not protocol specified|0|||
126429961|NCT00644423|454870017|FG000|Overall Study|Lost to Follow-up|1|||
126429962|NCT00644423|454870018|FG001|Overall Study|Lost to Follow-up|1|||
126677935|NCT02037295|455779002|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
126429963|NCT01908426|454870019|FG000|Overall Study|Adverse Event|98|||
126429964|NCT01908426|454870020|FG001|Overall Study|Adverse Event|11|||
126429965|NCT01908426|454870019|FG000|Overall Study|Clinical Deterioration|72|||
126429966|NCT01908426|454870020|FG001|Overall Study|Clinical Deterioration|38|||
126429967|NCT01908426|454870019|FG000|Overall Study|Lack of Efficacy|3|||
126429968|NCT01908426|454870020|FG001|Overall Study|Lack of Efficacy|0|||
126429969|NCT01908426|454870019|FG000|Overall Study|Lost to Follow-up|0|||
126429970|NCT01908426|454870020|FG001|Overall Study|Lost to Follow-up|1|||
126429971|NCT01908426|454870019|FG000|Overall Study|Physician Decision|3|||
126429972|NCT01908426|454870020|FG001|Overall Study|Physician Decision|3|||
126429973|NCT01908426|454870019|FG000|Overall Study|Withdrawal by Subject|11|||
126429974|NCT01908426|454870020|FG001|Overall Study|Withdrawal by Subject|6|||
126429975|NCT01908426|454870019|FG000|Overall Study|Progressive Disease|206|||
126429976|NCT01908426|454870020|FG001|Overall Study|Progressive Disease|152|||
126429977|NCT01908426|454870019|FG000|Overall Study|Protocol Violation|1|||
126429978|NCT01908426|454870020|FG001|Overall Study|Protocol Violation|0|||
126677936|NCT01140451|455779003|FG000|Overall Study|Withdrawal by Subject|26|||
126677937|NCT01140451|455779004|FG001|Overall Study|Withdrawal by Subject|33|||
126429979|NCT01908426|454870019|FG000|Overall Study|No Study Treatment Given|3|||
126429980|NCT01908426|454870020|FG001|Overall Study|No Study Treatment Given|0|||
126429981|NCT02426580|454870025|FG000|Overall Study|Death|2|||
126429982|NCT02426580|454870026|FG001|Overall Study|Death|2|||
126429983|NCT02426580|454870025|FG000|Overall Study|Lost to Follow-up|0|||
126429984|NCT02426580|454870026|FG001|Overall Study|Lost to Follow-up|9|||
126429985|NCT02426580|454870025|FG000|Overall Study|transfer to hemodialysis|5|||
126429986|NCT02426580|454870026|FG001|Overall Study|transfer to hemodialysis|5|||
126429987|NCT02426580|454870025|FG000|Overall Study|Kidney transplant|3|||
126429988|NCT02426580|454870026|FG001|Overall Study|Kidney transplant|0|||
126429989|NCT02426580|454870025|FG000|Overall Study|Allergic to egg white|1|||
126429990|NCT02426580|454870026|FG001|Overall Study|Allergic to egg white|0|||
126429991|NCT05482308|454870038|FG000|Overall Study|Withdrawal by Subject|1|||
126429992|NCT05482308|454870039|FG001|Overall Study|Withdrawal by Subject|0|||
126429993|NCT05482308|454870038|FG000|Overall Study|No longer meets eligibility criteria|0|||
126429994|NCT05482308|454870039|FG001|Overall Study|No longer meets eligibility criteria|1|||
126429995|NCT00416624|454870043|FG000|Overall Study|Withdrawal by Subject|1|||
126429996|NCT00416624|454870044|FG001|Overall Study|Withdrawal by Subject|6|||
126429997|NCT00416624|454870045|FG002|Overall Study|Withdrawal by Subject|4|||
126429998|NCT00416624|454870046|FG003|Overall Study|Withdrawal by Subject|9|||
126429999|NCT00416624|454870043|FG000|Overall Study|Death|4|||
126430000|NCT00416624|454870044|FG001|Overall Study|Death|7|||
126430001|NCT00416624|454870045|FG002|Overall Study|Death|7|||
126430002|NCT00416624|454870046|FG003|Overall Study|Death|1|||
126430003|NCT00416624|454870043|FG000|Overall Study|Adverse Event|8|||
126430004|NCT00416624|454870044|FG001|Overall Study|Adverse Event|3|||
126430005|NCT00416624|454870045|FG002|Overall Study|Adverse Event|2|||
126677938|NCT01140451|455779003|FG000|Overall Study|Adverse Event|2|||
126430006|NCT00416624|454870046|FG003|Overall Study|Adverse Event|2|||
126430007|NCT00416624|454870043|FG000|Overall Study|Other|8|||
126430008|NCT00416624|454870044|FG001|Overall Study|Other|11|||
126430009|NCT00416624|454870045|FG002|Overall Study|Other|5|||
126430010|NCT00416624|454870046|FG003|Overall Study|Other|5|||
126430011|NCT00416624|454870043|FG000|Overall Study|Cancel|1|||
126430012|NCT00416624|454870044|FG001|Overall Study|Cancel|0|||
126430013|NCT00416624|454870045|FG002|Overall Study|Cancel|0|||
126430014|NCT00416624|454870046|FG003|Overall Study|Cancel|0|||
126430015|NCT00141453|454870053|FG000|Overall Study|Protocol Violation|6|||
126430016|NCT00141453|454870054|FG001|Overall Study|Protocol Violation|5|||
126430017|NCT03585660|454870057|FG000|Overall Study|operator error|1|||
126430018|NCT03585660|454870057|FG000|Overall Study|technical error|2|||
126430019|NCT03585660|454870057|FG000|Overall Study|hip prosthesis|2|||
126430020|NCT03585660|454870057|FG000|Overall Study|did not undergo biopsy|8|||
126430021|NCT03585660|454870057|FG000|Overall Study|scanner problem|2|||
126430022|NCT03760029|454870062|FG000|Overall Study|Death|1|||
126430023|NCT03760029|454870063|FG001|Overall Study|Death|0|||
126430024|NCT03760029|454870064|FG002|Overall Study|Death|0|||
126430025|NCT03760029|454870062|FG000|Overall Study|Lost to Follow-up|0|||
126430026|NCT03760029|454870063|FG001|Overall Study|Lost to Follow-up|2|||
126430027|NCT03760029|454870064|FG002|Overall Study|Lost to Follow-up|1|||
126430028|NCT03760029|454870062|FG000|Overall Study|Withdrawal by Subject|1|||
126430029|NCT03760029|454870063|FG001|Overall Study|Withdrawal by Subject|4|||
126430030|NCT03760029|454870064|FG002|Overall Study|Withdrawal by Subject|1|||
126430031|NCT03760029|454870062|FG000|Overall Study|Withdrawal by parent/guardian|4|||
126430032|NCT03760029|454870063|FG001|Overall Study|Withdrawal by parent/guardian|4|||
126430033|NCT03760029|454870064|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126430034|NCT03760029|454870062|FG000|Overall Study|Other|2|||
126430035|NCT03760029|454870063|FG001|Overall Study|Other|1|||
126430036|NCT03760029|454870064|FG002|Overall Study|Other|0|||
126430037|NCT04890652|454870068|FG000|Overall Study|Withdrawal by Subject|2|||
126430038|NCT03748823|454870072|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
126677939|NCT01140451|455779004|FG001|Overall Study|Adverse Event|6|||
126677940|NCT01140451|455779003|FG000|Overall Study|Physician Decision|5|||
126430039|NCT03748823|454870073|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
126677941|NCT01140451|455779004|FG001|Overall Study|Physician Decision|3|||
126677942|NCT01140451|455779003|FG000|Overall Study|Lost to Follow-up|2|||
126677943|NCT01140451|455779004|FG001|Overall Study|Lost to Follow-up|0|||
126430040|NCT03748823|454870072|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
126430041|NCT03748823|454870073|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
126677944|NCT01140451|455779003|FG000|Overall Study|Participants Planning Pregnancy|3|||
126430042|NCT03748823|454870072|FG000|Extension Period|Withdrawal by Subject|9|||
126430043|NCT03748823|454870073|FG001|Extension Period|Withdrawal by Subject|12|||
126430044|NCT03748823|454870072|FG000|Extension Period|Death|2|||
126430045|NCT03748823|454870073|FG001|Extension Period|Death|2|||
126430046|NCT03748823|454870072|FG000|Extension Period|Other than Specified|0|||
126430047|NCT03748823|454870073|FG001|Extension Period|Other than Specified|1|||
126430048|NCT03748823|454870072|FG000|Extension Period|Protocol Violation|1|||
126677945|NCT01140451|455779004|FG001|Overall Study|Participants Planning Pregnancy|0|||
126677946|NCT01324232|455779007|FG000|Overall Study|Protocol Violation|0|||
126677947|NCT01324232|455779008|FG001|Overall Study|Protocol Violation|0|||
126677948|NCT01324232|455779009|FG002|Overall Study|Protocol Violation|0|||
126677949|NCT01324232|455779010|FG003|Overall Study|Protocol Violation|2|||
126677950|NCT01324232|455779007|FG000|Overall Study|Missing|0|||
126677951|NCT01324232|455779008|FG001|Overall Study|Missing|0|||
126677952|NCT01324232|455779009|FG002|Overall Study|Missing|1|||
126677953|NCT01324232|455779010|FG003|Overall Study|Missing|0|||
126343464|NCT01799889|454554064|FG001|Overall Study|Withdrawal by Subject|6|||
126343465|NCT01799889|454554065|FG002|Overall Study|Withdrawal by Subject|4|||
126343466|NCT01799889|454554066|FG003|Overall Study|Withdrawal by Subject|0|||
126343467|NCT01799889|454554067|FG004|Overall Study|Withdrawal by Subject|5|||
126343468|NCT01799889|454554068|FG005|Overall Study|Withdrawal by Subject|1|||
126343469|NCT01799889|454554069|FG006|Overall Study|Withdrawal by Subject|3|||
126343470|NCT01799889|454554070|FG007|Overall Study|Withdrawal by Subject|1|||
126343471|NCT01799889|454554071|FG008|Overall Study|Withdrawal by Subject|2|||
126343472|NCT01799889|454554072|FG009|Overall Study|Withdrawal by Subject|1|||
126343473|NCT01799889|454554073|FG010|Overall Study|Withdrawal by Subject|1|||
126343474|NCT01799889|454554074|FG011|Overall Study|Withdrawal by Subject|1|||
126343475|NCT01799889|454554063|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126343476|NCT01799889|454554064|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126343477|NCT01799889|454554065|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126343478|NCT01799889|454554066|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126343479|NCT01799889|454554067|FG004|Overall Study|Non-Compliance With Study Drug|0|||
126343480|NCT01799889|454554068|FG005|Overall Study|Non-Compliance With Study Drug|1|||
126343481|NCT01799889|454554069|FG006|Overall Study|Non-Compliance With Study Drug|0|||
126343482|NCT01799889|454554070|FG007|Overall Study|Non-Compliance With Study Drug|0|||
126343483|NCT01799889|454554071|FG008|Overall Study|Non-Compliance With Study Drug|0|||
126343484|NCT01799889|454554072|FG009|Overall Study|Non-Compliance With Study Drug|0|||
126343485|NCT01799889|454554073|FG010|Overall Study|Non-Compliance With Study Drug|0|||
126343486|NCT01799889|454554074|FG011|Overall Study|Non-Compliance With Study Drug|0|||
126343487|NCT00750269|454554075|FG000|Overall Study|Protocol Violation|0|||
126343488|NCT00750269|454554076|FG001|Overall Study|Protocol Violation|1|||
126343489|NCT00750269|454554077|FG002|Overall Study|Protocol Violation|1|||
126343490|NCT00750269|454554078|FG003|Overall Study|Protocol Violation|2|||
126343491|NCT00750269|454554079|FG004|Overall Study|Protocol Violation|4|||
126343492|NCT00750269|454554075|FG000|Overall Study|Withdrawal by Subject|0|||
126343493|NCT00750269|454554076|FG001|Overall Study|Withdrawal by Subject|0|||
126343494|NCT00750269|454554077|FG002|Overall Study|Withdrawal by Subject|2|||
126343495|NCT00750269|454554078|FG003|Overall Study|Withdrawal by Subject|2|||
126343496|NCT00750269|454554079|FG004|Overall Study|Withdrawal by Subject|2|||
126343497|NCT00750269|454554075|FG000|Overall Study|Physician Decision|0|||
126343498|NCT00750269|454554076|FG001|Overall Study|Physician Decision|0|||
126343499|NCT00750269|454554077|FG002|Overall Study|Physician Decision|0|||
126343500|NCT00750269|454554078|FG003|Overall Study|Physician Decision|0|||
126343501|NCT00750269|454554079|FG004|Overall Study|Physician Decision|2|||
126343502|NCT00750269|454554075|FG000|Overall Study|Patient too large for positioning|0|||
126343503|NCT00750269|454554076|FG001|Overall Study|Patient too large for positioning|0|||
126343504|NCT00750269|454554077|FG002|Overall Study|Patient too large for positioning|1|||
126343505|NCT00750269|454554078|FG003|Overall Study|Patient too large for positioning|0|||
126343506|NCT00750269|454554079|FG004|Overall Study|Patient too large for positioning|0|||
126343507|NCT00750269|454554075|FG000|Overall Study|Site error|0|||
126343508|NCT00750269|454554076|FG001|Overall Study|Site error|0|||
126343509|NCT00750269|454554077|FG002|Overall Study|Site error|0|||
126343510|NCT00750269|454554078|FG003|Overall Study|Site error|1|||
126343511|NCT00750269|454554079|FG004|Overall Study|Site error|0|||
126343512|NCT00750269|454554075|FG000|Overall Study|SBRT plan could not be drawn|0|||
126343513|NCT00750269|454554076|FG001|Overall Study|SBRT plan could not be drawn|0|||
126343514|NCT00750269|454554077|FG002|Overall Study|SBRT plan could not be drawn|0|||
126343515|NCT00750269|454554078|FG003|Overall Study|SBRT plan could not be drawn|0|||
126343516|NCT00750269|454554079|FG004|Overall Study|SBRT plan could not be drawn|1|||
126343517|NCT00750269|454554075|FG000|Overall Study|Fiducials could not be placed|0|||
126343518|NCT00750269|454554076|FG001|Overall Study|Fiducials could not be placed|0|||
126343519|NCT00750269|454554077|FG002|Overall Study|Fiducials could not be placed|0|||
126343520|NCT00750269|454554078|FG003|Overall Study|Fiducials could not be placed|0|||
126677954|NCT01324232|455779007|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
126343521|NCT00750269|454554079|FG004|Overall Study|Fiducials could not be placed|1|||
126343522|NCT03944616|454554080|FG000|Overall Study|Lost to Follow-up|0|||
126343523|NCT03944616|454554081|FG001|Overall Study|Lost to Follow-up|2|||
126343524|NCT01721798|454554082|FG000|Overall Study|Death|0|||
126343525|NCT01721798|454554083|FG001|Overall Study|Death|0|||
126343526|NCT01721798|454554084|FG002|Overall Study|Death|1|||
126343527|NCT01721798|454554085|FG003|Overall Study|Death|1|||
126677955|NCT01324232|455779008|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
126677956|NCT01324232|455779009|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
126430049|NCT03748823|454870073|FG001|Extension Period|Protocol Violation|0|||
126430050|NCT03748823|454870072|FG000|Extension Period|Lost to Follow-up|0|||
126430051|NCT03748823|454870073|FG001|Extension Period|Lost to Follow-up|1|||
126430052|NCT03748823|454870072|FG000|Extension Period|Lack of Efficacy|0|||
126430053|NCT03748823|454870073|FG001|Extension Period|Lack of Efficacy|1|||
126430054|NCT03748823|454870072|FG000|Extension Period|Physician Decision|1|||
126430055|NCT03748823|454870073|FG001|Extension Period|Physician Decision|2|||
126430056|NCT01011673|454870074|FG000|Randomized|Secondary headache|2|||
126430057|NCT01011673|454870075|FG001|Randomized|Secondary headache|1|||
126430058|NCT01011673|454870074|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
126430059|NCT01011673|454870075|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
126430060|NCT00626275|454870076|FG000|Part A - Treatment Period 1|Adverse Event|1|||
126430061|NCT00626275|454870077|FG001|Part A - Treatment Period 1|Adverse Event|0|||
126430062|NCT00626275|454870078|FG002|Part A - Treatment Period 1|Adverse Event|0|||
126430063|NCT00626275|454870079|FG003|Part A - Treatment Period 1|Adverse Event|0|||
126430064|NCT00626275|454870080|FG004|Part A - Treatment Period 1|Adverse Event|0|||
126430065|NCT00626275|454870081|FG005|Part A - Treatment Period 1|Adverse Event|0|||
126430066|NCT00626275|454870082|FG006|Part A - Treatment Period 1|Adverse Event|0|||
126430067|NCT00626275|454870083|FG007|Part A - Treatment Period 1|Adverse Event|0|||
126430068|NCT00626275|454870076|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
126430069|NCT00626275|454870077|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
126430070|NCT00626275|454870078|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
126430071|NCT00626275|454870079|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
126430072|NCT00626275|454870080|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
126430073|NCT00626275|454870081|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
126430074|NCT00626275|454870082|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
126430075|NCT00626275|454870083|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
126430076|NCT00626275|454870076|FG000|Part B|Lost to Follow-up|0|||
126430077|NCT00626275|454870077|FG001|Part B|Lost to Follow-up|0|||
126430078|NCT00626275|454870078|FG002|Part B|Lost to Follow-up|0|||
126430079|NCT00626275|454870079|FG003|Part B|Lost to Follow-up|0|||
126430080|NCT00626275|454870080|FG004|Part B|Lost to Follow-up|0|||
126430081|NCT00626275|454870081|FG005|Part B|Lost to Follow-up|0|||
126430082|NCT00626275|454870082|FG006|Part B|Lost to Follow-up|1|||
126430083|NCT00626275|454870083|FG007|Part B|Lost to Follow-up|0|||
126430084|NCT00626275|454870076|FG000|Part B|Withdrawal by Subject|0|||
126430085|NCT00626275|454870077|FG001|Part B|Withdrawal by Subject|0|||
126430086|NCT00626275|454870078|FG002|Part B|Withdrawal by Subject|0|||
126430087|NCT00626275|454870079|FG003|Part B|Withdrawal by Subject|0|||
126430088|NCT00626275|454870080|FG004|Part B|Withdrawal by Subject|0|||
126430089|NCT00626275|454870081|FG005|Part B|Withdrawal by Subject|0|||
126430090|NCT00626275|454870082|FG006|Part B|Withdrawal by Subject|0|||
126430091|NCT00626275|454870083|FG007|Part B|Withdrawal by Subject|1|||
126430092|NCT01476722|454870084|FG000|Overall Study|Adverse Event|1|||
126430093|NCT03261336|454870085|FG000|Overall Study|Adverse Event|1|||
126430094|NCT01069484|454870088|FG000|Overall Study|Death-in-near-family|1|||
126430095|NCT01069484|454870089|FG001|Overall Study|Death-in-near-family|0|||
126430096|NCT01069484|454870088|FG000|Overall Study|No specific reason|8|||
126430097|NCT01069484|454870089|FG001|Overall Study|No specific reason|2|||
126430098|NCT01069484|454870088|FG000|Overall Study|Illness mother or child|3|||
126430099|NCT01069484|454870089|FG001|Overall Study|Illness mother or child|1|||
126430100|NCT00292942|454870090|FG000|Overall Study|Withdrawal by Subject|0|||
126430101|NCT00292942|454870091|FG001|Overall Study|Withdrawal by Subject|0|||
126430102|NCT00292942|454870092|FG002|Overall Study|Withdrawal by Subject|1|||
126430103|NCT00292942|454870093|FG003|Overall Study|Withdrawal by Subject|0|||
126430104|NCT00292942|454870090|FG000|Overall Study|Adverse Event|0|||
126430105|NCT00292942|454870091|FG001|Overall Study|Adverse Event|0|||
126430106|NCT00292942|454870092|FG002|Overall Study|Adverse Event|0|||
126430107|NCT00292942|454870093|FG003|Overall Study|Adverse Event|1|||
126430108|NCT00644358|454870094|FG000|Overall Study|Adverse Event|124|||
126430109|NCT00644358|454870094|FG000|Overall Study|Lost to Follow-up|105|||
126430110|NCT00644358|454870094|FG000|Overall Study|Consent Withdrawal|64|||
126677957|NCT01324232|455779010|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
126430111|NCT00644358|454870094|FG000|Overall Study|Lack of Effectiveness|39|||
126430112|NCT00644358|454870094|FG000|Overall Study|Protocol Violation|5|||
126430113|NCT00644358|454870094|FG000|Overall Study|Noncompliance|14|||
126430114|NCT00644358|454870094|FG000|Overall Study|Other Unspecified|11|||
126430115|NCT00651924|454870101|FG000|Overall Study|Withdrawal by PI|0|||
126430116|NCT00651924|454870102|FG001|Overall Study|Withdrawal by PI|2|||
126430117|NCT00651924|454870101|FG000|Overall Study|Withdrawal by Subject|0|||
126430118|NCT00651924|454870102|FG001|Overall Study|Withdrawal by Subject|5|||
126430119|NCT00758771|454870103|FG000|Overall Study|Withdrawal by Subject|1|||
126430120|NCT00758771|454870104|FG001|Overall Study|Withdrawal by Subject|1|||
126430121|NCT00758771|454870103|FG000|Overall Study|Did not meet eligibility criteria|2|||
126430122|NCT00758771|454870104|FG001|Overall Study|Did not meet eligibility criteria|4|||
126430123|NCT00960063|454870105|FG000|Overall Study|Adverse Event|1|||
126430124|NCT00960063|454870106|FG001|Overall Study|Adverse Event|0|||
126430125|NCT00960063|454870107|FG002|Overall Study|Adverse Event|0|||
126430126|NCT00960063|454870105|FG000|Overall Study|Progression of Disease|0|||
126677958|NCT01324232|455779007|FG000|Overall Study|Lack of Efficacy|2|||
126677959|NCT01324232|455779008|FG001|Overall Study|Lack of Efficacy|1|||
126677960|NCT01324232|455779009|FG002|Overall Study|Lack of Efficacy|2|||
126677961|NCT01324232|455779010|FG003|Overall Study|Lack of Efficacy|2|||
126677962|NCT01324232|455779007|FG000|Overall Study|Participant Refused Medication|0|||
126677963|NCT01324232|455779008|FG001|Overall Study|Participant Refused Medication|1|||
126677964|NCT01324232|455779009|FG002|Overall Study|Participant Refused Medication|0|||
126677965|NCT01324232|455779010|FG003|Overall Study|Participant Refused Medication|0|||
126677966|NCT01324232|455779007|FG000|Overall Study|Intercurrent illness|0|||
126677967|NCT01324232|455779008|FG001|Overall Study|Intercurrent illness|0|||
126677968|NCT01324232|455779009|FG002|Overall Study|Intercurrent illness|0|||
126677969|NCT01324232|455779010|FG003|Overall Study|Intercurrent illness|1|||
126677970|NCT01324232|455779007|FG000|Overall Study|Adverse Event|2|||
126677971|NCT01324232|455779008|FG001|Overall Study|Adverse Event|5|||
126677972|NCT01324232|455779009|FG002|Overall Study|Adverse Event|6|||
126430127|NCT00960063|454870106|FG001|Overall Study|Progression of Disease|0|||
126677973|NCT01324232|455779010|FG003|Overall Study|Adverse Event|6|||
126677974|NCT01324232|455779007|FG000|Overall Study|Withdrawal by Subject|0|||
126677975|NCT01324232|455779008|FG001|Overall Study|Withdrawal by Subject|3|||
126677976|NCT01324232|455779009|FG002|Overall Study|Withdrawal by Subject|4|||
126677977|NCT01324232|455779010|FG003|Overall Study|Withdrawal by Subject|0|||
126677978|NCT01324232|455779007|FG000|Overall Study|Lost to Follow-up|1|||
126677979|NCT01324232|455779008|FG001|Overall Study|Lost to Follow-up|0|||
126677980|NCT01324232|455779009|FG002|Overall Study|Lost to Follow-up|0|||
126677981|NCT01324232|455779010|FG003|Overall Study|Lost to Follow-up|0|||
126677982|NCT00661531|455779011|FG000|Overall Study|Withdrawal by Subject|3|||
126677983|NCT02614859|455779013|FG000|Overall Study|Physician Decision|0|||
126677984|NCT02614859|455779014|FG001|Overall Study|Physician Decision|1|||
126677985|NCT04081363|455779019|FG000|Overall Study|Withdrawal by Subject|1|||
126677986|NCT04081363|455779020|FG001|Overall Study|Withdrawal by Subject|0|||
126677987|NCT00618410|455779021|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
126677988|NCT00618410|455779022|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
126677989|NCT00705783|455779023|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
126677990|NCT00705783|455779024|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
126677991|NCT00705783|455779025|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
126677992|NCT00705783|455779023|FG000|Conversion Phase|Lost to Follow-up|13|||
126677993|NCT00705783|455779024|FG001|Conversion Phase|Lost to Follow-up|0|||
126677994|NCT00705783|455779025|FG002|Conversion Phase|Lost to Follow-up|0|||
126677995|NCT00705783|455779023|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
126677996|NCT00705783|455779024|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
126677997|NCT00705783|455779025|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
126677998|NCT00705783|455779023|FG000|Conversion Phase|Withdrawn by Investigator|4|||
126677999|NCT00705783|455779024|FG001|Conversion Phase|Withdrawn by Investigator|0|||
126678000|NCT00705783|455779025|FG002|Conversion Phase|Withdrawn by Investigator|0|||
126678001|NCT00705783|455779023|FG000|Conversion Phase|Withdrew Consent|24|||
126678002|NCT00705783|455779024|FG001|Conversion Phase|Withdrew Consent|0|||
126678003|NCT00705783|455779025|FG002|Conversion Phase|Withdrew Consent|0|||
126678004|NCT00705783|455779023|FG000|Conversion Phase|Protocol Deviation|2|||
126678005|NCT00705783|455779024|FG001|Conversion Phase|Protocol Deviation|0|||
126678006|NCT00705783|455779025|FG002|Conversion Phase|Protocol Deviation|0|||
126678007|NCT00705783|455779023|FG000|Conversion Phase|Adverse Event|11|||
126678008|NCT00705783|455779024|FG001|Conversion Phase|Adverse Event|0|||
126678009|NCT00705783|455779025|FG002|Conversion Phase|Adverse Event|0|||
126678010|NCT00705783|455779023|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
126678011|NCT00705783|455779024|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
126678012|NCT00705783|455779025|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
126678013|NCT00705783|455779023|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
126678014|NCT00705783|455779024|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
126678015|NCT00705783|455779025|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
126430128|NCT00960063|454870107|FG002|Overall Study|Progression of Disease|3|||
126678016|NCT00705783|455779023|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
126678017|NCT00705783|455779024|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
126678018|NCT00705783|455779025|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
126678019|NCT00705783|455779023|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
126678020|NCT00705783|455779024|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
126678021|NCT00705783|455779025|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
126678022|NCT00705783|455779023|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
126678023|NCT00705783|455779024|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
126678024|NCT00705783|455779025|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
126678025|NCT00705783|455779023|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
126678026|NCT00705783|455779024|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
126430129|NCT00771914|454870108|FG000|Overall Study|Physician Decision|0|||
126678027|NCT00705783|455779025|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
126678028|NCT00705783|455779023|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
126678029|NCT00705783|455779024|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
126678030|NCT00705783|455779025|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
126343528|NCT01721798|454554082|FG000|Overall Study|Lost to Follow-up|2|||
126343529|NCT01721798|454554083|FG001|Overall Study|Lost to Follow-up|2|||
126343530|NCT01721798|454554084|FG002|Overall Study|Lost to Follow-up|9|||
126343531|NCT01721798|454554085|FG003|Overall Study|Lost to Follow-up|9|||
126343532|NCT01721798|454554082|FG000|Overall Study|Pregnancy|0|||
126343533|NCT01721798|454554083|FG001|Overall Study|Pregnancy|0|||
126343534|NCT01721798|454554084|FG002|Overall Study|Pregnancy|1|||
126343535|NCT01721798|454554085|FG003|Overall Study|Pregnancy|1|||
126343536|NCT01721798|454554082|FG000|Overall Study|Withdrawal by Subject|1|||
126343537|NCT01721798|454554083|FG001|Overall Study|Withdrawal by Subject|0|||
126343538|NCT01721798|454554084|FG002|Overall Study|Withdrawal by Subject|2|||
126343539|NCT01721798|454554085|FG003|Overall Study|Withdrawal by Subject|1|||
126343540|NCT01721798|454554082|FG000|Overall Study|Not eligible for 24 month visit|1|||
126343541|NCT01721798|454554083|FG001|Overall Study|Not eligible for 24 month visit|0|||
126343542|NCT01721798|454554084|FG002|Overall Study|Not eligible for 24 month visit|8|||
126343543|NCT01721798|454554085|FG003|Overall Study|Not eligible for 24 month visit|7|||
126343544|NCT01294046|454554086|FG000|Overall Study|Infection and surgical explant|1|||
126343545|NCT01294046|454554086|FG000|Overall Study|Eligibility criteria expanded|1|||
126343546|NCT01294046|454554086|FG000|Overall Study|Stimulation response inadqequate|1|||
126343547|NCT00577408|454554089|FG000|Overall Study|Stopped attending study visits|9|||
126343548|NCT00577408|454554090|FG001|Overall Study|Stopped attending study visits|11|||
126343549|NCT00577408|454554089|FG000|Overall Study|Continued opioid use|3|||
126343550|NCT00577408|454554090|FG001|Overall Study|Continued opioid use|2|||
126343551|NCT00577408|454554089|FG000|Overall Study|Non-compliance with study meds|0|||
126343552|NCT00577408|454554090|FG001|Overall Study|Non-compliance with study meds|3|||
126343553|NCT00577408|454554089|FG000|Overall Study|Refused Oral Naltrexone|0|||
126343554|NCT00577408|454554090|FG001|Overall Study|Refused Oral Naltrexone|1|||
126343555|NCT00577408|454554089|FG000|Overall Study|Moved out of state|0|||
126343556|NCT00577408|454554090|FG001|Overall Study|Moved out of state|1|||
126343557|NCT00577408|454554089|FG000|Overall Study|Scheduling Issues|0|||
126343558|NCT00577408|454554090|FG001|Overall Study|Scheduling Issues|3|||
126343559|NCT00577408|454554089|FG000|Overall Study|Death|0|||
126343560|NCT00577408|454554090|FG001|Overall Study|Death|1|||
126343561|NCT00577408|454554089|FG000|Overall Study|Psychiatric hospitalization|0|||
126343562|NCT00577408|454554090|FG001|Overall Study|Psychiatric hospitalization|1|||
126343563|NCT00656617|454554091|FG000|Overall Study|Adverse Event|1|||
126343564|NCT00656617|454554091|FG000|Overall Study|Death|2|||
126343565|NCT00656617|454554091|FG000|Overall Study|Insurance Issues|2|||
126343566|NCT00656617|454554091|FG000|Overall Study|Move to different clinical trial|2|||
126343567|NCT02349386|454554101|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
126343568|NCT02349386|454554102|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
126343569|NCT02349386|454554103|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
126343570|NCT02349386|454554104|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
126343571|NCT02349386|454554101|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
126343572|NCT02349386|454554102|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
126343573|NCT02349386|454554103|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
126343574|NCT02349386|454554104|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
126343575|NCT02349386|454554101|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
126343576|NCT02349386|454554102|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
126343577|NCT02349386|454554103|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
126343578|NCT02349386|454554104|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
126343579|NCT02349386|454554101|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
126343580|NCT02349386|454554102|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
126343581|NCT02349386|454554103|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
126343582|NCT02349386|454554104|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
126343583|NCT02349386|454554101|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
126343584|NCT02349386|454554102|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
126343585|NCT02349386|454554103|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
126343586|NCT02349386|454554104|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
126343587|NCT02349386|454554101|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
126343588|NCT02349386|454554102|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
126343589|NCT02349386|454554103|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
126343590|NCT02349386|454554104|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
126343591|NCT00091819|454554105|FG000|Overall Study|Adverse Event|1|||
126343592|NCT00091819|454554106|FG001|Overall Study|Adverse Event|1|||
126678031|NCT00705783|455779023|FG000|Oral Stabilization Phase|Adverse Event|14|||
126678032|NCT00705783|455779024|FG001|Oral Stabilization Phase|Adverse Event|0|||
126430130|NCT00771914|454870109|FG001|Overall Study|Physician Decision|0|||
126430131|NCT00771914|454870110|FG002|Overall Study|Physician Decision|0|||
126430132|NCT00771914|454870111|FG003|Overall Study|Physician Decision|1|||
126430133|NCT00771914|454870108|FG000|Overall Study|Lost to Follow-up|0|||
126430134|NCT00771914|454870109|FG001|Overall Study|Lost to Follow-up|0|||
126430135|NCT00771914|454870110|FG002|Overall Study|Lost to Follow-up|0|||
126430136|NCT00771914|454870111|FG003|Overall Study|Lost to Follow-up|1|||
126430137|NCT02978417|454870115|FG000|Overall Study|Lost to Follow-up|2|||
126430138|NCT02978417|454870116|FG001|Overall Study|Lost to Follow-up|2|||
126430139|NCT05083351|454870121|FG000|Overall Study|Adverse Event|3|||
126430140|NCT05083351|454870121|FG000|Overall Study|Did not meet data inclusion criteria|8|||
126678033|NCT00705783|455779025|FG002|Oral Stabilization Phase|Adverse Event|0|||
126678034|NCT00705783|455779023|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
126678035|NCT00705783|455779024|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126678036|NCT00705783|455779025|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126678037|NCT00705783|455779023|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
126678038|NCT00705783|455779024|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126343593|NCT00091819|454554105|FG000|Overall Study|Death|4|||
126343594|NCT00091819|454554106|FG001|Overall Study|Death|5|||
126343595|NCT00091819|454554105|FG000|Overall Study|Lost to Follow-up|26|||
126343596|NCT00091819|454554106|FG001|Overall Study|Lost to Follow-up|23|||
126343597|NCT00091819|454554105|FG000|Overall Study|Withdrawal by Subject|5|||
126343598|NCT00091819|454554106|FG001|Overall Study|Withdrawal by Subject|8|||
126343599|NCT00091819|454554105|FG000|Overall Study|Protocol Violation|1|||
126343600|NCT00091819|454554106|FG001|Overall Study|Protocol Violation|2|||
126343601|NCT00091819|454554105|FG000|Overall Study|Other|2|||
126343602|NCT00091819|454554106|FG001|Overall Study|Other|3|||
126343603|NCT00091819|454554105|FG000|Overall Study|Never received study treatment|3|||
126343604|NCT00091819|454554106|FG001|Overall Study|Never received study treatment|4|||
126343605|NCT00961415|454554107|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
126343606|NCT00961415|454554108|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
126343607|NCT00961415|454554109|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
126343608|NCT00961415|454554107|FG000|Induction Treatment Phase|Death|77|||
126343609|NCT00961415|454554108|FG001|Induction Treatment Phase|Death|0|||
126343610|NCT00961415|454554109|FG002|Induction Treatment Phase|Death|0|||
126343611|NCT00961415|454554107|FG000|Induction Treatment Phase|Protocol Violation|1|||
126343612|NCT00961415|454554108|FG001|Induction Treatment Phase|Protocol Violation|0|||
126343613|NCT00961415|454554109|FG002|Induction Treatment Phase|Protocol Violation|0|||
126343614|NCT00961415|454554107|FG000|Induction Treatment Phase|Physician Decision|2|||
126343615|NCT00961415|454554108|FG001|Induction Treatment Phase|Physician Decision|0|||
126343616|NCT00961415|454554109|FG002|Induction Treatment Phase|Physician Decision|0|||
126343617|NCT00961415|454554107|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
126343618|NCT00961415|454554108|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
126343619|NCT00961415|454554109|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
126343620|NCT00961415|454554107|FG000|Induction Treatment Phase|Other Reason|5|||
126343621|NCT00961415|454554108|FG001|Induction Treatment Phase|Other Reason|0|||
126343622|NCT00961415|454554109|FG002|Induction Treatment Phase|Other Reason|0|||
126343623|NCT00961415|454554107|FG000|Maintenance Treatment Phase|Death|0|||
126343624|NCT00961415|454554108|FG001|Maintenance Treatment Phase|Death|42|||
126343625|NCT00961415|454554109|FG002|Maintenance Treatment Phase|Death|34|||
126343626|NCT00961415|454554107|FG000|Maintenance Treatment Phase|Investigators decision|0|||
126343627|NCT00961415|454554108|FG001|Maintenance Treatment Phase|Investigators decision|2|||
126343628|NCT00961415|454554109|FG002|Maintenance Treatment Phase|Investigators decision|0|||
126343629|NCT00961415|454554107|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
126343630|NCT00961415|454554108|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
126343631|NCT00961415|454554109|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
126343632|NCT00961415|454554107|FG000|Maintenance Treatment Phase|Other reason|0|||
126343633|NCT00961415|454554108|FG001|Maintenance Treatment Phase|Other reason|1|||
126343634|NCT00961415|454554109|FG002|Maintenance Treatment Phase|Other reason|3|||
126343635|NCT04759131|454554113|FG000|Overall Study|Investigator's discretion|1|||
126343636|NCT04759131|454554114|FG001|Overall Study|Investigator's discretion|0|||
126343637|NCT04759131|454554113|FG000|Overall Study|Subject withdrawal|1|||
126343638|NCT04759131|454554114|FG001|Overall Study|Subject withdrawal|0|||
126343639|NCT05144945|454554115|FG000|Overall Study|Withdrawal by Subject|1|||
126430141|NCT05083351|454870121|FG000|Overall Study|Did not meet eligibility criteria|19|||
126430142|NCT05083351|454870121|FG000|Overall Study|Study Staff Decision|19|||
126430143|NCT01759420|454870127|FG000|Overall Study|Screen failure|5|||
126678039|NCT00705783|455779025|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126343640|NCT05144945|454554116|FG001|Overall Study|Withdrawal by Subject|0|||
126343641|NCT03692949|454554117|FG000|Overall Study|Lost to Follow-up|0|||
126343642|NCT03692949|454554118|FG001|Overall Study|Lost to Follow-up|0|||
126343643|NCT03692949|454554119|FG002|Overall Study|Lost to Follow-up|0|||
126343644|NCT03692949|454554120|FG003|Overall Study|Lost to Follow-up|0|||
126343645|NCT03692949|454554121|FG004|Overall Study|Lost to Follow-up|0|||
126678040|NCT00705783|455779023|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
126678041|NCT00705783|455779024|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
126678042|NCT00705783|455779025|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
126678043|NCT00705783|455779023|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
126678044|NCT00705783|455779024|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
126678045|NCT00705783|455779025|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
126678046|NCT00705783|455779023|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
126678047|NCT00705783|455779024|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
126678048|NCT00705783|455779025|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
126678049|NCT00705783|455779023|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
126678050|NCT00705783|455779024|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
126678051|NCT00705783|455779025|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
126678052|NCT00705783|455779023|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
126678053|NCT00705783|455779024|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
126678054|NCT00705783|455779025|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
126678055|NCT00705783|455779023|FG000|Depot Stabilization Phase|Adverse Event|17|||
126678056|NCT00705783|455779024|FG001|Depot Stabilization Phase|Adverse Event|0|||
126678057|NCT00705783|455779025|FG002|Depot Stabilization Phase|Adverse Event|0|||
126678058|NCT00705783|455779023|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
126678059|NCT00705783|455779024|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126678060|NCT00705783|455779025|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126678061|NCT00705783|455779023|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
126678062|NCT00705783|455779024|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126678063|NCT00705783|455779025|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126678064|NCT00705783|455779023|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
126678065|NCT00705783|455779024|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
126678066|NCT00705783|455779025|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
126678067|NCT00705783|455779023|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
126678068|NCT00705783|455779024|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
126678069|NCT00705783|455779025|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
126678070|NCT00705783|455779023|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
126678071|NCT00705783|455779024|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
126678072|NCT00705783|455779025|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
126678073|NCT00705783|455779023|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
126678074|NCT00705783|455779024|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
126678075|NCT00705783|455779025|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
126343646|NCT03692949|454554122|FG005|Overall Study|Lost to Follow-up|0|||
126343647|NCT03692949|454554123|FG006|Overall Study|Lost to Follow-up|0|||
126343648|NCT03692949|454554124|FG007|Overall Study|Lost to Follow-up|1|||
126343649|NCT02592824|454554126|FG000|Overall Study|Protocol Violation|5|||
126343650|NCT02592824|454554127|FG001|Overall Study|Protocol Violation|3|||
126343651|NCT02592824|454554126|FG000|Overall Study|Lost to Follow-up|2|||
126343652|NCT02592824|454554127|FG001|Overall Study|Lost to Follow-up|1|||
126343653|NCT03426878|454554128|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
126343654|NCT03426878|454554128|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
126343655|NCT03426878|454554128|FG000|Overall Study|Declined to receive results|3|||
126343656|NCT03426878|454554128|FG000|Overall Study|Received negative results by mailed letter|65|||
126343657|NCT03426878|454554128|FG000|Overall Study|Lost to Follow-up|177|||
126343658|NCT00560404|454554129|FG000|Overall Study|Adverse Event|2|||
126343659|NCT00560404|454554130|FG001|Overall Study|Adverse Event|3|||
126343660|NCT00560404|454554129|FG000|Overall Study|Death|3|||
126343661|NCT00560404|454554130|FG001|Overall Study|Death|3|||
126343662|NCT00560404|454554129|FG000|Overall Study|Protocol Violation|12|||
126343663|NCT00560404|454554130|FG001|Overall Study|Protocol Violation|7|||
126343664|NCT00560404|454554129|FG000|Overall Study|Administrative Reasons|1|||
126343665|NCT00560404|454554130|FG001|Overall Study|Administrative Reasons|1|||
126343666|NCT00560404|454554129|FG000|Overall Study|Withdrew Consent|4|||
126343667|NCT00560404|454554130|FG001|Overall Study|Withdrew Consent|0|||
126343668|NCT00560404|454554129|FG000|Overall Study|Failure to return|1|||
126343669|NCT00560404|454554130|FG001|Overall Study|Failure to return|2|||
126343670|NCT00560404|454554129|FG000|Overall Study|Other withdrawal reason|13|||
126343671|NCT00560404|454554130|FG001|Overall Study|Other withdrawal reason|5|||
126678076|NCT00705783|455779023|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
126678077|NCT00705783|455779024|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
126678078|NCT00705783|455779025|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
126678079|NCT00705783|455779023|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
126678080|NCT00705783|455779024|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
126678081|NCT00705783|455779025|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
126678082|NCT00705783|455779023|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
126343672|NCT00392223|454554137|FG000|Overall Study|Adverse Event|5|||
126343673|NCT00392223|454554138|FG001|Overall Study|Adverse Event|4|||
126343674|NCT00392223|454554137|FG000|Overall Study|Lost to Follow-up|1|||
126678083|NCT00705783|455779024|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
126678084|NCT00705783|455779025|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
126678085|NCT00705783|455779023|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
126678086|NCT00705783|455779024|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
126678087|NCT00705783|455779025|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
126678088|NCT00705783|455779023|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
126678089|NCT00705783|455779024|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
126678090|NCT00705783|455779025|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
126678091|NCT02184195|455779026|FG000|Overall Study|Patient decision|5|||
126678092|NCT02184195|455779027|FG001|Overall Study|Patient decision|2|||
126343675|NCT00392223|454554138|FG001|Overall Study|Lost to Follow-up|4|||
126343676|NCT00392223|454554137|FG000|Overall Study|Protocol Violation|0|||
126343677|NCT00392223|454554138|FG001|Overall Study|Protocol Violation|3|||
126343678|NCT00392223|454554137|FG000|Overall Study|Withdrawal by Subject|3|||
126343679|NCT00392223|454554138|FG001|Overall Study|Withdrawal by Subject|2|||
126343680|NCT01991795|454554139|FG000|Overall Study|Lost to Follow-up|6|||
126343681|NCT01991795|454554140|FG001|Overall Study|Lost to Follow-up|4|||
126343682|NCT01991795|454554139|FG000|Overall Study|Withdrawal by Subject|117|||
126343683|NCT01991795|454554140|FG001|Overall Study|Withdrawal by Subject|94|||
126343684|NCT01991795|454554139|FG000|Overall Study|Site prematurely closed by sponsor|26|||
126343685|NCT01991795|454554140|FG001|Overall Study|Site prematurely closed by sponsor|25|||
126343686|NCT03104374|454554144|FG000|Period 1|Adverse Event|7|||
126343687|NCT03104374|454554145|FG001|Period 1|Adverse Event|7|||
126343688|NCT03104374|454554146|FG002|Period 1|Adverse Event|12|||
126343689|NCT03104374|454554147|FG003|Period 1|Adverse Event|14|||
126343690|NCT03104374|454554144|FG000|Period 1|Withdrawal by Subject|18|||
126343691|NCT03104374|454554145|FG001|Period 1|Withdrawal by Subject|9|||
126343692|NCT03104374|454554146|FG002|Period 1|Withdrawal by Subject|10|||
126343693|NCT03104374|454554147|FG003|Period 1|Withdrawal by Subject|17|||
126343694|NCT03104374|454554144|FG000|Period 1|Lost to Follow-up|4|||
126343695|NCT03104374|454554145|FG001|Period 1|Lost to Follow-up|4|||
126343696|NCT03104374|454554146|FG002|Period 1|Lost to Follow-up|6|||
126343697|NCT03104374|454554147|FG003|Period 1|Lost to Follow-up|8|||
126343698|NCT03104374|454554144|FG000|Period 1|Lack of Efficacy|6|||
126343699|NCT03104374|454554145|FG001|Period 1|Lack of Efficacy|7|||
126343700|NCT03104374|454554146|FG002|Period 1|Lack of Efficacy|12|||
126343701|NCT03104374|454554147|FG003|Period 1|Lack of Efficacy|6|||
126343702|NCT03104374|454554144|FG000|Period 1|Other|2|||
126343703|NCT03104374|454554145|FG001|Period 1|Other|2|||
126343704|NCT03104374|454554146|FG002|Period 1|Other|4|||
126343705|NCT03104374|454554147|FG003|Period 1|Other|7|||
126343706|NCT03104374|454554144|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
126343707|NCT03104374|454554145|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
126343708|NCT03104374|454554146|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
126343709|NCT03104374|454554147|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
126343710|NCT03104374|454554144|FG000|Period 2|Adverse Event|4|||
126343711|NCT03104374|454554145|FG001|Period 2|Adverse Event|7|||
126343712|NCT03104374|454554146|FG002|Period 2|Adverse Event|10|||
126343713|NCT03104374|454554147|FG003|Period 2|Adverse Event|10|||
126343714|NCT03104374|454554144|FG000|Period 2|Withdrawal by Subject|3|||
126343715|NCT03104374|454554145|FG001|Period 2|Withdrawal by Subject|7|||
126343716|NCT03104374|454554146|FG002|Period 2|Withdrawal by Subject|13|||
126343717|NCT03104374|454554147|FG003|Period 2|Withdrawal by Subject|16|||
126343718|NCT03104374|454554144|FG000|Period 2|Lost to Follow-up|2|||
126343719|NCT03104374|454554145|FG001|Period 2|Lost to Follow-up|2|||
126343720|NCT03104374|454554146|FG002|Period 2|Lost to Follow-up|3|||
126343721|NCT03104374|454554147|FG003|Period 2|Lost to Follow-up|5|||
126343722|NCT03104374|454554144|FG000|Period 2|Lack of Efficacy|2|||
126343723|NCT03104374|454554145|FG001|Period 2|Lack of Efficacy|4|||
126343724|NCT03104374|454554146|FG002|Period 2|Lack of Efficacy|7|||
126343725|NCT03104374|454554147|FG003|Period 2|Lack of Efficacy|4|||
126343726|NCT03104374|454554144|FG000|Period 2|COVID-19 Infection|0|||
126343727|NCT03104374|454554145|FG001|Period 2|COVID-19 Infection|0|||
126343728|NCT03104374|454554146|FG002|Period 2|COVID-19 Infection|1|||
126343729|NCT03104374|454554147|FG003|Period 2|COVID-19 Infection|0|||
126343730|NCT03104374|454554144|FG000|Period 2|Other|3|||
126343731|NCT03104374|454554145|FG001|Period 2|Other|2|||
126343732|NCT03104374|454554146|FG002|Period 2|Other|2|||
126343733|NCT03104374|454554147|FG003|Period 2|Other|4|||
126343734|NCT02121210|454554150|FG000|Overall Study|Adverse Event|5|||
126343735|NCT02121210|454554151|FG001|Overall Study|Adverse Event|7|||
126343736|NCT02121210|454554150|FG000|Overall Study|Lack of Efficacy|2|||
126343737|NCT02121210|454554151|FG001|Overall Study|Lack of Efficacy|0|||
126343738|NCT02121210|454554150|FG000|Overall Study|Other than specified above|0|||
126678093|NCT02184195|455779026|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126343739|NCT02121210|454554151|FG001|Overall Study|Other than specified above|2|||
126343740|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
126678094|NCT02184195|455779027|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126678095|NCT02184195|455779026|FG000|Overall Study|Death|67|||
126678096|NCT02184195|455779027|FG001|Overall Study|Death|44|||
126678097|NCT02184195|455779026|FG000|Overall Study|Lost to Follow-up|1|||
126678098|NCT02184195|455779027|FG001|Overall Study|Lost to Follow-up|5|||
126678099|NCT02184195|455779026|FG000|Overall Study|Other|0|||
126678100|NCT02184195|455779027|FG001|Overall Study|Other|3|||
126678101|NCT03029143|455779030|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
126678102|NCT03029143|455779031|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
126678103|NCT03029143|455779032|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
126678104|NCT03029143|455779030|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
126678105|NCT03029143|455779031|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
126678106|NCT03029143|455779032|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
126678107|NCT03029143|455779030|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
126678108|NCT03029143|455779031|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
126678109|NCT03029143|455779032|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
126678110|NCT03029143|455779030|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
126678111|NCT03029143|455779031|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
126678112|NCT03029143|455779032|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
126678113|NCT03029143|455779030|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
126678114|NCT03029143|455779031|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
126678115|NCT03029143|455779032|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
126343741|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
126343742|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343743|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343744|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343745|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343746|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343747|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343748|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343749|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
126343750|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
126343751|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
126343752|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343753|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343754|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343755|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343756|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343757|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343758|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343759|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
126343760|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
126343761|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343762|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343763|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343764|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343765|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343766|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343767|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343768|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343769|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
126343770|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
126343771|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
126343772|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343773|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343774|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343775|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343776|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343777|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343778|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343779|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
126343780|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
126678116|NCT03029143|455779030|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
126678117|NCT03029143|455779031|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
126678118|NCT03029143|455779032|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
126430144|NCT01759420|454870127|FG000|Overall Study|Inaccurate EKG machine readings|1|||
126430145|NCT01129622|454870130|FG000|Overall Study|Withdrawal by Subject|2|||
126430146|NCT00960375|454870133|FG000|Overall Study|Lost to Follow-up|20|||
126430147|NCT00960375|454870134|FG001|Overall Study|Lost to Follow-up|22|||
126430148|NCT00591006|454870135|FG000|Overall Study|Withdrawal by Subject|0|||
126430149|NCT00591006|454870136|FG001|Overall Study|Withdrawal by Subject|0|||
126430150|NCT00591006|454870137|FG002|Overall Study|Withdrawal by Subject|0|||
126430151|NCT00591006|454870138|FG003|Overall Study|Withdrawal by Subject|0|||
126430152|NCT00591006|454870139|FG004|Overall Study|Withdrawal by Subject|0|||
126430153|NCT00591006|454870140|FG005|Overall Study|Withdrawal by Subject|0|||
126430154|NCT00591006|454870141|FG006|Overall Study|Withdrawal by Subject|0|||
126343781|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
126343782|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343783|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343784|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343785|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126430155|NCT00591006|454870142|FG007|Overall Study|Withdrawal by Subject|0|||
126430156|NCT00591006|454870143|FG008|Overall Study|Withdrawal by Subject|0|||
126430157|NCT00591006|454870144|FG009|Overall Study|Withdrawal by Subject|0|||
126430158|NCT00591006|454870145|FG010|Overall Study|Withdrawal by Subject|0|||
126430159|NCT00591006|454870146|FG011|Overall Study|Withdrawal by Subject|0|||
126430160|NCT00591006|454870147|FG012|Overall Study|Withdrawal by Subject|0|||
126430161|NCT00591006|454870148|FG013|Overall Study|Withdrawal by Subject|0|||
126430162|NCT00591006|454870149|FG014|Overall Study|Withdrawal by Subject|0|||
126430163|NCT00591006|454870150|FG015|Overall Study|Withdrawal by Subject|1|||
126430164|NCT00591006|454870151|FG016|Overall Study|Withdrawal by Subject|0|||
126430165|NCT00591006|454870152|FG017|Overall Study|Withdrawal by Subject|0|||
126430166|NCT00591006|454870153|FG018|Overall Study|Withdrawal by Subject|0|||
126430167|NCT00591006|454870154|FG019|Overall Study|Withdrawal by Subject|0|||
126430168|NCT00591006|454870155|FG020|Overall Study|Withdrawal by Subject|0|||
126430169|NCT00591006|454870156|FG021|Overall Study|Withdrawal by Subject|0|||
126430170|NCT00591006|454870157|FG022|Overall Study|Withdrawal by Subject|0|||
126430171|NCT00591006|454870158|FG023|Overall Study|Withdrawal by Subject|1|||
126430172|NCT00591006|454870135|FG000|Overall Study|Adverse Event|0|||
126430173|NCT00591006|454870136|FG001|Overall Study|Adverse Event|0|||
126430174|NCT00591006|454870137|FG002|Overall Study|Adverse Event|0|||
126430175|NCT00591006|454870138|FG003|Overall Study|Adverse Event|0|||
126430176|NCT00591006|454870139|FG004|Overall Study|Adverse Event|0|||
126430177|NCT00591006|454870140|FG005|Overall Study|Adverse Event|0|||
126430178|NCT00591006|454870141|FG006|Overall Study|Adverse Event|0|||
126430179|NCT00591006|454870142|FG007|Overall Study|Adverse Event|0|||
126430180|NCT00591006|454870143|FG008|Overall Study|Adverse Event|0|||
126430181|NCT00591006|454870144|FG009|Overall Study|Adverse Event|0|||
126430182|NCT00591006|454870145|FG010|Overall Study|Adverse Event|0|||
126430183|NCT00591006|454870146|FG011|Overall Study|Adverse Event|0|||
126430184|NCT00591006|454870147|FG012|Overall Study|Adverse Event|0|||
126343786|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343787|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343788|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343789|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
126343790|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
126343791|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
126343792|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343793|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343794|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343795|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343796|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343797|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343798|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343799|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
126343800|NCT01232283|454554152|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
126343801|NCT01232283|454554153|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
126343802|NCT01232283|454554154|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343803|NCT01232283|454554155|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126430185|NCT00591006|454870148|FG013|Overall Study|Adverse Event|0|||
126430186|NCT00591006|454870149|FG014|Overall Study|Adverse Event|0|||
126430187|NCT00591006|454870150|FG015|Overall Study|Adverse Event|0|||
126430188|NCT00591006|454870151|FG016|Overall Study|Adverse Event|0|||
126430189|NCT00591006|454870152|FG017|Overall Study|Adverse Event|0|||
126678119|NCT03029143|455779030|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
126430190|NCT00591006|454870153|FG018|Overall Study|Adverse Event|0|||
126430191|NCT00591006|454870154|FG019|Overall Study|Adverse Event|0|||
126430192|NCT00591006|454870155|FG020|Overall Study|Adverse Event|0|||
126678120|NCT03029143|455779031|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
126678121|NCT03029143|455779032|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
126678122|NCT03029143|455779030|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126678123|NCT03029143|455779031|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126678124|NCT03029143|455779032|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
126678125|NCT03029143|455779030|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
126678126|NCT03029143|455779031|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
126678127|NCT03029143|455779032|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
126678128|NCT03029143|455779030|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126678129|NCT03029143|455779031|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
126678130|NCT03029143|455779032|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
126678131|NCT03029143|455779030|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
126678132|NCT03029143|455779031|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
126678133|NCT03029143|455779032|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
126678134|NCT00974675|455779033|FG000|Overall Study|Adverse Event|2|||
126678135|NCT00974675|455779034|FG001|Overall Study|Adverse Event|1|||
126678136|NCT00974675|455779035|FG002|Overall Study|Adverse Event|1|||
126678137|NCT00974675|455779036|FG003|Overall Study|Adverse Event|1|||
126678138|NCT00974675|455779033|FG000|Overall Study|Physician Decision|0|||
126678139|NCT00974675|455779034|FG001|Overall Study|Physician Decision|0|||
126678140|NCT00974675|455779035|FG002|Overall Study|Physician Decision|1|||
126678141|NCT00974675|455779036|FG003|Overall Study|Physician Decision|0|||
126678142|NCT00974675|455779033|FG000|Overall Study|Participant on holiday; unable to attend|0|||
126678143|NCT00974675|455779034|FG001|Overall Study|Participant on holiday; unable to attend|0|||
126678144|NCT00974675|455779035|FG002|Overall Study|Participant on holiday; unable to attend|0|||
126678145|NCT00974675|455779036|FG003|Overall Study|Participant on holiday; unable to attend|1|||
126678146|NCT02121262|455779039|FG000|Overall Study|Adverse Event|6|||
126343804|NCT01232283|454554156|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343805|NCT01232283|454554157|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343806|NCT01232283|454554158|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343807|NCT01232283|454554159|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343808|NCT01232283|454554160|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343809|NCT01232283|454554161|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
126343810|NCT01232283|454554152|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343811|NCT01232283|454554153|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343812|NCT01232283|454554154|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
126343813|NCT01232283|454554155|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
126343814|NCT01232283|454554156|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343815|NCT01232283|454554157|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343816|NCT01232283|454554158|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343817|NCT01232283|454554159|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343818|NCT01232283|454554160|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343819|NCT01232283|454554161|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
126343820|NCT01232283|454554152|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343821|NCT01232283|454554153|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343822|NCT01232283|454554154|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
126343823|NCT01232283|454554155|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
126343824|NCT01232283|454554156|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343825|NCT01232283|454554157|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343826|NCT01232283|454554158|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343827|NCT01232283|454554159|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343828|NCT01232283|454554160|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343829|NCT01232283|454554161|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
126343830|NCT01232283|454554152|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343831|NCT01232283|454554153|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343832|NCT01232283|454554154|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
126343833|NCT01232283|454554155|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343834|NCT01232283|454554156|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343835|NCT01232283|454554157|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343836|NCT01232283|454554158|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343837|NCT01232283|454554159|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343838|NCT01232283|454554160|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343839|NCT01232283|454554161|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
126343840|NCT01232283|454554152|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343841|NCT01232283|454554153|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343842|NCT01232283|454554154|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
126678147|NCT02121262|455779040|FG001|Overall Study|Adverse Event|3|||
126678148|NCT02121262|455779039|FG000|Overall Study|Lack of Efficacy|3|||
126678149|NCT02121262|455779040|FG001|Overall Study|Lack of Efficacy|0|||
126678150|NCT02121262|455779039|FG000|Overall Study|Personal Reasons|19|||
126678151|NCT02121262|455779040|FG001|Overall Study|Personal Reasons|5|||
126678152|NCT02121262|455779039|FG000|Overall Study|Protocol Violation|1|||
126678153|NCT02121262|455779040|FG001|Overall Study|Protocol Violation|1|||
126678154|NCT02121262|455779039|FG000|Overall Study|Participant Dropped-out|0|||
126678155|NCT02121262|455779040|FG001|Overall Study|Participant Dropped-out|1|||
126678156|NCT02121262|455779039|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
126678157|NCT02121262|455779040|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
126678158|NCT02121262|455779039|FG000|Overall Study|Consent Withdrawn|1|||
126678159|NCT02121262|455779040|FG001|Overall Study|Consent Withdrawn|0|||
126678160|NCT02025907|455779046|FG000|Overall Study|Lack of Efficacy|1|||
126678161|NCT02025907|455779047|FG001|Overall Study|Lack of Efficacy|0|||
126343843|NCT01232283|454554155|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
126343844|NCT01232283|454554156|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343845|NCT01232283|454554157|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343846|NCT01232283|454554158|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343847|NCT01232283|454554159|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343848|NCT01232283|454554160|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343849|NCT01232283|454554161|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
126343850|NCT01232283|454554152|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343851|NCT01232283|454554153|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343852|NCT01232283|454554154|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
126343853|NCT01232283|454554155|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
126343854|NCT01232283|454554156|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343855|NCT01232283|454554157|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343856|NCT01232283|454554158|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343857|NCT01232283|454554159|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343858|NCT01232283|454554160|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343859|NCT01232283|454554161|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
126343860|NCT01232283|454554152|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
126343861|NCT01232283|454554153|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
126343862|NCT01232283|454554154|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
126343863|NCT01232283|454554155|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
126343864|NCT01232283|454554156|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
126343865|NCT01232283|454554157|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
126343866|NCT01232283|454554158|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
126343867|NCT01232283|454554159|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
126343868|NCT01232283|454554160|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
126343869|NCT01232283|454554161|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
126343870|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343871|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343872|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343873|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343874|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
126343875|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
126343876|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343877|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
126343878|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343879|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
126343880|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343881|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343882|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343883|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343884|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
126343885|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343886|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
126343887|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
126343888|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343889|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
126343890|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
126343891|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
126343892|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
126343893|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
126343894|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
126343895|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
126343896|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
126343897|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
126343898|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
126678162|NCT02025907|455779046|FG000|Overall Study|Withdrawal by Subject|15|||
126678163|NCT02025907|455779047|FG001|Overall Study|Withdrawal by Subject|8|||
126678164|NCT02025907|455779046|FG000|Overall Study|Protocol Violation|2|||
126678165|NCT02025907|455779047|FG001|Overall Study|Protocol Violation|0|||
126678166|NCT02025907|455779046|FG000|Overall Study|Physician Decision|2|||
126678167|NCT02025907|455779047|FG001|Overall Study|Physician Decision|0|||
126678168|NCT02025907|455779046|FG000|Overall Study|Lost to Follow-up|2|||
126678169|NCT02025907|455779047|FG001|Overall Study|Lost to Follow-up|2|||
126678170|NCT02025907|455779046|FG000|Overall Study|Adverse Event|3|||
126678171|NCT02025907|455779047|FG001|Overall Study|Adverse Event|1|||
126678172|NCT02025907|455779046|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
126678173|NCT02025907|455779047|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
126678174|NCT00282334|455779048|FG000|Overall Study|Withdrawal by Subject|8|||
126678175|NCT00282334|455779049|FG001|Overall Study|Withdrawal by Subject|5|||
126343899|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
126343900|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343901|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343902|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343903|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343904|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
126343905|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343906|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343907|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343908|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343909|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
126343910|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343911|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343912|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343913|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343914|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
126343915|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343916|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
126343917|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
126343918|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343919|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
126343920|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343921|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343922|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343923|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343924|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343925|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343926|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343927|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
126343928|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343929|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
126343930|NCT01232283|454554152|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343931|NCT01232283|454554153|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343932|NCT01232283|454554154|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343933|NCT01232283|454554155|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343934|NCT01232283|454554156|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343935|NCT01232283|454554157|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
126343936|NCT01232283|454554158|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343937|NCT01232283|454554159|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343938|NCT01232283|454554160|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343939|NCT01232283|454554161|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
126343940|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343941|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343942|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343943|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343944|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343945|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343946|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126343947|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
126678176|NCT00939783|455779053|FG000|Overall Study|Death|6|||
126678177|NCT00939783|455779053|FG000|Overall Study|Adverse Event|39|||
126678178|NCT00939783|455779053|FG000|Overall Study|Study Terminated by Sponsor|498|||
126678179|NCT00939783|455779053|FG000|Overall Study|Withdrawal by Subject|78|||
126678180|NCT00939783|455779053|FG000|Overall Study|Other|16|||
126678181|NCT00939783|455779053|FG000|Overall Study|Lost to Follow-up|8|||
126430193|NCT00591006|454870156|FG021|Overall Study|Adverse Event|0|||
126678182|NCT00939783|455779053|FG000|Overall Study|Protocol Violation|3|||
126678183|NCT00939783|455779053|FG000|Overall Study|Enrolled but not treated|1|||
126678184|NCT02255409|455779054|FG000|Overall Study|Administrative Reason|3|||
126678185|NCT02255409|455779055|FG001|Overall Study|Administrative Reason|7|||
126678186|NCT02255409|455779054|FG000|Overall Study|Withdrawal by Subject|1|||
126678187|NCT02255409|455779055|FG001|Overall Study|Withdrawal by Subject|5|||
126678188|NCT02255409|455779054|FG000|Overall Study|Lost to Follow-up|10|||
126678189|NCT02255409|455779055|FG001|Overall Study|Lost to Follow-up|19|||
126678190|NCT00473343|455779056|FG000|Overall Study|Adverse Event|9|||
126678191|NCT00473343|455779056|FG000|Overall Study|Lost to Follow-up|8|||
126678192|NCT00473343|455779056|FG000|Overall Study|Treatment failure|27|||
126678193|NCT00473343|455779056|FG000|Overall Study|Withdrew consent|3|||
126678194|NCT00473343|455779056|FG000|Overall Study|Other un-specified reason|3|||
126343948|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
126343949|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
126343950|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343951|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343952|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343953|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343954|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126430194|NCT00591006|454870157|FG022|Overall Study|Adverse Event|1|||
126430195|NCT00591006|454870158|FG023|Overall Study|Adverse Event|0|||
126430196|NCT00689390|454870159|FG000|Overall Study|Adverse Event|19|||
126430197|NCT00689390|454870160|FG001|Overall Study|Adverse Event|0|||
126430198|NCT00689390|454870159|FG000|Overall Study|Lost to Follow-up|179|||
126430199|NCT00689390|454870160|FG001|Overall Study|Lost to Follow-up|7|||
126343955|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343956|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343957|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
126343958|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
126343959|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
126343960|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343961|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343962|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343963|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343964|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343965|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343966|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343967|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
126343968|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
126343969|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
126343970|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343971|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343972|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343973|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343974|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343975|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343976|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343977|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
126343978|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
126343979|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
126343980|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343981|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343982|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343983|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343984|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343985|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343986|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343987|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
126343988|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
126343989|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
126430200|NCT00689390|454870159|FG000|Overall Study|Withdrawal by Subject|117|||
126430201|NCT00689390|454870160|FG001|Overall Study|Withdrawal by Subject|3|||
126430202|NCT00689390|454870159|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
126678195|NCT04247061|455779057|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
126430203|NCT00689390|454870160|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
126430204|NCT00689390|454870159|FG000|Overall Study|Non-Compliance With Protocol|21|||
126430205|NCT00689390|454870160|FG001|Overall Study|Non-Compliance With Protocol|0|||
126430206|NCT00689390|454870159|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
126430207|NCT00689390|454870160|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
126430208|NCT00689390|454870159|FG000|Overall Study|Administrative|37|||
126430209|NCT00689390|454870160|FG001|Overall Study|Administrative|0|||
126430210|NCT02343263|454870161|FG000|Overall Study|Physician Decision|5|||
126430211|NCT02343263|454870162|FG001|Overall Study|Physician Decision|3|||
126430212|NCT02343263|454870163|FG002|Overall Study|Physician Decision|1|||
126430213|NCT00525512|454870177|FG000|Double-Blind Phase|Adverse Event|48|||
126430214|NCT00525512|454870178|FG001|Double-Blind Phase|Adverse Event|28|||
126430215|NCT00525512|454870179|FG002|Double-Blind Phase|Adverse Event|0|||
126430216|NCT00525512|454870180|FG003|Double-Blind Phase|Adverse Event|0|||
126430217|NCT00525512|454870177|FG000|Double-Blind Phase|Protocol Violation|3|||
126430218|NCT00525512|454870178|FG001|Double-Blind Phase|Protocol Violation|1|||
126430219|NCT00525512|454870179|FG002|Double-Blind Phase|Protocol Violation|0|||
126430220|NCT00525512|454870180|FG003|Double-Blind Phase|Protocol Violation|0|||
126430221|NCT00525512|454870177|FG000|Double-Blind Phase|Lost to Follow-up|3|||
126430222|NCT00525512|454870178|FG001|Double-Blind Phase|Lost to Follow-up|7|||
126430223|NCT00525512|454870179|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126430224|NCT00525512|454870180|FG003|Double-Blind Phase|Lost to Follow-up|0|||
126715143|NCT01161524|455908695|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
126343990|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343991|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343992|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343993|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343994|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343995|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343996|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343997|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126343998|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
126343999|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
126344000|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344001|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344002|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344003|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344004|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344005|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344006|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344007|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344008|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
126344009|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
126344010|NCT01232283|454554152|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344011|NCT01232283|454554153|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344012|NCT01232283|454554154|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344013|NCT01232283|454554155|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344014|NCT01232283|454554156|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344015|NCT01232283|454554157|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344016|NCT01232283|454554158|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344017|NCT01232283|454554159|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
126344018|NCT01232283|454554160|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
126344019|NCT01232283|454554161|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
126344020|NCT02792504|454554162|FG000|Overall Study|Lost to Follow-up|24|||
126344021|NCT02792504|454554162|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
126344022|NCT00848497|454554169|FG000|Overall Study|Screen failure|2|||
126344023|NCT00848497|454554170|FG001|Overall Study|Screen failure|0|||
126344024|NCT00848497|454554169|FG000|Overall Study|Withdrawal by Subject|0|||
126344025|NCT00848497|454554170|FG001|Overall Study|Withdrawal by Subject|1|||
126344026|NCT02966834|454554171|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
126344027|NCT02966834|454554172|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
126344028|NCT02966834|454554173|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
126344029|NCT02966834|454554174|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
126344030|NCT02966834|454554175|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
126344031|NCT02966834|454554176|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
126344032|NCT02966834|454554171|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
126344033|NCT02966834|454554172|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126344034|NCT02966834|454554173|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126430225|NCT00525512|454870177|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
126430226|NCT00525512|454870178|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
126430227|NCT00525512|454870179|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
126430228|NCT00525512|454870180|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
126430229|NCT00525512|454870177|FG000|Double-Blind Phase|Lack of Efficacy|13|||
126430230|NCT00525512|454870178|FG001|Double-Blind Phase|Lack of Efficacy|5|||
126430231|NCT00525512|454870179|FG002|Double-Blind Phase|Lack of Efficacy|0|||
126430232|NCT00525512|454870180|FG003|Double-Blind Phase|Lack of Efficacy|0|||
126430233|NCT00525512|454870177|FG000|Double-Blind Phase|Other reason (not specified)|12|||
126430234|NCT00525512|454870178|FG001|Double-Blind Phase|Other reason (not specified)|13|||
126430235|NCT00525512|454870179|FG002|Double-Blind Phase|Other reason (not specified)|0|||
126430236|NCT00525512|454870180|FG003|Double-Blind Phase|Other reason (not specified)|0|||
126430237|NCT00525512|454870177|FG000|Open-Label Phase|Adverse Event|0|||
126430238|NCT00525512|454870178|FG001|Open-Label Phase|Adverse Event|0|||
126430239|NCT00525512|454870179|FG002|Open-Label Phase|Adverse Event|1|||
126430240|NCT00525512|454870180|FG003|Open-Label Phase|Adverse Event|0|||
126430241|NCT00525512|454870177|FG000|Open-Label Phase|Lost to Follow-up|0|||
126430242|NCT00525512|454870178|FG001|Open-Label Phase|Lost to Follow-up|0|||
126430243|NCT00525512|454870179|FG002|Open-Label Phase|Lost to Follow-up|1|||
126430244|NCT00525512|454870180|FG003|Open-Label Phase|Lost to Follow-up|0|||
126430245|NCT00525512|454870177|FG000|Open-Label Phase|Other reason (not specified)|0|||
126430246|NCT00525512|454870178|FG001|Open-Label Phase|Other reason (not specified)|0|||
126430247|NCT00525512|454870179|FG002|Open-Label Phase|Other reason (not specified)|4|||
126430248|NCT00525512|454870180|FG003|Open-Label Phase|Other reason (not specified)|5|||
126430249|NCT00402168|454870187|FG000|Randomized|Lost to Follow-up|1|||
126430250|NCT00402168|454870188|FG001|Randomized|Lost to Follow-up|0|||
126430251|NCT00402168|454870187|FG000|Randomized|Withdrawal by Subject|0|||
126430252|NCT00402168|454870188|FG001|Randomized|Withdrawal by Subject|1|||
126430253|NCT00402168|454870187|FG000|Treatment (up to 12 Months)|Death|0|||
126430254|NCT00402168|454870188|FG001|Treatment (up to 12 Months)|Death|1|||
126430255|NCT00402168|454870187|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
126430256|NCT00402168|454870188|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
126678196|NCT04247061|455779057|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
126678197|NCT04247061|455779057|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
126678198|NCT02370615|455779062|FG000|Overall Study|Adverse Event|1|||
126678199|NCT02370615|455779063|FG001|Overall Study|Adverse Event|0|||
126678200|NCT01136655|455779064|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
126678201|NCT01136655|455779064|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
126678202|NCT01136655|455779064|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
126678203|NCT01136655|455779064|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
126678204|NCT02287623|455779065|FG000|Overall Study|Protocol Violation|0|||
126678205|NCT02287623|455779066|FG001|Overall Study|Protocol Violation|1|||
126678206|NCT01585272|455779067|FG000|Overall Study|Adverse Event|22|||
126678207|NCT01585272|455779067|FG000|Overall Study|Protocol Violation|7|||
126678208|NCT01585272|455779067|FG000|Overall Study|Withdrawal by Subject|10|||
126678209|NCT00645593|455779068|FG000|Overall Study|Later found to be ineligible|1|||
126678210|NCT00645593|455779069|FG001|Overall Study|Later found to be ineligible|0|||
126678211|NCT02577146|455779074|FG000|Overall Study|Lost to Follow-up|8|||
126678212|NCT02577146|455779074|FG000|Overall Study|Physician Decision|3|||
126678213|NCT02577146|455779074|FG000|Overall Study|Screen Failure|17|||
126678214|NCT03765138|455779075|FG000|Overall Study|Lost to Follow-up|1|||
126678215|NCT01970501|455779076|FG000|Overall Study|Discontinuation of study by sponsor|16|||
126678216|NCT01970501|455779077|FG001|Overall Study|Discontinuation of study by sponsor|14|||
126678217|NCT01970501|455779076|FG000|Overall Study|Withdrawal by Subject|6|||
126678218|NCT01970501|455779077|FG001|Overall Study|Withdrawal by Subject|7|||
126678219|NCT01970501|455779076|FG000|Overall Study|Adverse Event|2|||
126678220|NCT01970501|455779077|FG001|Overall Study|Adverse Event|4|||
126344035|NCT02966834|454554174|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126344036|NCT02966834|454554175|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126344037|NCT02966834|454554176|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126344038|NCT02966834|454554171|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
126344039|NCT02966834|454554172|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
126344040|NCT02966834|454554173|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
126344041|NCT02966834|454554174|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
126344042|NCT02966834|454554175|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
126344043|NCT02966834|454554176|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
126430257|NCT00402168|454870187|FG000|Treatment (up to 12 Months)|non-specified|0|||
126430258|NCT00402168|454870188|FG001|Treatment (up to 12 Months)|non-specified|1|||
126678221|NCT01970501|455779076|FG000|Overall Study|Death|1|||
126678222|NCT01970501|455779077|FG001|Overall Study|Death|3|||
126430259|NCT00402168|454870187|FG000|Long Term (LT)|Adverse Event|1|||
126430260|NCT00402168|454870188|FG001|Long Term (LT)|Adverse Event|5|||
126430261|NCT00402168|454870187|FG000|Long Term (LT)|Withdrawal by Subject|4|||
126430262|NCT00402168|454870188|FG001|Long Term (LT)|Withdrawal by Subject|7|||
126430263|NCT00402168|454870187|FG000|Long Term (LT)|Pregnancy|0|||
126430264|NCT00402168|454870188|FG001|Long Term (LT)|Pregnancy|1|||
126430265|NCT00402168|454870187|FG000|Long Term (LT)|Lost to Follow-up|1|||
126430266|NCT00402168|454870188|FG001|Long Term (LT)|Lost to Follow-up|0|||
126430267|NCT00402168|454870187|FG000|Long Term (LT)|Death|4|||
126430268|NCT00402168|454870188|FG001|Long Term (LT)|Death|0|||
126430269|NCT00402168|454870187|FG000|Long Term (LT)|Lack of Efficacy|0|||
126430270|NCT00402168|454870188|FG001|Long Term (LT)|Lack of Efficacy|2|||
126430271|NCT00402168|454870187|FG000|Long Term (LT)|non-specified|1|||
126430272|NCT00402168|454870188|FG001|Long Term (LT)|non-specified|2|||
126430273|NCT00402168|454870187|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
126430274|NCT00402168|454870188|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
126430275|NCT00402168|454870187|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
126430276|NCT00402168|454870188|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
126430277|NCT00301808|454870194|FG000|Overall Study|Adverse Event|5|||
126430278|NCT00301808|454870194|FG000|Overall Study|Death|3|||
126430279|NCT00301808|454870194|FG000|Overall Study|Lack of Efficacy|4|||
126430280|NCT05893862|454870198|FG000|Overall Study|Physician Decision|0|||
126430281|NCT05893862|454870199|FG001|Overall Study|Physician Decision|1|||
126430282|NCT05893862|454870200|FG002|Overall Study|Physician Decision|0|||
126430283|NCT05893862|454870201|FG003|Overall Study|Physician Decision|0|||
126430284|NCT05893862|454870202|FG004|Overall Study|Physician Decision|1|||
126430285|NCT05893862|454870203|FG005|Overall Study|Physician Decision|0|||
126430286|NCT05893862|454870198|FG000|Overall Study|Withdrawal by Subject|1|||
126430287|NCT05893862|454870199|FG001|Overall Study|Withdrawal by Subject|7|||
126430288|NCT05893862|454870200|FG002|Overall Study|Withdrawal by Subject|1|||
126430289|NCT05893862|454870201|FG003|Overall Study|Withdrawal by Subject|3|||
126430290|NCT05893862|454870202|FG004|Overall Study|Withdrawal by Subject|3|||
126430291|NCT05893862|454870203|FG005|Overall Study|Withdrawal by Subject|2|||
126430292|NCT05893862|454870198|FG000|Overall Study|Adverse Event|1|||
126430293|NCT05893862|454870199|FG001|Overall Study|Adverse Event|4|||
126430294|NCT05893862|454870200|FG002|Overall Study|Adverse Event|2|||
126430295|NCT05893862|454870201|FG003|Overall Study|Adverse Event|2|||
126430296|NCT05893862|454870202|FG004|Overall Study|Adverse Event|1|||
126430297|NCT05893862|454870203|FG005|Overall Study|Adverse Event|0|||
126430298|NCT02429830|454870204|FG000|Overall Study|Lost to Follow-up|1|||
126430299|NCT02429830|454870204|FG000|Overall Study|Device Explant|2|||
126430300|NCT03346434|454871852|FG000|Overall Study|Randomized in Error|0|||
126430301|NCT03346434|454871853|FG001|Overall Study|Randomized in Error|0|||
126678223|NCT01970501|455779076|FG000|Overall Study|Physician Decision|2|||
126678224|NCT01970501|455779077|FG001|Overall Study|Physician Decision|0|||
126678225|NCT03803059|455779079|FG000|Overall Study|Protocol Violation|2|||
126678226|NCT03803059|455779079|FG000|Overall Study|Lost to Follow-up|1|||
126678227|NCT02116777|455779080|FG000|Overall Study|Adverse Event|0|||
126678228|NCT02116777|455779081|FG001|Overall Study|Adverse Event|0|||
126678229|NCT02116777|455779082|FG002|Overall Study|Adverse Event|0|||
126678230|NCT02116777|455779083|FG003|Overall Study|Adverse Event|0|||
126678231|NCT02116777|455779084|FG004|Overall Study|Adverse Event|2|||
126678232|NCT02116777|455779085|FG005|Overall Study|Adverse Event|2|||
126678233|NCT02116777|455779086|FG006|Overall Study|Adverse Event|0|||
126678234|NCT02116777|455779080|FG000|Overall Study|Death|0|||
126678235|NCT02116777|455779081|FG001|Overall Study|Death|0|||
126678236|NCT02116777|455779082|FG002|Overall Study|Death|0|||
126678237|NCT02116777|455779083|FG003|Overall Study|Death|1|||
126344044|NCT02966834|454554171|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
126344045|NCT02966834|454554172|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
126344046|NCT02966834|454554173|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
126344047|NCT02966834|454554174|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
126344048|NCT02966834|454554175|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
126344049|NCT02966834|454554176|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
126344050|NCT02966834|454554171|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126344051|NCT02966834|454554172|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126344052|NCT02966834|454554173|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126344053|NCT02966834|454554174|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
126344054|NCT02966834|454554175|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126344055|NCT02966834|454554176|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126344056|NCT02966834|454554171|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
126344057|NCT02966834|454554172|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
126344058|NCT02966834|454554173|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
126678238|NCT02116777|455779084|FG004|Overall Study|Death|0|||
126678239|NCT02116777|455779085|FG005|Overall Study|Death|0|||
126678240|NCT02116777|455779086|FG006|Overall Study|Death|0|||
126678241|NCT02116777|455779080|FG000|Overall Study|Lack of Efficacy|3|||
126678242|NCT02116777|455779081|FG001|Overall Study|Lack of Efficacy|3|||
126344059|NCT02966834|454554174|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
126344060|NCT02966834|454554175|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
126678243|NCT02116777|455779082|FG002|Overall Study|Lack of Efficacy|3|||
126678244|NCT02116777|455779083|FG003|Overall Study|Lack of Efficacy|8|||
126678245|NCT02116777|455779084|FG004|Overall Study|Lack of Efficacy|4|||
126678246|NCT02116777|455779085|FG005|Overall Study|Lack of Efficacy|1|||
126678247|NCT02116777|455779086|FG006|Overall Study|Lack of Efficacy|9|||
126678248|NCT02116777|455779080|FG000|Overall Study|Physician Decision|0|||
126678249|NCT02116777|455779081|FG001|Overall Study|Physician Decision|0|||
126678250|NCT02116777|455779082|FG002|Overall Study|Physician Decision|0|||
126678251|NCT02116777|455779083|FG003|Overall Study|Physician Decision|2|||
126678252|NCT02116777|455779084|FG004|Overall Study|Physician Decision|0|||
126678253|NCT02116777|455779085|FG005|Overall Study|Physician Decision|0|||
126678254|NCT02116777|455779086|FG006|Overall Study|Physician Decision|0|||
126678255|NCT02116777|455779080|FG000|Overall Study|Protocol Violation|0|||
126678256|NCT02116777|455779081|FG001|Overall Study|Protocol Violation|0|||
126678257|NCT02116777|455779082|FG002|Overall Study|Protocol Violation|0|||
126678258|NCT02116777|455779083|FG003|Overall Study|Protocol Violation|1|||
126678259|NCT02116777|455779084|FG004|Overall Study|Protocol Violation|0|||
126678260|NCT02116777|455779085|FG005|Overall Study|Protocol Violation|0|||
126678261|NCT02116777|455779086|FG006|Overall Study|Protocol Violation|0|||
126678262|NCT02116777|455779080|FG000|Overall Study|Withdrawal by Subject|0|||
126678263|NCT02116777|455779081|FG001|Overall Study|Withdrawal by Subject|0|||
126678264|NCT02116777|455779082|FG002|Overall Study|Withdrawal by Subject|0|||
126678265|NCT02116777|455779083|FG003|Overall Study|Withdrawal by Subject|1|||
126678266|NCT02116777|455779084|FG004|Overall Study|Withdrawal by Subject|0|||
126678267|NCT02116777|455779085|FG005|Overall Study|Withdrawal by Subject|0|||
126678268|NCT02116777|455779086|FG006|Overall Study|Withdrawal by Subject|0|||
126678269|NCT00102960|455779087|FG000|Overall Study|Death|23|||
126678270|NCT00102960|455779088|FG001|Overall Study|Death|11|||
126678271|NCT00102960|455779089|FG002|Overall Study|Death|11|||
126678272|NCT00102960|455779087|FG000|Overall Study|Lost to Follow-up|6|||
126678273|NCT00102960|455779088|FG001|Overall Study|Lost to Follow-up|12|||
126678274|NCT00102960|455779089|FG002|Overall Study|Lost to Follow-up|16|||
126678275|NCT00102960|455779087|FG000|Overall Study|Withdrawal by Subject|1|||
126678276|NCT00102960|455779088|FG001|Overall Study|Withdrawal by Subject|0|||
126678277|NCT00102960|455779089|FG002|Overall Study|Withdrawal by Subject|1|||
126678278|NCT00980200|455780528|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
126678279|NCT00980200|455780529|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
126678280|NCT00980200|455780530|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
126678281|NCT00980200|455780531|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
126678282|NCT00980200|455780532|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
126678283|NCT00980200|455780528|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
126678284|NCT00980200|455780529|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
126678285|NCT00980200|455780530|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
126678286|NCT00980200|455780531|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
126678287|NCT00980200|455780532|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
126678288|NCT00457015|455780533|FG000|Overall Study|Left study site against medical advice|0|||
126678289|NCT00457015|455780534|FG001|Overall Study|Left study site against medical advice|1|||
126678290|NCT02257372|455780537|FG000|Overall Study|Adverse Event|3|||
126678291|NCT02257372|455780538|FG001|Overall Study|Adverse Event|7|||
126678292|NCT02257372|455780537|FG000|Overall Study|Lack of Efficacy|2|||
126678293|NCT02257372|455780538|FG001|Overall Study|Lack of Efficacy|1|||
126678294|NCT02257372|455780537|FG000|Overall Study|Protocol Violation|1|||
126678295|NCT02257372|455780538|FG001|Overall Study|Protocol Violation|1|||
126678296|NCT02257372|455780537|FG000|Overall Study|Lost to Follow-up|0|||
126678297|NCT02257372|455780538|FG001|Overall Study|Lost to Follow-up|1|||
126430302|NCT03346434|454871854|FG002|Overall Study|Randomized in Error|0|||
126430303|NCT03346434|454871855|FG003|Overall Study|Randomized in Error|0|||
126430304|NCT03346434|454871856|FG004|Overall Study|Randomized in Error|1|||
126430305|NCT03346434|454871857|FG005|Overall Study|Randomized in Error|0|||
126430306|NCT03346434|454871852|FG000|Overall Study|Withdrawal by Subject|0|||
126430307|NCT03346434|454871853|FG001|Overall Study|Withdrawal by Subject|0|||
126430308|NCT03346434|454871854|FG002|Overall Study|Withdrawal by Subject|1|||
126430309|NCT03346434|454871855|FG003|Overall Study|Withdrawal by Subject|0|||
126678298|NCT02257372|455780537|FG000|Overall Study|Withdrew consent|1|||
126678299|NCT02257372|455780538|FG001|Overall Study|Withdrew consent|0|||
126678300|NCT01135498|455780540|FG000|Overall Study|Adverse Event|20|||
126678301|NCT01135498|455780540|FG000|Overall Study|Progressive disease|38|||
126678302|NCT01135498|455780540|FG000|Overall Study|Investigator judgement|25|||
126678303|NCT01135498|455780540|FG000|Overall Study|Withdrawal by Subject|4|||
126678304|NCT01135498|455780540|FG000|Overall Study|Death|1|||
126678305|NCT01135498|455780540|FG000|Overall Study|Ongoing at time of analysis|2|||
126678306|NCT02104583|455780541|FG000|Overall Study|New ICD or CRT-D implanted|2|||
126678307|NCT02104583|455780542|FG001|Overall Study|New ICD or CRT-D implanted|0|||
126678308|NCT02104583|455780543|FG002|Overall Study|New ICD or CRT-D implanted|1|||
126678309|NCT02104583|455780544|FG003|Overall Study|New ICD or CRT-D implanted|0|||
126678310|NCT02104583|455780545|FG004|Overall Study|New ICD or CRT-D implanted|0|||
126430310|NCT03346434|454871856|FG004|Overall Study|Withdrawal by Subject|1|||
126678311|NCT02104583|455780541|FG000|Overall Study|Death|2|||
126678312|NCT02104583|455780542|FG001|Overall Study|Death|1|||
126678313|NCT02104583|455780543|FG002|Overall Study|Death|3|||
126678314|NCT02104583|455780544|FG003|Overall Study|Death|3|||
126678315|NCT02104583|455780545|FG004|Overall Study|Death|5|||
126678316|NCT02104583|455780541|FG000|Overall Study|Subject required cardiac ablation|6|||
126678317|NCT02104583|455780542|FG001|Overall Study|Subject required cardiac ablation|4|||
126678318|NCT02104583|455780543|FG002|Overall Study|Subject required cardiac ablation|4|||
126678319|NCT02104583|455780544|FG003|Overall Study|Subject required cardiac ablation|5|||
126678320|NCT02104583|455780545|FG004|Overall Study|Subject required cardiac ablation|4|||
126678321|NCT02104583|455780541|FG000|Overall Study|Subject required prohibited medication|0|||
126678322|NCT02104583|455780542|FG001|Overall Study|Subject required prohibited medication|1|||
126678323|NCT02104583|455780543|FG002|Overall Study|Subject required prohibited medication|1|||
126678324|NCT02104583|455780544|FG003|Overall Study|Subject required prohibited medication|0|||
126678325|NCT02104583|455780545|FG004|Overall Study|Subject required prohibited medication|1|||
126678326|NCT02104583|455780541|FG000|Overall Study|Withdrew Consent|3|||
126678327|NCT02104583|455780542|FG001|Overall Study|Withdrew Consent|2|||
126678328|NCT02104583|455780543|FG002|Overall Study|Withdrew Consent|0|||
126678329|NCT02104583|455780544|FG003|Overall Study|Withdrew Consent|2|||
126678330|NCT02104583|455780545|FG004|Overall Study|Withdrew Consent|1|||
126678331|NCT02104583|455780541|FG000|Overall Study|Investigator's Discretion|1|||
126678332|NCT02104583|455780542|FG001|Overall Study|Investigator's Discretion|0|||
126678333|NCT02104583|455780543|FG002|Overall Study|Investigator's Discretion|0|||
126678334|NCT02104583|455780544|FG003|Overall Study|Investigator's Discretion|0|||
126678335|NCT02104583|455780545|FG004|Overall Study|Investigator's Discretion|0|||
126678336|NCT02104583|455780541|FG000|Overall Study|Protocol Violation|0|||
126678337|NCT02104583|455780542|FG001|Overall Study|Protocol Violation|0|||
126678338|NCT02104583|455780543|FG002|Overall Study|Protocol Violation|1|||
126678339|NCT02104583|455780544|FG003|Overall Study|Protocol Violation|0|||
126678340|NCT02104583|455780545|FG004|Overall Study|Protocol Violation|0|||
126678341|NCT02104583|455780541|FG000|Overall Study|Adverse Event|3|||
126678342|NCT02104583|455780542|FG001|Overall Study|Adverse Event|3|||
126678343|NCT02104583|455780543|FG002|Overall Study|Adverse Event|6|||
126678344|NCT02104583|455780544|FG003|Overall Study|Adverse Event|6|||
126678345|NCT02104583|455780545|FG004|Overall Study|Adverse Event|1|||
126678346|NCT02104583|455780541|FG000|Overall Study|Lost to Follow-up|1|||
126678347|NCT02104583|455780542|FG001|Overall Study|Lost to Follow-up|0|||
126678348|NCT02104583|455780543|FG002|Overall Study|Lost to Follow-up|0|||
126678349|NCT02104583|455780544|FG003|Overall Study|Lost to Follow-up|0|||
126678350|NCT02104583|455780545|FG004|Overall Study|Lost to Follow-up|0|||
126678351|NCT02104583|455780541|FG000|Overall Study|Randomized but Never Treated|0|||
126678352|NCT02104583|455780542|FG001|Overall Study|Randomized but Never Treated|0|||
126678353|NCT02104583|455780543|FG002|Overall Study|Randomized but Never Treated|0|||
126678354|NCT02104583|455780544|FG003|Overall Study|Randomized but Never Treated|1|||
126678355|NCT02104583|455780545|FG004|Overall Study|Randomized but Never Treated|0|||
126678356|NCT02830880|455780547|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
126678357|NCT02830880|455780547|FG000|Overall Study|Death|1|||
126678358|NCT02830880|455780547|FG000|Overall Study|Physician Decision|1|||
126678359|NCT03551509|455780556|FG000|Overall Study|Lost to Follow-up|0|||
126344061|NCT02966834|454554176|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
126344062|NCT00094445|454554178|FG000|Overall Study|Withdrawal by Subject|3|||
126344063|NCT00094445|454554178|FG000|Overall Study|Lost to Follow-up|1|||
126344064|NCT00094445|454554178|FG000|Overall Study|Progressive Disease|2|||
126344065|NCT00769561|454554179|FG000|Overall Study|Withdrawal by Subject|2|||
126344066|NCT00769561|454554180|FG001|Overall Study|Withdrawal by Subject|2|||
126678360|NCT03551509|455780557|FG001|Overall Study|Lost to Follow-up|1|||
126344067|NCT00769561|454554179|FG000|Overall Study|Lost to Follow-up|1|||
126344068|NCT00769561|454554180|FG001|Overall Study|Lost to Follow-up|3|||
126344069|NCT01773928|454554181|FG000|Overall Study|Adverse Event|0|||
126344070|NCT01773928|454554182|FG001|Overall Study|Adverse Event|0|||
126344071|NCT01773928|454554183|FG002|Overall Study|Adverse Event|0|||
126344072|NCT01773928|454554184|FG003|Overall Study|Adverse Event|0|||
126344073|NCT01773928|454554185|FG004|Overall Study|Adverse Event|0|||
126678361|NCT03551509|455780558|FG002|Overall Study|Lost to Follow-up|0|||
126678362|NCT01918007|455780564|FG000|Overall Study|Baseline oximetry not acceptable|11|||
126678363|NCT01918007|455780565|FG001|Overall Study|Baseline oximetry not acceptable|7|||
126678364|NCT01918007|455780564|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
126344074|NCT01773928|454554186|FG005|Overall Study|Adverse Event|0|||
126678365|NCT01918007|455780565|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
126678366|NCT01918007|455780564|FG000|Overall Study|Lost to Follow-up|4|||
126678367|NCT01918007|455780565|FG001|Overall Study|Lost to Follow-up|7|||
126678368|NCT00960661|455780569|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
126678369|NCT00960661|455780570|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
126678370|NCT00960661|455780571|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
126678371|NCT00960661|455780569|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
126344075|NCT01773928|454554187|FG006|Overall Study|Adverse Event|0|||
126344076|NCT01773928|454554188|FG007|Overall Study|Adverse Event|1|||
126344077|NCT01773928|454554189|FG008|Overall Study|Adverse Event|0|||
126430311|NCT03346434|454871857|FG005|Overall Study|Withdrawal by Subject|0|||
126430312|NCT03346434|454871852|FG000|Overall Study|Lost to Follow-up|0|||
126430313|NCT03346434|454871853|FG001|Overall Study|Lost to Follow-up|0|||
126430314|NCT03346434|454871854|FG002|Overall Study|Lost to Follow-up|0|||
126430315|NCT03346434|454871855|FG003|Overall Study|Lost to Follow-up|0|||
126430316|NCT03346434|454871856|FG004|Overall Study|Lost to Follow-up|1|||
126430317|NCT03346434|454871857|FG005|Overall Study|Lost to Follow-up|1|||
126430318|NCT03346434|454871852|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
126430319|NCT03346434|454871853|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
126430320|NCT03346434|454871854|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
126430321|NCT03346434|454871855|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
126430322|NCT03346434|454871856|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
126430323|NCT03346434|454871857|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
126430324|NCT01419236|454871861|FG000|Overall Study|Adverse Event|1|||
126430325|NCT01419236|454871862|FG001|Overall Study|Adverse Event|0|||
126430326|NCT01419236|454871861|FG000|Overall Study|Lack of Efficacy|0|||
126430327|NCT01419236|454871862|FG001|Overall Study|Lack of Efficacy|1|||
126430328|NCT01419236|454871861|FG000|Overall Study|Lost to Follow-up|1|||
126430329|NCT01419236|454871862|FG001|Overall Study|Lost to Follow-up|0|||
126430330|NCT01419236|454871861|FG000|Overall Study|Physician Decision|1|||
126430331|NCT01419236|454871862|FG001|Overall Study|Physician Decision|0|||
126430332|NCT01419236|454871861|FG000|Overall Study|Withdrawal by Subject|1|||
126430333|NCT01419236|454871862|FG001|Overall Study|Withdrawal by Subject|4|||
126430334|NCT01419236|454871861|FG000|Overall Study|Entry Criteria Not Met|1|||
126430335|NCT01419236|454871862|FG001|Overall Study|Entry Criteria Not Met|0|||
126430336|NCT00762359|454871869|FG000|Overall Study|Adverse Event|20|||
126430337|NCT00762359|454871870|FG001|Overall Study|Adverse Event|23|||
126430338|NCT00762359|454871869|FG000|Overall Study|Protocol Violation|21|||
126430339|NCT00762359|454871870|FG001|Overall Study|Protocol Violation|13|||
126430340|NCT00762359|454871869|FG000|Overall Study|Withdrawal by Subject|13|||
126430341|NCT00762359|454871870|FG001|Overall Study|Withdrawal by Subject|10|||
126430342|NCT00762359|454871869|FG000|Overall Study|Lack of Efficacy|0|||
126430343|NCT00762359|454871870|FG001|Overall Study|Lack of Efficacy|4|||
126430344|NCT00762359|454871869|FG000|Overall Study|Institution closed|2|||
126430345|NCT00762359|454871870|FG001|Overall Study|Institution closed|3|||
126430346|NCT00762359|454871869|FG000|Overall Study|Physician Decision|2|||
126430347|NCT00762359|454871870|FG001|Overall Study|Physician Decision|3|||
126430348|NCT00762359|454871869|FG000|Overall Study|Removal|0|||
126430349|NCT00762359|454871870|FG001|Overall Study|Removal|1|||
126430350|NCT00762359|454871869|FG000|Overall Study|Withdrew consent|1|||
126430351|NCT00762359|454871870|FG001|Overall Study|Withdrew consent|0|||
126678372|NCT00960661|455780570|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
126678373|NCT00960661|455780571|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
126678374|NCT00960661|455780569|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
126678375|NCT00960661|455780570|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
126678376|NCT00960661|455780571|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
126678377|NCT00960661|455780569|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
126678378|NCT00960661|455780570|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
126678379|NCT00960661|455780571|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
126678380|NCT00960661|455780569|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
126678381|NCT00960661|455780570|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
126678382|NCT00960661|455780571|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
126678383|NCT00960661|455780569|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
126678384|NCT00960661|455780570|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
126678385|NCT00960661|455780571|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
126678386|NCT00960661|455780569|FG000|Interventional Phase|Adverse Event|0|||
126678387|NCT00960661|455780570|FG001|Interventional Phase|Adverse Event|17|||
126678388|NCT00960661|455780571|FG002|Interventional Phase|Adverse Event|8|||
126678389|NCT00960661|455780569|FG000|Interventional Phase|Death|0|||
126678390|NCT00960661|455780570|FG001|Interventional Phase|Death|1|||
126678391|NCT00960661|455780571|FG002|Interventional Phase|Death|0|||
126678392|NCT00960661|455780569|FG000|Interventional Phase|Lost to Follow-up|0|||
126678393|NCT00960661|455780570|FG001|Interventional Phase|Lost to Follow-up|0|||
126678394|NCT00960661|455780571|FG002|Interventional Phase|Lost to Follow-up|2|||
126430352|NCT01453049|454871871|FG000|Overall Study|Protocol Violation|2|||
126430353|NCT01453049|454871872|FG001|Overall Study|Protocol Violation|5|||
126430354|NCT01453049|454871871|FG000|Overall Study|Lost to Follow-up|2|||
126430355|NCT01453049|454871872|FG001|Overall Study|Lost to Follow-up|1|||
126430356|NCT01453049|454871871|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
126430357|NCT01453049|454871872|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
126430358|NCT01453049|454871871|FG000|Overall Study|Withdrawal by Subject|1|||
126430359|NCT01453049|454871872|FG001|Overall Study|Withdrawal by Subject|0|||
126678395|NCT00960661|455780569|FG000|Interventional Phase|entry criteria not met|0|||
126678396|NCT00960661|455780570|FG001|Interventional Phase|entry criteria not met|3|||
126678397|NCT00960661|455780571|FG002|Interventional Phase|entry criteria not met|0|||
126678398|NCT00960661|455780569|FG000|Interventional Phase|Protocol Violation|0|||
126678399|NCT00960661|455780570|FG001|Interventional Phase|Protocol Violation|7|||
126678400|NCT00960661|455780571|FG002|Interventional Phase|Protocol Violation|2|||
126678401|NCT00960661|455780569|FG000|Interventional Phase|Withdrawal by Subject|0|||
126678402|NCT00960661|455780570|FG001|Interventional Phase|Withdrawal by Subject|18|||
126678403|NCT00960661|455780571|FG002|Interventional Phase|Withdrawal by Subject|29|||
126678404|NCT00960661|455780569|FG000|Interventional Phase|Physician Decision|0|||
126678405|NCT00960661|455780570|FG001|Interventional Phase|Physician Decision|3|||
126678406|NCT00960661|455780571|FG002|Interventional Phase|Physician Decision|5|||
126678407|NCT00960661|455780569|FG000|Interventional Phase|sponsor decision|0|||
126678408|NCT00960661|455780570|FG001|Interventional Phase|sponsor decision|1|||
126678409|NCT00960661|455780571|FG002|Interventional Phase|sponsor decision|0|||
126678410|NCT00960661|455780569|FG000|Interventional Phase|Lack of Efficacy|0|||
126678411|NCT00960661|455780570|FG001|Interventional Phase|Lack of Efficacy|2|||
126678412|NCT00960661|455780571|FG002|Interventional Phase|Lack of Efficacy|0|||
126678413|NCT02699892|455780572|FG000|Overall Study|Other|36|||
126678414|NCT00530270|455780579|FG000|Overall Study|Protocol Violation|1|||
126678415|NCT00530270|455780580|FG001|Overall Study|Protocol Violation|0|||
126678416|NCT01399788|455780587|FG000|First Intervention Period|Adverse Event|1|||
126678417|NCT01399788|455780588|FG001|First Intervention Period|Adverse Event|0|||
126678418|NCT02919436|455780590|FG000|Overall Study|Did not undergo surgery|16|||
126678419|NCT02919436|455780591|FG001|Overall Study|Did not undergo surgery|20|||
126678420|NCT02919436|455780590|FG000|Overall Study|Enrolled before trial registration|44|||
126678421|NCT02919436|455780591|FG001|Overall Study|Enrolled before trial registration|33|||
126678422|NCT03699007|455780592|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
126678423|NCT03699007|455780593|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
126678424|NCT03699007|455780592|FG000|6-month Follow Up|Lost to Follow-up|2|||
126678425|NCT03699007|455780593|FG001|6-month Follow Up|Lost to Follow-up|3|||
126678426|NCT04718974|455780596|FG000|Overall Study|Death|0|||
126678427|NCT04718974|455780597|FG001|Overall Study|Death|2|||
126678428|NCT04718974|455780596|FG000|Overall Study|Lost to Follow-up|10|||
126678429|NCT04718974|455780597|FG001|Overall Study|Lost to Follow-up|20|||
126678430|NCT04718974|455780596|FG000|Overall Study|Transferred out|2|||
126678431|NCT04718974|455780597|FG001|Overall Study|Transferred out|4|||
126678432|NCT03259074|455780598|FG000|Overall Study|Adverse Event|9|||
126678433|NCT03259074|455780599|FG001|Overall Study|Adverse Event|12|||
126678434|NCT03259074|455780600|FG002|Overall Study|Adverse Event|8|||
126678435|NCT03259074|455780598|FG000|Overall Study|Death|1|||
126678436|NCT03259074|455780599|FG001|Overall Study|Death|1|||
126678437|NCT03259074|455780600|FG002|Overall Study|Death|3|||
126678438|NCT03259074|455780598|FG000|Overall Study|Lost to Follow-up|2|||
126678439|NCT03259074|455780599|FG001|Overall Study|Lost to Follow-up|4|||
126678440|NCT03259074|455780600|FG002|Overall Study|Lost to Follow-up|3|||
126678441|NCT03259074|455780598|FG000|Overall Study|New Therapy For Study Indication|1|||
126678442|NCT03259074|455780599|FG001|Overall Study|New Therapy For Study Indication|2|||
126678443|NCT03259074|455780600|FG002|Overall Study|New Therapy For Study Indication|2|||
126678444|NCT03259074|455780598|FG000|Overall Study|Physician Decision|4|||
126678445|NCT03259074|455780599|FG001|Overall Study|Physician Decision|12|||
126678446|NCT03259074|455780600|FG002|Overall Study|Physician Decision|10|||
126678447|NCT03259074|455780598|FG000|Overall Study|Pregnancy|1|||
126678448|NCT03259074|455780599|FG001|Overall Study|Pregnancy|1|||
126678449|NCT03259074|455780600|FG002|Overall Study|Pregnancy|0|||
126678450|NCT03259074|455780598|FG000|Overall Study|Progressive Disease|1|||
126678451|NCT03259074|455780599|FG001|Overall Study|Progressive Disease|0|||
126678452|NCT03259074|455780600|FG002|Overall Study|Progressive Disease|0|||
126678453|NCT03259074|455780598|FG000|Overall Study|Protocol Deviation|1|||
126678454|NCT03259074|455780599|FG001|Overall Study|Protocol Deviation|1|||
126678455|NCT03259074|455780600|FG002|Overall Study|Protocol Deviation|3|||
126678456|NCT03259074|455780598|FG000|Overall Study|Subject/Guardian Decision|13|||
126678457|NCT03259074|455780599|FG001|Overall Study|Subject/Guardian Decision|16|||
126678458|NCT03259074|455780600|FG002|Overall Study|Subject/Guardian Decision|14|||
126678459|NCT01780662|455780601|FG000|Overall Study|Adverse Event|1|||
126678460|NCT01780662|455780602|FG001|Overall Study|Adverse Event|0|||
126678461|NCT01780662|455780603|FG002|Overall Study|Adverse Event|2|||
126678462|NCT01780662|455780601|FG000|Overall Study|Physician Decision|0|||
126678463|NCT01780662|455780602|FG001|Overall Study|Physician Decision|5|||
126678464|NCT01780662|455780603|FG002|Overall Study|Physician Decision|7|||
126678465|NCT01780662|455780601|FG000|Overall Study|Protocol Violation|0|||
126678466|NCT01780662|455780602|FG001|Overall Study|Protocol Violation|1|||
126678467|NCT01780662|455780603|FG002|Overall Study|Protocol Violation|0|||
126678468|NCT01780662|455780601|FG000|Overall Study|Ineligible|0|||
126678469|NCT01780662|455780602|FG001|Overall Study|Ineligible|0|||
126678470|NCT01780662|455780603|FG002|Overall Study|Ineligible|1|||
126678471|NCT00183274|455780604|FG000|Phase 1: Open-Label|Adverse Event|31|||
126678472|NCT00183274|455780605|FG001|Phase 1: Open-Label|Adverse Event|0|||
126678473|NCT00183274|455780606|FG002|Phase 1: Open-Label|Adverse Event|0|||
126678474|NCT00183274|455780607|FG003|Phase 1: Open-Label|Adverse Event|0|||
126678475|NCT00183274|455780608|FG004|Phase 1: Open-Label|Adverse Event|0|||
126678476|NCT00183274|455780609|FG005|Phase 1: Open-Label|Adverse Event|0|||
126678477|NCT00183274|455780604|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
126678478|NCT00183274|455780605|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
126678479|NCT00183274|455780606|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
126678480|NCT00183274|455780607|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
126678481|NCT00183274|455780608|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
126678482|NCT00183274|455780609|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
126678483|NCT00183274|455780604|FG000|Phase 1: Open-Label|Protocol Violation|11|||
126678484|NCT00183274|455780605|FG001|Phase 1: Open-Label|Protocol Violation|0|||
126678485|NCT00183274|455780606|FG002|Phase 1: Open-Label|Protocol Violation|0|||
126678486|NCT00183274|455780607|FG003|Phase 1: Open-Label|Protocol Violation|0|||
126678487|NCT00183274|455780608|FG004|Phase 1: Open-Label|Protocol Violation|0|||
126678488|NCT00183274|455780609|FG005|Phase 1: Open-Label|Protocol Violation|0|||
126678489|NCT00183274|455780604|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
126678490|NCT00183274|455780605|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
126678491|NCT00183274|455780606|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
126678492|NCT00183274|455780607|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
126678493|NCT00183274|455780608|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
126678494|NCT00183274|455780609|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
126678495|NCT00183274|455780604|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
126678496|NCT00183274|455780605|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
126678497|NCT00183274|455780606|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
126678498|NCT00183274|455780607|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
126678499|NCT00183274|455780608|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
126678500|NCT00183274|455780609|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
126678501|NCT00183274|455780604|FG000|Phase 1: Open-Label|Other|9|||
126678502|NCT00183274|455780605|FG001|Phase 1: Open-Label|Other|0|||
126678503|NCT00183274|455780606|FG002|Phase 1: Open-Label|Other|0|||
126678504|NCT00183274|455780607|FG003|Phase 1: Open-Label|Other|0|||
126678505|NCT00183274|455780608|FG004|Phase 1: Open-Label|Other|0|||
126678506|NCT00183274|455780609|FG005|Phase 1: Open-Label|Other|0|||
126678507|NCT00183274|455780604|FG000|Phase 2: Double-Blind|Relapsed|0|||
126678508|NCT00183274|455780605|FG001|Phase 2: Double-Blind|Relapsed|8|||
126678509|NCT00183274|455780606|FG002|Phase 2: Double-Blind|Relapsed|29|||
126678510|NCT00183274|455780607|FG003|Phase 2: Double-Blind|Relapsed|0|||
126678511|NCT00183274|455780608|FG004|Phase 2: Double-Blind|Relapsed|0|||
126678512|NCT00183274|455780609|FG005|Phase 2: Double-Blind|Relapsed|0|||
126678513|NCT00183274|455780604|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
126678514|NCT00183274|455780605|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
126678515|NCT00183274|455780606|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
126678516|NCT00183274|455780607|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
126678517|NCT00183274|455780608|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
126678518|NCT00183274|455780609|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
126678519|NCT00183274|455780604|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
126678520|NCT00183274|455780605|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
126678521|NCT00183274|455780606|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
126430360|NCT01453049|454871871|FG000|Overall Study|Randomized in Error|1|||
126430361|NCT01453049|454871872|FG001|Overall Study|Randomized in Error|0|||
126430362|NCT00882440|454871873|FG000|Overall Study|Adverse Event|2|||
126430363|NCT00882440|454871874|FG001|Overall Study|Adverse Event|2|||
126430364|NCT00882440|454871875|FG002|Overall Study|Adverse Event|2|||
126430365|NCT00882440|454871876|FG003|Overall Study|Adverse Event|1|||
126430366|NCT00882440|454871877|FG004|Overall Study|Adverse Event|1|||
126430367|NCT00882440|454871878|FG005|Overall Study|Adverse Event|4|||
126678522|NCT00183274|455780607|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
126678523|NCT00183274|455780608|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
126678524|NCT00183274|455780609|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
126678525|NCT00183274|455780604|FG000|Phase 3: Double-Blind|Relapsed|0|||
126678526|NCT00183274|455780605|FG001|Phase 3: Double-Blind|Relapsed|0|||
126678527|NCT00183274|455780606|FG002|Phase 3: Double-Blind|Relapsed|0|||
126678528|NCT00183274|455780607|FG003|Phase 3: Double-Blind|Relapsed|1|||
126678529|NCT00183274|455780608|FG004|Phase 3: Double-Blind|Relapsed|11|||
126678530|NCT00183274|455780609|FG005|Phase 3: Double-Blind|Relapsed|2|||
126678531|NCT02409290|455780610|FG000|Overall Study|Protocol Violation|3|||
126678532|NCT02409290|455780611|FG001|Overall Study|Protocol Violation|6|||
126678533|NCT02409290|455780612|FG002|Overall Study|Protocol Violation|9|||
126678534|NCT02409290|455780613|FG003|Overall Study|Protocol Violation|4|||
126430368|NCT00882440|454871879|FG006|Overall Study|Adverse Event|2|||
126430369|NCT00882440|454871873|FG000|Overall Study|Lack of Efficacy|3|||
126678535|NCT02409290|455780610|FG000|Overall Study|No positive culture/no baseline sample|3|||
126678536|NCT02409290|455780611|FG001|Overall Study|No positive culture/no baseline sample|9|||
126678537|NCT02409290|455780612|FG002|Overall Study|No positive culture/no baseline sample|6|||
126678538|NCT02409290|455780613|FG003|Overall Study|No positive culture/no baseline sample|5|||
126678539|NCT02409290|455780610|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
126430370|NCT00882440|454871874|FG001|Overall Study|Lack of Efficacy|5|||
126430371|NCT00882440|454871875|FG002|Overall Study|Lack of Efficacy|2|||
126678540|NCT02409290|455780611|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
126678541|NCT02409290|455780612|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
126678542|NCT02409290|455780613|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
126678543|NCT00708500|455780614|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
126678544|NCT00708500|455780615|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
126678545|NCT00708500|455780616|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
126430372|NCT00882440|454871876|FG003|Overall Study|Lack of Efficacy|0|||
126430373|NCT00882440|454871877|FG004|Overall Study|Lack of Efficacy|0|||
126678546|NCT00708500|455780614|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
126678547|NCT00708500|455780615|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
126678548|NCT00708500|455780616|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
126678549|NCT00708500|455780614|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
126678550|NCT00708500|455780615|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
126430374|NCT00882440|454871878|FG005|Overall Study|Lack of Efficacy|3|||
126430375|NCT00882440|454871879|FG006|Overall Study|Lack of Efficacy|0|||
126430376|NCT00882440|454871873|FG000|Overall Study|Lost to Follow-up|2|||
126430377|NCT00882440|454871874|FG001|Overall Study|Lost to Follow-up|0|||
126678551|NCT00708500|455780616|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
126678552|NCT00708500|455780614|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
126678553|NCT00708500|455780615|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
126678554|NCT00708500|455780616|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
126678555|NCT00708500|455780614|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
126678556|NCT00708500|455780615|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
126678557|NCT00708500|455780616|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
126678558|NCT00708500|455780614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
126678559|NCT00708500|455780615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
126678560|NCT00708500|455780616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
126678561|NCT00708500|455780614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
126678562|NCT00708500|455780615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
126678563|NCT00708500|455780616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
126678564|NCT00708500|455780614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
126678565|NCT00708500|455780615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
126678566|NCT00708500|455780616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
126678567|NCT00708500|455780614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
126678568|NCT00708500|455780615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
126678569|NCT00708500|455780616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
126678570|NCT00708500|455780614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
126678571|NCT00708500|455780615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
126678572|NCT00708500|455780616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
126678573|NCT00708500|455780614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
126678574|NCT00708500|455780615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
126678575|NCT00708500|455780616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
126678576|NCT00708500|455780614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
126678577|NCT00708500|455780615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
126678578|NCT00708500|455780616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
126678579|NCT00708500|455780614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
126678580|NCT00708500|455780615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
126678581|NCT00708500|455780616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
126678582|NCT00708500|455780614|FG000|FOLLOWUP|Adverse Event|0|||
126678583|NCT00708500|455780615|FG001|FOLLOWUP|Adverse Event|1|||
126678584|NCT00708500|455780616|FG002|FOLLOWUP|Adverse Event|0|||
126758635|NCT02681094|456066667|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
126344078|NCT01773928|454554181|FG000|Overall Study|Physician Decision|0|||
126344079|NCT01773928|454554182|FG001|Overall Study|Physician Decision|0|||
126344080|NCT01773928|454554183|FG002|Overall Study|Physician Decision|0|||
126344081|NCT01773928|454554184|FG003|Overall Study|Physician Decision|1|||
126344082|NCT01773928|454554185|FG004|Overall Study|Physician Decision|0|||
126344083|NCT01773928|454554186|FG005|Overall Study|Physician Decision|0|||
126344084|NCT01773928|454554187|FG006|Overall Study|Physician Decision|0|||
126344085|NCT01773928|454554188|FG007|Overall Study|Physician Decision|0|||
126344086|NCT01773928|454554189|FG008|Overall Study|Physician Decision|0|||
126344087|NCT01773928|454554181|FG000|Overall Study|Withdrawal by Subject|5|||
126430378|NCT00882440|454871875|FG002|Overall Study|Lost to Follow-up|1|||
126344088|NCT01773928|454554182|FG001|Overall Study|Withdrawal by Subject|4|||
126344089|NCT01773928|454554183|FG002|Overall Study|Withdrawal by Subject|4|||
126344090|NCT01773928|454554184|FG003|Overall Study|Withdrawal by Subject|4|||
126430379|NCT00882440|454871876|FG003|Overall Study|Lost to Follow-up|1|||
126430380|NCT00882440|454871877|FG004|Overall Study|Lost to Follow-up|1|||
126430381|NCT00882440|454871878|FG005|Overall Study|Lost to Follow-up|0|||
126430382|NCT00882440|454871879|FG006|Overall Study|Lost to Follow-up|1|||
126430383|NCT00882440|454871873|FG000|Overall Study|Protocol Violation|0|||
126430384|NCT00882440|454871874|FG001|Overall Study|Protocol Violation|0|||
126430385|NCT00882440|454871875|FG002|Overall Study|Protocol Violation|1|||
126430386|NCT00882440|454871876|FG003|Overall Study|Protocol Violation|1|||
126430387|NCT00882440|454871877|FG004|Overall Study|Protocol Violation|1|||
126430388|NCT00882440|454871878|FG005|Overall Study|Protocol Violation|0|||
126430389|NCT00882440|454871879|FG006|Overall Study|Protocol Violation|0|||
126430390|NCT00882440|454871873|FG000|Overall Study|Withdrawal by Subject|2|||
126430391|NCT00882440|454871874|FG001|Overall Study|Withdrawal by Subject|1|||
126430392|NCT00882440|454871875|FG002|Overall Study|Withdrawal by Subject|1|||
126430393|NCT00882440|454871876|FG003|Overall Study|Withdrawal by Subject|0|||
126430394|NCT00882440|454871877|FG004|Overall Study|Withdrawal by Subject|6|||
126430395|NCT00882440|454871878|FG005|Overall Study|Withdrawal by Subject|0|||
126430396|NCT00882440|454871879|FG006|Overall Study|Withdrawal by Subject|1|||
126430397|NCT00882440|454871873|FG000|Overall Study|Patient Uncooperative|2|||
126430398|NCT00882440|454871874|FG001|Overall Study|Patient Uncooperative|0|||
126430399|NCT00882440|454871875|FG002|Overall Study|Patient Uncooperative|0|||
126430400|NCT00882440|454871876|FG003|Overall Study|Patient Uncooperative|0|||
126430401|NCT00882440|454871877|FG004|Overall Study|Patient Uncooperative|1|||
126430402|NCT00882440|454871878|FG005|Overall Study|Patient Uncooperative|0|||
126430403|NCT00882440|454871879|FG006|Overall Study|Patient Uncooperative|0|||
126430404|NCT03287791|454871880|FG000|Overall Study|Insufficient Therapeutic Response|0|||
126430405|NCT03287791|454871881|FG001|Overall Study|Insufficient Therapeutic Response|0|||
126430406|NCT03287791|454871882|FG002|Overall Study|Insufficient Therapeutic Response|1|||
126430407|NCT03287791|454871880|FG000|Overall Study|Adverse Event|0|||
126430408|NCT03287791|454871881|FG001|Overall Study|Adverse Event|4|||
126430409|NCT03287791|454871882|FG002|Overall Study|Adverse Event|3|||
126430410|NCT03287791|454871880|FG000|Overall Study|Withdrawal by Subject|12|||
126430411|NCT03287791|454871881|FG001|Overall Study|Withdrawal by Subject|12|||
126430412|NCT03287791|454871882|FG002|Overall Study|Withdrawal by Subject|17|||
126430413|NCT03287791|454871880|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
126430414|NCT03287791|454871881|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
126430415|NCT03287791|454871882|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
126430416|NCT03287791|454871880|FG000|Overall Study|Lost to Follow-up|8|||
126430417|NCT03287791|454871881|FG001|Overall Study|Lost to Follow-up|14|||
126430418|NCT03287791|454871882|FG002|Overall Study|Lost to Follow-up|11|||
126430419|NCT03287791|454871880|FG000|Overall Study|Protocol Violation|7|||
126430420|NCT03287791|454871881|FG001|Overall Study|Protocol Violation|2|||
126430421|NCT03287791|454871882|FG002|Overall Study|Protocol Violation|1|||
126430422|NCT03287791|454871880|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
126430423|NCT03287791|454871881|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
126430424|NCT03287791|454871882|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
126430425|NCT03287791|454871880|FG000|Overall Study|Too much time between 2 visits|0|||
126430426|NCT03287791|454871881|FG001|Overall Study|Too much time between 2 visits|1|||
126430427|NCT03287791|454871882|FG002|Overall Study|Too much time between 2 visits|0|||
126430428|NCT03287791|454871880|FG000|Overall Study|Non-compliance|0|||
126430429|NCT03287791|454871881|FG001|Overall Study|Non-compliance|1|||
126430430|NCT03287791|454871882|FG002|Overall Study|Non-compliance|0|||
126430431|NCT03287791|454871880|FG000|Overall Study|Did not meet inclusion criteria|1|||
126430432|NCT03287791|454871881|FG001|Overall Study|Did not meet inclusion criteria|0|||
126344091|NCT01773928|454554185|FG004|Overall Study|Withdrawal by Subject|7|||
126344092|NCT01773928|454554186|FG005|Overall Study|Withdrawal by Subject|1|||
126344093|NCT01773928|454554187|FG006|Overall Study|Withdrawal by Subject|0|||
126344094|NCT01773928|454554188|FG007|Overall Study|Withdrawal by Subject|0|||
126344095|NCT01773928|454554189|FG008|Overall Study|Withdrawal by Subject|1|||
126344096|NCT01773928|454554181|FG000|Overall Study|Lost to Follow-up|0|||
126344097|NCT01773928|454554182|FG001|Overall Study|Lost to Follow-up|0|||
126344098|NCT01773928|454554183|FG002|Overall Study|Lost to Follow-up|0|||
126344099|NCT01773928|454554184|FG003|Overall Study|Lost to Follow-up|0|||
126344100|NCT01773928|454554185|FG004|Overall Study|Lost to Follow-up|0|||
126344101|NCT01773928|454554186|FG005|Overall Study|Lost to Follow-up|1|||
126344102|NCT01773928|454554187|FG006|Overall Study|Lost to Follow-up|0|||
126344103|NCT01773928|454554188|FG007|Overall Study|Lost to Follow-up|0|||
126344104|NCT01773928|454554189|FG008|Overall Study|Lost to Follow-up|0|||
126344105|NCT01773928|454554181|FG000|Overall Study|Subject misrepresented age|0|||
126430433|NCT03287791|454871882|FG002|Overall Study|Did not meet inclusion criteria|0|||
126430434|NCT03095651|454871884|FG000|Overall Study|Lost to Follow-up|1|||
126430435|NCT03095651|454871885|FG001|Overall Study|Lost to Follow-up|1|||
126430436|NCT03095651|454871886|FG002|Overall Study|Lost to Follow-up|0|||
126344106|NCT01773928|454554182|FG001|Overall Study|Subject misrepresented age|1|||
126344107|NCT01773928|454554183|FG002|Overall Study|Subject misrepresented age|0|||
126344108|NCT01773928|454554184|FG003|Overall Study|Subject misrepresented age|0|||
126430437|NCT03095651|454871887|FG003|Overall Study|Lost to Follow-up|1|||
126430438|NCT03095651|454871888|FG004|Overall Study|Lost to Follow-up|0|||
126430439|NCT03095651|454871889|FG005|Overall Study|Lost to Follow-up|0|||
126430440|NCT03095651|454871890|FG006|Overall Study|Lost to Follow-up|0|||
126430441|NCT03095651|454871891|FG007|Overall Study|Lost to Follow-up|0|||
126430442|NCT03095651|454871884|FG000|Overall Study|Withdrawal by Subject|0|||
126430443|NCT03095651|454871885|FG001|Overall Study|Withdrawal by Subject|0|||
126430444|NCT03095651|454871886|FG002|Overall Study|Withdrawal by Subject|0|||
126430445|NCT03095651|454871887|FG003|Overall Study|Withdrawal by Subject|0|||
126430446|NCT03095651|454871888|FG004|Overall Study|Withdrawal by Subject|0|||
126430447|NCT03095651|454871889|FG005|Overall Study|Withdrawal by Subject|1|||
126430448|NCT03095651|454871890|FG006|Overall Study|Withdrawal by Subject|0|||
126430449|NCT03095651|454871891|FG007|Overall Study|Withdrawal by Subject|0|||
126430450|NCT02250326|454871892|FG000|Treatment|Death|1|||
126430451|NCT02250326|454871893|FG001|Treatment|Death|13|||
126430452|NCT02250326|454871894|FG002|Treatment|Death|2|||
126430453|NCT02250326|454871892|FG000|Treatment|Adverse Event|8|||
126430454|NCT02250326|454871893|FG001|Treatment|Adverse Event|8|||
126430455|NCT02250326|454871894|FG002|Treatment|Adverse Event|9|||
126430456|NCT02250326|454871892|FG000|Treatment|Progressive Disease|42|||
126430457|NCT02250326|454871893|FG001|Treatment|Progressive Disease|40|||
126430458|NCT02250326|454871894|FG002|Treatment|Progressive Disease|47|||
126430459|NCT02250326|454871892|FG000|Treatment|Symptomatic Deterioration|9|||
126430460|NCT02250326|454871893|FG001|Treatment|Symptomatic Deterioration|4|||
126430461|NCT02250326|454871894|FG002|Treatment|Symptomatic Deterioration|10|||
126430462|NCT02250326|454871892|FG000|Treatment|Withdrawal by Subject|11|||
126430463|NCT02250326|454871893|FG001|Treatment|Withdrawal by Subject|6|||
126430464|NCT02250326|454871894|FG002|Treatment|Withdrawal by Subject|4|||
126430465|NCT02250326|454871892|FG000|Treatment|Other reasons|8|||
126430466|NCT02250326|454871893|FG001|Treatment|Other reasons|7|||
126430467|NCT02250326|454871894|FG002|Treatment|Other reasons|7|||
126430468|NCT02250326|454871892|FG000|Extension Period|Progressive Disease|0|||
126430469|NCT02250326|454871893|FG001|Extension Period|Progressive Disease|2|||
126430470|NCT02250326|454871894|FG002|Extension Period|Progressive Disease|0|||
126430471|NCT02250326|454871892|FG000|Extension Period|Withdrawal by Subject|0|||
126430472|NCT02250326|454871893|FG001|Extension Period|Withdrawal by Subject|1|||
126430473|NCT02250326|454871894|FG002|Extension Period|Withdrawal by Subject|0|||
126430474|NCT02250326|454871892|FG000|Extension Period|Withdrawal by investigator|0|||
126430475|NCT02250326|454871893|FG001|Extension Period|Withdrawal by investigator|1|||
126430476|NCT02250326|454871894|FG002|Extension Period|Withdrawal by investigator|0|||
126430477|NCT03924622|454871895|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
126430478|NCT03924622|454871896|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
126430479|NCT03924622|454871897|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
126430480|NCT03924622|454871898|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
126430481|NCT03924622|454871899|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
126430482|NCT03924622|454871900|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
126430483|NCT00866177|454871905|FG000|Overall Study|Withdrawal by Subject|1|||
126430484|NCT00866177|454871905|FG000|Overall Study|Not Treated|151|||
126430485|NCT05635461|454871908|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
126430486|NCT05635461|454871909|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
126430487|NCT05635461|454871910|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
126430488|NCT05635461|454871911|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
126430489|NCT05635461|454871912|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
126430490|NCT05635461|454871913|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
126430491|NCT05635461|454871908|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
126430492|NCT05635461|454871909|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
126430493|NCT05635461|454871910|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
126430494|NCT05635461|454871911|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
126430495|NCT05635461|454871912|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
126430496|NCT05635461|454871913|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
126430497|NCT05635461|454871908|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
126430498|NCT05635461|454871909|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
126678585|NCT00708500|455780614|FG000|FOLLOWUP|Lost to Follow-up|1|||
126678586|NCT00708500|455780615|FG001|FOLLOWUP|Lost to Follow-up|6|||
126430499|NCT05635461|454871910|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
126430500|NCT05635461|454871911|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
126430501|NCT05635461|454871912|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
126430502|NCT05635461|454871913|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
126430503|NCT02269124|454871919|FG000|Overall Study|Lost to Follow-up|1|||
126430504|NCT02269124|454871920|FG001|Overall Study|Lost to Follow-up|0|||
126430505|NCT02269124|454871919|FG000|Overall Study|Withdrawal by Subject|0|||
126430506|NCT02269124|454871920|FG001|Overall Study|Withdrawal by Subject|2|||
126430507|NCT00614575|454871921|FG000|Overall Study|Adverse Event|106|||
126430508|NCT00614575|454871921|FG000|Overall Study|Lost to Follow-up|55|||
126678587|NCT00708500|455780616|FG002|FOLLOWUP|Lost to Follow-up|4|||
126678588|NCT00708500|455780614|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
126678589|NCT00708500|455780615|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
126678590|NCT00708500|455780616|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
126678591|NCT00708500|455780614|FG000|FOLLOWUP|Subject withdrew consent|31|||
126678592|NCT00708500|455780615|FG001|FOLLOWUP|Subject withdrew consent|4|||
126678593|NCT00708500|455780616|FG002|FOLLOWUP|Subject withdrew consent|5|||
126678594|NCT00708500|455780614|FG000|FOLLOWUP|Non-compliance with protocol|5|||
126678595|NCT00708500|455780615|FG001|FOLLOWUP|Non-compliance with protocol|0|||
126678596|NCT00708500|455780616|FG002|FOLLOWUP|Non-compliance with protocol|1|||
126678597|NCT01394627|455780626|FG000|First Intervention (1 Day)|poor intravenous access|0|||
126678598|NCT01394627|455780627|FG001|First Intervention (1 Day)|poor intravenous access|1|||
126678599|NCT01394627|455780626|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
126344109|NCT01773928|454554185|FG004|Overall Study|Subject misrepresented age|0|||
126344110|NCT01773928|454554186|FG005|Overall Study|Subject misrepresented age|0|||
126344111|NCT01773928|454554187|FG006|Overall Study|Subject misrepresented age|0|||
126344112|NCT01773928|454554188|FG007|Overall Study|Subject misrepresented age|0|||
126344113|NCT01773928|454554189|FG008|Overall Study|Subject misrepresented age|0|||
126344114|NCT01773928|454554181|FG000|Overall Study|Subject met exclusion criteria|0|||
126344115|NCT01773928|454554182|FG001|Overall Study|Subject met exclusion criteria|0|||
126344116|NCT01773928|454554183|FG002|Overall Study|Subject met exclusion criteria|0|||
126344117|NCT01773928|454554184|FG003|Overall Study|Subject met exclusion criteria|0|||
126344118|NCT01773928|454554185|FG004|Overall Study|Subject met exclusion criteria|0|||
126344119|NCT01773928|454554186|FG005|Overall Study|Subject met exclusion criteria|0|||
126344120|NCT01773928|454554187|FG006|Overall Study|Subject met exclusion criteria|0|||
126344121|NCT01773928|454554188|FG007|Overall Study|Subject met exclusion criteria|0|||
126344122|NCT01773928|454554189|FG008|Overall Study|Subject met exclusion criteria|1|||
126344123|NCT01773928|454554181|FG000|Overall Study|Randomized, had to leave, never returned|0|||
126344124|NCT01773928|454554182|FG001|Overall Study|Randomized, had to leave, never returned|0|||
126344125|NCT01773928|454554183|FG002|Overall Study|Randomized, had to leave, never returned|0|||
126344126|NCT01773928|454554184|FG003|Overall Study|Randomized, had to leave, never returned|1|||
126344127|NCT01773928|454554185|FG004|Overall Study|Randomized, had to leave, never returned|0|||
126344128|NCT01773928|454554186|FG005|Overall Study|Randomized, had to leave, never returned|0|||
126344129|NCT01773928|454554187|FG006|Overall Study|Randomized, had to leave, never returned|0|||
126344130|NCT01773928|454554188|FG007|Overall Study|Randomized, had to leave, never returned|0|||
126344131|NCT01773928|454554189|FG008|Overall Study|Randomized, had to leave, never returned|0|||
126344132|NCT01773928|454554181|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
126344133|NCT01773928|454554182|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
126344134|NCT01773928|454554183|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
126344135|NCT01773928|454554184|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
126344136|NCT01773928|454554185|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
126344137|NCT01773928|454554186|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
126344138|NCT01773928|454554187|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
126344139|NCT01773928|454554188|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
126344140|NCT01773928|454554189|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
126344141|NCT03092752|454554190|FG000|Overall Study|Aged <40 years|14209|||
126344142|NCT03092752|454554190|FG000|Overall Study|At least one claim with T2DM|61299|||
126344143|NCT03092752|454554190|FG000|Overall Study|Having no claim of study drugs|29282|||
126344144|NCT03092752|454554190|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
126344145|NCT03092752|454554190|FG000|Overall Study|<6 month history|245900|||
126344146|NCT03729362|454555818|FG000|Overall Study|Withdrawal by Subject|2|||
126344147|NCT03729362|454555819|FG001|Overall Study|Withdrawal by Subject|0|||
126344148|NCT03729362|454555818|FG000|Overall Study|Physician Decision|1|||
126344149|NCT03729362|454555819|FG001|Overall Study|Physician Decision|0|||
126344150|NCT03729362|454555818|FG000|Overall Study|COVID-19 Pandemic|1|||
126344151|NCT03729362|454555819|FG001|Overall Study|COVID-19 Pandemic|0|||
126344152|NCT03729362|454555818|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
126344153|NCT03729362|454555819|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
126344154|NCT03729362|454555818|FG000|Overall Study|Adverse Event|0|||
126344155|NCT03729362|454555819|FG001|Overall Study|Adverse Event|1|||
126344156|NCT03729362|454555818|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
126344157|NCT03729362|454555819|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
126344158|NCT01113749|454555820|FG000|Overall Study|Lost to Follow-up|1|||
126344159|NCT01113749|454555821|FG001|Overall Study|Lost to Follow-up|2|||
126344160|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
126678600|NCT01394627|455780627|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
126344161|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
126344162|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Death|1|||
126344163|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Death|3|||
126344164|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
126430509|NCT00614575|454871921|FG000|Overall Study|Lack of Efficacy|14|||
126430510|NCT00614575|454871921|FG000|Overall Study|Withdrawal by Subject|6|||
126430511|NCT00614575|454871921|FG000|Overall Study|Death|3|||
126430512|NCT00614575|454871921|FG000|Overall Study|Physician Decision|2|||
126430513|NCT00614575|454871921|FG000|Overall Study|No data were collected.|18|||
126430514|NCT00614575|454871921|FG000|Overall Study|Irregularly enrolled patients|23|||
126430515|NCT00614575|454871921|FG000|Overall Study|No treatment|1|||
126430516|NCT03452540|454871922|FG000|Overall Study|Adverse Event|1|||
126430517|NCT03452540|454871922|FG000|Overall Study|Withdrawal by Subject|1|||
126430518|NCT03452540|454871922|FG000|Overall Study|Other SAE and AE|2|||
126430519|NCT01045460|454871925|FG000|Overall Study|Physician Decision|3|||
126430520|NCT01045460|454871926|FG001|Overall Study|Physician Decision|2|||
126430521|NCT01045460|454871925|FG000|Overall Study|Lost to Follow-up|0|||
126430522|NCT01045460|454871926|FG001|Overall Study|Lost to Follow-up|1|||
126430523|NCT01045460|454871925|FG000|Overall Study|Lack of Efficacy|3|||
126430524|NCT01045460|454871926|FG001|Overall Study|Lack of Efficacy|0|||
126430525|NCT04664153|454871927|FG000|Overall Study|Lack of Efficacy|0|||
126430526|NCT04664153|454871928|FG001|Overall Study|Lack of Efficacy|0|||
126430527|NCT04664153|454871929|FG002|Overall Study|Lack of Efficacy|1|||
126430528|NCT04664153|454871930|FG003|Overall Study|Lack of Efficacy|0|||
126430529|NCT04664153|454871927|FG000|Overall Study|Physician Decision|0|||
126430530|NCT04664153|454871928|FG001|Overall Study|Physician Decision|0|||
126430531|NCT04664153|454871929|FG002|Overall Study|Physician Decision|1|||
126430532|NCT04664153|454871930|FG003|Overall Study|Physician Decision|0|||
126430533|NCT04664153|454871927|FG000|Overall Study|Withdrawal by Subject|3|||
126430534|NCT04664153|454871928|FG001|Overall Study|Withdrawal by Subject|2|||
126430535|NCT04664153|454871929|FG002|Overall Study|Withdrawal by Subject|1|||
126430536|NCT04664153|454871930|FG003|Overall Study|Withdrawal by Subject|2|||
126430537|NCT04664153|454871927|FG000|Overall Study|Other|0|||
126430538|NCT04664153|454871928|FG001|Overall Study|Other|1|||
126430539|NCT04664153|454871929|FG002|Overall Study|Other|0|||
126430540|NCT04664153|454871930|FG003|Overall Study|Other|0|||
126430541|NCT04664153|454871927|FG000|Overall Study|Adverse Event|4|||
126430542|NCT04664153|454871928|FG001|Overall Study|Adverse Event|0|||
126430543|NCT04664153|454871929|FG002|Overall Study|Adverse Event|1|||
126430544|NCT04664153|454871930|FG003|Overall Study|Adverse Event|0|||
126430545|NCT00097500|454871931|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
126430546|NCT00097500|454871932|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
126430547|NCT00097500|454871931|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
126430548|NCT00097500|454871932|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
126430549|NCT00097500|454871931|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
126430550|NCT00097500|454871932|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
126430551|NCT00097500|454871931|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
126430552|NCT00097500|454871932|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
126430553|NCT00097500|454871931|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
126430554|NCT00097500|454871932|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
126430555|NCT00097500|454871931|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
126430556|NCT00097500|454871932|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
126430557|NCT00097500|454871931|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
126430558|NCT00097500|454871932|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
126430559|NCT00524485|454871936|FG000|Overall Study|Withdrawal by Subject|5|||
126430560|NCT01600885|454871939|FG000|First Period|Adverse Event|1|||
126430561|NCT01600885|454871940|FG001|First Period|Adverse Event|1|||
126430562|NCT01600885|454871939|FG000|First Period|moved out of area|1|||
126430563|NCT01600885|454871940|FG001|First Period|moved out of area|0|||
126430564|NCT00436332|454871941|FG000|Overall Study|Adverse Event|9|||
126430565|NCT00436332|454871941|FG000|Overall Study|Withdrawal by Subject|2|||
126430566|NCT00436332|454871941|FG000|Overall Study|Progression|59|||
126430567|NCT00436332|454871941|FG000|Overall Study|Death|2|||
126430568|NCT00436332|454871941|FG000|Overall Study|Not Protocol Specified|6|||
126430569|NCT00436332|454871941|FG000|Overall Study|Ineligible|2|||
126430570|NCT00436332|454871941|FG000|Overall Study|Never Received Treatment|3|||
126430571|NCT00005906|454871948|FG000|Overall Study|Lack of Efficacy|3|||
126430572|NCT02140047|454871949|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126430573|NCT02140047|454871950|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126430574|NCT02140047|454871951|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126430575|NCT01046565|454871952|FG000|Overall Study|Adverse Event|2|||
126430576|NCT01046565|454871952|FG000|Overall Study|Withdrawal by Subject|7|||
126430577|NCT01650558|454871953|FG000|Overall Study|Migration out of study area|61|||
126430578|NCT01650558|454871954|FG001|Overall Study|Migration out of study area|71|||
126430579|NCT01650558|454871955|FG002|Overall Study|Migration out of study area|56|||
126430580|NCT01650558|454871953|FG000|Overall Study|Lost to Follow-up|10|||
126430581|NCT01650558|454871954|FG001|Overall Study|Lost to Follow-up|13|||
126430582|NCT01650558|454871955|FG002|Overall Study|Lost to Follow-up|6|||
126430583|NCT01650558|454871953|FG000|Overall Study|Death|10|||
126430584|NCT01650558|454871954|FG001|Overall Study|Death|6|||
126430585|NCT01650558|454871955|FG002|Overall Study|Death|8|||
126678601|NCT01765920|455780628|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
126678602|NCT01765920|455780629|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
126678603|NCT01765920|455780628|FG000|Overall Study|Patient code disclosure|0|||
126678604|NCT01765920|455780629|FG001|Overall Study|Patient code disclosure|1|||
126678605|NCT01081249|455780630|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
126678606|NCT01081249|455780631|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
126678607|NCT03681119|455780632|FG000|Overall Study|No specific reason|4|||
126678608|NCT03681119|455780633|FG001|Overall Study|No specific reason|0|||
126678609|NCT03681119|455780632|FG000|Overall Study|Sickness|2|||
126678610|NCT03681119|455780633|FG001|Overall Study|Sickness|0|||
126678611|NCT00879645|455780637|FG000|Overall Study|Adverse Event|1|||
126678612|NCT00879645|455780638|FG001|Overall Study|Adverse Event|0|||
126678613|NCT00879645|455780639|FG002|Overall Study|Adverse Event|0|||
126678614|NCT00879645|455780640|FG003|Overall Study|Adverse Event|0|||
126678615|NCT03631732|455780641|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
126678616|NCT03631732|455780642|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
126678617|NCT03631732|455780641|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
126678618|NCT03631732|455780642|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
126678619|NCT03631732|455780641|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
126678620|NCT03631732|455780642|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
126678621|NCT03631732|455780641|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
126678622|NCT03631732|455780642|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
126678623|NCT03631732|455780641|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
126678624|NCT03631732|455780642|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
126678625|NCT03631732|455780641|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
126678626|NCT03631732|455780642|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
126678627|NCT03631732|455780641|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
126678628|NCT03631732|455780642|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
126678629|NCT03631732|455780641|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
126678630|NCT03631732|455780642|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
126678631|NCT03631732|455780641|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
126678632|NCT03631732|455780642|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
126678633|NCT03631732|455780641|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
126678634|NCT03631732|455780642|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
126678635|NCT04288154|455780643|FG000|Overall Study|Withdrawal by Subject|9|||
126678636|NCT04288154|455780644|FG001|Overall Study|Withdrawal by Subject|9|||
126678637|NCT02873936|455780648|FG000|Overall Study|Withdrew Consent|4|||
126678638|NCT02873936|455780649|FG001|Overall Study|Withdrew Consent|11|||
126678639|NCT02873936|455780650|FG002|Overall Study|Withdrew Consent|20|||
126678640|NCT02873936|455780648|FG000|Overall Study|Investigator's Discretion|3|||
126678641|NCT02873936|455780649|FG001|Overall Study|Investigator's Discretion|5|||
126678642|NCT02873936|455780650|FG002|Overall Study|Investigator's Discretion|4|||
126678643|NCT02873936|455780648|FG000|Overall Study|Adverse Event|3|||
126678644|NCT02873936|455780649|FG001|Overall Study|Adverse Event|5|||
126678645|NCT02873936|455780650|FG002|Overall Study|Adverse Event|3|||
126678646|NCT02873936|455780648|FG000|Overall Study|Protocol Violation|0|||
126678647|NCT02873936|455780649|FG001|Overall Study|Protocol Violation|1|||
126678648|NCT02873936|455780650|FG002|Overall Study|Protocol Violation|3|||
126678649|NCT02873936|455780648|FG000|Overall Study|Lost to Follow-up|1|||
126678650|NCT02873936|455780649|FG001|Overall Study|Lost to Follow-up|1|||
126344165|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
126344166|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
126344167|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
126344168|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
126344169|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
126344170|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
126344171|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
126344172|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
126344173|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
126344174|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
126344175|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
126344176|NCT00362232|454555822|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
126344177|NCT00362232|454555823|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
126344178|NCT00362232|454555822|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
126344179|NCT00362232|454555823|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
126344180|NCT00362232|454555822|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
126344181|NCT00362232|454555823|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
126678651|NCT02873936|455780650|FG002|Overall Study|Lost to Follow-up|1|||
126678652|NCT02873936|455780648|FG000|Overall Study|Non-compliance With Study Drug|1|||
126344182|NCT00362232|454555822|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
126678653|NCT02873936|455780649|FG001|Overall Study|Non-compliance With Study Drug|0|||
126678654|NCT02873936|455780650|FG002|Overall Study|Non-compliance With Study Drug|1|||
126678655|NCT02873936|455780648|FG000|Overall Study|Randomized but not Dosed|1|||
126678656|NCT02873936|455780649|FG001|Overall Study|Randomized but not Dosed|0|||
126678657|NCT02873936|455780650|FG002|Overall Study|Randomized but not Dosed|0|||
126678658|NCT00917150|455780651|FG000|Overall Study|Adverse Event|12|||
126678659|NCT00917150|455780652|FG001|Overall Study|Adverse Event|7|||
126678660|NCT00917150|455780653|FG002|Overall Study|Adverse Event|12|||
126344183|NCT00362232|454555823|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
126430586|NCT01650558|454871953|FG000|Overall Study|Withdrawal by Subject|1|||
126430587|NCT01650558|454871954|FG001|Overall Study|Withdrawal by Subject|1|||
126344184|NCT00362232|454555822|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
126344185|NCT00362232|454555823|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
126344186|NCT00375752|454555827|FG000|Overall Study|Lack of Efficacy|4|||
126344187|NCT00375752|454555828|FG001|Overall Study|Lack of Efficacy|4|||
126344188|NCT00375752|454555827|FG000|Overall Study|Adverse Event|1|||
126344189|NCT00375752|454555828|FG001|Overall Study|Adverse Event|6|||
126344190|NCT00375752|454555827|FG000|Overall Study|Withdrawal by Subject|6|||
126344191|NCT00375752|454555828|FG001|Overall Study|Withdrawal by Subject|1|||
126344192|NCT00375752|454555827|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
126344193|NCT00375752|454555828|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
126344194|NCT00375752|454555827|FG000|Overall Study|Protocol Violation|0|||
126344195|NCT00375752|454555828|FG001|Overall Study|Protocol Violation|2|||
126344196|NCT00375752|454555827|FG000|Overall Study|Administrative Problems|0|||
126344197|NCT00375752|454555828|FG001|Overall Study|Administrative Problems|1|||
126344198|NCT00961064|454555834|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
126344199|NCT00961064|454555834|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
126344200|NCT00961064|454555834|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
126344201|NCT00961064|454555834|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
126344202|NCT00961064|454555834|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
126344203|NCT00961064|454555834|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
126344204|NCT00961064|454555834|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
126344205|NCT00961064|454555834|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
126344206|NCT00576758|454555835|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
126344207|NCT00576758|454555836|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
126344208|NCT00576758|454555835|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
126344209|NCT00576758|454555836|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
126344210|NCT00576758|454555835|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
126344211|NCT00576758|454555836|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
126344212|NCT00576758|454555835|FG000|Induction Treatment Period|Death|1|||
126344213|NCT00576758|454555836|FG001|Induction Treatment Period|Death|0|||
126344214|NCT00576758|454555835|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
126344215|NCT00576758|454555836|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
126344216|NCT00576758|454555835|FG000|Induction Treatment Period|Withdrew consent|1|||
126344217|NCT00576758|454555836|FG001|Induction Treatment Period|Withdrew consent|0|||
126344218|NCT00576758|454555835|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
126344219|NCT00576758|454555836|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
126344220|NCT00576758|454555835|FG000|Extension Treatment Period|Death|1|||
126344221|NCT00576758|454555836|FG001|Extension Treatment Period|Death|1|||
126344222|NCT00576758|454555835|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
126344223|NCT00576758|454555836|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
126344224|NCT00576758|454555835|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
126344225|NCT00576758|454555836|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
126344226|NCT00576758|454555835|FG000|Extension Treatment Period|Administrative/Other|3|||
126344227|NCT00576758|454555836|FG001|Extension Treatment Period|Administrative/Other|1|||
126344228|NCT00576758|454555835|FG000|Follow-up Period|Administrative/Other|6|||
126344229|NCT00576758|454555836|FG001|Follow-up Period|Administrative/Other|8|||
126344230|NCT00576758|454555835|FG000|Follow-up Period|Death|3|||
126344231|NCT00576758|454555836|FG001|Follow-up Period|Death|3|||
126344232|NCT00576758|454555835|FG000|Follow-up Period|Insufficient therapeutic response|16|||
126344233|NCT00576758|454555836|FG001|Follow-up Period|Insufficient therapeutic response|5|||
126344234|NCT00576758|454555835|FG000|Follow-up Period|Withdrew consent|2|||
126430588|NCT01650558|454871955|FG002|Overall Study|Withdrawal by Subject|3|||
126678661|NCT00917150|455780654|FG003|Overall Study|Adverse Event|11|||
126678662|NCT00917150|455780651|FG000|Overall Study|Death|1|||
126678663|NCT00917150|455780652|FG001|Overall Study|Death|4|||
126344235|NCT00576758|454555836|FG001|Follow-up Period|Withdrew consent|1|||
126430589|NCT01650558|454871953|FG000|Overall Study|Non-compliant participant|1|||
126344236|NCT00761319|454555837|FG000|Overall Study|Protocol Violation|21|||
126344237|NCT00761319|454555838|FG001|Overall Study|Protocol Violation|14|||
126344238|NCT00761319|454555837|FG000|Overall Study|Adverse Event|11|||
126344239|NCT00761319|454555838|FG001|Overall Study|Adverse Event|7|||
126678664|NCT00917150|455780653|FG002|Overall Study|Death|3|||
126678665|NCT00917150|455780654|FG003|Overall Study|Death|2|||
126430590|NCT01650558|454871954|FG001|Overall Study|Non-compliant participant|0|||
126430591|NCT01650558|454871955|FG002|Overall Study|Non-compliant participant|2|||
126430592|NCT01650558|454871953|FG000|Overall Study|Physician Decision|0|||
126430593|NCT01650558|454871954|FG001|Overall Study|Physician Decision|1|||
126430594|NCT01650558|454871955|FG002|Overall Study|Physician Decision|0|||
126430595|NCT00528957|454871958|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
126430596|NCT00528957|454871959|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
126430597|NCT00528957|454871958|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
126430598|NCT00528957|454871959|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
126430599|NCT00528957|454871958|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
126430600|NCT00528957|454871959|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
126430601|NCT00528957|454871958|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
126430602|NCT00528957|454871959|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
126430603|NCT00528957|454871958|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
126430604|NCT00528957|454871959|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
126430605|NCT00528957|454871958|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
126430606|NCT00528957|454871959|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
126678666|NCT00917150|455780651|FG000|Overall Study|Lost to Follow-up|1|||
126678667|NCT00917150|455780652|FG001|Overall Study|Lost to Follow-up|0|||
126678668|NCT00917150|455780653|FG002|Overall Study|Lost to Follow-up|4|||
126678669|NCT00917150|455780654|FG003|Overall Study|Lost to Follow-up|2|||
126678670|NCT00917150|455780651|FG000|Overall Study|Physician Decision|0|||
126678671|NCT00917150|455780652|FG001|Overall Study|Physician Decision|2|||
126678672|NCT00917150|455780653|FG002|Overall Study|Physician Decision|0|||
126678673|NCT00917150|455780654|FG003|Overall Study|Physician Decision|1|||
126678674|NCT00917150|455780651|FG000|Overall Study|Protocol Violation|5|||
126678675|NCT00917150|455780652|FG001|Overall Study|Protocol Violation|5|||
126678676|NCT00917150|455780653|FG002|Overall Study|Protocol Violation|3|||
126678677|NCT00917150|455780654|FG003|Overall Study|Protocol Violation|5|||
126678678|NCT00917150|455780651|FG000|Overall Study|Withdrawal by Subject|15|||
126678679|NCT00917150|455780652|FG001|Overall Study|Withdrawal by Subject|16|||
126678680|NCT00917150|455780653|FG002|Overall Study|Withdrawal by Subject|18|||
126678681|NCT00917150|455780654|FG003|Overall Study|Withdrawal by Subject|11|||
126678682|NCT00917150|455780651|FG000|Overall Study|Other than specified|3|||
126678683|NCT00917150|455780652|FG001|Overall Study|Other than specified|3|||
126678684|NCT00917150|455780653|FG002|Overall Study|Other than specified|2|||
126678685|NCT00917150|455780654|FG003|Overall Study|Other than specified|2|||
126678686|NCT01624662|455780655|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
126678687|NCT01624662|455780656|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
126678688|NCT01624662|455780657|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
126678689|NCT01624662|455780658|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
126678690|NCT01624662|455780655|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
126678691|NCT01624662|455780656|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
126678692|NCT01624662|455780657|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
126678693|NCT01624662|455780658|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
126678694|NCT01624662|455780655|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
126678695|NCT01624662|455780656|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
126678696|NCT01624662|455780657|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
126344240|NCT00761319|454555837|FG000|Overall Study|Withdrawal by Subject|8|||
126344241|NCT00761319|454555838|FG001|Overall Study|Withdrawal by Subject|7|||
126344242|NCT00761319|454555837|FG000|Overall Study|Noncompliance|4|||
126344243|NCT00761319|454555838|FG001|Overall Study|Noncompliance|3|||
126344244|NCT00761319|454555837|FG000|Overall Study|Lost to Follow-up|1|||
126344245|NCT00761319|454555838|FG001|Overall Study|Lost to Follow-up|1|||
126344246|NCT00761319|454555837|FG000|Overall Study|Nonspecified|2|||
126344247|NCT00761319|454555838|FG001|Overall Study|Nonspecified|2|||
126344248|NCT00761319|454555837|FG000|Overall Study|Missing|1|||
126344249|NCT00761319|454555838|FG001|Overall Study|Missing|0|||
126344250|NCT01715298|454555839|FG000|Overall Study|Lost to Follow-up|0|||
126344251|NCT01715298|454555840|FG001|Overall Study|Lost to Follow-up|2|||
126344252|NCT01715298|454555839|FG000|Overall Study|Patient/guardian decision|7|||
126344253|NCT01715298|454555840|FG001|Overall Study|Patient/guardian decision|9|||
126344254|NCT01499511|454555841|FG000|Overall Study|Death|1|||
126344255|NCT01499511|454555842|FG001|Overall Study|Death|0|||
126344256|NCT00726453|454555844|FG000|Primary Enrollment Group|Death|18|||
126344257|NCT00726453|454555845|FG001|Primary Enrollment Group|Death|0|||
126344258|NCT00726453|454555844|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
126344259|NCT00726453|454555845|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
126344260|NCT00726453|454555844|FG000|38 mm Length Group|Death|0|||
126344261|NCT00726453|454555845|FG001|38 mm Length Group|Death|3|||
126344262|NCT01432951|454555846|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
126344263|NCT00853385|454555847|FG000|Overall Study|Death|0|||
126678697|NCT01624662|455780658|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
126430607|NCT00528957|454871958|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
126430608|NCT00528957|454871959|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
126430609|NCT00528957|454871958|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
126430610|NCT00528957|454871959|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
126430611|NCT00528957|454871958|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
126430612|NCT00528957|454871959|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
126430613|NCT00528957|454871958|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
126430614|NCT00528957|454871959|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
126430615|NCT00528957|454871958|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
126430616|NCT00528957|454871959|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
126430617|NCT00528957|454871958|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
126430618|NCT00528957|454871959|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
126430619|NCT00528957|454871958|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
126430620|NCT00528957|454871959|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
126430621|NCT00528957|454871958|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
126430622|NCT00528957|454871959|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
126430623|NCT00528957|454871958|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
126430624|NCT00528957|454871959|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
126678698|NCT01624662|455780655|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
126678699|NCT01624662|455780656|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
126430625|NCT00528957|454871958|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
126430626|NCT00528957|454871959|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
126430627|NCT02051764|454871960|FG000|Overall Study|Study terminated by sponsor|0|||
126430628|NCT02051764|454871961|FG001|Overall Study|Study terminated by sponsor|7|||
126430629|NCT03624881|454871962|FG000|Overall Study|Screen Failure|14|||
126430630|NCT03624881|454871963|FG001|Overall Study|Screen Failure|0|||
126430631|NCT03624881|454871962|FG000|Overall Study|No Catheter Inserted|6|||
126430632|NCT03624881|454871963|FG001|Overall Study|No Catheter Inserted|1|||
126430633|NCT03624881|454871962|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
126430634|NCT03624881|454871963|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
126430635|NCT03624881|454871962|FG000|Overall Study|Death|2|||
126678700|NCT01624662|455780657|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
126678701|NCT01624662|455780658|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
126678702|NCT01624662|455780655|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
126678703|NCT01624662|455780656|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
126678704|NCT01624662|455780657|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
126678705|NCT01624662|455780658|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
126678706|NCT01624662|455780655|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
126678707|NCT01624662|455780656|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
126678708|NCT01624662|455780657|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
126678709|NCT01624662|455780658|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
126678710|NCT01624662|455780655|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
126678711|NCT01624662|455780656|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
126678712|NCT01624662|455780657|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
126678713|NCT01624662|455780658|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
126678714|NCT03099187|455780664|FG000|Double-blind Treatment|Adverse Event|19|||
126678715|NCT03099187|455780665|FG001|Double-blind Treatment|Adverse Event|1|||
126678716|NCT03099187|455780666|FG002|Double-blind Treatment|Adverse Event|0|||
126678717|NCT03099187|455780667|FG003|Double-blind Treatment|Adverse Event|0|||
126678718|NCT03099187|455780664|FG000|Double-blind Treatment|Death|1|||
126678719|NCT03099187|455780665|FG001|Double-blind Treatment|Death|3|||
126678720|NCT03099187|455780666|FG002|Double-blind Treatment|Death|0|||
126678721|NCT03099187|455780667|FG003|Double-blind Treatment|Death|0|||
126678722|NCT03099187|455780664|FG000|Double-blind Treatment|Lack of Efficacy|1|||
126678723|NCT03099187|455780665|FG001|Double-blind Treatment|Lack of Efficacy|0|||
126678724|NCT03099187|455780666|FG002|Double-blind Treatment|Lack of Efficacy|0|||
126678725|NCT03099187|455780667|FG003|Double-blind Treatment|Lack of Efficacy|0|||
126678726|NCT03099187|455780664|FG000|Double-blind Treatment|Physician Decision|2|||
126678727|NCT03099187|455780665|FG001|Double-blind Treatment|Physician Decision|1|||
126678728|NCT03099187|455780666|FG002|Double-blind Treatment|Physician Decision|0|||
126678729|NCT03099187|455780667|FG003|Double-blind Treatment|Physician Decision|0|||
126678730|NCT03099187|455780664|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
126678731|NCT03099187|455780665|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
126678732|NCT03099187|455780666|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
126678733|NCT03099187|455780667|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
126430636|NCT03624881|454871963|FG001|Overall Study|Death|0|||
126430637|NCT03624881|454871962|FG000|Overall Study|Lost to Follow-up|10|||
126430638|NCT03624881|454871963|FG001|Overall Study|Lost to Follow-up|4|||
126430639|NCT03624881|454871962|FG000|Overall Study|Withdrawal by Subject|12|||
126430640|NCT03624881|454871963|FG001|Overall Study|Withdrawal by Subject|1|||
126430641|NCT03557970|454871964|FG000|Overall Study|Study closure|1|||
126678734|NCT03099187|455780664|FG000|Double-blind Treatment|Lung transplantation|0|||
126678735|NCT03099187|455780665|FG001|Double-blind Treatment|Lung transplantation|1|||
126678736|NCT03099187|455780666|FG002|Double-blind Treatment|Lung transplantation|0|||
126678737|NCT03099187|455780667|FG003|Double-blind Treatment|Lung transplantation|0|||
126678738|NCT03099187|455780664|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
126678739|NCT03099187|455780665|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
126344264|NCT00853385|454555848|FG001|Overall Study|Death|0|||
126430642|NCT03557970|454871965|FG001|Overall Study|Study closure|0|||
126430643|NCT03557970|454871964|FG000|Overall Study|Physician Decision|0|||
126430644|NCT03557970|454871965|FG001|Overall Study|Physician Decision|1|||
126430645|NCT03557970|454871964|FG000|Overall Study|Death|0|||
126430646|NCT03557970|454871965|FG001|Overall Study|Death|1|||
126430647|NCT03155724|454871968|FG000|Overall Study|Death|3|||
126430648|NCT03155724|454871968|FG000|Overall Study|Physician Decision|1|||
126430649|NCT03155724|454871968|FG000|Overall Study|Study closure|7|||
126430650|NCT04258423|454871972|FG000|Overall Study|Study Closure|2|||
126344265|NCT00853385|454555849|FG002|Overall Study|Death|0|||
126344266|NCT00853385|454555850|FG003|Overall Study|Death|0|||
126344267|NCT00853385|454555851|FG004|Overall Study|Death|1|||
126344268|NCT00853385|454555847|FG000|Overall Study|Adverse Event|24|||
126344269|NCT00853385|454555848|FG001|Overall Study|Adverse Event|24|||
126344270|NCT00853385|454555849|FG002|Overall Study|Adverse Event|2|||
126344271|NCT00853385|454555850|FG003|Overall Study|Adverse Event|5|||
126344272|NCT00853385|454555851|FG004|Overall Study|Adverse Event|22|||
126344273|NCT00853385|454555847|FG000|Overall Study|Lack of Efficacy|6|||
126344274|NCT00853385|454555848|FG001|Overall Study|Lack of Efficacy|7|||
126344275|NCT00853385|454555849|FG002|Overall Study|Lack of Efficacy|3|||
126344276|NCT00853385|454555850|FG003|Overall Study|Lack of Efficacy|3|||
126344277|NCT00853385|454555851|FG004|Overall Study|Lack of Efficacy|6|||
126344278|NCT00853385|454555847|FG000|Overall Study|Lost to Follow-up|2|||
126344279|NCT00853385|454555848|FG001|Overall Study|Lost to Follow-up|1|||
126344280|NCT00853385|454555849|FG002|Overall Study|Lost to Follow-up|0|||
126344281|NCT00853385|454555850|FG003|Overall Study|Lost to Follow-up|0|||
126344282|NCT00853385|454555851|FG004|Overall Study|Lost to Follow-up|0|||
126344283|NCT00853385|454555847|FG000|Overall Study|Withdrawal by Subject|4|||
126344284|NCT00853385|454555848|FG001|Overall Study|Withdrawal by Subject|2|||
126344285|NCT00853385|454555849|FG002|Overall Study|Withdrawal by Subject|0|||
126344286|NCT00853385|454555850|FG003|Overall Study|Withdrawal by Subject|1|||
126344287|NCT00853385|454555851|FG004|Overall Study|Withdrawal by Subject|1|||
126344288|NCT00853385|454555847|FG000|Overall Study|Other|18|||
126344289|NCT00853385|454555848|FG001|Overall Study|Other|9|||
126344290|NCT00853385|454555849|FG002|Overall Study|Other|4|||
126344291|NCT00853385|454555850|FG003|Overall Study|Other|4|||
126344292|NCT00853385|454555851|FG004|Overall Study|Other|12|||
126344293|NCT00915525|454555854|FG000|Overall Study|Protocol Violation|9|||
126344294|NCT00915525|454555855|FG001|Overall Study|Protocol Violation|4|||
126344295|NCT00915525|454555854|FG000|Overall Study|Withdrawal by Subject|59|||
126344296|NCT00915525|454555855|FG001|Overall Study|Withdrawal by Subject|21|||
126344297|NCT00915525|454555854|FG000|Overall Study|Lost to Follow-up|27|||
126344298|NCT00915525|454555855|FG001|Overall Study|Lost to Follow-up|16|||
126344299|NCT00915525|454555854|FG000|Overall Study|Pregnancy|2|||
126344300|NCT00915525|454555855|FG001|Overall Study|Pregnancy|0|||
126344301|NCT00915525|454555854|FG000|Overall Study|Lack of Efficacy|15|||
126344302|NCT00915525|454555855|FG001|Overall Study|Lack of Efficacy|32|||
126344303|NCT00915525|454555854|FG000|Overall Study|Adverse Event|29|||
126344304|NCT00915525|454555855|FG001|Overall Study|Adverse Event|13|||
126344305|NCT00915525|454555854|FG000|Overall Study|Missing|12|||
126430651|NCT04258423|454871973|FG001|Overall Study|Study Closure|2|||
126430652|NCT00321789|454871974|FG000|Overall Study|Lost to Follow-up|4|||
126430653|NCT00321789|454871975|FG001|Overall Study|Lost to Follow-up|7|||
126430654|NCT00321789|454871974|FG000|Overall Study|Withdrawal by Subject|6|||
126678740|NCT03099187|455780666|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
126344306|NCT00915525|454555855|FG001|Overall Study|Missing|1|||
126344307|NCT00915525|454555854|FG000|Overall Study|Other Reason|35|||
126344308|NCT00915525|454555855|FG001|Overall Study|Other Reason|12|||
126344309|NCT00915525|454555854|FG000|Overall Study|Site Closed|27|||
126344310|NCT00915525|454555855|FG001|Overall Study|Site Closed|9|||
126344311|NCT00915525|454555854|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
126344312|NCT00915525|454555855|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
126344313|NCT00915525|454555854|FG000|Overall Study|Study Burden|28|||
126344314|NCT00915525|454555855|FG001|Overall Study|Study Burden|12|||
126344315|NCT00915525|454555854|FG000|Overall Study|Non-Compliance|3|||
126678741|NCT03099187|455780667|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
126344316|NCT00915525|454555855|FG001|Overall Study|Non-Compliance|1|||
126678742|NCT03099187|455780664|FG000|Double-blind Treatment|Disease progression|0|||
126344317|NCT00915525|454555854|FG000|Overall Study|Patient Moved|15|||
126344318|NCT00915525|454555855|FG001|Overall Study|Patient Moved|9|||
126344319|NCT00941928|454555856|FG000|Overall Study|Withdrawal by Subject|1|||
126344320|NCT00941928|454555856|FG000|Overall Study|Disease Progression|1|||
126344321|NCT02765035|454555868|FG000|First Intervention (90 Days)|Adverse Event|1|||
126344322|NCT02765035|454555869|FG001|First Intervention (90 Days)|Adverse Event|1|||
126344323|NCT02765035|454555868|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
126344324|NCT02765035|454555869|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
126344325|NCT01712178|454555870|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
126344326|NCT01712178|454555871|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
126344327|NCT01712178|454555870|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
126344328|NCT01712178|454555871|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
126344329|NCT01712178|454555870|FG000|Overall Study|Lost to Follow-up|0|||
126344330|NCT01712178|454555871|FG001|Overall Study|Lost to Follow-up|1|||
126344331|NCT00984867|454555872|FG000|Overall Study|Adverse Event|3|||
126344332|NCT00984867|454555873|FG001|Overall Study|Adverse Event|7|||
126344333|NCT00984867|454555872|FG000|Overall Study|Death|1|||
126344334|NCT00984867|454555873|FG001|Overall Study|Death|0|||
126344335|NCT00984867|454555872|FG000|Overall Study|Withdrawal by Subject|13|||
126344336|NCT00984867|454555873|FG001|Overall Study|Withdrawal by Subject|4|||
126344337|NCT00984867|454555872|FG000|Overall Study|Lost to Follow-up|3|||
126344338|NCT00984867|454555873|FG001|Overall Study|Lost to Follow-up|4|||
126344339|NCT00984867|454555872|FG000|Overall Study|Poor/non-compliance|0|||
126344340|NCT00984867|454555873|FG001|Overall Study|Poor/non-compliance|1|||
126344341|NCT00984867|454555872|FG000|Overall Study|Subject no longer meets study criteria|1|||
126344342|NCT00984867|454555873|FG001|Overall Study|Subject no longer meets study criteria|1|||
126344343|NCT00984867|454555872|FG000|Overall Study|site closing|1|||
126344344|NCT00984867|454555873|FG001|Overall Study|site closing|0|||
126344345|NCT00984867|454555872|FG000|Overall Study|lack of efficacy and subject compliance|1|||
126344346|NCT00984867|454555873|FG001|Overall Study|lack of efficacy and subject compliance|0|||
126344347|NCT01200355|454555878|FG000|Overall Study|Death|7|||
126344348|NCT01200355|454555879|FG001|Overall Study|Death|2|||
126344349|NCT03834350|454555880|FG000|Overall Study|Withdrawal by Subject|1|||
126344350|NCT02765165|454555881|FG000|Treatment Period|Progressive disease|3|||
126344351|NCT02765165|454555882|FG001|Treatment Period|Progressive disease|2|||
126344352|NCT02765165|454555883|FG002|Treatment Period|Progressive disease|3|||
126344353|NCT02765165|454555884|FG003|Treatment Period|Progressive disease|3|||
126344354|NCT02765165|454555885|FG004|Treatment Period|Progressive disease|4|||
126344355|NCT02765165|454555886|FG005|Treatment Period|Progressive disease|2|||
126344356|NCT02765165|454555887|FG006|Treatment Period|Progressive disease|2|||
126344357|NCT02765165|454555881|FG000|Treatment Period|Physician Decision|0|||
126344358|NCT02765165|454555882|FG001|Treatment Period|Physician Decision|1|||
126344359|NCT02765165|454555883|FG002|Treatment Period|Physician Decision|0|||
126344360|NCT02765165|454555884|FG003|Treatment Period|Physician Decision|0|||
126344361|NCT02765165|454555885|FG004|Treatment Period|Physician Decision|0|||
126344362|NCT02765165|454555886|FG005|Treatment Period|Physician Decision|0|||
126344363|NCT02765165|454555887|FG006|Treatment Period|Physician Decision|0|||
126344364|NCT02765165|454555881|FG000|Treatment Period|Adverse Event|0|||
126344365|NCT02765165|454555882|FG001|Treatment Period|Adverse Event|1|||
126344366|NCT02765165|454555883|FG002|Treatment Period|Adverse Event|0|||
126344367|NCT02765165|454555884|FG003|Treatment Period|Adverse Event|0|||
126344368|NCT02765165|454555885|FG004|Treatment Period|Adverse Event|0|||
126344369|NCT02765165|454555886|FG005|Treatment Period|Adverse Event|0|||
126344370|NCT02765165|454555887|FG006|Treatment Period|Adverse Event|0|||
126344371|NCT02765165|454555881|FG000|Treatment Period|Withdrawal by Subject|0|||
126344372|NCT02765165|454555882|FG001|Treatment Period|Withdrawal by Subject|0|||
126344373|NCT02765165|454555883|FG002|Treatment Period|Withdrawal by Subject|0|||
126344374|NCT02765165|454555884|FG003|Treatment Period|Withdrawal by Subject|0|||
126344375|NCT02765165|454555885|FG004|Treatment Period|Withdrawal by Subject|2|||
126344376|NCT02765165|454555886|FG005|Treatment Period|Withdrawal by Subject|0|||
126344377|NCT02765165|454555887|FG006|Treatment Period|Withdrawal by Subject|0|||
126344378|NCT02765165|454555881|FG000|Treatment Period|Study terminated|0|||
126430655|NCT00321789|454871975|FG001|Overall Study|Withdrawal by Subject|6|||
126344379|NCT02765165|454555882|FG001|Treatment Period|Study terminated|0|||
126344380|NCT02765165|454555883|FG002|Treatment Period|Study terminated|0|||
126344381|NCT02765165|454555884|FG003|Treatment Period|Study terminated|0|||
126344382|NCT02765165|454555885|FG004|Treatment Period|Study terminated|0|||
126344383|NCT02765165|454555886|FG005|Treatment Period|Study terminated|1|||
126344384|NCT02765165|454555887|FG006|Treatment Period|Study terminated|2|||
126344385|NCT02765165|454555881|FG000|Post-treatment Follow-up|Death|1|||
126344386|NCT02765165|454555882|FG001|Post-treatment Follow-up|Death|2|||
126344387|NCT02765165|454555883|FG002|Post-treatment Follow-up|Death|1|||
126344388|NCT02765165|454555884|FG003|Post-treatment Follow-up|Death|1|||
126344389|NCT02765165|454555885|FG004|Post-treatment Follow-up|Death|1|||
126344390|NCT02765165|454555886|FG005|Post-treatment Follow-up|Death|1|||
126344391|NCT02765165|454555887|FG006|Post-treatment Follow-up|Death|0|||
126344392|NCT02765165|454555881|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
126344393|NCT02765165|454555882|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
126344394|NCT02765165|454555883|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
126344395|NCT02765165|454555884|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
126344396|NCT02765165|454555885|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
126344397|NCT02765165|454555886|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
126344398|NCT02765165|454555887|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
126344399|NCT02765165|454555881|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
126344400|NCT02765165|454555882|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
126344401|NCT02765165|454555883|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
126344402|NCT02765165|454555884|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
126344403|NCT02765165|454555885|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
126344404|NCT02765165|454555886|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
126344405|NCT02765165|454555887|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
126344406|NCT02765165|454555881|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
126344407|NCT02765165|454555882|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
126344408|NCT02765165|454555883|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
126344409|NCT02765165|454555884|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
126344410|NCT02765165|454555885|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
126344411|NCT02765165|454555886|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
126344412|NCT02765165|454555887|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
126344413|NCT02765165|454555881|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
126344414|NCT02765165|454555882|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
126344415|NCT02765165|454555883|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
126344416|NCT02765165|454555884|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
126344417|NCT02765165|454555885|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
126344418|NCT02765165|454555886|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
126344419|NCT02765165|454555887|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
126344420|NCT02765165|454555881|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
126344421|NCT02765165|454555882|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
126344422|NCT02765165|454555883|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
126344423|NCT02765165|454555884|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
126344424|NCT02765165|454555885|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
126344425|NCT02765165|454555886|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
126344426|NCT02765165|454555887|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
126344427|NCT01206764|454555888|FG000|Overall Study|Adverse Event|20|||
126344428|NCT01206764|454555888|FG000|Overall Study|Abnormal laboratory value|2|||
126344429|NCT01206764|454555888|FG000|Overall Study|Abnormal test procedure result|1|||
126344430|NCT01206764|454555888|FG000|Overall Study|Patient withdrew consent|5|||
126344431|NCT01206764|454555888|FG000|Overall Study|Lost to Follow-up|6|||
126344432|NCT01206764|454555888|FG000|Overall Study|Death|11|||
126344433|NCT01206764|454555888|FG000|Overall Study|New cancer therapy|2|||
126344434|NCT01206764|454555888|FG000|Overall Study|Disease progression|88|||
126344435|NCT01206764|454555888|FG000|Overall Study|Protocol deviation|3|||
126344436|NCT02567188|454555889|FG000|Overall Study|Death|10|||
126344437|NCT02567188|454555889|FG000|Overall Study|Terminated Mircera Treatment|9|||
126344438|NCT02567188|454555889|FG000|Overall Study|Lost to Follow-up|5|||
126344439|NCT02567188|454555889|FG000|Overall Study|Adverse Event|1|||
126344440|NCT02567188|454555889|FG000|Overall Study|Withdrawal by Subject|1|||
126344441|NCT02567188|454555889|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
126344442|NCT02567188|454555889|FG000|Overall Study|Moved and Changed Clinic|1|||
126344443|NCT02567188|454555889|FG000|Overall Study|Started Hemodialysis|2|||
126344444|NCT02567188|454555889|FG000|Overall Study|Protocol Violation|5|||
126344445|NCT00321763|454555891|FG000|Overall Study|Adverse Event|1|||
126344446|NCT00321763|454555892|FG001|Overall Study|Adverse Event|1|||
126344447|NCT00321763|454555893|FG002|Overall Study|Adverse Event|0|||
126344448|NCT00321763|454555894|FG003|Overall Study|Adverse Event|1|||
126344449|NCT00321763|454555891|FG000|Overall Study|Withdrawal by Subject|2|||
126344450|NCT00321763|454555892|FG001|Overall Study|Withdrawal by Subject|0|||
126344451|NCT00321763|454555893|FG002|Overall Study|Withdrawal by Subject|1|||
126344452|NCT00321763|454555894|FG003|Overall Study|Withdrawal by Subject|0|||
126344453|NCT00321763|454555891|FG000|Overall Study|Lost to Follow-up|3|||
126344454|NCT00321763|454555892|FG001|Overall Study|Lost to Follow-up|1|||
126344455|NCT00321763|454555893|FG002|Overall Study|Lost to Follow-up|5|||
126344456|NCT00321763|454555894|FG003|Overall Study|Lost to Follow-up|4|||
126344457|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
126344458|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
126344459|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
126344460|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
126344461|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
126344462|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
126678743|NCT03099187|455780665|FG001|Double-blind Treatment|Disease progression|1|||
126678744|NCT03099187|455780666|FG002|Double-blind Treatment|Disease progression|0|||
126678745|NCT03099187|455780667|FG003|Double-blind Treatment|Disease progression|0|||
126678746|NCT03099187|455780664|FG000|Double-blind Treatment|Randomization error|0|||
126678747|NCT03099187|455780665|FG001|Double-blind Treatment|Randomization error|2|||
126678748|NCT03099187|455780666|FG002|Double-blind Treatment|Randomization error|0|||
126678749|NCT03099187|455780667|FG003|Double-blind Treatment|Randomization error|0|||
126344463|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
126344464|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
126344465|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
126344466|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
126344467|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
126344468|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
126344469|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
126344470|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
126344471|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
126344472|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
126344473|NCT00410163|454555895|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
126344474|NCT00410163|454555896|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
126344475|NCT00410163|454555895|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
126344476|NCT00410163|454555896|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
126344477|NCT00410163|454555895|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
126344478|NCT00410163|454555896|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
126344479|NCT00410163|454555895|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
126344480|NCT00410163|454555896|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
126344481|NCT00410163|454555895|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
126344482|NCT00410163|454555896|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
126344483|NCT00410163|454555895|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
126344484|NCT00410163|454555896|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
126344485|NCT00797563|454555898|FG000|Overall Study|Adverse Event|1|||
126344486|NCT00688597|454555899|FG000|Overall Study|Adverse Event|2|||
126344487|NCT00688597|454555900|FG001|Overall Study|Adverse Event|0|||
126344488|NCT00688597|454555901|FG002|Overall Study|Adverse Event|0|||
126344489|NCT00688597|454555899|FG000|Overall Study|Physician Decision|1|||
126344490|NCT00688597|454555900|FG001|Overall Study|Physician Decision|0|||
126344491|NCT00688597|454555901|FG002|Overall Study|Physician Decision|0|||
126344492|NCT05853120|454555904|FG000|Overall Study|Lost to Follow-up|4|||
126344493|NCT05853120|454555905|FG001|Overall Study|Lost to Follow-up|4|||
126344494|NCT05853120|454555904|FG000|Overall Study|Physician Decision|3|||
126344495|NCT05853120|454555905|FG001|Overall Study|Physician Decision|0|||
126344496|NCT05853120|454555904|FG000|Overall Study|Withdrawal by Subject|5|||
126344497|NCT05853120|454555905|FG001|Overall Study|Withdrawal by Subject|2|||
126344498|NCT00465517|454555910|FG000|Overall Study|Adverse Event|7|||
126344499|NCT00465517|454555911|FG001|Overall Study|Adverse Event|3|||
126344500|NCT00465517|454555910|FG000|Overall Study|Lost to Follow-up|1|||
126344501|NCT00465517|454555911|FG001|Overall Study|Lost to Follow-up|0|||
126344502|NCT00465517|454555910|FG000|Overall Study|Withdrawal by Subject|4|||
126344503|NCT00465517|454555911|FG001|Overall Study|Withdrawal by Subject|1|||
126344504|NCT05233761|454555918|FG000|Treatment Period A|Withdrawal by Subject|12|||
126344505|NCT05233761|454555919|FG001|Treatment Period A|Withdrawal by Subject|10|||
126344506|NCT05233761|454555918|FG000|Treatment Period A|Lost to Follow-up|6|||
126344507|NCT05233761|454555919|FG001|Treatment Period A|Lost to Follow-up|12|||
126344508|NCT05233761|454555918|FG000|Treatment Period A|Protocol Violation|8|||
126344509|NCT05233761|454555919|FG001|Treatment Period A|Protocol Violation|15|||
126344510|NCT01604785|454555920|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
126344511|NCT01604785|454555921|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
126344512|NCT05049122|454555924|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
126344513|NCT05049122|454555924|FG000|Overall Study|Participant moved|1|||
126344514|NCT05049122|454555924|FG000|Overall Study|At the direction of the doctor|1|||
126344515|NCT04798027|454555927|FG000|Overall Study|Protocol Violation|0|||
126344516|NCT04798027|454555928|FG001|Overall Study|Protocol Violation|0|||
126344517|NCT04798027|454555929|FG002|Overall Study|Protocol Violation|0|||
126344518|NCT04798027|454555930|FG003|Overall Study|Protocol Violation|0|||
126344519|NCT04798027|454555931|FG004|Overall Study|Protocol Violation|1|||
126344520|NCT04798027|454555932|FG005|Overall Study|Protocol Violation|0|||
126344521|NCT04798027|454555933|FG006|Overall Study|Protocol Violation|0|||
126344522|NCT04798027|454555934|FG007|Overall Study|Protocol Violation|1|||
126344523|NCT04798027|454555935|FG008|Overall Study|Protocol Violation|0|||
126344524|NCT04798027|454555927|FG000|Overall Study|Withdrawal by Subject|1|||
126344525|NCT04798027|454555928|FG001|Overall Study|Withdrawal by Subject|0|||
126678750|NCT03099187|455780664|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
126678751|NCT03099187|455780665|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
126678752|NCT03099187|455780666|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
126678753|NCT03099187|455780667|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
126678754|NCT03099187|455780664|FG000|12-month Safety Follow-up|Adverse Event|0|||
126678755|NCT03099187|455780665|FG001|12-month Safety Follow-up|Adverse Event|0|||
126678756|NCT03099187|455780666|FG002|12-month Safety Follow-up|Adverse Event|5|||
126678757|NCT03099187|455780667|FG003|12-month Safety Follow-up|Adverse Event|12|||
126678758|NCT03099187|455780664|FG000|12-month Safety Follow-up|Death|0|||
126678759|NCT03099187|455780665|FG001|12-month Safety Follow-up|Death|0|||
126678760|NCT03099187|455780666|FG002|12-month Safety Follow-up|Death|7|||
126678761|NCT03099187|455780667|FG003|12-month Safety Follow-up|Death|9|||
126678762|NCT03099187|455780664|FG000|12-month Safety Follow-up|Lung transplantation|0|||
126678763|NCT03099187|455780665|FG001|12-month Safety Follow-up|Lung transplantation|0|||
126678764|NCT03099187|455780666|FG002|12-month Safety Follow-up|Lung transplantation|2|||
126678765|NCT03099187|455780667|FG003|12-month Safety Follow-up|Lung transplantation|1|||
126678766|NCT03099187|455780664|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
126678767|NCT03099187|455780665|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
126678768|NCT03099187|455780666|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
126678769|NCT03099187|455780667|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
126678770|NCT03099187|455780664|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
126678771|NCT03099187|455780665|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
126678772|NCT03099187|455780666|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
126678773|NCT03099187|455780667|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
126678774|NCT03099187|455780664|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
126678775|NCT03099187|455780665|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
126678776|NCT03099187|455780666|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
126678777|NCT03099187|455780667|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
126678778|NCT03099187|455780664|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
126678779|NCT03099187|455780665|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
126678780|NCT03099187|455780666|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
126678781|NCT03099187|455780667|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
126678782|NCT01439555|455780668|FG000|Overall Study|Protocol Violation|1|||
126678783|NCT01246583|455780669|FG000|Overall Study|Lost to Follow-up|0|||
126678784|NCT01246583|455780670|FG001|Overall Study|Lost to Follow-up|0|||
126678785|NCT01246583|455780671|FG002|Overall Study|Lost to Follow-up|0|||
126678786|NCT01246583|455780672|FG003|Overall Study|Lost to Follow-up|1|||
126678787|NCT01246583|455780669|FG000|Overall Study|Protocol Violation|0|||
126678788|NCT01246583|455780670|FG001|Overall Study|Protocol Violation|0|||
126678789|NCT01246583|455780671|FG002|Overall Study|Protocol Violation|1|||
126678790|NCT01246583|455780672|FG003|Overall Study|Protocol Violation|0|||
126678791|NCT01246583|455780669|FG000|Overall Study|Withdrawal by Subject|1|||
126678792|NCT01246583|455780670|FG001|Overall Study|Withdrawal by Subject|0|||
126678793|NCT01246583|455780671|FG002|Overall Study|Withdrawal by Subject|0|||
126344526|NCT04798027|454555929|FG002|Overall Study|Withdrawal by Subject|1|||
126344527|NCT04798027|454555930|FG003|Overall Study|Withdrawal by Subject|1|||
126344528|NCT04798027|454555931|FG004|Overall Study|Withdrawal by Subject|1|||
126344529|NCT04798027|454555932|FG005|Overall Study|Withdrawal by Subject|1|||
126344530|NCT04798027|454555933|FG006|Overall Study|Withdrawal by Subject|3|||
126344531|NCT04798027|454555934|FG007|Overall Study|Withdrawal by Subject|2|||
126344532|NCT04798027|454555935|FG008|Overall Study|Withdrawal by Subject|2|||
126344533|NCT04798027|454555927|FG000|Overall Study|Lost to Follow-up|1|||
126344534|NCT04798027|454555928|FG001|Overall Study|Lost to Follow-up|3|||
126344535|NCT04798027|454555929|FG002|Overall Study|Lost to Follow-up|0|||
126344536|NCT04798027|454555930|FG003|Overall Study|Lost to Follow-up|0|||
126344537|NCT04798027|454555931|FG004|Overall Study|Lost to Follow-up|0|||
126344538|NCT04798027|454555932|FG005|Overall Study|Lost to Follow-up|1|||
126344539|NCT04798027|454555933|FG006|Overall Study|Lost to Follow-up|0|||
126344540|NCT04798027|454555934|FG007|Overall Study|Lost to Follow-up|0|||
126344541|NCT04798027|454555935|FG008|Overall Study|Lost to Follow-up|1|||
126344542|NCT04798027|454555927|FG000|Overall Study|Withdrawal by Sponsor|8|||
126344543|NCT04798027|454555928|FG001|Overall Study|Withdrawal by Sponsor|22|||
126344544|NCT04798027|454555929|FG002|Overall Study|Withdrawal by Sponsor|9|||
126344545|NCT04798027|454555930|FG003|Overall Study|Withdrawal by Sponsor|26|||
126678794|NCT01246583|455780672|FG003|Overall Study|Withdrawal by Subject|0|||
126678795|NCT04218201|455782603|FG000|Overall Study|Death|0|||
126678796|NCT04218201|455782604|FG001|Overall Study|Death|0|||
126344546|NCT04798027|454555931|FG004|Overall Study|Withdrawal by Sponsor|24|||
126344547|NCT04798027|454555932|FG005|Overall Study|Withdrawal by Sponsor|11|||
126344548|NCT04798027|454555933|FG006|Overall Study|Withdrawal by Sponsor|25|||
126344549|NCT04798027|454555934|FG007|Overall Study|Withdrawal by Sponsor|26|||
126344550|NCT04798027|454555935|FG008|Overall Study|Withdrawal by Sponsor|11|||
126344551|NCT04585893|454555936|FG000|Overall Study|Death|1|||
126678797|NCT04218201|455782605|FG002|Overall Study|Death|2|||
126678798|NCT04218201|455782606|FG003|Overall Study|Death|0|||
126430656|NCT00321789|454871974|FG000|Overall Study|Protocol Violation|5|||
126430657|NCT00321789|454871975|FG001|Overall Study|Protocol Violation|3|||
126430658|NCT03309020|454871977|FG000|Overall Study|Death|1|||
126430659|NCT03309020|454871978|FG001|Overall Study|Death|0|||
126430660|NCT03309020|454871977|FG000|Overall Study|Did not undergo surgery|2|||
126430661|NCT03309020|454871978|FG001|Overall Study|Did not undergo surgery|1|||
126430662|NCT02919761|454871981|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
126430663|NCT02919761|454871982|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
126678799|NCT04218201|455782603|FG000|Overall Study|Unable to contact participant|4|||
126678800|NCT04218201|455782604|FG001|Overall Study|Unable to contact participant|0|||
126430664|NCT02919761|454871983|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
126430665|NCT02919761|454871981|FG000|Part 1: Open Label|Adverse Event|1|||
126430666|NCT02919761|454871982|FG001|Part 1: Open Label|Adverse Event|0|||
126430667|NCT02919761|454871983|FG002|Part 1: Open Label|Adverse Event|0|||
126430668|NCT02919761|454871981|FG000|Part 1: Open Label|Lost to Follow-up|1|||
126678801|NCT04218201|455782605|FG002|Overall Study|Unable to contact participant|3|||
126678802|NCT04218201|455782606|FG003|Overall Study|Unable to contact participant|0|||
126678803|NCT04218201|455782603|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
126678804|NCT04218201|455782604|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
126678805|NCT04218201|455782605|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
126430669|NCT02919761|454871982|FG001|Part 1: Open Label|Lost to Follow-up|0|||
126430670|NCT02919761|454871983|FG002|Part 1: Open Label|Lost to Follow-up|0|||
126430671|NCT02919761|454871981|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
126430672|NCT02919761|454871982|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
126430673|NCT02919761|454871983|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
126430674|NCT02919761|454871981|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
126430675|NCT02919761|454871982|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
126430676|NCT02919761|454871983|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
126430677|NCT02919761|454871981|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
126430678|NCT02919761|454871982|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
126430679|NCT02919761|454871983|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
126430680|NCT02919761|454871981|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
126430681|NCT02919761|454871982|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
126430682|NCT02919761|454871983|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
126430683|NCT02919761|454871981|FG000|Part 1: Open Label|Termination by Sponsor|1|||
126430684|NCT02919761|454871982|FG001|Part 1: Open Label|Termination by Sponsor|0|||
126430685|NCT02919761|454871983|FG002|Part 1: Open Label|Termination by Sponsor|0|||
126430686|NCT02919761|454871981|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
126430687|NCT02919761|454871982|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
126430688|NCT02919761|454871983|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
126430689|NCT02919761|454871981|FG000|Part 2: Double-blind|Adverse Event|0|||
126430690|NCT02919761|454871982|FG001|Part 2: Double-blind|Adverse Event|1|||
126430691|NCT02919761|454871983|FG002|Part 2: Double-blind|Adverse Event|0|||
126678806|NCT04218201|455782606|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
126678807|NCT04218201|455782603|FG000|Overall Study|Withdrawal by Subject|2|||
126678808|NCT04218201|455782604|FG001|Overall Study|Withdrawal by Subject|0|||
126678809|NCT04218201|455782605|FG002|Overall Study|Withdrawal by Subject|0|||
126678810|NCT04218201|455782606|FG003|Overall Study|Withdrawal by Subject|0|||
126678811|NCT04218201|455782603|FG000|Overall Study|PCP plans to leave practice|0|||
126678812|NCT04218201|455782604|FG001|Overall Study|PCP plans to leave practice|8|||
126678813|NCT04218201|455782605|FG002|Overall Study|PCP plans to leave practice|0|||
126678814|NCT04218201|455782606|FG003|Overall Study|PCP plans to leave practice|5|||
126678815|NCT04218201|455782603|FG000|Overall Study|Reduced panel|0|||
126678816|NCT04218201|455782604|FG001|Overall Study|Reduced panel|0|||
126678817|NCT04218201|455782605|FG002|Overall Study|Reduced panel|0|||
126678818|NCT04218201|455782606|FG003|Overall Study|Reduced panel|1|||
126678819|NCT04218201|455782603|FG000|Overall Study|No longer interested in participating|0|||
126678820|NCT04218201|455782604|FG001|Overall Study|No longer interested in participating|1|||
126678821|NCT04218201|455782605|FG002|Overall Study|No longer interested in participating|0|||
126678822|NCT04218201|455782606|FG003|Overall Study|No longer interested in participating|0|||
126678823|NCT03723707|455782613|FG000|Overall Study|Death|32|||
126678824|NCT03723707|455782614|FG001|Overall Study|Death|32|||
126678825|NCT03723707|455782613|FG000|Overall Study|Admitted to long term care|12|||
126430692|NCT02919761|454871981|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
126678826|NCT03723707|455782614|FG001|Overall Study|Admitted to long term care|12|||
126678827|NCT03723707|455782613|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
126678828|NCT03723707|455782614|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
126678829|NCT03723707|455782613|FG000|Overall Study|Lost to Follow-up|40|||
126678830|NCT03723707|455782614|FG001|Overall Study|Lost to Follow-up|22|||
126678831|NCT03723707|455782613|FG000|Overall Study|Discontinued after study closure|24|||
126678832|NCT03723707|455782614|FG001|Overall Study|Discontinued after study closure|12|||
126678833|NCT05121480|455782615|FG000|Overall Study|Lack of Efficacy|2|||
126678834|NCT05121480|455782616|FG001|Overall Study|Lack of Efficacy|2|||
126678835|NCT05121480|455782617|FG002|Overall Study|Lack of Efficacy|1|||
126344552|NCT04585893|454555937|FG001|Overall Study|Death|0|||
126344553|NCT02100631|454557148|FG000|Overall Study|Withdrawal by Subject|1|||
126344554|NCT02100631|454557149|FG001|Overall Study|Withdrawal by Subject|0|||
126678836|NCT05121480|455782618|FG003|Overall Study|Lack of Efficacy|4|||
126678837|NCT05121480|455782619|FG004|Overall Study|Lack of Efficacy|0|||
126678838|NCT05121480|455782620|FG005|Overall Study|Lack of Efficacy|1|||
126678839|NCT05121480|455782621|FG006|Overall Study|Lack of Efficacy|0|||
126678840|NCT05121480|455782622|FG007|Overall Study|Lack of Efficacy|2|||
126678841|NCT05121480|455782615|FG000|Overall Study|Treatment Failure|0|||
126678842|NCT05121480|455782616|FG001|Overall Study|Treatment Failure|2|||
126678843|NCT05121480|455782617|FG002|Overall Study|Treatment Failure|0|||
126678844|NCT05121480|455782618|FG003|Overall Study|Treatment Failure|1|||
126678845|NCT05121480|455782619|FG004|Overall Study|Treatment Failure|0|||
126678846|NCT05121480|455782620|FG005|Overall Study|Treatment Failure|0|||
126678847|NCT05121480|455782621|FG006|Overall Study|Treatment Failure|0|||
126678848|NCT05121480|455782622|FG007|Overall Study|Treatment Failure|0|||
126678849|NCT05121480|455782615|FG000|Overall Study|Adverse Event|0|||
126678850|NCT05121480|455782616|FG001|Overall Study|Adverse Event|1|||
126678851|NCT05121480|455782617|FG002|Overall Study|Adverse Event|0|||
126678852|NCT05121480|455782618|FG003|Overall Study|Adverse Event|5|||
126678853|NCT05121480|455782619|FG004|Overall Study|Adverse Event|3|||
126344555|NCT02100631|454557150|FG002|Overall Study|Withdrawal by Subject|0|||
126344556|NCT02100631|454557148|FG000|Overall Study|Lost to Follow-up|3|||
126344557|NCT02100631|454557149|FG001|Overall Study|Lost to Follow-up|4|||
126344558|NCT02100631|454557150|FG002|Overall Study|Lost to Follow-up|0|||
126344559|NCT02100631|454557148|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
126344560|NCT02100631|454557149|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
126344561|NCT02100631|454557150|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
126344562|NCT00300053|454557151|FG000|Overall Study|Patient/Caregiver Preference|2|||
126344563|NCT00300053|454557152|FG001|Overall Study|Patient/Caregiver Preference|2|||
126344564|NCT00300053|454557153|FG002|Overall Study|Patient/Caregiver Preference|3|||
126344565|NCT00300053|454557151|FG000|Overall Study|Death|0|||
126344566|NCT00300053|454557152|FG001|Overall Study|Death|0|||
126344567|NCT00300053|454557153|FG002|Overall Study|Death|3|||
126344568|NCT00300053|454557151|FG000|Overall Study|Lost to Follow-up|0|||
126344569|NCT00300053|454557152|FG001|Overall Study|Lost to Follow-up|1|||
126344570|NCT00300053|454557153|FG002|Overall Study|Lost to Follow-up|0|||
126344571|NCT02472405|454557154|FG000|Overall Study|Lost to Follow-up|9|||
126344572|NCT02472405|454557154|FG000|Overall Study|Adverse Event|1|||
126344573|NCT03261401|454557155|FG000|Overall Study|Withdrawal by Subject|0|||
126344574|NCT03261401|454557156|FG001|Overall Study|Withdrawal by Subject|0|||
126344575|NCT03261401|454557157|FG002|Overall Study|Withdrawal by Subject|0|||
126344576|NCT03261401|454557158|FG003|Overall Study|Withdrawal by Subject|0|||
126344577|NCT03261401|454557159|FG004|Overall Study|Withdrawal by Subject|0|||
126344578|NCT03261401|454557160|FG005|Overall Study|Withdrawal by Subject|1|||
126344579|NCT03261401|454557161|FG006|Overall Study|Withdrawal by Subject|0|||
126344580|NCT03261401|454557162|FG007|Overall Study|Withdrawal by Subject|0|||
126344581|NCT03261401|454557163|FG008|Overall Study|Withdrawal by Subject|0|||
126344582|NCT03261401|454557164|FG009|Overall Study|Withdrawal by Subject|0|||
126344583|NCT03261401|454557165|FG010|Overall Study|Withdrawal by Subject|0|||
126344584|NCT03261401|454557166|FG011|Overall Study|Withdrawal by Subject|0|||
126344585|NCT03261401|454557167|FG012|Overall Study|Withdrawal by Subject|0|||
126344586|NCT03261401|454557155|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
126344587|NCT03261401|454557156|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
126344588|NCT03261401|454557157|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
126344589|NCT03261401|454557158|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
126344590|NCT03261401|454557159|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
126344591|NCT03261401|454557160|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
126344592|NCT03261401|454557161|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
126344593|NCT03261401|454557162|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
126344594|NCT03261401|454557163|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
126344595|NCT03261401|454557164|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
126344596|NCT03261401|454557165|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
126344597|NCT03261401|454557166|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
126344598|NCT03261401|454557167|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
126678854|NCT05121480|455782620|FG005|Overall Study|Adverse Event|2|||
126678855|NCT05121480|455782621|FG006|Overall Study|Adverse Event|0|||
126430693|NCT02919761|454871982|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
126678856|NCT05121480|455782622|FG007|Overall Study|Adverse Event|4|||
126678857|NCT05121480|455782615|FG000|Overall Study|Withdrawal by Subject|4|||
126344599|NCT01983930|454557173|FG000|Overall Study|Withdrawal by Subject|9|||
126344600|NCT01983930|454557174|FG001|Overall Study|Withdrawal by Subject|8|||
126678858|NCT05121480|455782616|FG001|Overall Study|Withdrawal by Subject|9|||
126344601|NCT01983930|454557173|FG000|Overall Study|Adverse Event|0|||
126344602|NCT01983930|454557174|FG001|Overall Study|Adverse Event|1|||
126344603|NCT03482024|454557179|FG000|Overall Study|Physician Decision|1|||
126344604|NCT03482024|454557180|FG001|Overall Study|Physician Decision|0|||
126344605|NCT03482024|454557181|FG002|Overall Study|Physician Decision|0|||
126344606|NCT03482024|454557182|FG003|Overall Study|Physician Decision|0|||
126344607|NCT03482024|454557183|FG004|Overall Study|Physician Decision|0|||
126344608|NCT00634504|454557184|FG000|Overall Study|Protocol Violation|1|||
126344609|NCT00634504|454557185|FG001|Overall Study|Protocol Violation|0|||
126344610|NCT05001620|454557188|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
126344611|NCT05001620|454557189|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
126344612|NCT00481676|454557190|FG000|Overall Study|Adverse Event|0|||
126344613|NCT00481676|454557191|FG001|Overall Study|Adverse Event|1|||
126344614|NCT00481676|454557190|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126344615|NCT00481676|454557191|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
126344616|NCT00481676|454557190|FG000|Overall Study|Administrative problem|1|||
126344617|NCT00481676|454557191|FG001|Overall Study|Administrative problem|0|||
126344618|NCT03937778|454557192|FG000|Overall Study|Withdrawal by Subject|1|||
126344619|NCT03937778|454557192|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
126344620|NCT00819039|454557193|FG000|Overall Study|Physician Decision|1|||
126344621|NCT00819039|454557194|FG001|Overall Study|Physician Decision|0|||
126344622|NCT00819039|454557195|FG002|Overall Study|Physician Decision|1|||
126344623|NCT00819039|454557193|FG000|Overall Study|Protocol Violation|1|||
126344624|NCT00819039|454557194|FG001|Overall Study|Protocol Violation|0|||
126344625|NCT00819039|454557195|FG002|Overall Study|Protocol Violation|0|||
126344626|NCT01240694|454557196|FG000|Overall Study|Adverse Event|9|||
126344627|NCT01240694|454557196|FG000|Overall Study|Lack of Efficacy|6|||
126344628|NCT01240694|454557196|FG000|Overall Study|Withdrawal by Subject|6|||
126344629|NCT01240694|454557196|FG000|Overall Study|Protocol Violation|2|||
126344630|NCT01240694|454557196|FG000|Overall Study|Lost to Follow-up|2|||
126344631|NCT01240694|454557196|FG000|Overall Study|Other than specified|3|||
126678859|NCT05121480|455782617|FG002|Overall Study|Withdrawal by Subject|1|||
126678860|NCT05121480|455782618|FG003|Overall Study|Withdrawal by Subject|8|||
126344632|NCT01240694|454557196|FG000|Overall Study|Withdrawn due to early study termination|107|||
126344633|NCT01513590|454557197|FG000|Overall Study|Adverse Event|2|||
126344634|NCT01513590|454557198|FG001|Overall Study|Adverse Event|3|||
126344635|NCT01513590|454557197|FG000|Overall Study|Withdrawal Criteria|3|||
126678861|NCT05121480|455782619|FG004|Overall Study|Withdrawal by Subject|0|||
126678862|NCT05121480|455782620|FG005|Overall Study|Withdrawal by Subject|9|||
126678863|NCT05121480|455782621|FG006|Overall Study|Withdrawal by Subject|0|||
126678864|NCT05121480|455782622|FG007|Overall Study|Withdrawal by Subject|4|||
126678865|NCT05121480|455782615|FG000|Overall Study|Non-compliance with the protocol|0|||
126678866|NCT05121480|455782616|FG001|Overall Study|Non-compliance with the protocol|0|||
126678867|NCT05121480|455782617|FG002|Overall Study|Non-compliance with the protocol|0|||
126678868|NCT05121480|455782618|FG003|Overall Study|Non-compliance with the protocol|0|||
126678869|NCT05121480|455782619|FG004|Overall Study|Non-compliance with the protocol|1|||
126678870|NCT05121480|455782620|FG005|Overall Study|Non-compliance with the protocol|6|||
126678871|NCT05121480|455782621|FG006|Overall Study|Non-compliance with the protocol|0|||
126678872|NCT05121480|455782622|FG007|Overall Study|Non-compliance with the protocol|1|||
126678873|NCT05121480|455782615|FG000|Overall Study|Lost to Follow-up|0|||
126678874|NCT05121480|455782616|FG001|Overall Study|Lost to Follow-up|4|||
126678875|NCT05121480|455782617|FG002|Overall Study|Lost to Follow-up|1|||
126678876|NCT05121480|455782618|FG003|Overall Study|Lost to Follow-up|3|||
126678877|NCT05121480|455782619|FG004|Overall Study|Lost to Follow-up|1|||
126678878|NCT05121480|455782620|FG005|Overall Study|Lost to Follow-up|1|||
126678879|NCT05121480|455782621|FG006|Overall Study|Lost to Follow-up|1|||
126678880|NCT05121480|455782622|FG007|Overall Study|Lost to Follow-up|4|||
126678881|NCT05121480|455782615|FG000|Overall Study|Physician Decision|0|||
126678882|NCT05121480|455782616|FG001|Overall Study|Physician Decision|0|||
126678883|NCT05121480|455782617|FG002|Overall Study|Physician Decision|0|||
126678884|NCT05121480|455782618|FG003|Overall Study|Physician Decision|0|||
126678885|NCT05121480|455782619|FG004|Overall Study|Physician Decision|0|||
126678886|NCT05121480|455782620|FG005|Overall Study|Physician Decision|1|||
126678887|NCT05121480|455782621|FG006|Overall Study|Physician Decision|0|||
126678888|NCT05121480|455782622|FG007|Overall Study|Physician Decision|1|||
126678889|NCT05121480|455782615|FG000|Overall Study|Other Reason|0|||
126678890|NCT05121480|455782616|FG001|Overall Study|Other Reason|0|||
126678891|NCT05121480|455782617|FG002|Overall Study|Other Reason|0|||
126344636|NCT01513590|454557198|FG001|Overall Study|Withdrawal Criteria|0|||
126344637|NCT01513590|454557197|FG000|Overall Study|Unclassified|5|||
126344638|NCT01513590|454557198|FG001|Overall Study|Unclassified|10|||
126678892|NCT05121480|455782618|FG003|Overall Study|Other Reason|0|||
126678893|NCT05121480|455782619|FG004|Overall Study|Other Reason|0|||
126344639|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
126344640|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
126344641|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
126678894|NCT05121480|455782620|FG005|Overall Study|Other Reason|1|||
126678895|NCT05121480|455782621|FG006|Overall Study|Other Reason|1|||
126678896|NCT05121480|455782622|FG007|Overall Study|Other Reason|1|||
126678897|NCT02831673|455782625|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
126678898|NCT02831673|455782626|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
126678899|NCT02831673|455782627|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
126678900|NCT02831673|455782628|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
126678901|NCT02831673|455782629|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
126678902|NCT02831673|455782625|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
126678903|NCT02831673|455782626|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
126678904|NCT02831673|455782627|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
126678905|NCT02831673|455782628|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
126678906|NCT02831673|455782629|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
126344642|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
126344643|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
126344644|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
126678907|NCT02831673|455782625|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
126678908|NCT02831673|455782626|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
126678909|NCT02831673|455782627|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
126678910|NCT02831673|455782628|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
126678911|NCT02831673|455782629|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
126678912|NCT02831673|455782625|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
126678913|NCT02831673|455782626|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
126678914|NCT02831673|455782627|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
126678915|NCT02831673|455782628|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
126678916|NCT02831673|455782629|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
126678917|NCT02831673|455782625|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
126678918|NCT02831673|455782626|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
126678919|NCT02831673|455782627|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
126344645|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
126678920|NCT02831673|455782628|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
126678921|NCT02831673|455782629|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
126678922|NCT02831673|455782625|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
126678923|NCT02831673|455782626|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
126678924|NCT02831673|455782627|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
126678925|NCT02831673|455782628|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
126678926|NCT02831673|455782629|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
126678927|NCT02831673|455782625|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
126678928|NCT02831673|455782626|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
126678929|NCT02831673|455782627|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
126678930|NCT02831673|455782628|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
126678931|NCT02831673|455782629|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
126678932|NCT02831673|455782625|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
126344646|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
126344647|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
126344648|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
126344649|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Death|3|||
126344650|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Death|1|||
126344651|NCT01056276|454557199|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
126344652|NCT01056276|454557200|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
126344653|NCT01056276|454557199|FG000|Maintenance Therapy|Toxicity|0|||
126344654|NCT01056276|454557200|FG001|Maintenance Therapy|Toxicity|2|||
126344655|NCT01056276|454557199|FG000|Maintenance Therapy|Progressive Disease|0|||
126344656|NCT01056276|454557200|FG001|Maintenance Therapy|Progressive Disease|9|||
126344657|NCT01056276|454557199|FG000|Maintenance Therapy|Physician Decision|0|||
126344658|NCT01056276|454557200|FG001|Maintenance Therapy|Physician Decision|1|||
126344659|NCT01056276|454557199|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
126344660|NCT01056276|454557200|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
126344661|NCT01056276|454557199|FG000|Maintenance Therapy|Intercurrent Illness|0|||
126678933|NCT02831673|455782626|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
126678934|NCT02831673|455782627|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
126678935|NCT02831673|455782628|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
126344662|NCT01056276|454557200|FG001|Maintenance Therapy|Intercurrent Illness|1|||
126344663|NCT01056276|454557199|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
126344664|NCT01056276|454557200|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
126678936|NCT02831673|455782629|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
126678937|NCT02831673|455782625|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
126678938|NCT02831673|455782626|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
126344665|NCT01881425|454557201|FG000|Overall Study|Death|5|||
126344666|NCT01881425|454557202|FG001|Overall Study|Death|1|||
126344667|NCT01881425|454557201|FG000|Overall Study|Withdrawal by Subject|8|||
126344668|NCT01881425|454557202|FG001|Overall Study|Withdrawal by Subject|3|||
126344669|NCT01881425|454557201|FG000|Overall Study|Physician Decision|2|||
126344670|NCT01881425|454557202|FG001|Overall Study|Physician Decision|1|||
126344671|NCT01881425|454557201|FG000|Overall Study|Adverse Event|3|||
126344672|NCT01881425|454557202|FG001|Overall Study|Adverse Event|0|||
126344673|NCT01881425|454557201|FG000|Overall Study|General Anesthesia panic attack|0|||
126344674|NCT01881425|454557202|FG001|Overall Study|General Anesthesia panic attack|1|||
126344675|NCT01881425|454557201|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
126344676|NCT01881425|454557202|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
126344677|NCT01881425|454557201|FG000|Overall Study|Lost to Follow-up|7|||
126344678|NCT01881425|454557202|FG001|Overall Study|Lost to Follow-up|2|||
126344679|NCT04424901|454557209|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
126344680|NCT04424901|454557210|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
126344681|NCT00147238|454557211|FG000|Overall Study|Inevaluable|8|||
126344682|NCT00297167|454557212|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
126344683|NCT00297167|454557213|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
126344684|NCT00297167|454557214|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
126344685|NCT00297167|454557212|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
126344686|NCT00297167|454557213|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
126344687|NCT00297167|454557214|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
126344688|NCT03185208|454557218|FG000|Overall Study|Did not start study medication|0|||
126344689|NCT03185208|454557219|FG001|Overall Study|Did not start study medication|3|||
126344690|NCT02410629|454557220|FG000|Overall Study|Family cannot commit to the study|2|||
126344691|NCT02410629|454557221|FG001|Overall Study|Family cannot commit to the study|1|||
126344692|NCT02410629|454557220|FG000|Overall Study|Subject returned to work|1|||
126344693|NCT02410629|454557221|FG001|Overall Study|Subject returned to work|0|||
126344694|NCT02410629|454557220|FG000|Overall Study|Subject moved back to home country|0|||
126344695|NCT02410629|454557221|FG001|Overall Study|Subject moved back to home country|1|||
126344696|NCT02410629|454557220|FG000|Overall Study|Subject underwent heart surgery|0|||
126344697|NCT02410629|454557221|FG001|Overall Study|Subject underwent heart surgery|1|||
126344698|NCT02701634|454557222|FG000|Overall Study|Adverse Event|2|||
126344699|NCT02701634|454557223|FG001|Overall Study|Adverse Event|3|||
126344700|NCT02701634|454557222|FG000|Overall Study|Death|1|||
126344701|NCT02701634|454557223|FG001|Overall Study|Death|0|||
126344702|NCT02701634|454557222|FG000|Overall Study|Investigator's Discretion|7|||
126344703|NCT02701634|454557223|FG001|Overall Study|Investigator's Discretion|4|||
126344704|NCT02701634|454557222|FG000|Overall Study|Study terminated by Sponsor|15|||
126344705|NCT02701634|454557223|FG001|Overall Study|Study terminated by Sponsor|17|||
126344706|NCT02701634|454557222|FG000|Overall Study|Withdrew Consent|6|||
126344707|NCT02701634|454557223|FG001|Overall Study|Withdrew Consent|7|||
126344708|NCT02701634|454557222|FG000|Overall Study|Randomized but not treated|1|||
126344709|NCT02701634|454557223|FG001|Overall Study|Randomized but not treated|0|||
126344710|NCT01186770|454557224|FG000|Overall Study|Ineligibility|0|||
126344711|NCT01186770|454557225|FG001|Overall Study|Ineligibility|0|||
126344712|NCT01186770|454557226|FG002|Overall Study|Ineligibility|2|||
126344713|NCT01186770|454557227|FG003|Overall Study|Ineligibility|0|||
126344714|NCT01186770|454557224|FG000|Overall Study|Protocol Violation|7|||
126344715|NCT01186770|454557225|FG001|Overall Study|Protocol Violation|9|||
126344716|NCT01186770|454557226|FG002|Overall Study|Protocol Violation|12|||
126344717|NCT01186770|454557227|FG003|Overall Study|Protocol Violation|14|||
126344718|NCT01186770|454557224|FG000|Overall Study|Adverse Event|2|||
126344719|NCT01186770|454557225|FG001|Overall Study|Adverse Event|9|||
126344720|NCT01186770|454557226|FG002|Overall Study|Adverse Event|7|||
126344721|NCT01186770|454557227|FG003|Overall Study|Adverse Event|9|||
126344722|NCT01186770|454557224|FG000|Overall Study|Withdrawal by Subject|15|||
126344723|NCT01186770|454557225|FG001|Overall Study|Withdrawal by Subject|13|||
126344724|NCT01186770|454557226|FG002|Overall Study|Withdrawal by Subject|11|||
126344725|NCT01186770|454557227|FG003|Overall Study|Withdrawal by Subject|17|||
126344726|NCT01186770|454557224|FG000|Overall Study|Lost to Follow-up|10|||
126344727|NCT01186770|454557225|FG001|Overall Study|Lost to Follow-up|6|||
126344728|NCT01186770|454557226|FG002|Overall Study|Lost to Follow-up|14|||
126344729|NCT01186770|454557227|FG003|Overall Study|Lost to Follow-up|9|||
126344730|NCT01186770|454557224|FG000|Overall Study|Insufficient response to treatment|7|||
126344731|NCT01186770|454557225|FG001|Overall Study|Insufficient response to treatment|8|||
126344732|NCT01186770|454557226|FG002|Overall Study|Insufficient response to treatment|5|||
126344733|NCT01186770|454557227|FG003|Overall Study|Insufficient response to treatment|7|||
126344734|NCT01186770|454557224|FG000|Overall Study|Other than specified|0|||
126344735|NCT01186770|454557225|FG001|Overall Study|Other than specified|1|||
126344736|NCT01186770|454557226|FG002|Overall Study|Other than specified|1|||
126344737|NCT01186770|454557227|FG003|Overall Study|Other than specified|2|||
126344738|NCT01033136|454557228|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
126344739|NCT01033136|454557229|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
126344740|NCT01572792|454557234|FG000|Lead-in Study|Lost to Follow-up|5|||
126678939|NCT02831673|455782627|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
126678940|NCT02831673|455782628|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
126678941|NCT02831673|455782629|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
126678942|NCT02831673|455782625|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126678943|NCT02831673|455782626|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126678944|NCT02831673|455782627|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
126678945|NCT02831673|455782628|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
126678946|NCT02831673|455782629|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
126678947|NCT02831673|455782625|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126678948|NCT02831673|455782626|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126678949|NCT02831673|455782627|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126678950|NCT02831673|455782628|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
126678951|NCT02831673|455782629|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
126678952|NCT02831673|455782625|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
126678953|NCT02831673|455782626|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
126678954|NCT02831673|455782627|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
126678955|NCT02831673|455782628|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
126678956|NCT02831673|455782629|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
126678957|NCT02831673|455782625|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
126678958|NCT02831673|455782626|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
126678959|NCT02831673|455782627|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
126678960|NCT02831673|455782628|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
126678961|NCT02831673|455782629|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
126678962|NCT02831673|455782625|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
126678963|NCT02831673|455782626|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
126678964|NCT02831673|455782627|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
126678965|NCT02831673|455782628|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
126678966|NCT02831673|455782629|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
126678967|NCT02831673|455782625|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
126678968|NCT02831673|455782626|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
126678969|NCT02831673|455782627|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
126678970|NCT02831673|455782628|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
126678971|NCT02831673|455782629|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
126678972|NCT02831673|455782625|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
126678973|NCT02831673|455782626|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
126678974|NCT02831673|455782627|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
126678975|NCT02831673|455782628|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
126678976|NCT02831673|455782629|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
126678977|NCT02831673|455782625|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126678978|NCT02831673|455782626|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126678979|NCT02831673|455782627|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126678980|NCT02831673|455782628|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
126678981|NCT02831673|455782629|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
126678982|NCT02831673|455782625|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126678983|NCT02831673|455782626|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126678984|NCT02831673|455782627|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126678985|NCT02831673|455782628|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
126678986|NCT02831673|455782629|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
126678987|NCT02831673|455782625|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126678988|NCT02831673|455782626|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126678989|NCT02831673|455782627|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126678990|NCT02831673|455782628|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
126678991|NCT02831673|455782629|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
126678992|NCT02831673|455782625|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126678993|NCT02831673|455782626|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126678994|NCT02831673|455782627|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126678995|NCT02831673|455782628|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
126678996|NCT02831673|455782629|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
126678997|NCT02356562|455782630|FG000|Overall Study|Withdrawal by Subject|0|||
126678998|NCT02356562|455782631|FG001|Overall Study|Withdrawal by Subject|1|||
126678999|NCT02356562|455782630|FG000|Overall Study|Re-entered treatment in a previous study|1|||
126679000|NCT02356562|455782631|FG001|Overall Study|Re-entered treatment in a previous study|0|||
126679001|NCT02356562|455782630|FG000|Overall Study|site closure|1|||
126430694|NCT02919761|454871983|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
126430695|NCT02919761|454871981|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
126679002|NCT02356562|455782631|FG001|Overall Study|site closure|0|||
126679003|NCT01351389|455782641|FG000|Overall Study|Withdrawal by Subject|7|||
126679004|NCT01351389|455782642|FG001|Overall Study|Withdrawal by Subject|0|||
126679005|NCT01351389|455782641|FG000|Overall Study|did not complete intervention|23|||
126679006|NCT01351389|455782642|FG001|Overall Study|did not complete intervention|15|||
126679007|NCT02646982|455782643|FG000|Overall Study|Adverse Event|1|||
126679008|NCT02646982|455782644|FG001|Overall Study|Adverse Event|1|||
126679009|NCT02646982|455782643|FG000|Overall Study|Withdrawal by Subject|2|||
126679010|NCT02646982|455782644|FG001|Overall Study|Withdrawal by Subject|1|||
126679011|NCT00713700|455782645|FG000|Overall Study|Lost to Follow-up|3|||
126679012|NCT00713700|455782645|FG000|Overall Study|Withdrawal by Subject|1|||
126679013|NCT01040351|455782646|FG000|Overall Study|poor ovarian response|1|||
126679014|NCT01040351|455782647|FG001|Overall Study|poor ovarian response|2|||
126679015|NCT01230307|455782648|FG000|Overall Study|LVAD Placement|0|||
126679016|NCT01230307|455782649|FG001|Overall Study|LVAD Placement|2|||
126679017|NCT00530894|455782654|FG000|Overall Study|Death|84|||
126679018|NCT00530894|455782655|FG001|Overall Study|Death|89|||
126679019|NCT00530894|455782656|FG002|Overall Study|Death|55|||
126679020|NCT00530894|455782657|FG003|Overall Study|Death|89|||
126679021|NCT00530894|455782654|FG000|Overall Study|Lost to Follow-up|1|||
126679022|NCT00530894|455782655|FG001|Overall Study|Lost to Follow-up|3|||
126679023|NCT00530894|455782656|FG002|Overall Study|Lost to Follow-up|0|||
126679024|NCT00530894|455782657|FG003|Overall Study|Lost to Follow-up|0|||
126679025|NCT00530894|455782654|FG000|Overall Study|Withdrawal by Subject|1|||
126679026|NCT00530894|455782655|FG001|Overall Study|Withdrawal by Subject|23|||
126679027|NCT00530894|455782656|FG002|Overall Study|Withdrawal by Subject|0|||
126679028|NCT00530894|455782657|FG003|Overall Study|Withdrawal by Subject|5|||
126679029|NCT00530894|455782654|FG000|Overall Study|Alive and censored prior to 1 year|2|||
126679030|NCT00530894|455782655|FG001|Overall Study|Alive and censored prior to 1 year|0|||
126679031|NCT00530894|455782656|FG002|Overall Study|Alive and censored prior to 1 year|0|||
126679032|NCT00530894|455782657|FG003|Overall Study|Alive and censored prior to 1 year|0|||
126679033|NCT02256540|455782658|FG000|Overall Study|Withdrawal by Subject|0|||
126679034|NCT02256540|455782659|FG001|Overall Study|Withdrawal by Subject|1|||
126679035|NCT02256540|455782660|FG002|Overall Study|Withdrawal by Subject|1|||
126679036|NCT02256540|455782658|FG000|Overall Study|Back pain preventing exercise|0|||
126679037|NCT02256540|455782659|FG001|Overall Study|Back pain preventing exercise|0|||
126679038|NCT02256540|455782660|FG002|Overall Study|Back pain preventing exercise|1|||
126679039|NCT03923426|455782668|FG000|Overall Study|Other|19|||
126679040|NCT03923426|455782668|FG000|Overall Study|Lost to Follow-up|16|||
126679041|NCT03923426|455782668|FG000|Overall Study|Death|107|||
126679042|NCT03923426|455782668|FG000|Overall Study|Incomplete response to question|13|||
126679043|NCT03719690|455782669|FG000|Overall Study|Withdrawal by Subject|5|||
126679044|NCT03719690|455782670|FG001|Overall Study|Withdrawal by Subject|10|||
126679045|NCT03719690|455782669|FG000|Overall Study|Death|40|||
126679046|NCT03719690|455782670|FG001|Overall Study|Death|149|||
126679047|NCT03719690|455782669|FG000|Overall Study|Miscellaneous|12|||
126679048|NCT03719690|455782670|FG001|Overall Study|Miscellaneous|56|||
126679049|NCT03719690|455782669|FG000|Overall Study|Lost to Follow-up|2|||
126679050|NCT03719690|455782670|FG001|Overall Study|Lost to Follow-up|18|||
126679051|NCT03719690|455782669|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
126679052|NCT03719690|455782670|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
126679053|NCT00769002|455782671|FG000|Overall Study|Study was not completed, no data|9|||
126679054|NCT00769002|455782672|FG001|Overall Study|Study was not completed, no data|9|||
126679055|NCT00847912|455782680|FG000|Overall Study|Protocol Violation|6|||
126679056|NCT00847912|455782681|FG001|Overall Study|Protocol Violation|7|||
126679057|NCT00847912|455782680|FG000|Overall Study|Withdrawal by Subject|3|||
126679058|NCT00847912|455782681|FG001|Overall Study|Withdrawal by Subject|6|||
126679059|NCT01732796|455782688|FG000|Overall Study|Adverse Event|16|||
126679060|NCT01732796|455782689|FG001|Overall Study|Adverse Event|16|||
126679061|NCT01732796|455782690|FG002|Overall Study|Adverse Event|4|||
126679062|NCT01732796|455782688|FG000|Overall Study|Lack of Efficacy|21|||
126430696|NCT02919761|454871982|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
126430697|NCT02919761|454871983|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
126679063|NCT01732796|455782689|FG001|Overall Study|Lack of Efficacy|18|||
126679064|NCT01732796|455782690|FG002|Overall Study|Lack of Efficacy|5|||
126679065|NCT01732796|455782688|FG000|Overall Study|Lost to Follow-up|2|||
126679066|NCT01732796|455782689|FG001|Overall Study|Lost to Follow-up|0|||
126679067|NCT01732796|455782690|FG002|Overall Study|Lost to Follow-up|0|||
126679068|NCT01732796|455782688|FG000|Overall Study|Withdrawal by Subject|6|||
126679069|NCT01732796|455782689|FG001|Overall Study|Withdrawal by Subject|8|||
126679070|NCT01732796|455782690|FG002|Overall Study|Withdrawal by Subject|2|||
126679071|NCT01732796|455782688|FG000|Overall Study|Other reason not defined above|1|||
126679072|NCT01732796|455782689|FG001|Overall Study|Other reason not defined above|0|||
126679073|NCT01732796|455782690|FG002|Overall Study|Other reason not defined above|2|||
126344741|NCT01572792|454557235|FG001|Lead-in Study|Lost to Follow-up|9|||
126344742|NCT01572792|454557236|FG002|Lead-in Study|Lost to Follow-up|4|||
126344743|NCT01572792|454557237|FG003|Lead-in Study|Lost to Follow-up|2|||
126344744|NCT01572792|454557238|FG004|Lead-in Study|Lost to Follow-up|4|||
126344745|NCT01572792|454557234|FG000|Lead-in Study|Withdrawal by Subject|22|||
126344746|NCT01572792|454557235|FG001|Lead-in Study|Withdrawal by Subject|11|||
126344747|NCT01572792|454557236|FG002|Lead-in Study|Withdrawal by Subject|12|||
126344748|NCT01572792|454557237|FG003|Lead-in Study|Withdrawal by Subject|24|||
126344749|NCT01572792|454557238|FG004|Lead-in Study|Withdrawal by Subject|11|||
126344750|NCT01572792|454557234|FG000|Lead-in Study|Protocol Violation|19|||
126344751|NCT01572792|454557235|FG001|Lead-in Study|Protocol Violation|10|||
126344752|NCT01572792|454557236|FG002|Lead-in Study|Protocol Violation|12|||
126344753|NCT01572792|454557237|FG003|Lead-in Study|Protocol Violation|13|||
126344754|NCT01572792|454557238|FG004|Lead-in Study|Protocol Violation|21|||
126344755|NCT01572792|454557234|FG000|Lead-in Study|Lack of Efficacy|20|||
126344756|NCT01572792|454557235|FG001|Lead-in Study|Lack of Efficacy|5|||
126344757|NCT01572792|454557236|FG002|Lead-in Study|Lack of Efficacy|4|||
126344758|NCT01572792|454557237|FG003|Lead-in Study|Lack of Efficacy|8|||
126344759|NCT01572792|454557238|FG004|Lead-in Study|Lack of Efficacy|10|||
126344760|NCT01572792|454557234|FG000|Lead-in Study|Adverse Event|21|||
126344761|NCT01572792|454557235|FG001|Lead-in Study|Adverse Event|21|||
126344762|NCT01572792|454557236|FG002|Lead-in Study|Adverse Event|22|||
126344763|NCT01572792|454557237|FG003|Lead-in Study|Adverse Event|16|||
126344764|NCT01572792|454557238|FG004|Lead-in Study|Adverse Event|14|||
126344765|NCT01572792|454557234|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
126344766|NCT01572792|454557235|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
126344767|NCT01572792|454557236|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
126344768|NCT01572792|454557237|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
126344769|NCT01572792|454557238|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
126344770|NCT01572792|454557234|FG000|Extension Study|Lost to Follow-up|6|||
126344771|NCT01572792|454557235|FG001|Extension Study|Lost to Follow-up|2|||
126344772|NCT01572792|454557236|FG002|Extension Study|Lost to Follow-up|0|||
126344773|NCT01572792|454557237|FG003|Extension Study|Lost to Follow-up|3|||
126344774|NCT01572792|454557238|FG004|Extension Study|Lost to Follow-up|3|||
126344775|NCT01572792|454557234|FG000|Extension Study|Withdrawal by Subject|7|||
126344776|NCT01572792|454557235|FG001|Extension Study|Withdrawal by Subject|6|||
126344777|NCT01572792|454557236|FG002|Extension Study|Withdrawal by Subject|11|||
126430698|NCT02919761|454871981|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
126679074|NCT00838331|455782694|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
126679075|NCT03972969|455782695|FG000|3-month Follow-up|Death|1|||
126679076|NCT03972969|455782696|FG001|3-month Follow-up|Death|1|||
126679077|NCT03972969|455782697|FG002|3-month Follow-up|Death|0|||
126679078|NCT03972969|455782695|FG000|6-month Follow-up|Death|1|||
126679079|NCT03972969|455782696|FG001|6-month Follow-up|Death|1|||
126679080|NCT03972969|455782697|FG002|6-month Follow-up|Death|1|||
126679081|NCT03972969|455782695|FG000|6-month Follow-up|Lost to Follow-up|2|||
126679082|NCT03972969|455782696|FG001|6-month Follow-up|Lost to Follow-up|2|||
126679083|NCT03972969|455782697|FG002|6-month Follow-up|Lost to Follow-up|2|||
126679084|NCT00732303|455782698|FG000|Overall Study|Study Terminated|2|||
126679085|NCT01074190|455782699|FG000|Overall Study|Emergency Cesarean Delivery|1|||
126679086|NCT01074190|455782700|FG001|Overall Study|Emergency Cesarean Delivery|2|||
126430699|NCT02919761|454871982|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
126430700|NCT02919761|454871983|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
126430701|NCT02919761|454871981|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
126430702|NCT02919761|454871982|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
126430703|NCT02919761|454871983|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
126430704|NCT02919761|454871981|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
126430705|NCT02919761|454871982|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
126430706|NCT02919761|454871983|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
126430707|NCT02919761|454871981|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
126430708|NCT02919761|454871982|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
126430709|NCT02919761|454871983|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
126430710|NCT03525444|454873503|FG000|Overall Study|Adverse Event|0|||
126430711|NCT03525444|454873504|FG001|Overall Study|Adverse Event|1|||
126430712|NCT03525444|454873503|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
126430713|NCT03525444|454873504|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
126430714|NCT03525444|454873503|FG000|Overall Study|Other|0|||
126430715|NCT03525444|454873504|FG001|Overall Study|Other|1|||
126430716|NCT00262860|454873505|FG000|Overall Study|Adverse Event|2|||
126430717|NCT02741128|454873506|FG000|Overall Study|Protocol Violation|4|||
126430718|NCT02741128|454873507|FG001|Overall Study|Protocol Violation|1|||
126344778|NCT01572792|454557237|FG003|Extension Study|Withdrawal by Subject|8|||
126344779|NCT01572792|454557238|FG004|Extension Study|Withdrawal by Subject|14|||
126430719|NCT02741128|454873506|FG000|Overall Study|Withdrawal by Subject|2|||
126430720|NCT02741128|454873507|FG001|Overall Study|Withdrawal by Subject|0|||
126679087|NCT01074190|455782701|FG002|Overall Study|Emergency Cesarean Delivery|1|||
126679088|NCT01074190|455782699|FG000|Overall Study|Protocol Violation|2|||
126679089|NCT01074190|455782700|FG001|Overall Study|Protocol Violation|1|||
126679090|NCT01074190|455782701|FG002|Overall Study|Protocol Violation|0|||
126679091|NCT01074190|455782699|FG000|Overall Study|Delivered in under 90 minutes|0|||
126679092|NCT01074190|455782700|FG001|Overall Study|Delivered in under 90 minutes|2|||
126679093|NCT01074190|455782701|FG002|Overall Study|Delivered in under 90 minutes|1|||
126679094|NCT01074190|455782699|FG000|Overall Study|Subject withdrew consent|1|||
126679095|NCT01074190|455782700|FG001|Overall Study|Subject withdrew consent|1|||
126679096|NCT01074190|455782701|FG002|Overall Study|Subject withdrew consent|1|||
126679097|NCT00264875|455782702|FG000|Overall Study|Adverse Event|6|||
126679098|NCT00264875|455782702|FG000|Overall Study|Lost to Follow-up|6|||
126679099|NCT00264875|455782702|FG000|Overall Study|Protocol Violation|11|||
126679100|NCT00264875|455782702|FG000|Overall Study|Withdrawal by Subject|7|||
126679101|NCT01500278|455782709|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
126679102|NCT01500278|455782710|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
126679103|NCT01500278|455782709|FG000|Week 0 - Week 12|Protocol Violation|10|||
126679104|NCT01500278|455782710|FG001|Week 0 - Week 12|Protocol Violation|16|||
126679105|NCT01500278|455782709|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
126679106|NCT01500278|455782710|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
126679107|NCT01500278|455782709|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
126679108|NCT01500278|455782710|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
126679109|NCT01500278|455782709|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
126679110|NCT01500278|455782710|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
126679111|NCT01500278|455782709|FG000|Week 0 - Week 12|Patient decision|1|||
126679112|NCT01500278|455782710|FG001|Week 0 - Week 12|Patient decision|0|||
126679113|NCT01500278|455782709|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
126679114|NCT01500278|455782710|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
126679115|NCT01500278|455782709|FG000|Week 0 - Week 12|Investigator decision|1|||
126679116|NCT01500278|455782710|FG001|Week 0 - Week 12|Investigator decision|0|||
126679117|NCT01500278|455782709|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
126430721|NCT02741128|454873506|FG000|Overall Study|Lost to Follow-up|1|||
126430722|NCT02741128|454873507|FG001|Overall Study|Lost to Follow-up|0|||
126430723|NCT02973100|454873508|FG000|Overall Study|Adverse Event|1|||
126430724|NCT02973100|454873509|FG001|Overall Study|Adverse Event|2|||
126430725|NCT02973100|454873510|FG002|Overall Study|Adverse Event|1|||
126430726|NCT02973100|454873511|FG003|Overall Study|Adverse Event|2|||
126430727|NCT02973100|454873508|FG000|Overall Study|Lost to Follow-up|3|||
126430728|NCT02973100|454873509|FG001|Overall Study|Lost to Follow-up|1|||
126430729|NCT02973100|454873510|FG002|Overall Study|Lost to Follow-up|1|||
126430730|NCT02973100|454873511|FG003|Overall Study|Lost to Follow-up|0|||
126430731|NCT02973100|454873508|FG000|Overall Study|Withdrawal by Subject|3|||
126430732|NCT02973100|454873509|FG001|Overall Study|Withdrawal by Subject|5|||
126430733|NCT02973100|454873510|FG002|Overall Study|Withdrawal by Subject|1|||
126430734|NCT02973100|454873511|FG003|Overall Study|Withdrawal by Subject|4|||
126430735|NCT02973100|454873508|FG000|Overall Study|Notification of change in address|0|||
126430736|NCT02973100|454873509|FG001|Overall Study|Notification of change in address|0|||
126430737|NCT02973100|454873510|FG002|Overall Study|Notification of change in address|0|||
126430738|NCT02973100|454873511|FG003|Overall Study|Notification of change in address|1|||
126430739|NCT02973100|454873508|FG000|Overall Study|Failed to attend Safety followup period|0|||
126430740|NCT02973100|454873509|FG001|Overall Study|Failed to attend Safety followup period|0|||
126430741|NCT02973100|454873510|FG002|Overall Study|Failed to attend Safety followup period|1|||
126430742|NCT02973100|454873511|FG003|Overall Study|Failed to attend Safety followup period|0|||
126430743|NCT01419769|454873512|FG000|Overall Study|Did not receive the AXIOS stent|3|||
126430744|NCT01419769|454873512|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
126430745|NCT00878501|454873513|FG000|Overall Study|Adverse Event|11|||
126430746|NCT00878501|454873514|FG001|Overall Study|Adverse Event|3|||
126430747|NCT00878501|454873515|FG002|Overall Study|Adverse Event|3|||
126430748|NCT00878501|454873513|FG000|Overall Study|Lack of Efficacy|2|||
126430749|NCT00878501|454873514|FG001|Overall Study|Lack of Efficacy|1|||
126430750|NCT00878501|454873515|FG002|Overall Study|Lack of Efficacy|0|||
126430751|NCT00878501|454873513|FG000|Overall Study|Withdrawal by Subject|2|||
126430752|NCT00878501|454873514|FG001|Overall Study|Withdrawal by Subject|1|||
126430753|NCT00878501|454873515|FG002|Overall Study|Withdrawal by Subject|2|||
126430754|NCT00878501|454873513|FG000|Overall Study|Protocol Violation|0|||
126679118|NCT01500278|455782710|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
126679119|NCT01500278|455782709|FG000|Week 0 - Week 12|Sponsor decision|1|||
126430755|NCT00878501|454873514|FG001|Overall Study|Protocol Violation|0|||
126679120|NCT01500278|455782710|FG001|Week 0 - Week 12|Sponsor decision|0|||
126679121|NCT01500278|455782709|FG000|Week 0 - Week 12|Personal reason|0|||
126679122|NCT01500278|455782710|FG001|Week 0 - Week 12|Personal reason|1|||
126679123|NCT01500278|455782709|FG000|Week 0 - Week 12|Other serious disease|0|||
126679124|NCT01500278|455782710|FG001|Week 0 - Week 12|Other serious disease|1|||
126430756|NCT00878501|454873515|FG002|Overall Study|Protocol Violation|1|||
126430757|NCT00878501|454873513|FG000|Overall Study|Incorrect enrolment|1|||
126430758|NCT00878501|454873514|FG001|Overall Study|Incorrect enrolment|2|||
126679125|NCT01500278|455782709|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
126679126|NCT01500278|455782710|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
126679127|NCT01500278|455782709|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
126679128|NCT01500278|455782710|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
126679129|NCT01500278|455782709|FG000|Week 13 - Week 104|Protocol Violation|6|||
126679130|NCT01500278|455782710|FG001|Week 13 - Week 104|Protocol Violation|6|||
126679131|NCT01500278|455782709|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
126679132|NCT01500278|455782710|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
126679133|NCT01500278|455782709|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
126679134|NCT01500278|455782710|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
126679135|NCT01500278|455782709|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
126679136|NCT01500278|455782710|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
126679137|NCT01500278|455782709|FG000|Week 13 - Week 104|Non/bad compliance|7|||
126679138|NCT01500278|455782710|FG001|Week 13 - Week 104|Non/bad compliance|5|||
126679139|NCT01500278|455782709|FG000|Week 13 - Week 104|Recurrent infections|1|||
126679140|NCT01500278|455782710|FG001|Week 13 - Week 104|Recurrent infections|0|||
126679141|NCT01500278|455782709|FG000|Week 13 - Week 104|False positive test|1|||
126430759|NCT00878501|454873515|FG002|Overall Study|Incorrect enrolment|0|||
126430760|NCT00878501|454873513|FG000|Overall Study|Intake of prohibited concom. medication|0|||
126430761|NCT00878501|454873514|FG001|Overall Study|Intake of prohibited concom. medication|0|||
126430762|NCT00878501|454873515|FG002|Overall Study|Intake of prohibited concom. medication|1|||
126430763|NCT00878501|454873513|FG000|Overall Study|Mis-randomisation of patient|1|||
126430764|NCT00878501|454873514|FG001|Overall Study|Mis-randomisation of patient|0|||
126430765|NCT00878501|454873515|FG002|Overall Study|Mis-randomisation of patient|0|||
126430766|NCT00878501|454873513|FG000|Overall Study|Administrative|0|||
126430767|NCT00878501|454873514|FG001|Overall Study|Administrative|0|||
126430768|NCT00878501|454873515|FG002|Overall Study|Administrative|1|||
126430769|NCT00812708|454873518|FG000|Overall Study|Device could not be implanted|2|||
126430770|NCT00812708|454873518|FG000|Overall Study|Lack of medical insurance|1|||
126430771|NCT00812708|454873518|FG000|Overall Study|Switched to another study|1|||
126430772|NCT00812708|454873518|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
126430773|NCT00812708|454873518|FG000|Overall Study|Signed consent but later withdrew|3|||
126430774|NCT01959503|454873519|FG000|Overall Study|Death|2|||
126430775|NCT01959503|454873520|FG001|Overall Study|Death|1|||
126430776|NCT01959503|454873519|FG000|Overall Study|Randomized but not treated|1|||
126430777|NCT01959503|454873520|FG001|Overall Study|Randomized but not treated|1|||
126430778|NCT01600326|454873521|FG000|Overall Study|Lost to Follow-up|1|||
126430779|NCT01600326|454873522|FG001|Overall Study|Lost to Follow-up|1|||
126430780|NCT01131507|454873524|FG000|Overall Study|Adverse Event|1|||
126430781|NCT01131507|454873524|FG000|Overall Study|Lost to Follow-up|1|||
126430782|NCT01131507|454873524|FG000|Overall Study|Withdrawal by Subject|1|||
126430783|NCT01393158|454873525|FG000|Overall Study|Adverse Event|1|||
126430784|NCT01393158|454873526|FG001|Overall Study|Adverse Event|0|||
126430785|NCT03224130|454873527|FG000|Overall Study|consent issue|0|||
126430786|NCT03224130|454873528|FG001|Overall Study|consent issue|1|||
126430787|NCT02587520|454873536|FG000|Overall Study|Protocol Violation|2|||
126430788|NCT02587520|454873537|FG001|Overall Study|Protocol Violation|0|||
126430789|NCT02587520|454873538|FG002|Overall Study|Protocol Violation|0|||
126430790|NCT02587520|454873539|FG003|Overall Study|Protocol Violation|2|||
126430791|NCT02587520|454873540|FG004|Overall Study|Protocol Violation|0|||
126430792|NCT02587520|454873541|FG005|Overall Study|Protocol Violation|1|||
126430793|NCT02587520|454873542|FG006|Overall Study|Protocol Violation|1|||
126430794|NCT02587520|454873543|FG007|Overall Study|Protocol Violation|1|||
126430795|NCT02587520|454873544|FG008|Overall Study|Protocol Violation|3|||
126430796|NCT02587520|454873545|FG009|Overall Study|Protocol Violation|3|||
126430797|NCT02587520|454873546|FG010|Overall Study|Protocol Violation|1|||
126430798|NCT02587520|454873547|FG011|Overall Study|Protocol Violation|2|||
126430799|NCT02587520|454873548|FG012|Overall Study|Protocol Violation|0|||
126430800|NCT02587520|454873549|FG013|Overall Study|Protocol Violation|0|||
126430801|NCT02587520|454873550|FG014|Overall Study|Protocol Violation|0|||
126679142|NCT01500278|455782710|FG001|Week 13 - Week 104|False positive test|2|||
126430802|NCT02587520|454873551|FG015|Overall Study|Protocol Violation|0|||
126430803|NCT02587520|454873552|FG016|Overall Study|Protocol Violation|0|||
126430804|NCT02587520|454873553|FG017|Overall Study|Protocol Violation|0|||
126430805|NCT02587520|454873536|FG000|Overall Study|Adverse Event|0|||
126430806|NCT02587520|454873537|FG001|Overall Study|Adverse Event|0|||
126430807|NCT02587520|454873538|FG002|Overall Study|Adverse Event|0|||
126430808|NCT02587520|454873539|FG003|Overall Study|Adverse Event|0|||
126679143|NCT01500278|455782709|FG000|Week 13 - Week 104|Sponsor request|4|||
126430809|NCT02587520|454873540|FG004|Overall Study|Adverse Event|0|||
126430810|NCT02587520|454873541|FG005|Overall Study|Adverse Event|0|||
126430811|NCT02587520|454873542|FG006|Overall Study|Adverse Event|0|||
126430812|NCT02587520|454873543|FG007|Overall Study|Adverse Event|0|||
126430813|NCT02587520|454873544|FG008|Overall Study|Adverse Event|0|||
126430814|NCT02587520|454873545|FG009|Overall Study|Adverse Event|0|||
126430815|NCT02587520|454873546|FG010|Overall Study|Adverse Event|0|||
126344780|NCT01572792|454557234|FG000|Extension Study|Protocol Violation|0|||
126344781|NCT01572792|454557235|FG001|Extension Study|Protocol Violation|4|||
126344782|NCT01572792|454557236|FG002|Extension Study|Protocol Violation|3|||
126344783|NCT01572792|454557237|FG003|Extension Study|Protocol Violation|4|||
126344784|NCT01572792|454557238|FG004|Extension Study|Protocol Violation|3|||
126344785|NCT01572792|454557234|FG000|Extension Study|Lack of Efficacy|2|||
126344786|NCT01572792|454557235|FG001|Extension Study|Lack of Efficacy|3|||
126344787|NCT01572792|454557236|FG002|Extension Study|Lack of Efficacy|3|||
126344788|NCT01572792|454557237|FG003|Extension Study|Lack of Efficacy|2|||
126344789|NCT01572792|454557238|FG004|Extension Study|Lack of Efficacy|2|||
126344790|NCT01572792|454557234|FG000|Extension Study|Adverse Event|7|||
126344791|NCT01572792|454557235|FG001|Extension Study|Adverse Event|6|||
126344792|NCT01572792|454557236|FG002|Extension Study|Adverse Event|5|||
126344793|NCT01572792|454557237|FG003|Extension Study|Adverse Event|6|||
126344794|NCT01572792|454557238|FG004|Extension Study|Adverse Event|4|||
126344795|NCT01572792|454557234|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
126344796|NCT01572792|454557235|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
126344797|NCT01572792|454557236|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
126344798|NCT01572792|454557237|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
126344799|NCT01572792|454557238|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
126344800|NCT03530696|454557239|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
126344801|NCT03530696|454557240|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
126344802|NCT02472353|454557241|FG000|Overall Study|Lost to Follow-up|1|||
126344803|NCT02472353|454557242|FG001|Overall Study|Lost to Follow-up|1|||
126344804|NCT02472353|454557241|FG000|Overall Study|Withdrawal by Subject|2|||
126344805|NCT02472353|454557242|FG001|Overall Study|Withdrawal by Subject|1|||
126430816|NCT02587520|454873547|FG011|Overall Study|Adverse Event|1|||
126430817|NCT02587520|454873548|FG012|Overall Study|Adverse Event|0|||
126430818|NCT02587520|454873549|FG013|Overall Study|Adverse Event|0|||
126430819|NCT02587520|454873550|FG014|Overall Study|Adverse Event|0|||
126430820|NCT02587520|454873551|FG015|Overall Study|Adverse Event|0|||
126430821|NCT02587520|454873552|FG016|Overall Study|Adverse Event|0|||
126430822|NCT02587520|454873553|FG017|Overall Study|Adverse Event|0|||
126430823|NCT02587520|454873536|FG000|Overall Study|Withdrawal by Subject|0|||
126430824|NCT02587520|454873537|FG001|Overall Study|Withdrawal by Subject|0|||
126430825|NCT02587520|454873538|FG002|Overall Study|Withdrawal by Subject|1|||
126430826|NCT02587520|454873539|FG003|Overall Study|Withdrawal by Subject|1|||
126430827|NCT02587520|454873540|FG004|Overall Study|Withdrawal by Subject|0|||
126430828|NCT02587520|454873541|FG005|Overall Study|Withdrawal by Subject|1|||
126430829|NCT02587520|454873542|FG006|Overall Study|Withdrawal by Subject|1|||
126430830|NCT02587520|454873543|FG007|Overall Study|Withdrawal by Subject|0|||
126430831|NCT02587520|454873544|FG008|Overall Study|Withdrawal by Subject|0|||
126430832|NCT02587520|454873545|FG009|Overall Study|Withdrawal by Subject|0|||
126430833|NCT02587520|454873546|FG010|Overall Study|Withdrawal by Subject|0|||
126430834|NCT02587520|454873547|FG011|Overall Study|Withdrawal by Subject|0|||
126679144|NCT01500278|455782710|FG001|Week 13 - Week 104|Sponsor request|0|||
126679145|NCT01500278|455782709|FG000|Week 13 - Week 104|Withdrawn in error|1|||
126679146|NCT01500278|455782710|FG001|Week 13 - Week 104|Withdrawn in error|0|||
126430835|NCT02587520|454873548|FG012|Overall Study|Withdrawal by Subject|0|||
126430836|NCT02587520|454873549|FG013|Overall Study|Withdrawal by Subject|1|||
126430837|NCT02587520|454873550|FG014|Overall Study|Withdrawal by Subject|0|||
126430838|NCT02587520|454873551|FG015|Overall Study|Withdrawal by Subject|0|||
126430839|NCT02587520|454873552|FG016|Overall Study|Withdrawal by Subject|0|||
126430840|NCT02587520|454873553|FG017|Overall Study|Withdrawal by Subject|0|||
126430841|NCT02587520|454873536|FG000|Overall Study|Lost to Follow-up|0|||
126430842|NCT02587520|454873537|FG001|Overall Study|Lost to Follow-up|2|||
126430843|NCT02587520|454873538|FG002|Overall Study|Lost to Follow-up|0|||
126430844|NCT02587520|454873539|FG003|Overall Study|Lost to Follow-up|2|||
126430845|NCT02587520|454873540|FG004|Overall Study|Lost to Follow-up|0|||
126430846|NCT02587520|454873541|FG005|Overall Study|Lost to Follow-up|1|||
126430847|NCT02587520|454873542|FG006|Overall Study|Lost to Follow-up|1|||
126430848|NCT02587520|454873543|FG007|Overall Study|Lost to Follow-up|1|||
126430849|NCT02587520|454873544|FG008|Overall Study|Lost to Follow-up|0|||
126430850|NCT02587520|454873545|FG009|Overall Study|Lost to Follow-up|2|||
126430851|NCT02587520|454873546|FG010|Overall Study|Lost to Follow-up|2|||
126430852|NCT02587520|454873547|FG011|Overall Study|Lost to Follow-up|1|||
126430853|NCT02587520|454873548|FG012|Overall Study|Lost to Follow-up|0|||
126430854|NCT02587520|454873549|FG013|Overall Study|Lost to Follow-up|0|||
126430855|NCT02587520|454873550|FG014|Overall Study|Lost to Follow-up|0|||
126430856|NCT02587520|454873551|FG015|Overall Study|Lost to Follow-up|0|||
126430857|NCT02587520|454873552|FG016|Overall Study|Lost to Follow-up|0|||
126430858|NCT02587520|454873553|FG017|Overall Study|Lost to Follow-up|0|||
126430859|NCT03284710|454873554|FG000|Overall Study|Withdrawal by Subject|1|||
126430860|NCT03284710|454873555|FG001|Overall Study|Withdrawal by Subject|0|||
126430861|NCT03284710|454873556|FG002|Overall Study|Withdrawal by Subject|1|||
126430862|NCT03284710|454873557|FG003|Overall Study|Withdrawal by Subject|6|||
126344806|NCT02472353|454557241|FG000|Overall Study|Study Termination|1|||
126344807|NCT02472353|454557242|FG001|Overall Study|Study Termination|4|||
126344808|NCT02855268|454557247|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
126344809|NCT02855268|454557248|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
126344810|NCT02855268|454557247|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
126344811|NCT02855268|454557248|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
126344812|NCT02855268|454557247|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
126344813|NCT02855268|454557248|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
126344814|NCT02855268|454557247|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
126344815|NCT02855268|454557248|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
126344816|NCT02855268|454557247|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
126344817|NCT02855268|454557248|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
126430863|NCT03284710|454873554|FG000|Overall Study|Lost to Follow-up|3|||
126430864|NCT03284710|454873555|FG001|Overall Study|Lost to Follow-up|3|||
126344818|NCT02855268|454557247|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
126344819|NCT02855268|454557248|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
126344820|NCT00639509|454557251|FG000|Overall Study|Death|1|||
126344821|NCT05722015|454557252|FG000|Overall Study|Death|57|||
126344822|NCT05722015|454557253|FG001|Overall Study|Death|37|||
126344823|NCT05722015|454557252|FG000|Overall Study|Lost to Follow-up|1|||
126344824|NCT05722015|454557253|FG001|Overall Study|Lost to Follow-up|0|||
126344825|NCT05722015|454557252|FG000|Overall Study|Withdrawal by Subject|5|||
126344826|NCT05722015|454557253|FG001|Overall Study|Withdrawal by Subject|1|||
126344827|NCT05722015|454557252|FG000|Overall Study|Participants Ongoing|188|||
126344828|NCT05722015|454557253|FG001|Overall Study|Participants Ongoing|88|||
126344829|NCT04513366|454557254|FG000|Treatment Phase|Withdrawal by Subject|6|||
126344830|NCT04513366|454557255|FG001|Treatment Phase|Withdrawal by Subject|8|||
126344831|NCT04513366|454557256|FG002|Treatment Phase|Withdrawal by Subject|3|||
126344832|NCT04513366|454557254|FG000|Treatment Phase|Lost to Follow-up|1|||
126344833|NCT04513366|454557255|FG001|Treatment Phase|Lost to Follow-up|2|||
126344834|NCT04513366|454557256|FG002|Treatment Phase|Lost to Follow-up|5|||
126344835|NCT04513366|454557254|FG000|Treatment Phase|Other than Specified|1|||
126344836|NCT04513366|454557255|FG001|Treatment Phase|Other than Specified|0|||
126344837|NCT04513366|454557256|FG002|Treatment Phase|Other than Specified|2|||
126344838|NCT04513366|454557254|FG000|Treatment Phase|Physician Decision|2|||
126344839|NCT04513366|454557255|FG001|Treatment Phase|Physician Decision|0|||
126344840|NCT04513366|454557256|FG002|Treatment Phase|Physician Decision|0|||
126344841|NCT04513366|454557254|FG000|Treatment Phase|Adverse Event|0|||
126344842|NCT04513366|454557255|FG001|Treatment Phase|Adverse Event|1|||
126344843|NCT04513366|454557256|FG002|Treatment Phase|Adverse Event|1|||
126344844|NCT04513366|454557254|FG000|Extension Phase|Withdrawal by Subject|3|||
126344845|NCT04513366|454557255|FG001|Extension Phase|Withdrawal by Subject|1|||
126344846|NCT04513366|454557256|FG002|Extension Phase|Withdrawal by Subject|1|||
126344847|NCT04513366|454557254|FG000|Extension Phase|Other than Specified|4|||
126344848|NCT04513366|454557255|FG001|Extension Phase|Other than Specified|0|||
126344849|NCT04513366|454557256|FG002|Extension Phase|Other than Specified|1|||
126344850|NCT04513366|454557254|FG000|Extension Phase|Lost to Follow-up|1|||
126344851|NCT04513366|454557255|FG001|Extension Phase|Lost to Follow-up|1|||
126344852|NCT04513366|454557256|FG002|Extension Phase|Lost to Follow-up|1|||
126344853|NCT04513366|454557254|FG000|Extension Phase|Sponsor Decision|0|||
126344854|NCT04513366|454557255|FG001|Extension Phase|Sponsor Decision|1|||
126344855|NCT04513366|454557256|FG002|Extension Phase|Sponsor Decision|0|||
126344856|NCT04513366|454557254|FG000|Extension Phase|Death|0|||
126344857|NCT04513366|454557255|FG001|Extension Phase|Death|1|||
126344858|NCT04513366|454557256|FG002|Extension Phase|Death|0|||
126344859|NCT04513366|454557254|FG000|Extension Phase|Adverse Event|0|||
126344860|NCT04513366|454557255|FG001|Extension Phase|Adverse Event|0|||
126344861|NCT04513366|454557256|FG002|Extension Phase|Adverse Event|1|||
126344862|NCT04478266|454557260|FG000|Overall Study|Adverse Event|20|||
126344863|NCT04478266|454557261|FG001|Overall Study|Adverse Event|21|||
126344864|NCT04478266|454557260|FG000|Overall Study|Progressive disease|146|||
126344865|NCT04478266|454557261|FG001|Overall Study|Progressive disease|168|||
126344866|NCT04478266|454557260|FG000|Overall Study|Poor compliance to protocol|1|||
126344867|NCT04478266|454557261|FG001|Overall Study|Poor compliance to protocol|0|||
126344868|NCT04478266|454557260|FG000|Overall Study|Withdrawal by Subject|19|||
126344869|NCT04478266|454557261|FG001|Overall Study|Withdrawal by Subject|16|||
126344870|NCT04478266|454557260|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
126344871|NCT04478266|454557261|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
126344872|NCT04478266|454557260|FG000|Overall Study|Study terminated by sponsor|33|||
126344873|NCT04478266|454557261|FG001|Overall Study|Study terminated by sponsor|35|||
126344874|NCT04478266|454557260|FG000|Overall Study|Other: unspecified|5|||
126344875|NCT04478266|454557261|FG001|Overall Study|Other: unspecified|7|||
126344876|NCT04478266|454557260|FG000|Overall Study|Randomized but not treated|1|||
126344877|NCT04478266|454557261|FG001|Overall Study|Randomized but not treated|1|||
126344878|NCT04058717|454557262|FG000|Randomization Period|Lost to Follow-up|2|||
126344879|NCT04058717|454557263|FG001|Randomization Period|Lost to Follow-up|3|||
126430865|NCT03284710|454873556|FG002|Overall Study|Lost to Follow-up|1|||
126430866|NCT03284710|454873557|FG003|Overall Study|Lost to Follow-up|0|||
126430867|NCT03284710|454873554|FG000|Overall Study|Physician Decision|1|||
126430868|NCT03284710|454873555|FG001|Overall Study|Physician Decision|0|||
126430869|NCT03284710|454873556|FG002|Overall Study|Physician Decision|0|||
126430870|NCT03284710|454873557|FG003|Overall Study|Physician Decision|0|||
126430871|NCT03284710|454873554|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
126430872|NCT03284710|454873555|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
126430873|NCT03284710|454873556|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
126430874|NCT03284710|454873557|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
126430875|NCT03284710|454873554|FG000|Overall Study|HIV Infection|0|||
126430876|NCT03284710|454873555|FG001|Overall Study|HIV Infection|2|||
126430877|NCT03284710|454873556|FG002|Overall Study|HIV Infection|2|||
126430878|NCT03284710|454873557|FG003|Overall Study|HIV Infection|1|||
126430879|NCT02412306|454873560|FG000|Overall Study|Lost to Follow-up|0|||
126430880|NCT02412306|454873561|FG001|Overall Study|Lost to Follow-up|1|||
126430881|NCT02412306|454873562|FG002|Overall Study|Lost to Follow-up|0|||
126430882|NCT02412306|454873563|FG003|Overall Study|Lost to Follow-up|0|||
126430883|NCT02412306|454873564|FG004|Overall Study|Lost to Follow-up|0|||
126430884|NCT02412306|454873560|FG000|Overall Study|Withdrawal by Subject|0|||
126430885|NCT02412306|454873561|FG001|Overall Study|Withdrawal by Subject|0|||
126430886|NCT02412306|454873562|FG002|Overall Study|Withdrawal by Subject|1|||
126430887|NCT02412306|454873563|FG003|Overall Study|Withdrawal by Subject|0|||
126430888|NCT02412306|454873564|FG004|Overall Study|Withdrawal by Subject|0|||
126430889|NCT02412306|454873560|FG000|Overall Study|Death|5|||
126430890|NCT02412306|454873561|FG001|Overall Study|Death|7|||
126430891|NCT02412306|454873562|FG002|Overall Study|Death|15|||
126430892|NCT02412306|454873563|FG003|Overall Study|Death|0|||
126430893|NCT02412306|454873564|FG004|Overall Study|Death|2|||
126430894|NCT01706458|454873568|FG000|Overall Study|Physician Decision|3|||
126430895|NCT01706458|454873569|FG001|Overall Study|Physician Decision|4|||
126430896|NCT04349891|454873575|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
126430897|NCT04349891|454873576|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
126430898|NCT04349891|454873575|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
126430899|NCT04349891|454873576|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
126430900|NCT04349891|454873575|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
126430901|NCT04349891|454873576|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
126430902|NCT04349891|454873575|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
126430903|NCT04349891|454873576|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
126430904|NCT02927301|454873579|FG000|Overall Study|Death|39|||
126430905|NCT02927301|454873579|FG000|Overall Study|Lost to Follow-up|8|||
126430906|NCT02927301|454873579|FG000|Overall Study|Physician Decision|2|||
126430907|NCT02927301|454873579|FG000|Overall Study|Withdrawal by Subject|12|||
126430908|NCT02927301|454873579|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
126430909|NCT04247347|454873584|FG000|Overall Study|Withdrawal by Subject|2|||
126430910|NCT04247347|454873585|FG001|Overall Study|Withdrawal by Subject|3|||
126430911|NCT04247347|454873586|FG002|Overall Study|Withdrawal by Subject|3|||
126430912|NCT04247347|454873584|FG000|Overall Study|Lost to Follow-up|1|||
126430913|NCT04247347|454873585|FG001|Overall Study|Lost to Follow-up|1|||
126430914|NCT04247347|454873586|FG002|Overall Study|Lost to Follow-up|1|||
126430915|NCT03562195|454873587|FG000|Overall Study|Adverse Event|0|||
126430916|NCT03562195|454873588|FG001|Overall Study|Adverse Event|6|||
126430917|NCT03562195|454873587|FG000|Overall Study|Lack of Efficacy|0|||
126430918|NCT03562195|454873588|FG001|Overall Study|Lack of Efficacy|5|||
126430919|NCT03562195|454873587|FG000|Overall Study|Protocol Violation|0|||
126430920|NCT03562195|454873588|FG001|Overall Study|Protocol Violation|1|||
126430921|NCT03562195|454873587|FG000|Overall Study|Lost to Follow-up|0|||
126430922|NCT03562195|454873588|FG001|Overall Study|Lost to Follow-up|1|||
126430923|NCT03562195|454873587|FG000|Overall Study|Physician Decision|1|||
126430924|NCT03562195|454873588|FG001|Overall Study|Physician Decision|0|||
126430925|NCT03562195|454873587|FG000|Overall Study|Withdrawal by Subject|3|||
126430926|NCT03562195|454873588|FG001|Overall Study|Withdrawal by Subject|0|||
126430927|NCT02529852|454873589|FG000|Overall Study|Withdrawal by Subject|2|||
126430928|NCT00472108|454873591|FG000|Overall Study|Lost to Follow-up|0|||
126430929|NCT00472108|454873592|FG001|Overall Study|Lost to Follow-up|1|||
126430930|NCT00642356|454873593|FG000|Overall Study|Adverse Event|1|||
126430931|NCT00642356|454873594|FG001|Overall Study|Adverse Event|0|||
126679147|NCT01500278|455782709|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
126679148|NCT01500278|455782710|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
126430932|NCT00642356|454873593|FG000|Overall Study|Protocol Violation|0|||
126430933|NCT00642356|454873594|FG001|Overall Study|Protocol Violation|3|||
126430934|NCT00642356|454873593|FG000|Overall Study|Lack of Efficacy|1|||
126430935|NCT00642356|454873594|FG001|Overall Study|Lack of Efficacy|0|||
126430936|NCT01009060|454873595|FG000|Overall Study|Adverse Event|1|||
126430937|NCT01009060|454873596|FG001|Overall Study|Adverse Event|2|||
126430938|NCT01009060|454873595|FG000|Overall Study|Protocol Violation|0|||
126430939|NCT01009060|454873596|FG001|Overall Study|Protocol Violation|1|||
126344880|NCT04058717|454557264|FG002|Randomization Period|Lost to Follow-up|4|||
126344881|NCT04058717|454557265|FG003|Randomization Period|Lost to Follow-up|4|||
126344882|NCT04058717|454557262|FG000|Randomization Period|Withdrawal by Subject|1|||
126344883|NCT04058717|454557263|FG001|Randomization Period|Withdrawal by Subject|3|||
126344884|NCT04058717|454557264|FG002|Randomization Period|Withdrawal by Subject|3|||
126344885|NCT04058717|454557265|FG003|Randomization Period|Withdrawal by Subject|3|||
126344886|NCT04058717|454557262|FG000|Randomization Period|PI decision|0|||
126344887|NCT04058717|454557263|FG001|Randomization Period|PI decision|1|||
126344888|NCT04058717|454557264|FG002|Randomization Period|PI decision|0|||
126344889|NCT04058717|454557265|FG003|Randomization Period|PI decision|0|||
126344890|NCT00671788|454557266|FG000|Overall Study|Adverse Event|8|||
126344891|NCT00671788|454557266|FG000|Overall Study|Refused further treatment|3|||
126344892|NCT00671788|454557266|FG000|Overall Study|Ineligible|1|||
126344893|NCT00671788|454557266|FG000|Overall Study|MD Decision|1|||
126344894|NCT00671788|454557266|FG000|Overall Study|Other|1|||
126344895|NCT01832766|454557267|FG000|Washout|Lost to Follow-up|0|||
126344896|NCT01832766|454557268|FG001|Washout|Lost to Follow-up|1|||
126344897|NCT03074500|454557273|FG000|Overall Study|Lost to Follow-up|1|||
126344898|NCT03074500|454557274|FG001|Overall Study|Lost to Follow-up|0|||
126344899|NCT03074500|454557275|FG002|Overall Study|Lost to Follow-up|0|||
126344900|NCT03074500|454557273|FG000|Overall Study|Lack of Efficacy|0|||
126344901|NCT03074500|454557274|FG001|Overall Study|Lack of Efficacy|1|||
126344902|NCT03074500|454557275|FG002|Overall Study|Lack of Efficacy|0|||
126344903|NCT03074500|454557273|FG000|Overall Study|Adverse Event|0|||
126344904|NCT03074500|454557274|FG001|Overall Study|Adverse Event|0|||
126344905|NCT03074500|454557275|FG002|Overall Study|Adverse Event|1|||
126344906|NCT03608163|454557276|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
126344907|NCT03608163|454557277|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
126344908|NCT02194465|454558463|FG000|Overall Study|Adverse Event|6|||
126344909|NCT02194465|454558464|FG001|Overall Study|Adverse Event|1|||
126344910|NCT02194465|454558465|FG002|Overall Study|Adverse Event|4|||
126344911|NCT02194465|454558466|FG003|Overall Study|Adverse Event|4|||
126344912|NCT02194465|454558467|FG004|Overall Study|Adverse Event|4|||
126344913|NCT02194465|454558468|FG005|Overall Study|Adverse Event|2|||
126344914|NCT02194465|454558469|FG006|Overall Study|Adverse Event|0|||
126344915|NCT02194465|454558463|FG000|Overall Study|Lost to Follow-up|0|||
126344916|NCT02194465|454558464|FG001|Overall Study|Lost to Follow-up|0|||
126344917|NCT02194465|454558465|FG002|Overall Study|Lost to Follow-up|0|||
126344918|NCT02194465|454558466|FG003|Overall Study|Lost to Follow-up|1|||
126344919|NCT02194465|454558467|FG004|Overall Study|Lost to Follow-up|0|||
126344920|NCT02194465|454558468|FG005|Overall Study|Lost to Follow-up|1|||
126344921|NCT02194465|454558469|FG006|Overall Study|Lost to Follow-up|0|||
126344922|NCT02194465|454558463|FG000|Overall Study|Physician Decision|1|||
126344923|NCT02194465|454558464|FG001|Overall Study|Physician Decision|0|||
126344924|NCT02194465|454558465|FG002|Overall Study|Physician Decision|0|||
126344925|NCT02194465|454558466|FG003|Overall Study|Physician Decision|0|||
126344926|NCT02194465|454558467|FG004|Overall Study|Physician Decision|0|||
126344927|NCT02194465|454558468|FG005|Overall Study|Physician Decision|0|||
126344928|NCT02194465|454558469|FG006|Overall Study|Physician Decision|0|||
126344929|NCT02194465|454558463|FG000|Overall Study|Protocol Violation|1|||
126344930|NCT02194465|454558464|FG001|Overall Study|Protocol Violation|1|||
126344931|NCT02194465|454558465|FG002|Overall Study|Protocol Violation|2|||
126344932|NCT02194465|454558466|FG003|Overall Study|Protocol Violation|1|||
126344933|NCT02194465|454558467|FG004|Overall Study|Protocol Violation|1|||
126344934|NCT02194465|454558468|FG005|Overall Study|Protocol Violation|0|||
126344935|NCT02194465|454558469|FG006|Overall Study|Protocol Violation|0|||
126344936|NCT02194465|454558463|FG000|Overall Study|Withdrawal by Subject|1|||
126344937|NCT02194465|454558464|FG001|Overall Study|Withdrawal by Subject|3|||
126344938|NCT02194465|454558465|FG002|Overall Study|Withdrawal by Subject|1|||
126344939|NCT02194465|454558466|FG003|Overall Study|Withdrawal by Subject|2|||
126344940|NCT02194465|454558467|FG004|Overall Study|Withdrawal by Subject|2|||
126344941|NCT02194465|454558468|FG005|Overall Study|Withdrawal by Subject|1|||
126344942|NCT02194465|454558469|FG006|Overall Study|Withdrawal by Subject|2|||
126344943|NCT02194465|454558463|FG000|Overall Study|Discontinued follow-up period|0|||
126344944|NCT02194465|454558464|FG001|Overall Study|Discontinued follow-up period|2|||
126344945|NCT02194465|454558465|FG002|Overall Study|Discontinued follow-up period|1|||
126344946|NCT02194465|454558466|FG003|Overall Study|Discontinued follow-up period|0|||
126344947|NCT02194465|454558467|FG004|Overall Study|Discontinued follow-up period|2|||
126344948|NCT02194465|454558468|FG005|Overall Study|Discontinued follow-up period|0|||
126344949|NCT02194465|454558469|FG006|Overall Study|Discontinued follow-up period|0|||
126344950|NCT01408641|454558470|FG000|Overall Study|Physician Decision|1|||
126344951|NCT01408641|454558471|FG001|Overall Study|Physician Decision|0|||
126344952|NCT03979313|454558472|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
126344953|NCT03979313|454558473|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
126344954|NCT03979313|454558472|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
126344955|NCT03979313|454558473|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
126344956|NCT03979313|454558472|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
126430940|NCT01009060|454873595|FG000|Overall Study|Lost to Follow-up|1|||
126430941|NCT01009060|454873596|FG001|Overall Study|Lost to Follow-up|0|||
126430942|NCT01009060|454873595|FG000|Overall Study|Physician Decision|1|||
126430943|NCT01009060|454873596|FG001|Overall Study|Physician Decision|1|||
126430944|NCT01009060|454873595|FG000|Overall Study|Withdrawal by Subject|1|||
126430945|NCT01009060|454873596|FG001|Overall Study|Withdrawal by Subject|1|||
126430946|NCT00286442|454873601|FG000|Overall Study|Hyperglycemic Rescue|19|||
126430947|NCT00286442|454873602|FG001|Overall Study|Hyperglycemic Rescue|17|||
126679149|NCT01500278|455782709|FG000|Week 13 - Week 104|Protocol deviation|1|||
126679150|NCT01500278|455782710|FG001|Week 13 - Week 104|Protocol deviation|0|||
126679151|NCT01500278|455782709|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
126679152|NCT01500278|455782710|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
126430948|NCT00286442|454873603|FG002|Overall Study|Hyperglycemic Rescue|25|||
126430949|NCT00286442|454873601|FG000|Overall Study|Adverse Event|7|||
126430950|NCT00286442|454873602|FG001|Overall Study|Adverse Event|6|||
126430951|NCT00286442|454873603|FG002|Overall Study|Adverse Event|1|||
126430952|NCT00286442|454873601|FG000|Overall Study|Protocol Violation|2|||
126430953|NCT00286442|454873602|FG001|Overall Study|Protocol Violation|4|||
126430954|NCT00286442|454873603|FG002|Overall Study|Protocol Violation|2|||
126430955|NCT00286442|454873601|FG000|Overall Study|Lost to Follow-up|5|||
126430956|NCT00286442|454873602|FG001|Overall Study|Lost to Follow-up|2|||
126430957|NCT00286442|454873603|FG002|Overall Study|Lost to Follow-up|1|||
126430958|NCT00286442|454873601|FG000|Overall Study|Physician Decision|1|||
126430959|NCT00286442|454873602|FG001|Overall Study|Physician Decision|1|||
126430960|NCT00286442|454873603|FG002|Overall Study|Physician Decision|1|||
126430961|NCT00286442|454873601|FG000|Overall Study|Administrative Error|1|||
126430962|NCT00286442|454873602|FG001|Overall Study|Administrative Error|1|||
126430963|NCT00286442|454873603|FG002|Overall Study|Administrative Error|0|||
126430964|NCT00286442|454873601|FG000|Overall Study|Withdrawal by Subject|2|||
126430965|NCT00286442|454873602|FG001|Overall Study|Withdrawal by Subject|14|||
126430966|NCT00286442|454873603|FG002|Overall Study|Withdrawal by Subject|2|||
126430967|NCT02542865|454873606|FG000|Overall Study|Identified as screen failure|1|||
126430968|NCT02542865|454873607|FG001|Overall Study|Identified as screen failure|0|||
126430969|NCT02542865|454873606|FG000|Overall Study|Withdrawal by Subject|16|||
126430970|NCT02542865|454873607|FG001|Overall Study|Withdrawal by Subject|0|||
126430971|NCT01339689|454873610|FG000|Overall Study|Adverse Event|1|||
126430972|NCT01339689|454873611|FG001|Overall Study|Adverse Event|2|||
126430973|NCT01339689|454873610|FG000|Overall Study|Lost to Follow-up|9|||
126430974|NCT01339689|454873611|FG001|Overall Study|Lost to Follow-up|3|||
126430975|NCT01339689|454873610|FG000|Overall Study|Withdrawal by Subject|3|||
126430976|NCT01339689|454873611|FG001|Overall Study|Withdrawal by Subject|0|||
126430977|NCT01339689|454873610|FG000|Overall Study|Noncompliance|1|||
126430978|NCT01339689|454873611|FG001|Overall Study|Noncompliance|0|||
126430979|NCT01339689|454873610|FG000|Overall Study|Relocated out of area|0|||
126430980|NCT01339689|454873611|FG001|Overall Study|Relocated out of area|1|||
126430981|NCT01339689|454873610|FG000|Overall Study|Other|2|||
126430982|NCT01339689|454873611|FG001|Overall Study|Other|2|||
126430983|NCT01339689|454873610|FG000|Overall Study|multiple reasons|1|||
126430984|NCT01339689|454873611|FG001|Overall Study|multiple reasons|1|||
126430985|NCT04571944|454873612|FG000|Overall Study|Death|1|||
126430986|NCT04571944|454873613|FG001|Overall Study|Death|0|||
126430987|NCT04571944|454873612|FG000|Overall Study|Withdrawal by Subject|3|||
126430988|NCT04571944|454873613|FG001|Overall Study|Withdrawal by Subject|0|||
126430989|NCT04571944|454873612|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
126430990|NCT04571944|454873613|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
126430991|NCT04913610|454873616|FG000|Randomized Participants|Did Not Receive Treatment|0|||
126430992|NCT04913610|454873617|FG001|Randomized Participants|Did Not Receive Treatment|0|||
126430993|NCT04913610|454873618|FG002|Randomized Participants|Did Not Receive Treatment|1|||
126430994|NCT04913610|454873619|FG003|Randomized Participants|Did Not Receive Treatment|1|||
126430995|NCT04913610|454873620|FG004|Randomized Participants|Did Not Receive Treatment|0|||
126430996|NCT04913610|454873616|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
126430997|NCT04913610|454873617|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
126430998|NCT04913610|454873618|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
126430999|NCT04913610|454873619|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
126431000|NCT04913610|454873620|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
126431001|NCT02358473|454873625|FG000|Overall Study|Disease Progession|6|||
126431002|NCT02358473|454873625|FG000|Overall Study|Adverse Event|3|||
126431003|NCT02358473|454873625|FG000|Overall Study|Withdrawal by Subject|2|||
126431004|NCT02358473|454873625|FG000|Overall Study|Physician Decision|2|||
126431005|NCT04819945|454873626|FG000|Overall Study|Lost to Follow-up|1|||
126431006|NCT04949191|454873627|FG000|Overall Study|Non-compliance with Study Drug|1|||
126431007|NCT04949191|454873628|FG001|Overall Study|Non-compliance with Study Drug|0|||
126431008|NCT04949191|454873629|FG002|Overall Study|Non-compliance with Study Drug|0|||
126431009|NCT04949191|454873630|FG003|Overall Study|Non-compliance with Study Drug|0|||
126431010|NCT04949191|454873627|FG000|Overall Study|Progressive Disease|0|||
126679153|NCT01500278|455782709|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
126679154|NCT01500278|455782710|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
126679155|NCT01500278|455782709|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
126679156|NCT01500278|455782710|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
126679157|NCT01500278|455782709|FG000|Week 13 - Week 104|Relocation|0|||
126679158|NCT01500278|455782710|FG001|Week 13 - Week 104|Relocation|1|||
126431011|NCT04949191|454873628|FG001|Overall Study|Progressive Disease|1|||
126431012|NCT04949191|454873629|FG002|Overall Study|Progressive Disease|0|||
126431013|NCT04949191|454873630|FG003|Overall Study|Progressive Disease|0|||
126431014|NCT04949191|454873627|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
126679159|NCT01500278|455782709|FG000|Week 13 - Week 104|Sponsor decision|0|||
126679160|NCT01500278|455782710|FG001|Week 13 - Week 104|Sponsor decision|2|||
126679161|NCT01500278|455782709|FG000|Week 13 - Week 104|Medical monitor decision|0|||
126679162|NCT01500278|455782710|FG001|Week 13 - Week 104|Medical monitor decision|2|||
126679163|NCT01500278|455782709|FG000|Week 13 - Week 104|Personal reason|0|||
126431015|NCT04949191|454873628|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
126679164|NCT01500278|455782710|FG001|Week 13 - Week 104|Personal reason|1|||
126679165|NCT01500278|455782709|FG000|Week 13 - Week 104|Not completed|0|||
126679166|NCT01500278|455782710|FG001|Week 13 - Week 104|Not completed|1|||
126679167|NCT01500278|455782709|FG000|Week 13 - Week 104|Death|2|||
126679168|NCT01500278|455782710|FG001|Week 13 - Week 104|Death|4|||
126679169|NCT01500278|455782709|FG000|Week 13 - Week 104|Adverse Event|54|||
126679170|NCT01500278|455782710|FG001|Week 13 - Week 104|Adverse Event|54|||
126679171|NCT01709435|455782714|FG000|Overall Study|Adverse Event|1|||
126679172|NCT01709435|455782715|FG001|Overall Study|Adverse Event|1|||
126679173|NCT01709435|455782716|FG002|Overall Study|Adverse Event|1|||
126679174|NCT01709435|455782717|FG003|Overall Study|Adverse Event|0|||
126679175|NCT01709435|455782718|FG004|Overall Study|Adverse Event|0|||
126679176|NCT01709435|455782719|FG005|Overall Study|Adverse Event|1|||
126679177|NCT01709435|455782714|FG000|Overall Study|Lack of Efficacy|5|||
126679178|NCT01709435|455782715|FG001|Overall Study|Lack of Efficacy|7|||
126679179|NCT01709435|455782716|FG002|Overall Study|Lack of Efficacy|2|||
126679180|NCT01709435|455782717|FG003|Overall Study|Lack of Efficacy|2|||
126679181|NCT01709435|455782718|FG004|Overall Study|Lack of Efficacy|6|||
126679182|NCT01709435|455782719|FG005|Overall Study|Lack of Efficacy|3|||
126679183|NCT01709435|455782714|FG000|Overall Study|Physician Decision|0|||
126431016|NCT04949191|454873629|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
126431017|NCT04949191|454873630|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
126431018|NCT04949191|454873627|FG000|Overall Study|Sponsor Terminated Study|0|||
126431019|NCT04949191|454873628|FG001|Overall Study|Sponsor Terminated Study|0|||
126431020|NCT04949191|454873629|FG002|Overall Study|Sponsor Terminated Study|1|||
126431021|NCT04949191|454873630|FG003|Overall Study|Sponsor Terminated Study|1|||
126431022|NCT02913482|454873631|FG000|Overall Study|Death|0|||
126431023|NCT02913482|454873632|FG001|Overall Study|Death|2|||
126431024|NCT02913482|454873633|FG002|Overall Study|Death|2|||
126431025|NCT02913482|454873631|FG000|Overall Study|Progressive Disease|1|||
126431026|NCT02913482|454873632|FG001|Overall Study|Progressive Disease|1|||
126431027|NCT02913482|454873633|FG002|Overall Study|Progressive Disease|1|||
126679184|NCT01709435|455782715|FG001|Overall Study|Physician Decision|1|||
126679185|NCT01709435|455782716|FG002|Overall Study|Physician Decision|0|||
126679186|NCT01709435|455782717|FG003|Overall Study|Physician Decision|1|||
126679187|NCT01709435|455782718|FG004|Overall Study|Physician Decision|2|||
126679188|NCT01709435|455782719|FG005|Overall Study|Physician Decision|0|||
126679189|NCT01709435|455782714|FG000|Overall Study|Withdrawal by Subject|0|||
126679190|NCT01709435|455782715|FG001|Overall Study|Withdrawal by Subject|0|||
126431028|NCT02913482|454873631|FG000|Overall Study|Reason not specified|0|||
126431029|NCT02913482|454873632|FG001|Overall Study|Reason not specified|0|||
126431030|NCT02913482|454873633|FG002|Overall Study|Reason not specified|1|||
126431031|NCT02913482|454873631|FG000|Overall Study|Withdrawal by Subject|0|||
126431032|NCT02913482|454873632|FG001|Overall Study|Withdrawal by Subject|1|||
126431033|NCT02913482|454873633|FG002|Overall Study|Withdrawal by Subject|1|||
126431034|NCT00918385|454873636|FG000|Monotherapy|Adverse Event|1|||
126679191|NCT01709435|455782716|FG002|Overall Study|Withdrawal by Subject|3|||
126679192|NCT01709435|455782717|FG003|Overall Study|Withdrawal by Subject|0|||
126679193|NCT01709435|455782718|FG004|Overall Study|Withdrawal by Subject|2|||
126679194|NCT01709435|455782719|FG005|Overall Study|Withdrawal by Subject|2|||
126679195|NCT00053417|455782720|FG000|Overall Study|Adverse Event|1|||
126679196|NCT00053417|455782721|FG001|Overall Study|Adverse Event|0|||
126679197|NCT00053417|455782722|FG002|Overall Study|Adverse Event|1|||
126679198|NCT00053417|455782723|FG003|Overall Study|Adverse Event|5|||
126431035|NCT00918385|454873637|FG001|Monotherapy|Adverse Event|6|||
126679199|NCT00053417|455782720|FG000|Overall Study|Non-Compliance|0|||
126679200|NCT00053417|455782721|FG001|Overall Study|Non-Compliance|0|||
126679201|NCT00053417|455782722|FG002|Overall Study|Non-Compliance|0|||
126679202|NCT00053417|455782723|FG003|Overall Study|Non-Compliance|1|||
126679203|NCT00053417|455782720|FG000|Overall Study|Withdrawal by Subject|0|||
126431036|NCT00918385|454873636|FG000|Monotherapy|Complicating illness|1|||
126431037|NCT00918385|454873637|FG001|Monotherapy|Complicating illness|0|||
126344957|NCT03979313|454558473|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
126344958|NCT03979313|454558472|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
126344959|NCT03979313|454558473|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
126344960|NCT03979313|454558472|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
126344961|NCT03979313|454558473|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
126344962|NCT03979313|454558472|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
126344963|NCT03979313|454558473|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
126344964|NCT03979313|454558472|FG000|All Subjects|Any Other Reason|16|||
126344965|NCT03979313|454558473|FG001|All Subjects|Any Other Reason|23|||
126344966|NCT03979313|454558472|FG000|All Subjects|Covid-19|1|||
126344967|NCT03979313|454558473|FG001|All Subjects|Covid-19|3|||
126344968|NCT03979313|454558472|FG000|All Subjects|Withdrawal by Subject|35|||
126344969|NCT03979313|454558473|FG001|All Subjects|Withdrawal by Subject|44|||
126344970|NCT03979313|454558472|FG000|All Subjects|Death|0|||
126344971|NCT03979313|454558473|FG001|All Subjects|Death|5|||
126344972|NCT03979313|454558472|FG000|All Subjects|Lost to Follow-up|28|||
126344973|NCT03979313|454558473|FG001|All Subjects|Lost to Follow-up|61|||
126344974|NCT00089648|454558474|FG000|Overall Study|Adverse Event|7|||
126344975|NCT00089648|454558474|FG000|Overall Study|Withdrawal by Subject|1|||
126344976|NCT00089648|454558474|FG000|Overall Study|Lack of Efficacy|33|||
126344977|NCT00423605|454558475|FG000|Overall Study|Adverse Event|129|||
126344978|NCT00423605|454558475|FG000|Overall Study|Withdrawal by Subject|36|||
126344979|NCT00423605|454558475|FG000|Overall Study|Lost to Follow-up|15|||
126344980|NCT00423605|454558475|FG000|Overall Study|Lack of Efficacy|38|||
126344981|NCT00423605|454558475|FG000|Overall Study|Sponsor Decision|3|||
126344982|NCT00423605|454558475|FG000|Overall Study|Physician Decision|8|||
126344983|NCT00423605|454558475|FG000|Overall Study|Protocol Violation|7|||
126344984|NCT00423605|454558475|FG000|Overall Study|Not one of the pre-specified options|5|||
126344985|NCT03183908|454558481|FG000|Overall Study|Missing Symptom Diary Data|0|||
126344986|NCT03183908|454558482|FG001|Overall Study|Missing Symptom Diary Data|2|||
126344987|NCT01240746|454558483|FG000|Overall Study|Adverse Event|2|||
126344988|NCT01240746|454558484|FG001|Overall Study|Adverse Event|0|||
126344989|NCT01240746|454558485|FG002|Overall Study|Adverse Event|10|||
126344990|NCT01240746|454558483|FG000|Overall Study|Lost to Follow-up|23|||
126344991|NCT01240746|454558484|FG001|Overall Study|Lost to Follow-up|20|||
126344992|NCT01240746|454558485|FG002|Overall Study|Lost to Follow-up|102|||
126344993|NCT01240746|454558483|FG000|Overall Study|Protocol Violation|24|||
126344994|NCT01240746|454558484|FG001|Overall Study|Protocol Violation|15|||
126344995|NCT01240746|454558485|FG002|Overall Study|Protocol Violation|72|||
126344996|NCT01240746|454558483|FG000|Overall Study|Withdrawal by Subject|10|||
126344997|NCT01240746|454558484|FG001|Overall Study|Withdrawal by Subject|13|||
126344998|NCT01240746|454558485|FG002|Overall Study|Withdrawal by Subject|59|||
126344999|NCT03738696|454558486|FG000|Overall Study|Withdrawal by Subject|0|||
126345000|NCT03738696|454558487|FG001|Overall Study|Withdrawal by Subject|1|||
126345001|NCT03738696|454558486|FG000|Overall Study|Lost to Follow-up|8|||
126345002|NCT03738696|454558487|FG001|Overall Study|Lost to Follow-up|14|||
126345003|NCT02566005|454558488|FG000|Overall Study|vaginal bleeding|0|||
126345004|NCT02566005|454558489|FG001|Overall Study|vaginal bleeding|1|||
126345005|NCT02566005|454558488|FG000|Overall Study|received foley|8|||
126345006|NCT02566005|454558489|FG001|Overall Study|received foley|0|||
126345007|NCT02566005|454558488|FG000|Overall Study|did not receive foley|0|||
126345008|NCT02566005|454558489|FG001|Overall Study|did not receive foley|1|||
126345009|NCT02566005|454558488|FG000|Overall Study|labor after randomization|0|||
126345010|NCT02566005|454558489|FG001|Overall Study|labor after randomization|4|||
126345011|NCT03617588|454558490|FG000|Overall Study|Withdrawal by Subject|1|||
126345012|NCT03617588|454558491|FG001|Overall Study|Withdrawal by Subject|0|||
126345013|NCT01294514|454558492|FG000|Overall Study|Excluded due to Arrhythmia|1|||
126345014|NCT02690727|454558493|FG000|Overall Study|Adverse Event|2|||
126345015|NCT02690727|454558494|FG001|Overall Study|Adverse Event|2|||
126345016|NCT00785629|454558499|FG000|Overall Study|Adverse Event|2|||
126345017|NCT00785629|454558500|FG001|Overall Study|Adverse Event|1|||
126345018|NCT00785629|454558501|FG002|Overall Study|Adverse Event|1|||
126345019|NCT00785629|454558502|FG003|Overall Study|Adverse Event|5|||
126345020|NCT00785629|454558499|FG000|Overall Study|Protocol Violation|1|||
126345021|NCT00785629|454558500|FG001|Overall Study|Protocol Violation|2|||
126345022|NCT00785629|454558501|FG002|Overall Study|Protocol Violation|4|||
126345023|NCT00785629|454558502|FG003|Overall Study|Protocol Violation|5|||
126345024|NCT00785629|454558499|FG000|Overall Study|administrative decision|5|||
126345025|NCT00785629|454558500|FG001|Overall Study|administrative decision|1|||
126345026|NCT00785629|454558501|FG002|Overall Study|administrative decision|3|||
126345027|NCT00785629|454558502|FG003|Overall Study|administrative decision|4|||
126345028|NCT00785629|454558499|FG000|Overall Study|Withdrawal by Subject|0|||
126345029|NCT00785629|454558500|FG001|Overall Study|Withdrawal by Subject|1|||
126345030|NCT00785629|454558501|FG002|Overall Study|Withdrawal by Subject|2|||
126345031|NCT00785629|454558502|FG003|Overall Study|Withdrawal by Subject|2|||
126345032|NCT00851591|454558504|FG000|Overall Study|Withdrawal by Subject|2|||
126345033|NCT00851591|454558505|FG001|Overall Study|Withdrawal by Subject|0|||
126431038|NCT00918385|454873636|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
126431039|NCT00918385|454873637|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
126431040|NCT00918385|454873636|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
126431041|NCT00918385|454873637|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
126431042|NCT00918385|454873636|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
126431043|NCT00918385|454873637|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
126431044|NCT00918385|454873636|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
126431045|NCT00918385|454873637|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
126431046|NCT00317473|454873639|FG000|Overall Study|Withdrawal by Subject|2|||
126431047|NCT00317473|454873640|FG001|Overall Study|Withdrawal by Subject|1|||
126431048|NCT00317473|454873641|FG002|Overall Study|Withdrawal by Subject|2|||
126431049|NCT00317473|454873642|FG003|Overall Study|Withdrawal by Subject|1|||
126431050|NCT00317473|454873643|FG004|Overall Study|Withdrawal by Subject|3|||
126431051|NCT00317473|454873644|FG005|Overall Study|Withdrawal by Subject|1|||
126431052|NCT00317473|454873639|FG000|Overall Study|Relocation|1|||
126431053|NCT00317473|454873640|FG001|Overall Study|Relocation|0|||
126431054|NCT00317473|454873641|FG002|Overall Study|Relocation|1|||
126431055|NCT00317473|454873642|FG003|Overall Study|Relocation|1|||
126431056|NCT00317473|454873643|FG004|Overall Study|Relocation|5|||
126431057|NCT00317473|454873644|FG005|Overall Study|Relocation|2|||
126431058|NCT00317473|454873639|FG000|Overall Study|Death|1|||
126431059|NCT00317473|454873640|FG001|Overall Study|Death|0|||
126431060|NCT00317473|454873641|FG002|Overall Study|Death|0|||
126431061|NCT00317473|454873642|FG003|Overall Study|Death|0|||
126431062|NCT00317473|454873643|FG004|Overall Study|Death|0|||
126431063|NCT00317473|454873644|FG005|Overall Study|Death|0|||
126431064|NCT00317473|454873639|FG000|Overall Study|Other|0|||
126431065|NCT00317473|454873640|FG001|Overall Study|Other|2|||
126431066|NCT00317473|454873641|FG002|Overall Study|Other|0|||
126431067|NCT00317473|454873642|FG003|Overall Study|Other|0|||
126431068|NCT00317473|454873643|FG004|Overall Study|Other|0|||
126431069|NCT00317473|454873644|FG005|Overall Study|Other|0|||
126431070|NCT01323582|454873648|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
126431071|NCT01323582|454873649|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
126431072|NCT01323582|454873648|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
126431073|NCT01323582|454873649|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
126431074|NCT01323582|454873648|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
126431075|NCT01323582|454873649|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
126431076|NCT03416868|454873650|FG000|Overall Study|Withdrawal by Subject|2|||
126431077|NCT03416868|454873650|FG000|Overall Study|Lost to Follow-up|1|||
126431078|NCT00083889|454873651|FG000|Overall Study|Adverse Event|76|||
126431079|NCT00083889|454873652|FG001|Overall Study|Adverse Event|86|||
126431080|NCT00083889|454873651|FG000|Overall Study|Protocol Violation|2|||
126431081|NCT00083889|454873652|FG001|Overall Study|Protocol Violation|2|||
126431082|NCT00083889|454873651|FG000|Overall Study|Withdrawal by Subject|22|||
126431083|NCT00083889|454873652|FG001|Overall Study|Withdrawal by Subject|24|||
126431084|NCT00083889|454873651|FG000|Overall Study|Lack of Efficacy|240|||
126431085|NCT00083889|454873652|FG001|Overall Study|Lack of Efficacy|219|||
126431086|NCT00083889|454873651|FG000|Overall Study|Decision of sponsor|32|||
126431087|NCT00083889|454873652|FG001|Overall Study|Decision of sponsor|4|||
126431088|NCT00083889|454873651|FG000|Overall Study|Randomized: did not take study drug|0|||
126431089|NCT00083889|454873652|FG001|Overall Study|Randomized: did not take study drug|15|||
126431090|NCT00083889|454873651|FG000|Overall Study|Completed on marketed sunitinub|3|||
126431091|NCT00083889|454873652|FG001|Overall Study|Completed on marketed sunitinub|0|||
126431092|NCT00083889|454873651|FG000|Overall Study|Crossover to SU011248|0|||
126431093|NCT00083889|454873652|FG001|Overall Study|Crossover to SU011248|25|||
126431094|NCT00948064|454875735|FG000|Phase I|No treatment received|1|||
126431095|NCT00948064|454875736|FG001|Phase I|No treatment received|0|||
126431096|NCT00948064|454875737|FG002|Phase I|No treatment received|0|||
126431097|NCT00948064|454875735|FG000|Phase II|Physician Decision|0|||
126431098|NCT00948064|454875736|FG001|Phase II|Physician Decision|0|||
126431099|NCT00948064|454875737|FG002|Phase II|Physician Decision|1|||
126431100|NCT00948064|454875735|FG000|Phase II|Withdrawal by Subject|0|||
126431101|NCT00948064|454875736|FG001|Phase II|Withdrawal by Subject|1|||
126431102|NCT00948064|454875737|FG002|Phase II|Withdrawal by Subject|0|||
126679204|NCT00053417|455782721|FG001|Overall Study|Withdrawal by Subject|1|||
126679205|NCT00053417|455782722|FG002|Overall Study|Withdrawal by Subject|0|||
126431103|NCT03409796|454875751|FG000|Overall Study|Adverse Event|2|||
126431104|NCT03409796|454875752|FG001|Overall Study|Adverse Event|0|||
126431105|NCT03409796|454875751|FG000|Overall Study|Other|0|||
126431106|NCT03409796|454875752|FG001|Overall Study|Other|1|||
126431107|NCT00740220|454875753|FG000|Overall Study|screen failures (non-COPD patients)|9|||
126431108|NCT01602224|454875754|FG000|Overall Study|Adverse Event|0|||
126431109|NCT01602224|454875755|FG001|Overall Study|Adverse Event|1|||
126431110|NCT01602224|454875756|FG002|Overall Study|Adverse Event|0|||
126431111|NCT01602224|454875754|FG000|Overall Study|Investigator Decison|1|||
126431112|NCT01602224|454875755|FG001|Overall Study|Investigator Decison|0|||
126431113|NCT01602224|454875756|FG002|Overall Study|Investigator Decison|0|||
126431114|NCT01602224|454875754|FG000|Overall Study|Lost to Follow-up|0|||
126431115|NCT01602224|454875755|FG001|Overall Study|Lost to Follow-up|0|||
126431116|NCT01602224|454875756|FG002|Overall Study|Lost to Follow-up|1|||
126431117|NCT01602224|454875754|FG000|Overall Study|Protocol Violation|0|||
126679206|NCT00053417|455782723|FG003|Overall Study|Withdrawal by Subject|0|||
126679207|NCT00053417|455782720|FG000|Overall Study|Lost to Follow-up|1|||
126679208|NCT00053417|455782721|FG001|Overall Study|Lost to Follow-up|1|||
126679209|NCT00053417|455782722|FG002|Overall Study|Lost to Follow-up|0|||
126679210|NCT00053417|455782723|FG003|Overall Study|Lost to Follow-up|0|||
126679211|NCT02182687|455782730|FG000|Overall Study|Withdrawal by Subject|4|||
126679212|NCT02182687|455782731|FG001|Overall Study|Withdrawal by Subject|0|||
126431118|NCT01602224|454875755|FG001|Overall Study|Protocol Violation|1|||
126431119|NCT01602224|454875756|FG002|Overall Study|Protocol Violation|0|||
126431120|NCT01602224|454875754|FG000|Overall Study|Sponsor Decision|2|||
126431121|NCT01602224|454875755|FG001|Overall Study|Sponsor Decision|3|||
126431122|NCT01602224|454875756|FG002|Overall Study|Sponsor Decision|2|||
126431123|NCT01602224|454875754|FG000|Overall Study|Withdrawal by Subject|5|||
126431124|NCT01602224|454875755|FG001|Overall Study|Withdrawal by Subject|3|||
126431125|NCT01602224|454875756|FG002|Overall Study|Withdrawal by Subject|3|||
126431126|NCT01352117|454875757|FG000|Overall Study|Death|15|||
126431127|NCT01352117|454875758|FG001|Overall Study|Death|16|||
126431128|NCT01352117|454875757|FG000|Overall Study|Withdrawal by Subject|1|||
126431129|NCT01352117|454875758|FG001|Overall Study|Withdrawal by Subject|0|||
126431130|NCT01352117|454875757|FG000|Overall Study|Lost to Follow-up|2|||
126431131|NCT01352117|454875758|FG001|Overall Study|Lost to Follow-up|7|||
126431132|NCT01352117|454875757|FG000|Overall Study|Non-adherent to study requirements|1|||
126431133|NCT01352117|454875758|FG001|Overall Study|Non-adherent to study requirements|1|||
126431134|NCT01352117|454875757|FG000|Overall Study|Did not initiate study treatment|1|||
126431135|NCT01352117|454875758|FG001|Overall Study|Did not initiate study treatment|0|||
126431136|NCT01352117|454875757|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
126431137|NCT01352117|454875758|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
126431138|NCT00633477|454875759|FG000|Overall Study|Death|1|||
126431139|NCT00633477|454875760|FG001|Overall Study|Death|0|||
126679213|NCT02182687|455782730|FG000|Overall Study|Adverse Event|1|||
126679214|NCT02182687|455782731|FG001|Overall Study|Adverse Event|0|||
126345034|NCT04009837|454558510|FG000|Overall Study|Withdrawal by Subject|5|||
126345035|NCT04009837|454558511|FG001|Overall Study|Withdrawal by Subject|4|||
126345036|NCT04009837|454558510|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
126345037|NCT04009837|454558511|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
126345038|NCT01129128|454558514|FG000|Overall Study|Lost to Follow-up|2|||
126345039|NCT01129128|454558515|FG001|Overall Study|Lost to Follow-up|2|||
126345040|NCT01129128|454558516|FG002|Overall Study|Lost to Follow-up|1|||
126345041|NCT01129128|454558514|FG000|Overall Study|Protocol Violation|0|||
126345042|NCT01129128|454558515|FG001|Overall Study|Protocol Violation|1|||
126345043|NCT01129128|454558516|FG002|Overall Study|Protocol Violation|0|||
126345044|NCT01129128|454558514|FG000|Overall Study|Withdrawal by Subject|0|||
126345045|NCT01129128|454558515|FG001|Overall Study|Withdrawal by Subject|1|||
126345046|NCT01129128|454558516|FG002|Overall Study|Withdrawal by Subject|3|||
126345047|NCT01129128|454558514|FG000|Overall Study|Physician Decision|1|||
126345048|NCT01129128|454558515|FG001|Overall Study|Physician Decision|0|||
126345049|NCT01129128|454558516|FG002|Overall Study|Physician Decision|0|||
126345050|NCT02763566|454558524|FG000|Overall Study|Lost to Follow-up|1|||
126345051|NCT02763566|454558525|FG001|Overall Study|Lost to Follow-up|4|||
126345052|NCT02763566|454558526|FG002|Overall Study|Lost to Follow-up|0|||
126345053|NCT02763566|454558527|FG003|Overall Study|Lost to Follow-up|1|||
126345054|NCT02763566|454558524|FG000|Overall Study|On study treatment at study conclusion|114|||
126345055|NCT02763566|454558525|FG001|Overall Study|On study treatment at study conclusion|34|||
126345056|NCT02763566|454558526|FG002|Overall Study|On study treatment at study conclusion|54|||
126345057|NCT02763566|454558527|FG003|Overall Study|On study treatment at study conclusion|13|||
126345058|NCT02763566|454558524|FG000|Overall Study|Withdrawal by Subject|3|||
126345059|NCT02763566|454558525|FG001|Overall Study|Withdrawal by Subject|1|||
126679215|NCT02182687|455782730|FG000|Overall Study|Lost to Follow-up|0|||
126679216|NCT02182687|455782731|FG001|Overall Study|Lost to Follow-up|1|||
126679217|NCT01297270|455782732|FG000|Overall Study|Adverse Event|19|||
126679218|NCT01297270|455782733|FG001|Overall Study|Adverse Event|32|||
126679219|NCT01297270|455782734|FG002|Overall Study|Adverse Event|5|||
126679220|NCT01297270|455782732|FG000|Overall Study|Lack of Efficacy|15|||
126679221|NCT01297270|455782733|FG001|Overall Study|Lack of Efficacy|17|||
126345060|NCT02763566|454558526|FG002|Overall Study|Withdrawal by Subject|0|||
126345061|NCT02763566|454558527|FG003|Overall Study|Withdrawal by Subject|0|||
126345062|NCT01933594|454558532|FG000|Overall Study|Lost to Follow-up|1|||
126345063|NCT01933594|454558533|FG001|Overall Study|Lost to Follow-up|0|||
126345064|NCT01933594|454558534|FG002|Overall Study|Lost to Follow-up|0|||
126431140|NCT00633477|454875759|FG000|Overall Study|Randomized but not treated|1|||
126431141|NCT00633477|454875760|FG001|Overall Study|Randomized but not treated|0|||
126431142|NCT00770653|454875764|FG000|Overall Study|Adverse Event|13|||
126431143|NCT00770653|454875765|FG001|Overall Study|Adverse Event|5|||
126431144|NCT00770653|454875764|FG000|Overall Study|Protocol Violation|8|||
126431145|NCT00770653|454875765|FG001|Overall Study|Protocol Violation|6|||
126431146|NCT00770653|454875764|FG000|Overall Study|Withdrawal by Subject|4|||
126431147|NCT00770653|454875765|FG001|Overall Study|Withdrawal by Subject|7|||
126431148|NCT00770653|454875764|FG000|Overall Study|Lack of Compliance|1|||
126431149|NCT00770653|454875765|FG001|Overall Study|Lack of Compliance|4|||
126431150|NCT00770653|454875764|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
126431151|NCT00770653|454875765|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
126431152|NCT00770653|454875764|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
126431153|NCT00770653|454875765|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
126431154|NCT00770653|454875764|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
126431155|NCT00770653|454875765|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
126431156|NCT00770653|454875764|FG000|Overall Study|Lost to Follow-up|1|||
126431157|NCT00770653|454875765|FG001|Overall Study|Lost to Follow-up|2|||
126679222|NCT01297270|455782734|FG002|Overall Study|Lack of Efficacy|15|||
126679223|NCT01297270|455782732|FG000|Overall Study|Lost to Follow-up|1|||
126679224|NCT01297270|455782733|FG001|Overall Study|Lost to Follow-up|2|||
126679225|NCT01297270|455782734|FG002|Overall Study|Lost to Follow-up|1|||
126679226|NCT01297270|455782732|FG000|Overall Study|Protocol Violation|0|||
126679227|NCT01297270|455782733|FG001|Overall Study|Protocol Violation|2|||
126679228|NCT01297270|455782734|FG002|Overall Study|Protocol Violation|0|||
126679229|NCT01297270|455782732|FG000|Overall Study|Withdrawal by Subject|7|||
126679230|NCT01297270|455782733|FG001|Overall Study|Withdrawal by Subject|15|||
126679231|NCT01297270|455782734|FG002|Overall Study|Withdrawal by Subject|7|||
126679232|NCT01297270|455782732|FG000|Overall Study|Other reason not defined above|3|||
126679233|NCT01297270|455782733|FG001|Overall Study|Other reason not defined above|3|||
126679234|NCT01297270|455782734|FG002|Overall Study|Other reason not defined above|1|||
126679235|NCT01297270|455782732|FG000|Overall Study|Not treated|0|||
126679236|NCT01297270|455782733|FG001|Overall Study|Not treated|1|||
126345065|NCT01933594|454558535|FG003|Overall Study|Lost to Follow-up|0|||
126431158|NCT00770653|454875764|FG000|Overall Study|Physician Decision|1|||
126431159|NCT00770653|454875765|FG001|Overall Study|Physician Decision|0|||
126431160|NCT04906499|454875771|FG000|Overall Study|Lack of time|1|||
126431161|NCT00179621|454875772|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
126431162|NCT00179621|454875773|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
126431163|NCT00179621|454875774|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
126431164|NCT00179621|454875775|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
126431165|NCT00179621|454875772|FG000|Double-Blind Period|Adverse Event|2|||
126431166|NCT00179621|454875773|FG001|Double-Blind Period|Adverse Event|7|||
126431167|NCT00179621|454875774|FG002|Double-Blind Period|Adverse Event|4|||
126431168|NCT00179621|454875775|FG003|Double-Blind Period|Adverse Event|0|||
126431169|NCT00179621|454875772|FG000|Double-Blind Period|Withdrawal by Subject|2|||
126431170|NCT00179621|454875773|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126431171|NCT00179621|454875774|FG002|Double-Blind Period|Withdrawal by Subject|3|||
126431172|NCT00179621|454875775|FG003|Double-Blind Period|Withdrawal by Subject|0|||
126431173|NCT00179621|454875772|FG000|Double-Blind Period|Death|0|||
126431174|NCT00179621|454875773|FG001|Double-Blind Period|Death|1|||
126431175|NCT00179621|454875774|FG002|Double-Blind Period|Death|2|||
126431176|NCT00179621|454875775|FG003|Double-Blind Period|Death|0|||
126431177|NCT00179621|454875772|FG000|Double-Blind Period|Protocol Violation|1|||
126431178|NCT00179621|454875773|FG001|Double-Blind Period|Protocol Violation|0|||
126431179|NCT00179621|454875774|FG002|Double-Blind Period|Protocol Violation|0|||
126431180|NCT00179621|454875775|FG003|Double-Blind Period|Protocol Violation|0|||
126431181|NCT00179621|454875772|FG000|Double-Blind Period|Other|0|||
126431182|NCT00179621|454875773|FG001|Double-Blind Period|Other|2|||
126431183|NCT00179621|454875774|FG002|Double-Blind Period|Other|2|||
126431184|NCT00179621|454875775|FG003|Double-Blind Period|Other|0|||
126431185|NCT00179621|454875772|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
126431186|NCT00179621|454875773|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
126431187|NCT00179621|454875774|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
126431188|NCT00179621|454875775|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
126431189|NCT00179621|454875772|FG000|Open-Label Period|Adverse Event|0|||
126345066|NCT01933594|454558536|FG004|Overall Study|Lost to Follow-up|1|||
126345067|NCT01933594|454558537|FG005|Overall Study|Lost to Follow-up|0|||
126345068|NCT01933594|454558532|FG000|Overall Study|Ineligible for subsequent study step|0|||
126345069|NCT01933594|454558533|FG001|Overall Study|Ineligible for subsequent study step|0|||
126345070|NCT01933594|454558534|FG002|Overall Study|Ineligible for subsequent study step|0|||
126345071|NCT01933594|454558535|FG003|Overall Study|Ineligible for subsequent study step|0|||
126345072|NCT01933594|454558536|FG004|Overall Study|Ineligible for subsequent study step|1|||
126345073|NCT01933594|454558537|FG005|Overall Study|Ineligible for subsequent study step|0|||
126345074|NCT02657551|454558546|FG000|Overall Study|Adverse Event|2|||
126431190|NCT00179621|454875773|FG001|Open-Label Period|Adverse Event|6|||
126431191|NCT00179621|454875774|FG002|Open-Label Period|Adverse Event|5|||
126431192|NCT00179621|454875775|FG003|Open-Label Period|Adverse Event|6|||
126431193|NCT00179621|454875772|FG000|Open-Label Period|Withdrawal by Subject|0|||
126431194|NCT00179621|454875773|FG001|Open-Label Period|Withdrawal by Subject|2|||
126679237|NCT01297270|455782734|FG002|Overall Study|Not treated|0|||
126679238|NCT02863809|455782737|FG000|Overall Study|Adverse Event|8|||
126679239|NCT02863809|455782738|FG001|Overall Study|Adverse Event|8|||
126679240|NCT02863809|455782737|FG000|Overall Study|Withdrawal by Subject|0|||
126345075|NCT02657551|454558546|FG000|Overall Study|Withdrawal by Subject|1|||
126345076|NCT02657551|454558546|FG000|Overall Study|Non-Compliance|1|||
126345077|NCT02657551|454558546|FG000|Overall Study|Progression / Relapse|4|||
126431195|NCT00179621|454875774|FG002|Open-Label Period|Withdrawal by Subject|2|||
126431196|NCT00179621|454875775|FG003|Open-Label Period|Withdrawal by Subject|2|||
126431197|NCT00179621|454875772|FG000|Open-Label Period|Death|0|||
126431198|NCT00179621|454875773|FG001|Open-Label Period|Death|0|||
126431199|NCT00179621|454875774|FG002|Open-Label Period|Death|1|||
126431200|NCT00179621|454875775|FG003|Open-Label Period|Death|2|||
126431201|NCT00179621|454875772|FG000|Open-Label Period|Other|0|||
126431202|NCT00179621|454875773|FG001|Open-Label Period|Other|1|||
126431203|NCT00179621|454875774|FG002|Open-Label Period|Other|1|||
126431204|NCT00179621|454875775|FG003|Open-Label Period|Other|2|||
126431205|NCT01751061|454875779|FG000|Overall Study|Death|1|||
126431206|NCT01751061|454875780|FG001|Overall Study|Death|0|||
126431207|NCT01751061|454875779|FG000|Overall Study|patient death|5|||
126431208|NCT01751061|454875780|FG001|Overall Study|patient death|0|||
126431209|NCT01751061|454875779|FG000|Overall Study|Lost to Follow-up|40|||
126431210|NCT01751061|454875780|FG001|Overall Study|Lost to Follow-up|25|||
126431211|NCT01751061|454875779|FG000|Overall Study|patient regained decisional capacity|4|||
126431212|NCT01751061|454875780|FG001|Overall Study|patient regained decisional capacity|8|||
126431213|NCT01751061|454875779|FG000|Overall Study|Withdrawal by Subject|4|||
126431214|NCT01751061|454875780|FG001|Overall Study|Withdrawal by Subject|1|||
126679241|NCT02863809|455782738|FG001|Overall Study|Withdrawal by Subject|1|||
126345078|NCT00315445|454558547|FG000|Overall Study|Adverse Event|7|||
126345079|NCT00315445|454558548|FG001|Overall Study|Adverse Event|12|||
126345080|NCT00315445|454558549|FG002|Overall Study|Adverse Event|15|||
126345081|NCT00315445|454558547|FG000|Overall Study|Lack of Efficacy|16|||
126345082|NCT00315445|454558548|FG001|Overall Study|Lack of Efficacy|1|||
126345083|NCT00315445|454558549|FG002|Overall Study|Lack of Efficacy|7|||
126345084|NCT00315445|454558547|FG000|Overall Study|Lost to Follow-up|1|||
126345085|NCT00315445|454558548|FG001|Overall Study|Lost to Follow-up|0|||
126345086|NCT00315445|454558549|FG002|Overall Study|Lost to Follow-up|1|||
126345087|NCT00315445|454558547|FG000|Overall Study|Protocol Violation|2|||
126345088|NCT00315445|454558548|FG001|Overall Study|Protocol Violation|0|||
126345089|NCT00315445|454558549|FG002|Overall Study|Protocol Violation|1|||
126345090|NCT00315445|454558547|FG000|Overall Study|Other|1|||
126345091|NCT00315445|454558548|FG001|Overall Study|Other|3|||
126345092|NCT00315445|454558549|FG002|Overall Study|Other|0|||
126345093|NCT01035138|454558550|FG000|Overall Study|Adverse Event|4|||
126345094|NCT01035138|454558551|FG001|Overall Study|Adverse Event|0|||
126345095|NCT01035138|454558552|FG002|Overall Study|Adverse Event|2|||
126345096|NCT01035138|454558550|FG000|Overall Study|Caregiver Decision|2|||
126345097|NCT01035138|454558551|FG001|Overall Study|Caregiver Decision|0|||
126345098|NCT01035138|454558552|FG002|Overall Study|Caregiver Decision|1|||
126345099|NCT01035138|454558550|FG000|Overall Study|Withdrawal by Subject|1|||
126345100|NCT01035138|454558551|FG001|Overall Study|Withdrawal by Subject|0|||
126345101|NCT01035138|454558552|FG002|Overall Study|Withdrawal by Subject|0|||
126345102|NCT01035138|454558550|FG000|Overall Study|Physician Decision|0|||
126345103|NCT01035138|454558551|FG001|Overall Study|Physician Decision|0|||
126345104|NCT01035138|454558552|FG002|Overall Study|Physician Decision|1|||
126345105|NCT01035138|454558550|FG000|Overall Study|Sponsor Decision|66|||
126345106|NCT01035138|454558551|FG001|Overall Study|Sponsor Decision|60|||
126345107|NCT01035138|454558552|FG002|Overall Study|Sponsor Decision|42|||
126345108|NCT01035138|454558550|FG000|Overall Study|Lost to Follow-up|0|||
126345109|NCT01035138|454558551|FG001|Overall Study|Lost to Follow-up|0|||
126345110|NCT01035138|454558552|FG002|Overall Study|Lost to Follow-up|1|||
126345111|NCT01811238|454558553|FG000|Overall Study|Withdrawal by Subject|42|||
126431215|NCT01751061|454875779|FG000|Overall Study|Physician Decision|2|||
126431216|NCT01751061|454875780|FG001|Overall Study|Physician Decision|0|||
126431217|NCT01194830|454875782|FG000|Overall Study|Adverse Event|3|||
126679242|NCT02863809|455782737|FG000|Overall Study|Lost to Follow-up|1|||
126679243|NCT02863809|455782738|FG001|Overall Study|Lost to Follow-up|1|||
126679244|NCT02863809|455782737|FG000|Overall Study|Death|1|||
126679245|NCT02863809|455782738|FG001|Overall Study|Death|0|||
126679246|NCT02829138|455782739|FG000|Overall Study|Withdrawal by Subject|1|||
126679247|NCT02829138|455782740|FG001|Overall Study|Withdrawal by Subject|0|||
126345112|NCT01811238|454558553|FG000|Overall Study|Adverse Event|25|||
126345113|NCT01811238|454558553|FG000|Overall Study|Protocol Violation|4|||
126431218|NCT01194830|454875783|FG001|Overall Study|Adverse Event|2|||
126431219|NCT01194830|454875782|FG000|Overall Study|Protocol Violation|5|||
126431220|NCT01194830|454875783|FG001|Overall Study|Protocol Violation|4|||
126345114|NCT01811238|454558553|FG000|Overall Study|Lack of Efficacy|4|||
126345115|NCT01811238|454558553|FG000|Overall Study|subject refused study medication|6|||
126345116|NCT02164916|454558556|FG000|Overall Study|Adverse Event|3|||
126345117|NCT02164916|454558557|FG001|Overall Study|Adverse Event|8|||
126431221|NCT01194830|454875782|FG000|Overall Study|Lost to Follow-up|9|||
126679248|NCT02411539|455782741|FG000|Overall Study|Lost to Follow-up|2|||
126431222|NCT01194830|454875783|FG001|Overall Study|Lost to Follow-up|7|||
126431223|NCT01194830|454875782|FG000|Overall Study|Withdrawal by Subject|2|||
126431224|NCT01194830|454875783|FG001|Overall Study|Withdrawal by Subject|1|||
126345118|NCT02164916|454558556|FG000|Overall Study|Death|1|||
126345119|NCT02164916|454558557|FG001|Overall Study|Death|1|||
126345120|NCT02164916|454558556|FG000|Overall Study|Refusal unrelated to adverse event|3|||
126345121|NCT02164916|454558557|FG001|Overall Study|Refusal unrelated to adverse event|7|||
126345122|NCT02164916|454558556|FG000|Overall Study|Progression|37|||
126345123|NCT02164916|454558557|FG001|Overall Study|Progression|26|||
126345124|NCT02164916|454558556|FG000|Overall Study|Not protocol specified|5|||
126345125|NCT02164916|454558557|FG001|Overall Study|Not protocol specified|1|||
126345126|NCT02164916|454558556|FG000|Overall Study|Reason under review|1|||
126345127|NCT02164916|454558557|FG001|Overall Study|Reason under review|6|||
126345128|NCT02164916|454558556|FG000|Overall Study|Not eligible|2|||
126345129|NCT02164916|454558557|FG001|Overall Study|Not eligible|5|||
126345130|NCT02916927|454558560|FG000|Overall Study|Discharged prior to study drug receipt|0|||
126345131|NCT02916927|454558561|FG001|Overall Study|Discharged prior to study drug receipt|2|||
126345132|NCT02916927|454558560|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
126345133|NCT02916927|454558561|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
126345134|NCT02916927|454558560|FG000|Overall Study|Withdrawal before first time point|1|||
126345135|NCT02916927|454558561|FG001|Overall Study|Withdrawal before first time point|0|||
126345136|NCT01925417|454558568|FG000|Overall Study|Withdrawal by Subject|2|||
126345137|NCT01925417|454558568|FG000|Overall Study|Death|1|||
126345138|NCT00655889|454558569|FG000|Overall Study|Inadequate cell growth|1|||
126345139|NCT00655889|454558569|FG000|Overall Study|Protocol Violation|1|||
126345140|NCT03479905|454558570|FG000|Overall Study|Other airway method used|4|||
126345141|NCT03479905|454558571|FG001|Overall Study|Other airway method used|5|||
126345142|NCT03479905|454558572|FG002|Overall Study|Other airway method used|5|||
126345143|NCT00720759|454558573|FG000|Overall Study|Lost to Follow-up|0|||
126345144|NCT00720759|454558574|FG001|Overall Study|Lost to Follow-up|1|||
126345145|NCT00720759|454558575|FG002|Overall Study|Lost to Follow-up|1|||
126345146|NCT00720759|454558576|FG003|Overall Study|Lost to Follow-up|0|||
126345147|NCT02318940|454558577|FG000|Overall Study|lost the record|1|||
126345148|NCT02318940|454558578|FG001|Overall Study|lost the record|0|||
126345149|NCT01047319|454558579|FG000|Overall Study|Teva requested participant withdrawal|3|||
126345150|NCT01047319|454558580|FG001|Overall Study|Teva requested participant withdrawal|0|||
126345151|NCT01047319|454558581|FG002|Overall Study|Teva requested participant withdrawal|1|||
126345152|NCT01047319|454558579|FG000|Overall Study|Protocol Violation|3|||
126345153|NCT01047319|454558580|FG001|Overall Study|Protocol Violation|2|||
126345154|NCT01047319|454558581|FG002|Overall Study|Protocol Violation|4|||
126345155|NCT01047319|454558579|FG000|Overall Study|Lack of Efficacy|4|||
126345156|NCT01047319|454558580|FG001|Overall Study|Lack of Efficacy|3|||
126345157|NCT01047319|454558581|FG002|Overall Study|Lack of Efficacy|3|||
126345158|NCT01047319|454558579|FG000|Overall Study|Death|5|||
126345159|NCT01047319|454558580|FG001|Overall Study|Death|1|||
126345160|NCT01047319|454558581|FG002|Overall Study|Death|5|||
126345161|NCT01047319|454558579|FG000|Overall Study|Pregnancy|13|||
126345162|NCT01047319|454558580|FG001|Overall Study|Pregnancy|8|||
126345163|NCT01047319|454558581|FG002|Overall Study|Pregnancy|8|||
126345164|NCT01047319|454558579|FG000|Overall Study|Physician Decision|12|||
126345165|NCT01047319|454558580|FG001|Overall Study|Physician Decision|9|||
126345166|NCT01047319|454558581|FG002|Overall Study|Physician Decision|10|||
126345167|NCT01047319|454558579|FG000|Overall Study|Lost to Follow-up|14|||
126345168|NCT01047319|454558580|FG001|Overall Study|Lost to Follow-up|10|||
126345169|NCT01047319|454558581|FG002|Overall Study|Lost to Follow-up|10|||
126345170|NCT01047319|454558579|FG000|Overall Study|Adverse Event|16|||
126345171|NCT01047319|454558580|FG001|Overall Study|Adverse Event|27|||
126345172|NCT01047319|454558581|FG002|Overall Study|Adverse Event|21|||
126345173|NCT01047319|454558579|FG000|Overall Study|Withdrawal by Subject|77|||
126345174|NCT01047319|454558580|FG001|Overall Study|Withdrawal by Subject|75|||
126345175|NCT01047319|454558581|FG002|Overall Study|Withdrawal by Subject|87|||
126345176|NCT01047319|454558579|FG000|Overall Study|Study terminated by Sponsor|198|||
126345177|NCT01047319|454558580|FG001|Overall Study|Study terminated by Sponsor|215|||
126345178|NCT01047319|454558581|FG002|Overall Study|Study terminated by Sponsor|203|||
126345179|NCT02598661|454558584|FG000|Overall Study|Death|27|||
126345180|NCT02598661|454558585|FG001|Overall Study|Death|34|||
126345181|NCT02598661|454558586|FG002|Overall Study|Death|14|||
126431225|NCT01194830|454875782|FG000|Overall Study|Lack of Efficacy|1|||
126431226|NCT01194830|454875783|FG001|Overall Study|Lack of Efficacy|1|||
126431227|NCT01194830|454875782|FG000|Overall Study|Non-compliance issues|4|||
126431228|NCT01194830|454875783|FG001|Overall Study|Non-compliance issues|4|||
126345182|NCT02598661|454558587|FG003|Overall Study|Death|1|||
126431229|NCT01194830|454875782|FG000|Overall Study|Other Reason|12|||
126345183|NCT02598661|454558588|FG004|Overall Study|Death|0|||
126345184|NCT02598661|454558584|FG000|Overall Study|Lost to Follow-up|2|||
126345185|NCT02598661|454558585|FG001|Overall Study|Lost to Follow-up|3|||
126345186|NCT02598661|454558586|FG002|Overall Study|Lost to Follow-up|2|||
126345187|NCT02598661|454558587|FG003|Overall Study|Lost to Follow-up|0|||
126345188|NCT02598661|454558588|FG004|Overall Study|Lost to Follow-up|0|||
126431230|NCT01194830|454875783|FG001|Overall Study|Other Reason|8|||
126431231|NCT01815918|454875786|FG000|Overall Study|Patient samples not analyzable|3|||
126431232|NCT01815918|454875787|FG001|Overall Study|Patient samples not analyzable|4|||
126431233|NCT01815918|454875786|FG000|Overall Study|Lack of Efficacy|15|||
126431234|NCT01815918|454875787|FG001|Overall Study|Lack of Efficacy|15|||
126431235|NCT02814916|454875790|FG000|Overall Study|Withdrawal of consent|0|||
126431236|NCT02814916|454875791|FG001|Overall Study|Withdrawal of consent|2|||
126431237|NCT02814916|454875792|FG002|Overall Study|Withdrawal of consent|0|||
126431238|NCT02814916|454875790|FG000|Overall Study|Lost to Follow-up|0|||
126431239|NCT02814916|454875791|FG001|Overall Study|Lost to Follow-up|1|||
126431240|NCT02814916|454875792|FG002|Overall Study|Lost to Follow-up|0|||
126431241|NCT02814916|454875790|FG000|Overall Study|Other, not specified|0|||
126431242|NCT02814916|454875791|FG001|Overall Study|Other, not specified|1|||
126431243|NCT02814916|454875792|FG002|Overall Study|Other, not specified|0|||
126431244|NCT04750824|454875801|FG000|Overall Study|Toxicity/intolerability|3|||
126679249|NCT02411539|455782742|FG001|Overall Study|Lost to Follow-up|0|||
126431245|NCT04750824|454875802|FG001|Overall Study|Toxicity/intolerability|1|||
126431246|NCT04750824|454875801|FG000|Overall Study|Death|1|||
126431247|NCT04750824|454875802|FG001|Overall Study|Death|3|||
126431248|NCT04750824|454875801|FG000|Overall Study|Scheduled duration of therapy complete|1|||
126431249|NCT04750824|454875802|FG001|Overall Study|Scheduled duration of therapy complete|9|||
126431250|NCT04750824|454875801|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
126431251|NCT04750824|454875802|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
126431252|NCT03547518|454875810|FG000|Overall Study|Lost to Follow-up|2|||
126431253|NCT03547518|454875811|FG001|Overall Study|Lost to Follow-up|0|||
126431254|NCT01018030|454875812|FG000|Overall Study|Adverse Event|10|||
126431255|NCT01018030|454875813|FG001|Overall Study|Adverse Event|5|||
126431256|NCT01018030|454875814|FG002|Overall Study|Adverse Event|5|||
126431257|NCT01018030|454875812|FG000|Overall Study|Withdrawal by Subject|2|||
126431258|NCT01018030|454875813|FG001|Overall Study|Withdrawal by Subject|2|||
126431259|NCT01018030|454875814|FG002|Overall Study|Withdrawal by Subject|4|||
126431260|NCT01018030|454875812|FG000|Overall Study|Lost to Follow-up|2|||
126431261|NCT01018030|454875813|FG001|Overall Study|Lost to Follow-up|0|||
126431262|NCT01018030|454875814|FG002|Overall Study|Lost to Follow-up|3|||
126431263|NCT01018030|454875812|FG000|Overall Study|Protocol Violation|2|||
126431264|NCT01018030|454875813|FG001|Overall Study|Protocol Violation|1|||
126431265|NCT01018030|454875814|FG002|Overall Study|Protocol Violation|0|||
126431266|NCT01018030|454875812|FG000|Overall Study|Physician Decision|1|||
126431267|NCT01018030|454875813|FG001|Overall Study|Physician Decision|0|||
126431268|NCT01018030|454875814|FG002|Overall Study|Physician Decision|1|||
126431269|NCT01018030|454875812|FG000|Overall Study|Lack of Efficacy|1|||
126431270|NCT01018030|454875813|FG001|Overall Study|Lack of Efficacy|0|||
126431271|NCT01018030|454875814|FG002|Overall Study|Lack of Efficacy|0|||
126431272|NCT01018030|454875812|FG000|Overall Study|Did Not Receive Study Drug|1|||
126431273|NCT01018030|454875813|FG001|Overall Study|Did Not Receive Study Drug|3|||
126431274|NCT01018030|454875814|FG002|Overall Study|Did Not Receive Study Drug|0|||
126431275|NCT03617172|454875815|FG000|Overall Study|Lost to Follow-up|1|||
126431276|NCT03617172|454875816|FG001|Overall Study|Lost to Follow-up|0|||
126431277|NCT00189540|454875817|FG000|Overall Study|Withdrawal by Subject|3|||
126431278|NCT00189540|454875818|FG001|Overall Study|Withdrawal by Subject|0|||
126431279|NCT00189540|454875817|FG000|Overall Study|Death|4|||
126431280|NCT00189540|454875818|FG001|Overall Study|Death|1|||
126345189|NCT02598661|454558584|FG000|Overall Study|Withdrawal by Subject|13|||
126345190|NCT02598661|454558585|FG001|Overall Study|Withdrawal by Subject|24|||
126345191|NCT02598661|454558586|FG002|Overall Study|Withdrawal by Subject|14|||
126345192|NCT02598661|454558587|FG003|Overall Study|Withdrawal by Subject|1|||
126345193|NCT02598661|454558588|FG004|Overall Study|Withdrawal by Subject|1|||
126345194|NCT02598661|454558584|FG000|Overall Study|Adverse Event|0|||
126345195|NCT02598661|454558585|FG001|Overall Study|Adverse Event|0|||
126345196|NCT02598661|454558586|FG002|Overall Study|Adverse Event|1|||
126345197|NCT02598661|454558587|FG003|Overall Study|Adverse Event|0|||
126345198|NCT02598661|454558588|FG004|Overall Study|Adverse Event|0|||
126345199|NCT02598661|454558584|FG000|Overall Study|Randomized, Never Treated|0|||
126345200|NCT02598661|454558585|FG001|Overall Study|Randomized, Never Treated|0|||
126431281|NCT01089504|454875819|FG000|Overall Study|Lost to Follow-up|1|||
126431282|NCT01089504|454875820|FG001|Overall Study|Lost to Follow-up|1|||
126431283|NCT01089504|454875819|FG000|Overall Study|Withdrawal by Subject|2|||
126431284|NCT01089504|454875820|FG001|Overall Study|Withdrawal by Subject|0|||
126431285|NCT00062439|454875821|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
126431286|NCT00062439|454875821|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
126431287|NCT00062439|454875821|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
126431288|NCT00062439|454875821|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
126431289|NCT00062439|454875821|FG000|Post Chemoradiation Assessment|Death|1|||
126431290|NCT00062439|454875821|FG000|Post Chemoradiation Assessment|Disease progression|2|||
126679250|NCT02411539|455782741|FG000|Overall Study|Confounding medical condition|0|||
126345201|NCT02598661|454558586|FG002|Overall Study|Randomized, Never Treated|0|||
126345202|NCT02598661|454558587|FG003|Overall Study|Randomized, Never Treated|0|||
126345203|NCT02598661|454558588|FG004|Overall Study|Randomized, Never Treated|1|||
126345204|NCT01366092|454558589|FG000|Overall Study|Progressive cGVHD|2|||
126679251|NCT02411539|455782742|FG001|Overall Study|Confounding medical condition|1|||
126679252|NCT04041284|455782745|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
126679253|NCT04041284|455782746|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
126679254|NCT04041284|455782745|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
126679255|NCT04041284|455782746|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
126679256|NCT04041284|455782745|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
126679257|NCT04041284|455782746|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
126679258|NCT04041284|455782745|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
126679259|NCT04041284|455782746|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
126679260|NCT04041284|455782745|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
126679261|NCT04041284|455782746|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
126679262|NCT04041284|455782745|FG000|DB Phase (12 Weeks)|Other than specified|1|||
126679263|NCT04041284|455782746|FG001|DB Phase (12 Weeks)|Other than specified|0|||
126679264|NCT04041284|455782745|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
126679265|NCT04041284|455782746|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
126679266|NCT04041284|455782745|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
126679267|NCT04041284|455782746|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
126679268|NCT04041284|455782745|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
126679269|NCT04041284|455782746|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
126679270|NCT04041284|455782745|FG000|OL Phase (12 Weeks)|Other than specified|6|||
126679271|NCT04041284|455782746|FG001|OL Phase (12 Weeks)|Other than specified|2|||
126679272|NCT00563186|455782747|FG000|Overall Study|LOS<48 hours|97|||
126679273|NCT00563186|455782748|FG001|Overall Study|LOS<48 hours|74|||
126679274|NCT00563186|455782747|FG000|Overall Study|Incomplete data|1|||
126679275|NCT00563186|455782748|FG001|Overall Study|Incomplete data|1|||
126679276|NCT00886600|455782749|FG000|Double-blind Monotherapy|Adverse Event|1|||
126679277|NCT00886600|455782750|FG001|Double-blind Monotherapy|Adverse Event|1|||
126679278|NCT00886600|455782751|FG002|Double-blind Monotherapy|Adverse Event|1|||
126679279|NCT00886600|455782752|FG003|Double-blind Monotherapy|Adverse Event|1|||
126679280|NCT00886600|455782749|FG000|Double-blind Monotherapy|Protocol Violation|0|||
126679281|NCT00886600|455782750|FG001|Double-blind Monotherapy|Protocol Violation|0|||
126345205|NCT01366092|454558589|FG000|Overall Study|Physician Decision|1|||
126345206|NCT01366092|454558589|FG000|Overall Study|Withdrawal by Subject|1|||
126345207|NCT02659865|454560105|FG000|Period 1|Withdrawal by Subject|1|||
126345208|NCT02659865|454560106|FG001|Period 1|Withdrawal by Subject|0|||
126345209|NCT02659865|454560107|FG002|Period 1|Withdrawal by Subject|0|||
126345210|NCT02659865|454560108|FG003|Period 1|Withdrawal by Subject|0|||
126345211|NCT02659865|454560109|FG004|Period 1|Withdrawal by Subject|0|||
126345212|NCT02659865|454560105|FG000|Period 1|Adverse Event|0|||
126345213|NCT02659865|454560106|FG001|Period 1|Adverse Event|0|||
126345214|NCT02659865|454560107|FG002|Period 1|Adverse Event|0|||
126345215|NCT02659865|454560108|FG003|Period 1|Adverse Event|0|||
126345216|NCT02659865|454560109|FG004|Period 1|Adverse Event|1|||
126345217|NCT01288430|454560111|FG000|Part 1|Progressive disease|2|||
126345218|NCT01288430|454560112|FG001|Part 1|Progressive disease|1|||
126345219|NCT01288430|454560113|FG002|Part 1|Progressive disease|1|||
126345220|NCT01288430|454560114|FG003|Part 1|Progressive disease|6|||
126345221|NCT01288430|454560115|FG004|Part 1|Progressive disease|2|||
126345222|NCT01288430|454560116|FG005|Part 1|Progressive disease|4|||
126345223|NCT01288430|454560117|FG006|Part 1|Progressive disease|2|||
126345224|NCT01288430|454560118|FG007|Part 1|Progressive disease|0|||
126345225|NCT01288430|454560119|FG008|Part 1|Progressive disease|0|||
126345226|NCT01288430|454560120|FG009|Part 1|Progressive disease|0|||
126345227|NCT01288430|454560111|FG000|Part 1|Clinical disease progression|0|||
126345228|NCT01288430|454560112|FG001|Part 1|Clinical disease progression|0|||
126345229|NCT01288430|454560113|FG002|Part 1|Clinical disease progression|1|||
126345230|NCT01288430|454560114|FG003|Part 1|Clinical disease progression|0|||
126345231|NCT01288430|454560115|FG004|Part 1|Clinical disease progression|0|||
126345232|NCT01288430|454560116|FG005|Part 1|Clinical disease progression|2|||
126345233|NCT01288430|454560117|FG006|Part 1|Clinical disease progression|2|||
126345234|NCT01288430|454560118|FG007|Part 1|Clinical disease progression|0|||
126345235|NCT01288430|454560119|FG008|Part 1|Clinical disease progression|0|||
126345236|NCT01288430|454560120|FG009|Part 1|Clinical disease progression|0|||
126345237|NCT01288430|454560111|FG000|Part 1|Death due to disease progression|0|||
126345238|NCT01288430|454560112|FG001|Part 1|Death due to disease progression|0|||
126345239|NCT01288430|454560113|FG002|Part 1|Death due to disease progression|0|||
126679282|NCT00886600|455782751|FG002|Double-blind Monotherapy|Protocol Violation|0|||
126679283|NCT00886600|455782752|FG003|Double-blind Monotherapy|Protocol Violation|1|||
126679284|NCT00886600|455782749|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
126679285|NCT00886600|455782750|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
126345240|NCT01288430|454560114|FG003|Part 1|Death due to disease progression|0|||
126345241|NCT01288430|454560115|FG004|Part 1|Death due to disease progression|1|||
126345242|NCT01288430|454560116|FG005|Part 1|Death due to disease progression|0|||
126345243|NCT01288430|454560117|FG006|Part 1|Death due to disease progression|0|||
126345244|NCT01288430|454560118|FG007|Part 1|Death due to disease progression|0|||
126679286|NCT00886600|455782751|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
126679287|NCT00886600|455782752|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
126679288|NCT00886600|455782749|FG000|Combination Therapy Period|Adverse Event|0|||
126679289|NCT00886600|455782750|FG001|Combination Therapy Period|Adverse Event|0|||
126679290|NCT00886600|455782751|FG002|Combination Therapy Period|Adverse Event|1|||
126679291|NCT00886600|455782752|FG003|Combination Therapy Period|Adverse Event|0|||
126679292|NCT00886600|455782749|FG000|Combination Therapy Period|Protocol Violation|0|||
126679293|NCT00886600|455782750|FG001|Combination Therapy Period|Protocol Violation|0|||
126679294|NCT00886600|455782751|FG002|Combination Therapy Period|Protocol Violation|1|||
126679295|NCT00886600|455782752|FG003|Combination Therapy Period|Protocol Violation|0|||
126679296|NCT01439204|455782753|FG000|Overall Study|Withdrawal by Subject|0|||
126679297|NCT01439204|455782754|FG001|Overall Study|Withdrawal by Subject|1|||
126679298|NCT01439204|455782753|FG000|Overall Study|Lost to Follow-up|0|||
126679299|NCT01439204|455782754|FG001|Overall Study|Lost to Follow-up|2|||
126679300|NCT01439204|455782753|FG000|Overall Study|No longer meets study criteria|1|||
126679301|NCT01439204|455782754|FG001|Overall Study|No longer meets study criteria|0|||
126679302|NCT01439204|455782753|FG000|Overall Study|poor/non-compliance|3|||
126679303|NCT01439204|455782754|FG001|Overall Study|poor/non-compliance|0|||
126679304|NCT03917823|455782757|FG000|Overall Study|Lost to Follow-up|1|||
126679305|NCT03917823|455782758|FG001|Overall Study|Lost to Follow-up|1|||
126679306|NCT03917823|455782757|FG000|Overall Study|Withdrawal by Subject|0|||
126679307|NCT03917823|455782758|FG001|Overall Study|Withdrawal by Subject|1|||
126679308|NCT03775421|455782759|FG000|Overall Study|Lost to Follow-up|2|||
126679309|NCT03775421|455782759|FG000|Overall Study|Withdrawal by Subject|10|||
126679310|NCT03775421|455782759|FG000|Overall Study|Physician Decision|3|||
126679311|NCT03775421|455782759|FG000|Overall Study|Death|1|||
126679312|NCT03775421|455782759|FG000|Overall Study|Study Terminated by Sponsor|94|||
126679313|NCT00135668|455782760|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
126679314|NCT00135668|455782761|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
126679315|NCT00135668|455782762|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
126679316|NCT00135668|455782763|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
126679317|NCT00455013|455782770|FG000|Short Term Period|Adverse Event|2|||
126679318|NCT00455013|455782771|FG001|Short Term Period|Adverse Event|5|||
126679319|NCT00455013|455782772|FG002|Short Term Period|Adverse Event|0|||
126679320|NCT00455013|455782770|FG000|Short Term Period|Withdrawal by Subject|0|||
126679321|NCT00455013|455782771|FG001|Short Term Period|Withdrawal by Subject|0|||
126679322|NCT00455013|455782772|FG002|Short Term Period|Withdrawal by Subject|1|||
126679323|NCT00455013|455782770|FG000|Short Term Period|Lack of Efficacy|4|||
126679324|NCT00455013|455782771|FG001|Short Term Period|Lack of Efficacy|0|||
126679325|NCT00455013|455782772|FG002|Short Term Period|Lack of Efficacy|0|||
126679326|NCT00455013|455782770|FG000|Short Term Period|Other|0|||
126679327|NCT00455013|455782771|FG001|Short Term Period|Other|0|||
126679328|NCT00455013|455782772|FG002|Short Term Period|Other|1|||
126679329|NCT00455013|455782770|FG000|Long Term Extension (LTE)|Adverse Event|0|||
126679330|NCT00455013|455782771|FG001|Long Term Extension (LTE)|Adverse Event|1|||
126679331|NCT00455013|455782772|FG002|Long Term Extension (LTE)|Adverse Event|1|||
126679332|NCT00455013|455782770|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
126679333|NCT00455013|455782771|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
126679334|NCT00455013|455782772|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
126679335|NCT00455013|455782770|FG000|Long Term Extension (LTE)|Death|1|||
126679336|NCT00455013|455782771|FG001|Long Term Extension (LTE)|Death|1|||
126679337|NCT00455013|455782772|FG002|Long Term Extension (LTE)|Death|0|||
126679338|NCT00455013|455782770|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
126679339|NCT00455013|455782771|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
126679340|NCT00455013|455782772|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
126679341|NCT00455013|455782770|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
126679342|NCT00455013|455782771|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
126679343|NCT00455013|455782772|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
126431291|NCT00062439|454875821|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
126431292|NCT00062439|454875821|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
126431293|NCT00062439|454875821|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
126431294|NCT00062439|454875821|FG000|Surgery|Physician Decision|4|||
126431295|NCT00062439|454875821|FG000|Surgery|Death|1|||
126431296|NCT00062439|454875821|FG000|Surgery|Adverse Event|2|||
126431297|NCT00062439|454875821|FG000|Consolidation Chemotherapy|Adverse Event|2|||
126679344|NCT00455013|455782770|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
126679345|NCT00455013|455782771|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
126679346|NCT00455013|455782772|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
126679347|NCT00455013|455782770|FG000|Long Term Extension (LTE)|non-specified|0|||
126679348|NCT00455013|455782771|FG001|Long Term Extension (LTE)|non-specified|0|||
126679349|NCT00455013|455782772|FG002|Long Term Extension (LTE)|non-specified|1|||
126679350|NCT02739620|455782775|FG000|Overall Study|Lost to Follow-up|3|||
126679351|NCT02739620|455782776|FG001|Overall Study|Lost to Follow-up|1|||
126679352|NCT02739620|455782775|FG000|Overall Study|Adverse Event|0|||
126679353|NCT02739620|455782776|FG001|Overall Study|Adverse Event|1|||
126679354|NCT05513625|455782777|FG000|Overall Study|Withdrawal by Subject|1|||
126679355|NCT00754793|455782778|FG000|Overall Study|voluntary withdrawn from study|0|||
126679356|NCT00754793|455782779|FG001|Overall Study|voluntary withdrawn from study|1|||
126679357|NCT03891264|455782785|FG000|Overall Study|Adverse Event|1|||
126679358|NCT03891264|455782785|FG000|Overall Study|Withdrawal by Subject|2|||
126679359|NCT03891264|455782785|FG000|Overall Study|Physician Decision|2|||
126679360|NCT01692275|455782786|FG000|Overall Study|Lost to Follow-up|57|||
126679361|NCT01692275|455782787|FG001|Overall Study|Lost to Follow-up|48|||
126679362|NCT01692275|455782786|FG000|Overall Study|Withdrawal by Subject|9|||
126679363|NCT01692275|455782787|FG001|Overall Study|Withdrawal by Subject|11|||
126679364|NCT04649255|455784441|FG000|Overall Study|Death|9|||
126679365|NCT04649255|455784441|FG000|Overall Study|Withdrawal by Subject|1|||
126679366|NCT01652885|455784445|FG000|Overall Study|Adverse Event|1|||
126679367|NCT00490568|455784446|FG000|Overall Study|Adverse Event|116|||
126679368|NCT00490568|455784446|FG000|Overall Study|Lost to Follow-up|13|||
126679369|NCT00490568|455784446|FG000|Overall Study|Protocol Violation|45|||
126679370|NCT00490568|455784446|FG000|Overall Study|Withdrawal by Subject|135|||
126679371|NCT00490568|455784446|FG000|Overall Study|Still in the study at termination|974|||
126679372|NCT00490568|455784446|FG000|Overall Study|Other|1|||
126679373|NCT00490568|455784446|FG000|Overall Study|Exclusion criteria met|1|||
126679374|NCT00490568|455784446|FG000|Overall Study|Caregiver related|20|||
126679375|NCT00490568|455784446|FG000|Overall Study|Abnormal ECG|25|||
126679376|NCT00490568|455784446|FG000|Overall Study|Participant refused follow-up|9|||
126679377|NCT00490568|455784446|FG000|Overall Study|Legal representative withdrew consent|1|||
126679378|NCT00490568|455784446|FG000|Overall Study|Disease progression|4|||
126679379|NCT00490568|455784446|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
126679380|NCT00490568|455784446|FG000|Overall Study|Investigator decision|3|||
126679381|NCT00490568|455784446|FG000|Overall Study|Non-Compliance|7|||
126679382|NCT00490568|455784446|FG000|Overall Study|Efficacy related|3|||
126679383|NCT00490568|455784446|FG000|Overall Study|Participant died|1|||
126679384|NCT00490568|455784446|FG000|Overall Study|Participant withdrawal due to surgery|1|||
126679385|NCT03451773|455784449|FG000|Overall Study|Death on study|1|||
126679386|NCT03451773|455784450|FG001|Overall Study|Death on study|5|||
126758636|NCT02681094|456066665|FG000|2 - Enrolled Participants Set|Other|6|||
126758637|NCT02681094|456066666|FG001|2 - Enrolled Participants Set|Other|6|||
126758638|NCT02681094|456066667|FG002|2 - Enrolled Participants Set|Other|7|||
126758639|NCT02681094|456066665|FG000|2 - Enrolled Participants Set|No treatment given|0|||
126758640|NCT02681094|456066666|FG001|2 - Enrolled Participants Set|No treatment given|1|||
126758641|NCT02681094|456066667|FG002|2 - Enrolled Participants Set|No treatment given|1|||
126758642|NCT01270139|456066670|FG000|Overall Study|Adverse Event|8|||
126758643|NCT01270139|456066671|FG001|Overall Study|Adverse Event|17|||
126758644|NCT01270139|456066672|FG002|Overall Study|Adverse Event|18|||
126758645|NCT01270139|456066670|FG000|Overall Study|Lost to Follow-up|10|||
126758646|NCT01270139|456066671|FG001|Overall Study|Lost to Follow-up|9|||
126431298|NCT01924845|454875822|FG000|Overall Study|Adverse Event|3|||
126431299|NCT01924845|454875822|FG000|Overall Study|Withdrawal by Subject|2|||
126431300|NCT01924845|454875822|FG000|Overall Study|Protocol Violation|1|||
126431301|NCT00001832|454875826|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
126431302|NCT00001832|454875827|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
126431303|NCT00001832|454875828|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
126431304|NCT00001832|454875829|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
126431305|NCT00001832|454875830|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
126431306|NCT00001832|454875831|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
126431307|NCT00001832|454875832|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
126431308|NCT00001832|454875833|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
126431309|NCT00001832|454875834|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
126431310|NCT00001832|454875835|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
126431311|NCT00001832|454875836|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
126431312|NCT00001832|454875837|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
126431313|NCT00001832|454875838|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
126431314|NCT00001832|454875839|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
126758647|NCT01270139|456066672|FG002|Overall Study|Lost to Follow-up|2|||
126758648|NCT00134563|456066673|FG000|Overall Study|Not treated due to protocol violation|0|||
126758649|NCT00134563|456066674|FG001|Overall Study|Not treated due to protocol violation|1|||
126758650|NCT00134563|456066675|FG002|Overall Study|Not treated due to protocol violation|1|||
126758651|NCT00134563|456066673|FG000|Overall Study|Adverse Event|29|||
126431315|NCT00001832|454875840|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
126431316|NCT00001832|454875826|FG000|Treatment Period|Death during treatment|0|||
126431317|NCT00001832|454875827|FG001|Treatment Period|Death during treatment|0|||
126431318|NCT00001832|454875828|FG002|Treatment Period|Death during treatment|0|||
126431319|NCT00001832|454875829|FG003|Treatment Period|Death during treatment|0|||
126679387|NCT03451773|455784449|FG000|Overall Study|Death during follow-up period|0|||
126758652|NCT00134563|456066674|FG001|Overall Study|Adverse Event|37|||
126345245|NCT01288430|454560119|FG008|Part 1|Death due to disease progression|0|||
126345246|NCT01288430|454560120|FG009|Part 1|Death due to disease progression|0|||
126345247|NCT01288430|454560111|FG000|Part 1|Adverse Event|0|||
126345248|NCT01288430|454560112|FG001|Part 1|Adverse Event|0|||
126345249|NCT01288430|454560113|FG002|Part 1|Adverse Event|3|||
126345250|NCT01288430|454560114|FG003|Part 1|Adverse Event|1|||
126345251|NCT01288430|454560115|FG004|Part 1|Adverse Event|0|||
126679388|NCT03451773|455784450|FG001|Overall Study|Death during follow-up period|1|||
126679389|NCT03468855|455784451|FG000|Overall Study|Adverse Event|2|||
126679390|NCT03468855|455784451|FG000|Overall Study|Lost to Follow-up|5|||
126679391|NCT03468855|455784451|FG000|Overall Study|Withdrawal by Subject|3|||
126679392|NCT03468855|455784451|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
126679393|NCT01908101|455784452|FG000|Overall Study|Physician Decision|1|||
126679394|NCT01908101|455784452|FG000|Overall Study|Withdrawal by Subject|1|||
126679395|NCT01908101|455784452|FG000|Overall Study|Incorrect Diagnosis|2|||
126679396|NCT01908101|455784452|FG000|Overall Study|Incorrect Starting Dose|1|||
126679397|NCT01908101|455784452|FG000|Overall Study|Did not complete the first cycle|4|||
126679398|NCT00412750|455784454|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126679399|NCT00412750|455784455|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126679400|NCT00412750|455784456|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126679401|NCT00412750|455784454|FG000|Overall Study|Administrative problems|21|||
126679402|NCT00412750|455784455|FG001|Overall Study|Administrative problems|17|||
126679403|NCT00412750|455784456|FG002|Overall Study|Administrative problems|14|||
126679404|NCT00412750|455784454|FG000|Overall Study|Adverse Event|8|||
126679405|NCT00412750|455784455|FG001|Overall Study|Adverse Event|3|||
126679406|NCT00412750|455784456|FG002|Overall Study|Adverse Event|3|||
126679407|NCT00412750|455784454|FG000|Overall Study|Lost to Follow-up|1|||
126679408|NCT00412750|455784455|FG001|Overall Study|Lost to Follow-up|0|||
126679409|NCT00412750|455784456|FG002|Overall Study|Lost to Follow-up|1|||
126679410|NCT00412750|455784454|FG000|Overall Study|Withdrawal by Subject|0|||
126679411|NCT00412750|455784455|FG001|Overall Study|Withdrawal by Subject|1|||
126679412|NCT00412750|455784456|FG002|Overall Study|Withdrawal by Subject|2|||
126679413|NCT00412750|455784454|FG000|Overall Study|Lack of Efficacy|0|||
126679414|NCT00412750|455784455|FG001|Overall Study|Lack of Efficacy|0|||
126679415|NCT00412750|455784456|FG002|Overall Study|Lack of Efficacy|3|||
126679416|NCT03882970|455784457|FG000|Overall Study|Adverse Event|5|||
126679417|NCT03882970|455784458|FG001|Overall Study|Adverse Event|7|||
126679418|NCT03882970|455784459|FG002|Overall Study|Adverse Event|3|||
126679419|NCT03882970|455784460|FG003|Overall Study|Adverse Event|1|||
126679420|NCT03882970|455784457|FG000|Overall Study|Death|1|||
126679421|NCT03882970|455784458|FG001|Overall Study|Death|2|||
126679422|NCT03882970|455784459|FG002|Overall Study|Death|1|||
126679423|NCT03882970|455784460|FG003|Overall Study|Death|1|||
126679424|NCT03882970|455784457|FG000|Overall Study|Lost to Follow-up|8|||
126345252|NCT01288430|454560116|FG005|Part 1|Adverse Event|0|||
126345253|NCT01288430|454560117|FG006|Part 1|Adverse Event|2|||
126679425|NCT03882970|455784458|FG001|Overall Study|Lost to Follow-up|9|||
126679426|NCT03882970|455784459|FG002|Overall Study|Lost to Follow-up|5|||
126679427|NCT03882970|455784460|FG003|Overall Study|Lost to Follow-up|5|||
126679428|NCT03882970|455784457|FG000|Overall Study|Physician Decision|0|||
126345254|NCT01288430|454560118|FG007|Part 1|Adverse Event|0|||
126345255|NCT01288430|454560119|FG008|Part 1|Adverse Event|0|||
126345256|NCT01288430|454560120|FG009|Part 1|Adverse Event|0|||
126345257|NCT01288430|454560111|FG000|Part 1|Other|0|||
126345258|NCT01288430|454560112|FG001|Part 1|Other|2|||
126345259|NCT01288430|454560113|FG002|Part 1|Other|0|||
126345260|NCT01288430|454560114|FG003|Part 1|Other|0|||
126345261|NCT01288430|454560115|FG004|Part 1|Other|0|||
126345262|NCT01288430|454560116|FG005|Part 1|Other|0|||
126345263|NCT01288430|454560117|FG006|Part 1|Other|1|||
126345264|NCT01288430|454560118|FG007|Part 1|Other|0|||
126345265|NCT01288430|454560119|FG008|Part 1|Other|0|||
126345266|NCT01288430|454560120|FG009|Part 1|Other|0|||
126345267|NCT01288430|454560111|FG000|Part 2|Progressive disease|0|||
126345268|NCT01288430|454560112|FG001|Part 2|Progressive disease|0|||
126345269|NCT01288430|454560113|FG002|Part 2|Progressive disease|0|||
126345270|NCT01288430|454560114|FG003|Part 2|Progressive disease|0|||
126345271|NCT01288430|454560115|FG004|Part 2|Progressive disease|0|||
126679429|NCT03882970|455784458|FG001|Overall Study|Physician Decision|2|||
126679430|NCT03882970|455784459|FG002|Overall Study|Physician Decision|2|||
126679431|NCT03882970|455784460|FG003|Overall Study|Physician Decision|2|||
126345272|NCT01288430|454560116|FG005|Part 2|Progressive disease|0|||
126345273|NCT01288430|454560117|FG006|Part 2|Progressive disease|0|||
126345274|NCT01288430|454560118|FG007|Part 2|Progressive disease|8|||
126345275|NCT01288430|454560119|FG008|Part 2|Progressive disease|7|||
126345276|NCT01288430|454560120|FG009|Part 2|Progressive disease|2|||
126345277|NCT01288430|454560111|FG000|Part 2|Clinical disease progression|0|||
126679432|NCT03882970|455784457|FG000|Overall Study|Protocol Violation|2|||
126679433|NCT03882970|455784458|FG001|Overall Study|Protocol Violation|0|||
126345278|NCT01288430|454560112|FG001|Part 2|Clinical disease progression|0|||
126345279|NCT01288430|454560113|FG002|Part 2|Clinical disease progression|0|||
126345280|NCT01288430|454560114|FG003|Part 2|Clinical disease progression|0|||
126345281|NCT01288430|454560115|FG004|Part 2|Clinical disease progression|0|||
126431320|NCT00001832|454875830|FG004|Treatment Period|Death during treatment|0|||
126431321|NCT00001832|454875831|FG005|Treatment Period|Death during treatment|1|||
126431322|NCT00001832|454875832|FG006|Treatment Period|Death during treatment|0|||
126431323|NCT00001832|454875833|FG007|Treatment Period|Death during treatment|0|||
126431324|NCT00001832|454875834|FG008|Treatment Period|Death during treatment|0|||
126431325|NCT00001832|454875835|FG009|Treatment Period|Death during treatment|0|||
126431326|NCT00001832|454875836|FG010|Treatment Period|Death during treatment|0|||
126431327|NCT00001832|454875837|FG011|Treatment Period|Death during treatment|0|||
126345282|NCT01288430|454560116|FG005|Part 2|Clinical disease progression|0|||
126345283|NCT01288430|454560117|FG006|Part 2|Clinical disease progression|0|||
126345284|NCT01288430|454560118|FG007|Part 2|Clinical disease progression|2|||
126345285|NCT01288430|454560119|FG008|Part 2|Clinical disease progression|0|||
126345286|NCT01288430|454560120|FG009|Part 2|Clinical disease progression|0|||
126345287|NCT01288430|454560111|FG000|Part 2|Withdrawal by Subject|0|||
126431328|NCT00001832|454875838|FG012|Treatment Period|Death during treatment|0|||
126431329|NCT00001832|454875839|FG013|Treatment Period|Death during treatment|0|||
126431330|NCT00001832|454875840|FG014|Treatment Period|Death during treatment|0|||
126431331|NCT00001832|454875826|FG000|Treatment Period|Not treated|0|||
126431332|NCT00001832|454875827|FG001|Treatment Period|Not treated|0|||
126431333|NCT00001832|454875828|FG002|Treatment Period|Not treated|0|||
126431334|NCT00001832|454875829|FG003|Treatment Period|Not treated|0|||
126431335|NCT00001832|454875830|FG004|Treatment Period|Not treated|0|||
126431336|NCT00001832|454875831|FG005|Treatment Period|Not treated|0|||
126431337|NCT00001832|454875832|FG006|Treatment Period|Not treated|0|||
126431338|NCT00001832|454875833|FG007|Treatment Period|Not treated|1|||
126431339|NCT00001832|454875834|FG008|Treatment Period|Not treated|0|||
126431340|NCT00001832|454875835|FG009|Treatment Period|Not treated|0|||
126431341|NCT00001832|454875836|FG010|Treatment Period|Not treated|0|||
126431342|NCT00001832|454875837|FG011|Treatment Period|Not treated|0|||
126431343|NCT00001832|454875838|FG012|Treatment Period|Not treated|0|||
126431344|NCT00001832|454875839|FG013|Treatment Period|Not treated|0|||
126431345|NCT00001832|454875840|FG014|Treatment Period|Not treated|0|||
126431346|NCT05106959|454875841|FG000|Overall Study|Lost to Follow-up|1|||
126431347|NCT01292486|454875842|FG000|Overall Study|Protocol Violation|2|||
126431348|NCT01292486|454875842|FG000|Overall Study|Did not meet screening criteria|2|||
126431349|NCT01292486|454875842|FG000|Overall Study|Adverse Event|1|||
126431350|NCT01292486|454875842|FG000|Overall Study|Physician Decision|1|||
126431351|NCT04602390|454875847|FG000|Overall Study|Withdrawal by Subject|0|||
126431352|NCT04602390|454875848|FG001|Overall Study|Withdrawal by Subject|0|||
126431353|NCT04602390|454875849|FG002|Overall Study|Withdrawal by Subject|0|||
126431354|NCT04602390|454875850|FG003|Overall Study|Withdrawal by Subject|0|||
126431355|NCT04602390|454875851|FG004|Overall Study|Withdrawal by Subject|1|||
126431356|NCT04602390|454875852|FG005|Overall Study|Withdrawal by Subject|0|||
126679434|NCT03882970|455784459|FG002|Overall Study|Protocol Violation|0|||
126679435|NCT03882970|455784460|FG003|Overall Study|Protocol Violation|0|||
126679436|NCT03882970|455784457|FG000|Overall Study|Withdrawal by Subject|8|||
126679437|NCT03882970|455784458|FG001|Overall Study|Withdrawal by Subject|17|||
126679438|NCT03882970|455784459|FG002|Overall Study|Withdrawal by Subject|7|||
126679439|NCT03882970|455784460|FG003|Overall Study|Withdrawal by Subject|22|||
126345288|NCT01288430|454560112|FG001|Part 2|Withdrawal by Subject|0|||
126345289|NCT01288430|454560113|FG002|Part 2|Withdrawal by Subject|0|||
126345290|NCT01288430|454560114|FG003|Part 2|Withdrawal by Subject|0|||
126345291|NCT01288430|454560115|FG004|Part 2|Withdrawal by Subject|0|||
126431357|NCT04602390|454875847|FG000|Overall Study|Adverse Event|0|||
126431358|NCT04602390|454875848|FG001|Overall Study|Adverse Event|0|||
126431359|NCT04602390|454875849|FG002|Overall Study|Adverse Event|0|||
126431360|NCT04602390|454875850|FG003|Overall Study|Adverse Event|0|||
126431361|NCT04602390|454875851|FG004|Overall Study|Adverse Event|0|||
126431362|NCT04602390|454875852|FG005|Overall Study|Adverse Event|1|||
126679440|NCT03882970|455784457|FG000|Overall Study|Personal Reason|2|||
126679441|NCT03882970|455784458|FG001|Overall Study|Personal Reason|3|||
126679442|NCT03882970|455784459|FG002|Overall Study|Personal Reason|1|||
126345292|NCT01288430|454560116|FG005|Part 2|Withdrawal by Subject|0|||
126345293|NCT01288430|454560117|FG006|Part 2|Withdrawal by Subject|0|||
126431363|NCT00265564|454875853|FG000|Overall Study|Lost to Follow-up|5|||
126431364|NCT00265564|454875854|FG001|Overall Study|Lost to Follow-up|7|||
126431365|NCT00265564|454875853|FG000|Overall Study|met exclusion criteria|5|||
126431366|NCT00265564|454875854|FG001|Overall Study|met exclusion criteria|2|||
126431367|NCT04739982|454875857|FG000|Overall Study|Lost to Follow-up|176|||
126431368|NCT04739982|454875858|FG001|Overall Study|Lost to Follow-up|65|||
126431369|NCT04739982|454875857|FG000|Overall Study|Withdrawal by Subject|19|||
126431370|NCT04739982|454875858|FG001|Overall Study|Withdrawal by Subject|0|||
126431371|NCT04739982|454875857|FG000|Overall Study|Protocol Violation|0|||
126345294|NCT01288430|454560118|FG007|Part 2|Withdrawal by Subject|1|||
126431372|NCT04739982|454875858|FG001|Overall Study|Protocol Violation|5|||
126431373|NCT00702702|454875859|FG000|Overall Study|Study prematurely terminated|56|||
126345295|NCT01288430|454560119|FG008|Part 2|Withdrawal by Subject|4|||
126431374|NCT02240485|454875860|FG000|3 Months Post-admission|Lost to Follow-up|1|||
126431375|NCT02240485|454875861|FG001|3 Months Post-admission|Lost to Follow-up|5|||
126431376|NCT02240485|454875860|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
126679443|NCT03882970|455784460|FG003|Overall Study|Personal Reason|3|||
126679444|NCT02830776|455784474|FG000|Overall Study|Lost to Follow-up|1|||
126679445|NCT00607386|455784475|FG000|Overall Study|Physician Decision|1|||
126679446|NCT00440947|455784476|FG000|36-Week Induction Phase|Adverse Event|16|||
126679447|NCT00440947|455784477|FG001|36-Week Induction Phase|Adverse Event|0|||
126431377|NCT02240485|454875861|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
126431378|NCT02240485|454875860|FG000|9 Months Post-admission|Lost to Follow-up|3|||
126431379|NCT02240485|454875861|FG001|9 Months Post-admission|Lost to Follow-up|1|||
126431380|NCT02240485|454875860|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
126431381|NCT02240485|454875861|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
126431382|NCT02240485|454875860|FG000|18 Months Post-admission|Lost to Follow-up|1|||
126431383|NCT02240485|454875861|FG001|18 Months Post-admission|Lost to Follow-up|1|||
126431384|NCT02240485|454875860|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
126431385|NCT02240485|454875861|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
126431386|NCT00953667|454875862|FG000|Overall Study|Lost to Follow-up|11|||
126431387|NCT00953667|454875862|FG000|Overall Study|Physician Decision|35|||
126431388|NCT00953667|454875862|FG000|Overall Study|Withdrawal by Subject|63|||
126431389|NCT00953667|454875862|FG000|Overall Study|Adverse Event|10|||
126431390|NCT00953667|454875862|FG000|Overall Study|poor venous access,unable to draw blood|4|||
126431391|NCT00475670|454875863|FG000|Overall Study|Death|0|||
126431392|NCT00475670|454875864|FG001|Overall Study|Death|1|||
126431393|NCT00475670|454875863|FG000|Overall Study|Lack of Efficacy|3|||
126431394|NCT00475670|454875864|FG001|Overall Study|Lack of Efficacy|34|||
126431395|NCT00475670|454875863|FG000|Overall Study|Refused treatment|0|||
126431396|NCT00475670|454875864|FG001|Overall Study|Refused treatment|2|||
126431397|NCT00475670|454875863|FG000|Overall Study|Failure to Return|0|||
126431398|NCT00475670|454875864|FG001|Overall Study|Failure to Return|1|||
126431399|NCT00475670|454875863|FG000|Overall Study|Other|0|||
126431400|NCT00475670|454875864|FG001|Overall Study|Other|3|||
126431401|NCT00918281|454875867|FG000|Overall Study|Physician Decision|29|||
126431402|NCT00388349|454875868|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
126431403|NCT00388349|454875869|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
126679448|NCT00440947|455784478|FG002|36-Week Induction Phase|Adverse Event|0|||
126679449|NCT00440947|455784479|FG003|36-Week Induction Phase|Adverse Event|0|||
126679450|NCT00440947|455784480|FG004|36-Week Induction Phase|Adverse Event|0|||
126679451|NCT00440947|455784476|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
126679452|NCT00440947|455784477|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
126679453|NCT00440947|455784478|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
126679454|NCT00440947|455784479|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
126679455|NCT00440947|455784480|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
126679456|NCT00440947|455784476|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
126679457|NCT00440947|455784477|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
126679458|NCT00440947|455784478|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
126679459|NCT00440947|455784479|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
126431404|NCT00112736|454875870|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
126431405|NCT00112736|454875871|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
126431406|NCT05435339|454875872|FG000|Overall Study|Death|1|||
126431407|NCT05435339|454875873|FG001|Overall Study|Death|0|||
126431408|NCT05435339|454875874|FG002|Overall Study|Death|3|||
126431409|NCT05435339|454875875|FG003|Overall Study|Death|1|||
126431410|NCT05435339|454875876|FG004|Overall Study|Death|3|||
126431411|NCT05435339|454875877|FG005|Overall Study|Death|2|||
126431412|NCT05435339|454875878|FG006|Overall Study|Death|4|||
126431413|NCT05435339|454875879|FG007|Overall Study|Death|6|||
126679460|NCT00440947|455784480|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
126679461|NCT00440947|455784476|FG000|36-Week Induction Phase|Non-compliance|10|||
126679462|NCT00440947|455784477|FG001|36-Week Induction Phase|Non-compliance|0|||
126679463|NCT00440947|455784478|FG002|36-Week Induction Phase|Non-compliance|0|||
126679464|NCT00440947|455784479|FG003|36-Week Induction Phase|Non-compliance|0|||
126679465|NCT00440947|455784480|FG004|36-Week Induction Phase|Non-compliance|0|||
126679466|NCT00440947|455784476|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
126431414|NCT05435339|454875872|FG000|Overall Study|Sponsor Decision|0|||
126431415|NCT05435339|454875873|FG001|Overall Study|Sponsor Decision|1|||
126431416|NCT05435339|454875874|FG002|Overall Study|Sponsor Decision|0|||
126431417|NCT05435339|454875875|FG003|Overall Study|Sponsor Decision|0|||
126431418|NCT05435339|454875876|FG004|Overall Study|Sponsor Decision|2|||
126431419|NCT05435339|454875877|FG005|Overall Study|Sponsor Decision|1|||
126431420|NCT05435339|454875878|FG006|Overall Study|Sponsor Decision|2|||
126431421|NCT05435339|454875879|FG007|Overall Study|Sponsor Decision|2|||
126431422|NCT05435339|454875872|FG000|Overall Study|Withdrawal by Subject|0|||
126431423|NCT05435339|454875873|FG001|Overall Study|Withdrawal by Subject|0|||
126431424|NCT05435339|454875874|FG002|Overall Study|Withdrawal by Subject|0|||
126758653|NCT00134563|456066675|FG002|Overall Study|Adverse Event|38|||
126431425|NCT05435339|454875875|FG003|Overall Study|Withdrawal by Subject|0|||
126431426|NCT05435339|454875876|FG004|Overall Study|Withdrawal by Subject|1|||
126431427|NCT05435339|454875877|FG005|Overall Study|Withdrawal by Subject|0|||
126431428|NCT05435339|454875878|FG006|Overall Study|Withdrawal by Subject|1|||
126431429|NCT05435339|454875879|FG007|Overall Study|Withdrawal by Subject|1|||
126431430|NCT00537394|454875883|FG000|First Year of Follow-up|Death|7|||
126431431|NCT00537394|454875884|FG001|First Year of Follow-up|Death|0|||
126431432|NCT00537394|454875885|FG002|First Year of Follow-up|Death|0|||
126431433|NCT00537394|454875883|FG000|First Year of Follow-up|Severe debilitation|1|||
126431434|NCT00537394|454875884|FG001|First Year of Follow-up|Severe debilitation|0|||
126431435|NCT00537394|454875885|FG002|First Year of Follow-up|Severe debilitation|1|||
126431436|NCT00537394|454875883|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
126431437|NCT00537394|454875884|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
126431438|NCT00537394|454875885|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
126431439|NCT00537394|454875883|FG000|First Year of Follow-up|Lost to Follow-up|1|||
126431440|NCT00537394|454875884|FG001|First Year of Follow-up|Lost to Follow-up|5|||
126431441|NCT00537394|454875885|FG002|First Year of Follow-up|Lost to Follow-up|1|||
126431442|NCT00537394|454875883|FG000|2nd Year of Follow-up|Death|4|||
126431443|NCT00537394|454875884|FG001|2nd Year of Follow-up|Death|1|||
126431444|NCT00537394|454875885|FG002|2nd Year of Follow-up|Death|2|||
126431445|NCT00537394|454875883|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
126679467|NCT00440947|455784477|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
126679468|NCT00440947|455784478|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
126679469|NCT00440947|455784479|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
126431446|NCT00537394|454875884|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
126431447|NCT00537394|454875885|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
126431448|NCT00537394|454875883|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
126431449|NCT00537394|454875884|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
126431450|NCT00537394|454875885|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
126431451|NCT00537394|454875883|FG000|2nd Year of Follow-up|Clinic site closure|1|||
126431452|NCT00537394|454875884|FG001|2nd Year of Follow-up|Clinic site closure|0|||
126431453|NCT00537394|454875885|FG002|2nd Year of Follow-up|Clinic site closure|0|||
126431454|NCT03473236|454875890|FG000|Overall Study|Withdrawal by Subject|0|||
126431455|NCT03473236|454875891|FG001|Overall Study|Withdrawal by Subject|0|||
126431456|NCT03473236|454875892|FG002|Overall Study|Withdrawal by Subject|0|||
126431457|NCT03473236|454875893|FG003|Overall Study|Withdrawal by Subject|0|||
126431458|NCT03473236|454875894|FG004|Overall Study|Withdrawal by Subject|0|||
126431459|NCT03473236|454875895|FG005|Overall Study|Withdrawal by Subject|1|||
126431460|NCT03473236|454875896|FG006|Overall Study|Withdrawal by Subject|0|||
126431461|NCT03473236|454875897|FG007|Overall Study|Withdrawal by Subject|0|||
126431462|NCT03473236|454875898|FG008|Overall Study|Withdrawal by Subject|1|||
126431463|NCT03473236|454875899|FG009|Overall Study|Withdrawal by Subject|0|||
126431464|NCT00685165|454875900|FG000|Washout Period of 14 Days|Adverse Event|1|||
126431465|NCT00685165|454875901|FG001|Washout Period of 14 Days|Adverse Event|0|||
126431466|NCT00849940|454875902|FG000|Overall Study|Physician Decision|4|||
126431467|NCT05135871|454875903|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
126431468|NCT05135871|454875904|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
126431469|NCT05135871|454875905|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
126431470|NCT05135871|454875906|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
126431471|NCT04886154|454875912|FG000|Overall Study|Adverse Event|0|||
126431472|NCT04886154|454875913|FG001|Overall Study|Adverse Event|0|||
126431473|NCT04886154|454875914|FG002|Overall Study|Adverse Event|0|||
126431474|NCT04886154|454875915|FG003|Overall Study|Adverse Event|0|||
126431475|NCT04886154|454875916|FG004|Overall Study|Adverse Event|1|||
126431476|NCT04886154|454875917|FG005|Overall Study|Adverse Event|0|||
126431477|NCT04886154|454875918|FG006|Overall Study|Adverse Event|0|||
126431478|NCT04886154|454875919|FG007|Overall Study|Adverse Event|1|||
126431479|NCT04886154|454875920|FG008|Overall Study|Adverse Event|1|||
126431480|NCT04886154|454875921|FG009|Overall Study|Adverse Event|0|||
126431481|NCT04886154|454875922|FG010|Overall Study|Adverse Event|0|||
126431482|NCT04886154|454875923|FG011|Overall Study|Adverse Event|1|||
126431483|NCT04886154|454875924|FG012|Overall Study|Adverse Event|0|||
126431484|NCT04886154|454875925|FG013|Overall Study|Adverse Event|0|||
126431485|NCT04886154|454875926|FG014|Overall Study|Adverse Event|3|||
126431486|NCT04886154|454875912|FG000|Overall Study|Lost to Follow-up|1|||
126431487|NCT04886154|454875913|FG001|Overall Study|Lost to Follow-up|0|||
126431488|NCT04886154|454875914|FG002|Overall Study|Lost to Follow-up|2|||
126431489|NCT04886154|454875915|FG003|Overall Study|Lost to Follow-up|0|||
126431490|NCT04886154|454875916|FG004|Overall Study|Lost to Follow-up|17|||
126431491|NCT04886154|454875917|FG005|Overall Study|Lost to Follow-up|7|||
126431492|NCT04886154|454875918|FG006|Overall Study|Lost to Follow-up|8|||
126431493|NCT04886154|454875919|FG007|Overall Study|Lost to Follow-up|7|||
126431494|NCT04886154|454875920|FG008|Overall Study|Lost to Follow-up|8|||
126431495|NCT04886154|454875921|FG009|Overall Study|Lost to Follow-up|0|||
126431496|NCT04886154|454875922|FG010|Overall Study|Lost to Follow-up|2|||
126431497|NCT04886154|454875923|FG011|Overall Study|Lost to Follow-up|0|||
126431498|NCT04886154|454875924|FG012|Overall Study|Lost to Follow-up|0|||
126431499|NCT04886154|454875925|FG013|Overall Study|Lost to Follow-up|0|||
126431500|NCT04886154|454875926|FG014|Overall Study|Lost to Follow-up|0|||
126431501|NCT04886154|454875912|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126431502|NCT04886154|454875913|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126431503|NCT04886154|454875914|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126431504|NCT04886154|454875915|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126431505|NCT04886154|454875916|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126431506|NCT04886154|454875917|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126679470|NCT00440947|455784480|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
126679471|NCT00440947|455784476|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
126679472|NCT00440947|455784477|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
126679473|NCT00440947|455784478|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
126679474|NCT00440947|455784479|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
126679475|NCT00440947|455784480|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
126431507|NCT04886154|454875918|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
126431508|NCT04886154|454875919|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126431509|NCT04886154|454875920|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126431510|NCT04886154|454875921|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126431511|NCT04886154|454875922|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126431512|NCT04886154|454875923|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126679476|NCT00440947|455784476|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
126679477|NCT00440947|455784477|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
126679478|NCT00440947|455784478|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
126679479|NCT00440947|455784479|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
126679480|NCT00440947|455784480|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
126679481|NCT00440947|455784476|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
126345296|NCT01288430|454560120|FG009|Part 2|Withdrawal by Subject|0|||
126345297|NCT01288430|454560111|FG000|Part 2|Adverse Event|0|||
126345298|NCT01288430|454560112|FG001|Part 2|Adverse Event|0|||
126345299|NCT01288430|454560113|FG002|Part 2|Adverse Event|0|||
126345300|NCT01288430|454560114|FG003|Part 2|Adverse Event|0|||
126345301|NCT01288430|454560115|FG004|Part 2|Adverse Event|0|||
126345302|NCT01288430|454560116|FG005|Part 2|Adverse Event|0|||
126345303|NCT01288430|454560117|FG006|Part 2|Adverse Event|0|||
126345304|NCT01288430|454560118|FG007|Part 2|Adverse Event|1|||
126345305|NCT01288430|454560119|FG008|Part 2|Adverse Event|1|||
126345306|NCT01288430|454560120|FG009|Part 2|Adverse Event|0|||
126345307|NCT01288430|454560111|FG000|Part 2|Other|0|||
126345308|NCT01288430|454560112|FG001|Part 2|Other|0|||
126345309|NCT01288430|454560113|FG002|Part 2|Other|0|||
126345310|NCT01288430|454560114|FG003|Part 2|Other|0|||
126345311|NCT01288430|454560115|FG004|Part 2|Other|0|||
126345312|NCT01288430|454560116|FG005|Part 2|Other|0|||
126345313|NCT01288430|454560117|FG006|Part 2|Other|0|||
126345314|NCT01288430|454560118|FG007|Part 2|Other|0|||
126345315|NCT01288430|454560119|FG008|Part 2|Other|0|||
126345316|NCT01288430|454560120|FG009|Part 2|Other|1|||
126345317|NCT03836053|454560126|FG000|Overall Study|Protocol-specified criteria|0|||
126345318|NCT03836053|454560127|FG001|Overall Study|Protocol-specified criteria|2|||
126345319|NCT03836053|454560128|FG002|Overall Study|Protocol-specified criteria|1|||
126345320|NCT03836053|454560126|FG000|Overall Study|Death|1|||
126345321|NCT03836053|454560127|FG001|Overall Study|Death|6|||
126345322|NCT03836053|454560128|FG002|Overall Study|Death|4|||
126345323|NCT03836053|454560126|FG000|Overall Study|Withdrawal of consent from study|0|||
126345324|NCT03836053|454560127|FG001|Overall Study|Withdrawal of consent from study|0|||
126345325|NCT03836053|454560128|FG002|Overall Study|Withdrawal of consent from study|1|||
126345326|NCT03836053|454560126|FG000|Overall Study|Decision by sponsor|0|||
126345327|NCT03836053|454560127|FG001|Overall Study|Decision by sponsor|2|||
126345328|NCT03836053|454560128|FG002|Overall Study|Decision by sponsor|4|||
126345329|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
126345330|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
126345331|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
126345332|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Death|1|||
126345333|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Death|1|||
126345334|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Death|0|||
126345335|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
126345336|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
126345337|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
126345338|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
126345339|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
126345340|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
126345341|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
126679482|NCT00440947|455784477|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
126679483|NCT00440947|455784478|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
126679484|NCT00440947|455784479|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
126679485|NCT00440947|455784480|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
126679486|NCT00440947|455784476|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
126679487|NCT00440947|455784477|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
126679488|NCT00440947|455784478|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
126345342|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
126345343|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
126345344|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
126345345|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
126345346|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
126345347|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
126345348|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
126345349|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
126345350|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
126345351|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
126345352|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
126345353|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
126345354|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
126345355|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
126345356|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
126345357|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
126345358|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
126345359|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Other|10|||
126345360|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Other|4|||
126345361|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Other|0|||
126345362|NCT04006457|454560129|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
126345363|NCT04006457|454560130|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
126345364|NCT04006457|454560131|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
126345365|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
126345366|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
126345367|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
126345368|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
126345369|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
126345370|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
126345371|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
126345372|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
126345373|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
126345374|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
126345375|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
126345376|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
126345377|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
126345378|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
126345379|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
126345380|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Other|2|||
126345381|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Other|3|||
126345382|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Other|0|||
126345383|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
126345384|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
126345385|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
126345386|NCT04006457|454560129|FG000|Main Study: Treatment Period 2|Ongoing|86|||
126345387|NCT04006457|454560130|FG001|Main Study: Treatment Period 2|Ongoing|96|||
126345388|NCT04006457|454560131|FG002|Main Study: Treatment Period 2|Ongoing|0|||
126345389|NCT04006457|454560129|FG000|Main Study Observation Period|Adverse Event|1|||
126345390|NCT04006457|454560130|FG001|Main Study Observation Period|Adverse Event|1|||
126345391|NCT04006457|454560131|FG002|Main Study Observation Period|Adverse Event|0|||
126345392|NCT04006457|454560129|FG000|Main Study Observation Period|Lost to Follow-up|0|||
126345393|NCT04006457|454560130|FG001|Main Study Observation Period|Lost to Follow-up|1|||
126345394|NCT04006457|454560131|FG002|Main Study Observation Period|Lost to Follow-up|0|||
126345395|NCT04006457|454560129|FG000|Main Study Observation Period|Pregnancy|1|||
126345396|NCT04006457|454560130|FG001|Main Study Observation Period|Pregnancy|0|||
126345397|NCT04006457|454560131|FG002|Main Study Observation Period|Pregnancy|0|||
126345398|NCT04006457|454560129|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
126345399|NCT04006457|454560130|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
126679489|NCT00440947|455784479|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
126679490|NCT00440947|455784480|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
126679491|NCT00440947|455784476|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
126679492|NCT00440947|455784477|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
126679493|NCT00440947|455784478|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
126679494|NCT00440947|455784479|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
126679495|NCT00440947|455784480|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
126679496|NCT00440947|455784476|FG000|36-Week Induction Phase|Incarceration|3|||
126679497|NCT00440947|455784477|FG001|36-Week Induction Phase|Incarceration|0|||
126679498|NCT00440947|455784478|FG002|36-Week Induction Phase|Incarceration|0|||
126679499|NCT00440947|455784479|FG003|36-Week Induction Phase|Incarceration|0|||
126679500|NCT00440947|455784480|FG004|36-Week Induction Phase|Incarceration|0|||
126679501|NCT00440947|455784476|FG000|36-Week Induction Phase|Pregnancy|1|||
126679502|NCT00440947|455784477|FG001|36-Week Induction Phase|Pregnancy|0|||
126679503|NCT00440947|455784478|FG002|36-Week Induction Phase|Pregnancy|0|||
126679504|NCT00440947|455784479|FG003|36-Week Induction Phase|Pregnancy|0|||
126679505|NCT00440947|455784480|FG004|36-Week Induction Phase|Pregnancy|0|||
126679506|NCT00440947|455784476|FG000|48-Week Randomization Phase|Adverse Event|0|||
126679507|NCT00440947|455784477|FG001|48-Week Randomization Phase|Adverse Event|2|||
126679508|NCT00440947|455784478|FG002|48-Week Randomization Phase|Adverse Event|5|||
126679509|NCT00440947|455784479|FG003|48-Week Randomization Phase|Adverse Event|0|||
126679510|NCT00440947|455784480|FG004|48-Week Randomization Phase|Adverse Event|0|||
126679511|NCT00440947|455784476|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
126679512|NCT00440947|455784477|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
126679513|NCT00440947|455784478|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
126679514|NCT00440947|455784479|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
126679515|NCT00440947|455784480|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
126679516|NCT00440947|455784476|FG000|48-Week Randomization Phase|Non-compliance|0|||
126679517|NCT00440947|455784477|FG001|48-Week Randomization Phase|Non-compliance|3|||
126679518|NCT00440947|455784478|FG002|48-Week Randomization Phase|Non-compliance|4|||
126679519|NCT00440947|455784479|FG003|48-Week Randomization Phase|Non-compliance|0|||
126679520|NCT00440947|455784480|FG004|48-Week Randomization Phase|Non-compliance|0|||
126679521|NCT00440947|455784476|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
126679522|NCT00440947|455784477|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
126679523|NCT00440947|455784478|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
126679524|NCT00440947|455784479|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
126679525|NCT00440947|455784480|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
126679526|NCT00440947|455784476|FG000|48-Week Randomization Phase|Protocol Violation|0|||
126679527|NCT00440947|455784477|FG001|48-Week Randomization Phase|Protocol Violation|0|||
126679528|NCT00440947|455784478|FG002|48-Week Randomization Phase|Protocol Violation|1|||
126679529|NCT00440947|455784479|FG003|48-Week Randomization Phase|Protocol Violation|0|||
126679530|NCT00440947|455784480|FG004|48-Week Randomization Phase|Protocol Violation|0|||
126345400|NCT04006457|454560131|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
126345401|NCT04006457|454560129|FG000|Main Study Observation Period|Other|8|||
126345402|NCT04006457|454560130|FG001|Main Study Observation Period|Other|16|||
126345403|NCT04006457|454560131|FG002|Main Study Observation Period|Other|0|||
126679531|NCT00440947|455784476|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
126679532|NCT00440947|455784477|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
126679533|NCT00440947|455784478|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
126679534|NCT00440947|455784479|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
126679535|NCT00440947|455784480|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
126679536|NCT00440947|455784476|FG000|48-Week Randomization Phase|Pregnancy|0|||
126679537|NCT00440947|455784477|FG001|48-Week Randomization Phase|Pregnancy|0|||
126679538|NCT00440947|455784478|FG002|48-Week Randomization Phase|Pregnancy|1|||
126679539|NCT00440947|455784479|FG003|48-Week Randomization Phase|Pregnancy|0|||
126345404|NCT04006457|454560129|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
126345405|NCT04006457|454560130|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
126345406|NCT04006457|454560131|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
126345407|NCT04006457|454560129|FG000|Main Study Observation Period|Ongoing|2|||
126345408|NCT04006457|454560130|FG001|Main Study Observation Period|Ongoing|1|||
126345409|NCT04006457|454560131|FG002|Main Study Observation Period|Ongoing|0|||
126345410|NCT04006457|454560129|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
126431513|NCT04886154|454875924|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126679540|NCT00440947|455784480|FG004|48-Week Randomization Phase|Pregnancy|0|||
126679541|NCT00440947|455784476|FG000|48-Week Randomization Phase|Incarceration|0|||
126345411|NCT04006457|454560130|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
126679542|NCT00440947|455784477|FG001|48-Week Randomization Phase|Incarceration|3|||
126679543|NCT00440947|455784478|FG002|48-Week Randomization Phase|Incarceration|0|||
126679544|NCT00440947|455784479|FG003|48-Week Randomization Phase|Incarceration|0|||
126679545|NCT00440947|455784480|FG004|48-Week Randomization Phase|Incarceration|0|||
126758654|NCT00134563|456066673|FG000|Overall Study|Lack of Efficacy|24|||
126758655|NCT00134563|456066674|FG001|Overall Study|Lack of Efficacy|14|||
126345412|NCT04006457|454560131|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
126679546|NCT00440947|455784476|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
126679547|NCT00440947|455784477|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
126679548|NCT00440947|455784478|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
126345413|NCT04486716|454560132|FG000|Core Phase|Subject decision|6|||
126345414|NCT04486716|454560132|FG000|Core Phase|Adverse Event|5|||
126345415|NCT04486716|454560132|FG000|Core Phase|Lost to Follow-up|1|||
126345416|NCT04486716|454560132|FG000|Core Phase|Physician Decision|1|||
126345417|NCT04486716|454560132|FG000|Core Phase|Enrolled subjects not treated|9|||
126345418|NCT02332707|454560133|FG000|Overall Study|Adverse Event|0|||
126345419|NCT02332707|454560134|FG001|Overall Study|Adverse Event|0|||
126345420|NCT02332707|454560135|FG002|Overall Study|Adverse Event|0|||
126345421|NCT02332707|454560136|FG003|Overall Study|Adverse Event|0|||
126345422|NCT02332707|454560137|FG004|Overall Study|Adverse Event|0|||
126345423|NCT02332707|454560138|FG005|Overall Study|Adverse Event|0|||
126345424|NCT02332707|454560139|FG006|Overall Study|Adverse Event|0|||
126345425|NCT02332707|454560140|FG007|Overall Study|Adverse Event|0|||
126345426|NCT02332707|454560141|FG008|Overall Study|Adverse Event|0|||
126345427|NCT02332707|454560142|FG009|Overall Study|Adverse Event|0|||
126345428|NCT02332707|454560143|FG010|Overall Study|Adverse Event|0|||
126345429|NCT02332707|454560144|FG011|Overall Study|Adverse Event|0|||
126345430|NCT02332707|454560145|FG012|Overall Study|Adverse Event|1|||
126345431|NCT02332707|454560146|FG013|Overall Study|Adverse Event|0|||
126345432|NCT02332707|454560147|FG014|Overall Study|Adverse Event|0|||
126345433|NCT02332707|454560148|FG015|Overall Study|Adverse Event|0|||
126345434|NCT02332707|454560149|FG016|Overall Study|Adverse Event|0|||
126345435|NCT02332707|454560150|FG017|Overall Study|Adverse Event|0|||
126345436|NCT02332707|454560133|FG000|Overall Study|Lost to Follow-up|0|||
126345437|NCT02332707|454560134|FG001|Overall Study|Lost to Follow-up|0|||
126345438|NCT02332707|454560135|FG002|Overall Study|Lost to Follow-up|0|||
126345439|NCT02332707|454560136|FG003|Overall Study|Lost to Follow-up|0|||
126345440|NCT02332707|454560137|FG004|Overall Study|Lost to Follow-up|0|||
126345441|NCT02332707|454560138|FG005|Overall Study|Lost to Follow-up|1|||
126345442|NCT02332707|454560139|FG006|Overall Study|Lost to Follow-up|0|||
126345443|NCT02332707|454560140|FG007|Overall Study|Lost to Follow-up|0|||
126345444|NCT02332707|454560141|FG008|Overall Study|Lost to Follow-up|0|||
126345445|NCT02332707|454560142|FG009|Overall Study|Lost to Follow-up|0|||
126345446|NCT02332707|454560143|FG010|Overall Study|Lost to Follow-up|2|||
126345447|NCT02332707|454560144|FG011|Overall Study|Lost to Follow-up|0|||
126345448|NCT02332707|454560145|FG012|Overall Study|Lost to Follow-up|3|||
126345449|NCT02332707|454560146|FG013|Overall Study|Lost to Follow-up|0|||
126345450|NCT02332707|454560147|FG014|Overall Study|Lost to Follow-up|0|||
126345451|NCT02332707|454560148|FG015|Overall Study|Lost to Follow-up|0|||
126345452|NCT02332707|454560149|FG016|Overall Study|Lost to Follow-up|0|||
126345453|NCT02332707|454560150|FG017|Overall Study|Lost to Follow-up|0|||
126345454|NCT02332707|454560133|FG000|Overall Study|Physician Decision|0|||
126345455|NCT02332707|454560134|FG001|Overall Study|Physician Decision|0|||
126345456|NCT02332707|454560135|FG002|Overall Study|Physician Decision|0|||
126345457|NCT02332707|454560136|FG003|Overall Study|Physician Decision|1|||
126345458|NCT02332707|454560137|FG004|Overall Study|Physician Decision|0|||
126345459|NCT02332707|454560138|FG005|Overall Study|Physician Decision|0|||
126345460|NCT02332707|454560139|FG006|Overall Study|Physician Decision|0|||
126345461|NCT02332707|454560140|FG007|Overall Study|Physician Decision|0|||
126345462|NCT02332707|454560141|FG008|Overall Study|Physician Decision|0|||
126345463|NCT02332707|454560142|FG009|Overall Study|Physician Decision|0|||
126345464|NCT02332707|454560143|FG010|Overall Study|Physician Decision|0|||
126345465|NCT02332707|454560144|FG011|Overall Study|Physician Decision|0|||
126345466|NCT02332707|454560145|FG012|Overall Study|Physician Decision|1|||
126345467|NCT02332707|454560146|FG013|Overall Study|Physician Decision|0|||
126345468|NCT02332707|454560147|FG014|Overall Study|Physician Decision|0|||
126345469|NCT02332707|454560148|FG015|Overall Study|Physician Decision|0|||
126345470|NCT02332707|454560149|FG016|Overall Study|Physician Decision|0|||
126345471|NCT02332707|454560150|FG017|Overall Study|Physician Decision|0|||
126345472|NCT02332707|454560133|FG000|Overall Study|Withdrawal by Subject|0|||
126345473|NCT02332707|454560134|FG001|Overall Study|Withdrawal by Subject|0|||
126345474|NCT02332707|454560135|FG002|Overall Study|Withdrawal by Subject|1|||
126345475|NCT02332707|454560136|FG003|Overall Study|Withdrawal by Subject|0|||
126345476|NCT02332707|454560137|FG004|Overall Study|Withdrawal by Subject|0|||
126345477|NCT02332707|454560138|FG005|Overall Study|Withdrawal by Subject|0|||
126679549|NCT00440947|455784479|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
126345478|NCT02332707|454560139|FG006|Overall Study|Withdrawal by Subject|0|||
126345479|NCT02332707|454560140|FG007|Overall Study|Withdrawal by Subject|0|||
126345480|NCT02332707|454560141|FG008|Overall Study|Withdrawal by Subject|0|||
126345481|NCT02332707|454560142|FG009|Overall Study|Withdrawal by Subject|3|||
126345482|NCT02332707|454560143|FG010|Overall Study|Withdrawal by Subject|0|||
126345483|NCT02332707|454560144|FG011|Overall Study|Withdrawal by Subject|0|||
126345484|NCT02332707|454560145|FG012|Overall Study|Withdrawal by Subject|0|||
126345485|NCT02332707|454560146|FG013|Overall Study|Withdrawal by Subject|0|||
126345486|NCT02332707|454560147|FG014|Overall Study|Withdrawal by Subject|0|||
126679550|NCT00440947|455784480|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
126679551|NCT00440947|455784476|FG000|48-Week Randomization Phase|Physician Decision|0|||
126679552|NCT00440947|455784477|FG001|48-Week Randomization Phase|Physician Decision|2|||
126679553|NCT00440947|455784478|FG002|48-Week Randomization Phase|Physician Decision|0|||
126679554|NCT00440947|455784479|FG003|48-Week Randomization Phase|Physician Decision|0|||
126679555|NCT00440947|455784480|FG004|48-Week Randomization Phase|Physician Decision|0|||
126679556|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
126679557|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
126679558|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
126679559|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
126679560|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
126679561|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
126679562|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
126679563|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
126679564|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
126679565|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
126679566|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
126679567|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
126679568|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
126679569|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
126679570|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
126679571|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
126431514|NCT04886154|454875925|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126431515|NCT04886154|454875926|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
126431516|NCT04886154|454875912|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126431517|NCT04886154|454875913|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126431518|NCT04886154|454875914|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126431519|NCT04886154|454875915|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126431520|NCT04886154|454875916|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126431521|NCT04886154|454875917|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126431522|NCT04886154|454875918|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
126431523|NCT04886154|454875919|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126431524|NCT04886154|454875920|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126431525|NCT04886154|454875921|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126431526|NCT04886154|454875922|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126431527|NCT04886154|454875923|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126431528|NCT04886154|454875924|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126431529|NCT04886154|454875925|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126431530|NCT04886154|454875926|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126431531|NCT04886154|454875912|FG000|Overall Study|Other, Not Specified|0|||
126431532|NCT04886154|454875913|FG001|Overall Study|Other, Not Specified|0|||
126431533|NCT04886154|454875914|FG002|Overall Study|Other, Not Specified|0|||
126431534|NCT04886154|454875915|FG003|Overall Study|Other, Not Specified|0|||
126431535|NCT04886154|454875916|FG004|Overall Study|Other, Not Specified|11|||
126431536|NCT04886154|454875917|FG005|Overall Study|Other, Not Specified|8|||
126431537|NCT04886154|454875918|FG006|Overall Study|Other, Not Specified|9|||
126431538|NCT04886154|454875919|FG007|Overall Study|Other, Not Specified|10|||
126431539|NCT04886154|454875920|FG008|Overall Study|Other, Not Specified|6|||
126431540|NCT04886154|454875921|FG009|Overall Study|Other, Not Specified|1|||
126431541|NCT04886154|454875922|FG010|Overall Study|Other, Not Specified|1|||
126431542|NCT04886154|454875923|FG011|Overall Study|Other, Not Specified|2|||
126431543|NCT04886154|454875924|FG012|Overall Study|Other, Not Specified|1|||
126431544|NCT04886154|454875925|FG013|Overall Study|Other, Not Specified|2|||
126431545|NCT04886154|454875926|FG014|Overall Study|Other, Not Specified|3|||
126431546|NCT01400698|454875928|FG000|Overall Study|Lost to Follow-up|2|||
126431547|NCT01400698|454875929|FG001|Overall Study|Lost to Follow-up|5|||
126431548|NCT01400698|454875930|FG002|Overall Study|Lost to Follow-up|2|||
126679572|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
126679573|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
126679574|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
126679575|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
126679576|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
126679577|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
126679578|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
126431549|NCT01400698|454875931|FG003|Overall Study|Lost to Follow-up|1|||
126431550|NCT01400698|454875932|FG004|Overall Study|Lost to Follow-up|4|||
126431551|NCT01400698|454875933|FG005|Overall Study|Lost to Follow-up|3|||
126431552|NCT01400698|454875928|FG000|Overall Study|Withdrawal by Subject|8|||
126431553|NCT01400698|454875929|FG001|Overall Study|Withdrawal by Subject|2|||
126345487|NCT02332707|454560148|FG015|Overall Study|Withdrawal by Subject|0|||
126345488|NCT02332707|454560149|FG016|Overall Study|Withdrawal by Subject|0|||
126345489|NCT02332707|454560150|FG017|Overall Study|Withdrawal by Subject|0|||
126345490|NCT04761822|454560151|FG000|Overall Study|Adverse Event|3|||
126345491|NCT04761822|454560152|FG001|Overall Study|Adverse Event|1|||
126345492|NCT04761822|454560153|FG002|Overall Study|Adverse Event|1|||
126345493|NCT04761822|454560154|FG003|Overall Study|Adverse Event|3|||
126345494|NCT04761822|454560151|FG000|Overall Study|Lost to Follow-up|1|||
126345495|NCT04761822|454560152|FG001|Overall Study|Lost to Follow-up|0|||
126345496|NCT04761822|454560153|FG002|Overall Study|Lost to Follow-up|2|||
126345497|NCT04761822|454560154|FG003|Overall Study|Lost to Follow-up|3|||
126345498|NCT04761822|454560151|FG000|Overall Study|Physician Decision|0|||
126345499|NCT04761822|454560152|FG001|Overall Study|Physician Decision|1|||
126345500|NCT04761822|454560153|FG002|Overall Study|Physician Decision|0|||
126345501|NCT04761822|454560154|FG003|Overall Study|Physician Decision|0|||
126345502|NCT04761822|454560151|FG000|Overall Study|Withdrawal by Subject|3|||
126345503|NCT04761822|454560152|FG001|Overall Study|Withdrawal by Subject|8|||
126345504|NCT04761822|454560153|FG002|Overall Study|Withdrawal by Subject|1|||
126345505|NCT04761822|454560154|FG003|Overall Study|Withdrawal by Subject|11|||
126345506|NCT04761822|454560151|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
126345507|NCT04761822|454560152|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
126345508|NCT04761822|454560153|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
126345509|NCT04761822|454560154|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
126345510|NCT04761822|454560151|FG000|Overall Study|Participant requested unblinding|0|||
126345511|NCT04761822|454560152|FG001|Overall Study|Participant requested unblinding|0|||
126345512|NCT04761822|454560153|FG002|Overall Study|Participant requested unblinding|0|||
126345513|NCT04761822|454560154|FG003|Overall Study|Participant requested unblinding|1|||
126345514|NCT02233413|454560159|FG000|Overall Study|Lost to Follow-up|7|||
126345515|NCT02233413|454560160|FG001|Overall Study|Lost to Follow-up|9|||
126345516|NCT02233413|454560159|FG000|Overall Study|Withdrawal by Subject|4|||
126345517|NCT02233413|454560160|FG001|Overall Study|Withdrawal by Subject|5|||
126345518|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
126345519|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
126345520|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
126345521|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
126345522|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
126431554|NCT01400698|454875930|FG002|Overall Study|Withdrawal by Subject|0|||
126431555|NCT01400698|454875931|FG003|Overall Study|Withdrawal by Subject|4|||
126431556|NCT01400698|454875932|FG004|Overall Study|Withdrawal by Subject|1|||
126431557|NCT01400698|454875933|FG005|Overall Study|Withdrawal by Subject|3|||
126679579|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
126679580|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
126679581|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
126679582|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
126679583|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
126679584|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
126679585|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
126679586|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
126679587|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
126679588|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
126679589|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
126679590|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
126679591|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
126679592|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
126679593|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
126679594|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
126679595|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
126679596|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
126679597|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
126679598|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
126679599|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
126679600|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
126679601|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
126679602|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
126679603|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
126679604|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
126345523|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
126345524|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
126345525|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
126431558|NCT01400698|454875928|FG000|Overall Study|Protocol Violation|0|||
126431559|NCT01400698|454875929|FG001|Overall Study|Protocol Violation|1|||
126345526|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
126345527|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
126345528|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
126345529|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
126345530|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
126345531|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
126345532|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
126345533|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
126345534|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
126345535|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
126345536|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
126345537|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
126345538|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
126345539|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
126345540|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
126345541|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
126345542|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
126345543|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
126345544|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
126345545|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
126345546|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
126345547|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
126345548|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
126345549|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
126345550|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
126345551|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
126345552|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
126345553|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
126345554|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
126345555|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
126345556|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
126345557|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
126345558|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
126345559|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
126345560|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
126345561|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
126345562|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
126345563|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
126345564|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
126345565|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
126345566|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
126345567|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
126345568|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
126345569|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
126345570|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
126345571|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
126345572|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
126345573|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
126345574|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
126345575|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
126345576|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
126345577|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
126345578|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
126345579|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
126345580|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
126345581|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
126345582|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
126345583|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
126345584|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
126345585|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
126679605|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
126431560|NCT01400698|454875930|FG002|Overall Study|Protocol Violation|0|||
126431561|NCT01400698|454875931|FG003|Overall Study|Protocol Violation|0|||
126431562|NCT01400698|454875932|FG004|Overall Study|Protocol Violation|1|||
126431563|NCT01400698|454875933|FG005|Overall Study|Protocol Violation|0|||
126679606|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
126679607|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
126679608|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
126679609|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
126679610|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
126679611|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Other|0|||
126679612|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Other|0|||
126679613|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Other|0|||
126679614|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Other|1|||
126679615|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Other|0|||
126679616|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
126679617|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
126679618|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
126679619|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
126679620|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
126679621|NCT00440947|455784476|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
126679622|NCT00440947|455784477|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
126679623|NCT00440947|455784478|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
126679624|NCT00440947|455784479|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
126679625|NCT00440947|455784480|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
126679626|NCT02716987|455784481|FG000|Overall Study|Ligand synthesis failure|0|||
126679627|NCT02716987|455784482|FG001|Overall Study|Ligand synthesis failure|0|||
126679628|NCT02716987|455784483|FG002|Overall Study|Ligand synthesis failure|1|||
126679629|NCT02716987|455784484|FG003|Overall Study|Ligand synthesis failure|0|||
126679630|NCT02716987|455784485|FG004|Overall Study|Ligand synthesis failure|0|||
126679631|NCT02716987|455784486|FG005|Overall Study|Ligand synthesis failure|0|||
126679632|NCT02716987|455784481|FG000|Overall Study|Withdrawal by Subject|0|||
126679633|NCT02716987|455784482|FG001|Overall Study|Withdrawal by Subject|0|||
126679634|NCT02716987|455784483|FG002|Overall Study|Withdrawal by Subject|0|||
126679635|NCT02716987|455784484|FG003|Overall Study|Withdrawal by Subject|0|||
126679636|NCT02716987|455784485|FG004|Overall Study|Withdrawal by Subject|1|||
126679637|NCT02716987|455784486|FG005|Overall Study|Withdrawal by Subject|1|||
126679638|NCT03223428|455784490|FG000|Overall Study|No longer taking Xermelo|27|||
126679639|NCT03223428|455784490|FG000|Overall Study|Declined Consent|1|||
126679640|NCT03223428|455784490|FG000|Overall Study|Non-responders|56|||
126679641|NCT03223428|455784490|FG000|Overall Study|Withdrawal by Subject|14|||
126679642|NCT01834274|455784491|FG000|Overall Study|Study Termination|41|||
126679643|NCT01834274|455784492|FG001|Overall Study|Study Termination|38|||
126679644|NCT01834274|455784491|FG000|Overall Study|Withdrawal by Subject|1|||
126679645|NCT01834274|455784492|FG001|Overall Study|Withdrawal by Subject|1|||
126679646|NCT01834274|455784491|FG000|Overall Study|Lost to Follow-up|3|||
126679647|NCT01834274|455784492|FG001|Overall Study|Lost to Follow-up|1|||
126679648|NCT01834274|455784491|FG000|Overall Study|Other|2|||
126679649|NCT01834274|455784492|FG001|Overall Study|Other|1|||
126679650|NCT01265797|455784501|FG000|Run-in Month|Withdrawal by Subject|0|||
126679651|NCT01265797|455784502|FG001|Run-in Month|Withdrawal by Subject|4|||
126679652|NCT01265797|455784501|FG000|Run-in Month|1st seizure during run-in month|0|||
126679653|NCT01265797|455784502|FG001|Run-in Month|1st seizure during run-in month|1|||
126679654|NCT01265797|455784501|FG000|Blinded Month|Lack of Efficacy|5|||
126679655|NCT01265797|455784502|FG001|Blinded Month|Lack of Efficacy|0|||
126679656|NCT01265797|455784501|FG000|Blinded Month|Lost to Follow-up|1|||
126679657|NCT01265797|455784502|FG001|Blinded Month|Lost to Follow-up|0|||
126679658|NCT01265797|455784501|FG000|Blinded Month|Protocol Violation|2|||
126679659|NCT01265797|455784502|FG001|Blinded Month|Protocol Violation|1|||
126679660|NCT01265797|455784501|FG000|Blinded Month|Adverse Event|2|||
126679661|NCT01265797|455784502|FG001|Blinded Month|Adverse Event|0|||
126679662|NCT01265797|455784501|FG000|Blinded Month|Diary data incomplete|0|||
126679663|NCT01265797|455784502|FG001|Blinded Month|Diary data incomplete|1|||
126679664|NCT01265797|455784501|FG000|Open Label Month|Lost to Follow-up|0|||
126679665|NCT01265797|455784502|FG001|Open Label Month|Lost to Follow-up|1|||
126679666|NCT02813694|455784503|FG000|Overall Study|Physician Decision|0|||
126679667|NCT02813694|455784504|FG001|Overall Study|Physician Decision|1|||
126679668|NCT02813694|455784503|FG000|Overall Study|Withdrawal by Subject|10|||
126679669|NCT02813694|455784504|FG001|Overall Study|Withdrawal by Subject|9|||
126679670|NCT02813694|455784503|FG000|Overall Study|Lost to Follow-up|1|||
126679671|NCT02813694|455784504|FG001|Overall Study|Lost to Follow-up|1|||
126431564|NCT01400698|454875928|FG000|Overall Study|Non-compliance|0|||
126679672|NCT02813694|455784503|FG000|Overall Study|Death|3|||
126679673|NCT02813694|455784504|FG001|Overall Study|Death|3|||
126679674|NCT02813694|455784503|FG000|Overall Study|Randomized- did not receive study drug|2|||
126758656|NCT00134563|456066675|FG002|Overall Study|Lack of Efficacy|17|||
126431565|NCT01400698|454875929|FG001|Overall Study|Non-compliance|1|||
126431566|NCT01400698|454875930|FG002|Overall Study|Non-compliance|0|||
126431567|NCT01400698|454875931|FG003|Overall Study|Non-compliance|1|||
126431568|NCT01400698|454875932|FG004|Overall Study|Non-compliance|0|||
126431569|NCT01400698|454875933|FG005|Overall Study|Non-compliance|0|||
126431570|NCT01400698|454875928|FG000|Overall Study|Adverse Event|1|||
126431571|NCT01400698|454875929|FG001|Overall Study|Adverse Event|0|||
126431572|NCT01400698|454875930|FG002|Overall Study|Adverse Event|0|||
126431573|NCT01400698|454875931|FG003|Overall Study|Adverse Event|0|||
126431574|NCT01400698|454875932|FG004|Overall Study|Adverse Event|0|||
126431575|NCT01400698|454875933|FG005|Overall Study|Adverse Event|0|||
126431576|NCT01400698|454875928|FG000|Overall Study|Other|4|||
126431577|NCT01400698|454875929|FG001|Overall Study|Other|2|||
126431578|NCT01400698|454875930|FG002|Overall Study|Other|0|||
126431579|NCT01400698|454875931|FG003|Overall Study|Other|2|||
126431580|NCT01400698|454875932|FG004|Overall Study|Other|1|||
126431581|NCT01400698|454875933|FG005|Overall Study|Other|0|||
126431582|NCT02891174|454877623|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
126431583|NCT02891174|454877624|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
126431584|NCT02891174|454877623|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
126431585|NCT02891174|454877624|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
126431586|NCT02891174|454877623|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
126431587|NCT02891174|454877624|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
126431588|NCT02891174|454877623|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
126431589|NCT02891174|454877624|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
126431590|NCT02891174|454877623|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
126431591|NCT02891174|454877624|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
126431592|NCT02891174|454877623|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
126431593|NCT02891174|454877624|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
126431594|NCT02891174|454877623|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
126431595|NCT02891174|454877624|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
126431596|NCT04124939|454877625|FG000|Overall Study|Lost to Follow-up|1|||
126431597|NCT04124939|454877626|FG001|Overall Study|Lost to Follow-up|3|||
126431598|NCT04235140|454877627|FG000|Overall Study|Adverse Event|2|||
126431599|NCT04235140|454877627|FG000|Overall Study|Lost to Follow-up|1|||
126431600|NCT04235140|454877627|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
126431601|NCT04235140|454877627|FG000|Overall Study|Commercial drug is available for participants|7|||
126431602|NCT04516746|454877631|FG000|Overall Study|Randomized but not Treated|51|||
126431603|NCT04516746|454877632|FG001|Overall Study|Randomized but not Treated|19|||
126431604|NCT04516746|454877631|FG000|Overall Study|Adverse Event|0|||
126431605|NCT04516746|454877632|FG001|Overall Study|Adverse Event|1|||
126431606|NCT04516746|454877631|FG000|Overall Study|Death|62|||
126431607|NCT04516746|454877632|FG001|Overall Study|Death|32|||
126431608|NCT04516746|454877631|FG000|Overall Study|Lost to Follow-up|3431|||
126431609|NCT04516746|454877632|FG001|Overall Study|Lost to Follow-up|1831|||
126431610|NCT04516746|454877631|FG000|Overall Study|Withdrawal by Subject|1946|||
126431611|NCT04516746|454877632|FG001|Overall Study|Withdrawal by Subject|1696|||
126431612|NCT04516746|454877631|FG000|Overall Study|Physician Decision|10|||
126431613|NCT04516746|454877632|FG001|Overall Study|Physician Decision|8|||
126431614|NCT04516746|454877631|FG000|Overall Study|Other|35|||
126431615|NCT04516746|454877632|FG001|Overall Study|Other|16|||
126431616|NCT03115359|454877635|FG000|Overall Study|Withdrawal by Subject|29|||
126431617|NCT03115359|454877636|FG001|Overall Study|Withdrawal by Subject|39|||
126431618|NCT03115359|454877635|FG000|Overall Study|Scheduling conflict|25|||
126431619|NCT03115359|454877636|FG001|Overall Study|Scheduling conflict|23|||
126431620|NCT03115359|454877635|FG000|Overall Study|Personal reasons including health|12|||
126431621|NCT03115359|454877636|FG001|Overall Study|Personal reasons including health|9|||
126431622|NCT03115359|454877635|FG000|Overall Study|Transportation barriers|3|||
126431623|NCT03115359|454877636|FG001|Overall Study|Transportation barriers|0|||
126431624|NCT03115359|454877635|FG000|Overall Study|No longer interested|5|||
126431625|NCT03115359|454877636|FG001|Overall Study|No longer interested|4|||
126431626|NCT03115359|454877635|FG000|Overall Study|No reason provided|45|||
126431627|NCT03115359|454877636|FG001|Overall Study|No reason provided|47|||
126431628|NCT05543265|454877642|FG000|Overall Study|Lost to Follow-up|3|||
126431629|NCT05543265|454877643|FG001|Overall Study|Lost to Follow-up|3|||
126431630|NCT05543265|454877642|FG000|Overall Study|Withdrawal by Subject|0|||
126431631|NCT05543265|454877643|FG001|Overall Study|Withdrawal by Subject|1|||
126679675|NCT02813694|455784504|FG001|Overall Study|Randomized- did not receive study drug|0|||
126431632|NCT05316597|454877644|FG000|First Session|Withdrawal by Subject|0|||
126431633|NCT05316597|454877645|FG001|First Session|Withdrawal by Subject|1|||
126431634|NCT05316597|454877644|FG000|Washout Period|Lost to Follow-up|1|||
126431635|NCT05316597|454877645|FG001|Washout Period|Lost to Follow-up|2|||
126431636|NCT05316597|454877644|FG000|Washout Period|Physician Decision|1|||
126431637|NCT05316597|454877645|FG001|Washout Period|Physician Decision|1|||
126679676|NCT02813694|455784503|FG000|Overall Study|Patient hospitalized|1|||
126679677|NCT02813694|455784504|FG001|Overall Study|Patient hospitalized|0|||
126679678|NCT02980224|455784507|FG000|Overall Study|Adverse Event|4|||
126679679|NCT02980224|455784508|FG001|Overall Study|Adverse Event|1|||
126679680|NCT02980224|455784507|FG000|Overall Study|Withdrawal by Subject|0|||
126679681|NCT02980224|455784508|FG001|Overall Study|Withdrawal by Subject|2|||
126679682|NCT00606320|455784509|FG000|Overall Study|Adverse Event|3|||
126679683|NCT00606320|455784509|FG000|Overall Study|Lack of Efficacy|5|||
126679684|NCT00606320|455784509|FG000|Overall Study|Physician Decision|7|||
126679685|NCT00606320|455784509|FG000|Overall Study|Protocol Violation|8|||
126679686|NCT00606320|455784509|FG000|Overall Study|Withdrawal by Subject|10|||
126679687|NCT00606320|455784509|FG000|Overall Study|Progression to depressive phase|4|||
126679688|NCT04839380|455784510|FG000|Overall Study|Withdrawal by Subject|2|||
126679689|NCT04839380|455784510|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
126679690|NCT01087905|455784511|FG000|Overall Study|Lost to Follow-up|24|||
126679691|NCT01087905|455784512|FG001|Overall Study|Lost to Follow-up|28|||
126679692|NCT01087905|455784513|FG002|Overall Study|Lost to Follow-up|18|||
126679693|NCT01087905|455784514|FG003|Overall Study|Lost to Follow-up|31|||
126679694|NCT01087905|455784515|FG004|Overall Study|Lost to Follow-up|27|||
126679695|NCT01087905|455784516|FG005|Overall Study|Lost to Follow-up|25|||
126679696|NCT01087905|455784517|FG006|Overall Study|Lost to Follow-up|20|||
126679697|NCT01087905|455784518|FG007|Overall Study|Lost to Follow-up|24|||
126679698|NCT01087905|455784511|FG000|Overall Study|Withdrawal by Subject|5|||
126679699|NCT01087905|455784512|FG001|Overall Study|Withdrawal by Subject|4|||
126679700|NCT01087905|455784513|FG002|Overall Study|Withdrawal by Subject|4|||
126679701|NCT01087905|455784514|FG003|Overall Study|Withdrawal by Subject|5|||
126679702|NCT01087905|455784515|FG004|Overall Study|Withdrawal by Subject|4|||
126431638|NCT05316597|454877644|FG000|Washout Period|Excluded before second session|1|||
126431639|NCT05316597|454877645|FG001|Washout Period|Excluded before second session|1|||
126431640|NCT05316597|454877644|FG000|Washout Period|Withdrawal by Subject|0|||
126431641|NCT05316597|454877645|FG001|Washout Period|Withdrawal by Subject|4|||
126431642|NCT05526716|454877646|FG000|Overall Study|Death|1|||
126431643|NCT05526716|454877647|FG001|Overall Study|Death|2|||
126431644|NCT05526716|454877646|FG000|Overall Study|Lost to Follow-up|17|||
126679703|NCT01087905|455784516|FG005|Overall Study|Withdrawal by Subject|3|||
126431645|NCT05526716|454877647|FG001|Overall Study|Lost to Follow-up|15|||
126431646|NCT05526716|454877646|FG000|Overall Study|Physician Decision|0|||
126431647|NCT05526716|454877647|FG001|Overall Study|Physician Decision|1|||
126431648|NCT05526716|454877646|FG000|Overall Study|Randomized by mistake without study treatment|0|||
126431649|NCT05526716|454877647|FG001|Overall Study|Randomized by mistake without study treatment|1|||
126431650|NCT05526716|454877646|FG000|Overall Study|Withdrawal by Subject|12|||
126431651|NCT05526716|454877647|FG001|Overall Study|Withdrawal by Subject|12|||
126431652|NCT05526716|454877646|FG000|Overall Study|Not reported|0|||
126431653|NCT05526716|454877647|FG001|Overall Study|Not reported|2|||
126431654|NCT02384551|454877649|FG000|Overall Study|Lost to Follow-up|13|||
126431655|NCT02384551|454877650|FG001|Overall Study|Lost to Follow-up|14|||
126431656|NCT02384551|454877651|FG002|Overall Study|Lost to Follow-up|14|||
126431657|NCT02384551|454877652|FG003|Overall Study|Lost to Follow-up|14|||
126431658|NCT04742556|454877653|FG000|Overall Study|Withdrawal by Subject|0|||
126431659|NCT04742556|454877654|FG001|Overall Study|Withdrawal by Subject|1|||
126431660|NCT04742556|454877655|FG002|Overall Study|Withdrawal by Subject|0|||
126431661|NCT04742556|454877653|FG000|Overall Study|Adverse Event|0|||
126431662|NCT04742556|454877654|FG001|Overall Study|Adverse Event|0|||
126431663|NCT04742556|454877655|FG002|Overall Study|Adverse Event|2|||
126431664|NCT04742556|454877653|FG000|Overall Study|Clinical disease progression|0|||
126431665|NCT04742556|454877654|FG001|Overall Study|Clinical disease progression|1|||
126431666|NCT04742556|454877655|FG002|Overall Study|Clinical disease progression|2|||
126431667|NCT04742556|454877653|FG000|Overall Study|Objective disease progression|3|||
126431668|NCT04742556|454877654|FG001|Overall Study|Objective disease progression|2|||
126431669|NCT04742556|454877655|FG002|Overall Study|Objective disease progression|4|||
126431670|NCT03035032|454877658|FG000|Overall Study|Adverse Event|2|||
126431671|NCT03035032|454877658|FG000|Overall Study|Death|9|||
126431672|NCT03035032|454877658|FG000|Overall Study|Lost to Follow-up|1|||
126431673|NCT03035032|454877658|FG000|Overall Study|Progressive Disease|22|||
126431674|NCT03035032|454877658|FG000|Overall Study|Protocol Violation|2|||
126431675|NCT03035032|454877658|FG000|Overall Study|Withdrawal by Subject|2|||
126431676|NCT03035032|454877658|FG000|Overall Study|Physician Decision|5|||
126431677|NCT02201524|454877661|FG000|Overall Study|Adverse Event|0|||
126431678|NCT02201524|454877662|FG001|Overall Study|Adverse Event|2|||
126431679|NCT02201524|454877663|FG002|Overall Study|Adverse Event|1|||
126431680|NCT02201524|454877664|FG003|Overall Study|Adverse Event|0|||
126431681|NCT02201524|454877661|FG000|Overall Study|Insufficient clinical response|1|||
126431682|NCT02201524|454877662|FG001|Overall Study|Insufficient clinical response|0|||
126679704|NCT01087905|455784517|FG006|Overall Study|Withdrawal by Subject|3|||
126679705|NCT01087905|455784518|FG007|Overall Study|Withdrawal by Subject|5|||
126679706|NCT01347554|455784519|FG000|Overall Study|Lack of Efficacy|7|||
126679707|NCT01347554|455784520|FG001|Overall Study|Lack of Efficacy|11|||
126679708|NCT02937818|455784524|FG000|Overall Study|Participants decision|2|||
126431683|NCT02201524|454877663|FG002|Overall Study|Insufficient clinical response|0|||
126431684|NCT02201524|454877664|FG003|Overall Study|Insufficient clinical response|0|||
126431685|NCT02201524|454877661|FG000|Overall Study|Lost to Follow-up|0|||
126431686|NCT02201524|454877662|FG001|Overall Study|Lost to Follow-up|0|||
126431687|NCT02201524|454877663|FG002|Overall Study|Lost to Follow-up|2|||
126431688|NCT02201524|454877664|FG003|Overall Study|Lost to Follow-up|0|||
126431689|NCT02201524|454877661|FG000|Overall Study|No longer meets eligibility criteria|0|||
126431690|NCT02201524|454877662|FG001|Overall Study|No longer meets eligibility criteria|0|||
126431691|NCT02201524|454877663|FG002|Overall Study|No longer meets eligibility criteria|0|||
126431692|NCT02201524|454877664|FG003|Overall Study|No longer meets eligibility criteria|2|||
126431693|NCT02201524|454877661|FG000|Overall Study|Protocol Violation|0|||
126431694|NCT02201524|454877662|FG001|Overall Study|Protocol Violation|0|||
126431695|NCT02201524|454877663|FG002|Overall Study|Protocol Violation|0|||
126431696|NCT02201524|454877664|FG003|Overall Study|Protocol Violation|1|||
126431697|NCT02201524|454877661|FG000|Overall Study|Withdrawal by Subject|0|||
126431698|NCT02201524|454877662|FG001|Overall Study|Withdrawal by Subject|0|||
126431699|NCT02201524|454877663|FG002|Overall Study|Withdrawal by Subject|1|||
126431700|NCT02201524|454877664|FG003|Overall Study|Withdrawal by Subject|1|||
126431701|NCT02201524|454877661|FG000|Overall Study|Other|1|||
126431702|NCT02201524|454877662|FG001|Overall Study|Other|1|||
126431703|NCT02201524|454877663|FG002|Overall Study|Other|0|||
126431704|NCT02201524|454877664|FG003|Overall Study|Other|0|||
126431705|NCT02914639|454877667|FG000|Overall Study|Withdrawal by Subject|0|||
126431706|NCT02914639|454877668|FG001|Overall Study|Withdrawal by Subject|2|||
126431707|NCT02546609|454877671|FG000|Overall Study|Withdrawal by Subject|0|||
126431708|NCT02546609|454877672|FG001|Overall Study|Withdrawal by Subject|1|||
126431709|NCT02546609|454877673|FG002|Overall Study|Withdrawal by Subject|2|||
126431710|NCT02546609|454877671|FG000|Overall Study|Adverse Event|0|||
126431711|NCT02546609|454877672|FG001|Overall Study|Adverse Event|6|||
126431712|NCT02546609|454877673|FG002|Overall Study|Adverse Event|1|||
126431713|NCT02546609|454877671|FG000|Overall Study|Protocol Violation|0|||
126431714|NCT02546609|454877672|FG001|Overall Study|Protocol Violation|1|||
126431715|NCT02546609|454877673|FG002|Overall Study|Protocol Violation|1|||
126431716|NCT02546609|454877671|FG000|Overall Study|Lost to Follow-up|2|||
126431717|NCT02546609|454877672|FG001|Overall Study|Lost to Follow-up|3|||
126431718|NCT02546609|454877673|FG002|Overall Study|Lost to Follow-up|1|||
126431719|NCT02546609|454877671|FG000|Overall Study|travel or work schedule restriction|0|||
126431720|NCT02546609|454877672|FG001|Overall Study|travel or work schedule restriction|0|||
126431721|NCT02546609|454877673|FG002|Overall Study|travel or work schedule restriction|2|||
126431722|NCT00914849|454877674|FG000|Overall Study|Withdrawal by Subject|1|||
126431723|NCT00914849|454877675|FG001|Overall Study|Withdrawal by Subject|0|||
126431724|NCT00914849|454877674|FG000|Overall Study|Not eligible|0|||
126431725|NCT00914849|454877675|FG001|Overall Study|Not eligible|1|||
126431726|NCT01553084|454877676|FG000|Overall Study|Withdrawal by Subject|15|||
126431727|NCT01553084|454877677|FG001|Overall Study|Withdrawal by Subject|13|||
126431728|NCT01553084|454877678|FG002|Overall Study|Withdrawal by Subject|35|||
126431729|NCT03988400|454877679|FG000|Overall Study|Adverse Event|1|||
126679709|NCT02937818|455784525|FG001|Overall Study|Participants decision|1|||
126679710|NCT02937818|455784526|FG002|Overall Study|Participants decision|1|||
126679711|NCT02937818|455784527|FG003|Overall Study|Participants decision|1|||
126679712|NCT02937818|455784524|FG000|Overall Study|Adverse Event|2|||
126679713|NCT02937818|455784525|FG001|Overall Study|Adverse Event|4|||
126679714|NCT02937818|455784526|FG002|Overall Study|Adverse Event|1|||
126679715|NCT02937818|455784527|FG003|Overall Study|Adverse Event|1|||
126679716|NCT02937818|455784524|FG000|Overall Study|Disease progression|17|||
126679717|NCT02937818|455784525|FG001|Overall Study|Disease progression|15|||
126679718|NCT02937818|455784526|FG002|Overall Study|Disease progression|7|||
126679719|NCT02937818|455784527|FG003|Overall Study|Disease progression|19|||
126679720|NCT02937818|455784524|FG000|Overall Study|Condition under investigation worsened|0|||
126431730|NCT03988400|454877680|FG001|Overall Study|Adverse Event|0|||
126431731|NCT03988400|454877679|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
126431732|NCT03988400|454877680|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
126431733|NCT03988400|454877679|FG000|Overall Study|Lost to Follow-up|0|||
126431734|NCT03988400|454877680|FG001|Overall Study|Lost to Follow-up|1|||
126431735|NCT04201431|454877682|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
126431736|NCT04201431|454877683|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
126679721|NCT02937818|455784525|FG001|Overall Study|Condition under investigation worsened|0|||
126679722|NCT02937818|455784526|FG002|Overall Study|Condition under investigation worsened|1|||
126679723|NCT02937818|455784527|FG003|Overall Study|Condition under investigation worsened|0|||
126431737|NCT04201431|454877684|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
126431738|NCT01546857|454877685|FG000|Overall Study|Withdrawal by Subject|2|||
126431739|NCT01546857|454877686|FG001|Overall Study|Withdrawal by Subject|3|||
126431740|NCT01176032|454877687|FG000|Overall Study|Adverse Event|1|||
126679724|NCT00205855|455784528|FG000|Overall Study|Only received temporary implants|16|||
126679725|NCT00205855|455784528|FG000|Overall Study|Withdrawal by Subject|5|||
126758657|NCT00134563|456066673|FG000|Overall Study|Protocol Violation|3|||
126679726|NCT01015768|455784530|FG000|Overall Study|Some subject data unuseable|4|||
126679727|NCT01015768|455784531|FG001|Overall Study|Some subject data unuseable|4|||
126679728|NCT02943564|455784532|FG000|Overall Study|Miscellaneous Reasons|0|||
126679729|NCT02943564|455784533|FG001|Overall Study|Miscellaneous Reasons|0|||
126679730|NCT02943564|455784534|FG002|Overall Study|Miscellaneous Reasons|3|||
126679731|NCT02943564|455784532|FG000|Overall Study|Site terminated by sponsor|0|||
126679732|NCT02943564|455784533|FG001|Overall Study|Site terminated by sponsor|1|||
126679733|NCT02943564|455784534|FG002|Overall Study|Site terminated by sponsor|0|||
126679734|NCT02943564|455784532|FG000|Overall Study|Non-compliance with study drug|0|||
126679735|NCT02943564|455784533|FG001|Overall Study|Non-compliance with study drug|1|||
126679736|NCT02943564|455784534|FG002|Overall Study|Non-compliance with study drug|0|||
126679737|NCT02943564|455784532|FG000|Overall Study|Pregnancy|0|||
126679738|NCT02943564|455784533|FG001|Overall Study|Pregnancy|1|||
126679739|NCT02943564|455784534|FG002|Overall Study|Pregnancy|1|||
126679740|NCT02943564|455784532|FG000|Overall Study|Protocol Violation|2|||
126679741|NCT02943564|455784533|FG001|Overall Study|Protocol Violation|2|||
126679742|NCT02943564|455784534|FG002|Overall Study|Protocol Violation|2|||
126679743|NCT02943564|455784532|FG000|Overall Study|Lost to Follow-up|1|||
126679744|NCT02943564|455784533|FG001|Overall Study|Lost to Follow-up|0|||
126679745|NCT02943564|455784534|FG002|Overall Study|Lost to Follow-up|0|||
126345586|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
126345587|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
126679746|NCT02943564|455784532|FG000|Overall Study|Withdrawal by Subject|6|||
126679747|NCT02943564|455784533|FG001|Overall Study|Withdrawal by Subject|5|||
126679748|NCT02943564|455784534|FG002|Overall Study|Withdrawal by Subject|2|||
126345588|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
126345589|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
126345590|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
126345591|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
126345592|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
126345593|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
126345594|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
126345595|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
126345596|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
126345597|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
126345598|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
126345599|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
126345600|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
126345601|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
126345602|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
126345603|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
126345604|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
126345605|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
126345606|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
126345607|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
126345608|NCT00090103|454560161|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
126679749|NCT02943564|455784532|FG000|Overall Study|Adverse Event|1|||
126679750|NCT02943564|455784533|FG001|Overall Study|Adverse Event|2|||
126679751|NCT02943564|455784534|FG002|Overall Study|Adverse Event|1|||
126679752|NCT02943564|455784532|FG000|Overall Study|Lack of Efficacy|0|||
126679753|NCT02943564|455784533|FG001|Overall Study|Lack of Efficacy|1|||
126679754|NCT02943564|455784534|FG002|Overall Study|Lack of Efficacy|0|||
126679755|NCT01073267|455784537|FG000|Overall Study|Disease Progression|3|||
126679756|NCT01225731|455784538|FG000|Part 1|Did not meet eligibility criteria|1|||
126679757|NCT01225731|455784539|FG001|Part 1|Did not meet eligibility criteria|0|||
126679758|NCT01225731|455784540|FG002|Part 1|Did not meet eligibility criteria|0|||
126679759|NCT01225731|455784541|FG003|Part 1|Did not meet eligibility criteria|0|||
126679760|NCT01225731|455784542|FG004|Part 1|Did not meet eligibility criteria|1|||
126679761|NCT01225731|455784543|FG005|Part 1|Did not meet eligibility criteria|0|||
126345609|NCT00090103|454560162|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
126345610|NCT00090103|454560163|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
126345611|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
126345612|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
126345613|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
126345614|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
126679762|NCT01225731|455784544|FG006|Part 1|Did not meet eligibility criteria|0|||
126679763|NCT01225731|455784545|FG007|Part 1|Did not meet eligibility criteria|0|||
126679764|NCT01225731|455784546|FG008|Part 1|Did not meet eligibility criteria|0|||
126679765|NCT01225731|455784547|FG009|Part 1|Did not meet eligibility criteria|0|||
126679766|NCT01225731|455784548|FG010|Part 1|Did not meet eligibility criteria|0|||
126679767|NCT01225731|455784549|FG011|Part 1|Did not meet eligibility criteria|0|||
126679768|NCT01225731|455784550|FG012|Part 1|Did not meet eligibility criteria|0|||
126679769|NCT01225731|455784538|FG000|Part 1|Adverse Event|1|||
126679770|NCT01225731|455784539|FG001|Part 1|Adverse Event|2|||
126345615|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
126345616|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
126345617|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
126345618|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
126345619|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
126345620|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
126345621|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
126345622|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
126345623|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
126345624|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
126345625|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
126345626|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
126345627|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
126345628|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
126345629|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
126345630|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
126345631|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
126345632|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
126345633|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
126345634|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
126345635|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
126345636|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
126345637|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
126345638|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
126345639|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
126345640|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
126345641|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
126345642|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
126345643|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
126345644|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
126345645|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
126345646|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
126345647|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
126345648|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
126345649|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
126345650|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
126345651|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
126345652|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
126345653|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
126345654|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
126345655|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
126345656|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
126345657|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
126345658|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
126345659|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Death|1|||
126345660|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Death|0|||
126345661|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Death|1|||
126345662|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
126345663|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
126345664|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
126345665|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
126345666|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
126345667|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
126345668|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
126345669|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
126345670|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
126345671|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
126345672|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
126345673|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
126345674|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
126345675|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
126679771|NCT01225731|455784540|FG002|Part 1|Adverse Event|1|||
126679772|NCT01225731|455784541|FG003|Part 1|Adverse Event|1|||
126431741|NCT01176032|454877688|FG001|Overall Study|Adverse Event|0|||
126431742|NCT01176032|454877687|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126431743|NCT01176032|454877688|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126431744|NCT01176032|454877687|FG000|Overall Study|Protocol Violation|1|||
126431745|NCT01176032|454877688|FG001|Overall Study|Protocol Violation|0|||
126431746|NCT01176032|454877687|FG000|Overall Study|Informed consent withdrawn|3|||
126431747|NCT01176032|454877688|FG001|Overall Study|Informed consent withdrawn|0|||
126431748|NCT01176032|454877687|FG000|Overall Study|Other|1|||
126431749|NCT01176032|454877688|FG001|Overall Study|Other|0|||
126431750|NCT01469221|454877689|FG000|Double Blind Phase|Protocol Violation|1|||
126431751|NCT01469221|454877690|FG001|Double Blind Phase|Protocol Violation|0|||
126431752|NCT01469221|454877691|FG002|Double Blind Phase|Protocol Violation|0|||
126431753|NCT01469221|454877689|FG000|Double Blind Phase|Physician Decision|1|||
126431754|NCT01469221|454877690|FG001|Double Blind Phase|Physician Decision|1|||
126431755|NCT01469221|454877691|FG002|Double Blind Phase|Physician Decision|0|||
126431756|NCT01469221|454877689|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
126431757|NCT01469221|454877690|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
126679773|NCT01225731|455784542|FG004|Part 1|Adverse Event|1|||
126679774|NCT01225731|455784543|FG005|Part 1|Adverse Event|0|||
126679775|NCT01225731|455784544|FG006|Part 1|Adverse Event|0|||
126679776|NCT01225731|455784545|FG007|Part 1|Adverse Event|0|||
126679777|NCT01225731|455784546|FG008|Part 1|Adverse Event|0|||
126679778|NCT01225731|455784547|FG009|Part 1|Adverse Event|0|||
126679779|NCT01225731|455784548|FG010|Part 1|Adverse Event|0|||
126679780|NCT01225731|455784549|FG011|Part 1|Adverse Event|0|||
126679781|NCT01225731|455784550|FG012|Part 1|Adverse Event|0|||
126679782|NCT01225731|455784538|FG000|Part 1|Withdrawal by Subject|0|||
126679783|NCT01225731|455784539|FG001|Part 1|Withdrawal by Subject|3|||
126679784|NCT01225731|455784540|FG002|Part 1|Withdrawal by Subject|0|||
126679785|NCT01225731|455784541|FG003|Part 1|Withdrawal by Subject|0|||
126679786|NCT01225731|455784542|FG004|Part 1|Withdrawal by Subject|4|||
126679787|NCT01225731|455784543|FG005|Part 1|Withdrawal by Subject|0|||
126679788|NCT01225731|455784544|FG006|Part 1|Withdrawal by Subject|0|||
126679789|NCT01225731|455784545|FG007|Part 1|Withdrawal by Subject|0|||
126679790|NCT01225731|455784546|FG008|Part 1|Withdrawal by Subject|0|||
126679791|NCT01225731|455784547|FG009|Part 1|Withdrawal by Subject|0|||
126679792|NCT01225731|455784548|FG010|Part 1|Withdrawal by Subject|0|||
126679793|NCT01225731|455784549|FG011|Part 1|Withdrawal by Subject|0|||
126431758|NCT01469221|454877691|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
126431759|NCT02004236|454877700|FG000|Overall Study|Lack of Efficacy|0|||
126431760|NCT02004236|454877701|FG001|Overall Study|Lack of Efficacy|0|||
126431761|NCT02004236|454877702|FG002|Overall Study|Lack of Efficacy|16|||
126431762|NCT00168844|454877703|FG000|Overall Study|Adverse Event|31|||
126431763|NCT00168844|454877704|FG001|Overall Study|Adverse Event|32|||
126431764|NCT00168844|454877705|FG002|Overall Study|Adverse Event|48|||
126431765|NCT00168844|454877703|FG000|Overall Study|Lost to Follow-up|4|||
126431766|NCT00168844|454877704|FG001|Overall Study|Lost to Follow-up|5|||
126431767|NCT00168844|454877705|FG002|Overall Study|Lost to Follow-up|11|||
126431768|NCT00168844|454877703|FG000|Overall Study|Withdrawal by Subject|12|||
126431769|NCT00168844|454877704|FG001|Overall Study|Withdrawal by Subject|9|||
126431770|NCT00168844|454877705|FG002|Overall Study|Withdrawal by Subject|19|||
126431771|NCT00168844|454877703|FG000|Overall Study|Protocol Violation|2|||
126679794|NCT01225731|455784550|FG012|Part 1|Withdrawal by Subject|0|||
126679795|NCT01225731|455784538|FG000|Part 1|Protocol Violation|0|||
126679796|NCT01225731|455784539|FG001|Part 1|Protocol Violation|0|||
126679797|NCT01225731|455784540|FG002|Part 1|Protocol Violation|0|||
126679798|NCT01225731|455784541|FG003|Part 1|Protocol Violation|1|||
126679799|NCT01225731|455784542|FG004|Part 1|Protocol Violation|0|||
126679800|NCT01225731|455784543|FG005|Part 1|Protocol Violation|0|||
126679801|NCT01225731|455784544|FG006|Part 1|Protocol Violation|0|||
126679802|NCT01225731|455784545|FG007|Part 1|Protocol Violation|0|||
126679803|NCT01225731|455784546|FG008|Part 1|Protocol Violation|0|||
126679804|NCT01225731|455784547|FG009|Part 1|Protocol Violation|0|||
126679805|NCT01225731|455784548|FG010|Part 1|Protocol Violation|0|||
126679806|NCT01225731|455784549|FG011|Part 1|Protocol Violation|0|||
126679807|NCT01225731|455784550|FG012|Part 1|Protocol Violation|0|||
126431772|NCT00168844|454877704|FG001|Overall Study|Protocol Violation|2|||
126431773|NCT00168844|454877705|FG002|Overall Study|Protocol Violation|4|||
126679808|NCT01225731|455784538|FG000|Part 2|Protocol Violation|0|||
126679809|NCT01225731|455784539|FG001|Part 2|Protocol Violation|0|||
126679810|NCT01225731|455784540|FG002|Part 2|Protocol Violation|0|||
126679811|NCT01225731|455784541|FG003|Part 2|Protocol Violation|0|||
126679812|NCT01225731|455784542|FG004|Part 2|Protocol Violation|0|||
126431774|NCT00168844|454877703|FG000|Overall Study|Other|6|||
126431775|NCT00168844|454877704|FG001|Overall Study|Other|7|||
126431776|NCT00168844|454877705|FG002|Overall Study|Other|9|||
126431777|NCT00601835|454877713|FG000|Overall Study|Withdrawal by Subject|9|||
126431778|NCT00601835|454877714|FG001|Overall Study|Withdrawal by Subject|6|||
126431779|NCT00601835|454877713|FG000|Overall Study|Physician Decision|1|||
126679813|NCT01225731|455784543|FG005|Part 2|Protocol Violation|1|||
126679814|NCT01225731|455784544|FG006|Part 2|Protocol Violation|0|||
126679815|NCT01225731|455784545|FG007|Part 2|Protocol Violation|0|||
126431780|NCT00601835|454877714|FG001|Overall Study|Physician Decision|0|||
126431781|NCT00601835|454877713|FG000|Overall Study|Lost to Follow-up|37|||
126431782|NCT00601835|454877714|FG001|Overall Study|Lost to Follow-up|5|||
126431783|NCT00601835|454877713|FG000|Overall Study|Adverse Event|1|||
126431784|NCT00601835|454877714|FG001|Overall Study|Adverse Event|1|||
126431785|NCT00601835|454877713|FG000|Overall Study|Relocate|12|||
126431786|NCT00601835|454877714|FG001|Overall Study|Relocate|2|||
126431787|NCT01927497|454877715|FG000|Overall Study|Death|0|||
126431788|NCT01927497|454877716|FG001|Overall Study|Death|1|||
126431789|NCT01927497|454877715|FG000|Overall Study|Protocol Violation|2|||
126431790|NCT01927497|454877716|FG001|Overall Study|Protocol Violation|0|||
126431791|NCT03914417|454877717|FG000|Overall Study|Withdrawal by Subject|2|||
126431792|NCT03361137|454877720|FG000|Overall Study|Reason not specified|1|||
126431793|NCT03361137|454877721|FG001|Overall Study|Reason not specified|0|||
126431794|NCT03361137|454877722|FG002|Overall Study|Reason not specified|0|||
126431795|NCT03361137|454877723|FG003|Overall Study|Reason not specified|0|||
126431796|NCT03361137|454877724|FG004|Overall Study|Reason not specified|0|||
126431797|NCT03009058|454877725|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
126431798|NCT01247324|454877728|FG000|Overall Study|Death|6|||
126431799|NCT01247324|454877729|FG001|Overall Study|Death|10|||
126431800|NCT01247324|454877728|FG000|Overall Study|Physician Decision|2|||
126431801|NCT01247324|454877729|FG001|Overall Study|Physician Decision|3|||
126431802|NCT01247324|454877728|FG000|Overall Study|Non-compliance with study drug|3|||
126431803|NCT01247324|454877729|FG001|Overall Study|Non-compliance with study drug|0|||
126431804|NCT01247324|454877728|FG000|Overall Study|Lack of Efficacy|24|||
126431805|NCT01247324|454877729|FG001|Overall Study|Lack of Efficacy|14|||
126431806|NCT01247324|454877728|FG000|Overall Study|Non-compliance|3|||
126431807|NCT01247324|454877729|FG001|Overall Study|Non-compliance|2|||
126431808|NCT01247324|454877728|FG000|Overall Study|Pregnancy|5|||
126431809|NCT01247324|454877729|FG001|Overall Study|Pregnancy|10|||
126431810|NCT01247324|454877728|FG000|Overall Study|Protocol Violation|1|||
126431811|NCT01247324|454877729|FG001|Overall Study|Protocol Violation|1|||
126431812|NCT01247324|454877728|FG000|Overall Study|Reason not specified|42|||
126431813|NCT01247324|454877729|FG001|Overall Study|Reason not specified|32|||
126431814|NCT01247324|454877728|FG000|Overall Study|Consent withdrawn by participant|41|||
126431815|NCT01247324|454877729|FG001|Overall Study|Consent withdrawn by participant|56|||
126431816|NCT01247324|454877728|FG000|Overall Study|Adverse Event|49|||
126431817|NCT01247324|454877729|FG001|Overall Study|Adverse Event|35|||
126431818|NCT01247324|454877728|FG000|Overall Study|Lost to Follow-up|3|||
126431819|NCT01247324|454877729|FG001|Overall Study|Lost to Follow-up|6|||
126431820|NCT01247324|454877728|FG000|Overall Study|Study Terminated by Sponsor|4|||
126431821|NCT01247324|454877729|FG001|Overall Study|Study Terminated by Sponsor|1|||
126431822|NCT01247324|454877728|FG000|Overall Study|Missing|2|||
126431823|NCT01247324|454877729|FG001|Overall Study|Missing|1|||
126431824|NCT01486966|454877730|FG000|Overall Study|Adverse Event|0|||
126431825|NCT01486966|454877731|FG001|Overall Study|Adverse Event|1|||
126431826|NCT01486966|454877730|FG000|Overall Study|Withdrawal by Subject|0|||
126431827|NCT01486966|454877731|FG001|Overall Study|Withdrawal by Subject|1|||
126431828|NCT00506350|454877732|FG000|Overall Study|Serious Adverse Event|1|||
126431829|NCT00506350|454877733|FG001|Overall Study|Serious Adverse Event|0|||
126431830|NCT00506350|454877734|FG002|Overall Study|Serious Adverse Event|0|||
126431831|NCT00506350|454877735|FG003|Overall Study|Serious Adverse Event|0|||
126431832|NCT00506350|454877736|FG004|Overall Study|Serious Adverse Event|0|||
126431833|NCT00506350|454877737|FG005|Overall Study|Serious Adverse Event|0|||
126431834|NCT00506350|454877738|FG006|Overall Study|Serious Adverse Event|0|||
126431835|NCT00506350|454877739|FG007|Overall Study|Serious Adverse Event|0|||
126431836|NCT00506350|454877740|FG008|Overall Study|Serious Adverse Event|0|||
126431837|NCT00506350|454877732|FG000|Overall Study|Adverse Event|0|||
126431838|NCT00506350|454877733|FG001|Overall Study|Adverse Event|0|||
126431839|NCT00506350|454877734|FG002|Overall Study|Adverse Event|0|||
126431840|NCT00506350|454877735|FG003|Overall Study|Adverse Event|0|||
126431841|NCT00506350|454877736|FG004|Overall Study|Adverse Event|0|||
126431842|NCT00506350|454877737|FG005|Overall Study|Adverse Event|0|||
126431843|NCT00506350|454877738|FG006|Overall Study|Adverse Event|0|||
126431844|NCT00506350|454877739|FG007|Overall Study|Adverse Event|1|||
126431845|NCT00506350|454877740|FG008|Overall Study|Adverse Event|1|||
126431846|NCT00506350|454877732|FG000|Overall Study|Protocol Violation|0|||
126431847|NCT00506350|454877733|FG001|Overall Study|Protocol Violation|0|||
126431848|NCT00506350|454877734|FG002|Overall Study|Protocol Violation|1|||
126431849|NCT00506350|454877735|FG003|Overall Study|Protocol Violation|0|||
126431850|NCT00506350|454877736|FG004|Overall Study|Protocol Violation|0|||
126679816|NCT01225731|455784546|FG008|Part 2|Protocol Violation|1|||
126431851|NCT00506350|454877737|FG005|Overall Study|Protocol Violation|0|||
126431852|NCT00506350|454877738|FG006|Overall Study|Protocol Violation|1|||
126431853|NCT00506350|454877739|FG007|Overall Study|Protocol Violation|0|||
126431854|NCT00506350|454877740|FG008|Overall Study|Protocol Violation|0|||
126431855|NCT00506350|454877732|FG000|Overall Study|Withdrawal by Subject|0|||
126431856|NCT00506350|454877733|FG001|Overall Study|Withdrawal by Subject|1|||
126431857|NCT00506350|454877734|FG002|Overall Study|Withdrawal by Subject|1|||
126679817|NCT01225731|455784547|FG009|Part 2|Protocol Violation|0|||
126679818|NCT01225731|455784548|FG010|Part 2|Protocol Violation|0|||
126679819|NCT01225731|455784549|FG011|Part 2|Protocol Violation|0|||
126679820|NCT01225731|455784550|FG012|Part 2|Protocol Violation|0|||
126679821|NCT01225731|455784538|FG000|Part 2|Adverse Event|0|||
126679822|NCT01225731|455784539|FG001|Part 2|Adverse Event|0|||
126679823|NCT01225731|455784540|FG002|Part 2|Adverse Event|0|||
126679824|NCT01225731|455784541|FG003|Part 2|Adverse Event|0|||
126679825|NCT01225731|455784542|FG004|Part 2|Adverse Event|0|||
126679826|NCT01225731|455784543|FG005|Part 2|Adverse Event|0|||
126679827|NCT01225731|455784544|FG006|Part 2|Adverse Event|4|||
126679828|NCT01225731|455784545|FG007|Part 2|Adverse Event|4|||
126345676|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
126345677|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
126345678|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
126345679|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
126345680|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
126345681|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
126345682|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
126345683|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Depression|0|||
126345684|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Depression|1|||
126345685|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Depression|0|||
126345686|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
126345687|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
126345688|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
126345689|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Jailed|0|||
126345690|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Jailed|1|||
126345691|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Jailed|0|||
126345692|NCT00090103|454560161|FG000|16-Week Safety Follow-up Period|Other|0|||
126345693|NCT00090103|454560162|FG001|16-Week Safety Follow-up Period|Other|1|||
126345694|NCT00090103|454560163|FG002|16-Week Safety Follow-up Period|Other|0|||
126345695|NCT04476043|454560168|FG000|Overall Study|Withdrawal by Subject|1|||
126345696|NCT04476043|454560169|FG001|Overall Study|Withdrawal by Subject|3|||
126345697|NCT04476043|454560170|FG002|Overall Study|Withdrawal by Subject|4|||
126345698|NCT04476043|454560171|FG003|Overall Study|Withdrawal by Subject|1|||
126345699|NCT04476043|454560168|FG000|Overall Study|Lost to Follow-up|1|||
126345700|NCT04476043|454560169|FG001|Overall Study|Lost to Follow-up|1|||
126345701|NCT04476043|454560170|FG002|Overall Study|Lost to Follow-up|2|||
126345702|NCT04476043|454560171|FG003|Overall Study|Lost to Follow-up|1|||
126345703|NCT04476043|454560168|FG000|Overall Study|Adverse Event|2|||
126345704|NCT04476043|454560169|FG001|Overall Study|Adverse Event|0|||
126345705|NCT04476043|454560170|FG002|Overall Study|Adverse Event|1|||
126345706|NCT04476043|454560171|FG003|Overall Study|Adverse Event|0|||
126345707|NCT04476043|454560168|FG000|Overall Study|Protocol Violation|0|||
126345708|NCT04476043|454560169|FG001|Overall Study|Protocol Violation|1|||
126345709|NCT04476043|454560170|FG002|Overall Study|Protocol Violation|0|||
126345710|NCT04476043|454560171|FG003|Overall Study|Protocol Violation|0|||
126345711|NCT02471183|454560174|FG000|Main Treatment Period|Adverse Event|1|||
126345712|NCT02471183|454560174|FG000|Main Treatment Period|Withdrawal by Subject|1|||
126345713|NCT02471183|454560174|FG000|Extended Treatment Period|Lack of Efficacy|1|||
126345714|NCT00141921|454560176|FG000|Overall Study|Remain on Study|28|||
126345715|NCT00141921|454560176|FG000|Overall Study|Withdrawal by Subject|42|||
126345716|NCT00141921|454560176|FG000|Overall Study|Lost to Follow-up|19|||
126345717|NCT00141921|454560176|FG000|Overall Study|Noncompliance|17|||
126345718|NCT00141921|454560176|FG000|Overall Study|Disease Progression|7|||
126345719|NCT00141921|454560176|FG000|Overall Study|Protocol Deviation|7|||
126345720|NCT00141921|454560176|FG000|Overall Study|Adverse Event|5|||
126345721|NCT00141921|454560176|FG000|Overall Study|Administrative Decision|2|||
126345722|NCT00141921|454560176|FG000|Overall Study|Pregnancy|4|||
126345723|NCT00141921|454560176|FG000|Overall Study|Ineligibility Determined|2|||
126345724|NCT00141921|454560176|FG000|Overall Study|Other|8|||
126345725|NCT02471339|454560178|FG000|Overall Study|Did not provide follow-up data|2|||
126345726|NCT02471339|454560179|FG001|Overall Study|Did not provide follow-up data|0|||
126345727|NCT00626639|454560181|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
126431858|NCT00506350|454877735|FG003|Overall Study|Withdrawal by Subject|1|||
126679829|NCT01225731|455784546|FG008|Part 2|Adverse Event|2|||
126679830|NCT01225731|455784547|FG009|Part 2|Adverse Event|0|||
126679831|NCT01225731|455784548|FG010|Part 2|Adverse Event|0|||
126679832|NCT01225731|455784549|FG011|Part 2|Adverse Event|0|||
126679833|NCT01225731|455784550|FG012|Part 2|Adverse Event|0|||
126679834|NCT01225731|455784538|FG000|Part 2|Lack of Efficacy|0|||
126679835|NCT01225731|455784539|FG001|Part 2|Lack of Efficacy|0|||
126679836|NCT01225731|455784540|FG002|Part 2|Lack of Efficacy|0|||
126345728|NCT00626639|454560182|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
126431859|NCT00506350|454877736|FG004|Overall Study|Withdrawal by Subject|4|||
126679837|NCT01225731|455784541|FG003|Part 2|Lack of Efficacy|0|||
126679838|NCT01225731|455784542|FG004|Part 2|Lack of Efficacy|0|||
126679839|NCT01225731|455784543|FG005|Part 2|Lack of Efficacy|1|||
126679840|NCT01225731|455784544|FG006|Part 2|Lack of Efficacy|0|||
126679841|NCT01225731|455784545|FG007|Part 2|Lack of Efficacy|12|||
126679842|NCT01225731|455784546|FG008|Part 2|Lack of Efficacy|3|||
126679843|NCT01225731|455784547|FG009|Part 2|Lack of Efficacy|0|||
126679844|NCT01225731|455784548|FG010|Part 2|Lack of Efficacy|0|||
126679845|NCT01225731|455784549|FG011|Part 2|Lack of Efficacy|0|||
126679846|NCT01225731|455784550|FG012|Part 2|Lack of Efficacy|0|||
126679847|NCT01225731|455784538|FG000|Part 2|Pregnancy|0|||
126679848|NCT01225731|455784539|FG001|Part 2|Pregnancy|0|||
126679849|NCT01225731|455784540|FG002|Part 2|Pregnancy|0|||
126679850|NCT01225731|455784541|FG003|Part 2|Pregnancy|0|||
126679851|NCT01225731|455784542|FG004|Part 2|Pregnancy|0|||
126679852|NCT01225731|455784543|FG005|Part 2|Pregnancy|0|||
126679853|NCT01225731|455784544|FG006|Part 2|Pregnancy|1|||
126679854|NCT01225731|455784545|FG007|Part 2|Pregnancy|0|||
126679855|NCT01225731|455784546|FG008|Part 2|Pregnancy|1|||
126679856|NCT01225731|455784547|FG009|Part 2|Pregnancy|0|||
126679857|NCT01225731|455784548|FG010|Part 2|Pregnancy|0|||
126679858|NCT01225731|455784549|FG011|Part 2|Pregnancy|0|||
126679859|NCT01225731|455784550|FG012|Part 2|Pregnancy|0|||
126679860|NCT01225731|455784538|FG000|Part 2|Lost to Follow-up|0|||
126679861|NCT01225731|455784539|FG001|Part 2|Lost to Follow-up|0|||
126679862|NCT01225731|455784540|FG002|Part 2|Lost to Follow-up|0|||
126679863|NCT01225731|455784541|FG003|Part 2|Lost to Follow-up|0|||
126679864|NCT01225731|455784542|FG004|Part 2|Lost to Follow-up|0|||
126679865|NCT01225731|455784543|FG005|Part 2|Lost to Follow-up|0|||
126679866|NCT01225731|455784544|FG006|Part 2|Lost to Follow-up|0|||
126679867|NCT01225731|455784545|FG007|Part 2|Lost to Follow-up|3|||
126679868|NCT01225731|455784546|FG008|Part 2|Lost to Follow-up|1|||
126679869|NCT01225731|455784547|FG009|Part 2|Lost to Follow-up|0|||
126679870|NCT01225731|455784548|FG010|Part 2|Lost to Follow-up|0|||
126679871|NCT01225731|455784549|FG011|Part 2|Lost to Follow-up|0|||
126679872|NCT01225731|455784550|FG012|Part 2|Lost to Follow-up|0|||
126679873|NCT01225731|455784538|FG000|Part 2|Physician Decision|0|||
126679874|NCT01225731|455784539|FG001|Part 2|Physician Decision|0|||
126679875|NCT01225731|455784540|FG002|Part 2|Physician Decision|0|||
126679876|NCT01225731|455784541|FG003|Part 2|Physician Decision|0|||
126679877|NCT01225731|455784542|FG004|Part 2|Physician Decision|0|||
126679878|NCT01225731|455784543|FG005|Part 2|Physician Decision|0|||
126679879|NCT01225731|455784544|FG006|Part 2|Physician Decision|0|||
126679880|NCT01225731|455784545|FG007|Part 2|Physician Decision|2|||
126679881|NCT01225731|455784546|FG008|Part 2|Physician Decision|2|||
126679882|NCT01225731|455784547|FG009|Part 2|Physician Decision|0|||
126679883|NCT01225731|455784548|FG010|Part 2|Physician Decision|0|||
126679884|NCT01225731|455784549|FG011|Part 2|Physician Decision|0|||
126679885|NCT01225731|455784550|FG012|Part 2|Physician Decision|0|||
126679886|NCT01225731|455784538|FG000|Part 2|Withdrawal by Subject|0|||
126679887|NCT01225731|455784539|FG001|Part 2|Withdrawal by Subject|0|||
126679888|NCT01225731|455784540|FG002|Part 2|Withdrawal by Subject|0|||
126679889|NCT01225731|455784541|FG003|Part 2|Withdrawal by Subject|0|||
126345729|NCT00827567|454560183|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
126345730|NCT01461551|454560184|FG000|Overall Study|Physician Decision|2|||
126345731|NCT01461551|454560185|FG001|Overall Study|Physician Decision|1|||
126345732|NCT01461551|454560186|FG002|Overall Study|Physician Decision|2|||
126345733|NCT01155141|454560187|FG000|Overall Study|Withdrawal by Subject|1|||
126345734|NCT01155141|454560187|FG000|Overall Study|Screen Failure|1|||
126345735|NCT00303186|454560188|FG000|Overall Study|Other|52|||
126345736|NCT03473197|454560189|FG000|Overall Study|Adverse Event|4|||
126345737|NCT03473197|454560189|FG000|Overall Study|Lost to Follow-up|1|||
126345738|NCT03473197|454560189|FG000|Overall Study|Withdrawal by Subject|5|||
126345739|NCT02326883|454560192|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
126345740|NCT02326883|454560193|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
126679890|NCT01225731|455784542|FG004|Part 2|Withdrawal by Subject|0|||
126679891|NCT01225731|455784543|FG005|Part 2|Withdrawal by Subject|1|||
126679892|NCT01225731|455784544|FG006|Part 2|Withdrawal by Subject|3|||
126679893|NCT01225731|455784545|FG007|Part 2|Withdrawal by Subject|4|||
126679894|NCT01225731|455784546|FG008|Part 2|Withdrawal by Subject|1|||
126679895|NCT01225731|455784547|FG009|Part 2|Withdrawal by Subject|0|||
126345741|NCT02326883|454560194|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
126679896|NCT01225731|455784548|FG010|Part 2|Withdrawal by Subject|0|||
126679897|NCT01225731|455784549|FG011|Part 2|Withdrawal by Subject|0|||
126679898|NCT01225731|455784550|FG012|Part 2|Withdrawal by Subject|0|||
126679899|NCT01225731|455784538|FG000|Part 3|Adverse Event|0|||
126679900|NCT01225731|455784539|FG001|Part 3|Adverse Event|0|||
126679901|NCT01225731|455784540|FG002|Part 3|Adverse Event|0|||
126679902|NCT01225731|455784541|FG003|Part 3|Adverse Event|0|||
126679903|NCT01225731|455784542|FG004|Part 3|Adverse Event|0|||
126679904|NCT01225731|455784543|FG005|Part 3|Adverse Event|0|||
126679905|NCT01225731|455784544|FG006|Part 3|Adverse Event|0|||
126679906|NCT01225731|455784545|FG007|Part 3|Adverse Event|0|||
126679907|NCT01225731|455784546|FG008|Part 3|Adverse Event|0|||
126679908|NCT01225731|455784547|FG009|Part 3|Adverse Event|0|||
126679909|NCT01225731|455784548|FG010|Part 3|Adverse Event|1|||
126679910|NCT01225731|455784549|FG011|Part 3|Adverse Event|1|||
126431860|NCT00506350|454877737|FG005|Overall Study|Withdrawal by Subject|1|||
126431861|NCT00506350|454877738|FG006|Overall Study|Withdrawal by Subject|1|||
126431862|NCT00506350|454877739|FG007|Overall Study|Withdrawal by Subject|2|||
126431863|NCT00506350|454877740|FG008|Overall Study|Withdrawal by Subject|0|||
126431864|NCT00506350|454877732|FG000|Overall Study|Lost to Follow-up|1|||
126431865|NCT00506350|454877733|FG001|Overall Study|Lost to Follow-up|1|||
126431866|NCT00506350|454877734|FG002|Overall Study|Lost to Follow-up|1|||
126431867|NCT00506350|454877735|FG003|Overall Study|Lost to Follow-up|1|||
126431868|NCT00506350|454877736|FG004|Overall Study|Lost to Follow-up|2|||
126431869|NCT00506350|454877737|FG005|Overall Study|Lost to Follow-up|1|||
126431870|NCT00506350|454877738|FG006|Overall Study|Lost to Follow-up|0|||
126431871|NCT00506350|454877739|FG007|Overall Study|Lost to Follow-up|0|||
126431872|NCT00506350|454877740|FG008|Overall Study|Lost to Follow-up|2|||
126431873|NCT00506350|454877732|FG000|Overall Study|Medical Reason|0|||
126431874|NCT00506350|454877733|FG001|Overall Study|Medical Reason|0|||
126431875|NCT00506350|454877734|FG002|Overall Study|Medical Reason|0|||
126431876|NCT00506350|454877735|FG003|Overall Study|Medical Reason|0|||
126679911|NCT01225731|455784550|FG012|Part 3|Adverse Event|0|||
126679912|NCT01225731|455784538|FG000|Part 3|Lost to Follow-up|0|||
126679913|NCT01225731|455784539|FG001|Part 3|Lost to Follow-up|0|||
126679914|NCT01225731|455784540|FG002|Part 3|Lost to Follow-up|0|||
126679915|NCT01225731|455784541|FG003|Part 3|Lost to Follow-up|0|||
126679916|NCT01225731|455784542|FG004|Part 3|Lost to Follow-up|0|||
126679917|NCT01225731|455784543|FG005|Part 3|Lost to Follow-up|0|||
126679918|NCT01225731|455784544|FG006|Part 3|Lost to Follow-up|0|||
126679919|NCT01225731|455784545|FG007|Part 3|Lost to Follow-up|0|||
126679920|NCT01225731|455784546|FG008|Part 3|Lost to Follow-up|0|||
126679921|NCT01225731|455784547|FG009|Part 3|Lost to Follow-up|0|||
126679922|NCT01225731|455784548|FG010|Part 3|Lost to Follow-up|1|||
126679923|NCT01225731|455784549|FG011|Part 3|Lost to Follow-up|2|||
126679924|NCT01225731|455784550|FG012|Part 3|Lost to Follow-up|1|||
126679925|NCT01225731|455784538|FG000|Part 3|Physician Decision|0|||
126679926|NCT01225731|455784539|FG001|Part 3|Physician Decision|0|||
126679927|NCT01225731|455784540|FG002|Part 3|Physician Decision|0|||
126679928|NCT01225731|455784541|FG003|Part 3|Physician Decision|0|||
126679929|NCT01225731|455784542|FG004|Part 3|Physician Decision|0|||
126431877|NCT00506350|454877736|FG004|Overall Study|Medical Reason|1|||
126431878|NCT00506350|454877737|FG005|Overall Study|Medical Reason|0|||
126679930|NCT01225731|455784543|FG005|Part 3|Physician Decision|0|||
126679931|NCT01225731|455784544|FG006|Part 3|Physician Decision|0|||
126679932|NCT01225731|455784545|FG007|Part 3|Physician Decision|0|||
126679933|NCT01225731|455784546|FG008|Part 3|Physician Decision|0|||
126679934|NCT01225731|455784547|FG009|Part 3|Physician Decision|0|||
126679935|NCT01225731|455784548|FG010|Part 3|Physician Decision|0|||
126679936|NCT01225731|455784549|FG011|Part 3|Physician Decision|1|||
126679937|NCT01225731|455784550|FG012|Part 3|Physician Decision|2|||
126679938|NCT01225731|455784538|FG000|Part 3|Withdrawal by Subject|0|||
126679939|NCT01225731|455784539|FG001|Part 3|Withdrawal by Subject|0|||
126679940|NCT01225731|455784540|FG002|Part 3|Withdrawal by Subject|0|||
126431879|NCT00506350|454877738|FG006|Overall Study|Medical Reason|0|||
126431880|NCT00506350|454877739|FG007|Overall Study|Medical Reason|0|||
126431881|NCT00506350|454877740|FG008|Overall Study|Medical Reason|0|||
126431882|NCT00506350|454877732|FG000|Overall Study|Other|1|||
126431883|NCT00506350|454877733|FG001|Overall Study|Other|1|||
126431884|NCT00506350|454877734|FG002|Overall Study|Other|3|||
126431885|NCT00506350|454877735|FG003|Overall Study|Other|0|||
126431886|NCT00506350|454877736|FG004|Overall Study|Other|3|||
126431887|NCT00506350|454877737|FG005|Overall Study|Other|0|||
126431888|NCT00506350|454877738|FG006|Overall Study|Other|0|||
126431889|NCT00506350|454877739|FG007|Overall Study|Other|2|||
126431890|NCT00506350|454877740|FG008|Overall Study|Other|2|||
126679941|NCT01225731|455784541|FG003|Part 3|Withdrawal by Subject|0|||
126679942|NCT01225731|455784542|FG004|Part 3|Withdrawal by Subject|0|||
126679943|NCT01225731|455784543|FG005|Part 3|Withdrawal by Subject|0|||
126679944|NCT01225731|455784544|FG006|Part 3|Withdrawal by Subject|0|||
126431891|NCT01691794|454877741|FG000|Overall Study|Poor/Non-Compliance|1|||
126679945|NCT01225731|455784545|FG007|Part 3|Withdrawal by Subject|0|||
126679946|NCT01225731|455784546|FG008|Part 3|Withdrawal by Subject|0|||
126679947|NCT01225731|455784547|FG009|Part 3|Withdrawal by Subject|0|||
126679948|NCT01225731|455784548|FG010|Part 3|Withdrawal by Subject|4|||
126679949|NCT01225731|455784549|FG011|Part 3|Withdrawal by Subject|6|||
126679950|NCT01225731|455784550|FG012|Part 3|Withdrawal by Subject|4|||
126679951|NCT00577642|455784551|FG000|Overall Study|Clinical Disease Progression|1|||
126679952|NCT01505634|455784556|FG000|Overall Study|Withdrawal by Subject|2|||
126431892|NCT01691794|454877742|FG001|Overall Study|Poor/Non-Compliance|4|||
126679953|NCT01505634|455784557|FG001|Overall Study|Withdrawal by Subject|5|||
126431893|NCT01691794|454877743|FG002|Overall Study|Poor/Non-Compliance|1|||
126431894|NCT01691794|454877741|FG000|Overall Study|Death|0|||
126758658|NCT00134563|456066674|FG001|Overall Study|Protocol Violation|2|||
126431895|NCT01691794|454877742|FG001|Overall Study|Death|0|||
126431896|NCT01691794|454877743|FG002|Overall Study|Death|1|||
126679954|NCT01505634|455784558|FG002|Overall Study|Withdrawal by Subject|1|||
126679955|NCT01505634|455784556|FG000|Overall Study|Physician Decision|1|||
126679956|NCT01505634|455784557|FG001|Overall Study|Physician Decision|1|||
126679957|NCT01505634|455784558|FG002|Overall Study|Physician Decision|0|||
126679958|NCT01505634|455784556|FG000|Overall Study|Adverse Event|1|||
126679959|NCT01505634|455784557|FG001|Overall Study|Adverse Event|0|||
126679960|NCT01505634|455784558|FG002|Overall Study|Adverse Event|0|||
126679961|NCT01505634|455784556|FG000|Overall Study|Insufficient supply of drug at site|1|||
126679962|NCT01505634|455784557|FG001|Overall Study|Insufficient supply of drug at site|0|||
126679963|NCT01505634|455784558|FG002|Overall Study|Insufficient supply of drug at site|0|||
126679964|NCT01505634|455784556|FG000|Overall Study|Protocol Violation|2|||
126679965|NCT01505634|455784557|FG001|Overall Study|Protocol Violation|0|||
126679966|NCT01505634|455784558|FG002|Overall Study|Protocol Violation|0|||
126679967|NCT01505634|455784556|FG000|Overall Study|Lost to Follow-up|1|||
126679968|NCT01505634|455784557|FG001|Overall Study|Lost to Follow-up|4|||
126679969|NCT01505634|455784558|FG002|Overall Study|Lost to Follow-up|4|||
126679970|NCT01505634|455784556|FG000|Overall Study|Death|1|||
126679971|NCT01505634|455784557|FG001|Overall Study|Death|0|||
126679972|NCT01505634|455784558|FG002|Overall Study|Death|0|||
126679973|NCT01505634|455784556|FG000|Overall Study|In a conflict zone|0|||
126679974|NCT01505634|455784557|FG001|Overall Study|In a conflict zone|0|||
126345742|NCT02736617|454560195|FG000|Treatment|Adverse Event|1|||
126345743|NCT02736617|454560195|FG000|Treatment|Lack of Efficacy|1|||
126345744|NCT02736617|454560195|FG000|Treatment|Withdrawal by Subject|1|||
126345745|NCT02736617|454560195|FG000|Maintenance|Lack of Efficacy|4|||
126345746|NCT02736617|454560195|FG000|Maintenance|Physician Decision|1|||
126345747|NCT02911116|454560198|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126345748|NCT02911116|454560199|FG001|Overall Study|Insufficient Therapeutic Response|0|||
126345749|NCT02911116|454560198|FG000|Overall Study|Lost to Follow-up|0|||
126345750|NCT02911116|454560199|FG001|Overall Study|Lost to Follow-up|1|||
126345751|NCT04796415|454560200|FG000|Overall Study|not interested|12|||
126345752|NCT04796415|454560200|FG000|Overall Study|health issue|8|||
126345753|NCT04796415|454560200|FG000|Overall Study|Other|4|||
126345754|NCT04796415|454560200|FG000|Overall Study|discharged from home health service|3|||
126345755|NCT04796415|454560200|FG000|Overall Study|re-hospitalization|2|||
126345756|NCT04796415|454560200|FG000|Overall Study|moving to nursing home|1|||
126345757|NCT04796415|454560200|FG000|Overall Study|lost contact|1|||
126345758|NCT02469857|454560201|FG000|Overall Study|Death|24|||
126345759|NCT02469857|454560202|FG001|Overall Study|Death|29|||
126345760|NCT02469857|454560201|FG000|Overall Study|Discontinuation|1|||
126345761|NCT02469857|454560202|FG001|Overall Study|Discontinuation|3|||
126345762|NCT02110693|454560203|FG000|Overall Study|Withdrawal by Subject|6|||
126345763|NCT02110693|454560204|FG001|Overall Study|Withdrawal by Subject|7|||
126345764|NCT02110693|454560203|FG000|Overall Study|skipped assessment|15|||
126345765|NCT02110693|454560204|FG001|Overall Study|skipped assessment|18|||
126345766|NCT02110693|454560203|FG000|Overall Study|technical difficulties|6|||
126345767|NCT02110693|454560204|FG001|Overall Study|technical difficulties|4|||
126345768|NCT02110693|454560203|FG000|Overall Study|Other|1|||
126345769|NCT02110693|454560204|FG001|Overall Study|Other|0|||
126345770|NCT04810962|454560205|FG000|Overall Study|Adverse Event|0|||
126345771|NCT04810962|454560206|FG001|Overall Study|Adverse Event|1|||
126345772|NCT04810962|454560205|FG000|Overall Study|Lost to Follow-up|2|||
126345773|NCT04810962|454560206|FG001|Overall Study|Lost to Follow-up|1|||
126345774|NCT04810962|454560205|FG000|Overall Study|Physician Decision|1|||
126345775|NCT04810962|454560206|FG001|Overall Study|Physician Decision|0|||
126345776|NCT04810962|454560205|FG000|Overall Study|Withdrawal by Subject|1|||
126345777|NCT04810962|454560206|FG001|Overall Study|Withdrawal by Subject|3|||
126345778|NCT04810962|454560205|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
126345779|NCT04810962|454560206|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
126345780|NCT00630292|454560210|FG000|Overall Study|Withdrawal by Subject|1|||
126345781|NCT00142415|454560211|FG000|Overall Study|Physician Decision|0|||
126345782|NCT00142415|454560212|FG001|Overall Study|Physician Decision|0|||
126345783|NCT00142415|454560213|FG002|Overall Study|Physician Decision|0|||
126345784|NCT00142415|454560214|FG003|Overall Study|Physician Decision|0|||
126345785|NCT00142415|454560215|FG004|Overall Study|Physician Decision|1|||
126345786|NCT00142415|454560216|FG005|Overall Study|Physician Decision|2|||
126345787|NCT01189266|454560217|FG000|Overall Study|Adverse Event|1|||
126345788|NCT01189266|454560218|FG001|Overall Study|Adverse Event|0|||
126345789|NCT01189266|454560219|FG002|Overall Study|Adverse Event|5|||
126345790|NCT01189266|454560217|FG000|Overall Study|Death|0|||
126345791|NCT01189266|454560218|FG001|Overall Study|Death|0|||
126679975|NCT01505634|455784558|FG002|Overall Study|In a conflict zone|1|||
126679976|NCT02054897|455784559|FG000|Overall Study|Withdrawal by Subject|2|||
126679977|NCT02054897|455784560|FG001|Overall Study|Withdrawal by Subject|0|||
126345792|NCT01189266|454560219|FG002|Overall Study|Death|5|||
126345793|NCT01189266|454560217|FG000|Overall Study|Lack of Efficacy|4|||
126345794|NCT01189266|454560218|FG001|Overall Study|Lack of Efficacy|5|||
126345795|NCT01189266|454560219|FG002|Overall Study|Lack of Efficacy|44|||
126345796|NCT01189266|454560217|FG000|Overall Study|Physician Decision|0|||
126679978|NCT02054897|455784561|FG002|Overall Study|Withdrawal by Subject|2|||
126679979|NCT02054897|455784559|FG000|Overall Study|Missing follow-up information|3|||
126758659|NCT00134563|456066675|FG002|Overall Study|Protocol Violation|5|||
126679980|NCT02054897|455784560|FG001|Overall Study|Missing follow-up information|5|||
126679981|NCT02054897|455784561|FG002|Overall Study|Missing follow-up information|3|||
126679982|NCT02054897|455784559|FG000|Overall Study|Lost to Follow-up|4|||
126679983|NCT02054897|455784560|FG001|Overall Study|Lost to Follow-up|2|||
126679984|NCT02054897|455784561|FG002|Overall Study|Lost to Follow-up|7|||
126679985|NCT02054897|455784559|FG000|Overall Study|Randomized but not exposed|1|||
126679986|NCT02054897|455784560|FG001|Overall Study|Randomized but not exposed|0|||
126679987|NCT02054897|455784561|FG002|Overall Study|Randomized but not exposed|0|||
126679988|NCT00794157|455784562|FG000|Overall Study|Adverse Event|4|||
126679989|NCT00794157|455784563|FG001|Overall Study|Adverse Event|1|||
126679990|NCT00794157|455784564|FG002|Overall Study|Adverse Event|8|||
126679991|NCT00794157|455784562|FG000|Overall Study|Subject withdrew consent|2|||
126679992|NCT00794157|455784563|FG001|Overall Study|Subject withdrew consent|0|||
126679993|NCT00794157|455784564|FG002|Overall Study|Subject withdrew consent|3|||
126679994|NCT00794157|455784562|FG000|Overall Study|Lost to Follow-up|2|||
126679995|NCT00794157|455784563|FG001|Overall Study|Lost to Follow-up|0|||
126679996|NCT00794157|455784564|FG002|Overall Study|Lost to Follow-up|1|||
126679997|NCT00794157|455784562|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126679998|NCT00794157|455784563|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126679999|NCT00794157|455784564|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126680000|NCT00794157|455784562|FG000|Overall Study|Administrative problems|1|||
126680001|NCT00794157|455784563|FG001|Overall Study|Administrative problems|7|||
126680002|NCT00794157|455784564|FG002|Overall Study|Administrative problems|4|||
126680003|NCT00794157|455784562|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126680004|NCT00794157|455784563|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126680005|NCT00794157|455784564|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126680006|NCT00794157|455784562|FG000|Overall Study|Protocol deviation|0|||
126680007|NCT00794157|455784563|FG001|Overall Study|Protocol deviation|1|||
126680008|NCT00794157|455784564|FG002|Overall Study|Protocol deviation|1|||
126680009|NCT00677014|455784565|FG000|Overall Study|Lost to Follow-up|20|||
126680010|NCT00677014|455784566|FG001|Overall Study|Lost to Follow-up|12|||
126680011|NCT00677014|455784567|FG002|Overall Study|Lost to Follow-up|24|||
126680012|NCT00677014|455784565|FG000|Overall Study|Death|6|||
126680013|NCT00677014|455784566|FG001|Overall Study|Death|15|||
126680014|NCT00677014|455784567|FG002|Overall Study|Death|7|||
126345797|NCT01189266|454560218|FG001|Overall Study|Physician Decision|0|||
126345798|NCT01189266|454560219|FG002|Overall Study|Physician Decision|1|||
126345799|NCT01189266|454560217|FG000|Overall Study|Protocol Violation|0|||
126345800|NCT01189266|454560218|FG001|Overall Study|Protocol Violation|1|||
126680015|NCT00677014|455784565|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
126680016|NCT00677014|455784566|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
126680017|NCT00677014|455784567|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
126345801|NCT01189266|454560219|FG002|Overall Study|Protocol Violation|1|||
126345802|NCT01189266|454560217|FG000|Overall Study|Withdrawal by Subject|0|||
126345803|NCT01189266|454560218|FG001|Overall Study|Withdrawal by Subject|0|||
126345804|NCT01189266|454560219|FG002|Overall Study|Withdrawal by Subject|1|||
126345805|NCT01189266|454560217|FG000|Overall Study|Patient refuses further therapy|1|||
126345806|NCT01189266|454560218|FG001|Overall Study|Patient refuses further therapy|0|||
126345807|NCT01189266|454560219|FG002|Overall Study|Patient refuses further therapy|7|||
126345808|NCT01189266|454560217|FG000|Overall Study|No treatment|0|||
126345809|NCT01189266|454560218|FG001|Overall Study|No treatment|0|||
126345810|NCT01189266|454560219|FG002|Overall Study|No treatment|1|||
126345811|NCT03620162|454560220|FG000|Overall Study|Physician Decision|4|||
126345812|NCT03620162|454560221|FG001|Overall Study|Physician Decision|0|||
126345813|NCT03620162|454560222|FG002|Overall Study|Physician Decision|1|||
126345814|NCT03620162|454560223|FG003|Overall Study|Physician Decision|0|||
126345815|NCT03620162|454560224|FG004|Overall Study|Physician Decision|2|||
126345816|NCT03620162|454560220|FG000|Overall Study|Lost to Follow-up|2|||
126345817|NCT03620162|454560221|FG001|Overall Study|Lost to Follow-up|6|||
126345818|NCT03620162|454560222|FG002|Overall Study|Lost to Follow-up|7|||
126345819|NCT03620162|454560223|FG003|Overall Study|Lost to Follow-up|3|||
126680018|NCT02374099|455784568|FG000|Overall Study|Adverse Event|1|||
126680019|NCT02374099|455784569|FG001|Overall Study|Adverse Event|0|||
126345820|NCT03620162|454560224|FG004|Overall Study|Lost to Follow-up|2|||
126680020|NCT02374099|455784568|FG000|Overall Study|Progressive Disease|35|||
126680021|NCT02374099|455784569|FG001|Overall Study|Progressive Disease|40|||
126680022|NCT02374099|455784568|FG000|Overall Study|Withdrawal by Subject|5|||
126680023|NCT02374099|455784569|FG001|Overall Study|Withdrawal by Subject|1|||
126680024|NCT02374099|455784568|FG000|Overall Study|Miscellaneous|2|||
126680025|NCT02374099|455784569|FG001|Overall Study|Miscellaneous|3|||
126680026|NCT02374099|455784568|FG000|Overall Study|Randomized, but not treated|2|||
126680027|NCT02374099|455784569|FG001|Overall Study|Randomized, but not treated|1|||
126680028|NCT02374099|455784568|FG000|Overall Study|Study Terminated by Sponsor|3|||
126680029|NCT02374099|455784569|FG001|Overall Study|Study Terminated by Sponsor|4|||
126345821|NCT03620162|454560220|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
126680030|NCT01033825|455784570|FG000|Overall Study|Withdrawal by Subject|2|||
126680031|NCT01033825|455784571|FG001|Overall Study|Withdrawal by Subject|3|||
126680032|NCT01033825|455784572|FG002|Overall Study|Withdrawal by Subject|2|||
126680033|NCT01033825|455784573|FG003|Overall Study|Withdrawal by Subject|1|||
126680034|NCT01033825|455784574|FG004|Overall Study|Withdrawal by Subject|1|||
126680035|NCT01033825|455784575|FG005|Overall Study|Withdrawal by Subject|0|||
126680036|NCT01033825|455784576|FG006|Overall Study|Withdrawal by Subject|0|||
126680037|NCT01033825|455784570|FG000|Overall Study|Adverse Event|0|||
126680038|NCT01033825|455784571|FG001|Overall Study|Adverse Event|0|||
126680039|NCT01033825|455784572|FG002|Overall Study|Adverse Event|0|||
126680040|NCT01033825|455784573|FG003|Overall Study|Adverse Event|1|||
126680041|NCT01033825|455784574|FG004|Overall Study|Adverse Event|0|||
126680042|NCT01033825|455784575|FG005|Overall Study|Adverse Event|0|||
126680043|NCT01033825|455784576|FG006|Overall Study|Adverse Event|0|||
126680044|NCT01033825|455784570|FG000|Overall Study|Protocol Violation|1|||
126680045|NCT01033825|455784571|FG001|Overall Study|Protocol Violation|0|||
126680046|NCT01033825|455784572|FG002|Overall Study|Protocol Violation|0|||
126680047|NCT01033825|455784573|FG003|Overall Study|Protocol Violation|0|||
126680048|NCT01033825|455784574|FG004|Overall Study|Protocol Violation|0|||
126680049|NCT01033825|455784575|FG005|Overall Study|Protocol Violation|0|||
126680050|NCT01033825|455784576|FG006|Overall Study|Protocol Violation|0|||
126680051|NCT01033825|455784570|FG000|Overall Study|Other|0|||
126680052|NCT01033825|455784571|FG001|Overall Study|Other|0|||
126680053|NCT01033825|455784572|FG002|Overall Study|Other|0|||
126680054|NCT01033825|455784573|FG003|Overall Study|Other|0|||
126680055|NCT01033825|455784574|FG004|Overall Study|Other|1|||
126680056|NCT01033825|455784575|FG005|Overall Study|Other|0|||
126680057|NCT01033825|455784576|FG006|Overall Study|Other|0|||
126680058|NCT01100437|455784577|FG000|Titration/Stabilization|Adverse Event|0|||
126680059|NCT01100437|455784578|FG001|Titration/Stabilization|Adverse Event|0|||
126680060|NCT01100437|455784579|FG002|Titration/Stabilization|Adverse Event|4|||
126680061|NCT01100437|455784577|FG000|Titration/Stabilization|Non-compliance|0|||
126680062|NCT01100437|455784578|FG001|Titration/Stabilization|Non-compliance|0|||
126680063|NCT01100437|455784579|FG002|Titration/Stabilization|Non-compliance|1|||
126680064|NCT01100437|455784577|FG000|Titration/Stabilization|Sponsor canceled study|0|||
126680065|NCT01100437|455784578|FG001|Titration/Stabilization|Sponsor canceled study|0|||
126680066|NCT01100437|455784579|FG002|Titration/Stabilization|Sponsor canceled study|1|||
126680067|NCT01100437|455784577|FG000|Maintenance|Withdrawal by Subject|0|||
126680068|NCT01100437|455784578|FG001|Maintenance|Withdrawal by Subject|0|||
126680069|NCT01100437|455784579|FG002|Maintenance|Withdrawal by Subject|1|||
126680070|NCT01100437|455784577|FG000|Maintenance|Sponsor termination of study|0|||
126680071|NCT01100437|455784578|FG001|Maintenance|Sponsor termination of study|0|||
126680072|NCT01100437|455784579|FG002|Maintenance|Sponsor termination of study|1|||
126680073|NCT00894556|455784582|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
126680074|NCT00894556|455784583|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
126680075|NCT00894556|455784584|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
126680076|NCT00894556|455784585|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
126680077|NCT00894556|455784582|FG000|Treatment Phase|Lost to Follow-up|2|||
126680078|NCT00894556|455784583|FG001|Treatment Phase|Lost to Follow-up|3|||
126680079|NCT00894556|455784584|FG002|Treatment Phase|Lost to Follow-up|1|||
126680080|NCT00894556|455784585|FG003|Treatment Phase|Lost to Follow-up|0|||
126680081|NCT00894556|455784582|FG000|Treatment Phase|Lack of Qualifying Event|2|||
126680082|NCT00894556|455784583|FG001|Treatment Phase|Lack of Qualifying Event|1|||
126680083|NCT00894556|455784584|FG002|Treatment Phase|Lack of Qualifying Event|0|||
126680084|NCT00894556|455784585|FG003|Treatment Phase|Lack of Qualifying Event|0|||
126680085|NCT03077685|455784588|FG000|Overall Study|Lost to Follow-up|0|||
126680086|NCT03077685|455784589|FG001|Overall Study|Lost to Follow-up|0|||
126345822|NCT03620162|454560221|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
126345823|NCT03620162|454560222|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
126345824|NCT03620162|454560223|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
126345825|NCT03620162|454560224|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
126345826|NCT01838876|454560227|FG000|Overall Study|Adverse Event|49|||
126345827|NCT01838876|454560227|FG000|Overall Study|Insufficient Therapeutic Response|10|||
126345828|NCT01838876|454560227|FG000|Overall Study|Protocol Violation|34|||
126345829|NCT01838876|454560227|FG000|Overall Study|Withdrawal of Consent|33|||
126680087|NCT03077685|455784590|FG002|Overall Study|Lost to Follow-up|0|||
126680088|NCT03077685|455784591|FG003|Overall Study|Lost to Follow-up|0|||
126680089|NCT03077685|455784592|FG004|Overall Study|Lost to Follow-up|1|||
126680090|NCT03077685|455784588|FG000|Overall Study|Death|0|||
126680091|NCT03077685|455784589|FG001|Overall Study|Death|0|||
126680092|NCT03077685|455784590|FG002|Overall Study|Death|1|||
126680093|NCT03077685|455784591|FG003|Overall Study|Death|1|||
126680094|NCT03077685|455784592|FG004|Overall Study|Death|3|||
126345830|NCT01838876|454560227|FG000|Overall Study|Lost to Follow-up|21|||
126680095|NCT03077685|455784588|FG000|Overall Study|Withdrawal by Subject|0|||
126680096|NCT03077685|455784589|FG001|Overall Study|Withdrawal by Subject|0|||
126680097|NCT03077685|455784590|FG002|Overall Study|Withdrawal by Subject|0|||
126680098|NCT03077685|455784591|FG003|Overall Study|Withdrawal by Subject|2|||
126680099|NCT03077685|455784592|FG004|Overall Study|Withdrawal by Subject|1|||
126680100|NCT03077685|455784588|FG000|Overall Study|Physician Decision|0|||
126680101|NCT03077685|455784589|FG001|Overall Study|Physician Decision|0|||
126680102|NCT03077685|455784590|FG002|Overall Study|Physician Decision|1|||
126680103|NCT03077685|455784591|FG003|Overall Study|Physician Decision|0|||
126680104|NCT03077685|455784592|FG004|Overall Study|Physician Decision|3|||
126680105|NCT03077685|455784588|FG000|Overall Study|Disease Progression|1|||
126680106|NCT03077685|455784589|FG001|Overall Study|Disease Progression|0|||
126680107|NCT03077685|455784590|FG002|Overall Study|Disease Progression|0|||
126680108|NCT03077685|455784591|FG003|Overall Study|Disease Progression|2|||
126680109|NCT03077685|455784592|FG004|Overall Study|Disease Progression|1|||
126680110|NCT03077685|455784588|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
126680111|NCT03077685|455784589|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
126680112|NCT03077685|455784590|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
126680113|NCT03077685|455784591|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
126680114|NCT03077685|455784592|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
126680115|NCT03077685|455784588|FG000|Overall Study|Subject entered hospice care|0|||
126680116|NCT03077685|455784589|FG001|Overall Study|Subject entered hospice care|0|||
126680117|NCT03077685|455784590|FG002|Overall Study|Subject entered hospice care|0|||
126680118|NCT03077685|455784591|FG003|Overall Study|Subject entered hospice care|0|||
126680119|NCT03077685|455784592|FG004|Overall Study|Subject entered hospice care|1|||
126680120|NCT03921424|455784593|FG000|Overall Study|Lost to Follow-up|0|||
126680121|NCT03921424|455784594|FG001|Overall Study|Lost to Follow-up|1|||
126680122|NCT03921424|455784593|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
126680123|NCT03921424|455784594|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
126680124|NCT02581202|455784604|FG000|Overall Study|Lack of Efficacy|2|||
126680125|NCT02581202|455784604|FG000|Overall Study|Withdrawal by Subject|4|||
126680126|NCT02581202|455784604|FG000|Overall Study|Lost to Follow-up|5|||
126680127|NCT02581202|455784604|FG000|Overall Study|Pregnancy|3|||
126680128|NCT01806779|455784614|FG000|Overall Study|Physician Decision|2|||
126680129|NCT01806779|455784615|FG001|Overall Study|Physician Decision|0|||
126680130|NCT01806779|455784616|FG002|Overall Study|Physician Decision|1|||
126680131|NCT01806779|455784614|FG000|Overall Study|Lack of Efficacy|1|||
126680132|NCT01806779|455784615|FG001|Overall Study|Lack of Efficacy|1|||
126680133|NCT01806779|455784616|FG002|Overall Study|Lack of Efficacy|0|||
126680134|NCT01806779|455784614|FG000|Overall Study|Lost to Follow-up|19|||
126680135|NCT01806779|455784615|FG001|Overall Study|Lost to Follow-up|20|||
126680136|NCT01806779|455784616|FG002|Overall Study|Lost to Follow-up|0|||
126680137|NCT01806779|455784614|FG000|Overall Study|Withdrawal by Subject|20|||
126680138|NCT01806779|455784615|FG001|Overall Study|Withdrawal by Subject|23|||
126680139|NCT01806779|455784616|FG002|Overall Study|Withdrawal by Subject|22|||
126680140|NCT02595450|455784619|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
126680141|NCT02595450|455784619|FG000|Overall Study|Enrolled, but not treated|8|||
126680142|NCT04294901|455784621|FG000|Overall Study|Death|86|||
126680143|NCT04294901|455784622|FG001|Overall Study|Death|110|||
126680144|NCT04294901|455784621|FG000|Overall Study|Provider did not have historical control patients|581|||
126680145|NCT04294901|455784622|FG001|Overall Study|Provider did not have historical control patients|0|||
126680146|NCT04294901|455784621|FG000|Overall Study|Provider did not have intervention patients|0|||
126680147|NCT04294901|455784622|FG001|Overall Study|Provider did not have intervention patients|98|||
126680148|NCT01934556|455784625|FG000|Overall Study|Withdrawal by Subject|0|||
126680149|NCT01934556|455784626|FG001|Overall Study|Withdrawal by Subject|1|||
126680150|NCT01934556|455784627|FG002|Overall Study|Withdrawal by Subject|1|||
126680151|NCT01934556|455784625|FG000|Overall Study|Lost to Follow-up|4|||
126680152|NCT01934556|455784626|FG001|Overall Study|Lost to Follow-up|10|||
126680153|NCT01934556|455784627|FG002|Overall Study|Lost to Follow-up|7|||
126680154|NCT01934556|455784625|FG000|Overall Study|Death|1|||
126680155|NCT01934556|455784626|FG001|Overall Study|Death|5|||
126680156|NCT01934556|455784627|FG002|Overall Study|Death|2|||
126680157|NCT03770260|455786120|FG000|Overall Study|Disease progression|0|||
126680158|NCT03770260|455786121|FG001|Overall Study|Disease progression|1|||
126345831|NCT01838876|454560227|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
126345832|NCT01838876|454560227|FG000|Overall Study|Reason not Specified|7|||
126680159|NCT03770260|455786122|FG002|Overall Study|Disease progression|0|||
126680160|NCT03770260|455786123|FG003|Overall Study|Disease progression|0|||
126680161|NCT00075400|455786124|FG000|Overall Study|Ineligible: wrong primary|1|||
126680162|NCT00075400|455786124|FG000|Overall Study|Never treated|2|||
126680163|NCT01395394|455786125|FG000|Baseline Study Visit|Protocol Violation|1|||
126680164|NCT01395394|455786126|FG001|Baseline Study Visit|Protocol Violation|0|||
126680165|NCT01395394|455786127|FG002|Baseline Study Visit|Protocol Violation|0|||
126680166|NCT02135692|455786128|FG000|Overall Study|Adverse Event|3|||
126345833|NCT01838876|454560227|FG000|Overall Study|Did not meet eligibility criteria|78|||
126345834|NCT02101294|454560228|FG000|Overall Study|Withdrawal by Subject|5|||
126345835|NCT02101294|454560228|FG000|Overall Study|Lost to Follow-up|6|||
126680167|NCT02135692|455786128|FG000|Overall Study|Lack of Efficacy|2|||
126680168|NCT02135692|455786128|FG000|Overall Study|Protocol Violation|2|||
126680169|NCT02135692|455786128|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
126680170|NCT02135692|455786128|FG000|Overall Study|Product commercially available|159|||
126680171|NCT02135692|455786128|FG000|Overall Study|Study closed/terminated|153|||
126680172|NCT02135692|455786128|FG000|Overall Study|Lost to Follow-up|4|||
126680173|NCT02135692|455786128|FG000|Overall Study|Withdrawal by Subject|15|||
126680174|NCT04429061|455786131|FG000|Overall Study|Lost to Follow-up|62|||
126680175|NCT04429061|455786132|FG001|Overall Study|Lost to Follow-up|87|||
126680176|NCT04429061|455786131|FG000|Overall Study|Withdrawal by Subject|3|||
126680177|NCT04429061|455786132|FG001|Overall Study|Withdrawal by Subject|4|||
126680178|NCT00879229|455786138|FG000|Overall Study|Study terminated by Sponsor|13|||
126680179|NCT00879229|455786139|FG001|Overall Study|Study terminated by Sponsor|12|||
126680180|NCT00879229|455786138|FG000|Overall Study|Death|4|||
126680181|NCT00879229|455786139|FG001|Overall Study|Death|2|||
126431897|NCT01691794|454877741|FG000|Overall Study|Lack of Efficacy|0|||
126431898|NCT01691794|454877742|FG001|Overall Study|Lack of Efficacy|7|||
126431899|NCT01691794|454877743|FG002|Overall Study|Lack of Efficacy|1|||
126431900|NCT01691794|454877741|FG000|Overall Study|Participant request to discontinue|0|||
126680182|NCT00879229|455786138|FG000|Overall Study|Adverse Event|2|||
126680183|NCT00879229|455786139|FG001|Overall Study|Adverse Event|0|||
126680184|NCT00879229|455786138|FG000|Overall Study|Withdrawal by Subject|1|||
126680185|NCT00879229|455786139|FG001|Overall Study|Withdrawal by Subject|0|||
126680186|NCT00879229|455786138|FG000|Overall Study|Clinical status did not improve|1|||
126680187|NCT00879229|455786139|FG001|Overall Study|Clinical status did not improve|0|||
126680188|NCT00879229|455786138|FG000|Overall Study|Other|1|||
126680189|NCT00879229|455786139|FG001|Overall Study|Other|0|||
126680190|NCT01097746|455786140|FG000|Overall Study|Adverse Event|4|||
126680191|NCT01097746|455786140|FG000|Overall Study|taken off study before any treatment given|1|||
126680192|NCT00631371|455786147|FG000|Overall Study|Lost to Follow-up|24|||
126680193|NCT00631371|455786148|FG001|Overall Study|Lost to Follow-up|19|||
126680194|NCT00631371|455786147|FG000|Overall Study|Other reason|5|||
126680195|NCT00631371|455786148|FG001|Overall Study|Other reason|12|||
126680196|NCT00631371|455786147|FG000|Overall Study|subject request|38|||
126680197|NCT00631371|455786148|FG001|Overall Study|subject request|45|||
126680198|NCT00631371|455786147|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
126680199|NCT00631371|455786148|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
126680200|NCT00631371|455786147|FG000|Overall Study|Death|263|||
126680201|NCT00631371|455786148|FG001|Overall Study|Death|239|||
126680202|NCT00390546|455786149|FG000|Overall Study|Renal impairment|1|||
126680203|NCT00390546|455786150|FG001|Overall Study|Renal impairment|0|||
126680204|NCT00390546|455786149|FG000|Overall Study|Physician Decision|5|||
126680205|NCT00390546|455786150|FG001|Overall Study|Physician Decision|5|||
126680206|NCT00812214|455786156|FG000|Overall Study|Lost to Follow-up|3|||
126680207|NCT00812214|455786157|FG001|Overall Study|Lost to Follow-up|1|||
126680208|NCT02145741|455786158|FG000|Overall Study|Progressive disease|3|||
126680209|NCT02145741|455786159|FG001|Overall Study|Progressive disease|6|||
126680210|NCT02145741|455786160|FG002|Overall Study|Progressive disease|6|||
126680211|NCT02145741|455786158|FG000|Overall Study|quality issue with the administered drug|3|||
126680212|NCT02145741|455786159|FG001|Overall Study|quality issue with the administered drug|0|||
126680213|NCT02145741|455786160|FG002|Overall Study|quality issue with the administered drug|0|||
126680214|NCT00129766|455786162|FG000|Overall Study|Death|3|||
126680215|NCT00129766|455786163|FG001|Overall Study|Death|8|||
126680216|NCT00129766|455786162|FG000|Overall Study|Withdrawal of consent|31|||
126680217|NCT00129766|455786163|FG001|Overall Study|Withdrawal of consent|30|||
126680218|NCT00129766|455786162|FG000|Overall Study|Lost to Follow-up|26|||
126680219|NCT00129766|455786163|FG001|Overall Study|Lost to Follow-up|21|||
126680220|NCT04091087|455786165|FG000|Overall Study|Not treated|1|||
126680221|NCT04091087|455786166|FG001|Overall Study|Not treated|0|||
126680222|NCT04091087|455786165|FG000|Overall Study|Adverse Event|4|||
126680223|NCT04091087|455786166|FG001|Overall Study|Adverse Event|4|||
126680224|NCT04091087|455786165|FG000|Overall Study|Protocol Violation|0|||
126680225|NCT04091087|455786166|FG001|Overall Study|Protocol Violation|1|||
126680226|NCT04091087|455786165|FG000|Overall Study|Withdrawal by Subject|5|||
126680227|NCT04091087|455786166|FG001|Overall Study|Withdrawal by Subject|2|||
126680228|NCT05440539|455786167|FG000|Overall Study|Lost to Follow-up|4|||
126680229|NCT05440539|455786168|FG001|Overall Study|Lost to Follow-up|4|||
126680230|NCT05440539|455786167|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
126680231|NCT05440539|455786168|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
126680232|NCT03808077|455786169|FG000|Overall Study|Physician Decision|2|||
126680233|NCT03808077|455786170|FG001|Overall Study|Physician Decision|3|||
126680234|NCT03808077|455786169|FG000|Overall Study|Withdrawal by Subject|1|||
126680235|NCT03808077|455786170|FG001|Overall Study|Withdrawal by Subject|0|||
126680236|NCT03808077|455786169|FG000|Overall Study|Equipment Issues|2|||
126680237|NCT03808077|455786170|FG001|Overall Study|Equipment Issues|1|||
126680238|NCT04152161|455786171|FG000|Overall Study|Death|0|||
126680239|NCT04152161|455786172|FG001|Overall Study|Death|1|||
126680240|NCT04152161|455786171|FG000|Overall Study|Physician Decision|0|||
126680241|NCT04152161|455786172|FG001|Overall Study|Physician Decision|1|||
126680242|NCT04152161|455786171|FG000|Overall Study|Lost to Follow-up|9|||
126680243|NCT04152161|455786172|FG001|Overall Study|Lost to Follow-up|3|||
126680244|NCT04152161|455786171|FG000|Overall Study|Protocol Violation|1|||
126431901|NCT01691794|454877742|FG001|Overall Study|Participant request to discontinue|1|||
126680245|NCT04152161|455786172|FG001|Overall Study|Protocol Violation|0|||
126680246|NCT04152161|455786171|FG000|Overall Study|Withdrawal by Subject|29|||
126345836|NCT03416179|454560229|FG000|Overall Study|Death|90|||
126345837|NCT03416179|454560230|FG001|Overall Study|Death|87|||
126680247|NCT04152161|455786172|FG001|Overall Study|Withdrawal by Subject|28|||
126680248|NCT04152161|455786171|FG000|Overall Study|Sponsor termination of study|750|||
126680249|NCT04152161|455786172|FG001|Overall Study|Sponsor termination of study|755|||
126680250|NCT04152161|455786171|FG000|Overall Study|Other|20|||
126680251|NCT04152161|455786172|FG001|Overall Study|Other|18|||
126680252|NCT03246958|455786173|FG000|Overall Study|Withdrawal by Subject|0|||
126680253|NCT03246958|455786174|FG001|Overall Study|Withdrawal by Subject|1|||
126680254|NCT03246958|455786175|FG002|Overall Study|Withdrawal by Subject|0|||
126680255|NCT03246958|455786176|FG003|Overall Study|Withdrawal by Subject|0|||
126680256|NCT03246958|455786177|FG004|Overall Study|Withdrawal by Subject|0|||
126680257|NCT03246958|455786178|FG005|Overall Study|Withdrawal by Subject|1|||
126680258|NCT03246958|455786179|FG006|Overall Study|Withdrawal by Subject|0|||
126680259|NCT03246958|455786173|FG000|Overall Study|Progression|13|||
126680260|NCT03246958|455786174|FG001|Overall Study|Progression|9|||
126680261|NCT03246958|455786175|FG002|Overall Study|Progression|3|||
126680262|NCT03246958|455786176|FG003|Overall Study|Progression|2|||
126680263|NCT03246958|455786177|FG004|Overall Study|Progression|1|||
126680264|NCT03246958|455786178|FG005|Overall Study|Progression|2|||
126680265|NCT03246958|455786179|FG006|Overall Study|Progression|1|||
126680266|NCT03246958|455786173|FG000|Overall Study|Adverse Event|2|||
126680267|NCT03246958|455786174|FG001|Overall Study|Adverse Event|2|||
126680268|NCT03246958|455786175|FG002|Overall Study|Adverse Event|0|||
126680269|NCT03246958|455786176|FG003|Overall Study|Adverse Event|1|||
126680270|NCT03246958|455786177|FG004|Overall Study|Adverse Event|1|||
126680271|NCT03246958|455786178|FG005|Overall Study|Adverse Event|0|||
126680272|NCT03246958|455786179|FG006|Overall Study|Adverse Event|2|||
126680273|NCT03246958|455786173|FG000|Overall Study|Death|0|||
126680274|NCT03246958|455786174|FG001|Overall Study|Death|1|||
126680275|NCT03246958|455786175|FG002|Overall Study|Death|0|||
126680276|NCT03246958|455786176|FG003|Overall Study|Death|0|||
126680277|NCT03246958|455786177|FG004|Overall Study|Death|0|||
126680278|NCT03246958|455786178|FG005|Overall Study|Death|0|||
126680279|NCT03246958|455786179|FG006|Overall Study|Death|0|||
126680280|NCT03246958|455786173|FG000|Overall Study|Physician Decision|0|||
126680281|NCT03246958|455786174|FG001|Overall Study|Physician Decision|0|||
126680282|NCT03246958|455786175|FG002|Overall Study|Physician Decision|0|||
126680283|NCT03246958|455786176|FG003|Overall Study|Physician Decision|1|||
126680284|NCT03246958|455786177|FG004|Overall Study|Physician Decision|0|||
126680285|NCT03246958|455786178|FG005|Overall Study|Physician Decision|0|||
126680286|NCT03246958|455786179|FG006|Overall Study|Physician Decision|0|||
126680287|NCT03246958|455786173|FG000|Overall Study|Never start treatment|1|||
126680288|NCT03246958|455786174|FG001|Overall Study|Never start treatment|0|||
126680289|NCT03246958|455786175|FG002|Overall Study|Never start treatment|0|||
126680290|NCT03246958|455786176|FG003|Overall Study|Never start treatment|0|||
126680291|NCT03246958|455786177|FG004|Overall Study|Never start treatment|0|||
126680292|NCT03246958|455786178|FG005|Overall Study|Never start treatment|0|||
126680293|NCT03246958|455786179|FG006|Overall Study|Never start treatment|0|||
126680294|NCT03246958|455786173|FG000|Overall Study|Over enrollment|0|||
126680295|NCT03246958|455786174|FG001|Overall Study|Over enrollment|2|||
126680296|NCT03246958|455786175|FG002|Overall Study|Over enrollment|0|||
126680297|NCT03246958|455786176|FG003|Overall Study|Over enrollment|0|||
126680298|NCT03246958|455786177|FG004|Overall Study|Over enrollment|0|||
126680299|NCT03246958|455786178|FG005|Overall Study|Over enrollment|0|||
126680300|NCT03246958|455786179|FG006|Overall Study|Over enrollment|0|||
126680301|NCT03703102|455786180|FG000|Overall Study|Adverse Event|4|||
126680302|NCT03703102|455786181|FG001|Overall Study|Adverse Event|3|||
126680303|NCT03703102|455786182|FG002|Overall Study|Adverse Event|7|||
126680304|NCT03703102|455786183|FG003|Overall Study|Adverse Event|3|||
126680305|NCT03703102|455786184|FG004|Overall Study|Adverse Event|13|||
126680306|NCT03703102|455786180|FG000|Overall Study|Lack of Efficacy|4|||
126680307|NCT03703102|455786181|FG001|Overall Study|Lack of Efficacy|0|||
126680308|NCT03703102|455786182|FG002|Overall Study|Lack of Efficacy|1|||
126680309|NCT03703102|455786183|FG003|Overall Study|Lack of Efficacy|4|||
126680310|NCT03703102|455786184|FG004|Overall Study|Lack of Efficacy|1|||
126680311|NCT03703102|455786180|FG000|Overall Study|Lost to Follow-up|0|||
126680312|NCT03703102|455786181|FG001|Overall Study|Lost to Follow-up|0|||
126680313|NCT03703102|455786182|FG002|Overall Study|Lost to Follow-up|1|||
126680314|NCT03703102|455786183|FG003|Overall Study|Lost to Follow-up|2|||
126345838|NCT03416179|454560231|FG002|Overall Study|Death|117|||
126345839|NCT03416179|454560232|FG003|Overall Study|Death|113|||
126345840|NCT03416179|454560229|FG000|Overall Study|Withdrawal by Subject|15|||
126680315|NCT03703102|455786184|FG004|Overall Study|Lost to Follow-up|2|||
126680316|NCT03703102|455786180|FG000|Overall Study|Physician Decision|2|||
126680317|NCT03703102|455786181|FG001|Overall Study|Physician Decision|2|||
126680318|NCT03703102|455786182|FG002|Overall Study|Physician Decision|2|||
126680319|NCT03703102|455786183|FG003|Overall Study|Physician Decision|2|||
126680320|NCT03703102|455786184|FG004|Overall Study|Physician Decision|4|||
126680321|NCT03703102|455786180|FG000|Overall Study|Withdrawal by Subject|7|||
126680322|NCT03703102|455786181|FG001|Overall Study|Withdrawal by Subject|5|||
126431902|NCT01691794|454877743|FG002|Overall Study|Participant request to discontinue|0|||
126431903|NCT01691794|454877741|FG000|Overall Study|Adverse Event|0|||
126431904|NCT01691794|454877742|FG001|Overall Study|Adverse Event|1|||
126431905|NCT01691794|454877743|FG002|Overall Study|Adverse Event|1|||
126431906|NCT01691794|454877741|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
126431907|NCT01691794|454877742|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
126431908|NCT01691794|454877743|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
126431909|NCT01691794|454877741|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
126431910|NCT01691794|454877742|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
126431911|NCT01691794|454877743|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
126431912|NCT04972786|454877744|FG000|First Intervention (1 Day)|Adverse Event|1|||
126431913|NCT04972786|454877745|FG001|First Intervention (1 Day)|Adverse Event|0|||
126431914|NCT00844844|454877746|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
126431915|NCT00844844|454877746|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
126431916|NCT00844844|454877746|FG000|Extension Treatment Period|Adverse Event|2|||
126431917|NCT00844844|454877746|FG000|Post Treatment Period|Withdrawal by Subject|1|||
126431918|NCT00668148|454877762|FG000|Overall Study|Adverse Event|5|||
126431919|NCT00668148|454877762|FG000|Overall Study|Subject Non-compliance|1|||
126431920|NCT00668148|454877762|FG000|Overall Study|Progressive Disease Before Treatment|2|||
126431921|NCT00668148|454877762|FG000|Overall Study|Withdrawal of Consent|2|||
126431922|NCT05472090|454877763|FG000|Overall Study|Adverse Event|2|||
126431923|NCT05472090|454877764|FG001|Overall Study|Adverse Event|3|||
126431924|NCT05472090|454877763|FG000|Overall Study|Lack of Efficacy|1|||
126431925|NCT05472090|454877764|FG001|Overall Study|Lack of Efficacy|0|||
126431926|NCT05472090|454877763|FG000|Overall Study|Physician Decision|1|||
126431927|NCT05472090|454877764|FG001|Overall Study|Physician Decision|0|||
126431928|NCT05472090|454877763|FG000|Overall Study|Withdrawal by Subject|2|||
126431929|NCT05472090|454877764|FG001|Overall Study|Withdrawal by Subject|0|||
126431930|NCT05472090|454877763|FG000|Overall Study|Lost to Follow-up|0|||
126431931|NCT05472090|454877764|FG001|Overall Study|Lost to Follow-up|3|||
126431932|NCT01350999|454877766|FG000|Overall Study|Adverse Event|4|||
126431933|NCT01350999|454877767|FG001|Overall Study|Adverse Event|9|||
126431934|NCT01350999|454877768|FG002|Overall Study|Adverse Event|10|||
126431935|NCT01350999|454877766|FG000|Overall Study|Voluntary withdrawal|3|||
126431936|NCT01350999|454877767|FG001|Overall Study|Voluntary withdrawal|4|||
126431937|NCT01350999|454877768|FG002|Overall Study|Voluntary withdrawal|6|||
126431938|NCT01350999|454877766|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
126431939|NCT01350999|454877767|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
126431940|NCT01350999|454877768|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
126431941|NCT00089297|454879860|FG000|Overall Study|Adverse Event|9|||
126431942|NCT00089297|454879860|FG000|Overall Study|Death|1|||
126431943|NCT00089297|454879860|FG000|Overall Study|Withdrawal by Subject|12|||
126431944|NCT00089297|454879860|FG000|Overall Study|Disease progression|2|||
126431945|NCT00089297|454879860|FG000|Overall Study|Ineligible|11|||
126431946|NCT00089297|454879860|FG000|Overall Study|Secondary malignancy|1|||
126431947|NCT00089297|454879860|FG000|Overall Study|IRB approval not ready|1|||
126431948|NCT00089297|454879860|FG000|Overall Study|Non-compliance|1|||
126431949|NCT02177695|454879865|FG000|ITT Analysis|Ineligible|5|||
126431950|NCT02177695|454879866|FG001|ITT Analysis|Ineligible|5|||
126431951|NCT02177695|454879865|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
126431952|NCT02177695|454879866|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
126431953|NCT02177695|454879865|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
126345841|NCT03416179|454560230|FG001|Overall Study|Withdrawal by Subject|20|||
126345842|NCT03416179|454560231|FG002|Overall Study|Withdrawal by Subject|6|||
126345843|NCT03416179|454560232|FG003|Overall Study|Withdrawal by Subject|9|||
126345844|NCT03416179|454560229|FG000|Overall Study|Lost to Follow-up|1|||
126345845|NCT03416179|454560230|FG001|Overall Study|Lost to Follow-up|1|||
126345846|NCT03416179|454560231|FG002|Overall Study|Lost to Follow-up|0|||
126345847|NCT03416179|454560232|FG003|Overall Study|Lost to Follow-up|3|||
126345848|NCT03416179|454560229|FG000|Overall Study|Study participation terminated by Sponsor|93|||
126345849|NCT03416179|454560230|FG001|Overall Study|Study participation terminated by Sponsor|91|||
126345850|NCT03416179|454560231|FG002|Overall Study|Study participation terminated by Sponsor|26|||
126345851|NCT03416179|454560232|FG003|Overall Study|Study participation terminated by Sponsor|31|||
126345852|NCT03416179|454560229|FG000|Overall Study|Other|2|||
126345853|NCT03416179|454560230|FG001|Overall Study|Other|3|||
126345854|NCT03416179|454560231|FG002|Overall Study|Other|1|||
126345855|NCT03416179|454560232|FG003|Overall Study|Other|0|||
126345856|NCT01682031|454560235|FG000|Overall Study|Withdrawal by Subject|0|||
126345857|NCT01682031|454560236|FG001|Overall Study|Withdrawal by Subject|1|||
126345858|NCT01682031|454560235|FG000|Overall Study|Adverse Event|0|||
126345859|NCT01682031|454560236|FG001|Overall Study|Adverse Event|2|||
126345860|NCT01682031|454560235|FG000|Overall Study|MRI results indicate increased nodul|0|||
126345861|NCT01682031|454560236|FG001|Overall Study|MRI results indicate increased nodul|1|||
126345862|NCT01682031|454560235|FG000|Overall Study|Patient could not swallow tablets|1|||
126345863|NCT01682031|454560236|FG001|Overall Study|Patient could not swallow tablets|0|||
126345864|NCT01682031|454560235|FG000|Overall Study|Patient stopped selenium on his own|0|||
126345865|NCT01682031|454560236|FG001|Overall Study|Patient stopped selenium on his own|1|||
126345866|NCT01056536|454560240|FG000|Overall Study|Lost to Follow-up|202|||
126345867|NCT01056536|454560241|FG001|Overall Study|Lost to Follow-up|116|||
126345868|NCT01056536|454560242|FG002|Overall Study|Lost to Follow-up|248|||
126345869|NCT00924898|454560243|FG000|Overall Study|Withdrawal by Subject|2|||
126345870|NCT03805841|454560244|FG000|Overall Study|Clinical Progression|2|||
126345871|NCT03805841|454560245|FG001|Overall Study|Clinical Progression|0|||
126345872|NCT03805841|454560246|FG002|Overall Study|Clinical Progression|0|||
126345873|NCT03805841|454560244|FG000|Overall Study|Death|0|||
126345874|NCT03805841|454560245|FG001|Overall Study|Death|3|||
126345875|NCT03805841|454560246|FG002|Overall Study|Death|1|||
126345876|NCT03805841|454560244|FG000|Overall Study|Lost to Follow-up|0|||
126345877|NCT03805841|454560245|FG001|Overall Study|Lost to Follow-up|0|||
126345878|NCT03805841|454560246|FG002|Overall Study|Lost to Follow-up|1|||
126345879|NCT03805841|454560244|FG000|Overall Study|Withdrawal by Subject|2|||
126345880|NCT03805841|454560245|FG001|Overall Study|Withdrawal by Subject|3|||
126345881|NCT03805841|454560246|FG002|Overall Study|Withdrawal by Subject|0|||
126345882|NCT03805841|454560244|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
126345883|NCT03805841|454560245|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
126345884|NCT03805841|454560246|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
126345885|NCT00846365|454560249|FG000|Overall Study|Adverse Event|20|||
126345886|NCT00846365|454560250|FG001|Overall Study|Adverse Event|30|||
126345887|NCT00846365|454560251|FG002|Overall Study|Adverse Event|11|||
126345888|NCT00846365|454560249|FG000|Overall Study|Protocol Violation|5|||
126345889|NCT00846365|454560250|FG001|Overall Study|Protocol Violation|4|||
126345890|NCT00846365|454560251|FG002|Overall Study|Protocol Violation|0|||
126345891|NCT00846365|454560249|FG000|Overall Study|Lost to Follow-up|8|||
126345892|NCT00846365|454560250|FG001|Overall Study|Lost to Follow-up|2|||
126345893|NCT00846365|454560251|FG002|Overall Study|Lost to Follow-up|5|||
126345894|NCT00846365|454560249|FG000|Overall Study|Withdrawal by Subject|11|||
126345895|NCT00846365|454560250|FG001|Overall Study|Withdrawal by Subject|11|||
126345896|NCT00846365|454560251|FG002|Overall Study|Withdrawal by Subject|9|||
126345897|NCT00846365|454560249|FG000|Overall Study|Pregnancy|1|||
126345898|NCT00846365|454560250|FG001|Overall Study|Pregnancy|0|||
126345899|NCT00846365|454560251|FG002|Overall Study|Pregnancy|0|||
126345900|NCT00846365|454560249|FG000|Overall Study|Lack of Efficacy|1|||
126345901|NCT00846365|454560250|FG001|Overall Study|Lack of Efficacy|1|||
126345902|NCT00846365|454560251|FG002|Overall Study|Lack of Efficacy|2|||
126345903|NCT00846365|454560249|FG000|Overall Study|Other|9|||
126345904|NCT00846365|454560250|FG001|Overall Study|Other|1|||
126345905|NCT00846365|454560251|FG002|Overall Study|Other|6|||
126345906|NCT01277861|454560255|FG000|Overall Study|Physician Decision|2|||
126345907|NCT01277861|454560256|FG001|Overall Study|Physician Decision|2|||
126345908|NCT00857389|454560257|FG000|Overall Study|Did not proceed to transplant|2|||
126345909|NCT01157845|454560258|FG000|Overall Study|Lost to Follow-up|5|||
126345910|NCT01157845|454560258|FG000|Overall Study|Withdrawal by Subject|12|||
126345911|NCT01157845|454560258|FG000|Overall Study|Physician Decision|3|||
126345912|NCT01157845|454560258|FG000|Overall Study|Protocol Violation|13|||
126345913|NCT01157845|454560258|FG000|Overall Study|Study was ended|1|||
126680323|NCT03703102|455786182|FG002|Overall Study|Withdrawal by Subject|5|||
126680324|NCT03703102|455786183|FG003|Overall Study|Withdrawal by Subject|5|||
126680325|NCT03703102|455786184|FG004|Overall Study|Withdrawal by Subject|9|||
126680326|NCT03703102|455786180|FG000|Overall Study|Ineligibility|0|||
126680327|NCT03703102|455786181|FG001|Overall Study|Ineligibility|0|||
126680328|NCT03703102|455786182|FG002|Overall Study|Ineligibility|1|||
126680329|NCT03703102|455786183|FG003|Overall Study|Ineligibility|0|||
126680330|NCT03703102|455786184|FG004|Overall Study|Ineligibility|0|||
126680331|NCT03703102|455786180|FG000|Overall Study|Protocol Deviation|4|||
126680332|NCT03703102|455786181|FG001|Overall Study|Protocol Deviation|4|||
126680333|NCT03703102|455786182|FG002|Overall Study|Protocol Deviation|3|||
126680334|NCT03703102|455786183|FG003|Overall Study|Protocol Deviation|0|||
126680335|NCT03703102|455786184|FG004|Overall Study|Protocol Deviation|0|||
126680336|NCT03703102|455786180|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126680337|NCT03703102|455786181|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126680338|NCT03703102|455786182|FG002|Overall Study|Non-Compliance with Study Drug|2|||
126680339|NCT03703102|455786183|FG003|Overall Study|Non-Compliance with Study Drug|1|||
126680340|NCT03703102|455786184|FG004|Overall Study|Non-Compliance with Study Drug|4|||
126680341|NCT01379274|455786185|FG000|Overall Study|funding withdrawn|1|||
126680342|NCT03363321|455786187|FG000|Overall Study|Withdrawal by Subject|0|||
126680343|NCT03363321|455786188|FG001|Overall Study|Withdrawal by Subject|1|||
126680344|NCT03363321|455786189|FG002|Overall Study|Withdrawal by Subject|0|||
126680345|NCT03363321|455786190|FG003|Overall Study|Withdrawal by Subject|1|||
126680346|NCT03363321|455786191|FG004|Overall Study|Withdrawal by Subject|0|||
126680347|NCT00631020|455786194|FG000|Overall Study|Lost to Follow-up|7|||
126680348|NCT00631020|455786194|FG000|Overall Study|Incarcerated|1|||
126680349|NCT03221751|455786198|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
126680350|NCT03221751|455786199|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
126680351|NCT03571646|455786200|FG000|Overall Study|Adverse Event|1|||
126680352|NCT03571646|455786201|FG001|Overall Study|Adverse Event|0|||
126680353|NCT03571646|455786200|FG000|Overall Study|Withdrawal by Subject|1|||
126680354|NCT03571646|455786201|FG001|Overall Study|Withdrawal by Subject|1|||
126680355|NCT03548935|455786202|FG000|Overall Study|Withdrawal by Subject|26|||
126680356|NCT03548935|455786203|FG001|Overall Study|Withdrawal by Subject|17|||
126680357|NCT03548935|455786202|FG000|Overall Study|Lost to Follow-up|39|||
126680358|NCT03548935|455786203|FG001|Overall Study|Lost to Follow-up|28|||
126680359|NCT03548935|455786202|FG000|Overall Study|Death|1|||
126680360|NCT03548935|455786203|FG001|Overall Study|Death|1|||
126680361|NCT00763815|455786204|FG000|Overall Study|Adverse Event|14|||
126345914|NCT01157845|454560258|FG000|Overall Study|Device malfunction|1|||
126345915|NCT03311555|454560259|FG000|Overall Study|Adverse Event|1|||
126345916|NCT03454555|454562228|FG000|Overall Study|Death|6|||
126345917|NCT03454555|454562229|FG001|Overall Study|Death|6|||
126345918|NCT03454555|454562228|FG000|Overall Study|Lost to Follow-up|31|||
126345919|NCT03454555|454562229|FG001|Overall Study|Lost to Follow-up|12|||
126345920|NCT03454555|454562228|FG000|Overall Study|Physician Decision|2|||
126345921|NCT03454555|454562229|FG001|Overall Study|Physician Decision|6|||
126345922|NCT03454555|454562228|FG000|Overall Study|Withdrawal by Subject|34|||
126345923|NCT03454555|454562229|FG001|Overall Study|Withdrawal by Subject|5|||
126345924|NCT03454555|454562228|FG000|Overall Study|Ineligible|1|||
126345925|NCT03454555|454562229|FG001|Overall Study|Ineligible|5|||
126345926|NCT05399680|454562230|FG000|Overall Study|Lost to Follow-up|1|||
126345927|NCT05399680|454562231|FG001|Overall Study|Lost to Follow-up|0|||
126345928|NCT05399680|454562230|FG000|Overall Study|Death|0|||
126345929|NCT05399680|454562231|FG001|Overall Study|Death|1|||
126345930|NCT04530630|454562232|FG000|Overall Study|Physician Decision|1|||
126345931|NCT03737994|454562235|FG000|Overall Study|Withdrawal by Subject|0|||
126345932|NCT03737994|454562236|FG001|Overall Study|Withdrawal by Subject|0|||
126345933|NCT03737994|454562237|FG002|Overall Study|Withdrawal by Subject|0|||
126345934|NCT03737994|454562238|FG003|Overall Study|Withdrawal by Subject|0|||
126345935|NCT03737994|454562239|FG004|Overall Study|Withdrawal by Subject|0|||
126345936|NCT03737994|454562240|FG005|Overall Study|Withdrawal by Subject|0|||
126345937|NCT03737994|454562241|FG006|Overall Study|Withdrawal by Subject|1|||
126345938|NCT01473134|454562242|FG000|Overall Study|Lost to Follow-up|21|||
126345939|NCT01473134|454562243|FG001|Overall Study|Lost to Follow-up|13|||
126345940|NCT01473134|454562242|FG000|Overall Study|Protocol Violation|32|||
126431954|NCT02177695|454879866|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
126680362|NCT00763815|455786205|FG001|Overall Study|Adverse Event|29|||
126680363|NCT00763815|455786204|FG000|Overall Study|Lack of Efficacy|10|||
126680364|NCT00763815|455786205|FG001|Overall Study|Lack of Efficacy|11|||
126680365|NCT00763815|455786204|FG000|Overall Study|Poor Compliance to Protocol|6|||
126680366|NCT00763815|455786205|FG001|Overall Study|Poor Compliance to Protocol|6|||
126680367|NCT00763815|455786204|FG000|Overall Study|Lost to Follow-up|2|||
126680368|NCT00763815|455786205|FG001|Overall Study|Lost to Follow-up|4|||
126680369|NCT00763815|455786204|FG000|Overall Study|Early Termination|1|||
126680370|NCT00763815|455786205|FG001|Overall Study|Early Termination|0|||
126345941|NCT01473134|454562243|FG001|Overall Study|Protocol Violation|19|||
126345942|NCT01473134|454562242|FG000|Overall Study|Withdrawal by Subject|1|||
126431955|NCT02177695|454879865|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
126431956|NCT02177695|454879866|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
126431957|NCT00419393|454879867|FG000|Overall Study|Adverse Event|5|||
126431958|NCT00419393|454879867|FG000|Overall Study|Protocol Violation|5|||
126431959|NCT00419393|454879867|FG000|Overall Study|Withdrawal by Subject|7|||
126431960|NCT00419393|454879867|FG000|Overall Study|Other: Sponsor request|3|||
126431961|NCT00419393|454879867|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
126431962|NCT00419393|454879867|FG000|Overall Study|Other: Site closure|1|||
126431963|NCT00419393|454879867|FG000|Overall Study|Other: Other health problems|1|||
126431964|NCT00419393|454879867|FG000|Overall Study|Other: Investigator decision|1|||
126431965|NCT00979901|454879868|FG000|Overall Study|Adverse Event|1|||
126431966|NCT00979901|454879869|FG001|Overall Study|Adverse Event|3|||
126431967|NCT00979901|454879870|FG002|Overall Study|Adverse Event|9|||
126431968|NCT00979901|454879871|FG003|Overall Study|Adverse Event|2|||
126431969|NCT00979901|454879868|FG000|Overall Study|Lack of Efficacy|8|||
126431970|NCT00979901|454879869|FG001|Overall Study|Lack of Efficacy|4|||
126431971|NCT00979901|454879870|FG002|Overall Study|Lack of Efficacy|9|||
126431972|NCT00979901|454879871|FG003|Overall Study|Lack of Efficacy|0|||
126431973|NCT00979901|454879868|FG000|Overall Study|Lost to Follow-up|1|||
126680371|NCT00763815|455786204|FG000|Overall Study|Familial and Personal Reasons|9|||
126680372|NCT00763815|455786205|FG001|Overall Study|Familial and Personal Reasons|16|||
126680373|NCT00763815|455786204|FG000|Overall Study|Physician Decision|1|||
126680374|NCT00763815|455786205|FG001|Overall Study|Physician Decision|0|||
126680375|NCT00763815|455786204|FG000|Overall Study|Withdrawal by Subject|7|||
126680376|NCT00763815|455786205|FG001|Overall Study|Withdrawal by Subject|12|||
126680377|NCT00763815|455786204|FG000|Overall Study|Protocol Violation|2|||
126680378|NCT00763815|455786205|FG001|Overall Study|Protocol Violation|5|||
126680379|NCT00763815|455786204|FG000|Overall Study|Sponsor's Decision|0|||
126680380|NCT00763815|455786205|FG001|Overall Study|Sponsor's Decision|1|||
126680381|NCT00283595|455786206|FG000|Overall Study|Withdrawal by Subject|1|||
126680382|NCT00283595|455786207|FG001|Overall Study|Withdrawal by Subject|2|||
126680383|NCT01263639|455786208|FG000|Overall Study|Lost to Follow-up|66|||
126680384|NCT01263639|455786209|FG001|Overall Study|Lost to Follow-up|70|||
126680385|NCT01263639|455786208|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
126680386|NCT01263639|455786209|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
126680387|NCT01576549|455786210|FG000|Overall Study|Sponsor Decision|2|||
126680388|NCT04951037|455786211|FG000|Overall Study|Lost to Follow-up|16|||
126680389|NCT04951037|455786211|FG000|Overall Study|Withdrawal by Subject|5|||
126680390|NCT04951037|455786211|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
126431974|NCT00979901|454879869|FG001|Overall Study|Lost to Follow-up|1|||
126431975|NCT00979901|454879870|FG002|Overall Study|Lost to Follow-up|2|||
126431976|NCT00979901|454879871|FG003|Overall Study|Lost to Follow-up|0|||
126431977|NCT00979901|454879868|FG000|Overall Study|Protocol Violation|2|||
126431978|NCT00979901|454879869|FG001|Overall Study|Protocol Violation|2|||
126431979|NCT00979901|454879870|FG002|Overall Study|Protocol Violation|7|||
126431980|NCT00979901|454879871|FG003|Overall Study|Protocol Violation|1|||
126431981|NCT00979901|454879868|FG000|Overall Study|Withdrawal by Subject|2|||
126431982|NCT00979901|454879869|FG001|Overall Study|Withdrawal by Subject|1|||
126431983|NCT00979901|454879870|FG002|Overall Study|Withdrawal by Subject|1|||
126431984|NCT00979901|454879871|FG003|Overall Study|Withdrawal by Subject|1|||
126431985|NCT00979901|454879868|FG000|Overall Study|Noncompliance|1|||
126431986|NCT00979901|454879869|FG001|Overall Study|Noncompliance|0|||
126431987|NCT00979901|454879870|FG002|Overall Study|Noncompliance|0|||
126431988|NCT00979901|454879871|FG003|Overall Study|Noncompliance|0|||
126431989|NCT00979901|454879868|FG000|Overall Study|out-of-state|1|||
126431990|NCT00979901|454879869|FG001|Overall Study|out-of-state|0|||
126431991|NCT00979901|454879870|FG002|Overall Study|out-of-state|0|||
126431992|NCT00979901|454879871|FG003|Overall Study|out-of-state|0|||
126431993|NCT00979901|454879868|FG000|Overall Study|vacation|1|||
126431994|NCT00979901|454879869|FG001|Overall Study|vacation|0|||
126680391|NCT02706873|455786212|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
126680392|NCT02706873|455786213|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
126431995|NCT00979901|454879870|FG002|Overall Study|vacation|0|||
126431996|NCT00979901|454879871|FG003|Overall Study|vacation|0|||
126431997|NCT00979901|454879868|FG000|Overall Study|elevated lab values pre-randomization|1|||
126431998|NCT00979901|454879869|FG001|Overall Study|elevated lab values pre-randomization|0|||
126431999|NCT00979901|454879870|FG002|Overall Study|elevated lab values pre-randomization|0|||
126432000|NCT00979901|454879871|FG003|Overall Study|elevated lab values pre-randomization|0|||
126432001|NCT00979901|454879868|FG000|Overall Study|Discontinued in Error|0|||
126680393|NCT02706873|455786214|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
126680394|NCT02706873|455786215|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
126680395|NCT02706873|455786212|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
126432002|NCT00979901|454879869|FG001|Overall Study|Discontinued in Error|1|||
126432003|NCT00979901|454879870|FG002|Overall Study|Discontinued in Error|0|||
126432004|NCT00979901|454879871|FG003|Overall Study|Discontinued in Error|0|||
126432005|NCT00979901|454879868|FG000|Overall Study|Left Country|0|||
126758660|NCT00134563|456066673|FG000|Overall Study|Lost to Follow-up|4|||
126345943|NCT01473134|454562243|FG001|Overall Study|Withdrawal by Subject|2|||
126345944|NCT01473134|454562242|FG000|Overall Study|Death|0|||
126345945|NCT01473134|454562243|FG001|Overall Study|Death|1|||
126345946|NCT01473134|454562242|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
126369375|NCT04380142|454648214|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
126680396|NCT02706873|455786213|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
126680397|NCT02706873|455786214|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
126680398|NCT02706873|455786215|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
126680399|NCT02706873|455786212|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
126680400|NCT02706873|455786213|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
126680401|NCT02706873|455786214|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
126680402|NCT02706873|455786215|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
126680403|NCT02706873|455786212|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
126680404|NCT02706873|455786213|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
126680405|NCT02706873|455786214|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
126680406|NCT02706873|455786215|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
126680407|NCT02706873|455786212|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
126680408|NCT02706873|455786213|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
126680409|NCT02706873|455786214|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
126680410|NCT02706873|455786215|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
126680411|NCT02706873|455786212|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
126680412|NCT02706873|455786213|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
126680413|NCT02706873|455786214|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
126680414|NCT02706873|455786215|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
126680415|NCT02706873|455786212|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
126680416|NCT02706873|455786213|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
126680417|NCT02706873|455786214|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
126680418|NCT02706873|455786215|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
126680419|NCT02706873|455786212|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
126680420|NCT02706873|455786213|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
126680421|NCT02706873|455786214|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
126680422|NCT02706873|455786215|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
126680423|NCT02706873|455786212|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
126680424|NCT02706873|455786213|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
126680425|NCT02706873|455786214|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
126680426|NCT02706873|455786215|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
126680427|NCT02706873|455786212|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
126680428|NCT02706873|455786213|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
126680429|NCT02706873|455786214|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
126680430|NCT02706873|455786215|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
126680431|NCT02706873|455786212|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
126680432|NCT02706873|455786213|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
126680433|NCT02706873|455786214|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
126680434|NCT02706873|455786215|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
126680435|NCT02706873|455786212|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
126680436|NCT02706873|455786213|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
126680437|NCT02706873|455786214|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
126345947|NCT01473134|454562243|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
126345948|NCT06217380|454562246|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
126345949|NCT06217380|454562246|FG000|Overall Study|Physician Decision|1|||
126345950|NCT06217380|454562246|FG000|Overall Study|Withdrawal by Subject|2|||
126345951|NCT06633965|454562247|FG000|Overall Study|Withdrawal by Subject|0|||
126345952|NCT06633965|454562248|FG001|Overall Study|Withdrawal by Subject|1|||
126345953|NCT00947544|454562251|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
126345954|NCT00947544|454562252|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
126345955|NCT01963611|454562260|FG000|Overall Study|Adverse Event|1|||
126345956|NCT01963611|454562261|FG001|Overall Study|Adverse Event|1|||
126345957|NCT01963611|454562262|FG002|Overall Study|Adverse Event|3|||
126345958|NCT01963611|454562263|FG003|Overall Study|Adverse Event|4|||
126345959|NCT01963611|454562264|FG004|Overall Study|Adverse Event|3|||
126345960|NCT01963611|454562260|FG000|Overall Study|Protocol Violation|0|||
126345961|NCT01963611|454562261|FG001|Overall Study|Protocol Violation|0|||
126345962|NCT01963611|454562262|FG002|Overall Study|Protocol Violation|0|||
126345963|NCT01963611|454562263|FG003|Overall Study|Protocol Violation|1|||
126345964|NCT01963611|454562264|FG004|Overall Study|Protocol Violation|0|||
126345965|NCT01963611|454562260|FG000|Overall Study|Lack of Efficacy|0|||
126345966|NCT01963611|454562261|FG001|Overall Study|Lack of Efficacy|0|||
126345967|NCT01963611|454562262|FG002|Overall Study|Lack of Efficacy|0|||
126345968|NCT01963611|454562263|FG003|Overall Study|Lack of Efficacy|1|||
126345969|NCT01963611|454562264|FG004|Overall Study|Lack of Efficacy|0|||
126345970|NCT01963611|454562260|FG000|Overall Study|Withdrawal by Subject|3|||
126680438|NCT02706873|455786215|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
126680439|NCT02706873|455786212|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
126680440|NCT02706873|455786213|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
126680441|NCT02706873|455786214|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
126680442|NCT02706873|455786215|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
126680443|NCT00586495|455786216|FG000|Treatment Period|Adverse Event|11|||
126680444|NCT00586495|455786216|FG000|Treatment Period|Death|1|||
126680445|NCT00586495|455786216|FG000|Treatment Period|Protocol Violation|1|||
126680446|NCT00586495|455786216|FG000|Treatment Period|Withdrawal by Subject|1|||
126680447|NCT00586495|455786216|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
126680448|NCT00586495|455786216|FG000|Treatment Period|Switch to commercial drug|10|||
126680449|NCT00586495|455786216|FG000|Follow-up|Death|40|||
126680450|NCT00586495|455786216|FG000|Follow-up|Lost to Follow-up|1|||
126680451|NCT00586495|455786216|FG000|Follow-up|Withdrawal by Subject|4|||
126680452|NCT00586495|455786216|FG000|Follow-up|Protocol driven decision point|37|||
126680453|NCT00586495|455786216|FG000|Follow-up|Switch to commercial drug|10|||
126680454|NCT02595723|455786217|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
126680455|NCT02595723|455786218|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
126680456|NCT02595723|455786219|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
126680457|NCT02595723|455786217|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
126680458|NCT02595723|455786218|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
126680459|NCT02595723|455786219|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
126680460|NCT00004259|455786220|FG000|Overall Study|Protocol Violation|1|||
126680461|NCT00004259|455786221|FG001|Overall Study|Protocol Violation|2|||
126680462|NCT00004259|455786222|FG002|Overall Study|Protocol Violation|0|||
126680463|NCT00004259|455786223|FG003|Overall Study|Protocol Violation|0|||
126680464|NCT00004259|455786220|FG000|Overall Study|Withdrawal by Subject|0|||
126680465|NCT00004259|455786221|FG001|Overall Study|Withdrawal by Subject|2|||
126680466|NCT00004259|455786222|FG002|Overall Study|Withdrawal by Subject|0|||
126680467|NCT00004259|455786223|FG003|Overall Study|Withdrawal by Subject|0|||
126680468|NCT00996944|455786224|FG000|Double-blind Treatment Period|Adverse Event|2|||
126680469|NCT00996944|455786225|FG001|Double-blind Treatment Period|Adverse Event|1|||
126680470|NCT00996944|455786224|FG000|Double-blind Treatment Period|Protocol Violation|1|||
126680471|NCT00996944|455786225|FG001|Double-blind Treatment Period|Protocol Violation|0|||
126680472|NCT00996944|455786224|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
126680473|NCT00996944|455786225|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
126680474|NCT00996944|455786224|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
126680475|NCT00996944|455786225|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
126680476|NCT00996944|455786224|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
126680477|NCT00996944|455786225|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
126680478|NCT00769184|455786226|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
126680479|NCT00769184|455786227|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
126680480|NCT00769184|455786226|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
126680481|NCT00769184|455786227|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
126758661|NCT00134563|456066674|FG001|Overall Study|Lost to Follow-up|0|||
126345971|NCT01963611|454562261|FG001|Overall Study|Withdrawal by Subject|2|||
126345972|NCT01963611|454562262|FG002|Overall Study|Withdrawal by Subject|1|||
126345973|NCT01963611|454562263|FG003|Overall Study|Withdrawal by Subject|1|||
126345974|NCT01963611|454562264|FG004|Overall Study|Withdrawal by Subject|3|||
126345975|NCT01963611|454562260|FG000|Overall Study|Other|47|||
126432006|NCT00979901|454879869|FG001|Overall Study|Left Country|0|||
126432007|NCT00979901|454879870|FG002|Overall Study|Left Country|1|||
126432008|NCT00979901|454879871|FG003|Overall Study|Left Country|0|||
126432009|NCT00979901|454879868|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
126432010|NCT00979901|454879869|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
126432011|NCT00979901|454879870|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
126432012|NCT00979901|454879871|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
126432013|NCT00446849|454879873|FG000|Acute Phase|Lack of Efficacy|64|||
126432014|NCT00446849|454879873|FG000|Acute Phase|Protocol Violation|10|||
126432015|NCT00446849|454879873|FG000|Acute Phase|Consent withdrawn|4|||
126432016|NCT00446849|454879873|FG000|Acute Phase|Lost to Follow-up|2|||
126432017|NCT00446849|454879873|FG000|Acute Phase|Physician Decision|1|||
126432018|NCT00446849|454879873|FG000|Acute Phase|noncompliance|1|||
126432019|NCT00446849|454879873|FG000|Maintenance Phase|Lack of Efficacy|40|||
126432020|NCT00446849|454879873|FG000|Maintenance Phase|Protocol Violation|7|||
126432021|NCT00446849|454879873|FG000|Maintenance Phase|Adverse Event|6|||
126432022|NCT00446849|454879873|FG000|Maintenance Phase|Consent withdrawn|5|||
126432023|NCT00446849|454879873|FG000|Maintenance Phase|Lost to Follow-up|3|||
126432024|NCT00446849|454879873|FG000|Maintenance Phase|Pregnancy|1|||
126432025|NCT00446849|454879873|FG000|Maintenance Phase|noncompliance|2|||
126432026|NCT00446849|454879873|FG000|Maintenance Phase|prohibited medication use|2|||
126432027|NCT00446849|454879873|FG000|Maintenance Phase|antibiotic use|1|||
126432028|NCT00446849|454879873|FG000|Maintenance Phase|study closure|1|||
126432029|NCT00446849|454879873|FG000|Maintenance Phase|hydrocodone use|1|||
126432030|NCT00446849|454879873|FG000|Maintenance Phase|concomitant medication use|1|||
126432031|NCT01317472|454879876|FG000|Overall Study|Withdrawal by Subject|1|||
126432032|NCT01317472|454879877|FG001|Overall Study|Withdrawal by Subject|0|||
126432033|NCT01317472|454879876|FG000|Overall Study|Unrelated hospitalization|1|||
126432034|NCT01317472|454879877|FG001|Overall Study|Unrelated hospitalization|0|||
126432035|NCT05546476|454879878|FG000|Period 1: Part A|Adverse Event|2|||
126432036|NCT05546476|454879879|FG001|Period 1: Part A|Adverse Event|0|||
126432037|NCT05546476|454879880|FG002|Period 1: Part A|Adverse Event|0|||
126432038|NCT05546476|454879881|FG003|Period 1: Part A|Adverse Event|1|||
126432039|NCT05546476|454879878|FG000|Period 1: Part A|Death|4|||
126432040|NCT05546476|454879879|FG001|Period 1: Part A|Death|4|||
126432041|NCT05546476|454879880|FG002|Period 1: Part A|Death|5|||
126432042|NCT05546476|454879881|FG003|Period 1: Part A|Death|6|||
126432043|NCT05546476|454879878|FG000|Period 1: Part A|Lack of Efficacy|0|||
126432044|NCT05546476|454879879|FG001|Period 1: Part A|Lack of Efficacy|0|||
126432045|NCT05546476|454879880|FG002|Period 1: Part A|Lack of Efficacy|0|||
126432046|NCT05546476|454879881|FG003|Period 1: Part A|Lack of Efficacy|1|||
126432047|NCT05546476|454879878|FG000|Period 1: Part A|Lost to Follow-up|0|||
126432048|NCT05546476|454879879|FG001|Period 1: Part A|Lost to Follow-up|0|||
126432049|NCT05546476|454879880|FG002|Period 1: Part A|Lost to Follow-up|0|||
126432050|NCT05546476|454879881|FG003|Period 1: Part A|Lost to Follow-up|1|||
126432051|NCT05546476|454879878|FG000|Period 1: Part A|Physician Decision|1|||
126680482|NCT00769184|455786226|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
126680483|NCT00769184|455786227|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
126680484|NCT00531752|455786228|FG000|First Double-blind Intervention Period|Adverse Event|2|||
126680485|NCT00531752|455786229|FG001|First Double-blind Intervention Period|Adverse Event|0|||
126680486|NCT00531752|455786230|FG002|First Double-blind Intervention Period|Adverse Event|1|||
126680487|NCT00531752|455786231|FG003|First Double-blind Intervention Period|Adverse Event|1|||
126432052|NCT05546476|454879879|FG001|Period 1: Part A|Physician Decision|0|||
126432053|NCT05546476|454879880|FG002|Period 1: Part A|Physician Decision|0|||
126432054|NCT05546476|454879881|FG003|Period 1: Part A|Physician Decision|0|||
126680488|NCT00531752|455786228|FG000|First Double-blind Intervention Period|Other|1|||
126432055|NCT05546476|454879878|FG000|Period 1: Part A|Progressive disease|3|||
126432056|NCT05546476|454879879|FG001|Period 1: Part A|Progressive disease|5|||
126432057|NCT05546476|454879880|FG002|Period 1: Part A|Progressive disease|0|||
126432058|NCT05546476|454879881|FG003|Period 1: Part A|Progressive disease|1|||
126432059|NCT05546476|454879878|FG000|Period 1: Part A|Withdrawal by Subject|1|||
126432060|NCT05546476|454879879|FG001|Period 1: Part A|Withdrawal by Subject|1|||
126432061|NCT05546476|454879880|FG002|Period 1: Part A|Withdrawal by Subject|1|||
126432062|NCT05546476|454879881|FG003|Period 1: Part A|Withdrawal by Subject|2|||
126680489|NCT00531752|455786229|FG001|First Double-blind Intervention Period|Other|4|||
126345976|NCT01963611|454562261|FG001|Overall Study|Other|46|||
126345977|NCT01963611|454562262|FG002|Overall Study|Other|48|||
126345978|NCT01963611|454562263|FG003|Overall Study|Other|45|||
126345979|NCT01963611|454562264|FG004|Overall Study|Other|45|||
126345980|NCT01126424|454562265|FG000|Overall Study|Adverse Event|0|||
126345981|NCT01126424|454562266|FG001|Overall Study|Adverse Event|0|||
126345982|NCT01126424|454562267|FG002|Overall Study|Adverse Event|0|||
126345983|NCT01126424|454562268|FG003|Overall Study|Adverse Event|0|||
126345984|NCT01126424|454562269|FG004|Overall Study|Adverse Event|1|||
126345985|NCT01126424|454562270|FG005|Overall Study|Adverse Event|0|||
126345986|NCT01126424|454562265|FG000|Overall Study|Withdrawal by Subject|0|||
126345987|NCT01126424|454562266|FG001|Overall Study|Withdrawal by Subject|0|||
126345988|NCT01126424|454562267|FG002|Overall Study|Withdrawal by Subject|1|||
126345989|NCT01126424|454562268|FG003|Overall Study|Withdrawal by Subject|3|||
126345990|NCT01126424|454562269|FG004|Overall Study|Withdrawal by Subject|1|||
126345991|NCT01126424|454562270|FG005|Overall Study|Withdrawal by Subject|0|||
126345992|NCT03801252|454562272|FG000|Overall Study|Protocol Violation|1|||
126345993|NCT03801252|454562273|FG001|Overall Study|Protocol Violation|2|||
126345994|NCT01134042|454562274|FG000|Overall Study|Adverse Event|3|||
126345995|NCT01134042|454562275|FG001|Overall Study|Adverse Event|7|||
126345996|NCT01134042|454562276|FG002|Overall Study|Adverse Event|2|||
126345997|NCT01134042|454562274|FG000|Overall Study|Lack of Efficacy|21|||
126345998|NCT01134042|454562275|FG001|Overall Study|Lack of Efficacy|6|||
126345999|NCT01134042|454562276|FG002|Overall Study|Lack of Efficacy|18|||
126346000|NCT01134042|454562274|FG000|Overall Study|Protocol Violation|5|||
126346001|NCT01134042|454562275|FG001|Overall Study|Protocol Violation|3|||
126346002|NCT01134042|454562276|FG002|Overall Study|Protocol Violation|5|||
126346003|NCT01134042|454562274|FG000|Overall Study|Lost to Follow-up|2|||
126346004|NCT01134042|454562275|FG001|Overall Study|Lost to Follow-up|0|||
126346005|NCT01134042|454562276|FG002|Overall Study|Lost to Follow-up|1|||
126346006|NCT01134042|454562274|FG000|Overall Study|Physician Decision|4|||
126346007|NCT01134042|454562275|FG001|Overall Study|Physician Decision|8|||
126346008|NCT01134042|454562276|FG002|Overall Study|Physician Decision|1|||
126346009|NCT01134042|454562274|FG000|Overall Study|Withdrawal by Subject|13|||
126346010|NCT01134042|454562275|FG001|Overall Study|Withdrawal by Subject|4|||
126346011|NCT01134042|454562276|FG002|Overall Study|Withdrawal by Subject|7|||
126346012|NCT00393367|454562277|FG000|Overall Study|Protocol Violation|2|||
126346013|NCT00393367|454562278|FG001|Overall Study|Protocol Violation|5|||
126346014|NCT00393367|454562277|FG000|Overall Study|Withdrawal by Subject|0|||
126346015|NCT00393367|454562278|FG001|Overall Study|Withdrawal by Subject|2|||
126346016|NCT03286504|454562279|FG000|Overall Study|Lost to Follow-up|19|||
126346017|NCT03286504|454562280|FG001|Overall Study|Lost to Follow-up|16|||
126346018|NCT01432327|454562281|FG000|Posttest 3 Months|depression|3|||
126346019|NCT01432327|454562282|FG001|Posttest 3 Months|depression|0|||
126346020|NCT01432327|454562283|FG002|Posttest 3 Months|depression|0|||
126346021|NCT01432327|454562284|FG003|Posttest 3 Months|depression|0|||
126346022|NCT01432327|454562281|FG000|Posttest 3 Months|Lost to Follow-up|1|||
126346023|NCT01432327|454562282|FG001|Posttest 3 Months|Lost to Follow-up|0|||
126346024|NCT01432327|454562283|FG002|Posttest 3 Months|Lost to Follow-up|2|||
126346025|NCT01432327|454562284|FG003|Posttest 3 Months|Lost to Follow-up|1|||
126346026|NCT01432327|454562281|FG000|Posttest 3 Months|Allergic reaction|0|||
126346027|NCT01432327|454562282|FG001|Posttest 3 Months|Allergic reaction|2|||
126346028|NCT01432327|454562283|FG002|Posttest 3 Months|Allergic reaction|0|||
126346029|NCT01432327|454562284|FG003|Posttest 3 Months|Allergic reaction|0|||
126346030|NCT01432327|454562281|FG000|Posttest 6 Months|Lost to Follow-up|0|||
126346031|NCT01432327|454562282|FG001|Posttest 6 Months|Lost to Follow-up|0|||
126346032|NCT01432327|454562283|FG002|Posttest 6 Months|Lost to Follow-up|3|||
126346033|NCT01432327|454562284|FG003|Posttest 6 Months|Lost to Follow-up|2|||
126346034|NCT01432327|454562281|FG000|Posttest 6 Months|Allergic reaction|0|||
126346035|NCT01432327|454562282|FG001|Posttest 6 Months|Allergic reaction|0|||
126346036|NCT01432327|454562283|FG002|Posttest 6 Months|Allergic reaction|1|||
126346037|NCT01432327|454562284|FG003|Posttest 6 Months|Allergic reaction|0|||
126346038|NCT01432327|454562281|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
126346039|NCT01432327|454562282|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
126346040|NCT01432327|454562283|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
126346041|NCT01432327|454562284|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
126346042|NCT01432327|454562281|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
126346043|NCT01432327|454562282|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
126346044|NCT01432327|454562283|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
126346045|NCT01432327|454562284|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
126346046|NCT01432327|454562281|FG000|Posttest 1 Year|Lost to Follow-up|0|||
126680490|NCT00531752|455786230|FG002|First Double-blind Intervention Period|Other|4|||
126680491|NCT00531752|455786231|FG003|First Double-blind Intervention Period|Other|0|||
126680492|NCT00531752|455786228|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
126680493|NCT00531752|455786229|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
126680494|NCT00531752|455786230|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
126680495|NCT00531752|455786231|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
126680496|NCT00531752|455786228|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
126680497|NCT00531752|455786229|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
126680498|NCT00531752|455786230|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
126680499|NCT00531752|455786231|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
126680500|NCT00531752|455786228|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
126680501|NCT00531752|455786229|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
126680502|NCT00531752|455786230|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
126680503|NCT00531752|455786231|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
126680504|NCT00531752|455786228|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
126680505|NCT00531752|455786229|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
126680506|NCT00531752|455786230|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
126680507|NCT00531752|455786231|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
126680508|NCT00531752|455786228|FG000|Second Double-blind Intervention Period|Other|1|||
126680509|NCT00531752|455786229|FG001|Second Double-blind Intervention Period|Other|1|||
126680510|NCT00531752|455786230|FG002|Second Double-blind Intervention Period|Other|0|||
126680511|NCT00531752|455786231|FG003|Second Double-blind Intervention Period|Other|0|||
126680512|NCT00531752|455786228|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
126346047|NCT01432327|454562282|FG001|Posttest 1 Year|Lost to Follow-up|0|||
126346048|NCT01432327|454562283|FG002|Posttest 1 Year|Lost to Follow-up|4|||
126346049|NCT01432327|454562284|FG003|Posttest 1 Year|Lost to Follow-up|2|||
126346050|NCT01432327|454562281|FG000|Posttest 1 Year|Allergic reaction|0|||
126346051|NCT01432327|454562282|FG001|Posttest 1 Year|Allergic reaction|0|||
126346052|NCT01432327|454562283|FG002|Posttest 1 Year|Allergic reaction|1|||
126346053|NCT01432327|454562284|FG003|Posttest 1 Year|Allergic reaction|1|||
126346054|NCT02030600|454562289|FG000|Treatment Period 1|Adverse Event|5|||
126346055|NCT02030600|454562290|FG001|Treatment Period 1|Adverse Event|7|||
126680513|NCT00531752|455786229|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
126680514|NCT00531752|455786230|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
126680515|NCT00531752|455786231|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
126680516|NCT00531752|455786228|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
126680517|NCT00531752|455786229|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
126680518|NCT00531752|455786230|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
126680519|NCT00531752|455786231|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
126680520|NCT00361270|455786234|FG000|Overall Study|Death|0|||
126680521|NCT00361270|455786235|FG001|Overall Study|Death|0|||
126680522|NCT00361270|455786236|FG002|Overall Study|Death|0|||
126680523|NCT00361270|455786237|FG003|Overall Study|Death|2|||
126680524|NCT00361270|455786234|FG000|Overall Study|Lost to Follow-up|4|||
126680525|NCT00361270|455786235|FG001|Overall Study|Lost to Follow-up|1|||
126680526|NCT00361270|455786236|FG002|Overall Study|Lost to Follow-up|0|||
126680527|NCT00361270|455786237|FG003|Overall Study|Lost to Follow-up|0|||
126680528|NCT00361270|455786234|FG000|Overall Study|Physician Decision|0|||
126680529|NCT00361270|455786235|FG001|Overall Study|Physician Decision|0|||
126680530|NCT00361270|455786236|FG002|Overall Study|Physician Decision|1|||
126680531|NCT00361270|455786237|FG003|Overall Study|Physician Decision|0|||
126680532|NCT00361270|455786234|FG000|Overall Study|Protocol Violation|9|||
126680533|NCT00361270|455786235|FG001|Overall Study|Protocol Violation|4|||
126680534|NCT00361270|455786236|FG002|Overall Study|Protocol Violation|5|||
126680535|NCT00361270|455786237|FG003|Overall Study|Protocol Violation|4|||
126680536|NCT00361270|455786234|FG000|Overall Study|Withdrawal by Subject|6|||
126680537|NCT00361270|455786235|FG001|Overall Study|Withdrawal by Subject|6|||
126680538|NCT00361270|455786236|FG002|Overall Study|Withdrawal by Subject|3|||
126680539|NCT00361270|455786237|FG003|Overall Study|Withdrawal by Subject|7|||
126680540|NCT00361270|455786234|FG000|Overall Study|Afraid of Hypnosis|1|||
126680541|NCT00361270|455786235|FG001|Overall Study|Afraid of Hypnosis|2|||
126680542|NCT00361270|455786236|FG002|Overall Study|Afraid of Hypnosis|0|||
126680543|NCT00361270|455786237|FG003|Overall Study|Afraid of Hypnosis|0|||
126680544|NCT00361270|455786234|FG000|Overall Study|Problems with Transportation|4|||
126680545|NCT00361270|455786235|FG001|Overall Study|Problems with Transportation|0|||
126680546|NCT00361270|455786236|FG002|Overall Study|Problems with Transportation|0|||
126680547|NCT00361270|455786237|FG003|Overall Study|Problems with Transportation|0|||
126680548|NCT00361270|455786234|FG000|Overall Study|Adverse Event|0|||
126680549|NCT00361270|455786235|FG001|Overall Study|Adverse Event|1|||
126680550|NCT00361270|455786236|FG002|Overall Study|Adverse Event|1|||
126680551|NCT00361270|455786237|FG003|Overall Study|Adverse Event|0|||
126680552|NCT02821715|455786239|FG000|Overall Study|Protocol Violation|1|||
126680553|NCT02821715|455786240|FG001|Overall Study|Protocol Violation|0|||
126680554|NCT02821715|455786241|FG002|Overall Study|Protocol Violation|0|||
126680555|NCT02821715|455786242|FG003|Overall Study|Protocol Violation|0|||
126680556|NCT02821715|455786243|FG004|Overall Study|Protocol Violation|0|||
126680557|NCT02821715|455786244|FG005|Overall Study|Protocol Violation|0|||
126680558|NCT00640328|455786245|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
126680559|NCT00640328|455786246|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
126680560|NCT00640328|455786247|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
126680561|NCT00640328|455786248|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
126680562|NCT00640328|455786249|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
126680563|NCT00640328|455786250|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
126680564|NCT00640328|455786245|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
126680565|NCT00640328|455786246|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
126680566|NCT00640328|455786247|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
126680567|NCT00640328|455786248|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
126680568|NCT00640328|455786249|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
126680569|NCT00640328|455786250|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
126680570|NCT00640328|455786245|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
126432063|NCT05546476|454879878|FG000|Period 1: Part A|Global deterioration of health status|2|||
126680571|NCT00640328|455786246|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
126680572|NCT00640328|455786247|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
126680573|NCT00640328|455786248|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
126680574|NCT00640328|455786249|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
126432064|NCT05546476|454879879|FG001|Period 1: Part A|Global deterioration of health status|2|||
126680575|NCT00640328|455786250|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
126680576|NCT00640328|455786245|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
126680577|NCT00640328|455786246|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
126680578|NCT00640328|455786247|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
126680579|NCT00640328|455786248|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
126680580|NCT00640328|455786249|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
126432065|NCT05546476|454879880|FG002|Period 1: Part A|Global deterioration of health status|1|||
126432066|NCT05546476|454879881|FG003|Period 1: Part A|Global deterioration of health status|4|||
126432067|NCT05546476|454879878|FG000|Period 1: Part A|Other: Unspecified|0|||
126432068|NCT05546476|454879879|FG001|Period 1: Part A|Other: Unspecified|2|||
126432069|NCT05546476|454879880|FG002|Period 1: Part A|Other: Unspecified|0|||
126432070|NCT05546476|454879881|FG003|Period 1: Part A|Other: Unspecified|0|||
126680581|NCT00640328|455786250|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
126432071|NCT05546476|454879878|FG000|Period 2: Part B|Ongoing|26|||
126432072|NCT05546476|454879879|FG001|Period 2: Part B|Ongoing|27|||
126432073|NCT05546476|454879880|FG002|Period 2: Part B|Ongoing|35|||
126432074|NCT05546476|454879881|FG003|Period 2: Part B|Ongoing|29|||
126432075|NCT00807911|454879886|FG000|Overall Study|Withdrawal by Subject|12|||
126432076|NCT00807911|454879887|FG001|Overall Study|Withdrawal by Subject|10|||
126432077|NCT00807911|454879886|FG000|Overall Study|Ineligible|0|||
126432078|NCT00807911|454879887|FG001|Overall Study|Ineligible|4|||
126432079|NCT02182895|454879888|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
126432080|NCT02182895|454879889|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
126432081|NCT02953652|454879890|FG000|Overall Study|Adverse Event|18|||
126432082|NCT02953652|454879890|FG000|Overall Study|Withdrawal by Subject|6|||
126432083|NCT02953652|454879890|FG000|Overall Study|Protocol Violation|1|||
126432084|NCT02953652|454879890|FG000|Overall Study|Disease Progression|27|||
126680582|NCT01326546|455786251|FG000|Overall Study|Lost to Follow-up|8|||
126680583|NCT01326546|455786252|FG001|Overall Study|Lost to Follow-up|7|||
126680584|NCT01326546|455786251|FG000|Overall Study|Protocol Violation|3|||
126680585|NCT01326546|455786252|FG001|Overall Study|Protocol Violation|4|||
126680586|NCT01326546|455786251|FG000|Overall Study|Pregnancy|0|||
126680587|NCT01326546|455786252|FG001|Overall Study|Pregnancy|1|||
126680588|NCT01326546|455786251|FG000|Overall Study|Adverse Event|1|||
126680589|NCT01326546|455786252|FG001|Overall Study|Adverse Event|0|||
126680590|NCT01326546|455786251|FG000|Overall Study|Withdrawal by Subject|5|||
126680591|NCT01326546|455786252|FG001|Overall Study|Withdrawal by Subject|1|||
126680592|NCT04294719|455786253|FG000|Overall Study|Withdrawal by Subject|1|||
126680593|NCT00081159|455786254|FG000|Overall Study|Withdrawal by Subject|0|||
126680594|NCT00081159|455786255|FG001|Overall Study|Withdrawal by Subject|3|||
126680595|NCT00081159|455786254|FG000|Overall Study|Myelosuppression prior to treatment|0|||
126680596|NCT00081159|455786255|FG001|Overall Study|Myelosuppression prior to treatment|1|||
126680597|NCT00081159|455786254|FG000|Overall Study|Lost to Follow-up|2|||
126680598|NCT00081159|455786255|FG001|Overall Study|Lost to Follow-up|1|||
126680599|NCT01714687|455786256|FG000|Overall Study|Withdrawal by Subject|1|||
126680600|NCT01714687|455786257|FG001|Overall Study|Withdrawal by Subject|0|||
126680601|NCT01714687|455786256|FG000|Overall Study|Lost to Follow-up|2|||
126680602|NCT01714687|455786257|FG001|Overall Study|Lost to Follow-up|4|||
126680603|NCT01553136|455786262|FG000|Overall Study|Adverse Event|3|||
126680604|NCT01553136|455786263|FG001|Overall Study|Adverse Event|2|||
126680605|NCT01553136|455786262|FG000|Overall Study|Withdrawal by Subject|2|||
126680606|NCT01553136|455786263|FG001|Overall Study|Withdrawal by Subject|3|||
126680607|NCT01553136|455786262|FG000|Overall Study|Lost to Follow-up|4|||
126680608|NCT01553136|455786263|FG001|Overall Study|Lost to Follow-up|10|||
126680609|NCT01553136|455786262|FG000|Overall Study|Physician Decision|2|||
126680610|NCT01553136|455786263|FG001|Overall Study|Physician Decision|3|||
126680611|NCT01553136|455786262|FG000|Overall Study|Scheduling Difficulties|5|||
126680612|NCT01553136|455786263|FG001|Overall Study|Scheduling Difficulties|4|||
126680613|NCT01979536|455786264|FG000|Overall Study|Physician Decision|2|||
126680614|NCT01979536|455786265|FG001|Overall Study|Physician Decision|3|||
126680615|NCT01979536|455786264|FG000|Overall Study|Withdrawal by Subject|0|||
126680616|NCT01979536|455786265|FG001|Overall Study|Withdrawal by Subject|1|||
126680617|NCT01979536|455786264|FG000|Overall Study|Refusal|0|||
126680618|NCT01979536|455786265|FG001|Overall Study|Refusal|1|||
126680619|NCT01979536|455786264|FG000|Overall Study|Relapse|0|||
126680620|NCT01979536|455786265|FG001|Overall Study|Relapse|1|||
126680621|NCT01979536|455786264|FG000|Overall Study|Study terminated by Sponsor|0|||
126680622|NCT01979536|455786265|FG001|Overall Study|Study terminated by Sponsor|1|||
126680623|NCT01979536|455786264|FG000|Overall Study|Did not start treatment|0|||
126680624|NCT01979536|455786265|FG001|Overall Study|Did not start treatment|1|||
126680625|NCT05038020|455786271|FG000|Overall Study|Early Termination|3|||
126680626|NCT05038020|455786272|FG001|Overall Study|Early Termination|0|||
126680627|NCT00609791|455788144|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
126680628|NCT02484911|455788145|FG000|Overall Study|Withdrawal by Subject|2|||
126680629|NCT02484911|455788146|FG001|Overall Study|Withdrawal by Subject|1|||
126680630|NCT02484911|455788145|FG000|Overall Study|Protocol Violation|2|||
126680631|NCT02484911|455788146|FG001|Overall Study|Protocol Violation|1|||
126432085|NCT00836589|454879893|FG000|Overall Study|Lost to Follow-up|246|||
126432086|NCT00836589|454879893|FG000|Overall Study|Death|429|||
126432087|NCT00836589|454879893|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
126432088|NCT02399215|454879915|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
126680632|NCT04129528|455788147|FG000|Overall Study|Adverse Event|1|||
126680633|NCT04129528|455788148|FG001|Overall Study|Adverse Event|0|||
126680634|NCT04129528|455788147|FG000|Overall Study|Physician Decision|1|||
126680635|NCT04129528|455788148|FG001|Overall Study|Physician Decision|1|||
126432089|NCT02399215|454879915|FG000|Overall Study|Withdrawal by Subject|1|||
126432090|NCT00772538|454879916|FG000|Overall Study|Adverse Event|6|||
126432091|NCT00772538|454879917|FG001|Overall Study|Adverse Event|6|||
126432092|NCT00772538|454879916|FG000|Overall Study|Protocol Violation|3|||
126432093|NCT00772538|454879917|FG001|Overall Study|Protocol Violation|3|||
126758662|NCT00134563|456066675|FG002|Overall Study|Lost to Follow-up|2|||
126432094|NCT00772538|454879916|FG000|Overall Study|Lost to Follow-up|1|||
126432095|NCT00772538|454879917|FG001|Overall Study|Lost to Follow-up|1|||
126432096|NCT00772538|454879916|FG000|Overall Study|Withdrawal by Subject|3|||
126432097|NCT00772538|454879917|FG001|Overall Study|Withdrawal by Subject|8|||
126432098|NCT00772538|454879916|FG000|Overall Study|Lack of Efficacy|0|||
126432099|NCT00772538|454879917|FG001|Overall Study|Lack of Efficacy|1|||
126432100|NCT00772538|454879916|FG000|Overall Study|Other|7|||
126432101|NCT00772538|454879917|FG001|Overall Study|Other|7|||
126432102|NCT00713609|454879918|FG000|Overall Study|Adverse Event|2|||
126758663|NCT00134563|456066673|FG000|Overall Study|progressive disease|11|||
126432103|NCT00713609|454879919|FG001|Overall Study|Adverse Event|0|||
126432104|NCT00713609|454879920|FG002|Overall Study|Adverse Event|2|||
126432105|NCT00713609|454879921|FG003|Overall Study|Adverse Event|2|||
126432106|NCT00713609|454879922|FG004|Overall Study|Adverse Event|3|||
126432107|NCT00713609|454879923|FG005|Overall Study|Adverse Event|1|||
126432108|NCT00713609|454879918|FG000|Overall Study|Lost to Follow-up|5|||
126432109|NCT00713609|454879919|FG001|Overall Study|Lost to Follow-up|7|||
126432110|NCT00713609|454879920|FG002|Overall Study|Lost to Follow-up|5|||
126432111|NCT00713609|454879921|FG003|Overall Study|Lost to Follow-up|5|||
126432112|NCT00713609|454879922|FG004|Overall Study|Lost to Follow-up|7|||
126346056|NCT02030600|454562289|FG000|Treatment Period 1|Lack of Efficacy|0|||
126346057|NCT02030600|454562290|FG001|Treatment Period 1|Lack of Efficacy|1|||
126346058|NCT02030600|454562289|FG000|Treatment Period 1|Lost to Follow-up|11|||
126346059|NCT02030600|454562290|FG001|Treatment Period 1|Lost to Follow-up|3|||
126346060|NCT02030600|454562289|FG000|Treatment Period 1|Protocol Violation|22|||
126346061|NCT02030600|454562290|FG001|Treatment Period 1|Protocol Violation|17|||
126346062|NCT02030600|454562289|FG000|Treatment Period 1|Withdrawal by Subject|13|||
126680636|NCT04129528|455788147|FG000|Overall Study|Withdrawal by Subject|1|||
126680637|NCT04129528|455788148|FG001|Overall Study|Withdrawal by Subject|1|||
126432113|NCT00713609|454879923|FG005|Overall Study|Lost to Follow-up|0|||
126680638|NCT01964352|455788153|FG000|Overall Study|Adverse Event|13|||
126346063|NCT02030600|454562290|FG001|Treatment Period 1|Withdrawal by Subject|17|||
126346064|NCT02030600|454562289|FG000|Treatment Period 1|Casebook Unsigned|1|||
126346065|NCT02030600|454562290|FG001|Treatment Period 1|Casebook Unsigned|0|||
126346066|NCT02030600|454562289|FG000|Treatment Period 1|Unclassified|1|||
126346067|NCT02030600|454562290|FG001|Treatment Period 1|Unclassified|0|||
126346068|NCT02030600|454562289|FG000|Treatment Period 2|Adverse Event|4|||
126346069|NCT02030600|454562290|FG001|Treatment Period 2|Adverse Event|4|||
126432114|NCT00713609|454879918|FG000|Overall Study|Lack of Efficacy|1|||
126306083|NCT02553499|454408869|FG000|Overall Study|Study Terminated by Sponsor|0|||
126306084|NCT02553499|454408870|FG001|Overall Study|Study Terminated by Sponsor|0|||
126306085|NCT02553499|454408871|FG002|Overall Study|Study Terminated by Sponsor|0|||
126306086|NCT02553499|454408872|FG003|Overall Study|Study Terminated by Sponsor|0|||
126306087|NCT02553499|454408873|FG004|Overall Study|Study Terminated by Sponsor|0|||
126306088|NCT02553499|454408874|FG005|Overall Study|Study Terminated by Sponsor|0|||
126306089|NCT02553499|454408875|FG006|Overall Study|Study Terminated by Sponsor|0|||
126306090|NCT02553499|454408876|FG007|Overall Study|Study Terminated by Sponsor|0|||
126306091|NCT02553499|454408877|FG008|Overall Study|Study Terminated by Sponsor|1|||
126306092|NCT02553499|454408878|FG009|Overall Study|Study Terminated by Sponsor|0|||
126306093|NCT02553499|454408879|FG010|Overall Study|Study Terminated by Sponsor|0|||
126306094|NCT02553499|454408880|FG011|Overall Study|Study Terminated by Sponsor|0|||
126306095|NCT02553499|454408881|FG012|Overall Study|Study Terminated by Sponsor|0|||
126306096|NCT02553499|454408882|FG013|Overall Study|Study Terminated by Sponsor|0|||
126306097|NCT02553499|454408869|FG000|Overall Study|Withdrawal by Subject|2|||
126306098|NCT02553499|454408870|FG001|Overall Study|Withdrawal by Subject|0|||
126306099|NCT02553499|454408871|FG002|Overall Study|Withdrawal by Subject|0|||
126306100|NCT02553499|454408872|FG003|Overall Study|Withdrawal by Subject|0|||
126306101|NCT02553499|454408873|FG004|Overall Study|Withdrawal by Subject|0|||
126306102|NCT02553499|454408874|FG005|Overall Study|Withdrawal by Subject|0|||
126306103|NCT02553499|454408875|FG006|Overall Study|Withdrawal by Subject|0|||
126346070|NCT02030600|454562289|FG000|Treatment Period 2|Lack of Efficacy|2|||
126346071|NCT02030600|454562290|FG001|Treatment Period 2|Lack of Efficacy|1|||
126346072|NCT02030600|454562289|FG000|Treatment Period 2|Lost to Follow-up|4|||
126346073|NCT02030600|454562290|FG001|Treatment Period 2|Lost to Follow-up|2|||
126346074|NCT02030600|454562289|FG000|Treatment Period 2|Protocol Violation|1|||
126346075|NCT02030600|454562290|FG001|Treatment Period 2|Protocol Violation|2|||
126346076|NCT02030600|454562289|FG000|Treatment Period 2|Withdrawal by Subject|13|||
126346077|NCT02030600|454562290|FG001|Treatment Period 2|Withdrawal by Subject|9|||
126680639|NCT01964352|455788154|FG001|Overall Study|Adverse Event|3|||
126680640|NCT01964352|455788155|FG002|Overall Study|Adverse Event|4|||
126346078|NCT02030600|454562289|FG000|Treatment Period 2|Unclassified|1|||
126346079|NCT02030600|454562290|FG001|Treatment Period 2|Unclassified|0|||
126346080|NCT01155323|454562291|FG000|First Intervention|exclusion criteria|1|||
126346081|NCT01155323|454562292|FG001|First Intervention|exclusion criteria|1|||
126346082|NCT01155323|454562291|FG000|Second Intervention|Lost to Follow-up|1|||
126346083|NCT01155323|454562292|FG001|Second Intervention|Lost to Follow-up|1|||
126346084|NCT00937950|454562302|FG000|Overall Study|Withdrawal by Subject|23|||
126346085|NCT00937950|454562302|FG000|Overall Study|Migrated/moved from study area|27|||
126346086|NCT00937950|454562302|FG000|Overall Study|Lost to Follow-up|144|||
126346087|NCT00937950|454562302|FG000|Overall Study|Missing confirmed|4|||
126346088|NCT00937950|454562302|FG000|Overall Study|Other|18|||
126346089|NCT04154956|454562303|FG000|Overall Study|Death|109|||
126346090|NCT04154956|454562304|FG001|Overall Study|Death|110|||
126346091|NCT04154956|454562303|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
126346092|NCT04154956|454562304|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
126346093|NCT04154956|454562303|FG000|Overall Study|Withdrawal by Subject|1|||
126346094|NCT04154956|454562304|FG001|Overall Study|Withdrawal by Subject|7|||
126346095|NCT04154956|454562303|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
126346096|NCT04154956|454562304|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
126346097|NCT00805532|454562305|FG000|Overall Study|invalid data|0|||
126346098|NCT00805532|454562306|FG001|Overall Study|invalid data|1|||
126346099|NCT01859741|454562307|FG000|Overall Study|Death|3|||
126346100|NCT01859741|454562308|FG001|Overall Study|Death|2|||
126346101|NCT01859741|454562309|FG002|Overall Study|Death|4|||
126346102|NCT01859741|454562310|FG003|Overall Study|Death|3|||
126346103|NCT01859741|454562311|FG004|Overall Study|Death|5|||
126346104|NCT01859741|454562312|FG005|Overall Study|Death|4|||
126346105|NCT01859741|454562313|FG006|Overall Study|Death|51|||
126346106|NCT01859741|454562314|FG007|Overall Study|Death|51|||
126346107|NCT01859741|454562307|FG000|Overall Study|Lost to Follow-up|0|||
126346108|NCT01859741|454562308|FG001|Overall Study|Lost to Follow-up|0|||
126346109|NCT01859741|454562309|FG002|Overall Study|Lost to Follow-up|0|||
126346110|NCT01859741|454562310|FG003|Overall Study|Lost to Follow-up|0|||
126346111|NCT01859741|454562311|FG004|Overall Study|Lost to Follow-up|0|||
126346112|NCT01859741|454562312|FG005|Overall Study|Lost to Follow-up|1|||
126346113|NCT01859741|454562313|FG006|Overall Study|Lost to Follow-up|0|||
126346114|NCT01859741|454562314|FG007|Overall Study|Lost to Follow-up|4|||
126346115|NCT01859741|454562307|FG000|Overall Study|Withdrawal by Subject|0|||
126346116|NCT01859741|454562308|FG001|Overall Study|Withdrawal by Subject|1|||
126346117|NCT01859741|454562309|FG002|Overall Study|Withdrawal by Subject|2|||
126346118|NCT01859741|454562310|FG003|Overall Study|Withdrawal by Subject|0|||
126346119|NCT01859741|454562311|FG004|Overall Study|Withdrawal by Subject|0|||
126346120|NCT01859741|454562312|FG005|Overall Study|Withdrawal by Subject|1|||
126346121|NCT01859741|454562313|FG006|Overall Study|Withdrawal by Subject|1|||
126346122|NCT01859741|454562314|FG007|Overall Study|Withdrawal by Subject|1|||
126346123|NCT01859741|454562307|FG000|Overall Study|Study Terminated by Sponsor|0|||
126346124|NCT01859741|454562308|FG001|Overall Study|Study Terminated by Sponsor|0|||
126346125|NCT01859741|454562309|FG002|Overall Study|Study Terminated by Sponsor|0|||
126346126|NCT01859741|454562310|FG003|Overall Study|Study Terminated by Sponsor|0|||
126346127|NCT01859741|454562311|FG004|Overall Study|Study Terminated by Sponsor|1|||
126346128|NCT01859741|454562312|FG005|Overall Study|Study Terminated by Sponsor|0|||
126346129|NCT01859741|454562313|FG006|Overall Study|Study Terminated by Sponsor|16|||
126346130|NCT01859741|454562314|FG007|Overall Study|Study Terminated by Sponsor|14|||
126346131|NCT01859741|454562307|FG000|Overall Study|Other|0|||
126346132|NCT01859741|454562308|FG001|Overall Study|Other|0|||
126346133|NCT01859741|454562309|FG002|Overall Study|Other|0|||
126346134|NCT01859741|454562310|FG003|Overall Study|Other|0|||
126346135|NCT01859741|454562311|FG004|Overall Study|Other|0|||
126346136|NCT01859741|454562312|FG005|Overall Study|Other|0|||
126346137|NCT01859741|454562313|FG006|Overall Study|Other|2|||
126346138|NCT01859741|454562314|FG007|Overall Study|Other|0|||
126346139|NCT02412657|454562316|FG000|Overall Study|Lost to Follow-up|1|||
126346140|NCT02412657|454562317|FG001|Overall Study|Lost to Follow-up|0|||
126346141|NCT02412657|454562318|FG002|Overall Study|Lost to Follow-up|0|||
126346142|NCT02412657|454562316|FG000|Overall Study|Protocol Violation|0|||
126346143|NCT02412657|454562317|FG001|Overall Study|Protocol Violation|2|||
126346144|NCT02412657|454562318|FG002|Overall Study|Protocol Violation|3|||
126346145|NCT00460798|454562319|FG000|Overall Study|Death|59|||
126346146|NCT00460798|454562319|FG000|Overall Study|Adverse Event|27|||
126346147|NCT00460798|454562319|FG000|Overall Study|Lost to Follow-up|19|||
126346148|NCT00460798|454562319|FG000|Overall Study|Progressive Disease|99|||
126346149|NCT00460798|454562319|FG000|Overall Study|Other|27|||
126346150|NCT00460798|454562319|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
126346151|NCT00460798|454562319|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
126346152|NCT01898130|454562320|FG000|Treatment|Withdrawal by Subject|2|||
126346153|NCT01898130|454562320|FG000|Treatment|Progressive Disease|4|||
126346154|NCT01898130|454562320|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
126346155|NCT01281306|454562327|FG000|Overall Study|Lack of Efficacy|0|||
126346156|NCT01281306|454562328|FG001|Overall Study|Lack of Efficacy|1|||
126346157|NCT01281306|454562329|FG002|Overall Study|Lack of Efficacy|3|||
126346158|NCT01281306|454562330|FG003|Overall Study|Lack of Efficacy|0|||
126346159|NCT01281306|454562331|FG004|Overall Study|Lack of Efficacy|2|||
126346160|NCT01281306|454562332|FG005|Overall Study|Lack of Efficacy|0|||
126346161|NCT01281306|454562333|FG006|Overall Study|Lack of Efficacy|1|||
126346162|NCT01281306|454562327|FG000|Overall Study|Withdrawal by Subject|1|||
126346163|NCT01281306|454562328|FG001|Overall Study|Withdrawal by Subject|0|||
126346164|NCT01281306|454562329|FG002|Overall Study|Withdrawal by Subject|2|||
126346165|NCT01281306|454562330|FG003|Overall Study|Withdrawal by Subject|4|||
126432115|NCT00713609|454879919|FG001|Overall Study|Lack of Efficacy|3|||
126680641|NCT01964352|455788156|FG003|Overall Study|Adverse Event|3|||
126680642|NCT01964352|455788153|FG000|Overall Study|Lack of Efficacy|6|||
126680643|NCT01964352|455788154|FG001|Overall Study|Lack of Efficacy|0|||
126680644|NCT01964352|455788155|FG002|Overall Study|Lack of Efficacy|0|||
126432116|NCT00713609|454879920|FG002|Overall Study|Lack of Efficacy|0|||
126432117|NCT00713609|454879921|FG003|Overall Study|Lack of Efficacy|0|||
126432118|NCT00713609|454879922|FG004|Overall Study|Lack of Efficacy|1|||
126432119|NCT00713609|454879923|FG005|Overall Study|Lack of Efficacy|0|||
126432120|NCT00713609|454879918|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
126432121|NCT00713609|454879919|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
126432122|NCT00713609|454879920|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
126432123|NCT00713609|454879921|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
126432124|NCT00713609|454879922|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
126432125|NCT00713609|454879923|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
126432126|NCT00713609|454879918|FG000|Overall Study|Withdrawal by Subject|6|||
126432127|NCT00713609|454879919|FG001|Overall Study|Withdrawal by Subject|1|||
126432128|NCT00713609|454879920|FG002|Overall Study|Withdrawal by Subject|5|||
126432129|NCT00713609|454879921|FG003|Overall Study|Withdrawal by Subject|1|||
126432130|NCT00713609|454879922|FG004|Overall Study|Withdrawal by Subject|5|||
126432131|NCT00713609|454879923|FG005|Overall Study|Withdrawal by Subject|7|||
126432132|NCT00713609|454879918|FG000|Overall Study|Protocol Violation|6|||
126432133|NCT00713609|454879919|FG001|Overall Study|Protocol Violation|3|||
126432134|NCT00713609|454879920|FG002|Overall Study|Protocol Violation|1|||
126432135|NCT00713609|454879921|FG003|Overall Study|Protocol Violation|1|||
126432136|NCT00713609|454879922|FG004|Overall Study|Protocol Violation|2|||
126432137|NCT00713609|454879923|FG005|Overall Study|Protocol Violation|0|||
126432138|NCT01903356|454879924|FG000|Overall Study|Lost to Follow-up|7|||
126432139|NCT01903356|454879924|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
126432140|NCT01903356|454879924|FG000|Overall Study|Violated the dosage and administration|3|||
126432141|NCT04529083|454879925|FG000|Overall Study|Withdrawal by Subject|3|||
126432142|NCT03305666|454879926|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
126432143|NCT03305666|454879927|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
126432144|NCT04196686|454879929|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
126432145|NCT04196686|454879930|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
126432146|NCT02587221|454879934|FG000|Overall Study|Adverse Event|3|||
126432147|NCT02587221|454879935|FG001|Overall Study|Adverse Event|3|||
126432148|NCT02587221|454879934|FG000|Overall Study|Death|33|||
126432149|NCT02587221|454879935|FG001|Overall Study|Death|34|||
126432150|NCT02587221|454879934|FG000|Overall Study|Withdrawal by Subject|66|||
126432151|NCT02587221|454879935|FG001|Overall Study|Withdrawal by Subject|61|||
126432152|NCT02587221|454879934|FG000|Overall Study|Lost to Follow-up|21|||
126432153|NCT02587221|454879935|FG001|Overall Study|Lost to Follow-up|19|||
126432154|NCT02587221|454879934|FG000|Overall Study|Protocol Violation|6|||
126432155|NCT02587221|454879935|FG001|Overall Study|Protocol Violation|5|||
126432156|NCT02587221|454879934|FG000|Overall Study|Other Reason or Unspecified|2|||
126432157|NCT02587221|454879935|FG001|Overall Study|Other Reason or Unspecified|1|||
126432158|NCT01001221|454879936|FG000|Overall Study|Adverse Event|1|||
126432159|NCT01001221|454879937|FG001|Overall Study|Adverse Event|2|||
126680645|NCT01964352|455788156|FG003|Overall Study|Lack of Efficacy|0|||
126680646|NCT01964352|455788153|FG000|Overall Study|Protocol Violation|2|||
126680647|NCT01964352|455788154|FG001|Overall Study|Protocol Violation|4|||
126346166|NCT01281306|454562331|FG004|Overall Study|Withdrawal by Subject|1|||
126346167|NCT01281306|454562332|FG005|Overall Study|Withdrawal by Subject|3|||
126346168|NCT01281306|454562333|FG006|Overall Study|Withdrawal by Subject|1|||
126346169|NCT01281306|454562327|FG000|Overall Study|Protocol deviation|0|||
126346170|NCT01281306|454562328|FG001|Overall Study|Protocol deviation|1|||
126346171|NCT01281306|454562329|FG002|Overall Study|Protocol deviation|1|||
126346172|NCT01281306|454562330|FG003|Overall Study|Protocol deviation|1|||
126346173|NCT01281306|454562331|FG004|Overall Study|Protocol deviation|1|||
126346174|NCT01281306|454562332|FG005|Overall Study|Protocol deviation|0|||
126346175|NCT01281306|454562333|FG006|Overall Study|Protocol deviation|0|||
126346176|NCT01281306|454562327|FG000|Overall Study|Condition no longer requires study drug|1|||
126346177|NCT01281306|454562328|FG001|Overall Study|Condition no longer requires study drug|0|||
126346178|NCT01281306|454562329|FG002|Overall Study|Condition no longer requires study drug|0|||
126346179|NCT01281306|454562330|FG003|Overall Study|Condition no longer requires study drug|0|||
126346180|NCT01281306|454562331|FG004|Overall Study|Condition no longer requires study drug|0|||
126346181|NCT01281306|454562332|FG005|Overall Study|Condition no longer requires study drug|1|||
126346182|NCT01281306|454562333|FG006|Overall Study|Condition no longer requires study drug|1|||
126346183|NCT01281306|454562327|FG000|Overall Study|Lost to Follow-up|1|||
126346184|NCT01281306|454562328|FG001|Overall Study|Lost to Follow-up|0|||
126432160|NCT01001221|454879938|FG002|Overall Study|Adverse Event|0|||
126432161|NCT01001221|454879939|FG003|Overall Study|Adverse Event|2|||
126432162|NCT01001221|454879940|FG004|Overall Study|Adverse Event|0|||
126680648|NCT01964352|455788155|FG002|Overall Study|Protocol Violation|0|||
126680649|NCT01964352|455788156|FG003|Overall Study|Protocol Violation|2|||
126680650|NCT01964352|455788153|FG000|Overall Study|Lost to Follow-up|1|||
126680651|NCT01964352|455788154|FG001|Overall Study|Lost to Follow-up|0|||
126680652|NCT01964352|455788155|FG002|Overall Study|Lost to Follow-up|0|||
126680653|NCT01964352|455788156|FG003|Overall Study|Lost to Follow-up|1|||
126680654|NCT01964352|455788153|FG000|Overall Study|Withdrawal by Subject|4|||
126680655|NCT01964352|455788154|FG001|Overall Study|Withdrawal by Subject|2|||
126680656|NCT01964352|455788155|FG002|Overall Study|Withdrawal by Subject|1|||
126680657|NCT01964352|455788156|FG003|Overall Study|Withdrawal by Subject|0|||
126680658|NCT01964352|455788153|FG000|Overall Study|Other than stated above|0|||
126680659|NCT01964352|455788154|FG001|Overall Study|Other than stated above|2|||
126680660|NCT01964352|455788155|FG002|Overall Study|Other than stated above|1|||
126680661|NCT01964352|455788156|FG003|Overall Study|Other than stated above|2|||
126680662|NCT00477165|455788159|FG000|Overall Study|Adverse Event|7|||
126680663|NCT00477165|455788160|FG001|Overall Study|Adverse Event|2|||
126680664|NCT00105443|455788161|FG000|Double-Blind Treatment|Adverse Event|1|||
126680665|NCT00105443|455788162|FG001|Double-Blind Treatment|Adverse Event|0|||
126680666|NCT00105443|455788163|FG002|Double-Blind Treatment|Adverse Event|0|||
126680667|NCT00105443|455788164|FG003|Double-Blind Treatment|Adverse Event|0|||
126680668|NCT00105443|455788161|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
126680669|NCT00105443|455788162|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
126680670|NCT00105443|455788163|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
126680671|NCT00105443|455788164|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
126680672|NCT00105443|455788161|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
126680673|NCT00105443|455788162|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
126680674|NCT00105443|455788163|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
126680675|NCT00105443|455788164|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
126680676|NCT00105443|455788161|FG000|Double-Blind Treatment|Physician Decision|1|||
126680677|NCT00105443|455788162|FG001|Double-Blind Treatment|Physician Decision|0|||
126680678|NCT00105443|455788163|FG002|Double-Blind Treatment|Physician Decision|2|||
126680679|NCT00105443|455788164|FG003|Double-Blind Treatment|Physician Decision|0|||
126680680|NCT00105443|455788161|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
126680681|NCT00105443|455788162|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
126680682|NCT00105443|455788163|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
126680683|NCT00105443|455788164|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
126346185|NCT01281306|454562329|FG002|Overall Study|Lost to Follow-up|0|||
126346186|NCT01281306|454562330|FG003|Overall Study|Lost to Follow-up|2|||
126346187|NCT01281306|454562331|FG004|Overall Study|Lost to Follow-up|0|||
126346188|NCT01281306|454562332|FG005|Overall Study|Lost to Follow-up|0|||
126346189|NCT01281306|454562333|FG006|Overall Study|Lost to Follow-up|1|||
126346190|NCT01281306|454562327|FG000|Overall Study|Death|1|||
126346191|NCT01281306|454562328|FG001|Overall Study|Death|0|||
126346192|NCT01281306|454562329|FG002|Overall Study|Death|0|||
126346193|NCT01281306|454562330|FG003|Overall Study|Death|0|||
126346194|NCT01281306|454562331|FG004|Overall Study|Death|0|||
126346195|NCT01281306|454562332|FG005|Overall Study|Death|0|||
126346196|NCT01281306|454562333|FG006|Overall Study|Death|0|||
126346197|NCT01281306|454562327|FG000|Overall Study|Adverse Event|3|||
126346198|NCT01281306|454562328|FG001|Overall Study|Adverse Event|2|||
126346199|NCT01281306|454562329|FG002|Overall Study|Adverse Event|2|||
126346200|NCT01281306|454562330|FG003|Overall Study|Adverse Event|3|||
126346201|NCT01281306|454562331|FG004|Overall Study|Adverse Event|5|||
126346202|NCT01281306|454562332|FG005|Overall Study|Adverse Event|3|||
126346203|NCT01281306|454562333|FG006|Overall Study|Adverse Event|3|||
126346204|NCT01281306|454562327|FG000|Overall Study|Randomized in error|1|||
126432163|NCT01001221|454879936|FG000|Overall Study|Disease progression|3|||
126680684|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
126680685|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
126680686|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
126346205|NCT01281306|454562328|FG001|Overall Study|Randomized in error|0|||
126346206|NCT01281306|454562329|FG002|Overall Study|Randomized in error|0|||
126432164|NCT01001221|454879937|FG001|Overall Study|Disease progression|2|||
126680687|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
126680688|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
126346207|NCT01281306|454562330|FG003|Overall Study|Randomized in error|1|||
126346208|NCT01281306|454562331|FG004|Overall Study|Randomized in error|0|||
126346209|NCT01281306|454562332|FG005|Overall Study|Randomized in error|0|||
126432165|NCT01001221|454879938|FG002|Overall Study|Disease progression|2|||
126432166|NCT01001221|454879939|FG003|Overall Study|Disease progression|4|||
126432167|NCT01001221|454879940|FG004|Overall Study|Disease progression|0|||
126432168|NCT01001221|454879936|FG000|Overall Study|Other|1|||
126432169|NCT01001221|454879937|FG001|Overall Study|Other|1|||
126432170|NCT01001221|454879938|FG002|Overall Study|Other|0|||
126432171|NCT01001221|454879939|FG003|Overall Study|Other|0|||
126432172|NCT01001221|454879940|FG004|Overall Study|Other|0|||
126432173|NCT01001221|454879936|FG000|Overall Study|Not treated; protocol exclusion|0|||
126432174|NCT01001221|454879937|FG001|Overall Study|Not treated; protocol exclusion|0|||
126432175|NCT01001221|454879938|FG002|Overall Study|Not treated; protocol exclusion|1|||
126432176|NCT01001221|454879939|FG003|Overall Study|Not treated; protocol exclusion|0|||
126432177|NCT01001221|454879940|FG004|Overall Study|Not treated; protocol exclusion|0|||
126432178|NCT01791244|454879942|FG000|Overall Study|Adverse Event|5|||
126432179|NCT01791244|454879943|FG001|Overall Study|Adverse Event|7|||
126432180|NCT01791244|454879942|FG000|Overall Study|Insufficient clinical response|10|||
126432181|NCT01791244|454879943|FG001|Overall Study|Insufficient clinical response|10|||
126432182|NCT01791244|454879942|FG000|Overall Study|Laboratory Abnormality|0|||
126432183|NCT01791244|454879943|FG001|Overall Study|Laboratory Abnormality|1|||
126432184|NCT01149096|454879945|FG000|Overall Study|Lost to Follow-up|0|||
126432185|NCT01149096|454879946|FG001|Overall Study|Lost to Follow-up|1|||
126432186|NCT04079296|454879950|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
126432187|NCT04079296|454879951|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
126432188|NCT04079296|454879952|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
126432189|NCT04079296|454879953|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
126432190|NCT04079296|454879954|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
126432191|NCT04079296|454879950|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
126432192|NCT04079296|454879951|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
126432193|NCT04079296|454879952|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
126432194|NCT04079296|454879953|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
126432195|NCT04079296|454879954|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
126432196|NCT04079296|454879950|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
126432197|NCT04079296|454879951|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
126432198|NCT04079296|454879952|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
126432199|NCT04079296|454879953|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
126432200|NCT04079296|454879954|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
126432201|NCT04079296|454879950|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
126432202|NCT04079296|454879951|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
126432203|NCT04079296|454879952|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
126432204|NCT04079296|454879953|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
126432205|NCT04079296|454879954|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
126432206|NCT04079296|454879950|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
126432207|NCT04079296|454879951|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
126432208|NCT04079296|454879952|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
126432209|NCT04079296|454879953|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
126432210|NCT04079296|454879954|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
126432211|NCT04079296|454879950|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
126432212|NCT04079296|454879951|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
126432213|NCT04079296|454879952|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
126432214|NCT04079296|454879953|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
126432215|NCT04079296|454879954|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
126432216|NCT04079296|454879950|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
126432217|NCT04079296|454879951|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
126680689|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
126680690|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
126432218|NCT04079296|454879952|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
126346210|NCT01281306|454562333|FG006|Overall Study|Randomized in error|0|||
126346211|NCT04491994|454562334|FG000|Overall Study|Withdrawal by Subject|10|||
126346212|NCT04491994|454562335|FG001|Overall Study|Withdrawal by Subject|5|||
126346213|NCT04491994|454562334|FG000|Overall Study|developed fever > 3 days|4|||
126346214|NCT04491994|454562335|FG001|Overall Study|developed fever > 3 days|1|||
126346215|NCT04491994|454562334|FG000|Overall Study|Protocol Violation|11|||
126346216|NCT04491994|454562335|FG001|Overall Study|Protocol Violation|2|||
126346217|NCT04491994|454562334|FG000|Overall Study|Lost to Follow-up|4|||
126346218|NCT04491994|454562335|FG001|Overall Study|Lost to Follow-up|3|||
126346219|NCT02320396|454562341|FG000|Overall Study|Adverse Event|2|||
126346220|NCT02320396|454562342|FG001|Overall Study|Adverse Event|2|||
126346221|NCT02320396|454562341|FG000|Overall Study|Pregnancy|0|||
126346222|NCT02320396|454562342|FG001|Overall Study|Pregnancy|1|||
126346223|NCT02320396|454562341|FG000|Overall Study|Protocol Violation|0|||
126346224|NCT02320396|454562342|FG001|Overall Study|Protocol Violation|1|||
126346225|NCT02320396|454562341|FG000|Overall Study|Withdrawal by Subject|2|||
126346226|NCT02320396|454562342|FG001|Overall Study|Withdrawal by Subject|0|||
126346227|NCT03331562|454562343|FG000|Overall Study|Adverse Event|2|||
126346228|NCT03331562|454562344|FG001|Overall Study|Adverse Event|0|||
126346229|NCT03331562|454562343|FG000|Overall Study|Death|1|||
126346230|NCT03331562|454562344|FG001|Overall Study|Death|0|||
126346231|NCT03718000|454562345|FG000|Overall Study|Relocation|2|||
126346232|NCT03718000|454562346|FG001|Overall Study|Relocation|4|||
126346233|NCT03718000|454562345|FG000|Overall Study|Pregnancy|0|||
126346234|NCT03718000|454562346|FG001|Overall Study|Pregnancy|1|||
126346235|NCT02441283|454562347|FG000|Overall Study|Withdrew consent|15|||
126346236|NCT02441283|454562347|FG000|Overall Study|Lost to Follow-up|42|||
126346237|NCT02441283|454562347|FG000|Overall Study|Death|1|||
126432219|NCT04079296|454879953|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
126432220|NCT04079296|454879954|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
126432221|NCT04079296|454879950|FG000|Dose Expansion Phase (168 Days)|Death|0|||
126346238|NCT02441283|454562347|FG000|Overall Study|Other, not specified|32|||
126346239|NCT00537277|454562348|FG000|Overall Study|Adverse Event|1|||
126346240|NCT00537277|454562348|FG000|Overall Study|Lack of Efficacy|2|||
126346241|NCT00537277|454562348|FG000|Overall Study|Lost to Follow-up|12|||
126346242|NCT00537277|454562348|FG000|Overall Study|Protocol Violation|11|||
126346243|NCT00537277|454562348|FG000|Overall Study|Unclassified|4|||
126346244|NCT00537277|454562348|FG000|Overall Study|Inability to tolerate trial medication|4|||
126346245|NCT00537277|454562348|FG000|Overall Study|Non-compliance with trial procedures|15|||
126346246|NCT00226655|454562349|FG000|Overall Study|Death|13|||
126346247|NCT00226655|454562349|FG000|Overall Study|Withdrawal by Subject|15|||
126346248|NCT00226655|454562349|FG000|Overall Study|Adverse Event|35|||
126346249|NCT00226655|454562349|FG000|Overall Study|Physician Decision|6|||
126346250|NCT00226655|454562349|FG000|Overall Study|Clinical deterioration|10|||
126346251|NCT01285518|454562353|FG000|Overall Study|Lost to Follow-up|0|||
126346252|NCT01285518|454562354|FG001|Overall Study|Lost to Follow-up|0|||
126346253|NCT01285518|454562355|FG002|Overall Study|Lost to Follow-up|0|||
126346254|NCT01285518|454562356|FG003|Overall Study|Lost to Follow-up|0|||
126346255|NCT01285518|454562357|FG004|Overall Study|Lost to Follow-up|0|||
126346256|NCT01285518|454562358|FG005|Overall Study|Lost to Follow-up|1|||
126346257|NCT01285518|454562359|FG006|Overall Study|Lost to Follow-up|0|||
126346258|NCT01285518|454562360|FG007|Overall Study|Lost to Follow-up|0|||
126346259|NCT00294658|454562361|FG000|Overall Study|Death|0|||
126346260|NCT00294658|454562362|FG001|Overall Study|Death|1|||
126346261|NCT00294658|454562361|FG000|Overall Study|Lost to Follow-up|4|||
126346262|NCT00294658|454562362|FG001|Overall Study|Lost to Follow-up|0|||
126346263|NCT00294658|454562361|FG000|Overall Study|Physician Decision|1|||
126346264|NCT00294658|454562362|FG001|Overall Study|Physician Decision|2|||
126346265|NCT00294658|454562361|FG000|Overall Study|Pregnancy|0|||
126346266|NCT00294658|454562362|FG001|Overall Study|Pregnancy|1|||
126346267|NCT00294658|454562361|FG000|Overall Study|Withdrawal by Subject|0|||
126346268|NCT00294658|454562362|FG001|Overall Study|Withdrawal by Subject|4|||
126346269|NCT00294658|454562361|FG000|Overall Study|Found to have invasive thymoma|1|||
126346270|NCT00294658|454562362|FG001|Overall Study|Found to have invasive thymoma|0|||
126346271|NCT00294658|454562361|FG000|Overall Study|Patient and family were not satisfied|0|||
126346272|NCT00294658|454562362|FG001|Overall Study|Patient and family were not satisfied|1|||
126346273|NCT01910441|454562368|FG000|Overall Study|Sponsor decision|0|||
126346274|NCT01910441|454562369|FG001|Overall Study|Sponsor decision|2|||
126346275|NCT01910441|454562368|FG000|Overall Study|Lost to Follow-up|6|||
126346276|NCT01910441|454562369|FG001|Overall Study|Lost to Follow-up|5|||
126346277|NCT01910441|454562368|FG000|Overall Study|Withdrawal by Subject|0|||
126346278|NCT01910441|454562369|FG001|Overall Study|Withdrawal by Subject|1|||
126346279|NCT01910441|454562368|FG000|Overall Study|Non-compliance|0|||
126346280|NCT01910441|454562369|FG001|Overall Study|Non-compliance|1|||
126346281|NCT01910441|454562368|FG000|Overall Study|Adverse Event|1|||
126346282|NCT01910441|454562369|FG001|Overall Study|Adverse Event|0|||
126346283|NCT01910441|454562368|FG000|Overall Study|Physician Decision|0|||
126346284|NCT01910441|454562369|FG001|Overall Study|Physician Decision|1|||
126346285|NCT02340949|454562370|FG000|Overall Study|Adverse Event|4|||
126346286|NCT02340949|454562371|FG001|Overall Study|Adverse Event|2|||
126346287|NCT02340949|454562370|FG000|Overall Study|Withdrawal by Subject|2|||
126346288|NCT02340949|454562371|FG001|Overall Study|Withdrawal by Subject|0|||
126346289|NCT02340949|454562370|FG000|Overall Study|Progression disease|6|||
126346290|NCT02340949|454562371|FG001|Overall Study|Progression disease|2|||
126346291|NCT02340949|454562370|FG000|Overall Study|Death|3|||
126346292|NCT02340949|454562371|FG001|Overall Study|Death|0|||
126346293|NCT02340949|454562370|FG000|Overall Study|Physician Decision|1|||
126432222|NCT04079296|454879951|FG001|Dose Expansion Phase (168 Days)|Death|0|||
126346294|NCT02340949|454562371|FG001|Overall Study|Physician Decision|0|||
126346295|NCT01192178|454562372|FG000|Overall Study|Withdrawal by Subject|6|||
126346296|NCT01192178|454562373|FG001|Overall Study|Withdrawal by Subject|10|||
126346297|NCT01192178|454562372|FG000|Overall Study|Protocol Violation|10|||
126346298|NCT01192178|454562373|FG001|Overall Study|Protocol Violation|3|||
126346299|NCT01192178|454562372|FG000|Overall Study|Physician Decision|2|||
126346300|NCT01192178|454562373|FG001|Overall Study|Physician Decision|4|||
126346301|NCT01192178|454562372|FG000|Overall Study|Lost to Follow-up|3|||
126346302|NCT01192178|454562373|FG001|Overall Study|Lost to Follow-up|3|||
126346303|NCT01192178|454562372|FG000|Overall Study|Adverse Event|2|||
126346304|NCT01192178|454562373|FG001|Overall Study|Adverse Event|1|||
126346305|NCT01192178|454562372|FG000|Overall Study|Lack of Efficacy|1|||
126346306|NCT01192178|454562373|FG001|Overall Study|Lack of Efficacy|2|||
126346307|NCT01977846|454562374|FG000|Total Study - Prospective|Death|0|||
126346308|NCT01977846|454562375|FG001|Total Study - Prospective|Death|1|||
126346309|NCT01977846|454562374|FG000|Total Study - Prospective|Lost to Follow-up|0|||
126346310|NCT01977846|454562375|FG001|Total Study - Prospective|Lost to Follow-up|8|||
126346311|NCT01977846|454562374|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
126346312|NCT01977846|454562375|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
126346313|NCT01977846|454562374|FG000|Total Study - Prospective|Not available at time of visit|0|||
126346314|NCT01977846|454562375|FG001|Total Study - Prospective|Not available at time of visit|5|||
126346315|NCT01977846|454562374|FG000|Total Study - Prospective|No show|0|||
126346316|NCT01977846|454562375|FG001|Total Study - Prospective|No show|1|||
126346317|NCT01977846|454562374|FG000|Total Study - Prospective|Protocol Violation|0|||
126346318|NCT01977846|454562375|FG001|Total Study - Prospective|Protocol Violation|1|||
126346319|NCT02460289|454562376|FG000|Overall Study|Adverse Event|1|||
126346320|NCT02460289|454562376|FG000|Overall Study|Withdrawal by Subject|8|||
126346321|NCT02460289|454562376|FG000|Overall Study|Lost to Follow-up|1|||
126346322|NCT01155570|454562377|FG000|Overall Study|Adverse Event|39|||
126346323|NCT01155570|454562377|FG000|Overall Study|Lack of Efficacy|46|||
126346324|NCT01155570|454562377|FG000|Overall Study|Participant's Economic Reasons|17|||
126346325|NCT01155570|454562377|FG000|Overall Study|No Hospital Visits|7|||
126346326|NCT01155570|454562377|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
126346327|NCT01155570|454562377|FG000|Overall Study|Adverse Event + Other Reasons|7|||
126346328|NCT01155570|454562377|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
126346329|NCT01155570|454562377|FG000|Overall Study|Other Reasons|23|||
126346330|NCT00296517|454562378|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
126346331|NCT00296517|454562379|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
126346332|NCT00296517|454562378|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
126346333|NCT00296517|454562379|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
126432223|NCT04079296|454879952|FG002|Dose Expansion Phase (168 Days)|Death|0|||
126346334|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
126346335|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
126346336|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
126432224|NCT04079296|454879953|FG003|Dose Expansion Phase (168 Days)|Death|1|||
126432225|NCT04079296|454879954|FG004|Dose Expansion Phase (168 Days)|Death|0|||
126432226|NCT01346358|454879967|FG000|Overall Study|Withdrawal by Subject|1|||
126432227|NCT01346358|454879968|FG001|Overall Study|Withdrawal by Subject|0|||
126432228|NCT01346358|454879969|FG002|Overall Study|Withdrawal by Subject|1|||
126432229|NCT01346358|454879970|FG003|Overall Study|Withdrawal by Subject|1|||
126432230|NCT01346358|454879971|FG004|Overall Study|Withdrawal by Subject|0|||
126432231|NCT01346358|454879972|FG005|Overall Study|Withdrawal by Subject|2|||
126432232|NCT01346358|454879973|FG006|Overall Study|Withdrawal by Subject|1|||
126432233|NCT01346358|454879974|FG007|Overall Study|Withdrawal by Subject|1|||
126680691|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
126680692|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
126680693|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
126680694|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
126680695|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
126680696|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
126432234|NCT01346358|454879975|FG008|Overall Study|Withdrawal by Subject|1|||
126432235|NCT01346358|454879967|FG000|Overall Study|Adverse Event|1|||
126432236|NCT01346358|454879968|FG001|Overall Study|Adverse Event|0|||
126432237|NCT01346358|454879969|FG002|Overall Study|Adverse Event|0|||
126432238|NCT01346358|454879970|FG003|Overall Study|Adverse Event|0|||
126432239|NCT01346358|454879971|FG004|Overall Study|Adverse Event|1|||
126432240|NCT01346358|454879972|FG005|Overall Study|Adverse Event|0|||
126432241|NCT01346358|454879973|FG006|Overall Study|Adverse Event|0|||
126432242|NCT01346358|454879974|FG007|Overall Study|Adverse Event|0|||
126432243|NCT01346358|454879975|FG008|Overall Study|Adverse Event|1|||
126432244|NCT01346358|454879967|FG000|Overall Study|Non-Compliance|0|||
126432245|NCT01346358|454879968|FG001|Overall Study|Non-Compliance|0|||
126432246|NCT01346358|454879969|FG002|Overall Study|Non-Compliance|0|||
126432247|NCT01346358|454879970|FG003|Overall Study|Non-Compliance|0|||
126432248|NCT01346358|454879971|FG004|Overall Study|Non-Compliance|0|||
126432249|NCT01346358|454879972|FG005|Overall Study|Non-Compliance|0|||
126432250|NCT01346358|454879973|FG006|Overall Study|Non-Compliance|0|||
126432251|NCT01346358|454879974|FG007|Overall Study|Non-Compliance|2|||
126432252|NCT01346358|454879975|FG008|Overall Study|Non-Compliance|0|||
126432253|NCT01346358|454879967|FG000|Overall Study|Physician Decision|0|||
126432254|NCT01346358|454879968|FG001|Overall Study|Physician Decision|1|||
126432255|NCT01346358|454879969|FG002|Overall Study|Physician Decision|0|||
126432256|NCT01346358|454879970|FG003|Overall Study|Physician Decision|0|||
126432257|NCT01346358|454879971|FG004|Overall Study|Physician Decision|0|||
126432258|NCT01346358|454879972|FG005|Overall Study|Physician Decision|0|||
126432259|NCT01346358|454879973|FG006|Overall Study|Physician Decision|0|||
126432260|NCT01346358|454879974|FG007|Overall Study|Physician Decision|1|||
126432261|NCT01346358|454879975|FG008|Overall Study|Physician Decision|1|||
126432262|NCT05058365|454879978|FG000|Overall Study|Migration|1|||
126432263|NCT05058365|454879979|FG001|Overall Study|Migration|1|||
126432264|NCT04038359|454879980|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
126432265|NCT04038359|454879981|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
126680697|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
126758664|NCT00134563|456066674|FG001|Overall Study|progressive disease|4|||
126432266|NCT04038359|454879980|FG000|Overall Study|Death|8|||
126432267|NCT04038359|454879981|FG001|Overall Study|Death|7|||
126432268|NCT04038359|454879980|FG000|Overall Study|Lost to Follow-up|3|||
126432269|NCT04038359|454879981|FG001|Overall Study|Lost to Follow-up|0|||
126432270|NCT04038359|454879980|FG000|Overall Study|Participant Moved|1|||
126432271|NCT04038359|454879981|FG001|Overall Study|Participant Moved|0|||
126432272|NCT04038359|454879980|FG000|Overall Study|Withdrawal by Subject|4|||
126432273|NCT04038359|454879981|FG001|Overall Study|Withdrawal by Subject|3|||
126432274|NCT04038359|454879980|FG000|Overall Study|Physician Decision|3|||
126432275|NCT04038359|454879981|FG001|Overall Study|Physician Decision|2|||
126432276|NCT04038359|454879980|FG000|Overall Study|Adverse Event|0|||
126432277|NCT04038359|454879981|FG001|Overall Study|Adverse Event|2|||
126432278|NCT04038359|454879980|FG000|Overall Study|Progressive Disease|0|||
126432279|NCT04038359|454879981|FG001|Overall Study|Progressive Disease|1|||
126432280|NCT00703014|454879982|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
126432281|NCT00703014|454879983|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
126432282|NCT00703014|454879984|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
126432283|NCT00703014|454879985|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
126432284|NCT00703014|454879982|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
126432285|NCT00703014|454879983|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
126432286|NCT00703014|454879984|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
126432287|NCT00703014|454879985|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
126432288|NCT05121766|454879986|FG000|Overall Study|Covid reinfection|3|||
126432289|NCT05121766|454879987|FG001|Overall Study|Covid reinfection|0|||
126432290|NCT05121766|454879986|FG000|Overall Study|Withdrawal by Subject|3|||
126432291|NCT05121766|454879987|FG001|Overall Study|Withdrawal by Subject|1|||
126432292|NCT05121766|454879986|FG000|Overall Study|Adverse Event|2|||
126758665|NCT00134563|456066675|FG002|Overall Study|progressive disease|2|||
126680698|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
126680699|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
126680700|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
126346337|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
126346338|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
126346339|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
126346340|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
126346341|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
126346342|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
126346343|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
126346344|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
126346345|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
126346346|NCT00296517|454562378|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
126346347|NCT00296517|454562379|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
126346348|NCT00964782|454562383|FG000|Overall Study|Lost to Follow-up|1|||
126346349|NCT00964782|454562384|FG001|Overall Study|Lost to Follow-up|0|||
126346350|NCT00596635|454562388|FG000|Overall Study|Lost to Follow-up|0|||
126346351|NCT00596635|454562389|FG001|Overall Study|Lost to Follow-up|2|||
126346352|NCT00596635|454562390|FG002|Overall Study|Lost to Follow-up|0|||
126346353|NCT00596635|454562388|FG000|Overall Study|Treatment for symptomatic UTI|4|||
126346354|NCT00596635|454562389|FG001|Overall Study|Treatment for symptomatic UTI|6|||
126346355|NCT00596635|454562390|FG002|Overall Study|Treatment for symptomatic UTI|3|||
126346356|NCT00596635|454562388|FG000|Overall Study|Hip fracture|2|||
126346357|NCT00596635|454562389|FG001|Overall Study|Hip fracture|3|||
126346358|NCT00596635|454562390|FG002|Overall Study|Hip fracture|3|||
126346359|NCT00596635|454562388|FG000|Overall Study|Could not provide urine specimen|1|||
126346360|NCT00596635|454562389|FG001|Overall Study|Could not provide urine specimen|2|||
126346361|NCT00596635|454562390|FG002|Overall Study|Could not provide urine specimen|2|||
126346362|NCT01143324|454562392|FG000|Overall Study|Lost to Follow-up|11|||
126346363|NCT01143324|454562392|FG000|Overall Study|Withdrawal by Subject|4|||
126346364|NCT01143324|454562392|FG000|Overall Study|Explant of the device|4|||
126346365|NCT01101178|454562397|FG000|Period 1|Withdrawal by Subject|1|||
126346366|NCT01101178|454562398|FG001|Period 1|Withdrawal by Subject|2|||
126346367|NCT01101178|454562397|FG000|Period 1|Positive drug screen|1|||
126346368|NCT01101178|454562398|FG001|Period 1|Positive drug screen|1|||
126346369|NCT01101178|454562397|FG000|Period 1|Adverse Event|2|||
126346370|NCT01101178|454562398|FG001|Period 1|Adverse Event|1|||
126346371|NCT01101178|454562397|FG000|Period 2|Withdrawal by Subject|0|||
126346372|NCT01101178|454562398|FG001|Period 2|Withdrawal by Subject|1|||
126346373|NCT01850641|454562399|FG000|Overall Study|Physician Decision|1|||
126346374|NCT01850641|454562399|FG000|Overall Study|Decrease in serum phosphorus|1|||
126346375|NCT01850641|454562399|FG000|Overall Study|Decrease in serum calcium|2|||
126346376|NCT01850641|454562399|FG000|Overall Study|Increase in serum ferritin|1|||
126346377|NCT00141817|454562400|FG000|Overall Study|Protocol Violation|0|||
126346378|NCT00141817|454562401|FG001|Overall Study|Protocol Violation|0|||
126346379|NCT00141817|454562402|FG002|Overall Study|Protocol Violation|1|||
126346380|NCT00141817|454562403|FG003|Overall Study|Protocol Violation|0|||
126346381|NCT00141817|454562400|FG000|Overall Study|Parent request|1|||
126346382|NCT00141817|454562401|FG001|Overall Study|Parent request|0|||
126346383|NCT00141817|454562402|FG002|Overall Study|Parent request|0|||
126346384|NCT00141817|454562403|FG003|Overall Study|Parent request|0|||
126346385|NCT00127803|454562404|FG000|Overall Study|Adverse Event|2|||
126346386|NCT00127803|454562405|FG001|Overall Study|Adverse Event|0|||
126346387|NCT00127803|454562406|FG002|Overall Study|Adverse Event|0|||
126346388|NCT00127803|454562407|FG003|Overall Study|Adverse Event|0|||
126346389|NCT00127803|454562404|FG000|Overall Study|Withdrawal by Subject|1|||
126346390|NCT00127803|454562405|FG001|Overall Study|Withdrawal by Subject|0|||
126346391|NCT00127803|454562406|FG002|Overall Study|Withdrawal by Subject|0|||
126346392|NCT00127803|454562407|FG003|Overall Study|Withdrawal by Subject|0|||
126346393|NCT00127803|454562404|FG000|Overall Study|Lost to Follow-up|0|||
126346394|NCT00127803|454562405|FG001|Overall Study|Lost to Follow-up|0|||
126346395|NCT00127803|454562406|FG002|Overall Study|Lost to Follow-up|0|||
126346396|NCT00127803|454562407|FG003|Overall Study|Lost to Follow-up|1|||
126346397|NCT00862992|454562408|FG000|Overall Study|Adverse Event|2|||
126346398|NCT00862992|454562409|FG001|Overall Study|Adverse Event|1|||
126346399|NCT00862992|454562410|FG002|Overall Study|Adverse Event|1|||
126346400|NCT00862992|454562408|FG000|Overall Study|Physician Decision|1|||
126346401|NCT00862992|454562409|FG001|Overall Study|Physician Decision|0|||
126346402|NCT00862992|454562410|FG002|Overall Study|Physician Decision|0|||
126346403|NCT00862992|454562408|FG000|Overall Study|Withdrawal by Subject|0|||
126346404|NCT00862992|454562409|FG001|Overall Study|Withdrawal by Subject|0|||
126346405|NCT00862992|454562410|FG002|Overall Study|Withdrawal by Subject|2|||
126346406|NCT02696798|454562419|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
126346407|NCT02696798|454562420|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
126346408|NCT02696798|454562421|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
126346409|NCT02696798|454562419|FG000|Blinded Treatment Dosing Period|Death|0|||
126346410|NCT02696798|454562420|FG001|Blinded Treatment Dosing Period|Death|0|||
126346411|NCT02696798|454562421|FG002|Blinded Treatment Dosing Period|Death|1|||
126346412|NCT02696798|454562419|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
126346413|NCT02696798|454562420|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
126346414|NCT02696798|454562421|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
126346415|NCT02696798|454562419|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
126346416|NCT02696798|454562420|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
126346417|NCT02696798|454562421|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
126346418|NCT02696798|454562419|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
126346419|NCT02696798|454562420|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
126346420|NCT02696798|454562421|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
126346421|NCT02696798|454562419|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
126346422|NCT02696798|454562420|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
126346423|NCT02696798|454562421|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
126346424|NCT02696798|454562419|FG000|Extended Treatment Period|Adverse Event|1|||
126346425|NCT02696798|454562420|FG001|Extended Treatment Period|Adverse Event|4|||
126346426|NCT02696798|454562421|FG002|Extended Treatment Period|Adverse Event|5|||
126346427|NCT02696798|454562419|FG000|Extended Treatment Period|Lack of Efficacy|7|||
126346428|NCT02696798|454562420|FG001|Extended Treatment Period|Lack of Efficacy|2|||
126346429|NCT02696798|454562421|FG002|Extended Treatment Period|Lack of Efficacy|2|||
126346430|NCT02696798|454562419|FG000|Extended Treatment Period|Lost to Follow-up|1|||
126346431|NCT02696798|454562420|FG001|Extended Treatment Period|Lost to Follow-up|0|||
126680701|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
126346432|NCT02696798|454562421|FG002|Extended Treatment Period|Lost to Follow-up|0|||
126346433|NCT02696798|454562419|FG000|Extended Treatment Period|Physician Decision|0|||
126346434|NCT02696798|454562420|FG001|Extended Treatment Period|Physician Decision|1|||
126346435|NCT02696798|454562421|FG002|Extended Treatment Period|Physician Decision|0|||
126346436|NCT02696798|454562419|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
126346437|NCT02696798|454562420|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
126346438|NCT02696798|454562421|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
126346439|NCT02696798|454562419|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
126346440|NCT02696798|454562420|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
126346441|NCT02696798|454562421|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
126346442|NCT02696798|454562419|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
126346443|NCT02696798|454562420|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
126346444|NCT02696798|454562421|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
126346445|NCT02696798|454562419|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
126346446|NCT02696798|454562420|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
126346447|NCT02696798|454562421|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
126346448|NCT02696798|454562419|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
126346449|NCT02696798|454562420|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
126346450|NCT02696798|454562421|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
126346451|NCT02696798|454562419|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
126346452|NCT02696798|454562420|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
126346453|NCT02696798|454562421|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
126346454|NCT02696798|454562419|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
126346455|NCT02696798|454562420|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
126346456|NCT02696798|454562421|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
126346457|NCT03675308|454564535|FG000|Overall Study|Adverse Event|3|||
126346458|NCT03675308|454564536|FG001|Overall Study|Adverse Event|2|||
126346459|NCT03675308|454564535|FG000|Overall Study|Withdrawal by Subject|6|||
126346460|NCT03675308|454564536|FG001|Overall Study|Withdrawal by Subject|4|||
126346461|NCT03675308|454564535|FG000|Overall Study|Lost to Follow-up|3|||
126346462|NCT03675308|454564536|FG001|Overall Study|Lost to Follow-up|0|||
126346463|NCT03675308|454564535|FG000|Overall Study|Lack of Efficacy|1|||
126346464|NCT03675308|454564536|FG001|Overall Study|Lack of Efficacy|1|||
126346465|NCT03675308|454564535|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
126346466|NCT03675308|454564536|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
126346467|NCT03675308|454564535|FG000|Overall Study|Other|0|||
126346468|NCT03675308|454564536|FG001|Overall Study|Other|1|||
126346469|NCT01386385|454564537|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
126346470|NCT01386385|454564538|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346471|NCT01386385|454564539|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346472|NCT01386385|454564540|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346473|NCT01386385|454564541|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346474|NCT01386385|454564542|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346475|NCT01386385|454564543|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346476|NCT01386385|454564544|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
126346477|NCT01386385|454564537|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
126346478|NCT01386385|454564538|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346479|NCT01386385|454564539|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346480|NCT01386385|454564540|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346481|NCT01386385|454564541|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346482|NCT01386385|454564542|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346483|NCT01386385|454564543|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346484|NCT01386385|454564544|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
126346485|NCT01386385|454564537|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346486|NCT01386385|454564538|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346487|NCT01386385|454564539|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
126346488|NCT01386385|454564540|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346489|NCT01386385|454564541|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346490|NCT01386385|454564542|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346491|NCT01386385|454564543|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346492|NCT01386385|454564544|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
126346493|NCT01386385|454564537|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126432293|NCT05121766|454879987|FG001|Overall Study|Adverse Event|4|||
126432294|NCT05121766|454879986|FG000|Overall Study|Lost to Follow-up|0|||
126432295|NCT05121766|454879987|FG001|Overall Study|Lost to Follow-up|1|||
126432296|NCT01033240|454879991|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
126432297|NCT01033240|454879992|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
126432298|NCT01033240|454879993|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
126432299|NCT01033240|454879991|FG000|Overall Study|Death|2|||
126432300|NCT01033240|454879992|FG001|Overall Study|Death|0|||
126432301|NCT01033240|454879993|FG002|Overall Study|Death|0|||
126432302|NCT01033240|454879991|FG000|Overall Study|Withdrew Consent|2|||
126432303|NCT01033240|454879992|FG001|Overall Study|Withdrew Consent|9|||
126346494|NCT01386385|454564538|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126346495|NCT01386385|454564539|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126346496|NCT01386385|454564540|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126346497|NCT01386385|454564541|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
126346498|NCT01386385|454564542|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126346499|NCT01386385|454564543|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126346500|NCT01386385|454564544|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
126346501|NCT01386385|454564537|FG000|Phase II Concurrent CRT|Adverse Event|0|||
126346502|NCT01386385|454564538|FG001|Phase II Concurrent CRT|Adverse Event|0|||
126346503|NCT01386385|454564539|FG002|Phase II Concurrent CRT|Adverse Event|0|||
126346504|NCT01386385|454564540|FG003|Phase II Concurrent CRT|Adverse Event|0|||
126346505|NCT01386385|454564541|FG004|Phase II Concurrent CRT|Adverse Event|0|||
126346506|NCT01386385|454564542|FG005|Phase II Concurrent CRT|Adverse Event|0|||
126346507|NCT01386385|454564543|FG006|Phase II Concurrent CRT|Adverse Event|3|||
126346508|NCT01386385|454564544|FG007|Phase II Concurrent CRT|Adverse Event|3|||
126346509|NCT01386385|454564537|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346510|NCT01386385|454564538|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346511|NCT01386385|454564539|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346512|NCT01386385|454564540|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346513|NCT01386385|454564541|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346514|NCT01386385|454564542|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346515|NCT01386385|454564543|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
126346516|NCT01386385|454564544|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
126346517|NCT01386385|454564537|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
126346518|NCT01386385|454564538|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
126346519|NCT01386385|454564539|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
126432304|NCT01033240|454879993|FG002|Overall Study|Withdrew Consent|2|||
126346520|NCT01386385|454564540|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
126432305|NCT01033240|454879991|FG000|Overall Study|Disease Progression|35|||
126432306|NCT01033240|454879992|FG001|Overall Study|Disease Progression|32|||
126346521|NCT01386385|454564541|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
126346522|NCT01386385|454564542|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
126346523|NCT01386385|454564543|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
126680702|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
126680703|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
126346524|NCT01386385|454564544|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
126680704|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
126346525|NCT01386385|454564537|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126758666|NCT00134563|456066673|FG000|Overall Study|did not wish to continue|33|||
126346526|NCT01386385|454564538|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126346527|NCT01386385|454564539|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126346528|NCT01386385|454564540|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126346529|NCT01386385|454564541|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126346530|NCT01386385|454564542|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126346531|NCT01386385|454564543|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
126680705|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
126680706|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
126346532|NCT01386385|454564544|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
126346533|NCT01386385|454564537|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
126346534|NCT01386385|454564538|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
126346535|NCT01386385|454564539|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
126346536|NCT01386385|454564540|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
126346537|NCT01386385|454564541|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
126346538|NCT01386385|454564542|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
126346539|NCT01386385|454564543|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
126346540|NCT01386385|454564544|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
126346541|NCT00788671|454564548|FG000|Overall Study|Death|2|||
126346542|NCT00788671|454564548|FG000|Overall Study|Unable to biopsy|1|||
126346543|NCT00788671|454564548|FG000|Overall Study|Withdrawal by Subject|4|||
126346544|NCT00788671|454564548|FG000|Overall Study|IUD expulsed|1|||
126432307|NCT01033240|454879993|FG002|Overall Study|Disease Progression|41|||
126346545|NCT00788671|454564548|FG000|Overall Study|Lost to follow up|2|||
126346546|NCT03405870|454564549|FG000|Overall Study|Withdrawal|1|||
126432308|NCT01033240|454879991|FG000|Overall Study|Investigator Discretion|0|||
126432309|NCT01033240|454879992|FG001|Overall Study|Investigator Discretion|0|||
126432310|NCT01033240|454879993|FG002|Overall Study|Investigator Discretion|2|||
126432311|NCT01033240|454879991|FG000|Overall Study|Other|0|||
126432312|NCT01033240|454879992|FG001|Overall Study|Other|1|||
126432313|NCT01033240|454879993|FG002|Overall Study|Other|2|||
126432314|NCT05468814|454879994|FG000|Overall Study|Lost to Follow-up|5|||
126432315|NCT05468814|454879995|FG001|Overall Study|Lost to Follow-up|6|||
126432316|NCT04716426|454879997|FG000|Overall Study|Vaccination|1|||
126432317|NCT04716426|454879998|FG001|Overall Study|Vaccination|1|||
126432318|NCT04716426|454879997|FG000|Overall Study|Contamination|1|||
126432319|NCT04716426|454879998|FG001|Overall Study|Contamination|0|||
126432320|NCT00551759|454879999|FG000|Overall Study|Adverse Event|7|||
126432321|NCT00551759|454879999|FG000|Overall Study|Death|5|||
126432322|NCT00551759|454879999|FG000|Overall Study|Ineligible|1|||
126432323|NCT02960217|454880000|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
126432324|NCT02960217|454880001|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
126432325|NCT02960217|454880000|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
126432326|NCT02960217|454880001|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
126432327|NCT02960217|454880000|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
126432328|NCT02960217|454880001|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
126432329|NCT02960217|454880000|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
126432330|NCT02960217|454880001|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
126432331|NCT02960217|454880000|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
126432332|NCT02960217|454880001|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
126432333|NCT02960217|454880000|FG000|Open-Label Extension Phase|Adverse Event|1|||
126432334|NCT02960217|454880001|FG001|Open-Label Extension Phase|Adverse Event|0|||
126432335|NCT02960217|454880000|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
126432336|NCT02960217|454880001|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
126432337|NCT02960217|454880000|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
126432338|NCT02960217|454880001|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
126432339|NCT02960217|454880000|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
126432340|NCT02960217|454880001|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
126432341|NCT00625131|454880004|FG000|Overall Study|Lost to Follow-up|3|||
126432342|NCT00625131|454880005|FG001|Overall Study|Lost to Follow-up|2|||
126432343|NCT00625131|454880006|FG002|Overall Study|Lost to Follow-up|0|||
126432344|NCT00625131|454880004|FG000|Overall Study|Withdrawal by Subject|1|||
126432345|NCT00625131|454880005|FG001|Overall Study|Withdrawal by Subject|0|||
126432346|NCT00625131|454880006|FG002|Overall Study|Withdrawal by Subject|5|||
126432347|NCT01743469|454880009|FG000|Active Treatment Phase|Adverse Event|10|||
126432348|NCT01743469|454880010|FG001|Active Treatment Phase|Adverse Event|5|||
126346547|NCT03405870|454564550|FG001|Overall Study|Withdrawal|0|||
126346548|NCT03405870|454564551|FG002|Overall Study|Withdrawal|1|||
126346549|NCT03405870|454564552|FG003|Overall Study|Withdrawal|0|||
126346550|NCT03405870|454564553|FG004|Overall Study|Withdrawal|0|||
126346551|NCT03405870|454564554|FG005|Overall Study|Withdrawal|0|||
126346552|NCT03405870|454564555|FG006|Overall Study|Withdrawal|1|||
126346553|NCT03405870|454564556|FG007|Overall Study|Withdrawal|0|||
126346554|NCT05172609|454564557|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
126346555|NCT05172609|454564558|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
126346556|NCT05172609|454564557|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
126346557|NCT05172609|454564558|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
126346558|NCT05172609|454564557|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
126346559|NCT05172609|454564558|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
126346560|NCT00549055|454564559|FG000|Overall Study|Adverse Event|4|||
126346561|NCT00549055|454564559|FG000|Overall Study|Lack of Efficacy|18|||
126346562|NCT00549055|454564559|FG000|Overall Study|Stabilization|5|||
126346563|NCT00549055|454564559|FG000|Overall Study|Progression to fibrosis|2|||
126432349|NCT01743469|454880011|FG002|Active Treatment Phase|Adverse Event|8|||
126432350|NCT01743469|454880012|FG003|Active Treatment Phase|Adverse Event|1|||
126432351|NCT01743469|454880009|FG000|Active Treatment Phase|Disease Progression|40|||
126432352|NCT01743469|454880010|FG001|Active Treatment Phase|Disease Progression|47|||
126432353|NCT01743469|454880011|FG002|Active Treatment Phase|Disease Progression|30|||
126432354|NCT01743469|454880012|FG003|Active Treatment Phase|Disease Progression|20|||
126432355|NCT01743469|454880009|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
126432356|NCT01743469|454880010|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
126432357|NCT01743469|454880011|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
126432358|NCT01743469|454880012|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
126346564|NCT00549055|454564559|FG000|Overall Study|Decrease of size|1|||
126346565|NCT00549055|454564559|FG000|Overall Study|Active choroidal neovascula increased|1|||
126346566|NCT00549055|454564559|FG000|Overall Study|Vitreous hemorrhage|1|||
126346567|NCT00549055|454564559|FG000|Overall Study|Growth choroidal neovascularisation|1|||
126346568|NCT00549055|454564559|FG000|Overall Study|Choroidal neovascularization|1|||
126346569|NCT00549055|454564559|FG000|Overall Study|Very low visual acuity (VA)|1|||
126346570|NCT03846479|454564560|FG000|Overall Study|Death|8|||
126346571|NCT03846479|454564560|FG000|Overall Study|Lost to Follow-up|1|||
126346572|NCT05020015|454564561|FG000|Overall Study|Ongoing on study|1|||
126346573|NCT05020015|454564562|FG001|Overall Study|Ongoing on study|3|||
126346574|NCT05020015|454564563|FG002|Overall Study|Ongoing on study|4|||
126346575|NCT05020015|454564564|FG003|Overall Study|Ongoing on study|7|||
126346576|NCT05020015|454564561|FG000|Overall Study|Death|2|||
126346577|NCT05020015|454564562|FG001|Overall Study|Death|3|||
126346578|NCT05020015|454564563|FG002|Overall Study|Death|4|||
126346579|NCT05020015|454564564|FG003|Overall Study|Death|0|||
126346580|NCT05020015|454564561|FG000|Overall Study|Withdrawal by Subject|0|||
126346581|NCT05020015|454564562|FG001|Overall Study|Withdrawal by Subject|0|||
126346582|NCT05020015|454564563|FG002|Overall Study|Withdrawal by Subject|1|||
126346583|NCT05020015|454564564|FG003|Overall Study|Withdrawal by Subject|0|||
126346584|NCT05020015|454564561|FG000|Overall Study|Reason Not Specified|0|||
126346585|NCT05020015|454564562|FG001|Overall Study|Reason Not Specified|0|||
126346586|NCT05020015|454564563|FG002|Overall Study|Reason Not Specified|2|||
126346587|NCT05020015|454564564|FG003|Overall Study|Reason Not Specified|0|||
126346588|NCT00614393|454564571|FG000|Overall Study|Adverse Event|20|||
126346589|NCT00614393|454564572|FG001|Overall Study|Adverse Event|2|||
126346590|NCT00614393|454564573|FG002|Overall Study|Adverse Event|3|||
126346591|NCT00614393|454564574|FG003|Overall Study|Adverse Event|13|||
126346592|NCT00614393|454564575|FG004|Overall Study|Adverse Event|21|||
126346593|NCT00614393|454564571|FG000|Overall Study|Lost to Follow-up|0|||
126346594|NCT00614393|454564572|FG001|Overall Study|Lost to Follow-up|0|||
126346595|NCT00614393|454564573|FG002|Overall Study|Lost to Follow-up|0|||
126346596|NCT00614393|454564574|FG003|Overall Study|Lost to Follow-up|1|||
126346597|NCT00614393|454564575|FG004|Overall Study|Lost to Follow-up|2|||
126346598|NCT00614393|454564571|FG000|Overall Study|Physician Decision|17|||
126346599|NCT00614393|454564572|FG001|Overall Study|Physician Decision|0|||
126346600|NCT00614393|454564573|FG002|Overall Study|Physician Decision|1|||
126346601|NCT00614393|454564574|FG003|Overall Study|Physician Decision|8|||
126346602|NCT00614393|454564575|FG004|Overall Study|Physician Decision|9|||
126346603|NCT00614393|454564571|FG000|Overall Study|Progressive Disease|118|||
126346604|NCT00614393|454564572|FG001|Overall Study|Progressive Disease|5|||
126346605|NCT00614393|454564573|FG002|Overall Study|Progressive Disease|5|||
126346606|NCT00614393|454564574|FG003|Overall Study|Progressive Disease|138|||
126346607|NCT00614393|454564575|FG004|Overall Study|Progressive Disease|130|||
126346608|NCT00614393|454564571|FG000|Overall Study|Protocol Violation|1|||
126346609|NCT00614393|454564572|FG001|Overall Study|Protocol Violation|0|||
126346610|NCT00614393|454564573|FG002|Overall Study|Protocol Violation|0|||
126346611|NCT00614393|454564574|FG003|Overall Study|Protocol Violation|0|||
126346612|NCT00614393|454564575|FG004|Overall Study|Protocol Violation|0|||
126346613|NCT00614393|454564571|FG000|Overall Study|Terminated by Sponsor|0|||
126346614|NCT00614393|454564572|FG001|Overall Study|Terminated by Sponsor|0|||
126346615|NCT00614393|454564573|FG002|Overall Study|Terminated by Sponsor|0|||
126346616|NCT00614393|454564574|FG003|Overall Study|Terminated by Sponsor|0|||
126346617|NCT00614393|454564575|FG004|Overall Study|Terminated by Sponsor|1|||
126346618|NCT00614393|454564571|FG000|Overall Study|Withdrawal by Subject|20|||
126346619|NCT00614393|454564572|FG001|Overall Study|Withdrawal by Subject|1|||
126346620|NCT00614393|454564573|FG002|Overall Study|Withdrawal by Subject|1|||
126346621|NCT00614393|454564574|FG003|Overall Study|Withdrawal by Subject|16|||
126346622|NCT00614393|454564575|FG004|Overall Study|Withdrawal by Subject|13|||
126346623|NCT00614393|454564571|FG000|Overall Study|Other|4|||
126346624|NCT00614393|454564572|FG001|Overall Study|Other|0|||
126346625|NCT00614393|454564573|FG002|Overall Study|Other|0|||
126346626|NCT00614393|454564574|FG003|Overall Study|Other|4|||
126346627|NCT00614393|454564575|FG004|Overall Study|Other|2|||
126346628|NCT00614393|454564571|FG000|Overall Study|Not Treated|0|||
126346629|NCT00614393|454564572|FG001|Overall Study|Not Treated|0|||
126346630|NCT00614393|454564573|FG002|Overall Study|Not Treated|0|||
126346631|NCT00614393|454564574|FG003|Overall Study|Not Treated|0|||
126346632|NCT00614393|454564575|FG004|Overall Study|Not Treated|2|||
126346633|NCT02328105|454564576|FG000|Overall Study|Death|6|||
126346634|NCT02328105|454564576|FG000|Overall Study|Withdrawal by Subject|1|||
126346635|NCT02328105|454564576|FG000|Overall Study|Still On Study in Follow-Up|4|||
126346636|NCT01588509|454564577|FG000|Overall Study|Lost to Follow-up|1|||
126346637|NCT01588509|454564578|FG001|Overall Study|Lost to Follow-up|0|||
126346638|NCT00855582|454564582|FG000|Overall Study|Adverse Event|2|||
126346639|NCT00855582|454564583|FG001|Overall Study|Adverse Event|6|||
126346640|NCT00855582|454564584|FG002|Overall Study|Adverse Event|3|||
126346641|NCT00855582|454564582|FG000|Overall Study|Death|1|||
126346642|NCT00855582|454564583|FG001|Overall Study|Death|0|||
126346643|NCT00855582|454564584|FG002|Overall Study|Death|0|||
126346644|NCT00855582|454564582|FG000|Overall Study|Lack of Efficacy|1|||
126346645|NCT00855582|454564583|FG001|Overall Study|Lack of Efficacy|3|||
126346646|NCT00855582|454564584|FG002|Overall Study|Lack of Efficacy|8|||
126346647|NCT00855582|454564582|FG000|Overall Study|Lost to Follow-up|1|||
126346648|NCT00855582|454564583|FG001|Overall Study|Lost to Follow-up|3|||
126346649|NCT00855582|454564584|FG002|Overall Study|Lost to Follow-up|1|||
126346650|NCT00855582|454564582|FG000|Overall Study|Physician Decision|0|||
126346651|NCT00855582|454564583|FG001|Overall Study|Physician Decision|0|||
126346652|NCT00855582|454564584|FG002|Overall Study|Physician Decision|1|||
126346653|NCT00855582|454564582|FG000|Overall Study|Protocol Violation|6|||
126346654|NCT00855582|454564583|FG001|Overall Study|Protocol Violation|2|||
126346655|NCT00855582|454564584|FG002|Overall Study|Protocol Violation|6|||
126346656|NCT00855582|454564582|FG000|Overall Study|Entry Criteria Not Met|8|||
126346657|NCT00855582|454564583|FG001|Overall Study|Entry Criteria Not Met|6|||
126346658|NCT00855582|454564584|FG002|Overall Study|Entry Criteria Not Met|3|||
126346659|NCT00855582|454564582|FG000|Overall Study|Withdrawal by Subject|7|||
126346660|NCT00855582|454564583|FG001|Overall Study|Withdrawal by Subject|4|||
126346661|NCT00855582|454564584|FG002|Overall Study|Withdrawal by Subject|8|||
126346662|NCT03345004|454564585|FG000|Overall Study|Physician Decision|1|||
126346663|NCT03345004|454564586|FG001|Overall Study|Physician Decision|0|||
126346664|NCT03345004|454564585|FG000|Overall Study|Withdrawal by Subject|0|||
126346665|NCT03345004|454564586|FG001|Overall Study|Withdrawal by Subject|1|||
126346666|NCT01013753|454564587|FG000|Overall Study|Adverse Event|8|||
126346667|NCT01013753|454564587|FG000|Overall Study|Protocol Violation|3|||
126346668|NCT01013753|454564587|FG000|Overall Study|Lost to Follow-up|1|||
126346669|NCT01013753|454564587|FG000|Overall Study|Withdrawal by Subject|2|||
126346670|NCT01013753|454564587|FG000|Overall Study|Other|2|||
126346671|NCT04757636|454564588|FG000|Overall Study|Adverse Event|25|||
126346672|NCT04757636|454564589|FG001|Overall Study|Adverse Event|8|||
126346673|NCT04757636|454564590|FG002|Overall Study|Adverse Event|11|||
126346674|NCT04757636|454564588|FG000|Overall Study|Death|9|||
126346675|NCT04757636|454564589|FG001|Overall Study|Death|12|||
126346676|NCT04757636|454564590|FG002|Overall Study|Death|6|||
126346677|NCT04757636|454564588|FG000|Overall Study|Lack of Efficacy|2|||
126346678|NCT04757636|454564589|FG001|Overall Study|Lack of Efficacy|0|||
126346679|NCT04757636|454564590|FG002|Overall Study|Lack of Efficacy|0|||
126346680|NCT04757636|454564588|FG000|Overall Study|Lost to Follow-up|1|||
126346681|NCT04757636|454564589|FG001|Overall Study|Lost to Follow-up|6|||
126346682|NCT04757636|454564590|FG002|Overall Study|Lost to Follow-up|7|||
126346683|NCT04757636|454564588|FG000|Overall Study|Physician Decision|1|||
126346684|NCT04757636|454564589|FG001|Overall Study|Physician Decision|3|||
126346685|NCT04757636|454564590|FG002|Overall Study|Physician Decision|4|||
126346686|NCT04757636|454564588|FG000|Overall Study|Withdrawal by Subject|20|||
126346687|NCT04757636|454564589|FG001|Overall Study|Withdrawal by Subject|23|||
126346688|NCT04757636|454564590|FG002|Overall Study|Withdrawal by Subject|18|||
126346689|NCT04757636|454564588|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
126346690|NCT04757636|454564589|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
126346691|NCT04757636|454564590|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
126346692|NCT04757636|454564588|FG000|Overall Study|Study Terminated by Sponsor|103|||
126346693|NCT04757636|454564589|FG001|Overall Study|Study Terminated by Sponsor|104|||
126346694|NCT04757636|454564590|FG002|Overall Study|Study Terminated by Sponsor|114|||
126346695|NCT04757636|454564588|FG000|Overall Study|Sponsor Decision|0|||
126346696|NCT04757636|454564589|FG001|Overall Study|Sponsor Decision|0|||
126346697|NCT04757636|454564590|FG002|Overall Study|Sponsor Decision|1|||
126346698|NCT04757636|454564588|FG000|Overall Study|Randomized in Error|0|||
126346699|NCT04757636|454564589|FG001|Overall Study|Randomized in Error|0|||
126346700|NCT04757636|454564590|FG002|Overall Study|Randomized in Error|2|||
126346701|NCT05350423|454564598|FG000|Overall Study|Lost to Follow-up|3|||
126346702|NCT05350423|454564599|FG001|Overall Study|Lost to Follow-up|3|||
126346703|NCT05350423|454564598|FG000|Overall Study|screen failure|5|||
126346704|NCT05350423|454564599|FG001|Overall Study|screen failure|6|||
126346705|NCT02097277|454564602|FG000|Overall Study|Subject no longer meets study criteria|0|||
126346706|NCT02097277|454564603|FG001|Overall Study|Subject no longer meets study criteria|1|||
126346707|NCT02097277|454564604|FG002|Overall Study|Subject no longer meets study criteria|0|||
126346708|NCT02097277|454564605|FG003|Overall Study|Subject no longer meets study criteria|1|||
126346709|NCT02097277|454564606|FG004|Overall Study|Subject no longer meets study criteria|0|||
126346710|NCT02097277|454564602|FG000|Overall Study|Subject request to discontinue treatment|0|||
126346711|NCT02097277|454564603|FG001|Overall Study|Subject request to discontinue treatment|0|||
126346712|NCT02097277|454564604|FG002|Overall Study|Subject request to discontinue treatment|0|||
126346713|NCT02097277|454564605|FG003|Overall Study|Subject request to discontinue treatment|0|||
126432359|NCT01743469|454880009|FG000|Active Treatment Phase|Missing|1|||
126432360|NCT01743469|454880010|FG001|Active Treatment Phase|Missing|0|||
126432361|NCT01743469|454880011|FG002|Active Treatment Phase|Missing|0|||
126346714|NCT02097277|454564606|FG004|Overall Study|Subject request to discontinue treatment|1|||
126346715|NCT02097277|454564602|FG000|Overall Study|Lost to Follow-up|0|||
126346716|NCT02097277|454564603|FG001|Overall Study|Lost to Follow-up|1|||
126346717|NCT02097277|454564604|FG002|Overall Study|Lost to Follow-up|1|||
126346718|NCT02097277|454564605|FG003|Overall Study|Lost to Follow-up|0|||
126346719|NCT02097277|454564606|FG004|Overall Study|Lost to Follow-up|0|||
126346720|NCT02097277|454564602|FG000|Overall Study|Withdrawal by Subject|2|||
126346721|NCT02097277|454564603|FG001|Overall Study|Withdrawal by Subject|1|||
126346722|NCT02097277|454564604|FG002|Overall Study|Withdrawal by Subject|0|||
126346723|NCT02097277|454564605|FG003|Overall Study|Withdrawal by Subject|1|||
126346724|NCT02097277|454564606|FG004|Overall Study|Withdrawal by Subject|0|||
126346725|NCT02097277|454564602|FG000|Overall Study|Adverse Event|0|||
126346726|NCT02097277|454564603|FG001|Overall Study|Adverse Event|0|||
126346727|NCT02097277|454564604|FG002|Overall Study|Adverse Event|1|||
126346728|NCT02097277|454564605|FG003|Overall Study|Adverse Event|2|||
126346729|NCT02097277|454564606|FG004|Overall Study|Adverse Event|0|||
126346730|NCT03320369|454564607|FG000|Overall Study|Adverse Event|1|||
126346731|NCT03320369|454564607|FG000|Overall Study|Withdrawal by Subject|2|||
126346732|NCT01732692|454564608|FG000|Overall Study|Adverse Event|0|||
126346733|NCT01732692|454564609|FG001|Overall Study|Adverse Event|1|||
126346734|NCT04167462|454564612|FG000|Overall Study|Other reasons|3|||
126346735|NCT04167462|454564613|FG001|Overall Study|Other reasons|2|||
126346736|NCT04167462|454564612|FG000|Overall Study|Withdrawal by Subject|6|||
126346737|NCT04167462|454564613|FG001|Overall Study|Withdrawal by Subject|7|||
126346738|NCT04167462|454564612|FG000|Overall Study|Adverse Event|4|||
126346739|NCT04167462|454564613|FG001|Overall Study|Adverse Event|0|||
126346740|NCT04167462|454564612|FG000|Overall Study|Pregnancy|1|||
126432362|NCT01743469|454880012|FG003|Active Treatment Phase|Missing|0|||
126680707|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
126346741|NCT04167462|454564613|FG001|Overall Study|Pregnancy|0|||
126346742|NCT04167462|454564612|FG000|Overall Study|Lack of Efficacy|0|||
126346743|NCT04167462|454564613|FG001|Overall Study|Lack of Efficacy|1|||
126346744|NCT02606253|454564614|FG000|Overall Study|Adverse Event|2|||
126346745|NCT02606253|454564615|FG001|Overall Study|Adverse Event|0|||
126346746|NCT02606253|454564616|FG002|Overall Study|Adverse Event|0|||
126346747|NCT02606253|454564614|FG000|Overall Study|Protocol Violation|2|||
126346748|NCT02606253|454564615|FG001|Overall Study|Protocol Violation|1|||
126346749|NCT02606253|454564616|FG002|Overall Study|Protocol Violation|0|||
126346750|NCT02606253|454564614|FG000|Overall Study|Physician Decision|1|||
126346751|NCT02606253|454564615|FG001|Overall Study|Physician Decision|1|||
126346752|NCT02606253|454564616|FG002|Overall Study|Physician Decision|0|||
126346753|NCT02475213|454564619|FG000|Overall Study|Adverse Event|2|||
126346754|NCT02475213|454564620|FG001|Overall Study|Adverse Event|0|||
126346755|NCT02475213|454564621|FG002|Overall Study|Adverse Event|0|||
126346756|NCT02475213|454564622|FG003|Overall Study|Adverse Event|1|||
126346757|NCT02475213|454564623|FG004|Overall Study|Adverse Event|1|||
126346758|NCT02475213|454564624|FG005|Overall Study|Adverse Event|4|||
126346759|NCT02475213|454564625|FG006|Overall Study|Adverse Event|6|||
126346760|NCT02475213|454564626|FG007|Overall Study|Adverse Event|2|||
126346761|NCT02475213|454564619|FG000|Overall Study|Physician Decision|1|||
126346762|NCT02475213|454564620|FG001|Overall Study|Physician Decision|1|||
126346763|NCT02475213|454564621|FG002|Overall Study|Physician Decision|1|||
126346764|NCT02475213|454564622|FG003|Overall Study|Physician Decision|0|||
126346765|NCT02475213|454564623|FG004|Overall Study|Physician Decision|0|||
126346766|NCT02475213|454564624|FG005|Overall Study|Physician Decision|1|||
126346767|NCT02475213|454564625|FG006|Overall Study|Physician Decision|4|||
126346768|NCT02475213|454564626|FG007|Overall Study|Physician Decision|0|||
126346769|NCT02475213|454564619|FG000|Overall Study|Progressive Disease|3|||
126346770|NCT02475213|454564620|FG001|Overall Study|Progressive Disease|2|||
126346771|NCT02475213|454564621|FG002|Overall Study|Progressive Disease|2|||
126346772|NCT02475213|454564622|FG003|Overall Study|Progressive Disease|13|||
126346773|NCT02475213|454564623|FG004|Overall Study|Progressive Disease|15|||
126346774|NCT02475213|454564624|FG005|Overall Study|Progressive Disease|25|||
126346775|NCT02475213|454564625|FG006|Overall Study|Progressive Disease|30|||
126346776|NCT02475213|454564626|FG007|Overall Study|Progressive Disease|10|||
126346777|NCT02475213|454564619|FG000|Overall Study|Death|0|||
126346778|NCT02475213|454564620|FG001|Overall Study|Death|0|||
126346779|NCT02475213|454564621|FG002|Overall Study|Death|0|||
126346780|NCT02475213|454564622|FG003|Overall Study|Death|0|||
126346781|NCT02475213|454564623|FG004|Overall Study|Death|0|||
126346782|NCT02475213|454564624|FG005|Overall Study|Death|4|||
126346783|NCT02475213|454564625|FG006|Overall Study|Death|1|||
126346784|NCT02475213|454564626|FG007|Overall Study|Death|0|||
126346785|NCT02475213|454564619|FG000|Overall Study|Protocol Violation|0|||
126346786|NCT02475213|454564620|FG001|Overall Study|Protocol Violation|0|||
126346787|NCT02475213|454564621|FG002|Overall Study|Protocol Violation|0|||
126346788|NCT02475213|454564622|FG003|Overall Study|Protocol Violation|0|||
126346789|NCT02475213|454564623|FG004|Overall Study|Protocol Violation|1|||
126346790|NCT02475213|454564624|FG005|Overall Study|Protocol Violation|0|||
126346791|NCT02475213|454564625|FG006|Overall Study|Protocol Violation|0|||
126346792|NCT02475213|454564626|FG007|Overall Study|Protocol Violation|0|||
126346793|NCT02475213|454564619|FG000|Overall Study|Withdrawal by Subject|0|||
126346794|NCT02475213|454564620|FG001|Overall Study|Withdrawal by Subject|0|||
126346795|NCT02475213|454564621|FG002|Overall Study|Withdrawal by Subject|0|||
126346796|NCT02475213|454564622|FG003|Overall Study|Withdrawal by Subject|1|||
126432363|NCT01743469|454880009|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
126346797|NCT02475213|454564623|FG004|Overall Study|Withdrawal by Subject|0|||
126346798|NCT02475213|454564624|FG005|Overall Study|Withdrawal by Subject|2|||
126346799|NCT02475213|454564625|FG006|Overall Study|Withdrawal by Subject|2|||
126346800|NCT02475213|454564626|FG007|Overall Study|Withdrawal by Subject|0|||
126346801|NCT02475213|454564619|FG000|Overall Study|Other|0|||
126346802|NCT02475213|454564620|FG001|Overall Study|Other|0|||
126346803|NCT02475213|454564621|FG002|Overall Study|Other|0|||
126346804|NCT02475213|454564622|FG003|Overall Study|Other|1|||
126346805|NCT02475213|454564623|FG004|Overall Study|Other|3|||
126346806|NCT02475213|454564624|FG005|Overall Study|Other|1|||
126346807|NCT02475213|454564625|FG006|Overall Study|Other|0|||
126346808|NCT02475213|454564626|FG007|Overall Study|Other|0|||
126346809|NCT05383209|454564629|FG000|Overall Study|Adverse Event: Non-ocular|0|||
126346810|NCT05383209|454564630|FG001|Overall Study|Adverse Event: Non-ocular|1|||
126346811|NCT05383209|454564631|FG002|Overall Study|Adverse Event: Non-ocular|0|||
126346812|NCT05383209|454564629|FG000|Overall Study|Lost to Follow-up|2|||
126346813|NCT05383209|454564630|FG001|Overall Study|Lost to Follow-up|1|||
126346814|NCT05383209|454564631|FG002|Overall Study|Lost to Follow-up|4|||
126346815|NCT05383209|454564629|FG000|Overall Study|Withdrawal by Subject|2|||
126346816|NCT05383209|454564630|FG001|Overall Study|Withdrawal by Subject|0|||
126346817|NCT05383209|454564631|FG002|Overall Study|Withdrawal by Subject|1|||
126346818|NCT05383209|454564629|FG000|Overall Study|Death|1|||
126346819|NCT05383209|454564630|FG001|Overall Study|Death|0|||
126432364|NCT01743469|454880010|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
126432365|NCT01743469|454880011|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
126346820|NCT05383209|454564631|FG002|Overall Study|Death|0|||
126346821|NCT05383209|454564629|FG000|Overall Study|Other|0|||
126346822|NCT05383209|454564630|FG001|Overall Study|Other|1|||
126346823|NCT05383209|454564631|FG002|Overall Study|Other|0|||
126346824|NCT01582451|454564632|FG000|Overall Study|Adverse Event|1|||
126346825|NCT01582451|454564633|FG001|Overall Study|Adverse Event|3|||
126432366|NCT01743469|454880012|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
126432367|NCT01743469|454880009|FG000|Follow-up Period - Post-Treatment|Death|43|||
126432368|NCT01743469|454880010|FG001|Follow-up Period - Post-Treatment|Death|47|||
126432369|NCT01743469|454880011|FG002|Follow-up Period - Post-Treatment|Death|22|||
126432370|NCT01743469|454880012|FG003|Follow-up Period - Post-Treatment|Death|16|||
126432371|NCT01743469|454880009|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
126432372|NCT01743469|454880010|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
126432373|NCT01743469|454880011|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
126432374|NCT01743469|454880012|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
126432375|NCT02138890|454880018|FG000|Overall Study|Adverse Event|1|||
126432376|NCT02138890|454880019|FG001|Overall Study|Adverse Event|0|||
126432377|NCT01446159|454880020|FG000|Overall Study|Withdrawal by Subject|1|||
126432378|NCT01446159|454880021|FG001|Overall Study|Withdrawal by Subject|0|||
126432379|NCT01446159|454880022|FG002|Overall Study|Withdrawal by Subject|14|||
126432380|NCT01446159|454880023|FG003|Overall Study|Withdrawal by Subject|11|||
126432381|NCT01446159|454880020|FG000|Overall Study|Lost to Follow-up|0|||
126432382|NCT01446159|454880021|FG001|Overall Study|Lost to Follow-up|0|||
126432383|NCT01446159|454880022|FG002|Overall Study|Lost to Follow-up|1|||
126432384|NCT01446159|454880023|FG003|Overall Study|Lost to Follow-up|2|||
126432385|NCT01446159|454880020|FG000|Overall Study|Death|2|||
126432386|NCT01446159|454880021|FG001|Overall Study|Death|3|||
126432387|NCT01446159|454880022|FG002|Overall Study|Death|43|||
126432388|NCT01446159|454880023|FG003|Overall Study|Death|36|||
126680708|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
126346826|NCT01582451|454564632|FG000|Overall Study|Death|3|||
126346827|NCT01582451|454564633|FG001|Overall Study|Death|3|||
126346828|NCT01582451|454564632|FG000|Overall Study|Lost to Follow-up|0|||
126346829|NCT01582451|454564633|FG001|Overall Study|Lost to Follow-up|2|||
126346830|NCT01582451|454564632|FG000|Overall Study|Protocol Violation|11|||
126346831|NCT01582451|454564633|FG001|Overall Study|Protocol Violation|3|||
126346832|NCT01582451|454564632|FG000|Overall Study|Withdrawal by Subject|13|||
126346833|NCT01582451|454564633|FG001|Overall Study|Withdrawal by Subject|9|||
126346834|NCT01582451|454564632|FG000|Overall Study|Physician Decision|3|||
126346835|NCT01582451|454564633|FG001|Overall Study|Physician Decision|0|||
126346836|NCT01582451|454564632|FG000|Overall Study|Sponsor Decision|1|||
126346837|NCT01582451|454564633|FG001|Overall Study|Sponsor Decision|0|||
126346838|NCT00717886|454564634|FG000|Overall Study|Withdrawal by Subject|3|||
126346839|NCT00717886|454564634|FG000|Overall Study|Treatment Failure|1|||
126346840|NCT01553851|454564635|FG000|Overall Study|Adverse Event|2|||
126346841|NCT01553851|454564635|FG000|Overall Study|constipation|1|||
126346842|NCT00487188|454564637|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
126346843|NCT00487188|454564638|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
126346844|NCT00487188|454564639|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
126346845|NCT00487188|454564637|FG000|Induction Phase|Adverse Event|5|||
126346846|NCT00487188|454564638|FG001|Induction Phase|Adverse Event|0|||
126346847|NCT00487188|454564639|FG002|Induction Phase|Adverse Event|0|||
126346848|NCT00487188|454564637|FG000|Induction Phase|Lack of Efficacy|0|||
126346849|NCT00487188|454564638|FG001|Induction Phase|Lack of Efficacy|1|||
126346850|NCT00487188|454564639|FG002|Induction Phase|Lack of Efficacy|0|||
126346851|NCT00487188|454564637|FG000|Induction Phase|Protocol Violation|1|||
126346852|NCT00487188|454564638|FG001|Induction Phase|Protocol Violation|0|||
126346853|NCT00487188|454564639|FG002|Induction Phase|Protocol Violation|0|||
126346854|NCT00487188|454564637|FG000|Induction Phase|Refused Treatment|1|||
126346855|NCT00487188|454564638|FG001|Induction Phase|Refused Treatment|2|||
126346856|NCT00487188|454564639|FG002|Induction Phase|Refused Treatment|0|||
126346857|NCT00487188|454564637|FG000|Induction Phase|Lost to Follow-up|2|||
126346858|NCT00487188|454564638|FG001|Induction Phase|Lost to Follow-up|2|||
126346859|NCT00487188|454564639|FG002|Induction Phase|Lost to Follow-up|0|||
126346860|NCT00487188|454564637|FG000|Induction Phase|Administrative|0|||
126346861|NCT00487188|454564638|FG001|Induction Phase|Administrative|1|||
126346862|NCT00487188|454564639|FG002|Induction Phase|Administrative|0|||
126346863|NCT00487188|454564637|FG000|Maintenance Phase|Adverse Event|1|||
126346864|NCT00487188|454564638|FG001|Maintenance Phase|Adverse Event|0|||
126346865|NCT00487188|454564639|FG002|Maintenance Phase|Adverse Event|0|||
126346866|NCT00487188|454564637|FG000|Maintenance Phase|Death|1|||
126346867|NCT00487188|454564638|FG001|Maintenance Phase|Death|0|||
126346868|NCT00487188|454564639|FG002|Maintenance Phase|Death|0|||
126346869|NCT00487188|454564637|FG000|Maintenance Phase|Lost to Follow-up|1|||
126346870|NCT00487188|454564638|FG001|Maintenance Phase|Lost to Follow-up|0|||
126346871|NCT00487188|454564639|FG002|Maintenance Phase|Lost to Follow-up|0|||
126346872|NCT00487188|454564637|FG000|Maintenance Phase|Administrative|0|||
126346873|NCT00487188|454564638|FG001|Maintenance Phase|Administrative|0|||
126346874|NCT00487188|454564639|FG002|Maintenance Phase|Administrative|1|||
126346875|NCT03822416|454564649|FG000|Overall Study|Lost to Follow-up|1|||
126346876|NCT03822416|454564650|FG001|Overall Study|Lost to Follow-up|0|||
126346877|NCT03822416|454564649|FG000|Overall Study|Withdrawal by Subject|0|||
126346878|NCT03822416|454564650|FG001|Overall Study|Withdrawal by Subject|1|||
126346879|NCT04666298|454564653|FG000|Overall Study|Subject decision|1|||
126346880|NCT04666298|454564654|FG001|Overall Study|Subject decision|0|||
126346881|NCT04666298|454564655|FG002|Overall Study|Subject decision|0|||
126346882|NCT04666298|454564656|FG003|Overall Study|Subject decision|2|||
126346883|NCT04666298|454564653|FG000|Overall Study|Death|1|||
126346884|NCT04666298|454564654|FG001|Overall Study|Death|0|||
126346885|NCT04666298|454564655|FG002|Overall Study|Death|0|||
126346886|NCT04666298|454564656|FG003|Overall Study|Death|0|||
126346887|NCT04666298|454564653|FG000|Overall Study|Lost to Follow-up|0|||
126346888|NCT04666298|454564654|FG001|Overall Study|Lost to Follow-up|0|||
126346889|NCT04666298|454564655|FG002|Overall Study|Lost to Follow-up|0|||
126346890|NCT04666298|454564656|FG003|Overall Study|Lost to Follow-up|1|||
126346891|NCT04666298|454564653|FG000|Overall Study|Physician Decision|0|||
126346892|NCT04666298|454564654|FG001|Overall Study|Physician Decision|0|||
126346893|NCT04666298|454564655|FG002|Overall Study|Physician Decision|0|||
126346894|NCT04666298|454564656|FG003|Overall Study|Physician Decision|1|||
126346895|NCT04666298|454564653|FG000|Overall Study|Protocol deviation|0|||
126346896|NCT04666298|454564654|FG001|Overall Study|Protocol deviation|0|||
126346897|NCT04666298|454564655|FG002|Overall Study|Protocol deviation|1|||
126346898|NCT04666298|454564656|FG003|Overall Study|Protocol deviation|0|||
126346899|NCT00844519|454564657|FG000|Overall Study|Withdrawal by Subject|1|||
126346900|NCT00844519|454564658|FG001|Overall Study|Withdrawal by Subject|1|||
126346901|NCT00844519|454564657|FG000|Overall Study|Adverse Event|1|||
126346902|NCT00844519|454564658|FG001|Overall Study|Adverse Event|0|||
126346903|NCT06438601|454564659|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
126432389|NCT01446159|454880020|FG000|Overall Study|Other|0|||
126432390|NCT01446159|454880021|FG001|Overall Study|Other|0|||
126432391|NCT01446159|454880022|FG002|Overall Study|Other|13|||
126432392|NCT01446159|454880023|FG003|Overall Study|Other|13|||
126432393|NCT00795535|454880025|FG000|Overall Study|incomplete data and technical problems|20|||
126432394|NCT01420861|454880026|FG000|Overall Study|Adverse Event|2|||
126432395|NCT01420861|454880026|FG000|Overall Study|Study terminated by Sponsor|7|||
126432396|NCT01420861|454880026|FG000|Overall Study|Screen failure|7|||
126432397|NCT01420861|454880026|FG000|Overall Study|Randomized not Treated|2|||
126432398|NCT01766050|454882129|FG000|Overall Study|Adverse Event|1|||
126432399|NCT01766050|454882129|FG000|Overall Study|Lost to Follow-up|1|||
126432400|NCT01766050|454882129|FG000|Overall Study|Withdrawal by Subject|2|||
126432401|NCT01910298|454882130|FG000|Overall Study|Adverse Event|1|||
126432402|NCT01910298|454882131|FG001|Overall Study|Adverse Event|0|||
126432403|NCT01910298|454882130|FG000|Overall Study|Withdrawal by Subject|2|||
126432404|NCT01910298|454882131|FG001|Overall Study|Withdrawal by Subject|7|||
126432405|NCT01910298|454882130|FG000|Overall Study|Protocol Deviation|0|||
126432406|NCT01910298|454882131|FG001|Overall Study|Protocol Deviation|5|||
126432407|NCT01910298|454882130|FG000|Overall Study|Lost to Follow-up|1|||
126432408|NCT01910298|454882131|FG001|Overall Study|Lost to Follow-up|1|||
126432409|NCT01910298|454882130|FG000|Overall Study|Study Terminated by Sponsor|1|||
126432410|NCT01910298|454882131|FG001|Overall Study|Study Terminated by Sponsor|17|||
126432411|NCT01910298|454882130|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126432412|NCT01910298|454882131|FG001|Overall Study|Other Miscellaneous Reasons|2|||
126432413|NCT03037385|454882135|FG000|Overall Study|Adverse Event|0|||
126432414|NCT03037385|454882136|FG001|Overall Study|Adverse Event|0|||
126432415|NCT03037385|454882137|FG002|Overall Study|Adverse Event|1|||
126432416|NCT03037385|454882138|FG003|Overall Study|Adverse Event|0|||
126432417|NCT03037385|454882139|FG004|Overall Study|Adverse Event|0|||
126432418|NCT03037385|454882140|FG005|Overall Study|Adverse Event|0|||
126432419|NCT03037385|454882141|FG006|Overall Study|Adverse Event|0|||
126432420|NCT03037385|454882142|FG007|Overall Study|Adverse Event|0|||
126432421|NCT03037385|454882143|FG008|Overall Study|Adverse Event|0|||
126432422|NCT03037385|454882144|FG009|Overall Study|Adverse Event|6|||
126432423|NCT03037385|454882135|FG000|Overall Study|Death|1|||
126432424|NCT03037385|454882136|FG001|Overall Study|Death|4|||
126432425|NCT03037385|454882137|FG002|Overall Study|Death|2|||
126432426|NCT03037385|454882138|FG003|Overall Study|Death|2|||
126432427|NCT03037385|454882139|FG004|Overall Study|Death|5|||
126432428|NCT03037385|454882140|FG005|Overall Study|Death|2|||
126432429|NCT03037385|454882141|FG006|Overall Study|Death|1|||
126432430|NCT03037385|454882142|FG007|Overall Study|Death|4|||
126432431|NCT03037385|454882143|FG008|Overall Study|Death|3|||
126432432|NCT03037385|454882144|FG009|Overall Study|Death|240|||
126432433|NCT03037385|454882135|FG000|Overall Study|Initiation of Another Therapy|1|||
126432434|NCT03037385|454882136|FG001|Overall Study|Initiation of Another Therapy|0|||
126432435|NCT03037385|454882137|FG002|Overall Study|Initiation of Another Therapy|0|||
126432436|NCT03037385|454882138|FG003|Overall Study|Initiation of Another Therapy|0|||
126432437|NCT03037385|454882139|FG004|Overall Study|Initiation of Another Therapy|0|||
126432438|NCT03037385|454882140|FG005|Overall Study|Initiation of Another Therapy|0|||
126432439|NCT03037385|454882141|FG006|Overall Study|Initiation of Another Therapy|0|||
126432440|NCT03037385|454882142|FG007|Overall Study|Initiation of Another Therapy|1|||
126432441|NCT03037385|454882143|FG008|Overall Study|Initiation of Another Therapy|0|||
126432442|NCT03037385|454882144|FG009|Overall Study|Initiation of Another Therapy|2|||
126432443|NCT03037385|454882135|FG000|Overall Study|Lost to Follow-up|0|||
126432444|NCT03037385|454882136|FG001|Overall Study|Lost to Follow-up|0|||
126432445|NCT03037385|454882137|FG002|Overall Study|Lost to Follow-up|0|||
126432446|NCT03037385|454882138|FG003|Overall Study|Lost to Follow-up|0|||
126432447|NCT03037385|454882139|FG004|Overall Study|Lost to Follow-up|0|||
126432448|NCT03037385|454882140|FG005|Overall Study|Lost to Follow-up|1|||
126432449|NCT03037385|454882141|FG006|Overall Study|Lost to Follow-up|0|||
126432450|NCT03037385|454882142|FG007|Overall Study|Lost to Follow-up|0|||
126432451|NCT03037385|454882143|FG008|Overall Study|Lost to Follow-up|0|||
126432452|NCT03037385|454882144|FG009|Overall Study|Lost to Follow-up|16|||
126432453|NCT03037385|454882135|FG000|Overall Study|Physician Decision|0|||
126680709|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
126432454|NCT03037385|454882136|FG001|Overall Study|Physician Decision|0|||
126432455|NCT03037385|454882137|FG002|Overall Study|Physician Decision|0|||
126432456|NCT03037385|454882138|FG003|Overall Study|Physician Decision|0|||
126432457|NCT03037385|454882139|FG004|Overall Study|Physician Decision|0|||
126680710|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
126432458|NCT03037385|454882140|FG005|Overall Study|Physician Decision|0|||
126432459|NCT03037385|454882141|FG006|Overall Study|Physician Decision|0|||
126432460|NCT03037385|454882142|FG007|Overall Study|Physician Decision|0|||
126432461|NCT03037385|454882143|FG008|Overall Study|Physician Decision|0|||
126432462|NCT03037385|454882144|FG009|Overall Study|Physician Decision|1|||
126432463|NCT03037385|454882135|FG000|Overall Study|Progressive Disease|0|||
126432464|NCT03037385|454882136|FG001|Overall Study|Progressive Disease|1|||
126432465|NCT03037385|454882137|FG002|Overall Study|Progressive Disease|1|||
126346904|NCT06438601|454564660|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
126346905|NCT06438601|454564659|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
126346906|NCT06438601|454564660|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
126346907|NCT01311661|454564663|FG000|Overall Study|Adverse Event|2|||
126346908|NCT01311661|454564663|FG000|Overall Study|Protocol Violation|3|||
126346909|NCT01311661|454564663|FG000|Overall Study|Withdrawal by Subject|2|||
126346910|NCT00207740|454564664|FG000|Overall Study|Adverse Event|4|||
126346911|NCT00207740|454564665|FG001|Overall Study|Adverse Event|14|||
126346912|NCT00207740|454564666|FG002|Overall Study|Adverse Event|14|||
126346913|NCT00207740|454564667|FG003|Overall Study|Adverse Event|11|||
126346914|NCT00207740|454564664|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126346915|NCT00207740|454564665|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126346916|NCT00207740|454564666|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126346917|NCT00207740|454564667|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
126346918|NCT00207740|454564664|FG000|Overall Study|Lost to Follow-up|0|||
126346919|NCT00207740|454564665|FG001|Overall Study|Lost to Follow-up|2|||
126346920|NCT00207740|454564666|FG002|Overall Study|Lost to Follow-up|1|||
126346921|NCT00207740|454564667|FG003|Overall Study|Lost to Follow-up|1|||
126346922|NCT00207740|454564664|FG000|Overall Study|Death|0|||
126346923|NCT00207740|454564665|FG001|Overall Study|Death|0|||
126346924|NCT00207740|454564666|FG002|Overall Study|Death|0|||
126346925|NCT00207740|454564667|FG003|Overall Study|Death|1|||
126346926|NCT00207740|454564664|FG000|Overall Study|Sponsor Directive|22|||
126346927|NCT00207740|454564665|FG001|Overall Study|Sponsor Directive|15|||
126346928|NCT00207740|454564666|FG002|Overall Study|Sponsor Directive|16|||
126346929|NCT00207740|454564667|FG003|Overall Study|Sponsor Directive|21|||
126346930|NCT00207740|454564664|FG000|Overall Study|Other|2|||
126346931|NCT00207740|454564665|FG001|Overall Study|Other|10|||
126346932|NCT00207740|454564666|FG002|Overall Study|Other|7|||
126346933|NCT00207740|454564667|FG003|Overall Study|Other|5|||
126346934|NCT00390013|454564668|FG000|Phase 1|tired|0|||
126346935|NCT00390013|454564669|FG001|Phase 1|tired|0|||
126346936|NCT00390013|454564670|FG002|Phase 1|tired|0|||
126346937|NCT00390013|454564671|FG003|Phase 1|tired|1|||
126346938|NCT00390013|454564668|FG000|Phase 2 First Treatment|tired|1|||
126346939|NCT00390013|454564669|FG001|Phase 2 First Treatment|tired|0|||
126346940|NCT00390013|454564670|FG002|Phase 2 First Treatment|tired|0|||
126346941|NCT00390013|454564671|FG003|Phase 2 First Treatment|tired|0|||
126346942|NCT00390013|454564668|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
126346943|NCT00390013|454564669|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
126346944|NCT00390013|454564670|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
126346945|NCT00390013|454564671|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
126346946|NCT03188822|454564674|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
126346947|NCT03188822|454564674|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
126346948|NCT02774889|454564688|FG000|Overall Study|Lost to Follow-up|2|||
126346949|NCT02774889|454564689|FG001|Overall Study|Lost to Follow-up|1|||
126346950|NCT00858988|454564690|FG000|Analysis|Lactulose unable to be detected in urine|2|||
126346951|NCT00858988|454564691|FG001|Analysis|Lactulose unable to be detected in urine|1|||
126346952|NCT01349595|454564692|FG000|Overall Study|Lack of funding|2|||
126346953|NCT01349595|454564693|FG001|Overall Study|Lack of funding|2|||
126346954|NCT04584788|454564711|FG000|Overall Study|Physician Decision|8|||
126346955|NCT04584788|454564711|FG000|Overall Study|Withdrawal by Subject|1|||
126346956|NCT04584788|454564711|FG000|Overall Study|Adverse Event|3|||
126346957|NCT00770809|454566825|FG000|Overall Study|Adverse Event|9|||
126346958|NCT00770809|454566826|FG001|Overall Study|Adverse Event|1|||
126346959|NCT00770809|454566827|FG002|Overall Study|Adverse Event|12|||
126346960|NCT00770809|454566825|FG000|Overall Study|Death|1|||
126346961|NCT00770809|454566826|FG001|Overall Study|Death|0|||
126346962|NCT00770809|454566827|FG002|Overall Study|Death|0|||
126346963|NCT00770809|454566825|FG000|Overall Study|Withdrawal by Subject|3|||
126346964|NCT00770809|454566826|FG001|Overall Study|Withdrawal by Subject|3|||
126346965|NCT00770809|454566827|FG002|Overall Study|Withdrawal by Subject|7|||
126346966|NCT00770809|454566825|FG000|Overall Study|Progression|2|||
126346967|NCT00770809|454566826|FG001|Overall Study|Progression|2|||
126758667|NCT00134563|456066674|FG001|Overall Study|did not wish to continue|32|||
126346968|NCT00770809|454566827|FG002|Overall Study|Progression|0|||
126346969|NCT00770809|454566825|FG000|Overall Study|Complicating illness|0|||
126346970|NCT00770809|454566826|FG001|Overall Study|Complicating illness|0|||
126346971|NCT00770809|454566827|FG002|Overall Study|Complicating illness|1|||
126346972|NCT00770809|454566825|FG000|Overall Study|Other Medical Reasons|2|||
126346973|NCT00770809|454566826|FG001|Overall Study|Other Medical Reasons|4|||
126346974|NCT00770809|454566827|FG002|Overall Study|Other Medical Reasons|3|||
126346975|NCT01091259|454566830|FG000|Overall Study|Adverse Event|3|||
126346976|NCT01091259|454566830|FG000|Overall Study|Lack of Efficacy|2|||
126346977|NCT03813654|454566831|FG000|Overall Study|Protocol Violation|0|||
126346978|NCT03813654|454566832|FG001|Overall Study|Protocol Violation|1|||
126346979|NCT03813654|454566833|FG002|Overall Study|Protocol Violation|2|||
126346980|NCT03813654|454566831|FG000|Overall Study|Withdrawal by Subject|1|||
126432466|NCT03037385|454882138|FG003|Overall Study|Progressive Disease|5|||
126432467|NCT03037385|454882139|FG004|Overall Study|Progressive Disease|2|||
126432468|NCT03037385|454882140|FG005|Overall Study|Progressive Disease|0|||
126432469|NCT03037385|454882141|FG006|Overall Study|Progressive Disease|1|||
126432470|NCT03037385|454882142|FG007|Overall Study|Progressive Disease|0|||
126432471|NCT03037385|454882143|FG008|Overall Study|Progressive Disease|0|||
126432472|NCT03037385|454882144|FG009|Overall Study|Progressive Disease|30|||
126432473|NCT03037385|454882135|FG000|Overall Study|Withdrawal by Subject|0|||
126432474|NCT03037385|454882136|FG001|Overall Study|Withdrawal by Subject|0|||
126432475|NCT03037385|454882137|FG002|Overall Study|Withdrawal by Subject|1|||
126432476|NCT03037385|454882138|FG003|Overall Study|Withdrawal by Subject|2|||
126432477|NCT03037385|454882139|FG004|Overall Study|Withdrawal by Subject|1|||
126432478|NCT03037385|454882140|FG005|Overall Study|Withdrawal by Subject|3|||
126432479|NCT03037385|454882141|FG006|Overall Study|Withdrawal by Subject|0|||
126432480|NCT03037385|454882142|FG007|Overall Study|Withdrawal by Subject|0|||
126432481|NCT03037385|454882143|FG008|Overall Study|Withdrawal by Subject|0|||
126432482|NCT03037385|454882144|FG009|Overall Study|Withdrawal by Subject|52|||
126432483|NCT03037385|454882135|FG000|Overall Study|Reason Not Specified|0|||
126432484|NCT03037385|454882136|FG001|Overall Study|Reason Not Specified|1|||
126432485|NCT03037385|454882137|FG002|Overall Study|Reason Not Specified|0|||
126432486|NCT03037385|454882138|FG003|Overall Study|Reason Not Specified|4|||
126432487|NCT03037385|454882139|FG004|Overall Study|Reason Not Specified|3|||
126432488|NCT03037385|454882140|FG005|Overall Study|Reason Not Specified|6|||
126432489|NCT03037385|454882141|FG006|Overall Study|Reason Not Specified|2|||
126432490|NCT03037385|454882142|FG007|Overall Study|Reason Not Specified|0|||
126432491|NCT03037385|454882143|FG008|Overall Study|Reason Not Specified|1|||
126432492|NCT03037385|454882144|FG009|Overall Study|Reason Not Specified|181|||
126432493|NCT04607668|454882152|FG000|Overall Study|Death|49|||
126432494|NCT04607668|454882153|FG001|Overall Study|Death|26|||
126432495|NCT04607668|454882152|FG000|Overall Study|Lost to Follow-up|3|||
126432496|NCT04607668|454882153|FG001|Overall Study|Lost to Follow-up|4|||
126432497|NCT04607668|454882152|FG000|Overall Study|Study terminated by Sponsor|92|||
126432498|NCT04607668|454882153|FG001|Overall Study|Study terminated by Sponsor|114|||
126432499|NCT04607668|454882152|FG000|Overall Study|Withdrawal by Subject|12|||
126432500|NCT04607668|454882153|FG001|Overall Study|Withdrawal by Subject|11|||
126432501|NCT04607668|454882152|FG000|Overall Study|Other, unspecified|8|||
126432502|NCT04607668|454882153|FG001|Overall Study|Other, unspecified|7|||
126432503|NCT01838694|454882154|FG000|Overall Study|Adverse Event|0|||
126432504|NCT01838694|454882155|FG001|Overall Study|Adverse Event|1|||
126432505|NCT00672555|454882156|FG000|Overall Study|Lost to Follow-up|4|||
126432506|NCT00672555|454882156|FG000|Overall Study|Did not want to answer questionnaire|2|||
126432507|NCT03623243|454882157|FG000|Overall Study|Adverse Event|15|||
126432508|NCT03623243|454882157|FG000|Overall Study|Guardian Decision|1|||
126432509|NCT03623243|454882157|FG000|Overall Study|New Therapy for Study Indication|1|||
126432510|NCT03623243|454882157|FG000|Overall Study|Protocol Deviation|3|||
126432511|NCT03623243|454882157|FG000|Overall Study|Physician Decision|4|||
126432512|NCT03623243|454882157|FG000|Overall Study|Patient Decision|15|||
126432513|NCT02153086|454882160|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
126432514|NCT02153086|454882160|FG000|Overall Study|Other|2|||
126432515|NCT03780452|454882164|FG000|Overall Study|Screening failure|2|||
126432516|NCT03186209|454882169|FG000|Overall Study|Withdrawal by Subject|11|||
126432517|NCT03186209|454882170|FG001|Overall Study|Withdrawal by Subject|22|||
126432518|NCT03186209|454882169|FG000|Overall Study|Pregnancy|1|||
126432519|NCT03186209|454882170|FG001|Overall Study|Pregnancy|0|||
126432520|NCT03186209|454882169|FG000|Overall Study|Adverse Event|4|||
126432521|NCT03186209|454882170|FG001|Overall Study|Adverse Event|0|||
126432522|NCT03186209|454882169|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
126432523|NCT03186209|454882170|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
126432524|NCT03186209|454882169|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
126432525|NCT03186209|454882170|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
126432526|NCT03186209|454882169|FG000|Overall Study|Fail to meet randomization criteria|0|||
126432527|NCT03186209|454882170|FG001|Overall Study|Fail to meet randomization criteria|1|||
126432528|NCT03186209|454882169|FG000|Overall Study|Lost to Follow-up|0|||
126432529|NCT03186209|454882170|FG001|Overall Study|Lost to Follow-up|1|||
126432530|NCT03796728|454882172|FG000|Overall Study|Lost to Follow-up|8|||
126432531|NCT03796728|454882172|FG000|Overall Study|Reason not Specified|16|||
126432532|NCT00333775|454882173|FG000|Overall Study|Death|144|||
126432533|NCT00333775|454882174|FG001|Overall Study|Death|149|||
126432534|NCT00333775|454882175|FG002|Overall Study|Death|143|||
126432535|NCT00333775|454882173|FG000|Overall Study|In Follow-up When Study Stopped|87|||
126432536|NCT00333775|454882174|FG001|Overall Study|In Follow-up When Study Stopped|92|||
126432537|NCT00333775|454882175|FG002|Overall Study|In Follow-up When Study Stopped|96|||
126432538|NCT00333775|454882173|FG000|Overall Study|Lost to Follow-up|10|||
126432539|NCT00333775|454882174|FG001|Overall Study|Lost to Follow-up|7|||
126432540|NCT00333775|454882175|FG002|Overall Study|Lost to Follow-up|8|||
126432541|NCT01383928|454882179|FG000|Overall Study|Initiation of ASCT|2|||
126432542|NCT01383928|454882180|FG001|Overall Study|Initiation of ASCT|1|||
126432543|NCT01383928|454882181|FG002|Overall Study|Initiation of ASCT|18|||
126432544|NCT01383928|454882179|FG000|Overall Study|Adverse Event|1|||
126432545|NCT01383928|454882180|FG001|Overall Study|Adverse Event|2|||
126432546|NCT01383928|454882181|FG002|Overall Study|Adverse Event|8|||
126432547|NCT01383928|454882179|FG000|Overall Study|Other|1|||
126432548|NCT01383928|454882180|FG001|Overall Study|Other|3|||
126432549|NCT01383928|454882181|FG002|Overall Study|Other|4|||
126432550|NCT01383928|454882179|FG000|Overall Study|Progressive Disease|1|||
126432551|NCT01383928|454882180|FG001|Overall Study|Progressive Disease|1|||
126432552|NCT01383928|454882181|FG002|Overall Study|Progressive Disease|5|||
126346981|NCT03813654|454566832|FG001|Overall Study|Withdrawal by Subject|0|||
126346982|NCT03813654|454566833|FG002|Overall Study|Withdrawal by Subject|0|||
126346983|NCT01208051|454566834|FG000|Total Enrollment|Withdrawal by Subject|0|||
126346984|NCT01208051|454566835|FG001|Total Enrollment|Withdrawal by Subject|1|||
126346985|NCT01208051|454566836|FG002|Total Enrollment|Withdrawal by Subject|0|||
126346986|NCT01208051|454566837|FG003|Total Enrollment|Withdrawal by Subject|0|||
126346987|NCT01208051|454566838|FG004|Total Enrollment|Withdrawal by Subject|2|||
126346988|NCT01208051|454566834|FG000|Total Enrollment|Brain metastases|0|||
126346989|NCT01208051|454566835|FG001|Total Enrollment|Brain metastases|0|||
126346990|NCT01208051|454566836|FG002|Total Enrollment|Brain metastases|1|||
126346991|NCT01208051|454566837|FG003|Total Enrollment|Brain metastases|0|||
126346992|NCT01208051|454566838|FG004|Total Enrollment|Brain metastases|0|||
126346993|NCT00973973|454566843|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
126346994|NCT00973973|454566844|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
126346995|NCT00973973|454566843|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
126346996|NCT00973973|454566844|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
126346997|NCT00973973|454566843|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
126346998|NCT00973973|454566844|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
126346999|NCT00973973|454566843|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
126347000|NCT00973973|454566844|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
126347001|NCT00973973|454566843|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
126347002|NCT00973973|454566844|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
126347003|NCT00973973|454566843|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
126347004|NCT00973973|454566844|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
126347005|NCT00973973|454566843|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
126347006|NCT00973973|454566844|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
126347007|NCT00973973|454566843|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
126347008|NCT00973973|454566844|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
126347009|NCT00973973|454566843|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
126347010|NCT00973973|454566844|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
126347011|NCT00973973|454566843|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
126347012|NCT00973973|454566844|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
126347013|NCT00973973|454566843|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
126347014|NCT00973973|454566844|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
126347015|NCT00973973|454566843|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
126347016|NCT00973973|454566844|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
126347017|NCT01541748|454566845|FG000|Overall Study|Lost to Follow-up|17|||
126347018|NCT01541748|454566845|FG000|Overall Study|Moved out of state|1|||
126347019|NCT01541748|454566845|FG000|Overall Study|Withdrawal by Subject|7|||
126347020|NCT01541748|454566845|FG000|Overall Study|Screen failure|5|||
126347021|NCT01541748|454566845|FG000|Overall Study|Did not receive study device|1|||
126347022|NCT06057064|454566846|FG000|Overall Study|Death|2|||
126347023|NCT06057064|454566847|FG001|Overall Study|Death|0|||
126347024|NCT06057064|454566846|FG000|Overall Study|Physician Decision|1|||
126347025|NCT06057064|454566847|FG001|Overall Study|Physician Decision|0|||
126347026|NCT06057064|454566846|FG000|Overall Study|Withdrawal by Subject|1|||
126347027|NCT06057064|454566847|FG001|Overall Study|Withdrawal by Subject|1|||
126347028|NCT02832037|454566848|FG000|Overall Study|Administrative reasons|0|||
126347029|NCT02832037|454566849|FG001|Overall Study|Administrative reasons|0|||
126347030|NCT02832037|454566850|FG002|Overall Study|Administrative reasons|1|||
126347031|NCT02832037|454566851|FG003|Overall Study|Administrative reasons|0|||
126347032|NCT02832037|454566852|FG004|Overall Study|Administrative reasons|0|||
126347033|NCT02832037|454566848|FG000|Overall Study|Protocol Violation|3|||
126347034|NCT02832037|454566849|FG001|Overall Study|Protocol Violation|0|||
126432553|NCT01383928|454882179|FG000|Overall Study|Withdrawal by Subject|0|||
126347035|NCT02832037|454566850|FG002|Overall Study|Protocol Violation|4|||
126432554|NCT01383928|454882180|FG001|Overall Study|Withdrawal by Subject|0|||
126432555|NCT01383928|454882181|FG002|Overall Study|Withdrawal by Subject|4|||
126432556|NCT01383928|454882179|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
126432557|NCT01383928|454882180|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
126432558|NCT01383928|454882181|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
126432559|NCT03651765|454882182|FG000|Overall Study|Adverse Event|6|||
126432560|NCT03651765|454882182|FG000|Overall Study|Lack of Efficacy|18|||
126347036|NCT02832037|454566851|FG003|Overall Study|Protocol Violation|1|||
126347037|NCT02832037|454566852|FG004|Overall Study|Protocol Violation|2|||
126347038|NCT02832037|454566848|FG000|Overall Study|Lost to Follow-up|2|||
126347039|NCT02832037|454566849|FG001|Overall Study|Lost to Follow-up|0|||
126347040|NCT02832037|454566850|FG002|Overall Study|Lost to Follow-up|3|||
126347041|NCT02832037|454566851|FG003|Overall Study|Lost to Follow-up|0|||
126347042|NCT02832037|454566852|FG004|Overall Study|Lost to Follow-up|5|||
126347043|NCT02832037|454566848|FG000|Overall Study|Withdrawal by Subject|9|||
126347044|NCT02832037|454566849|FG001|Overall Study|Withdrawal by Subject|8|||
126347045|NCT02832037|454566850|FG002|Overall Study|Withdrawal by Subject|0|||
126347046|NCT02832037|454566851|FG003|Overall Study|Withdrawal by Subject|4|||
126347047|NCT02832037|454566852|FG004|Overall Study|Withdrawal by Subject|8|||
126347048|NCT02832037|454566848|FG000|Overall Study|Adverse Event|5|||
126347049|NCT02832037|454566849|FG001|Overall Study|Adverse Event|4|||
126347050|NCT02832037|454566850|FG002|Overall Study|Adverse Event|0|||
126347051|NCT02832037|454566851|FG003|Overall Study|Adverse Event|2|||
126347052|NCT02832037|454566852|FG004|Overall Study|Adverse Event|4|||
126347053|NCT01137786|454566854|FG000|Overall Study|Lost to Follow-up|0|||
126347054|NCT01137786|454566855|FG001|Overall Study|Lost to Follow-up|2|||
126347055|NCT01137786|454566854|FG000|Overall Study|Withdrawal by Subject|1|||
126347056|NCT01137786|454566855|FG001|Overall Study|Withdrawal by Subject|1|||
126347057|NCT01531153|454566856|FG000|Overall Study|Withdrawal by Subject|10|||
126347058|NCT01531153|454566857|FG001|Overall Study|Withdrawal by Subject|9|||
126347059|NCT01531153|454566858|FG002|Overall Study|Withdrawal by Subject|15|||
126347060|NCT00770367|454566859|FG000|First Intervention|Withdrawal by Subject|0|||
126347061|NCT00770367|454566860|FG001|First Intervention|Withdrawal by Subject|2|||
126347062|NCT00770367|454566859|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
126347063|NCT00770367|454566860|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
126347064|NCT00770367|454566859|FG000|Second Intervention|Lost to Follow-up|2|||
126347065|NCT00770367|454566860|FG001|Second Intervention|Lost to Follow-up|0|||
126347066|NCT00435942|454566861|FG000|Overall Study|Death|17|||
126347067|NCT00435942|454566862|FG001|Overall Study|Death|10|||
126347068|NCT00435942|454566861|FG000|Overall Study|Withdrawal by Subject|2|||
126347069|NCT00435942|454566862|FG001|Overall Study|Withdrawal by Subject|0|||
126347070|NCT00435942|454566861|FG000|Overall Study|Lost to Follow-up|0|||
126347071|NCT00435942|454566862|FG001|Overall Study|Lost to Follow-up|16|||
126347072|NCT00435942|454566861|FG000|Overall Study|Conversion to Open Repair|1|||
126347073|NCT00435942|454566862|FG001|Overall Study|Conversion to Open Repair|0|||
126347074|NCT00435942|454566861|FG000|Overall Study|Technical Failure|3|||
126347075|NCT00435942|454566862|FG001|Overall Study|Technical Failure|0|||
126347076|NCT00435942|454566861|FG000|Overall Study|Other|0|||
126347077|NCT00435942|454566862|FG001|Overall Study|Other|1|||
126347078|NCT00920816|454566863|FG000|Overall Study|Death|116|||
126347079|NCT00920816|454566864|FG001|Overall Study|Death|63|||
126347080|NCT00920816|454566865|FG002|Overall Study|Death|8|||
126347081|NCT00920816|454566866|FG003|Overall Study|Death|3|||
126347082|NCT00920816|454566863|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
126347083|NCT00920816|454566864|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
126347084|NCT00920816|454566865|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
126347085|NCT00920816|454566866|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
126347086|NCT00920816|454566863|FG000|Overall Study|Global deterioration of health status|2|||
126347087|NCT00920816|454566864|FG001|Overall Study|Global deterioration of health status|0|||
126347088|NCT00920816|454566865|FG002|Overall Study|Global deterioration of health status|0|||
126347089|NCT00920816|454566866|FG003|Overall Study|Global deterioration of health status|0|||
126347090|NCT00920816|454566863|FG000|Overall Study|Objective progression or relapse|6|||
126347091|NCT00920816|454566864|FG001|Overall Study|Objective progression or relapse|2|||
126347092|NCT00920816|454566865|FG002|Overall Study|Objective progression or relapse|0|||
126347093|NCT00920816|454566866|FG003|Overall Study|Objective progression or relapse|0|||
126347094|NCT00920816|454566863|FG000|Overall Study|Other|26|||
126347095|NCT00920816|454566864|FG001|Overall Study|Other|15|||
126347096|NCT00920816|454566865|FG002|Overall Study|Other|1|||
126347097|NCT00920816|454566866|FG003|Overall Study|Other|2|||
126347098|NCT00920816|454566863|FG000|Overall Study|Lost to Follow-up|11|||
126347099|NCT00920816|454566864|FG001|Overall Study|Lost to Follow-up|2|||
126347100|NCT00920816|454566865|FG002|Overall Study|Lost to Follow-up|0|||
126347101|NCT00920816|454566866|FG003|Overall Study|Lost to Follow-up|0|||
126347102|NCT00920816|454566863|FG000|Overall Study|Adverse Event|1|||
126347103|NCT00920816|454566864|FG001|Overall Study|Adverse Event|1|||
126347104|NCT00920816|454566865|FG002|Overall Study|Adverse Event|1|||
126347105|NCT00920816|454566866|FG003|Overall Study|Adverse Event|0|||
126347106|NCT00920816|454566863|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
126347107|NCT00920816|454566864|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
126347108|NCT00920816|454566865|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
126347109|NCT00920816|454566866|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
126347110|NCT00920816|454566863|FG000|Overall Study|Randomized but not treated|3|||
126347111|NCT00920816|454566864|FG001|Overall Study|Randomized but not treated|0|||
126347112|NCT00920816|454566865|FG002|Overall Study|Randomized but not treated|0|||
126347113|NCT00920816|454566866|FG003|Overall Study|Randomized but not treated|0|||
126347114|NCT01180777|454566867|FG000|Overall Study|Protocol Violation|6|||
126347115|NCT01180777|454566867|FG000|Overall Study|Poor lens fit|4|||
126347116|NCT01180777|454566867|FG000|Overall Study|Lost to Follow-up|1|||
126347117|NCT01180777|454566867|FG000|Overall Study|Adverse Event|1|||
126347118|NCT05522751|454566872|FG000|Overall Study|Adverse Event|1|||
126347119|NCT00505921|454566873|FG000|Overall Study|Ineligible|1|||
126347120|NCT00505921|454566873|FG000|Overall Study|Failed to Mobilize|8|||
126347121|NCT02382939|454566879|FG000|Overall Study|Adverse Event|1|||
126347122|NCT02382939|454566880|FG001|Overall Study|Adverse Event|1|||
126347123|NCT02382939|454566879|FG000|Overall Study|Withdrawal by Subject|2|||
126347124|NCT02382939|454566880|FG001|Overall Study|Withdrawal by Subject|2|||
126347125|NCT00716417|454566881|FG000|Overall Study|Adverse Event|0|||
126347126|NCT00716417|454566882|FG001|Overall Study|Adverse Event|0|||
126347127|NCT00716417|454566883|FG002|Overall Study|Adverse Event|2|||
126347128|NCT00716417|454566884|FG003|Overall Study|Adverse Event|1|||
126347129|NCT00716417|454566885|FG004|Overall Study|Adverse Event|0|||
126347130|NCT00716417|454566886|FG005|Overall Study|Adverse Event|0|||
126347131|NCT00716417|454566887|FG006|Overall Study|Adverse Event|3|||
126347132|NCT00716417|454566888|FG007|Overall Study|Adverse Event|1|||
126347133|NCT00716417|454566889|FG008|Overall Study|Adverse Event|0|||
126347134|NCT00716417|454566890|FG009|Overall Study|Adverse Event|3|||
126347135|NCT00716417|454566881|FG000|Overall Study|Withdrawal by Subject|0|||
126347136|NCT00716417|454566882|FG001|Overall Study|Withdrawal by Subject|1|||
126347137|NCT00716417|454566883|FG002|Overall Study|Withdrawal by Subject|0|||
126347138|NCT00716417|454566884|FG003|Overall Study|Withdrawal by Subject|2|||
126347139|NCT00716417|454566885|FG004|Overall Study|Withdrawal by Subject|0|||
126347140|NCT00716417|454566886|FG005|Overall Study|Withdrawal by Subject|0|||
126347141|NCT00716417|454566887|FG006|Overall Study|Withdrawal by Subject|1|||
126347142|NCT00716417|454566888|FG007|Overall Study|Withdrawal by Subject|0|||
126347143|NCT00716417|454566889|FG008|Overall Study|Withdrawal by Subject|0|||
126347144|NCT00716417|454566890|FG009|Overall Study|Withdrawal by Subject|0|||
126347145|NCT00716417|454566881|FG000|Overall Study|Progressive disease|3|||
126347146|NCT00716417|454566882|FG001|Overall Study|Progressive disease|5|||
126347147|NCT00716417|454566883|FG002|Overall Study|Progressive disease|3|||
126347148|NCT00716417|454566884|FG003|Overall Study|Progressive disease|8|||
126347149|NCT00716417|454566885|FG004|Overall Study|Progressive disease|0|||
126347150|NCT00716417|454566886|FG005|Overall Study|Progressive disease|3|||
126347151|NCT00716417|454566887|FG006|Overall Study|Progressive disease|3|||
126347152|NCT00716417|454566888|FG007|Overall Study|Progressive disease|1|||
126347153|NCT00716417|454566889|FG008|Overall Study|Progressive disease|5|||
126347154|NCT00716417|454566890|FG009|Overall Study|Progressive disease|0|||
126347155|NCT00716417|454566881|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
126347156|NCT00716417|454566882|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
126347157|NCT00716417|454566883|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
126347158|NCT00716417|454566884|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
126347159|NCT00716417|454566885|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
126347160|NCT00716417|454566886|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
126347161|NCT00716417|454566887|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
126347162|NCT00716417|454566888|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
126347163|NCT00716417|454566889|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
126347164|NCT00716417|454566890|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
126347165|NCT00716417|454566881|FG000|Overall Study|On patient request due to toxicities|0|||
126347166|NCT00716417|454566882|FG001|Overall Study|On patient request due to toxicities|0|||
126347167|NCT00716417|454566883|FG002|Overall Study|On patient request due to toxicities|0|||
126347168|NCT00716417|454566884|FG003|Overall Study|On patient request due to toxicities|0|||
126347169|NCT00716417|454566885|FG004|Overall Study|On patient request due to toxicities|0|||
126347170|NCT00716417|454566886|FG005|Overall Study|On patient request due to toxicities|0|||
126347171|NCT00716417|454566887|FG006|Overall Study|On patient request due to toxicities|0|||
126347172|NCT00716417|454566888|FG007|Overall Study|On patient request due to toxicities|1|||
126347173|NCT00716417|454566889|FG008|Overall Study|On patient request due to toxicities|0|||
126347174|NCT00716417|454566890|FG009|Overall Study|On patient request due to toxicities|0|||
126347175|NCT01369433|454566891|FG000|Overall Study|Adverse Event|31|||
126347176|NCT01369433|454566892|FG001|Overall Study|Adverse Event|1|||
126347177|NCT01369433|454566891|FG000|Overall Study|Required significant surgical procedure|1|||
126347178|NCT01369433|454566892|FG001|Overall Study|Required significant surgical procedure|0|||
126347179|NCT01369433|454566891|FG000|Overall Study|Non-compliance|1|||
126347180|NCT01369433|454566892|FG001|Overall Study|Non-compliance|0|||
126347181|NCT01369433|454566891|FG000|Overall Study|Withdrawal by Subject|5|||
126432561|NCT03651765|454882182|FG000|Overall Study|Lost to Follow-up|5|||
126432562|NCT03651765|454882182|FG000|Overall Study|Non-Compliance with Study Drug|4|||
126432563|NCT03651765|454882182|FG000|Overall Study|Physician Decision|6|||
126432564|NCT03651765|454882182|FG000|Overall Study|Pregnancy|1|||
126432565|NCT03651765|454882182|FG000|Overall Study|Discontinued by Sponsor|40|||
126432566|NCT03651765|454882182|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
126432567|NCT03651765|454882182|FG000|Overall Study|Withdrawal by Subject|24|||
126432568|NCT03651765|454882182|FG000|Overall Study|Miscellaneous|6|||
126432569|NCT04842747|454882192|FG000|Overall Study|Withdrawal by Subject|6|||
126432570|NCT04842747|454882193|FG001|Overall Study|Withdrawal by Subject|2|||
126432571|NCT04842747|454882192|FG000|Overall Study|Lost to Follow-up|1|||
126432572|NCT04842747|454882193|FG001|Overall Study|Lost to Follow-up|2|||
126432573|NCT04842747|454882192|FG000|Overall Study|Physician Decision|1|||
126432574|NCT04842747|454882193|FG001|Overall Study|Physician Decision|0|||
126432575|NCT04842747|454882192|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
126432576|NCT04842747|454882193|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
126432577|NCT01451606|454882194|FG000|Overall Study|Withdrawal by Subject|4|||
126432578|NCT01451606|454882195|FG001|Overall Study|Withdrawal by Subject|3|||
126432579|NCT04011540|454882200|FG000|Overall Study|Lost to Follow-up|9|||
126432580|NCT04011540|454882201|FG001|Overall Study|Lost to Follow-up|6|||
126432581|NCT03668873|454882202|FG000|Overall Study|Lost to Follow-up|6|||
126432582|NCT03668873|454882203|FG001|Overall Study|Lost to Follow-up|3|||
126432583|NCT02183675|454882204|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
126432584|NCT02183675|454882205|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
126432585|NCT02183675|454882206|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
126432586|NCT02183675|454882207|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
126432587|NCT02183675|454882208|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
126432588|NCT02183675|454882209|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
126432589|NCT01521117|454882210|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
126432590|NCT01521117|454882211|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
126432591|NCT01521117|454882210|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
126432592|NCT01521117|454882211|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
126432593|NCT01521117|454882210|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
126432594|NCT01521117|454882211|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
126432595|NCT02761330|454882218|FG000|Treatment Week 1|Withdrawal by Subject|0|||
126432596|NCT02761330|454882219|FG001|Treatment Week 1|Withdrawal by Subject|0|||
126432597|NCT02761330|454882220|FG002|Treatment Week 1|Withdrawal by Subject|0|||
126432598|NCT02761330|454882221|FG003|Treatment Week 1|Withdrawal by Subject|1|||
126432599|NCT02761330|454882222|FG004|Treatment Week 1|Withdrawal by Subject|0|||
126432600|NCT02761330|454882223|FG005|Treatment Week 1|Withdrawal by Subject|1|||
126432601|NCT00980954|454882226|FG000|Overall Study|Protocol Violation|9|||
126432602|NCT00980954|454882227|FG001|Overall Study|Protocol Violation|15|||
126432603|NCT02657889|454882228|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
126432604|NCT02657889|454882229|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
126432605|NCT02657889|454882230|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
126432606|NCT02657889|454882231|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
126432607|NCT02657889|454882228|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
126432608|NCT02657889|454882229|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
126432609|NCT02657889|454882230|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
126432610|NCT02657889|454882231|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
126432611|NCT02657889|454882228|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
126432612|NCT02657889|454882229|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
126432613|NCT02657889|454882230|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
126432614|NCT02657889|454882231|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
126432615|NCT02657889|454882228|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
126432616|NCT02657889|454882229|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
126432617|NCT02657889|454882230|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
126432618|NCT02657889|454882231|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
126432619|NCT02657889|454882228|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
126432620|NCT02657889|454882229|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
126432621|NCT02657889|454882230|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
126432622|NCT02657889|454882231|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
126432623|NCT02657889|454882228|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
126432624|NCT02657889|454882229|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
126432625|NCT02657889|454882230|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
126432626|NCT02657889|454882231|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
126432627|NCT02657889|454882228|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
126432628|NCT02657889|454882229|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
126680711|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
126432629|NCT02657889|454882230|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
126432630|NCT02657889|454882231|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
126432631|NCT02657889|454882228|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
126432632|NCT02657889|454882229|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
126432633|NCT02657889|454882230|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
126432634|NCT02657889|454882231|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
126432635|NCT02657889|454882228|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
126432636|NCT02657889|454882229|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
126432637|NCT02657889|454882230|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
126432638|NCT02657889|454882231|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
126432639|NCT02657889|454882228|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
126432640|NCT02657889|454882229|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
126432641|NCT02657889|454882230|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
126432642|NCT02657889|454882231|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
126432643|NCT02657889|454882228|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
126432644|NCT02657889|454882229|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
126432645|NCT02657889|454882230|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
126432646|NCT02657889|454882231|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
126432647|NCT02657889|454882228|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
126432648|NCT02657889|454882229|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
126432649|NCT02657889|454882230|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
126432650|NCT02657889|454882231|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
126432651|NCT00374140|454882232|FG000|Overall Study|Lost to Follow-up|1|||
126432652|NCT00374140|454882232|FG000|Overall Study|Protocol Violation|1|||
126432653|NCT04576988|454882233|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
126432654|NCT04576988|454882234|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
126432655|NCT04576988|454882233|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
126432656|NCT04576988|454882234|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
126432657|NCT04576988|454882233|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
126432658|NCT04576988|454882234|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
126432659|NCT04576988|454882233|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
126432660|NCT04576988|454882234|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
126432661|NCT04576988|454882233|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
126432662|NCT04576988|454882234|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
126432663|NCT04576988|454882233|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
126432664|NCT04576988|454882234|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
126432665|NCT04576988|454882233|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
126432666|NCT04576988|454882234|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
126432667|NCT04576988|454882233|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
126432668|NCT04576988|454882234|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
126432669|NCT04576988|454882233|FG000|Long Term Double Blind (LTDB)|Death|2|||
126432670|NCT04576988|454882234|FG001|Long Term Double Blind (LTDB)|Death|1|||
126432671|NCT04576988|454882233|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
126432672|NCT04576988|454882234|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
126432673|NCT01576341|454882235|FG000|Overall Study|Withdrawal by Subject|24|||
126432674|NCT01576341|454882235|FG000|Overall Study|Adverse Event|10|||
126432675|NCT01576341|454882235|FG000|Overall Study|Death|21|||
126432676|NCT01576341|454882235|FG000|Overall Study|Physician Decision|2|||
126432677|NCT01576341|454882235|FG000|Overall Study|Lost to Follow-up|2|||
126432678|NCT01576341|454882235|FG000|Overall Study|Kidney transplantation|10|||
126432679|NCT01576341|454882235|FG000|Overall Study|Protocol Violation|12|||
126432680|NCT01576341|454882235|FG000|Overall Study|Other|12|||
126432681|NCT01844765|454882236|FG000|Overall Study|Adverse Event|6|||
126432682|NCT01844765|454882237|FG001|Overall Study|Adverse Event|8|||
126432683|NCT01844765|454882236|FG000|Overall Study|Withdrawal by Subject|2|||
126432684|NCT01844765|454882237|FG001|Overall Study|Withdrawal by Subject|3|||
126432685|NCT01844765|454882236|FG000|Overall Study|Disease progression|1|||
126432686|NCT01844765|454882237|FG001|Overall Study|Disease progression|0|||
126432687|NCT01844765|454882236|FG000|Overall Study|Administrative problems|3|||
126432688|NCT01844765|454882237|FG001|Overall Study|Administrative problems|4|||
126432689|NCT01844765|454882236|FG000|Overall Study|Protocol deviation|2|||
126432690|NCT01844765|454882237|FG001|Overall Study|Protocol deviation|0|||
126432691|NCT01844765|454882236|FG000|Overall Study|Untreated|1|||
126432692|NCT01844765|454882237|FG001|Overall Study|Untreated|0|||
126432693|NCT00617734|454882238|FG000|Overall Study|Withdrew Consent|2|||
126432694|NCT00617734|454882239|FG001|Overall Study|Withdrew Consent|0|||
126432695|NCT00617734|454882238|FG000|Overall Study|Adverse Event|4|||
126432696|NCT00617734|454882239|FG001|Overall Study|Adverse Event|1|||
126432697|NCT00617734|454882238|FG000|Overall Study|Protocol Violation|1|||
126347182|NCT01369433|454566892|FG001|Overall Study|Withdrawal by Subject|2|||
126347183|NCT01369433|454566891|FG000|Overall Study|Study terminated by Sponsor|67|||
126347184|NCT01369433|454566892|FG001|Overall Study|Study terminated by Sponsor|0|||
126347185|NCT01369433|454566891|FG000|Overall Study|Lost to Follow-up|1|||
126347186|NCT01369433|454566892|FG001|Overall Study|Lost to Follow-up|0|||
126347187|NCT01369433|454566891|FG000|Overall Study|Death|5|||
126347188|NCT01369433|454566892|FG001|Overall Study|Death|0|||
126347189|NCT01369433|454566891|FG000|Overall Study|Investigator discretion|6|||
126347190|NCT01369433|454566892|FG001|Overall Study|Investigator discretion|1|||
126347191|NCT01369433|454566891|FG000|Overall Study|Progressive Disease|92|||
126347192|NCT01369433|454566892|FG001|Overall Study|Progressive Disease|12|||
126347193|NCT02178956|454566897|FG000|Overall Study|Lost to Follow-up|4|||
126347194|NCT02178956|454566898|FG001|Overall Study|Lost to Follow-up|4|||
126347195|NCT02178956|454566897|FG000|Overall Study|Sponsor terminated study|49|||
126347196|NCT02178956|454566898|FG001|Overall Study|Sponsor terminated study|58|||
126347197|NCT02178956|454566897|FG000|Overall Study|Withdrawal by Subject|15|||
126347198|NCT02178956|454566898|FG001|Overall Study|Withdrawal by Subject|11|||
126347199|NCT02178956|454566897|FG000|Overall Study|Various Reasons|3|||
126347200|NCT02178956|454566898|FG001|Overall Study|Various Reasons|5|||
126347201|NCT01138046|454566899|FG000|Overall Study|Withdrawal due to death|6|||
126347202|NCT02709369|454566901|FG000|Overall Study|Lost to Follow-up|15|||
126347203|NCT02709369|454566901|FG000|Overall Study|Withdrawal by Subject|10|||
126347204|NCT02709369|454566901|FG000|Overall Study|Did not received intervention|2|||
126347205|NCT01900314|454566902|FG000|Overall Study|Lost to Follow-up|1|||
126347206|NCT01900314|454566903|FG001|Overall Study|Lost to Follow-up|0|||
126347207|NCT01900314|454566902|FG000|Overall Study|Protocol Violation|0|||
126347208|NCT01900314|454566903|FG001|Overall Study|Protocol Violation|1|||
126347209|NCT01900314|454566902|FG000|Overall Study|Withdrawal by Subject|3|||
126347210|NCT01900314|454566903|FG001|Overall Study|Withdrawal by Subject|3|||
126347211|NCT01104766|454566904|FG000|Overall Study|Did not meet inc/exc criteria|1|||
126347212|NCT01104766|454566905|FG001|Overall Study|Did not meet inc/exc criteria|0|||
126347213|NCT01104766|454566906|FG002|Overall Study|Did not meet inc/exc criteria|0|||
126347214|NCT01104766|454566907|FG003|Overall Study|Did not meet inc/exc criteria|0|||
126347215|NCT01104766|454566904|FG000|Overall Study|Adverse Event|17|||
126347216|NCT01104766|454566905|FG001|Overall Study|Adverse Event|15|||
126347217|NCT01104766|454566906|FG002|Overall Study|Adverse Event|20|||
126347218|NCT01104766|454566907|FG003|Overall Study|Adverse Event|14|||
126347219|NCT01104766|454566904|FG000|Overall Study|Lack of Efficacy|20|||
126347220|NCT01104766|454566905|FG001|Overall Study|Lack of Efficacy|15|||
126347221|NCT01104766|454566906|FG002|Overall Study|Lack of Efficacy|14|||
126347222|NCT01104766|454566907|FG003|Overall Study|Lack of Efficacy|8|||
126347223|NCT01104766|454566904|FG000|Overall Study|Protocol Violation|2|||
126347224|NCT01104766|454566905|FG001|Overall Study|Protocol Violation|0|||
126347225|NCT01104766|454566906|FG002|Overall Study|Protocol Violation|0|||
126347226|NCT01104766|454566907|FG003|Overall Study|Protocol Violation|0|||
126347227|NCT01104766|454566904|FG000|Overall Study|Withdrawal by Subject|17|||
126347228|NCT01104766|454566905|FG001|Overall Study|Withdrawal by Subject|19|||
126347229|NCT01104766|454566906|FG002|Overall Study|Withdrawal by Subject|25|||
126347230|NCT01104766|454566907|FG003|Overall Study|Withdrawal by Subject|15|||
126347231|NCT01104766|454566904|FG000|Overall Study|Lost to Follow-up|1|||
126347232|NCT01104766|454566905|FG001|Overall Study|Lost to Follow-up|2|||
126347233|NCT01104766|454566906|FG002|Overall Study|Lost to Follow-up|1|||
126347234|NCT01104766|454566907|FG003|Overall Study|Lost to Follow-up|1|||
126347235|NCT04225832|454566909|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
126347236|NCT04225832|454566910|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
126347237|NCT04225832|454566909|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
126347238|NCT04225832|454566910|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
126347239|NCT03965923|454566913|FG000|Overall Study|Withdrawal by Subject|1|||
126347240|NCT03965923|454566914|FG001|Overall Study|Withdrawal by Subject|2|||
126347241|NCT03965923|454566915|FG002|Overall Study|Withdrawal by Subject|3|||
126347242|NCT03965923|454566916|FG003|Overall Study|Withdrawal by Subject|1|||
126347243|NCT03965923|454566917|FG004|Overall Study|Withdrawal by Subject|2|||
126347244|NCT03965923|454566918|FG005|Overall Study|Withdrawal by Subject|0|||
126347245|NCT03965923|454566919|FG006|Overall Study|Withdrawal by Subject|4|||
126347246|NCT03965923|454566920|FG007|Overall Study|Withdrawal by Subject|3|||
126347247|NCT03965923|454566921|FG008|Overall Study|Withdrawal by Subject|4|||
126347248|NCT03965923|454566922|FG009|Overall Study|Withdrawal by Subject|0|||
126347249|NCT03965923|454566923|FG010|Overall Study|Withdrawal by Subject|2|||
126347250|NCT03965923|454566924|FG011|Overall Study|Withdrawal by Subject|0|||
126347251|NCT03965923|454566913|FG000|Overall Study|Lost to Follow-up|2|||
126347252|NCT03965923|454566914|FG001|Overall Study|Lost to Follow-up|1|||
126347253|NCT03965923|454566915|FG002|Overall Study|Lost to Follow-up|1|||
126347254|NCT03965923|454566916|FG003|Overall Study|Lost to Follow-up|0|||
126432698|NCT00617734|454882239|FG001|Overall Study|Protocol Violation|0|||
126432699|NCT00617734|454882238|FG000|Overall Study|Found Ineligible After Randomization|1|||
126432700|NCT00617734|454882239|FG001|Overall Study|Found Ineligible After Randomization|4|||
126432701|NCT00617734|454882238|FG000|Overall Study|Lost to Follow-up|0|||
126432702|NCT00617734|454882239|FG001|Overall Study|Lost to Follow-up|1|||
126432703|NCT00556075|454882246|FG000|Overall Study|Lost to Follow-up|3|||
126432704|NCT00556075|454882247|FG001|Overall Study|Lost to Follow-up|0|||
126432705|NCT00556075|454882248|FG002|Overall Study|Lost to Follow-up|3|||
126432706|NCT00556075|454882246|FG000|Overall Study|Withdrawal by Subject|3|||
126432707|NCT00556075|454882247|FG001|Overall Study|Withdrawal by Subject|3|||
126432708|NCT00556075|454882248|FG002|Overall Study|Withdrawal by Subject|0|||
126680712|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
126680713|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
126680714|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
126680715|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
126680716|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
126680717|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
126758668|NCT00134563|456066675|FG002|Overall Study|did not wish to continue|26|||
126432709|NCT00556075|454882246|FG000|Overall Study|Protocol Violation|1|||
126432710|NCT00556075|454882247|FG001|Overall Study|Protocol Violation|1|||
126432711|NCT00556075|454882248|FG002|Overall Study|Protocol Violation|3|||
126432712|NCT00556075|454882246|FG000|Overall Study|Not eligible|1|||
126432713|NCT00556075|454882247|FG001|Overall Study|Not eligible|1|||
126432714|NCT00556075|454882248|FG002|Overall Study|Not eligible|2|||
126432715|NCT00556075|454882246|FG000|Overall Study|Adverse Event|1|||
126432716|NCT00556075|454882247|FG001|Overall Study|Adverse Event|2|||
126432717|NCT00556075|454882248|FG002|Overall Study|Adverse Event|0|||
126432718|NCT00556075|454882246|FG000|Overall Study|Personal issues|4|||
126432719|NCT00556075|454882247|FG001|Overall Study|Personal issues|1|||
126432720|NCT00556075|454882248|FG002|Overall Study|Personal issues|0|||
126432721|NCT00556075|454882246|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
126432722|NCT00556075|454882247|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
126432723|NCT00556075|454882248|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
126432724|NCT02485691|454882249|FG000|Overall Study|Adverse Event|25|||
126432725|NCT02485691|454882250|FG001|Overall Study|Adverse Event|11|||
126432726|NCT02485691|454882249|FG000|Overall Study|Poor compliance to protocol|0|||
126432727|NCT02485691|454882250|FG001|Overall Study|Poor compliance to protocol|1|||
126432728|NCT02485691|454882249|FG000|Overall Study|Disease progression|57|||
126432729|NCT02485691|454882250|FG001|Overall Study|Disease progression|92|||
126432730|NCT02485691|454882249|FG000|Overall Study|Investigator's decision|23|||
126432731|NCT02485691|454882250|FG001|Overall Study|Investigator's decision|5|||
126432732|NCT02485691|454882249|FG000|Overall Study|Participant's request|13|||
126432733|NCT02485691|454882250|FG001|Overall Study|Participant's request|6|||
126432734|NCT02485691|454882249|FG000|Overall Study|Other reason|8|||
126432735|NCT02485691|454882250|FG001|Overall Study|Other reason|9|||
126432736|NCT02485691|454882249|FG000|Overall Study|Randomized and not treated|3|||
126432737|NCT02485691|454882250|FG001|Overall Study|Randomized and not treated|2|||
126432738|NCT00604565|454882251|FG000|Overall Study|Study terminated|0|||
126432739|NCT00604565|454882252|FG001|Overall Study|Study terminated|3|||
126432740|NCT04292535|454882253|FG000|Overall Study|Withdrawal by Subject|0|||
126432741|NCT04292535|454882254|FG001|Overall Study|Withdrawal by Subject|0|||
126432742|NCT04292535|454882255|FG002|Overall Study|Withdrawal by Subject|0|||
126432743|NCT04292535|454882256|FG003|Overall Study|Withdrawal by Subject|0|||
126432744|NCT04292535|454882257|FG004|Overall Study|Withdrawal by Subject|0|||
126432745|NCT04292535|454882258|FG005|Overall Study|Withdrawal by Subject|0|||
126432746|NCT04292535|454882259|FG006|Overall Study|Withdrawal by Subject|0|||
126432747|NCT04292535|454882260|FG007|Overall Study|Withdrawal by Subject|1|||
126432748|NCT04292535|454882261|FG008|Overall Study|Withdrawal by Subject|0|||
126432749|NCT04292535|454882262|FG009|Overall Study|Withdrawal by Subject|0|||
126432750|NCT04292535|454882263|FG010|Overall Study|Withdrawal by Subject|0|||
126432751|NCT04292535|454882264|FG011|Overall Study|Withdrawal by Subject|0|||
126432752|NCT04292535|454882265|FG012|Overall Study|Withdrawal by Subject|0|||
126432753|NCT04292535|454882266|FG013|Overall Study|Withdrawal by Subject|0|||
126432754|NCT04292535|454882253|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
126432755|NCT04292535|454882254|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
126432756|NCT04292535|454882255|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
126432757|NCT04292535|454882256|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
126432758|NCT04292535|454882257|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
126432759|NCT04292535|454882258|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
126432760|NCT04292535|454882259|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
126432761|NCT04292535|454882260|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
126432762|NCT04292535|454882261|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
126432763|NCT04292535|454882262|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
126432764|NCT04292535|454882263|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
126432765|NCT04292535|454882264|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
126432766|NCT04292535|454882265|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
126432767|NCT04292535|454882266|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
126432768|NCT04292535|454882253|FG000|Overall Study|Report of Dizziness|0|||
126432769|NCT04292535|454882254|FG001|Overall Study|Report of Dizziness|0|||
126432770|NCT04292535|454882255|FG002|Overall Study|Report of Dizziness|0|||
126432771|NCT04292535|454882256|FG003|Overall Study|Report of Dizziness|0|||
126432772|NCT04292535|454882257|FG004|Overall Study|Report of Dizziness|0|||
126432773|NCT04292535|454882258|FG005|Overall Study|Report of Dizziness|0|||
126432774|NCT04292535|454882259|FG006|Overall Study|Report of Dizziness|0|||
126432775|NCT04292535|454882260|FG007|Overall Study|Report of Dizziness|0|||
126432776|NCT04292535|454882261|FG008|Overall Study|Report of Dizziness|0|||
126432777|NCT04292535|454882262|FG009|Overall Study|Report of Dizziness|0|||
126432778|NCT04292535|454882263|FG010|Overall Study|Report of Dizziness|0|||
126432779|NCT04292535|454882264|FG011|Overall Study|Report of Dizziness|0|||
126432780|NCT04292535|454882265|FG012|Overall Study|Report of Dizziness|0|||
126432781|NCT04292535|454882266|FG013|Overall Study|Report of Dizziness|1|||
126432782|NCT04292535|454882253|FG000|Overall Study|Equipment Failure|0|||
126432783|NCT04292535|454882254|FG001|Overall Study|Equipment Failure|0|||
126432784|NCT04292535|454882255|FG002|Overall Study|Equipment Failure|0|||
126432785|NCT04292535|454882256|FG003|Overall Study|Equipment Failure|0|||
126432786|NCT04292535|454882257|FG004|Overall Study|Equipment Failure|0|||
126432787|NCT04292535|454882258|FG005|Overall Study|Equipment Failure|0|||
126432788|NCT04292535|454882259|FG006|Overall Study|Equipment Failure|0|||
126432789|NCT04292535|454882260|FG007|Overall Study|Equipment Failure|0|||
126432790|NCT04292535|454882261|FG008|Overall Study|Equipment Failure|0|||
126432791|NCT04292535|454882262|FG009|Overall Study|Equipment Failure|0|||
126432792|NCT04292535|454882263|FG010|Overall Study|Equipment Failure|0|||
126432793|NCT04292535|454882264|FG011|Overall Study|Equipment Failure|1|||
126432794|NCT04292535|454882265|FG012|Overall Study|Equipment Failure|0|||
126432795|NCT04292535|454882266|FG013|Overall Study|Equipment Failure|0|||
126432796|NCT03836625|454882267|FG000|Overall Study|Lost to Follow-up|9|||
126432797|NCT03836625|454882268|FG001|Overall Study|Lost to Follow-up|9|||
126432798|NCT03836625|454882267|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
126432799|NCT03836625|454882268|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
126432800|NCT03836625|454882267|FG000|Overall Study|Death|0|||
126432801|NCT03836625|454882268|FG001|Overall Study|Death|1|||
126432802|NCT03836625|454882267|FG000|Overall Study|Refused follow-up|0|||
126432803|NCT03836625|454882268|FG001|Overall Study|Refused follow-up|1|||
126432804|NCT04764162|454882271|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
126432805|NCT04764162|454882272|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
126432806|NCT03413891|454882273|FG000|Overall Study|Lost to Follow-up|2|||
126432807|NCT03413891|454882274|FG001|Overall Study|Lost to Follow-up|1|||
126432808|NCT03413891|454882273|FG000|Overall Study|Protocol Violation|0|||
126432809|NCT03413891|454882274|FG001|Overall Study|Protocol Violation|1|||
126432810|NCT04905134|454882277|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
126432811|NCT04905134|454882277|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
126432812|NCT03642873|454882278|FG000|Third Intervention (1 Day)|Screen failure|0|||
126432813|NCT03642873|454882279|FG001|Third Intervention (1 Day)|Screen failure|0|||
126432814|NCT03642873|454882280|FG002|Third Intervention (1 Day)|Screen failure|0|||
126432815|NCT03642873|454882281|FG003|Third Intervention (1 Day)|Screen failure|0|||
126432816|NCT03642873|454882282|FG004|Third Intervention (1 Day)|Screen failure|1|||
126432817|NCT03642873|454882283|FG005|Third Intervention (1 Day)|Screen failure|0|||
126432818|NCT05556265|454882284|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
126432819|NCT05556265|454882285|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
126432820|NCT05556265|454882286|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
126432821|NCT05556265|454882287|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
126432822|NCT05556265|454882288|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
126432823|NCT05556265|454882284|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
126432824|NCT05556265|454882285|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
126432825|NCT05556265|454882286|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
126432826|NCT05556265|454882287|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
126432827|NCT05556265|454882288|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
126432828|NCT05556265|454882284|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
126432829|NCT05556265|454882285|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
126432830|NCT05556265|454882286|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
126432831|NCT05556265|454882287|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
126715144|NCT01161524|455908696|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
126715145|NCT01161524|455908694|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
126432832|NCT05556265|454882288|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
126432833|NCT05556265|454882284|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
126432834|NCT05556265|454882285|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
126432835|NCT05556265|454882286|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
126432836|NCT05556265|454882287|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
126432837|NCT05556265|454882288|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
126432838|NCT05556265|454882284|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
126432839|NCT05556265|454882285|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
126432840|NCT05556265|454882286|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
126432841|NCT05556265|454882287|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
126432842|NCT05556265|454882288|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
126432843|NCT05556265|454882284|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
126432844|NCT05556265|454882285|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
126432845|NCT05556265|454882286|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
126432846|NCT05556265|454882287|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
126432847|NCT05556265|454882288|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
126432848|NCT05556265|454882284|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
126432849|NCT05556265|454882285|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
126432850|NCT05556265|454882286|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
126432851|NCT05556265|454882287|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
126432852|NCT05556265|454882288|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
126432853|NCT05556265|454882284|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
126432854|NCT05556265|454882285|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
126432855|NCT05556265|454882286|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
126432856|NCT05556265|454882287|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
126432857|NCT05556265|454882288|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
126432858|NCT05556265|454882284|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
126432859|NCT05556265|454882285|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
126432860|NCT05556265|454882286|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
126432861|NCT05556265|454882287|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
126432862|NCT05556265|454882288|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
126432863|NCT03221556|454882291|FG000|Allocation|post-randomization exclusion|0|||
126432864|NCT03221556|454882292|FG001|Allocation|post-randomization exclusion|1|||
126432865|NCT03221556|454882291|FG000|Follow-Up|Withdrawal by Subject|0|||
126432866|NCT03221556|454882292|FG001|Follow-Up|Withdrawal by Subject|1|||
126432867|NCT01253291|454882295|FG000|Overall Study|Withdrawal by Subject|1|||
126432868|NCT01253291|454882296|FG001|Overall Study|Withdrawal by Subject|1|||
126432869|NCT01253291|454882297|FG002|Overall Study|Withdrawal by Subject|0|||
126432870|NCT01253291|454882298|FG003|Overall Study|Withdrawal by Subject|0|||
126432871|NCT01253291|454882299|FG004|Overall Study|Withdrawal by Subject|0|||
126432872|NCT01253291|454882295|FG000|Overall Study|Adverse Event|0|||
126432873|NCT01253291|454882296|FG001|Overall Study|Adverse Event|1|||
126432874|NCT01253291|454882297|FG002|Overall Study|Adverse Event|0|||
126432875|NCT01253291|454882298|FG003|Overall Study|Adverse Event|0|||
126432876|NCT01253291|454882299|FG004|Overall Study|Adverse Event|0|||
126432877|NCT01253291|454882295|FG000|Overall Study|Lack of Efficacy|1|||
126432878|NCT01253291|454882296|FG001|Overall Study|Lack of Efficacy|0|||
126432879|NCT01253291|454882297|FG002|Overall Study|Lack of Efficacy|0|||
126432880|NCT01253291|454882298|FG003|Overall Study|Lack of Efficacy|0|||
126432881|NCT01253291|454882299|FG004|Overall Study|Lack of Efficacy|0|||
126432882|NCT01253291|454882295|FG000|Overall Study|Physician Decision|2|||
126432883|NCT01253291|454882296|FG001|Overall Study|Physician Decision|0|||
126432884|NCT01253291|454882297|FG002|Overall Study|Physician Decision|0|||
126432885|NCT01253291|454882298|FG003|Overall Study|Physician Decision|0|||
126432886|NCT01253291|454882299|FG004|Overall Study|Physician Decision|2|||
126432887|NCT02234843|454882300|FG000|Overall Study|Death|1|||
126432888|NCT02234843|454882301|FG001|Overall Study|Death|0|||
126432889|NCT02234843|454882302|FG002|Overall Study|Death|0|||
126432890|NCT02234843|454882303|FG003|Overall Study|Death|0|||
126432891|NCT02234843|454882304|FG004|Overall Study|Death|0|||
126432892|NCT02234843|454882305|FG005|Overall Study|Death|0|||
126432893|NCT02234843|454882306|FG006|Overall Study|Death|0|||
126432894|NCT02234843|454882307|FG007|Overall Study|Death|0|||
126432895|NCT02234843|454882308|FG008|Overall Study|Death|0|||
126432896|NCT02234843|454882309|FG009|Overall Study|Death|0|||
126432897|NCT02234843|454882300|FG000|Overall Study|Protocol Violation|1|||
126432898|NCT02234843|454882301|FG001|Overall Study|Protocol Violation|0|||
126432899|NCT02234843|454882302|FG002|Overall Study|Protocol Violation|1|||
126432900|NCT02234843|454882303|FG003|Overall Study|Protocol Violation|0|||
126432901|NCT02234843|454882304|FG004|Overall Study|Protocol Violation|0|||
126432902|NCT02234843|454882305|FG005|Overall Study|Protocol Violation|0|||
126680718|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
126347255|NCT03965923|454566917|FG004|Overall Study|Lost to Follow-up|2|||
126347256|NCT03965923|454566918|FG005|Overall Study|Lost to Follow-up|1|||
126347257|NCT03965923|454566919|FG006|Overall Study|Lost to Follow-up|2|||
126347258|NCT03965923|454566920|FG007|Overall Study|Lost to Follow-up|1|||
126347259|NCT03965923|454566921|FG008|Overall Study|Lost to Follow-up|0|||
126347260|NCT03965923|454566922|FG009|Overall Study|Lost to Follow-up|2|||
126347261|NCT03965923|454566923|FG010|Overall Study|Lost to Follow-up|0|||
126347262|NCT03965923|454566924|FG011|Overall Study|Lost to Follow-up|0|||
126347263|NCT03965923|454566913|FG000|Overall Study|Death|0|||
126347264|NCT03965923|454566914|FG001|Overall Study|Death|0|||
126347265|NCT03965923|454566915|FG002|Overall Study|Death|0|||
126347266|NCT03965923|454566916|FG003|Overall Study|Death|0|||
126347267|NCT03965923|454566917|FG004|Overall Study|Death|0|||
126347268|NCT03965923|454566918|FG005|Overall Study|Death|0|||
126347269|NCT03965923|454566919|FG006|Overall Study|Death|0|||
126347270|NCT03965923|454566920|FG007|Overall Study|Death|1|||
126347271|NCT03965923|454566921|FG008|Overall Study|Death|4|||
126347272|NCT03965923|454566922|FG009|Overall Study|Death|0|||
126347273|NCT03965923|454566923|FG010|Overall Study|Death|4|||
126347274|NCT03965923|454566924|FG011|Overall Study|Death|0|||
126347275|NCT03965923|454566913|FG000|Overall Study|Other reason|0|||
126680719|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
126680720|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
126680721|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
126680722|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
126680723|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
126680724|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
126680725|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
126680726|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
126680727|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
126680728|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
126680729|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
126680730|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
126680731|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
126680732|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
126680733|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
126680734|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
126680735|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
126680736|NCT00105443|455788161|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
126347276|NCT03965923|454566914|FG001|Overall Study|Other reason|0|||
126347277|NCT03965923|454566915|FG002|Overall Study|Other reason|0|||
126347278|NCT03965923|454566916|FG003|Overall Study|Other reason|1|||
126347279|NCT03965923|454566917|FG004|Overall Study|Other reason|0|||
126347280|NCT03965923|454566918|FG005|Overall Study|Other reason|0|||
126347281|NCT03965923|454566919|FG006|Overall Study|Other reason|0|||
126347282|NCT03965923|454566920|FG007|Overall Study|Other reason|0|||
126347283|NCT03965923|454566921|FG008|Overall Study|Other reason|0|||
126347284|NCT03965923|454566922|FG009|Overall Study|Other reason|0|||
126347285|NCT03965923|454566923|FG010|Overall Study|Other reason|2|||
126347286|NCT03965923|454566924|FG011|Overall Study|Other reason|0|||
126347287|NCT03282097|454566925|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
126347288|NCT03282097|454566926|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
126347289|NCT03282097|454566925|FG000|Intervention Visit Complete|Patient Death|13|||
126347290|NCT03282097|454566926|FG001|Intervention Visit Complete|Patient Death|15|||
126347291|NCT03282097|454566925|FG000|Intervention Visit Complete|Caregiver Death|0|||
126347292|NCT03282097|454566926|FG001|Intervention Visit Complete|Caregiver Death|3|||
126347293|NCT03282097|454566925|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
126347294|NCT03282097|454566926|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
126347295|NCT03282097|454566925|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
126347296|NCT03282097|454566926|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
126347297|NCT03282097|454566925|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
126347298|NCT03282097|454566926|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
126347299|NCT03282097|454566925|FG000|Primary Outcome Data Collection Complete|Missing|2|||
126347300|NCT03282097|454566926|FG001|Primary Outcome Data Collection Complete|Missing|3|||
126347301|NCT03282097|454566925|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
126347302|NCT03282097|454566926|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
126347303|NCT03282097|454566925|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
126347304|NCT03282097|454566926|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
126432903|NCT02234843|454882306|FG006|Overall Study|Protocol Violation|0|||
126432904|NCT02234843|454882307|FG007|Overall Study|Protocol Violation|0|||
126432905|NCT02234843|454882308|FG008|Overall Study|Protocol Violation|0|||
126432906|NCT02234843|454882309|FG009|Overall Study|Protocol Violation|0|||
126432907|NCT02234843|454882300|FG000|Overall Study|Efficacy outcome reached|2|||
126432908|NCT02234843|454882301|FG001|Overall Study|Efficacy outcome reached|0|||
126432909|NCT02234843|454882302|FG002|Overall Study|Efficacy outcome reached|0|||
126432910|NCT02234843|454882303|FG003|Overall Study|Efficacy outcome reached|0|||
126432911|NCT02234843|454882304|FG004|Overall Study|Efficacy outcome reached|0|||
126432912|NCT02234843|454882305|FG005|Overall Study|Efficacy outcome reached|2|||
126432913|NCT02234843|454882306|FG006|Overall Study|Efficacy outcome reached|0|||
126432914|NCT02234843|454882307|FG007|Overall Study|Efficacy outcome reached|0|||
126432915|NCT02234843|454882308|FG008|Overall Study|Efficacy outcome reached|0|||
126432916|NCT02234843|454882309|FG009|Overall Study|Efficacy outcome reached|0|||
126432917|NCT02234843|454882300|FG000|Overall Study|Patient convenience|2|||
126432918|NCT02234843|454882301|FG001|Overall Study|Patient convenience|0|||
126432919|NCT02234843|454882302|FG002|Overall Study|Patient convenience|0|||
126432920|NCT02234843|454882303|FG003|Overall Study|Patient convenience|0|||
126432921|NCT02234843|454882304|FG004|Overall Study|Patient convenience|0|||
126432922|NCT02234843|454882305|FG005|Overall Study|Patient convenience|1|||
126432923|NCT02234843|454882306|FG006|Overall Study|Patient convenience|0|||
126432924|NCT02234843|454882307|FG007|Overall Study|Patient convenience|0|||
126432925|NCT02234843|454882308|FG008|Overall Study|Patient convenience|0|||
126432926|NCT02234843|454882309|FG009|Overall Study|Patient convenience|0|||
126432927|NCT02234843|454882300|FG000|Overall Study|Withdrawal by Subject|5|||
126432928|NCT02234843|454882301|FG001|Overall Study|Withdrawal by Subject|1|||
126432929|NCT02234843|454882302|FG002|Overall Study|Withdrawal by Subject|1|||
126432930|NCT02234843|454882303|FG003|Overall Study|Withdrawal by Subject|0|||
126432931|NCT02234843|454882304|FG004|Overall Study|Withdrawal by Subject|0|||
126432932|NCT02234843|454882305|FG005|Overall Study|Withdrawal by Subject|7|||
126432933|NCT02234843|454882306|FG006|Overall Study|Withdrawal by Subject|0|||
126432934|NCT02234843|454882307|FG007|Overall Study|Withdrawal by Subject|0|||
126432935|NCT02234843|454882308|FG008|Overall Study|Withdrawal by Subject|0|||
126432936|NCT02234843|454882309|FG009|Overall Study|Withdrawal by Subject|0|||
126432937|NCT02234843|454882300|FG000|Overall Study|Recovery|1|||
126432938|NCT02234843|454882301|FG001|Overall Study|Recovery|0|||
126432939|NCT02234843|454882302|FG002|Overall Study|Recovery|0|||
126432940|NCT02234843|454882303|FG003|Overall Study|Recovery|0|||
126432941|NCT02234843|454882304|FG004|Overall Study|Recovery|0|||
126432942|NCT02234843|454882305|FG005|Overall Study|Recovery|0|||
126432943|NCT02234843|454882306|FG006|Overall Study|Recovery|0|||
126432944|NCT02234843|454882307|FG007|Overall Study|Recovery|0|||
126432945|NCT02234843|454882308|FG008|Overall Study|Recovery|0|||
126432946|NCT02234843|454882309|FG009|Overall Study|Recovery|0|||
126432947|NCT02234843|454882300|FG000|Overall Study|Other|0|||
126432948|NCT02234843|454882301|FG001|Overall Study|Other|2|||
126432949|NCT02234843|454882302|FG002|Overall Study|Other|0|||
126432950|NCT02234843|454882303|FG003|Overall Study|Other|1|||
126432951|NCT02234843|454882304|FG004|Overall Study|Other|0|||
126432952|NCT02234843|454882305|FG005|Overall Study|Other|1|||
126432953|NCT02234843|454882306|FG006|Overall Study|Other|0|||
126432954|NCT02234843|454882307|FG007|Overall Study|Other|1|||
126432955|NCT02234843|454882308|FG008|Overall Study|Other|0|||
126432956|NCT02234843|454882309|FG009|Overall Study|Other|0|||
126432957|NCT02234843|454882300|FG000|Overall Study|Physician Decision|4|||
126432958|NCT02234843|454882301|FG001|Overall Study|Physician Decision|1|||
126432959|NCT02234843|454882302|FG002|Overall Study|Physician Decision|0|||
126432960|NCT02234843|454882303|FG003|Overall Study|Physician Decision|1|||
126432961|NCT02234843|454882304|FG004|Overall Study|Physician Decision|0|||
126432962|NCT02234843|454882305|FG005|Overall Study|Physician Decision|0|||
126432963|NCT02234843|454882306|FG006|Overall Study|Physician Decision|0|||
126432964|NCT02234843|454882307|FG007|Overall Study|Physician Decision|1|||
126432965|NCT02234843|454882308|FG008|Overall Study|Physician Decision|0|||
126680737|NCT00105443|455788162|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
126432966|NCT02234843|454882309|FG009|Overall Study|Physician Decision|0|||
126432967|NCT02234843|454882300|FG000|Overall Study|Adverse Event|5|||
126432968|NCT02234843|454882301|FG001|Overall Study|Adverse Event|1|||
126432969|NCT02234843|454882302|FG002|Overall Study|Adverse Event|1|||
126432970|NCT02234843|454882303|FG003|Overall Study|Adverse Event|3|||
126432971|NCT02234843|454882304|FG004|Overall Study|Adverse Event|2|||
126432972|NCT02234843|454882305|FG005|Overall Study|Adverse Event|1|||
126432973|NCT02234843|454882306|FG006|Overall Study|Adverse Event|0|||
126432974|NCT02234843|454882307|FG007|Overall Study|Adverse Event|0|||
126432975|NCT02234843|454882308|FG008|Overall Study|Adverse Event|1|||
126432976|NCT02234843|454882309|FG009|Overall Study|Adverse Event|0|||
126432977|NCT02234843|454882300|FG000|Overall Study|Non-compliance with study drug|1|||
126432978|NCT02234843|454882301|FG001|Overall Study|Non-compliance with study drug|0|||
126347305|NCT03282097|454566925|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
126347306|NCT03282097|454566926|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
126347307|NCT06001021|454566930|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
126347308|NCT06001021|454566931|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
126347309|NCT06001021|454566932|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
126347310|NCT06001021|454566933|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
126347311|NCT06001021|454566934|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
126347312|NCT06001021|454566935|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
126347313|NCT06001021|454566936|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
126347314|NCT06001021|454566930|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
126347315|NCT06001021|454566931|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
126347316|NCT06001021|454566932|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
126347317|NCT06001021|454566933|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
126347318|NCT06001021|454566934|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
126347319|NCT06001021|454566935|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
126347320|NCT06001021|454566936|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
126347321|NCT02755090|454566937|FG000|Overall Study|equipment malfunction|1|||
126347322|NCT02755090|454566938|FG001|Overall Study|equipment malfunction|0|||
126347323|NCT04797169|454566940|FG000|Overall Study|Lost to Follow-up|84|||
126347324|NCT04797169|454566941|FG001|Overall Study|Lost to Follow-up|67|||
126347325|NCT04797169|454566940|FG000|Overall Study|Pregnancy|1|||
126347326|NCT04797169|454566941|FG001|Overall Study|Pregnancy|3|||
126347327|NCT04797169|454566940|FG000|Overall Study|Withdrawal by Subject|27|||
126347328|NCT04797169|454566941|FG001|Overall Study|Withdrawal by Subject|35|||
126347329|NCT03839641|454566950|FG000|Overall Study|Withdrawal by Subject|1|||
126347330|NCT03839641|454566951|FG001|Overall Study|Withdrawal by Subject|1|||
126347331|NCT04221490|454566952|FG000|At 30 Days Follow-up|Death|7|||
126347332|NCT04221490|454566952|FG000|At 30 Days Follow-up|Missed Visit|4|||
126347333|NCT04221490|454566952|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
126347334|NCT04221490|454566952|FG000|At 6 Months Follow-up|Death|9|||
126347335|NCT04221490|454566952|FG000|At 6 Months Follow-up|Physician Decision|1|||
126347336|NCT04221490|454566952|FG000|At 6 Months Follow-up|Missed Visit|8|||
126347337|NCT04221490|454566952|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
126347338|NCT03034967|454566953|FG000|Overall Study|Withdrawal by Subject|9|||
126347339|NCT03034967|454566954|FG001|Overall Study|Withdrawal by Subject|2|||
126347340|NCT03034967|454566955|FG002|Overall Study|Withdrawal by Subject|6|||
126347341|NCT03034967|454566956|FG003|Overall Study|Withdrawal by Subject|6|||
126347342|NCT03034967|454566957|FG004|Overall Study|Withdrawal by Subject|9|||
126347343|NCT03034967|454566958|FG005|Overall Study|Withdrawal by Subject|2|||
126347344|NCT03034967|454566953|FG000|Overall Study|Physician Decision|1|||
126347345|NCT03034967|454566954|FG001|Overall Study|Physician Decision|0|||
126347346|NCT03034967|454566955|FG002|Overall Study|Physician Decision|1|||
126347347|NCT03034967|454566956|FG003|Overall Study|Physician Decision|1|||
126347348|NCT03034967|454566957|FG004|Overall Study|Physician Decision|1|||
126347349|NCT03034967|454566958|FG005|Overall Study|Physician Decision|0|||
126347350|NCT03034967|454566953|FG000|Overall Study|Lost to Follow-up|0|||
126347351|NCT03034967|454566954|FG001|Overall Study|Lost to Follow-up|0|||
126347352|NCT03034967|454566955|FG002|Overall Study|Lost to Follow-up|0|||
126347353|NCT03034967|454566956|FG003|Overall Study|Lost to Follow-up|1|||
126347354|NCT03034967|454566957|FG004|Overall Study|Lost to Follow-up|0|||
126347355|NCT03034967|454566958|FG005|Overall Study|Lost to Follow-up|2|||
126347356|NCT03034967|454566953|FG000|Overall Study|Liver function test abnormality|0|||
126347357|NCT03034967|454566954|FG001|Overall Study|Liver function test abnormality|0|||
126347358|NCT03034967|454566955|FG002|Overall Study|Liver function test abnormality|1|||
126347359|NCT03034967|454566956|FG003|Overall Study|Liver function test abnormality|0|||
126347360|NCT03034967|454566957|FG004|Overall Study|Liver function test abnormality|0|||
126347361|NCT03034967|454566958|FG005|Overall Study|Liver function test abnormality|0|||
126347362|NCT03034967|454566953|FG000|Overall Study|Protocol Violation|1|||
126347363|NCT03034967|454566954|FG001|Overall Study|Protocol Violation|0|||
126347364|NCT03034967|454566955|FG002|Overall Study|Protocol Violation|0|||
126347365|NCT03034967|454566956|FG003|Overall Study|Protocol Violation|0|||
126347366|NCT03034967|454566957|FG004|Overall Study|Protocol Violation|0|||
126347367|NCT03034967|454566958|FG005|Overall Study|Protocol Violation|2|||
126347368|NCT03034967|454566953|FG000|Overall Study|Lack of Efficacy|0|||
126347369|NCT03034967|454566954|FG001|Overall Study|Lack of Efficacy|1|||
126347370|NCT03034967|454566955|FG002|Overall Study|Lack of Efficacy|2|||
126347371|NCT03034967|454566956|FG003|Overall Study|Lack of Efficacy|1|||
126347372|NCT03034967|454566957|FG004|Overall Study|Lack of Efficacy|1|||
126347373|NCT03034967|454566958|FG005|Overall Study|Lack of Efficacy|0|||
126347374|NCT03034967|454566953|FG000|Overall Study|Adverse Event, non-fatal|3|||
126347375|NCT03034967|454566954|FG001|Overall Study|Adverse Event, non-fatal|1|||
126680738|NCT00105443|455788163|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
126347376|NCT03034967|454566955|FG002|Overall Study|Adverse Event, non-fatal|2|||
126347377|NCT03034967|454566956|FG003|Overall Study|Adverse Event, non-fatal|0|||
126347378|NCT03034967|454566957|FG004|Overall Study|Adverse Event, non-fatal|2|||
126347379|NCT03034967|454566958|FG005|Overall Study|Adverse Event, non-fatal|8|||
126347380|NCT03034967|454566953|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
126347381|NCT03034967|454566954|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
126347382|NCT03034967|454566955|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
126347383|NCT03034967|454566956|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
126347384|NCT03034967|454566957|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
126347385|NCT03034967|454566958|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
126347386|NCT02550795|454566965|FG000|Overall Study|Physician Decision|0|||
126347387|NCT02550795|454566966|FG001|Overall Study|Physician Decision|1|||
126347388|NCT02550795|454566967|FG002|Overall Study|Physician Decision|0|||
126347389|NCT00879658|454566968|FG000|Overall Study|Abnormal laboratory value(s)|3|||
126347390|NCT00879658|454566969|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126347391|NCT00879658|454566970|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126347392|NCT00879658|454566971|FG003|Overall Study|Abnormal laboratory value(s)|1|||
126347393|NCT00879658|454566972|FG004|Overall Study|Abnormal laboratory value(s)|0|||
126347394|NCT00879658|454566973|FG005|Overall Study|Abnormal laboratory value(s)|0|||
126347395|NCT00879658|454566974|FG006|Overall Study|Abnormal laboratory value(s)|0|||
126347396|NCT00879658|454566968|FG000|Overall Study|Administrative problems|2|||
126347397|NCT00879658|454566969|FG001|Overall Study|Administrative problems|1|||
126347398|NCT00879658|454566970|FG002|Overall Study|Administrative problems|0|||
126347399|NCT00879658|454566971|FG003|Overall Study|Administrative problems|1|||
126347400|NCT00879658|454566972|FG004|Overall Study|Administrative problems|0|||
126347401|NCT00879658|454566973|FG005|Overall Study|Administrative problems|0|||
126347402|NCT00879658|454566974|FG006|Overall Study|Administrative problems|0|||
126347403|NCT00879658|454566968|FG000|Overall Study|Adverse Event|6|||
126347404|NCT00879658|454566969|FG001|Overall Study|Adverse Event|4|||
126347405|NCT00879658|454566970|FG002|Overall Study|Adverse Event|3|||
126680739|NCT00105443|455788164|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
126680740|NCT01157078|455788165|FG000|Overall Study|Withdrawal by Subject|12|||
126680741|NCT01157078|455788166|FG001|Overall Study|Withdrawal by Subject|14|||
126680742|NCT01157078|455788165|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
126680743|NCT01157078|455788166|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126680744|NCT01157078|455788165|FG000|Overall Study|Adverse Event|6|||
126680745|NCT01157078|455788166|FG001|Overall Study|Adverse Event|6|||
126680746|NCT01157078|455788165|FG000|Overall Study|Severe non-compliance to protocol|2|||
126680747|NCT01157078|455788166|FG001|Overall Study|Severe non-compliance to protocol|4|||
126680748|NCT01157078|455788165|FG000|Overall Study|Condition under investigation worsened|0|||
126680749|NCT01157078|455788166|FG001|Overall Study|Condition under investigation worsened|1|||
126680750|NCT01157078|455788165|FG000|Overall Study|Lack of Efficacy|2|||
126680751|NCT01157078|455788166|FG001|Overall Study|Lack of Efficacy|0|||
126680752|NCT01157078|455788165|FG000|Overall Study|Study-specific withdrawal criteria|2|||
126680753|NCT01157078|455788166|FG001|Overall Study|Study-specific withdrawal criteria|2|||
126680754|NCT01157078|455788165|FG000|Overall Study|Lost to Follow-up|7|||
126680755|NCT01157078|455788166|FG001|Overall Study|Lost to Follow-up|5|||
126680756|NCT01157078|455788165|FG000|Overall Study|Other|2|||
126680757|NCT01157078|455788166|FG001|Overall Study|Other|4|||
126680758|NCT00513409|455788171|FG000|Overall Study|Adverse Event|0|||
126680759|NCT00513409|455788172|FG001|Overall Study|Adverse Event|1|||
126680760|NCT00513409|455788171|FG000|Overall Study|Withdrawal by Subject|0|||
126680761|NCT00513409|455788172|FG001|Overall Study|Withdrawal by Subject|2|||
126680762|NCT00513409|455788171|FG000|Overall Study|Lost to Follow-up|0|||
126680763|NCT00513409|455788172|FG001|Overall Study|Lost to Follow-up|1|||
126347406|NCT00879658|454566971|FG003|Overall Study|Adverse Event|1|||
126347407|NCT00879658|454566972|FG004|Overall Study|Adverse Event|2|||
126347408|NCT00879658|454566973|FG005|Overall Study|Adverse Event|0|||
126347409|NCT00879658|454566974|FG006|Overall Study|Adverse Event|0|||
126347410|NCT00879658|454566968|FG000|Overall Study|Protocol Violation|1|||
126347411|NCT00879658|454566969|FG001|Overall Study|Protocol Violation|0|||
126347412|NCT00879658|454566970|FG002|Overall Study|Protocol Violation|0|||
126347413|NCT00879658|454566971|FG003|Overall Study|Protocol Violation|0|||
126347414|NCT00879658|454566972|FG004|Overall Study|Protocol Violation|0|||
126347415|NCT00879658|454566973|FG005|Overall Study|Protocol Violation|0|||
126347416|NCT00879658|454566974|FG006|Overall Study|Protocol Violation|0|||
126347417|NCT00879658|454566968|FG000|Overall Study|Withdrawal by Subject|3|||
126347418|NCT00879658|454566969|FG001|Overall Study|Withdrawal by Subject|0|||
126347419|NCT00879658|454566970|FG002|Overall Study|Withdrawal by Subject|2|||
126347420|NCT00879658|454566971|FG003|Overall Study|Withdrawal by Subject|0|||
126347421|NCT00879658|454566972|FG004|Overall Study|Withdrawal by Subject|0|||
126347422|NCT00879658|454566973|FG005|Overall Study|Withdrawal by Subject|1|||
126347423|NCT00879658|454566974|FG006|Overall Study|Withdrawal by Subject|0|||
126680764|NCT00513409|455788171|FG000|Overall Study|Physician Decision|1|||
126680765|NCT00513409|455788172|FG001|Overall Study|Physician Decision|0|||
126680766|NCT00513409|455788171|FG000|Overall Study|Visit 3 not done|1|||
126680767|NCT00513409|455788172|FG001|Overall Study|Visit 3 not done|2|||
126680768|NCT03189446|455788174|FG000|Overall Study|Adverse Event|2|||
126347424|NCT00879658|454566968|FG000|Overall Study|Lack of Efficacy|0|||
126347425|NCT00879658|454566969|FG001|Overall Study|Lack of Efficacy|0|||
126347426|NCT00879658|454566970|FG002|Overall Study|Lack of Efficacy|2|||
126347427|NCT00879658|454566971|FG003|Overall Study|Lack of Efficacy|0|||
126347428|NCT00879658|454566972|FG004|Overall Study|Lack of Efficacy|0|||
126347429|NCT00879658|454566973|FG005|Overall Study|Lack of Efficacy|0|||
126347430|NCT00879658|454566974|FG006|Overall Study|Lack of Efficacy|0|||
126347431|NCT00879658|454566968|FG000|Overall Study|misrandomized (never received study med)|0|||
126347432|NCT00879658|454566969|FG001|Overall Study|misrandomized (never received study med)|0|||
126347433|NCT00879658|454566970|FG002|Overall Study|misrandomized (never received study med)|0|||
126347434|NCT00879658|454566971|FG003|Overall Study|misrandomized (never received study med)|1|||
126347435|NCT00879658|454566972|FG004|Overall Study|misrandomized (never received study med)|0|||
126347436|NCT00879658|454566973|FG005|Overall Study|misrandomized (never received study med)|0|||
126347437|NCT00879658|454566974|FG006|Overall Study|misrandomized (never received study med)|0|||
126347438|NCT00580840|454566975|FG000|Run-in|Adverse Event|17|||
126347439|NCT00580840|454566976|FG001|Run-in|Adverse Event|0|||
126347440|NCT00580840|454566977|FG002|Run-in|Adverse Event|0|||
126347441|NCT00580840|454566978|FG003|Run-in|Adverse Event|0|||
126347442|NCT00580840|454566975|FG000|Run-in|Lack of Efficacy|93|||
126347443|NCT00580840|454566976|FG001|Run-in|Lack of Efficacy|0|||
126347444|NCT00580840|454566977|FG002|Run-in|Lack of Efficacy|0|||
126347445|NCT00580840|454566978|FG003|Run-in|Lack of Efficacy|0|||
126347446|NCT00580840|454566975|FG000|Run-in|Loss of Efficacy|1|||
126347447|NCT00580840|454566976|FG001|Run-in|Loss of Efficacy|0|||
126347448|NCT00580840|454566977|FG002|Run-in|Loss of Efficacy|0|||
126347449|NCT00580840|454566978|FG003|Run-in|Loss of Efficacy|0|||
126347450|NCT00580840|454566975|FG000|Run-in|Lost to Follow-up|4|||
126347451|NCT00580840|454566976|FG001|Run-in|Lost to Follow-up|0|||
126347452|NCT00580840|454566977|FG002|Run-in|Lost to Follow-up|0|||
126347453|NCT00580840|454566978|FG003|Run-in|Lost to Follow-up|0|||
126347454|NCT00580840|454566975|FG000|Run-in|Withdrawal by Subject|5|||
126347455|NCT00580840|454566976|FG001|Run-in|Withdrawal by Subject|0|||
126347456|NCT00580840|454566977|FG002|Run-in|Withdrawal by Subject|0|||
126347457|NCT00580840|454566978|FG003|Run-in|Withdrawal by Subject|0|||
126347458|NCT00580840|454566975|FG000|Run-in|Other: Per Sponsor Request|2|||
126347459|NCT00580840|454566976|FG001|Run-in|Other: Per Sponsor Request|0|||
126347460|NCT00580840|454566977|FG002|Run-in|Other: Per Sponsor Request|0|||
126347461|NCT00580840|454566978|FG003|Run-in|Other: Per Sponsor Request|0|||
126347462|NCT00580840|454566975|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
126347463|NCT00580840|454566976|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
126347464|NCT00580840|454566977|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
126347465|NCT00580840|454566978|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
126347466|NCT00580840|454566975|FG000|Run-in|Other: Exclusionary Lab Value|1|||
126347467|NCT00580840|454566976|FG001|Run-in|Other: Exclusionary Lab Value|0|||
126347468|NCT00580840|454566977|FG002|Run-in|Other: Exclusionary Lab Value|0|||
126347469|NCT00580840|454566978|FG003|Run-in|Other: Exclusionary Lab Value|0|||
126347470|NCT00580840|454566975|FG000|Double-Blind|Adverse Event|0|||
126347471|NCT00580840|454566976|FG001|Double-Blind|Adverse Event|3|||
126347472|NCT00580840|454566977|FG002|Double-Blind|Adverse Event|4|||
126347473|NCT00580840|454566978|FG003|Double-Blind|Adverse Event|1|||
126347474|NCT00580840|454566975|FG000|Double-Blind|Loss of Efficacy|0|||
126347475|NCT00580840|454566976|FG001|Double-Blind|Loss of Efficacy|1|||
126347476|NCT00580840|454566977|FG002|Double-Blind|Loss of Efficacy|2|||
126347477|NCT00580840|454566978|FG003|Double-Blind|Loss of Efficacy|10|||
126347478|NCT00580840|454566975|FG000|Double-Blind|Lost to Follow-up|0|||
126347479|NCT00580840|454566976|FG001|Double-Blind|Lost to Follow-up|1|||
126347480|NCT00580840|454566977|FG002|Double-Blind|Lost to Follow-up|0|||
126347481|NCT00580840|454566978|FG003|Double-Blind|Lost to Follow-up|2|||
126347482|NCT00580840|454566975|FG000|Double-Blind|Withdrawal by Subject|0|||
126347483|NCT00580840|454566976|FG001|Double-Blind|Withdrawal by Subject|1|||
126347484|NCT00580840|454566977|FG002|Double-Blind|Withdrawal by Subject|2|||
126347485|NCT00580840|454566978|FG003|Double-Blind|Withdrawal by Subject|2|||
126347486|NCT00580840|454566975|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
126347487|NCT00580840|454566976|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
126347488|NCT00580840|454566977|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
126347489|NCT00580840|454566978|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
126347490|NCT00580840|454566975|FG000|Double-Blind|Other: Forbidden Medication|0|||
126347491|NCT00580840|454566976|FG001|Double-Blind|Other: Forbidden Medication|0|||
126347492|NCT00580840|454566977|FG002|Double-Blind|Other: Forbidden Medication|1|||
126347493|NCT00580840|454566978|FG003|Double-Blind|Other: Forbidden Medication|0|||
126347494|NCT01551173|454566979|FG000|Overall Study|Withdrawal by Subject|11|||
126347495|NCT01551173|454566980|FG001|Overall Study|Withdrawal by Subject|16|||
126347496|NCT01551173|454566979|FG000|Overall Study|Adverse Event|7|||
126347497|NCT01551173|454566980|FG001|Overall Study|Adverse Event|6|||
126347498|NCT01551173|454566979|FG000|Overall Study|Lost to Follow-up|5|||
126347499|NCT01551173|454566980|FG001|Overall Study|Lost to Follow-up|7|||
126347500|NCT01551173|454566979|FG000|Overall Study|Other|5|||
126347501|NCT01551173|454566980|FG001|Overall Study|Other|3|||
126347502|NCT04530344|454566981|FG000|Overall Study|Lost to Follow-up|3|||
126347503|NCT04530344|454566982|FG001|Overall Study|Lost to Follow-up|3|||
126347504|NCT04530344|454566983|FG002|Overall Study|Lost to Follow-up|3|||
126347505|NCT04530344|454566984|FG003|Overall Study|Lost to Follow-up|10|||
126347506|NCT04530344|454566981|FG000|Overall Study|Withdrawal by Subject|14|||
126347507|NCT04530344|454566982|FG001|Overall Study|Withdrawal by Subject|5|||
126347508|NCT04530344|454566983|FG002|Overall Study|Withdrawal by Subject|18|||
126347509|NCT04530344|454566984|FG003|Overall Study|Withdrawal by Subject|33|||
126347510|NCT04530344|454566981|FG000|Overall Study|Adverse Event|0|||
126347511|NCT04530344|454566982|FG001|Overall Study|Adverse Event|0|||
126347512|NCT04530344|454566983|FG002|Overall Study|Adverse Event|0|||
126347513|NCT04530344|454566984|FG003|Overall Study|Adverse Event|1|||
126347514|NCT04530344|454566981|FG000|Overall Study|Lack of Efficacy|0|||
126347515|NCT04530344|454566982|FG001|Overall Study|Lack of Efficacy|0|||
126347516|NCT04530344|454566983|FG002|Overall Study|Lack of Efficacy|0|||
126347517|NCT04530344|454566984|FG003|Overall Study|Lack of Efficacy|1|||
126347518|NCT04530344|454566981|FG000|Overall Study|Physician Decision|0|||
126347519|NCT04530344|454566982|FG001|Overall Study|Physician Decision|0|||
126347520|NCT04530344|454566983|FG002|Overall Study|Physician Decision|1|||
126347521|NCT04530344|454566984|FG003|Overall Study|Physician Decision|1|||
126347522|NCT04530344|454566981|FG000|Overall Study|Pregnancy|0|||
126347523|NCT04530344|454566982|FG001|Overall Study|Pregnancy|0|||
126347524|NCT04530344|454566983|FG002|Overall Study|Pregnancy|2|||
126347525|NCT04530344|454566984|FG003|Overall Study|Pregnancy|1|||
126347526|NCT04530344|454566981|FG000|Overall Study|Protocol Violation|0|||
126347527|NCT04530344|454566982|FG001|Overall Study|Protocol Violation|0|||
126347528|NCT04530344|454566983|FG002|Overall Study|Protocol Violation|0|||
126347529|NCT04530344|454566984|FG003|Overall Study|Protocol Violation|1|||
126347530|NCT04530344|454566981|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
126347531|NCT04530344|454566982|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
126347532|NCT04530344|454566983|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
126347533|NCT04530344|454566984|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
126347534|NCT04530344|454566981|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
126347535|NCT04530344|454566982|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
126347536|NCT04530344|454566983|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
126347537|NCT04530344|454566984|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
126347538|NCT04530344|454566981|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
126347539|NCT04530344|454566982|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
126347540|NCT04530344|454566983|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
126347541|NCT04530344|454566984|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
126347542|NCT04530344|454566981|FG000|Overall Study|Personal Reasons|0|||
126347543|NCT04530344|454566982|FG001|Overall Study|Personal Reasons|0|||
126347544|NCT04530344|454566983|FG002|Overall Study|Personal Reasons|0|||
126347545|NCT04530344|454566984|FG003|Overall Study|Personal Reasons|1|||
126347546|NCT04530344|454566981|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
126347547|NCT04530344|454566982|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
126347548|NCT04530344|454566983|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
126347549|NCT04530344|454566984|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
126347550|NCT01402700|454566985|FG000|Overall Study|Death|3|||
126347551|NCT01402700|454566985|FG000|Overall Study|Withdrawal by Subject|3|||
126347552|NCT01402700|454566985|FG000|Overall Study|Missed Visit|1|||
126347553|NCT05523297|454566991|FG000|Overall Study|Death|7|||
126347554|NCT05523297|454566992|FG001|Overall Study|Death|8|||
126347555|NCT05523297|454566991|FG000|Overall Study|Lost to Follow-up|2|||
126347556|NCT05523297|454566992|FG001|Overall Study|Lost to Follow-up|1|||
126347557|NCT03462680|454566993|FG000|Overall Study|Withdrawal by Subject|3|||
126347558|NCT03462680|454566994|FG001|Overall Study|Withdrawal by Subject|5|||
126347559|NCT02246777|454566995|FG000|Overall Study|Adverse Event|2|||
126347560|NCT02246777|454566995|FG000|Overall Study|Change of residence|1|||
126347561|NCT02401230|454566996|FG000|Overall Study|Adverse Event|3|||
126347562|NCT02401230|454566997|FG001|Overall Study|Adverse Event|2|||
126347563|NCT02401230|454566998|FG002|Overall Study|Adverse Event|0|||
126347564|NCT02401230|454566996|FG000|Overall Study|Withdrawal by Subject|2|||
126347565|NCT02401230|454566997|FG001|Overall Study|Withdrawal by Subject|1|||
126347566|NCT02401230|454566998|FG002|Overall Study|Withdrawal by Subject|1|||
126347567|NCT02401230|454566996|FG000|Overall Study|Lost to Follow-up|1|||
126347568|NCT02401230|454566997|FG001|Overall Study|Lost to Follow-up|3|||
126347569|NCT02401230|454566998|FG002|Overall Study|Lost to Follow-up|3|||
126347570|NCT04133909|454566999|FG000|Overall Study|Death|11|||
126347571|NCT04133909|454567000|FG001|Overall Study|Death|11|||
126347572|NCT04133909|454566999|FG000|Overall Study|Adverse Event|4|||
126347573|NCT04133909|454567000|FG001|Overall Study|Adverse Event|5|||
126432979|NCT02234843|454882302|FG002|Overall Study|Non-compliance with study drug|0|||
126347574|NCT04133909|454566999|FG000|Overall Study|Lost to Follow-up|3|||
126347575|NCT04133909|454567000|FG001|Overall Study|Lost to Follow-up|5|||
126347576|NCT04133909|454566999|FG000|Overall Study|Physician Decision|4|||
126680769|NCT03189446|455788174|FG000|Overall Study|Withdrawal by Subject|2|||
126347577|NCT04133909|454567000|FG001|Overall Study|Physician Decision|7|||
126347578|NCT04133909|454566999|FG000|Overall Study|Withdrawal by Subject|40|||
126432980|NCT02234843|454882303|FG003|Overall Study|Non-compliance with study drug|0|||
126432981|NCT02234843|454882304|FG004|Overall Study|Non-compliance with study drug|0|||
126432982|NCT02234843|454882305|FG005|Overall Study|Non-compliance with study drug|1|||
126432983|NCT02234843|454882306|FG006|Overall Study|Non-compliance with study drug|1|||
126432984|NCT02234843|454882307|FG007|Overall Study|Non-compliance with study drug|0|||
126432985|NCT02234843|454882308|FG008|Overall Study|Non-compliance with study drug|0|||
126432986|NCT02234843|454882309|FG009|Overall Study|Non-compliance with study drug|0|||
126432987|NCT02234843|454882300|FG000|Overall Study|Lost to Follow-up|0|||
126432988|NCT02234843|454882301|FG001|Overall Study|Lost to Follow-up|1|||
126432989|NCT02234843|454882302|FG002|Overall Study|Lost to Follow-up|0|||
126432990|NCT02234843|454882303|FG003|Overall Study|Lost to Follow-up|0|||
126432991|NCT02234843|454882304|FG004|Overall Study|Lost to Follow-up|0|||
126432992|NCT02234843|454882305|FG005|Overall Study|Lost to Follow-up|0|||
126432993|NCT02234843|454882306|FG006|Overall Study|Lost to Follow-up|1|||
126347579|NCT04133909|454567000|FG001|Overall Study|Withdrawal by Subject|35|||
126347580|NCT04133909|454566999|FG000|Overall Study|Lack of Efficacy|2|||
126347581|NCT04133909|454567000|FG001|Overall Study|Lack of Efficacy|7|||
126347582|NCT04133909|454566999|FG000|Overall Study|Randomized in error|1|||
126347583|NCT04133909|454567000|FG001|Overall Study|Randomized in error|1|||
126347584|NCT00830765|454567001|FG000|Overall Study|Protocol Violation|3|||
126347585|NCT00830765|454567002|FG001|Overall Study|Protocol Violation|2|||
126347586|NCT01299909|454567003|FG000|Overall Study|Lost to Follow-up|22|||
126347587|NCT01299909|454567004|FG001|Overall Study|Lost to Follow-up|18|||
126347588|NCT01299909|454567005|FG002|Overall Study|Lost to Follow-up|17|||
126347589|NCT05399485|454568468|FG000|DBT Phase|Other|6|||
126347590|NCT05399485|454568469|FG001|DBT Phase|Other|5|||
126347591|NCT05399485|454568468|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
126347592|NCT05399485|454568469|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
126347593|NCT05399485|454568468|FG000|DBT Phase|Withdrawal by Subject|3|||
126347594|NCT05399485|454568469|FG001|DBT Phase|Withdrawal by Subject|2|||
126347595|NCT05399485|454568468|FG000|DBT Phase|Protocol Violation|2|||
126347596|NCT05399485|454568469|FG001|DBT Phase|Protocol Violation|1|||
126347597|NCT05399485|454568468|FG000|DBT Phase|Physician Decision|0|||
126347598|NCT05399485|454568469|FG001|DBT Phase|Physician Decision|1|||
126347599|NCT05399485|454568468|FG000|DBT Phase|Adverse Event|2|||
126347600|NCT05399485|454568469|FG001|DBT Phase|Adverse Event|1|||
126347601|NCT05399485|454568468|FG000|OLE Phase|Not reported|0|||
126347602|NCT05399485|454568469|FG001|OLE Phase|Not reported|1|||
126347603|NCT05399485|454568468|FG000|OLE Phase|Other|3|||
126347604|NCT05399485|454568469|FG001|OLE Phase|Other|3|||
126347605|NCT05399485|454568468|FG000|OLE Phase|Withdrawal by Subject|8|||
126347606|NCT05399485|454568469|FG001|OLE Phase|Withdrawal by Subject|5|||
126347607|NCT05399485|454568468|FG000|OLE Phase|Pregnancy|0|||
126347608|NCT05399485|454568469|FG001|OLE Phase|Pregnancy|1|||
126347609|NCT05399485|454568468|FG000|OLE Phase|Physician Decision|2|||
126347610|NCT05399485|454568469|FG001|OLE Phase|Physician Decision|0|||
126347611|NCT05399485|454568468|FG000|OLE Phase|Adverse Event|0|||
126347612|NCT05399485|454568469|FG001|OLE Phase|Adverse Event|1|||
126347613|NCT05399485|454568468|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
126347614|NCT05399485|454568469|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
126347615|NCT03474107|454568472|FG000|Overall Study|Adverse Event|42|||
126347616|NCT03474107|454568473|FG001|Overall Study|Adverse Event|46|||
126347617|NCT03474107|454568472|FG000|Overall Study|Death|2|||
126347618|NCT03474107|454568473|FG001|Overall Study|Death|2|||
126347619|NCT03474107|454568472|FG000|Overall Study|Lost to Follow-up|0|||
126347620|NCT03474107|454568473|FG001|Overall Study|Lost to Follow-up|1|||
126347621|NCT03474107|454568472|FG000|Overall Study|Progressive Disease|177|||
126347622|NCT03474107|454568473|FG001|Overall Study|Progressive Disease|180|||
126347623|NCT03474107|454568472|FG000|Overall Study|Protocol Violation|1|||
126347624|NCT03474107|454568473|FG001|Overall Study|Protocol Violation|1|||
126347625|NCT03474107|454568472|FG000|Overall Study|Withdrawal by Subject|15|||
126347626|NCT03474107|454568473|FG001|Overall Study|Withdrawal by Subject|27|||
126347627|NCT03474107|454568472|FG000|Overall Study|Physician Decision|7|||
126347628|NCT03474107|454568473|FG001|Overall Study|Physician Decision|22|||
126347629|NCT03474107|454568472|FG000|Overall Study|Miscellaneous|1|||
126347630|NCT03474107|454568473|FG001|Overall Study|Miscellaneous|6|||
126347631|NCT03095287|454568474|FG000|Overall Study|Treatment Failure|1|||
126347632|NCT03095287|454568474|FG000|Overall Study|Adverse Event|1|||
126347633|NCT02127671|454568477|FG000|Overall Study|Death|2|||
126432994|NCT02234843|454882307|FG007|Overall Study|Lost to Follow-up|0|||
126432995|NCT02234843|454882308|FG008|Overall Study|Lost to Follow-up|0|||
126347634|NCT02127671|454568478|FG001|Overall Study|Death|2|||
126347635|NCT02127671|454568477|FG000|Overall Study|Lost to Follow-up|4|||
126347636|NCT02127671|454568478|FG001|Overall Study|Lost to Follow-up|2|||
126347637|NCT02127671|454568477|FG000|Overall Study|Physician Decision|1|||
126432996|NCT02234843|454882309|FG009|Overall Study|Lost to Follow-up|0|||
126432997|NCT03905096|454882310|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
126680770|NCT03189446|455788174|FG000|Overall Study|Physician Decision|1|||
126347638|NCT02127671|454568478|FG001|Overall Study|Physician Decision|0|||
126347639|NCT02127671|454568477|FG000|Overall Study|incarceration|0|||
126432998|NCT03905096|454882311|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
126432999|NCT02016781|454882312|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
126433000|NCT02016781|454882313|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
126433001|NCT02016781|454882312|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
126433002|NCT02016781|454882313|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
126433003|NCT02016781|454882312|FG000|Final Database Lock|Withdrawal by Subject|2|||
126433004|NCT02016781|454882313|FG001|Final Database Lock|Withdrawal by Subject|1|||
126433005|NCT02016781|454882312|FG000|Final Database Lock|Lost to Follow-up|11|||
126433006|NCT02016781|454882313|FG001|Final Database Lock|Lost to Follow-up|4|||
126433007|NCT02016781|454882312|FG000|Final Database Lock|Missing data|0|||
126433008|NCT02016781|454882313|FG001|Final Database Lock|Missing data|3|||
126433009|NCT02336282|454882314|FG000|Overall Study|Unrelated illness|1|||
126433010|NCT02336282|454882314|FG000|Overall Study|Uncomfortable with technology|1|||
126433011|NCT02336282|454882314|FG000|Overall Study|Lost to Follow-up|1|||
126433012|NCT02336282|454882314|FG000|Overall Study|Not enough time to complete sessions|2|||
126433013|NCT03724942|454882316|FG000|Overall Study|Adverse Event|20|||
126433014|NCT03724942|454882317|FG001|Overall Study|Adverse Event|14|||
126433015|NCT03724942|454882316|FG000|Overall Study|Lack of Efficacy|0|||
126433016|NCT03724942|454882317|FG001|Overall Study|Lack of Efficacy|1|||
126433017|NCT03724942|454882316|FG000|Overall Study|Physician Decision|5|||
126433018|NCT03724942|454882317|FG001|Overall Study|Physician Decision|2|||
126433019|NCT03724942|454882316|FG000|Overall Study|Protocol Violation|1|||
126433020|NCT03724942|454882317|FG001|Overall Study|Protocol Violation|0|||
126433021|NCT03724942|454882316|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
126433022|NCT03724942|454882317|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
126433023|NCT03724942|454882316|FG000|Overall Study|Withdrawal by Legal Representative|3|||
126433024|NCT03724942|454882317|FG001|Overall Study|Withdrawal by Legal Representative|0|||
126433025|NCT04875975|454882318|FG000|Overall Study|Adverse Event|1|||
126433026|NCT04875975|454882319|FG001|Overall Study|Adverse Event|2|||
126433027|NCT04875975|454882318|FG000|Overall Study|Lack of Efficacy|2|||
126433028|NCT04875975|454882319|FG001|Overall Study|Lack of Efficacy|2|||
126433029|NCT04875975|454882318|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
126433030|NCT04875975|454882319|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
126433031|NCT04875975|454882318|FG000|Overall Study|Relapse With Insults|0|||
126433032|NCT04875975|454882319|FG001|Overall Study|Relapse With Insults|1|||
126433033|NCT04875975|454882318|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
126433034|NCT04875975|454882319|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
126433035|NCT04515771|454884171|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
126433036|NCT04515771|454884172|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
126433037|NCT04515771|454884171|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
126433038|NCT04515771|454884172|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
126433039|NCT04515771|454884171|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
126433040|NCT04515771|454884172|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
126433041|NCT01021020|454884174|FG000|Period I|Protocol Violation|1|||
126433042|NCT01021020|454884174|FG000|Period I|Withdrawal by Subject|1|||
126433043|NCT01021020|454884174|FG000|14 Day Washout Period A|Physician Decision|1|||
126433044|NCT00948246|454884175|FG000|Overall Study|Lost to Follow-up|11|||
126433045|NCT00948246|454884175|FG000|Overall Study|Adverse Event|11|||
126433046|NCT00948246|454884175|FG000|Overall Study|Death|1|||
126433047|NCT00948246|454884175|FG000|Overall Study|Withdrawal by Subject|1|||
126433048|NCT03598036|454884176|FG000|Overall Study|Withdrawal by Subject|1|||
126433049|NCT03598036|454884177|FG001|Overall Study|Withdrawal by Subject|0|||
126433050|NCT04199351|454884180|FG000|Overall Study|Decision by sponsor|0|||
126433051|NCT04199351|454884181|FG001|Overall Study|Decision by sponsor|0|||
126433052|NCT04199351|454884182|FG002|Overall Study|Decision by sponsor|0|||
126433053|NCT04199351|454884183|FG003|Overall Study|Decision by sponsor|2|||
126433054|NCT04199351|454884184|FG004|Overall Study|Decision by sponsor|0|||
126433055|NCT04199351|454884185|FG005|Overall Study|Decision by sponsor|0|||
126433056|NCT04199351|454884186|FG006|Overall Study|Decision by sponsor|0|||
126433057|NCT04199351|454884187|FG007|Overall Study|Decision by sponsor|0|||
126433058|NCT04199351|454884188|FG008|Overall Study|Decision by sponsor|0|||
126433059|NCT04199351|454884189|FG009|Overall Study|Decision by sponsor|6|||
126433060|NCT04199351|454884180|FG000|Overall Study|Lost to Follow-up|0|||
126433061|NCT04199351|454884181|FG001|Overall Study|Lost to Follow-up|0|||
126433062|NCT04199351|454884182|FG002|Overall Study|Lost to Follow-up|1|||
126433063|NCT04199351|454884183|FG003|Overall Study|Lost to Follow-up|0|||
126433064|NCT04199351|454884184|FG004|Overall Study|Lost to Follow-up|0|||
126433065|NCT04199351|454884185|FG005|Overall Study|Lost to Follow-up|1|||
126433066|NCT04199351|454884186|FG006|Overall Study|Lost to Follow-up|0|||
126433067|NCT04199351|454884187|FG007|Overall Study|Lost to Follow-up|0|||
126433068|NCT04199351|454884188|FG008|Overall Study|Lost to Follow-up|0|||
126433069|NCT04199351|454884189|FG009|Overall Study|Lost to Follow-up|0|||
126433070|NCT04199351|454884180|FG000|Overall Study|Withdrawal by Subject|0|||
126433071|NCT04199351|454884181|FG001|Overall Study|Withdrawal by Subject|1|||
126433072|NCT04199351|454884182|FG002|Overall Study|Withdrawal by Subject|0|||
126433073|NCT04199351|454884183|FG003|Overall Study|Withdrawal by Subject|0|||
126433074|NCT04199351|454884184|FG004|Overall Study|Withdrawal by Subject|1|||
126433075|NCT04199351|454884185|FG005|Overall Study|Withdrawal by Subject|4|||
126433076|NCT04199351|454884186|FG006|Overall Study|Withdrawal by Subject|2|||
126433077|NCT04199351|454884187|FG007|Overall Study|Withdrawal by Subject|0|||
126433078|NCT04199351|454884188|FG008|Overall Study|Withdrawal by Subject|3|||
126433079|NCT04199351|454884189|FG009|Overall Study|Withdrawal by Subject|0|||
126433080|NCT00474487|454884193|FG000|Overall Study|Withdrawal by Subject|6|||
126433081|NCT00474487|454884194|FG001|Overall Study|Withdrawal by Subject|0|||
126433082|NCT00474487|454884195|FG002|Overall Study|Withdrawal by Subject|0|||
126433083|NCT00474487|454884196|FG003|Overall Study|Withdrawal by Subject|0|||
126433084|NCT00474487|454884193|FG000|Overall Study|Lost to Follow-up|20|||
126433085|NCT00474487|454884194|FG001|Overall Study|Lost to Follow-up|1|||
126433086|NCT00474487|454884195|FG002|Overall Study|Lost to Follow-up|7|||
126433087|NCT00474487|454884196|FG003|Overall Study|Lost to Follow-up|0|||
126433088|NCT00474487|454884193|FG000|Overall Study|Inappropriate enrollment|4|||
126433089|NCT00474487|454884194|FG001|Overall Study|Inappropriate enrollment|0|||
126433090|NCT00474487|454884195|FG002|Overall Study|Inappropriate enrollment|7|||
126433091|NCT00474487|454884196|FG003|Overall Study|Inappropriate enrollment|0|||
126433092|NCT00474487|454884193|FG000|Overall Study|Death|0|||
126433093|NCT00474487|454884194|FG001|Overall Study|Death|1|||
126433094|NCT00474487|454884195|FG002|Overall Study|Death|0|||
126433095|NCT00474487|454884196|FG003|Overall Study|Death|0|||
126433096|NCT01488045|454884197|FG000|Overall Study|Withdrawal by Subject|6|||
126433097|NCT01488045|454884198|FG001|Overall Study|Withdrawal by Subject|11|||
126433098|NCT01488045|454884197|FG000|Overall Study|Failure to present for colonoscopy|3|||
126433099|NCT01488045|454884198|FG001|Overall Study|Failure to present for colonoscopy|6|||
126433100|NCT01488045|454884197|FG000|Overall Study|Failure to report exclusion criteria|0|||
126433101|NCT01488045|454884198|FG001|Overall Study|Failure to report exclusion criteria|1|||
126433102|NCT02230410|454884205|FG000|Overall Study|Screen Failure|3|||
126433103|NCT02388269|454884212|FG000|Overall Study|Adverse Event|2|||
126433104|NCT02388269|454884213|FG001|Overall Study|Adverse Event|0|||
126433105|NCT02388269|454884214|FG002|Overall Study|Adverse Event|0|||
126433106|NCT02388269|454884212|FG000|Overall Study|Withdrawal by Subject|1|||
126433107|NCT02388269|454884213|FG001|Overall Study|Withdrawal by Subject|2|||
126433108|NCT02388269|454884214|FG002|Overall Study|Withdrawal by Subject|0|||
126433109|NCT02388269|454884212|FG000|Overall Study|less than 50% stimulations|1|||
126433110|NCT02388269|454884213|FG001|Overall Study|less than 50% stimulations|0|||
126433111|NCT02388269|454884214|FG002|Overall Study|less than 50% stimulations|0|||
126433112|NCT02388269|454884212|FG000|Overall Study|no diary data|3|||
126433113|NCT02388269|454884213|FG001|Overall Study|no diary data|0|||
126433114|NCT02388269|454884214|FG002|Overall Study|no diary data|0|||
126433115|NCT02388269|454884212|FG000|Overall Study|Protocol Violation|2|||
126433116|NCT02388269|454884213|FG001|Overall Study|Protocol Violation|0|||
126433117|NCT02388269|454884214|FG002|Overall Study|Protocol Violation|0|||
126433118|NCT02388269|454884212|FG000|Overall Study|Screen Failure|0|||
126433119|NCT02388269|454884213|FG001|Overall Study|Screen Failure|0|||
126433120|NCT02388269|454884214|FG002|Overall Study|Screen Failure|10|||
126433121|NCT03448406|454884215|FG000|Overall Study|Noncompliance of scheduled visits|1|||
126433122|NCT03448406|454884216|FG001|Overall Study|Noncompliance of scheduled visits|2|||
126433123|NCT03448406|454884215|FG000|Overall Study|Withdrawal by Subject|1|||
126433124|NCT03448406|454884216|FG001|Overall Study|Withdrawal by Subject|2|||
126433125|NCT03448406|454884215|FG000|Overall Study|Protocol Violation|1|||
126433126|NCT03448406|454884216|FG001|Overall Study|Protocol Violation|0|||
126433127|NCT03448406|454884215|FG000|Overall Study|Adverse Event|8|||
126433128|NCT03448406|454884216|FG001|Overall Study|Adverse Event|9|||
126433129|NCT03405792|454884217|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
126433130|NCT03405792|454884218|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
126433131|NCT03405792|454884217|FG000|Overall Study|o Did not receive pembrolizumab|1|||
126433132|NCT03405792|454884218|FG001|Overall Study|o Did not receive pembrolizumab|0|||
126433133|NCT03962491|454884219|FG000|Overall Study|Lost to Follow-up|4|||
126433134|NCT03962491|454884220|FG001|Overall Study|Lost to Follow-up|5|||
126680771|NCT05634577|455788175|FG000|Overall Study|Lost to Follow-up|1|||
126433135|NCT03882021|454884221|FG000|Enrollment|Procedure aborted/cancelled|2|||
126433136|NCT03882021|454884221|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
126433137|NCT03882021|454884221|FG000|Enrollment to 3-Month|Death|1|||
126433138|NCT03882021|454884221|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
126433139|NCT03882021|454884221|FG000|Enrollment to 3-Month|Missed Visit|4|||
126433140|NCT03882021|454884221|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
126433141|NCT03882021|454884221|FG000|6-Month to 12-Month Visit|Death|1|||
126433142|NCT03882021|454884221|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
126433143|NCT01263769|454884222|FG000|Overall Study|Non-Compliant with treatment|1|||
126433144|NCT02242942|454884225|FG000|Overall Study|Death|17|||
126433145|NCT02242942|454884226|FG001|Overall Study|Death|20|||
126433146|NCT02242942|454884227|FG002|Overall Study|Death|2|||
126433147|NCT02242942|454884225|FG000|Overall Study|Physician Decision|1|||
126433148|NCT02242942|454884226|FG001|Overall Study|Physician Decision|0|||
126433149|NCT02242942|454884227|FG002|Overall Study|Physician Decision|0|||
126433150|NCT02242942|454884225|FG000|Overall Study|Withdrawal by Subject|8|||
126433151|NCT02242942|454884226|FG001|Overall Study|Withdrawal by Subject|10|||
126433152|NCT02242942|454884227|FG002|Overall Study|Withdrawal by Subject|0|||
126433153|NCT02242942|454884225|FG000|Overall Study|On-going in Study|190|||
126433154|NCT02242942|454884226|FG001|Overall Study|On-going in Study|186|||
126433155|NCT02242942|454884227|FG002|Overall Study|On-going in Study|11|||
126433156|NCT03259230|454884228|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
126433157|NCT03259230|454884229|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
126433158|NCT02559622|454884234|FG000|Overall Study|Progressive disease|0|||
126433159|NCT02559622|454884235|FG001|Overall Study|Progressive disease|1|||
126433160|NCT02559622|454884236|FG002|Overall Study|Progressive disease|0|||
126433161|NCT02559622|454884237|FG003|Overall Study|Progressive disease|0|||
126433162|NCT02559622|454884234|FG000|Overall Study|Adverse Event|0|||
126433163|NCT02559622|454884235|FG001|Overall Study|Adverse Event|2|||
126433164|NCT02559622|454884236|FG002|Overall Study|Adverse Event|2|||
126433165|NCT02559622|454884237|FG003|Overall Study|Adverse Event|2|||
126433166|NCT02559622|454884234|FG000|Overall Study|Patient/guardian decision|1|||
126433167|NCT02559622|454884235|FG001|Overall Study|Patient/guardian decision|2|||
126433168|NCT02559622|454884236|FG002|Overall Study|Patient/guardian decision|0|||
126433169|NCT02559622|454884237|FG003|Overall Study|Patient/guardian decision|1|||
126433170|NCT02163538|454884238|FG000|Overall Study|Protocol Violation|1|||
126433171|NCT02163538|454884239|FG001|Overall Study|Protocol Violation|0|||
126433172|NCT02163538|454884238|FG000|Overall Study|Physician Decision|0|||
126433173|NCT02163538|454884239|FG001|Overall Study|Physician Decision|1|||
126433174|NCT03019406|454884245|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
126433175|NCT03019406|454884246|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
126433176|NCT03019406|454884247|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
126433177|NCT03019406|454884248|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
126433178|NCT01339832|454884251|FG000|Overall Study|Lost to Follow-up|3|||
126433179|NCT01339832|454884251|FG000|Overall Study|Death|11|||
126433180|NCT00468169|454884252|FG000|Overall Study|Withdrawal by Subject|1|||
126433181|NCT00468169|454884253|FG001|Overall Study|Withdrawal by Subject|0|||
126433182|NCT00231816|454884254|FG000|Overall Study|Adverse Event|1|||
126433183|NCT00231816|454884255|FG001|Overall Study|Adverse Event|0|||
126433184|NCT00231816|454884254|FG000|Overall Study|Lost to Follow-up|8|||
126433185|NCT00231816|454884255|FG001|Overall Study|Lost to Follow-up|5|||
126433186|NCT00231816|454884254|FG000|Overall Study|Protocol Violation|2|||
126433187|NCT00231816|454884255|FG001|Overall Study|Protocol Violation|3|||
126433188|NCT00231816|454884254|FG000|Overall Study|Withdrawal by Subject|3|||
126433189|NCT00231816|454884255|FG001|Overall Study|Withdrawal by Subject|3|||
126433190|NCT00231816|454884254|FG000|Overall Study|Other|2|||
126433191|NCT00231816|454884255|FG001|Overall Study|Other|1|||
126433192|NCT01126749|454884260|FG000|Phase 1b|Other|0|||
126433193|NCT01126749|454884261|FG001|Phase 1b|Other|1|||
126433194|NCT01126749|454884262|FG002|Phase 1b|Other|0|||
126433195|NCT01126749|454884263|FG003|Phase 1b|Other|0|||
126433196|NCT01126749|454884260|FG000|Phase 1b|Withdrawal by Subject|0|||
126433197|NCT01126749|454884261|FG001|Phase 1b|Withdrawal by Subject|1|||
126433198|NCT01126749|454884262|FG002|Phase 1b|Withdrawal by Subject|0|||
126433199|NCT01126749|454884263|FG003|Phase 1b|Withdrawal by Subject|0|||
126433200|NCT01126749|454884260|FG000|Phase 1b|Death|3|||
126433201|NCT01126749|454884261|FG001|Phase 1b|Death|4|||
126433202|NCT01126749|454884262|FG002|Phase 1b|Death|0|||
126433203|NCT01126749|454884263|FG003|Phase 1b|Death|0|||
126433204|NCT01126749|454884260|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
126433205|NCT01126749|454884261|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
126433206|NCT01126749|454884262|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
126433207|NCT01126749|454884263|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
126433208|NCT01126749|454884260|FG000|Phase 2|Study Termination by Sponsor|0|||
126433209|NCT01126749|454884261|FG001|Phase 2|Study Termination by Sponsor|0|||
126433210|NCT01126749|454884262|FG002|Phase 2|Study Termination by Sponsor|12|||
126433211|NCT01126749|454884263|FG003|Phase 2|Study Termination by Sponsor|6|||
126433212|NCT01126749|454884260|FG000|Phase 2|Other|0|||
126433213|NCT01126749|454884261|FG001|Phase 2|Other|0|||
126433214|NCT01126749|454884262|FG002|Phase 2|Other|4|||
126433215|NCT01126749|454884263|FG003|Phase 2|Other|2|||
126433216|NCT01126749|454884260|FG000|Phase 2|Withdrawal by Subject|0|||
126433217|NCT01126749|454884261|FG001|Phase 2|Withdrawal by Subject|0|||
126433218|NCT01126749|454884262|FG002|Phase 2|Withdrawal by Subject|0|||
126433219|NCT01126749|454884263|FG003|Phase 2|Withdrawal by Subject|2|||
126433220|NCT01126749|454884260|FG000|Phase 2|Lost to Follow-up|0|||
126433221|NCT01126749|454884261|FG001|Phase 2|Lost to Follow-up|0|||
126433222|NCT01126749|454884262|FG002|Phase 2|Lost to Follow-up|0|||
126433223|NCT01126749|454884263|FG003|Phase 2|Lost to Follow-up|1|||
126433224|NCT01126749|454884260|FG000|Phase 2|Death|0|||
126433225|NCT01126749|454884261|FG001|Phase 2|Death|0|||
126433226|NCT01126749|454884262|FG002|Phase 2|Death|22|||
126433227|NCT01126749|454884263|FG003|Phase 2|Death|22|||
126433228|NCT01126749|454884260|FG000|Phase 2|Adverse Event|0|||
126433229|NCT01126749|454884261|FG001|Phase 2|Adverse Event|0|||
126433230|NCT01126749|454884262|FG002|Phase 2|Adverse Event|0|||
126433231|NCT01126749|454884263|FG003|Phase 2|Adverse Event|1|||
126433232|NCT01283139|454884265|FG000|Overall Study|Lost to Follow-up|5|||
126433233|NCT01283139|454884266|FG001|Overall Study|Lost to Follow-up|2|||
126433234|NCT01283139|454884267|FG002|Overall Study|Lost to Follow-up|3|||
126433235|NCT01283139|454884268|FG003|Overall Study|Lost to Follow-up|1|||
126433236|NCT01283139|454884265|FG000|Overall Study|Withdrawal by Subject|8|||
126433237|NCT01283139|454884266|FG001|Overall Study|Withdrawal by Subject|8|||
126433238|NCT01283139|454884267|FG002|Overall Study|Withdrawal by Subject|6|||
126433239|NCT01283139|454884268|FG003|Overall Study|Withdrawal by Subject|8|||
126433240|NCT01283139|454884265|FG000|Overall Study|Death|2|||
126433241|NCT01283139|454884266|FG001|Overall Study|Death|0|||
126433242|NCT01283139|454884267|FG002|Overall Study|Death|2|||
126433243|NCT01283139|454884268|FG003|Overall Study|Death|2|||
126433244|NCT01283139|454884265|FG000|Overall Study|Lack of Efficacy|1|||
126433245|NCT01283139|454884266|FG001|Overall Study|Lack of Efficacy|2|||
126433246|NCT01283139|454884267|FG002|Overall Study|Lack of Efficacy|2|||
126433247|NCT01283139|454884268|FG003|Overall Study|Lack of Efficacy|1|||
126433248|NCT01283139|454884265|FG000|Overall Study|Early termination due to AE/SAE|1|||
126433249|NCT01283139|454884266|FG001|Overall Study|Early termination due to AE/SAE|1|||
126433250|NCT01283139|454884267|FG002|Overall Study|Early termination due to AE/SAE|0|||
126433251|NCT01283139|454884268|FG003|Overall Study|Early termination due to AE/SAE|0|||
126433252|NCT01283139|454884265|FG000|Overall Study|Participant's refusal to continue|0|||
126433253|NCT01283139|454884266|FG001|Overall Study|Participant's refusal to continue|3|||
126433254|NCT01283139|454884267|FG002|Overall Study|Participant's refusal to continue|1|||
126433255|NCT01283139|454884268|FG003|Overall Study|Participant's refusal to continue|1|||
126433256|NCT01283139|454884265|FG000|Overall Study|Pregnancy|0|||
126433257|NCT01283139|454884266|FG001|Overall Study|Pregnancy|1|||
126433258|NCT01283139|454884267|FG002|Overall Study|Pregnancy|1|||
126433259|NCT01283139|454884268|FG003|Overall Study|Pregnancy|0|||
126433260|NCT01283139|454884265|FG000|Overall Study|Missed follow-up visit|0|||
126433261|NCT01283139|454884266|FG001|Overall Study|Missed follow-up visit|1|||
126433262|NCT01283139|454884267|FG002|Overall Study|Missed follow-up visit|2|||
126433263|NCT01283139|454884268|FG003|Overall Study|Missed follow-up visit|2|||
126433264|NCT01283139|454884265|FG000|Overall Study|Participant randomized in error|0|||
126433265|NCT01283139|454884266|FG001|Overall Study|Participant randomized in error|0|||
126433266|NCT01283139|454884267|FG002|Overall Study|Participant randomized in error|1|||
126433267|NCT01283139|454884268|FG003|Overall Study|Participant randomized in error|0|||
126433268|NCT00627393|454884271|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
126433269|NCT00627393|454884272|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
126433270|NCT00627393|454884271|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
126433271|NCT00627393|454884272|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
126433272|NCT00627393|454884271|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
126433273|NCT00627393|454884272|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
126433274|NCT00627393|454884271|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
126433275|NCT00627393|454884272|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
126433276|NCT01056822|454884273|FG000|Overall Study|Adverse Event|0|||
126433277|NCT01056822|454884274|FG001|Overall Study|Adverse Event|1|||
126433278|NCT01056822|454884273|FG000|Overall Study|Protocol Violation|6|||
126433279|NCT01056822|454884274|FG001|Overall Study|Protocol Violation|5|||
126433280|NCT01056822|454884273|FG000|Overall Study|Withdrawal by Subject|1|||
126433281|NCT01056822|454884274|FG001|Overall Study|Withdrawal by Subject|1|||
126433282|NCT01056822|454884273|FG000|Overall Study|Lost to Follow-up|1|||
126433283|NCT01056822|454884274|FG001|Overall Study|Lost to Follow-up|0|||
126433284|NCT00784563|454884275|FG000|Years 1 & 2|Withdrawal by Subject|3|||
126433285|NCT00784563|454884276|FG001|Years 1 & 2|Withdrawal by Subject|2|||
126433286|NCT00784563|454884277|FG002|Years 1 & 2|Withdrawal by Subject|0|||
126433287|NCT00784563|454884275|FG000|Years 1 & 2|Adverse Event|0|||
126433288|NCT00784563|454884276|FG001|Years 1 & 2|Adverse Event|3|||
126433289|NCT00784563|454884277|FG002|Years 1 & 2|Adverse Event|0|||
126433290|NCT00784563|454884275|FG000|Year 3|Withdrawal by Subject|0|||
126433291|NCT00784563|454884276|FG001|Year 3|Withdrawal by Subject|0|||
126433292|NCT00784563|454884277|FG002|Year 3|Withdrawal by Subject|2|||
126433293|NCT00784563|454884275|FG000|Year 3|Adverse Event|0|||
126433294|NCT00784563|454884276|FG001|Year 3|Adverse Event|0|||
126433295|NCT00784563|454884277|FG002|Year 3|Adverse Event|1|||
126433296|NCT01614249|454884278|FG000|Overall Study|Lost to Follow-up|11|||
126433297|NCT01614249|454884279|FG001|Overall Study|Lost to Follow-up|23|||
126433298|NCT02954536|454884280|FG000|Overall Study|Adverse Event|2|||
126433299|NCT02954536|454884280|FG000|Overall Study|Death|12|||
126433300|NCT05498649|454884281|FG000|Overall Study|Lost to Follow-up|1|||
126433301|NCT02946580|454884282|FG000|Overall Study|Withdrawal by Subject|1|||
126433302|NCT02946580|454884283|FG001|Overall Study|Withdrawal by Subject|2|||
126347640|NCT02127671|454568478|FG001|Overall Study|incarceration|1|||
126347641|NCT02127671|454568477|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
126347642|NCT02127671|454568478|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
126347643|NCT02394275|454568479|FG000|Overall Study|Adverse Event|22|||
126347644|NCT02394275|454568479|FG000|Overall Study|Lost to Follow-up|7|||
126347645|NCT00764517|454568485|FG000|Overall Study|Adverse Event|9|||
126347646|NCT00764517|454568486|FG001|Overall Study|Adverse Event|3|||
126347647|NCT00764517|454568485|FG000|Overall Study|Death|3|||
126347648|NCT00764517|454568486|FG001|Overall Study|Death|11|||
126347649|NCT00764517|454568485|FG000|Overall Study|Physician Decision|3|||
126347650|NCT00764517|454568486|FG001|Overall Study|Physician Decision|0|||
126347651|NCT00671060|454568494|FG000|Overall Study|Protocol Violation|1|||
126347652|NCT00671060|454568495|FG001|Overall Study|Protocol Violation|0|||
126347653|NCT00671060|454568494|FG000|Overall Study|Physician Decision|0|||
126347654|NCT00671060|454568495|FG001|Overall Study|Physician Decision|1|||
126347655|NCT02020941|454568496|FG000|Overall Study|Adverse Event|1|||
126347656|NCT02020941|454568496|FG000|Overall Study|Physician Decision|2|||
126347657|NCT02020941|454568496|FG000|Overall Study|Withdrawal by Subject|1|||
126347658|NCT02020941|454568496|FG000|Overall Study|Disease Progression|4|||
126347659|NCT02107898|454568499|FG000|Overall Study|Adverse Event|4|||
126347660|NCT02107898|454568500|FG001|Overall Study|Adverse Event|7|||
126347661|NCT02107898|454568499|FG000|Overall Study|Poor compliance to protocol|0|||
126347662|NCT02107898|454568500|FG001|Overall Study|Poor compliance to protocol|1|||
126347663|NCT02107898|454568499|FG000|Overall Study|Participant moved|0|||
126347664|NCT02107898|454568500|FG001|Overall Study|Participant moved|2|||
126347665|NCT02107898|454568499|FG000|Overall Study|Consent withdrawn by participant|2|||
126347666|NCT02107898|454568500|FG001|Overall Study|Consent withdrawn by participant|1|||
126347667|NCT02107898|454568499|FG000|Overall Study|Randomized but not treated|0|||
126347668|NCT02107898|454568500|FG001|Overall Study|Randomized but not treated|1|||
126347669|NCT03329989|454568501|FG000|Overall Study|Withdrawal by Subject|9|||
126347670|NCT03329989|454568501|FG000|Overall Study|Lost to Follow-up|8|||
126347671|NCT03329989|454568501|FG000|Overall Study|Adverse Event|5|||
126347672|NCT03329989|454568501|FG000|Overall Study|Protocol Violation|1|||
126347673|NCT01283386|454568506|FG000|Overall Study|Death|2|||
126347674|NCT01283386|454568507|FG001|Overall Study|Death|0|||
126347675|NCT01283386|454568506|FG000|Overall Study|Withdrawal by Subject|2|||
126347676|NCT01283386|454568507|FG001|Overall Study|Withdrawal by Subject|1|||
126347677|NCT01283386|454568506|FG000|Overall Study|Relapse of underlying disease|1|||
126347678|NCT01283386|454568507|FG001|Overall Study|Relapse of underlying disease|3|||
126347679|NCT01283386|454568506|FG000|Overall Study|Progression of underlying disease|2|||
126347680|NCT01283386|454568507|FG001|Overall Study|Progression of underlying disease|7|||
126347681|NCT01283386|454568506|FG000|Overall Study|Reason not specified|1|||
126347682|NCT01283386|454568507|FG001|Overall Study|Reason not specified|0|||
126347683|NCT01283386|454568506|FG000|Overall Study|Protocol Violation|0|||
126347684|NCT01283386|454568507|FG001|Overall Study|Protocol Violation|1|||
126347685|NCT03483103|454568510|FG000|Pre-Treatment Phase|Other reasons|1|||
126347686|NCT03483103|454568510|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
126347687|NCT03483103|454568510|FG000|Pre-Treatment Phase|Disease-related complications|1|||
126347688|NCT03483103|454568510|FG000|Pre-Treatment Phase|Death|5|||
126347689|NCT03483103|454568510|FG000|Treatment Phase|Withdrawal by Subject|7|||
126347690|NCT03483103|454568510|FG000|Treatment Phase|Other reasons|1|||
126347691|NCT03483103|454568510|FG000|Treatment Phase|Death|23|||
126347692|NCT03483103|454568510|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
126347693|NCT03483103|454568510|FG000|Treatment Phase|Received nonconforming product|1|||
126347694|NCT04115059|454568512|FG000|Overall Study|Withdrawal by Subject|1|||
126347695|NCT04115059|454568512|FG000|Overall Study|Lack of Efficacy|2|||
126347696|NCT06420232|454568513|FG000|Overall Study|Withdrawal by Subject|3|||
126347697|NCT03881371|454568518|FG000|Overall Study|Adverse Event|8|||
126347698|NCT03881371|454568519|FG001|Overall Study|Adverse Event|9|||
126347699|NCT03881371|454568518|FG000|Overall Study|Death|1|||
126347700|NCT03881371|454568519|FG001|Overall Study|Death|0|||
126347701|NCT03881371|454568518|FG000|Overall Study|Lost to Follow-up|1|||
126347702|NCT03881371|454568519|FG001|Overall Study|Lost to Follow-up|0|||
126347703|NCT03881371|454568518|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126347704|NCT03881371|454568519|FG001|Overall Study|Non-Compliance with Study Drug|2|||
126347705|NCT03881371|454568518|FG000|Overall Study|Physician Decision|3|||
126347706|NCT03881371|454568519|FG001|Overall Study|Physician Decision|3|||
126347707|NCT03881371|454568518|FG000|Overall Study|Withdrawal by Subject|2|||
126347708|NCT03881371|454568519|FG001|Overall Study|Withdrawal by Subject|10|||
126347709|NCT03881371|454568518|FG000|Overall Study|Discontinuation from Study|1|||
126347710|NCT03881371|454568519|FG001|Overall Study|Discontinuation from Study|0|||
126347711|NCT00933933|454568520|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
126347712|NCT00933933|454568521|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
126347713|NCT00933933|454568522|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
126347714|NCT00933933|454568520|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
126347715|NCT00933933|454568521|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
126433303|NCT02946580|454884282|FG000|Overall Study|Adverse Event|0|||
126433304|NCT02946580|454884283|FG001|Overall Study|Adverse Event|2|||
126433305|NCT02946580|454884282|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
126433306|NCT02946580|454884283|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
126433307|NCT03043313|454884287|FG000|Overall Study|Withdrawal by Subject|5|||
126433308|NCT03043313|454884288|FG001|Overall Study|Withdrawal by Subject|1|||
126433309|NCT03043313|454884289|FG002|Overall Study|Withdrawal by Subject|1|||
126433310|NCT03043313|454884287|FG000|Overall Study|Lost to Follow-up|1|||
126433311|NCT03043313|454884288|FG001|Overall Study|Lost to Follow-up|1|||
126433312|NCT03043313|454884289|FG002|Overall Study|Lost to Follow-up|0|||
126433313|NCT03043313|454884287|FG000|Overall Study|Death|28|||
126433314|NCT03043313|454884288|FG001|Overall Study|Death|26|||
126433315|NCT03043313|454884289|FG002|Overall Study|Death|17|||
126433316|NCT03043313|454884287|FG000|Overall Study|Participation terminated by sponsor|11|||
126433317|NCT03043313|454884288|FG001|Overall Study|Participation terminated by sponsor|13|||
126433318|NCT03043313|454884289|FG002|Overall Study|Participation terminated by sponsor|13|||
126433319|NCT00517296|454884292|FG000|Overall Study|Withdrawal by Subject|1|||
126433320|NCT00517296|454884293|FG001|Overall Study|Withdrawal by Subject|0|||
126433321|NCT04366349|454884294|FG000|Overall Study|Withdrawal by Subject|1|||
126433322|NCT04366349|454884295|FG001|Overall Study|Withdrawal by Subject|0|||
126433323|NCT04366349|454884296|FG002|Overall Study|Withdrawal by Subject|0|||
126433324|NCT04366349|454884297|FG003|Overall Study|Withdrawal by Subject|0|||
126433325|NCT04366349|454884298|FG004|Overall Study|Withdrawal by Subject|0|||
126433326|NCT04366349|454884299|FG005|Overall Study|Withdrawal by Subject|0|||
126433327|NCT00791934|454884301|FG000|Overall Study|Withdrawal by Subject|2|||
126433328|NCT00791934|454884301|FG000|Overall Study|Did not consent for extended follow-up|13|||
126433329|NCT02018562|454884305|FG000|Overall Study|Withdrawal by Subject|2|||
126433330|NCT02018562|454884306|FG001|Overall Study|Withdrawal by Subject|0|||
126433331|NCT02018562|454884305|FG000|Overall Study|Discharged prior to study completion|1|||
126433332|NCT02018562|454884306|FG001|Overall Study|Discharged prior to study completion|0|||
126433333|NCT05194124|454884308|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
126433334|NCT05194124|454884309|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
126433335|NCT05194124|454884310|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
126433336|NCT05194124|454884311|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
126433337|NCT05194124|454884312|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
126433338|NCT05194124|454884313|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
126433339|NCT05194124|454884314|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
126433340|NCT05194124|454884315|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
126433341|NCT05194124|454884316|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
126433342|NCT05194124|454884317|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
126433343|NCT05194124|454884308|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
126433344|NCT05194124|454884309|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
126433345|NCT05194124|454884310|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
126433346|NCT05194124|454884311|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
126433347|NCT05194124|454884312|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
126433348|NCT05194124|454884313|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
126433349|NCT05194124|454884314|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
126433350|NCT05194124|454884315|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
126433351|NCT05194124|454884316|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
126433352|NCT05194124|454884317|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
126433353|NCT04609319|454884318|FG000|Overall Study|Death|64|||
126433354|NCT04609319|454884319|FG001|Overall Study|Death|49|||
126433355|NCT04609319|454884320|FG002|Overall Study|Death|1|||
126433356|NCT04609319|454884318|FG000|Overall Study|Withdrawal of consent|15|||
126433357|NCT04609319|454884319|FG001|Overall Study|Withdrawal of consent|3|||
126433358|NCT04609319|454884320|FG002|Overall Study|Withdrawal of consent|0|||
126433359|NCT04609319|454884318|FG000|Overall Study|Lost to Follow-up|20|||
126433360|NCT04609319|454884319|FG001|Overall Study|Lost to Follow-up|33|||
126433361|NCT04609319|454884320|FG002|Overall Study|Lost to Follow-up|0|||
126433362|NCT04609319|454884318|FG000|Overall Study|Alive until end of follow-up|60|||
126433363|NCT04609319|454884319|FG001|Overall Study|Alive until end of follow-up|53|||
126433364|NCT04609319|454884320|FG002|Overall Study|Alive until end of follow-up|1|||
126433365|NCT03804528|454884332|FG000|Overall Study|Time Commitment|18|||
126433366|NCT03804528|454884332|FG000|Overall Study|Health Reasons|5|||
126433367|NCT03253393|454884333|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
126433368|NCT03253393|454884334|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
126433369|NCT03253393|454884335|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
126433370|NCT02443688|454885876|FG000|Overall Study|Adverse Event|2|||
126433371|NCT02443688|454885877|FG001|Overall Study|Adverse Event|3|||
126680772|NCT05634577|455788175|FG000|Overall Study|Withdrawal by Subject|1|||
126433372|NCT02443688|454885878|FG002|Overall Study|Adverse Event|2|||
126433373|NCT02443688|454885876|FG000|Overall Study|Lost to Follow-up|1|||
126433374|NCT02443688|454885877|FG001|Overall Study|Lost to Follow-up|0|||
126433375|NCT02443688|454885878|FG002|Overall Study|Lost to Follow-up|0|||
126433376|NCT02443688|454885876|FG000|Overall Study|Physician Decision|3|||
126433377|NCT02443688|454885877|FG001|Overall Study|Physician Decision|0|||
126433378|NCT02443688|454885878|FG002|Overall Study|Physician Decision|1|||
126433379|NCT02443688|454885876|FG000|Overall Study|Pregnancy|0|||
126433380|NCT02443688|454885877|FG001|Overall Study|Pregnancy|0|||
126433381|NCT02443688|454885878|FG002|Overall Study|Pregnancy|1|||
126433382|NCT02443688|454885876|FG000|Overall Study|Withdrawal by Subject|3|||
126433383|NCT02443688|454885877|FG001|Overall Study|Withdrawal by Subject|3|||
126433384|NCT02443688|454885878|FG002|Overall Study|Withdrawal by Subject|4|||
126433385|NCT02443688|454885876|FG000|Overall Study|Non-compliance with study drug|1|||
126433386|NCT02443688|454885877|FG001|Overall Study|Non-compliance with study drug|2|||
126433387|NCT02443688|454885878|FG002|Overall Study|Non-compliance with study drug|4|||
126433388|NCT02443688|454885876|FG000|Overall Study|Sponsor Request|2|||
126433389|NCT02443688|454885877|FG001|Overall Study|Sponsor Request|1|||
126433390|NCT02443688|454885878|FG002|Overall Study|Sponsor Request|0|||
126433391|NCT03182374|454885879|FG000|Overall Study|Lost to Follow-up|3|||
126433392|NCT03182374|454885880|FG001|Overall Study|Lost to Follow-up|2|||
126433393|NCT03182374|454885879|FG000|Overall Study|Lack of Efficacy|8|||
126433394|NCT03182374|454885880|FG001|Overall Study|Lack of Efficacy|14|||
126433395|NCT03182374|454885879|FG000|Overall Study|Withdrawal by Subject|1|||
126433396|NCT03182374|454885880|FG001|Overall Study|Withdrawal by Subject|1|||
126433397|NCT03182374|454885879|FG000|Overall Study|exit for non-compliance|1|||
126433398|NCT03182374|454885880|FG001|Overall Study|exit for non-compliance|1|||
126433399|NCT03182374|454885879|FG000|Overall Study|one subject was randomized but not treated|1|||
126433400|NCT03182374|454885880|FG001|Overall Study|one subject was randomized but not treated|0|||
126433401|NCT03182374|454885879|FG000|Overall Study|Other reasons|0|||
126433402|NCT03182374|454885880|FG001|Overall Study|Other reasons|3|||
126433403|NCT03198715|454885888|FG000|Overall Study|Death|0|||
126433404|NCT03198715|454885889|FG001|Overall Study|Death|0|||
126433405|NCT03198715|454885890|FG002|Overall Study|Death|1|||
126433406|NCT03198715|454885891|FG003|Overall Study|Death|0|||
126433407|NCT03198715|454885892|FG004|Overall Study|Death|2|||
126433408|NCT03198715|454885888|FG000|Overall Study|Other|0|||
126433409|NCT03198715|454885889|FG001|Overall Study|Other|1|||
126433410|NCT03198715|454885890|FG002|Overall Study|Other|1|||
126433411|NCT03198715|454885891|FG003|Overall Study|Other|0|||
126433412|NCT03198715|454885892|FG004|Overall Study|Other|0|||
126433413|NCT00616759|454885893|FG000|Overall Study|Physician Decision|2|||
126433414|NCT00616759|454885894|FG001|Overall Study|Physician Decision|0|||
126433415|NCT00616759|454885893|FG000|Overall Study|Withdrawal by Subject|1|||
126433416|NCT00616759|454885894|FG001|Overall Study|Withdrawal by Subject|2|||
126433417|NCT02007096|454885895|FG000|Overall Study|medication not available|2|||
126433418|NCT02007096|454885896|FG001|Overall Study|medication not available|0|||
126433419|NCT02007096|454885895|FG000|Overall Study|did not inject saline|0|||
126433420|NCT02007096|454885896|FG001|Overall Study|did not inject saline|3|||
126433421|NCT02007096|454885895|FG000|Overall Study|did not follow postoperative protocol|8|||
126433422|NCT02007096|454885896|FG001|Overall Study|did not follow postoperative protocol|11|||
126433423|NCT02007096|454885895|FG000|Overall Study|converted to open surgery|1|||
126433424|NCT02007096|454885896|FG001|Overall Study|converted to open surgery|1|||
126433425|NCT02007096|454885895|FG000|Overall Study|no mesh placed|0|||
126433426|NCT02007096|454885896|FG001|Overall Study|no mesh placed|1|||
126433427|NCT01231984|454885898|FG000|Study Period 1|Withdrawal by Subject|0|||
126433428|NCT01231984|454885899|FG001|Study Period 1|Withdrawal by Subject|0|||
126433429|NCT01231984|454885900|FG002|Study Period 1|Withdrawal by Subject|0|||
126433430|NCT01231984|454885901|FG003|Study Period 1|Withdrawal by Subject|1|||
126433431|NCT01231984|454885898|FG000|Study Period 1|Lost to Follow-up|1|||
126433432|NCT01231984|454885899|FG001|Study Period 1|Lost to Follow-up|1|||
126433433|NCT01231984|454885900|FG002|Study Period 1|Lost to Follow-up|1|||
126433434|NCT01231984|454885901|FG003|Study Period 1|Lost to Follow-up|0|||
126433435|NCT01231984|454885898|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
126433436|NCT01231984|454885899|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
126433437|NCT01231984|454885900|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
126433438|NCT01231984|454885901|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
126433439|NCT01231984|454885898|FG000|Study Period 1|Screen Failure|0|||
126433440|NCT01231984|454885899|FG001|Study Period 1|Screen Failure|0|||
126433441|NCT01231984|454885900|FG002|Study Period 1|Screen Failure|0|||
126433442|NCT01231984|454885901|FG003|Study Period 1|Screen Failure|1|||
126433443|NCT01231984|454885898|FG000|Study Period 1|Non-compliance with study requirements|5|||
126433444|NCT01231984|454885899|FG001|Study Period 1|Non-compliance with study requirements|0|||
126433445|NCT01231984|454885900|FG002|Study Period 1|Non-compliance with study requirements|2|||
126433446|NCT01231984|454885901|FG003|Study Period 1|Non-compliance with study requirements|1|||
126433447|NCT01231984|454885898|FG000|Study Period 1|Protocol Violation|3|||
126433448|NCT01231984|454885899|FG001|Study Period 1|Protocol Violation|4|||
126433449|NCT01231984|454885900|FG002|Study Period 1|Protocol Violation|2|||
126433450|NCT01231984|454885901|FG003|Study Period 1|Protocol Violation|3|||
126433451|NCT01231984|454885898|FG000|Study Period 1|Adverse Event|1|||
126433452|NCT01231984|454885899|FG001|Study Period 1|Adverse Event|0|||
126433453|NCT01231984|454885900|FG002|Study Period 1|Adverse Event|0|||
126433454|NCT01231984|454885901|FG003|Study Period 1|Adverse Event|0|||
126433455|NCT01231984|454885898|FG000|Study Period 1|Other|0|||
126433456|NCT01231984|454885899|FG001|Study Period 1|Other|0|||
126433457|NCT01231984|454885900|FG002|Study Period 1|Other|0|||
126433458|NCT01231984|454885901|FG003|Study Period 1|Other|1|||
126433459|NCT01231984|454885898|FG000|Study Period 2|Withdrawal by Subject|1|||
126433460|NCT01231984|454885899|FG001|Study Period 2|Withdrawal by Subject|1|||
126433461|NCT01231984|454885900|FG002|Study Period 2|Withdrawal by Subject|0|||
126433462|NCT01231984|454885901|FG003|Study Period 2|Withdrawal by Subject|0|||
126433463|NCT01231984|454885898|FG000|Study Period 2|Lost to Follow-up|1|||
126433464|NCT01231984|454885899|FG001|Study Period 2|Lost to Follow-up|0|||
126433465|NCT01231984|454885900|FG002|Study Period 2|Lost to Follow-up|0|||
126433466|NCT01231984|454885901|FG003|Study Period 2|Lost to Follow-up|3|||
126433467|NCT01231984|454885898|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
126433468|NCT01231984|454885899|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
126433469|NCT01231984|454885900|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
126433470|NCT01231984|454885901|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
126433471|NCT02923726|454885902|FG000|Overall Study|Death|196|||
126433472|NCT02923726|454885903|FG001|Overall Study|Death|175|||
126433473|NCT02923726|454885902|FG000|Overall Study|Withdrawal by Subject|337|||
126433474|NCT02923726|454885903|FG001|Overall Study|Withdrawal by Subject|307|||
126433475|NCT00481832|454885905|FG000|Enrollment|Physician Decision|8|||
126433476|NCT00481832|454885905|FG000|Enrollment|Unable to collect enough stem cells|2|||
126433477|NCT00481832|454885905|FG000|Inter-transplant Period|Adverse Event|4|||
126433478|NCT00481832|454885905|FG000|Inter-transplant Period|Death|3|||
126433479|NCT00481832|454885905|FG000|Inter-transplant Period|Physician Decision|4|||
126433480|NCT00481832|454885905|FG000|Inter-transplant Period|Disease relapse|11|||
126433481|NCT00481832|454885905|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
126433482|NCT02558894|454885908|FG000|Overall Study|Death; any cause, entire study duration|28|||
126433483|NCT02558894|454885909|FG001|Overall Study|Death; any cause, entire study duration|31|||
126433484|NCT02558894|454885908|FG000|Overall Study|Withdrawal by Subject|2|||
126433485|NCT02558894|454885909|FG001|Overall Study|Withdrawal by Subject|1|||
126433486|NCT02558894|454885908|FG000|Overall Study|Closure of Part A|2|||
126433487|NCT02558894|454885909|FG001|Overall Study|Closure of Part A|1|||
126433488|NCT02992288|454885910|FG000|Overall Study|Adverse Event|8|||
126433489|NCT02992288|454885911|FG001|Overall Study|Adverse Event|2|||
126433490|NCT02992288|454885912|FG002|Overall Study|Adverse Event|2|||
126433491|NCT02992288|454885913|FG003|Overall Study|Adverse Event|2|||
126433492|NCT02992288|454885914|FG004|Overall Study|Adverse Event|2|||
126433493|NCT02992288|454885915|FG005|Overall Study|Adverse Event|7|||
126433494|NCT02992288|454885910|FG000|Overall Study|Non-compliance with study drug|0|||
126433495|NCT02992288|454885911|FG001|Overall Study|Non-compliance with study drug|1|||
126433496|NCT02992288|454885912|FG002|Overall Study|Non-compliance with study drug|1|||
126433497|NCT02992288|454885913|FG003|Overall Study|Non-compliance with study drug|0|||
126433498|NCT02992288|454885914|FG004|Overall Study|Non-compliance with study drug|1|||
126433499|NCT02992288|454885915|FG005|Overall Study|Non-compliance with study drug|0|||
126433500|NCT02992288|454885910|FG000|Overall Study|Physician Decision|3|||
126433501|NCT02992288|454885911|FG001|Overall Study|Physician Decision|0|||
126433502|NCT02992288|454885912|FG002|Overall Study|Physician Decision|1|||
126433503|NCT02992288|454885913|FG003|Overall Study|Physician Decision|0|||
126433504|NCT02992288|454885914|FG004|Overall Study|Physician Decision|0|||
126433505|NCT02992288|454885915|FG005|Overall Study|Physician Decision|1|||
126433506|NCT02992288|454885910|FG000|Overall Study|Death|2|||
126433507|NCT02992288|454885911|FG001|Overall Study|Death|0|||
126433508|NCT02992288|454885912|FG002|Overall Study|Death|2|||
126433509|NCT02992288|454885913|FG003|Overall Study|Death|1|||
126433510|NCT02992288|454885914|FG004|Overall Study|Death|2|||
126433511|NCT02992288|454885915|FG005|Overall Study|Death|0|||
126433512|NCT02992288|454885910|FG000|Overall Study|Lost to Follow-up|0|||
126433513|NCT02992288|454885911|FG001|Overall Study|Lost to Follow-up|0|||
126433514|NCT02992288|454885912|FG002|Overall Study|Lost to Follow-up|0|||
126433515|NCT02992288|454885913|FG003|Overall Study|Lost to Follow-up|1|||
126680773|NCT01192022|455788176|FG000|Overall Study|Withdrawal of Consent|3|||
126433516|NCT02992288|454885914|FG004|Overall Study|Lost to Follow-up|0|||
126433517|NCT02992288|454885915|FG005|Overall Study|Lost to Follow-up|0|||
126433518|NCT02992288|454885910|FG000|Overall Study|Protocol Violation|0|||
126433519|NCT02992288|454885911|FG001|Overall Study|Protocol Violation|0|||
126433520|NCT02992288|454885912|FG002|Overall Study|Protocol Violation|0|||
126433521|NCT02992288|454885913|FG003|Overall Study|Protocol Violation|0|||
126433522|NCT02992288|454885914|FG004|Overall Study|Protocol Violation|0|||
126433523|NCT02992288|454885915|FG005|Overall Study|Protocol Violation|1|||
126433524|NCT02992288|454885910|FG000|Overall Study|Withdrawal by Subject|4|||
126433525|NCT02992288|454885911|FG001|Overall Study|Withdrawal by Subject|2|||
126433526|NCT02992288|454885912|FG002|Overall Study|Withdrawal by Subject|1|||
126433527|NCT02992288|454885913|FG003|Overall Study|Withdrawal by Subject|5|||
126433528|NCT02992288|454885914|FG004|Overall Study|Withdrawal by Subject|3|||
126433529|NCT02992288|454885915|FG005|Overall Study|Withdrawal by Subject|4|||
126433530|NCT02006472|454885919|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
126433531|NCT02006472|454885920|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
126433532|NCT02006472|454885921|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
126433533|NCT02006472|454885922|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
126433534|NCT02006472|454885923|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
126433535|NCT02006472|454885919|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
126433536|NCT02006472|454885920|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
126433537|NCT02006472|454885921|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
126433538|NCT02006472|454885922|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
126433539|NCT02006472|454885923|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
126433540|NCT02006472|454885919|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
126433541|NCT02006472|454885920|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
126433542|NCT02006472|454885921|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
126433543|NCT02006472|454885922|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
126433544|NCT02006472|454885923|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
126433545|NCT02006472|454885919|FG000|Period 1 (Through Week 26)|Other|1|||
126433546|NCT02006472|454885920|FG001|Period 1 (Through Week 26)|Other|5|||
126433547|NCT02006472|454885921|FG002|Period 1 (Through Week 26)|Other|0|||
126433548|NCT02006472|454885922|FG003|Period 1 (Through Week 26)|Other|2|||
126433549|NCT02006472|454885923|FG004|Period 1 (Through Week 26)|Other|3|||
126433550|NCT02006472|454885919|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
126433551|NCT02006472|454885920|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
126433552|NCT02006472|454885921|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
126433553|NCT02006472|454885922|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
126433554|NCT02006472|454885923|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
126433555|NCT02006472|454885919|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
126433556|NCT02006472|454885920|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
126433557|NCT02006472|454885921|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
126433558|NCT02006472|454885922|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
126433559|NCT02006472|454885923|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
126433560|NCT02006472|454885919|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
126433561|NCT02006472|454885920|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
126433562|NCT02006472|454885921|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
126433563|NCT02006472|454885922|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
126433564|NCT02006472|454885923|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
126433565|NCT02006472|454885919|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
126433566|NCT02006472|454885920|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
126433567|NCT02006472|454885921|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
126433568|NCT02006472|454885922|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
126433569|NCT02006472|454885923|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
126433570|NCT02006472|454885919|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
126433571|NCT02006472|454885920|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
126433572|NCT02006472|454885921|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
126433573|NCT02006472|454885922|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
126433574|NCT02006472|454885923|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
126433575|NCT02006472|454885919|FG000|Period 2 (Through Week 52)|Other|0|||
126433576|NCT02006472|454885920|FG001|Period 2 (Through Week 52)|Other|1|||
126433577|NCT02006472|454885921|FG002|Period 2 (Through Week 52)|Other|0|||
126433578|NCT02006472|454885922|FG003|Period 2 (Through Week 52)|Other|1|||
126433579|NCT02006472|454885923|FG004|Period 2 (Through Week 52)|Other|0|||
126433580|NCT02006472|454885919|FG000|Period 2 (Through Week 52)|Not treated|0|||
126433581|NCT02006472|454885920|FG001|Period 2 (Through Week 52)|Not treated|0|||
126433582|NCT02006472|454885921|FG002|Period 2 (Through Week 52)|Not treated|2|||
126433583|NCT02006472|454885922|FG003|Period 2 (Through Week 52)|Not treated|0|||
126433584|NCT02006472|454885923|FG004|Period 2 (Through Week 52)|Not treated|0|||
126433585|NCT02006472|454885919|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
126433586|NCT02006472|454885920|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
126433587|NCT02006472|454885921|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
126433588|NCT02006472|454885922|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
126433589|NCT02006472|454885923|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
126433590|NCT02006472|454885919|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
126433591|NCT02006472|454885920|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
126433592|NCT02006472|454885921|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
126433593|NCT02006472|454885922|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
126680774|NCT01192022|455788177|FG001|Overall Study|Withdrawal of Consent|1|||
126433594|NCT02006472|454885923|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
126433595|NCT00656513|454885924|FG000|Overall Study|Protocol Violation|1|||
126433596|NCT00656513|454885925|FG001|Overall Study|Protocol Violation|0|||
126433597|NCT00656513|454885926|FG002|Overall Study|Protocol Violation|2|||
126433598|NCT00656513|454885924|FG000|Overall Study|Withdrawal by Subject|0|||
126433599|NCT00656513|454885925|FG001|Overall Study|Withdrawal by Subject|11|||
126433600|NCT00656513|454885926|FG002|Overall Study|Withdrawal by Subject|4|||
126433601|NCT00656513|454885924|FG000|Overall Study|Death|0|||
126433602|NCT00656513|454885925|FG001|Overall Study|Death|0|||
126433603|NCT00656513|454885926|FG002|Overall Study|Death|1|||
126433604|NCT00656513|454885924|FG000|Overall Study|Missing data|0|||
126433605|NCT00656513|454885925|FG001|Overall Study|Missing data|11|||
126433606|NCT00656513|454885926|FG002|Overall Study|Missing data|9|||
126433607|NCT00656513|454885924|FG000|Overall Study|Incomplete treatment|3|||
126433608|NCT00656513|454885925|FG001|Overall Study|Incomplete treatment|0|||
126433609|NCT00656513|454885926|FG002|Overall Study|Incomplete treatment|0|||
126433610|NCT00656513|454885924|FG000|Overall Study|Treatment completed outside of timeframe|0|||
126433611|NCT00656513|454885925|FG001|Overall Study|Treatment completed outside of timeframe|3|||
126433612|NCT00656513|454885926|FG002|Overall Study|Treatment completed outside of timeframe|1|||
126433613|NCT00656513|454885924|FG000|Overall Study|Missing baseline form|0|||
126433614|NCT00656513|454885925|FG001|Overall Study|Missing baseline form|5|||
126433615|NCT00656513|454885926|FG002|Overall Study|Missing baseline form|5|||
126433616|NCT00087152|454885927|FG000|Overall Study|Ineligible|6|||
126433617|NCT02476617|454885934|FG000|Overall Study|Adverse Event|1|||
126433618|NCT02476617|454885934|FG000|Overall Study|Lost to Follow-up|1|||
126433619|NCT03486912|454885935|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
126433620|NCT03486912|454885936|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
126433621|NCT03486912|454885937|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
126433622|NCT03486912|454885938|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
126433623|NCT03486912|454885935|FG000|Treatment Period|Withdrawal by Subject|3|||
126433624|NCT03486912|454885936|FG001|Treatment Period|Withdrawal by Subject|3|||
126433625|NCT03486912|454885937|FG002|Treatment Period|Withdrawal by Subject|3|||
126433626|NCT03486912|454885938|FG003|Treatment Period|Withdrawal by Subject|2|||
126433627|NCT03486912|454885935|FG000|Treatment Period|Other Reasons|0|||
126433628|NCT03486912|454885936|FG001|Treatment Period|Other Reasons|2|||
126433629|NCT03486912|454885937|FG002|Treatment Period|Other Reasons|1|||
126433630|NCT03486912|454885938|FG003|Treatment Period|Other Reasons|1|||
126433631|NCT03486912|454885935|FG000|Treatment Period|Adverse Event|0|||
126433632|NCT03486912|454885936|FG001|Treatment Period|Adverse Event|1|||
126433633|NCT03486912|454885937|FG002|Treatment Period|Adverse Event|1|||
126433634|NCT03486912|454885938|FG003|Treatment Period|Adverse Event|0|||
126433635|NCT03486912|454885935|FG000|Treatment Period|Lost to Follow-up|1|||
126433636|NCT03486912|454885936|FG001|Treatment Period|Lost to Follow-up|0|||
126433637|NCT03486912|454885937|FG002|Treatment Period|Lost to Follow-up|0|||
126433638|NCT03486912|454885938|FG003|Treatment Period|Lost to Follow-up|2|||
126433639|NCT02491684|454885939|FG000|Treatment Phase|Adverse Event|2|||
126433640|NCT02491684|454885940|FG001|Treatment Phase|Adverse Event|2|||
126433641|NCT02491684|454885939|FG000|Treatment Phase|Incorrect randomisation|1|||
126433642|NCT02491684|454885940|FG001|Treatment Phase|Incorrect randomisation|0|||
126433643|NCT02491684|454885939|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
126433644|NCT02491684|454885940|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
126433645|NCT01436149|454885944|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
126433646|NCT01436149|454885945|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
126433647|NCT01436149|454885946|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
126433648|NCT01436149|454885944|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
126433649|NCT01436149|454885945|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
126433650|NCT01436149|454885946|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
126433651|NCT01436149|454885944|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
126433652|NCT01436149|454885945|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
126433653|NCT01436149|454885946|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
126433654|NCT01436149|454885944|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
126433655|NCT01436149|454885945|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
126433656|NCT01436149|454885946|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
126433657|NCT01436149|454885944|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
126433658|NCT01436149|454885945|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
126433659|NCT01436149|454885946|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
126433660|NCT01436149|454885944|FG000|Antidepressant Lead-in Phase|Other|119|||
126433661|NCT01436149|454885945|FG001|Antidepressant Lead-in Phase|Other|0|||
126433662|NCT01436149|454885946|FG002|Antidepressant Lead-in Phase|Other|0|||
126433663|NCT01436149|454885944|FG000|Randomized Phase|Adverse Event|9|||
126433664|NCT01436149|454885945|FG001|Randomized Phase|Adverse Event|10|||
126433665|NCT01436149|454885946|FG002|Randomized Phase|Adverse Event|11|||
126433666|NCT01436149|454885944|FG000|Randomized Phase|Protocol Violation|4|||
126433667|NCT01436149|454885945|FG001|Randomized Phase|Protocol Violation|5|||
126433668|NCT01436149|454885946|FG002|Randomized Phase|Protocol Violation|0|||
126433669|NCT01436149|454885944|FG000|Randomized Phase|Withdrawal by Subject|16|||
126433670|NCT01436149|454885945|FG001|Randomized Phase|Withdrawal by Subject|10|||
126433671|NCT01436149|454885946|FG002|Randomized Phase|Withdrawal by Subject|10|||
126433672|NCT01436149|454885944|FG000|Randomized Phase|Lost to Follow-up|34|||
126433673|NCT01436149|454885945|FG001|Randomized Phase|Lost to Follow-up|5|||
126433674|NCT01436149|454885946|FG002|Randomized Phase|Lost to Follow-up|6|||
126433675|NCT01436149|454885944|FG000|Randomized Phase|Lack of Efficacy|0|||
126433676|NCT01436149|454885945|FG001|Randomized Phase|Lack of Efficacy|0|||
126433677|NCT01436149|454885946|FG002|Randomized Phase|Lack of Efficacy|1|||
126433678|NCT01436149|454885944|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
126433679|NCT01436149|454885945|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
126433680|NCT01436149|454885946|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
126433681|NCT01436149|454885944|FG000|Randomized Phase|Other|12|||
126433682|NCT01436149|454885945|FG001|Randomized Phase|Other|5|||
126433683|NCT01436149|454885946|FG002|Randomized Phase|Other|11|||
126433684|NCT00561652|454885950|FG000|Overall Study|Withdrawal by Subject|0|||
126433685|NCT00561652|454885951|FG001|Overall Study|Withdrawal by Subject|1|||
126433686|NCT00894803|454885952|FG000|Overall Study|Death|20|||
126433687|NCT00894803|454885953|FG001|Overall Study|Death|4|||
126433688|NCT00894803|454885952|FG000|Overall Study|Lost to Follow-up|0|||
126433689|NCT00894803|454885953|FG001|Overall Study|Lost to Follow-up|1|||
126433690|NCT04484961|454885954|FG000|Overall Study|Lost to Follow-up|9|||
126433691|NCT04484961|454885955|FG001|Overall Study|Lost to Follow-up|9|||
126433692|NCT01667900|454885956|FG000|Part B|Death|0|||
126433693|NCT01667900|454885957|FG001|Part B|Death|0|||
126433694|NCT01667900|454885958|FG002|Part B|Death|0|||
126433695|NCT01667900|454885959|FG003|Part B|Death|0|||
126433696|NCT01667900|454885960|FG004|Part B|Death|0|||
126433697|NCT01667900|454885961|FG005|Part B|Death|0|||
126433698|NCT01667900|454885962|FG006|Part B|Death|0|||
126433699|NCT01667900|454885963|FG007|Part B|Death|0|||
126433700|NCT01667900|454885964|FG008|Part B|Death|0|||
126433701|NCT01667900|454885965|FG009|Part B|Death|0|||
126433702|NCT01667900|454885966|FG010|Part B|Death|0|||
126433703|NCT01667900|454885967|FG011|Part B|Death|0|||
126433704|NCT01667900|454885968|FG012|Part B|Death|0|||
126433705|NCT01667900|454885969|FG013|Part B|Death|0|||
126433706|NCT01667900|454885970|FG014|Part B|Death|0|||
126433707|NCT01667900|454885971|FG015|Part B|Death|0|||
126433708|NCT01667900|454885972|FG016|Part B|Death|1|||
126433709|NCT01667900|454885973|FG017|Part B|Death|0|||
126433710|NCT01667900|454885974|FG018|Part B|Death|0|||
126433711|NCT01667900|454885975|FG019|Part B|Death|0|||
126433712|NCT01075243|454885977|FG000|Overall Study|Lost to Follow-up|5|||
126433713|NCT01075243|454885978|FG001|Overall Study|Lost to Follow-up|2|||
126433714|NCT01075243|454885979|FG002|Overall Study|Lost to Follow-up|0|||
126433715|NCT01075243|454885977|FG000|Overall Study|Withdrawal by Subject|1|||
126433716|NCT01075243|454885978|FG001|Overall Study|Withdrawal by Subject|1|||
126433717|NCT01075243|454885979|FG002|Overall Study|Withdrawal by Subject|0|||
126433718|NCT00976274|454885980|FG000|Overall Study|Lost to Follow-up|5|||
126433719|NCT00976274|454885981|FG001|Overall Study|Lost to Follow-up|5|||
126433720|NCT00976274|454885980|FG000|Overall Study|Withdrawal by Subject|1|||
126433721|NCT00976274|454885981|FG001|Overall Study|Withdrawal by Subject|1|||
126433722|NCT00976274|454885980|FG000|Overall Study|Physician Decision|1|||
126433723|NCT00976274|454885981|FG001|Overall Study|Physician Decision|2|||
126433724|NCT00004563|454885984|FG000|Overall Study|Withdrawal by Subject|20|||
126433725|NCT00004563|454885985|FG001|Overall Study|Withdrawal by Subject|16|||
126433726|NCT00004563|454885984|FG000|Overall Study|Lack of Efficacy|3|||
126433727|NCT00004563|454885985|FG001|Overall Study|Lack of Efficacy|5|||
126433728|NCT00004563|454885984|FG000|Overall Study|Death|2|||
126433729|NCT00004563|454885985|FG001|Overall Study|Death|3|||
126433730|NCT00762164|454885990|FG000|Overall Study|Lost to Follow-up|1|||
126433731|NCT00762164|454885991|FG001|Overall Study|Lost to Follow-up|1|||
126433732|NCT00762164|454885990|FG000|Overall Study|Discontinued medication|2|||
126433733|NCT00762164|454885991|FG001|Overall Study|Discontinued medication|0|||
126433734|NCT00762164|454885990|FG000|Overall Study|Withdrawal by Subject|0|||
126433735|NCT00762164|454885991|FG001|Overall Study|Withdrawal by Subject|1|||
126433736|NCT03094416|454885992|FG000|Run-in|Screening failure|8|||
126433737|NCT03094416|454885992|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
126433738|NCT03094416|454885992|FG000|Run-in|Withdrawal by Subject|3|||
126433739|NCT03094416|454885992|FG000|Treatment Period|Withdrawal by Subject|2|||
126433740|NCT04528641|454885993|FG000|Overall Study|Withdrawal by Subject|0|||
126433741|NCT04528641|454885994|FG001|Overall Study|Withdrawal by Subject|0|||
126433742|NCT04528641|454885995|FG002|Overall Study|Withdrawal by Subject|0|||
126433743|NCT04528641|454885996|FG003|Overall Study|Withdrawal by Subject|1|||
126433744|NCT04528641|454885997|FG004|Overall Study|Withdrawal by Subject|0|||
126433745|NCT04528641|454885998|FG005|Overall Study|Withdrawal by Subject|1|||
126433746|NCT03474588|454885999|FG000|Overall Study|Withdrawal by Subject|4|||
126433747|NCT03474588|454886000|FG001|Overall Study|Withdrawal by Subject|3|||
126433748|NCT03474588|454885999|FG000|Overall Study|Death|0|||
126433749|NCT03474588|454886000|FG001|Overall Study|Death|1|||
126433750|NCT01607957|454886001|FG000|Overall Study|Not treated|1|||
126433751|NCT01607957|454886002|FG001|Overall Study|Not treated|1|||
126433752|NCT01607957|454886001|FG000|Overall Study|Death|367|||
126433753|NCT01607957|454886002|FG001|Overall Study|Death|211|||
126433754|NCT01607957|454886001|FG000|Overall Study|Lost to Follow-up|3|||
126347716|NCT00933933|454568522|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
126347717|NCT03329001|454568523|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
126347718|NCT03329001|454568524|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
126347719|NCT03329001|454568525|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
126347720|NCT03329001|454568526|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
126347721|NCT03329001|454568527|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
126347722|NCT03329001|454568528|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
126347723|NCT03329001|454568529|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
126347724|NCT03329001|454568530|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
126347725|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347726|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347727|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347728|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
126347729|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347730|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347731|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347732|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
126347733|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126347734|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126347735|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126347736|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
126347737|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126347738|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126369376|NCT04380142|454648212|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
126369377|NCT04380142|454648213|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
126369378|NCT04380142|454648214|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
126369379|NCT04716894|454648219|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
126369380|NCT04716894|454648219|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
126369381|NCT03773484|454648220|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
126369382|NCT01889251|454648221|FG000|Overall Study|Adverse Event|1|||
126369383|NCT01889251|454648222|FG001|Overall Study|Adverse Event|0|||
126369384|NCT01344226|454648230|FG000|Overall Study|Protocol Violation|2|||
126369385|NCT01344226|454648230|FG000|Overall Study|Withdrawal by Subject|3|||
126369386|NCT01344226|454648230|FG000|Overall Study|Lack of Efficacy|3|||
126369387|NCT03211416|454648232|FG000|Overall Study|Adverse Event|7|||
126369388|NCT03211416|454648232|FG000|Overall Study|Lack of Efficacy|2|||
126369389|NCT03211416|454648232|FG000|Overall Study|Physician Decision|1|||
126369390|NCT02302222|454648234|FG000|Overall Study|Physician Decision|0|||
126369391|NCT02302222|454648235|FG001|Overall Study|Physician Decision|4|||
126369392|NCT02302222|454648234|FG000|Overall Study|Lost to Follow-up|1|||
126369393|NCT02302222|454648235|FG001|Overall Study|Lost to Follow-up|0|||
126369394|NCT02302222|454648234|FG000|Overall Study|Treatment discontinued before day 5|0|||
126369395|NCT02302222|454648235|FG001|Overall Study|Treatment discontinued before day 5|1|||
126369396|NCT02302222|454648234|FG000|Overall Study|Withdrawn prior to any treatment|0|||
126369397|NCT02302222|454648235|FG001|Overall Study|Withdrawn prior to any treatment|1|||
126369398|NCT03781570|454648241|FG000|Overall Study|Technical Issues (equipment failure)|31|||
126369399|NCT03781570|454648241|FG000|Overall Study|Withdrawal by Subject|7|||
126369400|NCT03781570|454648241|FG000|Overall Study|Physical Constraints|11|||
126369401|NCT01107496|454648242|FG000|Overall Study|Adverse Event|1|||
126369402|NCT01107496|454648243|FG001|Overall Study|Adverse Event|0|||
126369403|NCT01107496|454648242|FG000|Overall Study|Lack of Efficacy|1|||
126369404|NCT01107496|454648243|FG001|Overall Study|Lack of Efficacy|0|||
126369405|NCT01107496|454648242|FG000|Overall Study|Protocol Violation|0|||
126369406|NCT01107496|454648243|FG001|Overall Study|Protocol Violation|1|||
126369407|NCT01107496|454648242|FG000|Overall Study|Lost to Follow-up|0|||
126369408|NCT01107496|454648243|FG001|Overall Study|Lost to Follow-up|1|||
126369409|NCT03709472|454648244|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
126369410|NCT03709472|454648245|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
126369411|NCT03709472|454648244|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
126369412|NCT03709472|454648245|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
126369413|NCT03559556|454648246|FG000|Overall Study|Withdrawal by Subject|1|||
126369414|NCT02496000|454648252|FG000|Overall Study|Withdrawal by Subject|1|||
126369415|NCT02496000|454648253|FG001|Overall Study|Withdrawal by Subject|2|||
126369416|NCT02496000|454648254|FG002|Overall Study|Withdrawal by Subject|0|||
126369417|NCT02496000|454648252|FG000|Overall Study|Lost to Follow-up|1|||
126369418|NCT02496000|454648253|FG001|Overall Study|Lost to Follow-up|0|||
126433755|NCT01607957|454886002|FG001|Overall Study|Lost to Follow-up|3|||
126433756|NCT01607957|454886001|FG000|Overall Study|Participant refusal|1|||
126433757|NCT01607957|454886002|FG001|Overall Study|Participant refusal|0|||
126433758|NCT04607005|454886013|FG000|Overall Study|Adverse Event|0|||
126433759|NCT04607005|454886014|FG001|Overall Study|Adverse Event|1|||
126433760|NCT04607005|454886013|FG000|Overall Study|Lack of Efficacy|1|||
126433761|NCT04607005|454886014|FG001|Overall Study|Lack of Efficacy|6|||
126433762|NCT04607005|454886013|FG000|Overall Study|Withdrawal by Subject|4|||
126433763|NCT04607005|454886014|FG001|Overall Study|Withdrawal by Subject|9|||
126433764|NCT04607005|454886013|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
126433765|NCT04607005|454886014|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
126433766|NCT03919773|454886023|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
126433767|NCT03919773|454886024|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
126433768|NCT03919773|454886023|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
126433769|NCT03919773|454886024|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
126433770|NCT04659044|454886027|FG000|Induction|Physician Decision|1|||
126433771|NCT04659044|454886027|FG000|Induction|Adverse Event|2|||
126433772|NCT03589859|454886028|FG000|Overall Study|Withdrawal by Subject|0|||
126433773|NCT03589859|454886029|FG001|Overall Study|Withdrawal by Subject|6|||
126433774|NCT02331134|454886030|FG000|Overall Study|Withdrawal by Subject|1|||
126433775|NCT04966013|454886031|FG000|Overall Study|Withdrawal by Subject|0|||
126433776|NCT04966013|454886032|FG001|Overall Study|Withdrawal by Subject|2|||
126433777|NCT04966013|454886033|FG002|Overall Study|Withdrawal by Subject|1|||
126433778|NCT04966013|454886031|FG000|Overall Study|Adverse Event|2|||
126433779|NCT04966013|454886032|FG001|Overall Study|Adverse Event|1|||
126433780|NCT04966013|454886033|FG002|Overall Study|Adverse Event|1|||
126433781|NCT03518086|454886037|FG000|Overall Study|Adverse Event|23|||
126433782|NCT03518086|454886038|FG001|Overall Study|Adverse Event|15|||
126433783|NCT03518086|454886039|FG002|Overall Study|Adverse Event|3|||
126433784|NCT03518086|454886040|FG003|Overall Study|Adverse Event|2|||
126433785|NCT03518086|454886037|FG000|Overall Study|Withdrawal by Subject|8|||
126433786|NCT03518086|454886038|FG001|Overall Study|Withdrawal by Subject|5|||
126433787|NCT03518086|454886039|FG002|Overall Study|Withdrawal by Subject|1|||
126433788|NCT03518086|454886040|FG003|Overall Study|Withdrawal by Subject|0|||
126433789|NCT03518086|454886037|FG000|Overall Study|Lack of Efficacy|5|||
126433790|NCT03518086|454886038|FG001|Overall Study|Lack of Efficacy|5|||
126433791|NCT03518086|454886039|FG002|Overall Study|Lack of Efficacy|0|||
126433792|NCT03518086|454886040|FG003|Overall Study|Lack of Efficacy|2|||
126433793|NCT03518086|454886037|FG000|Overall Study|Protocol Violation|1|||
126433794|NCT03518086|454886038|FG001|Overall Study|Protocol Violation|5|||
126433795|NCT03518086|454886039|FG002|Overall Study|Protocol Violation|1|||
126433796|NCT03518086|454886040|FG003|Overall Study|Protocol Violation|3|||
126433797|NCT03518086|454886037|FG000|Overall Study|Lost to Follow-up|0|||
126433798|NCT03518086|454886038|FG001|Overall Study|Lost to Follow-up|3|||
126433799|NCT03518086|454886039|FG002|Overall Study|Lost to Follow-up|0|||
126433800|NCT03518086|454886040|FG003|Overall Study|Lost to Follow-up|0|||
126433801|NCT03518086|454886037|FG000|Overall Study|Insufficient Diary Data|0|||
126433802|NCT03518086|454886038|FG001|Overall Study|Insufficient Diary Data|2|||
126433803|NCT03518086|454886039|FG002|Overall Study|Insufficient Diary Data|0|||
126433804|NCT03518086|454886040|FG003|Overall Study|Insufficient Diary Data|0|||
126433805|NCT03518086|454886037|FG000|Overall Study|Non- compliance to Protocol|0|||
126433806|NCT03518086|454886038|FG001|Overall Study|Non- compliance to Protocol|1|||
126433807|NCT03518086|454886039|FG002|Overall Study|Non- compliance to Protocol|0|||
126433808|NCT03518086|454886040|FG003|Overall Study|Non- compliance to Protocol|0|||
126433809|NCT03518086|454886037|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
126433810|NCT03518086|454886038|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
126433811|NCT03518086|454886039|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
126433812|NCT03518086|454886040|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
126433813|NCT03518086|454886037|FG000|Overall Study|Site Terminated by Sponsor|0|||
126433814|NCT03518086|454886038|FG001|Overall Study|Site Terminated by Sponsor|1|||
126433815|NCT03518086|454886039|FG002|Overall Study|Site Terminated by Sponsor|0|||
126433816|NCT03518086|454886040|FG003|Overall Study|Site Terminated by Sponsor|0|||
126433817|NCT03518086|454886037|FG000|Overall Study|Pregnancy|0|||
126433818|NCT03518086|454886038|FG001|Overall Study|Pregnancy|0|||
126433819|NCT03518086|454886039|FG002|Overall Study|Pregnancy|0|||
126433820|NCT03518086|454886040|FG003|Overall Study|Pregnancy|2|||
126433821|NCT05967260|454886041|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
126433822|NCT05967260|454886042|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
126433823|NCT00626106|454886043|FG000|Overall Study|Withdrawal by Subject|2|||
126433824|NCT00626106|454886044|FG001|Overall Study|Withdrawal by Subject|1|||
126433825|NCT00626106|454886043|FG000|Overall Study|Lost to Follow-up|1|||
126433826|NCT00626106|454886044|FG001|Overall Study|Lost to Follow-up|4|||
126433827|NCT00626106|454886043|FG000|Overall Study|Death|64|||
126433828|NCT00626106|454886044|FG001|Overall Study|Death|19|||
126347739|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126347740|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
126347741|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347742|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347743|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347744|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
126347745|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347746|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347747|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347748|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
126347749|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347750|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347751|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
126347752|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347753|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347754|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347755|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347756|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
126347757|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347758|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347759|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
126347760|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347761|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347762|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347763|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347764|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
126347765|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347766|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347767|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
126347768|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347769|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347770|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347771|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347772|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
126347773|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347774|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347775|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
126347776|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347777|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347778|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347779|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347780|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
126347781|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
126347782|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
126347783|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
126347784|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
126347785|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
126347786|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
126347787|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
126347788|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
126347789|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347790|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347791|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
126347792|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347793|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347794|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347795|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347796|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
126347797|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
126347798|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
126347799|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
126347800|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
126347801|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
126347802|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
126347803|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
126347804|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
126347805|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
126347806|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
126347807|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
126347808|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
126347809|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
126347810|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
126347811|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
126347812|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
126347813|NCT03329001|454568523|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
126347814|NCT03329001|454568524|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
126347815|NCT03329001|454568525|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
126347816|NCT03329001|454568526|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
126347817|NCT03329001|454568527|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
126347818|NCT03329001|454568528|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
126347819|NCT03329001|454568529|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
126347820|NCT03329001|454568530|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
126347821|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347822|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347823|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347824|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
126347825|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347826|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347827|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347828|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
126347829|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347830|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347831|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347832|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
126347833|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347834|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347835|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347836|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
126347837|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347838|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347839|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
126347840|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347841|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347842|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347843|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347844|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
126347845|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
126347846|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
126347847|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
126347848|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
126347849|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
126347850|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
126347851|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
126347852|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
126347853|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347854|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347855|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
126347856|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347857|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347858|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347859|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347860|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
126347861|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347862|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347863|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
126347864|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347865|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347866|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347867|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347868|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
126347869|NCT03329001|454568523|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347870|NCT03329001|454568524|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347871|NCT03329001|454568525|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347872|NCT03329001|454568526|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
126347873|NCT03329001|454568527|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347874|NCT03329001|454568528|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347875|NCT03329001|454568529|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347876|NCT03329001|454568530|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
126347877|NCT03329001|454568523|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347878|NCT03329001|454568524|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347879|NCT03329001|454568525|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347880|NCT03329001|454568526|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347881|NCT03329001|454568527|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347882|NCT03329001|454568528|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
126347883|NCT03329001|454568529|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347884|NCT03329001|454568530|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
126347885|NCT03329001|454568523|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347886|NCT03329001|454568524|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347887|NCT03329001|454568525|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347888|NCT03329001|454568526|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347889|NCT03329001|454568527|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
126347890|NCT03329001|454568528|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347891|NCT03329001|454568529|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347892|NCT03329001|454568530|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
126347893|NCT03329001|454568523|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
126347894|NCT03329001|454568524|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
126347895|NCT03329001|454568525|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
126433829|NCT05417438|454886045|FG000|Overall Study|Withdrawal by Subject|3|||
126433830|NCT02994108|454887585|FG000|Intervention Messages|Withdrawal by Subject|2|||
126433831|NCT02994108|454887586|FG001|Intervention Messages|Withdrawal by Subject|0|||
126433832|NCT02994108|454887585|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
126433833|NCT02994108|454887586|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
126433834|NCT02994108|454887585|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
126433835|NCT02994108|454887586|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
126433836|NCT02994108|454887585|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
126433837|NCT02994108|454887586|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
126433838|NCT00781768|454887587|FG000|Overall Study|Not transplanted.|0|||
126433839|NCT00781768|454887588|FG001|Overall Study|Not transplanted.|2|||
126433840|NCT00079417|454887597|FG000|Overall Study|Physician Decision|2|||
126433841|NCT00079417|454887597|FG000|Overall Study|Ineligible|7|||
126433842|NCT02458313|454887598|FG000|Overall Study|Withdrawal by Subject|6|||
126433843|NCT02458313|454887599|FG001|Overall Study|Withdrawal by Subject|8|||
126433844|NCT02458313|454887598|FG000|Overall Study|Excluded for motion during MRI|1|||
126433845|NCT02458313|454887599|FG001|Overall Study|Excluded for motion during MRI|2|||
126433846|NCT02081677|454887600|FG000|Overall Study|Adverse Event|0|||
126433847|NCT02081677|454887601|FG001|Overall Study|Adverse Event|0|||
126433848|NCT02081677|454887602|FG002|Overall Study|Adverse Event|1|||
126433849|NCT02081677|454887603|FG003|Overall Study|Adverse Event|0|||
126433850|NCT02081677|454887600|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
126433851|NCT02081677|454887601|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126433852|NCT02081677|454887602|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
126433853|NCT02081677|454887603|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
126433854|NCT02081677|454887600|FG000|Overall Study|Not comfortable with lens care system|1|||
126433855|NCT02081677|454887601|FG001|Overall Study|Not comfortable with lens care system|0|||
126433856|NCT02081677|454887602|FG002|Overall Study|Not comfortable with lens care system|0|||
126433857|NCT02081677|454887603|FG003|Overall Study|Not comfortable with lens care system|0|||
126433858|NCT02081677|454887600|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
126433859|NCT02081677|454887601|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
126433860|NCT02081677|454887602|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
126433861|NCT02081677|454887603|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
126433862|NCT00904969|454887604|FG000|Overall Study|Lost to Follow-up|4|||
126433863|NCT00904969|454887604|FG000|Overall Study|Withdrawal by Subject|3|||
126433864|NCT00904969|454887604|FG000|Overall Study|Additional Treatments|11|||
126433865|NCT00904969|454887604|FG000|Overall Study|Case Aborted; Subject Exited|1|||
126433866|NCT01097668|454887605|FG000|Overall Study|Withdrawal by Subject|1|||
126433867|NCT01097668|454887606|FG001|Overall Study|Withdrawal by Subject|2|||
126433868|NCT01097668|454887605|FG000|Overall Study|Lost to Follow-up|1|||
126433869|NCT01097668|454887606|FG001|Overall Study|Lost to Follow-up|0|||
126433870|NCT00199381|454887613|FG000|Overall Study|Withdrawal by Subject|38|||
126433871|NCT00199381|454887613|FG000|Overall Study|Adverse Event|73|||
126680775|NCT01192022|455788178|FG002|Overall Study|Withdrawal of Consent|0|||
126680776|NCT01192022|455788179|FG003|Overall Study|Withdrawal of Consent|0|||
126680777|NCT01192022|455788180|FG004|Overall Study|Withdrawal of Consent|0|||
126433872|NCT00199381|454887613|FG000|Overall Study|Protocol Violation|6|||
126433873|NCT00199381|454887613|FG000|Overall Study|Lack of Efficacy|27|||
126433874|NCT00199381|454887613|FG000|Overall Study|Not including due to early termination|37|||
126433875|NCT00199381|454887613|FG000|Overall Study|Study termination by Sponsor|323|||
126433876|NCT00385671|454887615|FG000|Overall Study|Adverse Event|14|||
126433877|NCT00385671|454887616|FG001|Overall Study|Adverse Event|27|||
126433878|NCT00385671|454887617|FG002|Overall Study|Adverse Event|18|||
126433879|NCT00385671|454887615|FG000|Overall Study|Lack of Efficacy|5|||
126680778|NCT01192022|455788176|FG000|Overall Study|Lost to Follow-up|4|||
126433880|NCT00385671|454887616|FG001|Overall Study|Lack of Efficacy|9|||
126433881|NCT00385671|454887617|FG002|Overall Study|Lack of Efficacy|5|||
126433882|NCT00385671|454887615|FG000|Overall Study|Lost to Follow-up|6|||
126433883|NCT00385671|454887616|FG001|Overall Study|Lost to Follow-up|6|||
126433884|NCT00385671|454887617|FG002|Overall Study|Lost to Follow-up|5|||
126433885|NCT00385671|454887615|FG000|Overall Study|Physician Decision|2|||
126433886|NCT00385671|454887616|FG001|Overall Study|Physician Decision|1|||
126433887|NCT00385671|454887617|FG002|Overall Study|Physician Decision|2|||
126347896|NCT03329001|454568526|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
126347897|NCT03329001|454568527|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
126347898|NCT03329001|454568528|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
126347899|NCT03329001|454568529|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
126347900|NCT03329001|454568530|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
126347901|NCT03329001|454568523|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347902|NCT03329001|454568524|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347903|NCT03329001|454568525|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347904|NCT03329001|454568526|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347905|NCT03329001|454568527|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
126347906|NCT03329001|454568528|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347907|NCT03329001|454568529|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347908|NCT03329001|454568530|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
126347909|NCT03329001|454568523|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
126347910|NCT03329001|454568524|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
126347911|NCT03329001|454568525|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
126347912|NCT03329001|454568526|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
126347913|NCT03329001|454568527|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
126347914|NCT03329001|454568528|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
126347915|NCT03329001|454568529|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
126347916|NCT03329001|454568530|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
126347917|NCT03329001|454568523|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
126347918|NCT03329001|454568524|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
126347919|NCT03329001|454568525|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
126347920|NCT03329001|454568526|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
126347921|NCT03329001|454568527|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
126347922|NCT03329001|454568528|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
126347923|NCT03329001|454568529|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
126347924|NCT03329001|454568530|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
126347925|NCT03329001|454568523|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347926|NCT03329001|454568524|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347927|NCT03329001|454568525|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347928|NCT03329001|454568526|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347929|NCT03329001|454568527|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347930|NCT03329001|454568528|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347931|NCT03329001|454568529|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
126347932|NCT03329001|454568530|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
126347933|NCT03329001|454568523|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
126347934|NCT03329001|454568524|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
126347935|NCT03329001|454568525|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
126347936|NCT03329001|454568526|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
126347937|NCT03329001|454568527|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
126347938|NCT03329001|454568528|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
126347939|NCT03329001|454568529|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
126347940|NCT03329001|454568530|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
126347941|NCT03329001|454568523|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
126347942|NCT03329001|454568524|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
126347943|NCT03329001|454568525|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
126347944|NCT03329001|454568526|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
126347945|NCT03329001|454568527|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
126347946|NCT03329001|454568528|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
126347947|NCT03329001|454568529|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
126347948|NCT03329001|454568530|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
126347949|NCT00963235|454568531|FG000|Overall Study|Withdrawal by Subject|22|||
126347950|NCT00963235|454568531|FG000|Overall Study|Lost to Follow-up|14|||
126347951|NCT00963235|454568531|FG000|Overall Study|Failed to return|9|||
126347952|NCT00963235|454568531|FG000|Overall Study|Protocol Violation|7|||
126347953|NCT00963235|454568531|FG000|Overall Study|Adverse Event|5|||
126347954|NCT00963235|454568531|FG000|Overall Study|Physician Decision|2|||
126347955|NCT00963235|454568531|FG000|Overall Study|Other|1|||
126433888|NCT00385671|454887615|FG000|Overall Study|Protocol Violation|5|||
126433889|NCT00385671|454887616|FG001|Overall Study|Protocol Violation|2|||
126433890|NCT00385671|454887617|FG002|Overall Study|Protocol Violation|1|||
126433891|NCT00385671|454887615|FG000|Overall Study|Sponsor Decision|2|||
126433892|NCT00385671|454887616|FG001|Overall Study|Sponsor Decision|2|||
126433893|NCT00385671|454887617|FG002|Overall Study|Sponsor Decision|1|||
126433894|NCT00385671|454887615|FG000|Overall Study|Withdrawal by Subject|4|||
126433895|NCT00385671|454887616|FG001|Overall Study|Withdrawal by Subject|4|||
126433896|NCT00385671|454887617|FG002|Overall Study|Withdrawal by Subject|4|||
126433897|NCT04944992|454887618|FG000|Overall Study|Lost to Follow-up|1|||
126433898|NCT04944992|454887619|FG001|Overall Study|Lost to Follow-up|1|||
126433899|NCT04944992|454887618|FG000|Overall Study|Physician Decision|1|||
126433900|NCT04944992|454887619|FG001|Overall Study|Physician Decision|0|||
126433901|NCT04944992|454887618|FG000|Overall Study|Withdrawal by Subject|6|||
126433902|NCT04944992|454887619|FG001|Overall Study|Withdrawal by Subject|1|||
126433903|NCT01295814|454887620|FG000|Overall Study|Lack of Efficacy|0|||
126433904|NCT01295814|454887621|FG001|Overall Study|Lack of Efficacy|2|||
126433905|NCT01295814|454887620|FG000|Overall Study|Withdrawal by Subject|2|||
126433906|NCT01295814|454887621|FG001|Overall Study|Withdrawal by Subject|0|||
126433907|NCT03414983|454887622|FG000|Pre-Treatment|Other reasons|1|||
126433908|NCT03414983|454887623|FG001|Pre-Treatment|Other reasons|0|||
126433909|NCT03414983|454887622|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
126433910|NCT03414983|454887623|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
126433911|NCT03414983|454887622|FG000|Pre-Treatment|Participant withdrew consent|1|||
126433912|NCT03414983|454887623|FG001|Pre-Treatment|Participant withdrew consent|3|||
126433913|NCT03414983|454887622|FG000|Treatment|Participant withdrew consent|4|||
126433914|NCT03414983|454887623|FG001|Treatment|Participant withdrew consent|3|||
126433915|NCT03414983|454887622|FG000|Treatment|Participant request to discontinue study treatment|8|||
126433916|NCT03414983|454887623|FG001|Treatment|Participant request to discontinue study treatment|10|||
126433917|NCT03414983|454887622|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
126433918|NCT03414983|454887623|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
126433919|NCT03414983|454887622|FG000|Treatment|Death|0|||
126433920|NCT03414983|454887623|FG001|Treatment|Death|1|||
126433921|NCT03414983|454887622|FG000|Treatment|Study Drug Toxicity|10|||
126433922|NCT03414983|454887623|FG001|Treatment|Study Drug Toxicity|5|||
126433923|NCT03414983|454887622|FG000|Treatment|Disease Progression|75|||
126433924|NCT03414983|454887623|FG001|Treatment|Disease Progression|29|||
126433925|NCT03414983|454887622|FG000|Treatment|Not reported|1|||
126433926|NCT03414983|454887623|FG001|Treatment|Not reported|0|||
126433927|NCT03414983|454887622|FG000|Treatment|Other reasons|3|||
126433928|NCT03414983|454887623|FG001|Treatment|Other reasons|2|||
126433929|NCT03414983|454887622|FG000|Treatment|Poor/non-compliance|2|||
126433930|NCT03414983|454887623|FG001|Treatment|Poor/non-compliance|0|||
126433931|NCT03414983|454887622|FG000|Treatment|Maximum clinical benefit|5|||
126433932|NCT03414983|454887623|FG001|Treatment|Maximum clinical benefit|9|||
126433933|NCT03414983|454887622|FG000|Treatment|Lost to Follow-up|0|||
126433934|NCT03414983|454887623|FG001|Treatment|Lost to Follow-up|1|||
126433935|NCT03414983|454887622|FG000|Treatment|Administrative reasons by sponsor|1|||
126433936|NCT03414983|454887623|FG001|Treatment|Administrative reasons by sponsor|0|||
126433937|NCT01775501|454887626|FG000|Overall Study|Discontinued prior to treatment|1|||
126433938|NCT03780244|454887634|FG000|Overall Study|Lost to Follow-up|1|||
126433939|NCT03780244|454887635|FG001|Overall Study|Lost to Follow-up|0|||
126433940|NCT03007966|454887639|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
126433941|NCT03007966|454887640|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
126433942|NCT01428258|454887641|FG000|Intervention 1|Withdrawal by Subject|2|||
126433943|NCT01428258|454887642|FG001|Intervention 1|Withdrawal by Subject|0|||
126433944|NCT00248625|454887643|FG000|Overall Study|Withdrawal by Subject|0|||
126433945|NCT00248625|454887644|FG001|Overall Study|Withdrawal by Subject|2|||
126433946|NCT03085095|454887645|FG000|Overall Study|Adverse Event|23|||
126433947|NCT03085095|454887646|FG001|Overall Study|Adverse Event|8|||
126433948|NCT03085095|454887645|FG000|Overall Study|Protocol Violation|0|||
126433949|NCT03085095|454887646|FG001|Overall Study|Protocol Violation|1|||
126433950|NCT03085095|454887645|FG000|Overall Study|Lost to Follow-up|2|||
126433951|NCT03085095|454887646|FG001|Overall Study|Lost to Follow-up|1|||
126433952|NCT03085095|454887645|FG000|Overall Study|Withdrawal by Subject|17|||
126433953|NCT03085095|454887646|FG001|Overall Study|Withdrawal by Subject|6|||
126433954|NCT03085095|454887645|FG000|Overall Study|Physician Decision|9|||
126433955|NCT03085095|454887646|FG001|Overall Study|Physician Decision|3|||
126433956|NCT03085095|454887645|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
126433957|NCT03085095|454887646|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
126433958|NCT03085095|454887645|FG000|Overall Study|Did not Receive Study Drug|2|||
126433959|NCT03085095|454887646|FG001|Overall Study|Did not Receive Study Drug|2|||
126433960|NCT03085095|454887645|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
126433961|NCT03085095|454887646|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
126433962|NCT00408317|454887647|FG000|First Intervention Period|Adverse Event|0|||
126433963|NCT00408317|454887648|FG001|First Intervention Period|Adverse Event|1|||
126433964|NCT00408317|454887647|FG000|Second Intervention Period|Adverse Event|2|||
126433965|NCT00408317|454887648|FG001|Second Intervention Period|Adverse Event|0|||
126433966|NCT00408317|454887647|FG000|Second Intervention Period|Protocol Violation|0|||
126433967|NCT00408317|454887648|FG001|Second Intervention Period|Protocol Violation|1|||
126433968|NCT00408317|454887647|FG000|Second Intervention Period|Withdrawal of consent|0|||
126433969|NCT00408317|454887648|FG001|Second Intervention Period|Withdrawal of consent|1|||
126433970|NCT01074502|454887649|FG000|Overall Study|Withdrawal by Subject|1|||
126433971|NCT00726063|454887653|FG000|Overall Study|Adverse Event|9|||
126433972|NCT00726063|454887654|FG001|Overall Study|Adverse Event|7|||
126433973|NCT05176314|454887656|FG000|Overall Study|Lost to Follow-up|2|||
126433974|NCT05176314|454887656|FG000|Overall Study|Physician Decision|1|||
126433975|NCT05176314|454887656|FG000|Overall Study|Adverse Event|1|||
126433976|NCT00286468|454887657|FG000|Overall Study|Hyperglycemic Rescue|28|||
126433977|NCT00286468|454887658|FG001|Overall Study|Hyperglycemic Rescue|30|||
126433978|NCT00286468|454887659|FG002|Overall Study|Hyperglycemic Rescue|31|||
126433979|NCT00286468|454887657|FG000|Overall Study|Adverse Event|2|||
126433980|NCT00286468|454887658|FG001|Overall Study|Adverse Event|6|||
126433981|NCT00286468|454887659|FG002|Overall Study|Adverse Event|4|||
126433982|NCT00286468|454887657|FG000|Overall Study|Protocol Violation|0|||
126433983|NCT00286468|454887658|FG001|Overall Study|Protocol Violation|3|||
126433984|NCT00286468|454887659|FG002|Overall Study|Protocol Violation|1|||
126433985|NCT00286468|454887657|FG000|Overall Study|Lost to Follow-up|1|||
126433986|NCT00286468|454887658|FG001|Overall Study|Lost to Follow-up|1|||
126433987|NCT00286468|454887659|FG002|Overall Study|Lost to Follow-up|2|||
126433988|NCT00286468|454887657|FG000|Overall Study|Withdrawal by Subject|3|||
126433989|NCT00286468|454887658|FG001|Overall Study|Withdrawal by Subject|8|||
126433990|NCT00286468|454887659|FG002|Overall Study|Withdrawal by Subject|11|||
126433991|NCT00286468|454887657|FG000|Overall Study|Physician Decision|3|||
126433992|NCT00286468|454887658|FG001|Overall Study|Physician Decision|2|||
126433993|NCT00286468|454887659|FG002|Overall Study|Physician Decision|1|||
126433994|NCT00074711|454887661|FG000|Overall Study|Withdrawal by Subject|1|||
126433995|NCT00074711|454887662|FG001|Overall Study|Withdrawal by Subject|1|||
126433996|NCT00074711|454887661|FG000|Overall Study|Lost to Follow-up|10|||
126433997|NCT00074711|454887662|FG001|Overall Study|Lost to Follow-up|8|||
126433998|NCT00074711|454887661|FG000|Overall Study|Participant stopped study drug|4|||
126433999|NCT00074711|454887662|FG001|Overall Study|Participant stopped study drug|6|||
126434000|NCT03466658|454887663|FG000|Overall Study|Withdrawal by Subject|3|||
126434001|NCT05365217|454887664|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126434002|NCT05365217|454887665|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126434003|NCT00129402|454887668|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
126434004|NCT00129402|454887669|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
126434005|NCT00129402|454887670|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
126434006|NCT00129402|454887671|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
126434007|NCT00129402|454887672|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
126434008|NCT00129402|454887673|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
126434009|NCT00129402|454887674|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
126434010|NCT00129402|454887668|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
126434011|NCT00129402|454887669|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
126434012|NCT00129402|454887670|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
126434013|NCT00129402|454887671|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
126434014|NCT00129402|454887672|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
126434015|NCT00129402|454887673|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
126434016|NCT00129402|454887674|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
126434017|NCT00129402|454887668|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
126434018|NCT00129402|454887669|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
126434019|NCT00129402|454887670|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
126434020|NCT00129402|454887671|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
126434021|NCT00129402|454887672|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
126434022|NCT00129402|454887673|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
126434023|NCT00129402|454887674|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
126434024|NCT00129402|454887668|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
126434025|NCT00129402|454887669|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
126434026|NCT00129402|454887670|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
126434027|NCT00129402|454887671|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
126434028|NCT00129402|454887672|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
126434029|NCT00129402|454887673|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
126434030|NCT00129402|454887674|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
126434031|NCT00129402|454887668|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
126434032|NCT00129402|454887669|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
126434033|NCT00129402|454887670|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
126434034|NCT00129402|454887671|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
126434035|NCT00129402|454887672|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
126434036|NCT00129402|454887673|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
126434037|NCT00129402|454887674|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
126434038|NCT00129402|454887668|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
126434039|NCT00129402|454887669|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
126434040|NCT00129402|454887670|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
126434041|NCT00129402|454887671|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
126434042|NCT00129402|454887672|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
126434043|NCT00129402|454887673|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
126434044|NCT00129402|454887674|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
126434045|NCT00129402|454887668|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
126347956|NCT01341470|454568533|FG000|Overall Study|Sponsor decision|0|||
126347957|NCT01341470|454568534|FG001|Overall Study|Sponsor decision|0|||
126347958|NCT01341470|454568535|FG002|Overall Study|Sponsor decision|1|||
126347959|NCT01341470|454568536|FG003|Overall Study|Sponsor decision|1|||
126347960|NCT01341470|454568537|FG004|Overall Study|Sponsor decision|0|||
126347961|NCT01341470|454568538|FG005|Overall Study|Sponsor decision|1|||
126347962|NCT01756235|454568539|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
126347963|NCT00311168|454568540|FG000|First Intervention|Withdrawal by Subject|2|||
126347964|NCT00311168|454568541|FG001|First Intervention|Withdrawal by Subject|2|||
126347965|NCT00311168|454568540|FG000|First Intervention|Lost to Follow-up|1|||
126347966|NCT00311168|454568541|FG001|First Intervention|Lost to Follow-up|1|||
126347967|NCT00311168|454568540|FG000|First Intervention|Protocol Violation|1|||
126347968|NCT00311168|454568541|FG001|First Intervention|Protocol Violation|1|||
126347969|NCT00311168|454568540|FG000|First Intervention|Adverse Event|1|||
126347970|NCT00311168|454568541|FG001|First Intervention|Adverse Event|0|||
126347971|NCT00311168|454568540|FG000|First Intervention|Other|2|||
126347972|NCT00311168|454568541|FG001|First Intervention|Other|2|||
126347973|NCT00311168|454568540|FG000|Second Intervention|Lost to Follow-up|9|||
126347974|NCT00311168|454568541|FG001|Second Intervention|Lost to Follow-up|2|||
126347975|NCT00311168|454568540|FG000|Second Intervention|Withdrawal by Subject|0|||
126347976|NCT00311168|454568541|FG001|Second Intervention|Withdrawal by Subject|1|||
126347977|NCT00311168|454568540|FG000|Second Intervention|Other|1|||
126347978|NCT00311168|454568541|FG001|Second Intervention|Other|1|||
126347979|NCT02337829|454568542|FG000|Overall Study|Death|0|||
126347980|NCT02337829|454568543|FG001|Overall Study|Death|1|||
126347981|NCT02337829|454568544|FG002|Overall Study|Death|0|||
126347982|NCT02337829|454568545|FG003|Overall Study|Death|0|||
126347983|NCT02337829|454568542|FG000|Overall Study|Study terminated by sponsor|12|||
126347984|NCT02337829|454568543|FG001|Overall Study|Study terminated by sponsor|10|||
126347985|NCT02337829|454568544|FG002|Overall Study|Study terminated by sponsor|5|||
126347986|NCT02337829|454568545|FG003|Overall Study|Study terminated by sponsor|6|||
126347987|NCT02337829|454568542|FG000|Overall Study|discontinued for other reasons|6|||
126347988|NCT02337829|454568543|FG001|Overall Study|discontinued for other reasons|3|||
126347989|NCT02337829|454568544|FG002|Overall Study|discontinued for other reasons|1|||
126347990|NCT02337829|454568545|FG003|Overall Study|discontinued for other reasons|4|||
126347991|NCT02879695|454568562|FG000|Overall Study|Did not start study treatment|2|||
126347992|NCT02879695|454568563|FG001|Overall Study|Did not start study treatment|0|||
126347993|NCT02879695|454568564|FG002|Overall Study|Did not start study treatment|3|||
126347994|NCT02879695|454568565|FG003|Overall Study|Did not start study treatment|0|||
126347995|NCT02442349|454568566|FG000|Overall Study|Death|95|||
126347996|NCT02442349|454568566|FG000|Overall Study|Withdrawal by Subject|27|||
126347997|NCT02442349|454568566|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
126347998|NCT02442349|454568566|FG000|Overall Study|Lost to Follow-up|1|||
126347999|NCT00314145|454568569|FG000|Overall Study|Withdrawal by Subject|8|||
126348000|NCT00314145|454568570|FG001|Overall Study|Withdrawal by Subject|10|||
126348001|NCT00314145|454568569|FG000|Overall Study|Lost to Follow-up|5|||
126348002|NCT00314145|454568570|FG001|Overall Study|Lost to Follow-up|12|||
126348003|NCT00314145|454568569|FG000|Overall Study|Physician Decision|3|||
126348004|NCT00314145|454568570|FG001|Overall Study|Physician Decision|4|||
126348005|NCT00314145|454568569|FG000|Overall Study|Adverse Event|0|||
126348006|NCT00314145|454568570|FG001|Overall Study|Adverse Event|3|||
126348007|NCT00314145|454568569|FG000|Overall Study|Protocol Violation|3|||
126434046|NCT00129402|454887669|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
126434047|NCT00129402|454887670|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
126434048|NCT00129402|454887671|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
126348008|NCT00314145|454568570|FG001|Overall Study|Protocol Violation|0|||
126348009|NCT00314145|454568569|FG000|Overall Study|Sponsor Decision|2|||
126348010|NCT00314145|454568570|FG001|Overall Study|Sponsor Decision|0|||
126348011|NCT03507790|454568571|FG000|Overall Study|Adverse Event|0|||
126348012|NCT03507790|454568572|FG001|Overall Study|Adverse Event|11|||
126434049|NCT00129402|454887672|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
126434050|NCT00129402|454887673|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
126434051|NCT00129402|454887674|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
126434052|NCT00129402|454887668|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
126434053|NCT00129402|454887669|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
126434054|NCT00129402|454887670|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
126434055|NCT00129402|454887671|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
126434056|NCT00129402|454887672|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
126434057|NCT00129402|454887673|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
126434058|NCT00129402|454887674|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
126434059|NCT00129402|454887668|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
126434060|NCT00129402|454887669|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
126434061|NCT00129402|454887670|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
126434062|NCT00129402|454887671|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
126434063|NCT00129402|454887672|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
126434064|NCT00129402|454887673|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
126434065|NCT00129402|454887674|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
126434066|NCT00129402|454887668|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
126434067|NCT00129402|454887669|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
126434068|NCT00129402|454887670|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
126434069|NCT00129402|454887671|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
126434070|NCT00129402|454887672|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
126434071|NCT00129402|454887673|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
126434072|NCT00129402|454887674|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
126434073|NCT00129402|454887668|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
126434074|NCT00129402|454887669|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
126434075|NCT00129402|454887670|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
126434076|NCT00129402|454887671|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
126434077|NCT00129402|454887672|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
126434078|NCT00129402|454887673|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
126434079|NCT00129402|454887674|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
126434080|NCT00129402|454887668|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
126434081|NCT00129402|454887669|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
126434082|NCT00129402|454887670|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
126434083|NCT00129402|454887671|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
126434084|NCT00129402|454887672|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
126434085|NCT00129402|454887673|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
126434086|NCT00129402|454887674|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
126434087|NCT00129402|454887668|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
126434088|NCT00129402|454887669|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
126434089|NCT00129402|454887670|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
126434090|NCT00129402|454887671|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
126434091|NCT00129402|454887672|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
126434092|NCT00129402|454887673|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
126434093|NCT00129402|454887674|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
126434094|NCT01527149|454887675|FG000|Overall Study|Death|2|||
126434095|NCT01680341|454887676|FG000|Overall Study|Adverse Event|3|||
126434096|NCT01680341|454887677|FG001|Overall Study|Adverse Event|2|||
126434097|NCT01680341|454887676|FG000|Overall Study|Unclassified|18|||
126434098|NCT01680341|454887677|FG001|Overall Study|Unclassified|15|||
126434099|NCT00499486|454887678|FG000|Overall Study|Withdrawal by Subject|16|||
126434100|NCT01643668|454887679|FG000|Overall Study|Death|1|||
126434101|NCT00322881|454887680|FG000|Overall Study|Death|2|||
126434102|NCT00322881|454887680|FG000|Overall Study|Adverse Event|1|||
126434103|NCT00322881|454887680|FG000|Overall Study|Disease Progression|2|||
126434104|NCT02285855|454887683|FG000|Overall Study|Withdrawal by Subject|2|||
126434105|NCT02285855|454887684|FG001|Overall Study|Withdrawal by Subject|1|||
126434106|NCT03253796|454887685|FG000|Period 1: Run-In|Adverse Event|4|||
126434107|NCT03253796|454887686|FG001|Period 1: Run-In|Adverse Event|0|||
126434108|NCT03253796|454887687|FG002|Period 1: Run-In|Adverse Event|0|||
126434109|NCT03253796|454887688|FG003|Period 1: Run-In|Adverse Event|0|||
126434110|NCT03253796|454887689|FG004|Period 1: Run-In|Adverse Event|0|||
126434111|NCT03253796|454887685|FG000|Period 1: Run-In|Lack of Efficacy|1|||
126434112|NCT03253796|454887686|FG001|Period 1: Run-In|Lack of Efficacy|0|||
126434113|NCT03253796|454887687|FG002|Period 1: Run-In|Lack of Efficacy|0|||
126434114|NCT03253796|454887688|FG003|Period 1: Run-In|Lack of Efficacy|0|||
126434115|NCT03253796|454887689|FG004|Period 1: Run-In|Lack of Efficacy|0|||
126434116|NCT03253796|454887685|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
126434117|NCT03253796|454887686|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
126434118|NCT03253796|454887687|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
126434119|NCT03253796|454887688|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
126434120|NCT03253796|454887689|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
126434121|NCT03253796|454887685|FG000|Period 1: Run-In|Protocol Violation|5|||
126434122|NCT03253796|454887686|FG001|Period 1: Run-In|Protocol Violation|0|||
126434123|NCT03253796|454887687|FG002|Period 1: Run-In|Protocol Violation|0|||
126434124|NCT03253796|454887688|FG003|Period 1: Run-In|Protocol Violation|0|||
126434125|NCT03253796|454887689|FG004|Period 1: Run-In|Protocol Violation|0|||
126434126|NCT03253796|454887685|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
126434127|NCT03253796|454887686|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
126434128|NCT03253796|454887687|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
126434129|NCT03253796|454887688|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
126434130|NCT03253796|454887689|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
126434131|NCT03253796|454887685|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
126434132|NCT03253796|454887686|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
126434133|NCT03253796|454887687|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
126434134|NCT03253796|454887688|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
126434135|NCT03253796|454887689|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
126434136|NCT03253796|454887685|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
126434137|NCT03253796|454887686|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
126434138|NCT03253796|454887687|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
126434139|NCT03253796|454887688|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
126434140|NCT03253796|454887689|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
126434141|NCT03253796|454887685|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
126434142|NCT03253796|454887686|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
126434143|NCT03253796|454887687|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
126434144|NCT03253796|454887688|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
126434145|NCT03253796|454887689|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
126434146|NCT03253796|454887685|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
126434147|NCT03253796|454887686|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
126434148|NCT03253796|454887687|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
126434149|NCT03253796|454887688|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
126434150|NCT03253796|454887689|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
126434151|NCT03253796|454887685|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
126434152|NCT03253796|454887686|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
126434153|NCT03253796|454887687|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
126434154|NCT03253796|454887688|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
126434155|NCT03253796|454887689|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
126434156|NCT03253796|454887685|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
126434157|NCT03253796|454887686|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
126434158|NCT03253796|454887687|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
126434159|NCT03253796|454887688|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
126434160|NCT03253796|454887689|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
126434161|NCT00528112|454887690|FG000|Treatment up to 3 Years|Adverse Event|313|||
126434162|NCT00528112|454887691|FG001|Treatment up to 3 Years|Adverse Event|278|||
126434163|NCT00528112|454887690|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
126434164|NCT00528112|454887691|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
126434165|NCT00528112|454887690|FG000|Treatment up to 3 Years|Protocol Violation|16|||
126434166|NCT00528112|454887691|FG001|Treatment up to 3 Years|Protocol Violation|16|||
126434167|NCT00528112|454887690|FG000|Treatment up to 3 Years|Death|0|||
126434168|NCT00528112|454887691|FG001|Treatment up to 3 Years|Death|1|||
126434169|NCT00528112|454887690|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
126434170|NCT00528112|454887691|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
126434171|NCT00528112|454887690|FG000|Treatment up to 3 Years|Pregnancy|9|||
126434172|NCT00528112|454887691|FG001|Treatment up to 3 Years|Pregnancy|10|||
126434173|NCT00528112|454887690|FG000|Treatment up to 3 Years|Other reasons|186|||
126434174|NCT00528112|454887691|FG001|Treatment up to 3 Years|Other reasons|186|||
126434175|NCT00528112|454887690|FG000|Extension Phase|Withdrawal by Subject|0|||
126434176|NCT00528112|454887691|FG001|Extension Phase|Withdrawal by Subject|3|||
126434177|NCT00528112|454887690|FG000|Extension Phase|Other reasons|0|||
126434178|NCT00528112|454887691|FG001|Extension Phase|Other reasons|100|||
126434179|NCT00528112|454887690|FG000|Extension Phase|Pregnancy|0|||
126434180|NCT00528112|454887691|FG001|Extension Phase|Pregnancy|3|||
126434181|NCT00528112|454887690|FG000|Extension Phase|Lost to Follow-up|0|||
126434182|NCT00528112|454887691|FG001|Extension Phase|Lost to Follow-up|12|||
126434183|NCT00528112|454887690|FG000|Extension Phase|Death|0|||
126434184|NCT00528112|454887691|FG001|Extension Phase|Death|1|||
126434185|NCT00528112|454887690|FG000|Extension Phase|Adverse Event|0|||
126434186|NCT00528112|454887691|FG001|Extension Phase|Adverse Event|36|||
126434187|NCT00528112|454887690|FG000|Extension Phase|Protocol Violation|0|||
126434188|NCT00528112|454887691|FG001|Extension Phase|Protocol Violation|2|||
126434189|NCT02718898|454887692|FG000|Blinded Treatment Period|Adverse Event|5|||
126434190|NCT02718898|454887693|FG001|Blinded Treatment Period|Adverse Event|1|||
126434191|NCT02718898|454887694|FG002|Blinded Treatment Period|Adverse Event|0|||
126434192|NCT02718898|454887695|FG003|Blinded Treatment Period|Adverse Event|0|||
126434193|NCT02718898|454887696|FG004|Blinded Treatment Period|Adverse Event|0|||
126434194|NCT02718898|454887697|FG005|Blinded Treatment Period|Adverse Event|0|||
126434195|NCT02718898|454887698|FG006|Blinded Treatment Period|Adverse Event|0|||
126434196|NCT02718898|454887692|FG000|Blinded Treatment Period|Physician Decision|1|||
126434197|NCT02718898|454887693|FG001|Blinded Treatment Period|Physician Decision|0|||
126434198|NCT02718898|454887694|FG002|Blinded Treatment Period|Physician Decision|0|||
126434199|NCT02718898|454887695|FG003|Blinded Treatment Period|Physician Decision|0|||
126434200|NCT02718898|454887696|FG004|Blinded Treatment Period|Physician Decision|0|||
126434201|NCT02718898|454887697|FG005|Blinded Treatment Period|Physician Decision|0|||
126434202|NCT02718898|454887698|FG006|Blinded Treatment Period|Physician Decision|0|||
126434203|NCT02718898|454887692|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
126434204|NCT02718898|454887693|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
126434205|NCT02718898|454887694|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
126434206|NCT02718898|454887695|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
126434207|NCT02718898|454887696|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
126434208|NCT02718898|454887697|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
126434209|NCT02718898|454887698|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
126434210|NCT02718898|454887692|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
126434211|NCT02718898|454887693|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
126434212|NCT02718898|454887694|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
126434213|NCT02718898|454887695|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
126434214|NCT02718898|454887696|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
126434215|NCT02718898|454887697|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
126434216|NCT02718898|454887698|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
126434217|NCT02718898|454887692|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
126434218|NCT02718898|454887693|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
126434219|NCT02718898|454887694|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
126434220|NCT02718898|454887695|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
126434221|NCT02718898|454887696|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
126434222|NCT02718898|454887697|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
126434223|NCT02718898|454887698|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
126434224|NCT02718898|454887692|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
126434225|NCT02718898|454887693|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
126434226|NCT02718898|454887694|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
126434227|NCT02718898|454887695|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
126434228|NCT02718898|454887696|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
126434229|NCT02718898|454887697|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
126434230|NCT02718898|454887698|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
126434231|NCT02718898|454887692|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126434232|NCT02718898|454887693|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126434233|NCT02718898|454887694|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
126434234|NCT02718898|454887695|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
126434235|NCT02718898|454887696|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126434236|NCT02718898|454887697|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126434237|NCT02718898|454887698|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126434238|NCT02718898|454887692|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
126434239|NCT02718898|454887693|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
126434240|NCT02718898|454887694|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
126434241|NCT02718898|454887695|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
126434242|NCT02718898|454887696|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
126434243|NCT02718898|454887697|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
126434244|NCT02718898|454887698|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
126434245|NCT02718898|454887692|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
126434246|NCT02718898|454887693|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
126434247|NCT02718898|454887694|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
126434248|NCT02718898|454887695|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
126434249|NCT02718898|454887696|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
126434250|NCT02718898|454887697|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
126434251|NCT02718898|454887698|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
126434252|NCT02718898|454887692|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
126434253|NCT02718898|454887693|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
126434254|NCT02718898|454887694|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
126434255|NCT02718898|454887695|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
126434256|NCT02718898|454887696|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
126434257|NCT02718898|454887697|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
126434258|NCT02718898|454887698|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
126434259|NCT02718898|454887692|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
126434260|NCT02718898|454887693|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
126434261|NCT02718898|454887694|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
126434262|NCT02718898|454887695|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
126434263|NCT02718898|454887696|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
126434264|NCT02718898|454887697|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
126434265|NCT02718898|454887698|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
126434266|NCT02718898|454887692|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
126434267|NCT02718898|454887693|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
126434268|NCT02718898|454887694|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
126434269|NCT02718898|454887695|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
126434270|NCT02718898|454887696|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
126434271|NCT02718898|454887697|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
126434272|NCT02718898|454887698|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
126434273|NCT02718898|454887692|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
126434274|NCT02718898|454887693|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
126434275|NCT02718898|454887694|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
126434276|NCT02718898|454887695|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
126434277|NCT02718898|454887696|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
126434278|NCT02718898|454887697|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
126434279|NCT02718898|454887698|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
126434280|NCT03337308|454887700|FG000|Overall Study|Adverse Event|2|||
126434281|NCT03337308|454887701|FG001|Overall Study|Adverse Event|3|||
126434282|NCT03337308|454887702|FG002|Overall Study|Adverse Event|3|||
126434283|NCT03337308|454887703|FG003|Overall Study|Adverse Event|1|||
126434284|NCT03337308|454887700|FG000|Overall Study|Lost to Follow-up|1|||
126434285|NCT03337308|454887701|FG001|Overall Study|Lost to Follow-up|2|||
126434286|NCT03337308|454887702|FG002|Overall Study|Lost to Follow-up|0|||
126434287|NCT03337308|454887703|FG003|Overall Study|Lost to Follow-up|0|||
126434288|NCT03337308|454887700|FG000|Overall Study|Withdrawal by Subject|2|||
126434289|NCT03337308|454887701|FG001|Overall Study|Withdrawal by Subject|1|||
126434290|NCT03337308|454887702|FG002|Overall Study|Withdrawal by Subject|2|||
126434291|NCT03337308|454887703|FG003|Overall Study|Withdrawal by Subject|1|||
126434292|NCT03337308|454887700|FG000|Overall Study|Protocol Violation|0|||
126434293|NCT03337308|454887701|FG001|Overall Study|Protocol Violation|1|||
126434294|NCT03337308|454887702|FG002|Overall Study|Protocol Violation|0|||
126434295|NCT03337308|454887703|FG003|Overall Study|Protocol Violation|0|||
126434296|NCT03341299|454887707|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
126434297|NCT03341299|454887708|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
126434298|NCT03341299|454887709|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
126434299|NCT03341299|454887710|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
126434300|NCT00945009|454887711|FG000|Overall Study|Lack of Efficacy|10|||
126434301|NCT00945009|454887712|FG001|Overall Study|Lack of Efficacy|0|||
126434302|NCT00945009|454887713|FG002|Overall Study|Lack of Efficacy|0|||
126434303|NCT00945009|454887711|FG000|Overall Study|Physician Decision|21|||
126434304|NCT00945009|454887712|FG001|Overall Study|Physician Decision|4|||
126434305|NCT00945009|454887713|FG002|Overall Study|Physician Decision|3|||
126434306|NCT00945009|454887711|FG000|Overall Study|Protocol Violation|6|||
126434307|NCT00945009|454887712|FG001|Overall Study|Protocol Violation|1|||
126434308|NCT00945009|454887713|FG002|Overall Study|Protocol Violation|0|||
126434309|NCT00945009|454887711|FG000|Overall Study|Withdrawal by Subject|1|||
126434310|NCT00945009|454887712|FG001|Overall Study|Withdrawal by Subject|0|||
126434311|NCT00945009|454887713|FG002|Overall Study|Withdrawal by Subject|0|||
126434312|NCT00945009|454887711|FG000|Overall Study|Ineligible|6|||
126434313|NCT00945009|454887712|FG001|Overall Study|Ineligible|1|||
126434314|NCT00945009|454887713|FG002|Overall Study|Ineligible|0|||
126434315|NCT00945009|454887711|FG000|Overall Study|Inevaluable|0|||
126434316|NCT00945009|454887712|FG001|Overall Study|Inevaluable|1|||
126434317|NCT00945009|454887713|FG002|Overall Study|Inevaluable|0|||
126434318|NCT00945009|454887711|FG000|Overall Study|Refusal of further protocol|1|||
126434319|NCT00945009|454887712|FG001|Overall Study|Refusal of further protocol|0|||
126434320|NCT00945009|454887713|FG002|Overall Study|Refusal of further protocol|0|||
126434321|NCT00303069|454889465|FG000|Overall Study|Lost to Follow-up|1|||
126434322|NCT00303069|454889466|FG001|Overall Study|Lost to Follow-up|0|||
126434323|NCT00303069|454889467|FG002|Overall Study|Lost to Follow-up|0|||
126434324|NCT00303069|454889468|FG003|Overall Study|Lost to Follow-up|2|||
126434325|NCT00303069|454889465|FG000|Overall Study|subject moved|1|||
126434326|NCT00303069|454889466|FG001|Overall Study|subject moved|0|||
126434327|NCT00303069|454889467|FG002|Overall Study|subject moved|0|||
126434328|NCT00303069|454889468|FG003|Overall Study|subject moved|0|||
126434329|NCT00303069|454889465|FG000|Overall Study|Recruitment into Army Reserves|0|||
126434330|NCT00303069|454889466|FG001|Overall Study|Recruitment into Army Reserves|0|||
126434331|NCT00303069|454889467|FG002|Overall Study|Recruitment into Army Reserves|1|||
126434332|NCT00303069|454889468|FG003|Overall Study|Recruitment into Army Reserves|0|||
126434333|NCT00092417|454889469|FG000|Overall Study|Lost to Follow-up|2|||
126434334|NCT00092417|454889470|FG001|Overall Study|Lost to Follow-up|0|||
126434335|NCT00092417|454889469|FG000|Overall Study|Withdrawal by Subject|2|||
126434336|NCT00092417|454889470|FG001|Overall Study|Withdrawal by Subject|1|||
126434337|NCT00092417|454889469|FG000|Overall Study|Other|1|||
126434338|NCT00092417|454889470|FG001|Overall Study|Other|0|||
126434339|NCT00751296|454889472|FG000|Overall Study|Adverse Event|2|||
126434340|NCT01972217|454889473|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
126434341|NCT01972217|454889474|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
126434342|NCT01972217|454889475|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
126434343|NCT01972217|454889476|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
126434344|NCT01972217|454889473|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
126434345|NCT01972217|454889474|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
126434346|NCT01972217|454889475|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
126434347|NCT01972217|454889476|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
126680779|NCT01192022|455788177|FG001|Overall Study|Lost to Follow-up|2|||
126680780|NCT01192022|455788178|FG002|Overall Study|Lost to Follow-up|1|||
126348013|NCT03507790|454568573|FG002|Overall Study|Adverse Event|3|||
126348014|NCT03507790|454568571|FG000|Overall Study|Withdrawal by Subject|2|||
126348015|NCT03507790|454568572|FG001|Overall Study|Withdrawal by Subject|0|||
126348016|NCT03507790|454568573|FG002|Overall Study|Withdrawal by Subject|0|||
126348017|NCT03507790|454568571|FG000|Overall Study|Subject moved to another location|1|||
126348018|NCT03507790|454568572|FG001|Overall Study|Subject moved to another location|2|||
126348019|NCT03507790|454568573|FG002|Overall Study|Subject moved to another location|0|||
126348020|NCT03507790|454568571|FG000|Overall Study|Non-compliance with study drug|0|||
126348021|NCT03507790|454568572|FG001|Overall Study|Non-compliance with study drug|0|||
126348022|NCT03507790|454568573|FG002|Overall Study|Non-compliance with study drug|1|||
126348023|NCT03507790|454568571|FG000|Overall Study|COVID 19 Pandemic|0|||
126348024|NCT03507790|454568572|FG001|Overall Study|COVID 19 Pandemic|1|||
126348025|NCT03507790|454568573|FG002|Overall Study|COVID 19 Pandemic|0|||
126348026|NCT03507790|454568571|FG000|Overall Study|Lost to Follow-up|0|||
126348027|NCT03507790|454568572|FG001|Overall Study|Lost to Follow-up|1|||
126348028|NCT03507790|454568573|FG002|Overall Study|Lost to Follow-up|0|||
126348029|NCT03507790|454568571|FG000|Overall Study|Discontinuation of the trial at the site|1|||
126348030|NCT03507790|454568572|FG001|Overall Study|Discontinuation of the trial at the site|1|||
126348031|NCT03507790|454568573|FG002|Overall Study|Discontinuation of the trial at the site|0|||
126348032|NCT03507790|454568571|FG000|Overall Study|Randomized in error|0|||
126348033|NCT03507790|454568572|FG001|Overall Study|Randomized in error|0|||
126348034|NCT03507790|454568573|FG002|Overall Study|Randomized in error|1|||
126348035|NCT01160614|454568576|FG000|Overall Study|Withdrawal by Subject|0|||
126348036|NCT01160614|454568577|FG001|Overall Study|Withdrawal by Subject|2|||
126348037|NCT03636477|454568578|FG000|Overall Study|Adverse Event|0|||
126348038|NCT03636477|454568579|FG001|Overall Study|Adverse Event|0|||
126348039|NCT03636477|454568580|FG002|Overall Study|Adverse Event|1|||
126348040|NCT03621592|454568581|FG000|Overall Study|Lost to Follow-up|1|||
126348041|NCT03621592|454568582|FG001|Overall Study|Lost to Follow-up|0|||
126348042|NCT03621592|454568581|FG000|Overall Study|Lack of Improvement|1|||
126348043|NCT03621592|454568582|FG001|Overall Study|Lack of Improvement|0|||
126348044|NCT03621592|454568581|FG000|Overall Study|Preference to receive wound care closer to home|1|||
126348045|NCT03621592|454568582|FG001|Overall Study|Preference to receive wound care closer to home|0|||
126348046|NCT03621592|454568581|FG000|Overall Study|Lack of healing|0|||
126348047|NCT03621592|454568582|FG001|Overall Study|Lack of healing|2|||
126348048|NCT00724945|454568590|FG000|Period 1|non-compliance|1|||
126348049|NCT00724945|454568591|FG001|Period 1|non-compliance|0|||
126348050|NCT00724945|454568590|FG000|Period 1|Adverse Event|1|||
126348051|NCT00724945|454568591|FG001|Period 1|Adverse Event|1|||
126348052|NCT00724945|454568590|FG000|Period 1|Lost to Follow-up|1|||
126348053|NCT00724945|454568591|FG001|Period 1|Lost to Follow-up|0|||
126348054|NCT00724945|454568590|FG000|Period 2|lens comfort issue|3|||
126348055|NCT00724945|454568591|FG001|Period 2|lens comfort issue|0|||
126348056|NCT00724945|454568590|FG000|Period 2|lens physiology issue|1|||
126348057|NCT00724945|454568591|FG001|Period 2|lens physiology issue|0|||
126348058|NCT03069989|454568592|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
126348059|NCT03069989|454568593|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
126348060|NCT04817410|454570923|FG000|Overall Study|Withdrawal by Subject|5|||
126348061|NCT04817410|454570923|FG000|Overall Study|Physician Decision|3|||
126348062|NCT03595748|454570925|FG000|Overall Study|Death|11|||
126348063|NCT03595748|454570926|FG001|Overall Study|Death|12|||
126348064|NCT03595748|454570925|FG000|Overall Study|Withdrawal by Subject|28|||
126348065|NCT03595748|454570926|FG001|Overall Study|Withdrawal by Subject|29|||
126348066|NCT03595748|454570925|FG000|Overall Study|Protocol Violation|0|||
126348067|NCT03595748|454570926|FG001|Overall Study|Protocol Violation|1|||
126348068|NCT04809974|454570928|FG000|Lead-in Phase|Withdrawal by Subject|3|||
126348069|NCT04809974|454570929|FG001|Lead-in Phase|Withdrawal by Subject|0|||
126348070|NCT04809974|454570930|FG002|Lead-in Phase|Withdrawal by Subject|0|||
126348071|NCT04809974|454570928|FG000|Lead-in Phase|No longer eligible|11|||
126348072|NCT04809974|454570929|FG001|Lead-in Phase|No longer eligible|0|||
126348073|NCT04809974|454570930|FG002|Lead-in Phase|No longer eligible|0|||
126348074|NCT04809974|454570928|FG000|Randomized Phase|Lost to Follow-up|0|||
126348075|NCT04809974|454570929|FG001|Randomized Phase|Lost to Follow-up|1|||
126348076|NCT04809974|454570930|FG002|Randomized Phase|Lost to Follow-up|5|||
126348077|NCT04809974|454570928|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
126348078|NCT04809974|454570929|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
126369419|NCT02496000|454648254|FG002|Overall Study|Lost to Follow-up|1|||
126369420|NCT02496000|454648252|FG000|Overall Study|Protocol Violation|0|||
126369421|NCT02496000|454648253|FG001|Overall Study|Protocol Violation|0|||
126369422|NCT02496000|454648254|FG002|Overall Study|Protocol Violation|1|||
126369423|NCT02496000|454648252|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
126369424|NCT02496000|454648253|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
126369425|NCT02496000|454648254|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
126369426|NCT02496000|454648252|FG000|Overall Study|undetermined|0|||
126369427|NCT02496000|454648253|FG001|Overall Study|undetermined|1|||
126369428|NCT02496000|454648254|FG002|Overall Study|undetermined|0|||
126369429|NCT02255656|454648255|FG000|Overall Study|Adverse Event|11|||
126369430|NCT02255656|454648255|FG000|Overall Study|Poor compliance to protocol|3|||
126369431|NCT02255656|454648255|FG000|Overall Study|Lost to Follow-up|30|||
126369432|NCT02255656|454648255|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
126369433|NCT02255656|454648255|FG000|Overall Study|Other|126|||
126369434|NCT01877278|454648256|FG000|Overall Study|Lost to Follow-up|3|||
126369435|NCT01877278|454648257|FG001|Overall Study|Lost to Follow-up|3|||
126369436|NCT05318287|454648258|FG000|Overall Study|Lost to Follow-up|8|||
126369437|NCT05185453|454648259|FG000|Overall Study|Lost to Follow-up|13|||
126369438|NCT05185453|454648260|FG001|Overall Study|Lost to Follow-up|3|||
126369439|NCT02457793|454648267|FG000|Overall Study|Reason not specified|0|||
126369440|NCT02457793|454648268|FG001|Overall Study|Reason not specified|0|||
126369441|NCT02457793|454648269|FG002|Overall Study|Reason not specified|0|||
126369442|NCT02457793|454648270|FG003|Overall Study|Reason not specified|1|||
126369443|NCT02457793|454648271|FG004|Overall Study|Reason not specified|1|||
126369444|NCT02457793|454648272|FG005|Overall Study|Reason not specified|1|||
126369445|NCT02457793|454648267|FG000|Overall Study|Withdrawal by Subject|0|||
126369446|NCT02457793|454648268|FG001|Overall Study|Withdrawal by Subject|4|||
126369447|NCT02457793|454648269|FG002|Overall Study|Withdrawal by Subject|2|||
126369448|NCT02457793|454648270|FG003|Overall Study|Withdrawal by Subject|2|||
126369449|NCT02457793|454648271|FG004|Overall Study|Withdrawal by Subject|2|||
126369450|NCT02457793|454648272|FG005|Overall Study|Withdrawal by Subject|2|||
126369451|NCT02457793|454648267|FG000|Overall Study|Adverse Event|0|||
126369452|NCT02457793|454648268|FG001|Overall Study|Adverse Event|0|||
126369453|NCT02457793|454648269|FG002|Overall Study|Adverse Event|0|||
126369454|NCT02457793|454648270|FG003|Overall Study|Adverse Event|1|||
126369455|NCT02457793|454648271|FG004|Overall Study|Adverse Event|0|||
126369456|NCT02457793|454648272|FG005|Overall Study|Adverse Event|0|||
126369457|NCT02457793|454648267|FG000|Overall Study|Physician Decision|1|||
126369458|NCT02457793|454648268|FG001|Overall Study|Physician Decision|0|||
126369459|NCT02457793|454648269|FG002|Overall Study|Physician Decision|1|||
126369460|NCT02457793|454648270|FG003|Overall Study|Physician Decision|1|||
126369461|NCT02457793|454648271|FG004|Overall Study|Physician Decision|1|||
126369462|NCT02457793|454648272|FG005|Overall Study|Physician Decision|3|||
126369463|NCT00835172|454648279|FG000|Washout|Protocol Violation|0|||
126369464|NCT00835172|454648280|FG001|Washout|Protocol Violation|1|||
126369465|NCT04890509|454648281|FG000|Overall Study|Death|4|||
126369466|NCT04890509|454648282|FG001|Overall Study|Death|4|||
126369467|NCT03274466|454648283|FG000|Overall Study|Withdrawal by Subject|7|||
126369468|NCT03274466|454648284|FG001|Overall Study|Withdrawal by Subject|3|||
126369469|NCT03274466|454648283|FG000|Overall Study|Protocol Specified Withdrawal|5|||
126369470|NCT03274466|454648284|FG001|Overall Study|Protocol Specified Withdrawal|11|||
126369471|NCT03274466|454648283|FG000|Overall Study|Lost to Follow-up|5|||
126369472|NCT03274466|454648284|FG001|Overall Study|Lost to Follow-up|7|||
126369473|NCT03274466|454648283|FG000|Overall Study|Subject Non-compliance|0|||
126369474|NCT03274466|454648284|FG001|Overall Study|Subject Non-compliance|1|||
126369475|NCT03274466|454648283|FG000|Overall Study|Adverse Event|3|||
126369476|NCT03274466|454648284|FG001|Overall Study|Adverse Event|3|||
126369477|NCT03274466|454648283|FG000|Overall Study|Physician Decision|0|||
126369478|NCT03274466|454648284|FG001|Overall Study|Physician Decision|1|||
126369479|NCT03274466|454648283|FG000|Overall Study|Protocol Violation|3|||
126369480|NCT03274466|454648284|FG001|Overall Study|Protocol Violation|3|||
126369481|NCT02989857|454650560|FG000|Randomization Phase|Not Treated|3|||
126369482|NCT02989857|454650561|FG001|Randomization Phase|Not Treated|2|||
126369483|NCT02989857|454650562|FG002|Randomization Phase|Not Treated|0|||
126369484|NCT01168596|454650567|FG000|Overall Study|Withdrawal by Subject|3|||
126369485|NCT01168596|454650568|FG001|Overall Study|Withdrawal by Subject|1|||
126434348|NCT01972217|454889473|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
126434349|NCT01972217|454889474|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
126434350|NCT01972217|454889475|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
126434351|NCT01972217|454889476|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
126434352|NCT01972217|454889473|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
126434353|NCT01972217|454889474|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
126434354|NCT01972217|454889475|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
126434355|NCT01972217|454889476|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
126434356|NCT01972217|454889473|FG000|Part B Double-blind, Randomised Period|Death|0|||
126434357|NCT01972217|454889474|FG001|Part B Double-blind, Randomised Period|Death|0|||
126434358|NCT01972217|454889475|FG002|Part B Double-blind, Randomised Period|Death|43|||
126434359|NCT01972217|454889476|FG003|Part B Double-blind, Randomised Period|Death|44|||
126434360|NCT01972217|454889473|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
126434361|NCT01972217|454889474|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
126434362|NCT01972217|454889475|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
126434363|NCT01972217|454889476|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
126434364|NCT01972217|454889473|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
126434365|NCT01972217|454889474|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
126434366|NCT01972217|454889475|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
126434367|NCT01972217|454889476|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
126434368|NCT01972217|454889473|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
126434369|NCT01972217|454889474|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
126434370|NCT01972217|454889475|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
126434371|NCT01972217|454889476|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
126434372|NCT01972217|454889473|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
126434373|NCT01972217|454889474|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
126434374|NCT01972217|454889475|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
126434375|NCT01972217|454889476|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
126434376|NCT00804908|454889480|FG000|Overall Study|Other|115|||
126434377|NCT00804908|454889481|FG001|Overall Study|Other|116|||
126434378|NCT00804908|454889482|FG002|Overall Study|Other|114|||
126434379|NCT01280903|454889483|FG000|Overall Study|Lost to Follow-up|23|||
126434380|NCT01280903|454889484|FG001|Overall Study|Lost to Follow-up|16|||
126434381|NCT03453164|454889485|FG000|Overall Study|Lack of Efficacy|16|||
126434382|NCT03453164|454889485|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
126434383|NCT03822117|454889487|FG000|Overall Study|Death|18|||
126434384|NCT03822117|454889488|FG001|Overall Study|Death|17|||
126434385|NCT03822117|454889489|FG002|Overall Study|Death|12|||
126434386|NCT03822117|454889490|FG003|Overall Study|Death|4|||
126434387|NCT03822117|454889487|FG000|Overall Study|Lost to Follow-up|1|||
126434388|NCT03822117|454889488|FG001|Overall Study|Lost to Follow-up|2|||
126434389|NCT03822117|454889489|FG002|Overall Study|Lost to Follow-up|3|||
126434390|NCT03822117|454889490|FG003|Overall Study|Lost to Follow-up|0|||
126434391|NCT03822117|454889487|FG000|Overall Study|Study Terminated by Sponsor|25|||
126434392|NCT03822117|454889488|FG001|Overall Study|Study Terminated by Sponsor|11|||
126434393|NCT03822117|454889489|FG002|Overall Study|Study Terminated by Sponsor|6|||
126434394|NCT03822117|454889490|FG003|Overall Study|Study Terminated by Sponsor|0|||
126434395|NCT03822117|454889487|FG000|Overall Study|Withdrawal by Subject|4|||
126434396|NCT03822117|454889488|FG001|Overall Study|Withdrawal by Subject|0|||
126434397|NCT03822117|454889489|FG002|Overall Study|Withdrawal by Subject|3|||
126434398|NCT03822117|454889490|FG003|Overall Study|Withdrawal by Subject|0|||
126434399|NCT03822117|454889487|FG000|Overall Study|Disease Progression|1|||
126434400|NCT03822117|454889488|FG001|Overall Study|Disease Progression|2|||
126434401|NCT03822117|454889489|FG002|Overall Study|Disease Progression|1|||
126434402|NCT03822117|454889490|FG003|Overall Study|Disease Progression|0|||
126434403|NCT03822117|454889487|FG000|Overall Study|Never Returned to Hospital|0|||
126434404|NCT03822117|454889488|FG001|Overall Study|Never Returned to Hospital|0|||
126434405|NCT03822117|454889489|FG002|Overall Study|Never Returned to Hospital|1|||
126434406|NCT03822117|454889490|FG003|Overall Study|Never Returned to Hospital|0|||
126434407|NCT03459079|454889491|FG000|Overall Study|Adverse Event|4|||
126434408|NCT03459079|454889492|FG001|Overall Study|Adverse Event|2|||
126434409|NCT03459079|454889493|FG002|Overall Study|Adverse Event|0|||
126434410|NCT03459079|454889491|FG000|Overall Study|Withdrawal by Subject|2|||
126434411|NCT03459079|454889492|FG001|Overall Study|Withdrawal by Subject|2|||
126434412|NCT03459079|454889493|FG002|Overall Study|Withdrawal by Subject|0|||
126434413|NCT02766023|454889496|FG000|Overall Study|Lost to Follow-up|23|||
126434414|NCT02766023|454889497|FG001|Overall Study|Lost to Follow-up|11|||
126434415|NCT02766023|454889496|FG000|Overall Study|Pregnancy|1|||
126434416|NCT02766023|454889497|FG001|Overall Study|Pregnancy|0|||
126434417|NCT02766023|454889496|FG000|Overall Study|Adverse Event|1|||
126434418|NCT02766023|454889497|FG001|Overall Study|Adverse Event|0|||
126434419|NCT02766023|454889496|FG000|Overall Study|Withdrawal by Subject|4|||
126434420|NCT02766023|454889497|FG001|Overall Study|Withdrawal by Subject|5|||
126680781|NCT01192022|455788179|FG003|Overall Study|Lost to Follow-up|1|||
126680782|NCT01192022|455788180|FG004|Overall Study|Lost to Follow-up|0|||
126680783|NCT01192022|455788176|FG000|Overall Study|Adverse Event|1|||
126680784|NCT01192022|455788177|FG001|Overall Study|Adverse Event|0|||
126680785|NCT01192022|455788178|FG002|Overall Study|Adverse Event|0|||
126680786|NCT01192022|455788179|FG003|Overall Study|Adverse Event|0|||
126680787|NCT01192022|455788180|FG004|Overall Study|Adverse Event|0|||
126680788|NCT01192022|455788176|FG000|Overall Study|Fatal Adverse Event|4|||
126680789|NCT01192022|455788177|FG001|Overall Study|Fatal Adverse Event|6|||
126680790|NCT01192022|455788178|FG002|Overall Study|Fatal Adverse Event|0|||
126348079|NCT04809974|454570930|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
126348080|NCT04809974|454570928|FG000|Randomized Phase|Adverse Event|0|||
126348081|NCT04809974|454570929|FG001|Randomized Phase|Adverse Event|1|||
126348082|NCT04809974|454570930|FG002|Randomized Phase|Adverse Event|4|||
126348083|NCT04809974|454570928|FG000|Randomized Phase|Withdrawal by Subject|0|||
126348084|NCT04809974|454570929|FG001|Randomized Phase|Withdrawal by Subject|0|||
126348085|NCT04809974|454570930|FG002|Randomized Phase|Withdrawal by Subject|5|||
126348086|NCT05493111|454570932|FG000|Overall Study|Adverse Event|3|||
126348087|NCT05493111|454570933|FG001|Overall Study|Adverse Event|4|||
126348088|NCT05493111|454570932|FG000|Overall Study|Withdrawal of Consent|19|||
126348089|NCT05493111|454570933|FG001|Overall Study|Withdrawal of Consent|10|||
126348090|NCT05493111|454570932|FG000|Overall Study|Non-compliance|1|||
126348091|NCT05493111|454570933|FG001|Overall Study|Non-compliance|1|||
126348092|NCT05493111|454570932|FG000|Overall Study|Lost to Follow-up|8|||
126348093|NCT05493111|454570933|FG001|Overall Study|Lost to Follow-up|1|||
126348094|NCT05493111|454570932|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
126348095|NCT05493111|454570933|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
126348096|NCT05493111|454570932|FG000|Overall Study|Withdrawal by Subject|1|||
126348097|NCT05493111|454570933|FG001|Overall Study|Withdrawal by Subject|1|||
126348098|NCT06125964|454570934|FG000|Overall Study|Lost to Follow-up|0|||
126348099|NCT06125964|454570935|FG001|Overall Study|Lost to Follow-up|1|||
126348100|NCT06125964|454570936|FG002|Overall Study|Lost to Follow-up|0|||
126348101|NCT06125964|454570937|FG003|Overall Study|Lost to Follow-up|0|||
126348102|NCT02469233|454570938|FG000|Overall Study|Death|1|||
126348103|NCT02469233|454570939|FG001|Overall Study|Death|1|||
126348104|NCT02469233|454570938|FG000|Overall Study|Lost to post or 6 month follow up|7|||
126348105|NCT02469233|454570939|FG001|Overall Study|Lost to post or 6 month follow up|2|||
126348106|NCT01787838|454570940|FG000|Overall Study|refused|1413|||
126348107|NCT01431976|454570941|FG000|Overall Study|Adverse Event|6|||
126348108|NCT01431976|454570941|FG000|Overall Study|Lack of Efficacy|2|||
126348109|NCT01431976|454570941|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
126348110|NCT01431976|454570941|FG000|Overall Study|Physician Decision|1|||
126348111|NCT01431976|454570941|FG000|Overall Study|Withdrawal by Subject|1|||
126348112|NCT01136954|454570947|FG000|Overall Study|Adverse Event|3|||
126348113|NCT01136954|454570948|FG001|Overall Study|Adverse Event|2|||
126348114|NCT01136954|454570947|FG000|Overall Study|Withdrawal by Subject|6|||
126348115|NCT01136954|454570948|FG001|Overall Study|Withdrawal by Subject|2|||
126348116|NCT01136954|454570947|FG000|Overall Study|Lack of Efficacy|14|||
126348117|NCT01136954|454570948|FG001|Overall Study|Lack of Efficacy|13|||
126348118|NCT01136954|454570947|FG000|Overall Study|Physician Decision|0|||
126348119|NCT01136954|454570948|FG001|Overall Study|Physician Decision|1|||
126348120|NCT01136954|454570947|FG000|Overall Study|Other|1|||
126348121|NCT01136954|454570948|FG001|Overall Study|Other|3|||
126348122|NCT00782067|454570949|FG000|Overall Study|Adverse Event|35|||
126348123|NCT00782067|454570949|FG000|Overall Study|Subject withdrew consent|11|||
126348124|NCT00782067|454570949|FG000|Overall Study|Lost to Follow-up|2|||
126348125|NCT00782067|454570949|FG000|Overall Study|Administrative problems|14|||
126348126|NCT00782067|454570949|FG000|Overall Study|Death|9|||
126348127|NCT00782067|454570949|FG000|Overall Study|Disease progression|43|||
126348128|NCT00782067|454570949|FG000|Overall Study|Protocol deviation|2|||
126348129|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
126348130|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
126348131|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
126348132|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
126348133|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
126348134|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
126348135|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
126348136|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
126348137|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
126348138|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
126348139|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
126348140|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
126348141|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
126348142|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
126348143|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
126680791|NCT01192022|455788179|FG003|Overall Study|Fatal Adverse Event|0|||
126680792|NCT01192022|455788180|FG004|Overall Study|Fatal Adverse Event|1|||
126348144|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
126348145|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
126348146|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
126348147|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
126348148|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
126348149|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
126348150|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
126348151|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
126348152|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
126348153|NCT00620542|454570950|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
126348154|NCT00620542|454570951|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
126348155|NCT00620542|454570952|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
126348156|NCT00620542|454570953|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
126348157|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
126348158|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
126348159|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
126306104|NCT02553499|454408876|FG007|Overall Study|Withdrawal by Subject|1|||
126306105|NCT02553499|454408877|FG008|Overall Study|Withdrawal by Subject|1|||
126306106|NCT02553499|454408878|FG009|Overall Study|Withdrawal by Subject|0|||
126306107|NCT02553499|454408879|FG010|Overall Study|Withdrawal by Subject|1|||
126306108|NCT02553499|454408880|FG011|Overall Study|Withdrawal by Subject|0|||
126306109|NCT02553499|454408881|FG012|Overall Study|Withdrawal by Subject|0|||
126306110|NCT02553499|454408882|FG013|Overall Study|Withdrawal by Subject|0|||
126306111|NCT01323387|454408883|FG000|Overall Study|Withdrawal by Subject|41|||
126306112|NCT01323387|454408883|FG000|Overall Study|Radiographic Data Unavailable|1|||
126306113|NCT01323387|454408883|FG000|Overall Study|Revision|14|||
126306114|NCT01323387|454408883|FG000|Overall Study|Protocol Violation|12|||
126306115|NCT01323387|454408883|FG000|Overall Study|Randomized but Never Treated|16|||
126306116|NCT02073929|454408895|FG000|Overall Study|Lost to Follow-up|2|||
126306117|NCT02073929|454408896|FG001|Overall Study|Lost to Follow-up|1|||
126306118|NCT02073929|454408895|FG000|Overall Study|Adverse Event|2|||
126306119|NCT02073929|454408896|FG001|Overall Study|Adverse Event|1|||
126306120|NCT02073929|454408895|FG000|Overall Study|Withdrawal by Subject|0|||
126306121|NCT02073929|454408896|FG001|Overall Study|Withdrawal by Subject|1|||
126306122|NCT03319732|454408897|FG000|Overall Study|Adverse Event|40|||
126306123|NCT03319732|454408897|FG000|Overall Study|Withdrawal by Subject|50|||
126306124|NCT03319732|454408897|FG000|Overall Study|MS relapse|10|||
126306125|NCT03319732|454408897|FG000|Overall Study|reason not specified|5|||
126306126|NCT00430573|454408898|FG000|Overall Study|Withdrawal by Subject|5|||
126306127|NCT04463251|454408899|FG000|Overall Study|Death|1|||
126306128|NCT04463251|454408900|FG001|Overall Study|Death|0|||
126306129|NCT04463251|454408901|FG002|Overall Study|Death|1|||
126306130|NCT04463251|454408899|FG000|Overall Study|Adverse Event|0|||
126680793|NCT01192022|455788176|FG000|Overall Study|Physician withdrew-patient hardship|1|||
126680794|NCT01192022|455788177|FG001|Overall Study|Physician withdrew-patient hardship|0|||
126680795|NCT01192022|455788178|FG002|Overall Study|Physician withdrew-patient hardship|0|||
126680796|NCT01192022|455788179|FG003|Overall Study|Physician withdrew-patient hardship|0|||
126680797|NCT01192022|455788180|FG004|Overall Study|Physician withdrew-patient hardship|0|||
126680798|NCT01192022|455788176|FG000|Overall Study|Patient too sick from chemotherapy|0|||
126680799|NCT01192022|455788177|FG001|Overall Study|Patient too sick from chemotherapy|1|||
126680800|NCT01192022|455788178|FG002|Overall Study|Patient too sick from chemotherapy|0|||
126680801|NCT01192022|455788179|FG003|Overall Study|Patient too sick from chemotherapy|0|||
126680802|NCT01192022|455788180|FG004|Overall Study|Patient too sick from chemotherapy|0|||
126680803|NCT01192022|455788176|FG000|Overall Study|Patient needed surgery|0|||
126680804|NCT01192022|455788177|FG001|Overall Study|Patient needed surgery|1|||
126348160|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
126348161|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
126348162|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
126348163|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
126348164|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
126348165|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
126348166|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
126348167|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
126348168|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
126348169|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
126348170|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
126348171|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
126348172|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
126348173|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
126348174|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
126348175|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
126348176|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
126348177|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
126348178|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
126348179|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
126348180|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
126348181|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
126348182|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
126348183|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
126348184|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
126348185|NCT00620542|454570950|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
126348186|NCT00620542|454570951|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
126348187|NCT00620542|454570952|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
126348188|NCT00620542|454570953|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
126348189|NCT01970371|454570956|FG000|Overall Study|Death|8|||
126348190|NCT01970371|454570957|FG001|Overall Study|Death|13|||
126348191|NCT01970371|454570958|FG002|Overall Study|Death|12|||
126348192|NCT01970371|454570956|FG000|Overall Study|Lost to Follow-up|0|||
126348193|NCT01970371|454570957|FG001|Overall Study|Lost to Follow-up|0|||
126680805|NCT01192022|455788178|FG002|Overall Study|Patient needed surgery|0|||
126680806|NCT01192022|455788179|FG003|Overall Study|Patient needed surgery|0|||
126348194|NCT01970371|454570958|FG002|Overall Study|Lost to Follow-up|1|||
126348195|NCT02239328|454570959|FG000|Overall Study|Benign disease noted at time of surgery|6|||
126348196|NCT02239328|454570959|FG000|Overall Study|Equipment or website malfunction|2|||
126348197|NCT04727749|454570960|FG000|Overall Study|Lost to Follow-up|10|||
126348198|NCT04727749|454570961|FG001|Overall Study|Lost to Follow-up|3|||
126348199|NCT01481779|454570962|FG000|Overall Study|Adverse Event|23|||
126348200|NCT01481779|454570963|FG001|Overall Study|Adverse Event|5|||
126348201|NCT01481779|454570962|FG000|Overall Study|Lost to Follow-up|3|||
126348202|NCT01481779|454570963|FG001|Overall Study|Lost to Follow-up|2|||
126348203|NCT01481779|454570962|FG000|Overall Study|Protocol Violation|2|||
126348204|NCT01481779|454570963|FG001|Overall Study|Protocol Violation|3|||
126348205|NCT01481779|454570962|FG000|Overall Study|Withdrawal by Subject|26|||
126348206|NCT01481779|454570963|FG001|Overall Study|Withdrawal by Subject|13|||
126348207|NCT01481779|454570962|FG000|Overall Study|Physician Decision|13|||
126348208|NCT01481779|454570963|FG001|Overall Study|Physician Decision|4|||
126348209|NCT01481779|454570962|FG000|Overall Study|Sponsor Decision|3|||
126348210|NCT01481779|454570963|FG001|Overall Study|Sponsor Decision|1|||
126348211|NCT02378181|454570964|FG000|Overall Study|Lost to Follow-up|2|||
126348212|NCT02378181|454570965|FG001|Overall Study|Lost to Follow-up|5|||
126348213|NCT02378181|454570964|FG000|Overall Study|Withdrawal by Subject|1|||
126348214|NCT02378181|454570965|FG001|Overall Study|Withdrawal by Subject|1|||
126348215|NCT02378181|454570964|FG000|Overall Study|Incarcerated|0|||
126348216|NCT02378181|454570965|FG001|Overall Study|Incarcerated|1|||
126348217|NCT03517137|454570976|FG000|Overall Study|Lack of Efficacy|1|||
126348218|NCT03517137|454570976|FG000|Overall Study|Adverse Event|2|||
126348219|NCT03517137|454570976|FG000|Overall Study|Withdrawal by Subject|2|||
126348220|NCT03517137|454570976|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
126348221|NCT02313155|454570978|FG000|Overall Study|Lost to Follow-up|0|||
126348222|NCT02313155|454570979|FG001|Overall Study|Lost to Follow-up|1|||
126348223|NCT00689936|454570980|FG000|Active Treatment Phase|Adverse Event|68|||
126348224|NCT00689936|454570981|FG001|Active Treatment Phase|Adverse Event|71|||
126348225|NCT00689936|454570982|FG002|Active Treatment Phase|Adverse Event|76|||
126348226|NCT00689936|454570980|FG000|Active Treatment Phase|Disease Progression|273|||
126348227|NCT00689936|454570981|FG001|Active Treatment Phase|Disease Progression|362|||
126348228|NCT00689936|454570982|FG002|Active Treatment Phase|Disease Progression|339|||
126348229|NCT00689936|454570980|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
126348230|NCT00689936|454570981|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
126348231|NCT00689936|454570982|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
126348232|NCT00689936|454570980|FG000|Active Treatment Phase|Death|60|||
126348233|NCT00689936|454570981|FG001|Active Treatment Phase|Death|28|||
126348234|NCT00689936|454570982|FG002|Active Treatment Phase|Death|37|||
126348235|NCT00689936|454570980|FG000|Active Treatment Phase|Lost to Follow-up|0|||
126348236|NCT00689936|454570981|FG001|Active Treatment Phase|Lost to Follow-up|2|||
126348237|NCT00689936|454570982|FG002|Active Treatment Phase|Lost to Follow-up|2|||
126348238|NCT00689936|454570980|FG000|Active Treatment Phase|Protocol Violation|2|||
126348239|NCT00689936|454570981|FG001|Active Treatment Phase|Protocol Violation|2|||
126348240|NCT00689936|454570982|FG002|Active Treatment Phase|Protocol Violation|4|||
126348241|NCT00689936|454570980|FG000|Active Treatment Phase|Study Close Out|64|||
126348242|NCT00689936|454570981|FG001|Active Treatment Phase|Study Close Out|26|||
126348243|NCT00689936|454570982|FG002|Active Treatment Phase|Study Close Out|21|||
126348244|NCT00689936|454570980|FG000|Active Treatment Phase|Miscellaneous|52|||
126348245|NCT00689936|454570981|FG001|Active Treatment Phase|Miscellaneous|34|||
126348246|NCT00689936|454570982|FG002|Active Treatment Phase|Miscellaneous|47|||
126348247|NCT00689936|454570980|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
126348248|NCT00689936|454570981|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
126348249|NCT00689936|454570982|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
126348250|NCT01303419|454570985|FG000|Overall Study|Discontinuation of study|60|||
126348251|NCT01303419|454570985|FG000|Overall Study|Did not complete both imaging methods|5|||
126348252|NCT01303419|454570985|FG000|Overall Study|Did not meet all I/E after screening|31|||
126348253|NCT01995201|454570986|FG000|From Baseline Until Week 24|Adverse Event|4|||
126348254|NCT01995201|454570987|FG001|From Baseline Until Week 24|Adverse Event|15|||
126348255|NCT01995201|454570988|FG002|From Baseline Until Week 24|Adverse Event|0|||
126348256|NCT01995201|454570989|FG003|From Baseline Until Week 24|Adverse Event|0|||
126348257|NCT01995201|454570990|FG004|From Baseline Until Week 24|Adverse Event|0|||
126348258|NCT01995201|454570991|FG005|From Baseline Until Week 24|Adverse Event|0|||
126348259|NCT01995201|454570992|FG006|From Baseline Until Week 24|Adverse Event|0|||
126348260|NCT01995201|454570986|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
126348261|NCT01995201|454570987|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
126348262|NCT01995201|454570988|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
126348263|NCT01995201|454570989|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
126348264|NCT01995201|454570990|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
126348265|NCT01995201|454570991|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
126680807|NCT01192022|455788180|FG004|Overall Study|Patient needed surgery|0|||
126348266|NCT01995201|454570992|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
126348267|NCT01995201|454570986|FG000|From Baseline Until Week 24|Death|0|||
126348268|NCT01995201|454570987|FG001|From Baseline Until Week 24|Death|1|||
126348269|NCT01995201|454570988|FG002|From Baseline Until Week 24|Death|0|||
126348270|NCT01995201|454570989|FG003|From Baseline Until Week 24|Death|0|||
126348271|NCT01995201|454570990|FG004|From Baseline Until Week 24|Death|0|||
126348272|NCT01995201|454570991|FG005|From Baseline Until Week 24|Death|0|||
126348273|NCT01995201|454570992|FG006|From Baseline Until Week 24|Death|0|||
126348274|NCT01995201|454570986|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
126348275|NCT01995201|454570987|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
126348276|NCT01995201|454570988|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
126348277|NCT01995201|454570989|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
126348278|NCT01995201|454570990|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
126348279|NCT01995201|454570991|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
126348280|NCT01995201|454570992|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
126348281|NCT01995201|454570986|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
126348282|NCT01995201|454570987|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
126348283|NCT01995201|454570988|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
126348284|NCT01995201|454570989|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
126348285|NCT01995201|454570990|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
126348286|NCT01995201|454570991|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
126348287|NCT01995201|454570992|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
126348288|NCT01995201|454570986|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
126348289|NCT01995201|454570987|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
126348290|NCT01995201|454570988|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
126348291|NCT01995201|454570989|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
126348292|NCT01995201|454570990|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
126348293|NCT01995201|454570991|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
126348294|NCT01995201|454570992|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
126348295|NCT01995201|454570986|FG000|From Baseline Until Week 24|Physician Decision|0|||
126348296|NCT01995201|454570987|FG001|From Baseline Until Week 24|Physician Decision|2|||
126348297|NCT01995201|454570988|FG002|From Baseline Until Week 24|Physician Decision|0|||
126348298|NCT01995201|454570989|FG003|From Baseline Until Week 24|Physician Decision|0|||
126348299|NCT01995201|454570990|FG004|From Baseline Until Week 24|Physician Decision|0|||
126348300|NCT01995201|454570991|FG005|From Baseline Until Week 24|Physician Decision|0|||
126348301|NCT01995201|454570992|FG006|From Baseline Until Week 24|Physician Decision|0|||
126348302|NCT01995201|454570986|FG000|From Baseline Until Week 24|Protocol Violation|0|||
126348303|NCT01995201|454570987|FG001|From Baseline Until Week 24|Protocol Violation|9|||
126348304|NCT01995201|454570988|FG002|From Baseline Until Week 24|Protocol Violation|0|||
126348305|NCT01995201|454570989|FG003|From Baseline Until Week 24|Protocol Violation|0|||
126348306|NCT01995201|454570990|FG004|From Baseline Until Week 24|Protocol Violation|0|||
126348307|NCT01995201|454570991|FG005|From Baseline Until Week 24|Protocol Violation|0|||
126348308|NCT01995201|454570992|FG006|From Baseline Until Week 24|Protocol Violation|0|||
126348309|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Adverse Event|0|||
126348310|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Adverse Event|0|||
126348311|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Adverse Event|2|||
126348312|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Adverse Event|1|||
126348313|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Adverse Event|1|||
126348314|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Adverse Event|3|||
126348315|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Adverse Event|1|||
126348316|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Death|0|||
126348317|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Death|0|||
126348318|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Death|0|||
126348319|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Death|0|||
126348320|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Death|0|||
126348321|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Death|2|||
126348322|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Death|0|||
126348323|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
126348324|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
126348325|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
126348326|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
126348327|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
126348328|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
126348329|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
126348330|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
126348331|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
126348332|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
126348333|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
126348334|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
126348335|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
126348336|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
126348337|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
126434421|NCT02766023|454889496|FG000|Overall Study|Physician Decision|1|||
126434422|NCT02766023|454889497|FG001|Overall Study|Physician Decision|0|||
126434423|NCT02766023|454889496|FG000|Overall Study|Not Eligible at Enrollment|0|||
126434424|NCT02766023|454889497|FG001|Overall Study|Not Eligible at Enrollment|1|||
126434425|NCT06271993|454889498|FG000|Overall Study|Not reactive to histamine|5|||
126434426|NCT06271993|454889499|FG001|Overall Study|Not reactive to histamine|5|||
126434427|NCT06271993|454889500|FG002|Overall Study|Not reactive to histamine|5|||
126434428|NCT04026113|454889505|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
126434429|NCT04026113|454889506|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
126434430|NCT04026113|454889507|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
126434431|NCT04026113|454889508|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
126434432|NCT04026113|454889505|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
126434433|NCT04026113|454889506|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
126434434|NCT04026113|454889507|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
126434435|NCT04026113|454889508|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
126434436|NCT04026113|454889505|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
126434437|NCT04026113|454889506|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
126434438|NCT04026113|454889507|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
126434439|NCT04026113|454889508|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
126434440|NCT04026113|454889505|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
126434441|NCT04026113|454889506|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
126434442|NCT04026113|454889507|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
126434443|NCT04026113|454889508|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
126434444|NCT04026113|454889505|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
126434445|NCT04026113|454889506|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
126434446|NCT04026113|454889507|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
126434447|NCT04026113|454889508|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
126434448|NCT04026113|454889505|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
126434449|NCT04026113|454889506|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
126434450|NCT04026113|454889507|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
126434451|NCT04026113|454889508|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
126434452|NCT04026113|454889505|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
126434453|NCT04026113|454889506|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
126434454|NCT04026113|454889507|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
126434455|NCT04026113|454889508|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
126434456|NCT04026113|454889505|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
126434457|NCT04026113|454889506|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
126434458|NCT04026113|454889507|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
126434459|NCT04026113|454889508|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
126434460|NCT04026113|454889505|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
126434461|NCT04026113|454889506|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
126434462|NCT04026113|454889507|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
126434463|NCT04026113|454889508|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
126434464|NCT04613362|454889510|FG000|3 Month Follow-up|Lost to Follow-up|1|||
126434465|NCT04613362|454889511|FG001|3 Month Follow-up|Lost to Follow-up|2|||
126434466|NCT04613362|454889510|FG000|6 Month Follow-up|Lost to Follow-up|0|||
126434467|NCT04613362|454889511|FG001|6 Month Follow-up|Lost to Follow-up|1|||
126434468|NCT02218372|454889512|FG000|Overall Study|Adverse Event|1|||
126434469|NCT02218372|454889513|FG001|Overall Study|Adverse Event|1|||
126434470|NCT02218372|454889512|FG000|Overall Study|Miscellaneous|2|||
126434471|NCT02218372|454889513|FG001|Overall Study|Miscellaneous|1|||
126434472|NCT02218372|454889512|FG000|Overall Study|Randomized but did not receive treatment|2|||
126434473|NCT02218372|454889513|FG001|Overall Study|Randomized but did not receive treatment|3|||
126348338|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
126348339|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
126434474|NCT02218372|454889512|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126434475|NCT02218372|454889513|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126434476|NCT00671658|454889522|FG000|Overall Study|Physician Decision|5|||
126434477|NCT01921205|454889523|FG000|Overall Study|Adverse Event|12|||
126434478|NCT01921205|454889524|FG001|Overall Study|Adverse Event|7|||
126434479|NCT01921205|454889523|FG000|Overall Study|Lack of Efficacy|1|||
126434480|NCT01921205|454889524|FG001|Overall Study|Lack of Efficacy|0|||
126434481|NCT01921205|454889523|FG000|Overall Study|Protocol Violation|1|||
126434482|NCT01921205|454889524|FG001|Overall Study|Protocol Violation|3|||
126434483|NCT01921205|454889523|FG000|Overall Study|Lost to Follow-up|1|||
126434484|NCT01921205|454889524|FG001|Overall Study|Lost to Follow-up|1|||
126434485|NCT01921205|454889523|FG000|Overall Study|Withdrawal by Subject|6|||
126434486|NCT01921205|454889524|FG001|Overall Study|Withdrawal by Subject|5|||
126434487|NCT01921205|454889523|FG000|Overall Study|Use Of Prohibited Medication|0|||
126434488|NCT01921205|454889524|FG001|Overall Study|Use Of Prohibited Medication|1|||
126434489|NCT01921205|454889523|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
126434490|NCT01921205|454889524|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
126434491|NCT01921205|454889523|FG000|Overall Study|Non Compliance Of The Parent|0|||
126680808|NCT01192022|455788176|FG000|Overall Study|Parents did not allow all follow up|0|||
126680809|NCT01192022|455788177|FG001|Overall Study|Parents did not allow all follow up|0|||
126680810|NCT01192022|455788178|FG002|Overall Study|Parents did not allow all follow up|0|||
126680811|NCT01192022|455788179|FG003|Overall Study|Parents did not allow all follow up|1|||
126680812|NCT01192022|455788180|FG004|Overall Study|Parents did not allow all follow up|0|||
126680813|NCT04839978|455788181|FG000|Overall Study|Lost to Follow-up|135|||
126680814|NCT04839978|455788182|FG001|Overall Study|Lost to Follow-up|147|||
126680815|NCT03865706|455788183|FG000|Overall Study|Death|0|||
126680816|NCT03865706|455788184|FG001|Overall Study|Death|3|||
126680817|NCT03865706|455788185|FG002|Overall Study|Death|1|||
126680818|NCT00781456|455788186|FG000|Overall Study|Adverse Event|3|||
126434492|NCT01921205|454889524|FG001|Overall Study|Non Compliance Of The Parent|1|||
126434493|NCT01921205|454889523|FG000|Overall Study|Non Compliance Of Child|0|||
126434494|NCT01921205|454889524|FG001|Overall Study|Non Compliance Of Child|1|||
126434495|NCT00456846|454889526|FG000|Overall Study|Adverse Event|2|||
126434496|NCT00456846|454889527|FG001|Overall Study|Adverse Event|15|||
126434497|NCT00456846|454889526|FG000|Overall Study|Physician Decision|11|||
126434498|NCT00456846|454889527|FG001|Overall Study|Physician Decision|6|||
126434499|NCT00456846|454889526|FG000|Overall Study|Protocol Deviation|2|||
126434500|NCT00456846|454889527|FG001|Overall Study|Protocol Deviation|0|||
126434501|NCT00456846|454889526|FG000|Overall Study|Participant Discretion|1|||
126434502|NCT00456846|454889527|FG001|Overall Study|Participant Discretion|5|||
126434503|NCT00456846|454889526|FG000|Overall Study|Other|0|||
126434504|NCT00456846|454889527|FG001|Overall Study|Other|2|||
126680819|NCT00781456|455788187|FG001|Overall Study|Adverse Event|3|||
126680820|NCT00781456|455788186|FG000|Overall Study|Withdrawal by Subject|3|||
126680821|NCT00781456|455788187|FG001|Overall Study|Withdrawal by Subject|5|||
126680822|NCT00781456|455788186|FG000|Overall Study|Protocol Violation|4|||
126680823|NCT00781456|455788187|FG001|Overall Study|Protocol Violation|1|||
126680824|NCT00781456|455788186|FG000|Overall Study|Noncompliance With Protocol|1|||
126680825|NCT00781456|455788187|FG001|Overall Study|Noncompliance With Protocol|1|||
126680826|NCT00781456|455788186|FG000|Overall Study|Lost to Follow-up|10|||
126680827|NCT00781456|455788187|FG001|Overall Study|Lost to Follow-up|5|||
126680828|NCT00781456|455788186|FG000|Overall Study|Other Reason, Unknown|0|||
126680829|NCT00781456|455788187|FG001|Overall Study|Other Reason, Unknown|1|||
126680830|NCT01594853|455788188|FG000|Overall Study|Withdrawal by Subject|1|||
126680831|NCT01594853|455788189|FG001|Overall Study|Withdrawal by Subject|1|||
126680832|NCT01594853|455788188|FG000|Overall Study|Lost to Follow-up|1|||
126680833|NCT01594853|455788189|FG001|Overall Study|Lost to Follow-up|1|||
126680834|NCT01594853|455788188|FG000|Overall Study|noncompliance with exercise|0|||
126680835|NCT01594853|455788189|FG001|Overall Study|noncompliance with exercise|1|||
126680836|NCT04677712|455788192|FG000|Overall Study|Lost to Follow-up|0|||
126680837|NCT04677712|455788193|FG001|Overall Study|Lost to Follow-up|1|||
126680838|NCT04677712|455788194|FG002|Overall Study|Lost to Follow-up|0|||
126680839|NCT04677712|455788195|FG003|Overall Study|Lost to Follow-up|0|||
126680840|NCT04677712|455788196|FG004|Overall Study|Lost to Follow-up|0|||
126680841|NCT04677712|455788197|FG005|Overall Study|Lost to Follow-up|0|||
126680842|NCT00711100|455788198|FG000|Overall Study|Lack of Efficacy|5|||
126680843|NCT00711100|455788198|FG000|Overall Study|Withdrawal by Subject|8|||
126434505|NCT03379818|454889528|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
126434506|NCT03379818|454889529|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
126434507|NCT03379818|454889528|FG000|Overall Study|Withdrawal by Subject|2|||
126434508|NCT03379818|454889529|FG001|Overall Study|Withdrawal by Subject|3|||
126434509|NCT03379818|454889528|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
126434510|NCT03379818|454889529|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
126434511|NCT03125395|454889531|FG000|Overall Study|Adverse Event|2|||
126434512|NCT03125395|454889531|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
126434513|NCT03125395|454889531|FG000|Overall Study|Physician Decision|2|||
126434514|NCT03125395|454889531|FG000|Overall Study|Commercial drug is available|5|||
126434515|NCT04030143|454889532|FG000|Overall Study|Adverse Event|5|||
126434516|NCT04030143|454889533|FG001|Overall Study|Adverse Event|10|||
126434517|NCT04030143|454889532|FG000|Overall Study|Lost to Follow-up|3|||
126434518|NCT04030143|454889533|FG001|Overall Study|Lost to Follow-up|7|||
126434519|NCT04030143|454889532|FG000|Overall Study|Protocol Deviation|2|||
126434520|NCT04030143|454889533|FG001|Overall Study|Protocol Deviation|2|||
126434521|NCT04030143|454889532|FG000|Overall Study|Withdrawal by Subject|16|||
126434522|NCT04030143|454889533|FG001|Overall Study|Withdrawal by Subject|18|||
126680844|NCT00783094|455788199|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
126434523|NCT04030143|454889532|FG000|Overall Study|Physician Decision|1|||
126348340|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
126348341|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
126348342|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
126348343|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
126348344|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Physician Decision|0|||
126348345|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Physician Decision|0|||
126348346|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Physician Decision|0|||
126348347|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Physician Decision|0|||
126348348|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Physician Decision|1|||
126348349|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Physician Decision|0|||
126758669|NCT00134563|456066673|FG000|Overall Study|Reason other than above|0|||
126434524|NCT04030143|454889533|FG001|Overall Study|Physician Decision|1|||
126434525|NCT04030143|454889532|FG000|Overall Study|Due to Covid-19|2|||
126434526|NCT04030143|454889533|FG001|Overall Study|Due to Covid-19|3|||
126434527|NCT04030143|454889532|FG000|Overall Study|Not Due to Covid-19|1|||
126434528|NCT04030143|454889533|FG001|Overall Study|Not Due to Covid-19|1|||
126434529|NCT00412984|454889534|FG000|Overall Study|Death|331|||
126434530|NCT00412984|454889535|FG001|Overall Study|Death|349|||
126434531|NCT00412984|454889534|FG000|Overall Study|Adverse Event|679|||
126434532|NCT00412984|454889535|FG001|Overall Study|Adverse Event|738|||
126434533|NCT00412984|454889534|FG000|Overall Study|Withdrawal by Subject|921|||
126434534|NCT00412984|454889535|FG001|Overall Study|Withdrawal by Subject|989|||
126434535|NCT00412984|454889534|FG000|Overall Study|Lost to Follow-up|51|||
126434536|NCT00412984|454889535|FG001|Overall Study|Lost to Follow-up|39|||
126434537|NCT00412984|454889534|FG000|Overall Study|Poor/Noncompliance|57|||
126680845|NCT00783094|455788200|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
126680846|NCT00783094|455788201|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
126680847|NCT00783094|455788199|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
126680848|NCT00783094|455788200|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
126680849|NCT00783094|455788201|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
126680850|NCT00783094|455788199|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
126680851|NCT00783094|455788200|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
126680852|NCT00783094|455788201|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
126680853|NCT00783094|455788199|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
126680854|NCT00783094|455788200|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
126680855|NCT00783094|455788201|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
126680856|NCT00783094|455788199|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
126680857|NCT00783094|455788200|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
126680858|NCT00783094|455788201|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
126680859|NCT00783094|455788199|FG000|Open-Label Extension Period|Adverse Event|12|||
126680860|NCT00783094|455788200|FG001|Open-Label Extension Period|Adverse Event|7|||
126680861|NCT00783094|455788201|FG002|Open-Label Extension Period|Adverse Event|16|||
126680862|NCT00783094|455788199|FG000|Open-Label Extension Period|Death|0|||
126680863|NCT00783094|455788200|FG001|Open-Label Extension Period|Death|0|||
126680864|NCT00783094|455788201|FG002|Open-Label Extension Period|Death|1|||
126680865|NCT00783094|455788199|FG000|Open-Label Extension Period|Protocol Violation|4|||
126680866|NCT00783094|455788200|FG001|Open-Label Extension Period|Protocol Violation|5|||
126680867|NCT00783094|455788201|FG002|Open-Label Extension Period|Protocol Violation|7|||
126680868|NCT00783094|455788199|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
126680869|NCT00783094|455788200|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
126680870|NCT00783094|455788201|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
126680871|NCT00783094|455788199|FG000|Open-Label Extension Period|Physician Decision|4|||
126680872|NCT00783094|455788200|FG001|Open-Label Extension Period|Physician Decision|2|||
126680873|NCT00783094|455788201|FG002|Open-Label Extension Period|Physician Decision|3|||
126680874|NCT00783094|455788199|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
126680875|NCT00783094|455788200|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
126680876|NCT00783094|455788201|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
126680877|NCT02513329|455788202|FG000|Overall Study|Lost to Follow-up|5|||
126680878|NCT02513329|455788203|FG001|Overall Study|Lost to Follow-up|2|||
126434538|NCT00412984|454889535|FG001|Overall Study|Poor/Noncompliance|77|||
126434539|NCT00412984|454889534|FG000|Overall Study|Pregnancy|1|||
126434540|NCT00412984|454889535|FG001|Overall Study|Pregnancy|0|||
126434541|NCT00412984|454889534|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
126434542|NCT00412984|454889535|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
126434543|NCT00412984|454889534|FG000|Overall Study|Administrative Reason by Sponsor|11|||
126434544|NCT00412984|454889535|FG001|Overall Study|Administrative Reason by Sponsor|8|||
126434545|NCT00412984|454889534|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
126434546|NCT00412984|454889535|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
126434547|NCT00412984|454889534|FG000|Overall Study|Other Reason|80|||
126434548|NCT00412984|454889535|FG001|Overall Study|Other Reason|92|||
126680879|NCT01294670|455788204|FG000|Overall Study|Not treated|1|||
126680880|NCT01294670|455788205|FG001|Overall Study|Not treated|0|||
126680881|NCT01294670|455788206|FG002|Overall Study|Not treated|0|||
126680882|NCT01294670|455788207|FG003|Overall Study|Not treated|0|||
126680883|NCT01294670|455788208|FG004|Overall Study|Not treated|0|||
126434549|NCT00412984|454889534|FG000|Overall Study|Not Reported|11|||
126434550|NCT00412984|454889535|FG001|Overall Study|Not Reported|12|||
126434551|NCT01499940|454889536|FG000|Overall Study|Study was withdrawn before completion.|9|||
126680884|NCT02083380|455788212|FG000|Overall Study|Lack of Efficacy|68|||
126680885|NCT02083380|455788213|FG001|Overall Study|Lack of Efficacy|79|||
126680886|NCT02083380|455788214|FG002|Overall Study|Lack of Efficacy|64|||
126680887|NCT02083380|455788212|FG000|Overall Study|Withdrawal by Subject|9|||
126680888|NCT02083380|455788213|FG001|Overall Study|Withdrawal by Subject|3|||
126348350|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Physician Decision|0|||
126348351|NCT01995201|454570986|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
126434552|NCT04218240|454889537|FG000|Overall Study|Withdrawal by Subject|6|||
126434553|NCT04218240|454889538|FG001|Overall Study|Withdrawal by Subject|0|||
126434554|NCT04218240|454889537|FG000|Overall Study|Lack of Efficacy|24|||
126434555|NCT04218240|454889538|FG001|Overall Study|Lack of Efficacy|19|||
126434556|NCT04218240|454889537|FG000|Overall Study|Physician Decision|0|||
126434557|NCT04218240|454889538|FG001|Overall Study|Physician Decision|1|||
126434558|NCT04218240|454889537|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
126434559|NCT04218240|454889538|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
126434560|NCT04914364|454889539|FG000|Overall Study|No longer eligible for study|1|||
126434561|NCT04914364|454889539|FG000|Overall Study|Lost to Follow-up|2|||
126434562|NCT04097678|454889540|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
126434563|NCT04097678|454889541|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
126434564|NCT03694678|454889542|FG000|Overall Study|Withdrawal by Subject|2|||
126434565|NCT03694678|454889543|FG001|Overall Study|Withdrawal by Subject|0|||
126434566|NCT03694678|454889542|FG000|Overall Study|Lost to Follow-up|2|||
126434567|NCT03694678|454889543|FG001|Overall Study|Lost to Follow-up|3|||
126434568|NCT01668784|454889544|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
126434569|NCT01668784|454889545|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
126434570|NCT01668784|454889544|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
126434571|NCT01668784|454889545|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
126434572|NCT01668784|454889544|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
126434573|NCT01668784|454889545|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
126434574|NCT01668784|454889544|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
126434575|NCT01668784|454889545|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
126434576|NCT01668784|454889544|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
126434577|NCT01668784|454889545|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
126434578|NCT01668784|454889544|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
126434579|NCT01668784|454889545|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
126434580|NCT01668784|454889544|FG000|Treatment Period|Disease Progression|316|||
126434581|NCT01668784|454889545|FG001|Treatment Period|Disease Progression|293|||
126434582|NCT01668784|454889544|FG000|Treatment Period|Study Drug Toxicity|46|||
126434583|NCT01668784|454889545|FG001|Treatment Period|Study Drug Toxicity|53|||
126434584|NCT01668784|454889544|FG000|Treatment Period|Death|1|||
126348352|NCT01995201|454570987|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
126348353|NCT01995201|454570988|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
126348354|NCT01995201|454570989|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
126348355|NCT01995201|454570990|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
126348356|NCT01995201|454570991|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
126348357|NCT01995201|454570992|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
126348358|NCT01136915|454570996|FG000|Overall Study|Lost to Follow-up|2|||
126348359|NCT01136915|454570997|FG001|Overall Study|Lost to Follow-up|0|||
126434585|NCT01668784|454889545|FG001|Treatment Period|Death|1|||
126434586|NCT01668784|454889544|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
126434587|NCT01668784|454889545|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
126348360|NCT01136915|454570996|FG000|Overall Study|Exclusion criterion met|0|||
126434588|NCT01668784|454889544|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
126434589|NCT01668784|454889545|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
126348361|NCT01136915|454570997|FG001|Overall Study|Exclusion criterion met|1|||
126348362|NCT05376358|454571000|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
126348363|NCT05376358|454571001|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
126348364|NCT05376358|454571000|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
126348365|NCT05376358|454571001|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
126348366|NCT05376358|454571000|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
126348367|NCT05376358|454571001|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
126348368|NCT05376358|454571000|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
126348369|NCT05376358|454571001|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
126348370|NCT05376358|454571000|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
126348371|NCT05376358|454571001|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
126348372|NCT05376358|454571000|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
126348373|NCT05376358|454571001|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
126348374|NCT02213926|454571002|FG000|Overall Study|Death|59|||
126348375|NCT02213926|454571002|FG000|Overall Study|Withdrawal by Subject|10|||
126348376|NCT02213926|454571002|FG000|Overall Study|study terminated by sponsor|51|||
126348377|NCT02213926|454571002|FG000|Overall Study|Lost to Follow-up|3|||
126348378|NCT02213926|454571002|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
126348379|NCT01044498|454571007|FG000|Overall Study|Withdrew consent|1|||
126348380|NCT01044498|454571008|FG001|Overall Study|Withdrew consent|1|||
126348381|NCT01044498|454571007|FG000|Overall Study|Adverse Event|1|||
126348382|NCT01044498|454571008|FG001|Overall Study|Adverse Event|1|||
126348383|NCT01044498|454571007|FG000|Overall Study|Other|1|||
126348384|NCT01044498|454571008|FG001|Overall Study|Other|0|||
126348385|NCT02327078|454571013|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
126348386|NCT02327078|454571014|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
126348387|NCT02327078|454571015|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
126348388|NCT02327078|454571016|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
126348389|NCT02327078|454571017|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
126348390|NCT02327078|454571018|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
126348391|NCT02327078|454571019|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
126348392|NCT02327078|454571020|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
126348393|NCT02327078|454571021|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
126348394|NCT02327078|454571013|FG000|Overall Study|Death|2|||
126348395|NCT02327078|454571014|FG001|Overall Study|Death|4|||
126348396|NCT02327078|454571015|FG002|Overall Study|Death|10|||
126348397|NCT02327078|454571016|FG003|Overall Study|Death|6|||
126348398|NCT02327078|454571017|FG004|Overall Study|Death|4|||
126348399|NCT02327078|454571018|FG005|Overall Study|Death|3|||
126348400|NCT02327078|454571019|FG006|Overall Study|Death|2|||
126348401|NCT02327078|454571020|FG007|Overall Study|Death|51|||
126348402|NCT02327078|454571021|FG008|Overall Study|Death|97|||
126348403|NCT02327078|454571013|FG000|Overall Study|Lost to Follow-up|0|||
126348404|NCT02327078|454571014|FG001|Overall Study|Lost to Follow-up|1|||
126348405|NCT02327078|454571015|FG002|Overall Study|Lost to Follow-up|1|||
126348406|NCT02327078|454571016|FG003|Overall Study|Lost to Follow-up|0|||
126348407|NCT02327078|454571017|FG004|Overall Study|Lost to Follow-up|0|||
126348408|NCT02327078|454571018|FG005|Overall Study|Lost to Follow-up|0|||
126348409|NCT02327078|454571019|FG006|Overall Study|Lost to Follow-up|0|||
126348410|NCT02327078|454571020|FG007|Overall Study|Lost to Follow-up|2|||
126348411|NCT02327078|454571021|FG008|Overall Study|Lost to Follow-up|5|||
126348412|NCT02327078|454571013|FG000|Overall Study|Site Terminated by Sponsor|1|||
126348413|NCT02327078|454571014|FG001|Overall Study|Site Terminated by Sponsor|0|||
126348414|NCT02327078|454571015|FG002|Overall Study|Site Terminated by Sponsor|1|||
126348415|NCT02327078|454571016|FG003|Overall Study|Site Terminated by Sponsor|4|||
126348416|NCT02327078|454571017|FG004|Overall Study|Site Terminated by Sponsor|0|||
126348417|NCT02327078|454571018|FG005|Overall Study|Site Terminated by Sponsor|0|||
126348418|NCT02327078|454571019|FG006|Overall Study|Site Terminated by Sponsor|0|||
126348419|NCT02327078|454571020|FG007|Overall Study|Site Terminated by Sponsor|11|||
126434590|NCT01668784|454889544|FG000|Treatment Period|Withdrawal by Subject|5|||
126434591|NCT01668784|454889545|FG001|Treatment Period|Withdrawal by Subject|3|||
126434592|NCT01668784|454889544|FG000|Treatment Period|Maximal Clinical Benefit|3|||
126348420|NCT02327078|454571021|FG008|Overall Study|Site Terminated by Sponsor|25|||
126348421|NCT02327078|454571013|FG000|Overall Study|Physician Decision|0|||
126348422|NCT02327078|454571014|FG001|Overall Study|Physician Decision|0|||
126348423|NCT02327078|454571015|FG002|Overall Study|Physician Decision|0|||
126348424|NCT02327078|454571016|FG003|Overall Study|Physician Decision|1|||
126348425|NCT02327078|454571017|FG004|Overall Study|Physician Decision|0|||
126348426|NCT02327078|454571018|FG005|Overall Study|Physician Decision|0|||
126348427|NCT02327078|454571019|FG006|Overall Study|Physician Decision|0|||
126348428|NCT02327078|454571020|FG007|Overall Study|Physician Decision|0|||
126348429|NCT02327078|454571021|FG008|Overall Study|Physician Decision|1|||
126348430|NCT02327078|454571013|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
126348431|NCT02327078|454571014|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
126348432|NCT02327078|454571015|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
126348433|NCT02327078|454571016|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
126348434|NCT02327078|454571017|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
126348435|NCT02327078|454571018|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
126348436|NCT02327078|454571019|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
126348437|NCT02327078|454571020|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
126348438|NCT02327078|454571021|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
126348439|NCT02327078|454571013|FG000|Overall Study|Reason not Specified|0|||
126348440|NCT02327078|454571014|FG001|Overall Study|Reason not Specified|0|||
126348441|NCT02327078|454571015|FG002|Overall Study|Reason not Specified|0|||
126348442|NCT02327078|454571016|FG003|Overall Study|Reason not Specified|0|||
126348443|NCT02327078|454571017|FG004|Overall Study|Reason not Specified|0|||
126348444|NCT02327078|454571018|FG005|Overall Study|Reason not Specified|0|||
126348445|NCT02327078|454571019|FG006|Overall Study|Reason not Specified|0|||
126348446|NCT02327078|454571020|FG007|Overall Study|Reason not Specified|5|||
126348447|NCT02327078|454571021|FG008|Overall Study|Reason not Specified|12|||
126348448|NCT05513950|454571022|FG000|Overall Study|Not treated due to technical reasons|0|||
126348449|NCT05513950|454571023|FG001|Overall Study|Not treated due to technical reasons|0|||
126348450|NCT05513950|454571024|FG002|Overall Study|Not treated due to technical reasons|1|||
126680889|NCT02083380|455788214|FG002|Overall Study|Withdrawal by Subject|7|||
126348451|NCT05513950|454571025|FG003|Overall Study|Not treated due to technical reasons|0|||
126348452|NCT06001866|454571026|FG000|Overall Study|Withdrawal by Subject|0|||
126348453|NCT06001866|454571027|FG001|Overall Study|Withdrawal by Subject|2|||
126348454|NCT06001866|454571026|FG000|Overall Study|Protocol Violation|0|||
126348455|NCT06001866|454571027|FG001|Overall Study|Protocol Violation|2|||
126348456|NCT02903914|454571028|FG000|Overall Study|Adverse Event|0|||
126348457|NCT02903914|454571029|FG001|Overall Study|Adverse Event|0|||
126348458|NCT02903914|454571030|FG002|Overall Study|Adverse Event|1|||
126348459|NCT02903914|454571031|FG003|Overall Study|Adverse Event|0|||
126348460|NCT02903914|454571032|FG004|Overall Study|Adverse Event|0|||
126348461|NCT02903914|454571033|FG005|Overall Study|Adverse Event|0|||
126348462|NCT02903914|454571034|FG006|Overall Study|Adverse Event|2|||
126348463|NCT02903914|454571035|FG007|Overall Study|Adverse Event|0|||
126348464|NCT02903914|454571028|FG000|Overall Study|Withdrawal by Subject|3|||
126348465|NCT02903914|454571029|FG001|Overall Study|Withdrawal by Subject|1|||
126348466|NCT02903914|454571030|FG002|Overall Study|Withdrawal by Subject|28|||
126348467|NCT02903914|454571031|FG003|Overall Study|Withdrawal by Subject|0|||
126348468|NCT02903914|454571032|FG004|Overall Study|Withdrawal by Subject|1|||
126348469|NCT02903914|454571033|FG005|Overall Study|Withdrawal by Subject|2|||
126348470|NCT02903914|454571034|FG006|Overall Study|Withdrawal by Subject|12|||
126348471|NCT02903914|454571035|FG007|Overall Study|Withdrawal by Subject|0|||
126348472|NCT02903914|454571028|FG000|Overall Study|Progressive Disease|1|||
126348473|NCT02903914|454571029|FG001|Overall Study|Progressive Disease|0|||
126348474|NCT02903914|454571030|FG002|Overall Study|Progressive Disease|4|||
126348475|NCT02903914|454571031|FG003|Overall Study|Progressive Disease|0|||
126348476|NCT02903914|454571032|FG004|Overall Study|Progressive Disease|0|||
126348477|NCT02903914|454571033|FG005|Overall Study|Progressive Disease|0|||
126348478|NCT02903914|454571034|FG006|Overall Study|Progressive Disease|2|||
126348479|NCT02903914|454571035|FG007|Overall Study|Progressive Disease|0|||
126348480|NCT02903914|454571028|FG000|Overall Study|Death|0|||
126348481|NCT02903914|454571029|FG001|Overall Study|Death|0|||
126348482|NCT02903914|454571030|FG002|Overall Study|Death|9|||
126348483|NCT02903914|454571031|FG003|Overall Study|Death|0|||
126348484|NCT02903914|454571032|FG004|Overall Study|Death|1|||
126348485|NCT02903914|454571033|FG005|Overall Study|Death|3|||
126348486|NCT02903914|454571034|FG006|Overall Study|Death|24|||
126348487|NCT02903914|454571035|FG007|Overall Study|Death|2|||
126348488|NCT02903914|454571028|FG000|Overall Study|Lost to Follow-up|0|||
126348489|NCT02903914|454571029|FG001|Overall Study|Lost to Follow-up|1|||
126348490|NCT02903914|454571030|FG002|Overall Study|Lost to Follow-up|0|||
126348491|NCT02903914|454571031|FG003|Overall Study|Lost to Follow-up|0|||
126348492|NCT02903914|454571032|FG004|Overall Study|Lost to Follow-up|2|||
126348493|NCT02903914|454571033|FG005|Overall Study|Lost to Follow-up|0|||
126348494|NCT02903914|454571034|FG006|Overall Study|Lost to Follow-up|1|||
126348495|NCT02903914|454571035|FG007|Overall Study|Lost to Follow-up|0|||
126348496|NCT02903914|454571028|FG000|Overall Study|Physician Decision|0|||
126348497|NCT02903914|454571029|FG001|Overall Study|Physician Decision|0|||
126348498|NCT02903914|454571030|FG002|Overall Study|Physician Decision|1|||
126348499|NCT02903914|454571031|FG003|Overall Study|Physician Decision|0|||
126348500|NCT02903914|454571032|FG004|Overall Study|Physician Decision|0|||
126348501|NCT02903914|454571033|FG005|Overall Study|Physician Decision|0|||
126348502|NCT02903914|454571034|FG006|Overall Study|Physician Decision|1|||
126348503|NCT02903914|454571035|FG007|Overall Study|Physician Decision|0|||
126348504|NCT02903914|454571028|FG000|Overall Study|Symptomatic Deterioration|0|||
126348505|NCT02903914|454571029|FG001|Overall Study|Symptomatic Deterioration|0|||
126348506|NCT02903914|454571030|FG002|Overall Study|Symptomatic Deterioration|1|||
126348507|NCT02903914|454571031|FG003|Overall Study|Symptomatic Deterioration|0|||
126348508|NCT02903914|454571032|FG004|Overall Study|Symptomatic Deterioration|0|||
126348509|NCT02903914|454571033|FG005|Overall Study|Symptomatic Deterioration|0|||
126348510|NCT02903914|454571034|FG006|Overall Study|Symptomatic Deterioration|0|||
126348511|NCT02903914|454571035|FG007|Overall Study|Symptomatic Deterioration|0|||
126348512|NCT02903914|454571028|FG000|Overall Study|New Cancer Therapy|2|||
126348513|NCT02903914|454571029|FG001|Overall Study|New Cancer Therapy|2|||
126348514|NCT02903914|454571030|FG002|Overall Study|New Cancer Therapy|21|||
126348515|NCT02903914|454571031|FG003|Overall Study|New Cancer Therapy|4|||
126348516|NCT02903914|454571032|FG004|Overall Study|New Cancer Therapy|3|||
126348517|NCT02903914|454571033|FG005|Overall Study|New Cancer Therapy|6|||
126348518|NCT02903914|454571034|FG006|Overall Study|New Cancer Therapy|56|||
126348519|NCT02903914|454571035|FG007|Overall Study|New Cancer Therapy|3|||
126348520|NCT02903914|454571028|FG000|Overall Study|Didn't Return to Site|1|||
126348521|NCT02903914|454571029|FG001|Overall Study|Didn't Return to Site|0|||
126348522|NCT02903914|454571030|FG002|Overall Study|Didn't Return to Site|1|||
126348523|NCT02903914|454571031|FG003|Overall Study|Didn't Return to Site|1|||
126348524|NCT02903914|454571032|FG004|Overall Study|Didn't Return to Site|0|||
126348525|NCT02903914|454571033|FG005|Overall Study|Didn't Return to Site|0|||
126348526|NCT02903914|454571034|FG006|Overall Study|Didn't Return to Site|2|||
126348527|NCT02903914|454571035|FG007|Overall Study|Didn't Return to Site|0|||
126348528|NCT02903914|454571028|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
126434593|NCT01668784|454889545|FG001|Treatment Period|Maximal Clinical Benefit|3|||
126434594|NCT01668784|454889544|FG000|Treatment Period|Other|2|||
126434595|NCT01668784|454889545|FG001|Treatment Period|Other|8|||
126434596|NCT01668784|454889544|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
126434597|NCT01668784|454889545|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
126434598|NCT03605667|454889553|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
126434599|NCT03605667|454889554|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
126434600|NCT03605667|454889553|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
126434601|NCT03605667|454889554|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
126434602|NCT03605667|454889553|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
126434603|NCT03605667|454889554|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
126680890|NCT02083380|455788212|FG000|Overall Study|Physician Decision|1|||
126680891|NCT02083380|455788213|FG001|Overall Study|Physician Decision|6|||
126680892|NCT02083380|455788214|FG002|Overall Study|Physician Decision|3|||
126680893|NCT02083380|455788212|FG000|Overall Study|Adverse Event|0|||
126434604|NCT03605667|454889553|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
126434605|NCT03605667|454889554|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
126434606|NCT03605667|454889553|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
126434607|NCT03605667|454889554|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
126434608|NCT03605667|454889553|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
126434609|NCT03605667|454889554|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
126434610|NCT03605667|454889553|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
126434611|NCT03605667|454889554|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
126434612|NCT03605667|454889553|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
126434613|NCT03605667|454889554|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
126434614|NCT03605667|454889553|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
126434615|NCT03605667|454889554|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
126434616|NCT03605667|454889553|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
126434617|NCT03605667|454889554|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
126434618|NCT03605667|454889553|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
126434619|NCT03605667|454889554|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
126434620|NCT03605667|454889553|FG000|OLE Phase (48 Weeks)|Other|6|||
126434621|NCT03605667|454889554|FG001|OLE Phase (48 Weeks)|Other|8|||
126680894|NCT02083380|455788213|FG001|Overall Study|Adverse Event|0|||
126680895|NCT02083380|455788214|FG002|Overall Study|Adverse Event|1|||
126680896|NCT02083380|455788212|FG000|Overall Study|Lost to Follow-up|5|||
126680897|NCT02083380|455788213|FG001|Overall Study|Lost to Follow-up|3|||
126680898|NCT02083380|455788214|FG002|Overall Study|Lost to Follow-up|3|||
126680899|NCT02083380|455788212|FG000|Overall Study|Other|8|||
126680900|NCT02083380|455788213|FG001|Overall Study|Other|4|||
126680901|NCT02083380|455788214|FG002|Overall Study|Other|6|||
126680902|NCT02412787|455788215|FG000|Overall Study|Withdrawal by Subject|9|||
126680903|NCT02412787|455788215|FG000|Overall Study|Participation Terminated by Investigator|1|||
126680904|NCT02412787|455788215|FG000|Overall Study|Site Terminated by Sponsor|21|||
126680905|NCT02412787|455788215|FG000|Overall Study|Technical Problems|1|||
126680906|NCT02412787|455788215|FG000|Overall Study|Reason Not Specified|1|||
126680907|NCT00001379|455788216|FG000|Initial Treatment|Disease progression|21|||
126680908|NCT00001379|455788217|FG001|Initial Treatment|Disease progression|3|||
126680909|NCT00001379|455788218|FG002|Initial Treatment|Disease progression|0|||
126680910|NCT00001379|455788219|FG003|Initial Treatment|Disease progression|0|||
126680911|NCT00001379|455788216|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
126680912|NCT00001379|455788217|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
126680913|NCT00001379|455788218|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
126680914|NCT00001379|455788219|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
126680915|NCT00001379|455788216|FG000|Initial Treatment|Received alternative treatment|2|||
126680916|NCT00001379|455788217|FG001|Initial Treatment|Received alternative treatment|1|||
126680917|NCT00001379|455788218|FG002|Initial Treatment|Received alternative treatment|0|||
126434622|NCT03605667|454889553|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
126434623|NCT03605667|454889554|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
126434624|NCT03605667|454889553|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
126434625|NCT03605667|454889554|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
126434626|NCT03605667|454889553|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
126434627|NCT03605667|454889554|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
126434628|NCT03605667|454889553|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
126434629|NCT03605667|454889554|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
126434630|NCT03605667|454889553|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
126434631|NCT03605667|454889554|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
126680918|NCT00001379|455788219|FG003|Initial Treatment|Received alternative treatment|0|||
126680919|NCT00001379|455788216|FG000|Initial Treatment|Refused further treatment|2|||
126680920|NCT00001379|455788217|FG001|Initial Treatment|Refused further treatment|0|||
126680921|NCT00001379|455788218|FG002|Initial Treatment|Refused further treatment|0|||
126434632|NCT03605667|454889553|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
126434633|NCT03605667|454889554|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
126434634|NCT03605667|454889553|FG000|OLE Phase (48 Weeks)|Death|0|||
126434635|NCT03605667|454889554|FG001|OLE Phase (48 Weeks)|Death|2|||
126434636|NCT03605667|454889553|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
126434637|NCT03605667|454889554|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
126434638|NCT02783690|454889562|FG000|Overall Study|Withdrawal by Subject|3|||
126434639|NCT02783690|454889563|FG001|Overall Study|Withdrawal by Subject|3|||
126434640|NCT03312231|454889567|FG000|Overall Study|Lost to Follow-up|2|||
126434641|NCT03312231|454889568|FG001|Overall Study|Lost to Follow-up|6|||
126434642|NCT03312231|454889569|FG002|Overall Study|Lost to Follow-up|1|||
126434643|NCT03312231|454889570|FG003|Overall Study|Lost to Follow-up|3|||
126434644|NCT03312231|454889571|FG004|Overall Study|Lost to Follow-up|1|||
126434645|NCT03312231|454889567|FG000|Overall Study|Withdrawal by Subject|0|||
126434646|NCT03312231|454889568|FG001|Overall Study|Withdrawal by Subject|3|||
126434647|NCT03312231|454889569|FG002|Overall Study|Withdrawal by Subject|1|||
126434648|NCT03312231|454889570|FG003|Overall Study|Withdrawal by Subject|0|||
126434649|NCT03312231|454889571|FG004|Overall Study|Withdrawal by Subject|0|||
126434650|NCT03312231|454889567|FG000|Overall Study|Death|0|||
126434651|NCT03312231|454889568|FG001|Overall Study|Death|1|||
126434652|NCT03312231|454889569|FG002|Overall Study|Death|1|||
126434653|NCT03312231|454889570|FG003|Overall Study|Death|0|||
126434654|NCT03312231|454889571|FG004|Overall Study|Death|0|||
126434655|NCT03312231|454889567|FG000|Overall Study|Study Vaccination not Received|1|||
126434656|NCT03312231|454889568|FG001|Overall Study|Study Vaccination not Received|1|||
126434657|NCT03312231|454889569|FG002|Overall Study|Study Vaccination not Received|1|||
126434658|NCT03312231|454889570|FG003|Overall Study|Study Vaccination not Received|0|||
126434659|NCT03312231|454889571|FG004|Overall Study|Study Vaccination not Received|0|||
126434660|NCT03157830|454889575|FG000|Overall Study|Lost to Follow-up|1|||
126306131|NCT04463251|454408900|FG001|Overall Study|Adverse Event|1|||
126434661|NCT03157830|454889575|FG000|Overall Study|Withdrawal by Subject|1|||
126306132|NCT04463251|454408901|FG002|Overall Study|Adverse Event|0|||
126306133|NCT04463251|454408899|FG000|Overall Study|Lost to Follow-up|0|||
126306134|NCT04463251|454408900|FG001|Overall Study|Lost to Follow-up|1|||
126306135|NCT04463251|454408901|FG002|Overall Study|Lost to Follow-up|0|||
126306136|NCT04463251|454408899|FG000|Overall Study|Withdrawal by Subject|0|||
126306137|NCT04463251|454408900|FG001|Overall Study|Withdrawal by Subject|2|||
126306138|NCT04463251|454408901|FG002|Overall Study|Withdrawal by Subject|2|||
126306139|NCT00072280|454408902|FG000|Treatment|Found ineligible|1|||
126306140|NCT00072280|454408903|FG001|Treatment|Found ineligible|2|||
126306141|NCT00072280|454408902|FG000|Follow-up|Early termination of study|2|||
126306142|NCT00072280|454408903|FG001|Follow-up|Early termination of study|2|||
126306143|NCT05020665|454408904|FG000|Overall Study|Study terminated by Sponsor|5|||
126348529|NCT02903914|454571029|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
126348530|NCT02903914|454571030|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
126348531|NCT02903914|454571031|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
126348532|NCT02903914|454571032|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
126348533|NCT02903914|454571033|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
126348534|NCT02903914|454571034|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
126348535|NCT02903914|454571035|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
126348536|NCT02903914|454571028|FG000|Overall Study|Follow-up Did Not Occur|0|||
126348537|NCT02903914|454571029|FG001|Overall Study|Follow-up Did Not Occur|1|||
126348538|NCT02903914|454571030|FG002|Overall Study|Follow-up Did Not Occur|1|||
126348539|NCT02903914|454571031|FG003|Overall Study|Follow-up Did Not Occur|0|||
126348540|NCT02903914|454571032|FG004|Overall Study|Follow-up Did Not Occur|2|||
126348541|NCT02903914|454571033|FG005|Overall Study|Follow-up Did Not Occur|0|||
126348542|NCT02903914|454571034|FG006|Overall Study|Follow-up Did Not Occur|8|||
126348543|NCT02903914|454571035|FG007|Overall Study|Follow-up Did Not Occur|0|||
126348544|NCT02903914|454571028|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
126348545|NCT02903914|454571029|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
126348546|NCT02903914|454571030|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
126348547|NCT02903914|454571031|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
126348548|NCT02903914|454571032|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
126348549|NCT02903914|454571033|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
126348550|NCT02903914|454571034|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
126348551|NCT02903914|454571035|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
126348552|NCT02903914|454571028|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
126348553|NCT02903914|454571029|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
126348554|NCT02903914|454571030|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
126348555|NCT02903914|454571031|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
126348556|NCT02903914|454571032|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
126348557|NCT02903914|454571033|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
126348558|NCT02903914|454571034|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
126348559|NCT02903914|454571035|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
126348560|NCT02903914|454571028|FG000|Overall Study|Clinical Disease Progression|0|||
126348561|NCT02903914|454571029|FG001|Overall Study|Clinical Disease Progression|0|||
126348562|NCT02903914|454571030|FG002|Overall Study|Clinical Disease Progression|2|||
126348563|NCT02903914|454571031|FG003|Overall Study|Clinical Disease Progression|0|||
126348564|NCT02903914|454571032|FG004|Overall Study|Clinical Disease Progression|0|||
126348565|NCT02903914|454571033|FG005|Overall Study|Clinical Disease Progression|0|||
126348566|NCT02903914|454571034|FG006|Overall Study|Clinical Disease Progression|0|||
126348567|NCT02903914|454571035|FG007|Overall Study|Clinical Disease Progression|0|||
126348568|NCT02903914|454571028|FG000|Overall Study|Completed Follow-up Period|0|||
126348569|NCT02903914|454571029|FG001|Overall Study|Completed Follow-up Period|0|||
126348570|NCT02903914|454571030|FG002|Overall Study|Completed Follow-up Period|6|||
126348571|NCT02903914|454571031|FG003|Overall Study|Completed Follow-up Period|2|||
126348572|NCT02903914|454571032|FG004|Overall Study|Completed Follow-up Period|1|||
126348573|NCT02903914|454571033|FG005|Overall Study|Completed Follow-up Period|0|||
126348574|NCT02903914|454571034|FG006|Overall Study|Completed Follow-up Period|9|||
126348575|NCT02903914|454571035|FG007|Overall Study|Completed Follow-up Period|1|||
126348576|NCT02903914|454571028|FG000|Overall Study|Taken off Treatment per Protocol|0|||
126348577|NCT02903914|454571029|FG001|Overall Study|Taken off Treatment per Protocol|0|||
126348578|NCT02903914|454571030|FG002|Overall Study|Taken off Treatment per Protocol|0|||
126348579|NCT02903914|454571031|FG003|Overall Study|Taken off Treatment per Protocol|0|||
126348580|NCT02903914|454571032|FG004|Overall Study|Taken off Treatment per Protocol|0|||
126348581|NCT02903914|454571033|FG005|Overall Study|Taken off Treatment per Protocol|1|||
126348582|NCT02903914|454571034|FG006|Overall Study|Taken off Treatment per Protocol|0|||
126348583|NCT02903914|454571035|FG007|Overall Study|Taken off Treatment per Protocol|0|||
126348584|NCT02903914|454571028|FG000|Overall Study|Refused Further Treatment/Contact|0|||
126348585|NCT02903914|454571029|FG001|Overall Study|Refused Further Treatment/Contact|0|||
126348586|NCT02903914|454571030|FG002|Overall Study|Refused Further Treatment/Contact|0|||
126348587|NCT02903914|454571031|FG003|Overall Study|Refused Further Treatment/Contact|0|||
126348588|NCT02903914|454571032|FG004|Overall Study|Refused Further Treatment/Contact|0|||
126348589|NCT02903914|454571033|FG005|Overall Study|Refused Further Treatment/Contact|0|||
126434662|NCT00400179|454889578|FG000|Overall Study|Adverse Event|2|||
126434663|NCT00400179|454889579|FG001|Overall Study|Adverse Event|2|||
126434664|NCT00400179|454889578|FG000|Overall Study|Death|1|||
126434665|NCT00400179|454889579|FG001|Overall Study|Death|2|||
126434666|NCT00400179|454889578|FG000|Overall Study|Withdrew Consent|1|||
126434667|NCT00400179|454889579|FG001|Overall Study|Withdrew Consent|5|||
126434668|NCT00400179|454889578|FG000|Overall Study|Disease progression|1|||
126434669|NCT00400179|454889579|FG001|Overall Study|Disease progression|1|||
126434670|NCT00400179|454889578|FG000|Overall Study|Intercurrent illness|0|||
126434671|NCT00400179|454889579|FG001|Overall Study|Intercurrent illness|1|||
126434672|NCT00400179|454889578|FG000|Overall Study|Investigator judgment|0|||
126434673|NCT00400179|454889579|FG001|Overall Study|Investigator judgment|1|||
126434674|NCT00400179|454889578|FG000|Overall Study|Randomization error/patient ineligible|1|||
126434675|NCT00400179|454889579|FG001|Overall Study|Randomization error/patient ineligible|6|||
126434676|NCT05138653|454889580|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
126434677|NCT05138653|454889581|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434678|NCT05138653|454889582|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434679|NCT05138653|454889583|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434680|NCT05138653|454889584|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434681|NCT05138653|454889585|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434682|NCT05138653|454889586|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434683|NCT05138653|454889587|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434684|NCT05138653|454889588|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434685|NCT05138653|454889589|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434686|NCT05138653|454889590|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434687|NCT05138653|454889591|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434688|NCT05138653|454889592|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434689|NCT05138653|454889593|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434690|NCT05138653|454889594|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434691|NCT05138653|454889595|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
126434692|NCT05138653|454889580|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434693|NCT05138653|454889581|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
126434694|NCT05138653|454889582|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434695|NCT05138653|454889583|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434696|NCT05138653|454889584|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434697|NCT05138653|454889585|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434698|NCT05138653|454889586|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434699|NCT05138653|454889587|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434700|NCT05138653|454889588|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
126434701|NCT05138653|454889589|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434702|NCT05138653|454889590|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434703|NCT05138653|454889591|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434704|NCT05138653|454889592|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434705|NCT05138653|454889593|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434706|NCT05138653|454889594|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434707|NCT05138653|454889595|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
126434708|NCT05138653|454889580|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434709|NCT05138653|454889581|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
126434710|NCT05138653|454889582|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434711|NCT05138653|454889583|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434712|NCT05138653|454889584|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
126434713|NCT05138653|454889585|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434714|NCT05138653|454889586|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434715|NCT05138653|454889587|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434716|NCT05138653|454889588|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434717|NCT05138653|454889589|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434718|NCT05138653|454889590|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434719|NCT05138653|454889591|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434720|NCT05138653|454889592|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434721|NCT05138653|454889593|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434722|NCT05138653|454889594|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434723|NCT05138653|454889595|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
126434724|NCT05138653|454889580|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434725|NCT05138653|454889581|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434726|NCT05138653|454889582|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434727|NCT05138653|454889583|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126348590|NCT02903914|454571034|FG006|Overall Study|Refused Further Treatment/Contact|1|||
126348591|NCT02903914|454571035|FG007|Overall Study|Refused Further Treatment/Contact|0|||
126348592|NCT02903914|454571028|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348593|NCT02903914|454571029|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348594|NCT02903914|454571030|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348595|NCT02903914|454571031|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348596|NCT02903914|454571032|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348597|NCT02903914|454571033|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348598|NCT02903914|454571034|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
126348599|NCT02903914|454571035|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
126348600|NCT04725188|454571038|FG000|Overall Study|Death|72|||
126348601|NCT04725188|454571039|FG001|Overall Study|Death|69|||
126348602|NCT04725188|454571040|FG002|Overall Study|Death|76|||
126348603|NCT04725188|454571038|FG000|Overall Study|Lost to Follow-up|1|||
126348604|NCT04725188|454571039|FG001|Overall Study|Lost to Follow-up|0|||
126348605|NCT04725188|454571040|FG002|Overall Study|Lost to Follow-up|1|||
126348606|NCT04725188|454571038|FG000|Overall Study|Withdrawal by Subject|2|||
126434728|NCT05138653|454889584|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434729|NCT05138653|454889585|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434730|NCT05138653|454889586|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
126434731|NCT05138653|454889587|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126348607|NCT04725188|454571039|FG001|Overall Study|Withdrawal by Subject|2|||
126348608|NCT04725188|454571040|FG002|Overall Study|Withdrawal by Subject|1|||
126348609|NCT04725188|454571038|FG000|Overall Study|Sponsor Decision|12|||
126348610|NCT04725188|454571039|FG001|Overall Study|Sponsor Decision|12|||
126348611|NCT04725188|454571040|FG002|Overall Study|Sponsor Decision|7|||
126348612|NCT03765073|454571041|FG000|Stage 1|Lost to Follow-up|1|||
126348613|NCT03765073|454571042|FG001|Stage 1|Lost to Follow-up|0|||
126348614|NCT03765073|454571043|FG002|Stage 1|Lost to Follow-up|0|||
126348615|NCT03765073|454571044|FG003|Stage 1|Lost to Follow-up|0|||
126348616|NCT03765073|454571045|FG004|Stage 1|Lost to Follow-up|0|||
126348617|NCT03765073|454571046|FG005|Stage 1|Lost to Follow-up|0|||
126348618|NCT03765073|454571047|FG006|Stage 1|Lost to Follow-up|0|||
126348619|NCT03765073|454571048|FG007|Stage 1|Lost to Follow-up|0|||
126348620|NCT03765073|454571049|FG008|Stage 1|Lost to Follow-up|0|||
126348621|NCT03765073|454571050|FG009|Stage 1|Lost to Follow-up|0|||
126348622|NCT03765073|454571051|FG010|Stage 1|Lost to Follow-up|0|||
126348623|NCT03765073|454571052|FG011|Stage 1|Lost to Follow-up|0|||
126348624|NCT03765073|454571053|FG012|Stage 1|Lost to Follow-up|0|||
126348625|NCT03765073|454571054|FG013|Stage 1|Lost to Follow-up|0|||
126348626|NCT03765073|454571055|FG014|Stage 1|Lost to Follow-up|0|||
126680922|NCT00001379|455788219|FG003|Initial Treatment|Refused further treatment|0|||
126348627|NCT03765073|454571056|FG015|Stage 1|Lost to Follow-up|0|||
126348628|NCT03765073|454571057|FG016|Stage 1|Lost to Follow-up|0|||
126348629|NCT03765073|454571058|FG017|Stage 1|Lost to Follow-up|0|||
126348630|NCT03765073|454571059|FG018|Stage 1|Lost to Follow-up|0|||
126680923|NCT00001379|455788216|FG000|Initial Treatment|Did not receive protocol treatment|0|||
126680924|NCT00001379|455788217|FG001|Initial Treatment|Did not receive protocol treatment|0|||
126680925|NCT00001379|455788218|FG002|Initial Treatment|Did not receive protocol treatment|5|||
126680926|NCT00001379|455788219|FG003|Initial Treatment|Did not receive protocol treatment|0|||
126680927|NCT00001379|455788216|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
126680928|NCT00001379|455788217|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
126680929|NCT00001379|455788218|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
126680930|NCT00001379|455788219|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
126680931|NCT00001379|455788216|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
126680932|NCT00001379|455788217|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
126680933|NCT00001379|455788218|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
126680934|NCT00001379|455788219|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
126680935|NCT00001379|455788216|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
126680936|NCT00001379|455788217|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
126680937|NCT00001379|455788218|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
126680938|NCT00001379|455788219|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
126680939|NCT00001379|455788216|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
126680940|NCT00001379|455788217|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
126680941|NCT00001379|455788218|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
126680942|NCT00001379|455788219|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
126680943|NCT00001379|455788216|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
126680944|NCT00001379|455788217|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
126680945|NCT00001379|455788218|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
126680946|NCT00001379|455788219|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
126680947|NCT02311153|455788222|FG000|Overall Study|Lost to Follow-up|5|||
126680948|NCT02311153|455788223|FG001|Overall Study|Lost to Follow-up|7|||
126680949|NCT00876187|455788224|FG000|Overall Study|Adverse Event|14|||
126680950|NCT00876187|455788225|FG001|Overall Study|Adverse Event|12|||
126680951|NCT00876187|455788226|FG002|Overall Study|Adverse Event|19|||
126680952|NCT00876187|455788227|FG003|Overall Study|Adverse Event|29|||
126680953|NCT00876187|455788228|FG004|Overall Study|Adverse Event|10|||
126680954|NCT00876187|455788224|FG000|Overall Study|Lack of Efficacy|59|||
126348631|NCT03765073|454571060|FG019|Stage 1|Lost to Follow-up|0|||
126348632|NCT03765073|454571061|FG020|Stage 1|Lost to Follow-up|0|||
126348633|NCT03765073|454571041|FG000|Stage 1|Withdrawal by participant|0|||
126348634|NCT03765073|454571042|FG001|Stage 1|Withdrawal by participant|1|||
126348635|NCT03765073|454571043|FG002|Stage 1|Withdrawal by participant|0|||
126348636|NCT03765073|454571044|FG003|Stage 1|Withdrawal by participant|0|||
126348637|NCT03765073|454571045|FG004|Stage 1|Withdrawal by participant|0|||
126348638|NCT03765073|454571046|FG005|Stage 1|Withdrawal by participant|0|||
126348639|NCT03765073|454571047|FG006|Stage 1|Withdrawal by participant|0|||
126348640|NCT03765073|454571048|FG007|Stage 1|Withdrawal by participant|0|||
126348641|NCT03765073|454571049|FG008|Stage 1|Withdrawal by participant|0|||
126348642|NCT03765073|454571050|FG009|Stage 1|Withdrawal by participant|0|||
126348643|NCT03765073|454571051|FG010|Stage 1|Withdrawal by participant|0|||
126348644|NCT03765073|454571052|FG011|Stage 1|Withdrawal by participant|0|||
126348645|NCT03765073|454571053|FG012|Stage 1|Withdrawal by participant|0|||
126348646|NCT03765073|454571054|FG013|Stage 1|Withdrawal by participant|0|||
126348647|NCT03765073|454571055|FG014|Stage 1|Withdrawal by participant|0|||
126348648|NCT03765073|454571056|FG015|Stage 1|Withdrawal by participant|0|||
126348649|NCT03765073|454571057|FG016|Stage 1|Withdrawal by participant|0|||
126348650|NCT03765073|454571058|FG017|Stage 1|Withdrawal by participant|0|||
126348651|NCT03765073|454571059|FG018|Stage 1|Withdrawal by participant|0|||
126348652|NCT03765073|454571060|FG019|Stage 1|Withdrawal by participant|0|||
126348653|NCT03765073|454571061|FG020|Stage 1|Withdrawal by participant|0|||
126348654|NCT03765073|454571041|FG000|Stage 2|Death|0|||
126348655|NCT03765073|454571042|FG001|Stage 2|Death|0|||
126348656|NCT03765073|454571043|FG002|Stage 2|Death|0|||
126348657|NCT03765073|454571044|FG003|Stage 2|Death|0|||
126348658|NCT03765073|454571045|FG004|Stage 2|Death|0|||
126348659|NCT03765073|454571046|FG005|Stage 2|Death|0|||
126348660|NCT03765073|454571047|FG006|Stage 2|Death|0|||
126348661|NCT03765073|454571048|FG007|Stage 2|Death|0|||
126348662|NCT03765073|454571049|FG008|Stage 2|Death|0|||
126434732|NCT05138653|454889588|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434733|NCT05138653|454889589|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434734|NCT05138653|454889590|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434735|NCT05138653|454889591|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434736|NCT05138653|454889592|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434737|NCT05138653|454889593|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434738|NCT05138653|454889594|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434739|NCT05138653|454889595|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
126434740|NCT05138653|454889580|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126434741|NCT05138653|454889581|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126434742|NCT05138653|454889582|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126434743|NCT05138653|454889583|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126434744|NCT05138653|454889584|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126434745|NCT05138653|454889585|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126434746|NCT05138653|454889586|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126434747|NCT05138653|454889587|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126434748|NCT05138653|454889588|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126434749|NCT05138653|454889589|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126434750|NCT05138653|454889590|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
126434751|NCT05138653|454889591|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126434752|NCT05138653|454889592|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
126434753|NCT05138653|454889593|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126434754|NCT05138653|454889594|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
126434755|NCT05138653|454889595|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
126680955|NCT00876187|455788225|FG001|Overall Study|Lack of Efficacy|34|||
126680956|NCT00876187|455788226|FG002|Overall Study|Lack of Efficacy|45|||
126680957|NCT00876187|455788227|FG003|Overall Study|Lack of Efficacy|34|||
126680958|NCT00876187|455788228|FG004|Overall Study|Lack of Efficacy|59|||
126680959|NCT00876187|455788224|FG000|Overall Study|Lost to Follow-up|9|||
126680960|NCT00876187|455788225|FG001|Overall Study|Lost to Follow-up|10|||
126680961|NCT00876187|455788226|FG002|Overall Study|Lost to Follow-up|8|||
126680962|NCT00876187|455788227|FG003|Overall Study|Lost to Follow-up|8|||
126680963|NCT00876187|455788228|FG004|Overall Study|Lost to Follow-up|11|||
126680964|NCT00876187|455788224|FG000|Overall Study|Protocol Violation|6|||
126680965|NCT00876187|455788225|FG001|Overall Study|Protocol Violation|7|||
126680966|NCT00876187|455788226|FG002|Overall Study|Protocol Violation|7|||
126680967|NCT00876187|455788227|FG003|Overall Study|Protocol Violation|6|||
126680968|NCT00876187|455788228|FG004|Overall Study|Protocol Violation|3|||
126680969|NCT00876187|455788224|FG000|Overall Study|Withdrawal by Subject|16|||
126680970|NCT00876187|455788225|FG001|Overall Study|Withdrawal by Subject|26|||
126680971|NCT00876187|455788226|FG002|Overall Study|Withdrawal by Subject|32|||
126680972|NCT00876187|455788227|FG003|Overall Study|Withdrawal by Subject|38|||
126680973|NCT00876187|455788228|FG004|Overall Study|Withdrawal by Subject|37|||
126680974|NCT00876187|455788224|FG000|Overall Study|Entered extension study|101|||
126680975|NCT00876187|455788225|FG001|Overall Study|Entered extension study|120|||
126680976|NCT00876187|455788226|FG002|Overall Study|Entered extension study|156|||
126680977|NCT00876187|455788227|FG003|Overall Study|Entered extension study|151|||
126680978|NCT00876187|455788228|FG004|Overall Study|Entered extension study|144|||
126680979|NCT00876187|455788224|FG000|Overall Study|Randomized but not treated|3|||
126680980|NCT00876187|455788225|FG001|Overall Study|Randomized but not treated|1|||
126680981|NCT00876187|455788226|FG002|Overall Study|Randomized but not treated|3|||
126680982|NCT00876187|455788227|FG003|Overall Study|Randomized but not treated|2|||
126680983|NCT00876187|455788228|FG004|Overall Study|Randomized but not treated|3|||
126680984|NCT00876187|455788224|FG000|Overall Study|Other|2|||
126680985|NCT00876187|455788225|FG001|Overall Study|Other|5|||
126680986|NCT00876187|455788226|FG002|Overall Study|Other|9|||
126680987|NCT00876187|455788227|FG003|Overall Study|Other|7|||
126680988|NCT00876187|455788228|FG004|Overall Study|Other|4|||
126680989|NCT00405067|455788233|FG000|Overall Study|Adverse Event|4|||
126680990|NCT00405067|455788234|FG001|Overall Study|Adverse Event|9|||
126680991|NCT00405067|455788235|FG002|Overall Study|Adverse Event|4|||
126680992|NCT00405067|455788233|FG000|Overall Study|Lost to Follow-up|0|||
126680993|NCT00405067|455788234|FG001|Overall Study|Lost to Follow-up|0|||
126680994|NCT00405067|455788235|FG002|Overall Study|Lost to Follow-up|1|||
126680995|NCT01650636|455788236|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
126680996|NCT01650636|455788237|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
126680997|NCT01650636|455788236|FG000|Washout up to 5 Months|Physician Decision|2|||
126680998|NCT01650636|455788237|FG001|Washout up to 5 Months|Physician Decision|2|||
126680999|NCT01650636|455788236|FG000|Washout up to 5 Months|Death|1|||
126681000|NCT01650636|455788237|FG001|Washout up to 5 Months|Death|0|||
126681001|NCT01650636|455788236|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
126434756|NCT05138653|454889580|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434757|NCT05138653|454889581|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434758|NCT05138653|454889582|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126681002|NCT01650636|455788237|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
126681003|NCT01650636|455788236|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
126681004|NCT01650636|455788237|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
126681005|NCT01650636|455788236|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
126681006|NCT01650636|455788237|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
126681007|NCT01560780|455788238|FG000|Overall Study|Death|2|||
126681008|NCT01560780|455788239|FG001|Overall Study|Death|1|||
126681009|NCT01560780|455788238|FG000|Overall Study|Patient Preference|11|||
126681010|NCT01560780|455788239|FG001|Overall Study|Patient Preference|11|||
126681011|NCT01032915|455788240|FG000|Overall Study|Adverse Event|2|||
126681012|NCT01032915|455788241|FG001|Overall Study|Adverse Event|2|||
126681013|NCT01032915|455788242|FG002|Overall Study|Adverse Event|1|||
126681014|NCT01032915|455788243|FG003|Overall Study|Adverse Event|1|||
126681015|NCT01032915|455788240|FG000|Overall Study|Abnormal test procedure result|0|||
126681016|NCT01032915|455788241|FG001|Overall Study|Abnormal test procedure result|0|||
126681017|NCT01032915|455788242|FG002|Overall Study|Abnormal test procedure result|1|||
126681018|NCT01032915|455788243|FG003|Overall Study|Abnormal test procedure result|0|||
126681019|NCT01032915|455788240|FG000|Overall Study|Withdrawal by Subject|0|||
126681020|NCT01032915|455788241|FG001|Overall Study|Withdrawal by Subject|3|||
126681021|NCT01032915|455788242|FG002|Overall Study|Withdrawal by Subject|1|||
126681022|NCT01032915|455788243|FG003|Overall Study|Withdrawal by Subject|1|||
126681023|NCT01032915|455788240|FG000|Overall Study|Administrative reasons|5|||
126681024|NCT01032915|455788241|FG001|Overall Study|Administrative reasons|6|||
126434759|NCT05138653|454889583|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434760|NCT05138653|454889584|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434761|NCT05138653|454889585|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434762|NCT05138653|454889586|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434763|NCT05138653|454889587|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434764|NCT05138653|454889588|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434765|NCT05138653|454889589|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434766|NCT05138653|454889590|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434767|NCT05138653|454889591|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434768|NCT05138653|454889592|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434769|NCT05138653|454889593|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434770|NCT05138653|454889594|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
126434771|NCT05138653|454889595|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
126434772|NCT05138653|454889580|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434773|NCT05138653|454889581|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434774|NCT05138653|454889582|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434775|NCT05138653|454889583|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434776|NCT05138653|454889584|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126681025|NCT01032915|455788242|FG002|Overall Study|Administrative reasons|4|||
126681026|NCT01032915|455788243|FG003|Overall Study|Administrative reasons|4|||
126681027|NCT01032915|455788240|FG000|Overall Study|Protocol Violation|1|||
126681028|NCT01032915|455788241|FG001|Overall Study|Protocol Violation|0|||
126434777|NCT05138653|454889585|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434778|NCT05138653|454889586|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434779|NCT05138653|454889587|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434780|NCT05138653|454889588|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434781|NCT05138653|454889589|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434782|NCT05138653|454889590|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434783|NCT05138653|454889591|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434784|NCT05138653|454889592|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434785|NCT05138653|454889593|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
126434786|NCT05138653|454889594|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434787|NCT05138653|454889595|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
126434788|NCT04825574|454889596|FG000|Overall Study|Commercial treatment became available|1|||
126434789|NCT04825574|454889596|FG000|Overall Study|Disease progression|1|||
126434790|NCT04272242|454889597|FG000|Overall Study|Withdrawal by Subject|3|||
126434791|NCT04272242|454889597|FG000|Overall Study|Lost to Follow-up|1|||
126434792|NCT04272242|454889597|FG000|Overall Study|Adverse Event|1|||
126434793|NCT02702492|454889598|FG000|Overall Study|Disease progression|3|||
126434794|NCT02702492|454889599|FG001|Overall Study|Disease progression|3|||
126434795|NCT02702492|454889600|FG002|Overall Study|Disease progression|2|||
126681029|NCT01032915|455788242|FG002|Overall Study|Protocol Violation|0|||
126681030|NCT01032915|455788243|FG003|Overall Study|Protocol Violation|1|||
126681031|NCT01577186|455788244|FG000|Overall Study|Adverse Event|23|||
126681032|NCT01577186|455788244|FG000|Overall Study|Death|1|||
126681033|NCT01577186|455788244|FG000|Overall Study|Lost to Follow-up|28|||
126681034|NCT01577186|455788244|FG000|Overall Study|Withdrawal by Subject|35|||
126681035|NCT01577186|455788244|FG000|Overall Study|Insufficient Response|18|||
126681036|NCT01577186|455788244|FG000|Overall Study|Ineligible to Continue|15|||
126681037|NCT01577186|455788244|FG000|Overall Study|Non-Compliant|8|||
126681038|NCT01577186|455788244|FG000|Overall Study|Other|2|||
126681039|NCT02915523|455788246|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
126681040|NCT02915523|455788247|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
126681041|NCT02915523|455788248|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
126681042|NCT02915523|455788249|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
126681043|NCT02915523|455788246|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
126681044|NCT02915523|455788247|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
126681045|NCT02915523|455788248|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
126681046|NCT02915523|455788249|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
126681047|NCT02915523|455788246|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
126681048|NCT02915523|455788247|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
126681049|NCT02915523|455788248|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
126681050|NCT02915523|455788249|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
126681051|NCT02915523|455788246|FG000|Expansion Phase (Phase 2)|Death|0|||
126681052|NCT02915523|455788247|FG001|Expansion Phase (Phase 2)|Death|0|||
126681053|NCT02915523|455788248|FG002|Expansion Phase (Phase 2)|Death|26|||
126681054|NCT02915523|455788249|FG003|Expansion Phase (Phase 2)|Death|53|||
126681055|NCT02915523|455788246|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
126681056|NCT02915523|455788247|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
126681057|NCT02915523|455788248|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
126681058|NCT02915523|455788249|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
126681059|NCT02915523|455788246|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
126681060|NCT02915523|455788247|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
126681061|NCT02915523|455788248|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
126681062|NCT02915523|455788249|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
126681063|NCT02915523|455788246|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
126681064|NCT02915523|455788247|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
126681065|NCT02915523|455788248|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
126681066|NCT02915523|455788249|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
126681067|NCT03287219|455788250|FG000|Overall Study|Protocol Violation|0|||
126681068|NCT03287219|455788251|FG001|Overall Study|Protocol Violation|2|||
126681069|NCT00930761|455788252|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
126681070|NCT00930761|455788253|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
126681071|NCT00930761|455788252|FG000|Overall Study|less than 3 music therapy sessions|0|||
126681072|NCT00930761|455788253|FG001|Overall Study|less than 3 music therapy sessions|3|||
126681073|NCT00957008|455788254|FG000|Overall Study|Withdrawal by Subject|13|||
126681074|NCT00957008|455788255|FG001|Overall Study|Withdrawal by Subject|10|||
126681075|NCT00957008|455788256|FG002|Overall Study|Withdrawal by Subject|12|||
126681076|NCT00957008|455788257|FG003|Overall Study|Withdrawal by Subject|16|||
126681077|NCT00957008|455788254|FG000|Overall Study|Lost to Follow-up|3|||
126681078|NCT00957008|455788255|FG001|Overall Study|Lost to Follow-up|1|||
126681079|NCT00957008|455788256|FG002|Overall Study|Lost to Follow-up|3|||
126681080|NCT00957008|455788257|FG003|Overall Study|Lost to Follow-up|4|||
126681081|NCT00957008|455788254|FG000|Overall Study|Physician Decision|1|||
126681082|NCT00957008|455788255|FG001|Overall Study|Physician Decision|0|||
126681083|NCT00957008|455788256|FG002|Overall Study|Physician Decision|1|||
126681084|NCT00957008|455788257|FG003|Overall Study|Physician Decision|1|||
126681085|NCT00957008|455788254|FG000|Overall Study|Relocated; Family conflict|4|||
126681086|NCT00957008|455788255|FG001|Overall Study|Relocated; Family conflict|1|||
126681087|NCT00957008|455788256|FG002|Overall Study|Relocated; Family conflict|1|||
126681088|NCT00957008|455788257|FG003|Overall Study|Relocated; Family conflict|3|||
126681089|NCT00915681|455788258|FG000|Overall Study|Screening failures|46|||
126681090|NCT01118351|455788259|FG000|Overall Study|Adverse Event|3|||
126681091|NCT01118351|455788259|FG000|Overall Study|Withdrawal by Subject|1|||
126681092|NCT00811135|455788260|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
126681093|NCT00811135|455788260|FG000|Overall Study|Death|3|||
126681094|NCT00811135|455788260|FG000|Overall Study|Protocol Violation|2|||
126681095|NCT00811135|455788260|FG000|Overall Study|Violation of Selection Criteria|1|||
126681096|NCT00811135|455788260|FG000|Overall Study|Refused Treatment|1|||
126681097|NCT00811135|455788260|FG000|Overall Study|Withdrawal by Subject|3|||
126681098|NCT00811135|455788260|FG000|Overall Study|Administrative/Other Unspecified|11|||
126681099|NCT00811135|455788260|FG000|Overall Study|Ongoing|59|||
126681100|NCT04677959|455788272|FG000|Overall Study|Adverse Event|1|||
126681101|NCT04677959|455788273|FG001|Overall Study|Adverse Event|9|||
126681102|NCT04677959|455788272|FG000|Overall Study|Withdrawal by Subject|2|||
126681103|NCT04677959|455788273|FG001|Overall Study|Withdrawal by Subject|15|||
126348663|NCT03765073|454571050|FG009|Stage 2|Death|1|||
126348664|NCT03765073|454571051|FG010|Stage 2|Death|0|||
126348665|NCT03765073|454571052|FG011|Stage 2|Death|1|||
126348666|NCT03765073|454571053|FG012|Stage 2|Death|0|||
126681104|NCT04677959|455788272|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126681105|NCT04677959|455788273|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126348667|NCT03765073|454571054|FG013|Stage 2|Death|0|||
126681106|NCT04677959|455788272|FG000|Overall Study|Non-compliance with study drug|0|||
126681107|NCT04677959|455788273|FG001|Overall Study|Non-compliance with study drug|2|||
126348668|NCT03765073|454571055|FG014|Stage 2|Death|0|||
126348669|NCT03765073|454571056|FG015|Stage 2|Death|0|||
126348670|NCT03765073|454571057|FG016|Stage 2|Death|2|||
126348671|NCT03765073|454571058|FG017|Stage 2|Death|0|||
126434796|NCT02702492|454889601|FG003|Overall Study|Disease progression|4|||
126434797|NCT02702492|454889602|FG004|Overall Study|Disease progression|4|||
126434798|NCT02702492|454889603|FG005|Overall Study|Disease progression|1|||
126434799|NCT02702492|454889604|FG006|Overall Study|Disease progression|2|||
126434800|NCT02702492|454889605|FG007|Overall Study|Disease progression|8|||
126434801|NCT02702492|454889606|FG008|Overall Study|Disease progression|5|||
126434802|NCT02702492|454889607|FG009|Overall Study|Disease progression|1|||
126434803|NCT02702492|454889608|FG010|Overall Study|Disease progression|0|||
126434804|NCT02702492|454889609|FG011|Overall Study|Disease progression|3|||
126434805|NCT02702492|454889610|FG012|Overall Study|Disease progression|2|||
126434806|NCT02702492|454889598|FG000|Overall Study|Clinical progression|0|||
126681108|NCT04677959|455788272|FG000|Overall Study|Protocol deviation|0|||
126681109|NCT04677959|455788273|FG001|Overall Study|Protocol deviation|11|||
126434807|NCT02702492|454889599|FG001|Overall Study|Clinical progression|0|||
126434808|NCT02702492|454889600|FG002|Overall Study|Clinical progression|2|||
126434809|NCT02702492|454889601|FG003|Overall Study|Clinical progression|1|||
126434810|NCT02702492|454889602|FG004|Overall Study|Clinical progression|0|||
126545284|NCT02567825|455290796|FG001|Overall Study|No follow-up post-randomization|1|||
126545285|NCT02567825|455290795|FG000|Overall Study|Follow-up less than 23 months|16|||
126545286|NCT02567825|455290796|FG001|Overall Study|Follow-up less than 23 months|20|||
126545287|NCT04741802|455290798|FG000|Overall Study|Death|1|||
126545288|NCT04741802|455290798|FG000|Overall Study|Lost to Follow-up|11|||
126681110|NCT04677959|455788272|FG000|Overall Study|Lost to Follow-up|9|||
126681111|NCT04677959|455788273|FG001|Overall Study|Lost to Follow-up|13|||
126681112|NCT04677959|455788272|FG000|Overall Study|Other than specified|0|||
126681113|NCT04677959|455788273|FG001|Overall Study|Other than specified|8|||
126681114|NCT01970995|455788274|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
126681115|NCT01970995|455788275|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
126681116|NCT01970995|455788276|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
126681117|NCT01970995|455788274|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
126681118|NCT01970995|455788275|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
126681119|NCT01970995|455788276|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
126681120|NCT05630937|455788277|FG000|Overall Study|Study terminated by sponsor|1|||
126681121|NCT05630937|455788278|FG001|Overall Study|Study terminated by sponsor|1|||
126681122|NCT05630937|455788279|FG002|Overall Study|Study terminated by sponsor|8|||
126681123|NCT05630937|455788280|FG003|Overall Study|Study terminated by sponsor|0|||
126681124|NCT05630937|455788277|FG000|Overall Study|Lost to Follow-up|0|||
126681125|NCT05630937|455788278|FG001|Overall Study|Lost to Follow-up|0|||
126681126|NCT05630937|455788279|FG002|Overall Study|Lost to Follow-up|1|||
126681127|NCT05630937|455788280|FG003|Overall Study|Lost to Follow-up|0|||
126681128|NCT05630937|455788277|FG000|Overall Study|Enrolled but not treated|0|||
126681129|NCT05630937|455788278|FG001|Overall Study|Enrolled but not treated|0|||
126681130|NCT05630937|455788279|FG002|Overall Study|Enrolled but not treated|0|||
126681131|NCT05630937|455788280|FG003|Overall Study|Enrolled but not treated|1|||
126681132|NCT01604265|455788286|FG000|Overall Study|Adverse Event|1|||
126681133|NCT01604265|455788287|FG001|Overall Study|Adverse Event|0|||
126681134|NCT01604265|455788286|FG000|Overall Study|Withdrawal by Subject|1|||
126681135|NCT01604265|455788287|FG001|Overall Study|Withdrawal by Subject|0|||
126681136|NCT02599961|455788288|FG000|Overall Study|Withdrawal by Subject|1|||
126681137|NCT02599961|455788288|FG000|Overall Study|Subject Non-Compliance|2|||
126681138|NCT02599961|455788288|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
126681139|NCT02599961|455788288|FG000|Overall Study|Other, Not Specified|3|||
126681140|NCT01422915|455788291|FG000|Overall Study|Adverse Event|1|||
126681141|NCT01152021|455788293|FG000|Overall Study|Adverse Event|4|||
126681142|NCT01152021|455788294|FG001|Overall Study|Adverse Event|4|||
126681143|NCT01152021|455788293|FG000|Overall Study|Study drug had expired|1|||
126681144|NCT01152021|455788294|FG001|Overall Study|Study drug had expired|0|||
126681145|NCT01152021|455788293|FG000|Overall Study|Physician Decision|1|||
126681146|NCT01152021|455788294|FG001|Overall Study|Physician Decision|1|||
126681147|NCT01152021|455788293|FG000|Overall Study|No access to study drug in Pharmacy|0|||
126681148|NCT01152021|455788294|FG001|Overall Study|No access to study drug in Pharmacy|1|||
126681149|NCT00385255|455788295|FG000|Overall Study|Serious Adverse Event|1|||
126681150|NCT00385255|455788296|FG001|Overall Study|Serious Adverse Event|2|||
126681151|NCT00385255|455788295|FG000|Overall Study|Protocol Violation|0|||
126681152|NCT00385255|455788296|FG001|Overall Study|Protocol Violation|4|||
126681153|NCT00385255|455788295|FG000|Overall Study|Withdrawal by Subject|0|||
126681154|NCT00385255|455788296|FG001|Overall Study|Withdrawal by Subject|8|||
126681155|NCT00385255|455788295|FG000|Overall Study|Migrated/moved from study area|0|||
126681156|NCT00385255|455788296|FG001|Overall Study|Migrated/moved from study area|1|||
126681157|NCT00385255|455788295|FG000|Overall Study|Lost to Follow-up|20|||
126681158|NCT00385255|455788296|FG001|Overall Study|Lost to Follow-up|58|||
126681159|NCT02443883|455788297|FG000|Overall Study|Adverse Event|0|||
126681160|NCT02443883|455788298|FG001|Overall Study|Adverse Event|1|||
126681161|NCT02443883|455788299|FG002|Overall Study|Adverse Event|0|||
126681162|NCT02443883|455788300|FG003|Overall Study|Adverse Event|0|||
126681163|NCT02443883|455788297|FG000|Overall Study|Lost to Follow-up|3|||
126681164|NCT02443883|455788298|FG001|Overall Study|Lost to Follow-up|2|||
126681165|NCT02443883|455788299|FG002|Overall Study|Lost to Follow-up|1|||
126545289|NCT01785563|455290801|FG000|Overall Study|Physician Decision|10|||
126545290|NCT01785563|455290801|FG000|Overall Study|Withdrawal by Subject|1|||
126681166|NCT02443883|455788300|FG003|Overall Study|Lost to Follow-up|0|||
126681167|NCT02443883|455788297|FG000|Overall Study|Physician Decision|1|||
126681168|NCT02443883|455788298|FG001|Overall Study|Physician Decision|1|||
126681169|NCT02443883|455788299|FG002|Overall Study|Physician Decision|0|||
126545291|NCT01785563|455290801|FG000|Overall Study|Protocol Violation|2|||
126545292|NCT01540565|455290802|FG000|Overall Study|Ineligible|2|||
126681170|NCT02443883|455788300|FG003|Overall Study|Physician Decision|3|||
126681171|NCT02443883|455788297|FG000|Overall Study|Withdrawal by Subject|1|||
126545293|NCT02306265|455290803|FG000|Overall Study|Withdrawal by Subject|1|||
126545294|NCT03107377|455290805|FG000|Overall Study|Adverse Event|3|||
126681172|NCT02443883|455788298|FG001|Overall Study|Withdrawal by Subject|0|||
126681173|NCT02443883|455788299|FG002|Overall Study|Withdrawal by Subject|0|||
126681174|NCT02443883|455788300|FG003|Overall Study|Withdrawal by Subject|2|||
126681175|NCT02443883|455788297|FG000|Overall Study|Randomized, but never treated|1|||
126681176|NCT02443883|455788298|FG001|Overall Study|Randomized, but never treated|0|||
126681177|NCT02443883|455788299|FG002|Overall Study|Randomized, but never treated|0|||
126681178|NCT02443883|455788300|FG003|Overall Study|Randomized, but never treated|0|||
126681179|NCT00506883|455788312|FG000|Overall Study|Lost to Follow-up|1|||
126681180|NCT00506883|455788313|FG001|Overall Study|Lost to Follow-up|1|||
126681181|NCT00506883|455788314|FG002|Overall Study|Lost to Follow-up|1|||
126681182|NCT00506883|455788312|FG000|Overall Study|Withdrawal by Subject|1|||
126681183|NCT00506883|455788313|FG001|Overall Study|Withdrawal by Subject|0|||
126681184|NCT00506883|455788314|FG002|Overall Study|Withdrawal by Subject|1|||
126681185|NCT00506883|455788312|FG000|Overall Study|Lack of Efficacy|0|||
126681186|NCT00506883|455788313|FG001|Overall Study|Lack of Efficacy|1|||
126681187|NCT00506883|455788314|FG002|Overall Study|Lack of Efficacy|1|||
126681188|NCT00506883|455788312|FG000|Overall Study|Other|5|||
126681189|NCT00506883|455788313|FG001|Overall Study|Other|1|||
126681190|NCT00506883|455788314|FG002|Overall Study|Other|1|||
126681191|NCT01445951|455788315|FG000|Overall Study|Adverse Event|16|||
126681192|NCT01445951|455788316|FG001|Overall Study|Adverse Event|9|||
126545295|NCT03107377|455290806|FG001|Overall Study|Adverse Event|3|||
126545296|NCT03107377|455290805|FG000|Overall Study|Protocol Violation|9|||
126545297|NCT03107377|455290806|FG001|Overall Study|Protocol Violation|12|||
126545298|NCT03107377|455290805|FG000|Overall Study|Physician Decision|3|||
126545299|NCT03107377|455290806|FG001|Overall Study|Physician Decision|6|||
126545300|NCT03107377|455290805|FG000|Overall Study|Pregnancy|7|||
126545301|NCT03107377|455290806|FG001|Overall Study|Pregnancy|7|||
126545302|NCT03107377|455290805|FG000|Overall Study|Withdrawal by Subject|16|||
126545303|NCT03107377|455290806|FG001|Overall Study|Withdrawal by Subject|22|||
126434811|NCT02702492|454889603|FG005|Overall Study|Clinical progression|2|||
126434812|NCT02702492|454889604|FG006|Overall Study|Clinical progression|1|||
126434813|NCT02702492|454889605|FG007|Overall Study|Clinical progression|4|||
126434814|NCT02702492|454889606|FG008|Overall Study|Clinical progression|0|||
126434815|NCT02702492|454889607|FG009|Overall Study|Clinical progression|0|||
126434816|NCT02702492|454889608|FG010|Overall Study|Clinical progression|1|||
126434817|NCT02702492|454889609|FG011|Overall Study|Clinical progression|2|||
126434818|NCT02702492|454889610|FG012|Overall Study|Clinical progression|0|||
126434819|NCT02702492|454889598|FG000|Overall Study|Adverse Event|0|||
126434820|NCT02702492|454889599|FG001|Overall Study|Adverse Event|0|||
126434821|NCT02702492|454889600|FG002|Overall Study|Adverse Event|1|||
126434822|NCT02702492|454889601|FG003|Overall Study|Adverse Event|2|||
126434823|NCT02702492|454889602|FG004|Overall Study|Adverse Event|1|||
126434824|NCT02702492|454889603|FG005|Overall Study|Adverse Event|0|||
126681193|NCT01445951|455788317|FG002|Overall Study|Adverse Event|0|||
126681194|NCT01445951|455788315|FG000|Overall Study|Protocol Violation|2|||
126681195|NCT01445951|455788316|FG001|Overall Study|Protocol Violation|2|||
126681196|NCT01445951|455788317|FG002|Overall Study|Protocol Violation|2|||
126681197|NCT01445951|455788315|FG000|Overall Study|Withdrawal by Subject|21|||
126681198|NCT01445951|455788316|FG001|Overall Study|Withdrawal by Subject|16|||
126681199|NCT01445951|455788317|FG002|Overall Study|Withdrawal by Subject|8|||
126681200|NCT01445951|455788315|FG000|Overall Study|Physician Decision|3|||
126681201|NCT01445951|455788316|FG001|Overall Study|Physician Decision|1|||
126681202|NCT01445951|455788317|FG002|Overall Study|Physician Decision|0|||
126681203|NCT01445951|455788315|FG000|Overall Study|Lost to Follow-up|1|||
126681204|NCT01445951|455788316|FG001|Overall Study|Lost to Follow-up|2|||
126681205|NCT01445951|455788317|FG002|Overall Study|Lost to Follow-up|4|||
126681206|NCT01445951|455788315|FG000|Overall Study|Pregnancy|0|||
126681207|NCT01445951|455788316|FG001|Overall Study|Pregnancy|1|||
126681208|NCT01445951|455788317|FG002|Overall Study|Pregnancy|4|||
126681209|NCT01445951|455788315|FG000|Overall Study|Death|0|||
126681210|NCT01445951|455788316|FG001|Overall Study|Death|0|||
126681211|NCT01445951|455788317|FG002|Overall Study|Death|1|||
126681212|NCT01445951|455788315|FG000|Overall Study|Non-compliance with study drug|1|||
126681213|NCT01445951|455788316|FG001|Overall Study|Non-compliance with study drug|2|||
126681214|NCT01445951|455788317|FG002|Overall Study|Non-compliance with study drug|0|||
126348672|NCT03765073|454571059|FG018|Stage 2|Death|0|||
126348673|NCT03765073|454571060|FG019|Stage 2|Death|0|||
126348674|NCT03765073|454571061|FG020|Stage 2|Death|0|||
126348675|NCT03765073|454571041|FG000|Stage 2|Lost to Follow-up|0|||
126348676|NCT03765073|454571042|FG001|Stage 2|Lost to Follow-up|0|||
126348677|NCT03765073|454571043|FG002|Stage 2|Lost to Follow-up|0|||
126348678|NCT03765073|454571044|FG003|Stage 2|Lost to Follow-up|5|||
126348679|NCT03765073|454571045|FG004|Stage 2|Lost to Follow-up|1|||
126348680|NCT03765073|454571046|FG005|Stage 2|Lost to Follow-up|0|||
126348681|NCT03765073|454571047|FG006|Stage 2|Lost to Follow-up|3|||
126348682|NCT03765073|454571048|FG007|Stage 2|Lost to Follow-up|3|||
126348683|NCT03765073|454571049|FG008|Stage 2|Lost to Follow-up|1|||
126348684|NCT03765073|454571050|FG009|Stage 2|Lost to Follow-up|6|||
126348685|NCT03765073|454571051|FG010|Stage 2|Lost to Follow-up|5|||
126348686|NCT03765073|454571052|FG011|Stage 2|Lost to Follow-up|1|||
126348687|NCT03765073|454571053|FG012|Stage 2|Lost to Follow-up|1|||
126348688|NCT03765073|454571054|FG013|Stage 2|Lost to Follow-up|3|||
126348689|NCT03765073|454571055|FG014|Stage 2|Lost to Follow-up|3|||
126348690|NCT03765073|454571056|FG015|Stage 2|Lost to Follow-up|1|||
126348691|NCT03765073|454571057|FG016|Stage 2|Lost to Follow-up|6|||
126348692|NCT03765073|454571058|FG017|Stage 2|Lost to Follow-up|0|||
126348693|NCT03765073|454571059|FG018|Stage 2|Lost to Follow-up|0|||
126434825|NCT02702492|454889604|FG006|Overall Study|Adverse Event|1|||
126434826|NCT02702492|454889605|FG007|Overall Study|Adverse Event|0|||
126545304|NCT03107377|455290805|FG000|Overall Study|Lost to Follow-up|37|||
126681215|NCT01445951|455788315|FG000|Overall Study|Non-compliance with protocol|0|||
126681216|NCT01445951|455788316|FG001|Overall Study|Non-compliance with protocol|1|||
126681217|NCT01445951|455788317|FG002|Overall Study|Non-compliance with protocol|0|||
126681218|NCT01445951|455788315|FG000|Overall Study|Sponsor decision - subject travel|0|||
126348694|NCT03765073|454571060|FG019|Stage 2|Lost to Follow-up|0|||
126348695|NCT03765073|454571061|FG020|Stage 2|Lost to Follow-up|0|||
126348696|NCT03765073|454571041|FG000|Stage 2|Other|0|||
126348697|NCT03765073|454571042|FG001|Stage 2|Other|0|||
126348698|NCT03765073|454571043|FG002|Stage 2|Other|0|||
126348699|NCT03765073|454571044|FG003|Stage 2|Other|0|||
126348700|NCT03765073|454571045|FG004|Stage 2|Other|0|||
126348701|NCT03765073|454571046|FG005|Stage 2|Other|0|||
126545305|NCT03107377|455290806|FG001|Overall Study|Lost to Follow-up|34|||
126348702|NCT03765073|454571047|FG006|Stage 2|Other|0|||
126348703|NCT03765073|454571048|FG007|Stage 2|Other|1|||
126348704|NCT03765073|454571049|FG008|Stage 2|Other|1|||
126348705|NCT03765073|454571050|FG009|Stage 2|Other|3|||
126348706|NCT03765073|454571051|FG010|Stage 2|Other|0|||
126348707|NCT03765073|454571052|FG011|Stage 2|Other|0|||
126348708|NCT03765073|454571053|FG012|Stage 2|Other|0|||
126348709|NCT03765073|454571054|FG013|Stage 2|Other|0|||
126348710|NCT03765073|454571055|FG014|Stage 2|Other|0|||
126348711|NCT03765073|454571056|FG015|Stage 2|Other|1|||
126348712|NCT03765073|454571057|FG016|Stage 2|Other|2|||
126348713|NCT03765073|454571058|FG017|Stage 2|Other|0|||
126348714|NCT03765073|454571059|FG018|Stage 2|Other|0|||
126348715|NCT03765073|454571060|FG019|Stage 2|Other|0|||
126348716|NCT03765073|454571061|FG020|Stage 2|Other|0|||
126348717|NCT03765073|454571041|FG000|Stage 2|Withdrawal by parent/guardian|0|||
126348718|NCT03765073|454571042|FG001|Stage 2|Withdrawal by parent/guardian|0|||
126348719|NCT03765073|454571043|FG002|Stage 2|Withdrawal by parent/guardian|0|||
126348720|NCT03765073|454571044|FG003|Stage 2|Withdrawal by parent/guardian|0|||
126348721|NCT03765073|454571045|FG004|Stage 2|Withdrawal by parent/guardian|0|||
126348722|NCT03765073|454571046|FG005|Stage 2|Withdrawal by parent/guardian|0|||
126348723|NCT03765073|454571047|FG006|Stage 2|Withdrawal by parent/guardian|0|||
126348724|NCT03765073|454571048|FG007|Stage 2|Withdrawal by parent/guardian|0|||
126348725|NCT03765073|454571049|FG008|Stage 2|Withdrawal by parent/guardian|0|||
126434827|NCT02702492|454889606|FG008|Overall Study|Adverse Event|2|||
126434828|NCT02702492|454889607|FG009|Overall Study|Adverse Event|0|||
126434829|NCT02702492|454889608|FG010|Overall Study|Adverse Event|0|||
126758670|NCT00134563|456066674|FG001|Overall Study|Reason other than above|2|||
126434830|NCT02702492|454889609|FG011|Overall Study|Adverse Event|0|||
126434831|NCT02702492|454889610|FG012|Overall Study|Adverse Event|1|||
126434832|NCT02702492|454889598|FG000|Overall Study|Other|0|||
126434833|NCT02702492|454889599|FG001|Overall Study|Other|0|||
126434834|NCT02702492|454889600|FG002|Overall Study|Other|0|||
126434835|NCT02702492|454889601|FG003|Overall Study|Other|0|||
126434836|NCT02702492|454889602|FG004|Overall Study|Other|0|||
126434837|NCT02702492|454889603|FG005|Overall Study|Other|0|||
126434838|NCT02702492|454889604|FG006|Overall Study|Other|0|||
126434839|NCT02702492|454889605|FG007|Overall Study|Other|0|||
126434840|NCT02702492|454889606|FG008|Overall Study|Other|0|||
126434841|NCT02702492|454889607|FG009|Overall Study|Other|0|||
126434842|NCT02702492|454889608|FG010|Overall Study|Other|0|||
126681219|NCT01445951|455788316|FG001|Overall Study|Sponsor decision - subject travel|1|||
126681220|NCT01445951|455788317|FG002|Overall Study|Sponsor decision - subject travel|0|||
126681221|NCT01445951|455788315|FG000|Overall Study|Cough|0|||
126681222|NCT01445951|455788316|FG001|Overall Study|Cough|1|||
126681223|NCT01445951|455788317|FG002|Overall Study|Cough|0|||
126681224|NCT00401375|455788322|FG000|Overall Study|Protocol Violation|2|||
126681225|NCT00401375|455788323|FG001|Overall Study|Protocol Violation|2|||
126681226|NCT00401375|455788324|FG002|Overall Study|Protocol Violation|1|||
126681227|NCT00401375|455788322|FG000|Overall Study|Adverse Event|6|||
126681228|NCT00401375|455788323|FG001|Overall Study|Adverse Event|11|||
126681229|NCT00401375|455788324|FG002|Overall Study|Adverse Event|10|||
126681230|NCT00401375|455788322|FG000|Overall Study|Withdrawal by Subject|9|||
126681231|NCT00401375|455788323|FG001|Overall Study|Withdrawal by Subject|7|||
126681232|NCT00401375|455788324|FG002|Overall Study|Withdrawal by Subject|7|||
126681233|NCT00401375|455788322|FG000|Overall Study|Lost to Follow-up|0|||
126681234|NCT00401375|455788323|FG001|Overall Study|Lost to Follow-up|1|||
126434843|NCT02702492|454889609|FG011|Overall Study|Other|0|||
126434844|NCT02702492|454889610|FG012|Overall Study|Other|1|||
126434845|NCT01824836|454889611|FG000|Overall Study|Adverse Event|48|||
126434846|NCT01824836|454889611|FG000|Overall Study|Withdrawal by Subject|63|||
126434847|NCT01824836|454889611|FG000|Overall Study|Other complicating disease|116|||
126434848|NCT01824836|454889611|FG000|Overall Study|Disease progression|5|||
126434849|NCT01824836|454889611|FG000|Overall Study|Alternative therapy|2|||
126434850|NCT01824836|454889611|FG000|Overall Study|Depression|1|||
126434851|NCT01824836|454889611|FG000|Overall Study|Non-compliance|3|||
126434852|NCT01824836|454889611|FG000|Overall Study|Patient regained ovarian function|3|||
126434853|NCT01824836|454889611|FG000|Overall Study|Lost to Follow-up|8|||
126434854|NCT01824836|454889611|FG000|Overall Study|Physician Decision|2|||
126434855|NCT01824836|454889611|FG000|Overall Study|Research office was closed|3|||
126434856|NCT01824836|454889611|FG000|Overall Study|Relocation|3|||
126434857|NCT01824836|454889611|FG000|Overall Study|Insurance-related issue|1|||
126434858|NCT01824836|454889611|FG000|Overall Study|Transportation issue|1|||
126434859|NCT01824836|454889611|FG000|Overall Study|Patient transferred care|1|||
126434860|NCT01824836|454889611|FG000|Overall Study|Unknown reasons|4|||
126434861|NCT01824836|454889611|FG000|Overall Study|Never started treatment|16|||
126434862|NCT02318706|454891571|FG000|Double-blind Phase|Adverse Event|7|||
126681235|NCT00401375|455788324|FG002|Overall Study|Lost to Follow-up|1|||
126681236|NCT00401375|455788322|FG000|Overall Study|Other than specified|2|||
126681237|NCT00401375|455788323|FG001|Overall Study|Other than specified|1|||
126681238|NCT00401375|455788324|FG002|Overall Study|Other than specified|3|||
126434863|NCT02318706|454891572|FG001|Double-blind Phase|Adverse Event|4|||
126434864|NCT02318706|454891573|FG002|Double-blind Phase|Adverse Event|3|||
126434865|NCT02318706|454891574|FG003|Double-blind Phase|Adverse Event|10|||
126434866|NCT02318706|454891575|FG004|Double-blind Phase|Adverse Event|0|||
126434867|NCT02318706|454891571|FG000|Double-blind Phase|Lost to Follow-up|1|||
126434868|NCT02318706|454891572|FG001|Double-blind Phase|Lost to Follow-up|0|||
126434869|NCT02318706|454891573|FG002|Double-blind Phase|Lost to Follow-up|0|||
126434870|NCT02318706|454891574|FG003|Double-blind Phase|Lost to Follow-up|0|||
126434871|NCT02318706|454891575|FG004|Double-blind Phase|Lost to Follow-up|0|||
126434872|NCT02318706|454891571|FG000|Double-blind Phase|Protocol Violation|4|||
126681239|NCT00401375|455788322|FG000|Overall Study|Randomized but not treated|3|||
126434873|NCT02318706|454891572|FG001|Double-blind Phase|Protocol Violation|2|||
126681240|NCT00401375|455788323|FG001|Overall Study|Randomized but not treated|3|||
126681241|NCT00401375|455788324|FG002|Overall Study|Randomized but not treated|3|||
126681242|NCT00950664|455788325|FG000|First Intervention|Lost to Follow-up|1|||
126681243|NCT00950664|455788326|FG001|First Intervention|Lost to Follow-up|3|||
126434874|NCT02318706|454891573|FG002|Double-blind Phase|Protocol Violation|4|||
126434875|NCT02318706|454891574|FG003|Double-blind Phase|Protocol Violation|3|||
126434876|NCT02318706|454891575|FG004|Double-blind Phase|Protocol Violation|0|||
126434877|NCT02318706|454891571|FG000|Double-blind Phase|Withdrawal by Subject|9|||
126434878|NCT02318706|454891572|FG001|Double-blind Phase|Withdrawal by Subject|5|||
126434879|NCT02318706|454891573|FG002|Double-blind Phase|Withdrawal by Subject|7|||
126434880|NCT02318706|454891574|FG003|Double-blind Phase|Withdrawal by Subject|10|||
126434881|NCT02318706|454891575|FG004|Double-blind Phase|Withdrawal by Subject|0|||
126434882|NCT02318706|454891571|FG000|Double-blind Phase|Other|4|||
126434883|NCT02318706|454891572|FG001|Double-blind Phase|Other|1|||
126434884|NCT02318706|454891573|FG002|Double-blind Phase|Other|2|||
126434885|NCT02318706|454891574|FG003|Double-blind Phase|Other|1|||
126434886|NCT02318706|454891575|FG004|Double-blind Phase|Other|0|||
126434887|NCT02318706|454891571|FG000|Double-blind Phase|Death|0|||
126434888|NCT02318706|454891572|FG001|Double-blind Phase|Death|0|||
126434889|NCT02318706|454891573|FG002|Double-blind Phase|Death|2|||
126434890|NCT02318706|454891574|FG003|Double-blind Phase|Death|0|||
126434891|NCT02318706|454891575|FG004|Double-blind Phase|Death|0|||
126434892|NCT02318706|454891571|FG000|Open-label Extension Phase|Adverse Event|0|||
126434893|NCT02318706|454891572|FG001|Open-label Extension Phase|Adverse Event|0|||
126681244|NCT00950664|455788325|FG000|First Intervention|Withdrawal by Subject|2|||
126681245|NCT00950664|455788326|FG001|First Intervention|Withdrawal by Subject|2|||
126681246|NCT03152019|455788327|FG000|Overall Study|Adverse Event|0|||
126681247|NCT03152019|455788328|FG001|Overall Study|Adverse Event|1|||
126681248|NCT00254501|455788334|FG000|Overall Study|Lost to Follow-up|1|||
126681249|NCT00254501|455788335|FG001|Overall Study|Lost to Follow-up|1|||
126681250|NCT00923130|455788336|FG000|Overall Study|Stopped treatment due to progression|17|||
126681251|NCT00923130|455788336|FG000|Overall Study|Death|1|||
126681252|NCT00923130|455788336|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
126681253|NCT00923130|455788336|FG000|Overall Study|Switched to alternative treatment|2|||
126681254|NCT00923130|455788336|FG000|Overall Study|Refused further treatment|2|||
126681255|NCT03709654|455789712|FG000|Overall Study|Lost to Follow-up|1|||
126681256|NCT03709654|455789713|FG001|Overall Study|Lost to Follow-up|1|||
126681257|NCT03709654|455789712|FG000|Overall Study|Withdrawal by Subject|1|||
126681258|NCT03709654|455789713|FG001|Overall Study|Withdrawal by Subject|1|||
126681259|NCT03709654|455789712|FG000|Overall Study|Adverse Event|1|||
126681260|NCT03709654|455789713|FG001|Overall Study|Adverse Event|0|||
126681261|NCT01902966|455789714|FG000|Overall Study|Death|1|||
126681262|NCT01902966|455789714|FG000|Overall Study|Physician Decision|1|||
126681263|NCT01902966|455789714|FG000|Overall Study|Withdrawal by Subject|1|||
126681264|NCT02631200|455789717|FG000|First Period|Death|1|||
126681265|NCT02631200|455789718|FG001|First Period|Death|2|||
126681266|NCT02631200|455789717|FG000|First Period|Patient ill-health|2|||
126681267|NCT02631200|455789718|FG001|First Period|Patient ill-health|4|||
126681268|NCT02631200|455789717|FG000|First Period|Withdrawal by Subject|4|||
126681269|NCT02631200|455789718|FG001|First Period|Withdrawal by Subject|1|||
126681270|NCT02631200|455789717|FG000|Deferred Period|Death|0|||
126681271|NCT02631200|455789718|FG001|Deferred Period|Death|1|||
126681272|NCT02631200|455789717|FG000|Deferred Period|Received kidney transplant|0|||
126681273|NCT02631200|455789718|FG001|Deferred Period|Received kidney transplant|1|||
126681274|NCT02631200|455789717|FG000|Deferred Period|Withdrawal by Subject|0|||
126681275|NCT02631200|455789718|FG001|Deferred Period|Withdrawal by Subject|2|||
126681276|NCT02631200|455789717|FG000|Deferred Period|Lost to Follow-up|0|||
126681277|NCT02631200|455789718|FG001|Deferred Period|Lost to Follow-up|1|||
126681278|NCT01081912|455789719|FG000|Conversion/Titration|Adverse Event|47|||
126681279|NCT01081912|455789720|FG001|Conversion/Titration|Adverse Event|0|||
126681280|NCT01081912|455789721|FG002|Conversion/Titration|Adverse Event|0|||
126681281|NCT01081912|455789719|FG000|Conversion/Titration|Lack of Efficacy|17|||
126681282|NCT01081912|455789720|FG001|Conversion/Titration|Lack of Efficacy|0|||
126681283|NCT01081912|455789721|FG002|Conversion/Titration|Lack of Efficacy|0|||
126681284|NCT01081912|455789719|FG000|Conversion/Titration|Lost to Follow-up|5|||
126434894|NCT02318706|454891573|FG002|Open-label Extension Phase|Adverse Event|0|||
126434895|NCT02318706|454891574|FG003|Open-label Extension Phase|Adverse Event|0|||
126434896|NCT02318706|454891575|FG004|Open-label Extension Phase|Adverse Event|21|||
126434897|NCT02318706|454891571|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
126434898|NCT02318706|454891572|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
126545306|NCT03107377|455290805|FG000|Overall Study|Other reason not specified|16|||
126681285|NCT01081912|455789720|FG001|Conversion/Titration|Lost to Follow-up|0|||
126681286|NCT01081912|455789721|FG002|Conversion/Titration|Lost to Follow-up|0|||
126681287|NCT01081912|455789719|FG000|Conversion/Titration|Physician Decision|2|||
126681288|NCT01081912|455789720|FG001|Conversion/Titration|Physician Decision|0|||
126681289|NCT01081912|455789721|FG002|Conversion/Titration|Physician Decision|0|||
126681290|NCT01081912|455789719|FG000|Conversion/Titration|Protocol Violation|67|||
126681291|NCT01081912|455789720|FG001|Conversion/Titration|Protocol Violation|0|||
126681292|NCT01081912|455789721|FG002|Conversion/Titration|Protocol Violation|0|||
126681293|NCT01081912|455789719|FG000|Conversion/Titration|Withdrawal by Subject|23|||
126681294|NCT01081912|455789720|FG001|Conversion/Titration|Withdrawal by Subject|0|||
126681295|NCT01081912|455789721|FG002|Conversion/Titration|Withdrawal by Subject|0|||
126681296|NCT01081912|455789719|FG000|Conversion/Titration|Non-Compliance|47|||
126681297|NCT01081912|455789720|FG001|Conversion/Titration|Non-Compliance|0|||
126681298|NCT01081912|455789721|FG002|Conversion/Titration|Non-Compliance|0|||
126681299|NCT01081912|455789719|FG000|Maintenance Treatment|Adverse Event|0|||
126681300|NCT01081912|455789720|FG001|Maintenance Treatment|Adverse Event|2|||
126681301|NCT01081912|455789721|FG002|Maintenance Treatment|Adverse Event|12|||
126434899|NCT02318706|454891573|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
126434900|NCT02318706|454891574|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
126434901|NCT02318706|454891575|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
126681302|NCT01081912|455789719|FG000|Maintenance Treatment|Lack of Efficacy|0|||
126681303|NCT01081912|455789720|FG001|Maintenance Treatment|Lack of Efficacy|14|||
126434902|NCT02318706|454891571|FG000|Open-label Extension Phase|Death|0|||
126434903|NCT02318706|454891572|FG001|Open-label Extension Phase|Death|0|||
126681304|NCT01081912|455789721|FG002|Maintenance Treatment|Lack of Efficacy|64|||
126348726|NCT03765073|454571050|FG009|Stage 2|Withdrawal by parent/guardian|0|||
126348727|NCT03765073|454571051|FG010|Stage 2|Withdrawal by parent/guardian|3|||
126348728|NCT03765073|454571052|FG011|Stage 2|Withdrawal by parent/guardian|3|||
126348729|NCT03765073|454571053|FG012|Stage 2|Withdrawal by parent/guardian|3|||
126348730|NCT03765073|454571054|FG013|Stage 2|Withdrawal by parent/guardian|1|||
126348731|NCT03765073|454571055|FG014|Stage 2|Withdrawal by parent/guardian|1|||
126348732|NCT03765073|454571056|FG015|Stage 2|Withdrawal by parent/guardian|0|||
126348733|NCT03765073|454571057|FG016|Stage 2|Withdrawal by parent/guardian|3|||
126348734|NCT03765073|454571058|FG017|Stage 2|Withdrawal by parent/guardian|0|||
126348735|NCT03765073|454571059|FG018|Stage 2|Withdrawal by parent/guardian|0|||
126434904|NCT02318706|454891573|FG002|Open-label Extension Phase|Death|0|||
126434905|NCT02318706|454891574|FG003|Open-label Extension Phase|Death|0|||
126681305|NCT01081912|455789719|FG000|Maintenance Treatment|Lost to Follow-up|0|||
126348736|NCT03765073|454571060|FG019|Stage 2|Withdrawal by parent/guardian|0|||
126348737|NCT03765073|454571061|FG020|Stage 2|Withdrawal by parent/guardian|0|||
126348738|NCT03765073|454571041|FG000|Stage 2|Withdrawal by Subject|0|||
126348739|NCT03765073|454571042|FG001|Stage 2|Withdrawal by Subject|0|||
126348740|NCT03765073|454571043|FG002|Stage 2|Withdrawal by Subject|0|||
126348741|NCT03765073|454571044|FG003|Stage 2|Withdrawal by Subject|3|||
126348742|NCT03765073|454571045|FG004|Stage 2|Withdrawal by Subject|3|||
126348743|NCT03765073|454571046|FG005|Stage 2|Withdrawal by Subject|3|||
126348744|NCT03765073|454571047|FG006|Stage 2|Withdrawal by Subject|0|||
126348745|NCT03765073|454571048|FG007|Stage 2|Withdrawal by Subject|1|||
126348746|NCT03765073|454571049|FG008|Stage 2|Withdrawal by Subject|0|||
126348747|NCT03765073|454571050|FG009|Stage 2|Withdrawal by Subject|5|||
126348748|NCT03765073|454571051|FG010|Stage 2|Withdrawal by Subject|0|||
126348749|NCT03765073|454571052|FG011|Stage 2|Withdrawal by Subject|0|||
126348750|NCT03765073|454571053|FG012|Stage 2|Withdrawal by Subject|0|||
126348751|NCT03765073|454571054|FG013|Stage 2|Withdrawal by Subject|0|||
126348752|NCT03765073|454571055|FG014|Stage 2|Withdrawal by Subject|0|||
126348753|NCT03765073|454571056|FG015|Stage 2|Withdrawal by Subject|0|||
126348754|NCT03765073|454571057|FG016|Stage 2|Withdrawal by Subject|0|||
126348755|NCT03765073|454571058|FG017|Stage 2|Withdrawal by Subject|0|||
126348756|NCT03765073|454571059|FG018|Stage 2|Withdrawal by Subject|0|||
126348757|NCT03765073|454571060|FG019|Stage 2|Withdrawal by Subject|0|||
126348758|NCT03765073|454571061|FG020|Stage 2|Withdrawal by Subject|0|||
126348759|NCT03765073|454571041|FG000|Stage 3|Adverse Event|0|||
126348760|NCT03765073|454571042|FG001|Stage 3|Adverse Event|0|||
126348761|NCT03765073|454571043|FG002|Stage 3|Adverse Event|0|||
126348762|NCT03765073|454571044|FG003|Stage 3|Adverse Event|0|||
126348763|NCT03765073|454571045|FG004|Stage 3|Adverse Event|0|||
126348764|NCT03765073|454571046|FG005|Stage 3|Adverse Event|0|||
126348765|NCT03765073|454571047|FG006|Stage 3|Adverse Event|0|||
126348766|NCT03765073|454571048|FG007|Stage 3|Adverse Event|0|||
126348767|NCT03765073|454571049|FG008|Stage 3|Adverse Event|0|||
126348768|NCT03765073|454571050|FG009|Stage 3|Adverse Event|0|||
126348769|NCT03765073|454571051|FG010|Stage 3|Adverse Event|0|||
126348770|NCT03765073|454571052|FG011|Stage 3|Adverse Event|0|||
126348771|NCT03765073|454571053|FG012|Stage 3|Adverse Event|0|||
126348772|NCT03765073|454571054|FG013|Stage 3|Adverse Event|0|||
126348773|NCT03765073|454571055|FG014|Stage 3|Adverse Event|0|||
126348774|NCT03765073|454571056|FG015|Stage 3|Adverse Event|0|||
126348775|NCT03765073|454571057|FG016|Stage 3|Adverse Event|0|||
126348776|NCT03765073|454571058|FG017|Stage 3|Adverse Event|0|||
126348777|NCT03765073|454571059|FG018|Stage 3|Adverse Event|1|||
126348778|NCT03765073|454571060|FG019|Stage 3|Adverse Event|0|||
126348779|NCT03765073|454571061|FG020|Stage 3|Adverse Event|0|||
126681306|NCT01081912|455789720|FG001|Maintenance Treatment|Lost to Follow-up|1|||
126681307|NCT01081912|455789721|FG002|Maintenance Treatment|Lost to Follow-up|0|||
126681308|NCT01081912|455789719|FG000|Maintenance Treatment|Physician Decision|0|||
126681309|NCT01081912|455789720|FG001|Maintenance Treatment|Physician Decision|0|||
126681310|NCT01081912|455789721|FG002|Maintenance Treatment|Physician Decision|1|||
126681311|NCT01081912|455789719|FG000|Maintenance Treatment|Protocol Violation|0|||
126681312|NCT01081912|455789720|FG001|Maintenance Treatment|Protocol Violation|1|||
126348780|NCT03765073|454571041|FG000|Stage 3|Death|0|||
126348781|NCT03765073|454571042|FG001|Stage 3|Death|0|||
126348782|NCT03765073|454571043|FG002|Stage 3|Death|0|||
126681313|NCT01081912|455789721|FG002|Maintenance Treatment|Protocol Violation|2|||
126348783|NCT03765073|454571044|FG003|Stage 3|Death|0|||
126681314|NCT01081912|455789719|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
126681315|NCT01081912|455789720|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
126681316|NCT01081912|455789721|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
126681317|NCT01081912|455789719|FG000|Maintenance Treatment|Non-Compliance|0|||
126681318|NCT01081912|455789720|FG001|Maintenance Treatment|Non-Compliance|4|||
126681319|NCT01081912|455789721|FG002|Maintenance Treatment|Non-Compliance|7|||
126681320|NCT01081912|455789719|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
126434906|NCT02318706|454891575|FG004|Open-label Extension Phase|Death|1|||
126434907|NCT02318706|454891571|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
126434908|NCT02318706|454891572|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
126434909|NCT02318706|454891573|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
126434910|NCT02318706|454891574|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
126434911|NCT02318706|454891575|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
126434912|NCT00992108|454891585|FG000|Overall Study|Lost to Follow-up|0|||
126434913|NCT00992108|454891586|FG001|Overall Study|Lost to Follow-up|1|||
126434914|NCT01702311|454891587|FG000|Overall Study|Withdrawal by Subject|3|||
126434915|NCT01702311|454891588|FG001|Overall Study|Withdrawal by Subject|2|||
126434916|NCT01702311|454891587|FG000|Overall Study|Discharge less than 24 hours|10|||
126434917|NCT01702311|454891588|FG001|Overall Study|Discharge less than 24 hours|7|||
126434918|NCT01702311|454891587|FG000|Overall Study|Physician Decision|3|||
126434919|NCT01702311|454891588|FG001|Overall Study|Physician Decision|4|||
126434920|NCT04106557|454891590|FG000|Overall Study|Physician Decision|0|||
126434921|NCT04106557|454891591|FG001|Overall Study|Physician Decision|1|||
126434922|NCT04106557|454891592|FG002|Overall Study|Physician Decision|0|||
126434923|NCT04106557|454891590|FG000|Overall Study|Protocol Violation|0|||
126434924|NCT04106557|454891591|FG001|Overall Study|Protocol Violation|1|||
126434925|NCT04106557|454891592|FG002|Overall Study|Protocol Violation|0|||
126434926|NCT01209689|454891593|FG000|Overall Study|Insufficient Therapeutic Response|7|||
126434927|NCT01209689|454891594|FG001|Overall Study|Insufficient Therapeutic Response|2|||
126434928|NCT01209689|454891593|FG000|Overall Study|Refused Treatment|8|||
126434929|NCT01209689|454891594|FG001|Overall Study|Refused Treatment|3|||
126434930|NCT01209689|454891593|FG000|Overall Study|Adverse Event|4|||
126434931|NCT01209689|454891594|FG001|Overall Study|Adverse Event|0|||
126434932|NCT01209689|454891593|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
126434933|NCT01209689|454891594|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
126434934|NCT01209689|454891593|FG000|Overall Study|Failure to Return|3|||
126434935|NCT01209689|454891594|FG001|Overall Study|Failure to Return|0|||
126434936|NCT01209689|454891593|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
126434937|NCT01209689|454891594|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
126434938|NCT03175367|454891595|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
126434939|NCT03175367|454891596|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
126434940|NCT03175367|454891597|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
126434941|NCT03175367|454891598|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
126434942|NCT03175367|454891599|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
126434943|NCT03175367|454891600|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
126434944|NCT03175367|454891601|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
126434945|NCT03175367|454891595|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
126434946|NCT03175367|454891596|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
126434947|NCT03175367|454891597|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
126434948|NCT03175367|454891598|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
126434949|NCT03175367|454891599|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
126434950|NCT03175367|454891600|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
126434951|NCT03175367|454891601|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
126681321|NCT01081912|455789720|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
126681322|NCT01081912|455789721|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
126681323|NCT03776175|455789722|FG000|Treatment Period (42 Days)|Adverse Event|0|||
126681324|NCT03776175|455789723|FG001|Treatment Period (42 Days)|Adverse Event|1|||
126681325|NCT03776175|455789724|FG002|Treatment Period (42 Days)|Adverse Event|1|||
126681326|NCT03776175|455789725|FG003|Treatment Period (42 Days)|Adverse Event|0|||
126681327|NCT03776175|455789722|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
126434952|NCT03175367|454891595|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
126434953|NCT03175367|454891596|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
126434954|NCT03175367|454891597|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
126434955|NCT03175367|454891598|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
126434956|NCT03175367|454891599|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126434957|NCT03175367|454891600|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
126434958|NCT03175367|454891601|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126434959|NCT03175367|454891595|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
126681328|NCT03776175|455789723|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
126681329|NCT03776175|455789724|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
126434960|NCT03175367|454891596|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
126434961|NCT03175367|454891597|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
126434962|NCT03175367|454891598|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
126434963|NCT03175367|454891599|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
126434964|NCT03175367|454891600|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
126434965|NCT03175367|454891601|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
126434966|NCT03175367|454891595|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
126434967|NCT03175367|454891596|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
126434968|NCT03175367|454891597|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
126434969|NCT03175367|454891598|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
126434970|NCT03175367|454891599|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
126434971|NCT03175367|454891600|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
126434972|NCT03175367|454891601|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
126434973|NCT03175367|454891595|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
126434974|NCT03175367|454891596|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
126434975|NCT03175367|454891597|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
126434976|NCT03175367|454891598|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
126434977|NCT03175367|454891599|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
126434978|NCT03175367|454891600|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
126434979|NCT03175367|454891601|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
126434980|NCT03175367|454891595|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126434981|NCT03175367|454891596|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126434982|NCT03175367|454891597|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126434983|NCT03175367|454891598|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126434984|NCT03175367|454891599|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126434985|NCT03175367|454891600|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
126434986|NCT03175367|454891601|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
126434987|NCT02151058|454891602|FG000|Overall Study|Withdrawal by Subject|1|||
126434988|NCT02151058|454891603|FG001|Overall Study|Withdrawal by Subject|1|||
126434989|NCT02151058|454891604|FG002|Overall Study|Withdrawal by Subject|3|||
126434990|NCT02151058|454891602|FG000|Overall Study|Lost to Follow-up|1|||
126434991|NCT02151058|454891603|FG001|Overall Study|Lost to Follow-up|0|||
126434992|NCT02151058|454891604|FG002|Overall Study|Lost to Follow-up|2|||
126434993|NCT03181932|454891606|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
126434994|NCT03181932|454891607|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
126434995|NCT03181932|454891606|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
126434996|NCT03181932|454891607|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
126434997|NCT03181932|454891606|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
126434998|NCT03181932|454891607|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
126434999|NCT03181932|454891606|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
126435000|NCT03181932|454891607|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
126435001|NCT03181932|454891606|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
126681330|NCT03776175|455789725|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
126681331|NCT03776175|455789722|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
126681332|NCT03776175|455789723|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
126681333|NCT03776175|455789724|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
126681334|NCT03776175|455789725|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
126681335|NCT03776175|455789722|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
126681336|NCT03776175|455789723|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
126348784|NCT03765073|454571045|FG004|Stage 3|Death|0|||
126348785|NCT03765073|454571046|FG005|Stage 3|Death|0|||
126348786|NCT03765073|454571047|FG006|Stage 3|Death|0|||
126348787|NCT03765073|454571048|FG007|Stage 3|Death|0|||
126348788|NCT03765073|454571049|FG008|Stage 3|Death|0|||
126348789|NCT03765073|454571050|FG009|Stage 3|Death|0|||
126348790|NCT03765073|454571051|FG010|Stage 3|Death|0|||
126348791|NCT03765073|454571052|FG011|Stage 3|Death|0|||
126348792|NCT03765073|454571053|FG012|Stage 3|Death|0|||
126348793|NCT03765073|454571054|FG013|Stage 3|Death|0|||
126348794|NCT03765073|454571055|FG014|Stage 3|Death|0|||
126348795|NCT03765073|454571056|FG015|Stage 3|Death|0|||
126348796|NCT03765073|454571057|FG016|Stage 3|Death|0|||
126348797|NCT03765073|454571058|FG017|Stage 3|Death|0|||
126348798|NCT03765073|454571059|FG018|Stage 3|Death|0|||
126348799|NCT03765073|454571060|FG019|Stage 3|Death|3|||
126348800|NCT03765073|454571061|FG020|Stage 3|Death|2|||
126348801|NCT03765073|454571041|FG000|Stage 3|Lost to Follow-up|0|||
126348802|NCT03765073|454571042|FG001|Stage 3|Lost to Follow-up|0|||
126348803|NCT03765073|454571043|FG002|Stage 3|Lost to Follow-up|0|||
126348804|NCT03765073|454571044|FG003|Stage 3|Lost to Follow-up|0|||
126348805|NCT03765073|454571045|FG004|Stage 3|Lost to Follow-up|0|||
126348806|NCT03765073|454571046|FG005|Stage 3|Lost to Follow-up|0|||
126348807|NCT03765073|454571047|FG006|Stage 3|Lost to Follow-up|0|||
126348808|NCT03765073|454571048|FG007|Stage 3|Lost to Follow-up|0|||
126348809|NCT03765073|454571049|FG008|Stage 3|Lost to Follow-up|0|||
126348810|NCT03765073|454571050|FG009|Stage 3|Lost to Follow-up|0|||
126348811|NCT03765073|454571051|FG010|Stage 3|Lost to Follow-up|0|||
126348812|NCT03765073|454571052|FG011|Stage 3|Lost to Follow-up|0|||
126348813|NCT03765073|454571053|FG012|Stage 3|Lost to Follow-up|0|||
126348814|NCT03765073|454571054|FG013|Stage 3|Lost to Follow-up|0|||
126348815|NCT03765073|454571055|FG014|Stage 3|Lost to Follow-up|0|||
126348816|NCT03765073|454571056|FG015|Stage 3|Lost to Follow-up|0|||
126348817|NCT03765073|454571057|FG016|Stage 3|Lost to Follow-up|0|||
126348818|NCT03765073|454571058|FG017|Stage 3|Lost to Follow-up|8|||
126348819|NCT03765073|454571059|FG018|Stage 3|Lost to Follow-up|5|||
126348820|NCT03765073|454571060|FG019|Stage 3|Lost to Follow-up|7|||
126348821|NCT03765073|454571061|FG020|Stage 3|Lost to Follow-up|4|||
126348822|NCT03765073|454571041|FG000|Stage 3|No longer meets eligibility criteria|0|||
126348823|NCT03765073|454571042|FG001|Stage 3|No longer meets eligibility criteria|0|||
126348824|NCT03765073|454571043|FG002|Stage 3|No longer meets eligibility criteria|0|||
126348825|NCT03765073|454571044|FG003|Stage 3|No longer meets eligibility criteria|0|||
126348826|NCT03765073|454571045|FG004|Stage 3|No longer meets eligibility criteria|0|||
126348827|NCT03765073|454571046|FG005|Stage 3|No longer meets eligibility criteria|0|||
126348828|NCT03765073|454571047|FG006|Stage 3|No longer meets eligibility criteria|0|||
126348829|NCT03765073|454571048|FG007|Stage 3|No longer meets eligibility criteria|0|||
126348830|NCT03765073|454571049|FG008|Stage 3|No longer meets eligibility criteria|0|||
126348831|NCT03765073|454571050|FG009|Stage 3|No longer meets eligibility criteria|0|||
126348832|NCT03765073|454571051|FG010|Stage 3|No longer meets eligibility criteria|0|||
126348833|NCT03765073|454571052|FG011|Stage 3|No longer meets eligibility criteria|0|||
126348834|NCT03765073|454571053|FG012|Stage 3|No longer meets eligibility criteria|0|||
126348835|NCT03765073|454571054|FG013|Stage 3|No longer meets eligibility criteria|0|||
126348836|NCT03765073|454571055|FG014|Stage 3|No longer meets eligibility criteria|0|||
126348837|NCT03765073|454571056|FG015|Stage 3|No longer meets eligibility criteria|0|||
126348838|NCT03765073|454571057|FG016|Stage 3|No longer meets eligibility criteria|0|||
126348839|NCT03765073|454571058|FG017|Stage 3|No longer meets eligibility criteria|0|||
126348840|NCT03765073|454571059|FG018|Stage 3|No longer meets eligibility criteria|1|||
126348841|NCT03765073|454571060|FG019|Stage 3|No longer meets eligibility criteria|0|||
126348842|NCT03765073|454571061|FG020|Stage 3|No longer meets eligibility criteria|1|||
126348843|NCT03765073|454571041|FG000|Stage 3|Other|0|||
126348844|NCT03765073|454571042|FG001|Stage 3|Other|0|||
126348845|NCT03765073|454571043|FG002|Stage 3|Other|0|||
126348846|NCT03765073|454571044|FG003|Stage 3|Other|0|||
126348847|NCT03765073|454571045|FG004|Stage 3|Other|0|||
126348848|NCT03765073|454571046|FG005|Stage 3|Other|0|||
126348849|NCT03765073|454571047|FG006|Stage 3|Other|0|||
126348850|NCT03765073|454571048|FG007|Stage 3|Other|0|||
126348851|NCT03765073|454571049|FG008|Stage 3|Other|0|||
126348852|NCT03765073|454571050|FG009|Stage 3|Other|0|||
126348853|NCT03765073|454571051|FG010|Stage 3|Other|0|||
126348854|NCT03765073|454571052|FG011|Stage 3|Other|0|||
126348855|NCT03765073|454571053|FG012|Stage 3|Other|0|||
126348856|NCT03765073|454571054|FG013|Stage 3|Other|0|||
126348857|NCT03765073|454571055|FG014|Stage 3|Other|0|||
126348858|NCT03765073|454571056|FG015|Stage 3|Other|0|||
126348859|NCT03765073|454571057|FG016|Stage 3|Other|0|||
126435002|NCT03181932|454891607|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
126435003|NCT03181932|454891606|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
126435004|NCT03181932|454891607|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
126435005|NCT03181932|454891606|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
126435006|NCT03181932|454891607|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
126435007|NCT03181932|454891606|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
126435008|NCT03181932|454891607|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
126435009|NCT03181932|454891606|FG000|Period 2 (Open-label Period)|Reason missing|2|||
126435010|NCT03181932|454891607|FG001|Period 2 (Open-label Period)|Reason missing|0|||
126435011|NCT00853307|454891608|FG000|Overall Study|Adverse Event|1|||
126435012|NCT00853307|454891609|FG001|Overall Study|Adverse Event|2|||
126435013|NCT00853307|454891608|FG000|Overall Study|Withdrawal by Subject|1|||
126435014|NCT00853307|454891609|FG001|Overall Study|Withdrawal by Subject|2|||
126435015|NCT00853307|454891608|FG000|Overall Study|Reason Not Specified|0|||
126435016|NCT00853307|454891609|FG001|Overall Study|Reason Not Specified|1|||
126435017|NCT00674817|454891610|FG000|Period 1|Withdrawal by Subject|2|||
126435018|NCT00674817|454891610|FG000|Period 1|Protocol Violation|1|||
126435019|NCT00674817|454891610|FG000|Period 3|Adverse Event|1|||
126435020|NCT00674817|454891610|FG000|Period 3|Protocol Violation|1|||
126435021|NCT00674817|454891610|FG000|Period 4|Adverse Event|1|||
126681337|NCT03776175|455789724|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
126435022|NCT01112917|454891611|FG000|Overall Study|Death|2|||
126435023|NCT01112917|454891612|FG001|Overall Study|Death|11|||
126435024|NCT01112917|454891611|FG000|Overall Study|Lost to Follow-up|1|||
126435025|NCT01112917|454891612|FG001|Overall Study|Lost to Follow-up|1|||
126435026|NCT01112917|454891611|FG000|Overall Study|Withdrawal by Subject|1|||
126435027|NCT01112917|454891612|FG001|Overall Study|Withdrawal by Subject|3|||
126435028|NCT01112917|454891611|FG000|Overall Study|Unable to Convert Filter|3|||
126435029|NCT01112917|454891612|FG001|Overall Study|Unable to Convert Filter|0|||
126435030|NCT02177123|454891613|FG000|Overall Study|Lost to Follow-up|6|||
126435031|NCT02177123|454891613|FG000|Overall Study|Withdrawal by Subject|4|||
126435032|NCT02177123|454891613|FG000|Overall Study|Adverse Event|4|||
126435033|NCT02177123|454891613|FG000|Overall Study|Physician Decision|3|||
126435034|NCT02177123|454891613|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
126435035|NCT02177123|454891613|FG000|Overall Study|Excluded for medical reasons|2|||
126435036|NCT02177123|454891613|FG000|Overall Study|Death|1|||
126435037|NCT02177123|454891613|FG000|Overall Study|Other|1|||
126435038|NCT02177123|454891613|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
126435039|NCT03199976|454891614|FG000|Overall Study|Lack of Efficacy|3|||
126435040|NCT03199976|454891615|FG001|Overall Study|Lack of Efficacy|6|||
126435041|NCT03199976|454891616|FG002|Overall Study|Lack of Efficacy|13|||
126435042|NCT03199976|454891614|FG000|Overall Study|Withdrawal by Subject|1|||
126435043|NCT03199976|454891615|FG001|Overall Study|Withdrawal by Subject|0|||
126435044|NCT03199976|454891616|FG002|Overall Study|Withdrawal by Subject|0|||
126435045|NCT03199976|454891614|FG000|Overall Study|Lost to Follow-up|0|||
126435046|NCT03199976|454891615|FG001|Overall Study|Lost to Follow-up|1|||
126435047|NCT03199976|454891616|FG002|Overall Study|Lost to Follow-up|1|||
126435048|NCT03697252|454891623|FG000|Overall Study|Adverse Event|3|||
126435049|NCT03697252|454891624|FG001|Overall Study|Adverse Event|2|||
126435050|NCT03697252|454891623|FG000|Overall Study|Withdrawal by Subject|14|||
126435051|NCT03697252|454891624|FG001|Overall Study|Withdrawal by Subject|14|||
126435052|NCT03697252|454891623|FG000|Overall Study|Lost to Follow-up|0|||
126435053|NCT03697252|454891624|FG001|Overall Study|Lost to Follow-up|1|||
126435054|NCT03697252|454891623|FG000|Overall Study|Physician Decision|1|||
126435055|NCT03697252|454891624|FG001|Overall Study|Physician Decision|1|||
126435056|NCT03697252|454891623|FG000|Overall Study|Other|0|||
126435057|NCT03697252|454891624|FG001|Overall Study|Other|1|||
126435058|NCT01780506|454891625|FG000|Double-Blind Phase|Randomized but not Treated|3|||
126435059|NCT01780506|454891626|FG001|Double-Blind Phase|Randomized but not Treated|2|||
126435060|NCT01780506|454891625|FG000|Double-Blind Phase|Adverse Event|4|||
126435061|NCT01780506|454891626|FG001|Double-Blind Phase|Adverse Event|14|||
126435062|NCT01780506|454891625|FG000|Double-Blind Phase|Death|1|||
126435063|NCT01780506|454891626|FG001|Double-Blind Phase|Death|2|||
126435064|NCT01780506|454891625|FG000|Double-Blind Phase|Pregnancy|2|||
126435065|NCT01780506|454891626|FG001|Double-Blind Phase|Pregnancy|1|||
126435066|NCT01780506|454891625|FG000|Double-Blind Phase|Lack of Efficacy|1|||
126435067|NCT01780506|454891626|FG001|Double-Blind Phase|Lack of Efficacy|1|||
126435068|NCT01780506|454891625|FG000|Double-Blind Phase|Investigator's Discretion|5|||
126435069|NCT01780506|454891626|FG001|Double-Blind Phase|Investigator's Discretion|2|||
126435070|NCT01780506|454891625|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
126435071|NCT01780506|454891626|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
126435072|NCT01780506|454891625|FG000|Double-Blind Phase|Protocol Violation|4|||
126435073|NCT01780506|454891626|FG001|Double-Blind Phase|Protocol Violation|3|||
126435074|NCT01780506|454891625|FG000|Double-Blind Phase|Withdrew Consent|23|||
126435075|NCT01780506|454891626|FG001|Double-Blind Phase|Withdrew Consent|24|||
126435076|NCT01780506|454891625|FG000|Double-Blind Phase|Lost to Follow-up|23|||
126435077|NCT01780506|454891626|FG001|Double-Blind Phase|Lost to Follow-up|26|||
126435078|NCT01780506|454891625|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
126435079|NCT01780506|454891626|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
126435080|NCT05236270|454891627|FG000|Overall Study|Lost to Follow-up|3|||
126435081|NCT05236270|454891628|FG001|Overall Study|Lost to Follow-up|2|||
126681338|NCT03776175|455789725|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
126681339|NCT03776175|455789722|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
126435082|NCT05236270|454891629|FG002|Overall Study|Lost to Follow-up|0|||
126435083|NCT05236270|454891630|FG003|Overall Study|Lost to Follow-up|0|||
126435084|NCT05236270|454891631|FG004|Overall Study|Lost to Follow-up|2|||
126348860|NCT03765073|454571058|FG017|Stage 3|Other|1|||
126348861|NCT03765073|454571059|FG018|Stage 3|Other|2|||
126348862|NCT03765073|454571060|FG019|Stage 3|Other|2|||
126348863|NCT03765073|454571061|FG020|Stage 3|Other|2|||
126348864|NCT03765073|454571041|FG000|Stage 3|Withdrawal by parent/guardian|0|||
126348865|NCT03765073|454571042|FG001|Stage 3|Withdrawal by parent/guardian|0|||
126348866|NCT03765073|454571043|FG002|Stage 3|Withdrawal by parent/guardian|0|||
126348867|NCT03765073|454571044|FG003|Stage 3|Withdrawal by parent/guardian|0|||
126348868|NCT03765073|454571045|FG004|Stage 3|Withdrawal by parent/guardian|0|||
126348869|NCT03765073|454571046|FG005|Stage 3|Withdrawal by parent/guardian|0|||
126348870|NCT03765073|454571047|FG006|Stage 3|Withdrawal by parent/guardian|0|||
126348871|NCT03765073|454571048|FG007|Stage 3|Withdrawal by parent/guardian|0|||
126348872|NCT03765073|454571049|FG008|Stage 3|Withdrawal by parent/guardian|0|||
126348873|NCT03765073|454571050|FG009|Stage 3|Withdrawal by parent/guardian|0|||
126348874|NCT03765073|454571051|FG010|Stage 3|Withdrawal by parent/guardian|0|||
126348875|NCT03765073|454571052|FG011|Stage 3|Withdrawal by parent/guardian|0|||
126348876|NCT03765073|454571053|FG012|Stage 3|Withdrawal by parent/guardian|0|||
126348877|NCT03765073|454571054|FG013|Stage 3|Withdrawal by parent/guardian|0|||
126348878|NCT03765073|454571055|FG014|Stage 3|Withdrawal by parent/guardian|0|||
126348879|NCT03765073|454571056|FG015|Stage 3|Withdrawal by parent/guardian|0|||
126348880|NCT03765073|454571057|FG016|Stage 3|Withdrawal by parent/guardian|0|||
126348881|NCT03765073|454571058|FG017|Stage 3|Withdrawal by parent/guardian|0|||
126348882|NCT03765073|454571059|FG018|Stage 3|Withdrawal by parent/guardian|0|||
126348883|NCT03765073|454571060|FG019|Stage 3|Withdrawal by parent/guardian|6|||
126348884|NCT03765073|454571061|FG020|Stage 3|Withdrawal by parent/guardian|9|||
126348885|NCT03765073|454571041|FG000|Stage 3|Withdrawal by Subject|0|||
126348886|NCT03765073|454571042|FG001|Stage 3|Withdrawal by Subject|0|||
126348887|NCT03765073|454571043|FG002|Stage 3|Withdrawal by Subject|0|||
126348888|NCT03765073|454571044|FG003|Stage 3|Withdrawal by Subject|0|||
126348889|NCT03765073|454571045|FG004|Stage 3|Withdrawal by Subject|0|||
126348890|NCT03765073|454571046|FG005|Stage 3|Withdrawal by Subject|0|||
126348891|NCT03765073|454571047|FG006|Stage 3|Withdrawal by Subject|0|||
126348892|NCT03765073|454571048|FG007|Stage 3|Withdrawal by Subject|0|||
126348893|NCT03765073|454571049|FG008|Stage 3|Withdrawal by Subject|0|||
126348894|NCT03765073|454571050|FG009|Stage 3|Withdrawal by Subject|0|||
126348895|NCT03765073|454571051|FG010|Stage 3|Withdrawal by Subject|0|||
126348896|NCT03765073|454571052|FG011|Stage 3|Withdrawal by Subject|0|||
126435085|NCT05236270|454891632|FG005|Overall Study|Lost to Follow-up|0|||
126435086|NCT05236270|454891633|FG006|Overall Study|Lost to Follow-up|1|||
126435087|NCT05236270|454891634|FG007|Overall Study|Lost to Follow-up|3|||
126435088|NCT02383576|454891635|FG000|Overall Study|Death|53|||
126435089|NCT02383576|454891636|FG001|Overall Study|Death|33|||
126435090|NCT02383576|454891635|FG000|Overall Study|Lost to Follow-up|7|||
126435091|NCT02383576|454891636|FG001|Overall Study|Lost to Follow-up|1|||
126435092|NCT02383576|454891635|FG000|Overall Study|Withdrew Consent|1|||
126435093|NCT02383576|454891636|FG001|Overall Study|Withdrew Consent|6|||
126435094|NCT02383576|454891635|FG000|Overall Study|Investigator's Decision|0|||
126435095|NCT02383576|454891636|FG001|Overall Study|Investigator's Decision|1|||
126435096|NCT02383576|454891635|FG000|Overall Study|Administrative/Other|2|||
126435097|NCT02383576|454891636|FG001|Overall Study|Administrative/Other|4|||
126435098|NCT02435212|454891637|FG000|Core Phase|Adverse Event|8|||
126435099|NCT02435212|454891638|FG001|Core Phase|Adverse Event|5|||
126435100|NCT02435212|454891637|FG000|Core Phase|Withdrawal by Subject|3|||
126435101|NCT02435212|454891638|FG001|Core Phase|Withdrawal by Subject|0|||
126435102|NCT02435212|454891637|FG000|Core Phase|Withdrawal by parent/guardian|9|||
126435103|NCT02435212|454891638|FG001|Core Phase|Withdrawal by parent/guardian|4|||
126681340|NCT03776175|455789723|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
126681341|NCT03776175|455789724|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
126681342|NCT03776175|455789725|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
126681343|NCT03776175|455789722|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
126681344|NCT03776175|455789723|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
126681345|NCT03776175|455789724|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
126681346|NCT03776175|455789725|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
126681347|NCT00414453|455789731|FG000|Overall Study|Abnormal lab work|16|||
126681348|NCT00845728|455789732|FG000|Overall Study|Abnormal laboratory value (s)|2|||
126681349|NCT00845728|455789733|FG001|Overall Study|Abnormal laboratory value (s)|2|||
126681350|NCT00845728|455789732|FG000|Overall Study|Patient's inability to use the device|4|||
126681351|NCT00845728|455789733|FG001|Overall Study|Patient's inability to use the device|6|||
126681352|NCT00845728|455789732|FG000|Overall Study|Abnormal test procedure result (s)|7|||
126681353|NCT00845728|455789733|FG001|Overall Study|Abnormal test procedure result (s)|2|||
126681354|NCT00845728|455789732|FG000|Overall Study|Lost to Follow-up|22|||
126681355|NCT00845728|455789733|FG001|Overall Study|Lost to Follow-up|13|||
126681356|NCT00845728|455789732|FG000|Overall Study|Death|24|||
126681357|NCT00845728|455789733|FG001|Overall Study|Death|26|||
126681358|NCT00845728|455789732|FG000|Overall Study|Administrative Problems|34|||
126681359|NCT00845728|455789733|FG001|Overall Study|Administrative Problems|26|||
126681360|NCT00845728|455789732|FG000|Overall Study|Protocol Violation|36|||
126681361|NCT00845728|455789733|FG001|Overall Study|Protocol Violation|24|||
126681362|NCT00845728|455789732|FG000|Overall Study|Lack of Efficacy|51|||
126681363|NCT00845728|455789733|FG001|Overall Study|Lack of Efficacy|39|||
126681364|NCT00845728|455789732|FG000|Overall Study|Adverse Event|101|||
126681365|NCT00845728|455789733|FG001|Overall Study|Adverse Event|96|||
126681366|NCT00845728|455789732|FG000|Overall Study|Withdrawal by Subject|105|||
126681367|NCT00845728|455789733|FG001|Overall Study|Withdrawal by Subject|108|||
126681368|NCT03245450|455789737|FG000|Overall Study|Radiological disease progression|3|||
126681369|NCT03245450|455789738|FG001|Overall Study|Radiological disease progression|3|||
126681370|NCT03245450|455789739|FG002|Overall Study|Radiological disease progression|2|||
126681371|NCT03245450|455789740|FG003|Overall Study|Radiological disease progression|2|||
126681372|NCT03245450|455789741|FG004|Overall Study|Radiological disease progression|7|||
126681373|NCT03245450|455789742|FG005|Overall Study|Radiological disease progression|6|||
126681374|NCT03245450|455789743|FG006|Overall Study|Radiological disease progression|6|||
126681375|NCT03245450|455789737|FG000|Overall Study|Clinical disease progression|0|||
126681376|NCT03245450|455789738|FG001|Overall Study|Clinical disease progression|0|||
126681377|NCT03245450|455789739|FG002|Overall Study|Clinical disease progression|1|||
126681378|NCT03245450|455789740|FG003|Overall Study|Clinical disease progression|0|||
126681379|NCT03245450|455789741|FG004|Overall Study|Clinical disease progression|0|||
126681380|NCT03245450|455789742|FG005|Overall Study|Clinical disease progression|2|||
126681381|NCT03245450|455789743|FG006|Overall Study|Clinical disease progression|0|||
126681382|NCT03245450|455789737|FG000|Overall Study|Other|0|||
126681383|NCT03245450|455789738|FG001|Overall Study|Other|0|||
126681384|NCT03245450|455789739|FG002|Overall Study|Other|0|||
126435104|NCT02435212|454891637|FG000|Core Phase|Protocol Violation|1|||
126435105|NCT02435212|454891638|FG001|Core Phase|Protocol Violation|2|||
126435106|NCT02435212|454891637|FG000|Core Phase|Physician Decision|3|||
126435107|NCT02435212|454891638|FG001|Core Phase|Physician Decision|0|||
126435108|NCT02435212|454891637|FG000|Core Phase|Lost to Follow-up|0|||
126435109|NCT02435212|454891638|FG001|Core Phase|Lost to Follow-up|1|||
126348897|NCT03765073|454571053|FG012|Stage 3|Withdrawal by Subject|0|||
126348898|NCT03765073|454571054|FG013|Stage 3|Withdrawal by Subject|0|||
126348899|NCT03765073|454571055|FG014|Stage 3|Withdrawal by Subject|0|||
126348900|NCT03765073|454571056|FG015|Stage 3|Withdrawal by Subject|0|||
126348901|NCT03765073|454571057|FG016|Stage 3|Withdrawal by Subject|0|||
126348902|NCT03765073|454571058|FG017|Stage 3|Withdrawal by Subject|8|||
126348903|NCT03765073|454571059|FG018|Stage 3|Withdrawal by Subject|11|||
126348904|NCT03765073|454571060|FG019|Stage 3|Withdrawal by Subject|0|||
126348905|NCT03765073|454571061|FG020|Stage 3|Withdrawal by Subject|0|||
126348906|NCT04225039|454571064|FG000|Overall Study|Withdrawal by Subject|1|||
126348907|NCT04225039|454571065|FG001|Overall Study|Withdrawal by Subject|0|||
126348908|NCT04225039|454571066|FG002|Overall Study|Withdrawal by Subject|0|||
126348909|NCT04225039|454571067|FG003|Overall Study|Withdrawal by Subject|1|||
126348910|NCT04225039|454571064|FG000|Overall Study|Currently active on study treatment|0|||
126348911|NCT04225039|454571065|FG001|Overall Study|Currently active on study treatment|1|||
126348912|NCT04225039|454571066|FG002|Overall Study|Currently active on study treatment|0|||
126348913|NCT04225039|454571067|FG003|Overall Study|Currently active on study treatment|0|||
126348914|NCT04225039|454571064|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
126348915|NCT04225039|454571065|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
126348916|NCT04225039|454571066|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
126348917|NCT04225039|454571067|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
126348918|NCT04225039|454571064|FG000|Overall Study|Ineligible for treatment|0|||
126348919|NCT04225039|454571065|FG001|Overall Study|Ineligible for treatment|0|||
126348920|NCT04225039|454571066|FG002|Overall Study|Ineligible for treatment|0|||
126348921|NCT04225039|454571067|FG003|Overall Study|Ineligible for treatment|4|||
126348922|NCT02802228|454571069|FG000|Overall Study|Withdrawal by Subject|2|||
126348923|NCT02802228|454571070|FG001|Overall Study|Withdrawal by Subject|0|||
126348924|NCT02802228|454571069|FG000|Overall Study|Lost to Follow-up|1|||
126348925|NCT02802228|454571070|FG001|Overall Study|Lost to Follow-up|0|||
126348926|NCT02802228|454571069|FG000|Overall Study|Adverse Event|1|||
126348927|NCT02802228|454571070|FG001|Overall Study|Adverse Event|0|||
126348928|NCT02802228|454571069|FG000|Overall Study|Physician Decision|1|||
126348929|NCT02802228|454571070|FG001|Overall Study|Physician Decision|0|||
126348930|NCT00695019|454571071|FG000|Overall Study|Withdrawal by Subject|8|||
126348931|NCT00695019|454571072|FG001|Overall Study|Withdrawal by Subject|6|||
126435110|NCT02435212|454891637|FG000|Core Phase|Lack of Efficacy|0|||
126435111|NCT02435212|454891638|FG001|Core Phase|Lack of Efficacy|1|||
126681385|NCT03245450|455789740|FG003|Overall Study|Other|1|||
126681386|NCT03245450|455789741|FG004|Overall Study|Other|1|||
126435112|NCT02435212|454891637|FG000|Core Phase|Recovery|1|||
126435113|NCT02435212|454891638|FG001|Core Phase|Recovery|0|||
126435114|NCT02435212|454891637|FG000|Optional Extension Phase|Adverse Event|3|||
126435115|NCT02435212|454891638|FG001|Optional Extension Phase|Adverse Event|9|||
126435116|NCT02435212|454891637|FG000|Optional Extension Phase|Physician Decision|6|||
126435117|NCT02435212|454891638|FG001|Optional Extension Phase|Physician Decision|8|||
126435118|NCT02435212|454891637|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
126435119|NCT02435212|454891638|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
126435120|NCT02435212|454891637|FG000|Optional Extension Phase|Lack of Efficacy|2|||
126435121|NCT02435212|454891638|FG001|Optional Extension Phase|Lack of Efficacy|3|||
126435122|NCT02435212|454891637|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
126435123|NCT02435212|454891638|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
126435124|NCT02435212|454891637|FG000|Optional Extension Phase|Protocol Violation|0|||
126435125|NCT02435212|454891638|FG001|Optional Extension Phase|Protocol Violation|1|||
126435126|NCT02435212|454891637|FG000|Optional Extension Phase|Recovery|1|||
126435127|NCT02435212|454891638|FG001|Optional Extension Phase|Recovery|1|||
126435128|NCT02435212|454891637|FG000|Optional Extension Phase|Death|1|||
126435129|NCT02435212|454891638|FG001|Optional Extension Phase|Death|0|||
126435130|NCT02435212|454891637|FG000|Optional Extension Phase|Technical problems|2|||
126435131|NCT02435212|454891638|FG001|Optional Extension Phase|Technical problems|0|||
126435132|NCT05966142|454891648|FG000|Overall Study|Death|3|||
126435133|NCT05966142|454891649|FG001|Overall Study|Death|3|||
126435134|NCT05966142|454891648|FG000|Overall Study|Lost to Follow-up|55|||
126435135|NCT05966142|454891649|FG001|Overall Study|Lost to Follow-up|52|||
126435136|NCT05966142|454891648|FG000|Overall Study|Physician Decision|1|||
126435137|NCT05966142|454891649|FG001|Overall Study|Physician Decision|0|||
126435138|NCT05966142|454891648|FG000|Overall Study|Withdrawal by Subject|9|||
126435139|NCT05966142|454891649|FG001|Overall Study|Withdrawal by Subject|8|||
126435140|NCT05966142|454891648|FG000|Overall Study|Duplicate Enrollment|1|||
126435141|NCT05966142|454891649|FG001|Overall Study|Duplicate Enrollment|0|||
126435142|NCT05966142|454891648|FG000|Overall Study|Study Logistical Reason|1|||
126435143|NCT05966142|454891649|FG001|Overall Study|Study Logistical Reason|0|||
126435144|NCT05966142|454891648|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
126435145|NCT05966142|454891649|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
126435146|NCT04852302|454891655|FG000|Overall Study|Withdrawal by Subject|2|||
126435147|NCT04852302|454891655|FG000|Overall Study|Did not complete CALM therapy.|2|||
126435148|NCT04711850|454891656|FG000|Overall Study|Graft loss|2|||
126435149|NCT04711850|454891657|FG001|Overall Study|Graft loss|1|||
126435150|NCT04711850|454891656|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
126435151|NCT04711850|454891657|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
126681387|NCT03245450|455789742|FG005|Overall Study|Other|1|||
126681388|NCT03245450|455789743|FG006|Overall Study|Other|1|||
126681389|NCT03245450|455789737|FG000|Overall Study|Withdrawal by Subject|0|||
126681390|NCT03245450|455789738|FG001|Overall Study|Withdrawal by Subject|1|||
126681391|NCT03245450|455789739|FG002|Overall Study|Withdrawal by Subject|0|||
126681392|NCT03245450|455789740|FG003|Overall Study|Withdrawal by Subject|0|||
126681393|NCT03245450|455789741|FG004|Overall Study|Withdrawal by Subject|0|||
126681394|NCT03245450|455789742|FG005|Overall Study|Withdrawal by Subject|0|||
126681395|NCT03245450|455789743|FG006|Overall Study|Withdrawal by Subject|0|||
126681396|NCT03245450|455789737|FG000|Overall Study|Adverse Event|0|||
126681397|NCT03245450|455789738|FG001|Overall Study|Adverse Event|0|||
126681398|NCT03245450|455789739|FG002|Overall Study|Adverse Event|0|||
126681399|NCT03245450|455789740|FG003|Overall Study|Adverse Event|0|||
126681400|NCT03245450|455789741|FG004|Overall Study|Adverse Event|1|||
126681401|NCT03245450|455789742|FG005|Overall Study|Adverse Event|0|||
126681402|NCT03245450|455789743|FG006|Overall Study|Adverse Event|2|||
126681403|NCT02429414|455789744|FG000|Overall Study|Physician Decision|0|||
126681404|NCT02429414|455789745|FG001|Overall Study|Physician Decision|1|||
126681405|NCT00464334|455789749|FG000|Overall Study|Adverse Event|0|||
126681406|NCT00464334|455789750|FG001|Overall Study|Adverse Event|0|||
126681407|NCT00464334|455789751|FG002|Overall Study|Adverse Event|0|||
126681408|NCT00464334|455789752|FG003|Overall Study|Adverse Event|1|||
126681409|NCT00464334|455789753|FG004|Overall Study|Adverse Event|1|||
126435152|NCT04711850|454891656|FG000|Overall Study|Study terminated by sponsor|5|||
126435153|NCT04711850|454891657|FG001|Overall Study|Study terminated by sponsor|3|||
126435154|NCT04711850|454891656|FG000|Overall Study|Sponsor decision|0|||
126435155|NCT04711850|454891657|FG001|Overall Study|Sponsor decision|2|||
126435156|NCT03267277|454891658|FG000|Overall Study|Withdrawal by Subject|1|||
126435157|NCT02340026|454891659|FG000|Treatment Phase|Withdrawal by Subject|2|||
126681410|NCT00464334|455789754|FG005|Overall Study|Adverse Event|1|||
126681411|NCT00464334|455789755|FG006|Overall Study|Adverse Event|0|||
126681412|NCT00464334|455789756|FG007|Overall Study|Adverse Event|0|||
126681413|NCT00464334|455789757|FG008|Overall Study|Adverse Event|2|||
126681414|NCT00464334|455789758|FG009|Overall Study|Adverse Event|1|||
126681415|NCT00464334|455789759|FG010|Overall Study|Adverse Event|2|||
126681416|NCT00464334|455789749|FG000|Overall Study|Lack of Efficacy|0|||
126681417|NCT00464334|455789750|FG001|Overall Study|Lack of Efficacy|1|||
126681418|NCT00464334|455789751|FG002|Overall Study|Lack of Efficacy|0|||
126681419|NCT00464334|455789752|FG003|Overall Study|Lack of Efficacy|0|||
126681420|NCT00464334|455789753|FG004|Overall Study|Lack of Efficacy|0|||
126681421|NCT00464334|455789754|FG005|Overall Study|Lack of Efficacy|0|||
126681422|NCT00464334|455789755|FG006|Overall Study|Lack of Efficacy|0|||
126681423|NCT00464334|455789756|FG007|Overall Study|Lack of Efficacy|0|||
126681424|NCT00464334|455789757|FG008|Overall Study|Lack of Efficacy|0|||
126681425|NCT00464334|455789758|FG009|Overall Study|Lack of Efficacy|0|||
126681426|NCT00464334|455789759|FG010|Overall Study|Lack of Efficacy|0|||
126681427|NCT00464334|455789749|FG000|Overall Study|Lost to Follow-up|0|||
126681428|NCT00464334|455789750|FG001|Overall Study|Lost to Follow-up|0|||
126348932|NCT00695019|454571073|FG002|Overall Study|Withdrawal by Subject|4|||
126348933|NCT00695019|454571071|FG000|Overall Study|Protocol Violation|1|||
126348934|NCT00695019|454571072|FG001|Overall Study|Protocol Violation|3|||
126348935|NCT00695019|454571073|FG002|Overall Study|Protocol Violation|1|||
126348936|NCT00695019|454571071|FG000|Overall Study|Lack of Efficacy|0|||
126348937|NCT00695019|454571072|FG001|Overall Study|Lack of Efficacy|0|||
126348938|NCT00695019|454571073|FG002|Overall Study|Lack of Efficacy|1|||
126348939|NCT00695019|454571071|FG000|Overall Study|Various|4|||
126348940|NCT00695019|454571072|FG001|Overall Study|Various|5|||
126348941|NCT00695019|454571073|FG002|Overall Study|Various|4|||
126348942|NCT02225587|454571074|FG000|Overall Study|Adverse Event|5|||
126681429|NCT00464334|455789751|FG002|Overall Study|Lost to Follow-up|1|||
126681430|NCT00464334|455789752|FG003|Overall Study|Lost to Follow-up|0|||
126681431|NCT00464334|455789753|FG004|Overall Study|Lost to Follow-up|1|||
126681432|NCT00464334|455789754|FG005|Overall Study|Lost to Follow-up|0|||
126681433|NCT00464334|455789755|FG006|Overall Study|Lost to Follow-up|1|||
126681434|NCT00464334|455789756|FG007|Overall Study|Lost to Follow-up|0|||
126681435|NCT00464334|455789757|FG008|Overall Study|Lost to Follow-up|0|||
126681436|NCT00464334|455789758|FG009|Overall Study|Lost to Follow-up|0|||
126681437|NCT00464334|455789759|FG010|Overall Study|Lost to Follow-up|2|||
126681438|NCT00464334|455789749|FG000|Overall Study|Progressive Disease|0|||
126681439|NCT00464334|455789750|FG001|Overall Study|Progressive Disease|0|||
126681440|NCT00464334|455789751|FG002|Overall Study|Progressive Disease|0|||
126681441|NCT00464334|455789752|FG003|Overall Study|Progressive Disease|0|||
126681442|NCT00464334|455789753|FG004|Overall Study|Progressive Disease|0|||
126681443|NCT00464334|455789754|FG005|Overall Study|Progressive Disease|1|||
126681444|NCT00464334|455789755|FG006|Overall Study|Progressive Disease|0|||
126681445|NCT00464334|455789756|FG007|Overall Study|Progressive Disease|0|||
126681446|NCT00464334|455789757|FG008|Overall Study|Progressive Disease|1|||
126681447|NCT00464334|455789758|FG009|Overall Study|Progressive Disease|0|||
126681448|NCT00464334|455789759|FG010|Overall Study|Progressive Disease|0|||
126681449|NCT00464334|455789749|FG000|Overall Study|Study Terminated by Sponsor|0|||
126681450|NCT00464334|455789750|FG001|Overall Study|Study Terminated by Sponsor|0|||
126681451|NCT00464334|455789751|FG002|Overall Study|Study Terminated by Sponsor|0|||
126681452|NCT00464334|455789752|FG003|Overall Study|Study Terminated by Sponsor|1|||
126681453|NCT00464334|455789753|FG004|Overall Study|Study Terminated by Sponsor|0|||
126681454|NCT00464334|455789754|FG005|Overall Study|Study Terminated by Sponsor|0|||
126681455|NCT00464334|455789755|FG006|Overall Study|Study Terminated by Sponsor|0|||
126681456|NCT00464334|455789756|FG007|Overall Study|Study Terminated by Sponsor|0|||
126681457|NCT00464334|455789757|FG008|Overall Study|Study Terminated by Sponsor|0|||
126681458|NCT00464334|455789758|FG009|Overall Study|Study Terminated by Sponsor|0|||
126681459|NCT00464334|455789759|FG010|Overall Study|Study Terminated by Sponsor|0|||
126681460|NCT00464334|455789749|FG000|Overall Study|Withdrawal by Subject|1|||
126681461|NCT00464334|455789750|FG001|Overall Study|Withdrawal by Subject|7|||
126681462|NCT00464334|455789751|FG002|Overall Study|Withdrawal by Subject|4|||
126681463|NCT00464334|455789752|FG003|Overall Study|Withdrawal by Subject|2|||
126681464|NCT00464334|455789753|FG004|Overall Study|Withdrawal by Subject|2|||
126681465|NCT00464334|455789754|FG005|Overall Study|Withdrawal by Subject|2|||
126681466|NCT00464334|455789755|FG006|Overall Study|Withdrawal by Subject|2|||
126681467|NCT00464334|455789756|FG007|Overall Study|Withdrawal by Subject|1|||
126681468|NCT00464334|455789757|FG008|Overall Study|Withdrawal by Subject|3|||
126681469|NCT00464334|455789758|FG009|Overall Study|Withdrawal by Subject|0|||
126681470|NCT00464334|455789759|FG010|Overall Study|Withdrawal by Subject|0|||
126681471|NCT00794677|455789768|FG000|First Intervention|Withdrawal by Subject|2|||
126681472|NCT00794677|455789769|FG001|First Intervention|Withdrawal by Subject|0|||
126681473|NCT01965262|455789779|FG000|Second Intervention (7 Days)|Discontinued|0|||
126681474|NCT01965262|455789780|FG001|Second Intervention (7 Days)|Discontinued|1|||
126681475|NCT01965262|455789779|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
126681476|NCT01965262|455789780|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
126681477|NCT01965262|455789779|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
126681478|NCT01965262|455789780|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
126681479|NCT00143312|455789781|FG000|Overall Study|Death|11|||
126681480|NCT00143312|455789781|FG000|Overall Study|Adverse Event|2|||
126758671|NCT00134563|456066675|FG002|Overall Study|Reason other than above|5|||
126681481|NCT00143312|455789781|FG000|Overall Study|Lost to Follow-up|1|||
126681482|NCT00143312|455789781|FG000|Overall Study|Other|1|||
126681483|NCT00143312|455789781|FG000|Overall Study|Withdrawal by Subject|1|||
126681484|NCT01029366|455789782|FG000|Overall Study|Withdrawal by Subject|1|||
126681485|NCT01029366|455789783|FG001|Overall Study|Withdrawal by Subject|0|||
126681486|NCT01029366|455789782|FG000|Overall Study|Death|1|||
126681487|NCT01029366|455789783|FG001|Overall Study|Death|1|||
126681488|NCT01029366|455789782|FG000|Overall Study|disease progression|2|||
126681489|NCT01029366|455789783|FG001|Overall Study|disease progression|0|||
126681490|NCT01029366|455789782|FG000|Overall Study|manufacturing failure|0|||
126681491|NCT01029366|455789783|FG001|Overall Study|manufacturing failure|1|||
126758672|NCT02452320|456066679|FG000|Overall Study|Adverse Event|0|||
126435158|NCT02340026|454891660|FG001|Treatment Phase|Withdrawal by Subject|2|||
126435159|NCT02340026|454891659|FG000|Follow-up Phase|Lost to Follow-up|1|||
126435160|NCT02340026|454891660|FG001|Follow-up Phase|Lost to Follow-up|0|||
126435161|NCT04849364|454891661|FG000|Overall Study|Eligibility criteria not meet|0|||
126435162|NCT04849364|454891662|FG001|Overall Study|Eligibility criteria not meet|1|||
126435163|NCT04849364|454891663|FG002|Overall Study|Eligibility criteria not meet|0|||
126435164|NCT03521570|454891674|FG000|Overall Study|Not eligible|11|||
126435165|NCT04531176|454891677|FG000|Overall Study|Study was stopped early|24|||
126435166|NCT04531176|454891678|FG001|Overall Study|Study was stopped early|26|||
126435167|NCT04531176|454891679|FG002|Overall Study|Study was stopped early|24|||
126435168|NCT01345240|454891692|FG000|Overall Study|Adverse Event|3|||
126435169|NCT01345240|454891693|FG001|Overall Study|Adverse Event|5|||
126435170|NCT01345240|454891694|FG002|Overall Study|Adverse Event|4|||
126435171|NCT01345240|454891695|FG003|Overall Study|Adverse Event|2|||
126435172|NCT01345240|454891696|FG004|Overall Study|Adverse Event|1|||
126435173|NCT01345240|454891692|FG000|Overall Study|Lost to Follow-up|8|||
126435174|NCT01345240|454891693|FG001|Overall Study|Lost to Follow-up|9|||
126435175|NCT01345240|454891694|FG002|Overall Study|Lost to Follow-up|14|||
126435176|NCT01345240|454891695|FG003|Overall Study|Lost to Follow-up|7|||
126435177|NCT01345240|454891696|FG004|Overall Study|Lost to Follow-up|9|||
126435178|NCT04298697|454891697|FG000|Overall Study|Lost to Follow-up|5|||
126435179|NCT04298697|454891698|FG001|Overall Study|Lost to Follow-up|5|||
126435180|NCT04298697|454891699|FG002|Overall Study|Lost to Follow-up|1|||
126435181|NCT04298697|454891700|FG003|Overall Study|Lost to Follow-up|0|||
126435182|NCT04298697|454891697|FG000|Overall Study|Withdrawal by Subject|0|||
126435183|NCT04298697|454891698|FG001|Overall Study|Withdrawal by Subject|3|||
126435184|NCT04298697|454891699|FG002|Overall Study|Withdrawal by Subject|2|||
126435185|NCT04298697|454891700|FG003|Overall Study|Withdrawal by Subject|3|||
126435186|NCT00449696|454891701|FG000|Overall Study|Other Treatment Required|6|||
126435187|NCT00449696|454891702|FG001|Overall Study|Other Treatment Required|1|||
126435188|NCT00449696|454891701|FG000|Overall Study|Withdrawal by Subject|5|||
126435189|NCT00449696|454891702|FG001|Overall Study|Withdrawal by Subject|5|||
126435190|NCT00449696|454891701|FG000|Overall Study|Lost to Follow-up|2|||
126435191|NCT00449696|454891702|FG001|Overall Study|Lost to Follow-up|3|||
126435192|NCT00449696|454891701|FG000|Overall Study|Others|7|||
126435193|NCT00449696|454891702|FG001|Overall Study|Others|0|||
126435194|NCT01903460|454891707|FG000|Overall Study|Adverse Event|0|||
126435195|NCT01903460|454891708|FG001|Overall Study|Adverse Event|0|||
126435196|NCT01903460|454891709|FG002|Overall Study|Adverse Event|0|||
126435197|NCT01903460|454891710|FG003|Overall Study|Adverse Event|1|||
126435198|NCT02246530|454891711|FG000|Overall Study|Lost to Follow-up|4|||
126435199|NCT02246530|454891712|FG001|Overall Study|Lost to Follow-up|0|||
126435200|NCT00888173|454891713|FG000|Overall Study|Wrong Primary|1|||
126435201|NCT00888173|454891713|FG000|Overall Study|Ineligible: required test not done|1|||
126435202|NCT01488890|454891714|FG000|Overall Study|Serious adverse event|2|||
126435203|NCT01488890|454891715|FG001|Overall Study|Serious adverse event|0|||
126435204|NCT01488890|454891716|FG002|Overall Study|Serious adverse event|0|||
126435205|NCT01488890|454891717|FG003|Overall Study|Serious adverse event|0|||
126435206|NCT01488890|454891714|FG000|Overall Study|Protocol Violation|3|||
126435207|NCT01488890|454891715|FG001|Overall Study|Protocol Violation|0|||
126435208|NCT01488890|454891716|FG002|Overall Study|Protocol Violation|4|||
126435209|NCT01488890|454891717|FG003|Overall Study|Protocol Violation|0|||
126435210|NCT01488890|454891714|FG000|Overall Study|Lost to Follow-up|13|||
126435211|NCT01488890|454891715|FG001|Overall Study|Lost to Follow-up|10|||
126435212|NCT01488890|454891716|FG002|Overall Study|Lost to Follow-up|20|||
126435213|NCT01488890|454891717|FG003|Overall Study|Lost to Follow-up|3|||
126435214|NCT01488890|454891714|FG000|Overall Study|Withdrawal by Subject|14|||
126435215|NCT01488890|454891715|FG001|Overall Study|Withdrawal by Subject|10|||
126435216|NCT01488890|454891716|FG002|Overall Study|Withdrawal by Subject|11|||
126435217|NCT01488890|454891717|FG003|Overall Study|Withdrawal by Subject|2|||
126435218|NCT05712460|454891718|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126435219|NCT05712460|454891719|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126435220|NCT05712460|454891720|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126435221|NCT05712460|454891721|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126435222|NCT05712460|454891722|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126435223|NCT05712460|454891723|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126681492|NCT00906087|455789789|FG000|Initial Washout|Withdrawal by Subject|1|||
126435224|NCT05712460|454891724|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126435225|NCT05712460|454891725|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
126435226|NCT05712460|454891726|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126435227|NCT05712460|454891727|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126435228|NCT05712460|454891728|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126435229|NCT05712460|454891729|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
126435230|NCT00829426|454891733|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
126435231|NCT00829426|454891734|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
126435232|NCT05135767|454891737|FG000|Baseline|Lost to Follow-up|1|||
126681493|NCT00906087|455789789|FG000|Initial Washout|Physician Decision|1|||
126681494|NCT00517829|455789802|FG000|Overall Study|Adverse Event|22|||
126681495|NCT00517829|455789803|FG001|Overall Study|Adverse Event|34|||
126435233|NCT05135767|454891738|FG001|Baseline|Lost to Follow-up|1|||
126435234|NCT05135767|454891737|FG000|Baseline|Withdrawal by Subject|0|||
126435235|NCT05135767|454891738|FG001|Baseline|Withdrawal by Subject|2|||
126435236|NCT05135767|454891737|FG000|Active Study Phase|Lost to Follow-up|2|||
126435237|NCT05135767|454891738|FG001|Active Study Phase|Lost to Follow-up|0|||
126435238|NCT02260934|454891739|FG000|Overall Study|Lost to Follow-up|2|||
126435239|NCT02260934|454891740|FG001|Overall Study|Lost to Follow-up|1|||
126435240|NCT02260934|454891739|FG000|Overall Study|Withdrawal by Subject|0|||
126435241|NCT02260934|454891740|FG001|Overall Study|Withdrawal by Subject|2|||
126435242|NCT02260934|454891739|FG000|Overall Study|Participant Relocated|1|||
126435243|NCT02260934|454891740|FG001|Overall Study|Participant Relocated|0|||
126435244|NCT02260934|454891739|FG000|Overall Study|Site error|0|||
126435245|NCT02260934|454891740|FG001|Overall Study|Site error|1|||
126435246|NCT03597347|454891741|FG000|Overall Study|Withdrawal by Subject|1|||
126435247|NCT03597347|454891742|FG001|Overall Study|Withdrawal by Subject|1|||
126435248|NCT03597347|454891743|FG002|Overall Study|Withdrawal by Subject|0|||
126435249|NCT03597347|454891741|FG000|Overall Study|Withdrawal due to Covid-19|3|||
126435250|NCT03597347|454891742|FG001|Overall Study|Withdrawal due to Covid-19|0|||
126435251|NCT03597347|454891743|FG002|Overall Study|Withdrawal due to Covid-19|0|||
126435252|NCT03597347|454891741|FG000|Overall Study|Sponsor decision to terminate study|3|||
126435253|NCT03597347|454891742|FG001|Overall Study|Sponsor decision to terminate study|2|||
126435254|NCT03597347|454891743|FG002|Overall Study|Sponsor decision to terminate study|4|||
126435255|NCT02532517|454891744|FG000|Overall Study|Did not complete 24-Month visit|4|||
126435256|NCT02532517|454891744|FG000|Overall Study|Failed Angiographic eligibility|1|||
126435257|NCT02532517|454891744|FG000|Overall Study|Lost to Follow-up|4|||
126435258|NCT02532517|454891744|FG000|Overall Study|Withdrawal by Subject|4|||
126435259|NCT02532517|454891744|FG000|Overall Study|Death|4|||
126435260|NCT05720897|454891745|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
126435261|NCT05720897|454891746|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
126435262|NCT04780061|454891747|FG000|Overall Study|Withdrawal by Subject|5|||
126435263|NCT04780061|454891748|FG001|Overall Study|Withdrawal by Subject|8|||
126435264|NCT04780061|454891747|FG000|Overall Study|Adverse Event|2|||
126435265|NCT04780061|454891748|FG001|Overall Study|Adverse Event|2|||
126435266|NCT04780061|454891747|FG000|Overall Study|Lost to Follow-up|1|||
126435267|NCT04780061|454891748|FG001|Overall Study|Lost to Follow-up|5|||
126435268|NCT02608684|454893779|FG000|Overall Study|Physician Decision|2|||
126435269|NCT02608684|454893779|FG000|Overall Study|Withdrawal by Subject|1|||
126435270|NCT01456039|454893781|FG000|Phase 1 (First Step)|Disease Progression|1|||
126435271|NCT01456039|454893782|FG001|Phase 1 (First Step)|Disease Progression|1|||
126435272|NCT01456039|454893783|FG002|Phase 1 (First Step)|Disease Progression|0|||
126435273|NCT01456039|454893781|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
126435274|NCT01456039|454893782|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
126435275|NCT01456039|454893783|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
126435276|NCT01456039|454893781|FG000|Phase 1 (First Step)|Adverse Event|0|||
126435277|NCT01456039|454893782|FG001|Phase 1 (First Step)|Adverse Event|3|||
126435278|NCT01456039|454893783|FG002|Phase 1 (First Step)|Adverse Event|0|||
126435279|NCT01456039|454893781|FG000|Phase 1 (First Step)|Other|0|||
126435280|NCT01456039|454893782|FG001|Phase 1 (First Step)|Other|1|||
126435281|NCT01456039|454893783|FG002|Phase 1 (First Step)|Other|0|||
126435282|NCT01456039|454893781|FG000|Phase 2 (Second Step)|Disease Progression|0|||
126435283|NCT01456039|454893782|FG001|Phase 2 (Second Step)|Disease Progression|0|||
126435284|NCT01456039|454893783|FG002|Phase 2 (Second Step)|Disease Progression|17|||
126435285|NCT01456039|454893781|FG000|Phase 2 (Second Step)|Adverse Event|0|||
126435286|NCT01456039|454893782|FG001|Phase 2 (Second Step)|Adverse Event|0|||
126435287|NCT01456039|454893783|FG002|Phase 2 (Second Step)|Adverse Event|10|||
126435288|NCT01456039|454893781|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
126435289|NCT01456039|454893782|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
126435290|NCT01456039|454893783|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
126435291|NCT01456039|454893781|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
126545307|NCT03107377|455290806|FG001|Overall Study|Other reason not specified|15|||
126681496|NCT00517829|455789802|FG000|Overall Study|Disease Progression|39|||
126681497|NCT00517829|455789803|FG001|Overall Study|Disease Progression|32|||
126435292|NCT01456039|454893782|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
126435293|NCT01456039|454893783|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
126435294|NCT01456039|454893781|FG000|Phase 2 (Second Step)|Other|0|||
126435295|NCT01456039|454893782|FG001|Phase 2 (Second Step)|Other|0|||
126435296|NCT01456039|454893783|FG002|Phase 2 (Second Step)|Other|1|||
126435297|NCT00755183|454893784|FG000|Overall Study|Adverse Event|5|||
126435298|NCT00755183|454893785|FG001|Overall Study|Adverse Event|2|||
126435299|NCT00755183|454893784|FG000|Overall Study|Protocol Violation|0|||
126435300|NCT00755183|454893785|FG001|Overall Study|Protocol Violation|1|||
126545308|NCT00130793|455290807|FG000|Overall Study|Lost to Follow-up|1|||
126545309|NCT00130793|455290808|FG001|Overall Study|Lost to Follow-up|4|||
126681498|NCT00517829|455789802|FG000|Overall Study|Patient Request|6|||
126348943|NCT02225587|454571075|FG001|Overall Study|Adverse Event|5|||
126348944|NCT02225587|454571074|FG000|Overall Study|Lost to Follow-up|5|||
126348945|NCT02225587|454571075|FG001|Overall Study|Lost to Follow-up|5|||
126348946|NCT02225587|454571074|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126348947|NCT02225587|454571075|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126348948|NCT02225587|454571074|FG000|Overall Study|Physician Decision|2|||
126348949|NCT02225587|454571075|FG001|Overall Study|Physician Decision|0|||
126348950|NCT02225587|454571074|FG000|Overall Study|Protocol Violation|1|||
126348951|NCT02225587|454571075|FG001|Overall Study|Protocol Violation|0|||
126348952|NCT02225587|454571074|FG000|Overall Study|Participant Moved|1|||
126348953|NCT02225587|454571075|FG001|Overall Study|Participant Moved|0|||
126435301|NCT00755183|454893784|FG000|Overall Study|Withdrawal by Subject|0|||
126435302|NCT00755183|454893785|FG001|Overall Study|Withdrawal by Subject|2|||
126348954|NCT02225587|454571074|FG000|Overall Study|Withdrawal by Subject|13|||
126348955|NCT02225587|454571075|FG001|Overall Study|Withdrawal by Subject|28|||
126348956|NCT03197129|454571084|FG000|Overall Study|did not answer the VPT: shyness|4|||
126348957|NCT03197129|454571085|FG001|Overall Study|did not answer the VPT: shyness|5|||
126348958|NCT01564407|454571086|FG000|Overall Study|Lost to Follow-up|0|||
126348959|NCT01564407|454571087|FG001|Overall Study|Lost to Follow-up|1|||
126348960|NCT01564407|454571088|FG002|Overall Study|Lost to Follow-up|0|||
126348961|NCT01564407|454571089|FG003|Overall Study|Lost to Follow-up|0|||
126348962|NCT01564407|454571090|FG004|Overall Study|Lost to Follow-up|0|||
126348963|NCT01564407|454571086|FG000|Overall Study|Withdrawal by Subject|0|||
126348964|NCT01564407|454571087|FG001|Overall Study|Withdrawal by Subject|1|||
126348965|NCT01564407|454571088|FG002|Overall Study|Withdrawal by Subject|0|||
126348966|NCT01564407|454571089|FG003|Overall Study|Withdrawal by Subject|0|||
126348967|NCT01564407|454571090|FG004|Overall Study|Withdrawal by Subject|0|||
126348968|NCT01564407|454571086|FG000|Overall Study|funding lost, study ended|0|||
126348969|NCT01564407|454571087|FG001|Overall Study|funding lost, study ended|0|||
126348970|NCT01564407|454571088|FG002|Overall Study|funding lost, study ended|0|||
126348971|NCT01564407|454571089|FG003|Overall Study|funding lost, study ended|1|||
126348972|NCT01564407|454571090|FG004|Overall Study|funding lost, study ended|0|||
126348973|NCT02296125|454571091|FG000|Overall Study|Withdrawal by Subject|18|||
126348974|NCT02296125|454571092|FG001|Overall Study|Withdrawal by Subject|8|||
126348975|NCT02296125|454571093|FG002|Overall Study|Withdrawal by Subject|6|||
126348976|NCT02296125|454571094|FG003|Overall Study|Withdrawal by Subject|2|||
126348977|NCT02296125|454571091|FG000|Overall Study|Adverse Event|41|||
126348978|NCT02296125|454571092|FG001|Overall Study|Adverse Event|52|||
126348979|NCT02296125|454571093|FG002|Overall Study|Adverse Event|9|||
126348980|NCT02296125|454571094|FG003|Overall Study|Adverse Event|4|||
126348981|NCT02296125|454571091|FG000|Overall Study|Severe non-compliance to protocol|0|||
126435303|NCT00755183|454893784|FG000|Overall Study|Administrative|2|||
126435304|NCT00755183|454893785|FG001|Overall Study|Administrative|1|||
126681499|NCT00517829|455789803|FG001|Overall Study|Patient Request|5|||
126681500|NCT00517829|455789802|FG000|Overall Study|Investigator Request|5|||
126348982|NCT02296125|454571092|FG001|Overall Study|Severe non-compliance to protocol|1|||
126348983|NCT02296125|454571093|FG002|Overall Study|Severe non-compliance to protocol|0|||
126348984|NCT02296125|454571094|FG003|Overall Study|Severe non-compliance to protocol|0|||
126348985|NCT02296125|454571091|FG000|Overall Study|Condition under investigation worsened|153|||
126348986|NCT02296125|454571092|FG001|Overall Study|Condition under investigation worsened|199|||
126348987|NCT02296125|454571093|FG002|Overall Study|Condition under investigation worsened|39|||
126348988|NCT02296125|454571094|FG003|Overall Study|Condition under investigation worsened|56|||
126348989|NCT02296125|454571091|FG000|Overall Study|Any reason not specifically recorded|6|||
126681501|NCT00517829|455789803|FG001|Overall Study|Investigator Request|3|||
126681502|NCT00517829|455789802|FG000|Overall Study|Other|3|||
126681503|NCT00517829|455789803|FG001|Overall Study|Other|1|||
126681504|NCT00796315|455789808|FG000|Overall Study|Protocol Violation|0|||
126681505|NCT00796315|455789809|FG001|Overall Study|Protocol Violation|1|||
126681506|NCT00796315|455789810|FG002|Overall Study|Protocol Violation|0|||
126681507|NCT01627860|455789815|FG000|Overall Study|Adverse Event|9|||
126348990|NCT02296125|454571092|FG001|Overall Study|Any reason not specifically recorded|4|||
126348991|NCT02296125|454571093|FG002|Overall Study|Any reason not specifically recorded|2|||
126681508|NCT01627860|455789816|FG001|Overall Study|Adverse Event|4|||
126758673|NCT02452320|456066680|FG001|Overall Study|Adverse Event|1|||
126306144|NCT05020665|454408905|FG001|Overall Study|Study terminated by Sponsor|4|||
126306145|NCT05020665|454408904|FG000|Overall Study|Death|2|||
126306146|NCT05020665|454408905|FG001|Overall Study|Death|1|||
126306147|NCT05020665|454408904|FG000|Overall Study|Physician Decision|0|||
126306148|NCT05020665|454408905|FG001|Overall Study|Physician Decision|1|||
126306149|NCT05020665|454408904|FG000|Overall Study|Withdrawal by Subject|0|||
126306150|NCT05020665|454408905|FG001|Overall Study|Withdrawal by Subject|1|||
126306151|NCT05020665|454408904|FG000|Overall Study|Reason not specified|1|||
126306152|NCT05020665|454408905|FG001|Overall Study|Reason not specified|0|||
126306153|NCT03689374|454408910|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
126306154|NCT03689374|454408911|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
126306155|NCT03689374|454408912|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
126306156|NCT03689374|454408910|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
126306157|NCT03689374|454408911|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
126306158|NCT03689374|454408912|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
126306159|NCT03689374|454408910|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
126306160|NCT03689374|454408911|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
126435305|NCT00148317|454893786|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
126681509|NCT01627860|455789815|FG000|Overall Study|Withdrawal by Subject|2|||
126681510|NCT01627860|455789816|FG001|Overall Study|Withdrawal by Subject|1|||
126681511|NCT01627860|455789815|FG000|Overall Study|Seizure frequency doubled|0|||
126681512|NCT01627860|455789816|FG001|Overall Study|Seizure frequency doubled|1|||
126681513|NCT01627860|455789815|FG000|Overall Study|Protocol Violation|1|||
126681514|NCT01627860|455789816|FG001|Overall Study|Protocol Violation|0|||
126681515|NCT02039375|455789817|FG000|Overall Study|Lost to Follow-up|2|||
126681516|NCT04770389|455789818|FG000|Overall Study|Adverse Event|1|||
126681517|NCT04770389|455789819|FG001|Overall Study|Adverse Event|2|||
126681518|NCT04770389|455789820|FG002|Overall Study|Adverse Event|0|||
126681519|NCT04770389|455789821|FG003|Overall Study|Adverse Event|1|||
126681520|NCT04770389|455789818|FG000|Overall Study|Withdrawal by Subject|0|||
126681521|NCT04770389|455789819|FG001|Overall Study|Withdrawal by Subject|2|||
126681522|NCT04770389|455789820|FG002|Overall Study|Withdrawal by Subject|1|||
126681523|NCT04770389|455789821|FG003|Overall Study|Withdrawal by Subject|0|||
126681524|NCT04770389|455789818|FG000|Overall Study|Failed attempt to draw blood|1|||
126681525|NCT04770389|455789819|FG001|Overall Study|Failed attempt to draw blood|0|||
126681526|NCT04770389|455789820|FG002|Overall Study|Failed attempt to draw blood|0|||
126681527|NCT04770389|455789821|FG003|Overall Study|Failed attempt to draw blood|0|||
126681528|NCT04770389|455789818|FG000|Overall Study|Left the country|0|||
126681529|NCT04770389|455789819|FG001|Overall Study|Left the country|0|||
126681530|NCT04770389|455789820|FG002|Overall Study|Left the country|1|||
126681531|NCT04770389|455789821|FG003|Overall Study|Left the country|2|||
126681532|NCT04770389|455789818|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
126681533|NCT04770389|455789819|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
126681534|NCT04770389|455789820|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
126681535|NCT04770389|455789821|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
126681536|NCT04770389|455789818|FG000|Overall Study|Lost to Follow-up|0|||
126681537|NCT04770389|455789819|FG001|Overall Study|Lost to Follow-up|0|||
126681538|NCT04770389|455789820|FG002|Overall Study|Lost to Follow-up|0|||
126681539|NCT04770389|455789821|FG003|Overall Study|Lost to Follow-up|1|||
126681540|NCT04770389|455789818|FG000|Overall Study|Moved away from study site|0|||
126681541|NCT04770389|455789819|FG001|Overall Study|Moved away from study site|1|||
126681542|NCT04770389|455789820|FG002|Overall Study|Moved away from study site|0|||
126681543|NCT04770389|455789821|FG003|Overall Study|Moved away from study site|0|||
126681544|NCT00689871|455789826|FG000|Overall Study|Lost to Follow-up|123|||
126681545|NCT00689871|455789827|FG001|Overall Study|Lost to Follow-up|13|||
126681546|NCT00689871|455789828|FG002|Overall Study|Lost to Follow-up|37|||
126681547|NCT00689871|455789829|FG003|Overall Study|Lost to Follow-up|1|||
126681548|NCT00689871|455789826|FG000|Overall Study|Explanted of All Study Devices|36|||
126681549|NCT00689871|455789827|FG001|Overall Study|Explanted of All Study Devices|25|||
126681550|NCT00689871|455789828|FG002|Overall Study|Explanted of All Study Devices|29|||
126681551|NCT00689871|455789829|FG003|Overall Study|Explanted of All Study Devices|3|||
126681552|NCT00689871|455789826|FG000|Overall Study|Withdrawal by Subject|13|||
126681553|NCT00689871|455789827|FG001|Overall Study|Withdrawal by Subject|3|||
126681554|NCT00689871|455789828|FG002|Overall Study|Withdrawal by Subject|4|||
126681555|NCT00689871|455789829|FG003|Overall Study|Withdrawal by Subject|1|||
126681556|NCT00689871|455789826|FG000|Overall Study|Death|1|||
126681557|NCT00689871|455789827|FG001|Overall Study|Death|10|||
126681558|NCT00689871|455789828|FG002|Overall Study|Death|2|||
126681559|NCT00689871|455789829|FG003|Overall Study|Death|2|||
126681560|NCT00689871|455789826|FG000|Overall Study|Physician Decision|2|||
126435306|NCT00148317|454893786|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
126435307|NCT00148317|454893786|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
126435308|NCT00335777|454893787|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
126435309|NCT00335777|454893787|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
126435310|NCT00335777|454893787|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
126435311|NCT00335777|454893787|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
126435312|NCT00335777|454893787|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
126435313|NCT04639245|454893788|FG000|Overall Study|Death|1|||
126435314|NCT00124943|454893791|FG000|Phase II|Adverse Event|0|||
126435315|NCT00124943|454893792|FG001|Phase II|Adverse Event|2|||
126435316|NCT00124943|454893793|FG002|Phase II|Adverse Event|0|||
126435317|NCT00124943|454893794|FG003|Phase II|Adverse Event|1|||
126435318|NCT00124943|454893791|FG000|Phase II|Protocol Violation|0|||
126435319|NCT00124943|454893792|FG001|Phase II|Protocol Violation|0|||
126435320|NCT00124943|454893793|FG002|Phase II|Protocol Violation|0|||
126435321|NCT00124943|454893794|FG003|Phase II|Protocol Violation|1|||
126435322|NCT00124943|454893791|FG000|Phase II|Lost to Follow-up|0|||
126681561|NCT00689871|455789827|FG001|Overall Study|Physician Decision|1|||
126681562|NCT00689871|455789828|FG002|Overall Study|Physician Decision|1|||
126681563|NCT00689871|455789829|FG003|Overall Study|Physician Decision|0|||
126681564|NCT00889265|455789834|FG000|Overall Study|Adverse Event|1|||
126681565|NCT00889265|455789834|FG000|Overall Study|Lost to Follow-up|5|||
126681566|NCT00889265|455789834|FG000|Overall Study|Protocol Violation|1|||
126348992|NCT02296125|454571094|FG003|Overall Study|Any reason not specifically recorded|0|||
126348993|NCT00157755|454571095|FG000|Overall Study|Death|2|||
126348994|NCT00157755|454571096|FG001|Overall Study|Death|3|||
126348995|NCT00157755|454571097|FG002|Overall Study|Death|3|||
126348996|NCT00157755|454571098|FG003|Overall Study|Death|2|||
126348997|NCT00157755|454571099|FG004|Overall Study|Death|0|||
126348998|NCT00157755|454571100|FG005|Overall Study|Death|0|||
126348999|NCT00157755|454571095|FG000|Overall Study|Lost to Follow-up|0|||
126349000|NCT00157755|454571096|FG001|Overall Study|Lost to Follow-up|0|||
126349001|NCT00157755|454571097|FG002|Overall Study|Lost to Follow-up|1|||
126349002|NCT00157755|454571098|FG003|Overall Study|Lost to Follow-up|0|||
126349003|NCT00157755|454571099|FG004|Overall Study|Lost to Follow-up|0|||
126349004|NCT00157755|454571100|FG005|Overall Study|Lost to Follow-up|0|||
126349005|NCT00157755|454571095|FG000|Overall Study|Withdrawal by Subject|0|||
126681567|NCT00250835|455789837|FG000|Overall Study|Withdrawal by Subject|1|||
126681568|NCT00159861|455789838|FG000|Core Study - 16 Weeks|Death|3|||
126681569|NCT00159861|455789839|FG001|Core Study - 16 Weeks|Death|0|||
126681570|NCT00159861|455789838|FG000|Core Study - 16 Weeks|Adverse Event|12|||
126681571|NCT00159861|455789839|FG001|Core Study - 16 Weeks|Adverse Event|6|||
126681572|NCT00159861|455789838|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
126681573|NCT00159861|455789839|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
126681574|NCT00159861|455789838|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
126681575|NCT00159861|455789839|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
126681576|NCT00159861|455789838|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
126681577|NCT00159861|455789839|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
126681578|NCT00159861|455789838|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
126681579|NCT00159861|455789839|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
126681580|NCT00159861|455789838|FG000|Extension Study - up to 3 Years|Death|24|||
126681581|NCT00159861|455789839|FG001|Extension Study - up to 3 Years|Death|28|||
126681582|NCT00159861|455789838|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
126681583|NCT00159861|455789839|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
126681584|NCT00159861|455789838|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
126681585|NCT00159861|455789839|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
126681586|NCT00159861|455789838|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
126681587|NCT00159861|455789839|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
126681588|NCT00159861|455789838|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
126681589|NCT00159861|455789839|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
126681590|NCT04489888|455789840|FG000|Overall Study|Death|75|||
126681591|NCT04489888|455789840|FG000|Overall Study|Sponsor Decision|26|||
126681592|NCT03349099|455789843|FG000|Overall Study|Physician Decision|3|||
126681593|NCT03349099|455789844|FG001|Overall Study|Physician Decision|4|||
126681594|NCT03349099|455789843|FG000|Overall Study|Stone migrated from the kidney|1|||
126681595|NCT03349099|455789844|FG001|Overall Study|Stone migrated from the kidney|0|||
126681596|NCT00278993|455789845|FG000|Overall Study|Adverse Event|24|||
126681597|NCT00278993|455789845|FG000|Overall Study|Withdrawal by Subject|5|||
126681598|NCT00278993|455789845|FG000|Overall Study|Progressive Disease|65|||
126681599|NCT00278993|455789845|FG000|Overall Study|Physician Decision|9|||
126681600|NCT00278993|455789845|FG000|Overall Study|Not Otherwise Specified|4|||
126681601|NCT04194528|455789851|FG000|Overall Study|Adverse Event|1|||
126681602|NCT00333359|455789854|FG000|Overall Study|Adverse Event|29|||
126681603|NCT00333359|455789855|FG001|Overall Study|Adverse Event|35|||
126681604|NCT00333359|455789854|FG000|Overall Study|Withdrawal by Subject|19|||
126681605|NCT00333359|455789855|FG001|Overall Study|Withdrawal by Subject|37|||
126681606|NCT00333359|455789854|FG000|Overall Study|Physician Decision|2|||
126681607|NCT00333359|455789855|FG001|Overall Study|Physician Decision|2|||
126681608|NCT00333359|455789854|FG000|Overall Study|Protocol Non-compliance|2|||
126681609|NCT00333359|455789855|FG001|Overall Study|Protocol Non-compliance|8|||
126681610|NCT00333359|455789854|FG000|Overall Study|Lost to Follow-up|15|||
126681611|NCT00333359|455789855|FG001|Overall Study|Lost to Follow-up|25|||
126681612|NCT00333359|455789854|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
126681613|NCT00333359|455789855|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
126681614|NCT00333359|455789854|FG000|Overall Study|Treatment Failure|3|||
126681615|NCT00333359|455789855|FG001|Overall Study|Treatment Failure|8|||
126681616|NCT00333359|455789854|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
126681617|NCT00333359|455789855|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
126681618|NCT01394939|455791299|FG000|Overall Study|Adverse Event|1|||
126681619|NCT01394939|455791300|FG001|Overall Study|Adverse Event|3|||
126681620|NCT01394939|455791301|FG002|Overall Study|Adverse Event|0|||
126681621|NCT01394939|455791302|FG003|Overall Study|Adverse Event|2|||
126681622|NCT01394939|455791299|FG000|Overall Study|Death|0|||
126681623|NCT01394939|455791300|FG001|Overall Study|Death|2|||
126349006|NCT00157755|454571096|FG001|Overall Study|Withdrawal by Subject|0|||
126349007|NCT00157755|454571097|FG002|Overall Study|Withdrawal by Subject|1|||
126349008|NCT00157755|454571098|FG003|Overall Study|Withdrawal by Subject|1|||
126349009|NCT00157755|454571099|FG004|Overall Study|Withdrawal by Subject|1|||
126349010|NCT00157755|454571100|FG005|Overall Study|Withdrawal by Subject|2|||
126349011|NCT00157755|454571095|FG000|Overall Study|Explant due to infection|0|||
126349012|NCT00157755|454571096|FG001|Overall Study|Explant due to infection|0|||
126681624|NCT01394939|455791301|FG002|Overall Study|Death|0|||
126681625|NCT01394939|455791302|FG003|Overall Study|Death|0|||
126681626|NCT01394939|455791299|FG000|Overall Study|Physician Decision|0|||
126681627|NCT01394939|455791300|FG001|Overall Study|Physician Decision|1|||
126681628|NCT01394939|455791301|FG002|Overall Study|Physician Decision|0|||
126681629|NCT01394939|455791302|FG003|Overall Study|Physician Decision|0|||
126681630|NCT01394939|455791299|FG000|Overall Study|Withdrawal by Subject|0|||
126681631|NCT01394939|455791300|FG001|Overall Study|Withdrawal by Subject|2|||
126681632|NCT01394939|455791301|FG002|Overall Study|Withdrawal by Subject|0|||
126681633|NCT01394939|455791302|FG003|Overall Study|Withdrawal by Subject|2|||
126681634|NCT01394939|455791299|FG000|Overall Study|Others|0|||
126681635|NCT01394939|455791300|FG001|Overall Study|Others|2|||
126681636|NCT01394939|455791301|FG002|Overall Study|Others|0|||
126435323|NCT00124943|454893792|FG001|Phase II|Lost to Follow-up|0|||
126435324|NCT00124943|454893793|FG002|Phase II|Lost to Follow-up|0|||
126435325|NCT00124943|454893794|FG003|Phase II|Lost to Follow-up|1|||
126435326|NCT00124943|454893791|FG000|Phase II|Withdrawal by Subject|0|||
126435327|NCT00124943|454893792|FG001|Phase II|Withdrawal by Subject|0|||
126435328|NCT00124943|454893793|FG002|Phase II|Withdrawal by Subject|0|||
126435329|NCT00124943|454893794|FG003|Phase II|Withdrawal by Subject|2|||
126435330|NCT03337477|454893795|FG000|Overall Study|not categorized into the listed ones|11|||
126435331|NCT03337477|454893796|FG001|Overall Study|not categorized into the listed ones|9|||
126435332|NCT03337477|454893795|FG000|Overall Study|Withdrawal by Subject|0|||
126435333|NCT03337477|454893796|FG001|Overall Study|Withdrawal by Subject|1|||
126435334|NCT03337477|454893795|FG000|Overall Study|Death|0|||
126435335|NCT03337477|454893796|FG001|Overall Study|Death|1|||
126435336|NCT03337477|454893795|FG000|Overall Study|Lost to Follow-up|0|||
126435337|NCT03337477|454893796|FG001|Overall Study|Lost to Follow-up|2|||
126435338|NCT01462370|454893803|FG000|Overall Study|Lack of Qualifying Event|1|||
126435339|NCT01462370|454893804|FG001|Overall Study|Lack of Qualifying Event|1|||
126435340|NCT01462370|454893803|FG000|Overall Study|Physician Decision|0|||
126435341|NCT01462370|454893804|FG001|Overall Study|Physician Decision|1|||
126435342|NCT01462370|454893803|FG000|Overall Study|Withdrawal by Subject|0|||
126435343|NCT01462370|454893804|FG001|Overall Study|Withdrawal by Subject|3|||
126435344|NCT02220920|454893805|FG000|Overall Study|Adverse Event|1|||
126435345|NCT02220920|454893806|FG001|Overall Study|Adverse Event|0|||
126435346|NCT02220920|454893805|FG000|Overall Study|Lack of Efficacy|0|||
126435347|NCT02220920|454893806|FG001|Overall Study|Lack of Efficacy|1|||
126435348|NCT02220920|454893805|FG000|Overall Study|Withdrawal by Subject|1|||
126435349|NCT02220920|454893806|FG001|Overall Study|Withdrawal by Subject|0|||
126435350|NCT02220920|454893805|FG000|Overall Study|Conflict with the stopping criteria|1|||
126435351|NCT02220920|454893806|FG001|Overall Study|Conflict with the stopping criteria|2|||
126435352|NCT00473564|454893807|FG000|Overall Study|robot surgery aborted in OR|23|||
126435353|NCT02118584|454893811|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
126435354|NCT02118584|454893812|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
126435355|NCT02118584|454893813|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
126435356|NCT02118584|454893811|FG000|Part 1: Open Label Extension Period|Death|9|||
126435357|NCT02118584|454893812|FG001|Part 1: Open Label Extension Period|Death|0|||
126435358|NCT02118584|454893813|FG002|Part 1: Open Label Extension Period|Death|0|||
126435359|NCT02118584|454893811|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
126435360|NCT02118584|454893812|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
126435361|NCT02118584|454893813|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
126435362|NCT02118584|454893811|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
126435363|NCT02118584|454893812|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
126435364|NCT02118584|454893813|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
126435365|NCT02118584|454893811|FG000|Part 1: Open Label Extension Period|Other|135|||
126435366|NCT02118584|454893812|FG001|Part 1: Open Label Extension Period|Other|0|||
126435367|NCT02118584|454893813|FG002|Part 1: Open Label Extension Period|Other|0|||
126435368|NCT02118584|454893811|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
126435369|NCT02118584|454893812|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
126435370|NCT02118584|454893813|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
126435371|NCT02118584|454893811|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
126435372|NCT02118584|454893812|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
126435373|NCT02118584|454893813|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
126435374|NCT02118584|454893811|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
126435375|NCT02118584|454893812|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
126435376|NCT02118584|454893813|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
126435377|NCT02118584|454893811|FG000|Part 1: Open Label Extension Period|Other|3|||
126435378|NCT02118584|454893812|FG001|Part 1: Open Label Extension Period|Other|0|||
126435379|NCT02118584|454893813|FG002|Part 1: Open Label Extension Period|Other|0|||
126545310|NCT00130793|455290807|FG000|Overall Study|Withdrew consent|2|||
126435380|NCT02118584|454893811|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
126435381|NCT02118584|454893812|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
126681637|NCT01394939|455791302|FG003|Overall Study|Others|3|||
126681638|NCT04682405|455791304|FG000|Overall Study|Adverse Event|0|||
126681639|NCT04682405|455791305|FG001|Overall Study|Adverse Event|1|||
126681640|NCT01339559|455791308|FG000|Overall Study|Adverse Event|92|||
126435382|NCT02118584|454893813|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
126435383|NCT02118584|454893811|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
126435384|NCT02118584|454893812|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
126435385|NCT02118584|454893813|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
126435386|NCT02118584|454893811|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
126435387|NCT02118584|454893812|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
126435388|NCT02118584|454893813|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
126435389|NCT02118584|454893811|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
126681641|NCT01339559|455791308|FG000|Overall Study|Death|5|||
126349013|NCT00157755|454571097|FG002|Overall Study|Explant due to infection|1|||
126349014|NCT00157755|454571098|FG003|Overall Study|Explant due to infection|0|||
126349015|NCT00157755|454571099|FG004|Overall Study|Explant due to infection|0|||
126349016|NCT00157755|454571100|FG005|Overall Study|Explant due to infection|0|||
126349017|NCT00157755|454571095|FG000|Overall Study|Medical reason|0|||
126349018|NCT00157755|454571096|FG001|Overall Study|Medical reason|0|||
126349019|NCT00157755|454571097|FG002|Overall Study|Medical reason|1|||
126349020|NCT00157755|454571098|FG003|Overall Study|Medical reason|1|||
126349021|NCT00157755|454571099|FG004|Overall Study|Medical reason|0|||
126349022|NCT00157755|454571100|FG005|Overall Study|Medical reason|0|||
126349023|NCT00157755|454571095|FG000|Overall Study|Study site closure|0|||
126349024|NCT00157755|454571096|FG001|Overall Study|Study site closure|1|||
126349025|NCT00157755|454571097|FG002|Overall Study|Study site closure|0|||
126349026|NCT00157755|454571098|FG003|Overall Study|Study site closure|0|||
126349027|NCT00157755|454571099|FG004|Overall Study|Study site closure|0|||
126349028|NCT00157755|454571100|FG005|Overall Study|Study site closure|0|||
126349029|NCT00157755|454571095|FG000|Overall Study|Subject non-compliance|0|||
126349030|NCT00157755|454571096|FG001|Overall Study|Subject non-compliance|0|||
126349031|NCT00157755|454571097|FG002|Overall Study|Subject non-compliance|0|||
126349032|NCT00157755|454571098|FG003|Overall Study|Subject non-compliance|0|||
126349033|NCT00157755|454571099|FG004|Overall Study|Subject non-compliance|0|||
126349034|NCT00157755|454571100|FG005|Overall Study|Subject non-compliance|1|||
126349035|NCT00157755|454571095|FG000|Overall Study|Study completion|0|||
126349036|NCT00157755|454571096|FG001|Overall Study|Study completion|0|||
126349037|NCT00157755|454571097|FG002|Overall Study|Study completion|0|||
126349038|NCT00157755|454571098|FG003|Overall Study|Study completion|0|||
126435390|NCT02118584|454893812|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
126435391|NCT02118584|454893813|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
126349039|NCT00157755|454571099|FG004|Overall Study|Study completion|1|||
126681642|NCT01339559|455791308|FG000|Overall Study|Lack of Efficacy|164|||
126681643|NCT01339559|455791308|FG000|Overall Study|Lost to Follow-up|22|||
126681644|NCT01339559|455791308|FG000|Overall Study|Subject choice|89|||
126681645|NCT01339559|455791308|FG000|Overall Study|Protocol Violation|15|||
126681646|NCT01339559|455791308|FG000|Overall Study|Study closure at site|1|||
126681647|NCT01339559|455791308|FG000|Overall Study|Incarcerated|2|||
126681648|NCT01339559|455791308|FG000|Overall Study|Epilepsy surgery|1|||
126681649|NCT01339559|455791308|FG000|Overall Study|Pregnancy planned|2|||
126681650|NCT01339559|455791308|FG000|Overall Study|Left the country|1|||
126681651|NCT01339559|455791308|FG000|Overall Study|Investigator decision|2|||
126681652|NCT01339559|455791308|FG000|Overall Study|Patient didn't wish to continue|1|||
126681653|NCT01339559|455791308|FG000|Overall Study|PI decision|1|||
126681654|NCT01049035|455791309|FG000|Overall Study|Serious adverse event|0|||
126681655|NCT01049035|455791310|FG001|Overall Study|Serious adverse event|1|||
126681656|NCT01049035|455791311|FG002|Overall Study|Serious adverse event|1|||
126681657|NCT01049035|455791312|FG003|Overall Study|Serious adverse event|2|||
126681658|NCT01049035|455791313|FG004|Overall Study|Serious adverse event|0|||
126681659|NCT01049035|455791314|FG005|Overall Study|Serious adverse event|0|||
126681660|NCT01049035|455791315|FG006|Overall Study|Serious adverse event|0|||
126681661|NCT01049035|455791309|FG000|Overall Study|Other adverse event (AE)|0|||
126681662|NCT01049035|455791310|FG001|Overall Study|Other adverse event (AE)|0|||
126349040|NCT00157755|454571100|FG005|Overall Study|Study completion|2|||
126349041|NCT03314935|454571103|FG000|Phase 1|Death|4|||
126349042|NCT03314935|454571104|FG001|Phase 1|Death|2|||
126349043|NCT03314935|454571105|FG002|Phase 1|Death|5|||
126349044|NCT03314935|454571106|FG003|Phase 1|Death|4|||
126349045|NCT03314935|454571107|FG004|Phase 1|Death|3|||
126349046|NCT03314935|454571108|FG005|Phase 1|Death|4|||
126349047|NCT03314935|454571109|FG006|Phase 1|Death|5|||
126349048|NCT03314935|454571110|FG007|Phase 1|Death|4|||
126349049|NCT03314935|454571111|FG008|Phase 1|Death|3|||
126349050|NCT03314935|454571112|FG009|Phase 1|Death|0|||
126349051|NCT03314935|454571113|FG010|Phase 1|Death|0|||
126349052|NCT03314935|454571114|FG011|Phase 1|Death|0|||
126349053|NCT03314935|454571115|FG012|Phase 1|Death|0|||
126349054|NCT03314935|454571116|FG013|Phase 1|Death|0|||
126349055|NCT03314935|454571117|FG014|Phase 1|Death|0|||
126349056|NCT03314935|454571103|FG000|Phase 1|Withdrawal by Subject|2|||
126349057|NCT03314935|454571104|FG001|Phase 1|Withdrawal by Subject|1|||
126349058|NCT03314935|454571105|FG002|Phase 1|Withdrawal by Subject|1|||
126349059|NCT03314935|454571106|FG003|Phase 1|Withdrawal by Subject|2|||
126349060|NCT03314935|454571107|FG004|Phase 1|Withdrawal by Subject|1|||
126349061|NCT03314935|454571108|FG005|Phase 1|Withdrawal by Subject|0|||
126349062|NCT03314935|454571109|FG006|Phase 1|Withdrawal by Subject|1|||
126349063|NCT03314935|454571110|FG007|Phase 1|Withdrawal by Subject|0|||
126349064|NCT03314935|454571111|FG008|Phase 1|Withdrawal by Subject|1|||
126349065|NCT03314935|454571112|FG009|Phase 1|Withdrawal by Subject|0|||
126349066|NCT03314935|454571113|FG010|Phase 1|Withdrawal by Subject|0|||
126349067|NCT03314935|454571114|FG011|Phase 1|Withdrawal by Subject|0|||
126349068|NCT03314935|454571115|FG012|Phase 1|Withdrawal by Subject|0|||
126349069|NCT03314935|454571116|FG013|Phase 1|Withdrawal by Subject|0|||
126349070|NCT03314935|454571117|FG014|Phase 1|Withdrawal by Subject|0|||
126349071|NCT03314935|454571103|FG000|Phase 1|Progressive Disease|2|||
126349072|NCT03314935|454571104|FG001|Phase 1|Progressive Disease|0|||
126349073|NCT03314935|454571105|FG002|Phase 1|Progressive Disease|0|||
126349074|NCT03314935|454571106|FG003|Phase 1|Progressive Disease|1|||
126349075|NCT03314935|454571107|FG004|Phase 1|Progressive Disease|0|||
126349076|NCT03314935|454571108|FG005|Phase 1|Progressive Disease|0|||
126349077|NCT03314935|454571109|FG006|Phase 1|Progressive Disease|0|||
126349078|NCT03314935|454571110|FG007|Phase 1|Progressive Disease|0|||
126349079|NCT03314935|454571111|FG008|Phase 1|Progressive Disease|0|||
126349080|NCT03314935|454571112|FG009|Phase 1|Progressive Disease|0|||
126349081|NCT03314935|454571113|FG010|Phase 1|Progressive Disease|0|||
126349082|NCT03314935|454571114|FG011|Phase 1|Progressive Disease|0|||
126349083|NCT03314935|454571115|FG012|Phase 1|Progressive Disease|0|||
126349084|NCT03314935|454571116|FG013|Phase 1|Progressive Disease|0|||
126349085|NCT03314935|454571117|FG014|Phase 1|Progressive Disease|0|||
126349086|NCT03314935|454571103|FG000|Phase 1|Study Terminated by Sponsor|0|||
126349087|NCT03314935|454571104|FG001|Phase 1|Study Terminated by Sponsor|1|||
126681663|NCT01049035|455791311|FG002|Overall Study|Other adverse event (AE)|0|||
126349088|NCT03314935|454571105|FG002|Phase 1|Study Terminated by Sponsor|0|||
126349089|NCT03314935|454571106|FG003|Phase 1|Study Terminated by Sponsor|0|||
126349090|NCT03314935|454571107|FG004|Phase 1|Study Terminated by Sponsor|0|||
126349091|NCT03314935|454571108|FG005|Phase 1|Study Terminated by Sponsor|0|||
126349092|NCT03314935|454571109|FG006|Phase 1|Study Terminated by Sponsor|0|||
126349093|NCT03314935|454571110|FG007|Phase 1|Study Terminated by Sponsor|0|||
126681664|NCT01049035|455791312|FG003|Overall Study|Other adverse event (AE)|1|||
126681665|NCT01049035|455791313|FG004|Overall Study|Other adverse event (AE)|0|||
126681666|NCT01049035|455791314|FG005|Overall Study|Other adverse event (AE)|0|||
126681667|NCT01049035|455791315|FG006|Overall Study|Other adverse event (AE)|0|||
126681668|NCT01049035|455791309|FG000|Overall Study|Non-compliance with the protocol|12|||
126681669|NCT01049035|455791310|FG001|Overall Study|Non-compliance with the protocol|6|||
126681670|NCT01049035|455791311|FG002|Overall Study|Non-compliance with the protocol|14|||
126681671|NCT01049035|455791312|FG003|Overall Study|Non-compliance with the protocol|5|||
126681672|NCT01049035|455791313|FG004|Overall Study|Non-compliance with the protocol|3|||
126681673|NCT01049035|455791314|FG005|Overall Study|Non-compliance with the protocol|4|||
126681674|NCT01049035|455791315|FG006|Overall Study|Non-compliance with the protocol|10|||
126349094|NCT03314935|454571111|FG008|Phase 1|Study Terminated by Sponsor|1|||
126349095|NCT03314935|454571112|FG009|Phase 1|Study Terminated by Sponsor|0|||
126349096|NCT03314935|454571113|FG010|Phase 1|Study Terminated by Sponsor|0|||
126349097|NCT03314935|454571114|FG011|Phase 1|Study Terminated by Sponsor|0|||
126349098|NCT03314935|454571115|FG012|Phase 1|Study Terminated by Sponsor|0|||
126349099|NCT03314935|454571116|FG013|Phase 1|Study Terminated by Sponsor|0|||
126349100|NCT03314935|454571117|FG014|Phase 1|Study Terminated by Sponsor|0|||
126349101|NCT03314935|454571103|FG000|Phase 1|"Captured as Other in Database"|0|||
126349102|NCT03314935|454571104|FG001|Phase 1|"Captured as Other in Database"|2|||
126349103|NCT03314935|454571105|FG002|Phase 1|"Captured as Other in Database"|0|||
126349104|NCT03314935|454571106|FG003|Phase 1|"Captured as Other in Database"|0|||
126349105|NCT03314935|454571107|FG004|Phase 1|"Captured as Other in Database"|0|||
126349106|NCT03314935|454571108|FG005|Phase 1|"Captured as Other in Database"|0|||
126349107|NCT03314935|454571109|FG006|Phase 1|"Captured as Other in Database"|1|||
126349108|NCT03314935|454571110|FG007|Phase 1|"Captured as Other in Database"|1|||
126349109|NCT03314935|454571111|FG008|Phase 1|"Captured as Other in Database"|1|||
126349110|NCT03314935|454571112|FG009|Phase 1|"Captured as Other in Database"|0|||
126349111|NCT03314935|454571113|FG010|Phase 1|"Captured as Other in Database"|0|||
126349112|NCT03314935|454571114|FG011|Phase 1|"Captured as Other in Database"|0|||
126349113|NCT03314935|454571115|FG012|Phase 1|"Captured as Other in Database"|0|||
126349114|NCT03314935|454571116|FG013|Phase 1|"Captured as Other in Database"|0|||
126349115|NCT03314935|454571117|FG014|Phase 1|"Captured as Other in Database"|0|||
126349116|NCT03314935|454571103|FG000|Phase 1|Lost to Follow-up|0|||
126349117|NCT03314935|454571104|FG001|Phase 1|Lost to Follow-up|0|||
126349118|NCT03314935|454571105|FG002|Phase 1|Lost to Follow-up|0|||
126349119|NCT03314935|454571106|FG003|Phase 1|Lost to Follow-up|0|||
126349120|NCT03314935|454571107|FG004|Phase 1|Lost to Follow-up|0|||
126349121|NCT03314935|454571108|FG005|Phase 1|Lost to Follow-up|0|||
126349122|NCT03314935|454571109|FG006|Phase 1|Lost to Follow-up|0|||
126349123|NCT03314935|454571110|FG007|Phase 1|Lost to Follow-up|0|||
126349124|NCT03314935|454571111|FG008|Phase 1|Lost to Follow-up|1|||
126349125|NCT03314935|454571112|FG009|Phase 1|Lost to Follow-up|0|||
126349126|NCT03314935|454571113|FG010|Phase 1|Lost to Follow-up|0|||
126349127|NCT03314935|454571114|FG011|Phase 1|Lost to Follow-up|0|||
126349128|NCT03314935|454571115|FG012|Phase 1|Lost to Follow-up|0|||
126349129|NCT03314935|454571116|FG013|Phase 1|Lost to Follow-up|0|||
126349130|NCT03314935|454571117|FG014|Phase 1|Lost to Follow-up|0|||
126349131|NCT03314935|454571103|FG000|Phase 2|Death|0|||
126349132|NCT03314935|454571104|FG001|Phase 2|Death|0|||
126349133|NCT03314935|454571105|FG002|Phase 2|Death|0|||
126349134|NCT03314935|454571106|FG003|Phase 2|Death|0|||
126349135|NCT03314935|454571107|FG004|Phase 2|Death|0|||
126349136|NCT03314935|454571108|FG005|Phase 2|Death|0|||
126349137|NCT03314935|454571109|FG006|Phase 2|Death|0|||
126349138|NCT03314935|454571110|FG007|Phase 2|Death|0|||
126349139|NCT03314935|454571111|FG008|Phase 2|Death|0|||
126349140|NCT03314935|454571112|FG009|Phase 2|Death|5|||
126349141|NCT03314935|454571113|FG010|Phase 2|Death|20|||
126349142|NCT03314935|454571114|FG011|Phase 2|Death|6|||
126349143|NCT03314935|454571115|FG012|Phase 2|Death|7|||
126349144|NCT03314935|454571116|FG013|Phase 2|Death|6|||
126349145|NCT03314935|454571117|FG014|Phase 2|Death|17|||
126349146|NCT03314935|454571103|FG000|Phase 2|Withdrawal by Subject|0|||
126349147|NCT03314935|454571104|FG001|Phase 2|Withdrawal by Subject|0|||
126349148|NCT03314935|454571105|FG002|Phase 2|Withdrawal by Subject|0|||
126349149|NCT03314935|454571106|FG003|Phase 2|Withdrawal by Subject|0|||
126349150|NCT03314935|454571107|FG004|Phase 2|Withdrawal by Subject|0|||
126681675|NCT01049035|455791309|FG000|Overall Study|Lost to Follow-up|5|||
126681676|NCT01049035|455791310|FG001|Overall Study|Lost to Follow-up|4|||
126349151|NCT03314935|454571108|FG005|Phase 2|Withdrawal by Subject|0|||
126435392|NCT02118584|454893811|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
126435393|NCT02118584|454893812|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
126435394|NCT02118584|454893813|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
126435395|NCT02118584|454893811|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
126435396|NCT02118584|454893812|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
126435397|NCT02118584|454893813|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
126435398|NCT02118584|454893811|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
126435399|NCT02118584|454893812|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
126681677|NCT01049035|455791311|FG002|Overall Study|Lost to Follow-up|4|||
126681678|NCT01049035|455791312|FG003|Overall Study|Lost to Follow-up|1|||
126681679|NCT01049035|455791313|FG004|Overall Study|Lost to Follow-up|0|||
126681680|NCT01049035|455791314|FG005|Overall Study|Lost to Follow-up|3|||
126435400|NCT02118584|454893813|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
126435401|NCT02118584|454893811|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
126435402|NCT02118584|454893812|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
126435403|NCT02118584|454893813|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
126435404|NCT02118584|454893811|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
126435405|NCT02118584|454893812|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
126435406|NCT02118584|454893813|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
126435407|NCT03103542|454893816|FG000|Overall Study|Physician Decision|2|||
126435408|NCT03103542|454893816|FG000|Overall Study|Adverse Event|2|||
126435409|NCT03103542|454893816|FG000|Overall Study|Other|2|||
126435410|NCT03103542|454893816|FG000|Overall Study|Withdrawal by Subject|1|||
126435411|NCT03566511|454893817|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
126435412|NCT03566511|454893818|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
126435413|NCT02939287|454893820|FG000|Overall Study|met exclusion criteria|1|||
126435414|NCT02939287|454893821|FG001|Overall Study|met exclusion criteria|1|||
126435415|NCT02939287|454893822|FG002|Overall Study|met exclusion criteria|1|||
126435416|NCT02939287|454893820|FG000|Overall Study|Did not complete survey|2|||
126435417|NCT02939287|454893821|FG001|Overall Study|Did not complete survey|2|||
126435418|NCT02939287|454893822|FG002|Overall Study|Did not complete survey|0|||
126435419|NCT02939287|454893820|FG000|Overall Study|Withdrawal by Subject|1|||
126435420|NCT02939287|454893821|FG001|Overall Study|Withdrawal by Subject|1|||
126435421|NCT02939287|454893822|FG002|Overall Study|Withdrawal by Subject|0|||
126435422|NCT00981656|454893823|FG000|Overall Study|Protocol Violation|1|||
126435423|NCT00981656|454893823|FG000|Overall Study|Did not start protocol treatment|2|||
126435424|NCT00687596|454893824|FG000|Overall Study|Adverse Event (AE)|10|||
126435425|NCT00687596|454893825|FG001|Overall Study|Adverse Event (AE)|3|||
126435426|NCT00687596|454893824|FG000|Overall Study|Radiological Disease Progression|6|||
126435427|NCT00687596|454893825|FG001|Overall Study|Radiological Disease Progression|2|||
126435428|NCT00687596|454893824|FG000|Overall Study|Clinical Disease Progression|1|||
126435429|NCT00687596|454893825|FG001|Overall Study|Clinical Disease Progression|3|||
126435430|NCT00687596|454893824|FG000|Overall Study|Investigator Discretion|3|||
126435431|NCT00687596|454893825|FG001|Overall Study|Investigator Discretion|1|||
126435432|NCT00687596|454893824|FG000|Overall Study|Sponsor Terminated Study|6|||
126435433|NCT00687596|454893825|FG001|Overall Study|Sponsor Terminated Study|17|||
126435434|NCT03406780|454893826|FG000|Overall Study|Withdrawal by Subject|1|||
126435435|NCT03406780|454893827|FG001|Overall Study|Withdrawal by Subject|1|||
126435436|NCT03406780|454893826|FG000|Overall Study|Other|0|||
126435437|NCT03406780|454893827|FG001|Overall Study|Other|2|||
126435438|NCT00837434|454893833|FG000|Overall Study|Physician Decision|3|||
126435439|NCT00837434|454893834|FG001|Overall Study|Physician Decision|0|||
126435440|NCT00837434|454893833|FG000|Overall Study|Lost to Follow-up|1|||
126435441|NCT00837434|454893834|FG001|Overall Study|Lost to Follow-up|1|||
126435442|NCT00837434|454893833|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
126435443|NCT00837434|454893834|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
126435444|NCT00837434|454893833|FG000|Overall Study|Noncompliant|2|||
126435445|NCT00837434|454893834|FG001|Overall Study|Noncompliant|0|||
126435446|NCT00837434|454893833|FG000|Overall Study|Baseline assessments not done in time|1|||
126435447|NCT00837434|454893834|FG001|Overall Study|Baseline assessments not done in time|0|||
126435448|NCT00837434|454893833|FG000|Overall Study|Unable to obtain study drug|1|||
126435449|NCT00837434|454893834|FG001|Overall Study|Unable to obtain study drug|0|||
126435450|NCT03041038|454893855|FG000|Overall Study|Withdrawal by Subject|4|||
126435451|NCT03041038|454893856|FG001|Overall Study|Withdrawal by Subject|0|||
126435452|NCT03041038|454893855|FG000|Overall Study|Lost to Follow-up|1|||
126435453|NCT03041038|454893856|FG001|Overall Study|Lost to Follow-up|1|||
126435454|NCT03041038|454893855|FG000|Overall Study|Protocol Violation|1|||
126435455|NCT03041038|454893856|FG001|Overall Study|Protocol Violation|1|||
126435456|NCT03331315|454893857|FG000|Overall Study|Physician Decision|18|||
126435457|NCT03331315|454893858|FG001|Overall Study|Physician Decision|14|||
126435458|NCT00360230|454893861|FG000|Overall Study|Withdrawal by Subject|1|||
126435459|NCT00360230|454893862|FG001|Overall Study|Withdrawal by Subject|1|||
126435460|NCT00360230|454893863|FG002|Overall Study|Withdrawal by Subject|0|||
126435461|NCT00360230|454893864|FG003|Overall Study|Withdrawal by Subject|1|||
126435462|NCT00360230|454893865|FG004|Overall Study|Withdrawal by Subject|1|||
126435463|NCT00360230|454893866|FG005|Overall Study|Withdrawal by Subject|1|||
126435464|NCT00360230|454893867|FG006|Overall Study|Withdrawal by Subject|0|||
126435465|NCT00360230|454893861|FG000|Overall Study|Migrated|4|||
126435466|NCT00360230|454893862|FG001|Overall Study|Migrated|1|||
126435467|NCT00360230|454893863|FG002|Overall Study|Migrated|3|||
126435468|NCT00360230|454893864|FG003|Overall Study|Migrated|1|||
126435469|NCT00360230|454893865|FG004|Overall Study|Migrated|4|||
126435470|NCT00360230|454893866|FG005|Overall Study|Migrated|1|||
126435471|NCT00360230|454893867|FG006|Overall Study|Migrated|1|||
126435472|NCT00360230|454893861|FG000|Overall Study|Other|1|||
126435473|NCT00360230|454893862|FG001|Overall Study|Other|0|||
126435474|NCT00360230|454893863|FG002|Overall Study|Other|0|||
126435475|NCT00360230|454893864|FG003|Overall Study|Other|0|||
126349152|NCT03314935|454571109|FG006|Phase 2|Withdrawal by Subject|0|||
126435476|NCT00360230|454893865|FG004|Overall Study|Other|0|||
126435477|NCT00360230|454893866|FG005|Overall Study|Other|0|||
126435478|NCT00360230|454893867|FG006|Overall Study|Other|0|||
126435479|NCT00360230|454893861|FG000|Overall Study|Protocol Violation|0|||
126435480|NCT00360230|454893862|FG001|Overall Study|Protocol Violation|0|||
126435481|NCT00360230|454893863|FG002|Overall Study|Protocol Violation|0|||
126435482|NCT00360230|454893864|FG003|Overall Study|Protocol Violation|0|||
126435483|NCT00360230|454893865|FG004|Overall Study|Protocol Violation|0|||
126435484|NCT00360230|454893866|FG005|Overall Study|Protocol Violation|1|||
126435485|NCT00360230|454893867|FG006|Overall Study|Protocol Violation|0|||
126435486|NCT00360230|454893861|FG000|Overall Study|Death|0|||
126435487|NCT00360230|454893862|FG001|Overall Study|Death|1|||
126435488|NCT00360230|454893863|FG002|Overall Study|Death|0|||
126435489|NCT00360230|454893864|FG003|Overall Study|Death|0|||
126435490|NCT00360230|454893865|FG004|Overall Study|Death|0|||
126435491|NCT00360230|454893866|FG005|Overall Study|Death|1|||
126435492|NCT00360230|454893867|FG006|Overall Study|Death|1|||
126435493|NCT00581308|454893868|FG000|Pre Discharge|Lost to Follow-up|1|||
126435494|NCT00581308|454893868|FG000|Pre Discharge|Device Removed|1|||
126435495|NCT00581308|454893868|FG000|Month 1|Lost to Follow-up|3|||
126435496|NCT00581308|454893868|FG000|Month 1|Withdrawal by Subject|2|||
126435497|NCT00581308|454893868|FG000|Month 1|Device Removed|2|||
126435498|NCT00581308|454893868|FG000|Month 1|Uknown|1|||
126435499|NCT00581308|454893868|FG000|Month 6|Lost to Follow-up|1|||
126435500|NCT00581308|454893868|FG000|Month 6|Withdrawal by Subject|2|||
126435501|NCT00581308|454893868|FG000|Month 12|Death|1|||
126435502|NCT00581308|454893868|FG000|Month 12|Lost to Follow-up|14|||
126435503|NCT00581308|454893868|FG000|Month 12|Withdrawal by Subject|3|||
126435504|NCT00581308|454893868|FG000|Month 12|Device Removed|1|||
126435505|NCT00581308|454893868|FG000|Month 12|Other|1|||
126435506|NCT00886379|454893869|FG000|Overall Study|Transferred Schools|0|||
126435507|NCT00886379|454893870|FG001|Overall Study|Transferred Schools|0|||
126435508|NCT00886379|454893871|FG002|Overall Study|Transferred Schools|2|||
126435509|NCT00886379|454893872|FG003|Overall Study|Transferred Schools|1|||
126435510|NCT00886379|454893873|FG004|Overall Study|Transferred Schools|1|||
126435511|NCT00886379|454893869|FG000|Overall Study|Final blood draw not obtained|3|||
126435512|NCT00886379|454893870|FG001|Overall Study|Final blood draw not obtained|3|||
126435513|NCT00886379|454893871|FG002|Overall Study|Final blood draw not obtained|4|||
126435514|NCT00886379|454893872|FG003|Overall Study|Final blood draw not obtained|2|||
126435515|NCT00886379|454893873|FG004|Overall Study|Final blood draw not obtained|2|||
126435516|NCT04558125|454893874|FG000|Overall Study|Death|1|||
126435517|NCT01614886|454893875|FG000|Overall Study|Adverse Event|15|||
126435518|NCT01614886|454893876|FG001|Overall Study|Adverse Event|20|||
126435519|NCT01614886|454893875|FG000|Overall Study|Withdrawal by Subject|4|||
126435520|NCT01614886|454893876|FG001|Overall Study|Withdrawal by Subject|4|||
126435521|NCT01614886|454893875|FG000|Overall Study|Death|1|||
126435522|NCT01614886|454893876|FG001|Overall Study|Death|0|||
126435523|NCT01614886|454893875|FG000|Overall Study|Protocol deviation|0|||
126435524|NCT01614886|454893876|FG001|Overall Study|Protocol deviation|2|||
126435525|NCT01207414|454893878|FG000|Overall Study|Adverse Event|25|||
126435526|NCT01207414|454893879|FG001|Overall Study|Adverse Event|39|||
126435527|NCT01207414|454893878|FG000|Overall Study|Abnormal test procedure results|0|||
126435528|NCT01207414|454893879|FG001|Overall Study|Abnormal test procedure results|1|||
126435529|NCT01207414|454893878|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
126435530|NCT01207414|454893879|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
126349153|NCT03314935|454571110|FG007|Phase 2|Withdrawal by Subject|0|||
126349154|NCT03314935|454571111|FG008|Phase 2|Withdrawal by Subject|0|||
126349155|NCT03314935|454571112|FG009|Phase 2|Withdrawal by Subject|1|||
126349156|NCT03314935|454571113|FG010|Phase 2|Withdrawal by Subject|4|||
126349157|NCT03314935|454571114|FG011|Phase 2|Withdrawal by Subject|0|||
126349158|NCT03314935|454571115|FG012|Phase 2|Withdrawal by Subject|1|||
126349159|NCT03314935|454571116|FG013|Phase 2|Withdrawal by Subject|0|||
126349160|NCT03314935|454571117|FG014|Phase 2|Withdrawal by Subject|1|||
126435531|NCT01207414|454893878|FG000|Overall Study|Patient withdrew consent|14|||
126435532|NCT01207414|454893879|FG001|Overall Study|Patient withdrew consent|11|||
126435533|NCT01207414|454893878|FG000|Overall Study|Lost to Follow-up|15|||
126435534|NCT01207414|454893879|FG001|Overall Study|Lost to Follow-up|17|||
126435535|NCT01207414|454893878|FG000|Overall Study|Administrative problems|1|||
126435536|NCT01207414|454893879|FG001|Overall Study|Administrative problems|1|||
126435537|NCT01207414|454893878|FG000|Overall Study|Protocol deviation|12|||
126435538|NCT01207414|454893879|FG001|Overall Study|Protocol deviation|9|||
126435539|NCT01207414|454893878|FG000|Overall Study|Randomized in error|1|||
126435540|NCT01207414|454893879|FG001|Overall Study|Randomized in error|0|||
126435541|NCT01748292|454893880|FG000|Overall Study|Adverse Event|2|||
126349161|NCT03314935|454571103|FG000|Phase 2|Progressive Disease|0|||
126435542|NCT01748292|454893881|FG001|Overall Study|Adverse Event|4|||
126435543|NCT01748292|454893880|FG000|Overall Study|Lost to Follow-up|0|||
126435544|NCT01748292|454893881|FG001|Overall Study|Lost to Follow-up|3|||
126435545|NCT01748292|454893880|FG000|Overall Study|Death|0|||
126435546|NCT01748292|454893881|FG001|Overall Study|Death|3|||
126435547|NCT01748292|454893880|FG000|Overall Study|Withdrawal by Subject|0|||
126435548|NCT01748292|454893881|FG001|Overall Study|Withdrawal by Subject|2|||
126435549|NCT01527370|454893882|FG000|Overall Study|Withdrawal by Subject|4|||
126435550|NCT01527370|454893882|FG000|Overall Study|Physician Decision|1|||
126435551|NCT01527370|454893882|FG000|Overall Study|Death|1|||
126435552|NCT01435382|454893887|FG000|Overall Study|Lost to Follow-up|1|||
126435553|NCT01435382|454893888|FG001|Overall Study|Lost to Follow-up|0|||
126435554|NCT01435382|454893889|FG002|Overall Study|Lost to Follow-up|1|||
126435555|NCT01435382|454893890|FG003|Overall Study|Lost to Follow-up|0|||
126435556|NCT01435382|454893887|FG000|Overall Study|Withdrawal by Subject|0|||
126435557|NCT01435382|454893888|FG001|Overall Study|Withdrawal by Subject|2|||
126435558|NCT01435382|454893889|FG002|Overall Study|Withdrawal by Subject|0|||
126435559|NCT01435382|454893890|FG003|Overall Study|Withdrawal by Subject|1|||
126435560|NCT00910650|454893891|FG000|Overall Study|Death|2|||
126435561|NCT03367793|454893892|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
126435562|NCT03367793|454893893|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
126435563|NCT03367793|454893894|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
126435564|NCT03367793|454893895|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
126435565|NCT03367793|454893896|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
126435566|NCT03367793|454893897|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
126435567|NCT00260533|454893898|FG000|Overall Study|Other|3|||
126435568|NCT00260533|454893899|FG001|Overall Study|Other|3|||
126435569|NCT01310777|454893901|FG000|Overall Study|Adverse Event|23|||
126435570|NCT01310777|454893902|FG001|Overall Study|Adverse Event|1|||
126435571|NCT01310777|454893903|FG002|Overall Study|Adverse Event|15|||
126435572|NCT01310777|454893901|FG000|Overall Study|Lost to Follow-up|0|||
126435573|NCT01310777|454893902|FG001|Overall Study|Lost to Follow-up|4|||
126435574|NCT01310777|454893903|FG002|Overall Study|Lost to Follow-up|1|||
126435575|NCT01310777|454893901|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
126435576|NCT01310777|454893902|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
126545311|NCT00130793|455290808|FG001|Overall Study|Withdrew consent|0|||
126545312|NCT00211237|455290809|FG000|Baseline|Withdrew|1|||
126545313|NCT00211237|455290810|FG001|Baseline|Withdrew|3|||
126545314|NCT00211237|455290811|FG002|Baseline|Withdrew|0|||
126545315|NCT00211237|455290809|FG000|Baseline|Refused random assignment|1|||
126545316|NCT00211237|455290810|FG001|Baseline|Refused random assignment|0|||
126545317|NCT00211237|455290811|FG002|Baseline|Refused random assignment|0|||
126545318|NCT00211237|455290809|FG000|1 Month|Death|2|||
126545319|NCT00211237|455290810|FG001|1 Month|Death|1|||
126545320|NCT00211237|455290811|FG002|1 Month|Death|0|||
126545321|NCT00211237|455290809|FG000|1 Month|Lost to Follow-up|0|||
126545322|NCT00211237|455290810|FG001|1 Month|Lost to Follow-up|2|||
126545323|NCT00211237|455290811|FG002|1 Month|Lost to Follow-up|0|||
126545324|NCT00211237|455290809|FG000|1 Month|Withdrew|0|||
126545325|NCT00211237|455290810|FG001|1 Month|Withdrew|4|||
126545326|NCT00211237|455290811|FG002|1 Month|Withdrew|0|||
126545327|NCT00211237|455290809|FG000|1 Month|Additional surgery needed|1|||
126545328|NCT00211237|455290810|FG001|1 Month|Additional surgery needed|0|||
126545329|NCT00211237|455290811|FG002|1 Month|Additional surgery needed|0|||
126545330|NCT00211237|455290809|FG000|1 Month|Non-medical problem|0|||
126545331|NCT00211237|455290810|FG001|1 Month|Non-medical problem|2|||
126545332|NCT00211237|455290811|FG002|1 Month|Non-medical problem|0|||
126681681|NCT01049035|455791315|FG006|Overall Study|Lost to Follow-up|3|||
126681682|NCT01049035|455791309|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
126681683|NCT01049035|455791310|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
126681684|NCT01049035|455791311|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
126681685|NCT01049035|455791312|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
126681686|NCT01049035|455791313|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
126681687|NCT01049035|455791314|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
126681688|NCT01049035|455791315|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
126681689|NCT02095535|455791316|FG000|Recruitment|Protocol Violation|2|||
126681690|NCT00623480|455791317|FG000|Overall Study|Lost to Follow-up|0|||
126681691|NCT00623480|455791318|FG001|Overall Study|Lost to Follow-up|1|||
126681692|NCT00623480|455791317|FG000|Overall Study|Withdrawal by Subject|2|||
126681693|NCT00623480|455791318|FG001|Overall Study|Withdrawal by Subject|4|||
126681694|NCT00623480|455791317|FG000|Overall Study|Lack of Efficacy|1|||
126681695|NCT00623480|455791318|FG001|Overall Study|Lack of Efficacy|0|||
126681696|NCT00623480|455791317|FG000|Overall Study|Non-compliant with study medication|4|||
126681697|NCT00623480|455791318|FG001|Overall Study|Non-compliant with study medication|0|||
126681698|NCT00623480|455791317|FG000|Overall Study|Protocol Violation|0|||
126681699|NCT00623480|455791318|FG001|Overall Study|Protocol Violation|1|||
126681700|NCT00623480|455791317|FG000|Overall Study|Site closed by sponsor|0|||
126681701|NCT00623480|455791318|FG001|Overall Study|Site closed by sponsor|1|||
126681702|NCT01877187|455791319|FG000|Overall Study|Death|2|||
126681703|NCT01877187|455791319|FG000|Overall Study|Withdrawal by Subject|4|||
126681704|NCT01877187|455791319|FG000|Overall Study|Lost to Follow-up|3|||
126681705|NCT01877187|455791319|FG000|Overall Study|Declining clinical status|11|||
126681706|NCT01877187|455791319|FG000|Overall Study|Liver transplant|2|||
126681707|NCT02559687|455791325|FG000|Overall Study|Death|112|||
126681708|NCT02559687|455791325|FG000|Overall Study|Sponsor Decision|5|||
126681709|NCT02559687|455791325|FG000|Overall Study|Withdrawal by Subject|4|||
126681710|NCT01784861|455791327|FG000|Overall Study|Adverse Event|0|||
126681711|NCT01784861|455791328|FG001|Overall Study|Adverse Event|0|||
126681712|NCT01784861|455791329|FG002|Overall Study|Adverse Event|1|||
126681713|NCT01784861|455791330|FG003|Overall Study|Adverse Event|2|||
126681714|NCT01784861|455791331|FG004|Overall Study|Adverse Event|1|||
126681715|NCT01784861|455791332|FG005|Overall Study|Adverse Event|0|||
126681716|NCT01784861|455791327|FG000|Overall Study|Withdrawal by Subject|0|||
126681717|NCT01784861|455791328|FG001|Overall Study|Withdrawal by Subject|0|||
126681718|NCT01784861|455791329|FG002|Overall Study|Withdrawal by Subject|0|||
126545333|NCT00211237|455290809|FG000|3 Months|Death|7|||
126545334|NCT00211237|455290810|FG001|3 Months|Death|3|||
126681719|NCT01784861|455791330|FG003|Overall Study|Withdrawal by Subject|1|||
126681720|NCT01784861|455791331|FG004|Overall Study|Withdrawal by Subject|0|||
126681721|NCT01784861|455791332|FG005|Overall Study|Withdrawal by Subject|0|||
126681722|NCT01784861|455791327|FG000|Overall Study|Physician Decision|0|||
126681723|NCT01784861|455791328|FG001|Overall Study|Physician Decision|0|||
126681724|NCT01784861|455791329|FG002|Overall Study|Physician Decision|0|||
126681725|NCT01784861|455791330|FG003|Overall Study|Physician Decision|2|||
126681726|NCT01784861|455791331|FG004|Overall Study|Physician Decision|0|||
126681727|NCT01784861|455791332|FG005|Overall Study|Physician Decision|1|||
126681728|NCT03948178|455791333|FG000|Overall Study|Protocol Violation|1|||
126681729|NCT03948178|455791333|FG000|Overall Study|Lost to Follow-up|2|||
126681730|NCT03948178|455791333|FG000|Overall Study|Withdrawal by Subject|2|||
126681731|NCT03948178|455791333|FG000|Overall Study|Reason not known|2|||
126681732|NCT03948178|455791333|FG000|Overall Study|Personal reason|14|||
126545335|NCT00211237|455290811|FG002|3 Months|Death|0|||
126545336|NCT00211237|455290809|FG000|3 Months|Could not comply with protocol|1|||
126545337|NCT00211237|455290810|FG001|3 Months|Could not comply with protocol|0|||
126681733|NCT03948178|455791333|FG000|Overall Study|Disease progression|30|||
126681734|NCT03948178|455791333|FG000|Overall Study|Adverse Event|12|||
126681735|NCT03948178|455791333|FG000|Overall Study|Sponsor terminated study|164|||
126681736|NCT02432235|455791334|FG000|Overall Study|Death|1|||
126681737|NCT02432235|455791335|FG001|Overall Study|Death|1|||
126681738|NCT02432235|455791336|FG002|Overall Study|Death|2|||
126681739|NCT02432235|455791337|FG003|Overall Study|Death|2|||
126681740|NCT02432235|455791338|FG004|Overall Study|Death|1|||
126349162|NCT03314935|454571104|FG001|Phase 2|Progressive Disease|0|||
126349163|NCT03314935|454571105|FG002|Phase 2|Progressive Disease|0|||
126349164|NCT03314935|454571106|FG003|Phase 2|Progressive Disease|0|||
126349165|NCT03314935|454571107|FG004|Phase 2|Progressive Disease|0|||
126349166|NCT03314935|454571108|FG005|Phase 2|Progressive Disease|0|||
126349167|NCT03314935|454571109|FG006|Phase 2|Progressive Disease|0|||
126349168|NCT03314935|454571110|FG007|Phase 2|Progressive Disease|0|||
126349169|NCT03314935|454571111|FG008|Phase 2|Progressive Disease|0|||
126349170|NCT03314935|454571112|FG009|Phase 2|Progressive Disease|1|||
126681741|NCT02432235|455791339|FG005|Overall Study|Death|3|||
126681742|NCT02432235|455791340|FG006|Overall Study|Death|11|||
126681743|NCT02432235|455791341|FG007|Overall Study|Death|15|||
126681744|NCT02432235|455791342|FG008|Overall Study|Death|15|||
126681745|NCT02432235|455791343|FG009|Overall Study|Death|3|||
126681746|NCT02432235|455791344|FG010|Overall Study|Death|1|||
126349171|NCT03314935|454571113|FG010|Phase 2|Progressive Disease|1|||
126349172|NCT03314935|454571114|FG011|Phase 2|Progressive Disease|1|||
126349173|NCT03314935|454571115|FG012|Phase 2|Progressive Disease|2|||
126349174|NCT03314935|454571116|FG013|Phase 2|Progressive Disease|0|||
126349175|NCT03314935|454571117|FG014|Phase 2|Progressive Disease|1|||
126349176|NCT03314935|454571103|FG000|Phase 2|Study Terminated by Sponsor|0|||
126349177|NCT03314935|454571104|FG001|Phase 2|Study Terminated by Sponsor|0|||
126349178|NCT03314935|454571105|FG002|Phase 2|Study Terminated by Sponsor|0|||
126349179|NCT03314935|454571106|FG003|Phase 2|Study Terminated by Sponsor|0|||
126349180|NCT03314935|454571107|FG004|Phase 2|Study Terminated by Sponsor|0|||
126349181|NCT03314935|454571108|FG005|Phase 2|Study Terminated by Sponsor|0|||
126349182|NCT03314935|454571109|FG006|Phase 2|Study Terminated by Sponsor|0|||
126349183|NCT03314935|454571110|FG007|Phase 2|Study Terminated by Sponsor|0|||
126349184|NCT03314935|454571111|FG008|Phase 2|Study Terminated by Sponsor|0|||
126349185|NCT03314935|454571112|FG009|Phase 2|Study Terminated by Sponsor|0|||
126349186|NCT03314935|454571113|FG010|Phase 2|Study Terminated by Sponsor|7|||
126349187|NCT03314935|454571114|FG011|Phase 2|Study Terminated by Sponsor|2|||
126349188|NCT03314935|454571115|FG012|Phase 2|Study Terminated by Sponsor|1|||
126349189|NCT03314935|454571116|FG013|Phase 2|Study Terminated by Sponsor|4|||
126349190|NCT03314935|454571117|FG014|Phase 2|Study Terminated by Sponsor|4|||
126349191|NCT03314935|454571103|FG000|Phase 2|Lost to Follow-up|0|||
126349192|NCT03314935|454571104|FG001|Phase 2|Lost to Follow-up|0|||
126349193|NCT03314935|454571105|FG002|Phase 2|Lost to Follow-up|0|||
126349194|NCT03314935|454571106|FG003|Phase 2|Lost to Follow-up|0|||
126349195|NCT03314935|454571107|FG004|Phase 2|Lost to Follow-up|0|||
126349196|NCT03314935|454571108|FG005|Phase 2|Lost to Follow-up|0|||
126349197|NCT03314935|454571109|FG006|Phase 2|Lost to Follow-up|0|||
126349198|NCT03314935|454571110|FG007|Phase 2|Lost to Follow-up|0|||
126349199|NCT03314935|454571111|FG008|Phase 2|Lost to Follow-up|0|||
126349200|NCT03314935|454571112|FG009|Phase 2|Lost to Follow-up|1|||
126349201|NCT03314935|454571113|FG010|Phase 2|Lost to Follow-up|0|||
126349202|NCT03314935|454571114|FG011|Phase 2|Lost to Follow-up|0|||
126349203|NCT03314935|454571115|FG012|Phase 2|Lost to Follow-up|0|||
126349204|NCT03314935|454571116|FG013|Phase 2|Lost to Follow-up|0|||
126349205|NCT03314935|454571117|FG014|Phase 2|Lost to Follow-up|1|||
126349206|NCT03314935|454571103|FG000|Phase 2|Physician Decision|0|||
126349207|NCT03314935|454571104|FG001|Phase 2|Physician Decision|0|||
126349208|NCT03314935|454571105|FG002|Phase 2|Physician Decision|0|||
126349209|NCT03314935|454571106|FG003|Phase 2|Physician Decision|0|||
126349210|NCT03314935|454571107|FG004|Phase 2|Physician Decision|0|||
126349211|NCT03314935|454571108|FG005|Phase 2|Physician Decision|0|||
126349212|NCT03314935|454571109|FG006|Phase 2|Physician Decision|0|||
126349213|NCT03314935|454571110|FG007|Phase 2|Physician Decision|0|||
126349214|NCT03314935|454571111|FG008|Phase 2|Physician Decision|0|||
126349215|NCT03314935|454571112|FG009|Phase 2|Physician Decision|0|||
126681747|NCT02432235|455791345|FG011|Overall Study|Death|0|||
126349216|NCT03314935|454571113|FG010|Phase 2|Physician Decision|1|||
126545338|NCT00211237|455290811|FG002|3 Months|Could not comply with protocol|0|||
126545339|NCT00211237|455290809|FG000|3 Months|Withdrew|0|||
126545340|NCT00211237|455290810|FG001|3 Months|Withdrew|1|||
126545341|NCT00211237|455290811|FG002|3 Months|Withdrew|0|||
126545342|NCT00211237|455290809|FG000|3 Months|Non-medical problem|0|||
126545343|NCT00211237|455290810|FG001|3 Months|Non-medical problem|0|||
126545344|NCT00211237|455290811|FG002|3 Months|Non-medical problem|1|||
126545345|NCT00211237|455290809|FG000|6 Months|Death|6|||
126545346|NCT00211237|455290810|FG001|6 Months|Death|0|||
126545347|NCT00211237|455290811|FG002|6 Months|Death|3|||
126545348|NCT00211237|455290809|FG000|6 Months|Lost to Follow-up|2|||
126545349|NCT00211237|455290810|FG001|6 Months|Lost to Follow-up|0|||
126545350|NCT00211237|455290811|FG002|6 Months|Lost to Follow-up|0|||
126545351|NCT00211237|455290809|FG000|6 Months|Could not comply with protocol|0|||
126545352|NCT00211237|455290810|FG001|6 Months|Could not comply with protocol|2|||
126545353|NCT00211237|455290811|FG002|6 Months|Could not comply with protocol|0|||
126545354|NCT00211237|455290809|FG000|12 Months|Death|8|||
126545355|NCT00211237|455290810|FG001|12 Months|Death|2|||
126545356|NCT00211237|455290811|FG002|12 Months|Death|3|||
126545357|NCT00211237|455290809|FG000|12 Months|Lost to Follow-up|1|||
126435577|NCT01310777|454893903|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
126435578|NCT01310777|454893901|FG000|Overall Study|Inadequate Control of IOP|5|||
126435579|NCT01310777|454893902|FG001|Overall Study|Inadequate Control of IOP|7|||
126435580|NCT01310777|454893903|FG002|Overall Study|Inadequate Control of IOP|10|||
126435581|NCT01310777|454893901|FG000|Overall Study|Other|4|||
126435582|NCT01310777|454893902|FG001|Overall Study|Other|1|||
126435583|NCT01310777|454893903|FG002|Overall Study|Other|2|||
126435584|NCT02224560|454893904|FG000|Overall Study|Protocol Deviation|1|||
126435585|NCT02224560|454893905|FG001|Overall Study|Protocol Deviation|0|||
126435586|NCT02224560|454893906|FG002|Overall Study|Protocol Deviation|0|||
126435587|NCT02224560|454893904|FG000|Overall Study|Withdrawal by Subject|2|||
126435588|NCT02224560|454893905|FG001|Overall Study|Withdrawal by Subject|0|||
126435589|NCT02224560|454893906|FG002|Overall Study|Withdrawal by Subject|1|||
126435590|NCT02224560|454893904|FG000|Overall Study|Met Withdrawal Criteria|1|||
126435591|NCT02224560|454893905|FG001|Overall Study|Met Withdrawal Criteria|0|||
126435592|NCT02224560|454893906|FG002|Overall Study|Met Withdrawal Criteria|0|||
126435593|NCT02224560|454893904|FG000|Overall Study|Adverse Event|4|||
126435594|NCT02224560|454893905|FG001|Overall Study|Adverse Event|1|||
126435595|NCT02224560|454893906|FG002|Overall Study|Adverse Event|1|||
126435596|NCT02224560|454893904|FG000|Overall Study|Withdrawn by Investigator|1|||
126435597|NCT02224560|454893905|FG001|Overall Study|Withdrawn by Investigator|1|||
126435598|NCT02224560|454893906|FG002|Overall Study|Withdrawn by Investigator|0|||
126435599|NCT02738801|454893913|FG000|Overall Study|Adverse Event|1|||
126435600|NCT02738801|454893914|FG001|Overall Study|Adverse Event|1|||
126435601|NCT02738801|454893913|FG000|Overall Study|Withdrawal by Subject|0|||
126435602|NCT02738801|454893914|FG001|Overall Study|Withdrawal by Subject|1|||
126435603|NCT03279081|454893915|FG000|Overall Study|Withdrawal by Subject|12|||
126435604|NCT03279081|454893916|FG001|Overall Study|Withdrawal by Subject|20|||
126435605|NCT03279081|454893915|FG000|Overall Study|Physician Decision|4|||
126435606|NCT03279081|454893916|FG001|Overall Study|Physician Decision|1|||
126435607|NCT03279081|454893915|FG000|Overall Study|Lost to Follow-up|8|||
126435608|NCT03279081|454893916|FG001|Overall Study|Lost to Follow-up|8|||
126435609|NCT03279081|454893915|FG000|Overall Study|Death|0|||
126435610|NCT03279081|454893916|FG001|Overall Study|Death|1|||
126435611|NCT03279081|454893915|FG000|Overall Study|Adverse Event|1|||
126435612|NCT03279081|454893916|FG001|Overall Study|Adverse Event|0|||
126435613|NCT03279081|454893915|FG000|Overall Study|Reason not Specified|14|||
126435614|NCT03279081|454893916|FG001|Overall Study|Reason not Specified|4|||
126435615|NCT01210313|454893925|FG000|Overall Study|Withdrawal by Subject|3|||
126435616|NCT01210313|454893925|FG000|Overall Study|Adverse Event|2|||
126435617|NCT01210313|454893925|FG000|Overall Study|Distant recurrence|4|||
126435618|NCT01210313|454893925|FG000|Overall Study|Non-compliance|7|||
126435619|NCT01710345|454893926|FG000|Overall Study|Adverse Event|0|||
126435620|NCT01710345|454893927|FG001|Overall Study|Adverse Event|2|||
126435621|NCT01710345|454893928|FG002|Overall Study|Adverse Event|0|||
126435622|NCT01710345|454893926|FG000|Overall Study|Lack of Efficacy|2|||
126435623|NCT01710345|454893927|FG001|Overall Study|Lack of Efficacy|3|||
126435624|NCT01710345|454893928|FG002|Overall Study|Lack of Efficacy|1|||
126435625|NCT01710345|454893926|FG000|Overall Study|Drug Dosing Error|1|||
126545358|NCT00211237|455290810|FG001|12 Months|Lost to Follow-up|0|||
126545359|NCT00211237|455290811|FG002|12 Months|Lost to Follow-up|1|||
126545360|NCT00211237|455290809|FG000|12 Months|Withdrew|0|||
126435626|NCT01710345|454893927|FG001|Overall Study|Drug Dosing Error|0|||
126435627|NCT01710345|454893928|FG002|Overall Study|Drug Dosing Error|0|||
126545361|NCT00211237|455290810|FG001|12 Months|Withdrew|0|||
126545362|NCT00211237|455290811|FG002|12 Months|Withdrew|1|||
126545363|NCT00211237|455290809|FG000|12 Months|unrelated medical problem|0|||
126435628|NCT01502293|454893931|FG000|Overall Study|Progressive Disease|20|||
126545364|NCT00211237|455290810|FG001|12 Months|unrelated medical problem|0|||
126545365|NCT00211237|455290811|FG002|12 Months|unrelated medical problem|1|||
126545366|NCT00453102|455290814|FG000|Overall Study|Withdrawal by Subject|2|||
126435629|NCT01502293|454893932|FG001|Overall Study|Progressive Disease|12|||
126435630|NCT01502293|454893933|FG002|Overall Study|Progressive Disease|2|||
126435631|NCT01502293|454893931|FG000|Overall Study|Withdrawal by Subject|3|||
126435632|NCT01502293|454893932|FG001|Overall Study|Withdrawal by Subject|3|||
126435633|NCT01502293|454893933|FG002|Overall Study|Withdrawal by Subject|1|||
126435634|NCT01502293|454893931|FG000|Overall Study|Adverse Event|0|||
126435635|NCT01502293|454893932|FG001|Overall Study|Adverse Event|2|||
126435636|NCT01502293|454893933|FG002|Overall Study|Adverse Event|0|||
126435637|NCT01502293|454893931|FG000|Overall Study|Reason Not Specified|2|||
126435638|NCT01502293|454893932|FG001|Overall Study|Reason Not Specified|0|||
126435639|NCT01502293|454893933|FG002|Overall Study|Reason Not Specified|0|||
126435640|NCT01502293|454893931|FG000|Overall Study|Physician Decision|0|||
126435641|NCT01502293|454893932|FG001|Overall Study|Physician Decision|0|||
126435642|NCT01502293|454893933|FG002|Overall Study|Physician Decision|1|||
126435643|NCT00774046|454893936|FG000|Screening|Not eligible|56|||
126435644|NCT00774046|454893936|FG000|Enrollment|Desired other therapy/refused|28|||
126435645|NCT00774046|454893936|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
126435646|NCT00888134|454893950|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
126435647|NCT00888134|454893950|FG000|Follow-up|being followed for long-term survival|1|||
126435648|NCT03041181|454893954|FG000|Overall Study|Disease Progression|1|||
126681748|NCT02432235|455791334|FG000|Overall Study|Withdrawal by Subject|0|||
126681749|NCT02432235|455791335|FG001|Overall Study|Withdrawal by Subject|1|||
126681750|NCT02432235|455791336|FG002|Overall Study|Withdrawal by Subject|0|||
126681751|NCT02432235|455791337|FG003|Overall Study|Withdrawal by Subject|0|||
126681752|NCT02432235|455791338|FG004|Overall Study|Withdrawal by Subject|0|||
126435649|NCT03041181|454893955|FG001|Overall Study|Disease Progression|2|||
126435650|NCT03224819|454893956|FG000|Overall Study|Withdrawal by Subject|0|||
126435651|NCT03224819|454893957|FG001|Overall Study|Withdrawal by Subject|0|||
126435652|NCT03224819|454893958|FG002|Overall Study|Withdrawal by Subject|0|||
126435653|NCT03224819|454893959|FG003|Overall Study|Withdrawal by Subject|0|||
126435654|NCT03224819|454893960|FG004|Overall Study|Withdrawal by Subject|0|||
126435655|NCT03224819|454893961|FG005|Overall Study|Withdrawal by Subject|0|||
126435656|NCT03224819|454893962|FG006|Overall Study|Withdrawal by Subject|0|||
126435657|NCT03224819|454893963|FG007|Overall Study|Withdrawal by Subject|0|||
126435658|NCT03224819|454893964|FG008|Overall Study|Withdrawal by Subject|0|||
126435659|NCT03224819|454893965|FG009|Overall Study|Withdrawal by Subject|0|||
126435660|NCT03224819|454893966|FG010|Overall Study|Withdrawal by Subject|0|||
126435661|NCT03224819|454893967|FG011|Overall Study|Withdrawal by Subject|0|||
126435662|NCT03224819|454893968|FG012|Overall Study|Withdrawal by Subject|1|||
126435663|NCT03224819|454893969|FG013|Overall Study|Withdrawal by Subject|0|||
126435664|NCT03224819|454893956|FG000|Overall Study|Sponsor Decision|0|||
126435665|NCT03224819|454893957|FG001|Overall Study|Sponsor Decision|0|||
126435666|NCT03224819|454893958|FG002|Overall Study|Sponsor Decision|0|||
126435667|NCT03224819|454893959|FG003|Overall Study|Sponsor Decision|1|||
126435668|NCT03224819|454893960|FG004|Overall Study|Sponsor Decision|1|||
126435669|NCT03224819|454893961|FG005|Overall Study|Sponsor Decision|2|||
126435670|NCT03224819|454893962|FG006|Overall Study|Sponsor Decision|1|||
126435671|NCT03224819|454893963|FG007|Overall Study|Sponsor Decision|1|||
126435672|NCT03224819|454893964|FG008|Overall Study|Sponsor Decision|1|||
126435673|NCT03224819|454893965|FG009|Overall Study|Sponsor Decision|2|||
126435674|NCT03224819|454893966|FG010|Overall Study|Sponsor Decision|1|||
126435675|NCT03224819|454893967|FG011|Overall Study|Sponsor Decision|1|||
126435676|NCT03224819|454893968|FG012|Overall Study|Sponsor Decision|1|||
126435677|NCT03224819|454893969|FG013|Overall Study|Sponsor Decision|0|||
126435678|NCT03224819|454893956|FG000|Overall Study|Lost to Follow-up|0|||
126435679|NCT03224819|454893957|FG001|Overall Study|Lost to Follow-up|0|||
126435680|NCT03224819|454893958|FG002|Overall Study|Lost to Follow-up|0|||
126435681|NCT03224819|454893959|FG003|Overall Study|Lost to Follow-up|0|||
126435682|NCT03224819|454893960|FG004|Overall Study|Lost to Follow-up|0|||
126435683|NCT03224819|454893961|FG005|Overall Study|Lost to Follow-up|0|||
126435684|NCT03224819|454893962|FG006|Overall Study|Lost to Follow-up|0|||
126435685|NCT03224819|454893963|FG007|Overall Study|Lost to Follow-up|0|||
126435686|NCT03224819|454893964|FG008|Overall Study|Lost to Follow-up|1|||
126435687|NCT03224819|454893965|FG009|Overall Study|Lost to Follow-up|0|||
126681753|NCT02432235|455791339|FG005|Overall Study|Withdrawal by Subject|2|||
126435688|NCT03224819|454893966|FG010|Overall Study|Lost to Follow-up|0|||
126435689|NCT03224819|454893967|FG011|Overall Study|Lost to Follow-up|0|||
126435690|NCT03224819|454893968|FG012|Overall Study|Lost to Follow-up|0|||
126435691|NCT03224819|454893969|FG013|Overall Study|Lost to Follow-up|0|||
126435692|NCT03224819|454893956|FG000|Overall Study|Death|0|||
126681754|NCT02432235|455791340|FG006|Overall Study|Withdrawal by Subject|5|||
126435693|NCT03224819|454893957|FG001|Overall Study|Death|1|||
126681755|NCT02432235|455791341|FG007|Overall Study|Withdrawal by Subject|3|||
126435694|NCT03224819|454893958|FG002|Overall Study|Death|0|||
126435695|NCT03224819|454893959|FG003|Overall Study|Death|0|||
126435696|NCT03224819|454893960|FG004|Overall Study|Death|0|||
126435697|NCT03224819|454893961|FG005|Overall Study|Death|0|||
126435698|NCT03224819|454893962|FG006|Overall Study|Death|0|||
126435699|NCT03224819|454893963|FG007|Overall Study|Death|1|||
126435700|NCT03224819|454893964|FG008|Overall Study|Death|0|||
126435701|NCT03224819|454893965|FG009|Overall Study|Death|0|||
126435702|NCT03224819|454893966|FG010|Overall Study|Death|0|||
126435703|NCT03224819|454893967|FG011|Overall Study|Death|1|||
126435704|NCT03224819|454893968|FG012|Overall Study|Death|0|||
126435705|NCT03224819|454893969|FG013|Overall Study|Death|0|||
126435706|NCT00107653|454893977|FG000|Overall Study|Adverse Event|24|||
126435707|NCT00107653|454893978|FG001|Overall Study|Adverse Event|43|||
126435708|NCT00107653|454893977|FG000|Overall Study|Insufficient Therapeutic Response|25|||
126435709|NCT00107653|454893978|FG001|Overall Study|Insufficient Therapeutic Response|11|||
126435710|NCT00107653|454893977|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
126435711|NCT00107653|454893978|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
126435712|NCT00107653|454893977|FG000|Overall Study|Protocol Violation|1|||
126435713|NCT00107653|454893978|FG001|Overall Study|Protocol Violation|0|||
126435714|NCT00107653|454893977|FG000|Overall Study|Withdrawal by Subject|12|||
126435715|NCT00107653|454893978|FG001|Overall Study|Withdrawal by Subject|13|||
126435716|NCT00107653|454893977|FG000|Overall Study|Lost to Follow-up|13|||
126435717|NCT00107653|454893978|FG001|Overall Study|Lost to Follow-up|5|||
126435718|NCT00107653|454893977|FG000|Overall Study|Administrative Reasons|3|||
126435719|NCT00107653|454893978|FG001|Overall Study|Administrative Reasons|3|||
126435720|NCT01838395|454893979|FG000|Overall Study|Withdrawal by Subject|0|||
126435721|NCT01838395|454893980|FG001|Overall Study|Withdrawal by Subject|0|||
126435722|NCT01838395|454893981|FG002|Overall Study|Withdrawal by Subject|0|||
126435723|NCT01838395|454893982|FG003|Overall Study|Withdrawal by Subject|0|||
126435724|NCT01838395|454893983|FG004|Overall Study|Withdrawal by Subject|1|||
126435725|NCT01838395|454893984|FG005|Overall Study|Withdrawal by Subject|0|||
126435726|NCT01838395|454893979|FG000|Overall Study|Death|0|||
126435727|NCT01838395|454893980|FG001|Overall Study|Death|0|||
126435728|NCT01838395|454893981|FG002|Overall Study|Death|1|||
126435729|NCT01838395|454893982|FG003|Overall Study|Death|0|||
126435730|NCT01838395|454893983|FG004|Overall Study|Death|0|||
126435731|NCT01838395|454893984|FG005|Overall Study|Death|0|||
126435732|NCT01838395|454893979|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
126435733|NCT01838395|454893980|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
126435734|NCT01838395|454893981|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
126435735|NCT01838395|454893982|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
126435736|NCT01838395|454893983|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
126435737|NCT01838395|454893984|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
126435738|NCT03694353|454893986|FG000|Overall Study|Withdrawal by Subject|1|||
126435739|NCT03694353|454893986|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
126435740|NCT00651742|454893987|FG000|Overall Study|Objective Disease Progression|22|||
126435741|NCT00651742|454893987|FG000|Overall Study|Toxicity|3|||
126435742|NCT00651742|454893987|FG000|Overall Study|Investigator Judgment|1|||
126435743|NCT00651742|454893987|FG000|Overall Study|Withdrawal of Consent|1|||
126435744|NCT00651742|454893987|FG000|Overall Study|Enrolled but not treated|1|||
126435745|NCT01535040|454893988|FG000|Overall Study|Physician Decision|0|||
126435746|NCT01535040|454893989|FG001|Overall Study|Physician Decision|1|||
126435747|NCT01535040|454893988|FG000|Overall Study|Withdrawal by Subject|13|||
126435748|NCT01535040|454893989|FG001|Overall Study|Withdrawal by Subject|10|||
126435749|NCT01535040|454893988|FG000|Overall Study|Never Started|9|||
126435750|NCT01535040|454893989|FG001|Overall Study|Never Started|4|||
126435751|NCT01535040|454893988|FG000|Overall Study|Toxicity|7|||
126435752|NCT01535040|454893989|FG001|Overall Study|Toxicity|5|||
126435753|NCT01535040|454893988|FG000|Overall Study|Multiple Reasons|1|||
126435754|NCT01535040|454893989|FG001|Overall Study|Multiple Reasons|1|||
126435755|NCT05430854|454893990|FG000|Overall Study|Trial terminated by Sponsor|39|||
126435756|NCT05430854|454893991|FG001|Overall Study|Trial terminated by Sponsor|50|||
126435757|NCT05430854|454893992|FG002|Overall Study|Trial terminated by Sponsor|46|||
126435758|NCT05430854|454893990|FG000|Overall Study|Withdrawal by Subject|0|||
126435759|NCT05430854|454893991|FG001|Overall Study|Withdrawal by Subject|3|||
126435760|NCT05430854|454893992|FG002|Overall Study|Withdrawal by Subject|0|||
126435761|NCT04314284|454893993|FG000|Overall Study|Withdrawal by Subject|4|||
126435762|NCT04314284|454893994|FG001|Overall Study|Withdrawal by Subject|7|||
126435763|NCT04314284|454893993|FG000|Overall Study|Consented but did not complete survey|0|||
126435764|NCT04314284|454893994|FG001|Overall Study|Consented but did not complete survey|6|||
126435765|NCT01652235|454893995|FG000|Overall Study|Death|9|||
126435766|NCT01652235|454893995|FG000|Overall Study|Lost to Follow-up|5|||
126435767|NCT01652235|454893995|FG000|Overall Study|Withdrawal by Subject|2|||
126435768|NCT02023086|454893996|FG000|Overall Study|Withdrawal by Subject|2|||
126435769|NCT02023086|454893997|FG001|Overall Study|Withdrawal by Subject|0|||
126435770|NCT03829228|454895504|FG000|Overall Study|Protocol Violation|1|||
126349217|NCT03314935|454571114|FG011|Phase 2|Physician Decision|0|||
126349218|NCT03314935|454571115|FG012|Phase 2|Physician Decision|0|||
126349219|NCT03314935|454571116|FG013|Phase 2|Physician Decision|0|||
126349220|NCT03314935|454571117|FG014|Phase 2|Physician Decision|0|||
126349221|NCT05845619|454571118|FG000|Overall Study|duplicate enrollment|2|||
126349222|NCT05845619|454571119|FG001|Overall Study|duplicate enrollment|2|||
126349223|NCT05845619|454571120|FG002|Overall Study|duplicate enrollment|1|||
126349224|NCT02382380|454571125|FG000|Overall Study|Withdrawal by Subject|2|||
126349225|NCT02382380|454571126|FG001|Overall Study|Withdrawal by Subject|2|||
126349226|NCT02382380|454571125|FG000|Overall Study|Lost to Follow-up|0|||
126349227|NCT02382380|454571126|FG001|Overall Study|Lost to Follow-up|1|||
126349228|NCT03785366|454571127|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
126349229|NCT03785366|454571128|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
126349230|NCT03785366|454571127|FG000|Overall Study|Lost to Follow-up|1|||
126349231|NCT03785366|454571128|FG001|Overall Study|Lost to Follow-up|0|||
126681756|NCT02432235|455791342|FG008|Overall Study|Withdrawal by Subject|1|||
126681757|NCT02432235|455791343|FG009|Overall Study|Withdrawal by Subject|0|||
126681758|NCT02432235|455791344|FG010|Overall Study|Withdrawal by Subject|0|||
126681759|NCT02432235|455791345|FG011|Overall Study|Withdrawal by Subject|0|||
126681760|NCT02432235|455791334|FG000|Overall Study|Lost to Follow-up|0|||
126681761|NCT02432235|455791335|FG001|Overall Study|Lost to Follow-up|0|||
126681762|NCT02432235|455791336|FG002|Overall Study|Lost to Follow-up|0|||
126681763|NCT02432235|455791337|FG003|Overall Study|Lost to Follow-up|0|||
126681764|NCT02432235|455791338|FG004|Overall Study|Lost to Follow-up|0|||
126681765|NCT02432235|455791339|FG005|Overall Study|Lost to Follow-up|1|||
126681766|NCT02432235|455791340|FG006|Overall Study|Lost to Follow-up|0|||
126435771|NCT03304626|454895507|FG000|Overall Study|Adverse Event|1|||
126435772|NCT03304626|454895508|FG001|Overall Study|Adverse Event|0|||
126435773|NCT03304626|454895507|FG000|Overall Study|Lack of Efficacy|1|||
126435774|NCT03304626|454895508|FG001|Overall Study|Lack of Efficacy|1|||
126435775|NCT04385277|454895511|FG000|Overall Study|Physician Decision|2|||
126435776|NCT04385277|454895511|FG000|Overall Study|Ineligible|1|||
126435777|NCT04385277|454895511|FG000|Overall Study|Patient/Parent Refusal|2|||
126435778|NCT02903771|454895520|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
126435779|NCT02903771|454895521|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
126435780|NCT02903771|454895522|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
126435781|NCT02903771|454895523|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
126435782|NCT02903771|454895524|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
126435783|NCT02903771|454895525|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
126435784|NCT02903771|454895526|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
126435785|NCT02903771|454895520|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
126435786|NCT02903771|454895521|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
126435787|NCT02903771|454895522|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
126435788|NCT02903771|454895523|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
126435789|NCT02903771|454895524|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
126435790|NCT02903771|454895525|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
126435791|NCT02903771|454895526|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
126435792|NCT02903771|454895520|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
126435793|NCT02903771|454895521|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
126435794|NCT02903771|454895522|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
126435795|NCT02903771|454895523|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
126435796|NCT02903771|454895524|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
126435797|NCT02903771|454895525|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
126435798|NCT02903771|454895526|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
126435799|NCT02903771|454895520|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
126435800|NCT02903771|454895521|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
126435801|NCT02903771|454895522|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
126435802|NCT02903771|454895523|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
126435803|NCT02903771|454895524|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
126435804|NCT02903771|454895525|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
126435805|NCT02903771|454895526|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
126435806|NCT02903771|454895520|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
126435807|NCT02903771|454895521|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
126435808|NCT02903771|454895522|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
126435809|NCT02903771|454895523|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
126435810|NCT02903771|454895524|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
126435811|NCT02903771|454895525|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
126435812|NCT02903771|454895526|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
126435813|NCT02903771|454895520|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
126435814|NCT02903771|454895521|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
126435815|NCT02903771|454895522|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
126545367|NCT01013792|455290817|FG000|Overall Study|Study suspended|2|||
126681767|NCT02432235|455791341|FG007|Overall Study|Lost to Follow-up|0|||
126681768|NCT02432235|455791342|FG008|Overall Study|Lost to Follow-up|1|||
126681769|NCT02432235|455791343|FG009|Overall Study|Lost to Follow-up|0|||
126349232|NCT03785366|454571127|FG000|Overall Study|Partial IUD Expulsion|0|||
126349233|NCT03785366|454571128|FG001|Overall Study|Partial IUD Expulsion|2|||
126349234|NCT03785366|454571127|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
126349235|NCT03785366|454571128|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
126349236|NCT04153864|454571129|FG000|Overall Study|Withdrawal by Subject|21|||
126349237|NCT04153864|454571130|FG001|Overall Study|Withdrawal by Subject|7|||
126349238|NCT04153864|454571131|FG002|Overall Study|Withdrawal by Subject|23|||
126349239|NCT04153864|454571132|FG003|Overall Study|Withdrawal by Subject|2|||
126349240|NCT04153864|454571129|FG000|Overall Study|Lost to Follow-up|4|||
126349241|NCT04153864|454571130|FG001|Overall Study|Lost to Follow-up|0|||
126349242|NCT04153864|454571131|FG002|Overall Study|Lost to Follow-up|3|||
126681770|NCT02432235|455791344|FG010|Overall Study|Lost to Follow-up|0|||
126349243|NCT04153864|454571132|FG003|Overall Study|Lost to Follow-up|0|||
126435816|NCT02903771|454895523|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
126435817|NCT02903771|454895524|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
126435818|NCT02903771|454895525|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
126435819|NCT02903771|454895526|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
126545368|NCT01013792|455290818|FG001|Overall Study|Study suspended|1|||
126681771|NCT02432235|455791345|FG011|Overall Study|Lost to Follow-up|0|||
126681772|NCT02432235|455791334|FG000|Overall Study|Miscellaneous|0|||
126681773|NCT02432235|455791335|FG001|Overall Study|Miscellaneous|0|||
126681774|NCT02432235|455791336|FG002|Overall Study|Miscellaneous|0|||
126681775|NCT02432235|455791337|FG003|Overall Study|Miscellaneous|0|||
126681776|NCT02432235|455791338|FG004|Overall Study|Miscellaneous|1|||
126681777|NCT02432235|455791339|FG005|Overall Study|Miscellaneous|6|||
126681778|NCT02432235|455791340|FG006|Overall Study|Miscellaneous|2|||
126681779|NCT02432235|455791341|FG007|Overall Study|Miscellaneous|2|||
126681780|NCT02432235|455791342|FG008|Overall Study|Miscellaneous|4|||
126681781|NCT02432235|455791343|FG009|Overall Study|Miscellaneous|0|||
126681782|NCT02432235|455791344|FG010|Overall Study|Miscellaneous|0|||
126681783|NCT02432235|455791345|FG011|Overall Study|Miscellaneous|1|||
126681784|NCT02970292|455791349|FG000|Overall Study|Physician Decision|1|||
126681785|NCT02970292|455791350|FG001|Overall Study|Physician Decision|1|||
126681786|NCT02970292|455791349|FG000|Overall Study|Withdrawal by Subject|11|||
126681787|NCT02970292|455791350|FG001|Overall Study|Withdrawal by Subject|5|||
126681788|NCT02970292|455791349|FG000|Overall Study|Noncompliance with study drug|2|||
126681789|NCT02970292|455791350|FG001|Overall Study|Noncompliance with study drug|2|||
126681790|NCT02970292|455791349|FG000|Overall Study|Adverse Event|5|||
126681791|NCT02970292|455791350|FG001|Overall Study|Adverse Event|0|||
126681792|NCT02970292|455791349|FG000|Overall Study|Lack of Efficacy|1|||
126681793|NCT02970292|455791350|FG001|Overall Study|Lack of Efficacy|0|||
126681794|NCT02970292|455791349|FG000|Overall Study|Lost to Follow-up|1|||
126681795|NCT02970292|455791350|FG001|Overall Study|Lost to Follow-up|0|||
126681796|NCT02970292|455791349|FG000|Overall Study|Protocol Violation|2|||
126681797|NCT02970292|455791350|FG001|Overall Study|Protocol Violation|0|||
126681798|NCT02970292|455791349|FG000|Overall Study|Other|1|||
126681799|NCT02970292|455791350|FG001|Overall Study|Other|0|||
126681800|NCT00513500|455791351|FG000|Overall Study|Lost to Follow-up|35|||
126681801|NCT00513500|455791352|FG001|Overall Study|Lost to Follow-up|39|||
126681802|NCT00513500|455791351|FG000|Overall Study|Death|2|||
126681803|NCT00513500|455791352|FG001|Overall Study|Death|1|||
126681804|NCT00513500|455791351|FG000|Overall Study|Hospitalized|4|||
126681805|NCT00513500|455791352|FG001|Overall Study|Hospitalized|14|||
126681806|NCT00749996|455791355|FG000|Overall Study|Lost to Follow-up|7|||
126681807|NCT00749996|455791356|FG001|Overall Study|Lost to Follow-up|4|||
126681808|NCT00749996|455791355|FG000|Overall Study|Withdrawal by Subject|5|||
126681809|NCT00749996|455791356|FG001|Overall Study|Withdrawal by Subject|4|||
126681810|NCT00749996|455791355|FG000|Overall Study|Protocol Violation|2|||
126681811|NCT00749996|455791356|FG001|Overall Study|Protocol Violation|3|||
126681812|NCT00749996|455791355|FG000|Overall Study|Physician Decision|2|||
126681813|NCT00749996|455791356|FG001|Overall Study|Physician Decision|0|||
126681814|NCT00749996|455791355|FG000|Overall Study|Pregnancy|0|||
126681815|NCT00749996|455791356|FG001|Overall Study|Pregnancy|2|||
126681816|NCT00749996|455791355|FG000|Overall Study|Adverse Event|1|||
126681817|NCT00749996|455791356|FG001|Overall Study|Adverse Event|0|||
126681818|NCT00749996|455791355|FG000|Overall Study|Death|1|||
126681819|NCT00749996|455791356|FG001|Overall Study|Death|0|||
126349244|NCT04153864|454571129|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
126349245|NCT04153864|454571130|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
126349246|NCT04153864|454571131|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
126349247|NCT04153864|454571132|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
126349248|NCT01348269|454572888|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
126349249|NCT01348269|454572889|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
126349250|NCT01348269|454572888|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
126349251|NCT01348269|454572889|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
126349252|NCT01348269|454572888|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
126349253|NCT01348269|454572889|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
126349254|NCT01697579|454572890|FG000|Base Study-Cycle 1|Adverse Event|1|||
126349255|NCT01697579|454572891|FG001|Base Study-Cycle 1|Adverse Event|0|||
126349256|NCT01697579|454572892|FG002|Base Study-Cycle 1|Adverse Event|0|||
126349257|NCT01697579|454572893|FG003|Base Study-Cycle 1|Adverse Event|0|||
126349258|NCT01697579|454572894|FG004|Base Study-Cycle 1|Adverse Event|0|||
126349259|NCT01697579|454572895|FG005|Base Study-Cycle 1|Adverse Event|0|||
126349260|NCT01697579|454572896|FG006|Base Study-Cycle 1|Adverse Event|0|||
126681820|NCT00606086|455791357|FG000|Overall Study|Adverse Event|1|||
126681821|NCT00606086|455791358|FG001|Overall Study|Adverse Event|1|||
126681822|NCT00606086|455791357|FG000|Overall Study|Lost to Follow-up|4|||
126681823|NCT00606086|455791358|FG001|Overall Study|Lost to Follow-up|8|||
126681824|NCT00606086|455791357|FG000|Overall Study|Protocol Violation|1|||
126681825|NCT00606086|455791358|FG001|Overall Study|Protocol Violation|0|||
126681826|NCT00606086|455791357|FG000|Overall Study|Withdrawal by Subject|5|||
126681827|NCT00606086|455791358|FG001|Overall Study|Withdrawal by Subject|3|||
126681828|NCT00606086|455791357|FG000|Overall Study|Non-compliance|0|||
126681829|NCT00606086|455791358|FG001|Overall Study|Non-compliance|1|||
126681830|NCT00606086|455791357|FG000|Overall Study|Randomized, not treated|1|||
126349261|NCT01697579|454572890|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
126349262|NCT01697579|454572891|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
126349263|NCT01697579|454572892|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
126349264|NCT01697579|454572893|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
126349265|NCT01697579|454572894|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
126349266|NCT01697579|454572895|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
126349267|NCT01697579|454572896|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
126349268|NCT01697579|454572890|FG000|Base Study-Cycle 1|Protocol Violation|0|||
126349269|NCT01697579|454572891|FG001|Base Study-Cycle 1|Protocol Violation|0|||
126349270|NCT01697579|454572892|FG002|Base Study-Cycle 1|Protocol Violation|0|||
126349271|NCT01697579|454572893|FG003|Base Study-Cycle 1|Protocol Violation|0|||
126349272|NCT01697579|454572894|FG004|Base Study-Cycle 1|Protocol Violation|3|||
126349273|NCT01697579|454572895|FG005|Base Study-Cycle 1|Protocol Violation|0|||
126349274|NCT01697579|454572896|FG006|Base Study-Cycle 1|Protocol Violation|0|||
126349275|NCT01697579|454572890|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
126349276|NCT01697579|454572891|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
126349277|NCT01697579|454572892|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
126349278|NCT01697579|454572893|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
126349279|NCT01697579|454572894|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
126349280|NCT01697579|454572895|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
126349281|NCT01697579|454572896|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
126349282|NCT01697579|454572890|FG000|Base Study-Cycle 1|Technical Problems|0|||
126349283|NCT01697579|454572891|FG001|Base Study-Cycle 1|Technical Problems|0|||
126349284|NCT01697579|454572892|FG002|Base Study-Cycle 1|Technical Problems|1|||
126349285|NCT01697579|454572893|FG003|Base Study-Cycle 1|Technical Problems|1|||
126349286|NCT01697579|454572894|FG004|Base Study-Cycle 1|Technical Problems|0|||
126349287|NCT01697579|454572895|FG005|Base Study-Cycle 1|Technical Problems|0|||
126349288|NCT01697579|454572896|FG006|Base Study-Cycle 1|Technical Problems|0|||
126349289|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Death|0|||
126349290|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Death|0|||
126349291|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Death|0|||
126349292|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Death|0|||
126349293|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Death|0|||
126349294|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Death|0|||
126349295|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Death|2|||
126681831|NCT00606086|455791358|FG001|Overall Study|Randomized, not treated|2|||
126349296|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126349297|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126349298|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126349299|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126349300|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126349301|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
126349302|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
126349303|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
126349304|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
126349305|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
126435820|NCT02903771|454895520|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
126435821|NCT02903771|454895521|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
126681832|NCT03215771|455791363|FG000|Overall Study|Withdrawal by Subject|2|||
126435822|NCT02903771|454895522|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
126435823|NCT02903771|454895523|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
126435824|NCT02903771|454895524|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
126435825|NCT02903771|454895525|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
126435826|NCT02903771|454895526|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
126435827|NCT02903771|454895520|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
126435828|NCT02903771|454895521|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
126435829|NCT02903771|454895522|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
126435830|NCT02903771|454895523|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
126435831|NCT02903771|454895524|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
126435832|NCT02903771|454895525|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
126435833|NCT02903771|454895526|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
126435834|NCT02903771|454895520|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
126435835|NCT02903771|454895521|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
126435836|NCT02903771|454895522|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
126435837|NCT02903771|454895523|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
126435838|NCT02903771|454895524|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
126435839|NCT02903771|454895525|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
126435840|NCT02903771|454895526|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
126435841|NCT02903771|454895520|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
126435842|NCT02903771|454895521|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
126435843|NCT02903771|454895522|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
126435844|NCT02903771|454895523|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
126435845|NCT02903771|454895524|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
126545369|NCT01013792|455290817|FG000|Overall Study|Adverse Event|0|||
126545370|NCT01013792|455290818|FG001|Overall Study|Adverse Event|3|||
126349306|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
126349307|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
126349308|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
126681833|NCT03215771|455791363|FG000|Overall Study|Physician Decision|1|||
126349309|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
126349310|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
126349311|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
126681834|NCT00542269|455791364|FG000|Overall Study|Adverse Event|10|||
126349312|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
126349313|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
126681835|NCT00542269|455791365|FG001|Overall Study|Adverse Event|4|||
126681836|NCT00542269|455791366|FG002|Overall Study|Adverse Event|5|||
126435846|NCT02903771|454895525|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
126435847|NCT02903771|454895526|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
126435848|NCT02903771|454895520|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
126435849|NCT02903771|454895521|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
126435850|NCT02903771|454895522|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
126435851|NCT02903771|454895523|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
126435852|NCT02903771|454895524|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
126435853|NCT02903771|454895525|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
126435854|NCT02903771|454895526|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
126435855|NCT03219723|454895527|FG000|Overall Study|Case Report Forms Uncollected|6|||
126435856|NCT03219723|454895527|FG000|Overall Study|Protocol Deviation|4|||
126435857|NCT03137381|454895528|FG000|Overall Study|Adverse Event|3|||
126435858|NCT03137381|454895529|FG001|Overall Study|Adverse Event|0|||
126435859|NCT03137381|454895530|FG002|Overall Study|Adverse Event|2|||
126435860|NCT03137381|454895531|FG003|Overall Study|Adverse Event|0|||
126435861|NCT03137381|454895528|FG000|Overall Study|Lost to Follow-up|2|||
126435862|NCT03137381|454895529|FG001|Overall Study|Lost to Follow-up|1|||
126435863|NCT03137381|454895530|FG002|Overall Study|Lost to Follow-up|1|||
126435864|NCT03137381|454895531|FG003|Overall Study|Lost to Follow-up|0|||
126681837|NCT00542269|455791364|FG000|Overall Study|Protocol Violation|1|||
126681838|NCT00542269|455791365|FG001|Overall Study|Protocol Violation|1|||
126681839|NCT00542269|455791366|FG002|Overall Study|Protocol Violation|0|||
126681840|NCT00542269|455791364|FG000|Overall Study|Withdrawal by Subject|1|||
126681841|NCT00542269|455791365|FG001|Overall Study|Withdrawal by Subject|0|||
126681842|NCT00542269|455791366|FG002|Overall Study|Withdrawal by Subject|0|||
126681843|NCT00542269|455791364|FG000|Overall Study|Administrative problems|1|||
126681844|NCT00542269|455791365|FG001|Overall Study|Administrative problems|1|||
126681845|NCT00542269|455791366|FG002|Overall Study|Administrative problems|1|||
126681846|NCT03873714|455791367|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
126681847|NCT03028870|455791368|FG000|Overall Study|Adverse Event|7|||
126681848|NCT03028870|455791369|FG001|Overall Study|Adverse Event|4|||
126681849|NCT03028870|455791370|FG002|Overall Study|Adverse Event|3|||
126681850|NCT03028870|455791371|FG003|Overall Study|Adverse Event|3|||
126681851|NCT03028870|455791368|FG000|Overall Study|Withdrawal by Subject|1|||
126681852|NCT03028870|455791369|FG001|Overall Study|Withdrawal by Subject|1|||
126681853|NCT03028870|455791370|FG002|Overall Study|Withdrawal by Subject|1|||
126681854|NCT03028870|455791371|FG003|Overall Study|Withdrawal by Subject|2|||
126681855|NCT03028870|455791368|FG000|Overall Study|Lost to Follow-up|1|||
126681856|NCT03028870|455791369|FG001|Overall Study|Lost to Follow-up|0|||
126681857|NCT03028870|455791370|FG002|Overall Study|Lost to Follow-up|0|||
126681858|NCT03028870|455791371|FG003|Overall Study|Lost to Follow-up|0|||
126681859|NCT03028870|455791368|FG000|Overall Study|Lack of Efficacy|3|||
126681860|NCT03028870|455791369|FG001|Overall Study|Lack of Efficacy|0|||
126681861|NCT03028870|455791370|FG002|Overall Study|Lack of Efficacy|0|||
126681862|NCT03028870|455791371|FG003|Overall Study|Lack of Efficacy|0|||
126681863|NCT03028870|455791368|FG000|Overall Study|Administrative|5|||
126681864|NCT03028870|455791369|FG001|Overall Study|Administrative|5|||
126349314|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
126349315|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
126349316|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
126349317|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
126349318|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
126349319|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
126349320|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
126349321|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
126349322|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
126349323|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
126349324|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
126349325|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
126349326|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
126349327|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
126349328|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
126349329|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
126349330|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
126349331|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
126349332|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
126349333|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
126349334|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
126349335|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
126349336|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
126349337|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
126349338|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
126349339|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
126349340|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
126349341|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
126349342|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
126349343|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
126349344|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
126349345|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
126681865|NCT03028870|455791370|FG002|Overall Study|Administrative|12|||
126681866|NCT03028870|455791371|FG003|Overall Study|Administrative|4|||
126681867|NCT00708123|455791374|FG000|Period 1|Protocol Violation|0|||
126681868|NCT00708123|455791375|FG001|Period 1|Protocol Violation|1|||
126681869|NCT00708123|455791376|FG002|Period 1|Protocol Violation|0|||
126681870|NCT00708123|455791377|FG003|Period 1|Protocol Violation|1|||
126435865|NCT03137381|454895528|FG000|Overall Study|Protocol deviation|1|||
126435866|NCT03137381|454895529|FG001|Overall Study|Protocol deviation|1|||
126435867|NCT03137381|454895530|FG002|Overall Study|Protocol deviation|0|||
126435868|NCT03137381|454895531|FG003|Overall Study|Protocol deviation|1|||
126435869|NCT03137381|454895528|FG000|Overall Study|Withdrawal by Investigator|0|||
126435870|NCT03137381|454895529|FG001|Overall Study|Withdrawal by Investigator|1|||
126435871|NCT03137381|454895530|FG002|Overall Study|Withdrawal by Investigator|1|||
126435872|NCT03137381|454895531|FG003|Overall Study|Withdrawal by Investigator|0|||
126435873|NCT03137381|454895528|FG000|Overall Study|Withdrawal by Subject|3|||
126435874|NCT03137381|454895529|FG001|Overall Study|Withdrawal by Subject|4|||
126435875|NCT03137381|454895530|FG002|Overall Study|Withdrawal by Subject|3|||
126435876|NCT03137381|454895531|FG003|Overall Study|Withdrawal by Subject|0|||
126435877|NCT03137381|454895528|FG000|Overall Study|Pregnancy|0|||
126349346|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
126349347|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
126349348|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
126349349|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
126349350|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
126349351|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
126349352|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
126349353|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
126349354|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
126349355|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
126349356|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
126349357|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
126349358|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
126349359|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
126349360|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
126349361|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
126349362|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
126349363|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
126349364|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
126349365|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
126349366|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
126349367|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
126349368|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
126349369|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
126349370|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
126349371|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
126349372|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
126349373|NCT01697579|454572890|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
126349374|NCT01697579|454572891|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
126681871|NCT00708123|455791378|FG004|Period 1|Protocol Violation|0|||
126681872|NCT00708123|455791374|FG000|Period 1|Adverse Event|0|||
126349375|NCT01697579|454572892|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
126349376|NCT01697579|454572893|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
126349377|NCT01697579|454572894|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
126545371|NCT01013792|455290817|FG000|Overall Study|Lost to Follow-up|0|||
126349378|NCT01697579|454572895|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
126681873|NCT00708123|455791375|FG001|Period 1|Adverse Event|0|||
126681874|NCT00708123|455791376|FG002|Period 1|Adverse Event|1|||
126349379|NCT01697579|454572896|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
126349380|NCT02452190|454572897|FG000|Overall Study|Withdrawal by Sponsor|1|||
126349381|NCT02452190|454572898|FG001|Overall Study|Withdrawal by Sponsor|3|||
126349382|NCT02452190|454572897|FG000|Overall Study|Pregnancy|1|||
126349383|NCT02452190|454572898|FG001|Overall Study|Pregnancy|0|||
126349384|NCT02452190|454572897|FG000|Overall Study|Investigator's Decision|2|||
126349385|NCT02452190|454572898|FG001|Overall Study|Investigator's Decision|0|||
126349386|NCT02452190|454572897|FG000|Overall Study|Lack of Efficacy|3|||
126349387|NCT02452190|454572898|FG001|Overall Study|Lack of Efficacy|1|||
126349388|NCT02452190|454572897|FG000|Overall Study|Lost to Follow-up|4|||
126349389|NCT02452190|454572898|FG001|Overall Study|Lost to Follow-up|3|||
126349390|NCT02452190|454572897|FG000|Overall Study|Adverse Event|2|||
126349391|NCT02452190|454572898|FG001|Overall Study|Adverse Event|5|||
126349392|NCT02452190|454572897|FG000|Overall Study|Withdrawal by Subject|20|||
126349393|NCT02452190|454572898|FG001|Overall Study|Withdrawal by Subject|11|||
126349394|NCT02452190|454572897|FG000|Overall Study|Noncompliance with study drug|1|||
126349395|NCT02452190|454572898|FG001|Overall Study|Noncompliance with study drug|0|||
126349396|NCT02452190|454572897|FG000|Overall Study|Participant traveled abroad|1|||
126349397|NCT02452190|454572898|FG001|Overall Study|Participant traveled abroad|0|||
126349398|NCT02452190|454572897|FG000|Overall Study|Death|0|||
126349399|NCT02452190|454572898|FG001|Overall Study|Death|1|||
126349400|NCT03112603|454572900|FG000|End of Randomization Period|Lost to Follow-up|3|||
126349401|NCT03112603|454572901|FG001|End of Randomization Period|Lost to Follow-up|0|||
126349402|NCT03112603|454572902|FG002|End of Randomization Period|Lost to Follow-up|0|||
126349403|NCT03112603|454572900|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
126349404|NCT03112603|454572901|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
126349405|NCT03112603|454572902|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
126349406|NCT03112603|454572900|FG000|End of Randomization Period|Physician Decision|43|||
126349407|NCT03112603|454572901|FG001|End of Randomization Period|Physician Decision|18|||
126349408|NCT03112603|454572902|FG002|End of Randomization Period|Physician Decision|0|||
126349409|NCT03112603|454572900|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
126349410|NCT03112603|454572901|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
126349411|NCT03112603|454572902|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
126349412|NCT03112603|454572900|FG000|End of Randomization Period|Death|10|||
126349413|NCT03112603|454572901|FG001|End of Randomization Period|Death|7|||
126349414|NCT03112603|454572902|FG002|End of Randomization Period|Death|0|||
126349415|NCT03112603|454572900|FG000|End of Randomization Period|Disease Relapse|12|||
126349416|NCT03112603|454572901|FG001|End of Randomization Period|Disease Relapse|7|||
126349417|NCT03112603|454572902|FG002|End of Randomization Period|Disease Relapse|0|||
126349418|NCT03112603|454572900|FG000|End of Randomization Period|Lack of Efficacy|25|||
126349419|NCT03112603|454572901|FG001|End of Randomization Period|Lack of Efficacy|77|||
126349420|NCT03112603|454572902|FG002|End of Randomization Period|Lack of Efficacy|0|||
126349421|NCT03112603|454572900|FG000|End of Randomization Period|Adverse Event|32|||
126349422|NCT03112603|454572901|FG001|End of Randomization Period|Adverse Event|12|||
126349423|NCT03112603|454572902|FG002|End of Randomization Period|Adverse Event|0|||
126349424|NCT03112603|454572900|FG000|End of Cross Over Period|Death|0|||
126349425|NCT03112603|454572901|FG001|End of Cross Over Period|Death|0|||
126349426|NCT03112603|454572902|FG002|End of Cross Over Period|Death|2|||
126349427|NCT03112603|454572900|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
126349428|NCT03112603|454572901|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
126349429|NCT03112603|454572902|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
126349430|NCT03112603|454572900|FG000|End of Cross Over Period|Physician Decision|0|||
126435878|NCT03137381|454895529|FG001|Overall Study|Pregnancy|0|||
126681875|NCT00708123|455791377|FG003|Period 1|Adverse Event|0|||
126435879|NCT03137381|454895530|FG002|Overall Study|Pregnancy|1|||
126435880|NCT03137381|454895531|FG003|Overall Study|Pregnancy|0|||
126435881|NCT00459316|454895536|FG000|Steps 1 & 2|Other eligibility failure|1|||
126435882|NCT00459316|454895537|FG001|Steps 1 & 2|Other eligibility failure|1|||
126435883|NCT00459316|454895538|FG002|Steps 1 & 2|Other eligibility failure|0|||
126435884|NCT00459316|454895536|FG000|Steps 1 & 2|Death|1|||
126435885|NCT00459316|454895537|FG001|Steps 1 & 2|Death|1|||
126435886|NCT00459316|454895538|FG002|Steps 1 & 2|Death|0|||
126435887|NCT00459316|454895536|FG000|Steps 1 & 2|Not able to get to clinic|7|||
126435888|NCT00459316|454895537|FG001|Steps 1 & 2|Not able to get to clinic|4|||
126435889|NCT00459316|454895538|FG002|Steps 1 & 2|Not able to get to clinic|0|||
126435890|NCT00459316|454895536|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
126435891|NCT00459316|454895537|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
126435892|NCT00459316|454895538|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
126435893|NCT00459316|454895536|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
126435894|NCT00459316|454895537|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
126435895|NCT00459316|454895538|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
126435896|NCT00459316|454895536|FG000|Steps 1 & 2|Lost to Follow-up|5|||
126435897|NCT00459316|454895537|FG001|Steps 1 & 2|Lost to Follow-up|0|||
126435898|NCT00459316|454895538|FG002|Steps 1 & 2|Lost to Follow-up|2|||
126435899|NCT00459316|454895536|FG000|Step 3|Withdrawal by Subject|3|||
126435900|NCT00459316|454895537|FG001|Step 3|Withdrawal by Subject|0|||
126435901|NCT00459316|454895538|FG002|Step 3|Withdrawal by Subject|1|||
126435902|NCT03044106|454895539|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
126435903|NCT03044106|454895540|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
126435904|NCT02057250|454895541|FG000|AID Assessment Phase|Adverse Event|3|||
126435905|NCT02057250|454895542|FG001|AID Assessment Phase|Adverse Event|2|||
126435906|NCT02057250|454895543|FG002|AID Assessment Phase|Adverse Event|6|||
126435907|NCT02057250|454895544|FG003|AID Assessment Phase|Adverse Event|1|||
126435908|NCT02057250|454895545|FG004|AID Assessment Phase|Adverse Event|0|||
126435909|NCT02057250|454895541|FG000|AID Assessment Phase|Other than specified above|1|||
126435910|NCT02057250|454895542|FG001|AID Assessment Phase|Other than specified above|1|||
126435911|NCT02057250|454895543|FG002|AID Assessment Phase|Other than specified above|1|||
126435912|NCT02057250|454895544|FG003|AID Assessment Phase|Other than specified above|1|||
126435913|NCT02057250|454895545|FG004|AID Assessment Phase|Other than specified above|0|||
126435914|NCT02057250|454895541|FG000|Extension Phase|Adverse Event|0|||
126435915|NCT02057250|454895542|FG001|Extension Phase|Adverse Event|0|||
126435916|NCT02057250|454895543|FG002|Extension Phase|Adverse Event|0|||
126435917|NCT02057250|454895544|FG003|Extension Phase|Adverse Event|0|||
126435918|NCT02057250|454895545|FG004|Extension Phase|Adverse Event|15|||
126435919|NCT02057250|454895541|FG000|Extension Phase|Lack of Efficacy|0|||
126435920|NCT02057250|454895542|FG001|Extension Phase|Lack of Efficacy|0|||
126435921|NCT02057250|454895543|FG002|Extension Phase|Lack of Efficacy|0|||
126435922|NCT02057250|454895544|FG003|Extension Phase|Lack of Efficacy|0|||
126435923|NCT02057250|454895545|FG004|Extension Phase|Lack of Efficacy|10|||
126435924|NCT02057250|454895541|FG000|Extension Phase|Entered in this period but not treated|0|||
126435925|NCT02057250|454895542|FG001|Extension Phase|Entered in this period but not treated|0|||
126435926|NCT02057250|454895543|FG002|Extension Phase|Entered in this period but not treated|0|||
126435927|NCT02057250|454895544|FG003|Extension Phase|Entered in this period but not treated|0|||
126435928|NCT02057250|454895545|FG004|Extension Phase|Entered in this period but not treated|4|||
126435929|NCT02057250|454895541|FG000|Extension Phase|Other than specified above|0|||
126435930|NCT02057250|454895542|FG001|Extension Phase|Other than specified above|0|||
126435931|NCT02057250|454895543|FG002|Extension Phase|Other than specified above|0|||
126435932|NCT02057250|454895544|FG003|Extension Phase|Other than specified above|0|||
126435933|NCT02057250|454895545|FG004|Extension Phase|Other than specified above|7|||
126435934|NCT02435992|454895547|FG000|Overall Study|non compliance with protocol|2|||
126435935|NCT02435992|454895548|FG001|Overall Study|non compliance with protocol|0|||
126435936|NCT02435992|454895549|FG002|Overall Study|non compliance with protocol|1|||
126435937|NCT02435992|454895550|FG003|Overall Study|non compliance with protocol|0|||
126435938|NCT02435992|454895551|FG004|Overall Study|non compliance with protocol|0|||
126435939|NCT02435992|454895547|FG000|Overall Study|Adverse Event|11|||
126435940|NCT02435992|454895548|FG001|Overall Study|Adverse Event|6|||
126435941|NCT02435992|454895549|FG002|Overall Study|Adverse Event|12|||
126435942|NCT02435992|454895550|FG003|Overall Study|Adverse Event|0|||
126435943|NCT02435992|454895551|FG004|Overall Study|Adverse Event|0|||
126435944|NCT02435992|454895547|FG000|Overall Study|Lack of Efficacy|4|||
126435945|NCT02435992|454895548|FG001|Overall Study|Lack of Efficacy|10|||
126435946|NCT02435992|454895549|FG002|Overall Study|Lack of Efficacy|9|||
126435947|NCT02435992|454895550|FG003|Overall Study|Lack of Efficacy|0|||
126435948|NCT02435992|454895551|FG004|Overall Study|Lack of Efficacy|0|||
126435949|NCT02435992|454895547|FG000|Overall Study|Withdrawal by Subject|10|||
126435950|NCT02435992|454895548|FG001|Overall Study|Withdrawal by Subject|8|||
126435951|NCT02435992|454895549|FG002|Overall Study|Withdrawal by Subject|20|||
126435952|NCT02435992|454895550|FG003|Overall Study|Withdrawal by Subject|0|||
126435953|NCT02435992|454895551|FG004|Overall Study|Withdrawal by Subject|0|||
126435954|NCT02435992|454895547|FG000|Overall Study|Other Reason|1|||
126349431|NCT03112603|454572901|FG001|End of Cross Over Period|Physician Decision|0|||
126349432|NCT03112603|454572902|FG002|End of Cross Over Period|Physician Decision|29|||
126349433|NCT03112603|454572900|FG000|End of Cross Over Period|Lack of Efficacy|0|||
126349434|NCT03112603|454572901|FG001|End of Cross Over Period|Lack of Efficacy|0|||
126349435|NCT03112603|454572902|FG002|End of Cross Over Period|Lack of Efficacy|8|||
126349436|NCT03112603|454572900|FG000|End of Cross Over Period|Adverse Event|0|||
126349437|NCT03112603|454572901|FG001|End of Cross Over Period|Adverse Event|0|||
126349438|NCT03112603|454572902|FG002|End of Cross Over Period|Adverse Event|6|||
126349439|NCT03112603|454572900|FG000|End of Cross Over Period|Disease Relapse|0|||
126349440|NCT03112603|454572901|FG001|End of Cross Over Period|Disease Relapse|0|||
126349441|NCT03112603|454572902|FG002|End of Cross Over Period|Disease Relapse|2|||
126349442|NCT03916926|454572906|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
126349443|NCT03916926|454572907|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
126349444|NCT03916926|454572906|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
126349445|NCT03916926|454572907|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
126435955|NCT02435992|454895548|FG001|Overall Study|Other Reason|0|||
126435956|NCT02435992|454895549|FG002|Overall Study|Other Reason|0|||
126435957|NCT02435992|454895550|FG003|Overall Study|Other Reason|0|||
126435958|NCT02435992|454895551|FG004|Overall Study|Other Reason|0|||
126435959|NCT02435992|454895547|FG000|Overall Study|Physician Decision|0|||
126435960|NCT02435992|454895548|FG001|Overall Study|Physician Decision|0|||
126435961|NCT02435992|454895549|FG002|Overall Study|Physician Decision|1|||
126435962|NCT02435992|454895550|FG003|Overall Study|Physician Decision|0|||
126435963|NCT02435992|454895551|FG004|Overall Study|Physician Decision|0|||
126435964|NCT01761877|454895552|FG000|Overall Study|Adverse Event|7|||
126435965|NCT01761877|454895553|FG001|Overall Study|Adverse Event|0|||
126435966|NCT01761877|454895552|FG000|Overall Study|Withdrawal by Subject|6|||
126435967|NCT01761877|454895553|FG001|Overall Study|Withdrawal by Subject|4|||
126435968|NCT01761877|454895552|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
126435969|NCT01761877|454895553|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
126435970|NCT01761877|454895552|FG000|Overall Study|Death|0|||
126435971|NCT01761877|454895553|FG001|Overall Study|Death|1|||
126435972|NCT01761877|454895552|FG000|Overall Study|MRI intolerant|1|||
126435973|NCT01761877|454895553|FG001|Overall Study|MRI intolerant|6|||
126435974|NCT02461758|454895555|FG000|Overall Study|Lost to Follow-up|0|||
126435975|NCT02461758|454895556|FG001|Overall Study|Lost to Follow-up|1|||
126435976|NCT02461758|454895557|FG002|Overall Study|Lost to Follow-up|1|||
126435977|NCT02461758|454895558|FG003|Overall Study|Lost to Follow-up|0|||
126435978|NCT01353898|454895567|FG000|Overall Study|Study site terminated|0|||
126435979|NCT01353898|454895568|FG001|Overall Study|Study site terminated|0|||
126435980|NCT01353898|454895569|FG002|Overall Study|Study site terminated|0|||
126681876|NCT00708123|455791378|FG004|Period 1|Adverse Event|0|||
126681877|NCT00708123|455791374|FG000|Period 2|Protocol Violation|0|||
126435981|NCT01353898|454895570|FG003|Overall Study|Study site terminated|0|||
126435982|NCT01353898|454895571|FG004|Overall Study|Study site terminated|0|||
126435983|NCT01353898|454895572|FG005|Overall Study|Study site terminated|1|||
126435984|NCT03558737|454895573|FG000|Overall Study|Death|1|||
126681878|NCT00708123|455791375|FG001|Period 2|Protocol Violation|0|||
126435985|NCT03558737|454895574|FG001|Overall Study|Death|1|||
126435986|NCT03104868|454895577|FG000|6 Week Follow up|Lost to Follow-up|5|||
126435987|NCT03104868|454895578|FG001|6 Week Follow up|Lost to Follow-up|8|||
126435988|NCT03104868|454895577|FG000|6 Week Follow up|Death|1|||
126435989|NCT03104868|454895578|FG001|6 Week Follow up|Death|1|||
126435990|NCT03104868|454895577|FG000|6 Week Follow up|Withdrawal by Subject|7|||
126435991|NCT03104868|454895578|FG001|6 Week Follow up|Withdrawal by Subject|6|||
126435992|NCT03104868|454895577|FG000|6 Week Follow up|Completed Later Timepoint|24|||
126435993|NCT03104868|454895578|FG001|6 Week Follow up|Completed Later Timepoint|22|||
126435994|NCT03104868|454895577|FG000|6 Month Follow up|Lost to Follow-up|2|||
126435995|NCT03104868|454895578|FG001|6 Month Follow up|Lost to Follow-up|2|||
126435996|NCT03104868|454895577|FG000|6 Month Follow up|Death|0|||
126435997|NCT03104868|454895578|FG001|6 Month Follow up|Death|1|||
126435998|NCT03104868|454895577|FG000|6 Month Follow up|Completed Later Timepoint|22|||
126435999|NCT03104868|454895578|FG001|6 Month Follow up|Completed Later Timepoint|32|||
126436000|NCT03104868|454895577|FG000|12 Month Follow up|Lost to Follow-up|1|||
126436001|NCT03104868|454895578|FG001|12 Month Follow up|Lost to Follow-up|2|||
126436002|NCT03104868|454895577|FG000|12 Month Follow up|Death|0|||
126436003|NCT03104868|454895578|FG001|12 Month Follow up|Death|1|||
126436004|NCT03104868|454895577|FG000|12 Month Follow up|Withdrawal by Subject|0|||
126436005|NCT03104868|454895578|FG001|12 Month Follow up|Withdrawal by Subject|3|||
126545372|NCT01013792|455290818|FG001|Overall Study|Lost to Follow-up|1|||
126681879|NCT00708123|455791376|FG002|Period 2|Protocol Violation|0|||
126436006|NCT03104868|454895577|FG000|12 Month Follow up|Completed Later Timepoint|32|||
126436007|NCT03104868|454895578|FG001|12 Month Follow up|Completed Later Timepoint|29|||
126436008|NCT03104868|454895577|FG000|18 Month Follow up|Lost to Follow-up|7|||
126681880|NCT00708123|455791377|FG003|Period 2|Protocol Violation|1|||
126436009|NCT03104868|454895578|FG001|18 Month Follow up|Lost to Follow-up|11|||
126436010|NCT03104868|454895577|FG000|18 Month Follow up|Death|2|||
126436011|NCT03104868|454895578|FG001|18 Month Follow up|Death|1|||
126436012|NCT03104868|454895577|FG000|18 Month Follow up|Withdrawal by Subject|1|||
126436013|NCT03104868|454895578|FG001|18 Month Follow up|Withdrawal by Subject|2|||
126436014|NCT03104868|454895577|FG000|18 Month Follow up|Graft Loss|1|||
126436015|NCT03104868|454895578|FG001|18 Month Follow up|Graft Loss|1|||
126436016|NCT03104868|454895577|FG000|18 Month Follow up|Completed Later Timepoint|19|||
126436017|NCT03104868|454895578|FG001|18 Month Follow up|Completed Later Timepoint|20|||
126436018|NCT03104868|454895577|FG000|24 Month Follow up|Lost to Follow-up|15|||
126436019|NCT03104868|454895578|FG001|24 Month Follow up|Lost to Follow-up|16|||
126436020|NCT03104868|454895577|FG000|24 Month Follow up|Death|3|||
126436021|NCT03104868|454895578|FG001|24 Month Follow up|Death|2|||
126436022|NCT03104868|454895577|FG000|24 Month Follow up|Withdrawal by Subject|1|||
126436023|NCT03104868|454895578|FG001|24 Month Follow up|Withdrawal by Subject|0|||
126436024|NCT03104868|454895577|FG000|24 Month Follow up|Graft Loss|2|||
126436025|NCT03104868|454895578|FG001|24 Month Follow up|Graft Loss|0|||
126436026|NCT03050801|454895581|FG000|Experiment 1|Lost to Follow-up|0|||
126436027|NCT03050801|454895582|FG001|Experiment 1|Lost to Follow-up|1|||
126436028|NCT03050801|454895583|FG002|Experiment 1|Lost to Follow-up|0|||
126436029|NCT03050801|454895584|FG003|Experiment 1|Lost to Follow-up|0|||
126436030|NCT03050801|454895585|FG004|Experiment 1|Lost to Follow-up|0|||
126436031|NCT03050801|454895586|FG005|Experiment 1|Lost to Follow-up|0|||
126436032|NCT03050801|454895581|FG000|Experiment 1|Physician Decision|0|||
126436033|NCT03050801|454895582|FG001|Experiment 1|Physician Decision|3|||
126436034|NCT03050801|454895583|FG002|Experiment 1|Physician Decision|0|||
126436035|NCT03050801|454895584|FG003|Experiment 1|Physician Decision|0|||
126436036|NCT03050801|454895585|FG004|Experiment 1|Physician Decision|0|||
126436037|NCT03050801|454895586|FG005|Experiment 1|Physician Decision|0|||
126436038|NCT03050801|454895581|FG000|Experiment 1|Change of experimental design|0|||
126436039|NCT03050801|454895582|FG001|Experiment 1|Change of experimental design|3|||
126436040|NCT03050801|454895583|FG002|Experiment 1|Change of experimental design|0|||
126436041|NCT03050801|454895584|FG003|Experiment 1|Change of experimental design|0|||
126436042|NCT03050801|454895585|FG004|Experiment 1|Change of experimental design|0|||
126436043|NCT03050801|454895586|FG005|Experiment 1|Change of experimental design|0|||
126436044|NCT03050801|454895581|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
126436045|NCT03050801|454895582|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
126436046|NCT03050801|454895583|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
126436047|NCT03050801|454895584|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
126436048|NCT03050801|454895585|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
126436049|NCT03050801|454895586|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
126436050|NCT03050801|454895581|FG000|Experiment 2|Lost to Follow-up|0|||
126436051|NCT03050801|454895582|FG001|Experiment 2|Lost to Follow-up|0|||
126436052|NCT03050801|454895583|FG002|Experiment 2|Lost to Follow-up|0|||
126681881|NCT00708123|455791378|FG004|Period 2|Protocol Violation|0|||
126436053|NCT03050801|454895584|FG003|Experiment 2|Lost to Follow-up|1|||
126436054|NCT03050801|454895585|FG004|Experiment 2|Lost to Follow-up|1|||
126436055|NCT03050801|454895586|FG005|Experiment 2|Lost to Follow-up|0|||
126436056|NCT03050801|454895581|FG000|Experiment 2|Physician Decision|0|||
126436057|NCT03050801|454895582|FG001|Experiment 2|Physician Decision|0|||
126436058|NCT03050801|454895583|FG002|Experiment 2|Physician Decision|0|||
126436059|NCT03050801|454895584|FG003|Experiment 2|Physician Decision|0|||
126436060|NCT03050801|454895585|FG004|Experiment 2|Physician Decision|1|||
126436061|NCT03050801|454895586|FG005|Experiment 2|Physician Decision|0|||
126681882|NCT00708123|455791374|FG000|Period 2|Other Reason|1|||
126436062|NCT03050801|454895581|FG000|Experiment 2|Pregnancy|0|||
126436063|NCT03050801|454895582|FG001|Experiment 2|Pregnancy|0|||
126436064|NCT03050801|454895583|FG002|Experiment 2|Pregnancy|0|||
126681883|NCT00708123|455791375|FG001|Period 2|Other Reason|0|||
126436065|NCT03050801|454895584|FG003|Experiment 2|Pregnancy|0|||
126436066|NCT03050801|454895585|FG004|Experiment 2|Pregnancy|1|||
126436067|NCT03050801|454895586|FG005|Experiment 2|Pregnancy|0|||
126436068|NCT03050801|454895581|FG000|Experiment 2|Withdrawal by Subject|0|||
126436069|NCT03050801|454895582|FG001|Experiment 2|Withdrawal by Subject|0|||
126436070|NCT03050801|454895583|FG002|Experiment 2|Withdrawal by Subject|0|||
126436071|NCT03050801|454895584|FG003|Experiment 2|Withdrawal by Subject|1|||
126436072|NCT03050801|454895585|FG004|Experiment 2|Withdrawal by Subject|0|||
126436073|NCT03050801|454895586|FG005|Experiment 2|Withdrawal by Subject|0|||
126436074|NCT03050801|454895581|FG000|Experiment 2|Poor data quality|0|||
126436075|NCT03050801|454895582|FG001|Experiment 2|Poor data quality|0|||
126436076|NCT03050801|454895583|FG002|Experiment 2|Poor data quality|0|||
126436077|NCT03050801|454895584|FG003|Experiment 2|Poor data quality|4|||
126436078|NCT03050801|454895585|FG004|Experiment 2|Poor data quality|1|||
126436079|NCT03050801|454895586|FG005|Experiment 2|Poor data quality|0|||
126436080|NCT03050801|454895581|FG000|Experiment 2|Discomfort during stimulation|0|||
126436081|NCT03050801|454895582|FG001|Experiment 2|Discomfort during stimulation|0|||
126436082|NCT03050801|454895583|FG002|Experiment 2|Discomfort during stimulation|0|||
126436083|NCT03050801|454895584|FG003|Experiment 2|Discomfort during stimulation|0|||
126436084|NCT03050801|454895585|FG004|Experiment 2|Discomfort during stimulation|0|||
126436085|NCT03050801|454895586|FG005|Experiment 2|Discomfort during stimulation|2|||
126436086|NCT00005780|454895587|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
126436087|NCT03600909|454895588|FG000|Overall Study|Not treated|0|||
126436088|NCT03600909|454895589|FG001|Overall Study|Not treated|3|||
126436089|NCT03600909|454895590|FG002|Overall Study|Not treated|0|||
126436090|NCT04973449|454895591|FG000|Overall Study|Withdrawal by Subject|3|||
126436091|NCT04973449|454895592|FG001|Overall Study|Withdrawal by Subject|3|||
126436092|NCT04973449|454895593|FG002|Overall Study|Withdrawal by Subject|2|||
126436093|NCT04973449|454895594|FG003|Overall Study|Withdrawal by Subject|5|||
126436094|NCT04973449|454895595|FG004|Overall Study|Withdrawal by Subject|5|||
126436095|NCT04973449|454895596|FG005|Overall Study|Withdrawal by Subject|4|||
126436096|NCT04973449|454895597|FG006|Overall Study|Withdrawal by Subject|7|||
126436097|NCT04973449|454895598|FG007|Overall Study|Withdrawal by Subject|5|||
126436098|NCT04973449|454895591|FG000|Overall Study|Lost to Follow-up|15|||
126436099|NCT04973449|454895592|FG001|Overall Study|Lost to Follow-up|16|||
126436100|NCT04973449|454895593|FG002|Overall Study|Lost to Follow-up|16|||
126436101|NCT04973449|454895594|FG003|Overall Study|Lost to Follow-up|13|||
126436102|NCT04973449|454895595|FG004|Overall Study|Lost to Follow-up|5|||
126436103|NCT04973449|454895596|FG005|Overall Study|Lost to Follow-up|6|||
126436104|NCT04973449|454895597|FG006|Overall Study|Lost to Follow-up|10|||
126436105|NCT04973449|454895598|FG007|Overall Study|Lost to Follow-up|6|||
126436106|NCT04973449|454895591|FG000|Overall Study|Death|1|||
126436107|NCT04973449|454895592|FG001|Overall Study|Death|0|||
126436108|NCT04973449|454895593|FG002|Overall Study|Death|0|||
126436109|NCT04973449|454895594|FG003|Overall Study|Death|0|||
126436110|NCT04973449|454895595|FG004|Overall Study|Death|0|||
126436111|NCT04973449|454895596|FG005|Overall Study|Death|1|||
126436112|NCT04973449|454895597|FG006|Overall Study|Death|0|||
126436113|NCT04973449|454895598|FG007|Overall Study|Death|0|||
126436114|NCT04973449|454895591|FG000|Overall Study|Other|1|||
126436115|NCT04973449|454895592|FG001|Overall Study|Other|1|||
126436116|NCT04973449|454895593|FG002|Overall Study|Other|2|||
126436117|NCT04973449|454895594|FG003|Overall Study|Other|1|||
126436118|NCT04973449|454895595|FG004|Overall Study|Other|4|||
126436119|NCT04973449|454895596|FG005|Overall Study|Other|0|||
126436120|NCT04973449|454895597|FG006|Overall Study|Other|2|||
126436121|NCT04973449|454895598|FG007|Overall Study|Other|2|||
126436122|NCT00521079|454895599|FG000|Overall Study|Adverse Event|7|||
126436123|NCT00521079|454895600|FG001|Overall Study|Adverse Event|1|||
126436124|NCT00521079|454895599|FG000|Overall Study|Lost to Follow-up|2|||
126436125|NCT00521079|454895600|FG001|Overall Study|Lost to Follow-up|1|||
126436126|NCT00521079|454895599|FG000|Overall Study|Withdrawal by Subject|5|||
126436127|NCT00521079|454895600|FG001|Overall Study|Withdrawal by Subject|3|||
126436128|NCT02651675|454895601|FG000|Overall Study|Death|0|||
126436129|NCT02651675|454895602|FG001|Overall Study|Death|0|||
126436130|NCT02651675|454895603|FG002|Overall Study|Death|1|||
126436131|NCT03674411|454895604|FG000|Overall Study|Non-treatment|4|||
126436132|NCT01506596|454895606|FG000|Overall Study|ineligible pathology|1|||
126436133|NCT04408989|454895607|FG000|Overall Study|Lost to Follow-up|0|||
126436134|NCT04408989|454895608|FG001|Overall Study|Lost to Follow-up|0|||
126436135|NCT04408989|454895609|FG002|Overall Study|Lost to Follow-up|1|||
126436136|NCT04408989|454895607|FG000|Overall Study|Withdrawal by Subject|0|||
126436137|NCT04408989|454895608|FG001|Overall Study|Withdrawal by Subject|0|||
126436138|NCT04408989|454895609|FG002|Overall Study|Withdrawal by Subject|2|||
126436139|NCT05082857|454895610|FG000|Overall Study|participants relocated and could not continue|2|||
126436140|NCT05082857|454895611|FG001|Overall Study|participants relocated and could not continue|1|||
126436141|NCT05082857|454895610|FG000|Overall Study|Lost to Follow-up|1|||
126436142|NCT05082857|454895611|FG001|Overall Study|Lost to Follow-up|3|||
126436143|NCT04606134|454895618|FG000|Overall Study|Adverse Event|0|||
126436144|NCT04606134|454895619|FG001|Overall Study|Adverse Event|1|||
126436145|NCT01099267|454895620|FG000|MDS-003 Study|Adverse Event|37|||
126436146|NCT01099267|454895620|FG000|MDS-003 Study|Lack of Efficacy|52|||
126436147|NCT01099267|454895620|FG000|MDS-003 Study|Withdrawal by Subject|8|||
126436148|NCT01099267|454895620|FG000|MDS-003 Study|Lost to Follow-up|1|||
126436149|NCT01099267|454895620|FG000|MDS-003 Study|Death|11|||
126436150|NCT01099267|454895620|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
126436151|NCT01099267|454895620|FG000|MDS-003 Study|Disease Progression|7|||
126436152|NCT01099267|454895620|FG000|MDS-003 Study|Investigator Decision|2|||
126436153|NCT01099267|454895620|FG000|MDS-003 Study|Non-Compliance|2|||
126436154|NCT01099267|454895620|FG000|MDS-003 Study|Loss of Response|1|||
126436155|NCT01099267|454895620|FG000|MDS-003 Study|Secondary Malign Disease|1|||
126436156|NCT04050553|454895631|FG000|Period 1|Physician Decision|2|||
126436157|NCT04050553|454895632|FG001|Period 1|Physician Decision|2|||
126436158|NCT04050553|454895631|FG000|Period 1|Adverse Event|1|||
126436159|NCT04050553|454895632|FG001|Period 1|Adverse Event|1|||
126436160|NCT04050553|454895631|FG000|Period 1|Withdrawal by Subject|0|||
126436161|NCT04050553|454895632|FG001|Period 1|Withdrawal by Subject|1|||
126436162|NCT04050553|454895631|FG000|Wash-out|Adverse Event|0|||
126436163|NCT04050553|454895632|FG001|Wash-out|Adverse Event|1|||
126436164|NCT04050553|454895631|FG000|Wash-out|Withdrawal by Subject|0|||
126436165|NCT04050553|454895632|FG001|Wash-out|Withdrawal by Subject|1|||
126436166|NCT03472885|454895635|FG000|24-Week Treatment Period|Adverse Event|1|||
126436167|NCT02201953|454895636|FG000|Overall Study|Randomized but Never Treated|1|||
126436168|NCT02201953|454895637|FG001|Overall Study|Randomized but Never Treated|5|||
126436169|NCT02201953|454895636|FG000|Overall Study|Lack of Efficacy|9|||
126436170|NCT02201953|454895637|FG001|Overall Study|Lack of Efficacy|30|||
126436171|NCT02201953|454895636|FG000|Overall Study|Lost to Follow-up|8|||
126436172|NCT02201953|454895637|FG001|Overall Study|Lost to Follow-up|8|||
126436173|NCT02201953|454895636|FG000|Overall Study|Withdrew Consent|2|||
126436174|NCT02201953|454895637|FG001|Overall Study|Withdrew Consent|5|||
126436175|NCT02201953|454895636|FG000|Overall Study|Adverse Event|0|||
126436176|NCT02201953|454895637|FG001|Overall Study|Adverse Event|5|||
126436177|NCT02201953|454895636|FG000|Overall Study|Death|0|||
126436178|NCT02201953|454895637|FG001|Overall Study|Death|3|||
126436179|NCT01615939|454896962|FG000|Overall Study|Lost to Follow-up|5|||
126436180|NCT01615939|454896963|FG001|Overall Study|Lost to Follow-up|0|||
126436181|NCT02892344|454896967|FG000|Overall Study|Protocol deviation|3|||
126436182|NCT02892344|454896968|FG001|Overall Study|Protocol deviation|4|||
126436183|NCT02892344|454896967|FG000|Overall Study|Adverse Event|1|||
126436184|NCT02892344|454896968|FG001|Overall Study|Adverse Event|8|||
126436185|NCT02892344|454896967|FG000|Overall Study|Lost to Follow-up|0|||
126436186|NCT02892344|454896968|FG001|Overall Study|Lost to Follow-up|1|||
126436187|NCT02892344|454896967|FG000|Overall Study|Non-compliance with study treatment|0|||
126436188|NCT02892344|454896968|FG001|Overall Study|Non-compliance with study treatment|1|||
126436189|NCT02892344|454896967|FG000|Overall Study|Physician Decision|0|||
126436190|NCT02892344|454896968|FG001|Overall Study|Physician Decision|2|||
126436191|NCT02892344|454896967|FG000|Overall Study|Subject/guardian decision|0|||
126681884|NCT00708123|455791376|FG002|Period 2|Other Reason|0|||
126681885|NCT00708123|455791377|FG003|Period 2|Other Reason|0|||
126681886|NCT00708123|455791378|FG004|Period 2|Other Reason|0|||
126436192|NCT02892344|454896968|FG001|Overall Study|Subject/guardian decision|4|||
126436193|NCT02892344|454896967|FG000|Overall Study|Technical problems|0|||
126436194|NCT02892344|454896968|FG001|Overall Study|Technical problems|1|||
126436195|NCT01520506|454896969|FG000|Overall Study|Missed Visit|4|||
126436196|NCT01520506|454896969|FG000|Overall Study|Lost to Follow-up|1|||
126436197|NCT01520506|454896969|FG000|Overall Study|Withdrawal by Subject|1|||
126436198|NCT00425269|454896970|FG000|Overall Study|Pregnancy|5|||
126436199|NCT00425269|454896971|FG001|Overall Study|Pregnancy|7|||
126436200|NCT00425269|454896970|FG000|Overall Study|Lost to Follow-up|9|||
126436201|NCT00425269|454896971|FG001|Overall Study|Lost to Follow-up|9|||
126436202|NCT00425269|454896970|FG000|Overall Study|moved or medical reason|5|||
126436203|NCT00425269|454896971|FG001|Overall Study|moved or medical reason|4|||
126436204|NCT01084655|454896976|FG000|Overall Study|Radiographic disease progression|3|||
126681887|NCT00708123|455791374|FG000|Period 3|Lost to Follow-up|0|||
126681888|NCT00708123|455791375|FG001|Period 3|Lost to Follow-up|0|||
126681889|NCT00708123|455791376|FG002|Period 3|Lost to Follow-up|1|||
126681890|NCT00708123|455791377|FG003|Period 3|Lost to Follow-up|1|||
126681891|NCT00708123|455791378|FG004|Period 3|Lost to Follow-up|0|||
126681892|NCT00708123|455791374|FG000|Period 4|Protocol Violation|0|||
126681893|NCT00708123|455791375|FG001|Period 4|Protocol Violation|1|||
126681894|NCT00708123|455791376|FG002|Period 4|Protocol Violation|0|||
126681895|NCT00708123|455791377|FG003|Period 4|Protocol Violation|0|||
126681896|NCT00708123|455791378|FG004|Period 4|Protocol Violation|0|||
126681897|NCT00845650|455791379|FG000|Overall Study|Withdrawal by Subject|0|||
126681898|NCT00845650|455791380|FG001|Overall Study|Withdrawal by Subject|0|||
126681899|NCT00845650|455791381|FG002|Overall Study|Withdrawal by Subject|0|||
126681900|NCT00845650|455791382|FG003|Overall Study|Withdrawal by Subject|0|||
126681901|NCT00845650|455791383|FG004|Overall Study|Withdrawal by Subject|2|||
126681902|NCT00845650|455791384|FG005|Overall Study|Withdrawal by Subject|0|||
126681903|NCT00845650|455791379|FG000|Overall Study|Lost to Follow-up|0|||
126681904|NCT00845650|455791380|FG001|Overall Study|Lost to Follow-up|0|||
126681905|NCT00845650|455791381|FG002|Overall Study|Lost to Follow-up|3|||
126681906|NCT00845650|455791382|FG003|Overall Study|Lost to Follow-up|1|||
126681907|NCT00845650|455791383|FG004|Overall Study|Lost to Follow-up|0|||
126681908|NCT00845650|455791384|FG005|Overall Study|Lost to Follow-up|1|||
126681909|NCT00845650|455791379|FG000|Overall Study|Sponsor hold on dosing|0|||
126681910|NCT00845650|455791380|FG001|Overall Study|Sponsor hold on dosing|0|||
126681911|NCT00845650|455791381|FG002|Overall Study|Sponsor hold on dosing|0|||
126681912|NCT00845650|455791382|FG003|Overall Study|Sponsor hold on dosing|0|||
126681913|NCT00845650|455791383|FG004|Overall Study|Sponsor hold on dosing|1|||
126681914|NCT00845650|455791384|FG005|Overall Study|Sponsor hold on dosing|1|||
126681915|NCT00845650|455791379|FG000|Overall Study|Unable to access IV line|1|||
126681916|NCT00845650|455791380|FG001|Overall Study|Unable to access IV line|0|||
126681917|NCT00845650|455791381|FG002|Overall Study|Unable to access IV line|0|||
126681918|NCT00845650|455791382|FG003|Overall Study|Unable to access IV line|0|||
126681919|NCT00845650|455791383|FG004|Overall Study|Unable to access IV line|0|||
126681920|NCT00845650|455791384|FG005|Overall Study|Unable to access IV line|0|||
126681921|NCT00814892|455791385|FG000|Overall Study|Disease Progression|1|||
126681922|NCT00814892|455791385|FG000|Overall Study|Study Termination|1|||
126681923|NCT04486950|455791386|FG000|Overall Study|Lost to Follow-up|0|||
126681924|NCT04486950|455791387|FG001|Overall Study|Lost to Follow-up|0|||
126349446|NCT03916926|454572906|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
126349447|NCT03916926|454572907|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
126349448|NCT03916926|454572906|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
126349449|NCT03916926|454572907|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
126349450|NCT03330197|454572908|FG000|Overall Study|Adverse Event|0|||
126349451|NCT03330197|454572909|FG001|Overall Study|Adverse Event|1|||
126349452|NCT03330197|454572908|FG000|Overall Study|Withdrawal by Subject|0|||
126349453|NCT03330197|454572909|FG001|Overall Study|Withdrawal by Subject|1|||
126349454|NCT04537299|454572910|FG000|Overall Study|Withdrawal by Subject|2|||
126349455|NCT04537299|454572911|FG001|Overall Study|Withdrawal by Subject|0|||
126349456|NCT04537299|454572910|FG000|Overall Study|Protocol Violation|1|||
126349457|NCT04537299|454572911|FG001|Overall Study|Protocol Violation|1|||
126349458|NCT00876343|454572918|FG000|Overall Study|Adverse Event|7|||
126349459|NCT00876343|454572919|FG001|Overall Study|Adverse Event|8|||
126349460|NCT00876343|454572920|FG002|Overall Study|Adverse Event|2|||
126349461|NCT00876343|454572918|FG000|Overall Study|Withdrawal by Subject|4|||
126349462|NCT00876343|454572919|FG001|Overall Study|Withdrawal by Subject|4|||
126349463|NCT00876343|454572920|FG002|Overall Study|Withdrawal by Subject|3|||
126349464|NCT00876343|454572918|FG000|Overall Study|Lack of Efficacy|0|||
126349465|NCT00876343|454572919|FG001|Overall Study|Lack of Efficacy|0|||
126349466|NCT00876343|454572920|FG002|Overall Study|Lack of Efficacy|1|||
126349467|NCT00876343|454572918|FG000|Overall Study|Protocol Violation|4|||
126349468|NCT00876343|454572919|FG001|Overall Study|Protocol Violation|1|||
126349469|NCT00876343|454572920|FG002|Overall Study|Protocol Violation|1|||
126349470|NCT00876343|454572918|FG000|Overall Study|Physician Decision|0|||
126349471|NCT00876343|454572919|FG001|Overall Study|Physician Decision|1|||
126349472|NCT00876343|454572920|FG002|Overall Study|Physician Decision|1|||
126681925|NCT04486950|455791388|FG002|Overall Study|Lost to Follow-up|0|||
126681926|NCT04486950|455791389|FG003|Overall Study|Lost to Follow-up|0|||
126681927|NCT04486950|455791390|FG004|Overall Study|Lost to Follow-up|0|||
126681928|NCT04486950|455791391|FG005|Overall Study|Lost to Follow-up|1|||
126681929|NCT04486950|455791392|FG006|Overall Study|Lost to Follow-up|0|||
126681930|NCT01119248|455791397|FG000|Overall Study|Physician Decision|5|||
126349473|NCT00876343|454572918|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
126349474|NCT00876343|454572919|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
126349475|NCT00876343|454572920|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
126349476|NCT00876343|454572918|FG000|Overall Study|Change of residence or other commitments|2|||
126681931|NCT00550680|455791398|FG000|Overall Study|Administrative Reasons|1|||
126681932|NCT00550680|455791398|FG000|Overall Study|Adverse Event|5|||
126349477|NCT00876343|454572919|FG001|Overall Study|Change of residence or other commitments|2|||
126349478|NCT00876343|454572920|FG002|Overall Study|Change of residence or other commitments|3|||
126349479|NCT01933932|454572923|FG000|Overall Study|Death|173|||
126349480|NCT01933932|454572924|FG001|Overall Study|Death|163|||
126349481|NCT01933932|454572923|FG000|Overall Study|Withdrawal by Subject|11|||
126349482|NCT01933932|454572924|FG001|Overall Study|Withdrawal by Subject|14|||
126349483|NCT01933932|454572923|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126349484|NCT01933932|454572924|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126349485|NCT01925794|454572928|FG000|180 Days|Death|2|||
126349486|NCT01925794|454572928|FG000|180 Days|Withdrawal by Subject|2|||
126349487|NCT01925794|454572928|FG000|270 Days|Death|2|||
126349488|NCT01925794|454572928|FG000|270 Days|Protocol Violation|3|||
126349489|NCT03126110|454572929|FG000|Phase 1|Death|2|||
126349490|NCT03126110|454572930|FG001|Phase 1|Death|2|||
126349491|NCT03126110|454572931|FG002|Phase 1|Death|4|||
126349492|NCT03126110|454572932|FG003|Phase 1|Death|3|||
126349493|NCT03126110|454572933|FG004|Phase 1|Death|4|||
126349494|NCT03126110|454572934|FG005|Phase 1|Death|4|||
126349495|NCT03126110|454572935|FG006|Phase 1|Death|3|||
126349496|NCT03126110|454572936|FG007|Phase 1|Death|4|||
126349497|NCT03126110|454572937|FG008|Phase 1|Death|5|||
126349498|NCT03126110|454572938|FG009|Phase 1|Death|2|||
126349499|NCT03126110|454572939|FG010|Phase 1|Death|6|||
126349500|NCT03126110|454572940|FG011|Phase 1|Death|0|||
126349501|NCT03126110|454572941|FG012|Phase 1|Death|0|||
126349502|NCT03126110|454572942|FG013|Phase 1|Death|0|||
126349503|NCT03126110|454572943|FG014|Phase 1|Death|0|||
126349504|NCT03126110|454572944|FG015|Phase 1|Death|0|||
126349505|NCT03126110|454572945|FG016|Phase 1|Death|0|||
126349506|NCT03126110|454572929|FG000|Phase 1|Lost to Follow-up|0|||
126349507|NCT03126110|454572930|FG001|Phase 1|Lost to Follow-up|1|||
126349508|NCT03126110|454572931|FG002|Phase 1|Lost to Follow-up|0|||
126349509|NCT03126110|454572932|FG003|Phase 1|Lost to Follow-up|0|||
126349510|NCT03126110|454572933|FG004|Phase 1|Lost to Follow-up|0|||
126349511|NCT03126110|454572934|FG005|Phase 1|Lost to Follow-up|0|||
126349512|NCT03126110|454572935|FG006|Phase 1|Lost to Follow-up|0|||
126349513|NCT03126110|454572936|FG007|Phase 1|Lost to Follow-up|0|||
126349514|NCT03126110|454572937|FG008|Phase 1|Lost to Follow-up|1|||
126349515|NCT03126110|454572938|FG009|Phase 1|Lost to Follow-up|0|||
126349516|NCT03126110|454572939|FG010|Phase 1|Lost to Follow-up|0|||
126349517|NCT03126110|454572940|FG011|Phase 1|Lost to Follow-up|0|||
126349518|NCT03126110|454572941|FG012|Phase 1|Lost to Follow-up|0|||
126349519|NCT03126110|454572942|FG013|Phase 1|Lost to Follow-up|0|||
126349520|NCT03126110|454572943|FG014|Phase 1|Lost to Follow-up|0|||
126349521|NCT03126110|454572944|FG015|Phase 1|Lost to Follow-up|0|||
126349522|NCT03126110|454572945|FG016|Phase 1|Lost to Follow-up|0|||
126349523|NCT03126110|454572929|FG000|Phase 1|Withdrawal by Subject|1|||
126349524|NCT03126110|454572930|FG001|Phase 1|Withdrawal by Subject|0|||
126349525|NCT03126110|454572931|FG002|Phase 1|Withdrawal by Subject|0|||
126349526|NCT03126110|454572932|FG003|Phase 1|Withdrawal by Subject|1|||
126349527|NCT03126110|454572933|FG004|Phase 1|Withdrawal by Subject|1|||
126349528|NCT03126110|454572934|FG005|Phase 1|Withdrawal by Subject|0|||
126349529|NCT03126110|454572935|FG006|Phase 1|Withdrawal by Subject|0|||
126349530|NCT03126110|454572936|FG007|Phase 1|Withdrawal by Subject|0|||
126349531|NCT03126110|454572937|FG008|Phase 1|Withdrawal by Subject|2|||
126349532|NCT03126110|454572938|FG009|Phase 1|Withdrawal by Subject|1|||
126349533|NCT03126110|454572939|FG010|Phase 1|Withdrawal by Subject|0|||
126349534|NCT03126110|454572940|FG011|Phase 1|Withdrawal by Subject|0|||
126349535|NCT03126110|454572941|FG012|Phase 1|Withdrawal by Subject|0|||
126349536|NCT03126110|454572942|FG013|Phase 1|Withdrawal by Subject|0|||
126349537|NCT03126110|454572943|FG014|Phase 1|Withdrawal by Subject|0|||
126349538|NCT03126110|454572944|FG015|Phase 1|Withdrawal by Subject|0|||
126436205|NCT01084655|454896977|FG001|Overall Study|Radiographic disease progression|2|||
126436206|NCT01084655|454896978|FG002|Overall Study|Radiographic disease progression|8|||
126436207|NCT01084655|454896976|FG000|Overall Study|Withdrawal by Subject|1|||
126436208|NCT01084655|454896977|FG001|Overall Study|Withdrawal by Subject|0|||
126436209|NCT01084655|454896978|FG002|Overall Study|Withdrawal by Subject|4|||
126436210|NCT01084655|454896976|FG000|Overall Study|Adverse Event|2|||
126436211|NCT01084655|454896977|FG001|Overall Study|Adverse Event|1|||
126436212|NCT01084655|454896978|FG002|Overall Study|Adverse Event|2|||
126436213|NCT01084655|454896976|FG000|Overall Study|Other|0|||
126436214|NCT01084655|454896977|FG001|Overall Study|Other|3|||
126436215|NCT01084655|454896978|FG002|Overall Study|Other|2|||
126436216|NCT01084655|454896976|FG000|Overall Study|Symptomatic deterioration|0|||
126436217|NCT01084655|454896977|FG001|Overall Study|Symptomatic deterioration|0|||
126436218|NCT01084655|454896978|FG002|Overall Study|Symptomatic deterioration|2|||
126436219|NCT01084655|454896976|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
126436220|NCT01084655|454896977|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
126436221|NCT01084655|454896978|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
126436222|NCT00535496|454896979|FG000|Overall Study|Lost to Follow-up|0|||
126436223|NCT00535496|454896980|FG001|Overall Study|Lost to Follow-up|1|||
126436224|NCT00535496|454896981|FG002|Overall Study|Lost to Follow-up|0|||
126436225|NCT00535496|454896982|FG003|Overall Study|Lost to Follow-up|0|||
126436226|NCT00535496|454896979|FG000|Overall Study|Not treated with sugammadex|0|||
126436227|NCT00535496|454896980|FG001|Overall Study|Not treated with sugammadex|1|||
126436228|NCT00535496|454896981|FG002|Overall Study|Not treated with sugammadex|0|||
126436229|NCT00535496|454896982|FG003|Overall Study|Not treated with sugammadex|0|||
126436230|NCT02326155|454896984|FG000|Overall Study|Adverse Event|21|||
126436231|NCT02326155|454896985|FG001|Overall Study|Adverse Event|5|||
126436232|NCT02326155|454896984|FG000|Overall Study|Death|3|||
126436233|NCT02326155|454896985|FG001|Overall Study|Death|0|||
126436234|NCT02326155|454896984|FG000|Overall Study|Lack of Efficacy|49|||
126436235|NCT02326155|454896985|FG001|Overall Study|Lack of Efficacy|5|||
126436236|NCT02326155|454896984|FG000|Overall Study|Lost to Follow-up|14|||
126436237|NCT02326155|454896985|FG001|Overall Study|Lost to Follow-up|3|||
126436238|NCT02326155|454896984|FG000|Overall Study|Protocol Violation|2|||
126436239|NCT02326155|454896985|FG001|Overall Study|Protocol Violation|0|||
126436240|NCT02326155|454896984|FG000|Overall Study|Withdrawal by Subject|34|||
126436241|NCT02326155|454896985|FG001|Overall Study|Withdrawal by Subject|11|||
126436242|NCT02326155|454896984|FG000|Overall Study|Disease progression|37|||
126436243|NCT02326155|454896985|FG001|Overall Study|Disease progression|4|||
126436244|NCT02326155|454896984|FG000|Overall Study|Study close|188|||
126436245|NCT02326155|454896985|FG001|Overall Study|Study close|21|||
126436246|NCT02326155|454896984|FG000|Overall Study|except for study close|46|||
126436247|NCT02326155|454896985|FG001|Overall Study|except for study close|13|||
126436248|NCT05024032|454896986|FG000|Overall Study|Withdrawal by Subject|0|||
126436249|NCT05024032|454896987|FG001|Overall Study|Withdrawal by Subject|3|||
126681933|NCT00550680|455791398|FG000|Overall Study|Death|3|||
126681934|NCT00550680|455791398|FG000|Overall Study|Early Improvement|1|||
126681935|NCT00550680|455791398|FG000|Overall Study|Lost to Follow-up|3|||
126681936|NCT00550680|455791398|FG000|Overall Study|Lack of Efficacy|1|||
126681937|NCT00550680|455791398|FG000|Overall Study|Other|10|||
126681938|NCT00550680|455791398|FG000|Overall Study|Protocol Violation|7|||
126681939|NCT00550680|455791398|FG000|Overall Study|Refused Treatment|19|||
126681940|NCT00550680|455791398|FG000|Overall Study|Screen Failure|6|||
126681941|NCT00562354|455791399|FG000|Overall Study|Physician Decision|0|||
126681942|NCT00562354|455791400|FG001|Overall Study|Physician Decision|1|||
126436250|NCT05024032|454896988|FG002|Overall Study|Withdrawal by Subject|4|||
126436251|NCT05024032|454896986|FG000|Overall Study|Adverse Event|0|||
126681943|NCT00562354|455791399|FG000|Overall Study|Lost to Follow-up|0|||
126681944|NCT00562354|455791400|FG001|Overall Study|Lost to Follow-up|1|||
126681945|NCT00317109|455791401|FG000|Overall Study|Withdrawal by Subject|2|||
126681946|NCT00317109|455791402|FG001|Overall Study|Withdrawal by Subject|0|||
126681947|NCT00317109|455791401|FG000|Overall Study|Migated/moved from study area|1|||
126681948|NCT00317109|455791402|FG001|Overall Study|Migated/moved from study area|0|||
126681949|NCT03693625|455791404|FG000|Overall Study|Adverse Event|2|||
126681950|NCT03693625|455791405|FG001|Overall Study|Adverse Event|0|||
126681951|NCT03693625|455791404|FG000|Overall Study|Study Terminated By Sponsor|20|||
126681952|NCT03693625|455791405|FG001|Overall Study|Study Terminated By Sponsor|7|||
126436252|NCT05024032|454896987|FG001|Overall Study|Adverse Event|1|||
126436253|NCT05024032|454896988|FG002|Overall Study|Adverse Event|0|||
126436254|NCT05024032|454896986|FG000|Overall Study|Protocol Deviation|1|||
126436255|NCT05024032|454896987|FG001|Overall Study|Protocol Deviation|0|||
126436256|NCT05024032|454896988|FG002|Overall Study|Protocol Deviation|0|||
126436257|NCT03591406|454896991|FG000|Overall Study|Adverse Event|5|||
126436258|NCT03591406|454896992|FG001|Overall Study|Adverse Event|3|||
126436259|NCT03591406|454896991|FG000|Overall Study|Protocol Violation|2|||
126436260|NCT03591406|454896992|FG001|Overall Study|Protocol Violation|1|||
126436261|NCT03591406|454896991|FG000|Overall Study|Withdrawal by Subject|0|||
126681953|NCT03693625|455791404|FG000|Overall Study|Withdrawal by Subject|1|||
126681954|NCT03693625|455791405|FG001|Overall Study|Withdrawal by Subject|1|||
126349539|NCT03126110|454572945|FG016|Phase 1|Withdrawal by Subject|0|||
126349540|NCT03126110|454572929|FG000|Phase 1|Safety follow-up no longer necessary|1|||
126349541|NCT03126110|454572930|FG001|Phase 1|Safety follow-up no longer necessary|0|||
126349542|NCT03126110|454572931|FG002|Phase 1|Safety follow-up no longer necessary|0|||
126349543|NCT03126110|454572932|FG003|Phase 1|Safety follow-up no longer necessary|0|||
126349544|NCT03126110|454572933|FG004|Phase 1|Safety follow-up no longer necessary|0|||
126349545|NCT03126110|454572934|FG005|Phase 1|Safety follow-up no longer necessary|0|||
126349546|NCT03126110|454572935|FG006|Phase 1|Safety follow-up no longer necessary|0|||
126349547|NCT03126110|454572936|FG007|Phase 1|Safety follow-up no longer necessary|0|||
126349548|NCT03126110|454572937|FG008|Phase 1|Safety follow-up no longer necessary|0|||
126349549|NCT03126110|454572938|FG009|Phase 1|Safety follow-up no longer necessary|0|||
126349550|NCT03126110|454572939|FG010|Phase 1|Safety follow-up no longer necessary|0|||
126349551|NCT03126110|454572940|FG011|Phase 1|Safety follow-up no longer necessary|0|||
126349552|NCT03126110|454572941|FG012|Phase 1|Safety follow-up no longer necessary|0|||
126349553|NCT03126110|454572942|FG013|Phase 1|Safety follow-up no longer necessary|0|||
126349554|NCT03126110|454572943|FG014|Phase 1|Safety follow-up no longer necessary|0|||
126349555|NCT03126110|454572944|FG015|Phase 1|Safety follow-up no longer necessary|0|||
126349556|NCT03126110|454572945|FG016|Phase 1|Safety follow-up no longer necessary|0|||
126349557|NCT03126110|454572929|FG000|Phase 1|Survival follow-up no longer necessary|0|||
126349558|NCT03126110|454572930|FG001|Phase 1|Survival follow-up no longer necessary|0|||
126349559|NCT03126110|454572931|FG002|Phase 1|Survival follow-up no longer necessary|1|||
126349560|NCT03126110|454572932|FG003|Phase 1|Survival follow-up no longer necessary|0|||
126349561|NCT03126110|454572933|FG004|Phase 1|Survival follow-up no longer necessary|0|||
126349562|NCT03126110|454572934|FG005|Phase 1|Survival follow-up no longer necessary|0|||
126349563|NCT03126110|454572935|FG006|Phase 1|Survival follow-up no longer necessary|0|||
126349564|NCT03126110|454572936|FG007|Phase 1|Survival follow-up no longer necessary|0|||
126349565|NCT03126110|454572937|FG008|Phase 1|Survival follow-up no longer necessary|0|||
126349566|NCT03126110|454572938|FG009|Phase 1|Survival follow-up no longer necessary|0|||
126349567|NCT03126110|454572939|FG010|Phase 1|Survival follow-up no longer necessary|0|||
126349568|NCT03126110|454572940|FG011|Phase 1|Survival follow-up no longer necessary|0|||
126349569|NCT03126110|454572941|FG012|Phase 1|Survival follow-up no longer necessary|0|||
126349570|NCT03126110|454572942|FG013|Phase 1|Survival follow-up no longer necessary|0|||
126349571|NCT03126110|454572943|FG014|Phase 1|Survival follow-up no longer necessary|0|||
126349572|NCT03126110|454572944|FG015|Phase 1|Survival follow-up no longer necessary|0|||
126349573|NCT03126110|454572945|FG016|Phase 1|Survival follow-up no longer necessary|0|||
126349574|NCT03126110|454572929|FG000|Phase 2|Study terminated by the sponsor|0|||
126349575|NCT03126110|454572930|FG001|Phase 2|Study terminated by the sponsor|0|||
126349576|NCT03126110|454572931|FG002|Phase 2|Study terminated by the sponsor|0|||
126349577|NCT03126110|454572932|FG003|Phase 2|Study terminated by the sponsor|0|||
126349578|NCT03126110|454572933|FG004|Phase 2|Study terminated by the sponsor|0|||
126349579|NCT03126110|454572934|FG005|Phase 2|Study terminated by the sponsor|0|||
126349580|NCT03126110|454572935|FG006|Phase 2|Study terminated by the sponsor|0|||
126349581|NCT03126110|454572936|FG007|Phase 2|Study terminated by the sponsor|0|||
126349582|NCT03126110|454572937|FG008|Phase 2|Study terminated by the sponsor|0|||
126349583|NCT03126110|454572938|FG009|Phase 2|Study terminated by the sponsor|0|||
126349584|NCT03126110|454572939|FG010|Phase 2|Study terminated by the sponsor|0|||
126349585|NCT03126110|454572940|FG011|Phase 2|Study terminated by the sponsor|0|||
126349586|NCT03126110|454572941|FG012|Phase 2|Study terminated by the sponsor|0|||
126349587|NCT03126110|454572942|FG013|Phase 2|Study terminated by the sponsor|4|||
126349588|NCT03126110|454572943|FG014|Phase 2|Study terminated by the sponsor|0|||
126349589|NCT03126110|454572944|FG015|Phase 2|Study terminated by the sponsor|0|||
126349590|NCT03126110|454572945|FG016|Phase 2|Study terminated by the sponsor|0|||
126349591|NCT03126110|454572929|FG000|Phase 2|Withdrawal by Subject|0|||
126349592|NCT03126110|454572930|FG001|Phase 2|Withdrawal by Subject|0|||
126349593|NCT03126110|454572931|FG002|Phase 2|Withdrawal by Subject|0|||
126349594|NCT03126110|454572932|FG003|Phase 2|Withdrawal by Subject|0|||
126349595|NCT03126110|454572933|FG004|Phase 2|Withdrawal by Subject|0|||
126349596|NCT03126110|454572934|FG005|Phase 2|Withdrawal by Subject|0|||
126349597|NCT03126110|454572935|FG006|Phase 2|Withdrawal by Subject|0|||
126349598|NCT03126110|454572936|FG007|Phase 2|Withdrawal by Subject|0|||
126349599|NCT03126110|454572937|FG008|Phase 2|Withdrawal by Subject|0|||
126349600|NCT03126110|454572938|FG009|Phase 2|Withdrawal by Subject|0|||
126349601|NCT03126110|454572939|FG010|Phase 2|Withdrawal by Subject|0|||
126349602|NCT03126110|454572940|FG011|Phase 2|Withdrawal by Subject|1|||
126349603|NCT03126110|454572941|FG012|Phase 2|Withdrawal by Subject|3|||
126349604|NCT03126110|454572942|FG013|Phase 2|Withdrawal by Subject|3|||
126349605|NCT03126110|454572943|FG014|Phase 2|Withdrawal by Subject|2|||
126349606|NCT03126110|454572944|FG015|Phase 2|Withdrawal by Subject|1|||
126349607|NCT03126110|454572945|FG016|Phase 2|Withdrawal by Subject|0|||
126349608|NCT03126110|454572929|FG000|Phase 2|Lost to Follow-up|0|||
126349609|NCT03126110|454572930|FG001|Phase 2|Lost to Follow-up|0|||
126436262|NCT03591406|454896992|FG001|Overall Study|Withdrawal by Subject|5|||
126436263|NCT02066181|454896993|FG000|Overall Study|Withdrawal by Subject|1|||
126436264|NCT02066181|454896994|FG001|Overall Study|Withdrawal by Subject|1|||
126436265|NCT01083771|454896995|FG000|Overall Study|non-compliant|2|||
126436266|NCT01083771|454896995|FG000|Overall Study|Withdrawal by Subject|3|||
126436267|NCT00939393|454896998|FG000|Overall Study|Withdrawal by Subject|1|||
126436268|NCT00939393|454896999|FG001|Overall Study|Withdrawal by Subject|0|||
126436269|NCT00939393|454896998|FG000|Overall Study|Lost to Follow-up|3|||
126436270|NCT00939393|454896999|FG001|Overall Study|Lost to Follow-up|0|||
126436271|NCT02851615|454897000|FG000|Overall Study|Cognitive Issue|1|||
126436272|NCT02851615|454897001|FG001|Overall Study|Cognitive Issue|0|||
126436273|NCT02851615|454897000|FG000|Overall Study|Lost to Follow-up|0|||
126436274|NCT02851615|454897001|FG001|Overall Study|Lost to Follow-up|4|||
126436275|NCT03714672|454897010|FG000|Overall Study|Adverse Event|0|||
126436276|NCT03714672|454897011|FG001|Overall Study|Adverse Event|0|||
126436277|NCT03714672|454897012|FG002|Overall Study|Adverse Event|3|||
126436278|NCT03714672|454897013|FG003|Overall Study|Adverse Event|0|||
126436279|NCT03714672|454897010|FG000|Overall Study|Physician Decision|0|||
126436280|NCT03714672|454897011|FG001|Overall Study|Physician Decision|1|||
126436281|NCT03714672|454897012|FG002|Overall Study|Physician Decision|0|||
126436282|NCT03714672|454897013|FG003|Overall Study|Physician Decision|0|||
126436283|NCT03714672|454897010|FG000|Overall Study|Other Reason|1|||
126436284|NCT03714672|454897011|FG001|Overall Study|Other Reason|2|||
126436285|NCT03714672|454897012|FG002|Overall Study|Other Reason|1|||
126436286|NCT03714672|454897013|FG003|Overall Study|Other Reason|1|||
126436287|NCT03714672|454897010|FG000|Overall Study|Lost to Follow-up|1|||
126436288|NCT03714672|454897011|FG001|Overall Study|Lost to Follow-up|1|||
126436289|NCT03714672|454897012|FG002|Overall Study|Lost to Follow-up|0|||
126436290|NCT03714672|454897013|FG003|Overall Study|Lost to Follow-up|0|||
126436291|NCT00371150|454897014|FG000|Overall Study|Lost to Follow-up|3|||
126436292|NCT00371150|454897015|FG001|Overall Study|Lost to Follow-up|2|||
126436293|NCT02345070|454897016|FG000|Overall Study|Adverse Event|12|||
126436294|NCT02345070|454897017|FG001|Overall Study|Adverse Event|8|||
126681955|NCT01508702|455791406|FG000|Overall Study|Adverse Event|7|||
126436295|NCT02345070|454897018|FG002|Overall Study|Adverse Event|16|||
126436296|NCT02345070|454897016|FG000|Overall Study|Poor compliance to protocol|2|||
126436297|NCT02345070|454897017|FG001|Overall Study|Poor compliance to protocol|0|||
126436298|NCT02345070|454897018|FG002|Overall Study|Poor compliance to protocol|0|||
126436299|NCT02345070|454897016|FG000|Overall Study|Other than specified above|6|||
126436300|NCT02345070|454897017|FG001|Overall Study|Other than specified above|3|||
126436301|NCT02345070|454897018|FG002|Overall Study|Other than specified above|7|||
126436302|NCT00321620|454897024|FG000|Overall Study|Death|269|||
126436303|NCT00321620|454897025|FG001|Overall Study|Death|294|||
126436304|NCT00321620|454897024|FG000|Overall Study|Withdrawal by Subject|164|||
126436305|NCT00321620|454897025|FG001|Overall Study|Withdrawal by Subject|147|||
126681956|NCT01508702|455791407|FG001|Overall Study|Adverse Event|3|||
126681957|NCT01508702|455791406|FG000|Overall Study|Gout flare|2|||
126681958|NCT01508702|455791407|FG001|Overall Study|Gout flare|0|||
126681959|NCT01508702|455791406|FG000|Overall Study|Protocol Violation|2|||
126681960|NCT01508702|455791407|FG001|Overall Study|Protocol Violation|1|||
126681961|NCT01508702|455791406|FG000|Overall Study|Lost to Follow-up|1|||
126681962|NCT01508702|455791407|FG001|Overall Study|Lost to Follow-up|2|||
126681963|NCT01508702|455791406|FG000|Overall Study|Withdrawal by Subject|11|||
126349610|NCT03126110|454572931|FG002|Phase 2|Lost to Follow-up|0|||
126349611|NCT03126110|454572932|FG003|Phase 2|Lost to Follow-up|0|||
126349612|NCT03126110|454572933|FG004|Phase 2|Lost to Follow-up|0|||
126349613|NCT03126110|454572934|FG005|Phase 2|Lost to Follow-up|0|||
126349614|NCT03126110|454572935|FG006|Phase 2|Lost to Follow-up|0|||
126349615|NCT03126110|454572936|FG007|Phase 2|Lost to Follow-up|0|||
126349616|NCT03126110|454572937|FG008|Phase 2|Lost to Follow-up|0|||
126349617|NCT03126110|454572938|FG009|Phase 2|Lost to Follow-up|0|||
126349618|NCT03126110|454572939|FG010|Phase 2|Lost to Follow-up|0|||
126349619|NCT03126110|454572940|FG011|Phase 2|Lost to Follow-up|1|||
126349620|NCT03126110|454572941|FG012|Phase 2|Lost to Follow-up|1|||
126349621|NCT03126110|454572942|FG013|Phase 2|Lost to Follow-up|1|||
126349622|NCT03126110|454572943|FG014|Phase 2|Lost to Follow-up|2|||
126349623|NCT03126110|454572944|FG015|Phase 2|Lost to Follow-up|0|||
126349624|NCT03126110|454572945|FG016|Phase 2|Lost to Follow-up|0|||
126349625|NCT03126110|454572929|FG000|Phase 2|Death|0|||
126349626|NCT03126110|454572930|FG001|Phase 2|Death|0|||
126349627|NCT03126110|454572931|FG002|Phase 2|Death|0|||
126349628|NCT03126110|454572932|FG003|Phase 2|Death|0|||
126349629|NCT03126110|454572933|FG004|Phase 2|Death|0|||
126349630|NCT03126110|454572934|FG005|Phase 2|Death|0|||
126349631|NCT03126110|454572935|FG006|Phase 2|Death|0|||
126349632|NCT03126110|454572936|FG007|Phase 2|Death|0|||
126349633|NCT03126110|454572937|FG008|Phase 2|Death|0|||
126349634|NCT03126110|454572938|FG009|Phase 2|Death|0|||
126349635|NCT03126110|454572939|FG010|Phase 2|Death|0|||
126349636|NCT03126110|454572940|FG011|Phase 2|Death|6|||
126349637|NCT03126110|454572941|FG012|Phase 2|Death|12|||
126349638|NCT03126110|454572942|FG013|Phase 2|Death|25|||
126349639|NCT03126110|454572943|FG014|Phase 2|Death|11|||
126349640|NCT03126110|454572944|FG015|Phase 2|Death|3|||
126349641|NCT03126110|454572945|FG016|Phase 2|Death|2|||
126349642|NCT03126110|454572929|FG000|Phase 2|Progressive Disease|0|||
126349643|NCT03126110|454572930|FG001|Phase 2|Progressive Disease|0|||
126349644|NCT03126110|454572931|FG002|Phase 2|Progressive Disease|0|||
126349645|NCT03126110|454572932|FG003|Phase 2|Progressive Disease|0|||
126349646|NCT03126110|454572933|FG004|Phase 2|Progressive Disease|0|||
126349647|NCT03126110|454572934|FG005|Phase 2|Progressive Disease|0|||
126349648|NCT03126110|454572935|FG006|Phase 2|Progressive Disease|0|||
126349649|NCT03126110|454572936|FG007|Phase 2|Progressive Disease|0|||
126349650|NCT03126110|454572937|FG008|Phase 2|Progressive Disease|0|||
126349651|NCT03126110|454572938|FG009|Phase 2|Progressive Disease|0|||
126349652|NCT03126110|454572939|FG010|Phase 2|Progressive Disease|0|||
126349653|NCT03126110|454572940|FG011|Phase 2|Progressive Disease|0|||
126349654|NCT03126110|454572941|FG012|Phase 2|Progressive Disease|0|||
126349655|NCT03126110|454572942|FG013|Phase 2|Progressive Disease|1|||
126349656|NCT03126110|454572943|FG014|Phase 2|Progressive Disease|0|||
126349657|NCT03126110|454572944|FG015|Phase 2|Progressive Disease|0|||
126349658|NCT03126110|454572945|FG016|Phase 2|Progressive Disease|0|||
126349659|NCT03126110|454572929|FG000|Phase 2|Started new treatment|0|||
126349660|NCT03126110|454572930|FG001|Phase 2|Started new treatment|0|||
126349661|NCT03126110|454572931|FG002|Phase 2|Started new treatment|0|||
126349662|NCT03126110|454572932|FG003|Phase 2|Started new treatment|0|||
126349663|NCT03126110|454572933|FG004|Phase 2|Started new treatment|0|||
126349664|NCT03126110|454572934|FG005|Phase 2|Started new treatment|0|||
126349665|NCT03126110|454572935|FG006|Phase 2|Started new treatment|0|||
126349666|NCT03126110|454572936|FG007|Phase 2|Started new treatment|0|||
126349667|NCT03126110|454572937|FG008|Phase 2|Started new treatment|0|||
126349668|NCT03126110|454572938|FG009|Phase 2|Started new treatment|0|||
126349669|NCT03126110|454572939|FG010|Phase 2|Started new treatment|0|||
126349670|NCT03126110|454572940|FG011|Phase 2|Started new treatment|0|||
126349671|NCT03126110|454572941|FG012|Phase 2|Started new treatment|0|||
126349672|NCT03126110|454572942|FG013|Phase 2|Started new treatment|0|||
126349673|NCT03126110|454572943|FG014|Phase 2|Started new treatment|1|||
126681964|NCT01508702|455791407|FG001|Overall Study|Withdrawal by Subject|7|||
126349674|NCT03126110|454572944|FG015|Phase 2|Started new treatment|0|||
126349675|NCT03126110|454572945|FG016|Phase 2|Started new treatment|0|||
126349676|NCT04235374|454572946|FG000|Overall Study|Death|91|||
126349677|NCT04235374|454572947|FG001|Overall Study|Death|91|||
126349678|NCT04235374|454572946|FG000|Overall Study|Refused|2|||
126349679|NCT04235374|454572947|FG001|Overall Study|Refused|2|||
126349680|NCT04235374|454572946|FG000|Overall Study|Unavailable|12|||
126349681|NCT04235374|454572947|FG001|Overall Study|Unavailable|3|||
126349682|NCT04235374|454572946|FG000|Overall Study|Withdrawal by Subject|0|||
126349683|NCT04235374|454572947|FG001|Overall Study|Withdrawal by Subject|1|||
126436306|NCT00321620|454897024|FG000|Overall Study|Disease progression|113|||
126436307|NCT00321620|454897025|FG001|Overall Study|Disease progression|117|||
126436308|NCT00321620|454897024|FG000|Overall Study|Adverse Event|43|||
126436309|NCT00321620|454897025|FG001|Overall Study|Adverse Event|56|||
126436310|NCT00321620|454897024|FG000|Overall Study|Lost to Follow-up|13|||
126436311|NCT00321620|454897025|FG001|Overall Study|Lost to Follow-up|9|||
126436312|NCT00321620|454897024|FG000|Overall Study|Physician Decision|4|||
126436313|NCT00321620|454897025|FG001|Overall Study|Physician Decision|1|||
126436314|NCT00321620|454897024|FG000|Overall Study|Noncompliance|14|||
126436315|NCT00321620|454897025|FG001|Overall Study|Noncompliance|7|||
126436316|NCT00321620|454897024|FG000|Overall Study|Protocol deviation|4|||
126436317|NCT00321620|454897025|FG001|Overall Study|Protocol deviation|3|||
126436318|NCT00321620|454897024|FG000|Overall Study|Ineligibility determined|2|||
126436319|NCT00321620|454897025|FG001|Overall Study|Ineligibility determined|3|||
126436320|NCT00321620|454897024|FG000|Overall Study|Participant request|75|||
126436321|NCT00321620|454897025|FG001|Overall Study|Participant request|52|||
126436322|NCT00321620|454897024|FG000|Overall Study|Other|42|||
126436323|NCT00321620|454897025|FG001|Overall Study|Other|33|||
126436324|NCT01980017|454897026|FG000|Overall Study|Lost to Follow-up|30|||
126436325|NCT01980017|454897027|FG001|Overall Study|Lost to Follow-up|21|||
126436326|NCT01980017|454897026|FG000|Overall Study|Death|0|||
126436327|NCT01980017|454897027|FG001|Overall Study|Death|1|||
126436328|NCT00423579|454897028|FG000|Overall Study|Lost to Follow-up|3|||
126436329|NCT00423579|454897029|FG001|Overall Study|Lost to Follow-up|0|||
126436330|NCT00423579|454897028|FG000|Overall Study|Protocol Violation|1|||
126436331|NCT00423579|454897029|FG001|Overall Study|Protocol Violation|3|||
126436332|NCT00423579|454897028|FG000|Overall Study|Diagnosis of diabetes|0|||
126436333|NCT00423579|454897029|FG001|Overall Study|Diagnosis of diabetes|1|||
126436334|NCT03773978|454897034|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
126436335|NCT03773978|454897035|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
126436336|NCT03773978|454897034|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
126436337|NCT03773978|454897035|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
126436338|NCT03773978|454897034|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
126436339|NCT03773978|454897035|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
126436340|NCT03773978|454897034|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
126436341|NCT03773978|454897035|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
126436342|NCT03773978|454897034|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
126436343|NCT03773978|454897035|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
126436344|NCT03773978|454897034|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
126436345|NCT03773978|454897035|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
126436346|NCT03773978|454897034|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
126436347|NCT03773978|454897035|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
126436348|NCT03773978|454897034|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
126436349|NCT03773978|454897035|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
126436350|NCT03773978|454897034|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
126436351|NCT03773978|454897035|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
126436352|NCT03773978|454897034|FG000|DBW Period|Adverse Event|2|||
126436353|NCT03773978|454897035|FG001|DBW Period|Adverse Event|2|||
126436354|NCT03773978|454897034|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
126436355|NCT03773978|454897035|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
126436356|NCT03773978|454897034|FG000|DBW Period|Withdrawal by Subject|2|||
126436357|NCT03773978|454897035|FG001|DBW Period|Withdrawal by Subject|1|||
126436358|NCT03773978|454897034|FG000|DBW Period|Due to epidemic or pandemic|5|||
126436359|NCT03773978|454897035|FG001|DBW Period|Due to epidemic or pandemic|6|||
126436360|NCT03773978|454897034|FG000|DBW Period|Study team decision|1|||
126436361|NCT03773978|454897035|FG001|DBW Period|Study team decision|0|||
126436362|NCT01033019|454897036|FG000|Overall Study|Withdrawal by Subject|1|||
126436363|NCT01033019|454897037|FG001|Overall Study|Withdrawal by Subject|0|||
126436364|NCT04672239|454897041|FG000|Week 2 Survey|Failed survey check items|1|||
126436365|NCT04672239|454897042|FG001|Week 2 Survey|Failed survey check items|2|||
126436366|NCT04672239|454897043|FG002|Week 2 Survey|Failed survey check items|3|||
126436367|NCT04672239|454897041|FG000|Week 2 Survey|Partially completed survey|7|||
126436368|NCT04672239|454897042|FG001|Week 2 Survey|Partially completed survey|1|||
126436369|NCT04672239|454897043|FG002|Week 2 Survey|Partially completed survey|4|||
126436370|NCT04672239|454897041|FG000|Week 2 Survey|Withdrawal by Subject|0|||
126436371|NCT04672239|454897042|FG001|Week 2 Survey|Withdrawal by Subject|1|||
126436372|NCT04672239|454897043|FG002|Week 2 Survey|Withdrawal by Subject|0|||
126436373|NCT04672239|454897041|FG000|Week 2 Survey|Lost to Follow-up|3|||
126436374|NCT04672239|454897042|FG001|Week 2 Survey|Lost to Follow-up|2|||
126349684|NCT04235374|454572946|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
126349685|NCT04235374|454572947|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
126349686|NCT00088153|454572950|FG000|Overall Study|Physician Decision|3|||
126349687|NCT00088153|454572951|FG001|Overall Study|Physician Decision|3|||
126349688|NCT00088153|454572950|FG000|Overall Study|Withdrawal by Subject|10|||
126349689|NCT00088153|454572951|FG001|Overall Study|Withdrawal by Subject|10|||
126349690|NCT00088153|454572950|FG000|Overall Study|Lost to Follow-up|11|||
126349691|NCT00088153|454572951|FG001|Overall Study|Lost to Follow-up|12|||
126349692|NCT00976027|454572952|FG000|Overall Study|Serious Adverse Event|36|||
126349693|NCT00976027|454572953|FG001|Overall Study|Serious Adverse Event|17|||
126349694|NCT00976027|454572952|FG000|Overall Study|Adverse Event|0|||
126349695|NCT00976027|454572953|FG001|Overall Study|Adverse Event|2|||
126349696|NCT00976027|454572952|FG000|Overall Study|Protocol Violation|60|||
126349697|NCT00976027|454572953|FG001|Overall Study|Protocol Violation|27|||
126349698|NCT00976027|454572952|FG000|Overall Study|Lost to Follow-up|208|||
126349699|NCT00976027|454572953|FG001|Overall Study|Lost to Follow-up|103|||
126349700|NCT00976027|454572952|FG000|Overall Study|Withdrawal by Subject|107|||
126349701|NCT00976027|454572953|FG001|Overall Study|Withdrawal by Subject|66|||
126349702|NCT01771107|454572958|FG000|Overall Study|Adverse Event|1|||
126349703|NCT01771107|454572959|FG001|Overall Study|Adverse Event|3|||
126349704|NCT01771107|454572958|FG000|Overall Study|Withdrawal by Subject|0|||
126349705|NCT01771107|454572959|FG001|Overall Study|Withdrawal by Subject|2|||
126349706|NCT01771107|454572958|FG000|Overall Study|Lost to Follow-up|0|||
126349707|NCT01771107|454572959|FG001|Overall Study|Lost to Follow-up|1|||
126349708|NCT01771107|454572958|FG000|Overall Study|participant moved|0|||
126349709|NCT01771107|454572959|FG001|Overall Study|participant moved|1|||
126349710|NCT01771107|454572958|FG000|Overall Study|Other|0|||
126349711|NCT01771107|454572959|FG001|Overall Study|Other|1|||
126349712|NCT05168800|454572965|FG000|Time 1 Survey|Did not start T1 survey|182|||
126349713|NCT05168800|454572966|FG001|Time 1 Survey|Did not start T1 survey|150|||
126349714|NCT05168800|454572967|FG002|Time 1 Survey|Did not start T1 survey|140|||
126349715|NCT05168800|454572965|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
126349716|NCT05168800|454572966|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
126349717|NCT05168800|454572967|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
126349718|NCT05168800|454572965|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
126349719|NCT05168800|454572966|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
126349720|NCT05168800|454572967|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
126349721|NCT05168800|454572965|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
126349722|NCT05168800|454572966|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
126349723|NCT05168800|454572967|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
126349724|NCT05168800|454572965|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
126349725|NCT05168800|454572966|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
126349726|NCT05168800|454572967|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
126349727|NCT05168800|454572965|FG000|Time 1 Survey|Withdrawal by Subject|6|||
126349728|NCT05168800|454572966|FG001|Time 1 Survey|Withdrawal by Subject|3|||
126349729|NCT05168800|454572967|FG002|Time 1 Survey|Withdrawal by Subject|2|||
126436375|NCT04672239|454897043|FG002|Week 2 Survey|Lost to Follow-up|5|||
126436376|NCT04672239|454897041|FG000|Week 6 Survey|Failed survey check items|2|||
126436377|NCT04672239|454897042|FG001|Week 6 Survey|Failed survey check items|2|||
126436378|NCT04672239|454897043|FG002|Week 6 Survey|Failed survey check items|2|||
126436379|NCT04672239|454897041|FG000|Week 6 Survey|Partially completed survey|3|||
126436380|NCT04672239|454897042|FG001|Week 6 Survey|Partially completed survey|3|||
126436381|NCT04672239|454897043|FG002|Week 6 Survey|Partially completed survey|2|||
126436382|NCT04672239|454897041|FG000|Week 6 Survey|Withdrawal by Subject|1|||
126436383|NCT04672239|454897042|FG001|Week 6 Survey|Withdrawal by Subject|1|||
126436384|NCT04672239|454897043|FG002|Week 6 Survey|Withdrawal by Subject|1|||
126436385|NCT04672239|454897041|FG000|Week 6 Survey|Withdrawn by PI|0|||
126436386|NCT04672239|454897042|FG001|Week 6 Survey|Withdrawn by PI|1|||
126436387|NCT04672239|454897043|FG002|Week 6 Survey|Withdrawn by PI|0|||
126436388|NCT04672239|454897041|FG000|Week 6 Survey|Lost to Follow-up|12|||
126436389|NCT04672239|454897042|FG001|Week 6 Survey|Lost to Follow-up|2|||
126436390|NCT04672239|454897043|FG002|Week 6 Survey|Lost to Follow-up|5|||
126436391|NCT04672239|454897041|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
126436392|NCT04672239|454897042|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
126436393|NCT04672239|454897043|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
126436394|NCT04672239|454897041|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
126436395|NCT04672239|454897042|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
126436396|NCT04672239|454897043|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
126436397|NCT04672239|454897041|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
126436398|NCT04672239|454897042|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
126436399|NCT04672239|454897043|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
126436400|NCT04672239|454897041|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
126436401|NCT04672239|454897042|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
126436402|NCT04672239|454897043|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
126436403|NCT04672239|454897041|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
126436404|NCT04672239|454897042|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
126436405|NCT04672239|454897043|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
126436406|NCT04672239|454897041|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
126436407|NCT04672239|454897042|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
126436408|NCT04672239|454897043|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
126436409|NCT04672239|454897041|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
126436410|NCT04672239|454897042|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
126436411|NCT04672239|454897043|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
126436412|NCT05408429|454897047|FG000|Overall Study|Lost to Follow-up|1|||
126436413|NCT05408429|454897048|FG001|Overall Study|Lost to Follow-up|1|||
126436414|NCT05408429|454897049|FG002|Overall Study|Lost to Follow-up|0|||
126436415|NCT05408429|454897047|FG000|Overall Study|Withdrawal by Subject|5|||
126436416|NCT05408429|454897048|FG001|Overall Study|Withdrawal by Subject|0|||
126436417|NCT05408429|454897049|FG002|Overall Study|Withdrawal by Subject|1|||
126436418|NCT01074970|454897051|FG000|Overall Study|Never Treated|0|||
126436419|NCT01074970|454897052|FG001|Overall Study|Never Treated|0|||
126436420|NCT01074970|454897053|FG002|Overall Study|Never Treated|8|||
126436421|NCT01074970|454897054|FG003|Overall Study|Never Treated|1|||
126436422|NCT01074970|454897051|FG000|Overall Study|Adverse Event|1|||
126436423|NCT01074970|454897052|FG001|Overall Study|Adverse Event|0|||
126436424|NCT01074970|454897053|FG002|Overall Study|Adverse Event|4|||
126436425|NCT01074970|454897054|FG003|Overall Study|Adverse Event|3|||
126436426|NCT01074970|454897051|FG000|Overall Study|Disease progression during treatment|3|||
126436427|NCT01074970|454897052|FG001|Overall Study|Disease progression during treatment|1|||
126436428|NCT01074970|454897053|FG002|Overall Study|Disease progression during treatment|2|||
126436429|NCT01074970|454897054|FG003|Overall Study|Disease progression during treatment|9|||
126436430|NCT01074970|454897051|FG000|Overall Study|Lost to Follow-up|0|||
126436431|NCT01074970|454897052|FG001|Overall Study|Lost to Follow-up|0|||
126436432|NCT01074970|454897053|FG002|Overall Study|Lost to Follow-up|1|||
126436433|NCT01074970|454897054|FG003|Overall Study|Lost to Follow-up|0|||
126436434|NCT01074970|454897051|FG000|Overall Study|Withdrawal by Subject|0|||
126436435|NCT01074970|454897052|FG001|Overall Study|Withdrawal by Subject|0|||
126436436|NCT01074970|454897053|FG002|Overall Study|Withdrawal by Subject|6|||
126436437|NCT01074970|454897054|FG003|Overall Study|Withdrawal by Subject|4|||
126436438|NCT05565742|454897059|FG000|Overall Study|Withdrawal by Subject|0|||
126436439|NCT05565742|454897060|FG001|Overall Study|Withdrawal by Subject|0|||
126436440|NCT05565742|454897061|FG002|Overall Study|Withdrawal by Subject|2|||
126436441|NCT05565742|454897062|FG003|Overall Study|Withdrawal by Subject|2|||
126436442|NCT05565742|454897063|FG004|Overall Study|Withdrawal by Subject|2|||
126436443|NCT05565742|454897059|FG000|Overall Study|Death|1|||
126436444|NCT05565742|454897060|FG001|Overall Study|Death|0|||
126436445|NCT05565742|454897061|FG002|Overall Study|Death|0|||
126436446|NCT05565742|454897062|FG003|Overall Study|Death|0|||
126436447|NCT05565742|454897063|FG004|Overall Study|Death|0|||
126436448|NCT05565742|454897059|FG000|Overall Study|Participant Travelled Abroad|0|||
126436449|NCT05565742|454897060|FG001|Overall Study|Participant Travelled Abroad|0|||
126436450|NCT05565742|454897061|FG002|Overall Study|Participant Travelled Abroad|0|||
126436451|NCT05565742|454897062|FG003|Overall Study|Participant Travelled Abroad|0|||
126436452|NCT05565742|454897063|FG004|Overall Study|Participant Travelled Abroad|1|||
126436453|NCT02855125|454897064|FG000|Overall Study|Withdrawal by Subject|2|||
126436454|NCT02855125|454897065|FG001|Overall Study|Withdrawal by Subject|2|||
126436455|NCT02855125|454897064|FG000|Overall Study|Clinical Disease Progression|5|||
126436456|NCT02855125|454897065|FG001|Overall Study|Clinical Disease Progression|4|||
126436457|NCT02855125|454897064|FG000|Overall Study|Radiologic Disease Progression|36|||
126436458|NCT02855125|454897065|FG001|Overall Study|Radiologic Disease Progression|39|||
126436459|NCT02855125|454897064|FG000|Overall Study|Adverse Event|11|||
126436460|NCT02855125|454897065|FG001|Overall Study|Adverse Event|7|||
126436461|NCT02855125|454897064|FG000|Overall Study|Physician Decision|1|||
126436462|NCT02855125|454897065|FG001|Overall Study|Physician Decision|0|||
126436463|NCT02855125|454897064|FG000|Overall Study|On Treatment|9|||
126436464|NCT02855125|454897065|FG001|Overall Study|On Treatment|11|||
126436465|NCT02855125|454897064|FG000|Overall Study|Randomized but not treated|0|||
126436466|NCT02855125|454897065|FG001|Overall Study|Randomized but not treated|1|||
126436467|NCT04467905|454897066|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
126436468|NCT04467905|454897067|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
126436469|NCT04467905|454897068|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
126436470|NCT04467905|454897066|FG000|Overall Study|Conversion to SR|0|||
126436471|NCT04467905|454897067|FG001|Overall Study|Conversion to SR|0|||
126436472|NCT04467905|454897068|FG002|Overall Study|Conversion to SR|3|||
126436473|NCT04467905|454897066|FG000|Overall Study|Technical issue with Holter ECG|0|||
126436474|NCT04467905|454897067|FG001|Overall Study|Technical issue with Holter ECG|0|||
126436475|NCT04467905|454897068|FG002|Overall Study|Technical issue with Holter ECG|3|||
126436476|NCT04467905|454897066|FG000|Overall Study|Hemodynamic instability|0|||
126436477|NCT04467905|454897067|FG001|Overall Study|Hemodynamic instability|0|||
126436478|NCT04467905|454897068|FG002|Overall Study|Hemodynamic instability|1|||
126436479|NCT04467905|454897066|FG000|Overall Study|Site misinterpretation of protocol|0|||
126436480|NCT04467905|454897067|FG001|Overall Study|Site misinterpretation of protocol|0|||
126436481|NCT04467905|454897068|FG002|Overall Study|Site misinterpretation of protocol|1|||
126436482|NCT05523089|454897071|FG000|Overall Study|Withdrawal by Subject|1|||
126681965|NCT01883635|455791408|FG000|Overall Study|Withdrawal by Subject|4|||
126681966|NCT01883635|455791409|FG001|Overall Study|Withdrawal by Subject|0|||
126681967|NCT01187953|455791410|FG000|Overall Study|Death|11|||
126681968|NCT01187953|455791411|FG001|Overall Study|Death|13|||
126681969|NCT01187953|455791410|FG000|Overall Study|Adverse Event|1|||
126681970|NCT01187953|455791411|FG001|Overall Study|Adverse Event|2|||
126681971|NCT01187953|455791410|FG000|Overall Study|Lost to Follow-up|0|||
126681972|NCT01187953|455791411|FG001|Overall Study|Lost to Follow-up|3|||
126681973|NCT01187953|455791410|FG000|Overall Study|Withdrawal by Subject|3|||
126681974|NCT01187953|455791411|FG001|Overall Study|Withdrawal by Subject|3|||
126681975|NCT01464307|455791412|FG000|Main Period|Death|0|||
126681976|NCT01464307|455791413|FG001|Main Period|Death|1|||
126681977|NCT01464307|455791412|FG000|Main Period|Adverse Event|6|||
126681978|NCT01464307|455791413|FG001|Main Period|Adverse Event|1|||
126681979|NCT01464307|455791412|FG000|Main Period|Lack of Efficacy|2|||
126681980|NCT01464307|455791413|FG001|Main Period|Lack of Efficacy|0|||
126681981|NCT01464307|455791412|FG000|Main Period|Withdrawal by Subject|5|||
126681982|NCT01464307|455791413|FG001|Main Period|Withdrawal by Subject|2|||
126681983|NCT01464307|455791412|FG000|Main Period|Predefined discontinuation criteria|2|||
126681984|NCT01464307|455791413|FG001|Main Period|Predefined discontinuation criteria|1|||
126681985|NCT01464307|455791412|FG000|Open-Label Extension Period|Adverse Event|15|||
126681986|NCT01464307|455791413|FG001|Open-Label Extension Period|Adverse Event|0|||
126681987|NCT01464307|455791412|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
126436483|NCT05523089|454897072|FG001|Overall Study|Withdrawal by Subject|0|||
126436484|NCT05523089|454897073|FG002|Overall Study|Withdrawal by Subject|0|||
126436485|NCT05523089|454897071|FG000|Overall Study|Lost to Follow-up|1|||
126436486|NCT05523089|454897072|FG001|Overall Study|Lost to Follow-up|0|||
126436487|NCT05523089|454897073|FG002|Overall Study|Lost to Follow-up|0|||
126436488|NCT02681523|454897074|FG000|Overall Study|Adverse Event|1|||
126436489|NCT02681523|454897074|FG000|Overall Study|Patient Non-compliance|1|||
126436490|NCT02638220|454897075|FG000|Overall Study|Lost to Follow-up|6|||
126436491|NCT02638220|454897075|FG000|Overall Study|Withdrawal by Subject|3|||
126436492|NCT02638220|454897075|FG000|Overall Study|Physician Decision|1|||
126436493|NCT02638220|454897075|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
126436494|NCT04323124|454897077|FG000|Overall Study|Adverse Event|0|||
126436495|NCT04323124|454897078|FG001|Overall Study|Adverse Event|0|||
126436496|NCT04323124|454897079|FG002|Overall Study|Adverse Event|0|||
126436497|NCT04323124|454897080|FG003|Overall Study|Adverse Event|0|||
126436498|NCT04323124|454897081|FG004|Overall Study|Adverse Event|0|||
126436499|NCT04323124|454897082|FG005|Overall Study|Adverse Event|1|||
126436500|NCT04323124|454897083|FG006|Overall Study|Adverse Event|0|||
126436501|NCT04323124|454897084|FG007|Overall Study|Adverse Event|1|||
126436502|NCT04323124|454897085|FG008|Overall Study|Adverse Event|1|||
126436503|NCT04323124|454897086|FG009|Overall Study|Adverse Event|0|||
126436504|NCT04323124|454897087|FG010|Overall Study|Adverse Event|0|||
126436505|NCT04323124|454897088|FG011|Overall Study|Adverse Event|0|||
126436506|NCT04323124|454897089|FG012|Overall Study|Adverse Event|0|||
126436507|NCT04323124|454897090|FG013|Overall Study|Adverse Event|0|||
126436508|NCT04323124|454897091|FG014|Overall Study|Adverse Event|0|||
126436509|NCT04323124|454897077|FG000|Overall Study|Other|0|||
126436510|NCT04323124|454897078|FG001|Overall Study|Other|0|||
126436511|NCT04323124|454897079|FG002|Overall Study|Other|0|||
126436512|NCT04323124|454897080|FG003|Overall Study|Other|0|||
126436513|NCT04323124|454897081|FG004|Overall Study|Other|1|||
126436514|NCT04323124|454897082|FG005|Overall Study|Other|0|||
126436515|NCT04323124|454897083|FG006|Overall Study|Other|0|||
126436516|NCT04323124|454897084|FG007|Overall Study|Other|0|||
126436517|NCT04323124|454897085|FG008|Overall Study|Other|1|||
126436518|NCT04323124|454897086|FG009|Overall Study|Other|0|||
126436519|NCT04323124|454897087|FG010|Overall Study|Other|0|||
126436520|NCT04323124|454897088|FG011|Overall Study|Other|0|||
126436521|NCT04323124|454897089|FG012|Overall Study|Other|0|||
126436522|NCT04323124|454897090|FG013|Overall Study|Other|0|||
126436523|NCT04323124|454897091|FG014|Overall Study|Other|0|||
126436524|NCT04323124|454897077|FG000|Overall Study|Coming from a red zone (COVID)|0|||
126436525|NCT04323124|454897078|FG001|Overall Study|Coming from a red zone (COVID)|0|||
126436526|NCT04323124|454897079|FG002|Overall Study|Coming from a red zone (COVID)|0|||
126436527|NCT04323124|454897080|FG003|Overall Study|Coming from a red zone (COVID)|0|||
126436528|NCT04323124|454897081|FG004|Overall Study|Coming from a red zone (COVID)|1|||
126436529|NCT04323124|454897082|FG005|Overall Study|Coming from a red zone (COVID)|1|||
126436530|NCT04323124|454897083|FG006|Overall Study|Coming from a red zone (COVID)|0|||
126436531|NCT04323124|454897084|FG007|Overall Study|Coming from a red zone (COVID)|0|||
126436532|NCT04323124|454897085|FG008|Overall Study|Coming from a red zone (COVID)|0|||
126436533|NCT04323124|454897086|FG009|Overall Study|Coming from a red zone (COVID)|0|||
126436534|NCT04323124|454897087|FG010|Overall Study|Coming from a red zone (COVID)|0|||
126436535|NCT04323124|454897088|FG011|Overall Study|Coming from a red zone (COVID)|0|||
126436536|NCT04323124|454897089|FG012|Overall Study|Coming from a red zone (COVID)|0|||
126436537|NCT04323124|454897090|FG013|Overall Study|Coming from a red zone (COVID)|0|||
126436538|NCT04323124|454897091|FG014|Overall Study|Coming from a red zone (COVID)|0|||
126436539|NCT04323124|454897077|FG000|Overall Study|No longer meets eligibility criteria|0|||
126436540|NCT04323124|454897078|FG001|Overall Study|No longer meets eligibility criteria|0|||
126436541|NCT04323124|454897079|FG002|Overall Study|No longer meets eligibility criteria|0|||
126436542|NCT04323124|454897080|FG003|Overall Study|No longer meets eligibility criteria|0|||
126436543|NCT04323124|454897081|FG004|Overall Study|No longer meets eligibility criteria|0|||
126436544|NCT04323124|454897082|FG005|Overall Study|No longer meets eligibility criteria|0|||
126436545|NCT04323124|454897083|FG006|Overall Study|No longer meets eligibility criteria|0|||
126436546|NCT04323124|454897084|FG007|Overall Study|No longer meets eligibility criteria|1|||
126436547|NCT04323124|454897085|FG008|Overall Study|No longer meets eligibility criteria|0|||
126681988|NCT01464307|455791413|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
126681989|NCT01464307|455791412|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
126681990|NCT01464307|455791413|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
126681991|NCT01464307|455791412|FG000|Open-Label Extension Period|Death|1|||
126681992|NCT01464307|455791413|FG001|Open-Label Extension Period|Death|0|||
126681993|NCT01464307|455791412|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
126681994|NCT01464307|455791413|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
126436548|NCT04323124|454897086|FG009|Overall Study|No longer meets eligibility criteria|0|||
126436549|NCT04323124|454897087|FG010|Overall Study|No longer meets eligibility criteria|0|||
126436550|NCT04323124|454897088|FG011|Overall Study|No longer meets eligibility criteria|0|||
126436551|NCT04323124|454897089|FG012|Overall Study|No longer meets eligibility criteria|0|||
126436552|NCT04323124|454897090|FG013|Overall Study|No longer meets eligibility criteria|1|||
126436553|NCT04323124|454897091|FG014|Overall Study|No longer meets eligibility criteria|1|||
126436554|NCT04323124|454897077|FG000|Overall Study|Study terminated by sponsor|0|||
126436555|NCT04323124|454897078|FG001|Overall Study|Study terminated by sponsor|0|||
126436556|NCT04323124|454897079|FG002|Overall Study|Study terminated by sponsor|0|||
126436557|NCT04323124|454897080|FG003|Overall Study|Study terminated by sponsor|0|||
126681995|NCT01464307|455791412|FG000|Open-Label Extension Period|Non-compliance|9|||
126681996|NCT01464307|455791413|FG001|Open-Label Extension Period|Non-compliance|0|||
126681997|NCT01464307|455791412|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
126681998|NCT01464307|455791413|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
126681999|NCT00761514|455791416|FG000|Overall Study|Adverse Event|1|||
126682000|NCT00761514|455791416|FG000|Overall Study|Withdrawal by Subject|2|||
126682001|NCT00761514|455791416|FG000|Overall Study|Lost to Follow-up|1|||
126682002|NCT00761514|455791416|FG000|Overall Study|Health insurance didn't cover study drug|1|||
126682003|NCT00761514|455791416|FG000|Overall Study|Problem complying with study visit|1|||
126682004|NCT00761514|455791416|FG000|Overall Study|Unable to pay for medications|1|||
126682005|NCT02457637|455791417|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
126682006|NCT04942925|455791420|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
126682007|NCT04942925|455791421|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
126682008|NCT04942925|455791420|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
126682009|NCT04942925|455791421|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
126682010|NCT01273883|455791422|FG000|First Intervention|Adverse Event|2|||
126682011|NCT01273883|455791423|FG001|First Intervention|Adverse Event|1|||
126682012|NCT01273883|455791422|FG000|Second Intervention|Lost to Follow-up|1|||
126682013|NCT01273883|455791423|FG001|Second Intervention|Lost to Follow-up|1|||
126682014|NCT01273883|455791422|FG000|Second Intervention|Lack of Efficacy|1|||
126682015|NCT01273883|455791423|FG001|Second Intervention|Lack of Efficacy|0|||
126682016|NCT03885089|455791425|FG000|Overall Study|No informed consent for publication of study results|2|||
126682017|NCT02043548|455791431|FG000|Overall Study|Lack of Efficacy|1|||
126682018|NCT02043548|455791432|FG001|Overall Study|Lack of Efficacy|0|||
126682019|NCT02043548|455791431|FG000|Overall Study|Adverse Event|0|||
126682020|NCT02043548|455791432|FG001|Overall Study|Adverse Event|1|||
126682021|NCT01430455|455791435|FG000|Overall Study|Withdrawal by Subject|1|||
126682022|NCT01430455|455791435|FG000|Overall Study|Switched to follow-up phase|1|||
126682023|NCT03829657|455791437|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
126682024|NCT03829657|455791438|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
126682025|NCT03829657|455791439|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
126682026|NCT03829657|455791440|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
126682027|NCT03829657|455791441|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
126682028|NCT03829657|455791437|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
126682029|NCT03829657|455791438|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
126682030|NCT03829657|455791439|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
126349730|NCT05168800|454572965|FG000|Time 2 Survey|Already excluded at Time 1|228|||
126349731|NCT05168800|454572966|FG001|Time 2 Survey|Already excluded at Time 1|202|||
126349732|NCT05168800|454572967|FG002|Time 2 Survey|Already excluded at Time 1|173|||
126349733|NCT05168800|454572965|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
126349734|NCT05168800|454572966|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
126349735|NCT05168800|454572967|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
126349736|NCT05168800|454572965|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
126349737|NCT05168800|454572966|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
126349738|NCT05168800|454572967|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
126349739|NCT05168800|454572965|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
126349740|NCT05168800|454572966|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
126349741|NCT05168800|454572967|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
126349742|NCT05168800|454572965|FG000|Time 2 Survey|Withdrawal by Subject|1|||
126349743|NCT05168800|454572966|FG001|Time 2 Survey|Withdrawal by Subject|0|||
126349744|NCT05168800|454572967|FG002|Time 2 Survey|Withdrawal by Subject|1|||
126349745|NCT05168800|454572965|FG000|Time 3 Survey|Already excluded at Time 1|228|||
126349746|NCT05168800|454572966|FG001|Time 3 Survey|Already excluded at Time 1|200|||
126349747|NCT05168800|454572967|FG002|Time 3 Survey|Already excluded at Time 1|173|||
126349748|NCT05168800|454572965|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
126349749|NCT05168800|454572966|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
126349750|NCT05168800|454572967|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
126349751|NCT05168800|454572965|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
126349752|NCT05168800|454572966|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
126349753|NCT05168800|454572967|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
126349754|NCT05168800|454572965|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
126349755|NCT05168800|454572966|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
126349756|NCT05168800|454572967|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
126682031|NCT03829657|455791440|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
126682032|NCT03829657|455791441|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
126682033|NCT03829657|455791437|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
126349757|NCT03240874|454572968|FG000|Overall Study|Lost to Follow-up|0|||
126349758|NCT03240874|454572969|FG001|Overall Study|Lost to Follow-up|2|||
126349759|NCT03240874|454572970|FG002|Overall Study|Lost to Follow-up|4|||
126349760|NCT03240874|454572971|FG003|Overall Study|Lost to Follow-up|1|||
126349761|NCT04958707|454572972|FG000|Post Intervention|Withdrawal by Subject|1|||
126349762|NCT04958707|454572973|FG001|Post Intervention|Withdrawal by Subject|0|||
126349763|NCT04958707|454572974|FG002|Post Intervention|Withdrawal by Subject|0|||
126349764|NCT04958707|454572972|FG000|3 Months Follow- up|Lost to Follow-up|0|||
126349765|NCT04958707|454572973|FG001|3 Months Follow- up|Lost to Follow-up|3|||
126349766|NCT04958707|454572974|FG002|3 Months Follow- up|Lost to Follow-up|0|||
126349767|NCT04958707|454572972|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
126349768|NCT04958707|454572973|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
126349769|NCT04958707|454572974|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
126349770|NCT00569127|454572975|FG000|Overall Study|Adverse Event|57|||
126349771|NCT00569127|454572976|FG001|Overall Study|Adverse Event|47|||
126349772|NCT00569127|454572975|FG000|Overall Study|Withdrawal by Subject|13|||
126349773|NCT00569127|454572976|FG001|Overall Study|Withdrawal by Subject|27|||
126349774|NCT00569127|454572975|FG000|Overall Study|Progression|99|||
126349775|NCT00569127|454572976|FG001|Overall Study|Progression|100|||
126349776|NCT00569127|454572975|FG000|Overall Study|Death|4|||
126349777|NCT00569127|454572976|FG001|Overall Study|Death|3|||
126349778|NCT00569127|454572975|FG000|Overall Study|Other|20|||
126349779|NCT00569127|454572976|FG001|Overall Study|Other|19|||
126349780|NCT00569127|454572975|FG000|Overall Study|Lost to Follow-up|0|||
126349781|NCT00569127|454572976|FG001|Overall Study|Lost to Follow-up|3|||
126349782|NCT00569127|454572975|FG000|Overall Study|Not Eligible|14|||
126349783|NCT00569127|454572976|FG001|Overall Study|Not Eligible|11|||
126349784|NCT00569127|454572975|FG000|Overall Study|Still on Treatment|7|||
126349785|NCT00569127|454572976|FG001|Overall Study|Still on Treatment|3|||
126349786|NCT04279522|454572978|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
126349787|NCT04279522|454572979|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
126349788|NCT04279522|454572978|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
126349789|NCT04279522|454572979|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
126349790|NCT04279522|454572978|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
126349791|NCT04279522|454572979|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
126349792|NCT04279522|454572978|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
126349793|NCT04279522|454572979|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
126349794|NCT04279522|454572978|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
126349795|NCT04279522|454572979|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
126349796|NCT04279522|454572978|FG000|Period 2: Open Label Phase|Physician Decision|0|||
126349797|NCT04279522|454572979|FG001|Period 2: Open Label Phase|Physician Decision|3|||
126349798|NCT04279522|454572978|FG000|Period 2: Open Label Phase|Adverse Event|0|||
126349799|NCT04279522|454572979|FG001|Period 2: Open Label Phase|Adverse Event|1|||
126349800|NCT04279522|454572978|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
126349801|NCT04279522|454572979|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
126349802|NCT02629159|454572982|FG000|Overall Study|Adverse Event|17|||
126682034|NCT03829657|455791438|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
126682035|NCT03829657|455791439|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
126682036|NCT03829657|455791440|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
126682037|NCT03829657|455791441|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
126682038|NCT03829657|455791437|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
126682039|NCT03829657|455791438|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
126682040|NCT03829657|455791439|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
126682041|NCT03829657|455791440|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
126682042|NCT03829657|455791441|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
126682043|NCT03829657|455791437|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
126682044|NCT03829657|455791438|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
126682045|NCT03829657|455791439|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
126682046|NCT03829657|455791440|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
126682047|NCT03829657|455791441|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
126682048|NCT03829657|455791437|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
126682049|NCT03829657|455791438|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
126682050|NCT03829657|455791439|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
126682051|NCT03829657|455791440|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
126682052|NCT03829657|455791441|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
126682053|NCT03829657|455791437|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
126682054|NCT03829657|455791438|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
126682055|NCT03829657|455791439|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
126682056|NCT03829657|455791440|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
126682057|NCT03829657|455791441|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
126682058|NCT03829657|455791437|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
126682059|NCT03829657|455791438|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
126682060|NCT03829657|455791439|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
126682061|NCT03829657|455791440|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
126682062|NCT03829657|455791441|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
126436558|NCT04323124|454897081|FG004|Overall Study|Study terminated by sponsor|0|||
126758674|NCT02406586|456066681|FG000|Overall Study|Lost to Follow-up|0|||
126682063|NCT03829657|455791437|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
126682064|NCT03829657|455791438|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
126682065|NCT03829657|455791439|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
126682066|NCT03829657|455791440|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
126682067|NCT03829657|455791441|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
126682068|NCT03829657|455791437|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
126682069|NCT03829657|455791438|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
126682070|NCT03829657|455791439|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
126682071|NCT03829657|455791440|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
126682072|NCT03829657|455791441|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
126682073|NCT01014689|455791442|FG000|Overall Study|Lack of Efficacy|0|||
126682074|NCT01014689|455791443|FG001|Overall Study|Lack of Efficacy|1|||
126682075|NCT01014689|455791442|FG000|Overall Study|Adverse Event|3|||
126682076|NCT01014689|455791443|FG001|Overall Study|Adverse Event|0|||
126682077|NCT01014689|455791442|FG000|Overall Study|Withdrawal by Subject|5|||
126682078|NCT01014689|455791443|FG001|Overall Study|Withdrawal by Subject|4|||
126682079|NCT01014689|455791442|FG000|Overall Study|Protocol Violation|1|||
126682080|NCT01014689|455791443|FG001|Overall Study|Protocol Violation|1|||
126682081|NCT01014689|455791442|FG000|Overall Study|Lost to Follow-up|3|||
126682082|NCT01014689|455791443|FG001|Overall Study|Lost to Follow-up|7|||
126682083|NCT01014689|455791442|FG000|Overall Study|Pregnancy|1|||
126682084|NCT01014689|455791443|FG001|Overall Study|Pregnancy|0|||
126682085|NCT02867995|455791446|FG000|Overall Study|Withdrawal by Subject|0|||
126682086|NCT02867995|455791447|FG001|Overall Study|Withdrawal by Subject|1|||
126682087|NCT02867995|455791446|FG000|Overall Study|Lost to Follow-up|0|||
126682088|NCT02867995|455791447|FG001|Overall Study|Lost to Follow-up|2|||
126349803|NCT02629159|454572983|FG001|Overall Study|Adverse Event|20|||
126349804|NCT02629159|454572984|FG002|Overall Study|Adverse Event|22|||
126349805|NCT02629159|454572982|FG000|Overall Study|Withdrawal by Subject|22|||
126349806|NCT02629159|454572983|FG001|Overall Study|Withdrawal by Subject|11|||
126349807|NCT02629159|454572984|FG002|Overall Study|Withdrawal by Subject|15|||
126349808|NCT02629159|454572982|FG000|Overall Study|Lost to Follow-up|7|||
126349809|NCT02629159|454572983|FG001|Overall Study|Lost to Follow-up|4|||
126349810|NCT02629159|454572984|FG002|Overall Study|Lost to Follow-up|5|||
126349811|NCT02629159|454572982|FG000|Overall Study|Lack of Efficacy|4|||
126349812|NCT02629159|454572983|FG001|Overall Study|Lack of Efficacy|0|||
126349813|NCT02629159|454572984|FG002|Overall Study|Lack of Efficacy|1|||
126349814|NCT02629159|454572982|FG000|Overall Study|Other|6|||
126349815|NCT02629159|454572983|FG001|Overall Study|Other|4|||
126349816|NCT02629159|454572984|FG002|Overall Study|Other|8|||
126349817|NCT03036254|454572989|FG000|Overall Study|Adverse Event|6|||
126349818|NCT03036254|454572990|FG001|Overall Study|Adverse Event|4|||
126349819|NCT03036254|454572989|FG000|Overall Study|Death|3|||
126349820|NCT03036254|454572990|FG001|Overall Study|Death|1|||
126349821|NCT03036254|454572989|FG000|Overall Study|Lack of Efficacy|5|||
126349822|NCT03036254|454572990|FG001|Overall Study|Lack of Efficacy|1|||
126349823|NCT03036254|454572989|FG000|Overall Study|Withdrawal by Subject|3|||
126349824|NCT03036254|454572990|FG001|Overall Study|Withdrawal by Subject|5|||
126349825|NCT04717557|454572999|FG000|Overall Study|Withdrawal by Subject|2|||
126349826|NCT04717557|454573000|FG001|Overall Study|Withdrawal by Subject|0|||
126349827|NCT04717557|454572999|FG000|Overall Study|Death|1|||
126349828|NCT04717557|454573000|FG001|Overall Study|Death|0|||
126349829|NCT05352399|454573002|FG000|Overall Study|Discontinued intervention|6|||
126349830|NCT01802281|454573005|FG000|Overall Study|Death|1|||
126349831|NCT01802281|454573006|FG001|Overall Study|Death|2|||
126349832|NCT01802281|454573005|FG000|Overall Study|Withdrawal by Subject|2|||
126349833|NCT01802281|454573006|FG001|Overall Study|Withdrawal by Subject|1|||
126349834|NCT01802281|454573005|FG000|Overall Study|Ineligible|5|||
126349835|NCT01802281|454573006|FG001|Overall Study|Ineligible|3|||
126349836|NCT02685735|454573007|FG000|Overall Study|Surgery Cancelled|4|||
126349837|NCT02685735|454573008|FG001|Overall Study|Surgery Cancelled|9|||
126349838|NCT02685735|454573007|FG000|Overall Study|Adverse Event|10|||
126349839|NCT02685735|454573008|FG001|Overall Study|Adverse Event|3|||
126349840|NCT02685735|454573007|FG000|Overall Study|Preop testing found to be incomplete|2|||
126349841|NCT02685735|454573008|FG001|Overall Study|Preop testing found to be incomplete|2|||
126349842|NCT02685735|454573007|FG000|Overall Study|Withdrawal by Subject|1|||
126349843|NCT02685735|454573008|FG001|Overall Study|Withdrawal by Subject|2|||
126349844|NCT02685735|454573007|FG000|Overall Study|Death|1|||
126349845|NCT02685735|454573008|FG001|Overall Study|Death|0|||
126349846|NCT00927472|454573018|FG000|Overall Study|Withdrawal by Subject|10|||
126349847|NCT00927472|454573019|FG001|Overall Study|Withdrawal by Subject|11|||
126349848|NCT00927472|454573018|FG000|Overall Study|Lost to Follow-up|1|||
126349849|NCT00927472|454573019|FG001|Overall Study|Lost to Follow-up|6|||
126349850|NCT00927472|454573018|FG000|Overall Study|Protocol Violation|0|||
126349851|NCT00927472|454573019|FG001|Overall Study|Protocol Violation|1|||
126349852|NCT00927472|454573018|FG000|Overall Study|Post treatment Assessment out of window|0|||
126682089|NCT02404103|455794529|FG000|Overall Study|Adverse Event|1|||
126682090|NCT02404103|455794530|FG001|Overall Study|Adverse Event|0|||
126682091|NCT02404103|455794529|FG000|Overall Study|Lost to Follow-up|3|||
126682092|NCT02404103|455794530|FG001|Overall Study|Lost to Follow-up|3|||
126682093|NCT00328627|455794531|FG000|Overall Study|Hyperglycemic Rescue|41|||
126682094|NCT00328627|455794532|FG001|Overall Study|Hyperglycemic Rescue|18|||
126682095|NCT00328627|455794533|FG002|Overall Study|Hyperglycemic Rescue|16|||
126682096|NCT00328627|455794534|FG003|Overall Study|Hyperglycemic Rescue|13|||
126682097|NCT00328627|455794535|FG004|Overall Study|Hyperglycemic Rescue|6|||
126436559|NCT04323124|454897082|FG005|Overall Study|Study terminated by sponsor|0|||
126682098|NCT00328627|455794536|FG005|Overall Study|Hyperglycemic Rescue|5|||
126682099|NCT00328627|455794537|FG006|Overall Study|Hyperglycemic Rescue|19|||
126682100|NCT00328627|455794538|FG007|Overall Study|Hyperglycemic Rescue|6|||
126436560|NCT04323124|454897083|FG006|Overall Study|Study terminated by sponsor|0|||
126682101|NCT00328627|455794539|FG008|Overall Study|Hyperglycemic Rescue|6|||
126682102|NCT00328627|455794540|FG009|Overall Study|Hyperglycemic Rescue|11|||
126682103|NCT00328627|455794541|FG010|Overall Study|Hyperglycemic Rescue|3|||
126682104|NCT00328627|455794542|FG011|Overall Study|Hyperglycemic Rescue|2|||
126682105|NCT00328627|455794531|FG000|Overall Study|Adverse Event|3|||
126682106|NCT00328627|455794532|FG001|Overall Study|Adverse Event|1|||
126682107|NCT00328627|455794533|FG002|Overall Study|Adverse Event|2|||
126682108|NCT00328627|455794534|FG003|Overall Study|Adverse Event|3|||
126349853|NCT00927472|454573019|FG001|Overall Study|Post treatment Assessment out of window|4|||
126349854|NCT04556097|454573020|FG000|Overall Study|Death|0|||
126349855|NCT04556097|454573021|FG001|Overall Study|Death|5|||
126349856|NCT04556097|454573022|FG002|Overall Study|Death|0|||
126349857|NCT04556097|454573023|FG003|Overall Study|Death|0|||
126349858|NCT04556097|454573020|FG000|Overall Study|No caregiver|43|||
126436561|NCT04323124|454897084|FG007|Overall Study|Study terminated by sponsor|0|||
126436562|NCT04323124|454897085|FG008|Overall Study|Study terminated by sponsor|0|||
126436563|NCT04323124|454897086|FG009|Overall Study|Study terminated by sponsor|0|||
126436564|NCT04323124|454897087|FG010|Overall Study|Study terminated by sponsor|0|||
126682109|NCT00328627|455794535|FG004|Overall Study|Adverse Event|1|||
126436565|NCT04323124|454897088|FG011|Overall Study|Study terminated by sponsor|2|||
126436566|NCT04323124|454897089|FG012|Overall Study|Study terminated by sponsor|1|||
126436567|NCT04323124|454897090|FG013|Overall Study|Study terminated by sponsor|0|||
126436568|NCT04323124|454897091|FG014|Overall Study|Study terminated by sponsor|0|||
126436569|NCT00489307|454897092|FG000|Overall Study|Death|1|||
126436570|NCT00489307|454897093|FG001|Overall Study|Death|1|||
126436571|NCT00489307|454897092|FG000|Overall Study|Lost to Follow-up|2|||
126436572|NCT00489307|454897093|FG001|Overall Study|Lost to Follow-up|2|||
126436573|NCT00489307|454897092|FG000|Overall Study|Physician Decision|1|||
126436574|NCT00489307|454897093|FG001|Overall Study|Physician Decision|0|||
126436575|NCT00489307|454897092|FG000|Overall Study|Withdrawal by Subject|2|||
126436576|NCT00489307|454897093|FG001|Overall Study|Withdrawal by Subject|4|||
126682110|NCT00328627|455794536|FG005|Overall Study|Adverse Event|2|||
126682111|NCT00328627|455794537|FG006|Overall Study|Adverse Event|1|||
126682112|NCT00328627|455794538|FG007|Overall Study|Adverse Event|2|||
126682113|NCT00328627|455794539|FG008|Overall Study|Adverse Event|0|||
126682114|NCT00328627|455794540|FG009|Overall Study|Adverse Event|7|||
126682115|NCT00328627|455794541|FG010|Overall Study|Adverse Event|5|||
126682116|NCT00328627|455794542|FG011|Overall Study|Adverse Event|4|||
126682117|NCT00328627|455794531|FG000|Overall Study|Protocol Violation|2|||
126682118|NCT00328627|455794532|FG001|Overall Study|Protocol Violation|2|||
126682119|NCT00328627|455794533|FG002|Overall Study|Protocol Violation|2|||
126682120|NCT00328627|455794534|FG003|Overall Study|Protocol Violation|8|||
126682121|NCT00328627|455794535|FG004|Overall Study|Protocol Violation|5|||
126682122|NCT00328627|455794536|FG005|Overall Study|Protocol Violation|5|||
126682123|NCT00328627|455794537|FG006|Overall Study|Protocol Violation|6|||
126682124|NCT00328627|455794538|FG007|Overall Study|Protocol Violation|2|||
126682125|NCT00328627|455794539|FG008|Overall Study|Protocol Violation|1|||
126682126|NCT00328627|455794540|FG009|Overall Study|Protocol Violation|4|||
126682127|NCT00328627|455794541|FG010|Overall Study|Protocol Violation|6|||
126682128|NCT00328627|455794542|FG011|Overall Study|Protocol Violation|2|||
126682129|NCT00328627|455794531|FG000|Overall Study|Lost to Follow-up|4|||
126682130|NCT00328627|455794532|FG001|Overall Study|Lost to Follow-up|2|||
126682131|NCT00328627|455794533|FG002|Overall Study|Lost to Follow-up|2|||
126682132|NCT00328627|455794534|FG003|Overall Study|Lost to Follow-up|4|||
126682133|NCT00328627|455794535|FG004|Overall Study|Lost to Follow-up|0|||
126682134|NCT00328627|455794536|FG005|Overall Study|Lost to Follow-up|2|||
126682135|NCT00328627|455794537|FG006|Overall Study|Lost to Follow-up|3|||
126682136|NCT00328627|455794538|FG007|Overall Study|Lost to Follow-up|0|||
126682137|NCT00328627|455794539|FG008|Overall Study|Lost to Follow-up|3|||
126682138|NCT00328627|455794540|FG009|Overall Study|Lost to Follow-up|2|||
126682139|NCT00328627|455794541|FG010|Overall Study|Lost to Follow-up|0|||
126682140|NCT00328627|455794542|FG011|Overall Study|Lost to Follow-up|1|||
126682141|NCT00328627|455794531|FG000|Overall Study|Withdrawal by Subject|5|||
126682142|NCT00328627|455794532|FG001|Overall Study|Withdrawal by Subject|4|||
126682143|NCT00328627|455794533|FG002|Overall Study|Withdrawal by Subject|5|||
126682144|NCT00328627|455794534|FG003|Overall Study|Withdrawal by Subject|6|||
126682145|NCT00328627|455794535|FG004|Overall Study|Withdrawal by Subject|2|||
126682146|NCT00328627|455794536|FG005|Overall Study|Withdrawal by Subject|5|||
126682147|NCT00328627|455794537|FG006|Overall Study|Withdrawal by Subject|4|||
126682148|NCT00328627|455794538|FG007|Overall Study|Withdrawal by Subject|4|||
126682149|NCT00328627|455794539|FG008|Overall Study|Withdrawal by Subject|4|||
126682150|NCT00328627|455794540|FG009|Overall Study|Withdrawal by Subject|5|||
126682151|NCT00328627|455794541|FG010|Overall Study|Withdrawal by Subject|2|||
126682152|NCT00328627|455794542|FG011|Overall Study|Withdrawal by Subject|7|||
126682153|NCT00328627|455794531|FG000|Overall Study|Pregnancy|0|||
126682154|NCT00328627|455794532|FG001|Overall Study|Pregnancy|1|||
126682155|NCT00328627|455794533|FG002|Overall Study|Pregnancy|0|||
126682156|NCT00328627|455794534|FG003|Overall Study|Pregnancy|0|||
126682157|NCT00328627|455794535|FG004|Overall Study|Pregnancy|0|||
126682158|NCT00328627|455794536|FG005|Overall Study|Pregnancy|0|||
126682159|NCT00328627|455794537|FG006|Overall Study|Pregnancy|0|||
126682160|NCT00328627|455794538|FG007|Overall Study|Pregnancy|0|||
126682161|NCT00328627|455794539|FG008|Overall Study|Pregnancy|0|||
126682162|NCT00328627|455794540|FG009|Overall Study|Pregnancy|0|||
126682163|NCT00328627|455794541|FG010|Overall Study|Pregnancy|0|||
126682164|NCT00328627|455794542|FG011|Overall Study|Pregnancy|0|||
126682165|NCT00328627|455794531|FG000|Overall Study|Physician Decision|4|||
126682166|NCT00328627|455794532|FG001|Overall Study|Physician Decision|3|||
126682167|NCT00328627|455794533|FG002|Overall Study|Physician Decision|1|||
126682168|NCT00328627|455794534|FG003|Overall Study|Physician Decision|2|||
126682169|NCT00328627|455794535|FG004|Overall Study|Physician Decision|1|||
126682170|NCT00328627|455794536|FG005|Overall Study|Physician Decision|1|||
126682171|NCT00328627|455794537|FG006|Overall Study|Physician Decision|1|||
126682172|NCT00328627|455794538|FG007|Overall Study|Physician Decision|0|||
126349859|NCT04556097|454573021|FG001|Overall Study|No caregiver|53|||
126349860|NCT04556097|454573022|FG002|Overall Study|No caregiver|0|||
126682173|NCT00328627|455794539|FG008|Overall Study|Physician Decision|3|||
126682174|NCT00328627|455794540|FG009|Overall Study|Physician Decision|2|||
126682175|NCT00328627|455794541|FG010|Overall Study|Physician Decision|1|||
126682176|NCT00328627|455794542|FG011|Overall Study|Physician Decision|0|||
126682177|NCT00328627|455794531|FG000|Overall Study|Other|0|||
126682178|NCT00328627|455794532|FG001|Overall Study|Other|0|||
126682179|NCT00328627|455794533|FG002|Overall Study|Other|0|||
126682180|NCT00328627|455794534|FG003|Overall Study|Other|1|||
126682181|NCT00328627|455794535|FG004|Overall Study|Other|0|||
126682182|NCT00328627|455794536|FG005|Overall Study|Other|0|||
126682183|NCT00328627|455794537|FG006|Overall Study|Other|1|||
126682184|NCT00328627|455794538|FG007|Overall Study|Other|0|||
126682185|NCT00328627|455794539|FG008|Overall Study|Other|0|||
126682186|NCT00328627|455794540|FG009|Overall Study|Other|1|||
126682187|NCT00328627|455794541|FG010|Overall Study|Other|1|||
126682188|NCT00328627|455794542|FG011|Overall Study|Other|0|||
126682189|NCT00522431|455794543|FG000|Overall Study|Adverse Event|5|||
126349861|NCT04556097|454573023|FG003|Overall Study|No caregiver|0|||
126349862|NCT04556097|454573020|FG000|Overall Study|Ineligible, SNF|2|||
126349863|NCT04556097|454573021|FG001|Overall Study|Ineligible, SNF|2|||
126349864|NCT04556097|454573022|FG002|Overall Study|Ineligible, SNF|0|||
126349865|NCT04556097|454573023|FG003|Overall Study|Ineligible, SNF|0|||
126349866|NCT04556097|454573020|FG000|Overall Study|Ineligible, health|3|||
126682190|NCT00522431|455794543|FG000|Overall Study|Protocol Violation|2|||
126682191|NCT00522431|455794543|FG000|Overall Study|Withdrawal by Subject|2|||
126682192|NCT00522431|455794543|FG000|Overall Study|Subject non-compliance|1|||
126682193|NCT00522431|455794543|FG000|Overall Study|Other/unknown|1|||
126349867|NCT04556097|454573021|FG001|Overall Study|Ineligible, health|4|||
126349868|NCT04556097|454573022|FG002|Overall Study|Ineligible, health|0|||
126349869|NCT04556097|454573023|FG003|Overall Study|Ineligible, health|0|||
126349870|NCT04556097|454573020|FG000|Overall Study|Ineligible, language|0|||
126682194|NCT01137773|455794544|FG000|Overall Study|Death|3|||
126682195|NCT01137773|455794545|FG001|Overall Study|Death|3|||
126682196|NCT01137773|455794544|FG000|Overall Study|Lost to Follow-up|6|||
126682197|NCT01137773|455794545|FG001|Overall Study|Lost to Follow-up|0|||
126682198|NCT03548558|455794546|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
126682199|NCT03548558|455794547|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
126682200|NCT03548558|455794548|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
126682201|NCT03548558|455794549|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
126682202|NCT03548558|455794550|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
126682203|NCT03548558|455794551|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
126682204|NCT03548558|455794552|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
126682205|NCT03548558|455794546|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
126682206|NCT03548558|455794547|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
126682207|NCT03548558|455794548|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
126682208|NCT03548558|455794549|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
126349871|NCT04556097|454573021|FG001|Overall Study|Ineligible, language|1|||
126682209|NCT03548558|455794550|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
126682210|NCT03548558|455794551|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
126682211|NCT03548558|455794552|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
126682212|NCT03548558|455794546|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
126682213|NCT03548558|455794547|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
126682214|NCT03548558|455794548|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
126682215|NCT03548558|455794549|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
126682216|NCT03548558|455794550|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
126682217|NCT03548558|455794551|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
126682218|NCT03548558|455794552|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
126682219|NCT03548558|455794546|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
126682220|NCT03548558|455794547|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
126682221|NCT03548558|455794548|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
126682222|NCT03548558|455794549|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
126682223|NCT03548558|455794550|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
126682224|NCT03548558|455794551|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
126682225|NCT03548558|455794552|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
126682226|NCT03548558|455794546|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
126682227|NCT03548558|455794547|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
126682228|NCT03548558|455794548|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
126682229|NCT03548558|455794549|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
126682230|NCT03548558|455794550|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
126682231|NCT03548558|455794551|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
126682232|NCT03548558|455794552|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
126682233|NCT03548558|455794546|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
126682234|NCT03548558|455794547|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
126682235|NCT03548558|455794548|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
126682236|NCT03548558|455794549|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
126682237|NCT03548558|455794550|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
126682238|NCT03548558|455794551|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
126682239|NCT03548558|455794552|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
126682240|NCT03273166|455794560|FG000|Overall Study|Withdrawn prior to Completion|31|||
126682241|NCT02669017|455794561|FG000|Overall Study|Death|1|||
126682242|NCT02669017|455794562|FG001|Overall Study|Death|2|||
126682243|NCT02669017|455794563|FG002|Overall Study|Death|2|||
126758675|NCT02406586|456066682|FG001|Overall Study|Lost to Follow-up|4|||
126758676|NCT02406586|456066683|FG002|Overall Study|Lost to Follow-up|2|||
126758677|NCT02406586|456066681|FG000|Overall Study|Withdrawal by Subject|1|||
126758678|NCT02406586|456066682|FG001|Overall Study|Withdrawal by Subject|0|||
126758679|NCT02406586|456066683|FG002|Overall Study|Withdrawal by Subject|0|||
126758680|NCT03382639|456066684|FG000|Overall Study|Adverse Event|2|||
126758681|NCT03382639|456066685|FG001|Overall Study|Adverse Event|0|||
126758682|NCT03382639|456066686|FG002|Overall Study|Adverse Event|1|||
126758683|NCT03382639|456066687|FG003|Overall Study|Adverse Event|1|||
126349872|NCT04556097|454573022|FG002|Overall Study|Ineligible, language|0|||
126349873|NCT04556097|454573023|FG003|Overall Study|Ineligible, language|0|||
126349874|NCT04556097|454573020|FG000|Overall Study|Ineligible, no longer in care management|0|||
126349875|NCT04556097|454573021|FG001|Overall Study|Ineligible, no longer in care management|2|||
126349876|NCT04556097|454573022|FG002|Overall Study|Ineligible, no longer in care management|1|||
126349877|NCT04556097|454573023|FG003|Overall Study|Ineligible, no longer in care management|0|||
126758684|NCT03382639|456066684|FG000|Overall Study|Lost to Follow-up|1|||
126682244|NCT02669017|455794564|FG003|Overall Study|Death|3|||
126682245|NCT02669017|455794565|FG004|Overall Study|Death|8|||
126682246|NCT02669017|455794566|FG005|Overall Study|Death|18|||
126682247|NCT02669017|455794567|FG006|Overall Study|Death|10|||
126682248|NCT02669017|455794568|FG007|Overall Study|Death|47|||
126682249|NCT02669017|455794569|FG008|Overall Study|Death|20|||
126682250|NCT02669017|455794561|FG000|Overall Study|Withdrawal by Subject|0|||
126682251|NCT02669017|455794562|FG001|Overall Study|Withdrawal by Subject|0|||
126682252|NCT02669017|455794563|FG002|Overall Study|Withdrawal by Subject|0|||
126682253|NCT02669017|455794564|FG003|Overall Study|Withdrawal by Subject|1|||
126682254|NCT02669017|455794565|FG004|Overall Study|Withdrawal by Subject|2|||
126682255|NCT02669017|455794566|FG005|Overall Study|Withdrawal by Subject|0|||
126682256|NCT02669017|455794567|FG006|Overall Study|Withdrawal by Subject|0|||
126682257|NCT02669017|455794568|FG007|Overall Study|Withdrawal by Subject|2|||
126682258|NCT02669017|455794569|FG008|Overall Study|Withdrawal by Subject|2|||
126682259|NCT02669017|455794561|FG000|Overall Study|Lost to Follow-up|0|||
126682260|NCT02669017|455794562|FG001|Overall Study|Lost to Follow-up|0|||
126682261|NCT02669017|455794563|FG002|Overall Study|Lost to Follow-up|0|||
126682262|NCT02669017|455794564|FG003|Overall Study|Lost to Follow-up|0|||
126682263|NCT02669017|455794565|FG004|Overall Study|Lost to Follow-up|0|||
126682264|NCT02669017|455794566|FG005|Overall Study|Lost to Follow-up|0|||
126682265|NCT02669017|455794567|FG006|Overall Study|Lost to Follow-up|0|||
126682266|NCT02669017|455794568|FG007|Overall Study|Lost to Follow-up|0|||
126682267|NCT02669017|455794569|FG008|Overall Study|Lost to Follow-up|1|||
126682268|NCT02669017|455794561|FG000|Overall Study|Miscellaneous|0|||
126682269|NCT02669017|455794562|FG001|Overall Study|Miscellaneous|0|||
126682270|NCT02669017|455794563|FG002|Overall Study|Miscellaneous|0|||
126682271|NCT02669017|455794564|FG003|Overall Study|Miscellaneous|0|||
126682272|NCT02669017|455794565|FG004|Overall Study|Miscellaneous|2|||
126682273|NCT02669017|455794566|FG005|Overall Study|Miscellaneous|1|||
126682274|NCT02669017|455794567|FG006|Overall Study|Miscellaneous|1|||
126682275|NCT02669017|455794568|FG007|Overall Study|Miscellaneous|13|||
126682276|NCT02669017|455794569|FG008|Overall Study|Miscellaneous|2|||
126682277|NCT01289015|455794570|FG000|Overall Study|Protocol Violation|12|||
126682278|NCT01289015|455794571|FG001|Overall Study|Protocol Violation|9|||
126682279|NCT01289015|455794570|FG000|Overall Study|Adverse Event|3|||
126682280|NCT01289015|455794571|FG001|Overall Study|Adverse Event|0|||
126682281|NCT01289015|455794570|FG000|Overall Study|Lost to Follow-up|33|||
126682282|NCT01289015|455794571|FG001|Overall Study|Lost to Follow-up|17|||
126682283|NCT01289015|455794570|FG000|Overall Study|Withdrawal by Subject|17|||
126682284|NCT01289015|455794571|FG001|Overall Study|Withdrawal by Subject|8|||
126682285|NCT01289015|455794570|FG000|Overall Study|Disease progression|1|||
126682286|NCT01289015|455794571|FG001|Overall Study|Disease progression|0|||
126682287|NCT01289015|455794570|FG000|Overall Study|Negative baseline culture and others|33|||
126682288|NCT01289015|455794571|FG001|Overall Study|Negative baseline culture and others|20|||
126682289|NCT03509350|455794576|FG000|Overall Study|Withdrawal by Subject|0|||
126682290|NCT03509350|455794577|FG001|Overall Study|Withdrawal by Subject|2|||
126682291|NCT01425203|455794578|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
126682292|NCT01425203|455794579|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
126682293|NCT01425203|455794580|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
126682294|NCT01425203|455794578|FG000|Treatment Phase|Failure at futility timepoint|8|||
126682295|NCT01425203|455794579|FG001|Treatment Phase|Failure at futility timepoint|27|||
126682296|NCT01425203|455794580|FG002|Treatment Phase|Failure at futility timepoint|0|||
126682297|NCT01425203|455794578|FG000|Treatment Phase|Other virologic failure criteria|5|||
126682298|NCT01425203|455794579|FG001|Treatment Phase|Other virologic failure criteria|3|||
126682299|NCT01425203|455794580|FG002|Treatment Phase|Other virologic failure criteria|0|||
126682300|NCT01425203|455794578|FG000|Treatment Phase|Unidentified reasons|11|||
126682301|NCT01425203|455794579|FG001|Treatment Phase|Unidentified reasons|5|||
126682302|NCT01425203|455794580|FG002|Treatment Phase|Unidentified reasons|0|||
126682303|NCT01425203|455794578|FG000|Treatment Phase|Did not receive treatment|0|||
126682304|NCT01425203|455794579|FG001|Treatment Phase|Did not receive treatment|1|||
126682305|NCT01425203|455794580|FG002|Treatment Phase|Did not receive treatment|0|||
126682306|NCT01425203|455794578|FG000|Crossover Phase|Failure at futility timepoint|0|||
126436577|NCT00489307|454897092|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
126436578|NCT00489307|454897093|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
126436579|NCT00489307|454897092|FG000|Overall Study|Surgery after assignment|1|||
126436580|NCT00489307|454897093|FG001|Overall Study|Surgery after assignment|0|||
126436581|NCT00489307|454897092|FG000|Overall Study|Did not fill up the forms|2|||
126682307|NCT01425203|455794579|FG001|Crossover Phase|Failure at futility timepoint|0|||
126682308|NCT01425203|455794580|FG002|Crossover Phase|Failure at futility timepoint|3|||
126682309|NCT01425203|455794578|FG000|Crossover Phase|Other virologic failure criteria|0|||
126682310|NCT01425203|455794579|FG001|Crossover Phase|Other virologic failure criteria|0|||
126682311|NCT01425203|455794580|FG002|Crossover Phase|Other virologic failure criteria|3|||
126682312|NCT00290433|455794585|FG000|Overall Study|Disease Progression|13|||
126682313|NCT00290433|455794585|FG000|Overall Study|Adverse Event|14|||
126682314|NCT00290433|455794585|FG000|Overall Study|Withdrawal by Subject|1|||
126436582|NCT00489307|454897093|FG001|Overall Study|Did not fill up the forms|1|||
126682315|NCT00290433|455794585|FG000|Overall Study|Non-Compliance|1|||
126682316|NCT00290433|455794585|FG000|Overall Study|Congestive Heart Failure|1|||
126682317|NCT00290433|455794585|FG000|Overall Study|Transplant in CR|5|||
126682318|NCT00290433|455794585|FG000|Overall Study|Unrelated Infection/Death|1|||
126682319|NCT03031301|455794588|FG000|Overall Study|Protocol Violation|4|||
126682320|NCT03031301|455794589|FG001|Overall Study|Protocol Violation|8|||
126682321|NCT03031301|455794588|FG000|Overall Study|Withdrawal by Subject|7|||
126682322|NCT03031301|455794589|FG001|Overall Study|Withdrawal by Subject|4|||
126682323|NCT03031301|455794588|FG000|Overall Study|Lost to Follow-up|4|||
126682324|NCT03031301|455794589|FG001|Overall Study|Lost to Follow-up|12|||
126682325|NCT03031301|455794588|FG000|Overall Study|Noncompliance|1|||
126682326|NCT03031301|455794589|FG001|Overall Study|Noncompliance|3|||
126682327|NCT03031301|455794588|FG000|Overall Study|Technical issue|1|||
126682328|NCT03031301|455794589|FG001|Overall Study|Technical issue|1|||
126682329|NCT03031301|455794588|FG000|Overall Study|Adverse Event|1|||
126682330|NCT03031301|455794589|FG001|Overall Study|Adverse Event|0|||
126682331|NCT00382993|455794596|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
126682332|NCT00382993|455794597|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
126682333|NCT00382993|455794596|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
126682334|NCT00382993|455794597|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
126682335|NCT00382993|455794596|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
126682336|NCT00382993|455794597|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
126682337|NCT00382993|455794596|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
126682338|NCT00382993|455794597|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
126682339|NCT00382993|455794596|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
126682340|NCT00382993|455794597|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
126682341|NCT00382993|455794596|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
126682342|NCT00382993|455794597|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
126682343|NCT00382993|455794596|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
126682344|NCT00382993|455794597|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
126682345|NCT00382993|455794596|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
126682346|NCT00382993|455794597|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
126682347|NCT00382993|455794596|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
126682348|NCT00382993|455794597|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
126682349|NCT00382993|455794596|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
126682350|NCT00382993|455794597|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
126682351|NCT02898259|455794598|FG000|Overall Study|Adverse Event|0|||
126682352|NCT02898259|455794599|FG001|Overall Study|Adverse Event|0|||
126682353|NCT02898259|455794600|FG002|Overall Study|Adverse Event|1|||
126682354|NCT02898259|455794601|FG003|Overall Study|Adverse Event|0|||
126682355|NCT02898259|455794602|FG004|Overall Study|Adverse Event|0|||
126682356|NCT02898259|455794598|FG000|Overall Study|Lack of Efficacy|1|||
126682357|NCT02898259|455794599|FG001|Overall Study|Lack of Efficacy|1|||
126682358|NCT02898259|455794600|FG002|Overall Study|Lack of Efficacy|3|||
126682359|NCT02898259|455794601|FG003|Overall Study|Lack of Efficacy|0|||
126682360|NCT02898259|455794602|FG004|Overall Study|Lack of Efficacy|0|||
126682361|NCT02898259|455794598|FG000|Overall Study|Lost to Follow-up|0|||
126682362|NCT02898259|455794599|FG001|Overall Study|Lost to Follow-up|0|||
126682363|NCT02898259|455794600|FG002|Overall Study|Lost to Follow-up|1|||
126682364|NCT02898259|455794601|FG003|Overall Study|Lost to Follow-up|0|||
126682365|NCT02898259|455794602|FG004|Overall Study|Lost to Follow-up|0|||
126682366|NCT02898259|455794598|FG000|Overall Study|Transformation before study began|0|||
126682367|NCT02898259|455794599|FG001|Overall Study|Transformation before study began|0|||
126682368|NCT02898259|455794600|FG002|Overall Study|Transformation before study began|0|||
126682369|NCT02898259|455794601|FG003|Overall Study|Transformation before study began|1|||
126682370|NCT02898259|455794602|FG004|Overall Study|Transformation before study began|0|||
126682371|NCT01046877|455794603|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
126436583|NCT00489307|454897092|FG000|Overall Study|Patient or family refusal|5|||
126436584|NCT00489307|454897093|FG001|Overall Study|Patient or family refusal|9|||
126436585|NCT03204188|454897096|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
126436586|NCT03204188|454897096|FG000|Immunotherapy Phase (1 Year)|Death|1|||
126436587|NCT03204188|454897096|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
126436588|NCT03204188|454897096|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
126436589|NCT02419001|454898614|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
126436590|NCT02419001|454898615|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
126682372|NCT01046877|455794603|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
126682373|NCT03016325|455794604|FG000|Treatment Period|Participant withdrew consent|0|||
126682374|NCT03016325|455794605|FG001|Treatment Period|Participant withdrew consent|1|||
126436591|NCT01198795|454898617|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
126436592|NCT01198795|454898617|FG000|Overall Study|Withdrawal by Subject|17|||
126682375|NCT03016325|455794606|FG002|Treatment Period|Participant withdrew consent|0|||
126682376|NCT03016325|455794607|FG003|Treatment Period|Participant withdrew consent|0|||
126682377|NCT03016325|455794608|FG004|Treatment Period|Participant withdrew consent|0|||
126682378|NCT03016325|455794609|FG005|Treatment Period|Participant withdrew consent|0|||
126682379|NCT03016325|455794610|FG006|Treatment Period|Participant withdrew consent|0|||
126682380|NCT03016325|455794611|FG007|Treatment Period|Participant withdrew consent|0|||
126682381|NCT03016325|455794604|FG000|Treatment Period|Death|0|||
126682382|NCT03016325|455794605|FG001|Treatment Period|Death|0|||
126682383|NCT03016325|455794606|FG002|Treatment Period|Death|0|||
126682384|NCT03016325|455794607|FG003|Treatment Period|Death|0|||
126682385|NCT03016325|455794608|FG004|Treatment Period|Death|2|||
126682386|NCT03016325|455794609|FG005|Treatment Period|Death|0|||
126682387|NCT03016325|455794610|FG006|Treatment Period|Death|0|||
126682388|NCT03016325|455794611|FG007|Treatment Period|Death|0|||
126682389|NCT03016325|455794604|FG000|Treatment Period|Participant refuses assessments|0|||
126682390|NCT03016325|455794605|FG001|Treatment Period|Participant refuses assessments|0|||
126682391|NCT03016325|455794606|FG002|Treatment Period|Participant refuses assessments|1|||
126682392|NCT03016325|455794607|FG003|Treatment Period|Participant refuses assessments|0|||
126682393|NCT03016325|455794608|FG004|Treatment Period|Participant refuses assessments|0|||
126682394|NCT03016325|455794609|FG005|Treatment Period|Participant refuses assessments|0|||
126682395|NCT03016325|455794610|FG006|Treatment Period|Participant refuses assessments|0|||
126682396|NCT03016325|455794611|FG007|Treatment Period|Participant refuses assessments|0|||
126682397|NCT03016325|455794604|FG000|32-Day Follow-Up Period|Death|2|||
126682398|NCT03016325|455794605|FG001|32-Day Follow-Up Period|Death|0|||
126682399|NCT03016325|455794606|FG002|32-Day Follow-Up Period|Death|5|||
126682400|NCT03016325|455794607|FG003|32-Day Follow-Up Period|Death|6|||
126682401|NCT03016325|455794608|FG004|32-Day Follow-Up Period|Death|3|||
126682402|NCT03016325|455794609|FG005|32-Day Follow-Up Period|Death|0|||
126682403|NCT03016325|455794610|FG006|32-Day Follow-Up Period|Death|0|||
126682404|NCT03016325|455794611|FG007|32-Day Follow-Up Period|Death|0|||
126682405|NCT03016325|455794604|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
126682406|NCT03016325|455794605|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
126682407|NCT03016325|455794606|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
126682408|NCT03016325|455794607|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
126682409|NCT03016325|455794608|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
126682410|NCT03016325|455794609|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
126682411|NCT03016325|455794610|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
126682412|NCT03016325|455794611|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
126682413|NCT03016325|455794604|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
126682414|NCT03016325|455794605|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
126682415|NCT03016325|455794606|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
126682416|NCT03016325|455794607|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
126682417|NCT03016325|455794608|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
126682418|NCT03016325|455794609|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
126682419|NCT03016325|455794610|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
126682420|NCT03016325|455794611|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
126682421|NCT03016325|455794604|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
126682422|NCT03016325|455794605|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
126682423|NCT03016325|455794606|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
126682424|NCT03016325|455794607|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
126682425|NCT03016325|455794608|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
126682426|NCT03016325|455794609|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
126682427|NCT03016325|455794610|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
126682428|NCT03016325|455794611|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
126682429|NCT03016325|455794604|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
126682430|NCT03016325|455794605|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
126682431|NCT03016325|455794606|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
126682432|NCT03016325|455794607|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
126682433|NCT03016325|455794608|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
126682434|NCT03016325|455794609|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
126682435|NCT03016325|455794610|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
126682436|NCT03016325|455794611|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
126682437|NCT03016325|455794604|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126682438|NCT03016325|455794605|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126682439|NCT03016325|455794606|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
126682440|NCT03016325|455794607|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126682441|NCT03016325|455794608|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126306161|NCT03689374|454408912|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
126682442|NCT03016325|455794609|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126682443|NCT03016325|455794610|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126682444|NCT03016325|455794611|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
126682445|NCT03016325|455794604|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126682446|NCT03016325|455794605|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
126682447|NCT03016325|455794606|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126682448|NCT03016325|455794607|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126682449|NCT03016325|455794608|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126682450|NCT03016325|455794609|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126682451|NCT03016325|455794610|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126682452|NCT03016325|455794611|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
126682453|NCT03016325|455794604|FG000|182-Day Follow-Up Period|Death|3|||
126682454|NCT03016325|455794605|FG001|182-Day Follow-Up Period|Death|3|||
126682455|NCT03016325|455794606|FG002|182-Day Follow-Up Period|Death|11|||
126682456|NCT03016325|455794607|FG003|182-Day Follow-Up Period|Death|12|||
126682457|NCT03016325|455794608|FG004|182-Day Follow-Up Period|Death|9|||
126682458|NCT03016325|455794609|FG005|182-Day Follow-Up Period|Death|0|||
126682459|NCT03016325|455794610|FG006|182-Day Follow-Up Period|Death|0|||
126682460|NCT03016325|455794611|FG007|182-Day Follow-Up Period|Death|1|||
126682461|NCT03016325|455794604|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
126682462|NCT03016325|455794605|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126682463|NCT03016325|455794606|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126682464|NCT03016325|455794607|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126682465|NCT03016325|455794608|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126682466|NCT03016325|455794609|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126682467|NCT03016325|455794610|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126682468|NCT03016325|455794611|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
126682469|NCT03016325|455794604|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
126682470|NCT03016325|455794605|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
126682471|NCT03016325|455794606|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
126682472|NCT03016325|455794607|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
126682473|NCT03016325|455794608|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
126682474|NCT03016325|455794609|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
126682475|NCT03016325|455794610|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
126682476|NCT03016325|455794611|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
126682477|NCT03016325|455794604|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126682478|NCT03016325|455794605|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126682479|NCT03016325|455794606|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126682480|NCT03016325|455794607|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126682481|NCT03016325|455794608|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
126682482|NCT03016325|455794609|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126682483|NCT03016325|455794610|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126682484|NCT03016325|455794611|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
126682485|NCT03016325|455794604|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
126682486|NCT03016325|455794605|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
126682487|NCT03016325|455794606|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
126682488|NCT03016325|455794607|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
126682489|NCT03016325|455794608|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
126682490|NCT03016325|455794609|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
126682491|NCT03016325|455794610|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
126682492|NCT03016325|455794611|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
126682493|NCT03016325|455794604|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126682494|NCT03016325|455794605|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126682495|NCT03016325|455794606|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126682496|NCT03016325|455794607|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
126682497|NCT03016325|455794608|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126682498|NCT03016325|455794609|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126682499|NCT03016325|455794610|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126682500|NCT03016325|455794611|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
126682501|NCT03016325|455794604|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126682502|NCT03016325|455794605|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
126682503|NCT03016325|455794606|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126682504|NCT03016325|455794607|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126349878|NCT04556097|454573020|FG000|Overall Study|No dementia|13|||
126436593|NCT01198795|454898617|FG000|Overall Study|Lost to Follow-up|15|||
126436594|NCT01198795|454898617|FG000|Overall Study|Adverse Event|9|||
126436595|NCT01198795|454898617|FG000|Overall Study|Lack of Efficacy|5|||
126436596|NCT01198795|454898617|FG000|Overall Study|Protocol Violation|2|||
126436597|NCT01198795|454898617|FG000|Overall Study|Other Reason|4|||
126436598|NCT00744497|454898618|FG000|Overall Study|Withdrawal by Subject|21|||
126436599|NCT00744497|454898619|FG001|Overall Study|Withdrawal by Subject|18|||
126436600|NCT00744497|454898618|FG000|Overall Study|Death|11|||
126436601|NCT00744497|454898619|FG001|Overall Study|Death|9|||
126436602|NCT00744497|454898618|FG000|Overall Study|Lost to Follow-up|4|||
126436603|NCT00744497|454898619|FG001|Overall Study|Lost to Follow-up|2|||
126436604|NCT00744497|454898618|FG000|Overall Study|Poor compliance/noncompliance|9|||
126436605|NCT00744497|454898619|FG001|Overall Study|Poor compliance/noncompliance|5|||
126436606|NCT00744497|454898618|FG000|Overall Study|No longer meets study criteria|7|||
126436607|NCT00744497|454898619|FG001|Overall Study|No longer meets study criteria|3|||
126436608|NCT00744497|454898618|FG000|Overall Study|Administrative Reason By Sponsor|25|||
126436609|NCT00744497|454898619|FG001|Overall Study|Administrative Reason By Sponsor|8|||
126436610|NCT00744497|454898618|FG000|Overall Study|Disease progression|312|||
126436611|NCT00744497|454898619|FG001|Overall Study|Disease progression|219|||
126436612|NCT00744497|454898618|FG000|Overall Study|Study drug toxicity|68|||
126436613|NCT00744497|454898619|FG001|Overall Study|Study drug toxicity|141|||
126436614|NCT00744497|454898618|FG000|Overall Study|Adverse event unrelated to study drug|78|||
126436615|NCT00744497|454898619|FG001|Overall Study|Adverse event unrelated to study drug|122|||
126682505|NCT03016325|455794608|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126682506|NCT03016325|455794609|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126682507|NCT03016325|455794610|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126682508|NCT03016325|455794611|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
126682509|NCT03016325|455794604|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
126682510|NCT03016325|455794605|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
126682511|NCT03016325|455794606|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
126682512|NCT03016325|455794607|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
126682513|NCT03016325|455794608|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
126682514|NCT03016325|455794609|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
126682515|NCT03016325|455794610|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
126682516|NCT03016325|455794611|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
126682517|NCT01902290|455794618|FG000|Overall Study|Withdrawal by Subject|19|||
126682518|NCT01902290|455794619|FG001|Overall Study|Withdrawal by Subject|27|||
126682519|NCT01902290|455794618|FG000|Overall Study|Lost to Follow-up|2|||
126682520|NCT01902290|455794619|FG001|Overall Study|Lost to Follow-up|2|||
126682521|NCT01902290|455794618|FG000|Overall Study|Death|1|||
126682522|NCT01902290|455794619|FG001|Overall Study|Death|0|||
126436616|NCT00744497|454898618|FG000|Overall Study|Patient requested to stop study drug|65|||
126436617|NCT00744497|454898619|FG001|Overall Study|Patient requested to stop study drug|80|||
126436618|NCT00744497|454898618|FG000|Overall Study|Maximum clinical benefit|141|||
126436619|NCT00744497|454898619|FG001|Overall Study|Maximum clinical benefit|142|||
126436620|NCT00744497|454898618|FG000|Overall Study|Not defined|19|||
126436621|NCT00744497|454898619|FG001|Overall Study|Not defined|13|||
126436622|NCT00936715|454898654|FG000|Overall Study|Investigators Discretion|1|||
126436623|NCT00936715|454898654|FG000|Overall Study|Protocol Violation|1|||
126436624|NCT00936715|454898654|FG000|Overall Study|Safety or Tolerability Reasons|4|||
126436625|NCT03819114|454898655|FG000|Overall Study|Protocol Violation|0|||
126436626|NCT03819114|454898656|FG001|Overall Study|Protocol Violation|1|||
126436627|NCT03819114|454898657|FG002|Overall Study|Protocol Violation|1|||
126436628|NCT03819114|454898658|FG003|Overall Study|Protocol Violation|0|||
126682523|NCT01902290|455794618|FG000|Overall Study|Sponsor Decision|26|||
126682524|NCT01902290|455794619|FG001|Overall Study|Sponsor Decision|24|||
126682525|NCT00109707|455794620|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
126682526|NCT00109707|455794621|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
126682527|NCT00109707|455794622|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
126682528|NCT00109707|455794620|FG000|Overall Study|Abnormal laboratory values|1|||
126682529|NCT00109707|455794621|FG001|Overall Study|Abnormal laboratory values|0|||
126682530|NCT00109707|455794622|FG002|Overall Study|Abnormal laboratory values|0|||
126682531|NCT00109707|455794620|FG000|Overall Study|Administrative problems|2|||
126436629|NCT03819114|454898655|FG000|Overall Study|Lost to Follow-up|0|||
126436630|NCT03819114|454898656|FG001|Overall Study|Lost to Follow-up|0|||
126436631|NCT03819114|454898657|FG002|Overall Study|Lost to Follow-up|1|||
126436632|NCT03819114|454898658|FG003|Overall Study|Lost to Follow-up|0|||
126436633|NCT02492763|454898659|FG000|Overall Study|Withdrawal by Subject|0|||
126436634|NCT02492763|454898660|FG001|Overall Study|Withdrawal by Subject|2|||
126436635|NCT02492763|454898661|FG002|Overall Study|Withdrawal by Subject|1|||
126682532|NCT00109707|455794621|FG001|Overall Study|Administrative problems|0|||
126682533|NCT00109707|455794622|FG002|Overall Study|Administrative problems|1|||
126682534|NCT00109707|455794620|FG000|Overall Study|Adverse Event|10|||
126682535|NCT00109707|455794621|FG001|Overall Study|Adverse Event|2|||
126682536|NCT00109707|455794622|FG002|Overall Study|Adverse Event|3|||
126682537|NCT00109707|455794620|FG000|Overall Study|Death|4|||
126682538|NCT00109707|455794621|FG001|Overall Study|Death|0|||
126682539|NCT00109707|455794622|FG002|Overall Study|Death|0|||
126682540|NCT00109707|455794620|FG000|Overall Study|Disease progression|12|||
126682541|NCT00109707|455794621|FG001|Overall Study|Disease progression|4|||
126682542|NCT00109707|455794622|FG002|Overall Study|Disease progression|3|||
126682543|NCT00109707|455794620|FG000|Overall Study|Lost to Follow-up|3|||
126682544|NCT00109707|455794621|FG001|Overall Study|Lost to Follow-up|0|||
126682545|NCT00109707|455794622|FG002|Overall Study|Lost to Follow-up|0|||
126682546|NCT00109707|455794620|FG000|Overall Study|Protocol Violation|1|||
126682547|NCT00109707|455794621|FG001|Overall Study|Protocol Violation|0|||
126682548|NCT00109707|455794622|FG002|Overall Study|Protocol Violation|0|||
126682549|NCT00109707|455794620|FG000|Overall Study|Patient withdrew consent|6|||
126682550|NCT00109707|455794621|FG001|Overall Study|Patient withdrew consent|1|||
126682551|NCT00109707|455794622|FG002|Overall Study|Patient withdrew consent|0|||
126682552|NCT02199080|455794626|FG000|Overall Study|Protocol Violation|12|||
126682553|NCT02250274|455794627|FG000|Overall Study|Insufficient blood draw amount|7|||
126682554|NCT02250274|455794628|FG001|Overall Study|Insufficient blood draw amount|6|||
126682555|NCT01277549|455794629|FG000|Overall Study|Failed to meet eligibility criteria|13|||
126682556|NCT01277549|455794630|FG001|Overall Study|Failed to meet eligibility criteria|9|||
126682557|NCT01277549|455794629|FG000|Overall Study|Withdrawal by Subject|1|||
126682558|NCT01277549|455794630|FG001|Overall Study|Withdrawal by Subject|3|||
126682559|NCT01277549|455794629|FG000|Overall Study|Protocol Violation|10|||
126682560|NCT01277549|455794630|FG001|Overall Study|Protocol Violation|1|||
126682561|NCT01277549|455794629|FG000|Overall Study|Physician Decision|2|||
126682562|NCT01277549|455794630|FG001|Overall Study|Physician Decision|1|||
126682563|NCT00446511|455794631|FG000|Overall Study|Adverse Event|7|||
126682564|NCT00446511|455794632|FG001|Overall Study|Adverse Event|2|||
126682565|NCT00446511|455794633|FG002|Overall Study|Adverse Event|3|||
126682566|NCT00446511|455794634|FG003|Overall Study|Adverse Event|1|||
126682567|NCT00446511|455794631|FG000|Overall Study|Protocol Violation|0|||
126682568|NCT00446511|455794632|FG001|Overall Study|Protocol Violation|0|||
126682569|NCT00446511|455794633|FG002|Overall Study|Protocol Violation|0|||
126682570|NCT00446511|455794634|FG003|Overall Study|Protocol Violation|1|||
126682571|NCT00446511|455794631|FG000|Overall Study|Withdrawal by Subject|0|||
126682572|NCT00446511|455794632|FG001|Overall Study|Withdrawal by Subject|0|||
126682573|NCT00446511|455794633|FG002|Overall Study|Withdrawal by Subject|0|||
126682574|NCT00446511|455794634|FG003|Overall Study|Withdrawal by Subject|3|||
126682575|NCT00446511|455794631|FG000|Overall Study|Administrative Problems|3|||
126682576|NCT00446511|455794632|FG001|Overall Study|Administrative Problems|0|||
126682577|NCT00446511|455794633|FG002|Overall Study|Administrative Problems|4|||
126682578|NCT00446511|455794634|FG003|Overall Study|Administrative Problems|1|||
126682579|NCT01618214|455794635|FG000|Overall Study|Adverse Event|3|||
126682580|NCT01618214|455794636|FG001|Overall Study|Adverse Event|1|||
126682581|NCT01618214|455794635|FG000|Overall Study|Lack of Efficacy|1|||
126682582|NCT01618214|455794636|FG001|Overall Study|Lack of Efficacy|1|||
126682583|NCT01618214|455794635|FG000|Overall Study|Protocol Violation|1|||
126682584|NCT01618214|455794636|FG001|Overall Study|Protocol Violation|4|||
126682585|NCT01618214|455794635|FG000|Overall Study|Withdrawal Criteria|1|||
126682586|NCT01618214|455794636|FG001|Overall Study|Withdrawal Criteria|2|||
126682587|NCT01618214|455794635|FG000|Overall Study|Unclassified|4|||
126682588|NCT01618214|455794636|FG001|Overall Study|Unclassified|5|||
126682589|NCT00574275|455794639|FG000|Overall Study|Randomized but not treated|2|||
126682590|NCT00574275|455794640|FG001|Overall Study|Randomized but not treated|3|||
126682591|NCT00574275|455794639|FG000|Overall Study|Adverse Event|32|||
126682592|NCT00574275|455794640|FG001|Overall Study|Adverse Event|76|||
126682593|NCT00574275|455794639|FG000|Overall Study|Disease progression|160|||
126682594|NCT00574275|455794640|FG001|Overall Study|Disease progression|146|||
126349879|NCT04556097|454573021|FG001|Overall Study|No dementia|3|||
126682595|NCT00574275|455794639|FG000|Overall Study|Lost to Follow-up|2|||
126682596|NCT00574275|455794640|FG001|Overall Study|Lost to Follow-up|1|||
126682597|NCT00574275|455794639|FG000|Overall Study|Study stopped based on DMC decision|62|||
126682598|NCT00574275|455794640|FG001|Overall Study|Study stopped based on DMC decision|23|||
126682599|NCT00574275|455794639|FG000|Overall Study|Withdrawal by Subject|15|||
126682600|NCT00574275|455794640|FG001|Overall Study|Withdrawal by Subject|17|||
126682601|NCT00574275|455794639|FG000|Overall Study|Error calculating tumor measurement|1|||
126682602|NCT00574275|455794640|FG001|Overall Study|Error calculating tumor measurement|0|||
126682603|NCT00574275|455794639|FG000|Overall Study|Physician Decision|1|||
126682604|NCT00574275|455794640|FG001|Overall Study|Physician Decision|1|||
126682605|NCT00574275|455794639|FG000|Overall Study|Protocol Violation|0|||
126349880|NCT04556097|454573022|FG002|Overall Study|No dementia|0|||
126349881|NCT04556097|454573023|FG003|Overall Study|No dementia|0|||
126349882|NCT04556097|454573020|FG000|Overall Study|Missing identifier|2|||
126682606|NCT00574275|455794640|FG001|Overall Study|Protocol Violation|1|||
126682607|NCT00574275|455794639|FG000|Overall Study|Patient and Investigator decision|0|||
126682608|NCT00574275|455794640|FG001|Overall Study|Patient and Investigator decision|1|||
126682609|NCT00574275|455794639|FG000|Overall Study|Insurance change|0|||
126682610|NCT00574275|455794640|FG001|Overall Study|Insurance change|1|||
126682611|NCT00574275|455794639|FG000|Overall Study|Operation for curative intent|0|||
126682612|NCT00574275|455794640|FG001|Overall Study|Operation for curative intent|1|||
126682613|NCT00652366|455794641|FG000|Overall Study|Adverse Event|8|||
126682614|NCT00652366|455794642|FG001|Overall Study|Adverse Event|4|||
126682615|NCT00652366|455794643|FG002|Overall Study|Adverse Event|7|||
126682616|NCT00652366|455794644|FG003|Overall Study|Adverse Event|17|||
126682617|NCT00652366|455794645|FG004|Overall Study|Adverse Event|13|||
126682618|NCT00652366|455794641|FG000|Overall Study|Death|5|||
126682619|NCT00652366|455794642|FG001|Overall Study|Death|4|||
126682620|NCT00652366|455794643|FG002|Overall Study|Death|1|||
126682621|NCT00652366|455794644|FG003|Overall Study|Death|8|||
126682622|NCT00652366|455794645|FG004|Overall Study|Death|5|||
126682623|NCT00652366|455794641|FG000|Overall Study|Lack of Efficacy|84|||
126682624|NCT00652366|455794642|FG001|Overall Study|Lack of Efficacy|58|||
126682625|NCT00652366|455794643|FG002|Overall Study|Lack of Efficacy|53|||
126682626|NCT00652366|455794644|FG003|Overall Study|Lack of Efficacy|133|||
126682627|NCT00652366|455794645|FG004|Overall Study|Lack of Efficacy|13|||
126682628|NCT00652366|455794641|FG000|Overall Study|Violation of Selection Criteria|0|||
126682629|NCT00652366|455794642|FG001|Overall Study|Violation of Selection Criteria|0|||
126682630|NCT00652366|455794643|FG002|Overall Study|Violation of Selection Criteria|1|||
126682631|NCT00652366|455794644|FG003|Overall Study|Violation of Selection Criteria|0|||
126682632|NCT00652366|455794645|FG004|Overall Study|Violation of Selection Criteria|0|||
126682633|NCT00652366|455794641|FG000|Overall Study|Protocol Violation|1|||
126682634|NCT00652366|455794642|FG001|Overall Study|Protocol Violation|0|||
126682635|NCT00652366|455794643|FG002|Overall Study|Protocol Violation|0|||
126682636|NCT00652366|455794644|FG003|Overall Study|Protocol Violation|0|||
126758685|NCT03382639|456066685|FG001|Overall Study|Lost to Follow-up|0|||
126758686|NCT03382639|456066686|FG002|Overall Study|Lost to Follow-up|0|||
126758687|NCT03382639|456066687|FG003|Overall Study|Lost to Follow-up|0|||
126758688|NCT03382639|456066684|FG000|Overall Study|Withdrawal by Subject|4|||
126758689|NCT03382639|456066685|FG001|Overall Study|Withdrawal by Subject|3|||
126758690|NCT03382639|456066686|FG002|Overall Study|Withdrawal by Subject|2|||
126758691|NCT03382639|456066687|FG003|Overall Study|Withdrawal by Subject|3|||
126758692|NCT03382639|456066684|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
126758693|NCT03382639|456066685|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
126758694|NCT03382639|456066686|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
126758695|NCT03382639|456066687|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
126758696|NCT03382639|456066684|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
126758697|NCT03382639|456066685|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
126758698|NCT03382639|456066686|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
126758699|NCT03382639|456066687|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
126758700|NCT03382639|456066684|FG000|Overall Study|Other|2|||
126758701|NCT03382639|456066685|FG001|Overall Study|Other|0|||
126758702|NCT03382639|456066686|FG002|Overall Study|Other|0|||
126758703|NCT03382639|456066687|FG003|Overall Study|Other|3|||
126758704|NCT03198559|456066690|FG000|Overall Study|Adverse Event|2|||
126758705|NCT01072175|456066691|FG000|Part A (Drug-Drug Interaction)|Death|1|||
126758706|NCT01072175|456066692|FG001|Part A (Drug-Drug Interaction)|Death|0|||
126758707|NCT01072175|456066693|FG002|Part A (Drug-Drug Interaction)|Death|0|||
126758708|NCT01072175|456066694|FG003|Part A (Drug-Drug Interaction)|Death|0|||
126758709|NCT01072175|456066695|FG004|Part A (Drug-Drug Interaction)|Death|0|||
126758710|NCT01072175|456066696|FG005|Part A (Drug-Drug Interaction)|Death|0|||
126758711|NCT01072175|456066697|FG006|Part A (Drug-Drug Interaction)|Death|0|||
126758712|NCT01072175|456066698|FG007|Part A (Drug-Drug Interaction)|Death|0|||
126758713|NCT01072175|456066699|FG008|Part A (Drug-Drug Interaction)|Death|0|||
126758714|NCT01072175|456066700|FG009|Part A (Drug-Drug Interaction)|Death|0|||
126758715|NCT01072175|456066701|FG010|Part A (Drug-Drug Interaction)|Death|0|||
126758716|NCT01072175|456066702|FG011|Part A (Drug-Drug Interaction)|Death|0|||
126758717|NCT01072175|456066703|FG012|Part A (Drug-Drug Interaction)|Death|0|||
126758718|NCT01072175|456066691|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
126758719|NCT01072175|456066692|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126758720|NCT01072175|456066693|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126758721|NCT01072175|456066694|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126682637|NCT00652366|455794645|FG004|Overall Study|Protocol Violation|0|||
126682638|NCT00652366|455794641|FG000|Overall Study|Refused treatment|3|||
126682639|NCT00652366|455794642|FG001|Overall Study|Refused treatment|7|||
126682640|NCT00652366|455794643|FG002|Overall Study|Refused treatment|6|||
126758722|NCT01072175|456066695|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126758723|NCT01072175|456066696|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126682641|NCT00652366|455794644|FG003|Overall Study|Refused treatment|17|||
126758724|NCT01072175|456066697|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126682642|NCT00652366|455794645|FG004|Overall Study|Refused treatment|5|||
126682643|NCT00652366|455794641|FG000|Overall Study|Other|5|||
126682644|NCT00652366|455794642|FG001|Overall Study|Other|2|||
126682645|NCT00652366|455794643|FG002|Overall Study|Other|3|||
126682646|NCT00652366|455794644|FG003|Overall Study|Other|4|||
126682647|NCT00652366|455794645|FG004|Overall Study|Other|0|||
126682648|NCT00137111|455794651|FG000|Total Therapy|Death|35|||
126682649|NCT00137111|455794652|FG001|Total Therapy|Death|0|||
126682650|NCT00137111|455794653|FG002|Total Therapy|Death|0|||
126682651|NCT00137111|455794654|FG003|Total Therapy|Death|0|||
126682652|NCT00137111|455794651|FG000|Total Therapy|Non Compliance|5|||
126682653|NCT00137111|455794652|FG001|Total Therapy|Non Compliance|0|||
126682654|NCT00137111|455794653|FG002|Total Therapy|Non Compliance|0|||
126682655|NCT00137111|455794654|FG003|Total Therapy|Non Compliance|0|||
126682656|NCT04703075|455794655|FG000|Overall Study|Adverse Event|11|||
126682657|NCT04703075|455794656|FG001|Overall Study|Adverse Event|7|||
126682658|NCT04703075|455794655|FG000|Overall Study|Lost to Follow-up|6|||
126682659|NCT04703075|455794656|FG001|Overall Study|Lost to Follow-up|12|||
126682660|NCT04703075|455794655|FG000|Overall Study|Physician Decision|3|||
126682661|NCT04703075|455794656|FG001|Overall Study|Physician Decision|0|||
126682662|NCT04703075|455794655|FG000|Overall Study|Moved|0|||
126682663|NCT04703075|455794656|FG001|Overall Study|Moved|2|||
126682664|NCT04703075|455794655|FG000|Overall Study|Index INH Resistant|0|||
126682665|NCT04703075|455794656|FG001|Overall Study|Index INH Resistant|1|||
126682666|NCT04703075|455794655|FG000|Overall Study|Lack of Efficacy|6|||
126682667|NCT04703075|455794656|FG001|Overall Study|Lack of Efficacy|18|||
126682668|NCT02425826|455794661|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
126682669|NCT02425826|455794662|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
126682670|NCT02425826|455794663|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
126682671|NCT02425826|455794661|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
126682672|NCT02425826|455794662|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
126682673|NCT02425826|455794663|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
126758725|NCT01072175|456066698|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126758726|NCT01072175|456066699|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126758727|NCT01072175|456066700|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126758728|NCT01072175|456066701|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126758729|NCT01072175|456066702|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126758730|NCT01072175|456066703|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
126758731|NCT01072175|456066691|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
126758732|NCT01072175|456066692|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126758733|NCT01072175|456066693|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126758734|NCT01072175|456066694|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126758735|NCT01072175|456066695|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126758736|NCT01072175|456066696|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126758737|NCT01072175|456066697|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126758738|NCT01072175|456066698|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126758739|NCT01072175|456066699|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126758740|NCT01072175|456066700|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126758741|NCT01072175|456066701|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126758742|NCT01072175|456066702|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126758743|NCT01072175|456066703|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
126758744|NCT01072175|456066691|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
126758745|NCT01072175|456066692|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
126758746|NCT01072175|456066693|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
126758747|NCT01072175|456066694|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
126758748|NCT01072175|456066695|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
126758749|NCT01072175|456066696|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
126758750|NCT01072175|456066697|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
126682674|NCT02425826|455794661|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
126758751|NCT01072175|456066698|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
126682675|NCT02425826|455794662|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
126682676|NCT02425826|455794663|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
126436636|NCT02492763|454898662|FG003|Overall Study|Withdrawal by Subject|0|||
126436637|NCT02492763|454898659|FG000|Overall Study|Adverse Event|3|||
126436638|NCT02492763|454898660|FG001|Overall Study|Adverse Event|1|||
126436639|NCT02492763|454898661|FG002|Overall Study|Adverse Event|1|||
126436640|NCT02492763|454898662|FG003|Overall Study|Adverse Event|2|||
126436641|NCT02492763|454898659|FG000|Overall Study|Death|0|||
126436642|NCT02492763|454898660|FG001|Overall Study|Death|0|||
126436643|NCT02492763|454898661|FG002|Overall Study|Death|1|||
126436644|NCT02492763|454898662|FG003|Overall Study|Death|0|||
126436645|NCT02492763|454898659|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
126436646|NCT02492763|454898660|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
126436647|NCT02492763|454898661|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
126436648|NCT02492763|454898662|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
126436649|NCT02492763|454898659|FG000|Overall Study|Lost to Follow-up|0|||
126436650|NCT02492763|454898660|FG001|Overall Study|Lost to Follow-up|0|||
126436651|NCT02492763|454898661|FG002|Overall Study|Lost to Follow-up|1|||
126436652|NCT02492763|454898662|FG003|Overall Study|Lost to Follow-up|0|||
126436653|NCT02492763|454898659|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126436654|NCT02492763|454898660|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126436655|NCT02492763|454898661|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126436656|NCT02492763|454898662|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126436657|NCT02492763|454898659|FG000|Overall Study|Screen Failure|0|||
126436658|NCT02492763|454898660|FG001|Overall Study|Screen Failure|0|||
126436659|NCT02492763|454898661|FG002|Overall Study|Screen Failure|0|||
126436660|NCT02492763|454898662|FG003|Overall Study|Screen Failure|1|||
126436661|NCT02492763|454898659|FG000|Overall Study|Study Terminated by Sponsor|13|||
126436662|NCT02492763|454898660|FG001|Overall Study|Study Terminated by Sponsor|10|||
126436663|NCT02492763|454898661|FG002|Overall Study|Study Terminated by Sponsor|6|||
126436664|NCT02492763|454898662|FG003|Overall Study|Study Terminated by Sponsor|10|||
126436665|NCT01337960|454898663|FG000|Overall Study|Lost to Follow-up|1|||
126436666|NCT01337960|454898664|FG001|Overall Study|Lost to Follow-up|0|||
126436667|NCT01337960|454898665|FG002|Overall Study|Lost to Follow-up|0|||
126436668|NCT01337960|454898663|FG000|Overall Study|Withdrawal by Subject|1|||
126436669|NCT01337960|454898664|FG001|Overall Study|Withdrawal by Subject|0|||
126436670|NCT01337960|454898665|FG002|Overall Study|Withdrawal by Subject|0|||
126436671|NCT01772316|454898666|FG000|Overall Study|Serious adverse event|1|||
126436672|NCT01772316|454898666|FG000|Overall Study|Inform consent withdrawn|1|||
126436673|NCT01772316|454898666|FG000|Overall Study|Withdrawn by sponsor decision|5|||
126436674|NCT01747876|454898668|FG000|Overall Study|Adverse Event|1|||
126436675|NCT01747876|454898669|FG001|Overall Study|Adverse Event|0|||
126436676|NCT01747876|454898670|FG002|Overall Study|Adverse Event|2|||
126436677|NCT01747876|454898668|FG000|Overall Study|Withdrawal by Subject|0|||
126436678|NCT01747876|454898669|FG001|Overall Study|Withdrawal by Subject|1|||
126758752|NCT01072175|456066699|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
126758753|NCT01072175|456066700|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
126758754|NCT01072175|456066701|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
126758755|NCT01072175|456066702|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
126758756|NCT01072175|456066703|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
126758757|NCT01072175|456066691|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126758758|NCT01072175|456066692|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126758759|NCT01072175|456066693|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
126758760|NCT01072175|456066694|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126758761|NCT01072175|456066695|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
126758762|NCT01072175|456066696|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126758763|NCT01072175|456066697|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126758764|NCT01072175|456066698|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126758765|NCT01072175|456066699|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126758766|NCT01072175|456066700|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126758767|NCT01072175|456066701|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126758768|NCT01072175|456066702|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126758769|NCT01072175|456066703|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
126758770|NCT01072175|456066691|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126758771|NCT01072175|456066692|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
126758772|NCT01072175|456066693|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126758773|NCT01072175|456066694|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
126436679|NCT01747876|454898670|FG002|Overall Study|Withdrawal by Subject|1|||
126436680|NCT01747876|454898668|FG000|Overall Study|Disease progression|4|||
126436681|NCT01747876|454898669|FG001|Overall Study|Disease progression|13|||
126436682|NCT01747876|454898670|FG002|Overall Study|Disease progression|8|||
126436683|NCT01747876|454898668|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
126436684|NCT01747876|454898669|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
126436685|NCT01747876|454898670|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
126436686|NCT02379728|454898673|FG000|Overall Study|Lost to Follow-up|1|||
126682677|NCT02425826|455794661|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
126682678|NCT02425826|455794662|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
126682679|NCT02425826|455794663|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
126682680|NCT02425826|455794661|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
126682681|NCT02425826|455794662|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
126682682|NCT02425826|455794663|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
126682683|NCT02425826|455794661|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
126682684|NCT02425826|455794662|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
126682685|NCT02425826|455794663|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
126682686|NCT02425826|455794661|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
126682687|NCT02425826|455794662|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
126682688|NCT02425826|455794663|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
126682689|NCT02425826|455794661|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
126682690|NCT02425826|455794662|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
126682691|NCT02425826|455794663|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
126682692|NCT02425826|455794661|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
126682693|NCT02425826|455794662|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
126682694|NCT02425826|455794663|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
126682695|NCT02425826|455794661|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
126682696|NCT02425826|455794662|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
126682697|NCT02425826|455794663|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
126682698|NCT01836783|455794666|FG000|Overall Study|Withdrawal by Subject|0|||
126682699|NCT01836783|455794667|FG001|Overall Study|Withdrawal by Subject|2|||
126682700|NCT02124564|455794672|FG000|Treatment Period|Adverse Event|2|||
126682701|NCT02124564|455794672|FG000|Treatment Period|Lack of Efficacy|3|||
126682702|NCT02124564|455794672|FG000|Treatment Period|Withdrawal by Subject|2|||
126682703|NCT01425008|455794679|FG000|Dose Escalation Phase|Progressive Disease|2|||
126682704|NCT01425008|455794680|FG001|Dose Escalation Phase|Progressive Disease|3|||
126682705|NCT01425008|455794681|FG002|Dose Escalation Phase|Progressive Disease|2|||
126682706|NCT01425008|455794682|FG003|Dose Escalation Phase|Progressive Disease|3|||
126682707|NCT01425008|455794683|FG004|Dose Escalation Phase|Progressive Disease|5|||
126682708|NCT01425008|455794684|FG005|Dose Escalation Phase|Progressive Disease|4|||
126682709|NCT01425008|455794685|FG006|Dose Escalation Phase|Progressive Disease|0|||
126682710|NCT01425008|455794686|FG007|Dose Escalation Phase|Progressive Disease|2|||
126682711|NCT01425008|455794687|FG008|Dose Escalation Phase|Progressive Disease|6|||
126682712|NCT01425008|455794688|FG009|Dose Escalation Phase|Progressive Disease|2|||
126682713|NCT01425008|455794689|FG010|Dose Escalation Phase|Progressive Disease|0|||
126682714|NCT01425008|455794690|FG011|Dose Escalation Phase|Progressive Disease|0|||
126682715|NCT01425008|455794691|FG012|Dose Escalation Phase|Progressive Disease|0|||
126682716|NCT01425008|455794692|FG013|Dose Escalation Phase|Progressive Disease|0|||
126682717|NCT01425008|455794693|FG014|Dose Escalation Phase|Progressive Disease|0|||
126682718|NCT01425008|455794694|FG015|Dose Escalation Phase|Progressive Disease|0|||
126682719|NCT01425008|455794695|FG016|Dose Escalation Phase|Progressive Disease|0|||
126682720|NCT01425008|455794696|FG017|Dose Escalation Phase|Progressive Disease|0|||
126682721|NCT01425008|455794697|FG018|Dose Escalation Phase|Progressive Disease|0|||
126682722|NCT01425008|455794679|FG000|Dose Escalation Phase|Adverse Event|2|||
126682723|NCT01425008|455794680|FG001|Dose Escalation Phase|Adverse Event|0|||
126682724|NCT01425008|455794681|FG002|Dose Escalation Phase|Adverse Event|0|||
126682725|NCT01425008|455794682|FG003|Dose Escalation Phase|Adverse Event|0|||
126682726|NCT01425008|455794683|FG004|Dose Escalation Phase|Adverse Event|0|||
126682727|NCT01425008|455794684|FG005|Dose Escalation Phase|Adverse Event|2|||
126682728|NCT01425008|455794685|FG006|Dose Escalation Phase|Adverse Event|0|||
126682729|NCT01425008|455794686|FG007|Dose Escalation Phase|Adverse Event|0|||
126682730|NCT01425008|455794687|FG008|Dose Escalation Phase|Adverse Event|2|||
126682731|NCT01425008|455794688|FG009|Dose Escalation Phase|Adverse Event|0|||
126436687|NCT02379728|454898674|FG001|Overall Study|Lost to Follow-up|0|||
126436688|NCT02379728|454898675|FG002|Overall Study|Lost to Follow-up|3|||
126436689|NCT02379728|454898676|FG003|Overall Study|Lost to Follow-up|0|||
126436690|NCT02379728|454898673|FG000|Overall Study|Withdrawal by Subject|5|||
126436691|NCT02379728|454898674|FG001|Overall Study|Withdrawal by Subject|0|||
126436692|NCT02379728|454898675|FG002|Overall Study|Withdrawal by Subject|5|||
126436693|NCT02379728|454898676|FG003|Overall Study|Withdrawal by Subject|3|||
126436694|NCT02379728|454898673|FG000|Overall Study|Protocol Violation|0|||
126436695|NCT02379728|454898674|FG001|Overall Study|Protocol Violation|0|||
126436696|NCT02379728|454898675|FG002|Overall Study|Protocol Violation|2|||
126682732|NCT01425008|455794689|FG010|Dose Escalation Phase|Adverse Event|0|||
126682733|NCT01425008|455794690|FG011|Dose Escalation Phase|Adverse Event|0|||
126436697|NCT02379728|454898676|FG003|Overall Study|Protocol Violation|0|||
126436698|NCT00914316|454898679|FG000|Phase 1|Physician Decision|4|||
126682734|NCT01425008|455794691|FG012|Dose Escalation Phase|Adverse Event|0|||
126436699|NCT00914316|454898680|FG001|Phase 1|Physician Decision|0|||
126436700|NCT00914316|454898681|FG002|Phase 1|Physician Decision|1|||
126682735|NCT01425008|455794692|FG013|Dose Escalation Phase|Adverse Event|0|||
126682736|NCT01425008|455794693|FG014|Dose Escalation Phase|Adverse Event|0|||
126682737|NCT01425008|455794694|FG015|Dose Escalation Phase|Adverse Event|0|||
126682738|NCT01425008|455794695|FG016|Dose Escalation Phase|Adverse Event|0|||
126682739|NCT01425008|455794696|FG017|Dose Escalation Phase|Adverse Event|0|||
126682740|NCT01425008|455794697|FG018|Dose Escalation Phase|Adverse Event|0|||
126682741|NCT01425008|455794679|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682742|NCT01425008|455794680|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682743|NCT01425008|455794681|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682744|NCT01425008|455794682|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682745|NCT01425008|455794683|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
126682746|NCT01425008|455794684|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682747|NCT01425008|455794685|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
126682748|NCT01425008|455794686|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
126682749|NCT01425008|455794687|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
126682750|NCT01425008|455794688|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682751|NCT01425008|455794689|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682752|NCT01425008|455794690|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682753|NCT01425008|455794691|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682754|NCT01425008|455794692|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682755|NCT01425008|455794693|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682756|NCT01425008|455794694|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682757|NCT01425008|455794695|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682758|NCT01425008|455794696|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126682759|NCT01425008|455794697|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126349883|NCT04556097|454573021|FG001|Overall Study|Missing identifier|4|||
126349884|NCT04556097|454573022|FG002|Overall Study|Missing identifier|0|||
126349885|NCT04556097|454573023|FG003|Overall Study|Missing identifier|0|||
126349886|NCT04556097|454573020|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
126349887|NCT04556097|454573021|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
126349888|NCT04556097|454573022|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
126349889|NCT04556097|454573023|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
126349890|NCT02516241|454573029|FG000|Overall Study|Death|255|||
126349891|NCT02516241|454573030|FG001|Overall Study|Death|262|||
126349892|NCT02516241|454573031|FG002|Overall Study|Death|270|||
126349893|NCT02516241|454573029|FG000|Overall Study|Lost to Follow-up|1|||
126349894|NCT02516241|454573030|FG001|Overall Study|Lost to Follow-up|1|||
126349895|NCT02516241|454573031|FG002|Overall Study|Lost to Follow-up|3|||
126349896|NCT02516241|454573029|FG000|Overall Study|Withdrawal by Subject|2|||
126349897|NCT02516241|454573030|FG001|Overall Study|Withdrawal by Subject|7|||
126349898|NCT02516241|454573031|FG002|Overall Study|Withdrawal by Subject|12|||
126349899|NCT02516241|454573029|FG000|Overall Study|participants ongoing at data cut-off|84|||
126349900|NCT02516241|454573030|FG001|Overall Study|participants ongoing at data cut-off|76|||
126349901|NCT02516241|454573031|FG002|Overall Study|participants ongoing at data cut-off|59|||
126349902|NCT03228537|454573032|FG000|Neoadjuvant|Adverse Event|2|||
126349903|NCT03228537|454573032|FG000|Neoadjuvant|Progression/Relapse|4|||
126349904|NCT03228537|454573032|FG000|Neoadjuvant|Death|1|||
126349905|NCT03228537|454573032|FG000|Surgery|Death|1|||
126349906|NCT03228537|454573032|FG000|Surgery|Other - Not Protocol Specified|2|||
126349907|NCT03228537|454573032|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
126349908|NCT03228537|454573032|FG000|Maintenance|Progression/Relapse|10|||
126349909|NCT05977868|454574057|FG000|Overall Study|Withdrawal by Subject|1|||
126349910|NCT05977868|454574058|FG001|Overall Study|Withdrawal by Subject|2|||
126349911|NCT05977868|454574057|FG000|Overall Study|Transitioned to comfort care|1|||
126349912|NCT05977868|454574058|FG001|Overall Study|Transitioned to comfort care|0|||
126349913|NCT03575364|454574065|FG000|Overall Study|Death|45|||
126349914|NCT03575364|454574065|FG000|Overall Study|Lost to Follow-up|114|||
126349915|NCT03575364|454574065|FG000|Overall Study|Withdrawal by Subject|21|||
126349916|NCT03575364|454574065|FG000|Overall Study|Physician Decision|11|||
126349917|NCT03575364|454574065|FG000|Overall Study|Subject Refused Follow-up|13|||
126349918|NCT03575364|454574065|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
126349919|NCT03575364|454574065|FG000|Overall Study|Patient moved out of the state|1|||
126349920|NCT03575364|454574065|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
126682760|NCT01425008|455794679|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
126682761|NCT01425008|455794680|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
126682762|NCT01425008|455794681|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
126682763|NCT01425008|455794682|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126682764|NCT01425008|455794683|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
126682765|NCT01425008|455794684|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
126682766|NCT01425008|455794685|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
126682767|NCT01425008|455794686|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
126682768|NCT01425008|455794687|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
126682769|NCT01425008|455794688|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
126682770|NCT01425008|455794689|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
126682771|NCT01425008|455794690|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
126682772|NCT01425008|455794691|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
126682773|NCT01425008|455794692|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
126682774|NCT01425008|455794693|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
126682775|NCT01425008|455794694|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
126682776|NCT01425008|455794695|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
126682777|NCT01425008|455794696|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
126682778|NCT01425008|455794697|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
126682779|NCT01425008|455794679|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682780|NCT01425008|455794680|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682781|NCT01425008|455794681|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
126682782|NCT01425008|455794682|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682783|NCT01425008|455794683|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682784|NCT01425008|455794684|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682785|NCT01425008|455794685|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682786|NCT01425008|455794686|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682787|NCT01425008|455794687|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
126682788|NCT01425008|455794688|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
126682789|NCT01425008|455794689|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682790|NCT01425008|455794690|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682791|NCT01425008|455794691|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682792|NCT01425008|455794692|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682793|NCT01425008|455794693|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682794|NCT01425008|455794694|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682795|NCT01425008|455794695|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682796|NCT01425008|455794696|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682797|NCT01425008|455794697|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
126682798|NCT01425008|455794679|FG000|Dose Escalation Phase|Other|0|||
126682799|NCT01425008|455794680|FG001|Dose Escalation Phase|Other|0|||
126436701|NCT00914316|454898682|FG003|Phase 1|Physician Decision|2|||
126436702|NCT00914316|454898679|FG000|Phase 1|Withdrawal by Subject|0|||
126436703|NCT00914316|454898680|FG001|Phase 1|Withdrawal by Subject|2|||
126436704|NCT00914316|454898681|FG002|Phase 1|Withdrawal by Subject|4|||
126682800|NCT01425008|455794681|FG002|Dose Escalation Phase|Other|0|||
126682801|NCT01425008|455794682|FG003|Dose Escalation Phase|Other|0|||
126682802|NCT01425008|455794683|FG004|Dose Escalation Phase|Other|0|||
126682803|NCT01425008|455794684|FG005|Dose Escalation Phase|Other|0|||
126436705|NCT00914316|454898682|FG003|Phase 1|Withdrawal by Subject|0|||
126436706|NCT00914316|454898679|FG000|Phase 1|Adverse Event|1|||
126436707|NCT00914316|454898680|FG001|Phase 1|Adverse Event|0|||
126436708|NCT00914316|454898681|FG002|Phase 1|Adverse Event|0|||
126436709|NCT00914316|454898682|FG003|Phase 1|Adverse Event|0|||
126436710|NCT00914316|454898679|FG000|Phase 2|Withdrawal by Subject|1|||
126436711|NCT00914316|454898680|FG001|Phase 2|Withdrawal by Subject|0|||
126436712|NCT00914316|454898681|FG002|Phase 2|Withdrawal by Subject|1|||
126436713|NCT00914316|454898682|FG003|Phase 2|Withdrawal by Subject|0|||
126436714|NCT05101122|454898684|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
126436715|NCT05101122|454898684|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
126436716|NCT05101122|454898684|FG000|AD313 80/5|Withdrawal by Subject|1|||
126436717|NCT05101122|454898684|FG000|AD313 80/10|Physician Decision|1|||
126682804|NCT01425008|455794685|FG006|Dose Escalation Phase|Other|0|||
126682805|NCT01425008|455794686|FG007|Dose Escalation Phase|Other|0|||
126682806|NCT01425008|455794687|FG008|Dose Escalation Phase|Other|1|||
126682807|NCT01425008|455794688|FG009|Dose Escalation Phase|Other|0|||
126436718|NCT03131219|454898686|FG000|Initial Evaluation Period|Adverse Event|2|||
126436719|NCT03131219|454898687|FG001|Initial Evaluation Period|Adverse Event|0|||
126682808|NCT01425008|455794689|FG010|Dose Escalation Phase|Other|0|||
126682809|NCT01425008|455794690|FG011|Dose Escalation Phase|Other|0|||
126682810|NCT01425008|455794691|FG012|Dose Escalation Phase|Other|0|||
126682811|NCT01425008|455794692|FG013|Dose Escalation Phase|Other|0|||
126682812|NCT01425008|455794693|FG014|Dose Escalation Phase|Other|0|||
126682813|NCT01425008|455794694|FG015|Dose Escalation Phase|Other|0|||
126436720|NCT03131219|454898686|FG000|Initial Evaluation Period|Protocol Violation|1|||
126436721|NCT03131219|454898687|FG001|Initial Evaluation Period|Protocol Violation|0|||
126682814|NCT01425008|455794695|FG016|Dose Escalation Phase|Other|0|||
126682815|NCT01425008|455794696|FG017|Dose Escalation Phase|Other|0|||
126682816|NCT01425008|455794697|FG018|Dose Escalation Phase|Other|0|||
126682817|NCT01425008|455794679|FG000|Dose Expansion Phase|Progressive Disease|0|||
126682818|NCT01425008|455794680|FG001|Dose Expansion Phase|Progressive Disease|0|||
126682819|NCT01425008|455794681|FG002|Dose Expansion Phase|Progressive Disease|0|||
126682820|NCT01425008|455794682|FG003|Dose Expansion Phase|Progressive Disease|0|||
126682821|NCT01425008|455794683|FG004|Dose Expansion Phase|Progressive Disease|0|||
126682822|NCT01425008|455794684|FG005|Dose Expansion Phase|Progressive Disease|0|||
126682823|NCT01425008|455794685|FG006|Dose Expansion Phase|Progressive Disease|0|||
126682824|NCT01425008|455794686|FG007|Dose Expansion Phase|Progressive Disease|0|||
126682825|NCT01425008|455794687|FG008|Dose Expansion Phase|Progressive Disease|0|||
126682826|NCT01425008|455794688|FG009|Dose Expansion Phase|Progressive Disease|0|||
126682827|NCT01425008|455794689|FG010|Dose Expansion Phase|Progressive Disease|10|||
126682828|NCT01425008|455794690|FG011|Dose Expansion Phase|Progressive Disease|4|||
126682829|NCT01425008|455794691|FG012|Dose Expansion Phase|Progressive Disease|12|||
126682830|NCT01425008|455794692|FG013|Dose Expansion Phase|Progressive Disease|1|||
126682831|NCT01425008|455794693|FG014|Dose Expansion Phase|Progressive Disease|5|||
126682832|NCT01425008|455794694|FG015|Dose Expansion Phase|Progressive Disease|8|||
126682833|NCT01425008|455794695|FG016|Dose Expansion Phase|Progressive Disease|9|||
126682834|NCT01425008|455794696|FG017|Dose Expansion Phase|Progressive Disease|2|||
126682835|NCT01425008|455794697|FG018|Dose Expansion Phase|Progressive Disease|10|||
126682836|NCT01425008|455794679|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
126682837|NCT01425008|455794680|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
126682838|NCT01425008|455794681|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
126682839|NCT01425008|455794682|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
126682840|NCT01425008|455794683|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
126682841|NCT01425008|455794684|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
126682842|NCT01425008|455794685|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
126682843|NCT01425008|455794686|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
126682844|NCT01425008|455794687|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
126682845|NCT01425008|455794688|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
126682846|NCT01425008|455794689|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
126682847|NCT01425008|455794690|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
126682848|NCT01425008|455794691|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
126682849|NCT01425008|455794692|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
126682850|NCT01425008|455794693|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
126682851|NCT01425008|455794694|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
126682852|NCT01425008|455794695|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
126682853|NCT01425008|455794696|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
126682854|NCT01425008|455794697|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
126682855|NCT01425008|455794679|FG000|Dose Expansion Phase|Other|0|||
126682856|NCT01425008|455794680|FG001|Dose Expansion Phase|Other|0|||
126682857|NCT01425008|455794681|FG002|Dose Expansion Phase|Other|0|||
126436722|NCT03131219|454898686|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
126436723|NCT03131219|454898687|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
126436724|NCT03131219|454898686|FG000|Initial Evaluation Period|Physician Decision|1|||
126436725|NCT03131219|454898687|FG001|Initial Evaluation Period|Physician Decision|0|||
126436726|NCT03131219|454898686|FG000|Extension Period|Physician Decision|1|||
126436727|NCT03131219|454898687|FG001|Extension Period|Physician Decision|0|||
126436728|NCT04945733|454898694|FG000|Overall Study|Physician Decision|1|||
126436729|NCT04945733|454898695|FG001|Overall Study|Physician Decision|3|||
126436730|NCT04945733|454898696|FG002|Overall Study|Physician Decision|0|||
126436731|NCT04945733|454898694|FG000|Overall Study|Withdrawal by Subject|3|||
126436732|NCT04945733|454898695|FG001|Overall Study|Withdrawal by Subject|3|||
126436733|NCT04945733|454898696|FG002|Overall Study|Withdrawal by Subject|0|||
126436734|NCT05660577|454898699|FG000|Overall Study|Discontinued|9|||
126436735|NCT01709721|454898706|FG000|Open Label Phase|Withdrawal by Subject|0|||
126436736|NCT01709721|454898707|FG001|Open Label Phase|Withdrawal by Subject|0|||
126436737|NCT01709721|454898708|FG002|Open Label Phase|Withdrawal by Subject|5|||
126436738|NCT01709721|454898706|FG000|Open Label Phase|Adverse Event|0|||
126436739|NCT01709721|454898707|FG001|Open Label Phase|Adverse Event|0|||
126436740|NCT01709721|454898708|FG002|Open Label Phase|Adverse Event|8|||
126682858|NCT01425008|455794682|FG003|Dose Expansion Phase|Other|0|||
126682859|NCT01425008|455794683|FG004|Dose Expansion Phase|Other|0|||
126436741|NCT01709721|454898706|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
126682860|NCT01425008|455794684|FG005|Dose Expansion Phase|Other|0|||
126682861|NCT01425008|455794685|FG006|Dose Expansion Phase|Other|0|||
126682862|NCT01425008|455794686|FG007|Dose Expansion Phase|Other|0|||
126682863|NCT01425008|455794687|FG008|Dose Expansion Phase|Other|0|||
126682864|NCT01425008|455794688|FG009|Dose Expansion Phase|Other|0|||
126682865|NCT01425008|455794689|FG010|Dose Expansion Phase|Other|0|||
126682866|NCT01425008|455794690|FG011|Dose Expansion Phase|Other|0|||
126682867|NCT01425008|455794691|FG012|Dose Expansion Phase|Other|1|||
126682868|NCT01425008|455794692|FG013|Dose Expansion Phase|Other|0|||
126436742|NCT01709721|454898707|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
126436743|NCT01709721|454898708|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
126436744|NCT01709721|454898706|FG000|Open Label Phase|Investigator Decision|0|||
126436745|NCT01709721|454898707|FG001|Open Label Phase|Investigator Decision|0|||
126436746|NCT01709721|454898708|FG002|Open Label Phase|Investigator Decision|1|||
126436747|NCT01709721|454898706|FG000|Open Label Phase|Sponsor Decision|0|||
126436748|NCT01709721|454898707|FG001|Open Label Phase|Sponsor Decision|0|||
126436749|NCT01709721|454898708|FG002|Open Label Phase|Sponsor Decision|2|||
126436750|NCT01709721|454898706|FG000|Open Label Phase|Protocol Violation|0|||
126436751|NCT01709721|454898707|FG001|Open Label Phase|Protocol Violation|0|||
126436752|NCT01709721|454898708|FG002|Open Label Phase|Protocol Violation|1|||
126436753|NCT01709721|454898706|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
126436754|NCT01709721|454898707|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
126436755|NCT01709721|454898708|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
126436756|NCT01709721|454898706|FG000|Open Label Phase|Inadequate Pain Control|0|||
126436757|NCT01709721|454898707|FG001|Open Label Phase|Inadequate Pain Control|0|||
126436758|NCT01709721|454898708|FG002|Open Label Phase|Inadequate Pain Control|37|||
126436759|NCT01709721|454898706|FG000|Open Label Phase|Other, Specify in text field in database|0|||
126436760|NCT01709721|454898707|FG001|Open Label Phase|Other, Specify in text field in database|0|||
126436761|NCT01709721|454898708|FG002|Open Label Phase|Other, Specify in text field in database|14|||
126436762|NCT01709721|454898706|FG000|Randomized Phase|Adverse Event|0|||
126436763|NCT01709721|454898707|FG001|Randomized Phase|Adverse Event|1|||
126436764|NCT01709721|454898708|FG002|Randomized Phase|Adverse Event|0|||
126436765|NCT01709721|454898706|FG000|Randomized Phase|Lost to Follow-up|1|||
126436766|NCT01709721|454898707|FG001|Randomized Phase|Lost to Follow-up|0|||
126436767|NCT01709721|454898708|FG002|Randomized Phase|Lost to Follow-up|0|||
126436768|NCT01709721|454898706|FG000|Randomized Phase|Inadequate Pain Control|1|||
126436769|NCT01709721|454898707|FG001|Randomized Phase|Inadequate Pain Control|2|||
126682869|NCT01425008|455794693|FG014|Dose Expansion Phase|Other|0|||
126682870|NCT01425008|455794694|FG015|Dose Expansion Phase|Other|0|||
126436770|NCT01709721|454898708|FG002|Randomized Phase|Inadequate Pain Control|0|||
126436771|NCT01709721|454898706|FG000|Randomized Phase|Other, Specify text field in database|1|||
126436772|NCT01709721|454898707|FG001|Randomized Phase|Other, Specify text field in database|3|||
126436773|NCT01709721|454898708|FG002|Randomized Phase|Other, Specify text field in database|0|||
126436774|NCT00763035|454898709|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
126436775|NCT00763035|454898710|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
126436776|NCT00763035|454898709|FG000|First Intervention|Adverse Event|0|||
126436777|NCT00763035|454898710|FG001|First Intervention|Adverse Event|1|||
126436778|NCT00763035|454898709|FG000|Second Intervention|Adverse Event|1|||
126436779|NCT00763035|454898710|FG001|Second Intervention|Adverse Event|0|||
126436780|NCT00763035|454898709|FG000|Second Intervention|Physician Decision|2|||
126436781|NCT00763035|454898710|FG001|Second Intervention|Physician Decision|0|||
126436782|NCT02131259|454898711|FG000|Overall Study|Progressive disease|751|||
126436783|NCT02131259|454898711|FG000|Overall Study|Adverse Event|341|||
126682871|NCT01425008|455794695|FG016|Dose Expansion Phase|Other|2|||
126682872|NCT01425008|455794696|FG017|Dose Expansion Phase|Other|0|||
126682873|NCT01425008|455794697|FG018|Dose Expansion Phase|Other|4|||
126682874|NCT01425008|455794679|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
126682875|NCT01425008|455794680|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
126682876|NCT01425008|455794681|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
126682877|NCT01425008|455794682|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
126682878|NCT01425008|455794683|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
126682879|NCT01425008|455794684|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
126682880|NCT01425008|455794685|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
126682881|NCT01425008|455794686|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
126682882|NCT01425008|455794687|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
126682883|NCT01425008|455794688|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
126682884|NCT01425008|455794689|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
126682885|NCT01425008|455794690|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
126682886|NCT01425008|455794691|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
126436784|NCT02131259|454898711|FG000|Overall Study|Lost to Follow-up|7|||
126436785|NCT02131259|454898711|FG000|Overall Study|Relocation|32|||
126436786|NCT02131259|454898711|FG000|Overall Study|Other|63|||
126436787|NCT02131259|454898711|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
126436788|NCT02131259|454898711|FG000|Overall Study|Progressive disease/relocation|1|||
126436789|NCT02131259|454898711|FG000|Overall Study|Progressive disease/other|2|||
126436790|NCT02131259|454898711|FG000|Overall Study|AE/lost to follow-up|1|||
126436791|NCT02131259|454898711|FG000|Overall Study|AE/other|1|||
126682887|NCT01425008|455794692|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
126436792|NCT02131259|454898711|FG000|Overall Study|Progressive disease/AE/other|1|||
126545373|NCT02100722|455290819|FG000|Overall Study|Withdrawal pre-procedure|4|||
126682888|NCT01425008|455794693|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
126682889|NCT01425008|455794694|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
126682890|NCT01425008|455794695|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
126682891|NCT01425008|455794696|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
126682892|NCT01425008|455794697|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
126682893|NCT01425008|455794679|FG000|Dose Expansion Phase|Adverse Event|0|||
126682894|NCT01425008|455794680|FG001|Dose Expansion Phase|Adverse Event|0|||
126682895|NCT01425008|455794681|FG002|Dose Expansion Phase|Adverse Event|0|||
126682896|NCT01425008|455794682|FG003|Dose Expansion Phase|Adverse Event|0|||
126682897|NCT01425008|455794683|FG004|Dose Expansion Phase|Adverse Event|0|||
126682898|NCT01425008|455794684|FG005|Dose Expansion Phase|Adverse Event|0|||
126682899|NCT01425008|455794685|FG006|Dose Expansion Phase|Adverse Event|0|||
126682900|NCT01425008|455794686|FG007|Dose Expansion Phase|Adverse Event|0|||
126682901|NCT01425008|455794687|FG008|Dose Expansion Phase|Adverse Event|0|||
126682902|NCT01425008|455794688|FG009|Dose Expansion Phase|Adverse Event|0|||
126682903|NCT01425008|455794689|FG010|Dose Expansion Phase|Adverse Event|2|||
126682904|NCT01425008|455794690|FG011|Dose Expansion Phase|Adverse Event|3|||
126682905|NCT01425008|455794691|FG012|Dose Expansion Phase|Adverse Event|3|||
126682906|NCT01425008|455794692|FG013|Dose Expansion Phase|Adverse Event|0|||
126682907|NCT01425008|455794693|FG014|Dose Expansion Phase|Adverse Event|1|||
126682908|NCT01425008|455794694|FG015|Dose Expansion Phase|Adverse Event|1|||
126682909|NCT01425008|455794695|FG016|Dose Expansion Phase|Adverse Event|5|||
126682910|NCT01425008|455794696|FG017|Dose Expansion Phase|Adverse Event|0|||
126682911|NCT01425008|455794697|FG018|Dose Expansion Phase|Adverse Event|3|||
126682912|NCT01425008|455794679|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
126682913|NCT01425008|455794680|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
126682914|NCT01425008|455794681|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
126682915|NCT01425008|455794682|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
126682916|NCT01425008|455794683|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
126682917|NCT01425008|455794684|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
126682918|NCT01425008|455794685|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
126682919|NCT01425008|455794686|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
126682920|NCT01425008|455794687|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
126682921|NCT01425008|455794688|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
126682922|NCT01425008|455794689|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
126682923|NCT01425008|455794690|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
126682924|NCT01425008|455794691|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
126682925|NCT01425008|455794692|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
126682926|NCT01425008|455794693|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
126682927|NCT01425008|455794694|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
126682928|NCT01425008|455794695|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
126682929|NCT01425008|455794696|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
126682930|NCT01425008|455794697|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
126682931|NCT01425008|455794679|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682932|NCT01425008|455794680|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682933|NCT01425008|455794681|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682934|NCT01425008|455794682|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682935|NCT01425008|455794683|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126758774|NCT01072175|456066695|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
126436793|NCT02131259|454898711|FG000|Overall Study|Missing|3|||
126682936|NCT01425008|455794684|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682937|NCT01425008|455794685|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682938|NCT01425008|455794686|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126758775|NCT01072175|456066696|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126758776|NCT01072175|456066697|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126758777|NCT01072175|456066698|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126758778|NCT01072175|456066699|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126758779|NCT01072175|456066700|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126758780|NCT01072175|456066701|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126758781|NCT01072175|456066702|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126758782|NCT01072175|456066703|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
126758783|NCT01072175|456066691|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126758784|NCT01072175|456066692|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126758785|NCT01072175|456066693|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
126682939|NCT01425008|455794687|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682940|NCT01425008|455794688|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126436794|NCT02161016|454898714|FG000|Overall Study|withdrawn by IRB|1|||
126436795|NCT00003475|454898715|FG000|Overall Study|Not evaluable|13|||
126682941|NCT01425008|455794689|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682942|NCT01425008|455794690|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682943|NCT01425008|455794691|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682944|NCT01425008|455794692|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682945|NCT01425008|455794693|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682946|NCT01425008|455794694|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682947|NCT01425008|455794695|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682948|NCT01425008|455794696|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126682949|NCT01425008|455794697|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
126682950|NCT00562588|455794698|FG000|Overall Study|Adverse Event|40|||
126682951|NCT00562588|455794699|FG001|Overall Study|Adverse Event|58|||
126682952|NCT00562588|455794698|FG000|Overall Study|Protocol Violation|30|||
126682953|NCT00562588|455794699|FG001|Overall Study|Protocol Violation|26|||
126682954|NCT00562588|455794698|FG000|Overall Study|Lost to Follow-up|12|||
126682955|NCT00562588|455794699|FG001|Overall Study|Lost to Follow-up|4|||
126682956|NCT00562588|455794698|FG000|Overall Study|Withdrawal by Subject|10|||
126682957|NCT00562588|455794699|FG001|Overall Study|Withdrawal by Subject|9|||
126682958|NCT00562588|455794698|FG000|Overall Study|Other|0|||
126682959|NCT00562588|455794699|FG001|Overall Study|Other|2|||
126682960|NCT03315871|455794700|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
126682961|NCT03315871|455794701|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
126682962|NCT03315871|455794702|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
126682963|NCT03315871|455794700|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
126682964|NCT03315871|455794701|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
126682965|NCT03315871|455794702|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
126682966|NCT03315871|455794700|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
126682967|NCT03315871|455794701|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
126682968|NCT03315871|455794702|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
126682969|NCT03315871|455794700|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
126682970|NCT03315871|455794701|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
126682971|NCT03315871|455794702|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
126682972|NCT03315871|455794700|FG000|PROSTVAC + CV301|Progressive disease|0|||
126682973|NCT03315871|455794701|FG001|PROSTVAC + CV301|Progressive disease|0|||
126682974|NCT03315871|455794702|FG002|PROSTVAC + CV301|Progressive disease|1|||
126682975|NCT03315871|455794700|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
126682976|NCT03315871|455794701|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
126682977|NCT03315871|455794702|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
126682978|NCT00150592|455796785|FG000|Overall Study|Adverse Event|4|||
126682979|NCT00150592|455796786|FG001|Overall Study|Adverse Event|1|||
126682980|NCT00150592|455796785|FG000|Overall Study|Protocol Violation|1|||
126682981|NCT00150592|455796786|FG001|Overall Study|Protocol Violation|0|||
126682982|NCT00150592|455796785|FG000|Overall Study|Withdrawal by Subject|1|||
126682983|NCT00150592|455796786|FG001|Overall Study|Withdrawal by Subject|2|||
126682984|NCT00150592|455796785|FG000|Overall Study|Non-compliance|1|||
126682985|NCT00150592|455796786|FG001|Overall Study|Non-compliance|0|||
126682986|NCT00874120|455796791|FG000|First Intervention|Adverse Event|0|||
126682987|NCT00874120|455796792|FG001|First Intervention|Adverse Event|1|||
126682988|NCT00874120|455796791|FG000|First Intervention|Withdrawal by Subject|2|||
126682989|NCT00874120|455796792|FG001|First Intervention|Withdrawal by Subject|0|||
126682990|NCT00874120|455796791|FG000|First Intervention|Lost to Follow-up|0|||
126682991|NCT00874120|455796792|FG001|First Intervention|Lost to Follow-up|1|||
126682992|NCT00874120|455796791|FG000|First Intervention|Protocol Violation|3|||
126682993|NCT00874120|455796792|FG001|First Intervention|Protocol Violation|0|||
126682994|NCT00874120|455796791|FG000|First Intervention|positive drug test|1|||
126682995|NCT00874120|455796792|FG001|First Intervention|positive drug test|0|||
126682996|NCT00874120|455796791|FG000|Second Intervention|Withdrawal by Subject|1|||
126682997|NCT00874120|455796792|FG001|Second Intervention|Withdrawal by Subject|0|||
126682998|NCT00874120|455796791|FG000|Second Intervention|Protocol Violation|1|||
126682999|NCT00874120|455796792|FG001|Second Intervention|Protocol Violation|0|||
126683000|NCT01823679|455796793|FG000|Overall Study|Death|1|||
126683001|NCT02164981|455796794|FG000|Started|Withdrawal by Subject|2|||
126683002|NCT02164981|455796795|FG001|Started|Withdrawal by Subject|1|||
126683003|NCT02164981|455796796|FG002|Started|Withdrawal by Subject|0|||
126683004|NCT02164981|455796794|FG000|Started|Protocol Violation|2|||
126436796|NCT00106704|454898716|FG000|Overall Study|Adverse Event|10|||
126436797|NCT00106704|454898717|FG001|Overall Study|Adverse Event|7|||
126683005|NCT02164981|455796795|FG001|Started|Protocol Violation|0|||
126436798|NCT00106704|454898716|FG000|Overall Study|Death|2|||
126683006|NCT02164981|455796796|FG002|Started|Protocol Violation|0|||
126683007|NCT02164981|455796794|FG000|Started|Adverse Event|1|||
126683008|NCT02164981|455796795|FG001|Started|Adverse Event|2|||
126436799|NCT00106704|454898717|FG001|Overall Study|Death|1|||
126436800|NCT00106704|454898716|FG000|Overall Study|Lack of Efficacy|67|||
126683009|NCT02164981|455796796|FG002|Started|Adverse Event|0|||
126683010|NCT02164981|455796794|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
126683011|NCT02164981|455796795|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
126683012|NCT02164981|455796796|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
126683013|NCT02164981|455796794|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
126683014|NCT02164981|455796795|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
126683015|NCT02164981|455796796|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
126683016|NCT02164981|455796794|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
126683017|NCT02164981|455796795|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
126683018|NCT02164981|455796796|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
126683019|NCT03311711|455796797|FG000|Overall Study|Death|1|||
126683020|NCT03311711|455796798|FG001|Overall Study|Death|0|||
126436801|NCT00106704|454898717|FG001|Overall Study|Lack of Efficacy|69|||
126436802|NCT00106704|454898716|FG000|Overall Study|Lost to Follow-up|7|||
126436803|NCT00106704|454898717|FG001|Overall Study|Lost to Follow-up|3|||
126436804|NCT00106704|454898716|FG000|Overall Study|Pregnancy|1|||
126436805|NCT00106704|454898717|FG001|Overall Study|Pregnancy|0|||
126436806|NCT00106704|454898716|FG000|Overall Study|Protocol Violation|4|||
126436807|NCT00106704|454898717|FG001|Overall Study|Protocol Violation|7|||
126436808|NCT00106704|454898716|FG000|Overall Study|Withdrawal by Subject|14|||
126436809|NCT00106704|454898717|FG001|Overall Study|Withdrawal by Subject|21|||
126436810|NCT00106704|454898716|FG000|Overall Study|Patient moved|1|||
126436811|NCT00106704|454898717|FG001|Overall Study|Patient moved|0|||
126436812|NCT00106704|454898716|FG000|Overall Study|Site terminated|0|||
126436813|NCT00106704|454898717|FG001|Overall Study|Site terminated|1|||
126436814|NCT00106704|454898716|FG000|Overall Study|Planned major surgery|1|||
126436815|NCT00106704|454898717|FG001|Overall Study|Planned major surgery|0|||
126436816|NCT00106704|454898716|FG000|Overall Study|Patient Received Glycemic Medication|22|||
126436817|NCT00106704|454898717|FG001|Overall Study|Patient Received Glycemic Medication|41|||
126436818|NCT00106704|454898716|FG000|Overall Study|Unable to re-enter US|1|||
126436819|NCT00106704|454898717|FG001|Overall Study|Unable to re-enter US|0|||
126436820|NCT00106704|454898716|FG000|Overall Study|Laboratory test|1|||
126436821|NCT00106704|454898717|FG001|Overall Study|Laboratory test|1|||
126436822|NCT03818321|454898718|FG000|Overall Study|Withdrawal by Subject|1|||
126436823|NCT03818321|454898719|FG001|Overall Study|Withdrawal by Subject|2|||
126436824|NCT03216226|454898723|FG000|Overall Study|Adverse Event|3|||
126436825|NCT03216226|454898724|FG001|Overall Study|Adverse Event|0|||
126436826|NCT03216226|454898723|FG000|Overall Study|Protocol Violation|1|||
126436827|NCT03216226|454898724|FG001|Overall Study|Protocol Violation|3|||
126436828|NCT03216226|454898723|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
126436829|NCT03216226|454898724|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
126436830|NCT03216226|454898723|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
126436831|NCT03216226|454898724|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
126436832|NCT03216226|454898723|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
126436833|NCT03216226|454898724|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
126436834|NCT03675126|454898725|FG000|Overall Study|Study Terminated by Sponsor|9|||
126436835|NCT03675126|454898725|FG000|Overall Study|Death|2|||
126436836|NCT03675126|454898725|FG000|Overall Study|Withdrawal by Subject|4|||
126436837|NCT00001959|454898726|FG000|Overall Study|newly diagnosed colon cancer|1|||
126436838|NCT00001959|454898726|FG000|Overall Study|disabling sedation|1|||
126436839|NCT00001959|454898726|FG000|Overall Study|non-compliance|1|||
126436840|NCT04189952|454898731|FG000|Follow-up Period|Death|1|||
126436841|NCT04189952|454898731|FG000|Follow-up Period|Withdrawal by Subject|1|||
126436842|NCT01052493|454898732|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
126436843|NCT01052493|454898733|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
126436844|NCT01052493|454898734|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
126436845|NCT01498068|454898735|FG000|Overall Study|Withdrawal by Subject|1|||
126436846|NCT01498068|454898736|FG001|Overall Study|Withdrawal by Subject|1|||
126436847|NCT01318915|454898739|FG000|Overall Study|Lost to Follow-up|1|||
126436848|NCT00453206|454898741|FG000|Overall Study|Death|1|||
126436849|NCT03866577|454898744|FG000|Overall Study|Protocol Violation|0|||
126436850|NCT03866577|454898745|FG001|Overall Study|Protocol Violation|0|||
126436851|NCT03866577|454898746|FG002|Overall Study|Protocol Violation|0|||
126436852|NCT03866577|454898747|FG003|Overall Study|Protocol Violation|0|||
126436853|NCT03866577|454898748|FG004|Overall Study|Protocol Violation|0|||
126436854|NCT03866577|454898749|FG005|Overall Study|Protocol Violation|0|||
126436855|NCT03866577|454898750|FG006|Overall Study|Protocol Violation|0|||
126436856|NCT03866577|454898751|FG007|Overall Study|Protocol Violation|0|||
126436857|NCT03866577|454898752|FG008|Overall Study|Protocol Violation|0|||
126436858|NCT03866577|454898753|FG009|Overall Study|Protocol Violation|0|||
126683021|NCT03311711|455796799|FG002|Overall Study|Death|0|||
126436859|NCT03866577|454898754|FG010|Overall Study|Protocol Violation|0|||
126436860|NCT03866577|454898755|FG011|Overall Study|Protocol Violation|1|||
126436861|NCT03866577|454898756|FG012|Overall Study|Protocol Violation|0|||
126436862|NCT03866577|454898744|FG000|Overall Study|Withdrawal by Subject|0|||
126436863|NCT03866577|454898745|FG001|Overall Study|Withdrawal by Subject|0|||
126436864|NCT03866577|454898746|FG002|Overall Study|Withdrawal by Subject|0|||
126436865|NCT03866577|454898747|FG003|Overall Study|Withdrawal by Subject|0|||
126436866|NCT03866577|454898748|FG004|Overall Study|Withdrawal by Subject|0|||
126436867|NCT03866577|454898749|FG005|Overall Study|Withdrawal by Subject|0|||
126683022|NCT03311711|455796800|FG003|Overall Study|Death|0|||
126436868|NCT03866577|454898750|FG006|Overall Study|Withdrawal by Subject|0|||
126436869|NCT03866577|454898751|FG007|Overall Study|Withdrawal by Subject|0|||
126436870|NCT03866577|454898752|FG008|Overall Study|Withdrawal by Subject|1|||
126436871|NCT03866577|454898753|FG009|Overall Study|Withdrawal by Subject|1|||
126436872|NCT03866577|454898754|FG010|Overall Study|Withdrawal by Subject|0|||
126436873|NCT03866577|454898755|FG011|Overall Study|Withdrawal by Subject|0|||
126436874|NCT03866577|454898756|FG012|Overall Study|Withdrawal by Subject|0|||
126436875|NCT03866577|454898744|FG000|Overall Study|Not qualified for IVIg infusion|0|||
126436876|NCT03866577|454898745|FG001|Overall Study|Not qualified for IVIg infusion|0|||
126436877|NCT03866577|454898746|FG002|Overall Study|Not qualified for IVIg infusion|0|||
126436878|NCT03866577|454898747|FG003|Overall Study|Not qualified for IVIg infusion|0|||
126436879|NCT03866577|454898748|FG004|Overall Study|Not qualified for IVIg infusion|0|||
126436880|NCT03866577|454898749|FG005|Overall Study|Not qualified for IVIg infusion|0|||
126436881|NCT03866577|454898750|FG006|Overall Study|Not qualified for IVIg infusion|0|||
126436882|NCT03866577|454898751|FG007|Overall Study|Not qualified for IVIg infusion|0|||
126436883|NCT03866577|454898752|FG008|Overall Study|Not qualified for IVIg infusion|0|||
126436884|NCT03866577|454898753|FG009|Overall Study|Not qualified for IVIg infusion|1|||
126436885|NCT03866577|454898754|FG010|Overall Study|Not qualified for IVIg infusion|0|||
126436886|NCT03866577|454898755|FG011|Overall Study|Not qualified for IVIg infusion|0|||
126436887|NCT03866577|454898756|FG012|Overall Study|Not qualified for IVIg infusion|0|||
126436888|NCT04825678|454898757|FG000|Overall Study|Decision by Sponsor|2|||
126436889|NCT04825678|454898758|FG001|Overall Study|Decision by Sponsor|3|||
126436890|NCT04825678|454898757|FG000|Overall Study|Withdrawal of Consent From Study|7|||
126436891|NCT04825678|454898758|FG001|Overall Study|Withdrawal of Consent From Study|9|||
126436892|NCT04825678|454898757|FG000|Overall Study|Lost to Follow-up|3|||
126436893|NCT04825678|454898758|FG001|Overall Study|Lost to Follow-up|4|||
126436894|NCT04825678|454898757|FG000|Overall Study|Never Received Investigational Product|1|||
126436895|NCT04825678|454898758|FG001|Overall Study|Never Received Investigational Product|1|||
126436896|NCT00734149|454898760|FG000|Overall Study|Withdrawal by Subject|1|||
126436897|NCT03043794|454898764|FG000|Overall Study|Lost to Follow-up|1|||
126436898|NCT01899040|454898766|FG000|Overall Study|Randomized in error|0|||
126436899|NCT01899040|454898767|FG001|Overall Study|Randomized in error|1|||
126436900|NCT01899040|454898768|FG002|Overall Study|Randomized in error|1|||
126436901|NCT01899040|454898766|FG000|Overall Study|Adverse Event|3|||
126436902|NCT01899040|454898767|FG001|Overall Study|Adverse Event|1|||
126436903|NCT01899040|454898768|FG002|Overall Study|Adverse Event|2|||
126436904|NCT01899040|454898766|FG000|Overall Study|Unspecified reasons|4|||
126436905|NCT01899040|454898767|FG001|Overall Study|Unspecified reasons|4|||
126436906|NCT01899040|454898768|FG002|Overall Study|Unspecified reasons|0|||
126436907|NCT01899040|454898766|FG000|Overall Study|Compliance issues|1|||
126436908|NCT01899040|454898767|FG001|Overall Study|Compliance issues|2|||
126436909|NCT01899040|454898768|FG002|Overall Study|Compliance issues|0|||
126436910|NCT04586205|454898775|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
126436911|NCT04586205|454898776|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
126436912|NCT01586364|454900869|FG000|Overall Study|Withdrawal by Subject|40|||
126436913|NCT01586364|454900869|FG000|Overall Study|Adverse Event|37|||
126436914|NCT01586364|454900869|FG000|Overall Study|Lost to Follow-up|17|||
126436915|NCT01586364|454900869|FG000|Overall Study|Protocol Violation|16|||
126436916|NCT01586364|454900869|FG000|Overall Study|Lack of Efficacy|1|||
126436917|NCT01586364|454900869|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
126436918|NCT01586364|454900869|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
126436919|NCT01586364|454900869|FG000|Overall Study|Other-Site closure due to PI illness|1|||
126436920|NCT01586364|454900869|FG000|Overall Study|Other-PI discretion, site closing|2|||
126436921|NCT01586364|454900869|FG000|Overall Study|Other-Not specified|1|||
126436922|NCT02083354|454900870|FG000|Overall Study|Withdrawal by Subject|9|||
126436923|NCT02083354|454900870|FG000|Overall Study|Lost to Follow-up|1|||
126436924|NCT02083354|454900870|FG000|Overall Study|Adverse Event|3|||
126436925|NCT02083354|454900870|FG000|Overall Study|Disease progression|46|||
126436926|NCT02083354|454900870|FG000|Overall Study|Study closed/terminated|5|||
126436927|NCT04328077|454900871|FG000|Overall Study|Lost to Follow-up|0|||
126436928|NCT04328077|454900872|FG001|Overall Study|Lost to Follow-up|1|||
126436929|NCT04328077|454900873|FG002|Overall Study|Lost to Follow-up|0|||
126436930|NCT04328077|454900874|FG003|Overall Study|Lost to Follow-up|0|||
126436931|NCT04328077|454900871|FG000|Overall Study|Withdrawal by Subject|0|||
126436932|NCT04328077|454900872|FG001|Overall Study|Withdrawal by Subject|1|||
126436933|NCT04328077|454900873|FG002|Overall Study|Withdrawal by Subject|1|||
126436934|NCT04328077|454900874|FG003|Overall Study|Withdrawal by Subject|3|||
126436935|NCT05291520|454900875|FG000|Overall Study|Lost to Follow-up|0|||
126436936|NCT05291520|454900876|FG001|Overall Study|Lost to Follow-up|0|||
126436937|NCT05291520|454900877|FG002|Overall Study|Lost to Follow-up|1|||
126436938|NCT01347112|454900878|FG000|Overall Study|Withdrawal by Subject|1|||
126436939|NCT01347112|454900879|FG001|Overall Study|Withdrawal by Subject|7|||
126436940|NCT01347112|454900878|FG000|Overall Study|Lost to Follow-up|3|||
126436941|NCT01347112|454900879|FG001|Overall Study|Lost to Follow-up|5|||
126436942|NCT00696072|454900884|FG000|Overall Study|continuing active treatment|10|||
126683023|NCT03311711|455796801|FG004|Overall Study|Death|0|||
126683024|NCT03311711|455796802|FG005|Overall Study|Death|0|||
126683025|NCT03311711|455796803|FG006|Overall Study|Death|1|||
126683026|NCT03311711|455796804|FG007|Overall Study|Death|0|||
126683027|NCT03311711|455796805|FG008|Overall Study|Death|1|||
126683028|NCT03311711|455796806|FG009|Overall Study|Death|0|||
126683029|NCT03311711|455796797|FG000|Overall Study|Death of dyad partner|0|||
126683030|NCT03311711|455796798|FG001|Overall Study|Death of dyad partner|1|||
126683031|NCT03311711|455796799|FG002|Overall Study|Death of dyad partner|0|||
126683032|NCT03311711|455796800|FG003|Overall Study|Death of dyad partner|0|||
126683033|NCT03311711|455796801|FG004|Overall Study|Death of dyad partner|0|||
126683034|NCT03311711|455796802|FG005|Overall Study|Death of dyad partner|0|||
126683035|NCT03311711|455796803|FG006|Overall Study|Death of dyad partner|0|||
126683036|NCT03311711|455796804|FG007|Overall Study|Death of dyad partner|1|||
126683037|NCT03311711|455796805|FG008|Overall Study|Death of dyad partner|0|||
126683038|NCT03311711|455796806|FG009|Overall Study|Death of dyad partner|1|||
126683039|NCT03311711|455796797|FG000|Overall Study|Lost to Follow-up|2|||
126683040|NCT03311711|455796798|FG001|Overall Study|Lost to Follow-up|2|||
126683041|NCT03311711|455796799|FG002|Overall Study|Lost to Follow-up|0|||
126683042|NCT03311711|455796800|FG003|Overall Study|Lost to Follow-up|0|||
126683043|NCT03311711|455796801|FG004|Overall Study|Lost to Follow-up|0|||
126683044|NCT03311711|455796802|FG005|Overall Study|Lost to Follow-up|0|||
126683045|NCT03311711|455796803|FG006|Overall Study|Lost to Follow-up|1|||
126683046|NCT03311711|455796804|FG007|Overall Study|Lost to Follow-up|1|||
126683047|NCT03311711|455796805|FG008|Overall Study|Lost to Follow-up|0|||
126683048|NCT03311711|455796806|FG009|Overall Study|Lost to Follow-up|0|||
126683049|NCT03311711|455796797|FG000|Overall Study|Withdrawal by Subject|1|||
126683050|NCT03311711|455796798|FG001|Overall Study|Withdrawal by Subject|1|||
126683051|NCT03311711|455796799|FG002|Overall Study|Withdrawal by Subject|0|||
126683052|NCT03311711|455796800|FG003|Overall Study|Withdrawal by Subject|0|||
126683053|NCT03311711|455796801|FG004|Overall Study|Withdrawal by Subject|0|||
126683054|NCT03311711|455796802|FG005|Overall Study|Withdrawal by Subject|0|||
126683055|NCT03311711|455796803|FG006|Overall Study|Withdrawal by Subject|3|||
126683056|NCT03311711|455796804|FG007|Overall Study|Withdrawal by Subject|3|||
126683057|NCT03311711|455796805|FG008|Overall Study|Withdrawal by Subject|0|||
126683058|NCT03311711|455796806|FG009|Overall Study|Withdrawal by Subject|0|||
126683059|NCT03548051|455796808|FG000|Overall Study|Death|1|||
126683060|NCT03548051|455796809|FG001|Overall Study|Death|1|||
126683061|NCT03548051|455796808|FG000|Overall Study|Withdrawal by Subject|1|||
126683062|NCT03548051|455796809|FG001|Overall Study|Withdrawal by Subject|0|||
126683063|NCT03927105|455796810|FG000|Overall Study|Death|1|||
126683064|NCT03927105|455796810|FG000|Overall Study|In observation for potential re-treatment|2|||
126683065|NCT03927105|455796810|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
126436943|NCT00696072|454900885|FG001|Overall Study|continuing active treatment|13|||
126436944|NCT00696072|454900884|FG000|Overall Study|Adverse Event|10|||
126436945|NCT00696072|454900885|FG001|Overall Study|Adverse Event|6|||
126436946|NCT00696072|454900884|FG000|Overall Study|Patient Request|3|||
126436947|NCT00696072|454900885|FG001|Overall Study|Patient Request|7|||
126436948|NCT00696072|454900884|FG000|Overall Study|Investigator Request|1|||
126436949|NCT00696072|454900885|FG001|Overall Study|Investigator Request|4|||
126436950|NCT00696072|454900884|FG000|Overall Study|Sponsor Request|0|||
126436951|NCT00696072|454900885|FG001|Overall Study|Sponsor Request|1|||
126436952|NCT00696072|454900884|FG000|Overall Study|Disease Progression|32|||
126436953|NCT00696072|454900885|FG001|Overall Study|Disease Progression|30|||
126436954|NCT00696072|454900884|FG000|Overall Study|Non-specified|1|||
126436955|NCT00696072|454900885|FG001|Overall Study|Non-specified|2|||
126436956|NCT00313014|454900892|FG000|Overall Study|Withdrawal by Subject|11|||
126436957|NCT00313014|454900893|FG001|Overall Study|Withdrawal by Subject|7|||
126436958|NCT00313014|454900894|FG002|Overall Study|Withdrawal by Subject|5|||
126436959|NCT00313014|454900892|FG000|Overall Study|Adverse Event|14|||
126436960|NCT00313014|454900893|FG001|Overall Study|Adverse Event|29|||
126436961|NCT00313014|454900894|FG002|Overall Study|Adverse Event|16|||
126436962|NCT00313014|454900892|FG000|Overall Study|Lost to Follow-up|7|||
126436963|NCT00313014|454900893|FG001|Overall Study|Lost to Follow-up|6|||
126436964|NCT00313014|454900894|FG002|Overall Study|Lost to Follow-up|10|||
126436965|NCT00313014|454900892|FG000|Overall Study|Administrative|9|||
126436966|NCT00313014|454900893|FG001|Overall Study|Administrative|6|||
126436967|NCT00313014|454900894|FG002|Overall Study|Administrative|14|||
126436968|NCT00313014|454900892|FG000|Overall Study|Lack of Efficacy|52|||
126436969|NCT00313014|454900893|FG001|Overall Study|Lack of Efficacy|25|||
126436970|NCT00313014|454900894|FG002|Overall Study|Lack of Efficacy|16|||
126683066|NCT00082888|455796813|FG000|Overall Study|Ineligible|1|||
126436971|NCT01391546|454900897|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
126436972|NCT01391546|454900898|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
126683067|NCT00082888|455796814|FG001|Overall Study|Ineligible|0|||
126683068|NCT00082888|455796815|FG002|Overall Study|Ineligible|0|||
126683069|NCT02684981|455796818|FG000|Overall Study|Permanently discontinued the treatment|157|||
126683070|NCT02684981|455796819|FG001|Overall Study|Permanently discontinued the treatment|161|||
126683071|NCT02684981|455796820|FG002|Overall Study|Permanently discontinued the treatment|110|||
126683072|NCT02684981|455796818|FG000|Overall Study|Other|83|||
126683073|NCT02684981|455796819|FG001|Overall Study|Other|49|||
126683074|NCT02684981|455796820|FG002|Overall Study|Other|17|||
126683075|NCT01745146|455796821|FG000|Overall Study|Withdrawal by Subject|1|||
126683076|NCT01745146|455796822|FG001|Overall Study|Withdrawal by Subject|3|||
126683077|NCT01745146|455796821|FG000|Overall Study|Lost to Follow-up|2|||
126683078|NCT01745146|455796822|FG001|Overall Study|Lost to Follow-up|0|||
126683079|NCT04623242|455796823|FG000|Overall Study|Withdrawal by Subject|7|||
126683080|NCT04623242|455796824|FG001|Overall Study|Withdrawal by Subject|12|||
126683081|NCT04623242|455796825|FG002|Overall Study|Withdrawal by Subject|5|||
126683082|NCT04623242|455796826|FG003|Overall Study|Withdrawal by Subject|7|||
126683083|NCT04623242|455796827|FG004|Overall Study|Withdrawal by Subject|0|||
126683084|NCT04623242|455796823|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
126683085|NCT04623242|455796824|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
126683086|NCT04623242|455796825|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
126683087|NCT04623242|455796826|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
126683088|NCT04623242|455796827|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
126683089|NCT04623242|455796823|FG000|Overall Study|Subject unblinded to mutation status|0|||
126683090|NCT04623242|455796824|FG001|Overall Study|Subject unblinded to mutation status|0|||
126683091|NCT04623242|455796825|FG002|Overall Study|Subject unblinded to mutation status|0|||
126683092|NCT04623242|455796826|FG003|Overall Study|Subject unblinded to mutation status|13|||
126683093|NCT04623242|455796827|FG004|Overall Study|Subject unblinded to mutation status|0|||
126683094|NCT00820898|455796828|FG000|Overall Study|Inelgible - wrong primary site|1|||
126683095|NCT00647556|455796831|FG000|Overall Study|Adverse Event|0|||
126683096|NCT00647556|455796832|FG001|Overall Study|Adverse Event|1|||
126683097|NCT00647556|455796831|FG000|Overall Study|Lost to Follow-up|1|||
126683098|NCT00647556|455796832|FG001|Overall Study|Lost to Follow-up|0|||
126683099|NCT00647556|455796831|FG000|Overall Study|Protocol Violation|0|||
126683100|NCT00647556|455796832|FG001|Overall Study|Protocol Violation|1|||
126683101|NCT00647556|455796831|FG000|Overall Study|Withdrawal by Subject|1|||
126683102|NCT00647556|455796832|FG001|Overall Study|Withdrawal by Subject|0|||
126683103|NCT00647556|455796831|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
126683104|NCT00647556|455796832|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
126683105|NCT05594173|455796833|FG000|Overall Study|Adverse Event|1|||
126683106|NCT05594173|455796833|FG000|Overall Study|COVID-19 Pandemic|2|||
126683107|NCT01652287|455796834|FG000|Overall Study|Withdrawal by Subject|2|||
126683108|NCT01652287|455796835|FG001|Overall Study|Withdrawal by Subject|0|||
126683109|NCT00763139|455796839|FG000|Overall Study|Adverse Event|4|||
126683110|NCT00763139|455796840|FG001|Overall Study|Adverse Event|2|||
126683111|NCT00763139|455796839|FG000|Overall Study|Withdrawal by Subject|0|||
126683112|NCT00763139|455796840|FG001|Overall Study|Withdrawal by Subject|1|||
126683113|NCT00763139|455796839|FG000|Overall Study|med change not allowed by protocol|1|||
126683114|NCT00763139|455796840|FG001|Overall Study|med change not allowed by protocol|0|||
126758786|NCT01072175|456066694|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
126758787|NCT01072175|456066695|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
126758788|NCT01072175|456066696|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126758789|NCT01072175|456066697|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126758790|NCT01072175|456066698|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126758791|NCT01072175|456066699|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126758792|NCT01072175|456066700|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126758793|NCT01072175|456066701|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126758794|NCT01072175|456066702|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126758795|NCT01072175|456066703|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
126758796|NCT01072175|456066691|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126758797|NCT01072175|456066692|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
126758798|NCT01072175|456066693|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126758799|NCT01072175|456066694|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
126758800|NCT01072175|456066695|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
126758801|NCT01072175|456066696|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126758802|NCT01072175|456066697|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126758803|NCT01072175|456066698|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126758804|NCT01072175|456066699|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126683115|NCT00179309|455796841|FG000|Treatment|Toxicity|2|||
126683116|NCT00179309|455796842|FG001|Treatment|Toxicity|3|||
126683117|NCT00179309|455796841|FG000|Treatment|Withdrawal by Subject|1|||
126683118|NCT00179309|455796842|FG001|Treatment|Withdrawal by Subject|2|||
126683119|NCT00179309|455796841|FG000|Treatment|Allergy|1|||
126683120|NCT00179309|455796842|FG001|Treatment|Allergy|0|||
126683121|NCT01709149|455796849|FG000|Open-label Lead-in Phase|Adverse Event|109|||
126683122|NCT01709149|455796850|FG001|Open-label Lead-in Phase|Adverse Event|0|||
126683123|NCT01709149|455796851|FG002|Open-label Lead-in Phase|Adverse Event|0|||
126683124|NCT01709149|455796849|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
126683125|NCT01709149|455796850|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
126683126|NCT01709149|455796851|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
126683127|NCT01709149|455796849|FG000|Open-label Lead-in Phase|Death|1|||
126683128|NCT01709149|455796850|FG001|Open-label Lead-in Phase|Death|0|||
126683129|NCT01709149|455796851|FG002|Open-label Lead-in Phase|Death|0|||
126683130|NCT01709149|455796849|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
126683131|NCT01709149|455796850|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
126683132|NCT01709149|455796851|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
126683133|NCT01709149|455796849|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
126683134|NCT01709149|455796850|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
126683135|NCT01709149|455796851|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
126683136|NCT01709149|455796849|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
126683137|NCT01709149|455796850|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
126683138|NCT01709149|455796851|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
126683139|NCT01709149|455796849|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
126683140|NCT01709149|455796850|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
126683141|NCT01709149|455796851|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
126683142|NCT01709149|455796849|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
126683143|NCT01709149|455796850|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
126683144|NCT01709149|455796851|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
126683145|NCT01709149|455796849|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
126683146|NCT01709149|455796850|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
126683147|NCT01709149|455796851|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
126683148|NCT01709149|455796849|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126683149|NCT01709149|455796850|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
126683150|NCT01709149|455796851|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126683151|NCT02797808|455796852|FG000|Overall Study|Withdrawal by Subject|1|||
126683152|NCT02797808|455796853|FG001|Overall Study|Withdrawal by Subject|1|||
126683153|NCT02797808|455796852|FG000|Overall Study|Physician Decision|6|||
126683154|NCT02797808|455796853|FG001|Overall Study|Physician Decision|2|||
126683155|NCT02192827|455796854|FG000|Overall Study|Lost to Follow-up|25|||
126683156|NCT02192827|455796855|FG001|Overall Study|Lost to Follow-up|27|||
126683157|NCT02192827|455796854|FG000|Overall Study|Given additional steroids with admission|13|||
126683158|NCT02192827|455796855|FG001|Overall Study|Given additional steroids with admission|11|||
126683159|NCT00535132|455796856|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
126683160|NCT00535132|455796857|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
126683161|NCT00535132|455796856|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
126683162|NCT00535132|455796857|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
126683163|NCT02590588|455796858|FG000|Overall Study|Adverse Event|1|||
126683164|NCT05098041|455796860|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
126683165|NCT01857869|455796862|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
126683166|NCT01857869|455796863|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
126683167|NCT01857869|455796864|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
126683168|NCT01857869|455796865|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
126683169|NCT01857869|455796866|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
126683170|NCT01857869|455796867|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
126683171|NCT01857869|455796868|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
126683172|NCT01857869|455796869|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
126683173|NCT01857869|455796870|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
126683174|NCT01857869|455796871|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
126683175|NCT01857869|455796862|FG000|Primary/Challenge Phase|Pregnancy|1|||
126683176|NCT01857869|455796863|FG001|Primary/Challenge Phase|Pregnancy|0|||
126683177|NCT01857869|455796864|FG002|Primary/Challenge Phase|Pregnancy|0|||
126683178|NCT01857869|455796865|FG003|Primary/Challenge Phase|Pregnancy|0|||
126683179|NCT01857869|455796866|FG004|Primary/Challenge Phase|Pregnancy|0|||
126683180|NCT01857869|455796867|FG005|Primary/Challenge Phase|Pregnancy|0|||
126683181|NCT01857869|455796868|FG006|Primary/Challenge Phase|Pregnancy|0|||
126683182|NCT01857869|455796869|FG007|Primary/Challenge Phase|Pregnancy|0|||
126758805|NCT01072175|456066700|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126758806|NCT01072175|456066701|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126758807|NCT01072175|456066702|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126758808|NCT01072175|456066703|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
126758809|NCT01072175|456066691|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
126758810|NCT01072175|456066692|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
126758811|NCT01072175|456066693|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
126683183|NCT01857869|455796870|FG008|Primary/Challenge Phase|Pregnancy|0|||
126683184|NCT01857869|455796871|FG009|Primary/Challenge Phase|Pregnancy|0|||
126683185|NCT01857869|455796862|FG000|Primary/Challenge Phase|Protocol Violation|1|||
126683186|NCT01857869|455796863|FG001|Primary/Challenge Phase|Protocol Violation|0|||
126683187|NCT01857869|455796864|FG002|Primary/Challenge Phase|Protocol Violation|0|||
126683188|NCT01857869|455796865|FG003|Primary/Challenge Phase|Protocol Violation|0|||
126683189|NCT01857869|455796866|FG004|Primary/Challenge Phase|Protocol Violation|0|||
126683190|NCT01857869|455796867|FG005|Primary/Challenge Phase|Protocol Violation|0|||
126683191|NCT01857869|455796868|FG006|Primary/Challenge Phase|Protocol Violation|0|||
126683192|NCT01857869|455796869|FG007|Primary/Challenge Phase|Protocol Violation|0|||
126683193|NCT01857869|455796870|FG008|Primary/Challenge Phase|Protocol Violation|0|||
126683194|NCT01857869|455796871|FG009|Primary/Challenge Phase|Protocol Violation|0|||
126683195|NCT01857869|455796862|FG000|Primary/Challenge Phase|Other|1|||
126683196|NCT01857869|455796863|FG001|Primary/Challenge Phase|Other|1|||
126683197|NCT01857869|455796864|FG002|Primary/Challenge Phase|Other|0|||
126683198|NCT01857869|455796865|FG003|Primary/Challenge Phase|Other|0|||
126683199|NCT01857869|455796866|FG004|Primary/Challenge Phase|Other|0|||
126683200|NCT01857869|455796867|FG005|Primary/Challenge Phase|Other|0|||
126683201|NCT01857869|455796868|FG006|Primary/Challenge Phase|Other|0|||
126683202|NCT01857869|455796869|FG007|Primary/Challenge Phase|Other|0|||
126683203|NCT01857869|455796870|FG008|Primary/Challenge Phase|Other|0|||
126683204|NCT01857869|455796871|FG009|Primary/Challenge Phase|Other|0|||
126683205|NCT01857869|455796862|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126683206|NCT01857869|455796863|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126683207|NCT01857869|455796864|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126683208|NCT01857869|455796865|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
126683209|NCT01857869|455796866|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126683210|NCT01857869|455796867|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126683211|NCT01857869|455796868|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126683212|NCT01857869|455796869|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126683213|NCT01857869|455796870|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126683214|NCT01857869|455796871|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
126683215|NCT01857869|455796862|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126683216|NCT01857869|455796863|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126683217|NCT01857869|455796864|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126683218|NCT01857869|455796865|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
126683219|NCT01857869|455796866|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126683220|NCT01857869|455796867|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126683221|NCT01857869|455796868|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126683222|NCT01857869|455796869|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126683223|NCT01857869|455796870|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126683224|NCT01857869|455796871|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
126683225|NCT02941627|455796901|FG000|Overall Study|Death|1|||
126683226|NCT02941627|455796901|FG000|Overall Study|Surgical failure|1|||
126683227|NCT02941627|455796901|FG000|Overall Study|cholesteatoma prevented implantation|1|||
126683228|NCT03594227|455796902|FG000|Overall Study|Adverse Event|2|||
126683229|NCT03594227|455796903|FG001|Overall Study|Adverse Event|1|||
126683230|NCT03594227|455796904|FG002|Overall Study|Adverse Event|0|||
126683231|NCT03594227|455796905|FG003|Overall Study|Adverse Event|2|||
126683232|NCT03594227|455796902|FG000|Overall Study|Lost to Follow-up|1|||
126683233|NCT03594227|455796903|FG001|Overall Study|Lost to Follow-up|1|||
126683234|NCT03594227|455796904|FG002|Overall Study|Lost to Follow-up|1|||
126683235|NCT03594227|455796905|FG003|Overall Study|Lost to Follow-up|0|||
126683236|NCT03594227|455796902|FG000|Overall Study|Withdrawal by Subject|1|||
126683237|NCT03594227|455796903|FG001|Overall Study|Withdrawal by Subject|1|||
126683238|NCT03594227|455796904|FG002|Overall Study|Withdrawal by Subject|1|||
126683239|NCT03594227|455796905|FG003|Overall Study|Withdrawal by Subject|1|||
126683240|NCT03594227|455796902|FG000|Overall Study|Pregnancy|0|||
126683241|NCT03594227|455796903|FG001|Overall Study|Pregnancy|1|||
126683242|NCT03594227|455796904|FG002|Overall Study|Pregnancy|0|||
126683243|NCT03594227|455796905|FG003|Overall Study|Pregnancy|0|||
126683244|NCT03594227|455796902|FG000|Overall Study|Sponsor Decision|0|||
126683245|NCT03594227|455796903|FG001|Overall Study|Sponsor Decision|0|||
126683246|NCT03594227|455796904|FG002|Overall Study|Sponsor Decision|0|||
126683247|NCT03594227|455796905|FG003|Overall Study|Sponsor Decision|1|||
126683248|NCT03594227|455796902|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
126683249|NCT03594227|455796903|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
126683250|NCT03594227|455796904|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
126683251|NCT03594227|455796905|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
126683252|NCT00790907|455796906|FG000|Overall Study|Adverse Event|9|||
126683253|NCT00790907|455796907|FG001|Overall Study|Adverse Event|7|||
126683254|NCT00790907|455796908|FG002|Overall Study|Adverse Event|6|||
126683255|NCT00790907|455796906|FG000|Overall Study|Physician Decision|304|||
126683256|NCT00790907|455796907|FG001|Overall Study|Physician Decision|271|||
126683257|NCT00790907|455796908|FG002|Overall Study|Physician Decision|255|||
126683258|NCT00790907|455796906|FG000|Overall Study|Withdrawal by Subject|1|||
126683259|NCT00790907|455796907|FG001|Overall Study|Withdrawal by Subject|7|||
126683260|NCT00790907|455796908|FG002|Overall Study|Withdrawal by Subject|5|||
126436973|NCT03363841|454900902|FG000|Overall Study|Adverse Event|1|||
126436974|NCT03363841|454900902|FG000|Overall Study|Withdrawal by Subject|1|||
126436975|NCT03363841|454900902|FG000|Overall Study|Death|7|||
126436976|NCT03363841|454900902|FG000|Overall Study|Physician Decision|1|||
126436977|NCT01744977|454900903|FG000|Overall Study|Withdrawal by Subject|1|||
126436978|NCT01744977|454900904|FG001|Overall Study|Withdrawal by Subject|2|||
126683261|NCT00790907|455796906|FG000|Overall Study|Bleeding Event|11|||
126683262|NCT00790907|455796907|FG001|Overall Study|Bleeding Event|16|||
126683263|NCT00790907|455796908|FG002|Overall Study|Bleeding Event|21|||
126683264|NCT00790907|455796906|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
126683265|NCT00790907|455796907|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
126683266|NCT00790907|455796908|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
126683267|NCT00790907|455796906|FG000|Overall Study|Qualifying Condition Not Present|29|||
126683268|NCT00790907|455796907|FG001|Overall Study|Qualifying Condition Not Present|14|||
126683269|NCT00790907|455796908|FG002|Overall Study|Qualifying Condition Not Present|16|||
126683270|NCT00790907|455796906|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
126683271|NCT00790907|455796907|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
126683272|NCT00790907|455796908|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
126683273|NCT00790907|455796906|FG000|Overall Study|Did Not Receive Study Drug|10|||
126683274|NCT00790907|455796907|FG001|Overall Study|Did Not Receive Study Drug|0|||
126683275|NCT00790907|455796908|FG002|Overall Study|Did Not Receive Study Drug|0|||
126683276|NCT01888640|455796909|FG000|Overall Study|Lost to Follow-up|1|||
126683277|NCT01888640|455796910|FG001|Overall Study|Lost to Follow-up|2|||
126683278|NCT01888640|455796911|FG002|Overall Study|Lost to Follow-up|0|||
126683279|NCT01888640|455796909|FG000|Overall Study|Withdrawal by Subject|15|||
126683280|NCT01888640|455796910|FG001|Overall Study|Withdrawal by Subject|11|||
126683281|NCT01888640|455796911|FG002|Overall Study|Withdrawal by Subject|4|||
126683282|NCT01888640|455796909|FG000|Overall Study|Minimum dose not met|10|||
126683283|NCT01888640|455796910|FG001|Overall Study|Minimum dose not met|16|||
126683284|NCT01888640|455796911|FG002|Overall Study|Minimum dose not met|0|||
126436979|NCT01744977|454900903|FG000|Overall Study|Death|2|||
126436980|NCT01744977|454900904|FG001|Overall Study|Death|3|||
126436981|NCT01744977|454900903|FG000|Overall Study|Lost to Follow-up|2|||
126436982|NCT01744977|454900904|FG001|Overall Study|Lost to Follow-up|0|||
126436983|NCT01744977|454900903|FG000|Overall Study|No longer meets inclusion|6|||
126436984|NCT01744977|454900904|FG001|Overall Study|No longer meets inclusion|0|||
126436985|NCT02156076|454900907|FG000|Treatment Period|no longer meets study criteria|0|||
126436986|NCT02156076|454900908|FG001|Treatment Period|no longer meets study criteria|0|||
126436987|NCT02156076|454900909|FG002|Treatment Period|no longer meets study criteria|1|||
126436988|NCT02156076|454900910|FG003|Treatment Period|no longer meets study criteria|0|||
126436989|NCT02156076|454900907|FG000|Treatment Period|Poor/non-compliance|0|||
126436990|NCT02156076|454900908|FG001|Treatment Period|Poor/non-compliance|1|||
126436991|NCT02156076|454900909|FG002|Treatment Period|Poor/non-compliance|0|||
126436992|NCT02156076|454900910|FG003|Treatment Period|Poor/non-compliance|0|||
126436993|NCT02156076|454900907|FG000|Treatment Period|Lost to Follow-up|0|||
126436994|NCT02156076|454900908|FG001|Treatment Period|Lost to Follow-up|0|||
126436995|NCT02156076|454900909|FG002|Treatment Period|Lost to Follow-up|0|||
126436996|NCT02156076|454900910|FG003|Treatment Period|Lost to Follow-up|1|||
126436997|NCT02156076|454900907|FG000|Treatment Period|Withdrawal by Subject|0|||
126436998|NCT02156076|454900908|FG001|Treatment Period|Withdrawal by Subject|0|||
126436999|NCT02156076|454900909|FG002|Treatment Period|Withdrawal by Subject|1|||
126683285|NCT01888640|455796909|FG000|Overall Study|Given wrong unit (placebo)|1|||
126683286|NCT01888640|455796910|FG001|Overall Study|Given wrong unit (placebo)|0|||
126683287|NCT01888640|455796911|FG002|Overall Study|Given wrong unit (placebo)|0|||
126683288|NCT01888640|455796909|FG000|Overall Study|Excluded for prior TENS|0|||
126683289|NCT01888640|455796910|FG001|Overall Study|Excluded for prior TENS|1|||
126683290|NCT01888640|455796911|FG002|Overall Study|Excluded for prior TENS|0|||
126437000|NCT02156076|454900910|FG003|Treatment Period|Withdrawal by Subject|0|||
126437001|NCT02156076|454900907|FG000|Treatment Period|Subject request to discontinue treatment|0|||
126545374|NCT02100722|455290820|FG001|Overall Study|Withdrawal pre-procedure|9|||
126683291|NCT01888640|455796909|FG000|Overall Study|Researcher Termination of Participant|0|||
126683292|NCT01888640|455796910|FG001|Overall Study|Researcher Termination of Participant|1|||
126683293|NCT01888640|455796911|FG002|Overall Study|Researcher Termination of Participant|1|||
126437002|NCT02156076|454900908|FG001|Treatment Period|Subject request to discontinue treatment|1|||
126437003|NCT02156076|454900909|FG002|Treatment Period|Subject request to discontinue treatment|0|||
126437004|NCT02156076|454900910|FG003|Treatment Period|Subject request to discontinue treatment|0|||
126437005|NCT02156076|454900907|FG000|Treatment Period|Adverse Event|0|||
126437006|NCT02156076|454900908|FG001|Treatment Period|Adverse Event|0|||
126437007|NCT02156076|454900909|FG002|Treatment Period|Adverse Event|0|||
126437008|NCT02156076|454900910|FG003|Treatment Period|Adverse Event|1|||
126437009|NCT02156076|454900907|FG000|Follow-up Period|Withdrawal by Subject|1|||
126437010|NCT02156076|454900908|FG001|Follow-up Period|Withdrawal by Subject|0|||
126437011|NCT02156076|454900909|FG002|Follow-up Period|Withdrawal by Subject|0|||
126437012|NCT02156076|454900910|FG003|Follow-up Period|Withdrawal by Subject|0|||
126437013|NCT01213472|454900913|FG000|Overall Study|Recurrence/Progressive disease|25|||
126437014|NCT01213472|454900913|FG000|Overall Study|Withdrawal by Subject|1|||
126437015|NCT01213472|454900913|FG000|Overall Study|Physician Decision|1|||
126437016|NCT04225897|454900915|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126437017|NCT04225897|454900916|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
126437018|NCT04225897|454900917|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126437019|NCT04225897|454900918|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126437020|NCT04225897|454900919|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126437021|NCT04225897|454900920|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126437022|NCT04225897|454900921|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126437023|NCT04225897|454900922|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126437024|NCT04225897|454900923|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126437025|NCT04225897|454900924|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126437026|NCT04225897|454900925|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126437027|NCT04225897|454900926|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
126437028|NCT04225897|454900915|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126437029|NCT04225897|454900916|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126437030|NCT04225897|454900917|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
126437031|NCT04225897|454900918|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126437032|NCT04225897|454900919|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126437033|NCT04225897|454900920|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126437034|NCT04225897|454900921|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126437035|NCT04225897|454900922|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126437036|NCT04225897|454900923|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126437037|NCT04225897|454900924|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126437038|NCT04225897|454900925|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126437039|NCT04225897|454900926|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
126437040|NCT04225897|454900915|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126437041|NCT04225897|454900916|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126437042|NCT04225897|454900917|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
126437043|NCT04225897|454900918|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126437044|NCT04225897|454900919|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126683294|NCT03436862|455796919|FG000|Overall Study|Adverse Event|4|||
126683295|NCT03436862|455796919|FG000|Overall Study|Progressive Disease|2|||
126683296|NCT02228590|455796921|FG000|Overall Study|Withdrawal by Subject|1|||
126683297|NCT00391222|455796922|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
126683298|NCT00391222|455796923|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
126683299|NCT00391222|455796924|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
126437045|NCT04225897|454900920|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126437046|NCT04225897|454900921|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126437047|NCT04225897|454900922|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126437048|NCT04225897|454900923|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126437049|NCT04225897|454900924|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126437050|NCT04225897|454900925|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126437051|NCT04225897|454900926|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
126437052|NCT04225897|454900915|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
126437053|NCT04225897|454900916|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
126437054|NCT04225897|454900917|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
126437055|NCT04225897|454900918|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
126683300|NCT00391222|455796925|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
126683301|NCT00391222|455796922|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
126683302|NCT00391222|455796923|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
126437056|NCT04225897|454900919|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
126437057|NCT04225897|454900920|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
126437058|NCT04225897|454900921|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
126683303|NCT00391222|455796924|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
126683304|NCT00391222|455796925|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
126683305|NCT00391222|455796922|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
126683306|NCT00391222|455796923|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
126683307|NCT00391222|455796924|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
126683308|NCT00391222|455796925|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
126683309|NCT00391222|455796922|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
126683310|NCT00391222|455796923|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
126683311|NCT00391222|455796924|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
126683312|NCT00391222|455796925|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
126683313|NCT00391222|455796922|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
126683314|NCT00391222|455796923|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
126683315|NCT00391222|455796924|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
126683316|NCT00391222|455796925|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
126683317|NCT00391222|455796922|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
126683318|NCT00391222|455796923|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
126683319|NCT00391222|455796924|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
126683320|NCT00391222|455796925|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
126683321|NCT00391222|455796922|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
126683322|NCT00391222|455796923|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
126683323|NCT00391222|455796924|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
126683324|NCT00391222|455796925|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
126683325|NCT00391222|455796922|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
126683326|NCT00391222|455796923|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
126683327|NCT00391222|455796924|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
126683328|NCT00391222|455796925|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
126683329|NCT00391222|455796922|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
126683330|NCT00391222|455796923|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
126683331|NCT00391222|455796924|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
126683332|NCT00391222|455796925|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
126683333|NCT00391222|455796922|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
126683334|NCT00391222|455796923|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
126683335|NCT00391222|455796924|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
126683336|NCT00391222|455796925|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
126683337|NCT00391222|455796922|FG000|Period III (Double-Blind Treatment)|Other|6|||
126683338|NCT00391222|455796923|FG001|Period III (Double-Blind Treatment)|Other|1|||
126683339|NCT00391222|455796924|FG002|Period III (Double-Blind Treatment)|Other|6|||
126683340|NCT00391222|455796925|FG003|Period III (Double-Blind Treatment)|Other|0|||
126683341|NCT01097863|455796926|FG000|Overall Study|Discomfort|1|||
126683342|NCT01097863|455796927|FG001|Overall Study|Discomfort|0|||
126683343|NCT01097863|455796928|FG002|Overall Study|Discomfort|1|||
126683344|NCT01097863|455796926|FG000|Overall Study|Did not return for final visit|0|||
126683345|NCT01097863|455796927|FG001|Overall Study|Did not return for final visit|0|||
126683346|NCT01097863|455796928|FG002|Overall Study|Did not return for final visit|1|||
126683347|NCT00960843|455796929|FG000|Overall Study|Lost to Follow-up|2|||
126683348|NCT00960843|455796930|FG001|Overall Study|Lost to Follow-up|0|||
126683349|NCT00960843|455796929|FG000|Overall Study|Protocol Violation|0|||
126683350|NCT00960843|455796930|FG001|Overall Study|Protocol Violation|4|||
126683351|NCT00960843|455796929|FG000|Overall Study|Repeated needle dislodgment|0|||
126683352|NCT00960843|455796930|FG001|Overall Study|Repeated needle dislodgment|1|||
126683353|NCT00490451|455796933|FG000|Overall Study|Adverse Event|3|||
126683354|NCT00490451|455796934|FG001|Overall Study|Adverse Event|3|||
126683355|NCT00490451|455796933|FG000|Overall Study|Death|3|||
126683356|NCT00490451|455796934|FG001|Overall Study|Death|1|||
126683357|NCT00490451|455796933|FG000|Overall Study|Withdrawal by Subject|2|||
126683358|NCT00490451|455796934|FG001|Overall Study|Withdrawal by Subject|0|||
126683359|NCT00490451|455796933|FG000|Overall Study|Investigator Decision|1|||
126683360|NCT00490451|455796934|FG001|Overall Study|Investigator Decision|0|||
126683361|NCT00490451|455796933|FG000|Overall Study|Protocol Violation|1|||
126683362|NCT00490451|455796934|FG001|Overall Study|Protocol Violation|0|||
126683363|NCT00490451|455796933|FG000|Overall Study|Progressive Disease|53|||
126683364|NCT00490451|455796934|FG001|Overall Study|Progressive Disease|34|||
126683365|NCT01181011|455796935|FG000|Overall Study|Adverse Event|2|||
126683366|NCT01181011|455796935|FG000|Overall Study|Lost to Follow-up|1|||
126683367|NCT02788747|455796936|FG000|Overall Study|Adverse Event|1|||
126683368|NCT02788747|455796937|FG001|Overall Study|Adverse Event|0|||
126683369|NCT02788747|455796938|FG002|Overall Study|Adverse Event|0|||
126683370|NCT01967550|455796939|FG000|Overall Study|Withdrawal by Subject|1|||
126683371|NCT01967550|455796940|FG001|Overall Study|Withdrawal by Subject|0|||
126683372|NCT01967550|455796939|FG000|Overall Study|Adverse Event|2|||
126683373|NCT01967550|455796940|FG001|Overall Study|Adverse Event|0|||
126683374|NCT01967550|455796939|FG000|Overall Study|Protocol Violation|2|||
126683375|NCT01967550|455796940|FG001|Overall Study|Protocol Violation|1|||
126683376|NCT01967550|455796939|FG000|Overall Study|Non Compliance|0|||
126683377|NCT01967550|455796940|FG001|Overall Study|Non Compliance|1|||
126683378|NCT00852995|455796943|FG000|Overall Study|Adverse Event|1|||
126683379|NCT00852995|455796944|FG001|Overall Study|Adverse Event|0|||
126683380|NCT00852995|455796945|FG002|Overall Study|Adverse Event|4|||
126683381|NCT00852995|455796946|FG003|Overall Study|Adverse Event|0|||
126683382|NCT00852995|455796947|FG004|Overall Study|Adverse Event|0|||
126683383|NCT00852995|455796943|FG000|Overall Study|Lost to Follow-up|0|||
126683384|NCT00852995|455796944|FG001|Overall Study|Lost to Follow-up|1|||
126683385|NCT00852995|455796945|FG002|Overall Study|Lost to Follow-up|1|||
126683386|NCT00852995|455796946|FG003|Overall Study|Lost to Follow-up|0|||
126683387|NCT00852995|455796947|FG004|Overall Study|Lost to Follow-up|0|||
126683388|NCT00852995|455796943|FG000|Overall Study|Withdrawal by Subject|4|||
126683389|NCT00852995|455796944|FG001|Overall Study|Withdrawal by Subject|0|||
126683390|NCT00852995|455796945|FG002|Overall Study|Withdrawal by Subject|0|||
126683391|NCT00852995|455796946|FG003|Overall Study|Withdrawal by Subject|1|||
126683392|NCT00852995|455796947|FG004|Overall Study|Withdrawal by Subject|2|||
126683393|NCT00852995|455796943|FG000|Overall Study|Non-Compliance|0|||
126683394|NCT00852995|455796944|FG001|Overall Study|Non-Compliance|0|||
126683395|NCT00852995|455796945|FG002|Overall Study|Non-Compliance|0|||
126683396|NCT00852995|455796946|FG003|Overall Study|Non-Compliance|2|||
126683397|NCT00852995|455796947|FG004|Overall Study|Non-Compliance|0|||
126683398|NCT00852995|455796943|FG000|Overall Study|Progressive Disease|1|||
126683399|NCT00852995|455796944|FG001|Overall Study|Progressive Disease|0|||
126683400|NCT00852995|455796945|FG002|Overall Study|Progressive Disease|0|||
126683401|NCT00852995|455796946|FG003|Overall Study|Progressive Disease|2|||
126683402|NCT00852995|455796947|FG004|Overall Study|Progressive Disease|1|||
126683403|NCT00852995|455796943|FG000|Overall Study|Physician Decision|1|||
126683404|NCT00852995|455796944|FG001|Overall Study|Physician Decision|0|||
126683405|NCT00852995|455796945|FG002|Overall Study|Physician Decision|0|||
126683406|NCT00852995|455796946|FG003|Overall Study|Physician Decision|0|||
126683407|NCT00852995|455796947|FG004|Overall Study|Physician Decision|0|||
126683408|NCT00852995|455796943|FG000|Overall Study|Protocol Violation|0|||
126683409|NCT00852995|455796944|FG001|Overall Study|Protocol Violation|0|||
126683410|NCT00852995|455796945|FG002|Overall Study|Protocol Violation|0|||
126683411|NCT00852995|455796946|FG003|Overall Study|Protocol Violation|0|||
126683412|NCT00852995|455796947|FG004|Overall Study|Protocol Violation|1|||
126683413|NCT00852995|455796943|FG000|Overall Study|Moved Out of Area|1|||
126683414|NCT00852995|455796944|FG001|Overall Study|Moved Out of Area|0|||
126683415|NCT00852995|455796945|FG002|Overall Study|Moved Out of Area|0|||
126683416|NCT00852995|455796946|FG003|Overall Study|Moved Out of Area|0|||
126683417|NCT00852995|455796947|FG004|Overall Study|Moved Out of Area|0|||
126683418|NCT04518462|455796951|FG000|Overall Study|Withdrawal by Subject|0|||
126683419|NCT04518462|455796952|FG001|Overall Study|Withdrawal by Subject|0|||
126683420|NCT04518462|455796953|FG002|Overall Study|Withdrawal by Subject|1|||
126683421|NCT04518462|455796951|FG000|Overall Study|Physician Decision|1|||
126683422|NCT04518462|455796952|FG001|Overall Study|Physician Decision|1|||
126683423|NCT04518462|455796953|FG002|Overall Study|Physician Decision|0|||
126683424|NCT01471782|455796957|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
126683425|NCT01471782|455796958|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
126683426|NCT01471782|455796959|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
126683427|NCT01471782|455796960|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
126683428|NCT01471782|455796961|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
126683429|NCT01471782|455796962|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
126683430|NCT01471782|455796957|FG000|Overall Study|Lack of Efficacy|1|||
126683431|NCT01471782|455796958|FG001|Overall Study|Lack of Efficacy|2|||
126683432|NCT01471782|455796959|FG002|Overall Study|Lack of Efficacy|1|||
126683433|NCT01471782|455796960|FG003|Overall Study|Lack of Efficacy|1|||
126683434|NCT01471782|455796961|FG004|Overall Study|Lack of Efficacy|5|||
126683435|NCT01471782|455796962|FG005|Overall Study|Lack of Efficacy|18|||
126683436|NCT01471782|455796957|FG000|Overall Study|Adverse Event|1|||
126683437|NCT01471782|455796958|FG001|Overall Study|Adverse Event|1|||
126683438|NCT01471782|455796959|FG002|Overall Study|Adverse Event|2|||
126683439|NCT01471782|455796960|FG003|Overall Study|Adverse Event|2|||
126683440|NCT01471782|455796961|FG004|Overall Study|Adverse Event|3|||
126683441|NCT01471782|455796962|FG005|Overall Study|Adverse Event|1|||
126683442|NCT01471782|455796957|FG000|Overall Study|Other|0|||
126683443|NCT01471782|455796958|FG001|Overall Study|Other|0|||
126683444|NCT01471782|455796959|FG002|Overall Study|Other|1|||
126683445|NCT01471782|455796960|FG003|Overall Study|Other|1|||
126683446|NCT01471782|455796961|FG004|Overall Study|Other|6|||
126683447|NCT01471782|455796962|FG005|Overall Study|Other|5|||
126683448|NCT01471782|455796957|FG000|Overall Study|Change of Chemotherapy|1|||
126683449|NCT01471782|455796958|FG001|Overall Study|Change of Chemotherapy|1|||
126683450|NCT01471782|455796959|FG002|Overall Study|Change of Chemotherapy|0|||
126683451|NCT01471782|455796960|FG003|Overall Study|Change of Chemotherapy|0|||
126683452|NCT01471782|455796961|FG004|Overall Study|Change of Chemotherapy|1|||
126683453|NCT01471782|455796962|FG005|Overall Study|Change of Chemotherapy|4|||
126683454|NCT01471782|455796957|FG000|Overall Study|Disease Relapse|0|||
126683455|NCT01471782|455796958|FG001|Overall Study|Disease Relapse|0|||
126683456|NCT01471782|455796959|FG002|Overall Study|Disease Relapse|0|||
126683457|NCT01471782|455796960|FG003|Overall Study|Disease Relapse|1|||
126683458|NCT01471782|455796961|FG004|Overall Study|Disease Relapse|2|||
126683459|NCT01471782|455796962|FG005|Overall Study|Disease Relapse|1|||
126683460|NCT01471782|455796957|FG000|Overall Study|Physician Decision|0|||
126683461|NCT01471782|455796958|FG001|Overall Study|Physician Decision|0|||
126683462|NCT01471782|455796959|FG002|Overall Study|Physician Decision|0|||
126683463|NCT01471782|455796960|FG003|Overall Study|Physician Decision|0|||
126683464|NCT01471782|455796961|FG004|Overall Study|Physician Decision|3|||
126683465|NCT01471782|455796962|FG005|Overall Study|Physician Decision|8|||
126683466|NCT01471782|455796957|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126683467|NCT01471782|455796958|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126683468|NCT01471782|455796959|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126683469|NCT01471782|455796960|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126683470|NCT01471782|455796961|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
126683471|NCT01471782|455796962|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126683472|NCT01471782|455796957|FG000|Overall Study|Death|0|||
126683473|NCT01471782|455796958|FG001|Overall Study|Death|0|||
126683474|NCT01471782|455796959|FG002|Overall Study|Death|0|||
126683475|NCT01471782|455796960|FG003|Overall Study|Death|0|||
126683476|NCT01471782|455796961|FG004|Overall Study|Death|0|||
126683477|NCT01471782|455796962|FG005|Overall Study|Death|1|||
126683478|NCT00805480|455796965|FG000|Overall Study|Withdrawal by Subject|13|||
126683479|NCT00805480|455796966|FG001|Overall Study|Withdrawal by Subject|5|||
126683480|NCT00805480|455796967|FG002|Overall Study|Withdrawal by Subject|11|||
126683481|NCT00805480|455796968|FG003|Overall Study|Withdrawal by Subject|5|||
126683482|NCT00805480|455796965|FG000|Overall Study|Lost to Follow-up|1|||
126437059|NCT04225897|454900922|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
126437060|NCT04225897|454900923|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
126437061|NCT04225897|454900924|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
126437062|NCT04225897|454900925|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
126437063|NCT04225897|454900926|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
126437064|NCT02085460|454900927|FG000|Overall Study|Adverse Event|2|||
126437065|NCT02085460|454900928|FG001|Overall Study|Adverse Event|2|||
126437066|NCT02085460|454900929|FG002|Overall Study|Adverse Event|1|||
126437067|NCT02085460|454900927|FG000|Overall Study|Physician Decision|1|||
126437068|NCT02085460|454900928|FG001|Overall Study|Physician Decision|1|||
126437069|NCT02085460|454900929|FG002|Overall Study|Physician Decision|2|||
126437070|NCT02085460|454900927|FG000|Overall Study|Withdrawal by Subject|11|||
126437071|NCT02085460|454900928|FG001|Overall Study|Withdrawal by Subject|5|||
126437072|NCT02085460|454900929|FG002|Overall Study|Withdrawal by Subject|7|||
126437073|NCT01285323|454900930|FG000|Overall Study|Adverse Event|9|||
126437074|NCT01285323|454900931|FG001|Overall Study|Adverse Event|8|||
126437075|NCT01285323|454900930|FG000|Overall Study|Lack of Efficacy|4|||
126437076|NCT01285323|454900931|FG001|Overall Study|Lack of Efficacy|2|||
126437077|NCT01285323|454900930|FG000|Overall Study|Withdrawal by Subject|15|||
126437078|NCT01285323|454900931|FG001|Overall Study|Withdrawal by Subject|11|||
126437079|NCT01285323|454900930|FG000|Overall Study|Protocol Violation|1|||
126437080|NCT01285323|454900931|FG001|Overall Study|Protocol Violation|2|||
126437081|NCT01285323|454900930|FG000|Overall Study|Non-compliance with study procedures|2|||
126437082|NCT01285323|454900931|FG001|Overall Study|Non-compliance with study procedures|3|||
126437083|NCT01285323|454900930|FG000|Overall Study|Lost to Follow-up|1|||
126683483|NCT00805480|455796966|FG001|Overall Study|Lost to Follow-up|2|||
126683484|NCT00805480|455796967|FG002|Overall Study|Lost to Follow-up|0|||
126683485|NCT00805480|455796968|FG003|Overall Study|Lost to Follow-up|0|||
126683486|NCT00805480|455796965|FG000|Overall Study|Adverse Event|0|||
126683487|NCT00805480|455796966|FG001|Overall Study|Adverse Event|0|||
126437084|NCT01285323|454900931|FG001|Overall Study|Lost to Follow-up|1|||
126683488|NCT00805480|455796967|FG002|Overall Study|Adverse Event|1|||
126683489|NCT00805480|455796968|FG003|Overall Study|Adverse Event|0|||
126683490|NCT04099251|455798378|FG000|Pre-Treatment|Other reasons|1|||
126683491|NCT04099251|455798379|FG001|Pre-Treatment|Other reasons|0|||
126683492|NCT04099251|455798378|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
126437085|NCT01285323|454900930|FG000|Overall Study|Other|1|||
126437086|NCT01285323|454900931|FG001|Overall Study|Other|3|||
126437087|NCT02703597|454900932|FG000|Assignment to Baseline|Lost to Follow-up|17|||
126437088|NCT02703597|454900933|FG001|Assignment to Baseline|Lost to Follow-up|16|||
126683493|NCT04099251|455798379|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
126683494|NCT04099251|455798378|FG000|Blinded Treatment Phase|Other reasons|16|||
126758812|NCT01072175|456066694|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
126758813|NCT01072175|456066695|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
126758814|NCT01072175|456066696|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
126758815|NCT01072175|456066697|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
126758816|NCT01072175|456066698|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
126758817|NCT01072175|456066699|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
126758818|NCT01072175|456066700|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
126758819|NCT01072175|456066701|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
126758820|NCT01072175|456066702|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
126758821|NCT01072175|456066703|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
126758822|NCT01072175|456066691|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126758823|NCT01072175|456066692|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126758824|NCT01072175|456066693|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126758825|NCT01072175|456066694|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126758826|NCT01072175|456066695|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126758827|NCT01072175|456066696|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
126758828|NCT01072175|456066697|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
126758829|NCT01072175|456066698|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
126758830|NCT01072175|456066699|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126758831|NCT01072175|456066700|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126758832|NCT01072175|456066701|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126758833|NCT01072175|456066702|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126758834|NCT01072175|456066703|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
126758835|NCT01072175|456066691|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126758836|NCT01072175|456066692|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126758837|NCT01072175|456066693|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126758838|NCT01072175|456066694|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126758839|NCT01072175|456066695|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126758840|NCT01072175|456066696|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126758841|NCT01072175|456066697|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
126758842|NCT01072175|456066698|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
126758843|NCT01072175|456066699|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126758844|NCT01072175|456066700|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126758845|NCT01072175|456066701|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126758846|NCT01072175|456066702|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126758847|NCT01072175|456066703|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
126758848|NCT01072175|456066691|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126758849|NCT01072175|456066692|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126758850|NCT01072175|456066693|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126758851|NCT01072175|456066694|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126758852|NCT01072175|456066695|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126758853|NCT01072175|456066696|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
126758854|NCT01072175|456066697|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
126758855|NCT01072175|456066698|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
126758856|NCT01072175|456066699|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126758857|NCT01072175|456066700|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126758858|NCT01072175|456066701|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126758859|NCT01072175|456066702|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126758860|NCT01072175|456066703|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
126758861|NCT01072175|456066691|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126758862|NCT01072175|456066692|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126758863|NCT01072175|456066693|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126758864|NCT01072175|456066694|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126758865|NCT01072175|456066695|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126758866|NCT01072175|456066696|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
126758867|NCT01072175|456066697|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
126758868|NCT01072175|456066698|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126758869|NCT01072175|456066699|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126758870|NCT01072175|456066700|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126758871|NCT01072175|456066701|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126758872|NCT01072175|456066702|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126758873|NCT01072175|456066703|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
126758874|NCT01072175|456066691|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126758875|NCT01072175|456066692|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126437089|NCT02703597|454900932|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
126437090|NCT02703597|454900933|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
126437091|NCT02703597|454900932|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
126437092|NCT02703597|454900933|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
126437093|NCT02703597|454900932|FG000|First Post-test to First Follow-up|Site drop out|0|||
126437094|NCT02703597|454900933|FG001|First Post-test to First Follow-up|Site drop out|58|||
126437095|NCT02703597|454900932|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
126437096|NCT02703597|454900933|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
126437097|NCT02703597|454900932|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
126437098|NCT02703597|454900933|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
126437099|NCT02703597|454900932|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
126437100|NCT02703597|454900933|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
126437101|NCT02796170|454900935|FG000|Overall Study|Lost to Follow-up|3|||
126437102|NCT02796170|454900936|FG001|Overall Study|Lost to Follow-up|0|||
126437103|NCT04313244|454900941|FG000|Overall Study|Withdrawal of Consent|3|||
126437104|NCT04313244|454900942|FG001|Overall Study|Withdrawal of Consent|3|||
126437105|NCT04313244|454900941|FG000|Overall Study|Met Exclusion Criteria|1|||
126437106|NCT04313244|454900942|FG001|Overall Study|Met Exclusion Criteria|0|||
126437107|NCT04313244|454900941|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
126437108|NCT04313244|454900942|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
126437109|NCT01472289|454900945|FG000|Overall Study|Death|2|||
126437110|NCT03879772|454900946|FG000|Overall Study|Adverse Event|2|||
126437111|NCT03879772|454900947|FG001|Overall Study|Adverse Event|2|||
126437112|NCT03879772|454900948|FG002|Overall Study|Adverse Event|3|||
126437113|NCT03879772|454900949|FG003|Overall Study|Adverse Event|4|||
126437114|NCT03879772|454900950|FG004|Overall Study|Adverse Event|3|||
126437115|NCT03879772|454900946|FG000|Overall Study|Treatment Failure|1|||
126437116|NCT03879772|454900947|FG001|Overall Study|Treatment Failure|0|||
126437117|NCT03879772|454900948|FG002|Overall Study|Treatment Failure|0|||
126437118|NCT03879772|454900949|FG003|Overall Study|Treatment Failure|2|||
126437119|NCT03879772|454900950|FG004|Overall Study|Treatment Failure|1|||
126437120|NCT03879772|454900946|FG000|Overall Study|Lost to Follow-up|0|||
126437121|NCT03879772|454900947|FG001|Overall Study|Lost to Follow-up|0|||
126437122|NCT03879772|454900948|FG002|Overall Study|Lost to Follow-up|0|||
126437123|NCT03879772|454900949|FG003|Overall Study|Lost to Follow-up|0|||
126437124|NCT03879772|454900950|FG004|Overall Study|Lost to Follow-up|1|||
126437125|NCT03879772|454900946|FG000|Overall Study|Withdrawal by Subject|0|||
126437126|NCT03879772|454900947|FG001|Overall Study|Withdrawal by Subject|1|||
126437127|NCT03879772|454900948|FG002|Overall Study|Withdrawal by Subject|3|||
126437128|NCT03879772|454900949|FG003|Overall Study|Withdrawal by Subject|1|||
126437129|NCT03879772|454900950|FG004|Overall Study|Withdrawal by Subject|1|||
126437130|NCT03879772|454900946|FG000|Overall Study|Protocol Violation|0|||
126437131|NCT03879772|454900947|FG001|Overall Study|Protocol Violation|0|||
126437132|NCT03879772|454900948|FG002|Overall Study|Protocol Violation|3|||
126437133|NCT03879772|454900949|FG003|Overall Study|Protocol Violation|1|||
126437134|NCT03879772|454900950|FG004|Overall Study|Protocol Violation|2|||
126437135|NCT03879772|454900946|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
126437136|NCT03879772|454900947|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
126437137|NCT03879772|454900948|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
126437138|NCT03879772|454900949|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
126437139|NCT03879772|454900950|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
126437140|NCT00871975|454900957|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
126437141|NCT00871975|454900957|FG000|Overall Study|Catheters could not be inserted|1|||
126437142|NCT00871975|454900957|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
126437143|NCT00871975|454900957|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
126437144|NCT05249582|454900958|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
126437145|NCT05249582|454900959|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
126437146|NCT05249582|454900958|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
126437147|NCT05249582|454900959|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
126437148|NCT05249582|454900958|FG000|Overall Study|Declined to use virtual reality headset|1|||
126683495|NCT04099251|455798379|FG001|Blinded Treatment Phase|Other reasons|7|||
126683496|NCT04099251|455798378|FG000|Blinded Treatment Phase|Disease recurrence|26|||
126437149|NCT05249582|454900959|FG001|Overall Study|Declined to use virtual reality headset|0|||
126437150|NCT00283296|454900960|FG000|Overall Study|in-home trial not completed|5|||
126437151|NCT02668653|454900961|FG000|Overall Study|Refractory disease|41|||
126437152|NCT02668653|454900962|FG001|Overall Study|Refractory disease|70|||
126437153|NCT02668653|454900961|FG000|Overall Study|Relapse|44|||
126437154|NCT02668653|454900962|FG001|Overall Study|Relapse|65|||
126437155|NCT02668653|454900961|FG000|Overall Study|Adverse Event|58|||
126437156|NCT02668653|454900962|FG001|Overall Study|Adverse Event|23|||
126437157|NCT02668653|454900961|FG000|Overall Study|Subject decision to stop study drug|25|||
126437158|NCT02668653|454900962|FG001|Overall Study|Subject decision to stop study drug|23|||
126437159|NCT02668653|454900961|FG000|Overall Study|Other reasons not specified|16|||
126437160|NCT02668653|454900962|FG001|Overall Study|Other reasons not specified|11|||
126437161|NCT02668653|454900961|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
126437162|NCT02668653|454900962|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
126437163|NCT02668653|454900961|FG000|Overall Study|Investigator decision|10|||
126437164|NCT02668653|454900962|FG001|Overall Study|Investigator decision|7|||
126437165|NCT02668653|454900961|FG000|Overall Study|Failure to meet continuation criteria|5|||
126437166|NCT02668653|454900962|FG001|Overall Study|Failure to meet continuation criteria|12|||
126437167|NCT02668653|454900961|FG000|Overall Study|Lost to Follow-up|1|||
126437168|NCT02668653|454900962|FG001|Overall Study|Lost to Follow-up|0|||
126437169|NCT02668653|454900961|FG000|Overall Study|Pregnancy|0|||
126437170|NCT02668653|454900962|FG001|Overall Study|Pregnancy|1|||
126683497|NCT04099251|455798379|FG001|Blinded Treatment Phase|Disease recurrence|41|||
126683498|NCT04099251|455798378|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
126683499|NCT04099251|455798379|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
126683500|NCT04099251|455798378|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
126683501|NCT04099251|455798379|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
126683502|NCT04099251|455798378|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
126683503|NCT04099251|455798379|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
126683504|NCT04099251|455798378|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
126683505|NCT04099251|455798379|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
126683506|NCT04099251|455798378|FG000|Blinded Treatment Phase|Death|6|||
126683507|NCT04099251|455798379|FG001|Blinded Treatment Phase|Death|2|||
126683508|NCT04099251|455798378|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
126683509|NCT04099251|455798379|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
126683510|NCT04099251|455798378|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
126683511|NCT04099251|455798379|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
126683512|NCT04099251|455798378|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
126683513|NCT04099251|455798379|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
126683514|NCT04099251|455798378|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
126683515|NCT04099251|455798379|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
126683516|NCT04099251|455798378|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
126683517|NCT04099251|455798379|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
126683518|NCT04099251|455798378|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
126683519|NCT04099251|455798379|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
126683520|NCT04099251|455798378|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
126683521|NCT04099251|455798379|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
126683522|NCT04099251|455798378|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
126683523|NCT04099251|455798379|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
126683524|NCT04099251|455798378|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
126683525|NCT04099251|455798379|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
126683526|NCT05032157|455798380|FG000|Overall Study|Adverse Event|12|||
126683527|NCT05032157|455798381|FG001|Overall Study|Adverse Event|7|||
126683528|NCT05032157|455798380|FG000|Overall Study|Pregnancy|0|||
126683529|NCT05032157|455798381|FG001|Overall Study|Pregnancy|2|||
126683530|NCT05032157|455798380|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126683531|NCT05032157|455798381|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
126683532|NCT05032157|455798380|FG000|Overall Study|Protocol Deviation|8|||
126683533|NCT05032157|455798381|FG001|Overall Study|Protocol Deviation|4|||
126683534|NCT05032157|455798380|FG000|Overall Study|Lost to Follow-up|1|||
126683535|NCT05032157|455798381|FG001|Overall Study|Lost to Follow-up|3|||
126683536|NCT05032157|455798380|FG000|Overall Study|Physician Decision|7|||
126683537|NCT05032157|455798381|FG001|Overall Study|Physician Decision|2|||
126683538|NCT05032157|455798380|FG000|Overall Study|Patient Decision|38|||
126683539|NCT05032157|455798381|FG001|Overall Study|Patient Decision|19|||
126683540|NCT03047980|455798382|FG000|Overall Study|Adverse Event|1|||
126683541|NCT01783678|455798383|FG000|Overall Study|Randomized but Not Treated|0|||
126437171|NCT02668653|454900961|FG000|Overall Study|Death|0|||
126437172|NCT02668653|454900962|FG001|Overall Study|Death|1|||
126683542|NCT01783678|455798384|FG001|Overall Study|Randomized but Not Treated|0|||
126683543|NCT01783678|455798385|FG002|Overall Study|Randomized but Not Treated|0|||
126683544|NCT01783678|455798386|FG003|Overall Study|Randomized but Not Treated|1|||
126437173|NCT02158442|454900965|FG000|Overall Study|Withdrawal by Subject|1|||
126437174|NCT02158442|454900966|FG001|Overall Study|Withdrawal by Subject|0|||
126437175|NCT02158442|454900965|FG000|Overall Study|Perfusion staff not available|1|||
126683545|NCT01783678|455798387|FG004|Overall Study|Randomized but Not Treated|0|||
126683546|NCT01783678|455798388|FG005|Overall Study|Randomized but Not Treated|0|||
126683547|NCT01783678|455798383|FG000|Overall Study|Lack of Efficacy|1|||
126683548|NCT01783678|455798384|FG001|Overall Study|Lack of Efficacy|13|||
126683549|NCT01783678|455798385|FG002|Overall Study|Lack of Efficacy|1|||
126683550|NCT01783678|455798386|FG003|Overall Study|Lack of Efficacy|3|||
126683551|NCT01783678|455798387|FG004|Overall Study|Lack of Efficacy|6|||
126683552|NCT01783678|455798388|FG005|Overall Study|Lack of Efficacy|5|||
126683553|NCT01783678|455798383|FG000|Overall Study|Lost to Follow-up|0|||
126758876|NCT01072175|456066693|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126758877|NCT01072175|456066694|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126758878|NCT01072175|456066695|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126758879|NCT01072175|456066696|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126758880|NCT01072175|456066697|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126758881|NCT01072175|456066698|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126758882|NCT01072175|456066699|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
126758883|NCT01072175|456066700|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126758884|NCT01072175|456066701|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126758885|NCT01072175|456066702|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126758886|NCT01072175|456066703|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
126758887|NCT01072175|456066691|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126758888|NCT01072175|456066692|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126758889|NCT01072175|456066693|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126758890|NCT01072175|456066694|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126758891|NCT01072175|456066695|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126758892|NCT01072175|456066696|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126758893|NCT01072175|456066697|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126758894|NCT01072175|456066698|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126758895|NCT01072175|456066699|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
126758896|NCT01072175|456066700|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126758897|NCT01072175|456066701|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126758898|NCT01072175|456066702|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126758899|NCT01072175|456066703|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
126758900|NCT01072175|456066691|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126758901|NCT01072175|456066692|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126758902|NCT01072175|456066693|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126758903|NCT01072175|456066694|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126758904|NCT01072175|456066695|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126758905|NCT01072175|456066696|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126758906|NCT01072175|456066697|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126758907|NCT01072175|456066698|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126758908|NCT01072175|456066699|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
126758909|NCT01072175|456066700|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126758910|NCT01072175|456066701|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126758911|NCT01072175|456066702|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126758912|NCT01072175|456066703|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
126758913|NCT01072175|456066691|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126758914|NCT01072175|456066692|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126758915|NCT01072175|456066693|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126758916|NCT01072175|456066694|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126758917|NCT01072175|456066695|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126758918|NCT01072175|456066696|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126758919|NCT01072175|456066697|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126437176|NCT02158442|454900966|FG001|Overall Study|Perfusion staff not available|0|||
126683554|NCT01783678|455798384|FG001|Overall Study|Lost to Follow-up|4|||
126683555|NCT01783678|455798385|FG002|Overall Study|Lost to Follow-up|0|||
126437177|NCT01294553|454900967|FG000|Overall Study|Duplicated Participants|1|||
126437178|NCT01294553|454900967|FG000|Overall Study|Protocol Violation|268|||
126437179|NCT00926237|454900970|FG000|Overall Study|Withdrawal by Subject|2|||
126437180|NCT00926237|454900971|FG001|Overall Study|Withdrawal by Subject|1|||
126437181|NCT00632229|454900977|FG000|Overall Study|Adverse Event|6|||
126437182|NCT00632229|454900978|FG001|Overall Study|Adverse Event|0|||
126437183|NCT00632229|454900977|FG000|Overall Study|Lost to Follow-up|0|||
126437184|NCT00632229|454900978|FG001|Overall Study|Lost to Follow-up|3|||
126437185|NCT00632229|454900977|FG000|Overall Study|Lack of Efficacy|0|||
126437186|NCT00632229|454900978|FG001|Overall Study|Lack of Efficacy|2|||
126437187|NCT00632229|454900977|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
126437188|NCT00632229|454900978|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
126437189|NCT05386329|454900979|FG000|Overall Study|Lost to Follow-up|3|||
126683556|NCT01783678|455798386|FG003|Overall Study|Lost to Follow-up|2|||
126683557|NCT01783678|455798387|FG004|Overall Study|Lost to Follow-up|1|||
126683558|NCT01783678|455798388|FG005|Overall Study|Lost to Follow-up|0|||
126683559|NCT01783678|455798383|FG000|Overall Study|Withdrew Consent|1|||
126683560|NCT01783678|455798384|FG001|Overall Study|Withdrew Consent|1|||
126683561|NCT01783678|455798385|FG002|Overall Study|Withdrew Consent|0|||
126437190|NCT00577889|454900980|FG000|Overall Study|Withdrawal by Subject|1|||
126437191|NCT00577889|454900981|FG001|Overall Study|Withdrawal by Subject|0|||
126437192|NCT00577889|454900982|FG002|Overall Study|Withdrawal by Subject|0|||
126437193|NCT02667119|454900986|FG000|Overall Study|Lost to Follow-up|3|||
126437194|NCT02667119|454900987|FG001|Overall Study|Lost to Follow-up|0|||
126437195|NCT03783078|454900988|FG000|Overall Study|Death|31|||
126437196|NCT03783078|454900988|FG000|Overall Study|Sponsor Decision|23|||
126437197|NCT03783078|454900988|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126437198|NCT02059278|454900990|FG000|Overall Study|Adverse Event|1|||
126437199|NCT02059278|454900991|FG001|Overall Study|Adverse Event|1|||
126437200|NCT02059278|454900990|FG000|Overall Study|Lost to Follow-up|1|||
126437201|NCT02059278|454900991|FG001|Overall Study|Lost to Follow-up|0|||
126437202|NCT02059278|454900990|FG000|Overall Study|Withdrawal by Subject|0|||
126437203|NCT02059278|454900991|FG001|Overall Study|Withdrawal by Subject|3|||
126437204|NCT02059278|454900990|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
126437205|NCT02059278|454900991|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
126437206|NCT00737672|454901000|FG000|Overall Study|Graft Abandonment|48|||
126437207|NCT00737672|454901001|FG001|Overall Study|Graft Abandonment|56|||
126437208|NCT00737672|454901000|FG000|Overall Study|Death|23|||
126437209|NCT00737672|454901001|FG001|Overall Study|Death|22|||
126437210|NCT00737672|454901000|FG000|Overall Study|Withdrawal by Subject|1|||
126437211|NCT00737672|454901001|FG001|Overall Study|Withdrawal by Subject|2|||
126437212|NCT00737672|454901000|FG000|Overall Study|Lost to Follow-up|1|||
126437213|NCT00737672|454901001|FG001|Overall Study|Lost to Follow-up|0|||
126437214|NCT00737672|454901000|FG000|Overall Study|Miscellaneous|7|||
126437215|NCT00737672|454901001|FG001|Overall Study|Miscellaneous|1|||
126437216|NCT00737672|454901000|FG000|Overall Study|Physician Decision|0|||
126437217|NCT00737672|454901001|FG001|Overall Study|Physician Decision|2|||
126437218|NCT02694185|454901003|FG000|Overall Study|Withdrawal by Subject|45|||
126437219|NCT02694185|454901004|FG001|Overall Study|Withdrawal by Subject|0|||
126437220|NCT05972993|454901016|FG000|Overall Study|Lost to Follow-up|2|||
126437221|NCT05972993|454901017|FG001|Overall Study|Lost to Follow-up|0|||
126437222|NCT05972993|454901018|FG002|Overall Study|Lost to Follow-up|1|||
126437223|NCT05972993|454901019|FG003|Overall Study|Lost to Follow-up|0|||
126437224|NCT05972993|454901020|FG004|Overall Study|Lost to Follow-up|0|||
126437225|NCT05972993|454901021|FG005|Overall Study|Lost to Follow-up|0|||
126437226|NCT05972993|454901022|FG006|Overall Study|Lost to Follow-up|0|||
126437227|NCT05972993|454901023|FG007|Overall Study|Lost to Follow-up|2|||
126437228|NCT05972993|454901024|FG008|Overall Study|Lost to Follow-up|0|||
126437229|NCT03818256|454901025|FG000|Overall Study|Withdrawal by Subject|2|||
126437230|NCT03818256|454901026|FG001|Overall Study|Withdrawal by Subject|2|||
126437231|NCT03818256|454901025|FG000|Overall Study|Adverse Event|3|||
126437232|NCT03818256|454901026|FG001|Overall Study|Adverse Event|1|||
126437233|NCT03818256|454901025|FG000|Overall Study|Lost to Follow-up|0|||
126437234|NCT03818256|454901026|FG001|Overall Study|Lost to Follow-up|5|||
126437235|NCT03818256|454901025|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
126437236|NCT03818256|454901026|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
126437237|NCT03818256|454901025|FG000|Overall Study|Not reporting for scheduled visits|1|||
126437238|NCT03818256|454901026|FG001|Overall Study|Not reporting for scheduled visits|0|||
126437239|NCT03818256|454901025|FG000|Overall Study|Non-compliant with investigational product|1|||
126437240|NCT03818256|454901026|FG001|Overall Study|Non-compliant with investigational product|0|||
126437241|NCT02594124|454901027|FG000|Overall Study|Adverse Event|0|||
126437242|NCT02594124|454901028|FG001|Overall Study|Adverse Event|5|||
126437243|NCT02594124|454901029|FG002|Overall Study|Adverse Event|8|||
126437244|NCT02594124|454901030|FG003|Overall Study|Adverse Event|1|||
126683562|NCT01783678|455798386|FG003|Overall Study|Withdrew Consent|2|||
126437245|NCT02594124|454901031|FG004|Overall Study|Adverse Event|0|||
126437246|NCT02594124|454901032|FG005|Overall Study|Adverse Event|0|||
126437247|NCT02594124|454901033|FG006|Overall Study|Adverse Event|2|||
126437248|NCT02594124|454901034|FG007|Overall Study|Adverse Event|2|||
126437249|NCT02594124|454901035|FG008|Overall Study|Adverse Event|0|||
126683563|NCT01783678|455798387|FG004|Overall Study|Withdrew Consent|0|||
126683564|NCT01783678|455798388|FG005|Overall Study|Withdrew Consent|0|||
126683565|NCT01995071|455798389|FG000|Overall Study|Adverse Event|0|||
126683566|NCT01995071|455798390|FG001|Overall Study|Adverse Event|0|||
126683567|NCT01995071|455798391|FG002|Overall Study|Adverse Event|0|||
126683568|NCT01995071|455798392|FG003|Overall Study|Adverse Event|0|||
126683569|NCT01995071|455798393|FG004|Overall Study|Adverse Event|0|||
126683570|NCT01995071|455798394|FG005|Overall Study|Adverse Event|0|||
126683571|NCT01995071|455798395|FG006|Overall Study|Adverse Event|1|||
126683572|NCT01995071|455798396|FG007|Overall Study|Adverse Event|0|||
126683573|NCT01995071|455798397|FG008|Overall Study|Adverse Event|0|||
126683574|NCT01995071|455798398|FG009|Overall Study|Adverse Event|0|||
126683575|NCT01995071|455798399|FG010|Overall Study|Adverse Event|0|||
126683576|NCT01995071|455798400|FG011|Overall Study|Adverse Event|0|||
126683577|NCT01995071|455798389|FG000|Overall Study|Moved|0|||
126683578|NCT01995071|455798390|FG001|Overall Study|Moved|0|||
126683579|NCT01995071|455798391|FG002|Overall Study|Moved|1|||
126683580|NCT01995071|455798392|FG003|Overall Study|Moved|0|||
126683581|NCT01995071|455798393|FG004|Overall Study|Moved|1|||
126683582|NCT01995071|455798394|FG005|Overall Study|Moved|0|||
126683583|NCT01995071|455798395|FG006|Overall Study|Moved|0|||
126683584|NCT01995071|455798396|FG007|Overall Study|Moved|0|||
126683585|NCT01995071|455798397|FG008|Overall Study|Moved|0|||
126683586|NCT01995071|455798398|FG009|Overall Study|Moved|0|||
126683587|NCT01995071|455798399|FG010|Overall Study|Moved|1|||
126683588|NCT01995071|455798400|FG011|Overall Study|Moved|0|||
126683589|NCT01995071|455798389|FG000|Overall Study|Lost to Follow-up|1|||
126683590|NCT01995071|455798390|FG001|Overall Study|Lost to Follow-up|0|||
126437250|NCT02594124|454901027|FG000|Overall Study|Withdrawal by Subject|2|||
126437251|NCT02594124|454901028|FG001|Overall Study|Withdrawal by Subject|3|||
126437252|NCT02594124|454901029|FG002|Overall Study|Withdrawal by Subject|5|||
126437253|NCT02594124|454901030|FG003|Overall Study|Withdrawal by Subject|1|||
126437254|NCT02594124|454901031|FG004|Overall Study|Withdrawal by Subject|8|||
126437255|NCT02594124|454901032|FG005|Overall Study|Withdrawal by Subject|4|||
126437256|NCT02594124|454901033|FG006|Overall Study|Withdrawal by Subject|13|||
126437257|NCT02594124|454901034|FG007|Overall Study|Withdrawal by Subject|19|||
126437258|NCT02594124|454901035|FG008|Overall Study|Withdrawal by Subject|0|||
126437259|NCT02594124|454901027|FG000|Overall Study|Physician Decision|0|||
126437260|NCT02594124|454901028|FG001|Overall Study|Physician Decision|2|||
126437261|NCT02594124|454901029|FG002|Overall Study|Physician Decision|0|||
126437262|NCT02594124|454901030|FG003|Overall Study|Physician Decision|0|||
126437263|NCT02594124|454901031|FG004|Overall Study|Physician Decision|0|||
126437264|NCT02594124|454901032|FG005|Overall Study|Physician Decision|0|||
126437265|NCT02594124|454901033|FG006|Overall Study|Physician Decision|0|||
126437266|NCT02594124|454901034|FG007|Overall Study|Physician Decision|1|||
126437267|NCT02594124|454901035|FG008|Overall Study|Physician Decision|0|||
126437268|NCT02594124|454901027|FG000|Overall Study|Commercial drug|0|||
126437269|NCT02594124|454901028|FG001|Overall Study|Commercial drug|1|||
126437270|NCT02594124|454901029|FG002|Overall Study|Commercial drug|6|||
126437271|NCT02594124|454901030|FG003|Overall Study|Commercial drug|3|||
126437272|NCT02594124|454901031|FG004|Overall Study|Commercial drug|0|||
126437273|NCT02594124|454901032|FG005|Overall Study|Commercial drug|0|||
126683591|NCT01995071|455798391|FG002|Overall Study|Lost to Follow-up|0|||
126437274|NCT02594124|454901033|FG006|Overall Study|Commercial drug|7|||
126683592|NCT01995071|455798392|FG003|Overall Study|Lost to Follow-up|0|||
126683593|NCT01995071|455798393|FG004|Overall Study|Lost to Follow-up|0|||
126683594|NCT01995071|455798394|FG005|Overall Study|Lost to Follow-up|0|||
126683595|NCT01995071|455798395|FG006|Overall Study|Lost to Follow-up|0|||
126683596|NCT01995071|455798396|FG007|Overall Study|Lost to Follow-up|1|||
126437275|NCT02594124|454901034|FG007|Overall Study|Commercial drug|11|||
126437276|NCT02594124|454901035|FG008|Overall Study|Commercial drug|2|||
126437277|NCT02594124|454901027|FG000|Overall Study|Reason Not Specified|1|||
126437278|NCT02594124|454901028|FG001|Overall Study|Reason Not Specified|3|||
126683597|NCT01995071|455798397|FG008|Overall Study|Lost to Follow-up|1|||
126683598|NCT01995071|455798398|FG009|Overall Study|Lost to Follow-up|0|||
126683599|NCT01995071|455798399|FG010|Overall Study|Lost to Follow-up|0|||
126683600|NCT01995071|455798400|FG011|Overall Study|Lost to Follow-up|0|||
126683601|NCT01995071|455798389|FG000|Overall Study|Incarcerated|0|||
126683602|NCT01995071|455798390|FG001|Overall Study|Incarcerated|0|||
126437279|NCT02594124|454901029|FG002|Overall Study|Reason Not Specified|4|||
126683603|NCT01995071|455798391|FG002|Overall Study|Incarcerated|0|||
126683604|NCT01995071|455798392|FG003|Overall Study|Incarcerated|0|||
126683605|NCT01995071|455798393|FG004|Overall Study|Incarcerated|0|||
126437280|NCT02594124|454901030|FG003|Overall Study|Reason Not Specified|0|||
126683606|NCT01995071|455798394|FG005|Overall Study|Incarcerated|0|||
126683607|NCT01995071|455798395|FG006|Overall Study|Incarcerated|0|||
126437281|NCT02594124|454901031|FG004|Overall Study|Reason Not Specified|0|||
126437282|NCT02594124|454901032|FG005|Overall Study|Reason Not Specified|1|||
126437283|NCT02594124|454901033|FG006|Overall Study|Reason Not Specified|1|||
126437284|NCT02594124|454901034|FG007|Overall Study|Reason Not Specified|6|||
126437285|NCT02594124|454901035|FG008|Overall Study|Reason Not Specified|1|||
126437286|NCT02514083|454901040|FG000|Overall Study|Adverse Event|1|||
126437287|NCT02121535|454902913|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
126437288|NCT02121535|454902914|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
126683608|NCT01995071|455798396|FG007|Overall Study|Incarcerated|1|||
126683609|NCT01995071|455798397|FG008|Overall Study|Incarcerated|0|||
126683610|NCT01995071|455798398|FG009|Overall Study|Incarcerated|0|||
126683611|NCT01995071|455798399|FG010|Overall Study|Incarcerated|0|||
126683612|NCT01995071|455798400|FG011|Overall Study|Incarcerated|0|||
126683613|NCT02543528|455798401|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
126683614|NCT02543528|455798402|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
126683615|NCT02543528|455798403|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
126683616|NCT02543528|455798404|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
126437289|NCT02121535|454902913|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
126437290|NCT02121535|454902914|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
126683617|NCT02543528|455798405|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
126683618|NCT02543528|455798401|FG000|Adaptation Period|Lens Handling Difficultes|0|||
126683619|NCT02543528|455798402|FG001|Adaptation Period|Lens Handling Difficultes|0|||
126683620|NCT02543528|455798403|FG002|Adaptation Period|Lens Handling Difficultes|0|||
126683621|NCT02543528|455798404|FG003|Adaptation Period|Lens Handling Difficultes|0|||
126683622|NCT02543528|455798405|FG004|Adaptation Period|Lens Handling Difficultes|8|||
126683623|NCT02543528|455798401|FG000|Adaptation Period|Lost to Follow-up|0|||
126437291|NCT00091949|454902915|FG000|Overall Study|Withdrawal by Subject|117|||
126437292|NCT00091949|454902916|FG001|Overall Study|Withdrawal by Subject|110|||
126437293|NCT00091949|454902915|FG000|Overall Study|Lost to Follow-up|58|||
126437294|NCT00091949|454902916|FG001|Overall Study|Lost to Follow-up|41|||
126437295|NCT01256788|454902917|FG000|Overall Study|Lost to Follow-up|5|||
126437296|NCT01256788|454902918|FG001|Overall Study|Lost to Follow-up|8|||
126437297|NCT01256788|454902919|FG002|Overall Study|Lost to Follow-up|3|||
126437298|NCT03312634|454902920|FG000|Overall Study|Adverse Event|11|||
126437299|NCT03312634|454902921|FG001|Overall Study|Adverse Event|0|||
126437300|NCT03312634|454902920|FG000|Overall Study|Sponsor request|2|||
126437301|NCT03312634|454902921|FG001|Overall Study|Sponsor request|0|||
126437302|NCT03312634|454902920|FG000|Overall Study|Withdrawal by Subject|31|||
126437303|NCT03312634|454902921|FG001|Overall Study|Withdrawal by Subject|9|||
126437304|NCT03312634|454902920|FG000|Overall Study|Enrolled in an interventional study|0|||
126437305|NCT03312634|454902921|FG001|Overall Study|Enrolled in an interventional study|52|||
126437306|NCT03312634|454902920|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
126437307|NCT03312634|454902921|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
126437308|NCT03312634|454902920|FG000|Overall Study|Death|0|||
126683624|NCT02543528|455798402|FG001|Adaptation Period|Lost to Follow-up|0|||
126683625|NCT02543528|455798403|FG002|Adaptation Period|Lost to Follow-up|0|||
126683626|NCT02543528|455798404|FG003|Adaptation Period|Lost to Follow-up|0|||
126683627|NCT02543528|455798405|FG004|Adaptation Period|Lost to Follow-up|14|||
126683628|NCT02543528|455798401|FG000|Adaptation Period|Adverse Event|0|||
126683629|NCT02543528|455798402|FG001|Adaptation Period|Adverse Event|0|||
126683630|NCT02543528|455798403|FG002|Adaptation Period|Adverse Event|0|||
126683631|NCT02543528|455798404|FG003|Adaptation Period|Adverse Event|0|||
126683632|NCT02543528|455798405|FG004|Adaptation Period|Adverse Event|2|||
126683633|NCT02543528|455798401|FG000|Extended Wear Period|Adverse Event|17|||
126683634|NCT02543528|455798402|FG001|Extended Wear Period|Adverse Event|11|||
126683635|NCT02543528|455798403|FG002|Extended Wear Period|Adverse Event|16|||
126683636|NCT02543528|455798404|FG003|Extended Wear Period|Adverse Event|3|||
126683637|NCT02543528|455798405|FG004|Extended Wear Period|Adverse Event|0|||
126683638|NCT02543528|455798401|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
126683639|NCT02543528|455798402|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
126437309|NCT03312634|454902921|FG001|Overall Study|Death|1|||
126437310|NCT03312634|454902920|FG000|Overall Study|Non-compliance|0|||
126437311|NCT03312634|454902921|FG001|Overall Study|Non-compliance|2|||
126437312|NCT03312634|454902920|FG000|Overall Study|Lost to Follow-up|0|||
126437313|NCT03312634|454902921|FG001|Overall Study|Lost to Follow-up|1|||
126437314|NCT03312634|454902920|FG000|Overall Study|Enrolled into non-interventional study|0|||
126437315|NCT03312634|454902921|FG001|Overall Study|Enrolled into non-interventional study|5|||
126683640|NCT02543528|455798403|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
126683641|NCT02543528|455798404|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
126683642|NCT02543528|455798405|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
126683643|NCT02543528|455798401|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
126683644|NCT02543528|455798402|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
126683645|NCT02543528|455798403|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
126683646|NCT02543528|455798404|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
126683647|NCT02543528|455798405|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
126683648|NCT02543528|455798401|FG000|Extended Wear Period|Lost to Follow-up|0|||
126683649|NCT02543528|455798402|FG001|Extended Wear Period|Lost to Follow-up|1|||
126683650|NCT02543528|455798403|FG002|Extended Wear Period|Lost to Follow-up|2|||
126683651|NCT02543528|455798404|FG003|Extended Wear Period|Lost to Follow-up|1|||
126683652|NCT02543528|455798405|FG004|Extended Wear Period|Lost to Follow-up|0|||
126683653|NCT02543528|455798401|FG000|Extended Wear Period|Withdrawal by Subject|10|||
126683654|NCT02543528|455798402|FG001|Extended Wear Period|Withdrawal by Subject|9|||
126683655|NCT02543528|455798403|FG002|Extended Wear Period|Withdrawal by Subject|4|||
126683656|NCT02543528|455798404|FG003|Extended Wear Period|Withdrawal by Subject|5|||
126683657|NCT02543528|455798405|FG004|Extended Wear Period|Withdrawal by Subject|0|||
126683658|NCT02049944|455798406|FG000|Overall Study|Protocol Violation|2|||
126683659|NCT00112905|455798407|FG000|Overall Study|Adverse Event|4|||
126683660|NCT00112905|455798407|FG000|Overall Study|Death|1|||
126683661|NCT00112905|455798407|FG000|Overall Study|Ineligibility|5|||
126683662|NCT00112905|455798407|FG000|Overall Study|Alternative treatment|1|||
126683663|NCT00112905|455798407|FG000|Overall Study|performance status was deteiorating|1|||
126683664|NCT01765673|455798408|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
126683665|NCT01042600|455798409|FG000|Overall Study|Ineligible|1|||
126683666|NCT01042600|455798410|FG001|Overall Study|Ineligible|0|||
126683667|NCT02600507|455798411|FG000|Overall Study|Adverse Event|3|||
126683668|NCT02600507|455798412|FG001|Overall Study|Adverse Event|15|||
126683669|NCT02600507|455798413|FG002|Overall Study|Adverse Event|5|||
126683670|NCT02600507|455798411|FG000|Overall Study|Lack of Efficacy|3|||
126683671|NCT02600507|455798412|FG001|Overall Study|Lack of Efficacy|8|||
126683672|NCT02600507|455798413|FG002|Overall Study|Lack of Efficacy|5|||
126683673|NCT02600507|455798411|FG000|Overall Study|Lost to Follow-up|3|||
126683674|NCT02600507|455798412|FG001|Overall Study|Lost to Follow-up|5|||
126683675|NCT02600507|455798413|FG002|Overall Study|Lost to Follow-up|2|||
126683676|NCT02600507|455798411|FG000|Overall Study|Protocol Violation|12|||
126683677|NCT02600507|455798412|FG001|Overall Study|Protocol Violation|4|||
126683678|NCT02600507|455798413|FG002|Overall Study|Protocol Violation|4|||
126683679|NCT02600507|455798411|FG000|Overall Study|Physician Decision|1|||
126683680|NCT02600507|455798412|FG001|Overall Study|Physician Decision|0|||
126683681|NCT02600507|455798413|FG002|Overall Study|Physician Decision|1|||
126683682|NCT02600507|455798411|FG000|Overall Study|Withdrawal by Subject|7|||
126683683|NCT02600507|455798412|FG001|Overall Study|Withdrawal by Subject|11|||
126683684|NCT02600507|455798413|FG002|Overall Study|Withdrawal by Subject|7|||
126683685|NCT02600507|455798411|FG000|Overall Study|Other|0|||
126683686|NCT02600507|455798412|FG001|Overall Study|Other|1|||
126683687|NCT02600507|455798413|FG002|Overall Study|Other|1|||
126683688|NCT00605085|455798419|FG000|Overall Study|Withdrawal by Subject|8|||
126683689|NCT00605085|455798420|FG001|Overall Study|Withdrawal by Subject|5|||
126683690|NCT00605085|455798419|FG000|Overall Study|Adverse Event|9|||
126683691|NCT00605085|455798420|FG001|Overall Study|Adverse Event|5|||
126683692|NCT00605085|455798419|FG000|Overall Study|Pregnancy|2|||
126683693|NCT00605085|455798420|FG001|Overall Study|Pregnancy|0|||
126683694|NCT00605085|455798419|FG000|Overall Study|Protocol Violation|3|||
126683695|NCT00605085|455798420|FG001|Overall Study|Protocol Violation|2|||
126683696|NCT00605085|455798419|FG000|Overall Study|Lost to Follow-up|10|||
126683697|NCT00605085|455798420|FG001|Overall Study|Lost to Follow-up|5|||
126683698|NCT00605085|455798419|FG000|Overall Study|administrative reasons|18|||
126683699|NCT00605085|455798420|FG001|Overall Study|administrative reasons|8|||
126683700|NCT00621504|455798421|FG000|Overall Study|Adverse Event|1|||
126683701|NCT00621504|455798422|FG001|Overall Study|Adverse Event|3|||
126683702|NCT00621504|455798421|FG000|Overall Study|At the request of sponsor/investigator|1|||
126683703|NCT00621504|455798422|FG001|Overall Study|At the request of sponsor/investigator|0|||
126683704|NCT00621504|455798421|FG000|Overall Study|Withdrew consent|9|||
126683705|NCT00621504|455798422|FG001|Overall Study|Withdrew consent|6|||
126683706|NCT00621504|455798421|FG000|Overall Study|Lost to Follow-up|8|||
126683707|NCT00621504|455798422|FG001|Overall Study|Lost to Follow-up|10|||
126683708|NCT00621504|455798421|FG000|Overall Study|Other|1|||
126683709|NCT00621504|455798422|FG001|Overall Study|Other|0|||
126683710|NCT00621504|455798421|FG000|Overall Study|Death|6|||
126683711|NCT00621504|455798422|FG001|Overall Study|Death|6|||
126683712|NCT03257267|455798427|FG000|Overall Study|Adverse Event|17|||
126683713|NCT03257267|455798428|FG001|Overall Study|Adverse Event|7|||
126683714|NCT03257267|455798427|FG000|Overall Study|Death|96|||
126683715|NCT03257267|455798428|FG001|Overall Study|Death|98|||
126683716|NCT03257267|455798427|FG000|Overall Study|Lost to Follow-up|2|||
126683717|NCT03257267|455798428|FG001|Overall Study|Lost to Follow-up|2|||
126683718|NCT03257267|455798427|FG000|Overall Study|Non-compliance with Study Drug|0|||
126683719|NCT03257267|455798428|FG001|Overall Study|Non-compliance with Study Drug|2|||
126683720|NCT03257267|455798427|FG000|Overall Study|Participant Decision|35|||
126683721|NCT03257267|455798428|FG001|Overall Study|Participant Decision|43|||
126437316|NCT03312634|454902920|FG000|Overall Study|Worsening clinical condition|0|||
126437317|NCT03312634|454902921|FG001|Overall Study|Worsening clinical condition|1|||
126437318|NCT03312634|454902920|FG000|Overall Study|Participant did not want to travel|0|||
126437319|NCT03312634|454902921|FG001|Overall Study|Participant did not want to travel|1|||
126437320|NCT03312634|454902920|FG000|Overall Study|Physician Decision|1|||
126437321|NCT03312634|454902921|FG001|Overall Study|Physician Decision|0|||
126437322|NCT03312634|454902920|FG000|Overall Study|Other|13|||
126437323|NCT03312634|454902921|FG001|Overall Study|Other|0|||
126437324|NCT00906204|454902924|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
126437325|NCT00906204|454902925|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
126437326|NCT00906204|454902924|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
126437327|NCT00906204|454902925|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
126683722|NCT03257267|455798427|FG000|Overall Study|Sponsor Decision|1|||
126683723|NCT03257267|455798428|FG001|Overall Study|Sponsor Decision|0|||
126683724|NCT03257267|455798427|FG000|Overall Study|Physician Decision|1|||
126683725|NCT03257267|455798428|FG001|Overall Study|Physician Decision|3|||
126683726|NCT03257267|455798427|FG000|Overall Study|Disease Progression|109|||
126683727|NCT03257267|455798428|FG001|Overall Study|Disease Progression|121|||
126683728|NCT03257267|455798427|FG000|Overall Study|Withdrawal by Subject|8|||
126683729|NCT03257267|455798428|FG001|Overall Study|Withdrawal by Subject|26|||
126683730|NCT03257267|455798427|FG000|Overall Study|Other|0|||
126683731|NCT03257267|455798428|FG001|Overall Study|Other|2|||
126683732|NCT01979523|455798429|FG000|Overall Study|Withdrawal by Subject|1|||
126683733|NCT01979523|455798430|FG001|Overall Study|Withdrawal by Subject|0|||
126683734|NCT01623271|455798435|FG000|Overall Study|Withdrawal by Subject|2|||
126683735|NCT00706134|455798436|FG000|Overall Study|Adverse Event|8|||
126683736|NCT00706134|455798437|FG001|Overall Study|Adverse Event|7|||
126683737|NCT00706134|455798438|FG002|Overall Study|Adverse Event|2|||
126683738|NCT00706134|455798439|FG003|Overall Study|Adverse Event|3|||
126683739|NCT00706134|455798436|FG000|Overall Study|Lost to Follow-up|0|||
126683740|NCT00706134|455798437|FG001|Overall Study|Lost to Follow-up|1|||
126683741|NCT00706134|455798438|FG002|Overall Study|Lost to Follow-up|0|||
126683742|NCT00706134|455798439|FG003|Overall Study|Lost to Follow-up|0|||
126683743|NCT00706134|455798436|FG000|Overall Study|Protocol Violation|0|||
126683744|NCT00706134|455798437|FG001|Overall Study|Protocol Violation|6|||
126683745|NCT00706134|455798438|FG002|Overall Study|Protocol Violation|0|||
126683746|NCT00706134|455798439|FG003|Overall Study|Protocol Violation|3|||
126683747|NCT00706134|455798436|FG000|Overall Study|Withdrawal by Subject|1|||
126683748|NCT00706134|455798437|FG001|Overall Study|Withdrawal by Subject|2|||
126683749|NCT00706134|455798438|FG002|Overall Study|Withdrawal by Subject|1|||
126683750|NCT00706134|455798439|FG003|Overall Study|Withdrawal by Subject|0|||
126683751|NCT00706134|455798436|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
126683752|NCT00706134|455798437|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126683753|NCT00706134|455798438|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
126683754|NCT00706134|455798439|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
126683755|NCT00706134|455798436|FG000|Overall Study|Did not meet study criteria|2|||
126683756|NCT00706134|455798437|FG001|Overall Study|Did not meet study criteria|0|||
126683757|NCT00706134|455798438|FG002|Overall Study|Did not meet study criteria|0|||
126683758|NCT00706134|455798439|FG003|Overall Study|Did not meet study criteria|0|||
126683759|NCT01982292|455798440|FG000|Overall Study|Adverse Event|2|||
126683760|NCT01982292|455798441|FG001|Overall Study|Adverse Event|0|||
126683761|NCT01982292|455798440|FG000|Overall Study|Death|1|||
126683762|NCT01982292|455798441|FG001|Overall Study|Death|0|||
126683763|NCT01982292|455798440|FG000|Overall Study|Lost to Follow-up|2|||
126683764|NCT01982292|455798441|FG001|Overall Study|Lost to Follow-up|0|||
126683765|NCT01982292|455798440|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
126683766|NCT01982292|455798441|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
126683767|NCT01982292|455798440|FG000|Overall Study|Protocol Deviation|1|||
126683768|NCT01982292|455798441|FG001|Overall Study|Protocol Deviation|0|||
126683769|NCT01982292|455798440|FG000|Overall Study|Patient/Guardian Decision|3|||
126683770|NCT01982292|455798441|FG001|Overall Study|Patient/Guardian Decision|1|||
126683771|NCT01982292|455798440|FG000|Overall Study|Technical Problems|2|||
126683772|NCT01982292|455798441|FG001|Overall Study|Technical Problems|0|||
126683773|NCT01659320|455798444|FG000|Overall Study|Withdrawal by Subject|2|||
126683774|NCT01659320|455798444|FG000|Overall Study|Physician Decision|1|||
126683775|NCT04312009|455798445|FG000|Overall Study|Withdrawal by Subject|2|||
126437328|NCT00906204|454902924|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
126437329|NCT00906204|454902925|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
126683776|NCT04312009|455798446|FG001|Overall Study|Withdrawal by Subject|1|||
126683777|NCT00488982|455798452|FG000|Course 1|Physician Decision|0|||
126683778|NCT00488982|455798453|FG001|Course 1|Physician Decision|2|||
126683779|NCT00488982|455798454|FG002|Course 1|Physician Decision|4|||
126683780|NCT00488982|455798452|FG000|Course 1|Withdrawal by Subject|0|||
126683781|NCT00488982|455798453|FG001|Course 1|Withdrawal by Subject|8|||
126683782|NCT00488982|455798454|FG002|Course 1|Withdrawal by Subject|2|||
126683783|NCT00488982|455798452|FG000|Course 1|nonprotocol therapy|0|||
126683784|NCT00488982|455798453|FG001|Course 1|nonprotocol therapy|2|||
126683785|NCT00488982|455798454|FG002|Course 1|nonprotocol therapy|2|||
126683786|NCT00488982|455798452|FG000|Course 1|Adverse Event|0|||
126683787|NCT00488982|455798453|FG001|Course 1|Adverse Event|0|||
126683788|NCT00488982|455798454|FG002|Course 1|Adverse Event|6|||
126683789|NCT01780831|455798456|FG000|Overall Study|Withdrawal by Subject|0|||
126683790|NCT01780831|455798457|FG001|Overall Study|Withdrawal by Subject|0|||
126683791|NCT01780831|455798458|FG002|Overall Study|Withdrawal by Subject|4|||
126683792|NCT01780831|455798459|FG003|Overall Study|Withdrawal by Subject|0|||
126683793|NCT01780831|455798456|FG000|Overall Study|Lost to Follow-up|0|||
126683794|NCT01780831|455798457|FG001|Overall Study|Lost to Follow-up|0|||
126683795|NCT01780831|455798458|FG002|Overall Study|Lost to Follow-up|0|||
126683796|NCT01780831|455798459|FG003|Overall Study|Lost to Follow-up|1|||
126683797|NCT02264990|455798462|FG000|Overall Study|Death|255|||
126683798|NCT02264990|455798463|FG001|Overall Study|Death|250|||
126683799|NCT02264990|455798462|FG000|Overall Study|Withdrawal by Subject|4|||
126683800|NCT02264990|455798463|FG001|Overall Study|Withdrawal by Subject|5|||
126683801|NCT02264990|455798462|FG000|Overall Study|Lost to Follow-up|1|||
126683802|NCT02264990|455798463|FG001|Overall Study|Lost to Follow-up|3|||
126683803|NCT02264990|455798462|FG000|Overall Study|Other|0|||
126683804|NCT02264990|455798463|FG001|Overall Study|Other|1|||
126683805|NCT00267748|455798465|FG000|Non-randomized Period|Progressive disease|10|||
126683806|NCT00267748|455798466|FG001|Non-randomized Period|Progressive disease|0|||
126683807|NCT00267748|455798467|FG002|Non-randomized Period|Progressive disease|0|||
126683808|NCT00267748|455798465|FG000|Non-randomized Period|Adverse Event|8|||
126683809|NCT00267748|455798466|FG001|Non-randomized Period|Adverse Event|0|||
126683810|NCT00267748|455798467|FG002|Non-randomized Period|Adverse Event|0|||
126683811|NCT00267748|455798465|FG000|Non-randomized Period|Death|1|||
126683812|NCT00267748|455798466|FG001|Non-randomized Period|Death|0|||
126683813|NCT00267748|455798467|FG002|Non-randomized Period|Death|0|||
126683814|NCT00267748|455798465|FG000|Non-randomized Period|Participant not willing to participate|1|||
126683815|NCT00267748|455798466|FG001|Non-randomized Period|Participant not willing to participate|0|||
126683816|NCT00267748|455798467|FG002|Non-randomized Period|Participant not willing to participate|0|||
126683817|NCT00267748|455798465|FG000|Non-randomized Period|Other|3|||
126683818|NCT00267748|455798466|FG001|Non-randomized Period|Other|0|||
126683819|NCT00267748|455798467|FG002|Non-randomized Period|Other|0|||
126683820|NCT00267748|455798465|FG000|Randomized Period|Death|0|||
126683821|NCT00267748|455798466|FG001|Randomized Period|Death|2|||
126683822|NCT00267748|455798467|FG002|Randomized Period|Death|3|||
126683823|NCT00267748|455798465|FG000|Randomized Period|Adverse Event|0|||
126683824|NCT00267748|455798466|FG001|Randomized Period|Adverse Event|23|||
126683825|NCT00267748|455798467|FG002|Randomized Period|Adverse Event|25|||
126683826|NCT00267748|455798465|FG000|Randomized Period|Global deterioration of health status|0|||
126683827|NCT00267748|455798466|FG001|Randomized Period|Global deterioration of health status|6|||
126683828|NCT00267748|455798467|FG002|Randomized Period|Global deterioration of health status|7|||
126683829|NCT00267748|455798465|FG000|Randomized Period|Lost to Follow-up|0|||
126683830|NCT00267748|455798466|FG001|Randomized Period|Lost to Follow-up|1|||
126683831|NCT00267748|455798467|FG002|Randomized Period|Lost to Follow-up|0|||
126683832|NCT00267748|455798465|FG000|Randomized Period|Objective progression or relapse|0|||
126683833|NCT00267748|455798466|FG001|Randomized Period|Objective progression or relapse|77|||
126683834|NCT00267748|455798467|FG002|Randomized Period|Objective progression or relapse|86|||
126683835|NCT00267748|455798465|FG000|Randomized Period|Withdrawal by Subject|0|||
126683836|NCT00267748|455798466|FG001|Randomized Period|Withdrawal by Subject|9|||
126683837|NCT00267748|455798467|FG002|Randomized Period|Withdrawal by Subject|2|||
126683838|NCT00267748|455798465|FG000|Randomized Period|Other|0|||
126683839|NCT00267748|455798466|FG001|Randomized Period|Other|9|||
126683840|NCT00267748|455798467|FG002|Randomized Period|Other|6|||
126683841|NCT00267748|455798465|FG000|Randomized Period|randomized but not treated|0|||
126683842|NCT00267748|455798466|FG001|Randomized Period|randomized but not treated|0|||
126683843|NCT00267748|455798467|FG002|Randomized Period|randomized but not treated|3|||
126683844|NCT01294800|455798468|FG000|Overall Study|Adverse Event|7|||
126683845|NCT01294800|455798469|FG001|Overall Study|Adverse Event|6|||
126683846|NCT01294800|455798470|FG002|Overall Study|Adverse Event|12|||
126683847|NCT01294800|455798471|FG003|Overall Study|Adverse Event|5|||
126683848|NCT01294800|455798468|FG000|Overall Study|Subject Withdrew Consent|2|||
126683849|NCT01294800|455798469|FG001|Overall Study|Subject Withdrew Consent|2|||
126683850|NCT01294800|455798470|FG002|Overall Study|Subject Withdrew Consent|2|||
126683851|NCT01294800|455798471|FG003|Overall Study|Subject Withdrew Consent|11|||
126683852|NCT01294800|455798468|FG000|Overall Study|Lost to Follow-up|0|||
126683853|NCT01294800|455798469|FG001|Overall Study|Lost to Follow-up|0|||
126683854|NCT01294800|455798470|FG002|Overall Study|Lost to Follow-up|1|||
126683855|NCT01294800|455798471|FG003|Overall Study|Lost to Follow-up|0|||
126683856|NCT01294800|455798468|FG000|Overall Study|Non-compliance With Protocol|0|||
126683857|NCT01294800|455798469|FG001|Overall Study|Non-compliance With Protocol|1|||
126683858|NCT01294800|455798470|FG002|Overall Study|Non-compliance With Protocol|1|||
126683859|NCT01294800|455798471|FG003|Overall Study|Non-compliance With Protocol|0|||
126683860|NCT01294800|455798468|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
126683861|NCT01294800|455798469|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
126683862|NCT01294800|455798470|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
126683863|NCT01294800|455798471|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
126683864|NCT01662895|455798472|FG000|Overall Study|Lost to Follow-up|0|||
126683865|NCT01662895|455798473|FG001|Overall Study|Lost to Follow-up|1|||
126683866|NCT00797732|455798477|FG000|Overall Study|Withdrawal by Subject|3|||
126683867|NCT00797732|455798478|FG001|Overall Study|Withdrawal by Subject|3|||
126683868|NCT00797732|455798479|FG002|Overall Study|Withdrawal by Subject|0|||
126683869|NCT00797732|455798477|FG000|Overall Study|Lost to Follow-up|1|||
126683870|NCT00797732|455798478|FG001|Overall Study|Lost to Follow-up|0|||
126683871|NCT00797732|455798479|FG002|Overall Study|Lost to Follow-up|0|||
126683872|NCT00797732|455798477|FG000|Overall Study|Death|1|||
126683873|NCT00797732|455798478|FG001|Overall Study|Death|0|||
126683874|NCT00797732|455798479|FG002|Overall Study|Death|0|||
126683875|NCT00797732|455798477|FG000|Overall Study|Not meet inclusion criteria|0|||
126683876|NCT00797732|455798478|FG001|Overall Study|Not meet inclusion criteria|0|||
126683877|NCT00797732|455798479|FG002|Overall Study|Not meet inclusion criteria|7|||
126683878|NCT00797732|455798477|FG000|Overall Study|Excluded due to time constraints|0|||
126683879|NCT00797732|455798478|FG001|Overall Study|Excluded due to time constraints|0|||
126683880|NCT00797732|455798479|FG002|Overall Study|Excluded due to time constraints|24|||
126683881|NCT00797732|455798477|FG000|Overall Study|Refused to Participate|0|||
126683882|NCT00797732|455798478|FG001|Overall Study|Refused to Participate|0|||
126683883|NCT00797732|455798479|FG002|Overall Study|Refused to Participate|123|||
126683884|NCT00401752|455798482|FG000|Overall Study|Adverse Event|2|||
126683885|NCT00401752|455798483|FG001|Overall Study|Adverse Event|5|||
126683886|NCT00401752|455798482|FG000|Overall Study|Withdrawal by Subject|2|||
126683887|NCT00401752|455798483|FG001|Overall Study|Withdrawal by Subject|6|||
126683888|NCT00401752|455798482|FG000|Overall Study|Lost to Follow-up|1|||
126683889|NCT00401752|455798483|FG001|Overall Study|Lost to Follow-up|4|||
126683890|NCT00401752|455798482|FG000|Overall Study|Development of any exclusion criteria|4|||
126683891|NCT00401752|455798483|FG001|Overall Study|Development of any exclusion criteria|2|||
126683892|NCT00401752|455798482|FG000|Overall Study|Physician Decision|1|||
126683893|NCT00401752|455798483|FG001|Overall Study|Physician Decision|1|||
126683894|NCT01895322|455798484|FG000|Overall Study|Adverse Event|1|||
126683895|NCT01895322|455798484|FG000|Overall Study|Withdrawal by Subject|2|||
126683896|NCT01895322|455798484|FG000|Overall Study|Protocol Violation|10|||
126683897|NCT02275338|455798485|FG000|Overall Study|Adverse Event|15|||
126683898|NCT02275338|455798485|FG000|Overall Study|Lack of Efficacy|3|||
126683899|NCT02275338|455798485|FG000|Overall Study|Withdrawal by Subject|4|||
126683900|NCT02275338|455798485|FG000|Overall Study|Disease progression (death)|1|||
126683901|NCT02275338|455798485|FG000|Overall Study|Ineligible to start Phase 2|4|||
126683902|NCT02275338|455798485|FG000|Overall Study|Reason not specified|5|||
126683903|NCT02275338|455798485|FG000|Overall Study|Does not meet entry criteria|1|||
126683904|NCT04607733|455798489|FG000|Overall Study|Lost to Follow-up|1|||
126683905|NCT04607733|455798490|FG001|Overall Study|Lost to Follow-up|0|||
126683906|NCT04607733|455798491|FG002|Overall Study|Lost to Follow-up|0|||
126683907|NCT04607733|455798492|FG003|Overall Study|Lost to Follow-up|1|||
126683908|NCT04607733|455798493|FG004|Overall Study|Lost to Follow-up|1|||
126683909|NCT04607733|455798494|FG005|Overall Study|Lost to Follow-up|0|||
126683910|NCT04607733|455798489|FG000|Overall Study|Withdrawal by Subject|0|||
126683911|NCT04607733|455798490|FG001|Overall Study|Withdrawal by Subject|0|||
126683912|NCT04607733|455798491|FG002|Overall Study|Withdrawal by Subject|0|||
126683913|NCT04607733|455798492|FG003|Overall Study|Withdrawal by Subject|0|||
126683914|NCT04607733|455798493|FG004|Overall Study|Withdrawal by Subject|1|||
126683915|NCT04607733|455798494|FG005|Overall Study|Withdrawal by Subject|0|||
126683916|NCT01827670|455798495|FG000|Overall Study|Withdrawal of Consent|3|||
126683917|NCT01827670|455798496|FG001|Overall Study|Withdrawal of Consent|2|||
126683918|NCT01827670|455798495|FG000|Overall Study|Lost to Follow-up|0|||
126683919|NCT01827670|455798496|FG001|Overall Study|Lost to Follow-up|1|||
126683920|NCT03603496|455798507|FG000|Overall Study|Death|19|||
126683921|NCT03603496|455798508|FG001|Overall Study|Death|24|||
126683922|NCT03603496|455798507|FG000|Overall Study|Lost to Follow-up|141|||
126683923|NCT03603496|455798508|FG001|Overall Study|Lost to Follow-up|141|||
126683924|NCT03603496|455798507|FG000|Overall Study|Withdrawal by Subject|26|||
126683925|NCT03603496|455798508|FG001|Overall Study|Withdrawal by Subject|20|||
126683926|NCT00835237|455798509|FG000|Overall Study|Lost to Follow-up|4|||
126683927|NCT00835237|455798510|FG001|Overall Study|Lost to Follow-up|0|||
126683928|NCT00835237|455798509|FG000|Overall Study|Withdrawal by Subject|2|||
126683929|NCT00835237|455798510|FG001|Overall Study|Withdrawal by Subject|0|||
126683930|NCT01265550|455798511|FG000|Pre Randomization|Withdrawal by Subject|0|||
126683931|NCT01265550|455798512|FG001|Pre Randomization|Withdrawal by Subject|0|||
126683932|NCT01265550|455798513|FG002|Pre Randomization|Withdrawal by Subject|0|||
126683933|NCT01265550|455798514|FG003|Pre Randomization|Withdrawal by Subject|70|||
126683934|NCT01265550|455798511|FG000|Pre Randomization|Technical Exclusions|0|||
126683935|NCT01265550|455798512|FG001|Pre Randomization|Technical Exclusions|0|||
126683936|NCT01265550|455798513|FG002|Pre Randomization|Technical Exclusions|0|||
126683937|NCT01265550|455798514|FG003|Pre Randomization|Technical Exclusions|54|||
126683938|NCT01265550|455798511|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
126683939|NCT01265550|455798512|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
126683940|NCT01265550|455798513|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
126683941|NCT01265550|455798514|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
126683942|NCT01265550|455798511|FG000|Pre Randomization|Non-GERD organic disorders|0|||
126683943|NCT01265550|455798512|FG001|Pre Randomization|Non-GERD organic disorders|0|||
126683944|NCT01265550|455798513|FG002|Pre Randomization|Non-GERD organic disorders|0|||
126683945|NCT01265550|455798514|FG003|Pre Randomization|Non-GERD organic disorders|23|||
126683946|NCT01265550|455798511|FG000|Pre Randomization|Functional heartburn|0|||
126683947|NCT01265550|455798512|FG001|Pre Randomization|Functional heartburn|0|||
126683948|NCT01265550|455798513|FG002|Pre Randomization|Functional heartburn|0|||
126683949|NCT01265550|455798514|FG003|Pre Randomization|Functional heartburn|99|||
126683950|NCT00623428|455798517|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
126683951|NCT00623428|455798518|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
126683952|NCT00623428|455798517|FG000|Treatment Period|Death|0|||
126683953|NCT00623428|455798518|FG001|Treatment Period|Death|1|||
126683954|NCT00623428|455798517|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
126683955|NCT00623428|455798518|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
126683956|NCT00623428|455798517|FG000|Treatment Period|Insufficient therapeutic response|0|||
126683957|NCT00623428|455798518|FG001|Treatment Period|Insufficient therapeutic response|2|||
126683958|NCT00623428|455798517|FG000|Treatment Period|Other|0|||
126683959|NCT00623428|455798518|FG001|Treatment Period|Other|1|||
126683960|NCT00623428|455798517|FG000|Treatment Period|Withdrawal by Subject|0|||
126683961|NCT00623428|455798518|FG001|Treatment Period|Withdrawal by Subject|1|||
126683962|NCT00623428|455798517|FG000|Follow-up Period|Relapse post-treatment|11|||
126683963|NCT00623428|455798518|FG001|Follow-up Period|Relapse post-treatment|3|||
126683964|NCT00623428|455798517|FG000|Follow-up Period|Failure to return|10|||
126683965|NCT00623428|455798518|FG001|Follow-up Period|Failure to return|2|||
126683966|NCT00623428|455798517|FG000|Follow-up Period|Patient withdrew consent|5|||
126683967|NCT00623428|455798518|FG001|Follow-up Period|Patient withdrew consent|4|||
126683968|NCT00623428|455798517|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
126683969|NCT00623428|455798518|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
126683970|NCT00623428|455798517|FG000|Follow-up Period|Did not cooperate|0|||
126683971|NCT00623428|455798518|FG001|Follow-up Period|Did not cooperate|3|||
126683972|NCT00623428|455798517|FG000|Follow-up Period|Reason not specified|1|||
126683973|NCT00623428|455798518|FG001|Follow-up Period|Reason not specified|1|||
126683974|NCT00623428|455798517|FG000|Follow-up Period|Death|0|||
126683975|NCT00623428|455798518|FG001|Follow-up Period|Death|1|||
126683976|NCT01929408|455798521|FG000|Overall Study|received HCT as initial treatment|8|||
126683977|NCT00293579|455798522|FG000|Overall Study|Withdrawal by Subject|1|||
126683978|NCT02703311|455798524|FG000|Overall Study|Death|5|||
126683979|NCT02703311|455798524|FG000|Overall Study|Withdrawal by Subject|3|||
126683980|NCT02069899|455798525|FG000|Overall Study|Adverse Event|6|||
126683981|NCT02069899|455798526|FG001|Overall Study|Adverse Event|0|||
126683982|NCT02069899|455798527|FG002|Overall Study|Adverse Event|1|||
126683983|NCT02069899|455798525|FG000|Overall Study|Withdrawal by Participant|2|||
126683984|NCT02069899|455798526|FG001|Overall Study|Withdrawal by Participant|0|||
126683985|NCT02069899|455798527|FG002|Overall Study|Withdrawal by Participant|0|||
126683986|NCT02069899|455798525|FG000|Overall Study|Lost to Follow-up|1|||
126683987|NCT02069899|455798526|FG001|Overall Study|Lost to Follow-up|0|||
126683988|NCT02069899|455798527|FG002|Overall Study|Lost to Follow-up|1|||
126683989|NCT02069899|455798525|FG000|Overall Study|Other|4|||
126683990|NCT02069899|455798526|FG001|Overall Study|Other|0|||
126683991|NCT02069899|455798527|FG002|Overall Study|Other|0|||
126683992|NCT02069899|455798525|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
126683993|NCT02069899|455798526|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
126683994|NCT02069899|455798527|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
126683995|NCT02069899|455798525|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
126683996|NCT02069899|455798526|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
126683997|NCT02069899|455798527|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
126683998|NCT00784654|455798530|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
126683999|NCT00784654|455798531|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
126684000|NCT00784654|455798532|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
126684001|NCT00784654|455798530|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
126684002|NCT00784654|455798531|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
126684003|NCT00784654|455798532|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
126684004|NCT00784654|455798530|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
126684005|NCT00784654|455798531|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
126684006|NCT00784654|455798532|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
126684007|NCT00784654|455798530|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
126437330|NCT00906204|454902924|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
126437331|NCT00906204|454902925|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
126437332|NCT00906204|454902924|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
126437333|NCT00906204|454902925|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
126437334|NCT01597596|454902926|FG000|Overall Study|Study terminated by sponsor|1|||
126437335|NCT01597596|454902927|FG001|Overall Study|Study terminated by sponsor|0|||
126437336|NCT01597596|454902926|FG000|Overall Study|Physician Decision|0|||
126437337|NCT01597596|454902927|FG001|Overall Study|Physician Decision|1|||
126437338|NCT02141295|454902942|FG000|Overall Study|Adverse Event|1|||
126437339|NCT02141295|454902943|FG001|Overall Study|Adverse Event|18|||
126437340|NCT02141295|454902944|FG002|Overall Study|Adverse Event|11|||
126437341|NCT02141295|454902942|FG000|Overall Study|Physician Decision|2|||
126437342|NCT02141295|454902943|FG001|Overall Study|Physician Decision|19|||
126684008|NCT00784654|455798531|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
126684009|NCT00784654|455798532|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
126684010|NCT00784654|455798530|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
126684011|NCT00784654|455798531|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
126684012|NCT00784654|455798532|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
126684013|NCT00784654|455798530|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
126684014|NCT00784654|455798531|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
126684015|NCT00784654|455798532|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
126684016|NCT00784654|455798530|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
126684017|NCT00784654|455798531|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
126684018|NCT00784654|455798532|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
126684019|NCT00784654|455798530|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
126684020|NCT00784654|455798531|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
126684021|NCT00784654|455798532|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
126684022|NCT00784654|455798530|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
126684023|NCT00784654|455798531|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
126684024|NCT00784654|455798532|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
126684025|NCT00784654|455798530|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
126684026|NCT00784654|455798531|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
126684027|NCT00784654|455798532|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
126684028|NCT00784654|455798530|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
126684029|NCT00784654|455798531|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
126684030|NCT00784654|455798532|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
126684031|NCT00784654|455798530|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
126684032|NCT00784654|455798531|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
126684033|NCT00784654|455798532|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
126684034|NCT00784654|455798530|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
126684035|NCT00784654|455798531|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
126684036|NCT00784654|455798532|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
126684037|NCT00784654|455798530|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126684038|NCT00784654|455798531|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
126684039|NCT00784654|455798532|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
126684040|NCT00784654|455798530|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
126684041|NCT00784654|455798531|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
126684042|NCT00784654|455798532|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
126684043|NCT00784654|455798530|FG000|Randomized Withdrawal Period|Adverse Event|0|||
126684044|NCT00784654|455798531|FG001|Randomized Withdrawal Period|Adverse Event|1|||
126684045|NCT00784654|455798532|FG002|Randomized Withdrawal Period|Adverse Event|1|||
126684046|NCT00784654|455798530|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
126684047|NCT00784654|455798531|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
126684048|NCT00784654|455798532|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
126684049|NCT00784654|455798530|FG000|Randomized Withdrawal Period|Family reasons|0|||
126684050|NCT00784654|455798531|FG001|Randomized Withdrawal Period|Family reasons|0|||
126684051|NCT00784654|455798532|FG002|Randomized Withdrawal Period|Family reasons|1|||
126684052|NCT01180660|455798535|FG000|Overall Study|Changed to open surgery|1|||
126684053|NCT01180660|455798536|FG001|Overall Study|Changed to open surgery|0|||
126684054|NCT00262873|455798537|FG000|Overall Study|Adverse Event|3|||
126684055|NCT00262873|455798537|FG000|Overall Study|Withdrawal by Subject|5|||
126684056|NCT00844753|455798538|FG000|Overall Study|Lack of Efficacy|1|||
126684057|NCT00844753|455798539|FG001|Overall Study|Lack of Efficacy|0|||
126684058|NCT00844753|455798540|FG002|Overall Study|Lack of Efficacy|2|||
126437343|NCT02141295|454902944|FG002|Overall Study|Physician Decision|14|||
126437344|NCT02141295|454902942|FG000|Overall Study|Study terminated by sponsor|0|||
126545375|NCT02100722|455290819|FG000|Overall Study|Withdrawal post-procedure|0|||
126684059|NCT00844753|455798541|FG003|Overall Study|Lack of Efficacy|2|||
126684060|NCT00844753|455798538|FG000|Overall Study|Adverse Event|3|||
126684061|NCT00844753|455798539|FG001|Overall Study|Adverse Event|2|||
126684062|NCT00844753|455798540|FG002|Overall Study|Adverse Event|5|||
126684063|NCT00844753|455798541|FG003|Overall Study|Adverse Event|5|||
126684064|NCT00844753|455798538|FG000|Overall Study|Lost to Follow-up|1|||
126684065|NCT00844753|455798539|FG001|Overall Study|Lost to Follow-up|1|||
126684066|NCT00844753|455798540|FG002|Overall Study|Lost to Follow-up|0|||
126684067|NCT00844753|455798541|FG003|Overall Study|Lost to Follow-up|1|||
126684068|NCT00844753|455798538|FG000|Overall Study|could not swallow medication|2|||
126684069|NCT00844753|455798539|FG001|Overall Study|could not swallow medication|0|||
126684070|NCT00844753|455798540|FG002|Overall Study|could not swallow medication|0|||
126684071|NCT00844753|455798541|FG003|Overall Study|could not swallow medication|0|||
126684072|NCT00844753|455798538|FG000|Overall Study|Withdrawal by Subject|1|||
126684073|NCT00844753|455798539|FG001|Overall Study|Withdrawal by Subject|0|||
126684074|NCT00844753|455798540|FG002|Overall Study|Withdrawal by Subject|0|||
126684075|NCT00844753|455798541|FG003|Overall Study|Withdrawal by Subject|3|||
126684076|NCT02500121|455798544|FG000|Overall Study|Lost to Follow-up|0|||
126684077|NCT02500121|455798545|FG001|Overall Study|Lost to Follow-up|1|||
126684078|NCT02500121|455798544|FG000|Overall Study|Withdrawal by Subject|1|||
126684079|NCT02500121|455798545|FG001|Overall Study|Withdrawal by Subject|1|||
126684080|NCT02500121|455798544|FG000|Overall Study|Death|26|||
126684081|NCT02500121|455798545|FG001|Overall Study|Death|24|||
126684082|NCT04418076|455798546|FG000|Overall Study|Death|1|||
126684083|NCT04418076|455798547|FG001|Overall Study|Death|0|||
126684084|NCT04418076|455798548|FG002|Overall Study|Death|0|||
126684085|NCT04418076|455798549|FG003|Overall Study|Death|0|||
126684086|NCT04418076|455798546|FG000|Overall Study|Lost to Follow-up|2|||
126684087|NCT04418076|455798547|FG001|Overall Study|Lost to Follow-up|5|||
126684088|NCT04418076|455798548|FG002|Overall Study|Lost to Follow-up|1|||
126684089|NCT04418076|455798549|FG003|Overall Study|Lost to Follow-up|2|||
126684090|NCT04418076|455798546|FG000|Overall Study|Withdrawal by Subject|1|||
126684091|NCT04418076|455798547|FG001|Overall Study|Withdrawal by Subject|0|||
126684092|NCT04418076|455798548|FG002|Overall Study|Withdrawal by Subject|1|||
126684093|NCT04418076|455798549|FG003|Overall Study|Withdrawal by Subject|1|||
126684094|NCT04418076|455798546|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
126684095|NCT04418076|455798547|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
126684096|NCT04418076|455798548|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
126684097|NCT04418076|455798549|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
126684098|NCT01314716|455798550|FG000|Double-Blind Phase|Randomized but not treated|1|||
126684099|NCT01314716|455798551|FG001|Double-Blind Phase|Randomized but not treated|1|||
126684100|NCT01314716|455798550|FG000|Double-Blind Phase|Adverse Event|10|||
126684101|NCT01314716|455798551|FG001|Double-Blind Phase|Adverse Event|4|||
126684102|NCT01314716|455798550|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
126684103|NCT01314716|455798551|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
126684104|NCT01314716|455798550|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126684105|NCT01314716|455798551|FG001|Double-Blind Phase|Lost to Follow-up|1|||
126684106|NCT01314716|455798550|FG000|Double-Blind Phase|Sponsor request|1|||
126684107|NCT01314716|455798551|FG001|Double-Blind Phase|Sponsor request|2|||
126684108|NCT01314716|455798550|FG000|Double-Blind Phase|Physician Decision|0|||
126684109|NCT01314716|455798551|FG001|Double-Blind Phase|Physician Decision|1|||
126684110|NCT01314716|455798550|FG000|Open-Label Phase|Adverse Event|4|||
126684111|NCT01314716|455798551|FG001|Open-Label Phase|Adverse Event|6|||
126684112|NCT01314716|455798550|FG000|Open-Label Phase|Withdrawal by Subject|1|||
126437345|NCT02141295|454902943|FG001|Overall Study|Study terminated by sponsor|6|||
126684113|NCT01314716|455798551|FG001|Open-Label Phase|Withdrawal by Subject|2|||
126684114|NCT01314716|455798550|FG000|Open-Label Phase|Physician Decision|5|||
126684115|NCT01314716|455798551|FG001|Open-Label Phase|Physician Decision|4|||
126684116|NCT01452152|455798552|FG000|Overall Study|Study termination by sponsor|5|||
126684117|NCT01452152|455798553|FG001|Overall Study|Study termination by sponsor|0|||
126684118|NCT01452152|455798554|FG002|Overall Study|Study termination by sponsor|4|||
126684119|NCT02627495|455800123|FG000|Overall Study|Withdrawal by Subject|4|||
126684120|NCT00880893|455800124|FG000|Overall Study|Protocol Violation|13|||
126684121|NCT00880893|455800125|FG001|Overall Study|Protocol Violation|1|||
126684122|NCT00880893|455800124|FG000|Overall Study|Withdrawal by Subject|15|||
126684123|NCT00880893|455800125|FG001|Overall Study|Withdrawal by Subject|11|||
126684124|NCT00880893|455800124|FG000|Overall Study|Lost to Follow-up|76|||
126684125|NCT00880893|455800125|FG001|Overall Study|Lost to Follow-up|33|||
126684126|NCT00880893|455800124|FG000|Overall Study|Serious adverse event|3|||
126684127|NCT00880893|455800125|FG001|Overall Study|Serious adverse event|0|||
126684128|NCT05048719|455800128|FG000|Overall Study|Withdrawal by Subject|2|||
126684129|NCT05048719|455800129|FG001|Overall Study|Withdrawal by Subject|1|||
126684130|NCT05048719|455800130|FG002|Overall Study|Withdrawal by Subject|3|||
126684131|NCT05048719|455800131|FG003|Overall Study|Withdrawal by Subject|1|||
126684132|NCT05048719|455800132|FG004|Overall Study|Withdrawal by Subject|0|||
126684133|NCT05048719|455800133|FG005|Overall Study|Withdrawal by Subject|2|||
126684134|NCT05048719|455800134|FG006|Overall Study|Withdrawal by Subject|1|||
126684135|NCT05048719|455800135|FG007|Overall Study|Withdrawal by Subject|1|||
126684136|NCT05048719|455800136|FG008|Overall Study|Withdrawal by Subject|0|||
126684137|NCT05048719|455800128|FG000|Overall Study|Death|1|||
126684138|NCT05048719|455800129|FG001|Overall Study|Death|0|||
126684139|NCT05048719|455800130|FG002|Overall Study|Death|0|||
126684140|NCT05048719|455800131|FG003|Overall Study|Death|0|||
126684141|NCT05048719|455800132|FG004|Overall Study|Death|0|||
126684142|NCT05048719|455800133|FG005|Overall Study|Death|0|||
126684143|NCT05048719|455800134|FG006|Overall Study|Death|0|||
126684144|NCT05048719|455800135|FG007|Overall Study|Death|0|||
126684145|NCT05048719|455800136|FG008|Overall Study|Death|0|||
126684146|NCT05048719|455800128|FG000|Overall Study|Adverse Event|0|||
126684147|NCT05048719|455800129|FG001|Overall Study|Adverse Event|1|||
126684148|NCT05048719|455800130|FG002|Overall Study|Adverse Event|2|||
126684149|NCT05048719|455800131|FG003|Overall Study|Adverse Event|0|||
126684150|NCT05048719|455800132|FG004|Overall Study|Adverse Event|1|||
126684151|NCT05048719|455800133|FG005|Overall Study|Adverse Event|0|||
126684152|NCT05048719|455800134|FG006|Overall Study|Adverse Event|0|||
126684153|NCT05048719|455800135|FG007|Overall Study|Adverse Event|0|||
126684154|NCT05048719|455800136|FG008|Overall Study|Adverse Event|0|||
126684155|NCT05048719|455800128|FG000|Overall Study|Lost to Follow-up|0|||
126684156|NCT05048719|455800129|FG001|Overall Study|Lost to Follow-up|0|||
126684157|NCT05048719|455800130|FG002|Overall Study|Lost to Follow-up|1|||
126684158|NCT05048719|455800131|FG003|Overall Study|Lost to Follow-up|3|||
126684159|NCT05048719|455800132|FG004|Overall Study|Lost to Follow-up|1|||
126684160|NCT05048719|455800133|FG005|Overall Study|Lost to Follow-up|1|||
126684161|NCT05048719|455800134|FG006|Overall Study|Lost to Follow-up|1|||
126684162|NCT05048719|455800135|FG007|Overall Study|Lost to Follow-up|1|||
126684163|NCT05048719|455800136|FG008|Overall Study|Lost to Follow-up|0|||
126684164|NCT05048719|455800128|FG000|Overall Study|Physician Decision|0|||
126684165|NCT05048719|455800129|FG001|Overall Study|Physician Decision|0|||
126684166|NCT05048719|455800130|FG002|Overall Study|Physician Decision|0|||
126684167|NCT05048719|455800131|FG003|Overall Study|Physician Decision|0|||
126684168|NCT05048719|455800132|FG004|Overall Study|Physician Decision|0|||
126684169|NCT05048719|455800133|FG005|Overall Study|Physician Decision|0|||
126684170|NCT05048719|455800134|FG006|Overall Study|Physician Decision|0|||
126684171|NCT05048719|455800135|FG007|Overall Study|Physician Decision|1|||
126684172|NCT05048719|455800136|FG008|Overall Study|Physician Decision|1|||
126684173|NCT05048719|455800128|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
126684174|NCT05048719|455800129|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126684175|NCT05048719|455800130|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126684176|NCT05048719|455800131|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126684177|NCT05048719|455800132|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126684178|NCT05048719|455800133|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126684179|NCT05048719|455800134|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126684180|NCT05048719|455800135|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126684181|NCT05048719|455800136|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
126684182|NCT05048719|455800128|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126684183|NCT05048719|455800129|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
126684184|NCT05048719|455800130|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126684185|NCT05048719|455800131|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126684186|NCT05048719|455800132|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126684187|NCT05048719|455800133|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126684188|NCT05048719|455800134|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126684189|NCT05048719|455800135|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126715146|NCT01161524|455908695|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
126715147|NCT01161524|455908696|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
126715148|NCT01161524|455908694|FG000|Core Study (23 Weeks)|Subject Choice|3|||
126715149|NCT01161524|455908695|FG001|Core Study (23 Weeks)|Subject Choice|2|||
126715150|NCT01161524|455908696|FG002|Core Study (23 Weeks)|Subject Choice|0|||
126715151|NCT01161524|455908694|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
126715152|NCT01161524|455908695|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
126715153|NCT01161524|455908696|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
126715154|NCT01161524|455908694|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
126715155|NCT01161524|455908695|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
126715156|NCT01161524|455908696|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
126715157|NCT01161524|455908694|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
126715158|NCT01161524|455908695|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
126715159|NCT01161524|455908696|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
126715160|NCT01161524|455908694|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
126684190|NCT05048719|455800136|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
126684191|NCT05048719|455800128|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126684192|NCT05048719|455800129|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
126684193|NCT05048719|455800130|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126684194|NCT05048719|455800131|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126684195|NCT05048719|455800132|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126684196|NCT05048719|455800133|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126684197|NCT05048719|455800134|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126684198|NCT05048719|455800135|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126684199|NCT05048719|455800136|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
126684200|NCT05048719|455800128|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126684201|NCT05048719|455800129|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126684202|NCT05048719|455800130|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126684203|NCT05048719|455800131|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
126684204|NCT05048719|455800132|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126684205|NCT05048719|455800133|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126684206|NCT05048719|455800134|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126684207|NCT05048719|455800135|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126684208|NCT05048719|455800136|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
126684209|NCT05048719|455800128|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126684210|NCT05048719|455800129|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126684211|NCT05048719|455800130|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126684212|NCT05048719|455800131|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126684213|NCT05048719|455800132|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126684214|NCT05048719|455800133|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
126758920|NCT01072175|456066698|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126758921|NCT01072175|456066699|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
126758922|NCT01072175|456066700|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126758923|NCT01072175|456066701|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126758924|NCT01072175|456066702|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126758925|NCT01072175|456066703|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
126758926|NCT01072175|456066691|FG000|Part D (HPMC Capsules)|Death|0|||
126758927|NCT01072175|456066692|FG001|Part D (HPMC Capsules)|Death|0|||
126758928|NCT01072175|456066693|FG002|Part D (HPMC Capsules)|Death|0|||
126758929|NCT01072175|456066694|FG003|Part D (HPMC Capsules)|Death|0|||
126758930|NCT01072175|456066695|FG004|Part D (HPMC Capsules)|Death|0|||
126758931|NCT01072175|456066696|FG005|Part D (HPMC Capsules)|Death|0|||
126758932|NCT01072175|456066697|FG006|Part D (HPMC Capsules)|Death|0|||
126758933|NCT01072175|456066698|FG007|Part D (HPMC Capsules)|Death|0|||
126758934|NCT01072175|456066699|FG008|Part D (HPMC Capsules)|Death|0|||
126758935|NCT01072175|456066700|FG009|Part D (HPMC Capsules)|Death|10|||
126758936|NCT01072175|456066701|FG010|Part D (HPMC Capsules)|Death|12|||
126758937|NCT01072175|456066702|FG011|Part D (HPMC Capsules)|Death|28|||
126758938|NCT01072175|456066703|FG012|Part D (HPMC Capsules)|Death|26|||
126758939|NCT01072175|456066691|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
126758940|NCT01072175|456066692|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
126758941|NCT01072175|456066693|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
126758942|NCT01072175|456066694|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
126758943|NCT01072175|456066695|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
126758944|NCT01072175|456066696|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
126758945|NCT01072175|456066697|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
126758946|NCT01072175|456066698|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
126758947|NCT01072175|456066699|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
126758948|NCT01072175|456066700|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
126758949|NCT01072175|456066701|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
126758950|NCT01072175|456066702|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
126758951|NCT01072175|456066703|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
126758952|NCT01072175|456066691|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126758953|NCT01072175|456066692|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126758954|NCT01072175|456066693|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126758955|NCT01072175|456066694|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126758956|NCT01072175|456066695|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126758957|NCT01072175|456066696|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126437346|NCT02141295|454902944|FG002|Overall Study|Study terminated by sponsor|6|||
126437347|NCT02141295|454902942|FG000|Overall Study|Non-compliance|0|||
126437348|NCT02141295|454902943|FG001|Overall Study|Non-compliance|1|||
126437349|NCT02141295|454902944|FG002|Overall Study|Non-compliance|0|||
126437350|NCT02141295|454902942|FG000|Overall Study|Progressive disease|3|||
126437351|NCT02141295|454902943|FG001|Overall Study|Progressive disease|32|||
126437352|NCT02141295|454902944|FG002|Overall Study|Progressive disease|50|||
126437353|NCT02141295|454902942|FG000|Overall Study|Reason not specified|0|||
126437354|NCT02141295|454902943|FG001|Overall Study|Reason not specified|9|||
126437355|NCT02141295|454902944|FG002|Overall Study|Reason not specified|10|||
126437356|NCT02141295|454902942|FG000|Overall Study|Withdrawal by Subject|0|||
126437357|NCT02141295|454902943|FG001|Overall Study|Withdrawal by Subject|9|||
126437358|NCT02141295|454902944|FG002|Overall Study|Withdrawal by Subject|4|||
126437359|NCT01710501|454902945|FG000|Overall Study|Lost to Follow-up|2|||
126437360|NCT01710501|454902946|FG001|Overall Study|Lost to Follow-up|0|||
126437361|NCT01710501|454902947|FG002|Overall Study|Lost to Follow-up|0|||
126437362|NCT02536976|454902948|FG000|Overall Study|Physician Decision|0|||
126437363|NCT02536976|454902949|FG001|Overall Study|Physician Decision|1|||
126437364|NCT01671319|454902952|FG000|Overall Study|Withdrawal by Subject|1|||
126437365|NCT01709084|454902953|FG000|Overall Study|Lost to Follow-up|4|||
126437366|NCT01709084|454902954|FG001|Overall Study|Lost to Follow-up|7|||
126437367|NCT01709084|454902953|FG000|Overall Study|Withdrawal by Subject|2|||
126437368|NCT01709084|454902954|FG001|Overall Study|Withdrawal by Subject|2|||
126437369|NCT01709084|454902953|FG000|Overall Study|Adverse Event|5|||
126437370|NCT01709084|454902954|FG001|Overall Study|Adverse Event|0|||
126437371|NCT01709084|454902953|FG000|Overall Study|Other|5|||
126437372|NCT01709084|454902954|FG001|Overall Study|Other|3|||
126437373|NCT01709084|454902953|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
126437374|NCT01709084|454902954|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
126437375|NCT01709084|454902953|FG000|Overall Study|Not Treated|0|||
126437376|NCT01709084|454902954|FG001|Overall Study|Not Treated|2|||
126437377|NCT02144610|454902955|FG000|Overall Study|Physician Decision|1|||
126437378|NCT02144610|454902956|FG001|Overall Study|Physician Decision|0|||
126437379|NCT02144610|454902955|FG000|Overall Study|Withdrawal by Subject|1|||
126437380|NCT02144610|454902956|FG001|Overall Study|Withdrawal by Subject|5|||
126437381|NCT02144610|454902955|FG000|Overall Study|Death|2|||
126437382|NCT02144610|454902956|FG001|Overall Study|Death|2|||
126437383|NCT02144610|454902955|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
126437384|NCT02144610|454902956|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
126437385|NCT02144610|454902955|FG000|Overall Study|Other|0|||
126437386|NCT02144610|454902956|FG001|Overall Study|Other|1|||
126437387|NCT01054885|454902957|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
126437388|NCT01054885|454902958|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126437389|NCT01054885|454902959|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126437390|NCT01054885|454902960|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126437391|NCT01054885|454902961|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126437392|NCT01054885|454902962|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126437393|NCT01054885|454902963|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126684215|NCT05048719|455800134|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126684216|NCT05048719|455800135|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126684217|NCT05048719|455800136|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
126684218|NCT04541004|455800137|FG000|Overall Study|Adverse Event|2|||
126684219|NCT02229552|455800139|FG000|Baseline|Withdrawal by Subject|6|||
126684220|NCT02229552|455800139|FG000|1-year Follow up|Withdrawal by Subject|7|||
126684221|NCT02229552|455800139|FG000|1-year Follow up|Lost to Follow-up|18|||
126684222|NCT02229552|455800139|FG000|2-Year Follow up|Withdrawal by Subject|9|||
126684223|NCT02229552|455800139|FG000|2-Year Follow up|Lost to Follow-up|17|||
126684224|NCT04872101|455800140|FG000|Overall Study|Withdrawal by Subject|10|||
126684225|NCT04872101|455800141|FG001|Overall Study|Withdrawal by Subject|16|||
126684226|NCT04872101|455800140|FG000|Overall Study|Lack of Efficacy|6|||
126684227|NCT04872101|455800141|FG001|Overall Study|Lack of Efficacy|14|||
126437394|NCT01054885|454902957|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
126437395|NCT01054885|454902958|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
126437396|NCT01054885|454902959|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
126437397|NCT01054885|454902960|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
126437398|NCT01054885|454902961|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
126437399|NCT01054885|454902962|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
126437400|NCT01054885|454902963|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
126437401|NCT01054885|454902957|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
126684228|NCT04872101|455800140|FG000|Overall Study|Adverse Event|1|||
126684229|NCT04872101|455800141|FG001|Overall Study|Adverse Event|6|||
126684230|NCT04872101|455800140|FG000|Overall Study|Lost to Follow-up|2|||
126684231|NCT04872101|455800141|FG001|Overall Study|Lost to Follow-up|1|||
126684232|NCT04872101|455800140|FG000|Overall Study|Pregnancy|2|||
126684233|NCT04872101|455800141|FG001|Overall Study|Pregnancy|0|||
126684234|NCT04872101|455800140|FG000|Overall Study|Prohibited Medication|1|||
126684235|NCT04872101|455800141|FG001|Overall Study|Prohibited Medication|0|||
126684236|NCT04872101|455800140|FG000|Overall Study|Not dosed|1|||
126684237|NCT04872101|455800141|FG001|Overall Study|Not dosed|0|||
126684238|NCT00971945|455800142|FG000|Overall Study|Progressive Disease|3|||
126684239|NCT00971945|455800142|FG000|Overall Study|Change in treatment policy|1|||
126684240|NCT00971945|455800142|FG000|Overall Study|Other reasons|2|||
126684241|NCT03354663|455800143|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
126684242|NCT03354663|455800143|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
126684243|NCT03354663|455800143|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
126684244|NCT03354663|455800143|FG000|Completed 30-day Visit|Missed Visit|1|||
126684245|NCT03691974|455800144|FG000|Overall Study|Physician Decision|1|||
126684246|NCT03691974|455800145|FG001|Overall Study|Physician Decision|0|||
126684247|NCT03691974|455800144|FG000|Overall Study|Adverse Event|1|||
126684248|NCT03691974|455800145|FG001|Overall Study|Adverse Event|0|||
126684249|NCT03691974|455800144|FG000|Overall Study|Withdrawal by Subject|11|||
126684250|NCT03691974|455800145|FG001|Overall Study|Withdrawal by Subject|9|||
126684251|NCT03691974|455800144|FG000|Overall Study|Protocol Violation|1|||
126684252|NCT03691974|455800145|FG001|Overall Study|Protocol Violation|0|||
126684253|NCT03691974|455800144|FG000|Overall Study|Lost to Follow-up|8|||
126684254|NCT03691974|455800145|FG001|Overall Study|Lost to Follow-up|7|||
126684255|NCT00746252|455800146|FG000|Overall Study|weight gain >7.5 %|1|||
126684256|NCT00746252|455800147|FG001|Overall Study|weight gain >7.5 %|2|||
126684257|NCT02239939|455800148|FG000|Overall Study|Adverse Event|1|||
126684258|NCT02239939|455800149|FG001|Overall Study|Adverse Event|0|||
126684259|NCT02239939|455800148|FG000|Overall Study|Withdrawal by Subject|1|||
126684260|NCT02239939|455800149|FG001|Overall Study|Withdrawal by Subject|1|||
126684261|NCT02239939|455800148|FG000|Overall Study|Lost to Follow-up|0|||
126684262|NCT02239939|455800149|FG001|Overall Study|Lost to Follow-up|1|||
126684263|NCT03325673|455800158|FG000|Overall Study|Adverse Event|4|||
126684264|NCT03325673|455800159|FG001|Overall Study|Adverse Event|0|||
126684265|NCT00590590|455800160|FG000|Overall Study|Lack of Efficacy|1|||
126684266|NCT00590590|455800161|FG001|Overall Study|Lack of Efficacy|2|||
126684267|NCT00590590|455800162|FG002|Overall Study|Lack of Efficacy|0|||
126684268|NCT00590590|455800160|FG000|Overall Study|Adverse Event|1|||
126684269|NCT00590590|455800161|FG001|Overall Study|Adverse Event|0|||
126684270|NCT00590590|455800162|FG002|Overall Study|Adverse Event|0|||
126684271|NCT00590590|455800160|FG000|Overall Study|Protocol Violation|0|||
126684272|NCT00590590|455800161|FG001|Overall Study|Protocol Violation|0|||
126684273|NCT00590590|455800162|FG002|Overall Study|Protocol Violation|2|||
126684274|NCT00590590|455800160|FG000|Overall Study|Lost to Follow-up|4|||
126684275|NCT00590590|455800161|FG001|Overall Study|Lost to Follow-up|1|||
126684276|NCT00590590|455800162|FG002|Overall Study|Lost to Follow-up|2|||
126684277|NCT00590590|455800160|FG000|Overall Study|Withdrawal by Subject|0|||
126684278|NCT00590590|455800161|FG001|Overall Study|Withdrawal by Subject|1|||
126684279|NCT00590590|455800162|FG002|Overall Study|Withdrawal by Subject|1|||
126684280|NCT00590590|455800160|FG000|Overall Study|Did not complete due to study closure|1|||
126684281|NCT00590590|455800161|FG001|Overall Study|Did not complete due to study closure|1|||
126684282|NCT00590590|455800162|FG002|Overall Study|Did not complete due to study closure|1|||
126684283|NCT00590590|455800160|FG000|Overall Study|Did not complete study|0|||
126684284|NCT00590590|455800161|FG001|Overall Study|Did not complete study|1|||
126684285|NCT00590590|455800162|FG002|Overall Study|Did not complete study|0|||
126684286|NCT01514682|455800163|FG000|Overall Study|Withdrawal by Subject|2|||
126684287|NCT01514682|455800164|FG001|Overall Study|Withdrawal by Subject|3|||
126684288|NCT01514682|455800163|FG000|Overall Study|Physician Decision|4|||
126684289|NCT01514682|455800164|FG001|Overall Study|Physician Decision|3|||
126684290|NCT01870401|455800165|FG000|Overall Study|Death|48|||
126684291|NCT01870401|455800166|FG001|Overall Study|Death|24|||
126684292|NCT01870401|455800165|FG000|Overall Study|Withdrawal by Subject|39|||
126684293|NCT01870401|455800166|FG001|Overall Study|Withdrawal by Subject|26|||
126684294|NCT01870401|455800165|FG000|Overall Study|Lost to Follow-up|19|||
126684295|NCT01870401|455800166|FG001|Overall Study|Lost to Follow-up|14|||
126684296|NCT01870401|455800165|FG000|Overall Study|Other|9|||
126684297|NCT01870401|455800166|FG001|Overall Study|Other|7|||
126684298|NCT01870401|455800165|FG000|Overall Study|On-going in the Study|35|||
126684299|NCT01870401|455800166|FG001|Overall Study|On-going in the Study|25|||
126684300|NCT02105454|455800169|FG000|Overall Study|Withdrawal by Subject|1|||
126684301|NCT00493870|455800171|FG000|Overall Study|Lost to Follow-up|12|||
126684302|NCT00493870|455800172|FG001|Overall Study|Lost to Follow-up|15|||
126684303|NCT00272038|455800173|FG000|Overall Study|withdrew before they received 2 cycles|7|||
126684304|NCT02721355|455800174|FG000|Overall Study|Lost to Follow-up|6|||
126684305|NCT02721355|455800175|FG001|Overall Study|Lost to Follow-up|1|||
126684306|NCT03605680|455800176|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
126684307|NCT03605680|455800177|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
126684308|NCT03605680|455800178|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
126684309|NCT03605680|455800179|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
126684310|NCT03605680|455800176|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
126684311|NCT03605680|455800177|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
126684312|NCT03605680|455800178|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
126684313|NCT03605680|455800179|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
126684314|NCT03605680|455800176|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
126684315|NCT03605680|455800177|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
126684316|NCT03605680|455800178|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
126684317|NCT03605680|455800179|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
126684318|NCT03605680|455800176|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
126684319|NCT03605680|455800177|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
126684320|NCT03605680|455800178|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
126684321|NCT03605680|455800179|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
126684322|NCT03605680|455800176|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
126684323|NCT03605680|455800177|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
126684324|NCT03605680|455800178|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
126684325|NCT03605680|455800179|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
126684326|NCT03605680|455800176|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
126684327|NCT03605680|455800177|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
126684328|NCT03605680|455800178|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
126684329|NCT03605680|455800179|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
126684330|NCT03605680|455800176|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
126684331|NCT03605680|455800177|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
126684332|NCT03605680|455800178|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
126684333|NCT03605680|455800179|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
126684334|NCT03605680|455800176|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
126684335|NCT03605680|455800177|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
126684336|NCT03605680|455800178|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
126684337|NCT03605680|455800179|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
126684338|NCT03605680|455800176|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
126684339|NCT03605680|455800177|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
126684340|NCT03605680|455800178|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
126684341|NCT03605680|455800179|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
126684342|NCT03605680|455800176|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
126684343|NCT03605680|455800177|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
126684344|NCT03605680|455800178|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
126684345|NCT03605680|455800179|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
126684346|NCT03605680|455800176|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
126684347|NCT03605680|455800177|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
126684348|NCT03605680|455800178|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
126684349|NCT03605680|455800179|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
126684350|NCT03605680|455800176|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126684351|NCT03605680|455800177|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126684352|NCT03605680|455800178|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126684353|NCT03605680|455800179|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
126684354|NCT03605680|455800176|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
126684355|NCT03605680|455800177|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
126684356|NCT03605680|455800178|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
126684357|NCT03605680|455800179|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
126684358|NCT03605680|455800176|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
126684359|NCT03605680|455800177|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
126684360|NCT03605680|455800178|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
126684361|NCT03605680|455800179|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
126684362|NCT03605680|455800176|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
126684363|NCT03605680|455800177|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
126684364|NCT03605680|455800178|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
126684365|NCT03605680|455800179|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
126684366|NCT03605680|455800176|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
126684367|NCT03605680|455800177|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
126684368|NCT03605680|455800178|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
126684369|NCT03605680|455800179|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
126684370|NCT03605680|455800176|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
126684371|NCT03605680|455800177|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
126684372|NCT03605680|455800178|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
126684373|NCT03605680|455800179|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
126684374|NCT03605680|455800176|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
126684375|NCT03605680|455800177|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
126684376|NCT03605680|455800178|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
126684377|NCT03605680|455800179|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
126684378|NCT03605680|455800176|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
126684379|NCT03605680|455800177|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
126684380|NCT03605680|455800178|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
126684381|NCT03605680|455800179|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
126684382|NCT00356278|455800180|FG000|Overall Study|Withdrawal by Subject|25|||
126684383|NCT00356278|455800181|FG001|Overall Study|Withdrawal by Subject|15|||
126684384|NCT00356278|455800182|FG002|Overall Study|Withdrawal by Subject|19|||
126684385|NCT00883337|455800183|FG000|Core Treatment Period|Adverse Event|9|||
126684386|NCT00883337|455800184|FG001|Core Treatment Period|Adverse Event|12|||
126684387|NCT00883337|455800185|FG002|Core Treatment Period|Adverse Event|22|||
126684388|NCT00883337|455800183|FG000|Core Treatment Period|Lack of Efficacy|7|||
126684389|NCT00883337|455800184|FG001|Core Treatment Period|Lack of Efficacy|4|||
126684390|NCT00883337|455800185|FG002|Core Treatment Period|Lack of Efficacy|2|||
126684391|NCT00883337|455800183|FG000|Core Treatment Period|Lost to Follow-up|1|||
126684392|NCT00883337|455800184|FG001|Core Treatment Period|Lost to Follow-up|1|||
126684393|NCT00883337|455800185|FG002|Core Treatment Period|Lost to Follow-up|0|||
126684394|NCT00883337|455800183|FG000|Core Treatment Period|Withdrawal by Subject|2|||
126684395|NCT00883337|455800184|FG001|Core Treatment Period|Withdrawal by Subject|2|||
126684396|NCT00883337|455800185|FG002|Core Treatment Period|Withdrawal by Subject|6|||
126684397|NCT00883337|455800183|FG000|Core Treatment Period|Wish to be pregnant|1|||
126684398|NCT00883337|455800184|FG001|Core Treatment Period|Wish to be pregnant|2|||
126684399|NCT00883337|455800185|FG002|Core Treatment Period|Wish to be pregnant|1|||
126684400|NCT00883337|455800183|FG000|Core Treatment Period|Poor compliance to protocol|0|||
126684401|NCT00883337|455800184|FG001|Core Treatment Period|Poor compliance to protocol|0|||
126684402|NCT00883337|455800185|FG002|Core Treatment Period|Poor compliance to protocol|1|||
126684403|NCT00883337|455800183|FG000|Core Treatment Period|Other than above|0|||
126684404|NCT00883337|455800184|FG001|Core Treatment Period|Other than above|1|||
126684405|NCT00883337|455800185|FG002|Core Treatment Period|Other than above|1|||
126684406|NCT00883337|455800183|FG000|Extension Treatment Period|Adverse Event|8|||
126684407|NCT00883337|455800184|FG001|Extension Treatment Period|Adverse Event|5|||
126684408|NCT00883337|455800185|FG002|Extension Treatment Period|Adverse Event|5|||
126684409|NCT00883337|455800183|FG000|Extension Treatment Period|Lack of Efficacy|8|||
126684410|NCT00883337|455800184|FG001|Extension Treatment Period|Lack of Efficacy|8|||
126684411|NCT00883337|455800185|FG002|Extension Treatment Period|Lack of Efficacy|8|||
126684412|NCT00883337|455800183|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
126684413|NCT00883337|455800184|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
126684414|NCT00883337|455800185|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
126437402|NCT01054885|454902958|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126437403|NCT01054885|454902959|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126437404|NCT01054885|454902960|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126437405|NCT01054885|454902961|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126437406|NCT01054885|454902962|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126437407|NCT01054885|454902963|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126437408|NCT01054885|454902957|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
126437409|NCT01054885|454902958|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126437410|NCT01054885|454902959|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126437411|NCT01054885|454902960|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126437412|NCT01054885|454902961|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126437413|NCT01054885|454902962|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126437414|NCT01054885|454902963|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126437415|NCT01054885|454902957|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
126437416|NCT01054885|454902958|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
126437417|NCT01054885|454902959|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
126437418|NCT01054885|454902960|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
126437419|NCT01054885|454902961|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
126437420|NCT01054885|454902962|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
126684415|NCT00883337|455800183|FG000|Extension Treatment Period|Lost to Follow-up|1|||
126684416|NCT00883337|455800184|FG001|Extension Treatment Period|Lost to Follow-up|0|||
126684417|NCT00883337|455800185|FG002|Extension Treatment Period|Lost to Follow-up|0|||
126684418|NCT00883337|455800183|FG000|Extension Treatment Period|Other than above|10|||
126684419|NCT00883337|455800184|FG001|Extension Treatment Period|Other than above|9|||
126684420|NCT00883337|455800185|FG002|Extension Treatment Period|Other than above|5|||
126684421|NCT00527605|455800186|FG000|Overall Study|Adverse Event|3|||
126684422|NCT00527605|455800187|FG001|Overall Study|Adverse Event|0|||
126684423|NCT00527605|455800186|FG000|Overall Study|Withdrawal by Subject|3|||
126684424|NCT00527605|455800187|FG001|Overall Study|Withdrawal by Subject|7|||
126684425|NCT00527605|455800186|FG000|Overall Study|Lost to Follow-up|6|||
126684426|NCT00527605|455800187|FG001|Overall Study|Lost to Follow-up|2|||
126684427|NCT00527605|455800186|FG000|Overall Study|Protocol Violation|1|||
126684428|NCT00527605|455800187|FG001|Overall Study|Protocol Violation|2|||
126684429|NCT01592760|455800188|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
126684430|NCT01592760|455800189|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
126684431|NCT01592760|455800190|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
126684432|NCT01678144|455800199|FG000|Stage 1: MAR Classic|Adverse Event|1|||
126684433|NCT02363686|455800200|FG000|Overall Study|Withdrawal by Subject|22|||
126684434|NCT02363686|455800200|FG000|Overall Study|incomplete FEES examinations|13|||
126684435|NCT01485627|455800203|FG000|Overall Study|Patient withdrew|6|||
126684436|NCT01485627|455800204|FG001|Overall Study|Patient withdrew|5|||
126684437|NCT01485627|455800203|FG000|Overall Study|Patient died|3|||
126684438|NCT01485627|455800204|FG001|Overall Study|Patient died|1|||
126684439|NCT01485627|455800203|FG000|Overall Study|Patient lost to followup|0|||
126758958|NCT01072175|456066697|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126758959|NCT01072175|456066698|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126758960|NCT01072175|456066699|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126758961|NCT01072175|456066700|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
126758962|NCT01072175|456066701|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
126758963|NCT01072175|456066702|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
126758964|NCT01072175|456066703|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
126758965|NCT01072175|456066691|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
126758966|NCT01072175|456066692|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
126758967|NCT01072175|456066693|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
126758968|NCT01072175|456066694|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
126758969|NCT01072175|456066695|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
126758970|NCT01072175|456066696|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
126758971|NCT01072175|456066697|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
126758972|NCT01072175|456066698|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
126758973|NCT01072175|456066699|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
126758974|NCT01072175|456066700|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
126758975|NCT01072175|456066701|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
126758976|NCT01072175|456066702|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
126758977|NCT01072175|456066703|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
126758978|NCT01072175|456066691|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126758979|NCT01072175|456066692|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126758980|NCT01072175|456066693|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126758981|NCT01072175|456066694|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126758982|NCT01072175|456066695|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126758983|NCT01072175|456066696|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126758984|NCT01072175|456066697|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126758985|NCT01072175|456066698|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126758986|NCT01072175|456066699|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126758987|NCT01072175|456066700|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126758988|NCT01072175|456066701|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
126758989|NCT01072175|456066702|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
126758990|NCT01072175|456066703|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
126758991|NCT00682539|456066704|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
126758992|NCT00682539|456066705|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
126758993|NCT00682539|456066706|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
126758994|NCT00682539|456066704|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
126758995|NCT00682539|456066705|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
126758996|NCT00682539|456066706|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
126758997|NCT02477215|456066709|FG000|Dose Escalation Phase|Physician Decision|1|||
126758998|NCT02477215|456066710|FG001|Dose Escalation Phase|Physician Decision|2|||
126758999|NCT02477215|456066711|FG002|Dose Escalation Phase|Physician Decision|0|||
126759000|NCT02477215|456066709|FG000|Fixed Dose Phase|Physician Decision|0|||
126759001|NCT02477215|456066710|FG001|Fixed Dose Phase|Physician Decision|7|||
126759002|NCT02477215|456066711|FG002|Fixed Dose Phase|Physician Decision|0|||
126759003|NCT01911546|456066714|FG000|Overall Study|Lost to Follow-up|1|||
126759004|NCT01911546|456066714|FG000|Overall Study|Everolimus was discontinued|5|||
126759005|NCT02210559|456066715|FG000|Overall Study|Progressive Disease|3|||
126437421|NCT01054885|454902963|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
126684440|NCT01485627|455800204|FG001|Overall Study|Patient lost to followup|1|||
126684441|NCT01485627|455800203|FG000|Overall Study|Caregiver withdrew|3|||
126684442|NCT01485627|455800204|FG001|Overall Study|Caregiver withdrew|3|||
126684443|NCT01485627|455800203|FG000|Overall Study|Caregiver lost to follow up|11|||
126684444|NCT01485627|455800204|FG001|Overall Study|Caregiver lost to follow up|12|||
126684445|NCT01485627|455800203|FG000|Overall Study|Caregiver died|1|||
126684446|NCT01485627|455800204|FG001|Overall Study|Caregiver died|0|||
126684447|NCT01485627|455800203|FG000|Overall Study|caregiver was not bereaved|42|||
126684448|NCT01485627|455800204|FG001|Overall Study|caregiver was not bereaved|35|||
126684449|NCT00774345|455800223|FG000|Pre-treatment|Other reasons|2|||
126684450|NCT00774345|455800224|FG001|Pre-treatment|Other reasons|0|||
126684451|NCT00774345|455800223|FG000|Treatment|Adverse Event|61|||
126684452|NCT00774345|455800224|FG001|Treatment|Adverse Event|15|||
126684453|NCT00774345|455800223|FG000|Treatment|Progressive Disease without histologic transformation|51|||
126684454|NCT00774345|455800224|FG001|Treatment|Progressive Disease without histologic transformation|111|||
126684455|NCT00774345|455800223|FG000|Treatment|Progressive Disease with histologic transformation|4|||
126684456|NCT00774345|455800224|FG001|Treatment|Progressive Disease with histologic transformation|2|||
126684457|NCT00774345|455800223|FG000|Treatment|Withdrawal by Subject|5|||
126684458|NCT00774345|455800224|FG001|Treatment|Withdrawal by Subject|2|||
126684459|NCT00774345|455800223|FG000|Treatment|Lost to Follow-up|1|||
126684460|NCT00774345|455800224|FG001|Treatment|Lost to Follow-up|1|||
126684461|NCT00774345|455800223|FG000|Treatment|Death|4|||
126684462|NCT00774345|455800224|FG001|Treatment|Death|0|||
126684463|NCT00774345|455800223|FG000|Treatment|Other Reasons|32|||
126684464|NCT00774345|455800224|FG001|Treatment|Other Reasons|26|||
126684465|NCT00075504|455800225|FG000|Overall Study|Withdrawal by Subject|9|||
126684466|NCT00075504|455800226|FG001|Overall Study|Withdrawal by Subject|7|||
126684467|NCT01692301|455800228|FG000|Overall Study|Adverse Event|15|||
126684468|NCT01692301|455800229|FG001|Overall Study|Adverse Event|12|||
126684469|NCT01692301|455800228|FG000|Overall Study|Death|1|||
126684470|NCT01692301|455800229|FG001|Overall Study|Death|2|||
126684471|NCT01692301|455800228|FG000|Overall Study|Lack of Efficacy|0|||
126684472|NCT01692301|455800229|FG001|Overall Study|Lack of Efficacy|5|||
126684473|NCT01692301|455800228|FG000|Overall Study|Non-compliance with study treatment|1|||
126684474|NCT01692301|455800229|FG001|Overall Study|Non-compliance with study treatment|2|||
126684475|NCT01692301|455800228|FG000|Overall Study|Protocol deviation|9|||
126684476|NCT01692301|455800229|FG001|Overall Study|Protocol deviation|2|||
126684477|NCT01692301|455800228|FG000|Overall Study|Patient/guardian decision|16|||
126684478|NCT01692301|455800229|FG001|Overall Study|Patient/guardian decision|15|||
126684479|NCT01692301|455800228|FG000|Overall Study|Technical problems|0|||
126684480|NCT01692301|455800229|FG001|Overall Study|Technical problems|1|||
126684481|NCT01692301|455800228|FG000|Overall Study|Physician Decision|2|||
126684482|NCT01692301|455800229|FG001|Overall Study|Physician Decision|2|||
126684483|NCT01692301|455800228|FG000|Overall Study|Lost to Follow-up|1|||
126684484|NCT01692301|455800229|FG001|Overall Study|Lost to Follow-up|1|||
126684485|NCT01142726|455800230|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
126684486|NCT01142726|455800231|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
126684487|NCT01142726|455800232|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
126684488|NCT01142726|455800230|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
126684489|NCT01142726|455800231|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
126759006|NCT02210559|456066716|FG001|Overall Study|Progressive Disease|2|||
126759007|NCT02210559|456066715|FG000|Overall Study|Adverse Event|2|||
126759008|NCT02210559|456066716|FG001|Overall Study|Adverse Event|2|||
126759009|NCT02210559|456066715|FG000|Overall Study|Physician Decision|1|||
126759010|NCT02210559|456066716|FG001|Overall Study|Physician Decision|0|||
126759011|NCT02210559|456066715|FG000|Overall Study|Withdrawal by Subject|0|||
126759012|NCT02210559|456066716|FG001|Overall Study|Withdrawal by Subject|1|||
126759013|NCT02210559|456066715|FG000|Overall Study|Other than specified|0|||
126759014|NCT02210559|456066716|FG001|Overall Study|Other than specified|1|||
126759015|NCT02546193|456066717|FG000|Overall Study|Withdrawal by Subject|2|||
126759016|NCT02546193|456066718|FG001|Overall Study|Withdrawal by Subject|0|||
126759017|NCT02546193|456066719|FG002|Overall Study|Withdrawal by Subject|1|||
126759018|NCT02546193|456066720|FG003|Overall Study|Withdrawal by Subject|0|||
126759019|NCT02546193|456066717|FG000|Overall Study|Not eligible at time of induction|4|||
126759020|NCT02546193|456066718|FG001|Overall Study|Not eligible at time of induction|6|||
126684490|NCT01142726|455800232|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
126684491|NCT01142726|455800230|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
126684492|NCT01142726|455800231|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
126684493|NCT01142726|455800232|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
126684494|NCT01142726|455800230|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
126684495|NCT01142726|455800231|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
126684496|NCT01142726|455800232|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
126684497|NCT01142726|455800230|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
126684498|NCT01142726|455800231|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
126684499|NCT01142726|455800232|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
126759021|NCT02546193|456066719|FG002|Overall Study|Not eligible at time of induction|1|||
126684500|NCT01142726|455800230|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
126684501|NCT01142726|455800231|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
126684502|NCT01142726|455800232|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
126684503|NCT01142726|455800230|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
126684504|NCT01142726|455800231|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
126684505|NCT01142726|455800232|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
126684506|NCT01142726|455800230|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
126684507|NCT01142726|455800231|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
126684508|NCT01142726|455800232|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
126684509|NCT01142726|455800230|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
126684510|NCT01142726|455800231|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
126684511|NCT01142726|455800232|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
126684512|NCT01142726|455800230|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
126684513|NCT01142726|455800231|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
126684514|NCT01142726|455800232|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
126684515|NCT01142726|455800230|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
126684516|NCT01142726|455800231|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
126684517|NCT01142726|455800232|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
126684518|NCT01142726|455800230|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
126684519|NCT01142726|455800231|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
126684520|NCT01142726|455800232|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
126684521|NCT01142726|455800230|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
126684522|NCT01142726|455800231|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
126684523|NCT01142726|455800232|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
126684524|NCT01142726|455800230|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
126684525|NCT01142726|455800231|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
126684526|NCT01142726|455800232|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
126684527|NCT01142726|455800230|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
126684528|NCT01142726|455800231|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
126684529|NCT01142726|455800232|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
126684530|NCT01142726|455800230|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
126684531|NCT01142726|455800231|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
126684532|NCT01142726|455800232|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
126684533|NCT01568593|455800233|FG000|Overall Study|Lack of Efficacy|4|||
126684534|NCT01568593|455800234|FG001|Overall Study|Lack of Efficacy|1|||
126684535|NCT01568593|455800233|FG000|Overall Study|Adverse Event|3|||
126684536|NCT01568593|455800234|FG001|Overall Study|Adverse Event|2|||
126684537|NCT02109484|455800235|FG000|Overall Study|Lost to Follow-up|0|||
126684538|NCT02109484|455800236|FG001|Overall Study|Lost to Follow-up|0|||
126684539|NCT02109484|455800237|FG002|Overall Study|Lost to Follow-up|0|||
126684540|NCT02109484|455800238|FG003|Overall Study|Lost to Follow-up|1|||
126684541|NCT02109484|455800239|FG004|Overall Study|Lost to Follow-up|1|||
126684542|NCT02109484|455800240|FG005|Overall Study|Lost to Follow-up|0|||
126684543|NCT02109484|455800241|FG006|Overall Study|Lost to Follow-up|1|||
126684544|NCT02109484|455800242|FG007|Overall Study|Lost to Follow-up|0|||
126684545|NCT02109484|455800235|FG000|Overall Study|Withdrawal by Subject|0|||
126684546|NCT02109484|455800236|FG001|Overall Study|Withdrawal by Subject|0|||
126684547|NCT02109484|455800237|FG002|Overall Study|Withdrawal by Subject|0|||
126684548|NCT02109484|455800238|FG003|Overall Study|Withdrawal by Subject|0|||
126684549|NCT02109484|455800239|FG004|Overall Study|Withdrawal by Subject|1|||
126684550|NCT02109484|455800240|FG005|Overall Study|Withdrawal by Subject|1|||
126684551|NCT02109484|455800241|FG006|Overall Study|Withdrawal by Subject|1|||
126684552|NCT02109484|455800242|FG007|Overall Study|Withdrawal by Subject|0|||
126684553|NCT02109484|455800235|FG000|Overall Study|Physician Decision|0|||
126684554|NCT02109484|455800236|FG001|Overall Study|Physician Decision|0|||
126684555|NCT02109484|455800237|FG002|Overall Study|Physician Decision|0|||
126684556|NCT02109484|455800238|FG003|Overall Study|Physician Decision|0|||
126684557|NCT02109484|455800239|FG004|Overall Study|Physician Decision|2|||
126684558|NCT02109484|455800240|FG005|Overall Study|Physician Decision|0|||
126759022|NCT02546193|456066720|FG003|Overall Study|Not eligible at time of induction|0|||
126759023|NCT01474291|456066721|FG000|Overall Study|Not Evaluable for Efficacy|26|||
126759024|NCT01474291|456066721|FG000|Overall Study|Lack of Treatment Efficacy|88|||
126759025|NCT01474291|456066721|FG000|Overall Study|Adverse Event|53|||
126759026|NCT01474291|456066721|FG000|Overall Study|Lost to Follow-up|29|||
126759027|NCT01474291|456066721|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
126759028|NCT01474291|456066721|FG000|Overall Study|No Reason Reported|10|||
126684559|NCT02109484|455800241|FG006|Overall Study|Physician Decision|0|||
126684560|NCT02109484|455800242|FG007|Overall Study|Physician Decision|0|||
126684561|NCT02109484|455800235|FG000|Overall Study|Death|0|||
126684562|NCT02109484|455800236|FG001|Overall Study|Death|0|||
126684563|NCT02109484|455800237|FG002|Overall Study|Death|0|||
126759029|NCT01474291|456066721|FG000|Overall Study|Death|2|||
126437422|NCT01054885|454902957|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
126437423|NCT01054885|454902958|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126437424|NCT01054885|454902959|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126437425|NCT01054885|454902960|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126437426|NCT01054885|454902961|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126437427|NCT01054885|454902962|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126437428|NCT01054885|454902963|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126437429|NCT01054885|454902957|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
126437430|NCT01054885|454902958|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
126437431|NCT01054885|454902959|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
126437432|NCT01054885|454902960|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
126437433|NCT01054885|454902961|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
126437434|NCT01054885|454902962|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
126437435|NCT01054885|454902963|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
126437436|NCT01054885|454902957|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126437437|NCT01054885|454902958|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126437438|NCT01054885|454902959|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
126437439|NCT01054885|454902960|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
126437440|NCT01054885|454902961|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126437441|NCT01054885|454902962|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
126437442|NCT01054885|454902963|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126684564|NCT02109484|455800238|FG003|Overall Study|Death|0|||
126684565|NCT02109484|455800239|FG004|Overall Study|Death|0|||
126684566|NCT02109484|455800240|FG005|Overall Study|Death|0|||
126684567|NCT02109484|455800241|FG006|Overall Study|Death|0|||
126684568|NCT02109484|455800242|FG007|Overall Study|Death|2|||
126684569|NCT02109484|455800235|FG000|Overall Study|Moved away from study area|0|||
126684570|NCT02109484|455800236|FG001|Overall Study|Moved away from study area|0|||
126684571|NCT02109484|455800237|FG002|Overall Study|Moved away from study area|0|||
126684572|NCT02109484|455800238|FG003|Overall Study|Moved away from study area|0|||
126684573|NCT02109484|455800239|FG004|Overall Study|Moved away from study area|0|||
126684574|NCT02109484|455800240|FG005|Overall Study|Moved away from study area|0|||
126684575|NCT02109484|455800241|FG006|Overall Study|Moved away from study area|1|||
126684576|NCT02109484|455800242|FG007|Overall Study|Moved away from study area|1|||
126684577|NCT02111993|455800247|FG000|Overall Study|Physician Decision|5|||
126684578|NCT02111993|455800248|FG001|Overall Study|Physician Decision|4|||
126684579|NCT03127384|455800255|FG000|Overall Study|Lost to Follow-up|4|||
126684580|NCT03127384|455800255|FG000|Overall Study|Subject request|2|||
126684581|NCT01026831|455800256|FG000|Overall Study|Adverse Event|4|||
126684582|NCT01026831|455800257|FG001|Overall Study|Adverse Event|3|||
126684583|NCT01026831|455800256|FG000|Overall Study|Lost to Follow-up|2|||
126684584|NCT01026831|455800257|FG001|Overall Study|Lost to Follow-up|0|||
126684585|NCT01026831|455800256|FG000|Overall Study|Physician Decision|1|||
126684586|NCT01026831|455800257|FG001|Overall Study|Physician Decision|1|||
126684587|NCT01026831|455800256|FG000|Overall Study|Protocol Violation|0|||
126684588|NCT01026831|455800257|FG001|Overall Study|Protocol Violation|2|||
126684589|NCT01026831|455800256|FG000|Overall Study|Withdrawal by Subject|7|||
126684590|NCT01026831|455800257|FG001|Overall Study|Withdrawal by Subject|5|||
126684591|NCT04417894|455800258|FG000|Overall Study|Lost to Follow-up|3|||
126684592|NCT04417894|455800259|FG001|Overall Study|Lost to Follow-up|0|||
126684593|NCT04417894|455800258|FG000|Overall Study|Withdrawal by Subject|7|||
126684594|NCT04417894|455800259|FG001|Overall Study|Withdrawal by Subject|6|||
126684595|NCT04417894|455800258|FG000|Overall Study|Lack of Efficacy|3|||
126684596|NCT04417894|455800259|FG001|Overall Study|Lack of Efficacy|1|||
126684597|NCT03440814|455800260|FG000|Overall Study|Adverse Event|2|||
126684598|NCT03440814|455800261|FG001|Overall Study|Adverse Event|1|||
126684599|NCT03440814|455800260|FG000|Overall Study|Lost to Follow-up|2|||
126684600|NCT03440814|455800261|FG001|Overall Study|Lost to Follow-up|0|||
126684601|NCT03440814|455800260|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
126684602|NCT03440814|455800261|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
126684603|NCT00879697|455800262|FG000|Overall Study|Physician Decision|2|||
126684604|NCT00879697|455800263|FG001|Overall Study|Physician Decision|2|||
126684605|NCT02751502|455800264|FG000|Overall Study|Lack of funding|4|||
126684606|NCT00088374|455800265|FG000|Overall Study|patient did not receive any 17AAG|1|||
126684607|NCT00088374|455800265|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
126684608|NCT02678390|455800266|FG000|AE (1 Day)|Withdrawal by Subject|0|||
126684609|NCT02678390|455800267|FG001|AE (1 Day)|Withdrawal by Subject|1|||
126684610|NCT00498173|455800268|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
126684611|NCT00498173|455800269|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
126684612|NCT00498173|455800270|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
126684613|NCT01110200|455800271|FG000|Overall Study|Adverse Event|28|||
126684614|NCT01110200|455800272|FG001|Overall Study|Adverse Event|28|||
126684615|NCT01110200|455800271|FG000|Overall Study|Withdrawal by Subject|25|||
126684616|NCT01110200|455800272|FG001|Overall Study|Withdrawal by Subject|32|||
126684617|NCT01110200|455800271|FG000|Overall Study|Lack of Efficacy|16|||
126684618|NCT01110200|455800272|FG001|Overall Study|Lack of Efficacy|25|||
126684619|NCT01110200|455800271|FG000|Overall Study|Protocol Violation|14|||
126684620|NCT01110200|455800272|FG001|Overall Study|Protocol Violation|12|||
126684621|NCT01110200|455800271|FG000|Overall Study|Physician Decision|13|||
126684622|NCT01110200|455800272|FG001|Overall Study|Physician Decision|17|||
126684623|NCT01110200|455800271|FG000|Overall Study|Lost to Follow-up|10|||
126684624|NCT01110200|455800272|FG001|Overall Study|Lost to Follow-up|7|||
126684625|NCT01632566|455800273|FG000|Overall Study|Withdrawal by Subject|0|||
126684626|NCT01632566|455800274|FG001|Overall Study|Withdrawal by Subject|1|||
126684627|NCT01632566|455800275|FG002|Overall Study|Withdrawal by Subject|0|||
126684628|NCT01632566|455800276|FG003|Overall Study|Withdrawal by Subject|0|||
126684629|NCT01632566|455800277|FG004|Overall Study|Withdrawal by Subject|0|||
126684630|NCT01632566|455800273|FG000|Overall Study|Sponsor Decision|0|||
126684631|NCT01632566|455800274|FG001|Overall Study|Sponsor Decision|2|||
126684632|NCT01632566|455800275|FG002|Overall Study|Sponsor Decision|9|||
126684633|NCT01632566|455800276|FG003|Overall Study|Sponsor Decision|2|||
126684634|NCT01632566|455800277|FG004|Overall Study|Sponsor Decision|2|||
126684635|NCT01318109|455800278|FG000|Overall Study|Adverse Event|0|||
126684636|NCT01318109|455800279|FG001|Overall Study|Adverse Event|2|||
126684637|NCT01318109|455800280|FG002|Overall Study|Adverse Event|0|||
126684638|NCT01318109|455800278|FG000|Overall Study|Withdrawal by Subject|1|||
126684639|NCT01318109|455800279|FG001|Overall Study|Withdrawal by Subject|0|||
126684640|NCT01318109|455800280|FG002|Overall Study|Withdrawal by Subject|0|||
126684641|NCT01318109|455800278|FG000|Overall Study|Schedule Conflict|0|||
126684642|NCT01318109|455800279|FG001|Overall Study|Schedule Conflict|1|||
126684643|NCT01318109|455800280|FG002|Overall Study|Schedule Conflict|0|||
126684644|NCT00264238|455800283|FG000|Overall Study|Protocol Violation|1|||
126684645|NCT01411085|455800284|FG000|Overall Study|Physician Decision|1|||
126684646|NCT01411085|455800284|FG000|Overall Study|Protocol Violation|1|||
126684647|NCT01411085|455800284|FG000|Overall Study|Adverse Event|1|||
126684648|NCT02193074|455800285|FG000|Overall Study|Withdrawal by Subject|1|||
126684649|NCT02193074|455800286|FG001|Overall Study|Withdrawal by Subject|2|||
126684650|NCT02193074|455800285|FG000|Overall Study|Adverse Event|16|||
126684651|NCT02193074|455800286|FG001|Overall Study|Adverse Event|13|||
126684652|NCT01534533|455800287|FG000|Overall Study|Lost to Follow-up|3|||
126684653|NCT01534533|455800288|FG001|Overall Study|Lost to Follow-up|0|||
126684654|NCT01534533|455800289|FG002|Overall Study|Lost to Follow-up|4|||
126684655|NCT01534533|455800290|FG003|Overall Study|Lost to Follow-up|3|||
126684656|NCT01534533|455800287|FG000|Overall Study|Withdrawal by Subject|5|||
126684657|NCT01534533|455800288|FG001|Overall Study|Withdrawal by Subject|3|||
126684658|NCT01534533|455800289|FG002|Overall Study|Withdrawal by Subject|4|||
126684659|NCT01534533|455800290|FG003|Overall Study|Withdrawal by Subject|1|||
126684660|NCT04311502|455801627|FG000|Overall Study|Death|1|||
126684661|NCT04311502|455801628|FG001|Overall Study|Death|1|||
126684662|NCT04311502|455801629|FG002|Overall Study|Death|1|||
126684663|NCT04311502|455801627|FG000|Overall Study|Lost to Follow-up|2|||
126684664|NCT04311502|455801628|FG001|Overall Study|Lost to Follow-up|3|||
126684665|NCT04311502|455801629|FG002|Overall Study|Lost to Follow-up|0|||
126684666|NCT04311502|455801627|FG000|Overall Study|Participant is in prison|1|||
126684667|NCT04311502|455801628|FG001|Overall Study|Participant is in prison|0|||
126684668|NCT04311502|455801629|FG002|Overall Study|Participant is in prison|0|||
126684669|NCT04311502|455801627|FG000|Overall Study|Participant moved out of country|1|||
126684670|NCT04311502|455801628|FG001|Overall Study|Participant moved out of country|0|||
126684671|NCT04311502|455801629|FG002|Overall Study|Participant moved out of country|0|||
126684672|NCT04311502|455801627|FG000|Overall Study|Withdrawal by Subject|2|||
126684673|NCT04311502|455801628|FG001|Overall Study|Withdrawal by Subject|0|||
126684674|NCT04311502|455801629|FG002|Overall Study|Withdrawal by Subject|0|||
126684675|NCT04311502|455801627|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
126759030|NCT01287403|456066722|FG000|1st Intervention (1 Day)|Adverse Event|1|||
126684676|NCT04311502|455801628|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
126684677|NCT04311502|455801629|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
126684678|NCT03040999|455801630|FG000|Overall Study|Lost to Follow-up|2|||
126684679|NCT03040999|455801631|FG001|Overall Study|Lost to Follow-up|2|||
126684680|NCT03040999|455801630|FG000|Overall Study|Withdrawal by Subject|12|||
126684681|NCT03040999|455801631|FG001|Overall Study|Withdrawal by Subject|13|||
126684682|NCT03040999|455801630|FG000|Overall Study|Death|155|||
126684683|NCT03040999|455801631|FG001|Overall Study|Death|171|||
126684684|NCT03040999|455801630|FG000|Overall Study|Physician Decision|0|||
126759031|NCT00148109|456066723|FG000|Overall Study|Lack of Efficacy|10|||
126759032|NCT00148109|456066724|FG001|Overall Study|Lack of Efficacy|18|||
126759033|NCT00148109|456066723|FG000|Overall Study|Adverse Event|0|||
126759034|NCT00148109|456066724|FG001|Overall Study|Adverse Event|2|||
126759035|NCT00148109|456066723|FG000|Overall Study|Withdrawal by Subject|2|||
126759036|NCT00148109|456066724|FG001|Overall Study|Withdrawal by Subject|0|||
126684685|NCT03040999|455801631|FG001|Overall Study|Physician Decision|3|||
126437443|NCT01054885|454902957|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
126437444|NCT01054885|454902958|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
126437445|NCT01054885|454902959|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
126437446|NCT01054885|454902960|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
126437447|NCT01054885|454902961|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
126437448|NCT01054885|454902962|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
126437449|NCT01054885|454902963|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
126437450|NCT01054885|454902957|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
126437451|NCT01054885|454902958|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
126437452|NCT01054885|454902959|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
126437453|NCT01054885|454902960|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
126437454|NCT01054885|454902961|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
126437455|NCT01054885|454902962|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
126437456|NCT01054885|454902963|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
126437457|NCT01054885|454902957|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
126437458|NCT01054885|454902958|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
126437459|NCT01054885|454902959|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
126437460|NCT01054885|454902960|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
126437461|NCT01054885|454902961|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
126437462|NCT01054885|454902962|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
126437463|NCT01054885|454902963|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
126437464|NCT01054885|454902957|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
126437465|NCT01054885|454902958|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
126437466|NCT01054885|454902959|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
126437467|NCT01054885|454902960|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
126437468|NCT01054885|454902961|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
126437469|NCT01054885|454902962|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
126437470|NCT01054885|454902963|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
126437471|NCT01054885|454902957|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126437472|NCT01054885|454902958|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
126437473|NCT01054885|454902959|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
126437474|NCT01054885|454902960|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126437475|NCT01054885|454902961|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126437476|NCT01054885|454902962|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
126437477|NCT01054885|454902963|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
126437478|NCT01054885|454902957|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
126437479|NCT01054885|454902958|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
126437480|NCT01054885|454902959|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
126437481|NCT01054885|454902960|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
126437482|NCT01054885|454902961|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
126437483|NCT01054885|454902962|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
126437484|NCT01054885|454902963|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
126437485|NCT01054885|454902957|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126437486|NCT01054885|454902958|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
126437487|NCT01054885|454902959|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
126437488|NCT01054885|454902960|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
126437489|NCT01054885|454902961|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
126437490|NCT01054885|454902962|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
126437491|NCT01054885|454902963|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
126437492|NCT00214201|454902965|FG000|Overall Study|Withdrawal by Subject|2|||
126437493|NCT00214201|454902966|FG001|Overall Study|Withdrawal by Subject|0|||
126437494|NCT00214201|454902965|FG000|Overall Study|Death|0|||
126437495|NCT00214201|454902966|FG001|Overall Study|Death|2|||
126437496|NCT01399372|454902967|FG000|Overall Study|Protocol Violation|3|||
126437497|NCT01399372|454902968|FG001|Overall Study|Protocol Violation|1|||
126437498|NCT01432730|454902969|FG000|Period 1|Adverse Event|2|||
126684686|NCT03657043|455801632|FG000|Overall Study|Withdrawal by Subject|1|||
126684687|NCT03657043|455801633|FG001|Overall Study|Withdrawal by Subject|1|||
126684688|NCT03657043|455801634|FG002|Overall Study|Withdrawal by Subject|0|||
126684689|NCT03657043|455801635|FG003|Overall Study|Withdrawal by Subject|0|||
126684690|NCT03657043|455801636|FG004|Overall Study|Withdrawal by Subject|4|||
126684691|NCT03657043|455801632|FG000|Overall Study|Study closure by Sponsor|0|||
126684692|NCT03657043|455801633|FG001|Overall Study|Study closure by Sponsor|2|||
126684693|NCT03657043|455801634|FG002|Overall Study|Study closure by Sponsor|0|||
126684694|NCT03657043|455801635|FG003|Overall Study|Study closure by Sponsor|0|||
126684695|NCT03657043|455801636|FG004|Overall Study|Study closure by Sponsor|17|||
126684696|NCT03657043|455801632|FG000|Overall Study|Lost to Follow-up|0|||
126684697|NCT03657043|455801633|FG001|Overall Study|Lost to Follow-up|0|||
126684698|NCT03657043|455801634|FG002|Overall Study|Lost to Follow-up|0|||
126684699|NCT03657043|455801635|FG003|Overall Study|Lost to Follow-up|0|||
126684700|NCT03657043|455801636|FG004|Overall Study|Lost to Follow-up|4|||
126684701|NCT03657043|455801632|FG000|Overall Study|Death|6|||
126684702|NCT03657043|455801633|FG001|Overall Study|Death|5|||
126684703|NCT03657043|455801634|FG002|Overall Study|Death|0|||
126684704|NCT03657043|455801635|FG003|Overall Study|Death|0|||
126684705|NCT03657043|455801636|FG004|Overall Study|Death|53|||
126684706|NCT03657043|455801632|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
126684707|NCT03657043|455801633|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
126684708|NCT03657043|455801634|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
126684709|NCT03657043|455801635|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
126684710|NCT03657043|455801636|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
126684711|NCT03657043|455801632|FG000|Overall Study|Adverse Event|0|||
126684712|NCT03657043|455801633|FG001|Overall Study|Adverse Event|0|||
126684713|NCT03657043|455801634|FG002|Overall Study|Adverse Event|0|||
126684714|NCT03657043|455801635|FG003|Overall Study|Adverse Event|0|||
126684715|NCT03657043|455801636|FG004|Overall Study|Adverse Event|2|||
126684716|NCT03657043|455801632|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
126684717|NCT03657043|455801633|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
126684718|NCT03657043|455801634|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
126684719|NCT03657043|455801635|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
126684720|NCT03657043|455801636|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
126684721|NCT03657043|455801632|FG000|Overall Study|Withdrawal - declined follow-up|0|||
126684722|NCT03657043|455801633|FG001|Overall Study|Withdrawal - declined follow-up|0|||
126684723|NCT03657043|455801634|FG002|Overall Study|Withdrawal - declined follow-up|0|||
126684724|NCT03657043|455801635|FG003|Overall Study|Withdrawal - declined follow-up|0|||
126684725|NCT03657043|455801636|FG004|Overall Study|Withdrawal - declined follow-up|1|||
126684726|NCT01736579|455801637|FG000|Overall Study|Termination of Study by Sponsor|2|||
126684727|NCT01736579|455801638|FG001|Overall Study|Termination of Study by Sponsor|2|||
126684728|NCT01408147|455801644|FG000|Overall Study|Withdrawal by Subject|0|||
126684729|NCT01408147|455801645|FG001|Overall Study|Withdrawal by Subject|1|||
126684730|NCT01662440|455801646|FG000|Overall Study|Adverse Event|1|||
126684731|NCT01662440|455801647|FG001|Overall Study|Adverse Event|0|||
126684732|NCT01662440|455801648|FG002|Overall Study|Adverse Event|0|||
126684733|NCT01662440|455801649|FG003|Overall Study|Adverse Event|1|||
126684734|NCT01662440|455801646|FG000|Overall Study|Death|0|||
126684735|NCT01662440|455801647|FG001|Overall Study|Death|1|||
126684736|NCT01662440|455801648|FG002|Overall Study|Death|0|||
126684737|NCT01662440|455801649|FG003|Overall Study|Death|0|||
126684738|NCT01662440|455801646|FG000|Overall Study|Lost to Follow-up|2|||
126684739|NCT01662440|455801647|FG001|Overall Study|Lost to Follow-up|2|||
126684740|NCT01662440|455801648|FG002|Overall Study|Lost to Follow-up|4|||
126684741|NCT01662440|455801649|FG003|Overall Study|Lost to Follow-up|1|||
126684742|NCT01662440|455801646|FG000|Overall Study|Subject moved to another country.|0|||
126684743|NCT01662440|455801647|FG001|Overall Study|Subject moved to another country.|1|||
126684744|NCT01662440|455801648|FG002|Overall Study|Subject moved to another country.|0|||
126684745|NCT01662440|455801649|FG003|Overall Study|Subject moved to another country.|0|||
126684746|NCT01662440|455801646|FG000|Overall Study|Protocol Violation|1|||
126684747|NCT01662440|455801647|FG001|Overall Study|Protocol Violation|0|||
126684748|NCT01662440|455801648|FG002|Overall Study|Protocol Violation|0|||
126684749|NCT01662440|455801649|FG003|Overall Study|Protocol Violation|0|||
126684750|NCT01662440|455801646|FG000|Overall Study|Withdrawal by Subject|5|||
126684751|NCT01662440|455801647|FG001|Overall Study|Withdrawal by Subject|2|||
126684752|NCT01662440|455801648|FG002|Overall Study|Withdrawal by Subject|2|||
126684753|NCT01662440|455801649|FG003|Overall Study|Withdrawal by Subject|2|||
126684754|NCT01661140|455801650|FG000|Open-Label Period|Adverse Event|44|||
126684755|NCT01661140|455801651|FG001|Open-Label Period|Adverse Event|0|||
126684756|NCT01661140|455801652|FG002|Open-Label Period|Adverse Event|0|||
126684757|NCT01661140|455801650|FG000|Open-Label Period|Protocol Violation|3|||
126684758|NCT01661140|455801651|FG001|Open-Label Period|Protocol Violation|0|||
126684759|NCT01661140|455801652|FG002|Open-Label Period|Protocol Violation|0|||
126684760|NCT01661140|455801650|FG000|Open-Label Period|Withdrawal by Subject|5|||
126684761|NCT01661140|455801651|FG001|Open-Label Period|Withdrawal by Subject|0|||
126684762|NCT01661140|455801652|FG002|Open-Label Period|Withdrawal by Subject|0|||
126684763|NCT01661140|455801650|FG000|Open-Label Period|Investigator Decision|3|||
126684764|NCT01661140|455801651|FG001|Open-Label Period|Investigator Decision|0|||
126684765|NCT01661140|455801652|FG002|Open-Label Period|Investigator Decision|0|||
126684766|NCT01661140|455801650|FG000|Open-Label Period|Death|1|||
126684767|NCT01661140|455801651|FG001|Open-Label Period|Death|0|||
126684768|NCT01661140|455801652|FG002|Open-Label Period|Death|0|||
126684769|NCT01661140|455801650|FG000|Open-Label Period|Administrative/Other|1|||
126684770|NCT01661140|455801651|FG001|Open-Label Period|Administrative/Other|0|||
126684771|NCT01661140|455801652|FG002|Open-Label Period|Administrative/Other|0|||
126759037|NCT00697255|456066725|FG000|Stage 1a|Insufficient ovarian response|1|||
126759038|NCT00697255|456066726|FG001|Stage 1a|Insufficient ovarian response|0|||
126684772|NCT01661140|455801650|FG000|Open-Label Period|Sponsor termination|16|||
126684773|NCT01661140|455801651|FG001|Open-Label Period|Sponsor termination|0|||
126684774|NCT01661140|455801652|FG002|Open-Label Period|Sponsor termination|0|||
126684775|NCT01661140|455801650|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
126684776|NCT01661140|455801651|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
126684777|NCT01661140|455801652|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
126684778|NCT01661140|455801650|FG000|Open-Label Period|Lost to Follow-up|2|||
126684779|NCT01661140|455801651|FG001|Open-Label Period|Lost to Follow-up|0|||
126684780|NCT01661140|455801652|FG002|Open-Label Period|Lost to Follow-up|0|||
126684781|NCT01661140|455801650|FG000|Double-Blind Period|Refused Treatment|0|||
126684782|NCT01661140|455801651|FG001|Double-Blind Period|Refused Treatment|0|||
126684783|NCT01661140|455801652|FG002|Double-Blind Period|Refused Treatment|1|||
126684784|NCT01661140|455801650|FG000|Double-Blind Period|Adverse Event|0|||
126684785|NCT01661140|455801651|FG001|Double-Blind Period|Adverse Event|16|||
126684786|NCT01661140|455801652|FG002|Double-Blind Period|Adverse Event|18|||
126684787|NCT01661140|455801650|FG000|Double-Blind Period|Protocol Violation|0|||
126684788|NCT01661140|455801651|FG001|Double-Blind Period|Protocol Violation|2|||
126684789|NCT01661140|455801652|FG002|Double-Blind Period|Protocol Violation|3|||
126684790|NCT01661140|455801650|FG000|Double-Blind Period|Withdrawal by Subject|0|||
126684791|NCT01661140|455801651|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126684792|NCT01661140|455801652|FG002|Double-Blind Period|Withdrawal by Subject|3|||
126684793|NCT01661140|455801650|FG000|Double-Blind Period|Investigator's Decision|0|||
126684794|NCT01661140|455801651|FG001|Double-Blind Period|Investigator's Decision|1|||
126684795|NCT01661140|455801652|FG002|Double-Blind Period|Investigator's Decision|2|||
126759039|NCT00697255|456066725|FG000|Stage 1a|Multifollicular growth|1|||
126759040|NCT00697255|456066726|FG001|Stage 1a|Multifollicular growth|0|||
126759041|NCT00697255|456066725|FG000|Stage 1a|Not growing of dominant follicle|1|||
126759042|NCT00697255|456066726|FG001|Stage 1a|Not growing of dominant follicle|0|||
126759043|NCT00697255|456066725|FG000|Stage 1b|Not growing of dominant follicle|0|||
126759044|NCT00697255|456066726|FG001|Stage 1b|Not growing of dominant follicle|1|||
126759045|NCT00697255|456066725|FG000|Stage 1b|Insufficient ovarian response|0|||
126759046|NCT00697255|456066726|FG001|Stage 1b|Insufficient ovarian response|1|||
126684796|NCT01661140|455801650|FG000|Double-Blind Period|Sponsor Termination|0|||
126684797|NCT01661140|455801651|FG001|Double-Blind Period|Sponsor Termination|14|||
126684798|NCT01661140|455801652|FG002|Double-Blind Period|Sponsor Termination|17|||
126684799|NCT01661140|455801650|FG000|Double-Blind Period|Administrative/Other|0|||
126684800|NCT01661140|455801651|FG001|Double-Blind Period|Administrative/Other|7|||
126684801|NCT01661140|455801652|FG002|Double-Blind Period|Administrative/Other|6|||
126684802|NCT01391000|455801654|FG000|Overall Study|Lost to Follow-up|2|||
126684803|NCT01391000|455801655|FG001|Overall Study|Lost to Follow-up|0|||
126684804|NCT00049673|455801656|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
126684805|NCT00049673|455801657|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
126684806|NCT00817531|455801658|FG000|Overall Study|Adverse Event|1|||
126684807|NCT00817531|455801658|FG000|Overall Study|Lack of Efficacy|1|||
126684808|NCT02475681|455801659|FG000|Overall Study|Death|16|||
126684809|NCT02475681|455801660|FG001|Overall Study|Death|6|||
126684810|NCT02475681|455801661|FG002|Overall Study|Death|9|||
126684811|NCT02475681|455801659|FG000|Overall Study|Physician Decision|0|||
126684812|NCT02475681|455801660|FG001|Overall Study|Physician Decision|3|||
126684813|NCT02475681|455801661|FG002|Overall Study|Physician Decision|1|||
126684814|NCT02475681|455801659|FG000|Overall Study|Withdrawal by Subject|12|||
126684815|NCT02475681|455801660|FG001|Overall Study|Withdrawal by Subject|6|||
126684816|NCT02475681|455801661|FG002|Overall Study|Withdrawal by Subject|9|||
126684817|NCT02475681|455801659|FG000|Overall Study|Lost to Follow-up|2|||
126684818|NCT02475681|455801660|FG001|Overall Study|Lost to Follow-up|1|||
126684819|NCT02475681|455801661|FG002|Overall Study|Lost to Follow-up|3|||
126684820|NCT02475681|455801659|FG000|Overall Study|Ongoing in Study|0|||
126684821|NCT02475681|455801660|FG001|Overall Study|Ongoing in Study|163|||
126684822|NCT02475681|455801661|FG002|Overall Study|Ongoing in Study|157|||
126684823|NCT02475681|455801659|FG000|Overall Study|Reasons other than above listed|2|||
126684824|NCT02475681|455801660|FG001|Overall Study|Reasons other than above listed|0|||
126684825|NCT02475681|455801661|FG002|Overall Study|Reasons other than above listed|0|||
126684826|NCT00132132|455801665|FG000|Overall Study|Lost to Follow-up|7|||
126684827|NCT00132132|455801666|FG001|Overall Study|Lost to Follow-up|2|||
126684828|NCT00494091|455801669|FG000|Overall Study|Death|5|||
126684829|NCT00494091|455801670|FG001|Overall Study|Death|54|||
126684830|NCT00494091|455801669|FG000|Overall Study|Lost to Follow-up|0|||
126684831|NCT00494091|455801670|FG001|Overall Study|Lost to Follow-up|4|||
126684832|NCT00494091|455801669|FG000|Overall Study|Other|1|||
126684833|NCT00494091|455801670|FG001|Overall Study|Other|11|||
126684834|NCT00494091|455801669|FG000|Overall Study|Withdrawal by Subject|0|||
126759047|NCT01005875|456066736|FG000|Overall Study|Death|3|||
126759048|NCT00242658|456066739|FG000|Overall Study|Lost to Follow-up|22|||
126684835|NCT00494091|455801670|FG001|Overall Study|Withdrawal by Subject|7|||
126684836|NCT00452699|455801673|FG000|Overall Study|Adverse Event|10|||
126684837|NCT00452699|455801674|FG001|Overall Study|Adverse Event|3|||
126684838|NCT00452699|455801673|FG000|Overall Study|Lack of Efficacy|6|||
126684839|NCT00452699|455801674|FG001|Overall Study|Lack of Efficacy|4|||
126684840|NCT00452699|455801673|FG000|Overall Study|Lost to Follow-up|6|||
126684841|NCT00452699|455801674|FG001|Overall Study|Lost to Follow-up|9|||
126684842|NCT00452699|455801673|FG000|Overall Study|Protocol Violation|21|||
126684843|NCT00452699|455801674|FG001|Overall Study|Protocol Violation|25|||
126684844|NCT00452699|455801673|FG000|Overall Study|Withdrawal by Subject|26|||
126684845|NCT00452699|455801674|FG001|Overall Study|Withdrawal by Subject|25|||
126684846|NCT00452699|455801673|FG000|Overall Study|Other|12|||
126684847|NCT00452699|455801674|FG001|Overall Study|Other|7|||
126684848|NCT03847987|455801675|FG000|Overall Study|Lost to Follow-up|1|||
126684849|NCT03847987|455801676|FG001|Overall Study|Lost to Follow-up|0|||
126684850|NCT03847987|455801675|FG000|Overall Study|Adverse Event|2|||
126684851|NCT03847987|455801676|FG001|Overall Study|Adverse Event|0|||
126684852|NCT02111564|455801679|FG000|Overall Study|Death|109|||
126684853|NCT02111564|455801680|FG001|Overall Study|Death|120|||
126684854|NCT02111564|455801679|FG000|Overall Study|Lost to Follow-up|2|||
126684855|NCT02111564|455801680|FG001|Overall Study|Lost to Follow-up|3|||
126684856|NCT02111564|455801679|FG000|Overall Study|Withdrawal by Subject|20|||
126684857|NCT02111564|455801680|FG001|Overall Study|Withdrawal by Subject|20|||
126684858|NCT00687362|455801681|FG000|Overall Study|Protocol Violation|2|||
126684859|NCT00687362|455801681|FG000|Overall Study|Withdrawal by Subject|1|||
126684860|NCT02354703|455801682|FG000|Overall Study|Withdrawal by Subject|1|||
126684861|NCT02354703|455801683|FG001|Overall Study|Withdrawal by Subject|1|||
126684862|NCT02354703|455801684|FG002|Overall Study|Withdrawal by Subject|1|||
126684863|NCT02354703|455801685|FG003|Overall Study|Withdrawal by Subject|1|||
126684864|NCT02354703|455801682|FG000|Overall Study|Lost to Follow-up|2|||
126759049|NCT00242658|456066740|FG001|Overall Study|Lost to Follow-up|19|||
126759050|NCT01815099|456066741|FG000|Overall Study|Lack of Efficacy|1|||
126759051|NCT01815099|456066741|FG000|Overall Study|unable to attend study visits|1|||
126759052|NCT00643851|456066742|FG000|Overall Study|Death|0|||
126759053|NCT00643851|456066743|FG001|Overall Study|Death|1|||
126759054|NCT00643851|456066744|FG002|Overall Study|Death|0|||
126759055|NCT00643851|456066742|FG000|Overall Study|Lack of Efficacy|0|||
126759056|NCT00643851|456066743|FG001|Overall Study|Lack of Efficacy|1|||
126759057|NCT00643851|456066744|FG002|Overall Study|Lack of Efficacy|0|||
126759058|NCT00643851|456066742|FG000|Overall Study|Adverse Event|2|||
126759059|NCT00643851|456066743|FG001|Overall Study|Adverse Event|6|||
126759060|NCT00643851|456066744|FG002|Overall Study|Adverse Event|6|||
126759061|NCT00643851|456066742|FG000|Overall Study|Lost to Follow-up|4|||
126759062|NCT00643851|456066743|FG001|Overall Study|Lost to Follow-up|6|||
126759063|NCT00643851|456066744|FG002|Overall Study|Lost to Follow-up|9|||
126759064|NCT00643851|456066742|FG000|Overall Study|Withdrawal by Subject|8|||
126759065|NCT00643851|456066743|FG001|Overall Study|Withdrawal by Subject|15|||
126759066|NCT00643851|456066744|FG002|Overall Study|Withdrawal by Subject|9|||
126759067|NCT00643851|456066742|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
126759068|NCT00643851|456066743|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
126759069|NCT00643851|456066744|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
126759070|NCT04806334|456066747|FG000|Overall Study|Withdrawal by Subject|1|||
126759071|NCT04557189|456066748|FG000|Overall Study|Adverse Event|0|||
126759072|NCT04557189|456066749|FG001|Overall Study|Adverse Event|1|||
126759073|NCT04557189|456066748|FG000|Overall Study|Lost to Follow-up|1|||
126349921|NCT03575364|454574065|FG000|Overall Study|Patient is lost to follow up|1|||
126759074|NCT04557189|456066749|FG001|Overall Study|Lost to Follow-up|1|||
126437499|NCT01432730|454902970|FG001|Period 1|Adverse Event|0|||
126759075|NCT04557189|456066748|FG000|Overall Study|Withdrawal by Subject|2|||
126759076|NCT04557189|456066749|FG001|Overall Study|Withdrawal by Subject|1|||
126759077|NCT04557189|456066748|FG000|Overall Study|Reason not Specified|3|||
126759078|NCT04557189|456066749|FG001|Overall Study|Reason not Specified|6|||
126684865|NCT02354703|455801683|FG001|Overall Study|Lost to Follow-up|7|||
126684866|NCT02354703|455801684|FG002|Overall Study|Lost to Follow-up|9|||
126684867|NCT02354703|455801685|FG003|Overall Study|Lost to Follow-up|2|||
126684868|NCT02354703|455801682|FG000|Overall Study|Adverse Event|0|||
126684869|NCT02354703|455801683|FG001|Overall Study|Adverse Event|0|||
126684870|NCT02354703|455801684|FG002|Overall Study|Adverse Event|1|||
126437500|NCT01432730|454902969|FG000|Period 2|Adverse Event|0|||
126437501|NCT01432730|454902970|FG001|Period 2|Adverse Event|4|||
126437502|NCT01421719|454902975|FG000|Overall Study|Withdrawal by Subject|4|||
126437503|NCT01712399|454902976|FG000|Overall Study|Lost to Follow-up|1|||
126437504|NCT01712399|454902976|FG000|Overall Study|Withdrawal by Subject|39|||
126437505|NCT01712399|454902976|FG000|Overall Study|Death|1|||
126437506|NCT01712399|454902976|FG000|Overall Study|Adverse Event|11|||
126437507|NCT01712399|454902976|FG000|Overall Study|Study closure|345|||
126437508|NCT01942837|454902977|FG000|Overall Study|Death|1|||
126437509|NCT01942837|454902977|FG000|Overall Study|Symptomatic or radiographic progression|49|||
126437510|NCT01942837|454902977|FG000|Overall Study|Adverse Event|6|||
126437511|NCT01942837|454902977|FG000|Overall Study|Physician Decision|3|||
126437512|NCT01942837|454902977|FG000|Overall Study|Withdrawal by Subject|2|||
126437513|NCT01942837|454902977|FG000|Overall Study|Intercurrent Illness|1|||
126437514|NCT01942837|454902977|FG000|Overall Study|On treatment|3|||
126437515|NCT01942837|454902977|FG000|Overall Study|Never initiate the treatment|2|||
126437516|NCT01298648|454902978|FG000|Overall Study|Withdrawal by Subject|2|||
126437517|NCT01298648|454902978|FG000|Overall Study|Lost to Follow-up|21|||
126437518|NCT02038933|454902994|FG000|Overall Study|Disease progression|104|||
126684871|NCT02354703|455801685|FG003|Overall Study|Adverse Event|0|||
126684872|NCT03468309|455801688|FG000|Overall Study|Lost to Follow-up|4|||
126684873|NCT03468309|455801688|FG000|Overall Study|Withdrawal by Subject|2|||
126684874|NCT01496885|455801692|FG000|Overall Study|Lost to Follow-up|13|||
126684875|NCT01496885|455801692|FG000|Overall Study|Withdrawal by Subject|7|||
126684876|NCT01496885|455801692|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
126437519|NCT02038933|454902994|FG000|Overall Study|Study drug toxicity|6|||
126437520|NCT02038933|454902994|FG000|Overall Study|Adverse event unrelated to study drug|6|||
126437521|NCT02038933|454902994|FG000|Overall Study|Participant request to discontinue treatment|2|||
126437522|NCT02038933|454902994|FG000|Overall Study|Lost to Follow-up|1|||
126684877|NCT01496885|455801692|FG000|Overall Study|Death|1|||
126759079|NCT01731600|456066752|FG000|Overall Study|Adverse Event|2|||
126759080|NCT01731600|456066753|FG001|Overall Study|Adverse Event|0|||
126759081|NCT01731600|456066752|FG000|Overall Study|Withdrawal criteria|1|||
126684878|NCT03446885|455801693|FG000|Overall Study|Lost to Follow-up|1|||
126684879|NCT03446885|455801694|FG001|Overall Study|Lost to Follow-up|0|||
126684880|NCT03446885|455801693|FG000|Overall Study|Did not complete entire visit|1|||
126684881|NCT03446885|455801694|FG001|Overall Study|Did not complete entire visit|0|||
126684882|NCT02728830|455801698|FG000|Overall Study|Exclusionary Surgery|9|||
126684883|NCT02728830|455801698|FG000|Overall Study|Exclusionary Pathology|6|||
126684884|NCT02728830|455801698|FG000|Overall Study|Physician Decision|3|||
126759082|NCT01731600|456066753|FG001|Overall Study|Withdrawal criteria|0|||
126759083|NCT01731600|456066752|FG000|Overall Study|Other reasons|3|||
126759084|NCT01731600|456066753|FG001|Overall Study|Other reasons|0|||
126759085|NCT00465894|456066754|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
126759086|NCT00465894|456066755|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
126684885|NCT02728830|455801698|FG000|Overall Study|Withdrawal by Subject|2|||
126684886|NCT02728830|455801698|FG000|Overall Study|Lost to Follow-up|1|||
126684887|NCT02728830|455801698|FG000|Overall Study|Exclusionary Lab Values|1|||
126759087|NCT00465894|456066754|FG000|Treatment For 12 Weeks|Family Issues|1|||
126759088|NCT00465894|456066755|FG001|Treatment For 12 Weeks|Family Issues|1|||
126759089|NCT00465894|456066754|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
126759090|NCT00465894|456066755|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
126759091|NCT01636076|456066756|FG000|Overall Study|Terminated by sponsor|1|||
126759092|NCT01636076|456066757|FG001|Overall Study|Terminated by sponsor|1|||
126759093|NCT01636076|456066756|FG000|Overall Study|Lack of Efficacy|0|||
126684888|NCT02728830|455801698|FG000|Overall Study|Contraindicated Illness|1|||
126759094|NCT01636076|456066757|FG001|Overall Study|Lack of Efficacy|1|||
126759095|NCT01636076|456066756|FG000|Overall Study|Lost to Follow-up|1|||
126759096|NCT01636076|456066757|FG001|Overall Study|Lost to Follow-up|0|||
126759097|NCT01636076|456066756|FG000|Overall Study|Physician Decision|1|||
126437523|NCT02038933|454902994|FG000|Overall Study|Other reasons|2|||
126437524|NCT03250273|454902995|FG000|Overall Study|Disease Progression|2|||
126437525|NCT03250273|454902996|FG001|Overall Study|Disease Progression|11|||
126684889|NCT02728830|455801698|FG000|Overall Study|Language Barrier|1|||
126684890|NCT00661271|455801699|FG000|Overall Study|Lost to Follow-up|28|||
126684891|NCT00661271|455801700|FG001|Overall Study|Lost to Follow-up|25|||
126684892|NCT01707693|455801701|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
126684893|NCT01707693|455801702|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
126684894|NCT01707693|455801701|FG000|Overall Study Allocation|Protocol Violation|4|||
126684895|NCT01707693|455801702|FG001|Overall Study Allocation|Protocol Violation|3|||
126684896|NCT01707693|455801701|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
126684897|NCT01707693|455801702|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
126684898|NCT01707693|455801701|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
126684899|NCT01707693|455801702|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
126684900|NCT00143455|455801703|FG000|Cohort 1|Adverse Event|8|||
126684901|NCT00143455|455801704|FG001|Cohort 1|Adverse Event|4|||
126684902|NCT00143455|455801705|FG002|Cohort 1|Adverse Event|0|||
126684903|NCT00143455|455801706|FG003|Cohort 1|Adverse Event|0|||
126684904|NCT00143455|455801703|FG000|Cohort 1|Death|5|||
126684905|NCT00143455|455801704|FG001|Cohort 1|Death|2|||
126684906|NCT00143455|455801705|FG002|Cohort 1|Death|0|||
126684907|NCT00143455|455801706|FG003|Cohort 1|Death|0|||
126684908|NCT00143455|455801703|FG000|Cohort 1|Progressive Disease|0|||
126684909|NCT00143455|455801704|FG001|Cohort 1|Progressive Disease|6|||
126684910|NCT00143455|455801705|FG002|Cohort 1|Progressive Disease|0|||
126684911|NCT00143455|455801706|FG003|Cohort 1|Progressive Disease|0|||
126684912|NCT00143455|455801703|FG000|Cohort 1|Withdrawal by Subject|1|||
126684913|NCT00143455|455801704|FG001|Cohort 1|Withdrawal by Subject|4|||
126684914|NCT00143455|455801705|FG002|Cohort 1|Withdrawal by Subject|0|||
126684915|NCT00143455|455801706|FG003|Cohort 1|Withdrawal by Subject|0|||
126684916|NCT00143455|455801703|FG000|Cohort 1|Randomized But Not Treated|0|||
126684917|NCT00143455|455801704|FG001|Cohort 1|Randomized But Not Treated|1|||
126684918|NCT00143455|455801705|FG002|Cohort 1|Randomized But Not Treated|0|||
126684919|NCT00143455|455801706|FG003|Cohort 1|Randomized But Not Treated|0|||
126684920|NCT00143455|455801703|FG000|Cohort 2|Adverse Event|0|||
126684921|NCT00143455|455801704|FG001|Cohort 2|Adverse Event|0|||
126684922|NCT00143455|455801705|FG002|Cohort 2|Adverse Event|42|||
126684923|NCT00143455|455801706|FG003|Cohort 2|Adverse Event|30|||
126684924|NCT00143455|455801703|FG000|Cohort 2|No Longer Required Study Treatment|0|||
126684925|NCT00143455|455801704|FG001|Cohort 2|No Longer Required Study Treatment|0|||
126684926|NCT00143455|455801705|FG002|Cohort 2|No Longer Required Study Treatment|1|||
126684927|NCT00143455|455801706|FG003|Cohort 2|No Longer Required Study Treatment|0|||
126684928|NCT00143455|455801703|FG000|Cohort 2|Protocol Violation|0|||
126684929|NCT00143455|455801704|FG001|Cohort 2|Protocol Violation|0|||
126684930|NCT00143455|455801705|FG002|Cohort 2|Protocol Violation|1|||
126684931|NCT00143455|455801706|FG003|Cohort 2|Protocol Violation|1|||
126684932|NCT00143455|455801703|FG000|Cohort 2|Lost to Follow-up|0|||
126684933|NCT00143455|455801704|FG001|Cohort 2|Lost to Follow-up|0|||
126684934|NCT00143455|455801705|FG002|Cohort 2|Lost to Follow-up|1|||
126684935|NCT00143455|455801706|FG003|Cohort 2|Lost to Follow-up|4|||
126684936|NCT00143455|455801703|FG000|Cohort 2|Death|0|||
126684937|NCT00143455|455801704|FG001|Cohort 2|Death|0|||
126684938|NCT00143455|455801705|FG002|Cohort 2|Death|20|||
126684939|NCT00143455|455801706|FG003|Cohort 2|Death|12|||
126684940|NCT00143455|455801703|FG000|Cohort 2|Progressive Disease|0|||
126684941|NCT00143455|455801704|FG001|Cohort 2|Progressive Disease|0|||
126684942|NCT00143455|455801705|FG002|Cohort 2|Progressive Disease|20|||
126684943|NCT00143455|455801706|FG003|Cohort 2|Progressive Disease|27|||
126684944|NCT00143455|455801703|FG000|Cohort 2|Withdrawal by Subject|0|||
126684945|NCT00143455|455801704|FG001|Cohort 2|Withdrawal by Subject|0|||
126684946|NCT00143455|455801705|FG002|Cohort 2|Withdrawal by Subject|13|||
126684947|NCT00143455|455801706|FG003|Cohort 2|Withdrawal by Subject|12|||
126684948|NCT00143455|455801703|FG000|Cohort 2|Other|0|||
126684949|NCT00143455|455801704|FG001|Cohort 2|Other|0|||
126684950|NCT00143455|455801705|FG002|Cohort 2|Other|7|||
126684951|NCT00143455|455801706|FG003|Cohort 2|Other|6|||
126684952|NCT00143455|455801703|FG000|Cohort 2|Randomized But Not Treated|0|||
126684953|NCT00143455|455801704|FG001|Cohort 2|Randomized But Not Treated|0|||
126684954|NCT00143455|455801705|FG002|Cohort 2|Randomized But Not Treated|1|||
126684955|NCT00143455|455801706|FG003|Cohort 2|Randomized But Not Treated|1|||
126437526|NCT03250273|454902995|FG000|Overall Study|Death|0|||
126437527|NCT03250273|454902996|FG001|Overall Study|Death|1|||
126437528|NCT04154904|454902997|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
126684956|NCT01325428|455801707|FG000|Part A|Progressive disease according to RECIST|9|||
126684957|NCT01325428|455801707|FG000|Part A|Clinical signs, symptoms of progression|2|||
126684958|NCT01325428|455801707|FG000|Part A|Other adverse event|1|||
126684959|NCT01325428|455801707|FG000|Part A|Refused continue taking trial medication|2|||
126684960|NCT01325428|455801707|FG000|Part A|Other reason not defined above|2|||
126684961|NCT01325428|455801707|FG000|Part B|Refused continue taking trial medication|2|||
126684962|NCT01325428|455801707|FG000|Part B|Other reason not defined above|1|||
126759098|NCT01636076|456066757|FG001|Overall Study|Physician Decision|1|||
126759099|NCT01636076|456066756|FG000|Overall Study|Non-compliance with study treatment|1|||
126759100|NCT01636076|456066757|FG001|Overall Study|Non-compliance with study treatment|1|||
126759101|NCT01636076|456066756|FG000|Overall Study|Adverse Event|6|||
126759102|NCT01636076|456066757|FG001|Overall Study|Adverse Event|11|||
126759103|NCT01636076|456066756|FG000|Overall Study|Withdrawal by Subject|7|||
126759104|NCT01636076|456066757|FG001|Overall Study|Withdrawal by Subject|10|||
126759105|NCT02173158|456066759|FG000|Efficacy Phase|Adverse Event|1|||
126759106|NCT01728454|456066771|FG000|Stage 1 and 2|Pregnancy|1|||
126759107|NCT01728454|456066772|FG001|Stage 1 and 2|Pregnancy|0|||
126759108|NCT01728454|456066773|FG002|Stage 1 and 2|Pregnancy|0|||
126759109|NCT01728454|456066771|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
126759110|NCT01728454|456066772|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
126759111|NCT01728454|456066773|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
126759112|NCT01728454|456066771|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
126759113|NCT01728454|456066772|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
126759114|NCT01728454|456066773|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
126759115|NCT01728454|456066771|FG000|Stage 1 and 2|Lost to Follow-up|1|||
126759116|NCT01728454|456066772|FG001|Stage 1 and 2|Lost to Follow-up|1|||
126759117|NCT01728454|456066773|FG002|Stage 1 and 2|Lost to Follow-up|0|||
126759118|NCT01728454|456066771|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
126759119|NCT01728454|456066772|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
126759120|NCT01728454|456066773|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
126759121|NCT01728454|456066771|FG000|Stage 3|Reason Missing|0|||
126759122|NCT01728454|456066772|FG001|Stage 3|Reason Missing|0|||
126759123|NCT01728454|456066773|FG002|Stage 3|Reason Missing|1|||
126759124|NCT01728454|456066771|FG000|Stage 3|Subject Required Other Treatment|0|||
126759125|NCT01728454|456066772|FG001|Stage 3|Subject Required Other Treatment|1|||
126759126|NCT01728454|456066773|FG002|Stage 3|Subject Required Other Treatment|0|||
126759127|NCT01728454|456066771|FG000|Stage 3|Pregnancy|1|||
126759128|NCT01728454|456066772|FG001|Stage 3|Pregnancy|0|||
126759129|NCT01728454|456066773|FG002|Stage 3|Pregnancy|0|||
126759130|NCT01728454|456066771|FG000|Stage 3|Withdrew Consent|1|||
126759131|NCT01728454|456066772|FG001|Stage 3|Withdrew Consent|0|||
126759132|NCT01728454|456066773|FG002|Stage 3|Withdrew Consent|1|||
126759133|NCT01728454|456066771|FG000|Stage 3|Non-compliance with Protocol|0|||
126759134|NCT01728454|456066772|FG001|Stage 3|Non-compliance with Protocol|0|||
126759135|NCT01728454|456066773|FG002|Stage 3|Non-compliance with Protocol|1|||
126759136|NCT01728454|456066771|FG000|Stage 3|Lost to Follow-up|0|||
126759137|NCT01728454|456066772|FG001|Stage 3|Lost to Follow-up|3|||
126759138|NCT01728454|456066773|FG002|Stage 3|Lost to Follow-up|1|||
126759139|NCT01728454|456066771|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
126759140|NCT01728454|456066772|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
126759141|NCT01728454|456066773|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
126759142|NCT01190839|456066774|FG000|Overall Study|Adverse Event|32|||
126759143|NCT01190839|456066775|FG001|Overall Study|Adverse Event|41|||
126759144|NCT01190839|456066774|FG000|Overall Study|Protocol Violation|2|||
126759145|NCT01190839|456066775|FG001|Overall Study|Protocol Violation|2|||
126759146|NCT01190839|456066774|FG000|Overall Study|Lost to Follow-up|7|||
126759147|NCT01190839|456066775|FG001|Overall Study|Lost to Follow-up|1|||
126759148|NCT01190839|456066774|FG000|Overall Study|Death|1|||
126545376|NCT02100722|455290820|FG001|Overall Study|Withdrawal post-procedure|3|||
126759149|NCT01190839|456066775|FG001|Overall Study|Death|0|||
126759150|NCT01190839|456066774|FG000|Overall Study|Trial stopped by Sponsor|71|||
126759151|NCT01190839|456066775|FG001|Overall Study|Trial stopped by Sponsor|68|||
126759152|NCT01190839|456066774|FG000|Overall Study|Undefined|35|||
126759153|NCT01190839|456066775|FG001|Overall Study|Undefined|31|||
126759154|NCT01190839|456066774|FG000|Overall Study|Randomized but not treated|2|||
126759155|NCT01190839|456066775|FG001|Overall Study|Randomized but not treated|4|||
126759156|NCT03077646|456066779|FG000|Overall Study|Lost to Follow-up|29|||
126759157|NCT03077646|456066780|FG001|Overall Study|Lost to Follow-up|30|||
126759158|NCT03077646|456066781|FG002|Overall Study|Lost to Follow-up|31|||
126437529|NCT04154904|454902998|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
126437530|NCT04154904|454902999|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
126437531|NCT04226742|454903000|FG000|Overall Study|Lost to Follow-up|16|||
126437532|NCT04226742|454903001|FG001|Overall Study|Lost to Follow-up|13|||
126437533|NCT04226742|454903000|FG000|Overall Study|Withdrawal by Subject|5|||
126437534|NCT04226742|454903001|FG001|Overall Study|Withdrawal by Subject|3|||
126437535|NCT01759446|454903003|FG000|Overall Study|Protocol Violation|1|||
126437536|NCT01759446|454903004|FG001|Overall Study|Protocol Violation|0|||
126437537|NCT01759446|454903005|FG002|Overall Study|Protocol Violation|1|||
126437538|NCT01759446|454903006|FG003|Overall Study|Protocol Violation|0|||
126437539|NCT01759446|454903007|FG004|Overall Study|Protocol Violation|0|||
126437540|NCT01759446|454903003|FG000|Overall Study|Withdrawal by Subject|0|||
126437541|NCT01759446|454903004|FG001|Overall Study|Withdrawal by Subject|1|||
126437542|NCT01759446|454903005|FG002|Overall Study|Withdrawal by Subject|0|||
126437543|NCT01759446|454903006|FG003|Overall Study|Withdrawal by Subject|1|||
126437544|NCT01759446|454903007|FG004|Overall Study|Withdrawal by Subject|0|||
126437545|NCT04646044|454903010|FG000|Overall Study|Lost to Follow-up|0|||
126437546|NCT04646044|454903011|FG001|Overall Study|Lost to Follow-up|0|||
126437547|NCT04646044|454903012|FG002|Overall Study|Lost to Follow-up|1|||
126437548|NCT04646044|454903013|FG003|Overall Study|Lost to Follow-up|0|||
126437549|NCT04646044|454903010|FG000|Overall Study|Withdrawal by Subject|0|||
126437550|NCT04646044|454903011|FG001|Overall Study|Withdrawal by Subject|1|||
126437551|NCT04646044|454903012|FG002|Overall Study|Withdrawal by Subject|0|||
126437552|NCT04646044|454903013|FG003|Overall Study|Withdrawal by Subject|0|||
126437553|NCT02606643|454903014|FG000|Overall Study|did not meet inclusion criteria|1|||
126437554|NCT02606643|454903015|FG001|Overall Study|did not meet inclusion criteria|3|||
126437555|NCT00907335|454903016|FG000|Overall Study|Withdrawal by Subject|2|||
126437556|NCT00907335|454903017|FG001|Overall Study|Withdrawal by Subject|0|||
126437557|NCT00907335|454903016|FG000|Overall Study|Adverse Event|4|||
126437558|NCT00907335|454903017|FG001|Overall Study|Adverse Event|1|||
126437559|NCT00907335|454903016|FG000|Overall Study|Lost to Follow-up|2|||
126437560|NCT00907335|454903017|FG001|Overall Study|Lost to Follow-up|0|||
126437561|NCT00912808|454903018|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
126437562|NCT00912808|454903019|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
126437563|NCT00912808|454903018|FG000|Washout|Withdrawal by Subject|0|||
126437564|NCT00912808|454903019|FG001|Washout|Withdrawal by Subject|1|||
126684963|NCT03713944|455801708|FG000|Study Treatment|Patient non-compliance|1|||
126684964|NCT03713944|455801708|FG000|Study Treatment|Alternative Cancer Therapy|3|||
126684965|NCT03713944|455801708|FG000|Study Treatment|Disease Progression|18|||
126684966|NCT03713944|455801708|FG000|Study Treatment|AE/Side Effects/Complications|2|||
126684967|NCT03713944|455801708|FG000|Study Treatment|Death|2|||
126684968|NCT03713944|455801708|FG000|Study Treatment|Withdrawal by Subject|1|||
126684969|NCT03713944|455801708|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
126684970|NCT03713944|455801708|FG000|Study Treatment|Symptomatic Deterioration|2|||
126684971|NCT03713944|455801708|FG000|Follow up|Withdrawal by Subject|2|||
126684972|NCT03713944|455801708|FG000|Follow up|Death|11|||
126684973|NCT03713944|455801708|FG000|Follow up|Study Terminated|3|||
126684974|NCT00419380|455801711|FG000|Overall Study|Lack of Efficacy|1|||
126684975|NCT00419380|455801712|FG001|Overall Study|Lack of Efficacy|7|||
126684976|NCT00419380|455801711|FG000|Overall Study|Physician Decision|0|||
126684977|NCT00419380|455801712|FG001|Overall Study|Physician Decision|1|||
126684978|NCT00419380|455801711|FG000|Overall Study|Lost to Follow-up|0|||
126684979|NCT00419380|455801712|FG001|Overall Study|Lost to Follow-up|1|||
126684980|NCT00419380|455801711|FG000|Overall Study|Withdrawal by Subject|0|||
126684981|NCT00419380|455801712|FG001|Overall Study|Withdrawal by Subject|1|||
126684982|NCT03099707|455801713|FG000|Overall Study|Withdrawal by Subject|0|||
126684983|NCT03099707|455801714|FG001|Overall Study|Withdrawal by Subject|3|||
126684984|NCT03099707|455801713|FG000|Overall Study|Lost to Follow-up|0|||
126684985|NCT03099707|455801714|FG001|Overall Study|Lost to Follow-up|1|||
126684986|NCT00343889|455801739|FG000|Overall Study|Lost to Follow-up|2|||
126684987|NCT00343889|455801740|FG001|Overall Study|Lost to Follow-up|0|||
126684988|NCT00343889|455801739|FG000|Overall Study|Withdrawal by Subject|0|||
126684989|NCT00343889|455801740|FG001|Overall Study|Withdrawal by Subject|1|||
126684990|NCT00343889|455801739|FG000|Overall Study|Protocol Violation|1|||
126684991|NCT00343889|455801740|FG001|Overall Study|Protocol Violation|0|||
126684992|NCT01294579|455801741|FG000|Overall Study|Disease progression|12|||
126684993|NCT01294579|455801741|FG000|Overall Study|Adverse Event|11|||
126684994|NCT01294579|455801741|FG000|Overall Study|Study closed/terminated|3|||
126684995|NCT01294579|455801741|FG000|Overall Study|Lost to Follow-up|1|||
126684996|NCT01294579|455801741|FG000|Overall Study|Physician Decision|3|||
126684997|NCT01294579|455801741|FG000|Overall Study|Withdrawal by Subject|5|||
126684998|NCT00487539|455801742|FG000|Overall Study|Adverse Event|3|||
126684999|NCT00487539|455801743|FG001|Overall Study|Adverse Event|2|||
126685000|NCT00487539|455801744|FG002|Overall Study|Adverse Event|1|||
126685001|NCT00487539|455801745|FG003|Overall Study|Adverse Event|1|||
126437565|NCT00912808|454903018|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
126437566|NCT00912808|454903019|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
126437567|NCT00912808|454903018|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
126437568|NCT00912808|454903019|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
126437569|NCT03873116|454903020|FG000|Part 1|Study drug discontinuation due to rash|0|||
126437570|NCT03873116|454903021|FG001|Part 1|Study drug discontinuation due to rash|0|||
126437571|NCT03873116|454903022|FG002|Part 1|Study drug discontinuation due to rash|0|||
126437572|NCT03873116|454903023|FG003|Part 1|Study drug discontinuation due to rash|0|||
126437573|NCT03873116|454903024|FG004|Part 1|Study drug discontinuation due to rash|0|||
126437574|NCT03873116|454903025|FG005|Part 1|Study drug discontinuation due to rash|1|||
126437575|NCT03873116|454903020|FG000|Part 2|Withdrawal by Subject|0|||
126437576|NCT03873116|454903021|FG001|Part 2|Withdrawal by Subject|0|||
126437577|NCT03873116|454903022|FG002|Part 2|Withdrawal by Subject|1|||
126437578|NCT03873116|454903023|FG003|Part 2|Withdrawal by Subject|0|||
126437579|NCT03873116|454903024|FG004|Part 2|Withdrawal by Subject|0|||
126437580|NCT03873116|454903025|FG005|Part 2|Withdrawal by Subject|0|||
126545377|NCT02100722|455290819|FG000|Overall Study|Lost to Follow-up|2|||
126685002|NCT00487539|455801742|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126685003|NCT00487539|455801743|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126685004|NCT00487539|455801744|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126685005|NCT00487539|455801745|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
126685006|NCT00487539|455801742|FG000|Overall Study|Other|3|||
126685007|NCT00487539|455801743|FG001|Overall Study|Other|1|||
126685008|NCT00487539|455801744|FG002|Overall Study|Other|2|||
126685009|NCT00487539|455801745|FG003|Overall Study|Other|2|||
126685010|NCT03499028|455801746|FG000|Overall Study|Lost to Follow-up|12|||
126685011|NCT03499028|455801747|FG001|Overall Study|Lost to Follow-up|9|||
126685012|NCT03499028|455801746|FG000|Overall Study|Withdrawal by Subject|5|||
126685013|NCT03499028|455801747|FG001|Overall Study|Withdrawal by Subject|8|||
126685014|NCT03499028|455801746|FG000|Overall Study|Unplanned SNF discharge|5|||
126685015|NCT03499028|455801747|FG001|Overall Study|Unplanned SNF discharge|8|||
126685016|NCT01437397|455801748|FG000|Overall Study|Lost to Follow-up|9|||
126685017|NCT01437397|455801749|FG001|Overall Study|Lost to Follow-up|4|||
126685018|NCT01437397|455801750|FG002|Overall Study|Lost to Follow-up|2|||
126685019|NCT01437397|455801751|FG003|Overall Study|Lost to Follow-up|4|||
126685020|NCT01437397|455801752|FG004|Overall Study|Lost to Follow-up|5|||
126685021|NCT01437397|455801748|FG000|Overall Study|Withdrawal by Subject|11|||
126685022|NCT01437397|455801749|FG001|Overall Study|Withdrawal by Subject|12|||
126685023|NCT01437397|455801750|FG002|Overall Study|Withdrawal by Subject|24|||
126685024|NCT01437397|455801751|FG003|Overall Study|Withdrawal by Subject|11|||
126685025|NCT01437397|455801752|FG004|Overall Study|Withdrawal by Subject|22|||
126685026|NCT01437397|455801748|FG000|Overall Study|Protocol Violation|10|||
126685027|NCT01437397|455801749|FG001|Overall Study|Protocol Violation|12|||
126685028|NCT01437397|455801750|FG002|Overall Study|Protocol Violation|13|||
126685029|NCT01437397|455801751|FG003|Overall Study|Protocol Violation|21|||
126685030|NCT01437397|455801752|FG004|Overall Study|Protocol Violation|19|||
126685031|NCT01437397|455801748|FG000|Overall Study|Lack of Efficacy|5|||
126685032|NCT01437397|455801749|FG001|Overall Study|Lack of Efficacy|4|||
126685033|NCT01437397|455801750|FG002|Overall Study|Lack of Efficacy|8|||
126685034|NCT01437397|455801751|FG003|Overall Study|Lack of Efficacy|10|||
126685035|NCT01437397|455801752|FG004|Overall Study|Lack of Efficacy|20|||
126685036|NCT01437397|455801748|FG000|Overall Study|Adverse Event|21|||
126685037|NCT01437397|455801749|FG001|Overall Study|Adverse Event|22|||
126685038|NCT01437397|455801750|FG002|Overall Study|Adverse Event|16|||
126685039|NCT01437397|455801751|FG003|Overall Study|Adverse Event|14|||
126685040|NCT01437397|455801752|FG004|Overall Study|Adverse Event|21|||
126685041|NCT01437397|455801748|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
126685042|NCT01437397|455801749|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
126685043|NCT01437397|455801750|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
126685044|NCT01437397|455801751|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
126685045|NCT01437397|455801752|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
126685046|NCT00903175|455801753|FG000|Period 1 - First Line|Adverse Event|36|||
126685047|NCT00903175|455801754|FG001|Period 1 - First Line|Adverse Event|50|||
126685048|NCT00903175|455801753|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
126685049|NCT00903175|455801754|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
126685050|NCT00903175|455801753|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
126685051|NCT00903175|455801754|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
126685052|NCT00903175|455801753|FG000|Period 1 - First Line|Protocol Violation|3|||
126685053|NCT00903175|455801754|FG001|Period 1 - First Line|Protocol Violation|3|||
126685054|NCT00903175|455801753|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
126685055|NCT00903175|455801754|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
126685056|NCT00903175|455801753|FG000|Period 1 - First Line|Administrative problems|12|||
126685057|NCT00903175|455801754|FG001|Period 1 - First Line|Administrative problems|13|||
126437581|NCT03873116|454903020|FG000|Part 2|Lab abnormality or AE|0|||
126437582|NCT03873116|454903021|FG001|Part 2|Lab abnormality or AE|0|||
126759159|NCT00765726|456066782|FG000|Overall Study|Withdrawal by Subject|1|||
126759160|NCT00765726|456066782|FG000|Overall Study|Discontinuation of study by sponsor|8|||
126759161|NCT02058966|456066783|FG000|Open-Label Methamphetamine|Adverse Event|1|||
126759162|NCT02058966|456066783|FG000|First Intervention|Withdrawal by Subject|1|||
126437583|NCT03873116|454903022|FG002|Part 2|Lab abnormality or AE|0|||
126437584|NCT03873116|454903023|FG003|Part 2|Lab abnormality or AE|0|||
126437585|NCT03873116|454903024|FG004|Part 2|Lab abnormality or AE|1|||
126437586|NCT03873116|454903025|FG005|Part 2|Lab abnormality or AE|0|||
126437587|NCT03873116|454903020|FG000|Part 3|Withdrawal by Subject|0|||
126437588|NCT03873116|454903021|FG001|Part 3|Withdrawal by Subject|0|||
126437589|NCT03873116|454903022|FG002|Part 3|Withdrawal by Subject|0|||
126437590|NCT03873116|454903023|FG003|Part 3|Withdrawal by Subject|0|||
126437591|NCT03873116|454903024|FG004|Part 3|Withdrawal by Subject|1|||
126437592|NCT03873116|454903025|FG005|Part 3|Withdrawal by Subject|0|||
126437593|NCT03345784|454903026|FG000|Overall Study|Withdrawal by Subject|2|||
126437594|NCT03345784|454903027|FG001|Overall Study|Withdrawal by Subject|1|||
126437595|NCT03777982|454903034|FG000|Overall Study|Physician Decision|0|||
126437596|NCT03777982|454903035|FG001|Overall Study|Physician Decision|1|||
126437597|NCT00870740|454903036|FG000|Overall Study|Adverse Event|2|||
126437598|NCT00870740|454903037|FG001|Overall Study|Adverse Event|1|||
126437599|NCT00870740|454903038|FG002|Overall Study|Adverse Event|3|||
126437600|NCT00870740|454903039|FG003|Overall Study|Adverse Event|2|||
126437601|NCT00870740|454903040|FG004|Overall Study|Adverse Event|1|||
126437602|NCT00870740|454903041|FG005|Overall Study|Adverse Event|6|||
126437603|NCT00870740|454903036|FG000|Overall Study|Consent Withdrawn|6|||
126437604|NCT00870740|454903037|FG001|Overall Study|Consent Withdrawn|3|||
126437605|NCT00870740|454903038|FG002|Overall Study|Consent Withdrawn|4|||
126437606|NCT00870740|454903039|FG003|Overall Study|Consent Withdrawn|6|||
126759163|NCT01265511|456066784|FG000|Overall Study|Lack of Efficacy|2|||
126759164|NCT01265511|456066785|FG001|Overall Study|Lack of Efficacy|1|||
126759165|NCT01265511|456066784|FG000|Overall Study|Met stopping rules|0|||
126759166|NCT01265511|456066785|FG001|Overall Study|Met stopping rules|2|||
126759167|NCT00323479|456066786|FG000|Overall Study|Adverse Event|2|||
126759168|NCT00323479|456066786|FG000|Overall Study|Withdrawal by Subject|2|||
126759169|NCT00323479|456066786|FG000|Overall Study|Protocol Violation|3|||
126759170|NCT00323479|456066786|FG000|Overall Study|house moving|1|||
126759171|NCT01362062|456066787|FG000|Overall Study|Adverse Event|1|||
126759172|NCT01362062|456066788|FG001|Overall Study|Adverse Event|0|||
126759173|NCT01362062|456066787|FG000|Overall Study|Lost to Follow-up|11|||
126759174|NCT01362062|456066788|FG001|Overall Study|Lost to Follow-up|0|||
126759175|NCT01362062|456066787|FG000|Overall Study|Withdrawal by Subject|2|||
126759176|NCT01362062|456066788|FG001|Overall Study|Withdrawal by Subject|0|||
126437607|NCT00870740|454903040|FG004|Overall Study|Consent Withdrawn|6|||
126759177|NCT01362062|456066787|FG000|Overall Study|Non-compliant participant|2|||
126759178|NCT01362062|456066788|FG001|Overall Study|Non-compliant participant|0|||
126759179|NCT01362062|456066787|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
126759180|NCT01362062|456066788|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
126759181|NCT01362062|456066787|FG000|Overall Study|Had significant improvement|9|||
126437608|NCT00870740|454903041|FG005|Overall Study|Consent Withdrawn|5|||
126437609|NCT00870740|454903036|FG000|Overall Study|Investigator Decision|2|||
126437610|NCT00870740|454903037|FG001|Overall Study|Investigator Decision|0|||
126437611|NCT00870740|454903038|FG002|Overall Study|Investigator Decision|1|||
126437612|NCT00870740|454903039|FG003|Overall Study|Investigator Decision|0|||
126437613|NCT00870740|454903040|FG004|Overall Study|Investigator Decision|0|||
126437614|NCT00870740|454903041|FG005|Overall Study|Investigator Decision|0|||
126437615|NCT00870740|454903036|FG000|Overall Study|Subject Non-compliance|0|||
126437616|NCT00870740|454903037|FG001|Overall Study|Subject Non-compliance|0|||
126437617|NCT00870740|454903038|FG002|Overall Study|Subject Non-compliance|0|||
126437618|NCT00870740|454903039|FG003|Overall Study|Subject Non-compliance|0|||
126437619|NCT00870740|454903040|FG004|Overall Study|Subject Non-compliance|0|||
126685058|NCT00903175|455801753|FG000|Period 1 - First Line|Death|17|||
126685059|NCT00903175|455801754|FG001|Period 1 - First Line|Death|10|||
126685060|NCT00903175|455801753|FG000|Period 2 - Second Line|Missing|1|||
126685061|NCT00903175|455801754|FG001|Period 2 - Second Line|Missing|0|||
126685062|NCT00903175|455801753|FG000|Period 2 - Second Line|Adverse Event|16|||
126685063|NCT00903175|455801754|FG001|Period 2 - Second Line|Adverse Event|20|||
126685064|NCT00903175|455801753|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
126685065|NCT00903175|455801754|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
126685066|NCT00903175|455801753|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
126685067|NCT00903175|455801754|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
126437620|NCT00870740|454903041|FG005|Overall Study|Subject Non-compliance|1|||
126685068|NCT00903175|455801753|FG000|Period 2 - Second Line|Administrative problems|19|||
126437621|NCT00870740|454903036|FG000|Overall Study|Death|0|||
126437622|NCT00870740|454903037|FG001|Overall Study|Death|0|||
126437623|NCT00870740|454903038|FG002|Overall Study|Death|0|||
126437624|NCT00870740|454903039|FG003|Overall Study|Death|0|||
126437625|NCT00870740|454903040|FG004|Overall Study|Death|1|||
126437626|NCT00870740|454903041|FG005|Overall Study|Death|0|||
126437627|NCT00870740|454903036|FG000|Overall Study|Other|2|||
126437628|NCT00870740|454903037|FG001|Overall Study|Other|5|||
126437629|NCT00870740|454903038|FG002|Overall Study|Other|2|||
126437630|NCT00870740|454903039|FG003|Overall Study|Other|4|||
126685069|NCT00903175|455801754|FG001|Period 2 - Second Line|Administrative problems|9|||
126685070|NCT00903175|455801753|FG000|Period 2 - Second Line|Death|5|||
126685071|NCT00903175|455801754|FG001|Period 2 - Second Line|Death|2|||
126685072|NCT03074474|455801759|FG000|Overall Study|Lost to Follow-up|10|||
126685073|NCT03074474|455801759|FG000|Overall Study|Withdrawal by Subject|10|||
126685074|NCT03074474|455801759|FG000|Overall Study|Death|4|||
126685075|NCT03074474|455801759|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
126685076|NCT00371865|455801762|FG000|Overall Study|Lack of Efficacy|0|||
126685077|NCT00371865|455801763|FG001|Overall Study|Lack of Efficacy|2|||
126685078|NCT00371865|455801762|FG000|Overall Study|Protocol Violation|3|||
126685079|NCT00371865|455801763|FG001|Overall Study|Protocol Violation|2|||
126685080|NCT00371865|455801762|FG000|Overall Study|Withdrawal by Subject|12|||
126685081|NCT00371865|455801763|FG001|Overall Study|Withdrawal by Subject|10|||
126685082|NCT01328951|455801765|FG000|Overall Study|Disease Progression|17|||
126685083|NCT01328951|455801766|FG001|Overall Study|Disease Progression|14|||
126685084|NCT01328951|455801765|FG000|Overall Study|Adverse Event|2|||
126685085|NCT01328951|455801766|FG001|Overall Study|Adverse Event|0|||
126685086|NCT01328951|455801765|FG000|Overall Study|Death|243|||
126685087|NCT01328951|455801766|FG001|Overall Study|Death|258|||
126685088|NCT01328951|455801765|FG000|Overall Study|Lost to Follow-up|6|||
126685089|NCT01328951|455801766|FG001|Overall Study|Lost to Follow-up|7|||
126685090|NCT01328951|455801765|FG000|Overall Study|Withdrawal by Subject|6|||
126685091|NCT01328951|455801766|FG001|Overall Study|Withdrawal by Subject|6|||
126685092|NCT01328951|455801765|FG000|Overall Study|Study Closed by the Sponsor|36|||
126685093|NCT01328951|455801766|FG001|Overall Study|Study Closed by the Sponsor|31|||
126685094|NCT01328951|455801765|FG000|Overall Study|Other|11|||
126685095|NCT01328951|455801766|FG001|Overall Study|Other|6|||
126685096|NCT04042103|455801769|FG000|Overall Study|Lost to Follow-up|1|||
126685097|NCT04042103|455801769|FG000|Overall Study|Withdrawal by Subject|1|||
126685098|NCT01003210|455801770|FG000|Overall Study|Lost to Follow-up|1|||
126685099|NCT01003210|455801771|FG001|Overall Study|Lost to Follow-up|3|||
126685100|NCT00271817|455801772|FG000|Part 1|Adverse Event|68|||
126685101|NCT00271817|455801773|FG001|Part 1|Adverse Event|25|||
126685102|NCT00271817|455801774|FG002|Part 1|Adverse Event|156|||
126685103|NCT00271817|455801772|FG000|Part 1|Lost to Follow-up|6|||
126685104|NCT00271817|455801773|FG001|Part 1|Lost to Follow-up|8|||
126685105|NCT00271817|455801774|FG002|Part 1|Lost to Follow-up|24|||
126685106|NCT00271817|455801772|FG000|Part 1|Protocol Violation|5|||
126685107|NCT00271817|455801773|FG001|Part 1|Protocol Violation|4|||
126685108|NCT00271817|455801774|FG002|Part 1|Protocol Violation|7|||
126685109|NCT00271817|455801772|FG000|Part 1|Patient Moved|3|||
126685110|NCT00271817|455801773|FG001|Part 1|Patient Moved|1|||
126685111|NCT00271817|455801774|FG002|Part 1|Patient Moved|5|||
126685112|NCT00271817|455801772|FG000|Part 1|Withdrawal by Subject|23|||
126685113|NCT00271817|455801773|FG001|Part 1|Withdrawal by Subject|17|||
126685114|NCT00271817|455801774|FG002|Part 1|Withdrawal by Subject|45|||
126685115|NCT00271817|455801772|FG000|Part 1|LDL < 50 mg/dL|1|||
126685116|NCT00271817|455801773|FG001|Part 1|LDL < 50 mg/dL|4|||
126685117|NCT00271817|455801774|FG002|Part 1|LDL < 50 mg/dL|48|||
126685118|NCT00271817|455801772|FG000|Part 2|Adverse Event|0|||
126685119|NCT00271817|455801773|FG001|Part 2|Adverse Event|17|||
126685120|NCT00271817|455801774|FG002|Part 2|Adverse Event|33|||
126685121|NCT00271817|455801772|FG000|Part 2|Lack of Efficacy|0|||
126685122|NCT00271817|455801773|FG001|Part 2|Lack of Efficacy|1|||
126685123|NCT00271817|455801774|FG002|Part 2|Lack of Efficacy|6|||
126685124|NCT00271817|455801772|FG000|Part 2|Lost to Follow-up|0|||
126685125|NCT00271817|455801773|FG001|Part 2|Lost to Follow-up|6|||
126685126|NCT00271817|455801774|FG002|Part 2|Lost to Follow-up|18|||
126685127|NCT00271817|455801772|FG000|Part 2|Protocol Violation|0|||
126685128|NCT00271817|455801773|FG001|Part 2|Protocol Violation|3|||
126685129|NCT00271817|455801774|FG002|Part 2|Protocol Violation|5|||
126685130|NCT00271817|455801772|FG000|Part 2|Patient Moved|0|||
126437631|NCT00870740|454903040|FG004|Overall Study|Other|3|||
126437632|NCT00870740|454903041|FG005|Overall Study|Other|5|||
126437633|NCT03755934|454903042|FG000|Overall Study|Adverse Event|4|||
126437634|NCT03755934|454903043|FG001|Overall Study|Adverse Event|1|||
126685131|NCT00271817|455801773|FG001|Part 2|Patient Moved|0|||
126685132|NCT00271817|455801774|FG002|Part 2|Patient Moved|5|||
126685133|NCT00271817|455801772|FG000|Part 2|Withdrawal by Subject|0|||
126685134|NCT00271817|455801773|FG001|Part 2|Withdrawal by Subject|2|||
126685135|NCT00271817|455801774|FG002|Part 2|Withdrawal by Subject|13|||
126685136|NCT00271817|455801772|FG000|Part 2|LDL < 50 mg/dL|0|||
126685137|NCT00271817|455801773|FG001|Part 2|LDL < 50 mg/dL|3|||
126685138|NCT00271817|455801774|FG002|Part 2|LDL < 50 mg/dL|4|||
126759182|NCT01362062|456066788|FG001|Overall Study|Had significant improvement|0|||
126685139|NCT04153188|455801777|FG000|Overall Study|Lost to Follow-up|1|||
126685140|NCT04153188|455801778|FG001|Overall Study|Lost to Follow-up|1|||
126685141|NCT04153188|455801777|FG000|Overall Study|Withdrawal by Subject|2|||
126685142|NCT04153188|455801778|FG001|Overall Study|Withdrawal by Subject|0|||
126685143|NCT04153188|455801777|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
126685144|NCT04153188|455801778|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
126685145|NCT00700271|455801779|FG000|Overall Study|Adverse Event|4|||
126685146|NCT00700271|455801780|FG001|Overall Study|Adverse Event|6|||
126685147|NCT00700271|455801779|FG000|Overall Study|Protocol Violation|1|||
126685148|NCT00700271|455801780|FG001|Overall Study|Protocol Violation|0|||
126685149|NCT00700271|455801779|FG000|Overall Study|Administrative Reasons|1|||
126685150|NCT00700271|455801780|FG001|Overall Study|Administrative Reasons|0|||
126685151|NCT00700271|455801779|FG000|Overall Study|Withdrawal by Subject|6|||
126685152|NCT00700271|455801780|FG001|Overall Study|Withdrawal by Subject|4|||
126685153|NCT00700271|455801779|FG000|Overall Study|Lost to Follow-up|2|||
126685154|NCT00700271|455801780|FG001|Overall Study|Lost to Follow-up|2|||
126685155|NCT03124563|455801783|FG000|Overall Study|Lost to Follow-up|1|||
126685156|NCT03124563|455801784|FG001|Overall Study|Lost to Follow-up|1|||
126685157|NCT03124563|455801783|FG000|Overall Study|Withdrawal by Subject|1|||
126685158|NCT03124563|455801784|FG001|Overall Study|Withdrawal by Subject|1|||
126685159|NCT03368170|455803265|FG000|Overall Study|Adverse Event|2|||
126685160|NCT03368170|455803266|FG001|Overall Study|Adverse Event|1|||
126685161|NCT02068547|455803267|FG000|Overall Study|Lost to Follow-up|3|||
126685162|NCT02068547|455803268|FG001|Overall Study|Lost to Follow-up|3|||
126685163|NCT02068547|455803267|FG000|Overall Study|Physician Decision|1|||
126685164|NCT02068547|455803268|FG001|Overall Study|Physician Decision|0|||
126685165|NCT00264004|455803276|FG000|Overall Study|Adverse Event|2|||
126685166|NCT00264004|455803277|FG001|Overall Study|Adverse Event|3|||
126685167|NCT00264004|455803278|FG002|Overall Study|Adverse Event|6|||
126685168|NCT00264004|455803279|FG003|Overall Study|Adverse Event|4|||
126685169|NCT00264004|455803276|FG000|Overall Study|Withdrawal by Subject|0|||
126685170|NCT00264004|455803277|FG001|Overall Study|Withdrawal by Subject|1|||
126685171|NCT00264004|455803278|FG002|Overall Study|Withdrawal by Subject|2|||
126685172|NCT00264004|455803279|FG003|Overall Study|Withdrawal by Subject|2|||
126685173|NCT00264004|455803276|FG000|Overall Study|Other|2|||
126685174|NCT00264004|455803277|FG001|Overall Study|Other|2|||
126685175|NCT00264004|455803278|FG002|Overall Study|Other|0|||
126685176|NCT00264004|455803279|FG003|Overall Study|Other|3|||
126685177|NCT00264004|455803276|FG000|Overall Study|Development study specific disc. crit.|1|||
126685178|NCT00264004|455803277|FG001|Overall Study|Development study specific disc. crit.|0|||
126685179|NCT00264004|455803278|FG002|Overall Study|Development study specific disc. crit.|1|||
126685180|NCT00264004|455803279|FG003|Overall Study|Development study specific disc. crit.|0|||
126685181|NCT00264004|455803276|FG000|Overall Study|Cond. under inv. worsened|9|||
126685182|NCT00264004|455803277|FG001|Overall Study|Cond. under inv. worsened|5|||
126685183|NCT00264004|455803278|FG002|Overall Study|Cond. under inv. worsened|3|||
126685184|NCT00264004|455803279|FG003|Overall Study|Cond. under inv. worsened|4|||
126685185|NCT00264004|455803276|FG000|Overall Study|Not treated|3|||
126685186|NCT00264004|455803277|FG001|Overall Study|Not treated|0|||
126685187|NCT00264004|455803278|FG002|Overall Study|Not treated|2|||
126685188|NCT00264004|455803279|FG003|Overall Study|Not treated|2|||
126685189|NCT00691483|455803280|FG000|Overall Study|Adverse Event|14|||
126685190|NCT00691483|455803281|FG001|Overall Study|Adverse Event|6|||
126685191|NCT00691483|455803280|FG000|Overall Study|Lost to Follow-up|17|||
126685192|NCT00691483|455803281|FG001|Overall Study|Lost to Follow-up|10|||
126685193|NCT00691483|455803280|FG000|Overall Study|Withdrawal by Subject|24|||
126685194|NCT00691483|455803281|FG001|Overall Study|Withdrawal by Subject|7|||
126685195|NCT00691483|455803280|FG000|Overall Study|Other known cause|6|||
126685196|NCT00691483|455803281|FG001|Overall Study|Other known cause|1|||
126685197|NCT00691483|455803280|FG000|Overall Study|Randomized by not treated|7|||
126685198|NCT00691483|455803281|FG001|Overall Study|Randomized by not treated|1|||
126759183|NCT00967343|456066789|FG000|Overall Study|Study termination by sponsor|12|||
126759184|NCT00967343|456066789|FG000|Overall Study|Death|24|||
126759185|NCT00967343|456066789|FG000|Overall Study|Relapse|1|||
126759186|NCT00967343|456066789|FG000|Overall Study|Lost to Follow-up|1|||
126759187|NCT00950755|456066790|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
126759188|NCT00950755|456066790|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
126759189|NCT00950755|456066790|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
126759190|NCT00950755|456066790|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
126759191|NCT00950755|456066790|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
126685199|NCT01262365|455803282|FG000|Overall Study|Lack of Efficacy|35|||
126685200|NCT01262365|455803283|FG001|Overall Study|Lack of Efficacy|30|||
126685201|NCT01262365|455803284|FG002|Overall Study|Lack of Efficacy|47|||
126685202|NCT01262365|455803282|FG000|Overall Study|Protocol Violation|3|||
126685203|NCT01262365|455803283|FG001|Overall Study|Protocol Violation|1|||
126685204|NCT01262365|455803284|FG002|Overall Study|Protocol Violation|1|||
126685205|NCT01262365|455803282|FG000|Overall Study|Lost to Follow-up|3|||
126685206|NCT01262365|455803283|FG001|Overall Study|Lost to Follow-up|7|||
126685207|NCT01262365|455803284|FG002|Overall Study|Lost to Follow-up|6|||
126685208|NCT01262365|455803282|FG000|Overall Study|Withdrawal by Subject|17|||
126685209|NCT01262365|455803283|FG001|Overall Study|Withdrawal by Subject|22|||
126685210|NCT01262365|455803284|FG002|Overall Study|Withdrawal by Subject|22|||
126685211|NCT01262365|455803282|FG000|Overall Study|Death|1|||
126685212|NCT01262365|455803283|FG001|Overall Study|Death|2|||
126685213|NCT01262365|455803284|FG002|Overall Study|Death|1|||
126685214|NCT01262365|455803282|FG000|Overall Study|Adverse Event|26|||
126685215|NCT01262365|455803283|FG001|Overall Study|Adverse Event|16|||
126685216|NCT01262365|455803284|FG002|Overall Study|Adverse Event|11|||
126685217|NCT01262365|455803282|FG000|Overall Study|sponsor decision|1|||
126685218|NCT01262365|455803283|FG001|Overall Study|sponsor decision|1|||
126685219|NCT01262365|455803284|FG002|Overall Study|sponsor decision|0|||
126685220|NCT01262365|455803282|FG000|Overall Study|Randomization error|1|||
126685221|NCT01262365|455803283|FG001|Overall Study|Randomization error|0|||
126685222|NCT01262365|455803284|FG002|Overall Study|Randomization error|2|||
126685223|NCT01262365|455803282|FG000|Overall Study|Non-compliance|1|||
126685224|NCT01262365|455803283|FG001|Overall Study|Non-compliance|0|||
126685225|NCT01262365|455803284|FG002|Overall Study|Non-compliance|2|||
126685226|NCT01262365|455803282|FG000|Overall Study|Suspected pregnancy|1|||
126685227|NCT01262365|455803283|FG001|Overall Study|Suspected pregnancy|0|||
126685228|NCT01262365|455803284|FG002|Overall Study|Suspected pregnancy|0|||
126685229|NCT01262365|455803282|FG000|Overall Study|Patient pregnant|1|||
126685230|NCT01262365|455803283|FG001|Overall Study|Patient pregnant|0|||
126685231|NCT01262365|455803284|FG002|Overall Study|Patient pregnant|1|||
126685232|NCT01262365|455803282|FG000|Overall Study|Toxicity related to study drug|0|||
126685233|NCT01262365|455803283|FG001|Overall Study|Toxicity related to study drug|1|||
126685234|NCT01262365|455803284|FG002|Overall Study|Toxicity related to study drug|0|||
126685235|NCT01262365|455803282|FG000|Overall Study|Cannot tolerate the protocol|0|||
126685236|NCT01262365|455803283|FG001|Overall Study|Cannot tolerate the protocol|1|||
126685237|NCT01262365|455803284|FG002|Overall Study|Cannot tolerate the protocol|0|||
126685238|NCT01262365|455803282|FG000|Overall Study|Patient unavailable|0|||
126685239|NCT01262365|455803283|FG001|Overall Study|Patient unavailable|0|||
126685240|NCT01262365|455803284|FG002|Overall Study|Patient unavailable|1|||
126685241|NCT00326898|455803285|FG000|Overall Study|Disease progression|52|||
126685242|NCT00326898|455803286|FG001|Overall Study|Disease progression|54|||
126685243|NCT00326898|455803287|FG002|Overall Study|Disease progression|102|||
126685244|NCT00326898|455803285|FG000|Overall Study|Adverse Event|124|||
126685245|NCT00326898|455803286|FG001|Overall Study|Adverse Event|128|||
126437635|NCT03755934|454903044|FG002|Overall Study|Adverse Event|1|||
126437636|NCT03755934|454903045|FG003|Overall Study|Adverse Event|3|||
126685246|NCT00326898|455803287|FG002|Overall Study|Adverse Event|33|||
126685247|NCT00326898|455803285|FG000|Overall Study|Death|2|||
126685248|NCT00326898|455803286|FG001|Overall Study|Death|0|||
126437637|NCT03755934|454903042|FG000|Overall Study|Physician Decision|2|||
126437638|NCT03755934|454903043|FG001|Overall Study|Physician Decision|0|||
126685249|NCT00326898|455803287|FG002|Overall Study|Death|0|||
126685250|NCT00326898|455803285|FG000|Overall Study|Withdrawal by Subject|134|||
126685251|NCT00326898|455803286|FG001|Overall Study|Withdrawal by Subject|128|||
126759192|NCT00950755|456066790|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
126759193|NCT00950755|456066790|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
126759194|NCT00950755|456066790|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
126759195|NCT00950755|456066790|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
126759196|NCT00950755|456066790|FG000|Long-Term Follow-Up|Death|8|||
126759197|NCT01004822|456068508|FG000|Overall Study|Objective progression or relapse|3|||
126759198|NCT01004822|456068509|FG001|Overall Study|Objective progression or relapse|3|||
126759199|NCT01004822|456068510|FG002|Overall Study|Objective progression or relapse|0|||
126759200|NCT01004822|456068511|FG003|Overall Study|Objective progression or relapse|1|||
126759201|NCT01004822|456068512|FG004|Overall Study|Objective progression or relapse|2|||
126759202|NCT01004822|456068513|FG005|Overall Study|Objective progression or relapse|2|||
126759203|NCT01004822|456068514|FG006|Overall Study|Objective progression or relapse|1|||
126759204|NCT01004822|456068515|FG007|Overall Study|Objective progression or relapse|4|||
126759205|NCT01004822|456068508|FG000|Overall Study|Global deterioration of health status|0|||
126759206|NCT01004822|456068509|FG001|Overall Study|Global deterioration of health status|0|||
126759207|NCT01004822|456068510|FG002|Overall Study|Global deterioration of health status|0|||
126759208|NCT01004822|456068511|FG003|Overall Study|Global deterioration of health status|1|||
126759209|NCT01004822|456068512|FG004|Overall Study|Global deterioration of health status|0|||
126759210|NCT01004822|456068513|FG005|Overall Study|Global deterioration of health status|0|||
126759211|NCT01004822|456068514|FG006|Overall Study|Global deterioration of health status|1|||
126759212|NCT01004822|456068515|FG007|Overall Study|Global deterioration of health status|0|||
126759213|NCT01004822|456068508|FG000|Overall Study|No longer willing to continue|0|||
126759214|NCT01004822|456068509|FG001|Overall Study|No longer willing to continue|0|||
126759215|NCT01004822|456068510|FG002|Overall Study|No longer willing to continue|0|||
126759216|NCT01004822|456068511|FG003|Overall Study|No longer willing to continue|1|||
126759217|NCT01004822|456068512|FG004|Overall Study|No longer willing to continue|2|||
126759218|NCT01004822|456068513|FG005|Overall Study|No longer willing to continue|1|||
126759219|NCT01004822|456068514|FG006|Overall Study|No longer willing to continue|1|||
126759220|NCT01004822|456068515|FG007|Overall Study|No longer willing to continue|0|||
126759221|NCT01004822|456068508|FG000|Overall Study|Adverse Event|0|||
126759222|NCT01004822|456068509|FG001|Overall Study|Adverse Event|0|||
126759223|NCT01004822|456068510|FG002|Overall Study|Adverse Event|0|||
126759224|NCT01004822|456068511|FG003|Overall Study|Adverse Event|0|||
126759225|NCT01004822|456068512|FG004|Overall Study|Adverse Event|0|||
126759226|NCT01004822|456068513|FG005|Overall Study|Adverse Event|0|||
126759227|NCT01004822|456068514|FG006|Overall Study|Adverse Event|1|||
126759228|NCT01004822|456068515|FG007|Overall Study|Adverse Event|1|||
126759229|NCT01004822|456068508|FG000|Overall Study|Other|0|||
126759230|NCT01004822|456068509|FG001|Overall Study|Other|0|||
126759231|NCT01004822|456068510|FG002|Overall Study|Other|4|||
126759232|NCT01004822|456068511|FG003|Overall Study|Other|1|||
126759233|NCT01004822|456068512|FG004|Overall Study|Other|0|||
126759234|NCT01004822|456068513|FG005|Overall Study|Other|1|||
126759235|NCT01004822|456068514|FG006|Overall Study|Other|0|||
126759236|NCT01004822|456068515|FG007|Overall Study|Other|0|||
126759237|NCT01858701|456068516|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
126759238|NCT01858701|456068517|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
126759239|NCT01858701|456068516|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
126759240|NCT01858701|456068517|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
126759241|NCT01858701|456068516|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
126759242|NCT01858701|456068517|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
126759243|NCT01858701|456068516|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
126759244|NCT01858701|456068517|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
126759245|NCT00421928|456068518|FG000|Overall Study|Adverse Event|61|||
126759246|NCT00421928|456068519|FG001|Overall Study|Adverse Event|140|||
126759247|NCT00421928|456068520|FG002|Overall Study|Adverse Event|22|||
126759248|NCT00421928|456068518|FG000|Overall Study|Lost to Follow-up|5|||
126759249|NCT00421928|456068519|FG001|Overall Study|Lost to Follow-up|0|||
126437639|NCT03755934|454903044|FG002|Overall Study|Physician Decision|0|||
126437640|NCT03755934|454903045|FG003|Overall Study|Physician Decision|1|||
126437641|NCT03755934|454903042|FG000|Overall Study|Withdrawal by Subject|5|||
126437642|NCT03755934|454903043|FG001|Overall Study|Withdrawal by Subject|0|||
126437643|NCT03755934|454903044|FG002|Overall Study|Withdrawal by Subject|0|||
126437644|NCT03755934|454903045|FG003|Overall Study|Withdrawal by Subject|1|||
126437645|NCT03755934|454903042|FG000|Overall Study|Other|3|||
126437646|NCT03755934|454903043|FG001|Overall Study|Other|1|||
126437647|NCT03755934|454903044|FG002|Overall Study|Other|3|||
126437648|NCT03755934|454903045|FG003|Overall Study|Other|1|||
126437649|NCT00307801|454903046|FG000|Overall Study|Adverse Event|12|||
126437650|NCT00307801|454903047|FG001|Overall Study|Adverse Event|4|||
126685252|NCT00326898|455803287|FG002|Overall Study|Withdrawal by Subject|32|||
126685253|NCT00326898|455803285|FG000|Overall Study|Alternative therapy|1|||
126685254|NCT00326898|455803286|FG001|Overall Study|Alternative therapy|0|||
126685255|NCT00326898|455803287|FG002|Overall Study|Alternative therapy|0|||
126437651|NCT00307801|454903046|FG000|Overall Study|Withdrawal by Subject|9|||
126685256|NCT00326898|455803285|FG000|Overall Study|Other complicating disease|5|||
126437652|NCT00307801|454903047|FG001|Overall Study|Withdrawal by Subject|4|||
126685257|NCT00326898|455803286|FG001|Overall Study|Other complicating disease|5|||
126437653|NCT00307801|454903046|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
126545378|NCT02100722|455290820|FG001|Overall Study|Lost to Follow-up|2|||
126685258|NCT00326898|455803287|FG002|Overall Study|Other complicating disease|4|||
126685259|NCT00326898|455803285|FG000|Overall Study|Other/Missing/Unknown|33|||
126685260|NCT00326898|455803286|FG001|Overall Study|Other/Missing/Unknown|28|||
126685261|NCT00326898|455803287|FG002|Overall Study|Other/Missing/Unknown|32|||
126685262|NCT03733392|455803291|FG000|Overall Study|Withdrawal by Subject|11|||
126685263|NCT03733392|455803292|FG001|Overall Study|Withdrawal by Subject|1|||
126685264|NCT03733392|455803291|FG000|Overall Study|Death|1|||
126685265|NCT03733392|455803292|FG001|Overall Study|Death|0|||
126685266|NCT03733392|455803291|FG000|Overall Study|Lost to Follow-up|5|||
126685267|NCT03733392|455803292|FG001|Overall Study|Lost to Follow-up|0|||
126685268|NCT03733392|455803291|FG000|Overall Study|Protocol Violation|0|||
126685269|NCT03733392|455803292|FG001|Overall Study|Protocol Violation|1|||
126685270|NCT03733392|455803291|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
126685271|NCT03733392|455803292|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
126759250|NCT00421928|456068520|FG002|Overall Study|Lost to Follow-up|3|||
126759251|NCT00421928|456068518|FG000|Overall Study|Withdrawal by Subject|50|||
126759252|NCT00421928|456068519|FG001|Overall Study|Withdrawal by Subject|48|||
126759253|NCT00421928|456068520|FG002|Overall Study|Withdrawal by Subject|43|||
126759254|NCT00421928|456068518|FG000|Overall Study|Lack of Efficacy|15|||
126759255|NCT00421928|456068519|FG001|Overall Study|Lack of Efficacy|7|||
126759256|NCT00421928|456068520|FG002|Overall Study|Lack of Efficacy|35|||
126759257|NCT00421928|456068518|FG000|Overall Study|Study drug non-compliant|6|||
126759258|NCT00421928|456068519|FG001|Overall Study|Study drug non-compliant|7|||
126759259|NCT00421928|456068520|FG002|Overall Study|Study drug non-compliant|4|||
126759260|NCT00421928|456068518|FG000|Overall Study|All other|26|||
126759261|NCT00421928|456068519|FG001|Overall Study|All other|21|||
126759262|NCT00421928|456068520|FG002|Overall Study|All other|27|||
126759263|NCT00421928|456068518|FG000|Overall Study|Death|0|||
126759264|NCT00421928|456068519|FG001|Overall Study|Death|1|||
126759265|NCT00421928|456068520|FG002|Overall Study|Death|0|||
126759266|NCT03799198|456068523|FG000|Overall Study|Lost to Follow-up|4|||
126759267|NCT03799198|456068524|FG001|Overall Study|Lost to Follow-up|8|||
126759268|NCT03799198|456068523|FG000|Overall Study|Death|0|||
126759269|NCT03799198|456068524|FG001|Overall Study|Death|1|||
126759270|NCT00548340|456068527|FG000|Overall Study|Protocol Violation|2|||
126759271|NCT00548340|456068528|FG001|Overall Study|Protocol Violation|3|||
126759272|NCT00548340|456068529|FG002|Overall Study|Protocol Violation|3|||
126759273|NCT00548340|456068527|FG000|Overall Study|Adverse Event|2|||
126759274|NCT00548340|456068528|FG001|Overall Study|Adverse Event|2|||
126759275|NCT00548340|456068529|FG002|Overall Study|Adverse Event|2|||
126759276|NCT00548340|456068527|FG000|Overall Study|Lost to Follow-up|1|||
126759277|NCT00548340|456068528|FG001|Overall Study|Lost to Follow-up|1|||
126759278|NCT00548340|456068529|FG002|Overall Study|Lost to Follow-up|0|||
126759279|NCT00548340|456068527|FG000|Overall Study|Withdrawal by Subject|2|||
126759280|NCT00548340|456068528|FG001|Overall Study|Withdrawal by Subject|4|||
126759281|NCT00548340|456068529|FG002|Overall Study|Withdrawal by Subject|3|||
126759282|NCT00548340|456068527|FG000|Overall Study|Other|1|||
126759283|NCT00548340|456068528|FG001|Overall Study|Other|1|||
126759284|NCT00548340|456068529|FG002|Overall Study|Other|1|||
126759285|NCT01096017|456068530|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
126759286|NCT01096017|456068531|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
126759287|NCT00501969|456068532|FG000|Overall Study|Major Protocol Violation|4|||
126759288|NCT00501969|456068532|FG000|Overall Study|Lack of Efficacy|29|||
126759289|NCT00501969|456068532|FG000|Overall Study|Adverse Event|76|||
126759290|NCT00501969|456068532|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
126759291|NCT00501969|456068532|FG000|Overall Study|Subject withdrew consent|51|||
126759292|NCT00501969|456068532|FG000|Overall Study|Lost to Follow-up|4|||
126759293|NCT00501969|456068532|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
126759294|NCT00501969|456068532|FG000|Overall Study|Other: Sponsors Request|10|||
126759295|NCT00501969|456068532|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
126759296|NCT00501969|456068532|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
126759297|NCT00501969|456068532|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
126759298|NCT00501969|456068532|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
126759299|NCT00501969|456068532|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
126759300|NCT00501969|456068532|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
126759301|NCT00501969|456068532|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
126759302|NCT00501969|456068532|FG000|Overall Study|Other: As Required by Local EC|2|||
126759303|NCT00501969|456068532|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
126759304|NCT00501969|456068532|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
126759305|NCT00665366|456068533|FG000|Overall Study|Lack of Efficacy|11|||
126685272|NCT03733392|455803291|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
126685273|NCT03733392|455803292|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
126759306|NCT00665366|456068534|FG001|Overall Study|Lack of Efficacy|10|||
126759307|NCT00665366|456068533|FG000|Overall Study|Adverse Event|25|||
126759308|NCT00665366|456068534|FG001|Overall Study|Adverse Event|23|||
126759309|NCT00665366|456068533|FG000|Overall Study|Withdrawal by Subject|11|||
126759310|NCT00665366|456068534|FG001|Overall Study|Withdrawal by Subject|14|||
126437654|NCT00307801|454903047|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
126437655|NCT00307801|454903046|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
126437656|NCT00307801|454903047|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
126437657|NCT00307801|454903046|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
126437658|NCT00307801|454903047|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
126437659|NCT00307801|454903046|FG000|Overall Study|Wrong Randomization|1|||
126685274|NCT03733392|455803291|FG000|Overall Study|Patient Non-Compliance|2|||
126685275|NCT03733392|455803292|FG001|Overall Study|Patient Non-Compliance|1|||
126759311|NCT00665366|456068533|FG000|Overall Study|Lost to Follow-up|3|||
126437660|NCT00307801|454903047|FG001|Overall Study|Wrong Randomization|0|||
126759312|NCT00665366|456068534|FG001|Overall Study|Lost to Follow-up|5|||
126759313|NCT00665366|456068533|FG000|Overall Study|Poor compliance/noncompliance|3|||
126759314|NCT00665366|456068534|FG001|Overall Study|Poor compliance/noncompliance|5|||
126759315|NCT00665366|456068533|FG000|Overall Study|Pregnancy|1|||
126759316|NCT00665366|456068534|FG001|Overall Study|Pregnancy|0|||
126759317|NCT00665366|456068533|FG000|Overall Study|No longer meets study criteria|0|||
126759318|NCT00665366|456068534|FG001|Overall Study|No longer meets study criteria|1|||
126759319|NCT00665366|456068533|FG000|Overall Study|Other reasons|4|||
126759320|NCT00665366|456068534|FG001|Overall Study|Other reasons|1|||
126759321|NCT05111548|456068535|FG000|Overall Study|Withdrawal by Subject|2|||
126759322|NCT05111548|456068536|FG001|Overall Study|Withdrawal by Subject|1|||
126685276|NCT03733392|455803291|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
126685277|NCT03733392|455803292|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
126685278|NCT03733392|455803291|FG000|Overall Study|Withdrawal prior to procedure|5|||
126685279|NCT03733392|455803292|FG001|Overall Study|Withdrawal prior to procedure|2|||
126685280|NCT02615990|455803300|FG000|Overall Study|study terminated|1|||
126685281|NCT02615990|455803301|FG001|Overall Study|study terminated|1|||
126685282|NCT01363986|455803302|FG000|Overall Study|Disease progression|1|||
126685283|NCT01637142|455803303|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
126685284|NCT00925015|455803304|FG000|Overall Study|Adverse Event|1|||
126685285|NCT00925015|455803305|FG001|Overall Study|Adverse Event|2|||
126685286|NCT00925015|455803306|FG002|Overall Study|Adverse Event|1|||
126685287|NCT00925015|455803304|FG000|Overall Study|Physician Decision|0|||
126685288|NCT00925015|455803305|FG001|Overall Study|Physician Decision|1|||
126685289|NCT00925015|455803306|FG002|Overall Study|Physician Decision|0|||
126685290|NCT00925015|455803304|FG000|Overall Study|Progressive Disease|7|||
126685291|NCT00925015|455803305|FG001|Overall Study|Progressive Disease|3|||
126685292|NCT00925015|455803306|FG002|Overall Study|Progressive Disease|4|||
126685293|NCT00925015|455803304|FG000|Overall Study|Withdrawal by Subject|0|||
126685294|NCT00925015|455803305|FG001|Overall Study|Withdrawal by Subject|0|||
126685295|NCT00925015|455803306|FG002|Overall Study|Withdrawal by Subject|1|||
126685296|NCT04986202|455803307|FG000|Overall Study|Death|10|||
126685297|NCT04986202|455803308|FG001|Overall Study|Death|3|||
126685298|NCT04986202|455803309|FG002|Overall Study|Death|10|||
126685299|NCT04986202|455803307|FG000|Overall Study|Physician Decision|3|||
126685300|NCT04986202|455803308|FG001|Overall Study|Physician Decision|1|||
126685301|NCT04986202|455803309|FG002|Overall Study|Physician Decision|2|||
126759323|NCT05111548|456068535|FG000|Overall Study|Adverse Event|1|||
126759324|NCT05111548|456068536|FG001|Overall Study|Adverse Event|0|||
126759325|NCT04516291|456068547|FG000|Treatment Period (24 Weeks)|Other|1|||
126759326|NCT04516291|456068548|FG001|Treatment Period (24 Weeks)|Other|0|||
126759327|NCT04516291|456068549|FG002|Treatment Period (24 Weeks)|Other|0|||
126759328|NCT04516291|456068550|FG003|Treatment Period (24 Weeks)|Other|2|||
126759329|NCT04516291|456068551|FG004|Treatment Period (24 Weeks)|Other|2|||
126759330|NCT04516291|456068552|FG005|Treatment Period (24 Weeks)|Other|4|||
126759331|NCT04516291|456068553|FG006|Treatment Period (24 Weeks)|Other|2|||
126759332|NCT04516291|456068554|FG007|Treatment Period (24 Weeks)|Other|0|||
126759333|NCT04516291|456068547|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126759334|NCT04516291|456068548|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
126759335|NCT04516291|456068549|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
126759336|NCT04516291|456068550|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126759337|NCT04516291|456068551|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
126759338|NCT04516291|456068552|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126437661|NCT00307801|454903046|FG000|Overall Study|Lack of Efficacy|0|||
126437662|NCT00307801|454903047|FG001|Overall Study|Lack of Efficacy|2|||
126437663|NCT00307801|454903046|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
126685302|NCT04986202|455803307|FG000|Overall Study|Withdrawal by Subject|4|||
126437664|NCT00307801|454903047|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
126685303|NCT04986202|455803308|FG001|Overall Study|Withdrawal by Subject|2|||
126437665|NCT00307801|454903046|FG000|Overall Study|Frustration with e-diary|1|||
126759339|NCT04516291|456068553|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126759340|NCT04516291|456068554|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126759341|NCT04516291|456068547|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
126759342|NCT04516291|456068548|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
126759343|NCT04516291|456068549|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
126437666|NCT00307801|454903047|FG001|Overall Study|Frustration with e-diary|0|||
126437667|NCT00307801|454903046|FG000|Overall Study|Protocol Violation|3|||
126437668|NCT00307801|454903047|FG001|Overall Study|Protocol Violation|2|||
126437669|NCT00307801|454903046|FG000|Overall Study|No reason specified|2|||
126437670|NCT00307801|454903047|FG001|Overall Study|No reason specified|0|||
126437671|NCT00307801|454903046|FG000|Overall Study|Pregnancy|0|||
126437672|NCT00307801|454903047|FG001|Overall Study|Pregnancy|1|||
126437673|NCT00551642|454903050|FG000|Treatment Period|Protocol Deviation|6|||
126437674|NCT00551642|454903051|FG001|Treatment Period|Protocol Deviation|11|||
126437675|NCT00551642|454903050|FG000|Treatment Period|Delivery device failure|1|||
126437676|NCT00551642|454903051|FG001|Treatment Period|Delivery device failure|3|||
126685304|NCT04986202|455803309|FG002|Overall Study|Withdrawal by Subject|4|||
126685305|NCT02468648|455803310|FG000|Overall Study|Death|1|||
126685306|NCT01368835|455803311|FG000|Overall Study|Inclusion criteria/photography quality|22|||
126685307|NCT01368835|455803311|FG000|Overall Study|Lost to Follow-up|11|||
126685308|NCT02754726|455803312|FG000|Overall Study|Progressive Disease by RECIST|13|||
126685309|NCT02754726|455803312|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
126685310|NCT02754726|455803312|FG000|Overall Study|Clinical Disease Progression|5|||
126685311|NCT02754726|455803312|FG000|Overall Study|Adverse Event|3|||
126759344|NCT04516291|456068550|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
126759345|NCT04516291|456068551|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
126759346|NCT04516291|456068552|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
126759347|NCT04516291|456068553|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
126759348|NCT04516291|456068554|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
126759349|NCT04516291|456068547|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126685312|NCT02754726|455803312|FG000|Overall Study|Withdrawal by Subject|1|||
126685313|NCT02754726|455803312|FG000|Overall Study|Tolerability|1|||
126685314|NCT01885000|455803313|FG000|Overall Study|Adverse Event|1|||
126685315|NCT01885000|455803314|FG001|Overall Study|Adverse Event|0|||
126685316|NCT01885000|455803313|FG000|Overall Study|Withdrawal by Subject|1|||
126685317|NCT01885000|455803314|FG001|Overall Study|Withdrawal by Subject|1|||
126685318|NCT01885000|455803313|FG000|Overall Study|Protocol Violation|0|||
126685319|NCT01885000|455803314|FG001|Overall Study|Protocol Violation|1|||
126685320|NCT03124784|455803315|FG000|Overall Study|Adverse Event|1|||
126685321|NCT03124784|455803315|FG000|Overall Study|Computer/Equip Malfunction|1|||
126685322|NCT01777152|455803321|FG000|Overall Study|Withdrawal by Subject|22|||
126685323|NCT01777152|455803322|FG001|Overall Study|Withdrawal by Subject|16|||
126685324|NCT01777152|455803321|FG000|Overall Study|Lost to Follow-up|3|||
126685325|NCT01777152|455803322|FG001|Overall Study|Lost to Follow-up|5|||
126685326|NCT01777152|455803321|FG000|Overall Study|Death|68|||
126685327|NCT01777152|455803322|FG001|Overall Study|Death|89|||
126685328|NCT01777152|455803321|FG000|Overall Study|Not eligible, no study drug received|1|||
126685329|NCT01777152|455803322|FG001|Overall Study|Not eligible, no study drug received|0|||
126685330|NCT01777152|455803321|FG000|Overall Study|Change of diagnosis|1|||
126685331|NCT01777152|455803322|FG001|Overall Study|Change of diagnosis|0|||
126685332|NCT02792842|455803323|FG000|Overall Study|Adverse Event|4|||
126685333|NCT02792842|455803324|FG001|Overall Study|Adverse Event|2|||
126685334|NCT02792842|455803325|FG002|Overall Study|Adverse Event|3|||
126685335|NCT02792842|455803323|FG000|Overall Study|Withdrawal by Subject|0|||
126685336|NCT02792842|455803324|FG001|Overall Study|Withdrawal by Subject|1|||
126685337|NCT02792842|455803325|FG002|Overall Study|Withdrawal by Subject|2|||
126685338|NCT02792842|455803323|FG000|Overall Study|Lost to Follow-up|0|||
126437677|NCT00551642|454903050|FG000|Treatment Period|Physician Decision|0|||
126437678|NCT00551642|454903051|FG001|Treatment Period|Physician Decision|1|||
126437679|NCT00551642|454903050|FG000|Treatment Period|Death|33|||
126437680|NCT00551642|454903051|FG001|Treatment Period|Death|31|||
126685339|NCT02792842|455803324|FG001|Overall Study|Lost to Follow-up|0|||
126437681|NCT00551642|454903050|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
126685340|NCT02792842|455803325|FG002|Overall Study|Lost to Follow-up|1|||
126437682|NCT00551642|454903051|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
126685341|NCT02792842|455803323|FG000|Overall Study|Schedule delay|0|||
126685342|NCT02792842|455803324|FG001|Overall Study|Schedule delay|1|||
126685343|NCT02792842|455803325|FG002|Overall Study|Schedule delay|1|||
126685344|NCT01415752|455803330|FG000|Induction (Step 1)|Ineligible|4|||
126685345|NCT01415752|455803331|FG001|Induction (Step 1)|Ineligible|3|||
126685346|NCT01415752|455803332|FG002|Induction (Step 1)|Ineligible|4|||
126685347|NCT01415752|455803333|FG003|Induction (Step 1)|Ineligible|4|||
126685348|NCT01415752|455803330|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
126685349|NCT01415752|455803331|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
126685350|NCT01415752|455803332|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
126685351|NCT01415752|455803333|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
126685352|NCT01415752|455803330|FG000|Maintenance (Step 2)|Adverse Event|3|||
126685353|NCT01415752|455803331|FG001|Maintenance (Step 2)|Adverse Event|4|||
126685354|NCT01415752|455803332|FG002|Maintenance (Step 2)|Adverse Event|9|||
126685355|NCT01415752|455803333|FG003|Maintenance (Step 2)|Adverse Event|6|||
126685356|NCT01415752|455803330|FG000|Maintenance (Step 2)|Death|1|||
126685357|NCT01415752|455803331|FG001|Maintenance (Step 2)|Death|1|||
126685358|NCT01415752|455803332|FG002|Maintenance (Step 2)|Death|2|||
126437683|NCT00551642|454903050|FG000|Treatment Period|Adverse Event|15|||
126437684|NCT00551642|454903051|FG001|Treatment Period|Adverse Event|12|||
126437685|NCT00551642|454903050|FG000|Treatment Period|Withdrawal by Subject|2|||
126437686|NCT00551642|454903051|FG001|Treatment Period|Withdrawal by Subject|1|||
126437687|NCT00474812|454903055|FG000|Overall Study|Withdrawal by Subject|5|||
126437688|NCT00474812|454903055|FG000|Overall Study|No Initiation of treatment|2|||
126437689|NCT03955146|454903058|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
126437690|NCT03955146|454903059|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
126437691|NCT03955146|454903060|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
126437692|NCT03955146|454903061|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
126437693|NCT03955146|454903058|FG000|DB Period (48 Weeks)|Adverse Event|2|||
126437694|NCT03955146|454903059|FG001|DB Period (48 Weeks)|Adverse Event|5|||
126437695|NCT03955146|454903060|FG002|DB Period (48 Weeks)|Adverse Event|1|||
126437696|NCT03955146|454903061|FG003|DB Period (48 Weeks)|Adverse Event|2|||
126437697|NCT03955146|454903058|FG000|DB Period (48 Weeks)|Death|13|||
126437698|NCT03955146|454903059|FG001|DB Period (48 Weeks)|Death|17|||
126437699|NCT03955146|454903060|FG002|DB Period (48 Weeks)|Death|1|||
126437700|NCT03955146|454903061|FG003|DB Period (48 Weeks)|Death|0|||
126437701|NCT03955146|454903058|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
126437702|NCT03955146|454903059|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
126437703|NCT03955146|454903060|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
126437704|NCT03955146|454903061|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
126437705|NCT03955146|454903058|FG000|DB Period (48 Weeks)|Disease Progression|2|||
126437706|NCT03955146|454903059|FG001|DB Period (48 Weeks)|Disease Progression|0|||
126437707|NCT03955146|454903060|FG002|DB Period (48 Weeks)|Disease Progression|0|||
126437708|NCT03955146|454903061|FG003|DB Period (48 Weeks)|Disease Progression|0|||
126437709|NCT03955146|454903058|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
126437710|NCT03955146|454903059|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
126437711|NCT03955146|454903060|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
126437712|NCT03955146|454903061|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
126437713|NCT03955146|454903058|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
126437714|NCT03955146|454903059|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
126437715|NCT03955146|454903060|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
126437716|NCT03955146|454903061|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
126437717|NCT03955146|454903058|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
126437718|NCT03955146|454903059|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
126437719|NCT03955146|454903060|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
126437720|NCT03955146|454903061|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
126685359|NCT01415752|455803333|FG003|Maintenance (Step 2)|Death|0|||
126685360|NCT01415752|455803330|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
126437721|NCT03955146|454903058|FG000|DB Period (48 Weeks)|Participant Decision|9|||
126437722|NCT03955146|454903059|FG001|DB Period (48 Weeks)|Participant Decision|12|||
126437723|NCT03955146|454903060|FG002|DB Period (48 Weeks)|Participant Decision|1|||
126437724|NCT03955146|454903061|FG003|DB Period (48 Weeks)|Participant Decision|1|||
126685361|NCT01415752|455803331|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
126685362|NCT01415752|455803332|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
126685363|NCT01415752|455803333|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
126685364|NCT01415752|455803330|FG000|Maintenance (Step 2)|Alternative therapy|0|||
126685365|NCT01415752|455803331|FG001|Maintenance (Step 2)|Alternative therapy|1|||
126685366|NCT01415752|455803332|FG002|Maintenance (Step 2)|Alternative therapy|0|||
126685367|NCT01415752|455803333|FG003|Maintenance (Step 2)|Alternative therapy|0|||
126685368|NCT01415752|455803330|FG000|Maintenance (Step 2)|Other reasons|3|||
126685369|NCT01415752|455803331|FG001|Maintenance (Step 2)|Other reasons|6|||
126685370|NCT01415752|455803332|FG002|Maintenance (Step 2)|Other reasons|4|||
126685371|NCT01415752|455803333|FG003|Maintenance (Step 2)|Other reasons|6|||
126685372|NCT01415752|455803330|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
126685373|NCT01415752|455803331|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
126685374|NCT01415752|455803332|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
126685375|NCT01415752|455803333|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
126685376|NCT01415752|455803330|FG000|Maintenance (Step 2)|ineligible|1|||
126685377|NCT01415752|455803331|FG001|Maintenance (Step 2)|ineligible|1|||
126685378|NCT01415752|455803332|FG002|Maintenance (Step 2)|ineligible|1|||
126685379|NCT01415752|455803333|FG003|Maintenance (Step 2)|ineligible|0|||
126685380|NCT01415752|455803330|FG000|Maintenance (Step 2)|Missing|4|||
126685381|NCT01415752|455803331|FG001|Maintenance (Step 2)|Missing|1|||
126685382|NCT01415752|455803332|FG002|Maintenance (Step 2)|Missing|4|||
126685383|NCT01415752|455803333|FG003|Maintenance (Step 2)|Missing|3|||
126685384|NCT00252057|455803336|FG000|Overall Study|Withdrawal by Subject|2|||
126685385|NCT00252057|455803337|FG001|Overall Study|Withdrawal by Subject|5|||
126685386|NCT00252057|455803336|FG000|Overall Study|Death|1|||
126685387|NCT00252057|455803337|FG001|Overall Study|Death|2|||
126685388|NCT00252057|455803336|FG000|Overall Study|Participant previously enrolled|0|||
126685389|NCT00252057|455803337|FG001|Overall Study|Participant previously enrolled|1|||
126685390|NCT01098071|455803343|FG000|Overall Study|Surgery (adenoidectomy)|2|||
126685391|NCT01098071|455803343|FG000|Overall Study|Lost to Follow-up|13|||
126685392|NCT01903837|455803346|FG000|Part A|Withdrawal by Subject|4|||
126685393|NCT01903837|455803347|FG001|Part A|Withdrawal by Subject|9|||
126685394|NCT01903837|455803348|FG002|Part A|Withdrawal by Subject|8|||
126685395|NCT01903837|455803349|FG003|Part A|Withdrawal by Subject|5|||
126685396|NCT01903837|455803346|FG000|Part A|Adverse Event|3|||
126685397|NCT01903837|455803347|FG001|Part A|Adverse Event|6|||
126685398|NCT01903837|455803348|FG002|Part A|Adverse Event|9|||
126685399|NCT01903837|455803349|FG003|Part A|Adverse Event|6|||
126685400|NCT01903837|455803346|FG000|Part A|Lost to Follow-up|9|||
126685401|NCT01903837|455803347|FG001|Part A|Lost to Follow-up|7|||
126685402|NCT01903837|455803348|FG002|Part A|Lost to Follow-up|7|||
126685403|NCT01903837|455803349|FG003|Part A|Lost to Follow-up|2|||
126685404|NCT01903837|455803346|FG000|Part A|Non-compliance with study drug|1|||
126685405|NCT01903837|455803347|FG001|Part A|Non-compliance with study drug|4|||
126685406|NCT01903837|455803348|FG002|Part A|Non-compliance with study drug|4|||
126685407|NCT01903837|455803349|FG003|Part A|Non-compliance with study drug|0|||
126685408|NCT01903837|455803346|FG000|Part A|Physician Decision|1|||
126685409|NCT01903837|455803347|FG001|Part A|Physician Decision|1|||
126685410|NCT01903837|455803348|FG002|Part A|Physician Decision|0|||
126685411|NCT01903837|455803349|FG003|Part A|Physician Decision|0|||
126685412|NCT01903837|455803346|FG000|Part A|Protocol Violation|1|||
126685413|NCT01903837|455803347|FG001|Part A|Protocol Violation|1|||
126685414|NCT01903837|455803348|FG002|Part A|Protocol Violation|0|||
126685415|NCT01903837|455803349|FG003|Part A|Protocol Violation|0|||
126685416|NCT01903837|455803346|FG000|Part B|Lost to Follow-up|0|||
126685417|NCT01903837|455803347|FG001|Part B|Lost to Follow-up|3|||
126685418|NCT01903837|455803348|FG002|Part B|Lost to Follow-up|3|||
126759350|NCT04516291|456068548|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126759351|NCT04516291|456068549|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126685419|NCT01903837|455803349|FG003|Part B|Lost to Follow-up|4|||
126685420|NCT01903837|455803346|FG000|Part B|Withdrawal by Subject|1|||
126685421|NCT01903837|455803347|FG001|Part B|Withdrawal by Subject|2|||
126685422|NCT01903837|455803348|FG002|Part B|Withdrawal by Subject|0|||
126685423|NCT01903837|455803349|FG003|Part B|Withdrawal by Subject|3|||
126685424|NCT01903837|455803346|FG000|Part B|Adverse Event|3|||
126685425|NCT01903837|455803347|FG001|Part B|Adverse Event|0|||
126685426|NCT01903837|455803348|FG002|Part B|Adverse Event|2|||
126685427|NCT01903837|455803349|FG003|Part B|Adverse Event|0|||
126685428|NCT01903837|455803346|FG000|Part B|Non-compliance with study drug|2|||
126685429|NCT01903837|455803347|FG001|Part B|Non-compliance with study drug|0|||
126685430|NCT01903837|455803348|FG002|Part B|Non-compliance with study drug|0|||
126685431|NCT01903837|455803349|FG003|Part B|Non-compliance with study drug|1|||
126685432|NCT01903837|455803346|FG000|Part B|Incarceration|2|||
126685433|NCT01903837|455803347|FG001|Part B|Incarceration|0|||
126685434|NCT01903837|455803348|FG002|Part B|Incarceration|0|||
126685435|NCT01903837|455803349|FG003|Part B|Incarceration|1|||
126685436|NCT01903837|455803346|FG000|Part B|Physician Decision|1|||
126685437|NCT01903837|455803347|FG001|Part B|Physician Decision|0|||
126685438|NCT01903837|455803348|FG002|Part B|Physician Decision|0|||
126685439|NCT01903837|455803349|FG003|Part B|Physician Decision|2|||
126685440|NCT01903837|455803346|FG000|Part B|Lack of Efficacy|0|||
126685441|NCT01903837|455803347|FG001|Part B|Lack of Efficacy|1|||
126685442|NCT01903837|455803348|FG002|Part B|Lack of Efficacy|0|||
126685443|NCT01903837|455803349|FG003|Part B|Lack of Efficacy|0|||
126685444|NCT04372927|455803351|FG000|Overall Study|Death|1|||
126685445|NCT01081795|455803352|FG000|Overall Study|Adverse Event|18|||
126685446|NCT01081795|455803353|FG001|Overall Study|Adverse Event|23|||
126685447|NCT01081795|455803354|FG002|Overall Study|Adverse Event|6|||
126685448|NCT01081795|455803352|FG000|Overall Study|Lack of Efficacy|7|||
126685449|NCT01081795|455803353|FG001|Overall Study|Lack of Efficacy|5|||
126685450|NCT01081795|455803354|FG002|Overall Study|Lack of Efficacy|19|||
126685451|NCT01081795|455803352|FG000|Overall Study|Subject's schedule|1|||
126685452|NCT01081795|455803353|FG001|Overall Study|Subject's schedule|1|||
126685453|NCT01081795|455803354|FG002|Overall Study|Subject's schedule|2|||
126685454|NCT01081795|455803352|FG000|Overall Study|Revocation of informed consent|2|||
126685455|NCT01081795|455803353|FG001|Overall Study|Revocation of informed consent|0|||
126685456|NCT01081795|455803354|FG002|Overall Study|Revocation of informed consent|0|||
126685457|NCT01081795|455803352|FG000|Overall Study|Ineligible for participation|1|||
126685458|NCT01081795|455803353|FG001|Overall Study|Ineligible for participation|0|||
126685459|NCT01081795|455803354|FG002|Overall Study|Ineligible for participation|0|||
126685460|NCT01081795|455803352|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
126685461|NCT01081795|455803353|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
126685462|NCT01081795|455803354|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
126685463|NCT01081795|455803352|FG000|Overall Study|Using drug with restricted days of use|2|||
126685464|NCT01081795|455803353|FG001|Overall Study|Using drug with restricted days of use|3|||
126685465|NCT01081795|455803354|FG002|Overall Study|Using drug with restricted days of use|2|||
126685466|NCT01081795|455803352|FG000|Overall Study|Other|1|||
126685467|NCT01081795|455803353|FG001|Overall Study|Other|2|||
126685468|NCT01081795|455803354|FG002|Overall Study|Other|0|||
126685469|NCT03847610|455803356|FG000|Overall Study|Withdrawal by Subject|1|||
126685470|NCT01445769|455803357|FG000|Overall Study|Consent Withdrawn|2|||
126685471|NCT01445769|455803357|FG000|Overall Study|Disease Progression|1|||
126685472|NCT01445769|455803357|FG000|Overall Study|Lost to Follow-up|5|||
126685473|NCT01967537|455803363|FG000|Overall Study|Withdrawal by Subject|52|||
126685474|NCT01967537|455803363|FG000|Overall Study|Refuse treatment|2|||
126685475|NCT01967537|455803363|FG000|Overall Study|Lost to Follow-up|6|||
126685476|NCT05130463|455803364|FG000|Overall Study|Unspecified reasons|2|||
126685477|NCT05130463|455803364|FG000|Overall Study|off-label indication dose|435|||
126685478|NCT03461757|455803365|FG000|Overall Study|Adverse Event|1|||
126685479|NCT03461757|455803366|FG001|Overall Study|Adverse Event|0|||
126685480|NCT03461757|455803365|FG000|Overall Study|Lost to Follow-up|13|||
126685481|NCT03461757|455803366|FG001|Overall Study|Lost to Follow-up|7|||
126685482|NCT03461757|455803365|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
126685483|NCT03461757|455803366|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
126685484|NCT03461757|455803365|FG000|Overall Study|Non-compliance with study treatment|0|||
126685485|NCT03461757|455803366|FG001|Overall Study|Non-compliance with study treatment|1|||
126685486|NCT03461757|455803365|FG000|Overall Study|Pregnancy|2|||
126685487|NCT03461757|455803366|FG001|Overall Study|Pregnancy|0|||
126685488|NCT03461757|455803365|FG000|Overall Study|Protocol Violation|1|||
126685489|NCT03461757|455803366|FG001|Overall Study|Protocol Violation|1|||
126685490|NCT03461757|455803365|FG000|Overall Study|Withdrawal by Subject|7|||
126759352|NCT04516291|456068550|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126759353|NCT04516291|456068551|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126759354|NCT04516291|456068552|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126685491|NCT03461757|455803366|FG001|Overall Study|Withdrawal by Subject|7|||
126685492|NCT03461757|455803365|FG000|Overall Study|Other Reasons|1|||
126685493|NCT03461757|455803366|FG001|Overall Study|Other Reasons|4|||
126685494|NCT03652662|455803367|FG000|Overall Study|Withdrawal by Subject|2|||
126685495|NCT03652662|455803368|FG001|Overall Study|Withdrawal by Subject|1|||
126685496|NCT03652662|455803367|FG000|Overall Study|Lost to Follow-up|1|||
126685497|NCT03652662|455803368|FG001|Overall Study|Lost to Follow-up|0|||
126685498|NCT03861559|455803369|FG000|Overall Study|Adverse Event|0|||
126685499|NCT03861559|455803370|FG001|Overall Study|Adverse Event|2|||
126685500|NCT03861559|455803369|FG000|Overall Study|Treatment failure|0|||
126685501|NCT03861559|455803370|FG001|Overall Study|Treatment failure|2|||
126685502|NCT03861559|455803369|FG000|Overall Study|Noncompliance|1|||
126685503|NCT03861559|455803370|FG001|Overall Study|Noncompliance|1|||
126685504|NCT03861559|455803369|FG000|Overall Study|Did not meet eligibility requirements|1|||
126685505|NCT03861559|455803370|FG001|Overall Study|Did not meet eligibility requirements|0|||
126685506|NCT03595553|455803371|FG000|Overall Study|Withdrawal by Subject|20|||
126685507|NCT03595553|455803372|FG001|Overall Study|Withdrawal by Subject|8|||
126685508|NCT03595553|455803371|FG000|Overall Study|Physician Decision|3|||
126685509|NCT03595553|455803372|FG001|Overall Study|Physician Decision|2|||
126437725|NCT03955146|454903058|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
126437726|NCT03955146|454903059|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
126437727|NCT03955146|454903060|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
126437728|NCT03955146|454903061|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
126437729|NCT03955146|454903058|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
126437730|NCT03955146|454903059|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
126437731|NCT03955146|454903060|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
126437732|NCT03955146|454903061|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
126437733|NCT03955146|454903058|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
126437734|NCT03955146|454903059|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
126685510|NCT03595553|455803371|FG000|Overall Study|Adverse Event|2|||
126685511|NCT03595553|455803372|FG001|Overall Study|Adverse Event|5|||
126685512|NCT03595553|455803371|FG000|Overall Study|Death|24|||
126685513|NCT03595553|455803372|FG001|Overall Study|Death|22|||
126437735|NCT03955146|454903060|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
126437736|NCT03955146|454903061|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
126685514|NCT03595553|455803371|FG000|Overall Study|Lost to Follow-up|6|||
126685515|NCT03595553|455803372|FG001|Overall Study|Lost to Follow-up|7|||
126685516|NCT03595553|455803371|FG000|Overall Study|Other as indicated in CSR|3|||
126685517|NCT03595553|455803372|FG001|Overall Study|Other as indicated in CSR|3|||
126685518|NCT03595553|455803371|FG000|Overall Study|Sponsor Decision|0|||
126685519|NCT03595553|455803372|FG001|Overall Study|Sponsor Decision|1|||
126685520|NCT01687712|455803373|FG000|Cycle 1|Not Biochemically Pregnant|386|||
126685521|NCT01687712|455803374|FG001|Cycle 1|Not Biochemically Pregnant|348|||
126685522|NCT01687712|455803373|FG000|Cycle 1|Early Pregnancy Loss|43|||
126685523|NCT01687712|455803374|FG001|Cycle 1|Early Pregnancy Loss|60|||
126685524|NCT01687712|455803373|FG000|Cycle 1|Ectopic Pregnancy|5|||
126685525|NCT01687712|455803374|FG001|Cycle 1|Ectopic Pregnancy|5|||
126685526|NCT01687712|455803373|FG000|Cycle 1|Heterotropic Pregnancy|1|||
126685527|NCT01687712|455803374|FG001|Cycle 1|Heterotropic Pregnancy|0|||
126685528|NCT01687712|455803373|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
126685529|NCT01687712|455803374|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
126685530|NCT01687712|455803373|FG000|Cycle 1|Abortion|3|||
126685531|NCT01687712|455803374|FG001|Cycle 1|Abortion|0|||
126685532|NCT01687712|455803373|FG000|Cycle 1|Intrauterine Fetal Death|0|||
126685533|NCT01687712|455803374|FG001|Cycle 1|Intrauterine Fetal Death|1|||
126685534|NCT01687712|455803373|FG000|Cycle 1|Lost to Follow-up|1|||
126685535|NCT01687712|455803374|FG001|Cycle 1|Lost to Follow-up|1|||
126685536|NCT01687712|455803373|FG000|Cycle 2|Not Biochemically Pregnant|74|||
126685537|NCT01687712|455803374|FG001|Cycle 2|Not Biochemically Pregnant|77|||
126685538|NCT01687712|455803373|FG000|Cycle 2|Early Pregnancy Loss|18|||
126685539|NCT01687712|455803374|FG001|Cycle 2|Early Pregnancy Loss|16|||
126685540|NCT01687712|455803373|FG000|Cycle 2|Ectopic Pregnancy|0|||
126685541|NCT01687712|455803374|FG001|Cycle 2|Ectopic Pregnancy|1|||
126685542|NCT01687712|455803373|FG000|Cycle 2|Still Birth|1|||
126685543|NCT01687712|455803374|FG001|Cycle 2|Still Birth|0|||
126685544|NCT01687712|455803373|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
126685545|NCT01687712|455803374|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
126685546|NCT01687712|455803373|FG000|Cycle 3|Not Biochemically Pregnant|21|||
126685547|NCT01687712|455803374|FG001|Cycle 3|Not Biochemically Pregnant|22|||
126685548|NCT01687712|455803373|FG000|Cycle 3|Early Pregnancy Loss|1|||
126685549|NCT01687712|455803374|FG001|Cycle 3|Early Pregnancy Loss|2|||
126685550|NCT01687712|455803373|FG000|Cycle 3|Ectopic Pregnancy|1|||
126685551|NCT01687712|455803374|FG001|Cycle 3|Ectopic Pregnancy|0|||
126685552|NCT01687712|455803373|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
126685553|NCT01687712|455803374|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
126685554|NCT01035905|455803375|FG000|Overall Study|Lack of Efficacy|1|||
126685555|NCT01035905|455803376|FG001|Overall Study|Lack of Efficacy|1|||
126685556|NCT00861744|455803377|FG000|Overall Study|Adverse Event|0|||
126685557|NCT00861744|455803378|FG001|Overall Study|Adverse Event|0|||
126685558|NCT00861744|455803379|FG002|Overall Study|Adverse Event|0|||
126685559|NCT00861744|455803380|FG003|Overall Study|Adverse Event|1|||
126685560|NCT00861744|455803377|FG000|Overall Study|Lost to Follow-up|7|||
126685561|NCT00861744|455803378|FG001|Overall Study|Lost to Follow-up|19|||
126685562|NCT00861744|455803379|FG002|Overall Study|Lost to Follow-up|17|||
126685563|NCT00861744|455803380|FG003|Overall Study|Lost to Follow-up|12|||
126685564|NCT00861744|455803377|FG000|Overall Study|Withdrawal by Subject|10|||
126685565|NCT00861744|455803378|FG001|Overall Study|Withdrawal by Subject|6|||
126685566|NCT00861744|455803379|FG002|Overall Study|Withdrawal by Subject|6|||
126685567|NCT00861744|455803380|FG003|Overall Study|Withdrawal by Subject|19|||
126685568|NCT00861744|455803377|FG000|Overall Study|Protocol Violation|0|||
126685569|NCT00861744|455803378|FG001|Overall Study|Protocol Violation|1|||
126685570|NCT00861744|455803379|FG002|Overall Study|Protocol Violation|0|||
126685571|NCT00861744|455803380|FG003|Overall Study|Protocol Violation|0|||
126685572|NCT00861744|455803377|FG000|Overall Study|Migration from study area|0|||
126685573|NCT00861744|455803378|FG001|Overall Study|Migration from study area|3|||
126685574|NCT00861744|455803379|FG002|Overall Study|Migration from study area|1|||
126685575|NCT00861744|455803380|FG003|Overall Study|Migration from study area|0|||
126685576|NCT00861744|455803377|FG000|Overall Study|Blood draws|0|||
126685577|NCT00861744|455803378|FG001|Overall Study|Blood draws|0|||
126685578|NCT00861744|455803379|FG002|Overall Study|Blood draws|0|||
126685579|NCT00861744|455803380|FG003|Overall Study|Blood draws|1|||
126685580|NCT05107765|455803381|FG000|Overall Study|Lost to Follow-up|4|||
126685581|NCT05107765|455803382|FG001|Overall Study|Lost to Follow-up|1|||
126685582|NCT05107765|455803381|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
126685583|NCT05107765|455803382|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
126685584|NCT05107765|455803381|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
126685585|NCT05107765|455803382|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
126685586|NCT03809611|455803383|FG000|Overall Study|Withdrawal by Subject|1|||
126685587|NCT03809611|455803384|FG001|Overall Study|Withdrawal by Subject|1|||
126685588|NCT02926950|455803385|FG000|Overall Study|Adverse Event|4|||
126685589|NCT02926950|455803386|FG001|Overall Study|Adverse Event|6|||
126685590|NCT02926950|455803385|FG000|Overall Study|At the participant's own request|21|||
126685591|NCT02926950|455803386|FG001|Overall Study|At the participant's own request|25|||
126437737|NCT03955146|454903058|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
126437738|NCT03955146|454903059|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
126437739|NCT03955146|454903060|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
126437740|NCT03955146|454903061|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
126437741|NCT03955146|454903058|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
126437742|NCT03955146|454903059|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
126685592|NCT02926950|455803385|FG000|Overall Study|Reason not Specified|17|||
126685593|NCT02926950|455803386|FG001|Overall Study|Reason not Specified|9|||
126685594|NCT02926950|455803385|FG000|Overall Study|Lost to Follow-up|7|||
126437743|NCT03955146|454903060|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
126437744|NCT03955146|454903061|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
126437745|NCT03955146|454903058|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
126437746|NCT03955146|454903059|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
126437747|NCT03955146|454903060|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
126437748|NCT03955146|454903061|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
126437749|NCT03955146|454903058|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
126437750|NCT03955146|454903059|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
126437751|NCT03955146|454903060|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
126437752|NCT03955146|454903061|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
126437753|NCT03955146|454903058|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
126437754|NCT03955146|454903059|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
126437755|NCT03955146|454903060|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
126437756|NCT03955146|454903061|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
126437757|NCT03955146|454903058|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
126437758|NCT03955146|454903059|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
126437759|NCT03955146|454903060|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
126437760|NCT03955146|454903061|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
126437761|NCT03955146|454903058|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
126437762|NCT03955146|454903059|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
126437763|NCT03955146|454903060|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
126437764|NCT03955146|454903061|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
126437765|NCT03955146|454903058|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
126437766|NCT03955146|454903059|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
126437767|NCT03955146|454903060|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
126437768|NCT03955146|454903061|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
126437769|NCT04363320|454903064|FG000|Overall Study|Lost to Follow-up|43|||
126437770|NCT04363320|454903065|FG001|Overall Study|Lost to Follow-up|42|||
126437771|NCT04363320|454903066|FG002|Overall Study|Lost to Follow-up|24|||
126437772|NCT04363320|454903067|FG003|Overall Study|Lost to Follow-up|29|||
126437773|NCT04363320|454903064|FG000|Overall Study|Death|0|||
126437774|NCT04363320|454903065|FG001|Overall Study|Death|0|||
126437775|NCT04363320|454903066|FG002|Overall Study|Death|1|||
126437776|NCT04363320|454903067|FG003|Overall Study|Death|0|||
126437777|NCT02002598|454903068|FG000|Dose Level 1|Withdrawal by Subject|1|||
126437778|NCT02002598|454903069|FG001|Dose Level 1|Withdrawal by Subject|0|||
126437779|NCT02002598|454903070|FG002|Dose Level 1|Withdrawal by Subject|0|||
126437780|NCT02002598|454903071|FG003|Dose Level 1|Withdrawal by Subject|0|||
126437781|NCT02002598|454903072|FG004|Dose Level 1|Withdrawal by Subject|0|||
126437782|NCT05632211|454903073|FG000|Overall Study|Withdrawal by Subject|2|||
126437783|NCT05632211|454903074|FG001|Overall Study|Withdrawal by Subject|0|||
126437784|NCT05632211|454903075|FG002|Overall Study|Withdrawal by Subject|2|||
126437785|NCT05632211|454903073|FG000|Overall Study|Other reasons|1|||
126437786|NCT05632211|454903074|FG001|Overall Study|Other reasons|1|||
126437787|NCT05632211|454903075|FG002|Overall Study|Other reasons|1|||
126437788|NCT02628873|454903076|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
126437789|NCT02628873|454903077|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
126437790|NCT02628873|454903076|FG000|Second Test (1 Hour)|Physician Decision|1|||
126437791|NCT02628873|454903077|FG001|Second Test (1 Hour)|Physician Decision|0|||
126437792|NCT00541658|454903078|FG000|Overall Study|Adverse Event|28|||
126437793|NCT00541658|454903079|FG001|Overall Study|Adverse Event|37|||
126437794|NCT00541658|454903080|FG002|Overall Study|Adverse Event|25|||
126437795|NCT00541658|454903078|FG000|Overall Study|Physician Decision|0|||
126437796|NCT00541658|454903079|FG001|Overall Study|Physician Decision|0|||
126437797|NCT00541658|454903080|FG002|Overall Study|Physician Decision|4|||
126437798|NCT00541658|454903078|FG000|Overall Study|Lost to Follow-up|3|||
126437799|NCT00541658|454903079|FG001|Overall Study|Lost to Follow-up|3|||
126437800|NCT00541658|454903080|FG002|Overall Study|Lost to Follow-up|6|||
126437801|NCT00541658|454903078|FG000|Overall Study|Protocol Violation|0|||
126437802|NCT00541658|454903079|FG001|Overall Study|Protocol Violation|1|||
126437803|NCT00541658|454903080|FG002|Overall Study|Protocol Violation|1|||
126437804|NCT00541658|454903078|FG000|Overall Study|Withdrawal by Subject|28|||
126685595|NCT02926950|455803386|FG001|Overall Study|Lost to Follow-up|8|||
126437805|NCT00541658|454903079|FG001|Overall Study|Withdrawal by Subject|32|||
126437806|NCT00541658|454903080|FG002|Overall Study|Withdrawal by Subject|32|||
126437807|NCT00541658|454903078|FG000|Overall Study|Took No Study Drug|1|||
126437808|NCT00541658|454903079|FG001|Overall Study|Took No Study Drug|0|||
126685596|NCT04341948|455803387|FG000|Overall Study|Adverse Event|0|||
126685597|NCT04341948|455803388|FG001|Overall Study|Adverse Event|1|||
126685598|NCT04341948|455803387|FG000|Overall Study|Lost to Follow-up|6|||
126685599|NCT04341948|455803388|FG001|Overall Study|Lost to Follow-up|1|||
126685600|NCT04341948|455803387|FG000|Overall Study|Physician Decision|1|||
126685601|NCT04341948|455803388|FG001|Overall Study|Physician Decision|2|||
126685602|NCT04341948|455803387|FG000|Overall Study|Withdrawal by Participant|6|||
126685603|NCT04341948|455803388|FG001|Overall Study|Withdrawal by Participant|3|||
126685604|NCT04341948|455803387|FG000|Overall Study|Lack of compliance by Participant|1|||
126685605|NCT04341948|455803388|FG001|Overall Study|Lack of compliance by Participant|0|||
126685606|NCT01535729|455805032|FG000|Overall Study|Withdrawal by Subject|2|||
126685607|NCT01535729|455805032|FG000|Overall Study|Disease progression|230|||
126685608|NCT01535729|455805032|FG000|Overall Study|Discontinued treatment|25|||
126685609|NCT01535729|455805032|FG000|Overall Study|Lost to Follow-up|8|||
126685610|NCT01535729|455805032|FG000|Overall Study|Death|52|||
126685611|NCT01535729|455805032|FG000|Overall Study|Other|19|||
126759355|NCT04516291|456068553|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126759356|NCT04516291|456068554|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126759357|NCT04516291|456068547|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
126759358|NCT04516291|456068548|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
126759359|NCT04516291|456068549|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
126759360|NCT04516291|456068550|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
126759361|NCT04516291|456068551|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
126759362|NCT04516291|456068552|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
126759363|NCT04516291|456068553|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
126759364|NCT04516291|456068554|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
126759365|NCT04516291|456068547|FG000|Follow-up Period (12 Weeks)|Other|0|||
126759366|NCT04516291|456068548|FG001|Follow-up Period (12 Weeks)|Other|1|||
126759367|NCT04516291|456068549|FG002|Follow-up Period (12 Weeks)|Other|0|||
126759368|NCT04516291|456068550|FG003|Follow-up Period (12 Weeks)|Other|2|||
126759369|NCT04516291|456068551|FG004|Follow-up Period (12 Weeks)|Other|0|||
126759370|NCT04516291|456068552|FG005|Follow-up Period (12 Weeks)|Other|0|||
126759371|NCT04516291|456068553|FG006|Follow-up Period (12 Weeks)|Other|0|||
126759372|NCT04516291|456068554|FG007|Follow-up Period (12 Weeks)|Other|0|||
126759373|NCT04516291|456068547|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126759374|NCT04516291|456068548|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126759375|NCT04516291|456068549|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126759376|NCT04516291|456068550|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126759377|NCT04516291|456068551|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
126759378|NCT04516291|456068552|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126759379|NCT04516291|456068553|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126759380|NCT04516291|456068554|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126759381|NCT04516291|456068547|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
126759382|NCT04516291|456068548|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
126759383|NCT04516291|456068549|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
126759384|NCT04516291|456068550|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
126759385|NCT04516291|456068551|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
126759386|NCT04516291|456068552|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
126759387|NCT04516291|456068553|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
126759388|NCT04516291|456068554|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
126759389|NCT00649220|456068555|FG000|Overall Study|Adverse Event|2|||
126759390|NCT00649220|456068555|FG000|Overall Study|Withdrawal by Subject|1|||
126759391|NCT02557308|456068556|FG000|Overall Study|Withdrawal by Subject|11|||
126685612|NCT01535729|455805032|FG000|Overall Study|Did not sign informed consent|1|||
126685613|NCT01535729|455805032|FG000|Overall Study|No previous chemotherapy|33|||
126685614|NCT01535729|455805032|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
126685615|NCT01535729|455805032|FG000|Overall Study|Protocol Violation|11|||
126685616|NCT01535729|455805032|FG000|Overall Study|Screening failure|1|||
126685617|NCT01535729|455805032|FG000|Overall Study|Not treated|9|||
126685618|NCT01535729|455805032|FG000|Overall Study|No participant record available|5|||
126685619|NCT02787850|455805033|FG000|Overall Study|Withdrawal by Subject|0|||
126685620|NCT02787850|455805034|FG001|Overall Study|Withdrawal by Subject|1|||
126685621|NCT02921971|455805037|FG000|Overall Study|Adverse Event|1|||
126685622|NCT02921971|455805038|FG001|Overall Study|Adverse Event|2|||
126685623|NCT02921971|455805037|FG000|Overall Study|Lack of Efficacy|3|||
126685624|NCT02921971|455805038|FG001|Overall Study|Lack of Efficacy|1|||
126685625|NCT02921971|455805037|FG000|Overall Study|Other than specified above|2|||
126685626|NCT02921971|455805038|FG001|Overall Study|Other than specified above|1|||
126685627|NCT02322710|455805039|FG000|Overall Study|No efficacy assessment post-baseline|0|||
126685628|NCT02322710|455805040|FG001|Overall Study|No efficacy assessment post-baseline|1|||
126685629|NCT02322710|455805039|FG000|Overall Study|Protocol Violation|20|||
126685630|NCT02322710|455805040|FG001|Overall Study|Protocol Violation|25|||
126685631|NCT04161131|455805041|FG000|Overall Study|Ineligible|2|||
126685632|NCT04161131|455805041|FG000|Overall Study|Lost to Follow-up|4|||
126685633|NCT04316585|455805042|FG000|Overall Study|Adverse Event|2|||
126685634|NCT04316585|455805043|FG001|Overall Study|Adverse Event|1|||
126685635|NCT04316585|455805042|FG000|Overall Study|Lost to Follow-up|1|||
126685636|NCT04316585|455805043|FG001|Overall Study|Lost to Follow-up|0|||
126685637|NCT04316585|455805042|FG000|Overall Study|Withdrawal by Subject|2|||
126685638|NCT04316585|455805043|FG001|Overall Study|Withdrawal by Subject|3|||
126685639|NCT04316585|455805042|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
126685640|NCT04316585|455805043|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
126685641|NCT04316585|455805042|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
126685642|NCT04316585|455805043|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
126685643|NCT00130832|455805044|FG000|Overall Study|Adverse Event|1|||
126685644|NCT00130832|455805045|FG001|Overall Study|Adverse Event|1|||
126685645|NCT00130832|455805044|FG000|Overall Study|Lost to Follow-up|1|||
126685646|NCT00130832|455805045|FG001|Overall Study|Lost to Follow-up|2|||
126685647|NCT00130832|455805044|FG000|Overall Study|Protocol Violation|6|||
126685648|NCT00130832|455805045|FG001|Overall Study|Protocol Violation|8|||
126685649|NCT00130832|455805044|FG000|Overall Study|Withdrawal by Subject|6|||
126685650|NCT00130832|455805045|FG001|Overall Study|Withdrawal by Subject|1|||
126685651|NCT00130832|455805044|FG000|Overall Study|Moved|2|||
126685652|NCT00130832|455805045|FG001|Overall Study|Moved|2|||
126685653|NCT00130832|455805044|FG000|Overall Study|Other|0|||
126685654|NCT00130832|455805045|FG001|Overall Study|Other|3|||
126685655|NCT03905863|455805046|FG000|Overall Study|Adverse Event|2|||
126759392|NCT02557308|456068557|FG001|Overall Study|Withdrawal by Subject|3|||
126759393|NCT02557308|456068558|FG002|Overall Study|Withdrawal by Subject|2|||
126759394|NCT02557308|456068559|FG003|Overall Study|Withdrawal by Subject|0|||
126759395|NCT02557308|456068560|FG004|Overall Study|Withdrawal by Subject|1|||
126685656|NCT03905863|455805047|FG001|Overall Study|Adverse Event|4|||
126685657|NCT03905863|455805046|FG000|Overall Study|Withdrawal by Subject|2|||
126437809|NCT00541658|454903080|FG002|Overall Study|Took No Study Drug|0|||
126437810|NCT04123470|454903081|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
126437811|NCT04123470|454903082|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
126437812|NCT04123470|454903081|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
126437813|NCT04123470|454903082|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
126437814|NCT04123470|454903081|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
126685658|NCT03905863|455805047|FG001|Overall Study|Withdrawal by Subject|2|||
126685659|NCT03905863|455805046|FG000|Overall Study|Physician Decision|0|||
126685660|NCT03905863|455805047|FG001|Overall Study|Physician Decision|3|||
126685661|NCT03905863|455805046|FG000|Overall Study|Lost to Follow-up|1|||
126685662|NCT03905863|455805047|FG001|Overall Study|Lost to Follow-up|0|||
126685663|NCT03905863|455805046|FG000|Overall Study|Protocol Violation|0|||
126685664|NCT03905863|455805047|FG001|Overall Study|Protocol Violation|2|||
126685665|NCT03905863|455805046|FG000|Overall Study|Death|0|||
126685666|NCT03905863|455805047|FG001|Overall Study|Death|1|||
126685667|NCT02944448|455805049|FG000|Overall Study|Adverse Event|37|||
126685668|NCT02944448|455805050|FG001|Overall Study|Adverse Event|6|||
126685669|NCT02944448|455805049|FG000|Overall Study|Lack of Efficacy|8|||
126685670|NCT02944448|455805050|FG001|Overall Study|Lack of Efficacy|5|||
126685671|NCT02944448|455805049|FG000|Overall Study|Lost to Follow-up|3|||
126685672|NCT02944448|455805050|FG001|Overall Study|Lost to Follow-up|1|||
126685673|NCT02944448|455805049|FG000|Overall Study|Protocol Violation|25|||
126685674|NCT02944448|455805050|FG001|Overall Study|Protocol Violation|7|||
126685675|NCT02944448|455805049|FG000|Overall Study|Withdrawal by Subject|14|||
126685676|NCT02944448|455805050|FG001|Overall Study|Withdrawal by Subject|4|||
126685677|NCT02944448|455805049|FG000|Overall Study|Sponsor did not supply drug in time|0|||
126685678|NCT02944448|455805050|FG001|Overall Study|Sponsor did not supply drug in time|1|||
126685679|NCT02944448|455805049|FG000|Overall Study|Noncompliant with dosing|1|||
126685680|NCT02944448|455805050|FG001|Overall Study|Noncompliant with dosing|0|||
126685681|NCT02944448|455805049|FG000|Overall Study|Abnormal laboratory values|1|||
126685682|NCT02944448|455805050|FG001|Overall Study|Abnormal laboratory values|0|||
126685683|NCT05499559|455805053|FG000|Overall Study|Lost to Follow-up|467|||
126685684|NCT04681170|455805054|FG000|Stratified Enrolment & run-in|Death|1|||
126685685|NCT04681170|455805055|FG001|Stratified Enrolment & run-in|Death|0|||
126685686|NCT04681170|455805054|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
126685687|NCT04681170|455805055|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
126685688|NCT04681170|455805054|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
126685689|NCT04681170|455805055|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
126685690|NCT04681170|455805054|FG000|Open Label Efficacy Phase|Adverse Event|0|||
126685691|NCT04681170|455805055|FG001|Open Label Efficacy Phase|Adverse Event|2|||
126685692|NCT04681170|455805054|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
126685693|NCT04681170|455805055|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
126685694|NCT04681170|455805054|FG000|Open Label Safety Phase|AEs and none compliance|0|||
126685695|NCT04681170|455805055|FG001|Open Label Safety Phase|AEs and none compliance|1|||
126685696|NCT02118792|455805056|FG000|Overall Study|Withdrawal by Subject|6|||
126685697|NCT02118792|455805057|FG001|Overall Study|Withdrawal by Subject|3|||
126685698|NCT02118792|455805056|FG000|Overall Study|Lost to Follow-up|4|||
126685699|NCT02118792|455805057|FG001|Overall Study|Lost to Follow-up|4|||
126685700|NCT02118792|455805056|FG000|Overall Study|Adverse Event|5|||
126685701|NCT02118792|455805057|FG001|Overall Study|Adverse Event|4|||
126685702|NCT02118792|455805056|FG000|Overall Study|Withdrawal by parent/guardian|14|||
126685703|NCT02118792|455805057|FG001|Overall Study|Withdrawal by parent/guardian|20|||
126685704|NCT02118792|455805056|FG000|Overall Study|Other|1|||
126685705|NCT02118792|455805057|FG001|Overall Study|Other|6|||
126685706|NCT02118792|455805056|FG000|Overall Study|Randomised but not treated|1|||
126685707|NCT02118792|455805057|FG001|Overall Study|Randomised but not treated|0|||
126685708|NCT05131204|455805058|FG000|Overall Study|Sponsor request|2|||
126685709|NCT05131204|455805059|FG001|Overall Study|Sponsor request|1|||
126685710|NCT02787863|455805060|FG000|Overall Study|Death|1|||
126685711|NCT02787863|455805061|FG001|Overall Study|Death|0|||
126685712|NCT02787863|455805062|FG002|Overall Study|Death|1|||
126685713|NCT02787863|455805063|FG003|Overall Study|Death|0|||
126685714|NCT02787863|455805064|FG004|Overall Study|Death|0|||
126685715|NCT02787863|455805065|FG005|Overall Study|Death|0|||
126437815|NCT04123470|454903082|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
126545379|NCT02100722|455290819|FG000|Overall Study|Continuing on study|751|||
126685716|NCT02787863|455805066|FG006|Overall Study|Death|0|||
126685717|NCT02787863|455805067|FG007|Overall Study|Death|0|||
126685718|NCT02787863|455805060|FG000|Overall Study|Withdrawal by Subject|0|||
126685719|NCT02787863|455805061|FG001|Overall Study|Withdrawal by Subject|1|||
126685720|NCT02787863|455805062|FG002|Overall Study|Withdrawal by Subject|1|||
126685721|NCT02787863|455805063|FG003|Overall Study|Withdrawal by Subject|0|||
126685722|NCT02787863|455805064|FG004|Overall Study|Withdrawal by Subject|0|||
126685723|NCT02787863|455805065|FG005|Overall Study|Withdrawal by Subject|0|||
126685724|NCT02787863|455805066|FG006|Overall Study|Withdrawal by Subject|0|||
126685725|NCT02787863|455805067|FG007|Overall Study|Withdrawal by Subject|0|||
126437816|NCT04123470|454903081|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
126437817|NCT04123470|454903082|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
126437818|NCT02195518|454903083|FG000|Overall Study|Adverse Event|1|||
126437819|NCT02195518|454903083|FG000|Overall Study|Protocol Violation|4|||
126437820|NCT02195518|454903083|FG000|Overall Study|Pregnancy|2|||
126437821|NCT02195518|454903083|FG000|Overall Study|Withdrawal by Subject|1|||
126437822|NCT02195518|454903083|FG000|Overall Study|Lost to Follow-up|1|||
126437823|NCT05530252|454903084|FG000|Overall Study|Lost to Follow-up|1|||
126437824|NCT05530252|454903085|FG001|Overall Study|Lost to Follow-up|1|||
126437825|NCT05530252|454903086|FG002|Overall Study|Lost to Follow-up|1|||
126437826|NCT04482647|454903092|FG000|Overall Study|Time constraints|2|||
126437827|NCT04482647|454903092|FG000|Overall Study|Health issues|1|||
126437828|NCT04482647|454903092|FG000|Overall Study|Death in the family|1|||
126437829|NCT04482647|454903092|FG000|Overall Study|Disliked the intervention|1|||
126437830|NCT04482647|454903092|FG000|Overall Study|No reasons specified|7|||
126437831|NCT04163341|454903093|FG000|Overall Study|Withdrawal by Subject|2|||
126437832|NCT04163341|454903094|FG001|Overall Study|Withdrawal by Subject|0|||
126437833|NCT04163341|454903093|FG000|Overall Study|Lost to Follow-up|3|||
126437834|NCT04163341|454903094|FG001|Overall Study|Lost to Follow-up|4|||
126437835|NCT02484391|454903095|FG000|Overall Study|Lack of Efficacy|15|||
126437836|NCT02484391|454903096|FG001|Overall Study|Lack of Efficacy|14|||
126437837|NCT02484391|454903097|FG002|Overall Study|Lack of Efficacy|3|||
126437838|NCT02484391|454903095|FG000|Overall Study|Lost to Follow-up|0|||
126437839|NCT02484391|454903096|FG001|Overall Study|Lost to Follow-up|0|||
126437840|NCT02484391|454903097|FG002|Overall Study|Lost to Follow-up|2|||
126437841|NCT02484391|454903095|FG000|Overall Study|Physician Decision|1|||
126437842|NCT02484391|454903096|FG001|Overall Study|Physician Decision|3|||
126437843|NCT02484391|454903097|FG002|Overall Study|Physician Decision|0|||
126437844|NCT02484391|454903095|FG000|Overall Study|Went to Transplant|5|||
126437845|NCT02484391|454903096|FG001|Overall Study|Went to Transplant|3|||
126437846|NCT02484391|454903097|FG002|Overall Study|Went to Transplant|2|||
126437847|NCT00911170|454903098|FG000|Treatment Period|Randomized in error|1|||
126437848|NCT00911170|454903099|FG001|Treatment Period|Randomized in error|1|||
126437849|NCT00911170|454903098|FG000|Treatment Period|Ineligibility determined|1|||
126437850|NCT00911170|454903099|FG001|Treatment Period|Ineligibility determined|3|||
126437851|NCT00911170|454903098|FG000|Treatment Period|Protocol deviation|1|||
126437852|NCT00911170|454903099|FG001|Treatment Period|Protocol deviation|2|||
126437853|NCT00911170|454903098|FG000|Treatment Period|Adverse Event|9|||
126437854|NCT00911170|454903099|FG001|Treatment Period|Adverse Event|10|||
126437855|NCT00911170|454903098|FG000|Treatment Period|Withdrawal by Subject|4|||
126437856|NCT00911170|454903099|FG001|Treatment Period|Withdrawal by Subject|4|||
126437857|NCT00911170|454903098|FG000|Treatment Period|Disease progression|0|||
126437858|NCT00911170|454903099|FG001|Treatment Period|Disease progression|2|||
126437859|NCT00911170|454903098|FG000|Treatment Period|Physician Decision|5|||
126437860|NCT00911170|454903099|FG001|Treatment Period|Physician Decision|5|||
126437861|NCT00911170|454903098|FG000|Treatment Period|Lost to Follow-up|0|||
126437862|NCT00911170|454903099|FG001|Treatment Period|Lost to Follow-up|1|||
126437863|NCT00911170|454903098|FG000|Treatment Period|Death|6|||
126437864|NCT00911170|454903099|FG001|Treatment Period|Death|9|||
126437865|NCT00911170|454903098|FG000|Long Term Follow-Up|Continuing in study|274|||
126545380|NCT02100722|455290820|FG001|Overall Study|Continuing on study|729|||
126759396|NCT02557308|456068561|FG005|Overall Study|Withdrawal by Subject|0|||
126759397|NCT02557308|456068562|FG006|Overall Study|Withdrawal by Subject|10|||
126759398|NCT02557308|456068563|FG007|Overall Study|Withdrawal by Subject|1|||
126759399|NCT02557308|456068556|FG000|Overall Study|Disease Progression|0|||
126759400|NCT02557308|456068557|FG001|Overall Study|Disease Progression|1|||
126759401|NCT02557308|456068558|FG002|Overall Study|Disease Progression|0|||
126759402|NCT02557308|456068559|FG003|Overall Study|Disease Progression|0|||
126759403|NCT02557308|456068560|FG004|Overall Study|Disease Progression|0|||
126759404|NCT02557308|456068561|FG005|Overall Study|Disease Progression|0|||
126759405|NCT02557308|456068562|FG006|Overall Study|Disease Progression|0|||
126759406|NCT02557308|456068563|FG007|Overall Study|Disease Progression|0|||
126759407|NCT02557308|456068556|FG000|Overall Study|Lack of Efficacy|3|||
126759408|NCT02557308|456068557|FG001|Overall Study|Lack of Efficacy|0|||
126759409|NCT02557308|456068558|FG002|Overall Study|Lack of Efficacy|0|||
126759410|NCT02557308|456068559|FG003|Overall Study|Lack of Efficacy|0|||
126759411|NCT02557308|456068560|FG004|Overall Study|Lack of Efficacy|0|||
126759412|NCT02557308|456068561|FG005|Overall Study|Lack of Efficacy|0|||
126759413|NCT02557308|456068562|FG006|Overall Study|Lack of Efficacy|1|||
126759414|NCT02557308|456068563|FG007|Overall Study|Lack of Efficacy|0|||
126759415|NCT02557308|456068556|FG000|Overall Study|Adverse Event|4|||
126759416|NCT02557308|456068557|FG001|Overall Study|Adverse Event|1|||
126759417|NCT02557308|456068558|FG002|Overall Study|Adverse Event|2|||
126759418|NCT02557308|456068559|FG003|Overall Study|Adverse Event|0|||
126759419|NCT02557308|456068560|FG004|Overall Study|Adverse Event|0|||
126759420|NCT02557308|456068561|FG005|Overall Study|Adverse Event|0|||
126437866|NCT00911170|454903099|FG001|Long Term Follow-Up|Continuing in study|269|||
126437867|NCT00911170|454903098|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
126437868|NCT00911170|454903099|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
126437869|NCT00911170|454903098|FG000|Long Term Follow-Up|Physician Decision|5|||
126437870|NCT00911170|454903099|FG001|Long Term Follow-Up|Physician Decision|4|||
126437871|NCT00911170|454903098|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
126437872|NCT00911170|454903099|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
126437873|NCT00911170|454903098|FG000|Long Term Follow-Up|Death|116|||
126437874|NCT00911170|454903099|FG001|Long Term Follow-Up|Death|121|||
126437875|NCT00905164|454903100|FG000|Period 1|Protocol Violation|0|||
126437876|NCT00905164|454903101|FG001|Period 1|Protocol Violation|1|||
126437877|NCT01389596|454905061|FG000|Overall Study|Protocol Violation|3|||
126437878|NCT01389596|454905062|FG001|Overall Study|Protocol Violation|4|||
126437879|NCT01389596|454905063|FG002|Overall Study|Protocol Violation|3|||
126437880|NCT01389596|454905061|FG000|Overall Study|Withdrawal by Subject|1|||
126437881|NCT01389596|454905062|FG001|Overall Study|Withdrawal by Subject|2|||
126437882|NCT01389596|454905063|FG002|Overall Study|Withdrawal by Subject|2|||
126437883|NCT01389596|454905061|FG000|Overall Study|Insufficient Clinical Response|3|||
126437884|NCT01389596|454905062|FG001|Overall Study|Insufficient Clinical Response|4|||
126437885|NCT01389596|454905063|FG002|Overall Study|Insufficient Clinical Response|5|||
126437886|NCT01389596|454905061|FG000|Overall Study|Adverse Event|1|||
126437887|NCT01389596|454905062|FG001|Overall Study|Adverse Event|4|||
126437888|NCT01389596|454905063|FG002|Overall Study|Adverse Event|0|||
126437889|NCT01389596|454905061|FG000|Overall Study|Death|0|||
126437890|NCT01389596|454905062|FG001|Overall Study|Death|1|||
126437891|NCT01389596|454905063|FG002|Overall Study|Death|0|||
126437892|NCT01389596|454905061|FG000|Overall Study|Other Unspecified|2|||
126437893|NCT01389596|454905062|FG001|Overall Study|Other Unspecified|1|||
126437894|NCT01389596|454905063|FG002|Overall Study|Other Unspecified|0|||
126437895|NCT01124006|454905067|FG000|Overall Study|Withdrawal by Subject|2|||
126685726|NCT02926209|455805075|FG000|Study Cohort|Poor Bowel Preparation|1|||
126437896|NCT01124006|454905068|FG001|Overall Study|Withdrawal by Subject|2|||
126437897|NCT01124006|454905069|FG002|Overall Study|Withdrawal by Subject|0|||
126437898|NCT01124006|454905067|FG000|Overall Study|Lost to Follow-up|1|||
126437899|NCT01124006|454905068|FG001|Overall Study|Lost to Follow-up|0|||
126437900|NCT01124006|454905069|FG002|Overall Study|Lost to Follow-up|1|||
126437901|NCT01124006|454905067|FG000|Overall Study|Other|0|||
126437902|NCT01124006|454905068|FG001|Overall Study|Other|0|||
126437903|NCT01124006|454905069|FG002|Overall Study|Other|1|||
126437904|NCT03877510|454905073|FG000|Overall Study|Death|6|||
126685727|NCT02926209|455805076|FG001|Study Cohort|Poor Bowel Preparation|0|||
126437905|NCT03877510|454905073|FG000|Overall Study|Lost to Follow-up|2|||
126437906|NCT03877510|454905073|FG000|Overall Study|Non-compliance with study drug|2|||
126437907|NCT03877510|454905073|FG000|Overall Study|Lack of Efficacy|14|||
126437908|NCT03877510|454905073|FG000|Overall Study|Adverse Event|20|||
126437909|NCT03877510|454905073|FG000|Overall Study|Withdrawal by Subject|22|||
126437910|NCT03877510|454905073|FG000|Overall Study|Miscellaneous|1|||
126437911|NCT02085161|454905075|FG000|Overall Study|Not Treated|1|||
126437912|NCT02085161|454905076|FG001|Overall Study|Not Treated|0|||
126437913|NCT02085161|454905077|FG002|Overall Study|Not Treated|0|||
126437914|NCT02085161|454905078|FG003|Overall Study|Not Treated|0|||
126437915|NCT02085161|454905075|FG000|Overall Study|Adverse Event|8|||
126437916|NCT02085161|454905076|FG001|Overall Study|Adverse Event|5|||
126437917|NCT02085161|454905077|FG002|Overall Study|Adverse Event|4|||
126437918|NCT02085161|454905078|FG003|Overall Study|Adverse Event|5|||
126437919|NCT02085161|454905075|FG000|Overall Study|Protocol Violation|0|||
126437920|NCT02085161|454905076|FG001|Overall Study|Protocol Violation|1|||
126437921|NCT02085161|454905077|FG002|Overall Study|Protocol Violation|0|||
126437922|NCT02085161|454905078|FG003|Overall Study|Protocol Violation|1|||
126437923|NCT02085161|454905075|FG000|Overall Study|Withdrawal by Subject|2|||
126437924|NCT02085161|454905076|FG001|Overall Study|Withdrawal by Subject|4|||
126437925|NCT02085161|454905077|FG002|Overall Study|Withdrawal by Subject|0|||
126437926|NCT02085161|454905078|FG003|Overall Study|Withdrawal by Subject|3|||
126437927|NCT02085161|454905075|FG000|Overall Study|Other Reason|1|||
126437928|NCT02085161|454905076|FG001|Overall Study|Other Reason|0|||
126437929|NCT02085161|454905077|FG002|Overall Study|Other Reason|1|||
126437930|NCT02085161|454905078|FG003|Overall Study|Other Reason|1|||
126437931|NCT01936870|454905083|FG000|Overall Study|No Visit After Treatment|176|||
126437932|NCT01936870|454905083|FG000|Overall Study|Protocol Violation|12|||
126437933|NCT01936870|454905083|FG000|Overall Study|No Drug Administration|1|||
126437934|NCT02399163|454905086|FG000|Overall Study|Adverse Event|2|||
126437935|NCT02399163|454905086|FG000|Overall Study|Protocol Deviation|2|||
126437936|NCT02399163|454905086|FG000|Overall Study|Withdrawal by Participant|5|||
126437937|NCT03910244|454905087|FG000|Overall Study|Adverse Event|14|||
126437938|NCT03910244|454905088|FG001|Overall Study|Adverse Event|0|||
126437939|NCT03910244|454905087|FG000|Overall Study|Death|1|||
126437940|NCT03910244|454905088|FG001|Overall Study|Death|0|||
126437941|NCT03910244|454905087|FG000|Overall Study|Lost to Follow-up|0|||
126437942|NCT03910244|454905088|FG001|Overall Study|Lost to Follow-up|2|||
126437943|NCT03910244|454905087|FG000|Overall Study|Joint withdrawal decision|1|||
126437944|NCT03910244|454905088|FG001|Overall Study|Joint withdrawal decision|0|||
126437945|NCT03910244|454905087|FG000|Overall Study|Study Terminated by Sponsor|7|||
126437946|NCT03910244|454905088|FG001|Overall Study|Study Terminated by Sponsor|4|||
126437947|NCT03910244|454905087|FG000|Overall Study|Physician Decision|1|||
126437948|NCT03910244|454905088|FG001|Overall Study|Physician Decision|0|||
126437949|NCT03910244|454905087|FG000|Overall Study|Protocol Violation|1|||
126437950|NCT03910244|454905088|FG001|Overall Study|Protocol Violation|0|||
126437951|NCT03910244|454905087|FG000|Overall Study|Withdrawal by Subject|7|||
126437952|NCT03910244|454905088|FG001|Overall Study|Withdrawal by Subject|2|||
126437953|NCT03594110|454905089|FG000|Interventional Part|Participant concerned about study treatment|23|||
126437954|NCT03594110|454905090|FG001|Interventional Part|Participant concerned about study treatment|28|||
126437955|NCT03594110|454905089|FG000|Interventional Part|Doctor advice|38|||
126437956|NCT03594110|454905090|FG001|Interventional Part|Doctor advice|40|||
126437957|NCT03594110|454905089|FG000|Interventional Part|Participants' wish|89|||
126437958|NCT03594110|454905090|FG001|Interventional Part|Participants' wish|68|||
126437959|NCT03594110|454905089|FG000|Interventional Part|Adverse event-non-fatal events|119|||
126437960|NCT03594110|454905090|FG001|Interventional Part|Adverse event-non-fatal events|116|||
126437961|NCT03594110|454905089|FG000|Interventional Part|Study drug stopped, reason missing|336|||
126437962|NCT03594110|454905090|FG001|Interventional Part|Study drug stopped, reason missing|294|||
126437963|NCT03594110|454905089|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
126437964|NCT03594110|454905090|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
126437965|NCT03594110|454905089|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
126437966|NCT03594110|454905090|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
126437967|NCT03594110|454905089|FG000|Interventional Part|Contraindicated drug started|32|||
126437968|NCT03594110|454905090|FG001|Interventional Part|Contraindicated drug started|18|||
126437969|NCT03594110|454905089|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
126437970|NCT03594110|454905090|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
126437971|NCT03594110|454905089|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
126437972|NCT03594110|454905090|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
126437973|NCT03594110|454905089|FG000|Non-interventional Part|Withdrawal by Subject|3|||
126437974|NCT03594110|454905090|FG001|Non-interventional Part|Withdrawal by Subject|4|||
126437975|NCT03594110|454905089|FG000|Non-interventional Part|Lost to Follow-up|45|||
126437976|NCT03594110|454905090|FG001|Non-interventional Part|Lost to Follow-up|41|||
126437977|NCT00803569|454905093|FG000|Overall Study|Progressive Disease|3|||
126437978|NCT00803569|454905093|FG000|Overall Study|Noncompliance|1|||
126437979|NCT00684021|454905096|FG000|Overall Study|MRI Contraindicated|1|||
126437980|NCT00684021|454905097|FG001|Overall Study|MRI Contraindicated|1|||
126437981|NCT00684021|454905098|FG002|Overall Study|MRI Contraindicated|1|||
126437982|NCT00684021|454905099|FG003|Overall Study|MRI Contraindicated|0|||
126685728|NCT00705939|455805077|FG000|Overall Study|Protocol Violation|0|||
126685729|NCT00705939|455805078|FG001|Overall Study|Protocol Violation|0|||
126685730|NCT00705939|455805079|FG002|Overall Study|Protocol Violation|1|||
126685731|NCT00705939|455805077|FG000|Overall Study|Withdrawal by Subject|0|||
126685732|NCT00705939|455805078|FG001|Overall Study|Withdrawal by Subject|1|||
126685733|NCT00705939|455805079|FG002|Overall Study|Withdrawal by Subject|3|||
126685734|NCT00705939|455805077|FG000|Overall Study|Physician Decision|0|||
126685735|NCT00705939|455805078|FG001|Overall Study|Physician Decision|1|||
126685736|NCT00705939|455805079|FG002|Overall Study|Physician Decision|0|||
126685737|NCT05048342|455805080|FG000|Overall Study|Adverse Event|1|||
126685738|NCT05048342|455805080|FG000|Overall Study|Subject decision|2|||
126685739|NCT01441063|455805081|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
126685740|NCT01441063|455805081|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
126685741|NCT03345472|455805085|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
126685742|NCT03345472|455805085|FG000|Implant to 3 Months|Physician Decision|1|||
126685743|NCT03345472|455805085|FG000|Implant to 3 Months|Adverse Event|1|||
126685744|NCT03345472|455805085|FG000|3 Months to 12 Months|Physician Decision|3|||
126685745|NCT03345472|455805085|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
126685746|NCT03345472|455805085|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
126685747|NCT03345472|455805085|FG000|3 Months to 12 Months|Adverse Event|1|||
126685748|NCT03345472|455805085|FG000|3 Months to 12 Months|Death|1|||
126685749|NCT01926782|455805086|FG000|Overall Study|Participant moved|2|||
126685750|NCT01926782|455805087|FG001|Overall Study|Participant moved|0|||
126685751|NCT01926782|455805088|FG002|Overall Study|Participant moved|1|||
126685752|NCT01926782|455805089|FG003|Overall Study|Participant moved|1|||
126685753|NCT01926782|455805090|FG004|Overall Study|Participant moved|0|||
126685754|NCT01926782|455805091|FG005|Overall Study|Participant moved|3|||
126685755|NCT01926782|455805086|FG000|Overall Study|Physician Decision|0|||
126685756|NCT01926782|455805087|FG001|Overall Study|Physician Decision|2|||
126685757|NCT01926782|455805088|FG002|Overall Study|Physician Decision|1|||
126685758|NCT01926782|455805089|FG003|Overall Study|Physician Decision|1|||
126685759|NCT01926782|455805090|FG004|Overall Study|Physician Decision|0|||
126685760|NCT01926782|455805091|FG005|Overall Study|Physician Decision|0|||
126685761|NCT01926782|455805086|FG000|Overall Study|Other than specified|2|||
126685762|NCT01926782|455805087|FG001|Overall Study|Other than specified|3|||
126685763|NCT01926782|455805088|FG002|Overall Study|Other than specified|5|||
126685764|NCT01926782|455805089|FG003|Overall Study|Other than specified|12|||
126685765|NCT01926782|455805090|FG004|Overall Study|Other than specified|4|||
126685766|NCT01926782|455805091|FG005|Overall Study|Other than specified|11|||
126685767|NCT01926782|455805086|FG000|Overall Study|Adverse Event|13|||
126685768|NCT01926782|455805087|FG001|Overall Study|Adverse Event|4|||
126685769|NCT01926782|455805088|FG002|Overall Study|Adverse Event|17|||
126685770|NCT01926782|455805089|FG003|Overall Study|Adverse Event|4|||
126685771|NCT01926782|455805090|FG004|Overall Study|Adverse Event|3|||
126685772|NCT01926782|455805091|FG005|Overall Study|Adverse Event|14|||
126685773|NCT01926782|455805086|FG000|Overall Study|Poor compliance to protocol|5|||
126685774|NCT01926782|455805087|FG001|Overall Study|Poor compliance to protocol|3|||
126685775|NCT01926782|455805088|FG002|Overall Study|Poor compliance to protocol|8|||
126685776|NCT01926782|455805089|FG003|Overall Study|Poor compliance to protocol|0|||
126685777|NCT01926782|455805090|FG004|Overall Study|Poor compliance to protocol|1|||
126685778|NCT01926782|455805091|FG005|Overall Study|Poor compliance to protocol|6|||
126685779|NCT01926782|455805086|FG000|Overall Study|Randomized and not treated|0|||
126759421|NCT02557308|456068562|FG006|Overall Study|Adverse Event|4|||
126759422|NCT02557308|456068563|FG007|Overall Study|Adverse Event|1|||
126685780|NCT01926782|455805087|FG001|Overall Study|Randomized and not treated|0|||
126685781|NCT01926782|455805088|FG002|Overall Study|Randomized and not treated|0|||
126685782|NCT01926782|455805089|FG003|Overall Study|Randomized and not treated|1|||
126685783|NCT01926782|455805090|FG004|Overall Study|Randomized and not treated|0|||
126685784|NCT01926782|455805091|FG005|Overall Study|Randomized and not treated|0|||
126685785|NCT01926782|455805086|FG000|Overall Study|Withdrawal by Subject|6|||
126685786|NCT01926782|455805087|FG001|Overall Study|Withdrawal by Subject|1|||
126685787|NCT01926782|455805088|FG002|Overall Study|Withdrawal by Subject|8|||
126759423|NCT02557308|456068556|FG000|Overall Study|Lost to Follow-up|2|||
126759424|NCT02557308|456068557|FG001|Overall Study|Lost to Follow-up|0|||
126759425|NCT02557308|456068558|FG002|Overall Study|Lost to Follow-up|1|||
126759426|NCT02557308|456068559|FG003|Overall Study|Lost to Follow-up|0|||
126759427|NCT02557308|456068560|FG004|Overall Study|Lost to Follow-up|0|||
126759428|NCT02557308|456068561|FG005|Overall Study|Lost to Follow-up|0|||
126759429|NCT02557308|456068562|FG006|Overall Study|Lost to Follow-up|2|||
126437983|NCT00684021|454905096|FG000|Overall Study|MRI not performed|0|||
126685788|NCT01926782|455805089|FG003|Overall Study|Withdrawal by Subject|1|||
126685789|NCT01926782|455805090|FG004|Overall Study|Withdrawal by Subject|0|||
126685790|NCT01926782|455805091|FG005|Overall Study|Withdrawal by Subject|5|||
126685791|NCT01926782|455805086|FG000|Overall Study|Related to study drug administration|0|||
126759430|NCT02557308|456068563|FG007|Overall Study|Lost to Follow-up|0|||
126759431|NCT02557308|456068556|FG000|Overall Study|Death|1|||
126759432|NCT02557308|456068557|FG001|Overall Study|Death|0|||
126437984|NCT00684021|454905097|FG001|Overall Study|MRI not performed|1|||
126759433|NCT02557308|456068558|FG002|Overall Study|Death|0|||
126759434|NCT02557308|456068559|FG003|Overall Study|Death|0|||
126759435|NCT02557308|456068560|FG004|Overall Study|Death|0|||
126759436|NCT02557308|456068561|FG005|Overall Study|Death|0|||
126759437|NCT02557308|456068562|FG006|Overall Study|Death|0|||
126759438|NCT02557308|456068563|FG007|Overall Study|Death|0|||
126759439|NCT02557308|456068556|FG000|Overall Study|Study Close|98|||
126759440|NCT02557308|456068557|FG001|Overall Study|Study Close|18|||
126759441|NCT02557308|456068558|FG002|Overall Study|Study Close|5|||
126759442|NCT02557308|456068559|FG003|Overall Study|Study Close|3|||
126437985|NCT00684021|454905098|FG002|Overall Study|MRI not performed|1|||
126437986|NCT00684021|454905099|FG003|Overall Study|MRI not performed|2|||
126437987|NCT00684021|454905096|FG000|Overall Study|Death|1|||
126437988|NCT00684021|454905097|FG001|Overall Study|Death|0|||
126437989|NCT00684021|454905098|FG002|Overall Study|Death|0|||
126685792|NCT01926782|455805087|FG001|Overall Study|Related to study drug administration|0|||
126685793|NCT01926782|455805088|FG002|Overall Study|Related to study drug administration|0|||
126685794|NCT01926782|455805089|FG003|Overall Study|Related to study drug administration|0|||
126437990|NCT00684021|454905099|FG003|Overall Study|Death|0|||
126759443|NCT02557308|456068560|FG004|Overall Study|Study Close|1|||
126759444|NCT02557308|456068561|FG005|Overall Study|Study Close|0|||
126759445|NCT02557308|456068562|FG006|Overall Study|Study Close|123|||
126759446|NCT02557308|456068563|FG007|Overall Study|Study Close|5|||
126759447|NCT02557308|456068556|FG000|Overall Study|Except for study close|5|||
126759448|NCT02557308|456068557|FG001|Overall Study|Except for study close|0|||
126759449|NCT02557308|456068558|FG002|Overall Study|Except for study close|0|||
126759450|NCT02557308|456068559|FG003|Overall Study|Except for study close|0|||
126759451|NCT02557308|456068560|FG004|Overall Study|Except for study close|3|||
126759452|NCT02557308|456068561|FG005|Overall Study|Except for study close|0|||
126759453|NCT02557308|456068562|FG006|Overall Study|Except for study close|6|||
126759454|NCT02557308|456068563|FG007|Overall Study|Except for study close|10|||
126759455|NCT00351611|456068566|FG000|Overall Study|Adverse Event|11|||
126437991|NCT04041414|454905100|FG000|Overall Study|Lost to Follow-up|1|||
126759456|NCT00351611|456068567|FG001|Overall Study|Adverse Event|3|||
126759457|NCT00351611|456068566|FG000|Overall Study|Death|1|||
126759458|NCT00351611|456068567|FG001|Overall Study|Death|0|||
126759459|NCT00351611|456068566|FG000|Overall Study|Lost to Follow-up|1|||
126759460|NCT00351611|456068567|FG001|Overall Study|Lost to Follow-up|0|||
126759461|NCT00351611|456068566|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
126759462|NCT00351611|456068567|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
126759463|NCT00351611|456068566|FG000|Overall Study|Other|1|||
126759464|NCT00351611|456068567|FG001|Overall Study|Other|0|||
126759465|NCT00351611|456068566|FG000|Overall Study|Protocol Violation|0|||
126759466|NCT00351611|456068567|FG001|Overall Study|Protocol Violation|2|||
126759467|NCT00267202|456068568|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
126545381|NCT02541383|455290823|FG000|Overall Study|Death|50|||
126759468|NCT00267202|456068569|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
126759469|NCT00267202|456068568|FG000|Overall Study|Withdrawal by Subject|12|||
126759470|NCT00267202|456068569|FG001|Overall Study|Withdrawal by Subject|15|||
126545382|NCT02541383|455290824|FG001|Overall Study|Death|37|||
126685795|NCT01926782|455805090|FG004|Overall Study|Related to study drug administration|0|||
126685796|NCT01926782|455805091|FG005|Overall Study|Related to study drug administration|2|||
126685797|NCT01665807|455805094|FG000|Overall Study|Withdrawal by Subject|2|||
126685798|NCT01665807|455805095|FG001|Overall Study|Withdrawal by Subject|0|||
126685799|NCT01665807|455805096|FG002|Overall Study|Withdrawal by Subject|1|||
126685800|NCT02462473|455805097|FG000|Overall Study|Death|1|||
126685801|NCT02462473|455805097|FG000|Overall Study|Other|3|||
126685802|NCT03298022|455805099|FG000|Overall Study|Lack of Efficacy|4|||
126685803|NCT03298022|455805099|FG000|Overall Study|Withdrawal by Subject|7|||
126685804|NCT03298022|455805099|FG000|Overall Study|Adverse Event|1|||
126759471|NCT00267202|456068568|FG000|Overall Study|Adverse Event|13|||
126759472|NCT00267202|456068569|FG001|Overall Study|Adverse Event|7|||
126759473|NCT00267202|456068568|FG000|Overall Study|Protocol Violation|2|||
126759474|NCT00267202|456068569|FG001|Overall Study|Protocol Violation|3|||
126759475|NCT00267202|456068568|FG000|Overall Study|Administrative problems|2|||
126759476|NCT00267202|456068569|FG001|Overall Study|Administrative problems|1|||
126759477|NCT00267202|456068568|FG000|Overall Study|Lost to Follow-up|3|||
126759478|NCT00267202|456068569|FG001|Overall Study|Lost to Follow-up|0|||
126759479|NCT00368069|456068570|FG000|Overall Study|Adverse Event|5|||
126759480|NCT00368069|456068571|FG001|Overall Study|Adverse Event|2|||
126759481|NCT00368069|456068570|FG000|Overall Study|Lack of Efficacy|0|||
126759482|NCT00368069|456068571|FG001|Overall Study|Lack of Efficacy|1|||
126685805|NCT03298022|455805099|FG000|Overall Study|disease relapse|1|||
126759483|NCT00368069|456068570|FG000|Overall Study|Lost to Follow-up|1|||
126759484|NCT00368069|456068571|FG001|Overall Study|Lost to Follow-up|0|||
126759485|NCT00368069|456068570|FG000|Overall Study|Protocol Violation|0|||
126759486|NCT00368069|456068571|FG001|Overall Study|Protocol Violation|2|||
126759487|NCT00368069|456068570|FG000|Overall Study|Withdrawal of Consent|2|||
126685806|NCT01400451|455805102|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
126685807|NCT01400451|455805103|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
126685808|NCT01400451|455805104|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
126685809|NCT01400451|455805102|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
126685810|NCT01400451|455805103|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
126685811|NCT01400451|455805104|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
126437992|NCT04041414|454905101|FG001|Overall Study|Lost to Follow-up|2|||
126437993|NCT04004988|454905102|FG000|Period 1|Physician Decision|2|||
126437994|NCT04004988|454905103|FG001|Period 1|Physician Decision|0|||
126437995|NCT04004988|454905102|FG000|Period 1|Withdrawal by Subject|0|||
126685812|NCT01400451|455805102|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
126685813|NCT01400451|455805103|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
126685814|NCT01400451|455805104|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
126685815|NCT01400451|455805102|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
126685816|NCT01400451|455805103|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
126685817|NCT01400451|455805104|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
126685818|NCT01400451|455805102|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
126685819|NCT01400451|455805103|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
126685820|NCT01400451|455805104|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
126685821|NCT01079182|455805107|FG000|Overall Study|Lost to Follow-up|1634|||
126685822|NCT01079182|455805107|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
126685823|NCT01079182|455805107|FG000|Overall Study|Lack of Efficacy|514|||
126685824|NCT01079182|455805107|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
126685825|NCT01079182|455805107|FG000|Overall Study|Reasons not Evaluated|271|||
126759488|NCT00368069|456068571|FG001|Overall Study|Withdrawal of Consent|1|||
126759489|NCT00368069|456068570|FG000|Overall Study|no blood sampling possible|0|||
126759490|NCT00368069|456068571|FG001|Overall Study|no blood sampling possible|1|||
126759491|NCT03907072|456068575|FG000|Overall Study|Study Terminated by Sponsor|2|||
126759492|NCT03907072|456068576|FG001|Overall Study|Study Terminated by Sponsor|2|||
126759493|NCT03907072|456068577|FG002|Overall Study|Study Terminated by Sponsor|2|||
126759494|NCT01430559|456068581|FG000|Overall Study|Adverse Event|7|||
126759495|NCT01430559|456068582|FG001|Overall Study|Adverse Event|3|||
126759496|NCT01430559|456068581|FG000|Overall Study|Entry criteria not met|1|||
126759497|NCT01430559|456068582|FG001|Overall Study|Entry criteria not met|1|||
126759498|NCT01430559|456068581|FG000|Overall Study|Lost to Follow-up|1|||
126759499|NCT01430559|456068582|FG001|Overall Study|Lost to Follow-up|0|||
126759500|NCT01430559|456068581|FG000|Overall Study|Medication error|1|||
126759501|NCT01430559|456068582|FG001|Overall Study|Medication error|0|||
126437996|NCT04004988|454905103|FG001|Period 1|Withdrawal by Subject|1|||
126759502|NCT01430559|456068581|FG000|Overall Study|Withdrawal by Subject|3|||
126759503|NCT01430559|456068582|FG001|Overall Study|Withdrawal by Subject|2|||
126759504|NCT01430559|456068581|FG000|Overall Study|Protocol Violation|1|||
126437997|NCT04004988|454905102|FG000|Period 1|Adverse Event|1|||
126437998|NCT04004988|454905103|FG001|Period 1|Adverse Event|2|||
126437999|NCT00930046|454905104|FG000|Overall Study|Wound catheter malfunctioned|1|||
126438000|NCT00930046|454905105|FG001|Overall Study|Wound catheter malfunctioned|2|||
126438001|NCT01598532|454905106|FG000|Overall Study|Lost to Follow-up|3|||
126438002|NCT01598532|454905106|FG000|Overall Study|Did not meet inclusion criteria|8|||
126438003|NCT04682366|454905107|FG000|Overall Study|Lost to Follow-up|1|||
126438004|NCT04682366|454905108|FG001|Overall Study|Lost to Follow-up|1|||
126438005|NCT00702221|454905109|FG000|Overall Study|Adverse Event|4|||
126438006|NCT00702221|454905110|FG001|Overall Study|Adverse Event|3|||
126438007|NCT04798196|454905113|FG000|Overall Study|Lost to Follow-up|3|||
126438008|NCT04798196|454905114|FG001|Overall Study|Lost to Follow-up|1|||
126438009|NCT04798196|454905115|FG002|Overall Study|Lost to Follow-up|3|||
126438010|NCT00728689|454905122|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
126438011|NCT00728689|454905123|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
126438012|NCT01867671|454905124|FG000|Overall Study|Adverse Event|5|||
126438013|NCT01867671|454905125|FG001|Overall Study|Adverse Event|3|||
126438014|NCT01867671|454905124|FG000|Overall Study|Anaphylaxis|0|||
126438015|NCT01867671|454905125|FG001|Overall Study|Anaphylaxis|1|||
126438016|NCT01867671|454905124|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
126438017|NCT01867671|454905125|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
126438018|NCT01867671|454905124|FG000|Overall Study|Lost to Follow-up|0|||
126438019|NCT01867671|454905125|FG001|Overall Study|Lost to Follow-up|1|||
126438020|NCT01867671|454905124|FG000|Overall Study|Non-compliance with Study Drug|1|||
126438021|NCT01867671|454905125|FG001|Overall Study|Non-compliance with Study Drug|2|||
126759505|NCT01430559|456068582|FG001|Overall Study|Protocol Violation|0|||
126759506|NCT01430559|456068581|FG000|Overall Study|Other|3|||
126438022|NCT01867671|454905124|FG000|Overall Study|Withdrawal by Subject|21|||
126438023|NCT01867671|454905125|FG001|Overall Study|Withdrawal by Subject|21|||
126438024|NCT01523366|454905126|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126438025|NCT01523366|454905127|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126438026|NCT01523366|454905126|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
126685826|NCT00720109|455805113|FG000|Induction Period|Did not meet eligibility criteria|3|||
126685827|NCT00720109|455805114|FG001|Induction Period|Did not meet eligibility criteria|0|||
126685828|NCT00720109|455805115|FG002|Induction Period|Did not meet eligibility criteria|0|||
126685829|NCT00720109|455805113|FG000|Induction Period|Bone Marrow Transplant|2|||
126685830|NCT00720109|455805114|FG001|Induction Period|Bone Marrow Transplant|0|||
126685831|NCT00720109|455805115|FG002|Induction Period|Bone Marrow Transplant|0|||
126685832|NCT00720109|455805113|FG000|Induction Period|Physician Decision|1|||
126685833|NCT00720109|455805114|FG001|Induction Period|Physician Decision|0|||
126685834|NCT00720109|455805115|FG002|Induction Period|Physician Decision|0|||
126685835|NCT00720109|455805113|FG000|Risk Stratification Period|Adverse Event|0|||
126685836|NCT00720109|455805114|FG001|Risk Stratification Period|Adverse Event|1|||
126685837|NCT00720109|455805115|FG002|Risk Stratification Period|Adverse Event|0|||
126685838|NCT00720109|455805113|FG000|Risk Stratification Period|Physician Decision|0|||
126685839|NCT00720109|455805114|FG001|Risk Stratification Period|Physician Decision|2|||
126685840|NCT00720109|455805115|FG002|Risk Stratification Period|Physician Decision|1|||
126685841|NCT00720109|455805113|FG000|Risk Stratification Period|Bone marrow transplant|0|||
126685842|NCT00720109|455805114|FG001|Risk Stratification Period|Bone marrow transplant|9|||
126685843|NCT00720109|455805115|FG002|Risk Stratification Period|Bone marrow transplant|7|||
126685844|NCT00720109|455805113|FG000|Risk Stratification Period|Disease progression or relapse|0|||
126685845|NCT00720109|455805114|FG001|Risk Stratification Period|Disease progression or relapse|2|||
126685846|NCT00720109|455805115|FG002|Risk Stratification Period|Disease progression or relapse|0|||
126685847|NCT00720109|455805113|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
126685848|NCT00720109|455805114|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
126685849|NCT00720109|455805115|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
126685850|NCT00512798|455805116|FG000|Overall Study|Death|0|||
126685851|NCT00512798|455805117|FG001|Overall Study|Death|3|||
126685852|NCT00512798|455805116|FG000|Overall Study|Adverse Event|2|||
126685853|NCT00512798|455805117|FG001|Overall Study|Adverse Event|4|||
126685854|NCT00512798|455805116|FG000|Overall Study|Progression of disease|14|||
126685855|NCT00512798|455805117|FG001|Overall Study|Progression of disease|20|||
126759507|NCT01430559|456068582|FG001|Overall Study|Other|3|||
126685856|NCT00512798|455805116|FG000|Overall Study|Withdrawal by Subject|3|||
126685857|NCT00512798|455805117|FG001|Overall Study|Withdrawal by Subject|0|||
126685858|NCT02508194|455805120|FG000|Overall Study|Death|5|||
126685859|NCT02508194|455805121|FG001|Overall Study|Death|3|||
126685860|NCT02508194|455805120|FG000|Overall Study|Lost to Follow-up|25|||
126685861|NCT02508194|455805121|FG001|Overall Study|Lost to Follow-up|18|||
126685862|NCT02508194|455805120|FG000|Overall Study|Withdrawal by Subject|20|||
126685863|NCT02508194|455805121|FG001|Overall Study|Withdrawal by Subject|18|||
126685864|NCT02508194|455805120|FG000|Overall Study|Error in Randomization|1|||
126685865|NCT02508194|455805121|FG001|Overall Study|Error in Randomization|3|||
126685866|NCT02508194|455805120|FG000|Overall Study|Principal Investigator Decision|1|||
126759508|NCT01430559|456068581|FG000|Overall Study|Randomized, Not Treated|3|||
126759509|NCT01430559|456068582|FG001|Overall Study|Randomized, Not Treated|3|||
126759510|NCT01177943|456068583|FG000|First Intervention|Withdrawal by Subject|2|||
126759511|NCT01177943|456068584|FG001|First Intervention|Withdrawal by Subject|0|||
126759512|NCT00808665|456068585|FG000|Overall Study|Withdrawal by Subject|1|||
126759513|NCT00808665|456068586|FG001|Overall Study|Withdrawal by Subject|0|||
126759514|NCT00808665|456068585|FG000|Overall Study|only required minimally invasive surgery|1|||
126759515|NCT00808665|456068586|FG001|Overall Study|only required minimally invasive surgery|0|||
126759516|NCT00808665|456068585|FG000|Overall Study|surgery cancelled|1|||
126759517|NCT00808665|456068586|FG001|Overall Study|surgery cancelled|0|||
126759518|NCT00808665|456068585|FG000|Overall Study|required an additional procedure|0|||
126759519|NCT00808665|456068586|FG001|Overall Study|required an additional procedure|1|||
126759520|NCT00808665|456068585|FG000|Overall Study|Physician Decision|3|||
126759521|NCT00808665|456068586|FG001|Overall Study|Physician Decision|1|||
126759522|NCT00808665|456068585|FG000|Overall Study|Medication stopped by resident|0|||
126759523|NCT00808665|456068586|FG001|Overall Study|Medication stopped by resident|1|||
126759524|NCT03319160|456068587|FG000|Overall Study|Data not available.|7|||
126759525|NCT00665002|456068588|FG000|Overall Study|Progression/relapse during treatment|11|||
126759526|NCT00665002|456068588|FG000|Overall Study|Cytogenetic resistance|1|||
126759527|NCT01303159|456068598|FG000|Overall Study|Death|16|||
126759528|NCT01303159|456068598|FG000|Overall Study|Study Termination|7|||
126759529|NCT03457701|456068599|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
126759530|NCT03457701|456068600|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
126759531|NCT03457701|456068599|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
126759532|NCT03457701|456068600|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
126759533|NCT02243306|456068601|FG000|Overall Study|Adverse Event|0|||
126438027|NCT01523366|454905127|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
126438028|NCT04543279|454905128|FG000|Overall Study|Withdrawal by Subject|1|||
126685867|NCT02508194|455805121|FG001|Overall Study|Principal Investigator Decision|2|||
126685868|NCT02158091|455805127|FG000|Overall Study|DLT|2|||
126685869|NCT02158091|455805128|FG001|Overall Study|DLT|1|||
126685870|NCT02158091|455805129|FG002|Overall Study|DLT|0|||
126759534|NCT02243306|456068602|FG001|Overall Study|Adverse Event|1|||
126759535|NCT02243306|456068601|FG000|Overall Study|Other: Reached stopping criteria|0|||
126759536|NCT02243306|456068602|FG001|Overall Study|Other: Reached stopping criteria|1|||
126438029|NCT04543279|454905129|FG001|Overall Study|Withdrawal by Subject|0|||
126759537|NCT02243306|456068601|FG000|Overall Study|Physician Decision|0|||
126685871|NCT03977467|455805130|FG000|Overall Study|Disease Progression|1|||
126685872|NCT03977467|455805131|FG001|Overall Study|Disease Progression|1|||
126685873|NCT03977467|455805132|FG002|Overall Study|Disease Progression|30|||
126685874|NCT03977467|455805133|FG003|Overall Study|Disease Progression|0|||
126438030|NCT04543279|454905128|FG000|Overall Study|Adverse Event|1|||
126438031|NCT04543279|454905129|FG001|Overall Study|Adverse Event|0|||
126685875|NCT03977467|455805130|FG000|Overall Study|Adverse Event|0|||
126685876|NCT03977467|455805131|FG001|Overall Study|Adverse Event|1|||
126685877|NCT03977467|455805132|FG002|Overall Study|Adverse Event|0|||
126685878|NCT03977467|455805133|FG003|Overall Study|Adverse Event|0|||
126685879|NCT03977467|455805130|FG000|Overall Study|Death|0|||
126685880|NCT03977467|455805131|FG001|Overall Study|Death|0|||
126685881|NCT03977467|455805132|FG002|Overall Study|Death|3|||
126685882|NCT03977467|455805133|FG003|Overall Study|Death|0|||
126685883|NCT03977467|455805130|FG000|Overall Study|Lack of Efficacy|0|||
126438032|NCT04543279|454905128|FG000|Overall Study|Physician Decision|1|||
126438033|NCT04543279|454905129|FG001|Overall Study|Physician Decision|0|||
126438034|NCT00929695|454905130|FG000|Overall Study|Death|2|||
126438035|NCT00929695|454905131|FG001|Overall Study|Death|1|||
126438036|NCT00929695|454905130|FG000|Overall Study|Withdrawal by Subject|0|||
126438037|NCT00929695|454905131|FG001|Overall Study|Withdrawal by Subject|2|||
126438038|NCT00929695|454905130|FG000|Overall Study|discharge home|4|||
126438039|NCT00929695|454905131|FG001|Overall Study|discharge home|3|||
126438040|NCT00929695|454905130|FG000|Overall Study|incorrect stratification|2|||
126438041|NCT00929695|454905131|FG001|Overall Study|incorrect stratification|0|||
126438042|NCT00887809|454905133|FG000|Overall Study|Patient Not Treated|3|||
126438043|NCT00887809|454905134|FG001|Overall Study|Patient Not Treated|0|||
126438044|NCT00887809|454905133|FG000|Overall Study|Death|1|||
126438045|NCT00887809|454905134|FG001|Overall Study|Death|0|||
126438046|NCT01352715|454905137|FG000|Overall Study|Death|3|||
126438047|NCT01352715|454905138|FG001|Overall Study|Death|3|||
126438048|NCT01352715|454905137|FG000|Overall Study|Lost to Follow-up|5|||
126438049|NCT01352715|454905138|FG001|Overall Study|Lost to Follow-up|7|||
126438050|NCT01352715|454905137|FG000|Overall Study|Withdrawal by Subject|4|||
126438051|NCT01352715|454905138|FG001|Overall Study|Withdrawal by Subject|8|||
126438052|NCT01352715|454905137|FG000|Overall Study|site closure|16|||
126438053|NCT01352715|454905138|FG001|Overall Study|site closure|15|||
126438054|NCT01352715|454905137|FG000|Overall Study|no final visit in closeout period|15|||
126438055|NCT01352715|454905138|FG001|Overall Study|no final visit in closeout period|12|||
126438056|NCT01352715|454905137|FG000|Overall Study|major ineligibility|2|||
126438057|NCT01352715|454905138|FG001|Overall Study|major ineligibility|1|||
126438058|NCT04596267|454905139|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
126438059|NCT04596267|454905140|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
126438060|NCT04596267|454905139|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
126438061|NCT04596267|454905140|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
126438062|NCT00071058|454905141|FG000|Overall Study|brain tumor-removed from study|1|||
126438063|NCT02000440|454905142|FG000|Overall Study|Adverse Event|3|||
126438064|NCT02000440|454905142|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
126438065|NCT04109547|454905143|FG000|Overall Study|Withdrawal by Subject|3|||
126438066|NCT04109547|454905144|FG001|Overall Study|Withdrawal by Subject|2|||
126438067|NCT04109547|454905145|FG002|Overall Study|Withdrawal by Subject|6|||
126438068|NCT04109547|454905146|FG003|Overall Study|Withdrawal by Subject|6|||
126438069|NCT04109547|454905143|FG000|Overall Study|Lost to Follow-up|0|||
126438070|NCT04109547|454905144|FG001|Overall Study|Lost to Follow-up|0|||
126438071|NCT04109547|454905145|FG002|Overall Study|Lost to Follow-up|0|||
126438072|NCT04109547|454905146|FG003|Overall Study|Lost to Follow-up|1|||
126438073|NCT04109547|454905143|FG000|Overall Study|Physician Decision|1|||
126438074|NCT04109547|454905144|FG001|Overall Study|Physician Decision|2|||
126438075|NCT04109547|454905145|FG002|Overall Study|Physician Decision|0|||
126438076|NCT04109547|454905146|FG003|Overall Study|Physician Decision|0|||
126438077|NCT01550003|454905147|FG000|Overall Study|Adverse Event|0|||
126438078|NCT01550003|454905148|FG001|Overall Study|Adverse Event|9|||
126438079|NCT01550003|454905149|FG002|Overall Study|Adverse Event|15|||
126438080|NCT01550003|454905147|FG000|Overall Study|Lack of Efficacy|4|||
126438081|NCT01550003|454905148|FG001|Overall Study|Lack of Efficacy|11|||
126438082|NCT01550003|454905149|FG002|Overall Study|Lack of Efficacy|15|||
126438083|NCT01550003|454905147|FG000|Overall Study|Protocol Violation|0|||
126438084|NCT01550003|454905148|FG001|Overall Study|Protocol Violation|3|||
126438085|NCT01550003|454905149|FG002|Overall Study|Protocol Violation|2|||
126438086|NCT01550003|454905147|FG000|Overall Study|Lost to Follow-up|1|||
126438087|NCT01550003|454905148|FG001|Overall Study|Lost to Follow-up|4|||
126438088|NCT01550003|454905149|FG002|Overall Study|Lost to Follow-up|8|||
126438089|NCT01550003|454905147|FG000|Overall Study|Consent withdrawn|2|||
126438090|NCT01550003|454905148|FG001|Overall Study|Consent withdrawn|11|||
126438091|NCT01550003|454905149|FG002|Overall Study|Consent withdrawn|23|||
126438092|NCT01550003|454905147|FG000|Overall Study|Missing|1|||
126438093|NCT01550003|454905148|FG001|Overall Study|Missing|0|||
126438094|NCT01550003|454905149|FG002|Overall Study|Missing|2|||
126545383|NCT02541383|455290825|FG002|Overall Study|Death|48|||
126438095|NCT01550003|454905147|FG000|Overall Study|Study closure as announced by sponsor|7|||
126438096|NCT01550003|454905148|FG001|Overall Study|Study closure as announced by sponsor|6|||
126438097|NCT01550003|454905149|FG002|Overall Study|Study closure as announced by sponsor|24|||
126438098|NCT01550003|454905147|FG000|Overall Study|Protocol Noncompliance|1|||
126438099|NCT01550003|454905148|FG001|Overall Study|Protocol Noncompliance|0|||
126438100|NCT01550003|454905149|FG002|Overall Study|Protocol Noncompliance|0|||
126438101|NCT01550003|454905147|FG000|Overall Study|Study closure|0|||
126438102|NCT01550003|454905148|FG001|Overall Study|Study closure|1|||
126438103|NCT01550003|454905149|FG002|Overall Study|Study closure|1|||
126438104|NCT01550003|454905147|FG000|Overall Study|Patient reached adulthood|0|||
126438105|NCT01550003|454905148|FG001|Overall Study|Patient reached adulthood|1|||
126438106|NCT01550003|454905149|FG002|Overall Study|Patient reached adulthood|0|||
126438107|NCT01550003|454905147|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
126438108|NCT01550003|454905148|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
126438109|NCT01550003|454905149|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
126438110|NCT01550003|454905147|FG000|Overall Study|Sponsor's order|0|||
126438111|NCT01550003|454905148|FG001|Overall Study|Sponsor's order|3|||
126438112|NCT01550003|454905149|FG002|Overall Study|Sponsor's order|3|||
126438113|NCT01550003|454905147|FG000|Overall Study|Sponsor's decision|1|||
126685884|NCT03977467|455805131|FG001|Overall Study|Lack of Efficacy|0|||
126685885|NCT03977467|455805132|FG002|Overall Study|Lack of Efficacy|1|||
126685886|NCT03977467|455805133|FG003|Overall Study|Lack of Efficacy|0|||
126685887|NCT03977467|455805130|FG000|Overall Study|Withdrawal by Subject|2|||
126685888|NCT03977467|455805131|FG001|Overall Study|Withdrawal by Subject|1|||
126685889|NCT03977467|455805132|FG002|Overall Study|Withdrawal by Subject|4|||
126685890|NCT03977467|455805133|FG003|Overall Study|Withdrawal by Subject|0|||
126685891|NCT03977467|455805130|FG000|Overall Study|Study Terminated|1|||
126685892|NCT03977467|455805131|FG001|Overall Study|Study Terminated|0|||
126685893|NCT03977467|455805132|FG002|Overall Study|Study Terminated|0|||
126685894|NCT03977467|455805133|FG003|Overall Study|Study Terminated|1|||
126685895|NCT05913232|455805134|FG000|Overall Study|Adverse Event|0|||
126685896|NCT05913232|455805135|FG001|Overall Study|Adverse Event|2|||
126685897|NCT05913232|455805136|FG002|Overall Study|Adverse Event|1|||
126685898|NCT05913232|455805137|FG003|Overall Study|Adverse Event|1|||
126685899|NCT01627899|455805138|FG000|Overall Study|Study terminated early by sponsor.|5|||
126685900|NCT01358864|455805146|FG000|Overall Study|Adverse Event|0|||
126685901|NCT01358864|455805147|FG001|Overall Study|Adverse Event|6|||
126685902|NCT01358864|455805148|FG002|Overall Study|Adverse Event|9|||
126685903|NCT01358864|455805149|FG003|Overall Study|Adverse Event|0|||
126685904|NCT01358864|455805150|FG004|Overall Study|Adverse Event|4|||
126685905|NCT01358864|455805151|FG005|Overall Study|Adverse Event|8|||
126685906|NCT01358864|455805152|FG006|Overall Study|Adverse Event|12|||
126685907|NCT01358864|455805153|FG007|Overall Study|Adverse Event|7|||
126685908|NCT01358864|455805146|FG000|Overall Study|Lack of Efficacy|26|||
126685909|NCT01358864|455805147|FG001|Overall Study|Lack of Efficacy|3|||
126685910|NCT01358864|455805148|FG002|Overall Study|Lack of Efficacy|4|||
126685911|NCT01358864|455805149|FG003|Overall Study|Lack of Efficacy|19|||
126685912|NCT01358864|455805150|FG004|Overall Study|Lack of Efficacy|7|||
126685913|NCT01358864|455805151|FG005|Overall Study|Lack of Efficacy|4|||
126685914|NCT01358864|455805152|FG006|Overall Study|Lack of Efficacy|49|||
126685915|NCT01358864|455805153|FG007|Overall Study|Lack of Efficacy|44|||
126685916|NCT01358864|455805146|FG000|Overall Study|Lost to Follow-up|0|||
126685917|NCT01358864|455805147|FG001|Overall Study|Lost to Follow-up|0|||
126685918|NCT01358864|455805148|FG002|Overall Study|Lost to Follow-up|1|||
126685919|NCT01358864|455805149|FG003|Overall Study|Lost to Follow-up|0|||
126685920|NCT01358864|455805150|FG004|Overall Study|Lost to Follow-up|0|||
126685921|NCT01358864|455805151|FG005|Overall Study|Lost to Follow-up|0|||
126685922|NCT01358864|455805152|FG006|Overall Study|Lost to Follow-up|0|||
126685923|NCT01358864|455805153|FG007|Overall Study|Lost to Follow-up|1|||
126685924|NCT01358864|455805146|FG000|Overall Study|Withdrawal by Subject|3|||
126685925|NCT01358864|455805147|FG001|Overall Study|Withdrawal by Subject|4|||
126685926|NCT01358864|455805148|FG002|Overall Study|Withdrawal by Subject|2|||
126685927|NCT01358864|455805149|FG003|Overall Study|Withdrawal by Subject|0|||
126685928|NCT01358864|455805150|FG004|Overall Study|Withdrawal by Subject|0|||
126685929|NCT01358864|455805151|FG005|Overall Study|Withdrawal by Subject|1|||
126685930|NCT01358864|455805152|FG006|Overall Study|Withdrawal by Subject|1|||
126685931|NCT01358864|455805153|FG007|Overall Study|Withdrawal by Subject|3|||
126685932|NCT01358864|455805146|FG000|Overall Study|Other reason not defined above|2|||
126685933|NCT01358864|455805147|FG001|Overall Study|Other reason not defined above|0|||
126685934|NCT01358864|455805148|FG002|Overall Study|Other reason not defined above|0|||
126685935|NCT01358864|455805149|FG003|Overall Study|Other reason not defined above|0|||
126685936|NCT01358864|455805150|FG004|Overall Study|Other reason not defined above|0|||
126685937|NCT01358864|455805151|FG005|Overall Study|Other reason not defined above|0|||
126685938|NCT01358864|455805152|FG006|Overall Study|Other reason not defined above|2|||
126685939|NCT01358864|455805153|FG007|Overall Study|Other reason not defined above|0|||
126685940|NCT01358864|455805146|FG000|Overall Study|Not treated|0|||
126685941|NCT01358864|455805147|FG001|Overall Study|Not treated|0|||
126685942|NCT01358864|455805148|FG002|Overall Study|Not treated|0|||
126685943|NCT01358864|455805149|FG003|Overall Study|Not treated|0|||
126685944|NCT01358864|455805150|FG004|Overall Study|Not treated|0|||
126685945|NCT01358864|455805151|FG005|Overall Study|Not treated|0|||
126685946|NCT01358864|455805152|FG006|Overall Study|Not treated|1|||
126685947|NCT01358864|455805153|FG007|Overall Study|Not treated|0|||
126685948|NCT04158648|455805161|FG000|Overall Study|Ongoing in the Study|69|||
126685949|NCT04158648|455805161|FG000|Overall Study|Withdrawal by Subject|4|||
126685950|NCT04209855|455805162|FG000|Overall Study|Death|161|||
126685951|NCT04209855|455805163|FG001|Overall Study|Death|177|||
126685952|NCT04209855|455805162|FG000|Overall Study|PI Discretion|1|||
126685953|NCT04209855|455805163|FG001|Overall Study|PI Discretion|1|||
126685954|NCT04209855|455805162|FG000|Overall Study|Lost to Follow-up|5|||
126685955|NCT04209855|455805163|FG001|Overall Study|Lost to Follow-up|2|||
126759538|NCT02243306|456068602|FG001|Overall Study|Physician Decision|1|||
126759539|NCT00496782|456068606|FG000|Overall Study|Protocol Violation|1|||
126759540|NCT00496782|456068607|FG001|Overall Study|Protocol Violation|2|||
126759541|NCT01288911|456068608|FG000|Double-blind Period|Death|11|||
126438114|NCT01550003|454905148|FG001|Overall Study|Sponsor's decision|5|||
126438115|NCT01550003|454905149|FG002|Overall Study|Sponsor's decision|4|||
126438116|NCT01550003|454905147|FG000|Overall Study|Subject mother passed away|0|||
126438117|NCT01550003|454905148|FG001|Overall Study|Subject mother passed away|1|||
126438118|NCT01550003|454905149|FG002|Overall Study|Subject mother passed away|0|||
126438119|NCT01550003|454905147|FG000|Overall Study|Discontinuation|0|||
126438120|NCT01550003|454905148|FG001|Overall Study|Discontinuation|1|||
126438121|NCT01550003|454905149|FG002|Overall Study|Discontinuation|0|||
126438122|NCT01550003|454905147|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
126438123|NCT01550003|454905148|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
126438124|NCT01550003|454905149|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
126438125|NCT01550003|454905147|FG000|Overall Study|Site closure|0|||
126438126|NCT01550003|454905148|FG001|Overall Study|Site closure|2|||
126438127|NCT01550003|454905149|FG002|Overall Study|Site closure|0|||
126438128|NCT01550003|454905147|FG000|Overall Study|Pregnancy|0|||
126438129|NCT01550003|454905148|FG001|Overall Study|Pregnancy|1|||
126438130|NCT01550003|454905149|FG002|Overall Study|Pregnancy|0|||
126438131|NCT01550003|454905147|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
126438132|NCT01550003|454905148|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
126438133|NCT01550003|454905149|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
126438134|NCT01550003|454905147|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
126438135|NCT01550003|454905148|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
126438136|NCT01550003|454905149|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
126438137|NCT01550003|454905147|FG000|Overall Study|Switching to adult rheumatologist|0|||
126438138|NCT01550003|454905148|FG001|Overall Study|Switching to adult rheumatologist|0|||
126438139|NCT01550003|454905149|FG002|Overall Study|Switching to adult rheumatologist|1|||
126438140|NCT01550003|454905147|FG000|Overall Study|Patient transition to adult care|0|||
126438141|NCT01550003|454905148|FG001|Overall Study|Patient transition to adult care|0|||
126438142|NCT01550003|454905149|FG002|Overall Study|Patient transition to adult care|1|||
126438143|NCT01550003|454905147|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
126438144|NCT01550003|454905148|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
126438145|NCT01550003|454905149|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
126438146|NCT01550003|454905147|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
126438147|NCT01550003|454905148|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
126438148|NCT01550003|454905149|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
126438149|NCT01550003|454905147|FG000|Overall Study|Per Sponsor request|1|||
126438150|NCT01550003|454905148|FG001|Overall Study|Per Sponsor request|0|||
126438151|NCT01550003|454905149|FG002|Overall Study|Per Sponsor request|1|||
126438152|NCT01550003|454905147|FG000|Overall Study|Patient not compliance|0|||
126438153|NCT01550003|454905148|FG001|Overall Study|Patient not compliance|0|||
126438154|NCT01550003|454905149|FG002|Overall Study|Patient not compliance|1|||
126438155|NCT01550003|454905147|FG000|Overall Study|Non-compliance|0|||
126438156|NCT01550003|454905148|FG001|Overall Study|Non-compliance|0|||
126438157|NCT01550003|454905149|FG002|Overall Study|Non-compliance|1|||
126438158|NCT01550003|454905147|FG000|Overall Study|Study closed|0|||
126438159|NCT01550003|454905148|FG001|Overall Study|Study closed|1|||
126438160|NCT01550003|454905149|FG002|Overall Study|Study closed|0|||
126438161|NCT01550003|454905147|FG000|Overall Study|Transitioned to adult rheumatology|0|||
126438162|NCT01550003|454905148|FG001|Overall Study|Transitioned to adult rheumatology|0|||
126438163|NCT01550003|454905149|FG002|Overall Study|Transitioned to adult rheumatology|1|||
126438164|NCT01656408|454905150|FG000|Overall Study|Adverse Event|0|||
126438165|NCT01656408|454905151|FG001|Overall Study|Adverse Event|0|||
126438166|NCT01656408|454905152|FG002|Overall Study|Adverse Event|1|||
126438167|NCT01656408|454905153|FG003|Overall Study|Adverse Event|0|||
126438168|NCT01656408|454905154|FG004|Overall Study|Adverse Event|0|||
126438169|NCT01656408|454905155|FG005|Overall Study|Adverse Event|1|||
126438170|NCT01656408|454905156|FG006|Overall Study|Adverse Event|1|||
126438171|NCT01656408|454905157|FG007|Overall Study|Adverse Event|0|||
126685956|NCT04209855|455805162|FG000|Overall Study|Withdrew consent|10|||
126685957|NCT04209855|455805163|FG001|Overall Study|Withdrew consent|24|||
126685958|NCT04209855|455805162|FG000|Overall Study|Sponsor decision|44|||
126685959|NCT04209855|455805163|FG001|Overall Study|Sponsor decision|18|||
126685960|NCT04209855|455805162|FG000|Overall Study|Other than specified|6|||
126685961|NCT04209855|455805163|FG001|Overall Study|Other than specified|4|||
126685962|NCT01250379|455805166|FG000|Overall Study|Death|141|||
126685963|NCT01250379|455805167|FG001|Overall Study|Death|148|||
126685964|NCT01250379|455805166|FG000|Overall Study|Withdrawal by Subject|32|||
126685965|NCT01250379|455805167|FG001|Overall Study|Withdrawal by Subject|20|||
126438172|NCT01656408|454905158|FG008|Overall Study|Adverse Event|1|||
126438173|NCT01656408|454905159|FG009|Overall Study|Adverse Event|0|||
126438174|NCT01656408|454905150|FG000|Overall Study|Physician Decision|1|||
126438175|NCT01656408|454905151|FG001|Overall Study|Physician Decision|0|||
126685966|NCT01250379|455805166|FG000|Overall Study|Physician Decision|11|||
126685967|NCT01250379|455805167|FG001|Overall Study|Physician Decision|3|||
126685968|NCT01250379|455805166|FG000|Overall Study|Protocol Violation|2|||
126685969|NCT01250379|455805167|FG001|Overall Study|Protocol Violation|8|||
126685970|NCT01250379|455805166|FG000|Overall Study|Lost to Follow-up|9|||
126685971|NCT01250379|455805167|FG001|Overall Study|Lost to Follow-up|6|||
126685972|NCT01250379|455805166|FG000|Overall Study|Adverse Event|5|||
126685973|NCT01250379|455805167|FG001|Overall Study|Adverse Event|4|||
126685974|NCT01250379|455805166|FG000|Overall Study|Other|0|||
126685975|NCT01250379|455805167|FG001|Overall Study|Other|4|||
126685976|NCT01250379|455805166|FG000|Overall Study|Participant noncompliance|2|||
126685977|NCT01250379|455805167|FG001|Overall Study|Participant noncompliance|0|||
126685978|NCT05902364|455805168|FG000|Overall Study|Adverse Event|1|||
126685979|NCT05902364|455805169|FG001|Overall Study|Adverse Event|0|||
126685980|NCT01489527|455805171|FG000|Overall Study|Pregnancy|9|||
126685981|NCT01489527|455805172|FG001|Overall Study|Pregnancy|14|||
126685982|NCT01489527|455805171|FG000|Overall Study|Participant moved|6|||
126685983|NCT01489527|455805172|FG001|Overall Study|Participant moved|7|||
126685984|NCT01489527|455805171|FG000|Overall Study|Withdrawal by Subject|0|||
126685985|NCT01489527|455805172|FG001|Overall Study|Withdrawal by Subject|4|||
126685986|NCT01489527|455805171|FG000|Overall Study|Lost to Follow-up|5|||
126685987|NCT01489527|455805172|FG001|Overall Study|Lost to Follow-up|1|||
126685988|NCT01489527|455805171|FG000|Overall Study|Procedures|1|||
126685989|NCT01489527|455805172|FG001|Overall Study|Procedures|0|||
126685990|NCT01489527|455805171|FG000|Overall Study|Not compliant|1|||
126685991|NCT01489527|455805172|FG001|Overall Study|Not compliant|0|||
126685992|NCT01984268|455805173|FG000|Overall Study|Study Terminated|15|||
126685993|NCT04899232|455805174|FG000|Screening Period|Physician Decision|1|||
126685994|NCT04899232|455805175|FG001|Screening Period|Physician Decision|0|||
126685995|NCT04899232|455805176|FG002|Screening Period|Physician Decision|0|||
126685996|NCT04899232|455805174|FG000|Screening Period|Withdrawal by Subject|1|||
126685997|NCT04899232|455805175|FG001|Screening Period|Withdrawal by Subject|0|||
126685998|NCT04899232|455805176|FG002|Screening Period|Withdrawal by Subject|0|||
126685999|NCT04899232|455805174|FG000|Screening Period|Participant discharged before receiving intervention|3|||
126686000|NCT04899232|455805175|FG001|Screening Period|Participant discharged before receiving intervention|0|||
126686001|NCT04899232|455805176|FG002|Screening Period|Participant discharged before receiving intervention|0|||
126686002|NCT00936208|455805178|FG000|Overall Study|Protocol Violation|37|||
126686003|NCT00936208|455805179|FG001|Overall Study|Protocol Violation|22|||
126686004|NCT01344876|455805182|FG000|Overall Study|Adverse Event|0|||
126686005|NCT01344876|455805183|FG001|Overall Study|Adverse Event|0|||
126686006|NCT01344876|455805184|FG002|Overall Study|Adverse Event|0|||
126686007|NCT01344876|455805185|FG003|Overall Study|Adverse Event|0|||
126686008|NCT01344876|455805186|FG004|Overall Study|Adverse Event|1|||
126686009|NCT01344876|455805182|FG000|Overall Study|Withdrawal by Subject|0|||
126686010|NCT01344876|455805183|FG001|Overall Study|Withdrawal by Subject|0|||
126686011|NCT01344876|455805184|FG002|Overall Study|Withdrawal by Subject|1|||
126686012|NCT01344876|455805185|FG003|Overall Study|Withdrawal by Subject|0|||
126686013|NCT01344876|455805186|FG004|Overall Study|Withdrawal by Subject|0|||
126686014|NCT01344876|455805182|FG000|Overall Study|Definite progression of primary disease|1|||
126686015|NCT01344876|455805183|FG001|Overall Study|Definite progression of primary disease|0|||
126686016|NCT01344876|455805184|FG002|Overall Study|Definite progression of primary disease|0|||
126686017|NCT01344876|455805185|FG003|Overall Study|Definite progression of primary disease|3|||
126686018|NCT01344876|455805186|FG004|Overall Study|Definite progression of primary disease|0|||
126686019|NCT04428424|455805187|FG000|Overall Study|Does not meet entrance criteria|132|||
126759542|NCT01288911|456068609|FG001|Double-blind Period|Death|7|||
126759543|NCT01288911|456068608|FG000|Double-blind Period|Lost to Follow-up|0|||
126759544|NCT01288911|456068609|FG001|Double-blind Period|Lost to Follow-up|2|||
126759545|NCT01288911|456068608|FG000|Double-blind Period|Progressive Disease|75|||
126759546|NCT01288911|456068609|FG001|Double-blind Period|Progressive Disease|103|||
126759547|NCT01288911|456068608|FG000|Double-blind Period|Protocol Violation|1|||
126759548|NCT01288911|456068609|FG001|Double-blind Period|Protocol Violation|0|||
126759549|NCT01288911|456068608|FG000|Double-blind Period|Withdrawal by Subject|25|||
126759550|NCT01288911|456068609|FG001|Double-blind Period|Withdrawal by Subject|26|||
126759551|NCT01288911|456068608|FG000|Double-blind Period|Miscellaneous Reason|29|||
126759552|NCT01288911|456068609|FG001|Double-blind Period|Miscellaneous Reason|42|||
126759553|NCT01288911|456068608|FG000|Double-blind Period|Randomized but never received study drug|1|||
126759554|NCT01288911|456068609|FG001|Double-blind Period|Randomized but never received study drug|2|||
126759555|NCT01288911|456068608|FG000|Open-label Period (All Enzalutamide)|Death|0|||
126759556|NCT01288911|456068609|FG001|Open-label Period (All Enzalutamide)|Death|1|||
126759557|NCT01288911|456068608|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
126759558|NCT01288911|456068609|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
126545384|NCT02541383|455290826|FG003|Overall Study|Death|41|||
126686020|NCT04428424|455805187|FG000|Overall Study|Lost to Follow-up|115|||
126686021|NCT04526665|455805188|FG000|Overall Study|Withdrawal by Subject|6|||
126686022|NCT04526665|455805189|FG001|Overall Study|Withdrawal by Subject|3|||
126686023|NCT04526665|455805188|FG000|Overall Study|Adverse Event|4|||
126686024|NCT04526665|455805189|FG001|Overall Study|Adverse Event|1|||
126759559|NCT01288911|456068608|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
126686025|NCT04526665|455805188|FG000|Overall Study|Physician Decision|2|||
126686026|NCT04526665|455805189|FG001|Overall Study|Physician Decision|2|||
126686027|NCT04526665|455805188|FG000|Overall Study|Death|2|||
126686028|NCT04526665|455805189|FG001|Overall Study|Death|0|||
126686029|NCT04526665|455805188|FG000|Overall Study|Other|0|||
126686030|NCT04526665|455805189|FG001|Overall Study|Other|1|||
126686031|NCT04622046|455805190|FG000|Intervention Period|Adverse Event|1|||
126686032|NCT04622046|455805190|FG000|Intervention Period|Withdrawal by Subject|2|||
126686033|NCT04622046|455805190|FG000|Extension Period|Ongoing in the Extension Period|21|||
126686034|NCT04647253|455805191|FG000|Overall Study|Death ≤ 365 Days|16|||
126686035|NCT04647253|455805192|FG001|Overall Study|Death ≤ 365 Days|7|||
126686036|NCT04647253|455805191|FG000|Overall Study|Physician Decision|0|||
126686037|NCT04647253|455805192|FG001|Overall Study|Physician Decision|1|||
126686038|NCT04647253|455805191|FG000|Overall Study|Withdrawal by Subject|7|||
126686039|NCT04647253|455805192|FG001|Overall Study|Withdrawal by Subject|2|||
126686040|NCT04647253|455805191|FG000|Overall Study|Missed 12-Month Visit|9|||
126686041|NCT04647253|455805192|FG001|Overall Study|Missed 12-Month Visit|7|||
126686042|NCT04647253|455805191|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
126686043|NCT04647253|455805192|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
126686044|NCT01284114|455806510|FG000|Overall Study|viral infection|1|||
126686045|NCT01284114|455806510|FG000|Overall Study|From the results of ALLTITUDE study|1|||
126686046|NCT01284114|455806510|FG000|Overall Study|Symptomatic hypotension|1|||
126686047|NCT01284114|455806510|FG000|Overall Study|dizziness|1|||
126686048|NCT03445000|455806512|FG000|Overall Study|Disease progression|8|||
126686049|NCT03445000|455806512|FG000|Overall Study|Adverse Event|3|||
126686050|NCT03445000|455806512|FG000|Overall Study|Death|2|||
126686051|NCT03445000|455806512|FG000|Overall Study|Physician Decision|1|||
126686052|NCT03704194|455806525|FG000|Overall Study|Withdrawal by Subject|0|||
126686053|NCT03704194|455806526|FG001|Overall Study|Withdrawal by Subject|1|||
126686054|NCT04656652|455806531|FG000|Overall Study|Lost to Follow-up|2|||
126686055|NCT04656652|455806532|FG001|Overall Study|Lost to Follow-up|2|||
126686056|NCT04656652|455806531|FG000|Overall Study|Death|213|||
126686057|NCT04656652|455806532|FG001|Overall Study|Death|212|||
126686058|NCT04656652|455806531|FG000|Overall Study|Other|1|||
126686059|NCT04656652|455806532|FG001|Overall Study|Other|0|||
126686060|NCT04656652|455806531|FG000|Overall Study|Withdrawal by Subject|15|||
126686061|NCT04656652|455806532|FG001|Overall Study|Withdrawal by Subject|29|||
126686062|NCT03118297|455806533|FG000|Overall Study|Lost to Follow-up|0|||
126686063|NCT03118297|455806534|FG001|Overall Study|Lost to Follow-up|2|||
126438176|NCT01656408|454905152|FG002|Overall Study|Physician Decision|1|||
126438177|NCT01656408|454905153|FG003|Overall Study|Physician Decision|0|||
126438178|NCT01656408|454905154|FG004|Overall Study|Physician Decision|1|||
126438179|NCT01656408|454905155|FG005|Overall Study|Physician Decision|1|||
126438180|NCT01656408|454905156|FG006|Overall Study|Physician Decision|0|||
126438181|NCT01656408|454905157|FG007|Overall Study|Physician Decision|1|||
126438182|NCT01656408|454905158|FG008|Overall Study|Physician Decision|1|||
126438183|NCT01656408|454905159|FG009|Overall Study|Physician Decision|3|||
126438184|NCT01690143|454905162|FG000|Overall Study|Withdrawal by Subject|1|||
126438185|NCT03995368|454905163|FG000|Overall Study|Lost to Follow-up|1|||
126438186|NCT03995368|454905164|FG001|Overall Study|Lost to Follow-up|4|||
126438187|NCT03995368|454905165|FG002|Overall Study|Lost to Follow-up|1|||
126438188|NCT03995368|454905163|FG000|Overall Study|Did not meet inclusion criteria|1|||
126438189|NCT03995368|454905164|FG001|Overall Study|Did not meet inclusion criteria|6|||
126438190|NCT03995368|454905165|FG002|Overall Study|Did not meet inclusion criteria|3|||
126438191|NCT03995368|454905163|FG000|Overall Study|Withdrawal by Subject|0|||
126438192|NCT03995368|454905164|FG001|Overall Study|Withdrawal by Subject|1|||
126438193|NCT03995368|454905165|FG002|Overall Study|Withdrawal by Subject|1|||
126438194|NCT03592186|454905166|FG000|Overall Study|Withdrawal by Subject|1|||
126438195|NCT03592186|454905167|FG001|Overall Study|Withdrawal by Subject|0|||
126438196|NCT03592186|454905166|FG000|Overall Study|Lost to Follow-up|16|||
126438197|NCT03592186|454905167|FG001|Overall Study|Lost to Follow-up|11|||
126438198|NCT00361296|454905174|FG000|Overall Study|Physician Decision|1|||
126438199|NCT00361296|454905174|FG000|Overall Study|Lack of Efficacy|2|||
126438200|NCT00198822|454905175|FG000|Overall Study|Lost to Follow-up|14|||
126438201|NCT00198822|454905176|FG001|Overall Study|Lost to Follow-up|20|||
126438202|NCT00198822|454905177|FG002|Overall Study|Lost to Follow-up|21|||
126438203|NCT03011099|454905180|FG000|Overall Study|Withdrawal by Subject|0|||
126438204|NCT03011099|454905181|FG001|Overall Study|Withdrawal by Subject|2|||
126438205|NCT02072668|454905185|FG000|Second Intervention|Lost to Follow-up|1|||
126438206|NCT02072668|454905186|FG001|Second Intervention|Lost to Follow-up|0|||
126438207|NCT01409707|454905187|FG000|Overall Study|Withdrawal by Subject|5|||
126438208|NCT01409707|454905188|FG001|Overall Study|Withdrawal by Subject|17|||
126438209|NCT01409707|454905189|FG002|Overall Study|Withdrawal by Subject|16|||
126438210|NCT01658436|454905190|FG000|Overall Study|Adverse Event|6|||
126438211|NCT01658436|454905191|FG001|Overall Study|Adverse Event|5|||
126438212|NCT01658436|454905190|FG000|Overall Study|Physician Decision|1|||
126438213|NCT01658436|454905191|FG001|Overall Study|Physician Decision|0|||
126438214|NCT01658436|454905190|FG000|Overall Study|Progressive disease|12|||
126438215|NCT01658436|454905191|FG001|Overall Study|Progressive disease|4|||
126438216|NCT01658436|454905190|FG000|Overall Study|Study terminated by sponsor|0|||
126438217|NCT01658436|454905191|FG001|Overall Study|Study terminated by sponsor|1|||
126438218|NCT01658436|454905190|FG000|Overall Study|Subject/guardian decision|0|||
126438219|NCT01658436|454905191|FG001|Overall Study|Subject/guardian decision|1|||
126438220|NCT01658436|454905190|FG000|Overall Study|Death|1|||
126438221|NCT01658436|454905191|FG001|Overall Study|Death|0|||
126438222|NCT01217229|454905192|FG000|Overall Study|Adverse Event|1|||
126438223|NCT01217229|454905192|FG000|Overall Study|Disease progression, deterioration|2|||
126438224|NCT01217229|454905192|FG000|Overall Study|Disease progression, Cheson criteria|14|||
126438225|NCT01217229|454905192|FG000|Overall Study|Protocol Violation|1|||
126438226|NCT01217229|454905192|FG000|Overall Study|Disease progression not confirmed|2|||
126438227|NCT04730804|454905202|FG000|Overall Study|Physician Decision|0|||
126686064|NCT02479802|455806535|FG000|Overall Study|Lost to Follow-up|1|||
126686065|NCT02479802|455806535|FG000|Overall Study|Adverse Event|1|||
126686066|NCT01978093|455806536|FG000|Overall Study|Death|1|||
126686067|NCT01978093|455806537|FG001|Overall Study|Death|0|||
126686068|NCT01978093|455806536|FG000|Overall Study|Adverse Event|0|||
126686069|NCT01978093|455806537|FG001|Overall Study|Adverse Event|5|||
126686070|NCT01978093|455806536|FG000|Overall Study|Protocol Violation|8|||
126686071|NCT01978093|455806537|FG001|Overall Study|Protocol Violation|2|||
126438228|NCT04730804|454905203|FG001|Overall Study|Physician Decision|0|||
126438229|NCT04730804|454905204|FG002|Overall Study|Physician Decision|0|||
126438230|NCT04730804|454905205|FG003|Overall Study|Physician Decision|0|||
126438231|NCT04730804|454905206|FG004|Overall Study|Physician Decision|0|||
126438232|NCT04730804|454905207|FG005|Overall Study|Physician Decision|1|||
126438233|NCT04730804|454905202|FG000|Overall Study|Withdrawal by Subject|0|||
126438234|NCT04730804|454905203|FG001|Overall Study|Withdrawal by Subject|0|||
126438235|NCT04730804|454905204|FG002|Overall Study|Withdrawal by Subject|0|||
126438236|NCT04730804|454905205|FG003|Overall Study|Withdrawal by Subject|0|||
126438237|NCT04730804|454905206|FG004|Overall Study|Withdrawal by Subject|1|||
126438238|NCT04730804|454905207|FG005|Overall Study|Withdrawal by Subject|2|||
126438239|NCT05366738|454907552|FG000|Overall Study|Adverse Event|0|||
126438240|NCT05366738|454907553|FG001|Overall Study|Adverse Event|1|||
126438241|NCT05366738|454907554|FG002|Overall Study|Adverse Event|0|||
126438242|NCT01803607|454907557|FG000|Overall Study|Adverse Event|5|||
126686072|NCT01978093|455806536|FG000|Overall Study|Withdrawal by Subject|29|||
126438243|NCT01803607|454907558|FG001|Overall Study|Adverse Event|3|||
126438244|NCT01803607|454907557|FG000|Overall Study|Lack of Efficacy|0|||
126438245|NCT01803607|454907558|FG001|Overall Study|Lack of Efficacy|1|||
126438246|NCT01803607|454907557|FG000|Overall Study|Protocol Violation|3|||
126438247|NCT01803607|454907558|FG001|Overall Study|Protocol Violation|2|||
126438248|NCT01803607|454907557|FG000|Overall Study|Study terminated by sponsor|54|||
126438249|NCT01803607|454907558|FG001|Overall Study|Study terminated by sponsor|56|||
126438250|NCT01803607|454907557|FG000|Overall Study|Withdrawal by Subject|6|||
126438251|NCT01803607|454907558|FG001|Overall Study|Withdrawal by Subject|5|||
126438252|NCT01281124|454907564|FG000|Overall Study|Death|1|||
126438253|NCT03038100|454907565|FG000|Overall Study|Death|289|||
126438254|NCT03038100|454907566|FG001|Overall Study|Death|272|||
126438255|NCT03038100|454907565|FG000|Overall Study|Lost to Follow-up|9|||
126438256|NCT03038100|454907566|FG001|Overall Study|Lost to Follow-up|10|||
126438257|NCT03038100|454907565|FG000|Overall Study|Protocol Deviation|1|||
126438258|NCT03038100|454907566|FG001|Overall Study|Protocol Deviation|4|||
126438259|NCT03038100|454907565|FG000|Overall Study|Withdrawal by Subject|45|||
126438260|NCT03038100|454907566|FG001|Overall Study|Withdrawal by Subject|51|||
126438261|NCT03038100|454907565|FG000|Overall Study|Study Terminated By Sponsor|305|||
126438262|NCT03038100|454907566|FG001|Overall Study|Study Terminated By Sponsor|311|||
126438263|NCT03038100|454907565|FG000|Overall Study|Physician Decision|1|||
126438264|NCT03038100|454907566|FG001|Overall Study|Physician Decision|3|||
126438265|NCT02392624|454907567|FG000|Overall Study|Withdrawal by Subject|15|||
126438266|NCT02392624|454907568|FG001|Overall Study|Withdrawal by Subject|12|||
126438267|NCT02392624|454907569|FG002|Overall Study|Withdrawal by Subject|9|||
126438268|NCT02392624|454907567|FG000|Overall Study|Adverse Event|4|||
126438269|NCT02392624|454907568|FG001|Overall Study|Adverse Event|1|||
126438270|NCT02392624|454907569|FG002|Overall Study|Adverse Event|2|||
126438271|NCT02392624|454907567|FG000|Overall Study|Pregnancy|1|||
126438272|NCT02392624|454907568|FG001|Overall Study|Pregnancy|0|||
126438273|NCT02392624|454907569|FG002|Overall Study|Pregnancy|0|||
126438274|NCT02392624|454907567|FG000|Overall Study|Protocol Violation|0|||
126438275|NCT02392624|454907568|FG001|Overall Study|Protocol Violation|0|||
126438276|NCT02392624|454907569|FG002|Overall Study|Protocol Violation|1|||
126438277|NCT02392624|454907567|FG000|Overall Study|Sponsor/Investigator Decision|2|||
126438278|NCT02392624|454907568|FG001|Overall Study|Sponsor/Investigator Decision|1|||
126438279|NCT02392624|454907569|FG002|Overall Study|Sponsor/Investigator Decision|0|||
126438280|NCT02392624|454907567|FG000|Overall Study|Other|49|||
126438281|NCT02392624|454907568|FG001|Overall Study|Other|1|||
126438282|NCT02392624|454907569|FG002|Overall Study|Other|1|||
126438283|NCT00706238|454907570|FG000|Overall Study|Disease progression|4|||
126686073|NCT01978093|455806537|FG001|Overall Study|Withdrawal by Subject|25|||
126686074|NCT01978093|455806536|FG000|Overall Study|Lost to Follow-up|11|||
126686075|NCT01978093|455806537|FG001|Overall Study|Lost to Follow-up|15|||
126686076|NCT01978093|455806536|FG000|Overall Study|Migrated/moved from study area|11|||
126438284|NCT00706238|454907570|FG000|Overall Study|Other|1|||
126438285|NCT03841604|454907575|FG000|Overall Study|Withdrawal by Subject|3|||
126438286|NCT03841604|454907576|FG001|Overall Study|Withdrawal by Subject|1|||
126438287|NCT03841604|454907575|FG000|Overall Study|Adverse Event|4|||
126438288|NCT03841604|454907576|FG001|Overall Study|Adverse Event|2|||
126438289|NCT03841604|454907575|FG000|Overall Study|Physician Decision|1|||
126438290|NCT03841604|454907576|FG001|Overall Study|Physician Decision|0|||
126686077|NCT01978093|455806537|FG001|Overall Study|Migrated/moved from study area|13|||
126686078|NCT01978093|455806536|FG000|Overall Study|Loss of kaiser coverage|4|||
126686079|NCT01978093|455806537|FG001|Overall Study|Loss of kaiser coverage|10|||
126686080|NCT01978093|455806536|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
126686081|NCT01978093|455806537|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
126686082|NCT01978093|455806536|FG000|Overall Study|Mother lost custody of child|0|||
126438291|NCT01417377|454907579|FG000|Overall Study|Lost to Follow-up|12|||
126438292|NCT01417377|454907579|FG000|Overall Study|Enrolled, but not treated|1|||
126438293|NCT02113982|454907580|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
126438294|NCT02113982|454907581|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
126438295|NCT02113982|454907582|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
126438296|NCT02113982|454907583|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
126759560|NCT01288911|456068609|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
126759561|NCT01288911|456068608|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
126759562|NCT01288911|456068609|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
126759563|NCT01288911|456068608|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
126759564|NCT01288911|456068609|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
126759565|NCT01288911|456068608|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
126545385|NCT02541383|455290827|FG004|Overall Study|Death|21|||
126759566|NCT01288911|456068609|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
126759567|NCT02431559|456068610|FG000|Overall Study|Adverse Event|0|||
126759568|NCT02431559|456068611|FG001|Overall Study|Adverse Event|1|||
126759569|NCT02431559|456068612|FG002|Overall Study|Adverse Event|0|||
126759570|NCT02431559|456068613|FG003|Overall Study|Adverse Event|4|||
126759571|NCT02431559|456068610|FG000|Overall Study|Progressive disease|2|||
126759572|NCT02431559|456068611|FG001|Overall Study|Progressive disease|1|||
126759573|NCT02431559|456068612|FG002|Overall Study|Progressive disease|4|||
126759574|NCT02431559|456068613|FG003|Overall Study|Progressive disease|22|||
126759575|NCT02431559|456068610|FG000|Overall Study|Withdrawal by Subject|0|||
126759576|NCT02431559|456068611|FG001|Overall Study|Withdrawal by Subject|1|||
126759577|NCT02431559|456068612|FG002|Overall Study|Withdrawal by Subject|0|||
126759578|NCT02431559|456068613|FG003|Overall Study|Withdrawal by Subject|4|||
126759579|NCT02431559|456068610|FG000|Overall Study|Physician Decision|0|||
126759580|NCT02431559|456068611|FG001|Overall Study|Physician Decision|0|||
126759581|NCT02431559|456068612|FG002|Overall Study|Physician Decision|0|||
126759582|NCT02431559|456068613|FG003|Overall Study|Physician Decision|1|||
126759583|NCT02543918|456068614|FG000|Overall Study|Never treated|0|||
126759584|NCT02543918|456068615|FG001|Overall Study|Never treated|1|||
126686083|NCT01978093|455806537|FG001|Overall Study|Mother lost custody of child|1|||
126686084|NCT01978093|455806536|FG000|Overall Study|Child was in care of grandmother|0|||
126686085|NCT01978093|455806537|FG001|Overall Study|Child was in care of grandmother|1|||
126686086|NCT01978093|455806536|FG000|Overall Study|N/A for vaccine administration|0|||
126686087|NCT01978093|455806537|FG001|Overall Study|N/A for vaccine administration|1|||
126686088|NCT02469090|455806541|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
126686089|NCT02469090|455806542|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
126686090|NCT02469090|455806543|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
126686091|NCT02469090|455806541|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
126686092|NCT02469090|455806542|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
126686093|NCT02469090|455806543|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
126686094|NCT02469090|455806541|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
126686095|NCT02469090|455806542|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
126686096|NCT02469090|455806543|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
126686097|NCT02469090|455806541|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
126686098|NCT02469090|455806542|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
126686099|NCT02469090|455806543|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
126686100|NCT02469090|455806541|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
126686101|NCT02469090|455806542|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
126686102|NCT02469090|455806543|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
126686103|NCT02469090|455806541|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
126686104|NCT02469090|455806542|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
126686105|NCT02469090|455806543|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
126686106|NCT02469090|455806541|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
126686107|NCT02469090|455806542|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
126686108|NCT02469090|455806543|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
126686109|NCT02469090|455806541|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
126686110|NCT02469090|455806542|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
126686111|NCT02469090|455806543|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
126686112|NCT03286842|455806544|FG000|Overall Study|Patients rolled over to another study|80|||
126686113|NCT01391507|455806548|FG000|Overall Study|Death|0|||
126686114|NCT01391507|455806549|FG001|Overall Study|Death|0|||
126686115|NCT01391507|455806550|FG002|Overall Study|Death|0|||
126686116|NCT01391507|455806551|FG003|Overall Study|Death|1|||
126686117|NCT01391507|455806548|FG000|Overall Study|Adverse Event|1|||
126686118|NCT01391507|455806549|FG001|Overall Study|Adverse Event|1|||
126686119|NCT01391507|455806550|FG002|Overall Study|Adverse Event|2|||
126686120|NCT01391507|455806551|FG003|Overall Study|Adverse Event|2|||
126686121|NCT01391507|455806548|FG000|Overall Study|Withdrawal by Subject|1|||
126686122|NCT01391507|455806549|FG001|Overall Study|Withdrawal by Subject|2|||
126759585|NCT02543918|456068614|FG000|Overall Study|Lost to Follow-up|1|||
126759586|NCT02543918|456068615|FG001|Overall Study|Lost to Follow-up|1|||
126759587|NCT02543918|456068614|FG000|Overall Study|Withdrawal by Subject|1|||
126759588|NCT02543918|456068615|FG001|Overall Study|Withdrawal by Subject|1|||
126759589|NCT02543918|456068614|FG000|Overall Study|Adverse Event|1|||
126759590|NCT02543918|456068615|FG001|Overall Study|Adverse Event|1|||
126686123|NCT01391507|455806550|FG002|Overall Study|Withdrawal by Subject|1|||
126686124|NCT01391507|455806551|FG003|Overall Study|Withdrawal by Subject|1|||
126686125|NCT01391507|455806548|FG000|Overall Study|Lack of Efficacy|0|||
126686126|NCT01391507|455806549|FG001|Overall Study|Lack of Efficacy|0|||
126686127|NCT01391507|455806550|FG002|Overall Study|Lack of Efficacy|0|||
126686128|NCT01391507|455806551|FG003|Overall Study|Lack of Efficacy|1|||
126686129|NCT01391507|455806548|FG000|Overall Study|Protocol Violation|2|||
126686130|NCT01391507|455806549|FG001|Overall Study|Protocol Violation|1|||
126686131|NCT01391507|455806550|FG002|Overall Study|Protocol Violation|1|||
126686132|NCT01391507|455806551|FG003|Overall Study|Protocol Violation|2|||
126686133|NCT01453855|455806552|FG000|Overall Study|Adverse Event|3|||
126686134|NCT01453855|455806553|FG001|Overall Study|Adverse Event|4|||
126686135|NCT01453855|455806552|FG000|Overall Study|Lost to Follow-up|2|||
126686136|NCT01453855|455806553|FG001|Overall Study|Lost to Follow-up|1|||
126686137|NCT01453855|455806552|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
126686138|NCT01453855|455806553|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
126686139|NCT01453855|455806552|FG000|Overall Study|Noncompliance|1|||
126686140|NCT01453855|455806553|FG001|Overall Study|Noncompliance|0|||
126686141|NCT01453855|455806552|FG000|Overall Study|Inadequate Control of IOP|1|||
126686142|NCT01453855|455806553|FG001|Overall Study|Inadequate Control of IOP|5|||
126686143|NCT01453855|455806552|FG000|Overall Study|Other|0|||
126686144|NCT01453855|455806553|FG001|Overall Study|Other|1|||
126686145|NCT01496066|455806560|FG000|Overall Study|Lost to Follow-up|8|||
126686146|NCT01496066|455806561|FG001|Overall Study|Lost to Follow-up|5|||
126686147|NCT01496066|455806560|FG000|Overall Study|Explant|3|||
126759591|NCT01411917|456068626|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
126686148|NCT01496066|455806561|FG001|Overall Study|Explant|0|||
126686149|NCT01496066|455806560|FG000|Overall Study|Death|1|||
126686150|NCT01496066|455806561|FG001|Overall Study|Death|4|||
126686151|NCT00070941|455806565|FG000|Overall Study|Adverse Event|10|||
126686152|NCT00070941|455806566|FG001|Overall Study|Adverse Event|8|||
126686153|NCT00070941|455806567|FG002|Overall Study|Adverse Event|4|||
126686154|NCT00094055|455806568|FG000|Overall Study|Adverse Event|11|||
126686155|NCT00094055|455806568|FG000|Overall Study|Death|4|||
126686156|NCT00094055|455806568|FG000|Overall Study|Lack of Efficacy|17|||
126686157|NCT00094055|455806568|FG000|Overall Study|Lost to Follow-up|2|||
126686158|NCT00094055|455806568|FG000|Overall Study|progressive disease|2|||
126686159|NCT00094055|455806568|FG000|Overall Study|clinical progression|1|||
126686160|NCT00094055|455806568|FG000|Overall Study|roll-over to another study|14|||
126686161|NCT00094055|455806568|FG000|Overall Study|Withdrawal by Subject|9|||
126686162|NCT00411554|455806570|FG000|Overall Study|Adverse Event|2|||
126686163|NCT00411554|455806571|FG001|Overall Study|Adverse Event|4|||
126759592|NCT01411917|456068627|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
126759593|NCT00540228|456068634|FG000|Overall Study|Adverse Event|2|||
126759594|NCT00540228|456068635|FG001|Overall Study|Adverse Event|0|||
126759595|NCT00540228|456068636|FG002|Overall Study|Adverse Event|0|||
126759596|NCT00540228|456068637|FG003|Overall Study|Adverse Event|0|||
126759597|NCT00540228|456068638|FG004|Overall Study|Adverse Event|0|||
126759598|NCT00540228|456068634|FG000|Overall Study|Lost to Follow-up|1|||
126759599|NCT00540228|456068635|FG001|Overall Study|Lost to Follow-up|1|||
126759600|NCT00540228|456068636|FG002|Overall Study|Lost to Follow-up|0|||
126759601|NCT00540228|456068637|FG003|Overall Study|Lost to Follow-up|0|||
126759602|NCT00540228|456068638|FG004|Overall Study|Lost to Follow-up|0|||
126759603|NCT02451137|456068641|FG000|Overall Study|Randomized but not treated|19|||
126759604|NCT02451137|456068642|FG001|Overall Study|Randomized but not treated|27|||
126759605|NCT02451137|456068641|FG000|Overall Study|Adverse Event|43|||
126759606|NCT02451137|456068642|FG001|Overall Study|Adverse Event|42|||
126759607|NCT02451137|456068641|FG000|Overall Study|Lack of Efficacy|4|||
126759608|NCT02451137|456068642|FG001|Overall Study|Lack of Efficacy|9|||
126759609|NCT02451137|456068641|FG000|Overall Study|Participant decision:discontinue insulin|41|||
126759610|NCT02451137|456068642|FG001|Overall Study|Participant decision:discontinue insulin|43|||
126759611|NCT02451137|456068641|FG000|Overall Study|Hypoglycemia|2|||
126759612|NCT02451137|456068642|FG001|Overall Study|Hypoglycemia|1|||
126759613|NCT02451137|456068641|FG000|Overall Study|Investigator's decision|23|||
126759614|NCT02451137|456068642|FG001|Overall Study|Investigator's decision|19|||
126759615|NCT02451137|456068641|FG000|Overall Study|Lost to Follow-up|53|||
126759616|NCT02451137|456068642|FG001|Overall Study|Lost to Follow-up|61|||
126759617|NCT02451137|456068641|FG000|Overall Study|Physician Decision|6|||
126759618|NCT02451137|456068642|FG001|Overall Study|Physician Decision|5|||
126759619|NCT02451137|456068641|FG000|Overall Study|Sponsor decision|13|||
126686164|NCT00411554|455806570|FG000|Overall Study|Lack of Efficacy|2|||
126686165|NCT00411554|455806571|FG001|Overall Study|Lack of Efficacy|5|||
126759620|NCT02451137|456068642|FG001|Overall Study|Sponsor decision|25|||
126759621|NCT02451137|456068641|FG000|Overall Study|Withdrawal by Subject|40|||
126349922|NCT03575364|454574065|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
126686166|NCT00411554|455806570|FG000|Overall Study|Withdrawal by Subject|3|||
126686167|NCT00411554|455806571|FG001|Overall Study|Withdrawal by Subject|0|||
126686168|NCT00411554|455806570|FG000|Overall Study|Patient Moved|1|||
126349923|NCT04092777|454574069|FG000|Overall Study|Lost to Follow-up|28|||
126349924|NCT04092777|454574070|FG001|Overall Study|Lost to Follow-up|46|||
126349925|NCT04092777|454574069|FG000|Overall Study|Withdrawal by Subject|8|||
126438297|NCT02113982|454907584|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
126438298|NCT02113982|454907585|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
126438299|NCT02113982|454907586|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
126349926|NCT04092777|454574070|FG001|Overall Study|Withdrawal by Subject|5|||
126349927|NCT02306161|454574071|FG000|Overall Study|Death|1|||
126686169|NCT00411554|455806571|FG001|Overall Study|Patient Moved|0|||
126686170|NCT00699907|455806572|FG000|Overall Study|Withdrawal by Subject|2|||
126686171|NCT00699907|455806573|FG001|Overall Study|Withdrawal by Subject|1|||
126686172|NCT00699907|455806574|FG002|Overall Study|Withdrawal by Subject|0|||
126686173|NCT00699907|455806572|FG000|Overall Study|No usable sample|0|||
126686174|NCT00699907|455806573|FG001|Overall Study|No usable sample|9|||
126686175|NCT00699907|455806574|FG002|Overall Study|No usable sample|8|||
126686176|NCT02161211|455806575|FG000|Overall Study|Lost to Follow-up|21|||
126349928|NCT02306161|454574072|FG001|Overall Study|Death|3|||
126349929|NCT02306161|454574071|FG000|Overall Study|Lack of Efficacy|20|||
126349930|NCT02306161|454574072|FG001|Overall Study|Lack of Efficacy|43|||
126349931|NCT02306161|454574071|FG000|Overall Study|Physician Decision|30|||
126349932|NCT02306161|454574072|FG001|Overall Study|Physician Decision|18|||
126349933|NCT02306161|454574071|FG000|Overall Study|Withdrawal by Subject|4|||
126349934|NCT02306161|454574072|FG001|Overall Study|Withdrawal by Subject|0|||
126349935|NCT02306161|454574071|FG000|Overall Study|Ineligible|9|||
126349936|NCT02306161|454574072|FG001|Overall Study|Ineligible|5|||
126349937|NCT01081951|454574073|FG000|Overall Study|Death|54|||
126349938|NCT01081951|454574074|FG001|Overall Study|Death|47|||
126349939|NCT01081951|454574073|FG000|Overall Study|Withdrawal by Subject|2|||
126349940|NCT01081951|454574074|FG001|Overall Study|Withdrawal by Subject|6|||
126349941|NCT01081951|454574073|FG000|Overall Study|Allocated treatment but did not take it|0|||
126686177|NCT02161211|455806576|FG001|Overall Study|Lost to Follow-up|27|||
126686178|NCT02161211|455806577|FG002|Overall Study|Lost to Follow-up|21|||
126759622|NCT02451137|456068642|FG001|Overall Study|Withdrawal by Subject|63|||
126759623|NCT02451137|456068641|FG000|Overall Study|Other than specified above|2|||
126759624|NCT02451137|456068642|FG001|Overall Study|Other than specified above|3|||
126759625|NCT01977573|456068645|FG000|Overall Study|Adverse Event|7|||
126759626|NCT01977573|456068646|FG001|Overall Study|Adverse Event|0|||
126759627|NCT01977573|456068647|FG002|Overall Study|Adverse Event|2|||
126759628|NCT01977573|456068648|FG003|Overall Study|Adverse Event|1|||
126759629|NCT01977573|456068645|FG000|Overall Study|Lost to Follow-up|1|||
126759630|NCT01977573|456068646|FG001|Overall Study|Lost to Follow-up|0|||
126759631|NCT01977573|456068647|FG002|Overall Study|Lost to Follow-up|0|||
126759632|NCT01977573|456068648|FG003|Overall Study|Lost to Follow-up|1|||
126759633|NCT01977573|456068645|FG000|Overall Study|Physician Decision|1|||
126759634|NCT01977573|456068646|FG001|Overall Study|Physician Decision|0|||
126759635|NCT01977573|456068647|FG002|Overall Study|Physician Decision|0|||
126686179|NCT02161211|455806575|FG000|Overall Study|Dropped|12|||
126686180|NCT02161211|455806576|FG001|Overall Study|Dropped|5|||
126438300|NCT02113982|454907587|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
126438301|NCT02113982|454907588|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
126438302|NCT02113982|454907589|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
126438303|NCT02113982|454907590|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
126438304|NCT02113982|454907591|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
126438305|NCT02113982|454907592|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
126438306|NCT02113982|454907593|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
126438307|NCT02113982|454907580|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
126438308|NCT02113982|454907581|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
126438309|NCT02113982|454907582|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
126438310|NCT02113982|454907583|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
126438311|NCT02113982|454907584|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
126438312|NCT02113982|454907585|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
126438313|NCT02113982|454907586|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
126438314|NCT02113982|454907587|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
126438315|NCT02113982|454907588|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
126438316|NCT02113982|454907589|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
126438317|NCT02113982|454907590|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
126438318|NCT02113982|454907591|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
126438319|NCT02113982|454907592|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
126438320|NCT02113982|454907593|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
126686181|NCT02161211|455806577|FG002|Overall Study|Dropped|9|||
126686182|NCT00430508|455806578|FG000|Overall Study|Adverse Event|2|||
126686183|NCT00430508|455806579|FG001|Overall Study|Adverse Event|3|||
126686184|NCT00430508|455806580|FG002|Overall Study|Adverse Event|5|||
126686185|NCT00430508|455806581|FG003|Overall Study|Adverse Event|3|||
126686186|NCT00430508|455806578|FG000|Overall Study|Withdrawal by Subject|0|||
126686187|NCT00430508|455806579|FG001|Overall Study|Withdrawal by Subject|1|||
126686188|NCT00430508|455806580|FG002|Overall Study|Withdrawal by Subject|1|||
126686189|NCT00430508|455806581|FG003|Overall Study|Withdrawal by Subject|1|||
126686190|NCT00430508|455806578|FG000|Overall Study|responder at visit 4|0|||
126686191|NCT00430508|455806579|FG001|Overall Study|responder at visit 4|0|||
126686192|NCT00430508|455806580|FG002|Overall Study|responder at visit 4|2|||
126686193|NCT00430508|455806581|FG003|Overall Study|responder at visit 4|0|||
126686194|NCT00430508|455806578|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
126686195|NCT00430508|455806579|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
126686196|NCT00430508|455806580|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
126686197|NCT00430508|455806581|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
126686198|NCT00430508|455806578|FG000|Overall Study|Other|1|||
126686199|NCT00430508|455806579|FG001|Overall Study|Other|1|||
126686200|NCT00430508|455806580|FG002|Overall Study|Other|3|||
126686201|NCT00430508|455806581|FG003|Overall Study|Other|0|||
126686202|NCT04673786|455806586|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
126686203|NCT04673786|455806587|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
126686204|NCT04673786|455806588|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
126686205|NCT04673786|455806586|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
126686206|NCT04673786|455806587|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
126686207|NCT04673786|455806588|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
126686208|NCT04673786|455806586|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
126686209|NCT04673786|455806587|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
126686210|NCT04673786|455806588|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
126759636|NCT01977573|456068648|FG003|Overall Study|Physician Decision|0|||
126686211|NCT04673786|455806586|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
126686212|NCT04673786|455806587|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
126686213|NCT04673786|455806588|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
126545386|NCT02541383|455290828|FG005|Overall Study|Death|25|||
126349942|NCT01081951|454574074|FG001|Overall Study|Allocated treatment but did not take it|1|||
126349943|NCT01081951|454574073|FG000|Overall Study|Lost to Follow-up|0|||
126349944|NCT01081951|454574074|FG001|Overall Study|Lost to Follow-up|1|||
126349945|NCT03806296|454574080|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
126349946|NCT03806296|454574081|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
126349947|NCT03806296|454574082|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
126349948|NCT03806296|454574080|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
126349949|NCT03806296|454574081|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
126349950|NCT03806296|454574082|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
126349951|NCT03806296|454574080|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
126349952|NCT03806296|454574081|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
126349953|NCT03806296|454574082|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
126349954|NCT04896385|454574083|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
126349955|NCT04896385|454574084|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
126349956|NCT04896385|454574085|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
126349957|NCT04896385|454574086|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
126349958|NCT04896385|454574083|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
126349959|NCT04896385|454574084|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
126349960|NCT04896385|454574085|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
126349961|NCT04896385|454574086|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
126349962|NCT04896385|454574083|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
126349963|NCT04896385|454574084|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
126349964|NCT04896385|454574085|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
126349965|NCT04896385|454574086|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
126349966|NCT04896385|454574083|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
126349967|NCT04896385|454574084|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
126349968|NCT04896385|454574085|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
126349969|NCT04896385|454574086|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
126349970|NCT04896385|454574083|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
126349971|NCT04896385|454574084|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
126349972|NCT04896385|454574085|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
126349973|NCT04896385|454574086|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
126349974|NCT04896385|454574083|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
126545387|NCT02541383|455290823|FG000|Overall Study|Lost to Follow-up|5|||
126349975|NCT04896385|454574084|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
126349976|NCT04896385|454574085|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
126349977|NCT04896385|454574086|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
126349978|NCT01931098|454574090|FG000|Overall Study|Withdrawal by Subject|0|||
126349979|NCT01931098|454574091|FG001|Overall Study|Withdrawal by Subject|1|||
126349980|NCT01931098|454574090|FG000|Overall Study|Enrolled in different protocol|0|||
126686214|NCT04673786|455806586|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
126686215|NCT04673786|455806587|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
126686216|NCT04673786|455806588|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
126759637|NCT01977573|456068645|FG000|Overall Study|Protocol Violation|3|||
126686217|NCT04673786|455806586|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
126349981|NCT01931098|454574091|FG001|Overall Study|Enrolled in different protocol|1|||
126349982|NCT01931098|454574090|FG000|Overall Study|Unable to begin trmt:active infection|0|||
126349983|NCT01931098|454574091|FG001|Overall Study|Unable to begin trmt:active infection|1|||
126349984|NCT01931098|454574090|FG000|Overall Study|Refused further treatment|0|||
126349985|NCT01931098|454574091|FG001|Overall Study|Refused further treatment|1|||
126349986|NCT01901562|454574095|FG000|Overall Study|Protocol Violation|5|||
126349987|NCT01901562|454574095|FG000|Overall Study|Excluded intraoperatively|4|||
126349988|NCT00790036|454574096|FG000|Overall Study|Abnormal lab values|3|||
126349989|NCT00790036|454574097|FG001|Overall Study|Abnormal lab values|2|||
126349990|NCT00790036|454574096|FG000|Overall Study|Administrative problems|5|||
126349991|NCT00790036|454574097|FG001|Overall Study|Administrative problems|9|||
126349992|NCT00790036|454574096|FG000|Overall Study|Adverse Event|113|||
126349993|NCT00790036|454574097|FG001|Overall Study|Adverse Event|44|||
126349994|NCT00790036|454574096|FG000|Overall Study|Death|1|||
126349995|NCT00790036|454574097|FG001|Overall Study|Death|0|||
126349996|NCT00790036|454574096|FG000|Overall Study|Disease progression|24|||
126349997|NCT00790036|454574097|FG001|Overall Study|Disease progression|48|||
126349998|NCT00790036|454574096|FG000|Overall Study|Lost to Follow-up|1|||
126349999|NCT00790036|454574097|FG001|Overall Study|Lost to Follow-up|2|||
126350000|NCT00790036|454574096|FG000|Overall Study|Protocol Violation|10|||
126350001|NCT00790036|454574097|FG001|Overall Study|Protocol Violation|2|||
126350002|NCT00790036|454574096|FG000|Overall Study|Withdrawal by Subject|18|||
126350003|NCT00790036|454574097|FG001|Overall Study|Withdrawal by Subject|7|||
126686218|NCT04673786|455806587|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
126350004|NCT00790036|454574096|FG000|Overall Study|Subject/guardian decision|20|||
126350005|NCT00790036|454574097|FG001|Overall Study|Subject/guardian decision|7|||
126350006|NCT02572167|454574100|FG000|Overall Study|Withdrawal by Subject|0|||
126686219|NCT04673786|455806588|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
126350007|NCT02572167|454574101|FG001|Overall Study|Withdrawal by Subject|3|||
126686220|NCT01422239|455806591|FG000|Overall Study|Lost to Follow-up|4|||
126686221|NCT01422239|455806592|FG001|Overall Study|Lost to Follow-up|3|||
126686222|NCT00903929|455806607|FG000|Overall Study|Withdrawal by Subject|0|||
126686223|NCT00903929|455806608|FG001|Overall Study|Withdrawal by Subject|0|||
126686224|NCT00903929|455806609|FG002|Overall Study|Withdrawal by Subject|1|||
126686225|NCT00903929|455806610|FG003|Overall Study|Withdrawal by Subject|2|||
126686226|NCT00903929|455806607|FG000|Overall Study|Adverse Event|0|||
126686227|NCT00903929|455806608|FG001|Overall Study|Adverse Event|0|||
126686228|NCT00903929|455806609|FG002|Overall Study|Adverse Event|0|||
126686229|NCT00903929|455806610|FG003|Overall Study|Adverse Event|1|||
126686230|NCT00516737|455806616|FG000|Overall Study|Lost to Follow-up|2|||
126686231|NCT00516737|455806617|FG001|Overall Study|Lost to Follow-up|0|||
126686232|NCT00516737|455806616|FG000|Overall Study|Physician Decision|0|||
126686233|NCT00516737|455806617|FG001|Overall Study|Physician Decision|1|||
126686234|NCT00516737|455806616|FG000|Overall Study|Withdrawal by Subject|0|||
126686235|NCT00516737|455806617|FG001|Overall Study|Withdrawal by Subject|1|||
126686236|NCT00516737|455806616|FG000|Overall Study|Lack of Qualifying Event|9|||
126686237|NCT00516737|455806617|FG001|Overall Study|Lack of Qualifying Event|6|||
126686238|NCT01844895|455806618|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
126686239|NCT01844895|455806618|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
126686240|NCT01844895|455806618|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
126686241|NCT01844895|455806618|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
126686242|NCT01844895|455806618|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
126686243|NCT01844895|455806618|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
126686244|NCT01844895|455806618|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
126686245|NCT00511355|455806620|FG000|Overall Study|Adverse Event|4|||
126686246|NCT00511355|455806621|FG001|Overall Study|Adverse Event|4|||
126686247|NCT00511355|455806620|FG000|Overall Study|Pregnancy Wish|1|||
126686248|NCT00511355|455806621|FG001|Overall Study|Pregnancy Wish|0|||
126686249|NCT00511355|455806620|FG000|Overall Study|Lost to Follow-up|2|||
126686250|NCT00511355|455806621|FG001|Overall Study|Lost to Follow-up|1|||
126686251|NCT00511355|455806620|FG000|Overall Study|Other Reason|0|||
126686252|NCT00511355|455806621|FG001|Overall Study|Other Reason|1|||
126686253|NCT00511355|455806620|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
126686254|NCT00511355|455806621|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
126686255|NCT00511355|455806620|FG000|Overall Study|Withdrawal of informed consent|0|||
126686256|NCT00511355|455806621|FG001|Overall Study|Withdrawal of informed consent|1|||
126686257|NCT00511355|455806620|FG000|Overall Study|Other reason pre-treatment|0|||
126686258|NCT00511355|455806621|FG001|Overall Study|Other reason pre-treatment|1|||
126686259|NCT00454805|455806624|FG000|Overall Study|Withdrawal by Subject|9|||
126686260|NCT00454805|455806625|FG001|Overall Study|Withdrawal by Subject|2|||
126686261|NCT00454805|455806624|FG000|Overall Study|Death|0|||
126686262|NCT00454805|455806625|FG001|Overall Study|Death|2|||
126686263|NCT00454805|455806624|FG000|Overall Study|Disease progression|16|||
126686264|NCT00454805|455806625|FG001|Overall Study|Disease progression|19|||
126686265|NCT00454805|455806624|FG000|Overall Study|In order to begin radiotherapy|1|||
126686266|NCT00454805|455806625|FG001|Overall Study|In order to begin radiotherapy|0|||
126686267|NCT03208231|455806636|FG000|Overall Study|Death|1|||
126686268|NCT03208231|455806637|FG001|Overall Study|Death|2|||
126686269|NCT03208231|455806636|FG000|Overall Study|Moved and unable to get to clinic|1|||
126686270|NCT03208231|455806637|FG001|Overall Study|Moved and unable to get to clinic|0|||
126686271|NCT03208231|455806636|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
126686272|NCT03208231|455806637|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
126686273|NCT04347239|455806638|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
126686274|NCT04347239|455806639|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
126686275|NCT04347239|455806640|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
126686276|NCT04347239|455806638|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
126686277|NCT04347239|455806639|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
126686278|NCT04347239|455806640|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
126686279|NCT00644787|455806643|FG000|Period 1: Titration Phase|Adverse Event|11|||
126759638|NCT01977573|456068646|FG001|Overall Study|Protocol Violation|1|||
126759639|NCT01977573|456068647|FG002|Overall Study|Protocol Violation|0|||
126686280|NCT00644787|455806644|FG001|Period 1: Titration Phase|Adverse Event|0|||
126759640|NCT01977573|456068648|FG003|Overall Study|Protocol Violation|0|||
126686281|NCT00644787|455806645|FG002|Period 1: Titration Phase|Adverse Event|0|||
126686282|NCT00644787|455806643|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
126686283|NCT00644787|455806644|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
126759641|NCT01977573|456068645|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
126350008|NCT02572167|454574102|FG002|Overall Study|Withdrawal by Subject|0|||
126350009|NCT02572167|454574100|FG000|Overall Study|Lost to Follow-up|2|||
126686284|NCT00644787|455806645|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
126686285|NCT00644787|455806643|FG000|Period 1: Titration Phase|Physician Decision|1|||
126686286|NCT00644787|455806644|FG001|Period 1: Titration Phase|Physician Decision|0|||
126686287|NCT00644787|455806645|FG002|Period 1: Titration Phase|Physician Decision|0|||
126686288|NCT00644787|455806643|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
126686289|NCT00644787|455806644|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
126686290|NCT00644787|455806645|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
126686291|NCT00644787|455806643|FG000|Period 1: Titration Phase|Worsening of complications|1|||
126686292|NCT00644787|455806644|FG001|Period 1: Titration Phase|Worsening of complications|0|||
126686293|NCT00644787|455806645|FG002|Period 1: Titration Phase|Worsening of complications|0|||
126686294|NCT00644787|455806643|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
126686295|NCT00644787|455806644|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
126686296|NCT00644787|455806645|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
126686297|NCT00644787|455806643|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
126686298|NCT00644787|455806644|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
126686299|NCT00644787|455806645|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
126686300|NCT00644787|455806643|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
126686301|NCT00644787|455806644|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
126686302|NCT00644787|455806645|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
126686303|NCT00644787|455806643|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
126686304|NCT00644787|455806644|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
126686305|NCT00644787|455806645|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
126686306|NCT00644787|455806643|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
126686307|NCT00644787|455806644|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
126686308|NCT00644787|455806645|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
126686309|NCT00644787|455806643|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
126686310|NCT00644787|455806644|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
126686311|NCT00644787|455806645|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
126686312|NCT00644787|455806643|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
126686313|NCT00644787|455806644|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
126686314|NCT00644787|455806645|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
126686315|NCT03355300|455806646|FG000|Overall Study|Physician Decision|0|||
126686316|NCT03355300|455806647|FG001|Overall Study|Physician Decision|1|||
126686317|NCT03355300|455806646|FG000|Overall Study|Lack of Efficacy|2|||
126686318|NCT03355300|455806647|FG001|Overall Study|Lack of Efficacy|1|||
126686319|NCT03355300|455806646|FG000|Overall Study|Other reason|1|||
126686320|NCT03355300|455806647|FG001|Overall Study|Other reason|0|||
126686321|NCT03048422|455806648|FG000|Overall Study|Death|1|||
126686322|NCT03048422|455806649|FG001|Overall Study|Death|0|||
126686323|NCT03048422|455806650|FG002|Overall Study|Death|0|||
126686324|NCT03048422|455806648|FG000|Overall Study|Lost to Follow-up|5|||
126686325|NCT03048422|455806649|FG001|Overall Study|Lost to Follow-up|0|||
126686326|NCT03048422|455806650|FG002|Overall Study|Lost to Follow-up|1|||
126686327|NCT03048422|455806648|FG000|Overall Study|Withdrawal by Subject|5|||
126686328|NCT03048422|455806649|FG001|Overall Study|Withdrawal by Subject|7|||
126686329|NCT03048422|455806650|FG002|Overall Study|Withdrawal by Subject|4|||
126686330|NCT03048422|455806648|FG000|Overall Study|Moved|3|||
126686331|NCT03048422|455806649|FG001|Overall Study|Moved|2|||
126686332|NCT03048422|455806650|FG002|Overall Study|Moved|2|||
126686333|NCT03048422|455806648|FG000|Overall Study|Noncompliant with Study Requirements|2|||
126686334|NCT03048422|455806649|FG001|Overall Study|Noncompliant with Study Requirements|1|||
126686335|NCT03048422|455806650|FG002|Overall Study|Noncompliant with Study Requirements|2|||
126686336|NCT03048422|455806648|FG000|Overall Study|Not Able to Get to Clinic|1|||
126686337|NCT03048422|455806649|FG001|Overall Study|Not Able to Get to Clinic|0|||
126350010|NCT02572167|454574101|FG001|Overall Study|Lost to Follow-up|5|||
126350011|NCT02572167|454574102|FG002|Overall Study|Lost to Follow-up|3|||
126350012|NCT02572167|454574100|FG000|Overall Study|Death|0|||
126350013|NCT02572167|454574101|FG001|Overall Study|Death|8|||
126686338|NCT03048422|455806650|FG002|Overall Study|Not Able to Get to Clinic|0|||
126686339|NCT03110224|455806654|FG000|Overall Study|Death|3|||
126686340|NCT03110224|455806654|FG000|Overall Study|Lost to Follow-up|132|||
126686341|NCT03110224|455806654|FG000|Overall Study|Physician Decision|2|||
126686342|NCT03110224|455806654|FG000|Overall Study|Site Closed by Physician|35|||
126686343|NCT03110224|455806654|FG000|Overall Study|Site Closed by Sponsor|202|||
126686344|NCT03110224|455806654|FG000|Overall Study|Withdrawal by Subject|9|||
126686345|NCT04818593|455806655|FG000|Overall Study|Low Oocyte Yield|8|||
126686346|NCT04818593|455806656|FG001|Overall Study|Low Oocyte Yield|8|||
126350014|NCT02572167|454574102|FG002|Overall Study|Death|3|||
126350015|NCT02572167|454574100|FG000|Overall Study|Did not meet inclusion criteria|0|||
126686347|NCT04818593|455806655|FG000|Overall Study|Not ICSI Insemination|7|||
126686348|NCT04818593|455806656|FG001|Overall Study|Not ICSI Insemination|7|||
126686349|NCT04818593|455806655|FG000|Overall Study|Poor Sperm Quality|2|||
126686350|NCT04818593|455806656|FG001|Overall Study|Poor Sperm Quality|2|||
126350016|NCT02572167|454574101|FG001|Overall Study|Did not meet inclusion criteria|0|||
126350017|NCT02572167|454574102|FG002|Overall Study|Did not meet inclusion criteria|1|||
126350018|NCT02572167|454574100|FG000|Overall Study|Study closure by Sponsor|4|||
126350019|NCT02572167|454574101|FG001|Overall Study|Study closure by Sponsor|40|||
126350020|NCT02572167|454574102|FG002|Overall Study|Study closure by Sponsor|24|||
126350021|NCT00005047|454574103|FG000|Overall Study|Withdrawal by Subject|12|||
126686351|NCT04818593|455806655|FG000|Overall Study|Withdrawal by Subject|2|||
126686352|NCT04818593|455806656|FG001|Overall Study|Withdrawal by Subject|2|||
126686353|NCT04818593|455806655|FG000|Overall Study|Conversion to IUI due to low response|1|||
126686354|NCT04818593|455806656|FG001|Overall Study|Conversion to IUI due to low response|1|||
126686355|NCT01564862|455806657|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
126686356|NCT01564862|455806658|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
126686357|NCT01564862|455806659|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
126686358|NCT01564862|455806657|FG000|Overall Study|Major Protocol Deviation|3|||
126686359|NCT01564862|455806658|FG001|Overall Study|Major Protocol Deviation|3|||
126686360|NCT01564862|455806659|FG002|Overall Study|Major Protocol Deviation|4|||
126686361|NCT01564862|455806657|FG000|Overall Study|Lost to Follow-up|10|||
126686362|NCT01564862|455806658|FG001|Overall Study|Lost to Follow-up|8|||
126686363|NCT01564862|455806659|FG002|Overall Study|Lost to Follow-up|6|||
126686364|NCT01564862|455806657|FG000|Overall Study|Voluntary Withdrawal|9|||
126686365|NCT01564862|455806658|FG001|Overall Study|Voluntary Withdrawal|6|||
126686366|NCT01564862|455806659|FG002|Overall Study|Voluntary Withdrawal|8|||
126686367|NCT01564862|455806657|FG000|Overall Study|Lack of Efficacy|1|||
126686368|NCT01564862|455806658|FG001|Overall Study|Lack of Efficacy|5|||
126686369|NCT01564862|455806659|FG002|Overall Study|Lack of Efficacy|6|||
126686370|NCT01564862|455806657|FG000|Overall Study|Other reason(s)|1|||
126686371|NCT01564862|455806658|FG001|Overall Study|Other reason(s)|0|||
126686372|NCT01564862|455806659|FG002|Overall Study|Other reason(s)|0|||
126686373|NCT01844986|455806660|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
126686374|NCT01844986|455806661|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
126686375|NCT01844986|455806660|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
126686376|NCT01844986|455806661|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
126686377|NCT01844986|455806660|FG000|Overall Study (Global Cohort)|Death|55|||
126686378|NCT01844986|455806661|FG001|Overall Study (Global Cohort)|Death|26|||
126686379|NCT01844986|455806660|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
126686380|NCT01844986|455806661|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
126686381|NCT01844986|455806660|FG000|Overall Study (China Cohort)|Death|10|||
126686382|NCT01844986|455806661|FG001|Overall Study (China Cohort)|Death|6|||
126686383|NCT02028455|455806662|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
126686384|NCT02028455|455806663|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
126686385|NCT02028455|455806664|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
126686386|NCT02028455|455806665|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
126686387|NCT02028455|455806666|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
126686388|NCT02028455|455806667|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
126686389|NCT02028455|455806668|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
126686390|NCT02028455|455806669|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
126686391|NCT02028455|455806662|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
126686392|NCT02028455|455806663|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
126686393|NCT02028455|455806664|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
126686394|NCT02028455|455806665|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
126686395|NCT02028455|455806666|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
126686396|NCT02028455|455806667|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
126686397|NCT02028455|455806668|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
126686398|NCT02028455|455806669|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
126686399|NCT02028455|455806662|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
126686400|NCT02028455|455806663|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
126686401|NCT02028455|455806664|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
126686402|NCT02028455|455806665|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
126686403|NCT02028455|455806666|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
126686404|NCT02028455|455806667|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
126686405|NCT02028455|455806668|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
126686406|NCT02028455|455806669|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
126686407|NCT02028455|455806662|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
126350022|NCT00005047|454574104|FG001|Overall Study|Withdrawal by Subject|0|||
126350023|NCT00005047|454574105|FG002|Overall Study|Withdrawal by Subject|0|||
126350024|NCT00005047|454574106|FG003|Overall Study|Withdrawal by Subject|0|||
126350025|NCT00005047|454574103|FG000|Overall Study|Adverse Event|5|||
126350026|NCT00005047|454574104|FG001|Overall Study|Adverse Event|0|||
126350027|NCT00005047|454574105|FG002|Overall Study|Adverse Event|0|||
126350028|NCT00005047|454574106|FG003|Overall Study|Adverse Event|0|||
126350029|NCT00005047|454574103|FG000|Overall Study|Lost to Follow-up|1|||
126350030|NCT00005047|454574104|FG001|Overall Study|Lost to Follow-up|0|||
126350031|NCT00005047|454574105|FG002|Overall Study|Lost to Follow-up|0|||
126350032|NCT00005047|454574106|FG003|Overall Study|Lost to Follow-up|0|||
126350033|NCT00005047|454574103|FG000|Overall Study|Lack of Efficacy|1|||
126350034|NCT00005047|454574104|FG001|Overall Study|Lack of Efficacy|0|||
126350035|NCT00005047|454574105|FG002|Overall Study|Lack of Efficacy|0|||
126350036|NCT00005047|454574106|FG003|Overall Study|Lack of Efficacy|0|||
126350037|NCT05248386|454574110|FG000|Overall Study|Technical problems|0|||
126350038|NCT05248386|454574111|FG001|Overall Study|Technical problems|1|||
126350039|NCT05248386|454574110|FG000|Overall Study|Withdrawal by Subject|15|||
126350040|NCT05248386|454574111|FG001|Overall Study|Withdrawal by Subject|10|||
126350041|NCT05248386|454574110|FG000|Overall Study|Physician Decision|0|||
126350042|NCT05248386|454574111|FG001|Overall Study|Physician Decision|1|||
126350043|NCT05248386|454574110|FG000|Overall Study|Adverse Event|2|||
126350044|NCT05248386|454574111|FG001|Overall Study|Adverse Event|4|||
126350045|NCT05248386|454574110|FG000|Overall Study|Other|1|||
126350046|NCT05248386|454574111|FG001|Overall Study|Other|0|||
126350047|NCT05248386|454574110|FG000|Overall Study|Lack of Efficacy|14|||
126350048|NCT05248386|454574111|FG001|Overall Study|Lack of Efficacy|12|||
126350049|NCT04967222|454574115|FG000|Randomized|Lost to Follow-up|0|||
126350050|NCT04967222|454574116|FG001|Randomized|Lost to Follow-up|1|||
126350051|NCT04967222|454574117|FG002|Randomized|Lost to Follow-up|1|||
126350052|NCT04967222|454574115|FG000|Randomized|Physician Decision|0|||
126350053|NCT04967222|454574116|FG001|Randomized|Physician Decision|0|||
126350054|NCT04967222|454574117|FG002|Randomized|Physician Decision|1|||
126350055|NCT04967222|454574115|FG000|Randomized|Withdrawal by Subject|0|||
126350056|NCT04967222|454574116|FG001|Randomized|Withdrawal by Subject|0|||
126350057|NCT04967222|454574117|FG002|Randomized|Withdrawal by Subject|2|||
126350058|NCT04967222|454574115|FG000|Randomized|abnormal finding in MRI|0|||
126350059|NCT04967222|454574116|FG001|Randomized|abnormal finding in MRI|2|||
126350060|NCT04967222|454574117|FG002|Randomized|abnormal finding in MRI|0|||
126350061|NCT01295944|454574118|FG000|Overall Study|Switched to alternative treatment|1|||
126350062|NCT01295944|454574118|FG000|Overall Study|Ineligible|9|||
126350063|NCT01295944|454574118|FG000|Overall Study|Withdrawal by Subject|1|||
126350064|NCT01295944|454574118|FG000|Overall Study|Participant chose to be treated in Peru|1|||
126350065|NCT01295944|454574118|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
126350066|NCT01295944|454574118|FG000|Overall Study|Physician Decision|1|||
126350067|NCT01295944|454574118|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
126350068|NCT01295944|454574118|FG000|Overall Study|Disease progression|4|||
126350069|NCT01295944|454574118|FG000|Overall Study|Transferred care before starting new treatment|1|||
126350070|NCT02783274|454574120|FG000|Overall Study|Withdrawal by Subject|16|||
126350071|NCT02783274|454574120|FG000|Overall Study|Physician Decision|6|||
126350072|NCT02783274|454574120|FG000|Overall Study|Death|9|||
126350073|NCT02783274|454574120|FG000|Overall Study|Lost to Follow-up|22|||
126350074|NCT02783274|454574120|FG000|Overall Study|Other|22|||
126350075|NCT04635423|454574125|FG000|Overall Study|Ongoing|493|||
126350076|NCT04635423|454574126|FG001|Overall Study|Ongoing|501|||
126350077|NCT04635423|454574125|FG000|Overall Study|Withdrawal by Subject|36|||
126350078|NCT04635423|454574126|FG001|Overall Study|Withdrawal by Subject|29|||
126350079|NCT05119569|454574131|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
126350080|NCT05119569|454574132|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
126350081|NCT05119569|454574133|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
126350082|NCT05119569|454574134|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
126350083|NCT05119569|454574131|FG000|Double Blind Treatment Phase|Adverse Event|6|||
126350084|NCT05119569|454574132|FG001|Double Blind Treatment Phase|Adverse Event|0|||
126350085|NCT05119569|454574133|FG002|Double Blind Treatment Phase|Adverse Event|0|||
126350086|NCT05119569|454574134|FG003|Double Blind Treatment Phase|Adverse Event|0|||
126350087|NCT05119569|454574131|FG000|Open Label Extension Phase|Ongoing in the study|0|||
126350088|NCT05119569|454574132|FG001|Open Label Extension Phase|Ongoing in the study|0|||
126438321|NCT02113982|454907580|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438322|NCT02113982|454907581|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438323|NCT02113982|454907582|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438324|NCT02113982|454907583|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438325|NCT02113982|454907584|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438326|NCT02113982|454907585|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438327|NCT02113982|454907586|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
126438328|NCT02113982|454907587|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438329|NCT02113982|454907588|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438330|NCT02113982|454907589|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438331|NCT02113982|454907590|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438332|NCT02113982|454907591|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438333|NCT02113982|454907592|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438334|NCT02113982|454907593|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
126438335|NCT02113982|454907580|FG000|Stage 1: Dose Escalation|Transplant|0|||
126438336|NCT02113982|454907581|FG001|Stage 1: Dose Escalation|Transplant|1|||
126438337|NCT02113982|454907582|FG002|Stage 1: Dose Escalation|Transplant|0|||
126438338|NCT02113982|454907583|FG003|Stage 1: Dose Escalation|Transplant|0|||
126438339|NCT02113982|454907584|FG004|Stage 1: Dose Escalation|Transplant|0|||
126438340|NCT02113982|454907585|FG005|Stage 1: Dose Escalation|Transplant|1|||
126438341|NCT02113982|454907586|FG006|Stage 1: Dose Escalation|Transplant|0|||
126545388|NCT02541383|455290824|FG001|Overall Study|Lost to Follow-up|3|||
126350089|NCT05119569|454574133|FG002|Open Label Extension Phase|Ongoing in the study|65|||
126350090|NCT05119569|454574134|FG003|Open Label Extension Phase|Ongoing in the study|34|||
126350091|NCT03980223|454574135|FG000|Overall Study|Lost to Follow-up|3|||
126350092|NCT03980223|454574136|FG001|Overall Study|Lost to Follow-up|7|||
126438342|NCT02113982|454907587|FG007|Stage 1: Dose Escalation|Transplant|0|||
126686408|NCT02028455|455806663|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
126686409|NCT02028455|455806664|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
126686410|NCT02028455|455806665|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
126686411|NCT02028455|455806666|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
126350093|NCT03980223|454574137|FG002|Overall Study|Lost to Follow-up|10|||
126350094|NCT03980223|454574138|FG003|Overall Study|Lost to Follow-up|8|||
126350095|NCT03980223|454574135|FG000|Overall Study|Withdrawal by Subject|0|||
126350096|NCT03980223|454574136|FG001|Overall Study|Withdrawal by Subject|0|||
126350097|NCT03980223|454574137|FG002|Overall Study|Withdrawal by Subject|1|||
126350098|NCT03980223|454574138|FG003|Overall Study|Withdrawal by Subject|2|||
126350099|NCT03980223|454574135|FG000|Overall Study|Physician Decision|0|||
126350100|NCT03980223|454574136|FG001|Overall Study|Physician Decision|0|||
126350101|NCT03980223|454574137|FG002|Overall Study|Physician Decision|1|||
126350102|NCT03980223|454574138|FG003|Overall Study|Physician Decision|0|||
126350103|NCT03980223|454574135|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
126350104|NCT03980223|454574136|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
126350105|NCT03980223|454574137|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
126350106|NCT03980223|454574138|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
126350107|NCT06239610|454574139|FG000|Overall Study|no usable migration data for minimum of one day|11|||
126350108|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
126350109|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
126350110|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
126686412|NCT02028455|455806667|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
126686413|NCT02028455|455806668|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
126686414|NCT02028455|455806669|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
126686415|NCT02396589|455806675|FG000|Intervention|Lost to Follow-up|1|||
126686416|NCT02396589|455806676|FG001|Intervention|Lost to Follow-up|0|||
126686417|NCT02396589|455806675|FG000|6 Month Follow-up|change in health status|0|||
126686418|NCT02396589|455806676|FG001|6 Month Follow-up|change in health status|1|||
126686419|NCT02396589|455806675|FG000|9 Month Follow-up|Death|0|||
126686420|NCT02396589|455806676|FG001|9 Month Follow-up|Death|1|||
126686421|NCT02396589|455806675|FG000|12 Month Follow up|Lost to Follow-up|0|||
126686422|NCT02396589|455806676|FG001|12 Month Follow up|Lost to Follow-up|2|||
126686423|NCT01761266|455808580|FG000|Overall Study|Death|415|||
126686424|NCT01761266|455808581|FG001|Overall Study|Death|402|||
126686425|NCT01761266|455808580|FG000|Overall Study|Lost to Follow-up|8|||
126686426|NCT01761266|455808581|FG001|Overall Study|Lost to Follow-up|12|||
126686427|NCT01761266|455808580|FG000|Overall Study|Withdrawal by Subject|14|||
126686428|NCT01761266|455808581|FG001|Overall Study|Withdrawal by Subject|10|||
126686429|NCT01761266|455808580|FG000|Overall Study|Sponsor Decision|41|||
126686430|NCT01761266|455808581|FG001|Overall Study|Sponsor Decision|52|||
126686431|NCT03409744|455808582|FG000|Overall Study|Death|2|||
126686432|NCT03409744|455808582|FG000|Overall Study|Physician Decision|5|||
126686433|NCT03409744|455808582|FG000|Overall Study|Pregnancy|1|||
126686434|NCT03409744|455808582|FG000|Overall Study|Lost to Follow-up|1|||
126686435|NCT03409744|455808582|FG000|Overall Study|Protocol Violation|1|||
126686436|NCT02740478|455808583|FG000|Overall Study|Withdrawal by Subject|1|||
126686437|NCT00699348|455808584|FG000|Overall Study|Death|6|||
126686438|NCT00699348|455808584|FG000|Overall Study|Adverse Event|15|||
126686439|NCT00699348|455808584|FG000|Overall Study|Withdrawal by Subject|11|||
126686440|NCT00699348|455808584|FG000|Overall Study|Protocol Violation|10|||
126686441|NCT00699348|455808584|FG000|Overall Study|Lack of Efficacy|8|||
126686442|NCT00699348|455808584|FG000|Overall Study|Failure to return|1|||
126686443|NCT00699348|455808584|FG000|Overall Study|Blood transfusion|24|||
126686444|NCT00699348|455808584|FG000|Overall Study|Renal transplantation|10|||
126686445|NCT00699348|455808584|FG000|Overall Study|Other|5|||
126686446|NCT03269344|455808585|FG000|Overall Study|Protocol Violation|4|||
126686447|NCT03269344|455808586|FG001|Overall Study|Protocol Violation|3|||
126686448|NCT02597855|455808587|FG000|Overall Study|Lost to Follow-up|2|||
126686449|NCT02597855|455808588|FG001|Overall Study|Lost to Follow-up|1|||
126686450|NCT01449708|455808591|FG000|Overall Study|Protocol Violation|0|||
126686451|NCT01449708|455808592|FG001|Overall Study|Protocol Violation|1|||
126686452|NCT01449708|455808591|FG000|Overall Study|surgical complication|1|||
126686453|NCT01449708|455808592|FG001|Overall Study|surgical complication|2|||
126686454|NCT01449708|455808591|FG000|Overall Study|respiratory failure|1|||
126686455|NCT01449708|455808592|FG001|Overall Study|respiratory failure|0|||
126686456|NCT00223496|455808595|FG000|Overall Study|screen failure|9|||
126350111|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
126350112|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
126350113|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
126350114|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
126350115|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
126350116|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
126350117|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
126350118|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
126350119|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
126350120|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
126350121|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
126350122|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
126350123|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
126350124|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
126350125|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
126350126|NCT01069939|454574145|FG000|Randomised and Included in the Analyses|Removal|1|||
126350127|NCT01069939|454574146|FG001|Randomised and Included in the Analyses|Removal|0|||
126350128|NCT05166876|454574147|FG000|Overall Study|Withdrawal by Subject|1|||
126350129|NCT05166876|454574148|FG001|Overall Study|Withdrawal by Subject|0|||
126350130|NCT05166876|454574149|FG002|Overall Study|Withdrawal by Subject|0|||
126350131|NCT00385840|454574151|FG000|Overall Study|Adverse Event|1|||
126350132|NCT00385840|454574152|FG001|Overall Study|Adverse Event|1|||
126350133|NCT00385840|454574151|FG000|Overall Study|Lost to Follow-up|3|||
126438343|NCT02113982|454907588|FG008|Stage 1: Dose Escalation|Transplant|0|||
126438344|NCT02113982|454907589|FG009|Stage 1: Dose Escalation|Transplant|0|||
126438345|NCT02113982|454907590|FG010|Stage 1: Dose Escalation|Transplant|0|||
126438346|NCT02113982|454907591|FG011|Stage 1: Dose Escalation|Transplant|0|||
126438347|NCT02113982|454907592|FG012|Stage 1: Dose Escalation|Transplant|0|||
126438348|NCT02113982|454907593|FG013|Stage 1: Dose Escalation|Transplant|0|||
126438349|NCT02113982|454907580|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
126350134|NCT00385840|454574152|FG001|Overall Study|Lost to Follow-up|13|||
126350135|NCT00832975|454574154|FG000|Overall Study|Lost to Follow-up|7|||
126350136|NCT00832975|454574154|FG000|Overall Study|Protocol Violation|6|||
126350137|NCT00832975|454574154|FG000|Overall Study|Death|5|||
126350138|NCT00832975|454574154|FG000|Overall Study|Physician Decision|4|||
126350139|NCT00832975|454574154|FG000|Overall Study|Withdrawal by Subject|3|||
126350140|NCT00832975|454574154|FG000|Overall Study|Other reasons|14|||
126350141|NCT02101853|454574158|FG000|Block 1 Induction|Adverse Event|11|||
126350142|NCT02101853|454574159|FG001|Block 1 Induction|Adverse Event|0|||
126350143|NCT02101853|454574160|FG002|Block 1 Induction|Adverse Event|0|||
126350144|NCT02101853|454574161|FG003|Block 1 Induction|Adverse Event|0|||
126438350|NCT02113982|454907581|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
126438351|NCT02113982|454907582|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
126350145|NCT02101853|454574162|FG004|Block 1 Induction|Adverse Event|0|||
126350146|NCT02101853|454574163|FG005|Block 1 Induction|Adverse Event|0|||
126350147|NCT02101853|454574158|FG000|Block 1 Induction|Death|20|||
126350148|NCT02101853|454574159|FG001|Block 1 Induction|Death|0|||
126438352|NCT02113982|454907583|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
126350149|NCT02101853|454574160|FG002|Block 1 Induction|Death|0|||
126350150|NCT02101853|454574161|FG003|Block 1 Induction|Death|0|||
126350151|NCT02101853|454574162|FG004|Block 1 Induction|Death|0|||
126350152|NCT02101853|454574163|FG005|Block 1 Induction|Death|0|||
126350153|NCT02101853|454574158|FG000|Block 1 Induction|Lack of Efficacy|6|||
126350154|NCT02101853|454574159|FG001|Block 1 Induction|Lack of Efficacy|0|||
126350155|NCT02101853|454574160|FG002|Block 1 Induction|Lack of Efficacy|0|||
126350156|NCT02101853|454574161|FG003|Block 1 Induction|Lack of Efficacy|0|||
126350157|NCT02101853|454574162|FG004|Block 1 Induction|Lack of Efficacy|0|||
126350158|NCT02101853|454574163|FG005|Block 1 Induction|Lack of Efficacy|0|||
126350159|NCT02101853|454574158|FG000|Block 1 Induction|Physician Decision|61|||
126350160|NCT02101853|454574159|FG001|Block 1 Induction|Physician Decision|0|||
126350161|NCT02101853|454574160|FG002|Block 1 Induction|Physician Decision|0|||
126350162|NCT02101853|454574161|FG003|Block 1 Induction|Physician Decision|0|||
126350163|NCT02101853|454574162|FG004|Block 1 Induction|Physician Decision|0|||
126350164|NCT02101853|454574163|FG005|Block 1 Induction|Physician Decision|0|||
126350165|NCT02101853|454574158|FG000|Block 1 Induction|Protocol Violation|2|||
126350166|NCT02101853|454574159|FG001|Block 1 Induction|Protocol Violation|0|||
126350167|NCT02101853|454574160|FG002|Block 1 Induction|Protocol Violation|0|||
126350168|NCT02101853|454574161|FG003|Block 1 Induction|Protocol Violation|0|||
126350169|NCT02101853|454574162|FG004|Block 1 Induction|Protocol Violation|0|||
126350170|NCT02101853|454574163|FG005|Block 1 Induction|Protocol Violation|0|||
126350171|NCT02101853|454574158|FG000|Block 1 Induction|Withdrawal by Subject|65|||
126350172|NCT02101853|454574159|FG001|Block 1 Induction|Withdrawal by Subject|0|||
126350173|NCT02101853|454574160|FG002|Block 1 Induction|Withdrawal by Subject|0|||
126350174|NCT02101853|454574161|FG003|Block 1 Induction|Withdrawal by Subject|0|||
126350175|NCT02101853|454574162|FG004|Block 1 Induction|Withdrawal by Subject|0|||
126350176|NCT02101853|454574163|FG005|Block 1 Induction|Withdrawal by Subject|0|||
126350177|NCT02101853|454574158|FG000|Block 1 Induction|Ineligible|8|||
126350178|NCT02101853|454574159|FG001|Block 1 Induction|Ineligible|0|||
126350179|NCT02101853|454574160|FG002|Block 1 Induction|Ineligible|0|||
126350180|NCT02101853|454574161|FG003|Block 1 Induction|Ineligible|0|||
126350181|NCT02101853|454574162|FG004|Block 1 Induction|Ineligible|0|||
126350182|NCT02101853|454574163|FG005|Block 1 Induction|Ineligible|0|||
126350183|NCT02101853|454574158|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
126350184|NCT02101853|454574159|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
126350185|NCT02101853|454574160|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
126350186|NCT02101853|454574161|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
126350187|NCT02101853|454574162|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
126350188|NCT02101853|454574163|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
126350189|NCT02101853|454574158|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
126350190|NCT02101853|454574159|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350191|NCT02101853|454574160|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350192|NCT02101853|454574161|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350193|NCT02101853|454574162|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350194|NCT02101853|454574163|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350195|NCT02101853|454574158|FG000|Post Induction Randomization|Adverse Event|0|||
126350196|NCT02101853|454574159|FG001|Post Induction Randomization|Adverse Event|3|||
126350197|NCT02101853|454574160|FG002|Post Induction Randomization|Adverse Event|8|||
126350198|NCT02101853|454574161|FG003|Post Induction Randomization|Adverse Event|4|||
126350199|NCT02101853|454574162|FG004|Post Induction Randomization|Adverse Event|4|||
126350200|NCT02101853|454574163|FG005|Post Induction Randomization|Adverse Event|0|||
126350201|NCT02101853|454574158|FG000|Post Induction Randomization|Death|0|||
126350202|NCT02101853|454574159|FG001|Post Induction Randomization|Death|9|||
126350203|NCT02101853|454574160|FG002|Post Induction Randomization|Death|2|||
126350204|NCT02101853|454574161|FG003|Post Induction Randomization|Death|2|||
126350205|NCT02101853|454574162|FG004|Post Induction Randomization|Death|0|||
126350206|NCT02101853|454574163|FG005|Post Induction Randomization|Death|0|||
126350207|NCT02101853|454574158|FG000|Post Induction Randomization|Lack of Efficacy|0|||
126686457|NCT00223496|455808595|FG000|Overall Study|Lost to Follow-up|4|||
126686458|NCT00223496|455808595|FG000|Overall Study|Lack of Efficacy|6|||
126686459|NCT00223496|455808595|FG000|Overall Study|Withdrawal by Subject|1|||
126686460|NCT00223496|455808595|FG000|Overall Study|Physician Decision|2|||
126686461|NCT00559507|455808596|FG000|Overall Study|Not treated, patient ineligible|3|||
126686462|NCT02889796|455808597|FG000|Overall Study|Withdrew Consent|18|||
126686463|NCT02889796|455808598|FG001|Overall Study|Withdrew Consent|29|||
126686464|NCT02889796|455808599|FG002|Overall Study|Withdrew Consent|20|||
126686465|NCT02889796|455808600|FG003|Overall Study|Withdrew Consent|1|||
126686466|NCT02889796|455808601|FG004|Overall Study|Withdrew Consent|2|||
126686467|NCT02889796|455808602|FG005|Overall Study|Withdrew Consent|35|||
126686468|NCT02889796|455808597|FG000|Overall Study|Investigator's Discretion|10|||
126686469|NCT02889796|455808598|FG001|Overall Study|Investigator's Discretion|9|||
126686470|NCT02889796|455808599|FG002|Overall Study|Investigator's Discretion|10|||
126686471|NCT02889796|455808600|FG003|Overall Study|Investigator's Discretion|3|||
126686472|NCT02889796|455808601|FG004|Overall Study|Investigator's Discretion|0|||
126686473|NCT02889796|455808602|FG005|Overall Study|Investigator's Discretion|15|||
126686474|NCT02889796|455808597|FG000|Overall Study|Adverse Event|17|||
126686475|NCT02889796|455808598|FG001|Overall Study|Adverse Event|8|||
126686476|NCT02889796|455808599|FG002|Overall Study|Adverse Event|8|||
126686477|NCT02889796|455808600|FG003|Overall Study|Adverse Event|4|||
126686478|NCT02889796|455808601|FG004|Overall Study|Adverse Event|1|||
126686479|NCT02889796|455808602|FG005|Overall Study|Adverse Event|7|||
126686480|NCT02889796|455808597|FG000|Overall Study|Lost to Follow-up|5|||
126686481|NCT02889796|455808598|FG001|Overall Study|Lost to Follow-up|7|||
126686482|NCT02889796|455808599|FG002|Overall Study|Lost to Follow-up|2|||
126686483|NCT02889796|455808600|FG003|Overall Study|Lost to Follow-up|0|||
126686484|NCT02889796|455808601|FG004|Overall Study|Lost to Follow-up|2|||
126686485|NCT02889796|455808602|FG005|Overall Study|Lost to Follow-up|6|||
126686486|NCT02889796|455808597|FG000|Overall Study|Protocol Violation|0|||
126686487|NCT02889796|455808598|FG001|Overall Study|Protocol Violation|1|||
126686488|NCT02889796|455808599|FG002|Overall Study|Protocol Violation|3|||
126686489|NCT02889796|455808600|FG003|Overall Study|Protocol Violation|0|||
126686490|NCT02889796|455808601|FG004|Overall Study|Protocol Violation|0|||
126686491|NCT02889796|455808602|FG005|Overall Study|Protocol Violation|4|||
126686492|NCT02889796|455808597|FG000|Overall Study|Non-compliance With Study Drug|0|||
126686493|NCT02889796|455808598|FG001|Overall Study|Non-compliance With Study Drug|2|||
126686494|NCT02889796|455808599|FG002|Overall Study|Non-compliance With Study Drug|0|||
126686495|NCT02889796|455808600|FG003|Overall Study|Non-compliance With Study Drug|0|||
126686496|NCT02889796|455808601|FG004|Overall Study|Non-compliance With Study Drug|1|||
126686497|NCT02889796|455808602|FG005|Overall Study|Non-compliance With Study Drug|2|||
126686498|NCT02889796|455808597|FG000|Overall Study|Death|1|||
126686499|NCT02889796|455808598|FG001|Overall Study|Death|1|||
126686500|NCT02889796|455808599|FG002|Overall Study|Death|0|||
126686501|NCT02889796|455808600|FG003|Overall Study|Death|1|||
126686502|NCT02889796|455808601|FG004|Overall Study|Death|0|||
126686503|NCT02889796|455808602|FG005|Overall Study|Death|1|||
126686504|NCT02889796|455808597|FG000|Overall Study|Pregnancy|0|||
126686505|NCT02889796|455808598|FG001|Overall Study|Pregnancy|1|||
126686506|NCT02889796|455808599|FG002|Overall Study|Pregnancy|1|||
126686507|NCT02889796|455808600|FG003|Overall Study|Pregnancy|0|||
126686508|NCT02889796|455808601|FG004|Overall Study|Pregnancy|0|||
126686509|NCT02889796|455808602|FG005|Overall Study|Pregnancy|0|||
126686510|NCT02889796|455808597|FG000|Overall Study|Randomized but not Dosed|2|||
126686511|NCT02889796|455808598|FG001|Overall Study|Randomized but not Dosed|0|||
126686512|NCT02889796|455808599|FG002|Overall Study|Randomized but not Dosed|0|||
126686513|NCT02889796|455808600|FG003|Overall Study|Randomized but not Dosed|0|||
126686514|NCT02889796|455808601|FG004|Overall Study|Randomized but not Dosed|0|||
126686515|NCT02889796|455808602|FG005|Overall Study|Randomized but not Dosed|2|||
126686516|NCT01407926|455808608|FG000|Overall Study|Lost to Follow-up|55|||
126686517|NCT02814565|455808609|FG000|Overall Study|Lack of Efficacy|0|||
126686518|NCT02814565|455808610|FG001|Overall Study|Lack of Efficacy|1|||
126686519|NCT02814565|455808609|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
126686520|NCT02814565|455808610|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
126686521|NCT01414257|455808611|FG000|Overall Study|No Visit After First Day of Treatment|12|||
126686522|NCT01414257|455808611|FG000|Overall Study|Protocol Violation|10|||
126686523|NCT01882907|455808614|FG000|Overall Study|Adverse Event|3|||
126686524|NCT01882907|455808615|FG001|Overall Study|Adverse Event|1|||
126686525|NCT01882907|455808614|FG000|Overall Study|Lack of Efficacy|0|||
126686526|NCT01882907|455808615|FG001|Overall Study|Lack of Efficacy|3|||
126686527|NCT01882907|455808614|FG000|Overall Study|Lost to Follow-up|1|||
126686528|NCT01882907|455808615|FG001|Overall Study|Lost to Follow-up|4|||
126686529|NCT01882907|455808614|FG000|Overall Study|Protocol Violation|10|||
126686530|NCT01882907|455808615|FG001|Overall Study|Protocol Violation|14|||
126686531|NCT01882907|455808614|FG000|Overall Study|Withdrawal by Subject|0|||
126686532|NCT01882907|455808615|FG001|Overall Study|Withdrawal by Subject|6|||
126686533|NCT01784965|455808619|FG000|Overall Study|Withdrawal by Subject|6|||
126686534|NCT01784965|455808620|FG001|Overall Study|Withdrawal by Subject|3|||
126686535|NCT01784965|455808619|FG000|Overall Study|Adverse Event|0|||
126350208|NCT02101853|454574159|FG001|Post Induction Randomization|Lack of Efficacy|14|||
126350209|NCT02101853|454574160|FG002|Post Induction Randomization|Lack of Efficacy|23|||
126686536|NCT01784965|455808620|FG001|Overall Study|Adverse Event|8|||
126686537|NCT03178487|455808623|FG000|Period 1|Adverse Event|1|||
126686538|NCT03178487|455808624|FG001|Period 1|Adverse Event|2|||
126686539|NCT03178487|455808623|FG000|Period 1|Withdrawal by Subject|2|||
126686540|NCT03178487|455808624|FG001|Period 1|Withdrawal by Subject|1|||
126686541|NCT03178487|455808623|FG000|Period 1|Lost to Follow-up|1|||
126350210|NCT02101853|454574161|FG003|Post Induction Randomization|Lack of Efficacy|18|||
126686542|NCT03178487|455808624|FG001|Period 1|Lost to Follow-up|0|||
126350211|NCT02101853|454574162|FG004|Post Induction Randomization|Lack of Efficacy|21|||
126350212|NCT02101853|454574163|FG005|Post Induction Randomization|Lack of Efficacy|0|||
126350213|NCT02101853|454574158|FG000|Post Induction Randomization|Physician Decision|0|||
126350214|NCT02101853|454574159|FG001|Post Induction Randomization|Physician Decision|43|||
126438353|NCT02113982|454907584|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
126438354|NCT02113982|454907585|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
126438355|NCT02113982|454907586|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
126438356|NCT02113982|454907587|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
126438357|NCT02113982|454907588|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
126438358|NCT02113982|454907589|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
126438359|NCT02113982|454907590|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
126438360|NCT02113982|454907591|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
126438361|NCT02113982|454907592|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
126438362|NCT02113982|454907593|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
126438363|NCT02113982|454907580|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
126438364|NCT02113982|454907581|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
126438365|NCT02113982|454907582|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
126438366|NCT02113982|454907583|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
126438367|NCT02113982|454907584|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
126438368|NCT02113982|454907585|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
126438369|NCT02113982|454907586|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
126438370|NCT02113982|454907587|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
126686543|NCT03178487|455808623|FG000|Period 1|Other|0|||
126686544|NCT03178487|455808624|FG001|Period 1|Other|1|||
126686545|NCT03178487|455808623|FG000|Period 2|Adverse Event|4|||
126686546|NCT03178487|455808624|FG001|Period 2|Adverse Event|4|||
126686547|NCT03178487|455808623|FG000|Period 2|Withdrawal by Subject|6|||
126686548|NCT03178487|455808624|FG001|Period 2|Withdrawal by Subject|6|||
126686549|NCT03178487|455808623|FG000|Period 2|Lost to Follow-up|2|||
126686550|NCT03178487|455808624|FG001|Period 2|Lost to Follow-up|2|||
126686551|NCT03178487|455808623|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
126686552|NCT03178487|455808624|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
126686553|NCT03178487|455808623|FG000|Period 2|Other|8|||
126686554|NCT03178487|455808624|FG001|Period 2|Other|7|||
126686555|NCT01562548|455808629|FG000|Overall Study|Lost to Follow-up|0|||
126686556|NCT01562548|455808630|FG001|Overall Study|Lost to Follow-up|0|||
126686557|NCT01562548|455808631|FG002|Overall Study|Lost to Follow-up|1|||
126686558|NCT01562548|455808632|FG003|Overall Study|Lost to Follow-up|0|||
126686559|NCT00493038|455808633|FG000|Treatment|Adverse Event|8|||
126686560|NCT00493038|455808634|FG001|Treatment|Adverse Event|4|||
126686561|NCT00493038|455808633|FG000|Treatment|Lost to Follow-up|5|||
126686562|NCT00493038|455808634|FG001|Treatment|Lost to Follow-up|3|||
126686563|NCT00493038|455808633|FG000|Treatment|Withdrawal by Subject|11|||
126686564|NCT00493038|455808634|FG001|Treatment|Withdrawal by Subject|12|||
126686565|NCT00493038|455808633|FG000|Treatment|Other|0|||
126686566|NCT00493038|455808634|FG001|Treatment|Other|1|||
126686567|NCT00493038|455808633|FG000|Follow-up|Lost to Follow-up|1|||
126686568|NCT00493038|455808634|FG001|Follow-up|Lost to Follow-up|0|||
126686569|NCT00577993|455808635|FG000|Overall Study|Adverse Event|1|||
126686570|NCT00577993|455808636|FG001|Overall Study|Adverse Event|0|||
126686571|NCT00577993|455808637|FG002|Overall Study|Adverse Event|0|||
126686572|NCT00577993|455808635|FG000|Overall Study|Death|0|||
126686573|NCT00577993|455808636|FG001|Overall Study|Death|1|||
126686574|NCT00577993|455808637|FG002|Overall Study|Death|1|||
126686575|NCT00577993|455808635|FG000|Overall Study|Lack of Efficacy|0|||
126686576|NCT00577993|455808636|FG001|Overall Study|Lack of Efficacy|1|||
126686577|NCT00577993|455808637|FG002|Overall Study|Lack of Efficacy|0|||
126438371|NCT02113982|454907588|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
126686578|NCT00577993|455808635|FG000|Overall Study|Protocol Violation|2|||
126686579|NCT00577993|455808636|FG001|Overall Study|Protocol Violation|3|||
126686580|NCT00577993|455808637|FG002|Overall Study|Protocol Violation|0|||
126686581|NCT00577993|455808635|FG000|Overall Study|Withdrawal by Subject|1|||
126686582|NCT00577993|455808636|FG001|Overall Study|Withdrawal by Subject|0|||
126686583|NCT00577993|455808637|FG002|Overall Study|Withdrawal by Subject|2|||
126686584|NCT00577993|455808635|FG000|Overall Study|Conversion|2|||
126686585|NCT00577993|455808636|FG001|Overall Study|Conversion|5|||
126686586|NCT00577993|455808637|FG002|Overall Study|Conversion|0|||
126686587|NCT00577993|455808635|FG000|Overall Study|Uninsured|1|||
126686588|NCT00577993|455808636|FG001|Overall Study|Uninsured|0|||
126686589|NCT00577993|455808637|FG002|Overall Study|Uninsured|0|||
126686590|NCT02217566|455808638|FG000|Overall Study|Lost to Follow-up|2|||
126686591|NCT02217566|455808638|FG000|Overall Study|Death|3|||
126686592|NCT02217566|455808638|FG000|Overall Study|Early study termination|6|||
126686593|NCT01847885|455808639|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
126686594|NCT01847885|455808640|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
126686595|NCT01847885|455808641|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
126686596|NCT01847885|455808639|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
126686597|NCT01847885|455808640|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
126438372|NCT02113982|454907589|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
126686598|NCT01847885|455808641|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
126686599|NCT01847885|455808639|FG000|Initial Enrollment (Consented)|Screen failure|39|||
126686600|NCT01847885|455808640|FG001|Initial Enrollment (Consented)|Screen failure|0|||
126350215|NCT02101853|454574160|FG002|Post Induction Randomization|Physician Decision|23|||
126350216|NCT02101853|454574161|FG003|Post Induction Randomization|Physician Decision|14|||
126350217|NCT02101853|454574162|FG004|Post Induction Randomization|Physician Decision|14|||
126350218|NCT02101853|454574163|FG005|Post Induction Randomization|Physician Decision|0|||
126350219|NCT02101853|454574158|FG000|Post Induction Randomization|Protocol Violation|0|||
126350220|NCT02101853|454574159|FG001|Post Induction Randomization|Protocol Violation|3|||
126350221|NCT02101853|454574160|FG002|Post Induction Randomization|Protocol Violation|0|||
126350222|NCT02101853|454574161|FG003|Post Induction Randomization|Protocol Violation|0|||
126350223|NCT02101853|454574162|FG004|Post Induction Randomization|Protocol Violation|0|||
126350224|NCT02101853|454574163|FG005|Post Induction Randomization|Protocol Violation|0|||
126350225|NCT02101853|454574158|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
126350226|NCT02101853|454574159|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
126350227|NCT02101853|454574160|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
126350228|NCT02101853|454574161|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
126350229|NCT02101853|454574162|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
126350230|NCT02101853|454574163|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
126369486|NCT00876447|454650571|FG000|Overall Study|Other miscellaneous reasons|3|||
126369487|NCT00876447|454650572|FG001|Overall Study|Other miscellaneous reasons|8|||
126369488|NCT00876447|454650571|FG000|Overall Study|Site closure|19|||
126686601|NCT01847885|455808641|FG002|Initial Enrollment (Consented)|Screen failure|0|||
126369489|NCT00876447|454650572|FG001|Overall Study|Site closure|14|||
126369490|NCT00876447|454650571|FG000|Overall Study|Protocol Violation|9|||
126369491|NCT00876447|454650572|FG001|Overall Study|Protocol Violation|3|||
126369492|NCT00876447|454650571|FG000|Overall Study|Personal reasons|30|||
126686602|NCT01847885|455808639|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
126686603|NCT01847885|455808640|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
126686604|NCT01847885|455808641|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
126686605|NCT01847885|455808639|FG000|Randomization|Protocol Violation|0|||
126686606|NCT01847885|455808640|FG001|Randomization|Protocol Violation|1|||
126686607|NCT01847885|455808641|FG002|Randomization|Protocol Violation|0|||
126686608|NCT01847885|455808639|FG000|Randomization|Withdrawal by Subject|0|||
126686609|NCT01847885|455808640|FG001|Randomization|Withdrawal by Subject|0|||
126686610|NCT01847885|455808641|FG002|Randomization|Withdrawal by Subject|2|||
126686611|NCT01847885|455808639|FG000|Randomization|Screen Failure|0|||
126686612|NCT01847885|455808640|FG001|Randomization|Screen Failure|3|||
126686613|NCT01847885|455808641|FG002|Randomization|Screen Failure|0|||
126686614|NCT02574637|455808644|FG000|Double-blind Period|Adverse Event|1|||
126686615|NCT02574637|455808645|FG001|Double-blind Period|Adverse Event|0|||
126438373|NCT02113982|454907590|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
126438374|NCT02113982|454907591|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
126438375|NCT02113982|454907592|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
126438376|NCT02113982|454907593|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
126438377|NCT02113982|454907580|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
126438378|NCT02113982|454907581|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
126759642|NCT01977573|456068646|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
126438379|NCT02113982|454907582|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
126438380|NCT02113982|454907583|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
126438381|NCT02113982|454907584|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
126438382|NCT02113982|454907585|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
126438383|NCT02113982|454907586|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
126438384|NCT02113982|454907587|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
126686616|NCT02574637|455808646|FG002|Double-blind Period|Adverse Event|0|||
126686617|NCT02574637|455808647|FG003|Double-blind Period|Adverse Event|0|||
126686618|NCT02574637|455808648|FG004|Double-blind Period|Adverse Event|0|||
126686619|NCT02574637|455808649|FG005|Double-blind Period|Adverse Event|0|||
126686620|NCT02574637|455808650|FG006|Double-blind Period|Adverse Event|0|||
126686621|NCT02574637|455808651|FG007|Double-blind Period|Adverse Event|0|||
126686622|NCT02574637|455808652|FG008|Double-blind Period|Adverse Event|0|||
126686623|NCT02574637|455808653|FG009|Double-blind Period|Adverse Event|0|||
126686624|NCT02574637|455808644|FG000|Double-blind Period|Lack of Efficacy|0|||
126438385|NCT02113982|454907588|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
126438386|NCT02113982|454907589|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
126686625|NCT02574637|455808645|FG001|Double-blind Period|Lack of Efficacy|0|||
126686626|NCT02574637|455808646|FG002|Double-blind Period|Lack of Efficacy|2|||
126686627|NCT02574637|455808647|FG003|Double-blind Period|Lack of Efficacy|0|||
126438387|NCT02113982|454907590|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
126686628|NCT02574637|455808648|FG004|Double-blind Period|Lack of Efficacy|0|||
126686629|NCT02574637|455808649|FG005|Double-blind Period|Lack of Efficacy|0|||
126686630|NCT02574637|455808650|FG006|Double-blind Period|Lack of Efficacy|0|||
126686631|NCT02574637|455808651|FG007|Double-blind Period|Lack of Efficacy|0|||
126686632|NCT02574637|455808652|FG008|Double-blind Period|Lack of Efficacy|0|||
126686633|NCT02574637|455808653|FG009|Double-blind Period|Lack of Efficacy|0|||
126686634|NCT02574637|455808644|FG000|Double-blind Period|Protocol Deviation|1|||
126686635|NCT02574637|455808645|FG001|Double-blind Period|Protocol Deviation|0|||
126686636|NCT02574637|455808646|FG002|Double-blind Period|Protocol Deviation|0|||
126686637|NCT02574637|455808647|FG003|Double-blind Period|Protocol Deviation|0|||
126686638|NCT02574637|455808648|FG004|Double-blind Period|Protocol Deviation|0|||
126686639|NCT02574637|455808649|FG005|Double-blind Period|Protocol Deviation|0|||
126686640|NCT02574637|455808650|FG006|Double-blind Period|Protocol Deviation|0|||
126686641|NCT02574637|455808651|FG007|Double-blind Period|Protocol Deviation|0|||
126686642|NCT02574637|455808652|FG008|Double-blind Period|Protocol Deviation|0|||
126686643|NCT02574637|455808653|FG009|Double-blind Period|Protocol Deviation|0|||
126686644|NCT02574637|455808644|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
126686645|NCT02574637|455808645|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
126686646|NCT02574637|455808646|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
126686647|NCT02574637|455808647|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
126686648|NCT02574637|455808648|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
126686649|NCT02574637|455808649|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
126686650|NCT02574637|455808650|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
126686651|NCT02574637|455808651|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
126686652|NCT02574637|455808652|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
126686653|NCT02574637|455808653|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
126686654|NCT02574637|455808644|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
126686655|NCT02574637|455808645|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
126686656|NCT02574637|455808646|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
126350231|NCT02101853|454574158|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350232|NCT02101853|454574159|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126686657|NCT02574637|455808647|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
126686658|NCT02574637|455808648|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
126686659|NCT02574637|455808649|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
126686660|NCT02574637|455808650|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
126686661|NCT02574637|455808651|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
126686662|NCT02574637|455808652|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
126686663|NCT02574637|455808653|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
126686664|NCT02574637|455808644|FG000|Double-blind Period|Reason Not Specified|0|||
126686665|NCT02574637|455808645|FG001|Double-blind Period|Reason Not Specified|0|||
126686666|NCT02574637|455808646|FG002|Double-blind Period|Reason Not Specified|0|||
126686667|NCT02574637|455808647|FG003|Double-blind Period|Reason Not Specified|1|||
126686668|NCT02574637|455808648|FG004|Double-blind Period|Reason Not Specified|0|||
126686669|NCT02574637|455808649|FG005|Double-blind Period|Reason Not Specified|0|||
126686670|NCT02574637|455808650|FG006|Double-blind Period|Reason Not Specified|0|||
126686671|NCT02574637|455808651|FG007|Double-blind Period|Reason Not Specified|0|||
126686672|NCT02574637|455808652|FG008|Double-blind Period|Reason Not Specified|0|||
126686673|NCT02574637|455808653|FG009|Double-blind Period|Reason Not Specified|0|||
126686674|NCT02574637|455808644|FG000|Open-label (OL) Period|Adverse Event|0|||
126686675|NCT02574637|455808645|FG001|Open-label (OL) Period|Adverse Event|0|||
126686676|NCT02574637|455808646|FG002|Open-label (OL) Period|Adverse Event|0|||
126686677|NCT02574637|455808647|FG003|Open-label (OL) Period|Adverse Event|0|||
126686678|NCT02574637|455808648|FG004|Open-label (OL) Period|Adverse Event|0|||
126686679|NCT02574637|455808649|FG005|Open-label (OL) Period|Adverse Event|0|||
126350233|NCT02101853|454574160|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350234|NCT02101853|454574161|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
126350235|NCT02101853|454574162|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126350236|NCT02101853|454574163|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
126686680|NCT02574637|455808650|FG006|Open-label (OL) Period|Adverse Event|0|||
126686681|NCT02574637|455808651|FG007|Open-label (OL) Period|Adverse Event|0|||
126686682|NCT02574637|455808652|FG008|Open-label (OL) Period|Adverse Event|1|||
126686683|NCT02574637|455808653|FG009|Open-label (OL) Period|Adverse Event|0|||
126686684|NCT02574637|455808644|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
126686685|NCT02574637|455808645|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
126686686|NCT02574637|455808646|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
126686687|NCT02574637|455808647|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
126686688|NCT02574637|455808648|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
126686689|NCT02574637|455808649|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
126686690|NCT02574637|455808650|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
126686691|NCT02574637|455808651|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
126686692|NCT02574637|455808652|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
126686693|NCT02574637|455808653|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
126686694|NCT02574637|455808644|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
126686695|NCT02574637|455808645|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
126686696|NCT02574637|455808646|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
126686697|NCT02574637|455808647|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
126686698|NCT02574637|455808648|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
126686699|NCT02574637|455808649|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
126686700|NCT02574637|455808650|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
126686701|NCT02574637|455808651|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
126686702|NCT02574637|455808652|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
126686703|NCT02574637|455808653|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
126686704|NCT03728309|455808657|FG000|Overall Study|Randomized but not Treated|0|||
126686705|NCT03728309|455808658|FG001|Overall Study|Randomized but not Treated|1|||
126686706|NCT03728309|455808657|FG000|Overall Study|Adverse Event|0|||
126686707|NCT03728309|455808658|FG001|Overall Study|Adverse Event|1|||
126686708|NCT03728309|455808657|FG000|Overall Study|Withdrawal by Subject|2|||
126686709|NCT03728309|455808658|FG001|Overall Study|Withdrawal by Subject|8|||
126350237|NCT02101853|454574158|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
126350238|NCT02101853|454574159|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
126350239|NCT02101853|454574160|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
126350240|NCT02101853|454574161|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
126350241|NCT02101853|454574162|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
126350242|NCT02101853|454574163|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
126350243|NCT02101853|454574158|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
126350244|NCT02101853|454574159|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
126350245|NCT02101853|454574160|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
126350246|NCT02101853|454574161|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
126350247|NCT02101853|454574162|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
126350248|NCT02101853|454574163|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
126350249|NCT02101853|454574158|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
126350250|NCT02101853|454574159|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
126350251|NCT02101853|454574160|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
126350252|NCT02101853|454574161|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
126350253|NCT02101853|454574162|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
126350254|NCT02101853|454574163|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
126686710|NCT03728309|455808657|FG000|Overall Study|Lost to Follow-up|9|||
126686711|NCT03728309|455808658|FG001|Overall Study|Lost to Follow-up|10|||
126686712|NCT03728309|455808657|FG000|Overall Study|Protocol Deviation|0|||
126686713|NCT03728309|455808658|FG001|Overall Study|Protocol Deviation|1|||
126350255|NCT02101853|454574158|FG000|Blinatumomab Salvage Therapy|Death|0|||
126350256|NCT02101853|454574159|FG001|Blinatumomab Salvage Therapy|Death|0|||
126350257|NCT02101853|454574160|FG002|Blinatumomab Salvage Therapy|Death|0|||
126350258|NCT02101853|454574161|FG003|Blinatumomab Salvage Therapy|Death|0|||
126350259|NCT02101853|454574162|FG004|Blinatumomab Salvage Therapy|Death|0|||
126350260|NCT02101853|454574163|FG005|Blinatumomab Salvage Therapy|Death|2|||
126350261|NCT02101853|454574158|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
126350262|NCT02101853|454574159|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
126350263|NCT02101853|454574160|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
126350264|NCT02101853|454574161|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
126350265|NCT02101853|454574162|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
126350266|NCT02101853|454574163|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
126350267|NCT02101853|454574158|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
126350268|NCT02101853|454574159|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
126350269|NCT02101853|454574160|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
126350270|NCT02101853|454574161|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
126350271|NCT02101853|454574162|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
126350272|NCT02101853|454574163|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
126350273|NCT02101853|454574158|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
126350274|NCT02101853|454574159|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
126350275|NCT02101853|454574160|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
126350276|NCT02101853|454574161|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
126350277|NCT02101853|454574162|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
126350278|NCT02101853|454574163|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
126350279|NCT02112916|454574164|FG000|Overall Study|Adverse Event|6|||
126350280|NCT02112916|454574165|FG001|Overall Study|Adverse Event|9|||
126350281|NCT02112916|454574166|FG002|Overall Study|Adverse Event|3|||
126350282|NCT02112916|454574167|FG003|Overall Study|Adverse Event|2|||
126350283|NCT02112916|454574164|FG000|Overall Study|Death|9|||
126350284|NCT02112916|454574165|FG001|Overall Study|Death|9|||
126350285|NCT02112916|454574166|FG002|Overall Study|Death|3|||
126350286|NCT02112916|454574167|FG003|Overall Study|Death|4|||
126350287|NCT02112916|454574164|FG000|Overall Study|Lost to Follow-up|1|||
126350288|NCT02112916|454574165|FG001|Overall Study|Lost to Follow-up|0|||
126350289|NCT02112916|454574166|FG002|Overall Study|Lost to Follow-up|0|||
126350290|NCT02112916|454574167|FG003|Overall Study|Lost to Follow-up|0|||
126350291|NCT02112916|454574164|FG000|Overall Study|Physician Decision|94|||
126350292|NCT02112916|454574165|FG001|Overall Study|Physician Decision|72|||
126350293|NCT02112916|454574166|FG002|Overall Study|Physician Decision|24|||
126350294|NCT02112916|454574167|FG003|Overall Study|Physician Decision|15|||
126350295|NCT02112916|454574164|FG000|Overall Study|Withdrawal by Subject|5|||
126350296|NCT02112916|454574165|FG001|Overall Study|Withdrawal by Subject|3|||
126350297|NCT02112916|454574166|FG002|Overall Study|Withdrawal by Subject|1|||
126350298|NCT02112916|454574167|FG003|Overall Study|Withdrawal by Subject|1|||
126350299|NCT02112916|454574164|FG000|Overall Study|Ineligible|4|||
126686714|NCT03728309|455808657|FG000|Overall Study|Due to COVID|1|||
126686715|NCT03728309|455808658|FG001|Overall Study|Due to COVID|3|||
126686716|NCT00953758|455808659|FG000|Overall Study|Death|2|||
126686717|NCT00953758|455808660|FG001|Overall Study|Death|0|||
126686718|NCT00953758|455808661|FG002|Overall Study|Death|1|||
126686719|NCT00953758|455808662|FG003|Overall Study|Death|1|||
126686720|NCT00953758|455808663|FG004|Overall Study|Death|1|||
126686721|NCT00953758|455808664|FG005|Overall Study|Death|1|||
126438388|NCT02113982|454907591|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
126438389|NCT02113982|454907592|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
126686722|NCT00953758|455808665|FG006|Overall Study|Death|1|||
126686723|NCT00953758|455808666|FG007|Overall Study|Death|3|||
126686724|NCT00953758|455808667|FG008|Overall Study|Death|1|||
126686725|NCT00953758|455808668|FG009|Overall Study|Death|0|||
126686726|NCT00953758|455808659|FG000|Overall Study|Participant refused further follow-up|0|||
126686727|NCT00953758|455808660|FG001|Overall Study|Participant refused further follow-up|0|||
126686728|NCT00953758|455808661|FG002|Overall Study|Participant refused further follow-up|1|||
126686729|NCT00953758|455808662|FG003|Overall Study|Participant refused further follow-up|0|||
126686730|NCT00953758|455808663|FG004|Overall Study|Participant refused further follow-up|3|||
126686731|NCT00953758|455808664|FG005|Overall Study|Participant refused further follow-up|0|||
126438390|NCT02113982|454907593|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
126438391|NCT02113982|454907580|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
126438392|NCT02113982|454907581|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
126438393|NCT02113982|454907582|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
126438394|NCT02113982|454907583|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
126438395|NCT02113982|454907584|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
126686732|NCT00953758|455808665|FG006|Overall Study|Participant refused further follow-up|0|||
126686733|NCT00953758|455808666|FG007|Overall Study|Participant refused further follow-up|0|||
126686734|NCT00953758|455808667|FG008|Overall Study|Participant refused further follow-up|1|||
126686735|NCT00953758|455808668|FG009|Overall Study|Participant refused further follow-up|0|||
126686736|NCT00953758|455808659|FG000|Overall Study|Lost to Follow-up|0|||
126686737|NCT00953758|455808660|FG001|Overall Study|Lost to Follow-up|0|||
126686738|NCT00953758|455808661|FG002|Overall Study|Lost to Follow-up|0|||
126686739|NCT00953758|455808662|FG003|Overall Study|Lost to Follow-up|1|||
126686740|NCT00953758|455808663|FG004|Overall Study|Lost to Follow-up|0|||
126686741|NCT00953758|455808664|FG005|Overall Study|Lost to Follow-up|0|||
126686742|NCT00953758|455808665|FG006|Overall Study|Lost to Follow-up|0|||
126686743|NCT00953758|455808666|FG007|Overall Study|Lost to Follow-up|1|||
126686744|NCT00953758|455808667|FG008|Overall Study|Lost to Follow-up|0|||
126686745|NCT00953758|455808668|FG009|Overall Study|Lost to Follow-up|1|||
126686746|NCT00953758|455808659|FG000|Overall Study|Physician Decision|0|||
126686747|NCT00953758|455808660|FG001|Overall Study|Physician Decision|0|||
126686748|NCT00953758|455808661|FG002|Overall Study|Physician Decision|0|||
126686749|NCT00953758|455808662|FG003|Overall Study|Physician Decision|0|||
126686750|NCT00953758|455808663|FG004|Overall Study|Physician Decision|1|||
126438396|NCT02113982|454907585|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
126438397|NCT02113982|454907586|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
126438398|NCT02113982|454907587|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
126438399|NCT02113982|454907588|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
126438400|NCT02113982|454907589|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
126438401|NCT02113982|454907590|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
126686751|NCT00953758|455808664|FG005|Overall Study|Physician Decision|0|||
126686752|NCT00953758|455808665|FG006|Overall Study|Physician Decision|0|||
126686753|NCT00953758|455808666|FG007|Overall Study|Physician Decision|0|||
126686754|NCT00953758|455808667|FG008|Overall Study|Physician Decision|0|||
126686755|NCT00953758|455808668|FG009|Overall Study|Physician Decision|0|||
126686756|NCT00953758|455808659|FG000|Overall Study|Disease progression|0|||
126686757|NCT00953758|455808660|FG001|Overall Study|Disease progression|0|||
126686758|NCT00953758|455808661|FG002|Overall Study|Disease progression|0|||
126686759|NCT00953758|455808662|FG003|Overall Study|Disease progression|0|||
126686760|NCT00953758|455808663|FG004|Overall Study|Disease progression|1|||
126686761|NCT00953758|455808664|FG005|Overall Study|Disease progression|0|||
126686762|NCT00953758|455808665|FG006|Overall Study|Disease progression|0|||
126438402|NCT02113982|454907591|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
126438403|NCT02113982|454907592|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
126438404|NCT02113982|454907593|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
126438405|NCT02113982|454907580|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
126438406|NCT02113982|454907581|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
126438407|NCT02113982|454907582|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
126438408|NCT02113982|454907583|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
126438409|NCT02113982|454907584|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
126438410|NCT02113982|454907585|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
126438411|NCT02113982|454907586|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
126686763|NCT00953758|455808666|FG007|Overall Study|Disease progression|0|||
126438412|NCT02113982|454907587|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
126438413|NCT02113982|454907588|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
126438414|NCT02113982|454907589|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
126438415|NCT02113982|454907590|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
126438416|NCT02113982|454907591|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
126438417|NCT02113982|454907592|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
126438418|NCT02113982|454907593|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
126438419|NCT02113982|454907580|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126438420|NCT02113982|454907581|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126438421|NCT02113982|454907582|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126438422|NCT02113982|454907583|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126438423|NCT02113982|454907584|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126438424|NCT02113982|454907585|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126438425|NCT02113982|454907586|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126438426|NCT02113982|454907587|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
126438427|NCT02113982|454907588|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126438428|NCT02113982|454907589|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
126438429|NCT02113982|454907590|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126438430|NCT02113982|454907591|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126438431|NCT02113982|454907592|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126438432|NCT02113982|454907593|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
126438433|NCT02113982|454907580|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126438434|NCT02113982|454907581|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126438435|NCT02113982|454907582|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126438436|NCT02113982|454907583|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126686764|NCT00953758|455808667|FG008|Overall Study|Disease progression|0|||
126686765|NCT00953758|455808668|FG009|Overall Study|Disease progression|0|||
126686766|NCT00953758|455808659|FG000|Overall Study|Participant went for transplant|0|||
126686767|NCT00953758|455808660|FG001|Overall Study|Participant went for transplant|0|||
126438437|NCT02113982|454907584|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126438438|NCT02113982|454907585|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126686768|NCT00953758|455808661|FG002|Overall Study|Participant went for transplant|0|||
126438439|NCT02113982|454907586|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126686769|NCT00953758|455808662|FG003|Overall Study|Participant went for transplant|0|||
126686770|NCT00953758|455808663|FG004|Overall Study|Participant went for transplant|0|||
126686771|NCT00953758|455808664|FG005|Overall Study|Participant went for transplant|0|||
126686772|NCT00953758|455808665|FG006|Overall Study|Participant went for transplant|0|||
126686773|NCT00953758|455808666|FG007|Overall Study|Participant went for transplant|0|||
126686774|NCT00953758|455808667|FG008|Overall Study|Participant went for transplant|1|||
126686775|NCT00953758|455808668|FG009|Overall Study|Participant went for transplant|0|||
126686776|NCT01164722|455808669|FG000|Overall Study|Adverse Event|0|||
126686777|NCT01164722|455808670|FG001|Overall Study|Adverse Event|1|||
126438440|NCT02113982|454907587|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
126438441|NCT02113982|454907588|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126438442|NCT02113982|454907589|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126438443|NCT02113982|454907590|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126438444|NCT02113982|454907591|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126438445|NCT02113982|454907592|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126438446|NCT02113982|454907593|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
126438447|NCT02113982|454907580|FG000|Stage 2: Cohort Expansion|Transplant|0|||
126438448|NCT02113982|454907581|FG001|Stage 2: Cohort Expansion|Transplant|0|||
126438449|NCT02113982|454907582|FG002|Stage 2: Cohort Expansion|Transplant|0|||
126438450|NCT02113982|454907583|FG003|Stage 2: Cohort Expansion|Transplant|0|||
126438451|NCT02113982|454907584|FG004|Stage 2: Cohort Expansion|Transplant|0|||
126438452|NCT02113982|454907585|FG005|Stage 2: Cohort Expansion|Transplant|0|||
126438453|NCT02113982|454907586|FG006|Stage 2: Cohort Expansion|Transplant|0|||
126438454|NCT02113982|454907587|FG007|Stage 2: Cohort Expansion|Transplant|0|||
126438455|NCT02113982|454907588|FG008|Stage 2: Cohort Expansion|Transplant|0|||
126438456|NCT02113982|454907589|FG009|Stage 2: Cohort Expansion|Transplant|4|||
126438457|NCT02113982|454907590|FG010|Stage 2: Cohort Expansion|Transplant|2|||
126438458|NCT02113982|454907591|FG011|Stage 2: Cohort Expansion|Transplant|0|||
126438459|NCT02113982|454907592|FG012|Stage 2: Cohort Expansion|Transplant|0|||
126438460|NCT02113982|454907593|FG013|Stage 2: Cohort Expansion|Transplant|0|||
126438461|NCT02113982|454907580|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
126438462|NCT02113982|454907581|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
126438463|NCT02113982|454907582|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
126438464|NCT02113982|454907583|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
126438465|NCT02113982|454907584|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
126438466|NCT02113982|454907585|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
126438467|NCT02113982|454907586|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
126438468|NCT02113982|454907587|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
126438469|NCT02113982|454907588|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
126438470|NCT02113982|454907589|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
126438471|NCT02113982|454907590|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
126438472|NCT02113982|454907591|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
126438473|NCT02113982|454907592|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
126438474|NCT02113982|454907593|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
126438475|NCT02113982|454907580|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
126438476|NCT02113982|454907581|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
126438477|NCT02113982|454907582|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
126438478|NCT02113982|454907583|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
126438479|NCT02113982|454907584|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
126438480|NCT02113982|454907585|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
126438481|NCT02113982|454907586|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
126438482|NCT02113982|454907587|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
126686778|NCT01164722|455808669|FG000|Overall Study|Withdrawal by Subject|3|||
126686779|NCT01164722|455808670|FG001|Overall Study|Withdrawal by Subject|4|||
126686780|NCT01164722|455808669|FG000|Overall Study|Lost to Follow-up|3|||
126438483|NCT02113982|454907588|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
126438484|NCT02113982|454907589|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
126438485|NCT02113982|454907590|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
126759643|NCT01977573|456068647|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
126759644|NCT01977573|456068648|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
126759645|NCT01977573|456068645|FG000|Overall Study|Withdrawal by Subject|6|||
126759646|NCT01977573|456068646|FG001|Overall Study|Withdrawal by Subject|1|||
126759647|NCT01977573|456068647|FG002|Overall Study|Withdrawal by Subject|1|||
126759648|NCT01977573|456068648|FG003|Overall Study|Withdrawal by Subject|1|||
126759649|NCT02993731|456068649|FG000|Overall Study|Study Termination|101|||
126759650|NCT02993731|456068650|FG001|Overall Study|Study Termination|105|||
126759651|NCT02545504|456068654|FG000|Overall Study|Death|174|||
126759652|NCT02545504|456068655|FG001|Overall Study|Death|168|||
126759653|NCT02545504|456068654|FG000|Overall Study|Unknown reason|30|||
126759654|NCT02545504|456068655|FG001|Overall Study|Unknown reason|32|||
126759655|NCT02545504|456068654|FG000|Overall Study|Withdrew consent|9|||
126759656|NCT02545504|456068655|FG001|Overall Study|Withdrew consent|11|||
126759657|NCT02545504|456068654|FG000|Overall Study|Investigator's discretion|3|||
126759658|NCT02545504|456068655|FG001|Overall Study|Investigator's discretion|1|||
126759659|NCT02545504|456068654|FG000|Overall Study|Lost to Follow-up|2|||
126759660|NCT02545504|456068655|FG001|Overall Study|Lost to Follow-up|2|||
126759661|NCT00508820|456068657|FG000|Overall Study|Adverse Event|6|||
126759662|NCT00508820|456068658|FG001|Overall Study|Adverse Event|10|||
126759663|NCT00508820|456068657|FG000|Overall Study|Death|6|||
126759664|NCT00508820|456068658|FG001|Overall Study|Death|8|||
126759665|NCT00508820|456068657|FG000|Overall Study|Lost to Follow-up|1|||
126759666|NCT00508820|456068658|FG001|Overall Study|Lost to Follow-up|1|||
126759667|NCT00508820|456068657|FG000|Overall Study|Physician Decision|8|||
126759668|NCT00508820|456068658|FG001|Overall Study|Physician Decision|2|||
126759669|NCT00508820|456068657|FG000|Overall Study|Pregnancy|0|||
126759670|NCT00508820|456068658|FG001|Overall Study|Pregnancy|2|||
126759671|NCT00508820|456068657|FG000|Overall Study|Protocol Violation|2|||
126759672|NCT00508820|456068658|FG001|Overall Study|Protocol Violation|0|||
126759673|NCT00508820|456068657|FG000|Overall Study|Withdrawal by Subject|10|||
126759674|NCT00508820|456068658|FG001|Overall Study|Withdrawal by Subject|12|||
126759675|NCT00508820|456068657|FG000|Overall Study|Other|11|||
126759676|NCT00508820|456068658|FG001|Overall Study|Other|2|||
126759677|NCT00508820|456068657|FG000|Overall Study|Noncompliance|1|||
126759678|NCT00508820|456068658|FG001|Overall Study|Noncompliance|0|||
126759679|NCT00508820|456068657|FG000|Overall Study|Requirement for alternative therapy|7|||
126759680|NCT00508820|456068658|FG001|Overall Study|Requirement for alternative therapy|15|||
126759681|NCT00508820|456068657|FG000|Overall Study|Protocol-specified Criteria|3|||
126759682|NCT00508820|456068658|FG001|Overall Study|Protocol-specified Criteria|12|||
126759683|NCT02926833|456070356|FG000|Overall Study|Death|1|||
126759684|NCT02926833|456070357|FG001|Overall Study|Death|1|||
126759685|NCT02926833|456070358|FG002|Overall Study|Death|2|||
126759686|NCT02926833|456070359|FG003|Overall Study|Death|13|||
126759687|NCT02926833|456070356|FG000|Overall Study|Lost to Follow-up|1|||
126759688|NCT02926833|456070357|FG001|Overall Study|Lost to Follow-up|2|||
126759689|NCT02926833|456070358|FG002|Overall Study|Lost to Follow-up|0|||
126350300|NCT02112916|454574165|FG001|Overall Study|Ineligible|8|||
126350301|NCT02112916|454574166|FG002|Overall Study|Ineligible|3|||
126350302|NCT02112916|454574167|FG003|Overall Study|Ineligible|8|||
126350303|NCT02112916|454574164|FG000|Overall Study|Inevaluable|6|||
126350304|NCT02112916|454574165|FG001|Overall Study|Inevaluable|4|||
126759690|NCT02926833|456070359|FG003|Overall Study|Lost to Follow-up|3|||
126759691|NCT02926833|456070356|FG000|Overall Study|Full Consent Withdrawal|0|||
126759692|NCT02926833|456070357|FG001|Overall Study|Full Consent Withdrawal|0|||
126759693|NCT02926833|456070358|FG002|Overall Study|Full Consent Withdrawal|0|||
126759694|NCT02926833|456070359|FG003|Overall Study|Full Consent Withdrawal|2|||
126759695|NCT02926833|456070356|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
126759696|NCT02926833|456070357|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
126759697|NCT02926833|456070358|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
126759698|NCT02926833|456070359|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
126759699|NCT02926833|456070356|FG000|Overall Study|Investigator Decision|0|||
126686781|NCT01164722|455808670|FG001|Overall Study|Lost to Follow-up|6|||
126686782|NCT01164722|455808669|FG000|Overall Study|met protocol criteria for non-treatment|11|||
126686783|NCT01164722|455808670|FG001|Overall Study|met protocol criteria for non-treatment|1|||
126686784|NCT01164722|455808669|FG000|Overall Study|enrolled on other study, concomitant med|1|||
126686785|NCT01164722|455808670|FG001|Overall Study|enrolled on other study, concomitant med|3|||
126686786|NCT00999908|455808671|FG000|Treatment Period 1|Subject withdrew consent|2|||
126686787|NCT00999908|455808672|FG001|Treatment Period 1|Subject withdrew consent|0|||
126686788|NCT00999908|455808673|FG002|Treatment Period 1|Subject withdrew consent|0|||
126686789|NCT00999908|455808671|FG000|Treatment Period 2|Protocol Violation|1|||
126686790|NCT00999908|455808672|FG001|Treatment Period 2|Protocol Violation|0|||
126686791|NCT00999908|455808673|FG002|Treatment Period 2|Protocol Violation|0|||
126686792|NCT01703858|455808674|FG000|Overall Study|Withdrawal by Subject|0|||
126686793|NCT01703858|455808675|FG001|Overall Study|Withdrawal by Subject|1|||
126686794|NCT01703858|455808676|FG002|Overall Study|Withdrawal by Subject|0|||
126686795|NCT01290692|455808681|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
126686796|NCT00993031|455808682|FG000|Overall Study|Death|0|||
126686797|NCT00993031|455808683|FG001|Overall Study|Death|1|||
126686798|NCT00993031|455808682|FG000|Overall Study|Physician Decision|0|||
126686799|NCT00993031|455808683|FG001|Overall Study|Physician Decision|2|||
126686800|NCT00993031|455808682|FG000|Overall Study|Withdrawal by Subject|3|||
126686801|NCT00993031|455808683|FG001|Overall Study|Withdrawal by Subject|3|||
126686802|NCT00993031|455808682|FG000|Overall Study|Lost to Follow-up|19|||
126686803|NCT00993031|455808683|FG001|Overall Study|Lost to Follow-up|13|||
126686804|NCT00706030|455808684|FG000|Overall Study|Disease Progression|4|||
126686805|NCT00706030|455808685|FG001|Overall Study|Disease Progression|6|||
126686806|NCT00706030|455808686|FG002|Overall Study|Disease Progression|46|||
126686807|NCT00706030|455808687|FG003|Overall Study|Disease Progression|12|||
126686808|NCT00706030|455808684|FG000|Overall Study|Adverse Event|1|||
126686809|NCT00706030|455808685|FG001|Overall Study|Adverse Event|0|||
126759700|NCT02926833|456070357|FG001|Overall Study|Investigator Decision|1|||
126759701|NCT02926833|456070358|FG002|Overall Study|Investigator Decision|0|||
126438486|NCT02113982|454907591|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
126438487|NCT02113982|454907592|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
126686810|NCT00706030|455808686|FG002|Overall Study|Adverse Event|4|||
126759702|NCT02926833|456070359|FG003|Overall Study|Investigator Decision|0|||
126759703|NCT02926833|456070356|FG000|Overall Study|Adverse Event|0|||
126759704|NCT02926833|456070357|FG001|Overall Study|Adverse Event|0|||
126759705|NCT02926833|456070358|FG002|Overall Study|Adverse Event|1|||
126759706|NCT02926833|456070359|FG003|Overall Study|Adverse Event|0|||
126438488|NCT02113982|454907593|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
126686811|NCT00706030|455808687|FG003|Overall Study|Adverse Event|2|||
126686812|NCT00706030|455808684|FG000|Overall Study|Withdrawal by Subject|1|||
126686813|NCT00706030|455808685|FG001|Overall Study|Withdrawal by Subject|0|||
126686814|NCT00706030|455808686|FG002|Overall Study|Withdrawal by Subject|2|||
126686815|NCT00706030|455808687|FG003|Overall Study|Withdrawal by Subject|0|||
126686816|NCT00706030|455808684|FG000|Overall Study|Physician Decision|0|||
126686817|NCT00706030|455808685|FG001|Overall Study|Physician Decision|0|||
126759707|NCT02926833|456070356|FG000|Overall Study|Partial Withdrawal of Consent|0|||
126759708|NCT02926833|456070357|FG001|Overall Study|Partial Withdrawal of Consent|0|||
126686818|NCT00706030|455808686|FG002|Overall Study|Physician Decision|2|||
126686819|NCT00706030|455808687|FG003|Overall Study|Physician Decision|0|||
126686820|NCT00706030|455808684|FG000|Overall Study|Not recorded|0|||
126686821|NCT00706030|455808685|FG001|Overall Study|Not recorded|0|||
126686822|NCT00706030|455808686|FG002|Overall Study|Not recorded|2|||
126686823|NCT00706030|455808687|FG003|Overall Study|Not recorded|0|||
126686824|NCT00706030|455808684|FG000|Overall Study|Protocol Violation|0|||
126686825|NCT00706030|455808685|FG001|Overall Study|Protocol Violation|0|||
126686826|NCT00706030|455808686|FG002|Overall Study|Protocol Violation|1|||
126686827|NCT00706030|455808687|FG003|Overall Study|Protocol Violation|1|||
126686828|NCT00706030|455808684|FG000|Overall Study|Failed to return|0|||
126686829|NCT00706030|455808685|FG001|Overall Study|Failed to return|0|||
126686830|NCT00706030|455808686|FG002|Overall Study|Failed to return|1|||
126686831|NCT00706030|455808687|FG003|Overall Study|Failed to return|0|||
126686832|NCT00706030|455808684|FG000|Overall Study|Symptomatic Deterioration|0|||
126686833|NCT00706030|455808685|FG001|Overall Study|Symptomatic Deterioration|0|||
126686834|NCT00706030|455808686|FG002|Overall Study|Symptomatic Deterioration|1|||
126686835|NCT00706030|455808687|FG003|Overall Study|Symptomatic Deterioration|0|||
126686836|NCT00706030|455808684|FG000|Overall Study|No treatment received|0|||
126686837|NCT00706030|455808685|FG001|Overall Study|No treatment received|0|||
126686838|NCT00706030|455808686|FG002|Overall Study|No treatment received|0|||
126686839|NCT00706030|455808687|FG003|Overall Study|No treatment received|1|||
126686840|NCT00706030|455808684|FG000|Overall Study|Death|0|||
126686841|NCT00706030|455808685|FG001|Overall Study|Death|0|||
126686842|NCT00706030|455808686|FG002|Overall Study|Death|1|||
126686843|NCT00706030|455808687|FG003|Overall Study|Death|0|||
126686844|NCT03870555|455808688|FG000|Period 3 (2 Days)|Adverse Event|1|||
126686845|NCT03870555|455808689|FG001|Period 3 (2 Days)|Adverse Event|0|||
126686846|NCT03870555|455808690|FG002|Period 3 (2 Days)|Adverse Event|0|||
126686847|NCT03167073|455808692|FG000|Overall Study|Stillbirth|1|||
126686848|NCT03167073|455808693|FG001|Overall Study|Stillbirth|0|||
126686849|NCT01276236|455808694|FG000|Overall Study|Lack of Efficacy|2|||
126686850|NCT01276236|455808694|FG000|Overall Study|Withdrawal by Subject|4|||
126686851|NCT00044512|455808695|FG000|Follow Up|Lost to Follow-up|2|||
126686852|NCT00357500|455808699|FG000|Overall Study|Adverse Event|3|||
126686853|NCT00357500|455808699|FG000|Overall Study|Withdrawal by Subject|5|||
126686854|NCT00357500|455808699|FG000|Overall Study|Progressive Disease|65|||
126686855|NCT00357500|455808699|FG000|Overall Study|Not Started Protocol Therapy|4|||
126686856|NCT02695628|455808700|FG000|Overall Study|Withdrawal by Subject|1|||
126686857|NCT02573155|455808701|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
126686858|NCT02573155|455808702|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
126686859|NCT02573155|455808701|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
126686860|NCT02573155|455808702|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
126686861|NCT02573155|455808701|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
126686862|NCT02573155|455808702|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
126686863|NCT02573155|455808701|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
126686864|NCT02573155|455808702|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
126686865|NCT02573155|455808701|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
126686866|NCT02573155|455808702|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
126686867|NCT02573155|455808701|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
126686868|NCT02573155|455808702|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
126686869|NCT02573155|455808701|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
126686870|NCT02573155|455808702|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
126686871|NCT02573155|455808701|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
126686872|NCT02573155|455808702|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
126686873|NCT01681433|455808703|FG000|Overall Study|Lack of Efficacy|23|||
126686874|NCT01681433|455808704|FG001|Overall Study|Lack of Efficacy|23|||
126686875|NCT01681433|455808703|FG000|Overall Study|Withdrawal by Subject|5|||
126686876|NCT01681433|455808704|FG001|Overall Study|Withdrawal by Subject|5|||
126686877|NCT01681433|455808703|FG000|Overall Study|Protocol Violation|2|||
126686878|NCT01681433|455808704|FG001|Overall Study|Protocol Violation|0|||
126686879|NCT01681433|455808703|FG000|Overall Study|Adverse Event|2|||
126686880|NCT01681433|455808704|FG001|Overall Study|Adverse Event|4|||
126686881|NCT01681433|455808703|FG000|Overall Study|Lost to Follow-up|0|||
126686882|NCT01681433|455808704|FG001|Overall Study|Lost to Follow-up|1|||
126686883|NCT02301403|455808705|FG000|Overall Study|Withdrawal by Subject|28|||
126686884|NCT02301403|455808706|FG001|Overall Study|Withdrawal by Subject|41|||
126686885|NCT02289950|455808726|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
126686886|NCT02289950|455808727|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
126686887|NCT02289950|455808726|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
126686888|NCT02289950|455808727|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
126686889|NCT02289950|455808726|FG000|Overall Study|Lost to Follow-up|1|||
126686890|NCT02289950|455808727|FG001|Overall Study|Lost to Follow-up|0|||
126686891|NCT02289950|455808726|FG000|Overall Study|Physician Decision|9|||
126686892|NCT02289950|455808727|FG001|Overall Study|Physician Decision|3|||
126686893|NCT02289950|455808726|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
126686894|NCT02289950|455808727|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
126686895|NCT02289950|455808726|FG000|Overall Study|Withdrawal by Subject|1|||
126686896|NCT02289950|455808727|FG001|Overall Study|Withdrawal by Subject|3|||
126686897|NCT02289950|455808726|FG000|Overall Study|Test article held for greater than 28 days|0|||
126686898|NCT02289950|455808727|FG001|Overall Study|Test article held for greater than 28 days|1|||
126686899|NCT02289950|455808726|FG000|Overall Study|Adverse Event|11|||
126686900|NCT02289950|455808727|FG001|Overall Study|Adverse Event|3|||
126686901|NCT02289950|455808726|FG000|Overall Study|Death|1|||
126686902|NCT02289950|455808727|FG001|Overall Study|Death|1|||
126686903|NCT02289950|455808726|FG000|Overall Study|Other|5|||
126686904|NCT02289950|455808727|FG001|Overall Study|Other|2|||
126686905|NCT02289950|455808726|FG000|Overall Study|Not Treated|2|||
126686906|NCT02289950|455808727|FG001|Overall Study|Not Treated|1|||
126686907|NCT02270242|455808728|FG000|Overall Study|Withdrawal by Subject|18|||
126686908|NCT02270242|455808729|FG001|Overall Study|Withdrawal by Subject|25|||
126686909|NCT02270242|455808728|FG000|Overall Study|Lost to Follow-up|41|||
126686910|NCT02270242|455808729|FG001|Overall Study|Lost to Follow-up|27|||
126686911|NCT02270242|455808728|FG000|Overall Study|Physician Decision|0|||
126686912|NCT02270242|455808729|FG001|Overall Study|Physician Decision|1|||
126686913|NCT02321436|455808730|FG000|Overall Study|Withdrawal by Subject|1|||
126686914|NCT02321436|455808731|FG001|Overall Study|Withdrawal by Subject|0|||
126686915|NCT02321436|455808730|FG000|Overall Study|Lost to Follow-up|0|||
126686916|NCT02321436|455808731|FG001|Overall Study|Lost to Follow-up|1|||
126686917|NCT05036083|455808732|FG000|Overall Study|Physician Decision|1|||
126686918|NCT05036083|455808732|FG000|Overall Study|Withdrawal by Subject|1|||
126686919|NCT05036083|455808732|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
126686920|NCT05036083|455808732|FG000|Overall Study|IV not sustainable|1|||
126686921|NCT04705051|455810819|FG000|Overall Study|Enrolled but not treated|1|||
126686922|NCT04705051|455810819|FG000|Overall Study|Study terminated by sponsor|23|||
126686923|NCT02968810|455810820|FG000|Overall Study|Lost to Follow-up|1|||
126686924|NCT02968810|455810821|FG001|Overall Study|Lost to Follow-up|0|||
126686925|NCT02968810|455810820|FG000|Overall Study|Physician Decision|1|||
126686926|NCT02968810|455810821|FG001|Overall Study|Physician Decision|0|||
126686927|NCT02968810|455810820|FG000|Overall Study|Withdrawal by Subject|1|||
126686928|NCT02968810|455810821|FG001|Overall Study|Withdrawal by Subject|3|||
126686929|NCT02968810|455810820|FG000|Overall Study|Disease Progression|0|||
126686930|NCT02968810|455810821|FG001|Overall Study|Disease Progression|1|||
126686931|NCT04137887|455810822|FG000|Overall Study|Death|102|||
126686932|NCT04137887|455810823|FG001|Overall Study|Death|92|||
126686933|NCT04137887|455810822|FG000|Overall Study|Withdrawal by Subject|2|||
126686934|NCT04137887|455810823|FG001|Overall Study|Withdrawal by Subject|3|||
126686935|NCT04137887|455810822|FG000|Overall Study|Randomized but not treated|0|||
126686936|NCT04137887|455810823|FG001|Overall Study|Randomized but not treated|1|||
126686937|NCT01790503|455810826|FG000|Overall Study|Adverse Event|1|||
126686938|NCT01790503|455810827|FG001|Overall Study|Adverse Event|0|||
126686939|NCT01790503|455810828|FG002|Overall Study|Adverse Event|0|||
126686940|NCT01790503|455810829|FG003|Overall Study|Adverse Event|0|||
126686941|NCT01790503|455810830|FG004|Overall Study|Adverse Event|0|||
126686942|NCT01790503|455810831|FG005|Overall Study|Adverse Event|2|||
126686943|NCT01790503|455810832|FG006|Overall Study|Adverse Event|0|||
126686944|NCT01790503|455810833|FG007|Overall Study|Adverse Event|0|||
126686945|NCT01790503|455810834|FG008|Overall Study|Adverse Event|2|||
126686946|NCT01790503|455810835|FG009|Overall Study|Adverse Event|4|||
126686947|NCT01790503|455810836|FG010|Overall Study|Adverse Event|7|||
126686948|NCT01790503|455810826|FG000|Overall Study|Withdrawal by Subject|0|||
126686949|NCT01790503|455810827|FG001|Overall Study|Withdrawal by Subject|0|||
126686950|NCT01790503|455810828|FG002|Overall Study|Withdrawal by Subject|1|||
126686951|NCT01790503|455810829|FG003|Overall Study|Withdrawal by Subject|1|||
126686952|NCT01790503|455810830|FG004|Overall Study|Withdrawal by Subject|1|||
126686953|NCT01790503|455810831|FG005|Overall Study|Withdrawal by Subject|2|||
126686954|NCT01790503|455810832|FG006|Overall Study|Withdrawal by Subject|1|||
126686955|NCT01790503|455810833|FG007|Overall Study|Withdrawal by Subject|0|||
126686956|NCT01790503|455810834|FG008|Overall Study|Withdrawal by Subject|0|||
126686957|NCT01790503|455810835|FG009|Overall Study|Withdrawal by Subject|0|||
126686958|NCT01790503|455810836|FG010|Overall Study|Withdrawal by Subject|1|||
126686959|NCT01790503|455810826|FG000|Overall Study|Disease progression|2|||
126686960|NCT01790503|455810827|FG001|Overall Study|Disease progression|1|||
126686961|NCT01790503|455810828|FG002|Overall Study|Disease progression|0|||
126686962|NCT01790503|455810829|FG003|Overall Study|Disease progression|1|||
126686963|NCT01790503|455810830|FG004|Overall Study|Disease progression|2|||
126686964|NCT01790503|455810831|FG005|Overall Study|Disease progression|1|||
126686965|NCT01790503|455810832|FG006|Overall Study|Disease progression|0|||
126686966|NCT01790503|455810833|FG007|Overall Study|Disease progression|1|||
126686967|NCT01790503|455810834|FG008|Overall Study|Disease progression|0|||
126350305|NCT02112916|454574166|FG002|Overall Study|Inevaluable|5|||
126759709|NCT02926833|456070358|FG002|Overall Study|Partial Withdrawal of Consent|0|||
126759710|NCT02926833|456070359|FG003|Overall Study|Partial Withdrawal of Consent|1|||
126759711|NCT01189201|456070362|FG000|Overall Study|Adverse Event|1|||
126759712|NCT01277757|456070363|FG000|Overall Study|Disease Progression|1|||
126759713|NCT01277757|456070363|FG000|Overall Study|Withdrawal by Subject|1|||
126759714|NCT04308668|456070364|FG000|Overall Study|Lost to Follow-up|32|||
126759715|NCT04308668|456070365|FG001|Overall Study|Lost to Follow-up|38|||
126759716|NCT04308668|456070364|FG000|Overall Study|Withdrawal by Subject|4|||
126686968|NCT01790503|455810835|FG009|Overall Study|Disease progression|17|||
126759717|NCT04308668|456070365|FG001|Overall Study|Withdrawal by Subject|4|||
126759718|NCT01266967|456070366|FG000|Overall Study|Death|69|||
126759719|NCT01266967|456070367|FG001|Overall Study|Death|61|||
126759720|NCT01266967|456070366|FG000|Overall Study|Study Closed/Terminated|15|||
126759721|NCT01266967|456070367|FG001|Overall Study|Study Closed/Terminated|17|||
126759722|NCT01266967|456070366|FG000|Overall Study|Lost to Follow-up|2|||
126759723|NCT01266967|456070367|FG001|Overall Study|Lost to Follow-up|1|||
126759724|NCT01266967|456070366|FG000|Overall Study|Physician Decision|0|||
126759725|NCT01266967|456070367|FG001|Overall Study|Physician Decision|1|||
126759726|NCT01266967|456070366|FG000|Overall Study|Withdrawal by Subject|3|||
126759727|NCT01266967|456070367|FG001|Overall Study|Withdrawal by Subject|3|||
126759728|NCT01945866|456070368|FG000|Overall Study|Eyes did not complete or were dropped|2|||
126759729|NCT01945866|456070369|FG001|Overall Study|Eyes did not complete or were dropped|0|||
126759730|NCT03808298|456070370|FG000|Overall Study|Adverse Event|3|||
126759731|NCT03808298|456070370|FG000|Overall Study|Physician Decision|1|||
126759732|NCT03808298|456070370|FG000|Overall Study|Withdrawal by Subject|1|||
126759733|NCT03808298|456070370|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
126759734|NCT01674010|456070371|FG000|Open Treatment Phase 1|Adverse Event|10|||
126759735|NCT01674010|456070372|FG001|Open Treatment Phase 1|Adverse Event|0|||
126759736|NCT01674010|456070373|FG002|Open Treatment Phase 1|Adverse Event|0|||
126759737|NCT01674010|456070371|FG000|Open Treatment Phase 1|Death|1|||
126759738|NCT01674010|456070372|FG001|Open Treatment Phase 1|Death|0|||
126759739|NCT01674010|456070373|FG002|Open Treatment Phase 1|Death|0|||
126759740|NCT01674010|456070371|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
126759741|NCT01674010|456070372|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
126759742|NCT01674010|456070373|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
126759743|NCT01674010|456070371|FG000|Open Treatment Phase 1|Physician Decision|9|||
126759744|NCT01674010|456070372|FG001|Open Treatment Phase 1|Physician Decision|0|||
126759745|NCT01674010|456070373|FG002|Open Treatment Phase 1|Physician Decision|0|||
126759746|NCT01674010|456070371|FG000|Open Treatment Phase 1|Protocol Violation|7|||
126686969|NCT01790503|455810836|FG010|Overall Study|Disease progression|7|||
126686970|NCT01790503|455810826|FG000|Overall Study|Protocol Violation|0|||
126686971|NCT01790503|455810827|FG001|Overall Study|Protocol Violation|0|||
126686972|NCT01790503|455810828|FG002|Overall Study|Protocol Violation|0|||
126686973|NCT01790503|455810829|FG003|Overall Study|Protocol Violation|0|||
126686974|NCT01790503|455810830|FG004|Overall Study|Protocol Violation|0|||
126686975|NCT01790503|455810831|FG005|Overall Study|Protocol Violation|0|||
126686976|NCT01790503|455810832|FG006|Overall Study|Protocol Violation|0|||
126686977|NCT01790503|455810833|FG007|Overall Study|Protocol Violation|0|||
126686978|NCT01790503|455810834|FG008|Overall Study|Protocol Violation|0|||
126686979|NCT01790503|455810835|FG009|Overall Study|Protocol Violation|1|||
126686980|NCT01790503|455810836|FG010|Overall Study|Protocol Violation|0|||
126686981|NCT01790503|455810826|FG000|Overall Study|Physician Decision|0|||
126686982|NCT01790503|455810827|FG001|Overall Study|Physician Decision|0|||
126686983|NCT01790503|455810828|FG002|Overall Study|Physician Decision|0|||
126686984|NCT01790503|455810829|FG003|Overall Study|Physician Decision|0|||
126686985|NCT01790503|455810830|FG004|Overall Study|Physician Decision|0|||
126686986|NCT01790503|455810831|FG005|Overall Study|Physician Decision|0|||
126686987|NCT01790503|455810832|FG006|Overall Study|Physician Decision|0|||
126350306|NCT02112916|454574167|FG003|Overall Study|Inevaluable|5|||
126350307|NCT02112916|454574164|FG000|Overall Study|Refusal of further protocol therapy|19|||
126686988|NCT01790503|455810833|FG007|Overall Study|Physician Decision|0|||
126686989|NCT01790503|455810834|FG008|Overall Study|Physician Decision|0|||
126686990|NCT01790503|455810835|FG009|Overall Study|Physician Decision|1|||
126759747|NCT01674010|456070372|FG001|Open Treatment Phase 1|Protocol Violation|0|||
126759748|NCT01674010|456070373|FG002|Open Treatment Phase 1|Protocol Violation|0|||
126759749|NCT01674010|456070371|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
126350308|NCT02112916|454574165|FG001|Overall Study|Refusal of further protocol therapy|16|||
126686991|NCT01790503|455810836|FG010|Overall Study|Physician Decision|1|||
126759750|NCT01674010|456070372|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
126686992|NCT01790503|455810826|FG000|Overall Study|Death|0|||
126686993|NCT01790503|455810827|FG001|Overall Study|Death|0|||
126686994|NCT01790503|455810828|FG002|Overall Study|Death|0|||
126686995|NCT01790503|455810829|FG003|Overall Study|Death|0|||
126686996|NCT01790503|455810830|FG004|Overall Study|Death|0|||
126686997|NCT01790503|455810831|FG005|Overall Study|Death|0|||
126686998|NCT01790503|455810832|FG006|Overall Study|Death|0|||
126686999|NCT01790503|455810833|FG007|Overall Study|Death|0|||
126687000|NCT01790503|455810834|FG008|Overall Study|Death|0|||
126687001|NCT01790503|455810835|FG009|Overall Study|Death|1|||
126687002|NCT01790503|455810836|FG010|Overall Study|Death|0|||
126687003|NCT01790503|455810826|FG000|Overall Study|Non Compliance|0|||
126687004|NCT01790503|455810827|FG001|Overall Study|Non Compliance|0|||
126687005|NCT01790503|455810828|FG002|Overall Study|Non Compliance|0|||
126687006|NCT01790503|455810829|FG003|Overall Study|Non Compliance|0|||
126687007|NCT01790503|455810830|FG004|Overall Study|Non Compliance|1|||
126687008|NCT01790503|455810831|FG005|Overall Study|Non Compliance|0|||
126687009|NCT01790503|455810832|FG006|Overall Study|Non Compliance|0|||
126687010|NCT01790503|455810833|FG007|Overall Study|Non Compliance|0|||
126687011|NCT01790503|455810834|FG008|Overall Study|Non Compliance|0|||
126687012|NCT01790503|455810835|FG009|Overall Study|Non Compliance|0|||
126687013|NCT01790503|455810836|FG010|Overall Study|Non Compliance|0|||
126687014|NCT01790503|455810826|FG000|Overall Study|Other|0|||
126687015|NCT01790503|455810827|FG001|Overall Study|Other|0|||
126687016|NCT01790503|455810828|FG002|Overall Study|Other|0|||
126687017|NCT01790503|455810829|FG003|Overall Study|Other|0|||
126687018|NCT01790503|455810830|FG004|Overall Study|Other|1|||
126687019|NCT01790503|455810831|FG005|Overall Study|Other|0|||
126687020|NCT01790503|455810832|FG006|Overall Study|Other|0|||
126687021|NCT01790503|455810833|FG007|Overall Study|Other|0|||
126687022|NCT01790503|455810834|FG008|Overall Study|Other|1|||
126687023|NCT01790503|455810835|FG009|Overall Study|Other|2|||
126687024|NCT01790503|455810836|FG010|Overall Study|Other|0|||
126687025|NCT00984204|455810848|FG000|Overall Study|Death|1|||
126687026|NCT00984204|455810848|FG000|Overall Study|Lost to Follow-up|4|||
126687027|NCT00984204|455810848|FG000|Overall Study|Lack of Efficacy|10|||
126687028|NCT01268293|455810850|FG000|Overall Study|Disease progression|7|||
126687029|NCT01268293|455810850|FG000|Overall Study|Adverse Event|1|||
126687030|NCT01268293|455810850|FG000|Overall Study|Subject choice|1|||
126687031|NCT05702515|455810851|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
126687032|NCT01396005|455810852|FG000|Overall Study|Withdrawal by Subject|0|||
126687033|NCT01396005|455810853|FG001|Overall Study|Withdrawal by Subject|1|||
126687034|NCT01396005|455810852|FG000|Overall Study|Non-compliance with protocol|0|||
126687035|NCT01396005|455810853|FG001|Overall Study|Non-compliance with protocol|1|||
126687036|NCT00424827|455810854|FG000|Overall Study|Adverse Event|1|||
126687037|NCT03757988|455810855|FG000|Overall Study|Withdrawal by Subject|1|||
126687038|NCT03806127|455810856|FG000|Overall Study|Withdrawal by Subject|4|||
126687039|NCT03806127|455810857|FG001|Overall Study|Withdrawal by Subject|5|||
126687040|NCT03806127|455810856|FG000|Overall Study|Protocol Violation|3|||
126687041|NCT03806127|455810857|FG001|Overall Study|Protocol Violation|1|||
126687042|NCT03806127|455810856|FG000|Overall Study|Adverse Event|3|||
126687043|NCT03806127|455810857|FG001|Overall Study|Adverse Event|0|||
126687044|NCT03806127|455810856|FG000|Overall Study|Unable to Complete Procedures|0|||
126687045|NCT03806127|455810857|FG001|Overall Study|Unable to Complete Procedures|1|||
126687046|NCT03806127|455810856|FG000|Overall Study|Pregnancy|0|||
126687047|NCT03806127|455810857|FG001|Overall Study|Pregnancy|1|||
126687048|NCT03806127|455810856|FG000|Overall Study|Lost to Follow-up|5|||
126687049|NCT03806127|455810857|FG001|Overall Study|Lost to Follow-up|1|||
126687050|NCT03806127|455810856|FG000|Overall Study|Physician Decision|1|||
126759751|NCT01674010|456070373|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
126350309|NCT02112916|454574166|FG002|Overall Study|Refusal of further protocol therapy|1|||
126687051|NCT03806127|455810857|FG001|Overall Study|Physician Decision|1|||
126687052|NCT03806127|455810856|FG000|Overall Study|Could Not Come Due to Covid|1|||
126759752|NCT01674010|456070371|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
126687053|NCT03806127|455810857|FG001|Overall Study|Could Not Come Due to Covid|0|||
126759753|NCT01674010|456070372|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
126687054|NCT03806127|455810856|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
126687055|NCT03806127|455810857|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
126687056|NCT03806127|455810856|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
126687057|NCT03806127|455810857|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
126687058|NCT03806127|455810856|FG000|Overall Study|Covid 19 Restrictions|2|||
126687059|NCT03806127|455810857|FG001|Overall Study|Covid 19 Restrictions|0|||
126687060|NCT03806127|455810856|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
126759754|NCT01674010|456070373|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
126759755|NCT01674010|456070371|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
126759756|NCT01674010|456070372|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
126759757|NCT01674010|456070373|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
126759758|NCT01674010|456070371|FG000|Randomization Phase 2|Adverse Event|0|||
126759759|NCT01674010|456070372|FG001|Randomization Phase 2|Adverse Event|1|||
126759760|NCT01674010|456070373|FG002|Randomization Phase 2|Adverse Event|1|||
126759761|NCT01674010|456070371|FG000|Randomization Phase 2|Lost to Follow-up|0|||
126687061|NCT03806127|455810857|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
126687062|NCT03806127|455810856|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
126687063|NCT03806127|455810857|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
126687064|NCT01467492|455810858|FG000|Overall Study|Withdrawal by Subject|6|||
126687065|NCT01467492|455810859|FG001|Overall Study|Withdrawal by Subject|4|||
126687066|NCT01467492|455810858|FG000|Overall Study|Study Terminated by Sponsor|6|||
126687067|NCT01467492|455810859|FG001|Overall Study|Study Terminated by Sponsor|4|||
126687068|NCT01467492|455810858|FG000|Overall Study|Adverse Event|4|||
126687069|NCT01467492|455810859|FG001|Overall Study|Adverse Event|3|||
126687070|NCT01467492|455810858|FG000|Overall Study|Lost to Follow-up|3|||
126687071|NCT01467492|455810859|FG001|Overall Study|Lost to Follow-up|2|||
126687072|NCT01467492|455810858|FG000|Overall Study|Undefined|2|||
126687073|NCT01467492|455810859|FG001|Overall Study|Undefined|0|||
126687074|NCT01467492|455810858|FG000|Overall Study|Enrolled But Not Treated|1|||
126759762|NCT01674010|456070372|FG001|Randomization Phase 2|Lost to Follow-up|1|||
126759763|NCT01674010|456070373|FG002|Randomization Phase 2|Lost to Follow-up|2|||
126759764|NCT01674010|456070371|FG000|Randomization Phase 2|Mood episode recurrence|0|||
126759765|NCT01674010|456070372|FG001|Randomization Phase 2|Mood episode recurrence|8|||
126759766|NCT01674010|456070373|FG002|Randomization Phase 2|Mood episode recurrence|2|||
126687075|NCT01467492|455810859|FG001|Overall Study|Enrolled But Not Treated|0|||
126687076|NCT00159432|455810862|FG000|Overall Study|Adverse Event|1|||
126759767|NCT01674010|456070371|FG000|Randomization Phase 2|Physician Decision|0|||
126759768|NCT01674010|456070372|FG001|Randomization Phase 2|Physician Decision|0|||
126759769|NCT01674010|456070373|FG002|Randomization Phase 2|Physician Decision|2|||
126759770|NCT01674010|456070371|FG000|Randomization Phase 2|Pregnancy|0|||
126759771|NCT01674010|456070372|FG001|Randomization Phase 2|Pregnancy|1|||
126759772|NCT01674010|456070373|FG002|Randomization Phase 2|Pregnancy|1|||
126759773|NCT01674010|456070371|FG000|Randomization Phase 2|Protocol Violation|0|||
126759774|NCT01674010|456070372|FG001|Randomization Phase 2|Protocol Violation|1|||
126759775|NCT01674010|456070373|FG002|Randomization Phase 2|Protocol Violation|1|||
126759776|NCT01674010|456070371|FG000|Randomization Phase 2|Sponsor Decision|0|||
126759777|NCT01674010|456070372|FG001|Randomization Phase 2|Sponsor Decision|42|||
126759778|NCT01674010|456070373|FG002|Randomization Phase 2|Sponsor Decision|45|||
126759779|NCT01674010|456070371|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
126759780|NCT01674010|456070372|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
126759781|NCT01674010|456070373|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
126759782|NCT03159455|456070374|FG000|Overall Study|Adverse Event|0|||
126759783|NCT03159455|456070375|FG001|Overall Study|Adverse Event|0|||
126759784|NCT03159455|456070376|FG002|Overall Study|Adverse Event|0|||
126759785|NCT03159455|456070377|FG003|Overall Study|Adverse Event|0|||
126759786|NCT03159455|456070378|FG004|Overall Study|Adverse Event|0|||
126759787|NCT03159455|456070379|FG005|Overall Study|Adverse Event|1|||
126759788|NCT01801475|456070387|FG000|Overall Study|Withdrawal by Subject|0|||
126759789|NCT01801475|456070388|FG001|Overall Study|Withdrawal by Subject|0|||
126759790|NCT01801475|456070389|FG002|Overall Study|Withdrawal by Subject|0|||
126545389|NCT02541383|455290825|FG002|Overall Study|Lost to Follow-up|1|||
126545390|NCT02541383|455290826|FG003|Overall Study|Lost to Follow-up|1|||
126687077|NCT00159432|455810862|FG000|Overall Study|Death|1|||
126687078|NCT00159432|455810862|FG000|Overall Study|Lack of Efficacy|8|||
126759791|NCT01801475|456070390|FG003|Overall Study|Withdrawal by Subject|0|||
126759792|NCT01801475|456070391|FG004|Overall Study|Withdrawal by Subject|1|||
126759793|NCT05056311|456070400|FG000|Overall Study|Lost to Follow-up|14|||
126759794|NCT05056311|456070400|FG000|Overall Study|Withdrawal by Subject|1|||
126759795|NCT05056311|456070400|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
126759796|NCT02713490|456070401|FG000|Overall Study|Withdrawal by Subject|2|||
126759797|NCT02713490|456070402|FG001|Overall Study|Withdrawal by Subject|1|||
126759798|NCT02713490|456070401|FG000|Overall Study|Did not receive study drug|1|||
126687079|NCT01491178|455810863|FG000|Overall Study|Adverse Event|1016|||
126687080|NCT01491178|455810863|FG000|Overall Study|Improvement of NVAF|210|||
126687081|NCT01491178|455810863|FG000|Overall Study|To conduct invasive treatment|59|||
126687082|NCT01491178|455810863|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
126759799|NCT02713490|456070402|FG001|Overall Study|Did not receive study drug|0|||
126759800|NCT02713490|456070401|FG000|Overall Study|Met exclusion criteria|0|||
126759801|NCT02713490|456070402|FG001|Overall Study|Met exclusion criteria|1|||
126759802|NCT00346775|456070403|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
126759803|NCT00346775|456070404|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
126687083|NCT01491178|455810863|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
126687084|NCT01491178|455810863|FG000|Overall Study|To take a contraindication|20|||
126687085|NCT01491178|455810863|FG000|Overall Study|Other than specified above|657|||
126687086|NCT05218499|455810864|FG000|Overall Study|Not treated|1|||
126687087|NCT05218499|455810865|FG001|Overall Study|Not treated|1|||
126687088|NCT05218499|455810866|FG002|Overall Study|Not treated|8|||
126687089|NCT05218499|455810864|FG000|Overall Study|Death|2|||
126687090|NCT05218499|455810865|FG001|Overall Study|Death|0|||
126687091|NCT05218499|455810866|FG002|Overall Study|Death|0|||
126687092|NCT05218499|455810864|FG000|Overall Study|Other than listed|3|||
126687093|NCT05218499|455810865|FG001|Overall Study|Other than listed|7|||
126687094|NCT05218499|455810866|FG002|Overall Study|Other than listed|10|||
126687095|NCT05218499|455810864|FG000|Overall Study|Protocol deviation|5|||
126687096|NCT05218499|455810865|FG001|Overall Study|Protocol deviation|6|||
126687097|NCT05218499|455810866|FG002|Overall Study|Protocol deviation|4|||
126687098|NCT05218499|455810864|FG000|Overall Study|Technical problems|0|||
126687099|NCT05218499|455810865|FG001|Overall Study|Technical problems|1|||
126687100|NCT05218499|455810866|FG002|Overall Study|Technical problems|0|||
126687101|NCT05218499|455810864|FG000|Overall Study|Burden of trial procedures|0|||
126687102|NCT05218499|455810865|FG001|Overall Study|Burden of trial procedures|1|||
126687103|NCT05218499|455810866|FG002|Overall Study|Burden of trial procedures|2|||
126687104|NCT05218499|455810864|FG000|Overall Study|Clinical disease progression|6|||
126687105|NCT05218499|455810865|FG001|Overall Study|Clinical disease progression|6|||
126687106|NCT05218499|455810866|FG002|Overall Study|Clinical disease progression|11|||
126687107|NCT05218499|455810864|FG000|Overall Study|Objective disease progression|44|||
126687108|NCT05218499|455810865|FG001|Overall Study|Objective disease progression|61|||
126687109|NCT05218499|455810866|FG002|Overall Study|Objective disease progression|42|||
126687110|NCT05218499|455810864|FG000|Overall Study|Adverse Event|11|||
126687111|NCT05218499|455810865|FG001|Overall Study|Adverse Event|36|||
126687112|NCT05218499|455810866|FG002|Overall Study|Adverse Event|9|||
126687113|NCT05218499|455810864|FG000|Overall Study|On treatment at time of snapshot|18|||
126687114|NCT05218499|455810865|FG001|Overall Study|On treatment at time of snapshot|29|||
126687115|NCT05218499|455810866|FG002|Overall Study|On treatment at time of snapshot|0|||
126687116|NCT05689047|455810867|FG000|Overall Study|Lost to Follow-up|0|||
126687117|NCT05689047|455810868|FG001|Overall Study|Lost to Follow-up|1|||
126687118|NCT05689047|455810867|FG000|Overall Study|Protocol Deviation|1|||
126687119|NCT05689047|455810868|FG001|Overall Study|Protocol Deviation|0|||
126687120|NCT01604512|455810869|FG000|Overall Study|Withdrawal by Subject|3|||
126687121|NCT01604512|455810869|FG000|Overall Study|Not treated|4|||
126687122|NCT03655756|455810870|FG000|Overall Study|Death|1|||
126687123|NCT00253630|455810871|FG000|Overall Study|ineligible|2|||
126687124|NCT03237065|455810872|FG000|Overall Study|Adverse Event|0|||
126687125|NCT03237065|455810873|FG001|Overall Study|Adverse Event|2|||
126687126|NCT03237065|455810872|FG000|Overall Study|Protocol Violation|0|||
126687127|NCT03237065|455810873|FG001|Overall Study|Protocol Violation|1|||
126687128|NCT03237065|455810872|FG000|Overall Study|Withdrawal by Subject|3|||
126687129|NCT03237065|455810873|FG001|Overall Study|Withdrawal by Subject|0|||
126687130|NCT03237065|455810872|FG000|Overall Study|Lost to Follow-up|1|||
126687131|NCT03237065|455810873|FG001|Overall Study|Lost to Follow-up|0|||
126687132|NCT03237065|455810872|FG000|Overall Study|Unable to obtain venous access|0|||
126687133|NCT03237065|455810873|FG001|Overall Study|Unable to obtain venous access|1|||
126687134|NCT00209339|455810874|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
126687135|NCT00209339|455810874|FG000|At 12 Months Follow-up|Death|1|||
126687136|NCT00209339|455810874|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
126687137|NCT00209339|455810874|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
126687138|NCT00209339|455810874|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
126687139|NCT00209339|455810874|FG000|At 24 Months Follow-up|Death|1|||
126687140|NCT00209339|455810874|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
126350310|NCT02112916|454574167|FG003|Overall Study|Refusal of further protocol therapy|7|||
126350311|NCT02112916|454574164|FG000|Overall Study|Development of SMN|1|||
126350312|NCT02112916|454574165|FG001|Overall Study|Development of SMN|0|||
126350313|NCT02112916|454574166|FG002|Overall Study|Development of SMN|0|||
126350314|NCT02112916|454574167|FG003|Overall Study|Development of SMN|1|||
126687141|NCT00209339|455810874|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
126687142|NCT00209339|455810874|FG000|At 4 Years Follow-up|Death|1|||
126687143|NCT00209339|455810874|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
126687144|NCT00209339|455810874|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
126687145|NCT00209339|455810874|FG000|At 5 Years Follow-up|Death|1|||
126687146|NCT00429858|455810875|FG000|Overall Study|Withdrawal by Subject|1|||
126687147|NCT00429858|455810875|FG000|Overall Study|Study Termination|1|||
126687148|NCT01764633|455810876|FG000|Overall Study|Withdrawal by Subject|105|||
126687149|NCT01764633|455810877|FG001|Overall Study|Withdrawal by Subject|88|||
126687150|NCT01764633|455810876|FG000|Overall Study|Lost to Follow-up|13|||
126687151|NCT01764633|455810877|FG001|Overall Study|Lost to Follow-up|5|||
126687152|NCT02268058|455810878|FG000|Overall Study|Protocol Violation|1|||
126350315|NCT02112916|454574164|FG000|Overall Study|Relapse/Progression|10|||
126350316|NCT02112916|454574165|FG001|Overall Study|Relapse/Progression|18|||
126759804|NCT00346775|456070403|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
126759805|NCT00346775|456070404|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
126759806|NCT00346775|456070403|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
126759807|NCT00346775|456070404|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
126759808|NCT01714726|456070405|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
126759809|NCT01714726|456070406|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
126759810|NCT01714726|456070407|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
126759811|NCT01714726|456070408|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
126759812|NCT01714726|456070405|FG000|Double-Blinded Induction Period|Adverse Event|0|||
126759813|NCT01714726|456070406|FG001|Double-Blinded Induction Period|Adverse Event|1|||
126759814|NCT01714726|456070407|FG002|Double-Blinded Induction Period|Adverse Event|0|||
126759815|NCT01714726|456070408|FG003|Double-Blinded Induction Period|Adverse Event|0|||
126759816|NCT01714726|456070405|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
126759817|NCT01714726|456070406|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
126759818|NCT01714726|456070407|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
126759819|NCT01714726|456070408|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
126759820|NCT01714726|456070405|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
126759821|NCT01714726|456070406|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
126759822|NCT01714726|456070407|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
126759823|NCT01714726|456070408|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
126759824|NCT01714726|456070405|FG000|Open-Label Period|Other|0|||
126759825|NCT01714726|456070406|FG001|Open-Label Period|Other|0|||
126759826|NCT01714726|456070407|FG002|Open-Label Period|Other|1|||
126759827|NCT01714726|456070408|FG003|Open-Label Period|Other|3|||
126759828|NCT01714726|456070405|FG000|Open-Label Period|Adverse Event|0|||
126759829|NCT01714726|456070406|FG001|Open-Label Period|Adverse Event|0|||
126759830|NCT01714726|456070407|FG002|Open-Label Period|Adverse Event|1|||
126759831|NCT01714726|456070408|FG003|Open-Label Period|Adverse Event|0|||
126759832|NCT01714726|456070405|FG000|Open-Label Period|Withdrawal by Subject|0|||
126759833|NCT01714726|456070406|FG001|Open-Label Period|Withdrawal by Subject|0|||
126759834|NCT01714726|456070407|FG002|Open-Label Period|Withdrawal by Subject|9|||
126759835|NCT01714726|456070408|FG003|Open-Label Period|Withdrawal by Subject|19|||
126759836|NCT01714726|456070405|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
126759837|NCT01714726|456070406|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
126759838|NCT01714726|456070407|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
126759839|NCT01714726|456070408|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
126759840|NCT01714726|456070405|FG000|Open-Label Period|Lost to Follow-up|0|||
126759841|NCT01714726|456070406|FG001|Open-Label Period|Lost to Follow-up|0|||
126759842|NCT01714726|456070407|FG002|Open-Label Period|Lost to Follow-up|3|||
126759843|NCT01714726|456070408|FG003|Open-Label Period|Lost to Follow-up|4|||
126759844|NCT02501642|456070409|FG000|Overall Study|Lost to Follow-up|7|||
126759845|NCT02501642|456070410|FG001|Overall Study|Lost to Follow-up|11|||
126759846|NCT02600559|456070421|FG000|Overall Study|Withdrawal by Subject|3|||
126759847|NCT02600559|456070421|FG000|Overall Study|Lost to Follow-up|20|||
126759848|NCT01545375|456070422|FG000|Overall Study|Adverse Event|2|||
126759849|NCT01545375|456070423|FG001|Overall Study|Adverse Event|1|||
126759850|NCT01545375|456070422|FG000|Overall Study|Lost to Follow-up|34|||
126759851|NCT01545375|456070423|FG001|Overall Study|Lost to Follow-up|31|||
126759852|NCT01545375|456070422|FG000|Overall Study|Protocol Violation|3|||
126759853|NCT01545375|456070423|FG001|Overall Study|Protocol Violation|3|||
126759854|NCT01545375|456070422|FG000|Overall Study|Withdrawal by Subject|58|||
126759855|NCT01545375|456070423|FG001|Overall Study|Withdrawal by Subject|55|||
126759856|NCT01846039|456070424|FG000|Overall Study|Protocol Violation|1|||
126759857|NCT01846039|456070424|FG000|Overall Study|Subject Withdrew Consent|1|||
126759858|NCT04854421|456070427|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
126759859|NCT04854421|456070428|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
126759860|NCT03472586|456070434|FG000|Overall Study|Physician Decision|6|||
126350317|NCT02112916|454574166|FG002|Overall Study|Relapse/Progression|15|||
126350318|NCT02112916|454574167|FG003|Overall Study|Relapse/Progression|2|||
126350319|NCT02112916|454574164|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
126350320|NCT02112916|454574165|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
126350321|NCT02112916|454574166|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
126350322|NCT02112916|454574167|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
126350323|NCT02112916|454574164|FG000|Overall Study|Still on Therapy|44|||
126759861|NCT03472586|456070434|FG000|Overall Study|Death|6|||
126759862|NCT03472586|456070434|FG000|Overall Study|Adverse Event|1|||
126759863|NCT02528331|456070435|FG000|Overall Study|Withdrawal by Subject|2|||
126759864|NCT06045026|456070438|FG000|Overall Study|Lost to Follow-up|60|||
126759865|NCT06045026|456070438|FG000|Overall Study|Adverse Event|12|||
126759866|NCT06045026|456070438|FG000|Overall Study|Withdrawal by Subject|3|||
126350324|NCT02112916|454574165|FG001|Overall Study|Still on Therapy|47|||
126687153|NCT02268058|455810879|FG001|Overall Study|Protocol Violation|0|||
126687154|NCT02268058|455810880|FG002|Overall Study|Protocol Violation|0|||
126687155|NCT02268058|455810881|FG003|Overall Study|Protocol Violation|0|||
126687156|NCT04781816|455810882|FG000|Overall Study|Adverse Event|0|||
126687157|NCT04781816|455810883|FG001|Overall Study|Adverse Event|1|||
126687158|NCT04781816|455810882|FG000|Overall Study|Withdrawal by Subject|1|||
126687159|NCT04781816|455810883|FG001|Overall Study|Withdrawal by Subject|1|||
126687160|NCT04781816|455810882|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
126687161|NCT04781816|455810883|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
126687162|NCT01100944|455810884|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
126687163|NCT01100944|455810885|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
126687164|NCT01100944|455810886|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
126687165|NCT01100944|455810884|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
126687166|NCT01100944|455810885|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
126687167|NCT01100944|455810886|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
126687168|NCT01100944|455810884|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
126687169|NCT01100944|455810885|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
126687170|NCT01100944|455810886|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
126687171|NCT01100944|455810884|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
126687172|NCT01100944|455810885|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
126687173|NCT01100944|455810886|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
126687174|NCT01639833|455810890|FG000|Overall Study|Death|4|||
126687175|NCT01639833|455810891|FG001|Overall Study|Death|2|||
126687176|NCT01639833|455810890|FG000|Overall Study|Withdrawal by Subject|2|||
126687177|NCT01639833|455810891|FG001|Overall Study|Withdrawal by Subject|2|||
126687178|NCT04029519|455810894|FG000|Overall Study|Protocol Violation|1|||
126687179|NCT04029519|455810894|FG000|Overall Study|Withdrawal by Subject|3|||
126687180|NCT04029519|455810894|FG000|Overall Study|Lost to Follow-up|1|||
126687181|NCT02064387|455810895|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126687182|NCT02064387|455810896|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126687183|NCT02064387|455810897|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126687184|NCT02064387|455810898|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126687185|NCT02064387|455810899|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126687186|NCT02064387|455810900|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126687187|NCT02064387|455810901|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126350325|NCT02112916|454574166|FG002|Overall Study|Still on Therapy|3|||
126350326|NCT02112916|454574167|FG003|Overall Study|Still on Therapy|2|||
126350327|NCT02112916|454574164|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
126687188|NCT02064387|455810902|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
126687189|NCT02064387|455810903|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126687190|NCT02064387|455810904|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
126687191|NCT02064387|455810905|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126687192|NCT02064387|455810906|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
126687193|NCT02064387|455810895|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126687194|NCT02064387|455810896|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126687195|NCT02064387|455810897|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126687196|NCT02064387|455810898|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126687197|NCT02064387|455810899|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126687198|NCT02064387|455810900|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126687199|NCT02064387|455810901|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126687200|NCT02064387|455810902|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
126687201|NCT02064387|455810903|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126687202|NCT02064387|455810904|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126687203|NCT02064387|455810905|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126687204|NCT02064387|455810906|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
126687205|NCT02064387|455810895|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126687206|NCT02064387|455810896|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126687207|NCT02064387|455810897|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126687208|NCT02064387|455810898|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126687209|NCT02064387|455810899|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126687210|NCT02064387|455810900|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126687211|NCT02064387|455810901|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126687212|NCT02064387|455810902|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126687213|NCT02064387|455810903|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
126687214|NCT02064387|455810904|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126687215|NCT02064387|455810905|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126687216|NCT02064387|455810906|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
126687217|NCT02064387|455810895|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
126687218|NCT02064387|455810896|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
126687219|NCT02064387|455810897|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
126687220|NCT02064387|455810898|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
126687221|NCT02064387|455810899|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
126687222|NCT02064387|455810900|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
126687223|NCT02064387|455810901|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
126687224|NCT02064387|455810902|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
126687225|NCT02064387|455810903|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
126687226|NCT02064387|455810904|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
126687227|NCT02064387|455810905|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
126687228|NCT02064387|455810906|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
126687229|NCT02064387|455810895|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126687230|NCT02064387|455810896|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126687231|NCT02064387|455810897|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126687232|NCT02064387|455810898|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126687233|NCT02064387|455810899|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126687234|NCT02064387|455810900|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126687235|NCT02064387|455810901|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126687236|NCT02064387|455810902|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126687237|NCT02064387|455810903|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126687238|NCT02064387|455810904|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126687239|NCT02064387|455810905|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
126687240|NCT02064387|455810906|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
126687241|NCT02706730|455810907|FG000|Overall Study|Adverse Event|3|||
126687242|NCT02706730|455810907|FG000|Overall Study|Lack of Efficacy|5|||
126687243|NCT02706730|455810907|FG000|Overall Study|Withdrawal by Subject|11|||
126687244|NCT02706730|455810907|FG000|Overall Study|Study Terminated by Sponsor|11|||
126687245|NCT02706730|455810907|FG000|Overall Study|Subject chose not to receive injection|3|||
126687246|NCT02499029|455810908|FG000|Overall Study|Lost to Follow-up|2|||
126687247|NCT02499029|455810909|FG001|Overall Study|Lost to Follow-up|2|||
126687248|NCT02499029|455810908|FG000|Overall Study|Physician Decision|2|||
126687249|NCT02499029|455810909|FG001|Overall Study|Physician Decision|1|||
126687250|NCT02499029|455810908|FG000|Overall Study|Death|1|||
126687251|NCT02499029|455810909|FG001|Overall Study|Death|0|||
126687252|NCT01536860|455810912|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
126687253|NCT01536860|455810913|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
126687254|NCT01536860|455810914|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
126687255|NCT03889639|455810917|FG000|Overall Study|Withdrawal by Subject|0|||
126687256|NCT03889639|455810918|FG001|Overall Study|Withdrawal by Subject|0|||
126687257|NCT03889639|455810919|FG002|Overall Study|Withdrawal by Subject|0|||
126687258|NCT03889639|455810920|FG003|Overall Study|Withdrawal by Subject|0|||
126687259|NCT03889639|455810921|FG004|Overall Study|Withdrawal by Subject|0|||
126687260|NCT03889639|455810922|FG005|Overall Study|Withdrawal by Subject|0|||
126687261|NCT03889639|455810923|FG006|Overall Study|Withdrawal by Subject|0|||
126687262|NCT03889639|455810924|FG007|Overall Study|Withdrawal by Subject|1|||
126687263|NCT00927095|455810925|FG000|Overall Study|Adverse Event|3|||
126687264|NCT00927095|455810926|FG001|Overall Study|Adverse Event|1|||
126687265|NCT00927095|455810927|FG002|Overall Study|Adverse Event|0|||
126687266|NCT00927095|455810925|FG000|Overall Study|Withdrawal by Subject|2|||
126687267|NCT00927095|455810926|FG001|Overall Study|Withdrawal by Subject|1|||
126687268|NCT00927095|455810927|FG002|Overall Study|Withdrawal by Subject|1|||
126687269|NCT00927095|455810925|FG000|Overall Study|Physician Decision|1|||
126687270|NCT00927095|455810926|FG001|Overall Study|Physician Decision|2|||
126687271|NCT00927095|455810927|FG002|Overall Study|Physician Decision|1|||
126687272|NCT02556255|455810931|FG000|Overall Study|Lost to Follow-up|4|||
126687273|NCT03115151|455810932|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
126687274|NCT03115151|455810933|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
126687275|NCT03115151|455810932|FG000|Overall Study|Epidural catheter removal|1|||
126687276|NCT03115151|455810933|FG001|Overall Study|Epidural catheter removal|0|||
126687277|NCT03115151|455810932|FG000|Overall Study|Withdrawal by Subject|0|||
126687278|NCT03115151|455810933|FG001|Overall Study|Withdrawal by Subject|1|||
126687279|NCT03115151|455810932|FG000|Overall Study|Intervention not received according to the protocol.|1|||
126687280|NCT03115151|455810933|FG001|Overall Study|Intervention not received according to the protocol.|1|||
126687281|NCT03115151|455810932|FG000|Overall Study|Physician Decision|1|||
126687282|NCT03115151|455810933|FG001|Overall Study|Physician Decision|0|||
126687283|NCT03115151|455810932|FG000|Overall Study|Randomization not applied|1|||
126687284|NCT03115151|455810933|FG001|Overall Study|Randomization not applied|1|||
126687285|NCT01543087|455810939|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
126687286|NCT01543087|455810940|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
126687287|NCT01543087|455810941|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
126687288|NCT01543087|455810942|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
126759867|NCT06045026|456070438|FG000|Overall Study|Enrollment closed|1|||
126759868|NCT01399619|456070439|FG000|Overall Study|Adverse Event|10|||
126759869|NCT01399619|456070440|FG001|Overall Study|Adverse Event|0|||
126759870|NCT01399619|456070441|FG002|Overall Study|Adverse Event|4|||
126759871|NCT01399619|456070442|FG003|Overall Study|Adverse Event|10|||
126687289|NCT01543087|455810943|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
126687290|NCT01543087|455810944|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
126687291|NCT01543087|455810939|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
126687292|NCT01543087|455810940|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
126687293|NCT01543087|455810941|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
126687294|NCT01543087|455810942|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
126687295|NCT01543087|455810943|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
126687296|NCT01543087|455810944|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
126759872|NCT01399619|456070439|FG000|Overall Study|Lack of Efficacy|9|||
126759873|NCT01399619|456070440|FG001|Overall Study|Lack of Efficacy|0|||
126759874|NCT01399619|456070441|FG002|Overall Study|Lack of Efficacy|5|||
126687297|NCT01543087|455810939|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
126687298|NCT01543087|455810940|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
126687299|NCT01543087|455810941|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
126687300|NCT01543087|455810942|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
126687301|NCT01543087|455810943|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
126687302|NCT01543087|455810944|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
126687303|NCT01543087|455810939|FG000|Stage 1 (48 Months)|Other than specified|5|||
126687304|NCT01543087|455810940|FG001|Stage 1 (48 Months)|Other than specified|0|||
126687305|NCT01543087|455810941|FG002|Stage 1 (48 Months)|Other than specified|9|||
126687306|NCT01543087|455810942|FG003|Stage 1 (48 Months)|Other than specified|0|||
126687307|NCT01543087|455810943|FG004|Stage 1 (48 Months)|Other than specified|0|||
126687308|NCT01543087|455810944|FG005|Stage 1 (48 Months)|Other than specified|0|||
126687309|NCT01543087|455810939|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
126687310|NCT01543087|455810940|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
126687311|NCT01543087|455810941|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
126687312|NCT01543087|455810942|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
126687313|NCT01543087|455810943|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
126687314|NCT01543087|455810944|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
126687315|NCT01543087|455810939|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
126687316|NCT01543087|455810940|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
126687317|NCT01543087|455810941|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
126687318|NCT01543087|455810942|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
126687319|NCT01543087|455810943|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
126687320|NCT01543087|455810944|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
126687321|NCT01543087|455810939|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
126687322|NCT01543087|455810940|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
126687323|NCT01543087|455810941|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
126687324|NCT01543087|455810942|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
126687325|NCT01543087|455810943|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
126687326|NCT01543087|455810944|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
126687327|NCT02682901|455810945|FG000|Overall Study|Adverse Event|10|||
126687328|NCT02682901|455810946|FG001|Overall Study|Adverse Event|3|||
126687329|NCT02682901|455810945|FG000|Overall Study|Lack of Efficacy|0|||
126687330|NCT02682901|455810946|FG001|Overall Study|Lack of Efficacy|1|||
126687331|NCT03694925|455810948|FG000|Overall Study|Inadequate laboratory testing|0|||
126687332|NCT03694925|455810949|FG001|Overall Study|Inadequate laboratory testing|3|||
126687333|NCT03694925|455810950|FG002|Overall Study|Inadequate laboratory testing|0|||
126687334|NCT02799069|455810951|FG000|Overall Study|Adverse Event|0|||
126687335|NCT02799069|455810952|FG001|Overall Study|Adverse Event|2|||
126687336|NCT02799069|455810953|FG002|Overall Study|Adverse Event|2|||
126687337|NCT02799069|455810951|FG000|Overall Study|Lack of Efficacy|2|||
126687338|NCT02799069|455810952|FG001|Overall Study|Lack of Efficacy|0|||
126687339|NCT02799069|455810953|FG002|Overall Study|Lack of Efficacy|0|||
126687340|NCT02799069|455810951|FG000|Overall Study|Lost to Follow-up|1|||
126687341|NCT02799069|455810952|FG001|Overall Study|Lost to Follow-up|1|||
126687342|NCT02799069|455810953|FG002|Overall Study|Lost to Follow-up|0|||
126687343|NCT02799069|455810951|FG000|Overall Study|Withdrawal by Subject|4|||
126687344|NCT02799069|455810952|FG001|Overall Study|Withdrawal by Subject|4|||
126687345|NCT02799069|455810953|FG002|Overall Study|Withdrawal by Subject|3|||
126687346|NCT02799069|455810951|FG000|Overall Study|Protocol Violation|1|||
126687347|NCT02799069|455810952|FG001|Overall Study|Protocol Violation|0|||
126687348|NCT02799069|455810953|FG002|Overall Study|Protocol Violation|2|||
126687349|NCT03033875|455810954|FG000|Overall Study|Withdrawal by Subject|5|||
126687350|NCT03033875|455810955|FG001|Overall Study|Withdrawal by Subject|9|||
126687351|NCT03033875|455810956|FG002|Overall Study|Withdrawal by Subject|4|||
126687352|NCT03033875|455810954|FG000|Overall Study|Other|14|||
126687353|NCT03033875|455810955|FG001|Overall Study|Other|15|||
126687354|NCT03033875|455810956|FG002|Overall Study|Other|8|||
126687355|NCT00730639|455810958|FG000|Overall Study|Adverse Event|3|||
126687356|NCT00730639|455810959|FG001|Overall Study|Adverse Event|0|||
126687357|NCT00730639|455810960|FG002|Overall Study|Adverse Event|9|||
126687358|NCT00730639|455810961|FG003|Overall Study|Adverse Event|8|||
126687359|NCT00730639|455810962|FG004|Overall Study|Adverse Event|23|||
126687360|NCT00730639|455810958|FG000|Overall Study|Complete Response|0|||
126687361|NCT00730639|455810959|FG001|Overall Study|Complete Response|0|||
126687362|NCT00730639|455810960|FG002|Overall Study|Complete Response|2|||
126687363|NCT00730639|455810961|FG003|Overall Study|Complete Response|2|||
126687364|NCT00730639|455810962|FG004|Overall Study|Complete Response|1|||
126687365|NCT00730639|455810958|FG000|Overall Study|Completed Maximum Cycles|0|||
126687366|NCT00730639|455810959|FG001|Overall Study|Completed Maximum Cycles|0|||
126687367|NCT00730639|455810960|FG002|Overall Study|Completed Maximum Cycles|11|||
126687368|NCT00730639|455810961|FG003|Overall Study|Completed Maximum Cycles|3|||
126687369|NCT00730639|455810962|FG004|Overall Study|Completed Maximum Cycles|6|||
126687370|NCT00730639|455810958|FG000|Overall Study|Death|0|||
126687371|NCT00730639|455810959|FG001|Overall Study|Death|0|||
126687372|NCT00730639|455810960|FG002|Overall Study|Death|0|||
126687373|NCT00730639|455810961|FG003|Overall Study|Death|0|||
126687374|NCT00730639|455810962|FG004|Overall Study|Death|2|||
126687375|NCT00730639|455810958|FG000|Overall Study|Disease Progression|12|||
126687376|NCT00730639|455810959|FG001|Overall Study|Disease Progression|13|||
126687377|NCT00730639|455810960|FG002|Overall Study|Disease Progression|48|||
126687378|NCT00730639|455810961|FG003|Overall Study|Disease Progression|32|||
126687379|NCT00730639|455810962|FG004|Overall Study|Disease Progression|88|||
126687380|NCT00730639|455810958|FG000|Overall Study|non-specified|0|||
126687381|NCT00730639|455810959|FG001|Overall Study|non-specified|0|||
126687382|NCT00730639|455810960|FG002|Overall Study|non-specified|4|||
126687383|NCT00730639|455810961|FG003|Overall Study|non-specified|2|||
126687384|NCT00730639|455810962|FG004|Overall Study|non-specified|3|||
126687385|NCT00730639|455810958|FG000|Overall Study|Protocol Violation|0|||
126687386|NCT00730639|455810959|FG001|Overall Study|Protocol Violation|0|||
126687387|NCT00730639|455810960|FG002|Overall Study|Protocol Violation|1|||
126687388|NCT00730639|455810961|FG003|Overall Study|Protocol Violation|0|||
126687389|NCT00730639|455810962|FG004|Overall Study|Protocol Violation|0|||
126687390|NCT00730639|455810958|FG000|Overall Study|Withdrawal by Subject|0|||
126687391|NCT00730639|455810959|FG001|Overall Study|Withdrawal by Subject|0|||
126687392|NCT00730639|455810960|FG002|Overall Study|Withdrawal by Subject|6|||
126687393|NCT00730639|455810961|FG003|Overall Study|Withdrawal by Subject|3|||
126687394|NCT00730639|455810962|FG004|Overall Study|Withdrawal by Subject|4|||
126687395|NCT00730639|455810958|FG000|Overall Study|Treatment on-going|2|||
126687396|NCT00730639|455810959|FG001|Overall Study|Treatment on-going|5|||
126687397|NCT00730639|455810960|FG002|Overall Study|Treatment on-going|5|||
126687398|NCT00730639|455810961|FG003|Overall Study|Treatment on-going|4|||
126687399|NCT00730639|455810962|FG004|Overall Study|Treatment on-going|4|||
126687400|NCT02665286|455810963|FG000|Overall Study|Lost to Follow-up|3|||
126687401|NCT02665286|455810964|FG001|Overall Study|Lost to Follow-up|2|||
126687402|NCT02665286|455810965|FG002|Overall Study|Lost to Follow-up|1|||
126687403|NCT03064841|455810971|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
126687404|NCT03064841|455810971|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
126687405|NCT03064841|455810971|FG000|Overall Study|Screen failure|2|||
126687406|NCT03434977|455810972|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
126687407|NCT03434977|455810973|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
126687408|NCT00217087|455810974|FG000|Overall Study|decided to have esophagectomy|1|||
126687409|NCT00217087|455810975|FG001|Overall Study|decided to have esophagectomy|2|||
126687410|NCT00217087|455810974|FG000|Overall Study|completed less than 12 months return|10|||
126687411|NCT00217087|455810975|FG001|Overall Study|completed less than 12 months return|18|||
126687412|NCT03920670|455810976|FG000|Overall Study|Protocol Violation|2|||
126687413|NCT03920670|455810977|FG001|Overall Study|Protocol Violation|2|||
126687414|NCT03920670|455810976|FG000|Overall Study|Adverse Event|1|||
126687415|NCT03920670|455810977|FG001|Overall Study|Adverse Event|0|||
126438489|NCT02113982|454907580|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
126687416|NCT05574062|455810978|FG000|Pre Run-In|Screening failure|3|||
126687417|NCT05574062|455810979|FG001|Pre Run-In|Screening failure|0|||
126687418|NCT05574062|455810980|FG002|Pre Run-In|Screening failure|0|||
126687419|NCT05574062|455810981|FG003|Pre Run-In|Screening failure|0|||
126687420|NCT05574062|455810982|FG004|Pre Run-In|Screening failure|0|||
126687421|NCT05574062|455810978|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
126687422|NCT05574062|455810979|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
126687423|NCT05574062|455810980|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
126687424|NCT05574062|455810981|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
126687425|NCT05574062|455810982|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
126687426|NCT05574062|455810978|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
126687427|NCT05574062|455810979|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
126687428|NCT05574062|455810980|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
126687429|NCT05574062|455810981|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
126687430|NCT05574062|455810982|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
126687431|NCT05574062|455810978|FG000|Continuation Phase Period 1|Physician Decision|1|||
126687432|NCT05574062|455810979|FG001|Continuation Phase Period 1|Physician Decision|0|||
126687433|NCT05574062|455810980|FG002|Continuation Phase Period 1|Physician Decision|0|||
126687434|NCT05574062|455810981|FG003|Continuation Phase Period 1|Physician Decision|0|||
126687435|NCT05574062|455810982|FG004|Continuation Phase Period 1|Physician Decision|0|||
126687436|NCT05574062|455810978|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
126687437|NCT05574062|455810979|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
126687438|NCT05574062|455810980|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
126687439|NCT05574062|455810981|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
126687440|NCT05574062|455810982|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
126687441|NCT05574062|455810978|FG000|Continuation Phase Period 1|Adverse Event|1|||
126687442|NCT05574062|455810979|FG001|Continuation Phase Period 1|Adverse Event|0|||
126687443|NCT05574062|455810980|FG002|Continuation Phase Period 1|Adverse Event|0|||
126687444|NCT05574062|455810981|FG003|Continuation Phase Period 1|Adverse Event|0|||
126687445|NCT05574062|455810982|FG004|Continuation Phase Period 1|Adverse Event|0|||
126687446|NCT05574062|455810978|FG000|Continuation Phase Period 1|Death|1|||
126687447|NCT05574062|455810979|FG001|Continuation Phase Period 1|Death|0|||
126687448|NCT05574062|455810980|FG002|Continuation Phase Period 1|Death|0|||
126687449|NCT05574062|455810981|FG003|Continuation Phase Period 1|Death|0|||
126687450|NCT05574062|455810982|FG004|Continuation Phase Period 1|Death|0|||
126687451|NCT05574062|455810978|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
126687452|NCT05574062|455810979|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
126687453|NCT05574062|455810980|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
126687454|NCT05574062|455810981|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
126687455|NCT05574062|455810982|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
126687456|NCT04770779|455810985|FG000|Overall Study|Randomized, never treated|0|||
126687457|NCT04770779|455810986|FG001|Overall Study|Randomized, never treated|1|||
126687458|NCT04770779|455810985|FG000|Overall Study|Adverse Event|9|||
126687459|NCT04770779|455810986|FG001|Overall Study|Adverse Event|1|||
126687460|NCT04770779|455810985|FG000|Overall Study|Withdrawal by Subject|7|||
126438490|NCT02113982|454907581|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
126438491|NCT02113982|454907582|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
126438492|NCT02113982|454907583|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
126438493|NCT02113982|454907584|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
126687461|NCT04770779|455810986|FG001|Overall Study|Withdrawal by Subject|1|||
126687462|NCT04770779|455810985|FG000|Overall Study|Pregnancy|0|||
126687463|NCT04770779|455810986|FG001|Overall Study|Pregnancy|1|||
126687464|NCT04820309|455810987|FG000|Overall Study|Adverse Event|96|||
126687465|NCT04820309|455810987|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
126687466|NCT04820309|455810987|FG000|Overall Study|Consent Withdrawn|93|||
126687467|NCT04820309|455810987|FG000|Overall Study|failure to adhere to protocol|32|||
126687468|NCT04820309|455810987|FG000|Overall Study|alcohol or drug use|6|||
126687469|NCT04820309|455810987|FG000|Overall Study|Lost to Follow-up|46|||
126687470|NCT04820309|455810987|FG000|Overall Study|Death|2|||
126687471|NCT04820309|455810987|FG000|Overall Study|Pregnancy|1|||
126687472|NCT04820309|455810987|FG000|Overall Study|Other reasons|12|||
126687473|NCT03692052|455810988|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
126438494|NCT02113982|454907585|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
126438495|NCT02113982|454907586|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
126438496|NCT02113982|454907587|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
126438497|NCT02113982|454907588|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
126438498|NCT02113982|454907589|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
126438499|NCT02113982|454907590|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
126438500|NCT02113982|454907591|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
126687474|NCT03692052|455810988|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
126687475|NCT03692052|455810988|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
126687476|NCT03692052|455810988|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
126687477|NCT05600309|455810991|FG000|Overall Study|Death|41|||
126687478|NCT05600309|455810992|FG001|Overall Study|Death|38|||
126687479|NCT05600309|455810991|FG000|Overall Study|Sponsor Decision|9|||
126687480|NCT05600309|455810992|FG001|Overall Study|Sponsor Decision|6|||
126687481|NCT02482129|455810995|FG000|Overall Study|Adverse Event-prior to treatment|0|||
126687482|NCT02482129|455810996|FG001|Overall Study|Adverse Event-prior to treatment|1|||
126687483|NCT02482129|455810995|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
126687484|NCT02482129|455810996|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
126438501|NCT02113982|454907592|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
126438502|NCT02113982|454907593|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
126438503|NCT02113982|454907580|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
126438504|NCT02113982|454907581|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
126438505|NCT02113982|454907582|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
126687485|NCT02482129|455810995|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
126687486|NCT02482129|455810996|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
126687487|NCT02482129|455810995|FG000|Overall Study|Criteria not met-prior to treatment|1|||
126687488|NCT02482129|455810996|FG001|Overall Study|Criteria not met-prior to treatment|0|||
126687489|NCT02482129|455810995|FG000|Overall Study|Adverse Event|1|||
126687490|NCT02482129|455810996|FG001|Overall Study|Adverse Event|0|||
126687491|NCT02482129|455810995|FG000|Overall Study|Withdrawal by Subject|2|||
126438506|NCT02113982|454907583|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
126438507|NCT02113982|454907584|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
126438508|NCT02113982|454907585|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
126438509|NCT02113982|454907586|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
126438510|NCT02113982|454907587|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
126687492|NCT02482129|455810996|FG001|Overall Study|Withdrawal by Subject|0|||
126687493|NCT02482129|455810995|FG000|Overall Study|Criteria not met|1|||
126687494|NCT02482129|455810996|FG001|Overall Study|Criteria not met|0|||
126438511|NCT02113982|454907588|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
126438512|NCT02113982|454907589|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
126545391|NCT02541383|455290827|FG004|Overall Study|Lost to Follow-up|3|||
126687495|NCT03505021|455810997|FG000|Overall Study|Protocol Violation|1|||
126687496|NCT03505021|455810998|FG001|Overall Study|Protocol Violation|0|||
126687497|NCT03505021|455810997|FG000|Overall Study|Death|9|||
126687498|NCT03505021|455810998|FG001|Overall Study|Death|8|||
126687499|NCT03505021|455810997|FG000|Overall Study|Consent withdrawn by subject|6|||
126687500|NCT03505021|455810998|FG001|Overall Study|Consent withdrawn by subject|1|||
126687501|NCT03505021|455810997|FG000|Overall Study|Lost to Follow-up|5|||
126687502|NCT03505021|455810998|FG001|Overall Study|Lost to Follow-up|3|||
126687503|NCT03505021|455810997|FG000|Overall Study|Adverse Event|26|||
126687504|NCT03505021|455810998|FG001|Overall Study|Adverse Event|9|||
126687505|NCT03505021|455810997|FG000|Overall Study|Disease progression|33|||
126687506|NCT03505021|455810998|FG001|Overall Study|Disease progression|17|||
126687507|NCT03505021|455810997|FG000|Overall Study|Other|11|||
126687508|NCT03505021|455810998|FG001|Overall Study|Other|5|||
126687509|NCT03505021|455810997|FG000|Overall Study|Personal reason|21|||
126687510|NCT03505021|455810998|FG001|Overall Study|Personal reason|12|||
126687511|NCT03087955|455812944|FG000|Overall Study|Death|4|||
126687512|NCT03087955|455812945|FG001|Overall Study|Death|0|||
126687513|NCT03087955|455812944|FG000|Overall Study|Lack of Efficacy|2|||
126687514|NCT03087955|455812945|FG001|Overall Study|Lack of Efficacy|0|||
126687515|NCT03087955|455812944|FG000|Overall Study|Lost to Follow-up|1|||
126687516|NCT03087955|455812945|FG001|Overall Study|Lost to Follow-up|0|||
126687517|NCT02392429|455812946|FG000|Screening|Screen failure|15|||
126687518|NCT02392429|455812946|FG000|Enrolled Participants|Ineligible due to disease|3|||
126687519|NCT02392429|455812946|FG000|Enrolled Participants|Withdrawal by Subject|4|||
126687520|NCT02392429|455812946|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
126687521|NCT02392429|455812946|FG000|Evaluable|Death|5|||
126687522|NCT02392429|455812946|FG000|Evaluable|Withdrawal by Subject|1|||
126687523|NCT02392429|455812946|FG000|Evaluable|Adverse Event|1|||
126687524|NCT02392429|455812946|FG000|Evaluable|remission bone marrow biopsy|3|||
126687525|NCT03656562|455812947|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
126687526|NCT03656562|455812948|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
126687527|NCT03656562|455812949|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
126687528|NCT03656562|455812950|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
126687529|NCT03656562|455812947|FG000|Overall Study|Physician Decision|1|||
126687530|NCT03656562|455812948|FG001|Overall Study|Physician Decision|2|||
126687531|NCT03656562|455812949|FG002|Overall Study|Physician Decision|0|||
126687532|NCT03656562|455812950|FG003|Overall Study|Physician Decision|0|||
126687533|NCT03656562|455812947|FG000|Overall Study|Subject Decision|3|||
126687534|NCT03656562|455812948|FG001|Overall Study|Subject Decision|5|||
126687535|NCT03656562|455812949|FG002|Overall Study|Subject Decision|0|||
126687536|NCT03656562|455812950|FG003|Overall Study|Subject Decision|2|||
126687537|NCT01178138|455812951|FG000|Overall Study|Lost to Follow-up|8|||
126687538|NCT01178138|455812951|FG000|Overall Study|Withdrawal by Subject|7|||
126687539|NCT01178138|455812951|FG000|Overall Study|Physician Decision|8|||
126687540|NCT01241708|455812952|FG000|Overall Study|Withdrawal by Subject|6|||
126687541|NCT01241708|455812952|FG000|Overall Study|Screen Failure|6|||
126687542|NCT01241708|455812952|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
126687543|NCT01241708|455812952|FG000|Overall Study|Lost to Follow-up|5|||
126687544|NCT04183335|455812953|FG000|Overall Study|Adverse Event|1|||
126687545|NCT04183335|455812954|FG001|Overall Study|Adverse Event|0|||
126687546|NCT04183335|455812953|FG000|Overall Study|Withdrawal by Subject|12|||
126687547|NCT04183335|455812954|FG001|Overall Study|Withdrawal by Subject|3|||
126687548|NCT02605642|455812955|FG000|Overall Study|Other|11|||
126687549|NCT02605642|455812956|FG001|Overall Study|Other|1|||
126687550|NCT02605642|455812955|FG000|Overall Study|Participant non-compliance|2|||
126687551|NCT02605642|455812956|FG001|Overall Study|Participant non-compliance|4|||
126687552|NCT02605642|455812955|FG000|Overall Study|Physician Decision|10|||
126687553|NCT02605642|455812956|FG001|Overall Study|Physician Decision|0|||
126687554|NCT02605642|455812955|FG000|Overall Study|Lost to Follow-up|12|||
126687555|NCT02605642|455812956|FG001|Overall Study|Lost to Follow-up|1|||
126687556|NCT02605642|455812955|FG000|Overall Study|Adverse Event|14|||
126687557|NCT02605642|455812956|FG001|Overall Study|Adverse Event|2|||
126687558|NCT02605642|455812955|FG000|Overall Study|Withdrawal by Subject|23|||
126687559|NCT02605642|455812956|FG001|Overall Study|Withdrawal by Subject|2|||
126687560|NCT02605642|455812955|FG000|Overall Study|Lack of response|24|||
126687561|NCT02605642|455812956|FG001|Overall Study|Lack of response|11|||
126687562|NCT00618748|455812966|FG000|Overall Study|Adverse Event|4|||
126687563|NCT00618748|455812967|FG001|Overall Study|Adverse Event|3|||
126687564|NCT00618748|455812968|FG002|Overall Study|Adverse Event|8|||
126687565|NCT00618748|455812966|FG000|Overall Study|Physician Decision|3|||
126687566|NCT00618748|455812967|FG001|Overall Study|Physician Decision|1|||
126687567|NCT00618748|455812968|FG002|Overall Study|Physician Decision|1|||
126687568|NCT00618748|455812966|FG000|Overall Study|Withdrawal by Subject|4|||
126687569|NCT00618748|455812967|FG001|Overall Study|Withdrawal by Subject|1|||
126687570|NCT00618748|455812968|FG002|Overall Study|Withdrawal by Subject|5|||
126687571|NCT03946670|455812976|FG000|Overall Study|Progressive Disease|26|||
126687572|NCT03946670|455812977|FG001|Overall Study|Progressive Disease|23|||
126687573|NCT03946670|455812976|FG000|Overall Study|Adverse Event|7|||
126687574|NCT03946670|455812977|FG001|Overall Study|Adverse Event|9|||
126687575|NCT03946670|455812976|FG000|Overall Study|Death|5|||
126687576|NCT03946670|455812977|FG001|Overall Study|Death|6|||
126687577|NCT03946670|455812976|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
126687578|NCT03946670|455812977|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
126687579|NCT03946670|455812976|FG000|Overall Study|Subject Decision|4|||
126687580|NCT03946670|455812977|FG001|Overall Study|Subject Decision|4|||
126687581|NCT03946670|455812976|FG000|Overall Study|Physician Decision|3|||
126687582|NCT03946670|455812977|FG001|Overall Study|Physician Decision|3|||
126687583|NCT03946670|455812976|FG000|Overall Study|New Therapy for Study Indication|1|||
126687584|NCT03946670|455812977|FG001|Overall Study|New Therapy for Study Indication|0|||
126687585|NCT03946670|455812976|FG000|Overall Study|Not treated|1|||
126687586|NCT03946670|455812977|FG001|Overall Study|Not treated|1|||
126687587|NCT03132636|455812978|FG000|Overall Study|Adverse Event|1|||
126687588|NCT03132636|455812979|FG001|Overall Study|Adverse Event|2|||
126687589|NCT03132636|455812978|FG000|Overall Study|Death|4|||
126687590|NCT03132636|455812979|FG001|Overall Study|Death|7|||
126687591|NCT03132636|455812978|FG000|Overall Study|Lost to Follow-up|3|||
126687592|NCT03132636|455812979|FG001|Overall Study|Lost to Follow-up|2|||
126687593|NCT03132636|455812978|FG000|Overall Study|Non compliance with protocol by participant|1|||
126687594|NCT03132636|455812979|FG001|Overall Study|Non compliance with protocol by participant|1|||
126687595|NCT03132636|455812978|FG000|Overall Study|Subject decision|1|||
126687596|NCT03132636|455812979|FG001|Overall Study|Subject decision|9|||
126687597|NCT03132636|455812978|FG000|Overall Study|Sponsor decision|0|||
126687598|NCT03132636|455812979|FG001|Overall Study|Sponsor decision|1|||
126687599|NCT03132636|455812978|FG000|Overall Study|Physician Decision|1|||
126687600|NCT03132636|455812979|FG001|Overall Study|Physician Decision|0|||
126687601|NCT03132636|455812978|FG000|Overall Study|Progressive disease|33|||
126687602|NCT03132636|455812979|FG001|Overall Study|Progressive disease|36|||
126687603|NCT03132636|455812978|FG000|Overall Study|Withdrawal of consent|2|||
126687604|NCT03132636|455812979|FG001|Overall Study|Withdrawal of consent|5|||
126687605|NCT03132636|455812978|FG000|Overall Study|Did not re-consent|1|||
126687606|NCT03132636|455812979|FG001|Overall Study|Did not re-consent|0|||
126687607|NCT03132636|455812978|FG000|Overall Study|Lost insurance coverage|1|||
126687608|NCT03132636|455812979|FG001|Overall Study|Lost insurance coverage|0|||
126687609|NCT03132636|455812978|FG000|Overall Study|Related to radiological outcomes|0|||
126687610|NCT03132636|455812979|FG001|Overall Study|Related to radiological outcomes|1|||
126687611|NCT03132636|455812978|FG000|Overall Study|Unable to come to site for continued visits|0|||
126687612|NCT03132636|455812979|FG001|Overall Study|Unable to come to site for continued visits|1|||
126687613|NCT04537208|455812984|FG000|Overall Study|Adverse Event|0|||
126687614|NCT04537208|455812985|FG001|Overall Study|Adverse Event|0|||
126687615|NCT04537208|455812986|FG002|Overall Study|Adverse Event|0|||
126687616|NCT04537208|455812987|FG003|Overall Study|Adverse Event|0|||
126687617|NCT04537208|455812988|FG004|Overall Study|Adverse Event|0|||
126687618|NCT04537208|455812989|FG005|Overall Study|Adverse Event|0|||
126687619|NCT04537208|455812990|FG006|Overall Study|Adverse Event|0|||
126687620|NCT04537208|455812991|FG007|Overall Study|Adverse Event|0|||
126687621|NCT04537208|455812992|FG008|Overall Study|Adverse Event|1|||
126687622|NCT04537208|455812993|FG009|Overall Study|Adverse Event|0|||
126687623|NCT04537208|455812994|FG010|Overall Study|Adverse Event|0|||
126687624|NCT04537208|455812984|FG000|Overall Study|Protocol deviation|0|||
126687625|NCT04537208|455812985|FG001|Overall Study|Protocol deviation|0|||
126687626|NCT04537208|455812986|FG002|Overall Study|Protocol deviation|2|||
126687627|NCT04537208|455812987|FG003|Overall Study|Protocol deviation|0|||
126687628|NCT04537208|455812988|FG004|Overall Study|Protocol deviation|0|||
126687629|NCT04537208|455812989|FG005|Overall Study|Protocol deviation|2|||
126687630|NCT04537208|455812990|FG006|Overall Study|Protocol deviation|4|||
126687631|NCT04537208|455812991|FG007|Overall Study|Protocol deviation|0|||
126687632|NCT04537208|455812992|FG008|Overall Study|Protocol deviation|1|||
126687633|NCT04537208|455812993|FG009|Overall Study|Protocol deviation|0|||
126687634|NCT04537208|455812994|FG010|Overall Study|Protocol deviation|2|||
126350328|NCT02112916|454574165|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
126687635|NCT04537208|455812984|FG000|Overall Study|Withdrawal by Subject|4|||
126687636|NCT04537208|455812985|FG001|Overall Study|Withdrawal by Subject|2|||
126687637|NCT04537208|455812986|FG002|Overall Study|Withdrawal by Subject|1|||
126687638|NCT04537208|455812987|FG003|Overall Study|Withdrawal by Subject|3|||
126687639|NCT04537208|455812988|FG004|Overall Study|Withdrawal by Subject|5|||
126687640|NCT04537208|455812989|FG005|Overall Study|Withdrawal by Subject|1|||
126687641|NCT04537208|455812990|FG006|Overall Study|Withdrawal by Subject|6|||
126687642|NCT04537208|455812991|FG007|Overall Study|Withdrawal by Subject|1|||
126687643|NCT04537208|455812992|FG008|Overall Study|Withdrawal by Subject|7|||
126687644|NCT04537208|455812993|FG009|Overall Study|Withdrawal by Subject|2|||
126687645|NCT04537208|455812994|FG010|Overall Study|Withdrawal by Subject|4|||
126687646|NCT04537208|455812984|FG000|Overall Study|Lost to Follow-up|4|||
126759875|NCT01399619|456070442|FG003|Overall Study|Lack of Efficacy|0|||
126687647|NCT04537208|455812985|FG001|Overall Study|Lost to Follow-up|1|||
126687648|NCT04537208|455812986|FG002|Overall Study|Lost to Follow-up|3|||
126687649|NCT04537208|455812987|FG003|Overall Study|Lost to Follow-up|4|||
126687650|NCT04537208|455812988|FG004|Overall Study|Lost to Follow-up|3|||
126687651|NCT04537208|455812989|FG005|Overall Study|Lost to Follow-up|2|||
126687652|NCT04537208|455812990|FG006|Overall Study|Lost to Follow-up|3|||
126687653|NCT04537208|455812991|FG007|Overall Study|Lost to Follow-up|2|||
126687654|NCT04537208|455812992|FG008|Overall Study|Lost to Follow-up|7|||
126687655|NCT04537208|455812993|FG009|Overall Study|Lost to Follow-up|2|||
126687656|NCT04537208|455812994|FG010|Overall Study|Lost to Follow-up|2|||
126687657|NCT03083886|455812996|FG000|Overall Study|Withdrawal by Subject|51|||
126687658|NCT03083886|455812997|FG001|Overall Study|Withdrawal by Subject|73|||
126687659|NCT03083886|455812998|FG002|Overall Study|Withdrawal by Subject|104|||
126687660|NCT03083886|455812996|FG000|Overall Study|Missing Baseline data|43|||
126687661|NCT03083886|455812997|FG001|Overall Study|Missing Baseline data|42|||
126687662|NCT03083886|455812998|FG002|Overall Study|Missing Baseline data|31|||
126687663|NCT03083886|455812996|FG000|Overall Study|Investigator terminated|1|||
126687664|NCT03083886|455812997|FG001|Overall Study|Investigator terminated|6|||
126687665|NCT03083886|455812998|FG002|Overall Study|Investigator terminated|3|||
126687666|NCT04161495|455812999|FG000|Overall Study|Withdrawal by Subject|3|||
126687667|NCT04161495|455813000|FG001|Overall Study|Withdrawal by Subject|0|||
126687668|NCT04161495|455812999|FG000|Overall Study|Protocol Violation|1|||
126687669|NCT04161495|455813000|FG001|Overall Study|Protocol Violation|0|||
126687670|NCT04161495|455812999|FG000|Overall Study|Prohibited concomitant medication|3|||
126687671|NCT04161495|455813000|FG001|Overall Study|Prohibited concomitant medication|0|||
126687672|NCT04161495|455812999|FG000|Overall Study|Adverse Event|1|||
126687673|NCT04161495|455813000|FG001|Overall Study|Adverse Event|0|||
126687674|NCT04161495|455812999|FG000|Overall Study|Other - Unspecified|1|||
126687675|NCT04161495|455813000|FG001|Overall Study|Other - Unspecified|0|||
126687676|NCT04161495|455812999|FG000|Overall Study|Death|0|||
126687677|NCT04161495|455813000|FG001|Overall Study|Death|1|||
126687678|NCT01587079|455813001|FG000|Overall Study|Protocol-specified criteria|9|||
126687679|NCT01587079|455813001|FG000|Overall Study|Protocol Violation|5|||
126687680|NCT01587079|455813001|FG000|Overall Study|Lost to Follow-up|2|||
126687681|NCT01587079|455813001|FG000|Overall Study|Physician Decision|2|||
126687682|NCT01587079|455813001|FG000|Overall Study|Withdrawal by Subject|7|||
126687683|NCT01587079|455813001|FG000|Overall Study|Adverse Event|14|||
126687684|NCT01239160|455813003|FG000|Overall Study|Lost to Follow-up|3|||
126687685|NCT01239160|455813004|FG001|Overall Study|Lost to Follow-up|5|||
126687686|NCT01239160|455813005|FG002|Overall Study|Lost to Follow-up|0|||
126687687|NCT01239160|455813003|FG000|Overall Study|Withdrawal by Subject|17|||
126687688|NCT01239160|455813004|FG001|Overall Study|Withdrawal by Subject|6|||
126687689|NCT01239160|455813005|FG002|Overall Study|Withdrawal by Subject|2|||
126687690|NCT01239160|455813003|FG000|Overall Study|Physician Decision|5|||
126687691|NCT01239160|455813004|FG001|Overall Study|Physician Decision|7|||
126687692|NCT01239160|455813005|FG002|Overall Study|Physician Decision|2|||
126687693|NCT01239160|455813003|FG000|Overall Study|Early Termination Due to Study Closure|0|||
126687694|NCT01239160|455813004|FG001|Overall Study|Early Termination Due to Study Closure|1|||
126687695|NCT01239160|455813005|FG002|Overall Study|Early Termination Due to Study Closure|6|||
126687696|NCT00704964|455813007|FG000|Overall Study|Not completed on time|328|||
126687697|NCT04418765|455813008|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
126687698|NCT04418765|455813009|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
126687699|NCT04418765|455813010|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
126687700|NCT04418765|455813008|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
126687701|NCT04418765|455813009|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
126687702|NCT04418765|455813010|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
126687703|NCT04418765|455813008|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
126687704|NCT04418765|455813009|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
126759876|NCT01399619|456070439|FG000|Overall Study|Withdrawal by Subject|6|||
126350329|NCT02112916|454574166|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
126350330|NCT02112916|454574167|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
126350331|NCT02112916|454574164|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
126687705|NCT04418765|455813010|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
126687706|NCT04418765|455813008|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
126687707|NCT04418765|455813009|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
126687708|NCT04418765|455813010|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
126687709|NCT04418765|455813008|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
126687710|NCT04418765|455813009|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
126687711|NCT04418765|455813010|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
126687712|NCT04418765|455813008|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
126687713|NCT04418765|455813009|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
126687714|NCT04418765|455813010|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
126350332|NCT02112916|454574165|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
126369493|NCT00876447|454650572|FG001|Overall Study|Personal reasons|28|||
126687715|NCT04418765|455813008|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
126687716|NCT04418765|455813009|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
126687717|NCT04418765|455813010|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
126687718|NCT04418765|455813008|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
126687719|NCT04418765|455813009|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
126687720|NCT04418765|455813010|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
126687721|NCT04418765|455813008|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
126687722|NCT04418765|455813009|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
126687723|NCT04418765|455813010|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
126687724|NCT04418765|455813008|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
126687725|NCT04418765|455813009|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
126687726|NCT04418765|455813010|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
126687727|NCT04418765|455813008|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
126687728|NCT04418765|455813009|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
126687729|NCT04418765|455813010|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
126687730|NCT04418765|455813008|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
126687731|NCT04418765|455813009|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
126687732|NCT04418765|455813010|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
126687733|NCT04418765|455813008|FG000|Extension Period (48 Weeks)|Other than specified|0|||
126687734|NCT04418765|455813009|FG001|Extension Period (48 Weeks)|Other than specified|5|||
126687735|NCT04418765|455813010|FG002|Extension Period (48 Weeks)|Other than specified|2|||
126687736|NCT01789970|455813011|FG000|Open-label Titration Period|Adverse Event|68|||
126687737|NCT01789970|455813012|FG001|Open-label Titration Period|Adverse Event|0|||
126687738|NCT01789970|455813013|FG002|Open-label Titration Period|Adverse Event|0|||
126687739|NCT01789970|455813011|FG000|Open-label Titration Period|Lack of Efficacy|31|||
126687740|NCT01789970|455813012|FG001|Open-label Titration Period|Lack of Efficacy|0|||
126687741|NCT01789970|455813013|FG002|Open-label Titration Period|Lack of Efficacy|0|||
126687742|NCT01789970|455813011|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
126687743|NCT01789970|455813012|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
126687744|NCT01789970|455813013|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
126687745|NCT01789970|455813011|FG000|Open-label Titration Period|Protocol Violation|18|||
126687746|NCT01789970|455813012|FG001|Open-label Titration Period|Protocol Violation|0|||
126687747|NCT01789970|455813013|FG002|Open-label Titration Period|Protocol Violation|0|||
126687748|NCT01789970|455813011|FG000|Open-label Titration Period|Lost to Follow-up|5|||
126687749|NCT01789970|455813012|FG001|Open-label Titration Period|Lost to Follow-up|0|||
126687750|NCT01789970|455813013|FG002|Open-label Titration Period|Lost to Follow-up|0|||
126687751|NCT01789970|455813011|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
126687752|NCT01789970|455813012|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
126687753|NCT01789970|455813013|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
126687754|NCT01789970|455813011|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
126687755|NCT01789970|455813012|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
126687756|NCT01789970|455813013|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
126687757|NCT01789970|455813011|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
126687758|NCT01789970|455813012|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
126687759|NCT01789970|455813013|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
126687760|NCT01789970|455813011|FG000|Open-label Titration Period|Pregnancy|2|||
126687761|NCT01789970|455813012|FG001|Open-label Titration Period|Pregnancy|0|||
126687762|NCT01789970|455813013|FG002|Open-label Titration Period|Pregnancy|0|||
126687763|NCT01789970|455813011|FG000|Open-label Titration Period|Other|76|||
126687764|NCT01789970|455813012|FG001|Open-label Titration Period|Other|0|||
126687765|NCT01789970|455813013|FG002|Open-label Titration Period|Other|0|||
126687766|NCT01789970|455813011|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
126687767|NCT01789970|455813012|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
126687768|NCT01789970|455813013|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
126687769|NCT01789970|455813011|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
126687770|NCT01789970|455813012|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
126687771|NCT01789970|455813013|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
126350333|NCT02112916|454574166|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
126350334|NCT02112916|454574167|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
126350335|NCT04409002|454574168|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
126350336|NCT04835441|454574169|FG000|Overall Study|Physician Decision|4|||
126350337|NCT04835441|454574170|FG001|Overall Study|Physician Decision|4|||
126350338|NCT04835441|454574169|FG000|Overall Study|Other|1|||
126350339|NCT04835441|454574170|FG001|Overall Study|Other|1|||
126438513|NCT02113982|454907590|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
126350340|NCT04835441|454574169|FG000|Overall Study|Lost to Follow-up|0|||
126350341|NCT04835441|454574170|FG001|Overall Study|Lost to Follow-up|1|||
126350342|NCT05032196|454574171|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
126687772|NCT01789970|455813011|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
126687773|NCT01789970|455813012|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
126687774|NCT01789970|455813013|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
126687775|NCT01789970|455813011|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
126687776|NCT01789970|455813012|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
126687777|NCT01789970|455813013|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
126687778|NCT01789970|455813011|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
126687779|NCT01789970|455813012|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
126687780|NCT01789970|455813013|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
126687781|NCT01789970|455813011|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
126687782|NCT01789970|455813012|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
126687783|NCT01789970|455813013|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
126687784|NCT01789970|455813011|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
126687785|NCT01789970|455813012|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
126687786|NCT01789970|455813013|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
126687787|NCT01789970|455813011|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
126687788|NCT01789970|455813012|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
126687789|NCT01789970|455813013|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
126687790|NCT01789970|455813011|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
126687791|NCT01789970|455813012|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
126687792|NCT01789970|455813013|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
126687793|NCT01789970|455813011|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
126687794|NCT01789970|455813012|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
126687795|NCT01789970|455813013|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
126687796|NCT01789970|455813011|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
126687797|NCT01789970|455813012|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
126687798|NCT01789970|455813013|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
126687799|NCT01121393|455813014|FG000|Overall Study|Progressive disease|201|||
126687800|NCT01121393|455813015|FG001|Overall Study|Progressive disease|20|||
126687801|NCT01121393|455813014|FG000|Overall Study|Other Adverse events|24|||
126687802|NCT01121393|455813015|FG001|Overall Study|Other Adverse events|45|||
126687803|NCT01121393|455813014|FG000|Overall Study|Non-compliant with protocol|0|||
126687804|NCT01121393|455813015|FG001|Overall Study|Non-compliant with protocol|3|||
126687805|NCT01121393|455813014|FG000|Overall Study|Lost to Follow-up|1|||
126687806|NCT01121393|455813015|FG001|Overall Study|Lost to Follow-up|0|||
126687807|NCT01121393|455813014|FG000|Overall Study|Refused cont. medication|7|||
126687808|NCT01121393|455813015|FG001|Overall Study|Refused cont. medication|7|||
126687809|NCT01121393|455813014|FG000|Overall Study|Not treated|3|||
126687810|NCT01121393|455813015|FG001|Overall Study|Not treated|9|||
126687811|NCT01121393|455813014|FG000|Overall Study|Other than listed|6|||
126687812|NCT01121393|455813015|FG001|Overall Study|Other than listed|0|||
126687813|NCT02296242|455813020|FG000|Overall Study|Death|1|||
126687814|NCT02296242|455813021|FG001|Overall Study|Death|1|||
126687815|NCT02296242|455813022|FG002|Overall Study|Death|1|||
126687816|NCT02296242|455813023|FG003|Overall Study|Death|1|||
126687817|NCT02296242|455813024|FG004|Overall Study|Death|1|||
126687818|NCT02296242|455813020|FG000|Overall Study|Withdrawal by Subject|0|||
126687819|NCT02296242|455813021|FG001|Overall Study|Withdrawal by Subject|0|||
126687820|NCT02296242|455813022|FG002|Overall Study|Withdrawal by Subject|1|||
126687821|NCT02296242|455813023|FG003|Overall Study|Withdrawal by Subject|1|||
126687822|NCT02296242|455813024|FG004|Overall Study|Withdrawal by Subject|3|||
126687823|NCT02296242|455813020|FG000|Overall Study|Disease Progression|1|||
126687824|NCT02296242|455813021|FG001|Overall Study|Disease Progression|3|||
126687825|NCT02296242|455813022|FG002|Overall Study|Disease Progression|2|||
126687826|NCT02296242|455813023|FG003|Overall Study|Disease Progression|8|||
126687827|NCT02296242|455813024|FG004|Overall Study|Disease Progression|11|||
126687828|NCT02296242|455813020|FG000|Overall Study|Unacceptable Toxicity|0|||
126687829|NCT02296242|455813021|FG001|Overall Study|Unacceptable Toxicity|0|||
126687830|NCT02296242|455813022|FG002|Overall Study|Unacceptable Toxicity|0|||
126687831|NCT02296242|455813023|FG003|Overall Study|Unacceptable Toxicity|0|||
126687832|NCT02296242|455813024|FG004|Overall Study|Unacceptable Toxicity|1|||
126687833|NCT02296242|455813020|FG000|Overall Study|Patient Condition Changed|0|||
126687834|NCT02296242|455813021|FG001|Overall Study|Patient Condition Changed|0|||
126687835|NCT02296242|455813022|FG002|Overall Study|Patient Condition Changed|2|||
126687836|NCT02296242|455813023|FG003|Overall Study|Patient Condition Changed|0|||
126687837|NCT02296242|455813024|FG004|Overall Study|Patient Condition Changed|1|||
126687838|NCT02296242|455813020|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
126687839|NCT02296242|455813021|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
126687840|NCT02296242|455813022|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
126687841|NCT02296242|455813023|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
126687842|NCT02296242|455813024|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
126687843|NCT02296242|455813020|FG000|Overall Study|Lost to Follow-up|1|||
126687844|NCT02296242|455813021|FG001|Overall Study|Lost to Follow-up|0|||
126687845|NCT02296242|455813022|FG002|Overall Study|Lost to Follow-up|0|||
126687846|NCT02296242|455813023|FG003|Overall Study|Lost to Follow-up|0|||
126687847|NCT02296242|455813024|FG004|Overall Study|Lost to Follow-up|0|||
126687848|NCT02296242|455813020|FG000|Overall Study|Need for Hydroxyurea|2|||
126687849|NCT02296242|455813021|FG001|Overall Study|Need for Hydroxyurea|0|||
126687850|NCT02296242|455813022|FG002|Overall Study|Need for Hydroxyurea|0|||
126687851|NCT02296242|455813023|FG003|Overall Study|Need for Hydroxyurea|0|||
126687852|NCT02296242|455813024|FG004|Overall Study|Need for Hydroxyurea|0|||
126687853|NCT02296242|455813020|FG000|Overall Study|Screened for Other Protocol|0|||
126687854|NCT02296242|455813021|FG001|Overall Study|Screened for Other Protocol|1|||
126687855|NCT02296242|455813022|FG002|Overall Study|Screened for Other Protocol|0|||
126687856|NCT02296242|455813023|FG003|Overall Study|Screened for Other Protocol|0|||
126687857|NCT02296242|455813024|FG004|Overall Study|Screened for Other Protocol|0|||
126687858|NCT02296242|455813020|FG000|Overall Study|Physician Decision|0|||
126687859|NCT02296242|455813021|FG001|Overall Study|Physician Decision|1|||
126687860|NCT02296242|455813022|FG002|Overall Study|Physician Decision|0|||
126687861|NCT02296242|455813023|FG003|Overall Study|Physician Decision|1|||
126687862|NCT02296242|455813024|FG004|Overall Study|Physician Decision|0|||
126687863|NCT02296242|455813020|FG000|Overall Study|Alternative Treatment|0|||
126687864|NCT02296242|455813021|FG001|Overall Study|Alternative Treatment|0|||
126687865|NCT02296242|455813022|FG002|Overall Study|Alternative Treatment|0|||
126687866|NCT02296242|455813023|FG003|Overall Study|Alternative Treatment|1|||
126687867|NCT02296242|455813024|FG004|Overall Study|Alternative Treatment|0|||
126687868|NCT02296242|455813020|FG000|Overall Study|Adverse Event|0|||
126687869|NCT02296242|455813021|FG001|Overall Study|Adverse Event|0|||
126687870|NCT02296242|455813022|FG002|Overall Study|Adverse Event|0|||
126687871|NCT02296242|455813023|FG003|Overall Study|Adverse Event|1|||
126687872|NCT02296242|455813024|FG004|Overall Study|Adverse Event|0|||
126687873|NCT02296242|455813020|FG000|Overall Study|Lack of Efficacy|0|||
126687874|NCT02296242|455813021|FG001|Overall Study|Lack of Efficacy|0|||
126687875|NCT02296242|455813022|FG002|Overall Study|Lack of Efficacy|0|||
126687876|NCT02296242|455813023|FG003|Overall Study|Lack of Efficacy|0|||
126687877|NCT02296242|455813024|FG004|Overall Study|Lack of Efficacy|3|||
126687878|NCT04016311|455813028|FG000|Overall Study|Withdrawal by Subject|1|||
126687879|NCT04016311|455813029|FG001|Overall Study|Withdrawal by Subject|0|||
126687880|NCT01999582|455813035|FG000|Overall Study|Withdrawal by Subject|0|||
126687881|NCT01999582|455813036|FG001|Overall Study|Withdrawal by Subject|0|||
126687882|NCT01999582|455813037|FG002|Overall Study|Withdrawal by Subject|0|||
126687883|NCT01999582|455813038|FG003|Overall Study|Withdrawal by Subject|1|||
126687884|NCT01999582|455813039|FG004|Overall Study|Withdrawal by Subject|0|||
126687885|NCT01999582|455813040|FG005|Overall Study|Withdrawal by Subject|0|||
126687886|NCT01999582|455813035|FG000|Overall Study|Adverse Event|0|||
126687887|NCT01999582|455813036|FG001|Overall Study|Adverse Event|0|||
126687888|NCT01999582|455813037|FG002|Overall Study|Adverse Event|3|||
126687889|NCT01999582|455813038|FG003|Overall Study|Adverse Event|0|||
126687890|NCT01999582|455813039|FG004|Overall Study|Adverse Event|1|||
126687891|NCT01999582|455813040|FG005|Overall Study|Adverse Event|0|||
126687892|NCT01999582|455813035|FG000|Overall Study|Other Reasons|1|||
126687893|NCT01999582|455813036|FG001|Overall Study|Other Reasons|0|||
126350343|NCT05032196|454574172|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
126350344|NCT05032196|454574173|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
126687894|NCT01999582|455813037|FG002|Overall Study|Other Reasons|3|||
126687895|NCT01999582|455813038|FG003|Overall Study|Other Reasons|1|||
126687896|NCT01999582|455813039|FG004|Overall Study|Other Reasons|1|||
126687897|NCT01999582|455813040|FG005|Overall Study|Other Reasons|2|||
126687898|NCT01999582|455813035|FG000|Overall Study|Protocol Violation|1|||
126687899|NCT01999582|455813036|FG001|Overall Study|Protocol Violation|0|||
126350345|NCT05032196|454574174|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
126350346|NCT05032196|454574175|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
126687900|NCT01999582|455813037|FG002|Overall Study|Protocol Violation|0|||
126687901|NCT01999582|455813038|FG003|Overall Study|Protocol Violation|0|||
126687902|NCT01999582|455813039|FG004|Overall Study|Protocol Violation|0|||
126687903|NCT01999582|455813040|FG005|Overall Study|Protocol Violation|1|||
126687904|NCT01999582|455813035|FG000|Overall Study|Lack of Efficacy|1|||
126687905|NCT01999582|455813036|FG001|Overall Study|Lack of Efficacy|3|||
126687906|NCT01999582|455813037|FG002|Overall Study|Lack of Efficacy|0|||
126687907|NCT01999582|455813038|FG003|Overall Study|Lack of Efficacy|1|||
126687908|NCT01999582|455813039|FG004|Overall Study|Lack of Efficacy|0|||
126687909|NCT01999582|455813040|FG005|Overall Study|Lack of Efficacy|0|||
126687910|NCT02436876|455813047|FG000|Overall Study|Lost to Follow-up|0|||
126687911|NCT02436876|455813048|FG001|Overall Study|Lost to Follow-up|1|||
126687912|NCT02436876|455813049|FG002|Overall Study|Lost to Follow-up|1|||
126687913|NCT02436876|455813050|FG003|Overall Study|Lost to Follow-up|1|||
126687914|NCT02436876|455813047|FG000|Overall Study|Withdrawal by Subject|1|||
126687915|NCT02436876|455813048|FG001|Overall Study|Withdrawal by Subject|0|||
126687916|NCT02436876|455813049|FG002|Overall Study|Withdrawal by Subject|0|||
126687917|NCT02436876|455813050|FG003|Overall Study|Withdrawal by Subject|1|||
126687918|NCT02436876|455813047|FG000|Overall Study|Physician Decision|0|||
126687919|NCT02436876|455813048|FG001|Overall Study|Physician Decision|2|||
126687920|NCT02436876|455813049|FG002|Overall Study|Physician Decision|1|||
126687921|NCT02436876|455813050|FG003|Overall Study|Physician Decision|0|||
126687922|NCT02436876|455813047|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
126687923|NCT02436876|455813048|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
126687924|NCT02436876|455813049|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
126687925|NCT02436876|455813050|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
126687926|NCT05779072|455813052|FG000|Overall Study|Lost to Follow-up|0|||
126687927|NCT05779072|455813053|FG001|Overall Study|Lost to Follow-up|1|||
126687928|NCT05779072|455813052|FG000|Overall Study|Withdrawal by Subject|1|||
126687929|NCT05779072|455813053|FG001|Overall Study|Withdrawal by Subject|5|||
126687930|NCT02387580|455813057|FG000|Overall Study|Withdrawal by Subject|0|||
126687931|NCT02387580|455813058|FG001|Overall Study|Withdrawal by Subject|0|||
126687932|NCT02387580|455813059|FG002|Overall Study|Withdrawal by Subject|0|||
126687933|NCT02387580|455813060|FG003|Overall Study|Withdrawal by Subject|1|||
126687934|NCT02387580|455813061|FG004|Overall Study|Withdrawal by Subject|0|||
126687935|NCT02387580|455813062|FG005|Overall Study|Withdrawal by Subject|0|||
126687936|NCT00725075|455813063|FG000|Overall Study|Use of Excluded Medication|0|||
126687937|NCT00725075|455813064|FG001|Overall Study|Use of Excluded Medication|1|||
126687938|NCT00725075|455813065|FG002|Overall Study|Use of Excluded Medication|0|||
126687939|NCT00725075|455813063|FG000|Overall Study|Protocol Violation|0|||
126687940|NCT00725075|455813064|FG001|Overall Study|Protocol Violation|0|||
126687941|NCT00725075|455813065|FG002|Overall Study|Protocol Violation|1|||
126687942|NCT00725075|455813063|FG000|Overall Study|Lost to Follow-up|1|||
126687943|NCT00725075|455813064|FG001|Overall Study|Lost to Follow-up|0|||
126687944|NCT00725075|455813065|FG002|Overall Study|Lost to Follow-up|0|||
126687945|NCT00725075|455813063|FG000|Overall Study|Withdrawal by Subject|4|||
126687946|NCT00725075|455813064|FG001|Overall Study|Withdrawal by Subject|5|||
126687947|NCT00725075|455813065|FG002|Overall Study|Withdrawal by Subject|4|||
126687948|NCT00725075|455813063|FG000|Overall Study|Adverse Event|2|||
126687949|NCT00725075|455813064|FG001|Overall Study|Adverse Event|1|||
126687950|NCT00725075|455813065|FG002|Overall Study|Adverse Event|1|||
126687951|NCT00725075|455813063|FG000|Overall Study|Worsening of Disease|2|||
126687952|NCT00725075|455813064|FG001|Overall Study|Worsening of Disease|1|||
126687953|NCT00725075|455813065|FG002|Overall Study|Worsening of Disease|2|||
126687954|NCT00725075|455813063|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
126687955|NCT00725075|455813064|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
126350347|NCT05032196|454574176|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
126350348|NCT05032196|454574171|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
126350349|NCT05032196|454574172|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
126350350|NCT05032196|454574173|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
126350351|NCT05032196|454574174|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
126350352|NCT05032196|454574175|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
126687956|NCT00725075|455813065|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
126687957|NCT00725075|455813063|FG000|Overall Study|Other|1|||
126687958|NCT00725075|455813064|FG001|Overall Study|Other|0|||
126687959|NCT00725075|455813065|FG002|Overall Study|Other|0|||
126687960|NCT03984305|455813067|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
126687961|NCT03984305|455813068|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
126687962|NCT03984305|455813067|FG000|Overall Study|Withdrawal by Subject|3|||
126687963|NCT03984305|455813068|FG001|Overall Study|Withdrawal by Subject|3|||
126687964|NCT03984305|455813067|FG000|Overall Study|Lost to Follow-up|1|||
126687965|NCT03984305|455813068|FG001|Overall Study|Lost to Follow-up|0|||
126687966|NCT02340663|455813069|FG000|Overall Study|Lost to Follow-up|1|||
126687967|NCT02340663|455813070|FG001|Overall Study|Lost to Follow-up|0|||
126687968|NCT02340663|455813069|FG000|Overall Study|Protocol Violation|1|||
126687969|NCT02340663|455813070|FG001|Overall Study|Protocol Violation|0|||
126687970|NCT02340663|455813069|FG000|Overall Study|Withdrawal by Subject|3|||
126687971|NCT02340663|455813070|FG001|Overall Study|Withdrawal by Subject|1|||
126687972|NCT02979431|455813071|FG000|Overall Study|Parent/guardian withdrew consent|2|||
126687973|NCT02979431|455813072|FG001|Overall Study|Parent/guardian withdrew consent|1|||
126687974|NCT02979431|455813073|FG002|Overall Study|Parent/guardian withdrew consent|1|||
126350353|NCT05032196|454574176|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
126350354|NCT05032196|454574171|FG000|Period 2 (Multidose)|Physician Decision|0|||
126687975|NCT02979431|455813074|FG003|Overall Study|Parent/guardian withdrew consent|1|||
126687976|NCT02979431|455813071|FG000|Overall Study|Randomized but received no study drug|1|||
126687977|NCT02979431|455813072|FG001|Overall Study|Randomized but received no study drug|1|||
126687978|NCT02979431|455813073|FG002|Overall Study|Randomized but received no study drug|0|||
126687979|NCT02979431|455813074|FG003|Overall Study|Randomized but received no study drug|0|||
126687980|NCT02979431|455813071|FG000|Overall Study|Adverse Event|0|||
126687981|NCT02979431|455813072|FG001|Overall Study|Adverse Event|0|||
126687982|NCT02979431|455813073|FG002|Overall Study|Adverse Event|1|||
126687983|NCT02979431|455813074|FG003|Overall Study|Adverse Event|0|||
126687984|NCT02979431|455813071|FG000|Overall Study|Subject left country after Day14|1|||
126687985|NCT02979431|455813072|FG001|Overall Study|Subject left country after Day14|0|||
126687986|NCT02979431|455813073|FG002|Overall Study|Subject left country after Day14|0|||
126687987|NCT02979431|455813074|FG003|Overall Study|Subject left country after Day14|0|||
126687988|NCT01656434|455813075|FG000|Overall Study|Adverse Event|199|||
126687989|NCT01656434|455813076|FG001|Overall Study|Adverse Event|63|||
126687990|NCT01656434|455813075|FG000|Overall Study|Enrollment terminated at trial site|2|||
126687991|NCT01656434|455813076|FG001|Overall Study|Enrollment terminated at trial site|0|||
126687992|NCT01656434|455813075|FG000|Overall Study|Lost to Follow-up|309|||
126687993|NCT01656434|455813076|FG001|Overall Study|Lost to Follow-up|76|||
126687994|NCT01656434|455813075|FG000|Overall Study|Site discontinued study participation|24|||
126687995|NCT01656434|455813076|FG001|Overall Study|Site discontinued study participation|9|||
126687996|NCT01656434|455813075|FG000|Overall Study|Screen failure|2|||
126687997|NCT01656434|455813076|FG001|Overall Study|Screen failure|0|||
126687998|NCT01656434|455813075|FG000|Overall Study|Protocol Violation|7|||
126687999|NCT01656434|455813076|FG001|Overall Study|Protocol Violation|0|||
126688000|NCT01656434|455813075|FG000|Overall Study|Pregnancy wish|18|||
126688001|NCT01656434|455813076|FG001|Overall Study|Pregnancy wish|6|||
126688002|NCT01656434|455813075|FG000|Overall Study|Pregnancy|45|||
126688003|NCT01656434|455813076|FG001|Overall Study|Pregnancy|10|||
126688004|NCT01656434|455813075|FG000|Overall Study|Physician Decision|7|||
126688005|NCT01656434|455813076|FG001|Overall Study|Physician Decision|2|||
126688006|NCT01656434|455813075|FG000|Overall Study|Non-compliance with study drug|48|||
126688007|NCT01656434|455813076|FG001|Overall Study|Non-compliance with study drug|9|||
126688008|NCT01656434|455813075|FG000|Overall Study|Study terminated by sponsor|1501|||
126688009|NCT01656434|455813076|FG001|Overall Study|Study terminated by sponsor|348|||
126688010|NCT01656434|455813075|FG000|Overall Study|Participant discontinued; drug related|13|||
126688011|NCT01656434|455813076|FG001|Overall Study|Participant discontinued; drug related|4|||
126688012|NCT01656434|455813075|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
126688013|NCT01656434|455813076|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
126688014|NCT01656434|455813075|FG000|Overall Study|Non-compliance with protocol|39|||
126688015|NCT01656434|455813076|FG001|Overall Study|Non-compliance with protocol|15|||
126688016|NCT01656434|455813075|FG000|Overall Study|Participant moved|40|||
126688017|NCT01656434|455813076|FG001|Overall Study|Participant moved|12|||
126688018|NCT01656434|455813075|FG000|Overall Study|Participant withdrew consent|28|||
126438514|NCT02113982|454907591|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
126438515|NCT02113982|454907592|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
126438516|NCT02113982|454907593|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
126438517|NCT02113982|454907580|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126438518|NCT02113982|454907581|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126438519|NCT02113982|454907582|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126438520|NCT02113982|454907583|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126438521|NCT02113982|454907584|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126438522|NCT02113982|454907585|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126438523|NCT02113982|454907586|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126438524|NCT02113982|454907587|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126438525|NCT02113982|454907588|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126438526|NCT02113982|454907589|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126438527|NCT02113982|454907590|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126688019|NCT01656434|455813076|FG001|Overall Study|Participant withdrew consent|9|||
126438528|NCT02113982|454907591|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
126438529|NCT02113982|454907592|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126438530|NCT02113982|454907593|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
126438531|NCT02113982|454907580|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
126688020|NCT01656434|455813075|FG000|Overall Study|Withdrawal by Subject|64|||
126688021|NCT01656434|455813076|FG001|Overall Study|Withdrawal by Subject|7|||
126688022|NCT02004873|455813077|FG000|Overall Study|Implant unsuccessful|6|||
126688023|NCT02004873|455813077|FG000|Overall Study|Awaiting 6-month visit|390|||
126688024|NCT02004873|455813077|FG000|Overall Study|Missed 6-month visit|4|||
126688025|NCT02004873|455813077|FG000|Overall Study|Death|23|||
126688026|NCT02004873|455813077|FG000|Overall Study|Withdrawal by Subject|1|||
126688027|NCT01972074|455813085|FG000|Overall Study|Adverse Event|4|||
126688028|NCT01972074|455813086|FG001|Overall Study|Adverse Event|1|||
126688029|NCT01972074|455813087|FG002|Overall Study|Adverse Event|0|||
126688030|NCT01972074|455813085|FG000|Overall Study|Lack of Efficacy|1|||
126688031|NCT01972074|455813086|FG001|Overall Study|Lack of Efficacy|1|||
126688032|NCT01972074|455813087|FG002|Overall Study|Lack of Efficacy|0|||
126688033|NCT01972074|455813085|FG000|Overall Study|Lost to Follow-up|0|||
126688034|NCT01972074|455813086|FG001|Overall Study|Lost to Follow-up|1|||
126688035|NCT01972074|455813087|FG002|Overall Study|Lost to Follow-up|1|||
126688036|NCT01972074|455813085|FG000|Overall Study|Withdrawal by Subject|1|||
126688037|NCT01972074|455813086|FG001|Overall Study|Withdrawal by Subject|1|||
126688038|NCT01972074|455813087|FG002|Overall Study|Withdrawal by Subject|1|||
126688039|NCT01972074|455813085|FG000|Overall Study|Scanner Unavailable|0|||
126688040|NCT01972074|455813086|FG001|Overall Study|Scanner Unavailable|0|||
126688041|NCT01972074|455813087|FG002|Overall Study|Scanner Unavailable|1|||
126688042|NCT00980538|455813092|FG000|Overall Study|Lost to Follow-up|20|||
126688043|NCT00980538|455813092|FG000|Overall Study|Sponsor's Decision|4|||
126688044|NCT00980538|455813092|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
126688045|NCT00980538|455813092|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
126688046|NCT00980538|455813092|FG000|Overall Study|Switch to Commercially Available Medication|25|||
126688047|NCT00980538|455813092|FG000|Overall Study|Participant Non-Compliant|9|||
126688048|NCT00980538|455813092|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
126688049|NCT00980538|455813092|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
126688050|NCT00980538|455813092|FG000|Overall Study|Other|60|||
126350355|NCT05032196|454574172|FG001|Period 2 (Multidose)|Physician Decision|0|||
126350356|NCT05032196|454574173|FG002|Period 2 (Multidose)|Physician Decision|0|||
126350357|NCT05032196|454574174|FG003|Period 2 (Multidose)|Physician Decision|0|||
126350358|NCT05032196|454574175|FG004|Period 2 (Multidose)|Physician Decision|1|||
126350359|NCT05032196|454574176|FG005|Period 2 (Multidose)|Physician Decision|0|||
126350360|NCT05260008|454574177|FG000|Overall Study|Physician Decision|0|||
126688051|NCT00980538|455813092|FG000|Overall Study|Other|1|||
126688052|NCT03864653|455813093|FG000|Overall Study|Withdrawal by Subject|1|||
126688053|NCT00546052|455813094|FG000|Overall Study|Adverse Event|47|||
126688054|NCT00546052|455813094|FG000|Overall Study|Lost to Follow-up|144|||
126688055|NCT00546052|455813094|FG000|Overall Study|Protocol Violation|9|||
126350361|NCT05260008|454574178|FG001|Overall Study|Physician Decision|1|||
126350362|NCT05260008|454574179|FG002|Overall Study|Physician Decision|0|||
126350363|NCT05260008|454574180|FG003|Overall Study|Physician Decision|0|||
126350364|NCT05696847|454575316|FG000|Overall Study|Withdrawal by Subject|1|||
126350365|NCT05696847|454575317|FG001|Overall Study|Withdrawal by Subject|0|||
126688056|NCT00546052|455813094|FG000|Overall Study|Withdrawal by Subject|20|||
126688057|NCT00546052|455813094|FG000|Overall Study|Non Compliance|7|||
126688058|NCT01928381|455813097|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
126688059|NCT01928381|455813098|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
126438532|NCT02113982|454907581|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
126438533|NCT02113982|454907582|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
126438534|NCT02113982|454907583|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
126438535|NCT02113982|454907584|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
126438536|NCT02113982|454907585|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
126438537|NCT02113982|454907586|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
126438538|NCT02113982|454907587|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
126438539|NCT02113982|454907588|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
126438540|NCT02113982|454907589|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
126438541|NCT02113982|454907590|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
126438542|NCT02113982|454907591|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
126438543|NCT02113982|454907592|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
126438544|NCT02113982|454907593|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
126438545|NCT02113982|454907580|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438546|NCT02113982|454907581|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438547|NCT02113982|454907582|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438548|NCT02113982|454907583|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438549|NCT02113982|454907584|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438550|NCT02113982|454907585|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438551|NCT02113982|454907586|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438552|NCT02113982|454907587|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438553|NCT02113982|454907588|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438554|NCT02113982|454907589|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438555|NCT02113982|454907590|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438556|NCT02113982|454907591|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438557|NCT02113982|454907592|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
126438558|NCT02113982|454907593|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
126438559|NCT02113982|454907580|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
126438560|NCT02113982|454907581|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
126438561|NCT02113982|454907582|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
126438562|NCT02113982|454907583|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
126438563|NCT02113982|454907584|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
126438564|NCT02113982|454907585|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
126438565|NCT02113982|454907586|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
126438566|NCT02113982|454907587|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
126438567|NCT02113982|454907588|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
126438568|NCT02113982|454907589|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
126438569|NCT02113982|454907590|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
126438570|NCT02113982|454907591|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
126438571|NCT02113982|454907592|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
126438572|NCT02113982|454907593|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
126438573|NCT02113982|454907580|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126438574|NCT02113982|454907581|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126438575|NCT02113982|454907582|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126438576|NCT02113982|454907583|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126438577|NCT02113982|454907584|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126438578|NCT02113982|454907585|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126438579|NCT02113982|454907586|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126438580|NCT02113982|454907587|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126438581|NCT02113982|454907588|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126438582|NCT02113982|454907589|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126438583|NCT02113982|454907590|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126438584|NCT02113982|454907591|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
126438585|NCT02113982|454907592|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
126438586|NCT02113982|454907593|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
126438587|NCT02113982|454907580|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
126438588|NCT02113982|454907581|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
126438589|NCT02113982|454907582|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
126438590|NCT02113982|454907583|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
126438591|NCT02113982|454907584|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
126438592|NCT02113982|454907585|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
126438593|NCT02113982|454907586|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
126438594|NCT02113982|454907587|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
126545392|NCT02541383|455290828|FG005|Overall Study|Lost to Follow-up|0|||
126688060|NCT01928381|455813099|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
126350366|NCT05696847|454575318|FG002|Overall Study|Withdrawal by Subject|0|||
126350367|NCT05696847|454575319|FG003|Overall Study|Withdrawal by Subject|0|||
126350368|NCT05696847|454575320|FG004|Overall Study|Withdrawal by Subject|0|||
126688061|NCT01928381|455813100|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
126350369|NCT05696847|454575321|FG005|Overall Study|Withdrawal by Subject|0|||
126350370|NCT05696847|454575316|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126350371|NCT05696847|454575317|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126350372|NCT05696847|454575318|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126350373|NCT05696847|454575319|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126350374|NCT05696847|454575320|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126350375|NCT05696847|454575321|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126350376|NCT05696847|454575316|FG000|Overall Study|Adverse Event|0|||
126350377|NCT05696847|454575317|FG001|Overall Study|Adverse Event|0|||
126350378|NCT05696847|454575318|FG002|Overall Study|Adverse Event|0|||
126350379|NCT05696847|454575319|FG003|Overall Study|Adverse Event|0|||
126350380|NCT05696847|454575320|FG004|Overall Study|Adverse Event|0|||
126350381|NCT05696847|454575321|FG005|Overall Study|Adverse Event|1|||
126350382|NCT05696847|454575316|FG000|Overall Study|Sponsor Decision|0|||
126350383|NCT05696847|454575317|FG001|Overall Study|Sponsor Decision|0|||
126350384|NCT05696847|454575318|FG002|Overall Study|Sponsor Decision|0|||
126350385|NCT05696847|454575319|FG003|Overall Study|Sponsor Decision|1|||
126350386|NCT05696847|454575320|FG004|Overall Study|Sponsor Decision|0|||
126350387|NCT05696847|454575321|FG005|Overall Study|Sponsor Decision|0|||
126350388|NCT03323502|454575322|FG000|Overall Study|Resident could not be linked to CMS data|594|||
126350389|NCT03323502|454575323|FG001|Overall Study|Resident could not be linked to CMS data|435|||
126350390|NCT03323502|454575322|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
126350391|NCT03323502|454575323|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
126438595|NCT02113982|454907588|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
126688062|NCT01928381|455813101|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
126688063|NCT01928381|455813102|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
126688064|NCT01928381|455813103|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
126688065|NCT01928381|455813097|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
126688066|NCT01928381|455813098|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
126688067|NCT01928381|455813099|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
126688068|NCT01928381|455813100|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
126688069|NCT01928381|455813101|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
126688070|NCT01928381|455813102|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
126688071|NCT01928381|455813103|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
126688072|NCT01928381|455813097|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
126688073|NCT01928381|455813098|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
126688074|NCT01928381|455813099|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
126688075|NCT01928381|455813100|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
126688076|NCT01928381|455813101|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
126688077|NCT01928381|455813102|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
126688078|NCT01928381|455813103|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
126688079|NCT01928381|455813097|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
126688080|NCT01928381|455813098|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
126688081|NCT01928381|455813099|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
126688082|NCT01928381|455813100|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
126688083|NCT01928381|455813101|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
126688084|NCT01928381|455813102|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
126688085|NCT01928381|455813103|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
126688086|NCT01928381|455813097|FG000|Part 1 - Pain Training|Protocol Violation|1|||
126688087|NCT01928381|455813098|FG001|Part 1 - Pain Training|Protocol Violation|0|||
126688088|NCT01928381|455813099|FG002|Part 1 - Pain Training|Protocol Violation|0|||
126688089|NCT01928381|455813100|FG003|Part 1 - Pain Training|Protocol Violation|0|||
126688090|NCT01928381|455813101|FG004|Part 1 - Pain Training|Protocol Violation|0|||
126688091|NCT01928381|455813102|FG005|Part 1 - Pain Training|Protocol Violation|0|||
126688092|NCT01928381|455813103|FG006|Part 1 - Pain Training|Protocol Violation|0|||
126688093|NCT01928381|455813097|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
126688094|NCT01928381|455813098|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
126688095|NCT01928381|455813099|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
126688096|NCT01928381|455813100|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
126688097|NCT01928381|455813101|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
126688098|NCT01928381|455813102|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
126688099|NCT01928381|455813103|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
126688100|NCT01928381|455813097|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
126688101|NCT01928381|455813098|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
126688102|NCT01928381|455813099|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
126688103|NCT01928381|455813100|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
126688104|NCT01928381|455813101|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
126688105|NCT01928381|455813102|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
126688106|NCT01928381|455813103|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
126688107|NCT01928381|455813097|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
126688108|NCT01928381|455813098|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
126688109|NCT01928381|455813099|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
126688110|NCT01928381|455813100|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
126688111|NCT01928381|455813101|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
126688112|NCT01928381|455813102|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
126688113|NCT01928381|455813103|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
126688114|NCT01928381|455813097|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
126688115|NCT01928381|455813098|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
126688116|NCT01928381|455813099|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
126688117|NCT01928381|455813100|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
126688118|NCT01928381|455813101|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
126688119|NCT01928381|455813102|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
126688120|NCT01928381|455813103|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
126688121|NCT01928381|455813097|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
126688122|NCT01928381|455813098|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
126688123|NCT01928381|455813099|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
126688124|NCT01928381|455813100|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
126369494|NCT00876447|454650571|FG000|Overall Study|Lost to Follow-up|6|||
126369495|NCT00876447|454650572|FG001|Overall Study|Lost to Follow-up|15|||
126369496|NCT00876447|454650571|FG000|Overall Study|Pregnancy|4|||
126369497|NCT00876447|454650572|FG001|Overall Study|Pregnancy|2|||
126369498|NCT00876447|454650571|FG000|Overall Study|Lack of Efficacy|5|||
126350392|NCT03323502|454575322|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
126369499|NCT00876447|454650572|FG001|Overall Study|Lack of Efficacy|3|||
126438596|NCT02113982|454907589|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
126688125|NCT01928381|455813101|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
126688126|NCT01928381|455813102|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
126688127|NCT01928381|455813103|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
126688128|NCT01928381|455813097|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
126688129|NCT01928381|455813098|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
126688130|NCT01928381|455813099|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
126688131|NCT01928381|455813100|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
126688132|NCT01928381|455813101|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
126688133|NCT01928381|455813102|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
126688134|NCT01928381|455813103|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
126688135|NCT01928381|455813097|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
126688136|NCT01928381|455813098|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
126688137|NCT01928381|455813099|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
126688138|NCT01928381|455813100|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
126688139|NCT01928381|455813101|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
126688140|NCT01928381|455813102|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
126688141|NCT01928381|455813103|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
126688142|NCT01928381|455813097|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
126688143|NCT01928381|455813098|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
126688144|NCT01928381|455813099|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
126688145|NCT01928381|455813100|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
126688146|NCT01928381|455813101|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
126688147|NCT01928381|455813102|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
126688148|NCT01928381|455813103|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
126688149|NCT01928381|455813097|FG000|Washout First Intervention|Protocol Violation|0|||
126688150|NCT01928381|455813098|FG001|Washout First Intervention|Protocol Violation|0|||
126688151|NCT01928381|455813099|FG002|Washout First Intervention|Protocol Violation|0|||
126688152|NCT01928381|455813100|FG003|Washout First Intervention|Protocol Violation|0|||
126688153|NCT01928381|455813101|FG004|Washout First Intervention|Protocol Violation|1|||
126688154|NCT01928381|455813102|FG005|Washout First Intervention|Protocol Violation|0|||
126688155|NCT01928381|455813103|FG006|Washout First Intervention|Protocol Violation|0|||
126688156|NCT01928381|455813097|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
126688157|NCT01928381|455813098|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
126688158|NCT01928381|455813099|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
126688159|NCT01928381|455813100|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
126688160|NCT01928381|455813101|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
126688161|NCT01928381|455813102|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
126688162|NCT01928381|455813103|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
126688163|NCT01928381|455813097|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
126688164|NCT01928381|455813098|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
126688165|NCT01928381|455813099|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
126688166|NCT01928381|455813100|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
126688167|NCT01928381|455813101|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
126688168|NCT01928381|455813102|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
126688169|NCT01928381|455813103|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
126688170|NCT04441905|455815097|FG000|Overall Study|Lost to Follow-up|1|||
126688171|NCT04441905|455815098|FG001|Overall Study|Lost to Follow-up|0|||
126688172|NCT04441905|455815099|FG002|Overall Study|Lost to Follow-up|0|||
126688173|NCT04441905|455815100|FG003|Overall Study|Lost to Follow-up|0|||
126688174|NCT04441905|455815101|FG004|Overall Study|Lost to Follow-up|0|||
126688175|NCT04441905|455815102|FG005|Overall Study|Lost to Follow-up|0|||
126688176|NCT04441905|455815097|FG000|Overall Study|Enrolled but treatment not administered|0|||
126688177|NCT04441905|455815098|FG001|Overall Study|Enrolled but treatment not administered|1|||
126688178|NCT04441905|455815099|FG002|Overall Study|Enrolled but treatment not administered|0|||
126688179|NCT04441905|455815100|FG003|Overall Study|Enrolled but treatment not administered|0|||
126688180|NCT04441905|455815101|FG004|Overall Study|Enrolled but treatment not administered|0|||
126438597|NCT02113982|454907590|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
126688181|NCT04441905|455815102|FG005|Overall Study|Enrolled but treatment not administered|0|||
126688182|NCT04441905|455815097|FG000|Overall Study|Became ineligible after enrollment|0|||
126438598|NCT02113982|454907591|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
126688183|NCT04441905|455815098|FG001|Overall Study|Became ineligible after enrollment|0|||
126759877|NCT01399619|456070440|FG001|Overall Study|Withdrawal by Subject|0|||
126688184|NCT04441905|455815099|FG002|Overall Study|Became ineligible after enrollment|0|||
126350393|NCT03323502|454575323|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
126350394|NCT03323502|454575322|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
126350395|NCT03323502|454575323|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
126350396|NCT03323502|454575322|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
126688185|NCT04441905|455815100|FG003|Overall Study|Became ineligible after enrollment|0|||
126688186|NCT04441905|455815101|FG004|Overall Study|Became ineligible after enrollment|1|||
126688187|NCT04441905|455815102|FG005|Overall Study|Became ineligible after enrollment|0|||
126688188|NCT04770753|455815103|FG000|Overall Study|Randomized, never treated|1|||
126688189|NCT04770753|455815104|FG001|Overall Study|Randomized, never treated|1|||
126688190|NCT04770753|455815103|FG000|Overall Study|Withdrawal by Subject|3|||
126688191|NCT04770753|455815104|FG001|Overall Study|Withdrawal by Subject|1|||
126688192|NCT04770753|455815103|FG000|Overall Study|Adverse Event|2|||
126688193|NCT04770753|455815104|FG001|Overall Study|Adverse Event|0|||
126688194|NCT04770753|455815103|FG000|Overall Study|Pregnancy|1|||
126688195|NCT04770753|455815104|FG001|Overall Study|Pregnancy|0|||
126688196|NCT04770753|455815103|FG000|Overall Study|Other un-specified|1|||
126350397|NCT03323502|454575323|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
126350398|NCT00975923|454575324|FG000|Overall Study|Withdrawal by Subject|0|||
126350399|NCT00975923|454575325|FG001|Overall Study|Withdrawal by Subject|1|||
126350400|NCT05291689|454575328|FG000|Overall Study|Adverse Event|3|||
126438599|NCT02113982|454907592|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
126438600|NCT02113982|454907593|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
126688197|NCT04770753|455815104|FG001|Overall Study|Other un-specified|0|||
126688198|NCT02775851|455815105|FG000|Overall Study|Adverse Event|1|||
126688199|NCT02775851|455815106|FG001|Overall Study|Adverse Event|10|||
126688200|NCT02775851|455815105|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
126688201|NCT02775851|455815106|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
126438601|NCT02113982|454907580|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438602|NCT02113982|454907581|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438603|NCT02113982|454907582|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438604|NCT02113982|454907583|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438605|NCT02113982|454907584|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438606|NCT02113982|454907585|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438607|NCT02113982|454907586|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438608|NCT02113982|454907587|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438609|NCT02113982|454907588|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438610|NCT02113982|454907589|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438611|NCT02113982|454907590|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438612|NCT02113982|454907591|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438613|NCT02113982|454907592|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
126438614|NCT02113982|454907593|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
126438615|NCT02113982|454907580|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438616|NCT02113982|454907581|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438617|NCT02113982|454907582|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438618|NCT02113982|454907583|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438619|NCT02113982|454907584|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438620|NCT02113982|454907585|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438621|NCT02113982|454907586|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438622|NCT02113982|454907587|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438623|NCT02113982|454907588|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438624|NCT02113982|454907589|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438625|NCT02113982|454907590|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438626|NCT02113982|454907591|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438627|NCT02113982|454907592|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
126438628|NCT02113982|454907593|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
126438629|NCT02113982|454907580|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126438630|NCT02113982|454907581|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126438631|NCT02113982|454907582|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126688202|NCT02775851|455815105|FG000|Overall Study|Progression/Relapse|0|||
126688203|NCT02775851|455815106|FG001|Overall Study|Progression/Relapse|4|||
126438632|NCT02113982|454907583|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126350401|NCT05291689|454575328|FG000|Overall Study|Lack of Efficacy|10|||
126350402|NCT05291689|454575328|FG000|Overall Study|Withdrawal by Subject|4|||
126350403|NCT02278354|454575329|FG000|Overall Study|Lost to Follow-up|2|||
126350404|NCT02278354|454575330|FG001|Overall Study|Lost to Follow-up|2|||
126350405|NCT02278354|454575329|FG000|Overall Study|Withdrawal by Subject|0|||
126350406|NCT02278354|454575330|FG001|Overall Study|Withdrawal by Subject|1|||
126759878|NCT01399619|456070441|FG002|Overall Study|Withdrawal by Subject|3|||
126759879|NCT01399619|456070442|FG003|Overall Study|Withdrawal by Subject|4|||
126759880|NCT01399619|456070439|FG000|Overall Study|Protocol Violation|0|||
126759881|NCT01399619|456070440|FG001|Overall Study|Protocol Violation|0|||
126350407|NCT02278354|454575329|FG000|Overall Study|<10 professional fights|2|||
126759882|NCT01399619|456070441|FG002|Overall Study|Protocol Violation|0|||
126759883|NCT01399619|456070442|FG003|Overall Study|Protocol Violation|1|||
126759884|NCT01399619|456070439|FG000|Overall Study|Not treated|0|||
126759885|NCT01399619|456070440|FG001|Overall Study|Not treated|0|||
126759886|NCT01399619|456070441|FG002|Overall Study|Not treated|0|||
126759887|NCT01399619|456070442|FG003|Overall Study|Not treated|2|||
126759888|NCT01980056|456070443|FG000|Overall Study|Death|1|||
126759889|NCT01980056|456070444|FG001|Overall Study|Death|1|||
126759890|NCT01980056|456070445|FG002|Overall Study|Death|0|||
126759891|NCT00408408|456070446|FG000|Overall Study|No follow up data|2|||
126759892|NCT00408408|456070447|FG001|Overall Study|No follow up data|3|||
126759893|NCT00408408|456070448|FG002|Overall Study|No follow up data|0|||
126759894|NCT00408408|456070449|FG003|Overall Study|No follow up data|7|||
126759895|NCT00408408|456070450|FG004|Overall Study|No follow up data|5|||
126759896|NCT00408408|456070451|FG005|Overall Study|No follow up data|3|||
126759897|NCT00399542|456070456|FG000|Overall Study|Adverse Event|18|||
126759898|NCT00399542|456070457|FG001|Overall Study|Adverse Event|15|||
126759899|NCT00399542|456070456|FG000|Overall Study|Protocol Violation|13|||
126759900|NCT00399542|456070457|FG001|Overall Study|Protocol Violation|3|||
126759901|NCT00399542|456070456|FG000|Overall Study|Withdrawal by Subject|28|||
126759902|NCT00399542|456070457|FG001|Overall Study|Withdrawal by Subject|10|||
126759903|NCT00399542|456070456|FG000|Overall Study|Lack of Efficacy|18|||
126759904|NCT00399542|456070457|FG001|Overall Study|Lack of Efficacy|8|||
126759905|NCT00399542|456070456|FG000|Overall Study|Lost to Follow-up|6|||
126759906|NCT00399542|456070457|FG001|Overall Study|Lost to Follow-up|6|||
126759907|NCT00399542|456070456|FG000|Overall Study|Other|1|||
126759908|NCT00399542|456070457|FG001|Overall Study|Other|0|||
126759909|NCT00399542|456070456|FG000|Overall Study|Physician Decision|0|||
126759910|NCT00399542|456070457|FG001|Overall Study|Physician Decision|1|||
126759911|NCT03172026|456070458|FG000|Overall Study|Withdrawal by Subject|1|||
126759912|NCT03172026|456070459|FG001|Overall Study|Withdrawal by Subject|0|||
126759913|NCT03172026|456070458|FG000|Overall Study|COVID restrictions|1|||
126759914|NCT03172026|456070459|FG001|Overall Study|COVID restrictions|0|||
126759915|NCT00265109|456070460|FG000|Overall Study|Withdrawal by Subject|5|||
126759916|NCT00265109|456070460|FG000|Overall Study|Adverse Event|1|||
126759917|NCT02463097|456070461|FG000|Overall Study|Withdrawal by Subject|1|||
126759918|NCT01757821|456070462|FG000|Overall Study|Adverse Event|1|||
126759919|NCT00334893|456070463|FG000|Overall Study|Not Treated|1|||
126759920|NCT00334893|456070464|FG001|Overall Study|Not Treated|0|||
126759921|NCT01552408|456070468|FG000|Overall Study|Lost to Follow-up|2|||
126759922|NCT01552408|456070469|FG001|Overall Study|Lost to Follow-up|0|||
126759923|NCT01552408|456070468|FG000|Overall Study|Relocation|0|||
126759924|NCT01552408|456070469|FG001|Overall Study|Relocation|1|||
126759925|NCT01552408|456070468|FG000|Overall Study|Withdrawal by Subject|2|||
126759926|NCT01552408|456070469|FG001|Overall Study|Withdrawal by Subject|1|||
126759927|NCT00606931|456070471|FG000|Overall Study|Withdrawal by Subject|3|||
126759928|NCT02924129|456070485|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
126759929|NCT02924129|456070486|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
126759930|NCT02924129|456070485|FG000|Overall Study|Withdrawal by Subject|2|||
126759931|NCT02924129|456070486|FG001|Overall Study|Withdrawal by Subject|2|||
126759932|NCT02924129|456070485|FG000|Overall Study|Physician Decision|1|||
126759933|NCT02924129|456070486|FG001|Overall Study|Physician Decision|0|||
126759934|NCT02924129|456070485|FG000|Overall Study|Missed Visit|0|||
126759935|NCT02924129|456070486|FG001|Overall Study|Missed Visit|1|||
126759936|NCT01348828|456070488|FG000|Overall Study|Death|20|||
126759937|NCT01348828|456070488|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
126759938|NCT01348828|456070488|FG000|Overall Study|Conversion|2|||
126759939|NCT01348828|456070488|FG000|Overall Study|missed visit|1|||
126759940|NCT00302731|456070489|FG000|Overall Study|Lost to Follow-up|1|||
126759941|NCT00302731|456070490|FG001|Overall Study|Lost to Follow-up|2|||
126759942|NCT00302731|456070491|FG002|Overall Study|Lost to Follow-up|0|||
126759943|NCT00302731|456070492|FG003|Overall Study|Lost to Follow-up|0|||
126759944|NCT00302731|456070489|FG000|Overall Study|Adverse Event|0|||
126759945|NCT00302731|456070490|FG001|Overall Study|Adverse Event|2|||
126759946|NCT00302731|456070491|FG002|Overall Study|Adverse Event|2|||
126759947|NCT00302731|456070492|FG003|Overall Study|Adverse Event|0|||
126759948|NCT00302731|456070489|FG000|Overall Study|Withdrawal by Subject|1|||
126759949|NCT00302731|456070490|FG001|Overall Study|Withdrawal by Subject|1|||
126759950|NCT00302731|456070491|FG002|Overall Study|Withdrawal by Subject|0|||
126759951|NCT00302731|456070492|FG003|Overall Study|Withdrawal by Subject|0|||
126688204|NCT02775851|455815105|FG000|Overall Study|Other - Not Protocol Specified|0|||
126688205|NCT02775851|455815106|FG001|Overall Study|Other - Not Protocol Specified|7|||
126688206|NCT02775851|455815105|FG000|Overall Study|Withdrawal by Subject|1|||
126688207|NCT02775851|455815106|FG001|Overall Study|Withdrawal by Subject|0|||
126688208|NCT03266016|455815110|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
126688209|NCT03266016|455815111|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
126688210|NCT03266016|455815112|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
126688211|NCT03266016|455815113|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
126688212|NCT03266016|455815110|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
126688213|NCT03266016|455815111|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
126688214|NCT03266016|455815112|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
126688215|NCT03266016|455815113|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
126688216|NCT00482014|455815114|FG000|Overall Study|Withdrawal by Subject|1|||
126688217|NCT00482014|455815115|FG001|Overall Study|Withdrawal by Subject|2|||
126688218|NCT00482014|455815116|FG002|Overall Study|Withdrawal by Subject|3|||
126688219|NCT00482014|455815117|FG003|Overall Study|Withdrawal by Subject|4|||
126688220|NCT00482014|455815114|FG000|Overall Study|Adverse Event|3|||
126688221|NCT00482014|455815115|FG001|Overall Study|Adverse Event|0|||
126688222|NCT00482014|455815116|FG002|Overall Study|Adverse Event|2|||
126688223|NCT00482014|455815117|FG003|Overall Study|Adverse Event|8|||
126688224|NCT00482014|455815114|FG000|Overall Study|Death|1|||
126688225|NCT00482014|455815115|FG001|Overall Study|Death|2|||
126688226|NCT00482014|455815116|FG002|Overall Study|Death|1|||
126688227|NCT00482014|455815117|FG003|Overall Study|Death|4|||
126688228|NCT00482014|455815114|FG000|Overall Study|Lack of Efficacy|1|||
126688229|NCT00482014|455815115|FG001|Overall Study|Lack of Efficacy|0|||
126688230|NCT00482014|455815116|FG002|Overall Study|Lack of Efficacy|4|||
126688231|NCT00482014|455815117|FG003|Overall Study|Lack of Efficacy|6|||
126688232|NCT00482014|455815114|FG000|Overall Study|Sponsor Decision|1|||
126688233|NCT00482014|455815115|FG001|Overall Study|Sponsor Decision|2|||
126688234|NCT00482014|455815116|FG002|Overall Study|Sponsor Decision|1|||
126688235|NCT00482014|455815117|FG003|Overall Study|Sponsor Decision|1|||
126688236|NCT03686397|455815118|FG000|Overall Study|Lack of Efficacy|3|||
126688237|NCT03686397|455815119|FG001|Overall Study|Lack of Efficacy|5|||
126688238|NCT03686397|455815118|FG000|Overall Study|Adverse Event|0|||
126688239|NCT03686397|455815119|FG001|Overall Study|Adverse Event|1|||
126688240|NCT03686397|455815118|FG000|Overall Study|Protocol Violation|0|||
126688241|NCT03686397|455815119|FG001|Overall Study|Protocol Violation|1|||
126688242|NCT03686397|455815118|FG000|Overall Study|Withdrawal by Subject|0|||
126688243|NCT03686397|455815119|FG001|Overall Study|Withdrawal by Subject|1|||
126688244|NCT03686397|455815118|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
126688245|NCT03686397|455815119|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
126688246|NCT03718143|455815126|FG000|Overall Study|Death|1|||
126688247|NCT03718143|455815127|FG001|Overall Study|Death|0|||
126688248|NCT03718143|455815128|FG002|Overall Study|Death|0|||
126688249|NCT03718143|455815126|FG000|Overall Study|Progression of Disease|1|||
126688250|NCT03718143|455815127|FG001|Overall Study|Progression of Disease|0|||
126688251|NCT03718143|455815128|FG002|Overall Study|Progression of Disease|0|||
126688252|NCT03718143|455815126|FG000|Overall Study|Withdrawal of Informed Consent|1|||
126688253|NCT03718143|455815127|FG001|Overall Study|Withdrawal of Informed Consent|2|||
126688254|NCT03718143|455815128|FG002|Overall Study|Withdrawal of Informed Consent|1|||
126688255|NCT05064059|455815129|FG000|Overall Study|Death|199|||
126688256|NCT05064059|455815130|FG001|Overall Study|Death|196|||
126688257|NCT05064059|455815129|FG000|Overall Study|Physician Decision|4|||
126688258|NCT05064059|455815130|FG001|Overall Study|Physician Decision|2|||
126688259|NCT05064059|455815129|FG000|Overall Study|Sponsor Decision|14|||
126688260|NCT05064059|455815130|FG001|Overall Study|Sponsor Decision|11|||
126688261|NCT05064059|455815129|FG000|Overall Study|Withdrawal by Subject|4|||
126688262|NCT05064059|455815130|FG001|Overall Study|Withdrawal by Subject|11|||
126688263|NCT01934140|455815131|FG000|Persistence Phase (Year 6-10)|Other|24|||
126688264|NCT01934140|455815132|FG001|Persistence Phase (Year 6-10)|Other|6|||
126688265|NCT01934140|455815131|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
126688266|NCT01934140|455815132|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
126688267|NCT01934140|455815131|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
126688268|NCT01934140|455815132|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
126688269|NCT01934140|455815131|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
126688270|NCT01934140|455815132|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
126688271|NCT01934140|455815131|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
126688272|NCT01934140|455815132|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
126688273|NCT01934140|455815131|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
126688274|NCT01934140|455815132|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
126688275|NCT01934140|455815131|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
126688276|NCT01934140|455815132|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
126688277|NCT01934140|455815131|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
126350408|NCT02278354|454575330|FG001|Overall Study|<10 professional fights|0|||
126350409|NCT02612155|454575332|FG000|Overall Study|Death|1|||
126350410|NCT02612155|454575333|FG001|Overall Study|Death|1|||
126688278|NCT01934140|455815132|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
126688279|NCT00200850|455815133|FG000|Overall Study|relocation|1|||
126350411|NCT02612155|454575332|FG000|Overall Study|Lost to Follow-up|2|||
126350412|NCT02612155|454575333|FG001|Overall Study|Lost to Follow-up|2|||
126350413|NCT04435626|454575336|FG000|Overall Study|Lost to Follow-up|1|||
126438633|NCT02113982|454907584|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126688280|NCT00200850|455815134|FG001|Overall Study|relocation|0|||
126688281|NCT00200850|455815135|FG002|Overall Study|relocation|1|||
126688282|NCT00200850|455815133|FG000|Overall Study|too busy|1|||
126688283|NCT00200850|455815134|FG001|Overall Study|too busy|0|||
126688284|NCT00200850|455815135|FG002|Overall Study|too busy|0|||
126438634|NCT02113982|454907585|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126688285|NCT00200850|455815133|FG000|Overall Study|Pregnancy|0|||
126688286|NCT00200850|455815134|FG001|Overall Study|Pregnancy|0|||
126688287|NCT00200850|455815135|FG002|Overall Study|Pregnancy|1|||
126688288|NCT00200850|455815133|FG000|Overall Study|Poor adherence|0|||
126688289|NCT00200850|455815134|FG001|Overall Study|Poor adherence|0|||
126688290|NCT00200850|455815135|FG002|Overall Study|Poor adherence|1|||
126688291|NCT00200850|455815133|FG000|Overall Study|optic neuritis|0|||
126688292|NCT00200850|455815134|FG001|Overall Study|optic neuritis|0|||
126688293|NCT00200850|455815135|FG002|Overall Study|optic neuritis|1|||
126688294|NCT00200850|455815133|FG000|Overall Study|Adverse Event|1|||
126688295|NCT00200850|455815134|FG001|Overall Study|Adverse Event|1|||
126688296|NCT00200850|455815135|FG002|Overall Study|Adverse Event|2|||
126688297|NCT00805740|455815136|FG000|Overall Study|Death|7|||
126688298|NCT00805740|455815137|FG001|Overall Study|Death|4|||
126688299|NCT00805740|455815136|FG000|Overall Study|Withdrawal by Subject|1|||
126688300|NCT00805740|455815137|FG001|Overall Study|Withdrawal by Subject|0|||
126688301|NCT00805740|455815136|FG000|Overall Study|Lost to Follow-up|1|||
126688302|NCT00805740|455815137|FG001|Overall Study|Lost to Follow-up|0|||
126688303|NCT00805740|455815136|FG000|Overall Study|Randomized, but not treated|2|||
126688304|NCT00805740|455815137|FG001|Overall Study|Randomized, but not treated|0|||
126688305|NCT02595879|455815138|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
126688306|NCT02595879|455815139|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
126688307|NCT04294459|455815140|FG000|Overall Study|Adverse Event|0|||
126688308|NCT04294459|455815141|FG001|Overall Study|Adverse Event|1|||
126688309|NCT01534676|455815142|FG000|Overall Study|Study closed due to poor enrollment|2|||
126688310|NCT01534676|455815143|FG001|Overall Study|Study closed due to poor enrollment|1|||
126688311|NCT02908880|455815145|FG000|Overall Study|Lost to Follow-up|4|||
126688312|NCT02908880|455815145|FG000|Overall Study|Explantation of the device|1|||
126688313|NCT02908880|455815145|FG000|Overall Study|Withdrawal by Subject|17|||
126688314|NCT02908880|455815145|FG000|Overall Study|Death|5|||
126688315|NCT03823391|455815149|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
126688316|NCT03823391|455815150|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
126688317|NCT03823391|455815149|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
126688318|NCT03823391|455815150|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
126759952|NCT00302731|456070489|FG000|Overall Study|Protocol Violation|1|||
126350414|NCT04435626|454575337|FG001|Overall Study|Lost to Follow-up|5|||
126688319|NCT02450487|455815151|FG000|Overall Study|Lost to Follow-up|3|||
126688320|NCT01790048|455815152|FG000|Overall Study|Incorrect Age|9|||
126759953|NCT00302731|456070490|FG001|Overall Study|Protocol Violation|0|||
126759954|NCT00302731|456070491|FG002|Overall Study|Protocol Violation|0|||
126688321|NCT01790048|455815153|FG001|Overall Study|Incorrect Age|14|||
126688322|NCT01790048|455815152|FG000|Overall Study|data entry error|0|||
126688323|NCT01790048|455815153|FG001|Overall Study|data entry error|1|||
126688324|NCT01790048|455815152|FG000|Overall Study|Other|0|||
126688325|NCT01790048|455815153|FG001|Overall Study|Other|2|||
126688326|NCT01790048|455815152|FG000|Overall Study|SAM at Enrollment|2|||
126688327|NCT01790048|455815153|FG001|Overall Study|SAM at Enrollment|0|||
126688328|NCT01790048|455815152|FG000|Overall Study|Measurement error|1|||
126688329|NCT01790048|455815153|FG001|Overall Study|Measurement error|0|||
126688330|NCT05030311|455815154|FG000|Overall Study|Technical problems|0|||
126688331|NCT05030311|455815155|FG001|Overall Study|Technical problems|1|||
126688332|NCT05030311|455815154|FG000|Overall Study|Withdrawal by Subject|31|||
126688333|NCT05030311|455815155|FG001|Overall Study|Withdrawal by Subject|17|||
126688334|NCT05030311|455815154|FG000|Overall Study|Adverse Event|13|||
126688335|NCT05030311|455815155|FG001|Overall Study|Adverse Event|5|||
126688336|NCT05030311|455815154|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126688337|NCT05030311|455815155|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126688338|NCT05030311|455815154|FG000|Overall Study|Physician Decision|5|||
126688339|NCT05030311|455815155|FG001|Overall Study|Physician Decision|2|||
126688340|NCT05030311|455815154|FG000|Overall Study|Lost to Follow-up|5|||
126688341|NCT05030311|455815155|FG001|Overall Study|Lost to Follow-up|1|||
126350415|NCT04435626|454575336|FG000|Overall Study|Withdrawal by Subject|6|||
126350416|NCT04435626|454575337|FG001|Overall Study|Withdrawal by Subject|7|||
126350417|NCT04435626|454575336|FG000|Overall Study|major GCP violations|8|||
126350418|NCT04435626|454575337|FG001|Overall Study|major GCP violations|7|||
126350419|NCT02864992|454575341|FG000|Overall Study|still on treatment|15|||
126350420|NCT02864992|454575342|FG001|Overall Study|still on treatment|1|||
126350421|NCT02864992|454575343|FG002|Overall Study|still on treatment|33|||
126350422|NCT05252702|454575344|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
126350423|NCT05252702|454575344|FG000|Overall Study|Death|16|||
126688342|NCT05030311|455815154|FG000|Overall Study|Protocol Violation|4|||
126350424|NCT05252702|454575344|FG000|Overall Study|System explant|5|||
126350425|NCT05252702|454575344|FG000|Overall Study|Lost to Follow-up|1|||
126350426|NCT05252702|454575344|FG000|Overall Study|Withdrawn by investigator|1|||
126688343|NCT05030311|455815155|FG001|Overall Study|Protocol Violation|4|||
126688344|NCT03042468|455815156|FG000|Overall Study|Death|0|||
126688345|NCT03042468|455815157|FG001|Overall Study|Death|1|||
126350427|NCT05252702|454575344|FG000|Overall Study|Visit not due|306|||
126350428|NCT05252702|454575344|FG000|Overall Study|Visit within window but not completed|92|||
126350429|NCT05252702|454575344|FG000|Overall Study|Unsuccessful implant|1|||
126350430|NCT00098475|454575350|FG000|Step 1|Progressive disease|33|||
126350431|NCT00098475|454575351|FG001|Step 1|Progressive disease|35|||
126688346|NCT03042468|455815158|FG002|Overall Study|Death|1|||
126688347|NCT03042468|455815159|FG003|Overall Study|Death|0|||
126688348|NCT03042468|455815160|FG004|Overall Study|Death|0|||
126688349|NCT03042468|455815161|FG005|Overall Study|Death|0|||
126688350|NCT03042468|455815156|FG000|Overall Study|Withdrawal by Subject|0|||
126688351|NCT03042468|455815157|FG001|Overall Study|Withdrawal by Subject|0|||
126350432|NCT00098475|454575352|FG002|Step 1|Progressive disease|2|||
126350433|NCT00098475|454575353|FG003|Step 1|Progressive disease|1|||
126350434|NCT00098475|454575350|FG000|Step 1|Adverse Event|56|||
126350435|NCT00098475|454575351|FG001|Step 1|Adverse Event|37|||
126350436|NCT00098475|454575352|FG002|Step 1|Adverse Event|0|||
126350437|NCT00098475|454575353|FG003|Step 1|Adverse Event|1|||
126350438|NCT00098475|454575350|FG000|Step 1|Death|8|||
126350439|NCT00098475|454575351|FG001|Step 1|Death|5|||
126688352|NCT03042468|455815158|FG002|Overall Study|Withdrawal by Subject|0|||
126688353|NCT03042468|455815159|FG003|Overall Study|Withdrawal by Subject|0|||
126688354|NCT03042468|455815160|FG004|Overall Study|Withdrawal by Subject|0|||
126688355|NCT03042468|455815161|FG005|Overall Study|Withdrawal by Subject|1|||
126688356|NCT03042468|455815156|FG000|Overall Study|Lost to Follow-up|0|||
126688357|NCT03042468|455815157|FG001|Overall Study|Lost to Follow-up|0|||
126688358|NCT03042468|455815158|FG002|Overall Study|Lost to Follow-up|0|||
126688359|NCT03042468|455815159|FG003|Overall Study|Lost to Follow-up|0|||
126688360|NCT03042468|455815160|FG004|Overall Study|Lost to Follow-up|1|||
126688361|NCT03042468|455815161|FG005|Overall Study|Lost to Follow-up|1|||
126688362|NCT02062658|455815166|FG000|Overall Study|Withdrawal by Subject|1|||
126688363|NCT02062658|455815166|FG000|Overall Study|Lack of Efficacy|1|||
126350440|NCT00098475|454575352|FG002|Step 1|Death|0|||
126688364|NCT02161562|455815167|FG000|Overall Study|Withdrawal by Subject|5|||
126350441|NCT00098475|454575353|FG003|Step 1|Death|1|||
126350442|NCT00098475|454575350|FG000|Step 1|Withdrawal by Subject|14|||
126350443|NCT00098475|454575351|FG001|Step 1|Withdrawal by Subject|11|||
126350444|NCT00098475|454575352|FG002|Step 1|Withdrawal by Subject|0|||
126350445|NCT00098475|454575353|FG003|Step 1|Withdrawal by Subject|0|||
126350446|NCT00098475|454575350|FG000|Step 1|Physician Decision|5|||
126759955|NCT00302731|456070492|FG003|Overall Study|Protocol Violation|0|||
126759956|NCT00302731|456070489|FG000|Overall Study|cancer unrelated to study discovered|1|||
126759957|NCT00302731|456070490|FG001|Overall Study|cancer unrelated to study discovered|0|||
126759958|NCT00302731|456070491|FG002|Overall Study|cancer unrelated to study discovered|1|||
126759959|NCT00302731|456070492|FG003|Overall Study|cancer unrelated to study discovered|0|||
126759960|NCT01000311|456070493|FG000|Overall Study|Adverse Event|2|||
126759961|NCT01000311|456070494|FG001|Overall Study|Adverse Event|5|||
126350447|NCT00098475|454575351|FG001|Step 1|Physician Decision|2|||
126350448|NCT00098475|454575352|FG002|Step 1|Physician Decision|0|||
126438635|NCT02113982|454907586|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126350449|NCT00098475|454575353|FG003|Step 1|Physician Decision|0|||
126350450|NCT00098475|454575350|FG000|Step 1|Alternative therapy|31|||
126350451|NCT00098475|454575351|FG001|Step 1|Alternative therapy|43|||
126688365|NCT02161562|455815168|FG001|Overall Study|Withdrawal by Subject|8|||
126438636|NCT02113982|454907587|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126438637|NCT02113982|454907588|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126438638|NCT02113982|454907589|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126438639|NCT02113982|454907590|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126438640|NCT02113982|454907591|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126438641|NCT02113982|454907592|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
126438642|NCT02113982|454907593|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
126438643|NCT01774721|454907594|FG000|Overall Study|Death|133|||
126688366|NCT02161562|455815167|FG000|Overall Study|Protocol Violation|9|||
126688367|NCT02161562|455815168|FG001|Overall Study|Protocol Violation|4|||
126688368|NCT02161562|455815167|FG000|Overall Study|Pregnancy|1|||
126438644|NCT01774721|454907595|FG001|Overall Study|Death|152|||
126438645|NCT01774721|454907594|FG000|Overall Study|Withdrawal by Subject|20|||
126438646|NCT01774721|454907595|FG001|Overall Study|Withdrawal by Subject|14|||
126350452|NCT00098475|454575352|FG002|Step 1|Alternative therapy|1|||
126350453|NCT00098475|454575353|FG003|Step 1|Alternative therapy|0|||
126350454|NCT00098475|454575350|FG000|Step 1|Other disease|2|||
126350455|NCT00098475|454575351|FG001|Step 1|Other disease|1|||
126350456|NCT00098475|454575352|FG002|Step 1|Other disease|1|||
126350457|NCT00098475|454575353|FG003|Step 1|Other disease|0|||
126350458|NCT00098475|454575350|FG000|Step 1|Never started treatment|0|||
126350459|NCT00098475|454575351|FG001|Step 1|Never started treatment|2|||
126350460|NCT00098475|454575352|FG002|Step 1|Never started treatment|0|||
126350461|NCT00098475|454575353|FG003|Step 1|Never started treatment|0|||
126350462|NCT00098475|454575350|FG000|Step 1|Still on treatment as of this analysis|14|||
126350463|NCT00098475|454575351|FG001|Step 1|Still on treatment as of this analysis|27|||
126350464|NCT00098475|454575352|FG002|Step 1|Still on treatment as of this analysis|0|||
126350465|NCT00098475|454575353|FG003|Step 1|Still on treatment as of this analysis|0|||
126350466|NCT00098475|454575350|FG000|Step 1|Knee surgery|1|||
126350467|NCT00098475|454575351|FG001|Step 1|Knee surgery|0|||
126350468|NCT00098475|454575352|FG002|Step 1|Knee surgery|0|||
126350469|NCT00098475|454575353|FG003|Step 1|Knee surgery|0|||
126350470|NCT00098475|454575350|FG000|Step 1|Complications|1|||
126350471|NCT00098475|454575351|FG001|Step 1|Complications|0|||
126350472|NCT00098475|454575352|FG002|Step 1|Complications|0|||
126350473|NCT00098475|454575353|FG003|Step 1|Complications|0|||
126350474|NCT00098475|454575350|FG000|Step 1|Cannot comply due to other tx|0|||
126350475|NCT00098475|454575351|FG001|Step 1|Cannot comply due to other tx|1|||
126350476|NCT00098475|454575352|FG002|Step 1|Cannot comply due to other tx|0|||
126350477|NCT00098475|454575353|FG003|Step 1|Cannot comply due to other tx|0|||
126350478|NCT00098475|454575350|FG000|Step 1|Both patient and physician's decision|2|||
126350479|NCT00098475|454575351|FG001|Step 1|Both patient and physician's decision|1|||
126350480|NCT00098475|454575352|FG002|Step 1|Both patient and physician's decision|0|||
126350481|NCT00098475|454575353|FG003|Step 1|Both patient and physician's decision|0|||
126438647|NCT01774721|454907594|FG000|Overall Study|Lost to Follow-up|6|||
126350482|NCT00098475|454575350|FG000|Step 1|Incorrect disease assessment|2|||
126688369|NCT02161562|455815168|FG001|Overall Study|Pregnancy|2|||
126688370|NCT02161562|455815167|FG000|Overall Study|Lost to Follow-up|3|||
126350483|NCT00098475|454575351|FG001|Step 1|Incorrect disease assessment|0|||
126350484|NCT00098475|454575352|FG002|Step 1|Incorrect disease assessment|0|||
126350485|NCT00098475|454575353|FG003|Step 1|Incorrect disease assessment|0|||
126350486|NCT00098475|454575350|FG000|Step 1|Off treatment for > specified timeframe|1|||
126350487|NCT00098475|454575351|FG001|Step 1|Off treatment for > specified timeframe|1|||
126350488|NCT00098475|454575352|FG002|Step 1|Off treatment for > specified timeframe|0|||
126350489|NCT00098475|454575353|FG003|Step 1|Off treatment for > specified timeframe|0|||
126438648|NCT01774721|454907595|FG001|Overall Study|Lost to Follow-up|7|||
126438649|NCT01774721|454907594|FG000|Overall Study|Did not meet eligibility criteria|0|||
126688371|NCT02161562|455815168|FG001|Overall Study|Lost to Follow-up|1|||
126688372|NCT02161562|455815167|FG000|Overall Study|Lack of Efficacy|4|||
126688373|NCT02161562|455815168|FG001|Overall Study|Lack of Efficacy|1|||
126688374|NCT02161562|455815167|FG000|Overall Study|Adverse Event|1|||
126688375|NCT02161562|455815168|FG001|Overall Study|Adverse Event|1|||
126688376|NCT02161562|455815167|FG000|Overall Study|Participant moved back to home country|1|||
126688377|NCT02161562|455815168|FG001|Overall Study|Participant moved back to home country|0|||
126438650|NCT01774721|454907595|FG001|Overall Study|Did not meet eligibility criteria|3|||
126688378|NCT02161562|455815167|FG000|Overall Study|Withdrew due to being out of the country|1|||
126688379|NCT02161562|455815168|FG001|Overall Study|Withdrew due to being out of the country|0|||
126688380|NCT02161562|455815167|FG000|Overall Study|Participant moved out of province|1|||
126688381|NCT02161562|455815168|FG001|Overall Study|Participant moved out of province|0|||
126688382|NCT00608985|455815172|FG000|Overall Study|Adverse Event|2|||
126688383|NCT00608985|455815173|FG001|Overall Study|Adverse Event|7|||
126688384|NCT00608985|455815174|FG002|Overall Study|Adverse Event|4|||
126688385|NCT00608985|455815175|FG003|Overall Study|Adverse Event|6|||
126759962|NCT01000311|456070493|FG000|Overall Study|Withdrawal by Subject|16|||
126759963|NCT01000311|456070494|FG001|Overall Study|Withdrawal by Subject|24|||
126759964|NCT01000311|456070493|FG000|Overall Study|Lost to Follow-up|15|||
126759965|NCT01000311|456070494|FG001|Overall Study|Lost to Follow-up|24|||
126438651|NCT01774721|454907594|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
126438652|NCT01774721|454907595|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
126759966|NCT01000311|456070493|FG000|Overall Study|Protocol Violation|1|||
126759967|NCT01000311|456070494|FG001|Overall Study|Protocol Violation|2|||
126688386|NCT00608985|455815172|FG000|Overall Study|Administrative/Other|7|||
126688387|NCT00608985|455815173|FG001|Overall Study|Administrative/Other|4|||
126688388|NCT00608985|455815174|FG002|Overall Study|Administrative/Other|1|||
126688389|NCT00608985|455815175|FG003|Overall Study|Administrative/Other|2|||
126688390|NCT00608985|455815172|FG000|Overall Study|Withdrawal of Consent|5|||
126688391|NCT00608985|455815173|FG001|Overall Study|Withdrawal of Consent|1|||
126688392|NCT00608985|455815174|FG002|Overall Study|Withdrawal of Consent|1|||
126688393|NCT00608985|455815175|FG003|Overall Study|Withdrawal of Consent|1|||
126688394|NCT00608985|455815172|FG000|Overall Study|Lost to Follow-up|2|||
126688395|NCT00608985|455815173|FG001|Overall Study|Lost to Follow-up|1|||
126688396|NCT00608985|455815174|FG002|Overall Study|Lost to Follow-up|0|||
126688397|NCT00608985|455815175|FG003|Overall Study|Lost to Follow-up|0|||
126688398|NCT03033745|455815176|FG000|Overall Study|Protocol Violation|0|||
126688399|NCT03033745|455815177|FG001|Overall Study|Protocol Violation|0|||
126688400|NCT03033745|455815178|FG002|Overall Study|Protocol Violation|1|||
126688401|NCT03033745|455815176|FG000|Overall Study|Adverse Event|1|||
126688402|NCT03033745|455815177|FG001|Overall Study|Adverse Event|0|||
126350490|NCT00098475|454575350|FG000|Step 1|Declining performance status|0|||
126350491|NCT00098475|454575351|FG001|Step 1|Declining performance status|1|||
126350492|NCT00098475|454575352|FG002|Step 1|Declining performance status|0|||
126350493|NCT00098475|454575353|FG003|Step 1|Declining performance status|0|||
126350494|NCT00098475|454575350|FG000|Step 1|Insurance issue|0|||
126688403|NCT03033745|455815178|FG002|Overall Study|Adverse Event|1|||
126688404|NCT03033745|455815176|FG000|Overall Study|Withdrawal by Subject|0|||
126688405|NCT03033745|455815177|FG001|Overall Study|Withdrawal by Subject|1|||
126688406|NCT03033745|455815178|FG002|Overall Study|Withdrawal by Subject|0|||
126688407|NCT02450578|455815179|FG000|Overall Study|ECG abnormality so not treated|1|||
126688408|NCT02450578|455815180|FG001|Overall Study|ECG abnormality so not treated|0|||
126688409|NCT02450578|455815181|FG002|Overall Study|ECG abnormality so not treated|0|||
126688410|NCT02450578|455815182|FG003|Overall Study|ECG abnormality so not treated|0|||
126688411|NCT00662792|455815183|FG000|Period 1|Personal Reasons|0|||
126688412|NCT00662792|455815184|FG001|Period 1|Personal Reasons|0|||
126688413|NCT00662792|455815185|FG002|Period 1|Personal Reasons|1|||
126688414|NCT00662792|455815186|FG003|Period 1|Personal Reasons|0|||
126688415|NCT00662792|455815183|FG000|Period 1|Refused continuing medication|0|||
126688416|NCT00662792|455815184|FG001|Period 1|Refused continuing medication|1|||
126688417|NCT00662792|455815185|FG002|Period 1|Refused continuing medication|1|||
126688418|NCT00662792|455815186|FG003|Period 1|Refused continuing medication|0|||
126688419|NCT00662792|455815183|FG000|Period 1|Lost to Follow-up|1|||
126688420|NCT00662792|455815184|FG001|Period 1|Lost to Follow-up|0|||
126350495|NCT00098475|454575351|FG001|Step 1|Insurance issue|1|||
126350496|NCT00098475|454575352|FG002|Step 1|Insurance issue|0|||
126350497|NCT00098475|454575353|FG003|Step 1|Insurance issue|0|||
126350498|NCT00098475|454575350|FG000|Step 1|Rising paraprotein|0|||
126688421|NCT00662792|455815185|FG002|Period 1|Lost to Follow-up|0|||
126688422|NCT00662792|455815186|FG003|Period 1|Lost to Follow-up|0|||
126688423|NCT00662792|455815183|FG000|Period 1|Other adverse event (AE)|0|||
126688424|NCT00662792|455815184|FG001|Period 1|Other adverse event (AE)|2|||
126350499|NCT00098475|454575351|FG001|Step 1|Rising paraprotein|1|||
126350500|NCT00098475|454575352|FG002|Step 1|Rising paraprotein|0|||
126350501|NCT00098475|454575353|FG003|Step 1|Rising paraprotein|0|||
126350502|NCT00098475|454575350|FG000|Step 1|Referred to other physicians|0|||
126350503|NCT00098475|454575351|FG001|Step 1|Referred to other physicians|1|||
126350504|NCT00098475|454575352|FG002|Step 1|Referred to other physicians|0|||
126350505|NCT00098475|454575353|FG003|Step 1|Referred to other physicians|0|||
126350506|NCT00098475|454575350|FG000|Step 1|Criteria to continue treatment not met|0|||
126350507|NCT00098475|454575351|FG001|Step 1|Criteria to continue treatment not met|1|||
126350508|NCT00098475|454575352|FG002|Step 1|Criteria to continue treatment not met|0|||
126350509|NCT00098475|454575353|FG003|Step 1|Criteria to continue treatment not met|0|||
126350510|NCT00098475|454575350|FG000|Step 1|Misinterpretation of lab data|0|||
126350511|NCT00098475|454575351|FG001|Step 1|Misinterpretation of lab data|1|||
126350512|NCT00098475|454575352|FG002|Step 1|Misinterpretation of lab data|0|||
126350513|NCT00098475|454575353|FG003|Step 1|Misinterpretation of lab data|0|||
126350514|NCT00098475|454575350|FG000|Step 1|Patient fell with fracture|1|||
126350515|NCT00098475|454575351|FG001|Step 1|Patient fell with fracture|0|||
126350516|NCT00098475|454575352|FG002|Step 1|Patient fell with fracture|0|||
126350517|NCT00098475|454575353|FG003|Step 1|Patient fell with fracture|0|||
126350518|NCT00098475|454575350|FG000|Step 1|Not documented|0|||
126350519|NCT00098475|454575351|FG001|Step 1|Not documented|1|||
126350520|NCT00098475|454575352|FG002|Step 1|Not documented|0|||
126350521|NCT00098475|454575353|FG003|Step 1|Not documented|0|||
126350522|NCT00098475|454575350|FG000|Step 2|Disease progression|1|||
126350523|NCT00098475|454575351|FG001|Step 2|Disease progression|4|||
126350524|NCT00098475|454575352|FG002|Step 2|Disease progression|0|||
126350525|NCT00098475|454575353|FG003|Step 2|Disease progression|0|||
126350526|NCT00098475|454575350|FG000|Step 2|Adverse Event|2|||
126350527|NCT00098475|454575351|FG001|Step 2|Adverse Event|0|||
126350528|NCT00098475|454575352|FG002|Step 2|Adverse Event|0|||
126350529|NCT00098475|454575353|FG003|Step 2|Adverse Event|0|||
126350530|NCT00098475|454575350|FG000|Step 2|Withdrawal by Subject|0|||
126350531|NCT00098475|454575351|FG001|Step 2|Withdrawal by Subject|2|||
126350532|NCT00098475|454575352|FG002|Step 2|Withdrawal by Subject|0|||
126350533|NCT00098475|454575353|FG003|Step 2|Withdrawal by Subject|0|||
126350534|NCT00098475|454575350|FG000|Step 2|Physician Decision|0|||
126350535|NCT00098475|454575351|FG001|Step 2|Physician Decision|1|||
126350536|NCT00098475|454575352|FG002|Step 2|Physician Decision|0|||
126350537|NCT00098475|454575353|FG003|Step 2|Physician Decision|0|||
126350538|NCT00098475|454575350|FG000|Step 2|Alternative therapy|1|||
126350539|NCT00098475|454575351|FG001|Step 2|Alternative therapy|2|||
126350540|NCT00098475|454575352|FG002|Step 2|Alternative therapy|0|||
126350541|NCT00098475|454575353|FG003|Step 2|Alternative therapy|0|||
126350542|NCT00098475|454575350|FG000|Step 2|Never started treatment|1|||
126350543|NCT00098475|454575351|FG001|Step 2|Never started treatment|1|||
126350544|NCT00098475|454575352|FG002|Step 2|Never started treatment|0|||
126350545|NCT00098475|454575353|FG003|Step 2|Never started treatment|0|||
126350546|NCT06354257|454575354|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126350547|NCT06354257|454575354|FG000|Treatment Period 2|Adverse Event|1|||
126350548|NCT03168672|454575355|FG000|Overall Study|Withdrawal by Subject|13|||
126350549|NCT03168672|454575355|FG000|Overall Study|Death|3|||
126350550|NCT03168672|454575355|FG000|Overall Study|Investigator's Decision|137|||
126688425|NCT00662792|455815185|FG002|Period 1|Other adverse event (AE)|0|||
126688426|NCT00662792|455815186|FG003|Period 1|Other adverse event (AE)|0|||
126688427|NCT00662792|455815183|FG000|Period 1|Worsening of disease under study (AE)|1|||
126688428|NCT00662792|455815184|FG001|Period 1|Worsening of disease under study (AE)|3|||
126688429|NCT00662792|455815185|FG002|Period 1|Worsening of disease under study (AE)|2|||
126688430|NCT00662792|455815186|FG003|Period 1|Worsening of disease under study (AE)|0|||
126688431|NCT00662792|455815183|FG000|Period 1|Not treated|0|||
126688432|NCT00662792|455815184|FG001|Period 1|Not treated|1|||
126688433|NCT00662792|455815185|FG002|Period 1|Not treated|0|||
126688434|NCT00662792|455815186|FG003|Period 1|Not treated|0|||
126688435|NCT00662792|455815183|FG000|Period 2|Worsening of disease under study|1|||
126688436|NCT00662792|455815184|FG001|Period 2|Worsening of disease under study|0|||
126688437|NCT00662792|455815185|FG002|Period 2|Worsening of disease under study|0|||
126688438|NCT00662792|455815186|FG003|Period 2|Worsening of disease under study|3|||
126688439|NCT00662792|455815183|FG000|Period 3|Refused continuing medication|1|||
126688440|NCT00662792|455815184|FG001|Period 3|Refused continuing medication|0|||
126688441|NCT00662792|455815185|FG002|Period 3|Refused continuing medication|1|||
126688442|NCT00662792|455815186|FG003|Period 3|Refused continuing medication|0|||
126688443|NCT00662792|455815183|FG000|Period 3|Other adverse event (AE)|0|||
126688444|NCT00662792|455815184|FG001|Period 3|Other adverse event (AE)|0|||
126688445|NCT00662792|455815185|FG002|Period 3|Other adverse event (AE)|1|||
126688446|NCT00662792|455815186|FG003|Period 3|Other adverse event (AE)|1|||
126688447|NCT00662792|455815183|FG000|Period 4|Refused continuing medication|0|||
126688448|NCT00662792|455815184|FG001|Period 4|Refused continuing medication|1|||
126688449|NCT00662792|455815185|FG002|Period 4|Refused continuing medication|0|||
126688450|NCT00662792|455815186|FG003|Period 4|Refused continuing medication|0|||
126688451|NCT00662792|455815183|FG000|Period 4|Other adverse event (AE)|1|||
126688452|NCT00662792|455815184|FG001|Period 4|Other adverse event (AE)|0|||
126688453|NCT00662792|455815185|FG002|Period 4|Other adverse event (AE)|0|||
126688454|NCT00662792|455815186|FG003|Period 4|Other adverse event (AE)|0|||
126688455|NCT00662792|455815183|FG000|Period 4|Worsening of disease under study (AE)|0|||
126688456|NCT00662792|455815184|FG001|Period 4|Worsening of disease under study (AE)|0|||
126688457|NCT00662792|455815185|FG002|Period 4|Worsening of disease under study (AE)|0|||
126688458|NCT00662792|455815186|FG003|Period 4|Worsening of disease under study (AE)|1|||
126688459|NCT00090545|455815189|FG000|Overall Study|Disease progression on study|21|||
126688460|NCT00090545|455815190|FG001|Overall Study|Disease progression on study|17|||
126688461|NCT00090545|455815189|FG000|Overall Study|Refused further treatment|1|||
126688462|NCT00090545|455815190|FG001|Overall Study|Refused further treatment|4|||
126688463|NCT00090545|455815189|FG000|Overall Study|Death|0|||
126688464|NCT00090545|455815190|FG001|Overall Study|Death|1|||
126688465|NCT00090545|455815189|FG000|Overall Study|Adverse Event|0|||
126688466|NCT00090545|455815190|FG001|Overall Study|Adverse Event|2|||
126688467|NCT00441545|455815191|FG000|First Intervention|Adverse Event|6|||
126688468|NCT00441545|455815192|FG001|First Intervention|Adverse Event|5|||
126688469|NCT00441545|455815191|FG000|First Intervention|Protocol Violation|2|||
126688470|NCT00441545|455815192|FG001|First Intervention|Protocol Violation|2|||
126350551|NCT03168672|454575355|FG000|Overall Study|Adverse Event|1|||
126350552|NCT03168672|454575355|FG000|Overall Study|Other|2|||
126350553|NCT03168672|454575355|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
126350554|NCT00433537|454575356|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
126350555|NCT00433537|454575357|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
126350556|NCT00433537|454575358|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
126350557|NCT00433537|454575356|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
126350558|NCT00433537|454575357|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
126350559|NCT00433537|454575358|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
126350560|NCT00433537|454575356|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
126350561|NCT00433537|454575357|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
126350562|NCT00433537|454575358|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
126350563|NCT00433537|454575356|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
126350564|NCT00433537|454575357|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
126350565|NCT00433537|454575358|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
126688471|NCT00441545|455815191|FG000|First Intervention|Withdrawal by Subject|3|||
126688472|NCT00441545|455815192|FG001|First Intervention|Withdrawal by Subject|3|||
126688473|NCT00441545|455815191|FG000|First Intervention|Kidney transplant|1|||
126688474|NCT00441545|455815192|FG001|First Intervention|Kidney transplant|1|||
126688475|NCT00441545|455815191|FG000|First Intervention|Lack of Efficacy|2|||
126688476|NCT00441545|455815192|FG001|First Intervention|Lack of Efficacy|0|||
126688477|NCT00441545|455815191|FG000|First Intervention|Subject exceeded safety criteria|0|||
126688478|NCT00441545|455815192|FG001|First Intervention|Subject exceeded safety criteria|1|||
126688479|NCT00441545|455815191|FG000|First Intervention|Subject met an exclusionary criteria|1|||
126688480|NCT00441545|455815192|FG001|First Intervention|Subject met an exclusionary criteria|0|||
126688481|NCT00441545|455815191|FG000|First Intervention|Extended hospitalization|1|||
126688482|NCT00441545|455815192|FG001|First Intervention|Extended hospitalization|0|||
126688483|NCT00441545|455815191|FG000|First Intervention|Site error|1|||
126688484|NCT00441545|455815192|FG001|First Intervention|Site error|0|||
126350566|NCT00433537|454575356|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
126350567|NCT00433537|454575357|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
126350568|NCT00433537|454575358|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
126350569|NCT00433537|454575356|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
126350570|NCT00433537|454575357|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
126350571|NCT00433537|454575358|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
126350572|NCT00433537|454575356|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
126350573|NCT00433537|454575357|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
126350574|NCT00433537|454575358|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
126350575|NCT00433537|454575356|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
126350576|NCT00433537|454575357|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
126350577|NCT00433537|454575358|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
126350578|NCT00433537|454575356|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
126350579|NCT00433537|454575357|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
126350580|NCT00433537|454575358|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
126350581|NCT03370276|454575359|FG000|Overall Study|Death|0|||
126350582|NCT03370276|454575360|FG001|Overall Study|Death|2|||
126350583|NCT03370276|454575361|FG002|Overall Study|Death|5|||
126350584|NCT00831844|454575362|FG000|Overall Study|Adverse Event|2|||
126350585|NCT00831844|454575363|FG001|Overall Study|Adverse Event|0|||
126350586|NCT00831844|454575364|FG002|Overall Study|Adverse Event|0|||
126350587|NCT00831844|454575365|FG003|Overall Study|Adverse Event|0|||
126350588|NCT00831844|454575366|FG004|Overall Study|Adverse Event|1|||
126350589|NCT00831844|454575367|FG005|Overall Study|Adverse Event|1|||
126350590|NCT00831844|454575368|FG006|Overall Study|Adverse Event|2|||
126350591|NCT00831844|454575369|FG007|Overall Study|Adverse Event|0|||
126350592|NCT00831844|454575370|FG008|Overall Study|Adverse Event|0|||
126350593|NCT00831844|454575371|FG009|Overall Study|Adverse Event|0|||
126350594|NCT00831844|454575362|FG000|Overall Study|Death|0|||
126350595|NCT00831844|454575363|FG001|Overall Study|Death|0|||
126350596|NCT00831844|454575364|FG002|Overall Study|Death|0|||
126350597|NCT00831844|454575365|FG003|Overall Study|Death|1|||
126350598|NCT00831844|454575366|FG004|Overall Study|Death|0|||
126350599|NCT00831844|454575367|FG005|Overall Study|Death|0|||
126350600|NCT00831844|454575368|FG006|Overall Study|Death|0|||
126688485|NCT00441545|455815191|FG000|First Intervention|Sponsor's request|1|||
126350601|NCT00831844|454575369|FG007|Overall Study|Death|0|||
126350602|NCT00831844|454575370|FG008|Overall Study|Death|0|||
126350603|NCT00831844|454575371|FG009|Overall Study|Death|0|||
126350604|NCT00831844|454575362|FG000|Overall Study|Lack of Efficacy|8|||
126350605|NCT00831844|454575363|FG001|Overall Study|Lack of Efficacy|10|||
126350606|NCT00831844|454575364|FG002|Overall Study|Lack of Efficacy|15|||
126688486|NCT00441545|455815192|FG001|First Intervention|Sponsor's request|0|||
126688487|NCT00441545|455815191|FG000|Second Intervention|Adverse Event|5|||
126688488|NCT00441545|455815192|FG001|Second Intervention|Adverse Event|2|||
126688489|NCT00441545|455815191|FG000|Second Intervention|Protocol Violation|4|||
126688490|NCT00441545|455815192|FG001|Second Intervention|Protocol Violation|1|||
126688491|NCT00441545|455815191|FG000|Second Intervention|Withdrawal by Subject|1|||
126688492|NCT00441545|455815192|FG001|Second Intervention|Withdrawal by Subject|1|||
126688493|NCT00441545|455815191|FG000|Second Intervention|Kidney Transplant|1|||
126688494|NCT00441545|455815192|FG001|Second Intervention|Kidney Transplant|1|||
126688495|NCT00441545|455815191|FG000|Second Intervention|Lack of Efficacy|0|||
126688496|NCT00441545|455815192|FG001|Second Intervention|Lack of Efficacy|1|||
126688497|NCT00441545|455815191|FG000|Second Intervention|Subject exceeded safety criteria|1|||
126688498|NCT00441545|455815192|FG001|Second Intervention|Subject exceeded safety criteria|0|||
126688499|NCT00441545|455815191|FG000|Second Intervention|Subject moved|0|||
126688500|NCT00441545|455815192|FG001|Second Intervention|Subject moved|1|||
126688501|NCT02347176|455815193|FG000|Overall Study|Lost to Follow-up|2|||
126688502|NCT02347176|455815194|FG001|Overall Study|Lost to Follow-up|3|||
126688503|NCT02347176|455815195|FG002|Overall Study|Lost to Follow-up|1|||
126688504|NCT02347176|455815196|FG003|Overall Study|Lost to Follow-up|1|||
126688505|NCT02347176|455815193|FG000|Overall Study|Withdrawal by Subject|9|||
126688506|NCT02347176|455815194|FG001|Overall Study|Withdrawal by Subject|5|||
126688507|NCT02347176|455815195|FG002|Overall Study|Withdrawal by Subject|5|||
126688508|NCT02347176|455815196|FG003|Overall Study|Withdrawal by Subject|3|||
126688509|NCT02347176|455815193|FG000|Overall Study|Other|1|||
126688510|NCT02347176|455815194|FG001|Overall Study|Other|2|||
126688511|NCT02347176|455815195|FG002|Overall Study|Other|2|||
126688512|NCT02347176|455815196|FG003|Overall Study|Other|0|||
126688513|NCT02809833|455815199|FG000|Overall Study|Death|3|||
126688514|NCT02809833|455815199|FG000|Overall Study|Intolerance|54|||
126688515|NCT02809833|455815199|FG000|Overall Study|Lack of Efficacy|89|||
126688516|NCT02809833|455815199|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
126688517|NCT02809833|455815199|FG000|Overall Study|Noncompliance|1|||
126688518|NCT02809833|455815199|FG000|Overall Study|Withdrawal by Subject|34|||
126688519|NCT02809833|455815199|FG000|Overall Study|Lost to Follow-up|35|||
126688520|NCT02809833|455815199|FG000|Overall Study|Adverse Event (AE)|24|||
126688521|NCT02809833|455815199|FG000|Overall Study|Other|5|||
126688522|NCT02809833|455815199|FG000|Overall Study|Missing Information|52|||
126688523|NCT00744874|455815200|FG000|Overall Study|Lost to Follow-up|1|||
126688524|NCT00744874|455815200|FG000|Overall Study|Withdrawal by Subject|1|||
126688525|NCT00744874|455815200|FG000|Overall Study|Study Device not available at procedure|1|||
126688526|NCT00744874|455815200|FG000|Overall Study|Unable to accomodate schedule|1|||
126688527|NCT03403205|455815203|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
126688528|NCT03403205|455815204|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
126688529|NCT03403205|455815205|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
126688530|NCT03403205|455815206|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
126688531|NCT03403205|455815207|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126688532|NCT03403205|455815208|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126688533|NCT03403205|455815203|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
126688534|NCT03403205|455815204|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126688535|NCT03403205|455815205|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
126688536|NCT03403205|455815206|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126688537|NCT03403205|455815207|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126688538|NCT03403205|455815208|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126688539|NCT03403205|455815203|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
126688540|NCT03403205|455815204|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
126688541|NCT03403205|455815205|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
126688542|NCT03403205|455815206|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
126688543|NCT03403205|455815207|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
126688544|NCT03403205|455815208|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
126688545|NCT03403205|455815203|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
126688546|NCT03403205|455815204|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
126350607|NCT00831844|454575365|FG003|Overall Study|Lack of Efficacy|8|||
126350608|NCT00831844|454575366|FG004|Overall Study|Lack of Efficacy|11|||
126350609|NCT00831844|454575367|FG005|Overall Study|Lack of Efficacy|17|||
126350610|NCT00831844|454575368|FG006|Overall Study|Lack of Efficacy|8|||
126350611|NCT00831844|454575369|FG007|Overall Study|Lack of Efficacy|9|||
126350612|NCT00831844|454575370|FG008|Overall Study|Lack of Efficacy|7|||
126350613|NCT00831844|454575371|FG009|Overall Study|Lack of Efficacy|0|||
126350614|NCT00831844|454575362|FG000|Overall Study|Physician Decision|0|||
126350615|NCT00831844|454575363|FG001|Overall Study|Physician Decision|1|||
126350616|NCT00831844|454575364|FG002|Overall Study|Physician Decision|3|||
126350617|NCT00831844|454575365|FG003|Overall Study|Physician Decision|1|||
126350618|NCT00831844|454575366|FG004|Overall Study|Physician Decision|1|||
126350619|NCT00831844|454575367|FG005|Overall Study|Physician Decision|1|||
126350620|NCT00831844|454575368|FG006|Overall Study|Physician Decision|0|||
126350621|NCT00831844|454575369|FG007|Overall Study|Physician Decision|0|||
126350622|NCT00831844|454575370|FG008|Overall Study|Physician Decision|1|||
126350623|NCT00831844|454575371|FG009|Overall Study|Physician Decision|0|||
126350624|NCT00831844|454575362|FG000|Overall Study|Withdrawal by Subject|0|||
126350625|NCT00831844|454575363|FG001|Overall Study|Withdrawal by Subject|0|||
126350626|NCT00831844|454575364|FG002|Overall Study|Withdrawal by Subject|1|||
126350627|NCT00831844|454575365|FG003|Overall Study|Withdrawal by Subject|0|||
126350628|NCT00831844|454575366|FG004|Overall Study|Withdrawal by Subject|0|||
126350629|NCT00831844|454575367|FG005|Overall Study|Withdrawal by Subject|0|||
126350630|NCT00831844|454575368|FG006|Overall Study|Withdrawal by Subject|0|||
126350631|NCT00831844|454575369|FG007|Overall Study|Withdrawal by Subject|1|||
126350632|NCT00831844|454575370|FG008|Overall Study|Withdrawal by Subject|1|||
126350633|NCT00831844|454575371|FG009|Overall Study|Withdrawal by Subject|0|||
126350634|NCT00831844|454575362|FG000|Overall Study|Ineligible|0|||
126350635|NCT00831844|454575363|FG001|Overall Study|Ineligible|1|||
126350636|NCT00831844|454575364|FG002|Overall Study|Ineligible|1|||
126350637|NCT00831844|454575365|FG003|Overall Study|Ineligible|0|||
126350638|NCT00831844|454575366|FG004|Overall Study|Ineligible|1|||
126350639|NCT00831844|454575367|FG005|Overall Study|Ineligible|0|||
126350640|NCT00831844|454575368|FG006|Overall Study|Ineligible|0|||
126350641|NCT00831844|454575369|FG007|Overall Study|Ineligible|0|||
126350642|NCT00831844|454575370|FG008|Overall Study|Ineligible|0|||
126350643|NCT00831844|454575371|FG009|Overall Study|Ineligible|0|||
126350644|NCT05436613|454575374|FG000|Overall Study|Lost to Follow-up|9|||
126350645|NCT05436613|454575374|FG000|Overall Study|Withdrawal by Subject|3|||
126350646|NCT04057365|454575375|FG000|Overall Study|Withdrawal by Subject|2|||
126350647|NCT04057365|454575376|FG001|Overall Study|Withdrawal by Subject|0|||
126350648|NCT04738487|454575377|FG000|Overall Study|Participant Ongoing in Study|298|||
126350649|NCT04738487|454575378|FG001|Overall Study|Participant Ongoing in Study|297|||
126350650|NCT04738487|454575377|FG000|Overall Study|Withdrawal by Subject|7|||
126350651|NCT04738487|454575378|FG001|Overall Study|Withdrawal by Subject|9|||
126350652|NCT04738487|454575377|FG000|Overall Study|Lost to Follow-up|2|||
126350653|NCT04738487|454575378|FG001|Overall Study|Lost to Follow-up|0|||
126350654|NCT04738487|454575377|FG000|Overall Study|Death|287|||
126350655|NCT04738487|454575378|FG001|Overall Study|Death|306|||
126350656|NCT03976375|454575379|FG000|Overall Study|Death|158|||
126545393|NCT02541383|455290823|FG000|Overall Study|Consent withdrawn|5|||
126759968|NCT01000311|456070493|FG000|Overall Study|Inappropriate enrollment|2|||
126759969|NCT01000311|456070494|FG001|Overall Study|Inappropriate enrollment|0|||
126759970|NCT01000311|456070493|FG000|Overall Study|Administrative reason|9|||
126350657|NCT03976375|454575380|FG001|Overall Study|Death|160|||
126350658|NCT03976375|454575381|FG002|Overall Study|Death|42|||
126350659|NCT03976375|454575379|FG000|Overall Study|Lost to Follow-up|2|||
126350660|NCT03976375|454575380|FG001|Overall Study|Lost to Follow-up|1|||
126350661|NCT03976375|454575381|FG002|Overall Study|Lost to Follow-up|1|||
126350662|NCT03976375|454575379|FG000|Overall Study|Withdrawal by Subject|5|||
126350663|NCT03976375|454575380|FG001|Overall Study|Withdrawal by Subject|9|||
126350664|NCT03976375|454575381|FG002|Overall Study|Withdrawal by Subject|4|||
126350665|NCT03976375|454575379|FG000|Overall Study|Sponsor decision|20|||
126350666|NCT03976375|454575380|FG001|Overall Study|Sponsor decision|19|||
126688547|NCT03403205|455815205|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
126688548|NCT03403205|455815206|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
126688549|NCT03403205|455815207|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
126688550|NCT03403205|455815208|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
126688551|NCT03403205|455815203|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
126688552|NCT03403205|455815204|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
126688553|NCT03403205|455815205|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
126688554|NCT03403205|455815206|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
126688555|NCT03403205|455815207|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
126688556|NCT03403205|455815208|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
126688557|NCT03403205|455815203|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
126688558|NCT03403205|455815204|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
126688559|NCT03403205|455815205|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
126688560|NCT03403205|455815206|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
126688561|NCT03403205|455815207|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
126688562|NCT03403205|455815208|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
126688563|NCT03403205|455815203|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
126688564|NCT03403205|455815204|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
126688565|NCT03403205|455815205|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
126688566|NCT03403205|455815206|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
126688567|NCT03403205|455815207|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
126688568|NCT03403205|455815208|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
126688569|NCT03403205|455815203|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
126688570|NCT03403205|455815204|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
126688571|NCT03403205|455815205|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
126688572|NCT03403205|455815206|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
126688573|NCT03403205|455815207|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
126688574|NCT03403205|455815208|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
126688575|NCT03403205|455815203|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
126688576|NCT03403205|455815204|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
126688577|NCT03403205|455815205|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
126688578|NCT03403205|455815206|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
126688579|NCT03403205|455815207|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
126688580|NCT03403205|455815208|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
126688581|NCT03403205|455815203|FG000|Extension Period (Up to 60 Months)|Death|1|||
126688582|NCT03403205|455815204|FG001|Extension Period (Up to 60 Months)|Death|0|||
126688583|NCT03403205|455815205|FG002|Extension Period (Up to 60 Months)|Death|0|||
126688584|NCT03403205|455815206|FG003|Extension Period (Up to 60 Months)|Death|0|||
126688585|NCT03403205|455815207|FG004|Extension Period (Up to 60 Months)|Death|0|||
126688586|NCT03403205|455815208|FG005|Extension Period (Up to 60 Months)|Death|0|||
126688587|NCT03403205|455815203|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
126688588|NCT03403205|455815204|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
126688589|NCT03403205|455815205|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
126688590|NCT03403205|455815206|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
126688591|NCT03403205|455815207|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
126688592|NCT03403205|455815208|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
126688593|NCT03403205|455815203|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
126688594|NCT03403205|455815204|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
126688595|NCT03403205|455815205|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
126688596|NCT03403205|455815206|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
126688597|NCT03403205|455815207|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
126688598|NCT03403205|455815208|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
126688599|NCT03403205|455815203|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
126688600|NCT03403205|455815204|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
126688601|NCT03403205|455815205|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
126688602|NCT03403205|455815206|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
126688603|NCT03403205|455815207|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
126688604|NCT03403205|455815208|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
126688605|NCT03403205|455815203|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
126688606|NCT03403205|455815204|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
126350667|NCT03976375|454575381|FG002|Overall Study|Sponsor decision|1|||
126688607|NCT03403205|455815205|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
126688608|NCT03403205|455815206|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
126688609|NCT03403205|455815207|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
126688610|NCT03403205|455815208|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
126688611|NCT03403205|455815203|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
126688612|NCT03403205|455815204|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
126688613|NCT03403205|455815205|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
126688614|NCT03403205|455815206|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
126688615|NCT03403205|455815207|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
126688616|NCT03403205|455815208|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
126688617|NCT03403205|455815203|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
126688618|NCT03403205|455815204|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
126688619|NCT03403205|455815205|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
126688620|NCT03403205|455815206|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
126688621|NCT03403205|455815207|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
126688622|NCT03403205|455815208|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
126688623|NCT01834729|455815209|FG000|Overall Study|Did not return bowel diaries|0|||
126688624|NCT01834729|455815210|FG001|Overall Study|Did not return bowel diaries|0|||
126688625|NCT01834729|455815211|FG002|Overall Study|Did not return bowel diaries|3|||
126688626|NCT01834729|455815212|FG003|Overall Study|Did not return bowel diaries|0|||
126688627|NCT01834729|455815209|FG000|Overall Study|Withdrawal by Subject|1|||
126688628|NCT01834729|455815210|FG001|Overall Study|Withdrawal by Subject|1|||
126688629|NCT01834729|455815211|FG002|Overall Study|Withdrawal by Subject|0|||
126688630|NCT01834729|455815212|FG003|Overall Study|Withdrawal by Subject|0|||
126688631|NCT01834729|455815209|FG000|Overall Study|Adverse Event|0|||
126350668|NCT05350202|454575382|FG000|Visit 1 - Baseline|Not-treated|18|||
126350669|NCT05350202|454575383|FG001|Visit 1 - Baseline|Not-treated|0|||
126350670|NCT05350202|454575382|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
126350671|NCT05350202|454575383|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
126350672|NCT05350202|454575382|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
126350673|NCT05350202|454575383|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
126350674|NCT05350202|454575382|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
126350675|NCT05350202|454575383|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
126350676|NCT05350202|454575382|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
126350677|NCT05350202|454575383|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
126350678|NCT05350202|454575382|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
126350679|NCT05350202|454575383|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
126350680|NCT05350202|454575382|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
126350681|NCT05350202|454575383|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
126350682|NCT03683030|454575392|FG000|Overall Study|Enrolled but screen failures|12|||
126350683|NCT03683030|454575393|FG001|Overall Study|Enrolled but screen failures|7|||
126350684|NCT03683030|454575392|FG000|Overall Study|Enrolled but no catheter inserted|11|||
126350685|NCT03683030|454575393|FG001|Overall Study|Enrolled but no catheter inserted|13|||
126350686|NCT03683030|454575392|FG000|Overall Study|Withdrawal by Subject|0|||
126350687|NCT03683030|454575393|FG001|Overall Study|Withdrawal by Subject|2|||
126350688|NCT03683030|454575392|FG000|Overall Study|Early termination by subject|1|||
126350689|NCT03683030|454575393|FG001|Overall Study|Early termination by subject|0|||
126350690|NCT03683030|454575392|FG000|Overall Study|Lost to Follow-up|0|||
126350691|NCT03683030|454575393|FG001|Overall Study|Lost to Follow-up|6|||
126350692|NCT03683030|454575392|FG000|Overall Study|Death|0|||
126350693|NCT03683030|454575393|FG001|Overall Study|Death|2|||
126350694|NCT03683030|454575392|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
126350695|NCT03683030|454575393|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
126350696|NCT02390284|454575394|FG000|Overall Study|Physician Decision|0|||
126438653|NCT01774721|454907594|FG000|Overall Study|Study terminated by sponsor|5|||
126438654|NCT01774721|454907595|FG001|Overall Study|Study terminated by sponsor|0|||
126688632|NCT01834729|455815210|FG001|Overall Study|Adverse Event|0|||
126688633|NCT01834729|455815211|FG002|Overall Study|Adverse Event|0|||
126688634|NCT01834729|455815212|FG003|Overall Study|Adverse Event|2|||
126688635|NCT02971670|455815213|FG000|Overall Study|Withdrawal by Subject|4|||
126688636|NCT02971670|455815214|FG001|Overall Study|Withdrawal by Subject|1|||
126688637|NCT02971670|455815215|FG002|Overall Study|Withdrawal by Subject|1|||
126438655|NCT01774721|454907594|FG000|Overall Study|Disease progression|5|||
126438656|NCT01774721|454907595|FG001|Overall Study|Disease progression|0|||
126438657|NCT00628108|454907596|FG000|Overall Study|Adverse Event|0|||
126438658|NCT00628108|454907597|FG001|Overall Study|Adverse Event|3|||
126438659|NCT00628108|454907596|FG000|Overall Study|Withdrawal by Subject|1|||
126438660|NCT00628108|454907597|FG001|Overall Study|Withdrawal by Subject|0|||
126438661|NCT03848832|454907598|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
126438662|NCT03848832|454907599|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
126438663|NCT03848832|454907600|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
126438664|NCT03848832|454907598|FG000|Overall Study|Withdrawal by Subject|0|||
126438665|NCT03848832|454907599|FG001|Overall Study|Withdrawal by Subject|0|||
126438666|NCT03848832|454907600|FG002|Overall Study|Withdrawal by Subject|1|||
126438667|NCT03848832|454907598|FG000|Overall Study|Withdrawal (Covid-19)|0|||
126438668|NCT03848832|454907599|FG001|Overall Study|Withdrawal (Covid-19)|2|||
126438669|NCT03848832|454907600|FG002|Overall Study|Withdrawal (Covid-19)|0|||
126438670|NCT03848832|454907598|FG000|Overall Study|Physician Decision|2|||
126438671|NCT03848832|454907599|FG001|Overall Study|Physician Decision|1|||
126438672|NCT03848832|454907600|FG002|Overall Study|Physician Decision|3|||
126438673|NCT03848832|454907598|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
126438674|NCT03848832|454907599|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
126438675|NCT03848832|454907600|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
126438676|NCT03848832|454907598|FG000|Overall Study|Adverse Event|1|||
126438677|NCT03848832|454907599|FG001|Overall Study|Adverse Event|0|||
126438678|NCT03848832|454907600|FG002|Overall Study|Adverse Event|0|||
126438679|NCT01907854|454907602|FG000|Overall Study|Protocol Violation|1|||
126438680|NCT01907854|454907603|FG001|Overall Study|Protocol Violation|1|||
126438681|NCT01907854|454907602|FG000|Overall Study|Withdrawal by Subject|9|||
126438682|NCT01907854|454907603|FG001|Overall Study|Withdrawal by Subject|7|||
126438683|NCT01907854|454907602|FG000|Overall Study|Lost to Follow-up|2|||
126438684|NCT01907854|454907603|FG001|Overall Study|Lost to Follow-up|2|||
126438685|NCT01907854|454907602|FG000|Overall Study|Unclassified|4|||
126438686|NCT01907854|454907603|FG001|Overall Study|Unclassified|3|||
126438687|NCT03774576|454907606|FG000|Period 2|Adverse Event|1|||
126438688|NCT02351817|454907607|FG000|Period 1|Adverse Event|1|||
126438689|NCT02351817|454907608|FG001|Period 1|Adverse Event|2|||
126438690|NCT02351817|454907607|FG000|Period 1|Lack of Efficacy|0|||
126438691|NCT02351817|454907608|FG001|Period 1|Lack of Efficacy|1|||
126438692|NCT02351817|454907607|FG000|Period 2|Adverse Event|0|||
126438693|NCT02351817|454907608|FG001|Period 2|Adverse Event|2|||
126438694|NCT02351817|454907607|FG000|Period 2|Protocol Violation|1|||
126438695|NCT02351817|454907608|FG001|Period 2|Protocol Violation|0|||
126438696|NCT02488915|454907611|FG000|Overall Study|Death|21|||
126438697|NCT02488915|454907611|FG000|Overall Study|Lost to Follow-up|4|||
126438698|NCT02488915|454907611|FG000|Overall Study|Withdrawal by Subject|1|||
126438699|NCT00927953|454907612|FG000|Overall Study|Death|2|||
126438700|NCT00927953|454907613|FG001|Overall Study|Death|1|||
126438701|NCT02976038|454907614|FG000|Overall Study|Physician Decision|22|||
126438702|NCT02976038|454907614|FG000|Overall Study|Withdrawal by Subject|3|||
126438703|NCT02976038|454907614|FG000|Overall Study|Lost to Follow-up|2|||
126438704|NCT02976038|454907614|FG000|Overall Study|Adverse Event|1|||
126438705|NCT01046396|454907615|FG000|Overall Study|Withdrawal by Subject|5|||
126438706|NCT01208207|454907616|FG000|Part I|Adverse Event|19|||
126438707|NCT01208207|454907617|FG001|Part I|Adverse Event|2|||
126438708|NCT01208207|454907618|FG002|Part I|Adverse Event|6|||
126438709|NCT01208207|454907619|FG003|Part I|Adverse Event|0|||
126438710|NCT01208207|454907620|FG004|Part I|Adverse Event|0|||
126438711|NCT01208207|454907621|FG005|Part I|Adverse Event|0|||
126438712|NCT01208207|454907622|FG006|Part I|Adverse Event|0|||
126438713|NCT01208207|454907616|FG000|Part I|Lack of Efficacy|21|||
126438714|NCT01208207|454907617|FG001|Part I|Lack of Efficacy|3|||
126438715|NCT01208207|454907618|FG002|Part I|Lack of Efficacy|2|||
126438716|NCT01208207|454907619|FG003|Part I|Lack of Efficacy|0|||
126438717|NCT01208207|454907620|FG004|Part I|Lack of Efficacy|0|||
126438718|NCT01208207|454907621|FG005|Part I|Lack of Efficacy|0|||
126438719|NCT01208207|454907622|FG006|Part I|Lack of Efficacy|0|||
126438720|NCT01208207|454907616|FG000|Part I|Lost to Follow-up|6|||
126438721|NCT01208207|454907617|FG001|Part I|Lost to Follow-up|1|||
126438722|NCT01208207|454907618|FG002|Part I|Lost to Follow-up|0|||
126438723|NCT01208207|454907619|FG003|Part I|Lost to Follow-up|0|||
126438724|NCT01208207|454907620|FG004|Part I|Lost to Follow-up|0|||
126438725|NCT01208207|454907621|FG005|Part I|Lost to Follow-up|0|||
126438726|NCT01208207|454907622|FG006|Part I|Lost to Follow-up|0|||
126438727|NCT01208207|454907616|FG000|Part I|Non-Compliance With Study Drug|1|||
126438728|NCT01208207|454907617|FG001|Part I|Non-Compliance With Study Drug|0|||
126438729|NCT01208207|454907618|FG002|Part I|Non-Compliance With Study Drug|1|||
126438730|NCT01208207|454907619|FG003|Part I|Non-Compliance With Study Drug|0|||
126438731|NCT01208207|454907620|FG004|Part I|Non-Compliance With Study Drug|0|||
126438732|NCT01208207|454907621|FG005|Part I|Non-Compliance With Study Drug|0|||
126438733|NCT01208207|454907622|FG006|Part I|Non-Compliance With Study Drug|0|||
126438734|NCT01208207|454907616|FG000|Part I|Physician Decision|0|||
126438735|NCT01208207|454907617|FG001|Part I|Physician Decision|1|||
126438736|NCT01208207|454907618|FG002|Part I|Physician Decision|0|||
126438737|NCT01208207|454907619|FG003|Part I|Physician Decision|0|||
126438738|NCT01208207|454907620|FG004|Part I|Physician Decision|0|||
126438739|NCT01208207|454907621|FG005|Part I|Physician Decision|0|||
126438740|NCT01208207|454907622|FG006|Part I|Physician Decision|0|||
126438741|NCT01208207|454907616|FG000|Part I|Progressive Disease|1|||
126438742|NCT01208207|454907617|FG001|Part I|Progressive Disease|0|||
126438743|NCT01208207|454907618|FG002|Part I|Progressive Disease|0|||
126438744|NCT01208207|454907619|FG003|Part I|Progressive Disease|0|||
126438745|NCT01208207|454907620|FG004|Part I|Progressive Disease|0|||
126438746|NCT01208207|454907621|FG005|Part I|Progressive Disease|0|||
126438747|NCT01208207|454907622|FG006|Part I|Progressive Disease|0|||
126438748|NCT01208207|454907616|FG000|Part I|Protocol Violation|8|||
126438749|NCT01208207|454907617|FG001|Part I|Protocol Violation|0|||
126438750|NCT01208207|454907618|FG002|Part I|Protocol Violation|2|||
126438751|NCT01208207|454907619|FG003|Part I|Protocol Violation|0|||
126438752|NCT01208207|454907620|FG004|Part I|Protocol Violation|0|||
126438753|NCT01208207|454907621|FG005|Part I|Protocol Violation|0|||
126438754|NCT01208207|454907622|FG006|Part I|Protocol Violation|0|||
126438755|NCT01208207|454907616|FG000|Part I|Withdrawal by Subject|14|||
126438756|NCT01208207|454907617|FG001|Part I|Withdrawal by Subject|4|||
126438757|NCT01208207|454907618|FG002|Part I|Withdrawal by Subject|4|||
126438758|NCT01208207|454907619|FG003|Part I|Withdrawal by Subject|0|||
126438759|NCT01208207|454907620|FG004|Part I|Withdrawal by Subject|0|||
126438760|NCT01208207|454907621|FG005|Part I|Withdrawal by Subject|0|||
126438761|NCT01208207|454907622|FG006|Part I|Withdrawal by Subject|0|||
126438762|NCT01208207|454907616|FG000|Part II|Withdrawal by Subject|0|||
126438763|NCT01208207|454907617|FG001|Part II|Withdrawal by Subject|0|||
126438764|NCT01208207|454907618|FG002|Part II|Withdrawal by Subject|0|||
126438765|NCT01208207|454907619|FG003|Part II|Withdrawal by Subject|10|||
126438766|NCT01208207|454907620|FG004|Part II|Withdrawal by Subject|9|||
126438767|NCT01208207|454907621|FG005|Part II|Withdrawal by Subject|3|||
126438768|NCT01208207|454907622|FG006|Part II|Withdrawal by Subject|5|||
126438769|NCT01208207|454907616|FG000|Part II|Adverse Event|0|||
126438770|NCT01208207|454907617|FG001|Part II|Adverse Event|0|||
126438771|NCT01208207|454907618|FG002|Part II|Adverse Event|0|||
126438772|NCT01208207|454907619|FG003|Part II|Adverse Event|5|||
126438773|NCT01208207|454907620|FG004|Part II|Adverse Event|9|||
126438774|NCT01208207|454907621|FG005|Part II|Adverse Event|4|||
126438775|NCT01208207|454907622|FG006|Part II|Adverse Event|2|||
126438776|NCT01208207|454907616|FG000|Part II|Lack of Efficacy|0|||
126438777|NCT01208207|454907617|FG001|Part II|Lack of Efficacy|0|||
126438778|NCT01208207|454907618|FG002|Part II|Lack of Efficacy|0|||
126438779|NCT01208207|454907619|FG003|Part II|Lack of Efficacy|6|||
126438780|NCT01208207|454907620|FG004|Part II|Lack of Efficacy|4|||
126438781|NCT01208207|454907621|FG005|Part II|Lack of Efficacy|3|||
126438782|NCT01208207|454907622|FG006|Part II|Lack of Efficacy|3|||
126438783|NCT01208207|454907616|FG000|Part II|Lost to Follow-up|0|||
126438784|NCT01208207|454907617|FG001|Part II|Lost to Follow-up|0|||
126438785|NCT01208207|454907618|FG002|Part II|Lost to Follow-up|0|||
126438786|NCT01208207|454907619|FG003|Part II|Lost to Follow-up|4|||
126438787|NCT01208207|454907620|FG004|Part II|Lost to Follow-up|0|||
126438788|NCT01208207|454907621|FG005|Part II|Lost to Follow-up|2|||
126438789|NCT01208207|454907622|FG006|Part II|Lost to Follow-up|1|||
126438790|NCT01208207|454907616|FG000|Part II|Non-Compliance With Study Drug|0|||
126438791|NCT01208207|454907617|FG001|Part II|Non-Compliance With Study Drug|0|||
126438792|NCT01208207|454907618|FG002|Part II|Non-Compliance With Study Drug|0|||
126438793|NCT01208207|454907619|FG003|Part II|Non-Compliance With Study Drug|4|||
126438794|NCT01208207|454907620|FG004|Part II|Non-Compliance With Study Drug|1|||
126438795|NCT01208207|454907621|FG005|Part II|Non-Compliance With Study Drug|1|||
126438796|NCT01208207|454907622|FG006|Part II|Non-Compliance With Study Drug|0|||
126438797|NCT01208207|454907616|FG000|Part II|Physician Decision|0|||
126438798|NCT01208207|454907617|FG001|Part II|Physician Decision|0|||
126438799|NCT01208207|454907618|FG002|Part II|Physician Decision|0|||
126438800|NCT01208207|454907619|FG003|Part II|Physician Decision|1|||
126438801|NCT01208207|454907620|FG004|Part II|Physician Decision|0|||
126438802|NCT01208207|454907621|FG005|Part II|Physician Decision|2|||
126438803|NCT01208207|454907622|FG006|Part II|Physician Decision|0|||
126438804|NCT01208207|454907616|FG000|Part II|Protocol Violation|0|||
126438805|NCT01208207|454907617|FG001|Part II|Protocol Violation|0|||
126438806|NCT01208207|454907618|FG002|Part II|Protocol Violation|0|||
126438807|NCT01208207|454907619|FG003|Part II|Protocol Violation|1|||
126438808|NCT01208207|454907620|FG004|Part II|Protocol Violation|0|||
126438809|NCT01208207|454907621|FG005|Part II|Protocol Violation|0|||
126438810|NCT01208207|454907622|FG006|Part II|Protocol Violation|0|||
126350697|NCT02390284|454575395|FG001|Overall Study|Physician Decision|0|||
126688638|NCT02971670|455815216|FG003|Overall Study|Withdrawal by Subject|2|||
126688639|NCT00288080|455815217|FG000|Overall Study|Withdrawal by Subject|1|||
126688640|NCT00288080|455815218|FG001|Overall Study|Withdrawal by Subject|3|||
126688641|NCT00288080|455815217|FG000|Overall Study|Protocol Violation|25|||
126688642|NCT00288080|455815218|FG001|Overall Study|Protocol Violation|20|||
126350698|NCT02390284|454575396|FG002|Overall Study|Physician Decision|9|||
126350699|NCT01922934|454575397|FG000|Eligible Patients|Death|0|||
126350700|NCT01922934|454575398|FG001|Eligible Patients|Death|7|||
126350701|NCT01922934|454575397|FG000|Eligible Patients|Physician Decision|17|||
126350702|NCT01922934|454575398|FG001|Eligible Patients|Physician Decision|0|||
126350703|NCT01922934|454575397|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
126350704|NCT01922934|454575398|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
126350705|NCT01922934|454575397|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
126350706|NCT01922934|454575398|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
126350707|NCT01922934|454575397|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
126350708|NCT01922934|454575398|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
126350709|NCT01922934|454575397|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
126350710|NCT01922934|454575398|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
126350711|NCT00658528|454575401|FG000|Overall Study|Adverse Event|5|||
126350712|NCT00658528|454575402|FG001|Overall Study|Adverse Event|7|||
126350713|NCT00658528|454575401|FG000|Overall Study|Lost to Follow-up|14|||
126350714|NCT00658528|454575402|FG001|Overall Study|Lost to Follow-up|22|||
126350715|NCT00658528|454575401|FG000|Overall Study|Withdrawal by Subject|8|||
126350716|NCT00658528|454575402|FG001|Overall Study|Withdrawal by Subject|6|||
126350717|NCT00658528|454575401|FG000|Overall Study|Withdrawal of consent|5|||
126350718|NCT00658528|454575402|FG001|Overall Study|Withdrawal of consent|6|||
126350719|NCT00658528|454575401|FG000|Overall Study|Other|8|||
126350720|NCT00658528|454575402|FG001|Overall Study|Other|4|||
126350721|NCT04017962|454575403|FG000|Overall Study|Death|2|||
126350722|NCT04017962|454575404|FG001|Overall Study|Death|0|||
126350723|NCT04017962|454575403|FG000|Overall Study|Lost to Follow-up|2|||
126350724|NCT04017962|454575404|FG001|Overall Study|Lost to Follow-up|0|||
126350725|NCT04017962|454575403|FG000|Overall Study|Physician Decision|1|||
126350726|NCT04017962|454575404|FG001|Overall Study|Physician Decision|0|||
126350727|NCT04017962|454575403|FG000|Overall Study|Discontinued LTV|5|||
126350728|NCT04017962|454575404|FG001|Overall Study|Discontinued LTV|0|||
126350729|NCT00462462|454575412|FG000|Overall Study|Physician Decision|0|||
126350730|NCT00462462|454575413|FG001|Overall Study|Physician Decision|1|||
126350731|NCT01163617|454575414|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350732|NCT01163617|454575415|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
126350733|NCT01163617|454575416|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350734|NCT01163617|454575417|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350735|NCT01163617|454575418|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350736|NCT01163617|454575419|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350737|NCT01163617|454575420|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350738|NCT01163617|454575421|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
126350739|NCT01163617|454575414|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126350740|NCT01163617|454575415|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
126350741|NCT01163617|454575416|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126350742|NCT01163617|454575417|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126350743|NCT01163617|454575418|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126350744|NCT01163617|454575419|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126688643|NCT00087646|455815219|FG000|Overall Study|Adverse Event|37|||
126688644|NCT00087646|455815220|FG001|Overall Study|Adverse Event|6|||
126688645|NCT00087646|455815221|FG002|Overall Study|Adverse Event|18|||
126688646|NCT00087646|455815222|FG003|Overall Study|Adverse Event|20|||
126688647|NCT00087646|455815219|FG000|Overall Study|Death|0|||
126688648|NCT00087646|455815220|FG001|Overall Study|Death|1|||
126688649|NCT00087646|455815221|FG002|Overall Study|Death|0|||
126688650|NCT00087646|455815222|FG003|Overall Study|Death|0|||
126688651|NCT00087646|455815219|FG000|Overall Study|Withdrawal by Subject|6|||
126688652|NCT00087646|455815220|FG001|Overall Study|Withdrawal by Subject|1|||
126688653|NCT00087646|455815221|FG002|Overall Study|Withdrawal by Subject|2|||
126688654|NCT00087646|455815222|FG003|Overall Study|Withdrawal by Subject|2|||
126688655|NCT00087646|455815219|FG000|Overall Study|Insufficient therapeutic response|64|||
126688656|NCT00087646|455815220|FG001|Overall Study|Insufficient therapeutic response|24|||
126688657|NCT00087646|455815221|FG002|Overall Study|Insufficient therapeutic response|38|||
126759971|NCT01000311|456070494|FG001|Overall Study|Administrative reason|15|||
126759972|NCT01610752|456070497|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
126350745|NCT01163617|454575420|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126350746|NCT01163617|454575421|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
126350747|NCT01163617|454575414|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350748|NCT01163617|454575415|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350749|NCT01163617|454575416|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
126350750|NCT01163617|454575417|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350751|NCT01163617|454575418|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350752|NCT01163617|454575419|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350753|NCT01163617|454575420|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350754|NCT01163617|454575421|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
126350755|NCT02394756|454575422|FG000|Period 1|Lens Discomfort|0|||
126350756|NCT02394756|454575423|FG001|Period 1|Lens Discomfort|0|||
126350757|NCT02394756|454575424|FG002|Period 1|Lens Discomfort|0|||
126350758|NCT02394756|454575425|FG003|Period 1|Lens Discomfort|0|||
126350759|NCT02394756|454575426|FG004|Period 1|Lens Discomfort|0|||
126350760|NCT02394756|454575427|FG005|Period 1|Lens Discomfort|1|||
126350761|NCT02394756|454575422|FG000|Period 1|Withdrawal by Subject|0|||
126350762|NCT02394756|454575423|FG001|Period 1|Withdrawal by Subject|1|||
126350763|NCT02394756|454575424|FG002|Period 1|Withdrawal by Subject|1|||
126350764|NCT02394756|454575425|FG003|Period 1|Withdrawal by Subject|1|||
126350765|NCT02394756|454575426|FG004|Period 1|Withdrawal by Subject|0|||
126350766|NCT02394756|454575427|FG005|Period 1|Withdrawal by Subject|0|||
126350767|NCT02394756|454575422|FG000|Period 2|Unsatisfactory Visual Response|0|||
126350768|NCT02394756|454575423|FG001|Period 2|Unsatisfactory Visual Response|0|||
126350769|NCT02394756|454575424|FG002|Period 2|Unsatisfactory Visual Response|0|||
126350770|NCT02394756|454575425|FG003|Period 2|Unsatisfactory Visual Response|0|||
126350771|NCT02394756|454575426|FG004|Period 2|Unsatisfactory Visual Response|1|||
126350772|NCT02394756|454575427|FG005|Period 2|Unsatisfactory Visual Response|0|||
126350773|NCT02335944|454575428|FG000|Treatment Phase|Progressive Disease|2|||
126350774|NCT02335944|454575429|FG001|Treatment Phase|Progressive Disease|5|||
126350775|NCT02335944|454575430|FG002|Treatment Phase|Progressive Disease|2|||
126350776|NCT02335944|454575431|FG003|Treatment Phase|Progressive Disease|11|||
126350777|NCT02335944|454575432|FG004|Treatment Phase|Progressive Disease|4|||
126350778|NCT02335944|454575433|FG005|Treatment Phase|Progressive Disease|25|||
126350779|NCT02335944|454575434|FG006|Treatment Phase|Progressive Disease|2|||
126350780|NCT02335944|454575435|FG007|Treatment Phase|Progressive Disease|30|||
126350781|NCT02335944|454575436|FG008|Treatment Phase|Progressive Disease|27|||
126350782|NCT02335944|454575437|FG009|Treatment Phase|Progressive Disease|0|||
126350783|NCT02335944|454575428|FG000|Treatment Phase|Adverse Event|2|||
126350784|NCT02335944|454575429|FG001|Treatment Phase|Adverse Event|0|||
126350785|NCT02335944|454575430|FG002|Treatment Phase|Adverse Event|0|||
126350786|NCT02335944|454575431|FG003|Treatment Phase|Adverse Event|2|||
126350787|NCT02335944|454575432|FG004|Treatment Phase|Adverse Event|1|||
126350788|NCT02335944|454575433|FG005|Treatment Phase|Adverse Event|15|||
126688658|NCT00087646|455815222|FG003|Overall Study|Insufficient therapeutic response|51|||
126350789|NCT02335944|454575434|FG006|Treatment Phase|Adverse Event|0|||
126350790|NCT02335944|454575435|FG007|Treatment Phase|Adverse Event|5|||
126350791|NCT02335944|454575436|FG008|Treatment Phase|Adverse Event|7|||
126438811|NCT01208207|454907616|FG000|Part II|Technical Problems|0|||
126688659|NCT00087646|455815219|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
126688660|NCT00087646|455815220|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
126688661|NCT00087646|455815221|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
126688662|NCT00087646|455815222|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
126759973|NCT01610752|456070498|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
126759974|NCT01610752|456070499|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
126759975|NCT02815670|456070500|FG000|Overall Study|Prematurely discontinued of the trial|1|||
126759976|NCT02354599|456070504|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126759977|NCT02354599|456070505|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
126759978|NCT02354599|456070506|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
126759979|NCT02354599|456070507|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
126759980|NCT02354599|456070508|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
126759981|NCT02354599|456070509|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
126350792|NCT02335944|454575437|FG009|Treatment Phase|Adverse Event|0|||
126350793|NCT02335944|454575428|FG000|Treatment Phase|Physician Decision|0|||
126350794|NCT02335944|454575429|FG001|Treatment Phase|Physician Decision|0|||
126759982|NCT02354599|456070504|FG000|Overall Study|Withdrawal by Subject|1|||
126350795|NCT02335944|454575430|FG002|Treatment Phase|Physician Decision|0|||
126350796|NCT02335944|454575431|FG003|Treatment Phase|Physician Decision|1|||
126350797|NCT02335944|454575432|FG004|Treatment Phase|Physician Decision|0|||
126350798|NCT02335944|454575433|FG005|Treatment Phase|Physician Decision|6|||
126350799|NCT02335944|454575434|FG006|Treatment Phase|Physician Decision|1|||
126350800|NCT02335944|454575435|FG007|Treatment Phase|Physician Decision|2|||
126350801|NCT02335944|454575436|FG008|Treatment Phase|Physician Decision|1|||
126350802|NCT02335944|454575437|FG009|Treatment Phase|Physician Decision|0|||
126350803|NCT02335944|454575428|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
126350804|NCT02335944|454575429|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
126350805|NCT02335944|454575430|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
126350806|NCT02335944|454575431|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
126350807|NCT02335944|454575432|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
126350808|NCT02335944|454575433|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
126350809|NCT02335944|454575434|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
126350810|NCT02335944|454575435|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
126350811|NCT02335944|454575436|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
126350812|NCT02335944|454575437|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
126350813|NCT02335944|454575428|FG000|Treatment Phase|Subject/Guardian Decision|0|||
126438812|NCT01208207|454907617|FG001|Part II|Technical Problems|0|||
126438813|NCT01208207|454907618|FG002|Part II|Technical Problems|0|||
126438814|NCT01208207|454907619|FG003|Part II|Technical Problems|1|||
126438815|NCT01208207|454907620|FG004|Part II|Technical Problems|0|||
126438816|NCT01208207|454907621|FG005|Part II|Technical Problems|1|||
126438817|NCT01208207|454907622|FG006|Part II|Technical Problems|0|||
126438818|NCT02531802|454907624|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
126438819|NCT02531802|454907625|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
126438820|NCT02531802|454907626|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
126438821|NCT02531802|454907627|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
126438822|NCT02531802|454907628|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
126438823|NCT02531802|454907629|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
126438824|NCT02531802|454907630|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
126438825|NCT02531802|454907631|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
126438826|NCT02531802|454907632|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
126438827|NCT02531802|454907633|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
126438828|NCT02531802|454907634|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
126438829|NCT02531802|454907635|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
126438830|NCT02531802|454907636|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
126438831|NCT02531802|454907637|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
126438832|NCT02531802|454907638|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
126438833|NCT02531802|454907639|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
126438834|NCT02531802|454907640|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
126438835|NCT02531802|454907641|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
126438836|NCT02531802|454907642|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
126438837|NCT02531802|454907643|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
126438838|NCT02531802|454907644|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
126438839|NCT02531802|454907624|FG000|Received Vaccination 2|Physician Decision|0|||
126438840|NCT02531802|454907625|FG001|Received Vaccination 2|Physician Decision|0|||
126438841|NCT02531802|454907626|FG002|Received Vaccination 2|Physician Decision|0|||
126438842|NCT02531802|454907627|FG003|Received Vaccination 2|Physician Decision|0|||
126438843|NCT02531802|454907628|FG004|Received Vaccination 2|Physician Decision|0|||
126438844|NCT02531802|454907629|FG005|Received Vaccination 2|Physician Decision|1|||
126438845|NCT02531802|454907630|FG006|Received Vaccination 2|Physician Decision|0|||
126438846|NCT02531802|454907631|FG007|Received Vaccination 2|Physician Decision|0|||
126688663|NCT00087646|455815219|FG000|Overall Study|Failure to Return|5|||
126688664|NCT00087646|455815220|FG001|Overall Study|Failure to Return|2|||
126688665|NCT00087646|455815221|FG002|Overall Study|Failure to Return|2|||
126688666|NCT00087646|455815222|FG003|Overall Study|Failure to Return|3|||
126688667|NCT00087646|455815219|FG000|Overall Study|Administrative/Other|6|||
126688668|NCT00087646|455815220|FG001|Overall Study|Administrative/Other|1|||
126688669|NCT00087646|455815221|FG002|Overall Study|Administrative/Other|1|||
126688670|NCT00087646|455815222|FG003|Overall Study|Administrative/Other|2|||
126688671|NCT00087646|455815219|FG000|Overall Study|Other Protocol Violation|3|||
126688672|NCT00087646|455815220|FG001|Overall Study|Other Protocol Violation|1|||
126688673|NCT00087646|455815221|FG002|Overall Study|Other Protocol Violation|0|||
126688674|NCT00087646|455815222|FG003|Overall Study|Other Protocol Violation|0|||
126688675|NCT00087646|455815219|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
126688676|NCT00087646|455815220|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
126688677|NCT00087646|455815221|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
126688678|NCT00087646|455815222|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
126688679|NCT01235962|455815223|FG000|Overall Study|Withdrawal by Subject|20|||
126688680|NCT01235962|455815224|FG001|Overall Study|Withdrawal by Subject|19|||
126688681|NCT01235962|455815225|FG002|Overall Study|Withdrawal by Subject|62|||
126688682|NCT01235962|455815226|FG003|Overall Study|Withdrawal by Subject|49|||
126688683|NCT01235962|455815223|FG000|Overall Study|Lost to Follow-up|21|||
126688684|NCT01235962|455815224|FG001|Overall Study|Lost to Follow-up|16|||
126688685|NCT01235962|455815225|FG002|Overall Study|Lost to Follow-up|47|||
126688686|NCT01235962|455815226|FG003|Overall Study|Lost to Follow-up|32|||
126688687|NCT01235962|455815223|FG000|Overall Study|Physician Decision|5|||
126688688|NCT01235962|455815224|FG001|Overall Study|Physician Decision|0|||
126688689|NCT01235962|455815225|FG002|Overall Study|Physician Decision|9|||
126688690|NCT01235962|455815226|FG003|Overall Study|Physician Decision|5|||
126688691|NCT01580397|455815229|FG000|Overall Study|Lack of Efficacy|14|||
126688692|NCT01353703|455815231|FG000|Overall Study|Migrated/moved from study area|1|||
126438847|NCT02531802|454907632|FG008|Received Vaccination 2|Physician Decision|0|||
126438848|NCT02531802|454907633|FG009|Received Vaccination 2|Physician Decision|2|||
126438849|NCT02531802|454907634|FG010|Received Vaccination 2|Physician Decision|0|||
126438850|NCT02531802|454907635|FG011|Received Vaccination 2|Physician Decision|0|||
126438851|NCT02531802|454907636|FG012|Received Vaccination 2|Physician Decision|0|||
126438852|NCT02531802|454907637|FG013|Received Vaccination 2|Physician Decision|1|||
126438853|NCT02531802|454907638|FG014|Received Vaccination 2|Physician Decision|0|||
126438854|NCT02531802|454907639|FG015|Received Vaccination 2|Physician Decision|0|||
126438855|NCT02531802|454907640|FG016|Received Vaccination 2|Physician Decision|0|||
126438856|NCT02531802|454907641|FG017|Received Vaccination 2|Physician Decision|1|||
126438857|NCT02531802|454907642|FG018|Received Vaccination 2|Physician Decision|0|||
126438858|NCT02531802|454907643|FG019|Received Vaccination 2|Physician Decision|0|||
126438859|NCT02531802|454907644|FG020|Received Vaccination 2|Physician Decision|0|||
126438860|NCT02531802|454907624|FG000|Received Vaccination 2|Adverse Event|0|||
126438861|NCT02531802|454907625|FG001|Received Vaccination 2|Adverse Event|0|||
126438862|NCT02531802|454907626|FG002|Received Vaccination 2|Adverse Event|0|||
126438863|NCT02531802|454907627|FG003|Received Vaccination 2|Adverse Event|0|||
126438864|NCT02531802|454907628|FG004|Received Vaccination 2|Adverse Event|0|||
126438865|NCT02531802|454907629|FG005|Received Vaccination 2|Adverse Event|2|||
126438866|NCT02531802|454907630|FG006|Received Vaccination 2|Adverse Event|0|||
126438867|NCT02531802|454907631|FG007|Received Vaccination 2|Adverse Event|0|||
126438868|NCT02531802|454907632|FG008|Received Vaccination 2|Adverse Event|0|||
126438869|NCT02531802|454907633|FG009|Received Vaccination 2|Adverse Event|0|||
126438870|NCT02531802|454907634|FG010|Received Vaccination 2|Adverse Event|0|||
126438871|NCT02531802|454907635|FG011|Received Vaccination 2|Adverse Event|0|||
126438872|NCT02531802|454907636|FG012|Received Vaccination 2|Adverse Event|0|||
126438873|NCT02531802|454907637|FG013|Received Vaccination 2|Adverse Event|0|||
126438874|NCT02531802|454907638|FG014|Received Vaccination 2|Adverse Event|0|||
126438875|NCT02531802|454907639|FG015|Received Vaccination 2|Adverse Event|0|||
126438876|NCT02531802|454907640|FG016|Received Vaccination 2|Adverse Event|0|||
126438877|NCT02531802|454907641|FG017|Received Vaccination 2|Adverse Event|2|||
126438878|NCT02531802|454907642|FG018|Received Vaccination 2|Adverse Event|1|||
126438879|NCT02531802|454907643|FG019|Received Vaccination 2|Adverse Event|0|||
126438880|NCT02531802|454907644|FG020|Received Vaccination 2|Adverse Event|1|||
126438881|NCT02531802|454907624|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
126438882|NCT02531802|454907625|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
126438883|NCT02531802|454907626|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
126438884|NCT02531802|454907627|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
126438885|NCT02531802|454907628|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
126438886|NCT02531802|454907629|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
126438887|NCT02531802|454907630|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
126438888|NCT02531802|454907631|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
126438889|NCT02531802|454907632|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
126438890|NCT02531802|454907633|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
126438891|NCT02531802|454907634|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
126438892|NCT02531802|454907635|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
126688693|NCT01353703|455815232|FG001|Overall Study|Migrated/moved from study area|0|||
126688694|NCT06098729|455815246|FG000|Overall Study|Withdrawal by Subject|1|||
126688695|NCT04925752|455815255|FG000|Overall Study|Still on Study|1826|||
126688696|NCT04925752|455815256|FG001|Overall Study|Still on Study|926|||
126438893|NCT02531802|454907636|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
126438894|NCT02531802|454907637|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
126438895|NCT02531802|454907638|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
126438896|NCT02531802|454907639|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
126438897|NCT02531802|454907640|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
126438898|NCT02531802|454907641|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
126438899|NCT02531802|454907642|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
126438900|NCT02531802|454907643|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
126438901|NCT02531802|454907644|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
126438902|NCT03987503|454907647|FG000|Overall Study|Lost to Follow-up|20|||
126438903|NCT03987503|454907647|FG000|Overall Study|Withdrawal by Subject|2|||
126438904|NCT01929317|454907657|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
126438905|NCT01929317|454907658|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
126438906|NCT01929317|454907657|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
126688697|NCT04925752|455815255|FG000|Overall Study|Withdrew Consent|128|||
126688698|NCT04925752|455815256|FG001|Overall Study|Withdrew Consent|59|||
126688699|NCT04925752|455815255|FG000|Overall Study|Lost to Follow-up|73|||
126688700|NCT04925752|455815256|FG001|Overall Study|Lost to Follow-up|47|||
126688701|NCT04925752|455815255|FG000|Overall Study|Randomized but Never Treated|12|||
126688702|NCT04925752|455815256|FG001|Overall Study|Randomized but Never Treated|9|||
126688703|NCT04925752|455815255|FG000|Overall Study|Hiv-1 Infection|6|||
126688704|NCT04925752|455815256|FG001|Overall Study|Hiv-1 Infection|7|||
126688705|NCT04925752|455815255|FG000|Overall Study|Investigator's discretion|8|||
126688706|NCT04925752|455815256|FG001|Overall Study|Investigator's discretion|5|||
126688707|NCT04925752|455815255|FG000|Overall Study|Non-compliance with Study Drug|8|||
126688708|NCT04925752|455815256|FG001|Overall Study|Non-compliance with Study Drug|5|||
126688709|NCT04925752|455815255|FG000|Overall Study|Adverse Event|5|||
126688710|NCT04925752|455815256|FG001|Overall Study|Adverse Event|2|||
126688711|NCT04925752|455815255|FG000|Overall Study|Death|4|||
126688712|NCT04925752|455815256|FG001|Overall Study|Death|2|||
126688713|NCT04925752|455815255|FG000|Overall Study|Protocol Violation|1|||
126688714|NCT04925752|455815256|FG001|Overall Study|Protocol Violation|3|||
126688715|NCT04925752|455815255|FG000|Overall Study|Withdrew Assent|1|||
126688716|NCT04925752|455815256|FG001|Overall Study|Withdrew Assent|0|||
126688717|NCT03467958|455815258|FG000|Overall Study|Adverse Event|20|||
126688718|NCT03467958|455815259|FG001|Overall Study|Adverse Event|32|||
126688719|NCT03467958|455815260|FG002|Overall Study|Adverse Event|5|||
126688720|NCT03467958|455815261|FG003|Overall Study|Adverse Event|3|||
126688721|NCT03467958|455815262|FG004|Overall Study|Adverse Event|3|||
126688722|NCT03467958|455815263|FG005|Overall Study|Adverse Event|3|||
126688723|NCT03467958|455815264|FG006|Overall Study|Adverse Event|6|||
126688724|NCT03467958|455815265|FG007|Overall Study|Adverse Event|5|||
126688725|NCT03467958|455815266|FG008|Overall Study|Adverse Event|0|||
126688726|NCT03467958|455815258|FG000|Overall Study|Lack of Efficacy|59|||
126688727|NCT03467958|455815259|FG001|Overall Study|Lack of Efficacy|120|||
126688728|NCT03467958|455815260|FG002|Overall Study|Lack of Efficacy|6|||
126688729|NCT03467958|455815261|FG003|Overall Study|Lack of Efficacy|9|||
126688730|NCT03467958|455815262|FG004|Overall Study|Lack of Efficacy|8|||
126688731|NCT03467958|455815263|FG005|Overall Study|Lack of Efficacy|9|||
126688732|NCT03467958|455815264|FG006|Overall Study|Lack of Efficacy|11|||
126688733|NCT03467958|455815265|FG007|Overall Study|Lack of Efficacy|9|||
126688734|NCT03467958|455815266|FG008|Overall Study|Lack of Efficacy|3|||
126688735|NCT03467958|455815258|FG000|Overall Study|Lost to Follow-up|1|||
126688736|NCT03467958|455815259|FG001|Overall Study|Lost to Follow-up|2|||
126688737|NCT03467958|455815260|FG002|Overall Study|Lost to Follow-up|1|||
126688738|NCT03467958|455815261|FG003|Overall Study|Lost to Follow-up|0|||
126688739|NCT03467958|455815262|FG004|Overall Study|Lost to Follow-up|4|||
126688740|NCT03467958|455815263|FG005|Overall Study|Lost to Follow-up|0|||
126688741|NCT03467958|455815264|FG006|Overall Study|Lost to Follow-up|0|||
126688742|NCT03467958|455815265|FG007|Overall Study|Lost to Follow-up|0|||
126350814|NCT02335944|454575429|FG001|Treatment Phase|Subject/Guardian Decision|0|||
126350815|NCT02335944|454575430|FG002|Treatment Phase|Subject/Guardian Decision|1|||
126350816|NCT02335944|454575431|FG003|Treatment Phase|Subject/Guardian Decision|0|||
126350817|NCT02335944|454575432|FG004|Treatment Phase|Subject/Guardian Decision|0|||
126350818|NCT02335944|454575433|FG005|Treatment Phase|Subject/Guardian Decision|1|||
126350819|NCT02335944|454575434|FG006|Treatment Phase|Subject/Guardian Decision|0|||
126350820|NCT02335944|454575435|FG007|Treatment Phase|Subject/Guardian Decision|4|||
126350821|NCT02335944|454575436|FG008|Treatment Phase|Subject/Guardian Decision|0|||
126350822|NCT02335944|454575437|FG009|Treatment Phase|Subject/Guardian Decision|0|||
126350823|NCT02335944|454575428|FG000|Post-treatment Follow-up|Progressive Disease|0|||
126350824|NCT02335944|454575429|FG001|Post-treatment Follow-up|Progressive Disease|0|||
126350825|NCT02335944|454575430|FG002|Post-treatment Follow-up|Progressive Disease|0|||
126350826|NCT02335944|454575431|FG003|Post-treatment Follow-up|Progressive Disease|1|||
126350827|NCT02335944|454575432|FG004|Post-treatment Follow-up|Progressive Disease|0|||
126350828|NCT02335944|454575433|FG005|Post-treatment Follow-up|Progressive Disease|9|||
126350829|NCT02335944|454575434|FG006|Post-treatment Follow-up|Progressive Disease|0|||
126350830|NCT02335944|454575435|FG007|Post-treatment Follow-up|Progressive Disease|2|||
126350831|NCT02335944|454575436|FG008|Post-treatment Follow-up|Progressive Disease|3|||
126688743|NCT03467958|455815266|FG008|Overall Study|Lost to Follow-up|0|||
126688744|NCT03467958|455815258|FG000|Overall Study|Other reasons|8|||
126688745|NCT03467958|455815259|FG001|Overall Study|Other reasons|14|||
126688746|NCT03467958|455815260|FG002|Overall Study|Other reasons|2|||
126688747|NCT03467958|455815261|FG003|Overall Study|Other reasons|1|||
126688748|NCT03467958|455815262|FG004|Overall Study|Other reasons|4|||
126688749|NCT03467958|455815263|FG005|Overall Study|Other reasons|0|||
126688750|NCT03467958|455815264|FG006|Overall Study|Other reasons|1|||
126688751|NCT03467958|455815265|FG007|Overall Study|Other reasons|0|||
126688752|NCT03467958|455815266|FG008|Overall Study|Other reasons|1|||
126688753|NCT03467958|455815258|FG000|Overall Study|Pregnancy|1|||
126688754|NCT03467958|455815259|FG001|Overall Study|Pregnancy|0|||
126438907|NCT01929317|454907658|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
126438908|NCT01929317|454907657|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
126438909|NCT01929317|454907658|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
126438910|NCT01929317|454907657|FG000|Long-term Phase|Adverse Event|5|||
126438911|NCT01929317|454907658|FG001|Long-term Phase|Adverse Event|1|||
126438912|NCT01929317|454907657|FG000|Long-term Phase|Physician Decision|3|||
126438913|NCT01929317|454907658|FG001|Long-term Phase|Physician Decision|0|||
126438914|NCT01929317|454907657|FG000|Long-term Phase|Withdrawal by Subject|4|||
126438915|NCT01929317|454907658|FG001|Long-term Phase|Withdrawal by Subject|0|||
126438916|NCT01929317|454907657|FG000|Long-term Phase|Protocol Violation|1|||
126438917|NCT01929317|454907658|FG001|Long-term Phase|Protocol Violation|0|||
126438918|NCT01929317|454907657|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
126438919|NCT01929317|454907658|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
126438920|NCT01929317|454907657|FG000|Long-term Phase|Study Closed/Terminated|5|||
126438921|NCT01929317|454907658|FG001|Long-term Phase|Study Closed/Terminated|3|||
126438922|NCT04322526|454907659|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
126438923|NCT04322526|454907660|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
126438924|NCT04322526|454907659|FG000|Washout (1 Week)|Lost to Follow-up|1|||
126438925|NCT04322526|454907660|FG001|Washout (1 Week)|Lost to Follow-up|2|||
126438926|NCT01716234|454907661|FG000|Overall Study|Protocol Violation|0|||
126438927|NCT01716234|454907662|FG001|Overall Study|Protocol Violation|0|||
126438928|NCT01716234|454907663|FG002|Overall Study|Protocol Violation|0|||
126438929|NCT01716234|454907664|FG003|Overall Study|Protocol Violation|1|||
126438930|NCT01716234|454907665|FG004|Overall Study|Protocol Violation|1|||
126438931|NCT01716234|454907666|FG005|Overall Study|Protocol Violation|1|||
126438932|NCT01716234|454907667|FG006|Overall Study|Protocol Violation|0|||
126438933|NCT01716234|454907661|FG000|Overall Study|Lack of Efficacy|0|||
126438934|NCT01716234|454907662|FG001|Overall Study|Lack of Efficacy|0|||
126438935|NCT01716234|454907663|FG002|Overall Study|Lack of Efficacy|0|||
126438936|NCT01716234|454907664|FG003|Overall Study|Lack of Efficacy|1|||
126438937|NCT01716234|454907665|FG004|Overall Study|Lack of Efficacy|0|||
126438938|NCT01716234|454907666|FG005|Overall Study|Lack of Efficacy|0|||
126438939|NCT01716234|454907667|FG006|Overall Study|Lack of Efficacy|0|||
126438940|NCT01716234|454907661|FG000|Overall Study|Did not meet protocol eligibility|0|||
126438941|NCT01716234|454907662|FG001|Overall Study|Did not meet protocol eligibility|0|||
126438942|NCT01716234|454907663|FG002|Overall Study|Did not meet protocol eligibility|1|||
126438943|NCT01716234|454907664|FG003|Overall Study|Did not meet protocol eligibility|0|||
126438944|NCT01716234|454907665|FG004|Overall Study|Did not meet protocol eligibility|0|||
126688755|NCT03467958|455815260|FG002|Overall Study|Pregnancy|0|||
126688756|NCT03467958|455815261|FG003|Overall Study|Pregnancy|0|||
126688757|NCT03467958|455815262|FG004|Overall Study|Pregnancy|0|||
126688758|NCT03467958|455815263|FG005|Overall Study|Pregnancy|1|||
126350832|NCT02335944|454575437|FG009|Post-treatment Follow-up|Progressive Disease|0|||
126350833|NCT02335944|454575428|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350834|NCT02335944|454575429|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350835|NCT02335944|454575430|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350836|NCT02335944|454575431|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350837|NCT02335944|454575432|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350838|NCT02335944|454575433|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
126350839|NCT02335944|454575434|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350840|NCT02335944|454575435|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350841|NCT02335944|454575436|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350842|NCT02335944|454575437|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
126350843|NCT02335944|454575428|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350844|NCT02335944|454575429|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350845|NCT02335944|454575430|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350846|NCT02335944|454575431|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350847|NCT02335944|454575432|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350848|NCT02335944|454575433|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350849|NCT02335944|454575434|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350850|NCT02335944|454575435|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
126350851|NCT02335944|454575436|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
126688759|NCT03467958|455815264|FG006|Overall Study|Pregnancy|0|||
126688760|NCT03467958|455815265|FG007|Overall Study|Pregnancy|0|||
126350852|NCT02335944|454575437|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
126350853|NCT02335944|454575428|FG000|Post-treatment Follow-up|Adverse Event|0|||
126350854|NCT02335944|454575429|FG001|Post-treatment Follow-up|Adverse Event|0|||
126350855|NCT02335944|454575430|FG002|Post-treatment Follow-up|Adverse Event|0|||
126438945|NCT01716234|454907666|FG005|Overall Study|Did not meet protocol eligibility|4|||
126438946|NCT01716234|454907667|FG006|Overall Study|Did not meet protocol eligibility|0|||
126438947|NCT01716234|454907661|FG000|Overall Study|Adverse Event|7|||
126688761|NCT03467958|455815266|FG008|Overall Study|Pregnancy|0|||
126688762|NCT03467958|455815258|FG000|Overall Study|Study terminated by sponsor|65|||
126688763|NCT03467958|455815259|FG001|Overall Study|Study terminated by sponsor|117|||
126688764|NCT03467958|455815260|FG002|Overall Study|Study terminated by sponsor|45|||
126688765|NCT03467958|455815261|FG003|Overall Study|Study terminated by sponsor|64|||
126688766|NCT03467958|455815262|FG004|Overall Study|Study terminated by sponsor|66|||
126688767|NCT03467958|455815263|FG005|Overall Study|Study terminated by sponsor|17|||
126688768|NCT03467958|455815264|FG006|Overall Study|Study terminated by sponsor|11|||
126688769|NCT03467958|455815265|FG007|Overall Study|Study terminated by sponsor|5|||
126688770|NCT03467958|455815266|FG008|Overall Study|Study terminated by sponsor|5|||
126688771|NCT03467958|455815258|FG000|Overall Study|Withdrawal by Subject|25|||
126688772|NCT03467958|455815259|FG001|Overall Study|Withdrawal by Subject|44|||
126688773|NCT03467958|455815260|FG002|Overall Study|Withdrawal by Subject|7|||
126688774|NCT03467958|455815261|FG003|Overall Study|Withdrawal by Subject|8|||
126688775|NCT03467958|455815262|FG004|Overall Study|Withdrawal by Subject|6|||
126688776|NCT03467958|455815263|FG005|Overall Study|Withdrawal by Subject|8|||
126688777|NCT03467958|455815264|FG006|Overall Study|Withdrawal by Subject|4|||
126688778|NCT03467958|455815265|FG007|Overall Study|Withdrawal by Subject|1|||
126688779|NCT03467958|455815266|FG008|Overall Study|Withdrawal by Subject|4|||
126688780|NCT00866307|455815267|FG000|Induction|Adverse Event|5|||
126688781|NCT00866307|455815268|FG001|Induction|Adverse Event|0|||
126688782|NCT00866307|455815269|FG002|Induction|Adverse Event|0|||
126688783|NCT00866307|455815267|FG000|Induction|Death|2|||
126350856|NCT02335944|454575431|FG003|Post-treatment Follow-up|Adverse Event|0|||
126350857|NCT02335944|454575432|FG004|Post-treatment Follow-up|Adverse Event|0|||
126350858|NCT02335944|454575433|FG005|Post-treatment Follow-up|Adverse Event|1|||
126350859|NCT02335944|454575434|FG006|Post-treatment Follow-up|Adverse Event|0|||
126350860|NCT02335944|454575435|FG007|Post-treatment Follow-up|Adverse Event|0|||
126350861|NCT02335944|454575436|FG008|Post-treatment Follow-up|Adverse Event|0|||
126350862|NCT02335944|454575437|FG009|Post-treatment Follow-up|Adverse Event|0|||
126350863|NCT02335944|454575428|FG000|Post-treatment Follow-up|Death|0|||
126350864|NCT02335944|454575429|FG001|Post-treatment Follow-up|Death|0|||
126350865|NCT02335944|454575430|FG002|Post-treatment Follow-up|Death|0|||
126350866|NCT02335944|454575431|FG003|Post-treatment Follow-up|Death|1|||
126350867|NCT02335944|454575432|FG004|Post-treatment Follow-up|Death|0|||
126350868|NCT02335944|454575433|FG005|Post-treatment Follow-up|Death|1|||
126350869|NCT02335944|454575434|FG006|Post-treatment Follow-up|Death|0|||
126350870|NCT02335944|454575435|FG007|Post-treatment Follow-up|Death|0|||
126350871|NCT02335944|454575436|FG008|Post-treatment Follow-up|Death|0|||
126350872|NCT02335944|454575437|FG009|Post-treatment Follow-up|Death|0|||
126350873|NCT02335944|454575428|FG000|Post-treatment Follow-up|Physician Decision|1|||
126350874|NCT02335944|454575429|FG001|Post-treatment Follow-up|Physician Decision|0|||
126350875|NCT02335944|454575430|FG002|Post-treatment Follow-up|Physician Decision|0|||
126350876|NCT02335944|454575431|FG003|Post-treatment Follow-up|Physician Decision|0|||
126350877|NCT02335944|454575432|FG004|Post-treatment Follow-up|Physician Decision|0|||
126350878|NCT02335944|454575433|FG005|Post-treatment Follow-up|Physician Decision|0|||
126350879|NCT02335944|454575434|FG006|Post-treatment Follow-up|Physician Decision|0|||
126350880|NCT02335944|454575435|FG007|Post-treatment Follow-up|Physician Decision|1|||
126350881|NCT02335944|454575436|FG008|Post-treatment Follow-up|Physician Decision|0|||
126350882|NCT02335944|454575437|FG009|Post-treatment Follow-up|Physician Decision|0|||
126350883|NCT01706328|454575443|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
126350884|NCT01706328|454575444|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
126369500|NCT00876447|454650571|FG000|Overall Study|Adverse Event|4|||
126688784|NCT00866307|455815268|FG001|Induction|Death|0|||
126688785|NCT00866307|455815269|FG002|Induction|Death|0|||
126688786|NCT00866307|455815267|FG000|Induction|Physician Decision|5|||
126350885|NCT01706328|454575445|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
126350886|NCT01706328|454575443|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
126438948|NCT01716234|454907662|FG001|Overall Study|Adverse Event|10|||
126438949|NCT01716234|454907663|FG002|Overall Study|Adverse Event|2|||
126438950|NCT01716234|454907664|FG003|Overall Study|Adverse Event|8|||
126438951|NCT01716234|454907665|FG004|Overall Study|Adverse Event|3|||
126438952|NCT01716234|454907666|FG005|Overall Study|Adverse Event|6|||
126438953|NCT01716234|454907667|FG006|Overall Study|Adverse Event|0|||
126438954|NCT01716234|454907661|FG000|Overall Study|Withdrawal by Subject|3|||
126438955|NCT01716234|454907662|FG001|Overall Study|Withdrawal by Subject|0|||
126438956|NCT01716234|454907663|FG002|Overall Study|Withdrawal by Subject|2|||
126438957|NCT01716234|454907664|FG003|Overall Study|Withdrawal by Subject|2|||
126438958|NCT01716234|454907665|FG004|Overall Study|Withdrawal by Subject|1|||
126438959|NCT01716234|454907666|FG005|Overall Study|Withdrawal by Subject|3|||
126438960|NCT01716234|454907667|FG006|Overall Study|Withdrawal by Subject|0|||
126438961|NCT01523756|454907669|FG000|Baseline Period|Adverse Event|0|||
126438962|NCT01523756|454907670|FG001|Baseline Period|Adverse Event|1|||
126438963|NCT01523756|454907669|FG000|Test Period 1|Adverse Event|1|||
126438964|NCT01523756|454907670|FG001|Test Period 1|Adverse Event|0|||
126438965|NCT01523756|454907669|FG000|Test Period 2|Withdrawal by Subject|0|||
126438966|NCT01523756|454907670|FG001|Test Period 2|Withdrawal by Subject|1|||
126438967|NCT00993967|454907671|FG000|Overall Study|Adverse Event|8|||
126438968|NCT00993967|454907671|FG000|Overall Study|Death|1|||
126438969|NCT00993967|454907671|FG000|Overall Study|Lost to Follow-up|14|||
126438970|NCT00993967|454907671|FG000|Overall Study|Withdrawal by Subject|36|||
126438971|NCT00993967|454907671|FG000|Overall Study|Protocol Violation|2|||
126438972|NCT00515619|454907672|FG000|Overall Study|Adverse Event|34|||
126438973|NCT00515619|454907672|FG000|Overall Study|Lack of Efficacy|92|||
126438974|NCT00515619|454907672|FG000|Overall Study|Withdrawal by Subject|66|||
126438975|NCT00515619|454907672|FG000|Overall Study|Protocol Violation|3|||
126438976|NCT00515619|454907672|FG000|Overall Study|Lost to Follow-up|4|||
126438977|NCT00515619|454907672|FG000|Overall Study|Unsatisfactory compliance|6|||
126438978|NCT00515619|454907672|FG000|Overall Study|Other: Site discontinuing trials|2|||
126438979|NCT00515619|454907672|FG000|Overall Study|Other: Subject cannot attend visits|2|||
126438980|NCT00515619|454907672|FG000|Overall Study|Other: Subject required surgery|1|||
126438981|NCT00515619|454907672|FG000|Overall Study|Other: Subject moved to another country|1|||
126438982|NCT00515619|454907672|FG000|Overall Study|Other: Investigator decision|1|||
126438983|NCT00515619|454907672|FG000|Overall Study|Other: Subject became pregnant|1|||
126438984|NCT00515619|454907672|FG000|Overall Study|Other: Request from sponsor|1|||
126438985|NCT00515619|454907672|FG000|Overall Study|Other: Drug available on license|1|||
126438986|NCT00515619|454907672|FG000|Overall Study|Other: Subject interested in other AED|1|||
126688787|NCT00866307|455815268|FG001|Induction|Physician Decision|0|||
126688788|NCT00866307|455815269|FG002|Induction|Physician Decision|0|||
126688789|NCT00866307|455815267|FG000|Induction|Progressive Disease|1|||
126688790|NCT00866307|455815268|FG001|Induction|Progressive Disease|0|||
126688791|NCT00866307|455815269|FG002|Induction|Progressive Disease|0|||
126688792|NCT00866307|455815267|FG000|Induction|Identification of Patients with Day 29 M|3|||
126688793|NCT00866307|455815268|FG001|Induction|Identification of Patients with Day 29 M|0|||
126688794|NCT00866307|455815269|FG002|Induction|Identification of Patients with Day 29 M|0|||
126688795|NCT00866307|455815267|FG000|Induction|Inadequate cytognetic samples th|1|||
126688796|NCT00866307|455815268|FG001|Induction|Inadequate cytognetic samples th|0|||
126688797|NCT00866307|455815269|FG002|Induction|Inadequate cytognetic samples th|0|||
126688798|NCT00866307|455815267|FG000|Induction|Improper post-induction consent|2|||
126688799|NCT00866307|455815268|FG001|Induction|Improper post-induction consent|0|||
126688800|NCT00866307|455815269|FG002|Induction|Improper post-induction consent|0|||
126688801|NCT00866307|455815267|FG000|Induction|Study was closed at the time|1|||
126350887|NCT01706328|454575444|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126350888|NCT01706328|454575445|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126350889|NCT01706328|454575443|FG000|2-week Run-in Period|Physician Decision|4|||
126350890|NCT01706328|454575444|FG001|2-week Run-in Period|Physician Decision|0|||
126350891|NCT01706328|454575445|FG002|2-week Run-in Period|Physician Decision|0|||
126350892|NCT01706328|454575443|FG000|2-week Run-in Period|Adverse Event|4|||
126350893|NCT01706328|454575444|FG001|2-week Run-in Period|Adverse Event|0|||
126350894|NCT01706328|454575445|FG002|2-week Run-in Period|Adverse Event|0|||
126350895|NCT01706328|454575443|FG000|2-week Run-in Period|Lost to Follow-up|2|||
126350896|NCT01706328|454575444|FG001|2-week Run-in Period|Lost to Follow-up|0|||
126350897|NCT01706328|454575445|FG002|2-week Run-in Period|Lost to Follow-up|0|||
126350898|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
126438987|NCT02760498|454907673|FG000|Overall Study|Adverse Event|3|||
126438988|NCT02760498|454907674|FG001|Overall Study|Adverse Event|3|||
126438989|NCT02760498|454907675|FG002|Overall Study|Adverse Event|1|||
126688802|NCT00866307|455815268|FG001|Induction|Study was closed at the time|0|||
126688803|NCT00866307|455815269|FG002|Induction|Study was closed at the time|0|||
126688804|NCT00866307|455815267|FG000|Consolidation/Maintenance|Adverse Event|0|||
126688805|NCT00866307|455815268|FG001|Consolidation/Maintenance|Adverse Event|0|||
126688806|NCT00866307|455815269|FG002|Consolidation/Maintenance|Adverse Event|8|||
126688807|NCT00866307|455815267|FG000|Consolidation/Maintenance|Death|0|||
126688808|NCT00866307|455815268|FG001|Consolidation/Maintenance|Death|0|||
126688809|NCT00866307|455815269|FG002|Consolidation/Maintenance|Death|1|||
126688810|NCT00866307|455815267|FG000|Consolidation/Maintenance|Physician Decision|0|||
126688811|NCT00866307|455815268|FG001|Consolidation/Maintenance|Physician Decision|3|||
126688812|NCT00866307|455815269|FG002|Consolidation/Maintenance|Physician Decision|2|||
126688813|NCT00866307|455815267|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
126688814|NCT00866307|455815268|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
126688815|NCT00866307|455815269|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
126688816|NCT00866307|455815267|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
126688817|NCT00866307|455815268|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
126688818|NCT00866307|455815269|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
126688819|NCT00866307|455815267|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
126688820|NCT00866307|455815268|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
126688821|NCT00866307|455815269|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
126688822|NCT00866307|455815267|FG000|Consolidation/Maintenance|Therapy error|0|||
126688823|NCT00866307|455815268|FG001|Consolidation/Maintenance|Therapy error|1|||
126759983|NCT02354599|456070505|FG001|Overall Study|Withdrawal by Subject|1|||
126759984|NCT02354599|456070506|FG002|Overall Study|Withdrawal by Subject|0|||
126759985|NCT02354599|456070507|FG003|Overall Study|Withdrawal by Subject|0|||
126759986|NCT02354599|456070508|FG004|Overall Study|Withdrawal by Subject|0|||
126350899|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
126350900|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
126350901|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
126350902|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
126350903|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
126350904|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
126350905|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
126350906|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
126350907|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
126350908|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
126350909|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
126350910|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
126350911|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
126350912|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
126350913|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
126350914|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
126350915|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
126350916|NCT01706328|454575443|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126350917|NCT01706328|454575444|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
126350918|NCT01706328|454575445|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
126350919|NCT03018938|454575448|FG000|Overall Study|Death|0|||
126350920|NCT03018938|454575449|FG001|Overall Study|Death|1|||
126350921|NCT03018938|454575448|FG000|Overall Study|Lost to Follow-up|21|||
126350922|NCT03018938|454575449|FG001|Overall Study|Lost to Follow-up|32|||
126350923|NCT03018938|454575448|FG000|Overall Study|Withdrawal by Subject|38|||
126350924|NCT03018938|454575449|FG001|Overall Study|Withdrawal by Subject|45|||
126350925|NCT03018938|454575448|FG000|Overall Study|Physician Decision|3|||
126350926|NCT03018938|454575449|FG001|Overall Study|Physician Decision|2|||
126350927|NCT03018938|454575448|FG000|Overall Study|Sponsor Decision|0|||
126688824|NCT00866307|455815269|FG002|Consolidation/Maintenance|Therapy error|0|||
126688825|NCT00866307|455815267|FG000|Consolidation/Maintenance|Non-compliance|0|||
126688826|NCT00866307|455815268|FG001|Consolidation/Maintenance|Non-compliance|0|||
126759987|NCT02354599|456070509|FG005|Overall Study|Withdrawal by Subject|0|||
126759988|NCT01087944|456070525|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
126759989|NCT01087944|456070526|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
126759990|NCT01087944|456070525|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
126759991|NCT01087944|456070526|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
126759992|NCT01159665|456070527|FG000|Overall Study|Withdrawal by Subject|0|||
126759993|NCT01159665|456070528|FG001|Overall Study|Withdrawal by Subject|1|||
126759994|NCT01159665|456070529|FG002|Overall Study|Withdrawal by Subject|0|||
126759995|NCT01159665|456070530|FG003|Overall Study|Withdrawal by Subject|0|||
126759996|NCT01159665|456070531|FG004|Overall Study|Withdrawal by Subject|0|||
126438990|NCT02760498|454907676|FG003|Overall Study|Adverse Event|1|||
126438991|NCT02760498|454907677|FG004|Overall Study|Adverse Event|0|||
126438992|NCT02760498|454907678|FG005|Overall Study|Adverse Event|6|||
126438993|NCT02760498|454907673|FG000|Overall Study|Death|7|||
126438994|NCT02760498|454907674|FG001|Overall Study|Death|5|||
126438995|NCT02760498|454907675|FG002|Overall Study|Death|5|||
126438996|NCT02760498|454907676|FG003|Overall Study|Death|7|||
126438997|NCT02760498|454907677|FG004|Overall Study|Death|0|||
126438998|NCT02760498|454907678|FG005|Overall Study|Death|23|||
126438999|NCT02760498|454907673|FG000|Overall Study|Lost to Follow-up|0|||
126439000|NCT02760498|454907674|FG001|Overall Study|Lost to Follow-up|0|||
126439001|NCT02760498|454907675|FG002|Overall Study|Lost to Follow-up|0|||
126439002|NCT02760498|454907676|FG003|Overall Study|Lost to Follow-up|0|||
126439003|NCT02760498|454907677|FG004|Overall Study|Lost to Follow-up|0|||
126439004|NCT02760498|454907678|FG005|Overall Study|Lost to Follow-up|3|||
126439005|NCT02760498|454907673|FG000|Overall Study|Non-compliance with study drug|0|||
126439006|NCT02760498|454907674|FG001|Overall Study|Non-compliance with study drug|2|||
126439007|NCT02760498|454907675|FG002|Overall Study|Non-compliance with study drug|0|||
126439008|NCT02760498|454907676|FG003|Overall Study|Non-compliance with study drug|0|||
126439009|NCT02760498|454907677|FG004|Overall Study|Non-compliance with study drug|0|||
126759997|NCT01159665|456070532|FG005|Overall Study|Withdrawal by Subject|0|||
126759998|NCT01377194|456070534|FG000|Overall Study|Adverse Event|3|||
126759999|NCT01377194|456070535|FG001|Overall Study|Adverse Event|12|||
126760000|NCT01377194|456070536|FG002|Overall Study|Adverse Event|19|||
126760001|NCT01377194|456070534|FG000|Overall Study|Lack of Efficacy|3|||
126350928|NCT03018938|454575449|FG001|Overall Study|Sponsor Decision|1|||
126439010|NCT02760498|454907678|FG005|Overall Study|Non-compliance with study drug|0|||
126439011|NCT02760498|454907673|FG000|Overall Study|Participant decision|1|||
126439012|NCT02760498|454907674|FG001|Overall Study|Participant decision|4|||
126439013|NCT02760498|454907675|FG002|Overall Study|Participant decision|2|||
126439014|NCT02760498|454907676|FG003|Overall Study|Participant decision|2|||
126439015|NCT02760498|454907677|FG004|Overall Study|Participant decision|1|||
126439016|NCT02760498|454907678|FG005|Overall Study|Participant decision|6|||
126439017|NCT02760498|454907673|FG000|Overall Study|Sponsor decision|0|||
126439018|NCT02760498|454907674|FG001|Overall Study|Sponsor decision|0|||
126439019|NCT02760498|454907675|FG002|Overall Study|Sponsor decision|0|||
126439020|NCT02760498|454907676|FG003|Overall Study|Sponsor decision|3|||
126439021|NCT02760498|454907677|FG004|Overall Study|Sponsor decision|0|||
126439022|NCT02760498|454907678|FG005|Overall Study|Sponsor decision|0|||
126760002|NCT01377194|456070535|FG001|Overall Study|Lack of Efficacy|3|||
126760003|NCT01377194|456070536|FG002|Overall Study|Lack of Efficacy|3|||
126350929|NCT03018938|454575448|FG000|Overall Study|Screen failure-After randomization|4|||
126350930|NCT03018938|454575449|FG001|Overall Study|Screen failure-After randomization|2|||
126350931|NCT03018938|454575448|FG000|Overall Study|Not recorded|0|||
126350932|NCT03018938|454575449|FG001|Overall Study|Not recorded|2|||
126350933|NCT02811159|454575452|FG000|Treatment Course 1|Lost to Follow-up|1|||
126350934|NCT00191100|454575453|FG000|Overall Study|Adverse Event|18|||
126350935|NCT00191100|454575454|FG001|Overall Study|Adverse Event|1|||
126350936|NCT00191100|454575453|FG000|Overall Study|Lost to Follow-up|2|||
126350937|NCT00191100|454575454|FG001|Overall Study|Lost to Follow-up|0|||
126350938|NCT00191100|454575453|FG000|Overall Study|Patient Moved|0|||
126350939|NCT00191100|454575454|FG001|Overall Study|Patient Moved|1|||
126350940|NCT00191100|454575453|FG000|Overall Study|Withdrawal by Subject|9|||
126350941|NCT00191100|454575454|FG001|Overall Study|Withdrawal by Subject|3|||
126350942|NCT00191100|454575453|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
126350943|NCT00191100|454575454|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
126350944|NCT00191100|454575453|FG000|Overall Study|Clinical Relapse|2|||
126350945|NCT00191100|454575454|FG001|Overall Study|Clinical Relapse|1|||
126350946|NCT00191100|454575453|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
126350947|NCT00191100|454575454|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
126439023|NCT02760498|454907673|FG000|Overall Study|Physician Decision|3|||
126439024|NCT02760498|454907674|FG001|Overall Study|Physician Decision|4|||
126439025|NCT02760498|454907675|FG002|Overall Study|Physician Decision|1|||
126439026|NCT02760498|454907676|FG003|Overall Study|Physician Decision|4|||
126439027|NCT02760498|454907677|FG004|Overall Study|Physician Decision|0|||
126760004|NCT01377194|456070534|FG000|Overall Study|Protocol Violation|4|||
126760005|NCT01377194|456070535|FG001|Overall Study|Protocol Violation|10|||
126760006|NCT01377194|456070536|FG002|Overall Study|Protocol Violation|6|||
126439028|NCT02760498|454907678|FG005|Overall Study|Physician Decision|2|||
126439029|NCT02760498|454907673|FG000|Overall Study|Disease progression|21|||
126439030|NCT02760498|454907674|FG001|Overall Study|Disease progression|19|||
126439031|NCT02760498|454907675|FG002|Overall Study|Disease progression|20|||
126439032|NCT02760498|454907676|FG003|Overall Study|Disease progression|18|||
126439033|NCT02760498|454907677|FG004|Overall Study|Disease progression|4|||
126439034|NCT02760498|454907678|FG005|Overall Study|Disease progression|55|||
126439035|NCT02760498|454907673|FG000|Overall Study|Withdrawal by Subject|4|||
126439036|NCT02760498|454907674|FG001|Overall Study|Withdrawal by Subject|7|||
126439037|NCT02760498|454907675|FG002|Overall Study|Withdrawal by Subject|5|||
126439038|NCT02760498|454907676|FG003|Overall Study|Withdrawal by Subject|1|||
126439039|NCT02760498|454907677|FG004|Overall Study|Withdrawal by Subject|0|||
126439040|NCT02760498|454907678|FG005|Overall Study|Withdrawal by Subject|6|||
126439041|NCT02760498|454907673|FG000|Overall Study|Other than specified|1|||
126439042|NCT02760498|454907674|FG001|Overall Study|Other than specified|6|||
126439043|NCT02760498|454907675|FG002|Overall Study|Other than specified|0|||
126439044|NCT02760498|454907676|FG003|Overall Study|Other than specified|3|||
126439045|NCT02760498|454907677|FG004|Overall Study|Other than specified|1|||
126439046|NCT02760498|454907678|FG005|Overall Study|Other than specified|0|||
126439047|NCT02760498|454907673|FG000|Overall Study|Not treated|0|||
126439048|NCT02760498|454907674|FG001|Overall Study|Not treated|0|||
126439049|NCT02760498|454907675|FG002|Overall Study|Not treated|0|||
126439050|NCT02760498|454907676|FG003|Overall Study|Not treated|0|||
126439051|NCT02760498|454907677|FG004|Overall Study|Not treated|0|||
126439052|NCT02760498|454907678|FG005|Overall Study|Not treated|2|||
126439053|NCT01467960|454907679|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
126439054|NCT01467960|454907680|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
126439055|NCT01467960|454907681|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
126439056|NCT01467960|454907682|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
126439057|NCT01467960|454907683|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
126439058|NCT01467960|454907684|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
126439059|NCT00771758|454907685|FG000|Overall Study|Adverse Event|2|||
126439060|NCT00771758|454907686|FG001|Overall Study|Adverse Event|8|||
126439061|NCT00771758|454907687|FG002|Overall Study|Adverse Event|1|||
126439062|NCT00771758|454907685|FG000|Overall Study|Lack of Efficacy|0|||
126439063|NCT00771758|454907686|FG001|Overall Study|Lack of Efficacy|2|||
126439064|NCT00771758|454907687|FG002|Overall Study|Lack of Efficacy|1|||
126439065|NCT00771758|454907685|FG000|Overall Study|Lost to Follow-up|1|||
126439066|NCT00771758|454907686|FG001|Overall Study|Lost to Follow-up|0|||
126439067|NCT00771758|454907687|FG002|Overall Study|Lost to Follow-up|0|||
126439068|NCT00771758|454907685|FG000|Overall Study|Protocol Violation|1|||
126439069|NCT00771758|454907686|FG001|Overall Study|Protocol Violation|0|||
126439070|NCT00771758|454907687|FG002|Overall Study|Protocol Violation|0|||
126439071|NCT00771758|454907685|FG000|Overall Study|Withdrawal by Subject|1|||
126439072|NCT00771758|454907686|FG001|Overall Study|Withdrawal by Subject|0|||
126439073|NCT00771758|454907687|FG002|Overall Study|Withdrawal by Subject|0|||
126439074|NCT00771758|454907685|FG000|Overall Study|Other|3|||
126439075|NCT00771758|454907686|FG001|Overall Study|Other|2|||
126439076|NCT00771758|454907687|FG002|Overall Study|Other|0|||
126439077|NCT03067077|454907688|FG000|Overall Study|Did not receive surgery|4|||
126439078|NCT03067077|454907689|FG001|Overall Study|Did not receive surgery|5|||
126439079|NCT03067077|454907688|FG000|Overall Study|Lost to Follow-up|3|||
126439080|NCT03067077|454907689|FG001|Overall Study|Lost to Follow-up|2|||
126439081|NCT00935584|454907692|FG000|Overall Study|Withdrawal by Subject|9|||
126439082|NCT00935584|454907693|FG001|Overall Study|Withdrawal by Subject|0|||
126439083|NCT00935584|454907692|FG000|Overall Study|Death|3|||
126439084|NCT00935584|454907693|FG001|Overall Study|Death|0|||
126439085|NCT00935584|454907692|FG000|Overall Study|Lost to Follow-up|8|||
126439086|NCT00935584|454907693|FG001|Overall Study|Lost to Follow-up|0|||
126688827|NCT00866307|455815269|FG002|Consolidation/Maintenance|Non-compliance|1|||
126688828|NCT00866307|455815267|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
126439087|NCT00935584|454907692|FG000|Overall Study|No show|9|||
126439088|NCT00935584|454907693|FG001|Overall Study|No show|0|||
126439089|NCT00935584|454907692|FG000|Overall Study|Relocated|3|||
126688829|NCT00866307|455815268|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
126439090|NCT00935584|454907693|FG001|Overall Study|Relocated|0|||
126439091|NCT00935584|454907692|FG000|Overall Study|Patient changed provider|3|||
126439092|NCT00935584|454907693|FG001|Overall Study|Patient changed provider|0|||
126439093|NCT00935584|454907692|FG000|Overall Study|Provider dropped out of study|14|||
126439094|NCT00935584|454907693|FG001|Overall Study|Provider dropped out of study|4|||
126439095|NCT00687193|454907695|FG000|Overall Study|Adverse Event|0|||
126439096|NCT00687193|454907696|FG001|Overall Study|Adverse Event|1|||
126439097|NCT00687193|454907697|FG002|Overall Study|Adverse Event|2|||
126439098|NCT00687193|454907698|FG003|Overall Study|Adverse Event|3|||
126439099|NCT00687193|454907699|FG004|Overall Study|Adverse Event|0|||
126439100|NCT00687193|454907700|FG005|Overall Study|Adverse Event|2|||
126439101|NCT00687193|454907695|FG000|Overall Study|Lack of Efficacy|1|||
126439102|NCT00687193|454907696|FG001|Overall Study|Lack of Efficacy|1|||
126688830|NCT00866307|455815269|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
126688831|NCT02925156|455815270|FG000|Overall Study|Lost to Follow-up|27|||
126688832|NCT02925156|455815271|FG001|Overall Study|Lost to Follow-up|53|||
126688833|NCT02925156|455815272|FG002|Overall Study|Lost to Follow-up|51|||
126688834|NCT02925156|455815273|FG003|Overall Study|Lost to Follow-up|59|||
126350948|NCT00191100|454575453|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
126350949|NCT00191100|454575454|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
126350950|NCT00191100|454575453|FG000|Overall Study|Physician Decision|3|||
126350951|NCT00191100|454575454|FG001|Overall Study|Physician Decision|1|||
126350952|NCT00191100|454575453|FG000|Overall Study|Death from Study Drug Toxicity|2|||
126350953|NCT00191100|454575454|FG001|Overall Study|Death from Study Drug Toxicity|0|||
126350954|NCT00191100|454575453|FG000|Overall Study|Protocol Violation|1|||
126350955|NCT00191100|454575454|FG001|Overall Study|Protocol Violation|1|||
126350956|NCT00191100|454575453|FG000|Overall Study|Death from Other Cause|1|||
126350957|NCT00191100|454575454|FG001|Overall Study|Death from Other Cause|0|||
126350958|NCT00191100|454575453|FG000|Overall Study|Reason Not Specified|0|||
126350959|NCT00191100|454575454|FG001|Overall Study|Reason Not Specified|1|||
126350960|NCT02916771|454575455|FG000|Overall Study|Withdrawal by Subject|9|||
126350961|NCT02916771|454575455|FG000|Overall Study|Physician Decision|1|||
126350962|NCT02916771|454575455|FG000|Overall Study|Began treatment for another active malignancy|1|||
126350963|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
126350964|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
126350965|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
126350966|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
126350967|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
126350968|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
126350969|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
126350970|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
126350971|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
126350972|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
126350973|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
126350974|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
126350975|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
126350976|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
126350977|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
126350978|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
126350979|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
126350980|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
126350981|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
126350982|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
126350983|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
126350984|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
126350985|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
126350986|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
126350987|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
126350988|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
126350989|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
126350990|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
126350991|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
126350992|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
126350993|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
126350994|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
126350995|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
126350996|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
126350997|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
126350998|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
126350999|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
126351000|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
126369501|NCT00876447|454650572|FG001|Overall Study|Adverse Event|8|||
126369502|NCT00366457|454650578|FG000|Overall Study|never began study therapy|2|||
126369503|NCT02538614|454650579|FG000|Overall Study|Progressive Disease|2|||
126688835|NCT02925156|455815274|FG004|Overall Study|Lost to Follow-up|89|||
126688836|NCT02925156|455815275|FG005|Overall Study|Lost to Follow-up|107|||
126688837|NCT02925156|455815276|FG006|Overall Study|Lost to Follow-up|34|||
126688838|NCT02925156|455815277|FG007|Overall Study|Lost to Follow-up|36|||
126688839|NCT02925156|455815278|FG008|Overall Study|Lost to Follow-up|73|||
126688840|NCT02925156|455815279|FG009|Overall Study|Lost to Follow-up|34|||
126688841|NCT02286947|455815282|FG000|Overall Study|Withdrawal by Subject|2|||
126688842|NCT01060059|455815283|FG000|Overall Study|Adverse Event|1|||
126688843|NCT01060059|455815284|FG001|Overall Study|Adverse Event|1|||
126688844|NCT01060059|455815283|FG000|Overall Study|Death|2|||
126688845|NCT01060059|455815284|FG001|Overall Study|Death|3|||
126688846|NCT01060059|455815283|FG000|Overall Study|Lost to Follow-up|18|||
126688847|NCT01060059|455815284|FG001|Overall Study|Lost to Follow-up|34|||
126688848|NCT01060059|455815283|FG000|Overall Study|entry criteria not met|4|||
126688849|NCT01060059|455815284|FG001|Overall Study|entry criteria not met|3|||
126688850|NCT01060059|455815283|FG000|Overall Study|Withdrawal by Subject|35|||
126439103|NCT00687193|454907697|FG002|Overall Study|Lack of Efficacy|0|||
126439104|NCT00687193|454907698|FG003|Overall Study|Lack of Efficacy|0|||
126439105|NCT00687193|454907699|FG004|Overall Study|Lack of Efficacy|0|||
126439106|NCT00687193|454907700|FG005|Overall Study|Lack of Efficacy|2|||
126439107|NCT00687193|454907695|FG000|Overall Study|Protocol Violation|1|||
126439108|NCT00687193|454907696|FG001|Overall Study|Protocol Violation|2|||
126439109|NCT00687193|454907697|FG002|Overall Study|Protocol Violation|0|||
126439110|NCT00687193|454907698|FG003|Overall Study|Protocol Violation|1|||
126439111|NCT00687193|454907699|FG004|Overall Study|Protocol Violation|2|||
126439112|NCT00687193|454907700|FG005|Overall Study|Protocol Violation|0|||
126439113|NCT01394016|454907701|FG000|Overall Study|Progressive Disease|2|||
126439114|NCT01394016|454907702|FG001|Overall Study|Progressive Disease|0|||
126439115|NCT01394016|454907703|FG002|Overall Study|Progressive Disease|0|||
126439116|NCT01394016|454907704|FG003|Overall Study|Progressive Disease|0|||
126439117|NCT01394016|454907705|FG004|Overall Study|Progressive Disease|0|||
126439118|NCT01394016|454907706|FG005|Overall Study|Progressive Disease|0|||
126439119|NCT01394016|454907707|FG006|Overall Study|Progressive Disease|0|||
126439120|NCT01394016|454907708|FG007|Overall Study|Progressive Disease|0|||
126439121|NCT01394016|454907709|FG008|Overall Study|Progressive Disease|0|||
126439122|NCT01394016|454907710|FG009|Overall Study|Progressive Disease|0|||
126439123|NCT01394016|454907711|FG010|Overall Study|Progressive Disease|0|||
126439124|NCT01394016|454907712|FG011|Overall Study|Progressive Disease|0|||
126439125|NCT01394016|454907713|FG012|Overall Study|Progressive Disease|0|||
126439126|NCT01394016|454907714|FG013|Overall Study|Progressive Disease|0|||
126439127|NCT01394016|454907715|FG014|Overall Study|Progressive Disease|0|||
126439128|NCT01394016|454907716|FG015|Overall Study|Progressive Disease|0|||
126439129|NCT01394016|454907717|FG016|Overall Study|Progressive Disease|0|||
126439130|NCT01394016|454907718|FG017|Overall Study|Progressive Disease|0|||
126439131|NCT01394016|454907719|FG018|Overall Study|Progressive Disease|0|||
126439132|NCT01394016|454907701|FG000|Overall Study|Withdrawal by Subject|0|||
126439133|NCT01394016|454907702|FG001|Overall Study|Withdrawal by Subject|0|||
126439134|NCT01394016|454907703|FG002|Overall Study|Withdrawal by Subject|0|||
126439135|NCT01394016|454907704|FG003|Overall Study|Withdrawal by Subject|0|||
126439136|NCT01394016|454907705|FG004|Overall Study|Withdrawal by Subject|0|||
126439137|NCT01394016|454907706|FG005|Overall Study|Withdrawal by Subject|0|||
126439138|NCT01394016|454907707|FG006|Overall Study|Withdrawal by Subject|0|||
126439139|NCT01394016|454907708|FG007|Overall Study|Withdrawal by Subject|1|||
126439140|NCT01394016|454907709|FG008|Overall Study|Withdrawal by Subject|1|||
126439141|NCT01394016|454907710|FG009|Overall Study|Withdrawal by Subject|1|||
126439142|NCT01394016|454907711|FG010|Overall Study|Withdrawal by Subject|4|||
126439143|NCT01394016|454907712|FG011|Overall Study|Withdrawal by Subject|0|||
126439144|NCT01394016|454907713|FG012|Overall Study|Withdrawal by Subject|0|||
126439145|NCT01394016|454907714|FG013|Overall Study|Withdrawal by Subject|3|||
126439146|NCT01394016|454907715|FG014|Overall Study|Withdrawal by Subject|1|||
126439147|NCT01394016|454907716|FG015|Overall Study|Withdrawal by Subject|3|||
126439148|NCT01394016|454907717|FG016|Overall Study|Withdrawal by Subject|1|||
126439149|NCT01394016|454907718|FG017|Overall Study|Withdrawal by Subject|1|||
126439150|NCT01394016|454907719|FG018|Overall Study|Withdrawal by Subject|2|||
126439151|NCT01394016|454907701|FG000|Overall Study|Adverse Event|0|||
126439152|NCT01394016|454907702|FG001|Overall Study|Adverse Event|0|||
126688851|NCT01060059|455815284|FG001|Overall Study|Withdrawal by Subject|23|||
126688852|NCT01060059|455815283|FG000|Overall Study|lack of glycemic control|2|||
126439153|NCT01394016|454907703|FG002|Overall Study|Adverse Event|0|||
126688853|NCT01060059|455815284|FG001|Overall Study|lack of glycemic control|1|||
126688854|NCT01060059|455815283|FG000|Overall Study|lack of compliance|5|||
126688855|NCT01060059|455815284|FG001|Overall Study|lack of compliance|2|||
126688856|NCT01614093|455815285|FG000|Overall Study|Withdrawal by Subject|1|||
126439154|NCT01394016|454907704|FG003|Overall Study|Adverse Event|0|||
126439155|NCT01394016|454907705|FG004|Overall Study|Adverse Event|0|||
126439156|NCT01394016|454907706|FG005|Overall Study|Adverse Event|0|||
126439157|NCT01394016|454907707|FG006|Overall Study|Adverse Event|0|||
126688857|NCT00848354|455815286|FG000|Phase 1|Adverse Event|5|||
126688858|NCT00848354|455815287|FG001|Phase 1|Adverse Event|4|||
126688859|NCT00848354|455815286|FG000|Phase 1|Discontinuation of study by sponsor|2|||
126439158|NCT01394016|454907708|FG007|Overall Study|Adverse Event|0|||
126439159|NCT01394016|454907709|FG008|Overall Study|Adverse Event|0|||
126439160|NCT01394016|454907710|FG009|Overall Study|Adverse Event|1|||
126439161|NCT01394016|454907711|FG010|Overall Study|Adverse Event|0|||
126439162|NCT01394016|454907712|FG011|Overall Study|Adverse Event|0|||
126439163|NCT01394016|454907713|FG012|Overall Study|Adverse Event|0|||
126439164|NCT01394016|454907714|FG013|Overall Study|Adverse Event|0|||
126439165|NCT01394016|454907715|FG014|Overall Study|Adverse Event|0|||
126439166|NCT01394016|454907716|FG015|Overall Study|Adverse Event|0|||
126439167|NCT01394016|454907717|FG016|Overall Study|Adverse Event|1|||
126439168|NCT01394016|454907718|FG017|Overall Study|Adverse Event|1|||
126439169|NCT01394016|454907719|FG018|Overall Study|Adverse Event|0|||
126439170|NCT01394016|454907701|FG000|Overall Study|Sponsor Decision|0|||
126439171|NCT01394016|454907702|FG001|Overall Study|Sponsor Decision|0|||
126439172|NCT01394016|454907703|FG002|Overall Study|Sponsor Decision|0|||
126439173|NCT01394016|454907704|FG003|Overall Study|Sponsor Decision|0|||
126439174|NCT01394016|454907705|FG004|Overall Study|Sponsor Decision|0|||
126439175|NCT01394016|454907706|FG005|Overall Study|Sponsor Decision|0|||
126439176|NCT01394016|454907707|FG006|Overall Study|Sponsor Decision|0|||
126439177|NCT01394016|454907708|FG007|Overall Study|Sponsor Decision|0|||
126439178|NCT01394016|454907709|FG008|Overall Study|Sponsor Decision|0|||
126439179|NCT01394016|454907710|FG009|Overall Study|Sponsor Decision|0|||
126439180|NCT01394016|454907711|FG010|Overall Study|Sponsor Decision|0|||
126439181|NCT01394016|454907712|FG011|Overall Study|Sponsor Decision|0|||
126439182|NCT01394016|454907713|FG012|Overall Study|Sponsor Decision|1|||
126439183|NCT01394016|454907714|FG013|Overall Study|Sponsor Decision|0|||
126439184|NCT01394016|454907715|FG014|Overall Study|Sponsor Decision|0|||
126439185|NCT01394016|454907716|FG015|Overall Study|Sponsor Decision|0|||
126439186|NCT01394016|454907717|FG016|Overall Study|Sponsor Decision|0|||
126439187|NCT01394016|454907718|FG017|Overall Study|Sponsor Decision|0|||
126439188|NCT01394016|454907719|FG018|Overall Study|Sponsor Decision|0|||
126439189|NCT01394016|454907701|FG000|Overall Study|Lost to Follow-up|0|||
126439190|NCT01394016|454907702|FG001|Overall Study|Lost to Follow-up|0|||
126439191|NCT01394016|454907703|FG002|Overall Study|Lost to Follow-up|0|||
126439192|NCT01394016|454907704|FG003|Overall Study|Lost to Follow-up|0|||
126439193|NCT01394016|454907705|FG004|Overall Study|Lost to Follow-up|0|||
126439194|NCT01394016|454907706|FG005|Overall Study|Lost to Follow-up|0|||
126439195|NCT01394016|454907707|FG006|Overall Study|Lost to Follow-up|0|||
126439196|NCT01394016|454907708|FG007|Overall Study|Lost to Follow-up|0|||
126439197|NCT01394016|454907709|FG008|Overall Study|Lost to Follow-up|0|||
126439198|NCT01394016|454907710|FG009|Overall Study|Lost to Follow-up|0|||
126439199|NCT01394016|454907711|FG010|Overall Study|Lost to Follow-up|0|||
126439200|NCT01394016|454907712|FG011|Overall Study|Lost to Follow-up|0|||
126439201|NCT01394016|454907713|FG012|Overall Study|Lost to Follow-up|0|||
126439202|NCT01394016|454907714|FG013|Overall Study|Lost to Follow-up|0|||
126439203|NCT01394016|454907715|FG014|Overall Study|Lost to Follow-up|0|||
126439204|NCT01394016|454907716|FG015|Overall Study|Lost to Follow-up|0|||
126439205|NCT01394016|454907717|FG016|Overall Study|Lost to Follow-up|0|||
126439206|NCT01394016|454907718|FG017|Overall Study|Lost to Follow-up|0|||
126439207|NCT01394016|454907719|FG018|Overall Study|Lost to Follow-up|1|||
126439208|NCT03534804|454907720|FG000|Overall Study|Withdrawal by Subject|1|||
126439209|NCT04986904|454907721|FG000|Overall Study|Lost to Follow-up|11|||
126439210|NCT04986904|454907721|FG000|Overall Study|Withdrawal by Subject|1|||
126439211|NCT00174187|454907722|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
126439212|NCT00174187|454907723|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
126439213|NCT00174187|454907724|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
126439214|NCT00174187|454907722|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
126439215|NCT00174187|454907723|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
126439216|NCT00174187|454907724|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
126439217|NCT00174187|454907722|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
126439218|NCT00174187|454907723|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
126439219|NCT00174187|454907724|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
126439220|NCT00174187|454907722|FG000|Period 1 (up to 3 Years)|Other|0|||
126439221|NCT00174187|454907723|FG001|Period 1 (up to 3 Years)|Other|1|||
126439222|NCT00174187|454907724|FG002|Period 1 (up to 3 Years)|Other|0|||
126439223|NCT00174187|454907722|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
126439224|NCT00174187|454907723|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
126439225|NCT00174187|454907724|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
126439226|NCT00174187|454907722|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
126688860|NCT00848354|455815287|FG001|Phase 1|Discontinuation of study by sponsor|1|||
126439227|NCT00174187|454907723|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
126439228|NCT00174187|454907724|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
126439229|NCT00174187|454907722|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
126688861|NCT00848354|455815286|FG000|Phase 1|Failed to return|0|||
126688862|NCT00848354|455815287|FG001|Phase 1|Failed to return|1|||
126439230|NCT00174187|454907723|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
126439231|NCT00174187|454907724|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
126439232|NCT00174187|454907722|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
126439233|NCT00174187|454907723|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
126439234|NCT00174187|454907724|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
126439235|NCT00174187|454907722|FG000|Period 2 (After 3 Years)|Other|0|||
126439236|NCT00174187|454907723|FG001|Period 2 (After 3 Years)|Other|0|||
126439237|NCT00174187|454907724|FG002|Period 2 (After 3 Years)|Other|5|||
126439238|NCT03435211|454907725|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
126439239|NCT00759941|454907726|FG000|Overall Study|Use of medication|1|||
126439240|NCT00759941|454907727|FG001|Overall Study|Use of medication|0|||
126439241|NCT00759941|454907726|FG000|Overall Study|Adverse Event|1|||
126439242|NCT00759941|454907727|FG001|Overall Study|Adverse Event|0|||
126439243|NCT00759941|454907726|FG000|Overall Study|Exited in error by site|1|||
126439244|NCT00759941|454907727|FG001|Overall Study|Exited in error by site|1|||
126439245|NCT03863080|454907728|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
126439246|NCT03863080|454907729|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
126439247|NCT03863080|454907730|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
126439248|NCT03863080|454907731|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
126439249|NCT03863080|454907728|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
126439250|NCT03863080|454907729|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
126439251|NCT03863080|454907730|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
126439252|NCT03863080|454907731|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
126439253|NCT03863080|454907728|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
126439254|NCT03863080|454907729|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
126439255|NCT03863080|454907730|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
126439256|NCT03863080|454907731|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
126439257|NCT01342211|454907732|FG000|Overall Study|Lost to Follow-up|0|||
126439258|NCT01342211|454907733|FG001|Overall Study|Lost to Follow-up|0|||
126439259|NCT01342211|454907734|FG002|Overall Study|Lost to Follow-up|0|||
126439260|NCT01342211|454907735|FG003|Overall Study|Lost to Follow-up|1|||
126439261|NCT01342211|454907736|FG004|Overall Study|Lost to Follow-up|0|||
126439262|NCT01342211|454907732|FG000|Overall Study|Adverse Event|0|||
126439263|NCT01342211|454907733|FG001|Overall Study|Adverse Event|0|||
126439264|NCT01342211|454907734|FG002|Overall Study|Adverse Event|0|||
126439265|NCT01342211|454907735|FG003|Overall Study|Adverse Event|0|||
126439266|NCT01342211|454907736|FG004|Overall Study|Adverse Event|1|||
126439267|NCT01342211|454907732|FG000|Overall Study|Withdrawal by Subject|0|||
126351001|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
126351002|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
126351003|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
126351004|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
126351005|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
126351006|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
126351007|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
126351008|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
126351009|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
126439268|NCT01342211|454907733|FG001|Overall Study|Withdrawal by Subject|0|||
126439269|NCT01342211|454907734|FG002|Overall Study|Withdrawal by Subject|0|||
126439270|NCT01342211|454907735|FG003|Overall Study|Withdrawal by Subject|1|||
126439271|NCT01342211|454907736|FG004|Overall Study|Withdrawal by Subject|0|||
126439272|NCT01342211|454907732|FG000|Overall Study|Randomized, but not Treated|0|||
126439273|NCT01342211|454907733|FG001|Overall Study|Randomized, but not Treated|2|||
126439274|NCT01342211|454907734|FG002|Overall Study|Randomized, but not Treated|0|||
126688863|NCT00848354|455815286|FG000|Phase 1|Lost to Follow-up|1|||
126688864|NCT00848354|455815287|FG001|Phase 1|Lost to Follow-up|1|||
126688865|NCT00848354|455815286|FG000|Phase 1|Unspecified Reason|1|||
126688866|NCT00848354|455815287|FG001|Phase 1|Unspecified Reason|1|||
126688867|NCT00848354|455815286|FG000|Phase 1|Protocol Violation|1|||
126688868|NCT00848354|455815287|FG001|Phase 1|Protocol Violation|1|||
126688869|NCT00848354|455815286|FG000|Phase 1|Withdrawal by Subject|2|||
126688870|NCT00848354|455815287|FG001|Phase 1|Withdrawal by Subject|4|||
126688871|NCT00848354|455815286|FG000|Phase 1|Lack of Efficacy|0|||
126688872|NCT00848354|455815287|FG001|Phase 1|Lack of Efficacy|1|||
126688873|NCT00848354|455815286|FG000|Phase 2 Year 1|Adverse Event|7|||
126688874|NCT00848354|455815287|FG001|Phase 2 Year 1|Adverse Event|2|||
126439275|NCT01342211|454907735|FG003|Overall Study|Randomized, but not Treated|0|||
126688875|NCT00848354|455815286|FG000|Phase 2 Year 1|Death|1|||
126688876|NCT00848354|455815287|FG001|Phase 2 Year 1|Death|0|||
126688877|NCT00848354|455815286|FG000|Phase 2 Year 1|Failed to Return|1|||
126688878|NCT00848354|455815287|FG001|Phase 2 Year 1|Failed to Return|1|||
126688879|NCT00848354|455815286|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
126688880|NCT00848354|455815287|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
126439276|NCT01342211|454907736|FG004|Overall Study|Randomized, but not Treated|1|||
126688881|NCT00848354|455815286|FG000|Phase 2 Year 1|Unspecified Reason|3|||
126688882|NCT00848354|455815287|FG001|Phase 2 Year 1|Unspecified Reason|0|||
126688883|NCT00848354|455815286|FG000|Phase 2 Year 1|Protocol Violation|4|||
126688884|NCT00848354|455815287|FG001|Phase 2 Year 1|Protocol Violation|1|||
126351010|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
126351011|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
126351012|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
126351013|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
126351014|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
126351015|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
126351016|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
126351017|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
126351018|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
126351019|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
126351020|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
126351021|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
126351022|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
126351023|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
126351024|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
126351025|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
126351026|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
126351027|NCT00217737|454575456|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
126351028|NCT00217737|454575457|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
126351029|NCT00217737|454575458|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
126351030|NCT00217737|454575459|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
126351031|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
126351032|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
126351033|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
126351034|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
126351035|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
126351036|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
126351037|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
126351038|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
126351039|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Study suspension|0|||
126351040|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Study suspension|45|||
126351041|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Study suspension|0|||
126351042|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Study suspension|0|||
126351043|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
126351044|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
126351045|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
126351046|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
126351047|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Death|2|||
126351048|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Death|3|||
126351049|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Death|0|||
126351050|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Death|0|||
126351051|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
126351052|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
126351053|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
126351054|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
126351055|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
126351056|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
126351057|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
126351058|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
126351059|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
126351060|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
126351061|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
126351062|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
126351063|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
126351064|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
126351065|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
126351066|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
126351067|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
126351068|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
126351069|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
126688885|NCT00848354|455815286|FG000|Phase 2 Year 1|Subject Request|1|||
126688886|NCT00848354|455815287|FG001|Phase 2 Year 1|Subject Request|2|||
126688887|NCT00848354|455815286|FG000|Phase 2 Year 2|Adverse Event|12|||
126439277|NCT01588522|454907752|FG000|Overall Study|Withdrawal by Subject|1|||
126439278|NCT01588522|454907753|FG001|Overall Study|Withdrawal by Subject|5|||
126439279|NCT01588522|454907754|FG002|Overall Study|Withdrawal by Subject|3|||
126439280|NCT01588522|454907755|FG003|Overall Study|Withdrawal by Subject|1|||
126439281|NCT01588522|454907756|FG004|Overall Study|Withdrawal by Subject|2|||
126439282|NCT01588522|454907757|FG005|Overall Study|Withdrawal by Subject|0|||
126439283|NCT01588522|454907752|FG000|Overall Study|Lack of Efficacy|0|||
126439284|NCT01588522|454907753|FG001|Overall Study|Lack of Efficacy|0|||
126439285|NCT01588522|454907754|FG002|Overall Study|Lack of Efficacy|0|||
126439286|NCT01588522|454907755|FG003|Overall Study|Lack of Efficacy|0|||
126439287|NCT01588522|454907756|FG004|Overall Study|Lack of Efficacy|1|||
126439288|NCT01588522|454907757|FG005|Overall Study|Lack of Efficacy|0|||
126439289|NCT01588522|454907752|FG000|Overall Study|Adverse Event|0|||
126439290|NCT01588522|454907753|FG001|Overall Study|Adverse Event|0|||
126439291|NCT01588522|454907754|FG002|Overall Study|Adverse Event|0|||
126439292|NCT01588522|454907755|FG003|Overall Study|Adverse Event|1|||
126439293|NCT01588522|454907756|FG004|Overall Study|Adverse Event|0|||
126439294|NCT01588522|454907757|FG005|Overall Study|Adverse Event|0|||
126439295|NCT01588522|454907752|FG000|Overall Study|Grade 2 alopecia|1|||
126439296|NCT01588522|454907753|FG001|Overall Study|Grade 2 alopecia|0|||
126439297|NCT01588522|454907754|FG002|Overall Study|Grade 2 alopecia|0|||
126439298|NCT01588522|454907755|FG003|Overall Study|Grade 2 alopecia|0|||
126439299|NCT01588522|454907756|FG004|Overall Study|Grade 2 alopecia|0|||
126439300|NCT01588522|454907757|FG005|Overall Study|Grade 2 alopecia|0|||
126439301|NCT01588522|454907752|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
126439302|NCT01588522|454907753|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
126439303|NCT01588522|454907754|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
126439304|NCT01588522|454907755|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
126439305|NCT01588522|454907756|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
126439306|NCT01588522|454907757|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
126439307|NCT01588522|454907752|FG000|Overall Study|Taken off taxane-based regimen|0|||
126439308|NCT01588522|454907753|FG001|Overall Study|Taken off taxane-based regimen|0|||
126439309|NCT01588522|454907754|FG002|Overall Study|Taken off taxane-based regimen|0|||
126439310|NCT01588522|454907755|FG003|Overall Study|Taken off taxane-based regimen|1|||
126439311|NCT01588522|454907756|FG004|Overall Study|Taken off taxane-based regimen|0|||
126439312|NCT01588522|454907757|FG005|Overall Study|Taken off taxane-based regimen|0|||
126439313|NCT01588522|454907752|FG000|Overall Study|Did not initiate chemotherapy|0|||
126439314|NCT01588522|454907753|FG001|Overall Study|Did not initiate chemotherapy|0|||
126439315|NCT01588522|454907754|FG002|Overall Study|Did not initiate chemotherapy|0|||
126439316|NCT01588522|454907755|FG003|Overall Study|Did not initiate chemotherapy|0|||
126439317|NCT01588522|454907756|FG004|Overall Study|Did not initiate chemotherapy|1|||
126439318|NCT01588522|454907757|FG005|Overall Study|Did not initiate chemotherapy|0|||
126439319|NCT03205423|454907760|FG000|Overall Study|Personal|1|||
126439320|NCT03205423|454907761|FG001|Overall Study|Personal|1|||
126439321|NCT03205423|454907760|FG000|Overall Study|Physician Decision|0|||
126439322|NCT03205423|454907761|FG001|Overall Study|Physician Decision|2|||
126439323|NCT05786651|454907764|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
126688888|NCT00848354|455815287|FG001|Phase 2 Year 2|Adverse Event|2|||
126688889|NCT00848354|455815286|FG000|Phase 2 Year 2|Death|2|||
126688890|NCT00848354|455815287|FG001|Phase 2 Year 2|Death|0|||
126439324|NCT04390763|454907765|FG000|Safety run-in Part|Adverse Event|4|||
126439325|NCT04390763|454907766|FG001|Safety run-in Part|Adverse Event|0|||
126439326|NCT04390763|454907767|FG002|Safety run-in Part|Adverse Event|0|||
126439327|NCT04390763|454907768|FG003|Safety run-in Part|Adverse Event|0|||
126439328|NCT04390763|454907765|FG000|Safety run-in Part|Physician Decision|1|||
126688891|NCT00848354|455815286|FG000|Phase 2 Year 2|Failed to return|3|||
126439329|NCT04390763|454907766|FG001|Safety run-in Part|Physician Decision|0|||
126439330|NCT04390763|454907767|FG002|Safety run-in Part|Physician Decision|0|||
126439331|NCT04390763|454907768|FG003|Safety run-in Part|Physician Decision|0|||
126439332|NCT04390763|454907765|FG000|Safety run-in Part|Progressive Disease|6|||
126439333|NCT04390763|454907766|FG001|Safety run-in Part|Progressive Disease|0|||
126439334|NCT04390763|454907767|FG002|Safety run-in Part|Progressive Disease|0|||
126545394|NCT02541383|455290824|FG001|Overall Study|Consent withdrawn|6|||
126688892|NCT00848354|455815287|FG001|Phase 2 Year 2|Failed to return|0|||
126688893|NCT00848354|455815286|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
126351070|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
126351071|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
126351072|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
126351073|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
126351074|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
126351075|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
126351076|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
126351077|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
126351078|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
126351079|NCT00217737|454575456|FG000|Step 2 Randomization/Registration|Other|1|||
126351080|NCT00217737|454575457|FG001|Step 2 Randomization/Registration|Other|2|||
126351081|NCT00217737|454575458|FG002|Step 2 Randomization/Registration|Other|0|||
126351082|NCT00217737|454575459|FG003|Step 2 Randomization/Registration|Other|0|||
126351083|NCT04132050|454576209|FG000|Period I (Double-blind Period)|Adverse Event|3|||
126351084|NCT04132050|454576210|FG001|Period I (Double-blind Period)|Adverse Event|0|||
126351085|NCT04132050|454576209|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
126351086|NCT04132050|454576210|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
126351087|NCT04132050|454576209|FG000|R788 Treatment Period|Adverse Event|5|||
126351088|NCT04132050|454576210|FG001|R788 Treatment Period|Adverse Event|0|||
126351089|NCT04132050|454576209|FG000|R788 Treatment Period|Lack of Efficacy|5|||
126351090|NCT04132050|454576210|FG001|R788 Treatment Period|Lack of Efficacy|0|||
126351091|NCT04132050|454576209|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
126351092|NCT04132050|454576210|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
126351093|NCT03506477|454576211|FG000|Overall Study|Withdrawal by Subject|1|||
126351094|NCT03506477|454576212|FG001|Overall Study|Withdrawal by Subject|0|||
126351095|NCT01757847|454576213|FG000|Overall Study|Withdrawal by Subject|3|||
126351096|NCT01757847|454576214|FG001|Overall Study|Withdrawal by Subject|4|||
126351097|NCT00843882|454576215|FG000|Step 1|Lack of Efficacy|14|||
126351098|NCT00843882|454576216|FG001|Step 1|Lack of Efficacy|10|||
126351099|NCT00843882|454576217|FG002|Step 1|Lack of Efficacy|21|||
126351100|NCT00843882|454576215|FG000|Step 1|Adverse Event|8|||
126351101|NCT00843882|454576216|FG001|Step 1|Adverse Event|17|||
126351102|NCT00843882|454576217|FG002|Step 1|Adverse Event|20|||
126351103|NCT00843882|454576215|FG000|Step 1|Death|1|||
126351104|NCT00843882|454576216|FG001|Step 1|Death|2|||
126351105|NCT00843882|454576217|FG002|Step 1|Death|4|||
126351106|NCT00843882|454576215|FG000|Step 1|Withdrawal by Subject|6|||
126351107|NCT00843882|454576216|FG001|Step 1|Withdrawal by Subject|12|||
126351108|NCT00843882|454576217|FG002|Step 1|Withdrawal by Subject|9|||
126351109|NCT00843882|454576215|FG000|Step 1|Physician Decision|0|||
126351110|NCT00843882|454576216|FG001|Step 1|Physician Decision|5|||
126351111|NCT00843882|454576217|FG002|Step 1|Physician Decision|1|||
126351112|NCT00843882|454576215|FG000|Step 1|Patient and physician's decision|0|||
126351113|NCT00843882|454576216|FG001|Step 1|Patient and physician's decision|0|||
126351114|NCT00843882|454576217|FG002|Step 1|Patient and physician's decision|1|||
126351115|NCT00843882|454576215|FG000|Step 1|Other complicating disease|1|||
126351116|NCT00843882|454576216|FG001|Step 1|Other complicating disease|3|||
126351117|NCT00843882|454576217|FG002|Step 1|Other complicating disease|4|||
126351118|NCT00843882|454576215|FG000|Step 1|Alternative therapy|0|||
126351119|NCT00843882|454576216|FG001|Step 1|Alternative therapy|1|||
126351120|NCT00843882|454576217|FG002|Step 1|Alternative therapy|1|||
126351121|NCT00843882|454576215|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
126351122|NCT00843882|454576216|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
126351123|NCT00843882|454576217|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
126351124|NCT00843882|454576215|FG000|Step 1|Off treatment reason unknown|0|||
126351125|NCT00843882|454576216|FG001|Step 1|Off treatment reason unknown|1|||
126351126|NCT00843882|454576217|FG002|Step 1|Off treatment reason unknown|4|||
126351127|NCT00843882|454576215|FG000|Step 1|Never started treatment|2|||
126351128|NCT00843882|454576216|FG001|Step 1|Never started treatment|0|||
126351129|NCT00843882|454576217|FG002|Step 1|Never started treatment|0|||
126351130|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
126351131|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
126351132|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
126351133|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
126351134|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
126351135|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
126351136|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
126351137|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
126351138|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
126351139|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
126351140|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
126351141|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
126688894|NCT00848354|455815287|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
126688895|NCT00848354|455815286|FG000|Phase 2 Year 2|Unspecified Reason|1|||
126688896|NCT00848354|455815287|FG001|Phase 2 Year 2|Unspecified Reason|0|||
126439335|NCT04390763|454907768|FG003|Safety run-in Part|Progressive Disease|0|||
126439336|NCT04390763|454907765|FG000|Randomized Part|Adverse Event|0|||
126439337|NCT04390763|454907766|FG001|Randomized Part|Adverse Event|11|||
126688897|NCT00848354|455815286|FG000|Phase 2 Year 2|Protocol Violation|1|||
126688898|NCT00848354|455815287|FG001|Phase 2 Year 2|Protocol Violation|1|||
126688899|NCT00848354|455815286|FG000|Phase 2 Year 2|Subject Request|1|||
126688900|NCT00848354|455815287|FG001|Phase 2 Year 2|Subject Request|1|||
126688901|NCT00848354|455815286|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
126688902|NCT00848354|455815287|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
126688903|NCT01777581|455815288|FG000|Overall Study|Lost to Follow-up|1|||
126688904|NCT01777581|455815289|FG001|Overall Study|Lost to Follow-up|1|||
126688905|NCT01777581|455815288|FG000|Overall Study|Adverse Event|2|||
126688906|NCT01777581|455815289|FG001|Overall Study|Adverse Event|0|||
126688907|NCT01777581|455815288|FG000|Overall Study|Lack of Efficacy|0|||
126688908|NCT01777581|455815289|FG001|Overall Study|Lack of Efficacy|1|||
126688909|NCT04202679|455815290|FG000|Overall Study|Adverse Event|2|||
126688910|NCT04202679|455815291|FG001|Overall Study|Adverse Event|0|||
126688911|NCT04202679|455815290|FG000|Overall Study|Poor compliance to protocol|1|||
126688912|NCT04202679|455815291|FG001|Overall Study|Poor compliance to protocol|0|||
126688913|NCT04202679|455815290|FG000|Overall Study|Withdrawal by Subject|23|||
126439338|NCT04390763|454907767|FG002|Randomized Part|Adverse Event|5|||
126439339|NCT04390763|454907768|FG003|Randomized Part|Adverse Event|5|||
126439340|NCT04390763|454907765|FG000|Randomized Part|Death|0|||
126439341|NCT04390763|454907766|FG001|Randomized Part|Death|3|||
126439342|NCT04390763|454907767|FG002|Randomized Part|Death|4|||
126439343|NCT04390763|454907768|FG003|Randomized Part|Death|2|||
126439344|NCT04390763|454907765|FG000|Randomized Part|Physician Decision|0|||
126439345|NCT04390763|454907766|FG001|Randomized Part|Physician Decision|2|||
126439346|NCT04390763|454907767|FG002|Randomized Part|Physician Decision|2|||
126439347|NCT04390763|454907768|FG003|Randomized Part|Physician Decision|9|||
126439348|NCT04390763|454907765|FG000|Randomized Part|Progressive Disease|0|||
126439349|NCT04390763|454907766|FG001|Randomized Part|Progressive Disease|24|||
126439350|NCT04390763|454907767|FG002|Randomized Part|Progressive Disease|31|||
126439351|NCT04390763|454907768|FG003|Randomized Part|Progressive Disease|23|||
126439352|NCT04390763|454907765|FG000|Randomized Part|Study terminated by sponsor|0|||
126439353|NCT04390763|454907766|FG001|Randomized Part|Study terminated by sponsor|1|||
126439354|NCT04390763|454907767|FG002|Randomized Part|Study terminated by sponsor|0|||
126439355|NCT04390763|454907768|FG003|Randomized Part|Study terminated by sponsor|0|||
126688914|NCT04202679|455815291|FG001|Overall Study|Withdrawal by Subject|6|||
126688915|NCT03406897|455815294|FG000|Overall Study|Lost to Follow-up|1|||
126439356|NCT04390763|454907765|FG000|Randomized Part|Participant Decision|0|||
126439357|NCT04390763|454907766|FG001|Randomized Part|Participant Decision|5|||
126688916|NCT03406897|455815295|FG001|Overall Study|Lost to Follow-up|2|||
126439358|NCT04390763|454907767|FG002|Randomized Part|Participant Decision|7|||
126688917|NCT03406897|455815294|FG000|Overall Study|Withdrawal by Subject|4|||
126688918|NCT03406897|455815295|FG001|Overall Study|Withdrawal by Subject|4|||
126688919|NCT03406897|455815294|FG000|Overall Study|Physician Decision|0|||
126688920|NCT03406897|455815295|FG001|Overall Study|Physician Decision|1|||
126688921|NCT00598975|455817141|FG000|Overall Study|Adverse Event|1|||
126439359|NCT04390763|454907768|FG003|Randomized Part|Participant Decision|6|||
126688922|NCT00598975|455817142|FG001|Overall Study|Adverse Event|1|||
126688923|NCT00598975|455817141|FG000|Overall Study|Brain metastases|1|||
126688924|NCT00598975|455817142|FG001|Overall Study|Brain metastases|0|||
126688925|NCT00598975|455817141|FG000|Overall Study|Withdrawal by Subject|1|||
126688926|NCT00598975|455817142|FG001|Overall Study|Withdrawal by Subject|1|||
126688927|NCT00598975|455817141|FG000|Overall Study|Withdrawal of consent|0|||
126688928|NCT00598975|455817142|FG001|Overall Study|Withdrawal of consent|1|||
126688929|NCT00598975|455817141|FG000|Overall Study|Disease progression|8|||
126688930|NCT00598975|455817142|FG001|Overall Study|Disease progression|3|||
126688931|NCT00598975|455817141|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
126688932|NCT00598975|455817142|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
126688933|NCT05227690|455817152|FG000|Overall Study|Adverse Event|5|||
126688934|NCT05227690|455817153|FG001|Overall Study|Adverse Event|6|||
126688935|NCT05227690|455817154|FG002|Overall Study|Adverse Event|10|||
126688936|NCT05227690|455817152|FG000|Overall Study|Lack of Efficacy|2|||
126688937|NCT05227690|455817153|FG001|Overall Study|Lack of Efficacy|4|||
126688938|NCT05227690|455817154|FG002|Overall Study|Lack of Efficacy|1|||
126688939|NCT05227690|455817152|FG000|Overall Study|Physician Decision|6|||
126688940|NCT05227690|455817153|FG001|Overall Study|Physician Decision|0|||
126688941|NCT05227690|455817154|FG002|Overall Study|Physician Decision|4|||
126688942|NCT05227690|455817152|FG000|Overall Study|Withdrawal of consent|28|||
126688943|NCT05227690|455817153|FG001|Overall Study|Withdrawal of consent|27|||
126688944|NCT05227690|455817154|FG002|Overall Study|Withdrawal of consent|21|||
126760007|NCT01377194|456070534|FG000|Overall Study|Withdrawal by Subject|8|||
126760008|NCT01377194|456070535|FG001|Overall Study|Withdrawal by Subject|10|||
126760009|NCT01377194|456070536|FG002|Overall Study|Withdrawal by Subject|7|||
126760010|NCT01377194|456070534|FG000|Overall Study|Lost to Follow-up|14|||
126760011|NCT01377194|456070535|FG001|Overall Study|Lost to Follow-up|8|||
126760012|NCT01377194|456070536|FG002|Overall Study|Lost to Follow-up|11|||
126760013|NCT04398030|456072331|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
126760014|NCT04398030|456072332|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
126760015|NCT04398030|456072331|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
126760016|NCT04398030|456072332|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
126760017|NCT02946515|456072335|FG000|Overall Study|Lost to Follow-up|2|||
126760018|NCT02946515|456072336|FG001|Overall Study|Lost to Follow-up|1|||
126760019|NCT00960869|456072340|FG000|Overall Study|Adverse Event|17|||
126760020|NCT00960869|456072341|FG001|Overall Study|Adverse Event|26|||
126760021|NCT00960869|456072340|FG000|Overall Study|Withdrawal by Subject|16|||
126760022|NCT00960869|456072341|FG001|Overall Study|Withdrawal by Subject|14|||
126760023|NCT00960869|456072340|FG000|Overall Study|Lost to Follow-up|1|||
126760024|NCT00960869|456072341|FG001|Overall Study|Lost to Follow-up|4|||
126760025|NCT00960869|456072340|FG000|Overall Study|Misc|19|||
126760026|NCT00960869|456072341|FG001|Overall Study|Misc|18|||
126760027|NCT01846442|456072345|FG000|Overall Study|Adverse Event|2|||
126760028|NCT01846442|456072346|FG001|Overall Study|Adverse Event|4|||
126760029|NCT01846442|456072347|FG002|Overall Study|Adverse Event|2|||
126760030|NCT01846442|456072348|FG003|Overall Study|Adverse Event|1|||
126760031|NCT01846442|456072345|FG000|Overall Study|Lost to Follow-up|0|||
126760032|NCT01846442|456072346|FG001|Overall Study|Lost to Follow-up|0|||
126760033|NCT01846442|456072347|FG002|Overall Study|Lost to Follow-up|1|||
126760034|NCT01846442|456072348|FG003|Overall Study|Lost to Follow-up|0|||
126760035|NCT01846442|456072345|FG000|Overall Study|Withdrawal by Subject|3|||
126760036|NCT01846442|456072346|FG001|Overall Study|Withdrawal by Subject|2|||
126760037|NCT01846442|456072347|FG002|Overall Study|Withdrawal by Subject|0|||
126760038|NCT01846442|456072348|FG003|Overall Study|Withdrawal by Subject|1|||
126760039|NCT01846442|456072345|FG000|Overall Study|Left the city/Lost medication|1|||
126760040|NCT01846442|456072346|FG001|Overall Study|Left the city/Lost medication|0|||
126760041|NCT01846442|456072347|FG002|Overall Study|Left the city/Lost medication|1|||
126760042|NCT01846442|456072348|FG003|Overall Study|Left the city/Lost medication|1|||
126760043|NCT01153971|456072351|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
126760044|NCT01153971|456072351|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
126760045|NCT01153971|456072351|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
126760046|NCT01153971|456072351|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
126439360|NCT04390763|454907765|FG000|Randomized Part|Not treated|0|||
126439361|NCT04390763|454907766|FG001|Randomized Part|Not treated|4|||
126439362|NCT04390763|454907767|FG002|Randomized Part|Not treated|2|||
126439363|NCT04390763|454907768|FG003|Randomized Part|Not treated|7|||
126439364|NCT04949490|454907769|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
126439365|NCT04949490|454907770|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
126439366|NCT04949490|454907771|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
126439367|NCT04949490|454907772|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
126545395|NCT02541383|455290825|FG002|Overall Study|Consent withdrawn|1|||
126688945|NCT05227690|455817152|FG000|Overall Study|Other, not specified|2|||
126688946|NCT05227690|455817153|FG001|Overall Study|Other, not specified|2|||
126688947|NCT05227690|455817154|FG002|Overall Study|Other, not specified|1|||
126688948|NCT04033367|455817155|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
126688949|NCT04033367|455817156|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
126688950|NCT04033367|455817155|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
126688951|NCT04033367|455817156|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
126688952|NCT04033367|455817155|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
126688953|NCT04033367|455817156|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
126688954|NCT04033367|455817155|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
126688955|NCT04033367|455817156|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
126688956|NCT02723201|455817157|FG000|Second Intervention Period|Protocol Violation|1|||
126688957|NCT02723201|455817158|FG001|Second Intervention Period|Protocol Violation|0|||
126688958|NCT02723201|455817159|FG002|Second Intervention Period|Protocol Violation|0|||
126688959|NCT02723201|455817157|FG000|Second Intervention Period|Adverse Event|1|||
126688960|NCT02723201|455817158|FG001|Second Intervention Period|Adverse Event|0|||
126688961|NCT02723201|455817159|FG002|Second Intervention Period|Adverse Event|0|||
126688962|NCT03472560|455817160|FG000|Overall Study|Subject transfer to continuation protocol|0|||
126688963|NCT03472560|455817161|FG001|Overall Study|Subject transfer to continuation protocol|1|||
126688964|NCT03472560|455817160|FG000|Overall Study|Withdrawal by Subject|4|||
126688965|NCT03472560|455817161|FG001|Overall Study|Withdrawal by Subject|0|||
126688966|NCT03472560|455817160|FG000|Overall Study|Progressive disease|24|||
126688967|NCT03472560|455817161|FG001|Overall Study|Progressive disease|8|||
126688968|NCT03472560|455817160|FG000|Overall Study|Physician Decision|1|||
126688969|NCT03472560|455817161|FG001|Overall Study|Physician Decision|0|||
126688970|NCT03472560|455817160|FG000|Overall Study|Death|7|||
126688971|NCT03472560|455817161|FG001|Overall Study|Death|4|||
126688972|NCT03472560|455817160|FG000|Overall Study|Adverse Event|5|||
126688973|NCT03472560|455817161|FG001|Overall Study|Adverse Event|3|||
126688974|NCT03472560|455817160|FG000|Overall Study|Global deterioration of health status|0|||
126688975|NCT03472560|455817161|FG001|Overall Study|Global deterioration of health status|4|||
126688976|NCT02421887|455817162|FG000|Overall Study|Lost to Follow-up|5|||
126688977|NCT02421887|455817163|FG001|Overall Study|Lost to Follow-up|0|||
126439368|NCT04949490|454907773|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
126439369|NCT04949490|454907774|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
126439370|NCT04949490|454907769|FG000|Group A and Group B|Withdrawal by Subject|0|||
126439371|NCT04949490|454907770|FG001|Group A and Group B|Withdrawal by Subject|0|||
126439372|NCT04949490|454907771|FG002|Group A and Group B|Withdrawal by Subject|1|||
126439373|NCT04949490|454907772|FG003|Group A and Group B|Withdrawal by Subject|0|||
126439374|NCT04949490|454907773|FG004|Group A and Group B|Withdrawal by Subject|0|||
126439375|NCT04949490|454907774|FG005|Group A and Group B|Withdrawal by Subject|0|||
126439376|NCT04949490|454907769|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
126439377|NCT04949490|454907770|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
126439378|NCT04949490|454907771|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
126439379|NCT04949490|454907772|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
126439380|NCT04949490|454907773|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
126439381|NCT04949490|454907774|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
126439382|NCT04949490|454907769|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
126439383|NCT04949490|454907770|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
126439384|NCT04949490|454907771|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
126439385|NCT04949490|454907772|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
126439386|NCT04949490|454907773|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
126439387|NCT04949490|454907774|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
126439388|NCT02017405|454907775|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
126439389|NCT02017405|454907776|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
126439390|NCT02017405|454907777|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
126439391|NCT02017405|454907778|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
126439392|NCT02017405|454907779|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
126439393|NCT02017405|454907780|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
126439394|NCT02017405|454907775|FG000|Open-label Phase|Adverse Event|1|||
126439395|NCT02017405|454907776|FG001|Open-label Phase|Adverse Event|1|||
126439396|NCT02017405|454907777|FG002|Open-label Phase|Adverse Event|0|||
126439397|NCT02017405|454907778|FG003|Open-label Phase|Adverse Event|0|||
126439398|NCT02017405|454907779|FG004|Open-label Phase|Adverse Event|0|||
126439399|NCT02017405|454907780|FG005|Open-label Phase|Adverse Event|0|||
126439400|NCT00777153|454909628|FG000|Overall Study|Lost to Follow-up|1|||
126439401|NCT00777153|454909629|FG001|Overall Study|Lost to Follow-up|1|||
126439402|NCT00777153|454909630|FG002|Overall Study|Lost to Follow-up|0|||
126439403|NCT00777153|454909628|FG000|Overall Study|Death|85|||
126439404|NCT00777153|454909629|FG001|Overall Study|Death|73|||
126439405|NCT00777153|454909630|FG002|Overall Study|Death|33|||
126439406|NCT00777153|454909628|FG000|Overall Study|Withdrawal by Subject|3|||
126439407|NCT00777153|454909629|FG001|Overall Study|Withdrawal by Subject|4|||
126688978|NCT02421887|455817162|FG000|Overall Study|Withdrawal by Subject|8|||
126439408|NCT00777153|454909630|FG002|Overall Study|Withdrawal by Subject|3|||
126439409|NCT00777153|454909628|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
126439410|NCT00777153|454909629|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
126439411|NCT00777153|454909630|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
126439412|NCT00554216|454909632|FG000|Overall Study|Lost to Follow-up|92|||
126439413|NCT00554216|454909633|FG001|Overall Study|Lost to Follow-up|31|||
126439414|NCT00554216|454909634|FG002|Overall Study|Lost to Follow-up|63|||
126439415|NCT00554216|454909632|FG000|Overall Study|Adverse Event|16|||
126439416|NCT00554216|454909633|FG001|Overall Study|Adverse Event|16|||
126439417|NCT00554216|454909634|FG002|Overall Study|Adverse Event|36|||
126439418|NCT00554216|454909632|FG000|Overall Study|Withdrawal by Subject|92|||
126439419|NCT00554216|454909633|FG001|Overall Study|Withdrawal by Subject|31|||
126439420|NCT00554216|454909634|FG002|Overall Study|Withdrawal by Subject|43|||
126439421|NCT00554216|454909632|FG000|Overall Study|Non compliance|10|||
126439422|NCT00554216|454909633|FG001|Overall Study|Non compliance|4|||
126439423|NCT00554216|454909634|FG002|Overall Study|Non compliance|5|||
126439424|NCT00554216|454909632|FG000|Overall Study|Pregnancy|2|||
126439425|NCT00554216|454909633|FG001|Overall Study|Pregnancy|1|||
126439426|NCT00554216|454909634|FG002|Overall Study|Pregnancy|14|||
126439427|NCT00554216|454909632|FG000|Overall Study|Restricted med|3|||
126439428|NCT00554216|454909633|FG001|Overall Study|Restricted med|1|||
126439429|NCT00554216|454909634|FG002|Overall Study|Restricted med|1|||
126439430|NCT00554216|454909632|FG000|Overall Study|Other|12|||
126439431|NCT00554216|454909633|FG001|Overall Study|Other|7|||
126439432|NCT00554216|454909634|FG002|Overall Study|Other|10|||
126439433|NCT00554216|454909632|FG000|Overall Study|Lack of Efficacy|15|||
126439434|NCT00554216|454909633|FG001|Overall Study|Lack of Efficacy|3|||
126439435|NCT00554216|454909634|FG002|Overall Study|Lack of Efficacy|0|||
126439436|NCT02079246|454909635|FG000|OLEX|Withdrawal before treatment|1|||
126439437|NCT02079246|454909636|FG001|OLEX|Withdrawal before treatment|0|||
126439438|NCT02079246|454909635|FG000|OLEX|Death|11|||
126439439|NCT02079246|454909636|FG001|OLEX|Death|0|||
126439440|NCT02079246|454909635|FG000|OLEX|Adverse Event|66|||
126439441|NCT02079246|454909636|FG001|OLEX|Adverse Event|0|||
126439442|NCT02079246|454909635|FG000|OLEX|Withdrawal by Subject|60|||
126439443|NCT02079246|454909636|FG001|OLEX|Withdrawal by Subject|0|||
126439444|NCT02079246|454909635|FG000|OLEX|Lost to Follow-up|6|||
126439445|NCT02079246|454909636|FG001|OLEX|Lost to Follow-up|0|||
126439446|NCT02079246|454909635|FG000|OLEX|Protocol Violation|6|||
126439447|NCT02079246|454909636|FG001|OLEX|Protocol Violation|0|||
126439448|NCT02079246|454909635|FG000|OLEX|Lack of Efficacy|3|||
126439449|NCT02079246|454909636|FG001|OLEX|Lack of Efficacy|0|||
126439450|NCT02079246|454909635|FG000|OLEX|Results of the lead-in studies|58|||
126439451|NCT02079246|454909636|FG001|OLEX|Results of the lead-in studies|0|||
126439452|NCT02079246|454909635|FG000|OLEX|Other: Disallowed medication|8|||
126688979|NCT02421887|455817163|FG001|Overall Study|Withdrawal by Subject|5|||
126688980|NCT02421887|455817162|FG000|Overall Study|Physician Decision|2|||
126688981|NCT02421887|455817163|FG001|Overall Study|Physician Decision|4|||
126688982|NCT02421887|455817162|FG000|Overall Study|Adverse Event|2|||
126688983|NCT02421887|455817163|FG001|Overall Study|Adverse Event|0|||
126688984|NCT00491179|455817166|FG000|Overall Study|Adverse Event|5|||
126439453|NCT02079246|454909636|FG001|OLEX|Other: Disallowed medication|0|||
126439454|NCT02079246|454909635|FG000|OLEX|Other: Insufficient compliance|2|||
126439455|NCT02079246|454909636|FG001|OLEX|Other: Insufficient compliance|0|||
126439456|NCT02079246|454909635|FG000|OLEX|Other: Caregiver unavailable|3|||
126439457|NCT02079246|454909636|FG001|OLEX|Other: Caregiver unavailable|0|||
126439458|NCT02079246|454909635|FG000|OLEX|Other: Coordinator decision|1|||
126439459|NCT02079246|454909636|FG001|OLEX|Other: Coordinator decision|0|||
126439460|NCT02079246|454909635|FG000|OLEX|Other: Worsening of condition|1|||
126439461|NCT02079246|454909636|FG001|OLEX|Other: Worsening of condition|0|||
126439462|NCT02079246|454909635|FG000|OLEX|Other: Moved to nursing home|1|||
126439463|NCT02079246|454909636|FG001|OLEX|Other: Moved to nursing home|0|||
126439464|NCT02079246|454909635|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
126439465|NCT02079246|454909636|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
126439466|NCT02079246|454909635|FG000|OLEX-MEM|Adverse Event|0|||
126439467|NCT02079246|454909636|FG001|OLEX-MEM|Adverse Event|6|||
126439468|NCT02079246|454909635|FG000|OLEX-MEM|Withdrawal by Subject|0|||
126439469|NCT02079246|454909636|FG001|OLEX-MEM|Withdrawal by Subject|7|||
126439470|NCT02079246|454909635|FG000|OLEX-MEM|Protocol Violation|0|||
126439471|NCT02079246|454909636|FG001|OLEX-MEM|Protocol Violation|2|||
126439472|NCT02079246|454909635|FG000|OLEX-MEM|Lost to Follow-up|0|||
126688985|NCT00491179|455817167|FG001|Overall Study|Adverse Event|1|||
126439473|NCT02079246|454909636|FG001|OLEX-MEM|Lost to Follow-up|1|||
126439474|NCT02079246|454909635|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
126688986|NCT00491179|455817166|FG000|Overall Study|Withdrawal by Subject|2|||
126688987|NCT00491179|455817167|FG001|Overall Study|Withdrawal by Subject|1|||
126439475|NCT02079246|454909636|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
126439476|NCT00463567|454909643|FG000|Overall Study|Adverse Event|29|||
126439477|NCT00463567|454909644|FG001|Overall Study|Adverse Event|26|||
126439478|NCT00463567|454909645|FG002|Overall Study|Adverse Event|17|||
126439479|NCT00463567|454909646|FG003|Overall Study|Adverse Event|46|||
126760047|NCT01153971|456072351|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
126351142|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
126439480|NCT00463567|454909647|FG004|Overall Study|Adverse Event|10|||
126439481|NCT00463567|454909648|FG005|Overall Study|Adverse Event|10|||
126439482|NCT00463567|454909649|FG006|Overall Study|Adverse Event|4|||
126439483|NCT00463567|454909643|FG000|Overall Study|Withdrawal by Subject|29|||
126439484|NCT00463567|454909644|FG001|Overall Study|Withdrawal by Subject|22|||
126439485|NCT00463567|454909645|FG002|Overall Study|Withdrawal by Subject|20|||
126439486|NCT00463567|454909646|FG003|Overall Study|Withdrawal by Subject|37|||
126439487|NCT00463567|454909647|FG004|Overall Study|Withdrawal by Subject|6|||
126439488|NCT00463567|454909648|FG005|Overall Study|Withdrawal by Subject|5|||
126439489|NCT00463567|454909649|FG006|Overall Study|Withdrawal by Subject|1|||
126439490|NCT00463567|454909643|FG000|Overall Study|Protocol Deviation|13|||
126439491|NCT00463567|454909644|FG001|Overall Study|Protocol Deviation|9|||
126439492|NCT00463567|454909645|FG002|Overall Study|Protocol Deviation|14|||
126439493|NCT00463567|454909646|FG003|Overall Study|Protocol Deviation|11|||
126439494|NCT00463567|454909647|FG004|Overall Study|Protocol Deviation|1|||
126439495|NCT00463567|454909648|FG005|Overall Study|Protocol Deviation|1|||
126439496|NCT00463567|454909649|FG006|Overall Study|Protocol Deviation|2|||
126439497|NCT00463567|454909643|FG000|Overall Study|Lost to Follow-up|12|||
126439498|NCT00463567|454909644|FG001|Overall Study|Lost to Follow-up|6|||
126439499|NCT00463567|454909645|FG002|Overall Study|Lost to Follow-up|13|||
126439500|NCT00463567|454909646|FG003|Overall Study|Lost to Follow-up|8|||
126439501|NCT00463567|454909647|FG004|Overall Study|Lost to Follow-up|1|||
126439502|NCT00463567|454909648|FG005|Overall Study|Lost to Follow-up|1|||
126439503|NCT00463567|454909649|FG006|Overall Study|Lost to Follow-up|1|||
126760048|NCT01153971|456072351|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
126760049|NCT01153971|456072351|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
126351143|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
126351144|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
126351145|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
126351146|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
126351147|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
126351148|NCT00843882|454576215|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
126351149|NCT00843882|454576216|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
126351150|NCT00843882|454576217|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
126351151|NCT05317546|454576218|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
126351152|NCT05317546|454576219|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
126351153|NCT03331250|454576220|FG000|Overall Study|Withdrawal by Subject|1|||
126351154|NCT04590963|454576221|FG000|Overall Study|Death|118|||
126351155|NCT04590963|454576222|FG001|Overall Study|Death|59|||
126351156|NCT04590963|454576221|FG000|Overall Study|Lost to Follow-up|1|||
126351157|NCT04590963|454576222|FG001|Overall Study|Lost to Follow-up|1|||
126351158|NCT04590963|454576221|FG000|Overall Study|Progressive disease|0|||
126351159|NCT04590963|454576222|FG001|Overall Study|Progressive disease|1|||
126351160|NCT04590963|454576221|FG000|Overall Study|Study terminated by sponsor|103|||
126351161|NCT04590963|454576222|FG001|Overall Study|Study terminated by sponsor|50|||
126351162|NCT04590963|454576221|FG000|Overall Study|Withdrawal by Subject|15|||
126351163|NCT04590963|454576222|FG001|Overall Study|Withdrawal by Subject|8|||
126351164|NCT04590963|454576221|FG000|Overall Study|Ongoing at data cut-off|9|||
126351165|NCT04590963|454576222|FG001|Overall Study|Ongoing at data cut-off|4|||
126351166|NCT04590963|454576221|FG000|Overall Study|Screen failure|1|||
126351167|NCT04590963|454576222|FG001|Overall Study|Screen failure|0|||
126351168|NCT01063114|454576223|FG000|Overall Study|Lost to Follow-up|1|||
126351169|NCT05556057|454576224|FG000|Overall Study|Lost to Follow-up|5|||
126351170|NCT05556057|454576225|FG001|Overall Study|Lost to Follow-up|4|||
126351171|NCT05556057|454576224|FG000|Overall Study|Withdrawal by Subject|0|||
126351172|NCT05556057|454576225|FG001|Overall Study|Withdrawal by Subject|2|||
126351173|NCT02466971|454576229|FG000|Overall Study|eligible and never treated|14|||
126351174|NCT02466971|454576230|FG001|Overall Study|eligible and never treated|20|||
126351175|NCT02466971|454576229|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
126351176|NCT02466971|454576230|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
126351177|NCT02466971|454576229|FG000|Overall Study|ineligible and treated|1|||
126351178|NCT02466971|454576230|FG001|Overall Study|ineligible and treated|0|||
126439504|NCT00463567|454909643|FG000|Overall Study|Administrative problems|5|||
126439505|NCT00463567|454909644|FG001|Overall Study|Administrative problems|3|||
126439506|NCT00463567|454909645|FG002|Overall Study|Administrative problems|6|||
126760050|NCT03410693|456072352|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
126351179|NCT02466971|454576229|FG000|Overall Study|ineligible and never treated|0|||
126351180|NCT02466971|454576230|FG001|Overall Study|ineligible and never treated|1|||
126351181|NCT04818112|454576235|FG000|Overall Study|Withdrawal by Subject|54|||
126351182|NCT04818112|454576236|FG001|Overall Study|Withdrawal by Subject|12|||
126439507|NCT00463567|454909646|FG003|Overall Study|Administrative problems|9|||
126439508|NCT00463567|454909647|FG004|Overall Study|Administrative problems|3|||
126439509|NCT00463567|454909648|FG005|Overall Study|Administrative problems|2|||
126760051|NCT03410693|456072353|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
126760052|NCT03410693|456072352|FG000|Overall Study|Disc trt: Lost to follow up|0|||
126760053|NCT03410693|456072353|FG001|Overall Study|Disc trt: Lost to follow up|1|||
126760054|NCT03410693|456072352|FG000|Overall Study|Disc trt: radiological progression|58|||
126760055|NCT03410693|456072353|FG001|Overall Study|Disc trt: radiological progression|50|||
126351183|NCT04818112|454576235|FG000|Overall Study|Lost to Follow-up|38|||
126351184|NCT04818112|454576236|FG001|Overall Study|Lost to Follow-up|10|||
126351185|NCT01937299|454576243|FG000|Overall Study|Adverse Event|13|||
126351186|NCT01937299|454576244|FG001|Overall Study|Adverse Event|0|||
126351187|NCT01937299|454576243|FG000|Overall Study|Lack of Efficacy|0|||
126351188|NCT01937299|454576244|FG001|Overall Study|Lack of Efficacy|4|||
126351189|NCT01937299|454576243|FG000|Overall Study|Withdrawal by Subject|1|||
126351190|NCT01937299|454576244|FG001|Overall Study|Withdrawal by Subject|0|||
126351191|NCT01260948|454576245|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
126351192|NCT01260948|454576246|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
126351193|NCT01260948|454576245|FG000|Second Intervention|Emesis|0|||
126351194|NCT01260948|454576246|FG001|Second Intervention|Emesis|1|||
126351195|NCT02406612|454576247|FG000|Overall Study|Screening Failure|3|||
126351196|NCT02406612|454576248|FG001|Overall Study|Screening Failure|0|||
126351197|NCT02406612|454576247|FG000|Overall Study|Intra-procedural Exclusion|1|||
126351198|NCT02406612|454576248|FG001|Overall Study|Intra-procedural Exclusion|3|||
126351199|NCT02406612|454576247|FG000|Overall Study|Guidewire Failure|0|||
126351200|NCT02406612|454576248|FG001|Overall Study|Guidewire Failure|1|||
126351201|NCT01525589|454576253|FG000|Overall Study|Non-treatment-related AE|1|||
126351202|NCT01525589|454576254|FG001|Overall Study|Non-treatment-related AE|0|||
126351203|NCT01525589|454576255|FG002|Overall Study|Non-treatment-related AE|0|||
126351204|NCT01525589|454576253|FG000|Overall Study|Progressive disease|48|||
126351205|NCT01525589|454576254|FG001|Overall Study|Progressive disease|15|||
126351206|NCT01525589|454576255|FG002|Overall Study|Progressive disease|29|||
126351207|NCT01525589|454576253|FG000|Overall Study|Never treated|2|||
126351208|NCT01525589|454576254|FG001|Overall Study|Never treated|0|||
126351209|NCT01525589|454576255|FG002|Overall Study|Never treated|0|||
126351210|NCT01525589|454576253|FG000|Overall Study|Physician Decision|4|||
126351211|NCT01525589|454576254|FG001|Overall Study|Physician Decision|2|||
126351212|NCT01525589|454576255|FG002|Overall Study|Physician Decision|2|||
126351213|NCT01525589|454576253|FG000|Overall Study|Death|0|||
126351214|NCT01525589|454576254|FG001|Overall Study|Death|0|||
126351215|NCT01525589|454576255|FG002|Overall Study|Death|2|||
126351216|NCT01525589|454576253|FG000|Overall Study|Treatment-related AE|1|||
126351217|NCT01525589|454576254|FG001|Overall Study|Treatment-related AE|1|||
126351218|NCT01525589|454576255|FG002|Overall Study|Treatment-related AE|2|||
126351219|NCT01525589|454576253|FG000|Overall Study|Other reasons|0|||
126351220|NCT01525589|454576254|FG001|Overall Study|Other reasons|1|||
126351221|NCT01525589|454576255|FG002|Overall Study|Other reasons|0|||
126351222|NCT01525589|454576253|FG000|Overall Study|Withdrawal by Subject|0|||
126351223|NCT01525589|454576254|FG001|Overall Study|Withdrawal by Subject|1|||
126351224|NCT01525589|454576255|FG002|Overall Study|Withdrawal by Subject|0|||
126351225|NCT05759338|454576256|FG000|Overall Study|Withdrawal by Subject|3|||
126351226|NCT02924376|454576257|FG000|Overall Study|Progressive Disease|4|||
126351227|NCT02924376|454576258|FG001|Overall Study|Progressive Disease|0|||
126351228|NCT02924376|454576259|FG002|Overall Study|Progressive Disease|1|||
126351229|NCT02924376|454576260|FG003|Overall Study|Progressive Disease|0|||
126351230|NCT02924376|454576257|FG000|Overall Study|Death|73|||
126351231|NCT02924376|454576258|FG001|Overall Study|Death|18|||
126351232|NCT02924376|454576259|FG002|Overall Study|Death|15|||
126351233|NCT02924376|454576260|FG003|Overall Study|Death|2|||
126351234|NCT02924376|454576257|FG000|Overall Study|Lost to Follow-up|3|||
126351235|NCT02924376|454576258|FG001|Overall Study|Lost to Follow-up|0|||
126351236|NCT02924376|454576259|FG002|Overall Study|Lost to Follow-up|0|||
126351237|NCT02924376|454576260|FG003|Overall Study|Lost to Follow-up|0|||
126351238|NCT02924376|454576257|FG000|Overall Study|Study Terminated by Sponsor|19|||
126351239|NCT02924376|454576258|FG001|Overall Study|Study Terminated by Sponsor|0|||
126760056|NCT03410693|456072352|FG000|Overall Study|Disc trt: Other|1|||
126760057|NCT03410693|456072353|FG001|Overall Study|Disc trt: Other|0|||
126760058|NCT03410693|456072352|FG000|Overall Study|Study drug never administered|1|||
126351240|NCT02924376|454576259|FG002|Overall Study|Study Terminated by Sponsor|0|||
126351241|NCT02924376|454576260|FG003|Overall Study|Study Terminated by Sponsor|0|||
126351242|NCT02924376|454576257|FG000|Overall Study|Physician Decision|1|||
126760059|NCT03410693|456072353|FG001|Overall Study|Study drug never administered|6|||
126351243|NCT02924376|454576258|FG001|Overall Study|Physician Decision|0|||
126351244|NCT02924376|454576259|FG002|Overall Study|Physician Decision|0|||
126351245|NCT02924376|454576260|FG003|Overall Study|Physician Decision|0|||
126351246|NCT02924376|454576257|FG000|Overall Study|Withdrawal by Subject|7|||
126351247|NCT02924376|454576258|FG001|Overall Study|Withdrawal by Subject|2|||
126351248|NCT02924376|454576259|FG002|Overall Study|Withdrawal by Subject|1|||
126351249|NCT02924376|454576260|FG003|Overall Study|Withdrawal by Subject|0|||
126351250|NCT02924376|454576257|FG000|Overall Study|Rolled Over to Another Study|1|||
126351251|NCT02924376|454576258|FG001|Overall Study|Rolled Over to Another Study|0|||
126369504|NCT00189423|454650584|FG000|Overall Study|Death|746|||
126351252|NCT02924376|454576259|FG002|Overall Study|Rolled Over to Another Study|0|||
126351253|NCT02924376|454576260|FG003|Overall Study|Rolled Over to Another Study|0|||
126351254|NCT06481579|454576262|FG000|Overall Study|Death|1|||
126351255|NCT06481579|454576263|FG001|Overall Study|Death|0|||
126351256|NCT06481579|454576262|FG000|Overall Study|Withdrawal by Subject|3|||
126351257|NCT06481579|454576263|FG001|Overall Study|Withdrawal by Subject|0|||
126351258|NCT06481579|454576262|FG000|Overall Study|Other|1|||
126351259|NCT06481579|454576263|FG001|Overall Study|Other|1|||
126351260|NCT06170827|454576264|FG000|Overall Study|Withdrawal by Subject|1|||
126351261|NCT06170827|454576265|FG001|Overall Study|Withdrawal by Subject|1|||
126351262|NCT04611126|454576266|FG000|Overall Study|TIL expansion unsuccessful|1|||
126351263|NCT04611126|454576267|FG001|Overall Study|TIL expansion unsuccessful|0|||
126351264|NCT03459846|454576272|FG000|Overall Study|Death|52|||
126351265|NCT03459846|454576273|FG001|Overall Study|Death|46|||
126351266|NCT03459846|454576272|FG000|Overall Study|Study terminated by sponsor|24|||
126351267|NCT03459846|454576273|FG001|Overall Study|Study terminated by sponsor|28|||
126351268|NCT03459846|454576272|FG000|Overall Study|Withdrawal by Subject|2|||
126351269|NCT03459846|454576273|FG001|Overall Study|Withdrawal by Subject|2|||
126351270|NCT06455111|454576276|FG000|Overall Study|Withdrawal by Subject|11|||
126351271|NCT06455111|454576277|FG001|Overall Study|Withdrawal by Subject|4|||
126351272|NCT05763875|454576282|FG000|Overall Study|Subject decision|5|||
126351273|NCT05763875|454576283|FG001|Overall Study|Subject decision|2|||
126351274|NCT05763875|454576284|FG002|Overall Study|Subject decision|1|||
126351275|NCT05763875|454576282|FG000|Overall Study|Lost to Follow-up|4|||
126351276|NCT05763875|454576283|FG001|Overall Study|Lost to Follow-up|1|||
126351277|NCT05763875|454576284|FG002|Overall Study|Lost to Follow-up|2|||
126351278|NCT05763875|454576282|FG000|Overall Study|Adverse Event|1|||
126351279|NCT05763875|454576283|FG001|Overall Study|Adverse Event|0|||
126351280|NCT05763875|454576284|FG002|Overall Study|Adverse Event|0|||
126351281|NCT05578872|454576287|FG000|Overall Study|Withdrawal by Subject|2|||
126351282|NCT05578872|454576288|FG001|Overall Study|Withdrawal by Subject|1|||
126351283|NCT05578872|454576287|FG000|Overall Study|Adverse Event|1|||
126351284|NCT05578872|454576288|FG001|Overall Study|Adverse Event|1|||
126351285|NCT05578872|454576287|FG000|Overall Study|Physician Decision|1|||
126351286|NCT05578872|454576288|FG001|Overall Study|Physician Decision|2|||
126351287|NCT05578872|454576287|FG000|Overall Study|Progressive disease|10|||
126351288|NCT05578872|454576288|FG001|Overall Study|Progressive disease|9|||
126351289|NCT05578872|454576287|FG000|Overall Study|Sponsor decision|0|||
126351290|NCT05578872|454576288|FG001|Overall Study|Sponsor decision|1|||
126351291|NCT05578872|454576287|FG000|Overall Study|Toxicity and Patient's decision|0|||
126351292|NCT05578872|454576288|FG001|Overall Study|Toxicity and Patient's decision|1|||
126351293|NCT02717611|454577047|FG000|Overall Study|Death|13|||
126351294|NCT02717611|454577047|FG000|Overall Study|Withdrawal by Subject|6|||
126351295|NCT02717611|454577047|FG000|Overall Study|Active, not recruiting|40|||
126351296|NCT02717611|454577047|FG000|Overall Study|Complicating disease|1|||
126351297|NCT06187909|454577048|FG000|Overall Study|Withdrawal by Subject|2|||
126351298|NCT06187909|454577049|FG001|Overall Study|Withdrawal by Subject|2|||
126351299|NCT02676973|454577050|FG000|Overall Study|Withdrawal by Subject|9|||
126351300|NCT02676973|454577051|FG001|Overall Study|Withdrawal by Subject|8|||
126351301|NCT02676973|454577052|FG002|Overall Study|Withdrawal by Subject|11|||
126351302|NCT02676973|454577050|FG000|Overall Study|Lost to Follow-up|8|||
126351303|NCT02676973|454577051|FG001|Overall Study|Lost to Follow-up|12|||
126351304|NCT02676973|454577052|FG002|Overall Study|Lost to Follow-up|8|||
126351305|NCT02676973|454577050|FG000|Overall Study|Death|2|||
126351306|NCT02676973|454577051|FG001|Overall Study|Death|1|||
126351307|NCT02676973|454577052|FG002|Overall Study|Death|5|||
126351308|NCT05020743|454577054|FG000|Overall Study|Enrollment in Interventional Study|2|||
126351309|NCT05020743|454577055|FG001|Overall Study|Enrollment in Interventional Study|9|||
126351310|NCT05020743|454577056|FG002|Overall Study|Enrollment in Interventional Study|0|||
126351311|NCT05020743|454577054|FG000|Overall Study|Withdrawal by Subject|0|||
126351312|NCT05020743|454577055|FG001|Overall Study|Withdrawal by Subject|3|||
126351313|NCT05020743|454577056|FG002|Overall Study|Withdrawal by Subject|1|||
126351314|NCT05020743|454577054|FG000|Overall Study|Lost to Follow-up|1|||
126351315|NCT05020743|454577055|FG001|Overall Study|Lost to Follow-up|0|||
126351316|NCT05020743|454577056|FG002|Overall Study|Lost to Follow-up|0|||
126351317|NCT05020743|454577054|FG000|Overall Study|Study Termination by Sponsor|10|||
126351318|NCT05020743|454577055|FG001|Overall Study|Study Termination by Sponsor|11|||
126351319|NCT05020743|454577056|FG002|Overall Study|Study Termination by Sponsor|10|||
126351320|NCT03488524|454577057|FG000|Overall Study|Withdrawal by Subject|51|||
126351321|NCT03488524|454577057|FG000|Overall Study|Death|19|||
126351322|NCT03488524|454577057|FG000|Overall Study|Study Sponsor|11|||
126351323|NCT03488524|454577057|FG000|Overall Study|Physician Decision|4|||
126351324|NCT03488524|454577057|FG000|Overall Study|Lost to Follow-up|3|||
126351325|NCT00325416|454577058|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
126351326|NCT00325416|454577059|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
126688988|NCT01505894|455817168|FG000|Overall Study|Adverse Event|1|||
126688989|NCT01505894|455817169|FG001|Overall Study|Adverse Event|0|||
126688990|NCT01505894|455817170|FG002|Overall Study|Adverse Event|0|||
126688991|NCT01505894|455817171|FG003|Overall Study|Adverse Event|0|||
126688992|NCT01505894|455817172|FG004|Overall Study|Adverse Event|0|||
126688993|NCT01505894|455817173|FG005|Overall Study|Adverse Event|0|||
126688994|NCT01505894|455817174|FG006|Overall Study|Adverse Event|0|||
126688995|NCT01505894|455817175|FG007|Overall Study|Adverse Event|0|||
126351327|NCT00325416|454577058|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
126351328|NCT00325416|454577059|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
126351329|NCT00325416|454577058|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
126351330|NCT00325416|454577059|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
126351331|NCT00325416|454577058|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
126351332|NCT00325416|454577059|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
126351333|NCT00325416|454577058|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
126351334|NCT00325416|454577059|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
126351335|NCT00325416|454577058|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
126351336|NCT00325416|454577059|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
126351337|NCT02324153|454577060|FG000|Overall Study|Withdrawal by Subject|4|||
126351338|NCT02324153|454577061|FG001|Overall Study|Withdrawal by Subject|1|||
126351339|NCT02324153|454577060|FG000|Overall Study|Surgery postponed after randomization|3|||
126351340|NCT02324153|454577061|FG001|Overall Study|Surgery postponed after randomization|0|||
126351341|NCT02324153|454577060|FG000|Overall Study|Developed delirium preoperatively|1|||
126351342|NCT02324153|454577061|FG001|Overall Study|Developed delirium preoperatively|0|||
126351343|NCT03122106|454577064|FG000|Overall Study|Not enough tissue|1|||
126351344|NCT03122106|454577064|FG000|Overall Study|Disease progression during screening|2|||
126351345|NCT03122106|454577064|FG000|Overall Study|Poor RNA quality for vaccine|1|||
126351346|NCT01913353|454577066|FG000|Overall Study|Adverse Event|2|||
126351347|NCT01913353|454577067|FG001|Overall Study|Adverse Event|0|||
126351348|NCT01913353|454577066|FG000|Overall Study|Physician Decision|0|||
126351349|NCT01913353|454577067|FG001|Overall Study|Physician Decision|2|||
126351350|NCT01913353|454577066|FG000|Overall Study|Withdrawal by Subject|20|||
126351351|NCT01913353|454577067|FG001|Overall Study|Withdrawal by Subject|6|||
126351352|NCT01913353|454577066|FG000|Overall Study|multiple reasons|10|||
126351353|NCT01913353|454577067|FG001|Overall Study|multiple reasons|7|||
126351354|NCT01147458|454577069|FG000|First Intervention|Study terminated by sponsor|8|||
126351355|NCT01147458|454577070|FG001|First Intervention|Study terminated by sponsor|8|||
126351356|NCT01147458|454577071|FG002|First Intervention|Study terminated by sponsor|7|||
126351357|NCT01147458|454577072|FG003|First Intervention|Study terminated by sponsor|8|||
126351358|NCT01147458|454577069|FG000|First Intervention|Protocol Violation|2|||
126351359|NCT01147458|454577070|FG001|First Intervention|Protocol Violation|3|||
126351360|NCT01147458|454577071|FG002|First Intervention|Protocol Violation|2|||
126351361|NCT01147458|454577072|FG003|First Intervention|Protocol Violation|3|||
126351362|NCT01147458|454577069|FG000|First Intervention|Withdrawal by Subject|3|||
126351363|NCT01147458|454577070|FG001|First Intervention|Withdrawal by Subject|0|||
126351364|NCT01147458|454577071|FG002|First Intervention|Withdrawal by Subject|1|||
126351365|NCT01147458|454577072|FG003|First Intervention|Withdrawal by Subject|0|||
126351366|NCT01147458|454577069|FG000|First Intervention|Adverse Event|0|||
126351367|NCT01147458|454577070|FG001|First Intervention|Adverse Event|3|||
126351368|NCT01147458|454577071|FG002|First Intervention|Adverse Event|2|||
126351369|NCT01147458|454577072|FG003|First Intervention|Adverse Event|3|||
126351370|NCT01147458|454577069|FG000|First Intervention|Other|1|||
126351371|NCT01147458|454577070|FG001|First Intervention|Other|2|||
126351372|NCT01147458|454577071|FG002|First Intervention|Other|0|||
126351373|NCT01147458|454577072|FG003|First Intervention|Other|0|||
126351374|NCT01147458|454577069|FG000|Second Intervention|Study terminated by sponsor|7|||
126351375|NCT01147458|454577070|FG001|Second Intervention|Study terminated by sponsor|5|||
126351376|NCT01147458|454577071|FG002|Second Intervention|Study terminated by sponsor|5|||
126351377|NCT01147458|454577072|FG003|Second Intervention|Study terminated by sponsor|3|||
126351378|NCT01147458|454577069|FG000|Second Intervention|Protocol Violation|0|||
126688996|NCT01505894|455817176|FG008|Overall Study|Adverse Event|0|||
126351379|NCT01147458|454577070|FG001|Second Intervention|Protocol Violation|1|||
126351380|NCT01147458|454577071|FG002|Second Intervention|Protocol Violation|1|||
126351381|NCT01147458|454577072|FG003|Second Intervention|Protocol Violation|0|||
126351382|NCT01147458|454577069|FG000|Second Intervention|Withdrawal by Subject|0|||
126688997|NCT01505894|455817168|FG000|Overall Study|Other than specified|0|||
126688998|NCT01505894|455817169|FG001|Overall Study|Other than specified|0|||
126439510|NCT00463567|454909649|FG006|Overall Study|Administrative problems|2|||
126439511|NCT00463567|454909643|FG000|Overall Study|Lack of Efficacy|4|||
126439512|NCT00463567|454909644|FG001|Overall Study|Lack of Efficacy|9|||
126439513|NCT00463567|454909645|FG002|Overall Study|Lack of Efficacy|9|||
126439514|NCT00463567|454909646|FG003|Overall Study|Lack of Efficacy|17|||
126439515|NCT00463567|454909647|FG004|Overall Study|Lack of Efficacy|1|||
126439516|NCT00463567|454909648|FG005|Overall Study|Lack of Efficacy|0|||
126439517|NCT00463567|454909649|FG006|Overall Study|Lack of Efficacy|1|||
126439518|NCT00463567|454909643|FG000|Overall Study|Abnormal lab value(s)|1|||
126439519|NCT00463567|454909644|FG001|Overall Study|Abnormal lab value(s)|1|||
126439520|NCT00463567|454909645|FG002|Overall Study|Abnormal lab value(s)|2|||
126439521|NCT00463567|454909646|FG003|Overall Study|Abnormal lab value(s)|1|||
126439522|NCT00463567|454909647|FG004|Overall Study|Abnormal lab value(s)|1|||
126439523|NCT00463567|454909648|FG005|Overall Study|Abnormal lab value(s)|0|||
126439524|NCT00463567|454909649|FG006|Overall Study|Abnormal lab value(s)|0|||
126439525|NCT00463567|454909643|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126439526|NCT00463567|454909644|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126439527|NCT00463567|454909645|FG002|Overall Study|Abnormal test procedure result(s)|6|||
126760060|NCT03410693|456072352|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
126760061|NCT03410693|456072353|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
126760062|NCT03410693|456072352|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
126760063|NCT03410693|456072353|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
126760064|NCT03410693|456072352|FG000|Overall Study|Disc trt: Physician decision|0|||
126760065|NCT03410693|456072353|FG001|Overall Study|Disc trt: Physician decision|5|||
126760066|NCT03410693|456072352|FG000|Overall Study|Disc trt: clinical progression|1|||
126760067|NCT03410693|456072353|FG001|Overall Study|Disc trt: clinical progression|5|||
126760068|NCT03410693|456072352|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
126760069|NCT03410693|456072353|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
126760070|NCT00953576|456072354|FG000|Overall Study|Adverse Event|0|||
126760071|NCT00953576|456072355|FG001|Overall Study|Adverse Event|1|||
126369505|NCT00189423|454650585|FG001|Overall Study|Death|747|||
126369506|NCT00189423|454650584|FG000|Overall Study|Withdrawal by Subject|9|||
126369507|NCT00189423|454650585|FG001|Overall Study|Withdrawal by Subject|9|||
126369508|NCT00189423|454650584|FG000|Overall Study|Lost to Follow-up|10|||
126369509|NCT00189423|454650585|FG001|Overall Study|Lost to Follow-up|10|||
126369510|NCT04622592|454650588|FG000|Overall Study|Death|0|||
126369511|NCT04622592|454650589|FG001|Overall Study|Death|0|||
126369512|NCT04622592|454650590|FG002|Overall Study|Death|1|||
126369513|NCT04622592|454650591|FG003|Overall Study|Death|0|||
126369514|NCT04622592|454650592|FG004|Overall Study|Death|0|||
126369515|NCT04622592|454650593|FG005|Overall Study|Death|0|||
126369516|NCT04622592|454650594|FG006|Overall Study|Death|0|||
126369517|NCT04622592|454650595|FG007|Overall Study|Death|1|||
126369518|NCT04622592|454650588|FG000|Overall Study|Lost to Follow-up|0|||
126369519|NCT04622592|454650589|FG001|Overall Study|Lost to Follow-up|0|||
126369520|NCT04622592|454650590|FG002|Overall Study|Lost to Follow-up|0|||
126369521|NCT04622592|454650591|FG003|Overall Study|Lost to Follow-up|3|||
126369522|NCT04622592|454650592|FG004|Overall Study|Lost to Follow-up|1|||
126369523|NCT04622592|454650593|FG005|Overall Study|Lost to Follow-up|0|||
126369524|NCT04622592|454650594|FG006|Overall Study|Lost to Follow-up|2|||
126369525|NCT04622592|454650595|FG007|Overall Study|Lost to Follow-up|2|||
126369526|NCT04622592|454650588|FG000|Overall Study|Physician Decision|0|||
126369527|NCT04622592|454650589|FG001|Overall Study|Physician Decision|0|||
126369528|NCT04622592|454650590|FG002|Overall Study|Physician Decision|0|||
126369529|NCT04622592|454650591|FG003|Overall Study|Physician Decision|0|||
126369530|NCT04622592|454650592|FG004|Overall Study|Physician Decision|1|||
126369531|NCT04622592|454650593|FG005|Overall Study|Physician Decision|0|||
126369532|NCT04622592|454650594|FG006|Overall Study|Physician Decision|0|||
126369533|NCT04622592|454650595|FG007|Overall Study|Physician Decision|0|||
126369534|NCT04622592|454650588|FG000|Overall Study|Withdrawal by Subject|1|||
126369535|NCT04622592|454650589|FG001|Overall Study|Withdrawal by Subject|0|||
126369536|NCT04622592|454650590|FG002|Overall Study|Withdrawal by Subject|2|||
126369537|NCT04622592|454650591|FG003|Overall Study|Withdrawal by Subject|0|||
126369538|NCT04622592|454650592|FG004|Overall Study|Withdrawal by Subject|0|||
126369539|NCT04622592|454650593|FG005|Overall Study|Withdrawal by Subject|0|||
126369540|NCT04622592|454650594|FG006|Overall Study|Withdrawal by Subject|1|||
126369541|NCT04622592|454650595|FG007|Overall Study|Withdrawal by Subject|4|||
126369542|NCT04622592|454650588|FG000|Overall Study|Other than specified above|0|||
126369543|NCT04622592|454650589|FG001|Overall Study|Other than specified above|0|||
126369544|NCT04622592|454650590|FG002|Overall Study|Other than specified above|1|||
126369545|NCT04622592|454650591|FG003|Overall Study|Other than specified above|0|||
126369546|NCT04622592|454650592|FG004|Overall Study|Other than specified above|0|||
126369547|NCT04622592|454650593|FG005|Overall Study|Other than specified above|0|||
126369548|NCT04622592|454650594|FG006|Overall Study|Other than specified above|0|||
126369549|NCT04622592|454650595|FG007|Overall Study|Other than specified above|0|||
126369550|NCT01497197|454650596|FG000|Overall Study|Lost to Follow-up|1|||
126439528|NCT00463567|454909646|FG003|Overall Study|Abnormal test procedure result(s)|2|||
126439529|NCT00463567|454909647|FG004|Overall Study|Abnormal test procedure result(s)|0|||
126351383|NCT01147458|454577070|FG001|Second Intervention|Withdrawal by Subject|1|||
126351384|NCT01147458|454577071|FG002|Second Intervention|Withdrawal by Subject|0|||
126351385|NCT01147458|454577072|FG003|Second Intervention|Withdrawal by Subject|0|||
126351386|NCT01147458|454577069|FG000|Second Intervention|Adverse Event|2|||
126351387|NCT01147458|454577070|FG001|Second Intervention|Adverse Event|0|||
126351388|NCT01147458|454577071|FG002|Second Intervention|Adverse Event|1|||
126351389|NCT01147458|454577072|FG003|Second Intervention|Adverse Event|1|||
126351390|NCT01147458|454577069|FG000|Second Intervention|Other|0|||
126351391|NCT01147458|454577070|FG001|Second Intervention|Other|0|||
126351392|NCT01147458|454577071|FG002|Second Intervention|Other|1|||
126351393|NCT01147458|454577072|FG003|Second Intervention|Other|0|||
126351394|NCT03550209|454577073|FG000|Overall Study|Lost to Follow-up|1|||
126351395|NCT03550209|454577074|FG001|Overall Study|Lost to Follow-up|0|||
126351396|NCT03550209|454577075|FG002|Overall Study|Lost to Follow-up|1|||
126351397|NCT03550209|454577076|FG003|Overall Study|Lost to Follow-up|0|||
126351398|NCT03550209|454577073|FG000|Overall Study|Withdrawal by Subject|0|||
126351399|NCT03550209|454577074|FG001|Overall Study|Withdrawal by Subject|3|||
126351400|NCT03550209|454577075|FG002|Overall Study|Withdrawal by Subject|1|||
126351401|NCT03550209|454577076|FG003|Overall Study|Withdrawal by Subject|2|||
126351402|NCT03550209|454577073|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
126351403|NCT03550209|454577074|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
126351404|NCT03550209|454577075|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
126351405|NCT03550209|454577076|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
126351406|NCT02555878|454577077|FG000|Overall Study|Lost to Follow-up|2|||
126351407|NCT02555878|454577078|FG001|Overall Study|Lost to Follow-up|3|||
126351408|NCT02555878|454577077|FG000|Overall Study|Withdrawal by Subject|48|||
126351409|NCT02555878|454577078|FG001|Overall Study|Withdrawal by Subject|48|||
126351410|NCT02555878|454577077|FG000|Overall Study|Adverse Event|12|||
126351411|NCT02555878|454577078|FG001|Overall Study|Adverse Event|8|||
126351412|NCT02555878|454577077|FG000|Overall Study|Death|74|||
126351413|NCT02555878|454577078|FG001|Overall Study|Death|59|||
126351414|NCT02555878|454577077|FG000|Overall Study|Protocol Violation|1|||
126351415|NCT02555878|454577078|FG001|Overall Study|Protocol Violation|2|||
126351416|NCT02555878|454577077|FG000|Overall Study|Physician Decision|12|||
126351417|NCT02555878|454577078|FG001|Overall Study|Physician Decision|13|||
126351418|NCT02555878|454577077|FG000|Overall Study|Other|17|||
126351419|NCT02555878|454577078|FG001|Overall Study|Other|17|||
126351420|NCT00765076|454577079|FG000|Overall Study|Adverse Event|1|||
126351421|NCT00765076|454577080|FG001|Overall Study|Adverse Event|0|||
126351422|NCT00765076|454577081|FG002|Overall Study|Adverse Event|0|||
126351423|NCT00765076|454577079|FG000|Overall Study|Withdrawal by Subject|0|||
126351424|NCT00765076|454577080|FG001|Overall Study|Withdrawal by Subject|0|||
126351425|NCT00765076|454577081|FG002|Overall Study|Withdrawal by Subject|1|||
126351426|NCT02875080|454577082|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
126351427|NCT02875080|454577083|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
126351428|NCT02875080|454577084|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
126351429|NCT00768053|454577085|FG000|Overall Study|Adverse Event|10|||
126351430|NCT00768053|454577085|FG000|Overall Study|Lost to Follow-up|1|||
126351431|NCT01164475|454577086|FG000|Overall Study|Lack of Efficacy|1|||
126351432|NCT01164475|454577087|FG001|Overall Study|Lack of Efficacy|0|||
126351433|NCT01164475|454577086|FG000|Overall Study|Other|0|||
126351434|NCT01164475|454577087|FG001|Overall Study|Other|1|||
126351435|NCT01164475|454577086|FG000|Overall Study|Progressive disease|0|||
126351436|NCT01164475|454577087|FG001|Overall Study|Progressive disease|1|||
126351437|NCT01164475|454577086|FG000|Overall Study|Protocol Violation|1|||
126351438|NCT01164475|454577087|FG001|Overall Study|Protocol Violation|0|||
126351439|NCT04603066|454577089|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
126351440|NCT04603066|454577090|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
126351441|NCT04134845|454577091|FG000|Overall Study|withdrawl by PI|12|||
126351442|NCT04134845|454577092|FG001|Overall Study|withdrawl by PI|5|||
126351443|NCT01371981|454577093|FG000|Overall Study|Adverse Event|12|||
126351444|NCT01371981|454577094|FG001|Overall Study|Adverse Event|17|||
126351445|NCT01371981|454577095|FG002|Overall Study|Adverse Event|0|||
126351446|NCT01371981|454577096|FG003|Overall Study|Adverse Event|4|||
126439530|NCT00463567|454909648|FG005|Overall Study|Abnormal test procedure result(s)|2|||
126351447|NCT01371981|454577097|FG004|Overall Study|Adverse Event|1|||
126351448|NCT01371981|454577098|FG005|Overall Study|Adverse Event|0|||
126351449|NCT01371981|454577093|FG000|Overall Study|Death|22|||
126351450|NCT01371981|454577094|FG001|Overall Study|Death|16|||
126351451|NCT01371981|454577095|FG002|Overall Study|Death|0|||
126351452|NCT01371981|454577096|FG003|Overall Study|Death|0|||
126351453|NCT01371981|454577097|FG004|Overall Study|Death|2|||
126351454|NCT01371981|454577098|FG005|Overall Study|Death|2|||
126439531|NCT00463567|454909649|FG006|Overall Study|Abnormal test procedure result(s)|0|||
126439532|NCT00463567|454909643|FG000|Overall Study|Death|1|||
126439533|NCT00463567|454909644|FG001|Overall Study|Death|0|||
126439534|NCT00463567|454909645|FG002|Overall Study|Death|2|||
126439535|NCT00463567|454909646|FG003|Overall Study|Death|0|||
126439536|NCT00463567|454909647|FG004|Overall Study|Death|0|||
126439537|NCT00463567|454909648|FG005|Overall Study|Death|0|||
126439538|NCT00463567|454909649|FG006|Overall Study|Death|0|||
126439539|NCT03077412|454909654|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
126439540|NCT03077412|454909655|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
126439541|NCT03077412|454909656|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
126439542|NCT03077412|454909654|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
126439543|NCT03077412|454909655|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
126439544|NCT03077412|454909656|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
126439545|NCT03077412|454909654|FG000|Overall Study|Adverse Event|1|||
126439546|NCT03077412|454909655|FG001|Overall Study|Adverse Event|2|||
126439547|NCT03077412|454909656|FG002|Overall Study|Adverse Event|2|||
126439548|NCT03077412|454909654|FG000|Overall Study|Investigator's Discretion|0|||
126439549|NCT03077412|454909655|FG001|Overall Study|Investigator's Discretion|1|||
126439550|NCT03077412|454909656|FG002|Overall Study|Investigator's Discretion|1|||
126439551|NCT03077412|454909654|FG000|Overall Study|Withdrew Consent|0|||
126439552|NCT03077412|454909655|FG001|Overall Study|Withdrew Consent|2|||
126439553|NCT03077412|454909656|FG002|Overall Study|Withdrew Consent|0|||
126439554|NCT02266888|454909657|FG000|Overall Study|Death|2|||
126439555|NCT02266888|454909658|FG001|Overall Study|Death|2|||
126439556|NCT02266888|454909659|FG002|Overall Study|Death|4|||
126439557|NCT02266888|454909660|FG003|Overall Study|Death|2|||
126439558|NCT02266888|454909657|FG000|Overall Study|Physician Decision|0|||
126439559|NCT02266888|454909658|FG001|Overall Study|Physician Decision|1|||
126439560|NCT02266888|454909659|FG002|Overall Study|Physician Decision|2|||
126439561|NCT02266888|454909660|FG003|Overall Study|Physician Decision|2|||
126439562|NCT02266888|454909657|FG000|Overall Study|Study Terminated|5|||
126439563|NCT02266888|454909658|FG001|Overall Study|Study Terminated|1|||
126439564|NCT02266888|454909659|FG002|Overall Study|Study Terminated|0|||
126439565|NCT02266888|454909660|FG003|Overall Study|Study Terminated|0|||
126439566|NCT02266888|454909657|FG000|Overall Study|No Longer Eligible|0|||
126439567|NCT02266888|454909658|FG001|Overall Study|No Longer Eligible|0|||
126439568|NCT02266888|454909659|FG002|Overall Study|No Longer Eligible|0|||
126439569|NCT02266888|454909660|FG003|Overall Study|No Longer Eligible|2|||
126439570|NCT02266888|454909657|FG000|Overall Study|Randomization Closed|0|||
126439571|NCT02266888|454909658|FG001|Overall Study|Randomization Closed|0|||
126439572|NCT02266888|454909659|FG002|Overall Study|Randomization Closed|4|||
126439573|NCT02266888|454909660|FG003|Overall Study|Randomization Closed|0|||
126439574|NCT02266888|454909657|FG000|Overall Study|Personnel unavailable at transplant|0|||
126439575|NCT02266888|454909658|FG001|Overall Study|Personnel unavailable at transplant|0|||
126439576|NCT02266888|454909659|FG002|Overall Study|Personnel unavailable at transplant|0|||
126439577|NCT02266888|454909660|FG003|Overall Study|Personnel unavailable at transplant|1|||
126439578|NCT02266888|454909657|FG000|Overall Study|Transfer of care|0|||
126439579|NCT02266888|454909658|FG001|Overall Study|Transfer of care|0|||
126439580|NCT02266888|454909659|FG002|Overall Study|Transfer of care|1|||
126439581|NCT02266888|454909660|FG003|Overall Study|Transfer of care|0|||
126439582|NCT02351856|454909661|FG000|Overall Study|Adverse Event|2|||
126439583|NCT02351856|454909661|FG000|Overall Study|Physician Decision|5|||
126439584|NCT02351856|454909661|FG000|Overall Study|Study terminated by sponsor|1|||
126439585|NCT00918255|454909662|FG000|Overall Study|Adverse Event|1|||
126439586|NCT00918255|454909663|FG001|Overall Study|Adverse Event|0|||
126439587|NCT00918255|454909664|FG002|Overall Study|Adverse Event|0|||
126439588|NCT00918255|454909662|FG000|Overall Study|Withdrawal by Subject|1|||
126439589|NCT00918255|454909663|FG001|Overall Study|Withdrawal by Subject|0|||
126439590|NCT00918255|454909664|FG002|Overall Study|Withdrawal by Subject|2|||
126439591|NCT00918255|454909662|FG000|Overall Study|Lack of Efficacy|1|||
126439592|NCT00918255|454909663|FG001|Overall Study|Lack of Efficacy|0|||
126439593|NCT00918255|454909664|FG002|Overall Study|Lack of Efficacy|0|||
126688999|NCT01505894|455817170|FG002|Overall Study|Other than specified|0|||
126439594|NCT00918255|454909662|FG000|Overall Study|Lost to Follow-up|1|||
126439595|NCT00918255|454909663|FG001|Overall Study|Lost to Follow-up|0|||
126439596|NCT00918255|454909664|FG002|Overall Study|Lost to Follow-up|2|||
126439597|NCT00918255|454909662|FG000|Overall Study|Exceeded allowed number of interventions|0|||
126439598|NCT00918255|454909663|FG001|Overall Study|Exceeded allowed number of interventions|0|||
126439599|NCT00918255|454909664|FG002|Overall Study|Exceeded allowed number of interventions|1|||
126439600|NCT00918255|454909662|FG000|Overall Study|Non-compliance|1|||
126439601|NCT00918255|454909663|FG001|Overall Study|Non-compliance|0|||
126439602|NCT00918255|454909664|FG002|Overall Study|Non-compliance|0|||
126439603|NCT00918255|454909662|FG000|Overall Study|Investigator discretion|1|||
126439604|NCT00918255|454909663|FG001|Overall Study|Investigator discretion|0|||
126439605|NCT00918255|454909664|FG002|Overall Study|Investigator discretion|0|||
126439606|NCT01193244|454909665|FG000|Overall Study|Withdrawal by Subject|79|||
126439607|NCT01193244|454909666|FG001|Overall Study|Withdrawal by Subject|97|||
126439608|NCT01193244|454909665|FG000|Overall Study|Other|303|||
126439609|NCT01193244|454909666|FG001|Overall Study|Other|278|||
126439610|NCT01193244|454909665|FG000|Overall Study|Lost to Follow-up|6|||
126439611|NCT01193244|454909666|FG001|Overall Study|Lost to Follow-up|15|||
126439612|NCT03763877|454909668|FG000|Overall Study|Withdrawal by Subject|3|||
126439613|NCT03763877|454909669|FG001|Overall Study|Withdrawal by Subject|1|||
126439614|NCT03763877|454909670|FG002|Overall Study|Withdrawal by Subject|3|||
126439615|NCT03763877|454909671|FG003|Overall Study|Withdrawal by Subject|4|||
126439616|NCT03763877|454909668|FG000|Overall Study|Adverse Event|1|||
126439617|NCT03763877|454909669|FG001|Overall Study|Adverse Event|1|||
126439618|NCT03763877|454909670|FG002|Overall Study|Adverse Event|3|||
126439619|NCT03763877|454909671|FG003|Overall Study|Adverse Event|1|||
126439620|NCT03763877|454909668|FG000|Overall Study|Protocol Violation|1|||
126439621|NCT03763877|454909669|FG001|Overall Study|Protocol Violation|1|||
126439622|NCT03763877|454909670|FG002|Overall Study|Protocol Violation|0|||
126439623|NCT03763877|454909671|FG003|Overall Study|Protocol Violation|0|||
126439624|NCT03763877|454909668|FG000|Overall Study|Lost to Follow-up|0|||
126439625|NCT03763877|454909669|FG001|Overall Study|Lost to Follow-up|1|||
126439626|NCT03763877|454909670|FG002|Overall Study|Lost to Follow-up|1|||
126439627|NCT03763877|454909671|FG003|Overall Study|Lost to Follow-up|0|||
126439628|NCT03040336|454909672|FG000|Overall Study|Death|1|||
126439629|NCT03040336|454909673|FG001|Overall Study|Death|0|||
126439630|NCT03040336|454909672|FG000|Overall Study|Withdrawal by Subject|2|||
126439631|NCT03040336|454909673|FG001|Overall Study|Withdrawal by Subject|3|||
126439632|NCT00068692|454909678|FG000|Step 1: Registration|Disese progression/relapse|5|||
126439633|NCT00068692|454909679|FG001|Step 1: Registration|Disese progression/relapse|0|||
126439634|NCT00068692|454909680|FG002|Step 1: Registration|Disese progression/relapse|0|||
126439635|NCT00068692|454909681|FG003|Step 1: Registration|Disese progression/relapse|0|||
126439636|NCT00068692|454909682|FG004|Step 1: Registration|Disese progression/relapse|0|||
126439637|NCT00068692|454909683|FG005|Step 1: Registration|Disese progression/relapse|0|||
126439638|NCT00068692|454909684|FG006|Step 1: Registration|Disese progression/relapse|0|||
126439639|NCT00068692|454909685|FG007|Step 1: Registration|Disese progression/relapse|0|||
126439640|NCT00068692|454909678|FG000|Step 1: Registration|Adverse Event|7|||
126439641|NCT00068692|454909679|FG001|Step 1: Registration|Adverse Event|0|||
126439642|NCT00068692|454909680|FG002|Step 1: Registration|Adverse Event|0|||
126439643|NCT00068692|454909681|FG003|Step 1: Registration|Adverse Event|0|||
126439644|NCT00068692|454909682|FG004|Step 1: Registration|Adverse Event|0|||
126439645|NCT00068692|454909683|FG005|Step 1: Registration|Adverse Event|0|||
126439646|NCT00068692|454909684|FG006|Step 1: Registration|Adverse Event|0|||
126439647|NCT00068692|454909685|FG007|Step 1: Registration|Adverse Event|0|||
126439648|NCT00068692|454909678|FG000|Step 1: Registration|Death|1|||
126439649|NCT00068692|454909679|FG001|Step 1: Registration|Death|0|||
126439650|NCT00068692|454909680|FG002|Step 1: Registration|Death|0|||
126439651|NCT00068692|454909681|FG003|Step 1: Registration|Death|0|||
126439652|NCT00068692|454909682|FG004|Step 1: Registration|Death|0|||
126439653|NCT00068692|454909683|FG005|Step 1: Registration|Death|0|||
126439654|NCT00068692|454909684|FG006|Step 1: Registration|Death|0|||
126439655|NCT00068692|454909685|FG007|Step 1: Registration|Death|0|||
126439656|NCT00068692|454909678|FG000|Step 1: Registration|Withdrawal by Subject|11|||
126439657|NCT00068692|454909679|FG001|Step 1: Registration|Withdrawal by Subject|0|||
126439658|NCT00068692|454909680|FG002|Step 1: Registration|Withdrawal by Subject|0|||
126439659|NCT00068692|454909681|FG003|Step 1: Registration|Withdrawal by Subject|0|||
126439660|NCT00068692|454909682|FG004|Step 1: Registration|Withdrawal by Subject|0|||
126439661|NCT00068692|454909683|FG005|Step 1: Registration|Withdrawal by Subject|0|||
126439662|NCT00068692|454909684|FG006|Step 1: Registration|Withdrawal by Subject|0|||
126439663|NCT00068692|454909685|FG007|Step 1: Registration|Withdrawal by Subject|0|||
126439664|NCT00068692|454909678|FG000|Step 1: Registration|Alternative therapy|2|||
126439665|NCT00068692|454909679|FG001|Step 1: Registration|Alternative therapy|0|||
126439666|NCT00068692|454909680|FG002|Step 1: Registration|Alternative therapy|0|||
126439667|NCT00068692|454909681|FG003|Step 1: Registration|Alternative therapy|0|||
126439668|NCT00068692|454909682|FG004|Step 1: Registration|Alternative therapy|0|||
126439669|NCT00068692|454909683|FG005|Step 1: Registration|Alternative therapy|0|||
126439670|NCT00068692|454909684|FG006|Step 1: Registration|Alternative therapy|0|||
126439671|NCT00068692|454909685|FG007|Step 1: Registration|Alternative therapy|0|||
126439672|NCT00068692|454909678|FG000|Step 1: Registration|Complicating disease|2|||
126439673|NCT00068692|454909679|FG001|Step 1: Registration|Complicating disease|0|||
126439674|NCT00068692|454909680|FG002|Step 1: Registration|Complicating disease|0|||
126439675|NCT00068692|454909681|FG003|Step 1: Registration|Complicating disease|0|||
126689000|NCT01505894|455817171|FG003|Overall Study|Other than specified|0|||
126439676|NCT00068692|454909682|FG004|Step 1: Registration|Complicating disease|0|||
126439677|NCT00068692|454909683|FG005|Step 1: Registration|Complicating disease|0|||
126439678|NCT00068692|454909684|FG006|Step 1: Registration|Complicating disease|0|||
126439679|NCT00068692|454909685|FG007|Step 1: Registration|Complicating disease|0|||
126439680|NCT00068692|454909678|FG000|Step 1: Registration|Protocol Violation|1|||
126439681|NCT00068692|454909679|FG001|Step 1: Registration|Protocol Violation|0|||
126439682|NCT00068692|454909680|FG002|Step 1: Registration|Protocol Violation|0|||
126439683|NCT00068692|454909681|FG003|Step 1: Registration|Protocol Violation|0|||
126439684|NCT00068692|454909682|FG004|Step 1: Registration|Protocol Violation|0|||
126439685|NCT00068692|454909683|FG005|Step 1: Registration|Protocol Violation|0|||
126439686|NCT00068692|454909684|FG006|Step 1: Registration|Protocol Violation|0|||
126439687|NCT00068692|454909685|FG007|Step 1: Registration|Protocol Violation|0|||
126439688|NCT00068692|454909678|FG000|Step 1: Registration|Not eligible|6|||
126439689|NCT00068692|454909679|FG001|Step 1: Registration|Not eligible|0|||
126439690|NCT00068692|454909680|FG002|Step 1: Registration|Not eligible|0|||
126439691|NCT00068692|454909681|FG003|Step 1: Registration|Not eligible|0|||
126439692|NCT00068692|454909682|FG004|Step 1: Registration|Not eligible|0|||
126439693|NCT00068692|454909683|FG005|Step 1: Registration|Not eligible|0|||
126439694|NCT00068692|454909684|FG006|Step 1: Registration|Not eligible|0|||
126439695|NCT00068692|454909685|FG007|Step 1: Registration|Not eligible|0|||
126439696|NCT00068692|454909678|FG000|Step 1: Registration|Other|2|||
126439697|NCT00068692|454909679|FG001|Step 1: Registration|Other|0|||
126439698|NCT00068692|454909680|FG002|Step 1: Registration|Other|0|||
126439699|NCT00068692|454909681|FG003|Step 1: Registration|Other|0|||
126439700|NCT00068692|454909682|FG004|Step 1: Registration|Other|0|||
126439701|NCT00068692|454909683|FG005|Step 1: Registration|Other|0|||
126439702|NCT00068692|454909684|FG006|Step 1: Registration|Other|0|||
126439703|NCT00068692|454909685|FG007|Step 1: Registration|Other|0|||
126439704|NCT00068692|454909678|FG000|Step 1: Registration|Not start protocol therapy|3|||
126439705|NCT00068692|454909679|FG001|Step 1: Registration|Not start protocol therapy|0|||
126439706|NCT00068692|454909680|FG002|Step 1: Registration|Not start protocol therapy|0|||
126439707|NCT00068692|454909681|FG003|Step 1: Registration|Not start protocol therapy|0|||
126439708|NCT00068692|454909682|FG004|Step 1: Registration|Not start protocol therapy|0|||
126439709|NCT00068692|454909683|FG005|Step 1: Registration|Not start protocol therapy|0|||
126439710|NCT00068692|454909684|FG006|Step 1: Registration|Not start protocol therapy|0|||
126439711|NCT00068692|454909685|FG007|Step 1: Registration|Not start protocol therapy|0|||
126439712|NCT00068692|454909678|FG000|Step 1: Registration|Registered but not randomized|0|||
126439713|NCT00068692|454909679|FG001|Step 1: Registration|Registered but not randomized|1|||
126439714|NCT00068692|454909680|FG002|Step 1: Registration|Registered but not randomized|0|||
126439715|NCT00068692|454909681|FG003|Step 1: Registration|Registered but not randomized|0|||
126439716|NCT00068692|454909682|FG004|Step 1: Registration|Registered but not randomized|0|||
126439717|NCT00068692|454909683|FG005|Step 1: Registration|Registered but not randomized|0|||
126439718|NCT00068692|454909684|FG006|Step 1: Registration|Registered but not randomized|0|||
126439719|NCT00068692|454909685|FG007|Step 1: Registration|Registered but not randomized|0|||
126439720|NCT00068692|454909678|FG000|Step 2: Randomization|Disesae progression/replase|0|||
126439721|NCT00068692|454909679|FG001|Step 2: Randomization|Disesae progression/replase|0|||
126439722|NCT00068692|454909680|FG002|Step 2: Randomization|Disesae progression/replase|1|||
126439723|NCT00068692|454909681|FG003|Step 2: Randomization|Disesae progression/replase|1|||
126439724|NCT00068692|454909682|FG004|Step 2: Randomization|Disesae progression/replase|0|||
126439725|NCT00068692|454909683|FG005|Step 2: Randomization|Disesae progression/replase|0|||
126439726|NCT00068692|454909684|FG006|Step 2: Randomization|Disesae progression/replase|0|||
126439727|NCT00068692|454909685|FG007|Step 2: Randomization|Disesae progression/replase|0|||
126439728|NCT00068692|454909678|FG000|Step 2: Randomization|Adverse Event|0|||
126439729|NCT00068692|454909679|FG001|Step 2: Randomization|Adverse Event|0|||
126439730|NCT00068692|454909680|FG002|Step 2: Randomization|Adverse Event|4|||
126439731|NCT00068692|454909681|FG003|Step 2: Randomization|Adverse Event|2|||
126439732|NCT00068692|454909682|FG004|Step 2: Randomization|Adverse Event|2|||
126439733|NCT00068692|454909683|FG005|Step 2: Randomization|Adverse Event|3|||
126439734|NCT00068692|454909684|FG006|Step 2: Randomization|Adverse Event|4|||
126439735|NCT00068692|454909685|FG007|Step 2: Randomization|Adverse Event|4|||
126439736|NCT00068692|454909678|FG000|Step 2: Randomization|Death|0|||
126439737|NCT00068692|454909679|FG001|Step 2: Randomization|Death|0|||
126439738|NCT00068692|454909680|FG002|Step 2: Randomization|Death|0|||
126439739|NCT00068692|454909681|FG003|Step 2: Randomization|Death|0|||
126439740|NCT00068692|454909682|FG004|Step 2: Randomization|Death|1|||
126439741|NCT00068692|454909683|FG005|Step 2: Randomization|Death|0|||
126439742|NCT00068692|454909684|FG006|Step 2: Randomization|Death|0|||
126439743|NCT00068692|454909685|FG007|Step 2: Randomization|Death|1|||
126439744|NCT00068692|454909678|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
126439745|NCT00068692|454909679|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
126439746|NCT00068692|454909680|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
126439747|NCT00068692|454909681|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
126439748|NCT00068692|454909682|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
126351455|NCT01371981|454577093|FG000|Overall Study|Lack of Efficacy|69|||
126351456|NCT01371981|454577094|FG001|Overall Study|Lack of Efficacy|61|||
126351457|NCT01371981|454577095|FG002|Overall Study|Lack of Efficacy|4|||
126351458|NCT01371981|454577096|FG003|Overall Study|Lack of Efficacy|8|||
126351459|NCT01371981|454577097|FG004|Overall Study|Lack of Efficacy|5|||
126351460|NCT01371981|454577098|FG005|Overall Study|Lack of Efficacy|0|||
126351461|NCT01371981|454577093|FG000|Overall Study|Physician Decision|48|||
126351462|NCT01371981|454577094|FG001|Overall Study|Physician Decision|63|||
126351463|NCT01371981|454577095|FG002|Overall Study|Physician Decision|1|||
126351464|NCT01371981|454577096|FG003|Overall Study|Physician Decision|7|||
126351465|NCT01371981|454577097|FG004|Overall Study|Physician Decision|14|||
126351466|NCT01371981|454577098|FG005|Overall Study|Physician Decision|3|||
126351467|NCT01371981|454577093|FG000|Overall Study|Withdrawal by Subject|12|||
126351468|NCT01371981|454577094|FG001|Overall Study|Withdrawal by Subject|19|||
126351469|NCT01371981|454577095|FG002|Overall Study|Withdrawal by Subject|1|||
126351470|NCT01371981|454577096|FG003|Overall Study|Withdrawal by Subject|2|||
126351471|NCT01371981|454577097|FG004|Overall Study|Withdrawal by Subject|10|||
126351472|NCT01371981|454577098|FG005|Overall Study|Withdrawal by Subject|3|||
126351473|NCT01371981|454577093|FG000|Overall Study|Ineligible|19|||
126351474|NCT01371981|454577094|FG001|Overall Study|Ineligible|13|||
126351475|NCT01371981|454577095|FG002|Overall Study|Ineligible|0|||
126351476|NCT01371981|454577096|FG003|Overall Study|Ineligible|0|||
126351477|NCT01371981|454577097|FG004|Overall Study|Ineligible|0|||
126351478|NCT01371981|454577098|FG005|Overall Study|Ineligible|4|||
126351479|NCT01371981|454577093|FG000|Overall Study|Did not start treatment|2|||
126351480|NCT01371981|454577094|FG001|Overall Study|Did not start treatment|3|||
126351481|NCT01371981|454577095|FG002|Overall Study|Did not start treatment|0|||
126351482|NCT01371981|454577096|FG003|Overall Study|Did not start treatment|0|||
126351483|NCT01371981|454577097|FG004|Overall Study|Did not start treatment|0|||
126351484|NCT01371981|454577098|FG005|Overall Study|Did not start treatment|2|||
126351485|NCT03244189|454577099|FG000|Overall Study|Death|0|||
126351486|NCT03244189|454577100|FG001|Overall Study|Death|2|||
126351487|NCT03244189|454577099|FG000|Overall Study|Lost to Follow-up|92|||
126351488|NCT03244189|454577100|FG001|Overall Study|Lost to Follow-up|107|||
126351489|NCT03244189|454577099|FG000|Overall Study|Physician Decision|4|||
126351490|NCT03244189|454577100|FG001|Overall Study|Physician Decision|2|||
126351491|NCT03244189|454577099|FG000|Overall Study|Pregnancy|7|||
126351492|NCT03244189|454577100|FG001|Overall Study|Pregnancy|5|||
126351493|NCT03244189|454577099|FG000|Overall Study|Protocol Violation|0|||
126351494|NCT03244189|454577100|FG001|Overall Study|Protocol Violation|2|||
126351495|NCT03244189|454577099|FG000|Overall Study|Withdrawal by Subject|45|||
126351496|NCT03244189|454577100|FG001|Overall Study|Withdrawal by Subject|23|||
126351497|NCT03244189|454577099|FG000|Overall Study|Technical Problems|2|||
126351498|NCT03244189|454577100|FG001|Overall Study|Technical Problems|0|||
126351499|NCT05253807|454577101|FG000|Overall Study|Death|1|||
126351500|NCT05253807|454577102|FG001|Overall Study|Death|4|||
126351501|NCT05253807|454577101|FG000|Overall Study|Withdrawal by Subject|1|||
126351502|NCT05253807|454577102|FG001|Overall Study|Withdrawal by Subject|0|||
126351503|NCT05253807|454577101|FG000|Overall Study|Study Terminated by Sponsor|1|||
126351504|NCT05253807|454577102|FG001|Overall Study|Study Terminated by Sponsor|1|||
126351505|NCT02145390|454577111|FG000|Overall Study|Withdrawal by Subject|1|||
126351506|NCT01732783|454577963|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
126351507|NCT01732783|454577964|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
126351508|NCT01732783|454577965|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
126351509|NCT01732783|454577963|FG000|Overall Study|Death|13|||
126351510|NCT01732783|454577964|FG001|Overall Study|Death|4|||
126351511|NCT01732783|454577965|FG002|Overall Study|Death|1|||
126351512|NCT01732783|454577963|FG000|Overall Study|Lost to Follow-up|7|||
126351513|NCT01732783|454577964|FG001|Overall Study|Lost to Follow-up|1|||
126351514|NCT01732783|454577965|FG002|Overall Study|Lost to Follow-up|1|||
126351515|NCT01732783|454577963|FG000|Overall Study|Administrative Decision|8|||
126351516|NCT01732783|454577964|FG001|Overall Study|Administrative Decision|2|||
126351517|NCT01732783|454577965|FG002|Overall Study|Administrative Decision|1|||
126351518|NCT01732783|454577963|FG000|Overall Study|Withdrawal by Subject|1|||
126351519|NCT01732783|454577964|FG001|Overall Study|Withdrawal by Subject|0|||
126351520|NCT01732783|454577965|FG002|Overall Study|Withdrawal by Subject|0|||
126351521|NCT04598828|454577966|FG000|Overall Study|Physician Decision|1|||
126351522|NCT04598828|454577967|FG001|Overall Study|Physician Decision|0|||
126351523|NCT04598828|454577966|FG000|Overall Study|Withdrawal by Subject|0|||
126351524|NCT04598828|454577967|FG001|Overall Study|Withdrawal by Subject|1|||
126351525|NCT04598828|454577966|FG000|Overall Study|Withdrawal by Subject|0|||
126351526|NCT04598828|454577967|FG001|Overall Study|Withdrawal by Subject|1|||
126351527|NCT01078662|454577968|FG000|Overall Study|Death|41|||
126351528|NCT01078662|454577969|FG001|Overall Study|Death|103|||
126351529|NCT01078662|454577970|FG002|Overall Study|Death|18|||
126351530|NCT01078662|454577971|FG003|Overall Study|Death|5|||
126351531|NCT01078662|454577972|FG004|Overall Study|Death|8|||
126351532|NCT01078662|454577968|FG000|Overall Study|Patients reached data cut-off|12|||
126369551|NCT01497197|454650597|FG001|Overall Study|Lost to Follow-up|0|||
126439749|NCT00068692|454909683|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
126439750|NCT00068692|454909684|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
126439751|NCT00068692|454909685|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
126439752|NCT00068692|454909678|FG000|Step 2: Randomization|alternative therapy|0|||
126439753|NCT00068692|454909679|FG001|Step 2: Randomization|alternative therapy|0|||
126439754|NCT00068692|454909680|FG002|Step 2: Randomization|alternative therapy|0|||
126439755|NCT00068692|454909681|FG003|Step 2: Randomization|alternative therapy|1|||
126439756|NCT00068692|454909682|FG004|Step 2: Randomization|alternative therapy|1|||
126439757|NCT00068692|454909683|FG005|Step 2: Randomization|alternative therapy|0|||
126439758|NCT00068692|454909684|FG006|Step 2: Randomization|alternative therapy|0|||
126439759|NCT00068692|454909685|FG007|Step 2: Randomization|alternative therapy|0|||
126439760|NCT00068692|454909678|FG000|Step 2: Randomization|Physician Decision|0|||
126439761|NCT00068692|454909679|FG001|Step 2: Randomization|Physician Decision|0|||
126439762|NCT00068692|454909680|FG002|Step 2: Randomization|Physician Decision|0|||
126439763|NCT00068692|454909681|FG003|Step 2: Randomization|Physician Decision|1|||
126439764|NCT00068692|454909682|FG004|Step 2: Randomization|Physician Decision|1|||
126439765|NCT00068692|454909683|FG005|Step 2: Randomization|Physician Decision|0|||
126439766|NCT00068692|454909684|FG006|Step 2: Randomization|Physician Decision|0|||
126439767|NCT00068692|454909685|FG007|Step 2: Randomization|Physician Decision|0|||
126439768|NCT00068692|454909678|FG000|Step 2: Randomization|Other|0|||
126439769|NCT00068692|454909679|FG001|Step 2: Randomization|Other|0|||
126439770|NCT00068692|454909680|FG002|Step 2: Randomization|Other|0|||
126439771|NCT00068692|454909681|FG003|Step 2: Randomization|Other|1|||
126439772|NCT00068692|454909682|FG004|Step 2: Randomization|Other|0|||
126439773|NCT00068692|454909683|FG005|Step 2: Randomization|Other|1|||
126439774|NCT00068692|454909684|FG006|Step 2: Randomization|Other|0|||
126439775|NCT00068692|454909685|FG007|Step 2: Randomization|Other|0|||
126439776|NCT00068692|454909678|FG000|Step 2: Randomization|never start protocol therapy|0|||
126439777|NCT00068692|454909679|FG001|Step 2: Randomization|never start protocol therapy|0|||
126439778|NCT00068692|454909680|FG002|Step 2: Randomization|never start protocol therapy|1|||
126439779|NCT00068692|454909681|FG003|Step 2: Randomization|never start protocol therapy|0|||
126439780|NCT00068692|454909682|FG004|Step 2: Randomization|never start protocol therapy|1|||
126439781|NCT00068692|454909683|FG005|Step 2: Randomization|never start protocol therapy|0|||
126439782|NCT00068692|454909684|FG006|Step 2: Randomization|never start protocol therapy|0|||
126439783|NCT00068692|454909685|FG007|Step 2: Randomization|never start protocol therapy|0|||
126439784|NCT00248040|454909690|FG000|Overall Study|transplantectomy|2|||
126439785|NCT00248040|454909691|FG001|Overall Study|transplantectomy|1|||
126439786|NCT00248040|454909692|FG002|Overall Study|transplantectomy|3|||
126439787|NCT00248040|454909690|FG000|Overall Study|transplant cancelled post treat start|1|||
126439788|NCT00248040|454909691|FG001|Overall Study|transplant cancelled post treat start|0|||
126439789|NCT00248040|454909692|FG002|Overall Study|transplant cancelled post treat start|0|||
126439790|NCT00248040|454909690|FG000|Overall Study|Death|0|||
126439791|NCT00248040|454909691|FG001|Overall Study|Death|0|||
126439792|NCT00248040|454909692|FG002|Overall Study|Death|1|||
126439793|NCT01760733|454909703|FG000|Waiting List|Death|18|||
126439794|NCT01760733|454909703|FG000|Waiting List|Removed from waiting list|41|||
126439795|NCT01760733|454909703|FG000|Waiting List|Not received a transplant yet|13|||
126439796|NCT01760733|454909703|FG000|Transplanted|Not reached 10 years post transplant|184|||
126439797|NCT01760733|454909703|FG000|Transplanted|Death|26|||
126439798|NCT01760733|454909703|FG000|Transplanted|Graft loss|7|||
126439799|NCT02404025|454909704|FG000|Overall Study|Adverse Event|1|||
126439800|NCT02404025|454909704|FG000|Overall Study|Lack of Efficacy|3|||
126439801|NCT01524796|454909705|FG000|Overall Study|Adverse Event|13|||
126439802|NCT01524796|454909705|FG000|Overall Study|Lack of Efficacy|3|||
126439803|NCT01524796|454909705|FG000|Overall Study|Lost to Follow-up|1|||
126439804|NCT01524796|454909705|FG000|Overall Study|The price|1|||
126439805|NCT01524796|454909705|FG000|Overall Study|Withdrawal by Subject|4|||
126439806|NCT01524796|454909705|FG000|Overall Study|Move|1|||
126439807|NCT01524796|454909705|FG000|Overall Study|Deterioration of pains|1|||
126439808|NCT01524796|454909705|FG000|Overall Study|Gall stone surgery|1|||
126439809|NCT01524796|454909705|FG000|Overall Study|Nervous about confidentiality|1|||
126439810|NCT01524796|454909705|FG000|Overall Study|Switch to carbamazapine|1|||
126439811|NCT01524796|454909705|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
126439812|NCT03938259|454909708|FG000|Overall Study|unable to establish baseline for ventilation|1|||
126439813|NCT03938259|454909709|FG001|Overall Study|unable to establish baseline for ventilation|1|||
126439814|NCT01002339|454909710|FG000|Overall Study|Withdrawal by Subject|0|||
126439815|NCT01002339|454909711|FG001|Overall Study|Withdrawal by Subject|1|||
126439816|NCT01002339|454909712|FG002|Overall Study|Withdrawal by Subject|0|||
126439817|NCT01002339|454909710|FG000|Overall Study|Incorrect treatment assignment|0|||
126439818|NCT01002339|454909711|FG001|Overall Study|Incorrect treatment assignment|0|||
126439819|NCT01002339|454909712|FG002|Overall Study|Incorrect treatment assignment|1|||
126439820|NCT01002339|454909710|FG000|Overall Study|Protocol Violation|0|||
126439821|NCT01002339|454909711|FG001|Overall Study|Protocol Violation|0|||
126439822|NCT01002339|454909712|FG002|Overall Study|Protocol Violation|2|||
126439823|NCT01002339|454909710|FG000|Overall Study|Lung cancer detected before transplant|0|||
126439824|NCT01002339|454909711|FG001|Overall Study|Lung cancer detected before transplant|0|||
126439825|NCT01002339|454909712|FG002|Overall Study|Lung cancer detected before transplant|1|||
126439826|NCT01002339|454909710|FG000|Overall Study|Randomized. Not transplanted|0|||
126439827|NCT01002339|454909711|FG001|Overall Study|Randomized. Not transplanted|0|||
126439828|NCT01002339|454909712|FG002|Overall Study|Randomized. Not transplanted|1|||
126439829|NCT02215252|454909713|FG000|Overall Study|Adverse Event|1|||
126439830|NCT02215252|454909714|FG001|Overall Study|Adverse Event|5|||
126439831|NCT02215252|454909715|FG002|Overall Study|Adverse Event|2|||
126439832|NCT02215252|454909713|FG000|Overall Study|Lost to Follow-up|0|||
126439833|NCT02215252|454909714|FG001|Overall Study|Lost to Follow-up|0|||
126439834|NCT02215252|454909715|FG002|Overall Study|Lost to Follow-up|1|||
126439835|NCT02215252|454909713|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
126439836|NCT02215252|454909714|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
126439837|NCT02215252|454909715|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
126439838|NCT02215252|454909713|FG000|Overall Study|Protocol Violation|0|||
126439839|NCT02215252|454909714|FG001|Overall Study|Protocol Violation|1|||
126439840|NCT02215252|454909715|FG002|Overall Study|Protocol Violation|0|||
126439841|NCT02215252|454909713|FG000|Overall Study|Withdrawal by Subject|1|||
126439842|NCT02215252|454909714|FG001|Overall Study|Withdrawal by Subject|0|||
126439843|NCT02215252|454909715|FG002|Overall Study|Withdrawal by Subject|0|||
126439844|NCT02215252|454909713|FG000|Overall Study|Other|0|||
126439845|NCT02215252|454909714|FG001|Overall Study|Other|1|||
126439846|NCT02215252|454909715|FG002|Overall Study|Other|1|||
126439847|NCT02633306|454909716|FG000|Overall Study|Withdrawal by Subject|3|||
126439848|NCT00956007|454909717|FG000|Overall Study|Protocol Violation|27|||
126439849|NCT00956007|454909718|FG001|Overall Study|Protocol Violation|23|||
126439850|NCT01746901|454909719|FG000|Naloxone Challenge Phase|Adverse Event|2|||
126439851|NCT01746901|454909720|FG001|Naloxone Challenge Phase|Adverse Event|0|||
126439852|NCT01746901|454909721|FG002|Naloxone Challenge Phase|Adverse Event|0|||
126439853|NCT01746901|454909722|FG003|Naloxone Challenge Phase|Adverse Event|0|||
126439854|NCT01746901|454909723|FG004|Naloxone Challenge Phase|Adverse Event|0|||
126439855|NCT01746901|454909724|FG005|Naloxone Challenge Phase|Adverse Event|0|||
126439856|NCT01746901|454909725|FG006|Naloxone Challenge Phase|Adverse Event|0|||
126439857|NCT01746901|454909726|FG007|Naloxone Challenge Phase|Adverse Event|0|||
126439858|NCT01746901|454909727|FG008|Naloxone Challenge Phase|Adverse Event|0|||
126439859|NCT01746901|454909719|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
126439860|NCT01746901|454909720|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
126439861|NCT01746901|454909721|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
126439862|NCT01746901|454909722|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
126439863|NCT01746901|454909723|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
126439864|NCT01746901|454909724|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
126439865|NCT01746901|454909725|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
126439866|NCT01746901|454909726|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
126439867|NCT01746901|454909727|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
126439868|NCT01746901|454909719|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126439869|NCT01746901|454909720|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
126439870|NCT01746901|454909721|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126439871|NCT01746901|454909722|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126439872|NCT01746901|454909723|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126439873|NCT01746901|454909724|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126439874|NCT01746901|454909725|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126439875|NCT01746901|454909726|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126439876|NCT01746901|454909727|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126439877|NCT01746901|454909719|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
126439878|NCT01746901|454909720|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
126439879|NCT01746901|454909721|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
126439880|NCT01746901|454909722|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
126439881|NCT01746901|454909723|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
126439882|NCT01746901|454909724|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
126689001|NCT01505894|455817172|FG004|Overall Study|Other than specified|1|||
126689002|NCT01505894|455817173|FG005|Overall Study|Other than specified|0|||
126689003|NCT01505894|455817174|FG006|Overall Study|Other than specified|0|||
126689004|NCT01505894|455817175|FG007|Overall Study|Other than specified|0|||
126439883|NCT01746901|454909725|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
126439884|NCT01746901|454909726|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
126439885|NCT01746901|454909727|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
126439886|NCT01746901|454909719|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
126439887|NCT01746901|454909720|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
126439888|NCT01746901|454909721|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
126439889|NCT01746901|454909722|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
126689005|NCT01505894|455817176|FG008|Overall Study|Other than specified|0|||
126689006|NCT04269395|455817177|FG000|Overall Study|Lost to Follow-up|1|||
126351533|NCT01078662|454577969|FG001|Overall Study|Patients reached data cut-off|53|||
126351534|NCT01078662|454577970|FG002|Overall Study|Patients reached data cut-off|2|||
126351535|NCT01078662|454577971|FG003|Overall Study|Patients reached data cut-off|2|||
126351536|NCT01078662|454577972|FG004|Overall Study|Patients reached data cut-off|3|||
126351537|NCT01078662|454577968|FG000|Overall Study|Withdrawal by Subject|4|||
126351538|NCT01078662|454577969|FG001|Overall Study|Withdrawal by Subject|11|||
126351539|NCT01078662|454577970|FG002|Overall Study|Withdrawal by Subject|1|||
126351540|NCT01078662|454577971|FG003|Overall Study|Withdrawal by Subject|0|||
126351541|NCT01078662|454577972|FG004|Overall Study|Withdrawal by Subject|0|||
126351542|NCT01078662|454577968|FG000|Overall Study|Protocol Violation|0|||
126351543|NCT01078662|454577969|FG001|Overall Study|Protocol Violation|1|||
126351544|NCT01078662|454577970|FG002|Overall Study|Protocol Violation|0|||
126351545|NCT01078662|454577971|FG003|Overall Study|Protocol Violation|0|||
126351546|NCT01078662|454577972|FG004|Overall Study|Protocol Violation|0|||
126351547|NCT01078662|454577968|FG000|Overall Study|Lost to Follow-up|1|||
126351548|NCT01078662|454577969|FG001|Overall Study|Lost to Follow-up|0|||
126351549|NCT01078662|454577970|FG002|Overall Study|Lost to Follow-up|0|||
126351550|NCT01078662|454577971|FG003|Overall Study|Lost to Follow-up|0|||
126351551|NCT01078662|454577972|FG004|Overall Study|Lost to Follow-up|0|||
126351552|NCT04589650|454577973|FG000|Overall Study|Subject decision|6|||
126351553|NCT04589650|454577974|FG001|Overall Study|Subject decision|2|||
126351554|NCT04589650|454577975|FG002|Overall Study|Subject decision|2|||
126351555|NCT04589650|454577976|FG003|Overall Study|Subject decision|0|||
126351556|NCT04589650|454577977|FG004|Overall Study|Subject decision|0|||
126351557|NCT04589650|454577978|FG005|Overall Study|Subject decision|0|||
126351558|NCT04589650|454577973|FG000|Overall Study|Adverse Event|3|||
126351559|NCT04589650|454577974|FG001|Overall Study|Adverse Event|1|||
126351560|NCT04589650|454577975|FG002|Overall Study|Adverse Event|1|||
126351561|NCT04589650|454577976|FG003|Overall Study|Adverse Event|1|||
126351562|NCT04589650|454577977|FG004|Overall Study|Adverse Event|0|||
126351563|NCT04589650|454577978|FG005|Overall Study|Adverse Event|1|||
126351564|NCT04589650|454577973|FG000|Overall Study|Physician Decision|1|||
126351565|NCT04589650|454577974|FG001|Overall Study|Physician Decision|1|||
126351566|NCT04589650|454577975|FG002|Overall Study|Physician Decision|0|||
126351567|NCT04589650|454577976|FG003|Overall Study|Physician Decision|0|||
126351568|NCT04589650|454577977|FG004|Overall Study|Physician Decision|0|||
126351569|NCT04589650|454577978|FG005|Overall Study|Physician Decision|0|||
126351570|NCT04589650|454577973|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126351571|NCT04589650|454577974|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126351572|NCT04589650|454577975|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126351573|NCT04589650|454577976|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
126439890|NCT01746901|454909723|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
126439891|NCT01746901|454909724|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
126439892|NCT01746901|454909725|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
126439893|NCT01746901|454909726|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
126439894|NCT01746901|454909727|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
126439895|NCT01746901|454909719|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126439896|NCT01746901|454909720|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
126439897|NCT01746901|454909721|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
126439898|NCT01746901|454909722|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126439899|NCT01746901|454909723|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126439900|NCT01746901|454909724|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126439901|NCT01746901|454909725|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126439902|NCT01746901|454909726|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126439903|NCT01746901|454909727|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126439904|NCT01746901|454909719|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
126439905|NCT01746901|454909720|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
126439906|NCT01746901|454909721|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
126351574|NCT04589650|454577977|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
126351575|NCT04589650|454577978|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
126439907|NCT01746901|454909722|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
126689007|NCT04269395|455817178|FG001|Overall Study|Lost to Follow-up|0|||
126689008|NCT04269395|455817177|FG000|Overall Study|Study terminated by Sponsor|13|||
126351576|NCT04589650|454577973|FG000|Overall Study|Death|0|||
126351577|NCT04589650|454577974|FG001|Overall Study|Death|0|||
126351578|NCT04589650|454577975|FG002|Overall Study|Death|0|||
126351579|NCT04589650|454577976|FG003|Overall Study|Death|1|||
126351580|NCT04589650|454577977|FG004|Overall Study|Death|0|||
126351581|NCT04589650|454577978|FG005|Overall Study|Death|0|||
126351582|NCT04589650|454577973|FG000|Overall Study|Guardian Decision|0|||
126351583|NCT04589650|454577974|FG001|Overall Study|Guardian Decision|0|||
126351584|NCT04589650|454577975|FG002|Overall Study|Guardian Decision|0|||
126351585|NCT04589650|454577976|FG003|Overall Study|Guardian Decision|1|||
126351586|NCT04589650|454577977|FG004|Overall Study|Guardian Decision|0|||
126351587|NCT04589650|454577978|FG005|Overall Study|Guardian Decision|0|||
126351588|NCT04937387|454577979|FG000|Overall Study|Adverse Event|1|||
126351589|NCT04937387|454577980|FG001|Overall Study|Adverse Event|0|||
126351590|NCT04937387|454577981|FG002|Overall Study|Adverse Event|2|||
126351591|NCT04937387|454577982|FG003|Overall Study|Adverse Event|0|||
126351592|NCT04937387|454577979|FG000|Overall Study|Lack of Efficacy|1|||
126439908|NCT01746901|454909723|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
126689009|NCT04269395|455817178|FG001|Overall Study|Study terminated by Sponsor|10|||
126351593|NCT04937387|454577980|FG001|Overall Study|Lack of Efficacy|0|||
126351594|NCT04937387|454577981|FG002|Overall Study|Lack of Efficacy|0|||
126351595|NCT04937387|454577982|FG003|Overall Study|Lack of Efficacy|1|||
126439909|NCT01746901|454909724|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
126439910|NCT01746901|454909725|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
126439911|NCT01746901|454909726|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
126439912|NCT01746901|454909727|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
126439913|NCT01746901|454909719|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
126439914|NCT01746901|454909720|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
126439915|NCT01746901|454909721|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
126439916|NCT01746901|454909722|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
126439917|NCT01746901|454909723|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
126439918|NCT01746901|454909724|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
126439919|NCT01746901|454909725|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
126439920|NCT01746901|454909726|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
126439921|NCT01746901|454909727|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
126439922|NCT01746901|454909719|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
126439923|NCT01746901|454909720|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
126439924|NCT01746901|454909721|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
126439925|NCT01746901|454909722|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
126439926|NCT01746901|454909723|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
126439927|NCT01746901|454909724|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
126439928|NCT01746901|454909725|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
126439929|NCT01746901|454909726|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
126439930|NCT01746901|454909727|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
126439931|NCT01746901|454909719|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
126439932|NCT01746901|454909720|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
126439933|NCT01746901|454909721|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
126439934|NCT01746901|454909722|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
126439935|NCT01746901|454909723|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
126689010|NCT00584233|455817179|FG000|Overall Study|Withdrawal by Subject|5|||
126689011|NCT00584233|455817179|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
126689012|NCT03529773|455817180|FG000|Overall Study|Adverse Event|0|||
126439936|NCT01746901|454909724|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
126689013|NCT03529773|455817181|FG001|Overall Study|Adverse Event|0|||
126689014|NCT03529773|455817182|FG002|Overall Study|Adverse Event|0|||
126351596|NCT04937387|454577979|FG000|Overall Study|Withdrawal by Subject|1|||
126351597|NCT04937387|454577980|FG001|Overall Study|Withdrawal by Subject|0|||
126351598|NCT04937387|454577981|FG002|Overall Study|Withdrawal by Subject|1|||
126351599|NCT04937387|454577982|FG003|Overall Study|Withdrawal by Subject|1|||
126351600|NCT04937387|454577979|FG000|Overall Study|Randomized in error|0|||
126351601|NCT04937387|454577980|FG001|Overall Study|Randomized in error|0|||
126351602|NCT04937387|454577981|FG002|Overall Study|Randomized in error|0|||
126351603|NCT04937387|454577982|FG003|Overall Study|Randomized in error|1|||
126689015|NCT03529773|455817183|FG003|Overall Study|Adverse Event|0|||
126689016|NCT03529773|455817184|FG004|Overall Study|Adverse Event|0|||
126351604|NCT03421808|454577987|FG000|Overall Study|COVID related problems|2|||
126689017|NCT03529773|455817185|FG005|Overall Study|Adverse Event|0|||
126760072|NCT00953576|456072354|FG000|Overall Study|Ineligible after Consent|2|||
126760073|NCT00953576|456072355|FG001|Overall Study|Ineligible after Consent|0|||
126760074|NCT03628781|456072362|FG000|Overall Study|Lost to Follow-up|16|||
126760075|NCT03628781|456072363|FG001|Overall Study|Lost to Follow-up|8|||
126760076|NCT03628781|456072362|FG000|Overall Study|Withdrawal by Subject|16|||
126760077|NCT03628781|456072363|FG001|Overall Study|Withdrawal by Subject|1|||
126760078|NCT00656669|456072364|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
126760079|NCT00656669|456072364|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
126760080|NCT00656669|456072364|FG000|AC (Cycles 6-9)|Adverse Event|1|||
126760081|NCT00656669|456072364|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
126760082|NCT03778021|456072365|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
126760083|NCT03778021|456072366|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
126760084|NCT00679042|456072369|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
126760085|NCT00679042|456072369|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
126760086|NCT00679042|456072369|FG000|5-Year Follow Up|Death|1|||
126760087|NCT00679042|456072369|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
126760088|NCT00679042|456072369|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
126760089|NCT02687815|456072370|FG000|Overall Study|Lost to Follow-up|2|||
126760090|NCT02687815|456072371|FG001|Overall Study|Lost to Follow-up|4|||
126760091|NCT02687815|456072370|FG000|Overall Study|Withdrawal by Subject|2|||
126760092|NCT02687815|456072371|FG001|Overall Study|Withdrawal by Subject|4|||
126760093|NCT01224171|456072377|FG000|Overall Study|Adverse Event|8|||
126760094|NCT01224171|456072378|FG001|Overall Study|Adverse Event|4|||
126760095|NCT01224171|456072377|FG000|Overall Study|Protocol Violation|0|||
126760096|NCT01224171|456072378|FG001|Overall Study|Protocol Violation|1|||
126760097|NCT01224171|456072377|FG000|Overall Study|Lack of Efficacy|5|||
126760098|NCT01224171|456072378|FG001|Overall Study|Lack of Efficacy|1|||
126760099|NCT01224171|456072377|FG000|Overall Study|Withdrawal of Consent|2|||
126760100|NCT01224171|456072378|FG001|Overall Study|Withdrawal of Consent|4|||
126760101|NCT01224171|456072377|FG000|Overall Study|Lost to Follow-up|0|||
126760102|NCT01224171|456072378|FG001|Overall Study|Lost to Follow-up|3|||
126760103|NCT03737812|456072379|FG000|Overall Study|Withdrawal by Subject|1|||
126760104|NCT03737812|456072380|FG001|Overall Study|Withdrawal by Subject|2|||
126760105|NCT03737812|456072381|FG002|Overall Study|Withdrawal by Subject|1|||
126760106|NCT03737812|456072379|FG000|Overall Study|Sponsor Discontinued the Study|4|||
126760107|NCT03737812|456072380|FG001|Overall Study|Sponsor Discontinued the Study|3|||
126760108|NCT03737812|456072381|FG002|Overall Study|Sponsor Discontinued the Study|2|||
126760109|NCT03737812|456072379|FG000|Overall Study|Adverse Event|0|||
126760110|NCT03737812|456072380|FG001|Overall Study|Adverse Event|1|||
126760111|NCT03737812|456072381|FG002|Overall Study|Adverse Event|0|||
126689018|NCT03529773|455817186|FG006|Overall Study|Adverse Event|0|||
126689019|NCT03529773|455817187|FG007|Overall Study|Adverse Event|0|||
126689020|NCT03529773|455817188|FG008|Overall Study|Adverse Event|0|||
126689021|NCT03529773|455817189|FG009|Overall Study|Adverse Event|0|||
126689022|NCT03529773|455817190|FG010|Overall Study|Adverse Event|0|||
126689023|NCT03529773|455817191|FG011|Overall Study|Adverse Event|0|||
126689024|NCT03529773|455817192|FG012|Overall Study|Adverse Event|0|||
126689025|NCT03529773|455817193|FG013|Overall Study|Adverse Event|0|||
126689026|NCT03529773|455817194|FG014|Overall Study|Adverse Event|0|||
126689027|NCT03529773|455817195|FG015|Overall Study|Adverse Event|0|||
126689028|NCT03529773|455817196|FG016|Overall Study|Adverse Event|0|||
126689029|NCT03529773|455817197|FG017|Overall Study|Adverse Event|0|||
126689030|NCT03529773|455817198|FG018|Overall Study|Adverse Event|0|||
126689031|NCT03529773|455817199|FG019|Overall Study|Adverse Event|0|||
126760112|NCT03737812|456072379|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
126760113|NCT03737812|456072380|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
126760114|NCT03737812|456072381|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
126760115|NCT02624713|456072382|FG000|Overall Study|Lost to Follow-up|14|||
126760116|NCT02624713|456072383|FG001|Overall Study|Lost to Follow-up|0|||
126760117|NCT00285857|456072384|FG000|Overall Study|Withdrawal by Subject|2|||
126760118|NCT00285857|456072384|FG000|Overall Study|Inadequate initial breast cytology|1|||
126760119|NCT00285857|456072384|FG000|Overall Study|Adverse Event|1|||
126760120|NCT01161173|456072387|FG000|Overall Study|Protocol Violation|13|||
126760121|NCT01161173|456072387|FG000|Overall Study|Lost to Follow-up|7|||
126760122|NCT01161173|456072387|FG000|Overall Study|Progressive Disease|82|||
126760123|NCT01161173|456072387|FG000|Overall Study|Withdrawal of Consent|5|||
126689032|NCT03529773|455817200|FG020|Overall Study|Adverse Event|0|||
126689033|NCT03529773|455817201|FG021|Overall Study|Adverse Event|0|||
126689034|NCT03529773|455817202|FG022|Overall Study|Adverse Event|0|||
126689035|NCT03529773|455817203|FG023|Overall Study|Adverse Event|0|||
126689036|NCT03529773|455817204|FG024|Overall Study|Adverse Event|0|||
126689037|NCT03529773|455817205|FG025|Overall Study|Adverse Event|0|||
126760124|NCT01161173|456072387|FG000|Overall Study|Unacceptable Toxicity|21|||
126760125|NCT01161173|456072387|FG000|Overall Study|Death|194|||
126760126|NCT01161173|456072387|FG000|Overall Study|End of Study|2|||
126760127|NCT01161173|456072387|FG000|Overall Study|Reasons Not Specified|23|||
126439937|NCT01746901|454909725|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
126439938|NCT01746901|454909726|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
126439939|NCT01746901|454909727|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
126439940|NCT01746901|454909719|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
126439941|NCT01746901|454909720|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
126439942|NCT01746901|454909721|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
126439943|NCT01746901|454909722|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
126439944|NCT01746901|454909723|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
126439945|NCT01746901|454909724|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
126439946|NCT01746901|454909725|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
126439947|NCT01746901|454909726|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
126439948|NCT01746901|454909727|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
126439949|NCT01746901|454909719|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
126439950|NCT01746901|454909720|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
126439951|NCT01746901|454909721|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
126439952|NCT01746901|454909722|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
126439953|NCT01746901|454909723|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
126439954|NCT01746901|454909724|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
126439955|NCT01746901|454909725|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
126439956|NCT01746901|454909726|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
126439957|NCT01746901|454909727|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
126439958|NCT02968004|454909731|FG000|Main Study Phase|Adverse Event|1|||
126439959|NCT02968004|454909732|FG001|Main Study Phase|Adverse Event|0|||
126439960|NCT02968004|454909731|FG000|Main Study Phase|Withdrawal by Subject|0|||
126439961|NCT02968004|454909732|FG001|Main Study Phase|Withdrawal by Subject|1|||
126439962|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
126439963|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
126439964|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
126439965|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
126439966|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
126439967|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
126439968|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
126439969|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
126439970|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
126439971|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
126439972|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
126439973|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
126439974|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
126439975|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
126439976|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
126439977|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
126439978|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
126760128|NCT00612456|456072393|FG000|Overall Study|Adverse Event|1|||
126760129|NCT00612456|456072394|FG001|Overall Study|Adverse Event|0|||
126760130|NCT00612456|456072395|FG002|Overall Study|Adverse Event|0|||
126689038|NCT03529773|455817206|FG026|Overall Study|Adverse Event|0|||
126689039|NCT03529773|455817207|FG027|Overall Study|Adverse Event|0|||
126689040|NCT03529773|455817208|FG028|Overall Study|Adverse Event|0|||
126689041|NCT03529773|455817209|FG029|Overall Study|Adverse Event|0|||
126689042|NCT03529773|455817210|FG030|Overall Study|Adverse Event|1|||
126689043|NCT03529773|455817211|FG031|Overall Study|Adverse Event|0|||
126689044|NCT03529773|455817212|FG032|Overall Study|Adverse Event|0|||
126689045|NCT03529773|455817213|FG033|Overall Study|Adverse Event|0|||
126689046|NCT03529773|455817214|FG034|Overall Study|Adverse Event|0|||
126689047|NCT03529773|455817215|FG035|Overall Study|Adverse Event|1|||
126689048|NCT03529773|455817216|FG036|Overall Study|Adverse Event|0|||
126689049|NCT03529773|455817217|FG037|Overall Study|Adverse Event|0|||
126689050|NCT03529773|455817218|FG038|Overall Study|Adverse Event|1|||
126689051|NCT03529773|455817219|FG039|Overall Study|Adverse Event|1|||
126689052|NCT03529773|455817180|FG000|Overall Study|Death|0|||
126689053|NCT03529773|455817181|FG001|Overall Study|Death|0|||
126689054|NCT03529773|455817182|FG002|Overall Study|Death|0|||
126689055|NCT03529773|455817183|FG003|Overall Study|Death|0|||
126689056|NCT03529773|455817184|FG004|Overall Study|Death|0|||
126689057|NCT03529773|455817185|FG005|Overall Study|Death|0|||
126689058|NCT03529773|455817186|FG006|Overall Study|Death|0|||
126689059|NCT03529773|455817187|FG007|Overall Study|Death|0|||
126689060|NCT03529773|455817188|FG008|Overall Study|Death|0|||
126689061|NCT03529773|455817189|FG009|Overall Study|Death|0|||
126689062|NCT03529773|455817190|FG010|Overall Study|Death|0|||
126689063|NCT03529773|455817191|FG011|Overall Study|Death|0|||
126689064|NCT03529773|455817192|FG012|Overall Study|Death|1|||
126689065|NCT03529773|455817193|FG013|Overall Study|Death|0|||
126689066|NCT03529773|455817194|FG014|Overall Study|Death|0|||
126689067|NCT03529773|455817195|FG015|Overall Study|Death|0|||
126689068|NCT03529773|455817196|FG016|Overall Study|Death|0|||
126689069|NCT03529773|455817197|FG017|Overall Study|Death|0|||
126689070|NCT03529773|455817198|FG018|Overall Study|Death|0|||
126689071|NCT03529773|455817199|FG019|Overall Study|Death|1|||
126351605|NCT03421808|454577988|FG001|Overall Study|COVID related problems|0|||
126351606|NCT03421808|454577987|FG000|Overall Study|Withdrawal by Subject|1|||
126351607|NCT03421808|454577988|FG001|Overall Study|Withdrawal by Subject|0|||
126689072|NCT03529773|455817200|FG020|Overall Study|Death|0|||
126689073|NCT03529773|455817201|FG021|Overall Study|Death|0|||
126689074|NCT03529773|455817202|FG022|Overall Study|Death|1|||
126689075|NCT03529773|455817203|FG023|Overall Study|Death|0|||
126689076|NCT03529773|455817204|FG024|Overall Study|Death|0|||
126689077|NCT03529773|455817205|FG025|Overall Study|Death|0|||
126689078|NCT03529773|455817206|FG026|Overall Study|Death|0|||
126689079|NCT03529773|455817207|FG027|Overall Study|Death|0|||
126689080|NCT03529773|455817208|FG028|Overall Study|Death|0|||
126689081|NCT03529773|455817209|FG029|Overall Study|Death|0|||
126689082|NCT03529773|455817210|FG030|Overall Study|Death|0|||
126689083|NCT03529773|455817211|FG031|Overall Study|Death|0|||
126689084|NCT03529773|455817212|FG032|Overall Study|Death|0|||
126689085|NCT03529773|455817213|FG033|Overall Study|Death|1|||
126689086|NCT03529773|455817214|FG034|Overall Study|Death|1|||
126689087|NCT03529773|455817215|FG035|Overall Study|Death|0|||
126689088|NCT03529773|455817216|FG036|Overall Study|Death|1|||
126689089|NCT03529773|455817217|FG037|Overall Study|Death|0|||
126689090|NCT03529773|455817218|FG038|Overall Study|Death|0|||
126689091|NCT03529773|455817219|FG039|Overall Study|Death|0|||
126689092|NCT03529773|455817180|FG000|Overall Study|Lost to Follow-up|0|||
126689093|NCT03529773|455817181|FG001|Overall Study|Lost to Follow-up|0|||
126689094|NCT03529773|455817182|FG002|Overall Study|Lost to Follow-up|1|||
126689095|NCT03529773|455817183|FG003|Overall Study|Lost to Follow-up|0|||
126689096|NCT03529773|455817184|FG004|Overall Study|Lost to Follow-up|1|||
126689097|NCT03529773|455817185|FG005|Overall Study|Lost to Follow-up|1|||
126689098|NCT03529773|455817186|FG006|Overall Study|Lost to Follow-up|0|||
126689099|NCT03529773|455817187|FG007|Overall Study|Lost to Follow-up|0|||
126689100|NCT03529773|455817188|FG008|Overall Study|Lost to Follow-up|0|||
126689101|NCT03529773|455817189|FG009|Overall Study|Lost to Follow-up|0|||
126689102|NCT03529773|455817190|FG010|Overall Study|Lost to Follow-up|0|||
126351608|NCT03421808|454577987|FG000|Overall Study|Protocol Violation|0|||
126760131|NCT00612456|456072393|FG000|Overall Study|Lack of Efficacy|1|||
126689103|NCT03529773|455817191|FG011|Overall Study|Lost to Follow-up|0|||
126439979|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
126439980|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
126439981|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
126439982|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
126439983|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
126439984|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
126439985|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
126439986|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
126439987|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
126439988|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
126439989|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
126439990|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
126439991|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
126689104|NCT03529773|455817192|FG012|Overall Study|Lost to Follow-up|0|||
126689105|NCT03529773|455817193|FG013|Overall Study|Lost to Follow-up|1|||
126689106|NCT03529773|455817194|FG014|Overall Study|Lost to Follow-up|4|||
126689107|NCT03529773|455817195|FG015|Overall Study|Lost to Follow-up|1|||
126689108|NCT03529773|455817196|FG016|Overall Study|Lost to Follow-up|1|||
126689109|NCT03529773|455817197|FG017|Overall Study|Lost to Follow-up|0|||
126689110|NCT03529773|455817198|FG018|Overall Study|Lost to Follow-up|1|||
126689111|NCT03529773|455817199|FG019|Overall Study|Lost to Follow-up|1|||
126689112|NCT03529773|455817200|FG020|Overall Study|Lost to Follow-up|2|||
126689113|NCT03529773|455817201|FG021|Overall Study|Lost to Follow-up|4|||
126689114|NCT03529773|455817202|FG022|Overall Study|Lost to Follow-up|3|||
126689115|NCT03529773|455817203|FG023|Overall Study|Lost to Follow-up|4|||
126689116|NCT03529773|455817204|FG024|Overall Study|Lost to Follow-up|3|||
126689117|NCT03529773|455817205|FG025|Overall Study|Lost to Follow-up|5|||
126689118|NCT03529773|455817206|FG026|Overall Study|Lost to Follow-up|5|||
126689119|NCT03529773|455817207|FG027|Overall Study|Lost to Follow-up|0|||
126689120|NCT03529773|455817208|FG028|Overall Study|Lost to Follow-up|0|||
126689121|NCT03529773|455817209|FG029|Overall Study|Lost to Follow-up|0|||
126689122|NCT03529773|455817210|FG030|Overall Study|Lost to Follow-up|1|||
126689123|NCT03529773|455817211|FG031|Overall Study|Lost to Follow-up|0|||
126689124|NCT03529773|455817212|FG032|Overall Study|Lost to Follow-up|0|||
126689125|NCT03529773|455817213|FG033|Overall Study|Lost to Follow-up|1|||
126689126|NCT03529773|455817214|FG034|Overall Study|Lost to Follow-up|1|||
126689127|NCT03529773|455817215|FG035|Overall Study|Lost to Follow-up|0|||
126689128|NCT03529773|455817216|FG036|Overall Study|Lost to Follow-up|0|||
126689129|NCT03529773|455817217|FG037|Overall Study|Lost to Follow-up|3|||
126689130|NCT03529773|455817218|FG038|Overall Study|Lost to Follow-up|1|||
126689131|NCT03529773|455817219|FG039|Overall Study|Lost to Follow-up|1|||
126689132|NCT03529773|455817180|FG000|Overall Study|No longer meets eligibility criteria|0|||
126689133|NCT03529773|455817181|FG001|Overall Study|No longer meets eligibility criteria|0|||
126689134|NCT03529773|455817182|FG002|Overall Study|No longer meets eligibility criteria|0|||
126689135|NCT03529773|455817183|FG003|Overall Study|No longer meets eligibility criteria|0|||
126689136|NCT03529773|455817184|FG004|Overall Study|No longer meets eligibility criteria|0|||
126689137|NCT03529773|455817185|FG005|Overall Study|No longer meets eligibility criteria|0|||
126689138|NCT03529773|455817186|FG006|Overall Study|No longer meets eligibility criteria|0|||
126689139|NCT03529773|455817187|FG007|Overall Study|No longer meets eligibility criteria|0|||
126689140|NCT03529773|455817188|FG008|Overall Study|No longer meets eligibility criteria|0|||
126689141|NCT03529773|455817189|FG009|Overall Study|No longer meets eligibility criteria|0|||
126689142|NCT03529773|455817190|FG010|Overall Study|No longer meets eligibility criteria|0|||
126689143|NCT03529773|455817191|FG011|Overall Study|No longer meets eligibility criteria|0|||
126689144|NCT03529773|455817192|FG012|Overall Study|No longer meets eligibility criteria|0|||
126689145|NCT03529773|455817193|FG013|Overall Study|No longer meets eligibility criteria|0|||
126689146|NCT03529773|455817194|FG014|Overall Study|No longer meets eligibility criteria|0|||
126689147|NCT03529773|455817195|FG015|Overall Study|No longer meets eligibility criteria|0|||
126689148|NCT03529773|455817196|FG016|Overall Study|No longer meets eligibility criteria|0|||
126689149|NCT03529773|455817197|FG017|Overall Study|No longer meets eligibility criteria|0|||
126689150|NCT03529773|455817198|FG018|Overall Study|No longer meets eligibility criteria|0|||
126689151|NCT03529773|455817199|FG019|Overall Study|No longer meets eligibility criteria|0|||
126689152|NCT03529773|455817200|FG020|Overall Study|No longer meets eligibility criteria|0|||
126689153|NCT03529773|455817201|FG021|Overall Study|No longer meets eligibility criteria|0|||
126689154|NCT03529773|455817202|FG022|Overall Study|No longer meets eligibility criteria|1|||
126689155|NCT03529773|455817203|FG023|Overall Study|No longer meets eligibility criteria|0|||
126439992|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
126689156|NCT03529773|455817204|FG024|Overall Study|No longer meets eligibility criteria|0|||
126689157|NCT03529773|455817205|FG025|Overall Study|No longer meets eligibility criteria|0|||
126439993|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
126689158|NCT03529773|455817206|FG026|Overall Study|No longer meets eligibility criteria|0|||
126689159|NCT03529773|455817207|FG027|Overall Study|No longer meets eligibility criteria|0|||
126760132|NCT00612456|456072394|FG001|Overall Study|Lack of Efficacy|1|||
126760133|NCT00612456|456072395|FG002|Overall Study|Lack of Efficacy|0|||
126760134|NCT00612456|456072393|FG000|Overall Study|Withdrawal by Subject|0|||
126760135|NCT00612456|456072394|FG001|Overall Study|Withdrawal by Subject|1|||
126760136|NCT00612456|456072395|FG002|Overall Study|Withdrawal by Subject|0|||
126760137|NCT01258803|456072396|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
126760138|NCT01258803|456072397|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
126689160|NCT03529773|455817208|FG028|Overall Study|No longer meets eligibility criteria|0|||
126689161|NCT03529773|455817209|FG029|Overall Study|No longer meets eligibility criteria|0|||
126689162|NCT03529773|455817210|FG030|Overall Study|No longer meets eligibility criteria|0|||
126689163|NCT03529773|455817211|FG031|Overall Study|No longer meets eligibility criteria|0|||
126689164|NCT03529773|455817212|FG032|Overall Study|No longer meets eligibility criteria|0|||
126689165|NCT03529773|455817213|FG033|Overall Study|No longer meets eligibility criteria|0|||
126689166|NCT03529773|455817214|FG034|Overall Study|No longer meets eligibility criteria|0|||
126689167|NCT03529773|455817215|FG035|Overall Study|No longer meets eligibility criteria|0|||
126689168|NCT03529773|455817216|FG036|Overall Study|No longer meets eligibility criteria|0|||
126689169|NCT03529773|455817217|FG037|Overall Study|No longer meets eligibility criteria|0|||
126689170|NCT03529773|455817218|FG038|Overall Study|No longer meets eligibility criteria|1|||
126760139|NCT01258803|456072398|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
126760140|NCT01258803|456072399|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
126760141|NCT01258803|456072400|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
126760142|NCT01258803|456072401|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
126760143|NCT01258803|456072396|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
126760144|NCT01258803|456072397|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
126760145|NCT01258803|456072398|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
126760146|NCT01258803|456072399|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
126760147|NCT01258803|456072400|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
126760148|NCT01258803|456072401|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
126760149|NCT01258803|456072396|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
126351609|NCT03421808|454577988|FG001|Overall Study|Protocol Violation|1|||
126351610|NCT00632359|454577991|FG000|Overall Study|Withdrawal by Subject|2|||
126689171|NCT03529773|455817219|FG039|Overall Study|No longer meets eligibility criteria|0|||
126689172|NCT03529773|455817180|FG000|Overall Study|Other|0|||
126689173|NCT03529773|455817181|FG001|Overall Study|Other|0|||
126689174|NCT03529773|455817182|FG002|Overall Study|Other|0|||
126351611|NCT06717399|454577992|FG000|Overall Study|Death|1|||
126351612|NCT02180867|454577995|FG000|Overall Study|Adverse Event|3|||
126351613|NCT02180867|454577996|FG001|Overall Study|Adverse Event|4|||
126351614|NCT02180867|454577997|FG002|Overall Study|Adverse Event|1|||
126351615|NCT02180867|454577998|FG003|Overall Study|Adverse Event|5|||
126689175|NCT03529773|455817183|FG003|Overall Study|Other|0|||
126689176|NCT03529773|455817184|FG004|Overall Study|Other|0|||
126689177|NCT03529773|455817185|FG005|Overall Study|Other|0|||
126689178|NCT03529773|455817186|FG006|Overall Study|Other|0|||
126689179|NCT03529773|455817187|FG007|Overall Study|Other|0|||
126760150|NCT01258803|456072397|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
126439994|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
126439995|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
126439996|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
126439997|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
126439998|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
126439999|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
126440000|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
126440001|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
126440002|NCT02968004|454909731|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
126440003|NCT02968004|454909732|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
126689180|NCT03529773|455817188|FG008|Overall Study|Other|0|||
126689181|NCT03529773|455817189|FG009|Overall Study|Other|0|||
126689182|NCT03529773|455817190|FG010|Overall Study|Other|0|||
126689183|NCT03529773|455817191|FG011|Overall Study|Other|0|||
126689184|NCT03529773|455817192|FG012|Overall Study|Other|1|||
126689185|NCT03529773|455817193|FG013|Overall Study|Other|0|||
126689186|NCT03529773|455817194|FG014|Overall Study|Other|2|||
126689187|NCT03529773|455817195|FG015|Overall Study|Other|0|||
126351616|NCT02180867|454577999|FG004|Overall Study|Adverse Event|0|||
126351617|NCT02180867|454578000|FG005|Overall Study|Adverse Event|0|||
126351618|NCT02180867|454578001|FG006|Overall Study|Adverse Event|0|||
126351619|NCT02180867|454577995|FG000|Overall Study|Death|0|||
126351620|NCT02180867|454577996|FG001|Overall Study|Death|0|||
126351621|NCT02180867|454577997|FG002|Overall Study|Death|0|||
126351622|NCT02180867|454577998|FG003|Overall Study|Death|0|||
126351623|NCT02180867|454577999|FG004|Overall Study|Death|1|||
126351624|NCT02180867|454578000|FG005|Overall Study|Death|0|||
126351625|NCT02180867|454578001|FG006|Overall Study|Death|0|||
126440004|NCT05029362|454909733|FG000|Overall Study|Lost to Follow-up|9|||
126440005|NCT00419952|454909736|FG000|Overall Study|Adverse Event|8|||
126440006|NCT00419952|454909737|FG001|Overall Study|Adverse Event|10|||
126440007|NCT00419952|454909736|FG000|Overall Study|Withdrawal by Subject|44|||
126440008|NCT00419952|454909737|FG001|Overall Study|Withdrawal by Subject|43|||
126440009|NCT00419952|454909736|FG000|Overall Study|Lost to Follow-up|43|||
126440010|NCT00419952|454909737|FG001|Overall Study|Lost to Follow-up|34|||
126440011|NCT00419952|454909736|FG000|Overall Study|Protocol Violation|32|||
126440012|NCT00419952|454909737|FG001|Overall Study|Protocol Violation|24|||
126440013|NCT00419952|454909736|FG000|Overall Study|Pregnancy|4|||
126440014|NCT00419952|454909737|FG001|Overall Study|Pregnancy|2|||
126440015|NCT00419952|454909736|FG000|Overall Study|Physician Decision|1|||
126440016|NCT00419952|454909737|FG001|Overall Study|Physician Decision|3|||
126440017|NCT00419952|454909736|FG000|Overall Study|Incorrectly enrolled|10|||
126440018|NCT00419952|454909737|FG001|Overall Study|Incorrectly enrolled|3|||
126440019|NCT00419952|454909736|FG000|Overall Study|Intake of prohibited medication|2|||
126440020|NCT00419952|454909737|FG001|Overall Study|Intake of prohibited medication|2|||
126440021|NCT00419952|454909736|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
126440022|NCT00419952|454909737|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
126440023|NCT00419952|454909736|FG000|Overall Study|Diary or medication non-compliance|2|||
126440024|NCT00419952|454909737|FG001|Overall Study|Diary or medication non-compliance|4|||
126440025|NCT00419952|454909736|FG000|Overall Study|Abnormal ECG|1|||
126440026|NCT00419952|454909737|FG001|Overall Study|Abnormal ECG|0|||
126440027|NCT03126591|454909738|FG000|Overall Study|Death|6|||
126440028|NCT03126591|454909739|FG001|Overall Study|Death|3|||
126760151|NCT01258803|456072398|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
126440029|NCT03126591|454909740|FG002|Overall Study|Death|17|||
126440030|NCT03126591|454909738|FG000|Overall Study|Progressive Disease|0|||
126440031|NCT03126591|454909739|FG001|Overall Study|Progressive Disease|1|||
126351626|NCT02180867|454577995|FG000|Overall Study|Lack of Efficacy|0|||
126351627|NCT02180867|454577996|FG001|Overall Study|Lack of Efficacy|2|||
126351628|NCT02180867|454577997|FG002|Overall Study|Lack of Efficacy|0|||
126351629|NCT02180867|454577998|FG003|Overall Study|Lack of Efficacy|1|||
126351630|NCT02180867|454577999|FG004|Overall Study|Lack of Efficacy|6|||
126351631|NCT02180867|454578000|FG005|Overall Study|Lack of Efficacy|0|||
126351632|NCT02180867|454578001|FG006|Overall Study|Lack of Efficacy|1|||
126351633|NCT02180867|454577995|FG000|Overall Study|Physician Decision|1|||
126351634|NCT02180867|454577996|FG001|Overall Study|Physician Decision|3|||
126351635|NCT02180867|454577997|FG002|Overall Study|Physician Decision|1|||
126351636|NCT02180867|454577998|FG003|Overall Study|Physician Decision|10|||
126351637|NCT02180867|454577999|FG004|Overall Study|Physician Decision|9|||
126351638|NCT02180867|454578000|FG005|Overall Study|Physician Decision|3|||
126351639|NCT02180867|454578001|FG006|Overall Study|Physician Decision|4|||
126351640|NCT02180867|454577995|FG000|Overall Study|Withdrawal by Subject|0|||
126351641|NCT02180867|454577996|FG001|Overall Study|Withdrawal by Subject|0|||
126351642|NCT02180867|454577997|FG002|Overall Study|Withdrawal by Subject|0|||
126351643|NCT02180867|454577998|FG003|Overall Study|Withdrawal by Subject|1|||
126351644|NCT02180867|454577999|FG004|Overall Study|Withdrawal by Subject|1|||
126351645|NCT02180867|454578000|FG005|Overall Study|Withdrawal by Subject|0|||
126351646|NCT02180867|454578001|FG006|Overall Study|Withdrawal by Subject|0|||
126351647|NCT02180867|454577995|FG000|Overall Study|Ineligible|1|||
126351648|NCT02180867|454577996|FG001|Overall Study|Ineligible|2|||
126351649|NCT02180867|454577997|FG002|Overall Study|Ineligible|0|||
126351650|NCT02180867|454577998|FG003|Overall Study|Ineligible|3|||
126351651|NCT02180867|454577999|FG004|Overall Study|Ineligible|5|||
126351652|NCT02180867|454578000|FG005|Overall Study|Ineligible|0|||
126351653|NCT02180867|454578001|FG006|Overall Study|Ineligible|0|||
126351654|NCT02180867|454577995|FG000|Overall Study|Repeat Eligibility Studies|0|||
126351655|NCT02180867|454577996|FG001|Overall Study|Repeat Eligibility Studies|0|||
126351656|NCT02180867|454577997|FG002|Overall Study|Repeat Eligibility Studies|0|||
126351657|NCT02180867|454577998|FG003|Overall Study|Repeat Eligibility Studies|0|||
126351658|NCT02180867|454577999|FG004|Overall Study|Repeat Eligibility Studies|1|||
126351659|NCT02180867|454578000|FG005|Overall Study|Repeat Eligibility Studies|0|||
126351660|NCT02180867|454578001|FG006|Overall Study|Repeat Eligibility Studies|0|||
126351661|NCT02180867|454577995|FG000|Overall Study|Refusal of further protocol therapy|1|||
126351662|NCT02180867|454577996|FG001|Overall Study|Refusal of further protocol therapy|0|||
126351663|NCT02180867|454577997|FG002|Overall Study|Refusal of further protocol therapy|2|||
126351664|NCT02180867|454577998|FG003|Overall Study|Refusal of further protocol therapy|6|||
126351665|NCT02180867|454577999|FG004|Overall Study|Refusal of further protocol therapy|4|||
126351666|NCT02180867|454578000|FG005|Overall Study|Refusal of further protocol therapy|0|||
126351667|NCT02180867|454578001|FG006|Overall Study|Refusal of further protocol therapy|0|||
126351668|NCT02337686|454578002|FG000|Overall Study|Adverse Event|1|||
126351669|NCT00177671|454578867|FG000|Overall Study|Withdrawal by Subject|5|||
126351670|NCT00177671|454578868|FG001|Overall Study|Withdrawal by Subject|6|||
126351671|NCT00177671|454578867|FG000|Overall Study|medical complications|2|||
126351672|NCT00177671|454578868|FG001|Overall Study|medical complications|0|||
126351673|NCT00177671|454578867|FG000|Overall Study|Adverse Event|6|||
126351674|NCT00177671|454578868|FG001|Overall Study|Adverse Event|0|||
126351675|NCT00177671|454578867|FG000|Overall Study|Physician Decision|12|||
126351676|NCT00177671|454578868|FG001|Overall Study|Physician Decision|8|||
126351677|NCT02293499|454578869|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
126369552|NCT01497197|454650596|FG000|Overall Study|Protocol Violation|0|||
126760152|NCT01258803|456072399|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
126760153|NCT01258803|456072400|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
126351678|NCT02293499|454578870|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
126689188|NCT03529773|455817196|FG016|Overall Study|Other|0|||
126689189|NCT03529773|455817197|FG017|Overall Study|Other|3|||
126689190|NCT03529773|455817198|FG018|Overall Study|Other|0|||
126689191|NCT03529773|455817199|FG019|Overall Study|Other|0|||
126689192|NCT03529773|455817200|FG020|Overall Study|Other|1|||
126689193|NCT03529773|455817201|FG021|Overall Study|Other|0|||
126689194|NCT03529773|455817202|FG022|Overall Study|Other|1|||
126689195|NCT03529773|455817203|FG023|Overall Study|Other|0|||
126689196|NCT03529773|455817204|FG024|Overall Study|Other|3|||
126689197|NCT03529773|455817205|FG025|Overall Study|Other|2|||
126689198|NCT03529773|455817206|FG026|Overall Study|Other|2|||
126689199|NCT03529773|455817207|FG027|Overall Study|Other|0|||
126689200|NCT03529773|455817208|FG028|Overall Study|Other|0|||
126689201|NCT03529773|455817209|FG029|Overall Study|Other|0|||
126689202|NCT03529773|455817210|FG030|Overall Study|Other|0|||
126689203|NCT03529773|455817211|FG031|Overall Study|Other|0|||
126689204|NCT03529773|455817212|FG032|Overall Study|Other|0|||
126689205|NCT03529773|455817213|FG033|Overall Study|Other|0|||
126689206|NCT03529773|455817214|FG034|Overall Study|Other|1|||
126689207|NCT03529773|455817215|FG035|Overall Study|Other|1|||
126689208|NCT03529773|455817216|FG036|Overall Study|Other|0|||
126689209|NCT03529773|455817217|FG037|Overall Study|Other|0|||
126689210|NCT03529773|455817218|FG038|Overall Study|Other|0|||
126689211|NCT03529773|455817219|FG039|Overall Study|Other|0|||
126689212|NCT03529773|455817180|FG000|Overall Study|Physician Decision|0|||
126689213|NCT03529773|455817181|FG001|Overall Study|Physician Decision|0|||
126689214|NCT03529773|455817182|FG002|Overall Study|Physician Decision|0|||
126689215|NCT03529773|455817183|FG003|Overall Study|Physician Decision|0|||
126689216|NCT03529773|455817184|FG004|Overall Study|Physician Decision|0|||
126689217|NCT03529773|455817185|FG005|Overall Study|Physician Decision|0|||
126689218|NCT03529773|455817186|FG006|Overall Study|Physician Decision|0|||
126689219|NCT03529773|455817187|FG007|Overall Study|Physician Decision|0|||
126689220|NCT03529773|455817188|FG008|Overall Study|Physician Decision|0|||
126689221|NCT03529773|455817189|FG009|Overall Study|Physician Decision|0|||
126689222|NCT03529773|455817190|FG010|Overall Study|Physician Decision|0|||
126689223|NCT03529773|455817191|FG011|Overall Study|Physician Decision|0|||
126689224|NCT03529773|455817192|FG012|Overall Study|Physician Decision|0|||
126689225|NCT03529773|455817193|FG013|Overall Study|Physician Decision|0|||
126689226|NCT03529773|455817194|FG014|Overall Study|Physician Decision|0|||
126689227|NCT03529773|455817195|FG015|Overall Study|Physician Decision|0|||
126689228|NCT03529773|455817196|FG016|Overall Study|Physician Decision|0|||
126689229|NCT03529773|455817197|FG017|Overall Study|Physician Decision|0|||
126689230|NCT03529773|455817198|FG018|Overall Study|Physician Decision|0|||
126689231|NCT03529773|455817199|FG019|Overall Study|Physician Decision|1|||
126689232|NCT03529773|455817200|FG020|Overall Study|Physician Decision|1|||
126689233|NCT03529773|455817201|FG021|Overall Study|Physician Decision|0|||
126689234|NCT03529773|455817202|FG022|Overall Study|Physician Decision|0|||
126689235|NCT03529773|455817203|FG023|Overall Study|Physician Decision|0|||
126689236|NCT03529773|455817204|FG024|Overall Study|Physician Decision|0|||
126689237|NCT03529773|455817205|FG025|Overall Study|Physician Decision|0|||
126689238|NCT03529773|455817206|FG026|Overall Study|Physician Decision|0|||
126689239|NCT03529773|455817207|FG027|Overall Study|Physician Decision|0|||
126351679|NCT02293499|454578871|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
126351680|NCT02293499|454578869|FG000|Intervention - Camp|Withdrawal by Subject|3|||
126351681|NCT02293499|454578870|FG001|Intervention - Camp|Withdrawal by Subject|6|||
126351682|NCT02293499|454578871|FG002|Intervention - Camp|Withdrawal by Subject|2|||
126351683|NCT02293499|454578869|FG000|Intervention - Camp|these are those not showing up at camp|24|||
126351684|NCT02293499|454578870|FG001|Intervention - Camp|these are those not showing up at camp|28|||
126351685|NCT02293499|454578871|FG002|Intervention - Camp|these are those not showing up at camp|4|||
126351686|NCT02293499|454578869|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
126351687|NCT02293499|454578870|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
126351688|NCT02293499|454578871|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
126351689|NCT02293499|454578869|FG000|3 Month Follow Up|Lost to Follow-up|14|||
126351690|NCT02293499|454578870|FG001|3 Month Follow Up|Lost to Follow-up|15|||
126351691|NCT02293499|454578871|FG002|3 Month Follow Up|Lost to Follow-up|6|||
126351692|NCT02293499|454578869|FG000|6 Month Follow Up|Lost to Follow-up|17|||
126351693|NCT02293499|454578870|FG001|6 Month Follow Up|Lost to Follow-up|27|||
126351694|NCT02293499|454578871|FG002|6 Month Follow Up|Lost to Follow-up|6|||
126351695|NCT02293499|454578869|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
126351696|NCT02293499|454578870|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
126351697|NCT02293499|454578871|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
126351698|NCT02293499|454578869|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
126351699|NCT02293499|454578870|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
126689240|NCT03529773|455817208|FG028|Overall Study|Physician Decision|0|||
126689241|NCT03529773|455817209|FG029|Overall Study|Physician Decision|0|||
126689242|NCT03529773|455817210|FG030|Overall Study|Physician Decision|0|||
126689243|NCT03529773|455817211|FG031|Overall Study|Physician Decision|0|||
126689244|NCT03529773|455817212|FG032|Overall Study|Physician Decision|0|||
126689245|NCT03529773|455817213|FG033|Overall Study|Physician Decision|0|||
126689246|NCT03529773|455817214|FG034|Overall Study|Physician Decision|0|||
126351700|NCT02293499|454578871|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
126351701|NCT02293499|454578869|FG000|9 Month Follow Up|Lost to Follow-up|24|||
126351702|NCT02293499|454578870|FG001|9 Month Follow Up|Lost to Follow-up|28|||
126351703|NCT02293499|454578871|FG002|9 Month Follow Up|Lost to Follow-up|4|||
126351704|NCT02293499|454578869|FG000|12 Month Follow Up|Lost to Follow-up|26|||
126351705|NCT02293499|454578870|FG001|12 Month Follow Up|Lost to Follow-up|25|||
126351706|NCT02293499|454578871|FG002|12 Month Follow Up|Lost to Follow-up|6|||
126351707|NCT02293499|454578869|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
126351708|NCT02293499|454578870|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
126351709|NCT02293499|454578871|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
126351710|NCT02293499|454578869|FG000|15 Month Follow Up|Lost to Follow-up|22|||
126351711|NCT02293499|454578870|FG001|15 Month Follow Up|Lost to Follow-up|22|||
126351712|NCT02293499|454578871|FG002|15 Month Follow Up|Lost to Follow-up|7|||
126351713|NCT00690898|454578872|FG000|SCREENING|Screen failure|18|||
126351714|NCT00690898|454578872|FG000|TREATMENT|Adverse Event|3|||
126351715|NCT00690898|454578872|FG000|TREATMENT|Lack of Efficacy|18|||
126351716|NCT00690898|454578872|FG000|TREATMENT|Withdrawal by Subject|4|||
126351717|NCT00690898|454578872|FG000|TREATMENT|Other (not otherwise specified)|1|||
126351718|NCT01847209|454578875|FG000|Overall Study|Withdrawal by Subject|1|||
126351719|NCT01847209|454578875|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
126351720|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
126351721|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
126351722|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
126351723|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
126351724|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
126351725|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
126351726|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
126351727|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
126351728|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
126351729|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
126351730|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Death|0|||
126351731|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Death|0|||
126351732|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Death|1|||
126689247|NCT03529773|455817215|FG035|Overall Study|Physician Decision|0|||
126689248|NCT03529773|455817216|FG036|Overall Study|Physician Decision|0|||
126689249|NCT03529773|455817217|FG037|Overall Study|Physician Decision|0|||
126689250|NCT03529773|455817218|FG038|Overall Study|Physician Decision|0|||
126689251|NCT03529773|455817219|FG039|Overall Study|Physician Decision|0|||
126689252|NCT03529773|455817180|FG000|Overall Study|Protocol Violation|0|||
126689253|NCT03529773|455817181|FG001|Overall Study|Protocol Violation|0|||
126689254|NCT03529773|455817182|FG002|Overall Study|Protocol Violation|0|||
126689255|NCT03529773|455817183|FG003|Overall Study|Protocol Violation|0|||
126689256|NCT03529773|455817184|FG004|Overall Study|Protocol Violation|0|||
126689257|NCT03529773|455817185|FG005|Overall Study|Protocol Violation|0|||
126351733|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Death|0|||
126351734|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Death|0|||
126351735|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
126689258|NCT03529773|455817186|FG006|Overall Study|Protocol Violation|0|||
126689259|NCT03529773|455817187|FG007|Overall Study|Protocol Violation|0|||
126689260|NCT03529773|455817188|FG008|Overall Study|Protocol Violation|0|||
126440032|NCT03126591|454909740|FG002|Overall Study|Progressive Disease|2|||
126440033|NCT03126591|454909738|FG000|Overall Study|Terminated by Sponsor|0|||
126440034|NCT03126591|454909739|FG001|Overall Study|Terminated by Sponsor|1|||
126440035|NCT03126591|454909740|FG002|Overall Study|Terminated by Sponsor|4|||
126440036|NCT03126591|454909738|FG000|Overall Study|Withdrawal by Subject|1|||
126440037|NCT03126591|454909739|FG001|Overall Study|Withdrawal by Subject|1|||
126440038|NCT03126591|454909740|FG002|Overall Study|Withdrawal by Subject|4|||
126440039|NCT02158546|454909741|FG000|Overall Study|Physician Decision|0|||
126440040|NCT02158546|454909742|FG001|Overall Study|Physician Decision|1|||
126440041|NCT02158546|454909743|FG002|Overall Study|Physician Decision|0|||
126440042|NCT02158546|454909744|FG003|Overall Study|Physician Decision|0|||
126440043|NCT02158546|454909741|FG000|Overall Study|Non-compliance|0|||
126440044|NCT02158546|454909742|FG001|Overall Study|Non-compliance|1|||
126440045|NCT02158546|454909743|FG002|Overall Study|Non-compliance|0|||
126440046|NCT02158546|454909744|FG003|Overall Study|Non-compliance|1|||
126440047|NCT02158546|454909741|FG000|Overall Study|Failure to meet eligibility criteria|0|||
126440048|NCT02158546|454909742|FG001|Overall Study|Failure to meet eligibility criteria|1|||
126440049|NCT02158546|454909743|FG002|Overall Study|Failure to meet eligibility criteria|0|||
126440050|NCT02158546|454909744|FG003|Overall Study|Failure to meet eligibility criteria|0|||
126440051|NCT02158546|454909741|FG000|Overall Study|Lack of Efficacy|1|||
126440052|NCT02158546|454909742|FG001|Overall Study|Lack of Efficacy|1|||
126440053|NCT02158546|454909743|FG002|Overall Study|Lack of Efficacy|0|||
126440054|NCT02158546|454909744|FG003|Overall Study|Lack of Efficacy|0|||
126440055|NCT02158546|454909741|FG000|Overall Study|Adverse Event|2|||
126440056|NCT02158546|454909742|FG001|Overall Study|Adverse Event|2|||
126440057|NCT02158546|454909743|FG002|Overall Study|Adverse Event|0|||
126440058|NCT02158546|454909744|FG003|Overall Study|Adverse Event|0|||
126440059|NCT02158546|454909741|FG000|Overall Study|Withdrawal by Subject|6|||
126440060|NCT02158546|454909742|FG001|Overall Study|Withdrawal by Subject|2|||
126440061|NCT02158546|454909743|FG002|Overall Study|Withdrawal by Subject|1|||
126440062|NCT02158546|454909744|FG003|Overall Study|Withdrawal by Subject|0|||
126440063|NCT02158546|454909741|FG000|Overall Study|Lost to Follow-up|5|||
126440064|NCT02158546|454909742|FG001|Overall Study|Lost to Follow-up|4|||
126440065|NCT02158546|454909743|FG002|Overall Study|Lost to Follow-up|0|||
126440066|NCT02158546|454909744|FG003|Overall Study|Lost to Follow-up|1|||
126440067|NCT02158546|454909741|FG000|Overall Study|Site Excluded|5|||
126440068|NCT02158546|454909742|FG001|Overall Study|Site Excluded|5|||
126440069|NCT02158546|454909743|FG002|Overall Study|Site Excluded|3|||
126440070|NCT02158546|454909744|FG003|Overall Study|Site Excluded|4|||
126440071|NCT02900378|454909745|FG000|Randomization (Visit 2)|Adverse Event|14|||
126440072|NCT02900378|454909746|FG001|Randomization (Visit 2)|Adverse Event|11|||
126440073|NCT02900378|454909745|FG000|Randomization (Visit 2)|Death|1|||
126440074|NCT02900378|454909746|FG001|Randomization (Visit 2)|Death|4|||
126440075|NCT02900378|454909745|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
126440076|NCT02900378|454909746|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
126440077|NCT02900378|454909745|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
126440078|NCT02900378|454909746|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
126440079|NCT02900378|454909745|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
126440080|NCT02900378|454909746|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
126440081|NCT02900378|454909745|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
126545396|NCT02541383|455290826|FG003|Overall Study|Consent withdrawn|1|||
126351736|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
126351737|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
126351738|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
126351739|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
126351740|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Other|2|||
126351741|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Other|1|||
126351742|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Other|0|||
126689261|NCT03529773|455817189|FG009|Overall Study|Protocol Violation|0|||
126351743|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Other|0|||
126351744|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Other|0|||
126351745|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
126351746|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
126689262|NCT03529773|455817190|FG010|Overall Study|Protocol Violation|0|||
126689263|NCT03529773|455817191|FG011|Overall Study|Protocol Violation|0|||
126689264|NCT03529773|455817192|FG012|Overall Study|Protocol Violation|0|||
126689265|NCT03529773|455817193|FG013|Overall Study|Protocol Violation|0|||
126689266|NCT03529773|455817194|FG014|Overall Study|Protocol Violation|0|||
126351747|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
126351748|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
126351749|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
126351750|NCT03317496|454578896|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
126351751|NCT03317496|454578897|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
126351752|NCT03317496|454578898|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
126351753|NCT03317496|454578899|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
126351754|NCT03317496|454578900|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
126351755|NCT03317496|454578896|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
126351756|NCT03317496|454578897|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
126351757|NCT03317496|454578898|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
126351758|NCT03317496|454578899|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
126689267|NCT03529773|455817195|FG015|Overall Study|Protocol Violation|0|||
126689268|NCT03529773|455817196|FG016|Overall Study|Protocol Violation|0|||
126689269|NCT03529773|455817197|FG017|Overall Study|Protocol Violation|0|||
126689270|NCT03529773|455817198|FG018|Overall Study|Protocol Violation|0|||
126760154|NCT01258803|456072401|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
126351759|NCT03317496|454578900|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
126351760|NCT03317496|454578896|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
126440082|NCT02900378|454909746|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
126440083|NCT02900378|454909745|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
126440084|NCT02900378|454909746|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
126440085|NCT01249261|454909749|FG000|Overall Study|Withdrawal by Subject|1|||
126440086|NCT01249261|454909750|FG001|Overall Study|Withdrawal by Subject|0|||
126440087|NCT02819804|454909751|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
126440088|NCT00482053|454909755|FG000|Inter-treatment Period|Disease progression|1|||
126440089|NCT00346697|454909757|FG000|Overall Study|Lost to Follow-up|0|||
126440090|NCT00346697|454909758|FG001|Overall Study|Lost to Follow-up|1|||
126440091|NCT03815929|454909761|FG000|Overall Study|Lost to Follow-up|2|||
126440092|NCT03815929|454909762|FG001|Overall Study|Lost to Follow-up|1|||
126440093|NCT03815929|454909763|FG002|Overall Study|Lost to Follow-up|0|||
126440094|NCT03815929|454909761|FG000|Overall Study|Physician Decision|2|||
126440095|NCT03815929|454909762|FG001|Overall Study|Physician Decision|2|||
126440096|NCT03815929|454909763|FG002|Overall Study|Physician Decision|0|||
126440097|NCT03815929|454909761|FG000|Overall Study|Withdrawal by Subject|0|||
126440098|NCT03815929|454909762|FG001|Overall Study|Withdrawal by Subject|0|||
126440099|NCT03815929|454909763|FG002|Overall Study|Withdrawal by Subject|1|||
126440100|NCT03326713|454909764|FG000|Overall Study|Death|2|||
126440101|NCT03326713|454909765|FG001|Overall Study|Death|1|||
126440102|NCT03326713|454909766|FG002|Overall Study|Death|0|||
126440103|NCT03326713|454909764|FG000|Overall Study|Lost to Follow-up|20|||
126440104|NCT03326713|454909765|FG001|Overall Study|Lost to Follow-up|21|||
126440105|NCT03326713|454909766|FG002|Overall Study|Lost to Follow-up|33|||
126440106|NCT03326713|454909764|FG000|Overall Study|Withdrawal by Subject|1|||
126440107|NCT03326713|454909765|FG001|Overall Study|Withdrawal by Subject|2|||
126440108|NCT03326713|454909766|FG002|Overall Study|Withdrawal by Subject|11|||
126440109|NCT03326713|454909764|FG000|Overall Study|Found Ineligible|11|||
126440110|NCT03326713|454909765|FG001|Overall Study|Found Ineligible|11|||
126440111|NCT03326713|454909766|FG002|Overall Study|Found Ineligible|8|||
126440112|NCT06078124|454909772|FG000|Overall Study|Lost to Follow-up|14|||
126440113|NCT06078124|454909773|FG001|Overall Study|Lost to Follow-up|14|||
126440114|NCT01198977|454909774|FG000|Overall Study|Lost to Follow-up|1|||
126440115|NCT01198977|454909775|FG001|Overall Study|Lost to Follow-up|0|||
126440116|NCT04721977|454909781|FG000|Overall Study|Death|15|||
126440117|NCT04721977|454909781|FG000|Overall Study|Ongoing|51|||
126440118|NCT02864394|454909782|FG000|Overall Study|Death|184|||
126440119|NCT02864394|454909783|FG001|Overall Study|Death|189|||
126440120|NCT02864394|454909782|FG000|Overall Study|Lost to Follow-up|0|||
126440121|NCT02864394|454909783|FG001|Overall Study|Lost to Follow-up|2|||
126440122|NCT02864394|454909782|FG000|Overall Study|Sponsor Decision|26|||
126689271|NCT03529773|455817199|FG019|Overall Study|Protocol Violation|0|||
126351761|NCT03317496|454578897|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
126351762|NCT03317496|454578898|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
126351763|NCT03317496|454578899|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
126351764|NCT03317496|454578900|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
126351765|NCT03317496|454578896|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
126351766|NCT03317496|454578897|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
126351767|NCT03317496|454578898|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
126351768|NCT03317496|454578899|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
126440123|NCT02864394|454909783|FG001|Overall Study|Sponsor Decision|11|||
126440124|NCT02864394|454909782|FG000|Overall Study|Withdrawal by Subject|3|||
126440125|NCT02864394|454909783|FG001|Overall Study|Withdrawal by Subject|10|||
126351769|NCT03317496|454578900|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
126351770|NCT03317496|454578896|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
126351771|NCT03317496|454578897|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
126440126|NCT01458392|454911298|FG000|Overall Study|Death|2|||
126440127|NCT01458392|454911299|FG001|Overall Study|Death|11|||
126440128|NCT01458392|454911300|FG002|Overall Study|Death|22|||
126440129|NCT01458392|454911298|FG000|Overall Study|At the discretion of the sponsor|0|||
126440130|NCT01458392|454911299|FG001|Overall Study|At the discretion of the sponsor|2|||
126440131|NCT01458392|454911300|FG002|Overall Study|At the discretion of the sponsor|7|||
126440132|NCT01458392|454911298|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
126689272|NCT03529773|455817200|FG020|Overall Study|Protocol Violation|0|||
126689273|NCT03529773|455817201|FG021|Overall Study|Protocol Violation|0|||
126440133|NCT01458392|454911299|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
126440134|NCT01458392|454911300|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
126440135|NCT03557034|454911311|FG000|Overall Study|Withdrawal by Subject|1|||
126440136|NCT03557034|454911312|FG001|Overall Study|Withdrawal by Subject|0|||
126440137|NCT02118961|454911313|FG000|Overall Study|Withdrawal by Subject|1|||
126440138|NCT02118961|454911314|FG001|Overall Study|Withdrawal by Subject|0|||
126440139|NCT03809104|454911315|FG000|Overall Study|Withdrawal by Subject|3|||
126440140|NCT00790842|454911316|FG000|Dose Level 1|Adverse Event|1|||
126440141|NCT00790842|454911317|FG001|Dose Level 1|Adverse Event|0|||
126440142|NCT00790842|454911318|FG002|Dose Level 1|Adverse Event|0|||
126440143|NCT00790842|454911319|FG003|Dose Level 1|Adverse Event|2|||
126440144|NCT00790842|454911320|FG004|Dose Level 1|Adverse Event|0|||
126440145|NCT00790842|454911321|FG005|Dose Level 1|Adverse Event|0|||
126440146|NCT00790842|454911322|FG006|Dose Level 1|Adverse Event|0|||
126440147|NCT00790842|454911323|FG007|Dose Level 1|Adverse Event|1|||
126440148|NCT00790842|454911324|FG008|Dose Level 1|Adverse Event|0|||
126440149|NCT00790842|454911325|FG009|Dose Level 1|Adverse Event|0|||
126440150|NCT00790842|454911326|FG010|Dose Level 1|Adverse Event|0|||
126440151|NCT00790842|454911316|FG000|Dose Level 1|Physician Decision|1|||
126689274|NCT03529773|455817202|FG022|Overall Study|Protocol Violation|0|||
126689275|NCT03529773|455817203|FG023|Overall Study|Protocol Violation|0|||
126440152|NCT00790842|454911317|FG001|Dose Level 1|Physician Decision|0|||
126440153|NCT00790842|454911318|FG002|Dose Level 1|Physician Decision|0|||
126440154|NCT00790842|454911319|FG003|Dose Level 1|Physician Decision|0|||
126440155|NCT00790842|454911320|FG004|Dose Level 1|Physician Decision|0|||
126440156|NCT00790842|454911321|FG005|Dose Level 1|Physician Decision|0|||
126440157|NCT00790842|454911322|FG006|Dose Level 1|Physician Decision|0|||
126440158|NCT00790842|454911323|FG007|Dose Level 1|Physician Decision|1|||
126351772|NCT03317496|454578898|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
126351773|NCT03317496|454578899|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
126351774|NCT03317496|454578900|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
126351775|NCT03317496|454578896|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
126351776|NCT03317496|454578897|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
126351777|NCT03317496|454578898|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
126351778|NCT03317496|454578899|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
126440159|NCT00790842|454911324|FG008|Dose Level 1|Physician Decision|0|||
126689276|NCT03529773|455817204|FG024|Overall Study|Protocol Violation|0|||
126689277|NCT03529773|455817205|FG025|Overall Study|Protocol Violation|0|||
126689278|NCT03529773|455817206|FG026|Overall Study|Protocol Violation|0|||
126689279|NCT03529773|455817207|FG027|Overall Study|Protocol Violation|0|||
126369553|NCT01497197|454650597|FG001|Overall Study|Protocol Violation|2|||
126369554|NCT01497197|454650596|FG000|Overall Study|Withdrawal by Subject|2|||
126369555|NCT01497197|454650597|FG001|Overall Study|Withdrawal by Subject|1|||
126351779|NCT03317496|454578900|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
126351780|NCT03317496|454578896|FG000|Phase 2: Treatment|Adverse Event|0|||
126351781|NCT03317496|454578897|FG001|Phase 2: Treatment|Adverse Event|0|||
126351782|NCT03317496|454578898|FG002|Phase 2: Treatment|Adverse Event|0|||
126351783|NCT03317496|454578899|FG003|Phase 2: Treatment|Adverse Event|0|||
126351784|NCT03317496|454578900|FG004|Phase 2: Treatment|Adverse Event|6|||
126351785|NCT03317496|454578896|FG000|Phase 2: Treatment|Progressive disease|0|||
126351786|NCT03317496|454578897|FG001|Phase 2: Treatment|Progressive disease|0|||
126351787|NCT03317496|454578898|FG002|Phase 2: Treatment|Progressive disease|0|||
126351788|NCT03317496|454578899|FG003|Phase 2: Treatment|Progressive disease|0|||
126351789|NCT03317496|454578900|FG004|Phase 2: Treatment|Progressive disease|22|||
126351790|NCT03317496|454578896|FG000|Phase 2: Treatment|Other|0|||
126351791|NCT03317496|454578897|FG001|Phase 2: Treatment|Other|0|||
126351792|NCT03317496|454578898|FG002|Phase 2: Treatment|Other|0|||
126351793|NCT03317496|454578899|FG003|Phase 2: Treatment|Other|0|||
126351794|NCT03317496|454578900|FG004|Phase 2: Treatment|Other|4|||
126351795|NCT03317496|454578896|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
126351796|NCT03317496|454578897|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
126351797|NCT03317496|454578898|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
126351798|NCT03317496|454578899|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
126351799|NCT03317496|454578900|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
126351800|NCT03317496|454578896|FG000|Phase 2: Treatment|Physician Decision|0|||
126351801|NCT03317496|454578897|FG001|Phase 2: Treatment|Physician Decision|0|||
126351802|NCT03317496|454578898|FG002|Phase 2: Treatment|Physician Decision|0|||
126351803|NCT03317496|454578899|FG003|Phase 2: Treatment|Physician Decision|0|||
126351804|NCT03317496|454578900|FG004|Phase 2: Treatment|Physician Decision|1|||
126351805|NCT03317496|454578896|FG000|Phase 2: Treatment|Death|0|||
126351806|NCT03317496|454578897|FG001|Phase 2: Treatment|Death|0|||
126351807|NCT03317496|454578898|FG002|Phase 2: Treatment|Death|0|||
126351808|NCT03317496|454578899|FG003|Phase 2: Treatment|Death|0|||
126351809|NCT03317496|454578900|FG004|Phase 2: Treatment|Death|1|||
126351810|NCT03317496|454578896|FG000|Phase 2: Follow-up|Death|0|||
126351811|NCT03317496|454578897|FG001|Phase 2: Follow-up|Death|0|||
126351812|NCT03317496|454578898|FG002|Phase 2: Follow-up|Death|0|||
126351813|NCT03317496|454578899|FG003|Phase 2: Follow-up|Death|0|||
126351814|NCT03317496|454578900|FG004|Phase 2: Follow-up|Death|24|||
126351815|NCT03317496|454578896|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
126351816|NCT03317496|454578897|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
126440160|NCT00790842|454911325|FG009|Dose Level 1|Physician Decision|0|||
126440161|NCT00790842|454911326|FG010|Dose Level 1|Physician Decision|0|||
126351817|NCT03317496|454578898|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
126351818|NCT03317496|454578899|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
126351819|NCT03317496|454578900|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
126351820|NCT03317496|454578896|FG000|Phase 2: Follow-up|Other|0|||
126351821|NCT03317496|454578897|FG001|Phase 2: Follow-up|Other|0|||
126351822|NCT03317496|454578898|FG002|Phase 2: Follow-up|Other|0|||
126351823|NCT03317496|454578899|FG003|Phase 2: Follow-up|Other|0|||
126351824|NCT03317496|454578900|FG004|Phase 2: Follow-up|Other|1|||
126351825|NCT03317496|454578896|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
126351826|NCT03317496|454578897|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
126351827|NCT03317496|454578898|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
126351828|NCT03317496|454578899|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
126351829|NCT03317496|454578900|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
126351830|NCT02737618|454578901|FG000|Overall Study|Withdrawal by Subject|9|||
126351831|NCT00817063|454578904|FG000|Overall Study|Adverse Event|32|||
126351832|NCT00817063|454578905|FG001|Overall Study|Adverse Event|13|||
126351833|NCT00817063|454578904|FG000|Overall Study|Death|1|||
126351834|NCT00817063|454578905|FG001|Overall Study|Death|1|||
126351835|NCT00817063|454578904|FG000|Overall Study|Lack of Efficacy|33|||
126351836|NCT00817063|454578905|FG001|Overall Study|Lack of Efficacy|86|||
126351837|NCT00817063|454578904|FG000|Overall Study|Failure to Return|13|||
126351838|NCT00817063|454578905|FG001|Overall Study|Failure to Return|12|||
126351839|NCT00817063|454578904|FG000|Overall Study|Violation of Selection at Entry|7|||
126351840|NCT00817063|454578905|FG001|Overall Study|Violation of Selection at Entry|4|||
126351841|NCT00817063|454578904|FG000|Overall Study|Protocol Violation|3|||
126351842|NCT00817063|454578905|FG001|Overall Study|Protocol Violation|8|||
126351843|NCT00817063|454578904|FG000|Overall Study|Withdrawal by Subject|17|||
126351844|NCT00817063|454578905|FG001|Overall Study|Withdrawal by Subject|37|||
126351845|NCT00817063|454578904|FG000|Overall Study|Early Improvement|19|||
126351846|NCT00817063|454578905|FG001|Overall Study|Early Improvement|4|||
126351847|NCT00817063|454578904|FG000|Overall Study|Administrative|10|||
126351848|NCT00817063|454578905|FG001|Overall Study|Administrative|4|||
126351849|NCT00817063|454578904|FG000|Overall Study|Abnormality of Laboratory Test|2|||
126351850|NCT00817063|454578905|FG001|Overall Study|Abnormality of Laboratory Test|1|||
126351851|NCT02362451|454578907|FG000|Overall Study|Withdrawal by Subject|0|||
126351852|NCT02362451|454578908|FG001|Overall Study|Withdrawal by Subject|1|||
126351853|NCT02362451|454578907|FG000|Overall Study|Lack of Efficacy|2|||
126351854|NCT02362451|454578908|FG001|Overall Study|Lack of Efficacy|0|||
126351855|NCT02362451|454578907|FG000|Overall Study|Progression|1|||
126351856|NCT02362451|454578908|FG001|Overall Study|Progression|0|||
126351857|NCT02362451|454578907|FG000|Overall Study|Participant chose other therapy.|1|||
126351858|NCT02362451|454578908|FG001|Overall Study|Participant chose other therapy.|0|||
126351859|NCT01879852|454578909|FG000|Overall Study|Withdrawal by Subject|2|||
126351860|NCT01879852|454578910|FG001|Overall Study|Withdrawal by Subject|0|||
126351861|NCT02696616|454578912|FG000|Overall Study|Adverse Event|0|||
126351862|NCT02696616|454578913|FG001|Overall Study|Adverse Event|1|||
126689280|NCT03529773|455817208|FG028|Overall Study|Protocol Violation|0|||
126689281|NCT03529773|455817209|FG029|Overall Study|Protocol Violation|0|||
126440162|NCT00790842|454911316|FG000|Dose Level 1|Withdrawal by Subject|1|||
126440163|NCT00790842|454911317|FG001|Dose Level 1|Withdrawal by Subject|0|||
126689282|NCT03529773|455817210|FG030|Overall Study|Protocol Violation|1|||
126351863|NCT02696616|454578914|FG002|Overall Study|Adverse Event|0|||
126351864|NCT02696616|454578915|FG003|Overall Study|Adverse Event|0|||
126351865|NCT02696616|454578916|FG004|Overall Study|Adverse Event|0|||
126351866|NCT02696616|454578917|FG005|Overall Study|Adverse Event|0|||
126351867|NCT02696616|454578918|FG006|Overall Study|Adverse Event|0|||
126351868|NCT01500083|454578919|FG000|Overall Study|Adverse Event|4|||
126351869|NCT01500083|454578920|FG001|Overall Study|Adverse Event|17|||
126351870|NCT01500083|454578919|FG000|Overall Study|Death|0|||
126351871|NCT01500083|454578920|FG001|Overall Study|Death|2|||
126351872|NCT01500083|454578919|FG000|Overall Study|Lost to Follow-up|1|||
126351873|NCT01500083|454578920|FG001|Overall Study|Lost to Follow-up|0|||
126351874|NCT01500083|454578919|FG000|Overall Study|Withdrawal of Consent|0|||
126351875|NCT01500083|454578920|FG001|Overall Study|Withdrawal of Consent|1|||
126351876|NCT01500083|454578919|FG000|Overall Study|Disease Progression|2|||
126351877|NCT01500083|454578920|FG001|Overall Study|Disease Progression|10|||
126351878|NCT01500083|454578919|FG000|Overall Study|Investigator Discretion|3|||
126351879|NCT01500083|454578920|FG001|Overall Study|Investigator Discretion|8|||
126351880|NCT01500083|454578919|FG000|Overall Study|Other Reasons|2|||
126351881|NCT01500083|454578920|FG001|Overall Study|Other Reasons|5|||
126351882|NCT01555931|454578921|FG000|Overall Study|Lost to Follow-up|2|||
126351883|NCT01555931|454578922|FG001|Overall Study|Lost to Follow-up|5|||
126351884|NCT01922011|454578923|FG000|Overall Study|Protocol Violation|0|||
126351885|NCT01922011|454578924|FG001|Overall Study|Protocol Violation|1|||
126351886|NCT01922011|454578923|FG000|Overall Study|Physician Decision|0|||
126351887|NCT01922011|454578924|FG001|Overall Study|Physician Decision|1|||
126351888|NCT01922011|454578923|FG000|Overall Study|Parent/Guardian Decision|3|||
126351889|NCT01922011|454578924|FG001|Overall Study|Parent/Guardian Decision|0|||
126351890|NCT01922011|454578923|FG000|Overall Study|Lost to Follow-up|0|||
126351891|NCT01922011|454578924|FG001|Overall Study|Lost to Follow-up|1|||
126351892|NCT01922011|454578923|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
126351893|NCT01922011|454578924|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
126351894|NCT01922011|454578923|FG000|Overall Study|Not Treated|1|||
126351895|NCT01922011|454578924|FG001|Overall Study|Not Treated|0|||
126351896|NCT01922011|454578923|FG000|Overall Study|Lack of willing home health agency|1|||
126351897|NCT01922011|454578924|FG001|Overall Study|Lack of willing home health agency|0|||
126351898|NCT01922011|454578923|FG000|Overall Study|Randomized in error|1|||
126351899|NCT01922011|454578924|FG001|Overall Study|Randomized in error|0|||
126351900|NCT02299167|454578927|FG000|Overall Study|patients were excluded from the study|11|||
126689283|NCT03529773|455817211|FG031|Overall Study|Protocol Violation|0|||
126351901|NCT04615507|454578928|FG000|Period 1|Covid-19 exposure|2|||
126351902|NCT04615507|454578929|FG001|Period 1|Covid-19 exposure|1|||
126351903|NCT04615507|454578928|FG000|Period 2|Covid-19 exposure|0|||
126351904|NCT04615507|454578929|FG001|Period 2|Covid-19 exposure|1|||
126440164|NCT00790842|454911318|FG002|Dose Level 1|Withdrawal by Subject|0|||
126440165|NCT00790842|454911319|FG003|Dose Level 1|Withdrawal by Subject|0|||
126440166|NCT00790842|454911320|FG004|Dose Level 1|Withdrawal by Subject|0|||
126440167|NCT00790842|454911321|FG005|Dose Level 1|Withdrawal by Subject|0|||
126440168|NCT00790842|454911322|FG006|Dose Level 1|Withdrawal by Subject|0|||
126440169|NCT00790842|454911323|FG007|Dose Level 1|Withdrawal by Subject|0|||
126440170|NCT00790842|454911324|FG008|Dose Level 1|Withdrawal by Subject|0|||
126440171|NCT00790842|454911325|FG009|Dose Level 1|Withdrawal by Subject|0|||
126440172|NCT00790842|454911326|FG010|Dose Level 1|Withdrawal by Subject|0|||
126440173|NCT00790842|454911316|FG000|Dose Level 2|Death|0|||
126440174|NCT00790842|454911317|FG001|Dose Level 2|Death|1|||
126440175|NCT00790842|454911318|FG002|Dose Level 2|Death|0|||
126440176|NCT00790842|454911319|FG003|Dose Level 2|Death|0|||
126440177|NCT00790842|454911320|FG004|Dose Level 2|Death|1|||
126440178|NCT00790842|454911321|FG005|Dose Level 2|Death|0|||
126440179|NCT00790842|454911322|FG006|Dose Level 2|Death|0|||
126440180|NCT00790842|454911323|FG007|Dose Level 2|Death|0|||
126440181|NCT00790842|454911324|FG008|Dose Level 2|Death|0|||
126440182|NCT00790842|454911325|FG009|Dose Level 2|Death|0|||
126440183|NCT00790842|454911326|FG010|Dose Level 2|Death|0|||
126440184|NCT00790842|454911316|FG000|Dose Level 2|Physician Decision|0|||
126440185|NCT00790842|454911317|FG001|Dose Level 2|Physician Decision|1|||
126440186|NCT00790842|454911318|FG002|Dose Level 2|Physician Decision|0|||
126440187|NCT00790842|454911319|FG003|Dose Level 2|Physician Decision|0|||
126440188|NCT00790842|454911320|FG004|Dose Level 2|Physician Decision|0|||
126440189|NCT00790842|454911321|FG005|Dose Level 2|Physician Decision|0|||
126440190|NCT00790842|454911322|FG006|Dose Level 2|Physician Decision|0|||
126440191|NCT00790842|454911323|FG007|Dose Level 2|Physician Decision|0|||
126440192|NCT00790842|454911324|FG008|Dose Level 2|Physician Decision|0|||
126440193|NCT00790842|454911325|FG009|Dose Level 2|Physician Decision|0|||
126440194|NCT00790842|454911326|FG010|Dose Level 2|Physician Decision|0|||
126440195|NCT00790842|454911316|FG000|Dose Level 2|Withdrawal by Subject|0|||
126440196|NCT00790842|454911317|FG001|Dose Level 2|Withdrawal by Subject|1|||
126440197|NCT00790842|454911318|FG002|Dose Level 2|Withdrawal by Subject|0|||
126440198|NCT00790842|454911319|FG003|Dose Level 2|Withdrawal by Subject|0|||
126440199|NCT00790842|454911320|FG004|Dose Level 2|Withdrawal by Subject|0|||
126440200|NCT00790842|454911321|FG005|Dose Level 2|Withdrawal by Subject|0|||
126440201|NCT00790842|454911322|FG006|Dose Level 2|Withdrawal by Subject|0|||
126440202|NCT00790842|454911323|FG007|Dose Level 2|Withdrawal by Subject|0|||
126440203|NCT00790842|454911324|FG008|Dose Level 2|Withdrawal by Subject|0|||
126351905|NCT04615507|454578928|FG000|Period 2|Protocol Violation|1|||
126351906|NCT04615507|454578929|FG001|Period 2|Protocol Violation|0|||
126351907|NCT04615507|454578928|FG000|Period 2|Withdrawal by Subject|1|||
126351908|NCT04615507|454578929|FG001|Period 2|Withdrawal by Subject|0|||
126351909|NCT04615507|454578928|FG000|Period 2|Adverse Event|0|||
126351910|NCT04615507|454578929|FG001|Period 2|Adverse Event|1|||
126760155|NCT00920582|456072402|FG000|Overall Study|Lost to Follow-up|5|||
126351911|NCT04615507|454578928|FG000|Period 3|Covid-19 exposure|0|||
126351912|NCT04615507|454578929|FG001|Period 3|Covid-19 exposure|1|||
126351913|NCT00700635|454578930|FG000|Overall Study|Adverse Event|1|||
126689284|NCT03529773|455817212|FG032|Overall Study|Protocol Violation|0|||
126689285|NCT03529773|455817213|FG033|Overall Study|Protocol Violation|0|||
126689286|NCT03529773|455817214|FG034|Overall Study|Protocol Violation|0|||
126351914|NCT00700635|454578931|FG001|Overall Study|Adverse Event|0|||
126351915|NCT00700635|454578932|FG002|Overall Study|Adverse Event|0|||
126351916|NCT00700635|454578930|FG000|Overall Study|Lost to Follow-up|1|||
126689287|NCT03529773|455817215|FG035|Overall Study|Protocol Violation|0|||
126689288|NCT03529773|455817216|FG036|Overall Study|Protocol Violation|0|||
126689289|NCT03529773|455817217|FG037|Overall Study|Protocol Violation|0|||
126689290|NCT03529773|455817218|FG038|Overall Study|Protocol Violation|0|||
126689291|NCT03529773|455817219|FG039|Overall Study|Protocol Violation|0|||
126689292|NCT03529773|455817180|FG000|Overall Study|Withdrawal by Subject|0|||
126689293|NCT03529773|455817181|FG001|Overall Study|Withdrawal by Subject|0|||
126689294|NCT03529773|455817182|FG002|Overall Study|Withdrawal by Subject|0|||
126689295|NCT03529773|455817183|FG003|Overall Study|Withdrawal by Subject|0|||
126689296|NCT03529773|455817184|FG004|Overall Study|Withdrawal by Subject|0|||
126689297|NCT03529773|455817185|FG005|Overall Study|Withdrawal by Subject|0|||
126689298|NCT03529773|455817186|FG006|Overall Study|Withdrawal by Subject|0|||
126689299|NCT03529773|455817187|FG007|Overall Study|Withdrawal by Subject|1|||
126689300|NCT03529773|455817188|FG008|Overall Study|Withdrawal by Subject|0|||
126689301|NCT03529773|455817189|FG009|Overall Study|Withdrawal by Subject|1|||
126689302|NCT03529773|455817190|FG010|Overall Study|Withdrawal by Subject|1|||
126689303|NCT03529773|455817191|FG011|Overall Study|Withdrawal by Subject|0|||
126689304|NCT03529773|455817192|FG012|Overall Study|Withdrawal by Subject|0|||
126689305|NCT03529773|455817193|FG013|Overall Study|Withdrawal by Subject|0|||
126689306|NCT03529773|455817194|FG014|Overall Study|Withdrawal by Subject|0|||
126689307|NCT03529773|455817195|FG015|Overall Study|Withdrawal by Subject|3|||
126689308|NCT03529773|455817196|FG016|Overall Study|Withdrawal by Subject|0|||
126689309|NCT03529773|455817197|FG017|Overall Study|Withdrawal by Subject|2|||
126689310|NCT03529773|455817198|FG018|Overall Study|Withdrawal by Subject|3|||
126689311|NCT03529773|455817199|FG019|Overall Study|Withdrawal by Subject|1|||
126689312|NCT03529773|455817200|FG020|Overall Study|Withdrawal by Subject|3|||
126689313|NCT03529773|455817201|FG021|Overall Study|Withdrawal by Subject|1|||
126689314|NCT03529773|455817202|FG022|Overall Study|Withdrawal by Subject|1|||
126689315|NCT03529773|455817203|FG023|Overall Study|Withdrawal by Subject|2|||
126689316|NCT03529773|455817204|FG024|Overall Study|Withdrawal by Subject|2|||
126689317|NCT03529773|455817205|FG025|Overall Study|Withdrawal by Subject|4|||
126689318|NCT03529773|455817206|FG026|Overall Study|Withdrawal by Subject|2|||
126689319|NCT03529773|455817207|FG027|Overall Study|Withdrawal by Subject|1|||
126689320|NCT03529773|455817208|FG028|Overall Study|Withdrawal by Subject|1|||
126689321|NCT03529773|455817209|FG029|Overall Study|Withdrawal by Subject|0|||
126689322|NCT03529773|455817210|FG030|Overall Study|Withdrawal by Subject|0|||
126689323|NCT03529773|455817211|FG031|Overall Study|Withdrawal by Subject|0|||
126689324|NCT03529773|455817212|FG032|Overall Study|Withdrawal by Subject|0|||
126689325|NCT03529773|455817213|FG033|Overall Study|Withdrawal by Subject|0|||
126689326|NCT03529773|455817214|FG034|Overall Study|Withdrawal by Subject|1|||
126689327|NCT03529773|455817215|FG035|Overall Study|Withdrawal by Subject|2|||
126689328|NCT03529773|455817216|FG036|Overall Study|Withdrawal by Subject|0|||
126689329|NCT03529773|455817217|FG037|Overall Study|Withdrawal by Subject|2|||
126689330|NCT03529773|455817218|FG038|Overall Study|Withdrawal by Subject|1|||
126689331|NCT03529773|455817219|FG039|Overall Study|Withdrawal by Subject|1|||
126689332|NCT03529773|455817180|FG000|Overall Study|Screen Failure|0|||
126689333|NCT03529773|455817181|FG001|Overall Study|Screen Failure|0|||
126689334|NCT03529773|455817182|FG002|Overall Study|Screen Failure|0|||
126689335|NCT03529773|455817183|FG003|Overall Study|Screen Failure|0|||
126689336|NCT03529773|455817184|FG004|Overall Study|Screen Failure|0|||
126689337|NCT03529773|455817185|FG005|Overall Study|Screen Failure|0|||
126689338|NCT03529773|455817186|FG006|Overall Study|Screen Failure|0|||
126689339|NCT03529773|455817187|FG007|Overall Study|Screen Failure|0|||
126689340|NCT03529773|455817188|FG008|Overall Study|Screen Failure|0|||
126351917|NCT00700635|454578931|FG001|Overall Study|Lost to Follow-up|3|||
126351918|NCT00700635|454578932|FG002|Overall Study|Lost to Follow-up|0|||
126689341|NCT03529773|455817189|FG009|Overall Study|Screen Failure|0|||
126689342|NCT03529773|455817190|FG010|Overall Study|Screen Failure|0|||
126689343|NCT03529773|455817191|FG011|Overall Study|Screen Failure|0|||
126689344|NCT03529773|455817192|FG012|Overall Study|Screen Failure|0|||
126689345|NCT03529773|455817193|FG013|Overall Study|Screen Failure|0|||
126689346|NCT03529773|455817194|FG014|Overall Study|Screen Failure|0|||
126689347|NCT03529773|455817195|FG015|Overall Study|Screen Failure|0|||
126689348|NCT03529773|455817196|FG016|Overall Study|Screen Failure|0|||
126689349|NCT03529773|455817197|FG017|Overall Study|Screen Failure|0|||
126689350|NCT03529773|455817198|FG018|Overall Study|Screen Failure|0|||
126689351|NCT03529773|455817199|FG019|Overall Study|Screen Failure|0|||
126689352|NCT03529773|455817200|FG020|Overall Study|Screen Failure|0|||
126689353|NCT03529773|455817201|FG021|Overall Study|Screen Failure|0|||
126351919|NCT00700635|454578930|FG000|Overall Study|Protocol Violation|2|||
126689354|NCT03529773|455817202|FG022|Overall Study|Screen Failure|0|||
126689355|NCT03529773|455817203|FG023|Overall Study|Screen Failure|0|||
126689356|NCT03529773|455817204|FG024|Overall Study|Screen Failure|0|||
126689357|NCT03529773|455817205|FG025|Overall Study|Screen Failure|0|||
126689358|NCT03529773|455817206|FG026|Overall Study|Screen Failure|0|||
126689359|NCT03529773|455817207|FG027|Overall Study|Screen Failure|0|||
126689360|NCT03529773|455817208|FG028|Overall Study|Screen Failure|0|||
126689361|NCT03529773|455817209|FG029|Overall Study|Screen Failure|0|||
126689362|NCT03529773|455817210|FG030|Overall Study|Screen Failure|0|||
126689363|NCT03529773|455817211|FG031|Overall Study|Screen Failure|0|||
126689364|NCT03529773|455817212|FG032|Overall Study|Screen Failure|0|||
126689365|NCT03529773|455817213|FG033|Overall Study|Screen Failure|0|||
126689366|NCT03529773|455817214|FG034|Overall Study|Screen Failure|0|||
126689367|NCT03529773|455817215|FG035|Overall Study|Screen Failure|0|||
126689368|NCT03529773|455817216|FG036|Overall Study|Screen Failure|1|||
126689369|NCT03529773|455817217|FG037|Overall Study|Screen Failure|1|||
126689370|NCT03529773|455817218|FG038|Overall Study|Screen Failure|0|||
126689371|NCT03529773|455817219|FG039|Overall Study|Screen Failure|1|||
126351920|NCT00700635|454578931|FG001|Overall Study|Protocol Violation|2|||
126351921|NCT00700635|454578932|FG002|Overall Study|Protocol Violation|0|||
126351922|NCT00700635|454578930|FG000|Overall Study|Withdrawal by Subject|7|||
126351923|NCT00700635|454578931|FG001|Overall Study|Withdrawal by Subject|3|||
126351924|NCT00700635|454578932|FG002|Overall Study|Withdrawal by Subject|1|||
126351925|NCT05172570|454578933|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
126351926|NCT05172570|454578934|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
126351927|NCT05172570|454578935|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
126351928|NCT05172570|454578933|FG000|Overall Study|PI Decision due to equipment shortages|0|||
126351929|NCT05172570|454578934|FG001|Overall Study|PI Decision due to equipment shortages|0|||
126351930|NCT05172570|454578935|FG002|Overall Study|PI Decision due to equipment shortages|1|||
126351931|NCT02872714|454578938|FG000|Overall Study|Progressive Disease|1|||
126351932|NCT02872714|454578939|FG001|Overall Study|Progressive Disease|2|||
126351933|NCT02872714|454578940|FG002|Overall Study|Progressive Disease|0|||
126351934|NCT02872714|454578941|FG003|Overall Study|Progressive Disease|0|||
126351935|NCT02872714|454578942|FG004|Overall Study|Progressive Disease|0|||
126351936|NCT02872714|454578938|FG000|Overall Study|Death|87|||
126351937|NCT02872714|454578939|FG001|Overall Study|Death|36|||
126351938|NCT02872714|454578940|FG002|Overall Study|Death|8|||
126351939|NCT02872714|454578941|FG003|Overall Study|Death|81|||
126351940|NCT02872714|454578942|FG004|Overall Study|Death|2|||
126351941|NCT02872714|454578938|FG000|Overall Study|Lost to Follow-up|2|||
126351942|NCT02872714|454578939|FG001|Overall Study|Lost to Follow-up|1|||
126351943|NCT02872714|454578940|FG002|Overall Study|Lost to Follow-up|0|||
126351944|NCT02872714|454578941|FG003|Overall Study|Lost to Follow-up|3|||
126351945|NCT02872714|454578942|FG004|Overall Study|Lost to Follow-up|0|||
126351946|NCT02872714|454578938|FG000|Overall Study|Physician Decision|0|||
126351947|NCT02872714|454578939|FG001|Overall Study|Physician Decision|0|||
126351948|NCT02872714|454578940|FG002|Overall Study|Physician Decision|0|||
126351949|NCT02872714|454578941|FG003|Overall Study|Physician Decision|1|||
126351950|NCT02872714|454578942|FG004|Overall Study|Physician Decision|0|||
126351951|NCT02872714|454578938|FG000|Overall Study|Withdrawal by Subject|1|||
126351952|NCT02872714|454578939|FG001|Overall Study|Withdrawal by Subject|3|||
126351953|NCT02872714|454578940|FG002|Overall Study|Withdrawal by Subject|0|||
126351954|NCT02872714|454578941|FG003|Overall Study|Withdrawal by Subject|2|||
126351955|NCT02872714|454578942|FG004|Overall Study|Withdrawal by Subject|0|||
126351956|NCT02872714|454578938|FG000|Overall Study|Captured as Other|2|||
126351957|NCT02872714|454578939|FG001|Overall Study|Captured as Other|0|||
126351958|NCT02872714|454578940|FG002|Overall Study|Captured as Other|0|||
126351959|NCT02872714|454578941|FG003|Overall Study|Captured as Other|1|||
126351960|NCT02872714|454578942|FG004|Overall Study|Captured as Other|0|||
126351961|NCT00980460|454578943|FG000|Overall Study|Death|0|||
126351962|NCT00980460|454578944|FG001|Overall Study|Death|0|||
126351963|NCT00980460|454578945|FG002|Overall Study|Death|1|||
126351964|NCT00980460|454578946|FG003|Overall Study|Death|2|||
126351965|NCT00980460|454578947|FG004|Overall Study|Death|1|||
126351966|NCT00980460|454578943|FG000|Overall Study|Lack of Efficacy|0|||
126351967|NCT00980460|454578944|FG001|Overall Study|Lack of Efficacy|0|||
126351968|NCT00980460|454578945|FG002|Overall Study|Lack of Efficacy|10|||
126351969|NCT00980460|454578946|FG003|Overall Study|Lack of Efficacy|6|||
126351970|NCT00980460|454578947|FG004|Overall Study|Lack of Efficacy|8|||
126689372|NCT03529773|455817180|FG000|Overall Study|Randomized but not vaccinated|0|||
126689373|NCT03529773|455817181|FG001|Overall Study|Randomized but not vaccinated|0|||
126689374|NCT03529773|455817182|FG002|Overall Study|Randomized but not vaccinated|0|||
126351971|NCT00980460|454578943|FG000|Overall Study|Lost to Follow-up|0|||
126351972|NCT00980460|454578944|FG001|Overall Study|Lost to Follow-up|0|||
126351973|NCT00980460|454578945|FG002|Overall Study|Lost to Follow-up|0|||
126351974|NCT00980460|454578946|FG003|Overall Study|Lost to Follow-up|1|||
126689375|NCT03529773|455817183|FG003|Overall Study|Randomized but not vaccinated|0|||
126351975|NCT00980460|454578947|FG004|Overall Study|Lost to Follow-up|0|||
126689376|NCT03529773|455817184|FG004|Overall Study|Randomized but not vaccinated|0|||
126351976|NCT00980460|454578943|FG000|Overall Study|Physician Decision|0|||
126351977|NCT00980460|454578944|FG001|Overall Study|Physician Decision|0|||
126351978|NCT00980460|454578945|FG002|Overall Study|Physician Decision|11|||
126351979|NCT00980460|454578946|FG003|Overall Study|Physician Decision|5|||
126351980|NCT00980460|454578947|FG004|Overall Study|Physician Decision|3|||
126351981|NCT00980460|454578943|FG000|Overall Study|Withdrawal by Subject|0|||
126351982|NCT00980460|454578944|FG001|Overall Study|Withdrawal by Subject|0|||
126351983|NCT00980460|454578945|FG002|Overall Study|Withdrawal by Subject|1|||
126351984|NCT00980460|454578946|FG003|Overall Study|Withdrawal by Subject|0|||
126351985|NCT00980460|454578947|FG004|Overall Study|Withdrawal by Subject|0|||
126351986|NCT00980460|454578943|FG000|Overall Study|Ineligible|0|||
126351987|NCT00980460|454578944|FG001|Overall Study|Ineligible|2|||
126351988|NCT00980460|454578945|FG002|Overall Study|Ineligible|3|||
126351989|NCT00980460|454578946|FG003|Overall Study|Ineligible|1|||
126351990|NCT00980460|454578947|FG004|Overall Study|Ineligible|4|||
126351991|NCT00980460|454578943|FG000|Overall Study|Refusal of further therapy|0|||
126351992|NCT00980460|454578944|FG001|Overall Study|Refusal of further therapy|2|||
126351993|NCT00980460|454578945|FG002|Overall Study|Refusal of further therapy|3|||
126351994|NCT00980460|454578946|FG003|Overall Study|Refusal of further therapy|2|||
126351995|NCT00980460|454578947|FG004|Overall Study|Refusal of further therapy|0|||
126351996|NCT00980460|454578943|FG000|Overall Study|No therapy within 42 days of resection|0|||
126351997|NCT00980460|454578944|FG001|Overall Study|No therapy within 42 days of resection|0|||
126351998|NCT00980460|454578945|FG002|Overall Study|No therapy within 42 days of resection|3|||
126351999|NCT00980460|454578946|FG003|Overall Study|No therapy within 42 days of resection|1|||
126352000|NCT00980460|454578947|FG004|Overall Study|No therapy within 42 days of resection|0|||
126352001|NCT00980460|454578943|FG000|Overall Study|No transplant by protocol timepoints|0|||
126440204|NCT00790842|454911325|FG009|Dose Level 2|Withdrawal by Subject|0|||
126440205|NCT00790842|454911326|FG010|Dose Level 2|Withdrawal by Subject|0|||
126440206|NCT00790842|454911316|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126440207|NCT00790842|454911317|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126440208|NCT00790842|454911318|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126440209|NCT00790842|454911319|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126440210|NCT00790842|454911320|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126440211|NCT00790842|454911321|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126440212|NCT00790842|454911322|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126440213|NCT00790842|454911323|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126440214|NCT00790842|454911324|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
126352002|NCT00980460|454578944|FG001|Overall Study|No transplant by protocol timepoints|0|||
126352003|NCT00980460|454578945|FG002|Overall Study|No transplant by protocol timepoints|3|||
126352004|NCT00980460|454578946|FG003|Overall Study|No transplant by protocol timepoints|0|||
126352005|NCT00980460|454578947|FG004|Overall Study|No transplant by protocol timepoints|0|||
126352006|NCT02008370|454579571|FG000|Overall Study|Lost to Follow-up|7|||
126352007|NCT01001104|454579576|FG000|Overall Study|Adverse Event|2|||
126352008|NCT01001104|454579577|FG001|Overall Study|Adverse Event|1|||
126352009|NCT01001104|454579578|FG002|Overall Study|Adverse Event|0|||
126352010|NCT01001104|454579579|FG003|Overall Study|Adverse Event|0|||
126352011|NCT01001104|454579576|FG000|Overall Study|Lost to Follow-up|0|||
126352012|NCT01001104|454579577|FG001|Overall Study|Lost to Follow-up|0|||
126352013|NCT01001104|454579578|FG002|Overall Study|Lost to Follow-up|1|||
126352014|NCT01001104|454579579|FG003|Overall Study|Lost to Follow-up|0|||
126352015|NCT01001104|454579576|FG000|Overall Study|Entry Criteria Not Met|0|||
126352016|NCT01001104|454579577|FG001|Overall Study|Entry Criteria Not Met|0|||
126352017|NCT01001104|454579578|FG002|Overall Study|Entry Criteria Not Met|0|||
126352018|NCT01001104|454579579|FG003|Overall Study|Entry Criteria Not Met|1|||
126352019|NCT01001104|454579576|FG000|Overall Study|Withdrawal by Subject|0|||
126352020|NCT01001104|454579577|FG001|Overall Study|Withdrawal by Subject|0|||
126352021|NCT01001104|454579578|FG002|Overall Study|Withdrawal by Subject|0|||
126352022|NCT01001104|454579579|FG003|Overall Study|Withdrawal by Subject|2|||
126352023|NCT02397837|454579581|FG000|Overall Study|Withdrawal by Subject|6|||
126352024|NCT02397837|454579582|FG001|Overall Study|Withdrawal by Subject|5|||
126352025|NCT02397837|454579581|FG000|Overall Study|Physician Decision|1|||
126352026|NCT02397837|454579582|FG001|Overall Study|Physician Decision|1|||
126352027|NCT00599313|454579583|FG000|Overall Study|Adverse Event|19|||
126352028|NCT00599313|454579583|FG000|Overall Study|Disease Progression|12|||
126352029|NCT00599313|454579583|FG000|Overall Study|Patient Request|4|||
126352030|NCT00599313|454579583|FG000|Overall Study|Ineligible|1|||
126352031|NCT02536794|454579584|FG000|Reached 1st Response Assessment|Adverse Event|2|||
126352032|NCT02536794|454579584|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
126352033|NCT02536794|454579584|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
126352034|NCT02536794|454579584|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
126352035|NCT02536794|454579584|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
126352036|NCT02536794|454579584|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
126352037|NCT01496456|454579591|FG000|Overall Study|Protocol Violation|1|||
126352038|NCT01496456|454579591|FG000|Overall Study|Lost to Follow-up|7|||
126352039|NCT01695746|454579594|FG000|Overall Study|Adverse Event|1|||
126352040|NCT01695746|454579594|FG000|Overall Study|Non-compliance by the participant|3|||
126352041|NCT01695746|454579594|FG000|Overall Study|Protocol Violation|5|||
126352042|NCT01695746|454579594|FG000|Overall Study|Participant not willing to participate|3|||
126352043|NCT01202591|454579596|FG000|Overall Study|Adverse Event|2|||
126352044|NCT01202591|454579597|FG001|Overall Study|Adverse Event|1|||
126352045|NCT01202591|454579598|FG002|Overall Study|Adverse Event|4|||
126352046|NCT01202591|454579599|FG003|Overall Study|Adverse Event|4|||
126352047|NCT01202591|454579600|FG004|Overall Study|Adverse Event|0|||
126689377|NCT03529773|455817185|FG005|Overall Study|Randomized but not vaccinated|0|||
126689378|NCT03529773|455817186|FG006|Overall Study|Randomized but not vaccinated|0|||
126689379|NCT03529773|455817187|FG007|Overall Study|Randomized but not vaccinated|0|||
126689380|NCT03529773|455817188|FG008|Overall Study|Randomized but not vaccinated|0|||
126689381|NCT03529773|455817189|FG009|Overall Study|Randomized but not vaccinated|0|||
126352048|NCT01202591|454579601|FG005|Overall Study|Adverse Event|0|||
126352049|NCT01202591|454579596|FG000|Overall Study|Other reason as per investigator|3|||
126352050|NCT01202591|454579597|FG001|Overall Study|Other reason as per investigator|4|||
126352051|NCT01202591|454579598|FG002|Overall Study|Other reason as per investigator|7|||
126352052|NCT01202591|454579599|FG003|Overall Study|Other reason as per investigator|3|||
126352053|NCT01202591|454579600|FG004|Overall Study|Other reason as per investigator|1|||
126352054|NCT01202591|454579601|FG005|Overall Study|Other reason as per investigator|3|||
126689382|NCT03529773|455817190|FG010|Overall Study|Randomized but not vaccinated|0|||
126440215|NCT00790842|454911325|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126440216|NCT00790842|454911326|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
126440217|NCT00790842|454911316|FG000|Dose Level 3|Adverse Event|0|||
126440218|NCT00790842|454911317|FG001|Dose Level 3|Adverse Event|0|||
126440219|NCT00790842|454911318|FG002|Dose Level 3|Adverse Event|1|||
126440220|NCT00790842|454911319|FG003|Dose Level 3|Adverse Event|0|||
126440221|NCT00790842|454911320|FG004|Dose Level 3|Adverse Event|0|||
126689383|NCT03529773|455817191|FG011|Overall Study|Randomized but not vaccinated|0|||
126689384|NCT03529773|455817192|FG012|Overall Study|Randomized but not vaccinated|0|||
126689385|NCT03529773|455817193|FG013|Overall Study|Randomized but not vaccinated|0|||
126689386|NCT03529773|455817194|FG014|Overall Study|Randomized but not vaccinated|0|||
126689387|NCT03529773|455817195|FG015|Overall Study|Randomized but not vaccinated|0|||
126440222|NCT00790842|454911321|FG005|Dose Level 3|Adverse Event|0|||
126440223|NCT00790842|454911322|FG006|Dose Level 3|Adverse Event|0|||
126440224|NCT00790842|454911323|FG007|Dose Level 3|Adverse Event|0|||
126440225|NCT00790842|454911324|FG008|Dose Level 3|Adverse Event|0|||
126440226|NCT00790842|454911325|FG009|Dose Level 3|Adverse Event|0|||
126440227|NCT00790842|454911326|FG010|Dose Level 3|Adverse Event|0|||
126440228|NCT00790842|454911316|FG000|Dose Level 3|Withdrawal by Subject|0|||
126440229|NCT00790842|454911317|FG001|Dose Level 3|Withdrawal by Subject|0|||
126440230|NCT00790842|454911318|FG002|Dose Level 3|Withdrawal by Subject|3|||
126440231|NCT00790842|454911319|FG003|Dose Level 3|Withdrawal by Subject|0|||
126440232|NCT00790842|454911320|FG004|Dose Level 3|Withdrawal by Subject|0|||
126440233|NCT00790842|454911321|FG005|Dose Level 3|Withdrawal by Subject|0|||
126440234|NCT00790842|454911322|FG006|Dose Level 3|Withdrawal by Subject|0|||
126440235|NCT00790842|454911323|FG007|Dose Level 3|Withdrawal by Subject|0|||
126440236|NCT00790842|454911324|FG008|Dose Level 3|Withdrawal by Subject|0|||
126440237|NCT00790842|454911325|FG009|Dose Level 3|Withdrawal by Subject|2|||
126689388|NCT03529773|455817196|FG016|Overall Study|Randomized but not vaccinated|0|||
126440238|NCT00790842|454911326|FG010|Dose Level 3|Withdrawal by Subject|0|||
126689389|NCT03529773|455817197|FG017|Overall Study|Randomized but not vaccinated|1|||
126440239|NCT00790842|454911316|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
126440240|NCT00790842|454911317|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
126545397|NCT02541383|455290827|FG004|Overall Study|Consent withdrawn|0|||
126352055|NCT01202591|454579596|FG000|Overall Study|Withdrawal by Subject|0|||
126352056|NCT01202591|454579597|FG001|Overall Study|Withdrawal by Subject|0|||
126352057|NCT01202591|454579598|FG002|Overall Study|Withdrawal by Subject|0|||
126352058|NCT01202591|454579599|FG003|Overall Study|Withdrawal by Subject|0|||
126352059|NCT01202591|454579600|FG004|Overall Study|Withdrawal by Subject|2|||
126352060|NCT01202591|454579601|FG005|Overall Study|Withdrawal by Subject|1|||
126352061|NCT01202591|454579596|FG000|Overall Study|Objective Disease Progression|0|||
126352062|NCT01202591|454579597|FG001|Overall Study|Objective Disease Progression|0|||
126352063|NCT01202591|454579598|FG002|Overall Study|Objective Disease Progression|0|||
126440241|NCT00790842|454911318|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
126440242|NCT00790842|454911319|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
126352064|NCT01202591|454579599|FG003|Overall Study|Objective Disease Progression|0|||
126352065|NCT01202591|454579600|FG004|Overall Study|Objective Disease Progression|2|||
126440243|NCT00790842|454911320|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
126440244|NCT00790842|454911321|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
126440245|NCT00790842|454911322|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
126440246|NCT00790842|454911323|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
126440247|NCT00790842|454911324|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
126440248|NCT00790842|454911325|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
126440249|NCT00790842|454911326|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
126440250|NCT00790842|454911316|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
126440251|NCT00790842|454911317|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
126352066|NCT01202591|454579601|FG005|Overall Study|Objective Disease Progression|0|||
126352067|NCT02830087|454579604|FG000|Overall Study|No study staff to follow-up patients|4|||
126352068|NCT02830087|454579605|FG001|Overall Study|No study staff to follow-up patients|4|||
126352069|NCT02830087|454579606|FG002|Overall Study|No study staff to follow-up patients|4|||
126352070|NCT02830087|454579607|FG003|Overall Study|No study staff to follow-up patients|3|||
126352071|NCT02830087|454579608|FG004|Overall Study|No study staff to follow-up patients|3|||
126352072|NCT02830087|454579609|FG005|Overall Study|No study staff to follow-up patients|3|||
126352073|NCT02583269|454579610|FG000|Overall Study|Patient hospitalized prior to start|1|||
126352074|NCT02583269|454579611|FG001|Overall Study|Patient hospitalized prior to start|0|||
126352075|NCT02583269|454579612|FG002|Overall Study|Patient hospitalized prior to start|0|||
126440252|NCT00790842|454911318|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
126440253|NCT00790842|454911319|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
126440254|NCT00790842|454911320|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
126440255|NCT00790842|454911321|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
126689390|NCT03529773|455817198|FG018|Overall Study|Randomized but not vaccinated|0|||
126689391|NCT03529773|455817199|FG019|Overall Study|Randomized but not vaccinated|0|||
126689392|NCT03529773|455817200|FG020|Overall Study|Randomized but not vaccinated|0|||
126689393|NCT03529773|455817201|FG021|Overall Study|Randomized but not vaccinated|0|||
126440256|NCT00790842|454911322|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
126689394|NCT03529773|455817202|FG022|Overall Study|Randomized but not vaccinated|0|||
126689395|NCT03529773|455817203|FG023|Overall Study|Randomized but not vaccinated|0|||
126352076|NCT02583269|454579613|FG003|Overall Study|Patient hospitalized prior to start|0|||
126352077|NCT02583269|454579614|FG004|Overall Study|Patient hospitalized prior to start|0|||
126352078|NCT03611946|454579618|FG000|Overall Study|Withdrawal by Subject|0|||
126352079|NCT03611946|454579619|FG001|Overall Study|Withdrawal by Subject|0|||
126352080|NCT03611946|454579620|FG002|Overall Study|Withdrawal by Subject|1|||
126689396|NCT03529773|455817204|FG024|Overall Study|Randomized but not vaccinated|0|||
126352081|NCT03611946|454579621|FG003|Overall Study|Withdrawal by Subject|0|||
126689397|NCT03529773|455817205|FG025|Overall Study|Randomized but not vaccinated|0|||
126689398|NCT03529773|455817206|FG026|Overall Study|Randomized but not vaccinated|0|||
126352082|NCT02207608|454579625|FG000|Overall Study|Adverse Event|1|||
126689399|NCT03529773|455817207|FG027|Overall Study|Randomized but not vaccinated|1|||
126440257|NCT00790842|454911323|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
126440258|NCT00790842|454911324|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
126440259|NCT00790842|454911325|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
126440260|NCT00790842|454911326|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
126440261|NCT00790842|454911316|FG000|Dose Level 4|Adverse Event|0|||
126440262|NCT00790842|454911317|FG001|Dose Level 4|Adverse Event|0|||
126440263|NCT00790842|454911318|FG002|Dose Level 4|Adverse Event|0|||
126440264|NCT00790842|454911319|FG003|Dose Level 4|Adverse Event|0|||
126440265|NCT00790842|454911320|FG004|Dose Level 4|Adverse Event|0|||
126440266|NCT00790842|454911321|FG005|Dose Level 4|Adverse Event|0|||
126440267|NCT00790842|454911322|FG006|Dose Level 4|Adverse Event|1|||
126440268|NCT00790842|454911323|FG007|Dose Level 4|Adverse Event|0|||
126440269|NCT00790842|454911324|FG008|Dose Level 4|Adverse Event|0|||
126440270|NCT00790842|454911325|FG009|Dose Level 4|Adverse Event|0|||
126440271|NCT00790842|454911326|FG010|Dose Level 4|Adverse Event|0|||
126440272|NCT00790842|454911316|FG000|Dose Level 4|Physician Decision|0|||
126440273|NCT00790842|454911317|FG001|Dose Level 4|Physician Decision|0|||
126440274|NCT00790842|454911318|FG002|Dose Level 4|Physician Decision|0|||
126440275|NCT00790842|454911319|FG003|Dose Level 4|Physician Decision|0|||
126440276|NCT00790842|454911320|FG004|Dose Level 4|Physician Decision|0|||
126440277|NCT00790842|454911321|FG005|Dose Level 4|Physician Decision|0|||
126440278|NCT00790842|454911322|FG006|Dose Level 4|Physician Decision|1|||
126440279|NCT00790842|454911323|FG007|Dose Level 4|Physician Decision|0|||
126440280|NCT00790842|454911324|FG008|Dose Level 4|Physician Decision|0|||
126689400|NCT03529773|455817208|FG028|Overall Study|Randomized but not vaccinated|0|||
126689401|NCT03529773|455817209|FG029|Overall Study|Randomized but not vaccinated|0|||
126440281|NCT00790842|454911325|FG009|Dose Level 4|Physician Decision|0|||
126440282|NCT00790842|454911326|FG010|Dose Level 4|Physician Decision|1|||
126440283|NCT00790842|454911316|FG000|Dose Level 4|Withdrawal by Subject|0|||
126440284|NCT00790842|454911317|FG001|Dose Level 4|Withdrawal by Subject|0|||
126440285|NCT00790842|454911318|FG002|Dose Level 4|Withdrawal by Subject|0|||
126440286|NCT00790842|454911319|FG003|Dose Level 4|Withdrawal by Subject|0|||
126440287|NCT00790842|454911320|FG004|Dose Level 4|Withdrawal by Subject|0|||
126440288|NCT00790842|454911321|FG005|Dose Level 4|Withdrawal by Subject|0|||
126440289|NCT00790842|454911322|FG006|Dose Level 4|Withdrawal by Subject|0|||
126352083|NCT02207608|454579626|FG001|Overall Study|Adverse Event|0|||
126352084|NCT03580928|454579630|FG000|Overall Study|Death|0|||
126352085|NCT03580928|454579631|FG001|Overall Study|Death|3|||
126352086|NCT03580928|454579630|FG000|Overall Study|Withdrawal by Subject|2|||
126352087|NCT03580928|454579631|FG001|Overall Study|Withdrawal by Subject|1|||
126352088|NCT03580928|454579630|FG000|Overall Study|Lost to Follow-up|2|||
126352089|NCT03580928|454579631|FG001|Overall Study|Lost to Follow-up|0|||
126352090|NCT03580928|454579630|FG000|Overall Study|Progressive Disease|0|||
126352091|NCT03580928|454579631|FG001|Overall Study|Progressive Disease|1|||
126352092|NCT05800145|454579632|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
126352093|NCT05800145|454579633|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126352094|NCT05800145|454579634|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126352095|NCT05800145|454579635|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
126352096|NCT05800145|454579636|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126440290|NCT00790842|454911323|FG007|Dose Level 4|Withdrawal by Subject|0|||
126440291|NCT00790842|454911324|FG008|Dose Level 4|Withdrawal by Subject|0|||
126440292|NCT00790842|454911325|FG009|Dose Level 4|Withdrawal by Subject|0|||
126440293|NCT00790842|454911326|FG010|Dose Level 4|Withdrawal by Subject|1|||
126440294|NCT00790842|454911316|FG000|Expansion Cohort|Adverse Event|0|||
126440295|NCT00790842|454911317|FG001|Expansion Cohort|Adverse Event|0|||
126760156|NCT00920582|456072403|FG001|Overall Study|Lost to Follow-up|1|||
126760157|NCT00920582|456072404|FG002|Overall Study|Lost to Follow-up|2|||
126760158|NCT00920582|456072405|FG003|Overall Study|Lost to Follow-up|0|||
126760159|NCT00920582|456072402|FG000|Overall Study|Withdrawal by Subject|5|||
126760160|NCT00920582|456072403|FG001|Overall Study|Withdrawal by Subject|4|||
126760161|NCT00920582|456072404|FG002|Overall Study|Withdrawal by Subject|6|||
126760162|NCT00920582|456072405|FG003|Overall Study|Withdrawal by Subject|3|||
126760163|NCT00920582|456072402|FG000|Overall Study|Protocol Violation|1|||
126760164|NCT00920582|456072403|FG001|Overall Study|Protocol Violation|0|||
126760165|NCT00920582|456072404|FG002|Overall Study|Protocol Violation|0|||
126760166|NCT00920582|456072405|FG003|Overall Study|Protocol Violation|0|||
126760167|NCT00920582|456072402|FG000|Overall Study|Other|2|||
126440296|NCT00790842|454911318|FG002|Expansion Cohort|Adverse Event|0|||
126440297|NCT00790842|454911319|FG003|Expansion Cohort|Adverse Event|0|||
126760168|NCT00920582|456072403|FG001|Overall Study|Other|1|||
126760169|NCT00920582|456072404|FG002|Overall Study|Other|3|||
126760170|NCT00920582|456072405|FG003|Overall Study|Other|2|||
126760171|NCT04652245|456072411|FG000|Wash-Out Period|Adverse Event|0|||
126440298|NCT00790842|454911320|FG004|Expansion Cohort|Adverse Event|0|||
126760172|NCT04652245|456072412|FG001|Wash-Out Period|Adverse Event|2|||
126760173|NCT04652245|456072411|FG000|Wash-Out Period|Withdrawal by Subject|0|||
126440299|NCT00790842|454911321|FG005|Expansion Cohort|Adverse Event|0|||
126440300|NCT00790842|454911322|FG006|Expansion Cohort|Adverse Event|1|||
126440301|NCT00790842|454911323|FG007|Expansion Cohort|Adverse Event|0|||
126440302|NCT00790842|454911324|FG008|Expansion Cohort|Adverse Event|0|||
126440303|NCT00790842|454911325|FG009|Expansion Cohort|Adverse Event|0|||
126440304|NCT00790842|454911326|FG010|Expansion Cohort|Adverse Event|0|||
126440305|NCT00790842|454911316|FG000|Expansion Cohort|Death|0|||
126440306|NCT00790842|454911317|FG001|Expansion Cohort|Death|0|||
126440307|NCT00790842|454911318|FG002|Expansion Cohort|Death|2|||
126440308|NCT00790842|454911319|FG003|Expansion Cohort|Death|0|||
126440309|NCT00790842|454911320|FG004|Expansion Cohort|Death|0|||
126440310|NCT00790842|454911321|FG005|Expansion Cohort|Death|0|||
126440311|NCT00790842|454911322|FG006|Expansion Cohort|Death|0|||
126440312|NCT00790842|454911323|FG007|Expansion Cohort|Death|0|||
126440313|NCT00790842|454911324|FG008|Expansion Cohort|Death|0|||
126440314|NCT00790842|454911325|FG009|Expansion Cohort|Death|0|||
126440315|NCT00790842|454911326|FG010|Expansion Cohort|Death|0|||
126440316|NCT00790842|454911316|FG000|Expansion Cohort|Physician Decision|0|||
126440317|NCT00790842|454911317|FG001|Expansion Cohort|Physician Decision|0|||
126440318|NCT00790842|454911318|FG002|Expansion Cohort|Physician Decision|1|||
126440319|NCT00790842|454911319|FG003|Expansion Cohort|Physician Decision|0|||
126440320|NCT00790842|454911320|FG004|Expansion Cohort|Physician Decision|0|||
126440321|NCT00790842|454911321|FG005|Expansion Cohort|Physician Decision|0|||
126440322|NCT00790842|454911322|FG006|Expansion Cohort|Physician Decision|0|||
126440323|NCT00790842|454911323|FG007|Expansion Cohort|Physician Decision|0|||
126440324|NCT00790842|454911324|FG008|Expansion Cohort|Physician Decision|0|||
126440325|NCT00790842|454911325|FG009|Expansion Cohort|Physician Decision|0|||
126440326|NCT00790842|454911326|FG010|Expansion Cohort|Physician Decision|0|||
126440327|NCT00790842|454911316|FG000|Expansion Cohort|Withdrawal by Subject|0|||
126440328|NCT00790842|454911317|FG001|Expansion Cohort|Withdrawal by Subject|0|||
126440329|NCT00790842|454911318|FG002|Expansion Cohort|Withdrawal by Subject|3|||
126440330|NCT00790842|454911319|FG003|Expansion Cohort|Withdrawal by Subject|0|||
126440331|NCT00790842|454911320|FG004|Expansion Cohort|Withdrawal by Subject|0|||
126440332|NCT00790842|454911321|FG005|Expansion Cohort|Withdrawal by Subject|0|||
126440333|NCT00790842|454911322|FG006|Expansion Cohort|Withdrawal by Subject|0|||
126440334|NCT00790842|454911323|FG007|Expansion Cohort|Withdrawal by Subject|0|||
126440335|NCT00790842|454911324|FG008|Expansion Cohort|Withdrawal by Subject|0|||
126440336|NCT00790842|454911325|FG009|Expansion Cohort|Withdrawal by Subject|0|||
126440337|NCT00790842|454911326|FG010|Expansion Cohort|Withdrawal by Subject|0|||
126440338|NCT00790842|454911316|FG000|Expansion Cohort|Study Closure|0|||
126440339|NCT00790842|454911317|FG001|Expansion Cohort|Study Closure|0|||
126440340|NCT00790842|454911318|FG002|Expansion Cohort|Study Closure|1|||
126440341|NCT00790842|454911319|FG003|Expansion Cohort|Study Closure|0|||
126440342|NCT00790842|454911320|FG004|Expansion Cohort|Study Closure|0|||
126440343|NCT00790842|454911321|FG005|Expansion Cohort|Study Closure|0|||
126440344|NCT00790842|454911322|FG006|Expansion Cohort|Study Closure|0|||
126440345|NCT00790842|454911323|FG007|Expansion Cohort|Study Closure|0|||
126440346|NCT00790842|454911324|FG008|Expansion Cohort|Study Closure|0|||
126440347|NCT00790842|454911325|FG009|Expansion Cohort|Study Closure|0|||
126440348|NCT00790842|454911326|FG010|Expansion Cohort|Study Closure|0|||
126440349|NCT00724698|454911327|FG000|Overall Study|Adverse Event|9|||
126689402|NCT03529773|455817210|FG030|Overall Study|Randomized but not vaccinated|0|||
126689403|NCT03529773|455817211|FG031|Overall Study|Randomized but not vaccinated|0|||
126689404|NCT03529773|455817212|FG032|Overall Study|Randomized but not vaccinated|0|||
126689405|NCT03529773|455817213|FG033|Overall Study|Randomized but not vaccinated|0|||
126689406|NCT03529773|455817214|FG034|Overall Study|Randomized but not vaccinated|0|||
126689407|NCT03529773|455817215|FG035|Overall Study|Randomized but not vaccinated|0|||
126440350|NCT00724698|454911327|FG000|Overall Study|Failure of Therapy|4|||
126440351|NCT00724698|454911327|FG000|Overall Study|Poor Compliance|16|||
126440352|NCT00724698|454911327|FG000|Overall Study|Lost to Follow-up|36|||
126440353|NCT00724698|454911327|FG000|Overall Study|No Info|25|||
126440354|NCT05021978|454911328|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
126545398|NCT02541383|455290828|FG005|Overall Study|Consent withdrawn|0|||
126352097|NCT05800145|454579637|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126352098|NCT05800145|454579632|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
126352099|NCT05800145|454579633|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
126352100|NCT05800145|454579634|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
126352101|NCT05800145|454579635|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
126352102|NCT05800145|454579636|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
126352103|NCT05800145|454579637|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
126352104|NCT05800145|454579632|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
126352105|NCT05800145|454579633|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
126760174|NCT04652245|456072412|FG001|Wash-Out Period|Withdrawal by Subject|2|||
126760175|NCT04419558|456072415|FG000|DB Period (48 Weeks)|Adverse Event|6|||
126352106|NCT05800145|454579634|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
126352107|NCT05800145|454579635|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
126352108|NCT05800145|454579636|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
126352109|NCT05800145|454579637|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
126352110|NCT02850406|454579638|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352111|NCT02850406|454579639|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352112|NCT02850406|454579640|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352113|NCT02850406|454579641|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
126352114|NCT02850406|454579642|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352115|NCT02850406|454579643|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352116|NCT02850406|454579644|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352117|NCT02850406|454579645|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
126352118|NCT02850406|454579638|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
126689408|NCT03529773|455817216|FG036|Overall Study|Randomized but not vaccinated|0|||
126689409|NCT03529773|455817217|FG037|Overall Study|Randomized but not vaccinated|0|||
126689410|NCT03529773|455817218|FG038|Overall Study|Randomized but not vaccinated|0|||
126689411|NCT03529773|455817219|FG039|Overall Study|Randomized but not vaccinated|0|||
126352119|NCT02850406|454579639|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
126352120|NCT02850406|454579640|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
126352121|NCT02850406|454579641|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
126352122|NCT02850406|454579642|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
126352123|NCT02850406|454579643|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
126352124|NCT02850406|454579644|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
126352125|NCT02850406|454579645|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
126352126|NCT02850406|454579638|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126352127|NCT02850406|454579639|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126352128|NCT02850406|454579640|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
126352129|NCT02850406|454579641|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126352130|NCT02850406|454579642|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126352131|NCT02850406|454579643|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126352132|NCT02850406|454579644|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126352133|NCT02850406|454579645|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
126352134|NCT02850406|454579638|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
126352135|NCT02850406|454579639|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
126352136|NCT02850406|454579640|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
126352137|NCT02850406|454579641|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
126352138|NCT02850406|454579642|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
126352139|NCT02850406|454579643|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
126306162|NCT03689374|454408910|FG000|Treatment Period (Week 0 to 52)|Death|0|||
126306163|NCT03689374|454408911|FG001|Treatment Period (Week 0 to 52)|Death|11|||
126306164|NCT03689374|454408912|FG002|Treatment Period (Week 0 to 52)|Death|1|||
126306165|NCT00078767|454410213|FG000|Overall Study|Withdrawal by Subject|1|||
126306166|NCT00078767|454410214|FG001|Overall Study|Withdrawal by Subject|1|||
126306167|NCT02282631|454410215|FG000|Overall Study|Lost to Follow-up|2|||
126306168|NCT02282631|454410216|FG001|Overall Study|Lost to Follow-up|0|||
126306169|NCT00831311|454410217|FG000|Overall Study|Definitive Contraindication|3|||
126306170|NCT00831311|454410218|FG001|Overall Study|Definitive Contraindication|3|||
126306171|NCT00831311|454410217|FG000|Overall Study|Lost to Follow-up|3|||
126306172|NCT00831311|454410218|FG001|Overall Study|Lost to Follow-up|0|||
126306173|NCT00831311|454410217|FG000|Overall Study|Physician Decision|0|||
126306174|NCT00831311|454410218|FG001|Overall Study|Physician Decision|1|||
126306175|NCT00831311|454410217|FG000|Overall Study|Withdrawal by Subject|6|||
126306176|NCT00831311|454410218|FG001|Overall Study|Withdrawal by Subject|4|||
126306177|NCT01841762|454410220|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
126306178|NCT01841762|454410220|FG000|Treatment Period|Adverse Event|16|||
126306179|NCT01841762|454410220|FG000|Treatment Period|Death|1|||
126306180|NCT01841762|454410220|FG000|Treatment Period|Withdrawal by Subject|7|||
126306181|NCT01841762|454410220|FG000|Treatment Period|Lost to Follow-up|1|||
126306182|NCT01841762|454410220|FG000|Treatment Period|Physician Decision|2|||
126306183|NCT01841762|454410220|FG000|Treatment Period|Other, including non-compliance|5|||
126306184|NCT01841762|454410220|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
126306185|NCT01841762|454410220|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
126352140|NCT02850406|454579644|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
126352141|NCT02850406|454579645|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
126440355|NCT05021978|454911329|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
126440356|NCT05021978|454911330|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
126440357|NCT05021978|454911331|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
126440358|NCT05021978|454911328|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
126689412|NCT01340209|455817220|FG000|Overall Study|Adverse Event|1|||
126689413|NCT01340209|455817221|FG001|Overall Study|Adverse Event|1|||
126689414|NCT01340209|455817222|FG002|Overall Study|Adverse Event|2|||
126689415|NCT01340209|455817220|FG000|Overall Study|Protocol Violation|1|||
126689416|NCT01340209|455817221|FG001|Overall Study|Protocol Violation|2|||
126689417|NCT01340209|455817222|FG002|Overall Study|Protocol Violation|1|||
126689418|NCT01340209|455817220|FG000|Overall Study|Withdrawal by Subject|0|||
126306186|NCT01841762|454410220|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
126306187|NCT01841762|454410220|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
126306188|NCT03260244|454410221|FG000|Overall Study|Death|19|||
126306189|NCT03260244|454410221|FG000|Overall Study|Lost to Follow-up|60|||
126306190|NCT03260244|454410221|FG000|Overall Study|Withdrawal by Subject|48|||
126440359|NCT05021978|454911329|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
126306191|NCT03260244|454410221|FG000|Overall Study|Procedure Not Performed|21|||
126352142|NCT02850406|454579638|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
126689419|NCT01340209|455817221|FG001|Overall Study|Withdrawal by Subject|0|||
126352143|NCT02850406|454579639|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
126352144|NCT02850406|454579640|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
126352145|NCT02850406|454579641|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
126352146|NCT02850406|454579642|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
126352147|NCT02850406|454579643|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
126352148|NCT02850406|454579644|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
126352149|NCT02850406|454579645|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
126352150|NCT02850406|454579638|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352151|NCT02850406|454579639|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352152|NCT02850406|454579640|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352153|NCT02850406|454579641|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352154|NCT02850406|454579642|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
126352155|NCT02850406|454579643|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
126352156|NCT02850406|454579644|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352157|NCT02850406|454579645|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352158|NCT02850406|454579638|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352159|NCT02850406|454579639|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352160|NCT02850406|454579640|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352161|NCT02850406|454579641|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352162|NCT02850406|454579642|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
126352163|NCT02850406|454579643|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352164|NCT02850406|454579644|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352165|NCT02850406|454579645|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
126352166|NCT02850406|454579638|FG000|Part C (Up to 52 Weeks)|Other|0|||
126352167|NCT02850406|454579639|FG001|Part C (Up to 52 Weeks)|Other|0|||
126352168|NCT02850406|454579640|FG002|Part C (Up to 52 Weeks)|Other|0|||
126352169|NCT02850406|454579641|FG003|Part C (Up to 52 Weeks)|Other|0|||
126440360|NCT05021978|454911330|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
126440361|NCT05021978|454911331|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
126440362|NCT02177032|454911334|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
126440363|NCT02177032|454911335|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
126440364|NCT02177032|454911336|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
126689420|NCT01340209|455817222|FG002|Overall Study|Withdrawal by Subject|1|||
126689421|NCT01340209|455817220|FG000|Overall Study|Other reason not defined above|3|||
126689422|NCT01340209|455817221|FG001|Overall Study|Other reason not defined above|5|||
126689423|NCT01340209|455817222|FG002|Overall Study|Other reason not defined above|4|||
126352170|NCT02850406|454579642|FG004|Part C (Up to 52 Weeks)|Other|1|||
126352171|NCT02850406|454579643|FG005|Part C (Up to 52 Weeks)|Other|3|||
126352172|NCT02850406|454579644|FG006|Part C (Up to 52 Weeks)|Other|0|||
126689424|NCT01537211|455817223|FG000|Overall Study|Lost to Follow-up|0|||
126352173|NCT02850406|454579645|FG007|Part C (Up to 52 Weeks)|Other|0|||
126352174|NCT02850406|454579638|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
126352175|NCT02850406|454579639|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
126352176|NCT02850406|454579640|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
126352177|NCT02850406|454579641|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
126352178|NCT02850406|454579642|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
126352179|NCT02850406|454579643|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
126352180|NCT02850406|454579644|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
126352181|NCT02850406|454579645|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
126352182|NCT02850406|454579638|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352183|NCT02850406|454579639|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352184|NCT02850406|454579640|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352185|NCT02850406|454579641|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352186|NCT02850406|454579642|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352187|NCT02850406|454579643|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352188|NCT02850406|454579644|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
126352189|NCT02850406|454579645|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
126352190|NCT02850406|454579638|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
126352191|NCT02850406|454579639|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
126352192|NCT02850406|454579640|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
126352193|NCT02850406|454579641|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
126352194|NCT02850406|454579642|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
126352195|NCT02850406|454579643|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
126352196|NCT02850406|454579644|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
126352197|NCT02850406|454579645|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
126352198|NCT02850406|454579638|FG000|Part D (Up to 52 Weeks)|Other|0|||
126352199|NCT02850406|454579639|FG001|Part D (Up to 52 Weeks)|Other|0|||
126352200|NCT02850406|454579640|FG002|Part D (Up to 52 Weeks)|Other|0|||
126352201|NCT02850406|454579641|FG003|Part D (Up to 52 Weeks)|Other|0|||
126352202|NCT02850406|454579642|FG004|Part D (Up to 52 Weeks)|Other|0|||
126352203|NCT02850406|454579643|FG005|Part D (Up to 52 Weeks)|Other|0|||
126352204|NCT02850406|454579644|FG006|Part D (Up to 52 Weeks)|Other|0|||
126352205|NCT02850406|454579645|FG007|Part D (Up to 52 Weeks)|Other|1|||
126352206|NCT04167670|454580665|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
126352207|NCT04167670|454580666|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
126352208|NCT04167670|454580667|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
126352209|NCT04167670|454580665|FG000|Overall Study|Significant protocol deviation|3|||
126352210|NCT04167670|454580666|FG001|Overall Study|Significant protocol deviation|1|||
126352211|NCT04167670|454580667|FG002|Overall Study|Significant protocol deviation|0|||
126440365|NCT02177032|454911337|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
126440366|NCT02177032|454911334|FG000|Overall Study|Lost to Follow-up|0|||
126440367|NCT02177032|454911335|FG001|Overall Study|Lost to Follow-up|2|||
126440368|NCT02177032|454911336|FG002|Overall Study|Lost to Follow-up|0|||
126440369|NCT02177032|454911337|FG003|Overall Study|Lost to Follow-up|0|||
126440370|NCT02177032|454911334|FG000|Overall Study|OTHER|2|||
126440371|NCT02177032|454911335|FG001|Overall Study|OTHER|0|||
126440372|NCT02177032|454911336|FG002|Overall Study|OTHER|1|||
126440373|NCT02177032|454911337|FG003|Overall Study|OTHER|0|||
126440374|NCT02177032|454911334|FG000|Overall Study|Withdrawal by Subject|1|||
126440375|NCT02177032|454911335|FG001|Overall Study|Withdrawal by Subject|0|||
126440376|NCT02177032|454911336|FG002|Overall Study|Withdrawal by Subject|1|||
126440377|NCT02177032|454911337|FG003|Overall Study|Withdrawal by Subject|0|||
126440378|NCT00665652|454911338|FG000|Overall Study|Adverse Event|4|||
126440379|NCT00665652|454911338|FG000|Overall Study|Death|1|||
126440380|NCT00665652|454911338|FG000|Overall Study|No longer met inclusion criteria.|1|||
126440381|NCT02556177|454911341|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
126440382|NCT02556177|454911342|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
126440383|NCT02558296|454911348|FG000|Completed the Study Through Week 24|Adverse Event|9|||
126440384|NCT02558296|454911349|FG001|Completed the Study Through Week 24|Adverse Event|3|||
126440385|NCT02558296|454911348|FG000|Completed the Study Through Week 24|Death|7|||
126440386|NCT02558296|454911349|FG001|Completed the Study Through Week 24|Death|7|||
126440387|NCT02558296|454911348|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
126440388|NCT02558296|454911349|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
126440389|NCT02558296|454911348|FG000|Completed the Study Through Week 24|Physician Decision|1|||
126440390|NCT02558296|454911349|FG001|Completed the Study Through Week 24|Physician Decision|0|||
126440391|NCT02558296|454911348|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
126440392|NCT02558296|454911349|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
126440393|NCT02558296|454911348|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
126440394|NCT02558296|454911349|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
126440395|NCT02558296|454911348|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
126440396|NCT02558296|454911349|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
126440397|NCT02558296|454911348|FG000|Completed the Study|Adverse Event|14|||
126440398|NCT02558296|454911349|FG001|Completed the Study|Adverse Event|5|||
126440399|NCT02558296|454911348|FG000|Completed the Study|Death|39|||
126440400|NCT02558296|454911349|FG001|Completed the Study|Death|25|||
126440401|NCT02558296|454911348|FG000|Completed the Study|Lost to Follow-up|31|||
126440402|NCT02558296|454911349|FG001|Completed the Study|Lost to Follow-up|23|||
126440403|NCT02558296|454911348|FG000|Completed the Study|Physician Decision|6|||
126440404|NCT02558296|454911349|FG001|Completed the Study|Physician Decision|0|||
126440405|NCT02558296|454911348|FG000|Completed the Study|Protocol Violation|2|||
126440406|NCT02558296|454911349|FG001|Completed the Study|Protocol Violation|1|||
126440407|NCT02558296|454911348|FG000|Completed the Study|Withdrawal by Subject|53|||
126440408|NCT02558296|454911349|FG001|Completed the Study|Withdrawal by Subject|31|||
126440409|NCT02558296|454911348|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
126440410|NCT02558296|454911349|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
126440411|NCT01055197|454911365|FG000|Overall Study|Protocol Violation|7|||
126440412|NCT01055197|454911366|FG001|Overall Study|Protocol Violation|2|||
126440413|NCT01055197|454911365|FG000|Overall Study|Withdrawal by Subject|2|||
126440414|NCT01055197|454911366|FG001|Overall Study|Withdrawal by Subject|0|||
126440415|NCT00389610|454911367|FG000|Overall Study|Disease Progression|0|||
126440416|NCT00389610|454911368|FG001|Overall Study|Disease Progression|19|||
126440417|NCT00389610|454911367|FG000|Overall Study|Death|0|||
126440418|NCT00389610|454911368|FG001|Overall Study|Death|1|||
126440419|NCT00389610|454911367|FG000|Overall Study|Physician Decision|0|||
126440420|NCT00389610|454911368|FG001|Overall Study|Physician Decision|1|||
126440421|NCT00389610|454911367|FG000|Overall Study|Withdrawal by Subject|0|||
126440422|NCT00389610|454911368|FG001|Overall Study|Withdrawal by Subject|1|||
126440423|NCT00538902|454911369|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
126352212|NCT04167670|454580665|FG000|Overall Study|Lost to Follow-up|0|||
126352213|NCT04167670|454580666|FG001|Overall Study|Lost to Follow-up|3|||
126352214|NCT04167670|454580667|FG002|Overall Study|Lost to Follow-up|3|||
126352215|NCT04167670|454580665|FG000|Overall Study|Voluntary Withdrawal|0|||
126352216|NCT04167670|454580666|FG001|Overall Study|Voluntary Withdrawal|1|||
126352217|NCT04167670|454580667|FG002|Overall Study|Voluntary Withdrawal|1|||
126352218|NCT04167670|454580665|FG000|Overall Study|Withdrawal of Consent|4|||
126352219|NCT04167670|454580666|FG001|Overall Study|Withdrawal of Consent|1|||
126352220|NCT04167670|454580667|FG002|Overall Study|Withdrawal of Consent|3|||
126352221|NCT04167670|454580665|FG000|Overall Study|Miscellaneous|7|||
126352222|NCT04167670|454580666|FG001|Overall Study|Miscellaneous|5|||
126352223|NCT04167670|454580667|FG002|Overall Study|Miscellaneous|3|||
126352224|NCT00876395|454580672|FG000|Overall Study|Untreated|8|||
126352225|NCT00876395|454580673|FG001|Overall Study|Untreated|1|||
126352226|NCT00876395|454580672|FG000|Overall Study|Adverse Event|63|||
126352227|NCT00876395|454580673|FG001|Overall Study|Adverse Event|11|||
126352228|NCT00876395|454580672|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126352229|NCT00876395|454580673|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126352230|NCT00876395|454580672|FG000|Overall Study|Disease progression|259|||
126352231|NCT00876395|454580673|FG001|Overall Study|Disease progression|162|||
126352232|NCT00876395|454580672|FG000|Overall Study|New cancer therapy|25|||
126352233|NCT00876395|454580673|FG001|Overall Study|New cancer therapy|7|||
126352234|NCT00876395|454580672|FG000|Overall Study|Protocol Violation|5|||
126352235|NCT00876395|454580673|FG001|Overall Study|Protocol Violation|2|||
126352236|NCT00876395|454580672|FG000|Overall Study|Withdrawal by Subject|66|||
126352237|NCT00876395|454580673|FG001|Overall Study|Withdrawal by Subject|33|||
126352238|NCT00876395|454580672|FG000|Overall Study|Lost to Follow-up|2|||
126352239|NCT00876395|454580673|FG001|Overall Study|Lost to Follow-up|0|||
126352240|NCT00876395|454580672|FG000|Overall Study|Administrative problems|39|||
126352241|NCT00876395|454580673|FG001|Overall Study|Administrative problems|23|||
126352242|NCT00876395|454580672|FG000|Overall Study|Death|12|||
126352243|NCT00876395|454580673|FG001|Overall Study|Death|0|||
126352244|NCT03807843|454580674|FG000|Overall Study|Lost to Follow-up|1|||
126352245|NCT03807843|454580675|FG001|Overall Study|Lost to Follow-up|0|||
126440424|NCT00538902|454911370|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
126440425|NCT00538902|454911371|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
126440426|NCT00538902|454911369|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
126440427|NCT00538902|454911370|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
126440428|NCT00538902|454911371|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
126440429|NCT00538902|454911369|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
126440430|NCT00538902|454911370|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
126545399|NCT02541383|455290823|FG000|Overall Study|Sponsor's decision|1|||
126352246|NCT01312129|454580676|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
126352247|NCT01312129|454580677|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
126352248|NCT00729586|454580678|FG000|Overall Study|Ineligible|0|||
126352249|NCT00729586|454580679|FG001|Overall Study|Ineligible|1|||
126352250|NCT00729586|454580678|FG000|Overall Study|never treated|1|||
126352251|NCT00729586|454580679|FG001|Overall Study|never treated|0|||
126352252|NCT00662259|454580680|FG000|Overall Study|Adverse Event|2|||
126352253|NCT00662259|454580681|FG001|Overall Study|Adverse Event|0|||
126352254|NCT01750346|454580682|FG000|Overall Study|Adverse Event|1|||
126689425|NCT01537211|455817224|FG001|Overall Study|Lost to Follow-up|1|||
126689426|NCT04142983|455817225|FG000|Overall Study|Lost to Follow-up|73|||
126689427|NCT04142983|455817225|FG000|Overall Study|Withdrawal by Subject|10|||
126689428|NCT04142983|455817225|FG000|Overall Study|Physician Decision|1|||
126689429|NCT04142983|455817225|FG000|Overall Study|Adverse Event|1|||
126352255|NCT01750346|454580683|FG001|Overall Study|Adverse Event|0|||
126352256|NCT01750346|454580684|FG002|Overall Study|Adverse Event|0|||
126352257|NCT02034591|454580685|FG000|Overall Study|Withdrawal by Subject|0|||
126352258|NCT02034591|454580686|FG001|Overall Study|Withdrawal by Subject|0|||
126352259|NCT02034591|454580687|FG002|Overall Study|Withdrawal by Subject|0|||
126689430|NCT04142983|455817225|FG000|Overall Study|No longer eligible|4|||
126352260|NCT02034591|454580688|FG003|Overall Study|Withdrawal by Subject|0|||
126440431|NCT00538902|454911371|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
126440432|NCT00538902|454911369|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
126440433|NCT00538902|454911370|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
126440434|NCT00538902|454911371|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
126440435|NCT00538902|454911369|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
126440436|NCT00538902|454911370|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
126440437|NCT00538902|454911371|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
126440438|NCT00538902|454911369|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
126440439|NCT00538902|454911370|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
126440440|NCT00538902|454911371|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
126440441|NCT00538902|454911369|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
126440442|NCT00538902|454911370|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
126440443|NCT00538902|454911371|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
126440444|NCT00538902|454911369|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
126440445|NCT00538902|454911370|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
126440446|NCT00538902|454911371|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
126440447|NCT03739203|454911372|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
126440448|NCT03739203|454911373|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
126440449|NCT03739203|454911374|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
126440450|NCT03739203|454911372|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
126440451|NCT03739203|454911373|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126440452|NCT03739203|454911374|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
126440453|NCT03739203|454911372|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
126440454|NCT03739203|454911373|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
126440455|NCT03739203|454911374|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
126440456|NCT03739203|454911372|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
126440457|NCT03739203|454911373|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
126440458|NCT03739203|454911374|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
126440459|NCT03739203|454911372|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
126440460|NCT03739203|454911373|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
126440461|NCT03739203|454911374|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
126440462|NCT03739203|454911372|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
126440463|NCT03739203|454911373|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
126440464|NCT03739203|454911374|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
126440465|NCT03739203|454911372|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
126440466|NCT03739203|454911373|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
126440467|NCT03739203|454911374|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
126760176|NCT04419558|456072416|FG001|DB Period (48 Weeks)|Adverse Event|6|||
126760177|NCT04419558|456072415|FG000|DB Period (48 Weeks)|Death|14|||
126760178|NCT04419558|456072416|FG001|DB Period (48 Weeks)|Death|11|||
126689431|NCT04142983|455817225|FG000|Overall Study|Screen Failure|10|||
126689432|NCT02475655|455817228|FG000|Overall Study|Lost to Follow-up|0|||
126689433|NCT02475655|455817229|FG001|Overall Study|Lost to Follow-up|1|||
126689434|NCT00257010|455817238|FG000|Overall Study|Lack of Efficacy|11|||
126689435|NCT00257010|455817238|FG000|Overall Study|Lost to Follow-up|53|||
126689436|NCT00257010|455817238|FG000|Overall Study|Withdrawal by Subject|34|||
126689437|NCT00257010|455817238|FG000|Overall Study|Adverse Event|10|||
126689438|NCT00257010|455817238|FG000|Overall Study|various|11|||
126689439|NCT00257010|455817238|FG000|Overall Study|no headache reported|9|||
126689440|NCT00323557|455817239|FG000|Overall Study|Physician Decision|1|||
126689441|NCT00323557|455817240|FG001|Overall Study|Physician Decision|0|||
126689442|NCT00197054|455817241|FG000|Overall Study|Withdrawal by Subject|9|||
126689443|NCT00197054|455817242|FG001|Overall Study|Withdrawal by Subject|3|||
126689444|NCT00197054|455817243|FG002|Overall Study|Withdrawal by Subject|3|||
126689445|NCT00197054|455817241|FG000|Overall Study|Moved from area|7|||
126689446|NCT00197054|455817242|FG001|Overall Study|Moved from area|14|||
126689447|NCT00197054|455817243|FG002|Overall Study|Moved from area|9|||
126689448|NCT00197054|455817241|FG000|Overall Study|Lost to Follow-up|1|||
126689449|NCT00197054|455817242|FG001|Overall Study|Lost to Follow-up|4|||
126689450|NCT00197054|455817243|FG002|Overall Study|Lost to Follow-up|0|||
126689451|NCT01699087|455817247|FG000|Overall Study|Lost to Follow-up|7|||
126689452|NCT01699087|455817247|FG000|Overall Study|Screen failure (prior to treatment)|15|||
126689453|NCT01699087|455817247|FG000|Overall Study|Unable to make future visits|2|||
126689454|NCT03021642|455817248|FG000|Washout Period (21 Days)|Adverse Event|1|||
126689455|NCT03021642|455817249|FG001|Washout Period (21 Days)|Adverse Event|1|||
126689456|NCT02474082|455817250|FG000|Overall Study|Adverse Event|2|||
126689457|NCT02474082|455817251|FG001|Overall Study|Adverse Event|32|||
126689458|NCT02474082|455817250|FG000|Overall Study|Withdrawal of informed consent|1|||
126689459|NCT02474082|455817251|FG001|Overall Study|Withdrawal of informed consent|11|||
126689460|NCT02474082|455817250|FG000|Overall Study|Lost to Follow-up|2|||
126689461|NCT02474082|455817251|FG001|Overall Study|Lost to Follow-up|2|||
126689462|NCT02474082|455817250|FG000|Overall Study|Dose tapering not achieved|0|||
126689463|NCT02474082|455817251|FG001|Overall Study|Dose tapering not achieved|4|||
126689464|NCT02474082|455817250|FG000|Overall Study|Participant/guardian decision|1|||
126689465|NCT02474082|455817251|FG001|Overall Study|Participant/guardian decision|2|||
126689466|NCT02474082|455817250|FG000|Overall Study|Non-compliance with study treatment|0|||
126689467|NCT02474082|455817251|FG001|Overall Study|Non-compliance with study treatment|2|||
126689468|NCT02474082|455817250|FG000|Overall Study|Protocol deviation|0|||
126689469|NCT02474082|455817251|FG001|Overall Study|Protocol deviation|1|||
126689470|NCT00523991|455817256|FG000|Overall Study|Adverse Event|6|||
126689471|NCT00523991|455817257|FG001|Overall Study|Adverse Event|5|||
126689472|NCT00523991|455817256|FG000|Overall Study|Protocol Violation|1|||
126689473|NCT00523991|455817257|FG001|Overall Study|Protocol Violation|4|||
126689474|NCT00523991|455817256|FG000|Overall Study|Lost to Follow-up|4|||
126689475|NCT00523991|455817257|FG001|Overall Study|Lost to Follow-up|1|||
126689476|NCT00523991|455817256|FG000|Overall Study|Withdrawal by Subject|7|||
126689477|NCT00523991|455817257|FG001|Overall Study|Withdrawal by Subject|17|||
126689478|NCT00523991|455817256|FG000|Overall Study|Other reason (not specified)|3|||
126352261|NCT02034591|454580689|FG004|Overall Study|Withdrawal by Subject|1|||
126352262|NCT02034591|454580690|FG005|Overall Study|Withdrawal by Subject|0|||
126352263|NCT01121926|454580693|FG000|First Intervention Period|Adverse Event|1|||
126689479|NCT00523991|455817257|FG001|Overall Study|Other reason (not specified)|0|||
126689480|NCT00193063|455817258|FG000|Overall Study|Lack of Efficacy|3|||
126689481|NCT00193063|455817258|FG000|Overall Study|Adverse Event|1|||
126689482|NCT01017952|455817260|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
126689483|NCT01017952|455817261|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126689484|NCT01017952|455817262|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126689485|NCT01017952|455817263|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126715161|NCT01161524|455908695|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
126715162|NCT01161524|455908696|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
126715163|NCT01161524|455908694|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
126715164|NCT01161524|455908695|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
126715165|NCT01161524|455908696|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
126715166|NCT00231062|455908705|FG000|Overall Study|Physician Decision|6|||
126715167|NCT01052012|455908706|FG000|Overall Study|Not treated|2|||
126715168|NCT01052012|455908707|FG001|Overall Study|Not treated|5|||
126715169|NCT01052012|455908708|FG002|Overall Study|Not treated|0|||
126715170|NCT01052012|455908709|FG003|Overall Study|Not treated|0|||
126715171|NCT01052012|455908710|FG004|Overall Study|Not treated|11|||
126715172|NCT01052012|455908711|FG005|Overall Study|Not treated|8|||
126715173|NCT01052012|455908706|FG000|Overall Study|Adverse Event|1|||
126715174|NCT01052012|455908707|FG001|Overall Study|Adverse Event|0|||
126715175|NCT01052012|455908708|FG002|Overall Study|Adverse Event|0|||
126715176|NCT01052012|455908709|FG003|Overall Study|Adverse Event|1|||
126715177|NCT01052012|455908710|FG004|Overall Study|Adverse Event|0|||
126440468|NCT03739203|454911372|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
126440469|NCT03739203|454911373|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
126440470|NCT03739203|454911374|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
126440471|NCT03739203|454911372|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
126440472|NCT03739203|454911373|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
126440473|NCT03739203|454911374|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
126440474|NCT03739203|454911372|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
126440475|NCT03739203|454911373|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
126440476|NCT03739203|454911374|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
126440477|NCT03739203|454911372|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
126440478|NCT03739203|454911373|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
126440479|NCT03739203|454911374|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
126440480|NCT03131570|454911375|FG000|Overall Study|Adverse Event|1|||
126440481|NCT03131570|454911376|FG001|Overall Study|Adverse Event|0|||
126440482|NCT01782378|454911377|FG000|First Series|Lost to Follow-up|7|||
126440483|NCT01782378|454911378|FG001|First Series|Lost to Follow-up|8|||
126440484|NCT01782378|454911377|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
126440485|NCT01782378|454911378|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
126440486|NCT01782378|454911377|FG000|Second Series|Lost to Follow-up|8|||
126440487|NCT01782378|454911378|FG001|Second Series|Lost to Follow-up|7|||
126440488|NCT01782378|454911377|FG000|Second Series|Did not choose to complete S2 Optional|18|||
126440489|NCT01782378|454911378|FG001|Second Series|Did not choose to complete S2 Optional|0|||
126440490|NCT00830440|454911379|FG000|Overall Study|Protocol Violation|1|||
126440491|NCT00830440|454911380|FG001|Overall Study|Protocol Violation|0|||
126440492|NCT00830440|454911379|FG000|Overall Study|Withdrawal by Subject|1|||
126440493|NCT00830440|454911380|FG001|Overall Study|Withdrawal by Subject|0|||
126440494|NCT00830440|454911379|FG000|Overall Study|unsuccessful procedure|4|||
126440495|NCT00830440|454911380|FG001|Overall Study|unsuccessful procedure|0|||
126440496|NCT00830440|454911379|FG000|Overall Study|Adverse Event|2|||
126440497|NCT00830440|454911380|FG001|Overall Study|Adverse Event|0|||
126440498|NCT01967940|454911385|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
126440499|NCT01967940|454911386|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
126440500|NCT01967940|454911387|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
126440501|NCT01967940|454911388|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
126440502|NCT01967940|454911385|FG000|Part 2|Adverse Event|0|||
126440503|NCT01967940|454911386|FG001|Part 2|Adverse Event|0|||
126440504|NCT01967940|454911387|FG002|Part 2|Adverse Event|0|||
126440505|NCT01967940|454911388|FG003|Part 2|Adverse Event|1|||
126440506|NCT01967940|454911385|FG000|Part 2|Unknown Reason|0|||
126440507|NCT01967940|454911386|FG001|Part 2|Unknown Reason|0|||
126440508|NCT01967940|454911387|FG002|Part 2|Unknown Reason|0|||
126440509|NCT01967940|454911388|FG003|Part 2|Unknown Reason|1|||
126440510|NCT01663103|454911389|FG000|Overall Study|Withdrawal by Subject|1|||
126440511|NCT01663103|454911390|FG001|Overall Study|Withdrawal by Subject|2|||
126440512|NCT01663103|454911389|FG000|Overall Study|Adverse Event|1|||
126440513|NCT01663103|454911390|FG001|Overall Study|Adverse Event|0|||
126440514|NCT01663103|454911389|FG000|Overall Study|dog bite|1|||
126440515|NCT01663103|454911390|FG001|Overall Study|dog bite|0|||
126440516|NCT03113487|454911395|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
126440517|NCT00391586|454911399|FG000|Overall Study|Progressive disease|13|||
126440518|NCT00391586|454911399|FG000|Overall Study|Adverse Event|5|||
126440519|NCT00391586|454911399|FG000|Overall Study|Physician Decision|2|||
126440520|NCT00391586|454911399|FG000|Overall Study|Death|4|||
126440521|NCT00904982|454911401|FG000|Overall Study|Withdrawal by Subject|2|||
126440522|NCT00904982|454911402|FG001|Overall Study|Withdrawal by Subject|0|||
126440523|NCT00904982|454911403|FG002|Overall Study|Withdrawal by Subject|0|||
126689486|NCT01017952|455817264|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126689487|NCT01017952|455817260|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
126689488|NCT01017952|455817261|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
126689489|NCT01017952|455817262|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
126440524|NCT00904982|454911404|FG003|Overall Study|Withdrawal by Subject|0|||
126440525|NCT02420821|454911412|FG000|Overall Study|Lost to Follow-up|6|||
126440526|NCT02420821|454911413|FG001|Overall Study|Lost to Follow-up|6|||
126440527|NCT02420821|454911412|FG000|Overall Study|Non-compliance|0|||
126440528|NCT02420821|454911413|FG001|Overall Study|Non-compliance|2|||
126440529|NCT02420821|454911412|FG000|Overall Study|Physician Decision|6|||
126440530|NCT02420821|454911413|FG001|Overall Study|Physician Decision|2|||
126440531|NCT02420821|454911412|FG000|Overall Study|Withdrawal by Subject|32|||
126715178|NCT01052012|455908711|FG005|Overall Study|Adverse Event|0|||
126689490|NCT01017952|455817263|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
126689491|NCT01017952|455817264|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
126689492|NCT01017952|455817260|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
126689493|NCT01017952|455817261|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
126689494|NCT01017952|455817262|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
126689495|NCT01017952|455817263|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
126689496|NCT01017952|455817264|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
126689497|NCT01017952|455817260|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
126689498|NCT01017952|455817261|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126689499|NCT01017952|455817262|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126689500|NCT01017952|455817263|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126689501|NCT01017952|455817264|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126689502|NCT01017952|455817260|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
126689503|NCT01017952|455817261|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
126689504|NCT01017952|455817262|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
126689505|NCT01017952|455817263|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
126689506|NCT01017952|455817264|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
126689507|NCT01017952|455817260|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
126689508|NCT01017952|455817261|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126689509|NCT01017952|455817262|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126689510|NCT01017952|455817263|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126689511|NCT01017952|455817264|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126689512|NCT01017952|455817260|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
126689513|NCT01017952|455817261|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
126689514|NCT01017952|455817262|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
126689515|NCT01017952|455817263|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
126689516|NCT01017952|455817264|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
126689517|NCT01017952|455817260|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126689518|NCT01017952|455817261|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
126689519|NCT01017952|455817262|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
126689520|NCT01017952|455817263|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
126689521|NCT01017952|455817264|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
126689522|NCT01017952|455817260|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
126689523|NCT01017952|455817261|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
126689524|NCT01017952|455817262|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
126689525|NCT01017952|455817263|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
126689526|NCT01017952|455817264|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
126689527|NCT01017952|455817260|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
126689528|NCT01017952|455817261|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
126689529|NCT01017952|455817262|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
126689530|NCT01017952|455817263|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
126689531|NCT01017952|455817264|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
126689532|NCT01017952|455817260|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
126689533|NCT01017952|455817261|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
126689534|NCT01017952|455817262|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
126689535|NCT01017952|455817263|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
126689536|NCT01017952|455817264|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
126689537|NCT01017952|455817260|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
126689538|NCT01017952|455817261|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
126689539|NCT01017952|455817262|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
126689540|NCT01017952|455817263|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
126689541|NCT01017952|455817264|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
126689542|NCT01017952|455817260|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126689543|NCT01017952|455817261|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
126689544|NCT01017952|455817262|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
126689545|NCT01017952|455817263|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
126689546|NCT01017952|455817264|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
126689547|NCT01017952|455817260|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
126689548|NCT01017952|455817261|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
126689549|NCT01017952|455817262|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
126689550|NCT01017952|455817263|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
126689551|NCT01017952|455817264|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
126760179|NCT04419558|456072415|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
126760180|NCT04419558|456072416|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
126689552|NCT01064167|455817265|FG000|Overall Study|Protocol Violation|14|||
126689553|NCT01064167|455817266|FG001|Overall Study|Protocol Violation|15|||
126689554|NCT02902120|455817267|FG000|Overall Study|Lack of Efficacy|1|||
126689555|NCT02302963|455817273|FG000|Overall Study|Withdrawal by Subject|2|||
126689556|NCT02302963|455817274|FG001|Overall Study|Withdrawal by Subject|1|||
126689557|NCT02302963|455817273|FG000|Overall Study|Steroid injection|0|||
126689558|NCT02302963|455817274|FG001|Overall Study|Steroid injection|1|||
126689559|NCT02302963|455817273|FG000|Overall Study|Physician Decision|1|||
126689560|NCT02302963|455817274|FG001|Overall Study|Physician Decision|0|||
126689561|NCT03687502|455817277|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
126689562|NCT03687502|455817277|FG000|Overall Study|Lumason not available|1|||
126689563|NCT01724528|455817278|FG000|Overall Study|Death|3|||
126689564|NCT01724528|455817279|FG001|Overall Study|Death|0|||
126689565|NCT01724528|455817278|FG000|Overall Study|Withdrawal by Subject|0|||
126689566|NCT01724528|455817279|FG001|Overall Study|Withdrawal by Subject|2|||
126689567|NCT01724528|455817278|FG000|Overall Study|Protocol Violation|0|||
126689568|NCT01724528|455817279|FG001|Overall Study|Protocol Violation|1|||
126689569|NCT01724528|455817278|FG000|Overall Study|Patient refused to attend last visit|1|||
126689570|NCT01724528|455817279|FG001|Overall Study|Patient refused to attend last visit|0|||
126689571|NCT01634555|455817284|FG000|Overall Study|Adverse Event|3|||
126689572|NCT01634555|455817284|FG000|Overall Study|Physician Decision|1|||
126689573|NCT06228586|455817285|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
126689574|NCT06228586|455817286|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
126689575|NCT01299766|455818720|FG000|Overall Study|Death|5|||
126689576|NCT01299766|455818721|FG001|Overall Study|Death|4|||
126689577|NCT01299766|455818720|FG000|Overall Study|Withdrawal by Subject|29|||
126689578|NCT01299766|455818721|FG001|Overall Study|Withdrawal by Subject|19|||
126689579|NCT00403260|455818724|FG000|Overall Study|Adverse Event|5|||
126689580|NCT00403260|455818725|FG001|Overall Study|Adverse Event|4|||
126689581|NCT00403260|455818724|FG000|Overall Study|Withdrawal by Subject|5|||
126689582|NCT00403260|455818725|FG001|Overall Study|Withdrawal by Subject|6|||
126689583|NCT00403260|455818724|FG000|Overall Study|Lost to Follow-up|49|||
126689584|NCT00403260|455818725|FG001|Overall Study|Lost to Follow-up|25|||
126689585|NCT00403260|455818724|FG000|Overall Study|Re-appearance of P. falciparum|34|||
126689586|NCT00403260|455818725|FG001|Overall Study|Re-appearance of P. falciparum|25|||
126689587|NCT00403260|455818724|FG000|Overall Study|P. vivax infection|26|||
126689588|NCT00403260|455818725|FG001|Overall Study|P. vivax infection|4|||
126689589|NCT00403260|455818724|FG000|Overall Study|Mixed infection with P. vivax|2|||
126689590|NCT00403260|455818725|FG001|Overall Study|Mixed infection with P. vivax|0|||
126689591|NCT00403260|455818724|FG000|Overall Study|Mixed infection with P. falciparum|1|||
126689592|NCT00403260|455818725|FG001|Overall Study|Mixed infection with P. falciparum|0|||
126689593|NCT00403260|455818724|FG000|Overall Study|P. vivax infection at screening|1|||
126689594|NCT00403260|455818725|FG001|Overall Study|P. vivax infection at screening|0|||
126689595|NCT00403260|455818724|FG000|Overall Study|P. ovale infection|1|||
126689596|NCT00403260|455818725|FG001|Overall Study|P. ovale infection|0|||
126689597|NCT00403260|455818724|FG000|Overall Study|Gametocyte re-appearance|1|||
126689598|NCT00403260|455818725|FG001|Overall Study|Gametocyte re-appearance|1|||
126689599|NCT00403260|455818724|FG000|Overall Study|Withdrawn from study accidentally|0|||
126689600|NCT00403260|455818725|FG001|Overall Study|Withdrawn from study accidentally|1|||
126689601|NCT01354028|455818726|FG000|Overall Study|Physician Decision|0|||
126689602|NCT01354028|455818727|FG001|Overall Study|Physician Decision|2|||
126689603|NCT01354028|455818726|FG000|Overall Study|Discharged before study start|2|||
126689604|NCT01354028|455818727|FG001|Overall Study|Discharged before study start|2|||
126689605|NCT01354028|455818726|FG000|Overall Study|No quiet alert state|0|||
126689606|NCT01354028|455818727|FG001|Overall Study|No quiet alert state|1|||
126689607|NCT00935883|455818730|FG000|Treatment Period|Physician Decision|1|||
126689608|NCT00935883|455818731|FG001|Treatment Period|Physician Decision|0|||
126689609|NCT00935883|455818730|FG000|Treatment Period|Withdrawal by Subject|0|||
126760181|NCT04419558|456072415|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
126760182|NCT04419558|456072416|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
126760183|NCT04419558|456072415|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
126689610|NCT00935883|455818731|FG001|Treatment Period|Withdrawal by Subject|2|||
126689611|NCT02770326|455818736|FG000|Overall Study|Death|3|||
126689612|NCT02770326|455818736|FG000|Overall Study|Lost to Follow-up|1|||
126689613|NCT02971202|455818737|FG000|Overall Study|Pregnancy|1|||
126689614|NCT02971202|455818738|FG001|Overall Study|Pregnancy|0|||
126689615|NCT02971202|455818739|FG002|Overall Study|Pregnancy|0|||
126689616|NCT02971202|455818737|FG000|Overall Study|screen fail after consent|1|||
126689617|NCT02971202|455818738|FG001|Overall Study|screen fail after consent|0|||
126352264|NCT01121926|454580694|FG001|First Intervention Period|Adverse Event|0|||
126352265|NCT01121926|454580693|FG000|Washout Period|Adverse Event|0|||
126352266|NCT01121926|454580694|FG001|Washout Period|Adverse Event|1|||
126352267|NCT01121926|454580693|FG000|Washout Period|Positive pregnancy test|0|||
126352268|NCT01121926|454580694|FG001|Washout Period|Positive pregnancy test|1|||
126440532|NCT02420821|454911413|FG001|Overall Study|Withdrawal by Subject|25|||
126440533|NCT02420821|454911412|FG000|Overall Study|Death|270|||
126440534|NCT02420821|454911413|FG001|Overall Study|Death|263|||
126440535|NCT02420821|454911412|FG000|Overall Study|Study Terminated By Sponsor|145|||
126440536|NCT02420821|454911413|FG001|Overall Study|Study Terminated By Sponsor|149|||
126440537|NCT02420821|454911412|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
126440538|NCT02420821|454911413|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
126440539|NCT02420821|454911412|FG000|Overall Study|Adverse Event|0|||
126440540|NCT02420821|454911413|FG001|Overall Study|Adverse Event|1|||
126440541|NCT02420821|454911412|FG000|Overall Study|Protinuria|0|||
126440542|NCT02420821|454911413|FG001|Overall Study|Protinuria|1|||
126440543|NCT02420821|454911412|FG000|Overall Study|Progressive Disease|1|||
126440544|NCT02420821|454911413|FG001|Overall Study|Progressive Disease|1|||
126440545|NCT02420821|454911412|FG000|Overall Study|Disease Progression|0|||
126440546|NCT02420821|454911413|FG001|Overall Study|Disease Progression|1|||
126440547|NCT02420821|454911412|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
126440548|NCT02420821|454911413|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
126440549|NCT00686712|454911414|FG000|Overall Study|Protocol Violation|8|||
126440550|NCT00686712|454911415|FG001|Overall Study|Protocol Violation|8|||
126440551|NCT00686712|454911416|FG002|Overall Study|Protocol Violation|10|||
126440552|NCT00686712|454911414|FG000|Overall Study|Lost to Follow-up|1|||
126440553|NCT00686712|454911415|FG001|Overall Study|Lost to Follow-up|2|||
126440554|NCT00686712|454911416|FG002|Overall Study|Lost to Follow-up|3|||
126440555|NCT00686712|454911414|FG000|Overall Study|Adverse Event|1|||
126689618|NCT02971202|455818739|FG002|Overall Study|screen fail after consent|1|||
126352269|NCT00416949|454580695|FG000|Overall Study|Patients refused to participate|5|||
126352270|NCT02782468|454580696|FG000|Overall Study|Progressive Disease|2|||
126352271|NCT02782468|454580697|FG001|Overall Study|Progressive Disease|5|||
126352272|NCT02782468|454580698|FG002|Overall Study|Progressive Disease|0|||
126352273|NCT02782468|454580699|FG003|Overall Study|Progressive Disease|4|||
126352274|NCT02782468|454580696|FG000|Overall Study|Adverse Event|0|||
126352275|NCT02782468|454580697|FG001|Overall Study|Adverse Event|2|||
126352276|NCT02782468|454580698|FG002|Overall Study|Adverse Event|2|||
126352277|NCT02782468|454580699|FG003|Overall Study|Adverse Event|3|||
126352278|NCT02782468|454580696|FG000|Overall Study|Other|0|||
126352279|NCT02782468|454580697|FG001|Overall Study|Other|0|||
126352280|NCT02782468|454580698|FG002|Overall Study|Other|1|||
126352281|NCT02782468|454580699|FG003|Overall Study|Other|1|||
126352282|NCT02782468|454580696|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
126352283|NCT02782468|454580697|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
126352284|NCT02782468|454580698|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
126352285|NCT02782468|454580699|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
126352286|NCT02782468|454580696|FG000|Overall Study|Symptomatic Deterioration|0|||
126352287|NCT02782468|454580697|FG001|Overall Study|Symptomatic Deterioration|0|||
126352288|NCT02782468|454580698|FG002|Overall Study|Symptomatic Deterioration|0|||
126352289|NCT02782468|454580699|FG003|Overall Study|Symptomatic Deterioration|1|||
126440556|NCT00686712|454911415|FG001|Overall Study|Adverse Event|1|||
126440557|NCT00686712|454911416|FG002|Overall Study|Adverse Event|0|||
126440558|NCT04119414|454911417|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
126440559|NCT03058146|454911418|FG000|Overall Study|Withdrawal by Subject|4|||
126440560|NCT03058146|454911419|FG001|Overall Study|Withdrawal by Subject|1|||
126440561|NCT03058146|454911418|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
126440562|NCT03058146|454911419|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
126440563|NCT01352793|454911422|FG000|Overall Study|Lost to Follow-up|289|||
126440564|NCT01352793|454911423|FG001|Overall Study|Lost to Follow-up|125|||
126440565|NCT01352793|454911422|FG000|Overall Study|Withdrawal by Subject|120|||
126440566|NCT01352793|454911423|FG001|Overall Study|Withdrawal by Subject|55|||
126440567|NCT01352793|454911422|FG000|Overall Study|Protocol Violation|44|||
126440568|NCT01352793|454911423|FG001|Overall Study|Protocol Violation|23|||
126440569|NCT01352793|454911422|FG000|Overall Study|Adverse Event|44|||
126440570|NCT01352793|454911423|FG001|Overall Study|Adverse Event|10|||
126440571|NCT01352793|454911422|FG000|Overall Study|Physician Decision|1|||
126440572|NCT01352793|454911423|FG001|Overall Study|Physician Decision|0|||
126440573|NCT01352793|454911422|FG000|Overall Study|Pregnancy|26|||
126440574|NCT01352793|454911423|FG001|Overall Study|Pregnancy|8|||
126440575|NCT01352793|454911422|FG000|Overall Study|Other|25|||
126440576|NCT01352793|454911423|FG001|Overall Study|Other|7|||
126440577|NCT01352793|454911422|FG000|Overall Study|Medication error|2|||
126440578|NCT01352793|454911423|FG001|Overall Study|Medication error|2|||
126440579|NCT01352793|454911422|FG000|Overall Study|Death|1|||
126440580|NCT01352793|454911423|FG001|Overall Study|Death|0|||
126440581|NCT01352793|454911422|FG000|Overall Study|Randomized but not vaccinated|8|||
126440582|NCT01352793|454911423|FG001|Overall Study|Randomized but not vaccinated|0|||
126440583|NCT01352793|454911422|FG000|Overall Study|No longer meets eligibility criteria|25|||
126440584|NCT01352793|454911423|FG001|Overall Study|No longer meets eligibility criteria|15|||
126440585|NCT02839200|454911426|FG000|Overall Study|Withdrawal by Subject|2|||
126440586|NCT02839200|454911427|FG001|Overall Study|Withdrawal by Subject|0|||
126440587|NCT02839200|454911428|FG002|Overall Study|Withdrawal by Subject|1|||
126440588|NCT02839200|454911429|FG003|Overall Study|Withdrawal by Subject|0|||
126440589|NCT02839200|454911430|FG004|Overall Study|Withdrawal by Subject|0|||
126440590|NCT02839200|454911431|FG005|Overall Study|Withdrawal by Subject|1|||
126440591|NCT02839200|454911426|FG000|Overall Study|Lost to Follow-up|2|||
126440592|NCT02839200|454911427|FG001|Overall Study|Lost to Follow-up|0|||
126440593|NCT02839200|454911428|FG002|Overall Study|Lost to Follow-up|0|||
126440594|NCT02839200|454911429|FG003|Overall Study|Lost to Follow-up|0|||
126440595|NCT02839200|454911430|FG004|Overall Study|Lost to Follow-up|1|||
126440596|NCT02839200|454911431|FG005|Overall Study|Lost to Follow-up|0|||
126440597|NCT02839200|454911426|FG000|Overall Study|Adverse Event|0|||
126440598|NCT02839200|454911427|FG001|Overall Study|Adverse Event|0|||
126440599|NCT02839200|454911428|FG002|Overall Study|Adverse Event|0|||
126440600|NCT02839200|454911429|FG003|Overall Study|Adverse Event|0|||
126440601|NCT02839200|454911430|FG004|Overall Study|Adverse Event|1|||
126440602|NCT02839200|454911431|FG005|Overall Study|Adverse Event|0|||
126440603|NCT02839200|454911426|FG000|Overall Study|Randomized in error|0|||
126440604|NCT02839200|454911427|FG001|Overall Study|Randomized in error|1|||
126440605|NCT02839200|454911428|FG002|Overall Study|Randomized in error|0|||
126440606|NCT02839200|454911429|FG003|Overall Study|Randomized in error|0|||
126440607|NCT02839200|454911430|FG004|Overall Study|Randomized in error|0|||
126440608|NCT02839200|454911431|FG005|Overall Study|Randomized in error|0|||
126440609|NCT01094119|454911434|FG000|Overall Study|Lack of Efficacy|2|||
126440610|NCT01094119|454911435|FG001|Overall Study|Lack of Efficacy|4|||
126440611|NCT02205736|454911436|FG000|Overall Study|Lost to Follow-up|106|||
126440612|NCT01285557|454911437|FG000|Overall Study|Death|173|||
126440613|NCT01285557|454911438|FG001|Overall Study|Death|90|||
126440614|NCT01285557|454911437|FG000|Overall Study|Lost to Follow-up|6|||
126440615|NCT01285557|454911438|FG001|Overall Study|Lost to Follow-up|2|||
126440616|NCT01285557|454911437|FG000|Overall Study|Withdrew Consent|6|||
126440617|NCT01285557|454911438|FG001|Overall Study|Withdrew Consent|1|||
126440618|NCT01285557|454911437|FG000|Overall Study|Sponsor Study Termination|23|||
126440619|NCT01285557|454911438|FG001|Overall Study|Sponsor Study Termination|13|||
126440620|NCT01285557|454911437|FG000|Overall Study|Randomized but not treated|1|||
126440621|NCT01285557|454911438|FG001|Overall Study|Randomized but not treated|1|||
126760184|NCT04419558|456072416|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
126440622|NCT01285557|454911437|FG000|Overall Study|Study follow-up ongoing|28|||
126440623|NCT01285557|454911438|FG001|Overall Study|Study follow-up ongoing|14|||
126440624|NCT01285557|454911437|FG000|Overall Study|Sponsor Decision|2|||
126440625|NCT01285557|454911438|FG001|Overall Study|Sponsor Decision|1|||
126440626|NCT05615922|454911440|FG000|Overall Study|Lost to Follow-up|1|||
126440627|NCT03173248|454911444|FG000|Overall Study|Death|28|||
126440628|NCT03173248|454911445|FG001|Overall Study|Death|46|||
126440629|NCT03173248|454911444|FG000|Overall Study|Lost to Follow-up|0|||
126440630|NCT03173248|454911445|FG001|Overall Study|Lost to Follow-up|1|||
126440631|NCT03173248|454911444|FG000|Overall Study|Withdrawal by Subject|6|||
126440632|NCT03173248|454911445|FG001|Overall Study|Withdrawal by Subject|4|||
126440633|NCT03173248|454911444|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
126440634|NCT03173248|454911445|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
126440635|NCT01648751|454911448|FG000|Overall Study|Withdrawal by Subject|2|||
126689619|NCT01946178|455818740|FG000|Overall Study|Pregnancy|1|||
126689620|NCT01946178|455818740|FG000|Overall Study|Lost to Follow-up|1|||
126689621|NCT02634580|455818741|FG000|Double-blind Treatment Period|Subject Request|1|||
126689622|NCT02634580|455818742|FG001|Double-blind Treatment Period|Subject Request|0|||
126689623|NCT02634580|455818743|FG002|Double-blind Treatment Period|Subject Request|1|||
126689624|NCT02634580|455818744|FG003|Double-blind Treatment Period|Subject Request|1|||
126689625|NCT02634580|455818741|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
126689626|NCT02634580|455818742|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
126689627|NCT02634580|455818743|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
126689628|NCT02634580|455818744|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
126689629|NCT01622569|455818745|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
126689630|NCT01622569|455818746|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
126689631|NCT01622569|455818747|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
126689632|NCT01622569|455818748|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
126689633|NCT01622569|455818745|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
126689634|NCT01622569|455818746|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
126689635|NCT01622569|455818747|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
126689636|NCT01622569|455818748|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
126689637|NCT01622569|455818745|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
126689638|NCT01622569|455818746|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
126689639|NCT01622569|455818747|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
126689640|NCT01622569|455818748|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
126689641|NCT01622569|455818745|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
126689642|NCT01622569|455818746|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
126689643|NCT01622569|455818747|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
126689644|NCT01622569|455818748|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
126689645|NCT01622569|455818745|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
126689646|NCT01622569|455818746|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
126689647|NCT01622569|455818747|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
126689648|NCT01622569|455818748|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
126689649|NCT01622569|455818745|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
126689650|NCT01622569|455818746|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
126689651|NCT01622569|455818747|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
126689652|NCT01622569|455818748|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
126689653|NCT01622569|455818745|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
126689654|NCT01622569|455818746|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
126689655|NCT01622569|455818747|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
126689656|NCT01622569|455818748|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
126689657|NCT01622569|455818745|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
126689658|NCT01622569|455818746|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
126689659|NCT01622569|455818747|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
126689660|NCT01622569|455818748|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
126689661|NCT01001702|455818749|FG000|Overall Study|Lost to Follow-up|7|||
126689662|NCT01001702|455818749|FG000|Overall Study|Adverse Event|7|||
126689663|NCT01001702|455818749|FG000|Overall Study|Sponsor Discontinued Study|4|||
126689664|NCT01001702|455818749|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
126689665|NCT01001702|455818749|FG000|Overall Study|Investigator withdrew Subject|10|||
126689666|NCT01001702|455818749|FG000|Overall Study|Withdrawal by Subject|19|||
126689667|NCT01001702|455818749|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
126689668|NCT02222714|455818752|FG000|Overall Study|Death|0|||
126689669|NCT02222714|455818753|FG001|Overall Study|Death|2|||
126689670|NCT02222714|455818754|FG002|Overall Study|Death|3|||
126689671|NCT02222714|455818755|FG003|Overall Study|Death|4|||
126689672|NCT02222714|455818756|FG004|Overall Study|Death|6|||
126689673|NCT02222714|455818752|FG000|Overall Study|Withdrawal by Subject|0|||
126689674|NCT02222714|455818753|FG001|Overall Study|Withdrawal by Subject|0|||
126689675|NCT02222714|455818754|FG002|Overall Study|Withdrawal by Subject|1|||
126689676|NCT02222714|455818755|FG003|Overall Study|Withdrawal by Subject|0|||
126440636|NCT01648751|454911449|FG001|Overall Study|Withdrawal by Subject|3|||
126440637|NCT02991768|454911453|FG000|Overall Study|Physician Decision|4|||
126352290|NCT02782468|454580696|FG000|Overall Study|Withdrawal by Subject|1|||
126352291|NCT02782468|454580697|FG001|Overall Study|Withdrawal by Subject|0|||
126352292|NCT02782468|454580698|FG002|Overall Study|Withdrawal by Subject|0|||
126352293|NCT02782468|454580699|FG003|Overall Study|Withdrawal by Subject|0|||
126352294|NCT01410604|454580701|FG000|Overall Study|Adverse Event|2|||
126352295|NCT01410604|454580702|FG001|Overall Study|Adverse Event|1|||
126352296|NCT01410604|454580701|FG000|Overall Study|Lost to Follow-up|1|||
126352297|NCT01410604|454580702|FG001|Overall Study|Lost to Follow-up|0|||
126352298|NCT01410604|454580701|FG000|Overall Study|Physician Decision|0|||
126352299|NCT01410604|454580702|FG001|Overall Study|Physician Decision|1|||
126352300|NCT00356590|454580703|FG000|Overall Study|Adverse Event|54|||
126352301|NCT00356590|454580703|FG000|Overall Study|Death|10|||
126352302|NCT00356590|454580703|FG000|Overall Study|Lost to Follow-up|35|||
126352303|NCT00356590|454580703|FG000|Overall Study|Physician Decision|46|||
126352304|NCT00356590|454580703|FG000|Overall Study|Withdrawal by Subject|41|||
126352305|NCT00356590|454580703|FG000|Overall Study|Completed month 12 only|2|||
126352306|NCT00356590|454580703|FG000|Overall Study|Protocol issues|6|||
126352307|NCT00356590|454580703|FG000|Overall Study|Response status|28|||
126352308|NCT00356590|454580703|FG000|Overall Study|Other|52|||
126352309|NCT00898807|454580711|FG000|Overall Study|Withdrawal by Subject|5|||
126352310|NCT00898807|454580712|FG001|Overall Study|Withdrawal by Subject|3|||
126352311|NCT00898807|454580711|FG000|Overall Study|Family pressure to discontinue|2|||
126352312|NCT00898807|454580712|FG001|Overall Study|Family pressure to discontinue|2|||
126352313|NCT00898807|454580711|FG000|Overall Study|Lost to Follow-up|1|||
126352314|NCT00898807|454580712|FG001|Overall Study|Lost to Follow-up|3|||
126352315|NCT00898807|454580711|FG000|Overall Study|Death|0|||
126352316|NCT00898807|454580712|FG001|Overall Study|Death|1|||
126352317|NCT04919161|454580713|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
126352318|NCT04919161|454580714|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
126352319|NCT04919161|454580713|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
126352320|NCT04919161|454580714|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
126352321|NCT04919161|454580713|FG000|Overall Study|Acute ankle sprain after session 1|0|||
126352322|NCT04919161|454580714|FG001|Overall Study|Acute ankle sprain after session 1|1|||
126352323|NCT00712920|454580715|FG000|Overall Study|Adverse Event|3|||
126352324|NCT00712920|454580716|FG001|Overall Study|Adverse Event|4|||
126352325|NCT00712920|454580717|FG002|Overall Study|Adverse Event|7|||
126352326|NCT00712920|454580715|FG000|Overall Study|Withdrawal by Subject|4|||
126352327|NCT00712920|454580716|FG001|Overall Study|Withdrawal by Subject|2|||
126352328|NCT00712920|454580717|FG002|Overall Study|Withdrawal by Subject|1|||
126352329|NCT00712920|454580715|FG000|Overall Study|Lost to Follow-up|1|||
126352330|NCT00712920|454580716|FG001|Overall Study|Lost to Follow-up|4|||
126352331|NCT00712920|454580717|FG002|Overall Study|Lost to Follow-up|0|||
126352332|NCT00712920|454580715|FG000|Overall Study|Lack of Efficacy|1|||
126352333|NCT00712920|454580716|FG001|Overall Study|Lack of Efficacy|0|||
126352334|NCT00712920|454580717|FG002|Overall Study|Lack of Efficacy|1|||
126352335|NCT00712920|454580715|FG000|Overall Study|Other|5|||
126352336|NCT00712920|454580716|FG001|Overall Study|Other|7|||
126352337|NCT00712920|454580717|FG002|Overall Study|Other|3|||
126352338|NCT00712920|454580715|FG000|Overall Study|Non-compliance|3|||
126352339|NCT00712920|454580716|FG001|Overall Study|Non-compliance|0|||
126352340|NCT00712920|454580717|FG002|Overall Study|Non-compliance|0|||
126352341|NCT02489773|454580718|FG000|Overall Study|Lost to Follow-up|4|||
126352342|NCT02489773|454580719|FG001|Overall Study|Lost to Follow-up|1|||
126352343|NCT02489773|454580718|FG000|Overall Study|Physician Decision|1|||
126352344|NCT02489773|454580719|FG001|Overall Study|Physician Decision|0|||
126352345|NCT02489773|454580718|FG000|Overall Study|Withdrawal by Subject|1|||
126352346|NCT02489773|454580719|FG001|Overall Study|Withdrawal by Subject|0|||
126352347|NCT02489773|454580718|FG000|Overall Study|Leave the country or the state|1|||
126352348|NCT02489773|454580719|FG001|Overall Study|Leave the country or the state|1|||
126352349|NCT02115386|454580722|FG000|Overall Study|Protocol Violation|1|||
126352350|NCT02115386|454580722|FG000|Overall Study|Administrative - trial was terminated|6|||
126352351|NCT02493855|454580723|FG000|Overall Study|Non-compliance|1|||
126352352|NCT02493855|454580724|FG001|Overall Study|Non-compliance|0|||
126352353|NCT02493855|454580725|FG002|Overall Study|Non-compliance|0|||
126352354|NCT02493855|454580723|FG000|Overall Study|Adverse Event|0|||
126352355|NCT02493855|454580724|FG001|Overall Study|Adverse Event|1|||
126352356|NCT02493855|454580725|FG002|Overall Study|Adverse Event|0|||
126352357|NCT02493855|454580723|FG000|Overall Study|Withdrawal by Subject|1|||
126352358|NCT02493855|454580724|FG001|Overall Study|Withdrawal by Subject|0|||
126440638|NCT03467750|454911454|FG000|Overall Study|Surgery canceled|1|||
126440639|NCT03467750|454911455|FG001|Overall Study|Surgery canceled|0|||
126440640|NCT03467750|454911454|FG000|Overall Study|Protocol Violation|1|||
126440641|NCT03467750|454911455|FG001|Overall Study|Protocol Violation|1|||
126440642|NCT03467750|454911454|FG000|Overall Study|Withdrawal by Subject|0|||
126440643|NCT03467750|454911455|FG001|Overall Study|Withdrawal by Subject|1|||
126440644|NCT05673876|454911456|FG000|Overall Study|Death|3|||
126440645|NCT05673876|454911457|FG001|Overall Study|Death|1|||
126440646|NCT05673876|454911456|FG000|Overall Study|Study Terminated by Sponsor|0|||
126440647|NCT05673876|454911457|FG001|Overall Study|Study Terminated by Sponsor|1|||
126440648|NCT05673876|454911456|FG000|Overall Study|Physician Decision|0|||
126440649|NCT05673876|454911457|FG001|Overall Study|Physician Decision|1|||
126440650|NCT04500158|454911460|FG000|Overall Study|Physician Decision|17|||
126440651|NCT04500158|454911461|FG001|Overall Study|Physician Decision|11|||
126440652|NCT02749422|454911464|FG000|Overall Study|Lost to Follow-up|0|||
126440653|NCT02749422|454911465|FG001|Overall Study|Lost to Follow-up|2|||
126440654|NCT02749422|454911464|FG000|Overall Study|Ineligible|0|||
126440655|NCT02749422|454911465|FG001|Overall Study|Ineligible|1|||
126440656|NCT02807402|454911470|FG000|Overall Study|Failure to Return|1|||
126440657|NCT02807402|454911470|FG000|Overall Study|Death|3|||
126440658|NCT02807402|454911470|FG000|Overall Study|Other|2|||
126440659|NCT04922216|454911471|FG000|Overall Study|Withdrawal by Subject|0|||
126440660|NCT04922216|454911472|FG001|Overall Study|Withdrawal by Subject|1|||
126440661|NCT04922216|454911473|FG002|Overall Study|Withdrawal by Subject|0|||
126440662|NCT04922216|454911474|FG003|Overall Study|Withdrawal by Subject|0|||
126440663|NCT04922216|454911475|FG004|Overall Study|Withdrawal by Subject|0|||
126440664|NCT04922216|454911476|FG005|Overall Study|Withdrawal by Subject|0|||
126440665|NCT04922216|454911477|FG006|Overall Study|Withdrawal by Subject|0|||
126440666|NCT04922216|454911478|FG007|Overall Study|Withdrawal by Subject|2|||
126440667|NCT04922216|454911479|FG008|Overall Study|Withdrawal by Subject|0|||
126440668|NCT04922216|454911480|FG009|Overall Study|Withdrawal by Subject|0|||
126440669|NCT04922216|454911481|FG010|Overall Study|Withdrawal by Subject|0|||
126440670|NCT04922216|454911482|FG011|Overall Study|Withdrawal by Subject|0|||
126440671|NCT04922216|454911483|FG012|Overall Study|Withdrawal by Subject|1|||
126440672|NCT04922216|454911484|FG013|Overall Study|Withdrawal by Subject|1|||
126440673|NCT04922216|454911485|FG014|Overall Study|Withdrawal by Subject|1|||
126440674|NCT04922216|454911486|FG015|Overall Study|Withdrawal by Subject|0|||
126440675|NCT04922216|454911487|FG016|Overall Study|Withdrawal by Subject|0|||
126440676|NCT04922216|454911488|FG017|Overall Study|Withdrawal by Subject|1|||
126440677|NCT04922216|454911489|FG018|Overall Study|Withdrawal by Subject|1|||
126440678|NCT04922216|454911490|FG019|Overall Study|Withdrawal by Subject|1|||
126440679|NCT04922216|454911491|FG020|Overall Study|Withdrawal by Subject|1|||
126440680|NCT04922216|454911492|FG021|Overall Study|Withdrawal by Subject|0|||
126440681|NCT04922216|454911493|FG022|Overall Study|Withdrawal by Subject|0|||
126440682|NCT04922216|454911494|FG023|Overall Study|Withdrawal by Subject|2|||
126440683|NCT04922216|454911495|FG024|Overall Study|Withdrawal by Subject|0|||
126440684|NCT04922216|454911496|FG025|Overall Study|Withdrawal by Subject|0|||
126440685|NCT04922216|454911497|FG026|Overall Study|Withdrawal by Subject|1|||
126440686|NCT04922216|454911498|FG027|Overall Study|Withdrawal by Subject|0|||
126440687|NCT04922216|454911499|FG028|Overall Study|Withdrawal by Subject|0|||
126440688|NCT04922216|454911500|FG029|Overall Study|Withdrawal by Subject|0|||
126440689|NCT04922216|454911501|FG030|Overall Study|Withdrawal by Subject|1|||
126440690|NCT04922216|454911502|FG031|Overall Study|Withdrawal by Subject|0|||
126440691|NCT04922216|454911471|FG000|Overall Study|Lost to Follow-up|1|||
126440692|NCT04922216|454911472|FG001|Overall Study|Lost to Follow-up|0|||
126440693|NCT04922216|454911473|FG002|Overall Study|Lost to Follow-up|2|||
126440694|NCT04922216|454911474|FG003|Overall Study|Lost to Follow-up|0|||
126440695|NCT04922216|454911475|FG004|Overall Study|Lost to Follow-up|0|||
126440696|NCT04922216|454911476|FG005|Overall Study|Lost to Follow-up|2|||
126440697|NCT04922216|454911477|FG006|Overall Study|Lost to Follow-up|0|||
126440698|NCT04922216|454911478|FG007|Overall Study|Lost to Follow-up|1|||
126440699|NCT04922216|454911479|FG008|Overall Study|Lost to Follow-up|1|||
126440700|NCT04922216|454911480|FG009|Overall Study|Lost to Follow-up|2|||
126440701|NCT04922216|454911481|FG010|Overall Study|Lost to Follow-up|2|||
126440702|NCT04922216|454911482|FG011|Overall Study|Lost to Follow-up|1|||
126440703|NCT04922216|454911483|FG012|Overall Study|Lost to Follow-up|1|||
126440704|NCT04922216|454911484|FG013|Overall Study|Lost to Follow-up|0|||
126715179|NCT01052012|455908706|FG000|Overall Study|Lost to Follow-up|0|||
126440705|NCT04922216|454911485|FG014|Overall Study|Lost to Follow-up|1|||
126440706|NCT04922216|454911486|FG015|Overall Study|Lost to Follow-up|0|||
126440707|NCT04922216|454911487|FG016|Overall Study|Lost to Follow-up|0|||
126440708|NCT04922216|454911488|FG017|Overall Study|Lost to Follow-up|2|||
126440709|NCT04922216|454911489|FG018|Overall Study|Lost to Follow-up|1|||
126440710|NCT04922216|454911490|FG019|Overall Study|Lost to Follow-up|0|||
126440711|NCT04922216|454911491|FG020|Overall Study|Lost to Follow-up|1|||
126440712|NCT04922216|454911492|FG021|Overall Study|Lost to Follow-up|0|||
126440713|NCT04922216|454911493|FG022|Overall Study|Lost to Follow-up|2|||
126440714|NCT04922216|454911494|FG023|Overall Study|Lost to Follow-up|1|||
126440715|NCT04922216|454911495|FG024|Overall Study|Lost to Follow-up|0|||
126689677|NCT02222714|455818756|FG004|Overall Study|Withdrawal by Subject|1|||
126689678|NCT01940484|455818757|FG000|Overall Study|Withdrawal by Subject|3|||
126689679|NCT01940484|455818757|FG000|Overall Study|Underwent transplantation|4|||
126689680|NCT01940484|455818757|FG000|Overall Study|Death|2|||
126689681|NCT01940484|455818757|FG000|Overall Study|Adverse Event|1|||
126689682|NCT01285908|455818758|FG000|Baseline Measurement|unable to insert catheter|1|||
126689683|NCT01285908|455818759|FG001|Baseline Measurement|unable to insert catheter|0|||
126689684|NCT01285908|455818760|FG002|Baseline Measurement|unable to insert catheter|0|||
126689685|NCT01285908|455818758|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
126689686|NCT01285908|455818759|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
126689687|NCT01285908|455818760|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
126689688|NCT01285908|455818758|FG000|Baseline Measurement|unable to tolerate procedure|1|||
126689689|NCT01285908|455818759|FG001|Baseline Measurement|unable to tolerate procedure|0|||
126689690|NCT01285908|455818760|FG002|Baseline Measurement|unable to tolerate procedure|0|||
126689691|NCT00643994|455818765|FG000|Overall Study|Death|24|||
126689692|NCT00643994|455818765|FG000|Overall Study|Lost to Follow-up|72|||
126689693|NCT04317274|455818778|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
126689694|NCT04317274|455818779|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
126689695|NCT04317274|455818780|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
126689696|NCT04317274|455818781|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
126689697|NCT00797823|455818783|FG000|First Period (Initial Randomization)|Physician Decision|1|||
126689698|NCT00797823|455818784|FG001|First Period (Initial Randomization)|Physician Decision|0|||
126689699|NCT00797823|455818785|FG002|First Period (Initial Randomization)|Physician Decision|0|||
126689700|NCT02568046|455818786|FG000|Overall Study|Adverse Event|0|||
126689701|NCT02568046|455818787|FG001|Overall Study|Adverse Event|1|||
126689702|NCT02568046|455818786|FG000|Overall Study|Death|2|||
126689703|NCT02568046|455818787|FG001|Overall Study|Death|0|||
126689704|NCT02568046|455818786|FG000|Overall Study|Progressive Disease|1|||
126689705|NCT02568046|455818787|FG001|Overall Study|Progressive Disease|0|||
126689706|NCT02568046|455818786|FG000|Overall Study|Withdrawal by Subject|2|||
126689707|NCT02568046|455818787|FG001|Overall Study|Withdrawal by Subject|1|||
126689708|NCT02568046|455818786|FG000|Overall Study|Other Events|0|||
126689709|NCT02568046|455818787|FG001|Overall Study|Other Events|1|||
126689710|NCT01127165|455818793|FG000|Overall Study|Adverse Event|2|||
126689711|NCT01127165|455818794|FG001|Overall Study|Adverse Event|2|||
126689712|NCT01127165|455818793|FG000|Overall Study|Lack of Efficacy|10|||
126689713|NCT01127165|455818794|FG001|Overall Study|Lack of Efficacy|8|||
126689714|NCT01127165|455818793|FG000|Overall Study|Lost to Follow-up|3|||
126689715|NCT01127165|455818794|FG001|Overall Study|Lost to Follow-up|5|||
126689716|NCT01127165|455818793|FG000|Overall Study|Withdrawal by Subject|1|||
126689717|NCT01127165|455818794|FG001|Overall Study|Withdrawal by Subject|3|||
126689718|NCT01127165|455818793|FG000|Overall Study|Protocol Violation|0|||
126689719|NCT01127165|455818794|FG001|Overall Study|Protocol Violation|1|||
126689720|NCT00379795|455818795|FG000|Overall Study|Death|31|||
126689721|NCT00379795|455818796|FG001|Overall Study|Death|8|||
126689722|NCT00379795|455818797|FG002|Overall Study|Death|6|||
126689723|NCT00379795|455818798|FG003|Overall Study|Death|4|||
126689724|NCT00379795|455818799|FG004|Overall Study|Death|7|||
126689725|NCT00379795|455818795|FG000|Overall Study|Adverse Event|17|||
126689726|NCT00379795|455818796|FG001|Overall Study|Adverse Event|3|||
126689727|NCT00379795|455818797|FG002|Overall Study|Adverse Event|3|||
126689728|NCT00379795|455818798|FG003|Overall Study|Adverse Event|1|||
126689729|NCT00379795|455818799|FG004|Overall Study|Adverse Event|4|||
126689730|NCT00379795|455818795|FG000|Overall Study|Lost to Follow-up|8|||
126689731|NCT00379795|455818796|FG001|Overall Study|Lost to Follow-up|1|||
126689732|NCT00379795|455818797|FG002|Overall Study|Lost to Follow-up|2|||
126689733|NCT00379795|455818798|FG003|Overall Study|Lost to Follow-up|1|||
126689734|NCT00379795|455818799|FG004|Overall Study|Lost to Follow-up|4|||
126689735|NCT00379795|455818795|FG000|Overall Study|Physician Decision|25|||
126689736|NCT00379795|455818796|FG001|Overall Study|Physician Decision|0|||
126689737|NCT00379795|455818797|FG002|Overall Study|Physician Decision|2|||
126689738|NCT00379795|455818798|FG003|Overall Study|Physician Decision|2|||
126689739|NCT00379795|455818799|FG004|Overall Study|Physician Decision|2|||
126689740|NCT00379795|455818795|FG000|Overall Study|Withdrawal by Subject|94|||
126689741|NCT00379795|455818796|FG001|Overall Study|Withdrawal by Subject|11|||
126689742|NCT00379795|455818797|FG002|Overall Study|Withdrawal by Subject|19|||
126689743|NCT00379795|455818798|FG003|Overall Study|Withdrawal by Subject|7|||
126689744|NCT00379795|455818799|FG004|Overall Study|Withdrawal by Subject|14|||
126689745|NCT00379795|455818795|FG000|Overall Study|Subject non-compliance|7|||
126689746|NCT00379795|455818796|FG001|Overall Study|Subject non-compliance|2|||
126689747|NCT00379795|455818797|FG002|Overall Study|Subject non-compliance|0|||
126689748|NCT00379795|455818798|FG003|Overall Study|Subject non-compliance|0|||
126689749|NCT00379795|455818799|FG004|Overall Study|Subject non-compliance|1|||
126689750|NCT00379795|455818795|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
126689751|NCT00379795|455818796|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
126689752|NCT00379795|455818797|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
126689753|NCT00379795|455818798|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
126689754|NCT00379795|455818799|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
126689755|NCT00379795|455818795|FG000|Overall Study|Subjects condition mandated intervention|34|||
126689756|NCT00379795|455818796|FG001|Overall Study|Subjects condition mandated intervention|9|||
126689757|NCT00379795|455818797|FG002|Overall Study|Subjects condition mandated intervention|7|||
126689758|NCT00379795|455818798|FG003|Overall Study|Subjects condition mandated intervention|5|||
126689759|NCT00379795|455818799|FG004|Overall Study|Subjects condition mandated intervention|7|||
126689760|NCT00379795|455818795|FG000|Overall Study|Sponsor's decision|257|||
126689761|NCT00379795|455818796|FG001|Overall Study|Sponsor's decision|17|||
126689762|NCT00379795|455818797|FG002|Overall Study|Sponsor's decision|54|||
126689763|NCT00379795|455818798|FG003|Overall Study|Sponsor's decision|47|||
126689764|NCT00379795|455818799|FG004|Overall Study|Sponsor's decision|10|||
126689765|NCT03175549|455818800|FG000|Overall Study|Lost to Follow-up|2|||
126689766|NCT03175549|455818801|FG001|Overall Study|Lost to Follow-up|2|||
126689767|NCT03175549|455818800|FG000|Overall Study|Medication non-compliance|2|||
126689768|NCT03175549|455818801|FG001|Overall Study|Medication non-compliance|2|||
126689769|NCT00763321|455818802|FG000|Open-label Period|Adverse Event|24|||
126689770|NCT00763321|455818803|FG001|Open-label Period|Adverse Event|0|||
126689771|NCT00763321|455818804|FG002|Open-label Period|Adverse Event|0|||
126689772|NCT00763321|455818802|FG000|Open-label Period|Lost to Follow-up|14|||
126689773|NCT00763321|455818803|FG001|Open-label Period|Lost to Follow-up|0|||
126689774|NCT00763321|455818804|FG002|Open-label Period|Lost to Follow-up|0|||
126689775|NCT00763321|455818802|FG000|Open-label Period|Withdrawal by Subject|7|||
126689776|NCT00763321|455818803|FG001|Open-label Period|Withdrawal by Subject|0|||
126689777|NCT00763321|455818804|FG002|Open-label Period|Withdrawal by Subject|0|||
126689778|NCT00763321|455818802|FG000|Open-label Period|Subject noncompliant|7|||
126689779|NCT00763321|455818803|FG001|Open-label Period|Subject noncompliant|0|||
126440716|NCT04922216|454911496|FG025|Overall Study|Lost to Follow-up|2|||
126440717|NCT04922216|454911497|FG026|Overall Study|Lost to Follow-up|0|||
126440718|NCT04922216|454911498|FG027|Overall Study|Lost to Follow-up|0|||
126689780|NCT00763321|455818804|FG002|Open-label Period|Subject noncompliant|0|||
126689781|NCT00763321|455818802|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
126440719|NCT04922216|454911499|FG028|Overall Study|Lost to Follow-up|1|||
126440720|NCT04922216|454911500|FG029|Overall Study|Lost to Follow-up|0|||
126689782|NCT00763321|455818803|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
126689783|NCT00763321|455818804|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
126689784|NCT00763321|455818802|FG000|Open-label Period|Lack of Efficacy|2|||
126689785|NCT00763321|455818803|FG001|Open-label Period|Lack of Efficacy|0|||
126689786|NCT00763321|455818804|FG002|Open-label Period|Lack of Efficacy|0|||
126689787|NCT00763321|455818802|FG000|Open-label Period|Other|4|||
126689788|NCT00763321|455818803|FG001|Open-label Period|Other|0|||
126689789|NCT00763321|455818804|FG002|Open-label Period|Other|0|||
126689790|NCT00763321|455818802|FG000|Double-blind Period|Lack of Efficacy|0|||
126689791|NCT00763321|455818803|FG001|Double-blind Period|Lack of Efficacy|9|||
126689792|NCT00763321|455818804|FG002|Double-blind Period|Lack of Efficacy|17|||
126689793|NCT00763321|455818802|FG000|Double-blind Period|Adverse Event|0|||
126689794|NCT00763321|455818803|FG001|Double-blind Period|Adverse Event|4|||
126689795|NCT00763321|455818804|FG002|Double-blind Period|Adverse Event|4|||
126689796|NCT00763321|455818802|FG000|Double-blind Period|Lost to Follow-up|0|||
126689797|NCT00763321|455818803|FG001|Double-blind Period|Lost to Follow-up|4|||
126689798|NCT00763321|455818804|FG002|Double-blind Period|Lost to Follow-up|2|||
126689799|NCT00763321|455818802|FG000|Double-blind Period|Withdrawal by Subject|0|||
126689800|NCT00763321|455818803|FG001|Double-blind Period|Withdrawal by Subject|2|||
126689801|NCT00763321|455818804|FG002|Double-blind Period|Withdrawal by Subject|3|||
126689802|NCT00763321|455818802|FG000|Double-blind Period|Other|0|||
126689803|NCT00763321|455818803|FG001|Double-blind Period|Other|2|||
126689804|NCT00763321|455818804|FG002|Double-blind Period|Other|3|||
126689805|NCT02435849|455818805|FG000|Overall Study|Death|23|||
126689806|NCT02435849|455818806|FG001|Overall Study|Death|0|||
126689807|NCT02435849|455818805|FG000|Overall Study|Lack of Efficacy|10|||
126689808|NCT02435849|455818806|FG001|Overall Study|Lack of Efficacy|0|||
126689809|NCT02435849|455818805|FG000|Overall Study|New therapy for study indication|8|||
126689810|NCT02435849|455818806|FG001|Overall Study|New therapy for study indication|0|||
126689811|NCT02435849|455818805|FG000|Overall Study|Subject/guardian decision|5|||
126689812|NCT02435849|455818806|FG001|Overall Study|Subject/guardian decision|1|||
126689813|NCT02435849|455818805|FG000|Overall Study|Lost to Follow-up|1|||
126689814|NCT02435849|455818806|FG001|Overall Study|Lost to Follow-up|0|||
126689815|NCT02435849|455818805|FG000|Overall Study|Physician Decision|1|||
126689816|NCT02435849|455818806|FG001|Overall Study|Physician Decision|0|||
126689817|NCT02486757|455818807|FG000|Overall Study|Lost to Follow-up|1|||
126689818|NCT04849780|455818808|FG000|Period 1|Covid-19 Related|1|||
126689819|NCT04849780|455818809|FG001|Period 1|Covid-19 Related|0|||
126689820|NCT04849780|455818808|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
126689821|NCT04849780|455818809|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
126689822|NCT04849780|455818808|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
126689823|NCT04849780|455818809|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
126689824|NCT02435914|455818810|FG000|Overall Study|Ocular Adverse Event|1|||
126689825|NCT02435914|455818811|FG001|Overall Study|Ocular Adverse Event|0|||
126689826|NCT02435914|455818812|FG002|Overall Study|Ocular Adverse Event|0|||
126689827|NCT02435914|455818813|FG003|Overall Study|Ocular Adverse Event|0|||
126689828|NCT02435914|455818810|FG000|Overall Study|Withdrawal by Subject|0|||
126689829|NCT02435914|455818811|FG001|Overall Study|Withdrawal by Subject|1|||
126689830|NCT02435914|455818812|FG002|Overall Study|Withdrawal by Subject|0|||
126689831|NCT02435914|455818813|FG003|Overall Study|Withdrawal by Subject|0|||
126689832|NCT02435914|455818810|FG000|Overall Study|Other Miscellaneous Reason|0|||
126689833|NCT02435914|455818811|FG001|Overall Study|Other Miscellaneous Reason|0|||
126689834|NCT02435914|455818812|FG002|Overall Study|Other Miscellaneous Reason|1|||
126689835|NCT02435914|455818813|FG003|Overall Study|Other Miscellaneous Reason|0|||
126689836|NCT01405053|455818814|FG000|Overall Study|Adverse Event|3|||
126440721|NCT04922216|454911501|FG030|Overall Study|Lost to Follow-up|2|||
126440722|NCT04922216|454911502|FG031|Overall Study|Lost to Follow-up|1|||
126440723|NCT04988477|454911504|FG000|Overall Study|Death|1|||
126440724|NCT04988477|454911505|FG001|Overall Study|Death|0|||
126440725|NCT04988477|454911506|FG002|Overall Study|Death|0|||
126440726|NCT04988477|454911504|FG000|Overall Study|Lost to Follow-up|5|||
126440727|NCT04988477|454911505|FG001|Overall Study|Lost to Follow-up|2|||
126440728|NCT04988477|454911506|FG002|Overall Study|Lost to Follow-up|0|||
126440729|NCT04988477|454911504|FG000|Overall Study|Withdrawal by Subject|2|||
126440730|NCT04988477|454911505|FG001|Overall Study|Withdrawal by Subject|0|||
126689837|NCT01405053|455818815|FG001|Overall Study|Adverse Event|0|||
126689838|NCT01405053|455818814|FG000|Overall Study|Lost to Follow-up|0|||
126689839|NCT01405053|455818815|FG001|Overall Study|Lost to Follow-up|1|||
126689840|NCT01405053|455818814|FG000|Overall Study|Participant choice|2|||
126689841|NCT01405053|455818815|FG001|Overall Study|Participant choice|1|||
126689842|NCT01405053|455818814|FG000|Overall Study|Inadequate therapeutic effect|2|||
126689843|NCT01405053|455818815|FG001|Overall Study|Inadequate therapeutic effect|1|||
126689844|NCT01405053|455818814|FG000|Overall Study|Withdrawal by Subject|3|||
126689845|NCT01405053|455818815|FG001|Overall Study|Withdrawal by Subject|4|||
126689846|NCT01405053|455818814|FG000|Overall Study|Other|0|||
126689847|NCT01405053|455818815|FG001|Overall Study|Other|1|||
126689848|NCT02175680|455818821|FG000|Overall Study|non-compliance|1|||
126689849|NCT02175680|455818821|FG000|Overall Study|other non-medical reason|1|||
126689850|NCT03979274|455818822|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126689851|NCT03979274|455818823|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126440731|NCT04988477|454911506|FG002|Overall Study|Withdrawal by Subject|0|||
126440732|NCT04610281|454913187|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
126440733|NCT04610281|454913188|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
126440734|NCT00753506|454913190|FG000|Overall Study|Withdrawal by Subject|4|||
126440735|NCT00753506|454913191|FG001|Overall Study|Withdrawal by Subject|1|||
126352359|NCT02493855|454580725|FG002|Overall Study|Withdrawal by Subject|0|||
126352360|NCT02453048|454580726|FG000|Overall Study|Only part of initial 6 mo. study|0|||
126352361|NCT02453048|454580727|FG001|Overall Study|Only part of initial 6 mo. study|0|||
126352362|NCT02453048|454580728|FG002|Overall Study|Only part of initial 6 mo. study|0|||
126352363|NCT02453048|454580729|FG003|Overall Study|Only part of initial 6 mo. study|0|||
126352364|NCT02453048|454580730|FG004|Overall Study|Only part of initial 6 mo. study|6|||
126760185|NCT04419558|456072415|FG000|DB Period (48 Weeks)|Disease Progression|1|||
126760186|NCT04419558|456072416|FG001|DB Period (48 Weeks)|Disease Progression|0|||
126760187|NCT04419558|456072415|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
126440736|NCT00753506|454913190|FG000|Overall Study|Lost to Follow-up|2|||
126440737|NCT00753506|454913191|FG001|Overall Study|Lost to Follow-up|0|||
126440738|NCT00753506|454913190|FG000|Overall Study|Other reason|1|||
126440739|NCT00753506|454913191|FG001|Overall Study|Other reason|1|||
126440740|NCT00719472|454913195|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
126440741|NCT00719472|454913195|FG000|Enrolled in Study|Subject decision to withdraw|8|||
126440742|NCT00719472|454913195|FG000|Enrolled in Study|Various Reasons|17|||
126440743|NCT00719472|454913195|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
126440744|NCT00719472|454913195|FG000|Received Cycle 1 Treatment|Death|5|||
126440745|NCT00719472|454913195|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
126440746|NCT00719472|454913195|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
126440747|NCT00719472|454913195|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
126440748|NCT00719472|454913195|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
126440749|NCT00719472|454913195|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
126440750|NCT00719472|454913195|FG000|Received Cycle 2 Treatment|Death|6|||
126440751|NCT00719472|454913195|FG000|Received Cycle 2 Treatment|Disease progression|3|||
126440752|NCT00719472|454913195|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
126440753|NCT00719472|454913195|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
126440754|NCT00719472|454913195|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
126440755|NCT00719472|454913195|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
126440756|NCT01244893|454913196|FG000|Baseline|Protocol Violation|0|||
126440757|NCT01244893|454913197|FG001|Baseline|Protocol Violation|1|||
126440758|NCT01244893|454913196|FG000|1-Week Follow Up|Lost to Follow-up|1|||
126440759|NCT01244893|454913197|FG001|1-Week Follow Up|Lost to Follow-up|0|||
126440760|NCT00521404|454913198|FG000|Overall Study|Adverse Event|13|||
126440761|NCT00521404|454913198|FG000|Overall Study|Disease Progression|33|||
126440762|NCT00521404|454913198|FG000|Overall Study|Investigator decision|5|||
126440763|NCT00521404|454913198|FG000|Overall Study|Withdrawal of consent|3|||
126440764|NCT00521404|454913198|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
126440765|NCT00521404|454913198|FG000|Overall Study|Other|7|||
126440766|NCT02282605|454913200|FG000|Overall Study|negative SA result on Day -1|3|||
126440767|NCT02282605|454913201|FG001|Overall Study|negative SA result on Day -1|0|||
126440768|NCT02282605|454913202|FG002|Overall Study|negative SA result on Day -1|0|||
126440769|NCT03584789|454913205|FG000|Overall Study|refused EHR permission|19|||
126440770|NCT03584789|454913206|FG001|Overall Study|refused EHR permission|28|||
126440771|NCT03584789|454913207|FG002|Overall Study|refused EHR permission|23|||
126440772|NCT03584789|454913205|FG000|Overall Study|patients tied to a provider who retired|0|||
126440773|NCT03584789|454913206|FG001|Overall Study|patients tied to a provider who retired|0|||
126440774|NCT03584789|454913207|FG002|Overall Study|patients tied to a provider who retired|3|||
126440775|NCT00711191|454913208|FG000|Overall Study|Adverse Event|1|||
126440776|NCT00711191|454913209|FG001|Overall Study|Adverse Event|1|||
126440777|NCT00711191|454913210|FG002|Overall Study|Adverse Event|2|||
126440778|NCT00711191|454913208|FG000|Overall Study|Objective progression or relapse|2|||
126440779|NCT00711191|454913209|FG001|Overall Study|Objective progression or relapse|3|||
126760188|NCT04419558|456072416|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
126760189|NCT04419558|456072415|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
126760190|NCT04419558|456072416|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
126440780|NCT00711191|454913210|FG002|Overall Study|Objective progression or relapse|7|||
126760191|NCT04419558|456072415|FG000|DB Period (48 Weeks)|Participant Decision|4|||
126760192|NCT04419558|456072416|FG001|DB Period (48 Weeks)|Participant Decision|3|||
126440781|NCT00711191|454913208|FG000|Overall Study|Withdrawal by Subject|0|||
126440782|NCT00711191|454913209|FG001|Overall Study|Withdrawal by Subject|1|||
126440783|NCT00711191|454913210|FG002|Overall Study|Withdrawal by Subject|3|||
126440784|NCT02035267|454913211|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
126440785|NCT02035267|454913212|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
126689852|NCT01665144|455818824|FG000|Core Part|Withdrawal by Subject|96|||
126689853|NCT01665144|455818825|FG001|Core Part|Withdrawal by Subject|77|||
126689854|NCT01665144|455818826|FG002|Core Part|Withdrawal by Subject|0|||
126689855|NCT01665144|455818824|FG000|Core Part|Adverse Event|45|||
126689856|NCT01665144|455818825|FG001|Core Part|Adverse Event|18|||
126689857|NCT01665144|455818826|FG002|Core Part|Adverse Event|0|||
126689858|NCT01665144|455818824|FG000|Core Part|Lack of Efficacy|16|||
126689859|NCT01665144|455818825|FG001|Core Part|Lack of Efficacy|11|||
126689860|NCT01665144|455818826|FG002|Core Part|Lack of Efficacy|0|||
126689861|NCT01665144|455818824|FG000|Core Part|Lost to Follow-up|9|||
126689862|NCT01665144|455818825|FG001|Core Part|Lost to Follow-up|8|||
126689863|NCT01665144|455818826|FG002|Core Part|Lost to Follow-up|0|||
126689864|NCT01665144|455818824|FG000|Core Part|Physician Decision|13|||
126689865|NCT01665144|455818825|FG001|Core Part|Physician Decision|1|||
126689866|NCT01665144|455818826|FG002|Core Part|Physician Decision|0|||
126689867|NCT01665144|455818824|FG000|Core Part|Progressive disease|8|||
126689868|NCT01665144|455818825|FG001|Core Part|Progressive disease|4|||
126689869|NCT01665144|455818826|FG002|Core Part|Progressive disease|0|||
126689870|NCT01665144|455818824|FG000|Core Part|Non-compliance with study treatment|5|||
126689871|NCT01665144|455818825|FG001|Core Part|Non-compliance with study treatment|0|||
126689872|NCT01665144|455818826|FG002|Core Part|Non-compliance with study treatment|0|||
126689873|NCT01665144|455818824|FG000|Core Part|Death|3|||
126689874|NCT01665144|455818825|FG001|Core Part|Death|1|||
126689875|NCT01665144|455818826|FG002|Core Part|Death|0|||
126689876|NCT01665144|455818824|FG000|Core Part|Protocol deviation|3|||
126689877|NCT01665144|455818825|FG001|Core Part|Protocol deviation|1|||
126689878|NCT01665144|455818826|FG002|Core Part|Protocol deviation|0|||
126689879|NCT01665144|455818824|FG000|Core Part|New therapy for study indication|2|||
126689880|NCT01665144|455818825|FG001|Core Part|New therapy for study indication|1|||
126689881|NCT01665144|455818826|FG002|Core Part|New therapy for study indication|0|||
126689882|NCT01665144|455818824|FG000|Core Part|Technical problems|2|||
126689883|NCT01665144|455818825|FG001|Core Part|Technical problems|0|||
126689884|NCT01665144|455818826|FG002|Core Part|Technical problems|0|||
126689885|NCT01665144|455818824|FG000|Extension Part|Patient/guardian decision|180|||
126689886|NCT01665144|455818825|FG001|Extension Part|Patient/guardian decision|0|||
126689887|NCT01665144|455818826|FG002|Extension Part|Patient/guardian decision|98|||
126689888|NCT01665144|455818824|FG000|Extension Part|Adverse Event|104|||
126689889|NCT01665144|455818825|FG001|Extension Part|Adverse Event|0|||
126689890|NCT01665144|455818826|FG002|Extension Part|Adverse Event|59|||
126689891|NCT01665144|455818824|FG000|Extension Part|Study closed early|42|||
126689892|NCT01665144|455818825|FG001|Extension Part|Study closed early|0|||
126689893|NCT01665144|455818826|FG002|Extension Part|Study closed early|19|||
126689894|NCT01665144|455818824|FG000|Extension Part|Progressive disease|36|||
126689895|NCT01665144|455818825|FG001|Extension Part|Progressive disease|0|||
126689896|NCT01665144|455818826|FG002|Extension Part|Progressive disease|14|||
126689897|NCT01665144|455818824|FG000|Extension Part|Lack of Efficacy|37|||
126689898|NCT01665144|455818825|FG001|Extension Part|Lack of Efficacy|0|||
126689899|NCT01665144|455818826|FG002|Extension Part|Lack of Efficacy|12|||
126689900|NCT01665144|455818824|FG000|Extension Part|Physician Decision|29|||
126689901|NCT01665144|455818825|FG001|Extension Part|Physician Decision|0|||
126440786|NCT02035267|454913213|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
126440787|NCT02035267|454913214|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
126689902|NCT01665144|455818826|FG002|Extension Part|Physician Decision|13|||
126689903|NCT01665144|455818824|FG000|Extension Part|Technical problems|20|||
126689904|NCT01665144|455818825|FG001|Extension Part|Technical problems|0|||
126689905|NCT01665144|455818826|FG002|Extension Part|Technical problems|8|||
126689906|NCT01665144|455818824|FG000|Extension Part|Death|20|||
126689907|NCT01665144|455818825|FG001|Extension Part|Death|0|||
126689908|NCT01665144|455818826|FG002|Extension Part|Death|4|||
126689909|NCT01665144|455818824|FG000|Extension Part|Missing|12|||
126689910|NCT01665144|455818825|FG001|Extension Part|Missing|0|||
126689911|NCT01665144|455818826|FG002|Extension Part|Missing|6|||
126689912|NCT01665144|455818824|FG000|Extension Part|Lost to Follow-up|9|||
126689913|NCT01665144|455818825|FG001|Extension Part|Lost to Follow-up|0|||
126689914|NCT01665144|455818826|FG002|Extension Part|Lost to Follow-up|5|||
126689915|NCT01665144|455818824|FG000|Extension Part|New therapy for study indication|3|||
126689916|NCT01665144|455818825|FG001|Extension Part|New therapy for study indication|0|||
126689917|NCT01665144|455818826|FG002|Extension Part|New therapy for study indication|2|||
126689918|NCT01665144|455818824|FG000|Extension Part|Protocol deviation|3|||
126689919|NCT01665144|455818825|FG001|Extension Part|Protocol deviation|0|||
126689920|NCT01665144|455818826|FG002|Extension Part|Protocol deviation|0|||
126689921|NCT01913483|455818831|FG000|Overall Study|Withdrawal by Subject|1|||
126689922|NCT01913483|455818832|FG001|Overall Study|Withdrawal by Subject|2|||
126689923|NCT01913483|455818831|FG000|Overall Study|Lost to Follow-up|6|||
126689924|NCT01913483|455818832|FG001|Overall Study|Lost to Follow-up|3|||
126689925|NCT01913483|455818831|FG000|Overall Study|Death|14|||
126689926|NCT01913483|455818832|FG001|Overall Study|Death|17|||
126689927|NCT01816243|455818833|FG000|Overall Study|Adverse Event|6|||
126689928|NCT01816243|455818833|FG000|Overall Study|Lost to Follow-up|1|||
126689929|NCT01816243|455818833|FG000|Overall Study|Lack of Efficacy|1|||
126689930|NCT01816243|455818833|FG000|Overall Study|Not eligible for the study|1|||
126689931|NCT01816243|455818833|FG000|Overall Study|Amputation|3|||
126689932|NCT00915343|455818834|FG000|Part B - Open Label Period|Treatment switch|0|||
126689933|NCT00915343|455818835|FG001|Part B - Open Label Period|Treatment switch|0|||
126689934|NCT00915343|455818836|FG002|Part B - Open Label Period|Treatment switch|1|||
126689935|NCT00915343|455818834|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
126689936|NCT00915343|455818835|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
126352365|NCT02453048|454580726|FG000|Overall Study|Lost to Follow-up|0|||
126352366|NCT02453048|454580727|FG001|Overall Study|Lost to Follow-up|1|||
126352367|NCT02453048|454580728|FG002|Overall Study|Lost to Follow-up|2|||
126352368|NCT02453048|454580729|FG003|Overall Study|Lost to Follow-up|0|||
126352369|NCT02453048|454580730|FG004|Overall Study|Lost to Follow-up|0|||
126352370|NCT01482221|454580731|FG000|Overall Study|Lack of Efficacy|1|||
126352371|NCT01482221|454580732|FG001|Overall Study|Lack of Efficacy|0|||
126352372|NCT01482221|454580733|FG002|Overall Study|Lack of Efficacy|1|||
126352373|NCT01482221|454580731|FG000|Overall Study|Lost to Follow-up|3|||
126352374|NCT01482221|454580732|FG001|Overall Study|Lost to Follow-up|2|||
126352375|NCT01482221|454580733|FG002|Overall Study|Lost to Follow-up|1|||
126352376|NCT01482221|454580731|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
126352377|NCT01482221|454580732|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
126352378|NCT01482221|454580733|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
126352379|NCT01482221|454580731|FG000|Overall Study|Condition under Investigation Worsened|3|||
126352380|NCT01482221|454580732|FG001|Overall Study|Condition under Investigation Worsened|2|||
126352381|NCT01482221|454580733|FG002|Overall Study|Condition under Investigation Worsened|4|||
126352382|NCT01482221|454580731|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
126352383|NCT01482221|454580732|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
126352384|NCT01482221|454580733|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
126352385|NCT01482221|454580731|FG000|Overall Study|Adverse Event|1|||
126352386|NCT01482221|454580732|FG001|Overall Study|Adverse Event|7|||
126352387|NCT01482221|454580733|FG002|Overall Study|Adverse Event|3|||
126352388|NCT01482221|454580731|FG000|Overall Study|Withdrawal by Subject|10|||
126352389|NCT01482221|454580732|FG001|Overall Study|Withdrawal by Subject|7|||
126352390|NCT01482221|454580733|FG002|Overall Study|Withdrawal by Subject|12|||
126352391|NCT01482221|454580731|FG000|Overall Study|Incorrect randomization|0|||
126352392|NCT01482221|454580732|FG001|Overall Study|Incorrect randomization|1|||
126352393|NCT01482221|454580733|FG002|Overall Study|Incorrect randomization|0|||
126352394|NCT01482221|454580731|FG000|Overall Study|Physician Decision|0|||
126352395|NCT01482221|454580732|FG001|Overall Study|Physician Decision|1|||
126352396|NCT01482221|454580733|FG002|Overall Study|Physician Decision|0|||
126689937|NCT00915343|455818836|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
126689938|NCT01920711|455818837|FG000|Overall Study|Death|347|||
126689939|NCT01920711|455818838|FG001|Overall Study|Death|356|||
126689940|NCT01920711|455818837|FG000|Overall Study|Lost to Follow-up|13|||
126689941|NCT01920711|455818838|FG001|Overall Study|Lost to Follow-up|14|||
126689942|NCT01920711|455818837|FG000|Overall Study|Withdrawal by Subject|4|||
126689943|NCT01920711|455818838|FG001|Overall Study|Withdrawal by Subject|3|||
126689944|NCT02319044|455818839|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
126689945|NCT02319044|455818840|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
126689946|NCT02319044|455818841|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
126689947|NCT02319044|455818839|FG000|Overall Study|Withdrawal by Subject|3|||
126689948|NCT02319044|455818840|FG001|Overall Study|Withdrawal by Subject|3|||
126689949|NCT02319044|455818841|FG002|Overall Study|Withdrawal by Subject|6|||
126689950|NCT02319044|455818839|FG000|Overall Study|Condition under investigation worsened|100|||
126760193|NCT04419558|456072415|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
126760194|NCT04419558|456072416|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
126760195|NCT04419558|456072415|FG000|OLE Period (48 Weeks)|Death|4|||
126760196|NCT04419558|456072416|FG001|OLE Period (48 Weeks)|Death|6|||
126760197|NCT04419558|456072415|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
126760198|NCT04419558|456072416|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
126760199|NCT04419558|456072415|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
126760200|NCT04419558|456072416|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
126760201|NCT00903357|456072417|FG000|First Intervention|Withdrawal by Subject|5|||
126760202|NCT00903357|456072418|FG001|First Intervention|Withdrawal by Subject|3|||
126760203|NCT00903357|456072417|FG000|First Intervention|Flu|0|||
126760204|NCT00903357|456072418|FG001|First Intervention|Flu|1|||
126760205|NCT00903357|456072417|FG000|Wash Out Period of 2 Weeks|Flu|0|||
126760206|NCT00903357|456072418|FG001|Wash Out Period of 2 Weeks|Flu|1|||
126760207|NCT00903357|456072417|FG000|Second Intervention|Lost to Follow-up|1|||
126760208|NCT00903357|456072418|FG001|Second Intervention|Lost to Follow-up|0|||
126760209|NCT05146999|456072420|FG000|Overall Study|Withdrew consent|6|||
126760210|NCT05146999|456072421|FG001|Overall Study|Withdrew consent|1|||
126760211|NCT05146999|456072420|FG000|Overall Study|Lost to Follow-up|3|||
126760212|NCT05146999|456072421|FG001|Overall Study|Lost to Follow-up|2|||
126760213|NCT05146999|456072420|FG000|Overall Study|Other|1|||
126760214|NCT05146999|456072421|FG001|Overall Study|Other|3|||
126760215|NCT04668157|456072422|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
126760216|NCT04668157|456072423|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
126760217|NCT04668157|456072422|FG000|Treatment Period (52 Weeks)|Other|0|||
126760218|NCT04668157|456072423|FG001|Treatment Period (52 Weeks)|Other|2|||
126760219|NCT00383292|456072424|FG000|Overall Study|Adverse Event|4|||
126760220|NCT00383292|456072425|FG001|Overall Study|Adverse Event|1|||
126689951|NCT02319044|455818840|FG001|Overall Study|Condition under investigation worsened|50|||
126689952|NCT02319044|455818841|FG002|Overall Study|Condition under investigation worsened|46|||
126760221|NCT00383292|456072426|FG002|Overall Study|Adverse Event|2|||
126760222|NCT00383292|456072424|FG000|Overall Study|Death|3|||
126760223|NCT00383292|456072425|FG001|Overall Study|Death|3|||
126760224|NCT00383292|456072426|FG002|Overall Study|Death|3|||
126760225|NCT00383292|456072424|FG000|Overall Study|Physician Decision|4|||
126760226|NCT00383292|456072425|FG001|Overall Study|Physician Decision|0|||
126352397|NCT03086343|454580734|FG000|Period 1|Adverse Event|7|||
126352398|NCT03086343|454580735|FG001|Period 1|Adverse Event|7|||
126352399|NCT03086343|454580736|FG002|Period 1|Adverse Event|0|||
126352400|NCT03086343|454580737|FG003|Period 1|Adverse Event|1|||
126352401|NCT03086343|454580734|FG000|Period 1|Withdrawal by Subject|6|||
126352402|NCT03086343|454580735|FG001|Period 1|Withdrawal by Subject|10|||
126352403|NCT03086343|454580736|FG002|Period 1|Withdrawal by Subject|0|||
126352404|NCT03086343|454580737|FG003|Period 1|Withdrawal by Subject|0|||
126352405|NCT03086343|454580734|FG000|Period 1|Lost to Follow-up|1|||
126352406|NCT03086343|454580735|FG001|Period 1|Lost to Follow-up|3|||
126352407|NCT03086343|454580736|FG002|Period 1|Lost to Follow-up|1|||
126352408|NCT03086343|454580737|FG003|Period 1|Lost to Follow-up|0|||
126352409|NCT03086343|454580734|FG000|Period 1|Other, Not Specified|10|||
126352410|NCT03086343|454580735|FG001|Period 1|Other, Not Specified|12|||
126352411|NCT03086343|454580736|FG002|Period 1|Other, Not Specified|2|||
126352412|NCT03086343|454580737|FG003|Period 1|Other, Not Specified|1|||
126352413|NCT03086343|454580734|FG000|Period 1|Missing|1|||
126352414|NCT03086343|454580735|FG001|Period 1|Missing|0|||
126352415|NCT03086343|454580736|FG002|Period 1|Missing|0|||
126352416|NCT03086343|454580737|FG003|Period 1|Missing|0|||
126352417|NCT03086343|454580734|FG000|Period 2|Adverse Event|20|||
126352418|NCT03086343|454580735|FG001|Period 2|Adverse Event|11|||
126352419|NCT03086343|454580736|FG002|Period 2|Adverse Event|1|||
126352420|NCT03086343|454580737|FG003|Period 2|Adverse Event|2|||
126352421|NCT03086343|454580734|FG000|Period 2|Withdrawal by Subject|15|||
126352422|NCT03086343|454580735|FG001|Period 2|Withdrawal by Subject|25|||
126352423|NCT03086343|454580736|FG002|Period 2|Withdrawal by Subject|2|||
126352424|NCT03086343|454580737|FG003|Period 2|Withdrawal by Subject|2|||
126352425|NCT03086343|454580734|FG000|Period 2|Lost to Follow-up|6|||
126352426|NCT03086343|454580735|FG001|Period 2|Lost to Follow-up|11|||
126352427|NCT03086343|454580736|FG002|Period 2|Lost to Follow-up|1|||
126689953|NCT02319044|455818839|FG000|Overall Study|Adverse Event|17|||
126689954|NCT02319044|455818840|FG001|Overall Study|Adverse Event|2|||
126440788|NCT02035267|454913211|FG000|Overall Study|Adverse Event|0|||
126440789|NCT02035267|454913212|FG001|Overall Study|Adverse Event|0|||
126440790|NCT02035267|454913213|FG002|Overall Study|Adverse Event|1|||
126440791|NCT02035267|454913214|FG003|Overall Study|Adverse Event|0|||
126440792|NCT02035267|454913211|FG000|Overall Study|Lost to Follow-up|0|||
126440793|NCT02035267|454913212|FG001|Overall Study|Lost to Follow-up|0|||
126440794|NCT02035267|454913213|FG002|Overall Study|Lost to Follow-up|0|||
126440795|NCT02035267|454913214|FG003|Overall Study|Lost to Follow-up|1|||
126440796|NCT02035267|454913211|FG000|Overall Study|Other unspecified|0|||
126440797|NCT02035267|454913212|FG001|Overall Study|Other unspecified|1|||
126689955|NCT02319044|455818841|FG002|Overall Study|Adverse Event|8|||
126715180|NCT01052012|455908707|FG001|Overall Study|Lost to Follow-up|0|||
126440798|NCT02035267|454913213|FG002|Overall Study|Other unspecified|0|||
126440799|NCT02035267|454913214|FG003|Overall Study|Other unspecified|0|||
126440800|NCT02803580|454913216|FG000|Overall Study|Death|13|||
126440801|NCT02803580|454913216|FG000|Overall Study|Lost to Follow-up|19|||
126440802|NCT02803580|454913216|FG000|Overall Study|Withdrawal by Subject|3|||
126440803|NCT02803580|454913216|FG000|Overall Study|Inclusion in clinical trial|1|||
126440804|NCT00836693|454913222|FG000|Overall Study|Adverse Event|4|||
126440805|NCT00836693|454913223|FG001|Overall Study|Adverse Event|1|||
126440806|NCT00836693|454913222|FG000|Overall Study|Sponsor Decision|0|||
126440807|NCT00836693|454913223|FG001|Overall Study|Sponsor Decision|1|||
126440808|NCT00836693|454913222|FG000|Overall Study|Physician Decision|2|||
126440809|NCT00836693|454913223|FG001|Overall Study|Physician Decision|0|||
126440810|NCT00836693|454913222|FG000|Overall Study|Withdrawal by Subject|9|||
126440811|NCT00836693|454913223|FG001|Overall Study|Withdrawal by Subject|4|||
126440812|NCT00836693|454913222|FG000|Overall Study|Protocol Violation|1|||
126440813|NCT00836693|454913223|FG001|Overall Study|Protocol Violation|0|||
126440814|NCT00836693|454913222|FG000|Overall Study|Lost to Follow-up|1|||
126440815|NCT00836693|454913223|FG001|Overall Study|Lost to Follow-up|0|||
126440816|NCT02612779|454913224|FG000|Overall Study|Administrative reason by sponsor|4|||
126440817|NCT02612779|454913225|FG001|Overall Study|Administrative reason by sponsor|1|||
126440818|NCT02612779|454913224|FG000|Overall Study|No longer meet study criteria|0|||
126440819|NCT02612779|454913225|FG001|Overall Study|No longer meet study criteria|1|||
126440820|NCT02612779|454913224|FG000|Overall Study|Disease progression|29|||
126440821|NCT02612779|454913225|FG001|Overall Study|Disease progression|2|||
126440822|NCT02612779|454913224|FG000|Overall Study|Study drug toxicity|10|||
126440823|NCT02612779|454913225|FG001|Overall Study|Study drug toxicity|1|||
126440824|NCT02612779|454913224|FG000|Overall Study|Death|1|||
126440825|NCT02612779|454913225|FG001|Overall Study|Death|0|||
126440826|NCT02612779|454913224|FG000|Overall Study|Adverse event unrelated to study drug|5|||
126440827|NCT02612779|454913225|FG001|Overall Study|Adverse event unrelated to study drug|0|||
126440828|NCT02612779|454913224|FG000|Overall Study|Participant withdrew consent|4|||
126440829|NCT02612779|454913225|FG001|Overall Study|Participant withdrew consent|0|||
126440830|NCT02612779|454913224|FG000|Overall Study|Lost to Follow-up|1|||
126440831|NCT02612779|454913225|FG001|Overall Study|Lost to Follow-up|0|||
126440832|NCT02612779|454913224|FG000|Overall Study|Maximum clinical benefit|10|||
126440833|NCT02612779|454913225|FG001|Overall Study|Maximum clinical benefit|1|||
126440834|NCT02612779|454913224|FG000|Overall Study|Other reasons|4|||
126440835|NCT02612779|454913225|FG001|Overall Study|Other reasons|0|||
126440836|NCT01750229|454913226|FG000|Randomized Crossover Phase|Adverse Event|1|||
126440837|NCT01750229|454913226|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
126440838|NCT01750229|454913226|FG000|Long-term Follow-up Phase|Adverse Event|2|||
126440839|NCT01750229|454913226|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
126440840|NCT03722238|454913229|FG000|Overall Study|Protocol Violation|1|||
126440841|NCT03722238|454913230|FG001|Overall Study|Protocol Violation|0|||
126440842|NCT03722238|454913229|FG000|Overall Study|Physician Decision|1|||
126440843|NCT03722238|454913230|FG001|Overall Study|Physician Decision|0|||
126440844|NCT03722238|454913229|FG000|Overall Study|Death|1|||
126440845|NCT03722238|454913230|FG001|Overall Study|Death|0|||
126440846|NCT03722238|454913229|FG000|Overall Study|Lost to Follow-up|6|||
126440847|NCT03722238|454913230|FG001|Overall Study|Lost to Follow-up|0|||
126440848|NCT03722238|454913229|FG000|Overall Study|Partial missing data|44|||
126440849|NCT03722238|454913230|FG001|Overall Study|Partial missing data|1|||
126440850|NCT03722238|454913229|FG000|Overall Study|Withdrawal by Subject|2|||
126440851|NCT03722238|454913230|FG001|Overall Study|Withdrawal by Subject|0|||
126440852|NCT03722238|454913229|FG000|Overall Study|Other|4|||
126689956|NCT02319044|455818839|FG000|Overall Study|Study specific discontinuation criteria|2|||
126689957|NCT02319044|455818840|FG001|Overall Study|Study specific discontinuation criteria|2|||
126440853|NCT03722238|454913230|FG001|Overall Study|Other|0|||
126440854|NCT03722238|454913229|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
126440855|NCT03722238|454913230|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
126440856|NCT03722238|454913229|FG000|Overall Study|Did not meet risk classification group criteria|90|||
126440857|NCT03722238|454913230|FG001|Overall Study|Did not meet risk classification group criteria|0|||
126440858|NCT03722238|454913229|FG000|Overall Study|Did not sign consent|17|||
126440859|NCT03722238|454913230|FG001|Overall Study|Did not sign consent|0|||
126440860|NCT03722238|454913229|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
126440861|NCT03722238|454913230|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
126440862|NCT03722238|454913229|FG000|Overall Study|Not willing to purchase study medication|142|||
126440863|NCT03722238|454913230|FG001|Overall Study|Not willing to purchase study medication|0|||
126440864|NCT03722238|454913229|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
126440865|NCT03722238|454913230|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
126440866|NCT00885170|454913239|FG000|Overall Study|Adverse Event|12|||
126440867|NCT00885170|454913240|FG001|Overall Study|Adverse Event|4|||
126440868|NCT00885170|454913239|FG000|Overall Study|Excessive bone loss|6|||
126440869|NCT00885170|454913240|FG001|Overall Study|Excessive bone loss|3|||
126440870|NCT00885170|454913239|FG000|Overall Study|Lost to Follow-up|2|||
126440871|NCT00885170|454913240|FG001|Overall Study|Lost to Follow-up|1|||
126440872|NCT00885170|454913239|FG000|Overall Study|Physician Decision|2|||
126440873|NCT00885170|454913240|FG001|Overall Study|Physician Decision|1|||
126440874|NCT00885170|454913239|FG000|Overall Study|Protocol Violation|3|||
126440875|NCT00885170|454913240|FG001|Overall Study|Protocol Violation|1|||
126440876|NCT00885170|454913239|FG000|Overall Study|Withdrawal by Subject|13|||
126440877|NCT00885170|454913240|FG001|Overall Study|Withdrawal by Subject|13|||
126440878|NCT03771664|454913241|FG000|Overall Study|Adverse Event|1|||
126440879|NCT03771664|454913242|FG001|Overall Study|Adverse Event|0|||
126440880|NCT03771664|454913241|FG000|Overall Study|Lost to Follow-up|1|||
126440881|NCT03771664|454913242|FG001|Overall Study|Lost to Follow-up|0|||
126440882|NCT03771664|454913241|FG000|Overall Study|Withdrawal by Participant|1|||
126440883|NCT03771664|454913242|FG001|Overall Study|Withdrawal by Participant|4|||
126440884|NCT03771664|454913241|FG000|Overall Study|Randomized but not Treated|0|||
126440885|NCT03771664|454913242|FG001|Overall Study|Randomized but not Treated|1|||
126440886|NCT00561925|454913243|FG000|14 Day Lead-In Period|Adverse Event|38|||
126440887|NCT00561925|454913244|FG001|14 Day Lead-In Period|Adverse Event|0|||
126440888|NCT00561925|454913245|FG002|14 Day Lead-In Period|Adverse Event|0|||
126440889|NCT00561925|454913246|FG003|14 Day Lead-In Period|Adverse Event|0|||
126440890|NCT00561925|454913247|FG004|14 Day Lead-In Period|Adverse Event|0|||
126440891|NCT00561925|454913243|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
126440892|NCT00561925|454913244|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
126440893|NCT00561925|454913245|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
126440894|NCT00561925|454913246|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
126440895|NCT00561925|454913247|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
126440896|NCT00561925|454913243|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
126440897|NCT00561925|454913244|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
126440898|NCT00561925|454913245|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
126440899|NCT00561925|454913246|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
126440900|NCT00561925|454913247|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
126440901|NCT00561925|454913243|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
126440902|NCT00561925|454913244|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
126440903|NCT00561925|454913245|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
126440904|NCT00561925|454913246|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
126440905|NCT00561925|454913247|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
126440906|NCT00561925|454913243|FG000|14 Day Lead-In Period|Other|5|||
126440907|NCT00561925|454913244|FG001|14 Day Lead-In Period|Other|0|||
126440908|NCT00561925|454913245|FG002|14 Day Lead-In Period|Other|0|||
126440909|NCT00561925|454913246|FG003|14 Day Lead-In Period|Other|0|||
126440910|NCT00561925|454913247|FG004|14 Day Lead-In Period|Other|0|||
126440911|NCT00561925|454913243|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
126440912|NCT00561925|454913244|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
126440913|NCT00561925|454913245|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
126440914|NCT00561925|454913246|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
126689958|NCT02319044|455818841|FG002|Overall Study|Study specific discontinuation criteria|1|||
126689959|NCT02319044|455818839|FG000|Overall Study|Not treated|0|||
126440915|NCT00561925|454913247|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
126689960|NCT02319044|455818840|FG001|Overall Study|Not treated|2|||
126689961|NCT02319044|455818841|FG002|Overall Study|Not treated|2|||
126689962|NCT03434379|455818842|FG000|Global Period|Lost to Follow-up|3|||
126440916|NCT00561925|454913243|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
126440917|NCT00561925|454913244|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
126440918|NCT00561925|454913245|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
126440919|NCT00561925|454913246|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
126440920|NCT00561925|454913247|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
126440921|NCT00561925|454913243|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
126689963|NCT03434379|455818843|FG001|Global Period|Lost to Follow-up|6|||
126689964|NCT03434379|455818844|FG002|Global Period|Lost to Follow-up|0|||
126689965|NCT03434379|455818845|FG003|Global Period|Lost to Follow-up|0|||
126689966|NCT03434379|455818842|FG000|Global Period|Death|115|||
126689967|NCT03434379|455818843|FG001|Global Period|Death|228|||
126689968|NCT03434379|455818844|FG002|Global Period|Death|0|||
126689969|NCT03434379|455818845|FG003|Global Period|Death|0|||
126689970|NCT03434379|455818842|FG000|Global Period|Withdrawal by Subject|20|||
126689971|NCT03434379|455818843|FG001|Global Period|Withdrawal by Subject|21|||
126689972|NCT03434379|455818844|FG002|Global Period|Withdrawal by Subject|0|||
126689973|NCT03434379|455818845|FG003|Global Period|Withdrawal by Subject|0|||
126689974|NCT03434379|455818842|FG000|Global Period|Reason Unspecified|0|||
126689975|NCT03434379|455818843|FG001|Global Period|Reason Unspecified|1|||
126689976|NCT03434379|455818844|FG002|Global Period|Reason Unspecified|0|||
126689977|NCT03434379|455818845|FG003|Global Period|Reason Unspecified|0|||
126689978|NCT03434379|455818842|FG000|Global Period|Study Ended by Sponsor|26|||
126689979|NCT03434379|455818843|FG001|Global Period|Study Ended by Sponsor|80|||
126689980|NCT03434379|455818844|FG002|Global Period|Study Ended by Sponsor|0|||
126689981|NCT03434379|455818845|FG003|Global Period|Study Ended by Sponsor|0|||
126689982|NCT03434379|455818842|FG000|Global Period|Physician Decision|1|||
126689983|NCT03434379|455818843|FG001|Global Period|Physician Decision|0|||
126689984|NCT03434379|455818844|FG002|Global Period|Physician Decision|0|||
126689985|NCT03434379|455818845|FG003|Global Period|Physician Decision|0|||
126689986|NCT03434379|455818842|FG000|China Extension Period|Lost to Follow-up|0|||
126689987|NCT03434379|455818843|FG001|China Extension Period|Lost to Follow-up|0|||
126689988|NCT03434379|455818844|FG002|China Extension Period|Lost to Follow-up|2|||
126689989|NCT03434379|455818845|FG003|China Extension Period|Lost to Follow-up|3|||
126689990|NCT03434379|455818842|FG000|China Extension Period|Death|0|||
126689991|NCT03434379|455818843|FG001|China Extension Period|Death|0|||
126689992|NCT03434379|455818844|FG002|China Extension Period|Death|46|||
126689993|NCT03434379|455818845|FG003|China Extension Period|Death|88|||
126689994|NCT03434379|455818842|FG000|China Extension Period|Withdrawal by Subject|0|||
126689995|NCT03434379|455818843|FG001|China Extension Period|Withdrawal by Subject|0|||
126689996|NCT03434379|455818844|FG002|China Extension Period|Withdrawal by Subject|8|||
126689997|NCT03434379|455818845|FG003|China Extension Period|Withdrawal by Subject|6|||
126689998|NCT03434379|455818842|FG000|China Extension Period|Study Ended by Sponsor|0|||
126689999|NCT03434379|455818843|FG001|China Extension Period|Study Ended by Sponsor|0|||
126690000|NCT03434379|455818844|FG002|China Extension Period|Study Ended by Sponsor|5|||
126690001|NCT03434379|455818845|FG003|China Extension Period|Study Ended by Sponsor|36|||
126690002|NCT00911989|455818846|FG000|Overall Study|Adverse Event|1|||
126690003|NCT01145066|455818847|FG000|Overall Study|To resume NSAIDs|2|||
126690004|NCT01145066|455818848|FG001|Overall Study|To resume NSAIDs|2|||
126690005|NCT01145066|455818849|FG002|Overall Study|To resume NSAIDs|1|||
126690006|NCT01145066|455818847|FG000|Overall Study|Non-related surgery|0|||
126690007|NCT01145066|455818848|FG001|Overall Study|Non-related surgery|0|||
126690008|NCT01145066|455818849|FG002|Overall Study|Non-related surgery|1|||
126690009|NCT01145066|455818847|FG000|Overall Study|Withdrawal by Subject|0|||
126690010|NCT01145066|455818848|FG001|Overall Study|Withdrawal by Subject|0|||
126690011|NCT01145066|455818849|FG002|Overall Study|Withdrawal by Subject|2|||
126690012|NCT01145066|455818847|FG000|Overall Study|To start new med|1|||
126690013|NCT01145066|455818848|FG001|Overall Study|To start new med|0|||
126690014|NCT01145066|455818849|FG002|Overall Study|To start new med|0|||
126690015|NCT01145066|455818847|FG000|Overall Study|problems swallowing capsule|1|||
126690016|NCT01145066|455818848|FG001|Overall Study|problems swallowing capsule|0|||
126760227|NCT00383292|456072426|FG002|Overall Study|Physician Decision|1|||
126760228|NCT00383292|456072424|FG000|Overall Study|Withdrawal by Subject|3|||
126760229|NCT00383292|456072425|FG001|Overall Study|Withdrawal by Subject|2|||
126760230|NCT00383292|456072426|FG002|Overall Study|Withdrawal by Subject|2|||
126760231|NCT00383292|456072424|FG000|Overall Study|Other|1|||
126760232|NCT00383292|456072425|FG001|Overall Study|Other|0|||
126690017|NCT01145066|455818849|FG002|Overall Study|problems swallowing capsule|0|||
126690018|NCT01145066|455818847|FG000|Overall Study|Abdominal discomfort|0|||
126690019|NCT01145066|455818848|FG001|Overall Study|Abdominal discomfort|1|||
126690020|NCT01145066|455818849|FG002|Overall Study|Abdominal discomfort|0|||
126690021|NCT01145066|455818847|FG000|Overall Study|Low platelet count|0|||
126690022|NCT01145066|455818848|FG001|Overall Study|Low platelet count|1|||
126690023|NCT01145066|455818849|FG002|Overall Study|Low platelet count|0|||
126690024|NCT04949841|455818859|FG000|Overall Study|Adverse Event|7|||
126690025|NCT04949841|455818859|FG000|Overall Study|Death|1|||
126690026|NCT04949841|455818859|FG000|Overall Study|Withdrawal by Subject|52|||
126690027|NCT04949841|455818859|FG000|Overall Study|Pregnancy|4|||
126760233|NCT00383292|456072426|FG002|Overall Study|Other|0|||
126690028|NCT04949841|455818859|FG000|Overall Study|Lost to Follow-up|9|||
126760234|NCT03329404|456072427|FG000|Overall Study|The study was suspended.|1|||
126690029|NCT04949841|455818859|FG000|Overall Study|Lack of Efficacy|55|||
126690030|NCT04949841|455818859|FG000|Overall Study|Various reasons|9|||
126690031|NCT00500682|455818862|FG000|Overall Study|Adverse Event|37|||
126440922|NCT00561925|454913244|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
126440923|NCT00561925|454913245|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
126440924|NCT00561925|454913246|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
126440925|NCT00561925|454913247|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
126440926|NCT00561925|454913243|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
126440927|NCT00561925|454913244|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
126440928|NCT00561925|454913245|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
126440929|NCT00561925|454913246|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
126440930|NCT00561925|454913247|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
126440931|NCT00561925|454913243|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
126440932|NCT00561925|454913244|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
126440933|NCT00561925|454913245|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
126440934|NCT00561925|454913246|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
126440935|NCT00561925|454913247|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
126440936|NCT00561925|454913243|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
126440937|NCT00561925|454913244|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
126440938|NCT00561925|454913245|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
126440939|NCT00561925|454913246|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
126440940|NCT00561925|454913247|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
126440941|NCT00561925|454913243|FG000|144-week Double-blind, Double-dummy|Death|0|||
126440942|NCT00561925|454913244|FG001|144-week Double-blind, Double-dummy|Death|6|||
126440943|NCT00561925|454913245|FG002|144-week Double-blind, Double-dummy|Death|3|||
126440944|NCT00561925|454913246|FG003|144-week Double-blind, Double-dummy|Death|0|||
126440945|NCT00561925|454913247|FG004|144-week Double-blind, Double-dummy|Death|0|||
126440946|NCT00561925|454913243|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
126440947|NCT00561925|454913244|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
126440948|NCT00561925|454913245|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
126440949|NCT00561925|454913246|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
126440950|NCT00561925|454913247|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
126440951|NCT00561925|454913243|FG000|144-week Double-blind, Double-dummy|Other|0|||
126440952|NCT00561925|454913244|FG001|144-week Double-blind, Double-dummy|Other|8|||
126440953|NCT00561925|454913245|FG002|144-week Double-blind, Double-dummy|Other|11|||
126440954|NCT00561925|454913246|FG003|144-week Double-blind, Double-dummy|Other|0|||
126440955|NCT00561925|454913247|FG004|144-week Double-blind, Double-dummy|Other|0|||
126440956|NCT00561925|454913243|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
126440957|NCT00561925|454913244|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
126440958|NCT00561925|454913245|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
126440959|NCT00561925|454913246|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
126440960|NCT00561925|454913247|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
126440961|NCT00891904|454913248|FG000|Overall Study|Death|1|||
126440962|NCT00891904|454913248|FG000|Overall Study|Adverse Event|1|||
126440963|NCT03096288|454913250|FG000|Overall Study|Withdrawal by Subject|0|||
126440964|NCT03096288|454913251|FG001|Overall Study|Withdrawal by Subject|1|||
126440965|NCT03096288|454913252|FG002|Overall Study|Withdrawal by Subject|0|||
126440966|NCT03096288|454913253|FG003|Overall Study|Withdrawal by Subject|1|||
126440967|NCT01411891|454913257|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
126440968|NCT01411891|454913258|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
126440969|NCT02004093|454913259|FG000|Overall Study|Death|2|||
126440970|NCT02004093|454913260|FG001|Overall Study|Death|1|||
126440971|NCT02004093|454913259|FG000|Overall Study|Lack of Efficacy|66|||
126440972|NCT02004093|454913260|FG001|Overall Study|Lack of Efficacy|62|||
126440973|NCT02004093|454913259|FG000|Overall Study|Protocol Violation|0|||
126440974|NCT02004093|454913260|FG001|Overall Study|Protocol Violation|1|||
126440975|NCT02004093|454913259|FG000|Overall Study|Lost to Follow-up|0|||
126440976|NCT02004093|454913260|FG001|Overall Study|Lost to Follow-up|1|||
126440977|NCT02004093|454913259|FG000|Overall Study|Withdrawal by Subject|3|||
126440978|NCT02004093|454913260|FG001|Overall Study|Withdrawal by Subject|7|||
126440979|NCT02004093|454913259|FG000|Overall Study|Other|3|||
126440980|NCT02004093|454913260|FG001|Overall Study|Other|1|||
126440981|NCT04639258|454913262|FG000|Overall Study|Screen failure|5|||
126440982|NCT04639258|454913262|FG000|Overall Study|Physician Decision|2|||
126440983|NCT04639258|454913262|FG000|Overall Study|Early study termination|3|||
126440984|NCT04639258|454913262|FG000|Overall Study|Withdrawal by Subject|1|||
126440985|NCT00734539|454913263|FG000|Main Study|Death|33|||
126440986|NCT00734539|454913264|FG001|Main Study|Death|32|||
126440987|NCT00734539|454913263|FG000|Main Study|Physician Decision|2|||
126440988|NCT00734539|454913264|FG001|Main Study|Physician Decision|0|||
126440989|NCT00734539|454913263|FG000|Main Study|Withdrawal by Subject|1|||
126440990|NCT00734539|454913264|FG001|Main Study|Withdrawal by Subject|3|||
126440991|NCT00734539|454913263|FG000|Main Study|Enrolled in error; ineligible|1|||
126440992|NCT00734539|454913264|FG001|Main Study|Enrolled in error; ineligible|0|||
126440993|NCT02504151|454913267|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
126352428|NCT03086343|454580737|FG003|Period 2|Lost to Follow-up|0|||
126352429|NCT03086343|454580734|FG000|Period 2|COVID-19 Infection|5|||
126352430|NCT03086343|454580735|FG001|Period 2|COVID-19 Infection|0|||
126352431|NCT03086343|454580736|FG002|Period 2|COVID-19 Infection|0|||
126352432|NCT03086343|454580737|FG003|Period 2|COVID-19 Infection|0|||
126690032|NCT00500682|455818863|FG001|Overall Study|Adverse Event|29|||
126690033|NCT00500682|455818862|FG000|Overall Study|Death|25|||
126690034|NCT00500682|455818863|FG001|Overall Study|Death|16|||
126352433|NCT03086343|454580734|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
126352434|NCT03086343|454580735|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
126352435|NCT03086343|454580736|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
126352436|NCT03086343|454580737|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
126352437|NCT03086343|454580734|FG000|Period 2|Other, Not Specified|23|||
126352438|NCT03086343|454580735|FG001|Period 2|Other, Not Specified|22|||
126352439|NCT03086343|454580736|FG002|Period 2|Other, Not Specified|2|||
126352440|NCT03086343|454580737|FG003|Period 2|Other, Not Specified|4|||
126352441|NCT01047501|454580738|FG000|Overall Study|Adverse Event|7|||
126352442|NCT01047501|454580739|FG001|Overall Study|Adverse Event|8|||
126352443|NCT01047501|454580740|FG002|Overall Study|Adverse Event|5|||
126352444|NCT01047501|454580738|FG000|Overall Study|Withdrew Consent|6|||
126352445|NCT01047501|454580739|FG001|Overall Study|Withdrew Consent|2|||
126352446|NCT01047501|454580740|FG002|Overall Study|Withdrew Consent|4|||
126352447|NCT01047501|454580738|FG000|Overall Study|Lost to Follow-up|0|||
126352448|NCT01047501|454580739|FG001|Overall Study|Lost to Follow-up|1|||
126352449|NCT01047501|454580740|FG002|Overall Study|Lost to Follow-up|1|||
126352450|NCT01047501|454580738|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
126352451|NCT01047501|454580739|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
126352452|NCT01047501|454580740|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
126352453|NCT01047501|454580738|FG000|Overall Study|Death|1|||
126352454|NCT01047501|454580739|FG001|Overall Study|Death|0|||
126352455|NCT01047501|454580740|FG002|Overall Study|Death|0|||
126352456|NCT01047501|454580738|FG000|Overall Study|Other discontinuation|1|||
126352457|NCT01047501|454580739|FG001|Overall Study|Other discontinuation|0|||
126352458|NCT01047501|454580740|FG002|Overall Study|Other discontinuation|1|||
126352459|NCT01047501|454580738|FG000|Overall Study|Investigator judgement|0|||
126352460|NCT01047501|454580739|FG001|Overall Study|Investigator judgement|0|||
126352461|NCT01047501|454580740|FG002|Overall Study|Investigator judgement|1|||
126352462|NCT00741611|454580741|FG000|Overall Study|Death|0|||
126352463|NCT00741611|454580742|FG001|Overall Study|Death|0|||
126352464|NCT00741611|454580743|FG002|Overall Study|Death|1|||
126352465|NCT00741611|454580741|FG000|Overall Study|Withdrawal by Subject|0|||
126352466|NCT00741611|454580742|FG001|Overall Study|Withdrawal by Subject|2|||
126352467|NCT00741611|454580743|FG002|Overall Study|Withdrawal by Subject|2|||
126352468|NCT01510756|454580746|FG000|Overall Study|Death|1|||
126352469|NCT01510756|454580746|FG000|Overall Study|Lack of Efficacy|2|||
126352470|NCT01510756|454580746|FG000|Overall Study|Physician Decision|1|||
126352471|NCT03600428|454580750|FG000|Overall Study|Not eligible|0|||
126690035|NCT00500682|455818862|FG000|Overall Study|Lost to Follow-up|11|||
126352472|NCT03600428|454580751|FG001|Overall Study|Not eligible|1|||
126352473|NCT03600428|454580750|FG000|Overall Study|Lost to Follow-up|5|||
126352474|NCT03600428|454580751|FG001|Overall Study|Lost to Follow-up|4|||
126352475|NCT04398134|454580752|FG000|Overall Study|Adverse Event|0|||
126352476|NCT04398134|454580753|FG001|Overall Study|Adverse Event|0|||
126352477|NCT04398134|454580754|FG002|Overall Study|Adverse Event|1|||
126352478|NCT04398134|454580755|FG003|Overall Study|Adverse Event|0|||
126352479|NCT04398134|454580752|FG000|Overall Study|Withdrawal by Subject|2|||
126352480|NCT04398134|454580753|FG001|Overall Study|Withdrawal by Subject|0|||
126690036|NCT00500682|455818863|FG001|Overall Study|Lost to Follow-up|11|||
126440994|NCT02504151|454913268|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
126440995|NCT02504151|454913267|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
126352481|NCT04398134|454580754|FG002|Overall Study|Withdrawal by Subject|0|||
126352482|NCT04398134|454580755|FG003|Overall Study|Withdrawal by Subject|1|||
126352483|NCT04398134|454580752|FG000|Overall Study|Study Terminated by Sponsor|30|||
126352484|NCT04398134|454580753|FG001|Overall Study|Study Terminated by Sponsor|11|||
126352485|NCT04398134|454580754|FG002|Overall Study|Study Terminated by Sponsor|32|||
126352486|NCT04398134|454580755|FG003|Overall Study|Study Terminated by Sponsor|11|||
126352487|NCT00153920|454580757|FG000|Overall Study|Adverse Event|9|||
126352488|NCT00153920|454580757|FG000|Overall Study|Progressive Disease|9|||
126352489|NCT00153920|454580757|FG000|Overall Study|Physician Decision|3|||
126352490|NCT00153920|454580757|FG000|Overall Study|Lack of Response|3|||
126352491|NCT00153920|454580757|FG000|Overall Study|Death|2|||
126352492|NCT00153920|454580757|FG000|Overall Study|Withdrawal by Subject|1|||
126352493|NCT00153920|454580757|FG000|Overall Study|Non-Protocol Therapy|1|||
126352494|NCT00153920|454580757|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
126690037|NCT00500682|455818862|FG000|Overall Study|Physician Decision|6|||
126690038|NCT00500682|455818863|FG001|Overall Study|Physician Decision|10|||
126690039|NCT00500682|455818862|FG000|Overall Study|Pregnancy|2|||
126690040|NCT00500682|455818863|FG001|Overall Study|Pregnancy|0|||
126440996|NCT02504151|454913268|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
126690041|NCT00500682|455818862|FG000|Overall Study|Protocol Violation|1|||
126690042|NCT00500682|455818863|FG001|Overall Study|Protocol Violation|3|||
126690043|NCT00500682|455818862|FG000|Overall Study|Withdrawal by Subject|80|||
126690044|NCT00500682|455818863|FG001|Overall Study|Withdrawal by Subject|74|||
126690045|NCT00500682|455818862|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
126715181|NCT01052012|455908708|FG002|Overall Study|Lost to Follow-up|0|||
126440997|NCT02504151|454913267|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
126440998|NCT02504151|454913268|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126440999|NCT02504151|454913267|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
126441000|NCT02504151|454913268|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
126441001|NCT02557139|454913274|FG000|Overall Study|Significant liver elevation|1|||
126441002|NCT02557139|454913275|FG001|Overall Study|Significant liver elevation|0|||
126441003|NCT02557139|454913276|FG002|Overall Study|Significant liver elevation|1|||
126441004|NCT02557139|454913274|FG000|Overall Study|Withdrawal by Subject|1|||
126441005|NCT02557139|454913275|FG001|Overall Study|Withdrawal by Subject|0|||
126441006|NCT02557139|454913276|FG002|Overall Study|Withdrawal by Subject|0|||
126441007|NCT02557139|454913274|FG000|Overall Study|Illness of prohibited medication|0|||
126441008|NCT02557139|454913275|FG001|Overall Study|Illness of prohibited medication|0|||
126441009|NCT02557139|454913276|FG002|Overall Study|Illness of prohibited medication|1|||
126441010|NCT01454102|454913278|FG000|Overall Study|Continuing in the treatment period|0|||
126441011|NCT01454102|454913279|FG001|Overall Study|Continuing in the treatment period|0|||
126441012|NCT01454102|454913280|FG002|Overall Study|Continuing in the treatment period|0|||
126441013|NCT01454102|454913281|FG003|Overall Study|Continuing in the treatment period|0|||
126441014|NCT01454102|454913282|FG004|Overall Study|Continuing in the treatment period|3|||
126441015|NCT01454102|454913283|FG005|Overall Study|Continuing in the treatment period|3|||
126441016|NCT01454102|454913284|FG006|Overall Study|Continuing in the treatment period|2|||
126441017|NCT01454102|454913285|FG007|Overall Study|Continuing in the treatment period|0|||
126441018|NCT01454102|454913286|FG008|Overall Study|Continuing in the treatment period|1|||
126441019|NCT01454102|454913287|FG009|Overall Study|Continuing in the treatment period|0|||
126441020|NCT01454102|454913288|FG010|Overall Study|Continuing in the treatment period|0|||
126441021|NCT01454102|454913289|FG011|Overall Study|Continuing in the treatment period|4|||
126441022|NCT01454102|454913290|FG012|Overall Study|Continuing in the treatment period|7|||
126441023|NCT01454102|454913291|FG013|Overall Study|Continuing in the treatment period|4|||
126441024|NCT01454102|454913292|FG014|Overall Study|Continuing in the treatment period|3|||
126441025|NCT01454102|454913293|FG015|Overall Study|Continuing in the treatment period|1|||
126441026|NCT02592798|454913298|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
126441027|NCT02592798|454913299|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
126441028|NCT02592798|454913298|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
126441029|NCT02592798|454913299|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
126441030|NCT02592798|454913298|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
126441031|NCT02592798|454913299|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
126441032|NCT02592798|454913298|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
126441033|NCT02592798|454913299|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
126441034|NCT02592798|454913298|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
126441035|NCT02592798|454913299|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
126441036|NCT02592798|454913298|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
126441037|NCT02592798|454913299|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
126441038|NCT02592798|454913298|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
126441039|NCT02592798|454913299|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
126441040|NCT02592798|454913298|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
126441041|NCT02592798|454913299|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
126441042|NCT02592798|454913298|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
126441043|NCT02592798|454913299|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
126441044|NCT02592798|454913298|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
126441045|NCT02592798|454913299|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
126441046|NCT02592798|454913298|FG000|Transition From DB2 to OLE|Other reasons|1|||
126441047|NCT02592798|454913299|FG001|Transition From DB2 to OLE|Other reasons|0|||
126441048|NCT02592798|454913298|FG000|Open Label Period (OLE)|Other reasons|0|||
126441049|NCT02592798|454913299|FG001|Open Label Period (OLE)|Other reasons|2|||
126441050|NCT02592798|454913298|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
126441051|NCT02592798|454913299|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
126441052|NCT02592798|454913298|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
126441053|NCT02592798|454913299|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
126441054|NCT02592798|454913298|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
126441055|NCT02592798|454913299|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
126441056|NCT02592798|454913298|FG000|Open Label Period (OLE)|Adverse Event|0|||
126441057|NCT02592798|454913299|FG001|Open Label Period (OLE)|Adverse Event|1|||
126441058|NCT00705016|454913300|FG000|Overall Study|Adverse Event|6|||
126441059|NCT00705016|454913301|FG001|Overall Study|Adverse Event|11|||
126441060|NCT00705016|454913302|FG002|Overall Study|Adverse Event|10|||
126441061|NCT00705016|454913300|FG000|Overall Study|Death|5|||
126441062|NCT00705016|454913301|FG001|Overall Study|Death|7|||
126441063|NCT00705016|454913302|FG002|Overall Study|Death|5|||
126441064|NCT00705016|454913300|FG000|Overall Study|Protocol Violation|0|||
126441065|NCT00705016|454913301|FG001|Overall Study|Protocol Violation|1|||
126441066|NCT00705016|454913302|FG002|Overall Study|Protocol Violation|1|||
126441067|NCT00705016|454913300|FG000|Overall Study|Withdrawal by Subject|4|||
126441068|NCT00705016|454913301|FG001|Overall Study|Withdrawal by Subject|3|||
126441069|NCT00705016|454913302|FG002|Overall Study|Withdrawal by Subject|2|||
126441070|NCT00705016|454913300|FG000|Overall Study|Progressive Disease|33|||
126441071|NCT00705016|454913301|FG001|Overall Study|Progressive Disease|29|||
126441072|NCT00705016|454913302|FG002|Overall Study|Progressive Disease|33|||
126352495|NCT00153920|454580757|FG000|Overall Study|Progressive Disease before Trt|1|||
126352496|NCT01666652|454580763|FG000|Overall Study|Serious Adverse Event|0|||
126352497|NCT01666652|454580764|FG001|Overall Study|Serious Adverse Event|0|||
126352498|NCT01666652|454580765|FG002|Overall Study|Serious Adverse Event|0|||
126352499|NCT01666652|454580766|FG003|Overall Study|Serious Adverse Event|1|||
126352500|NCT01666652|454580767|FG004|Overall Study|Serious Adverse Event|0|||
126352501|NCT01666652|454580763|FG000|Overall Study|Withdrawal by Subject|0|||
126352502|NCT01666652|454580764|FG001|Overall Study|Withdrawal by Subject|0|||
126352503|NCT01666652|454580765|FG002|Overall Study|Withdrawal by Subject|0|||
126352504|NCT01666652|454580766|FG003|Overall Study|Withdrawal by Subject|0|||
126352505|NCT01666652|454580767|FG004|Overall Study|Withdrawal by Subject|1|||
126352506|NCT01666652|454580763|FG000|Overall Study|Moved from study area|1|||
126352507|NCT01666652|454580764|FG001|Overall Study|Moved from study area|0|||
126352508|NCT01666652|454580765|FG002|Overall Study|Moved from study area|0|||
126352509|NCT01666652|454580766|FG003|Overall Study|Moved from study area|2|||
126352510|NCT01666652|454580767|FG004|Overall Study|Moved from study area|0|||
126352511|NCT01666652|454580763|FG000|Overall Study|Lost to Follow-up|1|||
126352512|NCT01666652|454580764|FG001|Overall Study|Lost to Follow-up|1|||
126352513|NCT01666652|454580765|FG002|Overall Study|Lost to Follow-up|1|||
126352514|NCT01666652|454580766|FG003|Overall Study|Lost to Follow-up|1|||
126352515|NCT01666652|454580767|FG004|Overall Study|Lost to Follow-up|0|||
126352516|NCT01018979|454580768|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
126352517|NCT01018979|454580769|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
126352518|NCT01018979|454580768|FG000|Overall Study|Not received at least one dose|0|||
126352519|NCT01018979|454580769|FG001|Overall Study|Not received at least one dose|1|||
126352520|NCT03010501|454580772|FG000|Study Week 1|Withdrawal by Subject|2|||
126352521|NCT03010501|454580773|FG001|Study Week 1|Withdrawal by Subject|1|||
126352522|NCT03010501|454580774|FG002|Study Week 1|Withdrawal by Subject|0|||
126352523|NCT03010501|454580775|FG003|Study Week 1|Withdrawal by Subject|2|||
126352524|NCT03010501|454580776|FG004|Study Week 1|Withdrawal by Subject|0|||
126352525|NCT03010501|454580777|FG005|Study Week 1|Withdrawal by Subject|0|||
126352526|NCT03010501|454580772|FG000|Study Week 3|Withdrawal by Subject|0|||
126352527|NCT03010501|454580773|FG001|Study Week 3|Withdrawal by Subject|0|||
126352528|NCT03010501|454580774|FG002|Study Week 3|Withdrawal by Subject|0|||
126352529|NCT03010501|454580775|FG003|Study Week 3|Withdrawal by Subject|1|||
126352530|NCT03010501|454580776|FG004|Study Week 3|Withdrawal by Subject|0|||
126352531|NCT03010501|454580777|FG005|Study Week 3|Withdrawal by Subject|0|||
126352532|NCT00640289|454580778|FG000|Overall Study|Death|3|||
126352533|NCT00640289|454580778|FG000|Overall Study|Withdrawal by Subject|1|||
126352534|NCT00640289|454580778|FG000|Overall Study|Lost to Follow-up|1|||
126352535|NCT00640289|454580778|FG000|Overall Study|Data collected under different amendment|2|||
126352536|NCT00640289|454580778|FG000|Overall Study|Transferred to another center|1|||
126441073|NCT00705016|454913300|FG000|Overall Study|Symptomatic Deterioration|3|||
126441074|NCT00705016|454913301|FG001|Overall Study|Symptomatic Deterioration|1|||
126441075|NCT00705016|454913302|FG002|Overall Study|Symptomatic Deterioration|1|||
126441076|NCT00705016|454913300|FG000|Overall Study|Other|9|||
126352537|NCT00640289|454580778|FG000|Overall Study|Missing status|5|||
126352538|NCT00544882|454580781|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
126352539|NCT00544882|454580782|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
126352540|NCT00544882|454580783|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
126441077|NCT00705016|454913301|FG001|Overall Study|Other|6|||
126441078|NCT00705016|454913302|FG002|Overall Study|Other|6|||
126352541|NCT00544882|454580781|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
126441079|NCT00942604|454913306|FG000|Overall Study|Protocol Violation|1|||
126441080|NCT00942604|454913307|FG001|Overall Study|Protocol Violation|1|||
126352542|NCT00544882|454580782|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
126352543|NCT00544882|454580783|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
126352544|NCT00544882|454580781|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
126352545|NCT00544882|454580782|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
126352546|NCT00544882|454580783|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
126352547|NCT00544882|454580781|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
126352548|NCT00544882|454580782|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
126352549|NCT00544882|454580783|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
126352550|NCT00544882|454580781|FG000|Cycle 3: Follow-up|Noncompliance|0|||
126352551|NCT00544882|454580782|FG001|Cycle 3: Follow-up|Noncompliance|1|||
126352552|NCT00544882|454580783|FG002|Cycle 3: Follow-up|Noncompliance|0|||
126352553|NCT00544882|454580781|FG000|Cycle 3: Follow-up|Pregnancy|0|||
126352554|NCT00544882|454580782|FG001|Cycle 3: Follow-up|Pregnancy|1|||
126352555|NCT00544882|454580783|FG002|Cycle 3: Follow-up|Pregnancy|0|||
126352556|NCT03043573|454580784|FG000|Overall Study|Lost to Follow-up|3|||
126352557|NCT03043573|454580785|FG001|Overall Study|Lost to Follow-up|3|||
126352558|NCT03043573|454580784|FG000|Overall Study|Physician Decision|0|||
126352559|NCT03043573|454580785|FG001|Overall Study|Physician Decision|5|||
126352560|NCT03043573|454580784|FG000|Overall Study|Withdrawal by Subject|0|||
126352561|NCT03043573|454580785|FG001|Overall Study|Withdrawal by Subject|4|||
126352562|NCT01251861|454580788|FG000|Overall Study|Disease progression|6|||
126352563|NCT01251861|454580789|FG001|Overall Study|Disease progression|6|||
126352564|NCT01251861|454580788|FG000|Overall Study|Adverse Event|2|||
126352565|NCT01251861|454580789|FG001|Overall Study|Adverse Event|17|||
126352566|NCT01251861|454580788|FG000|Overall Study|Withdrawal by Subject|2|||
126352567|NCT01251861|454580789|FG001|Overall Study|Withdrawal by Subject|2|||
126352568|NCT01251861|454580788|FG000|Overall Study|Alternative therapy|1|||
126352569|NCT01251861|454580789|FG001|Overall Study|Alternative therapy|0|||
126690046|NCT00500682|455818863|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
126690047|NCT01182428|455818866|FG000|Overall Study|Physician Decision|1|||
126690048|NCT01182428|455818867|FG001|Overall Study|Physician Decision|0|||
126690049|NCT01182428|455818866|FG000|Overall Study|Lost to Follow-up|9|||
126690050|NCT01182428|455818867|FG001|Overall Study|Lost to Follow-up|1|||
126690051|NCT01182428|455818866|FG000|Overall Study|Withdrawal by Subject|1|||
126690052|NCT01182428|455818867|FG001|Overall Study|Withdrawal by Subject|0|||
126690053|NCT01227902|455820675|FG000|Overall Study|Adverse Event|12|||
126690054|NCT01227902|455820676|FG001|Overall Study|Adverse Event|8|||
126690055|NCT01227902|455820677|FG002|Overall Study|Adverse Event|11|||
126690056|NCT01227902|455820678|FG003|Overall Study|Adverse Event|4|||
126690057|NCT01227902|455820675|FG000|Overall Study|Lack of Efficacy|1|||
126690058|NCT01227902|455820676|FG001|Overall Study|Lack of Efficacy|2|||
126690059|NCT01227902|455820677|FG002|Overall Study|Lack of Efficacy|2|||
126690060|NCT01227902|455820678|FG003|Overall Study|Lack of Efficacy|1|||
126690061|NCT01227902|455820675|FG000|Overall Study|Protocol Violation|1|||
126690062|NCT01227902|455820676|FG001|Overall Study|Protocol Violation|0|||
126690063|NCT01227902|455820677|FG002|Overall Study|Protocol Violation|0|||
126690064|NCT01227902|455820678|FG003|Overall Study|Protocol Violation|0|||
126690065|NCT01227902|455820675|FG000|Overall Study|Lost to Follow-up|0|||
126690066|NCT01227902|455820676|FG001|Overall Study|Lost to Follow-up|0|||
126690067|NCT01227902|455820677|FG002|Overall Study|Lost to Follow-up|1|||
126690068|NCT01227902|455820678|FG003|Overall Study|Lost to Follow-up|2|||
126690069|NCT01227902|455820675|FG000|Overall Study|Physician Decision|0|||
126690070|NCT01227902|455820676|FG001|Overall Study|Physician Decision|1|||
126690071|NCT01227902|455820677|FG002|Overall Study|Physician Decision|1|||
126690072|NCT01227902|455820678|FG003|Overall Study|Physician Decision|0|||
126690073|NCT01227902|455820675|FG000|Overall Study|Withdrawal by Subject|4|||
126690074|NCT01227902|455820676|FG001|Overall Study|Withdrawal by Subject|2|||
126690075|NCT01227902|455820677|FG002|Overall Study|Withdrawal by Subject|4|||
126690076|NCT01227902|455820678|FG003|Overall Study|Withdrawal by Subject|3|||
126690077|NCT05280756|455820679|FG000|Overall Study|Lost to Follow-up|1|||
126690078|NCT05280756|455820680|FG001|Overall Study|Lost to Follow-up|1|||
126690079|NCT02527707|455820685|FG000|Overall Study|Adverse Event|1|||
126690080|NCT02527707|455820685|FG000|Overall Study|Adverse Event|1|||
126690081|NCT00930059|455820686|FG000|Overall Study|Death|1|||
126690082|NCT00930059|455820687|FG001|Overall Study|Death|0|||
126690083|NCT00930059|455820686|FG000|Overall Study|Did not meet entrance criteria|1|||
126690084|NCT00930059|455820687|FG001|Overall Study|Did not meet entrance criteria|1|||
126690085|NCT00930059|455820686|FG000|Overall Study|Withdrawal by Subject|3|||
126352570|NCT01251861|454580788|FG000|Overall Study|Other complicating disease|0|||
126352571|NCT01251861|454580789|FG001|Overall Study|Other complicating disease|1|||
126352572|NCT01251861|454580788|FG000|Overall Study|Physician Decision|1|||
126352573|NCT01251861|454580789|FG001|Overall Study|Physician Decision|0|||
126690086|NCT00930059|455820687|FG001|Overall Study|Withdrawal by Subject|4|||
126690087|NCT00930059|455820686|FG000|Overall Study|Other|1|||
126690088|NCT00930059|455820687|FG001|Overall Study|Other|0|||
126690089|NCT00930059|455820686|FG000|Overall Study|1 site terminated by sponsor|1|||
126690090|NCT00930059|455820687|FG001|Overall Study|1 site terminated by sponsor|1|||
126690091|NCT00930059|455820686|FG000|Overall Study|Adverse Event|1|||
126690092|NCT00930059|455820687|FG001|Overall Study|Adverse Event|6|||
126690093|NCT04002310|455820690|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
126690094|NCT04002310|455820691|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
126690095|NCT04002310|455820692|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
126690096|NCT04002310|455820693|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
126690097|NCT04002310|455820694|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
126690098|NCT00542997|455820695|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
126690099|NCT00542997|455820695|FG000|Wash in / Wash Out Period|Adverse Event|3|||
126690100|NCT00542997|455820695|FG000|Efficacy Period|Adverse Event|3|||
126690101|NCT02949128|455820698|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
126690102|NCT02949128|455820698|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
126690103|NCT02949128|455820698|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
126715182|NCT01052012|455908709|FG003|Overall Study|Lost to Follow-up|0|||
126715183|NCT01052012|455908710|FG004|Overall Study|Lost to Follow-up|1|||
126441081|NCT00942604|454913306|FG000|Overall Study|Adverse Event|0|||
126441082|NCT00942604|454913307|FG001|Overall Study|Adverse Event|1|||
126441083|NCT00942604|454913306|FG000|Overall Study|Withdrawal by Subject|0|||
126690104|NCT02949128|455820698|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
126690105|NCT02949128|455820698|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
126690106|NCT02949128|455820698|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
126352574|NCT01251861|454580788|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
126352575|NCT01251861|454580789|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
126352576|NCT01251861|454580788|FG000|Overall Study|Other|1|||
126352577|NCT01251861|454580789|FG001|Overall Study|Other|0|||
126352578|NCT01251861|454580788|FG000|Overall Study|Never started therapy|4|||
126352579|NCT01251861|454580789|FG001|Overall Study|Never started therapy|1|||
126352580|NCT01251861|454580788|FG000|Overall Study|Potential interaction of drugs|0|||
126352581|NCT01251861|454580789|FG001|Overall Study|Potential interaction of drugs|1|||
126352582|NCT00479232|454582045|FG000|Overall Study|Adverse Event|0|||
126352583|NCT00479232|454582046|FG001|Overall Study|Adverse Event|0|||
126352584|NCT00479232|454582047|FG002|Overall Study|Adverse Event|5|||
126352585|NCT00479232|454582048|FG003|Overall Study|Adverse Event|0|||
126352586|NCT00479232|454582049|FG004|Overall Study|Adverse Event|0|||
126352587|NCT00479232|454582050|FG005|Overall Study|Adverse Event|10|||
126352588|NCT00479232|454582045|FG000|Overall Study|Deviation from Protocol|0|||
126352589|NCT00479232|454582046|FG001|Overall Study|Deviation from Protocol|0|||
126352590|NCT00479232|454582047|FG002|Overall Study|Deviation from Protocol|1|||
126352591|NCT00479232|454582048|FG003|Overall Study|Deviation from Protocol|0|||
126352592|NCT00479232|454582049|FG004|Overall Study|Deviation from Protocol|0|||
126352593|NCT00479232|454582050|FG005|Overall Study|Deviation from Protocol|0|||
126352594|NCT00479232|454582045|FG000|Overall Study|Lack of Efficacy|0|||
126352595|NCT00479232|454582046|FG001|Overall Study|Lack of Efficacy|0|||
126352596|NCT00479232|454582047|FG002|Overall Study|Lack of Efficacy|2|||
126352597|NCT00479232|454582048|FG003|Overall Study|Lack of Efficacy|0|||
126352598|NCT00479232|454582049|FG004|Overall Study|Lack of Efficacy|0|||
126352599|NCT00479232|454582050|FG005|Overall Study|Lack of Efficacy|4|||
126690107|NCT02949128|455820698|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
126352600|NCT00479232|454582045|FG000|Overall Study|Physician Decision|0|||
126352601|NCT00479232|454582046|FG001|Overall Study|Physician Decision|0|||
126352602|NCT00479232|454582047|FG002|Overall Study|Physician Decision|2|||
126352603|NCT00479232|454582048|FG003|Overall Study|Physician Decision|0|||
126352604|NCT00479232|454582049|FG004|Overall Study|Physician Decision|0|||
126352605|NCT00479232|454582050|FG005|Overall Study|Physician Decision|1|||
126352606|NCT00479232|454582045|FG000|Overall Study|Progressive Disease|3|||
126690108|NCT02949128|455820698|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
126690109|NCT02949128|455820698|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
126690110|NCT02949128|455820698|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
126690111|NCT03064763|455820702|FG000|Overall Study|Lost to Follow-up|1|||
126690112|NCT03064763|455820702|FG000|Overall Study|Death|8|||
126690113|NCT00808444|455820712|FG000|Overall Study|Withdrawal by Subject|1|||
126690114|NCT00808444|455820713|FG001|Overall Study|Withdrawal by Subject|0|||
126690115|NCT00808444|455820712|FG000|Overall Study|Lost to Follow-up|0|||
126690116|NCT00808444|455820713|FG001|Overall Study|Lost to Follow-up|1|||
126690117|NCT01461044|455820714|FG000|Overall Study|Death|58|||
126690118|NCT01461044|455820715|FG001|Overall Study|Death|35|||
126690119|NCT01461044|455820714|FG000|Overall Study|Lost to Follow-up|12|||
126690120|NCT01461044|455820715|FG001|Overall Study|Lost to Follow-up|5|||
126690121|NCT00716976|455820716|FG000|Overall Study|Adverse Event|2|||
126690122|NCT00716976|455820717|FG001|Overall Study|Adverse Event|0|||
126690123|NCT00716976|455820716|FG000|Overall Study|Death|1|||
126690124|NCT00716976|455820717|FG001|Overall Study|Death|0|||
126690125|NCT00716976|455820716|FG000|Overall Study|Physician Decision|2|||
126690126|NCT00716976|455820717|FG001|Overall Study|Physician Decision|2|||
126690127|NCT00716976|455820716|FG000|Overall Study|Withdrawal by Subject|5|||
126690128|NCT00716976|455820717|FG001|Overall Study|Withdrawal by Subject|1|||
126690129|NCT00716976|455820716|FG000|Overall Study|Premature discontinuation cisplatin|5|||
126690130|NCT00716976|455820717|FG001|Overall Study|Premature discontinuation cisplatin|4|||
126690131|NCT00716976|455820716|FG000|Overall Study|Radiation during protocol|1|||
126690132|NCT00716976|455820717|FG001|Overall Study|Radiation during protocol|0|||
126690133|NCT00716976|455820716|FG000|Overall Study|Ineligibles|4|||
126690134|NCT00716976|455820717|FG001|Overall Study|Ineligibles|2|||
126690135|NCT00122135|455820718|FG000|Overall Study|Withdrawal by Subject|3|||
126690136|NCT00122135|455820719|FG001|Overall Study|Withdrawal by Subject|0|||
126690137|NCT00975156|455820725|FG000|Overall Study|Protocol Violation|0|||
126690138|NCT00975156|455820726|FG001|Overall Study|Protocol Violation|1|||
126690139|NCT03106779|455820732|FG000|Overall Study|Lack of Efficacy|33|||
126690140|NCT03106779|455820733|FG001|Overall Study|Lack of Efficacy|24|||
126690141|NCT03106779|455820732|FG000|Overall Study|Adverse Event|8|||
126690142|NCT03106779|455820733|FG001|Overall Study|Adverse Event|16|||
126690143|NCT03106779|455820732|FG000|Overall Study|Physician Decision|10|||
126441084|NCT00942604|454913307|FG001|Overall Study|Withdrawal by Subject|1|||
126441085|NCT00942604|454913306|FG000|Overall Study|Patient relocation|1|||
126441086|NCT00942604|454913307|FG001|Overall Study|Patient relocation|1|||
126441087|NCT01188343|454913308|FG000|Overall Study|Not vaccinated|0|||
126441088|NCT01188343|454913309|FG001|Overall Study|Not vaccinated|2|||
126441089|NCT01188343|454913310|FG002|Overall Study|Not vaccinated|1|||
126441090|NCT01188343|454913308|FG000|Overall Study|Withdrawal by Subject|1|||
126441091|NCT01188343|454913309|FG001|Overall Study|Withdrawal by Subject|24|||
126441092|NCT01188343|454913310|FG002|Overall Study|Withdrawal by Subject|0|||
126441093|NCT01143246|454913311|FG000|Overall Study|Adverse Event|24|||
126441094|NCT01143246|454913312|FG001|Overall Study|Adverse Event|28|||
126441095|NCT01143246|454913311|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
126441096|NCT01143246|454913312|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
126441097|NCT01143246|454913311|FG000|Overall Study|Lost to Follow-up|0|||
126441098|NCT01143246|454913312|FG001|Overall Study|Lost to Follow-up|1|||
126441099|NCT01143246|454913311|FG000|Overall Study|Death|16|||
126441100|NCT01143246|454913312|FG001|Overall Study|Death|15|||
126441101|NCT01143246|454913311|FG000|Overall Study|Reason not Specified|3|||
126441102|NCT01143246|454913312|FG001|Overall Study|Reason not Specified|5|||
126441103|NCT05375760|454913313|FG000|Overall Study|Adverse Event|1|||
126441104|NCT05375760|454913314|FG001|Overall Study|Adverse Event|0|||
126441105|NCT05375760|454913313|FG000|Overall Study|Death|0|||
126441106|NCT05375760|454913314|FG001|Overall Study|Death|1|||
126441107|NCT05375760|454913313|FG000|Overall Study|Lost to Follow-up|6|||
126441108|NCT05375760|454913314|FG001|Overall Study|Lost to Follow-up|6|||
126441109|NCT05375760|454913313|FG000|Overall Study|Withdrawal by Subject|17|||
126441110|NCT05375760|454913314|FG001|Overall Study|Withdrawal by Subject|19|||
126441111|NCT05375760|454913313|FG000|Overall Study|Dosing halted by FDA|96|||
126441112|NCT05375760|454913314|FG001|Overall Study|Dosing halted by FDA|100|||
126441113|NCT05375760|454913313|FG000|Overall Study|Not compliant with study visit|2|||
126441114|NCT05375760|454913314|FG001|Overall Study|Not compliant with study visit|0|||
126441115|NCT05375760|454913313|FG000|Overall Study|Physician Decision|1|||
126690144|NCT03106779|455820733|FG001|Overall Study|Physician Decision|6|||
126690145|NCT03106779|455820732|FG000|Overall Study|Patient/guardian decision|4|||
126441116|NCT05375760|454913314|FG001|Overall Study|Physician Decision|0|||
126690146|NCT03106779|455820733|FG001|Overall Study|Patient/guardian decision|3|||
126690147|NCT03106779|455820732|FG000|Overall Study|Progressive disease|1|||
126690148|NCT03106779|455820733|FG001|Overall Study|Progressive disease|3|||
126690149|NCT03106779|455820732|FG000|Overall Study|Lost to Follow-up|1|||
126690150|NCT03106779|455820733|FG001|Overall Study|Lost to Follow-up|2|||
126690151|NCT03106779|455820732|FG000|Overall Study|Death|1|||
126690152|NCT03106779|455820733|FG001|Overall Study|Death|0|||
126441117|NCT05375760|454913313|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
126441118|NCT05375760|454913314|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
126441119|NCT05375760|454913313|FG000|Overall Study|Participant moved|1|||
126441120|NCT05375760|454913314|FG001|Overall Study|Participant moved|0|||
126690153|NCT03106779|455820732|FG000|Overall Study|Protocol Violation|1|||
126690154|NCT03106779|455820733|FG001|Overall Study|Protocol Violation|0|||
126690155|NCT03106779|455820732|FG000|Overall Study|Not treated|1|||
126690156|NCT03106779|455820733|FG001|Overall Study|Not treated|0|||
126690157|NCT02288247|455820734|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
126690158|NCT02288247|455820735|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
126690159|NCT02288247|455820734|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
126690160|NCT02288247|455820735|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
126690161|NCT02288247|455820734|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
126690162|NCT02288247|455820735|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
126690163|NCT02288247|455820734|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
126690164|NCT02288247|455820735|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
126690165|NCT02288247|455820734|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
126690166|NCT02288247|455820735|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
126690167|NCT02288247|455820734|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
126690168|NCT02288247|455820735|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
126690169|NCT02288247|455820734|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
126690170|NCT02288247|455820735|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
126690171|NCT02288247|455820734|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
126690172|NCT02288247|455820735|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
126690173|NCT02288247|455820734|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
126690174|NCT02288247|455820735|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
126690175|NCT02288247|455820734|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
126690176|NCT02288247|455820735|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
126690177|NCT02288247|455820734|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
126690178|NCT02288247|455820735|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
126690179|NCT02288247|455820734|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
126690180|NCT02288247|455820735|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
126690181|NCT02288247|455820734|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
126690182|NCT02288247|455820735|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
126690183|NCT02288247|455820734|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
126690184|NCT02288247|455820735|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
126690185|NCT02288247|455820734|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
126690186|NCT02288247|455820735|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
126690187|NCT02288247|455820734|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
126690188|NCT02288247|455820735|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
126690189|NCT04093531|455820736|FG000|Overall Study|failed screening|4|||
126690190|NCT00634569|455820737|FG000|Overall Study|Withdrawal by Subject|0|||
126690191|NCT00634569|455820738|FG001|Overall Study|Withdrawal by Subject|4|||
126690192|NCT00634569|455820737|FG000|Overall Study|Physician Decision|0|||
126690193|NCT00634569|455820738|FG001|Overall Study|Physician Decision|1|||
126690194|NCT02918019|455820739|FG000|Overall Study|Death|0|||
126690195|NCT02918019|455820740|FG001|Overall Study|Death|0|||
126690196|NCT02918019|455820741|FG002|Overall Study|Death|1|||
126690197|NCT02918019|455820742|FG003|Overall Study|Death|0|||
126690198|NCT02918019|455820739|FG000|Overall Study|Lost to Follow-up|1|||
126352607|NCT00479232|454582046|FG001|Overall Study|Progressive Disease|1|||
126352608|NCT00479232|454582047|FG002|Overall Study|Progressive Disease|12|||
126690199|NCT02918019|455820740|FG001|Overall Study|Lost to Follow-up|1|||
126690200|NCT02918019|455820741|FG002|Overall Study|Lost to Follow-up|0|||
126690201|NCT02918019|455820742|FG003|Overall Study|Lost to Follow-up|1|||
126352609|NCT00479232|454582048|FG003|Overall Study|Progressive Disease|3|||
126690202|NCT02918019|455820739|FG000|Overall Study|Principal investigator request|0|||
126690203|NCT02918019|455820740|FG001|Overall Study|Principal investigator request|0|||
126690204|NCT02918019|455820741|FG002|Overall Study|Principal investigator request|0|||
126690205|NCT02918019|455820742|FG003|Overall Study|Principal investigator request|1|||
126690206|NCT02918019|455820739|FG000|Overall Study|Physician Decision|1|||
126690207|NCT02918019|455820740|FG001|Overall Study|Physician Decision|3|||
126690208|NCT02918019|455820741|FG002|Overall Study|Physician Decision|2|||
126690209|NCT02918019|455820742|FG003|Overall Study|Physician Decision|0|||
126690210|NCT02918019|455820739|FG000|Overall Study|Protocol deviation|1|||
126690211|NCT02918019|455820740|FG001|Overall Study|Protocol deviation|1|||
126690212|NCT02918019|455820741|FG002|Overall Study|Protocol deviation|0|||
126690213|NCT02918019|455820742|FG003|Overall Study|Protocol deviation|2|||
126690214|NCT02918019|455820739|FG000|Overall Study|Withdrawal by Subject|3|||
126690215|NCT02918019|455820740|FG001|Overall Study|Withdrawal by Subject|4|||
126690216|NCT02918019|455820741|FG002|Overall Study|Withdrawal by Subject|6|||
126690217|NCT02918019|455820742|FG003|Overall Study|Withdrawal by Subject|4|||
126690218|NCT02918019|455820739|FG000|Overall Study|Adverse Event|0|||
126690219|NCT02918019|455820740|FG001|Overall Study|Adverse Event|1|||
126690220|NCT02918019|455820741|FG002|Overall Study|Adverse Event|0|||
126690221|NCT02918019|455820742|FG003|Overall Study|Adverse Event|1|||
126690222|NCT01212185|455820743|FG000|Overall Study|Protocol Violation|2|||
126690223|NCT01212185|455820744|FG001|Overall Study|Protocol Violation|1|||
126690224|NCT03222349|455820745|FG000|Overall Study|Treatment B not done|5|||
126690225|NCT03222349|455820746|FG001|Overall Study|Treatment B not done|0|||
126690226|NCT03222349|455820745|FG000|Overall Study|Lost to Follow-up|1|||
126760235|NCT03329404|456072428|FG001|Overall Study|The study was suspended.|4|||
126690227|NCT03222349|455820746|FG001|Overall Study|Lost to Follow-up|2|||
126690228|NCT03222349|455820745|FG000|Overall Study|Withdrawal by Subject|1|||
126352610|NCT00479232|454582049|FG004|Overall Study|Progressive Disease|3|||
126352611|NCT00479232|454582050|FG005|Overall Study|Progressive Disease|12|||
126352612|NCT00479232|454582045|FG000|Overall Study|Withdrew Consent|0|||
126352613|NCT00479232|454582046|FG001|Overall Study|Withdrew Consent|2|||
126352614|NCT00479232|454582047|FG002|Overall Study|Withdrew Consent|6|||
126352615|NCT00479232|454582048|FG003|Overall Study|Withdrew Consent|0|||
126352616|NCT00479232|454582049|FG004|Overall Study|Withdrew Consent|1|||
126352617|NCT00479232|454582050|FG005|Overall Study|Withdrew Consent|3|||
126352618|NCT01373229|454582051|FG000|Overall Study|Death|3|||
126352619|NCT01373229|454582051|FG000|Overall Study|Physician Decision|3|||
126352620|NCT00587457|454582052|FG000|Overall Study|Adverse Event|1|||
126352621|NCT00587457|454582053|FG001|Overall Study|Adverse Event|2|||
126352622|NCT00587457|454582054|FG002|Overall Study|Adverse Event|1|||
126352623|NCT00587457|454582052|FG000|Overall Study|Disease progression|2|||
126352624|NCT00587457|454582053|FG001|Overall Study|Disease progression|0|||
126352625|NCT00587457|454582054|FG002|Overall Study|Disease progression|2|||
126352626|NCT00587457|454582052|FG000|Overall Study|Initiation of alternative therapy|0|||
126352627|NCT00587457|454582053|FG001|Overall Study|Initiation of alternative therapy|1|||
126352628|NCT00587457|454582054|FG002|Overall Study|Initiation of alternative therapy|0|||
126352629|NCT00587457|454582052|FG000|Overall Study|Undefined|0|||
126352630|NCT00587457|454582053|FG001|Overall Study|Undefined|0|||
126352631|NCT00587457|454582054|FG002|Overall Study|Undefined|1|||
126352632|NCT00587457|454582052|FG000|Overall Study|Development of neutralizing Abs|0|||
126352633|NCT00587457|454582053|FG001|Overall Study|Development of neutralizing Abs|0|||
126352634|NCT00587457|454582054|FG002|Overall Study|Development of neutralizing Abs|1|||
126352635|NCT00924651|454582057|FG000|Overall Study|Chemo started too soon|2|||
126352636|NCT00924651|454582058|FG001|Overall Study|Chemo started too soon|3|||
126352637|NCT00924651|454582057|FG000|Overall Study|No Reason|3|||
126352638|NCT00924651|454582058|FG001|Overall Study|No Reason|7|||
126352639|NCT00924651|454582057|FG000|Overall Study|Overwhelmed|6|||
126352640|NCT00924651|454582058|FG001|Overall Study|Overwhelmed|6|||
126690229|NCT03222349|455820746|FG001|Overall Study|Withdrawal by Subject|0|||
126690230|NCT03222349|455820745|FG000|Overall Study|Treatment A not done|0|||
126690231|NCT03222349|455820746|FG001|Overall Study|Treatment A not done|5|||
126760236|NCT01016912|456072429|FG000|End of Treatment Period|Lack of Efficacy|0|||
126352641|NCT00924651|454582057|FG000|Overall Study|Noncompliant|1|||
126352642|NCT00924651|454582058|FG001|Overall Study|Noncompliant|4|||
126352643|NCT00924651|454582057|FG000|Overall Study|Medical|1|||
126352644|NCT00924651|454582058|FG001|Overall Study|Medical|3|||
126352645|NCT00924651|454582057|FG000|Overall Study|Changed Mind|10|||
126352646|NCT00924651|454582058|FG001|Overall Study|Changed Mind|1|||
126352647|NCT00924651|454582057|FG000|Overall Study|Incomplete Form|2|||
126352648|NCT00924651|454582058|FG001|Overall Study|Incomplete Form|1|||
126352649|NCT01991314|454582059|FG000|Overall Study|Adverse Event|5|||
126352650|NCT01991314|454582060|FG001|Overall Study|Adverse Event|1|||
126352651|NCT01991314|454582059|FG000|Overall Study|Lost to Follow-up|6|||
126352652|NCT01991314|454582060|FG001|Overall Study|Lost to Follow-up|10|||
126352653|NCT00970944|454582062|FG000|Overall Study|Death|1|||
126352654|NCT00970944|454582063|FG001|Overall Study|Death|0|||
126352655|NCT00970944|454582062|FG000|Overall Study|Physician Decision|0|||
126352656|NCT00970944|454582063|FG001|Overall Study|Physician Decision|2|||
126352657|NCT00972738|454582064|FG000|Overall Study|Adverse Event|7|||
126352658|NCT00972738|454582065|FG001|Overall Study|Adverse Event|1|||
126352659|NCT00972738|454582066|FG002|Overall Study|Adverse Event|8|||
126352660|NCT00972738|454582064|FG000|Overall Study|Protocol Violation|2|||
126352661|NCT00972738|454582065|FG001|Overall Study|Protocol Violation|1|||
126352662|NCT00972738|454582066|FG002|Overall Study|Protocol Violation|3|||
126352663|NCT00972738|454582064|FG000|Overall Study|Lost to Follow-up|1|||
126352664|NCT00972738|454582065|FG001|Overall Study|Lost to Follow-up|0|||
126352665|NCT00972738|454582066|FG002|Overall Study|Lost to Follow-up|1|||
126352666|NCT00972738|454582064|FG000|Overall Study|Lack of Efficacy|5|||
126352667|NCT00972738|454582065|FG001|Overall Study|Lack of Efficacy|1|||
126352668|NCT00972738|454582066|FG002|Overall Study|Lack of Efficacy|11|||
126352669|NCT00972738|454582064|FG000|Overall Study|Withdrawal by Subject|5|||
126352670|NCT00972738|454582065|FG001|Overall Study|Withdrawal by Subject|1|||
126352671|NCT00972738|454582066|FG002|Overall Study|Withdrawal by Subject|4|||
126352672|NCT00972738|454582064|FG000|Overall Study|Moved|0|||
126352673|NCT00972738|454582065|FG001|Overall Study|Moved|0|||
126352674|NCT00972738|454582066|FG002|Overall Study|Moved|1|||
126352675|NCT00972738|454582064|FG000|Overall Study|Other|1|||
126352676|NCT00972738|454582065|FG001|Overall Study|Other|2|||
126352677|NCT00972738|454582066|FG002|Overall Study|Other|1|||
126352678|NCT03915067|454582067|FG000|Overall Study|Adverse Event|0|||
126352679|NCT03915067|454582068|FG001|Overall Study|Adverse Event|0|||
126352680|NCT03915067|454582069|FG002|Overall Study|Adverse Event|1|||
126352681|NCT03915067|454582067|FG000|Overall Study|Withdrawal by Subject|4|||
126352682|NCT03915067|454582068|FG001|Overall Study|Withdrawal by Subject|3|||
126352683|NCT03915067|454582069|FG002|Overall Study|Withdrawal by Subject|0|||
126352684|NCT03915067|454582067|FG000|Overall Study|Lost to Follow-up|3|||
126352685|NCT03915067|454582068|FG001|Overall Study|Lost to Follow-up|2|||
126352686|NCT03915067|454582069|FG002|Overall Study|Lost to Follow-up|0|||
126690232|NCT03222349|455820745|FG000|Overall Study|Study terminated by sponsor|1|||
126690233|NCT03222349|455820746|FG001|Overall Study|Study terminated by sponsor|0|||
126690234|NCT00094757|455820750|FG000|Overall Study|Adverse Event|11|||
126690235|NCT00094757|455820751|FG001|Overall Study|Adverse Event|9|||
126690236|NCT00094757|455820752|FG002|Overall Study|Adverse Event|6|||
126690237|NCT00094757|455820750|FG000|Overall Study|Lack of Efficacy|11|||
126690238|NCT00094757|455820751|FG001|Overall Study|Lack of Efficacy|15|||
126690239|NCT00094757|455820752|FG002|Overall Study|Lack of Efficacy|8|||
126352687|NCT03915067|454582067|FG000|Overall Study|Protocol Deviation|0|||
126690240|NCT00094757|455820750|FG000|Overall Study|Lost to Follow-up|3|||
126690241|NCT00094757|455820751|FG001|Overall Study|Lost to Follow-up|5|||
126760237|NCT01016912|456072430|FG001|End of Treatment Period|Lack of Efficacy|1|||
126760238|NCT01016912|456072431|FG002|End of Treatment Period|Lack of Efficacy|0|||
126352688|NCT03915067|454582068|FG001|Overall Study|Protocol Deviation|0|||
126352689|NCT03915067|454582069|FG002|Overall Study|Protocol Deviation|1|||
126352690|NCT03915067|454582067|FG000|Overall Study|Covid-19 Related Issues|2|||
126352691|NCT03915067|454582068|FG001|Overall Study|Covid-19 Related Issues|4|||
126352692|NCT03915067|454582069|FG002|Overall Study|Covid-19 Related Issues|4|||
126690242|NCT00094757|455820752|FG002|Overall Study|Lost to Follow-up|6|||
126352693|NCT03915067|454582067|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
126352694|NCT03915067|454582068|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
126352695|NCT03915067|454582069|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
126352696|NCT01033942|454582070|FG000|Overall Study|Withdrawal by Subject|1|||
126352697|NCT01033942|454582071|FG001|Overall Study|Withdrawal by Subject|1|||
126352698|NCT01033942|454582072|FG002|Overall Study|Withdrawal by Subject|1|||
126352699|NCT01033942|454582070|FG000|Overall Study|Lost to Follow-up|1|||
126352700|NCT01033942|454582071|FG001|Overall Study|Lost to Follow-up|0|||
126352701|NCT01033942|454582072|FG002|Overall Study|Lost to Follow-up|0|||
126760239|NCT01016912|456072432|FG003|End of Treatment Period|Lack of Efficacy|4|||
126760240|NCT01016912|456072433|FG004|End of Treatment Period|Lack of Efficacy|4|||
126760241|NCT01016912|456072429|FG000|End of Treatment Period|Adverse Event|0|||
126306192|NCT03260244|454410221|FG000|Overall Study|Enrollment Criteria Not Met|31|||
126441121|NCT00363480|454913315|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
126441122|NCT00363480|454913315|FG000|Overall Study|Adverse Event|4|||
126441123|NCT00363480|454913315|FG000|Overall Study|Lost to Follow-up|5|||
126441124|NCT00363480|454913315|FG000|Overall Study|Withdrawal by Subject|5|||
126441125|NCT00363480|454913315|FG000|Overall Study|Non-compliance of subject|1|||
126441126|NCT00363480|454913315|FG000|Overall Study|Participant discontinued on its own|1|||
126690243|NCT00094757|455820750|FG000|Overall Study|Patient Moved|2|||
126441127|NCT05567783|454913316|FG000|Overall Study|Death|2|||
126441128|NCT05567783|454913317|FG001|Overall Study|Death|3|||
126441129|NCT05567783|454913318|FG002|Overall Study|Death|0|||
126441130|NCT05567783|454913316|FG000|Overall Study|Lost to Follow-up|25|||
126441131|NCT05567783|454913317|FG001|Overall Study|Lost to Follow-up|19|||
126441132|NCT05567783|454913318|FG002|Overall Study|Lost to Follow-up|17|||
126441133|NCT05567783|454913316|FG000|Overall Study|Physician Decision|10|||
126441134|NCT05567783|454913317|FG001|Overall Study|Physician Decision|7|||
126441135|NCT05567783|454913318|FG002|Overall Study|Physician Decision|9|||
126441136|NCT05567783|454913316|FG000|Overall Study|Study Terminated by Sponsor|924|||
126441137|NCT05567783|454913317|FG001|Overall Study|Study Terminated by Sponsor|937|||
126441138|NCT05567783|454913318|FG002|Overall Study|Study Terminated by Sponsor|941|||
126441139|NCT05567783|454913316|FG000|Overall Study|Withdrawal by Subject|23|||
126441140|NCT05567783|454913317|FG001|Overall Study|Withdrawal by Subject|27|||
126441141|NCT05567783|454913318|FG002|Overall Study|Withdrawal by Subject|24|||
126441142|NCT05567783|454913316|FG000|Overall Study|Incarcerated|1|||
126441143|NCT05567783|454913317|FG001|Overall Study|Incarcerated|0|||
126441144|NCT05567783|454913318|FG002|Overall Study|Incarcerated|0|||
126441145|NCT05567783|454913316|FG000|Overall Study|Participant randomized in error|4|||
126441146|NCT05567783|454913317|FG001|Overall Study|Participant randomized in error|2|||
126441147|NCT05567783|454913318|FG002|Overall Study|Participant randomized in error|2|||
126441148|NCT03944577|454913326|FG000|Overall Study|Adverse Event|3|||
126441149|NCT00949702|454913331|FG000|Overall Study|Death|40|||
126441150|NCT00949702|454913331|FG000|Overall Study|Disease progression|7|||
126441151|NCT00949702|454913331|FG000|Overall Study|Withdrawal of consent|1|||
126441152|NCT01654302|454913332|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
126441153|NCT01654302|454913333|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
126690244|NCT00094757|455820751|FG001|Overall Study|Patient Moved|1|||
126690245|NCT00094757|455820752|FG002|Overall Study|Patient Moved|1|||
126690246|NCT00094757|455820750|FG000|Overall Study|Protocol Violation|8|||
126690247|NCT00094757|455820751|FG001|Overall Study|Protocol Violation|5|||
126690248|NCT00094757|455820752|FG002|Overall Study|Protocol Violation|3|||
126690249|NCT00094757|455820750|FG000|Overall Study|Withdrawal by Subject|14|||
126690250|NCT00094757|455820751|FG001|Overall Study|Withdrawal by Subject|21|||
126690251|NCT00094757|455820752|FG002|Overall Study|Withdrawal by Subject|5|||
126690252|NCT00094757|455820750|FG000|Overall Study|Other|3|||
126690253|NCT00094757|455820751|FG001|Overall Study|Other|3|||
126690254|NCT00094757|455820752|FG002|Overall Study|Other|1|||
126690255|NCT00094757|455820750|FG000|Overall Study|Protocol specified discontinuation|1|||
126690256|NCT00094757|455820751|FG001|Overall Study|Protocol specified discontinuation|3|||
126690257|NCT00094757|455820752|FG002|Overall Study|Protocol specified discontinuation|0|||
126690258|NCT00756938|455820753|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
126690259|NCT00756938|455820754|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
126441154|NCT00630838|454913338|FG000|Overall Study|Death|0|||
126690260|NCT00756938|455820755|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
126690261|NCT00756938|455820756|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
126441155|NCT00630838|454913339|FG001|Overall Study|Death|1|||
126441156|NCT00630838|454913338|FG000|Overall Study|Lost to Follow-up|0|||
126441157|NCT00630838|454913339|FG001|Overall Study|Lost to Follow-up|1|||
126441158|NCT00670748|454913340|FG000|Overall Study|Death during treatment|1|||
126441159|NCT00670748|454913341|FG001|Overall Study|Death during treatment|1|||
126441160|NCT00670748|454913342|FG002|Overall Study|Death during treatment|1|||
126441161|NCT00670748|454913343|FG003|Overall Study|Death during treatment|0|||
126441162|NCT00670748|454913340|FG000|Overall Study|Not off study|2|||
126441163|NCT00670748|454913341|FG001|Overall Study|Not off study|1|||
126690262|NCT00756938|455820753|FG000|12-week Base Study|Protocol Violation|0|||
126690263|NCT00756938|455820754|FG001|12-week Base Study|Protocol Violation|0|||
126352702|NCT01033942|454582070|FG000|Overall Study|Enrolled in Extension Study|0|||
126352703|NCT01033942|454582071|FG001|Overall Study|Enrolled in Extension Study|3|||
126352704|NCT01033942|454582072|FG002|Overall Study|Enrolled in Extension Study|0|||
126352705|NCT02693418|454582073|FG000|Overall Study|Lost to Follow-up|1|||
126352706|NCT02693418|454582074|FG001|Overall Study|Lost to Follow-up|2|||
126352707|NCT02693418|454582075|FG002|Overall Study|Lost to Follow-up|0|||
126352708|NCT02693418|454582076|FG003|Overall Study|Lost to Follow-up|0|||
126352709|NCT02693418|454582077|FG004|Overall Study|Lost to Follow-up|0|||
126352710|NCT02693418|454582073|FG000|Overall Study|Menses during study period|0|||
126441164|NCT00670748|454913342|FG002|Overall Study|Not off study|1|||
126441165|NCT00670748|454913343|FG003|Overall Study|Not off study|1|||
126441166|NCT03278249|454913350|FG000|Overall Study|Withdrawal by Subject|2|||
126441167|NCT03278249|454913350|FG000|Overall Study|Lost to Follow-up|1|||
126441168|NCT04145349|454915218|FG000|Overall Study|Withdrawal by Subject|3|||
126441169|NCT04145349|454915219|FG001|Overall Study|Withdrawal by Subject|0|||
126441170|NCT04145349|454915218|FG000|Overall Study|Lost to Follow-up|0|||
126441171|NCT04145349|454915219|FG001|Overall Study|Lost to Follow-up|1|||
126441172|NCT04145349|454915218|FG000|Overall Study|On study treatment (Ongoing)|0|||
126441173|NCT04145349|454915219|FG001|Overall Study|On study treatment (Ongoing)|1|||
126441174|NCT01148979|454915220|FG000|Overall Study|Lost to Follow-up|0|||
126441175|NCT01148979|454915221|FG001|Overall Study|Lost to Follow-up|1|||
126441176|NCT00775190|454915222|FG000|Overall Study|Lost to Follow-up|2|||
126441177|NCT00775190|454915223|FG001|Overall Study|Lost to Follow-up|3|||
126441178|NCT00775190|454915222|FG000|Overall Study|Withdrawal by Subject|1|||
126441179|NCT00775190|454915223|FG001|Overall Study|Withdrawal by Subject|2|||
126441180|NCT00775190|454915222|FG000|Overall Study|Protocol Violation|1|||
126441181|NCT00775190|454915223|FG001|Overall Study|Protocol Violation|0|||
126441182|NCT01376804|454915224|FG000|Treatment Period|Withdrawal by Subject|1|||
126441183|NCT01376804|454915224|FG000|Treatment Period|Adverse Event|6|||
126441184|NCT01376804|454915224|FG000|Treatment Period|Patient did not receive study drug|1|||
126441185|NCT00904033|454915229|FG000|Overall Study|Withdrawal by Subject|1|||
126441186|NCT00904033|454915230|FG001|Overall Study|Withdrawal by Subject|1|||
126441187|NCT00904033|454915231|FG002|Overall Study|Withdrawal by Subject|0|||
126441188|NCT00904033|454915232|FG003|Overall Study|Withdrawal by Subject|0|||
126441189|NCT00904033|454915229|FG000|Overall Study|Physician Decision|0|||
126441190|NCT00904033|454915230|FG001|Overall Study|Physician Decision|0|||
126441191|NCT00904033|454915231|FG002|Overall Study|Physician Decision|1|||
126441192|NCT00904033|454915232|FG003|Overall Study|Physician Decision|0|||
126441193|NCT00904033|454915229|FG000|Overall Study|Unable to obtain final blood draw|0|||
126441194|NCT00904033|454915230|FG001|Overall Study|Unable to obtain final blood draw|0|||
126441195|NCT00904033|454915231|FG002|Overall Study|Unable to obtain final blood draw|0|||
126441196|NCT00904033|454915232|FG003|Overall Study|Unable to obtain final blood draw|2|||
126441197|NCT01357850|454915233|FG000|Overall Study|Lost to Follow-up|1|||
126441198|NCT01357850|454915234|FG001|Overall Study|Lost to Follow-up|0|||
126441199|NCT01357850|454915235|FG002|Overall Study|Lost to Follow-up|0|||
126441200|NCT01357850|454915236|FG003|Overall Study|Lost to Follow-up|0|||
126441201|NCT01600716|454915239|FG000|Overall Study|Other Reasons|3|||
126441202|NCT01600716|454915240|FG001|Overall Study|Other Reasons|1|||
126441203|NCT01600716|454915239|FG000|Overall Study|Personal Reasons|0|||
126441204|NCT01600716|454915240|FG001|Overall Study|Personal Reasons|2|||
126441205|NCT01600716|454915239|FG000|Overall Study|Lost to Follow-up|0|||
126441206|NCT01600716|454915240|FG001|Overall Study|Lost to Follow-up|2|||
126441207|NCT01600716|454915239|FG000|Overall Study|Pregnancy|1|||
126441208|NCT01600716|454915240|FG001|Overall Study|Pregnancy|0|||
126441209|NCT01600716|454915239|FG000|Overall Study|Lack of Efficacy|2|||
126441210|NCT01600716|454915240|FG001|Overall Study|Lack of Efficacy|1|||
126441211|NCT01600716|454915239|FG000|Overall Study|Adverse Event|1|||
126441212|NCT01600716|454915240|FG001|Overall Study|Adverse Event|1|||
126441213|NCT03349034|454915243|FG000|Overall Study|catheters dislodged during transport|2|||
126441214|NCT03349034|454915244|FG001|Overall Study|catheters dislodged during transport|0|||
126441215|NCT03349034|454915243|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
126441216|NCT03349034|454915244|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
126441217|NCT03349034|454915243|FG000|Overall Study|soft tissue flap used|1|||
126441218|NCT03349034|454915244|FG001|Overall Study|soft tissue flap used|0|||
126441219|NCT03349034|454915243|FG000|Overall Study|Other|0|||
126441220|NCT03349034|454915244|FG001|Overall Study|Other|1|||
126441221|NCT01177397|454915245|FG000|Overall Study|Protocol Violation|0|||
126441222|NCT01177397|454915246|FG001|Overall Study|Protocol Violation|0|||
126441223|NCT01177397|454915247|FG002|Overall Study|Protocol Violation|0|||
126441224|NCT01177397|454915248|FG003|Overall Study|Protocol Violation|0|||
126441225|NCT01177397|454915249|FG004|Overall Study|Protocol Violation|0|||
126441226|NCT01177397|454915250|FG005|Overall Study|Protocol Violation|1|||
126441227|NCT01177397|454915251|FG006|Overall Study|Protocol Violation|0|||
126441228|NCT01177397|454915252|FG007|Overall Study|Protocol Violation|0|||
126441229|NCT01177397|454915253|FG008|Overall Study|Protocol Violation|0|||
126441230|NCT01177397|454915254|FG009|Overall Study|Protocol Violation|0|||
126441231|NCT01177397|454915255|FG010|Overall Study|Protocol Violation|0|||
126441232|NCT01177397|454915256|FG011|Overall Study|Protocol Violation|0|||
126441233|NCT01177397|454915245|FG000|Overall Study|Lost to Follow-up|0|||
126441234|NCT01177397|454915246|FG001|Overall Study|Lost to Follow-up|0|||
126441235|NCT01177397|454915247|FG002|Overall Study|Lost to Follow-up|0|||
126441236|NCT01177397|454915248|FG003|Overall Study|Lost to Follow-up|0|||
126441237|NCT01177397|454915249|FG004|Overall Study|Lost to Follow-up|1|||
126441238|NCT01177397|454915250|FG005|Overall Study|Lost to Follow-up|0|||
126441239|NCT01177397|454915251|FG006|Overall Study|Lost to Follow-up|0|||
126441240|NCT01177397|454915252|FG007|Overall Study|Lost to Follow-up|2|||
126441241|NCT01177397|454915253|FG008|Overall Study|Lost to Follow-up|0|||
126441242|NCT01177397|454915254|FG009|Overall Study|Lost to Follow-up|0|||
126441243|NCT01177397|454915255|FG010|Overall Study|Lost to Follow-up|0|||
126441244|NCT01177397|454915256|FG011|Overall Study|Lost to Follow-up|0|||
126441245|NCT01177397|454915245|FG000|Overall Study|Death|0|||
126441246|NCT01177397|454915246|FG001|Overall Study|Death|0|||
126441247|NCT01177397|454915247|FG002|Overall Study|Death|1|||
126441248|NCT01177397|454915248|FG003|Overall Study|Death|1|||
126441249|NCT01177397|454915249|FG004|Overall Study|Death|0|||
126441250|NCT01177397|454915250|FG005|Overall Study|Death|0|||
126441251|NCT01177397|454915251|FG006|Overall Study|Death|0|||
126441252|NCT01177397|454915252|FG007|Overall Study|Death|5|||
126441253|NCT01177397|454915253|FG008|Overall Study|Death|2|||
126441254|NCT01177397|454915254|FG009|Overall Study|Death|1|||
126441255|NCT01177397|454915255|FG010|Overall Study|Death|0|||
126441256|NCT01177397|454915256|FG011|Overall Study|Death|0|||
126441257|NCT01177397|454915245|FG000|Overall Study|Withdrawal by Subject|0|||
126441258|NCT01177397|454915246|FG001|Overall Study|Withdrawal by Subject|0|||
126441259|NCT01177397|454915247|FG002|Overall Study|Withdrawal by Subject|1|||
126441260|NCT01177397|454915248|FG003|Overall Study|Withdrawal by Subject|1|||
126441261|NCT01177397|454915249|FG004|Overall Study|Withdrawal by Subject|1|||
126441262|NCT01177397|454915250|FG005|Overall Study|Withdrawal by Subject|2|||
126441263|NCT01177397|454915251|FG006|Overall Study|Withdrawal by Subject|0|||
126441264|NCT01177397|454915252|FG007|Overall Study|Withdrawal by Subject|5|||
126441265|NCT01177397|454915253|FG008|Overall Study|Withdrawal by Subject|9|||
126441266|NCT01177397|454915254|FG009|Overall Study|Withdrawal by Subject|1|||
126441267|NCT01177397|454915255|FG010|Overall Study|Withdrawal by Subject|1|||
126441268|NCT01177397|454915256|FG011|Overall Study|Withdrawal by Subject|0|||
126441269|NCT01177397|454915245|FG000|Overall Study|Adverse Event|0|||
126441270|NCT01177397|454915246|FG001|Overall Study|Adverse Event|0|||
126441271|NCT01177397|454915247|FG002|Overall Study|Adverse Event|1|||
126441272|NCT01177397|454915248|FG003|Overall Study|Adverse Event|2|||
126441273|NCT01177397|454915249|FG004|Overall Study|Adverse Event|0|||
126441274|NCT01177397|454915250|FG005|Overall Study|Adverse Event|12|||
126441275|NCT01177397|454915251|FG006|Overall Study|Adverse Event|1|||
126441276|NCT01177397|454915252|FG007|Overall Study|Adverse Event|14|||
126441277|NCT01177397|454915253|FG008|Overall Study|Adverse Event|8|||
126441278|NCT01177397|454915254|FG009|Overall Study|Adverse Event|6|||
126441279|NCT01177397|454915255|FG010|Overall Study|Adverse Event|3|||
126760242|NCT01016912|456072430|FG001|End of Treatment Period|Adverse Event|1|||
126441280|NCT01177397|454915256|FG011|Overall Study|Adverse Event|7|||
126441281|NCT01177397|454915245|FG000|Overall Study|Disease progression|1|||
126441282|NCT01177397|454915246|FG001|Overall Study|Disease progression|2|||
126441283|NCT01177397|454915247|FG002|Overall Study|Disease progression|5|||
126441284|NCT01177397|454915248|FG003|Overall Study|Disease progression|5|||
126441285|NCT01177397|454915249|FG004|Overall Study|Disease progression|4|||
126441286|NCT01177397|454915250|FG005|Overall Study|Disease progression|10|||
126441287|NCT01177397|454915251|FG006|Overall Study|Disease progression|10|||
126441288|NCT01177397|454915252|FG007|Overall Study|Disease progression|21|||
126441289|NCT01177397|454915253|FG008|Overall Study|Disease progression|18|||
126441290|NCT01177397|454915254|FG009|Overall Study|Disease progression|12|||
126441291|NCT01177397|454915255|FG010|Overall Study|Disease progression|10|||
126441292|NCT01177397|454915256|FG011|Overall Study|Disease progression|8|||
126441293|NCT01177397|454915245|FG000|Overall Study|Other reasons|0|||
126352711|NCT02693418|454582074|FG001|Overall Study|Menses during study period|0|||
126352712|NCT02693418|454582075|FG002|Overall Study|Menses during study period|2|||
126352713|NCT02693418|454582076|FG003|Overall Study|Menses during study period|0|||
126352714|NCT02693418|454582077|FG004|Overall Study|Menses during study period|0|||
126352715|NCT02260986|454582083|FG000|Overall Study|Adverse Event|24|||
126352716|NCT02260986|454582084|FG001|Overall Study|Adverse Event|0|||
126352717|NCT02260986|454582085|FG002|Overall Study|Adverse Event|11|||
126352718|NCT02260986|454582083|FG000|Overall Study|Lack of Efficacy|27|||
126352719|NCT02260986|454582084|FG001|Overall Study|Lack of Efficacy|3|||
126352720|NCT02260986|454582085|FG002|Overall Study|Lack of Efficacy|0|||
126690264|NCT00756938|455820755|FG002|12-week Base Study|Protocol Violation|1|||
126352721|NCT02260986|454582083|FG000|Overall Study|Protocol Violation|14|||
126352722|NCT02260986|454582084|FG001|Overall Study|Protocol Violation|5|||
126352723|NCT02260986|454582085|FG002|Overall Study|Protocol Violation|16|||
126352724|NCT02260986|454582083|FG000|Overall Study|Car accident|0|||
126352725|NCT02260986|454582084|FG001|Overall Study|Car accident|0|||
126352726|NCT02260986|454582085|FG002|Overall Study|Car accident|1|||
126352727|NCT02260986|454582083|FG000|Overall Study|Withdrawal by Subject|17|||
126352728|NCT02260986|454582084|FG001|Overall Study|Withdrawal by Subject|4|||
126352729|NCT02260986|454582085|FG002|Overall Study|Withdrawal by Subject|9|||
126352730|NCT02260986|454582083|FG000|Overall Study|Incorrect randomization|0|||
126352731|NCT02260986|454582084|FG001|Overall Study|Incorrect randomization|1|||
126352732|NCT02260986|454582085|FG002|Overall Study|Incorrect randomization|0|||
126352733|NCT02260986|454582083|FG000|Overall Study|Lack of investigation product supply|2|||
126352734|NCT02260986|454582084|FG001|Overall Study|Lack of investigation product supply|0|||
126352735|NCT02260986|454582085|FG002|Overall Study|Lack of investigation product supply|1|||
126352736|NCT02260986|454582083|FG000|Overall Study|Lost to Follow-up|4|||
126352737|NCT02260986|454582084|FG001|Overall Study|Lost to Follow-up|0|||
126352738|NCT02260986|454582085|FG002|Overall Study|Lost to Follow-up|3|||
126352739|NCT02260986|454582083|FG000|Overall Study|Pregnancy|2|||
126352740|NCT02260986|454582084|FG001|Overall Study|Pregnancy|0|||
126352741|NCT02260986|454582085|FG002|Overall Study|Pregnancy|0|||
126352742|NCT01793935|454582088|FG000|Overall Study|Pregnancy|1|||
126352743|NCT01793935|454582089|FG001|Overall Study|Pregnancy|0|||
126352744|NCT01793935|454582088|FG000|Overall Study|Protocol Violation|2|||
126352745|NCT01793935|454582089|FG001|Overall Study|Protocol Violation|1|||
126352746|NCT01793935|454582088|FG000|Overall Study|Adverse Event|2|||
126352747|NCT01793935|454582089|FG001|Overall Study|Adverse Event|0|||
126352748|NCT01793935|454582088|FG000|Overall Study|Patient did not take study medication|1|||
126352749|NCT01793935|454582089|FG001|Overall Study|Patient did not take study medication|1|||
126352750|NCT01793935|454582088|FG000|Overall Study|Lost to Follow-up|0|||
126352751|NCT01793935|454582089|FG001|Overall Study|Lost to Follow-up|1|||
126352752|NCT01771913|454582091|FG000|Overall Study|Withdrawal by Subject|1|||
126352753|NCT01771913|454582092|FG001|Overall Study|Withdrawal by Subject|0|||
126352754|NCT04307394|454582093|FG000|Overall Study|Lost to Follow-up|3|||
126352755|NCT04307394|454582093|FG000|Overall Study|Withdrawal by Subject|2|||
126352756|NCT00313170|454582095|FG000|Overall Study|Death|2|||
126352757|NCT00313170|454582096|FG001|Overall Study|Death|4|||
126352758|NCT00313170|454582097|FG002|Overall Study|Death|2|||
126352759|NCT00313170|454582095|FG000|Overall Study|Adverse Event|1|||
126352760|NCT00313170|454582096|FG001|Overall Study|Adverse Event|2|||
126352761|NCT00313170|454582097|FG002|Overall Study|Adverse Event|0|||
126352762|NCT00313170|454582095|FG000|Overall Study|Disease progression|31|||
126352763|NCT00313170|454582096|FG001|Overall Study|Disease progression|26|||
126352764|NCT00313170|454582097|FG002|Overall Study|Disease progression|27|||
126352765|NCT00313170|454582095|FG000|Overall Study|Withdrawal by Subject|1|||
126352766|NCT00313170|454582096|FG001|Overall Study|Withdrawal by Subject|0|||
126352767|NCT00313170|454582097|FG002|Overall Study|Withdrawal by Subject|1|||
126352768|NCT00313170|454582095|FG000|Overall Study|Incorrect enrollment|0|||
126352769|NCT00313170|454582096|FG001|Overall Study|Incorrect enrollment|2|||
126352770|NCT00313170|454582097|FG002|Overall Study|Incorrect enrollment|1|||
126352771|NCT00313170|454582095|FG000|Overall Study|Lost to Follow-up|0|||
126352772|NCT00313170|454582096|FG001|Overall Study|Lost to Follow-up|0|||
126352773|NCT00313170|454582097|FG002|Overall Study|Lost to Follow-up|1|||
126352774|NCT00313170|454582095|FG000|Overall Study|Progression (investigators opinion)|1|||
126352775|NCT00313170|454582096|FG001|Overall Study|Progression (investigators opinion)|0|||
126352776|NCT00313170|454582097|FG002|Overall Study|Progression (investigators opinion)|0|||
126690265|NCT00756938|455820756|FG003|12-week Base Study|Protocol Violation|0|||
126690266|NCT00756938|455820753|FG000|12-week Base Study|Lost to Follow-up|1|||
126690267|NCT00756938|455820754|FG001|12-week Base Study|Lost to Follow-up|0|||
126690268|NCT00756938|455820755|FG002|12-week Base Study|Lost to Follow-up|0|||
126690269|NCT00756938|455820756|FG003|12-week Base Study|Lost to Follow-up|0|||
126352777|NCT04900272|454582098|FG000|Overall Study|Lost to Follow-up|2|||
126352778|NCT04900272|454582098|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
126352779|NCT04900272|454582098|FG000|Overall Study|Withdrawal by Subject|1|||
126352780|NCT05059080|454582100|FG000|Overall Study|Withdrawal by Subject|3|||
126352781|NCT05059080|454582100|FG000|Overall Study|Study Terminated by Sponsor|64|||
126352782|NCT05607043|454582101|FG000|Overall Study|Lost to Follow-up|2|||
126352783|NCT00429299|454582109|FG000|Overall Study|Disease Progression|1|||
126352784|NCT00429299|454582110|FG001|Overall Study|Disease Progression|1|||
126352785|NCT00429299|454582111|FG002|Overall Study|Disease Progression|0|||
126352786|NCT00429299|454582109|FG000|Overall Study|Adverse Event|2|||
126352787|NCT00429299|454582110|FG001|Overall Study|Adverse Event|5|||
126352788|NCT00429299|454582111|FG002|Overall Study|Adverse Event|1|||
126352789|NCT00429299|454582109|FG000|Overall Study|Protocol Violation|1|||
126352790|NCT00429299|454582110|FG001|Overall Study|Protocol Violation|0|||
126352791|NCT00429299|454582111|FG002|Overall Study|Protocol Violation|0|||
126352792|NCT00429299|454582109|FG000|Overall Study|Withdrawal by Subject|0|||
126352793|NCT00429299|454582110|FG001|Overall Study|Withdrawal by Subject|1|||
126352794|NCT00429299|454582111|FG002|Overall Study|Withdrawal by Subject|3|||
126352795|NCT04871113|454582112|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352796|NCT04871113|454582113|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352797|NCT04871113|454582114|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352798|NCT04871113|454582115|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126690270|NCT00756938|455820753|FG000|Optional Extension|Lack of Efficacy|0|||
126441294|NCT01177397|454915246|FG001|Overall Study|Other reasons|0|||
126441295|NCT01177397|454915247|FG002|Overall Study|Other reasons|1|||
126441296|NCT01177397|454915248|FG003|Overall Study|Other reasons|0|||
126441297|NCT01177397|454915249|FG004|Overall Study|Other reasons|1|||
126441298|NCT01177397|454915250|FG005|Overall Study|Other reasons|1|||
126441299|NCT01177397|454915251|FG006|Overall Study|Other reasons|2|||
126441300|NCT01177397|454915252|FG007|Overall Study|Other reasons|6|||
126441301|NCT01177397|454915253|FG008|Overall Study|Other reasons|10|||
126441302|NCT01177397|454915254|FG009|Overall Study|Other reasons|8|||
126441303|NCT01177397|454915255|FG010|Overall Study|Other reasons|0|||
126441304|NCT01177397|454915256|FG011|Overall Study|Other reasons|2|||
126441305|NCT00865566|454915257|FG000|Overall Study|Death|1|||
126441306|NCT00865566|454915258|FG001|Overall Study|Death|11|||
126441307|NCT00865566|454915257|FG000|Overall Study|Lost to Follow-up|314|||
126441308|NCT00865566|454915258|FG001|Overall Study|Lost to Follow-up|315|||
126441309|NCT00865566|454915257|FG000|Overall Study|Withdrawal by Subject|45|||
126441310|NCT00865566|454915258|FG001|Overall Study|Withdrawal by Subject|65|||
126441311|NCT00865566|454915257|FG000|Overall Study|Physician Decision|0|||
126441312|NCT00865566|454915258|FG001|Overall Study|Physician Decision|1|||
126441313|NCT00865566|454915257|FG000|Overall Study|Participant relocated|78|||
126441314|NCT00865566|454915258|FG001|Overall Study|Participant relocated|107|||
126441315|NCT00865566|454915257|FG000|Overall Study|Participant unable to adhere|27|||
126441316|NCT00865566|454915258|FG001|Overall Study|Participant unable to adhere|42|||
126441317|NCT00865566|454915257|FG000|Overall Study|Other; N=245 due to early study closure|154|||
126441318|NCT00865566|454915258|FG001|Overall Study|Other; N=245 due to early study closure|139|||
126441319|NCT00865566|454915257|FG000|Overall Study|HIV infection|5|||
126441320|NCT00865566|454915258|FG001|Overall Study|HIV infection|7|||
126441321|NCT00815659|454915259|FG000|Overall Study|Adverse Event|9|||
126690271|NCT00756938|455820754|FG001|Optional Extension|Lack of Efficacy|0|||
126690272|NCT00756938|455820755|FG002|Optional Extension|Lack of Efficacy|0|||
126690273|NCT00756938|455820756|FG003|Optional Extension|Lack of Efficacy|1|||
126690274|NCT00756938|455820753|FG000|Optional Extension|End of Study|0|||
126352799|NCT04871113|454582116|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352800|NCT04871113|454582117|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
126352801|NCT04871113|454582118|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352802|NCT04871113|454582119|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352803|NCT04871113|454582120|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352804|NCT04871113|454582121|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
126352805|NCT04871113|454582112|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352806|NCT04871113|454582113|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352807|NCT04871113|454582114|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352808|NCT04871113|454582115|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352809|NCT04871113|454582116|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352810|NCT04871113|454582117|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352811|NCT04871113|454582118|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
126352812|NCT04871113|454582119|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
126352813|NCT04871113|454582120|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352814|NCT04871113|454582121|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
126352815|NCT01257542|454582124|FG000|Overall Study|Protocol Violation|3|||
126352816|NCT01257542|454582125|FG001|Overall Study|Protocol Violation|5|||
126352817|NCT01257542|454582124|FG000|Overall Study|Withdrawal by Subject|0|||
126352818|NCT01257542|454582125|FG001|Overall Study|Withdrawal by Subject|2|||
126352819|NCT00770484|454582128|FG000|Overall Study|Withdrawal by Subject|1|||
126352820|NCT00770484|454582129|FG001|Overall Study|Withdrawal by Subject|0|||
126352821|NCT04327271|454582130|FG000|Overall Study|Death|1|||
126352822|NCT04327271|454582131|FG001|Overall Study|Death|0|||
126352823|NCT04327271|454582130|FG000|Overall Study|Withdrawal by Subject|1|||
126352824|NCT04327271|454582131|FG001|Overall Study|Withdrawal by Subject|0|||
126352825|NCT04327271|454582130|FG000|Overall Study|randomization error (data capture)|4|||
126352826|NCT04327271|454582131|FG001|Overall Study|randomization error (data capture)|3|||
126352827|NCT01479530|454582133|FG000|Overall Study|Adverse Event|5|||
126352828|NCT01479530|454582134|FG001|Overall Study|Adverse Event|6|||
126352829|NCT01479530|454582133|FG000|Overall Study|Lack of Efficacy|0|||
126352830|NCT01479530|454582134|FG001|Overall Study|Lack of Efficacy|1|||
126352831|NCT01479530|454582133|FG000|Overall Study|Protocol Violation|2|||
126352832|NCT01479530|454582134|FG001|Overall Study|Protocol Violation|3|||
126352833|NCT01479530|454582133|FG000|Overall Study|Withdrawal of Consent|3|||
126441322|NCT00815659|454915259|FG000|Overall Study|Withdrawal by Subject|9|||
126441323|NCT00815659|454915259|FG000|Overall Study|Lost to Follow-up|4|||
126441324|NCT00815659|454915259|FG000|Overall Study|Protocol Violation|1|||
126441325|NCT02395471|454915260|FG000|Overall Study|Lost to Follow-up|2|||
126441326|NCT02395471|454915261|FG001|Overall Study|Lost to Follow-up|0|||
126441327|NCT02395471|454915260|FG000|Overall Study|Withdrawal by Subject|2|||
126760243|NCT01016912|456072431|FG002|End of Treatment Period|Adverse Event|1|||
126352834|NCT01479530|454582134|FG001|Overall Study|Withdrawal of Consent|2|||
126352835|NCT00303628|454582135|FG000|Overall Study|Disease progression|0|||
126352836|NCT00303628|454582136|FG001|Overall Study|Disease progression|1|||
126352837|NCT00303628|454582135|FG000|Overall Study|Adverse Event|26|||
126352838|NCT00303628|454582136|FG001|Overall Study|Adverse Event|36|||
126352839|NCT00303628|454582135|FG000|Overall Study|Death|0|||
126352840|NCT00303628|454582136|FG001|Overall Study|Death|1|||
126352841|NCT00303628|454582135|FG000|Overall Study|Withdrawal by Subject|11|||
126352842|NCT00303628|454582136|FG001|Overall Study|Withdrawal by Subject|20|||
126352843|NCT00303628|454582135|FG000|Overall Study|Alternative therapy|2|||
126352844|NCT00303628|454582136|FG001|Overall Study|Alternative therapy|0|||
126352845|NCT00303628|454582135|FG000|Overall Study|Other complicating disease|0|||
126352846|NCT00303628|454582136|FG001|Overall Study|Other complicating disease|1|||
126352847|NCT00303628|454582135|FG000|Overall Study|Not start protocol therapy|3|||
126352848|NCT00303628|454582136|FG001|Overall Study|Not start protocol therapy|5|||
126352849|NCT00303628|454582135|FG000|Overall Study|Other|8|||
126352850|NCT00303628|454582136|FG001|Overall Study|Other|9|||
126352851|NCT00776997|454582138|FG000|Overall Study|Adverse Event|2|||
126352852|NCT02948400|454582139|FG000|Overall Study|Withdrawal by Subject|17|||
126352853|NCT02948400|454582140|FG001|Overall Study|Withdrawal by Subject|10|||
126352854|NCT02948400|454582139|FG000|Overall Study|failed to attend appointments|47|||
126352855|NCT02948400|454582140|FG001|Overall Study|failed to attend appointments|34|||
126352856|NCT02948400|454582139|FG000|Overall Study|COVID-related closure|6|||
126352857|NCT02948400|454582140|FG001|Overall Study|COVID-related closure|2|||
126352858|NCT02948400|454582139|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
126352859|NCT02948400|454582140|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
126352860|NCT02948400|454582139|FG000|Overall Study|motion sickness in virtual reality|2|||
126352861|NCT02948400|454582140|FG001|Overall Study|motion sickness in virtual reality|0|||
126352862|NCT02403271|454582141|FG000|Period 1|Other varied reasons|1|||
126352863|NCT02403271|454582142|FG001|Period 1|Other varied reasons|0|||
126352864|NCT02403271|454582141|FG000|Period 2|Withdrawal by Subject|0|||
126352865|NCT02403271|454582142|FG001|Period 2|Withdrawal by Subject|14|||
126352866|NCT02403271|454582141|FG000|Period 2|Death|0|||
126352867|NCT02403271|454582142|FG001|Period 2|Death|84|||
126352868|NCT02403271|454582141|FG000|Period 2|Lost to Follow-up|0|||
126352869|NCT02403271|454582142|FG001|Period 2|Lost to Follow-up|2|||
126352870|NCT02403271|454582141|FG000|Period 2|Study Terminated by Sponsor|0|||
126352871|NCT02403271|454582142|FG001|Period 2|Study Terminated by Sponsor|14|||
126352872|NCT02403271|454582141|FG000|Period 2|Other varied reasons|0|||
126352873|NCT02403271|454582142|FG001|Period 2|Other varied reasons|10|||
126352874|NCT03487445|454582143|FG000|Randomization|Not treated for administrative reasons|1|||
126352875|NCT03487445|454582144|FG001|Randomization|Not treated for administrative reasons|0|||
126352876|NCT03301714|454582145|FG000|Overall Study|Lost to Follow-up|10|||
126352877|NCT03301714|454582146|FG001|Overall Study|Lost to Follow-up|4|||
126352878|NCT03301714|454582147|FG002|Overall Study|Lost to Follow-up|4|||
126352879|NCT03301714|454582145|FG000|Overall Study|Did not receive allocated intervention|0|||
126352880|NCT03301714|454582146|FG001|Overall Study|Did not receive allocated intervention|2|||
126352881|NCT03301714|454582147|FG002|Overall Study|Did not receive allocated intervention|3|||
126352882|NCT03599713|454582159|FG000|Overall Study|Death|38|||
126352883|NCT03599713|454582160|FG001|Overall Study|Death|3|||
126352884|NCT03599713|454582159|FG000|Overall Study|Withdrawal by Subject|17|||
126352885|NCT03599713|454582160|FG001|Overall Study|Withdrawal by Subject|0|||
126352886|NCT03599713|454582159|FG000|Overall Study|Lost to Follow-up|4|||
126352887|NCT03599713|454582160|FG001|Overall Study|Lost to Follow-up|0|||
126352888|NCT03599713|454582159|FG000|Overall Study|Discontinued Due to End of Study|42|||
126352889|NCT03599713|454582160|FG001|Overall Study|Discontinued Due to End of Study|3|||
126352890|NCT01127061|454583323|FG000|Overall Study|Lost to Follow-up|7|||
126352891|NCT01127061|454583324|FG001|Overall Study|Lost to Follow-up|10|||
126352892|NCT01127061|454583323|FG000|Overall Study|Physician Decision|3|||
126352893|NCT01127061|454583324|FG001|Overall Study|Physician Decision|3|||
126352894|NCT04827446|454583325|FG000|Overall Study|Lost to Follow-up|1|||
126352895|NCT04827446|454583326|FG001|Overall Study|Lost to Follow-up|1|||
126352896|NCT04827446|454583325|FG000|Overall Study|Death|2|||
126352897|NCT04827446|454583326|FG001|Overall Study|Death|0|||
126352898|NCT04827446|454583325|FG000|Overall Study|Withdrawal by Subject|2|||
126352899|NCT04827446|454583326|FG001|Overall Study|Withdrawal by Subject|2|||
126352900|NCT00003456|454583329|FG000|Overall Study|Not evaluable|8|||
126690275|NCT00756938|455820754|FG001|Optional Extension|End of Study|0|||
126690276|NCT00756938|455820755|FG002|Optional Extension|End of Study|0|||
126690277|NCT00756938|455820756|FG003|Optional Extension|End of Study|11|||
126690278|NCT00756938|455820753|FG000|Optional Extension|Protocol-specific criteria met|0|||
126690279|NCT00756938|455820754|FG001|Optional Extension|Protocol-specific criteria met|0|||
126690280|NCT00756938|455820755|FG002|Optional Extension|Protocol-specific criteria met|0|||
126690281|NCT00756938|455820756|FG003|Optional Extension|Protocol-specific criteria met|9|||
126690282|NCT00756938|455820753|FG000|Optional Extension|Physician Decision|0|||
126690283|NCT00756938|455820754|FG001|Optional Extension|Physician Decision|0|||
126690284|NCT00756938|455820755|FG002|Optional Extension|Physician Decision|0|||
126690285|NCT00756938|455820756|FG003|Optional Extension|Physician Decision|3|||
126690286|NCT00756938|455820753|FG000|Optional Extension|Lost to Follow-up|0|||
126690287|NCT00756938|455820754|FG001|Optional Extension|Lost to Follow-up|0|||
126690288|NCT00756938|455820755|FG002|Optional Extension|Lost to Follow-up|0|||
126690289|NCT00756938|455820756|FG003|Optional Extension|Lost to Follow-up|1|||
126690290|NCT00756938|455820753|FG000|Optional Extension|Protocol Violation|0|||
126690291|NCT00756938|455820754|FG001|Optional Extension|Protocol Violation|0|||
126690292|NCT00756938|455820755|FG002|Optional Extension|Protocol Violation|0|||
126690293|NCT00756938|455820756|FG003|Optional Extension|Protocol Violation|1|||
126690294|NCT00756938|455820753|FG000|Optional Extension|Withdrawal by Subject|0|||
126690295|NCT00756938|455820754|FG001|Optional Extension|Withdrawal by Subject|0|||
126690296|NCT00756938|455820755|FG002|Optional Extension|Withdrawal by Subject|0|||
126352901|NCT05399771|454583330|FG000|Overall Study|Physician Decision|3|||
126352902|NCT05399771|454583330|FG000|Overall Study|Adverse Event|1|||
126352903|NCT00143507|454583333|FG000|Overall Study|Death|572|||
126352904|NCT00143507|454583334|FG001|Overall Study|Death|547|||
126352905|NCT00143507|454583333|FG000|Overall Study|Withdrawal by Subject|114|||
126352906|NCT00143507|454583334|FG001|Overall Study|Withdrawal by Subject|102|||
126352907|NCT00143507|454583333|FG000|Overall Study|Lost to Follow-up|1|||
126352908|NCT00143507|454583334|FG001|Overall Study|Lost to Follow-up|0|||
126352909|NCT00143507|454583333|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
126352910|NCT00143507|454583334|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
126352911|NCT00484159|454583335|FG000|Overall Study|Lost to Follow-up|1|||
126352912|NCT00484159|454583336|FG001|Overall Study|Lost to Follow-up|1|||
126352913|NCT00484159|454583337|FG002|Overall Study|Lost to Follow-up|0|||
126352914|NCT03234881|454583338|FG000|Overall Study|Lost to Follow-up|9|||
126352915|NCT03234881|454583339|FG001|Overall Study|Lost to Follow-up|3|||
126352916|NCT02513199|454583342|FG000|Treatment|Death|1|||
126352917|NCT02513199|454583342|FG000|Treatment|Lost to Follow-up|1|||
126352918|NCT02513199|454583342|FG000|Follow-Up|Death|11|||
126352919|NCT00407511|454583354|FG000|Overall Study|Adverse Event|9|||
126352920|NCT00407511|454583354|FG000|Overall Study|Lost to Follow-up|4|||
126352921|NCT00407511|454583354|FG000|Overall Study|Other|5|||
126352922|NCT00407511|454583354|FG000|Overall Study|Withdrawal by Subject|4|||
126352923|NCT00529035|454583355|FG000|Overall Study|Withdrawal by Subject|1|||
126352924|NCT03439514|454583356|FG000|Double-Blind Treatment Period|Other|4|||
126352925|NCT03439514|454583357|FG001|Double-Blind Treatment Period|Other|1|||
126352926|NCT03439514|454583356|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
126352927|NCT03439514|454583357|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126352928|NCT03439514|454583356|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
126352929|NCT03439514|454583357|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
126352930|NCT03439514|454583356|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
126352931|NCT03439514|454583357|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
126352932|NCT03439514|454583356|FG000|Double-Blind Treatment Period|Death|1|||
126352933|NCT03439514|454583357|FG001|Double-Blind Treatment Period|Death|2|||
126352934|NCT02175758|454583358|FG000|Treatment Phase|Lost to Follow-up|0|||
126352935|NCT02175758|454583359|FG001|Treatment Phase|Lost to Follow-up|1|||
126352936|NCT02175758|454583360|FG002|Treatment Phase|Lost to Follow-up|0|||
126352937|NCT02175758|454583361|FG003|Treatment Phase|Lost to Follow-up|0|||
126352938|NCT02175758|454583362|FG004|Treatment Phase|Lost to Follow-up|0|||
126352939|NCT02175758|454583363|FG005|Treatment Phase|Lost to Follow-up|0|||
126352940|NCT02175758|454583358|FG000|Treatment Phase|Adverse Event|0|||
126352941|NCT02175758|454583359|FG001|Treatment Phase|Adverse Event|0|||
126352942|NCT02175758|454583360|FG002|Treatment Phase|Adverse Event|0|||
126352943|NCT02175758|454583361|FG003|Treatment Phase|Adverse Event|0|||
126352944|NCT02175758|454583362|FG004|Treatment Phase|Adverse Event|1|||
126352945|NCT02175758|454583363|FG005|Treatment Phase|Adverse Event|0|||
126352946|NCT00800540|454583366|FG000|Period One: 6 Weeks|Noncompliance|1|||
126352947|NCT00800540|454583367|FG001|Period One: 6 Weeks|Noncompliance|0|||
126352948|NCT00800540|454583366|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
126352949|NCT00800540|454583367|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
126352950|NCT00800540|454583366|FG000|Period 2: 6 Weeks|Adverse Event|0|||
126352951|NCT00800540|454583367|FG001|Period 2: 6 Weeks|Adverse Event|1|||
126352952|NCT03927157|454583368|FG000|Overall Study|Adverse Event|1|||
126352953|NCT03927157|454583369|FG001|Overall Study|Adverse Event|3|||
126352954|NCT03927157|454583368|FG000|Overall Study|Protocol Violation|1|||
126690297|NCT00756938|455820756|FG003|Optional Extension|Withdrawal by Subject|10|||
126441328|NCT02395471|454915261|FG001|Overall Study|Withdrawal by Subject|1|||
126441329|NCT02395471|454915260|FG000|Overall Study|Physician Decision|1|||
126441330|NCT02395471|454915261|FG001|Overall Study|Physician Decision|0|||
126441331|NCT02395471|454915260|FG000|Overall Study|Protocol Violation|0|||
126441332|NCT02395471|454915261|FG001|Overall Study|Protocol Violation|1|||
126441333|NCT02395471|454915260|FG000|Overall Study|Failure to swollow sponge twice|1|||
126441334|NCT02395471|454915261|FG001|Overall Study|Failure to swollow sponge twice|0|||
126441335|NCT02395471|454915260|FG000|Overall Study|Patient did not return for procedure|0|||
126441336|NCT02395471|454915261|FG001|Overall Study|Patient did not return for procedure|1|||
126441337|NCT02395471|454915260|FG000|Overall Study|Subject not eligible|1|||
126441338|NCT02395471|454915261|FG001|Overall Study|Subject not eligible|0|||
126441339|NCT03847896|454915262|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
126441340|NCT03847896|454915263|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
126441341|NCT03847896|454915264|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
126441342|NCT03847896|454915265|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
126441343|NCT03847896|454915266|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
126441344|NCT03847896|454915262|FG000|Overall Study|Withdrawal by Subject|2|||
126441345|NCT03847896|454915263|FG001|Overall Study|Withdrawal by Subject|10|||
126441346|NCT03847896|454915264|FG002|Overall Study|Withdrawal by Subject|5|||
126441347|NCT03847896|454915265|FG003|Overall Study|Withdrawal by Subject|9|||
126441348|NCT03847896|454915266|FG004|Overall Study|Withdrawal by Subject|8|||
126545400|NCT02541383|455290824|FG001|Overall Study|Sponsor's decision|1|||
126352955|NCT03927157|454583369|FG001|Overall Study|Protocol Violation|2|||
126352956|NCT03927157|454583368|FG000|Overall Study|Withdrawal by Subject|8|||
126352957|NCT03927157|454583369|FG001|Overall Study|Withdrawal by Subject|21|||
126352958|NCT03927157|454583368|FG000|Overall Study|Due to COVID-19 pandemic|5|||
126352959|NCT03927157|454583369|FG001|Overall Study|Due to COVID-19 pandemic|2|||
126352960|NCT03927157|454583368|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
126352961|NCT03927157|454583369|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
126352962|NCT03927157|454583368|FG000|Overall Study|Other than above|0|||
126352963|NCT03927157|454583369|FG001|Overall Study|Other than above|1|||
126352964|NCT02447029|454583370|FG000|Overall Study|Withdrawal by Subject|3|||
126352965|NCT02447029|454583371|FG001|Overall Study|Withdrawal by Subject|2|||
126352966|NCT01239745|454583372|FG000|Overall Study|Study terminated by sponsor|45|||
126352967|NCT01239745|454583372|FG000|Overall Study|Adverse Event|1|||
126352968|NCT00726557|454583373|FG000|Overall Study|Screening failure|4|||
126352969|NCT00726557|454583373|FG000|Overall Study|No end of treatment documentation|37|||
126352970|NCT00726557|454583373|FG000|Overall Study|No follow-up documentation available|55|||
126352971|NCT00726557|454583373|FG000|Overall Study|Treatment less than 3 months|17|||
126352972|NCT00726557|454583373|FG000|Overall Study|Inclusion criteria not met|15|||
126352973|NCT00081458|454583374|FG000|Overall Study|Adverse Event|1|||
126352974|NCT00081458|454583375|FG001|Overall Study|Adverse Event|5|||
126352975|NCT00081458|454583376|FG002|Overall Study|Adverse Event|2|||
126352976|NCT00081458|454583374|FG000|Overall Study|Withdrawal by Subject|0|||
126352977|NCT00081458|454583375|FG001|Overall Study|Withdrawal by Subject|3|||
126352978|NCT00081458|454583376|FG002|Overall Study|Withdrawal by Subject|1|||
126352979|NCT00081458|454583374|FG000|Overall Study|Randomized but not dosed|0|||
126352980|NCT00081458|454583375|FG001|Overall Study|Randomized but not dosed|0|||
126352981|NCT00081458|454583376|FG002|Overall Study|Randomized but not dosed|1|||
126352982|NCT00549328|454583377|FG000|Overall Study|Adverse Event|2|||
126352983|NCT00549328|454583377|FG000|Overall Study|Disease Progression|10|||
126352984|NCT00549328|454583377|FG000|Overall Study|Death|1|||
126441349|NCT03847896|454915262|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126441350|NCT03847896|454915263|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126441351|NCT03847896|454915264|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126441352|NCT03847896|454915265|FG003|Overall Study|Withdrawal by parent/guardian|0|||
126441353|NCT03847896|454915266|FG004|Overall Study|Withdrawal by parent/guardian|0|||
126441354|NCT03847896|454915262|FG000|Overall Study|Adverse Event|2|||
126441355|NCT03847896|454915263|FG001|Overall Study|Adverse Event|1|||
126441356|NCT03847896|454915264|FG002|Overall Study|Adverse Event|3|||
126441357|NCT03847896|454915265|FG003|Overall Study|Adverse Event|2|||
126441358|NCT03847896|454915266|FG004|Overall Study|Adverse Event|4|||
126441359|NCT03847896|454915262|FG000|Overall Study|A severe exacerbation event|0|||
126441360|NCT03847896|454915263|FG001|Overall Study|A severe exacerbation event|0|||
126441361|NCT03847896|454915264|FG002|Overall Study|A severe exacerbation event|0|||
126441362|NCT03847896|454915265|FG003|Overall Study|A severe exacerbation event|0|||
126441363|NCT03847896|454915266|FG004|Overall Study|A severe exacerbation event|3|||
126441364|NCT03847896|454915262|FG000|Overall Study|Protocol Violation|0|||
126441365|NCT03847896|454915263|FG001|Overall Study|Protocol Violation|2|||
126441366|NCT03847896|454915264|FG002|Overall Study|Protocol Violation|1|||
126441367|NCT03847896|454915265|FG003|Overall Study|Protocol Violation|0|||
126441368|NCT03847896|454915266|FG004|Overall Study|Protocol Violation|2|||
126441369|NCT03847896|454915262|FG000|Overall Study|Lost to Follow-up|0|||
126441370|NCT03847896|454915263|FG001|Overall Study|Lost to Follow-up|0|||
126441371|NCT03847896|454915264|FG002|Overall Study|Lost to Follow-up|0|||
126441372|NCT03847896|454915265|FG003|Overall Study|Lost to Follow-up|1|||
126441373|NCT03847896|454915266|FG004|Overall Study|Lost to Follow-up|0|||
126441374|NCT03847896|454915262|FG000|Overall Study|Condition under investigation worsened|0|||
126441375|NCT03847896|454915263|FG001|Overall Study|Condition under investigation worsened|0|||
126441376|NCT03847896|454915264|FG002|Overall Study|Condition under investigation worsened|0|||
126441377|NCT03847896|454915265|FG003|Overall Study|Condition under investigation worsened|1|||
126441378|NCT03847896|454915266|FG004|Overall Study|Condition under investigation worsened|1|||
126441379|NCT03847896|454915262|FG000|Overall Study|Lack of Efficacy|0|||
126441380|NCT03847896|454915263|FG001|Overall Study|Lack of Efficacy|0|||
126441381|NCT03847896|454915264|FG002|Overall Study|Lack of Efficacy|0|||
126441382|NCT03847896|454915265|FG003|Overall Study|Lack of Efficacy|2|||
126441383|NCT03847896|454915266|FG004|Overall Study|Lack of Efficacy|2|||
126441384|NCT03847896|454915262|FG000|Overall Study|Other reasons|3|||
126441385|NCT03847896|454915263|FG001|Overall Study|Other reasons|3|||
126441386|NCT03847896|454915264|FG002|Overall Study|Other reasons|1|||
126441387|NCT03847896|454915265|FG003|Overall Study|Other reasons|2|||
126441388|NCT03847896|454915266|FG004|Overall Study|Other reasons|1|||
126441389|NCT00118417|454915267|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
126441390|NCT00118417|454915268|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
126441391|NCT00118417|454915267|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
126441392|NCT00118417|454915268|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
126441393|NCT00118417|454915267|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
126441394|NCT00118417|454915268|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
126441395|NCT00118417|454915267|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
126441396|NCT00118417|454915268|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
126690298|NCT00756938|455820753|FG000|Optional Extension|Adverse Event|0|||
126690299|NCT00756938|455820754|FG001|Optional Extension|Adverse Event|0|||
126690300|NCT00756938|455820755|FG002|Optional Extension|Adverse Event|0|||
126441397|NCT00118417|454915267|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
126441398|NCT00118417|454915268|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
126441399|NCT02978781|454915269|FG000|Part A|Adverse Event|1|||
126441400|NCT02978781|454915270|FG001|Part A|Adverse Event|1|||
126441401|NCT02978781|454915271|FG002|Part A|Adverse Event|0|||
126441402|NCT02978781|454915272|FG003|Part A|Adverse Event|0|||
126441403|NCT02978781|454915273|FG004|Part A|Adverse Event|0|||
126441404|NCT02978781|454915269|FG000|Part A|Withdrawal by Subject|0|||
126690301|NCT00756938|455820756|FG003|Optional Extension|Adverse Event|1|||
126690302|NCT01808612|455820757|FG000|Treatment Period|Adverse Event|8|||
126441405|NCT02978781|454915270|FG001|Part A|Withdrawal by Subject|1|||
126441406|NCT02978781|454915271|FG002|Part A|Withdrawal by Subject|0|||
126690303|NCT01808612|455820758|FG001|Treatment Period|Adverse Event|4|||
126441407|NCT02978781|454915272|FG003|Part A|Withdrawal by Subject|0|||
126441408|NCT02978781|454915273|FG004|Part A|Withdrawal by Subject|0|||
126441409|NCT02978781|454915269|FG000|Part B|Withdrawal by Subject|0|||
126441410|NCT02978781|454915270|FG001|Part B|Withdrawal by Subject|0|||
126441411|NCT02978781|454915271|FG002|Part B|Withdrawal by Subject|0|||
126441412|NCT02978781|454915272|FG003|Part B|Withdrawal by Subject|1|||
126441413|NCT02978781|454915273|FG004|Part B|Withdrawal by Subject|0|||
126441414|NCT02978781|454915269|FG000|Part C|Adverse Event|0|||
126441415|NCT02978781|454915270|FG001|Part C|Adverse Event|0|||
126441416|NCT02978781|454915271|FG002|Part C|Adverse Event|0|||
126441417|NCT02978781|454915272|FG003|Part C|Adverse Event|0|||
126441418|NCT02978781|454915273|FG004|Part C|Adverse Event|2|||
126441419|NCT02978781|454915269|FG000|Part C|Withdrawal by Subject|0|||
126441420|NCT02978781|454915270|FG001|Part C|Withdrawal by Subject|0|||
126441421|NCT02978781|454915271|FG002|Part C|Withdrawal by Subject|0|||
126441422|NCT02978781|454915272|FG003|Part C|Withdrawal by Subject|0|||
126441423|NCT02978781|454915273|FG004|Part C|Withdrawal by Subject|1|||
126441424|NCT02978781|454915269|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
126441425|NCT02978781|454915270|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
126441426|NCT02978781|454915271|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
126441427|NCT02978781|454915272|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
126441428|NCT02978781|454915273|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
126441429|NCT00785785|454915274|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
126441430|NCT00785785|454915275|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
126441431|NCT00785785|454915274|FG000|Core Phase up to 36 Months|Adverse Event|31|||
126441432|NCT00785785|454915275|FG001|Core Phase up to 36 Months|Adverse Event|21|||
126441433|NCT00785785|454915274|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
126441434|NCT00785785|454915275|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
126441435|NCT00785785|454915274|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
126441436|NCT00785785|454915275|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
126441437|NCT00785785|454915274|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
126441438|NCT00785785|454915275|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
126441439|NCT00785785|454915274|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
126441440|NCT00785785|454915275|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
126441441|NCT00785785|454915274|FG000|Core Phase up to 36 Months|Administrative problems|3|||
126441442|NCT00785785|454915275|FG001|Core Phase up to 36 Months|Administrative problems|3|||
126441443|NCT00785785|454915274|FG000|Core Phase up to 36 Months|Death|5|||
126441444|NCT00785785|454915275|FG001|Core Phase up to 36 Months|Death|8|||
126441445|NCT00785785|454915274|FG000|Core Phase up to 36 Months|Disease progression|139|||
126441446|NCT00785785|454915275|FG001|Core Phase up to 36 Months|Disease progression|119|||
126441447|NCT00785785|454915274|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
126441448|NCT00785785|454915275|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
126441449|NCT00785785|454915274|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
126441450|NCT00785785|454915275|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
126441451|NCT00785785|454915274|FG000|Optional Extension Phase|Adverse Event|4|||
126441452|NCT00785785|454915275|FG001|Optional Extension Phase|Adverse Event|5|||
126441453|NCT00785785|454915274|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
126352985|NCT00549328|454583377|FG000|Overall Study|Use of Prohibited Medication|1|||
126352986|NCT01946802|454583382|FG000|Overall Study|Death|1|||
126352987|NCT01946802|454583382|FG000|Overall Study|Withdrawal by Subject|2|||
126352988|NCT01946802|454583382|FG000|Overall Study|Combined septic shock|1|||
126352989|NCT01946802|454583382|FG000|Overall Study|Protocol Violation|1|||
126352990|NCT03097315|454583383|FG000|Overall Study|Withdrawal by Subject|1|||
126352991|NCT03384966|454583384|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
126352992|NCT03384966|454583385|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
126352993|NCT03384966|454583386|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
126352994|NCT03384966|454583384|FG000|Follow-up Period|Adverse Event|1|||
126352995|NCT03384966|454583385|FG001|Follow-up Period|Adverse Event|0|||
126352996|NCT03384966|454583386|FG002|Follow-up Period|Adverse Event|0|||
126352997|NCT02202616|454583387|FG000|Overall Study|Screen failed|24|||
126352998|NCT02202616|454583387|FG000|Overall Study|Adverse Event|32|||
126441454|NCT00785785|454915275|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
126441455|NCT00785785|454915274|FG000|Optional Extension Phase|Lost to Follow-up|1|||
126441456|NCT00785785|454915275|FG001|Optional Extension Phase|Lost to Follow-up|0|||
126352999|NCT02202616|454583387|FG000|Overall Study|Protocol deviation|18|||
126353000|NCT02202616|454583387|FG000|Overall Study|Patient withdrew consent|12|||
126441457|NCT00785785|454915274|FG000|Optional Extension Phase|Administrative problems|2|||
126441458|NCT00785785|454915275|FG001|Optional Extension Phase|Administrative problems|0|||
126353001|NCT02202616|454583387|FG000|Overall Study|Lost to Follow-up|6|||
126690304|NCT01808612|455820759|FG002|Treatment Period|Adverse Event|3|||
126690305|NCT01808612|455820757|FG000|Treatment Period|Lost to Follow-up|2|||
126690306|NCT01808612|455820758|FG001|Treatment Period|Lost to Follow-up|2|||
126690307|NCT01808612|455820759|FG002|Treatment Period|Lost to Follow-up|1|||
126690308|NCT01808612|455820757|FG000|Treatment Period|Protocol Violation|1|||
126690309|NCT01808612|455820758|FG001|Treatment Period|Protocol Violation|0|||
126690310|NCT01808612|455820759|FG002|Treatment Period|Protocol Violation|0|||
126690311|NCT01808612|455820757|FG000|Treatment Period|Withdrawal by Subject|1|||
126690312|NCT01808612|455820758|FG001|Treatment Period|Withdrawal by Subject|0|||
126690313|NCT01808612|455820759|FG002|Treatment Period|Withdrawal by Subject|4|||
126690314|NCT01808612|455820757|FG000|Treatment Period|Physician Decision|1|||
126690315|NCT01808612|455820758|FG001|Treatment Period|Physician Decision|0|||
126690316|NCT01808612|455820759|FG002|Treatment Period|Physician Decision|4|||
126690317|NCT01808612|455820757|FG000|Treatment Period|Sponsor Decision|1|||
126690318|NCT01808612|455820758|FG001|Treatment Period|Sponsor Decision|0|||
126690319|NCT01808612|455820759|FG002|Treatment Period|Sponsor Decision|0|||
126690320|NCT01808612|455820757|FG000|Treatment Period|Lack of Efficacy|1|||
126690321|NCT01808612|455820758|FG001|Treatment Period|Lack of Efficacy|1|||
126690322|NCT01808612|455820759|FG002|Treatment Period|Lack of Efficacy|2|||
126690323|NCT01808612|455820757|FG000|Discontinuation Period|Adverse Event|1|||
126690324|NCT01808612|455820758|FG001|Discontinuation Period|Adverse Event|0|||
126690325|NCT01808612|455820759|FG002|Discontinuation Period|Adverse Event|0|||
126690326|NCT01808612|455820757|FG000|Discontinuation Period|Physician Decision|1|||
126690327|NCT01808612|455820758|FG001|Discontinuation Period|Physician Decision|0|||
126690328|NCT01808612|455820759|FG002|Discontinuation Period|Physician Decision|0|||
126690329|NCT01808612|455820757|FG000|Discontinuation Period|Lost to Follow-up|0|||
126690330|NCT01808612|455820758|FG001|Discontinuation Period|Lost to Follow-up|1|||
126690331|NCT01808612|455820759|FG002|Discontinuation Period|Lost to Follow-up|0|||
126690332|NCT04823949|455820760|FG000|Overall Study|Withdrawal by Subject|0|||
126441459|NCT00785785|454915274|FG000|Optional Extension Phase|Death|1|||
126690333|NCT04823949|455820761|FG001|Overall Study|Withdrawal by Subject|4|||
126690334|NCT04823949|455820760|FG000|Overall Study|Physician Decision|0|||
126690335|NCT04823949|455820761|FG001|Overall Study|Physician Decision|1|||
126760244|NCT01016912|456072432|FG003|End of Treatment Period|Adverse Event|0|||
126760245|NCT01016912|456072433|FG004|End of Treatment Period|Adverse Event|0|||
126690336|NCT01700192|455820762|FG000|Overall Study|Adverse Event|73|||
126353002|NCT02202616|454583387|FG000|Overall Study|Administrative problems|6|||
126690337|NCT01700192|455820763|FG001|Overall Study|Adverse Event|18|||
126690338|NCT01700192|455820762|FG000|Overall Study|Lack of Efficacy|1|||
126690339|NCT01700192|455820763|FG001|Overall Study|Lack of Efficacy|0|||
126353003|NCT02202616|454583387|FG000|Overall Study|Abnormal test procedure result|1|||
126353004|NCT02202616|454583387|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126353005|NCT01334515|454583388|FG000|Overall Study|Adverse Event|1|||
126353006|NCT01334515|454583389|FG001|Overall Study|Adverse Event|6|||
126690340|NCT01700192|455820762|FG000|Overall Study|Lost to Follow-up|42|||
126690341|NCT01700192|455820763|FG001|Overall Study|Lost to Follow-up|29|||
126690342|NCT01700192|455820762|FG000|Overall Study|Noncompliance with study drug|0|||
126690343|NCT01700192|455820763|FG001|Overall Study|Noncompliance with study drug|5|||
126690344|NCT01700192|455820762|FG000|Overall Study|Physician Decision|2|||
126690345|NCT01700192|455820763|FG001|Overall Study|Physician Decision|3|||
126690346|NCT01700192|455820762|FG000|Overall Study|Pregnancy|1|||
126690347|NCT01700192|455820763|FG001|Overall Study|Pregnancy|4|||
126690348|NCT01700192|455820762|FG000|Overall Study|Progressive disease|1|||
126690349|NCT01700192|455820763|FG001|Overall Study|Progressive disease|0|||
126760246|NCT01016912|456072429|FG000|End of Treatment Period|Completed double-blind period only|0|||
126353007|NCT01334515|454583388|FG000|Overall Study|Death|1|||
126353008|NCT01334515|454583389|FG001|Overall Study|Death|0|||
126690350|NCT01700192|455820762|FG000|Overall Study|Protocol Violation|3|||
126690351|NCT01700192|455820763|FG001|Overall Study|Protocol Violation|4|||
126690352|NCT01700192|455820762|FG000|Overall Study|Technical problems|0|||
126690353|NCT01700192|455820763|FG001|Overall Study|Technical problems|1|||
126690354|NCT01700192|455820762|FG000|Overall Study|Withdrawal by Subject|56|||
126690355|NCT01700192|455820763|FG001|Overall Study|Withdrawal by Subject|64|||
126690356|NCT01700192|455820762|FG000|Overall Study|Never received study drug|1|||
126690357|NCT01700192|455820763|FG001|Overall Study|Never received study drug|0|||
126690358|NCT03403192|455820766|FG000|Overall Study|Lost to Follow-up|1|||
126690359|NCT03403192|455820767|FG001|Overall Study|Lost to Follow-up|2|||
126690360|NCT03403192|455820768|FG002|Overall Study|Lost to Follow-up|0|||
126690361|NCT03403192|455820769|FG003|Overall Study|Lost to Follow-up|0|||
126690362|NCT03403192|455820766|FG000|Overall Study|Unable to respond|0|||
126690363|NCT03403192|455820767|FG001|Overall Study|Unable to respond|1|||
126690364|NCT03403192|455820768|FG002|Overall Study|Unable to respond|0|||
126690365|NCT03403192|455820769|FG003|Overall Study|Unable to respond|0|||
126690366|NCT03403192|455820766|FG000|Overall Study|Incomplete|3|||
126690367|NCT03403192|455820767|FG001|Overall Study|Incomplete|1|||
126690368|NCT03403192|455820768|FG002|Overall Study|Incomplete|3|||
126690369|NCT03403192|455820769|FG003|Overall Study|Incomplete|6|||
126690370|NCT02793232|455820770|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126690371|NCT02793232|455820771|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126690372|NCT02793232|455820772|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126690373|NCT02793232|455820773|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126690374|NCT02793232|455820774|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
126690375|NCT02793232|455820775|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126690376|NCT02793232|455820776|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
126690377|NCT02793232|455820777|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126690378|NCT02793232|455820778|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
126690379|NCT01298492|455820779|FG000|Overall Study|Death|2|||
126690380|NCT01298492|455820779|FG000|Overall Study|Insufficient Clinical Response|22|||
126690381|NCT01298492|455820779|FG000|Overall Study|Lost to Follow-up|12|||
126690382|NCT01298492|455820779|FG000|Overall Study|Withdrawal by Subject|47|||
126690383|NCT01298492|455820779|FG000|Overall Study|Other (Unspecified)|7|||
126690384|NCT01298492|455820779|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
126690385|NCT01298492|455820779|FG000|Overall Study|Protocol Violation|2|||
126690386|NCT01298492|455820779|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
126690387|NCT01298492|455820779|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
126690388|NCT00352105|455820780|FG000|Overall Study|Death|5|||
126690389|NCT00352105|455820780|FG000|Overall Study|Withdrawal by Subject|5|||
126690390|NCT00352105|455820780|FG000|Overall Study|Lack of Efficacy|9|||
126690391|NCT00352105|455820780|FG000|Overall Study|Adverse Event|19|||
126690392|NCT00352105|455820780|FG000|Overall Study|Protocol Violation|2|||
126690393|NCT02551159|455820781|FG000|Overall Study|Death|352|||
126690394|NCT02551159|455820782|FG001|Overall Study|Death|174|||
126690395|NCT02551159|455820783|FG002|Overall Study|Death|161|||
126690396|NCT02551159|455820781|FG000|Overall Study|Withdrawal by Subject|8|||
126690397|NCT02551159|455820782|FG001|Overall Study|Withdrawal by Subject|5|||
126690398|NCT02551159|455820783|FG002|Overall Study|Withdrawal by Subject|16|||
126690399|NCT02551159|455820781|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
126690400|NCT02551159|455820782|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
126690401|NCT02551159|455820783|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
126690402|NCT00268242|455820784|FG000|Overall Study|Death|1|||
126690403|NCT00993928|455820785|FG000|Overall Study|Withdrawal by Subject|4|||
126690404|NCT00993928|455820786|FG001|Overall Study|Withdrawal by Subject|7|||
126690405|NCT00993928|455820785|FG000|Overall Study|ineligible|1|||
126690406|NCT00993928|455820786|FG001|Overall Study|ineligible|0|||
126690407|NCT04871711|455820787|FG000|Overall Study|Withdrawal by Subject|11|||
126690408|NCT04871711|455820788|FG001|Overall Study|Withdrawal by Subject|5|||
126690409|NCT04871711|455820787|FG000|Overall Study|Lack of Efficacy|5|||
126690410|NCT04871711|455820788|FG001|Overall Study|Lack of Efficacy|7|||
126760247|NCT01016912|456072430|FG001|End of Treatment Period|Completed double-blind period only|1|||
126760248|NCT01016912|456072431|FG002|End of Treatment Period|Completed double-blind period only|0|||
126441460|NCT00785785|454915275|FG001|Optional Extension Phase|Death|5|||
126690411|NCT04871711|455820787|FG000|Overall Study|Adverse Event|2|||
126690412|NCT04871711|455820788|FG001|Overall Study|Adverse Event|6|||
126690413|NCT04871711|455820787|FG000|Overall Study|Various reasons|2|||
126690414|NCT04871711|455820788|FG001|Overall Study|Various reasons|1|||
126690415|NCT04871711|455820787|FG000|Overall Study|Lost to Follow-up|0|||
126441461|NCT00785785|454915274|FG000|Optional Extension Phase|Disease progression|22|||
126441462|NCT00785785|454915275|FG001|Optional Extension Phase|Disease progression|70|||
126441463|NCT00785785|454915274|FG000|Optional Extension Phase|Protocol deviation|0|||
126441464|NCT00785785|454915275|FG001|Optional Extension Phase|Protocol deviation|2|||
126441465|NCT00785785|454915274|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
126441466|NCT00785785|454915275|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
126441467|NCT02453321|454915276|FG000|Overall Study|Weakness|1|||
126441468|NCT02453321|454915277|FG001|Overall Study|Weakness|1|||
126441469|NCT02453321|454915278|FG002|Overall Study|Weakness|2|||
126441470|NCT02453321|454915276|FG000|Overall Study|Deep Venous Thrombosis|0|||
126441471|NCT02453321|454915277|FG001|Overall Study|Deep Venous Thrombosis|1|||
126441472|NCT02453321|454915278|FG002|Overall Study|Deep Venous Thrombosis|0|||
126441473|NCT00357552|454915279|FG000|Screening|Did not meet eligibility criteria|84|||
126441474|NCT00357552|454915279|FG000|Weeks 0 to 24|Death|1|||
126441475|NCT00357552|454915279|FG000|Weeks 24 to 104|Death|3|||
126441476|NCT00357552|454915279|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
126441477|NCT00882557|454915282|FG000|Overall Study|Withdrawal by Subject|1|||
126441478|NCT00882557|454915283|FG001|Overall Study|Withdrawal by Subject|0|||
126441479|NCT00882557|454915282|FG000|Overall Study|Trouble with Vein Access|1|||
126441480|NCT00882557|454915283|FG001|Overall Study|Trouble with Vein Access|0|||
126441481|NCT00882557|454915282|FG000|Overall Study|Randomized Not Treated|0|||
126441482|NCT00882557|454915283|FG001|Overall Study|Randomized Not Treated|1|||
126441483|NCT01383356|454915288|FG000|Period 1|Adverse Event|5|||
126441484|NCT01383356|454915289|FG001|Period 1|Adverse Event|3|||
126441485|NCT01383356|454915288|FG000|Period 1|Non-compliance|3|||
126441486|NCT01383356|454915289|FG001|Period 1|Non-compliance|0|||
126441487|NCT01383356|454915288|FG000|Period 1|Out of Range Mid-study-Test|0|||
126441488|NCT01383356|454915289|FG001|Period 1|Out of Range Mid-study-Test|1|||
126441489|NCT01383356|454915288|FG000|Period 1|Personal|0|||
126441490|NCT01383356|454915289|FG001|Period 1|Personal|2|||
126441491|NCT00602472|454915295|FG000|Overall Study|Adverse Event|5|||
126441492|NCT00602472|454915296|FG001|Overall Study|Adverse Event|23|||
126441493|NCT00602472|454915295|FG000|Overall Study|Protocol Violation|4|||
126441494|NCT00602472|454915296|FG001|Overall Study|Protocol Violation|19|||
126441495|NCT00602472|454915295|FG000|Overall Study|Withdrawal by Subject|8|||
126441496|NCT00602472|454915296|FG001|Overall Study|Withdrawal by Subject|14|||
126441497|NCT00602472|454915295|FG000|Overall Study|Other incl. lack of efficacy|4|||
126441498|NCT00602472|454915296|FG001|Overall Study|Other incl. lack of efficacy|2|||
126441499|NCT03038880|454915297|FG000|Overall Study|Death|1|||
126441500|NCT03038880|454915298|FG001|Overall Study|Death|2|||
126441501|NCT03038880|454915299|FG002|Overall Study|Death|0|||
126441502|NCT03038880|454915297|FG000|Overall Study|Physician Decision|2|||
126441503|NCT03038880|454915298|FG001|Overall Study|Physician Decision|1|||
126441504|NCT03038880|454915299|FG002|Overall Study|Physician Decision|0|||
126441505|NCT02054104|454915306|FG000|Overall Study|Did not want to continue due to college classes|1|||
126441506|NCT02054104|454915307|FG001|Overall Study|Did not want to continue due to college classes|0|||
126441507|NCT02054104|454915306|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
126441508|NCT02054104|454915307|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
126441509|NCT02054104|454915306|FG000|Overall Study|No evidence of immunologic response|2|||
126441510|NCT02054104|454915307|FG001|Overall Study|No evidence of immunologic response|2|||
126441511|NCT02054104|454915306|FG000|Overall Study|Disease Progression On Study|4|||
126441512|NCT02054104|454915307|FG001|Overall Study|Disease Progression On Study|5|||
126441513|NCT02054104|454915306|FG000|Overall Study|Diagnosis of lymphoma|0|||
126441514|NCT02054104|454915307|FG001|Overall Study|Diagnosis of lymphoma|1|||
126441515|NCT02054104|454915306|FG000|Overall Study|Inconclusive response|0|||
126441516|NCT02054104|454915307|FG001|Overall Study|Inconclusive response|1|||
126441517|NCT00823615|454915308|FG000|Period 2|Lost to Follow-up|2|||
126441518|NCT00823615|454915309|FG001|Period 2|Lost to Follow-up|0|||
126441519|NCT00823615|454915308|FG000|Period 2|Time/Job Conflict|1|||
126441520|NCT00823615|454915309|FG001|Period 2|Time/Job Conflict|2|||
126441521|NCT03926611|454915310|FG000|Overall Study|Adverse Event|0|||
126441522|NCT03926611|454915311|FG001|Overall Study|Adverse Event|0|||
126441523|NCT03926611|454915312|FG002|Overall Study|Adverse Event|0|||
126441524|NCT03926611|454915313|FG003|Overall Study|Adverse Event|3|||
126441525|NCT03926611|454915314|FG004|Overall Study|Adverse Event|1|||
126353009|NCT01334515|454583388|FG000|Overall Study|Lack of Efficacy|8|||
126353010|NCT01334515|454583389|FG001|Overall Study|Lack of Efficacy|21|||
126353011|NCT01334515|454583388|FG000|Overall Study|Physician Decision|1|||
126353012|NCT01334515|454583389|FG001|Overall Study|Physician Decision|1|||
126353013|NCT01334515|454583388|FG000|Overall Study|Withdrawal by Subject|1|||
126353014|NCT01334515|454583389|FG001|Overall Study|Withdrawal by Subject|1|||
126353015|NCT03637374|454583390|FG000|Overall Study|Death|2|||
126353016|NCT03637374|454583391|FG001|Overall Study|Death|0|||
126353017|NCT02836769|454583395|FG000|Overall Study|Lost to Follow-up|10|||
126353018|NCT02836769|454583395|FG000|Overall Study|Medical withdrawal|2|||
126353019|NCT02836769|454583395|FG000|Overall Study|Withdrawal by Subject|3|||
126353020|NCT00376506|454583404|FG000|Overall Study|Death|0|||
126353021|NCT00376506|454583405|FG001|Overall Study|Death|2|||
126353022|NCT00221104|454583407|FG000|Overall Study|Adverse Event|1|||
126353023|NCT00221104|454583408|FG001|Overall Study|Adverse Event|0|||
126353024|NCT00221104|454583407|FG000|Overall Study|Physician Decision|1|||
126353025|NCT00221104|454583408|FG001|Overall Study|Physician Decision|0|||
126353026|NCT00221104|454583407|FG000|Overall Study|Protocol Violation|2|||
126353027|NCT00221104|454583408|FG001|Overall Study|Protocol Violation|0|||
126441526|NCT03926611|454915315|FG005|Overall Study|Adverse Event|3|||
126760249|NCT01016912|456072432|FG003|End of Treatment Period|Completed double-blind period only|0|||
126353028|NCT00221104|454583407|FG000|Overall Study|Withdrawal by Subject|42|||
126353029|NCT00221104|454583408|FG001|Overall Study|Withdrawal by Subject|29|||
126353030|NCT00221104|454583407|FG000|Overall Study|Others|37|||
126353031|NCT00221104|454583408|FG001|Overall Study|Others|47|||
126353032|NCT02989389|454583409|FG000|Period 1|Lost to Follow-up|0|||
126353033|NCT02989389|454583410|FG001|Period 1|Lost to Follow-up|1|||
126353034|NCT02989389|454583411|FG002|Period 1|Lost to Follow-up|0|||
126353035|NCT02989389|454583412|FG003|Period 1|Lost to Follow-up|0|||
126353036|NCT02989389|454583413|FG004|Period 1|Lost to Follow-up|0|||
126353037|NCT02989389|454583414|FG005|Period 1|Lost to Follow-up|0|||
126353038|NCT02989389|454583415|FG006|Period 1|Lost to Follow-up|0|||
126353039|NCT02989389|454583416|FG007|Period 1|Lost to Follow-up|0|||
126353040|NCT02989389|454583417|FG008|Period 1|Lost to Follow-up|0|||
126353041|NCT02989389|454583418|FG009|Period 1|Lost to Follow-up|0|||
126353042|NCT02989389|454583409|FG000|Period 1|Physician Decision|0|||
126353043|NCT02989389|454583410|FG001|Period 1|Physician Decision|0|||
126353044|NCT02989389|454583411|FG002|Period 1|Physician Decision|0|||
126353045|NCT02989389|454583412|FG003|Period 1|Physician Decision|0|||
126353046|NCT02989389|454583413|FG004|Period 1|Physician Decision|0|||
126353047|NCT02989389|454583414|FG005|Period 1|Physician Decision|0|||
126353048|NCT02989389|454583415|FG006|Period 1|Physician Decision|0|||
126353049|NCT02989389|454583416|FG007|Period 1|Physician Decision|0|||
126353050|NCT02989389|454583417|FG008|Period 1|Physician Decision|1|||
126441527|NCT03926611|454915316|FG006|Overall Study|Adverse Event|0|||
126690416|NCT04871711|455820788|FG001|Overall Study|Lost to Follow-up|2|||
126353051|NCT02989389|454583418|FG009|Period 1|Physician Decision|0|||
126353052|NCT00374868|454583419|FG000|Overall Study|Adverse Event|12|||
126353053|NCT00374868|454583419|FG000|Overall Study|Progressive Disease|7|||
126690417|NCT03551743|455820792|FG000|Overall Study|Adverse Event|1|||
126690418|NCT03551743|455820793|FG001|Overall Study|Adverse Event|0|||
126690419|NCT03551743|455820794|FG002|Overall Study|Adverse Event|0|||
126690420|NCT03551743|455820795|FG003|Overall Study|Adverse Event|0|||
126690421|NCT03551743|455820792|FG000|Overall Study|Withdrawal by Subject|1|||
126690422|NCT03551743|455820793|FG001|Overall Study|Withdrawal by Subject|0|||
126690423|NCT03551743|455820794|FG002|Overall Study|Withdrawal by Subject|0|||
126690424|NCT03551743|455820795|FG003|Overall Study|Withdrawal by Subject|0|||
126690425|NCT04556617|455820800|FG000|Overall Study|progressive disease|0|||
126690426|NCT04556617|455820801|FG001|Overall Study|progressive disease|2|||
126690427|NCT04556617|455820802|FG002|Overall Study|progressive disease|2|||
126690428|NCT04556617|455820803|FG003|Overall Study|progressive disease|1|||
126690429|NCT04556617|455820804|FG004|Overall Study|progressive disease|1|||
126690430|NCT04556617|455820800|FG000|Overall Study|Physician Decision|0|||
126690431|NCT04556617|455820801|FG001|Overall Study|Physician Decision|0|||
126690432|NCT04556617|455820802|FG002|Overall Study|Physician Decision|2|||
126690433|NCT04556617|455820803|FG003|Overall Study|Physician Decision|0|||
126690434|NCT04556617|455820804|FG004|Overall Study|Physician Decision|0|||
126690435|NCT04556617|455820800|FG000|Overall Study|Adverse Event|0|||
126690436|NCT04556617|455820801|FG001|Overall Study|Adverse Event|0|||
126690437|NCT04556617|455820802|FG002|Overall Study|Adverse Event|2|||
126690438|NCT04556617|455820803|FG003|Overall Study|Adverse Event|3|||
126690439|NCT04556617|455820804|FG004|Overall Study|Adverse Event|0|||
126690440|NCT04556617|455820800|FG000|Overall Study|Withdrawal by Subject|0|||
126690441|NCT04556617|455820801|FG001|Overall Study|Withdrawal by Subject|2|||
126690442|NCT04556617|455820802|FG002|Overall Study|Withdrawal by Subject|1|||
126690443|NCT04556617|455820803|FG003|Overall Study|Withdrawal by Subject|1|||
126690444|NCT04556617|455820804|FG004|Overall Study|Withdrawal by Subject|0|||
126690445|NCT04556617|455820800|FG000|Overall Study|PSA increase|0|||
126690446|NCT04556617|455820801|FG001|Overall Study|PSA increase|1|||
126690447|NCT04556617|455820802|FG002|Overall Study|PSA increase|0|||
126690448|NCT04556617|455820803|FG003|Overall Study|PSA increase|0|||
126690449|NCT04556617|455820804|FG004|Overall Study|PSA increase|0|||
126353054|NCT00374868|454583419|FG000|Overall Study|Physician Decision|13|||
126353055|NCT00374868|454583419|FG000|Overall Study|Lost to Follow-up|1|||
126353056|NCT00374868|454583419|FG000|Overall Study|Death|2|||
126353057|NCT00374868|454583419|FG000|Overall Study|Other - Not Specified|1|||
126353058|NCT04470427|454583420|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
126353059|NCT04470427|454583421|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
126353060|NCT04470427|454583422|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
126353061|NCT04470427|454583423|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
126353062|NCT04470427|454583424|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
126353063|NCT04470427|454583425|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
126353064|NCT04470427|454583420|FG000|Part B :Open-label|Other than specified|0|||
126353065|NCT04470427|454583421|FG001|Part B :Open-label|Other than specified|0|||
126353066|NCT04470427|454583422|FG002|Part B :Open-label|Other than specified|788|||
126353067|NCT04470427|454583423|FG003|Part B :Open-label|Other than specified|0|||
126441528|NCT03926611|454915310|FG000|Overall Study|Lack of Efficacy|1|||
126441529|NCT03926611|454915311|FG001|Overall Study|Lack of Efficacy|2|||
126690450|NCT04556617|455820800|FG000|Overall Study|Sponsor study termination|1|||
126690451|NCT04556617|455820801|FG001|Overall Study|Sponsor study termination|0|||
126690452|NCT04556617|455820802|FG002|Overall Study|Sponsor study termination|0|||
126353068|NCT04470427|454583424|FG004|Part B :Open-label|Other than specified|523|||
126690453|NCT04556617|455820803|FG003|Overall Study|Sponsor study termination|0|||
126690454|NCT04556617|455820804|FG004|Overall Study|Sponsor study termination|0|||
126690455|NCT03179436|455820805|FG000|Overall Study|Withdrawal by Subject|1|||
126690456|NCT03179436|455820806|FG001|Overall Study|Withdrawal by Subject|0|||
126690457|NCT03179436|455820807|FG002|Overall Study|Withdrawal by Subject|0|||
126353069|NCT04470427|454583425|FG005|Part B :Open-label|Other than specified|0|||
126353070|NCT04470427|454583420|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
126353071|NCT04470427|454583421|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
126690458|NCT03179436|455820808|FG003|Overall Study|Withdrawal by Subject|4|||
126690459|NCT03179436|455820809|FG004|Overall Study|Withdrawal by Subject|2|||
126690460|NCT03179436|455820810|FG005|Overall Study|Withdrawal by Subject|2|||
126690461|NCT03179436|455820811|FG006|Overall Study|Withdrawal by Subject|5|||
126441530|NCT03926611|454915312|FG002|Overall Study|Lack of Efficacy|0|||
126441531|NCT03926611|454915313|FG003|Overall Study|Lack of Efficacy|0|||
126441532|NCT03926611|454915314|FG004|Overall Study|Lack of Efficacy|1|||
126441533|NCT03926611|454915315|FG005|Overall Study|Lack of Efficacy|0|||
126441534|NCT03926611|454915316|FG006|Overall Study|Lack of Efficacy|1|||
126441535|NCT03926611|454915310|FG000|Overall Study|Physician Decision|0|||
126441536|NCT03926611|454915311|FG001|Overall Study|Physician Decision|0|||
126441537|NCT03926611|454915312|FG002|Overall Study|Physician Decision|0|||
126441538|NCT03926611|454915313|FG003|Overall Study|Physician Decision|0|||
126441539|NCT03926611|454915314|FG004|Overall Study|Physician Decision|0|||
126441540|NCT03926611|454915315|FG005|Overall Study|Physician Decision|1|||
126441541|NCT03926611|454915316|FG006|Overall Study|Physician Decision|0|||
126441542|NCT03926611|454915310|FG000|Overall Study|Protocol Violation|1|||
126441543|NCT03926611|454915311|FG001|Overall Study|Protocol Violation|0|||
126441544|NCT03926611|454915312|FG002|Overall Study|Protocol Violation|0|||
126441545|NCT03926611|454915313|FG003|Overall Study|Protocol Violation|1|||
126441546|NCT03926611|454915314|FG004|Overall Study|Protocol Violation|1|||
126690462|NCT03179436|455820812|FG007|Overall Study|Withdrawal by Subject|0|||
126690463|NCT03179436|455820813|FG008|Overall Study|Withdrawal by Subject|3|||
126690464|NCT03179436|455820814|FG009|Overall Study|Withdrawal by Subject|0|||
126690465|NCT03179436|455820815|FG010|Overall Study|Withdrawal by Subject|0|||
126690466|NCT03179436|455820816|FG011|Overall Study|Withdrawal by Subject|0|||
126690467|NCT03179436|455820805|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126690468|NCT03179436|455820806|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126690469|NCT03179436|455820807|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126690470|NCT03179436|455820808|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126690471|NCT03179436|455820809|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126690472|NCT03179436|455820810|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126690473|NCT03179436|455820811|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
126690474|NCT03179436|455820812|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
126690475|NCT03179436|455820813|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
126441547|NCT03926611|454915315|FG005|Overall Study|Protocol Violation|1|||
126441548|NCT03926611|454915316|FG006|Overall Study|Protocol Violation|1|||
126441549|NCT03926611|454915310|FG000|Overall Study|Technical problems|0|||
126441550|NCT03926611|454915311|FG001|Overall Study|Technical problems|0|||
126441551|NCT03926611|454915312|FG002|Overall Study|Technical problems|0|||
126441552|NCT03926611|454915313|FG003|Overall Study|Technical problems|0|||
126715184|NCT01052012|455908711|FG005|Overall Study|Lost to Follow-up|0|||
126441553|NCT03926611|454915314|FG004|Overall Study|Technical problems|0|||
126441554|NCT03926611|454915315|FG005|Overall Study|Technical problems|1|||
126441555|NCT03926611|454915316|FG006|Overall Study|Technical problems|0|||
126441556|NCT03926611|454915310|FG000|Overall Study|Withdrawal by Subject|1|||
126441557|NCT03926611|454915311|FG001|Overall Study|Withdrawal by Subject|1|||
126441558|NCT03926611|454915312|FG002|Overall Study|Withdrawal by Subject|1|||
126441559|NCT03926611|454915313|FG003|Overall Study|Withdrawal by Subject|0|||
126441560|NCT03926611|454915314|FG004|Overall Study|Withdrawal by Subject|0|||
126441561|NCT03926611|454915315|FG005|Overall Study|Withdrawal by Subject|1|||
126441562|NCT03926611|454915316|FG006|Overall Study|Withdrawal by Subject|3|||
126441563|NCT03926611|454915310|FG000|Overall Study|Covid-19 pandemic|0|||
126441564|NCT03926611|454915311|FG001|Overall Study|Covid-19 pandemic|0|||
126441565|NCT03926611|454915312|FG002|Overall Study|Covid-19 pandemic|1|||
126441566|NCT03926611|454915313|FG003|Overall Study|Covid-19 pandemic|0|||
126441567|NCT03926611|454915314|FG004|Overall Study|Covid-19 pandemic|1|||
126441568|NCT03926611|454915315|FG005|Overall Study|Covid-19 pandemic|2|||
126441569|NCT03926611|454915316|FG006|Overall Study|Covid-19 pandemic|0|||
126441570|NCT00084136|454915317|FG000|PI Comparison|Death|10|||
126441571|NCT00084136|454915318|FG001|PI Comparison|Death|9|||
126441572|NCT00084136|454915319|FG002|PI Comparison|Death|0|||
126441573|NCT00084136|454915317|FG000|PI Comparison|Lost to Follow-up|11|||
126441574|NCT00084136|454915318|FG001|PI Comparison|Lost to Follow-up|8|||
126441575|NCT00084136|454915319|FG002|PI Comparison|Lost to Follow-up|0|||
126441576|NCT00084136|454915317|FG000|PI Comparison|Withdrawal by Subject|33|||
126441577|NCT00084136|454915318|FG001|PI Comparison|Withdrawal by Subject|30|||
126441578|NCT00084136|454915319|FG002|PI Comparison|Withdrawal by Subject|0|||
126441579|NCT00084136|454915317|FG000|PI Comparison|Clinic site closed|1|||
126441580|NCT00084136|454915318|FG001|PI Comparison|Clinic site closed|0|||
126441581|NCT00084136|454915319|FG002|PI Comparison|Clinic site closed|0|||
126441582|NCT00084136|454915317|FG000|NRTI Comparison|Death|20|||
126441583|NCT00084136|454915318|FG001|NRTI Comparison|Death|0|||
126441584|NCT00084136|454915319|FG002|NRTI Comparison|Death|18|||
126441585|NCT00084136|454915317|FG000|NRTI Comparison|Lost to Follow-up|14|||
126441586|NCT00084136|454915318|FG001|NRTI Comparison|Lost to Follow-up|0|||
126441587|NCT00084136|454915319|FG002|NRTI Comparison|Lost to Follow-up|12|||
126441588|NCT00084136|454915317|FG000|NRTI Comparison|Withdrawal by Subject|54|||
126441589|NCT00084136|454915318|FG001|NRTI Comparison|Withdrawal by Subject|0|||
126441590|NCT00084136|454915319|FG002|NRTI Comparison|Withdrawal by Subject|38|||
126690476|NCT03179436|455820814|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
126690477|NCT03179436|455820815|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
126690478|NCT03179436|455820816|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
126690479|NCT03179436|455820805|FG000|Overall Study|Sponsor Decision|0|||
126690480|NCT03179436|455820806|FG001|Overall Study|Sponsor Decision|0|||
126690481|NCT03179436|455820807|FG002|Overall Study|Sponsor Decision|1|||
126690482|NCT03179436|455820808|FG003|Overall Study|Sponsor Decision|3|||
126690483|NCT03179436|455820809|FG004|Overall Study|Sponsor Decision|9|||
126690484|NCT03179436|455820810|FG005|Overall Study|Sponsor Decision|7|||
126690485|NCT03179436|455820811|FG006|Overall Study|Sponsor Decision|2|||
126690486|NCT03179436|455820812|FG007|Overall Study|Sponsor Decision|4|||
126690487|NCT03179436|455820813|FG008|Overall Study|Sponsor Decision|23|||
126690488|NCT03179436|455820814|FG009|Overall Study|Sponsor Decision|6|||
126690489|NCT03179436|455820815|FG010|Overall Study|Sponsor Decision|7|||
126690490|NCT03179436|455820816|FG011|Overall Study|Sponsor Decision|5|||
126441591|NCT00084136|454915317|FG000|NRTI Comparison|Clinic site closed|12|||
126441592|NCT00084136|454915318|FG001|NRTI Comparison|Clinic site closed|0|||
126441593|NCT00084136|454915319|FG002|NRTI Comparison|Clinic site closed|14|||
126441594|NCT00084136|454915317|FG000|NRTI Comparison|Not reason above|1|||
126441595|NCT00084136|454915318|FG001|NRTI Comparison|Not reason above|0|||
126441596|NCT00084136|454915319|FG002|NRTI Comparison|Not reason above|0|||
126441597|NCT02230670|454915320|FG000|Overall Study|Adverse Event|1|||
126441598|NCT02230670|454915321|FG001|Overall Study|Adverse Event|2|||
126441599|NCT02230670|454915320|FG000|Overall Study|Withdrawal by Subject|2|||
126441600|NCT02230670|454915321|FG001|Overall Study|Withdrawal by Subject|2|||
126441601|NCT02230670|454915320|FG000|Overall Study|Physician Decision|0|||
126441602|NCT02230670|454915321|FG001|Overall Study|Physician Decision|1|||
126441603|NCT02230670|454915320|FG000|Overall Study|Protocol Violation|0|||
126441604|NCT02230670|454915321|FG001|Overall Study|Protocol Violation|1|||
126441605|NCT02230670|454915320|FG000|Overall Study|Progression to Child-Pugh C|1|||
126441606|NCT02230670|454915321|FG001|Overall Study|Progression to Child-Pugh C|2|||
126441607|NCT00414596|454915324|FG000|Overall Study|Protocol Violation|2|||
126441608|NCT00297258|454915326|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
126441609|NCT00297258|454915326|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
126441610|NCT00297258|454915326|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
126441611|NCT00297258|454915326|FG000|Overall Study|Intercurrent Illness|3|||
126690491|NCT03179436|455820805|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
126690492|NCT03179436|455820806|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
126441612|NCT00297258|454915326|FG000|Overall Study|Intercurrent Death|2|||
126441613|NCT00297258|454915326|FG000|Overall Study|Deteriorization of General Condition|1|||
126441614|NCT00297258|454915326|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
126441615|NCT00297258|454915326|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
126441616|NCT00297258|454915326|FG000|Overall Study|Switch to Commercial Treatment|1|||
126545401|NCT02541383|455290825|FG002|Overall Study|Sponsor's decision|0|||
126690493|NCT03179436|455820807|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
126690494|NCT03179436|455820808|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
126690495|NCT03179436|455820809|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
126690496|NCT03179436|455820810|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
126690497|NCT03179436|455820811|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
126690498|NCT03179436|455820812|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
126690499|NCT03179436|455820813|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
126690500|NCT03179436|455820814|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
126690501|NCT03179436|455820815|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
126690502|NCT03179436|455820816|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
126690503|NCT03179436|455820805|FG000|Overall Study|Lost to Follow-up|1|||
126690504|NCT03179436|455820806|FG001|Overall Study|Lost to Follow-up|0|||
126690505|NCT03179436|455820807|FG002|Overall Study|Lost to Follow-up|0|||
126690506|NCT03179436|455820808|FG003|Overall Study|Lost to Follow-up|1|||
126690507|NCT03179436|455820809|FG004|Overall Study|Lost to Follow-up|0|||
126690508|NCT03179436|455820810|FG005|Overall Study|Lost to Follow-up|1|||
126690509|NCT03179436|455820811|FG006|Overall Study|Lost to Follow-up|0|||
126690510|NCT03179436|455820812|FG007|Overall Study|Lost to Follow-up|0|||
126690511|NCT03179436|455820813|FG008|Overall Study|Lost to Follow-up|1|||
126690512|NCT03179436|455820814|FG009|Overall Study|Lost to Follow-up|1|||
126690513|NCT03179436|455820815|FG010|Overall Study|Lost to Follow-up|0|||
126690514|NCT03179436|455820816|FG011|Overall Study|Lost to Follow-up|0|||
126690515|NCT03179436|455820805|FG000|Overall Study|Death|12|||
126690516|NCT03179436|455820806|FG001|Overall Study|Death|17|||
126690517|NCT03179436|455820807|FG002|Overall Study|Death|7|||
126690518|NCT03179436|455820808|FG003|Overall Study|Death|32|||
126353072|NCT04470427|454583422|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
126353073|NCT04470427|454583423|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
126353074|NCT04470427|454583424|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
126353075|NCT04470427|454583425|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
126353076|NCT04470427|454583420|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
126353077|NCT04470427|454583421|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
126353078|NCT04470427|454583422|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
126353079|NCT04470427|454583423|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
126353080|NCT04470427|454583424|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
126353081|NCT04470427|454583425|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
126353082|NCT01179516|454583426|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
126353083|NCT01179516|454583427|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
126353084|NCT01179516|454583428|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
126353085|NCT01179516|454583426|FG000|Overall Study|Lack of Efficacy|4|||
126353086|NCT01179516|454583427|FG001|Overall Study|Lack of Efficacy|2|||
126353087|NCT01179516|454583428|FG002|Overall Study|Lack of Efficacy|0|||
126353088|NCT01179516|454583426|FG000|Overall Study|Noncompliance with Study Drug|2|||
126353089|NCT01179516|454583427|FG001|Overall Study|Noncompliance with Study Drug|0|||
126353090|NCT01179516|454583428|FG002|Overall Study|Noncompliance with Study Drug|1|||
126353091|NCT01179516|454583426|FG000|Overall Study|Protocol Deviations|4|||
126353092|NCT01179516|454583427|FG001|Overall Study|Protocol Deviations|3|||
126353093|NCT01179516|454583428|FG002|Overall Study|Protocol Deviations|3|||
126353094|NCT01179516|454583426|FG000|Overall Study|Withdrawal of Consent|2|||
126690519|NCT03179436|455820809|FG004|Overall Study|Death|29|||
126690520|NCT03179436|455820810|FG005|Overall Study|Death|30|||
126690521|NCT03179436|455820811|FG006|Overall Study|Death|33|||
126690522|NCT03179436|455820812|FG007|Overall Study|Death|9|||
126690523|NCT03179436|455820813|FG008|Overall Study|Death|84|||
126690524|NCT03179436|455820814|FG009|Overall Study|Death|33|||
126353095|NCT01179516|454583427|FG001|Overall Study|Withdrawal of Consent|6|||
126353096|NCT01179516|454583428|FG002|Overall Study|Withdrawal of Consent|10|||
126353097|NCT01179516|454583426|FG000|Overall Study|Lost to Follow-up|7|||
126353098|NCT01179516|454583427|FG001|Overall Study|Lost to Follow-up|7|||
126690525|NCT03179436|455820815|FG010|Overall Study|Death|22|||
126690526|NCT03179436|455820816|FG011|Overall Study|Death|15|||
126690527|NCT05168267|455820817|FG000|Overall Study|Withdrawal by Subject|2|||
126690528|NCT05168267|455820818|FG001|Overall Study|Withdrawal by Subject|1|||
126690529|NCT05168267|455820817|FG000|Overall Study|Withdrawn by Therapist|1|||
126690530|NCT05168267|455820818|FG001|Overall Study|Withdrawn by Therapist|1|||
126690531|NCT05168267|455820817|FG000|Overall Study|Left Facility|1|||
126690532|NCT05168267|455820818|FG001|Overall Study|Left Facility|0|||
126690533|NCT00803179|455820819|FG000|Overall Study|Lost to Follow-up|3|||
126690534|NCT04811716|455820823|FG000|Overall Study|Withdrawal by Subject|2|||
126690535|NCT04811716|455820824|FG001|Overall Study|Withdrawal by Subject|0|||
126690536|NCT01877083|455820828|FG000|Treatment Phase|Disease Progression|10|||
126690537|NCT01877083|455820828|FG000|Treatment Phase|Clinical Progression|1|||
126690538|NCT01877083|455820828|FG000|Treatment Phase|Adverse Event|6|||
126690539|NCT01877083|455820828|FG000|Treatment Phase|Withdrawal by Subject|2|||
126690540|NCT01877083|455820828|FG000|Treatment Phase|Lost to Follow-up|1|||
126690541|NCT01877083|455820828|FG000|Extension Phase|Disease Progression|3|||
126690542|NCT01877083|455820828|FG000|Extension Phase|Adverse Event|2|||
126690543|NCT00429585|455820831|FG000|Overall Study|Death|1|||
126690544|NCT00429585|455820832|FG001|Overall Study|Death|0|||
126690545|NCT00429585|455820831|FG000|Overall Study|Lost to Follow-up|27|||
126690546|NCT00429585|455820832|FG001|Overall Study|Lost to Follow-up|20|||
126690547|NCT00429585|455820831|FG000|Overall Study|Physician Decision|2|||
126690548|NCT00429585|455820832|FG001|Overall Study|Physician Decision|0|||
126690549|NCT01582308|455820833|FG000|Period 1|Withdrawal by Subject|0|||
126690550|NCT01582308|455820834|FG001|Period 1|Withdrawal by Subject|0|||
126690551|NCT01582308|455820835|FG002|Period 1|Withdrawal by Subject|0|||
126690552|NCT01582308|455820836|FG003|Period 1|Withdrawal by Subject|0|||
126690553|NCT01582308|455820837|FG004|Period 1|Withdrawal by Subject|0|||
126690554|NCT01582308|455820838|FG005|Period 1|Withdrawal by Subject|0|||
126690555|NCT01582308|455820839|FG006|Period 1|Withdrawal by Subject|1|||
126690556|NCT01582308|455820840|FG007|Period 1|Withdrawal by Subject|0|||
126690557|NCT01582308|455820841|FG008|Period 1|Withdrawal by Subject|0|||
126690558|NCT01582308|455820842|FG009|Period 1|Withdrawal by Subject|0|||
126690559|NCT01582308|455820833|FG000|10-day Washout Following Period 1|Physician Decision|0|||
126690560|NCT01582308|455820834|FG001|10-day Washout Following Period 1|Physician Decision|0|||
126690561|NCT01582308|455820835|FG002|10-day Washout Following Period 1|Physician Decision|0|||
126690562|NCT01582308|455820836|FG003|10-day Washout Following Period 1|Physician Decision|0|||
126690563|NCT01582308|455820837|FG004|10-day Washout Following Period 1|Physician Decision|1|||
126690564|NCT01582308|455820838|FG005|10-day Washout Following Period 1|Physician Decision|0|||
126690565|NCT01582308|455820839|FG006|10-day Washout Following Period 1|Physician Decision|0|||
126690566|NCT01582308|455820840|FG007|10-day Washout Following Period 1|Physician Decision|0|||
126690567|NCT01582308|455820841|FG008|10-day Washout Following Period 1|Physician Decision|0|||
126690568|NCT01582308|455820842|FG009|10-day Washout Following Period 1|Physician Decision|0|||
126690569|NCT01582308|455820833|FG000|Period 4|Physician Decision|1|||
126690570|NCT01582308|455820834|FG001|Period 4|Physician Decision|0|||
126690571|NCT01582308|455820835|FG002|Period 4|Physician Decision|0|||
126690572|NCT01582308|455820836|FG003|Period 4|Physician Decision|0|||
126690573|NCT01582308|455820837|FG004|Period 4|Physician Decision|0|||
126690574|NCT01582308|455820838|FG005|Period 4|Physician Decision|1|||
126690575|NCT01582308|455820839|FG006|Period 4|Physician Decision|0|||
126690576|NCT01582308|455820840|FG007|Period 4|Physician Decision|0|||
126690577|NCT01582308|455820841|FG008|Period 4|Physician Decision|0|||
126690578|NCT01582308|455820842|FG009|Period 4|Physician Decision|1|||
126690579|NCT02363478|455822337|FG000|Overall Study|Lost to Follow-up|4|||
126690580|NCT02363478|455822337|FG000|Overall Study|Adverse Event|4|||
126690581|NCT00768898|455822338|FG000|Overall Study|Unrelated injury|1|||
126690582|NCT00768898|455822338|FG000|Overall Study|Headache|1|||
126760250|NCT01016912|456072433|FG004|End of Treatment Period|Completed double-blind period only|0|||
126760251|NCT01016912|456072429|FG000|Follow-up Period|Other reason|0|||
126760252|NCT01016912|456072430|FG001|Follow-up Period|Other reason|0|||
126760253|NCT01016912|456072431|FG002|Follow-up Period|Other reason|1|||
126353099|NCT01179516|454583428|FG002|Overall Study|Lost to Follow-up|3|||
126690583|NCT03160560|455822341|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
126690584|NCT03160560|455822342|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126690585|NCT03160560|455822343|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126690586|NCT03160560|455822344|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
126690587|NCT03160560|455822341|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
126690588|NCT03160560|455822342|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
126690589|NCT03160560|455822343|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
126690590|NCT03160560|455822344|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
126690591|NCT01430442|455822347|FG000|Overall Study|Subject Withdrew Consent|3|||
126690592|NCT01430442|455822348|FG001|Overall Study|Subject Withdrew Consent|0|||
126690593|NCT01430442|455822349|FG002|Overall Study|Subject Withdrew Consent|1|||
126690594|NCT01430442|455822350|FG003|Overall Study|Subject Withdrew Consent|0|||
126690595|NCT01430442|455822351|FG004|Overall Study|Subject Withdrew Consent|2|||
126690596|NCT01430442|455822352|FG005|Overall Study|Subject Withdrew Consent|1|||
126690597|NCT01430442|455822353|FG006|Overall Study|Subject Withdrew Consent|5|||
126690598|NCT01430442|455822354|FG007|Overall Study|Subject Withdrew Consent|2|||
126690599|NCT01430442|455822347|FG000|Overall Study|Lost to Follow-up|2|||
126690600|NCT01430442|455822348|FG001|Overall Study|Lost to Follow-up|0|||
126690601|NCT01430442|455822349|FG002|Overall Study|Lost to Follow-up|1|||
126690602|NCT01430442|455822350|FG003|Overall Study|Lost to Follow-up|2|||
126690603|NCT01430442|455822351|FG004|Overall Study|Lost to Follow-up|2|||
126690604|NCT01430442|455822352|FG005|Overall Study|Lost to Follow-up|1|||
126690605|NCT01430442|455822353|FG006|Overall Study|Lost to Follow-up|5|||
126690606|NCT01430442|455822354|FG007|Overall Study|Lost to Follow-up|1|||
126690607|NCT01430442|455822347|FG000|Overall Study|Pregnancy|1|||
126690608|NCT01430442|455822348|FG001|Overall Study|Pregnancy|0|||
126690609|NCT01430442|455822349|FG002|Overall Study|Pregnancy|0|||
126690610|NCT01430442|455822350|FG003|Overall Study|Pregnancy|0|||
126690611|NCT01430442|455822351|FG004|Overall Study|Pregnancy|0|||
126690612|NCT01430442|455822352|FG005|Overall Study|Pregnancy|1|||
126690613|NCT01430442|455822353|FG006|Overall Study|Pregnancy|0|||
126690614|NCT01430442|455822354|FG007|Overall Study|Pregnancy|0|||
126690615|NCT01430442|455822347|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
126690616|NCT01430442|455822348|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
126690617|NCT01430442|455822349|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
126690618|NCT01430442|455822350|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
126690619|NCT01430442|455822351|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
126690620|NCT01430442|455822352|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
126690621|NCT01430442|455822353|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
126690622|NCT01430442|455822354|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
126690623|NCT01641939|455822355|FG000|Overall Study|Death|90|||
126690624|NCT01641939|455822356|FG001|Overall Study|Death|187|||
126690625|NCT01641939|455822357|FG002|Overall Study|Death|61|||
126690626|NCT01641939|455822355|FG000|Overall Study|Lost to Follow-up|3|||
126690627|NCT01641939|455822356|FG001|Overall Study|Lost to Follow-up|2|||
126690628|NCT01641939|455822357|FG002|Overall Study|Lost to Follow-up|1|||
126690629|NCT01641939|455822355|FG000|Overall Study|Withdrawal by Subject|14|||
126353100|NCT01179516|454583426|FG000|Overall Study|Other|2|||
126353101|NCT01179516|454583427|FG001|Overall Study|Other|0|||
126353102|NCT01179516|454583428|FG002|Overall Study|Other|2|||
126353103|NCT03349515|454583430|FG000|Overall Study|Lack of Efficacy|2|||
126353104|NCT03349515|454583431|FG001|Overall Study|Lack of Efficacy|0|||
126353105|NCT03349515|454583430|FG000|Overall Study|Physician Decision|3|||
126353106|NCT03349515|454583431|FG001|Overall Study|Physician Decision|1|||
126353107|NCT03412890|454583432|FG000|Overall Study|Adverse Event|5|||
126353108|NCT03412890|454583433|FG001|Overall Study|Adverse Event|5|||
126353109|NCT03412890|454583434|FG002|Overall Study|Adverse Event|9|||
126353110|NCT03412890|454583432|FG000|Overall Study|Protocol deviation|2|||
126353111|NCT03412890|454583433|FG001|Overall Study|Protocol deviation|1|||
126353112|NCT03412890|454583434|FG002|Overall Study|Protocol deviation|2|||
126353113|NCT03412890|454583432|FG000|Overall Study|Lost to Follow-up|7|||
126353114|NCT03412890|454583433|FG001|Overall Study|Lost to Follow-up|10|||
126353115|NCT03412890|454583434|FG002|Overall Study|Lost to Follow-up|10|||
126353116|NCT03412890|454583432|FG000|Overall Study|Withdrawal by Subject|9|||
126353117|NCT03412890|454583433|FG001|Overall Study|Withdrawal by Subject|12|||
126353118|NCT03412890|454583434|FG002|Overall Study|Withdrawal by Subject|11|||
126353119|NCT03412890|454583432|FG000|Overall Study|Lack of Efficacy|2|||
126353120|NCT03412890|454583433|FG001|Overall Study|Lack of Efficacy|7|||
126353121|NCT03412890|454583434|FG002|Overall Study|Lack of Efficacy|5|||
126690630|NCT01641939|455822356|FG001|Overall Study|Withdrawal by Subject|11|||
126353122|NCT03412890|454583432|FG000|Overall Study|Other|5|||
126353123|NCT03412890|454583433|FG001|Overall Study|Other|6|||
126353124|NCT03412890|454583434|FG002|Overall Study|Other|5|||
126353125|NCT03412890|454583432|FG000|Overall Study|Participants who did not receive any study drug|0|||
126353126|NCT03412890|454583433|FG001|Overall Study|Participants who did not receive any study drug|1|||
126690631|NCT01641939|455822357|FG002|Overall Study|Withdrawal by Subject|5|||
126690632|NCT01641939|455822355|FG000|Overall Study|Study Terminated by Sponsor|10|||
126690633|NCT01641939|455822356|FG001|Overall Study|Study Terminated by Sponsor|28|||
126690634|NCT01641939|455822357|FG002|Overall Study|Study Terminated by Sponsor|3|||
126353127|NCT03412890|454583434|FG002|Overall Study|Participants who did not receive any study drug|0|||
126353128|NCT02315625|454583435|FG000|First Intervention|Disease Progression|1|||
126353129|NCT02315625|454583436|FG001|First Intervention|Disease Progression|0|||
126690635|NCT03068325|455822358|FG000|Overall Study|Lost to Follow-up|5|||
126760254|NCT01016912|456072432|FG003|Follow-up Period|Other reason|1|||
126690636|NCT00454779|455822361|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
126690637|NCT00454779|455822362|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
126353130|NCT02315625|454583435|FG000|Second Intervention|Physician Decision|2|||
126353131|NCT02315625|454583436|FG001|Second Intervention|Physician Decision|1|||
126353132|NCT02315625|454583435|FG000|Second Intervention|Study closure|1|||
126353133|NCT02315625|454583436|FG001|Second Intervention|Study closure|0|||
126353134|NCT02315625|454583435|FG000|Second Intervention|Disease Progression|1|||
126353135|NCT02315625|454583436|FG001|Second Intervention|Disease Progression|0|||
126353136|NCT00021255|454583437|FG000|Overall Study|Death|1|||
126353137|NCT00021255|454583438|FG001|Overall Study|Death|0|||
126353138|NCT00021255|454583439|FG002|Overall Study|Death|2|||
126353139|NCT00021255|454583437|FG000|Overall Study|Breast cancer relapse|5|||
126353140|NCT00021255|454583438|FG001|Overall Study|Breast cancer relapse|18|||
126353141|NCT00021255|454583439|FG002|Overall Study|Breast cancer relapse|11|||
126353142|NCT00021255|454583437|FG000|Overall Study|Second primary malignancy|0|||
126353143|NCT00021255|454583438|FG001|Overall Study|Second primary malignancy|4|||
126690638|NCT00454779|455822361|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
126353144|NCT00021255|454583439|FG002|Overall Study|Second primary malignancy|1|||
126353145|NCT00021255|454583437|FG000|Overall Study|Withdrawal by Subject|41|||
126353146|NCT00021255|454583438|FG001|Overall Study|Withdrawal by Subject|64|||
126353147|NCT00021255|454583439|FG002|Overall Study|Withdrawal by Subject|26|||
126353148|NCT00021255|454583437|FG000|Overall Study|Lost to Follow-up|0|||
126353149|NCT00021255|454583438|FG001|Overall Study|Lost to Follow-up|2|||
126353150|NCT00021255|454583439|FG002|Overall Study|Lost to Follow-up|3|||
126353151|NCT00021255|454583437|FG000|Overall Study|Cardiac toxicity|0|||
126441617|NCT00297258|454915326|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
126441618|NCT05038982|454915327|FG000|Overall Study|Withdrawal by Subject|0|||
126441619|NCT05038982|454915328|FG001|Overall Study|Withdrawal by Subject|2|||
126441620|NCT03133793|454915329|FG000|Overall Study|Withdrawal by Subject|0|||
126441621|NCT03133793|454915330|FG001|Overall Study|Withdrawal by Subject|4|||
126441622|NCT03133793|454915331|FG002|Overall Study|Withdrawal by Subject|2|||
126441623|NCT03133793|454915332|FG003|Overall Study|Withdrawal by Subject|4|||
126441624|NCT03133793|454915329|FG000|Overall Study|Lost to Follow-up|1|||
126441625|NCT03133793|454915330|FG001|Overall Study|Lost to Follow-up|0|||
126441626|NCT03133793|454915331|FG002|Overall Study|Lost to Follow-up|2|||
126441627|NCT03133793|454915332|FG003|Overall Study|Lost to Follow-up|0|||
126441628|NCT03133793|454915329|FG000|Overall Study|Death|0|||
126441629|NCT03133793|454915330|FG001|Overall Study|Death|0|||
126441630|NCT03133793|454915331|FG002|Overall Study|Death|0|||
126441631|NCT03133793|454915332|FG003|Overall Study|Death|1|||
126441632|NCT04476797|454915333|FG000|Overall Study|Withdrawal by Subject|1|||
126441633|NCT04476797|454915334|FG001|Overall Study|Withdrawal by Subject|0|||
126441634|NCT04476797|454915335|FG002|Overall Study|Withdrawal by Subject|0|||
126441635|NCT04476797|454915333|FG000|Overall Study|Death|0|||
126441636|NCT04476797|454915334|FG001|Overall Study|Death|1|||
126441637|NCT04476797|454915335|FG002|Overall Study|Death|2|||
126441638|NCT04476797|454915333|FG000|Overall Study|Sponsor Terminated Study|0|||
126441639|NCT04476797|454915334|FG001|Overall Study|Sponsor Terminated Study|18|||
126441640|NCT04476797|454915335|FG002|Overall Study|Sponsor Terminated Study|17|||
126441641|NCT03614156|454915336|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
126441642|NCT03614156|454915337|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
126441643|NCT03614156|454915338|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
126441644|NCT03614156|454915339|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
126441645|NCT03614156|454915336|FG000|Open-Label Treatment Period|Adverse Event|7|||
126441646|NCT03614156|454915337|FG001|Open-Label Treatment Period|Adverse Event|0|||
126441647|NCT03614156|454915338|FG002|Open-Label Treatment Period|Adverse Event|0|||
126441648|NCT03614156|454915339|FG003|Open-Label Treatment Period|Adverse Event|0|||
126441649|NCT03614156|454915336|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
126441650|NCT03614156|454915337|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
126441651|NCT03614156|454915338|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
126441652|NCT03614156|454915339|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
126441653|NCT03614156|454915336|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
126441654|NCT03614156|454915337|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
126441655|NCT03614156|454915338|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
126441656|NCT03614156|454915339|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
126441657|NCT03614156|454915336|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
126441658|NCT03614156|454915337|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
126441659|NCT03614156|454915338|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
126441660|NCT03614156|454915339|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
126441661|NCT03614156|454915336|FG000|Open-Label Treatment Period|Protocol Violation|2|||
126441662|NCT03614156|454915337|FG001|Open-Label Treatment Period|Protocol Violation|0|||
126441663|NCT03614156|454915338|FG002|Open-Label Treatment Period|Protocol Violation|0|||
126690639|NCT00454779|455822362|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
126690640|NCT00454779|455822361|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
126690641|NCT00454779|455822362|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
126353152|NCT00021255|454583438|FG001|Overall Study|Cardiac toxicity|61|||
126353153|NCT00021255|454583439|FG002|Overall Study|Cardiac toxicity|32|||
126353154|NCT00021255|454583437|FG000|Overall Study|Herceptin toxicity|0|||
126353155|NCT00021255|454583438|FG001|Overall Study|Herceptin toxicity|22|||
126353156|NCT00021255|454583439|FG002|Overall Study|Herceptin toxicity|6|||
126353157|NCT00021255|454583437|FG000|Overall Study|Adverse Event|46|||
126353158|NCT00021255|454583438|FG001|Overall Study|Adverse Event|30|||
126353159|NCT00021255|454583439|FG002|Overall Study|Adverse Event|18|||
126353160|NCT00021255|454583437|FG000|Overall Study|Protocol Violation|0|||
126353161|NCT00021255|454583438|FG001|Overall Study|Protocol Violation|2|||
126353162|NCT00021255|454583439|FG002|Overall Study|Protocol Violation|0|||
126353163|NCT00021255|454583437|FG000|Overall Study|Other than specified above|0|||
126353164|NCT00021255|454583438|FG001|Overall Study|Other than specified above|38|||
126353165|NCT00021255|454583439|FG002|Overall Study|Other than specified above|19|||
126353166|NCT00021255|454583437|FG000|Overall Study|Missing|0|||
126353167|NCT00021255|454583438|FG001|Overall Study|Missing|27|||
126353168|NCT00021255|454583439|FG002|Overall Study|Missing|13|||
126353169|NCT00021255|454583437|FG000|Overall Study|Randomized but not treated|28|||
126353170|NCT00021255|454583438|FG001|Overall Study|Randomized but not treated|2|||
126353171|NCT00021255|454583439|FG002|Overall Study|Randomized but not treated|18|||
126353172|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
126353173|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
126353174|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
126353175|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
126441664|NCT03614156|454915339|FG003|Open-Label Treatment Period|Protocol Violation|0|||
126441665|NCT03614156|454915336|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
126441666|NCT03614156|454915337|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
126441667|NCT03614156|454915338|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
126545402|NCT02541383|455290826|FG003|Overall Study|Sponsor's decision|0|||
126760255|NCT01016912|456072433|FG004|Follow-up Period|Other reason|0|||
126353176|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
126353177|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
126353178|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
126353179|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
126353180|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
126353181|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
126353182|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
126353183|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
126353184|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
126353185|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
126353186|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
126353187|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
126353188|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
126353189|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
126353190|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
126353191|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
126353192|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
126353193|NCT02337946|454583442|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
126353194|NCT02337946|454583443|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
126353195|NCT02337946|454583444|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
126353196|NCT02337946|454583442|FG000|In-between Period|Without Informed Consent|1|||
126353197|NCT02337946|454583443|FG001|In-between Period|Without Informed Consent|0|||
126353198|NCT02337946|454583444|FG002|In-between Period|Without Informed Consent|0|||
126353199|NCT02337946|454583442|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
126353200|NCT02337946|454583443|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
126353201|NCT02337946|454583444|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
126353202|NCT02337946|454583442|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
126353203|NCT02337946|454583443|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
126353204|NCT02337946|454583444|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
126353205|NCT02337946|454583442|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
126353206|NCT02337946|454583443|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
126353207|NCT02337946|454583444|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
126353208|NCT02337946|454583442|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
126353209|NCT02337946|454583443|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
126353210|NCT02337946|454583444|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
126353211|NCT02337946|454583442|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
126353212|NCT02337946|454583443|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
126353213|NCT02337946|454583444|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
126353214|NCT02337946|454583442|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
126353215|NCT02337946|454583443|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
126353216|NCT02337946|454583444|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
126353217|NCT05324371|454583446|FG000|Overall Study|Withdrawal by Subject|1|||
126353218|NCT05324371|454583446|FG000|Overall Study|Death|1|||
126353219|NCT02949934|454583448|FG000|Natural Drinking Period|Adverse Event|1|||
126353220|NCT02949934|454583449|FG001|Natural Drinking Period|Adverse Event|0|||
126353221|NCT02949934|454583450|FG002|Natural Drinking Period|Adverse Event|0|||
126353222|NCT02949934|454583451|FG003|Natural Drinking Period|Adverse Event|1|||
126353223|NCT02949934|454583452|FG004|Natural Drinking Period|Adverse Event|0|||
126353224|NCT02949934|454583453|FG005|Natural Drinking Period|Adverse Event|0|||
126353225|NCT02949934|454583448|FG000|Natural Drinking Period|Lost to Follow-up|0|||
126353226|NCT02949934|454583449|FG001|Natural Drinking Period|Lost to Follow-up|0|||
126353227|NCT02949934|454583450|FG002|Natural Drinking Period|Lost to Follow-up|0|||
126353228|NCT02949934|454583451|FG003|Natural Drinking Period|Lost to Follow-up|0|||
126353229|NCT02949934|454583452|FG004|Natural Drinking Period|Lost to Follow-up|1|||
126353230|NCT02949934|454583453|FG005|Natural Drinking Period|Lost to Follow-up|0|||
126760256|NCT02221882|456072434|FG000|Overall Study|Withdrawal by Subject|0|||
126760257|NCT02221882|456072435|FG001|Overall Study|Withdrawal by Subject|0|||
126353231|NCT02949934|454583448|FG000|Neuroimaging|Protocol Violation|2|||
126353232|NCT02949934|454583449|FG001|Neuroimaging|Protocol Violation|0|||
126353233|NCT02949934|454583450|FG002|Neuroimaging|Protocol Violation|0|||
126353234|NCT02949934|454583451|FG003|Neuroimaging|Protocol Violation|0|||
126353235|NCT02949934|454583452|FG004|Neuroimaging|Protocol Violation|1|||
126353236|NCT02949934|454583453|FG005|Neuroimaging|Protocol Violation|0|||
126353237|NCT02949934|454583448|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
126353238|NCT02949934|454583449|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
126690642|NCT00454779|455822361|FG000|First-line Treatment Phase|Protocol Violation|0|||
126690643|NCT00454779|455822362|FG001|First-line Treatment Phase|Protocol Violation|1|||
126690644|NCT00454779|455822361|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
126690645|NCT00454779|455822362|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
126690646|NCT00454779|455822361|FG000|First-line Treatment Phase|Ongoing|1|||
126690647|NCT00454779|455822362|FG001|First-line Treatment Phase|Ongoing|0|||
126690648|NCT00454779|455822361|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
126690649|NCT00454779|455822362|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
126690650|NCT00454779|455822361|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
126690651|NCT00454779|455822362|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
126690652|NCT00454779|455822361|FG000|Second-line Treatment Phase|Ongoing|0|||
126690653|NCT00454779|455822362|FG001|Second-line Treatment Phase|Ongoing|1|||
126690654|NCT05425563|455822366|FG000|Overall Study|Withdrawal by Subject|17|||
126690655|NCT00168831|455822369|FG000|Overall Study|Adverse Event|36|||
126690656|NCT00168831|455822370|FG001|Overall Study|Adverse Event|47|||
126690657|NCT00168831|455822371|FG002|Overall Study|Adverse Event|74|||
126690658|NCT00168831|455822369|FG000|Overall Study|Lost to Follow-up|5|||
126690659|NCT00168831|455822370|FG001|Overall Study|Lost to Follow-up|6|||
126690660|NCT00168831|455822371|FG002|Overall Study|Lost to Follow-up|4|||
126690661|NCT00168831|455822369|FG000|Overall Study|Withdrawal by Subject|7|||
126690662|NCT00168831|455822370|FG001|Overall Study|Withdrawal by Subject|14|||
126690663|NCT00168831|455822371|FG002|Overall Study|Withdrawal by Subject|19|||
126690664|NCT00168831|455822369|FG000|Overall Study|Protocol Violation|6|||
126690665|NCT00168831|455822370|FG001|Overall Study|Protocol Violation|11|||
126690666|NCT00168831|455822371|FG002|Overall Study|Protocol Violation|11|||
126690667|NCT00168831|455822369|FG000|Overall Study|Other|6|||
126690668|NCT00168831|455822370|FG001|Overall Study|Other|3|||
126690669|NCT00168831|455822371|FG002|Overall Study|Other|6|||
126690670|NCT02009878|455822373|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
126690671|NCT02009878|455822374|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
126690672|NCT02009878|455822375|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
126690673|NCT04652804|455822378|FG000|Overall Study|Ineligible post randomization|1|||
126690674|NCT04652804|455822379|FG001|Overall Study|Ineligible post randomization|0|||
126690675|NCT04652804|455822380|FG002|Overall Study|Ineligible post randomization|1|||
126690676|NCT04652804|455822381|FG003|Overall Study|Ineligible post randomization|0|||
126690677|NCT04652804|455822382|FG004|Overall Study|Ineligible post randomization|1|||
126441668|NCT03614156|454915339|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
126441669|NCT03614156|454915336|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
126441670|NCT03614156|454915337|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
126441671|NCT03614156|454915338|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
126690678|NCT04652804|455822383|FG005|Overall Study|Ineligible post randomization|1|||
126690679|NCT04652804|455822378|FG000|Overall Study|Missing SVR lab results|2|||
126690680|NCT04652804|455822379|FG001|Overall Study|Missing SVR lab results|0|||
126353239|NCT02949934|454583450|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
126353240|NCT02949934|454583451|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
126353241|NCT02949934|454583452|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
126353242|NCT02949934|454583453|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
126353243|NCT02949934|454583448|FG000|Neuroimaging|Not scanned|0|||
126353244|NCT02949934|454583449|FG001|Neuroimaging|Not scanned|0|||
126353245|NCT02949934|454583450|FG002|Neuroimaging|Not scanned|1|||
126353246|NCT02949934|454583451|FG003|Neuroimaging|Not scanned|0|||
126353247|NCT02949934|454583452|FG004|Neuroimaging|Not scanned|0|||
126353248|NCT02949934|454583453|FG005|Neuroimaging|Not scanned|2|||
126353249|NCT02949934|454583448|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
126353250|NCT02949934|454583449|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
126353251|NCT02949934|454583450|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
126353252|NCT02949934|454583451|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
126353253|NCT02949934|454583452|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
126353254|NCT02949934|454583453|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
126690681|NCT04652804|455822380|FG002|Overall Study|Missing SVR lab results|0|||
126690682|NCT04652804|455822381|FG003|Overall Study|Missing SVR lab results|0|||
126690683|NCT04652804|455822382|FG004|Overall Study|Missing SVR lab results|0|||
126690684|NCT04652804|455822383|FG005|Overall Study|Missing SVR lab results|0|||
126690685|NCT03634800|455822384|FG000|Overall Study|Adverse Event|1|||
126690686|NCT03634800|455822384|FG000|Overall Study|Disease Progression|4|||
126353255|NCT02949934|454583448|FG000|Bar Laboratory|Adverse Event|1|||
126353256|NCT02949934|454583449|FG001|Bar Laboratory|Adverse Event|0|||
126353257|NCT02949934|454583450|FG002|Bar Laboratory|Adverse Event|2|||
126690687|NCT03634800|455822384|FG000|Overall Study|Withdrawal by Subject|1|||
126690688|NCT00343512|455822391|FG000|Overall Study|Withdrawal by Subject|2|||
126690689|NCT00191451|455822394|FG000|Overall Study|Withdrawal by Subject|2|||
126690690|NCT00191451|455822395|FG001|Overall Study|Withdrawal by Subject|3|||
126690691|NCT00191451|455822396|FG002|Overall Study|Withdrawal by Subject|5|||
126690692|NCT00191451|455822394|FG000|Overall Study|Physician Decision|2|||
126690693|NCT00191451|455822395|FG001|Overall Study|Physician Decision|9|||
126690694|NCT00191451|455822396|FG002|Overall Study|Physician Decision|6|||
126690695|NCT00191451|455822394|FG000|Overall Study|Sponsor Decision|1|||
126690696|NCT00191451|455822395|FG001|Overall Study|Sponsor Decision|0|||
126690697|NCT00191451|455822396|FG002|Overall Study|Sponsor Decision|0|||
126690698|NCT00191451|455822394|FG000|Overall Study|Ineligible|0|||
126690699|NCT00191451|455822395|FG001|Overall Study|Ineligible|1|||
126690700|NCT00191451|455822396|FG002|Overall Study|Ineligible|0|||
126690701|NCT00191451|455822394|FG000|Overall Study|Reason Not Specified|2|||
126690702|NCT00191451|455822395|FG001|Overall Study|Reason Not Specified|1|||
126690703|NCT00191451|455822396|FG002|Overall Study|Reason Not Specified|3|||
126690704|NCT00684515|455822397|FG000|Overall Study|Adverse Event|3|||
126690705|NCT00684515|455822398|FG001|Overall Study|Adverse Event|3|||
126690706|NCT00684515|455822399|FG002|Overall Study|Adverse Event|1|||
126690707|NCT00684515|455822397|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
126690708|NCT00684515|455822398|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
126690709|NCT00684515|455822399|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
126690710|NCT04428411|455822400|FG000|Overall Study|Lost to Follow-up|114|||
126690711|NCT00272987|455822401|FG000|Overall Study|Adverse Event|1|||
126690712|NCT00272987|455822402|FG001|Overall Study|Adverse Event|0|||
126690713|NCT00272987|455822403|FG002|Overall Study|Adverse Event|0|||
126690714|NCT00272987|455822401|FG000|Overall Study|Lost to Follow-up|3|||
126690715|NCT00272987|455822402|FG001|Overall Study|Lost to Follow-up|1|||
126690716|NCT00272987|455822403|FG002|Overall Study|Lost to Follow-up|1|||
126690717|NCT00272987|455822401|FG000|Overall Study|Withdrawal by Subject|1|||
126690718|NCT00272987|455822402|FG001|Overall Study|Withdrawal by Subject|0|||
126690719|NCT00272987|455822403|FG002|Overall Study|Withdrawal by Subject|3|||
126690720|NCT00272987|455822401|FG000|Overall Study|Sponsor Terminated study|0|||
126690721|NCT00272987|455822402|FG001|Overall Study|Sponsor Terminated study|1|||
126690722|NCT00272987|455822403|FG002|Overall Study|Sponsor Terminated study|1|||
126690723|NCT00272987|455822401|FG000|Overall Study|Disease progression|1|||
126690724|NCT00272987|455822402|FG001|Overall Study|Disease progression|1|||
126690725|NCT00272987|455822403|FG002|Overall Study|Disease progression|2|||
126690726|NCT00272987|455822401|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
126690727|NCT00272987|455822402|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
126690728|NCT00272987|455822403|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
126690729|NCT00272987|455822401|FG000|Overall Study|Death|1|||
126690730|NCT00272987|455822402|FG001|Overall Study|Death|0|||
126690731|NCT00272987|455822403|FG002|Overall Study|Death|0|||
126690732|NCT01163786|455822404|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
126690733|NCT01163786|455822404|FG000|Treatment With Bortezomib|Adverse Event|2|||
126690734|NCT01163786|455822404|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
126690735|NCT03555266|455822405|FG000|Overall Study|Protocol Violation|6|||
126690736|NCT03555266|455822406|FG001|Overall Study|Protocol Violation|4|||
126690737|NCT01554579|455822407|FG000|Overall Study|Adverse Event|6|||
126690738|NCT01554579|455822408|FG001|Overall Study|Adverse Event|25|||
126690739|NCT01554579|455822407|FG000|Overall Study|Lack of Efficacy|2|||
126690740|NCT01554579|455822408|FG001|Overall Study|Lack of Efficacy|1|||
126690741|NCT01554579|455822407|FG000|Overall Study|Withdrawal by Subject|2|||
126690742|NCT01554579|455822408|FG001|Overall Study|Withdrawal by Subject|1|||
126690743|NCT01192347|455822412|FG000|Overall Study|Death|3|||
126690744|NCT01192347|455822412|FG000|Overall Study|Lost to Follow-up|3|||
126690745|NCT01192347|455822412|FG000|Overall Study|Withdrawal by Subject|1|||
126690746|NCT01192347|455822412|FG000|Overall Study|Adverse Event|1|||
126690747|NCT01192347|455822412|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
126690748|NCT01192347|455822412|FG000|Overall Study|Patient seen in different hospital|1|||
126690749|NCT01192347|455822412|FG000|Overall Study|Patient not visiting hospital regularly|1|||
126690750|NCT01192347|455822412|FG000|Overall Study|Patient did not show up for visits|1|||
126690751|NCT03543410|455822414|FG000|Overall Study|Adverse Event|10|||
126690752|NCT03543410|455822415|FG001|Overall Study|Adverse Event|8|||
126690753|NCT03543410|455822416|FG002|Overall Study|Adverse Event|2|||
126690754|NCT03543410|455822414|FG000|Overall Study|Lack of Efficacy|0|||
126690755|NCT03543410|455822415|FG001|Overall Study|Lack of Efficacy|1|||
126690756|NCT03543410|455822416|FG002|Overall Study|Lack of Efficacy|0|||
126690757|NCT03543410|455822414|FG000|Overall Study|Lost to Follow-up|0|||
126690758|NCT03543410|455822415|FG001|Overall Study|Lost to Follow-up|1|||
126690759|NCT03543410|455822416|FG002|Overall Study|Lost to Follow-up|0|||
126690760|NCT03543410|455822414|FG000|Overall Study|Withdrawal by Subject|5|||
126690761|NCT03543410|455822415|FG001|Overall Study|Withdrawal by Subject|2|||
126690762|NCT03543410|455822416|FG002|Overall Study|Withdrawal by Subject|8|||
126690763|NCT03543410|455822414|FG000|Overall Study|Protocol Violation|0|||
126690764|NCT03543410|455822415|FG001|Overall Study|Protocol Violation|1|||
126353258|NCT02949934|454583451|FG003|Bar Laboratory|Adverse Event|0|||
126353259|NCT02949934|454583452|FG004|Bar Laboratory|Adverse Event|1|||
126353260|NCT02949934|454583453|FG005|Bar Laboratory|Adverse Event|0|||
126353261|NCT02949934|454583448|FG000|Bar Laboratory|Protocol Violation|0|||
126353262|NCT02949934|454583449|FG001|Bar Laboratory|Protocol Violation|0|||
126353263|NCT02949934|454583450|FG002|Bar Laboratory|Protocol Violation|0|||
126353264|NCT02949934|454583451|FG003|Bar Laboratory|Protocol Violation|1|||
126353265|NCT02949934|454583452|FG004|Bar Laboratory|Protocol Violation|0|||
126353266|NCT02949934|454583453|FG005|Bar Laboratory|Protocol Violation|0|||
126353267|NCT03720847|454584386|FG000|Washout|Physician Decision|1|||
126353268|NCT03720847|454584387|FG001|Washout|Physician Decision|2|||
126353269|NCT01239680|454584388|FG000|Overall Study|Withdrawal by Subject|2|||
126353270|NCT01239680|454584389|FG001|Overall Study|Withdrawal by Subject|0|||
126353271|NCT03033901|454584390|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
126353272|NCT03033901|454584390|FG000|Overall Study|Refused PSG|23|||
126353273|NCT03033901|454584390|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
126353274|NCT03033901|454584390|FG000|Overall Study|Missing Oximetry Data|3|||
126353275|NCT01521364|454584398|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
126353276|NCT01521364|454584398|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
126353277|NCT02636283|454584399|FG000|Overall Study|Adverse Event|2|||
126353278|NCT02636283|454584400|FG001|Overall Study|Adverse Event|0|||
126690765|NCT03543410|455822416|FG002|Overall Study|Protocol Violation|0|||
126690766|NCT03543410|455822414|FG000|Overall Study|Due to COVID-19|4|||
126353279|NCT02636283|454584399|FG000|Overall Study|Trial Terminated Prematurely|0|||
126353280|NCT02636283|454584400|FG001|Overall Study|Trial Terminated Prematurely|3|||
126353281|NCT00195429|454584403|FG000|Overall Study|Adverse Event|2|||
126353282|NCT00195429|454584404|FG001|Overall Study|Adverse Event|4|||
126353283|NCT00195429|454584403|FG000|Overall Study|Lack of Efficacy|2|||
126441672|NCT03614156|454915339|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
126690767|NCT03543410|455822415|FG001|Overall Study|Due to COVID-19|0|||
126690768|NCT03543410|455822416|FG002|Overall Study|Due to COVID-19|2|||
126690769|NCT03543410|455822414|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
126690770|NCT03543410|455822415|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
126690771|NCT03543410|455822416|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
126690772|NCT03543410|455822414|FG000|Overall Study|Not Due to COVID-19|2|||
126690773|NCT03543410|455822415|FG001|Overall Study|Not Due to COVID-19|0|||
126690774|NCT03543410|455822416|FG002|Overall Study|Not Due to COVID-19|1|||
126690775|NCT02883244|455822417|FG000|Overall Study|Lost to Follow-up|0|||
126690776|NCT02883244|455822418|FG001|Overall Study|Lost to Follow-up|1|||
126690777|NCT02317562|455822425|FG000|Overall Study|Physician Decision|1|||
126690778|NCT02317562|455822425|FG000|Overall Study|early termination of the study|8|||
126353284|NCT00195429|454584404|FG001|Overall Study|Lack of Efficacy|1|||
126353285|NCT00195429|454584403|FG000|Overall Study|Lost to Follow-up|1|||
126353286|NCT00195429|454584404|FG001|Overall Study|Lost to Follow-up|0|||
126353287|NCT02541903|454584405|FG000|Overall Study|Death|1|||
126353288|NCT04795323|454584406|FG000|Overall Study|Did not interact with TARA|1|||
126353289|NCT04795323|454584407|FG001|Overall Study|Did not interact with TARA|0|||
126353290|NCT02691663|454584409|FG000|Overall Study|Screen failure after baseline|2|||
126353291|NCT02691663|454584410|FG001|Overall Study|Screen failure after baseline|2|||
126353292|NCT02691663|454584409|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
126353293|NCT02691663|454584410|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
126353294|NCT02691663|454584409|FG000|Overall Study|Withdrawn after Follow up 2|1|||
126353295|NCT02691663|454584410|FG001|Overall Study|Withdrawn after Follow up 2|1|||
126353296|NCT02691663|454584409|FG000|Overall Study|Lost to Follow-up|3|||
126353297|NCT02691663|454584410|FG001|Overall Study|Lost to Follow-up|2|||
126353298|NCT03142750|454584411|FG000|Overall Study|Lost to Follow-up|4|||
126353299|NCT03142750|454584412|FG001|Overall Study|Lost to Follow-up|1|||
126353300|NCT04925934|454584413|FG000|Overall Study|Adverse Event|1|||
126353301|NCT04925934|454584414|FG001|Overall Study|Adverse Event|0|||
126353302|NCT04925934|454584415|FG002|Overall Study|Adverse Event|0|||
126353303|NCT04925934|454584413|FG000|Overall Study|Lost to Follow-up|2|||
126353304|NCT04925934|454584414|FG001|Overall Study|Lost to Follow-up|0|||
126353305|NCT04925934|454584415|FG002|Overall Study|Lost to Follow-up|1|||
126353306|NCT04925934|454584413|FG000|Overall Study|Death|0|||
126353307|NCT04925934|454584414|FG001|Overall Study|Death|1|||
126353308|NCT04925934|454584415|FG002|Overall Study|Death|0|||
126353309|NCT04925934|454584413|FG000|Overall Study|Withdrawal by Subject|8|||
126353310|NCT04925934|454584414|FG001|Overall Study|Withdrawal by Subject|5|||
126353311|NCT04925934|454584415|FG002|Overall Study|Withdrawal by Subject|9|||
126353312|NCT04925934|454584413|FG000|Overall Study|Other|2|||
126353313|NCT04925934|454584414|FG001|Overall Study|Other|2|||
126353314|NCT04925934|454584415|FG002|Overall Study|Other|2|||
126690779|NCT02317562|455822425|FG000|Overall Study|Lack of Efficacy|4|||
126690780|NCT02317562|455822425|FG000|Overall Study|Withdrawal by Subject|1|||
126353315|NCT04925934|454584413|FG000|Overall Study|Eastern European Conflict|7|||
126353316|NCT04925934|454584414|FG001|Overall Study|Eastern European Conflict|3|||
126353317|NCT04925934|454584415|FG002|Overall Study|Eastern European Conflict|2|||
126353318|NCT03158688|454584416|FG000|Overall Study|Withdrawal by Subject|14|||
126353319|NCT03158688|454584417|FG001|Overall Study|Withdrawal by Subject|28|||
126441673|NCT03614156|454915336|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
126353320|NCT03158688|454584416|FG000|Overall Study|Decision by sponsor|13|||
126353321|NCT03158688|454584417|FG001|Overall Study|Decision by sponsor|37|||
126353322|NCT03158688|454584416|FG000|Overall Study|Lost to Follow-up|4|||
126353323|NCT03158688|454584417|FG001|Overall Study|Lost to Follow-up|3|||
126690781|NCT00626093|455822426|FG000|Overall Study|Lost to Follow-up|5|||
126690782|NCT00626093|455822426|FG000|Overall Study|Death|1|||
126690783|NCT00626093|455822426|FG000|Overall Study|Physician Decision|4|||
126690784|NCT00626093|455822426|FG000|Overall Study|Withdrawal by Subject|6|||
126690785|NCT00626093|455822426|FG000|Overall Study|Protocol Violation|1|||
126690786|NCT00626093|455822426|FG000|Overall Study|One of the required devices not implante|6|||
126690787|NCT03891901|455822427|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
126690788|NCT03891901|455822428|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126690789|NCT03891901|455822429|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126690790|NCT03891901|455822430|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126690791|NCT03891901|455822431|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126690792|NCT03891901|455822432|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126690793|NCT03891901|455822433|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126690794|NCT03891901|455822434|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126690795|NCT03891901|455822435|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
126690796|NCT03891901|455822427|FG000|Overall Study|Adverse Event|2|||
126690797|NCT03891901|455822428|FG001|Overall Study|Adverse Event|2|||
126690798|NCT03891901|455822429|FG002|Overall Study|Adverse Event|0|||
126690799|NCT03891901|455822430|FG003|Overall Study|Adverse Event|0|||
126690800|NCT03891901|455822431|FG004|Overall Study|Adverse Event|0|||
126690801|NCT03891901|455822432|FG005|Overall Study|Adverse Event|0|||
126690802|NCT03891901|455822433|FG006|Overall Study|Adverse Event|0|||
126690803|NCT03891901|455822434|FG007|Overall Study|Adverse Event|0|||
126690804|NCT03891901|455822435|FG008|Overall Study|Adverse Event|0|||
126690805|NCT03891901|455822427|FG000|Overall Study|Poor venous access|1|||
126690806|NCT03891901|455822428|FG001|Overall Study|Poor venous access|0|||
126690807|NCT03891901|455822429|FG002|Overall Study|Poor venous access|0|||
126690808|NCT03891901|455822430|FG003|Overall Study|Poor venous access|0|||
126690809|NCT03891901|455822431|FG004|Overall Study|Poor venous access|0|||
126690810|NCT03891901|455822432|FG005|Overall Study|Poor venous access|0|||
126690811|NCT03891901|455822433|FG006|Overall Study|Poor venous access|0|||
126690812|NCT03891901|455822434|FG007|Overall Study|Poor venous access|0|||
126353324|NCT03158688|454584416|FG000|Overall Study|Death|74|||
126353325|NCT03158688|454584417|FG001|Overall Study|Death|142|||
126353326|NCT01944774|454584425|FG000|Overall Study|Withdrawal by Subject|2|||
126353327|NCT01944774|454584426|FG001|Overall Study|Withdrawal by Subject|3|||
126353328|NCT01944774|454584427|FG002|Overall Study|Withdrawal by Subject|3|||
126353329|NCT01944774|454584425|FG000|Overall Study|Adverse Event|3|||
126353330|NCT01944774|454584426|FG001|Overall Study|Adverse Event|2|||
126353331|NCT01944774|454584427|FG002|Overall Study|Adverse Event|3|||
126353332|NCT01944774|454584425|FG000|Overall Study|Lack of Efficacy|1|||
126353333|NCT01944774|454584426|FG001|Overall Study|Lack of Efficacy|2|||
126353334|NCT01944774|454584427|FG002|Overall Study|Lack of Efficacy|2|||
126353335|NCT01944774|454584425|FG000|Overall Study|Lost to Follow-up|0|||
126353336|NCT01944774|454584426|FG001|Overall Study|Lost to Follow-up|1|||
126353337|NCT01944774|454584427|FG002|Overall Study|Lost to Follow-up|0|||
126353338|NCT03188185|454584428|FG000|Stage 1|Adverse Event|4|||
126353339|NCT03188185|454584429|FG001|Stage 1|Adverse Event|12|||
126353340|NCT03188185|454584430|FG002|Stage 1|Adverse Event|0|||
126353341|NCT03188185|454584431|FG003|Stage 1|Adverse Event|0|||
126353342|NCT03188185|454584428|FG000|Stage 1|Lack of Efficacy|0|||
126353343|NCT03188185|454584429|FG001|Stage 1|Lack of Efficacy|2|||
126353344|NCT03188185|454584430|FG002|Stage 1|Lack of Efficacy|0|||
126353345|NCT03188185|454584431|FG003|Stage 1|Lack of Efficacy|0|||
126353346|NCT03188185|454584428|FG000|Stage 1|Lost to Follow-up|6|||
126353347|NCT03188185|454584429|FG001|Stage 1|Lost to Follow-up|1|||
126353348|NCT03188185|454584430|FG002|Stage 1|Lost to Follow-up|0|||
126353349|NCT03188185|454584431|FG003|Stage 1|Lost to Follow-up|0|||
126353350|NCT03188185|454584428|FG000|Stage 1|Withdrawal by Subject|9|||
126353351|NCT03188185|454584429|FG001|Stage 1|Withdrawal by Subject|0|||
126690813|NCT03891901|455822435|FG008|Overall Study|Poor venous access|0|||
126690814|NCT03891901|455822427|FG000|Overall Study|Withdrawal by Subject|0|||
126690815|NCT03891901|455822428|FG001|Overall Study|Withdrawal by Subject|2|||
126690816|NCT03891901|455822429|FG002|Overall Study|Withdrawal by Subject|0|||
126690817|NCT03891901|455822430|FG003|Overall Study|Withdrawal by Subject|0|||
126353352|NCT03188185|454584430|FG002|Stage 1|Withdrawal by Subject|0|||
126353353|NCT03188185|454584431|FG003|Stage 1|Withdrawal by Subject|0|||
126353354|NCT03188185|454584428|FG000|Stage 1|Identified as a professional patient|0|||
126353355|NCT03188185|454584429|FG001|Stage 1|Identified as a professional patient|1|||
126353356|NCT03188185|454584430|FG002|Stage 1|Identified as a professional patient|0|||
126353357|NCT03188185|454584431|FG003|Stage 1|Identified as a professional patient|0|||
126353358|NCT03188185|454584428|FG000|Stage 2|Adverse Event|0|||
126353359|NCT03188185|454584429|FG001|Stage 2|Adverse Event|0|||
126353360|NCT03188185|454584430|FG002|Stage 2|Adverse Event|2|||
126353361|NCT03188185|454584431|FG003|Stage 2|Adverse Event|4|||
126353362|NCT03188185|454584428|FG000|Stage 2|Lack of Efficacy|0|||
126353363|NCT03188185|454584429|FG001|Stage 2|Lack of Efficacy|0|||
126353364|NCT03188185|454584430|FG002|Stage 2|Lack of Efficacy|3|||
126690818|NCT03891901|455822431|FG004|Overall Study|Withdrawal by Subject|0|||
126690819|NCT03891901|455822432|FG005|Overall Study|Withdrawal by Subject|0|||
126690820|NCT03891901|455822433|FG006|Overall Study|Withdrawal by Subject|0|||
126690821|NCT03891901|455822434|FG007|Overall Study|Withdrawal by Subject|0|||
126690822|NCT03891901|455822435|FG008|Overall Study|Withdrawal by Subject|0|||
126690823|NCT00603915|455822436|FG000|Overall Study|Physician Decision|1|||
126690824|NCT00573794|455822442|FG000|Overall Study|Adverse Event|81|||
126353365|NCT03188185|454584431|FG003|Stage 2|Lack of Efficacy|0|||
126353366|NCT03188185|454584428|FG000|Stage 2|Lost to Follow-up|0|||
126353367|NCT03188185|454584429|FG001|Stage 2|Lost to Follow-up|0|||
126353368|NCT03188185|454584430|FG002|Stage 2|Lost to Follow-up|1|||
126353369|NCT03188185|454584431|FG003|Stage 2|Lost to Follow-up|0|||
126353370|NCT03188185|454584428|FG000|Stage 2|Physician Decision|0|||
126353371|NCT03188185|454584429|FG001|Stage 2|Physician Decision|0|||
126353372|NCT03188185|454584430|FG002|Stage 2|Physician Decision|0|||
126353373|NCT03188185|454584431|FG003|Stage 2|Physician Decision|1|||
126353374|NCT03188185|454584428|FG000|Stage 2|Withdrawal by Subject|0|||
126353375|NCT03188185|454584429|FG001|Stage 2|Withdrawal by Subject|0|||
126353376|NCT03188185|454584430|FG002|Stage 2|Withdrawal by Subject|3|||
126353377|NCT03188185|454584431|FG003|Stage 2|Withdrawal by Subject|1|||
126353378|NCT02503865|454584434|FG000|Overall Study|Moved out of area|1|||
126353379|NCT02503865|454584435|FG001|Overall Study|Moved out of area|8|||
126353380|NCT02503865|454584436|FG002|Overall Study|Moved out of area|0|||
126353381|NCT02503865|454584434|FG000|Overall Study|Refused treatment|4|||
126353382|NCT02503865|454584435|FG001|Overall Study|Refused treatment|39|||
126353383|NCT02503865|454584436|FG002|Overall Study|Refused treatment|2|||
126353384|NCT01132755|454584439|FG000|Overall Study|Procedure not done due to medical reason|23|||
126353385|NCT01132755|454584439|FG000|Overall Study|Protocol Violation|15|||
126353386|NCT01132755|454584439|FG000|Overall Study|Withdrawal by Subject|4|||
126353387|NCT02232698|454584440|FG000|Overall Study|Pregnancy|1|||
126353388|NCT02232698|454584441|FG001|Overall Study|Pregnancy|1|||
126353389|NCT02232698|454584440|FG000|Overall Study|Met exclusion criteria|1|||
126353390|NCT02232698|454584441|FG001|Overall Study|Met exclusion criteria|1|||
126353391|NCT02232698|454584440|FG000|Overall Study|Had device-associated symptoms|7|||
126353392|NCT02232698|454584441|FG001|Overall Study|Had device-associated symptoms|0|||
126353393|NCT02232698|454584440|FG000|Overall Study|Non-compliance with study device|1|||
126353394|NCT02232698|454584441|FG001|Overall Study|Non-compliance with study device|4|||
126353395|NCT02232698|454584440|FG000|Overall Study|Allocated to control group|0|||
126353396|NCT02232698|454584441|FG001|Overall Study|Allocated to control group|3|||
126353397|NCT02232698|454584440|FG000|Overall Study|Withdrawal by Subject|0|||
126353398|NCT02232698|454584441|FG001|Overall Study|Withdrawal by Subject|11|||
126353399|NCT02393755|454584442|FG000|Overall Study|Withdrawal by Subject|0|||
126353400|NCT02393755|454584443|FG001|Overall Study|Withdrawal by Subject|3|||
126353401|NCT02393755|454584442|FG000|Overall Study|Adverse Event|0|||
126353402|NCT02393755|454584443|FG001|Overall Study|Adverse Event|2|||
126353403|NCT02393755|454584442|FG000|Overall Study|Physician Decision|0|||
126353404|NCT02393755|454584443|FG001|Overall Study|Physician Decision|2|||
126353405|NCT01786109|454584444|FG000|Overall Study|fail manometry barostat tube placement|1|||
126353406|NCT01786109|454584445|FG001|Overall Study|fail manometry barostat tube placement|0|||
126353407|NCT01786109|454584446|FG002|Overall Study|fail manometry barostat tube placement|0|||
126353408|NCT01786109|454584444|FG000|Overall Study|unrelated illness|0|||
126353409|NCT01786109|454584445|FG001|Overall Study|unrelated illness|0|||
126353410|NCT01786109|454584446|FG002|Overall Study|unrelated illness|1|||
126353411|NCT01786109|454584444|FG000|Overall Study|adverse effects colon preparation|0|||
126353412|NCT01786109|454584445|FG001|Overall Study|adverse effects colon preparation|0|||
126353413|NCT01786109|454584446|FG002|Overall Study|adverse effects colon preparation|1|||
126353414|NCT04069520|454584456|FG000|Overall Study|Lost to Follow-up|0|||
126353415|NCT04069520|454584457|FG001|Overall Study|Lost to Follow-up|2|||
126353416|NCT04069520|454584456|FG000|Overall Study|Withdrawal by Subject|0|||
126353417|NCT04069520|454584457|FG001|Overall Study|Withdrawal by Subject|1|||
126353418|NCT04069520|454584456|FG000|Overall Study|Prior Injury|1|||
126353419|NCT04069520|454584457|FG001|Overall Study|Prior Injury|0|||
126353420|NCT04069520|454584456|FG000|Overall Study|Orthodontia|1|||
126353421|NCT04069520|454584457|FG001|Overall Study|Orthodontia|0|||
126353422|NCT04069520|454584456|FG000|Overall Study|Cut from team|0|||
126353423|NCT04069520|454584457|FG001|Overall Study|Cut from team|2|||
126353424|NCT01068912|454584458|FG000|Overall Study|Adverse Event|2|||
126353425|NCT01068912|454584459|FG001|Overall Study|Adverse Event|3|||
126353426|NCT01068912|454584460|FG002|Overall Study|Adverse Event|2|||
126353427|NCT01068912|454584458|FG000|Overall Study|Withdrawal by Subject|5|||
126353428|NCT01068912|454584459|FG001|Overall Study|Withdrawal by Subject|6|||
126353429|NCT01068912|454584460|FG002|Overall Study|Withdrawal by Subject|6|||
126353430|NCT01068912|454584458|FG000|Overall Study|Lost to Follow-up|3|||
126353431|NCT01068912|454584459|FG001|Overall Study|Lost to Follow-up|7|||
126353432|NCT01068912|454584460|FG002|Overall Study|Lost to Follow-up|3|||
126690825|NCT00573794|455822442|FG000|Overall Study|Withdrew Consent|90|||
126353433|NCT01068912|454584458|FG000|Overall Study|Protocol Violation|0|||
126353434|NCT01068912|454584459|FG001|Overall Study|Protocol Violation|2|||
126690826|NCT00573794|455822442|FG000|Overall Study|Lost to Follow-up|13|||
126690827|NCT00573794|455822442|FG000|Overall Study|Protocol Violation|6|||
126353435|NCT01068912|454584460|FG002|Overall Study|Protocol Violation|0|||
126353436|NCT01068912|454584458|FG000|Overall Study|aggravation influenza|1|||
126353437|NCT01068912|454584459|FG001|Overall Study|aggravation influenza|1|||
126353438|NCT01068912|454584460|FG002|Overall Study|aggravation influenza|1|||
126353439|NCT01068912|454584458|FG000|Overall Study|other underlying illness|0|||
126353440|NCT01068912|454584459|FG001|Overall Study|other underlying illness|3|||
126353441|NCT01068912|454584460|FG002|Overall Study|other underlying illness|3|||
126353442|NCT04822194|454584461|FG000|Overall Study|Withdrawal by Subject|5|||
126353443|NCT04822194|454584462|FG001|Overall Study|Withdrawal by Subject|4|||
126353444|NCT04822194|454584461|FG000|Overall Study|Technical issues with MR scanner|1|||
126353445|NCT04822194|454584462|FG001|Overall Study|Technical issues with MR scanner|0|||
126353446|NCT04822194|454584461|FG000|Overall Study|Lost to Follow-up|5|||
126353447|NCT04822194|454584462|FG001|Overall Study|Lost to Follow-up|7|||
126353448|NCT01947933|454584464|FG000|Overall Study|Withdrawal by Subject|0|||
126353449|NCT01947933|454584465|FG001|Overall Study|Withdrawal by Subject|0|||
126353450|NCT01947933|454584466|FG002|Overall Study|Withdrawal by Subject|1|||
126353451|NCT01947933|454584467|FG003|Overall Study|Withdrawal by Subject|0|||
126353452|NCT01947933|454584468|FG004|Overall Study|Withdrawal by Subject|0|||
126353453|NCT01947933|454584469|FG005|Overall Study|Withdrawal by Subject|0|||
126353454|NCT01947933|454584470|FG006|Overall Study|Withdrawal by Subject|0|||
126353455|NCT01947933|454584471|FG007|Overall Study|Withdrawal by Subject|0|||
126353456|NCT01947933|454584472|FG008|Overall Study|Withdrawal by Subject|0|||
126353457|NCT01947933|454584464|FG000|Overall Study|Lost to Follow-up|0|||
126353458|NCT01947933|454584465|FG001|Overall Study|Lost to Follow-up|0|||
126690828|NCT00573794|455822442|FG000|Overall Study|Lack of Efficacy|94|||
126690829|NCT00573794|455822442|FG000|Overall Study|Other|46|||
126690830|NCT02026063|455822445|FG000|Overall Study|Physician Decision|0|||
126690831|NCT02026063|455822446|FG001|Overall Study|Physician Decision|10|||
126690832|NCT02026063|455822445|FG000|Overall Study|Noncompliance with Study Drug|1|||
126690833|NCT02026063|455822446|FG001|Overall Study|Noncompliance with Study Drug|1|||
126690834|NCT02026063|455822445|FG000|Overall Study|Withdrawal of Consent|1|||
126690835|NCT02026063|455822446|FG001|Overall Study|Withdrawal of Consent|6|||
126690836|NCT02026063|455822445|FG000|Overall Study|Adverse Event|5|||
126690837|NCT02026063|455822446|FG001|Overall Study|Adverse Event|20|||
126690838|NCT02026063|455822445|FG000|Overall Study|Lack of Efficacy|0|||
126690839|NCT02026063|455822446|FG001|Overall Study|Lack of Efficacy|4|||
126690840|NCT02026063|455822445|FG000|Overall Study|Lost to Follow-up|0|||
126690841|NCT02026063|455822446|FG001|Overall Study|Lost to Follow-up|1|||
126690842|NCT02026063|455822445|FG000|Overall Study|Reason not Specified|2|||
126690843|NCT02026063|455822446|FG001|Overall Study|Reason not Specified|7|||
126690844|NCT01116544|455822448|FG000|Overall Study|Protocol Violation|1|||
126690845|NCT01116544|455822449|FG001|Overall Study|Protocol Violation|0|||
126690846|NCT01116544|455822448|FG000|Overall Study|Withdrawal by Subject|1|||
126690847|NCT01116544|455822449|FG001|Overall Study|Withdrawal by Subject|1|||
126690848|NCT02183519|455822450|FG000|Overall Study|computer error|3|||
126690849|NCT02183519|455822451|FG001|Overall Study|computer error|0|||
126690850|NCT02183519|455822450|FG000|Overall Study|Did not respond to cough inducter|0|||
126690851|NCT02183519|455822451|FG001|Overall Study|Did not respond to cough inducter|3|||
126690852|NCT05702736|455822452|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
126690853|NCT05702736|455822453|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
126690854|NCT05702736|455822452|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
126690855|NCT05702736|455822453|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
126690856|NCT02937350|455822456|FG000|Overall Study|Withdrawal by Subject|0|||
126690857|NCT02937350|455822457|FG001|Overall Study|Withdrawal by Subject|1|||
126690858|NCT02937350|455822458|FG002|Overall Study|Withdrawal by Subject|0|||
126690859|NCT03110900|455822459|FG000|Overall Study|Sponsor withdrew|1|||
126690860|NCT03110900|455822460|FG001|Overall Study|Sponsor withdrew|1|||
126690861|NCT02320487|455822466|FG000|Overall Study|Reason not Specified|1|||
126690862|NCT02320487|455822466|FG000|Overall Study|Physician Decision|5|||
126690863|NCT02320487|455822466|FG000|Overall Study|Withdrawal by Subject|1|||
126690864|NCT02320487|455822466|FG000|Overall Study|Death|3|||
126690865|NCT02320487|455822466|FG000|Overall Study|Adverse Event|11|||
126690866|NCT00684957|455822470|FG000|Overall Study|Withdrawal by Subject|1|||
126690867|NCT00684957|455822471|FG001|Overall Study|Withdrawal by Subject|1|||
126690868|NCT00684957|455822470|FG000|Overall Study|Lost to Follow-up|1|||
126690869|NCT00684957|455822471|FG001|Overall Study|Lost to Follow-up|0|||
126690870|NCT04439175|455824031|FG000|Overall Study|Never started treatment|4|||
126690871|NCT04439175|455824031|FG000|Overall Study|Ineligible|5|||
126690872|NCT04439175|455824031|FG000|Overall Study|Adverse Event|6|||
126690873|NCT04439175|455824031|FG000|Overall Study|Death|4|||
126690874|NCT04439175|455824031|FG000|Overall Study|Disease progression|44|||
126690875|NCT04439175|455824031|FG000|Overall Study|Withdrawal by Subject|4|||
126441674|NCT03614156|454915337|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
126690876|NCT04439175|455824031|FG000|Overall Study|Alternative Therapy|1|||
126690877|NCT04439175|455824031|FG000|Overall Study|Other|2|||
126690878|NCT02554929|455824032|FG000|Overall Study|Lost to Follow-up|4|||
126353459|NCT01947933|454584466|FG002|Overall Study|Lost to Follow-up|0|||
126353460|NCT01947933|454584467|FG003|Overall Study|Lost to Follow-up|0|||
126353461|NCT01947933|454584468|FG004|Overall Study|Lost to Follow-up|0|||
126353462|NCT01947933|454584469|FG005|Overall Study|Lost to Follow-up|0|||
126690879|NCT02554929|455824033|FG001|Overall Study|Lost to Follow-up|4|||
126690880|NCT02554929|455824032|FG000|Overall Study|Withdrawal by Subject|2|||
126690881|NCT02554929|455824033|FG001|Overall Study|Withdrawal by Subject|8|||
126690882|NCT00546364|455824034|FG000|Overall Study|Disease progression|5|||
126690883|NCT00546364|455824035|FG001|Overall Study|Disease progression|11|||
126690884|NCT00546364|455824036|FG002|Overall Study|Disease progression|8|||
126690885|NCT00546364|455824034|FG000|Overall Study|Completed and off treatment|1|||
126690886|NCT00546364|455824035|FG001|Overall Study|Completed and off treatment|0|||
126690887|NCT00546364|455824036|FG002|Overall Study|Completed and off treatment|2|||
126690888|NCT00546364|455824034|FG000|Overall Study|Administrative reason by sponsor|1|||
126690889|NCT00546364|455824035|FG001|Overall Study|Administrative reason by sponsor|0|||
126690890|NCT00546364|455824036|FG002|Overall Study|Administrative reason by sponsor|0|||
126690891|NCT00546364|455824034|FG000|Overall Study|Poor compliance/noncompliance|0|||
126690892|NCT00546364|455824035|FG001|Overall Study|Poor compliance/noncompliance|0|||
126690893|NCT00546364|455824036|FG002|Overall Study|Poor compliance/noncompliance|1|||
126690894|NCT00546364|455824034|FG000|Overall Study|No longer meets study criteria|1|||
126690895|NCT00546364|455824035|FG001|Overall Study|No longer meets study criteria|1|||
126690896|NCT00546364|455824036|FG002|Overall Study|No longer meets study criteria|0|||
126690897|NCT00546364|455824034|FG000|Overall Study|Withdrawal by Subject|5|||
126690898|NCT00546364|455824035|FG001|Overall Study|Withdrawal by Subject|6|||
126690899|NCT00546364|455824036|FG002|Overall Study|Withdrawal by Subject|3|||
126690900|NCT00546364|455824034|FG000|Overall Study|Prior taxotere|1|||
126690901|NCT00546364|455824035|FG001|Overall Study|Prior taxotere|0|||
126690902|NCT00546364|455824036|FG002|Overall Study|Prior taxotere|0|||
126690903|NCT00546364|455824034|FG000|Overall Study|Mixed response|1|||
126760258|NCT02221882|456072436|FG002|Overall Study|Withdrawal by Subject|4|||
126760259|NCT02221882|456072437|FG003|Overall Study|Withdrawal by Subject|2|||
126760260|NCT02221882|456072438|FG004|Overall Study|Withdrawal by Subject|2|||
126760261|NCT02221882|456072439|FG005|Overall Study|Withdrawal by Subject|2|||
126760262|NCT02221882|456072434|FG000|Overall Study|Death|0|||
126353463|NCT01947933|454584470|FG006|Overall Study|Lost to Follow-up|0|||
126353464|NCT01947933|454584471|FG007|Overall Study|Lost to Follow-up|0|||
126353465|NCT01947933|454584472|FG008|Overall Study|Lost to Follow-up|1|||
126353466|NCT00294398|454584475|FG000|Overall Study|Lost to Follow-up|21|||
126353467|NCT00294398|454584476|FG001|Overall Study|Lost to Follow-up|26|||
126353468|NCT02965833|454584477|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
126353469|NCT02965833|454584478|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
126353470|NCT02965833|454584477|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
126353471|NCT02965833|454584478|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
126690904|NCT00546364|455824035|FG001|Overall Study|Mixed response|0|||
126690905|NCT00546364|455824036|FG002|Overall Study|Mixed response|0|||
126690906|NCT00546364|455824034|FG000|Overall Study|Palliative treatment|1|||
126760263|NCT02221882|456072435|FG001|Overall Study|Death|1|||
126441675|NCT03614156|454915338|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
126441676|NCT03614156|454915339|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
126441677|NCT03614156|454915336|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126441678|NCT03614156|454915337|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
126441679|NCT03614156|454915338|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
126441680|NCT03614156|454915339|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
126441681|NCT03614156|454915336|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
126441682|NCT03614156|454915337|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
126441683|NCT03614156|454915338|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
126441684|NCT03614156|454915339|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
126441685|NCT03614156|454915336|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
126441686|NCT03614156|454915337|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
126441687|NCT03614156|454915338|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
126441688|NCT03614156|454915339|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
126441689|NCT03614156|454915336|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
126441690|NCT03614156|454915337|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
126353472|NCT02965833|454584477|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
126353473|NCT02965833|454584478|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
126353474|NCT02965833|454584477|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
126353475|NCT02965833|454584478|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
126353476|NCT02965833|454584477|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
126353477|NCT02965833|454584478|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
126353478|NCT00118287|454584482|FG000|Overall Study|Intracranial haemorrhage|1|||
126353479|NCT00118287|454584482|FG000|Overall Study|Muscle pain|1|||
126353480|NCT03407482|454584483|FG000|Overall Study|Adverse Event|12|||
126441691|NCT03614156|454915338|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
126441692|NCT03614156|454915339|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
126441693|NCT03614156|454915336|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
126441694|NCT03614156|454915337|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
126441695|NCT03614156|454915338|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
126441696|NCT03614156|454915339|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
126441697|NCT03614156|454915336|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
126441698|NCT03614156|454915337|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
126441699|NCT03614156|454915338|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
126441700|NCT03614156|454915339|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
126441701|NCT03614156|454915336|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
126441702|NCT03614156|454915337|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
126441703|NCT03614156|454915338|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
126441704|NCT03614156|454915339|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
126441705|NCT03614156|454915336|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
126441706|NCT03614156|454915337|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
126441707|NCT03614156|454915338|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
126441708|NCT03614156|454915339|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
126441709|NCT04287517|454915341|FG000|Overall Study|Withdrawal by Subject|1|||
126441710|NCT04287517|454915342|FG001|Overall Study|Withdrawal by Subject|1|||
126441711|NCT03070964|454915343|FG000|Overall Study|Progressive disease|8|||
126441712|NCT03070964|454915343|FG000|Overall Study|Treatment-unrelated adverse event|2|||
126441713|NCT03070964|454915343|FG000|Overall Study|Never treated|1|||
126441714|NCT03070964|454915343|FG000|Overall Study|Physician Decision|1|||
126441715|NCT03070964|454915343|FG000|Overall Study|Withdrawal by Subject|1|||
126441716|NCT03070964|454915343|FG000|Overall Study|Adverse Event|1|||
126441717|NCT00834093|454915346|FG000|Overall Study|Progressive Disease|3|||
126441718|NCT00834093|454915346|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
126441719|NCT02745119|454915347|FG000|Overall Study|Adverse Event|1|||
126441720|NCT02745119|454915348|FG001|Overall Study|Adverse Event|0|||
126441721|NCT02745119|454915349|FG002|Overall Study|Adverse Event|1|||
126441722|NCT02745119|454915350|FG003|Overall Study|Adverse Event|3|||
126441723|NCT02745119|454915347|FG000|Overall Study|Death|3|||
126441724|NCT02745119|454915348|FG001|Overall Study|Death|3|||
126441725|NCT02745119|454915349|FG002|Overall Study|Death|0|||
126441726|NCT02745119|454915350|FG003|Overall Study|Death|4|||
126441727|NCT02745119|454915347|FG000|Overall Study|Lost to Follow-up|0|||
126441728|NCT02745119|454915348|FG001|Overall Study|Lost to Follow-up|0|||
126441729|NCT02745119|454915349|FG002|Overall Study|Lost to Follow-up|0|||
126441730|NCT02745119|454915350|FG003|Overall Study|Lost to Follow-up|1|||
126441731|NCT02745119|454915347|FG000|Overall Study|Protocol Deviation|0|||
126441732|NCT02745119|454915348|FG001|Overall Study|Protocol Deviation|0|||
126441733|NCT02745119|454915349|FG002|Overall Study|Protocol Deviation|0|||
126441734|NCT02745119|454915350|FG003|Overall Study|Protocol Deviation|1|||
126441735|NCT02745119|454915347|FG000|Overall Study|Withdrawal by Subject|7|||
126441736|NCT02745119|454915348|FG001|Overall Study|Withdrawal by Subject|15|||
126441737|NCT02745119|454915349|FG002|Overall Study|Withdrawal by Subject|8|||
126441738|NCT02745119|454915350|FG003|Overall Study|Withdrawal by Subject|14|||
126441739|NCT02745119|454915347|FG000|Overall Study|Study Terminated by Sponsor|134|||
126441740|NCT02745119|454915348|FG001|Overall Study|Study Terminated by Sponsor|252|||
126441741|NCT02745119|454915349|FG002|Overall Study|Study Terminated by Sponsor|135|||
126441742|NCT02745119|454915350|FG003|Overall Study|Study Terminated by Sponsor|251|||
126441743|NCT02745119|454915347|FG000|Overall Study|Physician Decision|0|||
126690907|NCT00546364|455824035|FG001|Overall Study|Palliative treatment|0|||
126690908|NCT00546364|455824036|FG002|Overall Study|Palliative treatment|1|||
126441744|NCT02745119|454915348|FG001|Overall Study|Physician Decision|2|||
126441745|NCT02745119|454915349|FG002|Overall Study|Physician Decision|2|||
126690909|NCT00546364|455824034|FG000|Overall Study|Target lesions resected|1|||
126441746|NCT02745119|454915350|FG003|Overall Study|Physician Decision|2|||
126441747|NCT02745119|454915347|FG000|Overall Study|Reason Not Specified|0|||
126441748|NCT02745119|454915348|FG001|Overall Study|Reason Not Specified|2|||
126441749|NCT02745119|454915349|FG002|Overall Study|Reason Not Specified|0|||
126441750|NCT02745119|454915350|FG003|Overall Study|Reason Not Specified|1|||
126441751|NCT01587924|454915351|FG000|Overall Study|Adverse Event|0|||
126441752|NCT01587924|454915352|FG001|Overall Study|Adverse Event|2|||
126353481|NCT03407482|454584483|FG000|Overall Study|Disease Relapse|1|||
126353482|NCT03407482|454584483|FG000|Overall Study|Lost to Follow-up|1|||
126353483|NCT03407482|454584483|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126353484|NCT03407482|454584483|FG000|Overall Study|Pregnancy|2|||
126353485|NCT03407482|454584483|FG000|Overall Study|Protocol Violation|1|||
126353486|NCT03407482|454584483|FG000|Overall Study|Study Terminated By Sponsor|106|||
126353487|NCT03407482|454584483|FG000|Overall Study|Withdrawal by Subject|6|||
126353488|NCT03407482|454584483|FG000|Overall Study|Data Entry Error|1|||
126353489|NCT03442569|454584486|FG000|Overall Study|Subject was ineligible after enrollment|1|||
126353490|NCT01214720|454584489|FG000|Overall Study|Alive and still on treatment|34|||
126353491|NCT01214720|454584490|FG001|Overall Study|Alive and still on treatment|18|||
126353492|NCT01214720|454584489|FG000|Overall Study|Alive and in follow-up|45|||
126353493|NCT01214720|454584490|FG001|Overall Study|Alive and in follow-up|48|||
126353494|NCT01214720|454584489|FG000|Overall Study|Lost to Follow-up|6|||
126353495|NCT01214720|454584490|FG001|Overall Study|Lost to Follow-up|2|||
126353496|NCT02347787|454584491|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
126353497|NCT02347787|454584492|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
126353498|NCT02347787|454584491|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
126353499|NCT02347787|454584492|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
126353500|NCT02347787|454584491|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
126353501|NCT02347787|454584492|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
126353502|NCT02347787|454584491|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
126353503|NCT02347787|454584492|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
126353504|NCT05643794|454585791|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
126353505|NCT05643794|454585792|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
126353506|NCT05643794|454585793|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
126353507|NCT05643794|454585791|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
126353508|NCT05643794|454585792|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126353509|NCT05643794|454585793|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126353510|NCT05643794|454585791|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
126353511|NCT05643794|454585792|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
126353512|NCT05643794|454585793|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
126353513|NCT05643794|454585791|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
126353514|NCT05643794|454585792|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
126353515|NCT05643794|454585793|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
126353516|NCT05643794|454585791|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
126353517|NCT05643794|454585792|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
126353518|NCT05643794|454585793|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
126441753|NCT01587924|454915353|FG002|Overall Study|Adverse Event|0|||
126441754|NCT01587924|454915354|FG003|Overall Study|Adverse Event|0|||
126441755|NCT01587924|454915351|FG000|Overall Study|Protocol Violation|2|||
126353519|NCT05643794|454585791|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
126353520|NCT05643794|454585792|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
126353521|NCT05643794|454585793|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
126353522|NCT01363076|454585798|FG000|Overall Study|Withdrawal by Subject|0|||
126353523|NCT01363076|454585799|FG001|Overall Study|Withdrawal by Subject|1|||
126353524|NCT04706403|454585800|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
126353525|NCT04706403|454585801|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
126353526|NCT04706403|454585802|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
126353527|NCT04706403|454585803|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
126353528|NCT04706403|454585804|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
126353529|NCT00182637|454585805|FG000|Overall Study|Adverse Event|2|||
126353530|NCT00182637|454585805|FG000|Overall Study|Disease Progression|1|||
126353531|NCT04766333|454585807|FG000|Overall Study|Lost to Follow-up|40|||
126353532|NCT04766333|454585808|FG001|Overall Study|Lost to Follow-up|826|||
126353533|NCT00639379|454585812|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
126353534|NCT00639379|454585813|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
126353535|NCT00639379|454585812|FG000|Period 1 - 2 Weeks|lens issue|3|||
126353536|NCT00639379|454585813|FG001|Period 1 - 2 Weeks|lens issue|0|||
126353537|NCT00723944|454585814|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
126353538|NCT00723944|454585815|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
126353539|NCT00723944|454585814|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
126353540|NCT00723944|454585815|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
126353541|NCT00723944|454585814|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
126353542|NCT00723944|454585815|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
126353543|NCT05177094|454585816|FG000|Overall Study|Adverse Event|5|||
126353544|NCT05177094|454585817|FG001|Overall Study|Adverse Event|5|||
126353545|NCT05177094|454585816|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
126353546|NCT05177094|454585817|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
126353547|NCT05177094|454585816|FG000|Overall Study|Protocol Deviation|3|||
126353548|NCT05177094|454585817|FG001|Overall Study|Protocol Deviation|0|||
126353549|NCT05177094|454585816|FG000|Overall Study|Withdrawal by Subject|6|||
126353550|NCT05177094|454585817|FG001|Overall Study|Withdrawal by Subject|3|||
126353551|NCT05177094|454585816|FG000|Overall Study|Participant could not tolerate long study visits|1|||
126353552|NCT05177094|454585817|FG001|Overall Study|Participant could not tolerate long study visits|0|||
126353553|NCT02400736|454585818|FG000|Overall Study|Lost to Follow-up|6|||
126353554|NCT02400736|454585819|FG001|Overall Study|Lost to Follow-up|6|||
126353555|NCT02400736|454585818|FG000|Overall Study|Withdrawal by Subject|2|||
126353556|NCT02400736|454585819|FG001|Overall Study|Withdrawal by Subject|1|||
126353557|NCT02400736|454585818|FG000|Overall Study|Moved from the area|3|||
126353558|NCT02400736|454585819|FG001|Overall Study|Moved from the area|1|||
126353559|NCT02383173|454585822|FG000|Overall Study|Palliative Care Team withdrew|0|||
126353560|NCT02383173|454585823|FG001|Overall Study|Palliative Care Team withdrew|2|||
126353561|NCT01297244|454585824|FG000|Overall Study|Progressive disease|22|||
126353562|NCT01297244|454585825|FG001|Overall Study|Progressive disease|3|||
126353563|NCT01297244|454585824|FG000|Overall Study|Adverse Event|9|||
126353564|NCT01297244|454585825|FG001|Overall Study|Adverse Event|1|||
126353565|NCT01297244|454585824|FG000|Overall Study|Death|1|||
126353566|NCT01297244|454585825|FG001|Overall Study|Death|1|||
126353567|NCT01297244|454585824|FG000|Overall Study|Clinical progression|1|||
126353568|NCT01297244|454585825|FG001|Overall Study|Clinical progression|1|||
126353569|NCT01297244|454585824|FG000|Overall Study|Withdrawal by Subject|2|||
126353570|NCT01297244|454585825|FG001|Overall Study|Withdrawal by Subject|0|||
126353571|NCT03677401|454585826|FG000|Overall Study|Adverse Event|4|||
126353572|NCT03677401|454585827|FG001|Overall Study|Adverse Event|14|||
126353573|NCT03677401|454585826|FG000|Overall Study|Lack of Efficacy|3|||
126353574|NCT03677401|454585827|FG001|Overall Study|Lack of Efficacy|1|||
126353575|NCT03677401|454585826|FG000|Overall Study|Withdrawal by Subject|2|||
126353576|NCT03677401|454585827|FG001|Overall Study|Withdrawal by Subject|2|||
126353577|NCT03677401|454585826|FG000|Overall Study|Sponsor decision|0|||
126353578|NCT03677401|454585827|FG001|Overall Study|Sponsor decision|1|||
126353579|NCT03677401|454585826|FG000|Overall Study|Reason Unspecified|1|||
126353580|NCT03677401|454585827|FG001|Overall Study|Reason Unspecified|0|||
126353581|NCT01177410|454585830|FG000|Overall Study|Adverse Event|0|||
126353582|NCT01177410|454585831|FG001|Overall Study|Adverse Event|2|||
126353583|NCT01177410|454585832|FG002|Overall Study|Adverse Event|2|||
126353584|NCT01177410|454585830|FG000|Overall Study|Withdrawal by Subject|1|||
126353585|NCT01177410|454585831|FG001|Overall Study|Withdrawal by Subject|4|||
126353586|NCT01177410|454585832|FG002|Overall Study|Withdrawal by Subject|3|||
126353587|NCT01177410|454585830|FG000|Overall Study|Lost to Follow-up|0|||
126441756|NCT01587924|454915352|FG001|Overall Study|Protocol Violation|1|||
126441757|NCT01587924|454915353|FG002|Overall Study|Protocol Violation|2|||
126441758|NCT01587924|454915354|FG003|Overall Study|Protocol Violation|1|||
126441759|NCT01587924|454915351|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
126441760|NCT01587924|454915352|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
126441761|NCT01587924|454915353|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
126441762|NCT01587924|454915354|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
126441763|NCT01587924|454915351|FG000|Overall Study|Withdrawal by Subject|0|||
126441764|NCT01587924|454915352|FG001|Overall Study|Withdrawal by Subject|1|||
126441765|NCT01587924|454915353|FG002|Overall Study|Withdrawal by Subject|1|||
126441766|NCT01587924|454915354|FG003|Overall Study|Withdrawal by Subject|0|||
126441767|NCT00432172|454915355|FG000|Overall Study|Physician Decision|0|||
126441768|NCT00432172|454915356|FG001|Overall Study|Physician Decision|0|||
126441769|NCT00432172|454915357|FG002|Overall Study|Physician Decision|2|||
126441770|NCT00432172|454915358|FG003|Overall Study|Physician Decision|0|||
126441771|NCT00432172|454915355|FG000|Overall Study|Adverse Event|4|||
126441772|NCT00432172|454915356|FG001|Overall Study|Adverse Event|2|||
126690910|NCT00546364|455824035|FG001|Overall Study|Target lesions resected|0|||
126690911|NCT00546364|455824036|FG002|Overall Study|Target lesions resected|0|||
126690912|NCT00546364|455824034|FG000|Overall Study|Physician Decision|0|||
126441773|NCT00432172|454915357|FG002|Overall Study|Adverse Event|4|||
126441774|NCT00432172|454915358|FG003|Overall Study|Adverse Event|3|||
126441775|NCT00432172|454915355|FG000|Overall Study|Disease progression|0|||
126441776|NCT00432172|454915356|FG001|Overall Study|Disease progression|2|||
126441777|NCT00432172|454915357|FG002|Overall Study|Disease progression|5|||
126441778|NCT00432172|454915358|FG003|Overall Study|Disease progression|1|||
126441779|NCT00432172|454915355|FG000|Overall Study|Withdrawal by Subject|0|||
126441780|NCT00432172|454915356|FG001|Overall Study|Withdrawal by Subject|1|||
126441781|NCT00432172|454915357|FG002|Overall Study|Withdrawal by Subject|0|||
126441782|NCT00432172|454915358|FG003|Overall Study|Withdrawal by Subject|2|||
126690913|NCT00546364|455824035|FG001|Overall Study|Physician Decision|0|||
126690914|NCT00546364|455824036|FG002|Overall Study|Physician Decision|1|||
126690915|NCT00546364|455824034|FG000|Overall Study|Sponsor decision|0|||
126690916|NCT00546364|455824035|FG001|Overall Study|Sponsor decision|0|||
126690917|NCT00546364|455824036|FG002|Overall Study|Sponsor decision|1|||
126690918|NCT00667576|455824037|FG000|Overall Study|Withdrawal by Subject|1|||
126690919|NCT00667576|455824038|FG001|Overall Study|Withdrawal by Subject|0|||
126690920|NCT00667576|455824039|FG002|Overall Study|Withdrawal by Subject|1|||
126690921|NCT00667576|455824040|FG003|Overall Study|Withdrawal by Subject|1|||
126690922|NCT00667576|455824041|FG004|Overall Study|Withdrawal by Subject|1|||
126690923|NCT00667576|455824037|FG000|Overall Study|Adverse Event|1|||
126690924|NCT00667576|455824038|FG001|Overall Study|Adverse Event|1|||
126690925|NCT00667576|455824039|FG002|Overall Study|Adverse Event|0|||
126690926|NCT00667576|455824040|FG003|Overall Study|Adverse Event|0|||
126690927|NCT00667576|455824041|FG004|Overall Study|Adverse Event|0|||
126690928|NCT00667576|455824037|FG000|Overall Study|Lost to Follow-up|0|||
126690929|NCT00667576|455824038|FG001|Overall Study|Lost to Follow-up|0|||
126441783|NCT00432172|454915355|FG000|Overall Study|No treatment received|2|||
126441784|NCT00432172|454915356|FG001|Overall Study|No treatment received|2|||
126441785|NCT00432172|454915357|FG002|Overall Study|No treatment received|0|||
126441786|NCT00432172|454915358|FG003|Overall Study|No treatment received|1|||
126441787|NCT02425943|454915359|FG000|Overall Study|Adverse Event|3|||
126441788|NCT02425943|454915360|FG001|Overall Study|Adverse Event|1|||
126441789|NCT02425943|454915359|FG000|Overall Study|Lost to Follow-up|59|||
126441790|NCT02425943|454915360|FG001|Overall Study|Lost to Follow-up|37|||
126441791|NCT02425943|454915359|FG000|Overall Study|Protocol Violation|4|||
126690930|NCT00667576|455824039|FG002|Overall Study|Lost to Follow-up|1|||
126690931|NCT00667576|455824040|FG003|Overall Study|Lost to Follow-up|0|||
126441792|NCT02425943|454915360|FG001|Overall Study|Protocol Violation|1|||
126441793|NCT02425943|454915359|FG000|Overall Study|Withdrawal by Subject|64|||
126441794|NCT02425943|454915360|FG001|Overall Study|Withdrawal by Subject|31|||
126441795|NCT02425943|454915359|FG000|Overall Study|Other|6|||
126690932|NCT00667576|455824041|FG004|Overall Study|Lost to Follow-up|0|||
126690933|NCT00667576|455824037|FG000|Overall Study|Protocol Violation|0|||
126690934|NCT00667576|455824038|FG001|Overall Study|Protocol Violation|0|||
126690935|NCT00667576|455824039|FG002|Overall Study|Protocol Violation|0|||
126690936|NCT00667576|455824040|FG003|Overall Study|Protocol Violation|1|||
126690937|NCT00667576|455824041|FG004|Overall Study|Protocol Violation|0|||
126690938|NCT00667576|455824037|FG000|Overall Study|Physician Decision|0|||
126690939|NCT00667576|455824038|FG001|Overall Study|Physician Decision|0|||
126690940|NCT00667576|455824039|FG002|Overall Study|Physician Decision|0|||
126690941|NCT00667576|455824040|FG003|Overall Study|Physician Decision|1|||
126690942|NCT00667576|455824041|FG004|Overall Study|Physician Decision|0|||
126690943|NCT00667576|455824037|FG000|Overall Study|Missed Visit|0|||
126690944|NCT00667576|455824038|FG001|Overall Study|Missed Visit|0|||
126690945|NCT00667576|455824039|FG002|Overall Study|Missed Visit|0|||
126690946|NCT00667576|455824040|FG003|Overall Study|Missed Visit|1|||
126690947|NCT00667576|455824041|FG004|Overall Study|Missed Visit|0|||
126690948|NCT01390389|455824042|FG000|Overall Study|Withdrawal by Subject|2|||
126690949|NCT01390389|455824043|FG001|Overall Study|Withdrawal by Subject|0|||
126690950|NCT01390389|455824042|FG000|Overall Study|Screen Fail|2|||
126690951|NCT01390389|455824043|FG001|Overall Study|Screen Fail|1|||
126690952|NCT02002975|455824044|FG000|Overall Study|Case Report Forms Uncollected|135|||
126690953|NCT02002975|455824044|FG000|Overall Study|Protocol Deviation|437|||
126690954|NCT00772629|455824045|FG000|Overall Study|Subject was not vaccinated|1|||
126690955|NCT00772629|455824046|FG001|Overall Study|Subject was not vaccinated|0|||
126690956|NCT05162066|455824050|FG000|Overall Study|Adverse Event|1|||
126690957|NCT05162066|455824051|FG001|Overall Study|Adverse Event|0|||
126690958|NCT05162066|455824052|FG002|Overall Study|Adverse Event|0|||
126690959|NCT05162066|455824050|FG000|Overall Study|Perceived lack of efficacy|1|||
126690960|NCT05162066|455824051|FG001|Overall Study|Perceived lack of efficacy|0|||
126690961|NCT05162066|455824052|FG002|Overall Study|Perceived lack of efficacy|0|||
126690962|NCT01072344|455824053|FG000|Overall Study|Relasped-reached end point|7|||
126690963|NCT01072344|455824054|FG001|Overall Study|Relasped-reached end point|12|||
126690964|NCT01072344|455824053|FG000|Overall Study|Protocol Violation|1|||
126690965|NCT01072344|455824054|FG001|Overall Study|Protocol Violation|2|||
126690966|NCT01072344|455824053|FG000|Overall Study|Lost to Follow-up|3|||
126690967|NCT01072344|455824054|FG001|Overall Study|Lost to Follow-up|4|||
126690968|NCT01871090|455824055|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
126690969|NCT01871090|455824056|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
126690970|NCT01871090|455824055|FG000|Overall Study|Interrogation not completed correctly|1|||
126690971|NCT01871090|455824056|FG001|Overall Study|Interrogation not completed correctly|0|||
126690972|NCT01871090|455824055|FG000|Overall Study|Subject Non-Compliance|0|||
126690973|NCT01871090|455824056|FG001|Overall Study|Subject Non-Compliance|1|||
126690974|NCT03569202|455824066|FG000|Part 3|Physician Decision|1|||
126690975|NCT03569202|455824067|FG001|Part 3|Physician Decision|0|||
126441796|NCT02425943|454915360|FG001|Overall Study|Other|0|||
126441797|NCT01106248|454915362|FG000|Overall Study|Adverse Event|1|||
126441798|NCT01106248|454915362|FG000|Overall Study|Administrative|2|||
126441799|NCT00357903|454915363|FG000|Overall Study|Adverse Event|87|||
126441800|NCT00357903|454915364|FG001|Overall Study|Adverse Event|4|||
126441801|NCT00357903|454915363|FG000|Overall Study|Death|33|||
126441802|NCT00357903|454915364|FG001|Overall Study|Death|0|||
126441803|NCT00357903|454915363|FG000|Overall Study|Lost to Follow-up|23|||
126441804|NCT00357903|454915364|FG001|Overall Study|Lost to Follow-up|4|||
126441805|NCT00357903|454915363|FG000|Overall Study|Physician Decision|39|||
126441806|NCT00357903|454915364|FG001|Overall Study|Physician Decision|5|||
126441807|NCT00357903|454915363|FG000|Overall Study|Withdrawal by Subject|57|||
126441808|NCT00357903|454915364|FG001|Overall Study|Withdrawal by Subject|7|||
126441809|NCT00357903|454915363|FG000|Overall Study|Completed month 12 only|0|||
126441810|NCT00357903|454915364|FG001|Overall Study|Completed month 12 only|1|||
126441811|NCT00357903|454915363|FG000|Overall Study|Protocol issues|14|||
126441812|NCT00357903|454915364|FG001|Overall Study|Protocol issues|3|||
126441813|NCT00357903|454915363|FG000|Overall Study|Response status|61|||
126441814|NCT00357903|454915364|FG001|Overall Study|Response status|9|||
126441815|NCT00357903|454915363|FG000|Overall Study|Other|49|||
126441816|NCT00357903|454915364|FG001|Overall Study|Other|10|||
126441817|NCT00606593|454915365|FG000|Overall Study|Adverse Event|0|||
126441818|NCT00606593|454915366|FG001|Overall Study|Adverse Event|0|||
126441819|NCT00606593|454915367|FG002|Overall Study|Adverse Event|0|||
126441820|NCT00606593|454915368|FG003|Overall Study|Adverse Event|1|||
126441821|NCT00606593|454915369|FG004|Overall Study|Adverse Event|1|||
126441822|NCT00606593|454915370|FG005|Overall Study|Adverse Event|0|||
126690976|NCT03569202|455824066|FG000|Part 3|Other|1|||
126690977|NCT03569202|455824067|FG001|Part 3|Other|1|||
126690978|NCT00420511|455824068|FG000|Overall Study|Adverse Event|1|||
126690979|NCT00420511|455824069|FG001|Overall Study|Adverse Event|1|||
126441823|NCT00606593|454915371|FG006|Overall Study|Adverse Event|1|||
126441824|NCT00606593|454915372|FG007|Overall Study|Adverse Event|2|||
126690980|NCT00420511|455824068|FG000|Overall Study|Lost to Follow-up|1|||
126690981|NCT00420511|455824069|FG001|Overall Study|Lost to Follow-up|0|||
126690982|NCT02415712|455824070|FG000|Overall Study|Protocol Violation|16|||
126690983|NCT01668654|455824071|FG000|Overall Study|Study Closed/Terminated|3|||
126690984|NCT01668654|455824071|FG000|Overall Study|Withdrawal by Subject|1|||
126441825|NCT00606593|454915373|FG008|Overall Study|Adverse Event|1|||
126690985|NCT04557384|455824072|FG000|Overall Study|Study Terminated by Sponsor|1|||
126690986|NCT04557384|455824072|FG000|Overall Study|Death|1|||
126441826|NCT00606593|454915374|FG009|Overall Study|Adverse Event|0|||
126441827|NCT00606593|454915365|FG000|Overall Study|Withdrawal of consent|1|||
126441828|NCT00606593|454915366|FG001|Overall Study|Withdrawal of consent|0|||
126441829|NCT00606593|454915367|FG002|Overall Study|Withdrawal of consent|1|||
126441830|NCT00606593|454915368|FG003|Overall Study|Withdrawal of consent|0|||
126690987|NCT02397473|455824074|FG000|Treatment Phase|Adverse Event|1|||
126441831|NCT00606593|454915369|FG004|Overall Study|Withdrawal of consent|0|||
126441832|NCT00606593|454915370|FG005|Overall Study|Withdrawal of consent|0|||
126441833|NCT00606593|454915371|FG006|Overall Study|Withdrawal of consent|0|||
126441834|NCT00606593|454915372|FG007|Overall Study|Withdrawal of consent|0|||
126441835|NCT00606593|454915373|FG008|Overall Study|Withdrawal of consent|0|||
126441836|NCT00606593|454915374|FG009|Overall Study|Withdrawal of consent|0|||
126441837|NCT00606593|454915365|FG000|Overall Study|Administrative/Other|0|||
126441838|NCT00606593|454915366|FG001|Overall Study|Administrative/Other|0|||
126441839|NCT00606593|454915367|FG002|Overall Study|Administrative/Other|1|||
126441840|NCT00606593|454915368|FG003|Overall Study|Administrative/Other|0|||
126441841|NCT00606593|454915369|FG004|Overall Study|Administrative/Other|0|||
126441842|NCT00606593|454915370|FG005|Overall Study|Administrative/Other|0|||
126441843|NCT00606593|454915371|FG006|Overall Study|Administrative/Other|0|||
126441844|NCT00606593|454915372|FG007|Overall Study|Administrative/Other|0|||
126441845|NCT00606593|454915373|FG008|Overall Study|Administrative/Other|0|||
126441846|NCT00606593|454915374|FG009|Overall Study|Administrative/Other|0|||
126441847|NCT03181529|454915377|FG000|Overall Study|Withdrawal by Subject|1|||
126441848|NCT03181529|454915378|FG001|Overall Study|Withdrawal by Subject|1|||
126441849|NCT03181529|454915377|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
126441850|NCT03181529|454915378|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
126441851|NCT06042855|454915385|FG000|Overall Study|No Receipt of Study Drug|48|||
126441852|NCT06042855|454915386|FG001|Overall Study|No Receipt of Study Drug|57|||
126441853|NCT06042855|454915385|FG000|Overall Study|Administratively Withdrawn|59|||
126441854|NCT06042855|454915386|FG001|Overall Study|Administratively Withdrawn|59|||
126441855|NCT03313037|454915387|FG000|Overall Study|Protocol Violation|4|||
126441856|NCT03313037|454915388|FG001|Overall Study|Protocol Violation|1|||
126441857|NCT03313037|454915387|FG000|Overall Study|Other|1|||
126441858|NCT03313037|454915388|FG001|Overall Study|Other|1|||
126441859|NCT03313037|454915387|FG000|Overall Study|Withdrawal by Subject|4|||
126441860|NCT03313037|454915388|FG001|Overall Study|Withdrawal by Subject|3|||
126441861|NCT03313037|454915387|FG000|Overall Study|No longer meets eligibility criteria|1|||
126441862|NCT03313037|454915388|FG001|Overall Study|No longer meets eligibility criteria|7|||
126441863|NCT03313037|454915387|FG000|Overall Study|Lost to Follow-up|9|||
126441864|NCT03313037|454915388|FG001|Overall Study|Lost to Follow-up|8|||
126441865|NCT03313037|454915387|FG000|Overall Study|Randomized but not treated|1|||
126441866|NCT03313037|454915388|FG001|Overall Study|Randomized but not treated|0|||
126441867|NCT02379091|454915389|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126441868|NCT02379091|454915390|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
126441869|NCT02379091|454915391|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
126690988|NCT02397473|455824075|FG001|Treatment Phase|Adverse Event|2|||
126690989|NCT02397473|455824074|FG000|Treatment Phase|Lack of Efficacy|8|||
126690990|NCT02397473|455824075|FG001|Treatment Phase|Lack of Efficacy|1|||
126441870|NCT02379091|454915392|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
126441871|NCT02379091|454915389|FG000|Overall Study|Principal Investigator Discretion|0|||
126441872|NCT02379091|454915390|FG001|Overall Study|Principal Investigator Discretion|1|||
126441873|NCT02379091|454915391|FG002|Overall Study|Principal Investigator Discretion|0|||
126441874|NCT02379091|454915392|FG003|Overall Study|Principal Investigator Discretion|0|||
126441875|NCT02379091|454915389|FG000|Overall Study|Lost to Follow-up|0|||
126441876|NCT02379091|454915390|FG001|Overall Study|Lost to Follow-up|0|||
126441877|NCT02379091|454915391|FG002|Overall Study|Lost to Follow-up|0|||
126441878|NCT02379091|454915392|FG003|Overall Study|Lost to Follow-up|1|||
126441879|NCT02379091|454915389|FG000|Overall Study|Voluntary Withdrawal|2|||
126441880|NCT02379091|454915390|FG001|Overall Study|Voluntary Withdrawal|5|||
126441881|NCT02379091|454915391|FG002|Overall Study|Voluntary Withdrawal|2|||
126441882|NCT02379091|454915392|FG003|Overall Study|Voluntary Withdrawal|4|||
126441883|NCT02379091|454915389|FG000|Overall Study|Study Termination|7|||
126441884|NCT02379091|454915390|FG001|Overall Study|Study Termination|2|||
126441885|NCT02379091|454915391|FG002|Overall Study|Study Termination|5|||
126441886|NCT02379091|454915392|FG003|Overall Study|Study Termination|8|||
126441887|NCT02379091|454915389|FG000|Overall Study|Lack of Efficacy|3|||
126441888|NCT02379091|454915390|FG001|Overall Study|Lack of Efficacy|0|||
126441889|NCT02379091|454915391|FG002|Overall Study|Lack of Efficacy|0|||
126441890|NCT02379091|454915392|FG003|Overall Study|Lack of Efficacy|0|||
126441891|NCT02129699|454915395|FG000|Overall Study|Did not start treatment|3|||
126441892|NCT02129699|454915396|FG001|Overall Study|Did not start treatment|2|||
126441893|NCT01076361|454915400|FG000|Overall Study|22 leads were excluded from analysis|21|||
126441894|NCT04801420|454915406|FG000|Overall Study|Other|1|||
126441895|NCT04801420|454915407|FG001|Overall Study|Other|2|||
126441896|NCT04801420|454915408|FG002|Overall Study|Other|1|||
126441897|NCT04801420|454915406|FG000|Overall Study|Lost to Follow-up|7|||
126441898|NCT04801420|454915407|FG001|Overall Study|Lost to Follow-up|9|||
126441899|NCT04801420|454915408|FG002|Overall Study|Lost to Follow-up|10|||
126441900|NCT04801420|454915406|FG000|Overall Study|Moved from study area|0|||
126441901|NCT04801420|454915407|FG001|Overall Study|Moved from study area|1|||
126441902|NCT04801420|454915408|FG002|Overall Study|Moved from study area|1|||
126441903|NCT04801420|454915406|FG000|Overall Study|Withdrawal by Subject|5|||
126441904|NCT04801420|454915407|FG001|Overall Study|Withdrawal by Subject|1|||
126441905|NCT04801420|454915408|FG002|Overall Study|Withdrawal by Subject|4|||
126441906|NCT04801420|454915406|FG000|Overall Study|Individual stopping criteria reached|0|||
126441907|NCT04801420|454915407|FG001|Overall Study|Individual stopping criteria reached|1|||
126441908|NCT04801420|454915408|FG002|Overall Study|Individual stopping criteria reached|0|||
126441909|NCT04801420|454915406|FG000|Overall Study|Ongoing in the study|195|||
126441910|NCT04801420|454915407|FG001|Overall Study|Ongoing in the study|195|||
126441911|NCT04801420|454915408|FG002|Overall Study|Ongoing in the study|192|||
126441912|NCT04774094|454915409|FG000|Overall Study|Other|2|||
126441913|NCT04774094|454915409|FG000|Overall Study|Withdrawal by Subject|9|||
126441914|NCT04774094|454915409|FG000|Overall Study|Lost to Follow-up|7|||
126441915|NCT04774094|454915409|FG000|Overall Study|Lack of Efficacy|5|||
126441916|NCT04774094|454915409|FG000|Overall Study|Death|17|||
126441917|NCT04774094|454915409|FG000|Overall Study|Adverse Event|4|||
126441918|NCT00892099|454916872|FG000|Overall Study|Death|1|||
126441919|NCT00892099|454916873|FG001|Overall Study|Death|0|||
126441920|NCT00892099|454916874|FG002|Overall Study|Death|1|||
126441921|NCT00892099|454916872|FG000|Overall Study|Adverse Event|1|||
126441922|NCT00892099|454916873|FG001|Overall Study|Adverse Event|0|||
126441923|NCT00892099|454916874|FG002|Overall Study|Adverse Event|0|||
126441924|NCT00892099|454916872|FG000|Overall Study|replocated|1|||
126441925|NCT00892099|454916873|FG001|Overall Study|replocated|0|||
126441926|NCT00892099|454916874|FG002|Overall Study|replocated|2|||
126441927|NCT00892099|454916872|FG000|Overall Study|Prolonged hospitalization|1|||
126441928|NCT00892099|454916873|FG001|Overall Study|Prolonged hospitalization|0|||
126441929|NCT00892099|454916874|FG002|Overall Study|Prolonged hospitalization|1|||
126441930|NCT00892099|454916872|FG000|Overall Study|no further details|1|||
126441931|NCT00892099|454916873|FG001|Overall Study|no further details|0|||
126441932|NCT00892099|454916874|FG002|Overall Study|no further details|1|||
126441933|NCT00892099|454916872|FG000|Overall Study|kidney function recovered|0|||
126441934|NCT00892099|454916873|FG001|Overall Study|kidney function recovered|1|||
126441935|NCT00892099|454916874|FG002|Overall Study|kidney function recovered|0|||
126441936|NCT00892099|454916872|FG000|Overall Study|investigator decision|0|||
126441937|NCT00892099|454916873|FG001|Overall Study|investigator decision|0|||
126441938|NCT00892099|454916874|FG002|Overall Study|investigator decision|1|||
126441939|NCT00892099|454916872|FG000|Overall Study|Lost to Follow-up|0|||
126441940|NCT00892099|454916873|FG001|Overall Study|Lost to Follow-up|0|||
126441941|NCT00892099|454916874|FG002|Overall Study|Lost to Follow-up|1|||
126441942|NCT01657019|454916875|FG000|Overall Study|Withdrawal by Subject|65|||
126441943|NCT01657019|454916875|FG000|Overall Study|Adverse Event|55|||
126441944|NCT01657019|454916875|FG000|Overall Study|Lost to Follow-up|48|||
126441945|NCT01657019|454916875|FG000|Overall Study|Protocol Violation|6|||
126441946|NCT01657019|454916875|FG000|Overall Study|Lack of Efficacy|3|||
126441947|NCT01657019|454916875|FG000|Overall Study|Other|58|||
126441948|NCT00998296|454916878|FG000|Overall Study|Progressive disease|0|||
126441949|NCT00998296|454916879|FG001|Overall Study|Progressive disease|1|||
126441950|NCT00998296|454916880|FG002|Overall Study|Progressive disease|0|||
126441951|NCT00998296|454916881|FG003|Overall Study|Progressive disease|0|||
126441952|NCT00998296|454916882|FG004|Overall Study|Progressive disease|0|||
126441953|NCT00998296|454916883|FG005|Overall Study|Progressive disease|0|||
126441954|NCT00998296|454916884|FG006|Overall Study|Progressive disease|1|||
126441955|NCT00998296|454916885|FG007|Overall Study|Progressive disease|0|||
126441956|NCT00998296|454916886|FG008|Overall Study|Progressive disease|0|||
126441957|NCT00998296|454916887|FG009|Overall Study|Progressive disease|14|||
126441958|NCT00998296|454916888|FG010|Overall Study|Progressive disease|5|||
126441959|NCT00998296|454916878|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
126441960|NCT00998296|454916879|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
126441961|NCT00998296|454916880|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
126441962|NCT00998296|454916881|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
126441963|NCT00998296|454916882|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
126441964|NCT00998296|454916883|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
126441965|NCT00998296|454916884|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
126690991|NCT02397473|455824074|FG000|Treatment Phase|Lost to Follow-up|1|||
126690992|NCT02397473|455824075|FG001|Treatment Phase|Lost to Follow-up|0|||
126690993|NCT02397473|455824074|FG000|Treatment Phase|Withdrawal by Subject|2|||
126690994|NCT02397473|455824075|FG001|Treatment Phase|Withdrawal by Subject|1|||
126690995|NCT02397473|455824074|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
126690996|NCT02397473|455824075|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
126690997|NCT02397473|455824074|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
126690998|NCT02397473|455824075|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
126353588|NCT01177410|454585831|FG001|Overall Study|Lost to Follow-up|1|||
126353589|NCT01177410|454585832|FG002|Overall Study|Lost to Follow-up|0|||
126353590|NCT00875667|454585836|FG000|Overall Study|Adverse Event|29|||
126353591|NCT00875667|454585837|FG001|Overall Study|Adverse Event|10|||
126353592|NCT00875667|454585836|FG000|Overall Study|Withdrawal by Subject|17|||
126353593|NCT00875667|454585837|FG001|Overall Study|Withdrawal by Subject|5|||
126353594|NCT00875667|454585836|FG000|Overall Study|Death|7|||
126353595|NCT00875667|454585837|FG001|Overall Study|Death|2|||
126353596|NCT00875667|454585836|FG000|Overall Study|Protocol Violation|2|||
126353597|NCT00875667|454585837|FG001|Overall Study|Protocol Violation|0|||
126353598|NCT00875667|454585836|FG000|Overall Study|Disease Progression|100|||
126353599|NCT00875667|454585837|FG001|Overall Study|Disease Progression|49|||
126353600|NCT00875667|454585836|FG000|Overall Study|Miscellaneous|12|||
126353601|NCT00875667|454585837|FG001|Overall Study|Miscellaneous|6|||
126353602|NCT00875667|454585836|FG000|Overall Study|Randomized but no Study Drug Given|3|||
126353603|NCT00875667|454585837|FG001|Overall Study|Randomized but no Study Drug Given|1|||
126353604|NCT00894647|454585838|FG000|Overall Study|Adverse Event|5|||
126441966|NCT00998296|454916885|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
126441967|NCT00998296|454916886|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
126441968|NCT00998296|454916887|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
126441969|NCT00998296|454916888|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
126441970|NCT00998296|454916878|FG000|Overall Study|Other adverse event|0|||
126441971|NCT00998296|454916879|FG001|Overall Study|Other adverse event|0|||
126441972|NCT00998296|454916880|FG002|Overall Study|Other adverse event|0|||
126441973|NCT00998296|454916881|FG003|Overall Study|Other adverse event|0|||
126441974|NCT00998296|454916882|FG004|Overall Study|Other adverse event|1|||
126441975|NCT00998296|454916883|FG005|Overall Study|Other adverse event|0|||
126690999|NCT02397473|455824074|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
126691000|NCT02397473|455824075|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
126691001|NCT02397473|455824074|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
126691002|NCT02397473|455824075|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
126760264|NCT02221882|456072436|FG002|Overall Study|Death|0|||
126353605|NCT00894647|454585839|FG001|Overall Study|Adverse Event|4|||
126353606|NCT00894647|454585838|FG000|Overall Study|Withdrawal by Subject|4|||
126353607|NCT00894647|454585839|FG001|Overall Study|Withdrawal by Subject|4|||
126353608|NCT00894647|454585838|FG000|Overall Study|Lost to Follow-up|0|||
126353609|NCT00894647|454585839|FG001|Overall Study|Lost to Follow-up|2|||
126353610|NCT00894647|454585838|FG000|Overall Study|Non-compliance with study procedures|0|||
126353611|NCT00894647|454585839|FG001|Overall Study|Non-compliance with study procedures|2|||
126353612|NCT00894647|454585838|FG000|Overall Study|Other, not due to AE|1|||
126353613|NCT00894647|454585839|FG001|Overall Study|Other, not due to AE|2|||
126353614|NCT02143778|454585845|FG000|Overall Study|Withdrawal by Subject|2|||
126353615|NCT02143778|454585845|FG000|Overall Study|Device malfunction|1|||
126353616|NCT00625378|454585847|FG000|Overall Study|Adverse Event|22|||
126353617|NCT00625378|454585848|FG001|Overall Study|Adverse Event|0|||
126353618|NCT00625378|454585847|FG000|Overall Study|Withdrawal by Subject|16|||
126353619|NCT00625378|454585848|FG001|Overall Study|Withdrawal by Subject|0|||
126353620|NCT00625378|454585847|FG000|Overall Study|Death|38|||
126353621|NCT00625378|454585848|FG001|Overall Study|Death|0|||
126353622|NCT00625378|454585847|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
126353623|NCT00625378|454585848|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
126353624|NCT00625378|454585847|FG000|Overall Study|Lost to Follow-up|17|||
126353625|NCT00625378|454585848|FG001|Overall Study|Lost to Follow-up|0|||
126353626|NCT00625378|454585847|FG000|Overall Study|Non-compliant with study medication|3|||
126353627|NCT00625378|454585848|FG001|Overall Study|Non-compliant with study medication|0|||
126353628|NCT00625378|454585847|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
126353629|NCT00625378|454585848|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
126353630|NCT00625378|454585847|FG000|Overall Study|Medical decision|1|||
126353631|NCT00625378|454585848|FG001|Overall Study|Medical decision|0|||
126353632|NCT00625378|454585847|FG000|Overall Study|Multiple toxicities|1|||
126353633|NCT00625378|454585848|FG001|Overall Study|Multiple toxicities|0|||
126353634|NCT00625378|454585847|FG000|Overall Study|New cancer|1|||
126353635|NCT00625378|454585848|FG001|Overall Study|New cancer|0|||
126353636|NCT00625378|454585847|FG000|Overall Study|PTA program|2|||
126353637|NCT00625378|454585848|FG001|Overall Study|PTA program|0|||
126353638|NCT00625378|454585847|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
126353639|NCT00625378|454585848|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
126353640|NCT00625378|454585847|FG000|Overall Study|Sponsor decision|1|||
126353641|NCT00625378|454585848|FG001|Overall Study|Sponsor decision|0|||
126353642|NCT00625378|454585847|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
126353643|NCT00625378|454585848|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
126353644|NCT00625378|454585847|FG000|Overall Study|Switch to commercial drug|6|||
126441976|NCT00998296|454916884|FG006|Overall Study|Other adverse event|0|||
126441977|NCT00998296|454916885|FG007|Overall Study|Other adverse event|0|||
126441978|NCT00998296|454916886|FG008|Overall Study|Other adverse event|0|||
126441979|NCT00998296|454916887|FG009|Overall Study|Other adverse event|1|||
126441980|NCT00998296|454916888|FG010|Overall Study|Other adverse event|2|||
126441981|NCT00998296|454916878|FG000|Overall Study|Refused to continue taking trial med.|0|||
126441982|NCT00998296|454916879|FG001|Overall Study|Refused to continue taking trial med.|0|||
126441983|NCT00998296|454916880|FG002|Overall Study|Refused to continue taking trial med.|0|||
126441984|NCT00998296|454916881|FG003|Overall Study|Refused to continue taking trial med.|0|||
126441985|NCT00998296|454916882|FG004|Overall Study|Refused to continue taking trial med.|0|||
126441986|NCT00998296|454916883|FG005|Overall Study|Refused to continue taking trial med.|0|||
126441987|NCT00998296|454916884|FG006|Overall Study|Refused to continue taking trial med.|0|||
126441988|NCT00998296|454916885|FG007|Overall Study|Refused to continue taking trial med.|0|||
126441989|NCT00998296|454916886|FG008|Overall Study|Refused to continue taking trial med.|0|||
126441990|NCT00998296|454916887|FG009|Overall Study|Refused to continue taking trial med.|2|||
126441991|NCT00998296|454916888|FG010|Overall Study|Refused to continue taking trial med.|0|||
126441992|NCT00998296|454916878|FG000|Overall Study|Reason other than those specified above|0|||
126441993|NCT00998296|454916879|FG001|Overall Study|Reason other than those specified above|0|||
126441994|NCT00998296|454916880|FG002|Overall Study|Reason other than those specified above|0|||
126441995|NCT00998296|454916881|FG003|Overall Study|Reason other than those specified above|0|||
126441996|NCT00998296|454916882|FG004|Overall Study|Reason other than those specified above|0|||
126441997|NCT00998296|454916883|FG005|Overall Study|Reason other than those specified above|0|||
126441998|NCT00998296|454916884|FG006|Overall Study|Reason other than those specified above|0|||
126441999|NCT00998296|454916885|FG007|Overall Study|Reason other than those specified above|0|||
126442000|NCT00998296|454916886|FG008|Overall Study|Reason other than those specified above|0|||
126442001|NCT00998296|454916887|FG009|Overall Study|Reason other than those specified above|1|||
126442002|NCT00998296|454916888|FG010|Overall Study|Reason other than those specified above|0|||
126442003|NCT02346721|454916889|FG000|Overall Study|Withdrew Consent|3|||
126442004|NCT02346721|454916889|FG000|Overall Study|Lack of Efficacy|1|||
126442005|NCT04396639|454916892|FG000|Overall Study|Withdrawal by Subject|1|||
126442006|NCT04396639|454916892|FG000|Overall Study|Other|1|||
126442007|NCT01544335|454916893|FG000|Overall Study|Lost to Follow-up|27|||
126442008|NCT01544335|454916893|FG000|Overall Study|Death|4|||
126442009|NCT01544335|454916893|FG000|Overall Study|Disease progression|3|||
126442010|NCT01544335|454916893|FG000|Overall Study|Baseline Measurements not Available|19|||
126442011|NCT01532986|454916896|FG000|Overall Study|Death|9|||
126442012|NCT01532986|454916897|FG001|Overall Study|Death|9|||
126442013|NCT01532986|454916896|FG000|Overall Study|Withdrawal by Subject|7|||
126442014|NCT01532986|454916897|FG001|Overall Study|Withdrawal by Subject|10|||
126691003|NCT02397473|455824074|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
126353645|NCT00625378|454585848|FG001|Overall Study|Switch to commercial drug|1|||
126353646|NCT00625378|454585847|FG000|Overall Study|Missing|2|||
126353647|NCT00625378|454585848|FG001|Overall Study|Missing|0|||
126353648|NCT00625378|454585847|FG000|Overall Study|End of treatment not available|2|||
126353649|NCT00625378|454585848|FG001|Overall Study|End of treatment not available|0|||
126353650|NCT00625378|454585847|FG000|Overall Study|Never treated|2|||
126353651|NCT00625378|454585848|FG001|Overall Study|Never treated|0|||
126353652|NCT02639559|454585850|FG000|Overall Study|Mobilization failure|0|||
126353653|NCT02639559|454585851|FG001|Overall Study|Mobilization failure|3|||
126353654|NCT02639559|454585850|FG000|Overall Study|Issues with vascular acess|1|||
126353655|NCT02639559|454585851|FG001|Overall Study|Issues with vascular acess|0|||
126353656|NCT03880565|454585852|FG000|Overall Study|Withdrawal by Subject|1|||
126353657|NCT03880565|454585853|FG001|Overall Study|Withdrawal by Subject|0|||
126353658|NCT02969018|454585858|FG000|Overall Study|Adverse Event|2|||
126353659|NCT02969018|454585859|FG001|Overall Study|Adverse Event|4|||
126691004|NCT02397473|455824075|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
126691005|NCT01337973|455824076|FG000|Overall Study|Lost to Follow-up|2|||
126353660|NCT02969018|454585860|FG002|Overall Study|Adverse Event|1|||
126353661|NCT02969018|454585861|FG003|Overall Study|Adverse Event|2|||
126353662|NCT02969018|454585862|FG004|Overall Study|Adverse Event|0|||
126353663|NCT02969018|454585863|FG005|Overall Study|Adverse Event|1|||
126442015|NCT01532986|454916896|FG000|Overall Study|Physician Decision|7|||
126442016|NCT01532986|454916897|FG001|Overall Study|Physician Decision|5|||
126442017|NCT04614974|454916898|FG000|Overall Study|Lost to Follow-up|14|||
126442018|NCT04614974|454916899|FG001|Overall Study|Lost to Follow-up|11|||
126442019|NCT01635153|454916900|FG000|Overall Study|Lost to Follow-up|40|||
126442020|NCT01635153|454916901|FG001|Overall Study|Lost to Follow-up|43|||
126442021|NCT00658359|454916902|FG000|Overall Study|Death|3|||
126442022|NCT00658359|454916903|FG001|Overall Study|Death|1|||
126442023|NCT00658359|454916904|FG002|Overall Study|Death|2|||
126442024|NCT00658359|454916902|FG000|Overall Study|Adverse Event|13|||
126442025|NCT00658359|454916903|FG001|Overall Study|Adverse Event|6|||
126442026|NCT00658359|454916904|FG002|Overall Study|Adverse Event|9|||
126442027|NCT00658359|454916902|FG000|Overall Study|Protocol Violation|1|||
126442028|NCT00658359|454916903|FG001|Overall Study|Protocol Violation|0|||
126442029|NCT00658359|454916904|FG002|Overall Study|Protocol Violation|0|||
126442030|NCT00658359|454916902|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
126442031|NCT00658359|454916903|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
126442032|NCT00658359|454916904|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
126442033|NCT00658359|454916902|FG000|Overall Study|Withdrawal by Subject|7|||
126442034|NCT00658359|454916903|FG001|Overall Study|Withdrawal by Subject|4|||
126442035|NCT00658359|454916904|FG002|Overall Study|Withdrawal by Subject|2|||
126442036|NCT00658359|454916902|FG000|Overall Study|Lost to Follow-up|2|||
126442037|NCT00658359|454916903|FG001|Overall Study|Lost to Follow-up|2|||
126442038|NCT00658359|454916904|FG002|Overall Study|Lost to Follow-up|4|||
126442039|NCT00658359|454916902|FG000|Overall Study|Lack of Efficacy|0|||
126442040|NCT00658359|454916903|FG001|Overall Study|Lack of Efficacy|1|||
126442041|NCT00658359|454916904|FG002|Overall Study|Lack of Efficacy|0|||
126442042|NCT02754440|454916905|FG000|Overall Study|Protocol Violation|3|||
126442043|NCT02754440|454916906|FG001|Overall Study|Protocol Violation|2|||
126442044|NCT02754440|454916907|FG002|Overall Study|Protocol Violation|2|||
126442045|NCT02754440|454916908|FG003|Overall Study|Protocol Violation|6|||
126442046|NCT02754440|454916905|FG000|Overall Study|Adverse Event|3|||
126442047|NCT02754440|454916906|FG001|Overall Study|Adverse Event|1|||
126442048|NCT02754440|454916907|FG002|Overall Study|Adverse Event|0|||
126442049|NCT02754440|454916908|FG003|Overall Study|Adverse Event|9|||
126442050|NCT02754440|454916905|FG000|Overall Study|Withdrawal by Subject|0|||
126442051|NCT02754440|454916906|FG001|Overall Study|Withdrawal by Subject|0|||
126442052|NCT02754440|454916907|FG002|Overall Study|Withdrawal by Subject|0|||
126442053|NCT02754440|454916908|FG003|Overall Study|Withdrawal by Subject|1|||
126442054|NCT02754440|454916905|FG000|Overall Study|Equipment failure|0|||
126442055|NCT02754440|454916906|FG001|Overall Study|Equipment failure|5|||
126442056|NCT02754440|454916907|FG002|Overall Study|Equipment failure|5|||
126442057|NCT02754440|454916908|FG003|Overall Study|Equipment failure|7|||
126442058|NCT02754440|454916905|FG000|Overall Study|Subject issues not resulting in AE|0|||
126442059|NCT02754440|454916906|FG001|Overall Study|Subject issues not resulting in AE|0|||
126442060|NCT02754440|454916907|FG002|Overall Study|Subject issues not resulting in AE|0|||
126442061|NCT02754440|454916908|FG003|Overall Study|Subject issues not resulting in AE|12|||
126442062|NCT02560558|454916909|FG000|Overall Study|Adverse Event|1|||
126442063|NCT02560558|454916910|FG001|Overall Study|Adverse Event|0|||
126442064|NCT02560558|454916909|FG000|Overall Study|Death|0|||
126442065|NCT02560558|454916910|FG001|Overall Study|Death|2|||
126442066|NCT02560558|454916909|FG000|Overall Study|Lost to Follow-up|0|||
126442067|NCT02560558|454916910|FG001|Overall Study|Lost to Follow-up|4|||
126442068|NCT02560558|454916909|FG000|Overall Study|Protocol Violation|3|||
126442069|NCT02560558|454916910|FG001|Overall Study|Protocol Violation|0|||
126442070|NCT02560558|454916909|FG000|Overall Study|Withdrawal by Subject|3|||
126442071|NCT02560558|454916910|FG001|Overall Study|Withdrawal by Subject|0|||
126442072|NCT01263197|454916917|FG000|First Intervention (Period 1)|Adverse Event|0|||
126442073|NCT01263197|454916918|FG001|First Intervention (Period 1)|Adverse Event|0|||
126442074|NCT01263197|454916919|FG002|First Intervention (Period 1)|Adverse Event|0|||
126442075|NCT01263197|454916920|FG003|First Intervention (Period 1)|Adverse Event|0|||
126442076|NCT01263197|454916921|FG004|First Intervention (Period 1)|Adverse Event|0|||
126442077|NCT01263197|454916922|FG005|First Intervention (Period 1)|Adverse Event|1|||
126442078|NCT01263197|454916917|FG000|Washout Period 1|Protocol Violation|0|||
126442079|NCT01263197|454916918|FG001|Washout Period 1|Protocol Violation|0|||
126442080|NCT01263197|454916919|FG002|Washout Period 1|Protocol Violation|0|||
126442081|NCT01263197|454916920|FG003|Washout Period 1|Protocol Violation|0|||
126442082|NCT01263197|454916921|FG004|Washout Period 1|Protocol Violation|1|||
126442083|NCT01263197|454916922|FG005|Washout Period 1|Protocol Violation|0|||
126442084|NCT01263197|454916917|FG000|Washout Period 2|Physician Decision|0|||
126442085|NCT01263197|454916918|FG001|Washout Period 2|Physician Decision|0|||
126442086|NCT01263197|454916919|FG002|Washout Period 2|Physician Decision|0|||
126442087|NCT01263197|454916920|FG003|Washout Period 2|Physician Decision|0|||
126442088|NCT01263197|454916921|FG004|Washout Period 2|Physician Decision|0|||
126442089|NCT01263197|454916922|FG005|Washout Period 2|Physician Decision|1|||
126442090|NCT01263197|454916917|FG000|Washout Period 2|Protocol Violation|0|||
126442091|NCT01263197|454916918|FG001|Washout Period 2|Protocol Violation|0|||
126442092|NCT01263197|454916919|FG002|Washout Period 2|Protocol Violation|0|||
126442093|NCT01263197|454916920|FG003|Washout Period 2|Protocol Violation|1|||
126442094|NCT01263197|454916921|FG004|Washout Period 2|Protocol Violation|0|||
126442095|NCT01263197|454916922|FG005|Washout Period 2|Protocol Violation|0|||
126442096|NCT01263197|454916917|FG000|Third Intervention (Period 3)|Adverse Event|0|||
126442097|NCT01263197|454916918|FG001|Third Intervention (Period 3)|Adverse Event|1|||
126442098|NCT01263197|454916919|FG002|Third Intervention (Period 3)|Adverse Event|0|||
126442099|NCT01263197|454916920|FG003|Third Intervention (Period 3)|Adverse Event|0|||
126442100|NCT01263197|454916921|FG004|Third Intervention (Period 3)|Adverse Event|0|||
126442101|NCT01263197|454916922|FG005|Third Intervention (Period 3)|Adverse Event|0|||
126442102|NCT01134055|454916923|FG000|Overall Study|Adverse Event|5|||
126442103|NCT01134055|454916924|FG001|Overall Study|Adverse Event|2|||
126442104|NCT01134055|454916925|FG002|Overall Study|Adverse Event|2|||
126442105|NCT01134055|454916926|FG003|Overall Study|Adverse Event|2|||
126442106|NCT01134055|454916927|FG004|Overall Study|Adverse Event|5|||
126442107|NCT01134055|454916928|FG005|Overall Study|Adverse Event|7|||
126442108|NCT01134055|454916929|FG006|Overall Study|Adverse Event|2|||
126442109|NCT01134055|454916923|FG000|Overall Study|Lost to Follow-up|0|||
126691006|NCT01337973|455824077|FG001|Overall Study|Lost to Follow-up|4|||
126353664|NCT02969018|454585864|FG006|Overall Study|Adverse Event|2|||
126353665|NCT02969018|454585865|FG007|Overall Study|Adverse Event|0|||
126353666|NCT02969018|454585858|FG000|Overall Study|Lack of Efficacy|0|||
126353667|NCT02969018|454585859|FG001|Overall Study|Lack of Efficacy|1|||
126353668|NCT02969018|454585860|FG002|Overall Study|Lack of Efficacy|0|||
126353669|NCT02969018|454585861|FG003|Overall Study|Lack of Efficacy|0|||
126691007|NCT01337973|455824078|FG002|Overall Study|Lost to Follow-up|3|||
126353670|NCT02969018|454585862|FG004|Overall Study|Lack of Efficacy|1|||
126353671|NCT02969018|454585863|FG005|Overall Study|Lack of Efficacy|1|||
126353672|NCT02969018|454585864|FG006|Overall Study|Lack of Efficacy|1|||
126353673|NCT02969018|454585865|FG007|Overall Study|Lack of Efficacy|1|||
126353674|NCT02969018|454585858|FG000|Overall Study|Lost to Follow-up|1|||
126353675|NCT02969018|454585859|FG001|Overall Study|Lost to Follow-up|2|||
126353676|NCT02969018|454585860|FG002|Overall Study|Lost to Follow-up|2|||
126353677|NCT02969018|454585861|FG003|Overall Study|Lost to Follow-up|0|||
126353678|NCT02969018|454585862|FG004|Overall Study|Lost to Follow-up|1|||
126353679|NCT02969018|454585863|FG005|Overall Study|Lost to Follow-up|1|||
126353680|NCT02969018|454585864|FG006|Overall Study|Lost to Follow-up|0|||
126353681|NCT02969018|454585865|FG007|Overall Study|Lost to Follow-up|1|||
126353682|NCT02969018|454585858|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
126353683|NCT02969018|454585859|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126353684|NCT02969018|454585860|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
126353685|NCT02969018|454585861|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
126353686|NCT02969018|454585862|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
126353687|NCT02969018|454585863|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
126442110|NCT01134055|454916924|FG001|Overall Study|Lost to Follow-up|1|||
126442111|NCT01134055|454916925|FG002|Overall Study|Lost to Follow-up|0|||
126442112|NCT01134055|454916926|FG003|Overall Study|Lost to Follow-up|1|||
126442113|NCT01134055|454916927|FG004|Overall Study|Lost to Follow-up|0|||
126353688|NCT02969018|454585864|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
126353689|NCT02969018|454585865|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
126442114|NCT01134055|454916928|FG005|Overall Study|Lost to Follow-up|0|||
126442115|NCT01134055|454916929|FG006|Overall Study|Lost to Follow-up|0|||
126442116|NCT01134055|454916923|FG000|Overall Study|Withdrawal by Subject|3|||
126442117|NCT01134055|454916924|FG001|Overall Study|Withdrawal by Subject|3|||
126442118|NCT01134055|454916925|FG002|Overall Study|Withdrawal by Subject|1|||
126442119|NCT01134055|454916926|FG003|Overall Study|Withdrawal by Subject|2|||
126442120|NCT01134055|454916927|FG004|Overall Study|Withdrawal by Subject|0|||
126442121|NCT01134055|454916928|FG005|Overall Study|Withdrawal by Subject|0|||
126442122|NCT01134055|454916929|FG006|Overall Study|Withdrawal by Subject|8|||
126442123|NCT01134055|454916923|FG000|Overall Study|Protocol Violation|0|||
126442124|NCT01134055|454916924|FG001|Overall Study|Protocol Violation|0|||
126442125|NCT01134055|454916925|FG002|Overall Study|Protocol Violation|0|||
126442126|NCT01134055|454916926|FG003|Overall Study|Protocol Violation|1|||
126442127|NCT01134055|454916927|FG004|Overall Study|Protocol Violation|1|||
126442128|NCT01134055|454916928|FG005|Overall Study|Protocol Violation|0|||
126691008|NCT01337973|455824076|FG000|Overall Study|Death|1|||
126691009|NCT01337973|455824077|FG001|Overall Study|Death|2|||
126691010|NCT01337973|455824078|FG002|Overall Study|Death|1|||
126691011|NCT01337973|455824076|FG000|Overall Study|Withdrawal by Subject|10|||
126442129|NCT01134055|454916929|FG006|Overall Study|Protocol Violation|0|||
126442130|NCT01134055|454916923|FG000|Overall Study|Physician Decision|0|||
126442131|NCT01134055|454916924|FG001|Overall Study|Physician Decision|0|||
126442132|NCT01134055|454916925|FG002|Overall Study|Physician Decision|0|||
126691012|NCT01337973|455824077|FG001|Overall Study|Withdrawal by Subject|8|||
126442133|NCT01134055|454916926|FG003|Overall Study|Physician Decision|0|||
126442134|NCT01134055|454916927|FG004|Overall Study|Physician Decision|0|||
126442135|NCT01134055|454916928|FG005|Overall Study|Physician Decision|0|||
126442136|NCT01134055|454916929|FG006|Overall Study|Physician Decision|1|||
126442137|NCT03023397|454916934|FG000|Run-In|Failed screening allergen challenge|1|||
126442138|NCT03023397|454916935|FG001|Run-In|Failed screening allergen challenge|0|||
126442139|NCT03023397|454916936|FG002|Run-In|Failed screening allergen challenge|0|||
126442140|NCT03023397|454916934|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
126442141|NCT03023397|454916935|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
126442142|NCT03023397|454916936|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
126442143|NCT01146795|454916940|FG000|Overall Study|Withdrawal by Subject|4|||
126442144|NCT01146795|454916940|FG000|Overall Study|Adverse Event|6|||
126442145|NCT01146795|454916940|FG000|Overall Study|Still in treatment at study closure|10|||
126442146|NCT03853109|454916941|FG000|Overall Study|Withdrawal by Subject|0|||
126442147|NCT03853109|454916942|FG001|Overall Study|Withdrawal by Subject|0|||
126442148|NCT03853109|454916943|FG002|Overall Study|Withdrawal by Subject|1|||
126442149|NCT03853109|454916944|FG003|Overall Study|Withdrawal by Subject|2|||
126442150|NCT03853109|454916945|FG004|Overall Study|Withdrawal by Subject|1|||
126442151|NCT03853109|454916946|FG005|Overall Study|Withdrawal by Subject|4|||
126442152|NCT03853109|454916947|FG006|Overall Study|Withdrawal by Subject|5|||
126691013|NCT01337973|455824078|FG002|Overall Study|Withdrawal by Subject|4|||
126691014|NCT01337973|455824076|FG000|Overall Study|missing data on primary outcome|3|||
126691015|NCT01337973|455824077|FG001|Overall Study|missing data on primary outcome|1|||
126760265|NCT02221882|456072437|FG003|Overall Study|Death|0|||
126691016|NCT01337973|455824078|FG002|Overall Study|missing data on primary outcome|3|||
126691017|NCT00254566|455824080|FG000|Overall Study|Death|1|||
126691018|NCT00254566|455824081|FG001|Overall Study|Death|0|||
126691019|NCT00254566|455824080|FG000|Overall Study|Adverse Event|5|||
126691020|NCT00254566|455824081|FG001|Overall Study|Adverse Event|4|||
126691021|NCT00254566|455824080|FG000|Overall Study|Lack of Efficacy|12|||
126691022|NCT00254566|455824081|FG001|Overall Study|Lack of Efficacy|9|||
126691023|NCT00254566|455824080|FG000|Overall Study|Other|1|||
126691024|NCT00254566|455824081|FG001|Overall Study|Other|5|||
126353690|NCT02969018|454585858|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126353691|NCT02969018|454585859|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126353692|NCT02969018|454585860|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126353693|NCT02969018|454585861|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126353694|NCT02969018|454585862|FG004|Overall Study|Non-Compliance With Study Drug|0|||
126353695|NCT02969018|454585863|FG005|Overall Study|Non-Compliance With Study Drug|0|||
126353696|NCT02969018|454585864|FG006|Overall Study|Non-Compliance With Study Drug|0|||
126353697|NCT02969018|454585865|FG007|Overall Study|Non-Compliance With Study Drug|0|||
126353698|NCT02969018|454585858|FG000|Overall Study|Other|0|||
126353699|NCT02969018|454585859|FG001|Overall Study|Other|0|||
126353700|NCT02969018|454585860|FG002|Overall Study|Other|0|||
126353701|NCT02969018|454585861|FG003|Overall Study|Other|1|||
126353702|NCT02969018|454585862|FG004|Overall Study|Other|0|||
126353703|NCT02969018|454585863|FG005|Overall Study|Other|0|||
126353704|NCT02969018|454585864|FG006|Overall Study|Other|0|||
126353705|NCT02969018|454585865|FG007|Overall Study|Other|2|||
126353706|NCT02969018|454585858|FG000|Overall Study|Pregnancy|0|||
126353707|NCT02969018|454585859|FG001|Overall Study|Pregnancy|0|||
126353708|NCT02969018|454585860|FG002|Overall Study|Pregnancy|0|||
126353709|NCT02969018|454585861|FG003|Overall Study|Pregnancy|0|||
126353710|NCT02969018|454585862|FG004|Overall Study|Pregnancy|0|||
126353711|NCT02969018|454585863|FG005|Overall Study|Pregnancy|1|||
126353712|NCT02969018|454585864|FG006|Overall Study|Pregnancy|0|||
126353713|NCT02969018|454585865|FG007|Overall Study|Pregnancy|0|||
126353714|NCT02969018|454585858|FG000|Overall Study|Protocol Violation|0|||
126353715|NCT02969018|454585859|FG001|Overall Study|Protocol Violation|0|||
126353716|NCT02969018|454585860|FG002|Overall Study|Protocol Violation|1|||
126353717|NCT02969018|454585861|FG003|Overall Study|Protocol Violation|1|||
126353718|NCT02969018|454585862|FG004|Overall Study|Protocol Violation|0|||
126353719|NCT02969018|454585863|FG005|Overall Study|Protocol Violation|0|||
126353720|NCT02969018|454585864|FG006|Overall Study|Protocol Violation|0|||
126353721|NCT02969018|454585865|FG007|Overall Study|Protocol Violation|0|||
126353722|NCT02969018|454585858|FG000|Overall Study|Withdrawal by Subject|0|||
126353723|NCT02969018|454585859|FG001|Overall Study|Withdrawal by Subject|1|||
126353724|NCT02969018|454585860|FG002|Overall Study|Withdrawal by Subject|2|||
126353725|NCT02969018|454585861|FG003|Overall Study|Withdrawal by Subject|1|||
126353726|NCT02969018|454585862|FG004|Overall Study|Withdrawal by Subject|0|||
126353727|NCT02969018|454585863|FG005|Overall Study|Withdrawal by Subject|4|||
126353728|NCT02969018|454585864|FG006|Overall Study|Withdrawal by Subject|4|||
126353729|NCT02969018|454585865|FG007|Overall Study|Withdrawal by Subject|3|||
126353730|NCT00367458|454585866|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
126353731|NCT00367458|454585867|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
126353732|NCT05762679|454585873|FG000|Overall Study|Withdrawal by Subject|1|||
126353733|NCT05762679|454585873|FG000|Overall Study|No analyzable imaging data|1|||
126353734|NCT03670628|454585874|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
126353735|NCT03670628|454585875|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
126353736|NCT03670628|454585874|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
126353737|NCT03670628|454585875|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
126353738|NCT01716156|454585877|FG000|Overall Study|Protocol Violation|1|||
126353739|NCT01716156|454585878|FG001|Overall Study|Protocol Violation|0|||
126353740|NCT01716156|454585879|FG002|Overall Study|Protocol Violation|0|||
126353741|NCT01716156|454585877|FG000|Overall Study|Withdrawal by Subject|0|||
126353742|NCT01716156|454585878|FG001|Overall Study|Withdrawal by Subject|1|||
126353743|NCT01716156|454585879|FG002|Overall Study|Withdrawal by Subject|2|||
126691025|NCT00254566|455824080|FG000|Overall Study|Withdrawal by Subject|5|||
126353744|NCT01716156|454585877|FG000|Overall Study|Lost to Follow-up|1|||
126353745|NCT01716156|454585878|FG001|Overall Study|Lost to Follow-up|0|||
126353746|NCT01716156|454585879|FG002|Overall Study|Lost to Follow-up|0|||
126353747|NCT03925220|454585880|FG000|Overall Study|Withdrawal by Subject|4|||
126353748|NCT03925220|454585881|FG001|Overall Study|Withdrawal by Subject|4|||
126353749|NCT03925220|454585882|FG002|Overall Study|Withdrawal by Subject|4|||
126353750|NCT03925220|454585883|FG003|Overall Study|Withdrawal by Subject|4|||
126691026|NCT00254566|455824081|FG001|Overall Study|Withdrawal by Subject|6|||
126691027|NCT00254566|455824080|FG000|Overall Study|Lost to Follow-up|7|||
126691028|NCT00254566|455824081|FG001|Overall Study|Lost to Follow-up|2|||
126691029|NCT00364689|455824085|FG000|Overall Study|Lost to Follow-up|1|||
126691030|NCT01114529|455824086|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
126691031|NCT01114529|455824087|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
126691032|NCT01114529|455824088|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
126353751|NCT03925220|454585880|FG000|Overall Study|Lost to Follow-up|40|||
126353752|NCT03925220|454585881|FG001|Overall Study|Lost to Follow-up|46|||
126353753|NCT03925220|454585882|FG002|Overall Study|Lost to Follow-up|37|||
126353754|NCT03925220|454585883|FG003|Overall Study|Lost to Follow-up|38|||
126353755|NCT05561140|454585884|FG000|Randomized Treatment Period|Adverse Event|1|||
126353756|NCT05561140|454585885|FG001|Randomized Treatment Period|Adverse Event|0|||
126353757|NCT05561140|454585884|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
126353758|NCT05561140|454585885|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
126353759|NCT05561140|454585884|FG000|Open Label Treatment Period|Adverse Event|6|||
126353760|NCT05561140|454585885|FG001|Open Label Treatment Period|Adverse Event|4|||
126353761|NCT05561140|454585884|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
126353762|NCT05561140|454585885|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
126353763|NCT05561140|454585884|FG000|Open Label Treatment Period|Physician Decision|0|||
126353764|NCT05561140|454585885|FG001|Open Label Treatment Period|Physician Decision|1|||
126353765|NCT05561140|454585884|FG000|Open Label Treatment Period|Pregnancy|1|||
126353766|NCT05561140|454585885|FG001|Open Label Treatment Period|Pregnancy|0|||
126353767|NCT05561140|454585884|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
126353768|NCT05561140|454585885|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
126353769|NCT05561140|454585884|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
126353770|NCT05561140|454585885|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
126353771|NCT05561140|454585884|FG000|Open Label Treatment Period|Other|1|||
126353772|NCT05561140|454585885|FG001|Open Label Treatment Period|Other|0|||
126353773|NCT06377488|454585886|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
126353774|NCT06377488|454585886|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
126353775|NCT06377488|454585886|FG000|Overall Study|Protocol Violation|1|||
126353776|NCT06377488|454585886|FG000|Overall Study|Lost to Follow-up|1|||
126353777|NCT06377488|454585886|FG000|Overall Study|Incorrect Lens Dispensed|2|||
126353778|NCT03325439|454585887|FG000|Overall Study|Ineligibility|3|||
126353779|NCT00774748|454585890|FG000|Overall Study|Lost to Follow-up|3|||
126353780|NCT00303953|454585891|FG000|Overall Study|Ineligible|1|||
126353781|NCT00303953|454585891|FG000|Overall Study|Death|1|||
126353782|NCT00303953|454585891|FG000|Overall Study|Adverse Event|4|||
126353783|NCT00303953|454585891|FG000|Overall Study|Lack of Efficacy|12|||
126353784|NCT00303953|454585891|FG000|Overall Study|Physician Decision|1|||
126353785|NCT00387127|454585892|FG000|Overall Study|Lost to Follow-up|0|||
126353786|NCT00387127|454585893|FG001|Overall Study|Lost to Follow-up|4|||
126353787|NCT00387127|454585892|FG000|Overall Study|Death|16|||
126353788|NCT00387127|454585893|FG001|Overall Study|Death|16|||
126353789|NCT00387127|454585892|FG000|Overall Study|Physician Decision|0|||
126353790|NCT00387127|454585893|FG001|Overall Study|Physician Decision|1|||
126353791|NCT00387127|454585892|FG000|Overall Study|Withdrawal by Subject|3|||
126353792|NCT00387127|454585893|FG001|Overall Study|Withdrawal by Subject|2|||
126353793|NCT00387127|454585892|FG000|Overall Study|Required by Protocol Amendment #4|12|||
126353794|NCT00387127|454585893|FG001|Overall Study|Required by Protocol Amendment #4|10|||
126353795|NCT00387127|454585892|FG000|Overall Study|Serious Adverse Event|1|||
126353796|NCT00387127|454585893|FG001|Overall Study|Serious Adverse Event|1|||
126353797|NCT00387127|454585892|FG000|Overall Study|Sponsor Unblinded|1|||
126353798|NCT00387127|454585893|FG001|Overall Study|Sponsor Unblinded|0|||
126353799|NCT05089357|454585894|FG000|Overall Study|Withdrawal by Subject|23|||
126353800|NCT05089357|454585894|FG000|Overall Study|Lost to Follow-up|6|||
126353801|NCT05089357|454585894|FG000|Overall Study|Medical reason|1|||
126353802|NCT05089357|454585894|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
126353803|NCT05089357|454585894|FG000|Overall Study|Pregnancy|2|||
126353804|NCT05537571|454585895|FG000|Overall Study|Withdrawal by Subject|1|||
126353805|NCT05537571|454585896|FG001|Overall Study|Withdrawal by Subject|1|||
126353806|NCT05537571|454585897|FG002|Overall Study|Withdrawal by Subject|0|||
126353807|NCT05537571|454585898|FG003|Overall Study|Withdrawal by Subject|0|||
126353808|NCT05537571|454585899|FG004|Overall Study|Withdrawal by Subject|0|||
126353809|NCT05537571|454585895|FG000|Overall Study|Adverse Event|2|||
126353810|NCT05537571|454585896|FG001|Overall Study|Adverse Event|0|||
126353811|NCT05537571|454585897|FG002|Overall Study|Adverse Event|0|||
126353812|NCT05537571|454585898|FG003|Overall Study|Adverse Event|0|||
126353813|NCT05537571|454585899|FG004|Overall Study|Adverse Event|0|||
126353814|NCT05537571|454585895|FG000|Overall Study|Hepatitis A screening result|2|||
126353815|NCT05537571|454585896|FG001|Overall Study|Hepatitis A screening result|0|||
126353816|NCT05537571|454585897|FG002|Overall Study|Hepatitis A screening result|0|||
126442153|NCT03853109|454916948|FG007|Overall Study|Withdrawal by Subject|3|||
126442154|NCT03853109|454916941|FG000|Overall Study|Decision by Sponsor|0|||
126442155|NCT03853109|454916942|FG001|Overall Study|Decision by Sponsor|0|||
126442156|NCT03853109|454916943|FG002|Overall Study|Decision by Sponsor|1|||
126442157|NCT03853109|454916944|FG003|Overall Study|Decision by Sponsor|0|||
126442158|NCT03853109|454916945|FG004|Overall Study|Decision by Sponsor|1|||
126442159|NCT03853109|454916946|FG005|Overall Study|Decision by Sponsor|1|||
126442160|NCT03853109|454916947|FG006|Overall Study|Decision by Sponsor|10|||
126442161|NCT03853109|454916948|FG007|Overall Study|Decision by Sponsor|2|||
126442162|NCT03853109|454916941|FG000|Overall Study|Lost to Follow-up|0|||
126442163|NCT03853109|454916942|FG001|Overall Study|Lost to Follow-up|0|||
126442164|NCT03853109|454916943|FG002|Overall Study|Lost to Follow-up|0|||
126442165|NCT03853109|454916944|FG003|Overall Study|Lost to Follow-up|0|||
126442166|NCT03853109|454916945|FG004|Overall Study|Lost to Follow-up|1|||
126442167|NCT03853109|454916946|FG005|Overall Study|Lost to Follow-up|3|||
126442168|NCT03853109|454916947|FG006|Overall Study|Lost to Follow-up|0|||
126442169|NCT03853109|454916948|FG007|Overall Study|Lost to Follow-up|0|||
126442170|NCT03853109|454916941|FG000|Overall Study|Death|2|||
126442171|NCT03853109|454916942|FG001|Overall Study|Death|5|||
126442172|NCT03853109|454916943|FG002|Overall Study|Death|8|||
126442173|NCT03853109|454916944|FG003|Overall Study|Death|10|||
126442174|NCT03853109|454916945|FG004|Overall Study|Death|3|||
126442175|NCT03853109|454916946|FG005|Overall Study|Death|20|||
126442176|NCT03853109|454916947|FG006|Overall Study|Death|10|||
126442177|NCT03853109|454916948|FG007|Overall Study|Death|5|||
126442178|NCT01721044|454916951|FG000|Treatment Period|Adverse Event|7|||
126442179|NCT01721044|454916952|FG001|Treatment Period|Adverse Event|7|||
126442180|NCT01721044|454916953|FG002|Treatment Period|Adverse Event|10|||
126442181|NCT01721044|454916951|FG000|Treatment Period|Death|0|||
126442182|NCT01721044|454916952|FG001|Treatment Period|Death|0|||
126442183|NCT01721044|454916953|FG002|Treatment Period|Death|1|||
126442184|NCT01721044|454916951|FG000|Treatment Period|Lack of Efficacy|16|||
126442185|NCT01721044|454916952|FG001|Treatment Period|Lack of Efficacy|4|||
126442186|NCT01721044|454916953|FG002|Treatment Period|Lack of Efficacy|4|||
126442187|NCT01721044|454916951|FG000|Treatment Period|Lost to Follow-up|0|||
126442188|NCT01721044|454916952|FG001|Treatment Period|Lost to Follow-up|0|||
126442189|NCT01721044|454916953|FG002|Treatment Period|Lost to Follow-up|1|||
126442190|NCT01721044|454916951|FG000|Treatment Period|Physician Decision|1|||
126442191|NCT01721044|454916952|FG001|Treatment Period|Physician Decision|0|||
126442192|NCT01721044|454916953|FG002|Treatment Period|Physician Decision|2|||
126442193|NCT01721044|454916951|FG000|Treatment Period|Protocol Violation|1|||
126442194|NCT01721044|454916952|FG001|Treatment Period|Protocol Violation|0|||
126691033|NCT01114529|455824086|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
126691034|NCT01114529|455824087|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
126691035|NCT01114529|455824088|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
126760266|NCT02221882|456072438|FG004|Overall Study|Death|0|||
126442195|NCT01721044|454916953|FG002|Treatment Period|Protocol Violation|0|||
126442196|NCT01721044|454916951|FG000|Treatment Period|Withdrawal by Subject|7|||
126442197|NCT01721044|454916952|FG001|Treatment Period|Withdrawal by Subject|6|||
126442198|NCT01721044|454916953|FG002|Treatment Period|Withdrawal by Subject|1|||
126442199|NCT04032093|454916954|FG000|Overall Study|Lost to Follow-up|7|||
126442200|NCT04032093|454916955|FG001|Overall Study|Lost to Follow-up|7|||
126442201|NCT04032093|454916956|FG002|Overall Study|Lost to Follow-up|6|||
126442202|NCT04032093|454916957|FG003|Overall Study|Lost to Follow-up|10|||
126442203|NCT04032093|454916958|FG004|Overall Study|Lost to Follow-up|13|||
126442204|NCT04032093|454916959|FG005|Overall Study|Lost to Follow-up|7|||
126442205|NCT04032093|454916960|FG006|Overall Study|Lost to Follow-up|7|||
126442206|NCT04032093|454916961|FG007|Overall Study|Lost to Follow-up|5|||
126442207|NCT04032093|454916962|FG008|Overall Study|Lost to Follow-up|9|||
126442208|NCT04032093|454916963|FG009|Overall Study|Lost to Follow-up|12|||
126442209|NCT04032093|454916954|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
126442210|NCT04032093|454916955|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126442211|NCT04032093|454916956|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
126442212|NCT04032093|454916957|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
126442213|NCT04032093|454916958|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
126442214|NCT04032093|454916959|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
126442215|NCT04032093|454916960|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
126442216|NCT04032093|454916961|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
126442217|NCT04032093|454916962|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
126442218|NCT04032093|454916963|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
126442219|NCT04032093|454916954|FG000|Overall Study|Other|1|||
126442220|NCT04032093|454916955|FG001|Overall Study|Other|0|||
126442221|NCT04032093|454916956|FG002|Overall Study|Other|0|||
126442222|NCT04032093|454916957|FG003|Overall Study|Other|1|||
126442223|NCT04032093|454916958|FG004|Overall Study|Other|1|||
126442224|NCT04032093|454916959|FG005|Overall Study|Other|0|||
126442225|NCT04032093|454916960|FG006|Overall Study|Other|0|||
126442226|NCT04032093|454916961|FG007|Overall Study|Other|0|||
126442227|NCT04032093|454916962|FG008|Overall Study|Other|0|||
126442228|NCT04032093|454916963|FG009|Overall Study|Other|1|||
126442229|NCT04032093|454916954|FG000|Overall Study|Withdrawal by Subject|1|||
126442230|NCT04032093|454916955|FG001|Overall Study|Withdrawal by Subject|3|||
126442231|NCT04032093|454916956|FG002|Overall Study|Withdrawal by Subject|2|||
126442232|NCT04032093|454916957|FG003|Overall Study|Withdrawal by Subject|2|||
126442233|NCT04032093|454916958|FG004|Overall Study|Withdrawal by Subject|3|||
126442234|NCT04032093|454916959|FG005|Overall Study|Withdrawal by Subject|0|||
126442235|NCT04032093|454916960|FG006|Overall Study|Withdrawal by Subject|0|||
126442236|NCT04032093|454916961|FG007|Overall Study|Withdrawal by Subject|0|||
126442237|NCT04032093|454916962|FG008|Overall Study|Withdrawal by Subject|0|||
126442238|NCT04032093|454916963|FG009|Overall Study|Withdrawal by Subject|0|||
126442239|NCT04032093|454916954|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126442240|NCT04032093|454916955|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126442241|NCT04032093|454916956|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126442242|NCT04032093|454916957|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126442243|NCT04032093|454916958|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126442244|NCT04032093|454916959|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126442245|NCT04032093|454916960|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
126442246|NCT04032093|454916961|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
126442247|NCT04032093|454916962|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
126442248|NCT04032093|454916963|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
126442249|NCT04032093|454916954|FG000|Overall Study|Adverse Event|0|||
126442250|NCT04032093|454916955|FG001|Overall Study|Adverse Event|0|||
126442251|NCT04032093|454916956|FG002|Overall Study|Adverse Event|0|||
126442252|NCT04032093|454916957|FG003|Overall Study|Adverse Event|0|||
126442253|NCT04032093|454916958|FG004|Overall Study|Adverse Event|0|||
126442254|NCT04032093|454916959|FG005|Overall Study|Adverse Event|0|||
126442255|NCT04032093|454916960|FG006|Overall Study|Adverse Event|0|||
126442256|NCT04032093|454916961|FG007|Overall Study|Adverse Event|0|||
126442257|NCT04032093|454916962|FG008|Overall Study|Adverse Event|0|||
126442258|NCT04032093|454916963|FG009|Overall Study|Adverse Event|1|||
126442259|NCT04032093|454916954|FG000|Overall Study|Physician Decision|0|||
126442260|NCT04032093|454916955|FG001|Overall Study|Physician Decision|0|||
126442261|NCT04032093|454916956|FG002|Overall Study|Physician Decision|0|||
126442262|NCT04032093|454916957|FG003|Overall Study|Physician Decision|0|||
126442263|NCT04032093|454916958|FG004|Overall Study|Physician Decision|0|||
126442264|NCT04032093|454916959|FG005|Overall Study|Physician Decision|1|||
126442265|NCT04032093|454916960|FG006|Overall Study|Physician Decision|0|||
126442266|NCT04032093|454916961|FG007|Overall Study|Physician Decision|0|||
126442267|NCT04032093|454916962|FG008|Overall Study|Physician Decision|0|||
126442268|NCT04032093|454916963|FG009|Overall Study|Physician Decision|0|||
126442269|NCT01457703|454916968|FG000|Overall Study|Screen Failure|5|||
126442270|NCT01457703|454916969|FG001|Overall Study|Screen Failure|7|||
126442271|NCT01457703|454916968|FG000|Overall Study|Withdrawal by Subject|1|||
126691036|NCT01114529|455824086|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
126691037|NCT01114529|455824087|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
126691038|NCT01114529|455824088|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
126691039|NCT01114529|455824086|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
126691040|NCT01114529|455824087|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
126691041|NCT01114529|455824088|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
126691042|NCT01114529|455824086|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
126691043|NCT01114529|455824087|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
126691044|NCT01114529|455824088|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
126691045|NCT01114529|455824086|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
126691046|NCT01114529|455824087|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
126691047|NCT01114529|455824088|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
126691048|NCT01114529|455824086|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
126691049|NCT01114529|455824087|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
126691050|NCT01114529|455824088|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
126442272|NCT01457703|454916969|FG001|Overall Study|Withdrawal by Subject|4|||
126442273|NCT02952820|454916970|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
126691051|NCT01114529|455824086|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
126442274|NCT02952820|454916971|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
126442275|NCT02952820|454916972|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
126442276|NCT02952820|454916970|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
126442277|NCT02952820|454916971|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
126442278|NCT02952820|454916972|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
126442279|NCT02952820|454916970|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
126442280|NCT02952820|454916971|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
126442281|NCT02952820|454916972|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
126442282|NCT02952820|454916970|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
126442283|NCT02952820|454916971|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
126442284|NCT02952820|454916972|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
126442285|NCT02952820|454916970|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
126442286|NCT02952820|454916971|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
126442287|NCT02952820|454916972|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
126442288|NCT02952820|454916970|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
126442289|NCT02952820|454916971|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
126442290|NCT02952820|454916972|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
126442291|NCT02952820|454916970|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
126442292|NCT02952820|454916971|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
126442293|NCT02952820|454916972|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
126442294|NCT02952820|454916970|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
126442295|NCT02952820|454916971|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
126442296|NCT02952820|454916972|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
126442297|NCT02952820|454916970|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
126442298|NCT02952820|454916971|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
126442299|NCT02952820|454916972|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
126442300|NCT02952820|454916970|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
126442301|NCT02952820|454916971|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
126442302|NCT02952820|454916972|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
126442303|NCT02952820|454916970|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
126442304|NCT02952820|454916971|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
126442305|NCT02952820|454916972|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
126442306|NCT02952820|454916970|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
126442307|NCT02952820|454916971|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
126442308|NCT02952820|454916972|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
126442309|NCT02952820|454916970|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
126442310|NCT02952820|454916971|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
126442311|NCT02952820|454916972|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
126442312|NCT02952820|454916970|FG000|Active Treatment Period (6 Months)|Not treated|0|||
126442313|NCT02952820|454916971|FG001|Active Treatment Period (6 Months)|Not treated|0|||
126442314|NCT02952820|454916972|FG002|Active Treatment Period (6 Months)|Not treated|1|||
126442315|NCT04139018|454916973|FG000|Overall Study|Screen fail|1|||
126442316|NCT04139018|454916974|FG001|Overall Study|Screen fail|0|||
126442317|NCT04139018|454916973|FG000|Overall Study|Withdrawal by Subject|2|||
126442318|NCT04139018|454916974|FG001|Overall Study|Withdrawal by Subject|0|||
126442319|NCT04139018|454916973|FG000|Overall Study|Lost to Follow-up|0|||
126442320|NCT04139018|454916974|FG001|Overall Study|Lost to Follow-up|1|||
126442321|NCT03486834|454916975|FG000|Overall Study|Withdrawal by Subject|46|||
126442322|NCT03486834|454916976|FG001|Overall Study|Withdrawal by Subject|46|||
126442323|NCT03486834|454916977|FG002|Overall Study|Withdrawal by Subject|52|||
126442324|NCT03486834|454916975|FG000|Overall Study|Adverse Event|8|||
126442325|NCT03486834|454916976|FG001|Overall Study|Adverse Event|7|||
126442326|NCT03486834|454916977|FG002|Overall Study|Adverse Event|0|||
126442327|NCT03486834|454916975|FG000|Overall Study|Lost to Follow-up|41|||
126442328|NCT03486834|454916976|FG001|Overall Study|Lost to Follow-up|24|||
126442329|NCT03486834|454916977|FG002|Overall Study|Lost to Follow-up|39|||
126442330|NCT03486834|454916975|FG000|Overall Study|Non-compliance with Study Drug|2|||
126442331|NCT03486834|454916976|FG001|Overall Study|Non-compliance with Study Drug|2|||
126442332|NCT03486834|454916977|FG002|Overall Study|Non-compliance with Study Drug|0|||
126442333|NCT03486834|454916975|FG000|Overall Study|Physician Decision|5|||
126442334|NCT03486834|454916976|FG001|Overall Study|Physician Decision|2|||
126442335|NCT03486834|454916977|FG002|Overall Study|Physician Decision|3|||
126442336|NCT03486834|454916975|FG000|Overall Study|Pregnancy|10|||
126442337|NCT03486834|454916976|FG001|Overall Study|Pregnancy|12|||
126442338|NCT03486834|454916977|FG002|Overall Study|Pregnancy|12|||
126442339|NCT03486834|454916975|FG000|Overall Study|Protocol Deviation|2|||
126442340|NCT03486834|454916976|FG001|Overall Study|Protocol Deviation|3|||
126442341|NCT03486834|454916977|FG002|Overall Study|Protocol Deviation|3|||
126442342|NCT03486834|454916975|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126442343|NCT03486834|454916976|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
126442344|NCT03486834|454916977|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
126442345|NCT03486834|454916975|FG000|Overall Study|Randomized but not treated|4|||
126442346|NCT03486834|454916976|FG001|Overall Study|Randomized but not treated|4|||
126442347|NCT03486834|454916977|FG002|Overall Study|Randomized but not treated|1|||
126442348|NCT00525161|454917002|FG000|Overall Study|Adverse Event|1|||
126442349|NCT02447003|454917003|FG000|Overall Study|Other|0|||
126442350|NCT02447003|454917004|FG001|Overall Study|Other|4|||
126442351|NCT02447003|454917003|FG000|Overall Study|Site discontinued|0|||
126442352|NCT02447003|454917004|FG001|Overall Study|Site discontinued|2|||
126442353|NCT02447003|454917003|FG000|Overall Study|Physician Decision|0|||
126442354|NCT02447003|454917004|FG001|Overall Study|Physician Decision|1|||
126442355|NCT02447003|454917003|FG000|Overall Study|Withdrawal by Subject|4|||
126442356|NCT02447003|454917004|FG001|Overall Study|Withdrawal by Subject|3|||
126442357|NCT02447003|454917003|FG000|Overall Study|Sponsor Decision|6|||
126442358|NCT02447003|454917004|FG001|Overall Study|Sponsor Decision|11|||
126442359|NCT02447003|454917003|FG000|Overall Study|Progressive Disease|1|||
126442360|NCT02447003|454917004|FG001|Overall Study|Progressive Disease|0|||
126442361|NCT02447003|454917003|FG000|Overall Study|Lost to Follow-up|5|||
126442362|NCT02447003|454917004|FG001|Overall Study|Lost to Follow-up|0|||
126442363|NCT02447003|454917003|FG000|Overall Study|Death|154|||
126442364|NCT02447003|454917004|FG001|Overall Study|Death|63|||
126442365|NCT03848728|454917005|FG000|Overall Study|Death|16|||
126442366|NCT03848728|454917006|FG001|Overall Study|Death|13|||
126442367|NCT03848728|454917005|FG000|Overall Study|Outmigrated to non-study community|98|||
126442368|NCT03848728|454917006|FG001|Overall Study|Outmigrated to non-study community|106|||
126442369|NCT03848728|454917005|FG000|Overall Study|Transfered to non-study clinic|32|||
126442370|NCT03848728|454917006|FG001|Overall Study|Transfered to non-study clinic|48|||
126442371|NCT03848728|454917005|FG000|Overall Study|Withdrawal by Subject|1|||
126442372|NCT03848728|454917006|FG001|Overall Study|Withdrawal by Subject|0|||
126442373|NCT04161157|454917007|FG000|Overall Study|Lost to Follow-up|4|||
126442374|NCT04161157|454917007|FG000|Overall Study|Death|3|||
126442375|NCT04161157|454917007|FG000|Overall Study|Ineligible|2|||
126442376|NCT04161157|454917007|FG000|Overall Study|Withdrawal by Subject|4|||
126442377|NCT01108185|454917008|FG000|Overall Study|Non-compliance|15|||
126442378|NCT01108185|454917008|FG000|Overall Study|Lost to Follow-up|12|||
126442379|NCT02581410|454917009|FG000|Vaccination Phase|Adverse Event|2|||
126442380|NCT02581410|454917010|FG001|Vaccination Phase|Adverse Event|1|||
126442381|NCT02581410|454917009|FG000|Vaccination Phase|Withdrawal by Subject|0|||
126442382|NCT02581410|454917010|FG001|Vaccination Phase|Withdrawal by Subject|1|||
126442383|NCT02581410|454917009|FG000|Vaccination Phase|Migrated/moved from study area|0|||
126442384|NCT02581410|454917010|FG001|Vaccination Phase|Migrated/moved from study area|1|||
126442385|NCT02581410|454917009|FG000|End of Study Phase|Adverse Event|4|||
126442386|NCT02581410|454917010|FG001|End of Study Phase|Adverse Event|3|||
126442387|NCT02581410|454917009|FG000|End of Study Phase|Withdrawal by Subject|1|||
126442388|NCT02581410|454917010|FG001|End of Study Phase|Withdrawal by Subject|2|||
126442389|NCT02581410|454917009|FG000|End of Study Phase|Migrated/moved from study area|0|||
126442390|NCT02581410|454917010|FG001|End of Study Phase|Migrated/moved from study area|3|||
126442391|NCT02581410|454917009|FG000|End of Study Phase|Lost to Follow-up|0|||
126442392|NCT02581410|454917010|FG001|End of Study Phase|Lost to Follow-up|2|||
126442393|NCT02581410|454917009|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
126442394|NCT02581410|454917010|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
126442395|NCT06083506|454917016|FG000|Overall Study|Physician Decision|2|||
126442396|NCT06083506|454917016|FG000|Overall Study|Lack of Efficacy|1|||
126442397|NCT02000115|454917017|FG000|Overall Study|Death|56|||
126442398|NCT02000115|454917018|FG001|Overall Study|Death|45|||
126442399|NCT02000115|454917019|FG002|Overall Study|Death|0|||
126442400|NCT02000115|454917020|FG003|Overall Study|Death|0|||
126442401|NCT02000115|454917017|FG000|Overall Study|Missed Visit|6|||
126442402|NCT02000115|454917018|FG001|Overall Study|Missed Visit|8|||
126442403|NCT02000115|454917019|FG002|Overall Study|Missed Visit|1|||
126442404|NCT02000115|454917020|FG003|Overall Study|Missed Visit|0|||
126442405|NCT02000115|454917017|FG000|Overall Study|Protocol Violation|2|||
126442406|NCT02000115|454917018|FG001|Overall Study|Protocol Violation|1|||
126442407|NCT02000115|454917019|FG002|Overall Study|Protocol Violation|0|||
126442408|NCT02000115|454917020|FG003|Overall Study|Protocol Violation|0|||
126442409|NCT02000115|454917017|FG000|Overall Study|Physician Decision|2|||
126442410|NCT02000115|454917018|FG001|Overall Study|Physician Decision|0|||
126442411|NCT02000115|454917019|FG002|Overall Study|Physician Decision|0|||
126442412|NCT02000115|454917020|FG003|Overall Study|Physician Decision|0|||
126442413|NCT02000115|454917017|FG000|Overall Study|Withdrawal by Subject|11|||
126442414|NCT02000115|454917018|FG001|Overall Study|Withdrawal by Subject|11|||
126442415|NCT02000115|454917019|FG002|Overall Study|Withdrawal by Subject|0|||
126442416|NCT02000115|454917020|FG003|Overall Study|Withdrawal by Subject|0|||
126442417|NCT02000115|454917017|FG000|Overall Study|Lost to Follow-up|0|||
126442418|NCT02000115|454917018|FG001|Overall Study|Lost to Follow-up|1|||
126442419|NCT02000115|454917019|FG002|Overall Study|Lost to Follow-up|0|||
126442420|NCT02000115|454917020|FG003|Overall Study|Lost to Follow-up|0|||
126442421|NCT02000115|454917017|FG000|Overall Study|Non-compliance|2|||
126442422|NCT02000115|454917018|FG001|Overall Study|Non-compliance|1|||
126442423|NCT02000115|454917019|FG002|Overall Study|Non-compliance|0|||
126442424|NCT02000115|454917020|FG003|Overall Study|Non-compliance|0|||
126442425|NCT02000115|454917017|FG000|Overall Study|Withdrawn on day of randomization|0|||
126442426|NCT02000115|454917018|FG001|Overall Study|Withdrawn on day of randomization|1|||
126442427|NCT02000115|454917019|FG002|Overall Study|Withdrawn on day of randomization|0|||
126442428|NCT02000115|454917020|FG003|Overall Study|Withdrawn on day of randomization|0|||
126442429|NCT02000115|454917017|FG000|Overall Study|Still on Study|0|||
126442430|NCT02000115|454917018|FG001|Overall Study|Still on Study|0|||
126442431|NCT02000115|454917019|FG002|Overall Study|Still on Study|0|||
126442432|NCT02000115|454917020|FG003|Overall Study|Still on Study|53|||
126442433|NCT03493464|454917025|FG000|Overall Study|Surgery not performed|1|||
126442434|NCT02374450|454917026|FG000|Overall Study|Protocol Violation|0|||
126442435|NCT02374450|454917027|FG001|Overall Study|Protocol Violation|1|||
126442436|NCT02374450|454917028|FG002|Overall Study|Protocol Violation|0|||
126442437|NCT02374450|454917026|FG000|Overall Study|Withdrawal by Subject|91|||
126442438|NCT02374450|454917027|FG001|Overall Study|Withdrawal by Subject|110|||
126442439|NCT02374450|454917028|FG002|Overall Study|Withdrawal by Subject|4|||
126442440|NCT02374450|454917026|FG000|Overall Study|Lost to Follow-up|168|||
126442441|NCT02374450|454917027|FG001|Overall Study|Lost to Follow-up|194|||
126442442|NCT02374450|454917028|FG002|Overall Study|Lost to Follow-up|138|||
126442443|NCT02374450|454917026|FG000|Overall Study|Death|173|||
126442444|NCT02374450|454917027|FG001|Overall Study|Death|185|||
126442445|NCT02374450|454917028|FG002|Overall Study|Death|81|||
126442446|NCT02374450|454917026|FG000|Overall Study|Migrated from the study area|538|||
126442447|NCT02374450|454917027|FG001|Overall Study|Migrated from the study area|648|||
126442448|NCT02374450|454917028|FG002|Overall Study|Migrated from the study area|181|||
126442449|NCT02374450|454917026|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
126442450|NCT02374450|454917027|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
126442451|NCT02374450|454917028|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
126442452|NCT02374450|454917026|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
126442453|NCT02374450|454917027|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
126442454|NCT02374450|454917028|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
126442455|NCT02374450|454917026|FG000|Overall Study|Other|0|||
126442456|NCT02374450|454917027|FG001|Overall Study|Other|21|||
126442457|NCT02374450|454917028|FG002|Overall Study|Other|79|||
126442458|NCT01646125|454918508|FG000|Overall Study|Untreated|2|||
126442459|NCT01646125|454918509|FG001|Overall Study|Untreated|5|||
126442460|NCT01646125|454918508|FG000|Overall Study|Adverse Event|2|||
126442461|NCT01646125|454918509|FG001|Overall Study|Adverse Event|1|||
126442462|NCT01646125|454918508|FG000|Overall Study|Death|1|||
126442463|NCT01646125|454918509|FG001|Overall Study|Death|1|||
126442464|NCT01646125|454918508|FG000|Overall Study|Physician Decision|1|||
126442465|NCT01646125|454918509|FG001|Overall Study|Physician Decision|3|||
126442466|NCT01646125|454918508|FG000|Overall Study|Progressive disease|22|||
126442467|NCT01646125|454918509|FG001|Overall Study|Progressive disease|16|||
126442468|NCT01646125|454918508|FG000|Overall Study|Study terminated by sponsor|2|||
126442469|NCT01646125|454918509|FG001|Overall Study|Study terminated by sponsor|1|||
126442470|NCT01646125|454918508|FG000|Overall Study|Subject/Guardian decision|1|||
126442471|NCT01646125|454918509|FG001|Overall Study|Subject/Guardian decision|1|||
126442472|NCT01528969|454918516|FG000|Overall Study|absent from the school at baseline|2|||
126442473|NCT01528969|454918517|FG001|Overall Study|absent from the school at baseline|0|||
126442474|NCT01106690|454918518|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
126442475|NCT01106690|454918519|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
126442476|NCT01106690|454918520|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
126442477|NCT01106690|454918518|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
126442478|NCT01106690|454918519|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
126442479|NCT01106690|454918520|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
126442480|NCT01106690|454918518|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
126442481|NCT01106690|454918519|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
126442482|NCT01106690|454918520|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
126442483|NCT01106690|454918518|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
126442484|NCT01106690|454918519|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
126442485|NCT01106690|454918520|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
126442486|NCT01106690|454918518|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
126442487|NCT01106690|454918519|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
126442488|NCT01106690|454918520|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
126442489|NCT01106690|454918518|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126442490|NCT01106690|454918519|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
126442491|NCT01106690|454918520|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126442492|NCT01106690|454918518|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
126442493|NCT01106690|454918519|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126442494|NCT01106690|454918520|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126442495|NCT01106690|454918518|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
126442496|NCT01106690|454918519|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
126442497|NCT01106690|454918520|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
126442498|NCT01106690|454918518|FG000|Core Period: Baseline to Week 26|Other|10|||
126442499|NCT01106690|454918519|FG001|Core Period: Baseline to Week 26|Other|2|||
126442500|NCT01106690|454918520|FG002|Core Period: Baseline to Week 26|Other|6|||
126442501|NCT01106690|454918518|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
126442502|NCT01106690|454918519|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
126442503|NCT01106690|454918520|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
126442504|NCT01106690|454918518|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126442505|NCT01106690|454918519|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
126442506|NCT01106690|454918520|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
126442507|NCT01106690|454918518|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126442508|NCT01106690|454918519|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
126442509|NCT01106690|454918520|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
126442510|NCT01106690|454918518|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
126442511|NCT01106690|454918519|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
126442512|NCT01106690|454918520|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
126442513|NCT01106690|454918518|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
126442514|NCT01106690|454918519|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
126442515|NCT01106690|454918520|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126442516|NCT01106690|454918518|FG000|Extension Period: Week 26 to Week 52|Other|8|||
126442517|NCT01106690|454918519|FG001|Extension Period: Week 26 to Week 52|Other|3|||
126442518|NCT01106690|454918520|FG002|Extension Period: Week 26 to Week 52|Other|4|||
126442519|NCT01106690|454918518|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
126442520|NCT01106690|454918519|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126442521|NCT01106690|454918520|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126442522|NCT03219528|454918526|FG000|Overall Study|Lost to Follow-up|5|||
126442523|NCT03219528|454918527|FG001|Overall Study|Lost to Follow-up|4|||
126442524|NCT03219528|454918526|FG000|Overall Study|Withdrawal by Subject|4|||
126442525|NCT03219528|454918527|FG001|Overall Study|Withdrawal by Subject|4|||
126442526|NCT02120898|454918528|FG000|Overall Study|Withdrawal by Subject|4|||
126442527|NCT02120898|454918529|FG001|Overall Study|Withdrawal by Subject|2|||
126442528|NCT02120898|454918530|FG002|Overall Study|Withdrawal by Subject|2|||
126442529|NCT02120898|454918528|FG000|Overall Study|Non-compliance with study drug|3|||
126442530|NCT02120898|454918529|FG001|Overall Study|Non-compliance with study drug|0|||
126442531|NCT02120898|454918530|FG002|Overall Study|Non-compliance with study drug|0|||
126442532|NCT02120898|454918528|FG000|Overall Study|Adverse Event|1|||
126442533|NCT02120898|454918529|FG001|Overall Study|Adverse Event|2|||
126442534|NCT02120898|454918530|FG002|Overall Study|Adverse Event|1|||
126442535|NCT02120898|454918528|FG000|Overall Study|Protocol Violation|1|||
126442536|NCT02120898|454918529|FG001|Overall Study|Protocol Violation|2|||
126442537|NCT02120898|454918530|FG002|Overall Study|Protocol Violation|0|||
126442538|NCT02120898|454918528|FG000|Overall Study|Lost to Follow-up|0|||
126442539|NCT02120898|454918529|FG001|Overall Study|Lost to Follow-up|0|||
126442540|NCT02120898|454918530|FG002|Overall Study|Lost to Follow-up|1|||
126442541|NCT00831181|454918531|FG000|Overall Study|Adverse Event|12|||
126442542|NCT00196313|454918534|FG000|Overall Study|Protocol Violation|2|||
126442543|NCT00196313|454918535|FG001|Overall Study|Protocol Violation|3|||
126442544|NCT00196313|454918534|FG000|Overall Study|Withdrawal by Subject|3|||
126442545|NCT00196313|454918535|FG001|Overall Study|Withdrawal by Subject|1|||
126442546|NCT00196313|454918534|FG000|Overall Study|Adverse Event|3|||
126442547|NCT00196313|454918535|FG001|Overall Study|Adverse Event|1|||
126353817|NCT05537571|454585898|FG003|Overall Study|Hepatitis A screening result|0|||
126353818|NCT05537571|454585899|FG004|Overall Study|Hepatitis A screening result|0|||
126353819|NCT05537571|454585895|FG000|Overall Study|Lost to Follow-up|0|||
126353820|NCT05537571|454585896|FG001|Overall Study|Lost to Follow-up|0|||
126353821|NCT05537571|454585897|FG002|Overall Study|Lost to Follow-up|1|||
126353822|NCT05537571|454585898|FG003|Overall Study|Lost to Follow-up|0|||
126353823|NCT05537571|454585899|FG004|Overall Study|Lost to Follow-up|1|||
126353824|NCT05752487|454585904|FG000|Overall Study|Enrolled, not treated|9|||
126353825|NCT05752487|454585904|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
126353826|NCT05752487|454585904|FG000|Overall Study|Withdrawal by Subject|2|||
126353827|NCT03091439|454585905|FG000|Overall Study|Study Terminated by the Sponsor|1|||
126353828|NCT03091439|454585906|FG001|Overall Study|Study Terminated by the Sponsor|0|||
126353829|NCT01860989|454585907|FG000|Overall Study|Unsatisfactory therapeutic|5|||
126353830|NCT01685437|454585910|FG000|Overall Study|Withdrawal by Subject|22|||
126353831|NCT01685437|454585910|FG000|Overall Study|Lost to Follow-up|3|||
126353832|NCT01685437|454585910|FG000|Overall Study|Adverse Event|1|||
126353833|NCT01685437|454585910|FG000|Overall Study|Protocol Violation|4|||
126353834|NCT01685437|454585910|FG000|Overall Study|Unable to make visits due to work|1|||
126353835|NCT03770455|454585917|FG000|Overall Study|Screen failures|3|||
126353836|NCT01039675|454585920|FG000|Overall Study|Adverse Event|0|||
126353837|NCT01039675|454585921|FG001|Overall Study|Adverse Event|2|||
126353838|NCT01039675|454585920|FG000|Overall Study|Lack of Efficacy|0|||
126353839|NCT01039675|454585921|FG001|Overall Study|Lack of Efficacy|2|||
126353840|NCT01039675|454585920|FG000|Overall Study|Withdrawal by Subject|0|||
126353841|NCT01039675|454585921|FG001|Overall Study|Withdrawal by Subject|1|||
126353842|NCT01039675|454585920|FG000|Overall Study|Lost to Follow-up|0|||
126353843|NCT01039675|454585921|FG001|Overall Study|Lost to Follow-up|1|||
126353844|NCT01039675|454585920|FG000|Overall Study|Physician Decision|0|||
126353845|NCT01039675|454585921|FG001|Overall Study|Physician Decision|1|||
126353846|NCT00134719|454587495|FG000|Primary Vaccination Phase|Adverse Event|4|||
126353847|NCT00134719|454587496|FG001|Primary Vaccination Phase|Adverse Event|0|||
126353848|NCT00134719|454587497|FG002|Primary Vaccination Phase|Adverse Event|0|||
126353849|NCT00134719|454587495|FG000|Primary Vaccination Phase|Protocol Violation|1|||
126353850|NCT00134719|454587496|FG001|Primary Vaccination Phase|Protocol Violation|0|||
126353851|NCT00134719|454587497|FG002|Primary Vaccination Phase|Protocol Violation|0|||
126353852|NCT00134719|454587495|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
126353853|NCT00134719|454587496|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
126353854|NCT00134719|454587497|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
126353855|NCT00134719|454587495|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
126353856|NCT00134719|454587496|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
126353857|NCT00134719|454587497|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
126353858|NCT00134719|454587495|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
126353859|NCT00134719|454587496|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
126353860|NCT00134719|454587497|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
126353861|NCT00134719|454587495|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
126353862|NCT00134719|454587496|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
126353863|NCT00134719|454587497|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
126353864|NCT03439839|454587498|FG000|Overall Study|Death|3|||
126353865|NCT03439839|454587499|FG001|Overall Study|Death|0|||
126353866|NCT02582632|454587505|FG000|Overall Study|Other|1|||
126353867|NCT03298061|454587506|FG000|Overall Study|Adverse Event|3|||
126353868|NCT03298061|454587506|FG000|Overall Study|Lack of Efficacy|6|||
126353869|NCT03298061|454587506|FG000|Overall Study|Protocol Violation|1|||
126353870|NCT03298061|454587506|FG000|Overall Study|Physician Decision|7|||
126353871|NCT03298061|454587506|FG000|Overall Study|Withdrawal by Subject|10|||
126353872|NCT00992836|454587509|FG000|Overall Study|Lost to Follow-up|1|||
126353873|NCT00992836|454587509|FG000|Overall Study|Withdrawal by Subject|2|||
126353874|NCT00992836|454587509|FG000|Overall Study|Protocol Violation|2|||
126353875|NCT01617967|454587513|FG000|Overall Study|Protocol Violation|0|||
126353876|NCT01617967|454587514|FG001|Overall Study|Protocol Violation|0|||
126353877|NCT01617967|454587515|FG002|Overall Study|Protocol Violation|0|||
126353878|NCT01617967|454587516|FG003|Overall Study|Protocol Violation|1|||
126353879|NCT01617967|454587517|FG004|Overall Study|Protocol Violation|0|||
126353880|NCT01617967|454587518|FG005|Overall Study|Protocol Violation|0|||
126353881|NCT01617967|454587513|FG000|Overall Study|Withdrawal by Subject|0|||
126353882|NCT01617967|454587514|FG001|Overall Study|Withdrawal by Subject|0|||
126353883|NCT01617967|454587515|FG002|Overall Study|Withdrawal by Subject|0|||
126353884|NCT01617967|454587516|FG003|Overall Study|Withdrawal by Subject|0|||
126353885|NCT01617967|454587517|FG004|Overall Study|Withdrawal by Subject|0|||
126442548|NCT00196313|454918534|FG000|Overall Study|Subject Pregnant|1|||
126353886|NCT01617967|454587518|FG005|Overall Study|Withdrawal by Subject|1|||
126353887|NCT01617967|454587513|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
126353888|NCT01617967|454587514|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
126442549|NCT00196313|454918535|FG001|Overall Study|Subject Pregnant|1|||
126442550|NCT00196313|454918534|FG000|Overall Study|Lost to Follow-up|2|||
126442551|NCT00196313|454918535|FG001|Overall Study|Lost to Follow-up|2|||
126442552|NCT00043979|454918536|FG000|Period 1|recipient with progressive disease|7|||
126442553|NCT00043979|454918537|FG001|Period 1|recipient with progressive disease|4|||
126442554|NCT00043979|454918538|FG002|Period 1|recipient with progressive disease|3|||
126442555|NCT04085289|454918539|FG000|Overall Study|Withdrawal by Subject|0|||
126442556|NCT04085289|454918540|FG001|Overall Study|Withdrawal by Subject|0|||
126442557|NCT04085289|454918541|FG002|Overall Study|Withdrawal by Subject|1|||
126442558|NCT02919995|454918548|FG000|Overall Study|Adverse Event|0|||
126442559|NCT02919995|454918549|FG001|Overall Study|Adverse Event|0|||
126442560|NCT02919995|454918550|FG002|Overall Study|Adverse Event|0|||
126442561|NCT02919995|454918551|FG003|Overall Study|Adverse Event|0|||
126442562|NCT02919995|454918552|FG004|Overall Study|Adverse Event|0|||
126442563|NCT02919995|454918553|FG005|Overall Study|Adverse Event|1|||
126442564|NCT02454517|454918564|FG000|Overall Study|Withdrawal by Subject|3|||
126442565|NCT02454517|454918565|FG001|Overall Study|Withdrawal by Subject|0|||
126442566|NCT02454517|454918564|FG000|Overall Study|Lost to Follow-up|4|||
126442567|NCT02454517|454918565|FG001|Overall Study|Lost to Follow-up|7|||
126442568|NCT02454517|454918564|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
126442569|NCT02454517|454918565|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
126442570|NCT00473382|454918566|FG000|Core Study|Adverse Event|3|||
126442571|NCT00473382|454918567|FG001|Core Study|Adverse Event|1|||
126442572|NCT00473382|454918568|FG002|Core Study|Adverse Event|1|||
126442573|NCT00473382|454918566|FG000|Core Study|Death|3|||
126442574|NCT00473382|454918567|FG001|Core Study|Death|5|||
126442575|NCT00473382|454918568|FG002|Core Study|Death|10|||
126442576|NCT00473382|454918566|FG000|Core Study|Lost to Follow-up|3|||
126442577|NCT00473382|454918567|FG001|Core Study|Lost to Follow-up|3|||
126442578|NCT00473382|454918568|FG002|Core Study|Lost to Follow-up|3|||
126442579|NCT00473382|454918566|FG000|Core Study|Physician Decision|1|||
126442580|NCT00473382|454918567|FG001|Core Study|Physician Decision|2|||
126442581|NCT00473382|454918568|FG002|Core Study|Physician Decision|2|||
126442582|NCT00473382|454918566|FG000|Core Study|Subject non-compliance|5|||
126442583|NCT00473382|454918567|FG001|Core Study|Subject non-compliance|2|||
126442584|NCT00473382|454918568|FG002|Core Study|Subject non-compliance|1|||
126442585|NCT00473382|454918566|FG000|Core Study|Subject needed other treatment|1|||
126442586|NCT00473382|454918567|FG001|Core Study|Subject needed other treatment|3|||
126442587|NCT00473382|454918568|FG002|Core Study|Subject needed other treatment|2|||
126442588|NCT00473382|454918566|FG000|Core Study|Subject's decision|12|||
126442589|NCT00473382|454918567|FG001|Core Study|Subject's decision|11|||
126442590|NCT00473382|454918568|FG002|Core Study|Subject's decision|10|||
126442591|NCT00473382|454918566|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
126442592|NCT00473382|454918567|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
126442593|NCT00473382|454918568|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
126442594|NCT00473382|454918566|FG000|Open-label Extension Through Month 48|Death|1|||
126442595|NCT00473382|454918567|FG001|Open-label Extension Through Month 48|Death|3|||
126442596|NCT00473382|454918568|FG002|Open-label Extension Through Month 48|Death|3|||
126442597|NCT00473382|454918566|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
126442598|NCT00473382|454918567|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
126442599|NCT00473382|454918568|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
126442600|NCT00473382|454918566|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
126442601|NCT00473382|454918567|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
126442602|NCT00473382|454918568|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
126442603|NCT00473382|454918566|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
126442604|NCT00473382|454918567|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
126442605|NCT00473382|454918568|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
126442606|NCT00473382|454918566|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
126442607|NCT00473382|454918567|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
126442608|NCT00473382|454918568|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
126442609|NCT00473382|454918566|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
126442610|NCT00473382|454918567|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
126442611|NCT00473382|454918568|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
126442612|NCT00473382|454918566|FG000|Open-label Extension Through Month 60|Death|1|||
126442613|NCT00473382|454918567|FG001|Open-label Extension Through Month 60|Death|7|||
126442614|NCT00473382|454918568|FG002|Open-label Extension Through Month 60|Death|4|||
126442615|NCT00473382|454918566|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
126442616|NCT00473382|454918567|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
126442617|NCT00473382|454918568|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
126442618|NCT00473382|454918566|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
126442619|NCT00473382|454918567|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
126442620|NCT00473382|454918568|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
126691052|NCT01114529|455824087|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
126691053|NCT01114529|455824088|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
126691054|NCT01114529|455824086|FG000|Completed Study Medication at Month 24|Death|2|||
126691055|NCT01114529|455824087|FG001|Completed Study Medication at Month 24|Death|1|||
126691056|NCT01114529|455824088|FG002|Completed Study Medication at Month 24|Death|2|||
126691057|NCT01114529|455824086|FG000|Completed Study Medication at Month 24|Graft loss|0|||
126691058|NCT01114529|455824087|FG001|Completed Study Medication at Month 24|Graft loss|2|||
126691059|NCT01114529|455824088|FG002|Completed Study Medication at Month 24|Graft loss|0|||
126691060|NCT01114529|455824086|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
126691061|NCT01114529|455824087|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
126691062|NCT01114529|455824088|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
126691063|NCT01114529|455824086|FG000|Completed Study Medication at Month 24|Missing|2|||
126691064|NCT01114529|455824087|FG001|Completed Study Medication at Month 24|Missing|0|||
126691065|NCT01114529|455824088|FG002|Completed Study Medication at Month 24|Missing|0|||
126691066|NCT01114529|455824086|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
126691067|NCT01114529|455824087|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
126691068|NCT01114529|455824088|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
126691069|NCT01114529|455824086|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
126691070|NCT01114529|455824087|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
126691071|NCT01114529|455824088|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
126691072|NCT01114529|455824086|FG000|Completed Study Phase at Month 24|Death|8|||
126691073|NCT01114529|455824087|FG001|Completed Study Phase at Month 24|Death|5|||
126691074|NCT01114529|455824088|FG002|Completed Study Phase at Month 24|Death|4|||
126691075|NCT01114529|455824086|FG000|Completed Study Phase at Month 24|Other|2|||
126691076|NCT01114529|455824087|FG001|Completed Study Phase at Month 24|Other|0|||
126691077|NCT01114529|455824088|FG002|Completed Study Phase at Month 24|Other|0|||
126691078|NCT01114529|455824086|FG000|Completed Study Phase at Month 24|Missing|2|||
126691079|NCT01114529|455824087|FG001|Completed Study Phase at Month 24|Missing|0|||
126691080|NCT01114529|455824088|FG002|Completed Study Phase at Month 24|Missing|0|||
126691081|NCT02167945|455824094|FG000|Overall Study|Adverse Event|16|||
126691082|NCT02167945|455824094|FG000|Overall Study|Withdrew Consent|42|||
126691083|NCT02167945|455824094|FG000|Overall Study|Lost to Follow-up|122|||
126691084|NCT02167945|455824094|FG000|Overall Study|COVID-19 logistical restrictions|6|||
126691085|NCT02167945|455824094|FG000|Overall Study|Other, not specified|63|||
126691086|NCT00132730|455824095|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
126691087|NCT00132730|455824096|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
126691088|NCT00132730|455824097|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
126691089|NCT00132730|455824098|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
126691090|NCT00132730|455824099|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
126691091|NCT00132730|455824100|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
126353889|NCT01617967|454587515|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
126691092|NCT00132730|455824095|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
126691093|NCT00132730|455824096|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
126760267|NCT02221882|456072439|FG005|Overall Study|Death|0|||
126353890|NCT01617967|454587516|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
126353891|NCT01617967|454587517|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
126353892|NCT01617967|454587518|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
126353893|NCT05276804|454587523|FG000|Overall Study|screen failure|23|||
126353894|NCT05276804|454587524|FG001|Overall Study|screen failure|0|||
126353895|NCT02827708|454587525|FG000|Overall Study|Lost to Follow-up|3|||
126353896|NCT02827708|454587526|FG001|Overall Study|Lost to Follow-up|1|||
126353897|NCT02827708|454587525|FG000|Overall Study|Withdrawal by Subject|1|||
126353898|NCT02827708|454587526|FG001|Overall Study|Withdrawal by Subject|2|||
126353899|NCT02827708|454587525|FG000|Overall Study|Death|1|||
126353900|NCT02827708|454587526|FG001|Overall Study|Death|2|||
126353901|NCT01137812|454587527|FG000|Overall Study|Adverse Event|21|||
126353902|NCT01137812|454587528|FG001|Overall Study|Adverse Event|14|||
126353903|NCT01137812|454587527|FG000|Overall Study|Lost to Follow-up|6|||
126353904|NCT01137812|454587528|FG001|Overall Study|Lost to Follow-up|8|||
126353905|NCT01137812|454587527|FG000|Overall Study|Physician Decision|25|||
126353906|NCT01137812|454587528|FG001|Overall Study|Physician Decision|17|||
126353907|NCT01137812|454587527|FG000|Overall Study|Protocol Violation|5|||
126353908|NCT01137812|454587528|FG001|Overall Study|Protocol Violation|4|||
126691094|NCT00132730|455824097|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
126691095|NCT00132730|455824098|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
126691096|NCT00132730|455824099|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
126691097|NCT00132730|455824100|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
126691098|NCT00132730|455824095|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
126691099|NCT00132730|455824096|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
126691100|NCT00132730|455824097|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
126691101|NCT00132730|455824098|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
126691102|NCT00132730|455824099|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
126691103|NCT00132730|455824100|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
126691104|NCT00132730|455824095|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
126691105|NCT00132730|455824096|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
126691106|NCT00132730|455824097|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
126691107|NCT00132730|455824098|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
126691108|NCT00132730|455824099|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
126691109|NCT00132730|455824100|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
126691110|NCT00132730|455824095|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
126691111|NCT00132730|455824096|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
126691112|NCT00132730|455824097|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
126691113|NCT00132730|455824098|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
126691114|NCT00132730|455824099|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
126691115|NCT00132730|455824100|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
126691116|NCT00132730|455824095|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
126691117|NCT00132730|455824096|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
126691118|NCT00132730|455824097|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
126691119|NCT00132730|455824098|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
126691120|NCT00132730|455824099|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
126691121|NCT00132730|455824100|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
126691122|NCT00132730|455824095|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
126691123|NCT00132730|455824096|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
126691124|NCT00132730|455824097|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
126691125|NCT00132730|455824098|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
126691126|NCT00132730|455824099|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
126691127|NCT00132730|455824100|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
126691128|NCT00132730|455824095|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
126691129|NCT00132730|455824096|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
126691130|NCT00132730|455824097|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
126691131|NCT00132730|455824098|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
126691132|NCT00132730|455824099|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
126691133|NCT00132730|455824100|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
126442621|NCT00473382|454918566|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
126442622|NCT00473382|454918567|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
126442623|NCT00473382|454918568|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
126442624|NCT00473382|454918566|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
126442625|NCT00473382|454918567|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
126442626|NCT00473382|454918568|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
126442627|NCT01189032|454918569|FG000|Overall Study|Adverse Event|1|||
126442628|NCT01189032|454918570|FG001|Overall Study|Adverse Event|3|||
126442629|NCT01189032|454918571|FG002|Overall Study|Adverse Event|4|||
126442630|NCT01189032|454918569|FG000|Overall Study|Lack of Efficacy|2|||
126691134|NCT00132730|455824095|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
126691135|NCT00132730|455824096|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
126691136|NCT00132730|455824097|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
126691137|NCT00132730|455824098|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
126691138|NCT00132730|455824099|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
126691139|NCT00132730|455824100|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
126691140|NCT00132730|455824095|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
126691141|NCT00132730|455824096|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
126691142|NCT00132730|455824097|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
126691143|NCT00132730|455824098|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
126691144|NCT00132730|455824099|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
126353909|NCT01137812|454587527|FG000|Overall Study|Withdrawal by Subject|5|||
126353910|NCT01137812|454587528|FG001|Overall Study|Withdrawal by Subject|13|||
126353911|NCT01137812|454587527|FG000|Overall Study|Death|2|||
126353912|NCT01137812|454587528|FG001|Overall Study|Death|0|||
126353913|NCT01137812|454587527|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
126353914|NCT01137812|454587528|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
126353915|NCT01137812|454587527|FG000|Overall Study|Other|19|||
126353916|NCT01137812|454587528|FG001|Overall Study|Other|27|||
126353917|NCT04621760|454587532|FG000|Overall Study|Lost to Follow-up|2|||
126353918|NCT04621760|454587533|FG001|Overall Study|Lost to Follow-up|4|||
126353919|NCT04621760|454587532|FG000|Overall Study|Withdrawal by Subject|1|||
126353920|NCT04621760|454587533|FG001|Overall Study|Withdrawal by Subject|0|||
126353921|NCT04602000|454587534|FG000|Overall Study|Withdrawal by Subject|3|||
126353922|NCT04602000|454587535|FG001|Overall Study|Withdrawal by Subject|6|||
126353923|NCT04602000|454587536|FG002|Overall Study|Withdrawal by Subject|3|||
126353924|NCT04602000|454587537|FG003|Overall Study|Withdrawal by Subject|27|||
126353925|NCT04602000|454587538|FG004|Overall Study|Withdrawal by Subject|39|||
126760268|NCT00796367|456072440|FG000|Overall Study|Adverse Event|6|||
126353926|NCT04602000|454587534|FG000|Overall Study|Physician Decision|1|||
126353927|NCT04602000|454587535|FG001|Overall Study|Physician Decision|0|||
126353928|NCT04602000|454587536|FG002|Overall Study|Physician Decision|0|||
126353929|NCT04602000|454587537|FG003|Overall Study|Physician Decision|2|||
126353930|NCT04602000|454587538|FG004|Overall Study|Physician Decision|2|||
126353931|NCT04602000|454587534|FG000|Overall Study|Death|0|||
126353932|NCT04602000|454587535|FG001|Overall Study|Death|1|||
126353933|NCT04602000|454587536|FG002|Overall Study|Death|0|||
126353934|NCT04602000|454587537|FG003|Overall Study|Death|1|||
126353935|NCT04602000|454587538|FG004|Overall Study|Death|2|||
126353936|NCT04602000|454587534|FG000|Overall Study|Lost to Follow-up|0|||
126353937|NCT04602000|454587535|FG001|Overall Study|Lost to Follow-up|0|||
126353938|NCT04602000|454587536|FG002|Overall Study|Lost to Follow-up|0|||
126353939|NCT04602000|454587537|FG003|Overall Study|Lost to Follow-up|3|||
126353940|NCT04602000|454587538|FG004|Overall Study|Lost to Follow-up|4|||
126353941|NCT04602000|454587534|FG000|Overall Study|Other|4|||
126353942|NCT04602000|454587535|FG001|Overall Study|Other|1|||
126353943|NCT04602000|454587536|FG002|Overall Study|Other|2|||
126353944|NCT04602000|454587537|FG003|Overall Study|Other|5|||
126353945|NCT04602000|454587538|FG004|Overall Study|Other|4|||
126353946|NCT04602000|454587534|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
126353947|NCT04602000|454587535|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
126353948|NCT04602000|454587536|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
126353949|NCT04602000|454587537|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
126353950|NCT04602000|454587538|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
126353951|NCT00471354|454587540|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
126353952|NCT00471354|454587540|FG000|Overall Study|Adverse Event|13|||
126353953|NCT00471354|454587540|FG000|Overall Study|Protocol Violation|12|||
126353954|NCT00471354|454587540|FG000|Overall Study|Withdrawal by Subject|1|||
126353955|NCT00471354|454587540|FG000|Overall Study|Physician Decision|4|||
126353956|NCT00471354|454587540|FG000|Overall Study|Sponsor Decision|1|||
126353957|NCT00471354|454587540|FG000|Overall Study|Lost to Follow-up|3|||
126353958|NCT00471354|454587540|FG000|Overall Study|Lack of Efficacy|5|||
126353959|NCT00471354|454587540|FG000|Overall Study|Patient/Caregiver Decision|12|||
126353960|NCT01875237|454587541|FG000|Overall Study|GVDH before DLI|1|||
126353961|NCT01875237|454587542|FG001|Overall Study|GVDH before DLI|0|||
126353962|NCT01875237|454587541|FG000|Overall Study|DLI cells could not be produced|1|||
126353963|NCT01875237|454587542|FG001|Overall Study|DLI cells could not be produced|0|||
126353964|NCT01913470|454587546|FG000|Overall Study|Lost to Follow-up|0|||
126353965|NCT01913470|454587547|FG001|Overall Study|Lost to Follow-up|1|||
126353966|NCT01913470|454587546|FG000|Overall Study|Physician Decision|0|||
126353967|NCT01913470|454587547|FG001|Overall Study|Physician Decision|1|||
126353968|NCT01913470|454587546|FG000|Overall Study|Withdrawal by Subject|0|||
126442631|NCT01189032|454918570|FG001|Overall Study|Lack of Efficacy|3|||
126442632|NCT01189032|454918571|FG002|Overall Study|Lack of Efficacy|0|||
126442633|NCT01189032|454918569|FG000|Overall Study|Withdrawal by Subject|1|||
126442634|NCT01189032|454918570|FG001|Overall Study|Withdrawal by Subject|0|||
126442635|NCT01189032|454918571|FG002|Overall Study|Withdrawal by Subject|1|||
126442636|NCT01189032|454918569|FG000|Overall Study|Protocol Violation|1|||
126442637|NCT01189032|454918570|FG001|Overall Study|Protocol Violation|1|||
126442638|NCT01189032|454918571|FG002|Overall Study|Protocol Violation|1|||
126442639|NCT00275509|454918572|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
126442640|NCT00275509|454918573|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
126442641|NCT03196349|454918574|FG000|Overall Study|Did not receive study drug|0|||
126442642|NCT03196349|454918575|FG001|Overall Study|Did not receive study drug|1|||
126442643|NCT03196349|454918576|FG002|Overall Study|Did not receive study drug|2|||
126442644|NCT03196349|454918574|FG000|Overall Study|No data entered|2|||
126442645|NCT03196349|454918575|FG001|Overall Study|No data entered|4|||
126442646|NCT03196349|454918576|FG002|Overall Study|No data entered|0|||
126442647|NCT03196349|454918574|FG000|Overall Study|Study Terminated early|15|||
126442648|NCT03196349|454918575|FG001|Overall Study|Study Terminated early|9|||
126442649|NCT03196349|454918576|FG002|Overall Study|Study Terminated early|11|||
126442650|NCT03388164|454918581|FG000|Overall Study|Withdrawal by Subject|3|||
126442651|NCT03388164|454918582|FG001|Overall Study|Withdrawal by Subject|1|||
126442652|NCT03967444|454918583|FG000|Overall Study|Lost to Follow-up|1|||
126442653|NCT03967444|454918584|FG001|Overall Study|Lost to Follow-up|2|||
126442654|NCT01821118|454918591|FG000|Overall Study|Death|0|||
126442655|NCT01821118|454918592|FG001|Overall Study|Death|1|||
126442656|NCT01605799|454918593|FG000|Overall Study|Withdrawal by Subject|2|||
126442657|NCT01605799|454918594|FG001|Overall Study|Withdrawal by Subject|1|||
126442658|NCT00345358|454918595|FG000|Primary Vaccination Phase|Other|0|||
126442659|NCT00345358|454918596|FG001|Primary Vaccination Phase|Other|1|||
126442660|NCT00345358|454918597|FG002|Primary Vaccination Phase|Other|1|||
126442661|NCT00345358|454918598|FG003|Primary Vaccination Phase|Other|0|||
126442662|NCT00345358|454918595|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
126760269|NCT00796367|456072441|FG001|Overall Study|Adverse Event|4|||
126442663|NCT00345358|454918596|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
126442664|NCT00345358|454918597|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
126442665|NCT00345358|454918598|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
126442666|NCT00345358|454918595|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
126442667|NCT00345358|454918596|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
126442668|NCT00345358|454918597|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
126442669|NCT00345358|454918598|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
126760270|NCT00796367|456072442|FG002|Overall Study|Adverse Event|7|||
126442670|NCT00345358|454918595|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
126760271|NCT00796367|456072440|FG000|Overall Study|Lost to Follow-up|5|||
126760272|NCT00796367|456072441|FG001|Overall Study|Lost to Follow-up|4|||
126760273|NCT00796367|456072442|FG002|Overall Study|Lost to Follow-up|21|||
126760274|NCT00796367|456072440|FG000|Overall Study|Withdrawal by Subject|9|||
126442671|NCT00345358|454918596|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
126442672|NCT00345358|454918597|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
126442673|NCT00345358|454918598|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
126442674|NCT00345358|454918595|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
126442675|NCT00345358|454918596|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
126442676|NCT00345358|454918597|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
126442677|NCT00345358|454918598|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
126442678|NCT00345358|454918595|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
126442679|NCT00345358|454918596|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
126442680|NCT00345358|454918597|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
126442681|NCT00345358|454918598|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
126442682|NCT02892448|454918599|FG000|Overall Study|Screening failure|2|||
126442683|NCT02892448|454918600|FG001|Overall Study|Screening failure|2|||
126442684|NCT02892448|454918601|FG002|Overall Study|Screening failure|1|||
126442685|NCT01012440|454918602|FG000|Overall Study|Withdrawal by Subject|2|||
126442686|NCT00594815|454918603|FG000|Overall Study|Never Treated|3|||
126442687|NCT00594815|454918603|FG000|Overall Study|Withdrawal by Subject|2|||
126442688|NCT00594815|454918603|FG000|Overall Study|Toxicity|4|||
126442689|NCT02691507|454918604|FG000|Overall Study|Missed Visit 3|0|||
126442690|NCT02691507|454918605|FG001|Overall Study|Missed Visit 3|1|||
126442691|NCT01812252|454918606|FG000|Overall Study|Persistent Disease|1|||
126442692|NCT01812252|454918607|FG001|Overall Study|Persistent Disease|0|||
126442693|NCT01812252|454918606|FG000|Overall Study|Not transplanted|11|||
126442694|NCT01812252|454918607|FG001|Overall Study|Not transplanted|11|||
126442695|NCT01812252|454918606|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
126442696|NCT01812252|454918607|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
126442697|NCT01812252|454918606|FG000|Overall Study|Withdrawal by Subject|1|||
126691145|NCT00132730|455824100|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
126691146|NCT00132730|455824095|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
126691147|NCT00132730|455824096|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
126442698|NCT01812252|454918607|FG001|Overall Study|Withdrawal by Subject|1|||
126442699|NCT01812252|454918606|FG000|Overall Study|Screen Failure|1|||
126442700|NCT01812252|454918607|FG001|Overall Study|Screen Failure|0|||
126442701|NCT04634253|454918609|FG000|Overall Study|Adverse Event|1|||
126691148|NCT00132730|455824097|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
126691149|NCT00132730|455824098|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
126691150|NCT00132730|455824099|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
126691151|NCT00132730|455824100|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
126691152|NCT00132730|455824095|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
126691153|NCT00132730|455824096|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
126691154|NCT00132730|455824097|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
126691155|NCT00132730|455824098|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
126691156|NCT00132730|455824099|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
126691157|NCT00132730|455824100|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
126691158|NCT02623335|455824101|FG000|Overall Study|Death|8|||
126691159|NCT02623335|455824102|FG001|Overall Study|Death|7|||
126691160|NCT02623335|455824101|FG000|Overall Study|Lost to Follow-up|15|||
126691161|NCT02623335|455824102|FG001|Overall Study|Lost to Follow-up|23|||
126691162|NCT02623335|455824101|FG000|Overall Study|Withdrawal by Subject|2|||
126691163|NCT02623335|455824102|FG001|Overall Study|Withdrawal by Subject|5|||
126691164|NCT02623335|455824101|FG000|Overall Study|Protocol Violation|2|||
126691165|NCT02623335|455824102|FG001|Overall Study|Protocol Violation|1|||
126353969|NCT01913470|454587547|FG001|Overall Study|Withdrawal by Subject|1|||
126691166|NCT03739528|455824103|FG000|Overall Study|Not treated|8|||
126691167|NCT03739528|455824104|FG001|Overall Study|Not treated|12|||
126691168|NCT03739528|455824103|FG000|Overall Study|Treatment and study discontinued|6|||
126691169|NCT03739528|455824104|FG001|Overall Study|Treatment and study discontinued|2|||
126691170|NCT03739528|455824103|FG000|Overall Study|Treatment discontinued + study completed|1|||
126691171|NCT03739528|455824104|FG001|Overall Study|Treatment discontinued + study completed|3|||
126691172|NCT01046695|455824105|FG000|Overall Study|Subject had a pacemaker|0|||
126691173|NCT01046695|455824106|FG001|Overall Study|Subject had a pacemaker|1|||
126691174|NCT01046695|455824105|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
126691175|NCT01046695|455824106|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
126691176|NCT01058096|455824107|FG000|Double-blind Treatment Phase|Adverse Event|11|||
126691177|NCT01058096|455824108|FG001|Double-blind Treatment Phase|Adverse Event|15|||
126691178|NCT01058096|455824107|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
126691179|NCT01058096|455824108|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
126691180|NCT01058096|455824107|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
126691181|NCT01058096|455824108|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
126353970|NCT02573467|454587548|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
126353971|NCT02573467|454587549|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
126353972|NCT02573467|454587550|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
126353973|NCT02573467|454587551|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
126353974|NCT02573467|454587548|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
126353975|NCT02573467|454587549|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
126353976|NCT02573467|454587550|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
126353977|NCT02573467|454587551|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
126353978|NCT02573467|454587548|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
126353979|NCT02573467|454587549|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
126353980|NCT02573467|454587550|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
126353981|NCT02573467|454587551|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
126353982|NCT02573467|454587548|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
126353983|NCT02573467|454587549|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
126353984|NCT02573467|454587550|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
126353985|NCT02573467|454587551|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
126353986|NCT02573467|454587548|FG000|Post-treatment Follow up Epoch|Death|1|||
126353987|NCT02573467|454587549|FG001|Post-treatment Follow up Epoch|Death|1|||
126353988|NCT02573467|454587550|FG002|Post-treatment Follow up Epoch|Death|0|||
126353989|NCT02573467|454587551|FG003|Post-treatment Follow up Epoch|Death|1|||
126353990|NCT02573467|454587548|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
126353991|NCT02573467|454587549|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
126353992|NCT02573467|454587550|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
126353993|NCT02573467|454587551|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
126353994|NCT02573467|454587548|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
126353995|NCT02573467|454587549|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
126353996|NCT02573467|454587550|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
126691182|NCT01058096|455824107|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
126691183|NCT01058096|455824108|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
126691184|NCT01058096|455824107|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
126691185|NCT01058096|455824108|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
126691186|NCT01058096|455824107|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
126353997|NCT02573467|454587551|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
126353998|NCT00923702|454587552|FG000|Overall Study|Ongoing enrollment|0|||
126353999|NCT00923702|454587553|FG001|Overall Study|Ongoing enrollment|0|||
126354000|NCT00923702|454587554|FG002|Overall Study|Ongoing enrollment|0|||
126354001|NCT00923702|454587555|FG003|Overall Study|Ongoing enrollment|0|||
126354002|NCT00923702|454587556|FG004|Overall Study|Ongoing enrollment|354|||
126354003|NCT02153827|454587557|FG000|Overall Study|Lost to Follow-up|3|||
126354004|NCT02153827|454587558|FG001|Overall Study|Lost to Follow-up|9|||
126354005|NCT04790201|454587559|FG000|Overall Study|Lost to Follow-up|0|||
126354006|NCT04790201|454587560|FG001|Overall Study|Lost to Follow-up|0|||
126354007|NCT04790201|454587561|FG002|Overall Study|Lost to Follow-up|2|||
126354008|NCT04790201|454587559|FG000|Overall Study|Death|0|||
126354009|NCT04790201|454587560|FG001|Overall Study|Death|1|||
126354010|NCT04790201|454587561|FG002|Overall Study|Death|0|||
126354011|NCT04790201|454587559|FG000|Overall Study|Protocol Violation|1|||
126354012|NCT04790201|454587560|FG001|Overall Study|Protocol Violation|0|||
126354013|NCT04790201|454587561|FG002|Overall Study|Protocol Violation|1|||
126354014|NCT04339972|454587565|FG000|Overall Study|Scheduling Issues|3|||
126354015|NCT04339972|454587566|FG001|Overall Study|Scheduling Issues|3|||
126354016|NCT04339972|454587565|FG000|Overall Study|dropout|1|||
126354017|NCT04339972|454587566|FG001|Overall Study|dropout|1|||
126354018|NCT04339972|454587565|FG000|Overall Study|Technical issues|1|||
126354019|NCT04339972|454587566|FG001|Overall Study|Technical issues|0|||
126354020|NCT04339972|454587565|FG000|Overall Study|Claustraphobia|0|||
126354021|NCT04339972|454587566|FG001|Overall Study|Claustraphobia|1|||
126354022|NCT02942407|454587568|FG000|Overall Study|Lost to Follow-up|3|||
126354023|NCT02942407|454587569|FG001|Overall Study|Lost to Follow-up|2|||
126354024|NCT02942407|454587568|FG000|Overall Study|Withdrawal by Subject|7|||
126354025|NCT02942407|454587569|FG001|Overall Study|Withdrawal by Subject|9|||
126354026|NCT02942407|454587568|FG000|Overall Study|Death|16|||
126354027|NCT02942407|454587569|FG001|Overall Study|Death|13|||
126354028|NCT05221866|454587570|FG000|Overall Study|Withdrawal by Subject|5|||
126354029|NCT05221866|454587571|FG001|Overall Study|Withdrawal by Subject|7|||
126354030|NCT05221866|454587572|FG002|Overall Study|Withdrawal by Subject|6|||
126354031|NCT05221866|454587573|FG003|Overall Study|Withdrawal by Subject|4|||
126354032|NCT05221866|454587570|FG000|Overall Study|Physician Decision|3|||
126354033|NCT05221866|454587571|FG001|Overall Study|Physician Decision|2|||
126354034|NCT05221866|454587572|FG002|Overall Study|Physician Decision|1|||
126354035|NCT05221866|454587573|FG003|Overall Study|Physician Decision|4|||
126354036|NCT05221866|454587570|FG000|Overall Study|Lost to Follow-up|12|||
126354037|NCT05221866|454587571|FG001|Overall Study|Lost to Follow-up|17|||
126354038|NCT05221866|454587572|FG002|Overall Study|Lost to Follow-up|14|||
126354039|NCT05221866|454587573|FG003|Overall Study|Lost to Follow-up|14|||
126354040|NCT05221866|454587570|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
126354041|NCT05221866|454587571|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
126354042|NCT05221866|454587572|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
126354043|NCT05221866|454587573|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
126691187|NCT01058096|455824108|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
126354044|NCT00866320|454587575|FG000|Overall Study|Withdrawal by Subject|4|||
126354045|NCT00866320|454587575|FG000|Overall Study|Death|2|||
126354046|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
126354047|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
126442702|NCT04634253|454918610|FG001|Overall Study|Adverse Event|1|||
126691188|NCT00939692|455824109|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
126691189|NCT00939692|455824110|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
126691190|NCT00939692|455824109|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
126691191|NCT00939692|455824110|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
126691192|NCT03433781|455824116|FG000|Overall Study|Progression of Disease|1|||
126691193|NCT03433781|455824117|FG001|Overall Study|Progression of Disease|0|||
126691194|NCT03433781|455824118|FG002|Overall Study|Progression of Disease|0|||
126691195|NCT03433781|455824116|FG000|Overall Study|Physician Decision|0|||
126691196|NCT03433781|455824117|FG001|Overall Study|Physician Decision|1|||
126691197|NCT03433781|455824118|FG002|Overall Study|Physician Decision|0|||
126691198|NCT00408694|455824119|FG000|Overall Study|Ineligible|1|||
126691199|NCT00408694|455824119|FG000|Overall Study|No protocol treatment|1|||
126691200|NCT03261531|455824122|FG000|Overall Study|Withdrawal by Subject|4|||
126691201|NCT00820755|455824125|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
126691202|NCT00820755|455824126|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
126691203|NCT00820755|455824127|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
126691204|NCT00820755|455824125|FG000|Period 1: Combination Therapy Phase|Death|28|||
126691205|NCT00820755|455824126|FG001|Period 1: Combination Therapy Phase|Death|0|||
126691206|NCT00820755|455824127|FG002|Period 1: Combination Therapy Phase|Death|0|||
126691207|NCT00820755|455824125|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
126691208|NCT00820755|455824126|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
126691209|NCT00820755|455824127|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
126691210|NCT00820755|455824125|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
126691211|NCT00820755|455824126|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
126691212|NCT00820755|455824127|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
126691213|NCT00820755|455824125|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
126691214|NCT00820755|455824126|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
126691215|NCT00820755|455824127|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
126691216|NCT00820755|455824125|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
126691217|NCT00820755|455824126|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
126691218|NCT00820755|455824127|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
126691219|NCT00820755|455824125|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
126691220|NCT00820755|455824126|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
126691221|NCT00820755|455824127|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
126691222|NCT00820755|455824125|FG000|Period 1: Combination Therapy Phase|Other|11|||
126691223|NCT00820755|455824126|FG001|Period 1: Combination Therapy Phase|Other|0|||
126691224|NCT00820755|455824127|FG002|Period 1: Combination Therapy Phase|Other|0|||
126691225|NCT00820755|455824125|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
126691226|NCT00820755|455824126|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
126691227|NCT00820755|455824127|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
126691228|NCT00880256|455824130|FG000|Overall Study|Lost to Follow-up|28|||
126691229|NCT00091832|455824141|FG000|Overall Study|Physician Decision|1|||
126691230|NCT00091832|455824142|FG001|Overall Study|Physician Decision|0|||
126691231|NCT00091832|455824143|FG002|Overall Study|Physician Decision|0|||
126691232|NCT00091832|455824144|FG003|Overall Study|Physician Decision|0|||
126691233|NCT00091832|455824145|FG004|Overall Study|Physician Decision|0|||
126691234|NCT00091832|455824146|FG005|Overall Study|Physician Decision|0|||
126691235|NCT00091832|455824141|FG000|Overall Study|Adverse Event|0|||
126691236|NCT00091832|455824142|FG001|Overall Study|Adverse Event|0|||
126691237|NCT00091832|455824143|FG002|Overall Study|Adverse Event|0|||
126691238|NCT00091832|455824144|FG003|Overall Study|Adverse Event|1|||
126691239|NCT00091832|455824145|FG004|Overall Study|Adverse Event|3|||
126691240|NCT00091832|455824146|FG005|Overall Study|Adverse Event|0|||
126691241|NCT00091832|455824141|FG000|Overall Study|Withdrawal by Subject|4|||
126691242|NCT00091832|455824142|FG001|Overall Study|Withdrawal by Subject|5|||
126691243|NCT00091832|455824143|FG002|Overall Study|Withdrawal by Subject|0|||
126691244|NCT00091832|455824144|FG003|Overall Study|Withdrawal by Subject|1|||
126691245|NCT00091832|455824145|FG004|Overall Study|Withdrawal by Subject|3|||
126691246|NCT00091832|455824146|FG005|Overall Study|Withdrawal by Subject|1|||
126691247|NCT00091832|455824141|FG000|Overall Study|Death|6|||
126691248|NCT00091832|455824142|FG001|Overall Study|Death|4|||
126691249|NCT00091832|455824143|FG002|Overall Study|Death|5|||
126691250|NCT00091832|455824144|FG003|Overall Study|Death|8|||
126691251|NCT00091832|455824145|FG004|Overall Study|Death|5|||
126691252|NCT00091832|455824146|FG005|Overall Study|Death|6|||
126691253|NCT00091832|455824141|FG000|Overall Study|Disease Progression|2|||
126691254|NCT00091832|455824142|FG001|Overall Study|Disease Progression|0|||
126691255|NCT00091832|455824143|FG002|Overall Study|Disease Progression|0|||
126691256|NCT00091832|455824144|FG003|Overall Study|Disease Progression|1|||
126691257|NCT00091832|455824145|FG004|Overall Study|Disease Progression|1|||
126691258|NCT00091832|455824146|FG005|Overall Study|Disease Progression|2|||
126691259|NCT00091832|455824141|FG000|Overall Study|Ineligibility Determined|0|||
126691260|NCT00091832|455824142|FG001|Overall Study|Ineligibility Determined|0|||
126691261|NCT00091832|455824143|FG002|Overall Study|Ineligibility Determined|1|||
126691262|NCT00091832|455824144|FG003|Overall Study|Ineligibility Determined|0|||
126691263|NCT00091832|455824145|FG004|Overall Study|Ineligibility Determined|1|||
126691264|NCT00091832|455824146|FG005|Overall Study|Ineligibility Determined|0|||
126691265|NCT00091832|455824141|FG000|Overall Study|Lost to Follow-up|1|||
126691266|NCT00091832|455824142|FG001|Overall Study|Lost to Follow-up|0|||
126691267|NCT00091832|455824143|FG002|Overall Study|Lost to Follow-up|3|||
126691268|NCT00091832|455824144|FG003|Overall Study|Lost to Follow-up|3|||
126691269|NCT00091832|455824145|FG004|Overall Study|Lost to Follow-up|2|||
126691270|NCT00091832|455824146|FG005|Overall Study|Lost to Follow-up|1|||
126691271|NCT00091832|455824141|FG000|Overall Study|Noncompliance|0|||
126691272|NCT00091832|455824142|FG001|Overall Study|Noncompliance|1|||
126691273|NCT00091832|455824143|FG002|Overall Study|Noncompliance|0|||
126691274|NCT00091832|455824144|FG003|Overall Study|Noncompliance|0|||
126691275|NCT00091832|455824145|FG004|Overall Study|Noncompliance|0|||
126442703|NCT04634253|454918611|FG002|Overall Study|Adverse Event|0|||
126442704|NCT04634253|454918609|FG000|Overall Study|Physician Decision|0|||
126442705|NCT04634253|454918610|FG001|Overall Study|Physician Decision|1|||
126442706|NCT04634253|454918611|FG002|Overall Study|Physician Decision|0|||
126442707|NCT04634253|454918609|FG000|Overall Study|Withdrawal by Subject|1|||
126442708|NCT04634253|454918610|FG001|Overall Study|Withdrawal by Subject|0|||
126442709|NCT04634253|454918611|FG002|Overall Study|Withdrawal by Subject|3|||
126442710|NCT03155841|454918612|FG000|Overall Study|Protocol Violation|3|||
126442711|NCT03155841|454918613|FG001|Overall Study|Protocol Violation|4|||
126442712|NCT00607373|454918618|FG000|Treatment Period|Adverse Event|0|||
126442713|NCT00607373|454918619|FG001|Treatment Period|Adverse Event|4|||
126442714|NCT00607373|454918618|FG000|Treatment Period|Physician Decision|0|||
126442715|NCT00607373|454918619|FG001|Treatment Period|Physician Decision|1|||
126442716|NCT00607373|454918618|FG000|Treatment Period|Withdrawal by Subject|0|||
126442717|NCT00607373|454918619|FG001|Treatment Period|Withdrawal by Subject|1|||
126442718|NCT00607373|454918618|FG000|Follow-up Period|Other|0|||
126442719|NCT00607373|454918619|FG001|Follow-up Period|Other|1|||
126442720|NCT00607373|454918618|FG000|Follow-up Period|Protocol Violation|0|||
126442721|NCT00607373|454918619|FG001|Follow-up Period|Protocol Violation|1|||
126442722|NCT00607373|454918618|FG000|Follow-up Period|Withdrawal by Subject|1|||
126442723|NCT00607373|454918619|FG001|Follow-up Period|Withdrawal by Subject|3|||
126442724|NCT01918306|454918620|FG000|Overall Study|progresive disease|4|||
126442725|NCT01918306|454918621|FG001|Overall Study|progresive disease|0|||
126691276|NCT00091832|455824146|FG005|Overall Study|Noncompliance|0|||
126691277|NCT00091832|455824141|FG000|Overall Study|Other|0|||
126691278|NCT00091832|455824142|FG001|Overall Study|Other|1|||
126691279|NCT00091832|455824143|FG002|Overall Study|Other|2|||
126691280|NCT00091832|455824144|FG003|Overall Study|Other|0|||
126691281|NCT00091832|455824145|FG004|Overall Study|Other|0|||
126691282|NCT00091832|455824146|FG005|Overall Study|Other|0|||
126691283|NCT00091832|455824141|FG000|Overall Study|Protocol Violation|0|||
126691284|NCT00091832|455824142|FG001|Overall Study|Protocol Violation|0|||
126691285|NCT00091832|455824143|FG002|Overall Study|Protocol Violation|1|||
126691286|NCT00091832|455824144|FG003|Overall Study|Protocol Violation|0|||
126691287|NCT00091832|455824145|FG004|Overall Study|Protocol Violation|0|||
126691288|NCT00091832|455824146|FG005|Overall Study|Protocol Violation|1|||
126691289|NCT02154087|455824151|FG000|Overall Study|Study Termination|1|||
126691290|NCT00486278|455824152|FG000|Overall Study|Adverse Event|5|||
126691291|NCT00486278|455824152|FG000|Overall Study|Withdrawal by Subject|2|||
126691292|NCT00486278|455824152|FG000|Overall Study|Physician Decision|2|||
126691293|NCT05501119|455824153|FG000|Overall Study|Withdrawal by Subject|2|||
126691294|NCT05501119|455824153|FG000|Overall Study|Lost to Follow-up|5|||
126691295|NCT02542072|455824154|FG000|First Intervention (1 Month)|Adverse Event|1|||
126691296|NCT02542072|455824155|FG001|First Intervention (1 Month)|Adverse Event|1|||
126691297|NCT02542072|455824154|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
126691298|NCT02542072|455824155|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
126691299|NCT02542072|455824154|FG000|First Intervention (1 Month)|Lens discomfort|1|||
126691300|NCT02542072|455824155|FG001|First Intervention (1 Month)|Lens discomfort|2|||
126691301|NCT02542072|455824154|FG000|First Intervention (1 Month)|Protocol Violation|1|||
126691302|NCT02542072|455824155|FG001|First Intervention (1 Month)|Protocol Violation|0|||
126691303|NCT02542072|455824154|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
126691304|NCT02542072|455824155|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
126691305|NCT02542072|455824154|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
126691306|NCT02542072|455824155|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
126691307|NCT01356589|455824159|FG000|Overall Study|Enrolled, but not treated|3|||
126691308|NCT01356589|455824159|FG000|Overall Study|Dose data not recorded|2|||
126691309|NCT00695565|455824160|FG000|Overall Study|Lost to Follow-up|4|||
126691310|NCT00695565|455824161|FG001|Overall Study|Lost to Follow-up|4|||
126691311|NCT00695565|455824160|FG000|Overall Study|Adverse Event|3|||
126442726|NCT01918306|454918622|FG002|Overall Study|progresive disease|1|||
126442727|NCT01918306|454918623|FG003|Overall Study|progresive disease|1|||
126442728|NCT01918306|454918620|FG000|Overall Study|Withdrawal by Subject|0|||
126442729|NCT01918306|454918621|FG001|Overall Study|Withdrawal by Subject|0|||
126442730|NCT01918306|454918622|FG002|Overall Study|Withdrawal by Subject|0|||
126442731|NCT01918306|454918623|FG003|Overall Study|Withdrawal by Subject|2|||
126442732|NCT01918306|454918620|FG000|Overall Study|neutropenia|1|||
126442733|NCT01918306|454918621|FG001|Overall Study|neutropenia|0|||
126442734|NCT01918306|454918622|FG002|Overall Study|neutropenia|0|||
126442735|NCT01918306|454918623|FG003|Overall Study|neutropenia|0|||
126442736|NCT01918306|454918620|FG000|Overall Study|Lack of Efficacy|1|||
126442737|NCT01918306|454918621|FG001|Overall Study|Lack of Efficacy|0|||
126442738|NCT01918306|454918622|FG002|Overall Study|Lack of Efficacy|0|||
126442739|NCT01918306|454918623|FG003|Overall Study|Lack of Efficacy|0|||
126442740|NCT01918306|454918620|FG000|Overall Study|progress disease, crossover|0|||
126442741|NCT01918306|454918621|FG001|Overall Study|progress disease, crossover|0|||
126442742|NCT01918306|454918622|FG002|Overall Study|progress disease, crossover|1|||
126442743|NCT01918306|454918623|FG003|Overall Study|progress disease, crossover|0|||
126442744|NCT02170077|454918624|FG000|Overall Study|Withdrawal by Subject|3|||
126442745|NCT02170077|454918625|FG001|Overall Study|Withdrawal by Subject|4|||
126442746|NCT02170077|454918626|FG002|Overall Study|Withdrawal by Subject|2|||
126442747|NCT02170077|454918624|FG000|Overall Study|Adverse Event|4|||
126442748|NCT02170077|454918625|FG001|Overall Study|Adverse Event|4|||
126442749|NCT02170077|454918626|FG002|Overall Study|Adverse Event|4|||
126442750|NCT02170077|454918624|FG000|Overall Study|Lost to Follow-up|0|||
126691312|NCT00695565|455824161|FG001|Overall Study|Adverse Event|1|||
126442751|NCT02170077|454918625|FG001|Overall Study|Lost to Follow-up|1|||
126442752|NCT02170077|454918626|FG002|Overall Study|Lost to Follow-up|0|||
126442753|NCT02170077|454918624|FG000|Overall Study|Exclusion criteria|2|||
126442754|NCT02170077|454918625|FG001|Overall Study|Exclusion criteria|2|||
126691313|NCT00695565|455824160|FG000|Overall Study|Protocol Violation|3|||
126442755|NCT02170077|454918626|FG002|Overall Study|Exclusion criteria|5|||
126442756|NCT02170077|454918624|FG000|Overall Study|Exacerbation of seizures|0|||
126442757|NCT02170077|454918625|FG001|Overall Study|Exacerbation of seizures|2|||
126442758|NCT02170077|454918626|FG002|Overall Study|Exacerbation of seizures|1|||
126442759|NCT01780974|454918627|FG000|Overall Study|Death|1|||
126442760|NCT01780974|454918628|FG001|Overall Study|Death|0|||
126442761|NCT01780974|454918627|FG000|Overall Study|Adverse Event|1|||
126442762|NCT01780974|454918628|FG001|Overall Study|Adverse Event|3|||
126442763|NCT01724346|454918629|FG000|Overall Study|Death|42|||
126442764|NCT01724346|454918630|FG001|Overall Study|Death|42|||
126442765|NCT01724346|454918629|FG000|Overall Study|Lost to Follow-up|5|||
126442766|NCT01724346|454918630|FG001|Overall Study|Lost to Follow-up|1|||
126442767|NCT01724346|454918629|FG000|Overall Study|Withdrawal by Subject|27|||
126442768|NCT01724346|454918630|FG001|Overall Study|Withdrawal by Subject|19|||
126442769|NCT01724346|454918629|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
126442770|NCT01724346|454918630|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
126442771|NCT02876601|454918631|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
126442772|NCT02876601|454918632|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
126442773|NCT02876601|454918633|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
126442774|NCT02876601|454918634|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
126442775|NCT00256997|454918635|FG000|Overall Study|Protocol Violation|1|||
126442776|NCT00256997|454918636|FG001|Overall Study|Protocol Violation|4|||
126442777|NCT00256997|454918635|FG000|Overall Study|Lack of Efficacy|1|||
126442778|NCT00256997|454918636|FG001|Overall Study|Lack of Efficacy|4|||
126442779|NCT00256997|454918635|FG000|Overall Study|Death|2|||
126442780|NCT00256997|454918636|FG001|Overall Study|Death|0|||
126442781|NCT00256997|454918635|FG000|Overall Study|Adverse Event|4|||
126442782|NCT00256997|454918636|FG001|Overall Study|Adverse Event|0|||
126442783|NCT00256997|454918635|FG000|Overall Study|Lost to Follow-up|3|||
126442784|NCT00256997|454918636|FG001|Overall Study|Lost to Follow-up|5|||
126442785|NCT00256997|454918635|FG000|Overall Study|Withdrawal by Subject|13|||
126442786|NCT00256997|454918636|FG001|Overall Study|Withdrawal by Subject|3|||
126442787|NCT00256997|454918635|FG000|Overall Study|Started but not treated|2|||
126442788|NCT00256997|454918636|FG001|Overall Study|Started but not treated|0|||
126442789|NCT00256997|454918635|FG000|Overall Study|Other|5|||
126442790|NCT00256997|454918636|FG001|Overall Study|Other|8|||
126442791|NCT00256997|454918635|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
126442792|NCT00256997|454918636|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
126442793|NCT00256997|454918635|FG000|Overall Study|Participant Non-compliant|3|||
126442794|NCT00256997|454918636|FG001|Overall Study|Participant Non-compliant|6|||
126442795|NCT00256997|454918635|FG000|Overall Study|Investigator Withdrew Participant|2|||
126442796|NCT00256997|454918636|FG001|Overall Study|Investigator Withdrew Participant|1|||
126442797|NCT03529422|454918637|FG000|Overall Study|Withdrawal by Subject|1|||
126442798|NCT03529422|454918637|FG000|Overall Study|Protocol Violation|1|||
126442799|NCT03529422|454918637|FG000|Overall Study|Disease progression|2|||
126442800|NCT05006573|454918638|FG000|Double-blind Treatment Period|Physician Decision|2|||
126442801|NCT05006573|454918639|FG001|Double-blind Treatment Period|Physician Decision|0|||
126442802|NCT05006573|454918638|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
126442803|NCT05006573|454918639|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
126442804|NCT05006573|454918638|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
126442805|NCT05006573|454918639|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
126442806|NCT05006573|454918638|FG000|Double-blind Treatment Period|Protocol Violation|2|||
126442807|NCT05006573|454918639|FG001|Double-blind Treatment Period|Protocol Violation|0|||
126442808|NCT05006573|454918638|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
126442809|NCT05006573|454918639|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
126442810|NCT05006573|454918638|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
126442811|NCT05006573|454918639|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
126442812|NCT01967238|454918640|FG000|Overall Study|Adverse Event|1|||
126442813|NCT01967238|454918641|FG001|Overall Study|Adverse Event|1|||
126442814|NCT01967238|454918642|FG002|Overall Study|Adverse Event|0|||
126442815|NCT01967238|454918640|FG000|Overall Study|Lost to Follow-up|1|||
126442816|NCT01967238|454918641|FG001|Overall Study|Lost to Follow-up|0|||
126442817|NCT01967238|454918642|FG002|Overall Study|Lost to Follow-up|1|||
126442818|NCT01967238|454918640|FG000|Overall Study|Withdrawal by Subject|0|||
126442819|NCT01967238|454918641|FG001|Overall Study|Withdrawal by Subject|0|||
126442820|NCT01967238|454918642|FG002|Overall Study|Withdrawal by Subject|1|||
126442821|NCT05232682|454918643|FG000|Overall Study|Lost to Follow-up|2|||
126442822|NCT03387085|454918644|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
126442823|NCT01442103|454919997|FG000|Overall Study|Lost to Follow-up|2|||
126442824|NCT02202759|454919998|FG000|Overall Study|Study Terminated by Sponsor|3|||
126442825|NCT02202759|454919999|FG001|Overall Study|Study Terminated by Sponsor|3|||
126442826|NCT02202759|454920000|FG002|Overall Study|Study Terminated by Sponsor|3|||
126442827|NCT02202759|454919998|FG000|Overall Study|Withdrawal by Subject|2|||
126442828|NCT02202759|454919999|FG001|Overall Study|Withdrawal by Subject|1|||
126442829|NCT02202759|454920000|FG002|Overall Study|Withdrawal by Subject|1|||
126442830|NCT02202759|454919998|FG000|Overall Study|Reason not Specified|4|||
126442831|NCT02202759|454919999|FG001|Overall Study|Reason not Specified|11|||
126442832|NCT02202759|454920000|FG002|Overall Study|Reason not Specified|10|||
126442833|NCT01987453|454920001|FG000|Overall Study|Death|0|||
126442834|NCT01987453|454920002|FG001|Overall Study|Death|0|||
126442835|NCT01987453|454920003|FG002|Overall Study|Death|1|||
126442836|NCT01987453|454920001|FG000|Overall Study|Lack of Efficacy|1|||
126442837|NCT01987453|454920002|FG001|Overall Study|Lack of Efficacy|12|||
126442838|NCT01987453|454920003|FG002|Overall Study|Lack of Efficacy|0|||
126442839|NCT01590888|454920005|FG000|Overall Study|Adverse Event|3|||
126442840|NCT01590888|454920006|FG001|Overall Study|Adverse Event|0|||
126442841|NCT01590888|454920007|FG002|Overall Study|Adverse Event|1|||
126442842|NCT01590888|454920005|FG000|Overall Study|Lost to Follow-up|1|||
126442843|NCT01590888|454920006|FG001|Overall Study|Lost to Follow-up|0|||
126442844|NCT01590888|454920007|FG002|Overall Study|Lost to Follow-up|0|||
126442845|NCT04953728|454920008|FG000|Overall Study|Withdrawal by Subject|3|||
126442846|NCT04953728|454920008|FG000|Overall Study|Physician Decision|1|||
126442847|NCT02105662|454920011|FG000|Overall Study|Lost to Follow-up|5|||
126442848|NCT02105662|454920011|FG000|Overall Study|Withdrawal by Subject|1|||
126442849|NCT02331277|454920014|FG000|Overall Study|Withdrawal by Subject|1|||
126442850|NCT02331277|454920015|FG001|Overall Study|Withdrawal by Subject|0|||
126442851|NCT03978117|454920016|FG000|Overall Study|Non-Compliance|26|||
126442852|NCT03978117|454920017|FG001|Overall Study|Non-Compliance|26|||
126442853|NCT03978117|454920016|FG000|Overall Study|Lost to Follow-up|4|||
126442854|NCT03978117|454920017|FG001|Overall Study|Lost to Follow-up|4|||
126442855|NCT05462756|454920018|FG000|Treatment Period|Adverse Event|3|||
126442856|NCT05462756|454920019|FG001|Treatment Period|Adverse Event|0|||
126442857|NCT05462756|454920018|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
126442858|NCT05462756|454920019|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
126442859|NCT05462756|454920018|FG000|Treatment Period|Death|0|||
126442860|NCT05462756|454920019|FG001|Treatment Period|Death|1|||
126442861|NCT05462756|454920018|FG000|Treatment Period|Lost to Follow-up|2|||
126442862|NCT05462756|454920019|FG001|Treatment Period|Lost to Follow-up|1|||
126442863|NCT05462756|454920018|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
126442864|NCT05462756|454920019|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
126442865|NCT05462756|454920018|FG000|Treatment Period|Physician Decision|2|||
126442866|NCT05462756|454920019|FG001|Treatment Period|Physician Decision|0|||
126442867|NCT05462756|454920018|FG000|Treatment Period|Protocol Violation|0|||
126442868|NCT05462756|454920019|FG001|Treatment Period|Protocol Violation|1|||
126442869|NCT05462756|454920018|FG000|Treatment Period|Withdrawal by Subject|5|||
126354048|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
126354049|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Death|1|||
126354050|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Death|0|||
126354051|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Death|0|||
126354052|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
126354053|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
126354054|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
126354055|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
126354056|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
126354057|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
126354058|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
126354059|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
126354060|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
126354061|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
126354062|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
126354063|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
126354064|NCT05073315|454587576|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
126354065|NCT05073315|454587577|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
126354066|NCT05073315|454587578|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
126354067|NCT05073315|454587576|FG000|Period 2|Adverse Event|0|||
126442870|NCT05462756|454920019|FG001|Treatment Period|Withdrawal by Subject|12|||
126354068|NCT05073315|454587577|FG001|Period 2|Adverse Event|3|||
126354069|NCT05073315|454587578|FG002|Period 2|Adverse Event|6|||
126354070|NCT05073315|454587576|FG000|Period 2|Lost to Follow-up|0|||
126354071|NCT05073315|454587577|FG001|Period 2|Lost to Follow-up|5|||
126691314|NCT00695565|455824161|FG001|Overall Study|Protocol Violation|1|||
126354072|NCT05073315|454587578|FG002|Period 2|Lost to Follow-up|5|||
126354073|NCT05073315|454587576|FG000|Period 2|Withdrawal by Subject|0|||
126354074|NCT05073315|454587577|FG001|Period 2|Withdrawal by Subject|4|||
126354075|NCT05073315|454587578|FG002|Period 2|Withdrawal by Subject|9|||
126354076|NCT05073315|454587576|FG000|Period 2|Protocol Violation|0|||
126354077|NCT05073315|454587577|FG001|Period 2|Protocol Violation|0|||
126354078|NCT05073315|454587578|FG002|Period 2|Protocol Violation|1|||
126354079|NCT01529268|454587579|FG000|Overall Study|Lost to Follow-up|9|||
126354080|NCT01529268|454587580|FG001|Overall Study|Lost to Follow-up|3|||
126354081|NCT01529268|454587579|FG000|Overall Study|Moved|3|||
126354082|NCT01529268|454587580|FG001|Overall Study|Moved|0|||
126354083|NCT02691572|454587585|FG000|Overall Study|Withdrawal by Subject|1|||
126354084|NCT02691572|454587586|FG001|Overall Study|Withdrawal by Subject|0|||
126354085|NCT02691572|454587585|FG000|Overall Study|Protocol Violation|0|||
126354086|NCT02691572|454587586|FG001|Overall Study|Protocol Violation|1|||
126354087|NCT00699751|454587587|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
126354088|NCT00699751|454587588|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
126354089|NCT00699751|454587587|FG000|Period 1: Without/Before Drug Switch|Death|28|||
126354090|NCT00699751|454587588|FG001|Period 1: Without/Before Drug Switch|Death|29|||
126354091|NCT00699751|454587587|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
126354092|NCT00699751|454587588|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
126354093|NCT00699751|454587587|FG000|Period 1: Without/Before Drug Switch|Other|30|||
126354094|NCT00699751|454587588|FG001|Period 1: Without/Before Drug Switch|Other|20|||
126354095|NCT00699751|454587587|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
126354096|NCT00699751|454587588|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
126354097|NCT00699751|454587587|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
126354098|NCT00699751|454587588|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
126354099|NCT00699751|454587587|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
126354100|NCT00699751|454587588|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
126354101|NCT00699751|454587587|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
126354102|NCT00699751|454587588|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
126354103|NCT00985790|454587591|FG000|Overall Study|Withdrawal by Subject|1|||
126354104|NCT00985790|454587592|FG001|Overall Study|Withdrawal by Subject|1|||
126354105|NCT00985790|454587591|FG000|Overall Study|Lost to Follow-up|6|||
126354106|NCT00985790|454587592|FG001|Overall Study|Lost to Follow-up|7|||
126354107|NCT04180696|454587593|FG000|Overall Study|Death|5|||
126354108|NCT04180696|454587594|FG001|Overall Study|Death|6|||
126354109|NCT04180696|454587593|FG000|Overall Study|Lost to Follow-up|1|||
126354110|NCT04180696|454587594|FG001|Overall Study|Lost to Follow-up|0|||
126354111|NCT04180696|454587593|FG000|Overall Study|Withdrawal by Subject|0|||
126354112|NCT04180696|454587594|FG001|Overall Study|Withdrawal by Subject|1|||
126354113|NCT04739709|454587597|FG000|Overall Study|Physician Decision|1|||
126354114|NCT04739709|454587598|FG001|Overall Study|Physician Decision|0|||
126354115|NCT04124965|454587599|FG000|Overall Study|Adverse event, non-fatal|3|||
126354116|NCT04124965|454587600|FG001|Overall Study|Adverse event, non-fatal|1|||
126354117|NCT04124965|454587599|FG000|Overall Study|Withdrawal by Subject|1|||
126354118|NCT04124965|454587600|FG001|Overall Study|Withdrawal by Subject|1|||
126354119|NCT04124965|454587599|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
126354120|NCT04124965|454587600|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
126354121|NCT04124965|454587599|FG000|Overall Study|Pregnancy|1|||
126354122|NCT04124965|454587600|FG001|Overall Study|Pregnancy|0|||
126354123|NCT04124965|454587599|FG000|Overall Study|Sponsor and participant decision|0|||
126354124|NCT04124965|454587600|FG001|Overall Study|Sponsor and participant decision|1|||
126354125|NCT04124965|454587599|FG000|Overall Study|Personal surgery|0|||
126354126|NCT04124965|454587600|FG001|Overall Study|Personal surgery|1|||
126354127|NCT04124965|454587599|FG000|Overall Study|Physician Decision|0|||
126354128|NCT04124965|454587600|FG001|Overall Study|Physician Decision|1|||
126354129|NCT02184156|454587601|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
126354130|NCT02184156|454587602|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
126354131|NCT02184156|454587601|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
126354132|NCT02184156|454587602|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
126354133|NCT00002874|454587603|FG000|Overall Study|Withdrawal by Subject|1|||
126354134|NCT00002874|454587604|FG001|Overall Study|Withdrawal by Subject|1|||
126354135|NCT00002874|454587603|FG000|Overall Study|Protocol Violation|44|||
126354136|NCT00002874|454587604|FG001|Overall Study|Protocol Violation|34|||
126354137|NCT01397747|454587605|FG000|Overall Study|Multitarget DNA test excluded|689|||
126354138|NCT01397747|454587605|FG000|Overall Study|Colonoscopy excluded|304|||
126354139|NCT01397747|454587605|FG000|Overall Study|FIT excluded|34|||
126354140|NCT03828383|454587608|FG000|Overall Study|Lost to Follow-up|3|||
126354141|NCT03828383|454587609|FG001|Overall Study|Lost to Follow-up|2|||
126354142|NCT03828383|454587608|FG000|Overall Study|Withdrawal by Subject|4|||
126354143|NCT03828383|454587609|FG001|Overall Study|Withdrawal by Subject|5|||
126354144|NCT00504309|454587610|FG000|Overall Study|Death|0|||
126354145|NCT00504309|454587611|FG001|Overall Study|Death|0|||
126354146|NCT00504309|454587612|FG002|Overall Study|Death|0|||
126354147|NCT00504309|454587613|FG003|Overall Study|Death|0|||
126354148|NCT00504309|454587614|FG004|Overall Study|Death|1|||
126354149|NCT00504309|454587615|FG005|Overall Study|Death|0|||
126354150|NCT00504309|454587610|FG000|Overall Study|Withdrawal by Subject|0|||
126354151|NCT00504309|454587611|FG001|Overall Study|Withdrawal by Subject|0|||
126354152|NCT00504309|454587612|FG002|Overall Study|Withdrawal by Subject|1|||
126354153|NCT00504309|454587613|FG003|Overall Study|Withdrawal by Subject|0|||
126354154|NCT00504309|454587614|FG004|Overall Study|Withdrawal by Subject|0|||
126354155|NCT00504309|454587615|FG005|Overall Study|Withdrawal by Subject|0|||
126354156|NCT01018953|454587618|FG000|Overall Study|Adverse Event|2|||
126354157|NCT01018953|454587618|FG000|Overall Study|Withdrawal by Subject|1|||
126354158|NCT01018953|454587618|FG000|Overall Study|Study termination by sponsor|5|||
126354159|NCT01407367|454587624|FG000|Overall Study|Death|24|||
126354160|NCT01407367|454587625|FG001|Overall Study|Death|32|||
126354161|NCT01407367|454587624|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
126354162|NCT01407367|454587625|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
126354163|NCT01407367|454587624|FG000|Overall Study|Withdrawal by Subject|4|||
126354164|NCT01407367|454587625|FG001|Overall Study|Withdrawal by Subject|15|||
126354165|NCT01407367|454587624|FG000|Overall Study|Lost to Follow-up|0|||
126354166|NCT01407367|454587625|FG001|Overall Study|Lost to Follow-up|2|||
126354167|NCT01452347|454587626|FG000|Overall Study|Adverse Event|2|||
126354168|NCT01452347|454587627|FG001|Overall Study|Adverse Event|1|||
126354169|NCT01452347|454587626|FG000|Overall Study|Non compliance protocol|2|||
126354170|NCT01452347|454587627|FG001|Overall Study|Non compliance protocol|0|||
126354171|NCT01452347|454587626|FG000|Overall Study|Lost to Follow-up|2|||
126354172|NCT01452347|454587627|FG001|Overall Study|Lost to Follow-up|0|||
126354173|NCT01452347|454587626|FG000|Overall Study|Withdrawal by Subject|3|||
126354174|NCT01452347|454587627|FG001|Overall Study|Withdrawal by Subject|3|||
126354175|NCT01452347|454587626|FG000|Overall Study|Not treated|6|||
126354176|NCT01452347|454587627|FG001|Overall Study|Not treated|3|||
126354177|NCT01452347|454587626|FG000|Overall Study|Other reason not defined above|2|||
126354178|NCT01452347|454587627|FG001|Overall Study|Other reason not defined above|0|||
126354179|NCT02642679|454589317|FG000|Overall Study|Withdrawal by Subject|1|||
126354180|NCT02642679|454589317|FG000|Overall Study|Physician Decision|1|||
126760275|NCT00796367|456072441|FG001|Overall Study|Withdrawal by Subject|11|||
126760276|NCT00796367|456072442|FG002|Overall Study|Withdrawal by Subject|12|||
126760277|NCT00796367|456072440|FG000|Overall Study|Lack of Efficacy|2|||
126760278|NCT00796367|456072441|FG001|Overall Study|Lack of Efficacy|1|||
126760279|NCT00796367|456072442|FG002|Overall Study|Lack of Efficacy|0|||
126354181|NCT02642679|454589317|FG000|Overall Study|Physician Decision|1|||
126760280|NCT00796367|456072440|FG000|Overall Study|non compliance|3|||
126760281|NCT00796367|456072441|FG001|Overall Study|non compliance|1|||
126760282|NCT00796367|456072442|FG002|Overall Study|non compliance|1|||
126442871|NCT05462756|454920018|FG000|Follow-Up Period|Adverse Event|1|||
126442872|NCT05462756|454920019|FG001|Follow-Up Period|Adverse Event|0|||
126442873|NCT05462756|454920018|FG000|Follow-Up Period|Death|1|||
126442874|NCT05462756|454920019|FG001|Follow-Up Period|Death|0|||
126442875|NCT05462756|454920018|FG000|Follow-Up Period|Lost to Follow-up|3|||
126442876|NCT05462756|454920019|FG001|Follow-Up Period|Lost to Follow-up|1|||
126442877|NCT05462756|454920018|FG000|Follow-Up Period|Withdrawal by Subject|0|||
126442878|NCT05462756|454920019|FG001|Follow-Up Period|Withdrawal by Subject|4|||
126442879|NCT00990704|454920022|FG000|Overall Study|Adverse Event|1|||
126442880|NCT00990704|454920023|FG001|Overall Study|Adverse Event|1|||
126442881|NCT00990704|454920022|FG000|Overall Study|Physician Decision|0|||
126442882|NCT00990704|454920023|FG001|Overall Study|Physician Decision|1|||
126442883|NCT04040933|454920024|FG000|Overall Study|Protocol Violation|1|||
126442884|NCT04040933|454920024|FG000|Overall Study|Withdrawal by Subject|2|||
126442885|NCT01354899|454920028|FG000|Overall Study|discharge from the hospital|2|||
126442886|NCT01354899|454920028|FG000|Overall Study|Protocol Violation|1|||
126442887|NCT00641667|454920029|FG000|Overall Study|Withdrawal by Subject|1|||
126442888|NCT00641667|454920029|FG000|Overall Study|Adverse Event|1|||
126442889|NCT00641667|454920029|FG000|Overall Study|Physician Decision|1|||
126442890|NCT00641667|454920029|FG000|Overall Study|Worsening of underlying disease|3|||
126442891|NCT01235741|454920030|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
126442892|NCT01235741|454920031|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
126442893|NCT01235741|454920032|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
126442894|NCT01235741|454920030|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
126442895|NCT01235741|454920031|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
126442896|NCT01235741|454920032|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
126442897|NCT01235741|454920030|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
126442898|NCT01235741|454920031|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
126442899|NCT01235741|454920032|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
126442900|NCT01235741|454920030|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
126442901|NCT01235741|454920031|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
126442902|NCT01235741|454920032|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
126442903|NCT01235741|454920030|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
126442904|NCT01235741|454920031|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
126442905|NCT01235741|454920032|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
126442906|NCT01235741|454920030|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
126442907|NCT01235741|454920031|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
126442908|NCT01235741|454920032|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
126442909|NCT01235741|454920030|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
126442910|NCT01235741|454920031|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
126442911|NCT01235741|454920032|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
126442912|NCT01235741|454920030|FG000|Randomized to Treatment|Adverse Event|0|||
126442913|NCT01235741|454920031|FG001|Randomized to Treatment|Adverse Event|1|||
126442914|NCT01235741|454920032|FG002|Randomized to Treatment|Adverse Event|1|||
126442915|NCT01235741|454920030|FG000|Randomized to Treatment|Sponsor terminated study|0|||
126442916|NCT01235741|454920031|FG001|Randomized to Treatment|Sponsor terminated study|35|||
126442917|NCT01235741|454920032|FG002|Randomized to Treatment|Sponsor terminated study|34|||
126442918|NCT01235741|454920030|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
126442919|NCT01235741|454920031|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
126442920|NCT01235741|454920032|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
126442921|NCT01235741|454920030|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
126442922|NCT01235741|454920031|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
126442923|NCT01235741|454920032|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
126442924|NCT01235741|454920030|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
126442925|NCT01235741|454920031|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
126442926|NCT01235741|454920032|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
126442927|NCT01705509|454920033|FG000|Inclusion CPET|Screen Failure|5|||
126442928|NCT01705509|454920033|FG000|Inclusion CPET|Withdrawal by Subject|2|||
126442929|NCT01705509|454920033|FG000|CPET w/ Ranexa|Screen Failure|2|||
126691315|NCT00695565|455824160|FG000|Overall Study|Withdrawal by Subject|1|||
126691316|NCT00695565|455824161|FG001|Overall Study|Withdrawal by Subject|1|||
126691317|NCT00695565|455824160|FG000|Overall Study|Lack of Efficacy|1|||
126691318|NCT00695565|455824161|FG001|Overall Study|Lack of Efficacy|1|||
126442930|NCT00220636|454920034|FG000|Overall Study|Withdrawal by Subject|4|||
126442931|NCT01662102|454920035|FG000|Overall Study|Sponsor's decision|1|||
126442932|NCT01662102|454920036|FG001|Overall Study|Sponsor's decision|0|||
126442933|NCT02863419|454920037|FG000|Overall Study|Lost to Follow-up|0|||
126691319|NCT00695565|455824160|FG000|Overall Study|Subject did not follow instructions|1|||
126691320|NCT00695565|455824161|FG001|Overall Study|Subject did not follow instructions|1|||
126691321|NCT01462266|455824162|FG000|Overall Study|Adverse Event|7|||
126691322|NCT01462266|455824163|FG001|Overall Study|Adverse Event|6|||
126691323|NCT01462266|455824162|FG000|Overall Study|Death|2|||
126691324|NCT01462266|455824163|FG001|Overall Study|Death|1|||
126691325|NCT01462266|455824162|FG000|Overall Study|Lack of Efficacy|0|||
126691326|NCT01462266|455824163|FG001|Overall Study|Lack of Efficacy|2|||
126691327|NCT01462266|455824162|FG000|Overall Study|Lost to Follow-up|4|||
126354182|NCT01112267|454589319|FG000|Overall Study|Adverse Event|24|||
126354183|NCT01112267|454589320|FG001|Overall Study|Adverse Event|6|||
126354184|NCT01112267|454589319|FG000|Overall Study|Withdrawal by Subject|3|||
126354185|NCT01112267|454589320|FG001|Overall Study|Withdrawal by Subject|5|||
126354186|NCT01112267|454589319|FG000|Overall Study|Protocol Violation|5|||
126354187|NCT01112267|454589320|FG001|Overall Study|Protocol Violation|3|||
126354188|NCT01112267|454589319|FG000|Overall Study|Participants not compliant|1|||
126354189|NCT01112267|454589320|FG001|Overall Study|Participants not compliant|2|||
126354190|NCT01112267|454589319|FG000|Overall Study|Participants not receive any study drug|1|||
126354191|NCT01112267|454589320|FG001|Overall Study|Participants not receive any study drug|2|||
126354192|NCT05638737|454589323|FG000|Overall Study|Withdrawal by Subject|4|||
126354193|NCT05638737|454589324|FG001|Overall Study|Withdrawal by Subject|7|||
126691328|NCT01462266|455824163|FG001|Overall Study|Lost to Follow-up|3|||
126442934|NCT02863419|454920038|FG001|Overall Study|Lost to Follow-up|1|||
126442935|NCT02863419|454920039|FG002|Overall Study|Lost to Follow-up|4|||
126442936|NCT02863419|454920037|FG000|Overall Study|Withdrawal by Subject|5|||
126442937|NCT02863419|454920038|FG001|Overall Study|Withdrawal by Subject|5|||
126442938|NCT02863419|454920039|FG002|Overall Study|Withdrawal by Subject|3|||
126442939|NCT02863419|454920037|FG000|Overall Study|Died|3|||
126442940|NCT02863419|454920038|FG001|Overall Study|Died|4|||
126442941|NCT02863419|454920039|FG002|Overall Study|Died|1|||
126442942|NCT02577718|454920042|FG000|Overall Study|Death|6|||
126442943|NCT02577718|454920042|FG000|Overall Study|Withdrawal by Subject|2|||
126442944|NCT01995838|454920043|FG000|Overall Study|Lost to Follow-up|0|||
126442945|NCT01995838|454920044|FG001|Overall Study|Lost to Follow-up|1|||
126442946|NCT01995838|454920045|FG002|Overall Study|Lost to Follow-up|0|||
126442947|NCT01995838|454920046|FG003|Overall Study|Lost to Follow-up|0|||
126442948|NCT01995838|454920047|FG004|Overall Study|Lost to Follow-up|0|||
126442949|NCT01995838|454920048|FG005|Overall Study|Lost to Follow-up|0|||
126442950|NCT01995838|454920049|FG006|Overall Study|Lost to Follow-up|1|||
126442951|NCT01995838|454920043|FG000|Overall Study|Participant choice|2|||
126442952|NCT01995838|454920044|FG001|Overall Study|Participant choice|0|||
126442953|NCT01995838|454920045|FG002|Overall Study|Participant choice|0|||
126442954|NCT01995838|454920046|FG003|Overall Study|Participant choice|0|||
126442955|NCT01995838|454920047|FG004|Overall Study|Participant choice|0|||
126442956|NCT01995838|454920048|FG005|Overall Study|Participant choice|1|||
126442957|NCT01995838|454920049|FG006|Overall Study|Participant choice|1|||
126442958|NCT01995838|454920043|FG000|Overall Study|Adverse Event|0|||
126442959|NCT01995838|454920044|FG001|Overall Study|Adverse Event|0|||
126442960|NCT01995838|454920045|FG002|Overall Study|Adverse Event|0|||
126442961|NCT01995838|454920046|FG003|Overall Study|Adverse Event|0|||
126442962|NCT01995838|454920047|FG004|Overall Study|Adverse Event|0|||
126442963|NCT01995838|454920048|FG005|Overall Study|Adverse Event|0|||
126442964|NCT01995838|454920049|FG006|Overall Study|Adverse Event|1|||
126442965|NCT01995838|454920043|FG000|Overall Study|Withdrawal by Subject|0|||
126442966|NCT01995838|454920044|FG001|Overall Study|Withdrawal by Subject|0|||
126442967|NCT01995838|454920045|FG002|Overall Study|Withdrawal by Subject|0|||
126442968|NCT01995838|454920046|FG003|Overall Study|Withdrawal by Subject|0|||
126442969|NCT01995838|454920047|FG004|Overall Study|Withdrawal by Subject|1|||
126691329|NCT01462266|455824162|FG000|Overall Study|Non-compliance with study drug|3|||
126442970|NCT01995838|454920048|FG005|Overall Study|Withdrawal by Subject|0|||
126442971|NCT01995838|454920049|FG006|Overall Study|Withdrawal by Subject|0|||
126442972|NCT01995838|454920043|FG000|Overall Study|Other|3|||
126442973|NCT01995838|454920044|FG001|Overall Study|Other|1|||
126442974|NCT01995838|454920045|FG002|Overall Study|Other|0|||
126442975|NCT01995838|454920046|FG003|Overall Study|Other|2|||
126442976|NCT01995838|454920047|FG004|Overall Study|Other|1|||
126442977|NCT01995838|454920048|FG005|Overall Study|Other|1|||
126442978|NCT01995838|454920049|FG006|Overall Study|Other|2|||
126442979|NCT01967576|454920050|FG000|Overall Study|Withdrawal by Subject|3|||
126442980|NCT01967576|454920050|FG000|Overall Study|Progressed/Removed from treatment|1|||
126442981|NCT01967576|454920050|FG000|Overall Study|Study closing at site|1|||
126442982|NCT01967576|454920050|FG000|Overall Study|Adverse Event|1|||
126442983|NCT01967576|454920050|FG000|Overall Study|Refused further treatment|1|||
126442984|NCT00499083|454920051|FG000|Overall Study|Not evaluable|3|||
126442985|NCT00686686|454920052|FG000|Overall Study|Non-compliance|1|||
126442986|NCT00686686|454920052|FG000|Overall Study|Adverse Event|2|||
126442987|NCT00686686|454920052|FG000|Overall Study|Lost to Follow-up|3|||
126442988|NCT00131248|454920056|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
126442989|NCT00131248|454920057|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
126442990|NCT00477386|454920058|FG000|Overall Study|Adverse Event|4|||
126442991|NCT00477386|454920059|FG001|Overall Study|Adverse Event|8|||
126442992|NCT00477386|454920058|FG000|Overall Study|Disease progression, relapse|3|||
126760283|NCT00796367|456072440|FG000|Overall Study|Pregnancy|1|||
126442993|NCT00477386|454920059|FG001|Overall Study|Disease progression, relapse|4|||
126442994|NCT00477386|454920058|FG000|Overall Study|Disease progression, refractory|1|||
126442995|NCT00477386|454920059|FG001|Overall Study|Disease progression, refractory|3|||
126442996|NCT00477386|454920058|FG000|Overall Study|Other|1|||
126442997|NCT00477386|454920059|FG001|Overall Study|Other|2|||
126442998|NCT00477386|454920058|FG000|Overall Study|Physician Decision|1|||
126442999|NCT00477386|454920059|FG001|Overall Study|Physician Decision|0|||
126760284|NCT00796367|456072441|FG001|Overall Study|Pregnancy|0|||
126443000|NCT00477386|454920058|FG000|Overall Study|Withdrawal by Subject|1|||
126443001|NCT00477386|454920059|FG001|Overall Study|Withdrawal by Subject|0|||
126443002|NCT01254422|454920060|FG000|Overall Study|Protocol Violation|1|||
126443003|NCT01254422|454920061|FG001|Overall Study|Protocol Violation|0|||
126443004|NCT01254422|454920060|FG000|Overall Study|Adverse Event|1|||
126443005|NCT01254422|454920061|FG001|Overall Study|Adverse Event|0|||
126443006|NCT01254422|454920060|FG000|Overall Study|Serious adverse event|0|||
126443007|NCT01254422|454920061|FG001|Overall Study|Serious adverse event|1|||
126443008|NCT01254422|454920060|FG000|Overall Study|Lost to Follow-up|1|||
126443009|NCT01254422|454920061|FG001|Overall Study|Lost to Follow-up|0|||
126443010|NCT02207088|454920062|FG000|Overall Study|Adverse Event|2|||
126760285|NCT00796367|456072442|FG002|Overall Study|Pregnancy|1|||
126760286|NCT00796367|456072440|FG000|Overall Study|Requirement for restricted medication|2|||
126760287|NCT00796367|456072441|FG001|Overall Study|Requirement for restricted medication|0|||
126760288|NCT00796367|456072442|FG002|Overall Study|Requirement for restricted medication|2|||
126760289|NCT00796367|456072440|FG000|Overall Study|other|2|||
126760290|NCT00796367|456072441|FG001|Overall Study|other|4|||
126760291|NCT00796367|456072442|FG002|Overall Study|other|3|||
126760292|NCT05664672|456072443|FG000|Overall Study|Adverse Event|0|||
126760293|NCT05664672|456072444|FG001|Overall Study|Adverse Event|0|||
126760294|NCT05664672|456072445|FG002|Overall Study|Adverse Event|0|||
126760295|NCT05664672|456072446|FG003|Overall Study|Adverse Event|0|||
126760296|NCT05664672|456072447|FG004|Overall Study|Adverse Event|0|||
126760297|NCT05664672|456072448|FG005|Overall Study|Adverse Event|1|||
126760298|NCT05664672|456072443|FG000|Overall Study|Withdrawal by Subject|0|||
126760299|NCT05664672|456072444|FG001|Overall Study|Withdrawal by Subject|1|||
126760300|NCT05664672|456072445|FG002|Overall Study|Withdrawal by Subject|3|||
126760301|NCT05664672|456072446|FG003|Overall Study|Withdrawal by Subject|0|||
126760302|NCT05664672|456072447|FG004|Overall Study|Withdrawal by Subject|5|||
126760303|NCT05664672|456072448|FG005|Overall Study|Withdrawal by Subject|6|||
126760304|NCT05664672|456072443|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
126760305|NCT05664672|456072444|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
126760306|NCT05664672|456072445|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
126760307|NCT05664672|456072446|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
126760308|NCT05664672|456072447|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
126760309|NCT05664672|456072448|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
126760310|NCT05664672|456072443|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
126760311|NCT05664672|456072444|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
126760312|NCT05664672|456072445|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
126760313|NCT05664672|456072446|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
126760314|NCT05664672|456072447|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
126760315|NCT05664672|456072448|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
126760316|NCT04236986|456072459|FG000|Overall Study|Withdrawal by Subject|3|||
126760317|NCT04236986|456072460|FG001|Overall Study|Withdrawal by Subject|1|||
126760318|NCT04034225|456072461|FG000|Overall Study|Death|3|||
126760319|NCT04034225|456072461|FG000|Overall Study|Withdrawal by Subject|2|||
126760320|NCT04034225|456072461|FG000|Overall Study|Study termination by Sponsor|18|||
126760321|NCT04034225|456072461|FG000|Overall Study|Physician Decision|1|||
126760322|NCT04034225|456072461|FG000|Overall Study|Lack of Efficacy|1|||
126760323|NCT01326481|456072467|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
126760324|NCT00307736|456072468|FG000|Overall Study|Adverse Event|0|||
126760325|NCT00307736|456072469|FG001|Overall Study|Adverse Event|0|||
126760326|NCT00307736|456072470|FG002|Overall Study|Adverse Event|1|||
126760327|NCT00307736|456072471|FG003|Overall Study|Adverse Event|3|||
126760328|NCT00307736|456072468|FG000|Overall Study|Withdrawal by Subject|0|||
126760329|NCT00307736|456072469|FG001|Overall Study|Withdrawal by Subject|0|||
126760330|NCT00307736|456072470|FG002|Overall Study|Withdrawal by Subject|2|||
126760331|NCT00307736|456072471|FG003|Overall Study|Withdrawal by Subject|0|||
126760332|NCT02260791|456072474|FG000|Overall Study|Lost to Follow-up|4|||
126760333|NCT02260791|456072475|FG001|Overall Study|Lost to Follow-up|4|||
126443011|NCT00643162|454920063|FG000|Overall Study|Withdrawal by Subject|1|||
126760334|NCT02260791|456072474|FG000|Overall Study|Lack of Efficacy|2|||
126760335|NCT02260791|456072475|FG001|Overall Study|Lack of Efficacy|1|||
126760336|NCT02260791|456072474|FG000|Overall Study|Adverse Event|13|||
126760337|NCT02260791|456072475|FG001|Overall Study|Adverse Event|9|||
126760338|NCT02260791|456072474|FG000|Overall Study|Death|1|||
126760339|NCT02260791|456072475|FG001|Overall Study|Death|0|||
126760340|NCT02260791|456072474|FG000|Overall Study|Withdrawal by Subject|11|||
126545403|NCT02541383|455290827|FG004|Overall Study|Sponsor's decision|0|||
126760341|NCT02260791|456072475|FG001|Overall Study|Withdrawal by Subject|16|||
126760342|NCT02260791|456072474|FG000|Overall Study|Screen failure|0|||
126443012|NCT00643162|454920064|FG001|Overall Study|Withdrawal by Subject|1|||
126760343|NCT02260791|456072475|FG001|Overall Study|Screen failure|1|||
126443013|NCT02284243|454920065|FG000|Overall Study|Lack of Efficacy|3|||
126443014|NCT02284243|454920066|FG001|Overall Study|Lack of Efficacy|3|||
126545404|NCT02541383|455290828|FG005|Overall Study|Sponsor's decision|0|||
126443015|NCT02284243|454920065|FG000|Overall Study|Adverse Event|1|||
126443016|NCT02284243|454920066|FG001|Overall Study|Adverse Event|0|||
126443017|NCT00541385|454920069|FG000|Overall Study|Adverse Event|6|||
126443018|NCT00541385|454920070|FG001|Overall Study|Adverse Event|3|||
126443019|NCT00541385|454920069|FG000|Overall Study|Withdrawal by Subject|2|||
126443020|NCT00541385|454920070|FG001|Overall Study|Withdrawal by Subject|2|||
126443021|NCT00541385|454920069|FG000|Overall Study|Lost to Follow-up|6|||
126443022|NCT00541385|454920070|FG001|Overall Study|Lost to Follow-up|1|||
126443023|NCT00541385|454920069|FG000|Overall Study|Parasite reappearance/malaria|67|||
126443024|NCT00541385|454920070|FG001|Overall Study|Parasite reappearance/malaria|32|||
126443025|NCT01499355|454920073|FG000|Run-In Period|Study Termination|15|||
126443026|NCT01499355|454920074|FG001|Run-In Period|Study Termination|0|||
126443027|NCT01499355|454920075|FG002|Run-In Period|Study Termination|0|||
126443028|NCT01499355|454920076|FG003|Run-In Period|Study Termination|0|||
126443029|NCT01499355|454920073|FG000|Run-In Period|Other|3|||
126443030|NCT01499355|454920074|FG001|Run-In Period|Other|0|||
126443031|NCT01499355|454920075|FG002|Run-In Period|Other|0|||
126443032|NCT01499355|454920076|FG003|Run-In Period|Other|0|||
126443033|NCT01499355|454920073|FG000|Run-In Period|Death|2|||
126443034|NCT01499355|454920074|FG001|Run-In Period|Death|0|||
126443035|NCT01499355|454920075|FG002|Run-In Period|Death|0|||
126443036|NCT01499355|454920076|FG003|Run-In Period|Death|0|||
126443037|NCT01499355|454920073|FG000|Run-In Period|Investigator Decision|2|||
126443038|NCT01499355|454920074|FG001|Run-In Period|Investigator Decision|0|||
126443039|NCT01499355|454920075|FG002|Run-In Period|Investigator Decision|0|||
126443040|NCT01499355|454920076|FG003|Run-In Period|Investigator Decision|0|||
126443041|NCT01499355|454920073|FG000|Run-In Period|Consent Withdrawn|1|||
126443042|NCT01499355|454920074|FG001|Run-In Period|Consent Withdrawn|0|||
126443043|NCT01499355|454920075|FG002|Run-In Period|Consent Withdrawn|0|||
126443044|NCT01499355|454920076|FG003|Run-In Period|Consent Withdrawn|0|||
126443045|NCT01499355|454920073|FG000|Run-In Period|Adverse Event|8|||
126443046|NCT01499355|454920074|FG001|Run-In Period|Adverse Event|0|||
126443047|NCT01499355|454920075|FG002|Run-In Period|Adverse Event|0|||
126443048|NCT01499355|454920076|FG003|Run-In Period|Adverse Event|0|||
126443049|NCT01499355|454920073|FG000|Double-Blind Period|Adverse Event|0|||
126443050|NCT01499355|454920074|FG001|Double-Blind Period|Adverse Event|2|||
126443051|NCT01499355|454920075|FG002|Double-Blind Period|Adverse Event|3|||
126443052|NCT01499355|454920076|FG003|Double-Blind Period|Adverse Event|2|||
126443053|NCT01499355|454920073|FG000|Double-Blind Period|Study Termination|0|||
126443054|NCT01499355|454920074|FG001|Double-Blind Period|Study Termination|18|||
126443055|NCT01499355|454920075|FG002|Double-Blind Period|Study Termination|16|||
126443056|NCT01499355|454920076|FG003|Double-Blind Period|Study Termination|14|||
126443057|NCT01499355|454920073|FG000|Double-Blind Period|Other|0|||
126443058|NCT01499355|454920074|FG001|Double-Blind Period|Other|1|||
126443059|NCT01499355|454920075|FG002|Double-Blind Period|Other|2|||
126443060|NCT01499355|454920076|FG003|Double-Blind Period|Other|2|||
126443061|NCT01499355|454920073|FG000|Double-Blind Period|Death|0|||
126443062|NCT01499355|454920074|FG001|Double-Blind Period|Death|1|||
126443063|NCT01499355|454920075|FG002|Double-Blind Period|Death|0|||
126443064|NCT01499355|454920076|FG003|Double-Blind Period|Death|0|||
126443065|NCT01499355|454920073|FG000|Double-Blind Period|Investigator Decision|0|||
126443066|NCT01499355|454920074|FG001|Double-Blind Period|Investigator Decision|0|||
126443067|NCT01499355|454920075|FG002|Double-Blind Period|Investigator Decision|3|||
126443068|NCT01499355|454920076|FG003|Double-Blind Period|Investigator Decision|3|||
126443069|NCT01499355|454920073|FG000|Double-Blind Period|Consent Withdrawn|0|||
126443070|NCT01499355|454920074|FG001|Double-Blind Period|Consent Withdrawn|0|||
126443071|NCT01499355|454920075|FG002|Double-Blind Period|Consent Withdrawn|1|||
126443072|NCT01499355|454920076|FG003|Double-Blind Period|Consent Withdrawn|2|||
126443073|NCT01499355|454920073|FG000|Double-Blind Period|Lost to Follow-up|0|||
126443074|NCT01499355|454920074|FG001|Double-Blind Period|Lost to Follow-up|1|||
126443075|NCT01499355|454920075|FG002|Double-Blind Period|Lost to Follow-up|0|||
126443076|NCT01499355|454920076|FG003|Double-Blind Period|Lost to Follow-up|0|||
126443077|NCT02699749|454920081|FG000|Overall Study|Other|0|||
126443078|NCT02699749|454920082|FG001|Overall Study|Other|0|||
126443079|NCT02699749|454920083|FG002|Overall Study|Other|2|||
126443080|NCT02699749|454920084|FG003|Overall Study|Other|0|||
126443081|NCT02699749|454920085|FG004|Overall Study|Other|0|||
126443082|NCT02699749|454920086|FG005|Overall Study|Other|1|||
126443083|NCT02699749|454920087|FG006|Overall Study|Other|1|||
126443084|NCT02699749|454920088|FG007|Overall Study|Other|0|||
126443085|NCT02699749|454920089|FG008|Overall Study|Other|0|||
126443086|NCT02699749|454920090|FG009|Overall Study|Other|0|||
126443087|NCT02699749|454920091|FG010|Overall Study|Other|1|||
126443088|NCT02699749|454920092|FG011|Overall Study|Other|0|||
126443089|NCT02699749|454920093|FG012|Overall Study|Other|0|||
126354194|NCT03641924|454589327|FG000|Overall Study|Withdrawal by Subject|26|||
126354195|NCT03641924|454589327|FG000|Overall Study|Lost to Follow-up|16|||
126354196|NCT03641924|454589327|FG000|Overall Study|Protocol Violation|10|||
126354197|NCT04333498|454589328|FG000|Overall Study|Lost to Follow-up|1|||
126354198|NCT04333498|454589329|FG001|Overall Study|Lost to Follow-up|0|||
126354199|NCT04333498|454589328|FG000|Overall Study|Lost to Follow-up|0|||
126354200|NCT04333498|454589329|FG001|Overall Study|Lost to Follow-up|1|||
126354201|NCT01565694|454589330|FG000|Dose-Titration Period|Adverse Event|4|||
126354202|NCT01565694|454589330|FG000|Dose-Titration Period|Protocol Violation|10|||
126354203|NCT01565694|454589330|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
126354204|NCT05417113|454589334|FG000|Overall Study|Lost to Follow-up|2|||
126354205|NCT05417113|454589335|FG001|Overall Study|Lost to Follow-up|2|||
126354206|NCT01022580|454589336|FG000|Overall Study|Death|18|||
126354207|NCT01022580|454589337|FG001|Overall Study|Death|22|||
126354208|NCT00541229|454589338|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
126354209|NCT00541229|454589339|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
126354210|NCT00541229|454589340|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
126354211|NCT00541229|454589341|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
126354212|NCT00541229|454589342|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
126354213|NCT00541229|454589343|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
126354214|NCT00541229|454589338|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
126354215|NCT00541229|454589339|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
126354216|NCT00541229|454589340|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
126354217|NCT00541229|454589341|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
126354218|NCT00541229|454589342|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
126354219|NCT00541229|454589343|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
126354220|NCT00541229|454589338|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
126354221|NCT00541229|454589339|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
126354222|NCT00541229|454589340|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
126354223|NCT00541229|454589341|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
126354224|NCT00541229|454589342|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
126354225|NCT00541229|454589343|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
126354226|NCT00541229|454589338|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
126354227|NCT00541229|454589339|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
126354228|NCT00541229|454589340|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
126354229|NCT00541229|454589341|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
126354230|NCT00541229|454589342|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
126354231|NCT00541229|454589343|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
126354232|NCT00541229|454589338|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
126354233|NCT00541229|454589339|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
126354234|NCT00541229|454589340|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
126354235|NCT00541229|454589341|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
126354236|NCT00541229|454589342|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
126354237|NCT00541229|454589343|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
126354238|NCT00541229|454589338|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
126354239|NCT00541229|454589339|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
126354240|NCT00541229|454589340|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
126354241|NCT00541229|454589341|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
126354242|NCT00541229|454589342|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
126354243|NCT00541229|454589343|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
126354244|NCT00541229|454589338|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
126443090|NCT02699749|454920094|FG013|Overall Study|Other|0|||
126443091|NCT02699749|454920081|FG000|Overall Study|Progressive Disease|3|||
126443092|NCT02699749|454920082|FG001|Overall Study|Progressive Disease|3|||
126443093|NCT02699749|454920083|FG002|Overall Study|Progressive Disease|14|||
126691330|NCT01462266|455824163|FG001|Overall Study|Non-compliance with study drug|0|||
126691331|NCT01462266|455824162|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
126354245|NCT00541229|454589339|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
126354246|NCT00541229|454589340|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
126354247|NCT00541229|454589341|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
126354248|NCT00541229|454589342|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
126354249|NCT00541229|454589343|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
126354250|NCT00541229|454589338|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
126354251|NCT00541229|454589339|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
126354252|NCT00541229|454589340|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
126354253|NCT00541229|454589341|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
126354254|NCT00541229|454589342|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
126354255|NCT00541229|454589343|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
126354256|NCT00541229|454589338|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
126354257|NCT00541229|454589339|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
126354258|NCT00541229|454589340|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
126354259|NCT00541229|454589341|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
126354260|NCT00541229|454589342|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
126354261|NCT00541229|454589343|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
126354262|NCT00541229|454589338|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
126354263|NCT00541229|454589339|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
126354264|NCT00541229|454589340|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
126354265|NCT00541229|454589341|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
126354266|NCT00541229|454589342|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
126354267|NCT00541229|454589343|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
126354268|NCT00541229|454589338|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
126354269|NCT00541229|454589339|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
126354270|NCT00541229|454589340|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
126354271|NCT00541229|454589341|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
126354272|NCT00541229|454589342|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
126354273|NCT00541229|454589343|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
126354274|NCT00541229|454589338|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
126691332|NCT01462266|455824163|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
126691333|NCT01462266|455824162|FG000|Overall Study|Physician Decision|2|||
126691334|NCT01462266|455824163|FG001|Overall Study|Physician Decision|5|||
126354275|NCT00541229|454589339|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
126354276|NCT00541229|454589340|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
126354277|NCT00541229|454589341|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
126354278|NCT00541229|454589342|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
126354279|NCT00541229|454589343|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
126691335|NCT01462266|455824162|FG000|Overall Study|Protocol Violation|1|||
126691336|NCT01462266|455824163|FG001|Overall Study|Protocol Violation|3|||
126691337|NCT01462266|455824162|FG000|Overall Study|Withdrawal by Subject|7|||
126354280|NCT00541229|454589338|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
126354281|NCT00541229|454589339|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
126354282|NCT00541229|454589340|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
126354283|NCT00541229|454589341|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
126354284|NCT00541229|454589342|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
126354285|NCT00541229|454589343|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
126354286|NCT00541229|454589338|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
126354287|NCT00541229|454589339|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
126354288|NCT00541229|454589340|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
126354289|NCT00541229|454589341|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
126354290|NCT00541229|454589342|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
126354291|NCT00541229|454589343|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
126354292|NCT00541229|454589338|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
126354293|NCT00541229|454589339|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
126354294|NCT00541229|454589340|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
126354295|NCT00541229|454589341|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
126354296|NCT00541229|454589342|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
126354297|NCT00541229|454589343|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
126354298|NCT00541229|454589338|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
126354299|NCT00541229|454589339|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
126354300|NCT00541229|454589340|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
126354301|NCT00541229|454589341|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
126354302|NCT00541229|454589342|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
126354303|NCT00541229|454589343|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
126354304|NCT01807520|454589344|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
126354305|NCT01807520|454589345|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
126443094|NCT02699749|454920084|FG003|Overall Study|Progressive Disease|3|||
126691338|NCT01462266|455824163|FG001|Overall Study|Withdrawal by Subject|2|||
126443095|NCT02699749|454920085|FG004|Overall Study|Progressive Disease|3|||
126443096|NCT02699749|454920086|FG005|Overall Study|Progressive Disease|7|||
126443097|NCT02699749|454920087|FG006|Overall Study|Progressive Disease|5|||
126443098|NCT02699749|454920088|FG007|Overall Study|Progressive Disease|5|||
126443099|NCT02699749|454920089|FG008|Overall Study|Progressive Disease|6|||
126443100|NCT02699749|454920090|FG009|Overall Study|Progressive Disease|6|||
126443101|NCT02699749|454920091|FG010|Overall Study|Progressive Disease|5|||
126443102|NCT02699749|454920092|FG011|Overall Study|Progressive Disease|4|||
126443103|NCT02699749|454920093|FG012|Overall Study|Progressive Disease|3|||
126443104|NCT02699749|454920094|FG013|Overall Study|Progressive Disease|5|||
126443105|NCT02699749|454920081|FG000|Overall Study|Death|0|||
126443106|NCT02699749|454920082|FG001|Overall Study|Death|0|||
126443107|NCT02699749|454920083|FG002|Overall Study|Death|0|||
126443108|NCT02699749|454920084|FG003|Overall Study|Death|0|||
126443109|NCT02699749|454920085|FG004|Overall Study|Death|0|||
126443110|NCT02699749|454920086|FG005|Overall Study|Death|0|||
126443111|NCT02699749|454920087|FG006|Overall Study|Death|0|||
126443112|NCT02699749|454920088|FG007|Overall Study|Death|0|||
126443113|NCT02699749|454920089|FG008|Overall Study|Death|0|||
126443114|NCT02699749|454920090|FG009|Overall Study|Death|0|||
126443115|NCT02699749|454920091|FG010|Overall Study|Death|0|||
126443116|NCT02699749|454920092|FG011|Overall Study|Death|0|||
126443117|NCT02699749|454920093|FG012|Overall Study|Death|0|||
126443118|NCT02699749|454920094|FG013|Overall Study|Death|1|||
126443119|NCT02699749|454920081|FG000|Overall Study|Lost to Follow-up|0|||
126443120|NCT02699749|454920082|FG001|Overall Study|Lost to Follow-up|0|||
126443121|NCT02699749|454920083|FG002|Overall Study|Lost to Follow-up|0|||
126443122|NCT02699749|454920084|FG003|Overall Study|Lost to Follow-up|0|||
126443123|NCT02699749|454920085|FG004|Overall Study|Lost to Follow-up|0|||
126443124|NCT02699749|454920086|FG005|Overall Study|Lost to Follow-up|1|||
126443125|NCT02699749|454920087|FG006|Overall Study|Lost to Follow-up|0|||
126443126|NCT02699749|454920088|FG007|Overall Study|Lost to Follow-up|1|||
126443127|NCT02699749|454920089|FG008|Overall Study|Lost to Follow-up|0|||
126443128|NCT02699749|454920090|FG009|Overall Study|Lost to Follow-up|0|||
126443129|NCT02699749|454920091|FG010|Overall Study|Lost to Follow-up|0|||
126443130|NCT02699749|454920092|FG011|Overall Study|Lost to Follow-up|0|||
126443131|NCT02699749|454920093|FG012|Overall Study|Lost to Follow-up|0|||
126443132|NCT02699749|454920094|FG013|Overall Study|Lost to Follow-up|0|||
126443133|NCT02721966|454920096|FG000|Overall Study|Protocol Violation|1|||
126443134|NCT02721966|454920097|FG001|Overall Study|Protocol Violation|0|||
126443135|NCT02721966|454920098|FG002|Overall Study|Protocol Violation|0|||
126443136|NCT02721966|454920099|FG003|Overall Study|Protocol Violation|0|||
126443137|NCT02721966|454920100|FG004|Overall Study|Protocol Violation|0|||
126443138|NCT02721966|454920096|FG000|Overall Study|Withdrawal by Subject|9|||
126443139|NCT02721966|454920097|FG001|Overall Study|Withdrawal by Subject|2|||
126443140|NCT02721966|454920098|FG002|Overall Study|Withdrawal by Subject|3|||
126443141|NCT02721966|454920099|FG003|Overall Study|Withdrawal by Subject|7|||
126443142|NCT02721966|454920100|FG004|Overall Study|Withdrawal by Subject|0|||
126443143|NCT02721966|454920096|FG000|Overall Study|Adverse Event|4|||
126443144|NCT02721966|454920097|FG001|Overall Study|Adverse Event|4|||
126443145|NCT02721966|454920098|FG002|Overall Study|Adverse Event|3|||
126443146|NCT02721966|454920099|FG003|Overall Study|Adverse Event|0|||
126443147|NCT02721966|454920100|FG004|Overall Study|Adverse Event|0|||
126443148|NCT02721966|454920096|FG000|Overall Study|Death|1|||
126443149|NCT02721966|454920097|FG001|Overall Study|Death|0|||
126443150|NCT02721966|454920098|FG002|Overall Study|Death|0|||
126443151|NCT02721966|454920099|FG003|Overall Study|Death|0|||
126443152|NCT02721966|454920100|FG004|Overall Study|Death|0|||
126443153|NCT02721966|454920096|FG000|Overall Study|Lack of Efficacy|7|||
126443154|NCT02721966|454920097|FG001|Overall Study|Lack of Efficacy|4|||
126443155|NCT02721966|454920098|FG002|Overall Study|Lack of Efficacy|0|||
126443156|NCT02721966|454920099|FG003|Overall Study|Lack of Efficacy|0|||
126443157|NCT02721966|454920100|FG004|Overall Study|Lack of Efficacy|0|||
126443158|NCT02721966|454920096|FG000|Overall Study|Lost to Follow-up|0|||
126443159|NCT02721966|454920097|FG001|Overall Study|Lost to Follow-up|0|||
126443160|NCT02721966|454920098|FG002|Overall Study|Lost to Follow-up|3|||
126443161|NCT02721966|454920099|FG003|Overall Study|Lost to Follow-up|0|||
126443162|NCT02721966|454920100|FG004|Overall Study|Lost to Follow-up|0|||
126443163|NCT02721966|454920096|FG000|Overall Study|Physician Decision|1|||
126443164|NCT02721966|454920097|FG001|Overall Study|Physician Decision|1|||
126443165|NCT02721966|454920098|FG002|Overall Study|Physician Decision|0|||
126443166|NCT02721966|454920099|FG003|Overall Study|Physician Decision|0|||
126443167|NCT02721966|454920100|FG004|Overall Study|Physician Decision|0|||
126443168|NCT02721966|454920096|FG000|Overall Study|Pregnancy|1|||
126443169|NCT02721966|454920097|FG001|Overall Study|Pregnancy|0|||
126443170|NCT02721966|454920098|FG002|Overall Study|Pregnancy|0|||
126443171|NCT02721966|454920099|FG003|Overall Study|Pregnancy|0|||
126443172|NCT02721966|454920100|FG004|Overall Study|Pregnancy|0|||
126443173|NCT02721966|454920096|FG000|Overall Study|Did not continue to period 2|5|||
126443174|NCT02721966|454920097|FG001|Overall Study|Did not continue to period 2|12|||
126443175|NCT02721966|454920098|FG002|Overall Study|Did not continue to period 2|0|||
126443176|NCT02721966|454920099|FG003|Overall Study|Did not continue to period 2|0|||
126443177|NCT02721966|454920100|FG004|Overall Study|Did not continue to period 2|5|||
126443178|NCT03857867|454920101|FG000|Overall Study|Physician Decision|1|||
126443179|NCT02157883|454920102|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
126443180|NCT02157883|454920102|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
126443181|NCT02157883|454920102|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
126443182|NCT02157883|454920102|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
126691339|NCT01462266|455824162|FG000|Overall Study|Screen failure|1|||
126691340|NCT01462266|455824163|FG001|Overall Study|Screen failure|1|||
126354306|NCT01807520|454589346|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
126354307|NCT01807520|454589347|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
126354308|NCT01807520|454589348|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
126354309|NCT01807520|454589349|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
126354310|NCT01807520|454589350|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
126354311|NCT01807520|454589344|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
126354312|NCT01807520|454589345|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
126354313|NCT01807520|454589346|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
126354314|NCT01807520|454589347|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
126354315|NCT01807520|454589348|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
126354316|NCT01807520|454589349|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
126354317|NCT01807520|454589350|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
126354318|NCT01807520|454589344|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
126354319|NCT01807520|454589345|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
126354320|NCT01807520|454589346|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
126354321|NCT01807520|454589347|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
126354322|NCT01807520|454589348|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
126354323|NCT01807520|454589349|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
126354324|NCT01807520|454589350|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
126354325|NCT01807520|454589344|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
126354326|NCT01807520|454589345|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
126354327|NCT01807520|454589346|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
126354328|NCT01807520|454589347|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
126354329|NCT01807520|454589348|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
126354330|NCT01807520|454589349|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
126443183|NCT02157883|454920102|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
126691341|NCT01106846|455824164|FG000|Overall Study|Change in surgical procedure|0|||
126691342|NCT01106846|455824165|FG001|Overall Study|Change in surgical procedure|1|||
126691343|NCT02419508|455824174|FG000|Overall Study|Adverse Event|9|||
126691344|NCT02419508|455824175|FG001|Overall Study|Adverse Event|3|||
126443184|NCT00888940|454920103|FG000|Overall Study|Adverse Event|12|||
126443185|NCT00888940|454920104|FG001|Overall Study|Adverse Event|3|||
126443186|NCT00888940|454920103|FG000|Overall Study|Lost to Follow-up|5|||
126443187|NCT00888940|454920104|FG001|Overall Study|Lost to Follow-up|5|||
126443188|NCT00888940|454920103|FG000|Overall Study|Randomized Not Treated|11|||
126443189|NCT00888940|454920104|FG001|Overall Study|Randomized Not Treated|13|||
126443190|NCT00750438|454920106|FG000|Overall Study|Protocol Violation|4|||
126443191|NCT00750438|454920107|FG001|Overall Study|Protocol Violation|1|||
126443192|NCT00750438|454920106|FG000|Overall Study|Physician Decision|2|||
126443193|NCT00750438|454920107|FG001|Overall Study|Physician Decision|2|||
126443194|NCT00750438|454920106|FG000|Overall Study|Withdrawal by Subject|1|||
126443195|NCT00750438|454920107|FG001|Overall Study|Withdrawal by Subject|1|||
126443196|NCT02736578|454920108|FG000|Overall Study|Adverse Event|1|||
126691345|NCT02419508|455824174|FG000|Overall Study|Withdrawal by Subject|1|||
126691346|NCT02419508|455824175|FG001|Overall Study|Withdrawal by Subject|0|||
126691347|NCT02419508|455824174|FG000|Overall Study|Other - Reason not specified|0|||
126691348|NCT02419508|455824175|FG001|Overall Study|Other - Reason not specified|1|||
126443197|NCT02736578|454920109|FG001|Overall Study|Adverse Event|0|||
126443198|NCT00354432|454920110|FG000|Overall Study|Adverse Event|3|||
126443199|NCT00354432|454920111|FG001|Overall Study|Adverse Event|1|||
126691349|NCT01738971|455824181|FG000|Overall Study|Lost to Follow-up|19|||
126443200|NCT00354432|454920112|FG002|Overall Study|Adverse Event|5|||
126443201|NCT00354432|454920113|FG003|Overall Study|Adverse Event|5|||
126443202|NCT00354432|454920110|FG000|Overall Study|Off/Toxicity|3|||
126443203|NCT00354432|454920111|FG001|Overall Study|Off/Toxicity|7|||
126443204|NCT00354432|454920112|FG002|Overall Study|Off/Toxicity|5|||
126443205|NCT00354432|454920113|FG003|Overall Study|Off/Toxicity|5|||
126443206|NCT02827877|454920114|FG000|Overall Study|Withdrawal by Subject|1|||
126443207|NCT01071798|454921192|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
126443208|NCT01071798|454921192|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
126691350|NCT01738971|455824182|FG001|Overall Study|Lost to Follow-up|30|||
126691351|NCT01738971|455824183|FG002|Overall Study|Lost to Follow-up|17|||
126691352|NCT01031446|455824192|FG000|Overall Study|Disease Progression|38|||
126691353|NCT01031446|455824192|FG000|Overall Study|Adverse Event|9|||
126691354|NCT01031446|455824192|FG000|Overall Study|Physician Decision|4|||
126691355|NCT01031446|455824192|FG000|Overall Study|Withdrawal by Subject|3|||
126691356|NCT01031446|455824192|FG000|Overall Study|Still on treatment|1|||
126691357|NCT02447848|455824193|FG000|Overall Study|Patient discharged|3|||
126691358|NCT02447848|455824193|FG000|Overall Study|Lack of Efficacy|4|||
126691359|NCT02447848|455824193|FG000|Overall Study|Withdrawal by Subject|4|||
126691360|NCT04484285|455826235|FG000|Overall Study|Unable to operate stimulator|3|||
126691361|NCT04484285|455826236|FG001|Overall Study|Unable to operate stimulator|0|||
126691362|NCT05888103|455826237|FG000|Overall Study|Participant decision|3|||
126691363|NCT05888103|455826238|FG001|Overall Study|Participant decision|3|||
126691364|NCT02324270|455826239|FG000|Overall Study|Withdrawal by Subject|0|||
126691365|NCT02324270|455826240|FG001|Overall Study|Withdrawal by Subject|1|||
126691366|NCT02324270|455826241|FG002|Overall Study|Withdrawal by Subject|0|||
126691367|NCT02324270|455826239|FG000|Overall Study|Lost to Follow-up|4|||
126691368|NCT02324270|455826240|FG001|Overall Study|Lost to Follow-up|3|||
126691369|NCT02324270|455826241|FG002|Overall Study|Lost to Follow-up|4|||
126691370|NCT02324270|455826239|FG000|Overall Study|Protocol Violation|0|||
126691371|NCT02324270|455826240|FG001|Overall Study|Protocol Violation|1|||
126691372|NCT02324270|455826241|FG002|Overall Study|Protocol Violation|1|||
126691373|NCT02324270|455826239|FG000|Overall Study|Non Compliance with Study Drug|1|||
126691374|NCT02324270|455826240|FG001|Overall Study|Non Compliance with Study Drug|2|||
126691375|NCT02324270|455826241|FG002|Overall Study|Non Compliance with Study Drug|0|||
126691376|NCT00680836|455826242|FG000|Overall Study|Withdrawal by Subject|3|||
126691377|NCT00680836|455826243|FG001|Overall Study|Withdrawal by Subject|0|||
126691378|NCT00680836|455826242|FG000|Overall Study|Lost to Follow-up|3|||
126691379|NCT00680836|455826243|FG001|Overall Study|Lost to Follow-up|1|||
126691380|NCT00680836|455826242|FG000|Overall Study|Physician Decision|2|||
126691381|NCT00680836|455826243|FG001|Overall Study|Physician Decision|1|||
126691382|NCT03968419|455826245|FG000|Treatment Period|Adverse Event|0|||
126691383|NCT03968419|455826246|FG001|Treatment Period|Adverse Event|0|||
126691384|NCT03968419|455826247|FG002|Treatment Period|Adverse Event|1|||
126691385|NCT03968419|455826245|FG000|Safety Follow-up Period|Death|3|||
126691386|NCT03968419|455826246|FG001|Safety Follow-up Period|Death|2|||
126691387|NCT03968419|455826247|FG002|Safety Follow-up Period|Death|1|||
126691388|NCT03968419|455826245|FG000|Safety Follow-up Period|Subject Decision|2|||
126691389|NCT03968419|455826246|FG001|Safety Follow-up Period|Subject Decision|1|||
126691390|NCT03968419|455826247|FG002|Safety Follow-up Period|Subject Decision|0|||
126691391|NCT03593915|455826248|FG000|Overall Study|Adverse Event|0|||
126691392|NCT03593915|455826249|FG001|Overall Study|Adverse Event|0|||
126691393|NCT03593915|455826250|FG002|Overall Study|Adverse Event|0|||
126691394|NCT03593915|455826251|FG003|Overall Study|Adverse Event|1|||
126691395|NCT03593915|455826252|FG004|Overall Study|Adverse Event|0|||
126691396|NCT03593915|455826253|FG005|Overall Study|Adverse Event|0|||
126691397|NCT03593915|455826248|FG000|Overall Study|Physician Decision|0|||
126354331|NCT01807520|454589350|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
126354332|NCT01807520|454589344|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
126354333|NCT01807520|454589345|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
126354334|NCT01807520|454589346|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
126354335|NCT01807520|454589347|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
126691398|NCT03593915|455826249|FG001|Overall Study|Physician Decision|0|||
126691399|NCT03593915|455826250|FG002|Overall Study|Physician Decision|0|||
126691400|NCT03593915|455826251|FG003|Overall Study|Physician Decision|0|||
126691401|NCT03593915|455826252|FG004|Overall Study|Physician Decision|0|||
126691402|NCT03593915|455826253|FG005|Overall Study|Physician Decision|1|||
126691403|NCT02894840|455826254|FG000|Overall Study|Lost to Follow-up|1|||
126691404|NCT02894840|455826255|FG001|Overall Study|Lost to Follow-up|0|||
126691405|NCT02894840|455826256|FG002|Overall Study|Lost to Follow-up|3|||
126354336|NCT01807520|454589348|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
126354337|NCT01807520|454589349|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
126354338|NCT01807520|454589350|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
126691406|NCT02894840|455826257|FG003|Overall Study|Lost to Follow-up|0|||
126691407|NCT00167245|455826259|FG000|Overall Study|Lost to Follow-up|20|||
126691408|NCT00167245|455826260|FG001|Overall Study|Lost to Follow-up|31|||
126354339|NCT01807520|454589344|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
126354340|NCT01807520|454589345|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
126691409|NCT00167245|455826259|FG000|Overall Study|Withdrawal by Subject|5|||
126691410|NCT00167245|455826260|FG001|Overall Study|Withdrawal by Subject|8|||
126691411|NCT00167245|455826259|FG000|Overall Study|Incarcerated|3|||
126691412|NCT00167245|455826260|FG001|Overall Study|Incarcerated|2|||
126691413|NCT00167245|455826259|FG000|Overall Study|Drowsy|1|||
126691414|NCT00167245|455826260|FG001|Overall Study|Drowsy|0|||
126691415|NCT00804687|455826265|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
126691416|NCT00804687|455826266|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
126691417|NCT00804687|455826267|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
126443209|NCT01071798|454921192|FG000|Participants Who Received One Cycle|Patient requirement|20|||
126443210|NCT01071798|454921192|FG000|Participants Who Received One Cycle|Death|5|||
126443211|NCT01071798|454921192|FG000|Participants Who Received One Cycle|Change of therapy|6|||
126443212|NCT01071798|454921192|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
126443213|NCT01071798|454921192|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
126443214|NCT01071798|454921192|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
126443215|NCT01071798|454921192|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
126443216|NCT01071798|454921192|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
126443217|NCT00145158|454921195|FG000|Overall Study|premature withdrawal|2|||
126443218|NCT00145158|454921196|FG001|Overall Study|premature withdrawal|3|||
126443219|NCT01227018|454921200|FG000|Overall Study|Disease progression|9|||
126443220|NCT01227018|454921200|FG000|Overall Study|Toxicity|2|||
126443221|NCT01227018|454921200|FG000|Overall Study|Withdrew after beginning treatment|4|||
126443222|NCT00753649|454921201|FG000|Overall Study|Migrated/moved from study area|1|||
126443223|NCT00753649|454921202|FG001|Overall Study|Migrated/moved from study area|0|||
126443224|NCT00753649|454921201|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
126443225|NCT00753649|454921202|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
126443226|NCT00753649|454921201|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
126354341|NCT01807520|454589346|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
126354342|NCT01807520|454589347|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
126354343|NCT01807520|454589348|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
126354344|NCT01807520|454589349|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
126354345|NCT01807520|454589350|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
126354346|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
126354347|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
126443227|NCT00753649|454921202|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
126443228|NCT00753649|454921201|FG000|Overall Study|Protocol Violation|2|||
126691418|NCT00804687|455826268|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
126691419|NCT00804687|455826269|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
126354348|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
126443229|NCT00753649|454921202|FG001|Overall Study|Protocol Violation|0|||
126443230|NCT00499616|454921203|FG000|Overall Study|Death|1|||
126443231|NCT00499616|454921204|FG001|Overall Study|Death|5|||
126443232|NCT00499616|454921205|FG002|Overall Study|Death|3|||
126443233|NCT00499616|454921206|FG003|Overall Study|Death|1|||
126691420|NCT00804687|455826270|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
126691421|NCT00804687|455826265|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
126691422|NCT00804687|455826266|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
126691423|NCT00804687|455826267|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
126691424|NCT00804687|455826268|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
126691425|NCT00804687|455826269|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
126691426|NCT00804687|455826270|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
126691427|NCT00804687|455826265|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
126691428|NCT00804687|455826266|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
126691429|NCT00804687|455826267|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
126691430|NCT00804687|455826268|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
126691431|NCT00804687|455826269|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
126443234|NCT00499616|454921203|FG000|Overall Study|Lack of Efficacy|5|||
126443235|NCT00499616|454921204|FG001|Overall Study|Lack of Efficacy|0|||
126443236|NCT00499616|454921205|FG002|Overall Study|Lack of Efficacy|19|||
126443237|NCT00499616|454921206|FG003|Overall Study|Lack of Efficacy|0|||
126443238|NCT00499616|454921203|FG000|Overall Study|Lost to Follow-up|0|||
126443239|NCT00499616|454921204|FG001|Overall Study|Lost to Follow-up|0|||
126443240|NCT00499616|454921205|FG002|Overall Study|Lost to Follow-up|1|||
126443241|NCT00499616|454921206|FG003|Overall Study|Lost to Follow-up|0|||
126443242|NCT00499616|454921203|FG000|Overall Study|Physician Decision|6|||
126691432|NCT00804687|455826270|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
126691433|NCT00804687|455826265|FG000|Period 5: Treatment Period|Positive drug test|1|||
126691434|NCT00804687|455826266|FG001|Period 5: Treatment Period|Positive drug test|0|||
126691435|NCT00804687|455826267|FG002|Period 5: Treatment Period|Positive drug test|0|||
126691436|NCT00804687|455826268|FG003|Period 5: Treatment Period|Positive drug test|0|||
126691437|NCT00804687|455826269|FG004|Period 5: Treatment Period|Positive drug test|0|||
126354349|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
126354350|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
126354351|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
126354352|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
126354353|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
126354354|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
126354355|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
126354356|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
126691438|NCT00804687|455826270|FG005|Period 5: Treatment Period|Positive drug test|0|||
126691439|NCT00688909|455826273|FG000|Overall Study|Adverse Event|28|||
126443243|NCT00499616|454921204|FG001|Overall Study|Physician Decision|16|||
126443244|NCT00499616|454921205|FG002|Overall Study|Physician Decision|9|||
126691440|NCT00688909|455826273|FG000|Overall Study|Patient withdrew consent|2|||
126691441|NCT00688909|455826273|FG000|Overall Study|Administrative problems|1|||
126691442|NCT00688909|455826273|FG000|Overall Study|Protocol Violation|2|||
126691443|NCT01220414|455826274|FG000|Overall Study|Withdrawal by Subject|1|||
126691444|NCT01220414|455826275|FG001|Overall Study|Withdrawal by Subject|0|||
126691445|NCT01220414|455826276|FG002|Overall Study|Withdrawal by Subject|0|||
126691446|NCT01220414|455826277|FG003|Overall Study|Withdrawal by Subject|1|||
126691447|NCT00860158|455826285|FG000|Overall Study|Study Terminated|1|||
126691448|NCT00669617|455826287|FG000|Period 1|Withdrawal by Subject|0|||
126691449|NCT00669617|455826288|FG001|Period 1|Withdrawal by Subject|0|||
126691450|NCT00669617|455826289|FG002|Period 1|Withdrawal by Subject|1|||
126354357|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
126354358|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
126354359|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
126354360|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
126354361|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
126354362|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
126354363|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
126354364|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
126354365|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
126354366|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
126354367|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
126354368|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
126354369|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
126354370|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
126354371|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
126354372|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
126354373|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
126354374|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
126354375|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
126354376|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
126354377|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
126354378|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
126354379|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
126354380|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
126354381|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
126354382|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
126354383|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
126354384|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
126354385|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
126354386|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
126354387|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
126354388|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
126354389|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
126354390|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
126354391|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
126354392|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
126354393|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
126354394|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
126354395|NCT01807520|454589344|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
126354396|NCT01807520|454589345|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
126354397|NCT01807520|454589346|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
126354398|NCT01807520|454589347|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
126354399|NCT01807520|454589348|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
126354400|NCT01807520|454589349|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
126354401|NCT01807520|454589350|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
126354402|NCT01807520|454589344|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
126354403|NCT01807520|454589345|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
126354404|NCT01807520|454589346|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
126354405|NCT01807520|454589347|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
126354406|NCT01807520|454589348|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
126354407|NCT01807520|454589349|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
126354408|NCT01807520|454589350|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
126354409|NCT01807520|454589344|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
126443245|NCT00499616|454921206|FG003|Overall Study|Physician Decision|0|||
126443246|NCT00499616|454921203|FG000|Overall Study|Withdrawal by Subject|1|||
126354410|NCT01807520|454589345|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
126354411|NCT01807520|454589346|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
126354412|NCT01807520|454589347|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
126354413|NCT01807520|454589348|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
126443247|NCT00499616|454921204|FG001|Overall Study|Withdrawal by Subject|0|||
126691451|NCT00669617|455826290|FG003|Period 1|Withdrawal by Subject|0|||
126691452|NCT00669617|455826291|FG004|Period 1|Withdrawal by Subject|0|||
126691453|NCT00669617|455826287|FG000|Period 1|Protocol Deviation|0|||
126691454|NCT00669617|455826288|FG001|Period 1|Protocol Deviation|0|||
126691455|NCT00669617|455826289|FG002|Period 1|Protocol Deviation|0|||
126691456|NCT00669617|455826290|FG003|Period 1|Protocol Deviation|0|||
126443248|NCT00499616|454921205|FG002|Overall Study|Withdrawal by Subject|1|||
126443249|NCT00499616|454921206|FG003|Overall Study|Withdrawal by Subject|0|||
126443250|NCT00499616|454921203|FG000|Overall Study|Ineligible|1|||
126443251|NCT00499616|454921204|FG001|Overall Study|Ineligible|2|||
126443252|NCT00499616|454921205|FG002|Overall Study|Ineligible|0|||
126443253|NCT00499616|454921206|FG003|Overall Study|Ineligible|15|||
126443254|NCT00499616|454921203|FG000|Overall Study|Not evaluable|0|||
126443255|NCT00499616|454921204|FG001|Overall Study|Not evaluable|0|||
126443256|NCT00499616|454921205|FG002|Overall Study|Not evaluable|0|||
126443257|NCT00499616|454921206|FG003|Overall Study|Not evaluable|41|||
126443258|NCT00499616|454921203|FG000|Overall Study|Patient/Parent Refusal|1|||
126443259|NCT00499616|454921204|FG001|Overall Study|Patient/Parent Refusal|5|||
126443260|NCT00499616|454921205|FG002|Overall Study|Patient/Parent Refusal|3|||
126443261|NCT00499616|454921206|FG003|Overall Study|Patient/Parent Refusal|0|||
126443262|NCT01938716|454921214|FG000|Overall Study|Physician Decision|2|||
126443263|NCT01938716|454921214|FG000|Overall Study|Withdrawal by Subject|2|||
126443264|NCT00098813|454921215|FG000|Overall Study|Death|8|||
126443265|NCT00098813|454921215|FG000|Overall Study|Protocol Violation|1|||
126443266|NCT00098813|454921215|FG000|Overall Study|Withdrawal by Subject|7|||
126443267|NCT00098813|454921215|FG000|Overall Study|Progression of Disease|1|||
126691457|NCT00669617|455826291|FG004|Period 1|Protocol Deviation|1|||
126691458|NCT00669617|455826287|FG000|Period 3|Lost to Follow-up|1|||
126691459|NCT00669617|455826288|FG001|Period 3|Lost to Follow-up|0|||
126760344|NCT02260791|456072474|FG000|Overall Study|Protocol deviation|2|||
126760345|NCT02260791|456072475|FG001|Overall Study|Protocol deviation|3|||
126443268|NCT00098813|454921215|FG000|Overall Study|Other complicating disease|1|||
126443269|NCT00098813|454921215|FG000|Overall Study|Reversal of RAI resistance|1|||
126443270|NCT00433004|454921218|FG000|Overall Study|Lost to Follow-up|5|||
126443271|NCT00433004|454921219|FG001|Overall Study|Lost to Follow-up|7|||
126443272|NCT00330967|454921220|FG000|Overall Study|Withdrawal by Subject|0|||
126443273|NCT00330967|454921221|FG001|Overall Study|Withdrawal by Subject|5|||
126443274|NCT00330967|454921220|FG000|Overall Study|Physician Decision|0|||
126443275|NCT00330967|454921221|FG001|Overall Study|Physician Decision|9|||
126443276|NCT01470326|454921222|FG000|Overall Study|Protocol Violation|32|||
126443277|NCT01470326|454921222|FG000|Overall Study|No Drug Administration Information|2|||
126443278|NCT01470326|454921222|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
126443279|NCT01166282|454921223|FG000|Open-label Period|Adverse Event|0|||
126443280|NCT01166282|454921224|FG001|Open-label Period|Adverse Event|0|||
126443281|NCT01166282|454921225|FG002|Open-label Period|Adverse Event|6|||
126443282|NCT01166282|454921223|FG000|Open-label Period|Withdrawal by Subject|0|||
126443283|NCT01166282|454921224|FG001|Open-label Period|Withdrawal by Subject|0|||
126443284|NCT01166282|454921225|FG002|Open-label Period|Withdrawal by Subject|4|||
126443285|NCT01166282|454921223|FG000|Open-label Period|Lack of Efficacy|0|||
126443286|NCT01166282|454921224|FG001|Open-label Period|Lack of Efficacy|0|||
126443287|NCT01166282|454921225|FG002|Open-label Period|Lack of Efficacy|2|||
126443288|NCT01166282|454921223|FG000|Open-label Period|Remission|0|||
126443289|NCT01166282|454921224|FG001|Open-label Period|Remission|0|||
126443290|NCT01166282|454921225|FG002|Open-label Period|Remission|4|||
126443291|NCT01166282|454921223|FG000|Open-label Period|Irregular Compliance|0|||
126443292|NCT01166282|454921224|FG001|Open-label Period|Irregular Compliance|0|||
126443293|NCT01166282|454921225|FG002|Open-label Period|Irregular Compliance|1|||
126443294|NCT00380367|454921228|FG000|Overall Study|Lost to Follow-up|1|||
126443295|NCT00380367|454921228|FG000|Overall Study|Withdrawal by Subject|1|||
126443296|NCT00392769|454921232|FG000|Overall Study|Clinical Deterioration|9|||
126443297|NCT00392769|454921232|FG000|Overall Study|Adverse Event|1|||
126443298|NCT00060840|454921241|FG000|Overall Study|Change in surgical plan|2|||
126443299|NCT00060840|454921242|FG001|Overall Study|Change in surgical plan|6|||
126691460|NCT00669617|455826289|FG002|Period 3|Lost to Follow-up|0|||
126760346|NCT04246996|456072477|FG000|Overall Study|Physician Decision|1|||
126443300|NCT00060840|454921241|FG000|Overall Study|Death|0|||
126691461|NCT00669617|455826290|FG003|Period 3|Lost to Follow-up|0|||
126760347|NCT04246996|456072478|FG001|Overall Study|Physician Decision|1|||
126443301|NCT00060840|454921242|FG001|Overall Study|Death|1|||
126443302|NCT00060840|454921241|FG000|Overall Study|Withdrawal by Subject|0|||
126443303|NCT00060840|454921242|FG001|Overall Study|Withdrawal by Subject|1|||
126443304|NCT00060840|454921241|FG000|Overall Study|Subinvestigator unavailable|0|||
126443305|NCT00060840|454921242|FG001|Overall Study|Subinvestigator unavailable|1|||
126443306|NCT00060840|454921241|FG000|Overall Study|Physician Decision|1|||
126443307|NCT00060840|454921242|FG001|Overall Study|Physician Decision|0|||
126443308|NCT00060840|454921241|FG000|Overall Study|Other|1|||
126443309|NCT00060840|454921242|FG001|Overall Study|Other|0|||
126443310|NCT03710161|454921243|FG000|Overall Study|Study halted due to COVID pandemic|3|||
126691462|NCT00669617|455826291|FG004|Period 3|Lost to Follow-up|0|||
126760348|NCT04246996|456072477|FG000|Overall Study|Did not meet eligibility criteria|1|||
126443311|NCT03710161|454921244|FG001|Overall Study|Study halted due to COVID pandemic|2|||
126443312|NCT04269889|454921248|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
126443313|NCT04308291|454921249|FG000|Run-In Phase|Withdrawal by Subject|4|||
126443314|NCT04308291|454921249|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
126443315|NCT04308291|454921249|FG000|Study Phase 6-M|Physician Decision|2|||
126443316|NCT04308291|454921249|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
126443317|NCT04308291|454921249|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
126443318|NCT04308291|454921249|FG000|Study Phase 12-M|Physician Decision|2|||
126443319|NCT04308291|454921249|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
126443320|NCT01526733|454921250|FG000|Phase 1|Protocol Violation|1|||
126443321|NCT01526733|454921251|FG001|Phase 1|Protocol Violation|0|||
126443322|NCT01526733|454921250|FG000|Phase 1|Withdrawal by Subject|1|||
126443323|NCT01526733|454921251|FG001|Phase 1|Withdrawal by Subject|1|||
126443324|NCT01599637|454921252|FG000|Overall Study|administrative problems|0|||
126443325|NCT01599637|454921253|FG001|Overall Study|administrative problems|2|||
126443326|NCT01599637|454921254|FG002|Overall Study|administrative problems|0|||
126443327|NCT01599637|454921252|FG000|Overall Study|Adverse Event|1|||
126443328|NCT01599637|454921253|FG001|Overall Study|Adverse Event|0|||
126443329|NCT01599637|454921254|FG002|Overall Study|Adverse Event|0|||
126443330|NCT02565108|454921255|FG000|Overall Study|Adverse Event|1|||
126443331|NCT02565108|454921256|FG001|Overall Study|Adverse Event|0|||
126443332|NCT02565108|454921255|FG000|Overall Study|Withdrew Consent|1|||
126443333|NCT02565108|454921256|FG001|Overall Study|Withdrew Consent|0|||
126443334|NCT01310075|454921257|FG000|Overall Study|Lost to Follow-up|1|||
126443335|NCT01310075|454921258|FG001|Overall Study|Lost to Follow-up|0|||
126443336|NCT01310075|454921257|FG000|Overall Study|Physician Decision|10|||
126443337|NCT01310075|454921258|FG001|Overall Study|Physician Decision|7|||
126443338|NCT01310075|454921257|FG000|Overall Study|Protocol Violation|2|||
126443339|NCT01310075|454921258|FG001|Overall Study|Protocol Violation|2|||
126443340|NCT01310075|454921257|FG000|Overall Study|Withdrawal by Subject|1|||
126443341|NCT01310075|454921258|FG001|Overall Study|Withdrawal by Subject|1|||
126443342|NCT02395081|454921259|FG000|Overall Study|Withdrawal by Subject|1|||
126443343|NCT02395081|454921260|FG001|Overall Study|Withdrawal by Subject|1|||
126443344|NCT02395081|454921261|FG002|Overall Study|Withdrawal by Subject|0|||
126443345|NCT02395081|454921259|FG000|Overall Study|Moved where blood couldn't be collected|4|||
126443346|NCT02395081|454921260|FG001|Overall Study|Moved where blood couldn't be collected|1|||
126443347|NCT02395081|454921261|FG002|Overall Study|Moved where blood couldn't be collected|3|||
126443348|NCT02395081|454921259|FG000|Overall Study|Fetal Loss|2|||
126443349|NCT02395081|454921260|FG001|Overall Study|Fetal Loss|3|||
126443350|NCT02395081|454921261|FG002|Overall Study|Fetal Loss|1|||
126443351|NCT02991040|454921262|FG000|Overall Study|Withdrawal by Subject|2|||
126443352|NCT02991040|454921262|FG000|Overall Study|Lost to Follow-up|2|||
126443353|NCT01869764|454921263|FG000|Overall Study|Withdrawal by Subject|0|||
126443354|NCT01869764|454921264|FG001|Overall Study|Withdrawal by Subject|2|||
126443355|NCT01286480|454921265|FG000|Overall Study|Withdrawal by Subject|5|||
126443356|NCT01286480|454921266|FG001|Overall Study|Withdrawal by Subject|3|||
126443357|NCT01626872|454921267|FG000|Overall Study|Physician Decision|13|||
126443358|NCT01626872|454921268|FG001|Overall Study|Physician Decision|9|||
126443359|NCT01626872|454921269|FG002|Overall Study|Physician Decision|6|||
126443360|NCT01626872|454921267|FG000|Overall Study|Withdrawal by Subject|19|||
126443361|NCT01626872|454921268|FG001|Overall Study|Withdrawal by Subject|27|||
126443362|NCT01626872|454921269|FG002|Overall Study|Withdrawal by Subject|8|||
126443363|NCT01626872|454921267|FG000|Overall Study|Adverse Event (including Death)|20|||
126443364|NCT01626872|454921268|FG001|Overall Study|Adverse Event (including Death)|28|||
126443365|NCT01626872|454921269|FG002|Overall Study|Adverse Event (including Death)|8|||
126443366|NCT01626872|454921267|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
126443367|NCT01626872|454921268|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
126443368|NCT01626872|454921269|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
126443369|NCT00960999|454921270|FG000|Overall Study|Withdrawal by Subject|1|||
126443370|NCT00960999|454921271|FG001|Overall Study|Withdrawal by Subject|0|||
126443371|NCT00960999|454921270|FG000|Overall Study|Protocol Violation|5|||
126443372|NCT00960999|454921271|FG001|Overall Study|Protocol Violation|2|||
126443373|NCT00960999|454921270|FG000|Overall Study|RT dose constraints not met|2|||
126691463|NCT05499520|455826292|FG000|Overall Study|Lost to Follow-up|0|||
126691464|NCT05499520|455826293|FG001|Overall Study|Lost to Follow-up|0|||
126443374|NCT00960999|454921271|FG001|Overall Study|RT dose constraints not met|0|||
126443375|NCT01696188|454921272|FG000|Overall Study|Protocol Violation|1|||
126443376|NCT01696188|454921273|FG001|Overall Study|Protocol Violation|1|||
126443377|NCT01578486|454921274|FG000|Overall Study|Physician Decision|3|||
126443378|NCT01578486|454921274|FG000|Overall Study|Withdrawal by Subject|2|||
126691465|NCT05499520|455826294|FG002|Overall Study|Lost to Follow-up|38|||
126691466|NCT05499520|455826295|FG003|Overall Study|Lost to Follow-up|41|||
126691467|NCT05499520|455826296|FG004|Overall Study|Lost to Follow-up|46|||
126443379|NCT02536963|454921275|FG000|Overall Study|Withdrawal by Subject|18|||
126443380|NCT02668393|454921277|FG000|Overall Study|Progressive disease|6|||
126443381|NCT02668393|454921278|FG001|Overall Study|Progressive disease|3|||
126354414|NCT01807520|454589349|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
126354415|NCT01807520|454589350|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
126354416|NCT01807520|454589344|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
126354417|NCT01807520|454589345|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
126354418|NCT01807520|454589346|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
126354419|NCT01807520|454589347|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
126354420|NCT01807520|454589348|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
126354421|NCT01807520|454589349|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
126354422|NCT01807520|454589350|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
126354423|NCT01797185|454589353|FG000|Overall Study|Adverse Event|5|||
126354424|NCT01797185|454589354|FG001|Overall Study|Adverse Event|15|||
126354425|NCT01797185|454589355|FG002|Overall Study|Adverse Event|6|||
126354426|NCT01797185|454589353|FG000|Overall Study|Withdrawal by Subject|6|||
126354427|NCT01797185|454589354|FG001|Overall Study|Withdrawal by Subject|9|||
126354428|NCT01797185|454589355|FG002|Overall Study|Withdrawal by Subject|5|||
126354429|NCT01797185|454589353|FG000|Overall Study|Site terminated|8|||
126354430|NCT01797185|454589354|FG001|Overall Study|Site terminated|4|||
126354431|NCT01797185|454589355|FG002|Overall Study|Site terminated|0|||
126354432|NCT01797185|454589353|FG000|Overall Study|Lost to Follow-up|2|||
126354433|NCT01797185|454589354|FG001|Overall Study|Lost to Follow-up|6|||
126354434|NCT01797185|454589355|FG002|Overall Study|Lost to Follow-up|1|||
126354435|NCT01797185|454589353|FG000|Overall Study|Withdrawn per sponsor|5|||
126354436|NCT01797185|454589354|FG001|Overall Study|Withdrawn per sponsor|0|||
126354437|NCT01797185|454589355|FG002|Overall Study|Withdrawn per sponsor|0|||
126354438|NCT01797185|454589353|FG000|Overall Study|Physician Decision|1|||
126354439|NCT01797185|454589354|FG001|Overall Study|Physician Decision|3|||
126354440|NCT01797185|454589355|FG002|Overall Study|Physician Decision|0|||
126354441|NCT01797185|454589353|FG000|Overall Study|Protocol Violation|1|||
126354442|NCT01797185|454589354|FG001|Overall Study|Protocol Violation|1|||
126354443|NCT01797185|454589355|FG002|Overall Study|Protocol Violation|0|||
126354444|NCT03418675|454589358|FG000|Overall Study|Lost to Follow-up|13|||
126354445|NCT03418675|454589359|FG001|Overall Study|Lost to Follow-up|10|||
126354446|NCT03418675|454589358|FG000|Overall Study|Adverse Event|2|||
126354447|NCT03418675|454589359|FG001|Overall Study|Adverse Event|0|||
126354448|NCT00421733|454589362|FG000|Overall Study|Adverse Event|4|||
126354449|NCT00421733|454589363|FG001|Overall Study|Adverse Event|9|||
126354450|NCT00421733|454589364|FG002|Overall Study|Adverse Event|2|||
126354451|NCT00421733|454589362|FG000|Overall Study|Lost to Follow-up|1|||
126354452|NCT00421733|454589363|FG001|Overall Study|Lost to Follow-up|2|||
126354453|NCT00421733|454589364|FG002|Overall Study|Lost to Follow-up|4|||
126354454|NCT00421733|454589362|FG000|Overall Study|Withdrawal by Subject|1|||
126354455|NCT00421733|454589363|FG001|Overall Study|Withdrawal by Subject|2|||
126354456|NCT00421733|454589364|FG002|Overall Study|Withdrawal by Subject|7|||
126354457|NCT00421733|454589362|FG000|Overall Study|Death|0|||
126354458|NCT00421733|454589363|FG001|Overall Study|Death|3|||
126354459|NCT00421733|454589364|FG002|Overall Study|Death|0|||
126354460|NCT00421733|454589362|FG000|Overall Study|Required dialysis|1|||
126354461|NCT00421733|454589363|FG001|Overall Study|Required dialysis|0|||
126354462|NCT00421733|454589364|FG002|Overall Study|Required dialysis|0|||
126354463|NCT00421733|454589362|FG000|Overall Study|Administrative|2|||
126354464|NCT00421733|454589363|FG001|Overall Study|Administrative|0|||
126354465|NCT00421733|454589364|FG002|Overall Study|Administrative|0|||
126354466|NCT00421733|454589362|FG000|Overall Study|Did not satisfy entry criteria|1|||
126354467|NCT00421733|454589363|FG001|Overall Study|Did not satisfy entry criteria|3|||
126354468|NCT00421733|454589364|FG002|Overall Study|Did not satisfy entry criteria|2|||
126354469|NCT00421733|454589362|FG000|Overall Study|Sponsor request|1|||
126354470|NCT00421733|454589363|FG001|Overall Study|Sponsor request|0|||
126354471|NCT00421733|454589364|FG002|Overall Study|Sponsor request|3|||
126354472|NCT00421733|454589362|FG000|Overall Study|Protocol deviation|4|||
126354473|NCT00421733|454589363|FG001|Overall Study|Protocol deviation|7|||
126354474|NCT00421733|454589364|FG002|Overall Study|Protocol deviation|2|||
126354475|NCT02265744|454589365|FG000|Overall Study|Poor/Non-compliance|1|||
126354476|NCT02265744|454589366|FG001|Overall Study|Poor/Non-compliance|1|||
126354477|NCT02265744|454589367|FG002|Overall Study|Poor/Non-compliance|0|||
126354478|NCT02265744|454589368|FG003|Overall Study|Poor/Non-compliance|0|||
126354479|NCT02265744|454589369|FG004|Overall Study|Poor/Non-compliance|2|||
126354480|NCT02265744|454589365|FG000|Overall Study|Lost to Follow-up|0|||
126354481|NCT02265744|454589366|FG001|Overall Study|Lost to Follow-up|0|||
126354482|NCT02265744|454589367|FG002|Overall Study|Lost to Follow-up|0|||
126354483|NCT02265744|454589368|FG003|Overall Study|Lost to Follow-up|1|||
126354484|NCT02265744|454589369|FG004|Overall Study|Lost to Follow-up|0|||
126354485|NCT02265744|454589365|FG000|Overall Study|Death|0|||
126354486|NCT02265744|454589366|FG001|Overall Study|Death|0|||
126354487|NCT02265744|454589367|FG002|Overall Study|Death|0|||
126354488|NCT02265744|454589368|FG003|Overall Study|Death|2|||
126354489|NCT02265744|454589369|FG004|Overall Study|Death|0|||
126354490|NCT02265744|454589365|FG000|Overall Study|Withdrawal by Subject|2|||
126354491|NCT02265744|454589366|FG001|Overall Study|Withdrawal by Subject|0|||
126354492|NCT02265744|454589367|FG002|Overall Study|Withdrawal by Subject|0|||
126354493|NCT02265744|454589368|FG003|Overall Study|Withdrawal by Subject|2|||
126354494|NCT02265744|454589369|FG004|Overall Study|Withdrawal by Subject|0|||
126354495|NCT02265744|454589365|FG000|Overall Study|Participant request to discontinue|2|||
126354496|NCT02265744|454589366|FG001|Overall Study|Participant request to discontinue|2|||
126354497|NCT02265744|454589367|FG002|Overall Study|Participant request to discontinue|2|||
126354498|NCT02265744|454589368|FG003|Overall Study|Participant request to discontinue|0|||
126354499|NCT02265744|454589369|FG004|Overall Study|Participant request to discontinue|0|||
126354500|NCT02265744|454589365|FG000|Overall Study|Adverse Event|8|||
126354501|NCT02265744|454589366|FG001|Overall Study|Adverse Event|4|||
126354502|NCT02265744|454589367|FG002|Overall Study|Adverse Event|9|||
126354503|NCT02265744|454589368|FG003|Overall Study|Adverse Event|8|||
126354504|NCT02265744|454589369|FG004|Overall Study|Adverse Event|2|||
126354505|NCT02265744|454589365|FG000|Overall Study|Lack of Efficacy|2|||
126354506|NCT02265744|454589366|FG001|Overall Study|Lack of Efficacy|4|||
126354507|NCT02265744|454589367|FG002|Overall Study|Lack of Efficacy|3|||
126354508|NCT02265744|454589368|FG003|Overall Study|Lack of Efficacy|4|||
126354509|NCT02265744|454589369|FG004|Overall Study|Lack of Efficacy|5|||
126354510|NCT02265744|454589365|FG000|Overall Study|Reason not provided by Investigator|1|||
126354511|NCT02265744|454589366|FG001|Overall Study|Reason not provided by Investigator|0|||
126354512|NCT02265744|454589367|FG002|Overall Study|Reason not provided by Investigator|0|||
126354513|NCT02265744|454589368|FG003|Overall Study|Reason not provided by Investigator|2|||
126354514|NCT02265744|454589369|FG004|Overall Study|Reason not provided by Investigator|0|||
126354515|NCT02265744|454589365|FG000|Overall Study|Administrative reason by sponsor|3|||
126354516|NCT02265744|454589366|FG001|Overall Study|Administrative reason by sponsor|2|||
126354517|NCT02265744|454589367|FG002|Overall Study|Administrative reason by sponsor|2|||
126354518|NCT02265744|454589368|FG003|Overall Study|Administrative reason by sponsor|3|||
126354519|NCT02265744|454589369|FG004|Overall Study|Administrative reason by sponsor|3|||
126354520|NCT02265744|454589365|FG000|Overall Study|Subject no longer meets study criteria|0|||
126354521|NCT02265744|454589366|FG001|Overall Study|Subject no longer meets study criteria|0|||
126354522|NCT02265744|454589367|FG002|Overall Study|Subject no longer meets study criteria|0|||
126354523|NCT02265744|454589368|FG003|Overall Study|Subject no longer meets study criteria|0|||
126354524|NCT02265744|454589369|FG004|Overall Study|Subject no longer meets study criteria|1|||
126354525|NCT02265744|454589365|FG000|Overall Study|Pregnancy|1|||
126354526|NCT02265744|454589366|FG001|Overall Study|Pregnancy|2|||
126354527|NCT02265744|454589367|FG002|Overall Study|Pregnancy|1|||
126354528|NCT02265744|454589368|FG003|Overall Study|Pregnancy|1|||
126354529|NCT02265744|454589369|FG004|Overall Study|Pregnancy|0|||
126354530|NCT05161936|454589372|FG000|Overall Study|Study terminated by Sponsor|1|||
126354531|NCT05161936|454589373|FG001|Overall Study|Study terminated by Sponsor|0|||
126354532|NCT05161936|454589374|FG002|Overall Study|Study terminated by Sponsor|0|||
126354533|NCT05161936|454589372|FG000|Overall Study|Withdrawal by Subject|0|||
126354534|NCT05161936|454589373|FG001|Overall Study|Withdrawal by Subject|0|||
126354535|NCT05161936|454589374|FG002|Overall Study|Withdrawal by Subject|1|||
126354536|NCT04999020|454589382|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
126354537|NCT04999020|454589383|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
126354538|NCT04999020|454589384|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
126354539|NCT04999020|454589385|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
126354540|NCT04999020|454589382|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
126354541|NCT04999020|454589383|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
126354542|NCT04999020|454589384|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
126354543|NCT04999020|454589385|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
126354544|NCT04999020|454589382|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
126354545|NCT04999020|454589383|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
126354546|NCT04999020|454589384|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
126354547|NCT04999020|454589385|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
126354548|NCT04999020|454589382|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126354549|NCT04999020|454589383|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126354550|NCT04999020|454589384|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
126354551|NCT04999020|454589385|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
126354552|NCT04999020|454589382|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
126354553|NCT04999020|454589383|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
126354554|NCT04999020|454589384|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
126354555|NCT04999020|454589385|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
126354556|NCT04999020|454589382|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
126354557|NCT04999020|454589383|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
126354558|NCT04999020|454589384|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
126354559|NCT04999020|454589385|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
126354560|NCT04999020|454589382|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
126354561|NCT04999020|454589383|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
126354562|NCT04999020|454589384|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
126354563|NCT04999020|454589385|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
126354564|NCT04999020|454589382|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
126354565|NCT04999020|454589383|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
126354566|NCT04999020|454589384|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
126354567|NCT04999020|454589385|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
126354568|NCT02448043|454589386|FG000|Overall Study|Withdrawal by Subject|2|||
126354569|NCT02448043|454589387|FG001|Overall Study|Withdrawal by Subject|2|||
126354570|NCT02448043|454589386|FG000|Overall Study|Protocol Violation|1|||
126354571|NCT02448043|454589387|FG001|Overall Study|Protocol Violation|2|||
126354572|NCT00933166|454589392|FG000|Overall Study|Lost to Follow-up|4|||
126354573|NCT00933166|454589392|FG000|Overall Study|Lack of Efficacy|9|||
126354574|NCT00933166|454589392|FG000|Overall Study|Unavailable|4|||
126354575|NCT00933166|454589392|FG000|Overall Study|Withdrawal by Subject|1|||
126354576|NCT02112552|454589401|FG000|Overall Study|Withdrawal by Subject|1|||
126354577|NCT02112552|454589401|FG000|Overall Study|Adverse Event|1|||
126354578|NCT03501277|454589402|FG000|Intervention Period 1 (4 Days)|Other|0|||
126354579|NCT03501277|454589403|FG001|Intervention Period 1 (4 Days)|Other|0|||
126354580|NCT03501277|454589404|FG002|Intervention Period 1 (4 Days)|Other|1|||
126354581|NCT03501277|454589405|FG003|Intervention Period 1 (4 Days)|Other|0|||
126691468|NCT05499520|455826297|FG005|Overall Study|Lost to Follow-up|0|||
126691469|NCT05499520|455826298|FG006|Overall Study|Lost to Follow-up|31|||
126691470|NCT05499520|455826299|FG007|Overall Study|Lost to Follow-up|45|||
126691471|NCT05499520|455826300|FG008|Overall Study|Lost to Follow-up|42|||
126691472|NCT05499520|455826301|FG009|Overall Study|Lost to Follow-up|0|||
126691473|NCT05499520|455826302|FG010|Overall Study|Lost to Follow-up|0|||
126691474|NCT05499520|455826303|FG011|Overall Study|Lost to Follow-up|37|||
126354582|NCT03501277|454589402|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
126354583|NCT03501277|454589403|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
126354584|NCT03501277|454589404|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
126691475|NCT05499520|455826304|FG012|Overall Study|Lost to Follow-up|53|||
126354585|NCT03501277|454589405|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
126354586|NCT03501277|454589402|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
126443382|NCT02668393|454921277|FG000|Overall Study|Adverse Event|0|||
126443383|NCT02668393|454921278|FG001|Overall Study|Adverse Event|2|||
126443384|NCT02668393|454921277|FG000|Overall Study|Withdrawal from the trial|0|||
126443385|NCT02668393|454921278|FG001|Overall Study|Withdrawal from the trial|1|||
126443386|NCT02668393|454921277|FG000|Overall Study|Lack of benefit and side effects|1|||
126443387|NCT02668393|454921278|FG001|Overall Study|Lack of benefit and side effects|0|||
126443388|NCT02141204|454921279|FG000|Overall Study|Lost to Follow-up|2|||
126443389|NCT02141204|454921280|FG001|Overall Study|Lost to Follow-up|1|||
126443390|NCT02141204|454921279|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
126443391|NCT02141204|454921280|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
126443392|NCT02141204|454921279|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
126443393|NCT02141204|454921280|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
126443394|NCT02141204|454921279|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
126443395|NCT02141204|454921280|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
126443396|NCT01958164|454921281|FG000|Overall Study|Adverse Event|0|||
126443397|NCT01958164|454921282|FG001|Overall Study|Adverse Event|2|||
126443398|NCT01958164|454921281|FG000|Overall Study|Lost to Follow-up|2|||
126443399|NCT01958164|454921282|FG001|Overall Study|Lost to Follow-up|3|||
126443400|NCT02963506|454921283|FG000|Double-Blind Period|Adverse Event|0|||
126443401|NCT02963506|454921284|FG001|Double-Blind Period|Adverse Event|0|||
126443402|NCT02963506|454921285|FG002|Double-Blind Period|Adverse Event|1|||
126443403|NCT02963506|454921286|FG003|Double-Blind Period|Adverse Event|0|||
126443404|NCT02963506|454921287|FG004|Double-Blind Period|Adverse Event|0|||
126443405|NCT02963506|454921288|FG005|Double-Blind Period|Adverse Event|0|||
126443406|NCT02963506|454921289|FG006|Double-Blind Period|Adverse Event|0|||
126443407|NCT02963506|454921290|FG007|Double-Blind Period|Adverse Event|0|||
126443408|NCT02963506|454921291|FG008|Double-Blind Period|Adverse Event|0|||
126443409|NCT02963506|454921292|FG009|Double-Blind Period|Adverse Event|0|||
126443410|NCT02963506|454921293|FG010|Double-Blind Period|Adverse Event|0|||
126443411|NCT02963506|454921294|FG011|Double-Blind Period|Adverse Event|0|||
126443412|NCT02963506|454921295|FG012|Double-Blind Period|Adverse Event|0|||
126443413|NCT02963506|454921283|FG000|Double-Blind Period|Death|0|||
126443414|NCT02963506|454921284|FG001|Double-Blind Period|Death|0|||
126443415|NCT02963506|454921285|FG002|Double-Blind Period|Death|0|||
126443416|NCT02963506|454921286|FG003|Double-Blind Period|Death|1|||
126443417|NCT02963506|454921287|FG004|Double-Blind Period|Death|0|||
126443418|NCT02963506|454921288|FG005|Double-Blind Period|Death|0|||
126443419|NCT02963506|454921289|FG006|Double-Blind Period|Death|0|||
126443420|NCT02963506|454921290|FG007|Double-Blind Period|Death|0|||
126443421|NCT02963506|454921291|FG008|Double-Blind Period|Death|0|||
126443422|NCT02963506|454921292|FG009|Double-Blind Period|Death|0|||
126443423|NCT02963506|454921293|FG010|Double-Blind Period|Death|0|||
126443424|NCT02963506|454921294|FG011|Double-Blind Period|Death|0|||
126443425|NCT02963506|454921295|FG012|Double-Blind Period|Death|0|||
126443426|NCT02963506|454921283|FG000|Double-Blind Period|Lost to Follow-up|0|||
126443427|NCT02963506|454921284|FG001|Double-Blind Period|Lost to Follow-up|1|||
126443428|NCT02963506|454921285|FG002|Double-Blind Period|Lost to Follow-up|0|||
126443429|NCT02963506|454921286|FG003|Double-Blind Period|Lost to Follow-up|0|||
126443430|NCT02963506|454921287|FG004|Double-Blind Period|Lost to Follow-up|0|||
126443431|NCT02963506|454921288|FG005|Double-Blind Period|Lost to Follow-up|0|||
126443432|NCT02963506|454921289|FG006|Double-Blind Period|Lost to Follow-up|0|||
126443433|NCT02963506|454921290|FG007|Double-Blind Period|Lost to Follow-up|0|||
126443434|NCT02963506|454921291|FG008|Double-Blind Period|Lost to Follow-up|0|||
126443435|NCT02963506|454921292|FG009|Double-Blind Period|Lost to Follow-up|0|||
126443436|NCT02963506|454921293|FG010|Double-Blind Period|Lost to Follow-up|0|||
126443437|NCT02963506|454921294|FG011|Double-Blind Period|Lost to Follow-up|0|||
126443438|NCT02963506|454921295|FG012|Double-Blind Period|Lost to Follow-up|0|||
126443439|NCT02963506|454921283|FG000|Double-Blind Period|Withdrawal by Subject|0|||
126443440|NCT02963506|454921284|FG001|Double-Blind Period|Withdrawal by Subject|0|||
126443441|NCT02963506|454921285|FG002|Double-Blind Period|Withdrawal by Subject|1|||
126443442|NCT02963506|454921286|FG003|Double-Blind Period|Withdrawal by Subject|1|||
126443443|NCT02963506|454921287|FG004|Double-Blind Period|Withdrawal by Subject|0|||
126443444|NCT02963506|454921288|FG005|Double-Blind Period|Withdrawal by Subject|0|||
126443445|NCT02963506|454921289|FG006|Double-Blind Period|Withdrawal by Subject|0|||
126443446|NCT02963506|454921290|FG007|Double-Blind Period|Withdrawal by Subject|0|||
126443447|NCT02963506|454921291|FG008|Double-Blind Period|Withdrawal by Subject|0|||
126443448|NCT02963506|454921292|FG009|Double-Blind Period|Withdrawal by Subject|0|||
126443449|NCT02963506|454921293|FG010|Double-Blind Period|Withdrawal by Subject|0|||
126443450|NCT02963506|454921294|FG011|Double-Blind Period|Withdrawal by Subject|0|||
126443451|NCT02963506|454921295|FG012|Double-Blind Period|Withdrawal by Subject|0|||
126443452|NCT02963506|454921283|FG000|Double-Blind Period|No compliance|0|||
126443453|NCT02963506|454921284|FG001|Double-Blind Period|No compliance|1|||
126443454|NCT02963506|454921285|FG002|Double-Blind Period|No compliance|0|||
126443455|NCT02963506|454921286|FG003|Double-Blind Period|No compliance|0|||
126443456|NCT02963506|454921287|FG004|Double-Blind Period|No compliance|0|||
126443457|NCT02963506|454921288|FG005|Double-Blind Period|No compliance|0|||
126443458|NCT02963506|454921289|FG006|Double-Blind Period|No compliance|0|||
126443459|NCT02963506|454921290|FG007|Double-Blind Period|No compliance|0|||
126443460|NCT02963506|454921291|FG008|Double-Blind Period|No compliance|0|||
126443461|NCT02963506|454921292|FG009|Double-Blind Period|No compliance|0|||
126443462|NCT02963506|454921293|FG010|Double-Blind Period|No compliance|0|||
126443463|NCT02963506|454921294|FG011|Double-Blind Period|No compliance|0|||
126443464|NCT02963506|454921295|FG012|Double-Blind Period|No compliance|0|||
126443465|NCT02963506|454921283|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
126443466|NCT02963506|454921284|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
126443467|NCT02963506|454921285|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
126443468|NCT02963506|454921286|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
126443469|NCT02963506|454921287|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
126443470|NCT02963506|454921288|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
126443471|NCT02963506|454921289|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
126443472|NCT02963506|454921290|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
126443473|NCT02963506|454921291|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
126443474|NCT02963506|454921292|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
126443475|NCT02963506|454921293|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
126443476|NCT02963506|454921294|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
126443477|NCT02963506|454921295|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
126443478|NCT02963506|454921283|FG000|Dose-Blind Period|Adverse Event|0|||
126443479|NCT02963506|454921284|FG001|Dose-Blind Period|Adverse Event|0|||
126443480|NCT02963506|454921285|FG002|Dose-Blind Period|Adverse Event|0|||
126443481|NCT02963506|454921286|FG003|Dose-Blind Period|Adverse Event|0|||
126443482|NCT02963506|454921287|FG004|Dose-Blind Period|Adverse Event|0|||
126443483|NCT02963506|454921288|FG005|Dose-Blind Period|Adverse Event|1|||
126443484|NCT02963506|454921289|FG006|Dose-Blind Period|Adverse Event|3|||
126443485|NCT02963506|454921290|FG007|Dose-Blind Period|Adverse Event|2|||
126443486|NCT02963506|454921291|FG008|Dose-Blind Period|Adverse Event|2|||
126443487|NCT02963506|454921292|FG009|Dose-Blind Period|Adverse Event|2|||
126443488|NCT02963506|454921293|FG010|Dose-Blind Period|Adverse Event|1|||
126443489|NCT02963506|454921294|FG011|Dose-Blind Period|Adverse Event|1|||
126443490|NCT02963506|454921295|FG012|Dose-Blind Period|Adverse Event|6|||
126443491|NCT02963506|454921283|FG000|Dose-Blind Period|Lack of Efficacy|0|||
126443492|NCT02963506|454921284|FG001|Dose-Blind Period|Lack of Efficacy|0|||
126443493|NCT02963506|454921285|FG002|Dose-Blind Period|Lack of Efficacy|0|||
126443494|NCT02963506|454921286|FG003|Dose-Blind Period|Lack of Efficacy|0|||
126443495|NCT02963506|454921287|FG004|Dose-Blind Period|Lack of Efficacy|0|||
126443496|NCT02963506|454921288|FG005|Dose-Blind Period|Lack of Efficacy|0|||
126443497|NCT02963506|454921289|FG006|Dose-Blind Period|Lack of Efficacy|0|||
126443498|NCT02963506|454921290|FG007|Dose-Blind Period|Lack of Efficacy|1|||
126443499|NCT02963506|454921291|FG008|Dose-Blind Period|Lack of Efficacy|0|||
126443500|NCT02963506|454921292|FG009|Dose-Blind Period|Lack of Efficacy|1|||
126443501|NCT02963506|454921293|FG010|Dose-Blind Period|Lack of Efficacy|0|||
126443502|NCT02963506|454921294|FG011|Dose-Blind Period|Lack of Efficacy|0|||
126443503|NCT02963506|454921295|FG012|Dose-Blind Period|Lack of Efficacy|0|||
126443504|NCT02963506|454921283|FG000|Dose-Blind Period|Lost to Follow-up|0|||
126443505|NCT02963506|454921284|FG001|Dose-Blind Period|Lost to Follow-up|0|||
126443506|NCT02963506|454921285|FG002|Dose-Blind Period|Lost to Follow-up|0|||
126443507|NCT02963506|454921286|FG003|Dose-Blind Period|Lost to Follow-up|0|||
126443508|NCT02963506|454921287|FG004|Dose-Blind Period|Lost to Follow-up|0|||
126443509|NCT02963506|454921288|FG005|Dose-Blind Period|Lost to Follow-up|1|||
126443510|NCT02963506|454921289|FG006|Dose-Blind Period|Lost to Follow-up|0|||
126443511|NCT02963506|454921290|FG007|Dose-Blind Period|Lost to Follow-up|0|||
126443512|NCT02963506|454921291|FG008|Dose-Blind Period|Lost to Follow-up|1|||
126443513|NCT02963506|454921292|FG009|Dose-Blind Period|Lost to Follow-up|0|||
126443514|NCT02963506|454921293|FG010|Dose-Blind Period|Lost to Follow-up|0|||
126443515|NCT02963506|454921294|FG011|Dose-Blind Period|Lost to Follow-up|1|||
126443516|NCT02963506|454921295|FG012|Dose-Blind Period|Lost to Follow-up|0|||
126443517|NCT02963506|454921283|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
126443518|NCT02963506|454921284|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
126443519|NCT02963506|454921285|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
126443520|NCT02963506|454921286|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
126691476|NCT05499520|455826305|FG013|Overall Study|Lost to Follow-up|49|||
126691477|NCT05499520|455826306|FG014|Overall Study|Lost to Follow-up|0|||
126760349|NCT04246996|456072478|FG001|Overall Study|Did not meet eligibility criteria|4|||
126760350|NCT02985541|456073737|FG000|Overall Study|Withdrawal by Subject|33|||
126760351|NCT02985541|456073737|FG000|Overall Study|Lost to Follow-up|26|||
126443521|NCT02963506|454921287|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
126691478|NCT05499520|455826307|FG015|Overall Study|Lost to Follow-up|36|||
126691479|NCT05499520|455826308|FG016|Overall Study|Lost to Follow-up|58|||
126691480|NCT05499520|455826309|FG017|Overall Study|Lost to Follow-up|53|||
126691481|NCT01613326|455826310|FG000|Overall Study|Adverse Event|7|||
126691482|NCT01613326|455826311|FG001|Overall Study|Adverse Event|5|||
126691483|NCT01613326|455826310|FG000|Overall Study|Withdrawal by Subject|3|||
126691484|NCT01613326|455826311|FG001|Overall Study|Withdrawal by Subject|4|||
126691485|NCT01613326|455826310|FG000|Overall Study|Abnormal test procedure result(s)|2|||
126691486|NCT01613326|455826311|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126691487|NCT01613326|455826310|FG000|Overall Study|inability to use device|1|||
126691488|NCT01613326|455826311|FG001|Overall Study|inability to use device|0|||
126691489|NCT01613326|455826310|FG000|Overall Study|Lack of Efficacy|0|||
126691490|NCT01613326|455826311|FG001|Overall Study|Lack of Efficacy|1|||
126691491|NCT01613326|455826310|FG000|Overall Study|Lost to Follow-up|0|||
126691492|NCT01613326|455826311|FG001|Overall Study|Lost to Follow-up|1|||
126691493|NCT01613326|455826310|FG000|Overall Study|Administrative|0|||
126691494|NCT01613326|455826311|FG001|Overall Study|Administrative|2|||
126691495|NCT01613326|455826310|FG000|Overall Study|Protocol Violation|0|||
126691496|NCT01613326|455826311|FG001|Overall Study|Protocol Violation|1|||
126691497|NCT03980938|455826312|FG000|Treatment Period 1|Study Terminated|1|||
126691498|NCT03980938|455826313|FG001|Treatment Period 1|Study Terminated|1|||
126691499|NCT03980938|455826312|FG000|Treatment Period 2|Study Terminated|2|||
126691500|NCT03980938|455826313|FG001|Treatment Period 2|Study Terminated|2|||
126691501|NCT00840827|455826314|FG000|Overall Study|Adverse Event|1|||
126691502|NCT00840827|455826314|FG000|Overall Study|Lack of Efficacy|4|||
126691503|NCT00840827|455826314|FG000|Overall Study|Physician Decision|1|||
126691504|NCT01445535|455826315|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
126691505|NCT01445535|455826316|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
126691506|NCT01445535|455826317|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
126691507|NCT01445535|455826318|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
126691508|NCT01445535|455826315|FG000|Overall Study|Disease progression|1|||
126691509|NCT01445535|455826316|FG001|Overall Study|Disease progression|0|||
126691510|NCT01445535|455826317|FG002|Overall Study|Disease progression|1|||
126691511|NCT01445535|455826318|FG003|Overall Study|Disease progression|0|||
126691512|NCT01445535|455826315|FG000|Overall Study|PI discretion|0|||
126691513|NCT01445535|455826316|FG001|Overall Study|PI discretion|0|||
126691514|NCT01445535|455826317|FG002|Overall Study|PI discretion|0|||
126691515|NCT01445535|455826318|FG003|Overall Study|PI discretion|1|||
126691516|NCT02494596|455826321|FG000|Overall Study|Insufficient Therapeutic Response|3|||
126691517|NCT02494596|455826322|FG001|Overall Study|Insufficient Therapeutic Response|3|||
126691518|NCT02494596|455826323|FG002|Overall Study|Insufficient Therapeutic Response|1|||
126691519|NCT02494596|455826321|FG000|Overall Study|Adverse Event|0|||
126691520|NCT02494596|455826322|FG001|Overall Study|Adverse Event|1|||
126691521|NCT02494596|455826323|FG002|Overall Study|Adverse Event|0|||
126691522|NCT02494596|455826321|FG000|Overall Study|Refused Treatment|0|||
126691523|NCT02494596|455826322|FG001|Overall Study|Refused Treatment|1|||
126691524|NCT02494596|455826323|FG002|Overall Study|Refused Treatment|0|||
126691525|NCT00059202|455826324|FG000|Overall Study|Withdrawal by Subject|5|||
126691526|NCT00059202|455826325|FG001|Overall Study|Withdrawal by Subject|9|||
126691527|NCT00059202|455826324|FG000|Overall Study|Protocol Violation|1|||
126691528|NCT00059202|455826325|FG001|Overall Study|Protocol Violation|3|||
126691529|NCT00059202|455826324|FG000|Overall Study|drug toxicity|0|||
126691530|NCT00059202|455826325|FG001|Overall Study|drug toxicity|3|||
126354587|NCT03501277|454589403|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
126354588|NCT03501277|454589404|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
126354589|NCT03501277|454589405|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
126354590|NCT03501277|454589402|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
126354591|NCT03501277|454589403|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
126354592|NCT03501277|454589404|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
126354593|NCT03501277|454589405|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
126443522|NCT02963506|454921288|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
126443523|NCT02963506|454921289|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
126443524|NCT02963506|454921290|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
126691531|NCT02658448|455826329|FG000|Overall Study|Lost to Follow-up|1|||
126691532|NCT00584194|455826330|FG000|Overall Study|Other|135|||
126691533|NCT00927368|455826332|FG000|Overall Study|enrollment in another study|1|||
126691534|NCT00927368|455826333|FG001|Overall Study|enrollment in another study|1|||
126760352|NCT02985541|456073737|FG000|Overall Study|Adverse Event|27|||
126354594|NCT01327703|454589406|FG000|Second Treatment Period|Adverse Event|1|||
126354595|NCT01327703|454589407|FG001|Second Treatment Period|Adverse Event|1|||
126354596|NCT01327703|454589406|FG000|Second Treatment Period|Protocol Violation|0|||
126354597|NCT01327703|454589407|FG001|Second Treatment Period|Protocol Violation|1|||
126354598|NCT01131585|454589408|FG000|Overall Study|Adverse Event|0|||
126354599|NCT01131585|454589409|FG001|Overall Study|Adverse Event|2|||
126354600|NCT01131585|454589408|FG000|Overall Study|Abnormal laboratory value|1|||
126354601|NCT01131585|454589409|FG001|Overall Study|Abnormal laboratory value|0|||
126443525|NCT02963506|454921291|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
126443526|NCT02963506|454921292|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
126354602|NCT01131585|454589408|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126443527|NCT02963506|454921293|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
126354603|NCT01131585|454589409|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126354604|NCT01131585|454589408|FG000|Overall Study|Protocol Violation|2|||
126354605|NCT01131585|454589409|FG001|Overall Study|Protocol Violation|1|||
126354606|NCT01131585|454589408|FG000|Overall Study|Withdrawal by Subject|3|||
126354607|NCT01131585|454589409|FG001|Overall Study|Withdrawal by Subject|3|||
126354608|NCT01131585|454589408|FG000|Overall Study|Lost to Follow-up|0|||
126354609|NCT01131585|454589409|FG001|Overall Study|Lost to Follow-up|1|||
126354610|NCT01131585|454589408|FG000|Overall Study|Administrative problems|1|||
126354611|NCT01131585|454589409|FG001|Overall Study|Administrative problems|1|||
126354612|NCT01131585|454589408|FG000|Overall Study|Study termination|78|||
126354613|NCT01131585|454589409|FG001|Overall Study|Study termination|32|||
126354614|NCT00812097|454589410|FG000|Overall Study|Death|3|||
126354615|NCT00812097|454589411|FG001|Overall Study|Death|10|||
126354616|NCT00812097|454589412|FG002|Overall Study|Death|3|||
126354617|NCT00812097|454589413|FG003|Overall Study|Death|3|||
126354618|NCT00812097|454589410|FG000|Overall Study|Withdrawal by Subject|14|||
126354619|NCT00812097|454589411|FG001|Overall Study|Withdrawal by Subject|12|||
126354620|NCT00812097|454589412|FG002|Overall Study|Withdrawal by Subject|8|||
126354621|NCT00812097|454589413|FG003|Overall Study|Withdrawal by Subject|2|||
126354622|NCT00812097|454589410|FG000|Overall Study|Lost to Follow-up|90|||
126354623|NCT00812097|454589411|FG001|Overall Study|Lost to Follow-up|14|||
126354624|NCT00812097|454589412|FG002|Overall Study|Lost to Follow-up|17|||
126354625|NCT00812097|454589413|FG003|Overall Study|Lost to Follow-up|5|||
126354626|NCT00812097|454589410|FG000|Overall Study|Explantation of study device(s)|27|||
126354627|NCT00812097|454589411|FG001|Overall Study|Explantation of study device(s)|29|||
126354628|NCT00812097|454589412|FG002|Overall Study|Explantation of study device(s)|14|||
126354629|NCT00812097|454589413|FG003|Overall Study|Explantation of study device(s)|20|||
126354630|NCT00812097|454589410|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
126354631|NCT00812097|454589411|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
126354632|NCT00812097|454589412|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
126354633|NCT00812097|454589413|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
126354634|NCT00927082|454589414|FG000|Overall Study|Lost to Follow-up|9|||
126354635|NCT00927082|454589415|FG001|Overall Study|Lost to Follow-up|8|||
126354636|NCT00927082|454589416|FG002|Overall Study|Lost to Follow-up|12|||
126354637|NCT00927082|454589417|FG003|Overall Study|Lost to Follow-up|16|||
126760353|NCT02985541|456073737|FG000|Overall Study|Physician Decision|2|||
126760354|NCT02985541|456073737|FG000|Overall Study|Pregnancy|2|||
126760355|NCT02985541|456073737|FG000|Overall Study|Wish for pregnancy|44|||
126760356|NCT02985541|456073737|FG000|Overall Study|Other reason|5|||
126760357|NCT02985541|456073737|FG000|Overall Study|Not valid for analysis|2|||
126760358|NCT00792467|456073745|FG000|Overall Study|progression of disease|17|||
126760359|NCT00792467|456073745|FG000|Overall Study|Adverse Event|1|||
126760360|NCT00792467|456073745|FG000|Overall Study|patient request|1|||
126760361|NCT00792467|456073745|FG000|Overall Study|Lost to Follow-up|1|||
126354638|NCT00927082|454589414|FG000|Overall Study|Withdrawal by Subject|3|||
126760362|NCT00792467|456073745|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
126760363|NCT00792467|456073745|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
126760364|NCT03911401|456073746|FG000|Overall Study|Adverse Event|1|||
126760365|NCT03911401|456073747|FG001|Overall Study|Adverse Event|2|||
126760366|NCT03911401|456073748|FG002|Overall Study|Adverse Event|5|||
126354639|NCT00927082|454589415|FG001|Overall Study|Withdrawal by Subject|2|||
126354640|NCT00927082|454589416|FG002|Overall Study|Withdrawal by Subject|7|||
126354641|NCT00927082|454589417|FG003|Overall Study|Withdrawal by Subject|2|||
126354642|NCT00927082|454589414|FG000|Overall Study|Death|0|||
126760367|NCT03911401|456073746|FG000|Overall Study|Lack of Efficacy|1|||
126760368|NCT03911401|456073747|FG001|Overall Study|Lack of Efficacy|1|||
126760369|NCT03911401|456073748|FG002|Overall Study|Lack of Efficacy|8|||
126760370|NCT03911401|456073746|FG000|Overall Study|Physician Decision|0|||
126760371|NCT03911401|456073747|FG001|Overall Study|Physician Decision|0|||
126760372|NCT03911401|456073748|FG002|Overall Study|Physician Decision|1|||
126760373|NCT03911401|456073746|FG000|Overall Study|Withdrawal by Subject|1|||
126760374|NCT03911401|456073747|FG001|Overall Study|Withdrawal by Subject|2|||
126443528|NCT02963506|454921294|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
126760375|NCT03911401|456073748|FG002|Overall Study|Withdrawal by Subject|0|||
126760376|NCT03911401|456073746|FG000|Overall Study|Withdrawal by parent/guardian|4|||
126760377|NCT03911401|456073747|FG001|Overall Study|Withdrawal by parent/guardian|4|||
126760378|NCT03911401|456073748|FG002|Overall Study|Withdrawal by parent/guardian|11|||
126760379|NCT00462501|456073749|FG000|Overall Study|Not treated|3|||
126760380|NCT00462501|456073749|FG000|Overall Study|Adverse Event|2|||
126760381|NCT00483574|456073750|FG000|Overall Study|Adverse Event|6|||
126760382|NCT00483574|456073751|FG001|Overall Study|Adverse Event|0|||
126760383|NCT00483574|456073750|FG000|Overall Study|Protocol Violation|28|||
126760384|NCT00483574|456073751|FG001|Overall Study|Protocol Violation|9|||
126760385|NCT00483574|456073750|FG000|Overall Study|Lost to Follow-up|16|||
126760386|NCT00483574|456073751|FG001|Overall Study|Lost to Follow-up|4|||
126760387|NCT00483574|456073750|FG000|Overall Study|Withdrawal by Subject|52|||
126760388|NCT00483574|456073751|FG001|Overall Study|Withdrawal by Subject|0|||
126760389|NCT00998166|456073752|FG000|Overall Study|Early Study Termination|8|||
126760390|NCT00933543|456073767|FG000|Overall Study|Adverse Event|2|||
126760391|NCT00933543|456073768|FG001|Overall Study|Adverse Event|1|||
126760392|NCT00933543|456073767|FG000|Overall Study|Lost to Follow-up|0|||
126760393|NCT00933543|456073768|FG001|Overall Study|Lost to Follow-up|1|||
126760394|NCT00933543|456073767|FG000|Overall Study|Withdrawal by Subject|0|||
126760395|NCT00933543|456073768|FG001|Overall Study|Withdrawal by Subject|1|||
126760396|NCT00933543|456073767|FG000|Overall Study|Lack of Efficacy|0|||
126760397|NCT00933543|456073768|FG001|Overall Study|Lack of Efficacy|3|||
126760398|NCT00933543|456073767|FG000|Overall Study|Other|1|||
126443529|NCT02963506|454921295|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
126443530|NCT02963506|454921283|FG000|Dose-Blind Period|Sponsor decision|0|||
126443531|NCT02963506|454921284|FG001|Dose-Blind Period|Sponsor decision|0|||
126443532|NCT02963506|454921285|FG002|Dose-Blind Period|Sponsor decision|0|||
126443533|NCT02963506|454921286|FG003|Dose-Blind Period|Sponsor decision|0|||
126691535|NCT00927368|455826334|FG002|Overall Study|enrollment in another study|2|||
126691536|NCT00927368|455826332|FG000|Overall Study|Lost to Follow-up|4|||
126691537|NCT00927368|455826333|FG001|Overall Study|Lost to Follow-up|0|||
126691538|NCT00927368|455826334|FG002|Overall Study|Lost to Follow-up|0|||
126691539|NCT00927368|455826332|FG000|Overall Study|equipment failure|1|||
126691540|NCT00927368|455826333|FG001|Overall Study|equipment failure|0|||
126691541|NCT00927368|455826334|FG002|Overall Study|equipment failure|0|||
126691542|NCT00927368|455826332|FG000|Overall Study|ineligible post randomization|0|||
126691543|NCT00927368|455826333|FG001|Overall Study|ineligible post randomization|3|||
126691544|NCT00927368|455826334|FG002|Overall Study|ineligible post randomization|1|||
126691545|NCT00927368|455826332|FG000|Overall Study|cancellation of surgery|0|||
126691546|NCT00927368|455826333|FG001|Overall Study|cancellation of surgery|1|||
126691547|NCT00927368|455826334|FG002|Overall Study|cancellation of surgery|2|||
126691548|NCT02624492|455826335|FG000|Overall Study|Adverse Event|2|||
126691549|NCT02624492|455826336|FG001|Overall Study|Adverse Event|2|||
126760399|NCT00933543|456073768|FG001|Overall Study|Other|1|||
126760400|NCT04988035|456073769|FG000|Overall Study|Death|19|||
126760401|NCT04988035|456073770|FG001|Overall Study|Death|13|||
126760402|NCT04988035|456073769|FG000|Overall Study|Lost to Follow-up|12|||
126760403|NCT04988035|456073770|FG001|Overall Study|Lost to Follow-up|6|||
126760404|NCT04988035|456073769|FG000|Overall Study|Protocol Violation|0|||
126691550|NCT02624492|455826337|FG002|Overall Study|Adverse Event|2|||
126691551|NCT02624492|455826335|FG000|Overall Study|Progressive disease|0|||
126691552|NCT02624492|455826336|FG001|Overall Study|Progressive disease|2|||
126691553|NCT02624492|455826337|FG002|Overall Study|Progressive disease|3|||
126691554|NCT00331409|455826341|FG000|Overall Study|Lack of Efficacy|4|||
126354643|NCT00927082|454589415|FG001|Overall Study|Death|0|||
126354644|NCT00927082|454589416|FG002|Overall Study|Death|1|||
126354645|NCT00927082|454589417|FG003|Overall Study|Death|0|||
126354646|NCT00927082|454589414|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
126354647|NCT00927082|454589415|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
126354648|NCT00927082|454589416|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
126354649|NCT00927082|454589417|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
126354650|NCT00317369|454589418|FG000|Overall Study|Adverse Event|2|||
126691555|NCT03072160|455826345|FG000|Overall Study|Adverse Event|3|||
126354651|NCT00317369|454589419|FG001|Overall Study|Adverse Event|1|||
126691556|NCT03072160|455826346|FG001|Overall Study|Adverse Event|1|||
126691557|NCT03072160|455826345|FG000|Overall Study|Refused further treatment|6|||
126691558|NCT03072160|455826346|FG001|Overall Study|Refused further treatment|1|||
126354652|NCT00317369|454589420|FG002|Overall Study|Adverse Event|0|||
126354653|NCT00317369|454589418|FG000|Overall Study|Lack of Efficacy|0|||
126354654|NCT00317369|454589419|FG001|Overall Study|Lack of Efficacy|1|||
126354655|NCT00317369|454589420|FG002|Overall Study|Lack of Efficacy|1|||
126354656|NCT00317369|454589418|FG000|Overall Study|Withdrawal by Subject|0|||
126354657|NCT00317369|454589419|FG001|Overall Study|Withdrawal by Subject|0|||
126354658|NCT00317369|454589420|FG002|Overall Study|Withdrawal by Subject|1|||
126354659|NCT00849472|454589421|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
126354660|NCT00849472|454589421|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
126443534|NCT02963506|454921287|FG004|Dose-Blind Period|Sponsor decision|0|||
126443535|NCT02963506|454921288|FG005|Dose-Blind Period|Sponsor decision|1|||
126443536|NCT02963506|454921289|FG006|Dose-Blind Period|Sponsor decision|0|||
126443537|NCT02963506|454921290|FG007|Dose-Blind Period|Sponsor decision|0|||
126443538|NCT02963506|454921291|FG008|Dose-Blind Period|Sponsor decision|0|||
126443539|NCT02963506|454921292|FG009|Dose-Blind Period|Sponsor decision|0|||
126443540|NCT02963506|454921293|FG010|Dose-Blind Period|Sponsor decision|0|||
126443541|NCT02963506|454921294|FG011|Dose-Blind Period|Sponsor decision|0|||
126443542|NCT02963506|454921295|FG012|Dose-Blind Period|Sponsor decision|0|||
126443543|NCT02963506|454921283|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
126443544|NCT02963506|454921284|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
126443545|NCT02963506|454921285|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
126443546|NCT02963506|454921286|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
126443547|NCT02963506|454921287|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
126443548|NCT02963506|454921288|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
126443549|NCT02963506|454921289|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
126443550|NCT02963506|454921290|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
126443551|NCT02963506|454921291|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
126443552|NCT02963506|454921292|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
126443553|NCT02963506|454921293|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
126443554|NCT02963506|454921294|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
126443555|NCT02963506|454921295|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
126443556|NCT00828204|454921298|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
126443557|NCT00828204|454921299|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
126443558|NCT00828204|454921298|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
126443559|NCT00828204|454921299|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
126443560|NCT00828204|454921298|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
126443561|NCT00828204|454921299|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
126443562|NCT00828204|454921298|FG000|Main Study: After Study Restart|Adverse Event|0|||
126443563|NCT00828204|454921299|FG001|Main Study: After Study Restart|Adverse Event|2|||
126443564|NCT00828204|454921298|FG000|Main Study: After Study Restart|Noncompliance|0|||
126443565|NCT00828204|454921299|FG001|Main Study: After Study Restart|Noncompliance|1|||
126443566|NCT00828204|454921298|FG000|Extension Study|Lost to Follow-up|0|||
126443567|NCT00828204|454921299|FG001|Extension Study|Lost to Follow-up|1|||
126443568|NCT00828204|454921298|FG000|Extension Study|Physician Decision|0|||
126443569|NCT00828204|454921299|FG001|Extension Study|Physician Decision|2|||
126443570|NCT00928408|454921306|FG000|Overall Study|Other|2|||
126443571|NCT00928408|454921306|FG000|Overall Study|Withdrawal by Subject|4|||
126443572|NCT00928408|454921306|FG000|Overall Study|Death|5|||
126443573|NCT00928408|454921306|FG000|Overall Study|Lost to Follow-up|12|||
126443574|NCT00787644|454921307|FG000|Overall Study|Lost to Follow-up|1|||
126443575|NCT00787644|454921308|FG001|Overall Study|Lost to Follow-up|1|||
126443576|NCT00787644|454921307|FG000|Overall Study|Withdrawal by Subject|1|||
126443577|NCT00787644|454921308|FG001|Overall Study|Withdrawal by Subject|1|||
126443578|NCT00536744|454921309|FG000|Overall Study|Adverse Event|13|||
126443579|NCT00536744|454921310|FG001|Overall Study|Adverse Event|10|||
126443580|NCT00536744|454921309|FG000|Overall Study|Death|2|||
126443581|NCT00536744|454921310|FG001|Overall Study|Death|1|||
126443582|NCT00536744|454921309|FG000|Overall Study|Physician Decision|3|||
126443583|NCT00536744|454921310|FG001|Overall Study|Physician Decision|1|||
126443584|NCT00536744|454921309|FG000|Overall Study|Lost to Follow-up|3|||
126443585|NCT00536744|454921310|FG001|Overall Study|Lost to Follow-up|5|||
126443586|NCT00536744|454921309|FG000|Overall Study|Withdrawal by Subject|7|||
126443587|NCT00536744|454921310|FG001|Overall Study|Withdrawal by Subject|8|||
126443588|NCT00536744|454921309|FG000|Overall Study|PI tried alternative treatment|1|||
126443589|NCT00536744|454921310|FG001|Overall Study|PI tried alternative treatment|3|||
126443590|NCT02908672|454921311|FG000|Run-in Period|Death|12|||
126443591|NCT02908672|454921312|FG001|Run-in Period|Death|10|||
126443592|NCT02908672|454921313|FG002|Run-in Period|Death|0|||
126443593|NCT02908672|454921314|FG003|Run-in Period|Death|0|||
126443594|NCT02908672|454921311|FG000|Run-in Period|Lost to Follow-up|1|||
126691559|NCT03072160|455826345|FG000|Overall Study|Physician Decision|1|||
126443595|NCT02908672|454921312|FG001|Run-in Period|Lost to Follow-up|1|||
126443596|NCT02908672|454921313|FG002|Run-in Period|Lost to Follow-up|0|||
126443597|NCT02908672|454921314|FG003|Run-in Period|Lost to Follow-up|0|||
126443598|NCT02908672|454921311|FG000|Run-in Period|Reason Not Specified|2|||
126691560|NCT03072160|455826346|FG001|Overall Study|Physician Decision|0|||
126691561|NCT03072160|455826345|FG000|Overall Study|Disease progression on study|1|||
126354661|NCT00849472|454589421|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
126691562|NCT03072160|455826346|FG001|Overall Study|Disease progression on study|1|||
126691563|NCT03072160|455826345|FG000|Overall Study|No contact|0|||
126443599|NCT02908672|454921312|FG001|Run-in Period|Reason Not Specified|0|||
126443600|NCT02908672|454921313|FG002|Run-in Period|Reason Not Specified|0|||
126691564|NCT03072160|455826346|FG001|Overall Study|No contact|1|||
126691565|NCT02239263|455826347|FG000|Overall Study|Protocol Violation|6|||
126691566|NCT04276207|455826349|FG000|Period 1|Withdrawal by Subject|0|||
126691567|NCT04276207|455826350|FG001|Period 1|Withdrawal by Subject|1|||
126691568|NCT01463098|455826351|FG000|Part A (11 Days)|Participant Choice|2|||
126691569|NCT01463098|455826352|FG001|Part A (11 Days)|Participant Choice|0|||
126691570|NCT01463098|455826353|FG002|Part A (11 Days)|Participant Choice|0|||
126691571|NCT01463098|455826354|FG003|Part A (11 Days)|Participant Choice|0|||
126691572|NCT01463098|455826355|FG004|Part A (11 Days)|Participant Choice|0|||
126760405|NCT04988035|456073770|FG001|Overall Study|Protocol Violation|1|||
126443601|NCT02908672|454921314|FG003|Run-in Period|Reason Not Specified|0|||
126443602|NCT02908672|454921311|FG000|Run-in Period|Protocol Violation|1|||
126443603|NCT02908672|454921312|FG001|Run-in Period|Protocol Violation|1|||
126443604|NCT02908672|454921313|FG002|Run-in Period|Protocol Violation|0|||
126443605|NCT02908672|454921314|FG003|Run-in Period|Protocol Violation|0|||
126443606|NCT02908672|454921311|FG000|Run-in Period|Study Ended by Sponsor|5|||
126443607|NCT02908672|454921312|FG001|Run-in Period|Study Ended by Sponsor|1|||
126443608|NCT02908672|454921313|FG002|Run-in Period|Study Ended by Sponsor|0|||
126443609|NCT02908672|454921314|FG003|Run-in Period|Study Ended by Sponsor|0|||
126443610|NCT02908672|454921311|FG000|Run-in Period|Withdrawal by Subject|3|||
126443611|NCT02908672|454921312|FG001|Run-in Period|Withdrawal by Subject|9|||
126443612|NCT02908672|454921313|FG002|Run-in Period|Withdrawal by Subject|0|||
126443613|NCT02908672|454921314|FG003|Run-in Period|Withdrawal by Subject|0|||
126443614|NCT02908672|454921311|FG000|Triple Combination Period|Death|0|||
126443615|NCT02908672|454921312|FG001|Triple Combination Period|Death|0|||
126443616|NCT02908672|454921313|FG002|Triple Combination Period|Death|150|||
126443617|NCT02908672|454921314|FG003|Triple Combination Period|Death|127|||
126443618|NCT02908672|454921311|FG000|Triple Combination Period|Lost to Follow-up|0|||
126443619|NCT02908672|454921312|FG001|Triple Combination Period|Lost to Follow-up|0|||
126443620|NCT02908672|454921313|FG002|Triple Combination Period|Lost to Follow-up|6|||
126443621|NCT02908672|454921314|FG003|Triple Combination Period|Lost to Follow-up|8|||
126443622|NCT02908672|454921311|FG000|Triple Combination Period|Reason Not Specified|0|||
126443623|NCT02908672|454921312|FG001|Triple Combination Period|Reason Not Specified|0|||
126443624|NCT02908672|454921313|FG002|Triple Combination Period|Reason Not Specified|0|||
126443625|NCT02908672|454921314|FG003|Triple Combination Period|Reason Not Specified|1|||
126443626|NCT02908672|454921311|FG000|Triple Combination Period|Physician Decision|0|||
126443627|NCT02908672|454921312|FG001|Triple Combination Period|Physician Decision|0|||
126443628|NCT02908672|454921313|FG002|Triple Combination Period|Physician Decision|1|||
126443629|NCT02908672|454921314|FG003|Triple Combination Period|Physician Decision|1|||
126443630|NCT02908672|454921311|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
126443631|NCT02908672|454921312|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
126443632|NCT02908672|454921313|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
126443633|NCT02908672|454921314|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
126443634|NCT02908672|454921311|FG000|Triple Combination Period|Withdrawal by Subject|0|||
126443635|NCT02908672|454921312|FG001|Triple Combination Period|Withdrawal by Subject|0|||
126443636|NCT02908672|454921313|FG002|Triple Combination Period|Withdrawal by Subject|13|||
126545405|NCT03500640|455290831|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
126760406|NCT04988035|456073769|FG000|Overall Study|Withdrawal by Subject|2|||
126760407|NCT04988035|456073770|FG001|Overall Study|Withdrawal by Subject|4|||
126545406|NCT03500640|455290832|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
126691573|NCT01463098|455826356|FG005|Part A (11 Days)|Participant Choice|0|||
126354662|NCT00849472|454589421|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
126354663|NCT00849472|454589421|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
126354664|NCT00849472|454589421|FG000|Weekly Paclitaxel|Disease Progression|1|||
126354665|NCT00849472|454589421|FG000|Weekly Paclitaxel|Adverse Event|11|||
126354666|NCT00849472|454589421|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
126354667|NCT00849472|454589421|FG000|Weekly Paclitaxel|Physician Decision|3|||
126691574|NCT01463098|455826357|FG006|Part A (11 Days)|Participant Choice|0|||
126354668|NCT00849472|454589421|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
126354669|NCT00849472|454589421|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
126691575|NCT01463098|455826358|FG007|Part A (11 Days)|Participant Choice|0|||
126691576|NCT01463098|455826359|FG008|Part A (11 Days)|Participant Choice|1|||
126691577|NCT01463098|455826360|FG009|Part A (11 Days)|Participant Choice|0|||
126443637|NCT02908672|454921314|FG003|Triple Combination Period|Withdrawal by Subject|16|||
126443638|NCT04163016|454921315|FG000|Enrollment|Adverse Event|1|||
126443639|NCT04163016|454921316|FG001|Enrollment|Adverse Event|0|||
126443640|NCT04163016|454921317|FG002|Enrollment|Adverse Event|0|||
126443641|NCT04163016|454921318|FG003|Enrollment|Adverse Event|0|||
126443642|NCT04163016|454921315|FG000|Treatment|Adverse Event|0|||
126443643|NCT04163016|454921316|FG001|Treatment|Adverse Event|1|||
126443644|NCT04163016|454921317|FG002|Treatment|Adverse Event|0|||
126443645|NCT04163016|454921318|FG003|Treatment|Adverse Event|0|||
126691578|NCT01463098|455826361|FG010|Part A (11 Days)|Participant Choice|0|||
126691579|NCT01463098|455826362|FG011|Part A (11 Days)|Participant Choice|0|||
126443646|NCT04163016|454921315|FG000|Treatment|Withdrawal by Subject|0|||
126443647|NCT04163016|454921316|FG001|Treatment|Withdrawal by Subject|2|||
126443648|NCT04163016|454921317|FG002|Treatment|Withdrawal by Subject|0|||
126443649|NCT04163016|454921318|FG003|Treatment|Withdrawal by Subject|0|||
126443650|NCT04163016|454921315|FG000|Treatment|Indeterminate TB-test|0|||
126443651|NCT04163016|454921316|FG001|Treatment|Indeterminate TB-test|0|||
126443652|NCT04163016|454921317|FG002|Treatment|Indeterminate TB-test|0|||
126443653|NCT04163016|454921318|FG003|Treatment|Indeterminate TB-test|1|||
126354670|NCT00849472|454589421|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
126354671|NCT00849472|454589421|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
126354672|NCT00849472|454589421|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
126354673|NCT00849472|454589421|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
126354674|NCT00849472|454589421|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
126691580|NCT01463098|455826363|FG012|Part A (11 Days)|Participant Choice|0|||
126691581|NCT01463098|455826364|FG013|Part A (11 Days)|Participant Choice|0|||
126691582|NCT01463098|455826351|FG000|Part A (11 Days)|Lost to Follow-up|0|||
126691583|NCT01463098|455826352|FG001|Part A (11 Days)|Lost to Follow-up|0|||
126691584|NCT01463098|455826353|FG002|Part A (11 Days)|Lost to Follow-up|0|||
126691585|NCT01463098|455826354|FG003|Part A (11 Days)|Lost to Follow-up|0|||
126691586|NCT01463098|455826355|FG004|Part A (11 Days)|Lost to Follow-up|1|||
126691587|NCT01463098|455826356|FG005|Part A (11 Days)|Lost to Follow-up|0|||
126691588|NCT01463098|455826357|FG006|Part A (11 Days)|Lost to Follow-up|0|||
126691589|NCT01463098|455826358|FG007|Part A (11 Days)|Lost to Follow-up|0|||
126691590|NCT01463098|455826359|FG008|Part A (11 Days)|Lost to Follow-up|0|||
126354675|NCT00849472|454589421|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
126354676|NCT00825175|454589422|FG000|Overall Study|Withdrawal by Subject|0|||
126354677|NCT00825175|454589423|FG001|Overall Study|Withdrawal by Subject|5|||
126354678|NCT03370302|454589428|FG000|Dose Escalation Phase|Other|0|||
126354679|NCT03370302|454589429|FG001|Dose Escalation Phase|Other|1|||
126354680|NCT03370302|454589430|FG002|Dose Escalation Phase|Other|1|||
126354681|NCT03370302|454589431|FG003|Dose Escalation Phase|Other|0|||
126354682|NCT03370302|454589432|FG004|Dose Escalation Phase|Other|0|||
126354683|NCT03370302|454589433|FG005|Dose Escalation Phase|Other|0|||
126354684|NCT03370302|454589428|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
126354685|NCT03370302|454589429|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
126354686|NCT03370302|454589430|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
126354687|NCT03370302|454589431|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126354688|NCT03370302|454589432|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
126354689|NCT03370302|454589433|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
126354690|NCT03370302|454589428|FG000|Dose Escalation Phase|Adverse Event|1|||
126354691|NCT03370302|454589429|FG001|Dose Escalation Phase|Adverse Event|0|||
126354692|NCT03370302|454589430|FG002|Dose Escalation Phase|Adverse Event|2|||
126354693|NCT03370302|454589431|FG003|Dose Escalation Phase|Adverse Event|0|||
126354694|NCT03370302|454589432|FG004|Dose Escalation Phase|Adverse Event|0|||
126354695|NCT03370302|454589433|FG005|Dose Escalation Phase|Adverse Event|0|||
126354696|NCT03370302|454589428|FG000|Dose Escalation Phase|Progressive Disease|2|||
126691591|NCT01463098|455826360|FG009|Part A (11 Days)|Lost to Follow-up|0|||
126354697|NCT03370302|454589429|FG001|Dose Escalation Phase|Progressive Disease|4|||
126354698|NCT03370302|454589430|FG002|Dose Escalation Phase|Progressive Disease|2|||
126354699|NCT03370302|454589431|FG003|Dose Escalation Phase|Progressive Disease|0|||
126354700|NCT03370302|454589432|FG004|Dose Escalation Phase|Progressive Disease|3|||
126354701|NCT03370302|454589433|FG005|Dose Escalation Phase|Progressive Disease|1|||
126354702|NCT03370302|454589428|FG000|Dose Expansion Phase|Progressive Disease|0|||
126354703|NCT03370302|454589429|FG001|Dose Expansion Phase|Progressive Disease|0|||
126354704|NCT03370302|454589430|FG002|Dose Expansion Phase|Progressive Disease|0|||
126354705|NCT03370302|454589431|FG003|Dose Expansion Phase|Progressive Disease|6|||
126354706|NCT03370302|454589432|FG004|Dose Expansion Phase|Progressive Disease|0|||
126354707|NCT03370302|454589433|FG005|Dose Expansion Phase|Progressive Disease|0|||
126354708|NCT01428128|454589434|FG000|Overall Study|Withdrawal by Subject|4|||
126354709|NCT01428128|454589434|FG000|Overall Study|Screen failure by p53|10|||
126354710|NCT01428128|454589434|FG000|Overall Study|Received Neulasta in one cycle|2|||
126354711|NCT01428128|454589434|FG000|Overall Study|Adverse Event|1|||
126354712|NCT00424008|454589436|FG000|Overall Study|Adverse Event|8|||
126354713|NCT00424008|454589437|FG001|Overall Study|Adverse Event|6|||
126354714|NCT00424008|454589436|FG000|Overall Study|Lack of Efficacy|40|||
126354715|NCT00424008|454589437|FG001|Overall Study|Lack of Efficacy|34|||
126354716|NCT00424008|454589436|FG000|Overall Study|Lost to Follow-up|1|||
126354717|NCT00424008|454589437|FG001|Overall Study|Lost to Follow-up|2|||
126354718|NCT00424008|454589436|FG000|Overall Study|Withdrawal by Subject|5|||
126354719|NCT00424008|454589437|FG001|Overall Study|Withdrawal by Subject|8|||
126354720|NCT00424008|454589436|FG000|Overall Study|Noncompliance with protocol|13|||
126354721|NCT00424008|454589437|FG001|Overall Study|Noncompliance with protocol|7|||
126354722|NCT00424008|454589436|FG000|Overall Study|Did not meet protocol eligibility|16|||
126354723|NCT00424008|454589437|FG001|Overall Study|Did not meet protocol eligibility|21|||
126354724|NCT00424008|454589436|FG000|Overall Study|Administrative|266|||
126354725|NCT00424008|454589437|FG001|Overall Study|Administrative|257|||
126354726|NCT02593864|454589440|FG000|Overall Study|Withdrawal by Subject|3|||
126354727|NCT02593864|454589440|FG000|Overall Study|Lost to Follow-up|3|||
126354728|NCT02530242|454589455|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
126354729|NCT02530242|454589456|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
126354730|NCT00283959|454589457|FG000|Extension Period|Low Compliance|1|||
126354731|NCT05591755|454589458|FG000|Overall Study|Screen Failure|1|||
126354732|NCT05591755|454589459|FG001|Overall Study|Screen Failure|0|||
126354733|NCT05591755|454589460|FG002|Overall Study|Screen Failure|0|||
126354734|NCT05591755|454589461|FG003|Overall Study|Screen Failure|0|||
126354735|NCT05591755|454589458|FG000|Overall Study|Protocol Violation|0|||
126354736|NCT05591755|454589459|FG001|Overall Study|Protocol Violation|0|||
126354737|NCT05591755|454589460|FG002|Overall Study|Protocol Violation|2|||
126354738|NCT05591755|454589461|FG003|Overall Study|Protocol Violation|0|||
126354739|NCT05591755|454589458|FG000|Overall Study|Withdrawal by Subject|0|||
126354740|NCT05591755|454589459|FG001|Overall Study|Withdrawal by Subject|1|||
126354741|NCT05591755|454589460|FG002|Overall Study|Withdrawal by Subject|0|||
126354742|NCT05591755|454589461|FG003|Overall Study|Withdrawal by Subject|0|||
126354743|NCT00433290|454589462|FG000|Overall Study|Adverse Event|24|||
126354744|NCT00433290|454589463|FG001|Overall Study|Adverse Event|7|||
126443654|NCT04163016|454921315|FG000|Treatment|Participant did not want to continue in study|0|||
126443655|NCT04163016|454921316|FG001|Treatment|Participant did not want to continue in study|0|||
126443656|NCT04163016|454921317|FG002|Treatment|Participant did not want to continue in study|0|||
126443657|NCT04163016|454921318|FG003|Treatment|Participant did not want to continue in study|1|||
126443658|NCT00123422|454922831|FG000|Overall Study|Physician Decision|2|||
126443659|NCT00123422|454922832|FG001|Overall Study|Physician Decision|2|||
126443660|NCT00123422|454922833|FG002|Overall Study|Physician Decision|6|||
126443661|NCT00123422|454922831|FG000|Overall Study|Withdrawal by Subject|1|||
126443662|NCT00123422|454922832|FG001|Overall Study|Withdrawal by Subject|2|||
126443663|NCT00123422|454922833|FG002|Overall Study|Withdrawal by Subject|2|||
126443664|NCT00123422|454922831|FG000|Overall Study|Lost to Follow-up|1|||
126443665|NCT00123422|454922832|FG001|Overall Study|Lost to Follow-up|2|||
126443666|NCT00123422|454922833|FG002|Overall Study|Lost to Follow-up|2|||
126443667|NCT01255436|454922836|FG000|Overall Study|Lost to Follow-up|178|||
126443668|NCT01255436|454922837|FG001|Overall Study|Lost to Follow-up|191|||
126443669|NCT01255436|454922836|FG000|Overall Study|Death, stroke, or MI|4|||
126443670|NCT01255436|454922837|FG001|Overall Study|Death, stroke, or MI|3|||
126443671|NCT01358721|454922838|FG000|Overall Study|Withdrawal by Subject|0|||
126443672|NCT01358721|454922839|FG001|Overall Study|Withdrawal by Subject|0|||
126443673|NCT01358721|454922840|FG002|Overall Study|Withdrawal by Subject|0|||
126443674|NCT01358721|454922841|FG003|Overall Study|Withdrawal by Subject|1|||
126443675|NCT01358721|454922838|FG000|Overall Study|Death|0|||
126443676|NCT01358721|454922839|FG001|Overall Study|Death|2|||
126443677|NCT01358721|454922840|FG002|Overall Study|Death|0|||
126443678|NCT01358721|454922841|FG003|Overall Study|Death|0|||
126443679|NCT01358721|454922838|FG000|Overall Study|Study Drug Toxicity|1|||
126443680|NCT01358721|454922839|FG001|Overall Study|Study Drug Toxicity|3|||
126443681|NCT01358721|454922840|FG002|Overall Study|Study Drug Toxicity|4|||
126443682|NCT01358721|454922841|FG003|Overall Study|Study Drug Toxicity|5|||
126443683|NCT01358721|454922838|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
126443684|NCT01358721|454922839|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
126443685|NCT01358721|454922840|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
126443686|NCT01358721|454922841|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
126443687|NCT01358721|454922838|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
126443688|NCT01358721|454922839|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
126443689|NCT01358721|454922840|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
126443690|NCT01358721|454922841|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
126443691|NCT01358721|454922838|FG000|Overall Study|Adverse Event related to study drug|1|||
126443692|NCT01358721|454922839|FG001|Overall Study|Adverse Event related to study drug|0|||
126443693|NCT01358721|454922840|FG002|Overall Study|Adverse Event related to study drug|0|||
126443694|NCT01358721|454922841|FG003|Overall Study|Adverse Event related to study drug|1|||
126443695|NCT01358721|454922838|FG000|Overall Study|Disease Progression|19|||
126443696|NCT01358721|454922839|FG001|Overall Study|Disease Progression|15|||
126443697|NCT01358721|454922840|FG002|Overall Study|Disease Progression|17|||
126443698|NCT01358721|454922841|FG003|Overall Study|Disease Progression|15|||
126354745|NCT00433290|454589462|FG000|Overall Study|Lack of Efficacy|1|||
126354746|NCT00433290|454589463|FG001|Overall Study|Lack of Efficacy|5|||
126354747|NCT00433290|454589462|FG000|Overall Study|Withdrawal by Subject|4|||
126354748|NCT00433290|454589463|FG001|Overall Study|Withdrawal by Subject|2|||
126354749|NCT00433290|454589462|FG000|Overall Study|Protocol Violation|3|||
126354750|NCT00433290|454589463|FG001|Overall Study|Protocol Violation|2|||
126354751|NCT00433290|454589462|FG000|Overall Study|Physician Decision|2|||
126354752|NCT00433290|454589463|FG001|Overall Study|Physician Decision|0|||
126354753|NCT00433290|454589462|FG000|Overall Study|Entry Criteria Not Met|0|||
126354754|NCT00433290|454589463|FG001|Overall Study|Entry Criteria Not Met|1|||
126354755|NCT00433290|454589462|FG000|Overall Study|Lost to Follow-up|1|||
126354756|NCT00433290|454589463|FG001|Overall Study|Lost to Follow-up|0|||
126354757|NCT01483651|454589464|FG000|Overall Study|Withdrawal by Subject|0|||
126354758|NCT01483651|454589465|FG001|Overall Study|Withdrawal by Subject|1|||
126354759|NCT01483651|454589466|FG002|Overall Study|Withdrawal by Subject|1|||
126354760|NCT01483651|454589467|FG003|Overall Study|Withdrawal by Subject|0|||
126354761|NCT01483651|454589468|FG004|Overall Study|Withdrawal by Subject|0|||
126354762|NCT01483651|454589469|FG005|Overall Study|Withdrawal by Subject|1|||
126354763|NCT00308685|454589478|FG000|Overall Study|Lost to Follow-up|1|||
126354764|NCT00308685|454589479|FG001|Overall Study|Lost to Follow-up|0|||
126354765|NCT00308685|454589478|FG000|Overall Study|Need to administer prohibited medication|1|||
126354766|NCT00308685|454589479|FG001|Overall Study|Need to administer prohibited medication|2|||
126354767|NCT00308685|454589478|FG000|Overall Study|Other than specified|1|||
126354768|NCT00308685|454589479|FG001|Overall Study|Other than specified|3|||
126354769|NCT03345095|454589480|FG000|Overall Study|Lack of Efficacy|184|||
126354770|NCT03345095|454589481|FG001|Overall Study|Lack of Efficacy|156|||
126354771|NCT03345095|454589480|FG000|Overall Study|Adverse Event|36|||
126354772|NCT03345095|454589481|FG001|Overall Study|Adverse Event|118|||
126443699|NCT01358721|454922838|FG000|Overall Study|Out of State/Unmet Criteria|0|||
126443700|NCT01358721|454922839|FG001|Overall Study|Out of State/Unmet Criteria|0|||
126443701|NCT01358721|454922840|FG002|Overall Study|Out of State/Unmet Criteria|1|||
126443702|NCT01358721|454922841|FG003|Overall Study|Out of State/Unmet Criteria|0|||
126443703|NCT01908803|454922842|FG000|Overall Study|Adverse Event|1|||
126443704|NCT01908803|454922843|FG001|Overall Study|Adverse Event|0|||
126443705|NCT01908803|454922842|FG000|Overall Study|Physician Decision|0|||
126443706|NCT01908803|454922843|FG001|Overall Study|Physician Decision|1|||
126443707|NCT01908803|454922842|FG000|Overall Study|Withdrawal by Subject|1|||
126443708|NCT01908803|454922843|FG001|Overall Study|Withdrawal by Subject|0|||
126443709|NCT01908803|454922842|FG000|Overall Study|Randomization Error|1|||
126443710|NCT01908803|454922843|FG001|Overall Study|Randomization Error|0|||
126443711|NCT01908803|454922842|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
126443712|NCT01908803|454922843|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
126443713|NCT01864603|454922844|FG000|Stage 2|DSMB design modification|86056|||
126443714|NCT01864603|454922845|FG001|Stage 2|DSMB design modification|92558|||
126443715|NCT01554241|454922846|FG000|Overall Study|Death|3|||
126443716|NCT01554241|454922847|FG001|Overall Study|Death|1|||
126443717|NCT01554241|454922848|FG002|Overall Study|Death|1|||
126443718|NCT01554241|454922849|FG003|Overall Study|Death|0|||
126443719|NCT01554241|454922846|FG000|Overall Study|protocol specified renal stone|0|||
126443720|NCT01554241|454922847|FG001|Overall Study|protocol specified renal stone|0|||
126443721|NCT01554241|454922848|FG002|Overall Study|protocol specified renal stone|0|||
126443722|NCT01554241|454922849|FG003|Overall Study|protocol specified renal stone|1|||
126443723|NCT01554241|454922846|FG000|Overall Study|protocol specified change in eGFR|0|||
126443724|NCT01554241|454922847|FG001|Overall Study|protocol specified change in eGFR|0|||
126443725|NCT01554241|454922848|FG002|Overall Study|protocol specified change in eGFR|1|||
126443726|NCT01554241|454922849|FG003|Overall Study|protocol specified change in eGFR|0|||
126443727|NCT01554241|454922846|FG000|Overall Study|Withdrawal by Subject|0|||
126443728|NCT01554241|454922847|FG001|Overall Study|Withdrawal by Subject|0|||
126443729|NCT01554241|454922848|FG002|Overall Study|Withdrawal by Subject|2|||
126443730|NCT01554241|454922849|FG003|Overall Study|Withdrawal by Subject|0|||
126443731|NCT00372593|454922850|FG000|Overall Study|Adverse Event|43|||
126443732|NCT00372593|454922851|FG001|Overall Study|Adverse Event|45|||
126443733|NCT00372593|454922852|FG002|Overall Study|Adverse Event|0|||
126443734|NCT00372593|454922850|FG000|Overall Study|Death|16|||
126443735|NCT00372593|454922851|FG001|Overall Study|Death|20|||
126443736|NCT00372593|454922852|FG002|Overall Study|Death|1|||
126443737|NCT00372593|454922850|FG000|Overall Study|Lack of Efficacy|82|||
126443738|NCT00372593|454922851|FG001|Overall Study|Lack of Efficacy|71|||
126443739|NCT00372593|454922852|FG002|Overall Study|Lack of Efficacy|2|||
126443740|NCT00372593|454922850|FG000|Overall Study|Lost to Follow-up|1|||
126443741|NCT00372593|454922851|FG001|Overall Study|Lost to Follow-up|0|||
126691592|NCT01463098|455826361|FG010|Part A (11 Days)|Lost to Follow-up|0|||
126691593|NCT01463098|455826362|FG011|Part A (11 Days)|Lost to Follow-up|0|||
126691594|NCT01463098|455826363|FG012|Part A (11 Days)|Lost to Follow-up|0|||
126691595|NCT01463098|455826364|FG013|Part A (11 Days)|Lost to Follow-up|0|||
126691596|NCT01463098|455826351|FG000|Part B (11 Days)|Participant Choice|0|||
126691597|NCT01463098|455826352|FG001|Part B (11 Days)|Participant Choice|0|||
126691598|NCT01463098|455826353|FG002|Part B (11 Days)|Participant Choice|0|||
126443742|NCT00372593|454922852|FG002|Overall Study|Lost to Follow-up|0|||
126443743|NCT00372593|454922850|FG000|Overall Study|Physician Decision|42|||
126443744|NCT00372593|454922851|FG001|Overall Study|Physician Decision|41|||
126443745|NCT00372593|454922852|FG002|Overall Study|Physician Decision|0|||
126443746|NCT00372593|454922850|FG000|Overall Study|Ineligible|20|||
126443747|NCT00372593|454922851|FG001|Overall Study|Ineligible|21|||
126443748|NCT00372593|454922852|FG002|Overall Study|Ineligible|1|||
126443749|NCT03534180|454922853|FG000|Overall Study|Withdrawal by Subject|1|||
126443750|NCT00790088|454922856|FG000|Overall Study|Protocol Violation|11|||
126443751|NCT00790088|454922856|FG000|Overall Study|Withdrawal by Subject|17|||
126443752|NCT00790088|454922856|FG000|Overall Study|Lost to Follow-up|7|||
126691599|NCT01463098|455826354|FG003|Part B (11 Days)|Participant Choice|0|||
126691600|NCT01463098|455826355|FG004|Part B (11 Days)|Participant Choice|0|||
126691601|NCT01463098|455826356|FG005|Part B (11 Days)|Participant Choice|0|||
126691602|NCT01463098|455826357|FG006|Part B (11 Days)|Participant Choice|0|||
126691603|NCT01463098|455826358|FG007|Part B (11 Days)|Participant Choice|0|||
126691604|NCT01463098|455826359|FG008|Part B (11 Days)|Participant Choice|0|||
126691605|NCT01463098|455826360|FG009|Part B (11 Days)|Participant Choice|0|||
126691606|NCT01463098|455826361|FG010|Part B (11 Days)|Participant Choice|0|||
126691607|NCT01463098|455826362|FG011|Part B (11 Days)|Participant Choice|1|||
126691608|NCT01463098|455826363|FG012|Part B (11 Days)|Participant Choice|0|||
126691609|NCT01463098|455826364|FG013|Part B (11 Days)|Participant Choice|0|||
126691610|NCT04451330|455826369|FG000|Overall Study|Adverse Event|1|||
126691611|NCT04451330|455826370|FG001|Overall Study|Adverse Event|2|||
126691612|NCT04451330|455826369|FG000|Overall Study|Lost to Follow-up|5|||
126691613|NCT04451330|455826370|FG001|Overall Study|Lost to Follow-up|0|||
126691614|NCT04451330|455826369|FG000|Overall Study|Withdrawal by Subject|3|||
126691615|NCT04451330|455826370|FG001|Overall Study|Withdrawal by Subject|1|||
126691616|NCT04451330|455826369|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126691617|NCT04451330|455826370|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126691618|NCT04451330|455826369|FG000|Overall Study|Other than specified|0|||
126691619|NCT04451330|455826370|FG001|Overall Study|Other than specified|1|||
126443753|NCT00790088|454922856|FG000|Overall Study|Physician Decision|4|||
126443754|NCT04329806|454922857|FG000|Overall Study|Physician Decision|3|||
126443755|NCT04329806|454922858|FG001|Overall Study|Physician Decision|4|||
126443756|NCT02636595|454922861|FG000|Overall Study|Lost to Follow-up|1|||
126443757|NCT02636595|454922861|FG000|Overall Study|Other|1|||
126443758|NCT02578706|454922865|FG000|Overall Study|Withdrawal by Subject|1|||
126443759|NCT02578706|454922866|FG001|Overall Study|Withdrawal by Subject|0|||
126443760|NCT02578706|454922867|FG002|Overall Study|Withdrawal by Subject|0|||
126691620|NCT02769624|455826371|FG000|Overall Study|Lost to Follow-up|0|||
126443761|NCT02578706|454922865|FG000|Overall Study|Lost to Follow-up|0|||
126691621|NCT02769624|455826372|FG001|Overall Study|Lost to Follow-up|1|||
126691622|NCT05099640|455826373|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
126691623|NCT05099640|455826374|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
126443762|NCT02578706|454922866|FG001|Overall Study|Lost to Follow-up|4|||
126443763|NCT02578706|454922867|FG002|Overall Study|Lost to Follow-up|0|||
126443764|NCT02578706|454922865|FG000|Overall Study|Physician Decision|0|||
126443765|NCT02578706|454922866|FG001|Overall Study|Physician Decision|1|||
126443766|NCT02578706|454922867|FG002|Overall Study|Physician Decision|0|||
126443767|NCT02015637|454922871|FG000|Overall Study|Lost to Follow-up|3|||
126443768|NCT02015637|454922872|FG001|Overall Study|Lost to Follow-up|5|||
126443769|NCT02015637|454922871|FG000|Overall Study|Adverse Event|3|||
126443770|NCT02015637|454922872|FG001|Overall Study|Adverse Event|0|||
126443771|NCT02015637|454922871|FG000|Overall Study|Did not take study drug|2|||
126443772|NCT02015637|454922872|FG001|Overall Study|Did not take study drug|0|||
126443773|NCT02223858|454922877|FG000|Overall Study|Death|1|||
126443774|NCT02223858|454922878|FG001|Overall Study|Death|1|||
126443775|NCT02223858|454922877|FG000|Overall Study|Lost to Follow-up|6|||
126443776|NCT02223858|454922878|FG001|Overall Study|Lost to Follow-up|11|||
126443777|NCT02223858|454922877|FG000|Overall Study|Withdrawal by Subject|8|||
126443778|NCT02223858|454922878|FG001|Overall Study|Withdrawal by Subject|5|||
126443779|NCT02223858|454922877|FG000|Overall Study|Refused|9|||
126443780|NCT02223858|454922878|FG001|Overall Study|Refused|9|||
126443781|NCT04455815|454922879|FG000|Randomisation Phase|Adverse Event|1|||
126443782|NCT04455815|454922880|FG001|Randomisation Phase|Adverse Event|0|||
126443783|NCT04455815|454922879|FG000|Treatment Phase|Adverse Event|0|||
126443784|NCT04455815|454922880|FG001|Treatment Phase|Adverse Event|1|||
126443785|NCT04455815|454922879|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
126443786|NCT04455815|454922880|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
126443787|NCT04455815|454922879|FG000|Treatment Phase|Withdrawal by Subject|1|||
126443788|NCT04455815|454922880|FG001|Treatment Phase|Withdrawal by Subject|1|||
126443789|NCT02106390|454922881|FG000|Overall Study|Withdrawal by Subject|15|||
126443790|NCT02106390|454922882|FG001|Overall Study|Withdrawal by Subject|16|||
126443791|NCT02106390|454922883|FG002|Overall Study|Withdrawal by Subject|15|||
126443792|NCT02106390|454922881|FG000|Overall Study|Lost to Follow-up|25|||
126443793|NCT02106390|454922882|FG001|Overall Study|Lost to Follow-up|20|||
126443794|NCT02106390|454922883|FG002|Overall Study|Lost to Follow-up|13|||
126443795|NCT02106390|454922881|FG000|Overall Study|Other: Administrative Reason|8|||
126443796|NCT02106390|454922882|FG001|Overall Study|Other: Administrative Reason|5|||
126443797|NCT02106390|454922883|FG002|Overall Study|Other: Administrative Reason|12|||
126443798|NCT02106390|454922881|FG000|Overall Study|Other: Unspecified|1|||
126443799|NCT02106390|454922882|FG001|Overall Study|Other: Unspecified|4|||
126443800|NCT02106390|454922883|FG002|Overall Study|Other: Unspecified|2|||
126443801|NCT02106390|454922881|FG000|Overall Study|Adverse Event|0|||
126443802|NCT02106390|454922882|FG001|Overall Study|Adverse Event|2|||
126443803|NCT02106390|454922883|FG002|Overall Study|Adverse Event|1|||
126443804|NCT02106390|454922881|FG000|Overall Study|Protocol Violation|0|||
126443805|NCT02106390|454922882|FG001|Overall Study|Protocol Violation|1|||
126443806|NCT02106390|454922883|FG002|Overall Study|Protocol Violation|0|||
126443807|NCT03198507|454922884|FG000|Overall Study|Withdrawal by Subject|1|||
126443808|NCT03198507|454922885|FG001|Overall Study|Withdrawal by Subject|0|||
126443809|NCT00241839|454922890|FG000|Overall Study|Withdrawal by Subject|18|||
126443810|NCT00241839|454922891|FG001|Overall Study|Withdrawal by Subject|17|||
126443811|NCT00241839|454922890|FG000|Overall Study|Adverse Event|1|||
126443812|NCT00241839|454922891|FG001|Overall Study|Adverse Event|1|||
126443813|NCT00439517|454922894|FG000|Overall Study|Subject on treatment|1|||
126443814|NCT00439517|454922895|FG001|Overall Study|Subject on treatment|0|||
126443815|NCT00439517|454922894|FG000|Overall Study|Subject in survival follow-up|1|||
126443816|NCT00439517|454922895|FG001|Overall Study|Subject in survival follow-up|0|||
126443817|NCT02304367|454922898|FG000|Overall Study|Lack of Response to Bruosumab|1|||
126443818|NCT02304367|454922898|FG000|Overall Study|Sponsor Decision|3|||
126443819|NCT02304367|454922898|FG000|Overall Study|Death|2|||
126443820|NCT02304367|454922898|FG000|Overall Study|Physician Decision|1|||
126443821|NCT02304367|454922898|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
126443822|NCT00526071|454922899|FG000|Overall Study|Adverse Event|1|||
126443823|NCT00526071|454922899|FG000|Overall Study|Withdrawal by Subject|1|||
126443824|NCT00526071|454922899|FG000|Overall Study|Lack of Response to Study Drug|4|||
126443825|NCT00318643|454922905|FG000|Overall Study|Adverse Event|0|||
126443826|NCT00318643|454922906|FG001|Overall Study|Adverse Event|0|||
126443827|NCT00318643|454922907|FG002|Overall Study|Adverse Event|0|||
126443828|NCT00318643|454922908|FG003|Overall Study|Adverse Event|0|||
126443829|NCT00318643|454922909|FG004|Overall Study|Adverse Event|1|||
126443830|NCT00318643|454922905|FG000|Overall Study|Participant's Decision|0|||
126443831|NCT00318643|454922906|FG001|Overall Study|Participant's Decision|0|||
126760408|NCT04988035|456073769|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
126760409|NCT04988035|456073770|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
126760410|NCT03602976|456073771|FG000|Overall Study|Withdrawal by Subject|1|||
126760411|NCT04837807|456073772|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
126760412|NCT04837807|456073773|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
126760413|NCT04626947|456073774|FG000|Overall Study|Study terminated|14|||
126760414|NCT01428882|456073775|FG000|Overall Study|Lack of Efficacy|2|||
126443832|NCT00318643|454922907|FG002|Overall Study|Participant's Decision|0|||
126443833|NCT00318643|454922908|FG003|Overall Study|Participant's Decision|0|||
126443834|NCT00318643|454922909|FG004|Overall Study|Participant's Decision|1|||
126443835|NCT00318643|454922905|FG000|Overall Study|Investigator's Decision|0|||
126443836|NCT00318643|454922906|FG001|Overall Study|Investigator's Decision|0|||
126443837|NCT00318643|454922907|FG002|Overall Study|Investigator's Decision|0|||
126443838|NCT00318643|454922908|FG003|Overall Study|Investigator's Decision|0|||
126443839|NCT00318643|454922909|FG004|Overall Study|Investigator's Decision|1|||
126443840|NCT02500797|454922912|FG000|Overall Study|Cancel (rapid disease progression)|0|||
126443841|NCT02500797|454922913|FG001|Overall Study|Cancel (rapid disease progression)|0|||
126443842|NCT02500797|454922914|FG002|Overall Study|Cancel (rapid disease progression)|0|||
126443843|NCT02500797|454922915|FG003|Overall Study|Cancel (rapid disease progression)|0|||
126443844|NCT02500797|454922916|FG004|Overall Study|Cancel (rapid disease progression)|1|||
126443845|NCT02500797|454922917|FG005|Overall Study|Cancel (rapid disease progression)|1|||
126443846|NCT02500797|454922918|FG006|Overall Study|Cancel (rapid disease progression)|0|||
126443847|NCT02500797|454922919|FG007|Overall Study|Cancel (rapid disease progression)|0|||
126443848|NCT02500797|454922912|FG000|Overall Study|Withdrawal by Subject|1|||
126443849|NCT02500797|454922913|FG001|Overall Study|Withdrawal by Subject|0|||
126443850|NCT02500797|454922914|FG002|Overall Study|Withdrawal by Subject|0|||
126443851|NCT02500797|454922915|FG003|Overall Study|Withdrawal by Subject|0|||
126443852|NCT02500797|454922916|FG004|Overall Study|Withdrawal by Subject|0|||
126443853|NCT02500797|454922917|FG005|Overall Study|Withdrawal by Subject|0|||
126443854|NCT02500797|454922918|FG006|Overall Study|Withdrawal by Subject|0|||
126443855|NCT02500797|454922919|FG007|Overall Study|Withdrawal by Subject|0|||
126760415|NCT01428882|456073776|FG001|Overall Study|Lack of Efficacy|7|||
126443856|NCT00357006|454922924|FG000|Overall Study|Lost to Follow-up|1|||
126760416|NCT01428882|456073775|FG000|Overall Study|Protocol Violation|4|||
126443857|NCT00357006|454922925|FG001|Overall Study|Lost to Follow-up|2|||
126443858|NCT00357006|454922926|FG002|Overall Study|Lost to Follow-up|1|||
126443859|NCT00357006|454922924|FG000|Overall Study|Withdrawal by Subject|1|||
126443860|NCT00357006|454922925|FG001|Overall Study|Withdrawal by Subject|3|||
126443861|NCT00357006|454922926|FG002|Overall Study|Withdrawal by Subject|2|||
126443862|NCT01216189|454922927|FG000|Overall Study|Lost to Follow-up|21|||
126443863|NCT01216189|454922928|FG001|Overall Study|Lost to Follow-up|3|||
126443864|NCT01216189|454922927|FG000|Overall Study|Death|4|||
126443865|NCT01216189|454922928|FG001|Overall Study|Death|2|||
126443866|NCT01469377|454922929|FG000|Overall Study|Protocol Deviation|7|||
126443867|NCT01469377|454922930|FG001|Overall Study|Protocol Deviation|10|||
126443868|NCT01469377|454922931|FG002|Overall Study|Protocol Deviation|10|||
126443869|NCT01469377|454922929|FG000|Overall Study|Lost to Follow-up|3|||
126443870|NCT01469377|454922930|FG001|Overall Study|Lost to Follow-up|2|||
126443871|NCT01469377|454922931|FG002|Overall Study|Lost to Follow-up|5|||
126443872|NCT01469377|454922929|FG000|Overall Study|Withdrawal of Consent|12|||
126443873|NCT01469377|454922930|FG001|Overall Study|Withdrawal of Consent|14|||
126443874|NCT01469377|454922931|FG002|Overall Study|Withdrawal of Consent|15|||
126443875|NCT01469377|454922929|FG000|Overall Study|Adverse Event|8|||
126443876|NCT01469377|454922930|FG001|Overall Study|Adverse Event|18|||
126443877|NCT01469377|454922931|FG002|Overall Study|Adverse Event|36|||
126443878|NCT01469377|454922929|FG000|Overall Study|Insufficient Therapeutic Response|3|||
126443879|NCT01469377|454922930|FG001|Overall Study|Insufficient Therapeutic Response|4|||
126443880|NCT01469377|454922931|FG002|Overall Study|Insufficient Therapeutic Response|0|||
126443881|NCT01469377|454922929|FG000|Overall Study|Other Miscellaneous Reasons|2|||
126443882|NCT01469377|454922930|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126443883|NCT01469377|454922931|FG002|Overall Study|Other Miscellaneous Reasons|0|||
126443884|NCT01733680|454922932|FG000|Overall Study|Withdrawal by Subject|0|||
126443885|NCT01733680|454922933|FG001|Overall Study|Withdrawal by Subject|1|||
126443886|NCT04139798|454922934|FG000|Overall Study|Withdrawal by Subject|6|||
126443887|NCT04139798|454922935|FG001|Overall Study|Withdrawal by Subject|5|||
126443888|NCT04139798|454922934|FG000|Overall Study|Lost to Follow-up|2|||
126443889|NCT04139798|454922935|FG001|Overall Study|Lost to Follow-up|5|||
126443890|NCT04139798|454922934|FG000|Overall Study|Discontinued|4|||
126443891|NCT04139798|454922935|FG001|Overall Study|Discontinued|2|||
126443892|NCT04139798|454922934|FG000|Overall Study|Adverse Event|1|||
126443893|NCT04139798|454922935|FG001|Overall Study|Adverse Event|3|||
126443894|NCT04139798|454922934|FG000|Overall Study|Protocol Violation|1|||
126443895|NCT04139798|454922935|FG001|Overall Study|Protocol Violation|0|||
126443896|NCT02357368|454922939|FG000|Overall Study|Lost to Follow-up|0|||
126443897|NCT02357368|454922940|FG001|Overall Study|Lost to Follow-up|0|||
126443898|NCT02357368|454922941|FG002|Overall Study|Lost to Follow-up|0|||
126443899|NCT02357368|454922942|FG003|Overall Study|Lost to Follow-up|1|||
126443900|NCT02357368|454922939|FG000|Overall Study|Pregnancy|3|||
126443901|NCT02357368|454922940|FG001|Overall Study|Pregnancy|2|||
126443902|NCT02357368|454922941|FG002|Overall Study|Pregnancy|0|||
126443903|NCT02357368|454922942|FG003|Overall Study|Pregnancy|0|||
126443904|NCT02357368|454922939|FG000|Overall Study|Withdrawal by Subject|3|||
126443905|NCT02357368|454922940|FG001|Overall Study|Withdrawal by Subject|1|||
126443906|NCT02357368|454922941|FG002|Overall Study|Withdrawal by Subject|1|||
126760417|NCT01428882|456073776|FG001|Overall Study|Protocol Violation|3|||
126760418|NCT00429026|456073779|FG000|Overall Study|Inevaluable for response.|40|||
126760419|NCT03831282|456073782|FG000|Overall Study|Could not place sensor|1|||
126443907|NCT02357368|454922942|FG003|Overall Study|Withdrawal by Subject|2|||
126443908|NCT02377817|454922943|FG000|Overall Study|Transportation/childcare barriers.|2|||
126443909|NCT02377817|454922944|FG001|Overall Study|Transportation/childcare barriers.|0|||
126443910|NCT02377817|454922943|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
126760420|NCT03556202|456073783|FG000|Extension Treatment Period|Adverse Event|18|||
126760421|NCT03556202|456073784|FG001|Extension Treatment Period|Adverse Event|14|||
126760422|NCT03556202|456073785|FG002|Extension Treatment Period|Adverse Event|9|||
126760423|NCT03556202|456073783|FG000|Extension Treatment Period|Death|2|||
126760424|NCT03556202|456073784|FG001|Extension Treatment Period|Death|6|||
126760425|NCT03556202|456073785|FG002|Extension Treatment Period|Death|0|||
126760426|NCT03556202|456073783|FG000|Extension Treatment Period|Lack of Efficacy|5|||
126760427|NCT03556202|456073784|FG001|Extension Treatment Period|Lack of Efficacy|12|||
126760428|NCT03556202|456073785|FG002|Extension Treatment Period|Lack of Efficacy|18|||
126443911|NCT02377817|454922944|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
126443912|NCT03895840|454922945|FG000|Overall Study|Withdrawal by Subject|21|||
126443913|NCT01147874|454922948|FG000|Overall Study|Adverse Event|5|||
126443914|NCT01147874|454922948|FG000|Overall Study|Investigator's Request|1|||
126443915|NCT01147874|454922948|FG000|Overall Study|Lost to Follow-up|25|||
126443916|NCT01147874|454922948|FG000|Overall Study|Other|5|||
126443917|NCT01147874|454922948|FG000|Overall Study|Protocol Violation|5|||
126443918|NCT01147874|454922948|FG000|Overall Study|Sponsor's Decision|2|||
126443919|NCT01147874|454922948|FG000|Overall Study|Withdrawal by Subject|24|||
126443920|NCT00467753|454922949|FG000|Overall Study|Lost to Follow-up|1|||
126443921|NCT00467753|454922950|FG001|Overall Study|Lost to Follow-up|2|||
126760429|NCT03556202|456073783|FG000|Extension Treatment Period|Lost to Follow-up|9|||
126760430|NCT03556202|456073784|FG001|Extension Treatment Period|Lost to Follow-up|20|||
126443922|NCT00467753|454922949|FG000|Overall Study|Adverse Event|2|||
126443923|NCT00467753|454922950|FG001|Overall Study|Adverse Event|0|||
126443924|NCT02175030|454922951|FG000|Overall Study|Failed screen after consent|7|||
126443925|NCT02175030|454922952|FG001|Overall Study|Failed screen after consent|6|||
126443926|NCT02175030|454922951|FG000|Overall Study|Failed IUD Insertion|20|||
126443927|NCT02175030|454922952|FG001|Overall Study|Failed IUD Insertion|21|||
126443928|NCT02175030|454922951|FG000|Overall Study|Physician Decision|1|||
126443929|NCT02175030|454922952|FG001|Overall Study|Physician Decision|1|||
126443930|NCT02175030|454922951|FG000|Overall Study|Lost to Follow-up|6|||
126443931|NCT02175030|454922952|FG001|Overall Study|Lost to Follow-up|6|||
126443932|NCT02175030|454922951|FG000|Overall Study|Withdrawal by Subject|1|||
126443933|NCT02175030|454922952|FG001|Overall Study|Withdrawal by Subject|4|||
126443934|NCT00885534|454922953|FG000|Overall Study|Patient deemed ineligible|1|||
126443935|NCT02817464|454922954|FG000|Overall Study|Lost to Follow-up|1|||
126443936|NCT02817464|454922955|FG001|Overall Study|Lost to Follow-up|0|||
126443937|NCT02817464|454922954|FG000|Overall Study|Discontinued early due to personal decision|1|||
126443938|NCT02817464|454922955|FG001|Overall Study|Discontinued early due to personal decision|1|||
126443939|NCT01273519|454922958|FG000|Overall Study|Adverse Event|3|||
126443940|NCT01273519|454922959|FG001|Overall Study|Adverse Event|0|||
126443941|NCT01273519|454922960|FG002|Overall Study|Adverse Event|0|||
126443942|NCT01273519|454922958|FG000|Overall Study|Lost to Follow-up|2|||
126443943|NCT01273519|454922959|FG001|Overall Study|Lost to Follow-up|1|||
126443944|NCT01273519|454922960|FG002|Overall Study|Lost to Follow-up|3|||
126443945|NCT01273519|454922958|FG000|Overall Study|Lack of Efficacy|8|||
126443946|NCT01273519|454922959|FG001|Overall Study|Lack of Efficacy|3|||
126443947|NCT01273519|454922960|FG002|Overall Study|Lack of Efficacy|4|||
126443948|NCT01273519|454922958|FG000|Overall Study|Other|6|||
126443949|NCT01273519|454922959|FG001|Overall Study|Other|1|||
126443950|NCT01273519|454922960|FG002|Overall Study|Other|1|||
126443951|NCT04292899|454922961|FG000|Overall Study|Death|21|||
126443952|NCT04292899|454922962|FG001|Overall Study|Death|28|||
126443953|NCT04292899|454922963|FG002|Overall Study|Death|188|||
126443954|NCT04292899|454922964|FG003|Overall Study|Death|371|||
126443955|NCT04292899|454922961|FG000|Overall Study|Lost to Follow-up|8|||
126443956|NCT04292899|454922962|FG001|Overall Study|Lost to Follow-up|4|||
126443957|NCT04292899|454922963|FG002|Overall Study|Lost to Follow-up|22|||
126443958|NCT04292899|454922964|FG003|Overall Study|Lost to Follow-up|235|||
126443959|NCT04292899|454922961|FG000|Overall Study|Withdrew consent|1|||
126443960|NCT04292899|454922962|FG001|Overall Study|Withdrew consent|0|||
126760431|NCT03556202|456073785|FG002|Extension Treatment Period|Lost to Follow-up|2|||
126354773|NCT03345095|454589480|FG000|Overall Study|Withdrawal by Subject|22|||
126354774|NCT03345095|454589481|FG001|Overall Study|Withdrawal by Subject|59|||
126354775|NCT03345095|454589480|FG000|Overall Study|Physician Decision|3|||
126354776|NCT03345095|454589481|FG001|Overall Study|Physician Decision|18|||
126354777|NCT03345095|454589480|FG000|Overall Study|Death|2|||
126354778|NCT03345095|454589481|FG001|Overall Study|Death|4|||
126354779|NCT03345095|454589480|FG000|Overall Study|Other reasons|2|||
126354780|NCT03345095|454589481|FG001|Overall Study|Other reasons|11|||
126354781|NCT03345095|454589480|FG000|Overall Study|Protocol Violation|0|||
126354782|NCT03345095|454589481|FG001|Overall Study|Protocol Violation|1|||
126354783|NCT01121575|454589482|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
126354784|NCT01121575|454589483|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
126354785|NCT01121575|454589484|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
126354786|NCT01121575|454589485|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
126354787|NCT01121575|454589486|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
126354788|NCT01121575|454589487|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
126354789|NCT01121575|454589482|FG000|Overall Study|Unspecified Reasons|8|||
126354790|NCT01121575|454589483|FG001|Overall Study|Unspecified Reasons|6|||
126354791|NCT01121575|454589484|FG002|Overall Study|Unspecified Reasons|7|||
126354792|NCT01121575|454589485|FG003|Overall Study|Unspecified Reasons|5|||
126354793|NCT01121575|454589486|FG004|Overall Study|Unspecified Reasons|13|||
126354794|NCT01121575|454589487|FG005|Overall Study|Unspecified Reasons|10|||
126354795|NCT01121575|454589482|FG000|Overall Study|Death|6|||
126354796|NCT01121575|454589483|FG001|Overall Study|Death|0|||
126354797|NCT01121575|454589484|FG002|Overall Study|Death|0|||
126354798|NCT01121575|454589485|FG003|Overall Study|Death|1|||
126354799|NCT01121575|454589486|FG004|Overall Study|Death|7|||
126354800|NCT01121575|454589487|FG005|Overall Study|Death|1|||
126354801|NCT03158311|454589488|FG000|Overall Study|Subject/Guardian Decision|10|||
126354802|NCT03158311|454589489|FG001|Overall Study|Subject/Guardian Decision|6|||
126354803|NCT03158311|454589490|FG002|Overall Study|Subject/Guardian Decision|11|||
126354804|NCT03158311|454589488|FG000|Overall Study|Adverse Event|5|||
126354805|NCT03158311|454589489|FG001|Overall Study|Adverse Event|3|||
126354806|NCT03158311|454589490|FG002|Overall Study|Adverse Event|3|||
126354807|NCT03158311|454589488|FG000|Overall Study|Techinical Problems|3|||
126354808|NCT03158311|454589489|FG001|Overall Study|Techinical Problems|1|||
126354809|NCT03158311|454589490|FG002|Overall Study|Techinical Problems|5|||
126354810|NCT03158311|454589488|FG000|Overall Study|Physician Decision|2|||
126354811|NCT03158311|454589489|FG001|Overall Study|Physician Decision|3|||
126760432|NCT03556202|456073783|FG000|Extension Treatment Period|Pregnancy|2|||
126354812|NCT03158311|454589490|FG002|Overall Study|Physician Decision|7|||
126354813|NCT03158311|454589488|FG000|Overall Study|Lost to Follow-up|1|||
126354814|NCT03158311|454589489|FG001|Overall Study|Lost to Follow-up|1|||
126354815|NCT03158311|454589490|FG002|Overall Study|Lost to Follow-up|1|||
126354816|NCT03158311|454589488|FG000|Overall Study|Sponsor decision|1|||
126354817|NCT03158311|454589489|FG001|Overall Study|Sponsor decision|0|||
126354818|NCT03158311|454589490|FG002|Overall Study|Sponsor decision|0|||
126354819|NCT03158311|454589488|FG000|Overall Study|Pregnancy|0|||
126354820|NCT03158311|454589489|FG001|Overall Study|Pregnancy|2|||
126354821|NCT03158311|454589490|FG002|Overall Study|Pregnancy|0|||
126354822|NCT03158311|454589488|FG000|Overall Study|Randomized in error|0|||
126354823|NCT03158311|454589489|FG001|Overall Study|Randomized in error|0|||
126354824|NCT03158311|454589490|FG002|Overall Study|Randomized in error|1|||
126354825|NCT02665455|454589492|FG000|Overall Study|Withdrawal by Subject|6|||
126354826|NCT02665455|454589492|FG000|Overall Study|Lost to Follow-up|1|||
126354827|NCT02665455|454589492|FG000|Overall Study|Adverse Event|1|||
126354828|NCT02665455|454589492|FG000|Overall Study|Protocol Violation|1|||
126354829|NCT00724503|454589493|FG000|Overall Study|Lost to Follow-up|4|||
126354830|NCT00724503|454589494|FG001|Overall Study|Lost to Follow-up|8|||
126354831|NCT00724503|454589493|FG000|Overall Study|Withdrawal by Subject|11|||
126354832|NCT00724503|454589494|FG001|Overall Study|Withdrawal by Subject|23|||
126354833|NCT00724503|454589493|FG000|Overall Study|Death|190|||
126354834|NCT00724503|454589494|FG001|Overall Study|Death|182|||
126354835|NCT00724503|454589493|FG000|Overall Study|Adverse Event|1|||
126354836|NCT00724503|454589494|FG001|Overall Study|Adverse Event|0|||
126354837|NCT00724503|454589493|FG000|Overall Study|Not otherwise specified|4|||
126354838|NCT00724503|454589494|FG001|Overall Study|Not otherwise specified|7|||
126354839|NCT01186419|454589495|FG000|Overall Study|Withdrawal by Subject|5|||
126760433|NCT03556202|456073784|FG001|Extension Treatment Period|Pregnancy|4|||
126760434|NCT03556202|456073785|FG002|Extension Treatment Period|Pregnancy|3|||
126760435|NCT03556202|456073783|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
126760436|NCT03556202|456073784|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
126760437|NCT03556202|456073785|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
126760438|NCT03556202|456073783|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
126760439|NCT03556202|456073784|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
126760440|NCT03556202|456073785|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
126760441|NCT03556202|456073783|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
126760442|NCT03556202|456073784|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
126760443|NCT03556202|456073785|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
126760444|NCT03556202|456073783|FG000|Extension Treatment Period|Physician Decision|0|||
126760445|NCT03556202|456073784|FG001|Extension Treatment Period|Physician Decision|8|||
126760446|NCT03556202|456073785|FG002|Extension Treatment Period|Physician Decision|2|||
126760447|NCT03556202|456073783|FG000|Extension Treatment Period|Protocol Violation|0|||
126760448|NCT03556202|456073784|FG001|Extension Treatment Period|Protocol Violation|1|||
126760449|NCT03556202|456073785|FG002|Extension Treatment Period|Protocol Violation|1|||
126760450|NCT03556202|456073783|FG000|Extension Treatment Period|Sponsor Decision|0|||
126760451|NCT03556202|456073784|FG001|Extension Treatment Period|Sponsor Decision|1|||
126760452|NCT03556202|456073785|FG002|Extension Treatment Period|Sponsor Decision|0|||
126760453|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
126760454|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
126760455|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
126760456|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Death|1|||
126760457|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Death|0|||
126760458|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Death|0|||
126760459|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
126760460|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
126760461|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
126760462|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
126760463|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
126760464|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
126760465|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
126354840|NCT01186419|454589496|FG001|Overall Study|Withdrawal by Subject|3|||
126354841|NCT01186419|454589495|FG000|Overall Study|Adverse Event|1|||
126354842|NCT01186419|454589496|FG001|Overall Study|Adverse Event|2|||
126443961|NCT04292899|454922963|FG002|Overall Study|Withdrew consent|11|||
126760466|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
126760467|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
126760468|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
126354843|NCT01186419|454589495|FG000|Overall Study|Physician Decision|0|||
126354844|NCT01186419|454589496|FG001|Overall Study|Physician Decision|3|||
126354845|NCT01186419|454589495|FG000|Overall Study|Other|1|||
126354846|NCT01186419|454589496|FG001|Overall Study|Other|1|||
126354847|NCT01928771|454589500|FG000|Overall Study|Adverse Event|6|||
126354848|NCT01928771|454589501|FG001|Overall Study|Adverse Event|5|||
126443962|NCT04292899|454922964|FG003|Overall Study|Withdrew consent|32|||
126443963|NCT04292899|454922961|FG000|Overall Study|Adverse Event|2|||
126443964|NCT04292899|454922962|FG001|Overall Study|Adverse Event|1|||
126443965|NCT04292899|454922963|FG002|Overall Study|Adverse Event|2|||
126443966|NCT04292899|454922964|FG003|Overall Study|Adverse Event|2|||
126443967|NCT04292899|454922961|FG000|Overall Study|Investigator's Discretion|0|||
126443968|NCT04292899|454922962|FG001|Overall Study|Investigator's Discretion|0|||
126443969|NCT04292899|454922963|FG002|Overall Study|Investigator's Discretion|0|||
126443970|NCT04292899|454922964|FG003|Overall Study|Investigator's Discretion|3|||
126443971|NCT04292899|454922961|FG000|Overall Study|Non-compliance With Study Drug|0|||
126443972|NCT04292899|454922962|FG001|Overall Study|Non-compliance With Study Drug|0|||
126443973|NCT04292899|454922963|FG002|Overall Study|Non-compliance With Study Drug|0|||
126443974|NCT04292899|454922964|FG003|Overall Study|Non-compliance With Study Drug|1|||
126443975|NCT04292899|454922961|FG000|Overall Study|Protocol Violation|0|||
126443976|NCT04292899|454922962|FG001|Overall Study|Protocol Violation|0|||
126443977|NCT04292899|454922963|FG002|Overall Study|Protocol Violation|0|||
126443978|NCT04292899|454922964|FG003|Overall Study|Protocol Violation|1|||
126443979|NCT02302339|454922965|FG000|Overall Study|Lost to Follow-up|1|||
126443980|NCT02302339|454922966|FG001|Overall Study|Lost to Follow-up|0|||
126443981|NCT02302339|454922967|FG002|Overall Study|Lost to Follow-up|0|||
126443982|NCT02302339|454922968|FG003|Overall Study|Lost to Follow-up|0|||
126443983|NCT02302339|454922965|FG000|Overall Study|Withdrawal by Subject|0|||
126443984|NCT02302339|454922966|FG001|Overall Study|Withdrawal by Subject|2|||
126443985|NCT02302339|454922967|FG002|Overall Study|Withdrawal by Subject|1|||
126443986|NCT02302339|454922968|FG003|Overall Study|Withdrawal by Subject|0|||
126443987|NCT01642589|454922972|FG000|Overall Study|Withdrawal by Subject|1|||
126443988|NCT01642589|454922973|FG001|Overall Study|Withdrawal by Subject|1|||
126443989|NCT01185080|454922978|FG000|Overall Study|Adverse Event|1|||
126443990|NCT01185080|454922979|FG001|Overall Study|Adverse Event|1|||
126443991|NCT01185080|454922980|FG002|Overall Study|Adverse Event|0|||
126443992|NCT01185080|454922978|FG000|Overall Study|Personal reasons|0|||
126443993|NCT01185080|454922979|FG001|Overall Study|Personal reasons|0|||
126443994|NCT01185080|454922980|FG002|Overall Study|Personal reasons|1|||
126443995|NCT01104311|454922985|FG000|Overall Study|Withdrawal by Subject|6|||
126443996|NCT01104311|454922986|FG001|Overall Study|Withdrawal by Subject|6|||
126443997|NCT01104311|454922985|FG000|Overall Study|Protocol Violation|0|||
126443998|NCT01104311|454922986|FG001|Overall Study|Protocol Violation|1|||
126443999|NCT01104311|454922985|FG000|Overall Study|Physician Decision|2|||
126444000|NCT01104311|454922986|FG001|Overall Study|Physician Decision|2|||
126444001|NCT01104311|454922985|FG000|Overall Study|low compliance|1|||
126444002|NCT01104311|454922986|FG001|Overall Study|low compliance|1|||
126444003|NCT01104311|454922985|FG000|Overall Study|Adverse Event|1|||
126444004|NCT01104311|454922986|FG001|Overall Study|Adverse Event|2|||
126444005|NCT02605122|454924884|FG000|Overall Study|Withdrawal by Subject|4|||
126444006|NCT02605122|454924885|FG001|Overall Study|Withdrawal by Subject|1|||
126444007|NCT02605122|454924884|FG000|Overall Study|Lost to Follow-up|1|||
126444008|NCT02605122|454924885|FG001|Overall Study|Lost to Follow-up|1|||
126444009|NCT00807001|454924893|FG000|Overall Study|Non-compliance|0|||
126444010|NCT00807001|454924894|FG001|Overall Study|Non-compliance|1|||
126444011|NCT00807001|454924895|FG002|Overall Study|Non-compliance|0|||
126444012|NCT00807001|454924896|FG003|Overall Study|Non-compliance|0|||
126444013|NCT00807001|454924897|FG004|Overall Study|Non-compliance|0|||
126444014|NCT00854113|454924898|FG000|Overall Study|Adverse Event|0|||
126444015|NCT00854113|454924899|FG001|Overall Study|Adverse Event|0|||
126444016|NCT00854113|454924900|FG002|Overall Study|Adverse Event|0|||
126444017|NCT00854113|454924901|FG003|Overall Study|Adverse Event|0|||
126444018|NCT00854113|454924902|FG004|Overall Study|Adverse Event|0|||
126444019|NCT00854113|454924903|FG005|Overall Study|Adverse Event|0|||
126444020|NCT00854113|454924904|FG006|Overall Study|Adverse Event|0|||
126444021|NCT00854113|454924905|FG007|Overall Study|Adverse Event|2|||
126444022|NCT00854113|454924906|FG008|Overall Study|Adverse Event|0|||
126444023|NCT00854113|454924907|FG009|Overall Study|Adverse Event|0|||
126444024|NCT00854113|454924908|FG010|Overall Study|Adverse Event|0|||
126444025|NCT00854113|454924898|FG000|Overall Study|Withdrawal by Subject|0|||
126444026|NCT00854113|454924899|FG001|Overall Study|Withdrawal by Subject|0|||
126444027|NCT00854113|454924900|FG002|Overall Study|Withdrawal by Subject|0|||
126444028|NCT00854113|454924901|FG003|Overall Study|Withdrawal by Subject|0|||
126444029|NCT00854113|454924902|FG004|Overall Study|Withdrawal by Subject|0|||
126444030|NCT00854113|454924903|FG005|Overall Study|Withdrawal by Subject|0|||
126444031|NCT00854113|454924904|FG006|Overall Study|Withdrawal by Subject|0|||
126444032|NCT00854113|454924905|FG007|Overall Study|Withdrawal by Subject|1|||
126444033|NCT00854113|454924906|FG008|Overall Study|Withdrawal by Subject|1|||
126444034|NCT00854113|454924907|FG009|Overall Study|Withdrawal by Subject|0|||
126444035|NCT00854113|454924908|FG010|Overall Study|Withdrawal by Subject|0|||
126444036|NCT02273596|454924912|FG000|24-Week Treatment Period|Adverse Event|3|||
126444037|NCT02273596|454924912|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
126444038|NCT02273596|454924912|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
126444039|NCT02273596|454924912|FG000|24-Week Treatment Period|Physician Decision|1|||
126691624|NCT05099640|455826375|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
126691625|NCT05099640|455826373|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
126691626|NCT05099640|455826374|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
126691627|NCT05099640|455826375|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
126691628|NCT05099640|455826373|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
126691629|NCT05099640|455826374|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
126691630|NCT05099640|455826375|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
126691631|NCT05099640|455826373|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
126691632|NCT05099640|455826374|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
126691633|NCT05099640|455826375|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
126691634|NCT05099640|455826373|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
126691635|NCT05099640|455826374|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
126691636|NCT05099640|455826375|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
126691637|NCT05099640|455826373|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
126691638|NCT05099640|455826374|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
126691639|NCT05099640|455826375|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
126691640|NCT00179959|455826376|FG000|Overall Study|Lost to Follow-up|3|||
126691641|NCT00179959|455826377|FG001|Overall Study|Lost to Follow-up|1|||
126691642|NCT00179959|455826376|FG000|Overall Study|Withdrawal by Subject|3|||
126691643|NCT00179959|455826377|FG001|Overall Study|Withdrawal by Subject|2|||
126691644|NCT01528787|455826378|FG000|Overall Study|Withdrawal by Subject|0|||
126691645|NCT01528787|455826379|FG001|Overall Study|Withdrawal by Subject|0|||
126691646|NCT01528787|455826380|FG002|Overall Study|Withdrawal by Subject|0|||
126691647|NCT01528787|455826381|FG003|Overall Study|Withdrawal by Subject|1|||
126691648|NCT01528787|455826378|FG000|Overall Study|Family Emergency|0|||
126691649|NCT01528787|455826379|FG001|Overall Study|Family Emergency|0|||
126691650|NCT01528787|455826380|FG002|Overall Study|Family Emergency|1|||
126691651|NCT01528787|455826381|FG003|Overall Study|Family Emergency|0|||
126691652|NCT00448708|455826382|FG000|Overall Study|Death|21|||
126691653|NCT00448708|455826383|FG001|Overall Study|Death|17|||
126691654|NCT00448708|455826382|FG000|Overall Study|Withdrawal by Subject|8|||
126691655|NCT00448708|455826383|FG001|Overall Study|Withdrawal by Subject|4|||
126691656|NCT00448708|455826382|FG000|Overall Study|Lost to Follow-up|6|||
126691657|NCT00448708|455826383|FG001|Overall Study|Lost to Follow-up|8|||
126691658|NCT00448708|455826382|FG000|Overall Study|not listed|0|||
126691659|NCT00448708|455826383|FG001|Overall Study|not listed|2|||
126691660|NCT00666926|455826385|FG000|Overall Study|Adverse Event|0|||
126691661|NCT00666926|455826386|FG001|Overall Study|Adverse Event|0|||
126691662|NCT00666926|455826387|FG002|Overall Study|Adverse Event|0|||
126691663|NCT00666926|455826388|FG003|Overall Study|Adverse Event|0|||
126691664|NCT00666926|455826389|FG004|Overall Study|Adverse Event|0|||
126691665|NCT00666926|455826390|FG005|Overall Study|Adverse Event|0|||
126691666|NCT00666926|455826391|FG006|Overall Study|Adverse Event|0|||
126691667|NCT00666926|455826392|FG007|Overall Study|Adverse Event|0|||
126691668|NCT00666926|455826393|FG008|Overall Study|Adverse Event|0|||
126691669|NCT00666926|455826394|FG009|Overall Study|Adverse Event|2|||
126691670|NCT00666926|455826395|FG010|Overall Study|Adverse Event|2|||
126691671|NCT00666926|455826396|FG011|Overall Study|Adverse Event|2|||
126691672|NCT00666926|455826397|FG012|Overall Study|Adverse Event|0|||
126691673|NCT00666926|455826398|FG013|Overall Study|Adverse Event|1|||
126691674|NCT00666926|455826399|FG014|Overall Study|Adverse Event|0|||
126691675|NCT00666926|455826400|FG015|Overall Study|Adverse Event|0|||
126691676|NCT00666926|455826385|FG000|Overall Study|Laboratory abnormality|0|||
126354849|NCT01928771|454589502|FG002|Overall Study|Adverse Event|1|||
126354850|NCT01928771|454589500|FG000|Overall Study|Death|2|||
126354851|NCT01928771|454589501|FG001|Overall Study|Death|2|||
126354852|NCT01928771|454589502|FG002|Overall Study|Death|2|||
126354853|NCT01928771|454589500|FG000|Overall Study|Lost to Follow-up|5|||
126354854|NCT01928771|454589501|FG001|Overall Study|Lost to Follow-up|6|||
126354855|NCT01928771|454589502|FG002|Overall Study|Lost to Follow-up|3|||
126354856|NCT01928771|454589500|FG000|Overall Study|Withdrawal by Subject|20|||
126354857|NCT01928771|454589501|FG001|Overall Study|Withdrawal by Subject|15|||
126354858|NCT01928771|454589502|FG002|Overall Study|Withdrawal by Subject|17|||
126354859|NCT01928771|454589500|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
126354860|NCT01928771|454589501|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
126354861|NCT01928771|454589502|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
126354862|NCT01928771|454589500|FG000|Overall Study|Other Reasons|9|||
126354863|NCT01928771|454589501|FG001|Overall Study|Other Reasons|9|||
126354864|NCT01928771|454589502|FG002|Overall Study|Other Reasons|14|||
126354865|NCT01928771|454589500|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
126354866|NCT01928771|454589501|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
126354867|NCT01928771|454589502|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
126354868|NCT03932331|454589503|FG000|Overall Study|Death|0|||
126354869|NCT03932331|454589504|FG001|Overall Study|Death|7|||
126354870|NCT03932331|454589505|FG002|Overall Study|Death|2|||
126354871|NCT03932331|454589503|FG000|Overall Study|Withdrawal by Subject|0|||
126444040|NCT02273596|454924912|FG000|24-Week Treatment Period|Protocol Deviation|1|||
126444041|NCT02273596|454924912|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
126444042|NCT02273596|454924912|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
126444043|NCT02273596|454924912|FG000|Extension Period|Lost to Follow-up|1|||
126444044|NCT02273596|454924912|FG000|Extension Period|Protocol Deviation|1|||
126444045|NCT02604160|454924913|FG000|Overall Study|Protocol Violation|0|||
126444046|NCT02604160|454924914|FG001|Overall Study|Protocol Violation|1|||
126444047|NCT02604160|454924913|FG000|Overall Study|Physician Decision|0|||
126444048|NCT02604160|454924914|FG001|Overall Study|Physician Decision|1|||
126444049|NCT01596062|454924915|FG000|Overall Study|Adverse Event|1|||
126444050|NCT01596062|454924916|FG001|Overall Study|Adverse Event|0|||
126444051|NCT01596062|454924917|FG002|Overall Study|Adverse Event|2|||
126444052|NCT01596062|454924915|FG000|Overall Study|Lack of Efficacy|0|||
126444053|NCT01596062|454924916|FG001|Overall Study|Lack of Efficacy|0|||
126444054|NCT01596062|454924917|FG002|Overall Study|Lack of Efficacy|1|||
126444055|NCT02139592|454924918|FG000|Overall Study|Case Report Forms Uncollected|8|||
126444056|NCT03180840|454924919|FG000|Overall Study|Withdrawal by Subject|1|||
126444057|NCT01413204|454924927|FG000|Overall Study|Adverse Event|1|||
126444058|NCT01413204|454924928|FG001|Overall Study|Adverse Event|2|||
126444059|NCT01413204|454924929|FG002|Overall Study|Adverse Event|2|||
126444060|NCT01413204|454924927|FG000|Overall Study|Physician Decision|3|||
126444061|NCT01413204|454924928|FG001|Overall Study|Physician Decision|0|||
126444062|NCT01413204|454924929|FG002|Overall Study|Physician Decision|2|||
126444063|NCT01413204|454924927|FG000|Overall Study|Withdrawal by Subject|1|||
126444064|NCT01413204|454924928|FG001|Overall Study|Withdrawal by Subject|4|||
126444065|NCT01413204|454924929|FG002|Overall Study|Withdrawal by Subject|4|||
126444066|NCT01413204|454924927|FG000|Overall Study|Clearly not eligible for the study|0|||
126444067|NCT01413204|454924928|FG001|Overall Study|Clearly not eligible for the study|0|||
126444068|NCT01413204|454924929|FG002|Overall Study|Clearly not eligible for the study|1|||
126444069|NCT01413204|454924927|FG000|Overall Study|Fasting plasma glucose level increased|1|||
126444070|NCT01413204|454924928|FG001|Overall Study|Fasting plasma glucose level increased|0|||
126444071|NCT01413204|454924929|FG002|Overall Study|Fasting plasma glucose level increased|10|||
126444072|NCT00867815|454924932|FG000|Overall Study|Lost to Follow-up|1|||
126444073|NCT00001213|454924933|FG000|Overall Study|Death|18|||
126444074|NCT05661409|454924939|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
126444075|NCT05661409|454924940|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
126444076|NCT05661409|454924941|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
126444077|NCT05661409|454924942|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
126444078|NCT05661409|454924943|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
126444079|NCT05661409|454924944|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
126444080|NCT05661409|454924939|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
126444081|NCT05661409|454924940|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
126691677|NCT00666926|455826386|FG001|Overall Study|Laboratory abnormality|0|||
126691678|NCT00666926|455826387|FG002|Overall Study|Laboratory abnormality|0|||
126691679|NCT00666926|455826388|FG003|Overall Study|Laboratory abnormality|0|||
126691680|NCT00666926|455826389|FG004|Overall Study|Laboratory abnormality|0|||
126691681|NCT00666926|455826390|FG005|Overall Study|Laboratory abnormality|0|||
126444082|NCT05661409|454924941|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
126444083|NCT05661409|454924942|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
126444084|NCT05661409|454924943|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
126444085|NCT05661409|454924944|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
126444086|NCT05661409|454924939|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
126444087|NCT05661409|454924940|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
126444088|NCT05661409|454924941|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
126444089|NCT05661409|454924942|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
126444090|NCT05661409|454924943|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
126444091|NCT05661409|454924944|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
126444092|NCT05661409|454924939|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
126444093|NCT05661409|454924940|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
126444094|NCT05661409|454924941|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
126444095|NCT05661409|454924942|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
126444096|NCT05661409|454924943|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
126444097|NCT05661409|454924944|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
126444098|NCT05661409|454924939|FG000|Overall Study|Miscommu-nication about administration|0|||
126444099|NCT05661409|454924940|FG001|Overall Study|Miscommu-nication about administration|0|||
126444100|NCT05661409|454924941|FG002|Overall Study|Miscommu-nication about administration|0|||
126444101|NCT05661409|454924942|FG003|Overall Study|Miscommu-nication about administration|0|||
126691682|NCT00666926|455826391|FG006|Overall Study|Laboratory abnormality|0|||
126545407|NCT03500640|455290833|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
126691683|NCT00666926|455826392|FG007|Overall Study|Laboratory abnormality|0|||
126691684|NCT00666926|455826393|FG008|Overall Study|Laboratory abnormality|0|||
126354872|NCT03932331|454589504|FG001|Overall Study|Withdrawal by Subject|3|||
126354873|NCT03932331|454589505|FG002|Overall Study|Withdrawal by Subject|0|||
126354874|NCT03932331|454589503|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
126354875|NCT03932331|454589504|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
126354876|NCT03932331|454589505|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
126354877|NCT03932331|454589503|FG000|Overall Study|Progressive disease|3|||
126354878|NCT03932331|454589504|FG001|Overall Study|Progressive disease|0|||
126354879|NCT03932331|454589505|FG002|Overall Study|Progressive disease|0|||
126354880|NCT03932331|454589503|FG000|Overall Study|Lung infection|1|||
126354881|NCT03932331|454589504|FG001|Overall Study|Lung infection|0|||
126354882|NCT03932331|454589505|FG002|Overall Study|Lung infection|0|||
126354883|NCT03932331|454589503|FG000|Overall Study|Other|0|||
126354884|NCT03932331|454589504|FG001|Overall Study|Other|0|||
126354885|NCT03932331|454589505|FG002|Overall Study|Other|58|||
126354886|NCT01937117|454589506|FG000|Overall Study|Disease Progression|7|||
126354887|NCT01937117|454589506|FG000|Overall Study|Physician Decision|4|||
126354888|NCT01937117|454589506|FG000|Overall Study|Adverse Event|2|||
126354889|NCT04633447|454591159|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
126354890|NCT04633447|454591160|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
126354891|NCT04633447|454591159|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
126354892|NCT04633447|454591160|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
126354893|NCT04633447|454591159|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
126354894|NCT04633447|454591160|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
126354895|NCT04633447|454591159|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
126354896|NCT04633447|454591160|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
126354897|NCT04633447|454591159|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
126354898|NCT04633447|454591160|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
126354899|NCT04633447|454591159|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
126354900|NCT04633447|454591160|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
126354901|NCT01500096|454591162|FG000|Overall Study|Lost to Follow-up|1|||
126354902|NCT01500096|454591163|FG001|Overall Study|Lost to Follow-up|0|||
126354903|NCT01500096|454591164|FG002|Overall Study|Lost to Follow-up|0|||
126354904|NCT01500096|454591165|FG003|Overall Study|Lost to Follow-up|2|||
126354905|NCT01734928|454591166|FG000|Randomization|Physician Decision|0|||
126354906|NCT01734928|454591167|FG001|Randomization|Physician Decision|1|||
126354907|NCT01734928|454591166|FG000|Randomization|clinical progression|0|||
126354908|NCT01734928|454591167|FG001|Randomization|clinical progression|1|||
126354909|NCT01734928|454591166|FG000|Randomization|progressive disease|0|||
126354910|NCT01734928|454591167|FG001|Randomization|progressive disease|2|||
126354911|NCT01734928|454591166|FG000|Randomization|Withdrew informed consent|0|||
126354912|NCT01734928|454591167|FG001|Randomization|Withdrew informed consent|4|||
126354913|NCT01734928|454591166|FG000|Randomization|Death|1|||
126354914|NCT01734928|454591167|FG001|Randomization|Death|0|||
126354915|NCT01734928|454591166|FG000|Randomization|Randomization error|1|||
126354916|NCT01734928|454591167|FG001|Randomization|Randomization error|0|||
126354917|NCT01734928|454591166|FG000|Randomization|Lost to Follow-up|1|||
126354918|NCT01734928|454591167|FG001|Randomization|Lost to Follow-up|0|||
126354919|NCT01734928|454591166|FG000|Treatment Period|Lost to Follow-up|0|||
126354920|NCT01734928|454591167|FG001|Treatment Period|Lost to Follow-up|2|||
126354921|NCT01734928|454591166|FG000|Treatment Period|Progressive Disease|167|||
126354922|NCT01734928|454591167|FG001|Treatment Period|Progressive Disease|165|||
126354923|NCT01734928|454591166|FG000|Treatment Period|Adverse Event|39|||
126354924|NCT01734928|454591167|FG001|Treatment Period|Adverse Event|52|||
126354925|NCT01734928|454591166|FG000|Treatment Period|Withdrawal of Consent|25|||
126354926|NCT01734928|454591167|FG001|Treatment Period|Withdrawal of Consent|22|||
126354927|NCT01734928|454591166|FG000|Treatment Period|Death|20|||
126354928|NCT01734928|454591167|FG001|Treatment Period|Death|9|||
126354929|NCT01734928|454591166|FG000|Treatment Period|Other Reasons|27|||
126354930|NCT01734928|454591167|FG001|Treatment Period|Other Reasons|19|||
126354931|NCT01734928|454591166|FG000|Treatment Period|Pregnancy|0|||
126354932|NCT01734928|454591167|FG001|Treatment Period|Pregnancy|1|||
126354933|NCT03600350|454591168|FG000|Overall Study|Death|1|||
126354934|NCT03600350|454591168|FG000|Overall Study|On Follow Up|18|||
126354935|NCT01105130|454591169|FG000|Overall Study|Withdrawal by Subject|4|||
126354936|NCT01105130|454591170|FG001|Overall Study|Withdrawal by Subject|6|||
126354937|NCT01105130|454591171|FG002|Overall Study|Withdrawal by Subject|2|||
126354938|NCT01105130|454591169|FG000|Overall Study|Never Started|2|||
126354939|NCT01105130|454591170|FG001|Overall Study|Never Started|2|||
126354940|NCT01105130|454591171|FG002|Overall Study|Never Started|4|||
126354941|NCT01105130|454591169|FG000|Overall Study|Toxicity|1|||
126354942|NCT01105130|454591170|FG001|Overall Study|Toxicity|3|||
126354943|NCT01105130|454591171|FG002|Overall Study|Toxicity|2|||
126354944|NCT01105130|454591169|FG000|Overall Study|Multiple Reasons|3|||
126354945|NCT01105130|454591170|FG001|Overall Study|Multiple Reasons|0|||
126354946|NCT01105130|454591171|FG002|Overall Study|Multiple Reasons|2|||
126354947|NCT01363440|454591174|FG000|Overall Study|Adverse Event|5|||
126354948|NCT01363440|454591175|FG001|Overall Study|Adverse Event|4|||
126691685|NCT00666926|455826394|FG009|Overall Study|Laboratory abnormality|0|||
126691686|NCT00666926|455826395|FG010|Overall Study|Laboratory abnormality|1|||
126354949|NCT01363440|454591176|FG002|Overall Study|Adverse Event|4|||
126354950|NCT01363440|454591174|FG000|Overall Study|Death|3|||
126354951|NCT01363440|454591175|FG001|Overall Study|Death|7|||
126354952|NCT01363440|454591176|FG002|Overall Study|Death|5|||
126354953|NCT01363440|454591174|FG000|Overall Study|Withdrawal by Subject|9|||
126354954|NCT01363440|454591175|FG001|Overall Study|Withdrawal by Subject|11|||
126354955|NCT01363440|454591176|FG002|Overall Study|Withdrawal by Subject|11|||
126354956|NCT01363440|454591174|FG000|Overall Study|Lost to Follow-up|2|||
126354957|NCT01363440|454591175|FG001|Overall Study|Lost to Follow-up|4|||
126354958|NCT01363440|454591176|FG002|Overall Study|Lost to Follow-up|5|||
126354959|NCT01363440|454591174|FG000|Overall Study|Other|4|||
126354960|NCT01363440|454591175|FG001|Overall Study|Other|5|||
126354961|NCT01363440|454591176|FG002|Overall Study|Other|2|||
126354962|NCT02323334|454591177|FG000|Period 3|Lost to Follow-up|0|||
126354963|NCT02323334|454591178|FG001|Period 3|Lost to Follow-up|0|||
126354964|NCT02323334|454591179|FG002|Period 3|Lost to Follow-up|1|||
126354965|NCT02323334|454591180|FG003|Period 3|Lost to Follow-up|0|||
126354966|NCT02323334|454591181|FG004|Period 3|Lost to Follow-up|0|||
126354967|NCT02323334|454591182|FG005|Period 3|Lost to Follow-up|0|||
126354968|NCT02323334|454591183|FG006|Period 3|Lost to Follow-up|0|||
126354969|NCT02323334|454591184|FG007|Period 3|Lost to Follow-up|0|||
126354970|NCT02323334|454591185|FG008|Period 3|Lost to Follow-up|0|||
126354971|NCT02323334|454591186|FG009|Period 3|Lost to Follow-up|0|||
126354972|NCT02323334|454591187|FG010|Period 3|Lost to Follow-up|0|||
126354973|NCT02323334|454591188|FG011|Period 3|Lost to Follow-up|0|||
126354974|NCT02323334|454591189|FG012|Period 3|Lost to Follow-up|0|||
126354975|NCT02323334|454591190|FG013|Period 3|Lost to Follow-up|0|||
126354976|NCT02323334|454591191|FG014|Period 3|Lost to Follow-up|0|||
126354977|NCT02323334|454591192|FG015|Period 3|Lost to Follow-up|0|||
126354978|NCT02323334|454591193|FG016|Period 3|Lost to Follow-up|0|||
126354979|NCT02323334|454591177|FG000|Period 3|Withdrawal by Subject|1|||
126354980|NCT02323334|454591178|FG001|Period 3|Withdrawal by Subject|0|||
126354981|NCT02323334|454591179|FG002|Period 3|Withdrawal by Subject|0|||
126354982|NCT02323334|454591180|FG003|Period 3|Withdrawal by Subject|0|||
126354983|NCT02323334|454591181|FG004|Period 3|Withdrawal by Subject|0|||
126354984|NCT02323334|454591182|FG005|Period 3|Withdrawal by Subject|0|||
126354985|NCT02323334|454591183|FG006|Period 3|Withdrawal by Subject|0|||
126354986|NCT02323334|454591184|FG007|Period 3|Withdrawal by Subject|0|||
126354987|NCT02323334|454591185|FG008|Period 3|Withdrawal by Subject|0|||
126354988|NCT02323334|454591186|FG009|Period 3|Withdrawal by Subject|0|||
126354989|NCT02323334|454591187|FG010|Period 3|Withdrawal by Subject|0|||
126354990|NCT02323334|454591188|FG011|Period 3|Withdrawal by Subject|0|||
126354991|NCT02323334|454591189|FG012|Period 3|Withdrawal by Subject|0|||
126354992|NCT02323334|454591190|FG013|Period 3|Withdrawal by Subject|0|||
126354993|NCT02323334|454591191|FG014|Period 3|Withdrawal by Subject|0|||
126354994|NCT02323334|454591192|FG015|Period 3|Withdrawal by Subject|0|||
126354995|NCT02323334|454591193|FG016|Period 3|Withdrawal by Subject|0|||
126354996|NCT03520569|454591195|FG000|Overall Study|Withdrawal by Subject|1|||
126354997|NCT03422718|454591196|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
126354998|NCT03422718|454591197|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
126354999|NCT03422718|454591198|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
126355000|NCT03422718|454591199|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
126355001|NCT03422718|454591200|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
126355002|NCT03422718|454591201|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
126355003|NCT03422718|454591202|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
126355004|NCT03422718|454591203|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
126355005|NCT03422718|454591196|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
126355006|NCT03422718|454591197|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
126355007|NCT03422718|454591198|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
126355008|NCT03422718|454591199|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
126355009|NCT03422718|454591200|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
126355010|NCT03422718|454591201|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
126355011|NCT03422718|454591202|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
126355012|NCT03422718|454591203|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
126355013|NCT03422718|454591196|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
126355014|NCT03422718|454591197|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
126355015|NCT03422718|454591198|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
126355016|NCT03422718|454591199|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
126355017|NCT03422718|454591200|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
126355018|NCT03422718|454591201|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
126355019|NCT03422718|454591202|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
126691687|NCT00666926|455826396|FG011|Overall Study|Laboratory abnormality|0|||
126444102|NCT05661409|454924943|FG004|Overall Study|Miscommu-nication about administration|0|||
126444103|NCT05661409|454924944|FG005|Overall Study|Miscommu-nication about administration|1|||
126444104|NCT04439136|454924945|FG000|Overall Study|Ineligible|1|||
126444105|NCT04439136|454924945|FG000|Overall Study|Never Started Treatment|2|||
126444106|NCT04439136|454924945|FG000|Overall Study|Adverse Event|4|||
126444107|NCT04439136|454924945|FG000|Overall Study|Death|3|||
126444108|NCT04439136|454924945|FG000|Overall Study|Disease Progression|27|||
126444109|NCT04439136|454924945|FG000|Overall Study|Alternative Therapy|1|||
126444110|NCT04439136|454924945|FG000|Overall Study|Increased Tumor Burden|1|||
126444111|NCT04439136|454924945|FG000|Overall Study|Symptomatic Detrioration|1|||
126444112|NCT03682770|454924946|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
126444113|NCT03682770|454924947|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
126444114|NCT03682770|454924948|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
126444115|NCT03682770|454924949|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
126444116|NCT03682770|454924950|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
126444117|NCT03682770|454924951|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
126444118|NCT03682770|454924952|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
126444119|NCT03682770|454924946|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
126444120|NCT03682770|454924947|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
126444121|NCT03682770|454924948|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
126444122|NCT03682770|454924949|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
126444123|NCT03682770|454924950|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
126444124|NCT03682770|454924951|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
126444125|NCT03682770|454924952|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
126444126|NCT03682770|454924946|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
126444127|NCT03682770|454924947|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
126444128|NCT03682770|454924948|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
126444129|NCT03682770|454924949|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
126444130|NCT03682770|454924950|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
126444131|NCT03682770|454924951|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
126444132|NCT03682770|454924952|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
126444133|NCT03682770|454924946|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
126444134|NCT03682770|454924947|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
126444135|NCT03682770|454924948|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
126444136|NCT03682770|454924949|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
126444137|NCT03682770|454924950|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
126444138|NCT03682770|454924951|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
126444139|NCT03682770|454924952|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
126444140|NCT03682770|454924946|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
126444141|NCT03682770|454924947|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
126444142|NCT03682770|454924948|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
126444143|NCT03682770|454924949|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
126444144|NCT03682770|454924950|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
126444145|NCT03682770|454924951|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
126444146|NCT03682770|454924952|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
126444147|NCT03682770|454924946|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
126444148|NCT03682770|454924947|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
126444149|NCT03682770|454924948|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
126444150|NCT03682770|454924949|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
126444151|NCT03682770|454924950|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
126444152|NCT03682770|454924951|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
126444153|NCT03682770|454924952|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
126444154|NCT03682770|454924946|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
126444155|NCT03682770|454924947|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
126444156|NCT03682770|454924948|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
126444157|NCT03682770|454924949|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
126444158|NCT03682770|454924950|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
126444159|NCT03682770|454924951|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
126444160|NCT03682770|454924952|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
126444161|NCT03682770|454924946|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
126444162|NCT03682770|454924947|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
126444163|NCT03682770|454924948|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
126444164|NCT03682770|454924949|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
126444165|NCT03682770|454924950|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
126444166|NCT03682770|454924951|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
126444167|NCT03682770|454924952|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
126444168|NCT03682770|454924946|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
126444169|NCT03682770|454924947|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
126444170|NCT03682770|454924948|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
126444171|NCT03682770|454924949|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
126444172|NCT03682770|454924950|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
126444173|NCT03682770|454924951|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
126444174|NCT03682770|454924952|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
126444175|NCT03682770|454924946|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
126444176|NCT03682770|454924947|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
126444177|NCT03682770|454924948|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
126444178|NCT03682770|454924949|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
126444179|NCT03682770|454924950|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
126444180|NCT03682770|454924951|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
126444181|NCT03682770|454924952|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
126444182|NCT03682770|454924946|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
126444183|NCT03682770|454924947|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
126444184|NCT03682770|454924948|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
126444185|NCT03682770|454924949|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
126444186|NCT03682770|454924950|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
126444187|NCT03682770|454924951|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
126444188|NCT03682770|454924952|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
126444189|NCT03682770|454924946|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
126444190|NCT03682770|454924947|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
126444191|NCT03682770|454924948|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
126444192|NCT03682770|454924949|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
126444193|NCT03682770|454924950|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
126444194|NCT03682770|454924951|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
126444195|NCT03682770|454924952|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
126444196|NCT02362282|454924953|FG000|Overall Study|Withdrawal by Subject|1|||
126444197|NCT02362282|454924954|FG001|Overall Study|Withdrawal by Subject|0|||
126444198|NCT03599089|454924959|FG000|Overall Study|Lost to Follow-up|1|||
126444199|NCT03599089|454924960|FG001|Overall Study|Lost to Follow-up|0|||
126444200|NCT03599089|454924961|FG002|Overall Study|Lost to Follow-up|0|||
126444201|NCT03599089|454924962|FG003|Overall Study|Lost to Follow-up|0|||
126444202|NCT03599089|454924959|FG000|Overall Study|Withdrawal by Subject|2|||
126444203|NCT03599089|454924960|FG001|Overall Study|Withdrawal by Subject|1|||
126444204|NCT03599089|454924961|FG002|Overall Study|Withdrawal by Subject|0|||
126444205|NCT03599089|454924962|FG003|Overall Study|Withdrawal by Subject|0|||
126444206|NCT03599089|454924959|FG000|Overall Study|Lack of Efficacy|0|||
126444207|NCT03599089|454924960|FG001|Overall Study|Lack of Efficacy|0|||
126444208|NCT03599089|454924961|FG002|Overall Study|Lack of Efficacy|1|||
126444209|NCT03599089|454924962|FG003|Overall Study|Lack of Efficacy|2|||
126444210|NCT03214666|454924963|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
126444211|NCT03214666|454924964|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
126444212|NCT03214666|454924965|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
126444213|NCT03214666|454924966|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
126444214|NCT03214666|454924967|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
126444215|NCT03214666|454924968|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
126444216|NCT00470275|454924969|FG000|Overall Study|Death|1|||
126444217|NCT00470275|454924969|FG000|Overall Study|Lack of Efficacy|7|||
126444218|NCT00470275|454924969|FG000|Overall Study|Withdrawal by Subject|2|||
126444219|NCT01519921|454924970|FG000|Overall Study|Adverse Event|10|||
126444220|NCT01519921|454924971|FG001|Overall Study|Adverse Event|9|||
126444221|NCT01519921|454924970|FG000|Overall Study|Lack of Efficacy|4|||
126444222|NCT01519921|454924971|FG001|Overall Study|Lack of Efficacy|3|||
126444223|NCT01519921|454924970|FG000|Overall Study|Withdrawal by Subject|3|||
126444224|NCT01519921|454924971|FG001|Overall Study|Withdrawal by Subject|0|||
126444225|NCT01519921|454924970|FG000|Overall Study|Lost to Follow-up|2|||
126444226|NCT01519921|454924971|FG001|Overall Study|Lost to Follow-up|1|||
126444227|NCT01519921|454924970|FG000|Overall Study|Treatment refusal|2|||
126691688|NCT00666926|455826397|FG012|Overall Study|Laboratory abnormality|0|||
126691689|NCT00666926|455826398|FG013|Overall Study|Laboratory abnormality|0|||
126444228|NCT01519921|454924971|FG001|Overall Study|Treatment refusal|1|||
126691690|NCT00666926|455826399|FG014|Overall Study|Laboratory abnormality|0|||
126444229|NCT01519921|454924970|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
126444230|NCT01519921|454924971|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
126444231|NCT01415882|454924974|FG000|Overall Study|Ineligible|1|||
126691691|NCT00666926|455826400|FG015|Overall Study|Laboratory abnormality|1|||
126691692|NCT00666926|455826385|FG000|Overall Study|Lack of Efficacy|0|||
126691693|NCT00666926|455826386|FG001|Overall Study|Lack of Efficacy|0|||
126444232|NCT01415882|454924975|FG001|Overall Study|Ineligible|0|||
126444233|NCT01415882|454924976|FG002|Overall Study|Ineligible|0|||
126444234|NCT01415882|454924977|FG003|Overall Study|Ineligible|3|||
126444235|NCT01415882|454924978|FG004|Overall Study|Ineligible|0|||
126444236|NCT01415882|454924974|FG000|Overall Study|Withdrawal by Subject|0|||
126444237|NCT01415882|454924975|FG001|Overall Study|Withdrawal by Subject|1|||
126444238|NCT01415882|454924976|FG002|Overall Study|Withdrawal by Subject|0|||
126444239|NCT01415882|454924977|FG003|Overall Study|Withdrawal by Subject|1|||
126444240|NCT01415882|454924978|FG004|Overall Study|Withdrawal by Subject|0|||
126444241|NCT00976560|454924979|FG000|Overall Study|Adverse Event|5|||
126444242|NCT00976560|454924980|FG001|Overall Study|Adverse Event|5|||
126444243|NCT00976560|454924979|FG000|Overall Study|Lack of Efficacy|3|||
126444244|NCT00976560|454924980|FG001|Overall Study|Lack of Efficacy|5|||
126444245|NCT00976560|454924979|FG000|Overall Study|Protocol Violation|1|||
126444246|NCT00976560|454924980|FG001|Overall Study|Protocol Violation|0|||
126444247|NCT00976560|454924979|FG000|Overall Study|Lost to Follow-up|1|||
126444248|NCT00976560|454924980|FG001|Overall Study|Lost to Follow-up|0|||
126444249|NCT00976560|454924979|FG000|Overall Study|Physician Decision|2|||
126444250|NCT00976560|454924980|FG001|Overall Study|Physician Decision|0|||
126444251|NCT00976560|454924979|FG000|Overall Study|Withdrawal by Subject|2|||
126444252|NCT00976560|454924980|FG001|Overall Study|Withdrawal by Subject|3|||
126444253|NCT00125164|454924983|FG000|Overall Study|Adverse Event|0|||
126444254|NCT00125164|454924984|FG001|Overall Study|Adverse Event|0|||
126444255|NCT00125164|454924985|FG002|Overall Study|Adverse Event|2|||
126444256|NCT00125164|454924986|FG003|Overall Study|Adverse Event|4|||
126444257|NCT00125164|454924983|FG000|Overall Study|Lost to Follow-up|0|||
126444258|NCT00125164|454924984|FG001|Overall Study|Lost to Follow-up|0|||
126444259|NCT00125164|454924985|FG002|Overall Study|Lost to Follow-up|1|||
126444260|NCT00125164|454924986|FG003|Overall Study|Lost to Follow-up|1|||
126444261|NCT00125164|454924983|FG000|Overall Study|Withdrawal by Subject|2|||
126444262|NCT00125164|454924984|FG001|Overall Study|Withdrawal by Subject|0|||
126444263|NCT00125164|454924985|FG002|Overall Study|Withdrawal by Subject|1|||
126444264|NCT00125164|454924986|FG003|Overall Study|Withdrawal by Subject|1|||
126444265|NCT01339052|454924987|FG000|Overall Study|Disease progression|13|||
126444266|NCT01339052|454924988|FG001|Overall Study|Disease progression|46|||
126444267|NCT01339052|454924987|FG000|Overall Study|Adverse Event|1|||
126444268|NCT01339052|454924988|FG001|Overall Study|Adverse Event|1|||
126444269|NCT01339052|454924987|FG000|Overall Study|Withdrawal by Subject|0|||
126444270|NCT01339052|454924988|FG001|Overall Study|Withdrawal by Subject|3|||
126444271|NCT01339052|454924987|FG000|Overall Study|Physician Decision|1|||
126444272|NCT01339052|454924988|FG001|Overall Study|Physician Decision|0|||
126444273|NCT02637037|454924989|FG000|Overall Study|Positive drug screen at admission|1|||
126444274|NCT02637037|454924990|FG001|Overall Study|Positive drug screen at admission|0|||
126444275|NCT02637037|454924989|FG000|Overall Study|Withdrawal by Subject|2|||
126444276|NCT02637037|454924990|FG001|Overall Study|Withdrawal by Subject|1|||
126444277|NCT02637037|454924989|FG000|Overall Study|Adverse Event|1|||
126444278|NCT02637037|454924990|FG001|Overall Study|Adverse Event|0|||
126444279|NCT03339219|454924991|FG000|Overall Study|Death|12|||
126444280|NCT03339219|454924991|FG000|Overall Study|Site Terminated by Sponsor|22|||
126444281|NCT03339219|454924991|FG000|Overall Study|Withdrawal by Subject|1|||
126444282|NCT01932437|454924992|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
126444283|NCT01932437|454924993|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
126444284|NCT01932437|454924994|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
126444285|NCT01932437|454924995|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
126444286|NCT01932437|454924996|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
126444287|NCT01932437|454924997|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
126444288|NCT00074490|454924998|FG000|Overall Study|Progressive malignancy|0|||
126760469|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
126444289|NCT00074490|454924999|FG001|Overall Study|Progressive malignancy|7|||
126444290|NCT00074490|454925000|FG002|Overall Study|Progressive malignancy|0|||
126444291|NCT00074490|454925001|FG003|Overall Study|Progressive malignancy|0|||
126444292|NCT00074490|454925002|FG004|Overall Study|Progressive malignancy|3|||
126444293|NCT00074490|454925003|FG005|Overall Study|Progressive malignancy|0|||
126760470|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
126444294|NCT02722499|454925004|FG000|Overall Study|Lost to Follow-up|2|||
126444295|NCT02722499|454925005|FG001|Overall Study|Lost to Follow-up|0|||
126444296|NCT02722499|454925006|FG002|Overall Study|Lost to Follow-up|1|||
126444297|NCT04638660|454925017|FG000|Overall Study|Withdrawal by Subject|2|||
126444298|NCT04638660|454925018|FG001|Overall Study|Withdrawal by Subject|0|||
126444299|NCT04638660|454925017|FG000|Overall Study|Lost to Follow-up|1|||
126444300|NCT04638660|454925018|FG001|Overall Study|Lost to Follow-up|0|||
126444301|NCT03610269|454925020|FG000|Overall Study|Physician Decision|10|||
126444302|NCT03610269|454925020|FG000|Overall Study|Protocol Violation|1|||
126444303|NCT03610269|454925020|FG000|Overall Study|Unable to draw blood|1|||
126355020|NCT03422718|454591203|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
126355021|NCT03422718|454591196|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
126355022|NCT03422718|454591197|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
126355023|NCT03422718|454591198|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
126355024|NCT03422718|454591199|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
126355025|NCT03422718|454591200|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
126355026|NCT03422718|454591201|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
126355027|NCT03422718|454591202|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
126355028|NCT03422718|454591203|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
126355029|NCT03422718|454591196|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
126355030|NCT03422718|454591197|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
126355031|NCT03422718|454591198|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
126355032|NCT03422718|454591199|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
126355033|NCT03422718|454591200|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
126355034|NCT03422718|454591201|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
126355035|NCT03422718|454591202|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
126355036|NCT03422718|454591203|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
126355037|NCT03422718|454591196|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
126355038|NCT03422718|454591197|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
126355039|NCT03422718|454591198|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
126355040|NCT03422718|454591199|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
126355041|NCT03422718|454591200|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
126355042|NCT03422718|454591201|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
126355043|NCT03422718|454591202|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
126355044|NCT03422718|454591203|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
126355045|NCT01178411|454591204|FG000|Overall Study|Adverse Event|5|||
126355046|NCT01178411|454591204|FG000|Overall Study|Withdrawal by Subject|4|||
126355047|NCT01178411|454591204|FG000|Overall Study|Protocol Violation|1|||
126355048|NCT01178411|454591204|FG000|Overall Study|Progressive disease per RECIST|32|||
126355049|NCT01178411|454591204|FG000|Overall Study|Progressive disease per clinician|9|||
126355050|NCT01178411|454591204|FG000|Overall Study|Physician Decision|6|||
126355051|NCT01178411|454591204|FG000|Overall Study|Death|1|||
126355052|NCT01178411|454591204|FG000|Overall Study|No reason provided|1|||
126355053|NCT01178411|454591204|FG000|Overall Study|Drug manufacturing ended|1|||
126355054|NCT01129284|454591205|FG000|Overall Study|Adverse Event|2|||
126355055|NCT01129284|454591206|FG001|Overall Study|Adverse Event|0|||
126355056|NCT01129284|454591207|FG002|Overall Study|Adverse Event|1|||
126355057|NCT01625182|454591215|FG000|Overall Study|Administrative problems|1|||
126355058|NCT01625182|454591216|FG001|Overall Study|Administrative problems|0|||
126355059|NCT01625182|454591215|FG000|Overall Study|Protocol deviation|0|||
126355060|NCT01625182|454591216|FG001|Overall Study|Protocol deviation|2|||
126355061|NCT01625182|454591215|FG000|Overall Study|Adverse Event|2|||
126355062|NCT01625182|454591216|FG001|Overall Study|Adverse Event|0|||
126355063|NCT01625182|454591215|FG000|Overall Study|Withdrawal by Subject|5|||
126355064|NCT01625182|454591216|FG001|Overall Study|Withdrawal by Subject|1|||
126355065|NCT01625182|454591215|FG000|Overall Study|Lack of Efficacy|12|||
126355066|NCT01625182|454591216|FG001|Overall Study|Lack of Efficacy|8|||
126355067|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
126355068|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
126355069|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
126355070|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
126355071|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
126355072|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
126355073|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
126355074|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
126355075|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
126355076|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
126355077|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
126355078|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
126355079|NCT00447278|454591217|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
126355080|NCT00447278|454591218|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
126444304|NCT03610269|454925020|FG000|Overall Study|Screen fail|4|||
126355081|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
126355082|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
126355083|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
126355084|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
126355085|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
126444305|NCT04411667|454925023|FG000|Overall Study|Physician Decision|1|||
126444306|NCT04411667|454925024|FG001|Overall Study|Physician Decision|0|||
126444307|NCT00067002|454925025|FG000|Overall Study|Early Death|1|||
126444308|NCT00067002|454925026|FG001|Overall Study|Early Death|2|||
126444309|NCT00067002|454925025|FG000|Overall Study|Delayed|1|||
126444310|NCT00067002|454925026|FG001|Overall Study|Delayed|1|||
126444311|NCT00067002|454925025|FG000|Overall Study|Graft Failure|5|||
126444312|NCT00067002|454925026|FG001|Overall Study|Graft Failure|6|||
126444313|NCT01354314|454925031|FG000|Overall Study|Lost to Follow-up|1|||
126444314|NCT01354314|454925032|FG001|Overall Study|Lost to Follow-up|0|||
126444315|NCT01354314|454925033|FG002|Overall Study|Lost to Follow-up|1|||
126355086|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
126355087|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
126355088|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
126355089|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
126355090|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
126355091|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
126355092|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
126355093|NCT00447278|454591217|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
126355094|NCT00447278|454591218|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
126355095|NCT05427916|454591222|FG000|Overall Study|Adverse Event|3|||
126355096|NCT05427916|454591223|FG001|Overall Study|Adverse Event|0|||
126355097|NCT05427916|454591222|FG000|Overall Study|Lack of Efficacy|6|||
126355098|NCT05427916|454591223|FG001|Overall Study|Lack of Efficacy|0|||
126355099|NCT05427916|454591222|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
126355100|NCT05427916|454591223|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
126355101|NCT03558672|454591224|FG000|Overall Study|Study Early Termination|10|||
126355102|NCT01158404|454591232|FG000|Overall Study|Withdrawal by Subject|0|||
126355103|NCT01158404|454591233|FG001|Overall Study|Withdrawal by Subject|1|||
126355104|NCT01158404|454591234|FG002|Overall Study|Withdrawal by Subject|0|||
126355105|NCT01158404|454591235|FG003|Overall Study|Withdrawal by Subject|0|||
126355106|NCT01158404|454591236|FG004|Overall Study|Withdrawal by Subject|3|||
126355107|NCT01158404|454591237|FG005|Overall Study|Withdrawal by Subject|1|||
126355108|NCT01158404|454591238|FG006|Overall Study|Withdrawal by Subject|0|||
126355109|NCT01158404|454591239|FG007|Overall Study|Withdrawal by Subject|1|||
126355110|NCT01158404|454591232|FG000|Overall Study|Physician Decision|0|||
126355111|NCT01158404|454591233|FG001|Overall Study|Physician Decision|0|||
126355112|NCT01158404|454591234|FG002|Overall Study|Physician Decision|0|||
126355113|NCT01158404|454591235|FG003|Overall Study|Physician Decision|0|||
126355114|NCT01158404|454591236|FG004|Overall Study|Physician Decision|0|||
126355115|NCT01158404|454591237|FG005|Overall Study|Physician Decision|0|||
126355116|NCT01158404|454591238|FG006|Overall Study|Physician Decision|0|||
126355117|NCT01158404|454591239|FG007|Overall Study|Physician Decision|1|||
126355118|NCT01158404|454591232|FG000|Overall Study|Progressive Disease|0|||
126355119|NCT01158404|454591233|FG001|Overall Study|Progressive Disease|0|||
126355120|NCT01158404|454591234|FG002|Overall Study|Progressive Disease|0|||
126355121|NCT01158404|454591235|FG003|Overall Study|Progressive Disease|0|||
126355122|NCT01158404|454591236|FG004|Overall Study|Progressive Disease|0|||
126355123|NCT01158404|454591237|FG005|Overall Study|Progressive Disease|0|||
126355124|NCT01158404|454591238|FG006|Overall Study|Progressive Disease|1|||
126355125|NCT01158404|454591239|FG007|Overall Study|Progressive Disease|0|||
126355126|NCT02384460|454591241|FG000|Overall Study|Protocol Violation|0|||
126355127|NCT02384460|454591242|FG001|Overall Study|Protocol Violation|1|||
126355128|NCT02384460|454591241|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
126355129|NCT02384460|454591242|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
126355130|NCT02384460|454591241|FG000|Overall Study|Adverse Event|5|||
126355131|NCT02384460|454591242|FG001|Overall Study|Adverse Event|2|||
126355132|NCT02384460|454591241|FG000|Overall Study|Withdrawal by Subject|0|||
126355133|NCT02384460|454591242|FG001|Overall Study|Withdrawal by Subject|3|||
126355134|NCT02384460|454591241|FG000|Overall Study|Elective medical treatment|1|||
126355135|NCT02384460|454591242|FG001|Overall Study|Elective medical treatment|0|||
126355136|NCT02384460|454591241|FG000|Overall Study|Non-compliance|1|||
126355137|NCT02384460|454591242|FG001|Overall Study|Non-compliance|0|||
126355138|NCT01060111|454591243|FG000|Overall Study|Adverse Event|9|||
126355139|NCT01060111|454591244|FG001|Overall Study|Adverse Event|5|||
126355140|NCT01060111|454591245|FG002|Overall Study|Adverse Event|18|||
126355141|NCT01060111|454591243|FG000|Overall Study|Lack of Efficacy|2|||
126355142|NCT01060111|454591244|FG001|Overall Study|Lack of Efficacy|1|||
126355143|NCT01060111|454591245|FG002|Overall Study|Lack of Efficacy|0|||
126355144|NCT01060111|454591243|FG000|Overall Study|Inappropriate participant|5|||
126355145|NCT01060111|454591244|FG001|Overall Study|Inappropriate participant|4|||
126355146|NCT01060111|454591245|FG002|Overall Study|Inappropriate participant|5|||
126355147|NCT01060111|454591243|FG000|Overall Study|Participants' evasion for hospital visit|0|||
126355148|NCT01060111|454591244|FG001|Overall Study|Participants' evasion for hospital visit|3|||
126355149|NCT01060111|454591245|FG002|Overall Study|Participants' evasion for hospital visit|2|||
126444316|NCT01354314|454925034|FG003|Overall Study|Lost to Follow-up|1|||
126444317|NCT01354314|454925031|FG000|Overall Study|Withdrawal by Subject|0|||
126444318|NCT01354314|454925032|FG001|Overall Study|Withdrawal by Subject|0|||
126444319|NCT01354314|454925033|FG002|Overall Study|Withdrawal by Subject|1|||
126444320|NCT01354314|454925034|FG003|Overall Study|Withdrawal by Subject|0|||
126444321|NCT01354314|454925031|FG000|Overall Study|Adverse Event|0|||
126444322|NCT01354314|454925032|FG001|Overall Study|Adverse Event|0|||
126444323|NCT01354314|454925033|FG002|Overall Study|Adverse Event|0|||
126444324|NCT01354314|454925034|FG003|Overall Study|Adverse Event|1|||
126444325|NCT01354314|454925031|FG000|Overall Study|Protocol Violation|1|||
126444326|NCT01354314|454925032|FG001|Overall Study|Protocol Violation|1|||
126691694|NCT00666926|455826387|FG002|Overall Study|Lack of Efficacy|0|||
126691695|NCT00666926|455826388|FG003|Overall Study|Lack of Efficacy|0|||
126691696|NCT00666926|455826389|FG004|Overall Study|Lack of Efficacy|0|||
126691697|NCT00666926|455826390|FG005|Overall Study|Lack of Efficacy|1|||
126444327|NCT01354314|454925033|FG002|Overall Study|Protocol Violation|0|||
126444328|NCT01354314|454925034|FG003|Overall Study|Protocol Violation|0|||
126444329|NCT01354314|454925031|FG000|Overall Study|Less than 90% Adherence|4|||
126444330|NCT01354314|454925032|FG001|Overall Study|Less than 90% Adherence|2|||
126444331|NCT01354314|454925033|FG002|Overall Study|Less than 90% Adherence|6|||
126444332|NCT01354314|454925034|FG003|Overall Study|Less than 90% Adherence|4|||
126444333|NCT00478023|454925035|FG000|Overall Study|Adverse Event|11|||
126444334|NCT00478023|454925036|FG001|Overall Study|Adverse Event|7|||
126444335|NCT00478023|454925037|FG002|Overall Study|Adverse Event|8|||
126444336|NCT00478023|454925038|FG003|Overall Study|Adverse Event|14|||
126444337|NCT00478023|454925039|FG004|Overall Study|Adverse Event|6|||
126444338|NCT00478023|454925035|FG000|Overall Study|Death|1|||
126444339|NCT00478023|454925036|FG001|Overall Study|Death|0|||
126444340|NCT00478023|454925037|FG002|Overall Study|Death|0|||
126444341|NCT00478023|454925038|FG003|Overall Study|Death|0|||
126444342|NCT00478023|454925039|FG004|Overall Study|Death|0|||
126444343|NCT00478023|454925035|FG000|Overall Study|Lack of Efficacy|11|||
126444344|NCT00478023|454925036|FG001|Overall Study|Lack of Efficacy|10|||
126444345|NCT00478023|454925037|FG002|Overall Study|Lack of Efficacy|4|||
126444346|NCT00478023|454925038|FG003|Overall Study|Lack of Efficacy|5|||
126444347|NCT00478023|454925039|FG004|Overall Study|Lack of Efficacy|41|||
126444348|NCT00478023|454925035|FG000|Overall Study|Lost to Follow-up|3|||
126444349|NCT00478023|454925036|FG001|Overall Study|Lost to Follow-up|1|||
126444350|NCT00478023|454925037|FG002|Overall Study|Lost to Follow-up|1|||
126444351|NCT00478023|454925038|FG003|Overall Study|Lost to Follow-up|1|||
126444352|NCT00478023|454925039|FG004|Overall Study|Lost to Follow-up|0|||
126444353|NCT00478023|454925035|FG000|Overall Study|Withdrawal by Subject|2|||
126444354|NCT00478023|454925036|FG001|Overall Study|Withdrawal by Subject|3|||
126444355|NCT00478023|454925037|FG002|Overall Study|Withdrawal by Subject|2|||
126444356|NCT00478023|454925038|FG003|Overall Study|Withdrawal by Subject|4|||
126444357|NCT00478023|454925039|FG004|Overall Study|Withdrawal by Subject|5|||
126444358|NCT00478023|454925035|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
126444359|NCT00478023|454925036|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
126444360|NCT00478023|454925037|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
126444361|NCT00478023|454925038|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
126444362|NCT00478023|454925039|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
126444363|NCT00714870|454925041|FG000|Overall Study|Lost to Follow-up|22|||
126444364|NCT00714870|454925042|FG001|Overall Study|Lost to Follow-up|5|||
126444365|NCT00714870|454925041|FG000|Overall Study|patient unable to come b/c back pain|1|||
126444366|NCT00714870|454925042|FG001|Overall Study|patient unable to come b/c back pain|0|||
126444367|NCT00714870|454925041|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
126444368|NCT00714870|454925042|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
126444369|NCT02453711|454925044|FG000|Overall Study|Withdrawal by Subject|5|||
126444370|NCT02453711|454925045|FG001|Overall Study|Withdrawal by Subject|4|||
126444371|NCT02453711|454925046|FG002|Overall Study|Withdrawal by Subject|6|||
126444372|NCT02453711|454925047|FG003|Overall Study|Withdrawal by Subject|4|||
126444373|NCT02453711|454925048|FG004|Overall Study|Withdrawal by Subject|1|||
126444374|NCT02453711|454925049|FG005|Overall Study|Withdrawal by Subject|1|||
126444375|NCT02453711|454925050|FG006|Overall Study|Withdrawal by Subject|0|||
126444376|NCT02453711|454925051|FG007|Overall Study|Withdrawal by Subject|1|||
126444377|NCT02453711|454925052|FG008|Overall Study|Withdrawal by Subject|7|||
126691698|NCT00666926|455826391|FG006|Overall Study|Lack of Efficacy|0|||
126444378|NCT02453711|454925044|FG000|Overall Study|Lost to Follow-up|5|||
126444379|NCT02453711|454925045|FG001|Overall Study|Lost to Follow-up|3|||
126444380|NCT02453711|454925046|FG002|Overall Study|Lost to Follow-up|2|||
126691699|NCT00666926|455826392|FG007|Overall Study|Lack of Efficacy|0|||
126691700|NCT00666926|455826393|FG008|Overall Study|Lack of Efficacy|0|||
126444381|NCT02453711|454925047|FG003|Overall Study|Lost to Follow-up|3|||
126444382|NCT02453711|454925048|FG004|Overall Study|Lost to Follow-up|1|||
126444383|NCT02453711|454925049|FG005|Overall Study|Lost to Follow-up|5|||
126444384|NCT02453711|454925050|FG006|Overall Study|Lost to Follow-up|2|||
126444385|NCT02453711|454925051|FG007|Overall Study|Lost to Follow-up|6|||
126444386|NCT02453711|454925052|FG008|Overall Study|Lost to Follow-up|6|||
126691701|NCT00666926|455826394|FG009|Overall Study|Lack of Efficacy|0|||
126691702|NCT00666926|455826395|FG010|Overall Study|Lack of Efficacy|0|||
126444387|NCT02453711|454925044|FG000|Overall Study|Death|0|||
126444388|NCT02453711|454925045|FG001|Overall Study|Death|0|||
126444389|NCT02453711|454925046|FG002|Overall Study|Death|0|||
126444390|NCT02453711|454925047|FG003|Overall Study|Death|0|||
126444391|NCT02453711|454925048|FG004|Overall Study|Death|0|||
126444392|NCT02453711|454925049|FG005|Overall Study|Death|0|||
126444393|NCT02453711|454925050|FG006|Overall Study|Death|1|||
126444394|NCT02453711|454925051|FG007|Overall Study|Death|0|||
126444395|NCT02453711|454925052|FG008|Overall Study|Death|0|||
126444396|NCT02453711|454925044|FG000|Overall Study|Unclassified|1|||
126444397|NCT02453711|454925045|FG001|Overall Study|Unclassified|0|||
126691703|NCT00666926|455826396|FG011|Overall Study|Lack of Efficacy|1|||
126691704|NCT00666926|455826397|FG012|Overall Study|Lack of Efficacy|0|||
126691705|NCT00666926|455826398|FG013|Overall Study|Lack of Efficacy|0|||
126691706|NCT00666926|455826399|FG014|Overall Study|Lack of Efficacy|0|||
126691707|NCT00666926|455826400|FG015|Overall Study|Lack of Efficacy|0|||
126691708|NCT00666926|455826385|FG000|Overall Study|Lost to Follow-up|0|||
126691709|NCT00666926|455826386|FG001|Overall Study|Lost to Follow-up|0|||
126691710|NCT00666926|455826387|FG002|Overall Study|Lost to Follow-up|0|||
126355150|NCT01060111|454591243|FG000|Overall Study|Participants' non-cooperation|8|||
126355151|NCT01060111|454591244|FG001|Overall Study|Participants' non-cooperation|6|||
126355152|NCT01060111|454591245|FG002|Overall Study|Participants' non-cooperation|6|||
126355153|NCT01060111|454591243|FG000|Overall Study|Adverse event and insufficient effect|0|||
126355154|NCT01060111|454591244|FG001|Overall Study|Adverse event and insufficient effect|1|||
126355155|NCT01060111|454591245|FG002|Overall Study|Adverse event and insufficient effect|0|||
126355156|NCT01060111|454591243|FG000|Overall Study|Participants' non-cooperation|1|||
126355157|NCT01060111|454591244|FG001|Overall Study|Participants' non-cooperation|0|||
126355158|NCT01060111|454591245|FG002|Overall Study|Participants' non-cooperation|0|||
126355159|NCT01060111|454591243|FG000|Overall Study|Other|2|||
126355160|NCT01060111|454591244|FG001|Overall Study|Other|3|||
126355161|NCT01060111|454591245|FG002|Overall Study|Other|4|||
126355162|NCT00997126|454591247|FG000|Overall Study|Physician Decision|7|||
126355163|NCT00997126|454591248|FG001|Overall Study|Physician Decision|11|||
126355164|NCT00896233|454591256|FG000|Overall Study|Claustrophobia during MRI|1|||
126355165|NCT04280562|454591257|FG000|Study|Adverse Event|2|||
126355166|NCT04280562|454591258|FG001|Study|Adverse Event|0|||
126355167|NCT04280562|454591257|FG000|Study|Lost to Follow-up|3|||
126355168|NCT04280562|454591258|FG001|Study|Lost to Follow-up|3|||
126355169|NCT02965456|454591259|FG000|Overall Study|Lost to Follow-up|40|||
126355170|NCT02965456|454591260|FG001|Overall Study|Lost to Follow-up|18|||
126355171|NCT02965456|454591259|FG000|Overall Study|Subject Request|22|||
126355172|NCT02965456|454591260|FG001|Overall Study|Subject Request|13|||
126355173|NCT02965456|454591259|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
126355174|NCT02965456|454591260|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
126355175|NCT02965456|454591259|FG000|Overall Study|Adverse Event|3|||
126355176|NCT02965456|454591260|FG001|Overall Study|Adverse Event|0|||
126355177|NCT02965456|454591259|FG000|Overall Study|Noncompliance with Study Drug|1|||
126355178|NCT02965456|454591260|FG001|Overall Study|Noncompliance with Study Drug|1|||
126355179|NCT02965456|454591259|FG000|Overall Study|Worsening Condition|0|||
126355180|NCT02965456|454591260|FG001|Overall Study|Worsening Condition|2|||
126355181|NCT02965456|454591259|FG000|Overall Study|Lack of Efficacy|1|||
126355182|NCT02965456|454591260|FG001|Overall Study|Lack of Efficacy|0|||
126355183|NCT02965456|454591259|FG000|Overall Study|Physician Decision|0|||
126355184|NCT02965456|454591260|FG001|Overall Study|Physician Decision|1|||
126355185|NCT02965456|454591259|FG000|Overall Study|Pregnancy|1|||
126355186|NCT02965456|454591260|FG001|Overall Study|Pregnancy|0|||
126355187|NCT02965456|454591259|FG000|Overall Study|Protocol Violation|0|||
126355188|NCT02965456|454591260|FG001|Overall Study|Protocol Violation|1|||
126355189|NCT02965456|454591259|FG000|Overall Study|Participant ran out of study drug|0|||
126355190|NCT02965456|454591260|FG001|Overall Study|Participant ran out of study drug|1|||
126355191|NCT02583477|454591261|FG000|Overall Study|Adverse Event|0|||
126355192|NCT02583477|454591262|FG001|Overall Study|Adverse Event|2|||
126355193|NCT02583477|454591261|FG000|Overall Study|Death|1|||
126355194|NCT02583477|454591262|FG001|Overall Study|Death|16|||
126355195|NCT02583477|454591261|FG000|Overall Study|Study terminated|2|||
126355196|NCT02583477|454591262|FG001|Overall Study|Study terminated|2|||
126355197|NCT04465955|454591263|FG000|Overall Study|Withdrew consent|6|||
126355198|NCT04465955|454591264|FG001|Overall Study|Withdrew consent|10|||
126355199|NCT04465955|454591265|FG002|Overall Study|Withdrew consent|7|||
126355200|NCT04465955|454591263|FG000|Overall Study|Adverse Event|6|||
126355201|NCT04465955|454591264|FG001|Overall Study|Adverse Event|5|||
126355202|NCT04465955|454591265|FG002|Overall Study|Adverse Event|1|||
126355203|NCT04465955|454591263|FG000|Overall Study|Lost to Follow-up|2|||
126355204|NCT04465955|454591264|FG001|Overall Study|Lost to Follow-up|0|||
126355205|NCT04465955|454591265|FG002|Overall Study|Lost to Follow-up|3|||
126444398|NCT02453711|454925046|FG002|Overall Study|Unclassified|1|||
126444399|NCT02453711|454925047|FG003|Overall Study|Unclassified|0|||
126444400|NCT02453711|454925048|FG004|Overall Study|Unclassified|0|||
126691711|NCT00666926|455826388|FG003|Overall Study|Lost to Follow-up|1|||
126691712|NCT00666926|455826389|FG004|Overall Study|Lost to Follow-up|0|||
126355206|NCT04465955|454591263|FG000|Overall Study|Other|1|||
126355207|NCT04465955|454591264|FG001|Overall Study|Other|1|||
126355208|NCT04465955|454591265|FG002|Overall Study|Other|3|||
126355209|NCT01860404|454591272|FG000|Overall Study|Lost to Follow-up|3|||
126355210|NCT01860404|454591273|FG001|Overall Study|Lost to Follow-up|4|||
126355211|NCT01860404|454591274|FG002|Overall Study|Lost to Follow-up|1|||
126355212|NCT01860404|454591275|FG003|Overall Study|Lost to Follow-up|6|||
126355213|NCT01860404|454591276|FG004|Overall Study|Lost to Follow-up|4|||
126355214|NCT01860404|454591272|FG000|Overall Study|Withdrawal by Subject|0|||
126355215|NCT01860404|454591273|FG001|Overall Study|Withdrawal by Subject|0|||
126355216|NCT01860404|454591274|FG002|Overall Study|Withdrawal by Subject|4|||
126355217|NCT01860404|454591275|FG003|Overall Study|Withdrawal by Subject|0|||
126355218|NCT01860404|454591276|FG004|Overall Study|Withdrawal by Subject|0|||
126355219|NCT02762604|454591277|FG000|Overall Study|Lost to Follow-up|2|||
126355220|NCT02762604|454591278|FG001|Overall Study|Lost to Follow-up|7|||
126355221|NCT02762604|454591277|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
126355222|NCT02762604|454591278|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
126355223|NCT06038643|454591279|FG000|Overall Study|Withdrawal by Subject|9|||
126355224|NCT06038643|454591280|FG001|Overall Study|Withdrawal by Subject|4|||
126355225|NCT06038643|454591279|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
126355226|NCT06038643|454591280|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
126355227|NCT05259033|454591290|FG000|Overall Study|Withdrawal by Subject|10|||
126355228|NCT05259033|454591291|FG001|Overall Study|Withdrawal by Subject|5|||
126355229|NCT05259033|454591290|FG000|Overall Study|Lost to Follow-up|1|||
126355230|NCT05259033|454591291|FG001|Overall Study|Lost to Follow-up|0|||
126355231|NCT05259033|454591290|FG000|Overall Study|Death|2|||
126355232|NCT05259033|454591291|FG001|Overall Study|Death|0|||
126355233|NCT04210375|454591292|FG000|Overall Study|Death|0|||
126355234|NCT04210375|454591293|FG001|Overall Study|Death|1|||
126355235|NCT04210375|454591294|FG002|Overall Study|Death|0|||
126355236|NCT04210375|454591295|FG003|Overall Study|Death|0|||
126355237|NCT01405911|454591296|FG000|Overall Study|Pre-treatment lab AE|0|||
126355238|NCT01405911|454591297|FG001|Overall Study|Pre-treatment lab AE|1|||
126355239|NCT01405911|454591298|FG002|Overall Study|Pre-treatment lab AE|0|||
126355240|NCT01405911|454591296|FG000|Overall Study|Lost to Follow-up|0|||
126355241|NCT01405911|454591297|FG001|Overall Study|Lost to Follow-up|1|||
126355242|NCT01405911|454591298|FG002|Overall Study|Lost to Follow-up|0|||
126355243|NCT01405911|454591296|FG000|Overall Study|Protocol Violation|1|||
126355244|NCT01405911|454591297|FG001|Overall Study|Protocol Violation|0|||
126355245|NCT01405911|454591298|FG002|Overall Study|Protocol Violation|0|||
126355246|NCT01405911|454591296|FG000|Overall Study|Withdrawal by Subject|3|||
126355247|NCT01405911|454591297|FG001|Overall Study|Withdrawal by Subject|1|||
126355248|NCT01405911|454591298|FG002|Overall Study|Withdrawal by Subject|1|||
126355249|NCT01980888|454591301|FG000|Overall Study|Study Terminated by Sponsor|116|||
126355250|NCT01980888|454591302|FG001|Overall Study|Study Terminated by Sponsor|122|||
126355251|NCT01980888|454591301|FG000|Overall Study|Withdrew Consent|17|||
126355252|NCT01980888|454591302|FG001|Overall Study|Withdrew Consent|6|||
126355253|NCT01980888|454591301|FG000|Overall Study|Investigator's Discretion|8|||
126355254|NCT01980888|454591302|FG001|Overall Study|Investigator's Discretion|3|||
126355255|NCT01980888|454591301|FG000|Overall Study|Non-Compliance with Study Drug|3|||
126355256|NCT01980888|454591302|FG001|Overall Study|Non-Compliance with Study Drug|2|||
126355257|NCT05762744|454591304|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
126355258|NCT05762744|454591305|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
126355259|NCT05762744|454591304|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
126355260|NCT05762744|454591305|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
126355261|NCT01671059|454591306|FG000|Overall Study|Adverse Event|4|||
126355262|NCT01671059|454591306|FG000|Overall Study|Lack of Efficacy|1|||
126355263|NCT01560416|454591307|FG000|Randomized Phase|Crossover Participants|7|||
126355264|NCT01560416|454591308|FG001|Randomized Phase|Crossover Participants|0|||
126355265|NCT01179399|454591309|FG000|Overall Study|Adverse Event|1|||
126355266|NCT01179399|454591309|FG000|Overall Study|Lack of Efficacy|30|||
126355267|NCT01179399|454591309|FG000|Overall Study|Withdrawal by Subject|1|||
126355268|NCT03334175|454591310|FG000|Overall Study|Lost to Follow-up|0|||
126355269|NCT03334175|454591311|FG001|Overall Study|Lost to Follow-up|1|||
126355270|NCT03738215|454591312|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
126355271|NCT03738215|454591313|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
126355272|NCT03738215|454591314|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
126355273|NCT03738215|454591312|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
126355274|NCT03738215|454591313|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
126355275|NCT03738215|454591314|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126355276|NCT03738215|454591312|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
126355277|NCT03738215|454591313|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
126355278|NCT03738215|454591314|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
126355279|NCT03738215|454591312|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
126444401|NCT02453711|454925049|FG005|Overall Study|Unclassified|0|||
126444402|NCT02453711|454925050|FG006|Overall Study|Unclassified|0|||
126444403|NCT02453711|454925051|FG007|Overall Study|Unclassified|0|||
126444404|NCT02453711|454925052|FG008|Overall Study|Unclassified|0|||
126355280|NCT03738215|454591313|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
126355281|NCT03738215|454591314|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
126355282|NCT03738215|454591312|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
126355283|NCT03738215|454591313|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
126355284|NCT03738215|454591314|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
126355285|NCT03738215|454591312|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
126355286|NCT03738215|454591313|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
126444405|NCT03695367|454925053|FG000|Overall Study|Missed the Day 28 visit.|1|||
126444406|NCT03695367|454925054|FG001|Overall Study|Missed the Day 28 visit.|0|||
126760471|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
126355287|NCT03738215|454591314|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
126355288|NCT03738215|454591312|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
126355289|NCT03738215|454591313|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
126355290|NCT03738215|454591314|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
126355291|NCT03738215|454591312|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
126355292|NCT03738215|454591313|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
126355293|NCT03738215|454591314|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
126355294|NCT03738215|454591312|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
126355295|NCT03738215|454591313|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
126355296|NCT03738215|454591314|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
126355297|NCT03738215|454591312|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
126355298|NCT03738215|454591313|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
126355299|NCT03738215|454591314|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
126355300|NCT01695772|454591316|FG000|Overall Study|Withdrawal by Subject|18|||
126355301|NCT01695772|454591316|FG000|Overall Study|Progressive Disease|8|||
126355302|NCT01695772|454591316|FG000|Overall Study|Investigator Decision|5|||
126355303|NCT01695772|454591316|FG000|Overall Study|Lost to Follow-up|4|||
126355304|NCT01695772|454591316|FG000|Overall Study|Protocol Violation|2|||
126355305|NCT01695772|454591316|FG000|Overall Study|Unspecified Reason|1|||
126355306|NCT03921541|454592973|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
126355307|NCT03921541|454592974|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
126355308|NCT01653262|454592975|FG000|Overall Study|Lack of Efficacy|1|||
126355309|NCT01653262|454592975|FG000|Overall Study|SAE, non-fatal|1|||
126355310|NCT01653262|454592975|FG000|Overall Study|AE, non-serious non-fatal|1|||
126355311|NCT00420407|454592977|FG000|Overall Study|Lost to Follow-up|0|||
126355312|NCT00420407|454592978|FG001|Overall Study|Lost to Follow-up|3|||
126355313|NCT00420407|454592977|FG000|Overall Study|Physician Decision|2|||
126760472|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
126760473|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
126355314|NCT00420407|454592978|FG001|Overall Study|Physician Decision|1|||
126355315|NCT00420407|454592977|FG000|Overall Study|subject identified as detainee|1|||
126355316|NCT00420407|454592978|FG001|Overall Study|subject identified as detainee|0|||
126355317|NCT00420407|454592977|FG000|Overall Study|subject identified as Jehovah's witness|1|||
126355318|NCT00420407|454592978|FG001|Overall Study|subject identified as Jehovah's witness|0|||
126355319|NCT00420407|454592977|FG000|Overall Study|Withdrawal by Subject|0|||
126355320|NCT00420407|454592978|FG001|Overall Study|Withdrawal by Subject|2|||
126355321|NCT02724644|454592979|FG000|Overall Study|Adverse Event|7|||
126355322|NCT02724644|454592980|FG001|Overall Study|Adverse Event|1|||
126355323|NCT02724644|454592979|FG000|Overall Study|Lost to Follow-up|6|||
126355324|NCT02724644|454592980|FG001|Overall Study|Lost to Follow-up|2|||
126355325|NCT02724644|454592979|FG000|Overall Study|Withdrawal by Subject|7|||
126355326|NCT02724644|454592980|FG001|Overall Study|Withdrawal by Subject|1|||
126355327|NCT02724644|454592979|FG000|Overall Study|Administrative|1|||
126355328|NCT02724644|454592980|FG001|Overall Study|Administrative|0|||
126355329|NCT01778985|454592981|FG000|Overall Study|Lost to Follow-up|1|||
126355330|NCT01778985|454592982|FG001|Overall Study|Lost to Follow-up|0|||
126355331|NCT01778985|454592981|FG000|Overall Study|Physician Decision|2|||
126355332|NCT01778985|454592982|FG001|Overall Study|Physician Decision|2|||
126355333|NCT01778985|454592981|FG000|Overall Study|Protocol Violation|4|||
126355334|NCT01778985|454592982|FG001|Overall Study|Protocol Violation|1|||
126355335|NCT00088881|454592983|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
126355336|NCT00088881|454592983|FG000|Step 1 - R-CHOP|Adverse Event|1|||
126355337|NCT00088881|454592983|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
126355338|NCT00088881|454592983|FG000|Step 1 - R-CHOP|Physician Decision|1|||
126355339|NCT00088881|454592983|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
126355340|NCT00088881|454592983|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
126355341|NCT00088881|454592983|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
126355342|NCT01631188|454592989|FG000|Overall Study|Physician Decision|75|||
126355343|NCT00835978|454592990|FG000|Overall Study|Death|33|||
126355344|NCT00835978|454592991|FG001|Overall Study|Death|40|||
126355345|NCT00835978|454592992|FG002|Overall Study|Death|49|||
126355346|NCT00835978|454592993|FG003|Overall Study|Death|4|||
126355347|NCT00835978|454592990|FG000|Overall Study|Lost to Follow-up|3|||
126355348|NCT00835978|454592991|FG001|Overall Study|Lost to Follow-up|4|||
126355349|NCT00835978|454592992|FG002|Overall Study|Lost to Follow-up|2|||
126355350|NCT00835978|454592993|FG003|Overall Study|Lost to Follow-up|1|||
126355351|NCT00835978|454592990|FG000|Overall Study|Other|5|||
126355352|NCT00835978|454592991|FG001|Overall Study|Other|1|||
126355353|NCT00835978|454592992|FG002|Overall Study|Other|8|||
126355354|NCT00835978|454592993|FG003|Overall Study|Other|0|||
126355355|NCT00835978|454592990|FG000|Overall Study|Objective progression or relapse|2|||
126355356|NCT00835978|454592991|FG001|Overall Study|Objective progression or relapse|0|||
126355357|NCT00835978|454592992|FG002|Overall Study|Objective progression or relapse|1|||
126355358|NCT00835978|454592993|FG003|Overall Study|Objective progression or relapse|0|||
126355359|NCT00835978|454592990|FG000|Overall Study|Adverse Event|1|||
126355360|NCT00835978|454592991|FG001|Overall Study|Adverse Event|0|||
126355361|NCT00835978|454592992|FG002|Overall Study|Adverse Event|1|||
126355362|NCT00835978|454592993|FG003|Overall Study|Adverse Event|0|||
126355363|NCT00835978|454592990|FG000|Overall Study|Withdrawal by Subject|0|||
126355364|NCT00835978|454592991|FG001|Overall Study|Withdrawal by Subject|3|||
126355365|NCT00835978|454592992|FG002|Overall Study|Withdrawal by Subject|0|||
126444407|NCT03695367|454925053|FG000|Overall Study|Lost to Follow-up|0|||
126444408|NCT03695367|454925054|FG001|Overall Study|Lost to Follow-up|1|||
126444409|NCT03695367|454925053|FG000|Overall Study|Withdrawal by Subject|0|||
126444410|NCT03695367|454925054|FG001|Overall Study|Withdrawal by Subject|1|||
126444411|NCT03695367|454925053|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
126444412|NCT03695367|454925054|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
126444413|NCT01209325|454925058|FG000|Overall Study|Lost to Follow-up|24|||
126444414|NCT01209325|454925058|FG000|Overall Study|Adverse Event|1|||
126444415|NCT01209325|454925058|FG000|Overall Study|Relocated|3|||
126444416|NCT01209325|454925058|FG000|Overall Study|Refusal after starting therapy|8|||
126444417|NCT01209325|454925058|FG000|Overall Study|Protocol Violation|4|||
126444418|NCT01209325|454925058|FG000|Overall Study|Refusal prior to therapy|1|||
126444419|NCT01209325|454925058|FG000|Overall Study|Incarceration|2|||
126444420|NCT00396253|454925059|FG000|Overall Study|Protocol Violation|1|||
126444421|NCT00396253|454925059|FG000|Overall Study|Withdrawal by Subject|7|||
126444422|NCT00396253|454925059|FG000|Overall Study|Death|3|||
126444423|NCT00396253|454925059|FG000|Overall Study|Physician Decision|1|||
126444424|NCT00396253|454925059|FG000|Overall Study|Change in eligibility status|1|||
126444425|NCT05340478|454925061|FG000|Overall Study|Scheduling Issues|10|||
126444426|NCT05340478|454925062|FG001|Overall Study|Scheduling Issues|4|||
126444427|NCT05340478|454925061|FG000|Overall Study|Neither member of dyad started treatment|2|||
126444428|NCT05340478|454925062|FG001|Overall Study|Neither member of dyad started treatment|2|||
126444429|NCT05340478|454925061|FG000|Overall Study|Withdrawn from study|2|||
126444430|NCT05340478|454925062|FG001|Overall Study|Withdrawn from study|2|||
126444431|NCT05340478|454925061|FG000|Overall Study|Lost to Follow-up|1|||
126444432|NCT05340478|454925062|FG001|Overall Study|Lost to Follow-up|4|||
126444433|NCT00092443|454925065|FG000|Overall Study|Adverse Event|9|||
126444434|NCT00092443|454925066|FG001|Overall Study|Adverse Event|13|||
126444435|NCT00092443|454925065|FG000|Overall Study|Lost to Follow-up|7|||
126444436|NCT00092443|454925066|FG001|Overall Study|Lost to Follow-up|3|||
126444437|NCT00092443|454925065|FG000|Overall Study|Protocol Violation|11|||
126444438|NCT00092443|454925066|FG001|Overall Study|Protocol Violation|9|||
126444439|NCT00092443|454925065|FG000|Overall Study|Withdrawal by Subject|9|||
126444440|NCT00092443|454925066|FG001|Overall Study|Withdrawal by Subject|11|||
126444441|NCT00092443|454925065|FG000|Overall Study|Moved|5|||
126444442|NCT00092443|454925066|FG001|Overall Study|Moved|5|||
126444443|NCT00092443|454925065|FG000|Overall Study|Other|17|||
126444444|NCT00092443|454925066|FG001|Overall Study|Other|13|||
126444445|NCT02506244|454925067|FG000|Overall Study|Did not undergo active monitoring|458|||
126355366|NCT00835978|454592993|FG003|Overall Study|Withdrawal by Subject|5|||
126355367|NCT00835978|454592990|FG000|Overall Study|Study terminated by sponsor|12|||
126355368|NCT00835978|454592991|FG001|Overall Study|Study terminated by sponsor|8|||
126355369|NCT00835978|454592992|FG002|Overall Study|Study terminated by sponsor|30|||
126355370|NCT00835978|454592993|FG003|Overall Study|Study terminated by sponsor|0|||
126355371|NCT03684057|454592994|FG000|Overall Study|Withdrawal by Subject|4|||
126355372|NCT03684057|454592995|FG001|Overall Study|Withdrawal by Subject|5|||
126355373|NCT02927145|454592996|FG000|Initial Recruitment|Withdrawal by Subject|0|||
126355374|NCT02927145|454592997|FG001|Initial Recruitment|Withdrawal by Subject|1|||
126355375|NCT02927145|454592998|FG002|Initial Recruitment|Withdrawal by Subject|1|||
126355376|NCT02927145|454592999|FG003|Initial Recruitment|Withdrawal by Subject|4|||
126355377|NCT02927145|454593000|FG004|Initial Recruitment|Withdrawal by Subject|1|||
126355378|NCT02927145|454593001|FG005|Initial Recruitment|Withdrawal by Subject|1|||
126355379|NCT02927145|454593002|FG006|Initial Recruitment|Withdrawal by Subject|0|||
126355380|NCT02927145|454593003|FG007|Initial Recruitment|Withdrawal by Subject|0|||
126355381|NCT02927145|454593004|FG008|Initial Recruitment|Withdrawal by Subject|2|||
126355382|NCT02927145|454592996|FG000|Initial Recruitment|Adverse Event|0|||
126355383|NCT02927145|454592997|FG001|Initial Recruitment|Adverse Event|0|||
126355384|NCT02927145|454592998|FG002|Initial Recruitment|Adverse Event|0|||
126355385|NCT02927145|454592999|FG003|Initial Recruitment|Adverse Event|0|||
126355386|NCT02927145|454593000|FG004|Initial Recruitment|Adverse Event|2|||
126355387|NCT02927145|454593001|FG005|Initial Recruitment|Adverse Event|0|||
126444446|NCT02506244|454925068|FG001|Overall Study|Did not undergo active monitoring|459|||
126444447|NCT02506244|454925069|FG002|Overall Study|Did not undergo active monitoring|0|||
126444448|NCT03207763|454926569|FG000|Overall Study|Lost to Follow-up|1|||
126444449|NCT03207763|454926570|FG001|Overall Study|Lost to Follow-up|0|||
126444450|NCT04555616|454926573|FG000|Overall Study|Death|1|||
126444451|NCT04555616|454926574|FG001|Overall Study|Death|0|||
126444452|NCT04555616|454926575|FG002|Overall Study|Death|1|||
126444453|NCT04555616|454926573|FG000|Overall Study|Withdrawal by Subject|2|||
126691713|NCT00666926|455826390|FG005|Overall Study|Lost to Follow-up|0|||
126691714|NCT00666926|455826391|FG006|Overall Study|Lost to Follow-up|0|||
126691715|NCT00666926|455826392|FG007|Overall Study|Lost to Follow-up|0|||
126760474|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
126760475|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
126355388|NCT02927145|454593002|FG006|Initial Recruitment|Adverse Event|0|||
126355389|NCT02927145|454593003|FG007|Initial Recruitment|Adverse Event|0|||
126355390|NCT02927145|454593004|FG008|Initial Recruitment|Adverse Event|0|||
126355391|NCT02927145|454592996|FG000|Invitation for Additional Challenge|Pregnancy|0|||
126355392|NCT02927145|454592997|FG001|Invitation for Additional Challenge|Pregnancy|0|||
126355393|NCT02927145|454592998|FG002|Invitation for Additional Challenge|Pregnancy|0|||
126355394|NCT02927145|454592999|FG003|Invitation for Additional Challenge|Pregnancy|0|||
126355395|NCT02927145|454593000|FG004|Invitation for Additional Challenge|Pregnancy|0|||
126355396|NCT02927145|454593001|FG005|Invitation for Additional Challenge|Pregnancy|0|||
126355397|NCT02927145|454593002|FG006|Invitation for Additional Challenge|Pregnancy|1|||
126355398|NCT02927145|454593003|FG007|Invitation for Additional Challenge|Pregnancy|0|||
126355399|NCT02927145|454593004|FG008|Invitation for Additional Challenge|Pregnancy|0|||
126355400|NCT00327171|454593005|FG000|Overall Study|Did not receive study medication|3|||
126355401|NCT00327171|454593006|FG001|Overall Study|Did not receive study medication|0|||
126355402|NCT00327171|454593005|FG000|Overall Study|Adverse Event|23|||
126355403|NCT00327171|454593006|FG001|Overall Study|Adverse Event|23|||
126355404|NCT00327171|454593005|FG000|Overall Study|Disease progression/lack of efficacy|68|||
126355405|NCT00327171|454593006|FG001|Overall Study|Disease progression/lack of efficacy|69|||
126355406|NCT00327171|454593005|FG000|Overall Study|Investigator/participant request|1|||
126355407|NCT00327171|454593006|FG001|Overall Study|Investigator/participant request|8|||
126355408|NCT00327171|454593005|FG000|Overall Study|Clinical progression|12|||
126355409|NCT00327171|454593006|FG001|Overall Study|Clinical progression|8|||
126355410|NCT00327171|454593005|FG000|Overall Study|Undisclosed history of ischemia|0|||
126355411|NCT00327171|454593006|FG001|Overall Study|Undisclosed history of ischemia|1|||
126355412|NCT00327171|454593005|FG000|Overall Study|Other|1|||
126355413|NCT00327171|454593006|FG001|Overall Study|Other|0|||
126355414|NCT02506036|454593009|FG000|First Intervention (4-6 Weeks)|Death|1|||
126355415|NCT02506036|454593010|FG001|First Intervention (4-6 Weeks)|Death|0|||
126355416|NCT02506036|454593009|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
126355417|NCT02506036|454593010|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
126355418|NCT02506036|454593009|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
126355419|NCT02506036|454593010|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
126355420|NCT00530075|454593011|FG000|Overall Study|Adverse Event|1|||
126355421|NCT00530075|454593011|FG000|Overall Study|Death|1|||
126355422|NCT00530075|454593011|FG000|Overall Study|Lack of Efficacy|3|||
126355423|NCT00530075|454593011|FG000|Overall Study|Protocol Violation|1|||
126355424|NCT00530075|454593011|FG000|Overall Study|Withdrawal by Subject|1|||
126355425|NCT00758043|454593015|FG000|Overall Study|Adverse Event|1|||
126355426|NCT00758043|454593016|FG001|Overall Study|Adverse Event|20|||
126355427|NCT00758043|454593017|FG002|Overall Study|Adverse Event|12|||
126355428|NCT00758043|454593018|FG003|Overall Study|Adverse Event|62|||
126355429|NCT00758043|454593015|FG000|Overall Study|Lack of Efficacy|0|||
126355430|NCT00758043|454593016|FG001|Overall Study|Lack of Efficacy|6|||
126355431|NCT00758043|454593017|FG002|Overall Study|Lack of Efficacy|18|||
126355432|NCT00758043|454593018|FG003|Overall Study|Lack of Efficacy|12|||
126355433|NCT00758043|454593015|FG000|Overall Study|Refused Further Treatment|0|||
126355434|NCT00758043|454593016|FG001|Overall Study|Refused Further Treatment|11|||
126355435|NCT00758043|454593017|FG002|Overall Study|Refused Further Treatment|5|||
126355436|NCT00758043|454593018|FG003|Overall Study|Refused Further Treatment|8|||
126355437|NCT00758043|454593015|FG000|Overall Study|Lost to Follow-up|0|||
126355438|NCT00758043|454593016|FG001|Overall Study|Lost to Follow-up|2|||
126355439|NCT00758043|454593017|FG002|Overall Study|Lost to Follow-up|2|||
126355440|NCT00758043|454593018|FG003|Overall Study|Lost to Follow-up|5|||
126355441|NCT00758043|454593015|FG000|Overall Study|Withdrawal by Subject|0|||
126355442|NCT00758043|454593016|FG001|Overall Study|Withdrawal by Subject|1|||
126355443|NCT00758043|454593017|FG002|Overall Study|Withdrawal by Subject|1|||
126355444|NCT00758043|454593018|FG003|Overall Study|Withdrawal by Subject|4|||
126760476|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
126355445|NCT00758043|454593015|FG000|Overall Study|Required Prohibited Medication|0|||
126355446|NCT00758043|454593016|FG001|Overall Study|Required Prohibited Medication|0|||
126355447|NCT00758043|454593017|FG002|Overall Study|Required Prohibited Medication|1|||
126355448|NCT00758043|454593018|FG003|Overall Study|Required Prohibited Medication|3|||
126355449|NCT00758043|454593015|FG000|Overall Study|Non-Compliant With study Drug|0|||
126355450|NCT00758043|454593016|FG001|Overall Study|Non-Compliant With study Drug|0|||
126355451|NCT00758043|454593017|FG002|Overall Study|Non-Compliant With study Drug|0|||
126355452|NCT00758043|454593018|FG003|Overall Study|Non-Compliant With study Drug|1|||
126355453|NCT00758043|454593015|FG000|Overall Study|Other Reasons|0|||
126355454|NCT00758043|454593016|FG001|Overall Study|Other Reasons|1|||
126355455|NCT00758043|454593017|FG002|Overall Study|Other Reasons|0|||
126355456|NCT00758043|454593018|FG003|Overall Study|Other Reasons|5|||
126355457|NCT00552058|454593021|FG000|Overall Study|Adverse Event|8|||
126355458|NCT00552058|454593022|FG001|Overall Study|Adverse Event|7|||
126760477|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
126355459|NCT00552058|454593021|FG000|Overall Study|Lack of Efficacy|1|||
126355460|NCT00552058|454593022|FG001|Overall Study|Lack of Efficacy|5|||
126355461|NCT00552058|454593021|FG000|Overall Study|Lost to Follow-up|1|||
126355462|NCT00552058|454593022|FG001|Overall Study|Lost to Follow-up|0|||
126355463|NCT00552058|454593021|FG000|Overall Study|Withdrawal by Subject|4|||
126355464|NCT00552058|454593022|FG001|Overall Study|Withdrawal by Subject|4|||
126355465|NCT00552058|454593021|FG000|Overall Study|Other: Protocol Violation|0|||
126355466|NCT00552058|454593022|FG001|Overall Study|Other: Protocol Violation|1|||
126355467|NCT00552058|454593021|FG000|Overall Study|Other: Non Compliance|1|||
126355468|NCT00552058|454593022|FG001|Overall Study|Other: Non Compliance|2|||
126355469|NCT00552058|454593021|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
126355470|NCT00552058|454593022|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
126355471|NCT00552058|454593021|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
126355472|NCT00552058|454593022|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
126355473|NCT00552058|454593021|FG000|Overall Study|Other: Positive Stool Result|0|||
126355474|NCT00552058|454593022|FG001|Overall Study|Other: Positive Stool Result|1|||
126355475|NCT00552058|454593021|FG000|Overall Study|Other: Randomized in error|0|||
126355476|NCT00552058|454593022|FG001|Overall Study|Other: Randomized in error|1|||
126355477|NCT00552058|454593021|FG000|Overall Study|Other: Sponsors Decision|0|||
126355478|NCT00552058|454593022|FG001|Overall Study|Other: Sponsors Decision|1|||
126355479|NCT00552058|454593021|FG000|Overall Study|Other: Early Roll Over|1|||
126355480|NCT00552058|454593022|FG001|Overall Study|Other: Early Roll Over|0|||
126355481|NCT00845182|454593023|FG000|Overall Study|Lost to Follow-up|3|||
126355482|NCT00845182|454593024|FG001|Overall Study|Lost to Follow-up|3|||
126355483|NCT00845182|454593025|FG002|Overall Study|Lost to Follow-up|4|||
126355484|NCT00845182|454593023|FG000|Overall Study|Adverse Event|0|||
126355485|NCT00845182|454593024|FG001|Overall Study|Adverse Event|1|||
126355486|NCT00845182|454593025|FG002|Overall Study|Adverse Event|1|||
126355487|NCT00845182|454593023|FG000|Overall Study|Physician Decision|0|||
126355488|NCT00845182|454593024|FG001|Overall Study|Physician Decision|0|||
126355489|NCT00845182|454593025|FG002|Overall Study|Physician Decision|1|||
126355490|NCT01348698|454593026|FG000|Overall Study|Does not meet lesion size criteria|1|||
126355491|NCT01348698|454593026|FG000|Overall Study|Death|3|||
126355492|NCT01348698|454593026|FG000|Overall Study|PI decision to close study|68|||
126355493|NCT02595749|454593027|FG000|Overall Study|Withdrawal by Subject|12|||
126355494|NCT02595749|454593028|FG001|Overall Study|Withdrawal by Subject|7|||
126355495|NCT00263562|454593029|FG000|Overall Study|Protocol Violation|3|||
126355496|NCT00263562|454593030|FG001|Overall Study|Protocol Violation|0|||
126355497|NCT00986232|454593033|FG000|Overall Study|Adverse Event|1|||
126355498|NCT00986232|454593034|FG001|Overall Study|Adverse Event|2|||
126355499|NCT00986232|454593035|FG002|Overall Study|Adverse Event|3|||
126355500|NCT00986232|454593036|FG003|Overall Study|Adverse Event|0|||
126355501|NCT00986232|454593033|FG000|Overall Study|Lost to Follow-up|19|||
126355502|NCT00986232|454593034|FG001|Overall Study|Lost to Follow-up|12|||
126444454|NCT04555616|454926574|FG001|Overall Study|Withdrawal by Subject|1|||
126355503|NCT00986232|454593035|FG002|Overall Study|Lost to Follow-up|12|||
126355504|NCT00986232|454593036|FG003|Overall Study|Lost to Follow-up|7|||
126355505|NCT00986232|454593033|FG000|Overall Study|Protocol Violation|2|||
126355506|NCT00986232|454593034|FG001|Overall Study|Protocol Violation|3|||
126355507|NCT00986232|454593035|FG002|Overall Study|Protocol Violation|0|||
126355508|NCT00986232|454593036|FG003|Overall Study|Protocol Violation|1|||
126355509|NCT00986232|454593033|FG000|Overall Study|Withdrawal by Subject|13|||
126355510|NCT00986232|454593034|FG001|Overall Study|Withdrawal by Subject|16|||
126355511|NCT00986232|454593035|FG002|Overall Study|Withdrawal by Subject|12|||
126355512|NCT00986232|454593036|FG003|Overall Study|Withdrawal by Subject|3|||
126355513|NCT00986232|454593033|FG000|Overall Study|Missed one or more bleeds|13|||
126355514|NCT00986232|454593034|FG001|Overall Study|Missed one or more bleeds|10|||
126355515|NCT00986232|454593035|FG002|Overall Study|Missed one or more bleeds|6|||
126355516|NCT00986232|454593036|FG003|Overall Study|Missed one or more bleeds|7|||
126355517|NCT00986232|454593033|FG000|Overall Study|Incomplete safety follow-up|3|||
126355518|NCT00986232|454593034|FG001|Overall Study|Incomplete safety follow-up|7|||
126355519|NCT00986232|454593035|FG002|Overall Study|Incomplete safety follow-up|2|||
126355520|NCT00986232|454593036|FG003|Overall Study|Incomplete safety follow-up|2|||
126355521|NCT05558410|454593037|FG000|Overall Study|Adverse Event|1|||
126355522|NCT05558410|454593038|FG001|Overall Study|Adverse Event|2|||
126444455|NCT04555616|454926575|FG002|Overall Study|Withdrawal by Subject|0|||
126691716|NCT00666926|455826393|FG008|Overall Study|Lost to Follow-up|0|||
126691717|NCT00666926|455826394|FG009|Overall Study|Lost to Follow-up|0|||
126691718|NCT00666926|455826395|FG010|Overall Study|Lost to Follow-up|0|||
126691719|NCT00666926|455826396|FG011|Overall Study|Lost to Follow-up|0|||
126691720|NCT00666926|455826397|FG012|Overall Study|Lost to Follow-up|0|||
126691721|NCT00666926|455826398|FG013|Overall Study|Lost to Follow-up|0|||
126691722|NCT00666926|455826399|FG014|Overall Study|Lost to Follow-up|0|||
126691723|NCT00666926|455826400|FG015|Overall Study|Lost to Follow-up|0|||
126691724|NCT00666926|455826385|FG000|Overall Study|Other|2|||
126444456|NCT04816669|454926576|FG000|Part 1|Adverse Event|1|||
126444457|NCT04816669|454926577|FG001|Part 1|Adverse Event|1|||
126444458|NCT04816669|454926578|FG002|Part 1|Adverse Event|0|||
126444459|NCT04816669|454926579|FG003|Part 1|Adverse Event|0|||
126444460|NCT04816669|454926576|FG000|Part 1|Lost to Follow-up|2|||
126444461|NCT04816669|454926577|FG001|Part 1|Lost to Follow-up|2|||
126444462|NCT04816669|454926578|FG002|Part 1|Lost to Follow-up|0|||
126444463|NCT04816669|454926579|FG003|Part 1|Lost to Follow-up|0|||
126444464|NCT04816669|454926576|FG000|Part 1|Protocol Violation|0|||
126444465|NCT04816669|454926577|FG001|Part 1|Protocol Violation|1|||
126444466|NCT04816669|454926578|FG002|Part 1|Protocol Violation|0|||
126444467|NCT04816669|454926579|FG003|Part 1|Protocol Violation|0|||
126444468|NCT04816669|454926576|FG000|Part 1|Withdrawal by Subject|1|||
126691725|NCT00666926|455826386|FG001|Overall Study|Other|4|||
126691726|NCT00666926|455826387|FG002|Overall Study|Other|3|||
126691727|NCT00666926|455826388|FG003|Overall Study|Other|3|||
126691728|NCT00666926|455826389|FG004|Overall Study|Other|3|||
126691729|NCT00666926|455826390|FG005|Overall Study|Other|3|||
126691730|NCT00666926|455826391|FG006|Overall Study|Other|4|||
126691731|NCT00666926|455826392|FG007|Overall Study|Other|0|||
126691732|NCT00666926|455826393|FG008|Overall Study|Other|3|||
126691733|NCT00666926|455826394|FG009|Overall Study|Other|5|||
126691734|NCT00666926|455826395|FG010|Overall Study|Other|3|||
126691735|NCT00666926|455826396|FG011|Overall Study|Other|26|||
126691736|NCT00666926|455826397|FG012|Overall Study|Other|3|||
126691737|NCT00666926|455826398|FG013|Overall Study|Other|2|||
126691738|NCT00666926|455826399|FG014|Overall Study|Other|4|||
126691739|NCT00666926|455826400|FG015|Overall Study|Other|4|||
126691740|NCT00666926|455826385|FG000|Overall Study|Withdrawal by Subject|0|||
126691741|NCT00666926|455826386|FG001|Overall Study|Withdrawal by Subject|0|||
126691742|NCT00666926|455826387|FG002|Overall Study|Withdrawal by Subject|0|||
126444469|NCT04816669|454926577|FG001|Part 1|Withdrawal by Subject|2|||
126444470|NCT04816669|454926578|FG002|Part 1|Withdrawal by Subject|0|||
126444471|NCT04816669|454926579|FG003|Part 1|Withdrawal by Subject|0|||
126444472|NCT04816669|454926576|FG000|Part 2|Other|0|||
126444473|NCT04816669|454926577|FG001|Part 2|Other|0|||
126444474|NCT04816669|454926578|FG002|Part 2|Other|1|||
126691743|NCT00666926|455826388|FG003|Overall Study|Withdrawal by Subject|0|||
126691744|NCT00666926|455826389|FG004|Overall Study|Withdrawal by Subject|0|||
126691745|NCT00666926|455826390|FG005|Overall Study|Withdrawal by Subject|0|||
126691746|NCT00666926|455826391|FG006|Overall Study|Withdrawal by Subject|0|||
126691747|NCT00666926|455826392|FG007|Overall Study|Withdrawal by Subject|1|||
126691748|NCT00666926|455826393|FG008|Overall Study|Withdrawal by Subject|0|||
126691749|NCT00666926|455826394|FG009|Overall Study|Withdrawal by Subject|3|||
126691750|NCT00666926|455826395|FG010|Overall Study|Withdrawal by Subject|0|||
126691751|NCT00666926|455826396|FG011|Overall Study|Withdrawal by Subject|3|||
126691752|NCT00666926|455826397|FG012|Overall Study|Withdrawal by Subject|0|||
126691753|NCT00666926|455826398|FG013|Overall Study|Withdrawal by Subject|1|||
126691754|NCT00666926|455826399|FG014|Overall Study|Withdrawal by Subject|3|||
126691755|NCT00666926|455826400|FG015|Overall Study|Withdrawal by Subject|3|||
126691756|NCT00666926|455826385|FG000|Overall Study|Death|0|||
126691757|NCT00666926|455826386|FG001|Overall Study|Death|0|||
126691758|NCT00666926|455826387|FG002|Overall Study|Death|0|||
126691759|NCT00666926|455826388|FG003|Overall Study|Death|0|||
126691760|NCT00666926|455826389|FG004|Overall Study|Death|0|||
126691761|NCT00666926|455826390|FG005|Overall Study|Death|0|||
126691762|NCT00666926|455826391|FG006|Overall Study|Death|0|||
126691763|NCT00666926|455826392|FG007|Overall Study|Death|0|||
126691764|NCT00666926|455826393|FG008|Overall Study|Death|0|||
126691765|NCT00666926|455826394|FG009|Overall Study|Death|0|||
126691766|NCT00666926|455826395|FG010|Overall Study|Death|0|||
126691767|NCT00666926|455826396|FG011|Overall Study|Death|1|||
126691768|NCT00666926|455826397|FG012|Overall Study|Death|0|||
126691769|NCT00666926|455826398|FG013|Overall Study|Death|0|||
126444475|NCT04816669|454926579|FG003|Part 2|Other|0|||
126444476|NCT04816669|454926576|FG000|Part 2|Withdrawal by Subject|0|||
126444477|NCT04816669|454926577|FG001|Part 2|Withdrawal by Subject|0|||
126444478|NCT04816669|454926578|FG002|Part 2|Withdrawal by Subject|0|||
126444479|NCT04816669|454926579|FG003|Part 2|Withdrawal by Subject|1|||
126444480|NCT04816669|454926576|FG000|Part 2|Lost to Follow-up|0|||
126444481|NCT04816669|454926577|FG001|Part 2|Lost to Follow-up|0|||
126444482|NCT04816669|454926578|FG002|Part 2|Lost to Follow-up|1|||
126444483|NCT04816669|454926579|FG003|Part 2|Lost to Follow-up|0|||
126444484|NCT01229267|454926580|FG000|Overall Study|Adverse Event|4|||
126444485|NCT01229267|454926581|FG001|Overall Study|Adverse Event|6|||
126444486|NCT01229267|454926582|FG002|Overall Study|Adverse Event|3|||
126444487|NCT01229267|454926583|FG003|Overall Study|Adverse Event|2|||
126444488|NCT01229267|454926584|FG004|Overall Study|Adverse Event|10|||
126444489|NCT01229267|454926580|FG000|Overall Study|Death|40|||
126444490|NCT01229267|454926581|FG001|Overall Study|Death|37|||
126444491|NCT01229267|454926582|FG002|Overall Study|Death|35|||
126444492|NCT01229267|454926583|FG003|Overall Study|Death|13|||
126444493|NCT01229267|454926584|FG004|Overall Study|Death|103|||
126444494|NCT01229267|454926580|FG000|Overall Study|Withdrawal by Subject|23|||
126444495|NCT01229267|454926581|FG001|Overall Study|Withdrawal by Subject|22|||
126444496|NCT01229267|454926582|FG002|Overall Study|Withdrawal by Subject|32|||
126545408|NCT03500640|455290831|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
126691770|NCT00666926|455826399|FG014|Overall Study|Death|0|||
126691771|NCT00666926|455826400|FG015|Overall Study|Death|0|||
126691772|NCT00713219|455826404|FG000|Overall Study|Death|1|||
126691773|NCT00713219|455826404|FG000|Overall Study|Protocol Violation|1|||
126691774|NCT00464178|455826405|FG000|Overall Study|Protocol Violation|1|||
126691775|NCT00464178|455826405|FG000|Overall Study|Withdrawal by Subject|1|||
126691776|NCT01557166|455826408|FG000|Overall Study|Adverse Event|20|||
126691777|NCT01557166|455826409|FG001|Overall Study|Adverse Event|6|||
126691778|NCT01557166|455826408|FG000|Overall Study|Lack of Efficacy|2|||
126691779|NCT01557166|455826409|FG001|Overall Study|Lack of Efficacy|1|||
126691780|NCT01557166|455826408|FG000|Overall Study|Protocol Violation|8|||
126691781|NCT01557166|455826409|FG001|Overall Study|Protocol Violation|5|||
126691782|NCT01557166|455826408|FG000|Overall Study|Withdrawn consent|12|||
126691783|NCT01557166|455826409|FG001|Overall Study|Withdrawn consent|20|||
126691784|NCT01557166|455826408|FG000|Overall Study|Target dose not tolerated|1|||
126691785|NCT01557166|455826409|FG001|Overall Study|Target dose not tolerated|0|||
126691786|NCT01557166|455826408|FG000|Overall Study|Psychiatric disorder|1|||
126691787|NCT01557166|455826409|FG001|Overall Study|Psychiatric disorder|0|||
126691788|NCT01557166|455826408|FG000|Overall Study|Unclassified|2|||
126691789|NCT01557166|455826409|FG001|Overall Study|Unclassified|5|||
126691790|NCT00946309|455826410|FG000|Overall Study|Protocol Violation|1|||
126691791|NCT00946309|455826411|FG001|Overall Study|Protocol Violation|0|||
126691792|NCT00946309|455826410|FG000|Overall Study|Lost to Follow-up|0|||
126691793|NCT00946309|455826411|FG001|Overall Study|Lost to Follow-up|1|||
126444497|NCT01229267|454926583|FG003|Overall Study|Withdrawal by Subject|14|||
126444498|NCT01229267|454926584|FG004|Overall Study|Withdrawal by Subject|59|||
126444499|NCT01229267|454926580|FG000|Overall Study|Protocol Violation|0|||
126444500|NCT01229267|454926581|FG001|Overall Study|Protocol Violation|1|||
126444501|NCT01229267|454926582|FG002|Overall Study|Protocol Violation|0|||
126444502|NCT01229267|454926583|FG003|Overall Study|Protocol Violation|0|||
126444503|NCT01229267|454926584|FG004|Overall Study|Protocol Violation|0|||
126691794|NCT00946309|455826410|FG000|Overall Study|Procedure cancelled/discontinued|0|||
126691795|NCT00946309|455826411|FG001|Overall Study|Procedure cancelled/discontinued|3|||
126691796|NCT01469000|455826421|FG000|Overall Study|Withdrawal by Subject|16|||
126691797|NCT01469000|455826422|FG001|Overall Study|Withdrawal by Subject|3|||
126691798|NCT01469000|455826421|FG000|Overall Study|Sponsor Decision|4|||
126691799|NCT01469000|455826422|FG001|Overall Study|Sponsor Decision|1|||
126691800|NCT00686647|455826426|FG000|Overall Study|Lost to Follow-up|1|||
126691801|NCT00686647|455826426|FG000|Overall Study|Death|1|||
126691802|NCT01725750|455826435|FG000|Overall Study|Adverse Event|1|||
126691803|NCT01725750|455826436|FG001|Overall Study|Adverse Event|0|||
126691804|NCT01725750|455826435|FG000|Overall Study|Lost to Follow-up|1|||
126691805|NCT01725750|455826436|FG001|Overall Study|Lost to Follow-up|1|||
126691806|NCT01725750|455826435|FG000|Overall Study|Withdrawal by Subject|0|||
126691807|NCT01725750|455826436|FG001|Overall Study|Withdrawal by Subject|9|||
126691808|NCT00654498|455826441|FG000|Overall Study|Not Treated|1|||
126691809|NCT00654498|455826442|FG001|Overall Study|Not Treated|0|||
126691810|NCT00654498|455826441|FG000|Overall Study|Adverse Event|6|||
126691811|NCT00654498|455826442|FG001|Overall Study|Adverse Event|1|||
126691812|NCT00654498|455826441|FG000|Overall Study|Protocol Violation|1|||
126691813|NCT00654498|455826442|FG001|Overall Study|Protocol Violation|1|||
126691814|NCT00654498|455826441|FG000|Overall Study|Lost to Follow-up|1|||
126691815|NCT00654498|455826442|FG001|Overall Study|Lost to Follow-up|5|||
126691816|NCT00654498|455826441|FG000|Overall Study|Withdrawal by Subject|1|||
126691817|NCT00654498|455826442|FG001|Overall Study|Withdrawal by Subject|0|||
126691818|NCT00654498|455826441|FG000|Overall Study|Other reason not defined above|4|||
126691819|NCT00654498|455826442|FG001|Overall Study|Other reason not defined above|5|||
126691820|NCT02531646|455826443|FG000|Overall Study|equip. image processing issue|5|||
126691821|NCT02531646|455826444|FG001|Overall Study|equip. image processing issue|1|||
126691822|NCT02531646|455826445|FG002|Overall Study|equip. image processing issue|0|||
126691823|NCT00772668|455826448|FG000|Overall Study|Physician Decision|3|||
126691824|NCT03631706|455826449|FG000|Overall Study|Randomized, not treated|1|||
126691825|NCT03631706|455826450|FG001|Overall Study|Randomized, not treated|0|||
126691826|NCT06272370|455827801|FG000|Overall Study|Lost to Follow-up|0|||
126691827|NCT06272370|455827802|FG001|Overall Study|Lost to Follow-up|3|||
126691828|NCT06272370|455827803|FG002|Overall Study|Lost to Follow-up|1|||
126691829|NCT06272370|455827804|FG003|Overall Study|Lost to Follow-up|1|||
126691830|NCT02152345|455827805|FG000|Overall Study|Case Cancellations|2|||
126691831|NCT02152345|455827806|FG001|Overall Study|Case Cancellations|4|||
126691832|NCT02152345|455827805|FG000|Overall Study|Withdrawal by Subject|2|||
126691833|NCT02152345|455827806|FG001|Overall Study|Withdrawal by Subject|1|||
126691834|NCT01916980|455827807|FG000|Overall Study|Adverse Event|4|||
126691835|NCT01916980|455827808|FG001|Overall Study|Adverse Event|2|||
126691836|NCT01916980|455827807|FG000|Overall Study|Lack of Efficacy|2|||
126691837|NCT01916980|455827808|FG001|Overall Study|Lack of Efficacy|2|||
126691838|NCT01916980|455827807|FG000|Overall Study|Withdrawal by Subject|1|||
126691839|NCT01916980|455827808|FG001|Overall Study|Withdrawal by Subject|0|||
126355523|NCT05558410|454593039|FG002|Overall Study|Adverse Event|0|||
126355524|NCT05558410|454593037|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
126355525|NCT05558410|454593038|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
126355526|NCT05558410|454593039|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
126355527|NCT05558410|454593037|FG000|Overall Study|Lost to Follow-up|10|||
126355528|NCT05558410|454593038|FG001|Overall Study|Lost to Follow-up|17|||
126355529|NCT05558410|454593039|FG002|Overall Study|Lost to Follow-up|19|||
126355530|NCT05558410|454593037|FG000|Overall Study|Death|1|||
126355531|NCT05558410|454593038|FG001|Overall Study|Death|0|||
126355532|NCT05558410|454593039|FG002|Overall Study|Death|0|||
126691840|NCT03786432|455827809|FG000|Overall Study|Screen Failure after consent|1|||
126691841|NCT03786432|455827809|FG000|Overall Study|Lost to Follow-up|4|||
126691842|NCT03786432|455827809|FG000|Overall Study|did not complete 12 month CT scan|1|||
126355533|NCT05558410|454593037|FG000|Overall Study|Other non-compliance|0|||
126355534|NCT05558410|454593038|FG001|Overall Study|Other non-compliance|1|||
126691843|NCT00544869|455827810|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
126691844|NCT00544869|455827811|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
126691845|NCT00544869|455827812|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
126691846|NCT00544869|455827810|FG000|Overall Study|Adverse Event|6|||
126691847|NCT00544869|455827811|FG001|Overall Study|Adverse Event|1|||
126691848|NCT00544869|455827812|FG002|Overall Study|Adverse Event|0|||
126691849|NCT00544869|455827810|FG000|Overall Study|Lack of Efficacy|1|||
126691850|NCT00544869|455827811|FG001|Overall Study|Lack of Efficacy|1|||
126691851|NCT00544869|455827812|FG002|Overall Study|Lack of Efficacy|0|||
126691852|NCT00544869|455827810|FG000|Overall Study|Physician Decision|2|||
126691853|NCT00544869|455827811|FG001|Overall Study|Physician Decision|0|||
126691854|NCT00544869|455827812|FG002|Overall Study|Physician Decision|0|||
126691855|NCT00568555|455827815|FG000|Overall Study|Withdrawal by Subject|1|||
126691856|NCT00568555|455827816|FG001|Overall Study|Withdrawal by Subject|1|||
126444504|NCT01229267|454926580|FG000|Overall Study|Progressive disease|0|||
126691857|NCT00700180|455827817|FG000|Overall Study|Death|99|||
126691858|NCT00700180|455827818|FG001|Overall Study|Death|114|||
126691859|NCT00700180|455827817|FG000|Overall Study|Alive on treatment|5|||
126691860|NCT00700180|455827818|FG001|Overall Study|Alive on treatment|3|||
126444505|NCT01229267|454926581|FG001|Overall Study|Progressive disease|0|||
126444506|NCT01229267|454926582|FG002|Overall Study|Progressive disease|0|||
126444507|NCT01229267|454926583|FG003|Overall Study|Progressive disease|0|||
126444508|NCT01229267|454926584|FG004|Overall Study|Progressive disease|1|||
126444509|NCT01229267|454926580|FG000|Overall Study|Physician Decision|8|||
126444510|NCT01229267|454926581|FG001|Overall Study|Physician Decision|11|||
126444511|NCT01229267|454926582|FG002|Overall Study|Physician Decision|8|||
126444512|NCT01229267|454926583|FG003|Overall Study|Physician Decision|3|||
126691861|NCT00700180|455827817|FG000|Overall Study|Alive in follow-up|46|||
126691862|NCT00700180|455827818|FG001|Overall Study|Alive in follow-up|27|||
126691863|NCT00700180|455827817|FG000|Overall Study|Lost to Follow-up|4|||
126691864|NCT00700180|455827818|FG001|Overall Study|Lost to Follow-up|5|||
126691865|NCT02614079|455827821|FG000|Overall Study|Withdrawal by Subject|1|||
126691866|NCT03683394|455827822|FG000|Overall Study|Withdrawal by Subject|4|||
126691867|NCT03683394|455827823|FG001|Overall Study|Withdrawal by Subject|8|||
126691868|NCT03683394|455827822|FG000|Overall Study|Lost to Follow-up|7|||
126691869|NCT03683394|455827823|FG001|Overall Study|Lost to Follow-up|0|||
126691870|NCT03683394|455827822|FG000|Overall Study|Death|3|||
126444513|NCT01229267|454926584|FG004|Overall Study|Physician Decision|25|||
126691871|NCT03683394|455827823|FG001|Overall Study|Death|1|||
126691872|NCT03882424|455827824|FG000|Overall Study|Lost to Follow-up|3|||
126691873|NCT03882424|455827825|FG001|Overall Study|Lost to Follow-up|0|||
126691874|NCT03882424|455827826|FG002|Overall Study|Lost to Follow-up|0|||
126691875|NCT03882424|455827824|FG000|Overall Study|schedule conflict|1|||
126444514|NCT01229267|454926580|FG000|Overall Study|Lost to Follow-up|6|||
126444515|NCT01229267|454926581|FG001|Overall Study|Lost to Follow-up|5|||
126760478|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
126691876|NCT03882424|455827825|FG001|Overall Study|schedule conflict|0|||
126691877|NCT03882424|455827826|FG002|Overall Study|schedule conflict|0|||
126691878|NCT00236080|455827827|FG000|Overall Study|Adverse Event|0|||
126691879|NCT00236080|455827828|FG001|Overall Study|Adverse Event|0|||
126691880|NCT00236080|455827829|FG002|Overall Study|Adverse Event|3|||
126691881|NCT00236080|455827830|FG003|Overall Study|Adverse Event|1|||
126691882|NCT00236080|455827831|FG004|Overall Study|Adverse Event|0|||
126691883|NCT00236080|455827827|FG000|Overall Study|Lost to Follow-up|0|||
126691884|NCT00236080|455827828|FG001|Overall Study|Lost to Follow-up|1|||
126691885|NCT00236080|455827829|FG002|Overall Study|Lost to Follow-up|0|||
126691886|NCT00236080|455827830|FG003|Overall Study|Lost to Follow-up|0|||
126691887|NCT00236080|455827831|FG004|Overall Study|Lost to Follow-up|0|||
126444516|NCT01229267|454926582|FG002|Overall Study|Lost to Follow-up|8|||
126444517|NCT01229267|454926583|FG003|Overall Study|Lost to Follow-up|3|||
126444518|NCT01229267|454926584|FG004|Overall Study|Lost to Follow-up|22|||
126444519|NCT02446899|454926585|FG000|Overall Study|Adverse Event|4|||
126444520|NCT02446899|454926586|FG001|Overall Study|Adverse Event|7|||
126444521|NCT02446899|454926585|FG000|Overall Study|Condition Under Investigation Worsened|1|||
126444522|NCT02446899|454926586|FG001|Overall Study|Condition Under Investigation Worsened|4|||
126444523|NCT02446899|454926585|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
126444524|NCT02446899|454926586|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
126444525|NCT02446899|454926585|FG000|Overall Study|Lack of Efficacy|2|||
126444526|NCT02446899|454926586|FG001|Overall Study|Lack of Efficacy|8|||
126760479|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
126760480|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
126691888|NCT00236080|455827827|FG000|Overall Study|Physician Decision|1|||
126691889|NCT00236080|455827828|FG001|Overall Study|Physician Decision|0|||
126691890|NCT00236080|455827829|FG002|Overall Study|Physician Decision|1|||
126691891|NCT00236080|455827830|FG003|Overall Study|Physician Decision|1|||
126691892|NCT00236080|455827831|FG004|Overall Study|Physician Decision|1|||
126691893|NCT00236080|455827827|FG000|Overall Study|Withdrawal by Subject|1|||
126691894|NCT00236080|455827828|FG001|Overall Study|Withdrawal by Subject|0|||
126691895|NCT00236080|455827829|FG002|Overall Study|Withdrawal by Subject|0|||
126691896|NCT00236080|455827830|FG003|Overall Study|Withdrawal by Subject|0|||
126691897|NCT00236080|455827831|FG004|Overall Study|Withdrawal by Subject|0|||
126691898|NCT00236080|455827827|FG000|Overall Study|Miscellaneous|0|||
126691899|NCT00236080|455827828|FG001|Overall Study|Miscellaneous|0|||
126691900|NCT00236080|455827829|FG002|Overall Study|Miscellaneous|1|||
126691901|NCT00236080|455827830|FG003|Overall Study|Miscellaneous|0|||
126691902|NCT00236080|455827831|FG004|Overall Study|Miscellaneous|0|||
126691903|NCT02400255|455827832|FG000|Overall Study|Relapse|4|||
126691904|NCT02400255|455827833|FG001|Overall Study|Relapse|1|||
126691905|NCT02400255|455827834|FG002|Overall Study|Relapse|1|||
126691906|NCT02400255|455827835|FG003|Overall Study|Relapse|2|||
126691907|NCT02400255|455827832|FG000|Overall Study|Adverse Event|6|||
126691908|NCT02400255|455827833|FG001|Overall Study|Adverse Event|3|||
126691909|NCT02400255|455827834|FG002|Overall Study|Adverse Event|0|||
126444527|NCT02446899|454926585|FG000|Overall Study|Lost to Follow-up|1|||
126444528|NCT02446899|454926586|FG001|Overall Study|Lost to Follow-up|3|||
126444529|NCT02446899|454926585|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
126760481|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
126760482|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
126760483|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
126760484|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
126760485|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
126760486|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
126760487|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
126760488|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
126770398|NCT02575807|456112470|FG001|Overall Study|Terminated due to physician decision|0|||
126691910|NCT02400255|455827835|FG003|Overall Study|Adverse Event|0|||
126691911|NCT02400255|455827832|FG000|Overall Study|Physician Decision|6|||
126691912|NCT02400255|455827833|FG001|Overall Study|Physician Decision|0|||
126444530|NCT02446899|454926586|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
126444531|NCT02446899|454926585|FG000|Overall Study|Withdrawal by Subject|11|||
126691913|NCT02400255|455827834|FG002|Overall Study|Physician Decision|0|||
126691914|NCT02400255|455827835|FG003|Overall Study|Physician Decision|0|||
126691915|NCT02400255|455827832|FG000|Overall Study|Loss of insurance|1|||
126691916|NCT02400255|455827833|FG001|Overall Study|Loss of insurance|0|||
126691917|NCT02400255|455827834|FG002|Overall Study|Loss of insurance|0|||
126691918|NCT02400255|455827835|FG003|Overall Study|Loss of insurance|0|||
126691919|NCT01961544|455827839|FG000|Overall Study|Protocol Violation|1|||
126444532|NCT02446899|454926586|FG001|Overall Study|Withdrawal by Subject|19|||
126444533|NCT02446899|454926585|FG000|Overall Study|Miscellaneous|5|||
126691920|NCT01961544|455827839|FG000|Overall Study|Withdrawal by Subject|7|||
126691921|NCT01961544|455827839|FG000|Overall Study|Adverse Event|1|||
126691922|NCT01961544|455827839|FG000|Overall Study|Physician Decision|2|||
126691923|NCT01961544|455827839|FG000|Overall Study|Poor Tolerance|1|||
126691924|NCT01961544|455827839|FG000|Overall Study|Aggravation of Steral Pain|1|||
126691925|NCT00354601|455827840|FG000|Overall Study|Protocol Violation|1|||
126691926|NCT00354601|455827840|FG000|Overall Study|progression|1|||
126691927|NCT03603652|455827841|FG000|Overall Study|Death|2|||
126691928|NCT03213366|455827844|FG000|Overall Study|Lost to Follow-up|9|||
126691929|NCT03213366|455827845|FG001|Overall Study|Lost to Follow-up|4|||
126691930|NCT01960855|455827846|FG000|Overall Study|Subject noncompliant|1|||
126691931|NCT01960855|455827847|FG001|Overall Study|Subject noncompliant|0|||
126691932|NCT01960855|455827848|FG002|Overall Study|Subject noncompliant|0|||
126691933|NCT01960855|455827849|FG003|Overall Study|Subject noncompliant|0|||
126444534|NCT02446899|454926586|FG001|Overall Study|Miscellaneous|4|||
126444535|NCT02446899|454926585|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
126444536|NCT02446899|454926586|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
126444537|NCT04050202|454926587|FG000|Overall Study|Lost to Follow-up|2|||
126444538|NCT01499277|454926588|FG000|Overall Study|Adverse Event|3|||
126444539|NCT01499277|454926589|FG001|Overall Study|Adverse Event|6|||
126444540|NCT01499277|454926588|FG000|Overall Study|Death|3|||
126444541|NCT01499277|454926589|FG001|Overall Study|Death|2|||
126444542|NCT01499277|454926588|FG000|Overall Study|Lost to Follow-up|15|||
126444543|NCT01499277|454926589|FG001|Overall Study|Lost to Follow-up|8|||
126444544|NCT01499277|454926588|FG000|Overall Study|Protocol Violation|2|||
126444545|NCT01499277|454926589|FG001|Overall Study|Protocol Violation|3|||
126444546|NCT01499277|454926588|FG000|Overall Study|Withdrawal by Subject|16|||
126444547|NCT01499277|454926589|FG001|Overall Study|Withdrawal by Subject|6|||
126444548|NCT01499277|454926588|FG000|Overall Study|Lack of therapeutic response and other|8|||
126444549|NCT01499277|454926589|FG001|Overall Study|Lack of therapeutic response and other|7|||
126444550|NCT02974543|454926590|FG000|Overall Study|Withdrawal by Subject|1|||
126444551|NCT02974543|454926591|FG001|Overall Study|Withdrawal by Subject|0|||
126444552|NCT00742235|454926592|FG000|Overall Study|Lost to Follow-up|0|||
126444553|NCT00742235|454926593|FG001|Overall Study|Lost to Follow-up|31|||
126444554|NCT01237899|454926594|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
126444555|NCT01237899|454926595|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
126444556|NCT01237899|454926596|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
126444557|NCT01237899|454926597|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
126444558|NCT01237899|454926598|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
126444559|NCT01237899|454926599|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
126444560|NCT01237899|454926600|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
126444561|NCT01237899|454926601|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
126444562|NCT01237899|454926602|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
126444563|NCT01237899|454926603|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
126444564|NCT01237899|454926604|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
126444565|NCT02141438|454926606|FG000|Overall Study|Death|1308|||
126444566|NCT02141438|454926606|FG000|Overall Study|Lost to Follow-up|84|||
126444567|NCT02141438|454926606|FG000|Overall Study|Withdrawal by Subject|52|||
126444568|NCT02141438|454926606|FG000|Overall Study|Physician Decision|1|||
126444569|NCT02141438|454926606|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
126444570|NCT04730271|454926607|FG000|Overall Study|Adverse Event|0|||
126444571|NCT04730271|454926608|FG001|Overall Study|Adverse Event|2|||
126444572|NCT04730271|454926607|FG000|Overall Study|Withdrawal by Subject|1|||
126444573|NCT04730271|454926608|FG001|Overall Study|Withdrawal by Subject|1|||
126444574|NCT04730271|454926607|FG000|Overall Study|Protocol Violation|7|||
126444575|NCT04730271|454926608|FG001|Overall Study|Protocol Violation|13|||
126444576|NCT04730271|454926607|FG000|Overall Study|Lost to Follow-up|3|||
126444577|NCT04730271|454926608|FG001|Overall Study|Lost to Follow-up|3|||
126444578|NCT04730271|454926607|FG000|Overall Study|Death|1|||
126444579|NCT04730271|454926608|FG001|Overall Study|Death|0|||
126444580|NCT05782179|454926609|FG000|Overall Study|Adverse Event|0|||
126444581|NCT05782179|454926610|FG001|Overall Study|Adverse Event|0|||
126444582|NCT05782179|454926611|FG002|Overall Study|Adverse Event|2|||
126444583|NCT05782179|454926612|FG003|Overall Study|Adverse Event|0|||
126444584|NCT05782179|454926613|FG004|Overall Study|Adverse Event|0|||
126691934|NCT01960855|455827850|FG004|Overall Study|Subject noncompliant|0|||
126691935|NCT01960855|455827846|FG000|Overall Study|Adverse Event|2|||
126691936|NCT01960855|455827847|FG001|Overall Study|Adverse Event|0|||
126444585|NCT05782179|454926614|FG005|Overall Study|Adverse Event|0|||
126444586|NCT03675321|454926615|FG000|Overall Study|Lack of Efficacy|2|||
126444587|NCT03675321|454926616|FG001|Overall Study|Lack of Efficacy|2|||
126444588|NCT03675321|454926615|FG000|Overall Study|Withdrawal by Subject|1|||
126444589|NCT03675321|454926616|FG001|Overall Study|Withdrawal by Subject|3|||
126444590|NCT03565497|454926626|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
126444591|NCT03565497|454926627|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
126444592|NCT03565497|454926628|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
126444593|NCT03565497|454926626|FG000|Overall Study|Lost to Follow-up|1|||
126444594|NCT03565497|454926627|FG001|Overall Study|Lost to Follow-up|1|||
126444595|NCT03565497|454926628|FG002|Overall Study|Lost to Follow-up|2|||
126444596|NCT03565497|454926626|FG000|Overall Study|Withdrawal by Subject|1|||
126444597|NCT03565497|454926627|FG001|Overall Study|Withdrawal by Subject|1|||
126444598|NCT03565497|454926628|FG002|Overall Study|Withdrawal by Subject|1|||
126444599|NCT02999672|454926629|FG000|Overall Study|Death|0|||
126444600|NCT02999672|454926630|FG001|Overall Study|Death|1|||
126691937|NCT01960855|455827848|FG002|Overall Study|Adverse Event|6|||
126691938|NCT01960855|455827849|FG003|Overall Study|Adverse Event|2|||
126691939|NCT01960855|455827850|FG004|Overall Study|Adverse Event|2|||
126691940|NCT01960855|455827846|FG000|Overall Study|Lack of Efficacy|1|||
126691941|NCT01960855|455827847|FG001|Overall Study|Lack of Efficacy|1|||
126691942|NCT01960855|455827848|FG002|Overall Study|Lack of Efficacy|0|||
126691943|NCT01960855|455827849|FG003|Overall Study|Lack of Efficacy|0|||
126691944|NCT01960855|455827850|FG004|Overall Study|Lack of Efficacy|0|||
126691945|NCT01960855|455827846|FG000|Overall Study|Other|2|||
126691946|NCT01960855|455827847|FG001|Overall Study|Other|1|||
126691947|NCT01960855|455827848|FG002|Overall Study|Other|1|||
126691948|NCT01960855|455827849|FG003|Overall Study|Other|1|||
126691949|NCT01960855|455827850|FG004|Overall Study|Other|0|||
126691950|NCT01960855|455827846|FG000|Overall Study|Consent withdrawn by subject|3|||
126691951|NCT01960855|455827847|FG001|Overall Study|Consent withdrawn by subject|1|||
126691952|NCT01960855|455827848|FG002|Overall Study|Consent withdrawn by subject|2|||
126691953|NCT01960855|455827849|FG003|Overall Study|Consent withdrawn by subject|1|||
126691954|NCT01960855|455827850|FG004|Overall Study|Consent withdrawn by subject|1|||
126691955|NCT01960855|455827846|FG000|Overall Study|Lost to Follow-up|2|||
126691956|NCT01960855|455827847|FG001|Overall Study|Lost to Follow-up|1|||
126691957|NCT01960855|455827848|FG002|Overall Study|Lost to Follow-up|0|||
126691958|NCT01960855|455827849|FG003|Overall Study|Lost to Follow-up|0|||
126691959|NCT01960855|455827850|FG004|Overall Study|Lost to Follow-up|2|||
126691960|NCT02058147|455827851|FG000|Overall Study|Randomized but not treated|0|||
126691961|NCT02058147|455827852|FG001|Overall Study|Randomized but not treated|0|||
126691962|NCT02058147|455827853|FG002|Overall Study|Randomized but not treated|1|||
126691963|NCT02058147|455827851|FG000|Overall Study|Adverse Event|12|||
126691964|NCT02058147|455827852|FG001|Overall Study|Adverse Event|9|||
126691965|NCT02058147|455827853|FG002|Overall Study|Adverse Event|21|||
126691966|NCT02058147|455827851|FG000|Overall Study|Lack of Efficacy|1|||
126691967|NCT02058147|455827852|FG001|Overall Study|Lack of Efficacy|0|||
126691968|NCT02058147|455827853|FG002|Overall Study|Lack of Efficacy|3|||
126691969|NCT02058147|455827851|FG000|Overall Study|Poor compliance to protocol|8|||
126691970|NCT02058147|455827852|FG001|Overall Study|Poor compliance to protocol|9|||
126691971|NCT02058147|455827853|FG002|Overall Study|Poor compliance to protocol|4|||
126691972|NCT02058147|455827851|FG000|Overall Study|Other than specified|8|||
126691973|NCT02058147|455827852|FG001|Overall Study|Other than specified|9|||
126691974|NCT02058147|455827853|FG002|Overall Study|Other than specified|0|||
126691975|NCT00130286|455827858|FG000|Overall Study|Withdrawal by Subject|0|||
126691976|NCT00130286|455827859|FG001|Overall Study|Withdrawal by Subject|1|||
126691977|NCT00130286|455827860|FG002|Overall Study|Withdrawal by Subject|2|||
126444601|NCT02999672|454926629|FG000|Overall Study|Study Terminated by Sponsor|0|||
126444602|NCT02999672|454926630|FG001|Overall Study|Study Terminated by Sponsor|1|||
126444603|NCT02999672|454926629|FG000|Overall Study|Progressive Disease|9|||
126444604|NCT02999672|454926630|FG001|Overall Study|Progressive Disease|5|||
126444605|NCT02999672|454926629|FG000|Overall Study|Adverse Event|4|||
126444606|NCT02999672|454926630|FG001|Overall Study|Adverse Event|0|||
126444607|NCT02194985|454926633|FG000|Overall Study|Adverse Event|1|||
126444608|NCT02194985|454926633|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
126444609|NCT02194985|454926633|FG000|Overall Study|Physician Decision|4|||
126444610|NCT02194985|454926633|FG000|Overall Study|Lost to Follow-up|1|||
126444611|NCT02194985|454926633|FG000|Overall Study|Withdrawal by Subject|2|||
126444612|NCT02561832|454926634|FG000|Overall Study|Withdrawal by Subject|1|||
126691978|NCT00130286|455827861|FG003|Overall Study|Withdrawal by Subject|2|||
126691979|NCT00130286|455827858|FG000|Overall Study|Adverse Event|0|||
126691980|NCT00130286|455827859|FG001|Overall Study|Adverse Event|0|||
126444613|NCT02561832|454926635|FG001|Overall Study|Withdrawal by Subject|1|||
126444614|NCT02561832|454926634|FG000|Overall Study|Adverse Event|3|||
126444615|NCT02561832|454926635|FG001|Overall Study|Adverse Event|0|||
126691981|NCT00130286|455827860|FG002|Overall Study|Adverse Event|2|||
126691982|NCT00130286|455827861|FG003|Overall Study|Adverse Event|0|||
126691983|NCT00130286|455827858|FG000|Overall Study|Missing lab specimens|0|||
126691984|NCT00130286|455827859|FG001|Overall Study|Missing lab specimens|2|||
126691985|NCT00130286|455827860|FG002|Overall Study|Missing lab specimens|0|||
126691986|NCT00130286|455827861|FG003|Overall Study|Missing lab specimens|0|||
126691987|NCT03604445|455827862|FG000|Overall Study|Death|0|||
126691988|NCT03604445|455827863|FG001|Overall Study|Death|0|||
126691989|NCT03604445|455827864|FG002|Overall Study|Death|0|||
126691990|NCT03604445|455827865|FG003|Overall Study|Death|0|||
126691991|NCT03604445|455827866|FG004|Overall Study|Death|0|||
126691992|NCT03604445|455827867|FG005|Overall Study|Death|0|||
126691993|NCT03604445|455827868|FG006|Overall Study|Death|0|||
126691994|NCT03604445|455827869|FG007|Overall Study|Death|0|||
126444616|NCT02561832|454926634|FG000|Overall Study|Disease progression|3|||
126444617|NCT02561832|454926635|FG001|Overall Study|Disease progression|3|||
126444618|NCT03048578|454926637|FG000|Overall Study|Withdrawal by Subject|5|||
126444619|NCT03048578|454926638|FG001|Overall Study|Withdrawal by Subject|6|||
126444620|NCT03048578|454926637|FG000|Overall Study|Lost to Follow-up|22|||
126444621|NCT03048578|454926638|FG001|Overall Study|Lost to Follow-up|10|||
126444622|NCT03048578|454926637|FG000|Overall Study|Adverse Event|1|||
126444623|NCT03048578|454926638|FG001|Overall Study|Adverse Event|2|||
126444624|NCT03048578|454926637|FG000|Overall Study|Terminated|3|||
126444625|NCT03048578|454926638|FG001|Overall Study|Terminated|2|||
126444626|NCT00996333|454926643|FG000|Overall Study|Screen failure|1|||
126444627|NCT00996333|454926643|FG000|Overall Study|Withdrawal by Subject|1|||
126444628|NCT00996333|454926643|FG000|Overall Study|Death|4|||
126444629|NCT00996333|454926643|FG000|Overall Study|Adverse Event|1|||
126444630|NCT00996333|454926643|FG000|Overall Study|Physician Decision|1|||
126444631|NCT00996333|454926643|FG000|Overall Study|Other|5|||
126444632|NCT01301027|454926645|FG000|Overall Study|Physician Decision|2|||
126444633|NCT01301027|454926646|FG001|Overall Study|Physician Decision|0|||
126444634|NCT01301027|454926645|FG000|Overall Study|Withdrawal by Subject|2|||
126444635|NCT01301027|454926646|FG001|Overall Study|Withdrawal by Subject|3|||
126444636|NCT01301027|454926645|FG000|Overall Study|Adverse Event|0|||
126444637|NCT01301027|454926646|FG001|Overall Study|Adverse Event|2|||
126444638|NCT01301027|454926645|FG000|Overall Study|Fracture|1|||
126444639|NCT01301027|454926646|FG001|Overall Study|Fracture|3|||
126444640|NCT01301027|454926645|FG000|Overall Study|Transplant|0|||
126444641|NCT01301027|454926646|FG001|Overall Study|Transplant|2|||
126444642|NCT01301027|454926645|FG000|Overall Study|Volume Overload|3|||
126444643|NCT01301027|454926646|FG001|Overall Study|Volume Overload|0|||
126444644|NCT03566485|454926649|FG000|Overall Study|Disease progression|5|||
126444645|NCT03566485|454926650|FG001|Overall Study|Disease progression|4|||
126444646|NCT03566485|454926649|FG000|Overall Study|Clinical progression|0|||
126444647|NCT03566485|454926650|FG001|Overall Study|Clinical progression|1|||
126444648|NCT03566485|454926649|FG000|Overall Study|Toxicity|0|||
126444649|NCT03566485|454926650|FG001|Overall Study|Toxicity|2|||
126444650|NCT04999852|454926651|FG000|Overall Study|Withdrawal by Subject|11|||
126444651|NCT04999852|454926652|FG001|Overall Study|Withdrawal by Subject|1|||
126444652|NCT04999852|454926651|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
126444653|NCT04999852|454926652|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
126444654|NCT04939415|454926653|FG000|Overall Study|Withdrawal by Subject|1|||
126444655|NCT04939415|454926654|FG001|Overall Study|Withdrawal by Subject|3|||
126444656|NCT04939415|454926653|FG000|Overall Study|Lost to Follow-up|0|||
126444657|NCT04939415|454926654|FG001|Overall Study|Lost to Follow-up|2|||
126444658|NCT03399552|454926656|FG000|Overall Study|No evidence of disease|1|||
126444659|NCT03399552|454926656|FG000|Overall Study|Unevaluable|1|||
126444660|NCT01931566|454926657|FG000|Overall Study|Randomized But Not Treated|6|||
126444661|NCT01931566|454926658|FG001|Overall Study|Randomized But Not Treated|9|||
126444662|NCT01931566|454926659|FG002|Overall Study|Randomized But Not Treated|14|||
126444663|NCT01931566|454926657|FG000|Overall Study|Adverse Event|37|||
126444664|NCT01931566|454926658|FG001|Overall Study|Adverse Event|167|||
126444665|NCT01931566|454926659|FG002|Overall Study|Adverse Event|132|||
126444666|NCT01931566|454926657|FG000|Overall Study|Major Protocol Deviation|5|||
126444667|NCT01931566|454926658|FG001|Overall Study|Major Protocol Deviation|14|||
126444668|NCT01931566|454926659|FG002|Overall Study|Major Protocol Deviation|21|||
126691995|NCT03604445|455827870|FG008|Overall Study|Death|1|||
126691996|NCT03604445|455827862|FG000|Overall Study|Withdrawal by Subject|0|||
126691997|NCT03604445|455827863|FG001|Overall Study|Withdrawal by Subject|0|||
126691998|NCT03604445|455827864|FG002|Overall Study|Withdrawal by Subject|0|||
126444669|NCT01931566|454926657|FG000|Overall Study|Lost to Follow-up|3|||
126444670|NCT01931566|454926658|FG001|Overall Study|Lost to Follow-up|26|||
126444671|NCT01931566|454926659|FG002|Overall Study|Lost to Follow-up|23|||
126444672|NCT01931566|454926657|FG000|Overall Study|Voluntary Withdrawal|78|||
126444673|NCT01931566|454926658|FG001|Overall Study|Voluntary Withdrawal|245|||
126444674|NCT01931566|454926659|FG002|Overall Study|Voluntary Withdrawal|225|||
126444675|NCT01931566|454926657|FG000|Overall Study|Study Termination|289|||
126444676|NCT01931566|454926658|FG001|Overall Study|Study Termination|968|||
126444677|NCT01931566|454926659|FG002|Overall Study|Study Termination|1037|||
126444678|NCT01931566|454926657|FG000|Overall Study|Reason Not Specified|11|||
126444679|NCT01931566|454926658|FG001|Overall Study|Reason Not Specified|47|||
126444680|NCT01931566|454926659|FG002|Overall Study|Reason Not Specified|53|||
126444681|NCT01931566|454926657|FG000|Overall Study|Missing|0|||
126444682|NCT01931566|454926658|FG001|Overall Study|Missing|0|||
126444683|NCT01931566|454926659|FG002|Overall Study|Missing|1|||
126444684|NCT00760617|454926663|FG000|Overall Study|Adverse Event|5|||
126444685|NCT00760617|454926664|FG001|Overall Study|Adverse Event|2|||
126691999|NCT03604445|455827865|FG003|Overall Study|Withdrawal by Subject|0|||
126692000|NCT03604445|455827866|FG004|Overall Study|Withdrawal by Subject|0|||
126692001|NCT03604445|455827867|FG005|Overall Study|Withdrawal by Subject|0|||
126692002|NCT03604445|455827868|FG006|Overall Study|Withdrawal by Subject|1|||
126692003|NCT03604445|455827869|FG007|Overall Study|Withdrawal by Subject|0|||
126692004|NCT03604445|455827870|FG008|Overall Study|Withdrawal by Subject|0|||
126692005|NCT03604445|455827862|FG000|Overall Study|Missing visit|0|||
126692006|NCT03604445|455827863|FG001|Overall Study|Missing visit|0|||
126692007|NCT03604445|455827864|FG002|Overall Study|Missing visit|0|||
126692008|NCT03604445|455827865|FG003|Overall Study|Missing visit|0|||
126692009|NCT03604445|455827866|FG004|Overall Study|Missing visit|0|||
126692010|NCT03604445|455827867|FG005|Overall Study|Missing visit|1|||
126692011|NCT03604445|455827868|FG006|Overall Study|Missing visit|0|||
126692012|NCT03604445|455827869|FG007|Overall Study|Missing visit|1|||
126692013|NCT03604445|455827870|FG008|Overall Study|Missing visit|0|||
126692014|NCT03604445|455827862|FG000|Overall Study|Adverse Event|0|||
126692015|NCT03604445|455827863|FG001|Overall Study|Adverse Event|0|||
126355535|NCT05558410|454593039|FG002|Overall Study|Other non-compliance|2|||
126355536|NCT05558410|454593037|FG000|Overall Study|Sponsor Decision|1|||
126355537|NCT05558410|454593038|FG001|Overall Study|Sponsor Decision|0|||
126355538|NCT05558410|454593039|FG002|Overall Study|Sponsor Decision|0|||
126355539|NCT05558410|454593037|FG000|Overall Study|Other|1|||
126355540|NCT05558410|454593038|FG001|Overall Study|Other|0|||
126355541|NCT05558410|454593039|FG002|Overall Study|Other|1|||
126355542|NCT02400580|454593040|FG000|Overall Study|Withdrawal by Subject|1|||
126355543|NCT02400580|454593041|FG001|Overall Study|Withdrawal by Subject|1|||
126355544|NCT02400580|454593040|FG000|Overall Study|Adverse Event|1|||
126355545|NCT02400580|454593041|FG001|Overall Study|Adverse Event|0|||
126355546|NCT00965094|454593042|FG000|Overall Study|Adverse Event|5|||
126355547|NCT00965094|454593043|FG001|Overall Study|Adverse Event|0|||
126355548|NCT00965094|454593042|FG000|Overall Study|Lost to Follow-up|0|||
126355549|NCT00965094|454593043|FG001|Overall Study|Lost to Follow-up|1|||
126355550|NCT01336972|454593044|FG000|Overall Study|Adverse Event|1|||
126355551|NCT01336972|454593045|FG001|Overall Study|Adverse Event|1|||
126355552|NCT01336972|454593046|FG002|Overall Study|Adverse Event|0|||
126355553|NCT04433975|454593052|FG000|1-month Follow Up|Withdrawal by Subject|1|||
126355554|NCT04433975|454593053|FG001|1-month Follow Up|Withdrawal by Subject|1|||
126355555|NCT04433975|454593052|FG000|1-month Follow Up|Lost to Follow-up|21|||
126355556|NCT04433975|454593053|FG001|1-month Follow Up|Lost to Follow-up|25|||
126355557|NCT04433975|454593052|FG000|3-month Follow Up|Lost to Follow-up|20|||
126355558|NCT04433975|454593053|FG001|3-month Follow Up|Lost to Follow-up|24|||
126355559|NCT04433975|454593052|FG000|3-month Follow Up|Death|1|||
126355560|NCT04433975|454593053|FG001|3-month Follow Up|Death|0|||
126355561|NCT04433975|454593052|FG000|3-month Follow Up|Withdrawal by Subject|2|||
126355562|NCT04433975|454593053|FG001|3-month Follow Up|Withdrawal by Subject|0|||
126355563|NCT04433975|454593052|FG000|6-month Follow Up|Lost to Follow-up|23|||
126355564|NCT04433975|454593053|FG001|6-month Follow Up|Lost to Follow-up|28|||
126355565|NCT04433975|454593052|FG000|6-month Follow Up|Withdrawal by Subject|1|||
126355566|NCT04433975|454593053|FG001|6-month Follow Up|Withdrawal by Subject|1|||
126355567|NCT04433975|454593052|FG000|9-month Follow Up|Lost to Follow-up|27|||
126355568|NCT04433975|454593053|FG001|9-month Follow Up|Lost to Follow-up|36|||
126355569|NCT04433975|454593052|FG000|9-month Follow Up|Death|0|||
126355570|NCT04433975|454593053|FG001|9-month Follow Up|Death|1|||
126355571|NCT04433975|454593052|FG000|12-month Follow Up|Lost to Follow-up|27|||
126355572|NCT04433975|454593053|FG001|12-month Follow Up|Lost to Follow-up|31|||
126355573|NCT04606771|454593054|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
126355574|NCT04606771|454593055|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
126355575|NCT04606771|454593054|FG000|Overall Study|Death|5|||
126355576|NCT04606771|454593055|FG001|Overall Study|Death|6|||
126355577|NCT04606771|454593054|FG000|Overall Study|Wrong randomisation|0|||
126355578|NCT04606771|454593055|FG001|Overall Study|Wrong randomisation|1|||
126355579|NCT04392635|454593058|FG000|Overall Study|Lost to Follow-up|0|||
126355580|NCT04392635|454593059|FG001|Overall Study|Lost to Follow-up|1|||
126355581|NCT02030418|454593060|FG000|Overall Study|Death|78|||
126355582|NCT02030418|454593060|FG000|Overall Study|Missed 12-Month Visit|9|||
126692016|NCT03604445|455827864|FG002|Overall Study|Adverse Event|0|||
126692017|NCT03604445|455827865|FG003|Overall Study|Adverse Event|1|||
126692018|NCT03604445|455827866|FG004|Overall Study|Adverse Event|0|||
126770399|NCT02575807|456112471|FG002|Overall Study|Terminated due to physician decision|1|||
126355583|NCT02030418|454593060|FG000|Overall Study|Withdrawn|57|||
126355584|NCT04149353|454593064|FG000|Overall Study|Study terminated|1|||
126355585|NCT00887588|454593066|FG000|Core Period|Death|1|||
126355586|NCT00887588|454593067|FG001|Core Period|Death|1|||
126355587|NCT00887588|454593066|FG000|Core Period|Lost to Follow-up|3|||
126355588|NCT00887588|454593067|FG001|Core Period|Lost to Follow-up|1|||
126355589|NCT00887588|454593066|FG000|Core Period|Withdrawal by Subject|6|||
126355590|NCT00887588|454593067|FG001|Core Period|Withdrawal by Subject|8|||
126355591|NCT00887588|454593066|FG000|Core Period|Adverse Event|9|||
126692019|NCT03604445|455827867|FG005|Overall Study|Adverse Event|0|||
126692020|NCT03604445|455827868|FG006|Overall Study|Adverse Event|0|||
126692021|NCT03604445|455827869|FG007|Overall Study|Adverse Event|0|||
126692022|NCT03604445|455827870|FG008|Overall Study|Adverse Event|1|||
126692023|NCT01360645|455827875|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
126692024|NCT01360645|455827876|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
126692025|NCT01360645|455827877|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
126692026|NCT01360645|455827878|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
126692027|NCT01360645|455827875|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
126692028|NCT01360645|455827876|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
126692029|NCT01360645|455827877|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
126692030|NCT01360645|455827878|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
126692031|NCT01360645|455827875|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
126692032|NCT01360645|455827876|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
126692033|NCT01360645|455827877|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
126692034|NCT01360645|455827878|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
126692035|NCT01360645|455827875|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
126692036|NCT01360645|455827876|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
126692037|NCT01360645|455827877|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
126692038|NCT01360645|455827878|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
126692039|NCT01360645|455827875|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
126692040|NCT01360645|455827876|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
126444686|NCT00760617|454926665|FG002|Overall Study|Adverse Event|0|||
126444687|NCT00760617|454926663|FG000|Overall Study|Lost to Follow-up|0|||
126444688|NCT00760617|454926664|FG001|Overall Study|Lost to Follow-up|0|||
126444689|NCT00760617|454926665|FG002|Overall Study|Lost to Follow-up|5|||
126444690|NCT04625101|454926666|FG000|Overall Study|Withdrawal by Subject|0|||
126444691|NCT04625101|454926667|FG001|Overall Study|Withdrawal by Subject|1|||
126444692|NCT04625101|454926666|FG000|Overall Study|Protocol Deviation|1|||
126444693|NCT04625101|454926667|FG001|Overall Study|Protocol Deviation|0|||
126444694|NCT01160822|454926675|FG000|Overall Study|Adverse Event|0|||
126444695|NCT01160822|454926676|FG001|Overall Study|Adverse Event|0|||
126444696|NCT01160822|454926677|FG002|Overall Study|Adverse Event|0|||
126444697|NCT01160822|454926678|FG003|Overall Study|Adverse Event|0|||
126444698|NCT01160822|454926679|FG004|Overall Study|Adverse Event|1|||
126444699|NCT01160822|454926680|FG005|Overall Study|Adverse Event|2|||
126444700|NCT01160822|454926681|FG006|Overall Study|Adverse Event|5|||
126444701|NCT01160822|454926675|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126444702|NCT01160822|454926676|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126444703|NCT01160822|454926677|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126444704|NCT01160822|454926678|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
126444705|NCT01160822|454926679|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
126444706|NCT01160822|454926680|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
126444707|NCT01160822|454926681|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
126444708|NCT01160822|454926675|FG000|Overall Study|Withdrawal by Subject|0|||
126444709|NCT01160822|454926676|FG001|Overall Study|Withdrawal by Subject|0|||
126444710|NCT01160822|454926677|FG002|Overall Study|Withdrawal by Subject|0|||
126444711|NCT01160822|454926678|FG003|Overall Study|Withdrawal by Subject|0|||
126444712|NCT01160822|454926679|FG004|Overall Study|Withdrawal by Subject|0|||
126444713|NCT01160822|454926680|FG005|Overall Study|Withdrawal by Subject|0|||
126444714|NCT01160822|454926681|FG006|Overall Study|Withdrawal by Subject|1|||
126444715|NCT01160822|454926675|FG000|Overall Study|Lost to Follow-up|0|||
126444716|NCT01160822|454926676|FG001|Overall Study|Lost to Follow-up|0|||
126444717|NCT01160822|454926677|FG002|Overall Study|Lost to Follow-up|0|||
126444718|NCT01160822|454926678|FG003|Overall Study|Lost to Follow-up|0|||
126444719|NCT01160822|454926679|FG004|Overall Study|Lost to Follow-up|1|||
126444720|NCT01160822|454926680|FG005|Overall Study|Lost to Follow-up|0|||
126444721|NCT01160822|454926681|FG006|Overall Study|Lost to Follow-up|0|||
126444722|NCT01160822|454926675|FG000|Overall Study|Administrative problems|0|||
126444723|NCT01160822|454926676|FG001|Overall Study|Administrative problems|0|||
126444724|NCT01160822|454926677|FG002|Overall Study|Administrative problems|0|||
126444725|NCT01160822|454926678|FG003|Overall Study|Administrative problems|0|||
126444726|NCT01160822|454926679|FG004|Overall Study|Administrative problems|1|||
126692041|NCT01360645|455827877|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
126692042|NCT01360645|455827878|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
126692043|NCT01360645|455827875|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
126692044|NCT01360645|455827876|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
126444727|NCT01160822|454926680|FG005|Overall Study|Administrative problems|0|||
126444728|NCT01160822|454926681|FG006|Overall Study|Administrative problems|0|||
126444729|NCT01160822|454926675|FG000|Overall Study|Protocol deviation|0|||
126444730|NCT01160822|454926676|FG001|Overall Study|Protocol deviation|0|||
126444731|NCT01160822|454926677|FG002|Overall Study|Protocol deviation|0|||
126444732|NCT01160822|454926678|FG003|Overall Study|Protocol deviation|0|||
126692045|NCT01360645|455827877|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
126692046|NCT01360645|455827878|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
126692047|NCT01360645|455827875|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
126692048|NCT01360645|455827876|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
126692049|NCT01360645|455827877|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
126692050|NCT01360645|455827878|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
126692051|NCT01360645|455827875|FG000|Phase B (6 Weeks)|Adverse Event|0|||
126692052|NCT01360645|455827876|FG001|Phase B (6 Weeks)|Adverse Event|6|||
126692053|NCT01360645|455827877|FG002|Phase B (6 Weeks)|Adverse Event|0|||
126692054|NCT01360645|455827878|FG003|Phase B (6 Weeks)|Adverse Event|0|||
126692055|NCT01360645|455827875|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
126692056|NCT01360645|455827876|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
126692057|NCT01360645|455827877|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
126692058|NCT01360645|455827878|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
126692059|NCT01360645|455827875|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
126692060|NCT01360645|455827876|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
126692061|NCT01360645|455827877|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
126692062|NCT01360645|455827878|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
126692063|NCT01360645|455827875|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
126692064|NCT01360645|455827876|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
126692065|NCT01360645|455827877|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
126692066|NCT01360645|455827878|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
126692067|NCT01360645|455827875|FG000|Phase A+|Lost to Follow-up|0|||
126692068|NCT01360645|455827876|FG001|Phase A+|Lost to Follow-up|0|||
126692069|NCT01360645|455827877|FG002|Phase A+|Lost to Follow-up|0|||
126355592|NCT00887588|454593067|FG001|Core Period|Adverse Event|11|||
126355593|NCT00887588|454593066|FG000|Extension Period|Adverse Event|4|||
126444733|NCT01160822|454926679|FG004|Overall Study|Protocol deviation|2|||
126444734|NCT01160822|454926680|FG005|Overall Study|Protocol deviation|0|||
126692070|NCT01360645|455827878|FG003|Phase A+|Lost to Follow-up|7|||
126355594|NCT00887588|454593067|FG001|Extension Period|Adverse Event|4|||
126355595|NCT00887588|454593066|FG000|Extension Period|Death|0|||
126355596|NCT00887588|454593067|FG001|Extension Period|Death|1|||
126355597|NCT00887588|454593066|FG000|Extension Period|Protocol deviation|1|||
126355598|NCT00887588|454593067|FG001|Extension Period|Protocol deviation|0|||
126355599|NCT00887588|454593066|FG000|Extension Period|Lost to Follow-up|1|||
126355600|NCT00887588|454593067|FG001|Extension Period|Lost to Follow-up|0|||
126444735|NCT01160822|454926681|FG006|Overall Study|Protocol deviation|0|||
126692071|NCT01360645|455827875|FG000|Phase A+|Adverse Event|0|||
126692072|NCT01360645|455827876|FG001|Phase A+|Adverse Event|0|||
126692073|NCT01360645|455827877|FG002|Phase A+|Adverse Event|0|||
126692074|NCT01360645|455827878|FG003|Phase A+|Adverse Event|2|||
126692075|NCT01360645|455827875|FG000|Phase A+|Met Withdrawal Criteria|0|||
126355601|NCT03753542|454593070|FG000|Overall Study|Lost to Follow-up|9|||
126355602|NCT03753542|454593071|FG001|Overall Study|Lost to Follow-up|14|||
126355603|NCT06100250|454593072|FG000|Overall Study|Lost to Follow-up|5|||
126444736|NCT04717336|454926685|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
126692076|NCT01360645|455827876|FG001|Phase A+|Met Withdrawal Criteria|0|||
126692077|NCT01360645|455827877|FG002|Phase A+|Met Withdrawal Criteria|0|||
126692078|NCT01360645|455827878|FG003|Phase A+|Met Withdrawal Criteria|4|||
126692079|NCT01360645|455827875|FG000|Phase A+|Physician Decision|0|||
126692080|NCT01360645|455827876|FG001|Phase A+|Physician Decision|0|||
126692081|NCT01360645|455827877|FG002|Phase A+|Physician Decision|0|||
126692082|NCT01360645|455827878|FG003|Phase A+|Physician Decision|2|||
126692083|NCT01360645|455827875|FG000|Phase A+|Withdrawal by Subject|0|||
126692084|NCT01360645|455827876|FG001|Phase A+|Withdrawal by Subject|0|||
126692085|NCT01360645|455827877|FG002|Phase A+|Withdrawal by Subject|0|||
126692086|NCT01360645|455827878|FG003|Phase A+|Withdrawal by Subject|5|||
126692087|NCT01360645|455827875|FG000|Phase A+|Protocol Deviation|0|||
126692088|NCT01360645|455827876|FG001|Phase A+|Protocol Deviation|0|||
126692089|NCT01360645|455827877|FG002|Phase A+|Protocol Deviation|0|||
126692090|NCT01360645|455827878|FG003|Phase A+|Protocol Deviation|4|||
126692091|NCT01014585|455827879|FG000|Overall Study|Adverse Event|0|||
126692092|NCT01014585|455827880|FG001|Overall Study|Adverse Event|2|||
126760489|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
126760490|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
126760491|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
126760492|NCT03556202|456073783|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
126760493|NCT03556202|456073784|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
126760494|NCT03556202|456073785|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
126760495|NCT01539512|456073786|FG000|Overall Study|Adverse Event|9|||
126760496|NCT01539512|456073787|FG001|Overall Study|Adverse Event|7|||
126760497|NCT01539512|456073786|FG000|Overall Study|Physician Decision|1|||
126760498|NCT01539512|456073787|FG001|Overall Study|Physician Decision|1|||
126760499|NCT01539512|456073786|FG000|Overall Study|Withdrawal by Subject|12|||
126760500|NCT01539512|456073787|FG001|Overall Study|Withdrawal by Subject|5|||
126760501|NCT01539512|456073786|FG000|Overall Study|Richter's Transformation|1|||
126760502|NCT01539512|456073787|FG001|Overall Study|Richter's Transformation|0|||
126760503|NCT04479358|456073794|FG000|Overall Study|Withdrawal by Subject|0|||
126355604|NCT02021318|454593073|FG000|Overall Study|Adverse Event|2|||
126355605|NCT02021318|454593074|FG001|Overall Study|Adverse Event|1|||
126355606|NCT02021318|454593073|FG000|Overall Study|Death|33|||
126355607|NCT02021318|454593074|FG001|Overall Study|Death|34|||
126355608|NCT02021318|454593073|FG000|Overall Study|Lost to Follow-up|3|||
126355609|NCT02021318|454593074|FG001|Overall Study|Lost to Follow-up|3|||
126355610|NCT02021318|454593073|FG000|Overall Study|Progressive Disease|0|||
126355611|NCT02021318|454593074|FG001|Overall Study|Progressive Disease|1|||
126355612|NCT02021318|454593073|FG000|Overall Study|Withdrawal by Subject|30|||
126355613|NCT02021318|454593074|FG001|Overall Study|Withdrawal by Subject|18|||
126355614|NCT02021318|454593073|FG000|Overall Study|Physician Decision|3|||
126355615|NCT02021318|454593074|FG001|Overall Study|Physician Decision|3|||
126355616|NCT02021318|454593073|FG000|Overall Study|Miscellaneous|2|||
126692093|NCT01014585|455827881|FG002|Overall Study|Adverse Event|0|||
126692094|NCT01014585|455827882|FG003|Overall Study|Adverse Event|3|||
126692095|NCT01014585|455827879|FG000|Overall Study|Withdrawal by Subject|2|||
126692096|NCT01014585|455827880|FG001|Overall Study|Withdrawal by Subject|0|||
126692097|NCT01014585|455827881|FG002|Overall Study|Withdrawal by Subject|1|||
126692098|NCT01014585|455827882|FG003|Overall Study|Withdrawal by Subject|3|||
126692099|NCT01014585|455827879|FG000|Overall Study|Lost to Follow-up|0|||
126760504|NCT04479358|456073795|FG001|Overall Study|Withdrawal by Subject|0|||
126355617|NCT02021318|454593074|FG001|Overall Study|Miscellaneous|3|||
126355618|NCT00421993|454593076|FG000|Overall Study|Withdrawal by Subject|22|||
126355619|NCT00421993|454593077|FG001|Overall Study|Withdrawal by Subject|23|||
126355620|NCT00421993|454593078|FG002|Overall Study|Withdrawal by Subject|23|||
126692100|NCT01014585|455827880|FG001|Overall Study|Lost to Follow-up|0|||
126692101|NCT01014585|455827881|FG002|Overall Study|Lost to Follow-up|0|||
126760505|NCT04479358|456073796|FG002|Overall Study|Withdrawal by Subject|1|||
126760506|NCT04479358|456073797|FG003|Overall Study|Withdrawal by Subject|0|||
126355621|NCT00421993|454593079|FG003|Overall Study|Withdrawal by Subject|24|||
126760507|NCT04479358|456073798|FG004|Overall Study|Withdrawal by Subject|0|||
126760508|NCT04479358|456073799|FG005|Overall Study|Withdrawal by Subject|1|||
126760509|NCT01333501|456073800|FG000|Overall Study|Adverse Event|3|||
126355622|NCT00421993|454593076|FG000|Overall Study|Lost to Follow-up|18|||
126692102|NCT01014585|455827882|FG003|Overall Study|Lost to Follow-up|2|||
126692103|NCT01014585|455827879|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
126692104|NCT01014585|455827880|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
126692105|NCT01014585|455827881|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
126692106|NCT01014585|455827882|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
126692107|NCT04178772|455827886|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
126692108|NCT04178772|455827886|FG000|Overall Study|study terminated early due to COVID-19|7|||
126692109|NCT02817087|455827889|FG000|Overall Study|Withdrawal by Subject|2|||
126692110|NCT02817087|455827890|FG001|Overall Study|Withdrawal by Subject|0|||
126692111|NCT00508391|455827891|FG000|First Treatment|Withdrawal by Subject|6|||
126692112|NCT00508391|455827892|FG001|First Treatment|Withdrawal by Subject|3|||
126692113|NCT00508391|455827891|FG000|Second Treatment|Withdrawal by Subject|2|||
126692114|NCT00508391|455827892|FG001|Second Treatment|Withdrawal by Subject|0|||
126692115|NCT00802360|455827893|FG000|Overall Study|Stimulation failure|4|||
126692116|NCT00802360|455827894|FG001|Overall Study|Stimulation failure|0|||
126692117|NCT00802360|455827895|FG002|Overall Study|Stimulation failure|3|||
126355623|NCT00421993|454593077|FG001|Overall Study|Lost to Follow-up|19|||
126355624|NCT00421993|454593078|FG002|Overall Study|Lost to Follow-up|22|||
126355625|NCT00421993|454593079|FG003|Overall Study|Lost to Follow-up|20|||
126355626|NCT00421993|454593076|FG000|Overall Study|Adverse Event|11|||
126355627|NCT00421993|454593077|FG001|Overall Study|Adverse Event|1|||
126355628|NCT00421993|454593078|FG002|Overall Study|Adverse Event|6|||
126355629|NCT00421993|454593079|FG003|Overall Study|Adverse Event|4|||
126355630|NCT00421993|454593076|FG000|Overall Study|Protocol Violation|2|||
126355631|NCT00421993|454593077|FG001|Overall Study|Protocol Violation|2|||
126355632|NCT00421993|454593078|FG002|Overall Study|Protocol Violation|0|||
126355633|NCT00421993|454593079|FG003|Overall Study|Protocol Violation|1|||
126355634|NCT00421993|454593076|FG000|Overall Study|Lack of Efficacy|0|||
126355635|NCT00421993|454593077|FG001|Overall Study|Lack of Efficacy|3|||
126355636|NCT00421993|454593078|FG002|Overall Study|Lack of Efficacy|0|||
126355637|NCT00421993|454593079|FG003|Overall Study|Lack of Efficacy|5|||
126355638|NCT00421993|454593076|FG000|Overall Study|Pregnancy|0|||
126355639|NCT00421993|454593077|FG001|Overall Study|Pregnancy|1|||
126355640|NCT00421993|454593078|FG002|Overall Study|Pregnancy|1|||
126355641|NCT00421993|454593079|FG003|Overall Study|Pregnancy|2|||
126355642|NCT00421993|454593076|FG000|Overall Study|Subject transportation issues|0|||
126355643|NCT00421993|454593077|FG001|Overall Study|Subject transportation issues|0|||
126355644|NCT00421993|454593078|FG002|Overall Study|Subject transportation issues|0|||
126355645|NCT00421993|454593079|FG003|Overall Study|Subject transportation issues|1|||
126444737|NCT04717336|454926686|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
126692118|NCT00802360|455827896|FG003|Overall Study|Stimulation failure|3|||
126692119|NCT00802360|455827893|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
126692120|NCT00802360|455827894|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
126692121|NCT00802360|455827895|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
126692122|NCT00802360|455827896|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
126760510|NCT01333501|456073801|FG001|Overall Study|Adverse Event|1|||
126355646|NCT02015104|454593084|FG000|Overall Study|Withdrew consent after first dose drug|1|||
126355647|NCT02015104|454593085|FG001|Overall Study|Withdrew consent after first dose drug|0|||
126355648|NCT02015104|454593084|FG000|Overall Study|Withdrew consent prior to treatment|0|||
126355649|NCT02015104|454593085|FG001|Overall Study|Withdrew consent prior to treatment|1|||
126355650|NCT01030900|454593092|FG000|Overall Study|Not treated due to congestive heart failure|1|||
126355651|NCT01030900|454593092|FG000|Overall Study|Not treated due to rapid disease|1|||
126355652|NCT00441896|454593093|FG000|Overall Study|Withdrawal by Subject|0|||
126355653|NCT00441896|454593094|FG001|Overall Study|Withdrawal by Subject|0|||
126692123|NCT00802360|455827893|FG000|Overall Study|Cycle cancelled|0|||
126692124|NCT00802360|455827894|FG001|Overall Study|Cycle cancelled|1|||
126692125|NCT00802360|455827895|FG002|Overall Study|Cycle cancelled|1|||
126692126|NCT00802360|455827896|FG003|Overall Study|Cycle cancelled|1|||
126692127|NCT00802360|455827893|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
126692128|NCT00802360|455827894|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
126692129|NCT00802360|455827895|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
126692130|NCT00802360|455827896|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
126692131|NCT00802360|455827893|FG000|Overall Study|No positive serum pregnancy|17|||
126692132|NCT00802360|455827894|FG001|Overall Study|No positive serum pregnancy|20|||
126692133|NCT00802360|455827895|FG002|Overall Study|No positive serum pregnancy|14|||
126692134|NCT00802360|455827896|FG003|Overall Study|No positive serum pregnancy|10|||
126444738|NCT04717336|454926685|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
126444739|NCT04717336|454926686|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
126444740|NCT02116205|454926694|FG000|Overall Study|Withdrawal by Subject|2|||
126444741|NCT02116205|454926695|FG001|Overall Study|Withdrawal by Subject|4|||
126444742|NCT02116205|454926696|FG002|Overall Study|Withdrawal by Subject|1|||
126444743|NCT02116205|454926697|FG003|Overall Study|Withdrawal by Subject|3|||
126444744|NCT02116205|454926694|FG000|Overall Study|Lost to Follow-up|0|||
126444745|NCT02116205|454926695|FG001|Overall Study|Lost to Follow-up|2|||
126444746|NCT02116205|454926696|FG002|Overall Study|Lost to Follow-up|1|||
126444747|NCT02116205|454926697|FG003|Overall Study|Lost to Follow-up|2|||
126444748|NCT02116205|454926694|FG000|Overall Study|Physician Decision|0|||
126444749|NCT02116205|454926695|FG001|Overall Study|Physician Decision|1|||
126444750|NCT02116205|454926696|FG002|Overall Study|Physician Decision|1|||
126444751|NCT02116205|454926697|FG003|Overall Study|Physician Decision|1|||
126444752|NCT02116205|454926694|FG000|Overall Study|Exclusion criteria|0|||
126444753|NCT02116205|454926695|FG001|Overall Study|Exclusion criteria|0|||
126444754|NCT02116205|454926696|FG002|Overall Study|Exclusion criteria|1|||
126444755|NCT02116205|454926697|FG003|Overall Study|Exclusion criteria|0|||
126444756|NCT02541604|454926698|FG000|Overall Study|Death|6|||
126444757|NCT02541604|454926699|FG001|Overall Study|Death|5|||
126444758|NCT02541604|454926700|FG002|Overall Study|Death|7|||
126444759|NCT02541604|454926701|FG003|Overall Study|Death|2|||
126444760|NCT02541604|454926702|FG004|Overall Study|Death|9|||
126444761|NCT02541604|454926703|FG005|Overall Study|Death|8|||
126444762|NCT02541604|454926704|FG006|Overall Study|Death|9|||
126444763|NCT02541604|454926705|FG007|Overall Study|Death|9|||
126444764|NCT02541604|454926706|FG008|Overall Study|Death|3|||
126444765|NCT02541604|454926707|FG009|Overall Study|Death|4|||
126444766|NCT02541604|454926708|FG010|Overall Study|Death|2|||
126444767|NCT02541604|454926709|FG011|Overall Study|Death|3|||
126444768|NCT02541604|454926698|FG000|Overall Study|Lost to Follow-up|2|||
126444769|NCT02541604|454926699|FG001|Overall Study|Lost to Follow-up|0|||
126444770|NCT02541604|454926700|FG002|Overall Study|Lost to Follow-up|1|||
126444771|NCT02541604|454926701|FG003|Overall Study|Lost to Follow-up|0|||
126444772|NCT02541604|454926702|FG004|Overall Study|Lost to Follow-up|0|||
126444773|NCT02541604|454926703|FG005|Overall Study|Lost to Follow-up|1|||
126444774|NCT02541604|454926704|FG006|Overall Study|Lost to Follow-up|1|||
126444775|NCT02541604|454926705|FG007|Overall Study|Lost to Follow-up|0|||
126444776|NCT02541604|454926706|FG008|Overall Study|Lost to Follow-up|0|||
126444777|NCT02541604|454926707|FG009|Overall Study|Lost to Follow-up|0|||
126444778|NCT02541604|454926708|FG010|Overall Study|Lost to Follow-up|0|||
126444779|NCT02541604|454926709|FG011|Overall Study|Lost to Follow-up|0|||
126444780|NCT02541604|454926698|FG000|Overall Study|Withdrawal by Subject|2|||
126444781|NCT02541604|454926699|FG001|Overall Study|Withdrawal by Subject|0|||
126444782|NCT02541604|454926700|FG002|Overall Study|Withdrawal by Subject|1|||
126444783|NCT02541604|454926701|FG003|Overall Study|Withdrawal by Subject|0|||
126444784|NCT02541604|454926702|FG004|Overall Study|Withdrawal by Subject|1|||
126444785|NCT02541604|454926703|FG005|Overall Study|Withdrawal by Subject|1|||
126444786|NCT02541604|454926704|FG006|Overall Study|Withdrawal by Subject|0|||
126444787|NCT02541604|454926705|FG007|Overall Study|Withdrawal by Subject|0|||
126444788|NCT02541604|454926706|FG008|Overall Study|Withdrawal by Subject|1|||
126692135|NCT00802360|455827893|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
126444789|NCT02541604|454926707|FG009|Overall Study|Withdrawal by Subject|0|||
126444790|NCT02541604|454926708|FG010|Overall Study|Withdrawal by Subject|0|||
126444791|NCT02541604|454926709|FG011|Overall Study|Withdrawal by Subject|0|||
126444792|NCT02541604|454926698|FG000|Overall Study|Study Terminated by Sponsor|1|||
126692136|NCT00802360|455827894|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
126692137|NCT00802360|455827895|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
126692138|NCT00802360|455827896|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
126692139|NCT00802360|455827893|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
126444793|NCT02541604|454926699|FG001|Overall Study|Study Terminated by Sponsor|4|||
126444794|NCT02541604|454926700|FG002|Overall Study|Study Terminated by Sponsor|2|||
126444795|NCT02541604|454926701|FG003|Overall Study|Study Terminated by Sponsor|1|||
126444796|NCT02541604|454926702|FG004|Overall Study|Study Terminated by Sponsor|0|||
126444797|NCT02541604|454926703|FG005|Overall Study|Study Terminated by Sponsor|0|||
126692140|NCT00802360|455827894|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
126692141|NCT00802360|455827895|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
126692142|NCT00802360|455827896|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
126692143|NCT00802360|455827893|FG000|Overall Study|Other|2|||
126692144|NCT00802360|455827894|FG001|Overall Study|Other|3|||
126692145|NCT00802360|455827895|FG002|Overall Study|Other|6|||
126692146|NCT00802360|455827896|FG003|Overall Study|Other|3|||
126692147|NCT02041962|455827897|FG000|Overall Study|Lost Aetna Coverage|43|||
126355654|NCT00441896|454593095|FG002|Overall Study|Withdrawal by Subject|0|||
126355655|NCT00441896|454593096|FG003|Overall Study|Withdrawal by Subject|1|||
126355656|NCT00441896|454593097|FG004|Overall Study|Withdrawal by Subject|0|||
126355657|NCT00441896|454593098|FG005|Overall Study|Withdrawal by Subject|0|||
126355658|NCT00441896|454593099|FG006|Overall Study|Withdrawal by Subject|0|||
126355659|NCT00441896|454593100|FG007|Overall Study|Withdrawal by Subject|0|||
126355660|NCT00441896|454593101|FG008|Overall Study|Withdrawal by Subject|0|||
126355661|NCT00441896|454593102|FG009|Overall Study|Withdrawal by Subject|0|||
126355662|NCT00441896|454593093|FG000|Overall Study|Other|0|||
126355663|NCT00441896|454593094|FG001|Overall Study|Other|0|||
126355664|NCT00441896|454593095|FG002|Overall Study|Other|0|||
126355665|NCT00441896|454593096|FG003|Overall Study|Other|0|||
126355666|NCT00441896|454593097|FG004|Overall Study|Other|1|||
126355667|NCT00441896|454593098|FG005|Overall Study|Other|0|||
126355668|NCT00441896|454593099|FG006|Overall Study|Other|0|||
126355669|NCT00441896|454593100|FG007|Overall Study|Other|0|||
126355670|NCT00441896|454593101|FG008|Overall Study|Other|0|||
126355671|NCT00441896|454593102|FG009|Overall Study|Other|0|||
126355672|NCT01350973|454593103|FG000|Overall Study|Adverse Event|4|||
126355673|NCT01350973|454593104|FG001|Overall Study|Adverse Event|7|||
126355674|NCT01350973|454593105|FG002|Overall Study|Adverse Event|7|||
126355675|NCT01350973|454593103|FG000|Overall Study|Voluntary Withdrawal|2|||
126355676|NCT01350973|454593104|FG001|Overall Study|Voluntary Withdrawal|1|||
126355677|NCT01350973|454593105|FG002|Overall Study|Voluntary Withdrawal|1|||
126355678|NCT02638493|454593109|FG000|Overall Study|Inability to provide semen samples|2|||
126355679|NCT02638493|454593110|FG001|Overall Study|Inability to provide semen samples|0|||
126355680|NCT02638493|454593111|FG002|Overall Study|Inability to provide semen samples|0|||
126355681|NCT01033071|454593112|FG000|Overall Study|Adverse Event|28|||
126355682|NCT01033071|454593113|FG001|Overall Study|Adverse Event|51|||
126355683|NCT01033071|454593114|FG002|Overall Study|Adverse Event|26|||
126355684|NCT01033071|454593112|FG000|Overall Study|Protocol Violation|0|||
126355685|NCT01033071|454593113|FG001|Overall Study|Protocol Violation|2|||
126355686|NCT01033071|454593114|FG002|Overall Study|Protocol Violation|1|||
126355687|NCT01033071|454593112|FG000|Overall Study|Lost to Follow-up|4|||
126355688|NCT01033071|454593113|FG001|Overall Study|Lost to Follow-up|5|||
126355689|NCT01033071|454593114|FG002|Overall Study|Lost to Follow-up|5|||
126355690|NCT01033071|454593112|FG000|Overall Study|Withdrawal by Subject|17|||
126355691|NCT01033071|454593113|FG001|Overall Study|Withdrawal by Subject|14|||
126355692|NCT01033071|454593114|FG002|Overall Study|Withdrawal by Subject|11|||
126355693|NCT01033071|454593112|FG000|Overall Study|Lack of Efficacy|0|||
126355694|NCT01033071|454593113|FG001|Overall Study|Lack of Efficacy|1|||
126355695|NCT01033071|454593114|FG002|Overall Study|Lack of Efficacy|1|||
126355696|NCT01033071|454593112|FG000|Overall Study|Other|6|||
126355697|NCT01033071|454593113|FG001|Overall Study|Other|4|||
126355698|NCT01033071|454593114|FG002|Overall Study|Other|3|||
126355699|NCT00004859|454593117|FG000|Overall Study|Lack of Efficacy|43|||
126355700|NCT00004859|454593118|FG001|Overall Study|Lack of Efficacy|113|||
126355701|NCT00004859|454593117|FG000|Overall Study|Adverse Event|31|||
126355702|NCT00004859|454593118|FG001|Overall Study|Adverse Event|93|||
126692148|NCT02041962|455827898|FG001|Overall Study|Lost Aetna Coverage|40|||
126692149|NCT02041962|455827897|FG000|Overall Study|Death|1|||
126692150|NCT02041962|455827898|FG001|Overall Study|Death|1|||
126692151|NCT02041962|455827897|FG000|Overall Study|Lost to Follow-up|37|||
126692152|NCT02041962|455827898|FG001|Overall Study|Lost to Follow-up|32|||
126692153|NCT02041962|455827897|FG000|Overall Study|Withdrawal by Subject|0|||
126692154|NCT02041962|455827898|FG001|Overall Study|Withdrawal by Subject|11|||
126692155|NCT01225562|455827899|FG000|Overall Study|Withdrawal by Subject|52|||
126692156|NCT01225562|455827900|FG001|Overall Study|Withdrawal by Subject|50|||
126355703|NCT00004859|454593117|FG000|Overall Study|Death|5|||
126355704|NCT00004859|454593118|FG001|Overall Study|Death|5|||
126355705|NCT00004859|454593117|FG000|Overall Study|Withdrawal by Subject|7|||
126355706|NCT00004859|454593118|FG001|Overall Study|Withdrawal by Subject|33|||
126355707|NCT00004859|454593117|FG000|Overall Study|Protocol Violation|2|||
126355708|NCT00004859|454593118|FG001|Overall Study|Protocol Violation|2|||
126355709|NCT00004859|454593117|FG000|Overall Study|other disease|0|||
126355710|NCT00004859|454593118|FG001|Overall Study|other disease|3|||
126355711|NCT00004859|454593117|FG000|Overall Study|error|3|||
126355712|NCT00004859|454593118|FG001|Overall Study|error|1|||
126355713|NCT00004859|454593117|FG000|Overall Study|missing data|14|||
126355714|NCT00004859|454593118|FG001|Overall Study|missing data|11|||
126355715|NCT00004859|454593117|FG000|Overall Study|Other|13|||
126355716|NCT00004859|454593118|FG001|Overall Study|Other|21|||
126692157|NCT01225562|455827901|FG002|Overall Study|Withdrawal by Subject|52|||
126444798|NCT02541604|454926704|FG006|Overall Study|Study Terminated by Sponsor|0|||
126444799|NCT02541604|454926705|FG007|Overall Study|Study Terminated by Sponsor|0|||
126444800|NCT02541604|454926706|FG008|Overall Study|Study Terminated by Sponsor|0|||
126444801|NCT02541604|454926707|FG009|Overall Study|Study Terminated by Sponsor|0|||
126444802|NCT02541604|454926708|FG010|Overall Study|Study Terminated by Sponsor|0|||
126444803|NCT02541604|454926709|FG011|Overall Study|Study Terminated by Sponsor|0|||
126444804|NCT02541604|454926698|FG000|Overall Study|Medical condition may jeopardize safety|0|||
126444805|NCT02541604|454926699|FG001|Overall Study|Medical condition may jeopardize safety|0|||
126444806|NCT02541604|454926700|FG002|Overall Study|Medical condition may jeopardize safety|0|||
126444807|NCT02541604|454926701|FG003|Overall Study|Medical condition may jeopardize safety|0|||
126444808|NCT02541604|454926702|FG004|Overall Study|Medical condition may jeopardize safety|0|||
126444809|NCT02541604|454926703|FG005|Overall Study|Medical condition may jeopardize safety|0|||
126444810|NCT02541604|454926704|FG006|Overall Study|Medical condition may jeopardize safety|0|||
126444811|NCT02541604|454926705|FG007|Overall Study|Medical condition may jeopardize safety|1|||
126444812|NCT02541604|454926706|FG008|Overall Study|Medical condition may jeopardize safety|0|||
126444813|NCT02541604|454926707|FG009|Overall Study|Medical condition may jeopardize safety|0|||
126444814|NCT02541604|454926708|FG010|Overall Study|Medical condition may jeopardize safety|0|||
126444815|NCT02541604|454926709|FG011|Overall Study|Medical condition may jeopardize safety|0|||
126444816|NCT02752165|454926716|FG000|Overall Study|Withdrawal by Subject|6|||
126444817|NCT02752165|454926717|FG001|Overall Study|Withdrawal by Subject|6|||
126444818|NCT02752165|454926716|FG000|Overall Study|Protocol Violation|6|||
126444819|NCT02752165|454926717|FG001|Overall Study|Protocol Violation|5|||
126444820|NCT02752165|454926716|FG000|Overall Study|Lost to Follow-up|33|||
126760511|NCT01333501|456073800|FG000|Overall Study|Abnormal laboratory value|2|||
126760512|NCT01333501|456073801|FG001|Overall Study|Abnormal laboratory value|1|||
126760513|NCT01333501|456073800|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126760514|NCT01333501|456073801|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
126760515|NCT01333501|456073800|FG000|Overall Study|Withdrawn consent|3|||
126760516|NCT01333501|456073801|FG001|Overall Study|Withdrawn consent|12|||
126760517|NCT00674440|456073802|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
126760518|NCT00674440|456073802|FG000|Overall Study|did not have surgery, so unevaluable|7|||
126760519|NCT00674440|456073802|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
126760520|NCT02370173|456073803|FG000|Overall Study|Protocol Violation|1|||
126760521|NCT02370173|456073804|FG001|Overall Study|Protocol Violation|1|||
126760522|NCT02370173|456073803|FG000|Overall Study|Withdrawal by Subject|2|||
126760523|NCT02370173|456073804|FG001|Overall Study|Withdrawal by Subject|2|||
126444821|NCT02752165|454926717|FG001|Overall Study|Lost to Follow-up|38|||
126444822|NCT01704599|454926719|FG000|Overall Study|Adverse Event|1|||
126444823|NCT02840461|454926720|FG000|Overall Study|Adverse Event|1|||
126444824|NCT02840461|454926721|FG001|Overall Study|Adverse Event|5|||
126444825|NCT02840461|454926722|FG002|Overall Study|Adverse Event|3|||
126444826|NCT02840461|454926720|FG000|Overall Study|Lost to Follow-up|10|||
126444827|NCT02840461|454926721|FG001|Overall Study|Lost to Follow-up|7|||
126444828|NCT02840461|454926722|FG002|Overall Study|Lost to Follow-up|6|||
126444829|NCT02840461|454926720|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
126444830|NCT02840461|454926721|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
126444831|NCT02840461|454926722|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
126444832|NCT02840461|454926720|FG000|Overall Study|Protocol Violation|2|||
126444833|NCT02840461|454926721|FG001|Overall Study|Protocol Violation|3|||
126444834|NCT02840461|454926722|FG002|Overall Study|Protocol Violation|1|||
126444835|NCT02840461|454926720|FG000|Overall Study|Withdrawal by Subject|10|||
126444836|NCT02840461|454926721|FG001|Overall Study|Withdrawal by Subject|6|||
126444837|NCT02840461|454926722|FG002|Overall Study|Withdrawal by Subject|2|||
126444838|NCT02840461|454926720|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
126444839|NCT02840461|454926721|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
126444840|NCT02840461|454926722|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
126444841|NCT01737502|454926725|FG000|Phase I|Disease progression|2|||
126444842|NCT01737502|454926726|FG001|Phase I|Disease progression|3|||
126444843|NCT01737502|454926725|FG000|Phase I|Complicating disease|1|||
126444844|NCT01737502|454926726|FG001|Phase I|Complicating disease|0|||
126444845|NCT01737502|454926725|FG000|Phase II|Adverse Event|0|||
126444846|NCT01737502|454926726|FG001|Phase II|Adverse Event|3|||
126444847|NCT01737502|454926725|FG000|Phase II|Disease progression|0|||
126444848|NCT01737502|454926726|FG001|Phase II|Disease progression|18|||
126444849|NCT01737502|454926725|FG000|Phase II|Death|0|||
126444850|NCT01737502|454926726|FG001|Phase II|Death|1|||
126444851|NCT01737502|454926725|FG000|Phase II|Transition to hospice care|0|||
126444852|NCT01737502|454926726|FG001|Phase II|Transition to hospice care|1|||
126444853|NCT04672655|454926730|FG000|Overall Study|Lost to Follow-up|12|||
126444854|NCT04672655|454926731|FG001|Overall Study|Lost to Follow-up|17|||
126444855|NCT04672655|454926730|FG000|Overall Study|Withdrawal by Subject|1|||
126444856|NCT04672655|454926731|FG001|Overall Study|Withdrawal by Subject|0|||
126545409|NCT03500640|455290832|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
126692158|NCT01225562|455827899|FG000|Overall Study|Lost to Follow-up|3|||
126692159|NCT01225562|455827900|FG001|Overall Study|Lost to Follow-up|6|||
126692160|NCT01225562|455827901|FG002|Overall Study|Lost to Follow-up|1|||
126692161|NCT01481896|455827902|FG000|Overall Study|Lost to Follow-up|12|||
126692162|NCT01818726|455827905|FG000|Overall Study|Administrative reasons|5|||
126692163|NCT01818726|455827906|FG001|Overall Study|Administrative reasons|1|||
126692164|NCT01818726|455827905|FG000|Overall Study|Withdrawal by Subject|0|||
126692165|NCT01818726|455827906|FG001|Overall Study|Withdrawal by Subject|1|||
126692166|NCT01818726|455827905|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
126692167|NCT01818726|455827906|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
126692168|NCT01162421|455827907|FG000|Overall Study|Did not receive study drug|2|||
126692169|NCT01162421|455827908|FG001|Overall Study|Did not receive study drug|1|||
126692170|NCT01162421|455827907|FG000|Overall Study|Adverse Event|2|||
126692171|NCT01162421|455827908|FG001|Overall Study|Adverse Event|5|||
126692172|NCT01162421|455827907|FG000|Overall Study|Lost to Follow-up|0|||
126692173|NCT01162421|455827908|FG001|Overall Study|Lost to Follow-up|2|||
126692174|NCT01162421|455827907|FG000|Overall Study|Lack of Efficacy|2|||
126692175|NCT01162421|455827908|FG001|Overall Study|Lack of Efficacy|2|||
126692176|NCT01162421|455827907|FG000|Overall Study|Other|2|||
126692177|NCT01162421|455827908|FG001|Overall Study|Other|3|||
126692178|NCT03336502|455827909|FG000|Overall Study|Physician Decision|0|||
126692179|NCT03336502|455827910|FG001|Overall Study|Physician Decision|1|||
126692180|NCT03336502|455827909|FG000|Overall Study|Prohibited Drugs|1|||
126692181|NCT03336502|455827910|FG001|Overall Study|Prohibited Drugs|1|||
126692182|NCT03336502|455827909|FG000|Overall Study|Death|1|||
126692183|NCT03336502|455827910|FG001|Overall Study|Death|2|||
126692184|NCT03336502|455827909|FG000|Overall Study|Adverse Event|2|||
126692185|NCT03336502|455827910|FG001|Overall Study|Adverse Event|5|||
126692186|NCT00480857|455827912|FG000|Overall Study|Lack of Efficacy|2|||
126692187|NCT00611247|455827913|FG000|Overall Study|Death|1|||
126692188|NCT00611247|455827914|FG001|Overall Study|Death|5|||
126692189|NCT00611247|455827913|FG000|Overall Study|Lack of Efficacy|1|||
126692190|NCT00611247|455827914|FG001|Overall Study|Lack of Efficacy|16|||
126692191|NCT00565617|455827915|FG000|Overall Study|Withdrawal by Subject|1|||
126692192|NCT01890421|455827916|FG000|Overall Study|Adverse Event|1|||
126692193|NCT01890421|455827916|FG000|Overall Study|Other reason|10|||
126692194|NCT01446419|455827923|FG000|Overall Study|Death|1|||
126692195|NCT01446419|455827924|FG001|Overall Study|Death|0|||
126692196|NCT01446419|455827923|FG000|Overall Study|Withdrawal by Subject|1|||
126692197|NCT01446419|455827924|FG001|Overall Study|Withdrawal by Subject|1|||
126692198|NCT01446419|455827923|FG000|Overall Study|Terminated per protocol|3|||
126692199|NCT01446419|455827924|FG001|Overall Study|Terminated per protocol|0|||
126692200|NCT02867761|455827927|FG000|Overall Study|Participant withdrawn by investigator|0|||
126692201|NCT02867761|455827928|FG001|Overall Study|Participant withdrawn by investigator|1|||
126692202|NCT02867761|455827927|FG000|Overall Study|Lost to Follow-up|25|||
126692203|NCT02867761|455827928|FG001|Overall Study|Lost to Follow-up|18|||
126692204|NCT02867761|455827927|FG000|Overall Study|Unable to complete protocol|3|||
126692205|NCT02867761|455827928|FG001|Overall Study|Unable to complete protocol|7|||
126692206|NCT04506294|455827929|FG000|Overall Study|Lost to Follow-up|70|||
126692207|NCT04506294|455827930|FG001|Overall Study|Lost to Follow-up|20|||
126692208|NCT04506294|455827929|FG000|Overall Study|Withdrawal by Subject|16|||
126692209|NCT04506294|455827930|FG001|Overall Study|Withdrawal by Subject|2|||
126692210|NCT01465659|455827931|FG000|Completed 1 Cycle of Treatment|Death|0|||
126692211|NCT01465659|455827932|FG001|Completed 1 Cycle of Treatment|Death|1|||
126692212|NCT01465659|455827933|FG002|Completed 1 Cycle of Treatment|Death|0|||
126692213|NCT01465659|455827934|FG003|Completed 1 Cycle of Treatment|Death|0|||
126692214|NCT01465659|455827931|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
126692215|NCT01465659|455827932|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
126692216|NCT01465659|455827933|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
126692217|NCT01465659|455827934|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
126760524|NCT02442284|456073806|FG000|Overall Study|Adverse Event|1|||
126692218|NCT01465659|455827931|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
126692219|NCT01465659|455827932|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
126692220|NCT01465659|455827933|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
126692221|NCT01465659|455827934|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
126692222|NCT01465659|455827931|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
126692223|NCT01465659|455827932|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
126692224|NCT01465659|455827933|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
126692225|NCT01465659|455827934|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
126692226|NCT01465659|455827931|FG000|Completed Follow for 1 Year|Death|6|||
126692227|NCT01465659|455827932|FG001|Completed Follow for 1 Year|Death|3|||
126692228|NCT01465659|455827933|FG002|Completed Follow for 1 Year|Death|2|||
126692229|NCT01465659|455827934|FG003|Completed Follow for 1 Year|Death|4|||
126692230|NCT02445586|455827936|FG000|Overall Study|Death|14|||
126692231|NCT02445586|455827936|FG000|Overall Study|Withdrawal by Subject|13|||
126692232|NCT02445586|455827936|FG000|Overall Study|Disease Progression|10|||
126692233|NCT02445586|455827936|FG000|Overall Study|Protocol Violation|1|||
126692234|NCT02445586|455827936|FG000|Overall Study|Medical Condition|1|||
126692235|NCT00428597|455827937|FG000|Overall Study|Randomized but not treated|3|||
126692236|NCT00428597|455827938|FG001|Overall Study|Randomized but not treated|3|||
126692237|NCT00428597|455827937|FG000|Overall Study|Objective Progression or Relapse|19|||
126692238|NCT00428597|455827938|FG001|Overall Study|Objective Progression or Relapse|47|||
126692239|NCT00428597|455827937|FG000|Overall Study|Study Terminated by Sponsor|41|||
126692240|NCT00428597|455827938|FG001|Overall Study|Study Terminated by Sponsor|16|||
126692241|NCT00428597|455827937|FG000|Overall Study|Adverse Event|15|||
126692242|NCT00428597|455827938|FG001|Overall Study|Adverse Event|7|||
126692243|NCT00428597|455827937|FG000|Overall Study|Global Deterioration of Health Status|1|||
126692244|NCT00428597|455827938|FG001|Overall Study|Global Deterioration of Health Status|5|||
126692245|NCT00428597|455827937|FG000|Overall Study|Protocol Violation|2|||
126692246|NCT00428597|455827938|FG001|Overall Study|Protocol Violation|1|||
126692247|NCT00428597|455827937|FG000|Overall Study|Withdrawal by Subject|2|||
126692248|NCT00428597|455827938|FG001|Overall Study|Withdrawal by Subject|1|||
126692249|NCT00428597|455827937|FG000|Overall Study|Other|1|||
126692250|NCT00428597|455827938|FG001|Overall Study|Other|1|||
126692251|NCT00428597|455827937|FG000|Overall Study|Lost to Follow-up|0|||
126692252|NCT00428597|455827938|FG001|Overall Study|Lost to Follow-up|1|||
126355717|NCT04073407|454593119|FG000|Part 1|Withdrawal by Subject|1|||
126355718|NCT04073407|454593120|FG001|Part 1|Withdrawal by Subject|0|||
126355719|NCT04073407|454593119|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
126692253|NCT00428597|455827937|FG000|Overall Study|Pregnancy|1|||
126692254|NCT00428597|455827938|FG001|Overall Study|Pregnancy|0|||
126692255|NCT00428597|455827937|FG000|Overall Study|Death|1|||
126692256|NCT00428597|455827938|FG001|Overall Study|Death|3|||
126692257|NCT00578643|455827939|FG000|Overall Study|Death|1|||
126692258|NCT00578643|455827939|FG000|Overall Study|Lost to Follow-up|1|||
126760525|NCT02442284|456073806|FG000|Overall Study|Withdrew Consent|2|||
126355720|NCT04073407|454593120|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
126355721|NCT04073407|454593119|FG000|Part 2|Withdrawal by Subject|0|||
126355722|NCT04073407|454593120|FG001|Part 2|Withdrawal by Subject|1|||
126355723|NCT04941898|454595536|FG000|Overall Study|Protocol Violation|1|||
126355724|NCT00884949|454595537|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
126355725|NCT00884949|454595537|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
126355726|NCT03022630|454595538|FG000|Overall Study|Death|9|||
126444857|NCT04672655|454926730|FG000|Overall Study|Withdrawal by Study|1|||
126444858|NCT04672655|454926731|FG001|Overall Study|Withdrawal by Study|0|||
126444859|NCT00494676|454926732|FG000|Allocation|Withdrawal by Subject|2|||
126444860|NCT00494676|454926733|FG001|Allocation|Withdrawal by Subject|4|||
126444861|NCT00494676|454926732|FG000|First Intervention|Withdrawal by Subject|1|||
126444862|NCT00494676|454926733|FG001|First Intervention|Withdrawal by Subject|3|||
126355727|NCT03022630|454595539|FG001|Overall Study|Death|7|||
126444863|NCT00494676|454926732|FG000|Second Intervention|Withdrawal by Subject|1|||
126444864|NCT00494676|454926733|FG001|Second Intervention|Withdrawal by Subject|1|||
126355728|NCT03022630|454595538|FG000|Overall Study|Withdrawal by Subject|0|||
126355729|NCT03022630|454595539|FG001|Overall Study|Withdrawal by Subject|5|||
126444865|NCT03773796|454928128|FG000|Overall Study|Adverse Event|1|||
126355730|NCT01567085|454595542|FG000|Overall Study|Death|6|||
126444866|NCT03773796|454928128|FG000|Overall Study|Withdrawal by Subject|1|||
126444867|NCT03773796|454928128|FG000|Overall Study|Lack of Efficacy|1|||
126444868|NCT00796419|454928129|FG000|Overall Study|Death|0|||
126444869|NCT00796419|454928130|FG001|Overall Study|Death|1|||
126444870|NCT01250145|454928131|FG000|Overall Study|Adverse Event|2|||
126444871|NCT01250145|454928132|FG001|Overall Study|Adverse Event|1|||
126444872|NCT01250145|454928131|FG000|Overall Study|Withdrawal by Subject|0|||
126444873|NCT01250145|454928132|FG001|Overall Study|Withdrawal by Subject|4|||
126444874|NCT02687191|454928134|FG000|Overall Study|Death|0|||
126444875|NCT02687191|454928135|FG001|Overall Study|Death|1|||
126444876|NCT02687191|454928136|FG002|Overall Study|Death|1|||
126444877|NCT02687191|454928137|FG003|Overall Study|Death|0|||
126444878|NCT02687191|454928138|FG004|Overall Study|Death|1|||
126444879|NCT02687191|454928139|FG005|Overall Study|Death|1|||
126444880|NCT02687191|454928134|FG000|Overall Study|Withdrawal by Subject|0|||
126444881|NCT02687191|454928135|FG001|Overall Study|Withdrawal by Subject|0|||
126444882|NCT02687191|454928136|FG002|Overall Study|Withdrawal by Subject|0|||
126444883|NCT02687191|454928137|FG003|Overall Study|Withdrawal by Subject|1|||
126444884|NCT02687191|454928138|FG004|Overall Study|Withdrawal by Subject|0|||
126444885|NCT02687191|454928139|FG005|Overall Study|Withdrawal by Subject|0|||
126444886|NCT01788358|454928143|FG000|Overall Study|Other|11|||
126444887|NCT01788358|454928143|FG000|Overall Study|Logistical difficulties|1|||
126444888|NCT01788358|454928143|FG000|Overall Study|Lost to Follow-up|5|||
126444889|NCT01788358|454928143|FG000|Overall Study|Protocol Violation|3|||
126444890|NCT01788358|454928143|FG000|Overall Study|Withdrawal by Subject|26|||
126444891|NCT01788358|454928143|FG000|Overall Study|Lack of Efficacy|1|||
126444892|NCT01788358|454928143|FG000|Overall Study|Adverse Event|51|||
126444893|NCT05097963|454928144|FG000|Overall Study|Protocol Violation|13|||
126444894|NCT05097963|454928144|FG000|Overall Study|Withdrawal by Subject|21|||
126444895|NCT02873702|454928145|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
126444896|NCT02873702|454928146|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
126355731|NCT01567085|454595542|FG000|Overall Study|Adverse Event|6|||
126355732|NCT01567085|454595542|FG000|Overall Study|Lost to Follow-up|3|||
126355733|NCT01567085|454595542|FG000|Overall Study|Graft loss|2|||
126355734|NCT01567085|454595542|FG000|Overall Study|Renal transplantectomy|1|||
126355735|NCT01567085|454595542|FG000|Overall Study|Returned to chronic dialysis|1|||
126355736|NCT01567085|454595542|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
126355737|NCT00504231|454595546|FG000|Overall Study|Discrepant chart documentation re route|0|||
126355738|NCT00504231|454595547|FG001|Overall Study|Discrepant chart documentation re route|0|||
126355739|NCT00504231|454595548|FG002|Overall Study|Discrepant chart documentation re route|1|||
126355740|NCT00504231|454595549|FG003|Overall Study|Discrepant chart documentation re route|0|||
126355741|NCT03928704|454595551|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
126355742|NCT03928704|454595552|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
126355743|NCT03928704|454595553|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
126355744|NCT03928704|454595554|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
126355745|NCT03928704|454595555|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
126355746|NCT03928704|454595556|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
126355747|NCT03928704|454595551|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
126355748|NCT03928704|454595552|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
126355749|NCT03928704|454595553|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
126444897|NCT02873702|454928147|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
126444898|NCT02873702|454928148|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
126444899|NCT02873702|454928145|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
126692259|NCT01990261|455827941|FG000|Overall Study|Death Before Treatment Start|2|||
126692260|NCT01990261|455827941|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
126692261|NCT01990261|455827941|FG000|Overall Study|Death From other Causes|1|||
126692262|NCT01990261|455827941|FG000|Overall Study|Disease Progression (PD)|8|||
126692263|NCT01990261|455827941|FG000|Overall Study|PD Before Treatment Start|1|||
126692264|NCT01990261|455827941|FG000|Overall Study|Dossier not Approved|1|||
126692265|NCT01990261|455827941|FG000|Overall Study|Lost to Follow-up|2|||
126692266|NCT01445678|455827950|FG000|Overall Study|Adverse Event|12|||
126692267|NCT01445678|455827951|FG001|Overall Study|Adverse Event|8|||
126692268|NCT01445678|455827950|FG000|Overall Study|Lack of Efficacy|0|||
126692269|NCT01445678|455827951|FG001|Overall Study|Lack of Efficacy|2|||
126692270|NCT01445678|455827950|FG000|Overall Study|Lost to Follow-up|8|||
126692271|NCT01445678|455827951|FG001|Overall Study|Lost to Follow-up|5|||
126692272|NCT01445678|455827950|FG000|Overall Study|Protocol Violation|1|||
126692273|NCT01445678|455827951|FG001|Overall Study|Protocol Violation|1|||
126692274|NCT01445678|455827950|FG000|Overall Study|Withdrawal by Subject|9|||
126444900|NCT02873702|454928146|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
126444901|NCT02873702|454928147|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
126692275|NCT01445678|455827951|FG001|Overall Study|Withdrawal by Subject|5|||
126692276|NCT02307370|455827952|FG000|Overall Study|Death|5|||
126692277|NCT02307370|455827952|FG000|Overall Study|Lost to Follow-up|1|||
126692278|NCT02307370|455827952|FG000|Overall Study|Withdrawal by Subject|1|||
126692279|NCT02307370|455827952|FG000|Overall Study|Declined Addendum ICF|6|||
126692280|NCT02307370|455827952|FG000|Overall Study|No response during telephone contact|5|||
126692281|NCT02307370|455827952|FG000|Overall Study|Protocol Violation|1|||
126692282|NCT04698629|455827953|FG000|Overall Study|Adverse Event|1|||
126692283|NCT03344003|455827954|FG000|Overall Study|Switched to alternative treatment|1|||
126692284|NCT03344003|455827955|FG001|Overall Study|Switched to alternative treatment|0|||
126692285|NCT03344003|455827954|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
126692286|NCT03344003|455827955|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
126692287|NCT05847686|455830643|FG000|Overall Study|Withdrawal by Subject|3|||
126692288|NCT00352534|455830645|FG000|Initial Staging|Ineligible|8|||
126692289|NCT00352534|455830646|FG001|Initial Staging|Ineligible|9|||
126692290|NCT00352534|455830647|FG002|Initial Staging|Ineligible|0|||
126692291|NCT00352534|455830648|FG003|Initial Staging|Ineligible|0|||
126692292|NCT00352534|455830649|FG004|Initial Staging|Ineligible|0|||
126692293|NCT00352534|455830650|FG005|Initial Staging|Ineligible|0|||
126692294|NCT00352534|455830651|FG006|Initial Staging|Ineligible|0|||
126692295|NCT00352534|455830645|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
126692296|NCT00352534|455830646|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
126692297|NCT00352534|455830647|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
126692298|NCT00352534|455830648|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
126444902|NCT02873702|454928148|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
126444903|NCT02873702|454928145|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
126444904|NCT02873702|454928146|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
126692299|NCT00352534|455830649|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
126444905|NCT02873702|454928147|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
126692300|NCT00352534|455830650|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
126692301|NCT00352534|455830651|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
126692302|NCT00352534|455830645|FG000|Final Risk Group Assignment|Physician Decision|0|||
126692303|NCT00352534|455830646|FG001|Final Risk Group Assignment|Physician Decision|0|||
126692304|NCT00352534|455830647|FG002|Final Risk Group Assignment|Physician Decision|0|||
126692305|NCT00352534|455830648|FG003|Final Risk Group Assignment|Physician Decision|0|||
126692306|NCT00352534|455830649|FG004|Final Risk Group Assignment|Physician Decision|0|||
126692307|NCT00352534|455830650|FG005|Final Risk Group Assignment|Physician Decision|8|||
126692308|NCT00352534|455830651|FG006|Final Risk Group Assignment|Physician Decision|0|||
126692309|NCT00352534|455830645|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
126692310|NCT00352534|455830646|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
126692311|NCT00352534|455830647|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
126692312|NCT00352534|455830648|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
126692313|NCT00352534|455830649|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
126692314|NCT00352534|455830650|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
126692315|NCT00352534|455830651|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
126692316|NCT00352534|455830645|FG000|Final Risk Group Assignment|Ineligible|0|||
126692317|NCT00352534|455830646|FG001|Final Risk Group Assignment|Ineligible|0|||
126692318|NCT00352534|455830647|FG002|Final Risk Group Assignment|Ineligible|3|||
126692319|NCT00352534|455830648|FG003|Final Risk Group Assignment|Ineligible|1|||
126355750|NCT03928704|454595554|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
126355751|NCT03928704|454595555|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
126692320|NCT00352534|455830649|FG004|Final Risk Group Assignment|Ineligible|0|||
126692321|NCT00352534|455830650|FG005|Final Risk Group Assignment|Ineligible|13|||
126692322|NCT00352534|455830651|FG006|Final Risk Group Assignment|Ineligible|0|||
126692323|NCT00352534|455830645|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
126692324|NCT00352534|455830646|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
126692325|NCT00352534|455830647|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
126692326|NCT00352534|455830648|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
126692327|NCT00352534|455830649|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
126692328|NCT00352534|455830650|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
126692329|NCT00352534|455830651|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
126692330|NCT00352534|455830645|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
126692331|NCT00352534|455830646|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
126692332|NCT00352534|455830647|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
126692333|NCT00352534|455830648|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
126692334|NCT00352534|455830649|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
126692335|NCT00352534|455830650|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
126692336|NCT00352534|455830651|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
126692337|NCT00352534|455830645|FG000|Final Risk Group Assignment|Death|0|||
126692338|NCT00352534|455830646|FG001|Final Risk Group Assignment|Death|0|||
126692339|NCT00352534|455830647|FG002|Final Risk Group Assignment|Death|0|||
126692340|NCT00352534|455830648|FG003|Final Risk Group Assignment|Death|0|||
126692341|NCT00352534|455830649|FG004|Final Risk Group Assignment|Death|0|||
126692342|NCT00352534|455830650|FG005|Final Risk Group Assignment|Death|2|||
126692343|NCT00352534|455830651|FG006|Final Risk Group Assignment|Death|0|||
126692344|NCT01602341|455830652|FG000|Overall Study|Adverse Event|0|||
126692345|NCT01602341|455830653|FG001|Overall Study|Adverse Event|1|||
126692346|NCT04439279|455830654|FG000|Overall Study|Adverse Event|7|||
126355752|NCT03928704|454595556|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
126355753|NCT03928704|454595551|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
126355754|NCT03928704|454595552|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
126355755|NCT03928704|454595553|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
126355756|NCT03928704|454595554|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
126355757|NCT03928704|454595555|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
126355758|NCT03928704|454595556|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
126355759|NCT03928704|454595551|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
126355760|NCT03928704|454595552|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
126355761|NCT03928704|454595553|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
126355762|NCT03928704|454595554|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
126355763|NCT03928704|454595555|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
126355764|NCT03928704|454595556|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
126355765|NCT03928704|454595551|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
126355766|NCT03928704|454595552|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
126355767|NCT03928704|454595553|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
126692347|NCT04439279|455830654|FG000|Overall Study|Death|4|||
126692348|NCT04439279|455830654|FG000|Overall Study|Disease progression|17|||
126692349|NCT04439279|455830654|FG000|Overall Study|Complicating disease|3|||
126692350|NCT04439279|455830654|FG000|Overall Study|Withdrawal by Subject|2|||
126692351|NCT04439279|455830654|FG000|Overall Study|Ineligible|1|||
126692352|NCT04439279|455830654|FG000|Overall Study|Treatment still ongoing|1|||
126692353|NCT03521791|455830655|FG000|Overall Study|Protocol Violation|7|||
126692354|NCT03521791|455830656|FG001|Overall Study|Protocol Violation|17|||
126692355|NCT02090855|455830657|FG000|Overall Study|no evaluable Standard of Truth results|2|||
126692356|NCT00388947|455830659|FG000|Overall Study|Protocol Violation|47|||
126692357|NCT03038308|455830660|FG000|Overall Study|Surgical resection|1|||
126692358|NCT03038308|455830660|FG000|Overall Study|Withdrawal by Subject|2|||
126692359|NCT03038308|455830660|FG000|Overall Study|Lost to Follow-up|1|||
126692360|NCT04187092|455830661|FG000|Overall Study|Lost to Follow-up|1|||
126692361|NCT04187092|455830662|FG001|Overall Study|Lost to Follow-up|1|||
126692362|NCT04187092|455830661|FG000|Overall Study|Withdrawal by Subject|1|||
126692363|NCT04187092|455830662|FG001|Overall Study|Withdrawal by Subject|1|||
126692364|NCT04187092|455830661|FG000|Overall Study|Adverse Event|0|||
126692365|NCT04187092|455830662|FG001|Overall Study|Adverse Event|1|||
126692366|NCT01777763|455830677|FG000|Overall Study|Adverse Event|2|||
126692367|NCT01777763|455830678|FG001|Overall Study|Adverse Event|32|||
126692368|NCT01777763|455830677|FG000|Overall Study|Protocol Violation|1|||
126692369|NCT01777763|455830678|FG001|Overall Study|Protocol Violation|7|||
126692370|NCT01777763|455830677|FG000|Overall Study|Withdrawal by Subject|0|||
126692371|NCT01777763|455830678|FG001|Overall Study|Withdrawal by Subject|2|||
126692372|NCT01777763|455830677|FG000|Overall Study|Treatment Failure|1|||
126692373|NCT01777763|455830678|FG001|Overall Study|Treatment Failure|6|||
126692374|NCT00925600|455830685|FG000|Overall Study|Withdrawal by Subject|16|||
126692375|NCT00925600|455830686|FG001|Overall Study|Withdrawal by Subject|14|||
126692376|NCT00925600|455830685|FG000|Overall Study|Death|4|||
126692377|NCT00925600|455830686|FG001|Overall Study|Death|3|||
126444906|NCT02873702|454928148|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
126444907|NCT02873702|454928145|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
126692378|NCT00925600|455830685|FG000|Overall Study|Lost to Follow-up|2|||
126692379|NCT00925600|455830686|FG001|Overall Study|Lost to Follow-up|2|||
126692380|NCT00925600|455830685|FG000|Overall Study|Disease Progression|1|||
126692381|NCT00925600|455830686|FG001|Overall Study|Disease Progression|3|||
126692382|NCT00925600|455830685|FG000|Overall Study|Administrative Decision|1|||
126692383|NCT00925600|455830686|FG001|Overall Study|Administrative Decision|1|||
126692384|NCT00925600|455830685|FG000|Overall Study|Noncompliance|2|||
126692385|NCT00925600|455830686|FG001|Overall Study|Noncompliance|0|||
126692386|NCT00925600|455830685|FG000|Overall Study|Ineligibility Determined|2|||
126692387|NCT00925600|455830686|FG001|Overall Study|Ineligibility Determined|0|||
126692388|NCT00925600|455830685|FG000|Overall Study|Protocol Deviation|0|||
126692389|NCT00925600|455830686|FG001|Overall Study|Protocol Deviation|1|||
126444908|NCT02873702|454928146|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
126444909|NCT02873702|454928147|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
126444910|NCT02873702|454928148|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
126444911|NCT02873702|454928145|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
126444912|NCT02873702|454928146|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
126444913|NCT02873702|454928147|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
126444914|NCT02873702|454928148|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
126444915|NCT01039376|454928151|FG000|Overall Study|Lost to Follow-up|5|||
126444916|NCT01039376|454928152|FG001|Overall Study|Lost to Follow-up|12|||
126444917|NCT01039376|454928151|FG000|Overall Study|Physician Decision|15|||
126444918|NCT01039376|454928152|FG001|Overall Study|Physician Decision|10|||
126444919|NCT01039376|454928151|FG000|Overall Study|Withdrawal by Subject|20|||
126444920|NCT01039376|454928152|FG001|Overall Study|Withdrawal by Subject|32|||
126444921|NCT01039376|454928151|FG000|Overall Study|Study terminated by Sponsor|90|||
126444922|NCT01039376|454928152|FG001|Overall Study|Study terminated by Sponsor|72|||
126444923|NCT03252925|454928153|FG000|Overall Study|Withdrawal by Subject|1|||
126692390|NCT00925600|455830685|FG000|Overall Study|Requirement for Alternative Therapy|0|||
126692391|NCT00925600|455830686|FG001|Overall Study|Requirement for Alternative Therapy|1|||
126692392|NCT00925600|455830685|FG000|Overall Study|Other|3|||
126692393|NCT00925600|455830686|FG001|Overall Study|Other|1|||
126692394|NCT00925600|455830685|FG000|Overall Study|Adverse Event|1|||
126692395|NCT00925600|455830686|FG001|Overall Study|Adverse Event|2|||
126692396|NCT01974817|455830687|FG000|Overall Study|Death|4|||
126692397|NCT01974817|455830687|FG000|Overall Study|Lost to Follow-up|2|||
126692398|NCT01974817|455830687|FG000|Overall Study|Protocol Violation|2|||
126692399|NCT05512949|455830688|FG000|Overall Study|Lost to Follow-up|4|||
126692400|NCT05512949|455830689|FG001|Overall Study|Lost to Follow-up|6|||
126692401|NCT05512949|455830690|FG002|Overall Study|Lost to Follow-up|2|||
126692402|NCT05512949|455830688|FG000|Overall Study|Protocol Violation|0|||
126692403|NCT05512949|455830689|FG001|Overall Study|Protocol Violation|0|||
126692404|NCT05512949|455830690|FG002|Overall Study|Protocol Violation|1|||
126444924|NCT03252925|454928154|FG001|Overall Study|Withdrawal by Subject|0|||
126444925|NCT03252925|454928153|FG000|Overall Study|Protocol Violation|6|||
126444926|NCT03252925|454928154|FG001|Overall Study|Protocol Violation|0|||
126692405|NCT05512949|455830688|FG000|Overall Study|Withdrawal by Subject|1|||
126692406|NCT05512949|455830689|FG001|Overall Study|Withdrawal by Subject|1|||
126692407|NCT05512949|455830690|FG002|Overall Study|Withdrawal by Subject|2|||
126692408|NCT05512949|455830688|FG000|Overall Study|Completion status unknown|1|||
126692409|NCT05512949|455830689|FG001|Overall Study|Completion status unknown|3|||
126692410|NCT05512949|455830690|FG002|Overall Study|Completion status unknown|0|||
126692411|NCT04660643|455830691|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
126692412|NCT04660643|455830692|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
126692413|NCT04660643|455830693|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
126692414|NCT04660643|455830691|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
126692415|NCT04660643|455830692|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
126692416|NCT04660643|455830693|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
126692417|NCT04660643|455830691|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
126692418|NCT04660643|455830692|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
126692419|NCT04660643|455830693|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
126692420|NCT04660643|455830691|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
126692421|NCT04660643|455830692|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
126692422|NCT04660643|455830693|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
126692423|NCT04660643|455830691|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
126692424|NCT04660643|455830692|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
126692425|NCT04660643|455830693|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
126692426|NCT04660643|455830691|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
126692427|NCT04660643|455830692|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
126692428|NCT04660643|455830693|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
126692429|NCT04660643|455830691|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
126692430|NCT04660643|455830692|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
126692431|NCT04660643|455830693|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
126692432|NCT04660643|455830691|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
126692433|NCT04660643|455830692|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
126692434|NCT04660643|455830693|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
126692435|NCT04660643|455830691|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
126692436|NCT04660643|455830692|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
126692437|NCT04660643|455830693|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
126692438|NCT04660643|455830691|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
126692439|NCT04660643|455830692|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
126692440|NCT04660643|455830693|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
126692441|NCT04660643|455830691|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
126692442|NCT04660643|455830692|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
126355768|NCT03928704|454595554|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
126355769|NCT03928704|454595555|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
126355770|NCT03928704|454595556|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
126355771|NCT03928704|454595551|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
126355772|NCT03928704|454595552|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
126355773|NCT03928704|454595553|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
126355774|NCT03928704|454595554|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
126355775|NCT03928704|454595555|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
126355776|NCT03928704|454595556|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
126355777|NCT03928704|454595551|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
126355778|NCT03928704|454595552|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
126355779|NCT03928704|454595553|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
126355780|NCT03928704|454595554|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
126355781|NCT03928704|454595555|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
126355782|NCT03928704|454595556|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
126355783|NCT03928704|454595551|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
126355784|NCT03928704|454595552|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
126355785|NCT03928704|454595553|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
126355786|NCT03928704|454595554|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
126355787|NCT03928704|454595555|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
126355788|NCT03928704|454595556|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
126355789|NCT03928704|454595551|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
126355790|NCT03928704|454595552|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
126355791|NCT03928704|454595553|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
126355792|NCT03928704|454595554|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
126355793|NCT03928704|454595555|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
126355794|NCT03928704|454595556|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
126444927|NCT03252925|454928153|FG000|Overall Study|Adverse Event|1|||
126355795|NCT03928704|454595551|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
126355796|NCT03928704|454595552|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
126692443|NCT04660643|455830693|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
126692444|NCT04660643|455830691|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
126692445|NCT04660643|455830692|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
126692446|NCT04660643|455830693|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
126692447|NCT04660643|455830691|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
126692448|NCT04660643|455830692|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
126692449|NCT04660643|455830693|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
126692450|NCT04660643|455830691|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
126692451|NCT04660643|455830692|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
126692452|NCT04660643|455830693|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
126692453|NCT04660643|455830691|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
126692454|NCT04660643|455830692|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
126692455|NCT04660643|455830693|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
126692456|NCT04660643|455830691|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
126692457|NCT04660643|455830692|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
126692458|NCT04660643|455830693|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
126692459|NCT03988907|455830694|FG000|Overall Study|Unable to complete visit|0|||
126692460|NCT03988907|455830695|FG001|Overall Study|Unable to complete visit|1|||
126692461|NCT02810964|455830696|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
126692462|NCT02810964|455830697|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
126692463|NCT02810964|455830696|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
126692464|NCT02810964|455830697|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
126692465|NCT02810964|455830696|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
126692466|NCT02810964|455830697|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
126692467|NCT02810964|455830696|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
126692468|NCT02810964|455830697|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
126692469|NCT03969875|455830707|FG000|Overall Study|did not receive allocated intervention|3|||
126692470|NCT03969875|455830708|FG001|Overall Study|did not receive allocated intervention|3|||
126692471|NCT03969875|455830709|FG002|Overall Study|did not receive allocated intervention|4|||
126692472|NCT03969875|455830707|FG000|Overall Study|Protocol Violation|4|||
126692473|NCT03969875|455830708|FG001|Overall Study|Protocol Violation|2|||
126692474|NCT03969875|455830709|FG002|Overall Study|Protocol Violation|2|||
126692475|NCT01307033|455830710|FG000|8-week Double-blind Period|Adverse Event|2|||
126692476|NCT01307033|455830711|FG001|8-week Double-blind Period|Adverse Event|0|||
126692477|NCT01307033|455830712|FG002|8-week Double-blind Period|Adverse Event|0|||
126692478|NCT01307033|455830713|FG003|8-week Double-blind Period|Adverse Event|0|||
126692479|NCT01307033|455830710|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
126692480|NCT01307033|455830711|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
126692481|NCT01307033|455830712|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
126692482|NCT01307033|455830713|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
126692483|NCT01307033|455830710|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
126692484|NCT01307033|455830711|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
126692485|NCT01307033|455830712|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
126692486|NCT01307033|455830713|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
126692487|NCT01307033|455830710|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
126692488|NCT01307033|455830711|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
126692489|NCT01307033|455830712|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
126692490|NCT01307033|455830713|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
126692491|NCT01307033|455830710|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
126444928|NCT03252925|454928154|FG001|Overall Study|Adverse Event|0|||
126692492|NCT01307033|455830711|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
126692493|NCT01307033|455830712|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
126692494|NCT01307033|455830713|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
126692495|NCT01307033|455830710|FG000|44-week Open-label Extension|Adverse Event|0|||
126692496|NCT01307033|455830711|FG001|44-week Open-label Extension|Adverse Event|0|||
126692497|NCT01307033|455830712|FG002|44-week Open-label Extension|Adverse Event|2|||
126692498|NCT01307033|455830713|FG003|44-week Open-label Extension|Adverse Event|1|||
126692499|NCT01307033|455830710|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
126692500|NCT01307033|455830711|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
126692501|NCT01307033|455830712|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
126692502|NCT01307033|455830713|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
126692503|NCT01307033|455830710|FG000|44-week Open-label Extension|Physician Decision|0|||
126692504|NCT01307033|455830711|FG001|44-week Open-label Extension|Physician Decision|0|||
126692505|NCT01307033|455830712|FG002|44-week Open-label Extension|Physician Decision|1|||
126692506|NCT01307033|455830713|FG003|44-week Open-label Extension|Physician Decision|0|||
126692507|NCT01307033|455830710|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
126692508|NCT01307033|455830711|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
126692509|NCT01307033|455830712|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
126692510|NCT01307033|455830713|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
126692511|NCT01307033|455830710|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
126692512|NCT01307033|455830711|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
126692513|NCT01307033|455830712|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
126692514|NCT01307033|455830713|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
126692515|NCT01307033|455830710|FG000|44-week Open-label Extension|Death|0|||
126692516|NCT01307033|455830711|FG001|44-week Open-label Extension|Death|0|||
126692517|NCT01307033|455830712|FG002|44-week Open-label Extension|Death|0|||
126692518|NCT01307033|455830713|FG003|44-week Open-label Extension|Death|1|||
126692519|NCT01231555|455830714|FG000|Overall Study|Study terminated|8|||
126692520|NCT01231555|455830715|FG001|Overall Study|Study terminated|5|||
126692521|NCT01231555|455830716|FG002|Overall Study|Study terminated|8|||
126692522|NCT01231555|455830714|FG000|Overall Study|Withdrawal by Subject|0|||
126692523|NCT01231555|455830715|FG001|Overall Study|Withdrawal by Subject|2|||
126692524|NCT01231555|455830716|FG002|Overall Study|Withdrawal by Subject|0|||
126692525|NCT00947531|455830717|FG000|Overall Study|Withdrawal by Subject|10|||
126692526|NCT00947531|455830718|FG001|Overall Study|Withdrawal by Subject|7|||
126692527|NCT00947531|455830717|FG000|Overall Study|Administrative Reason|0|||
126692528|NCT00947531|455830718|FG001|Overall Study|Administrative Reason|1|||
126692529|NCT00947531|455830717|FG000|Overall Study|Adverse Event|2|||
126355797|NCT03928704|454595553|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
126355798|NCT03928704|454595554|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
126692530|NCT00947531|455830718|FG001|Overall Study|Adverse Event|2|||
126692531|NCT00947531|455830717|FG000|Overall Study|Lack of Efficacy|1|||
126692532|NCT00947531|455830718|FG001|Overall Study|Lack of Efficacy|0|||
126692533|NCT00947531|455830717|FG000|Overall Study|Other|1|||
126692534|NCT00947531|455830718|FG001|Overall Study|Other|1|||
126692535|NCT01773421|455830720|FG000|Treatment Phase|Other|0|||
126692536|NCT01773421|455830721|FG001|Treatment Phase|Other|0|||
126692537|NCT01773421|455830722|FG002|Treatment Phase|Other|2|||
126692538|NCT01773421|455830723|FG003|Treatment Phase|Other|0|||
126692539|NCT01773421|455830724|FG004|Treatment Phase|Other|0|||
126692540|NCT01773421|455830725|FG005|Treatment Phase|Other|0|||
126692541|NCT01773421|455830726|FG006|Treatment Phase|Other|0|||
126692542|NCT01773421|455830720|FG000|Treatment Phase|Adverse Event|0|||
126692543|NCT01773421|455830721|FG001|Treatment Phase|Adverse Event|0|||
126760526|NCT02442284|456073806|FG000|Overall Study|Lost to Follow-up|3|||
126355799|NCT03928704|454595555|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
126355800|NCT03928704|454595556|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
126355801|NCT04575324|454595559|FG000|Overall Study|Lost to Follow-up|29|||
126355802|NCT04575324|454595560|FG001|Overall Study|Lost to Follow-up|25|||
126355803|NCT04575324|454595559|FG000|Overall Study|Death|1|||
126355804|NCT04575324|454595560|FG001|Overall Study|Death|2|||
126355805|NCT04575324|454595559|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
126355806|NCT04575324|454595560|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
126355807|NCT00456612|454595566|FG000|Overall Study|Withdrawal by Subject|3|||
126692544|NCT01773421|455830722|FG002|Treatment Phase|Adverse Event|3|||
126692545|NCT01773421|455830723|FG003|Treatment Phase|Adverse Event|1|||
126692546|NCT01773421|455830724|FG004|Treatment Phase|Adverse Event|0|||
126692547|NCT01773421|455830725|FG005|Treatment Phase|Adverse Event|0|||
126692548|NCT01773421|455830726|FG006|Treatment Phase|Adverse Event|0|||
126692549|NCT01773421|455830720|FG000|Treatment Phase|Withdrawal by Subject|0|||
126692550|NCT01773421|455830721|FG001|Treatment Phase|Withdrawal by Subject|0|||
126692551|NCT01773421|455830722|FG002|Treatment Phase|Withdrawal by Subject|1|||
126760527|NCT02442284|456073806|FG000|Overall Study|Other|1|||
126355808|NCT00266812|454595567|FG000|Overall Study|Disease Progression|9|||
126355809|NCT00266812|454595568|FG001|Overall Study|Disease Progression|3|||
126692552|NCT01773421|455830723|FG003|Treatment Phase|Withdrawal by Subject|1|||
126692553|NCT01773421|455830724|FG004|Treatment Phase|Withdrawal by Subject|0|||
126692554|NCT01773421|455830725|FG005|Treatment Phase|Withdrawal by Subject|0|||
126692555|NCT01773421|455830726|FG006|Treatment Phase|Withdrawal by Subject|0|||
126692556|NCT01773421|455830720|FG000|Extension Phase|Other|0|||
126692557|NCT01773421|455830721|FG001|Extension Phase|Other|0|||
126692558|NCT01773421|455830722|FG002|Extension Phase|Other|0|||
126692559|NCT01773421|455830723|FG003|Extension Phase|Other|0|||
126692560|NCT01773421|455830724|FG004|Extension Phase|Other|1|||
126692561|NCT01773421|455830725|FG005|Extension Phase|Other|2|||
126692562|NCT01773421|455830726|FG006|Extension Phase|Other|0|||
126692563|NCT01773421|455830720|FG000|Extension Phase|Adverse Event|0|||
126692564|NCT01773421|455830721|FG001|Extension Phase|Adverse Event|0|||
126692565|NCT01773421|455830722|FG002|Extension Phase|Adverse Event|0|||
126692566|NCT01773421|455830723|FG003|Extension Phase|Adverse Event|0|||
126692567|NCT01773421|455830724|FG004|Extension Phase|Adverse Event|2|||
126692568|NCT01773421|455830725|FG005|Extension Phase|Adverse Event|0|||
126692569|NCT01773421|455830726|FG006|Extension Phase|Adverse Event|0|||
126692570|NCT02327260|455830727|FG000|Overall Study|Lost to Follow-up|2|||
126692571|NCT02327260|455830728|FG001|Overall Study|Lost to Follow-up|3|||
126692572|NCT02327260|455830729|FG002|Overall Study|Lost to Follow-up|2|||
126692573|NCT02327260|455830727|FG000|Overall Study|invalid phone number|1|||
126692574|NCT02327260|455830728|FG001|Overall Study|invalid phone number|1|||
126692575|NCT02327260|455830729|FG002|Overall Study|invalid phone number|0|||
126692576|NCT02327260|455830727|FG000|Overall Study|non-adherence to protocol|2|||
126692577|NCT02327260|455830728|FG001|Overall Study|non-adherence to protocol|0|||
126692578|NCT02327260|455830729|FG002|Overall Study|non-adherence to protocol|0|||
126444929|NCT03252925|454928153|FG000|Overall Study|Lost to Follow-up|6|||
126692579|NCT02327260|455830727|FG000|Overall Study|cognitive concerns|1|||
126692580|NCT02327260|455830728|FG001|Overall Study|cognitive concerns|0|||
126692581|NCT02327260|455830729|FG002|Overall Study|cognitive concerns|0|||
126355810|NCT00266812|454595567|FG000|Overall Study|Death|5|||
126355811|NCT00266812|454595568|FG001|Overall Study|Death|4|||
126355812|NCT00266812|454595567|FG000|Overall Study|Adverse Event|3|||
126355813|NCT00266812|454595568|FG001|Overall Study|Adverse Event|1|||
126760528|NCT01365182|456073807|FG000|Overall Study|Withdrawal by Subject|10|||
126760529|NCT01365182|456073808|FG001|Overall Study|Withdrawal by Subject|13|||
126760530|NCT01365182|456073809|FG002|Overall Study|Withdrawal by Subject|12|||
126760531|NCT01728194|456073814|FG000|Overall Study|Lost to Follow-up|4|||
126760532|NCT01728194|456073815|FG001|Overall Study|Lost to Follow-up|3|||
126760533|NCT01728194|456073814|FG000|Overall Study|Physician Decision|4|||
126760534|NCT01728194|456073815|FG001|Overall Study|Physician Decision|0|||
126760535|NCT01728194|456073814|FG000|Overall Study|Withdrawal by Subject|7|||
126760536|NCT01728194|456073815|FG001|Overall Study|Withdrawal by Subject|3|||
126760537|NCT01728194|456073814|FG000|Overall Study|Perceived Medication Side Effects|4|||
126760538|NCT01728194|456073815|FG001|Overall Study|Perceived Medication Side Effects|0|||
126760539|NCT01728194|456073814|FG000|Overall Study|Family Member Request|1|||
126760540|NCT01728194|456073815|FG001|Overall Study|Family Member Request|0|||
126760541|NCT04604015|456073817|FG000|Overall Study|Incomplete Data Collection|33|||
126760542|NCT02129192|456073818|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
126760543|NCT02129192|456073819|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
126760544|NCT01231620|456073821|FG000|Overall Study|Physician Decision|3|||
126760545|NCT01231620|456073822|FG001|Overall Study|Physician Decision|5|||
126760546|NCT01231620|456073823|FG002|Overall Study|Physician Decision|10|||
126760547|NCT01231620|456073821|FG000|Overall Study|Death|12|||
126760548|NCT01231620|456073822|FG001|Overall Study|Death|14|||
126760549|NCT01231620|456073823|FG002|Overall Study|Death|11|||
126760550|NCT01231620|456073821|FG000|Overall Study|Adverse Event|2|||
126760551|NCT01231620|456073822|FG001|Overall Study|Adverse Event|2|||
126760552|NCT01231620|456073823|FG002|Overall Study|Adverse Event|1|||
126760553|NCT01231620|456073821|FG000|Overall Study|Withdrawal by Subject|6|||
126760554|NCT01231620|456073822|FG001|Overall Study|Withdrawal by Subject|6|||
126760555|NCT01231620|456073823|FG002|Overall Study|Withdrawal by Subject|8|||
126760556|NCT01231620|456073821|FG000|Overall Study|Lost to Follow-up|3|||
126760557|NCT01231620|456073822|FG001|Overall Study|Lost to Follow-up|4|||
126760558|NCT01231620|456073823|FG002|Overall Study|Lost to Follow-up|9|||
126760559|NCT02576652|456073825|FG000|Overall Study|Withdrawal by Subject|2|||
126760560|NCT01078974|456073835|FG000|Overall Study|Adverse Event|3|||
126760561|NCT00553319|456073836|FG000|Overall Study|Lost to Follow-up|10|||
126760562|NCT00553319|456073837|FG001|Overall Study|Lost to Follow-up|9|||
126760563|NCT00553319|456073838|FG002|Overall Study|Lost to Follow-up|5|||
126760564|NCT00553319|456073836|FG000|Overall Study|wanted treatment elsewhere|2|||
126760565|NCT00553319|456073837|FG001|Overall Study|wanted treatment elsewhere|1|||
126760566|NCT00553319|456073838|FG002|Overall Study|wanted treatment elsewhere|1|||
126760567|NCT00553319|456073836|FG000|Overall Study|non-compliance|0|||
126760568|NCT00553319|456073837|FG001|Overall Study|non-compliance|0|||
126760569|NCT00553319|456073838|FG002|Overall Study|non-compliance|2|||
126760570|NCT00553319|456073836|FG000|Overall Study|incarceration|1|||
126760571|NCT00553319|456073837|FG001|Overall Study|incarceration|0|||
126760572|NCT00553319|456073838|FG002|Overall Study|incarceration|0|||
126760573|NCT00553319|456073836|FG000|Overall Study|moved|1|||
126760574|NCT00553319|456073837|FG001|Overall Study|moved|0|||
126760575|NCT00553319|456073838|FG002|Overall Study|moved|1|||
126760576|NCT03575975|456073844|FG000|Overall Study|Lost to Follow-up|1|||
126760577|NCT03575975|456073845|FG001|Overall Study|Lost to Follow-up|0|||
126760578|NCT03575975|456073846|FG002|Overall Study|Lost to Follow-up|0|||
126760579|NCT00495794|456073847|FG000|Overall Study|Pharmacist did not activate patient|522|||
126760580|NCT00495794|456073848|FG001|Overall Study|Pharmacist did not activate patient|0|||
126760581|NCT03039699|456073850|FG000|Overall Study|Incorrect inclusion|5|||
126760582|NCT03039699|456073851|FG001|Overall Study|Incorrect inclusion|4|||
126760583|NCT03039699|456073850|FG000|Overall Study|Lack of data to assess study endpoint|5|||
126760584|NCT03039699|456073851|FG001|Overall Study|Lack of data to assess study endpoint|3|||
126760585|NCT03039699|456073850|FG000|Overall Study|Bacterial infection|12|||
126355814|NCT00266812|454595567|FG000|Overall Study|Protocol Violation|0|||
126355815|NCT00266812|454595568|FG001|Overall Study|Protocol Violation|1|||
126355816|NCT00266812|454595567|FG000|Overall Study|Withdrawal by Subject|0|||
126760586|NCT03039699|456073851|FG001|Overall Study|Bacterial infection|28|||
126760587|NCT00129220|456073852|FG000|Study Period II|Adverse Event|9|||
126760588|NCT00129220|456073853|FG001|Study Period II|Adverse Event|5|||
126355817|NCT00266812|454595568|FG001|Overall Study|Withdrawal by Subject|2|||
126444930|NCT03252925|454928154|FG001|Overall Study|Lost to Follow-up|6|||
126760589|NCT00129220|456073854|FG002|Study Period II|Adverse Event|7|||
126760590|NCT00129220|456073852|FG000|Study Period II|Lack of Efficacy|15|||
126760591|NCT00129220|456073853|FG001|Study Period II|Lack of Efficacy|1|||
126760592|NCT00129220|456073854|FG002|Study Period II|Lack of Efficacy|28|||
126760593|NCT00129220|456073852|FG000|Study Period II|Entry Criteria Not Met|2|||
126760594|NCT00129220|456073853|FG001|Study Period II|Entry Criteria Not Met|0|||
126760595|NCT00129220|456073854|FG002|Study Period II|Entry Criteria Not Met|2|||
126760596|NCT00129220|456073852|FG000|Study Period II|Protocol Violation|4|||
126444931|NCT01075685|454928164|FG000|Overall Study|Protocol Violation|9|||
126444932|NCT01075685|454928165|FG001|Overall Study|Protocol Violation|1|||
126444933|NCT01075685|454928164|FG000|Overall Study|Withdrawal by Subject|20|||
126444934|NCT01075685|454928165|FG001|Overall Study|Withdrawal by Subject|5|||
126444935|NCT01075685|454928164|FG000|Overall Study|Lost to Follow-up|563|||
126444936|NCT01075685|454928165|FG001|Overall Study|Lost to Follow-up|220|||
126444937|NCT02858362|454928166|FG000|Overall Study|Protocol Violation|0|||
126444938|NCT02858362|454928167|FG001|Overall Study|Protocol Violation|1|||
126444939|NCT02858362|454928168|FG002|Overall Study|Protocol Violation|0|||
126444940|NCT02858362|454928166|FG000|Overall Study|Withdrawal by Subject|1|||
126444941|NCT02858362|454928167|FG001|Overall Study|Withdrawal by Subject|0|||
126444942|NCT02858362|454928168|FG002|Overall Study|Withdrawal by Subject|0|||
126444943|NCT02858362|454928166|FG000|Overall Study|Early Study Termination|0|||
126444944|NCT02858362|454928167|FG001|Overall Study|Early Study Termination|0|||
126444945|NCT02858362|454928168|FG002|Overall Study|Early Study Termination|3|||
126444946|NCT02858362|454928166|FG000|Overall Study|Lost to Follow-up|1|||
126444947|NCT02858362|454928167|FG001|Overall Study|Lost to Follow-up|0|||
126444948|NCT02858362|454928168|FG002|Overall Study|Lost to Follow-up|0|||
126444949|NCT01262989|454928169|FG000|Period 1|Lost to Follow-up|1|||
126444950|NCT01262989|454928170|FG001|Period 1|Lost to Follow-up|1|||
126444951|NCT01262989|454928169|FG000|Period 1|Intercurrent disease|0|||
126444952|NCT01262989|454928170|FG001|Period 1|Intercurrent disease|1|||
126444953|NCT01262989|454928169|FG000|Period 1|Positive answer for exclusion criteria|0|||
126444954|NCT01262989|454928170|FG001|Period 1|Positive answer for exclusion criteria|1|||
126444955|NCT01262989|454928169|FG000|Period 2|Intercurrent disease|0|||
126444956|NCT01262989|454928170|FG001|Period 2|Intercurrent disease|1|||
126444957|NCT02813577|454928171|FG000|Overall Study|Study terminated|4|||
126444958|NCT02023697|454928177|FG000|Treatment Period|Radiological progression|13|||
126444959|NCT02023697|454928178|FG001|Treatment Period|Radiological progression|17|||
126444960|NCT02023697|454928179|FG002|Treatment Period|Radiological progression|26|||
126444961|NCT02023697|454928177|FG000|Treatment Period|Never Treated|5|||
126692582|NCT03502330|455830730|FG000|Overall Study|Adverse Event|2|||
126692583|NCT03502330|455830731|FG001|Overall Study|Adverse Event|1|||
126692584|NCT03502330|455830732|FG002|Overall Study|Adverse Event|0|||
126692585|NCT03502330|455830733|FG003|Overall Study|Adverse Event|0|||
126692586|NCT03502330|455830734|FG004|Overall Study|Adverse Event|1|||
126692587|NCT03502330|455830735|FG005|Overall Study|Adverse Event|0|||
126692588|NCT03502330|455830736|FG006|Overall Study|Adverse Event|1|||
126692589|NCT03502330|455830737|FG007|Overall Study|Adverse Event|1|||
126692590|NCT03502330|455830738|FG008|Overall Study|Adverse Event|0|||
126692591|NCT03502330|455830730|FG000|Overall Study|Lack of Efficacy|1|||
126692592|NCT03502330|455830731|FG001|Overall Study|Lack of Efficacy|5|||
126692593|NCT03502330|455830732|FG002|Overall Study|Lack of Efficacy|3|||
126692594|NCT03502330|455830733|FG003|Overall Study|Lack of Efficacy|5|||
126692595|NCT03502330|455830734|FG004|Overall Study|Lack of Efficacy|1|||
126692596|NCT03502330|455830735|FG005|Overall Study|Lack of Efficacy|5|||
126692597|NCT03502330|455830736|FG006|Overall Study|Lack of Efficacy|5|||
126692598|NCT03502330|455830737|FG007|Overall Study|Lack of Efficacy|6|||
126692599|NCT03502330|455830738|FG008|Overall Study|Lack of Efficacy|0|||
126692600|NCT03502330|455830730|FG000|Overall Study|Physician Decision|0|||
126692601|NCT03502330|455830731|FG001|Overall Study|Physician Decision|0|||
126692602|NCT03502330|455830732|FG002|Overall Study|Physician Decision|0|||
126692603|NCT03502330|455830733|FG003|Overall Study|Physician Decision|0|||
126692604|NCT03502330|455830734|FG004|Overall Study|Physician Decision|1|||
126444962|NCT02023697|454928178|FG001|Treatment Period|Never Treated|6|||
126444963|NCT02023697|454928179|FG002|Treatment Period|Never Treated|10|||
126444964|NCT02023697|454928177|FG000|Treatment Period|Adverse Event|13|||
126444965|NCT02023697|454928178|FG001|Treatment Period|Adverse Event|25|||
126444966|NCT02023697|454928179|FG002|Treatment Period|Adverse Event|23|||
126692605|NCT03502330|455830735|FG005|Overall Study|Physician Decision|0|||
126692606|NCT03502330|455830736|FG006|Overall Study|Physician Decision|0|||
126692607|NCT03502330|455830737|FG007|Overall Study|Physician Decision|0|||
126692608|NCT03502330|455830738|FG008|Overall Study|Physician Decision|0|||
126692609|NCT03502330|455830730|FG000|Overall Study|Withdrawal by Subject|0|||
126692610|NCT03502330|455830731|FG001|Overall Study|Withdrawal by Subject|0|||
126444967|NCT02023697|454928177|FG000|Treatment Period|Logistical difficulties|1|||
126444968|NCT02023697|454928178|FG001|Treatment Period|Logistical difficulties|1|||
126444969|NCT02023697|454928179|FG002|Treatment Period|Logistical difficulties|1|||
126444970|NCT02023697|454928177|FG000|Treatment Period|Clinical progression|10|||
126692611|NCT03502330|455830732|FG002|Overall Study|Withdrawal by Subject|0|||
126692612|NCT03502330|455830733|FG003|Overall Study|Withdrawal by Subject|0|||
126692613|NCT03502330|455830734|FG004|Overall Study|Withdrawal by Subject|0|||
126692614|NCT03502330|455830735|FG005|Overall Study|Withdrawal by Subject|1|||
126692615|NCT03502330|455830736|FG006|Overall Study|Withdrawal by Subject|0|||
126692616|NCT03502330|455830737|FG007|Overall Study|Withdrawal by Subject|1|||
126692617|NCT03502330|455830738|FG008|Overall Study|Withdrawal by Subject|0|||
126692618|NCT03502330|455830730|FG000|Overall Study|Death|0|||
126692619|NCT03502330|455830731|FG001|Overall Study|Death|0|||
126692620|NCT03502330|455830732|FG002|Overall Study|Death|0|||
126692621|NCT03502330|455830733|FG003|Overall Study|Death|0|||
126692622|NCT03502330|455830734|FG004|Overall Study|Death|0|||
126692623|NCT03502330|455830735|FG005|Overall Study|Death|0|||
126692624|NCT03502330|455830736|FG006|Overall Study|Death|2|||
126692625|NCT03502330|455830737|FG007|Overall Study|Death|0|||
126692626|NCT03502330|455830738|FG008|Overall Study|Death|0|||
126444971|NCT02023697|454928178|FG001|Treatment Period|Clinical progression|8|||
126444972|NCT02023697|454928179|FG002|Treatment Period|Clinical progression|28|||
126444973|NCT02023697|454928177|FG000|Treatment Period|Withdrawal by Subject|4|||
126444974|NCT02023697|454928178|FG001|Treatment Period|Withdrawal by Subject|5|||
126444975|NCT02023697|454928179|FG002|Treatment Period|Withdrawal by Subject|13|||
126444976|NCT02023697|454928177|FG000|Treatment Period|Safety outcome reached|0|||
126444977|NCT02023697|454928178|FG001|Treatment Period|Safety outcome reached|1|||
126444978|NCT02023697|454928179|FG002|Treatment Period|Safety outcome reached|0|||
126444979|NCT02023697|454928177|FG000|Treatment Period|Physician Decision|0|||
126444980|NCT02023697|454928178|FG001|Treatment Period|Physician Decision|0|||
126444981|NCT02023697|454928179|FG002|Treatment Period|Physician Decision|1|||
126444982|NCT02023697|454928177|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
126444983|NCT02023697|454928178|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
126444984|NCT02023697|454928179|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
126444985|NCT02023697|454928177|FG000|Active Follow-up Period|Lost to Follow-up|1|||
126444986|NCT02023697|454928178|FG001|Active Follow-up Period|Lost to Follow-up|1|||
126444987|NCT02023697|454928179|FG002|Active Follow-up Period|Lost to Follow-up|1|||
126444988|NCT02023697|454928177|FG000|Active Follow-up Period|Deterioration of general condition|1|||
126444989|NCT02023697|454928178|FG001|Active Follow-up Period|Deterioration of general condition|1|||
126444990|NCT02023697|454928179|FG002|Active Follow-up Period|Deterioration of general condition|1|||
126444991|NCT02023697|454928177|FG000|Active Follow-up Period|Other unspecified|2|||
126444992|NCT02023697|454928178|FG001|Active Follow-up Period|Other unspecified|0|||
126444993|NCT02023697|454928179|FG002|Active Follow-up Period|Other unspecified|1|||
126444994|NCT02023697|454928177|FG000|Active Follow-up Period|Clinical progression|0|||
126444995|NCT02023697|454928178|FG001|Active Follow-up Period|Clinical progression|2|||
126444996|NCT02023697|454928179|FG002|Active Follow-up Period|Clinical progression|1|||
126444997|NCT02023697|454928177|FG000|Active Follow-up Period|Radiological progression|0|||
126444998|NCT02023697|454928178|FG001|Active Follow-up Period|Radiological progression|0|||
126444999|NCT02023697|454928179|FG002|Active Follow-up Period|Radiological progression|1|||
126445000|NCT02023697|454928177|FG000|Active Follow-up Period|Death|83|||
126445001|NCT02023697|454928178|FG001|Active Follow-up Period|Death|82|||
126445002|NCT02023697|454928179|FG002|Active Follow-up Period|Death|87|||
126445003|NCT02023697|454928177|FG000|Long-term Follow-up Period|Death|9|||
126445004|NCT02023697|454928178|FG001|Long-term Follow-up Period|Death|6|||
126445005|NCT02023697|454928179|FG002|Long-term Follow-up Period|Death|4|||
126445006|NCT02023697|454928177|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
126692627|NCT04656990|455830739|FG000|Baseline|pandemic|20|||
126692628|NCT04656990|455830740|FG001|Baseline|pandemic|24|||
126692629|NCT04656990|455830739|FG000|Follow Up Period|Lost to Follow-up|61|||
126692630|NCT04656990|455830740|FG001|Follow Up Period|Lost to Follow-up|73|||
126692631|NCT00282243|455830743|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
126692632|NCT00282243|455830743|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
126445007|NCT02023697|454928178|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
126445008|NCT02023697|454928179|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
126445009|NCT02023697|454928177|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
126692633|NCT00282243|455830743|FG000|Extension Treatment Period|Adverse Event|15|||
126692634|NCT00282243|455830743|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
126445010|NCT02023697|454928178|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
126445011|NCT02023697|454928179|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
126445012|NCT02023697|454928177|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
126445013|NCT02023697|454928178|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
126692635|NCT00282243|455830743|FG000|Extension Treatment Period|Non-compliance|2|||
126692636|NCT00282243|455830743|FG000|Extension Treatment Period|Physician Decision|1|||
126445014|NCT02023697|454928179|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
126445015|NCT02023697|454928177|FG000|Long-term Follow-up Period|Technical problems|0|||
126445016|NCT02023697|454928178|FG001|Long-term Follow-up Period|Technical problems|0|||
126445017|NCT02023697|454928179|FG002|Long-term Follow-up Period|Technical problems|1|||
126445018|NCT02023697|454928177|FG000|Long-term Follow-up Period|Other unspecified|6|||
126445019|NCT02023697|454928178|FG001|Long-term Follow-up Period|Other unspecified|3|||
126445020|NCT02023697|454928179|FG002|Long-term Follow-up Period|Other unspecified|5|||
126445021|NCT00845897|454928180|FG000|Overall Study|Lost to Follow-up|1|||
126445022|NCT00845897|454928181|FG001|Overall Study|Lost to Follow-up|1|||
126445023|NCT00845897|454928182|FG002|Overall Study|Lost to Follow-up|0|||
126445024|NCT00845897|454928180|FG000|Overall Study|Withdrawal by Subject|0|||
126445025|NCT00845897|454928181|FG001|Overall Study|Withdrawal by Subject|3|||
126445026|NCT00845897|454928182|FG002|Overall Study|Withdrawal by Subject|2|||
126445027|NCT00845897|454928180|FG000|Overall Study|Ulcer did not heal|1|||
126445028|NCT00845897|454928181|FG001|Overall Study|Ulcer did not heal|0|||
126445029|NCT00845897|454928182|FG002|Overall Study|Ulcer did not heal|1|||
126445030|NCT00845897|454928180|FG000|Overall Study|Too ill to participate|0|||
126445031|NCT00845897|454928181|FG001|Overall Study|Too ill to participate|1|||
126445032|NCT00845897|454928182|FG002|Overall Study|Too ill to participate|0|||
126445033|NCT00611026|454928183|FG000|Randomized to Double-blind Treatment|Not treated|2|||
126445034|NCT00611026|454928184|FG001|Randomized to Double-blind Treatment|Not treated|1|||
126445035|NCT00611026|454928185|FG002|Randomized to Double-blind Treatment|Not treated|3|||
126445036|NCT00611026|454928183|FG000|Double-blind Treatment Period|Death|1|||
126445037|NCT00611026|454928184|FG001|Double-blind Treatment Period|Death|0|||
126445038|NCT00611026|454928185|FG002|Double-blind Treatment Period|Death|0|||
126692637|NCT01070329|455830744|FG000|Overall Study|Adverse Event|13|||
126692638|NCT01070329|455830745|FG001|Overall Study|Adverse Event|10|||
126692639|NCT01070329|455830744|FG000|Overall Study|Lost to Follow-up|22|||
126692640|NCT01070329|455830745|FG001|Overall Study|Lost to Follow-up|12|||
126692641|NCT01070329|455830744|FG000|Overall Study|Withdrawal by Subject|9|||
126692642|NCT01070329|455830745|FG001|Overall Study|Withdrawal by Subject|11|||
126692643|NCT01070329|455830744|FG000|Overall Study|Protocol Violation|3|||
126692644|NCT01070329|455830745|FG001|Overall Study|Protocol Violation|8|||
126692645|NCT01070329|455830744|FG000|Overall Study|Lack of Efficacy|2|||
126692646|NCT01070329|455830745|FG001|Overall Study|Lack of Efficacy|6|||
126692647|NCT01070329|455830744|FG000|Overall Study|Physician Decision|2|||
126692648|NCT01070329|455830745|FG001|Overall Study|Physician Decision|1|||
126692649|NCT01070329|455830744|FG000|Overall Study|Entry Criteria Not Met|1|||
126692650|NCT01070329|455830745|FG001|Overall Study|Entry Criteria Not Met|0|||
126692651|NCT01070329|455830744|FG000|Overall Study|Sponsor Decision|0|||
126692652|NCT01070329|455830745|FG001|Overall Study|Sponsor Decision|1|||
126692653|NCT02863848|455830746|FG000|Overall Study|Lost to Follow-up|1|||
126692654|NCT02863848|455830747|FG001|Overall Study|Lost to Follow-up|1|||
126692655|NCT02863848|455830746|FG000|Overall Study|Protocol Violation|1|||
126692656|NCT02863848|455830747|FG001|Overall Study|Protocol Violation|2|||
126692657|NCT03588741|455830752|FG000|Overall Study|Withdrawal by Subject|1|||
126692658|NCT00548548|455830753|FG000|Overall Study|Death|345|||
126692659|NCT00548548|455830754|FG001|Overall Study|Death|348|||
126692660|NCT00548548|455830753|FG000|Overall Study|Lost to Follow-up|17|||
126692661|NCT00548548|455830754|FG001|Overall Study|Lost to Follow-up|18|||
126692662|NCT01705691|455830755|FG000|Overall Study|Death|1|||
126445039|NCT00611026|454928183|FG000|Double-blind Treatment Period|Adverse Event|9|||
126445040|NCT00611026|454928184|FG001|Double-blind Treatment Period|Adverse Event|28|||
126445041|NCT00611026|454928185|FG002|Double-blind Treatment Period|Adverse Event|46|||
126445042|NCT00611026|454928183|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
126445043|NCT00611026|454928184|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
126445044|NCT00611026|454928185|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
126692663|NCT01705691|455830756|FG001|Overall Study|Death|2|||
126692664|NCT01705691|455830755|FG000|Overall Study|Withdrawal by Subject|1|||
126692665|NCT01705691|455830756|FG001|Overall Study|Withdrawal by Subject|2|||
126692666|NCT01705691|455830755|FG000|Overall Study|Lost to Follow-up|1|||
126692667|NCT01705691|455830756|FG001|Overall Study|Lost to Follow-up|1|||
126692668|NCT01705691|455830755|FG000|Overall Study|Other|0|||
126692669|NCT01705691|455830756|FG001|Overall Study|Other|1|||
126692670|NCT02913313|455830757|FG000|Overall Study|DISEASE PROGRESSION|1|||
126692671|NCT02913313|455830758|FG001|Overall Study|DISEASE PROGRESSION|2|||
126692672|NCT02913313|455830759|FG002|Overall Study|DISEASE PROGRESSION|2|||
126692673|NCT02913313|455830760|FG003|Overall Study|DISEASE PROGRESSION|4|||
126692674|NCT02913313|455830761|FG004|Overall Study|DISEASE PROGRESSION|6|||
126692675|NCT02913313|455830762|FG005|Overall Study|DISEASE PROGRESSION|4|||
126692676|NCT02913313|455830763|FG006|Overall Study|DISEASE PROGRESSION|19|||
126692677|NCT02913313|455830764|FG007|Overall Study|DISEASE PROGRESSION|3|||
126692678|NCT02913313|455830765|FG008|Overall Study|DISEASE PROGRESSION|4|||
126692679|NCT02913313|455830766|FG009|Overall Study|DISEASE PROGRESSION|4|||
126692680|NCT02913313|455830767|FG010|Overall Study|DISEASE PROGRESSION|11|||
126692681|NCT02913313|455830768|FG011|Overall Study|DISEASE PROGRESSION|5|||
126692682|NCT02913313|455830769|FG012|Overall Study|DISEASE PROGRESSION|14|||
126692683|NCT02913313|455830770|FG013|Overall Study|DISEASE PROGRESSION|3|||
126692684|NCT02913313|455830757|FG000|Overall Study|Not Reported|0|||
126692685|NCT02913313|455830758|FG001|Overall Study|Not Reported|0|||
126692686|NCT02913313|455830759|FG002|Overall Study|Not Reported|0|||
126692687|NCT02913313|455830760|FG003|Overall Study|Not Reported|0|||
126692688|NCT02913313|455830761|FG004|Overall Study|Not Reported|1|||
126692689|NCT02913313|455830762|FG005|Overall Study|Not Reported|0|||
126692690|NCT02913313|455830763|FG006|Overall Study|Not Reported|0|||
126692691|NCT02913313|455830764|FG007|Overall Study|Not Reported|0|||
126692692|NCT02913313|455830765|FG008|Overall Study|Not Reported|0|||
126692693|NCT02913313|455830766|FG009|Overall Study|Not Reported|0|||
126692694|NCT02913313|455830767|FG010|Overall Study|Not Reported|4|||
126355818|NCT00266812|454595567|FG000|Overall Study|Discontinued before starting study drug|4|||
126355819|NCT00266812|454595568|FG001|Overall Study|Discontinued before starting study drug|0|||
126355820|NCT03695094|454595569|FG000|Overall Study|Adverse Event|1|||
126355821|NCT03695094|454595570|FG001|Overall Study|Adverse Event|1|||
126355822|NCT03695094|454595569|FG000|Overall Study|Withdrawal by Subject|1|||
126355823|NCT03695094|454595570|FG001|Overall Study|Withdrawal by Subject|0|||
126355824|NCT00784927|454595573|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
126355825|NCT00784927|454595573|FG000|Overall Study|Protocol Violation|1|||
126355826|NCT00784927|454595573|FG000|Overall Study|Ineligible|1|||
126355827|NCT01795937|454595578|FG000|Overall Study|Withdrawal by Subject|1|||
126355828|NCT01795937|454595579|FG001|Overall Study|Withdrawal by Subject|0|||
126355829|NCT01795937|454595580|FG002|Overall Study|Withdrawal by Subject|0|||
126355830|NCT01795937|454595578|FG000|Overall Study|Physician Decision|0|||
126355831|NCT01795937|454595579|FG001|Overall Study|Physician Decision|1|||
126355832|NCT01795937|454595580|FG002|Overall Study|Physician Decision|0|||
126355833|NCT01028053|454595581|FG000|Overall Study|Screen Failure|113|||
126355834|NCT01028053|454595581|FG000|Overall Study|Patient Request|11|||
126355835|NCT01028053|454595581|FG000|Overall Study|Protocol Violation|1|||
126355836|NCT01028053|454595581|FG000|Overall Study|Physician Decision|2|||
126355837|NCT01028053|454595581|FG000|Overall Study|Technical Problem|1|||
126355838|NCT01028053|454595581|FG000|Overall Study|Terminated by Sponsor|1|||
126355839|NCT01028053|454595581|FG000|Overall Study|Various reasons|4|||
126355840|NCT04027946|454595582|FG000|Overall Study|Screen failures|3|||
126355841|NCT00983957|454595583|FG000|Overall Study|Adverse Event|1|||
126355842|NCT00983957|454595583|FG000|Overall Study|Personal Reasons|1|||
126355843|NCT00790933|454595584|FG000|Overall Study|Adverse Event|94|||
126355844|NCT00790933|454595585|FG001|Overall Study|Adverse Event|119|||
126355845|NCT00790933|454595586|FG002|Overall Study|Adverse Event|65|||
126355846|NCT00790933|454595587|FG003|Overall Study|Adverse Event|5|||
126355847|NCT00790933|454595588|FG004|Overall Study|Adverse Event|69|||
126355848|NCT00790933|454595584|FG000|Overall Study|Protocol Violation(s)|8|||
126355849|NCT00790933|454595585|FG001|Overall Study|Protocol Violation(s)|18|||
126355850|NCT00790933|454595586|FG002|Overall Study|Protocol Violation(s)|7|||
126355851|NCT00790933|454595587|FG003|Overall Study|Protocol Violation(s)|0|||
126355852|NCT00790933|454595588|FG004|Overall Study|Protocol Violation(s)|12|||
126355853|NCT00790933|454595584|FG000|Overall Study|Lack of Efficacy|192|||
126355854|NCT00790933|454595585|FG001|Overall Study|Lack of Efficacy|176|||
126355855|NCT00790933|454595586|FG002|Overall Study|Lack of Efficacy|130|||
126355856|NCT00790933|454595587|FG003|Overall Study|Lack of Efficacy|1|||
126355857|NCT00790933|454595588|FG004|Overall Study|Lack of Efficacy|121|||
126355858|NCT00790933|454595584|FG000|Overall Study|Study Terminated by Sponsor|0|||
126355859|NCT00790933|454595585|FG001|Overall Study|Study Terminated by Sponsor|0|||
126445045|NCT00611026|454928183|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
126692695|NCT02913313|455830768|FG011|Overall Study|Not Reported|0|||
126355860|NCT00790933|454595586|FG002|Overall Study|Study Terminated by Sponsor|1|||
126355861|NCT00790933|454595587|FG003|Overall Study|Study Terminated by Sponsor|0|||
126355862|NCT00790933|454595588|FG004|Overall Study|Study Terminated by Sponsor|0|||
126355863|NCT00790933|454595584|FG000|Overall Study|Withdrawal by Subject|123|||
126355864|NCT00790933|454595585|FG001|Overall Study|Withdrawal by Subject|120|||
126355865|NCT00790933|454595586|FG002|Overall Study|Withdrawal by Subject|52|||
126355866|NCT00790933|454595587|FG003|Overall Study|Withdrawal by Subject|6|||
126355867|NCT00790933|454595588|FG004|Overall Study|Withdrawal by Subject|50|||
126692696|NCT02913313|455830769|FG012|Overall Study|Not Reported|0|||
126445046|NCT00611026|454928184|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
126445047|NCT00611026|454928185|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
126445048|NCT00611026|454928183|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
126445049|NCT00611026|454928184|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
126445050|NCT00611026|454928185|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
126445051|NCT00611026|454928183|FG000|Double-blind Treatment Period|Other|13|||
126445052|NCT00611026|454928184|FG001|Double-blind Treatment Period|Other|20|||
126445053|NCT00611026|454928185|FG002|Double-blind Treatment Period|Other|18|||
126445054|NCT05019521|454928186|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
126445055|NCT05019521|454928187|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
126445056|NCT05019521|454928188|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
126445057|NCT05019521|454928189|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
126445058|NCT05019521|454928190|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
126445059|NCT05019521|454928191|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
126445060|NCT05019521|454928192|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
126445061|NCT05019521|454928186|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
126445062|NCT05019521|454928187|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
126445063|NCT05019521|454928188|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
126445064|NCT05019521|454928189|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
126445065|NCT05019521|454928190|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
126445066|NCT05019521|454928191|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
126445067|NCT05019521|454928192|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
126445068|NCT05019521|454928186|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
126445069|NCT05019521|454928187|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
126445070|NCT05019521|454928188|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
126445071|NCT05019521|454928189|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
126692697|NCT02913313|455830770|FG013|Overall Study|Not Reported|0|||
126692698|NCT02913313|455830757|FG000|Overall Study|Other reasons|0|||
126692699|NCT02913313|455830758|FG001|Overall Study|Other reasons|0|||
126445072|NCT05019521|454928190|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
126445073|NCT05019521|454928191|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
126445074|NCT05019521|454928192|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
126445075|NCT05019521|454928186|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
126445076|NCT05019521|454928187|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
126445077|NCT05019521|454928188|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
126445078|NCT05019521|454928189|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
126445079|NCT05019521|454928190|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
126445080|NCT05019521|454928191|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
126445081|NCT05019521|454928192|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
126692700|NCT02913313|455830759|FG002|Overall Study|Other reasons|0|||
126692701|NCT02913313|455830760|FG003|Overall Study|Other reasons|0|||
126692702|NCT02913313|455830761|FG004|Overall Study|Other reasons|1|||
126692703|NCT02913313|455830762|FG005|Overall Study|Other reasons|0|||
126692704|NCT02913313|455830763|FG006|Overall Study|Other reasons|0|||
126692705|NCT02913313|455830764|FG007|Overall Study|Other reasons|0|||
126692706|NCT02913313|455830765|FG008|Overall Study|Other reasons|0|||
126692707|NCT02913313|455830766|FG009|Overall Study|Other reasons|0|||
126692708|NCT02913313|455830767|FG010|Overall Study|Other reasons|1|||
126692709|NCT02913313|455830768|FG011|Overall Study|Other reasons|0|||
126692710|NCT02913313|455830769|FG012|Overall Study|Other reasons|0|||
126692711|NCT02913313|455830770|FG013|Overall Study|Other reasons|0|||
126692712|NCT02913313|455830757|FG000|Overall Study|Withdrawal by Subject|0|||
126692713|NCT02913313|455830758|FG001|Overall Study|Withdrawal by Subject|0|||
126692714|NCT02913313|455830759|FG002|Overall Study|Withdrawal by Subject|1|||
126692715|NCT02913313|455830760|FG003|Overall Study|Withdrawal by Subject|0|||
126692716|NCT02913313|455830761|FG004|Overall Study|Withdrawal by Subject|0|||
126692717|NCT02913313|455830762|FG005|Overall Study|Withdrawal by Subject|0|||
126692718|NCT02913313|455830763|FG006|Overall Study|Withdrawal by Subject|1|||
126692719|NCT02913313|455830764|FG007|Overall Study|Withdrawal by Subject|1|||
126692720|NCT02913313|455830765|FG008|Overall Study|Withdrawal by Subject|0|||
126692721|NCT02913313|455830766|FG009|Overall Study|Withdrawal by Subject|0|||
126692722|NCT02913313|455830767|FG010|Overall Study|Withdrawal by Subject|1|||
126692723|NCT02913313|455830768|FG011|Overall Study|Withdrawal by Subject|0|||
126692724|NCT02913313|455830769|FG012|Overall Study|Withdrawal by Subject|0|||
126692725|NCT02913313|455830770|FG013|Overall Study|Withdrawal by Subject|0|||
126692726|NCT02913313|455830757|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126692727|NCT02913313|455830758|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126692728|NCT02913313|455830759|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126692729|NCT02913313|455830760|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126692730|NCT02913313|455830761|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126445082|NCT05019521|454928186|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
126445083|NCT05019521|454928187|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
126445084|NCT05019521|454928188|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
126445085|NCT05019521|454928189|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
126445086|NCT05019521|454928190|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
126445087|NCT05019521|454928191|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
126445088|NCT05019521|454928192|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
126692731|NCT02913313|455830762|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126445089|NCT05019521|454928186|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
126445090|NCT05019521|454928187|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
126445091|NCT05019521|454928188|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
126445092|NCT05019521|454928189|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
126692732|NCT02913313|455830763|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126692733|NCT02913313|455830764|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126692734|NCT02913313|455830765|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126692735|NCT02913313|455830766|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126692736|NCT02913313|455830767|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
126692737|NCT02913313|455830768|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
126692738|NCT02913313|455830769|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
126692739|NCT02913313|455830770|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
126692740|NCT02913313|455830757|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
126692741|NCT02913313|455830758|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
126692742|NCT02913313|455830759|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
126692743|NCT02913313|455830760|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
126692744|NCT02913313|455830761|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
126692745|NCT02913313|455830762|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
126692746|NCT02913313|455830763|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
126692747|NCT02913313|455830764|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
126692748|NCT02913313|455830765|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
126692749|NCT02913313|455830766|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
126692750|NCT02913313|455830767|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
126692751|NCT02913313|455830768|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
126692752|NCT02913313|455830769|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
126692753|NCT02913313|455830770|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
126692754|NCT04088409|455830771|FG000|Part A|Withdrawal by Subject|2|||
126692755|NCT04088409|455830772|FG001|Part A|Withdrawal by Subject|1|||
126692756|NCT04088409|455830771|FG000|Part A|Did Not Meet Randomization Criteria|2|||
126692757|NCT04088409|455830772|FG001|Part A|Did Not Meet Randomization Criteria|0|||
126692758|NCT04088409|455830771|FG000|Part A|Lack of Efficacy|9|||
126692759|NCT04088409|455830772|FG001|Part A|Lack of Efficacy|0|||
126692760|NCT04088409|455830771|FG000|Part A|Lost to Follow-up|1|||
126692761|NCT04088409|455830772|FG001|Part A|Lost to Follow-up|0|||
126692762|NCT04088409|455830771|FG000|Part A|Adverse Event|1|||
126692763|NCT04088409|455830772|FG001|Part A|Adverse Event|0|||
126692764|NCT04088409|455830771|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
126692765|NCT04088409|455830772|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
126692766|NCT04088409|455830771|FG000|Part B|Ongoing Treatment|10|||
126692767|NCT04088409|455830772|FG001|Part B|Ongoing Treatment|0|||
126692768|NCT04233229|455830773|FG000|Overall Study|Withdrawal by Subject|0|||
126692769|NCT04233229|455830774|FG001|Overall Study|Withdrawal by Subject|1|||
126692770|NCT04233229|455830773|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
126692771|NCT04233229|455830774|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
126692772|NCT04233229|455830773|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
126692773|NCT04233229|455830774|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
126692774|NCT00841763|455830775|FG000|Overall Study|Withdrawal by Subject|60|||
126692775|NCT00841763|455830776|FG001|Overall Study|Withdrawal by Subject|17|||
126692776|NCT00841763|455830777|FG002|Overall Study|Withdrawal by Subject|4|||
126692777|NCT00841763|455830778|FG003|Overall Study|Withdrawal by Subject|1|||
126692778|NCT00841763|455830775|FG000|Overall Study|Adverse Event|9|||
126692779|NCT00841763|455830776|FG001|Overall Study|Adverse Event|10|||
126692780|NCT00841763|455830777|FG002|Overall Study|Adverse Event|3|||
126692781|NCT00841763|455830778|FG003|Overall Study|Adverse Event|2|||
126445093|NCT05019521|454928190|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
126445094|NCT05019521|454928191|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
126463789|NCT00423670|455000238|FG007|Follow-up Period|Non-compliance with protocol|2|||
126692782|NCT00841763|455830775|FG000|Overall Study|Lost to Follow-up|63|||
126692783|NCT00841763|455830776|FG001|Overall Study|Lost to Follow-up|25|||
126692784|NCT00841763|455830777|FG002|Overall Study|Lost to Follow-up|0|||
126692785|NCT00841763|455830778|FG003|Overall Study|Lost to Follow-up|0|||
126692786|NCT00841763|455830775|FG000|Overall Study|Protocol Violation|20|||
126692787|NCT00841763|455830776|FG001|Overall Study|Protocol Violation|3|||
126445095|NCT05019521|454928192|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
126445096|NCT05019521|454928186|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
126445097|NCT05019521|454928187|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
126445098|NCT05019521|454928188|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
126445099|NCT05019521|454928189|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
126445100|NCT05019521|454928190|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
126445101|NCT05019521|454928191|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
126445102|NCT05019521|454928192|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
126692788|NCT00841763|455830777|FG002|Overall Study|Protocol Violation|1|||
126692789|NCT00841763|455830778|FG003|Overall Study|Protocol Violation|0|||
126692790|NCT00841763|455830775|FG000|Overall Study|Administrative Reasons|3|||
126692791|NCT00841763|455830776|FG001|Overall Study|Administrative Reasons|1|||
126692792|NCT00841763|455830777|FG002|Overall Study|Administrative Reasons|0|||
126692793|NCT00841763|455830778|FG003|Overall Study|Administrative Reasons|0|||
126692794|NCT00841763|455830775|FG000|Overall Study|Unable to Classify|7|||
126692795|NCT00841763|455830776|FG001|Overall Study|Unable to Classify|1|||
126692796|NCT00841763|455830777|FG002|Overall Study|Unable to Classify|0|||
126692797|NCT00841763|455830778|FG003|Overall Study|Unable to Classify|0|||
126692798|NCT02631538|455830779|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
126692799|NCT02631538|455830780|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
126692800|NCT02631538|455830781|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
126692801|NCT02631538|455830782|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
126692802|NCT02631538|455830779|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
126692803|NCT02631538|455830780|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
126692804|NCT02631538|455830781|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
126692805|NCT02631538|455830782|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
126692806|NCT02631538|455830779|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
126692807|NCT02631538|455830780|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
126692808|NCT02631538|455830781|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
126692809|NCT02631538|455830782|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
126692810|NCT02631538|455830779|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
126692811|NCT02631538|455830780|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
126692812|NCT02631538|455830781|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
126692813|NCT02631538|455830782|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
126692814|NCT02631538|455830779|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
126692815|NCT02631538|455830780|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
126692816|NCT02631538|455830781|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
126692817|NCT02631538|455830782|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
126692818|NCT02631538|455830779|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
126692819|NCT02631538|455830780|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
126692820|NCT02631538|455830781|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
126692821|NCT02631538|455830782|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
126692822|NCT00648167|455830783|FG000|Overall Study|Adverse Event|6|||
126692823|NCT00648167|455830783|FG000|Overall Study|unable to swallow tablets|1|||
126692824|NCT00440726|455830789|FG000|Phase 1|Dose-Limiting Toxicity|0|||
126692825|NCT00440726|455830790|FG001|Phase 1|Dose-Limiting Toxicity|1|||
126692826|NCT00440726|455830791|FG002|Phase 1|Dose-Limiting Toxicity|0|||
126692827|NCT00440726|455830789|FG000|Phase 1|Physician Decision|1|||
126692828|NCT00440726|455830790|FG001|Phase 1|Physician Decision|0|||
126692829|NCT00440726|455830791|FG002|Phase 1|Physician Decision|0|||
126692830|NCT00440726|455830789|FG000|Phase 2|Death|0|||
126692831|NCT00440726|455830790|FG001|Phase 2|Death|0|||
126692832|NCT00440726|455830791|FG002|Phase 2|Death|1|||
126692833|NCT00440726|455830789|FG000|Phase 2|Adverse Event|0|||
126692834|NCT00440726|455830790|FG001|Phase 2|Adverse Event|0|||
126692835|NCT00440726|455830791|FG002|Phase 2|Adverse Event|1|||
126692836|NCT01482910|455830792|FG000|Overall Study|Adverse Event|6|||
126692837|NCT01482910|455830793|FG001|Overall Study|Adverse Event|5|||
126692838|NCT01482910|455830792|FG000|Overall Study|Lost to Follow-up|0|||
126692839|NCT01482910|455830793|FG001|Overall Study|Lost to Follow-up|1|||
126692840|NCT01482910|455830792|FG000|Overall Study|Protocol Violation|1|||
126692841|NCT01482910|455830793|FG001|Overall Study|Protocol Violation|1|||
126692842|NCT01482910|455830792|FG000|Overall Study|Withdrawal by Subject|7|||
126692843|NCT01482910|455830793|FG001|Overall Study|Withdrawal by Subject|2|||
126692844|NCT01482910|455830792|FG000|Overall Study|Death|1|||
126692845|NCT01482910|455830793|FG001|Overall Study|Death|0|||
126692846|NCT03370770|455830794|FG000|Overall Study|Patient was followed in another hospital center|1|||
126692847|NCT03370770|455830794|FG000|Overall Study|Progressive Disease|98|||
126692848|NCT03370770|455830794|FG000|Overall Study|Adverse Event|2|||
126692849|NCT03370770|455830794|FG000|Overall Study|Death|5|||
126692850|NCT00234039|455830795|FG000|Overall Study|Adverse Event|2|||
126692851|NCT00234039|455830795|FG000|Overall Study|Progression/relapse|34|||
126692852|NCT00234039|455830795|FG000|Overall Study|Other - Not Protocol Specified|3|||
126692853|NCT00234039|455830795|FG000|Overall Study|Ineligible|9|||
126445103|NCT05019521|454928186|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
126445104|NCT05019521|454928187|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
126445105|NCT05019521|454928188|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
126445106|NCT05019521|454928189|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
126445107|NCT05019521|454928190|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
126445108|NCT05019521|454928191|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
126445109|NCT05019521|454928192|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
126445110|NCT05019521|454928186|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
126445111|NCT05019521|454928187|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
126445112|NCT05019521|454928188|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
126445113|NCT05019521|454928189|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
126445114|NCT05019521|454928190|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
126445115|NCT05019521|454928191|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
126445116|NCT05019521|454928192|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
126445117|NCT05019521|454928186|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
126445118|NCT05019521|454928187|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
126445119|NCT05019521|454928188|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
126445120|NCT05019521|454928189|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
126445121|NCT05019521|454928190|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
126445122|NCT05019521|454928191|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
126445123|NCT05019521|454928192|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
126445124|NCT05019521|454928186|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
126445125|NCT05019521|454928187|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
126445126|NCT05019521|454928188|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
126445127|NCT05019521|454928189|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
126445128|NCT05019521|454928190|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
126445129|NCT05019521|454928191|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
126445130|NCT05019521|454928192|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
126445131|NCT05019521|454928186|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
126445132|NCT05019521|454928187|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
126445133|NCT05019521|454928188|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
126445134|NCT05019521|454928189|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
126445135|NCT05019521|454928190|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
126445136|NCT05019521|454928191|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
126445137|NCT05019521|454928192|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
126445138|NCT05019521|454928186|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
126692854|NCT00234039|455830795|FG000|Overall Study|No Protocol Treatment Received|2|||
126692855|NCT00110019|455830798|FG000|Overall Study|Lack of Efficacy|253|||
126692856|NCT00110019|455830799|FG001|Overall Study|Lack of Efficacy|285|||
126692857|NCT00110019|455830798|FG000|Overall Study|Adverse Event|61|||
126692858|NCT00110019|455830799|FG001|Overall Study|Adverse Event|40|||
126692859|NCT00110019|455830798|FG000|Overall Study|Death|13|||
126692860|NCT00110019|455830799|FG001|Overall Study|Death|15|||
126692861|NCT00110019|455830798|FG000|Overall Study|Withdrawal by Subject|21|||
126692862|NCT00110019|455830799|FG001|Overall Study|Withdrawal by Subject|9|||
126692863|NCT00110019|455830798|FG000|Overall Study|alternative therapy|5|||
126692864|NCT00110019|455830799|FG001|Overall Study|alternative therapy|1|||
126692865|NCT00110019|455830798|FG000|Overall Study|complicating disease|1|||
126692866|NCT00110019|455830799|FG001|Overall Study|complicating disease|1|||
126692867|NCT00110019|455830798|FG000|Overall Study|symptom deterioration|13|||
126692868|NCT00110019|455830799|FG001|Overall Study|symptom deterioration|16|||
126692869|NCT00110019|455830798|FG000|Overall Study|Not start protocol therapy|17|||
126692870|NCT00110019|455830799|FG001|Overall Study|Not start protocol therapy|16|||
126692871|NCT00110019|455830798|FG000|Overall Study|other reasons|22|||
126692872|NCT00110019|455830799|FG001|Overall Study|other reasons|30|||
126692873|NCT04426695|455830802|FG000|Overall Study|Death|2|||
126692874|NCT04426695|455830803|FG001|Overall Study|Death|0|||
126692875|NCT04426695|455830804|FG002|Overall Study|Death|1|||
126692876|NCT04426695|455830805|FG003|Overall Study|Death|27|||
126692877|NCT04426695|455830806|FG004|Overall Study|Death|25|||
126692878|NCT04426695|455830807|FG005|Overall Study|Death|21|||
126692879|NCT04426695|455830808|FG006|Overall Study|Death|42|||
126692880|NCT04426695|455830809|FG007|Overall Study|Death|23|||
126692881|NCT04426695|455830810|FG008|Overall Study|Death|37|||
126692882|NCT04426695|455830811|FG009|Overall Study|Death|14|||
126692883|NCT04426695|455830812|FG010|Overall Study|Death|8|||
126692884|NCT04426695|455830813|FG011|Overall Study|Death|7|||
126692885|NCT04426695|455830814|FG012|Overall Study|Death|13|||
126692886|NCT04426695|455830815|FG013|Overall Study|Death|25|||
126692887|NCT04426695|455830816|FG014|Overall Study|Death|19|||
126692888|NCT04426695|455830817|FG015|Overall Study|Death|7|||
126692889|NCT04426695|455830818|FG016|Overall Study|Death|8|||
126445139|NCT05019521|454928187|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
126445140|NCT05019521|454928188|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
126463790|NCT03282565|455000240|FG000|Overall Study|COVID-19 Research Shutdown|0|||
126692890|NCT04426695|455830819|FG017|Overall Study|Death|4|||
126692891|NCT04426695|455830802|FG000|Overall Study|Lost to Follow-up|2|||
126692892|NCT04426695|455830803|FG001|Overall Study|Lost to Follow-up|4|||
126692893|NCT04426695|455830804|FG002|Overall Study|Lost to Follow-up|1|||
126692894|NCT04426695|455830805|FG003|Overall Study|Lost to Follow-up|19|||
126692895|NCT04426695|455830806|FG004|Overall Study|Lost to Follow-up|10|||
126692896|NCT04426695|455830807|FG005|Overall Study|Lost to Follow-up|14|||
126692897|NCT04426695|455830808|FG006|Overall Study|Lost to Follow-up|5|||
126692898|NCT04426695|455830809|FG007|Overall Study|Lost to Follow-up|14|||
126692899|NCT04426695|455830810|FG008|Overall Study|Lost to Follow-up|10|||
126692900|NCT04426695|455830811|FG009|Overall Study|Lost to Follow-up|11|||
126692901|NCT04426695|455830812|FG010|Overall Study|Lost to Follow-up|12|||
126692902|NCT04426695|455830813|FG011|Overall Study|Lost to Follow-up|6|||
126692903|NCT04426695|455830814|FG012|Overall Study|Lost to Follow-up|2|||
126692904|NCT04426695|455830815|FG013|Overall Study|Lost to Follow-up|2|||
126692905|NCT04426695|455830816|FG014|Overall Study|Lost to Follow-up|2|||
126692906|NCT04426695|455830817|FG015|Overall Study|Lost to Follow-up|0|||
126692907|NCT04426695|455830818|FG016|Overall Study|Lost to Follow-up|0|||
126692908|NCT04426695|455830819|FG017|Overall Study|Lost to Follow-up|0|||
126692909|NCT04426695|455830802|FG000|Overall Study|Participant Decision|1|||
126692910|NCT04426695|455830803|FG001|Overall Study|Participant Decision|2|||
126692911|NCT04426695|455830804|FG002|Overall Study|Participant Decision|2|||
126692912|NCT04426695|455830805|FG003|Overall Study|Participant Decision|12|||
126692913|NCT04426695|455830806|FG004|Overall Study|Participant Decision|18|||
126692914|NCT04426695|455830807|FG005|Overall Study|Participant Decision|22|||
126692915|NCT04426695|455830808|FG006|Overall Study|Participant Decision|13|||
126692916|NCT04426695|455830809|FG007|Overall Study|Participant Decision|13|||
126692917|NCT04426695|455830810|FG008|Overall Study|Participant Decision|10|||
126692918|NCT04426695|455830811|FG009|Overall Study|Participant Decision|15|||
126692919|NCT04426695|455830812|FG010|Overall Study|Participant Decision|16|||
126692920|NCT04426695|455830813|FG011|Overall Study|Participant Decision|17|||
126692921|NCT04426695|455830814|FG012|Overall Study|Participant Decision|2|||
126692922|NCT04426695|455830815|FG013|Overall Study|Participant Decision|1|||
126692923|NCT04426695|455830816|FG014|Overall Study|Participant Decision|2|||
126692924|NCT04426695|455830817|FG015|Overall Study|Participant Decision|0|||
126692925|NCT04426695|455830818|FG016|Overall Study|Participant Decision|0|||
126692926|NCT04426695|455830819|FG017|Overall Study|Participant Decision|0|||
126692927|NCT04426695|455830802|FG000|Overall Study|Adverse Event|0|||
126692928|NCT04426695|455830803|FG001|Overall Study|Adverse Event|0|||
126692929|NCT04426695|455830804|FG002|Overall Study|Adverse Event|0|||
126692930|NCT04426695|455830805|FG003|Overall Study|Adverse Event|0|||
126760597|NCT00129220|456073853|FG001|Study Period II|Protocol Violation|2|||
126760598|NCT00129220|456073854|FG002|Study Period II|Protocol Violation|1|||
126760599|NCT00129220|456073852|FG000|Study Period II|Physician Decision|0|||
126760600|NCT00129220|456073853|FG001|Study Period II|Physician Decision|1|||
126760601|NCT00129220|456073854|FG002|Study Period II|Physician Decision|0|||
126760602|NCT00129220|456073852|FG000|Study Period II|Withdrawal by Subject|1|||
126760603|NCT00129220|456073853|FG001|Study Period II|Withdrawal by Subject|3|||
126760604|NCT00129220|456073854|FG002|Study Period II|Withdrawal by Subject|4|||
126760605|NCT00129220|456073852|FG000|Study Period II|Reason Not Specified|2|||
126760606|NCT00129220|456073853|FG001|Study Period II|Reason Not Specified|0|||
126760607|NCT00129220|456073854|FG002|Study Period II|Reason Not Specified|5|||
126760608|NCT00129220|456073852|FG000|Study Period III|Adverse Event|1|||
126760609|NCT00129220|456073853|FG001|Study Period III|Adverse Event|0|||
126760610|NCT00129220|456073854|FG002|Study Period III|Adverse Event|3|||
126760611|NCT00129220|456073852|FG000|Study Period III|Protocol Violation|1|||
126760612|NCT00129220|456073853|FG001|Study Period III|Protocol Violation|1|||
126760613|NCT00129220|456073854|FG002|Study Period III|Protocol Violation|2|||
126760614|NCT00129220|456073852|FG000|Study Period III|Withdrawal by Subject|1|||
126760615|NCT00129220|456073853|FG001|Study Period III|Withdrawal by Subject|0|||
126760616|NCT00129220|456073854|FG002|Study Period III|Withdrawal by Subject|3|||
126692931|NCT04426695|455830806|FG004|Overall Study|Adverse Event|0|||
126692932|NCT04426695|455830807|FG005|Overall Study|Adverse Event|0|||
126760617|NCT00129220|456073852|FG000|Study Period III|Sponsor Decision|1|||
126760618|NCT00129220|456073853|FG001|Study Period III|Sponsor Decision|0|||
126760619|NCT00129220|456073854|FG002|Study Period III|Sponsor Decision|0|||
126692933|NCT04426695|455830808|FG006|Overall Study|Adverse Event|0|||
126692934|NCT04426695|455830809|FG007|Overall Study|Adverse Event|1|||
126692935|NCT04426695|455830810|FG008|Overall Study|Adverse Event|0|||
126692936|NCT04426695|455830811|FG009|Overall Study|Adverse Event|0|||
126692937|NCT04426695|455830812|FG010|Overall Study|Adverse Event|1|||
126692938|NCT04426695|455830813|FG011|Overall Study|Adverse Event|1|||
126692939|NCT04426695|455830814|FG012|Overall Study|Adverse Event|0|||
126692940|NCT04426695|455830815|FG013|Overall Study|Adverse Event|0|||
126692941|NCT04426695|455830816|FG014|Overall Study|Adverse Event|0|||
126692942|NCT04426695|455830817|FG015|Overall Study|Adverse Event|0|||
126692943|NCT04426695|455830818|FG016|Overall Study|Adverse Event|0|||
126692944|NCT04426695|455830819|FG017|Overall Study|Adverse Event|0|||
126692945|NCT04426695|455830802|FG000|Overall Study|Sponsor Request|0|||
126692946|NCT04426695|455830803|FG001|Overall Study|Sponsor Request|0|||
126692947|NCT04426695|455830804|FG002|Overall Study|Sponsor Request|0|||
126692948|NCT04426695|455830805|FG003|Overall Study|Sponsor Request|0|||
126692949|NCT04426695|455830806|FG004|Overall Study|Sponsor Request|0|||
126692950|NCT04426695|455830807|FG005|Overall Study|Sponsor Request|0|||
126692951|NCT04426695|455830808|FG006|Overall Study|Sponsor Request|1|||
126692952|NCT04426695|455830809|FG007|Overall Study|Sponsor Request|0|||
126692953|NCT04426695|455830810|FG008|Overall Study|Sponsor Request|0|||
126692954|NCT04426695|455830811|FG009|Overall Study|Sponsor Request|0|||
126692955|NCT04426695|455830812|FG010|Overall Study|Sponsor Request|0|||
126692956|NCT04426695|455830813|FG011|Overall Study|Sponsor Request|0|||
126692957|NCT04426695|455830814|FG012|Overall Study|Sponsor Request|0|||
126692958|NCT04426695|455830815|FG013|Overall Study|Sponsor Request|0|||
126692959|NCT04426695|455830816|FG014|Overall Study|Sponsor Request|0|||
126692960|NCT04426695|455830817|FG015|Overall Study|Sponsor Request|0|||
126692961|NCT04426695|455830818|FG016|Overall Study|Sponsor Request|0|||
126692962|NCT04426695|455830819|FG017|Overall Study|Sponsor Request|0|||
126692963|NCT04426695|455830802|FG000|Overall Study|Physician Decision|0|||
126692964|NCT04426695|455830803|FG001|Overall Study|Physician Decision|0|||
126692965|NCT04426695|455830804|FG002|Overall Study|Physician Decision|0|||
126692966|NCT04426695|455830805|FG003|Overall Study|Physician Decision|0|||
126692967|NCT04426695|455830806|FG004|Overall Study|Physician Decision|0|||
126692968|NCT04426695|455830807|FG005|Overall Study|Physician Decision|0|||
126692969|NCT04426695|455830808|FG006|Overall Study|Physician Decision|0|||
126692970|NCT04426695|455830809|FG007|Overall Study|Physician Decision|0|||
126692971|NCT04426695|455830810|FG008|Overall Study|Physician Decision|0|||
126692972|NCT04426695|455830811|FG009|Overall Study|Physician Decision|1|||
126692973|NCT04426695|455830812|FG010|Overall Study|Physician Decision|0|||
126692974|NCT04426695|455830813|FG011|Overall Study|Physician Decision|0|||
126692975|NCT04426695|455830814|FG012|Overall Study|Physician Decision|1|||
126692976|NCT04426695|455830815|FG013|Overall Study|Physician Decision|0|||
126692977|NCT04426695|455830816|FG014|Overall Study|Physician Decision|0|||
126692978|NCT04426695|455830817|FG015|Overall Study|Physician Decision|0|||
126692979|NCT04426695|455830818|FG016|Overall Study|Physician Decision|0|||
126692980|NCT04426695|455830819|FG017|Overall Study|Physician Decision|0|||
126692981|NCT04426695|455830802|FG000|Overall Study|Randomized but Never Treated|3|||
126692982|NCT04426695|455830803|FG001|Overall Study|Randomized but Never Treated|1|||
126692983|NCT04426695|455830804|FG002|Overall Study|Randomized but Never Treated|0|||
126692984|NCT04426695|455830805|FG003|Overall Study|Randomized but Never Treated|4|||
126692985|NCT04426695|455830806|FG004|Overall Study|Randomized but Never Treated|5|||
126692986|NCT04426695|455830807|FG005|Overall Study|Randomized but Never Treated|5|||
126692987|NCT04426695|455830808|FG006|Overall Study|Randomized but Never Treated|4|||
126692988|NCT04426695|455830809|FG007|Overall Study|Randomized but Never Treated|6|||
126692989|NCT04426695|455830810|FG008|Overall Study|Randomized but Never Treated|6|||
126692990|NCT04426695|455830811|FG009|Overall Study|Randomized but Never Treated|3|||
126692991|NCT04426695|455830812|FG010|Overall Study|Randomized but Never Treated|3|||
126692992|NCT04426695|455830813|FG011|Overall Study|Randomized but Never Treated|6|||
126692993|NCT04426695|455830814|FG012|Overall Study|Randomized but Never Treated|1|||
126692994|NCT04426695|455830815|FG013|Overall Study|Randomized but Never Treated|2|||
126692995|NCT04426695|455830816|FG014|Overall Study|Randomized but Never Treated|0|||
126692996|NCT04426695|455830817|FG015|Overall Study|Randomized but Never Treated|0|||
126692997|NCT04426695|455830818|FG016|Overall Study|Randomized but Never Treated|0|||
126692998|NCT04426695|455830819|FG017|Overall Study|Randomized but Never Treated|0|||
126692999|NCT04303000|455830820|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
126355868|NCT00790933|454595584|FG000|Overall Study|Lost to Follow-up|13|||
126355869|NCT00790933|454595585|FG001|Overall Study|Lost to Follow-up|31|||
126355870|NCT00790933|454595586|FG002|Overall Study|Lost to Follow-up|10|||
126355871|NCT00790933|454595587|FG003|Overall Study|Lost to Follow-up|1|||
126693000|NCT04303000|455830821|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
126760620|NCT00129220|456073852|FG000|Study Period III|Reason Not Specified|9|||
126355872|NCT00790933|454595588|FG004|Overall Study|Lost to Follow-up|15|||
126760621|NCT00129220|456073853|FG001|Study Period III|Reason Not Specified|0|||
126693001|NCT04303000|455830822|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
126693002|NCT00559273|455830823|FG000|Correction Period (20 Weeks)|Death|3|||
126693003|NCT00559273|455830824|FG001|Correction Period (20 Weeks)|Death|4|||
126693004|NCT00559273|455830823|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
126693005|NCT00559273|455830824|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
126693006|NCT00559273|455830823|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
126693007|NCT00559273|455830824|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
126693008|NCT00559273|455830823|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
126693009|NCT00559273|455830824|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
126355873|NCT00790933|454595584|FG000|Overall Study|Reason Not Specified|8|||
126355874|NCT00790933|454595585|FG001|Overall Study|Reason Not Specified|16|||
126355875|NCT00790933|454595586|FG002|Overall Study|Reason Not Specified|4|||
126355876|NCT00790933|454595587|FG003|Overall Study|Reason Not Specified|1|||
126355877|NCT00790933|454595588|FG004|Overall Study|Reason Not Specified|9|||
126355878|NCT00245570|454595589|FG000|Washout Between Periods III and IV|Adverse Event|0|||
126355879|NCT00245570|454595590|FG001|Washout Between Periods III and IV|Adverse Event|1|||
126355880|NCT00245570|454595591|FG002|Washout Between Periods III and IV|Adverse Event|0|||
126355881|NCT00245570|454595592|FG003|Washout Between Periods III and IV|Adverse Event|0|||
126355882|NCT00245570|454595593|FG004|Washout Between Periods III and IV|Adverse Event|0|||
126355883|NCT00245570|454595594|FG005|Washout Between Periods III and IV|Adverse Event|0|||
126355884|NCT01829165|454595595|FG000|Overall Study|Did not complete intervention|2|||
126355885|NCT01829165|454595596|FG001|Overall Study|Did not complete intervention|0|||
126355886|NCT04233580|454595615|FG000|Overall Study|Adverse Event|3|||
126355887|NCT04233580|454595616|FG001|Overall Study|Adverse Event|3|||
126355888|NCT04233580|454595615|FG000|Overall Study|Withdrawal by Subject|2|||
126355889|NCT04233580|454595616|FG001|Overall Study|Withdrawal by Subject|1|||
126355890|NCT02441114|454595618|FG000|Washout2|Withdrawal by Subject|4|||
126355891|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
126355892|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
126355893|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
126355894|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
126355895|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
126355896|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
126355897|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
126355898|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
126693010|NCT00559273|455830823|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
126693011|NCT00559273|455830824|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
126693012|NCT00559273|455830823|FG000|Evaluation Period (8 Weeks)|Death|1|||
126693013|NCT00559273|455830824|FG001|Evaluation Period (8 Weeks)|Death|3|||
126693014|NCT00559273|455830823|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
126693015|NCT00559273|455830824|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
126355899|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
126355900|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
126355901|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
126355902|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
126355903|NCT03446573|454595619|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
126355904|NCT03446573|454595620|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
126355905|NCT03446573|454595619|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
126355906|NCT03446573|454595620|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
126355907|NCT03446573|454595619|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
126693016|NCT00559273|455830823|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
126693017|NCT00559273|455830824|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
126693018|NCT00559273|455830823|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
126693019|NCT00559273|455830824|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
126693020|NCT00395967|455830829|FG000|Treatment Period|Failed Mobilization|1|||
126693021|NCT00395967|455830829|FG000|Follow-up Period|Death|1|||
126693022|NCT00395967|455830829|FG000|Follow-up Period|Lost to Follow-up|1|||
126693023|NCT01109940|455830830|FG000|Overall Study|Administrative problems|2|||
126693024|NCT01109940|455830831|FG001|Overall Study|Administrative problems|0|||
126693025|NCT01109940|455830832|FG002|Overall Study|Administrative problems|0|||
126693026|NCT01109940|455830833|FG003|Overall Study|Administrative problems|0|||
126693027|NCT01109940|455830830|FG000|Overall Study|Serious Adverse Event|2|||
126693028|NCT01109940|455830831|FG001|Overall Study|Serious Adverse Event|1|||
126693029|NCT01109940|455830832|FG002|Overall Study|Serious Adverse Event|0|||
126693030|NCT01109940|455830833|FG003|Overall Study|Serious Adverse Event|0|||
126693031|NCT01109940|455830830|FG000|Overall Study|Lost to Follow-up|1|||
126693032|NCT01109940|455830831|FG001|Overall Study|Lost to Follow-up|0|||
126693033|NCT01109940|455830832|FG002|Overall Study|Lost to Follow-up|0|||
126693034|NCT01109940|455830833|FG003|Overall Study|Lost to Follow-up|0|||
126693035|NCT01109940|455830830|FG000|Overall Study|Patient withdrew consent|1|||
126693036|NCT01109940|455830831|FG001|Overall Study|Patient withdrew consent|1|||
126693037|NCT01109940|455830832|FG002|Overall Study|Patient withdrew consent|0|||
126693038|NCT01109940|455830833|FG003|Overall Study|Patient withdrew consent|0|||
126693039|NCT01109940|455830830|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126693040|NCT01109940|455830831|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126693041|NCT01109940|455830832|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
126693042|NCT01109940|455830833|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
126693043|NCT03653390|455830834|FG000|Overall Study|Lost to Follow-up|12|||
126355908|NCT03446573|454595620|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
126355909|NCT03446573|454595619|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
126445141|NCT05019521|454928189|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
126445142|NCT05019521|454928190|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
126445143|NCT05019521|454928191|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
126445144|NCT05019521|454928192|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
126445145|NCT05019521|454928186|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
126445146|NCT05019521|454928187|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
126445147|NCT05019521|454928188|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
126445148|NCT05019521|454928189|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
126445149|NCT05019521|454928190|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
126445150|NCT05019521|454928191|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
126445151|NCT05019521|454928192|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
126445152|NCT05019521|454928186|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
126445153|NCT05019521|454928187|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
126445154|NCT05019521|454928188|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
126445155|NCT05019521|454928189|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
126445156|NCT05019521|454928190|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
126445157|NCT05019521|454928191|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
126445158|NCT05019521|454928192|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
126445159|NCT02533453|454928196|FG000|Overall Study|Adverse Event|6|||
126445160|NCT02533453|454928196|FG000|Overall Study|Protocol Violation|1|||
126693044|NCT03653390|455830835|FG001|Overall Study|Lost to Follow-up|8|||
126693045|NCT03653390|455830836|FG002|Overall Study|Lost to Follow-up|7|||
126693046|NCT03653390|455830834|FG000|Overall Study|Withdrawal by Subject|6|||
126693047|NCT03653390|455830835|FG001|Overall Study|Withdrawal by Subject|1|||
126693048|NCT03653390|455830836|FG002|Overall Study|Withdrawal by Subject|1|||
126693049|NCT03653390|455830834|FG000|Overall Study|Death|1|||
126693050|NCT03653390|455830835|FG001|Overall Study|Death|0|||
126693051|NCT03653390|455830836|FG002|Overall Study|Death|0|||
126693052|NCT03653390|455830834|FG000|Overall Study|Paper Survey Lost|1|||
126693053|NCT03653390|455830835|FG001|Overall Study|Paper Survey Lost|0|||
126693054|NCT03653390|455830836|FG002|Overall Study|Paper Survey Lost|0|||
126693055|NCT03118947|455830837|FG000|Overall Study|Adverse Event|7|||
126693056|NCT03118947|455830837|FG000|Overall Study|Death|3|||
126693057|NCT03118947|455830837|FG000|Overall Study|Lack of Efficacy|4|||
126693058|NCT03118947|455830837|FG000|Overall Study|Non-compliance with study drug|1|||
126693059|NCT03118947|455830837|FG000|Overall Study|Protocol Violation|2|||
126693060|NCT03118947|455830837|FG000|Overall Study|Withdrawal by Subject|3|||
126693061|NCT03118947|455830837|FG000|Overall Study|Withdrawal by caregiver|3|||
126693062|NCT03118947|455830837|FG000|Overall Study|Change in patient's living situation|4|||
126693063|NCT03118947|455830837|FG000|Overall Study|Lost to Follow-up|2|||
126693064|NCT01262976|455830844|FG000|Up to Month 2|Serious Adverse Event|0|||
126693065|NCT01262976|455830845|FG001|Up to Month 2|Serious Adverse Event|0|||
126693066|NCT01262976|455830846|FG002|Up to Month 2|Serious Adverse Event|1|||
126693067|NCT01262976|455830847|FG003|Up to Month 2|Serious Adverse Event|0|||
126693068|NCT01262976|455830848|FG004|Up to Month 2|Serious Adverse Event|0|||
126693069|NCT01262976|455830849|FG005|Up to Month 2|Serious Adverse Event|0|||
126693070|NCT01262976|455830844|FG000|Up to Month 2|Withdrawal by Subject|1|||
126693071|NCT01262976|455830845|FG001|Up to Month 2|Withdrawal by Subject|0|||
126693072|NCT01262976|455830846|FG002|Up to Month 2|Withdrawal by Subject|0|||
126693073|NCT01262976|455830847|FG003|Up to Month 2|Withdrawal by Subject|0|||
126693074|NCT01262976|455830848|FG004|Up to Month 2|Withdrawal by Subject|0|||
126693075|NCT01262976|455830849|FG005|Up to Month 2|Withdrawal by Subject|0|||
126693076|NCT01262976|455830844|FG000|Up to Month 2|Migrated/moved from study area|0|||
126693077|NCT01262976|455830845|FG001|Up to Month 2|Migrated/moved from study area|1|||
126693078|NCT01262976|455830846|FG002|Up to Month 2|Migrated/moved from study area|0|||
126693079|NCT01262976|455830847|FG003|Up to Month 2|Migrated/moved from study area|0|||
126693080|NCT01262976|455830848|FG004|Up to Month 2|Migrated/moved from study area|1|||
126693081|NCT01262976|455830849|FG005|Up to Month 2|Migrated/moved from study area|1|||
126693082|NCT01262976|455830844|FG000|Up to Month 2|Lost to Follow-up|1|||
126693083|NCT01262976|455830845|FG001|Up to Month 2|Lost to Follow-up|0|||
126693084|NCT01262976|455830846|FG002|Up to Month 2|Lost to Follow-up|0|||
126693085|NCT01262976|455830847|FG003|Up to Month 2|Lost to Follow-up|1|||
126693086|NCT01262976|455830848|FG004|Up to Month 2|Lost to Follow-up|1|||
126355910|NCT03446573|454595620|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
126355911|NCT03446573|454595619|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
126355912|NCT03446573|454595620|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
126355913|NCT03446573|454595619|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
126355914|NCT03446573|454595620|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
126355915|NCT03446573|454595619|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
126355916|NCT03446573|454595620|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
126355917|NCT01371565|454595621|FG000|Overall Study|Withdrawal by Subject|1|||
126355918|NCT01371565|454595621|FG000|Overall Study|Death|1|||
126355919|NCT01371565|454595621|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
126355920|NCT02070991|454595622|FG000|Overall Study|Death|2|||
126355921|NCT02070991|454595623|FG001|Overall Study|Death|0|||
126355922|NCT02070991|454595622|FG000|Overall Study|Withdrawal by Subject|1|||
126355923|NCT02070991|454595623|FG001|Overall Study|Withdrawal by Subject|0|||
126355924|NCT00827242|454595624|FG000|Overall Study|Withdrawal by Subject|2|||
126355925|NCT00827242|454595625|FG001|Overall Study|Withdrawal by Subject|4|||
126355926|NCT00827242|454595624|FG000|Overall Study|Protocol Violation|1|||
126355927|NCT00827242|454595625|FG001|Overall Study|Protocol Violation|3|||
126355928|NCT00827242|454595624|FG000|Overall Study|Lost to Follow-up|0|||
126355929|NCT00827242|454595625|FG001|Overall Study|Lost to Follow-up|3|||
126355930|NCT00827242|454595624|FG000|Overall Study|Adverse Event Excluding Death|2|||
126355931|NCT00827242|454595625|FG001|Overall Study|Adverse Event Excluding Death|1|||
126355932|NCT00827242|454595624|FG000|Overall Study|Entry Criteria Not Met|4|||
126355933|NCT00827242|454595625|FG001|Overall Study|Entry Criteria Not Met|1|||
126355934|NCT00827242|454595624|FG000|Overall Study|Physician Decision|2|||
126355935|NCT00827242|454595625|FG001|Overall Study|Physician Decision|0|||
126355936|NCT00827242|454595624|FG000|Overall Study|Death|1|||
126355937|NCT00827242|454595625|FG001|Overall Study|Death|0|||
126355938|NCT00827242|454595624|FG000|Overall Study|Lack of Efficacy|1|||
126355939|NCT00827242|454595625|FG001|Overall Study|Lack of Efficacy|0|||
126355940|NCT00899847|454595626|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
126355941|NCT05987540|454595627|FG000|Overall Study|Withdrawal by Subject|2|||
126355942|NCT05987540|454595627|FG000|Overall Study|Death|1|||
126355943|NCT05987540|454595627|FG000|Overall Study|Study Termination|1|||
126355944|NCT05987540|454595627|FG000|Overall Study|Adverse Event|2|||
126355945|NCT00471107|454595628|FG000|Overall Study|Technical problems/data loss|3|||
126355946|NCT00471107|454595629|FG001|Overall Study|Technical problems/data loss|1|||
126355947|NCT00471107|454595630|FG002|Overall Study|Technical problems/data loss|3|||
126355948|NCT01769443|454595631|FG000|Overall Study|Study closure|1|||
126355949|NCT01769443|454595632|FG001|Overall Study|Study closure|0|||
126693087|NCT01262976|455830849|FG005|Up to Month 2|Lost to Follow-up|1|||
126693088|NCT01262976|455830844|FG000|Up to Month 2|Other|1|||
126693089|NCT01262976|455830845|FG001|Up to Month 2|Other|0|||
126693090|NCT01262976|455830846|FG002|Up to Month 2|Other|0|||
126693091|NCT01262976|455830847|FG003|Up to Month 2|Other|1|||
126693092|NCT01262976|455830848|FG004|Up to Month 2|Other|0|||
126693093|NCT01262976|455830849|FG005|Up to Month 2|Other|2|||
126693094|NCT01262976|455830844|FG000|Up to Month 7|Serious Adverse Event|0|||
126693095|NCT01262976|455830845|FG001|Up to Month 7|Serious Adverse Event|0|||
126693096|NCT01262976|455830846|FG002|Up to Month 7|Serious Adverse Event|2|||
126693097|NCT01262976|455830847|FG003|Up to Month 7|Serious Adverse Event|0|||
126693098|NCT01262976|455830848|FG004|Up to Month 7|Serious Adverse Event|0|||
126693099|NCT01262976|455830849|FG005|Up to Month 7|Serious Adverse Event|0|||
126693100|NCT01262976|455830844|FG000|Up to Month 7|Withdrawal by Subject|1|||
126693101|NCT01262976|455830845|FG001|Up to Month 7|Withdrawal by Subject|0|||
126693102|NCT01262976|455830846|FG002|Up to Month 7|Withdrawal by Subject|0|||
126693103|NCT01262976|455830847|FG003|Up to Month 7|Withdrawal by Subject|0|||
126693104|NCT01262976|455830848|FG004|Up to Month 7|Withdrawal by Subject|0|||
126693105|NCT01262976|455830849|FG005|Up to Month 7|Withdrawal by Subject|0|||
126693106|NCT01262976|455830844|FG000|Up to Month 7|Migrated/moved from study area|0|||
126693107|NCT01262976|455830845|FG001|Up to Month 7|Migrated/moved from study area|0|||
126355950|NCT04996264|454595633|FG000|Overall Study|Lost to Follow-up|0|||
126355951|NCT04996264|454595634|FG001|Overall Study|Lost to Follow-up|1|||
126355952|NCT04996264|454595633|FG000|Overall Study|Withdrawal by Subject|4|||
126355953|NCT04996264|454595634|FG001|Overall Study|Withdrawal by Subject|3|||
126355954|NCT04996264|454595633|FG000|Overall Study|1 left AMA|0|||
126355955|NCT04996264|454595634|FG001|Overall Study|1 left AMA|1|||
126693108|NCT01262976|455830846|FG002|Up to Month 7|Migrated/moved from study area|1|||
126693109|NCT01262976|455830847|FG003|Up to Month 7|Migrated/moved from study area|3|||
126693110|NCT01262976|455830848|FG004|Up to Month 7|Migrated/moved from study area|1|||
126693111|NCT01262976|455830849|FG005|Up to Month 7|Migrated/moved from study area|1|||
126693112|NCT01262976|455830844|FG000|Up to Month 7|Lost to Follow-up|1|||
126693113|NCT01262976|455830845|FG001|Up to Month 7|Lost to Follow-up|0|||
126693114|NCT01262976|455830846|FG002|Up to Month 7|Lost to Follow-up|1|||
126693115|NCT01262976|455830847|FG003|Up to Month 7|Lost to Follow-up|3|||
126693116|NCT01262976|455830848|FG004|Up to Month 7|Lost to Follow-up|1|||
126693117|NCT01262976|455830849|FG005|Up to Month 7|Lost to Follow-up|3|||
126693118|NCT01262976|455830844|FG000|Up to Month 7|Other|3|||
126693119|NCT01262976|455830845|FG001|Up to Month 7|Other|0|||
126693120|NCT01262976|455830846|FG002|Up to Month 7|Other|2|||
126693121|NCT01262976|455830847|FG003|Up to Month 7|Other|0|||
126693122|NCT01262976|455830848|FG004|Up to Month 7|Other|0|||
126693123|NCT01262976|455830849|FG005|Up to Month 7|Other|0|||
126693124|NCT01262976|455830844|FG000|Up to Year 1|Serious Adverse Event|0|||
126693125|NCT01262976|455830845|FG001|Up to Year 1|Serious Adverse Event|0|||
126693126|NCT01262976|455830846|FG002|Up to Year 1|Serious Adverse Event|2|||
126693127|NCT01262976|455830847|FG003|Up to Year 1|Serious Adverse Event|0|||
126693128|NCT01262976|455830848|FG004|Up to Year 1|Serious Adverse Event|0|||
126693129|NCT01262976|455830849|FG005|Up to Year 1|Serious Adverse Event|0|||
126693130|NCT01262976|455830844|FG000|Up to Year 1|Withdrawal by Subject|1|||
126693131|NCT01262976|455830845|FG001|Up to Year 1|Withdrawal by Subject|0|||
126693132|NCT01262976|455830846|FG002|Up to Year 1|Withdrawal by Subject|0|||
126693133|NCT01262976|455830847|FG003|Up to Year 1|Withdrawal by Subject|0|||
126693134|NCT01262976|455830848|FG004|Up to Year 1|Withdrawal by Subject|0|||
126693135|NCT01262976|455830849|FG005|Up to Year 1|Withdrawal by Subject|0|||
126693136|NCT01262976|455830844|FG000|Up to Year 1|Migrated/moved from study area|1|||
126693137|NCT01262976|455830845|FG001|Up to Year 1|Migrated/moved from study area|0|||
126693138|NCT01262976|455830846|FG002|Up to Year 1|Migrated/moved from study area|0|||
126693139|NCT01262976|455830847|FG003|Up to Year 1|Migrated/moved from study area|3|||
126693140|NCT01262976|455830848|FG004|Up to Year 1|Migrated/moved from study area|3|||
126693141|NCT01262976|455830849|FG005|Up to Year 1|Migrated/moved from study area|2|||
126693142|NCT01262976|455830844|FG000|Up to Year 1|Lost to Follow-up|4|||
126693143|NCT01262976|455830845|FG001|Up to Year 1|Lost to Follow-up|0|||
126693144|NCT01262976|455830846|FG002|Up to Year 1|Lost to Follow-up|0|||
126693145|NCT01262976|455830847|FG003|Up to Year 1|Lost to Follow-up|1|||
126693146|NCT01262976|455830848|FG004|Up to Year 1|Lost to Follow-up|6|||
126693147|NCT01262976|455830849|FG005|Up to Year 1|Lost to Follow-up|5|||
126693148|NCT01262976|455830844|FG000|Up to Year 1|Other|3|||
126693149|NCT01262976|455830845|FG001|Up to Year 1|Other|1|||
126693150|NCT01262976|455830846|FG002|Up to Year 1|Other|0|||
126693151|NCT01262976|455830847|FG003|Up to Year 1|Other|0|||
126693152|NCT01262976|455830848|FG004|Up to Year 1|Other|2|||
126693153|NCT01262976|455830849|FG005|Up to Year 1|Other|1|||
126693154|NCT01262976|455830844|FG000|Up to Year 1|Subjects with unknown completion status|0|||
126693155|NCT01262976|455830845|FG001|Up to Year 1|Subjects with unknown completion status|0|||
126693156|NCT01262976|455830846|FG002|Up to Year 1|Subjects with unknown completion status|1|||
126693157|NCT01262976|455830847|FG003|Up to Year 1|Subjects with unknown completion status|0|||
126693158|NCT01262976|455830848|FG004|Up to Year 1|Subjects with unknown completion status|0|||
126693159|NCT01262976|455830849|FG005|Up to Year 1|Subjects with unknown completion status|1|||
126693160|NCT01262976|455830844|FG000|Up to Year 2|Serious Adverse Event|0|||
126693161|NCT01262976|455830845|FG001|Up to Year 2|Serious Adverse Event|0|||
126693162|NCT01262976|455830846|FG002|Up to Year 2|Serious Adverse Event|2|||
126693163|NCT01262976|455830847|FG003|Up to Year 2|Serious Adverse Event|0|||
126693164|NCT01262976|455830848|FG004|Up to Year 2|Serious Adverse Event|0|||
126693165|NCT01262976|455830849|FG005|Up to Year 2|Serious Adverse Event|0|||
126693166|NCT01262976|455830844|FG000|Up to Year 2|Withdrawal by Subject|1|||
126693167|NCT01262976|455830845|FG001|Up to Year 2|Withdrawal by Subject|0|||
126693168|NCT01262976|455830846|FG002|Up to Year 2|Withdrawal by Subject|0|||
126693169|NCT01262976|455830847|FG003|Up to Year 2|Withdrawal by Subject|0|||
126693170|NCT01262976|455830848|FG004|Up to Year 2|Withdrawal by Subject|0|||
126693171|NCT01262976|455830849|FG005|Up to Year 2|Withdrawal by Subject|0|||
126693172|NCT01262976|455830844|FG000|Up to Year 2|Migrated/moved from study area|0|||
126445161|NCT02533453|454928196|FG000|Overall Study|Withdrawal by Subject|2|||
126445162|NCT00068419|454928201|FG000|Overall Study|Adverse Event|3|||
126445163|NCT00068419|454928201|FG000|Overall Study|Lack of Efficacy|24|||
126445164|NCT00068419|454928201|FG000|Overall Study|Lost to Follow-up|1|||
126445165|NCT00068419|454928201|FG000|Overall Study|Physician Decision|7|||
126445166|NCT00068419|454928201|FG000|Overall Study|Withdrawal by Subject|14|||
126445167|NCT00068419|454928201|FG000|Overall Study|Ineligible|11|||
126445168|NCT02039843|454928208|FG000|Randomization and Observation Period|Adverse Event|2|||
126445169|NCT02039843|454928209|FG001|Randomization and Observation Period|Adverse Event|0|||
126445170|NCT02039843|454928208|FG000|Randomization and Observation Period|Death|1|||
126445171|NCT02039843|454928209|FG001|Randomization and Observation Period|Death|0|||
126445172|NCT02039843|454928208|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
126445173|NCT02039843|454928209|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
126445174|NCT02039843|454928208|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
126445175|NCT02039843|454928209|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
126445176|NCT02039843|454928208|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
126445177|NCT02039843|454928209|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
126445178|NCT02039843|454928208|FG000|Pairing With a Study Dog|Death|1|||
126445179|NCT02039843|454928209|FG001|Pairing With a Study Dog|Death|0|||
126445180|NCT02039843|454928208|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
126445181|NCT02039843|454928209|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
126445182|NCT02039843|454928208|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
126445183|NCT02039843|454928209|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
126445184|NCT02039843|454928208|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
126445185|NCT02039843|454928209|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
126445186|NCT01500720|454928210|FG000|Overall Study|Randomized But Not Treated|1|||
126445187|NCT01500720|454928211|FG001|Overall Study|Randomized But Not Treated|1|||
126445188|NCT01500720|454928210|FG000|Overall Study|Other|4|||
126445189|NCT01500720|454928211|FG001|Overall Study|Other|8|||
126445190|NCT02527421|454928212|FG000|Overall Study|Withdrawal by Subject|1|||
126445191|NCT02527421|454928213|FG001|Overall Study|Withdrawal by Subject|0|||
126693173|NCT01262976|455830845|FG001|Up to Year 2|Migrated/moved from study area|0|||
126693174|NCT01262976|455830846|FG002|Up to Year 2|Migrated/moved from study area|0|||
126693175|NCT01262976|455830847|FG003|Up to Year 2|Migrated/moved from study area|2|||
126445192|NCT00806819|454928214|FG000|Overall Study|progressive disease (modified RECIST )|217|||
126445193|NCT00806819|454928215|FG001|Overall Study|progressive disease (modified RECIST )|216|||
126445194|NCT00806819|454928214|FG000|Overall Study|Worsening or AE of underlying disease|18|||
126445195|NCT00806819|454928215|FG001|Overall Study|Worsening or AE of underlying disease|25|||
126445196|NCT00806819|454928214|FG000|Overall Study|Other AE|38|||
126445197|NCT00806819|454928215|FG001|Overall Study|Other AE|40|||
126445198|NCT00806819|454928214|FG000|Overall Study|Protocol Violation|9|||
126445199|NCT00806819|454928215|FG001|Overall Study|Protocol Violation|4|||
126445200|NCT00806819|454928214|FG000|Overall Study|Lost to Follow-up|1|||
126445201|NCT00806819|454928215|FG001|Overall Study|Lost to Follow-up|0|||
126445202|NCT00806819|454928214|FG000|Overall Study|Withdrawal by Subject|32|||
126445203|NCT00806819|454928215|FG001|Overall Study|Withdrawal by Subject|29|||
126445204|NCT00806819|454928214|FG000|Overall Study|Not treated|6|||
126445205|NCT00806819|454928215|FG001|Overall Study|Not treated|3|||
126445206|NCT00806819|454928214|FG000|Overall Study|Reasons other than stated above|25|||
126445207|NCT00806819|454928215|FG001|Overall Study|Reasons other than stated above|41|||
126445208|NCT03843541|454928224|FG000|Overall Study|Adverse Event|4|||
126445209|NCT03843541|454928225|FG001|Overall Study|Adverse Event|2|||
126445210|NCT03843541|454928226|FG002|Overall Study|Adverse Event|3|||
126445211|NCT03843541|454928224|FG000|Overall Study|Death|1|||
126445212|NCT03843541|454928225|FG001|Overall Study|Death|0|||
126445213|NCT03843541|454928226|FG002|Overall Study|Death|0|||
126445214|NCT03843541|454928224|FG000|Overall Study|Lack of adherence to study medication|0|||
126693176|NCT01262976|455830848|FG004|Up to Year 2|Migrated/moved from study area|1|||
126693177|NCT01262976|455830849|FG005|Up to Year 2|Migrated/moved from study area|2|||
126445215|NCT03843541|454928225|FG001|Overall Study|Lack of adherence to study medication|0|||
126445216|NCT03843541|454928226|FG002|Overall Study|Lack of adherence to study medication|1|||
126693178|NCT01262976|455830844|FG000|Up to Year 2|Lost to Follow-up|1|||
126693179|NCT01262976|455830845|FG001|Up to Year 2|Lost to Follow-up|1|||
126693180|NCT01262976|455830846|FG002|Up to Year 2|Lost to Follow-up|2|||
126445217|NCT03843541|454928224|FG000|Overall Study|Physician Decision|1|||
126445218|NCT03843541|454928225|FG001|Overall Study|Physician Decision|2|||
126445219|NCT03843541|454928226|FG002|Overall Study|Physician Decision|2|||
126445220|NCT03843541|454928224|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
126445221|NCT03843541|454928225|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
126445222|NCT03843541|454928226|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
126445223|NCT03843541|454928224|FG000|Overall Study|Withdrawal by Subject|6|||
126445224|NCT03843541|454928225|FG001|Overall Study|Withdrawal by Subject|9|||
126445225|NCT03843541|454928226|FG002|Overall Study|Withdrawal by Subject|7|||
126693181|NCT01262976|455830847|FG003|Up to Year 2|Lost to Follow-up|2|||
126693182|NCT01262976|455830848|FG004|Up to Year 2|Lost to Follow-up|3|||
126693183|NCT01262976|455830849|FG005|Up to Year 2|Lost to Follow-up|3|||
126693184|NCT01262976|455830844|FG000|Up to Year 2|Subjects with unknown completion status|0|||
126693185|NCT01262976|455830845|FG001|Up to Year 2|Subjects with unknown completion status|0|||
126693186|NCT01262976|455830846|FG002|Up to Year 2|Subjects with unknown completion status|1|||
126693187|NCT01262976|455830847|FG003|Up to Year 2|Subjects with unknown completion status|0|||
126693188|NCT01262976|455830848|FG004|Up to Year 2|Subjects with unknown completion status|0|||
126693189|NCT01262976|455830849|FG005|Up to Year 2|Subjects with unknown completion status|0|||
126693190|NCT01262976|455830844|FG000|Up to Year 2|Other|3|||
126693191|NCT01262976|455830845|FG001|Up to Year 2|Other|0|||
126693192|NCT01262976|455830846|FG002|Up to Year 2|Other|0|||
126693193|NCT01262976|455830847|FG003|Up to Year 2|Other|0|||
126693194|NCT01262976|455830848|FG004|Up to Year 2|Other|0|||
126693195|NCT01262976|455830849|FG005|Up to Year 2|Other|0|||
126693196|NCT01262976|455830844|FG000|Up to Year 3|Serious Adverse Event|0|||
126693197|NCT01262976|455830845|FG001|Up to Year 3|Serious Adverse Event|0|||
126693198|NCT01262976|455830846|FG002|Up to Year 3|Serious Adverse Event|2|||
126693199|NCT01262976|455830847|FG003|Up to Year 3|Serious Adverse Event|0|||
126693200|NCT01262976|455830848|FG004|Up to Year 3|Serious Adverse Event|0|||
126693201|NCT01262976|455830849|FG005|Up to Year 3|Serious Adverse Event|0|||
126693202|NCT01262976|455830844|FG000|Up to Year 3|Withdrawal by Subject|1|||
126693203|NCT01262976|455830845|FG001|Up to Year 3|Withdrawal by Subject|0|||
126693204|NCT01262976|455830846|FG002|Up to Year 3|Withdrawal by Subject|0|||
126693205|NCT01262976|455830847|FG003|Up to Year 3|Withdrawal by Subject|0|||
126693206|NCT01262976|455830848|FG004|Up to Year 3|Withdrawal by Subject|0|||
126693207|NCT01262976|455830849|FG005|Up to Year 3|Withdrawal by Subject|0|||
126693208|NCT01262976|455830844|FG000|Up to Year 3|Migrated/moved from study area|0|||
126693209|NCT01262976|455830845|FG001|Up to Year 3|Migrated/moved from study area|0|||
126693210|NCT01262976|455830846|FG002|Up to Year 3|Migrated/moved from study area|0|||
126693211|NCT01262976|455830847|FG003|Up to Year 3|Migrated/moved from study area|2|||
126693212|NCT01262976|455830848|FG004|Up to Year 3|Migrated/moved from study area|1|||
126693213|NCT01262976|455830849|FG005|Up to Year 3|Migrated/moved from study area|1|||
126693214|NCT01262976|455830844|FG000|Up to Year 3|Lost to Follow-up|2|||
126693215|NCT01262976|455830845|FG001|Up to Year 3|Lost to Follow-up|2|||
126693216|NCT01262976|455830846|FG002|Up to Year 3|Lost to Follow-up|4|||
126693217|NCT01262976|455830847|FG003|Up to Year 3|Lost to Follow-up|3|||
126693218|NCT01262976|455830848|FG004|Up to Year 3|Lost to Follow-up|1|||
126693219|NCT01262976|455830849|FG005|Up to Year 3|Lost to Follow-up|3|||
126693220|NCT01262976|455830844|FG000|Up to Year 3|Subjects with unknown completion status|0|||
126693221|NCT01262976|455830845|FG001|Up to Year 3|Subjects with unknown completion status|0|||
126693222|NCT01262976|455830846|FG002|Up to Year 3|Subjects with unknown completion status|1|||
126693223|NCT01262976|455830847|FG003|Up to Year 3|Subjects with unknown completion status|0|||
126693224|NCT01262976|455830848|FG004|Up to Year 3|Subjects with unknown completion status|0|||
126693225|NCT01262976|455830849|FG005|Up to Year 3|Subjects with unknown completion status|0|||
126693226|NCT01262976|455830844|FG000|Up to Year 3|Other|3|||
126693227|NCT01262976|455830845|FG001|Up to Year 3|Other|0|||
126693228|NCT01262976|455830846|FG002|Up to Year 3|Other|0|||
126693229|NCT01262976|455830847|FG003|Up to Year 3|Other|0|||
126693230|NCT01262976|455830848|FG004|Up to Year 3|Other|0|||
126693231|NCT01262976|455830849|FG005|Up to Year 3|Other|0|||
126693232|NCT01552681|455830850|FG000|Overall Study|Withdrawal by Subject|4|||
126355956|NCT04996264|454595633|FG000|Overall Study|Subject changed hospitals|0|||
126355957|NCT04996264|454595634|FG001|Overall Study|Subject changed hospitals|1|||
126355958|NCT04996264|454595633|FG000|Overall Study|unable to complete due to work|0|||
126355959|NCT04996264|454595634|FG001|Overall Study|unable to complete due to work|1|||
126355960|NCT01279200|454595635|FG000|Overall Study|Withdrawal by Subject|1|||
126355961|NCT01279200|454595636|FG001|Overall Study|Withdrawal by Subject|3|||
126355962|NCT01279200|454595635|FG000|Overall Study|Patient withdrawal due to high cost|0|||
126355963|NCT01279200|454595636|FG001|Overall Study|Patient withdrawal due to high cost|1|||
126355964|NCT01279200|454595635|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
126355965|NCT01279200|454595636|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
126355966|NCT01279200|454595635|FG000|Overall Study|ultrasound screening failure|0|||
126355967|NCT01279200|454595636|FG001|Overall Study|ultrasound screening failure|1|||
126355968|NCT01279200|454595635|FG000|Overall Study|Lost to Follow-up|0|||
126355969|NCT01279200|454595636|FG001|Overall Study|Lost to Follow-up|1|||
126355970|NCT01279200|454595635|FG000|Overall Study|Adverse Event|1|||
126355971|NCT01279200|454595636|FG001|Overall Study|Adverse Event|0|||
126693233|NCT01552681|455830851|FG001|Overall Study|Withdrawal by Subject|0|||
126693234|NCT01552681|455830850|FG000|Overall Study|Physician Decision|1|||
126693235|NCT01552681|455830851|FG001|Overall Study|Physician Decision|0|||
126693236|NCT01552681|455830850|FG000|Overall Study|Subject moved away|0|||
126355972|NCT01149538|454595639|FG000|Overall Study|Lost to Follow-up|0|||
126355973|NCT01149538|454595640|FG001|Overall Study|Lost to Follow-up|1|||
126355974|NCT01149538|454595639|FG000|Overall Study|Withdrawal by Subject|5|||
126445226|NCT03843541|454928224|FG000|Overall Study|Administration of rescue mucolytic|0|||
126693237|NCT01552681|455830851|FG001|Overall Study|Subject moved away|1|||
126693238|NCT02690194|455830853|FG000|Overall Study|Withdrawal by Subject|1|||
126693239|NCT02690194|455830854|FG001|Overall Study|Withdrawal by Subject|4|||
126693240|NCT02690194|455830855|FG002|Overall Study|Withdrawal by Subject|0|||
126693241|NCT01987908|455830856|FG000|Placebo Lead-in Period|Adverse Event|2|||
126693242|NCT01987908|455830857|FG001|Placebo Lead-in Period|Adverse Event|0|||
126693243|NCT01987908|455830858|FG002|Placebo Lead-in Period|Adverse Event|0|||
126693244|NCT01987908|455830856|FG000|Placebo Lead-in Period|Physician Decision|2|||
126693245|NCT01987908|455830857|FG001|Placebo Lead-in Period|Physician Decision|0|||
126693246|NCT01987908|455830858|FG002|Placebo Lead-in Period|Physician Decision|0|||
126693247|NCT01987908|455830856|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
126693248|NCT01987908|455830857|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
126693249|NCT01987908|455830858|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
126693250|NCT01987908|455830856|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
126693251|NCT01987908|455830857|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
126693252|NCT01987908|455830858|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
126693253|NCT01987908|455830856|FG000|Treatment Period|Adverse Event|0|||
126693254|NCT01987908|455830857|FG001|Treatment Period|Adverse Event|1|||
126693255|NCT01987908|455830858|FG002|Treatment Period|Adverse Event|1|||
126693256|NCT01987908|455830856|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
126693257|NCT01987908|455830857|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
126693258|NCT01987908|455830858|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
126693259|NCT01987908|455830856|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
126693260|NCT01987908|455830857|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
126693261|NCT01987908|455830858|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
126693262|NCT03665285|455830859|FG000|Overall Study|Started New Anticancer Treatment|1|||
126693263|NCT03665285|455830860|FG001|Overall Study|Started New Anticancer Treatment|1|||
126693264|NCT03665285|455830861|FG002|Overall Study|Started New Anticancer Treatment|2|||
126693265|NCT03665285|455830862|FG003|Overall Study|Started New Anticancer Treatment|4|||
126693266|NCT03665285|455830863|FG004|Overall Study|Started New Anticancer Treatment|1|||
126693267|NCT03665285|455830864|FG005|Overall Study|Started New Anticancer Treatment|1|||
126693268|NCT03665285|455830865|FG006|Overall Study|Started New Anticancer Treatment|2|||
126693269|NCT03665285|455830866|FG007|Overall Study|Started New Anticancer Treatment|15|||
126693270|NCT03665285|455830867|FG008|Overall Study|Started New Anticancer Treatment|1|||
126693271|NCT03665285|455830859|FG000|Overall Study|Disease Progression|0|||
126693272|NCT03665285|455830860|FG001|Overall Study|Disease Progression|0|||
126693273|NCT03665285|455830861|FG002|Overall Study|Disease Progression|3|||
126693274|NCT03665285|455830862|FG003|Overall Study|Disease Progression|1|||
126693275|NCT03665285|455830863|FG004|Overall Study|Disease Progression|0|||
126693276|NCT03665285|455830864|FG005|Overall Study|Disease Progression|0|||
126693277|NCT03665285|455830865|FG006|Overall Study|Disease Progression|0|||
126693278|NCT03665285|455830866|FG007|Overall Study|Disease Progression|7|||
126693279|NCT03665285|455830867|FG008|Overall Study|Disease Progression|1|||
126693280|NCT03665285|455830859|FG000|Overall Study|Hospice|0|||
126693281|NCT03665285|455830860|FG001|Overall Study|Hospice|0|||
126693282|NCT03665285|455830861|FG002|Overall Study|Hospice|0|||
126693283|NCT03665285|455830862|FG003|Overall Study|Hospice|0|||
126693284|NCT03665285|455830863|FG004|Overall Study|Hospice|0|||
126693285|NCT03665285|455830864|FG005|Overall Study|Hospice|0|||
126693286|NCT03665285|455830865|FG006|Overall Study|Hospice|0|||
126693287|NCT03665285|455830866|FG007|Overall Study|Hospice|2|||
126693288|NCT03665285|455830867|FG008|Overall Study|Hospice|0|||
126693289|NCT03665285|455830859|FG000|Overall Study|Withdrawal by Subject|0|||
126693290|NCT03665285|455830860|FG001|Overall Study|Withdrawal by Subject|0|||
126693291|NCT03665285|455830861|FG002|Overall Study|Withdrawal by Subject|0|||
126693292|NCT03665285|455830862|FG003|Overall Study|Withdrawal by Subject|0|||
126693293|NCT03665285|455830863|FG004|Overall Study|Withdrawal by Subject|1|||
126693294|NCT03665285|455830864|FG005|Overall Study|Withdrawal by Subject|0|||
126693295|NCT03665285|455830865|FG006|Overall Study|Withdrawal by Subject|0|||
126693296|NCT03665285|455830866|FG007|Overall Study|Withdrawal by Subject|2|||
126693297|NCT03665285|455830867|FG008|Overall Study|Withdrawal by Subject|0|||
126693298|NCT03665285|455830859|FG000|Overall Study|Physician Decision|0|||
126445227|NCT03843541|454928225|FG001|Overall Study|Administration of rescue mucolytic|0|||
126445228|NCT03843541|454928226|FG002|Overall Study|Administration of rescue mucolytic|1|||
126445229|NCT03843541|454928224|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
126693299|NCT03665285|455830860|FG001|Overall Study|Physician Decision|0|||
126693300|NCT03665285|455830861|FG002|Overall Study|Physician Decision|0|||
126693301|NCT03665285|455830862|FG003|Overall Study|Physician Decision|0|||
126693302|NCT03665285|455830863|FG004|Overall Study|Physician Decision|0|||
126693303|NCT03665285|455830864|FG005|Overall Study|Physician Decision|0|||
126693304|NCT03665285|455830865|FG006|Overall Study|Physician Decision|0|||
126693305|NCT03665285|455830866|FG007|Overall Study|Physician Decision|2|||
126693306|NCT03665285|455830867|FG008|Overall Study|Physician Decision|0|||
126693307|NCT02532855|455830870|FG000|Overall Study|Lost to Follow-up|4|||
126693308|NCT02532855|455830871|FG001|Overall Study|Lost to Follow-up|3|||
126693309|NCT02532855|455830870|FG000|Overall Study|Withdrawal by Subject|4|||
126693310|NCT02532855|455830871|FG001|Overall Study|Withdrawal by Subject|8|||
126693311|NCT01727258|455830872|FG000|Overall Study|Adverse Event|0|||
126693312|NCT01727258|455830873|FG001|Overall Study|Adverse Event|2|||
126693313|NCT01727258|455830874|FG002|Overall Study|Adverse Event|0|||
126693314|NCT01727258|455830872|FG000|Overall Study|Noncompliance with Study Drug|0|||
126693315|NCT01727258|455830873|FG001|Overall Study|Noncompliance with Study Drug|0|||
126693316|NCT01727258|455830874|FG002|Overall Study|Noncompliance with Study Drug|1|||
126693317|NCT01727258|455830872|FG000|Overall Study|Withdrawal by Subject|1|||
126693318|NCT01727258|455830873|FG001|Overall Study|Withdrawal by Subject|1|||
126693319|NCT01727258|455830874|FG002|Overall Study|Withdrawal by Subject|0|||
126693320|NCT01727258|455830872|FG000|Overall Study|Lost to Follow-up|1|||
126693321|NCT01727258|455830873|FG001|Overall Study|Lost to Follow-up|0|||
126693322|NCT01727258|455830874|FG002|Overall Study|Lost to Follow-up|0|||
126693323|NCT02471716|455830877|FG000|Overall Study|Withdrawal by Subject|0|||
126693324|NCT02471716|455830878|FG001|Overall Study|Withdrawal by Subject|1|||
126693325|NCT02471716|455830879|FG002|Overall Study|Withdrawal by Subject|0|||
126693326|NCT02471716|455830880|FG003|Overall Study|Withdrawal by Subject|2|||
126693327|NCT02471716|455830881|FG004|Overall Study|Withdrawal by Subject|5|||
126693328|NCT02471716|455830877|FG000|Overall Study|Study Terminiated by sponsor|0|||
126693329|NCT02471716|455830878|FG001|Overall Study|Study Terminiated by sponsor|0|||
126693330|NCT02471716|455830879|FG002|Overall Study|Study Terminiated by sponsor|0|||
126693331|NCT02471716|455830880|FG003|Overall Study|Study Terminiated by sponsor|1|||
126693332|NCT02471716|455830881|FG004|Overall Study|Study Terminiated by sponsor|0|||
126693333|NCT02471716|455830877|FG000|Overall Study|Lost to Follow-up|0|||
126693334|NCT02471716|455830878|FG001|Overall Study|Lost to Follow-up|0|||
126693335|NCT02471716|455830879|FG002|Overall Study|Lost to Follow-up|0|||
126693336|NCT02471716|455830880|FG003|Overall Study|Lost to Follow-up|3|||
126693337|NCT02471716|455830881|FG004|Overall Study|Lost to Follow-up|2|||
126693338|NCT02471716|455830877|FG000|Overall Study|Death|0|||
126693339|NCT02471716|455830878|FG001|Overall Study|Death|0|||
126693340|NCT02471716|455830879|FG002|Overall Study|Death|0|||
126693341|NCT02471716|455830880|FG003|Overall Study|Death|1|||
126693342|NCT02471716|455830881|FG004|Overall Study|Death|0|||
126693343|NCT02471716|455830877|FG000|Overall Study|Other|0|||
126693344|NCT02471716|455830878|FG001|Overall Study|Other|0|||
126693345|NCT02471716|455830879|FG002|Overall Study|Other|0|||
126693346|NCT02471716|455830880|FG003|Overall Study|Other|8|||
126693347|NCT02471716|455830881|FG004|Overall Study|Other|9|||
126693348|NCT02154425|455830884|FG000|Screening Period|Adverse Event|1|||
126693349|NCT00773279|455830885|FG000|Period 1|Adverse Event|2|||
126693350|NCT00773279|455830886|FG001|Period 1|Adverse Event|1|||
126693351|NCT00773279|455830885|FG000|Period 1|Lack of Efficacy|0|||
126693352|NCT00773279|455830886|FG001|Period 1|Lack of Efficacy|2|||
126693353|NCT00773279|455830885|FG000|Period 1|Unclassified|5|||
126693354|NCT00773279|455830886|FG001|Period 1|Unclassified|1|||
126693355|NCT00773279|455830885|FG000|Period 2|Adverse Event|0|||
126693356|NCT00773279|455830886|FG001|Period 2|Adverse Event|1|||
126693357|NCT00773279|455830885|FG000|Period 2|Lack of Efficacy|1|||
126693358|NCT00773279|455830886|FG001|Period 2|Lack of Efficacy|0|||
126693359|NCT00773279|455830885|FG000|Period 2|Protocol Violation|0|||
126693360|NCT00773279|455830886|FG001|Period 2|Protocol Violation|3|||
126693361|NCT00773279|455830885|FG000|Period 2|Unclassified|2|||
126693362|NCT00773279|455830886|FG001|Period 2|Unclassified|2|||
126693363|NCT02908516|455830893|FG000|Overall Study|Study Terminated|3|||
126693364|NCT02908516|455830894|FG001|Overall Study|Study Terminated|3|||
126693365|NCT01931059|455830897|FG000|Day 1|Pregnancy|0|||
126693366|NCT01931059|455830898|FG001|Day 1|Pregnancy|1|||
126693367|NCT01931059|455830897|FG000|Day3|Lost to Follow-up|1|||
126693368|NCT01931059|455830898|FG001|Day3|Lost to Follow-up|0|||
126693369|NCT00778830|455833213|FG000|Overall Study|Ongoing at data cut-off|0|||
126693370|NCT00778830|455833214|FG001|Overall Study|Ongoing at data cut-off|1|||
126693371|NCT01891643|455833215|FG000|Overall Study|Adverse event unrelated to study drug|2|||
126693372|NCT01891643|455833216|FG001|Overall Study|Adverse event unrelated to study drug|5|||
126693373|NCT01891643|455833215|FG000|Overall Study|Disease Progression|4|||
126693374|NCT01891643|455833216|FG001|Overall Study|Disease Progression|3|||
126693375|NCT01891643|455833215|FG000|Overall Study|Study Drug Toxicity|3|||
126693376|NCT01891643|455833216|FG001|Overall Study|Study Drug Toxicity|0|||
126693377|NCT01891643|455833215|FG000|Overall Study|Maximum Clinical Benefit|0|||
126693378|NCT01891643|455833216|FG001|Overall Study|Maximum Clinical Benefit|1|||
126693379|NCT01891643|455833215|FG000|Overall Study|Poor/Non-compliance|0|||
126693380|NCT01891643|455833216|FG001|Overall Study|Poor/Non-compliance|1|||
126693381|NCT01891643|455833215|FG000|Overall Study|Participant request to discontinue|1|||
126693382|NCT01891643|455833216|FG001|Overall Study|Participant request to discontinue|0|||
126693383|NCT01583179|455833217|FG000|Overall Study|Screen failure|1|||
126693384|NCT01583179|455833218|FG001|Overall Study|Screen failure|2|||
126693385|NCT01246206|455833219|FG000|Overall Study|Patient did not receive study regiments.|1|||
126693386|NCT04047797|455833220|FG000|Overall Study|Progressive Disease|1|||
126693387|NCT03523351|455833221|FG000|Overall Study|Death|13|||
126693388|NCT03523351|455833222|FG001|Overall Study|Death|11|||
126693389|NCT03523351|455833221|FG000|Overall Study|Lost to Follow-up|2|||
126693390|NCT03523351|455833222|FG001|Overall Study|Lost to Follow-up|3|||
126693391|NCT03523351|455833221|FG000|Overall Study|Withdrawal by Subject|4|||
126693392|NCT03523351|455833222|FG001|Overall Study|Withdrawal by Subject|0|||
126693393|NCT03523351|455833221|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
126693394|NCT03523351|455833222|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
126693395|NCT01097629|455833229|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
126693396|NCT01097629|455833230|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
126693397|NCT01097629|455833231|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
126693398|NCT01097629|455833232|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126693399|NCT01097629|455833233|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126693400|NCT01097629|455833234|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126693401|NCT01097629|455833235|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126693402|NCT01097629|455833236|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126693403|NCT01097629|455833229|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
126693404|NCT01097629|455833230|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
126693405|NCT01097629|455833231|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
126693406|NCT01097629|455833232|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126693407|NCT01097629|455833233|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126693408|NCT01097629|455833234|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126693409|NCT01097629|455833235|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126693410|NCT01097629|455833236|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126693411|NCT01097629|455833229|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
126693412|NCT01097629|455833230|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
126693413|NCT01097629|455833231|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
126693414|NCT01097629|455833232|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126693415|NCT01097629|455833233|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126693416|NCT01097629|455833234|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126693417|NCT01097629|455833235|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126693418|NCT01097629|455833236|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126693419|NCT01097629|455833229|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
126693420|NCT01097629|455833230|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
126693421|NCT01097629|455833231|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
126693422|NCT01097629|455833232|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126693423|NCT01097629|455833233|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126693424|NCT01097629|455833234|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126693425|NCT01097629|455833235|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126693426|NCT01097629|455833236|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126693427|NCT01097629|455833229|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
126693428|NCT01097629|455833230|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
126693429|NCT01097629|455833231|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
126693430|NCT01097629|455833232|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126693431|NCT01097629|455833233|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126693432|NCT01097629|455833234|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126693433|NCT01097629|455833235|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126693434|NCT01097629|455833236|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126693435|NCT01097629|455833229|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
126693436|NCT01097629|455833230|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
126693437|NCT01097629|455833231|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126693438|NCT01097629|455833232|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126693439|NCT01097629|455833233|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126693440|NCT01097629|455833234|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126693441|NCT01097629|455833235|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126693442|NCT01097629|455833236|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126693443|NCT01097629|455833229|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
126693444|NCT01097629|455833230|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
126693445|NCT01097629|455833231|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
126693446|NCT01097629|455833232|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126355975|NCT01149538|454595640|FG001|Overall Study|Withdrawal by Subject|3|||
126355976|NCT00888849|454595643|FG000|Overall Study|Death|4|||
126355977|NCT00888849|454595644|FG001|Overall Study|Death|7|||
126355978|NCT00888849|454595643|FG000|Overall Study|Lost to Follow-up|1|||
126355979|NCT00888849|454595644|FG001|Overall Study|Lost to Follow-up|2|||
126445230|NCT03843541|454928225|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
126445231|NCT03843541|454928226|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
126445232|NCT05767749|454928236|FG000|Overall Study|Withdrawal by Subject|0|||
126445233|NCT05767749|454928237|FG001|Overall Study|Withdrawal by Subject|0|||
126445234|NCT05767749|454928238|FG002|Overall Study|Withdrawal by Subject|2|||
126445235|NCT05767749|454928239|FG003|Overall Study|Withdrawal by Subject|2|||
126445236|NCT05767749|454928240|FG004|Overall Study|Withdrawal by Subject|2|||
126445237|NCT05767749|454928241|FG005|Overall Study|Withdrawal by Subject|2|||
126445238|NCT01077050|454930285|FG000|Overall Study|Subjects signed ICF could not be located|1|||
126445239|NCT01077050|454930285|FG000|Overall Study|Screen failure|8|||
126445240|NCT00684060|454930286|FG000|Overall Study|Lost to Follow-up|1|||
126445241|NCT00684060|454930287|FG001|Overall Study|Lost to Follow-up|0|||
126445242|NCT00684060|454930286|FG000|Overall Study|New stenosis identified|1|||
126445243|NCT00684060|454930287|FG001|Overall Study|New stenosis identified|0|||
126445244|NCT00684060|454930286|FG000|Overall Study|Unable to collect MRI|1|||
126445245|NCT00684060|454930287|FG001|Overall Study|Unable to collect MRI|2|||
126445246|NCT00684060|454930286|FG000|Overall Study|Death|0|||
126693447|NCT01097629|455833233|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126693448|NCT01097629|455833234|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126693449|NCT01097629|455833235|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126693450|NCT01097629|455833236|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126445247|NCT00684060|454930287|FG001|Overall Study|Death|1|||
126445248|NCT00702715|454930292|FG000|Overall Study|Lost to Follow-up|1|||
126445249|NCT00702715|454930293|FG001|Overall Study|Lost to Follow-up|0|||
126445250|NCT03751657|454930294|FG000|Overall Study|Physician Decision|0|||
126445251|NCT03751657|454930295|FG001|Overall Study|Physician Decision|1|||
126693451|NCT01097629|455833229|FG000|DB RO Phase|Withdrawal by Subject|0|||
126693452|NCT01097629|455833230|FG001|DB RO Phase|Withdrawal by Subject|0|||
126693453|NCT01097629|455833231|FG002|DB RO Phase|Withdrawal by Subject|0|||
126693454|NCT01097629|455833232|FG003|DB RO Phase|Withdrawal by Subject|0|||
126693455|NCT01097629|455833233|FG004|DB RO Phase|Withdrawal by Subject|0|||
126693456|NCT01097629|455833234|FG005|DB RO Phase|Withdrawal by Subject|0|||
126693457|NCT01097629|455833235|FG006|DB RO Phase|Withdrawal by Subject|0|||
126693458|NCT01097629|455833236|FG007|DB RO Phase|Withdrawal by Subject|1|||
126693459|NCT01097629|455833229|FG000|DB RO Phase|Protocol Violation|0|||
126693460|NCT01097629|455833230|FG001|DB RO Phase|Protocol Violation|0|||
126693461|NCT01097629|455833231|FG002|DB RO Phase|Protocol Violation|0|||
126693462|NCT01097629|455833232|FG003|DB RO Phase|Protocol Violation|1|||
126693463|NCT01097629|455833233|FG004|DB RO Phase|Protocol Violation|0|||
126693464|NCT01097629|455833234|FG005|DB RO Phase|Protocol Violation|1|||
126693465|NCT01097629|455833235|FG006|DB RO Phase|Protocol Violation|1|||
126693466|NCT01097629|455833236|FG007|DB RO Phase|Protocol Violation|0|||
126693467|NCT01097629|455833229|FG000|DB RO Phase|Lost to Follow-up|0|||
126693468|NCT01097629|455833230|FG001|DB RO Phase|Lost to Follow-up|0|||
126693469|NCT01097629|455833231|FG002|DB RO Phase|Lost to Follow-up|0|||
126693470|NCT01097629|455833232|FG003|DB RO Phase|Lost to Follow-up|0|||
126693471|NCT01097629|455833233|FG004|DB RO Phase|Lost to Follow-up|0|||
126693472|NCT01097629|455833234|FG005|DB RO Phase|Lost to Follow-up|0|||
126693473|NCT01097629|455833235|FG006|DB RO Phase|Lost to Follow-up|2|||
126693474|NCT01097629|455833236|FG007|DB RO Phase|Lost to Follow-up|0|||
126693475|NCT00132041|455833237|FG000|Baseline|Ineligible|6|||
126693476|NCT00132041|455833237|FG000|3 Months Post Ablation|Transplant|1|||
126693477|NCT00132041|455833237|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
126693478|NCT00132041|455833237|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
126693479|NCT00132041|455833237|FG000|6 Months Post Ablation|Death|2|||
126693480|NCT00132041|455833237|FG000|6 Months Post Ablation|Transplant|6|||
126693481|NCT00132041|455833237|FG000|9 Months Post Ablation|Death|1|||
126693482|NCT00132041|455833237|FG000|9 Months Post Ablation|Transplant|1|||
126693483|NCT00132041|455833237|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
126693484|NCT00132041|455833237|FG000|12 Months Post Ablation|Death|1|||
126693485|NCT00132041|455833237|FG000|12 Months Post Ablation|Transplant|1|||
126693486|NCT00132041|455833237|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
126693487|NCT00132041|455833237|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
126693488|NCT00132041|455833237|FG000|15 Months Post Ablation|Death|1|||
126693489|NCT00132041|455833237|FG000|15 Months Post Ablation|Transplant|5|||
126445252|NCT03751657|454930294|FG000|Overall Study|Withdrawal by Subject|1|||
126445253|NCT03751657|454930295|FG001|Overall Study|Withdrawal by Subject|1|||
126445254|NCT03751657|454930294|FG000|Overall Study|Lost to Follow-up|2|||
126445255|NCT03751657|454930295|FG001|Overall Study|Lost to Follow-up|1|||
126445256|NCT03894813|454930296|FG000|Overall Study|Adverse Event|1|||
126445257|NCT03894813|454930297|FG001|Overall Study|Adverse Event|1|||
126693490|NCT00132041|455833237|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
126693491|NCT00132041|455833237|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
126693492|NCT00132041|455833237|FG000|18 Months Post Ablation|Transplant|1|||
126693493|NCT00132041|455833237|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
126693494|NCT00132041|455833237|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
126445258|NCT03894813|454930296|FG000|Overall Study|Lack of Efficacy|3|||
126445259|NCT03894813|454930297|FG001|Overall Study|Lack of Efficacy|3|||
126445260|NCT03894813|454930296|FG000|Overall Study|Lost to Follow-up|1|||
126445261|NCT03894813|454930297|FG001|Overall Study|Lost to Follow-up|0|||
126445262|NCT03894813|454930296|FG000|Overall Study|Pregnancy|2|||
126445263|NCT03894813|454930297|FG001|Overall Study|Pregnancy|1|||
126445264|NCT03894813|454930296|FG000|Overall Study|Protocol Violation|3|||
126445265|NCT03894813|454930297|FG001|Overall Study|Protocol Violation|7|||
126445266|NCT03894813|454930296|FG000|Overall Study|Withdrawal by Subject|1|||
126445267|NCT03894813|454930297|FG001|Overall Study|Withdrawal by Subject|3|||
126445268|NCT03894813|454930296|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
126445269|NCT03894813|454930297|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
126445270|NCT03083873|454930299|FG000|Overall Study|Death|6|||
126445271|NCT03083873|454930300|FG001|Overall Study|Death|15|||
126445272|NCT03083873|454930301|FG002|Overall Study|Death|13|||
126445273|NCT03083873|454930302|FG003|Overall Study|Death|9|||
126445274|NCT03083873|454930303|FG004|Overall Study|Death|0|||
126445275|NCT03083873|454930299|FG000|Overall Study|Sponsor Terminated Study|0|||
126445276|NCT03083873|454930300|FG001|Overall Study|Sponsor Terminated Study|1|||
126445277|NCT03083873|454930301|FG002|Overall Study|Sponsor Terminated Study|2|||
126445278|NCT03083873|454930302|FG003|Overall Study|Sponsor Terminated Study|3|||
126445279|NCT03083873|454930303|FG004|Overall Study|Sponsor Terminated Study|0|||
126445280|NCT03083873|454930299|FG000|Overall Study|Lost to Follow-up|0|||
126445281|NCT03083873|454930300|FG001|Overall Study|Lost to Follow-up|1|||
126445282|NCT03083873|454930301|FG002|Overall Study|Lost to Follow-up|1|||
126445283|NCT03083873|454930302|FG003|Overall Study|Lost to Follow-up|0|||
126445284|NCT03083873|454930303|FG004|Overall Study|Lost to Follow-up|0|||
126445285|NCT03083873|454930299|FG000|Overall Study|Withdrawal by Subject|2|||
126445286|NCT03083873|454930300|FG001|Overall Study|Withdrawal by Subject|0|||
126445287|NCT03083873|454930301|FG002|Overall Study|Withdrawal by Subject|0|||
126445288|NCT03083873|454930302|FG003|Overall Study|Withdrawal by Subject|0|||
126445289|NCT03083873|454930303|FG004|Overall Study|Withdrawal by Subject|0|||
126445290|NCT03083873|454930299|FG000|Overall Study|Did Not Receive TIL|2|||
126445291|NCT03083873|454930300|FG001|Overall Study|Did Not Receive TIL|5|||
126445292|NCT03083873|454930301|FG002|Overall Study|Did Not Receive TIL|3|||
126445293|NCT03083873|454930302|FG003|Overall Study|Did Not Receive TIL|1|||
126445294|NCT03083873|454930303|FG004|Overall Study|Did Not Receive TIL|0|||
126445295|NCT01677377|454930304|FG000|Overall Study|Protocol Violation|1|||
126445296|NCT01677377|454930305|FG001|Overall Study|Protocol Violation|0|||
126445297|NCT01677377|454930306|FG002|Overall Study|Protocol Violation|0|||
126760622|NCT00129220|456073854|FG002|Study Period III|Reason Not Specified|2|||
126760623|NCT01883362|456073855|FG000|Treatment|Adverse Event|1|||
126760624|NCT01883362|456073856|FG001|Treatment|Adverse Event|8|||
126760625|NCT01883362|456073855|FG000|Treatment|Withdrawal by Subject|6|||
126760626|NCT01883362|456073856|FG001|Treatment|Withdrawal by Subject|2|||
126760627|NCT01883362|456073855|FG000|Treatment|Administrative problems|4|||
126760628|NCT01883362|456073856|FG001|Treatment|Administrative problems|1|||
126760629|NCT01883362|456073855|FG000|Treatment|Relapse|4|||
126760630|NCT01883362|456073856|FG001|Treatment|Relapse|2|||
126760631|NCT01883362|456073855|FG000|Treatment|Randomized, not treated|1|||
126760632|NCT01883362|456073856|FG001|Treatment|Randomized, not treated|1|||
126760633|NCT01883362|456073855|FG000|Post Treatment Follow-up|Protocol Violation|0|||
126760634|NCT01883362|456073856|FG001|Post Treatment Follow-up|Protocol Violation|1|||
126445298|NCT01677377|454930304|FG000|Overall Study|Lost to Follow-up|0|||
126445299|NCT01677377|454930305|FG001|Overall Study|Lost to Follow-up|1|||
126445300|NCT01677377|454930306|FG002|Overall Study|Lost to Follow-up|1|||
126445301|NCT01677377|454930304|FG000|Overall Study|Withdrawal by Subject|0|||
126445302|NCT01677377|454930305|FG001|Overall Study|Withdrawal by Subject|0|||
126445303|NCT01677377|454930306|FG002|Overall Study|Withdrawal by Subject|3|||
126445304|NCT01677377|454930304|FG000|Overall Study|Lack of Efficacy|0|||
126445305|NCT01677377|454930305|FG001|Overall Study|Lack of Efficacy|0|||
126445306|NCT01677377|454930306|FG002|Overall Study|Lack of Efficacy|1|||
126445307|NCT01677377|454930304|FG000|Overall Study|Pregnancy|0|||
126445308|NCT01677377|454930305|FG001|Overall Study|Pregnancy|0|||
126445309|NCT01677377|454930306|FG002|Overall Study|Pregnancy|1|||
126445310|NCT02656693|454930320|FG000|Overall Study|Pregnancy|1|||
126445311|NCT02656693|454930321|FG001|Overall Study|Pregnancy|1|||
126445312|NCT02656693|454930322|FG002|Overall Study|Pregnancy|1|||
126445313|NCT02656693|454930320|FG000|Overall Study|Bariatric surgery|0|||
126445314|NCT02656693|454930321|FG001|Overall Study|Bariatric surgery|1|||
126445315|NCT02656693|454930322|FG002|Overall Study|Bariatric surgery|2|||
126445316|NCT02269267|454930324|FG000|Overall Study|Death|5|||
126445317|NCT03805659|454930326|FG000|Overall Study|Withdrawal by Subject|0|||
126445318|NCT03805659|454930327|FG001|Overall Study|Withdrawal by Subject|1|||
126445319|NCT01069900|454930330|FG000|Overall Study|Technical problems|0|||
126760635|NCT01883362|456073855|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
126760636|NCT01883362|456073856|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
126760637|NCT01883362|456073855|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
126355980|NCT05507450|454595650|FG000|Overall Study|Death|0|||
126355981|NCT05507450|454595651|FG001|Overall Study|Death|0|||
126355982|NCT05507450|454595652|FG002|Overall Study|Death|1|||
126355983|NCT05507450|454595653|FG003|Overall Study|Death|0|||
126355984|NCT05507450|454595650|FG000|Overall Study|Lost to Follow-up|22|||
126355985|NCT05507450|454595651|FG001|Overall Study|Lost to Follow-up|20|||
126355986|NCT05507450|454595652|FG002|Overall Study|Lost to Follow-up|20|||
126445320|NCT01069900|454930331|FG001|Overall Study|Technical problems|1|||
126445321|NCT01069900|454930330|FG000|Overall Study|Lost to Follow-up|7|||
126445322|NCT01069900|454930331|FG001|Overall Study|Lost to Follow-up|1|||
126445323|NCT01069900|454930330|FG000|Overall Study|Withdrawal by Subject|6|||
126445324|NCT01069900|454930331|FG001|Overall Study|Withdrawal by Subject|1|||
126445325|NCT01069900|454930330|FG000|Overall Study|Protocol Violation|4|||
126445326|NCT01069900|454930331|FG001|Overall Study|Protocol Violation|1|||
126445327|NCT01069900|454930330|FG000|Overall Study|Insufficient Therapeutic effect|1|||
126693495|NCT01171820|455833238|FG000|Overall Study|Death|3|||
126693496|NCT01171820|455833239|FG001|Overall Study|Death|3|||
126693497|NCT01171820|455833238|FG000|Overall Study|Lost to Follow-up|0|||
126693498|NCT01171820|455833239|FG001|Overall Study|Lost to Follow-up|1|||
126693499|NCT01171820|455833238|FG000|Overall Study|Withdrawal by Subject|2|||
126693500|NCT01171820|455833239|FG001|Overall Study|Withdrawal by Subject|0|||
126693501|NCT01171820|455833238|FG000|Overall Study|Physician Decision|0|||
126693502|NCT01171820|455833239|FG001|Overall Study|Physician Decision|1|||
126693503|NCT01171820|455833238|FG000|Overall Study|1-Year Missed Visit|1|||
126693504|NCT01171820|455833239|FG001|Overall Study|1-Year Missed Visit|1|||
126693505|NCT02613208|455833240|FG000|Overall Study|Withdrawal by Subject|1|||
126693506|NCT02613208|455833240|FG000|Overall Study|Change of address|2|||
126693507|NCT02613208|455833240|FG000|Overall Study|Physician Decision|2|||
126693508|NCT02613208|455833240|FG000|Overall Study|Lost to Follow-up|5|||
126693509|NCT02613208|455833240|FG000|Overall Study|Death|37|||
126693510|NCT02663895|455833241|FG000|Overall Study|Adverse Event|3|||
126693511|NCT02663895|455833241|FG000|Overall Study|Physician Decision|2|||
126693512|NCT02663895|455833241|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
126693513|NCT02663895|455833241|FG000|Overall Study|Withdrawal by Subject|1|||
126445328|NCT01069900|454930331|FG001|Overall Study|Insufficient Therapeutic effect|0|||
126445329|NCT01168219|454930335|FG000|Overall Study|off study before starting treatment|2|||
126693514|NCT02804763|455833243|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
126693515|NCT02804763|455833244|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
126693516|NCT02804763|455833245|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
126693517|NCT02804763|455833246|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
126693518|NCT02804763|455833243|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
126693519|NCT02804763|455833244|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
126693520|NCT02804763|455833245|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
126693521|NCT02804763|455833246|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
126693522|NCT02804763|455833243|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
126693523|NCT02804763|455833244|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
126693524|NCT02804763|455833245|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
126693525|NCT02804763|455833246|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
126693526|NCT02804763|455833243|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
126693527|NCT02804763|455833244|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
126693528|NCT02804763|455833245|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
126693529|NCT02804763|455833246|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
126693530|NCT02804763|455833243|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
126693531|NCT02804763|455833244|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
126693532|NCT02804763|455833245|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
126693533|NCT02804763|455833246|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
126693534|NCT02804763|455833243|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
126693535|NCT02804763|455833244|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
126355987|NCT05507450|454595653|FG003|Overall Study|Lost to Follow-up|7|||
126355988|NCT05507450|454595650|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126355989|NCT05507450|454595651|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
126355990|NCT05507450|454595652|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126355991|NCT05507450|454595653|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126355992|NCT05507450|454595650|FG000|Overall Study|Withdrawal by Subject|4|||
126355993|NCT05507450|454595651|FG001|Overall Study|Withdrawal by Subject|11|||
126355994|NCT05507450|454595652|FG002|Overall Study|Withdrawal by Subject|7|||
126445330|NCT01168219|454930335|FG000|Overall Study|withdrew before transplant|1|||
126355995|NCT05507450|454595653|FG003|Overall Study|Withdrawal by Subject|3|||
126355996|NCT05507450|454595650|FG000|Overall Study|Participant left the country|0|||
126445331|NCT01168219|454930335|FG000|Overall Study|ineligible due to CML|2|||
126445332|NCT02600819|454930338|FG000|GEN Phase|Adverse Event|2|||
126355997|NCT05507450|454595651|FG001|Overall Study|Participant left the country|0|||
126355998|NCT05507450|454595652|FG002|Overall Study|Participant left the country|1|||
126355999|NCT05507450|454595653|FG003|Overall Study|Participant left the country|0|||
126356000|NCT00514917|454595657|FG000|Overall Study|Death|4|||
126356001|NCT00514917|454595658|FG001|Overall Study|Death|10|||
126356002|NCT00514917|454595657|FG000|Overall Study|Protocol Violation|1|||
126356003|NCT00514917|454595658|FG001|Overall Study|Protocol Violation|0|||
126356004|NCT00514917|454595657|FG000|Overall Study|Lost to Follow-up|4|||
126356005|NCT00514917|454595658|FG001|Overall Study|Lost to Follow-up|3|||
126445333|NCT02600819|454930339|FG001|GEN Phase|Adverse Event|0|||
126445334|NCT02600819|454930338|FG000|GEN Phase|Death|2|||
126445335|NCT02600819|454930339|FG001|GEN Phase|Death|0|||
126445336|NCT02600819|454930338|FG000|GEN Phase|Investigator's Discretion|4|||
126445337|NCT02600819|454930339|FG001|GEN Phase|Investigator's Discretion|0|||
126445338|NCT02600819|454930338|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
126445339|NCT02600819|454930339|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
126445340|NCT02600819|454930338|FG000|GEN Phase|Withdrew Consent|5|||
126445341|NCT02600819|454930339|FG001|GEN Phase|Withdrew Consent|0|||
126445342|NCT02600819|454930338|FG000|GEN Phase|Lost to Follow-up|2|||
126693536|NCT02804763|455833245|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
126693537|NCT02804763|455833246|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
126693538|NCT02472847|455833247|FG000|Overall Study|Withdrawal by Subject|1|||
126693539|NCT02472847|455833248|FG001|Overall Study|Withdrawal by Subject|5|||
126693540|NCT00623831|455833249|FG000|Overall Study|Withdrawal by Subject|1|||
126693541|NCT00623831|455833250|FG001|Overall Study|Withdrawal by Subject|0|||
126693542|NCT00623831|455833249|FG000|Overall Study|Progressive Disease|0|||
126693543|NCT00623831|455833250|FG001|Overall Study|Progressive Disease|1|||
126693544|NCT00270894|455833251|FG000|Overall Study|Adverse Event|1|||
126693545|NCT00270894|455833251|FG000|Overall Study|Withdrawal by Subject|1|||
126693546|NCT01748071|455833254|FG000|Overall Study|Adverse Event|2|||
126693547|NCT01748071|455833255|FG001|Overall Study|Adverse Event|2|||
126693548|NCT01748071|455833256|FG002|Overall Study|Adverse Event|0|||
126693549|NCT00793793|455833257|FG000|Overall Study|Adverse Event|0|||
126693550|NCT00793793|455833258|FG001|Overall Study|Adverse Event|0|||
126693551|NCT00793793|455833259|FG002|Overall Study|Adverse Event|1|||
126693552|NCT00793793|455833260|FG003|Overall Study|Adverse Event|1|||
126693553|NCT00793793|455833261|FG004|Overall Study|Adverse Event|0|||
126693554|NCT00793793|455833262|FG005|Overall Study|Adverse Event|1|||
126693555|NCT00793793|455833263|FG006|Overall Study|Adverse Event|2|||
126693556|NCT00793793|455833264|FG007|Overall Study|Adverse Event|0|||
126693557|NCT00793793|455833265|FG008|Overall Study|Adverse Event|0|||
126693558|NCT00793793|455833266|FG009|Overall Study|Adverse Event|0|||
126693559|NCT00793793|455833267|FG010|Overall Study|Adverse Event|0|||
126693560|NCT00793793|455833268|FG011|Overall Study|Adverse Event|2|||
126693561|NCT00793793|455833257|FG000|Overall Study|Protocol Violation|0|||
126693562|NCT00793793|455833258|FG001|Overall Study|Protocol Violation|0|||
126693563|NCT00793793|455833259|FG002|Overall Study|Protocol Violation|0|||
126693564|NCT00793793|455833260|FG003|Overall Study|Protocol Violation|1|||
126693565|NCT00793793|455833261|FG004|Overall Study|Protocol Violation|0|||
126693566|NCT00793793|455833262|FG005|Overall Study|Protocol Violation|0|||
126693567|NCT00793793|455833263|FG006|Overall Study|Protocol Violation|0|||
126693568|NCT00793793|455833264|FG007|Overall Study|Protocol Violation|0|||
126693569|NCT00793793|455833265|FG008|Overall Study|Protocol Violation|0|||
126693570|NCT00793793|455833266|FG009|Overall Study|Protocol Violation|0|||
126693571|NCT00793793|455833267|FG010|Overall Study|Protocol Violation|0|||
126693572|NCT00793793|455833268|FG011|Overall Study|Protocol Violation|0|||
126693573|NCT00793793|455833257|FG000|Overall Study|Lost to Follow-up|0|||
126693574|NCT00793793|455833258|FG001|Overall Study|Lost to Follow-up|0|||
126693575|NCT00793793|455833259|FG002|Overall Study|Lost to Follow-up|1|||
126693576|NCT00793793|455833260|FG003|Overall Study|Lost to Follow-up|0|||
126693577|NCT00793793|455833261|FG004|Overall Study|Lost to Follow-up|0|||
126693578|NCT00793793|455833262|FG005|Overall Study|Lost to Follow-up|0|||
126693579|NCT00793793|455833263|FG006|Overall Study|Lost to Follow-up|0|||
126693580|NCT00793793|455833264|FG007|Overall Study|Lost to Follow-up|0|||
126693581|NCT00793793|455833265|FG008|Overall Study|Lost to Follow-up|1|||
126693582|NCT00793793|455833266|FG009|Overall Study|Lost to Follow-up|3|||
126693583|NCT00793793|455833267|FG010|Overall Study|Lost to Follow-up|1|||
126693584|NCT00793793|455833268|FG011|Overall Study|Lost to Follow-up|0|||
126760638|NCT01883362|456073856|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
126693585|NCT00793793|455833257|FG000|Overall Study|Withdrawal by Subject|0|||
126760639|NCT01883362|456073855|FG000|Post Treatment Follow-up|Administrative problems|2|||
126356006|NCT00514917|454595657|FG000|Overall Study|Withdrawal by Subject|18|||
126356007|NCT00514917|454595658|FG001|Overall Study|Withdrawal by Subject|16|||
126445343|NCT02600819|454930339|FG001|GEN Phase|Lost to Follow-up|0|||
126445344|NCT02736890|454930340|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
126445345|NCT02736890|454930341|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
126693586|NCT00793793|455833258|FG001|Overall Study|Withdrawal by Subject|0|||
126693587|NCT00793793|455833259|FG002|Overall Study|Withdrawal by Subject|0|||
126693588|NCT00793793|455833260|FG003|Overall Study|Withdrawal by Subject|0|||
126445346|NCT02736890|454930340|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
126445347|NCT02736890|454930341|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
126445348|NCT01027273|454930342|FG000|Overall Study|Lost to Follow-up|57|||
126445349|NCT01027273|454930343|FG001|Overall Study|Lost to Follow-up|31|||
126445350|NCT01027273|454930342|FG000|Overall Study|Death|2|||
126445351|NCT01027273|454930343|FG001|Overall Study|Death|2|||
126445352|NCT02904954|454930345|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
126445353|NCT02904954|454930346|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
126445354|NCT02904954|454930345|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
126445355|NCT02904954|454930346|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
126445356|NCT02904954|454930345|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
126445357|NCT02904954|454930346|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
126445358|NCT02904954|454930345|FG000|Adjuvant Durvalumab|Recurrence|2|||
126445359|NCT02904954|454930346|FG001|Adjuvant Durvalumab|Recurrence|0|||
126445360|NCT02904954|454930345|FG000|Adjuvant Durvalumab|Adverse Event|2|||
126445361|NCT02904954|454930346|FG001|Adjuvant Durvalumab|Adverse Event|6|||
126445362|NCT02904954|454930345|FG000|Adjuvant Durvalumab|Participant wishes|12|||
126445363|NCT02904954|454930346|FG001|Adjuvant Durvalumab|Participant wishes|7|||
126445364|NCT02904954|454930345|FG000|Adjuvant Durvalumab|Physician Decision|2|||
126445365|NCT02904954|454930346|FG001|Adjuvant Durvalumab|Physician Decision|1|||
126445366|NCT02904954|454930345|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
126445367|NCT02904954|454930346|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
126445368|NCT02904954|454930345|FG000|Adjuvant Durvalumab|Death|0|||
126445369|NCT02904954|454930346|FG001|Adjuvant Durvalumab|Death|1|||
126445370|NCT02904954|454930345|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
126445371|NCT02904954|454930346|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
126445372|NCT03830892|454930347|FG000|Overall Study|Physician Decision|2|||
126693589|NCT00793793|455833261|FG004|Overall Study|Withdrawal by Subject|1|||
126693590|NCT00793793|455833262|FG005|Overall Study|Withdrawal by Subject|0|||
126693591|NCT00793793|455833263|FG006|Overall Study|Withdrawal by Subject|0|||
126693592|NCT00793793|455833264|FG007|Overall Study|Withdrawal by Subject|0|||
126693593|NCT00793793|455833265|FG008|Overall Study|Withdrawal by Subject|1|||
126693594|NCT00793793|455833266|FG009|Overall Study|Withdrawal by Subject|0|||
126693595|NCT00793793|455833267|FG010|Overall Study|Withdrawal by Subject|0|||
126693596|NCT00793793|455833268|FG011|Overall Study|Withdrawal by Subject|0|||
126693597|NCT00793793|455833257|FG000|Overall Study|reason not specified|0|||
126693598|NCT00793793|455833258|FG001|Overall Study|reason not specified|1|||
126693599|NCT00793793|455833259|FG002|Overall Study|reason not specified|0|||
126693600|NCT00793793|455833260|FG003|Overall Study|reason not specified|1|||
126693601|NCT00793793|455833261|FG004|Overall Study|reason not specified|1|||
126693602|NCT00793793|455833262|FG005|Overall Study|reason not specified|1|||
126693603|NCT00793793|455833263|FG006|Overall Study|reason not specified|2|||
126693604|NCT00793793|455833264|FG007|Overall Study|reason not specified|0|||
126693605|NCT00793793|455833265|FG008|Overall Study|reason not specified|7|||
126693606|NCT00793793|455833266|FG009|Overall Study|reason not specified|6|||
126693607|NCT00793793|455833267|FG010|Overall Study|reason not specified|2|||
126693608|NCT00793793|455833268|FG011|Overall Study|reason not specified|4|||
126693609|NCT00950170|455833269|FG000|Overall Study|Parent/Legal Guardian Request|1|||
126693610|NCT00950170|455833269|FG000|Overall Study|Adverse Event|2|||
126693611|NCT00950170|455833269|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
126693612|NCT02661594|455833270|FG000|Overall Study|Protocol Violation|1|||
126693613|NCT02661594|455833271|FG001|Overall Study|Protocol Violation|0|||
126693614|NCT02661594|455833272|FG002|Overall Study|Protocol Violation|1|||
126693615|NCT02661594|455833273|FG003|Overall Study|Protocol Violation|0|||
126693616|NCT02522767|455833274|FG000|Double-blind|Withdrawal by Subject|8|||
126693617|NCT02522767|455833275|FG001|Double-blind|Withdrawal by Subject|11|||
126693618|NCT02522767|455833274|FG000|Double-blind|Lost to Follow-up|1|||
126693619|NCT02522767|455833275|FG001|Double-blind|Lost to Follow-up|0|||
126693620|NCT02522767|455833274|FG000|Double-blind|Adverse Event|1|||
126693621|NCT02522767|455833275|FG001|Double-blind|Adverse Event|10|||
126693622|NCT02522767|455833274|FG000|Double-blind|Protocol Violation|0|||
126693623|NCT02522767|455833275|FG001|Double-blind|Protocol Violation|1|||
126693624|NCT02522767|455833274|FG000|Double-blind|Lack of Efficacy|0|||
126693625|NCT02522767|455833275|FG001|Double-blind|Lack of Efficacy|2|||
126693626|NCT02522767|455833274|FG000|Double-blind|Protocol Deviation|1|||
126693627|NCT02522767|455833275|FG001|Double-blind|Protocol Deviation|0|||
126693628|NCT02522767|455833274|FG000|Open-label|Withdrawal by Subject|2|||
126693629|NCT02522767|455833275|FG001|Open-label|Withdrawal by Subject|3|||
126693630|NCT02522767|455833274|FG000|Open-label|Lost to Follow-up|0|||
126445373|NCT03830892|454930348|FG001|Overall Study|Physician Decision|3|||
126445374|NCT03830892|454930347|FG000|Overall Study|Study terminated due to COVID|4|||
126445375|NCT03830892|454930348|FG001|Overall Study|Study terminated due to COVID|0|||
126445376|NCT03830892|454930347|FG000|Overall Study|Protocol Violation|0|||
126445377|NCT03830892|454930348|FG001|Overall Study|Protocol Violation|1|||
126445378|NCT03830892|454930347|FG000|Overall Study|Withdrawal by Subject|0|||
126693631|NCT02522767|455833275|FG001|Open-label|Lost to Follow-up|1|||
126693632|NCT02522767|455833274|FG000|Open-label|Adverse Event|2|||
126693633|NCT02522767|455833275|FG001|Open-label|Adverse Event|1|||
126693634|NCT02522767|455833274|FG000|Open-label|Lack of Efficacy|1|||
126693635|NCT02522767|455833275|FG001|Open-label|Lack of Efficacy|1|||
126693636|NCT02522767|455833274|FG000|Open-label|Protocol Violation|0|||
126693637|NCT02522767|455833275|FG001|Open-label|Protocol Violation|1|||
126693638|NCT00214461|455833276|FG000|Overall Study|Adverse Event|0|||
126693639|NCT00214461|455833277|FG001|Overall Study|Adverse Event|0|||
126693640|NCT00214461|455833278|FG002|Overall Study|Adverse Event|1|||
126693641|NCT00214461|455833279|FG003|Overall Study|Adverse Event|1|||
126693642|NCT00214461|455833276|FG000|Overall Study|Withdrawal by Subject|0|||
126693643|NCT00214461|455833277|FG001|Overall Study|Withdrawal by Subject|0|||
126693644|NCT00214461|455833278|FG002|Overall Study|Withdrawal by Subject|1|||
126693645|NCT00214461|455833279|FG003|Overall Study|Withdrawal by Subject|0|||
126693646|NCT03502187|455833280|FG000|Overall Study|Withdrawal by Subject|4|||
126693647|NCT03502187|455833281|FG001|Overall Study|Withdrawal by Subject|3|||
126693648|NCT03502187|455833282|FG002|Overall Study|Withdrawal by Subject|3|||
126693649|NCT03502187|455833280|FG000|Overall Study|Lost to Follow-up|5|||
126693650|NCT03502187|455833281|FG001|Overall Study|Lost to Follow-up|4|||
126693651|NCT03502187|455833282|FG002|Overall Study|Lost to Follow-up|5|||
126693652|NCT02908100|455833284|FG000|Overall Study|Adverse Event|7|||
126693653|NCT02908100|455833285|FG001|Overall Study|Adverse Event|6|||
126693654|NCT02908100|455833286|FG002|Overall Study|Adverse Event|9|||
126693655|NCT02908100|455833284|FG000|Overall Study|Death|2|||
126693656|NCT02908100|455833285|FG001|Overall Study|Death|0|||
126693657|NCT02908100|455833286|FG002|Overall Study|Death|0|||
126693658|NCT02908100|455833284|FG000|Overall Study|Lack of Efficacy|2|||
126693659|NCT02908100|455833285|FG001|Overall Study|Lack of Efficacy|3|||
126693660|NCT02908100|455833286|FG002|Overall Study|Lack of Efficacy|3|||
126693661|NCT02908100|455833284|FG000|Overall Study|Lost to Follow-up|0|||
126693662|NCT02908100|455833285|FG001|Overall Study|Lost to Follow-up|1|||
126693663|NCT02908100|455833286|FG002|Overall Study|Lost to Follow-up|2|||
126693664|NCT02908100|455833284|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126693665|NCT02908100|455833285|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126693666|NCT02908100|455833286|FG002|Overall Study|Non-Compliance With Study Drug|2|||
126693667|NCT02908100|455833284|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
126693668|NCT02908100|455833285|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
126693669|NCT02908100|455833286|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
126693670|NCT02908100|455833284|FG000|Overall Study|Physician Decision|0|||
126693671|NCT02908100|455833285|FG001|Overall Study|Physician Decision|1|||
126693672|NCT02908100|455833286|FG002|Overall Study|Physician Decision|0|||
126693673|NCT02908100|455833284|FG000|Overall Study|Pregnancy|1|||
126693674|NCT02908100|455833285|FG001|Overall Study|Pregnancy|2|||
126693675|NCT02908100|455833286|FG002|Overall Study|Pregnancy|0|||
126693676|NCT02908100|455833284|FG000|Overall Study|Withdrawal by Subject|8|||
126693677|NCT02908100|455833285|FG001|Overall Study|Withdrawal by Subject|7|||
126693678|NCT02908100|455833286|FG002|Overall Study|Withdrawal by Subject|5|||
126693679|NCT02908100|455833284|FG000|Overall Study|Randomised in Error|1|||
126693680|NCT02908100|455833285|FG001|Overall Study|Randomised in Error|0|||
126693681|NCT02908100|455833286|FG002|Overall Study|Randomised in Error|0|||
126693682|NCT00400400|455833289|FG000|Overall Study|Adverse Event|9|||
126693683|NCT00400400|455833290|FG001|Overall Study|Adverse Event|8|||
126693684|NCT00400400|455833289|FG000|Overall Study|Protocol Violation|2|||
126693685|NCT00400400|455833290|FG001|Overall Study|Protocol Violation|0|||
126693686|NCT00400400|455833289|FG000|Overall Study|Withdrawal by Subject|1|||
126693687|NCT00400400|455833290|FG001|Overall Study|Withdrawal by Subject|3|||
126693688|NCT00400400|455833289|FG000|Overall Study|Administrative Problem|1|||
126693689|NCT00400400|455833290|FG001|Overall Study|Administrative Problem|0|||
126693690|NCT00400400|455833289|FG000|Overall Study|Lost to Follow-up|0|||
126693691|NCT00400400|455833290|FG001|Overall Study|Lost to Follow-up|1|||
126693692|NCT00400400|455833289|FG000|Overall Study|Did not receive study drug|1|||
126693693|NCT00400400|455833290|FG001|Overall Study|Did not receive study drug|3|||
126693694|NCT01688050|455833291|FG000|Overall Study|Death|7|||
126693695|NCT01688050|455833291|FG000|Overall Study|Conversion to open repair|1|||
126693696|NCT01688050|455833291|FG000|Overall Study|Lost to Follow-up|13|||
126693697|NCT01688050|455833291|FG000|Overall Study|Withdrawal by Subject|10|||
126693698|NCT02789657|455833294|FG000|Overall Study|Withdrawal by Subject|2|||
126693699|NCT02789657|455833295|FG001|Overall Study|Withdrawal by Subject|0|||
126693700|NCT02789657|455833296|FG002|Overall Study|Withdrawal by Subject|0|||
126693701|NCT02789657|455833297|FG003|Overall Study|Withdrawal by Subject|0|||
126693702|NCT01214044|455833298|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
126693703|NCT01214044|455833298|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
126693704|NCT01214044|455833298|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
126693705|NCT01214044|455833298|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
126693706|NCT01214044|455833298|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
126693707|NCT01214044|455833298|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
126693708|NCT02772757|455833299|FG000|Overall Study|Withdrawal by Subject|1|||
126693709|NCT02772757|455833300|FG001|Overall Study|Withdrawal by Subject|0|||
126693710|NCT02772757|455833301|FG002|Overall Study|Withdrawal by Subject|1|||
126693711|NCT02772757|455833299|FG000|Overall Study|Protocol Violation|0|||
126693712|NCT02772757|455833300|FG001|Overall Study|Protocol Violation|0|||
126693713|NCT02772757|455833301|FG002|Overall Study|Protocol Violation|1|||
126693714|NCT02772757|455833299|FG000|Overall Study|Physician Decision|0|||
126693715|NCT02772757|455833300|FG001|Overall Study|Physician Decision|3|||
126693716|NCT02772757|455833301|FG002|Overall Study|Physician Decision|3|||
126693717|NCT04698525|455833302|FG000|Overall Study|Lost to Follow-up|1|||
126693718|NCT04698525|455833303|FG001|Overall Study|Lost to Follow-up|2|||
126693719|NCT04698525|455833302|FG000|Overall Study|Three suffered of Covid-19|2|||
126693720|NCT04698525|455833303|FG001|Overall Study|Three suffered of Covid-19|1|||
126693721|NCT00510276|455833307|FG000|Acute Double-Blind Phase|Adverse Event|21|||
126693722|NCT00510276|455833308|FG001|Acute Double-Blind Phase|Adverse Event|6|||
126693723|NCT00510276|455833307|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
126693724|NCT00510276|455833308|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
126693725|NCT00510276|455833307|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
126693726|NCT00510276|455833308|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
126693727|NCT00510276|455833307|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
126693728|NCT00510276|455833308|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
126693729|NCT00510276|455833307|FG000|Acute Double-Blind Phase|Physician Decision|0|||
126693730|NCT00510276|455833308|FG001|Acute Double-Blind Phase|Physician Decision|3|||
126356008|NCT00514917|454595657|FG000|Overall Study|Discontinued due to study closure|88|||
126356009|NCT00514917|454595658|FG001|Overall Study|Discontinued due to study closure|81|||
126356010|NCT00514917|454595657|FG000|Overall Study|Undefined|11|||
126356011|NCT00514917|454595658|FG001|Overall Study|Undefined|5|||
126356012|NCT02697422|454595659|FG000|Overall Study|Declined exit survey|9|||
126356013|NCT02697422|454595660|FG001|Overall Study|Declined exit survey|2|||
126356014|NCT02697422|454595659|FG000|Overall Study|Lost to Follow-up|13|||
126356015|NCT02697422|454595660|FG001|Overall Study|Lost to Follow-up|8|||
126356016|NCT02697422|454595659|FG000|Overall Study|Death|2|||
126356017|NCT02697422|454595660|FG001|Overall Study|Death|1|||
126356018|NCT02697422|454595659|FG000|Overall Study|Withdrawal by Subject|0|||
126356019|NCT02697422|454595660|FG001|Overall Study|Withdrawal by Subject|1|||
126356020|NCT02697422|454595659|FG000|Overall Study|Physician Decision|1|||
126356021|NCT02697422|454595660|FG001|Overall Study|Physician Decision|1|||
126356022|NCT02697422|454595659|FG000|Overall Study|Exit survey data lost|1|||
126356023|NCT02697422|454595660|FG001|Overall Study|Exit survey data lost|0|||
126356024|NCT01873833|454595664|FG000|Overall Study|Withdrawal by Subject|1|||
126356025|NCT03983109|454595667|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
126356026|NCT03983109|454595668|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
126356027|NCT02068599|454595669|FG000|Overall Study|Adverse Event|4|||
126356028|NCT02068599|454595670|FG001|Overall Study|Adverse Event|1|||
126356029|NCT02068599|454595671|FG002|Overall Study|Adverse Event|1|||
126356030|NCT02068599|454595669|FG000|Overall Study|Withdrawal by Subject|2|||
126356031|NCT02068599|454595670|FG001|Overall Study|Withdrawal by Subject|7|||
126356032|NCT02068599|454595671|FG002|Overall Study|Withdrawal by Subject|5|||
126356033|NCT02068599|454595669|FG000|Overall Study|Protocol Violation|4|||
126356034|NCT02068599|454595670|FG001|Overall Study|Protocol Violation|2|||
126356035|NCT02068599|454595671|FG002|Overall Study|Protocol Violation|3|||
126356036|NCT02068599|454595669|FG000|Overall Study|Lost to Follow-up|1|||
126356037|NCT02068599|454595670|FG001|Overall Study|Lost to Follow-up|0|||
126356038|NCT02068599|454595671|FG002|Overall Study|Lost to Follow-up|0|||
126356039|NCT02068599|454595669|FG000|Overall Study|Lack of Efficacy|0|||
126356040|NCT02068599|454595670|FG001|Overall Study|Lack of Efficacy|0|||
126356041|NCT02068599|454595671|FG002|Overall Study|Lack of Efficacy|3|||
126356042|NCT02068599|454595669|FG000|Overall Study|Noncompliance|0|||
126356043|NCT02068599|454595670|FG001|Overall Study|Noncompliance|0|||
126356044|NCT02068599|454595671|FG002|Overall Study|Noncompliance|1|||
126356045|NCT01871727|454595674|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
126356046|NCT01871727|454595675|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
126356047|NCT01871727|454595676|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
126693731|NCT00510276|455833307|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
126693732|NCT00510276|455833308|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
126693733|NCT00510276|455833307|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
126693734|NCT00510276|455833308|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
126693735|NCT00510276|455833307|FG000|Acute Double-Blind Phase|Subject Decision|26|||
126356048|NCT01871727|454595677|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
126356049|NCT01871727|454595678|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
126356050|NCT01871727|454595674|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
126356051|NCT01871727|454595675|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
126356052|NCT01871727|454595676|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
126356053|NCT01871727|454595677|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
126356054|NCT01871727|454595678|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
126356055|NCT01871727|454595674|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
126693736|NCT00510276|455833308|FG001|Acute Double-Blind Phase|Subject Decision|28|||
126760640|NCT01883362|456073856|FG001|Post Treatment Follow-up|Administrative problems|0|||
126760641|NCT01883362|456073855|FG000|Post Treatment Follow-up|Death|8|||
126760642|NCT01883362|456073856|FG001|Post Treatment Follow-up|Death|4|||
126760643|NCT01883362|456073855|FG000|Post Treatment Follow-up|Relapse|1|||
126760644|NCT01883362|456073856|FG001|Post Treatment Follow-up|Relapse|2|||
126760645|NCT02911285|456073857|FG000|Overall Study|Lost to Follow-up|8|||
126760646|NCT02911285|456073858|FG001|Overall Study|Lost to Follow-up|5|||
126760647|NCT02911285|456073857|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
126760648|NCT02911285|456073858|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
126760649|NCT01230489|456073859|FG000|Overall Study|Death|2|||
126760650|NCT01230489|456073859|FG000|Overall Study|Adverse Event|2|||
126760651|NCT01230489|456073859|FG000|Overall Study|Treatment modality changed|1|||
126760652|NCT01791543|456073860|FG000|Overall Study|Lost to Follow-up|1|||
126760653|NCT01791543|456073860|FG000|Overall Study|Adverse Event|1|||
126760654|NCT03996694|456075755|FG000|First Washout (7 Days)|positive urine drug screen|0|||
126760655|NCT03996694|456075756|FG001|First Washout (7 Days)|positive urine drug screen|0|||
126760656|NCT03996694|456075757|FG002|First Washout (7 Days)|positive urine drug screen|1|||
126760657|NCT03996694|456075758|FG003|First Washout (7 Days)|positive urine drug screen|0|||
126760658|NCT03996694|456075759|FG004|First Washout (7 Days)|positive urine drug screen|0|||
126760659|NCT03996694|456075760|FG005|First Washout (7 Days)|positive urine drug screen|0|||
126760660|NCT03996694|456075755|FG000|First Washout (7 Days)|Adverse Event|0|||
126760661|NCT03996694|456075756|FG001|First Washout (7 Days)|Adverse Event|1|||
126760662|NCT03996694|456075757|FG002|First Washout (7 Days)|Adverse Event|0|||
126760663|NCT03996694|456075758|FG003|First Washout (7 Days)|Adverse Event|0|||
126760664|NCT03996694|456075759|FG004|First Washout (7 Days)|Adverse Event|0|||
126760665|NCT03996694|456075760|FG005|First Washout (7 Days)|Adverse Event|0|||
126760666|NCT03996694|456075755|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
126760667|NCT03996694|456075756|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
126693737|NCT00510276|455833307|FG000|Extension Open-Label Phase|Adverse Event|9|||
126356056|NCT01871727|454595675|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
126693738|NCT00510276|455833308|FG001|Extension Open-Label Phase|Adverse Event|18|||
126693739|NCT00510276|455833307|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
126693740|NCT00510276|455833308|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
126693741|NCT00510276|455833307|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
126693742|NCT00510276|455833308|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
126693743|NCT00510276|455833307|FG000|Extension Open-Label Phase|Physician Decision|2|||
126693744|NCT00510276|455833308|FG001|Extension Open-Label Phase|Physician Decision|3|||
126356057|NCT01871727|454595676|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
126356058|NCT01871727|454595677|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
126356059|NCT01871727|454595678|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
126356060|NCT01871727|454595674|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
126356061|NCT01871727|454595675|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
126356062|NCT01871727|454595676|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
126356063|NCT01871727|454595677|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
126356064|NCT01871727|454595678|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
126356065|NCT01871727|454595674|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
126356066|NCT01871727|454595675|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
126356067|NCT01871727|454595676|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
126356068|NCT01871727|454595677|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
126356069|NCT01871727|454595678|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
126356070|NCT01871727|454595674|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
126356071|NCT01871727|454595675|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
126356072|NCT01871727|454595676|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
126356073|NCT01871727|454595677|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
126356074|NCT01871727|454595678|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
126356075|NCT01871727|454595674|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
126356076|NCT01871727|454595675|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
126356077|NCT01871727|454595676|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
126356078|NCT01871727|454595677|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
126356079|NCT01871727|454595678|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
126445379|NCT03830892|454930348|FG001|Overall Study|Withdrawal by Subject|2|||
126693745|NCT00510276|455833307|FG000|Extension Open-Label Phase|Protocol Violation|0|||
126693746|NCT00510276|455833308|FG001|Extension Open-Label Phase|Protocol Violation|1|||
126693747|NCT00510276|455833307|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
126760668|NCT03996694|456075757|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
126760669|NCT03996694|456075758|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
126760670|NCT03996694|456075759|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
126356080|NCT00309244|454595679|FG000|Overall Study|Adverse Event|29|||
126356081|NCT00309244|454595680|FG001|Overall Study|Adverse Event|12|||
126693748|NCT00510276|455833308|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
126693749|NCT00510276|455833307|FG000|Extension Open-Label Phase|Subject Decision|7|||
126693750|NCT00510276|455833308|FG001|Extension Open-Label Phase|Subject Decision|9|||
126693751|NCT03486392|455833311|FG000|Overall Study|Lost to Follow-up|0|||
126693752|NCT03486392|455833312|FG001|Overall Study|Lost to Follow-up|0|||
126693753|NCT03486392|455833313|FG002|Overall Study|Lost to Follow-up|8|||
126693754|NCT03486392|455833314|FG003|Overall Study|Lost to Follow-up|5|||
126693755|NCT03486392|455833315|FG004|Overall Study|Lost to Follow-up|2|||
126693756|NCT03486392|455833311|FG000|Overall Study|Withdrawal by Subject|3|||
126693757|NCT03486392|455833312|FG001|Overall Study|Withdrawal by Subject|0|||
126693758|NCT03486392|455833313|FG002|Overall Study|Withdrawal by Subject|6|||
126693759|NCT03486392|455833314|FG003|Overall Study|Withdrawal by Subject|4|||
126693760|NCT03486392|455833315|FG004|Overall Study|Withdrawal by Subject|1|||
126693761|NCT03486392|455833311|FG000|Overall Study|Death|0|||
126693762|NCT03486392|455833312|FG001|Overall Study|Death|0|||
126693763|NCT03486392|455833313|FG002|Overall Study|Death|0|||
126693764|NCT03486392|455833314|FG003|Overall Study|Death|0|||
126693765|NCT03486392|455833315|FG004|Overall Study|Death|1|||
126693766|NCT01731678|455833318|FG000|Overall Study|Withdrawal by Subject|3|||
126693767|NCT01731678|455833318|FG000|Overall Study|Did not meet inclusion criteria|1|||
126693768|NCT01731678|455833318|FG000|Overall Study|RMT too high, making TMS difficult|3|||
126693769|NCT00888355|455833325|FG000|Overall Study|Adverse Event|10|||
126693770|NCT00888355|455833326|FG001|Overall Study|Adverse Event|0|||
126693771|NCT00888355|455833327|FG002|Overall Study|Adverse Event|3|||
126693772|NCT00888355|455833328|FG003|Overall Study|Adverse Event|3|||
126445380|NCT04661579|454930349|FG000|Overall Study|Lost to Follow-up|19|||
126356082|NCT00309244|454595679|FG000|Overall Study|Lost to Follow-up|6|||
126356083|NCT00309244|454595680|FG001|Overall Study|Lost to Follow-up|22|||
126356084|NCT00309244|454595679|FG000|Overall Study|Physician Decision|5|||
126356085|NCT00309244|454595680|FG001|Overall Study|Physician Decision|8|||
126356086|NCT00309244|454595679|FG000|Overall Study|Protocol Violation|6|||
126356087|NCT00309244|454595680|FG001|Overall Study|Protocol Violation|3|||
126356088|NCT00309244|454595679|FG000|Overall Study|Withdrawal by Subject|50|||
126356089|NCT00309244|454595680|FG001|Overall Study|Withdrawal by Subject|32|||
126356090|NCT00309244|454595679|FG000|Overall Study|Various|7|||
126356091|NCT00309244|454595680|FG001|Overall Study|Various|7|||
126356092|NCT00309244|454595679|FG000|Overall Study|Randomized but not dosed|11|||
126356093|NCT00309244|454595680|FG001|Overall Study|Randomized but not dosed|12|||
126356094|NCT00309244|454595679|FG000|Overall Study|Death|4|||
126356095|NCT00309244|454595680|FG001|Overall Study|Death|1|||
126356096|NCT01263028|454595681|FG000|Overall Study|Withdrawal by Subject|1|||
126356097|NCT01263028|454595681|FG000|Overall Study|Adverse Event|1|||
126356098|NCT01263028|454595681|FG000|Overall Study|Study terminated due to low enrollment.|4|||
126356099|NCT00356421|454595682|FG000|Overall Study|Lack of Efficacy|3|||
126356100|NCT00356421|454595683|FG001|Overall Study|Lack of Efficacy|0|||
126356101|NCT00356421|454595682|FG000|Overall Study|Withdrawal by Subject|9|||
126356102|NCT00356421|454595683|FG001|Overall Study|Withdrawal by Subject|2|||
126356103|NCT00356421|454595682|FG000|Overall Study|Related to study drug|15|||
126356104|NCT00356421|454595683|FG001|Overall Study|Related to study drug|12|||
126356105|NCT00356421|454595682|FG000|Overall Study|Not related to study drug|5|||
126445381|NCT04661579|454930350|FG001|Overall Study|Lost to Follow-up|10|||
126356106|NCT00356421|454595683|FG001|Overall Study|Not related to study drug|3|||
126356107|NCT03019588|454595684|FG000|Overall Study|Death|44|||
126356108|NCT03019588|454595685|FG001|Overall Study|Death|46|||
126356109|NCT03019588|454595684|FG000|Overall Study|Study terminated by Sponsor|3|||
126356110|NCT03019588|454595685|FG001|Overall Study|Study terminated by Sponsor|1|||
126356111|NCT00501085|454595686|FG000|Overall Study|Lost to Follow-up|195|||
126356112|NCT00501085|454595686|FG000|Overall Study|Withdrawal by Subject|34|||
126693773|NCT00888355|455833325|FG000|Overall Study|Lack of Efficacy|9|||
126693774|NCT00888355|455833326|FG001|Overall Study|Lack of Efficacy|2|||
126693775|NCT00888355|455833327|FG002|Overall Study|Lack of Efficacy|5|||
126693776|NCT00888355|455833328|FG003|Overall Study|Lack of Efficacy|2|||
126693777|NCT00888355|455833325|FG000|Overall Study|Lost to Follow-up|0|||
126693778|NCT00888355|455833326|FG001|Overall Study|Lost to Follow-up|2|||
126760671|NCT03996694|456075760|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
126760672|NCT03996694|456075755|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
126445382|NCT04661579|454930351|FG002|Overall Study|Lost to Follow-up|2|||
126760673|NCT03996694|456075756|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
126760674|NCT03996694|456075757|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
126760675|NCT03996694|456075758|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
126760676|NCT03996694|456075759|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
126760677|NCT03996694|456075760|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
126760678|NCT00247416|456075765|FG000|Overall Study|3 patients were found to be ineligible|1|||
126760679|NCT00247416|456075766|FG001|Overall Study|3 patients were found to be ineligible|2|||
126760680|NCT00798161|456075767|FG000|Overall Study|Adverse Event|3|||
126760681|NCT00798161|456075768|FG001|Overall Study|Adverse Event|4|||
126760682|NCT00798161|456075769|FG002|Overall Study|Adverse Event|6|||
126760683|NCT00798161|456075770|FG003|Overall Study|Adverse Event|6|||
126760684|NCT00798161|456075771|FG004|Overall Study|Adverse Event|5|||
126760685|NCT00798161|456075772|FG005|Overall Study|Adverse Event|2|||
126760686|NCT00798161|456075773|FG006|Overall Study|Adverse Event|4|||
126760687|NCT00798161|456075767|FG000|Overall Study|Protocol Violation|2|||
126760688|NCT00798161|456075768|FG001|Overall Study|Protocol Violation|1|||
126760689|NCT00798161|456075769|FG002|Overall Study|Protocol Violation|3|||
126760690|NCT00798161|456075770|FG003|Overall Study|Protocol Violation|3|||
126760691|NCT00798161|456075771|FG004|Overall Study|Protocol Violation|3|||
126760692|NCT00798161|456075772|FG005|Overall Study|Protocol Violation|2|||
126760693|NCT00798161|456075773|FG006|Overall Study|Protocol Violation|0|||
126760694|NCT00798161|456075767|FG000|Overall Study|Lost to Follow-up|1|||
126760695|NCT00798161|456075768|FG001|Overall Study|Lost to Follow-up|3|||
126760696|NCT00798161|456075769|FG002|Overall Study|Lost to Follow-up|4|||
126760697|NCT00798161|456075770|FG003|Overall Study|Lost to Follow-up|3|||
126760698|NCT00798161|456075771|FG004|Overall Study|Lost to Follow-up|4|||
126760699|NCT00798161|456075772|FG005|Overall Study|Lost to Follow-up|0|||
126760700|NCT00798161|456075773|FG006|Overall Study|Lost to Follow-up|0|||
126760701|NCT00798161|456075767|FG000|Overall Study|Withdrawal by Subject|5|||
126760702|NCT00798161|456075768|FG001|Overall Study|Withdrawal by Subject|4|||
126760703|NCT00798161|456075769|FG002|Overall Study|Withdrawal by Subject|5|||
126760704|NCT00798161|456075770|FG003|Overall Study|Withdrawal by Subject|4|||
126760705|NCT00798161|456075771|FG004|Overall Study|Withdrawal by Subject|2|||
126760706|NCT00798161|456075772|FG005|Overall Study|Withdrawal by Subject|3|||
126760707|NCT00798161|456075773|FG006|Overall Study|Withdrawal by Subject|1|||
126760708|NCT00798161|456075767|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
126760709|NCT00798161|456075768|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
126760710|NCT00798161|456075769|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
126760711|NCT00798161|456075770|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
126760712|NCT00798161|456075771|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
126760713|NCT00798161|456075772|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
126760714|NCT00798161|456075773|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
126760715|NCT00761761|456075774|FG000|Overall Study|Lost to Follow-up|3|||
126760716|NCT00761761|456075775|FG001|Overall Study|Lost to Follow-up|1|||
126760717|NCT00761761|456075774|FG000|Overall Study|Withdrawal by Subject|3|||
126760718|NCT00761761|456075775|FG001|Overall Study|Withdrawal by Subject|0|||
126760719|NCT01982942|456075779|FG000|Overall Study|Adverse Event|10|||
126445383|NCT04661579|454930352|FG003|Overall Study|Lost to Follow-up|7|||
126445384|NCT04661579|454930353|FG004|Overall Study|Lost to Follow-up|11|||
126445385|NCT04661579|454930349|FG000|Overall Study|Physician Decision|2|||
126445386|NCT04661579|454930350|FG001|Overall Study|Physician Decision|0|||
126445387|NCT04661579|454930351|FG002|Overall Study|Physician Decision|0|||
126445388|NCT04661579|454930352|FG003|Overall Study|Physician Decision|1|||
126445389|NCT04661579|454930353|FG004|Overall Study|Physician Decision|0|||
126445390|NCT04661579|454930349|FG000|Overall Study|Withdrawal by Subject|1|||
126445391|NCT04661579|454930350|FG001|Overall Study|Withdrawal by Subject|4|||
126445392|NCT04661579|454930351|FG002|Overall Study|Withdrawal by Subject|0|||
126445393|NCT04661579|454930352|FG003|Overall Study|Withdrawal by Subject|2|||
126760720|NCT01982942|456075780|FG001|Overall Study|Adverse Event|5|||
126760721|NCT01982942|456075779|FG000|Overall Study|Lost to Follow-up|4|||
126760722|NCT01982942|456075780|FG001|Overall Study|Lost to Follow-up|3|||
126760723|NCT01982942|456075779|FG000|Overall Study|Multiple sclerosis progression|3|||
126760724|NCT01982942|456075780|FG001|Overall Study|Multiple sclerosis progression|2|||
126760725|NCT01982942|456075779|FG000|Overall Study|Wanted to try therapy not permitted|1|||
126760726|NCT01982942|456075780|FG001|Overall Study|Wanted to try therapy not permitted|0|||
126445394|NCT04661579|454930353|FG004|Overall Study|Withdrawal by Subject|0|||
126445395|NCT04661579|454930349|FG000|Overall Study|Death|1|||
126760727|NCT01982942|456075779|FG000|Overall Study|Subject declined future visits|0|||
126760728|NCT01982942|456075780|FG001|Overall Study|Subject declined future visits|1|||
126760729|NCT01982942|456075779|FG000|Overall Study|Left geographical area|2|||
126760730|NCT01982942|456075780|FG001|Overall Study|Left geographical area|0|||
126445396|NCT04661579|454930350|FG001|Overall Study|Death|0|||
126445397|NCT04661579|454930351|FG002|Overall Study|Death|0|||
126445398|NCT04661579|454930352|FG003|Overall Study|Death|0|||
126445399|NCT04661579|454930353|FG004|Overall Study|Death|0|||
126445400|NCT04661579|454930349|FG000|Overall Study|Other|1|||
126445401|NCT04661579|454930350|FG001|Overall Study|Other|2|||
126445402|NCT04661579|454930351|FG002|Overall Study|Other|1|||
126445403|NCT04661579|454930352|FG003|Overall Study|Other|1|||
126445404|NCT04661579|454930353|FG004|Overall Study|Other|1|||
126445405|NCT04661579|454930349|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
126445406|NCT04661579|454930350|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
126445407|NCT04661579|454930351|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
126445408|NCT04661579|454930352|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
126445409|NCT04661579|454930353|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
126445410|NCT00859456|454930355|FG000|Overall Study|Adverse Event|3|||
126445411|NCT00859456|454930355|FG000|Overall Study|Progressive disease|2|||
126445412|NCT00859456|454930355|FG000|Overall Study|Non-compliance|3|||
126445413|NCT00337675|454930356|FG000|Overall Study|Adverse Event|10|||
126445414|NCT00337675|454930357|FG001|Overall Study|Adverse Event|9|||
126445415|NCT00337675|454930358|FG002|Overall Study|Adverse Event|19|||
126445416|NCT00337675|454930356|FG000|Overall Study|Lack of Efficacy|10|||
126445417|NCT00337675|454930357|FG001|Overall Study|Lack of Efficacy|7|||
126445418|NCT00337675|454930358|FG002|Overall Study|Lack of Efficacy|9|||
126445419|NCT00337675|454930356|FG000|Overall Study|Lost to Follow-up|22|||
126445420|NCT00337675|454930357|FG001|Overall Study|Lost to Follow-up|19|||
126445421|NCT00337675|454930358|FG002|Overall Study|Lost to Follow-up|17|||
126445422|NCT00337675|454930356|FG000|Overall Study|Physician Decision|9|||
126445423|NCT00337675|454930357|FG001|Overall Study|Physician Decision|17|||
126445424|NCT00337675|454930358|FG002|Overall Study|Physician Decision|14|||
126445425|NCT00337675|454930356|FG000|Overall Study|Protocol Violation|21|||
126445426|NCT00337675|454930357|FG001|Overall Study|Protocol Violation|24|||
126693779|NCT00888355|455833327|FG002|Overall Study|Lost to Follow-up|2|||
126445427|NCT00337675|454930358|FG002|Overall Study|Protocol Violation|19|||
126445428|NCT00337675|454930356|FG000|Overall Study|Withdrawal by Subject|25|||
126445429|NCT00337675|454930357|FG001|Overall Study|Withdrawal by Subject|25|||
126693780|NCT00888355|455833328|FG003|Overall Study|Lost to Follow-up|0|||
126693781|NCT00888355|455833325|FG000|Overall Study|Protocol Violation|3|||
126693782|NCT00888355|455833326|FG001|Overall Study|Protocol Violation|2|||
126693783|NCT00888355|455833327|FG002|Overall Study|Protocol Violation|1|||
126693784|NCT00888355|455833328|FG003|Overall Study|Protocol Violation|2|||
126693785|NCT00888355|455833325|FG000|Overall Study|Withdrawal by Subject|0|||
126693786|NCT00888355|455833326|FG001|Overall Study|Withdrawal by Subject|3|||
126693787|NCT00888355|455833327|FG002|Overall Study|Withdrawal by Subject|1|||
126693788|NCT00888355|455833328|FG003|Overall Study|Withdrawal by Subject|3|||
126693789|NCT01551693|455833330|FG000|Overall Study|Disease Progression|1|||
126693790|NCT01551693|455833331|FG001|Overall Study|Disease Progression|0|||
126693791|NCT01551693|455833330|FG000|Overall Study|Adverse Event|0|||
126693792|NCT01551693|455833331|FG001|Overall Study|Adverse Event|1|||
126693793|NCT01551693|455833330|FG000|Overall Study|Withdrawal by Subject|0|||
126693794|NCT01551693|455833331|FG001|Overall Study|Withdrawal by Subject|1|||
126693795|NCT02251912|455833333|FG000|Overall Study|Withdrawal by Subject|2|||
126693796|NCT02251912|455833334|FG001|Overall Study|Withdrawal by Subject|3|||
126693797|NCT02251912|455833333|FG000|Overall Study|Adverse Event|0|||
126693798|NCT02251912|455833334|FG001|Overall Study|Adverse Event|2|||
126693799|NCT01107444|455833335|FG000|Overall Study|Withdrawal by Subject|8|||
126693800|NCT01107444|455833336|FG001|Overall Study|Withdrawal by Subject|12|||
126693801|NCT01107444|455833335|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
126693802|NCT01107444|455833336|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
126693803|NCT01948830|455833337|FG000|Overall Study|Physician Decision|1|||
126693804|NCT01948830|455833338|FG001|Overall Study|Physician Decision|3|||
126693805|NCT01948830|455833337|FG000|Overall Study|Protocol deviation|1|||
126693806|NCT01948830|455833338|FG001|Overall Study|Protocol deviation|2|||
126693807|NCT01948830|455833337|FG000|Overall Study|Lost to Follow-up|5|||
126693808|NCT01948830|455833338|FG001|Overall Study|Lost to Follow-up|4|||
126693809|NCT01948830|455833337|FG000|Overall Study|Withdrawal by Subject|14|||
126693810|NCT01948830|455833338|FG001|Overall Study|Withdrawal by Subject|17|||
126693811|NCT01948830|455833337|FG000|Overall Study|Adverse Event|9|||
126693812|NCT01948830|455833338|FG001|Overall Study|Adverse Event|2|||
126693813|NCT01948830|455833337|FG000|Overall Study|Death|3|||
126693814|NCT01948830|455833338|FG001|Overall Study|Death|4|||
126693815|NCT01133171|455833339|FG000|Overall Study|Withdrawal by Subject|1|||
126693816|NCT01133171|455833340|FG001|Overall Study|Withdrawal by Subject|2|||
126693817|NCT01133171|455833341|FG002|Overall Study|Withdrawal by Subject|0|||
126693818|NCT02526550|455833342|FG000|Overall Study|Lost to Follow-up|1|||
126693819|NCT03969888|455833345|FG000|Overall Study|Never Received Study Drug|0|||
126693820|NCT03969888|455833346|FG001|Overall Study|Never Received Study Drug|0|||
126693821|NCT03969888|455833347|FG002|Overall Study|Never Received Study Drug|1|||
126693822|NCT03969888|455833348|FG003|Overall Study|Never Received Study Drug|0|||
126693823|NCT03969888|455833349|FG004|Overall Study|Never Received Study Drug|0|||
126693824|NCT03969888|455833350|FG005|Overall Study|Never Received Study Drug|0|||
126693825|NCT03969888|455833351|FG006|Overall Study|Never Received Study Drug|1|||
126693826|NCT03969888|455833352|FG007|Overall Study|Never Received Study Drug|0|||
126693827|NCT03969888|455833345|FG000|Overall Study|Reason Not Specified|0|||
126693828|NCT03969888|455833346|FG001|Overall Study|Reason Not Specified|0|||
126693829|NCT03969888|455833347|FG002|Overall Study|Reason Not Specified|0|||
126693830|NCT03969888|455833348|FG003|Overall Study|Reason Not Specified|0|||
126693831|NCT03969888|455833349|FG004|Overall Study|Reason Not Specified|0|||
126693832|NCT03969888|455833350|FG005|Overall Study|Reason Not Specified|0|||
126693833|NCT03969888|455833351|FG006|Overall Study|Reason Not Specified|0|||
126693834|NCT03969888|455833352|FG007|Overall Study|Reason Not Specified|1|||
126693835|NCT00769119|455833354|FG000|Overall Study|Voluntary discontinuation|0|||
126693836|NCT00769119|455833355|FG001|Overall Study|Voluntary discontinuation|2|||
126693837|NCT00769119|455833354|FG000|Overall Study|Adverse Event|1|||
126693838|NCT00769119|455833355|FG001|Overall Study|Adverse Event|1|||
126693839|NCT00769119|455833354|FG000|Overall Study|Disallowed medication|1|||
126693840|NCT00769119|455833355|FG001|Overall Study|Disallowed medication|0|||
126693841|NCT01961115|455833361|FG000|Overall Study|Disease Progression|1|||
126760731|NCT01982942|456075779|FG000|Overall Study|Too many pills|1|||
126445430|NCT00337675|454930358|FG002|Overall Study|Withdrawal by Subject|19|||
126445431|NCT00337675|454930356|FG000|Overall Study|Progressive Disease|0|||
126693842|NCT01961115|455833362|FG001|Overall Study|Disease Progression|0|||
126693843|NCT01961115|455833363|FG002|Overall Study|Disease Progression|3|||
126693844|NCT01961115|455833361|FG000|Overall Study|Adverse Event|1|||
126693845|NCT01961115|455833362|FG001|Overall Study|Adverse Event|0|||
126693846|NCT01961115|455833363|FG002|Overall Study|Adverse Event|1|||
126693847|NCT03828487|455833364|FG000|Overall Study|Physician Decision|1|||
126693848|NCT03430986|455833365|FG000|24-week Control Period|Adverse Event|1|||
126693849|NCT03430986|455833366|FG001|24-week Control Period|Adverse Event|0|||
126693850|NCT03430986|455833365|FG000|24-week Control Period|Lost to Follow-up|2|||
126356113|NCT00501085|454595686|FG000|Overall Study|Subject Decision|1|||
126356114|NCT00501085|454595686|FG000|Overall Study|Revision Surgery|7|||
126356115|NCT00501085|454595686|FG000|Overall Study|Explantation Surgery|26|||
126356116|NCT00501085|454595686|FG000|Overall Study|Adverse Event|4|||
126356117|NCT00501085|454595686|FG000|Overall Study|Non-Compliance|24|||
126356118|NCT00501085|454595686|FG000|Overall Study|Study closed by sponsor|109|||
126356119|NCT00501085|454595686|FG000|Overall Study|Other loss to follow-up|32|||
126356120|NCT00366535|454595687|FG000|First Phase: 12 Weeks|Adverse Event|1|||
126356121|NCT00366535|454595688|FG001|First Phase: 12 Weeks|Adverse Event|3|||
126356122|NCT00366535|454595687|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
126356123|NCT00366535|454595688|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
126356124|NCT00366535|454595687|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
126356125|NCT00366535|454595688|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
126760732|NCT01982942|456075780|FG001|Overall Study|Too many pills|0|||
126356126|NCT00366535|454595687|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
126356127|NCT00366535|454595688|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
126356128|NCT02958527|454595693|FG000|Overall Study|Not collected CRFs|12|||
126356129|NCT00250718|454595696|FG000|Overall Study|Death|1|||
126356130|NCT00250718|454595696|FG000|Overall Study|Adverse Event|1|||
126760733|NCT01982942|456075779|FG000|Overall Study|MS Relapse|0|||
126693851|NCT03430986|455833366|FG001|24-week Control Period|Lost to Follow-up|2|||
126693852|NCT03430986|455833365|FG000|24-week Control Period|Withdrawal by Participant|5|||
126356131|NCT00250718|454595696|FG000|Overall Study|Withdrawal by Subject|1|||
126356132|NCT01666314|454595697|FG000|Overall Study|Adverse Event|3|||
126356133|NCT01666314|454595698|FG001|Overall Study|Adverse Event|13|||
126356134|NCT01666314|454595699|FG002|Overall Study|Adverse Event|7|||
126356135|NCT01666314|454595700|FG003|Overall Study|Adverse Event|7|||
126356136|NCT01666314|454595697|FG000|Overall Study|Progressive Disease|11|||
126356137|NCT01666314|454595698|FG001|Overall Study|Progressive Disease|9|||
126356138|NCT01666314|454595699|FG002|Overall Study|Progressive Disease|19|||
126356139|NCT01666314|454595700|FG003|Overall Study|Progressive Disease|20|||
126356140|NCT01666314|454595697|FG000|Overall Study|Symptomatic Deterioration|1|||
126356141|NCT01666314|454595698|FG001|Overall Study|Symptomatic Deterioration|0|||
126356142|NCT01666314|454595699|FG002|Overall Study|Symptomatic Deterioration|2|||
126356143|NCT01666314|454595700|FG003|Overall Study|Symptomatic Deterioration|0|||
126356144|NCT01666314|454595697|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
126356145|NCT01666314|454595698|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
126356146|NCT01666314|454595699|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
126356147|NCT01666314|454595700|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
126693853|NCT03430986|455833366|FG001|24-week Control Period|Withdrawal by Participant|0|||
126356148|NCT01666314|454595697|FG000|Overall Study|Withdrawal by Subject|1|||
126356149|NCT01666314|454595698|FG001|Overall Study|Withdrawal by Subject|1|||
126356150|NCT01666314|454595699|FG002|Overall Study|Withdrawal by Subject|2|||
126356151|NCT01666314|454595700|FG003|Overall Study|Withdrawal by Subject|3|||
126445432|NCT00337675|454930357|FG001|Overall Study|Progressive Disease|2|||
126445433|NCT00337675|454930358|FG002|Overall Study|Progressive Disease|0|||
126445434|NCT00337675|454930356|FG000|Overall Study|Trial Terminated|0|||
126445435|NCT00337675|454930357|FG001|Overall Study|Trial Terminated|0|||
126445436|NCT00337675|454930358|FG002|Overall Study|Trial Terminated|2|||
126760734|NCT01982942|456075780|FG001|Overall Study|MS Relapse|1|||
126445437|NCT01491607|454930363|FG000|Overall Study|Lost to Follow-up|7|||
126445438|NCT01491607|454930363|FG000|Overall Study|Withdrawal by Subject|3|||
126693854|NCT03430986|455833365|FG000|24-week Control Period|Protocol Deviation|0|||
126445439|NCT01317277|454930364|FG000|Overall Study|Lost to Follow-up|3|||
126445440|NCT01317277|454930365|FG001|Overall Study|Lost to Follow-up|1|||
126445441|NCT01317277|454930364|FG000|Overall Study|Lost MEMS|1|||
126445442|NCT01317277|454930365|FG001|Overall Study|Lost MEMS|1|||
126445443|NCT01317277|454930364|FG000|Overall Study|Unable to comply with intervention|1|||
126445444|NCT01317277|454930365|FG001|Overall Study|Unable to comply with intervention|0|||
126445445|NCT01317277|454930364|FG000|Overall Study|Withdrawal by Subject|1|||
126445446|NCT01317277|454930365|FG001|Overall Study|Withdrawal by Subject|0|||
126445447|NCT01317277|454930364|FG000|Overall Study|Adverse Event|1|||
126445448|NCT01317277|454930365|FG001|Overall Study|Adverse Event|0|||
126445449|NCT00774566|454930366|FG000|Overall Study|Protocol Violation|18|||
126445450|NCT00774566|454930367|FG001|Overall Study|Protocol Violation|15|||
126445451|NCT00775593|454930370|FG000|Overall Study|Unmet eligibility criteria|6|||
126445452|NCT00775593|454930370|FG000|Overall Study|Death|1|||
126445453|NCT02067676|454930371|FG000|Overall Study|Withdrawal by Subject|1|||
126445454|NCT02067676|454930372|FG001|Overall Study|Withdrawal by Subject|0|||
126445455|NCT02067676|454930373|FG002|Overall Study|Withdrawal by Subject|0|||
126445456|NCT02067676|454930374|FG003|Overall Study|Withdrawal by Subject|0|||
126445457|NCT02067676|454930375|FG004|Overall Study|Withdrawal by Subject|0|||
126445458|NCT02067676|454930376|FG005|Overall Study|Withdrawal by Subject|0|||
126445459|NCT03904693|454930384|FG000|Overall Study|Death|0|||
126445460|NCT03904693|454930385|FG001|Overall Study|Death|0|||
126445461|NCT03904693|454930386|FG002|Overall Study|Death|3|||
126445462|NCT03904693|454930384|FG000|Overall Study|Physician Decision|0|||
126445463|NCT03904693|454930385|FG001|Overall Study|Physician Decision|0|||
126445464|NCT03904693|454930386|FG002|Overall Study|Physician Decision|2|||
126445465|NCT03904693|454930384|FG000|Overall Study|Withdrawal by Subject|0|||
126445466|NCT03904693|454930385|FG001|Overall Study|Withdrawal by Subject|1|||
126445467|NCT03904693|454930386|FG002|Overall Study|Withdrawal by Subject|4|||
126445468|NCT00314795|454930389|FG000|Overall Study|Adverse Event|8|||
126445469|NCT00314795|454930389|FG000|Overall Study|Death|4|||
126445470|NCT00314795|454930389|FG000|Overall Study|Reason not Specified|3|||
126445471|NCT00314795|454930389|FG000|Overall Study|Renal Transplant|3|||
126445472|NCT00314795|454930389|FG000|Overall Study|Participants Withdrew Consent|2|||
126445473|NCT02624986|454930390|FG000|Overall Study|Death|0|||
126445474|NCT02624986|454930391|FG001|Overall Study|Death|1|||
126445475|NCT02624986|454930392|FG002|Overall Study|Death|2|||
126445476|NCT02624986|454930393|FG003|Overall Study|Death|2|||
126445477|NCT02624986|454930394|FG004|Overall Study|Death|2|||
126445478|NCT02624986|454930395|FG005|Overall Study|Death|0|||
126445479|NCT02624986|454930396|FG006|Overall Study|Death|0|||
126445480|NCT02624986|454930397|FG007|Overall Study|Death|1|||
126445481|NCT02624986|454930390|FG000|Overall Study|Study Terminated by Sponsor|1|||
126445482|NCT02624986|454930391|FG001|Overall Study|Study Terminated by Sponsor|1|||
126445483|NCT02624986|454930392|FG002|Overall Study|Study Terminated by Sponsor|0|||
126445484|NCT02624986|454930393|FG003|Overall Study|Study Terminated by Sponsor|1|||
126445485|NCT02624986|454930394|FG004|Overall Study|Study Terminated by Sponsor|2|||
126445486|NCT02624986|454930395|FG005|Overall Study|Study Terminated by Sponsor|2|||
126445487|NCT02624986|454930396|FG006|Overall Study|Study Terminated by Sponsor|4|||
126445488|NCT02624986|454930397|FG007|Overall Study|Study Terminated by Sponsor|3|||
126445489|NCT02624986|454930390|FG000|Overall Study|Progressive Disease|0|||
126445490|NCT02624986|454930391|FG001|Overall Study|Progressive Disease|1|||
126445491|NCT02624986|454930392|FG002|Overall Study|Progressive Disease|0|||
126445492|NCT02624986|454930393|FG003|Overall Study|Progressive Disease|0|||
126445493|NCT02624986|454930394|FG004|Overall Study|Progressive Disease|0|||
126445494|NCT02624986|454930395|FG005|Overall Study|Progressive Disease|0|||
126445495|NCT02624986|454930396|FG006|Overall Study|Progressive Disease|0|||
126445496|NCT02624986|454930397|FG007|Overall Study|Progressive Disease|0|||
126693855|NCT03430986|455833366|FG001|24-week Control Period|Protocol Deviation|2|||
126693856|NCT03430986|455833365|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
126445497|NCT02624986|454930390|FG000|Overall Study|Protocol Violation|1|||
126445498|NCT02624986|454930391|FG001|Overall Study|Protocol Violation|0|||
126445499|NCT02624986|454930392|FG002|Overall Study|Protocol Violation|0|||
126445500|NCT02624986|454930393|FG003|Overall Study|Protocol Violation|0|||
126445501|NCT02624986|454930394|FG004|Overall Study|Protocol Violation|0|||
126445502|NCT02624986|454930395|FG005|Overall Study|Protocol Violation|0|||
126445503|NCT02624986|454930396|FG006|Overall Study|Protocol Violation|0|||
126445504|NCT02624986|454930397|FG007|Overall Study|Protocol Violation|0|||
126445505|NCT02624986|454930390|FG000|Overall Study|Withdrawal by Subject|0|||
126445506|NCT02624986|454930391|FG001|Overall Study|Withdrawal by Subject|0|||
126445507|NCT02624986|454930392|FG002|Overall Study|Withdrawal by Subject|0|||
126445508|NCT02624986|454930393|FG003|Overall Study|Withdrawal by Subject|0|||
126445509|NCT02624986|454930394|FG004|Overall Study|Withdrawal by Subject|0|||
126445510|NCT02624986|454930395|FG005|Overall Study|Withdrawal by Subject|0|||
126445511|NCT02624986|454930396|FG006|Overall Study|Withdrawal by Subject|0|||
126445512|NCT02624986|454930397|FG007|Overall Study|Withdrawal by Subject|1|||
126693857|NCT03430986|455833366|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
126693858|NCT03430986|455833365|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
126693859|NCT03430986|455833366|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
126356152|NCT01666314|454595697|FG000|Overall Study|Reason not Specified|10|||
126356153|NCT01666314|454595698|FG001|Overall Study|Reason not Specified|7|||
126356154|NCT01666314|454595699|FG002|Overall Study|Reason not Specified|5|||
126356155|NCT01666314|454595700|FG003|Overall Study|Reason not Specified|5|||
126356156|NCT01301092|454595701|FG000|Overall Study|Lost to Follow-up|0|||
126356157|NCT01301092|454595702|FG001|Overall Study|Lost to Follow-up|0|||
126356158|NCT01301092|454595703|FG002|Overall Study|Lost to Follow-up|1|||
126356159|NCT01002105|454597742|FG000|Overall Study|Lost to Follow-up|10|||
126356160|NCT01002105|454597743|FG001|Overall Study|Lost to Follow-up|16|||
126356161|NCT01002105|454597742|FG000|Overall Study|non compliance|5|||
126356162|NCT01002105|454597743|FG001|Overall Study|non compliance|3|||
126356163|NCT01002105|454597742|FG000|Overall Study|condition worsened|4|||
126356164|NCT01002105|454597743|FG001|Overall Study|condition worsened|2|||
126356165|NCT02316613|454597744|FG000|Overall Study|Death|63|||
126356166|NCT02316613|454597744|FG000|Overall Study|Lost to Follow-up|9|||
126356167|NCT02316613|454597744|FG000|Overall Study|Lymphoma transformation|2|||
126356168|NCT02316613|454597744|FG000|Overall Study|Participant moved/changed medical team|11|||
126356169|NCT02316613|454597744|FG000|Overall Study|No data and duplicate cases|5|||
126356170|NCT02316613|454597744|FG000|Overall Study|Did not met selection criteria|14|||
126356171|NCT01166945|454597745|FG000|Randomized|diagnosed with Group A strep|4|||
126356172|NCT01166945|454597746|FG001|Randomized|diagnosed with Group A strep|4|||
126356173|NCT01166945|454597745|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
126356174|NCT01166945|454597746|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
126356175|NCT01166945|454597745|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
126356176|NCT01166945|454597746|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
126356177|NCT01166945|454597745|FG000|Day 30|Lost to Follow-up|4|||
126356178|NCT01166945|454597746|FG001|Day 30|Lost to Follow-up|3|||
126356179|NCT03309605|454597749|FG000|Overall Study|Adverse Event|0|||
126356180|NCT03309605|454597750|FG001|Overall Study|Adverse Event|0|||
126356181|NCT03309605|454597751|FG002|Overall Study|Adverse Event|0|||
126356182|NCT03309605|454597752|FG003|Overall Study|Adverse Event|1|||
126356183|NCT03309605|454597753|FG004|Overall Study|Adverse Event|0|||
126445513|NCT00802945|454930398|FG000|Overall Study|Death|27|||
126445514|NCT00802945|454930399|FG001|Overall Study|Death|23|||
126445515|NCT00802945|454930398|FG000|Overall Study|Terminated by sponsor|8|||
126445516|NCT00802945|454930399|FG001|Overall Study|Terminated by sponsor|12|||
126445517|NCT05307692|454930401|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
126445518|NCT05307692|454930402|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
126445519|NCT05307692|454930403|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
126445520|NCT05307692|454930404|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
126445521|NCT05307692|454930401|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
126445522|NCT05307692|454930402|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
126445523|NCT05307692|454930403|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
126445524|NCT05307692|454930404|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
126445525|NCT05307692|454930401|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
126445526|NCT05307692|454930402|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
126445527|NCT05307692|454930403|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
126445528|NCT05307692|454930404|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
126445529|NCT05307692|454930401|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
126445530|NCT05307692|454930402|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
126760735|NCT01982942|456075779|FG000|Overall Study|Chose to join a stem cell trial|0|||
126356184|NCT03309605|454597754|FG005|Overall Study|Adverse Event|0|||
126356185|NCT03309605|454597755|FG006|Overall Study|Adverse Event|2|||
126356186|NCT03309605|454597756|FG007|Overall Study|Adverse Event|1|||
126356187|NCT03309605|454597749|FG000|Overall Study|Withdrawal by Subject|0|||
126445531|NCT05307692|454930403|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
126445532|NCT05307692|454930404|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
126445533|NCT05307692|454930401|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
126445534|NCT05307692|454930402|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
126445535|NCT05307692|454930403|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
126445536|NCT05307692|454930404|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
126445537|NCT05307692|454930401|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
126445538|NCT05307692|454930402|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
126445539|NCT05307692|454930403|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
126445540|NCT05307692|454930404|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
126445541|NCT05307692|454930401|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
126445542|NCT05307692|454930402|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
126445543|NCT05307692|454930403|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
126445544|NCT05307692|454930404|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
126445545|NCT05307692|454930401|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
126445546|NCT05307692|454930402|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
126445547|NCT05307692|454930403|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
126445548|NCT05307692|454930404|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
126760736|NCT01982942|456075780|FG001|Overall Study|Chose to join a stem cell trial|1|||
126760737|NCT01982942|456075779|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
126760738|NCT01982942|456075780|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
126760739|NCT04511533|456075781|FG000|Treatment|Other|2|||
126760740|NCT04511533|456075781|FG000|Treatment|Withdrawal by Subject|11|||
126760741|NCT04511533|456075781|FG000|Treatment|Death|5|||
126760742|NCT04511533|456075781|FG000|Treatment|Physician Decision|1|||
126760743|NCT04511533|456075781|FG000|Treatment|Progressive Disease|61|||
126760744|NCT04511533|456075781|FG000|Follow-Up|Other|7|||
126760745|NCT04511533|456075781|FG000|Follow-Up|Withdrawal by Subject|5|||
126760746|NCT04511533|456075781|FG000|Follow-Up|Lost to Follow-up|2|||
126760747|NCT04511533|456075781|FG000|Follow-Up|Death|4|||
126760748|NCT02213666|456075782|FG000|Overall Study|Withdrawal by Subject|1|||
126760749|NCT02918968|456075785|FG000|1st Line AAT|Progressive disease|9|||
126760750|NCT02918968|456075786|FG001|1st Line AAT|Progressive disease|4|||
126760751|NCT02918968|456075785|FG000|1st Line AAT|Adverse Event|12|||
126760752|NCT02918968|456075786|FG001|1st Line AAT|Adverse Event|3|||
126760753|NCT02918968|456075785|FG000|1st Line AAT|Physician Decision|4|||
126760754|NCT02918968|456075786|FG001|1st Line AAT|Physician Decision|2|||
126760755|NCT02918968|456075785|FG000|1st Line AAT|Withdrawal by Subject|2|||
126760756|NCT02918968|456075786|FG001|1st Line AAT|Withdrawal by Subject|1|||
126760757|NCT02918968|456075785|FG000|1st Line AAT|Lost to Follow-up|0|||
126760758|NCT02918968|456075786|FG001|1st Line AAT|Lost to Follow-up|1|||
126760759|NCT02918968|456075785|FG000|1st Line AAT|Death|1|||
126760760|NCT02918968|456075786|FG001|1st Line AAT|Death|0|||
126445549|NCT02003924|454930411|FG000|Double-blind Phase|Lost to Follow-up|2|||
126445550|NCT02003924|454930412|FG001|Double-blind Phase|Lost to Follow-up|1|||
126445551|NCT02003924|454930413|FG002|Double-blind Phase|Lost to Follow-up|0|||
126445552|NCT02003924|454930411|FG000|Double-blind Phase|Protocol Violation|1|||
126445553|NCT02003924|454930412|FG001|Double-blind Phase|Protocol Violation|2|||
126445554|NCT02003924|454930413|FG002|Double-blind Phase|Protocol Violation|0|||
126445555|NCT02003924|454930411|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
126445556|NCT02003924|454930412|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
126445557|NCT02003924|454930413|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
126445558|NCT02003924|454930411|FG000|Double-blind Phase|Disease Progression|229|||
126445559|NCT02003924|454930412|FG001|Double-blind Phase|Disease Progression|247|||
126760761|NCT02918968|456075785|FG000|1st Line AAT|Miscellaneous|1|||
126760762|NCT02918968|456075786|FG001|1st Line AAT|Miscellaneous|0|||
126760763|NCT02918968|456075785|FG000|2nd Line AAT|Progressive disease|21|||
126760764|NCT02918968|456075786|FG001|2nd Line AAT|Progressive disease|3|||
126760765|NCT02918968|456075785|FG000|2nd Line AAT|Adverse Event|2|||
126760766|NCT02918968|456075786|FG001|2nd Line AAT|Adverse Event|5|||
126760767|NCT02918968|456075785|FG000|2nd Line AAT|Physician Decision|0|||
126760768|NCT02918968|456075786|FG001|2nd Line AAT|Physician Decision|1|||
126445560|NCT02003924|454930413|FG002|Double-blind Phase|Disease Progression|0|||
126445561|NCT02003924|454930411|FG000|Double-blind Phase|Adverse Event|120|||
126445562|NCT02003924|454930412|FG001|Double-blind Phase|Adverse Event|31|||
126445563|NCT02003924|454930413|FG002|Double-blind Phase|Adverse Event|0|||
126445564|NCT02003924|454930411|FG000|Double-blind Phase|Randomized But not Treated|3|||
126445565|NCT02003924|454930412|FG001|Double-blind Phase|Randomized But not Treated|3|||
126445566|NCT02003924|454930413|FG002|Double-blind Phase|Randomized But not Treated|0|||
126445567|NCT02003924|454930411|FG000|Double-blind Phase|Other|29|||
126445568|NCT02003924|454930412|FG001|Double-blind Phase|Other|50|||
126445569|NCT02003924|454930413|FG002|Double-blind Phase|Other|0|||
126445570|NCT02003924|454930411|FG000|Open-label Phase|Lost to Follow-up|0|||
126445571|NCT02003924|454930412|FG001|Open-label Phase|Lost to Follow-up|0|||
126445572|NCT02003924|454930413|FG002|Open-label Phase|Lost to Follow-up|1|||
126445573|NCT02003924|454930411|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
126445574|NCT02003924|454930412|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
126445575|NCT02003924|454930413|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
126445576|NCT02003924|454930411|FG000|Open-label Phase|Disease Progression|59|||
126445577|NCT02003924|454930412|FG001|Open-label Phase|Disease Progression|0|||
126445578|NCT02003924|454930413|FG002|Open-label Phase|Disease Progression|5|||
126445579|NCT02003924|454930411|FG000|Open-label Phase|Adverse Event|25|||
126445580|NCT02003924|454930412|FG001|Open-label Phase|Adverse Event|0|||
126445581|NCT02003924|454930413|FG002|Open-label Phase|Adverse Event|10|||
126445582|NCT02003924|454930411|FG000|Open-label Phase|Other|7|||
126445583|NCT02003924|454930412|FG001|Open-label Phase|Other|0|||
126445584|NCT02003924|454930413|FG002|Open-label Phase|Other|0|||
126445585|NCT02003924|454930411|FG000|Long-term Follow-up Phase|Death|288|||
126445586|NCT02003924|454930412|FG001|Long-term Follow-up Phase|Death|174|||
126356188|NCT03309605|454597750|FG001|Overall Study|Withdrawal by Subject|0|||
126356189|NCT03309605|454597751|FG002|Overall Study|Withdrawal by Subject|0|||
126356190|NCT03309605|454597752|FG003|Overall Study|Withdrawal by Subject|0|||
126356191|NCT03309605|454597753|FG004|Overall Study|Withdrawal by Subject|1|||
126356192|NCT03309605|454597754|FG005|Overall Study|Withdrawal by Subject|0|||
126356193|NCT03309605|454597755|FG006|Overall Study|Withdrawal by Subject|1|||
126693860|NCT01078805|455833367|FG000|Overall Study|Clinically significant abnormal lab|5|||
126693861|NCT01078805|455833367|FG000|Overall Study|Death|134|||
126693862|NCT01078805|455833367|FG000|Overall Study|Lost to Follow-up|676|||
126693863|NCT01078805|455833367|FG000|Overall Study|Physician Decision|169|||
126693864|NCT01078805|455833367|FG000|Overall Study|Serious adverse event|26|||
126693865|NCT01078805|455833367|FG000|Overall Study|Sponsor decision|46|||
126693866|NCT01078805|455833367|FG000|Overall Study|Withdrawal by Subject|739|||
126356194|NCT03309605|454597756|FG007|Overall Study|Withdrawal by Subject|1|||
126445587|NCT02003924|454930413|FG002|Long-term Follow-up Phase|Death|4|||
126445588|NCT02003924|454930411|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
126445589|NCT02003924|454930412|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
126445590|NCT02003924|454930413|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
126445591|NCT02003924|454930411|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
126445592|NCT02003924|454930412|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
126445593|NCT02003924|454930413|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
126445594|NCT02003924|454930411|FG000|Long-term Follow-up Phase|Other|5|||
126445595|NCT02003924|454930412|FG001|Long-term Follow-up Phase|Other|2|||
126445596|NCT02003924|454930413|FG002|Long-term Follow-up Phase|Other|1|||
126445597|NCT00560352|454930419|FG000|Overall Study|Adverse event unrelated to study drug|2|||
126445598|NCT00560352|454930420|FG001|Overall Study|Adverse event unrelated to study drug|1|||
126445599|NCT00560352|454930421|FG002|Overall Study|Adverse event unrelated to study drug|1|||
126445600|NCT00560352|454930419|FG000|Overall Study|Study drug toxicity|3|||
126445601|NCT00560352|454930420|FG001|Overall Study|Study drug toxicity|0|||
126445602|NCT00560352|454930421|FG002|Overall Study|Study drug toxicity|1|||
126445603|NCT00560352|454930419|FG000|Overall Study|Disease progression|0|||
126445604|NCT00560352|454930420|FG001|Overall Study|Disease progression|1|||
126445605|NCT00560352|454930421|FG002|Overall Study|Disease progression|1|||
126445606|NCT00560352|454930419|FG000|Overall Study|Withdrawal by Subject|1|||
126445607|NCT00560352|454930420|FG001|Overall Study|Withdrawal by Subject|1|||
126445608|NCT00560352|454930421|FG002|Overall Study|Withdrawal by Subject|1|||
126445609|NCT00560352|454930419|FG000|Overall Study|Maximum clinical benefit|1|||
126445610|NCT00560352|454930420|FG001|Overall Study|Maximum clinical benefit|0|||
126445611|NCT00560352|454930421|FG002|Overall Study|Maximum clinical benefit|0|||
126445612|NCT04434937|454930425|FG000|Overall Study|Death|4|||
126445613|NCT04434937|454930425|FG000|Overall Study|Withdrawal by Subject|1|||
126445614|NCT04434937|454930425|FG000|Overall Study|Transitioned to Rollover Study|19|||
126445615|NCT04434937|454930425|FG000|Overall Study|Progressive Disease|18|||
126445616|NCT00114517|454930426|FG000|Overall Study|Adverse Event|6|||
126445617|NCT00114517|454930427|FG001|Overall Study|Adverse Event|1|||
126445618|NCT00114517|454930428|FG002|Overall Study|Adverse Event|6|||
126445619|NCT00114517|454930429|FG003|Overall Study|Adverse Event|3|||
126445620|NCT00114517|454930426|FG000|Overall Study|Lost to Follow-up|2|||
126445621|NCT00114517|454930427|FG001|Overall Study|Lost to Follow-up|2|||
126445622|NCT00114517|454930428|FG002|Overall Study|Lost to Follow-up|2|||
126445623|NCT00114517|454930429|FG003|Overall Study|Lost to Follow-up|1|||
126445624|NCT00114517|454930426|FG000|Overall Study|Too busy|3|||
126445625|NCT00114517|454930427|FG001|Overall Study|Too busy|1|||
126445626|NCT00114517|454930428|FG002|Overall Study|Too busy|1|||
126445627|NCT00114517|454930429|FG003|Overall Study|Too busy|2|||
126445628|NCT00114517|454930426|FG000|Overall Study|Moved from area|0|||
126445629|NCT00114517|454930427|FG001|Overall Study|Moved from area|3|||
126760769|NCT02918968|456075785|FG000|2nd Line AAT|Withdrawal by Subject|2|||
126760770|NCT02918968|456075786|FG001|2nd Line AAT|Withdrawal by Subject|2|||
126760771|NCT02918968|456075785|FG000|2nd Line AAT|Death|0|||
126445630|NCT00114517|454930428|FG002|Overall Study|Moved from area|2|||
126445631|NCT00114517|454930429|FG003|Overall Study|Moved from area|1|||
126445632|NCT00114517|454930426|FG000|Overall Study|Did not want estradiol|1|||
126445633|NCT00114517|454930427|FG001|Overall Study|Did not want estradiol|1|||
126445634|NCT00114517|454930428|FG002|Overall Study|Did not want estradiol|0|||
126445635|NCT00114517|454930429|FG003|Overall Study|Did not want estradiol|0|||
126445636|NCT00114517|454930426|FG000|Overall Study|Armed-services duty|0|||
126445637|NCT00114517|454930427|FG001|Overall Study|Armed-services duty|1|||
126445638|NCT00114517|454930428|FG002|Overall Study|Armed-services duty|0|||
126445639|NCT00114517|454930429|FG003|Overall Study|Armed-services duty|1|||
126445640|NCT00114517|454930426|FG000|Overall Study|Competing family issue|0|||
126445641|NCT00114517|454930427|FG001|Overall Study|Competing family issue|1|||
126760772|NCT02918968|456075786|FG001|2nd Line AAT|Death|1|||
126445642|NCT00114517|454930428|FG002|Overall Study|Competing family issue|0|||
126445643|NCT00114517|454930429|FG003|Overall Study|Competing family issue|1|||
126445644|NCT00114517|454930426|FG000|Overall Study|Physician Decision|0|||
126445645|NCT00114517|454930427|FG001|Overall Study|Physician Decision|1|||
126445646|NCT00114517|454930428|FG002|Overall Study|Physician Decision|0|||
126445647|NCT00114517|454930429|FG003|Overall Study|Physician Decision|0|||
126445648|NCT00114517|454930426|FG000|Overall Study|Lost interest|0|||
126445649|NCT00114517|454930427|FG001|Overall Study|Lost interest|0|||
126445650|NCT00114517|454930428|FG002|Overall Study|Lost interest|1|||
126445651|NCT00114517|454930429|FG003|Overall Study|Lost interest|0|||
126445652|NCT00114517|454930426|FG000|Overall Study|Weight increase|0|||
126445653|NCT00114517|454930427|FG001|Overall Study|Weight increase|0|||
126445654|NCT00114517|454930428|FG002|Overall Study|Weight increase|1|||
126445655|NCT00114517|454930429|FG003|Overall Study|Weight increase|0|||
126445656|NCT00114517|454930426|FG000|Overall Study|Concern about blood clots|0|||
126445657|NCT00114517|454930427|FG001|Overall Study|Concern about blood clots|0|||
126445658|NCT00114517|454930428|FG002|Overall Study|Concern about blood clots|1|||
126445659|NCT00114517|454930429|FG003|Overall Study|Concern about blood clots|0|||
126445660|NCT00114517|454930426|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
126445661|NCT00114517|454930427|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
126445662|NCT00114517|454930428|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
126445663|NCT00114517|454930429|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
126445664|NCT00924027|454930431|FG000|Overall Study|Lost to Further Follow-Up|4|||
126445665|NCT00924027|454930432|FG001|Overall Study|Lost to Further Follow-Up|0|||
126445666|NCT00924027|454930433|FG002|Overall Study|Lost to Further Follow-Up|0|||
126445667|NCT00924027|454930434|FG003|Overall Study|Lost to Further Follow-Up|0|||
126445668|NCT00924027|454930431|FG000|Overall Study|Physician Decision|1|||
126445669|NCT00924027|454930432|FG001|Overall Study|Physician Decision|0|||
126445670|NCT00924027|454930433|FG002|Overall Study|Physician Decision|0|||
126445671|NCT00924027|454930434|FG003|Overall Study|Physician Decision|1|||
126445672|NCT00924027|454930431|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
126445673|NCT00924027|454930432|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
126445674|NCT00924027|454930433|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
126445675|NCT00924027|454930434|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
126445676|NCT00924027|454930431|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
126445677|NCT00924027|454930432|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
126445678|NCT00924027|454930433|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
126445679|NCT00924027|454930434|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
126445680|NCT00924027|454930431|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
126445681|NCT00924027|454930432|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
126445682|NCT00924027|454930433|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
126445683|NCT00924027|454930434|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
126445684|NCT04695977|454930435|FG000|Overall Study|Sponsor Decision|9|||
126445685|NCT04695977|454930436|FG001|Overall Study|Sponsor Decision|4|||
126445686|NCT04695977|454930435|FG000|Overall Study|Death|2|||
126445687|NCT04695977|454930436|FG001|Overall Study|Death|5|||
126445688|NCT03474965|454930437|FG000|Overall Study|Pregnancy|1|||
126445689|NCT03474965|454930438|FG001|Overall Study|Pregnancy|0|||
126445690|NCT03474965|454930439|FG002|Overall Study|Pregnancy|0|||
126445691|NCT03474965|454930440|FG003|Overall Study|Pregnancy|0|||
126445692|NCT03474965|454930437|FG000|Overall Study|Lost to Follow-up|0|||
126445693|NCT03474965|454930438|FG001|Overall Study|Lost to Follow-up|0|||
126445694|NCT03474965|454930439|FG002|Overall Study|Lost to Follow-up|1|||
126445695|NCT03474965|454930440|FG003|Overall Study|Lost to Follow-up|0|||
126445696|NCT03474965|454930437|FG000|Overall Study|Death|1|||
126445697|NCT03474965|454930438|FG001|Overall Study|Death|0|||
126445698|NCT03474965|454930439|FG002|Overall Study|Death|0|||
126445699|NCT03474965|454930440|FG003|Overall Study|Death|0|||
126445700|NCT03474965|454930437|FG000|Overall Study|Adverse Event|1|||
126445701|NCT03474965|454930438|FG001|Overall Study|Adverse Event|0|||
126445702|NCT03474965|454930439|FG002|Overall Study|Adverse Event|0|||
126445703|NCT03474965|454930440|FG003|Overall Study|Adverse Event|1|||
126445704|NCT03474965|454930437|FG000|Overall Study|Physician Decision|3|||
126693867|NCT01078805|455833367|FG000|Overall Study|Other|173|||
126445705|NCT03474965|454930438|FG001|Overall Study|Physician Decision|1|||
126445706|NCT03474965|454930439|FG002|Overall Study|Physician Decision|2|||
126445707|NCT03474965|454930440|FG003|Overall Study|Physician Decision|0|||
126445708|NCT03474965|454930437|FG000|Overall Study|Participant Decision|7|||
126445709|NCT03474965|454930438|FG001|Overall Study|Participant Decision|0|||
126445710|NCT03474965|454930439|FG002|Overall Study|Participant Decision|1|||
126445711|NCT03474965|454930440|FG003|Overall Study|Participant Decision|0|||
126445712|NCT03474965|454930437|FG000|Overall Study|Guardian Decision|4|||
126445713|NCT03474965|454930438|FG001|Overall Study|Guardian Decision|2|||
126445714|NCT03474965|454930439|FG002|Overall Study|Guardian Decision|7|||
126445715|NCT03474965|454930440|FG003|Overall Study|Guardian Decision|2|||
126693868|NCT01078805|455833367|FG000|Overall Study|Didn't take study drug|82|||
126445716|NCT02840799|454931873|FG000|Phase 1|Physician Decision|1|||
126445717|NCT02840799|454931874|FG001|Phase 1|Physician Decision|3|||
126445718|NCT02840799|454931873|FG000|Phase 1|Withdrawal by Subject|4|||
126445719|NCT02840799|454931874|FG001|Phase 1|Withdrawal by Subject|0|||
126445720|NCT02840799|454931873|FG000|Phase 2 (Crossover)|Adverse Event|0|||
126445721|NCT02840799|454931874|FG001|Phase 2 (Crossover)|Adverse Event|1|||
126445722|NCT02840799|454931873|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
126445723|NCT02840799|454931874|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
126445724|NCT01675544|454931880|FG000|Overall Study|Withdrawal by Subject|2|||
126445725|NCT02948634|454931888|FG000|Overall Study|Lack of efficacy and study suspended|10|||
126445726|NCT02948634|454931889|FG001|Overall Study|Lack of efficacy and study suspended|2|||
126445727|NCT01149148|454931890|FG000|Overall Study|Lost to Follow-up|1|||
126445728|NCT01149148|454931891|FG001|Overall Study|Lost to Follow-up|2|||
126445729|NCT01149148|454931890|FG000|Overall Study|Death|1|||
126445730|NCT01149148|454931891|FG001|Overall Study|Death|0|||
126445731|NCT01386970|454931893|FG000|Overall Study|Withdrawal by Subject|0|||
126445732|NCT01386970|454931894|FG001|Overall Study|Withdrawal by Subject|1|||
126445733|NCT01386970|454931893|FG000|Overall Study|Adverse Event|4|||
126445734|NCT01386970|454931894|FG001|Overall Study|Adverse Event|1|||
126445735|NCT04881942|454931895|FG000|Overall Study|Adverse Event|0|||
126445736|NCT04881942|454931896|FG001|Overall Study|Adverse Event|0|||
126445737|NCT04881942|454931897|FG002|Overall Study|Adverse Event|0|||
126445738|NCT04881942|454931898|FG003|Overall Study|Adverse Event|0|||
126445739|NCT04881942|454931899|FG004|Overall Study|Adverse Event|1|||
126445740|NCT04881942|454931895|FG000|Overall Study|Alternates|0|||
126445741|NCT04881942|454931896|FG001|Overall Study|Alternates|0|||
126445742|NCT04881942|454931897|FG002|Overall Study|Alternates|0|||
126445743|NCT04881942|454931898|FG003|Overall Study|Alternates|0|||
126445744|NCT04881942|454931899|FG004|Overall Study|Alternates|2|||
126445745|NCT02164461|454931900|FG000|Overall Study|Adverse Event|0|||
126356195|NCT00422461|454597759|FG000|Overall Study|Adverse Event|1|||
126356196|NCT00422461|454597760|FG001|Overall Study|Adverse Event|2|||
126356197|NCT00422461|454597761|FG002|Overall Study|Adverse Event|1|||
126356198|NCT00422461|454597762|FG003|Overall Study|Adverse Event|1|||
126356199|NCT00422461|454597759|FG000|Overall Study|Other|0|||
126356200|NCT00422461|454597760|FG001|Overall Study|Other|0|||
126356201|NCT00422461|454597761|FG002|Overall Study|Other|0|||
126356202|NCT00422461|454597762|FG003|Overall Study|Other|2|||
126356203|NCT00422461|454597759|FG000|Overall Study|Participants no longer willing to participate in study|1|||
126356204|NCT00422461|454597760|FG001|Overall Study|Participants no longer willing to participate in study|0|||
126356205|NCT00422461|454597761|FG002|Overall Study|Participants no longer willing to participate in study|0|||
126356206|NCT00422461|454597762|FG003|Overall Study|Participants no longer willing to participate in study|0|||
126356207|NCT00422461|454597759|FG000|Overall Study|Randomized but not treated|1|||
126356208|NCT00422461|454597760|FG001|Overall Study|Randomized but not treated|1|||
126356209|NCT00422461|454597761|FG002|Overall Study|Randomized but not treated|0|||
126356210|NCT00422461|454597762|FG003|Overall Study|Randomized but not treated|0|||
126356211|NCT01471574|454597763|FG000|Treatment Period|Lack of Efficacy|12|||
126356212|NCT01471574|454597764|FG001|Treatment Period|Lack of Efficacy|4|||
126356213|NCT01471574|454597765|FG002|Treatment Period|Lack of Efficacy|14|||
126356214|NCT01471574|454597766|FG003|Treatment Period|Lack of Efficacy|1|||
126356215|NCT01471574|454597763|FG000|Treatment Period|Adverse Event|7|||
126356216|NCT01471574|454597764|FG001|Treatment Period|Adverse Event|3|||
126356217|NCT01471574|454597765|FG002|Treatment Period|Adverse Event|6|||
126356218|NCT01471574|454597766|FG003|Treatment Period|Adverse Event|1|||
126356219|NCT01471574|454597763|FG000|Treatment Period|Withdrawal by Subject|5|||
126356220|NCT01471574|454597764|FG001|Treatment Period|Withdrawal by Subject|1|||
126445746|NCT02164461|454931901|FG001|Overall Study|Adverse Event|0|||
126445747|NCT02164461|454931902|FG002|Overall Study|Adverse Event|1|||
126445748|NCT02164461|454931900|FG000|Overall Study|Disease Progression|1|||
126445749|NCT02164461|454931901|FG001|Overall Study|Disease Progression|3|||
126445750|NCT02164461|454931902|FG002|Overall Study|Disease Progression|4|||
126356221|NCT01471574|454597765|FG002|Treatment Period|Withdrawal by Subject|1|||
126445751|NCT02164461|454931900|FG000|Overall Study|Withdrawal by Subject|0|||
126445752|NCT02164461|454931901|FG001|Overall Study|Withdrawal by Subject|3|||
126445753|NCT02164461|454931902|FG002|Overall Study|Withdrawal by Subject|0|||
126445754|NCT02100696|454931904|FG000|Induction Phase|Adverse Event|0|||
126693869|NCT01609842|455833368|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
126693870|NCT01609842|455833369|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
126693871|NCT02474329|455833370|FG000|Overall Study|Withdraw or did not contribute data.|13|||
126356222|NCT01471574|454597766|FG003|Treatment Period|Withdrawal by Subject|0|||
126356223|NCT01471574|454597763|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
126356224|NCT01471574|454597764|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
126356225|NCT01471574|454597765|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
126356226|NCT01471574|454597766|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
126356227|NCT01471574|454597763|FG000|Treatment Period|Lost to Follow-up|1|||
126356228|NCT01471574|454597764|FG001|Treatment Period|Lost to Follow-up|2|||
126356229|NCT01471574|454597765|FG002|Treatment Period|Lost to Follow-up|2|||
126356230|NCT01471574|454597766|FG003|Treatment Period|Lost to Follow-up|0|||
126356231|NCT01471574|454597763|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
126356232|NCT01471574|454597764|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
126356233|NCT01471574|454597765|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
126356234|NCT01471574|454597766|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
126356235|NCT01471574|454597763|FG000|Treatment Period|Other|1|||
126356236|NCT01471574|454597764|FG001|Treatment Period|Other|0|||
126356237|NCT01471574|454597765|FG002|Treatment Period|Other|0|||
126356238|NCT01471574|454597766|FG003|Treatment Period|Other|0|||
126356239|NCT01471574|454597763|FG000|Follow-up Period|Withdrawal by Subject|3|||
126356240|NCT01471574|454597764|FG001|Follow-up Period|Withdrawal by Subject|0|||
126356241|NCT01471574|454597765|FG002|Follow-up Period|Withdrawal by Subject|3|||
126356242|NCT01471574|454597766|FG003|Follow-up Period|Withdrawal by Subject|1|||
126356243|NCT01471574|454597763|FG000|Follow-up Period|Lost to Follow-up|4|||
126356244|NCT01471574|454597764|FG001|Follow-up Period|Lost to Follow-up|1|||
126356245|NCT01471574|454597765|FG002|Follow-up Period|Lost to Follow-up|3|||
126356246|NCT01471574|454597766|FG003|Follow-up Period|Lost to Follow-up|2|||
126356247|NCT01471574|454597763|FG000|Follow-up Period|Death|0|||
126356248|NCT01471574|454597764|FG001|Follow-up Period|Death|0|||
126356249|NCT01471574|454597765|FG002|Follow-up Period|Death|1|||
126356250|NCT01471574|454597766|FG003|Follow-up Period|Death|0|||
126693872|NCT03186989|455833371|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126693873|NCT03186989|455833372|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126693874|NCT03186989|455833373|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
126356251|NCT01471574|454597763|FG000|Follow-up Period|Follow-up no longer required|0|||
126356252|NCT01471574|454597764|FG001|Follow-up Period|Follow-up no longer required|1|||
126356253|NCT01471574|454597765|FG002|Follow-up Period|Follow-up no longer required|0|||
126356254|NCT01471574|454597766|FG003|Follow-up Period|Follow-up no longer required|0|||
126356255|NCT00574951|454597774|FG000|Overall Study|Ineligible - improper prior treatment|1|||
126356256|NCT01160744|454597789|FG000|Overall Study|Withdrawal by Subject|11|||
126356257|NCT01160744|454597790|FG001|Overall Study|Withdrawal by Subject|5|||
126356258|NCT01160744|454597791|FG002|Overall Study|Withdrawal by Subject|6|||
126356259|NCT01160744|454597792|FG003|Overall Study|Withdrawal by Subject|4|||
126356260|NCT01160744|454597789|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
126356261|NCT01160744|454597790|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
126356262|NCT01160744|454597791|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
126356263|NCT01160744|454597792|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
126356264|NCT02056288|454597793|FG000|In-Hospital Data|Surgery cancelled|1|||
126356265|NCT02056288|454597794|FG001|In-Hospital Data|Surgery cancelled|0|||
126356266|NCT02056288|454597793|FG000|In-Hospital Data|Protocol Violation|3|||
126356267|NCT02056288|454597794|FG001|In-Hospital Data|Protocol Violation|0|||
126356268|NCT02056288|454597793|FG000|In-Hospital Data|Physician Decision|1|||
126356269|NCT02056288|454597794|FG001|In-Hospital Data|Physician Decision|0|||
126356270|NCT02056288|454597793|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
126356271|NCT02056288|454597794|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
126356272|NCT02301429|454597795|FG000|Overall Study|not acceptable vascular anatomy|3|||
126356273|NCT00500110|454597796|FG000|Overall Study|Withdrawal by Subject|3|||
126356274|NCT01502072|454597797|FG000|Overall Study|Withdrawal by Subject|1|||
126356275|NCT01502072|454597798|FG001|Overall Study|Withdrawal by Subject|0|||
126445755|NCT02100696|454931905|FG001|Induction Phase|Adverse Event|0|||
126445756|NCT02100696|454931906|FG002|Induction Phase|Adverse Event|1|||
126445757|NCT02100696|454931907|FG003|Induction Phase|Adverse Event|0|||
126445758|NCT02100696|454931908|FG004|Induction Phase|Adverse Event|0|||
126445759|NCT02100696|454931909|FG005|Induction Phase|Adverse Event|0|||
126445760|NCT02100696|454931904|FG000|Induction Phase|Lost to Follow-up|1|||
126445761|NCT02100696|454931905|FG001|Induction Phase|Lost to Follow-up|0|||
126445762|NCT02100696|454931906|FG002|Induction Phase|Lost to Follow-up|1|||
126445763|NCT02100696|454931907|FG003|Induction Phase|Lost to Follow-up|0|||
126445764|NCT02100696|454931908|FG004|Induction Phase|Lost to Follow-up|0|||
126356276|NCT01502072|454597799|FG002|Overall Study|Withdrawal by Subject|0|||
126356277|NCT01502072|454597797|FG000|Overall Study|Death|0|||
126356278|NCT01502072|454597798|FG001|Overall Study|Death|1|||
126356279|NCT01502072|454597799|FG002|Overall Study|Death|0|||
126356280|NCT03954938|454597800|FG000|Overall Study|Withdrawal by Subject|2|||
126356281|NCT03954938|454597800|FG000|Overall Study|Adverse Event|1|||
126356282|NCT02217982|454597801|FG000|Overall Study|Trial discontinued|1|||
126356283|NCT02217982|454597802|FG001|Overall Study|Trial discontinued|0|||
126356284|NCT02217982|454597801|FG000|Overall Study|Adverse Event|0|||
126356285|NCT02217982|454597802|FG001|Overall Study|Adverse Event|1|||
126356286|NCT04676646|454597803|FG000|Open-label Run-in Phase|Adverse Event|3|||
126356287|NCT04676646|454597804|FG001|Open-label Run-in Phase|Adverse Event|0|||
126356288|NCT04676646|454597805|FG002|Open-label Run-in Phase|Adverse Event|0|||
126356289|NCT04676646|454597803|FG000|Open-label Run-in Phase|Death|3|||
126356290|NCT04676646|454597804|FG001|Open-label Run-in Phase|Death|0|||
126356291|NCT04676646|454597805|FG002|Open-label Run-in Phase|Death|0|||
126356292|NCT04676646|454597803|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
126356293|NCT04676646|454597804|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
126356294|NCT04676646|454597805|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
126356295|NCT04676646|454597803|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
126356296|NCT04676646|454597804|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
126356297|NCT04676646|454597805|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
126356298|NCT04676646|454597803|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
126356299|NCT04676646|454597804|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
126356300|NCT04676646|454597805|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
126356301|NCT04676646|454597803|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
126356302|NCT04676646|454597804|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
126356303|NCT04676646|454597805|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
126356304|NCT04676646|454597803|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
126356305|NCT04676646|454597804|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
126356306|NCT04676646|454597805|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
126356307|NCT04676646|454597803|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
126356308|NCT04676646|454597804|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
126356309|NCT04676646|454597805|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
126356310|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
126356311|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
126356312|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
126356313|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Death|0|||
126356314|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Death|1|||
126356315|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Death|2|||
126356316|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
126445765|NCT02100696|454931909|FG005|Induction Phase|Lost to Follow-up|0|||
126445766|NCT02100696|454931904|FG000|Induction Phase|Protocol Violation|0|||
126445767|NCT02100696|454931905|FG001|Induction Phase|Protocol Violation|1|||
126445768|NCT02100696|454931906|FG002|Induction Phase|Protocol Violation|1|||
126445769|NCT02100696|454931907|FG003|Induction Phase|Protocol Violation|0|||
126445770|NCT02100696|454931908|FG004|Induction Phase|Protocol Violation|0|||
126445771|NCT02100696|454931909|FG005|Induction Phase|Protocol Violation|0|||
126445772|NCT02100696|454931904|FG000|Induction Phase|Withdrawal by Subject|8|||
126445773|NCT02100696|454931905|FG001|Induction Phase|Withdrawal by Subject|2|||
126445774|NCT02100696|454931906|FG002|Induction Phase|Withdrawal by Subject|13|||
126445775|NCT02100696|454931907|FG003|Induction Phase|Withdrawal by Subject|0|||
126445776|NCT02100696|454931908|FG004|Induction Phase|Withdrawal by Subject|0|||
126445777|NCT02100696|454931909|FG005|Induction Phase|Withdrawal by Subject|0|||
126445778|NCT02100696|454931904|FG000|Induction Phase|Physician Decision|1|||
126445779|NCT02100696|454931905|FG001|Induction Phase|Physician Decision|0|||
126445780|NCT02100696|454931906|FG002|Induction Phase|Physician Decision|2|||
126445781|NCT02100696|454931907|FG003|Induction Phase|Physician Decision|0|||
126445782|NCT02100696|454931908|FG004|Induction Phase|Physician Decision|0|||
126445783|NCT02100696|454931909|FG005|Induction Phase|Physician Decision|0|||
126445784|NCT02100696|454931904|FG000|Induction Phase|Multiple Reasons|5|||
126445785|NCT02100696|454931905|FG001|Induction Phase|Multiple Reasons|2|||
126445786|NCT02100696|454931906|FG002|Induction Phase|Multiple Reasons|8|||
126445787|NCT02100696|454931907|FG003|Induction Phase|Multiple Reasons|0|||
126445788|NCT02100696|454931908|FG004|Induction Phase|Multiple Reasons|0|||
126445789|NCT02100696|454931909|FG005|Induction Phase|Multiple Reasons|0|||
126445790|NCT02100696|454931904|FG000|Maintenance Phase|Adverse Event|0|||
126445791|NCT02100696|454931905|FG001|Maintenance Phase|Adverse Event|0|||
126445792|NCT02100696|454931906|FG002|Maintenance Phase|Adverse Event|0|||
126445793|NCT02100696|454931907|FG003|Maintenance Phase|Adverse Event|0|||
126445794|NCT02100696|454931908|FG004|Maintenance Phase|Adverse Event|0|||
126445795|NCT02100696|454931909|FG005|Maintenance Phase|Adverse Event|2|||
126445796|NCT02100696|454931904|FG000|Maintenance Phase|Lost to Follow-up|0|||
126445797|NCT02100696|454931905|FG001|Maintenance Phase|Lost to Follow-up|0|||
126445798|NCT02100696|454931906|FG002|Maintenance Phase|Lost to Follow-up|0|||
126445799|NCT02100696|454931907|FG003|Maintenance Phase|Lost to Follow-up|0|||
126445800|NCT02100696|454931908|FG004|Maintenance Phase|Lost to Follow-up|1|||
126445801|NCT02100696|454931909|FG005|Maintenance Phase|Lost to Follow-up|0|||
126445802|NCT02100696|454931904|FG000|Maintenance Phase|Protocol Violation|0|||
126445803|NCT02100696|454931905|FG001|Maintenance Phase|Protocol Violation|0|||
126445804|NCT02100696|454931906|FG002|Maintenance Phase|Protocol Violation|0|||
126445805|NCT02100696|454931907|FG003|Maintenance Phase|Protocol Violation|0|||
126445806|NCT02100696|454931908|FG004|Maintenance Phase|Protocol Violation|1|||
126445807|NCT02100696|454931909|FG005|Maintenance Phase|Protocol Violation|0|||
126445808|NCT02100696|454931904|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126445809|NCT02100696|454931905|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126445810|NCT02100696|454931906|FG002|Maintenance Phase|Withdrawal by Subject|0|||
126445811|NCT02100696|454931907|FG003|Maintenance Phase|Withdrawal by Subject|1|||
126445812|NCT02100696|454931908|FG004|Maintenance Phase|Withdrawal by Subject|4|||
126445813|NCT02100696|454931909|FG005|Maintenance Phase|Withdrawal by Subject|2|||
126445814|NCT02100696|454931904|FG000|Maintenance Phase|Physician Decision|0|||
126445815|NCT02100696|454931905|FG001|Maintenance Phase|Physician Decision|0|||
126445816|NCT02100696|454931906|FG002|Maintenance Phase|Physician Decision|0|||
126445817|NCT02100696|454931907|FG003|Maintenance Phase|Physician Decision|0|||
126445818|NCT02100696|454931908|FG004|Maintenance Phase|Physician Decision|1|||
126445819|NCT02100696|454931909|FG005|Maintenance Phase|Physician Decision|0|||
126445820|NCT02100696|454931904|FG000|Maintenance Phase|Multiple Reasons|0|||
126445821|NCT02100696|454931905|FG001|Maintenance Phase|Multiple Reasons|0|||
126445822|NCT02100696|454931906|FG002|Maintenance Phase|Multiple Reasons|0|||
126445823|NCT02100696|454931907|FG003|Maintenance Phase|Multiple Reasons|0|||
126445824|NCT02100696|454931908|FG004|Maintenance Phase|Multiple Reasons|2|||
126445825|NCT02100696|454931909|FG005|Maintenance Phase|Multiple Reasons|1|||
126445826|NCT03865381|454931912|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
126445827|NCT03865381|454931912|FG000|Overall Study|Withdrawal by Subject|2|||
126445828|NCT05626322|454931913|FG000|Overall Study|Death|2|||
126445829|NCT05626322|454931914|FG001|Overall Study|Death|0|||
126445830|NCT05626322|454931915|FG002|Overall Study|Death|0|||
126445831|NCT05626322|454931913|FG000|Overall Study|Physician Decision|1|||
126445832|NCT05626322|454931914|FG001|Overall Study|Physician Decision|0|||
126445833|NCT05626322|454931915|FG002|Overall Study|Physician Decision|0|||
126445834|NCT05626322|454931913|FG000|Overall Study|Progressive Disease|0|||
126445835|NCT05626322|454931914|FG001|Overall Study|Progressive Disease|1|||
126445836|NCT05626322|454931915|FG002|Overall Study|Progressive Disease|1|||
126445837|NCT05626322|454931913|FG000|Overall Study|Study terminated by sponsor|0|||
126445838|NCT05626322|454931914|FG001|Overall Study|Study terminated by sponsor|1|||
126445839|NCT05626322|454931915|FG002|Overall Study|Study terminated by sponsor|0|||
126445840|NCT00369265|454931916|FG000|Overall Study|Study terminated|4|||
126445841|NCT00369265|454931917|FG001|Overall Study|Study terminated|7|||
126445842|NCT00048074|454931920|FG000|Overall Study|Adverse Event|46|||
126356317|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
126356318|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
126356319|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
126356320|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
126356321|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
126356322|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
126356323|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
126356324|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
126356325|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
126356326|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
126356327|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
126356328|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
126356329|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
126356330|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
126356331|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
126356332|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
126356333|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
126356334|NCT04676646|454597803|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
126356335|NCT04676646|454597804|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
126356336|NCT04676646|454597805|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
126356337|NCT04270760|454597806|FG000|Overall Study|Withdrawal by Subject|0|||
126356338|NCT04270760|454597807|FG001|Overall Study|Withdrawal by Subject|1|||
126356339|NCT04270760|454597808|FG002|Overall Study|Withdrawal by Subject|3|||
126356340|NCT04270760|454597809|FG003|Overall Study|Withdrawal by Subject|0|||
126356341|NCT04270760|454597810|FG004|Overall Study|Withdrawal by Subject|0|||
126356342|NCT04270760|454597806|FG000|Overall Study|Lost to Follow-up|1|||
126356343|NCT04270760|454597807|FG001|Overall Study|Lost to Follow-up|2|||
126356344|NCT04270760|454597808|FG002|Overall Study|Lost to Follow-up|1|||
126356345|NCT04270760|454597809|FG003|Overall Study|Lost to Follow-up|0|||
126356346|NCT04270760|454597810|FG004|Overall Study|Lost to Follow-up|0|||
126356347|NCT04270760|454597806|FG000|Overall Study|Death|0|||
126356348|NCT04270760|454597807|FG001|Overall Study|Death|0|||
126356349|NCT04270760|454597808|FG002|Overall Study|Death|0|||
126356350|NCT04270760|454597809|FG003|Overall Study|Death|0|||
126356351|NCT04270760|454597810|FG004|Overall Study|Death|1|||
126356352|NCT02421510|454597811|FG000|Overall Study|Other|4|||
126356353|NCT02421510|454597812|FG001|Overall Study|Other|2|||
126356354|NCT02421510|454597813|FG002|Overall Study|Other|3|||
126356355|NCT02421510|454597811|FG000|Overall Study|Protocol Violation|1|||
126356356|NCT02421510|454597812|FG001|Overall Study|Protocol Violation|2|||
126356357|NCT02421510|454597813|FG002|Overall Study|Protocol Violation|0|||
126356358|NCT02421510|454597811|FG000|Overall Study|Death|1|||
126356359|NCT02421510|454597812|FG001|Overall Study|Death|0|||
126356360|NCT02421510|454597813|FG002|Overall Study|Death|0|||
126356361|NCT02421510|454597811|FG000|Overall Study|Noncompliance with study drug|1|||
126356362|NCT02421510|454597812|FG001|Overall Study|Noncompliance with study drug|0|||
126356363|NCT02421510|454597813|FG002|Overall Study|Noncompliance with study drug|0|||
126356364|NCT02421510|454597811|FG000|Overall Study|Physician Decision|1|||
126356365|NCT02421510|454597812|FG001|Overall Study|Physician Decision|1|||
126356366|NCT02421510|454597813|FG002|Overall Study|Physician Decision|3|||
126356367|NCT02421510|454597811|FG000|Overall Study|Adverse Event|9|||
126356368|NCT02421510|454597812|FG001|Overall Study|Adverse Event|10|||
126356369|NCT02421510|454597813|FG002|Overall Study|Adverse Event|18|||
126356370|NCT02421510|454597811|FG000|Overall Study|Pregnancy|1|||
126356371|NCT02421510|454597812|FG001|Overall Study|Pregnancy|1|||
126356372|NCT02421510|454597813|FG002|Overall Study|Pregnancy|0|||
126356373|NCT02421510|454597811|FG000|Overall Study|Withdrawal by Subject|14|||
126356374|NCT02421510|454597812|FG001|Overall Study|Withdrawal by Subject|18|||
126445843|NCT00048074|454931921|FG001|Overall Study|Adverse Event|41|||
126356375|NCT02421510|454597813|FG002|Overall Study|Withdrawal by Subject|12|||
126356376|NCT02421510|454597811|FG000|Overall Study|Lost to Follow-up|1|||
126356377|NCT02421510|454597812|FG001|Overall Study|Lost to Follow-up|1|||
126356378|NCT02421510|454597813|FG002|Overall Study|Lost to Follow-up|0|||
126445844|NCT00048074|454931922|FG002|Overall Study|Adverse Event|53|||
126445845|NCT00048074|454931920|FG000|Overall Study|Death|3|||
126445846|NCT00048074|454931921|FG001|Overall Study|Death|3|||
126445847|NCT00048074|454931922|FG002|Overall Study|Death|2|||
126445848|NCT00048074|454931920|FG000|Overall Study|Lost to Follow-up|2|||
126445849|NCT00048074|454931921|FG001|Overall Study|Lost to Follow-up|6|||
126445850|NCT00048074|454931922|FG002|Overall Study|Lost to Follow-up|6|||
126445851|NCT00048074|454931920|FG000|Overall Study|Withdrawal by Subject|28|||
126445852|NCT00048074|454931921|FG001|Overall Study|Withdrawal by Subject|30|||
126445853|NCT00048074|454931922|FG002|Overall Study|Withdrawal by Subject|35|||
126445854|NCT00048074|454931920|FG000|Overall Study|Protocol Violation|1|||
126445855|NCT00048074|454931921|FG001|Overall Study|Protocol Violation|3|||
126445856|NCT00048074|454931922|FG002|Overall Study|Protocol Violation|0|||
126445857|NCT00048074|454931920|FG000|Overall Study|Study participation was terminated|0|||
126445858|NCT00048074|454931921|FG001|Overall Study|Study participation was terminated|1|||
126445859|NCT00048074|454931922|FG002|Overall Study|Study participation was terminated|0|||
126445860|NCT00048074|454931920|FG000|Overall Study|Husband ill|0|||
126445861|NCT00048074|454931921|FG001|Overall Study|Husband ill|1|||
126445862|NCT00048074|454931922|FG002|Overall Study|Husband ill|0|||
126445863|NCT00048074|454931920|FG000|Overall Study|Poor compliance|0|||
126445864|NCT00048074|454931921|FG001|Overall Study|Poor compliance|1|||
126445865|NCT00048074|454931922|FG002|Overall Study|Poor compliance|0|||
126445866|NCT00048074|454931920|FG000|Overall Study|Out of station|0|||
126445867|NCT00048074|454931921|FG001|Overall Study|Out of station|1|||
126445868|NCT00048074|454931922|FG002|Overall Study|Out of station|1|||
126445869|NCT00048074|454931920|FG000|Overall Study|Social reasons|1|||
126445870|NCT00048074|454931921|FG001|Overall Study|Social reasons|0|||
126445871|NCT00048074|454931922|FG002|Overall Study|Social reasons|0|||
126445872|NCT02873377|454931923|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
126445873|NCT02873377|454931924|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
126445874|NCT02873377|454931923|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
126445875|NCT02873377|454931924|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
126445876|NCT01032889|454931930|FG000|Overall Study|Adverse Event|2|||
126445877|NCT01032889|454931931|FG001|Overall Study|Adverse Event|2|||
126445878|NCT01032889|454931932|FG002|Overall Study|Adverse Event|0|||
126445879|NCT01032889|454931930|FG000|Overall Study|Withdrawal of Consent|1|||
126445880|NCT01032889|454931931|FG001|Overall Study|Withdrawal of Consent|2|||
126445881|NCT01032889|454931932|FG002|Overall Study|Withdrawal of Consent|1|||
126445882|NCT01032889|454931930|FG000|Overall Study|Patient Request|0|||
126445883|NCT01032889|454931931|FG001|Overall Study|Patient Request|1|||
126445884|NCT01032889|454931932|FG002|Overall Study|Patient Request|0|||
126445885|NCT01032889|454931930|FG000|Overall Study|Lost to Follow-up|1|||
126445886|NCT01032889|454931931|FG001|Overall Study|Lost to Follow-up|1|||
126445887|NCT01032889|454931932|FG002|Overall Study|Lost to Follow-up|0|||
126445888|NCT01032889|454931930|FG000|Overall Study|Lack of Submental Fat|2|||
126445889|NCT01032889|454931931|FG001|Overall Study|Lack of Submental Fat|8|||
126445890|NCT01032889|454931932|FG002|Overall Study|Lack of Submental Fat|1|||
126445891|NCT01032889|454931930|FG000|Overall Study|Miscellaneous Reasons|2|||
126445892|NCT01032889|454931931|FG001|Overall Study|Miscellaneous Reasons|1|||
126445893|NCT01032889|454931932|FG002|Overall Study|Miscellaneous Reasons|1|||
126445894|NCT00740857|454931937|FG000|Overall Study|Withdrawal by Subject|1|||
126445895|NCT00740857|454931938|FG001|Overall Study|Withdrawal by Subject|0|||
126445896|NCT00740857|454931939|FG002|Overall Study|Withdrawal by Subject|0|||
126445897|NCT03532451|454931943|FG000|Overall Study|Withdrawal by Subject|0|||
126445898|NCT03532451|454931944|FG001|Overall Study|Withdrawal by Subject|1|||
126445899|NCT03532451|454931943|FG000|Overall Study|Did not undergo surgery|1|||
126445900|NCT03532451|454931944|FG001|Overall Study|Did not undergo surgery|1|||
126445901|NCT01519167|454931945|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
126445902|NCT01519167|454931946|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
126445903|NCT01519167|454931945|FG000|Overall Study|Adverse Event|0|||
126445904|NCT01519167|454931946|FG001|Overall Study|Adverse Event|1|||
126445905|NCT01519167|454931945|FG000|Overall Study|Lack of Efficacy|0|||
126445906|NCT01519167|454931946|FG001|Overall Study|Lack of Efficacy|1|||
126445907|NCT01519167|454931945|FG000|Overall Study|Medical condition changes&deep sedation|0|||
126445908|NCT01519167|454931946|FG001|Overall Study|Medical condition changes&deep sedation|2|||
126445909|NCT01519167|454931945|FG000|Overall Study|Physician Decision|0|||
126445910|NCT01519167|454931946|FG001|Overall Study|Physician Decision|1|||
126445911|NCT04200352|454931957|FG000|Overall Study|Death|1|||
126445912|NCT04200352|454931957|FG000|Overall Study|Adverse Event|6|||
126445913|NCT04200352|454931957|FG000|Overall Study|Withdrawal by parent/guardian|6|||
126445914|NCT04200352|454931957|FG000|Overall Study|Lack of Efficacy|1|||
126445915|NCT04200352|454931957|FG000|Overall Study|Other than specified|6|||
126445916|NCT00993148|454931958|FG000|Overall Study|Lost to Follow-up|2|||
126445917|NCT00993148|454931958|FG000|Overall Study|never initiated treatment|1|||
126445918|NCT00233064|454931959|FG000|Overall Study|Lost to Follow-up|7|||
126445919|NCT00233064|454931960|FG001|Overall Study|Lost to Follow-up|7|||
126445920|NCT00233064|454931959|FG000|Overall Study|Withdrawal by Subject|5|||
126445921|NCT00233064|454931960|FG001|Overall Study|Withdrawal by Subject|3|||
126445922|NCT00233064|454931959|FG000|Overall Study|Death|0|||
126445923|NCT00233064|454931960|FG001|Overall Study|Death|1|||
126445924|NCT00233064|454931959|FG000|Overall Study|Relocation|0|||
126445925|NCT00233064|454931960|FG001|Overall Study|Relocation|1|||
126445926|NCT00233064|454931959|FG000|Overall Study|Protocol Violation|1|||
126445927|NCT00233064|454931960|FG001|Overall Study|Protocol Violation|0|||
126445928|NCT00233064|454931959|FG000|Overall Study|Moved to Dom. Republic|1|||
126445929|NCT00233064|454931960|FG001|Overall Study|Moved to Dom. Republic|0|||
126445930|NCT01120964|454931967|FG000|Overall Study|Did not receive full treatment|1|||
126445931|NCT01120964|454931968|FG001|Overall Study|Did not receive full treatment|0|||
126445932|NCT04237116|454931972|FG000|Overall Study|Adverse Event|0|||
126445933|NCT04237116|454931973|FG001|Overall Study|Adverse Event|1|||
126445934|NCT04237116|454931972|FG000|Overall Study|Study terminated by Sponsor|4|||
126445935|NCT04237116|454931973|FG001|Overall Study|Study terminated by Sponsor|1|||
126445936|NCT00472030|454931974|FG000|Overall Study|Physician Decision|1|||
126445937|NCT00472030|454931975|FG001|Overall Study|Physician Decision|0|||
126445938|NCT00829504|454931976|FG000|First Intervention|Adverse Event|1|||
126445939|NCT00829504|454931977|FG001|First Intervention|Adverse Event|0|||
126445940|NCT00829504|454931976|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
126445941|NCT00829504|454931977|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
126445942|NCT00829504|454931976|FG000|Second Intervention|Physician Decision|1|||
126445943|NCT00829504|454931977|FG001|Second Intervention|Physician Decision|0|||
126445944|NCT03212144|454931978|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
126445945|NCT03212144|454931979|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
126445946|NCT03212144|454931978|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
126445947|NCT03212144|454931979|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
126445948|NCT00599339|454931980|FG000|Overall Study|Adverse Event|79|||
126445949|NCT00599339|454931980|FG000|Overall Study|Withdrawal by Subject|137|||
126445950|NCT00599339|454931980|FG000|Overall Study|Other Reason|179|||
126445951|NCT00599339|454931980|FG000|Overall Study|Lost to Follow-up|221|||
126445952|NCT00599339|454931980|FG000|Overall Study|No valid data consent|36|||
126445953|NCT00599339|454931980|FG000|Overall Study|Study Termination Status Unknown|12|||
126445954|NCT00912197|454931983|FG000|Overall Study|Withdrawal by Subject|3|||
126445955|NCT00912197|454931984|FG001|Overall Study|Withdrawal by Subject|3|||
126445956|NCT01615029|454931990|FG000|Overall Study|Adverse Event|0|||
126445957|NCT01615029|454931991|FG001|Overall Study|Adverse Event|0|||
126445958|NCT01615029|454931992|FG002|Overall Study|Adverse Event|0|||
126445959|NCT01615029|454931993|FG003|Overall Study|Adverse Event|0|||
126445960|NCT01615029|454931994|FG004|Overall Study|Adverse Event|1|||
126445961|NCT01615029|454931990|FG000|Overall Study|Death|0|||
126445962|NCT01615029|454931991|FG001|Overall Study|Death|0|||
126445963|NCT01615029|454931992|FG002|Overall Study|Death|0|||
126445964|NCT01615029|454931993|FG003|Overall Study|Death|0|||
126445965|NCT01615029|454931994|FG004|Overall Study|Death|1|||
126445966|NCT01615029|454931990|FG000|Overall Study|Lost to Follow-up|0|||
126445967|NCT01615029|454931991|FG001|Overall Study|Lost to Follow-up|0|||
126445968|NCT01615029|454931992|FG002|Overall Study|Lost to Follow-up|0|||
126445969|NCT01615029|454931993|FG003|Overall Study|Lost to Follow-up|0|||
126445970|NCT01615029|454931994|FG004|Overall Study|Lost to Follow-up|1|||
126445971|NCT01615029|454931990|FG000|Overall Study|Progressive disease|2|||
126445972|NCT01615029|454931991|FG001|Overall Study|Progressive disease|1|||
126445973|NCT01615029|454931992|FG002|Overall Study|Progressive disease|1|||
126445974|NCT01615029|454931993|FG003|Overall Study|Progressive disease|1|||
126445975|NCT01615029|454931994|FG004|Overall Study|Progressive disease|5|||
126445976|NCT01615029|454931990|FG000|Overall Study|Physician Decision|0|||
126445977|NCT01615029|454931991|FG001|Overall Study|Physician Decision|0|||
126445978|NCT01615029|454931992|FG002|Overall Study|Physician Decision|0|||
126445979|NCT01615029|454931993|FG003|Overall Study|Physician Decision|0|||
126445980|NCT01615029|454931994|FG004|Overall Study|Physician Decision|1|||
126693875|NCT03186989|455833374|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
126693876|NCT03186989|455833375|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
126693877|NCT03186989|455833376|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126445981|NCT01615029|454931990|FG000|Overall Study|Ongoing|1|||
126445982|NCT01615029|454931991|FG001|Overall Study|Ongoing|2|||
126693878|NCT03186989|455833377|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126693879|NCT03186989|455833378|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126693880|NCT03186989|455833379|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126445983|NCT01615029|454931992|FG002|Overall Study|Ongoing|3|||
126445984|NCT01615029|454931993|FG003|Overall Study|Ongoing|2|||
126445985|NCT01615029|454931994|FG004|Overall Study|Ongoing|23|||
126693881|NCT03186989|455833380|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126445986|NCT01326104|454931995|FG000|Overall Study|progressed prior to vaccine|0|||
126445987|NCT01326104|454931996|FG001|Overall Study|progressed prior to vaccine|2|||
126445988|NCT01326104|454931995|FG000|Overall Study|unable to make vaccine|0|||
126445989|NCT01326104|454931996|FG001|Overall Study|unable to make vaccine|2|||
126445990|NCT01287741|454931997|FG000|Overall Study|Withdrawal by Subject|35|||
126445991|NCT01287741|454931998|FG001|Overall Study|Withdrawal by Subject|38|||
126445992|NCT01287741|454931997|FG000|Overall Study|Protocol Violation|2|||
126445993|NCT01287741|454931998|FG001|Overall Study|Protocol Violation|0|||
126445994|NCT01287741|454931997|FG000|Overall Study|Physician Decision|15|||
126445995|NCT01287741|454931998|FG001|Overall Study|Physician Decision|23|||
126445996|NCT01287741|454931997|FG000|Overall Study|Non-compliance|8|||
126445997|NCT01287741|454931998|FG001|Overall Study|Non-compliance|6|||
126445998|NCT01287741|454931997|FG000|Overall Study|Lost to Follow-up|10|||
126445999|NCT01287741|454931998|FG001|Overall Study|Lost to Follow-up|8|||
126446000|NCT01287741|454931997|FG000|Overall Study|Death|32|||
126446001|NCT01287741|454931998|FG001|Overall Study|Death|44|||
126446002|NCT01287741|454931997|FG000|Overall Study|Adverse Event|4|||
126446003|NCT01287741|454931998|FG001|Overall Study|Adverse Event|6|||
126446004|NCT01287741|454931997|FG000|Overall Study|Study terminated by Sponsor|307|||
126446005|NCT01287741|454931998|FG001|Overall Study|Study terminated by Sponsor|315|||
126446006|NCT01287741|454931997|FG000|Overall Study|Progressive disease|190|||
126446007|NCT01287741|454931998|FG001|Overall Study|Progressive disease|166|||
126446008|NCT01287741|454931997|FG000|Overall Study|Reason not specified|23|||
126446009|NCT01287741|454931998|FG001|Overall Study|Reason not specified|9|||
126446010|NCT04421027|454931999|FG000|Treatment Period|Adverse Event|5|||
126446011|NCT04421027|454932000|FG001|Treatment Period|Adverse Event|3|||
126446012|NCT04421027|454932001|FG002|Treatment Period|Adverse Event|0|||
126446013|NCT04421027|454932002|FG003|Treatment Period|Adverse Event|0|||
126446014|NCT04421027|454931999|FG000|Treatment Period|Death|98|||
126446015|NCT04421027|454932000|FG001|Treatment Period|Death|61|||
126446016|NCT04421027|454932001|FG002|Treatment Period|Death|0|||
126446017|NCT04421027|454932002|FG003|Treatment Period|Death|0|||
126446018|NCT04421027|454931999|FG000|Treatment Period|Lost to Follow-up|22|||
126446019|NCT04421027|454932000|FG001|Treatment Period|Lost to Follow-up|20|||
126446020|NCT04421027|454932001|FG002|Treatment Period|Lost to Follow-up|0|||
126446021|NCT04421027|454932002|FG003|Treatment Period|Lost to Follow-up|0|||
126446022|NCT04421027|454931999|FG000|Treatment Period|Other-Unknown|15|||
126446023|NCT04421027|454932000|FG001|Treatment Period|Other-Unknown|9|||
126446024|NCT04421027|454932001|FG002|Treatment Period|Other-Unknown|0|||
126446025|NCT04421027|454932002|FG003|Treatment Period|Other-Unknown|0|||
126446026|NCT04421027|454931999|FG000|Treatment Period|Physician Decision|1|||
126446027|NCT04421027|454932000|FG001|Treatment Period|Physician Decision|1|||
126446028|NCT04421027|454932001|FG002|Treatment Period|Physician Decision|0|||
126446029|NCT04421027|454932002|FG003|Treatment Period|Physician Decision|0|||
126446030|NCT04421027|454931999|FG000|Treatment Period|Withdrawal by Subject|7|||
126446031|NCT04421027|454932000|FG001|Treatment Period|Withdrawal by Subject|12|||
126446032|NCT04421027|454932001|FG002|Treatment Period|Withdrawal by Subject|0|||
126446033|NCT04421027|454932002|FG003|Treatment Period|Withdrawal by Subject|0|||
126446034|NCT04421027|454931999|FG000|Treatment Period|Randomized Not Dosed|9|||
126446035|NCT04421027|454932000|FG001|Treatment Period|Randomized Not Dosed|14|||
126446036|NCT04421027|454932001|FG002|Treatment Period|Randomized Not Dosed|0|||
126446037|NCT04421027|454932002|FG003|Treatment Period|Randomized Not Dosed|0|||
126446038|NCT04421027|454931999|FG000|Follow-Up Period|Adverse Event|0|||
126446039|NCT04421027|454932000|FG001|Follow-Up Period|Adverse Event|0|||
126446040|NCT04421027|454932001|FG002|Follow-Up Period|Adverse Event|0|||
126446041|NCT04421027|454932002|FG003|Follow-Up Period|Adverse Event|3|||
126446042|NCT04421027|454931999|FG000|Follow-Up Period|Death|0|||
126446043|NCT04421027|454932000|FG001|Follow-Up Period|Death|0|||
126446044|NCT04421027|454932001|FG002|Follow-Up Period|Death|16|||
126446045|NCT04421027|454932002|FG003|Follow-Up Period|Death|17|||
126446046|NCT04421027|454931999|FG000|Follow-Up Period|Lost to Follow-up|0|||
126446047|NCT04421027|454932000|FG001|Follow-Up Period|Lost to Follow-up|0|||
126446048|NCT04421027|454932001|FG002|Follow-Up Period|Lost to Follow-up|7|||
126446049|NCT04421027|454932002|FG003|Follow-Up Period|Lost to Follow-up|7|||
126446050|NCT04421027|454931999|FG000|Follow-Up Period|Protocol Deviation|0|||
126446051|NCT04421027|454932000|FG001|Follow-Up Period|Protocol Deviation|0|||
126446052|NCT04421027|454932001|FG002|Follow-Up Period|Protocol Deviation|1|||
126446053|NCT04421027|454932002|FG003|Follow-Up Period|Protocol Deviation|0|||
126446054|NCT04421027|454931999|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
126446055|NCT04421027|454932000|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
126446056|NCT04421027|454932001|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
126446057|NCT04421027|454932002|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
126446058|NCT04421027|454931999|FG000|Follow-Up Period|Left message, participant did not call back|0|||
126446059|NCT04421027|454932000|FG001|Follow-Up Period|Left message, participant did not call back|0|||
126446060|NCT04421027|454932001|FG002|Follow-Up Period|Left message, participant did not call back|0|||
126446061|NCT04421027|454932002|FG003|Follow-Up Period|Left message, participant did not call back|1|||
126446062|NCT04421027|454931999|FG000|Follow-Up Period|Participant died|0|||
126446063|NCT04421027|454932000|FG001|Follow-Up Period|Participant died|0|||
126446064|NCT04421027|454932001|FG002|Follow-Up Period|Participant died|0|||
126446065|NCT04421027|454932002|FG003|Follow-Up Period|Participant died|1|||
126446066|NCT04421027|454931999|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
126446067|NCT04421027|454932000|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
126446068|NCT04421027|454932001|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
126446069|NCT04421027|454932002|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
126446070|NCT02930018|454932004|FG000|Overall Study|Lost to Follow-up|1|||
126446071|NCT02930018|454932005|FG001|Overall Study|Lost to Follow-up|1|||
126446072|NCT02930018|454932004|FG000|Overall Study|Withdrawal by Subject|5|||
126446073|NCT02930018|454932005|FG001|Overall Study|Withdrawal by Subject|2|||
126446074|NCT00539864|454933593|FG000|Overall Study|Lost to Follow-up|0|||
126446075|NCT00539864|454933594|FG001|Overall Study|Lost to Follow-up|1|||
126446076|NCT00539864|454933593|FG000|Overall Study|Withdrawal by Subject|1|||
126446077|NCT00539864|454933594|FG001|Overall Study|Withdrawal by Subject|1|||
126446078|NCT02565784|454933595|FG000|First Treatment|Adverse Event|1|||
126446079|NCT02565784|454933595|FG000|First Treatment|Withdrawal by Subject|1|||
126446080|NCT02565784|454933595|FG000|Second Treatment|Withdrawal by Subject|2|||
126446081|NCT00943072|454933601|FG000|Overall Study|Adverse Event|0|||
126446082|NCT00943072|454933602|FG001|Overall Study|Adverse Event|3|||
126446083|NCT00943072|454933601|FG000|Overall Study|Death|0|||
126446084|NCT00943072|454933602|FG001|Overall Study|Death|2|||
126446085|NCT00943072|454933601|FG000|Overall Study|Withdrawal by Subject|3|||
126446086|NCT00943072|454933602|FG001|Overall Study|Withdrawal by Subject|1|||
126446087|NCT00943072|454933601|FG000|Overall Study|Protocol Violation|0|||
126446088|NCT00943072|454933602|FG001|Overall Study|Protocol Violation|1|||
126446089|NCT00943072|454933601|FG000|Overall Study|Lost to Follow-up|1|||
126446090|NCT00943072|454933602|FG001|Overall Study|Lost to Follow-up|2|||
126446091|NCT00943072|454933601|FG000|Overall Study|Lack of Efficacy|0|||
126446092|NCT00943072|454933602|FG001|Overall Study|Lack of Efficacy|4|||
126446093|NCT00943072|454933601|FG000|Overall Study|Other|1|||
126446094|NCT00943072|454933602|FG001|Overall Study|Other|1|||
126446095|NCT00552188|454933603|FG000|Overall Study|Adverse Event|0|||
126446096|NCT00552188|454933604|FG001|Overall Study|Adverse Event|2|||
126446097|NCT00552188|454933603|FG000|Overall Study|Lost to Follow-up|2|||
126446098|NCT00552188|454933604|FG001|Overall Study|Lost to Follow-up|1|||
126446099|NCT00552188|454933603|FG000|Overall Study|Withdrawal of consent|0|||
126446100|NCT00552188|454933604|FG001|Overall Study|Withdrawal of consent|1|||
126446101|NCT00552188|454933603|FG000|Overall Study|Subject returned to home country|0|||
126446102|NCT00552188|454933604|FG001|Overall Study|Subject returned to home country|1|||
126446103|NCT03887702|454933605|FG000|Overall Study|Study terminated|0|||
126446104|NCT03887702|454933606|FG001|Overall Study|Study terminated|0|||
126446105|NCT03887702|454933607|FG002|Overall Study|Study terminated|2|||
126446106|NCT03887702|454933608|FG003|Overall Study|Study terminated|2|||
126446107|NCT01193257|454933611|FG000|Overall Study|Death|202|||
126446108|NCT01193257|454933612|FG001|Overall Study|Death|391|||
126446109|NCT01193257|454933611|FG000|Overall Study|Study termination by sponsor|0|||
126446110|NCT01193257|454933612|FG001|Overall Study|Study termination by sponsor|3|||
126446111|NCT01193257|454933611|FG000|Overall Study|Withdrawal by Subject|26|||
126446112|NCT01193257|454933612|FG001|Overall Study|Withdrawal by Subject|86|||
126446113|NCT01193257|454933611|FG000|Overall Study|Lost to Follow-up|2|||
126446114|NCT01193257|454933612|FG001|Overall Study|Lost to Follow-up|3|||
126446115|NCT01193257|454933611|FG000|Overall Study|Unblinded due to futility|135|||
126446116|NCT01193257|454933612|FG001|Overall Study|Unblinded due to futility|251|||
126446117|NCT00476008|454933613|FG000|Overall Study|Adverse Event|4|||
126446118|NCT00476008|454933614|FG001|Overall Study|Adverse Event|4|||
126446119|NCT00476008|454933613|FG000|Overall Study|Placebo concerns|2|||
126446120|NCT00476008|454933614|FG001|Overall Study|Placebo concerns|2|||
126693882|NCT03186989|455833381|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
126693883|NCT03186989|455833371|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126693884|NCT03186989|455833372|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126693885|NCT03186989|455833373|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126693886|NCT03186989|455833374|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126693887|NCT03186989|455833375|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126693888|NCT03186989|455833376|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
126693889|NCT03186989|455833377|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126693890|NCT03186989|455833378|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126693891|NCT03186989|455833379|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126693892|NCT03186989|455833380|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126693893|NCT03186989|455833381|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
126693894|NCT03186989|455833371|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126693895|NCT03186989|455833372|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126693896|NCT03186989|455833373|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126693897|NCT03186989|455833374|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126693898|NCT03186989|455833375|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126356379|NCT02609633|454597818|FG000|Overall Study|Consent Withdrawn|0|||
126356380|NCT02609633|454597819|FG001|Overall Study|Consent Withdrawn|1|||
126693899|NCT03186989|455833376|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126693900|NCT03186989|455833377|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
126693901|NCT03186989|455833378|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126356381|NCT02609633|454597818|FG000|Overall Study|Protocol Deviation|1|||
126356382|NCT02609633|454597819|FG001|Overall Study|Protocol Deviation|0|||
126356383|NCT02609633|454597818|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
126356384|NCT02609633|454597819|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
126356385|NCT02609633|454597818|FG000|Overall Study|Reason not Specified|2|||
126356386|NCT02609633|454597819|FG001|Overall Study|Reason not Specified|1|||
126356387|NCT01096186|454597822|FG000|Overall Study|Adverse Event|16|||
126356388|NCT01096186|454597822|FG000|Overall Study|Death|4|||
126356389|NCT01096186|454597822|FG000|Overall Study|Lack of Efficacy|4|||
126356390|NCT01096186|454597822|FG000|Overall Study|Lost to Follow-up|2|||
126356391|NCT01096186|454597822|FG000|Overall Study|Withdrawal by Subject|22|||
126356392|NCT01096186|454597822|FG000|Overall Study|Physician Decision|1|||
126356393|NCT01096186|454597822|FG000|Overall Study|Noncompliance with study drug|1|||
126356394|NCT00122187|454597823|FG000|Overall Study|Withdrew because of resource limitations|2|||
126356395|NCT00122187|454597824|FG001|Overall Study|Withdrew because of resource limitations|2|||
126356396|NCT02061592|454597825|FG000|Period 1|Withdrawal by Subject|1|||
126356397|NCT02061592|454597826|FG001|Period 1|Withdrawal by Subject|0|||
126356398|NCT02061592|454597825|FG000|Period 1|Protocol Violation|1|||
126356399|NCT02061592|454597826|FG001|Period 1|Protocol Violation|0|||
126356400|NCT02061592|454597825|FG000|Period 2|Lost to Follow-up|0|||
126356401|NCT02061592|454597826|FG001|Period 2|Lost to Follow-up|1|||
126356402|NCT03338023|454597827|FG000|Overall Study|Withdrawal by Subject|3|||
126356403|NCT03338023|454597828|FG001|Overall Study|Withdrawal by Subject|4|||
126356404|NCT03338023|454597827|FG000|Overall Study|Protocol Violation|3|||
126356405|NCT03338023|454597828|FG001|Overall Study|Protocol Violation|3|||
126356406|NCT03338023|454597827|FG000|Overall Study|Lost to Follow-up|2|||
126356407|NCT03338023|454597828|FG001|Overall Study|Lost to Follow-up|1|||
126356408|NCT03338023|454597827|FG000|Overall Study|Physician Decision|1|||
126356409|NCT03338023|454597828|FG001|Overall Study|Physician Decision|2|||
126356410|NCT00685698|454597829|FG000|Overall Study|Withdrawal by Subject|1|||
126356411|NCT00685698|454597829|FG000|Overall Study|Protocol Violation|6|||
126356412|NCT00685698|454597829|FG000|Overall Study|Adverse Event|3|||
126356413|NCT00685698|454597829|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
126356414|NCT00685698|454597829|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
126356415|NCT00685698|454597829|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
126356416|NCT05061706|454597831|FG000|Overall Study|Adverse Event|29|||
126356417|NCT05061706|454597832|FG001|Overall Study|Adverse Event|1|||
126356418|NCT05061706|454597831|FG000|Overall Study|Lack of Efficacy|0|||
126356419|NCT05061706|454597832|FG001|Overall Study|Lack of Efficacy|1|||
126356420|NCT05061706|454597831|FG000|Overall Study|Lost to Follow-up|2|||
126356421|NCT05061706|454597832|FG001|Overall Study|Lost to Follow-up|2|||
126356422|NCT05061706|454597831|FG000|Overall Study|Protocol Violation|3|||
126356423|NCT05061706|454597832|FG001|Overall Study|Protocol Violation|1|||
126446121|NCT00476008|454933613|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
126356424|NCT05061706|454597831|FG000|Overall Study|Withdrawal by Subject|3|||
126356425|NCT05061706|454597832|FG001|Overall Study|Withdrawal by Subject|9|||
126356426|NCT00724893|454597833|FG000|Overall Study|Adverse Event|76|||
126356427|NCT00724893|454597834|FG001|Overall Study|Adverse Event|142|||
126356428|NCT00724893|454597833|FG000|Overall Study|Withdrawal by Subject|0|||
126356429|NCT00724893|454597834|FG001|Overall Study|Withdrawal by Subject|1|||
126356430|NCT00724893|454597833|FG000|Overall Study|Lack of virologic response|94|||
126356431|NCT00724893|454597834|FG001|Overall Study|Lack of virologic response|202|||
126356432|NCT00724893|454597833|FG000|Overall Study|Reason not specified|193|||
126356433|NCT00724893|454597834|FG001|Overall Study|Reason not specified|7|||
126356434|NCT00724893|454597833|FG000|Overall Study|Patient choice|0|||
126356435|NCT00724893|454597834|FG001|Overall Study|Patient choice|26|||
126446122|NCT00476008|454933614|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
126356436|NCT00724893|454597833|FG000|Overall Study|Geographic reasons|0|||
126446123|NCT00476008|454933613|FG000|Overall Study|Withdrawal by Subject|0|||
126446124|NCT00476008|454933614|FG001|Overall Study|Withdrawal by Subject|1|||
126446125|NCT00476008|454933613|FG000|Overall Study|Death|1|||
126446126|NCT00476008|454933614|FG001|Overall Study|Death|0|||
126446127|NCT00792571|454933620|FG000|Overall Study|Death|1|||
126446128|NCT00792571|454933620|FG000|Overall Study|Adverse Event|4|||
126446129|NCT00792571|454933620|FG000|Overall Study|Withdrawal by Subject|1|||
126446130|NCT00792571|454933620|FG000|Overall Study|Other|4|||
126446131|NCT01621802|454933621|FG000|Overall Study|Protocol Violation|0|||
126446132|NCT01621802|454933622|FG001|Overall Study|Protocol Violation|0|||
126446133|NCT01621802|454933623|FG002|Overall Study|Protocol Violation|0|||
126446134|NCT01621802|454933624|FG003|Overall Study|Protocol Violation|0|||
126446135|NCT01621802|454933625|FG004|Overall Study|Protocol Violation|0|||
126446136|NCT01621802|454933626|FG005|Overall Study|Protocol Violation|1|||
126446137|NCT01621802|454933621|FG000|Overall Study|Withdrawal by Subject|8|||
126446138|NCT01621802|454933622|FG001|Overall Study|Withdrawal by Subject|4|||
126446139|NCT01621802|454933623|FG002|Overall Study|Withdrawal by Subject|4|||
126446140|NCT01621802|454933624|FG003|Overall Study|Withdrawal by Subject|2|||
126446141|NCT01621802|454933625|FG004|Overall Study|Withdrawal by Subject|2|||
126446142|NCT01621802|454933626|FG005|Overall Study|Withdrawal by Subject|0|||
126446143|NCT01621802|454933621|FG000|Overall Study|Migrated/moved from study area|0|||
126446144|NCT01621802|454933622|FG001|Overall Study|Migrated/moved from study area|0|||
126693902|NCT03186989|455833379|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126693903|NCT03186989|455833380|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126693904|NCT03186989|455833381|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
126446145|NCT01621802|454933623|FG002|Overall Study|Migrated/moved from study area|2|||
126446146|NCT01621802|454933624|FG003|Overall Study|Migrated/moved from study area|0|||
126306193|NCT03260244|454410221|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
126446147|NCT01621802|454933625|FG004|Overall Study|Migrated/moved from study area|1|||
126446148|NCT01621802|454933626|FG005|Overall Study|Migrated/moved from study area|0|||
126446149|NCT01621802|454933621|FG000|Overall Study|Others|3|||
126446150|NCT01621802|454933622|FG001|Overall Study|Others|3|||
126446151|NCT01621802|454933623|FG002|Overall Study|Others|3|||
126446152|NCT01621802|454933624|FG003|Overall Study|Others|2|||
126446153|NCT01621802|454933625|FG004|Overall Study|Others|1|||
126446154|NCT01621802|454933626|FG005|Overall Study|Others|0|||
126446155|NCT01621802|454933621|FG000|Overall Study|Lost to Follow-up|36|||
126446156|NCT01621802|454933622|FG001|Overall Study|Lost to Follow-up|16|||
126693905|NCT03186989|455833371|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126693906|NCT03186989|455833372|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126693907|NCT03186989|455833373|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126693908|NCT03186989|455833374|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126693909|NCT03186989|455833375|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126693910|NCT03186989|455833376|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
126693911|NCT03186989|455833377|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
126446157|NCT01621802|454933623|FG002|Overall Study|Lost to Follow-up|24|||
126446158|NCT01621802|454933624|FG003|Overall Study|Lost to Follow-up|7|||
126446159|NCT01621802|454933625|FG004|Overall Study|Lost to Follow-up|31|||
126446160|NCT01621802|454933626|FG005|Overall Study|Lost to Follow-up|11|||
126446161|NCT03790696|454933628|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
126446162|NCT03790696|454933629|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
126760773|NCT00727246|456075789|FG000|Overall Study|could not complete MRI|0|||
126446163|NCT03436082|454933630|FG000|Overall Study|Did not undergo procedure|1|||
126446164|NCT03436082|454933631|FG001|Overall Study|Did not undergo procedure|0|||
126446165|NCT00950859|454933634|FG000|Overall Study|Adverse Event|3|||
126446166|NCT00950859|454933635|FG001|Overall Study|Adverse Event|3|||
126446167|NCT00950859|454933634|FG000|Overall Study|Insufficient Viral Load Response|12|||
126446168|NCT00950859|454933635|FG001|Overall Study|Insufficient Viral Load Response|3|||
126446169|NCT00950859|454933634|FG000|Overall Study|Protocol Violation|1|||
126446170|NCT00950859|454933635|FG001|Overall Study|Protocol Violation|1|||
126446171|NCT00950859|454933634|FG000|Overall Study|Lost to Follow-up|0|||
126446172|NCT00950859|454933635|FG001|Overall Study|Lost to Follow-up|3|||
126760774|NCT00727246|456075790|FG001|Overall Study|could not complete MRI|1|||
126760775|NCT00727246|456075791|FG002|Overall Study|could not complete MRI|0|||
126760776|NCT00727246|456075792|FG003|Overall Study|could not complete MRI|1|||
126760777|NCT00727246|456075789|FG000|Overall Study|incidental finding|0|||
126760778|NCT00727246|456075790|FG001|Overall Study|incidental finding|0|||
126760779|NCT00727246|456075791|FG002|Overall Study|incidental finding|0|||
126446173|NCT04896086|454933636|FG000|Overall Study|Lost to Follow-up|0|||
126446174|NCT04896086|454933637|FG001|Overall Study|Lost to Follow-up|2|||
126446175|NCT04896086|454933638|FG002|Overall Study|Lost to Follow-up|1|||
126446176|NCT04896086|454933639|FG003|Overall Study|Lost to Follow-up|0|||
126446177|NCT04896086|454933640|FG004|Overall Study|Lost to Follow-up|0|||
126446178|NCT04896086|454933636|FG000|Overall Study|Physician Decision|0|||
126446179|NCT04896086|454933637|FG001|Overall Study|Physician Decision|1|||
126446180|NCT04896086|454933638|FG002|Overall Study|Physician Decision|0|||
126446181|NCT04896086|454933639|FG003|Overall Study|Physician Decision|0|||
126446182|NCT04896086|454933640|FG004|Overall Study|Physician Decision|0|||
126446183|NCT04896086|454933636|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
126446184|NCT04896086|454933637|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
126446185|NCT04896086|454933638|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
126446186|NCT04896086|454933639|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
126446187|NCT04896086|454933640|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
126446188|NCT04896086|454933636|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
126446189|NCT04896086|454933637|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
126446190|NCT04896086|454933638|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
126446191|NCT04896086|454933639|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
126446192|NCT04896086|454933640|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
126446193|NCT02249832|454933643|FG000|Overall Study|Withdrawal by Subject|3|||
126446194|NCT02249832|454933643|FG000|Overall Study|Lost to Follow-up|10|||
126446195|NCT02563067|454933650|FG000|Overall Study|Subject/guardian decision|14|||
126356437|NCT00724893|454597834|FG001|Overall Study|Geographic reasons|11|||
126356438|NCT00724893|454597833|FG000|Overall Study|Incarceration|0|||
126356439|NCT00724893|454597834|FG001|Overall Study|Incarceration|9|||
126356440|NCT00724893|454597833|FG000|Overall Study|Substance abuse|0|||
126356441|NCT00724893|454597834|FG001|Overall Study|Substance abuse|3|||
126356442|NCT00724893|454597833|FG000|Overall Study|Financial reasons|0|||
126356443|NCT00724893|454597834|FG001|Overall Study|Financial reasons|2|||
126356444|NCT00724893|454597833|FG000|Overall Study|Assigned shorter treatment|0|||
126356445|NCT00724893|454597834|FG001|Overall Study|Assigned shorter treatment|2|||
126446196|NCT02563067|454933651|FG001|Overall Study|Subject/guardian decision|20|||
126693912|NCT03186989|455833378|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126693913|NCT03186989|455833379|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
126693914|NCT03186989|455833380|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126693915|NCT03186989|455833381|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
126693916|NCT00865020|455833390|FG000|Overall Study|Withdrawal by Subject|22|||
126693917|NCT00865020|455833391|FG001|Overall Study|Withdrawal by Subject|16|||
126693918|NCT00865020|455833390|FG000|Overall Study|Adverse Event|9|||
126693919|NCT00865020|455833391|FG001|Overall Study|Adverse Event|14|||
126356446|NCT00724893|454597833|FG000|Overall Study|Lost to Follow-up|0|||
126356447|NCT00724893|454597834|FG001|Overall Study|Lost to Follow-up|52|||
126693920|NCT00865020|455833390|FG000|Overall Study|Abnormal test procedure result(s)|6|||
126693921|NCT00865020|455833391|FG001|Overall Study|Abnormal test procedure result(s)|8|||
126693922|NCT00865020|455833390|FG000|Overall Study|Lost to Follow-up|6|||
126693923|NCT00865020|455833391|FG001|Overall Study|Lost to Follow-up|4|||
126693924|NCT00865020|455833390|FG000|Overall Study|Protocol deviation|4|||
126693925|NCT00865020|455833391|FG001|Overall Study|Protocol deviation|1|||
126693926|NCT00865020|455833390|FG000|Overall Study|Administrative problems|0|||
126760780|NCT00727246|456075792|FG003|Overall Study|incidental finding|1|||
126760781|NCT00727246|456075789|FG000|Overall Study|withdrawn|0|||
126760782|NCT00727246|456075790|FG001|Overall Study|withdrawn|0|||
126760783|NCT00727246|456075791|FG002|Overall Study|withdrawn|1|||
126760784|NCT00727246|456075792|FG003|Overall Study|withdrawn|0|||
126760785|NCT02696382|456075796|FG000|Overall Study|Death|7|||
126760786|NCT02696382|456075797|FG001|Overall Study|Death|2|||
126693927|NCT00865020|455833391|FG001|Overall Study|Administrative problems|2|||
126693928|NCT00865020|455833390|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126693929|NCT00865020|455833391|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126693930|NCT00865020|455833390|FG000|Overall Study|Death|0|||
126693931|NCT00865020|455833391|FG001|Overall Study|Death|1|||
126693932|NCT00865020|455833390|FG000|Overall Study|Randomized but discontinued|2|||
126693933|NCT00865020|455833391|FG001|Overall Study|Randomized but discontinued|4|||
126693934|NCT03641560|455833392|FG000|Overall Study|Withdrawal by Subject|6|||
126693935|NCT03641560|455833392|FG000|Overall Study|Progressive disease|40|||
126693936|NCT03641560|455833392|FG000|Overall Study|Death|6|||
126693937|NCT05900115|455834981|FG000|Overall Study|Lost to Follow-up|129|||
126693938|NCT05900115|455834982|FG001|Overall Study|Lost to Follow-up|98|||
126693939|NCT00619502|455834983|FG000|Overall Study|Lost to Follow-up|8|||
126693940|NCT00619502|455834984|FG001|Overall Study|Lost to Follow-up|10|||
126693941|NCT00771472|455834985|FG000|Overall Study|Physician Decision|2|||
126693942|NCT00771472|455834986|FG001|Overall Study|Physician Decision|3|||
126693943|NCT00771472|455834985|FG000|Overall Study|Progressive Disease|3|||
126693944|NCT00771472|455834986|FG001|Overall Study|Progressive Disease|1|||
126693945|NCT00771472|455834985|FG000|Overall Study|Protocol Violation|1|||
126693946|NCT00771472|455834986|FG001|Overall Study|Protocol Violation|0|||
126693947|NCT00880750|455834989|FG000|First Intervention|Adverse Event|1|||
126693948|NCT00880750|455834990|FG001|First Intervention|Adverse Event|0|||
126693949|NCT00880750|455834989|FG000|First Intervention|Unable to collect urine|4|||
126693950|NCT00880750|455834990|FG001|First Intervention|Unable to collect urine|0|||
126693951|NCT00880750|455834989|FG000|First Intervention|Non-compliance with meals|0|||
126693952|NCT00880750|455834990|FG001|First Intervention|Non-compliance with meals|1|||
126693953|NCT00880750|455834989|FG000|First Intervention|Withdrawal by Subject|2|||
126693954|NCT00880750|455834990|FG001|First Intervention|Withdrawal by Subject|0|||
126693955|NCT00880750|455834989|FG000|First Intervention|Lost to Follow-up|2|||
126693956|NCT00880750|455834990|FG001|First Intervention|Lost to Follow-up|0|||
126693957|NCT00880750|455834989|FG000|Second Intervention|Withdrawal by Subject|2|||
126693958|NCT00880750|455834990|FG001|Second Intervention|Withdrawal by Subject|2|||
126693959|NCT00880750|455834989|FG000|Second Intervention|Protocol Violation|1|||
126693960|NCT00880750|455834990|FG001|Second Intervention|Protocol Violation|0|||
126693961|NCT00880750|455834989|FG000|Second Intervention|Unable to collect urine|1|||
126693962|NCT00880750|455834990|FG001|Second Intervention|Unable to collect urine|0|||
126693963|NCT00483327|455834991|FG000|Overall Study|Adverse Event|1|||
126693964|NCT00483327|455834991|FG000|Overall Study|Withdrawal by Subject|3|||
126693965|NCT00483327|455834991|FG000|Overall Study|Lost to Follow-up|4|||
126693966|NCT00483327|455834991|FG000|Overall Study|Patient Non Compliance|2|||
126693967|NCT00670007|455834992|FG000|Overall Study|Drug abuse|1|||
126693968|NCT00670007|455834992|FG000|Overall Study|Lung transplant|1|||
126693969|NCT00670007|455834992|FG000|Overall Study|Travel/Vacation|1|||
126693970|NCT00670007|455834992|FG000|Overall Study|Adverse event, serious fatal|1|||
126693971|NCT00670007|455834992|FG000|Overall Study|Adverse Event|1|||
126693972|NCT00670007|455834992|FG000|Overall Study|Withdrawal by Subject|4|||
126693973|NCT00618722|455834993|FG000|Overall Study|Refusal of Treatment|0|||
126693974|NCT00618722|455834994|FG001|Overall Study|Refusal of Treatment|0|||
126760787|NCT02696382|456075796|FG000|Overall Study|Withdrawal by Subject|5|||
126693975|NCT00618722|455834995|FG002|Overall Study|Refusal of Treatment|1|||
126693976|NCT00618722|455834996|FG003|Overall Study|Refusal of Treatment|0|||
126693977|NCT00618722|455834993|FG000|Overall Study|Patient Request|1|||
126693978|NCT00618722|455834994|FG001|Overall Study|Patient Request|1|||
126693979|NCT00618722|455834995|FG002|Overall Study|Patient Request|1|||
126693980|NCT00618722|455834996|FG003|Overall Study|Patient Request|1|||
126693981|NCT00618722|455834993|FG000|Overall Study|Inability to Complete Study Procedure|0|||
126760788|NCT02696382|456075797|FG001|Overall Study|Withdrawal by Subject|12|||
126693982|NCT00618722|455834994|FG001|Overall Study|Inability to Complete Study Procedure|1|||
126693983|NCT00618722|455834995|FG002|Overall Study|Inability to Complete Study Procedure|0|||
126693984|NCT00618722|455834996|FG003|Overall Study|Inability to Complete Study Procedure|0|||
126693985|NCT00618722|455834993|FG000|Overall Study|Lost to Follow-up|2|||
126693986|NCT00618722|455834994|FG001|Overall Study|Lost to Follow-up|0|||
126693987|NCT00618722|455834995|FG002|Overall Study|Lost to Follow-up|0|||
126693988|NCT00618722|455834996|FG003|Overall Study|Lost to Follow-up|2|||
126693989|NCT00618722|455834993|FG000|Overall Study|Miscellaneous Reasons|0|||
126693990|NCT00618722|455834994|FG001|Overall Study|Miscellaneous Reasons|0|||
126693991|NCT00618722|455834995|FG002|Overall Study|Miscellaneous Reasons|1|||
126693992|NCT00618722|455834996|FG003|Overall Study|Miscellaneous Reasons|1|||
126693993|NCT00200057|455834999|FG000|Overall Study|Lack of Efficacy|3|||
126693994|NCT00200057|455834999|FG000|Overall Study|Exited due to terminal illness of PI|2|||
126760789|NCT02696382|456075796|FG000|Overall Study|Lost to Follow-up|4|||
126356448|NCT00724893|454597833|FG000|Overall Study|Unknown, missing data|1|||
126356449|NCT00724893|454597834|FG001|Overall Study|Unknown, missing data|1|||
126356450|NCT01078545|454597837|FG000|Overall Study|Lost to Follow-up|13|||
126356451|NCT01078545|454597837|FG000|Overall Study|Physician Decision|6|||
126356452|NCT01078545|454597837|FG000|Overall Study|Withdrawal by Subject|3|||
126760790|NCT02696382|456075797|FG001|Overall Study|Lost to Follow-up|7|||
126356453|NCT01078545|454597837|FG000|Overall Study|Death|3|||
126760791|NCT03781167|456075804|FG000|Overall Study|Adverse Event|23|||
126356454|NCT01078545|454597837|FG000|Overall Study|Participant moved to another physician|1|||
126356455|NCT01774370|454597840|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
126693995|NCT00200057|455834999|FG000|Overall Study|Withdrawal by Subject|1|||
126693996|NCT00200057|455834999|FG000|Overall Study|Change in medical condition|1|||
126693997|NCT00200057|455834999|FG000|Overall Study|Infection|1|||
126760792|NCT03781167|456075805|FG001|Overall Study|Adverse Event|25|||
126446197|NCT02563067|454933652|FG002|Overall Study|Subject/guardian decision|16|||
126446198|NCT02563067|454933650|FG000|Overall Study|Physician Decision|0|||
126446199|NCT02563067|454933651|FG001|Overall Study|Physician Decision|1|||
126446200|NCT02563067|454933652|FG002|Overall Study|Physician Decision|3|||
126446201|NCT02563067|454933650|FG000|Overall Study|Lost to Follow-up|1|||
126446202|NCT02563067|454933651|FG001|Overall Study|Lost to Follow-up|2|||
126446203|NCT02563067|454933652|FG002|Overall Study|Lost to Follow-up|0|||
126446204|NCT02563067|454933650|FG000|Overall Study|Technical problems|0|||
126446205|NCT02563067|454933651|FG001|Overall Study|Technical problems|1|||
126446206|NCT02563067|454933652|FG002|Overall Study|Technical problems|0|||
126446207|NCT02563067|454933650|FG000|Overall Study|Lack of Efficacy|1|||
126446208|NCT02563067|454933651|FG001|Overall Study|Lack of Efficacy|0|||
126446209|NCT02563067|454933652|FG002|Overall Study|Lack of Efficacy|0|||
126446210|NCT02563067|454933650|FG000|Overall Study|Death|0|||
126446211|NCT02563067|454933651|FG001|Overall Study|Death|1|||
126446212|NCT02563067|454933652|FG002|Overall Study|Death|1|||
126446213|NCT02563067|454933650|FG000|Overall Study|Adverse Event|2|||
126446214|NCT02563067|454933651|FG001|Overall Study|Adverse Event|1|||
126446215|NCT02563067|454933652|FG002|Overall Study|Adverse Event|0|||
126446216|NCT02563067|454933650|FG000|Overall Study|Death post Treatment/safety period|1|||
126446217|NCT02563067|454933651|FG001|Overall Study|Death post Treatment/safety period|0|||
126446218|NCT02563067|454933652|FG002|Overall Study|Death post Treatment/safety period|0|||
126446219|NCT03544333|454933658|FG000|Overall Study|Withdrawal by Subject|1|||
126446220|NCT03544333|454933659|FG001|Overall Study|Withdrawal by Subject|0|||
126446221|NCT01039519|454933664|FG000|Treatment|Progressive disease|20|||
126446222|NCT01039519|454933664|FG000|Treatment|Treatment failure|2|||
126446223|NCT01039519|454933664|FG000|Treatment|Adverse Event|3|||
126446224|NCT01039519|454933664|FG000|Treatment|Physician Decision|2|||
126446225|NCT01039519|454933664|FG000|Survival Follow-up|Death|23|||
126693998|NCT00200057|455834999|FG000|Overall Study|Death|1|||
126693999|NCT02965716|455835000|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
126694000|NCT02965716|455835001|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
126694001|NCT02965716|455835000|FG000|Overall Study|Progression/Relapse|8|||
126694002|NCT02965716|455835001|FG001|Overall Study|Progression/Relapse|16|||
126694003|NCT02965716|455835000|FG000|Overall Study|Death|1|||
126446226|NCT01039519|454933664|FG000|Survival Follow-up|Sponsor decision|4|||
126446227|NCT03052400|454933670|FG000|Overall Study|Lost to Follow-up|1|||
126446228|NCT03052400|454933671|FG001|Overall Study|Lost to Follow-up|0|||
126694004|NCT02965716|455835001|FG001|Overall Study|Death|0|||
126446229|NCT03052400|454933670|FG000|Overall Study|Withdrawal by Subject|0|||
126446230|NCT03052400|454933671|FG001|Overall Study|Withdrawal by Subject|1|||
126694005|NCT02965716|455835000|FG000|Overall Study|Not Protocol Specified|1|||
126446231|NCT00555061|454933672|FG000|Overall Study|Adverse Event|3|||
126446232|NCT00555061|454933672|FG000|Overall Study|Protocol Violation|1|||
126446233|NCT00555061|454933672|FG000|Overall Study|Lost to Follow-up|2|||
126446234|NCT00555061|454933672|FG000|Overall Study|Withdrawal by Subject|2|||
126446235|NCT00555061|454933672|FG000|Overall Study|Participant enrolled, but never treated|1|||
126446236|NCT00485134|454933674|FG000|Overall Study|Lost to Follow-up|1|||
126446237|NCT00485134|454933675|FG001|Overall Study|Lost to Follow-up|0|||
126446238|NCT00485134|454933676|FG002|Overall Study|Lost to Follow-up|0|||
126694006|NCT02965716|455835001|FG001|Overall Study|Not Protocol Specified|3|||
126694007|NCT03609619|455835005|FG000|Overall Study|Adverse Event|1|||
126694008|NCT03609619|455835006|FG001|Overall Study|Adverse Event|0|||
126694009|NCT03609619|455835005|FG000|Overall Study|Lack of Efficacy|1|||
126694010|NCT03609619|455835006|FG001|Overall Study|Lack of Efficacy|2|||
126356456|NCT01774370|454597840|FG000|Overall Study|Administered prior to the contract date|4|||
126356457|NCT01774370|454597840|FG000|Overall Study|Subjects of contraindications|34|||
126356458|NCT01774370|454597840|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
126356459|NCT01774370|454597840|FG000|Overall Study|Follow-up failure|34|||
126356460|NCT05436288|454597841|FG000|Overall Study|Lost to Follow-up|1|||
126356461|NCT05436288|454597841|FG000|Overall Study|Adverse Event|1|||
126356462|NCT01436500|454597845|FG000|Overall Study|Death|1|||
126356463|NCT01436500|454597846|FG001|Overall Study|Death|0|||
126356464|NCT01436500|454597847|FG002|Overall Study|Death|0|||
126356465|NCT01436500|454597848|FG003|Overall Study|Death|0|||
126356466|NCT01436500|454597849|FG004|Overall Study|Death|0|||
126356467|NCT01436500|454597845|FG000|Overall Study|Adverse Event|0|||
126356468|NCT01436500|454597846|FG001|Overall Study|Adverse Event|2|||
126356469|NCT01436500|454597847|FG002|Overall Study|Adverse Event|2|||
126356470|NCT01436500|454597848|FG003|Overall Study|Adverse Event|0|||
126356471|NCT01436500|454597849|FG004|Overall Study|Adverse Event|1|||
126356472|NCT01436500|454597845|FG000|Overall Study|Withdrawal by Subject|0|||
126356473|NCT01436500|454597846|FG001|Overall Study|Withdrawal by Subject|0|||
126356474|NCT01436500|454597847|FG002|Overall Study|Withdrawal by Subject|2|||
126356475|NCT01436500|454597848|FG003|Overall Study|Withdrawal by Subject|0|||
126356476|NCT01436500|454597849|FG004|Overall Study|Withdrawal by Subject|2|||
126356477|NCT01436500|454597845|FG000|Overall Study|Physician Decision|0|||
126356478|NCT01436500|454597846|FG001|Overall Study|Physician Decision|0|||
126356479|NCT01436500|454597847|FG002|Overall Study|Physician Decision|1|||
126356480|NCT01436500|454597848|FG003|Overall Study|Physician Decision|0|||
126356481|NCT01436500|454597849|FG004|Overall Study|Physician Decision|0|||
126356482|NCT01436500|454597845|FG000|Overall Study|liver transplant|1|||
126356483|NCT01436500|454597846|FG001|Overall Study|liver transplant|0|||
126356484|NCT01436500|454597847|FG002|Overall Study|liver transplant|0|||
126446239|NCT00485134|454933677|FG003|Overall Study|Lost to Follow-up|0|||
126446240|NCT00485134|454933678|FG004|Overall Study|Lost to Follow-up|0|||
126694011|NCT03609619|455835005|FG000|Overall Study|Protocol Violation|5|||
126356485|NCT01436500|454597848|FG003|Overall Study|liver transplant|0|||
126356486|NCT01436500|454597849|FG004|Overall Study|liver transplant|0|||
126356487|NCT01436500|454597845|FG000|Overall Study|initiation of dialysis|0|||
126356488|NCT01436500|454597846|FG001|Overall Study|initiation of dialysis|0|||
126356489|NCT01436500|454597847|FG002|Overall Study|initiation of dialysis|0|||
126356490|NCT01436500|454597848|FG003|Overall Study|initiation of dialysis|0|||
126694012|NCT03609619|455835006|FG001|Overall Study|Protocol Violation|0|||
126694013|NCT03609619|455835005|FG000|Overall Study|Withdrawal by Subject|2|||
126694014|NCT03609619|455835006|FG001|Overall Study|Withdrawal by Subject|3|||
126446241|NCT00485134|454933679|FG005|Overall Study|Lost to Follow-up|0|||
126446242|NCT00485134|454933680|FG006|Overall Study|Lost to Follow-up|0|||
126446243|NCT00485134|454933681|FG007|Overall Study|Lost to Follow-up|0|||
126446244|NCT00485134|454933674|FG000|Overall Study|Withdrawal by Subject|0|||
126446245|NCT00485134|454933675|FG001|Overall Study|Withdrawal by Subject|1|||
126446246|NCT00485134|454933676|FG002|Overall Study|Withdrawal by Subject|0|||
126446247|NCT00485134|454933677|FG003|Overall Study|Withdrawal by Subject|0|||
126446248|NCT00485134|454933678|FG004|Overall Study|Withdrawal by Subject|0|||
126446249|NCT00485134|454933679|FG005|Overall Study|Withdrawal by Subject|0|||
126446250|NCT00485134|454933680|FG006|Overall Study|Withdrawal by Subject|0|||
126446251|NCT00485134|454933681|FG007|Overall Study|Withdrawal by Subject|0|||
126446252|NCT00485134|454933674|FG000|Overall Study|Change in health status|0|||
126446253|NCT00485134|454933675|FG001|Overall Study|Change in health status|1|||
126446254|NCT00485134|454933676|FG002|Overall Study|Change in health status|2|||
126446255|NCT00485134|454933677|FG003|Overall Study|Change in health status|1|||
126446256|NCT00485134|454933678|FG004|Overall Study|Change in health status|0|||
126446257|NCT00485134|454933679|FG005|Overall Study|Change in health status|1|||
126446258|NCT00485134|454933680|FG006|Overall Study|Change in health status|0|||
126446259|NCT00485134|454933681|FG007|Overall Study|Change in health status|0|||
126446260|NCT00485134|454933674|FG000|Overall Study|Withdrew for adverse event|0|||
126446261|NCT00485134|454933675|FG001|Overall Study|Withdrew for adverse event|0|||
126446262|NCT00485134|454933676|FG002|Overall Study|Withdrew for adverse event|1|||
126446263|NCT00485134|454933677|FG003|Overall Study|Withdrew for adverse event|0|||
126446264|NCT00485134|454933678|FG004|Overall Study|Withdrew for adverse event|0|||
126446265|NCT00485134|454933679|FG005|Overall Study|Withdrew for adverse event|0|||
126446266|NCT00485134|454933680|FG006|Overall Study|Withdrew for adverse event|0|||
126446267|NCT00485134|454933681|FG007|Overall Study|Withdrew for adverse event|0|||
126446268|NCT00485134|454933674|FG000|Overall Study|Positive drug test|0|||
126446269|NCT00485134|454933675|FG001|Overall Study|Positive drug test|0|||
126446270|NCT00485134|454933676|FG002|Overall Study|Positive drug test|0|||
126446271|NCT00485134|454933677|FG003|Overall Study|Positive drug test|0|||
126446272|NCT00485134|454933678|FG004|Overall Study|Positive drug test|2|||
126446273|NCT00485134|454933679|FG005|Overall Study|Positive drug test|1|||
126446274|NCT00485134|454933680|FG006|Overall Study|Positive drug test|0|||
126446275|NCT00485134|454933681|FG007|Overall Study|Positive drug test|0|||
126446276|NCT00485134|454933674|FG000|Overall Study|Non-compliance|0|||
126446277|NCT00485134|454933675|FG001|Overall Study|Non-compliance|0|||
126446278|NCT00485134|454933676|FG002|Overall Study|Non-compliance|0|||
126446279|NCT00485134|454933677|FG003|Overall Study|Non-compliance|0|||
126446280|NCT00485134|454933678|FG004|Overall Study|Non-compliance|1|||
126446281|NCT00485134|454933679|FG005|Overall Study|Non-compliance|2|||
126446282|NCT00485134|454933680|FG006|Overall Study|Non-compliance|2|||
126446283|NCT00485134|454933681|FG007|Overall Study|Non-compliance|0|||
126446284|NCT00485134|454933674|FG000|Overall Study|Unable to comply with study schedule|0|||
126446285|NCT00485134|454933675|FG001|Overall Study|Unable to comply with study schedule|0|||
126446286|NCT00485134|454933676|FG002|Overall Study|Unable to comply with study schedule|0|||
126446287|NCT00485134|454933677|FG003|Overall Study|Unable to comply with study schedule|0|||
126446288|NCT00485134|454933678|FG004|Overall Study|Unable to comply with study schedule|0|||
126446289|NCT00485134|454933679|FG005|Overall Study|Unable to comply with study schedule|0|||
126446290|NCT00485134|454933680|FG006|Overall Study|Unable to comply with study schedule|0|||
126446291|NCT00485134|454933681|FG007|Overall Study|Unable to comply with study schedule|1|||
126446292|NCT00485134|454933674|FG000|Overall Study|Pregnancy|0|||
126446293|NCT00485134|454933675|FG001|Overall Study|Pregnancy|0|||
126446294|NCT00485134|454933676|FG002|Overall Study|Pregnancy|0|||
126446295|NCT00485134|454933677|FG003|Overall Study|Pregnancy|0|||
126446296|NCT00485134|454933678|FG004|Overall Study|Pregnancy|0|||
126446297|NCT00485134|454933679|FG005|Overall Study|Pregnancy|0|||
126446298|NCT00485134|454933680|FG006|Overall Study|Pregnancy|1|||
126446299|NCT00485134|454933681|FG007|Overall Study|Pregnancy|0|||
126446300|NCT00970684|454933682|FG000|Overall Study|Lack of Efficacy|5|||
126446301|NCT00970684|454933682|FG000|Overall Study|Adverse Event|4|||
126446302|NCT00970684|454933682|FG000|Overall Study|Withdrawal by Subject|1|||
126446303|NCT00481091|454933683|FG000|Overall Study|Withdrawal by Subject|0|||
126446304|NCT00481091|454933684|FG001|Overall Study|Withdrawal by Subject|1|||
126446305|NCT00481091|454933685|FG002|Overall Study|Withdrawal by Subject|1|||
126446306|NCT00481091|454933686|FG003|Overall Study|Withdrawal by Subject|0|||
126446307|NCT00481091|454933687|FG004|Overall Study|Withdrawal by Subject|0|||
126446308|NCT00481091|454933688|FG005|Overall Study|Withdrawal by Subject|0|||
126446309|NCT00481091|454933689|FG006|Overall Study|Withdrawal by Subject|0|||
126446310|NCT00481091|454933690|FG007|Overall Study|Withdrawal by Subject|0|||
126446311|NCT00481091|454933691|FG008|Overall Study|Withdrawal by Subject|1|||
126446312|NCT00481091|454933692|FG009|Overall Study|Withdrawal by Subject|6|||
126694015|NCT03609619|455835005|FG000|Overall Study|Lost to Follow-up|1|||
126446313|NCT00481091|454933683|FG000|Overall Study|Other, Not Specified|0|||
126694016|NCT03609619|455835006|FG001|Overall Study|Lost to Follow-up|1|||
126694017|NCT00956943|455835007|FG000|Overall Study|Lost to Follow-up|9|||
126694018|NCT00956943|455835008|FG001|Overall Study|Lost to Follow-up|10|||
126694019|NCT01400932|455835012|FG000|Overall Study|Adverse Event|10|||
126694020|NCT01400932|455835013|FG001|Overall Study|Adverse Event|5|||
126694021|NCT01400932|455835012|FG000|Overall Study|Lack of Efficacy|0|||
126694022|NCT01400932|455835013|FG001|Overall Study|Lack of Efficacy|3|||
126694023|NCT01400932|455835012|FG000|Overall Study|Withdrawal by Subject|2|||
126694024|NCT01400932|455835013|FG001|Overall Study|Withdrawal by Subject|6|||
126694025|NCT01400932|455835012|FG000|Overall Study|Lost to Follow-up|1|||
126694026|NCT01400932|455835013|FG001|Overall Study|Lost to Follow-up|0|||
126694027|NCT01400932|455835012|FG000|Overall Study|Protocol Deviation|0|||
126694028|NCT01400932|455835013|FG001|Overall Study|Protocol Deviation|1|||
126694029|NCT01400932|455835012|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126694030|NCT01400932|455835013|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126694031|NCT03244059|455835015|FG000|Specific Aim 1|Physician Decision|1|||
126694032|NCT03244059|455835016|FG001|Specific Aim 1|Physician Decision|0|||
126694033|NCT03244059|455835015|FG000|Specific Aim 2|Physician Decision|1|||
126694034|NCT03244059|455835016|FG001|Specific Aim 2|Physician Decision|0|||
126694035|NCT01276821|455835017|FG000|Overall Study|Protocol Violation|0|||
126694036|NCT01276821|455835018|FG001|Overall Study|Protocol Violation|1|||
126694037|NCT00605267|455835019|FG000|Overall Study|Adverse Event|0|||
126694038|NCT00605267|455835020|FG001|Overall Study|Adverse Event|1|||
126694039|NCT00605267|455835019|FG000|Overall Study|Lack of Efficacy|1|||
126694040|NCT00605267|455835020|FG001|Overall Study|Lack of Efficacy|5|||
126694041|NCT00605267|455835019|FG000|Overall Study|Withdrawal by Subject|2|||
126694042|NCT00605267|455835020|FG001|Overall Study|Withdrawal by Subject|3|||
126694043|NCT02939131|455835021|FG000|Overall Study|Unable to get to clinic|6|||
126694044|NCT02939131|455835022|FG001|Overall Study|Unable to get to clinic|4|||
126694045|NCT02939131|455835021|FG000|Overall Study|Lost to Follow-up|2|||
126694046|NCT02939131|455835022|FG001|Overall Study|Lost to Follow-up|4|||
126694047|NCT02939131|455835021|FG000|Overall Study|severe debilitation|1|||
126694048|NCT02939131|455835022|FG001|Overall Study|severe debilitation|0|||
126694049|NCT02939131|455835021|FG000|Overall Study|Other|0|||
126694050|NCT02939131|455835022|FG001|Overall Study|Other|1|||
126694051|NCT02939131|455835021|FG000|Overall Study|not willing to adhere to protocol|2|||
126694052|NCT02939131|455835022|FG001|Overall Study|not willing to adhere to protocol|0|||
126694053|NCT02720757|455835023|FG000|Overall Study|Other reason|5|||
126694054|NCT02720757|455835023|FG000|Overall Study|Loss of contact|4|||
126694055|NCT02720757|455835023|FG000|Overall Study|Informed consent withdrawal|1|||
126694056|NCT02720757|455835023|FG000|Overall Study|Patients wish to withdraw|2|||
126694057|NCT02720757|455835023|FG000|Overall Study|Missing|3|||
126694058|NCT02720757|455835023|FG000|Overall Study|General exclusion|3|||
126694059|NCT00883493|455835024|FG000|Overall Study|Adverse Event|11|||
126694060|NCT00883493|455835025|FG001|Overall Study|Adverse Event|12|||
126446314|NCT00481091|454933684|FG001|Overall Study|Other, Not Specified|1|||
126446315|NCT00481091|454933685|FG002|Overall Study|Other, Not Specified|1|||
126356491|NCT01436500|454597849|FG004|Overall Study|initiation of dialysis|1|||
126356492|NCT01436500|454597845|FG000|Overall Study|discontinued study drug|1|||
126356493|NCT01436500|454597846|FG001|Overall Study|discontinued study drug|0|||
126356494|NCT01436500|454597847|FG002|Overall Study|discontinued study drug|0|||
126356495|NCT01436500|454597848|FG003|Overall Study|discontinued study drug|0|||
126356496|NCT01436500|454597849|FG004|Overall Study|discontinued study drug|0|||
126356497|NCT01436500|454597845|FG000|Overall Study|Other|0|||
126356498|NCT01436500|454597846|FG001|Overall Study|Other|1|||
126356499|NCT01436500|454597847|FG002|Overall Study|Other|0|||
126356500|NCT01436500|454597848|FG003|Overall Study|Other|1|||
126356501|NCT01436500|454597849|FG004|Overall Study|Other|0|||
126356502|NCT01487161|454597853|FG000|Overall Study|Adverse Event|1|||
126356503|NCT01487161|454597854|FG001|Overall Study|Adverse Event|0|||
126356504|NCT01487161|454597855|FG002|Overall Study|Adverse Event|0|||
126356505|NCT01487161|454597856|FG003|Overall Study|Adverse Event|0|||
126356506|NCT01487161|454597853|FG000|Overall Study|Withdrawal by Subject|1|||
126356507|NCT01487161|454597854|FG001|Overall Study|Withdrawal by Subject|1|||
126356508|NCT01487161|454597855|FG002|Overall Study|Withdrawal by Subject|1|||
126356509|NCT01487161|454597856|FG003|Overall Study|Withdrawal by Subject|2|||
126356510|NCT01487161|454597853|FG000|Overall Study|missing data|0|||
126356511|NCT01487161|454597854|FG001|Overall Study|missing data|1|||
126356512|NCT01487161|454597855|FG002|Overall Study|missing data|0|||
126356513|NCT01487161|454597856|FG003|Overall Study|missing data|0|||
126356514|NCT02945046|454597857|FG000|Overall Study|Adverse Event|1|||
126356515|NCT02945046|454597858|FG001|Overall Study|Adverse Event|0|||
126356516|NCT02945046|454597859|FG002|Overall Study|Adverse Event|2|||
126356517|NCT02945046|454597857|FG000|Overall Study|Withdrawal by Subject|3|||
126356518|NCT02945046|454597858|FG001|Overall Study|Withdrawal by Subject|3|||
126356519|NCT02945046|454597859|FG002|Overall Study|Withdrawal by Subject|3|||
126356520|NCT02945046|454597857|FG000|Overall Study|Protocol Violation|2|||
126356521|NCT02945046|454597858|FG001|Overall Study|Protocol Violation|3|||
126356522|NCT02945046|454597859|FG002|Overall Study|Protocol Violation|2|||
126356523|NCT02945046|454597857|FG000|Overall Study|Lost to Follow-up|1|||
126356524|NCT02945046|454597858|FG001|Overall Study|Lost to Follow-up|1|||
126356525|NCT02945046|454597859|FG002|Overall Study|Lost to Follow-up|0|||
126356526|NCT02945046|454597857|FG000|Overall Study|Lack of Efficacy|1|||
126356527|NCT02945046|454597858|FG001|Overall Study|Lack of Efficacy|2|||
126356528|NCT02945046|454597859|FG002|Overall Study|Lack of Efficacy|1|||
126356529|NCT02945046|454597857|FG000|Overall Study|Other than specified|5|||
126356530|NCT02945046|454597858|FG001|Overall Study|Other than specified|4|||
126356531|NCT02945046|454597859|FG002|Overall Study|Other than specified|7|||
126356532|NCT03113136|454597860|FG000|Overall Study|Lost to Follow-up|22|||
126356533|NCT03113136|454597861|FG001|Overall Study|Lost to Follow-up|47|||
126356534|NCT03113136|454597862|FG002|Overall Study|Lost to Follow-up|54|||
126356535|NCT03113136|454597860|FG000|Overall Study|Withdrawal by Subject|4|||
126356536|NCT03113136|454597861|FG001|Overall Study|Withdrawal by Subject|13|||
126356537|NCT03113136|454597862|FG002|Overall Study|Withdrawal by Subject|14|||
126356538|NCT03113136|454597860|FG000|Overall Study|Ineligible|0|||
126356539|NCT03113136|454597861|FG001|Overall Study|Ineligible|2|||
126356540|NCT03113136|454597862|FG002|Overall Study|Ineligible|1|||
126356541|NCT03113136|454597860|FG000|Overall Study|Study Team Decision|1|||
126356542|NCT03113136|454597861|FG001|Overall Study|Study Team Decision|4|||
126694061|NCT00883493|455835024|FG000|Overall Study|Lack of Efficacy|4|||
126356543|NCT03113136|454597862|FG002|Overall Study|Study Team Decision|0|||
126356544|NCT02675452|454597863|FG000|Overall Study|Sponsor decision|0|||
126356545|NCT02675452|454597864|FG001|Overall Study|Sponsor decision|0|||
126356546|NCT02675452|454597865|FG002|Overall Study|Sponsor decision|0|||
126356547|NCT02675452|454597866|FG003|Overall Study|Sponsor decision|0|||
126446316|NCT00481091|454933686|FG003|Overall Study|Other, Not Specified|0|||
126446317|NCT00481091|454933687|FG004|Overall Study|Other, Not Specified|0|||
126446318|NCT00481091|454933688|FG005|Overall Study|Other, Not Specified|1|||
126446319|NCT00481091|454933689|FG006|Overall Study|Other, Not Specified|0|||
126446320|NCT00481091|454933690|FG007|Overall Study|Other, Not Specified|0|||
126446321|NCT00481091|454933691|FG008|Overall Study|Other, Not Specified|0|||
126446322|NCT00481091|454933692|FG009|Overall Study|Other, Not Specified|4|||
126446323|NCT00481091|454933683|FG000|Overall Study|Adverse Event|1|||
126446324|NCT00481091|454933684|FG001|Overall Study|Adverse Event|2|||
126446325|NCT00481091|454933685|FG002|Overall Study|Adverse Event|0|||
126446326|NCT00481091|454933686|FG003|Overall Study|Adverse Event|1|||
126446327|NCT00481091|454933687|FG004|Overall Study|Adverse Event|1|||
126446328|NCT00481091|454933688|FG005|Overall Study|Adverse Event|1|||
126446329|NCT00481091|454933689|FG006|Overall Study|Adverse Event|2|||
126446330|NCT00481091|454933690|FG007|Overall Study|Adverse Event|1|||
126446331|NCT00481091|454933691|FG008|Overall Study|Adverse Event|1|||
126446332|NCT00481091|454933692|FG009|Overall Study|Adverse Event|6|||
126446333|NCT00481091|454933683|FG000|Overall Study|Progressive disease clinical|0|||
126446334|NCT00481091|454933684|FG001|Overall Study|Progressive disease clinical|0|||
126446335|NCT00481091|454933685|FG002|Overall Study|Progressive disease clinical|0|||
126446336|NCT00481091|454933686|FG003|Overall Study|Progressive disease clinical|0|||
126446337|NCT00481091|454933687|FG004|Overall Study|Progressive disease clinical|0|||
126446338|NCT00481091|454933688|FG005|Overall Study|Progressive disease clinical|0|||
126446339|NCT00481091|454933689|FG006|Overall Study|Progressive disease clinical|0|||
126446340|NCT00481091|454933690|FG007|Overall Study|Progressive disease clinical|0|||
126446341|NCT00481091|454933691|FG008|Overall Study|Progressive disease clinical|1|||
126446342|NCT00481091|454933692|FG009|Overall Study|Progressive disease clinical|7|||
126446343|NCT00481091|454933683|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
126356548|NCT02675452|454597867|FG004|Overall Study|Sponsor decision|0|||
126356549|NCT02675452|454597868|FG005|Overall Study|Sponsor decision|0|||
126356550|NCT02675452|454597869|FG006|Overall Study|Sponsor decision|0|||
126356551|NCT02675452|454597870|FG007|Overall Study|Sponsor decision|0|||
126356552|NCT02675452|454597871|FG008|Overall Study|Sponsor decision|0|||
126356553|NCT02675452|454597872|FG009|Overall Study|Sponsor decision|1|||
126356554|NCT02675452|454597873|FG010|Overall Study|Sponsor decision|0|||
126356555|NCT02675452|454597874|FG011|Overall Study|Sponsor decision|0|||
126356556|NCT02675452|454597875|FG012|Overall Study|Sponsor decision|0|||
126356557|NCT02675452|454597876|FG013|Overall Study|Sponsor decision|2|||
126356558|NCT02675452|454597877|FG014|Overall Study|Sponsor decision|1|||
126356559|NCT02675452|454597878|FG015|Overall Study|Sponsor decision|0|||
126356560|NCT02675452|454597879|FG016|Overall Study|Sponsor decision|1|||
126356561|NCT02675452|454597880|FG017|Overall Study|Sponsor decision|0|||
126356562|NCT02675452|454597881|FG018|Overall Study|Sponsor decision|0|||
126356563|NCT02675452|454597882|FG019|Overall Study|Sponsor decision|0|||
126356564|NCT02675452|454597883|FG020|Overall Study|Sponsor decision|0|||
126356565|NCT02675452|454597884|FG021|Overall Study|Sponsor decision|0|||
126356566|NCT02675452|454597885|FG022|Overall Study|Sponsor decision|0|||
126356567|NCT02675452|454597886|FG023|Overall Study|Sponsor decision|0|||
126356568|NCT02675452|454597887|FG024|Overall Study|Sponsor decision|0|||
126356569|NCT02675452|454597888|FG025|Overall Study|Sponsor decision|0|||
126356570|NCT02675452|454597889|FG026|Overall Study|Sponsor decision|2|||
126356571|NCT02675452|454597890|FG027|Overall Study|Sponsor decision|0|||
126356572|NCT02675452|454597891|FG028|Overall Study|Sponsor decision|0|||
126356573|NCT02675452|454597863|FG000|Overall Study|Withdrawal by Subject|0|||
126356574|NCT02675452|454597864|FG001|Overall Study|Withdrawal by Subject|0|||
126356575|NCT02675452|454597865|FG002|Overall Study|Withdrawal by Subject|0|||
126356576|NCT02675452|454597866|FG003|Overall Study|Withdrawal by Subject|0|||
126356577|NCT02675452|454597867|FG004|Overall Study|Withdrawal by Subject|0|||
126694062|NCT00883493|455835025|FG001|Overall Study|Lack of Efficacy|3|||
126694063|NCT00883493|455835024|FG000|Overall Study|Lost to Follow-up|7|||
126356578|NCT02675452|454597868|FG005|Overall Study|Withdrawal by Subject|0|||
126356579|NCT02675452|454597869|FG006|Overall Study|Withdrawal by Subject|0|||
126356580|NCT02675452|454597870|FG007|Overall Study|Withdrawal by Subject|0|||
126356581|NCT02675452|454597871|FG008|Overall Study|Withdrawal by Subject|0|||
126356582|NCT02675452|454597872|FG009|Overall Study|Withdrawal by Subject|1|||
126356583|NCT02675452|454597873|FG010|Overall Study|Withdrawal by Subject|0|||
126356584|NCT02675452|454597874|FG011|Overall Study|Withdrawal by Subject|1|||
126356585|NCT02675452|454597875|FG012|Overall Study|Withdrawal by Subject|0|||
126760793|NCT03781167|456075804|FG000|Overall Study|Withdrew consent|16|||
126760794|NCT03781167|456075805|FG001|Overall Study|Withdrew consent|12|||
126760795|NCT03781167|456075804|FG000|Overall Study|Lost to Follow-up|0|||
126760796|NCT03781167|456075805|FG001|Overall Study|Lost to Follow-up|1|||
126760797|NCT03781167|456075804|FG000|Overall Study|Lack of Efficacy|4|||
126760798|NCT03781167|456075805|FG001|Overall Study|Lack of Efficacy|5|||
126760799|NCT03781167|456075804|FG000|Overall Study|Difficulty with drug delivery system|2|||
126760800|NCT03781167|456075805|FG001|Overall Study|Difficulty with drug delivery system|3|||
126760801|NCT03781167|456075804|FG000|Overall Study|Other, not specified|2|||
126760802|NCT03781167|456075805|FG001|Overall Study|Other, not specified|2|||
126760803|NCT01590628|456075813|FG000|Overall Study|Death|2|||
126760804|NCT01590628|456075814|FG001|Overall Study|Death|0|||
126760805|NCT00475657|456075815|FG000|Overall Study|Death|1|||
126760806|NCT00475657|456075815|FG000|Overall Study|Sponsor's Decision|3|||
126760807|NCT02992743|456075816|FG000|Overall Study|Withdrawal by Subject|1|||
126760808|NCT02992743|456075817|FG001|Overall Study|Withdrawal by Subject|1|||
126760809|NCT02992743|456075816|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
126760810|NCT02992743|456075817|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
126760811|NCT02992743|456075816|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
126760812|NCT02992743|456075817|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
126446344|NCT00481091|454933684|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
126760813|NCT02992743|456075816|FG000|Overall Study|No measurable disease|1|||
126760814|NCT02992743|456075817|FG001|Overall Study|No measurable disease|0|||
126760815|NCT02992743|456075816|FG000|Overall Study|Lost to Follow-up|0|||
126760816|NCT02992743|456075817|FG001|Overall Study|Lost to Follow-up|1|||
126446345|NCT00481091|454933685|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
126446346|NCT00481091|454933686|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
126446347|NCT00481091|454933687|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
126446348|NCT00481091|454933688|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
126446349|NCT00481091|454933689|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
126446350|NCT00481091|454933690|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
126446351|NCT00481091|454933691|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
126446352|NCT00481091|454933692|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
126446353|NCT00481091|454933683|FG000|Overall Study|Progressive disease other|1|||
126446354|NCT00481091|454933684|FG001|Overall Study|Progressive disease other|1|||
126694064|NCT00883493|455835025|FG001|Overall Study|Lost to Follow-up|6|||
126446355|NCT00481091|454933685|FG002|Overall Study|Progressive disease other|0|||
126694065|NCT00883493|455835024|FG000|Overall Study|Withdrawal by Subject|11|||
126694066|NCT00883493|455835025|FG001|Overall Study|Withdrawal by Subject|20|||
126694067|NCT00883493|455835024|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
126694068|NCT00883493|455835025|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
126694069|NCT00883493|455835024|FG000|Overall Study|Study specific disc. criteria|2|||
126446356|NCT00481091|454933686|FG003|Overall Study|Progressive disease other|1|||
126694070|NCT00883493|455835025|FG001|Overall Study|Study specific disc. criteria|0|||
126694071|NCT00883493|455835024|FG000|Overall Study|Other|5|||
126446357|NCT00481091|454933687|FG004|Overall Study|Progressive disease other|1|||
126446358|NCT00481091|454933688|FG005|Overall Study|Progressive disease other|1|||
126446359|NCT00481091|454933689|FG006|Overall Study|Progressive disease other|0|||
126446360|NCT00481091|454933690|FG007|Overall Study|Progressive disease other|2|||
126446361|NCT00481091|454933691|FG008|Overall Study|Progressive disease other|0|||
126446362|NCT00481091|454933692|FG009|Overall Study|Progressive disease other|0|||
126446363|NCT00481091|454933683|FG000|Overall Study|No reason given|0|||
126446364|NCT00481091|454933684|FG001|Overall Study|No reason given|0|||
126446365|NCT00481091|454933685|FG002|Overall Study|No reason given|1|||
126446366|NCT00481091|454933686|FG003|Overall Study|No reason given|1|||
126446367|NCT00481091|454933687|FG004|Overall Study|No reason given|1|||
126446368|NCT00481091|454933688|FG005|Overall Study|No reason given|0|||
126446369|NCT00481091|454933689|FG006|Overall Study|No reason given|1|||
126446370|NCT00481091|454933690|FG007|Overall Study|No reason given|1|||
126446371|NCT00481091|454933691|FG008|Overall Study|No reason given|1|||
126446372|NCT00481091|454933692|FG009|Overall Study|No reason given|4|||
126446373|NCT04294680|454933693|FG000|Overall Study|Withdrawal by Subject|2|||
126446374|NCT04294680|454933694|FG001|Overall Study|Withdrawal by Subject|1|||
126446375|NCT04294680|454933693|FG000|Overall Study|Follow-up visits completed outside of window|1|||
126446376|NCT04294680|454933694|FG001|Overall Study|Follow-up visits completed outside of window|0|||
126446377|NCT01296672|454933695|FG000|Overall Study|Lost to Follow-up|73|||
126446378|NCT01296672|454933696|FG001|Overall Study|Lost to Follow-up|18|||
126446379|NCT04027608|454933697|FG000|Overall Study|Withdrawal by Subject|13|||
126446380|NCT04027608|454933698|FG001|Overall Study|Withdrawal by Subject|2|||
126446381|NCT04027608|454933697|FG000|Overall Study|Protocol Violation|2|||
126446382|NCT04027608|454933698|FG001|Overall Study|Protocol Violation|1|||
126446383|NCT04027608|454933697|FG000|Overall Study|Physician Decision|1|||
126446384|NCT04027608|454933698|FG001|Overall Study|Physician Decision|0|||
126446385|NCT04027608|454933697|FG000|Overall Study|Lost to Follow-up|20|||
126446386|NCT04027608|454933698|FG001|Overall Study|Lost to Follow-up|4|||
126446387|NCT01349959|454933699|FG000|Overall Study|Adverse Event|7|||
126446388|NCT02675634|454933700|FG000|Test Period 1|Adverse Event|0|||
126446389|NCT02675634|454933701|FG001|Test Period 1|Adverse Event|1|||
126446390|NCT02675634|454933702|FG002|Test Period 1|Adverse Event|0|||
126446391|NCT02675634|454933703|FG003|Test Period 1|Adverse Event|1|||
126446392|NCT02675634|454933704|FG004|Test Period 1|Adverse Event|0|||
126446393|NCT02675634|454933705|FG005|Test Period 1|Adverse Event|0|||
126446394|NCT02675634|454933700|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
126446395|NCT02675634|454933701|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
126446396|NCT02675634|454933702|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
126446397|NCT02675634|454933703|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
126446398|NCT02675634|454933704|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
126446399|NCT02675634|454933705|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
126446400|NCT02675634|454933700|FG000|Test Period 2|Lack of Efficacy|1|||
126446401|NCT02675634|454933701|FG001|Test Period 2|Lack of Efficacy|0|||
126446402|NCT02675634|454933702|FG002|Test Period 2|Lack of Efficacy|0|||
126446403|NCT02675634|454933703|FG003|Test Period 2|Lack of Efficacy|0|||
126446404|NCT02675634|454933704|FG004|Test Period 2|Lack of Efficacy|0|||
126446405|NCT02675634|454933705|FG005|Test Period 2|Lack of Efficacy|0|||
126446406|NCT02675634|454933700|FG000|Test Period 2|Adverse Event|0|||
126446407|NCT02675634|454933701|FG001|Test Period 2|Adverse Event|0|||
126446408|NCT02675634|454933702|FG002|Test Period 2|Adverse Event|0|||
126446409|NCT02675634|454933703|FG003|Test Period 2|Adverse Event|0|||
126446410|NCT02675634|454933704|FG004|Test Period 2|Adverse Event|0|||
126446411|NCT02675634|454933705|FG005|Test Period 2|Adverse Event|1|||
126446412|NCT01652534|454933706|FG000|Overall Study|Lack of Efficacy|1|||
126446413|NCT01652534|454933707|FG001|Overall Study|Lack of Efficacy|0|||
126694072|NCT00883493|455835025|FG001|Overall Study|Other|3|||
126694073|NCT01084551|455835026|FG000|Overall Study|Adverse Event|2|||
126694074|NCT01084551|455835027|FG001|Overall Study|Adverse Event|9|||
126694075|NCT01084551|455835028|FG002|Overall Study|Adverse Event|4|||
126694076|NCT01084551|455835026|FG000|Overall Study|Lack of Efficacy|2|||
126446414|NCT03860259|454933708|FG000|Overall Study|Lost to Follow-up|5|||
126446415|NCT03860259|454933709|FG001|Overall Study|Lost to Follow-up|5|||
126446416|NCT03860259|454933708|FG000|Overall Study|Protocol Violation|1|||
126446417|NCT03860259|454933709|FG001|Overall Study|Protocol Violation|0|||
126446418|NCT00811018|454933710|FG000|Overall Study|Additional Chronic Treatment|31|||
126446419|NCT00811018|454933710|FG000|Overall Study|Adverse Event|79|||
126446420|NCT00811018|454933710|FG000|Overall Study|Death|147|||
126446421|NCT00811018|454933710|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
126446422|NCT00811018|454933710|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
126446423|NCT00811018|454933710|FG000|Overall Study|Investigator Decision|57|||
126446424|NCT00811018|454933710|FG000|Overall Study|Lost to Follow-up|19|||
126446425|NCT00811018|454933710|FG000|Overall Study|Pregnancy|6|||
126694077|NCT01084551|455835027|FG001|Overall Study|Lack of Efficacy|0|||
126694078|NCT01084551|455835028|FG002|Overall Study|Lack of Efficacy|1|||
126446426|NCT00811018|454933710|FG000|Overall Study|Sponsor Decision|450|||
126356586|NCT02675452|454597876|FG013|Overall Study|Withdrawal by Subject|1|||
126356587|NCT02675452|454597877|FG014|Overall Study|Withdrawal by Subject|1|||
126356588|NCT02675452|454597878|FG015|Overall Study|Withdrawal by Subject|0|||
126356589|NCT02675452|454597879|FG016|Overall Study|Withdrawal by Subject|2|||
126356590|NCT02675452|454597880|FG017|Overall Study|Withdrawal by Subject|0|||
126356591|NCT02675452|454597881|FG018|Overall Study|Withdrawal by Subject|0|||
126694079|NCT01084551|455835026|FG000|Overall Study|Withdrawal by Subject|2|||
126694080|NCT01084551|455835027|FG001|Overall Study|Withdrawal by Subject|1|||
126694081|NCT01084551|455835028|FG002|Overall Study|Withdrawal by Subject|0|||
126694082|NCT01084551|455835026|FG000|Overall Study|Protocol Violation|2|||
126694083|NCT01084551|455835027|FG001|Overall Study|Protocol Violation|4|||
126694084|NCT01084551|455835028|FG002|Overall Study|Protocol Violation|0|||
126694085|NCT01084551|455835026|FG000|Overall Study|Lost to Follow-up|0|||
126356592|NCT02675452|454597882|FG019|Overall Study|Withdrawal by Subject|0|||
126356593|NCT02675452|454597883|FG020|Overall Study|Withdrawal by Subject|0|||
126694086|NCT01084551|455835027|FG001|Overall Study|Lost to Follow-up|0|||
126694087|NCT01084551|455835028|FG002|Overall Study|Lost to Follow-up|3|||
126446427|NCT00811018|454933710|FG000|Overall Study|Withdrawal by Subject|70|||
126446428|NCT00811018|454933710|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
126446429|NCT00811018|454933710|FG000|Overall Study|Other|26|||
126446430|NCT00934362|454933714|FG000|Overall Study|Adverse Event|1|||
126446431|NCT00934362|454933715|FG001|Overall Study|Adverse Event|0|||
126446432|NCT03527732|454933716|FG000|Overall Study|Lost to Follow-up|21|||
126446433|NCT03527732|454933717|FG001|Overall Study|Lost to Follow-up|23|||
126446434|NCT03527732|454933718|FG002|Overall Study|Lost to Follow-up|80|||
126446435|NCT03527732|454933719|FG003|Overall Study|Lost to Follow-up|62|||
126446436|NCT03527732|454933720|FG004|Overall Study|Lost to Follow-up|12|||
126446437|NCT03527732|454933721|FG005|Overall Study|Lost to Follow-up|20|||
126446438|NCT02280408|454933722|FG000|Overall Study|Lost to Follow-up|0|||
126446439|NCT02280408|454933723|FG001|Overall Study|Lost to Follow-up|2|||
126446440|NCT02280408|454933724|FG002|Overall Study|Lost to Follow-up|0|||
126446441|NCT02280408|454933725|FG003|Overall Study|Lost to Follow-up|0|||
126446442|NCT01092117|454933726|FG000|Index Procedure to 1 Month|Death|1|||
126446443|NCT01092117|454933726|FG000|1 Month|Death|1|||
126446444|NCT01092117|454933726|FG000|1 Month|Withdrawal by Subject|1|||
126446445|NCT01092117|454933726|FG000|1 Month|Lost to Follow-up|1|||
126446446|NCT01092117|454933726|FG000|6 Months|Death|2|||
126446447|NCT01092117|454933726|FG000|6 Months|Withdrawal by Subject|3|||
126446448|NCT01092117|454933726|FG000|12 Month|Death|11|||
126446449|NCT01092117|454933726|FG000|12 Month|Withdrawal by Subject|2|||
126446450|NCT01092117|454933726|FG000|12 Month|Lost to Follow-up|1|||
126446451|NCT01092117|454933726|FG000|Year 2|Death|5|||
126446452|NCT01092117|454933726|FG000|Year 2|Withdrawal by Subject|4|||
126446453|NCT01092117|454933726|FG000|Year 2|Lost to Follow-up|1|||
126446454|NCT01092117|454933726|FG000|Year 3|Death|7|||
126446455|NCT01092117|454933726|FG000|Year 3|Withdrawal by Subject|9|||
126446456|NCT01092117|454933726|FG000|Year 3|Lost to Follow-up|3|||
126446457|NCT01092117|454933726|FG000|Year 4|Death|8|||
126446458|NCT01092117|454933726|FG000|Year 4|Withdrawal by Subject|4|||
126446459|NCT01092117|454933726|FG000|Year 4|Lost to Follow-up|4|||
126446460|NCT03710083|454933727|FG000|Overall Study|Withdrawal by Subject|2|||
126446461|NCT03710083|454933727|FG000|Overall Study|Unsuccessful Procedure|1|||
126446462|NCT05300763|454933728|FG000|Overall Study|Adverse Event|0|||
126446463|NCT05300763|454933729|FG001|Overall Study|Adverse Event|1|||
126446464|NCT05300763|454933728|FG000|Overall Study|Major Protocol Deviation|1|||
126446465|NCT05300763|454933729|FG001|Overall Study|Major Protocol Deviation|0|||
126446466|NCT05300763|454933728|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
126446467|NCT05300763|454933729|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
126446468|NCT00441064|454933734|FG000|Overall Study|Adverse Event|1|||
126446469|NCT00441064|454933735|FG001|Overall Study|Adverse Event|0|||
126446470|NCT00441064|454933734|FG000|Overall Study|Abnormal laboratory values|0|||
126446471|NCT00441064|454933735|FG001|Overall Study|Abnormal laboratory values|2|||
126446472|NCT00441064|454933734|FG000|Overall Study|Abnormal test procedure results|0|||
126446473|NCT00441064|454933735|FG001|Overall Study|Abnormal test procedure results|1|||
126446474|NCT00441064|454933734|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126446475|NCT00441064|454933735|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126446476|NCT00441064|454933734|FG000|Overall Study|Protocol Deviation|3|||
126446477|NCT00441064|454933735|FG001|Overall Study|Protocol Deviation|2|||
126446478|NCT00441064|454933734|FG000|Overall Study|Patient withdrew consent|5|||
126446479|NCT00441064|454933735|FG001|Overall Study|Patient withdrew consent|2|||
126446480|NCT00953056|454933736|FG000|Overall Study|Withdrew Consent|0|||
126446481|NCT00953056|454933737|FG001|Overall Study|Withdrew Consent|0|||
126446482|NCT00953056|454933738|FG002|Overall Study|Withdrew Consent|0|||
126446483|NCT00953056|454933739|FG003|Overall Study|Withdrew Consent|0|||
126446484|NCT00953056|454933740|FG004|Overall Study|Withdrew Consent|2|||
126446485|NCT00953056|454933741|FG005|Overall Study|Withdrew Consent|3|||
126446486|NCT00953056|454933736|FG000|Overall Study|Serious Adverse Event|0|||
126446487|NCT00953056|454933737|FG001|Overall Study|Serious Adverse Event|0|||
126446488|NCT00953056|454933738|FG002|Overall Study|Serious Adverse Event|0|||
126694088|NCT01084551|455835026|FG000|Overall Study|Physician Decision|1|||
126694089|NCT01084551|455835027|FG001|Overall Study|Physician Decision|0|||
126694090|NCT01084551|455835028|FG002|Overall Study|Physician Decision|0|||
126694091|NCT00463476|455835029|FG000|Overall Study|Withdrawal by Subject|1|||
126694092|NCT00463476|455835030|FG001|Overall Study|Withdrawal by Subject|2|||
126694093|NCT00463476|455835029|FG000|Overall Study|Lost to Follow-up|1|||
126694094|NCT00463476|455835030|FG001|Overall Study|Lost to Follow-up|1|||
126694095|NCT00988247|455835031|FG000|Overall Study|Adverse Event|17|||
126760817|NCT00761735|456075818|FG000|Overall Study|Lost to Follow-up|6|||
126760818|NCT00761735|456075818|FG000|Overall Study|Withdrawal by Subject|6|||
126760819|NCT00761735|456075818|FG000|Overall Study|Non-compliance with protocol|1|||
126760820|NCT00761735|456075818|FG000|Overall Study|Administrative|1|||
126760821|NCT00381680|456075821|FG000|Overall Study|Adverse Event|9|||
126760822|NCT00381680|456075822|FG001|Overall Study|Adverse Event|3|||
126760823|NCT00381680|456075821|FG000|Overall Study|Death|10|||
126760824|NCT00381680|456075822|FG001|Overall Study|Death|7|||
126760825|NCT00381680|456075821|FG000|Overall Study|Lost to Follow-up|3|||
126760826|NCT00381680|456075822|FG001|Overall Study|Lost to Follow-up|2|||
126760827|NCT00381680|456075821|FG000|Overall Study|Physician Decision|25|||
126760828|NCT00381680|456075822|FG001|Overall Study|Physician Decision|6|||
126760829|NCT00381680|456075821|FG000|Overall Study|Withdrawal by Subject|3|||
126760830|NCT00381680|456075822|FG001|Overall Study|Withdrawal by Subject|1|||
126760831|NCT00381680|456075821|FG000|Overall Study|Entry onto another COG Trial|1|||
126760832|NCT00381680|456075822|FG001|Overall Study|Entry onto another COG Trial|2|||
126760833|NCT00381680|456075821|FG000|Overall Study|Alternative Therapy|11|||
126760834|NCT00381680|456075822|FG001|Overall Study|Alternative Therapy|5|||
126760835|NCT00381680|456075821|FG000|Overall Study|Secondary Malignancy|3|||
126760836|NCT00381680|456075822|FG001|Overall Study|Secondary Malignancy|0|||
126760837|NCT00381680|456075821|FG000|Overall Study|Delay initiation|1|||
126760838|NCT00381680|456075822|FG001|Overall Study|Delay initiation|0|||
126760839|NCT00381680|456075821|FG000|Overall Study|Stem Cell Transplant|26|||
126760840|NCT00381680|456075822|FG001|Overall Study|Stem Cell Transplant|10|||
126760841|NCT00381680|456075821|FG000|Overall Study|Relapse|18|||
126760842|NCT00381680|456075822|FG001|Overall Study|Relapse|9|||
126760843|NCT00381680|456075821|FG000|Overall Study|Induction Failure|4|||
126760844|NCT00381680|456075822|FG001|Overall Study|Induction Failure|1|||
126760845|NCT00381680|456075821|FG000|Overall Study|Progression|1|||
126760846|NCT00381680|456075822|FG001|Overall Study|Progression|1|||
126760847|NCT00381680|456075821|FG000|Overall Study|Other not otherwise specified|7|||
126760848|NCT00381680|456075822|FG001|Overall Study|Other not otherwise specified|2|||
126694096|NCT00988247|455835032|FG001|Overall Study|Adverse Event|3|||
126694097|NCT00988247|455835031|FG000|Overall Study|Withdrawal by Subject|44|||
126694098|NCT00988247|455835032|FG001|Overall Study|Withdrawal by Subject|13|||
126694099|NCT00988247|455835031|FG000|Overall Study|Pregnancy|1|||
126694100|NCT00988247|455835032|FG001|Overall Study|Pregnancy|2|||
126694101|NCT00988247|455835031|FG000|Overall Study|Lost to Follow-up|11|||
126694102|NCT00988247|455835032|FG001|Overall Study|Lost to Follow-up|2|||
126694103|NCT00988247|455835031|FG000|Overall Study|Protocol Violation|4|||
126694104|NCT00988247|455835032|FG001|Overall Study|Protocol Violation|5|||
126694105|NCT00988247|455835031|FG000|Overall Study|Sponsor requested withdrawal|3|||
126694106|NCT00988247|455835032|FG001|Overall Study|Sponsor requested withdrawal|1|||
126694107|NCT00988247|455835031|FG000|Overall Study|Other|3|||
126694108|NCT00988247|455835032|FG001|Overall Study|Other|0|||
126694109|NCT04173741|455835033|FG000|Overall Study|IVC measurement cannot be done|1|||
126694110|NCT04173741|455835034|FG001|Overall Study|IVC measurement cannot be done|1|||
126694111|NCT00289913|455835035|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126694112|NCT00289913|455835036|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
126694113|NCT00289913|455835037|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126694114|NCT00289913|455835038|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126694115|NCT00289913|455835039|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126694116|NCT00289913|455835035|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
126694117|NCT00289913|455835036|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
126694118|NCT00289913|455835037|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
126694119|NCT00289913|455835038|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
126694120|NCT00289913|455835039|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
126694121|NCT00289913|455835035|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
126694122|NCT00289913|455835036|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
126694123|NCT00289913|455835037|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126694124|NCT00289913|455835038|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
126760849|NCT00381680|456075821|FG000|Overall Study|Ineligible|3|||
126760850|NCT00381680|456075822|FG001|Overall Study|Ineligible|1|||
126760851|NCT03290131|456075823|FG000|Overall Study|Adverse Event|22|||
126760852|NCT03290131|456075824|FG001|Overall Study|Adverse Event|57|||
126760853|NCT03290131|456075825|FG002|Overall Study|Adverse Event|11|||
126356594|NCT02675452|454597884|FG021|Overall Study|Withdrawal by Subject|0|||
126356595|NCT02675452|454597885|FG022|Overall Study|Withdrawal by Subject|3|||
126356596|NCT02675452|454597886|FG023|Overall Study|Withdrawal by Subject|0|||
126356597|NCT02675452|454597887|FG024|Overall Study|Withdrawal by Subject|1|||
126356598|NCT02675452|454597888|FG025|Overall Study|Withdrawal by Subject|0|||
126356599|NCT02675452|454597889|FG026|Overall Study|Withdrawal by Subject|1|||
126694125|NCT00289913|455835039|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
126694126|NCT00289913|455835035|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
126356600|NCT02675452|454597890|FG027|Overall Study|Withdrawal by Subject|3|||
126356601|NCT02675452|454597891|FG028|Overall Study|Withdrawal by Subject|4|||
126694127|NCT00289913|455835036|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
126694128|NCT00289913|455835037|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
126694129|NCT00289913|455835038|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
126694130|NCT00289913|455835039|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
126694131|NCT00289913|455835035|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126694132|NCT00289913|455835036|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126694133|NCT00289913|455835037|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126694134|NCT00289913|455835038|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
126694135|NCT00289913|455835039|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126694136|NCT00289913|455835035|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
126694137|NCT00289913|455835036|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
126694138|NCT00289913|455835037|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
126694139|NCT00289913|455835038|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
126694140|NCT00289913|455835039|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
126694141|NCT00289913|455835035|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
126694142|NCT00289913|455835036|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
126760854|NCT03290131|456075823|FG000|Overall Study|Withdrawal by Subject|18|||
126760855|NCT03290131|456075824|FG001|Overall Study|Withdrawal by Subject|13|||
126760856|NCT03290131|456075825|FG002|Overall Study|Withdrawal by Subject|8|||
126760857|NCT03290131|456075823|FG000|Overall Study|MS Relapse|2|||
126760858|NCT03290131|456075824|FG001|Overall Study|MS Relapse|1|||
126760859|NCT03290131|456075825|FG002|Overall Study|MS Relapse|0|||
126760860|NCT03290131|456075823|FG000|Overall Study|Unknown reason|0|||
126760861|NCT03290131|456075824|FG001|Overall Study|Unknown reason|1|||
126760862|NCT03290131|456075825|FG002|Overall Study|Unknown reason|0|||
126760863|NCT03099096|456075828|FG000|Overall Study|Adverse Event|1|||
126760864|NCT03099096|456075828|FG000|Overall Study|Physician Decision|1|||
126760865|NCT02190604|456075835|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760866|NCT02190604|456075836|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760867|NCT02190604|456075837|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760868|NCT02190604|456075838|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760869|NCT02190604|456075839|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760870|NCT02190604|456075840|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760871|NCT02190604|456075841|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760872|NCT02190604|456075842|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760873|NCT02190604|456075843|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760874|NCT02190604|456075844|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760875|NCT02190604|456075845|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760876|NCT02190604|456075846|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760877|NCT02190604|456075847|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760878|NCT02190604|456075848|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126446489|NCT00953056|454933739|FG003|Overall Study|Serious Adverse Event|0|||
126446490|NCT00953056|454933740|FG004|Overall Study|Serious Adverse Event|0|||
126446491|NCT00953056|454933741|FG005|Overall Study|Serious Adverse Event|1|||
126446492|NCT03962504|454933742|FG000|Overall Study|Other|11|||
126446493|NCT03962504|454933743|FG001|Overall Study|Other|32|||
126446494|NCT01077076|454933744|FG000|First Intervention|Withdrawal by Subject|1|||
126446495|NCT01077076|454933745|FG001|First Intervention|Withdrawal by Subject|0|||
126446496|NCT01077076|454933746|FG002|First Intervention|Withdrawal by Subject|0|||
126446497|NCT01077076|454933747|FG003|First Intervention|Withdrawal by Subject|0|||
126446498|NCT01077076|454933748|FG004|First Intervention|Withdrawal by Subject|0|||
126446499|NCT01077076|454933749|FG005|First Intervention|Withdrawal by Subject|0|||
126446500|NCT01077076|454933744|FG000|Third Intervention|Death in the participant's family|0|||
126694143|NCT00289913|455835037|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
126760879|NCT02190604|456075849|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
126760880|NCT02190604|456075850|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760881|NCT02190604|456075851|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126356602|NCT02675452|454597863|FG000|Overall Study|Death|0|||
126356603|NCT02675452|454597864|FG001|Overall Study|Death|0|||
126356604|NCT02675452|454597865|FG002|Overall Study|Death|1|||
126356605|NCT02675452|454597866|FG003|Overall Study|Death|0|||
126356606|NCT02675452|454597867|FG004|Overall Study|Death|0|||
126356607|NCT02675452|454597868|FG005|Overall Study|Death|1|||
126356608|NCT02675452|454597869|FG006|Overall Study|Death|0|||
126356609|NCT02675452|454597870|FG007|Overall Study|Death|0|||
126356610|NCT02675452|454597871|FG008|Overall Study|Death|1|||
126356611|NCT02675452|454597872|FG009|Overall Study|Death|0|||
126356612|NCT02675452|454597873|FG010|Overall Study|Death|0|||
126356613|NCT02675452|454597874|FG011|Overall Study|Death|0|||
126356614|NCT02675452|454597875|FG012|Overall Study|Death|1|||
126356615|NCT02675452|454597876|FG013|Overall Study|Death|0|||
126356616|NCT02675452|454597877|FG014|Overall Study|Death|0|||
126356617|NCT02675452|454597878|FG015|Overall Study|Death|2|||
126356618|NCT02675452|454597879|FG016|Overall Study|Death|0|||
126356619|NCT02675452|454597880|FG017|Overall Study|Death|0|||
126356620|NCT02675452|454597881|FG018|Overall Study|Death|4|||
126356621|NCT02675452|454597882|FG019|Overall Study|Death|3|||
126356622|NCT02675452|454597883|FG020|Overall Study|Death|3|||
126356623|NCT02675452|454597884|FG021|Overall Study|Death|3|||
126356624|NCT02675452|454597885|FG022|Overall Study|Death|7|||
126356625|NCT02675452|454597886|FG023|Overall Study|Death|5|||
126356626|NCT02675452|454597887|FG024|Overall Study|Death|3|||
126356627|NCT02675452|454597888|FG025|Overall Study|Death|4|||
126694144|NCT00289913|455835038|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
126694145|NCT00289913|455835039|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
126694146|NCT00289913|455835035|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
126694147|NCT00289913|455835036|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
126356628|NCT02675452|454597889|FG026|Overall Study|Death|7|||
126356629|NCT02675452|454597890|FG027|Overall Study|Death|6|||
126694148|NCT00289913|455835037|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
126356630|NCT02675452|454597891|FG028|Overall Study|Death|9|||
126356631|NCT02675452|454597863|FG000|Overall Study|Lost to Follow-up|0|||
126356632|NCT02675452|454597864|FG001|Overall Study|Lost to Follow-up|1|||
126356633|NCT02675452|454597865|FG002|Overall Study|Lost to Follow-up|0|||
126356634|NCT02675452|454597866|FG003|Overall Study|Lost to Follow-up|0|||
126356635|NCT02675452|454597867|FG004|Overall Study|Lost to Follow-up|0|||
126760882|NCT02190604|456075852|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760883|NCT02190604|456075853|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
126760884|NCT02190604|456075835|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760885|NCT02190604|456075836|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760886|NCT02190604|456075837|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760887|NCT02190604|456075838|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760888|NCT02190604|456075839|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760889|NCT02190604|456075840|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760890|NCT02190604|456075841|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760891|NCT02190604|456075842|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760892|NCT02190604|456075843|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760893|NCT02190604|456075844|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760894|NCT02190604|456075845|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760895|NCT02190604|456075846|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760896|NCT02190604|456075847|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760897|NCT02190604|456075848|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
126760898|NCT02190604|456075849|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760899|NCT02190604|456075850|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760900|NCT02190604|456075851|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760901|NCT02190604|456075852|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126760902|NCT02190604|456075853|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
126446501|NCT01077076|454933745|FG001|Third Intervention|Death in the participant's family|0|||
126446502|NCT01077076|454933746|FG002|Third Intervention|Death in the participant's family|0|||
126446503|NCT01077076|454933747|FG003|Third Intervention|Death in the participant's family|0|||
126446504|NCT01077076|454933748|FG004|Third Intervention|Death in the participant's family|0|||
126446505|NCT01077076|454933749|FG005|Third Intervention|Death in the participant's family|1|||
126356636|NCT02675452|454597868|FG005|Overall Study|Lost to Follow-up|0|||
126356637|NCT02675452|454597869|FG006|Overall Study|Lost to Follow-up|0|||
126356638|NCT02675452|454597870|FG007|Overall Study|Lost to Follow-up|0|||
126356639|NCT02675452|454597871|FG008|Overall Study|Lost to Follow-up|0|||
126356640|NCT02675452|454597872|FG009|Overall Study|Lost to Follow-up|0|||
126356641|NCT02675452|454597873|FG010|Overall Study|Lost to Follow-up|0|||
126356642|NCT02675452|454597874|FG011|Overall Study|Lost to Follow-up|0|||
126356643|NCT02675452|454597875|FG012|Overall Study|Lost to Follow-up|1|||
126356644|NCT02675452|454597876|FG013|Overall Study|Lost to Follow-up|0|||
126356645|NCT02675452|454597877|FG014|Overall Study|Lost to Follow-up|0|||
126356646|NCT02675452|454597878|FG015|Overall Study|Lost to Follow-up|0|||
126356647|NCT02675452|454597879|FG016|Overall Study|Lost to Follow-up|0|||
126356648|NCT02675452|454597880|FG017|Overall Study|Lost to Follow-up|0|||
126356649|NCT02675452|454597881|FG018|Overall Study|Lost to Follow-up|0|||
126356650|NCT02675452|454597882|FG019|Overall Study|Lost to Follow-up|0|||
126356651|NCT02675452|454597883|FG020|Overall Study|Lost to Follow-up|0|||
126356652|NCT02675452|454597884|FG021|Overall Study|Lost to Follow-up|0|||
126446506|NCT01976741|454933750|FG000|Overall Study|Withdrawal by Subject|1|||
126446507|NCT01976741|454933751|FG001|Overall Study|Withdrawal by Subject|0|||
126446508|NCT01976741|454933752|FG002|Overall Study|Withdrawal by Subject|1|||
126446509|NCT01976741|454933753|FG003|Overall Study|Withdrawal by Subject|1|||
126694149|NCT00289913|455835038|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
126694150|NCT00289913|455835039|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
126694151|NCT00289913|455835035|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
126694152|NCT00289913|455835036|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126694153|NCT00289913|455835037|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
126694154|NCT00289913|455835038|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126694155|NCT00289913|455835039|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126694156|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126694157|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126694158|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
126694159|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126694160|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126694161|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
126694162|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
126694163|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
126694164|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
126694165|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
126694166|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
126694167|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
126694168|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
126694169|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
126694170|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
126694171|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
126694172|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
126694173|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
126694174|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126694175|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126694176|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
126694177|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126694178|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
126694179|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126694180|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126694181|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
126694182|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
126694183|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
126694184|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
126694185|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
126694186|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
126694187|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
126694188|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
126694189|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
126694190|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
126694191|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
126694192|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
126694193|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
126694194|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
126760903|NCT00764465|456075856|FG000|Overall Study|Adverse Event|2|||
126446510|NCT01976741|454933754|FG004|Overall Study|Withdrawal by Subject|0|||
126694195|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
126694196|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
126356653|NCT02675452|454597885|FG022|Overall Study|Lost to Follow-up|0|||
126356654|NCT02675452|454597886|FG023|Overall Study|Lost to Follow-up|0|||
126356655|NCT02675452|454597887|FG024|Overall Study|Lost to Follow-up|0|||
126356656|NCT02675452|454597888|FG025|Overall Study|Lost to Follow-up|0|||
126356657|NCT02675452|454597889|FG026|Overall Study|Lost to Follow-up|1|||
126356658|NCT02675452|454597890|FG027|Overall Study|Lost to Follow-up|0|||
126356659|NCT02675452|454597891|FG028|Overall Study|Lost to Follow-up|0|||
126356660|NCT02675452|454597863|FG000|Overall Study|Other|0|||
126356661|NCT02675452|454597864|FG001|Overall Study|Other|0|||
126356662|NCT02675452|454597865|FG002|Overall Study|Other|0|||
126356663|NCT02675452|454597866|FG003|Overall Study|Other|0|||
126356664|NCT02675452|454597867|FG004|Overall Study|Other|0|||
126356665|NCT02675452|454597868|FG005|Overall Study|Other|0|||
126694197|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
126694198|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
126694199|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
126694200|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
126694201|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
126694202|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
126760904|NCT00764465|456075857|FG001|Overall Study|Adverse Event|0|||
126446511|NCT01976741|454933755|FG005|Overall Study|Withdrawal by Subject|0|||
126446512|NCT01976741|454933756|FG006|Overall Study|Withdrawal by Subject|1|||
126446513|NCT01976741|454933757|FG007|Overall Study|Withdrawal by Subject|4|||
126446514|NCT01976741|454933758|FG008|Overall Study|Withdrawal by Subject|0|||
126446515|NCT01976741|454933759|FG009|Overall Study|Withdrawal by Subject|0|||
126446516|NCT01976741|454933750|FG000|Overall Study|Adverse Event|0|||
126446517|NCT01976741|454933751|FG001|Overall Study|Adverse Event|0|||
126446518|NCT01976741|454933752|FG002|Overall Study|Adverse Event|2|||
126446519|NCT01976741|454933753|FG003|Overall Study|Adverse Event|0|||
126446520|NCT01976741|454933754|FG004|Overall Study|Adverse Event|0|||
126446521|NCT01976741|454933755|FG005|Overall Study|Adverse Event|0|||
126446522|NCT01976741|454933756|FG006|Overall Study|Adverse Event|3|||
126446523|NCT01976741|454933757|FG007|Overall Study|Adverse Event|8|||
126446524|NCT01976741|454933758|FG008|Overall Study|Adverse Event|1|||
126446525|NCT01976741|454933759|FG009|Overall Study|Adverse Event|4|||
126446526|NCT00889720|454933760|FG000|Overall Study|Withdrawal by Subject|4|||
126446527|NCT00889720|454933760|FG000|Overall Study|Other|4|||
126446528|NCT00670306|454933761|FG000|Overall Study|Adverse Event|8|||
126446529|NCT00670306|454933761|FG000|Overall Study|Lack of Efficacy|10|||
126446530|NCT00670306|454933761|FG000|Overall Study|Withdrawal by Subject|9|||
126446531|NCT00670306|454933761|FG000|Overall Study|Physician Decision|1|||
126446532|NCT00670306|454933761|FG000|Overall Study|Lost to Follow-up|8|||
126446533|NCT00670306|454933761|FG000|Overall Study|incl/excl criterias did not meet|19|||
126446534|NCT01327482|454933762|FG000|Overall Study|Adverse Event|1|||
126446535|NCT00476229|454933763|FG000|Overall Study|Progressive shortness of breath|1|||
126446536|NCT04193189|454933765|FG000|Overall Study|Lost to Follow-up|9|||
126446537|NCT04193189|454933766|FG001|Overall Study|Lost to Follow-up|7|||
126446538|NCT04193189|454933767|FG002|Overall Study|Lost to Follow-up|9|||
126446539|NCT04193189|454933768|FG003|Overall Study|Lost to Follow-up|0|||
126446540|NCT04193189|454933765|FG000|Overall Study|Withdrawal by Subject|1|||
126446541|NCT04193189|454933766|FG001|Overall Study|Withdrawal by Subject|2|||
126446542|NCT04193189|454933767|FG002|Overall Study|Withdrawal by Subject|2|||
126446543|NCT04193189|454933768|FG003|Overall Study|Withdrawal by Subject|0|||
126446544|NCT04193189|454933765|FG000|Overall Study|Death|1|||
126446545|NCT04193189|454933766|FG001|Overall Study|Death|1|||
126446546|NCT04193189|454933767|FG002|Overall Study|Death|0|||
126446547|NCT04193189|454933768|FG003|Overall Study|Death|0|||
126446548|NCT04193189|454933765|FG000|Overall Study|Protocol Violation|0|||
126446549|NCT04193189|454933766|FG001|Overall Study|Protocol Violation|0|||
126446550|NCT04193189|454933767|FG002|Overall Study|Protocol Violation|0|||
126446551|NCT04193189|454933768|FG003|Overall Study|Protocol Violation|1|||
126446552|NCT01088048|454935531|FG000|Overall Study|Adverse Event|7|||
126446553|NCT01088048|454935532|FG001|Overall Study|Adverse Event|9|||
126446554|NCT01088048|454935533|FG002|Overall Study|Adverse Event|7|||
126446555|NCT01088048|454935534|FG003|Overall Study|Adverse Event|5|||
126446556|NCT01088048|454935535|FG004|Overall Study|Adverse Event|6|||
126446557|NCT01088048|454935536|FG005|Overall Study|Adverse Event|3|||
126446558|NCT01088048|454935537|FG006|Overall Study|Adverse Event|3|||
126446559|NCT01088048|454935538|FG007|Overall Study|Adverse Event|0|||
126446560|NCT01088048|454935539|FG008|Overall Study|Adverse Event|2|||
126446561|NCT01088048|454935540|FG009|Overall Study|Adverse Event|2|||
126446562|NCT01088048|454935531|FG000|Overall Study|Withdrew Consent|1|||
126446563|NCT01088048|454935532|FG001|Overall Study|Withdrew Consent|1|||
126446564|NCT01088048|454935533|FG002|Overall Study|Withdrew Consent|1|||
126446565|NCT01088048|454935534|FG003|Overall Study|Withdrew Consent|1|||
126446566|NCT01088048|454935535|FG004|Overall Study|Withdrew Consent|2|||
126446567|NCT01088048|454935536|FG005|Overall Study|Withdrew Consent|1|||
126446568|NCT01088048|454935537|FG006|Overall Study|Withdrew Consent|0|||
126446569|NCT01088048|454935538|FG007|Overall Study|Withdrew Consent|2|||
126446570|NCT01088048|454935539|FG008|Overall Study|Withdrew Consent|2|||
126446571|NCT01088048|454935540|FG009|Overall Study|Withdrew Consent|1|||
126446572|NCT01088048|454935531|FG000|Overall Study|Concomitant Medication Prohibited|1|||
126446573|NCT01088048|454935532|FG001|Overall Study|Concomitant Medication Prohibited|0|||
126446574|NCT01088048|454935533|FG002|Overall Study|Concomitant Medication Prohibited|0|||
126446575|NCT01088048|454935534|FG003|Overall Study|Concomitant Medication Prohibited|0|||
126446576|NCT01088048|454935535|FG004|Overall Study|Concomitant Medication Prohibited|0|||
126446577|NCT01088048|454935536|FG005|Overall Study|Concomitant Medication Prohibited|0|||
126446578|NCT01088048|454935537|FG006|Overall Study|Concomitant Medication Prohibited|0|||
126446579|NCT01088048|454935538|FG007|Overall Study|Concomitant Medication Prohibited|0|||
126446580|NCT01088048|454935539|FG008|Overall Study|Concomitant Medication Prohibited|0|||
126446581|NCT01088048|454935540|FG009|Overall Study|Concomitant Medication Prohibited|0|||
126446582|NCT01088048|454935531|FG000|Overall Study|Investigator Request|2|||
126446583|NCT01088048|454935532|FG001|Overall Study|Investigator Request|2|||
126446584|NCT01088048|454935533|FG002|Overall Study|Investigator Request|0|||
126446585|NCT01088048|454935534|FG003|Overall Study|Investigator Request|0|||
126446586|NCT01088048|454935535|FG004|Overall Study|Investigator Request|3|||
126446587|NCT01088048|454935536|FG005|Overall Study|Investigator Request|1|||
126446588|NCT01088048|454935537|FG006|Overall Study|Investigator Request|1|||
126446589|NCT01088048|454935538|FG007|Overall Study|Investigator Request|0|||
126446590|NCT01088048|454935539|FG008|Overall Study|Investigator Request|0|||
126446591|NCT01088048|454935540|FG009|Overall Study|Investigator Request|0|||
126446592|NCT01088048|454935531|FG000|Overall Study|Patient Non-compliance|0|||
126446593|NCT01088048|454935532|FG001|Overall Study|Patient Non-compliance|1|||
126446594|NCT01088048|454935533|FG002|Overall Study|Patient Non-compliance|0|||
126446595|NCT01088048|454935534|FG003|Overall Study|Patient Non-compliance|0|||
126446596|NCT01088048|454935535|FG004|Overall Study|Patient Non-compliance|0|||
126446597|NCT01088048|454935536|FG005|Overall Study|Patient Non-compliance|0|||
126446598|NCT01088048|454935537|FG006|Overall Study|Patient Non-compliance|0|||
126446599|NCT01088048|454935538|FG007|Overall Study|Patient Non-compliance|0|||
126446600|NCT01088048|454935539|FG008|Overall Study|Patient Non-compliance|0|||
126446601|NCT01088048|454935540|FG009|Overall Study|Patient Non-compliance|0|||
126446602|NCT01088048|454935531|FG000|Overall Study|Disease Progression|7|||
126446603|NCT01088048|454935532|FG001|Overall Study|Disease Progression|4|||
126446604|NCT01088048|454935533|FG002|Overall Study|Disease Progression|3|||
126446605|NCT01088048|454935534|FG003|Overall Study|Disease Progression|5|||
126446606|NCT01088048|454935535|FG004|Overall Study|Disease Progression|3|||
126446607|NCT01088048|454935536|FG005|Overall Study|Disease Progression|3|||
126446608|NCT01088048|454935537|FG006|Overall Study|Disease Progression|2|||
126446609|NCT01088048|454935538|FG007|Overall Study|Disease Progression|1|||
126446610|NCT01088048|454935539|FG008|Overall Study|Disease Progression|0|||
126446611|NCT01088048|454935540|FG009|Overall Study|Disease Progression|0|||
126446612|NCT01088048|454935531|FG000|Overall Study|Death|1|||
126446613|NCT01088048|454935532|FG001|Overall Study|Death|5|||
126446614|NCT01088048|454935533|FG002|Overall Study|Death|3|||
126446615|NCT01088048|454935534|FG003|Overall Study|Death|3|||
126446616|NCT01088048|454935535|FG004|Overall Study|Death|1|||
126446617|NCT01088048|454935536|FG005|Overall Study|Death|3|||
126446618|NCT01088048|454935537|FG006|Overall Study|Death|0|||
126446619|NCT01088048|454935538|FG007|Overall Study|Death|0|||
126446620|NCT01088048|454935539|FG008|Overall Study|Death|3|||
126446621|NCT01088048|454935540|FG009|Overall Study|Death|1|||
126446622|NCT01088048|454935531|FG000|Overall Study|Other|3|||
126446623|NCT01088048|454935532|FG001|Overall Study|Other|5|||
126446624|NCT01088048|454935533|FG002|Overall Study|Other|0|||
126446625|NCT01088048|454935534|FG003|Overall Study|Other|0|||
126446626|NCT01088048|454935535|FG004|Overall Study|Other|2|||
126446627|NCT01088048|454935536|FG005|Overall Study|Other|0|||
126446628|NCT01088048|454935537|FG006|Overall Study|Other|0|||
126446629|NCT01088048|454935538|FG007|Overall Study|Other|2|||
126446630|NCT01088048|454935539|FG008|Overall Study|Other|0|||
126446631|NCT01088048|454935540|FG009|Overall Study|Other|0|||
126446632|NCT00808080|454935543|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
126356666|NCT02675452|454597869|FG006|Overall Study|Other|0|||
126356667|NCT02675452|454597870|FG007|Overall Study|Other|0|||
126356668|NCT02675452|454597871|FG008|Overall Study|Other|0|||
126356669|NCT02675452|454597872|FG009|Overall Study|Other|0|||
126356670|NCT02675452|454597873|FG010|Overall Study|Other|0|||
126356671|NCT02675452|454597874|FG011|Overall Study|Other|0|||
126356672|NCT02675452|454597875|FG012|Overall Study|Other|0|||
126356673|NCT02675452|454597876|FG013|Overall Study|Other|0|||
126356674|NCT02675452|454597877|FG014|Overall Study|Other|0|||
126356675|NCT02675452|454597878|FG015|Overall Study|Other|0|||
126356676|NCT02675452|454597879|FG016|Overall Study|Other|0|||
126356677|NCT02675452|454597880|FG017|Overall Study|Other|0|||
126356678|NCT02675452|454597881|FG018|Overall Study|Other|0|||
126446633|NCT01330108|454935544|FG000|Overall Study|Withdrawal by Subject|4|||
126446634|NCT00423917|454935547|FG000|Overall Study|Cancel|2|||
126446635|NCT00423917|454935547|FG000|Overall Study|Ineligible|1|||
126446636|NCT00243269|454935548|FG000|Overall Study|Protocol Violation|2|||
126446637|NCT00243269|454935549|FG001|Overall Study|Protocol Violation|1|||
126446638|NCT00243269|454935550|FG002|Overall Study|Protocol Violation|0|||
126446639|NCT00243269|454935551|FG003|Overall Study|Protocol Violation|1|||
126446640|NCT00243269|454935548|FG000|Overall Study|Lost to Follow-up|1|||
126446641|NCT00243269|454935549|FG001|Overall Study|Lost to Follow-up|0|||
126446642|NCT00243269|454935550|FG002|Overall Study|Lost to Follow-up|1|||
126446643|NCT00243269|454935551|FG003|Overall Study|Lost to Follow-up|3|||
126446644|NCT01396447|454935555|FG000|Overall Study|Did Not Receive Treatment|3|||
126446645|NCT01396447|454935556|FG001|Overall Study|Did Not Receive Treatment|2|||
126446646|NCT01396447|454935557|FG002|Overall Study|Did Not Receive Treatment|1|||
126446647|NCT01396447|454935558|FG003|Overall Study|Did Not Receive Treatment|0|||
126446648|NCT01396447|454935555|FG000|Overall Study|Adverse Event|15|||
126446649|NCT01396447|454935556|FG001|Overall Study|Adverse Event|12|||
126446650|NCT01396447|454935557|FG002|Overall Study|Adverse Event|12|||
126446651|NCT01396447|454935558|FG003|Overall Study|Adverse Event|17|||
126446652|NCT01396447|454935555|FG000|Overall Study|Insufficient Therapeutic Response|5|||
126446653|NCT01396447|454935556|FG001|Overall Study|Insufficient Therapeutic Response|5|||
126446654|NCT01396447|454935557|FG002|Overall Study|Insufficient Therapeutic Response|2|||
126446655|NCT01396447|454935558|FG003|Overall Study|Insufficient Therapeutic Response|4|||
126446656|NCT01396447|454935555|FG000|Overall Study|Protocol Violation|5|||
126446657|NCT01396447|454935556|FG001|Overall Study|Protocol Violation|2|||
126446658|NCT01396447|454935557|FG002|Overall Study|Protocol Violation|3|||
126694203|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
126694204|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
126694205|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
126694206|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
126694207|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
126694208|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
126446659|NCT01396447|454935558|FG003|Overall Study|Protocol Violation|7|||
126446660|NCT01396447|454935555|FG000|Overall Study|Withdrawal of Consent|11|||
126446661|NCT01396447|454935556|FG001|Overall Study|Withdrawal of Consent|9|||
126446662|NCT01396447|454935557|FG002|Overall Study|Withdrawal of Consent|4|||
126446663|NCT01396447|454935558|FG003|Overall Study|Withdrawal of Consent|15|||
126446664|NCT01396447|454935555|FG000|Overall Study|Lost to Follow-up|4|||
126446665|NCT01396447|454935556|FG001|Overall Study|Lost to Follow-up|8|||
126446666|NCT01396447|454935557|FG002|Overall Study|Lost to Follow-up|7|||
126446667|NCT01396447|454935558|FG003|Overall Study|Lost to Follow-up|9|||
126446668|NCT01396447|454935555|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126446669|NCT01396447|454935556|FG001|Overall Study|Other Miscellaneous Reasons|2|||
126446670|NCT01396447|454935557|FG002|Overall Study|Other Miscellaneous Reasons|1|||
126446671|NCT01396447|454935558|FG003|Overall Study|Other Miscellaneous Reasons|0|||
126446672|NCT00578292|454935559|FG000|Overall Study|Death|1|||
126446673|NCT00578292|454935559|FG000|Overall Study|Graft failure|2|||
126446674|NCT00856518|454935563|FG000|Overall Study|Lost to Follow-up|4|||
126446675|NCT00856518|454935564|FG001|Overall Study|Lost to Follow-up|2|||
126446676|NCT00947193|454935565|FG000|Overall Study|Lost to Follow-up|1|||
126446677|NCT00947193|454935566|FG001|Overall Study|Lost to Follow-up|0|||
126446678|NCT00947193|454935565|FG000|Overall Study|Withdrawal by Subject|1|||
126446679|NCT00947193|454935566|FG001|Overall Study|Withdrawal by Subject|0|||
126446680|NCT00947193|454935565|FG000|Overall Study|Factor VIII >1%|1|||
126446681|NCT00947193|454935566|FG001|Overall Study|Factor VIII >1%|0|||
126446682|NCT04849559|454935567|FG000|Overall Study|Withdrawal by Subject|2|||
126446683|NCT04849559|454935568|FG001|Overall Study|Withdrawal by Subject|1|||
126446684|NCT02105961|454935569|FG000|Overall Study|Adverse Event|18|||
126446685|NCT02105961|454935570|FG001|Overall Study|Adverse Event|7|||
126446686|NCT02105961|454935571|FG002|Overall Study|Adverse Event|13|||
126446687|NCT02105961|454935569|FG000|Overall Study|Lack of Efficacy|3|||
126446688|NCT02105961|454935570|FG001|Overall Study|Lack of Efficacy|0|||
126446689|NCT02105961|454935571|FG002|Overall Study|Lack of Efficacy|3|||
126446690|NCT02105961|454935569|FG000|Overall Study|Lost to Follow-up|2|||
126446691|NCT02105961|454935570|FG001|Overall Study|Lost to Follow-up|0|||
126694209|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
126694210|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
126446692|NCT02105961|454935571|FG002|Overall Study|Lost to Follow-up|1|||
126446693|NCT02105961|454935569|FG000|Overall Study|Physician Decision|3|||
126446694|NCT02105961|454935570|FG001|Overall Study|Physician Decision|3|||
126446695|NCT02105961|454935571|FG002|Overall Study|Physician Decision|2|||
126446696|NCT02105961|454935569|FG000|Overall Study|Withdrawal by Subject|15|||
126446697|NCT02105961|454935570|FG001|Overall Study|Withdrawal by Subject|7|||
126446698|NCT02105961|454935571|FG002|Overall Study|Withdrawal by Subject|11|||
126446699|NCT04154189|454935572|FG000|Overall Study|Withdrawal by Subject|4|||
126446700|NCT04154189|454935573|FG001|Overall Study|Withdrawal by Subject|6|||
126446701|NCT04154189|454935572|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
126694211|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
126694212|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
126694213|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
126694214|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
126694215|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
126356679|NCT02675452|454597882|FG019|Overall Study|Other|0|||
126356680|NCT02675452|454597883|FG020|Overall Study|Other|0|||
126356681|NCT02675452|454597884|FG021|Overall Study|Other|0|||
126356682|NCT02675452|454597885|FG022|Overall Study|Other|0|||
126356683|NCT02675452|454597886|FG023|Overall Study|Other|0|||
126356684|NCT02675452|454597887|FG024|Overall Study|Other|0|||
126356685|NCT02675452|454597888|FG025|Overall Study|Other|0|||
126356686|NCT02675452|454597889|FG026|Overall Study|Other|1|||
126356687|NCT02675452|454597890|FG027|Overall Study|Other|0|||
126356688|NCT02675452|454597891|FG028|Overall Study|Other|0|||
126356689|NCT02939781|454597892|FG000|Overall Study|Protocol Violation|8|||
126356690|NCT02939781|454597892|FG000|Overall Study|Withdrawal by Subject|1|||
126356691|NCT00689052|454597896|FG000|Overall Study|Adverse Event|4|||
126356692|NCT00689052|454597897|FG001|Overall Study|Adverse Event|6|||
126356693|NCT00689052|454597896|FG000|Overall Study|Protocol Violation|1|||
126356694|NCT00689052|454597897|FG001|Overall Study|Protocol Violation|0|||
126356695|NCT00689052|454597896|FG000|Overall Study|Lost to Follow-up|2|||
126356696|NCT00689052|454597897|FG001|Overall Study|Lost to Follow-up|0|||
126356697|NCT00689052|454597896|FG000|Overall Study|Withdrawal by Subject|2|||
126356698|NCT00689052|454597897|FG001|Overall Study|Withdrawal by Subject|0|||
126356699|NCT00689052|454597896|FG000|Overall Study|Early termination of the trial|22|||
126356700|NCT00689052|454597897|FG001|Overall Study|Early termination of the trial|24|||
126356701|NCT02569242|454597898|FG000|Overall Study|Death|1|||
126356702|NCT02569242|454597899|FG001|Overall Study|Death|0|||
126356703|NCT02569242|454597898|FG000|Overall Study|Withdrawal by Subject|0|||
126356704|NCT02569242|454597899|FG001|Overall Study|Withdrawal by Subject|1|||
126356705|NCT03003468|454597900|FG000|Overall Study|Withdrawal by Subject|0|||
126356706|NCT03003468|454597901|FG001|Overall Study|Withdrawal by Subject|0|||
126356707|NCT03003468|454597902|FG002|Overall Study|Withdrawal by Subject|1|||
126356708|NCT03003468|454597900|FG000|Overall Study|No measurable lesions|0|||
126356709|NCT03003468|454597901|FG001|Overall Study|No measurable lesions|0|||
126356710|NCT03003468|454597902|FG002|Overall Study|No measurable lesions|1|||
126356711|NCT02114684|454597903|FG000|Overall Study|Death|6|||
126356712|NCT02114684|454597904|FG001|Overall Study|Death|4|||
126356713|NCT02114684|454597903|FG000|Overall Study|Lost to Follow-up|1|||
126356714|NCT02114684|454597904|FG001|Overall Study|Lost to Follow-up|2|||
126356715|NCT02114684|454597903|FG000|Overall Study|Withdrawal by Subject|1|||
126356716|NCT02114684|454597904|FG001|Overall Study|Withdrawal by Subject|2|||
126356717|NCT02114684|454597903|FG000|Overall Study|Relocation|3|||
126356718|NCT02114684|454597904|FG001|Overall Study|Relocation|1|||
126356719|NCT02114684|454597903|FG000|Overall Study|Rifampicin resistant on culture|0|||
126356720|NCT02114684|454597904|FG001|Overall Study|Rifampicin resistant on culture|1|||
126356721|NCT02114684|454597903|FG000|Overall Study|Patient Incarcerated|1|||
126356722|NCT02114684|454597904|FG001|Overall Study|Patient Incarcerated|0|||
126356723|NCT04625972|454597907|FG000|Overall Study|Death|3|||
126356724|NCT04625972|454597908|FG001|Overall Study|Death|2|||
126356725|NCT04625972|454597907|FG000|Overall Study|Lost to Follow-up|82|||
126356726|NCT04625972|454597908|FG001|Overall Study|Lost to Follow-up|38|||
126356727|NCT04625972|454597907|FG000|Overall Study|Physician Decision|2|||
126356728|NCT04625972|454597908|FG001|Overall Study|Physician Decision|0|||
126356729|NCT04625972|454597907|FG000|Overall Study|Protocol Violation|0|||
126356730|NCT04625972|454597908|FG001|Overall Study|Protocol Violation|1|||
126356731|NCT04625972|454597907|FG000|Overall Study|Withdrawal by Subject|37|||
126356732|NCT04625972|454597908|FG001|Overall Study|Withdrawal by Subject|24|||
126356733|NCT04625972|454597907|FG000|Overall Study|Not specified elsewhere|8|||
126356734|NCT04625972|454597908|FG001|Overall Study|Not specified elsewhere|6|||
126356735|NCT03259308|454597915|FG000|Overall Study|Adverse Event|5|||
126356736|NCT03259308|454597916|FG001|Overall Study|Adverse Event|4|||
126356737|NCT03259308|454597917|FG002|Overall Study|Adverse Event|1|||
126694216|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
126694217|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
126694218|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
126694219|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
126694220|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
126694221|NCT00289913|455835035|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
126694222|NCT00289913|455835036|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
126694223|NCT00289913|455835037|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
126694224|NCT00289913|455835038|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
126694225|NCT00289913|455835039|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
126694226|NCT00289913|455835035|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126694227|NCT00289913|455835036|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
126694228|NCT00289913|455835037|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126694229|NCT00289913|455835038|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126694230|NCT00289913|455835039|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
126694231|NCT00289913|455835035|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
126694232|NCT00289913|455835036|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
126694233|NCT00289913|455835037|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
126694234|NCT00289913|455835038|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
126760905|NCT00764465|456075858|FG002|Overall Study|Adverse Event|0|||
126760906|NCT00764465|456075859|FG003|Overall Study|Adverse Event|1|||
126760907|NCT00764465|456075860|FG004|Overall Study|Adverse Event|1|||
126446702|NCT04154189|454935573|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
126446703|NCT04154189|454935572|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
126446704|NCT04154189|454935573|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
126446705|NCT04154189|454935572|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
126446706|NCT04154189|454935573|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
126446707|NCT04154189|454935572|FG000|Overall Study|Death|25|||
126446708|NCT04154189|454935573|FG001|Overall Study|Death|25|||
126446709|NCT02147561|454935576|FG000|Overall Study|Lost to Follow-up|3|||
126446710|NCT02147561|454935576|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
126446711|NCT01191762|454935577|FG000|Overall Study|Adverse Event|1|||
126446712|NCT01191762|454935578|FG001|Overall Study|Adverse Event|0|||
126446713|NCT00459186|454935581|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
126446714|NCT00459186|454935581|FG000|PET Imaging and Assessment|Adverse Event|3|||
126446715|NCT01485172|454935582|FG000|Overall Study|Adverse Event|2|||
126446716|NCT01485172|454935583|FG001|Overall Study|Adverse Event|1|||
126446717|NCT01485172|454935584|FG002|Overall Study|Adverse Event|2|||
126446718|NCT01485172|454935585|FG003|Overall Study|Adverse Event|2|||
126446719|NCT01485172|454935586|FG004|Overall Study|Adverse Event|1|||
126446720|NCT01485172|454935587|FG005|Overall Study|Adverse Event|2|||
126446721|NCT01485172|454935582|FG000|Overall Study|Lack of Efficacy|2|||
126446722|NCT01485172|454935583|FG001|Overall Study|Lack of Efficacy|0|||
126545410|NCT03500640|455290833|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
126545411|NCT03500640|455290831|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
126545412|NCT03500640|455290832|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
126545413|NCT03500640|455290833|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
126545414|NCT03500640|455290831|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
126545415|NCT03500640|455290832|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
126545416|NCT03500640|455290833|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
126545417|NCT03500640|455290831|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
126545418|NCT03500640|455290832|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
126545419|NCT03500640|455290833|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
126545420|NCT03500640|455290831|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
126545421|NCT03500640|455290832|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
126545422|NCT03500640|455290833|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
126545423|NCT03500640|455290831|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
126545424|NCT03500640|455290832|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
126545425|NCT03500640|455290833|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
126545426|NCT03500640|455290831|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
126545427|NCT03500640|455290832|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
126545428|NCT03500640|455290833|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
126545429|NCT03500640|455290831|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
126545430|NCT03500640|455290832|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
126545431|NCT03500640|455290833|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
126545432|NCT03500640|455290831|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
126545433|NCT03500640|455290832|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
126545434|NCT03500640|455290833|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
126545435|NCT01650519|455290834|FG000|Overall Study|Withdrawal by Subject|1|||
126545436|NCT01650519|455290835|FG001|Overall Study|Withdrawal by Subject|0|||
126545437|NCT05458024|455290838|FG000|Overall Study|Withdrawal by Subject|1|||
126545438|NCT05458024|455290839|FG001|Overall Study|Withdrawal by Subject|1|||
126545439|NCT02690077|455290842|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
126545440|NCT02690077|455290843|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
126545441|NCT02690077|455290842|FG000|Overall Study|Withdrawal by Subject|0|||
126545442|NCT02690077|455290843|FG001|Overall Study|Withdrawal by Subject|5|||
126545443|NCT02690077|455290842|FG000|Overall Study|Excluded by IRB|0|||
126545444|NCT02690077|455290843|FG001|Overall Study|Excluded by IRB|2|||
126545445|NCT01845974|455290844|FG000|Overall Study|screen failure|1|||
126545446|NCT01845974|455290845|FG001|Overall Study|screen failure|0|||
126545447|NCT02667886|455290846|FG000|Dose Escalation (Part A)|Adverse Event|1|||
126545448|NCT02667886|455290847|FG001|Dose Escalation (Part A)|Adverse Event|3|||
126545449|NCT02667886|455290848|FG002|Dose Escalation (Part A)|Adverse Event|1|||
126545450|NCT02667886|455290849|FG003|Dose Escalation (Part A)|Adverse Event|0|||
126545451|NCT02667886|455290850|FG004|Dose Escalation (Part A)|Adverse Event|0|||
126545452|NCT02667886|455290846|FG000|Dose Escalation (Part A)|Disease Progression|1|||
126545453|NCT02667886|455290847|FG001|Dose Escalation (Part A)|Disease Progression|4|||
126545454|NCT02667886|455290848|FG002|Dose Escalation (Part A)|Disease Progression|3|||
126545455|NCT02667886|455290849|FG003|Dose Escalation (Part A)|Disease Progression|0|||
126545456|NCT02667886|455290850|FG004|Dose Escalation (Part A)|Disease Progression|0|||
126545457|NCT02667886|455290846|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
126545458|NCT02667886|455290847|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
126545459|NCT02667886|455290848|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
126545460|NCT02667886|455290849|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
126694235|NCT00289913|455835039|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
126694236|NCT00289913|455835035|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126694237|NCT00289913|455835036|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126694238|NCT00289913|455835037|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126356738|NCT03259308|454597915|FG000|Overall Study|Withdrawal by Subject|2|||
126356739|NCT03259308|454597916|FG001|Overall Study|Withdrawal by Subject|1|||
126356740|NCT03259308|454597917|FG002|Overall Study|Withdrawal by Subject|3|||
126545461|NCT02667886|455290850|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
126545462|NCT02667886|455290846|FG000|Dose Expansion (Part B)|Adverse Event|0|||
126694239|NCT00289913|455835038|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
126356741|NCT03259308|454597915|FG000|Overall Study|Lost to Follow-up|0|||
126446723|NCT01485172|454935584|FG002|Overall Study|Lack of Efficacy|0|||
126446724|NCT01485172|454935585|FG003|Overall Study|Lack of Efficacy|0|||
126446725|NCT01485172|454935586|FG004|Overall Study|Lack of Efficacy|0|||
126446726|NCT01485172|454935587|FG005|Overall Study|Lack of Efficacy|0|||
126446727|NCT01485172|454935582|FG000|Overall Study|Protocol Violation|0|||
126446728|NCT01485172|454935583|FG001|Overall Study|Protocol Violation|0|||
126446729|NCT01485172|454935584|FG002|Overall Study|Protocol Violation|4|||
126446730|NCT01485172|454935585|FG003|Overall Study|Protocol Violation|5|||
126446731|NCT01485172|454935586|FG004|Overall Study|Protocol Violation|1|||
126446732|NCT01485172|454935587|FG005|Overall Study|Protocol Violation|0|||
126446733|NCT01485172|454935582|FG000|Overall Study|Protocol defined stopping criteria|1|||
126446734|NCT01485172|454935583|FG001|Overall Study|Protocol defined stopping criteria|0|||
126446735|NCT01485172|454935584|FG002|Overall Study|Protocol defined stopping criteria|0|||
126446736|NCT01485172|454935585|FG003|Overall Study|Protocol defined stopping criteria|0|||
126446737|NCT01485172|454935586|FG004|Overall Study|Protocol defined stopping criteria|1|||
126446738|NCT01485172|454935587|FG005|Overall Study|Protocol defined stopping criteria|0|||
126446739|NCT01485172|454935582|FG000|Overall Study|Lost to Follow-up|0|||
126446740|NCT01485172|454935583|FG001|Overall Study|Lost to Follow-up|0|||
126446741|NCT01485172|454935584|FG002|Overall Study|Lost to Follow-up|1|||
126446742|NCT01485172|454935585|FG003|Overall Study|Lost to Follow-up|0|||
126446743|NCT01485172|454935586|FG004|Overall Study|Lost to Follow-up|0|||
126446744|NCT01485172|454935587|FG005|Overall Study|Lost to Follow-up|1|||
126446745|NCT01485172|454935582|FG000|Overall Study|Physician Decision|0|||
126446746|NCT01485172|454935583|FG001|Overall Study|Physician Decision|0|||
126446747|NCT01485172|454935584|FG002|Overall Study|Physician Decision|0|||
126446748|NCT01485172|454935585|FG003|Overall Study|Physician Decision|0|||
126446749|NCT01485172|454935586|FG004|Overall Study|Physician Decision|1|||
126446750|NCT01485172|454935587|FG005|Overall Study|Physician Decision|0|||
126446751|NCT01485172|454935582|FG000|Overall Study|Withdrawal by Subject|2|||
126446752|NCT01485172|454935583|FG001|Overall Study|Withdrawal by Subject|0|||
126446753|NCT01485172|454935584|FG002|Overall Study|Withdrawal by Subject|0|||
126446754|NCT01485172|454935585|FG003|Overall Study|Withdrawal by Subject|1|||
126446755|NCT01485172|454935586|FG004|Overall Study|Withdrawal by Subject|1|||
126446756|NCT01485172|454935587|FG005|Overall Study|Withdrawal by Subject|1|||
126446757|NCT02283762|454935588|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
126446758|NCT02283762|454935589|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
126446759|NCT02283762|454935588|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
126446760|NCT02283762|454935589|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
126446761|NCT02283762|454935588|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
126446762|NCT02283762|454935589|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
126446763|NCT02283762|454935588|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
126446764|NCT02283762|454935589|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
126446765|NCT02283762|454935588|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
126446766|NCT02283762|454935589|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
126446767|NCT02283762|454935588|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
126446768|NCT02283762|454935589|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
126446769|NCT02283762|454935588|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
126446770|NCT02283762|454935589|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
126446771|NCT02283762|454935588|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
126446772|NCT02283762|454935589|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
126446773|NCT02283762|454935588|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
126446774|NCT02283762|454935589|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
126446775|NCT02283762|454935588|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
126446776|NCT02283762|454935589|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
126446777|NCT02283762|454935588|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
126446778|NCT02283762|454935589|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
126446779|NCT02283762|454935588|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
126446780|NCT02283762|454935589|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
126446781|NCT00202878|454935593|FG000|Overall Study|Death|964|||
126446782|NCT00202878|454935594|FG001|Overall Study|Death|968|||
126545463|NCT02667886|455290847|FG001|Dose Expansion (Part B)|Adverse Event|0|||
126545464|NCT02667886|455290848|FG002|Dose Expansion (Part B)|Adverse Event|0|||
126545465|NCT02667886|455290849|FG003|Dose Expansion (Part B)|Adverse Event|9|||
126545466|NCT02667886|455290850|FG004|Dose Expansion (Part B)|Adverse Event|0|||
126545467|NCT02667886|455290846|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
126545468|NCT02667886|455290847|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
126545469|NCT02667886|455290848|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
126545470|NCT02667886|455290849|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
126545471|NCT02667886|455290850|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
126545472|NCT02667886|455290846|FG000|Dose Expansion (Part B)|Disease Progression|0|||
126545473|NCT02667886|455290847|FG001|Dose Expansion (Part B)|Disease Progression|0|||
126545474|NCT02667886|455290848|FG002|Dose Expansion (Part B)|Disease Progression|0|||
126545475|NCT02667886|455290849|FG003|Dose Expansion (Part B)|Disease Progression|38|||
126545476|NCT02667886|455290850|FG004|Dose Expansion (Part B)|Disease Progression|0|||
126545477|NCT02667886|455290846|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
126545478|NCT02667886|455290847|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
126545479|NCT02667886|455290848|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
126545480|NCT02667886|455290849|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
126545481|NCT02667886|455290850|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
126545482|NCT02667886|455290846|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
126545483|NCT02667886|455290847|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
126545484|NCT02667886|455290848|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
126545485|NCT02667886|455290849|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
126545486|NCT02667886|455290850|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
126545487|NCT02667886|455290846|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
126545488|NCT02667886|455290847|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
126545489|NCT02667886|455290848|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
126545490|NCT02667886|455290849|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
126545491|NCT02667886|455290850|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
126545492|NCT00747123|455290851|FG000|Overall Study|Investigator's request|0|||
126545493|NCT00747123|455290852|FG001|Overall Study|Investigator's request|0|||
126545494|NCT00747123|455290853|FG002|Overall Study|Investigator's request|1|||
126545495|NCT00747123|455290854|FG003|Overall Study|Investigator's request|0|||
126545496|NCT00747123|455290851|FG000|Overall Study|Withdrew consent|0|||
126545497|NCT00747123|455290852|FG001|Overall Study|Withdrew consent|1|||
126545498|NCT00747123|455290853|FG002|Overall Study|Withdrew consent|0|||
126694240|NCT00289913|455835039|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
126545499|NCT00747123|455290854|FG003|Overall Study|Withdrew consent|0|||
126545500|NCT00747123|455290851|FG000|Overall Study|Adverse Event|0|||
126545501|NCT00747123|455290852|FG001|Overall Study|Adverse Event|1|||
126545502|NCT00747123|455290853|FG002|Overall Study|Adverse Event|0|||
126545503|NCT00747123|455290854|FG003|Overall Study|Adverse Event|1|||
126760908|NCT00764465|456075861|FG005|Overall Study|Adverse Event|1|||
126694241|NCT00289913|455835035|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126694242|NCT00289913|455835036|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126694243|NCT00289913|455835037|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126694244|NCT00289913|455835038|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
126694245|NCT00289913|455835039|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
126694246|NCT00289913|455835035|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
126694247|NCT00289913|455835036|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
126760909|NCT00764465|456075856|FG000|Overall Study|Withdrawal by Subject|0|||
126760910|NCT00764465|456075857|FG001|Overall Study|Withdrawal by Subject|1|||
126760911|NCT00764465|456075858|FG002|Overall Study|Withdrawal by Subject|1|||
126446783|NCT00202878|454935593|FG000|Overall Study|Only Vital Status Known|357|||
126446784|NCT00202878|454935594|FG001|Overall Study|Only Vital Status Known|356|||
126446785|NCT00202878|454935593|FG000|Overall Study|Lost to Follow-up|44|||
126446786|NCT00202878|454935594|FG001|Overall Study|Lost to Follow-up|49|||
126446787|NCT00202878|454935593|FG000|Overall Study|Site Closure|39|||
126446788|NCT00202878|454935594|FG001|Overall Study|Site Closure|36|||
126446789|NCT00202878|454935593|FG000|Overall Study|Withdrawal by Subject|795|||
126446790|NCT00202878|454935594|FG001|Overall Study|Withdrawal by Subject|808|||
126446791|NCT02920242|454935595|FG000|Overall Study|Withdrawal by Subject|1|||
126356742|NCT03259308|454597916|FG001|Overall Study|Lost to Follow-up|0|||
126356743|NCT03259308|454597917|FG002|Overall Study|Lost to Follow-up|1|||
126356744|NCT03259308|454597915|FG000|Overall Study|Pregnancy|0|||
126356745|NCT03259308|454597916|FG001|Overall Study|Pregnancy|0|||
126356746|NCT03259308|454597917|FG002|Overall Study|Pregnancy|1|||
126356747|NCT03259308|454597915|FG000|Overall Study|Protocol Deviation|0|||
126356748|NCT03259308|454597916|FG001|Overall Study|Protocol Deviation|3|||
126356749|NCT03259308|454597917|FG002|Overall Study|Protocol Deviation|0|||
126356750|NCT03259308|454597915|FG000|Overall Study|Lack of Efficacy|0|||
126356751|NCT03259308|454597916|FG001|Overall Study|Lack of Efficacy|0|||
126356752|NCT03259308|454597917|FG002|Overall Study|Lack of Efficacy|1|||
126356753|NCT00694122|454597918|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
126356754|NCT00694122|454597919|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
126356755|NCT00694122|454597918|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
126356756|NCT00694122|454597919|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
126356757|NCT00694122|454597918|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
126356758|NCT00694122|454597919|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
126356759|NCT01727154|454597922|FG000|Overall Study|Death|17|||
126356760|NCT01727154|454597922|FG000|Overall Study|Withdrawal by Subject|14|||
126356761|NCT01727154|454597922|FG000|Overall Study|Subject Withdrew Consent|18|||
126356762|NCT01727154|454597922|FG000|Overall Study|Study Terminated|6|||
126356763|NCT01727154|454597922|FG000|Overall Study|No Discontinuation Documentation|4|||
126356764|NCT00003474|454597923|FG000|Overall Study|Not Evaluable|14|||
126356765|NCT03020888|454597926|FG000|Overall Study|Physician Decision|4|||
126356766|NCT03020888|454597926|FG000|Overall Study|Withdrawal by Subject|6|||
126356767|NCT03020888|454597926|FG000|Overall Study|Insurance coverage|2|||
126356768|NCT03020888|454597926|FG000|Overall Study|Lost to Follow-up|1|||
126356769|NCT01198548|454597933|FG000|Overall Study|Disease Progression|9|||
126356770|NCT01198548|454597933|FG000|Overall Study|Administrative Decision|1|||
126356771|NCT01245062|454597935|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
126356772|NCT01245062|454597936|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
126356773|NCT01245062|454597937|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
126356774|NCT01245062|454597935|FG000|Randomization and Crossover Phase|Physician Decision|2|||
126356775|NCT01245062|454597936|FG001|Randomization and Crossover Phase|Physician Decision|4|||
126356776|NCT01245062|454597937|FG002|Randomization and Crossover Phase|Physician Decision|0|||
126356777|NCT01245062|454597935|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
126356778|NCT01245062|454597936|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
126356779|NCT01245062|454597937|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
126356780|NCT01245062|454597935|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
126356781|NCT01245062|454597936|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
126356782|NCT01245062|454597937|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
126356783|NCT01245062|454597935|FG000|Cross-over Phase|Lost to Follow-up|0|||
126356784|NCT01245062|454597936|FG001|Cross-over Phase|Lost to Follow-up|0|||
126356785|NCT01245062|454597937|FG002|Cross-over Phase|Lost to Follow-up|1|||
126356786|NCT01245062|454597935|FG000|Cross-over Phase|Physician Decision|0|||
126356787|NCT01245062|454597936|FG001|Cross-over Phase|Physician Decision|0|||
126356788|NCT01245062|454597937|FG002|Cross-over Phase|Physician Decision|1|||
126356789|NCT01245062|454597935|FG000|Cross-over Phase|Withdrew Consent|0|||
126356790|NCT01245062|454597936|FG001|Cross-over Phase|Withdrew Consent|0|||
126356791|NCT01245062|454597937|FG002|Cross-over Phase|Withdrew Consent|4|||
126356792|NCT01245062|454597935|FG000|Cross-over Phase|Study closed/ terminated|0|||
126356793|NCT01245062|454597936|FG001|Cross-over Phase|Study closed/ terminated|0|||
126446792|NCT02920242|454935596|FG001|Overall Study|Withdrawal by Subject|0|||
126694248|NCT00289913|455835037|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
126356794|NCT01245062|454597937|FG002|Cross-over Phase|Study closed/ terminated|11|||
126356795|NCT06025695|454597938|FG000|Overall Study|Adverse Event|5|||
126356796|NCT06025695|454597939|FG001|Overall Study|Adverse Event|6|||
126356797|NCT06025695|454597938|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
126356798|NCT06025695|454597939|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
126356799|NCT06025695|454597938|FG000|Overall Study|Other|23|||
126694249|NCT00289913|455835038|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
126356800|NCT06025695|454597939|FG001|Overall Study|Other|19|||
126356801|NCT06025695|454597938|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
126694250|NCT00289913|455835039|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
126694251|NCT00289913|455835035|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
126694252|NCT00289913|455835036|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
126694253|NCT00289913|455835037|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
126694254|NCT00289913|455835038|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
126694255|NCT00289913|455835039|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
126446793|NCT02920242|454935597|FG002|Overall Study|Withdrawal by Subject|1|||
126356802|NCT06025695|454597939|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
126356803|NCT03834883|454597940|FG000|Second Treatment|Withdrawal by Subject|1|||
126356804|NCT03834883|454597941|FG001|Second Treatment|Withdrawal by Subject|0|||
126356805|NCT03834883|454597942|FG002|Second Treatment|Withdrawal by Subject|0|||
126356806|NCT03834883|454597943|FG003|Second Treatment|Withdrawal by Subject|0|||
126356807|NCT03834883|454597940|FG000|Second Treatment|COVID-19 pandemic|1|||
126356808|NCT03834883|454597941|FG001|Second Treatment|COVID-19 pandemic|0|||
126356809|NCT03834883|454597942|FG002|Second Treatment|COVID-19 pandemic|1|||
126356810|NCT03834883|454597943|FG003|Second Treatment|COVID-19 pandemic|1|||
126356811|NCT00853047|454597946|FG000|Core Phase|Participant Request|0|||
126356812|NCT00853047|454597947|FG001|Core Phase|Participant Request|0|||
126356813|NCT00853047|454597948|FG002|Core Phase|Participant Request|0|||
126545504|NCT01483937|455290867|FG000|Overall Study|Withdrawal by Subject|4|||
126356814|NCT00853047|454597949|FG003|Core Phase|Participant Request|1|||
126356815|NCT00853047|454597950|FG004|Core Phase|Participant Request|0|||
126356816|NCT00853047|454597951|FG005|Core Phase|Participant Request|0|||
126545505|NCT01483937|455290868|FG001|Overall Study|Withdrawal by Subject|3|||
126446794|NCT02920242|454935595|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
126446795|NCT02920242|454935596|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
126446796|NCT02920242|454935597|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
126446797|NCT01587014|454935598|FG000|Overall Study|Death|2|||
126446798|NCT03801031|454935603|FG000|Overall Study|Lost to Follow-up|1|||
126446799|NCT03801031|454935604|FG001|Overall Study|Lost to Follow-up|0|||
126446800|NCT03801031|454935603|FG000|Overall Study|Unable to comply|1|||
126356817|NCT00853047|454597946|FG000|Open-Label Extension Phase|Participant Request|0|||
126446801|NCT03801031|454935604|FG001|Overall Study|Unable to comply|0|||
126356818|NCT00853047|454597947|FG001|Open-Label Extension Phase|Participant Request|0|||
126356819|NCT00853047|454597948|FG002|Open-Label Extension Phase|Participant Request|0|||
126356820|NCT00853047|454597949|FG003|Open-Label Extension Phase|Participant Request|0|||
126356821|NCT00853047|454597950|FG004|Open-Label Extension Phase|Participant Request|0|||
126356822|NCT00853047|454597951|FG005|Open-Label Extension Phase|Participant Request|7|||
126356823|NCT00853047|454597946|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
126545506|NCT05778526|455290873|FG000|Overall Study|Lost to Follow-up|0|||
126694256|NCT00289913|455835035|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
126694257|NCT00289913|455835036|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
126694258|NCT00289913|455835037|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
126694259|NCT00289913|455835038|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
126694260|NCT00289913|455835039|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
126694261|NCT00289913|455835035|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126545507|NCT05778526|455290874|FG001|Overall Study|Lost to Follow-up|1|||
126694262|NCT00289913|455835036|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
126694263|NCT00289913|455835037|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126694264|NCT00289913|455835038|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126694265|NCT00289913|455835039|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
126694266|NCT01169779|455835042|FG000|Overall Study|Adverse Event|3|||
126694267|NCT01169779|455835043|FG001|Overall Study|Adverse Event|11|||
126694268|NCT01169779|455835042|FG000|Overall Study|Lack of Efficacy|1|||
126694269|NCT01169779|455835043|FG001|Overall Study|Lack of Efficacy|0|||
126694270|NCT01169779|455835042|FG000|Overall Study|Protocol Violation|1|||
126694271|NCT01169779|455835043|FG001|Overall Study|Protocol Violation|1|||
126694272|NCT01169779|455835042|FG000|Overall Study|Withdrawal by Subject|3|||
126694273|NCT01169779|455835043|FG001|Overall Study|Withdrawal by Subject|2|||
126694274|NCT01169779|455835042|FG000|Overall Study|Familial and personal reasons|3|||
126694275|NCT01169779|455835043|FG001|Overall Study|Familial and personal reasons|3|||
126694276|NCT03617705|455835048|FG000|Overall Study|Withdrawal by Subject|2|||
126694277|NCT03617705|455835048|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
126694278|NCT03617705|455835048|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
126694279|NCT01061008|455835049|FG000|Overall Study|Badiocephalic fistula failed|3|||
126694280|NCT01061008|455835050|FG001|Overall Study|Badiocephalic fistula failed|2|||
126694281|NCT01061008|455835049|FG000|Overall Study|Death|1|||
126694282|NCT01061008|455835050|FG001|Overall Study|Death|0|||
126694283|NCT01061008|455835049|FG000|Overall Study|Withdrawal by Subject|1|||
126694284|NCT01061008|455835050|FG001|Overall Study|Withdrawal by Subject|3|||
126694285|NCT01061008|455835049|FG000|Overall Study|Unable to exercise following surgery|1|||
126694286|NCT01061008|455835050|FG001|Overall Study|Unable to exercise following surgery|0|||
126694287|NCT01061008|455835049|FG000|Overall Study|Adverse Event|0|||
126694288|NCT01061008|455835050|FG001|Overall Study|Adverse Event|1|||
126694289|NCT02024971|455835051|FG000|Overall Study|Data Not Available|30|||
126694290|NCT02024971|455835051|FG000|Overall Study|Lost to Follow-up|6|||
126694291|NCT00189462|455835060|FG000|Overall Study|Lack of Efficacy|5|||
126694292|NCT00189462|455835061|FG001|Overall Study|Lack of Efficacy|1|||
126694293|NCT00189462|455835060|FG000|Overall Study|Lost to Follow-up|18|||
126694294|NCT00189462|455835061|FG001|Overall Study|Lost to Follow-up|20|||
126694295|NCT00849667|455835065|FG000|Overall Study|Withdrawal by Subject|16|||
126694296|NCT00849667|455835066|FG001|Overall Study|Withdrawal by Subject|33|||
126694297|NCT00849667|455835067|FG002|Overall Study|Withdrawal by Subject|35|||
126694298|NCT00849667|455835065|FG000|Overall Study|Lost to Follow-up|8|||
126694299|NCT00849667|455835066|FG001|Overall Study|Lost to Follow-up|8|||
126694300|NCT00849667|455835067|FG002|Overall Study|Lost to Follow-up|8|||
126694301|NCT00849667|455835065|FG000|Overall Study|Adverse Event|1|||
126694302|NCT00849667|455835066|FG001|Overall Study|Adverse Event|2|||
126694303|NCT00849667|455835067|FG002|Overall Study|Adverse Event|0|||
126694304|NCT00849667|455835065|FG000|Overall Study|Other|18|||
126694305|NCT00849667|455835066|FG001|Overall Study|Other|19|||
126694306|NCT00849667|455835067|FG002|Overall Study|Other|18|||
126694307|NCT00849667|455835065|FG000|Overall Study|Progressive disease|119|||
126694308|NCT00849667|455835066|FG001|Overall Study|Progressive disease|100|||
126694309|NCT00849667|455835067|FG002|Overall Study|Progressive disease|112|||
126694310|NCT00849667|455835065|FG000|Overall Study|Sponsor decision|208|||
126694311|NCT00849667|455835066|FG001|Overall Study|Sponsor decision|204|||
126694312|NCT00849667|455835067|FG002|Overall Study|Sponsor decision|190|||
126694313|NCT00849667|455835065|FG000|Overall Study|Investigator discretion|0|||
126694314|NCT00849667|455835066|FG001|Overall Study|Investigator discretion|0|||
126694315|NCT00849667|455835067|FG002|Overall Study|Investigator discretion|1|||
126694316|NCT01262625|455835068|FG000|Overall Study|Administrative Error|1|||
126694317|NCT01262625|455835069|FG001|Overall Study|Administrative Error|1|||
126694318|NCT01262625|455835068|FG000|Overall Study|Site Closed|1|||
126694319|NCT01262625|455835069|FG001|Overall Study|Site Closed|0|||
126694320|NCT01299727|455835071|FG000|Overall Study|Withdrawal by Subject|1|||
126694321|NCT01299727|455835072|FG001|Overall Study|Withdrawal by Subject|0|||
126446802|NCT03801031|454935603|FG000|Overall Study|Withdrawal by Subject|0|||
126446803|NCT03801031|454935604|FG001|Overall Study|Withdrawal by Subject|1|||
126446804|NCT02948088|454935605|FG000|Overall Study|Lost to Follow-up|8|||
126446805|NCT02948088|454935605|FG000|Overall Study|Death|1|||
126446806|NCT02948088|454935605|FG000|Overall Study|Withdrawal by Subject|4|||
126446807|NCT02948088|454935605|FG000|Overall Study|Other|2|||
126446808|NCT01942733|454935606|FG000|Overall Study|Lost to Follow-up|1|||
126446809|NCT01942733|454935606|FG000|Overall Study|Non-compliance with IMP|1|||
126446810|NCT01942733|454935606|FG000|Overall Study|Administrative|1|||
126446811|NCT01409811|454935607|FG000|Overall Study|Insurance denial|1|||
126446812|NCT00634101|454935608|FG000|Overall Study|Study Terminated|3|||
126446813|NCT00634101|454935609|FG001|Overall Study|Study Terminated|3|||
126446814|NCT00634101|454935608|FG000|Overall Study|Lost to Follow-up|2|||
126446815|NCT00634101|454935609|FG001|Overall Study|Lost to Follow-up|0|||
126446816|NCT00838513|454935611|FG000|Screening Period|Screen Failure|3|||
126446817|NCT00838513|454935611|FG000|Extension Treatment Period|Death|1|||
126760912|NCT00764465|456075859|FG003|Overall Study|Withdrawal by Subject|0|||
126446818|NCT00838513|454935611|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
126446819|NCT00139477|454935615|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
126545508|NCT05778526|455290875|FG002|Overall Study|Lost to Follow-up|3|||
126356824|NCT00853047|454597947|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
126356825|NCT00853047|454597948|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
126356826|NCT00853047|454597949|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
126356827|NCT00853047|454597950|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
126356828|NCT00853047|454597951|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
126356829|NCT00853047|454597946|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
126356830|NCT00853047|454597947|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
126356831|NCT00853047|454597948|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
126356832|NCT00853047|454597949|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
126356833|NCT00853047|454597950|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
126356834|NCT00853047|454597951|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
126356835|NCT00853047|454597946|FG000|Open-Label Extension Phase|Investigator Decision|0|||
126356836|NCT00853047|454597947|FG001|Open-Label Extension Phase|Investigator Decision|0|||
126356837|NCT00853047|454597948|FG002|Open-Label Extension Phase|Investigator Decision|0|||
126356838|NCT00853047|454597949|FG003|Open-Label Extension Phase|Investigator Decision|0|||
126356839|NCT00853047|454597950|FG004|Open-Label Extension Phase|Investigator Decision|0|||
126356840|NCT00853047|454597951|FG005|Open-Label Extension Phase|Investigator Decision|1|||
126356841|NCT00853047|454597946|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
126356842|NCT00853047|454597947|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
126356843|NCT00853047|454597948|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
126356844|NCT00853047|454597949|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
126356845|NCT00853047|454597950|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
126356846|NCT00853047|454597951|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
126356847|NCT00160615|454599600|FG000|Overall Study|Adverse Event|5|||
126356848|NCT00160615|454599601|FG001|Overall Study|Adverse Event|12|||
126356849|NCT00160615|454599600|FG000|Overall Study|Withdrawal by Subject|0|||
126356850|NCT00160615|454599601|FG001|Overall Study|Withdrawal by Subject|2|||
126356851|NCT00160615|454599600|FG000|Overall Study|Lack of Efficacy|11|||
126356852|NCT00160615|454599601|FG001|Overall Study|Lack of Efficacy|23|||
126356853|NCT00160615|454599600|FG000|Overall Study|Patient decision|1|||
126356854|NCT00160615|454599601|FG001|Overall Study|Patient decision|2|||
126356855|NCT00160615|454599600|FG000|Overall Study|Investigator decision|1|||
126356856|NCT00160615|454599601|FG001|Overall Study|Investigator decision|1|||
126356857|NCT00160615|454599600|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
126356858|NCT00160615|454599601|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
126356859|NCT00160615|454599600|FG000|Overall Study|Switch to surgical treatment|0|||
126356860|NCT00160615|454599601|FG001|Overall Study|Switch to surgical treatment|2|||
126356861|NCT00160615|454599600|FG000|Overall Study|Non-compliance was suspected|0|||
126356862|NCT00160615|454599601|FG001|Overall Study|Non-compliance was suspected|1|||
126356863|NCT00160615|454599600|FG000|Overall Study|Poor compliance|0|||
126356864|NCT00160615|454599601|FG001|Overall Study|Poor compliance|1|||
126356865|NCT03166631|454599602|FG000|Overall Study|Progressive disease|2|||
126356866|NCT03166631|454599603|FG001|Overall Study|Progressive disease|1|||
126446820|NCT00139477|454935616|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
126760913|NCT00764465|456075860|FG004|Overall Study|Withdrawal by Subject|0|||
126356867|NCT03166631|454599604|FG002|Overall Study|Progressive disease|3|||
126356868|NCT03166631|454599605|FG003|Overall Study|Progressive disease|4|||
126356869|NCT03166631|454599606|FG004|Overall Study|Progressive disease|2|||
126356870|NCT03166631|454599607|FG005|Overall Study|Progressive disease|2|||
126356871|NCT03166631|454599608|FG006|Overall Study|Progressive disease|5|||
126694322|NCT01299727|455835073|FG002|Overall Study|Withdrawal by Subject|0|||
126694323|NCT01299727|455835071|FG000|Overall Study|Adverse Event|0|||
126694324|NCT01299727|455835072|FG001|Overall Study|Adverse Event|0|||
126694325|NCT01299727|455835073|FG002|Overall Study|Adverse Event|1|||
126694326|NCT01299727|455835071|FG000|Overall Study|Completed the Treatment Period|3|||
126694327|NCT01299727|455835072|FG001|Overall Study|Completed the Treatment Period|4|||
126694328|NCT01299727|455835073|FG002|Overall Study|Completed the Treatment Period|3|||
126446821|NCT00139477|454935615|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
126446822|NCT00139477|454935616|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
126446823|NCT00139477|454935615|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
126446824|NCT00139477|454935616|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
126446825|NCT00139477|454935615|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
126446826|NCT00139477|454935616|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
126446827|NCT00139477|454935615|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
126446828|NCT00139477|454935616|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
126446829|NCT00139477|454935615|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
126446830|NCT00139477|454935616|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
126446831|NCT00139477|454935615|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
126446832|NCT00139477|454935616|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
126446833|NCT00573144|454935624|FG000|Overall Study|Withdrawal by Subject|2|||
126446834|NCT00573144|454935625|FG001|Overall Study|Withdrawal by Subject|3|||
126446835|NCT00975780|454935626|FG000|Follow Up|Death|88|||
126446836|NCT00975780|454935627|FG001|Follow Up|Death|122|||
126446837|NCT00975780|454935626|FG000|Follow Up|Facility Withdrawal|7|||
126446838|NCT00975780|454935627|FG001|Follow Up|Facility Withdrawal|23|||
126446839|NCT00975780|454935626|FG000|Follow Up|Discharged from Facility|7|||
126694329|NCT00944034|455835075|FG000|Overall Study|Inappropriate enrollment|0|||
126760914|NCT00764465|456075861|FG005|Overall Study|Withdrawal by Subject|0|||
126446840|NCT00975780|454935627|FG001|Follow Up|Discharged from Facility|12|||
126446841|NCT02625909|454935630|FG000|Overall Study|Death|2|||
126446842|NCT02625909|454935631|FG001|Overall Study|Death|0|||
126446843|NCT02625909|454935630|FG000|Overall Study|Lost to Follow-up|3|||
126446844|NCT02625909|454935631|FG001|Overall Study|Lost to Follow-up|5|||
126694330|NCT00944034|455835076|FG001|Overall Study|Inappropriate enrollment|1|||
126760915|NCT00914940|456075862|FG000|D0 to D100 Post-transplant|Death|2|||
126760916|NCT00914940|456075862|FG000|D101 to 2 Years Post-transplant|Death|8|||
126545509|NCT05778526|455290873|FG000|Overall Study|Protocol Violation|0|||
126760917|NCT00914940|456075862|FG000|2 Years to 5 Years Post-transplant|Death|3|||
126760918|NCT04095039|456075864|FG000|Overall Study|Withdrawal by Subject|2|||
126760919|NCT04095039|456075865|FG001|Overall Study|Withdrawal by Subject|16|||
126760920|NCT04095039|456075864|FG000|Overall Study|Transplanted|21|||
126760921|NCT04095039|456075865|FG001|Overall Study|Transplanted|24|||
126760922|NCT04095039|456075864|FG000|Overall Study|Transferred to Non-study Facility|47|||
126760923|NCT04095039|456075865|FG001|Overall Study|Transferred to Non-study Facility|44|||
126760924|NCT04095039|456075864|FG000|Overall Study|Withdrawal from internvention target|0|||
126760925|NCT04095039|456075865|FG001|Overall Study|Withdrawal from internvention target|2|||
126760926|NCT04095039|456075864|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
126760927|NCT04095039|456075865|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
126760928|NCT04095039|456075864|FG000|Overall Study|Cacliphylaxis|0|||
126760929|NCT04095039|456075865|FG001|Overall Study|Cacliphylaxis|1|||
126760930|NCT04095039|456075864|FG000|Overall Study|Pregnancy|1|||
126760931|NCT04095039|456075865|FG001|Overall Study|Pregnancy|0|||
126545510|NCT05778526|455290874|FG001|Overall Study|Protocol Violation|0|||
126545511|NCT05778526|455290875|FG002|Overall Study|Protocol Violation|8|||
126545512|NCT04534114|455290878|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
126545513|NCT04534114|455290879|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
126545514|NCT04534114|455290880|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
126545515|NCT04534114|455290881|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
126545516|NCT04534114|455290878|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
126545517|NCT04534114|455290879|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
126545518|NCT04534114|455290880|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
126545519|NCT04534114|455290881|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
126545520|NCT04534114|455290878|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
126545521|NCT04534114|455290879|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
126545522|NCT04534114|455290880|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
126545523|NCT04534114|455290881|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
126545524|NCT04534114|455290878|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
126545525|NCT04534114|455290879|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
126545526|NCT04534114|455290880|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
126545527|NCT04534114|455290881|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
126545528|NCT04534114|455290878|FG000|Main Treatment Period|Physician Decision|0|||
126545529|NCT04534114|455290879|FG001|Main Treatment Period|Physician Decision|0|||
126545530|NCT04534114|455290880|FG002|Main Treatment Period|Physician Decision|0|||
126760932|NCT01990339|456075868|FG000|Overall Study|Data Not Available|49|||
126760933|NCT01990339|456075868|FG000|Overall Study|Voluntary Withdrawal|1402|||
126760934|NCT01990339|456075868|FG000|Overall Study|Lost to Follow-up|861|||
126760935|NCT01038609|456075869|FG000|Overall Study|Adverse Event|0|||
126760936|NCT01038609|456075870|FG001|Overall Study|Adverse Event|0|||
126760937|NCT01038609|456075871|FG002|Overall Study|Adverse Event|1|||
126760938|NCT01038609|456075872|FG003|Overall Study|Adverse Event|0|||
126545531|NCT04534114|455290881|FG003|Main Treatment Period|Physician Decision|1|||
126545532|NCT04534114|455290878|FG000|Main Treatment Period|Death|1|||
126760939|NCT01038609|456075873|FG004|Overall Study|Adverse Event|0|||
126760940|NCT01038609|456075869|FG000|Overall Study|Dosing Error|0|||
126760941|NCT01038609|456075870|FG001|Overall Study|Dosing Error|0|||
126694331|NCT00944034|455835077|FG002|Overall Study|Inappropriate enrollment|0|||
126694332|NCT00944034|455835078|FG003|Overall Study|Inappropriate enrollment|1|||
126694333|NCT00944034|455835079|FG004|Overall Study|Inappropriate enrollment|2|||
126694334|NCT00944034|455835080|FG005|Overall Study|Inappropriate enrollment|1|||
126694335|NCT00944034|455835081|FG006|Overall Study|Inappropriate enrollment|0|||
126694336|NCT00944034|455835082|FG007|Overall Study|Inappropriate enrollment|0|||
126694337|NCT00944034|455835083|FG008|Overall Study|Inappropriate enrollment|1|||
126356872|NCT03166631|454599609|FG007|Overall Study|Progressive disease|6|||
126356873|NCT03166631|454599610|FG008|Overall Study|Progressive disease|11|||
126356874|NCT03166631|454599611|FG009|Overall Study|Progressive disease|5|||
126356875|NCT03166631|454599612|FG010|Overall Study|Progressive disease|7|||
126356876|NCT03166631|454599602|FG000|Overall Study|Physician Decision|0|||
126356877|NCT03166631|454599603|FG001|Overall Study|Physician Decision|0|||
126356878|NCT03166631|454599604|FG002|Overall Study|Physician Decision|0|||
126356879|NCT03166631|454599605|FG003|Overall Study|Physician Decision|0|||
126356880|NCT03166631|454599606|FG004|Overall Study|Physician Decision|0|||
126356881|NCT03166631|454599607|FG005|Overall Study|Physician Decision|0|||
126356882|NCT03166631|454599608|FG006|Overall Study|Physician Decision|1|||
126356883|NCT03166631|454599609|FG007|Overall Study|Physician Decision|0|||
126356884|NCT03166631|454599610|FG008|Overall Study|Physician Decision|1|||
126356885|NCT03166631|454599611|FG009|Overall Study|Physician Decision|0|||
126356886|NCT03166631|454599612|FG010|Overall Study|Physician Decision|1|||
126356887|NCT03166631|454599602|FG000|Overall Study|Death|0|||
126356888|NCT03166631|454599603|FG001|Overall Study|Death|0|||
126356889|NCT03166631|454599604|FG002|Overall Study|Death|0|||
126356890|NCT03166631|454599605|FG003|Overall Study|Death|0|||
126356891|NCT03166631|454599606|FG004|Overall Study|Death|1|||
126356892|NCT03166631|454599607|FG005|Overall Study|Death|0|||
126356893|NCT03166631|454599608|FG006|Overall Study|Death|1|||
126356894|NCT03166631|454599609|FG007|Overall Study|Death|0|||
126356895|NCT03166631|454599610|FG008|Overall Study|Death|0|||
126356896|NCT03166631|454599611|FG009|Overall Study|Death|0|||
126356897|NCT03166631|454599612|FG010|Overall Study|Death|0|||
126356898|NCT03166631|454599602|FG000|Overall Study|Adverse Event|1|||
126356899|NCT03166631|454599603|FG001|Overall Study|Adverse Event|0|||
126356900|NCT03166631|454599604|FG002|Overall Study|Adverse Event|0|||
126356901|NCT03166631|454599605|FG003|Overall Study|Adverse Event|0|||
126356902|NCT03166631|454599606|FG004|Overall Study|Adverse Event|0|||
126356903|NCT03166631|454599607|FG005|Overall Study|Adverse Event|1|||
126356904|NCT03166631|454599608|FG006|Overall Study|Adverse Event|1|||
126356905|NCT03166631|454599609|FG007|Overall Study|Adverse Event|0|||
126356906|NCT03166631|454599610|FG008|Overall Study|Adverse Event|1|||
126356907|NCT03166631|454599611|FG009|Overall Study|Adverse Event|2|||
126356908|NCT03166631|454599612|FG010|Overall Study|Adverse Event|1|||
126545533|NCT04534114|455290879|FG001|Main Treatment Period|Death|0|||
126356909|NCT03166631|454599602|FG000|Overall Study|Withdrawal by Subject|0|||
126356910|NCT03166631|454599603|FG001|Overall Study|Withdrawal by Subject|0|||
126356911|NCT03166631|454599604|FG002|Overall Study|Withdrawal by Subject|0|||
126356912|NCT03166631|454599605|FG003|Overall Study|Withdrawal by Subject|0|||
126694338|NCT00944034|455835084|FG009|Overall Study|Inappropriate enrollment|1|||
126694339|NCT00944034|455835085|FG010|Overall Study|Inappropriate enrollment|0|||
126694340|NCT00944034|455835086|FG011|Overall Study|Inappropriate enrollment|0|||
126356913|NCT03166631|454599606|FG004|Overall Study|Withdrawal by Subject|0|||
126356914|NCT03166631|454599607|FG005|Overall Study|Withdrawal by Subject|0|||
126356915|NCT03166631|454599608|FG006|Overall Study|Withdrawal by Subject|0|||
126694341|NCT00944034|455835075|FG000|Overall Study|Withdrawal by Subject|3|||
126694342|NCT00944034|455835076|FG001|Overall Study|Withdrawal by Subject|2|||
126694343|NCT00944034|455835077|FG002|Overall Study|Withdrawal by Subject|6|||
126694344|NCT00944034|455835078|FG003|Overall Study|Withdrawal by Subject|2|||
126694345|NCT00944034|455835079|FG004|Overall Study|Withdrawal by Subject|5|||
126694346|NCT00944034|455835080|FG005|Overall Study|Withdrawal by Subject|8|||
126694347|NCT00944034|455835081|FG006|Overall Study|Withdrawal by Subject|2|||
126694348|NCT00944034|455835082|FG007|Overall Study|Withdrawal by Subject|2|||
126694349|NCT00944034|455835083|FG008|Overall Study|Withdrawal by Subject|3|||
126446845|NCT02625909|454935630|FG000|Overall Study|Lack of Efficacy|9|||
126446846|NCT02625909|454935631|FG001|Overall Study|Lack of Efficacy|2|||
126446847|NCT02625909|454935630|FG000|Overall Study|Reinfection|3|||
126446848|NCT02625909|454935631|FG001|Overall Study|Reinfection|2|||
126446849|NCT02367833|454935632|FG000|Overall Study|Withdrawal by Subject|1|||
126446850|NCT02367833|454935633|FG001|Overall Study|Withdrawal by Subject|1|||
126446851|NCT02367833|454935634|FG002|Overall Study|Withdrawal by Subject|0|||
126446852|NCT00035932|454935639|FG000|Overall Study|Adverse Event|10|||
126446853|NCT00035932|454935640|FG001|Overall Study|Adverse Event|9|||
126446854|NCT00035932|454935641|FG002|Overall Study|Adverse Event|9|||
126446855|NCT00035932|454935639|FG000|Overall Study|Death|0|||
126446856|NCT00035932|454935640|FG001|Overall Study|Death|0|||
126446857|NCT00035932|454935641|FG002|Overall Study|Death|1|||
126446858|NCT00035932|454935639|FG000|Overall Study|Disease Progression / Relapse|1|||
126446859|NCT00035932|454935640|FG001|Overall Study|Disease Progression / Relapse|1|||
126446860|NCT00035932|454935641|FG002|Overall Study|Disease Progression / Relapse|0|||
126446861|NCT00035932|454935639|FG000|Overall Study|Lost to Follow-up|4|||
126446862|NCT00035932|454935640|FG001|Overall Study|Lost to Follow-up|4|||
126446863|NCT00035932|454935641|FG002|Overall Study|Lost to Follow-up|3|||
126760942|NCT01038609|456075871|FG002|Overall Study|Dosing Error|0|||
126446864|NCT00035932|454935639|FG000|Overall Study|Noncompliance|6|||
126446865|NCT00035932|454935640|FG001|Overall Study|Noncompliance|7|||
126694350|NCT00944034|455835084|FG009|Overall Study|Withdrawal by Subject|4|||
126694351|NCT00944034|455835085|FG010|Overall Study|Withdrawal by Subject|0|||
126446866|NCT00035932|454935641|FG002|Overall Study|Noncompliance|6|||
126446867|NCT00035932|454935639|FG000|Overall Study|Protocol Violation While on Study|0|||
126446868|NCT00035932|454935640|FG001|Overall Study|Protocol Violation While on Study|1|||
126446869|NCT00035932|454935641|FG002|Overall Study|Protocol Violation While on Study|2|||
126446870|NCT00035932|454935639|FG000|Overall Study|Withdrawal by Subject|1|||
126446871|NCT00035932|454935640|FG001|Overall Study|Withdrawal by Subject|5|||
126446872|NCT00035932|454935641|FG002|Overall Study|Withdrawal by Subject|0|||
126446873|NCT00035932|454935639|FG000|Overall Study|Study Termination by Sponsor|1|||
126446874|NCT00035932|454935640|FG001|Overall Study|Study Termination by Sponsor|0|||
126446875|NCT00035932|454935641|FG002|Overall Study|Study Termination by Sponsor|0|||
126446876|NCT00035932|454935639|FG000|Overall Study|Lack of Efficacy|33|||
126446877|NCT00035932|454935640|FG001|Overall Study|Lack of Efficacy|33|||
126446878|NCT00035932|454935641|FG002|Overall Study|Lack of Efficacy|28|||
126446879|NCT04080167|454935644|FG000|Overall Study|Lost to Follow-up-Patients|7|||
126446880|NCT04080167|454935645|FG001|Overall Study|Lost to Follow-up-Patients|14|||
126446881|NCT04080167|454935646|FG002|Overall Study|Lost to Follow-up-Patients|0|||
126446882|NCT04080167|454935644|FG000|Overall Study|Lost to Follow-up-Providers|2|||
126446883|NCT04080167|454935645|FG001|Overall Study|Lost to Follow-up-Providers|2|||
126446884|NCT04080167|454935646|FG002|Overall Study|Lost to Follow-up-Providers|0|||
126446885|NCT04080167|454935644|FG000|Overall Study|Withdrawal by Subject|1|||
126446886|NCT04080167|454935645|FG001|Overall Study|Withdrawal by Subject|2|||
126446887|NCT04080167|454935646|FG002|Overall Study|Withdrawal by Subject|0|||
126446888|NCT04080167|454935644|FG000|Overall Study|Withdrawal by Provider|0|||
126446889|NCT04080167|454935645|FG001|Overall Study|Withdrawal by Provider|0|||
126446890|NCT04080167|454935646|FG002|Overall Study|Withdrawal by Provider|4|||
126446891|NCT04080167|454935644|FG000|Overall Study|Death-Patient|2|||
126446892|NCT04080167|454935645|FG001|Overall Study|Death-Patient|1|||
126446893|NCT04080167|454935646|FG002|Overall Study|Death-Patient|0|||
126446894|NCT04080167|454935644|FG000|Overall Study|Hydroxyurea New Starts|0|||
126446895|NCT04080167|454935645|FG001|Overall Study|Hydroxyurea New Starts|0|||
126446896|NCT04080167|454935646|FG002|Overall Study|Hydroxyurea New Starts|1|||
126446897|NCT04080167|454935644|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
126446898|NCT04080167|454935645|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
126446899|NCT04080167|454935646|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
126446900|NCT01459497|454935647|FG000|Overall Study|Inability to meet trial constraints.|1|||
126446901|NCT01459497|454935648|FG001|Overall Study|Inability to meet trial constraints.|0|||
126446902|NCT01459497|454935647|FG000|Overall Study|Physician Decision|1|||
126446903|NCT01459497|454935648|FG001|Overall Study|Physician Decision|1|||
126446904|NCT01459497|454935647|FG000|Overall Study|Hospitalization.|0|||
126446905|NCT01459497|454935648|FG001|Overall Study|Hospitalization.|3|||
126446906|NCT01459497|454935647|FG000|Overall Study|Disease progression.|0|||
126446907|NCT01459497|454935648|FG001|Overall Study|Disease progression.|1|||
126446908|NCT01192191|454935649|FG000|Overall Study|Adverse Event|7|||
126446909|NCT01192191|454935650|FG001|Overall Study|Adverse Event|12|||
126446910|NCT01192191|454935649|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
126446911|NCT01192191|454935650|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
126694352|NCT00944034|455835086|FG011|Overall Study|Withdrawal by Subject|4|||
126356916|NCT03166631|454599609|FG007|Overall Study|Withdrawal by Subject|0|||
126356917|NCT03166631|454599610|FG008|Overall Study|Withdrawal by Subject|1|||
126356918|NCT03166631|454599611|FG009|Overall Study|Withdrawal by Subject|1|||
126356919|NCT03166631|454599612|FG010|Overall Study|Withdrawal by Subject|0|||
126356920|NCT00567580|454599615|FG000|Overall Study|Protocol Violation|28|||
126356921|NCT00567580|454599616|FG001|Overall Study|Protocol Violation|24|||
126356922|NCT00567580|454599617|FG002|Overall Study|Protocol Violation|24|||
126356923|NCT03197935|454599620|FG000|Overall Study|Death due to any cause|26|||
126356924|NCT03197935|454599621|FG001|Overall Study|Death due to any cause|15|||
126356925|NCT03197935|454599620|FG000|Overall Study|Lost to Follow-up|3|||
126356926|NCT03197935|454599621|FG001|Overall Study|Lost to Follow-up|5|||
126356927|NCT03197935|454599620|FG000|Overall Study|Physician Decision|2|||
126356928|NCT03197935|454599621|FG001|Overall Study|Physician Decision|1|||
126356929|NCT03197935|454599620|FG000|Overall Study|Withdrawal by Subject|16|||
126356930|NCT03197935|454599621|FG001|Overall Study|Withdrawal by Subject|8|||
126356931|NCT00864513|454599622|FG000|Overall Study|Withdrawal by Subject|3|||
126356932|NCT00762788|454599623|FG000|Overall Study|Lost to Follow-up|26|||
126356933|NCT00762788|454599624|FG001|Overall Study|Lost to Follow-up|37|||
126356934|NCT00762788|454599625|FG002|Overall Study|Lost to Follow-up|21|||
126356935|NCT00762788|454599626|FG003|Overall Study|Lost to Follow-up|26|||
126356936|NCT00762788|454599627|FG004|Overall Study|Lost to Follow-up|13|||
126356937|NCT00762788|454599628|FG005|Overall Study|Lost to Follow-up|21|||
126356938|NCT03073109|454599629|FG000|Overall Study|Adverse Event|0|||
126356939|NCT03073109|454599630|FG001|Overall Study|Adverse Event|1|||
126356940|NCT03073109|454599629|FG000|Overall Study|Other|2|||
126356941|NCT03073109|454599630|FG001|Overall Study|Other|0|||
126356942|NCT03073109|454599629|FG000|Overall Study|Lost to Follow-up|8|||
126356943|NCT03073109|454599630|FG001|Overall Study|Lost to Follow-up|1|||
126446912|NCT01192191|454935649|FG000|Overall Study|Lost to Follow-up|0|||
126446913|NCT01192191|454935650|FG001|Overall Study|Lost to Follow-up|1|||
126356944|NCT05938010|454599631|FG000|Overall Study|Lost to Follow-up|2|||
126356945|NCT01562444|454599636|FG000|Overall Study|Did not meet entry criteria|2|||
126356946|NCT01562444|454599637|FG001|Overall Study|Did not meet entry criteria|0|||
126356947|NCT01562444|454599638|FG002|Overall Study|Did not meet entry criteria|3|||
126356948|NCT01562444|454599636|FG000|Overall Study|Did not comply with blood draw schedule|1|||
126545534|NCT04534114|455290880|FG002|Main Treatment Period|Death|0|||
126694353|NCT00944034|455835075|FG000|Overall Study|Lost to Follow-up|0|||
126356949|NCT01562444|454599637|FG001|Overall Study|Did not comply with blood draw schedule|0|||
126356950|NCT01562444|454599638|FG002|Overall Study|Did not comply with blood draw schedule|1|||
126356951|NCT01562444|454599636|FG000|Overall Study|Unavailable serological results|0|||
126356952|NCT01562444|454599637|FG001|Overall Study|Unavailable serological results|2|||
126356953|NCT01562444|454599638|FG002|Overall Study|Unavailable serological results|2|||
126356954|NCT01562444|454599636|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
126356955|NCT01562444|454599637|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
126356956|NCT01562444|454599638|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
126356957|NCT01562444|454599636|FG000|Overall Study|Protocol forbidden medication|1|||
126356958|NCT01562444|454599637|FG001|Overall Study|Protocol forbidden medication|0|||
126356959|NCT01562444|454599638|FG002|Overall Study|Protocol forbidden medication|0|||
126356960|NCT02568423|454599646|FG000|Overall Study|Lost to Follow-up|0|||
126356961|NCT02568423|454599647|FG001|Overall Study|Lost to Follow-up|2|||
126356962|NCT02568423|454599648|FG002|Overall Study|Lost to Follow-up|0|||
126356963|NCT02568423|454599649|FG003|Overall Study|Lost to Follow-up|0|||
126356964|NCT02568423|454599650|FG004|Overall Study|Lost to Follow-up|0|||
126356965|NCT02568423|454599651|FG005|Overall Study|Lost to Follow-up|0|||
126356966|NCT02568423|454599652|FG006|Overall Study|Lost to Follow-up|0|||
126356967|NCT02568423|454599653|FG007|Overall Study|Lost to Follow-up|0|||
126356968|NCT02568423|454599646|FG000|Overall Study|Physician Decision|0|||
126694354|NCT00944034|455835076|FG001|Overall Study|Lost to Follow-up|4|||
126545535|NCT04534114|455290881|FG003|Main Treatment Period|Death|1|||
126545536|NCT04534114|455290878|FG000|Main Treatment Period|Other reason|1|||
126545537|NCT04534114|455290879|FG001|Main Treatment Period|Other reason|1|||
126545538|NCT04534114|455290880|FG002|Main Treatment Period|Other reason|0|||
126545539|NCT04534114|455290881|FG003|Main Treatment Period|Other reason|0|||
126545540|NCT04534114|455290878|FG000|Main Treatment Period|Participant decision|1|||
126545541|NCT04534114|455290879|FG001|Main Treatment Period|Participant decision|3|||
126545542|NCT04534114|455290880|FG002|Main Treatment Period|Participant decision|3|||
126545543|NCT04534114|455290881|FG003|Main Treatment Period|Participant decision|1|||
126545544|NCT04534114|455290878|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
126545545|NCT04534114|455290879|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
126545546|NCT04534114|455290880|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
126545547|NCT04534114|455290881|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
126545548|NCT04534114|455290878|FG000|Main Treatment Period|Adverse Event|4|||
126545549|NCT04534114|455290879|FG001|Main Treatment Period|Adverse Event|2|||
126545550|NCT04534114|455290880|FG002|Main Treatment Period|Adverse Event|1|||
126545551|NCT04534114|455290881|FG003|Main Treatment Period|Adverse Event|2|||
126545552|NCT04534114|455290878|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
126545553|NCT04534114|455290879|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
126545554|NCT04534114|455290880|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
126545555|NCT04534114|455290881|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
126545556|NCT04534114|455290878|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
126545557|NCT04534114|455290879|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
126545558|NCT04534114|455290880|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
126545559|NCT04534114|455290881|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
126545560|NCT04534114|455290878|FG000|Extension Treatment Period|Other reason|0|||
126545561|NCT04534114|455290879|FG001|Extension Treatment Period|Other reason|1|||
126545562|NCT04534114|455290880|FG002|Extension Treatment Period|Other reason|0|||
126545563|NCT04534114|455290881|FG003|Extension Treatment Period|Other reason|0|||
126545564|NCT04534114|455290878|FG000|Extension Treatment Period|Death|0|||
126545565|NCT04534114|455290879|FG001|Extension Treatment Period|Death|0|||
126545566|NCT04534114|455290880|FG002|Extension Treatment Period|Death|1|||
126545567|NCT04534114|455290881|FG003|Extension Treatment Period|Death|2|||
126545568|NCT04534114|455290878|FG000|Extension Treatment Period|Adverse Event|0|||
126545569|NCT04534114|455290879|FG001|Extension Treatment Period|Adverse Event|1|||
126545570|NCT04534114|455290880|FG002|Extension Treatment Period|Adverse Event|0|||
126545571|NCT04534114|455290881|FG003|Extension Treatment Period|Adverse Event|1|||
126545572|NCT04534114|455290878|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
126545573|NCT04534114|455290879|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
126545574|NCT04534114|455290880|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
126545575|NCT04534114|455290881|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
126545576|NCT03287414|455290882|FG000|Treatment Epoch|Adverse Event|0|||
126545577|NCT03287414|455290883|FG001|Treatment Epoch|Adverse Event|1|||
126545578|NCT03287414|455290882|FG000|Treatment Epoch|Study terminated by sponsor|2|||
126545579|NCT03287414|455290883|FG001|Treatment Epoch|Study terminated by sponsor|2|||
126545580|NCT03287414|455290882|FG000|Treatment Epoch|Subject/Guardian decision|4|||
126545581|NCT03287414|455290883|FG001|Treatment Epoch|Subject/Guardian decision|0|||
126545582|NCT03287414|455290882|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
126545583|NCT03287414|455290883|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
126545584|NCT03287414|455290882|FG000|Treatment Epoch|Withdrawal by Subject|1|||
126545585|NCT03287414|455290883|FG001|Treatment Epoch|Withdrawal by Subject|0|||
126545586|NCT03287414|455290882|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
126545587|NCT03287414|455290883|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
126545588|NCT03287414|455290882|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
126545589|NCT03287414|455290883|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
126545590|NCT02759185|455290884|FG000|Stage 1|Adverse Event|0|||
126545591|NCT02759185|455290885|FG001|Stage 1|Adverse Event|1|||
126545592|NCT02759185|455290886|FG002|Stage 1|Adverse Event|3|||
126545593|NCT02759185|455290887|FG003|Stage 1|Adverse Event|0|||
126545594|NCT02759185|455290888|FG004|Stage 1|Adverse Event|0|||
126545595|NCT02759185|455290889|FG005|Stage 1|Adverse Event|0|||
126545596|NCT02759185|455290890|FG006|Stage 1|Adverse Event|0|||
126545597|NCT02759185|455290884|FG000|Stage 1|Withdrawal by Subject|1|||
126545598|NCT02759185|455290885|FG001|Stage 1|Withdrawal by Subject|0|||
126545599|NCT02759185|455290886|FG002|Stage 1|Withdrawal by Subject|0|||
126545600|NCT02759185|455290887|FG003|Stage 1|Withdrawal by Subject|0|||
126545601|NCT02759185|455290888|FG004|Stage 1|Withdrawal by Subject|0|||
126545602|NCT02759185|455290889|FG005|Stage 1|Withdrawal by Subject|0|||
126545603|NCT02759185|455290890|FG006|Stage 1|Withdrawal by Subject|0|||
126545604|NCT02759185|455290884|FG000|Stage 2|Adverse Event|0|||
126545605|NCT02759185|455290885|FG001|Stage 2|Adverse Event|0|||
126545606|NCT02759185|455290886|FG002|Stage 2|Adverse Event|0|||
126545607|NCT02759185|455290887|FG003|Stage 2|Adverse Event|0|||
126545608|NCT02759185|455290888|FG004|Stage 2|Adverse Event|1|||
126545609|NCT02759185|455290889|FG005|Stage 2|Adverse Event|2|||
126545610|NCT02759185|455290890|FG006|Stage 2|Adverse Event|0|||
126545611|NCT02759185|455290884|FG000|Stage 2|Withdrawal by Subject|0|||
126545612|NCT02759185|455290885|FG001|Stage 2|Withdrawal by Subject|0|||
126545613|NCT02759185|455290886|FG002|Stage 2|Withdrawal by Subject|0|||
126545614|NCT02759185|455290887|FG003|Stage 2|Withdrawal by Subject|0|||
126545615|NCT02759185|455290888|FG004|Stage 2|Withdrawal by Subject|1|||
126545616|NCT02759185|455290889|FG005|Stage 2|Withdrawal by Subject|1|||
126545617|NCT02759185|455290890|FG006|Stage 2|Withdrawal by Subject|1|||
126545618|NCT02668016|455290891|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
126545619|NCT02668016|455290891|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
126545620|NCT02668016|455290891|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
126545621|NCT02668016|455290891|FG000|Month 4|Withdrawal due to severe symptoms|1|||
126545622|NCT02668016|455290891|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
126545623|NCT02668016|455290891|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
126545624|NCT02668016|455290891|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
126545625|NCT02668016|455290891|FG000|Month 6|Withdrawal due to severe symptoms|2|||
126545626|NCT02668016|455290891|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
126545627|NCT02668016|455290891|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
126545628|NCT02668016|455290891|FG000|Month 8|Withdrawal due to severe symptoms|1|||
126545629|NCT02668016|455290891|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
126545630|NCT02668016|455290891|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
126545631|NCT02668016|455290891|FG000|Month 10|Withdrawal due to severe symptoms|1|||
126545632|NCT02668016|455290891|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
126545633|NCT02294474|455290901|FG000|Overall Study|Adverse Event|7|||
126446914|NCT01192191|454935649|FG000|Overall Study|Withdrawal by Subject|1|||
126446915|NCT01192191|454935650|FG001|Overall Study|Withdrawal by Subject|6|||
126446916|NCT03530124|454935651|FG000|Overall Study|Withdrawal by Subject|0|||
126446917|NCT03530124|454935652|FG001|Overall Study|Withdrawal by Subject|1|||
126446918|NCT03530124|454935651|FG000|Overall Study|Protocol Violation|1|||
126446919|NCT03530124|454935652|FG001|Overall Study|Protocol Violation|0|||
126446920|NCT03530124|454935651|FG000|Overall Study|Discharged prior to study completion|1|||
126446921|NCT03530124|454935652|FG001|Overall Study|Discharged prior to study completion|0|||
126446922|NCT01047553|454935653|FG000|Overall Study|Adverse Event|10|||
126446923|NCT01047553|454935654|FG001|Overall Study|Adverse Event|5|||
126446924|NCT01047553|454935653|FG000|Overall Study|Withdrawal by Subject|4|||
126446925|NCT01047553|454935654|FG001|Overall Study|Withdrawal by Subject|2|||
126545634|NCT02294474|455290902|FG001|Overall Study|Adverse Event|7|||
126545635|NCT02294474|455290901|FG000|Overall Study|Lack of Efficacy|2|||
126545636|NCT02294474|455290902|FG001|Overall Study|Lack of Efficacy|1|||
126545637|NCT02294474|455290901|FG000|Overall Study|Protocol Violation|4|||
126545638|NCT02294474|455290902|FG001|Overall Study|Protocol Violation|2|||
126545639|NCT02294474|455290901|FG000|Overall Study|Other than specified above|12|||
126694355|NCT00944034|455835077|FG002|Overall Study|Lost to Follow-up|2|||
126446926|NCT01047553|454935653|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
126446927|NCT01047553|454935654|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
126446928|NCT01047553|454935653|FG000|Overall Study|Lost to Follow-up|1|||
126446929|NCT01047553|454935654|FG001|Overall Study|Lost to Follow-up|0|||
126446930|NCT01047553|454935653|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
126446931|NCT01047553|454935654|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
126446932|NCT01047553|454935653|FG000|Overall Study|PI's decision|0|||
126446933|NCT01047553|454935654|FG001|Overall Study|PI's decision|1|||
126446934|NCT03179319|454935655|FG000|Overall Study|Lost to Follow-up|6|||
126446935|NCT03179319|454935656|FG001|Overall Study|Lost to Follow-up|0|||
126446936|NCT01120717|454935657|FG000|Overall Study|Withdrawal by Subject|11|||
126446937|NCT01120717|454935658|FG001|Overall Study|Withdrawal by Subject|6|||
126446938|NCT01120717|454935657|FG000|Overall Study|Adverse Event|10|||
126446939|NCT01120717|454935658|FG001|Overall Study|Adverse Event|6|||
126446940|NCT01120717|454935657|FG000|Overall Study|Protocol Deviation|2|||
126446941|NCT01120717|454935658|FG001|Overall Study|Protocol Deviation|5|||
126446942|NCT01120717|454935657|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126446943|NCT01120717|454935658|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126446944|NCT01120717|454935657|FG000|Overall Study|Lost to Follow-up|2|||
126446945|NCT01120717|454935658|FG001|Overall Study|Lost to Follow-up|3|||
126446946|NCT01120717|454935657|FG000|Overall Study|Death|3|||
126446947|NCT01120717|454935658|FG001|Overall Study|Death|1|||
126446948|NCT01120717|454935657|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
126446949|NCT01120717|454935658|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
126446950|NCT05334212|454935661|FG000|Overall Study|Study terminated prematurely|7|||
126446951|NCT01668589|454935662|FG000|Overall Study|Lost to Follow-up|29|||
126446952|NCT01668589|454935663|FG001|Overall Study|Lost to Follow-up|37|||
126446953|NCT01668589|454935664|FG002|Overall Study|Lost to Follow-up|15|||
126446954|NCT01668589|454935665|FG003|Overall Study|Lost to Follow-up|5|||
126446955|NCT01668589|454935662|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
126446956|NCT01668589|454935663|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
126446957|NCT01668589|454935664|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
126446958|NCT01668589|454935665|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
126446959|NCT01668589|454935662|FG000|Overall Study|Death|12|||
126446960|NCT01668589|454935663|FG001|Overall Study|Death|3|||
126446961|NCT01668589|454935664|FG002|Overall Study|Death|2|||
126446962|NCT01668589|454935665|FG003|Overall Study|Death|11|||
126446963|NCT01668589|454935662|FG000|Overall Study|Other|44|||
126446964|NCT01668589|454935663|FG001|Overall Study|Other|10|||
126446965|NCT01668589|454935664|FG002|Overall Study|Other|7|||
126446966|NCT01668589|454935665|FG003|Overall Study|Other|15|||
126446967|NCT04393454|454935666|FG000|Overall Study|Death|1|||
126446968|NCT04393454|454935666|FG000|Overall Study|Lost to Follow-up|1|||
126446969|NCT03304249|454935667|FG000|Overall Study|Lost to Follow-up|8|||
126446970|NCT03304249|454935668|FG001|Overall Study|Lost to Follow-up|10|||
126446971|NCT03304249|454935667|FG000|Overall Study|Withdrawal by Subject|12|||
126446972|NCT03304249|454935668|FG001|Overall Study|Withdrawal by Subject|2|||
126694356|NCT00944034|455835078|FG003|Overall Study|Lost to Follow-up|0|||
126694357|NCT00944034|455835079|FG004|Overall Study|Lost to Follow-up|5|||
126694358|NCT00944034|455835080|FG005|Overall Study|Lost to Follow-up|7|||
126446973|NCT03304249|454935667|FG000|Overall Study|Moved Out of District|4|||
126446974|NCT03304249|454935668|FG001|Overall Study|Moved Out of District|2|||
126446975|NCT02260180|454937874|FG000|Overall Study|Adverse Event|2|||
126446976|NCT02260180|454937875|FG001|Overall Study|Adverse Event|0|||
126446977|NCT02260180|454937876|FG002|Overall Study|Adverse Event|1|||
126446978|NCT03860818|454937880|FG000|Overall Study|Death|144|||
126446979|NCT03860818|454937881|FG001|Overall Study|Death|195|||
126694359|NCT00944034|455835081|FG006|Overall Study|Lost to Follow-up|0|||
126446980|NCT03860818|454937880|FG000|Overall Study|Graft Loss|32|||
126446981|NCT03860818|454937881|FG001|Overall Study|Graft Loss|45|||
126446982|NCT03126344|454937882|FG000|Overall Study|Lost to Follow-up|0|||
126446983|NCT03126344|454937883|FG001|Overall Study|Lost to Follow-up|0|||
126694360|NCT00944034|455835082|FG007|Overall Study|Lost to Follow-up|1|||
126356969|NCT02568423|454599647|FG001|Overall Study|Physician Decision|0|||
126356970|NCT02568423|454599648|FG002|Overall Study|Physician Decision|0|||
126356971|NCT02568423|454599649|FG003|Overall Study|Physician Decision|0|||
126356972|NCT02568423|454599650|FG004|Overall Study|Physician Decision|0|||
126356973|NCT02568423|454599651|FG005|Overall Study|Physician Decision|1|||
126356974|NCT02568423|454599652|FG006|Overall Study|Physician Decision|0|||
126356975|NCT02568423|454599653|FG007|Overall Study|Physician Decision|0|||
126356976|NCT01027416|454599657|FG000|Overall Study|Withdrawal by Subject|0|||
126356977|NCT01027416|454599658|FG001|Overall Study|Withdrawal by Subject|1|||
126356978|NCT01027416|454599657|FG000|Overall Study|Physician Decision|1|||
126356979|NCT01027416|454599658|FG001|Overall Study|Physician Decision|4|||
126356980|NCT00676052|454599660|FG000|Overall Study|Adverse Event|0|||
126446984|NCT03126344|454937884|FG002|Overall Study|Lost to Follow-up|5|||
126446985|NCT01139008|454937885|FG000|Overall Study|Withdrawal by Subject|5|||
126694361|NCT00944034|455835083|FG008|Overall Study|Lost to Follow-up|5|||
126446986|NCT01139008|454937885|FG000|Overall Study|Non-compliant, lost product|1|||
126446987|NCT01715857|454937886|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
126446988|NCT00505778|454937890|FG000|Overall Study|Adverse Event|2|||
126446989|NCT00505778|454937891|FG001|Overall Study|Adverse Event|7|||
126446990|NCT00505778|454937890|FG000|Overall Study|Physician Decision|8|||
126446991|NCT00505778|454937891|FG001|Overall Study|Physician Decision|14|||
126446992|NCT00505778|454937890|FG000|Overall Study|Lost to Follow-up|17|||
126446993|NCT00505778|454937891|FG001|Overall Study|Lost to Follow-up|23|||
126446994|NCT00505778|454937890|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
126446995|NCT00505778|454937891|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
126446996|NCT00505778|454937890|FG000|Overall Study|Protocol Violation|7|||
126446997|NCT00505778|454937891|FG001|Overall Study|Protocol Violation|9|||
126446998|NCT00505778|454937890|FG000|Overall Study|Withdrawal by Subject|29|||
126694362|NCT00944034|455835084|FG009|Overall Study|Lost to Follow-up|1|||
126446999|NCT00505778|454937891|FG001|Overall Study|Withdrawal by Subject|14|||
126447000|NCT00505778|454937890|FG000|Overall Study|Relapse|65|||
126447001|NCT00505778|454937891|FG001|Overall Study|Relapse|65|||
126694363|NCT00944034|455835085|FG010|Overall Study|Lost to Follow-up|1|||
126447002|NCT00505778|454937890|FG000|Overall Study|Took No Study Drug|2|||
126447003|NCT00505778|454937891|FG001|Overall Study|Took No Study Drug|2|||
126694364|NCT00944034|455835086|FG011|Overall Study|Lost to Follow-up|0|||
126447004|NCT05367492|454937893|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
126447005|NCT05367492|454937894|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
126447006|NCT05367492|454937895|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
126447007|NCT05367492|454937893|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
126447008|NCT05367492|454937894|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
126447009|NCT05367492|454937895|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
126447010|NCT05367492|454937893|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
126447011|NCT05367492|454937894|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
126447012|NCT05367492|454937895|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
126447013|NCT05367492|454937893|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
126447014|NCT05367492|454937894|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
126447015|NCT05367492|454937895|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
126447016|NCT03085797|454937897|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
126447017|NCT03085797|454937898|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
126447018|NCT03085797|454937897|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
126447019|NCT03085797|454937898|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
126447020|NCT03085797|454937897|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
126447021|NCT03085797|454937898|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
126447022|NCT00545272|454937900|FG000|Overall Study|Protocol deviation|0|||
126447023|NCT00545272|454937901|FG001|Overall Study|Protocol deviation|1|||
126447024|NCT00545272|454937902|FG002|Overall Study|Protocol deviation|0|||
126447025|NCT00545272|454937903|FG003|Overall Study|Protocol deviation|1|||
126447026|NCT00545272|454937904|FG004|Overall Study|Protocol deviation|0|||
126447027|NCT00545272|454937905|FG005|Overall Study|Protocol deviation|1|||
126447028|NCT00545272|454937900|FG000|Overall Study|Adverse Event|0|||
126447029|NCT00545272|454937901|FG001|Overall Study|Adverse Event|0|||
126447030|NCT00545272|454937902|FG002|Overall Study|Adverse Event|1|||
126447031|NCT00545272|454937903|FG003|Overall Study|Adverse Event|0|||
126447032|NCT00545272|454937904|FG004|Overall Study|Adverse Event|0|||
126447033|NCT00545272|454937905|FG005|Overall Study|Adverse Event|1|||
126447034|NCT00545272|454937900|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126447035|NCT00545272|454937901|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126447036|NCT00545272|454937902|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126447037|NCT00545272|454937903|FG003|Overall Study|Abnormal laboratory value(s)|0|||
126447038|NCT00545272|454937904|FG004|Overall Study|Abnormal laboratory value(s)|0|||
126447039|NCT00545272|454937905|FG005|Overall Study|Abnormal laboratory value(s)|1|||
126447040|NCT00545272|454937900|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126447041|NCT00545272|454937901|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126694365|NCT00944034|455835075|FG000|Overall Study|Death|0|||
126694366|NCT00944034|455835076|FG001|Overall Study|Death|0|||
126694367|NCT00944034|455835077|FG002|Overall Study|Death|1|||
126447042|NCT00545272|454937902|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126447043|NCT00545272|454937903|FG003|Overall Study|Abnormal test procedure result(s)|0|||
126447044|NCT00545272|454937904|FG004|Overall Study|Abnormal test procedure result(s)|1|||
126447045|NCT00545272|454937905|FG005|Overall Study|Abnormal test procedure result(s)|0|||
126447046|NCT00545272|454937900|FG000|Overall Study|Lost to Follow-up|0|||
126694368|NCT00944034|455835078|FG003|Overall Study|Death|0|||
126447047|NCT00545272|454937901|FG001|Overall Study|Lost to Follow-up|0|||
126447048|NCT00545272|454937902|FG002|Overall Study|Lost to Follow-up|0|||
126694369|NCT00944034|455835079|FG004|Overall Study|Death|0|||
126694370|NCT00944034|455835080|FG005|Overall Study|Death|0|||
126694371|NCT00944034|455835081|FG006|Overall Study|Death|0|||
126694372|NCT00944034|455835082|FG007|Overall Study|Death|0|||
126447049|NCT00545272|454937903|FG003|Overall Study|Lost to Follow-up|0|||
126447050|NCT00545272|454937904|FG004|Overall Study|Lost to Follow-up|1|||
126447051|NCT00545272|454937905|FG005|Overall Study|Lost to Follow-up|0|||
126447052|NCT01837823|454937906|FG000|Overall Study|Lost to Follow-up|6|||
126447053|NCT00436345|454937911|FG000|Overall Study|ICU resident beyond follow-up period|3|||
126447054|NCT00436345|454937912|FG001|Overall Study|ICU resident beyond follow-up period|0|||
126447055|NCT01175083|454937913|FG000|Primary Epoch|Withdrawal by Subject|0|||
126447056|NCT01175083|454937914|FG001|Primary Epoch|Withdrawal by Subject|0|||
126447057|NCT01175083|454937915|FG002|Primary Epoch|Withdrawal by Subject|0|||
126447058|NCT01175083|454937916|FG003|Primary Epoch|Withdrawal by Subject|0|||
126447059|NCT01175083|454937917|FG004|Primary Epoch|Withdrawal by Subject|0|||
126447060|NCT01175083|454937918|FG005|Primary Epoch|Withdrawal by Subject|2|||
126447061|NCT01175083|454937913|FG000|Primary Epoch|Lost to Follow-up|0|||
126447062|NCT01175083|454937914|FG001|Primary Epoch|Lost to Follow-up|0|||
126447063|NCT01175083|454937915|FG002|Primary Epoch|Lost to Follow-up|0|||
126447064|NCT01175083|454937916|FG003|Primary Epoch|Lost to Follow-up|0|||
126447065|NCT01175083|454937917|FG004|Primary Epoch|Lost to Follow-up|0|||
126447066|NCT01175083|454937918|FG005|Primary Epoch|Lost to Follow-up|1|||
126447067|NCT01175083|454937913|FG000|Booster Epoch|Death|0|||
126447068|NCT01175083|454937914|FG001|Booster Epoch|Death|0|||
126447069|NCT01175083|454937915|FG002|Booster Epoch|Death|1|||
126447070|NCT01175083|454937916|FG003|Booster Epoch|Death|0|||
126447071|NCT01175083|454937917|FG004|Booster Epoch|Death|0|||
126447072|NCT01175083|454937918|FG005|Booster Epoch|Death|0|||
126447073|NCT01175083|454937913|FG000|Booster Epoch|Withdrawal by Subject|0|||
126447074|NCT01175083|454937914|FG001|Booster Epoch|Withdrawal by Subject|0|||
126447075|NCT01175083|454937915|FG002|Booster Epoch|Withdrawal by Subject|0|||
126447076|NCT01175083|454937916|FG003|Booster Epoch|Withdrawal by Subject|1|||
126447077|NCT01175083|454937917|FG004|Booster Epoch|Withdrawal by Subject|0|||
126447078|NCT01175083|454937918|FG005|Booster Epoch|Withdrawal by Subject|0|||
126356981|NCT00676052|454599661|FG001|Overall Study|Adverse Event|1|||
126356982|NCT00676052|454599662|FG002|Overall Study|Adverse Event|1|||
126356983|NCT00676052|454599663|FG003|Overall Study|Adverse Event|2|||
126356984|NCT00676052|454599664|FG004|Overall Study|Adverse Event|2|||
126356985|NCT00676052|454599665|FG005|Overall Study|Adverse Event|2|||
126447079|NCT00475306|454937919|FG000|Overall Study|Protocol Violation|1|||
126447080|NCT00475306|454937920|FG001|Overall Study|Protocol Violation|1|||
126447081|NCT00475306|454937921|FG002|Overall Study|Protocol Violation|0|||
126447082|NCT00475306|454937922|FG003|Overall Study|Protocol Violation|1|||
126447083|NCT01716052|454937923|FG000|Overall Study|Withdrawal of funding|1|||
126447084|NCT01716052|454937924|FG001|Overall Study|Withdrawal of funding|1|||
126447085|NCT02405442|454937925|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
126447086|NCT02405442|454937926|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
126447087|NCT02405442|454937927|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
126447088|NCT02405442|454937928|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
126447089|NCT02405442|454937925|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
126760943|NCT01038609|456075872|FG003|Overall Study|Dosing Error|1|||
126760944|NCT01038609|456075873|FG004|Overall Study|Dosing Error|1|||
126760945|NCT01038609|456075869|FG000|Overall Study|Death in the Family|1|||
126760946|NCT01038609|456075870|FG001|Overall Study|Death in the Family|0|||
126356986|NCT00676052|454599660|FG000|Overall Study|Lack of Efficacy|2|||
126760947|NCT01038609|456075871|FG002|Overall Study|Death in the Family|0|||
126760948|NCT01038609|456075872|FG003|Overall Study|Death in the Family|0|||
126760949|NCT01038609|456075873|FG004|Overall Study|Death in the Family|0|||
126356987|NCT00676052|454599661|FG001|Overall Study|Lack of Efficacy|2|||
126356988|NCT00676052|454599662|FG002|Overall Study|Lack of Efficacy|1|||
126356989|NCT00676052|454599663|FG003|Overall Study|Lack of Efficacy|1|||
126356990|NCT00676052|454599664|FG004|Overall Study|Lack of Efficacy|2|||
126356991|NCT00676052|454599665|FG005|Overall Study|Lack of Efficacy|1|||
126356992|NCT00676052|454599660|FG000|Overall Study|Protocol Violation|5|||
126356993|NCT00676052|454599661|FG001|Overall Study|Protocol Violation|3|||
126356994|NCT00676052|454599662|FG002|Overall Study|Protocol Violation|2|||
126356995|NCT00676052|454599663|FG003|Overall Study|Protocol Violation|2|||
126356996|NCT00676052|454599664|FG004|Overall Study|Protocol Violation|1|||
126356997|NCT00676052|454599665|FG005|Overall Study|Protocol Violation|2|||
126356998|NCT00676052|454599660|FG000|Overall Study|Lost to Follow-up|0|||
126356999|NCT00676052|454599661|FG001|Overall Study|Lost to Follow-up|0|||
126357000|NCT00676052|454599662|FG002|Overall Study|Lost to Follow-up|0|||
126357001|NCT00676052|454599663|FG003|Overall Study|Lost to Follow-up|0|||
126357002|NCT00676052|454599664|FG004|Overall Study|Lost to Follow-up|1|||
126357003|NCT00676052|454599665|FG005|Overall Study|Lost to Follow-up|0|||
126357004|NCT00676052|454599660|FG000|Overall Study|Physician Decision|1|||
126357005|NCT00676052|454599661|FG001|Overall Study|Physician Decision|1|||
126357006|NCT00676052|454599662|FG002|Overall Study|Physician Decision|1|||
126357007|NCT00676052|454599663|FG003|Overall Study|Physician Decision|0|||
126357008|NCT00676052|454599664|FG004|Overall Study|Physician Decision|0|||
126357009|NCT00676052|454599665|FG005|Overall Study|Physician Decision|1|||
126357010|NCT00676052|454599660|FG000|Overall Study|Withdrawal by Subject|1|||
126357011|NCT00676052|454599661|FG001|Overall Study|Withdrawal by Subject|0|||
126357012|NCT00676052|454599662|FG002|Overall Study|Withdrawal by Subject|1|||
126357013|NCT00676052|454599663|FG003|Overall Study|Withdrawal by Subject|0|||
126545640|NCT02294474|455290902|FG001|Overall Study|Other than specified above|12|||
126760950|NCT01038609|456075869|FG000|Overall Study|Refusal of Blood Draws|0|||
126760951|NCT01038609|456075870|FG001|Overall Study|Refusal of Blood Draws|1|||
126760952|NCT01038609|456075871|FG002|Overall Study|Refusal of Blood Draws|0|||
126760953|NCT01038609|456075872|FG003|Overall Study|Refusal of Blood Draws|0|||
126357014|NCT00676052|454599664|FG004|Overall Study|Withdrawal by Subject|0|||
126357015|NCT00676052|454599665|FG005|Overall Study|Withdrawal by Subject|0|||
126357016|NCT02930941|454599666|FG000|Overall Study|Lost to Follow-up|1|||
126357017|NCT02930941|454599667|FG001|Overall Study|Lost to Follow-up|2|||
126357018|NCT00289978|454599670|FG000|Overall Study|Withdrawal by Subject|31|||
126357019|NCT00289978|454599671|FG001|Overall Study|Withdrawal by Subject|17|||
126357020|NCT00289978|454599672|FG002|Overall Study|Withdrawal by Subject|28|||
126357021|NCT00289978|454599670|FG000|Overall Study|Adverse Event|22|||
126357022|NCT00289978|454599671|FG001|Overall Study|Adverse Event|13|||
126357023|NCT00289978|454599672|FG002|Overall Study|Adverse Event|18|||
126357024|NCT00289978|454599670|FG000|Overall Study|Lack of Efficacy|13|||
126357025|NCT00289978|454599671|FG001|Overall Study|Lack of Efficacy|6|||
126357026|NCT00289978|454599672|FG002|Overall Study|Lack of Efficacy|25|||
126357027|NCT00289978|454599670|FG000|Overall Study|Abnormal laboratory value(s)|20|||
126357028|NCT00289978|454599671|FG001|Overall Study|Abnormal laboratory value(s)|9|||
126357029|NCT00289978|454599672|FG002|Overall Study|Abnormal laboratory value(s)|1|||
126357030|NCT00289978|454599670|FG000|Overall Study|Lost to Follow-up|3|||
126357031|NCT00289978|454599671|FG001|Overall Study|Lost to Follow-up|5|||
126357032|NCT00289978|454599672|FG002|Overall Study|Lost to Follow-up|7|||
126357033|NCT00289978|454599670|FG000|Overall Study|Protocol Violation|5|||
126357034|NCT00289978|454599671|FG001|Overall Study|Protocol Violation|5|||
126357035|NCT00289978|454599672|FG002|Overall Study|Protocol Violation|4|||
126357036|NCT00289978|454599670|FG000|Overall Study|Abnormal test procedure result(s)|2|||
126357037|NCT00289978|454599671|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126357038|NCT00289978|454599672|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126357039|NCT00289978|454599670|FG000|Overall Study|Death|1|||
126357040|NCT00289978|454599671|FG001|Overall Study|Death|0|||
126357041|NCT00289978|454599672|FG002|Overall Study|Death|2|||
126357042|NCT01967277|454599674|FG000|Overall Study|Lost to Follow-up|1|||
126357043|NCT01967277|454599675|FG001|Overall Study|Lost to Follow-up|2|||
126357044|NCT01967277|454599674|FG000|Overall Study|Unrelated illness|0|||
126357045|NCT01967277|454599675|FG001|Overall Study|Unrelated illness|1|||
126357046|NCT00103506|454599682|FG000|Overall Study|Study closed by sponsor|34|||
126357047|NCT00103506|454599683|FG001|Overall Study|Study closed by sponsor|37|||
126357048|NCT00103506|454599682|FG000|Overall Study|Death|257|||
126357049|NCT00103506|454599683|FG001|Overall Study|Death|253|||
126357050|NCT00103506|454599682|FG000|Overall Study|Lost to Follow-up|13|||
126357051|NCT00103506|454599683|FG001|Overall Study|Lost to Follow-up|13|||
126357052|NCT00103506|454599682|FG000|Overall Study|Withdrawal by Subject|18|||
126357053|NCT00103506|454599683|FG001|Overall Study|Withdrawal by Subject|21|||
126357054|NCT00585585|454599684|FG000|Overall Study|Adverse Event|1|||
126357055|NCT00585169|454599685|FG000|Overall Study|Withdrawal by Subject|1|||
126357056|NCT00710970|454599686|FG000|Overall Study|Never took drug|3|||
126357057|NCT01028560|454599687|FG000|Overall Study|Lack of Efficacy|3|||
126357058|NCT01028560|454599688|FG001|Overall Study|Lack of Efficacy|6|||
126357059|NCT01028560|454599687|FG000|Overall Study|Withdrawal by Subject|7|||
126357060|NCT01028560|454599688|FG001|Overall Study|Withdrawal by Subject|12|||
126357061|NCT03055221|454599689|FG000|Overall Study|Adverse Event|2|||
126357062|NCT03055221|454599689|FG000|Overall Study|Withdrawal by Subject|4|||
126357063|NCT03055221|454599689|FG000|Overall Study|Death|6|||
126357064|NCT03055221|454599689|FG000|Overall Study|Physician Decision|1|||
126357065|NCT03055221|454599689|FG000|Overall Study|Study terminated by Sponsor|3|||
126357066|NCT03055221|454599689|FG000|Overall Study|Lost to Follow-up|4|||
126357067|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
126357068|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
126357069|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
126357070|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
126357071|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
126357072|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
126357073|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
126357074|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
126357075|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
126357076|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
126357077|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
126357078|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
126357079|NCT01243424|454599690|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
126357080|NCT01243424|454599691|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
126545641|NCT05200936|455290903|FG000|Overall Study|Withdrawal by Subject|2|||
126545642|NCT05200936|455290904|FG001|Overall Study|Withdrawal by Subject|2|||
126545643|NCT05200936|455290903|FG000|Overall Study|Lost to Follow-up|2|||
126545644|NCT05200936|455290904|FG001|Overall Study|Lost to Follow-up|0|||
126357081|NCT01243424|454599690|FG000|Discontinuation From Treatment|Not treated|5|||
126357082|NCT01243424|454599691|FG001|Discontinuation From Treatment|Not treated|4|||
126357083|NCT01243424|454599690|FG000|Discontinuation From Treatment|Adverse Event|457|||
126357084|NCT01243424|454599691|FG001|Discontinuation From Treatment|Adverse Event|523|||
126357085|NCT01243424|454599690|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
126357086|NCT01243424|454599691|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
126357087|NCT01243424|454599690|FG000|Discontinuation From Treatment|Protocol Violation|46|||
126357088|NCT01243424|454599691|FG001|Discontinuation From Treatment|Protocol Violation|47|||
126357089|NCT01243424|454599690|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
126357090|NCT01243424|454599691|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
126357091|NCT01243424|454599690|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
126357092|NCT01243424|454599691|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
126357093|NCT01243424|454599690|FG000|Discontinuation From Treatment|Other than listed above|230|||
126357094|NCT01243424|454599691|FG001|Discontinuation From Treatment|Other than listed above|211|||
126357095|NCT00397930|454599694|FG000|Overall Study|Personal reasons|14|||
126357096|NCT00397930|454599695|FG001|Overall Study|Personal reasons|8|||
126357097|NCT00397930|454599694|FG000|Overall Study|Other medical|9|||
126357098|NCT00397930|454599695|FG001|Overall Study|Other medical|4|||
126357099|NCT00397930|454599694|FG000|Overall Study|Unknown reasons|9|||
126357100|NCT00397930|454599695|FG001|Overall Study|Unknown reasons|14|||
126357101|NCT00397930|454599694|FG000|Overall Study|Noncompliant|3|||
126357102|NCT00397930|454599695|FG001|Overall Study|Noncompliant|2|||
126357103|NCT00397930|454599694|FG000|Overall Study|Too time-consuming|2|||
126357104|NCT00397930|454599695|FG001|Overall Study|Too time-consuming|9|||
126357105|NCT00397930|454599694|FG000|Overall Study|Started own yoga program|1|||
126357106|NCT00397930|454599695|FG001|Overall Study|Started own yoga program|1|||
126357107|NCT00397930|454599694|FG000|Overall Study|Did not want to be in control group|0|||
126357108|NCT00397930|454599695|FG001|Overall Study|Did not want to be in control group|1|||
126357109|NCT00397930|454599694|FG000|Overall Study|Withdrawal by Subject|0|||
126357110|NCT00397930|454599695|FG001|Overall Study|Withdrawal by Subject|8|||
126357111|NCT00397930|454599694|FG000|Overall Study|Missing data|0|||
126357112|NCT00397930|454599695|FG001|Overall Study|Missing data|4|||
126357113|NCT00617903|454599703|FG000|Overall Study|Withdrawal by Subject|2|||
126357114|NCT00617903|454599704|FG001|Overall Study|Withdrawal by Subject|3|||
126357115|NCT00617903|454599703|FG000|Overall Study|Lost to Follow-up|1|||
126357116|NCT00617903|454599704|FG001|Overall Study|Lost to Follow-up|1|||
126357117|NCT00617903|454599703|FG000|Overall Study|Lack of Efficacy|0|||
126357118|NCT00617903|454599704|FG001|Overall Study|Lack of Efficacy|1|||
126357119|NCT00617903|454599703|FG000|Overall Study|Adverse Event|0|||
126357120|NCT00617903|454599704|FG001|Overall Study|Adverse Event|1|||
126357121|NCT00617903|454599703|FG000|Overall Study|noncompliance|0|||
126357122|NCT00617903|454599704|FG001|Overall Study|noncompliance|1|||
126357123|NCT05156125|454599705|FG000|Overall Study|Lack of Efficacy|1|||
126357124|NCT05156125|454599706|FG001|Overall Study|Lack of Efficacy|1|||
126357125|NCT05156125|454599707|FG002|Overall Study|Lack of Efficacy|1|||
126357126|NCT05156125|454599705|FG000|Overall Study|Physician Decision|0|||
126357127|NCT05156125|454599706|FG001|Overall Study|Physician Decision|0|||
126357128|NCT05156125|454599707|FG002|Overall Study|Physician Decision|1|||
126357129|NCT05156125|454599705|FG000|Overall Study|Non-compliance|0|||
126357130|NCT05156125|454599706|FG001|Overall Study|Non-compliance|1|||
126357131|NCT05156125|454599707|FG002|Overall Study|Non-compliance|1|||
126357132|NCT05156125|454599705|FG000|Overall Study|Withdrawal by Subject|0|||
126357133|NCT05156125|454599706|FG001|Overall Study|Withdrawal by Subject|0|||
126357134|NCT05156125|454599707|FG002|Overall Study|Withdrawal by Subject|1|||
126357135|NCT05156125|454599705|FG000|Overall Study|Adverse Event|2|||
126357136|NCT05156125|454599706|FG001|Overall Study|Adverse Event|1|||
126357137|NCT05156125|454599707|FG002|Overall Study|Adverse Event|0|||
126357138|NCT03123588|454599713|FG000|Overall Study|Study Terminated by Sponsor|2|||
126357139|NCT03123588|454599714|FG001|Overall Study|Study Terminated by Sponsor|5|||
126357140|NCT03123588|454599713|FG000|Overall Study|Withdrawal by Subject|1|||
126357141|NCT03123588|454599714|FG001|Overall Study|Withdrawal by Subject|0|||
126357142|NCT03123588|454599713|FG000|Overall Study|Adverse Event|1|||
126357143|NCT03123588|454599714|FG001|Overall Study|Adverse Event|0|||
126357144|NCT03123588|454599713|FG000|Overall Study|Physician Decision|2|||
126357145|NCT03123588|454599714|FG001|Overall Study|Physician Decision|1|||
126357146|NCT01698008|454599717|FG000|Overall Study|Withdrawal by Subject|1|||
126357147|NCT01698008|454599718|FG001|Overall Study|Withdrawal by Subject|2|||
126357148|NCT01814332|454599722|FG000|Overall Study|Adverse Event|8|||
126357149|NCT01814332|454599723|FG001|Overall Study|Adverse Event|3|||
126357150|NCT01814332|454599722|FG000|Overall Study|Withdrawal by Subject|3|||
126357151|NCT01814332|454599723|FG001|Overall Study|Withdrawal by Subject|8|||
126357152|NCT01814332|454599722|FG000|Overall Study|Protocol Violation|0|||
126545645|NCT05200936|455290903|FG000|Overall Study|Pregnancy|0|||
126447090|NCT02405442|454937926|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
126447091|NCT02405442|454937927|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
126447092|NCT02405442|454937928|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
126447093|NCT02405442|454937925|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
126447094|NCT02405442|454937926|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
126447095|NCT02405442|454937927|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
126447096|NCT02405442|454937928|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
126447097|NCT02405442|454937925|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
126447098|NCT02405442|454937926|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
126447099|NCT02405442|454937927|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
126447100|NCT02405442|454937928|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
126447101|NCT02405442|454937925|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
126447102|NCT02405442|454937926|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
126447103|NCT02405442|454937927|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
126447104|NCT02405442|454937928|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
126447105|NCT02405442|454937925|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
126447106|NCT02405442|454937926|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
126447107|NCT02405442|454937927|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
126447108|NCT02405442|454937928|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
126447109|NCT02405442|454937925|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
126447110|NCT02405442|454937926|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
126447111|NCT02405442|454937927|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
126447112|NCT02405442|454937928|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
126447113|NCT02405442|454937925|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
126447114|NCT02405442|454937926|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
126447115|NCT02405442|454937927|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
126447116|NCT02405442|454937928|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
126447117|NCT02405442|454937925|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
126447118|NCT02405442|454937926|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
126447119|NCT02405442|454937927|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
126447120|NCT02405442|454937928|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
126447121|NCT02405442|454937925|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
126447122|NCT02405442|454937926|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
126447123|NCT02405442|454937927|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
126447124|NCT02405442|454937928|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
126447125|NCT02405442|454937925|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
126447126|NCT02405442|454937926|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
126447127|NCT02405442|454937927|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
126447128|NCT02405442|454937928|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
126447129|NCT02405442|454937925|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
126447130|NCT02405442|454937926|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
126447131|NCT02405442|454937927|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
126447132|NCT02405442|454937928|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
126447133|NCT02405442|454937925|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
126447134|NCT02405442|454937926|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
126447135|NCT02405442|454937927|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
126447136|NCT02405442|454937928|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
126447137|NCT02405442|454937925|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
126447138|NCT02405442|454937926|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
126447139|NCT02405442|454937927|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
126447140|NCT02405442|454937928|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
126447141|NCT03275350|454937929|FG000|Overall Study|Lost to Follow-up|4|||
126447142|NCT03275350|454937930|FG001|Overall Study|Lost to Follow-up|6|||
126447143|NCT03275350|454937929|FG000|Overall Study|Death|2|||
126447144|NCT03275350|454937930|FG001|Overall Study|Death|1|||
126447145|NCT03275350|454937929|FG000|Overall Study|Physician Decision|1|||
126447146|NCT03275350|454937930|FG001|Overall Study|Physician Decision|0|||
126447147|NCT03275350|454937929|FG000|Overall Study|Incarcerated|1|||
126447148|NCT03275350|454937930|FG001|Overall Study|Incarcerated|1|||
126447149|NCT00926029|454937931|FG000|Overall Study|Lost to Follow-up|2|||
126447150|NCT00926029|454937932|FG001|Overall Study|Lost to Follow-up|1|||
126447151|NCT00926029|454937933|FG002|Overall Study|Lost to Follow-up|1|||
126447152|NCT04173494|454937936|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
126447153|NCT04173494|454937937|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
126447154|NCT04173494|454937936|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
126447155|NCT04173494|454937937|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
126447156|NCT04173494|454937936|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
126447157|NCT04173494|454937937|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
126447158|NCT04173494|454937936|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
126447159|NCT04173494|454937937|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
126447160|NCT04173494|454937936|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
126447161|NCT04173494|454937937|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
126447162|NCT04173494|454937936|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
126447163|NCT04173494|454937937|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
126447164|NCT04173494|454937936|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
126447165|NCT04173494|454937937|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
126447166|NCT04173494|454937936|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
126447167|NCT04173494|454937937|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
126447168|NCT04173494|454937936|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
126447169|NCT04173494|454937937|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
126447170|NCT04173494|454937936|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
126447171|NCT04173494|454937937|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
126447172|NCT04173494|454937936|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
126447173|NCT04173494|454937937|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
126447174|NCT04173494|454937936|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
126447175|NCT04173494|454937937|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
126447176|NCT04173494|454937936|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
126447177|NCT04173494|454937937|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
126447178|NCT04173494|454937936|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
126447179|NCT04173494|454937937|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
126447180|NCT04173494|454937936|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
126447181|NCT04173494|454937937|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
126447182|NCT04173494|454937936|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
126447183|NCT04173494|454937937|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
126447184|NCT02474069|454937938|FG000|Selection Phase (SP)|Adverse Event|8|||
126447185|NCT02474069|454937939|FG001|Selection Phase (SP)|Adverse Event|0|||
126447186|NCT02474069|454937940|FG002|Selection Phase (SP)|Adverse Event|0|||
126447187|NCT02474069|454937938|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
126447188|NCT02474069|454937939|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
126447189|NCT02474069|454937940|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
126447190|NCT02474069|454937938|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
126447191|NCT02474069|454937939|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
126447192|NCT02474069|454937940|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
126447193|NCT02474069|454937938|FG000|Selection Phase (SP)|Physician Decision|1|||
126447194|NCT02474069|454937939|FG001|Selection Phase (SP)|Physician Decision|0|||
126447195|NCT02474069|454937940|FG002|Selection Phase (SP)|Physician Decision|0|||
126447196|NCT02474069|454937938|FG000|Selection Phase (SP)|Protocol Violation|1|||
126447197|NCT02474069|454937939|FG001|Selection Phase (SP)|Protocol Violation|0|||
126447198|NCT02474069|454937940|FG002|Selection Phase (SP)|Protocol Violation|0|||
126447199|NCT02474069|454937938|FG000|Selection Phase (SP)|No longer requires treatment|1|||
126447200|NCT02474069|454937939|FG001|Selection Phase (SP)|No longer requires treatment|0|||
126447201|NCT02474069|454937940|FG002|Selection Phase (SP)|No longer requires treatment|0|||
126447202|NCT02474069|454937938|FG000|Selection Phase (SP)|Technical Problem|1|||
126447203|NCT02474069|454937939|FG001|Selection Phase (SP)|Technical Problem|0|||
126447204|NCT02474069|454937940|FG002|Selection Phase (SP)|Technical Problem|0|||
126447205|NCT02474069|454937938|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
126447206|NCT02474069|454937939|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
126447207|NCT02474069|454937940|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
126447208|NCT02474069|454937938|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
126447209|NCT02474069|454937939|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
126447210|NCT02474069|454937940|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
126357153|NCT01814332|454599723|FG001|Overall Study|Protocol Violation|4|||
126357154|NCT01814332|454599722|FG000|Overall Study|Lost to Follow-up|5|||
126357155|NCT01814332|454599723|FG001|Overall Study|Lost to Follow-up|1|||
126357156|NCT01755637|454599724|FG000|Period 1|Adverse Event|0|||
126357157|NCT01755637|454599725|FG001|Period 1|Adverse Event|1|||
126357158|NCT02287025|454599726|FG000|Overall Study|Not treated|2|||
126357159|NCT02287025|454599727|FG001|Overall Study|Not treated|0|||
126357160|NCT02287025|454599726|FG000|Overall Study|Progression of disease|3|||
126357161|NCT02287025|454599727|FG001|Overall Study|Progression of disease|2|||
126357162|NCT02287025|454599726|FG000|Overall Study|Adverse Event|2|||
126357163|NCT02287025|454599727|FG001|Overall Study|Adverse Event|4|||
126357164|NCT02287025|454599726|FG000|Overall Study|Withdrawal by Subject|2|||
126357165|NCT02287025|454599727|FG001|Overall Study|Withdrawal by Subject|2|||
126357166|NCT02287025|454599726|FG000|Overall Study|Screening failed|1|||
126357167|NCT02287025|454599727|FG001|Overall Study|Screening failed|1|||
126357168|NCT04053452|454599728|FG000|Overall Study|Withdrawal by Subject|1|||
126357169|NCT04053452|454599729|FG001|Overall Study|Withdrawal by Subject|0|||
126357170|NCT04053452|454599728|FG000|Overall Study|Time restraint due to inpatient needs|1|||
126357171|NCT04053452|454599729|FG001|Overall Study|Time restraint due to inpatient needs|2|||
126357172|NCT02959892|454599734|FG000|Overall Study|PET tracer synthesis failure|1|||
126357173|NCT02959892|454599735|FG001|Overall Study|PET tracer synthesis failure|0|||
126357174|NCT02959892|454599734|FG000|Overall Study|Study termination|0|||
126357175|NCT02959892|454599735|FG001|Overall Study|Study termination|1|||
126357176|NCT00799864|454599738|FG000|Overall Study|Participant reached a virologic endpoint|9|||
126357177|NCT00799864|454599739|FG001|Overall Study|Participant reached a virologic endpoint|2|||
126357178|NCT00799864|454599740|FG002|Overall Study|Participant reached a virologic endpoint|2|||
126357179|NCT00799864|454599741|FG003|Overall Study|Participant reached a virologic endpoint|0|||
126357180|NCT00799864|454599742|FG004|Overall Study|Participant reached a virologic endpoint|0|||
126357181|NCT00799864|454599738|FG000|Overall Study|Other|2|||
126357182|NCT00799864|454599739|FG001|Overall Study|Other|1|||
126357183|NCT00799864|454599740|FG002|Overall Study|Other|0|||
126357184|NCT00799864|454599741|FG003|Overall Study|Other|0|||
126357185|NCT00799864|454599742|FG004|Overall Study|Other|0|||
126357186|NCT02346370|454599743|FG000|Overall Study|Not treated|1|||
126357187|NCT02346370|454599744|FG001|Overall Study|Not treated|0|||
126357188|NCT02346370|454599745|FG002|Overall Study|Not treated|0|||
126447211|NCT02474069|454937938|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
126447212|NCT02474069|454937939|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
126447213|NCT02474069|454937940|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
126447214|NCT02474069|454937938|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
126447215|NCT02474069|454937939|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
126447216|NCT02474069|454937940|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
126447217|NCT02474069|454937938|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
126447218|NCT02474069|454937939|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
126447219|NCT02474069|454937940|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
126447220|NCT02474069|454937938|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
126447221|NCT02474069|454937939|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
126447222|NCT02474069|454937940|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
126447223|NCT01623050|454937943|FG000|Overall Study|Lost to Follow-up|9|||
126447224|NCT00393861|454937944|FG000|Overall Study|Adverse Event|2|||
126447225|NCT00393861|454937944|FG000|Overall Study|Disease Progression|24|||
126447226|NCT00486291|454937945|FG000|Overall Study|Adverse Event|3|||
126447227|NCT00486291|454937946|FG001|Overall Study|Adverse Event|4|||
126447228|NCT00486291|454937945|FG000|Overall Study|Lost to Follow-up|3|||
126447229|NCT00486291|454937946|FG001|Overall Study|Lost to Follow-up|7|||
126447230|NCT00486291|454937945|FG000|Overall Study|protocol non-compliance|10|||
126447231|NCT00486291|454937946|FG001|Overall Study|protocol non-compliance|15|||
126447232|NCT00486291|454937945|FG000|Overall Study|requirement for restricted medication|0|||
126447233|NCT00486291|454937946|FG001|Overall Study|requirement for restricted medication|3|||
126447234|NCT00126490|454937947|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
126447235|NCT03051178|454937948|FG000|Overall Study|Withdrawal by Subject|5|||
126447236|NCT01598506|454937949|FG000|Overall Study|Withdrawal by Subject|2|||
126447237|NCT01388335|454937952|FG000|Period 1|Progressive Disease|1|||
126447238|NCT01388335|454937952|FG000|Period 2|Progressive Disease|2|||
126447239|NCT01388335|454937952|FG000|Period 2|Sponsor Decision|1|||
126447240|NCT01388335|454937952|FG000|Safety Extension|Progressive Disease|7|||
126447241|NCT02167139|454937953|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
126447242|NCT02167139|454937954|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
126447243|NCT02167139|454937955|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
126447244|NCT02167139|454937956|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
126447245|NCT02167139|454937953|FG000|Randomised, Double-blind|Adverse Event|2|||
126447246|NCT02167139|454937954|FG001|Randomised, Double-blind|Adverse Event|9|||
126447247|NCT02167139|454937955|FG002|Randomised, Double-blind|Adverse Event|0|||
126447248|NCT02167139|454937956|FG003|Randomised, Double-blind|Adverse Event|0|||
126447249|NCT02167139|454937953|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
126447250|NCT02167139|454937954|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
126447251|NCT02167139|454937955|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
126447252|NCT02167139|454937956|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
126447253|NCT02167139|454937953|FG000|Randomised, Double-blind|Other|3|||
126447254|NCT02167139|454937954|FG001|Randomised, Double-blind|Other|0|||
126447255|NCT02167139|454937955|FG002|Randomised, Double-blind|Other|0|||
126447256|NCT02167139|454937956|FG003|Randomised, Double-blind|Other|0|||
126447257|NCT02167139|454937953|FG000|Transition-extension|Adverse Event|2|||
126447258|NCT02167139|454937954|FG001|Transition-extension|Adverse Event|0|||
126447259|NCT02167139|454937955|FG002|Transition-extension|Adverse Event|2|||
126447260|NCT02167139|454937956|FG003|Transition-extension|Adverse Event|3|||
126447261|NCT02167139|454937953|FG000|Transition-extension|Withdrawal by Subject|2|||
126545646|NCT05200936|455290904|FG001|Overall Study|Pregnancy|1|||
126545647|NCT01672853|455290905|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
126545648|NCT01672853|455290906|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
126545649|NCT01672853|455290907|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
126545650|NCT01672853|455290905|FG000|Overall Study|Pregnancy|0|||
126545651|NCT01672853|455290906|FG001|Overall Study|Pregnancy|1|||
126545652|NCT01672853|455290907|FG002|Overall Study|Pregnancy|0|||
126545653|NCT01672853|455290905|FG000|Overall Study|Investigator's Discretion|1|||
126545654|NCT01672853|455290906|FG001|Overall Study|Investigator's Discretion|0|||
126545655|NCT01672853|455290907|FG002|Overall Study|Investigator's Discretion|0|||
126545656|NCT01672853|455290905|FG000|Overall Study|Withdrew Consent|5|||
126545657|NCT01672853|455290906|FG001|Overall Study|Withdrew Consent|5|||
126545658|NCT01672853|455290907|FG002|Overall Study|Withdrew Consent|5|||
126545659|NCT01672853|455290905|FG000|Overall Study|Adverse Event|4|||
126545660|NCT01672853|455290906|FG001|Overall Study|Adverse Event|6|||
126545661|NCT01672853|455290907|FG002|Overall Study|Adverse Event|8|||
126545662|NCT01672853|455290905|FG000|Overall Study|Lost to Follow-up|0|||
126545663|NCT01672853|455290906|FG001|Overall Study|Lost to Follow-up|1|||
126545664|NCT01672853|455290907|FG002|Overall Study|Lost to Follow-up|0|||
126545665|NCT01672853|455290905|FG000|Overall Study|Randomized but Never Treated|0|||
126545666|NCT01672853|455290906|FG001|Overall Study|Randomized but Never Treated|0|||
126545667|NCT01672853|455290907|FG002|Overall Study|Randomized but Never Treated|1|||
126545668|NCT02944656|455290909|FG000|Overall Study|No longer eligible|3|||
126545669|NCT02944656|455290910|FG001|Overall Study|No longer eligible|0|||
126545670|NCT02944656|455290909|FG000|Overall Study|Lost to Follow-up|7|||
126545671|NCT02944656|455290910|FG001|Overall Study|Lost to Follow-up|10|||
126545672|NCT00118898|455290911|FG000|Overall Study|Death|6|||
126545673|NCT00118898|455290912|FG001|Overall Study|Death|11|||
126545674|NCT00118898|455290913|FG002|Overall Study|Death|6|||
126545675|NCT00118898|455290914|FG003|Overall Study|Death|8|||
126545676|NCT00118898|455290911|FG000|Overall Study|Lost to Follow-up|26|||
126545677|NCT00118898|455290912|FG001|Overall Study|Lost to Follow-up|34|||
126545678|NCT00118898|455290913|FG002|Overall Study|Lost to Follow-up|33|||
126545679|NCT00118898|455290914|FG003|Overall Study|Lost to Follow-up|33|||
126545680|NCT00118898|455290911|FG000|Overall Study|Withdrawal by Subject|10|||
126545681|NCT00118898|455290912|FG001|Overall Study|Withdrawal by Subject|5|||
126545682|NCT00118898|455290913|FG002|Overall Study|Withdrawal by Subject|8|||
126545683|NCT00118898|455290914|FG003|Overall Study|Withdrawal by Subject|8|||
126545684|NCT00118898|455290911|FG000|Overall Study|Site Closure|33|||
126545685|NCT00118898|455290912|FG001|Overall Study|Site Closure|31|||
126545686|NCT00118898|455290913|FG002|Overall Study|Site Closure|28|||
126545687|NCT00118898|455290914|FG003|Overall Study|Site Closure|37|||
126545688|NCT00118898|455290911|FG000|Overall Study|Severe debilitation|1|||
126545689|NCT00118898|455290912|FG001|Overall Study|Severe debilitation|4|||
126545690|NCT00118898|455290913|FG002|Overall Study|Severe debilitation|6|||
126545691|NCT00118898|455290914|FG003|Overall Study|Severe debilitation|4|||
126545692|NCT00118898|455290911|FG000|Overall Study|Not compliant with requirements|11|||
126545693|NCT00118898|455290912|FG001|Overall Study|Not compliant with requirements|13|||
126545694|NCT00118898|455290913|FG002|Overall Study|Not compliant with requirements|11|||
126545695|NCT00118898|455290914|FG003|Overall Study|Not compliant with requirements|11|||
126545696|NCT00118898|455290911|FG000|Overall Study|Not able to get to clinic|34|||
126545697|NCT00118898|455290912|FG001|Overall Study|Not able to get to clinic|43|||
126545698|NCT00118898|455290913|FG002|Overall Study|Not able to get to clinic|31|||
126545699|NCT00118898|455290914|FG003|Overall Study|Not able to get to clinic|40|||
126545700|NCT02243631|455292412|FG000|Overall Study|no synovial fluid on second aspirate|0|||
126545701|NCT02243631|455292413|FG001|Overall Study|no synovial fluid on second aspirate|1|||
126545702|NCT01785628|455292416|FG000|Overall Study|Lost to Follow-up|2|||
126545703|NCT01785628|455292417|FG001|Overall Study|Lost to Follow-up|3|||
126545704|NCT00840996|455292418|FG000|Overall Study|Withdrawal by Subject|1|||
126545705|NCT00840996|455292419|FG001|Overall Study|Withdrawal by Subject|0|||
126545706|NCT02746575|455292420|FG000|Overall Study|Surgery cancelled or time chaned|13|||
126760954|NCT01038609|456075873|FG004|Overall Study|Refusal of Blood Draws|0|||
126357189|NCT02346370|454599743|FG000|Overall Study|Withdrawal of consent|1|||
126357190|NCT02346370|454599744|FG001|Overall Study|Withdrawal of consent|0|||
126357191|NCT02346370|454599745|FG002|Overall Study|Withdrawal of consent|0|||
126357192|NCT02346370|454599743|FG000|Overall Study|Death|1|||
126357193|NCT02346370|454599744|FG001|Overall Study|Death|3|||
126357194|NCT02346370|454599745|FG002|Overall Study|Death|1|||
126447262|NCT02167139|454937954|FG001|Transition-extension|Withdrawal by Subject|0|||
126447263|NCT02167139|454937955|FG002|Transition-extension|Withdrawal by Subject|4|||
126447264|NCT02167139|454937956|FG003|Transition-extension|Withdrawal by Subject|1|||
126447265|NCT02167139|454937953|FG000|Transition-extension|Lack of Efficacy|0|||
126447266|NCT02167139|454937954|FG001|Transition-extension|Lack of Efficacy|0|||
126447267|NCT02167139|454937955|FG002|Transition-extension|Lack of Efficacy|1|||
126447268|NCT02167139|454937956|FG003|Transition-extension|Lack of Efficacy|1|||
126447269|NCT02167139|454937953|FG000|Transition-extension|Other|1|||
126447270|NCT02167139|454937954|FG001|Transition-extension|Other|0|||
126447271|NCT02167139|454937955|FG002|Transition-extension|Other|1|||
126447272|NCT02167139|454937956|FG003|Transition-extension|Other|0|||
126447273|NCT02167139|454937953|FG000|Transition-extension|Lost to Follow-up|1|||
126447274|NCT02167139|454937954|FG001|Transition-extension|Lost to Follow-up|0|||
126447275|NCT02167139|454937955|FG002|Transition-extension|Lost to Follow-up|0|||
126447276|NCT02167139|454937956|FG003|Transition-extension|Lost to Follow-up|0|||
126447277|NCT04413617|454937960|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
126447278|NCT04413617|454937961|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
126447279|NCT04413617|454937962|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
126447280|NCT04413617|454937963|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
126447281|NCT04413617|454937964|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
126447282|NCT04413617|454937960|FG000|Overall Study|Protocol Violation|0|||
126447283|NCT04413617|454937961|FG001|Overall Study|Protocol Violation|1|||
126447284|NCT04413617|454937962|FG002|Overall Study|Protocol Violation|0|||
126447285|NCT04413617|454937963|FG003|Overall Study|Protocol Violation|0|||
126357195|NCT02346370|454599743|FG000|Overall Study|Sponsor discontinued study|5|||
126357196|NCT02346370|454599744|FG001|Overall Study|Sponsor discontinued study|0|||
126357197|NCT02346370|454599745|FG002|Overall Study|Sponsor discontinued study|2|||
126357198|NCT02346370|454599743|FG000|Overall Study|Radiologic progression|0|||
126357199|NCT02346370|454599744|FG001|Overall Study|Radiologic progression|0|||
126357200|NCT02346370|454599745|FG002|Overall Study|Radiologic progression|1|||
126357201|NCT02346370|454599743|FG000|Overall Study|Physician Decision|0|||
126357202|NCT02346370|454599744|FG001|Overall Study|Physician Decision|1|||
126357203|NCT02346370|454599745|FG002|Overall Study|Physician Decision|0|||
126357204|NCT03528577|454599748|FG000|Sequence 1|Failed Spirometry|1|||
126357205|NCT03528577|454599748|FG000|Sequence 1|Restricted medication|1|||
126357206|NCT03528577|454599748|FG000|Sequence 2|Adverse Event|1|||
126357207|NCT03528577|454599748|FG000|Sequence 2|Withdrawal by Subject|1|||
126357208|NCT03528577|454599748|FG000|Sequence 2|Failed Spirometry|1|||
126357209|NCT03528577|454599748|FG000|Sequence 3|Failed Spirometry|1|||
126357210|NCT03528577|454599748|FG000|Sequence 4|Failed Spirometry|2|||
126357211|NCT03528577|454599748|FG000|Sequence 4|Adverse Event|1|||
126357212|NCT04882215|454599749|FG000|Overall Study|Withdrawal by Subject|5|||
126357213|NCT04882215|454599750|FG001|Overall Study|Withdrawal by Subject|0|||
126357214|NCT04263532|454599751|FG000|Overall Study|Withdrawal by Subject|2|||
126357215|NCT04263532|454599752|FG001|Overall Study|Withdrawal by Subject|0|||
126357216|NCT04098302|454599753|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
126447286|NCT04413617|454937964|FG004|Overall Study|Protocol Violation|1|||
126447287|NCT04413617|454937960|FG000|Overall Study|Lack of Efficacy|2|||
126447288|NCT04413617|454937961|FG001|Overall Study|Lack of Efficacy|0|||
126447289|NCT04413617|454937962|FG002|Overall Study|Lack of Efficacy|2|||
126447290|NCT04413617|454937963|FG003|Overall Study|Lack of Efficacy|1|||
126447291|NCT04413617|454937964|FG004|Overall Study|Lack of Efficacy|0|||
126694373|NCT00944034|455835083|FG008|Overall Study|Death|0|||
126694374|NCT00944034|455835084|FG009|Overall Study|Death|0|||
126694375|NCT00944034|455835085|FG010|Overall Study|Death|0|||
126447292|NCT04413617|454937960|FG000|Overall Study|Withdrawal by Subject|3|||
126447293|NCT04413617|454937961|FG001|Overall Study|Withdrawal by Subject|4|||
126447294|NCT04413617|454937962|FG002|Overall Study|Withdrawal by Subject|2|||
126447295|NCT04413617|454937963|FG003|Overall Study|Withdrawal by Subject|5|||
126447296|NCT04413617|454937964|FG004|Overall Study|Withdrawal by Subject|3|||
126694376|NCT00944034|455835086|FG011|Overall Study|Death|0|||
126694377|NCT00944034|455835075|FG000|Overall Study|Protocol Violation|2|||
126447297|NCT04413617|454937960|FG000|Overall Study|Death|1|||
126447298|NCT04413617|454937961|FG001|Overall Study|Death|0|||
126447299|NCT04413617|454937962|FG002|Overall Study|Death|0|||
126447300|NCT04413617|454937963|FG003|Overall Study|Death|0|||
126447301|NCT04413617|454937964|FG004|Overall Study|Death|0|||
126447302|NCT04413617|454937960|FG000|Overall Study|Adverse Event|1|||
126447303|NCT04413617|454937961|FG001|Overall Study|Adverse Event|0|||
126357217|NCT04098302|454599754|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
126357218|NCT04098302|454599755|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
126357219|NCT04098302|454599756|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
126357220|NCT04098302|454599753|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
126357221|NCT04098302|454599754|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
126357222|NCT04098302|454599755|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
126357223|NCT04098302|454599756|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
126357224|NCT04098302|454599753|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
126357225|NCT04098302|454599754|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
126357226|NCT04098302|454599755|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
126357227|NCT04098302|454599756|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
126357228|NCT04098302|454599753|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
126447304|NCT04413617|454937962|FG002|Overall Study|Adverse Event|0|||
126447305|NCT04413617|454937963|FG003|Overall Study|Adverse Event|1|||
126447306|NCT04413617|454937964|FG004|Overall Study|Adverse Event|1|||
126447307|NCT04413617|454937960|FG000|Overall Study|COVID-19|0|||
126447308|NCT04413617|454937961|FG001|Overall Study|COVID-19|1|||
126357229|NCT04098302|454599754|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
126357230|NCT04098302|454599755|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
126357231|NCT04098302|454599756|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
126357232|NCT04098302|454599753|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
126357233|NCT04098302|454599754|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
126357234|NCT04098302|454599755|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
126447309|NCT04413617|454937962|FG002|Overall Study|COVID-19|0|||
126447310|NCT04413617|454937963|FG003|Overall Study|COVID-19|0|||
126447311|NCT04413617|454937964|FG004|Overall Study|COVID-19|0|||
126447312|NCT02657408|454937965|FG000|Overall Study|Adverse Event|3|||
126447313|NCT02657408|454937966|FG001|Overall Study|Adverse Event|7|||
126447314|NCT00324961|454937968|FG000|Overall Study|Adverse Event|5|||
126447315|NCT00324961|454937968|FG000|Overall Study|Consent Withdrawn|11|||
126447316|NCT00324961|454937968|FG000|Overall Study|Lost to Follow-up|22|||
126447317|NCT00324961|454937968|FG000|Overall Study|Protocol Violation|3|||
126447318|NCT00324961|454937968|FG000|Overall Study|Other|2|||
126447319|NCT03350672|454937972|FG000|Overall Study|Withdrawal by Subject|7|||
126447320|NCT03350672|454937973|FG001|Overall Study|Withdrawal by Subject|0|||
126447321|NCT03350672|454937974|FG002|Overall Study|Withdrawal by Subject|0|||
126447322|NCT01583296|454937977|FG000|Overall Study|Withdrawal by Subject|11|||
126447323|NCT01583296|454937978|FG001|Overall Study|Withdrawal by Subject|10|||
126447324|NCT01063283|454937979|FG000|Cycle 1|Adverse Event|2|||
126447325|NCT01063283|454937980|FG001|Cycle 1|Adverse Event|0|||
126447326|NCT01063283|454937981|FG002|Cycle 1|Adverse Event|0|||
126447327|NCT01063283|454937979|FG000|Cycle 1|Technical failure in data collection|1|||
126447328|NCT01063283|454937980|FG001|Cycle 1|Technical failure in data collection|0|||
126447329|NCT01063283|454937981|FG002|Cycle 1|Technical failure in data collection|0|||
126447330|NCT05343624|454937982|FG000|Overall Study|Chart review not completed|1|||
126447331|NCT02504216|454937987|FG000|Overall Study|Lost to Follow-up|3|||
126447332|NCT02504216|454937988|FG001|Overall Study|Lost to Follow-up|3|||
126447333|NCT02504216|454937987|FG000|Overall Study|Withdrawal by Subject|8|||
126447334|NCT02504216|454937988|FG001|Overall Study|Withdrawal by Subject|12|||
126545707|NCT02746575|455292420|FG000|Overall Study|Received epidural|10|||
126357235|NCT04098302|454599756|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
126357236|NCT04098302|454599753|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
126357237|NCT04098302|454599754|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
126357238|NCT04098302|454599755|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
126357239|NCT04098302|454599756|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
126357240|NCT04098302|454599753|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
126357241|NCT04098302|454599754|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
126357242|NCT04098302|454599755|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
126357243|NCT04098302|454599756|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
126357244|NCT04098302|454599753|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
126357245|NCT04098302|454599754|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
126357246|NCT04098302|454599755|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
126357247|NCT04098302|454599756|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
126357248|NCT01290731|454599759|FG000|Overall Study|Withdrawal by Subject|1|||
126357249|NCT01399099|454599760|FG000|Overall Study|Lost to Follow-up|14|||
126357250|NCT01399099|454599760|FG000|Overall Study|Physician Decision|1|||
126357251|NCT01399099|454599760|FG000|Overall Study|Protocol Violation|1|||
126357252|NCT01399099|454599760|FG000|Overall Study|Skin Irritation|13|||
126357253|NCT01399099|454599760|FG000|Overall Study|Infection|1|||
126357254|NCT01399099|454599760|FG000|Overall Study|Miscellaneous|4|||
126357255|NCT01668537|454599761|FG000|Overall Study|Request to Discontinue Prematurely|1|||
126357256|NCT01668537|454599762|FG001|Overall Study|Request to Discontinue Prematurely|1|||
126357257|NCT01668537|454599761|FG000|Overall Study|Subject unwilling/unable to comply|5|||
126357258|NCT01668537|454599762|FG001|Overall Study|Subject unwilling/unable to comply|0|||
126357259|NCT01668537|454599761|FG000|Overall Study|Reason Precludes Participation|1|||
126357260|NCT01668537|454599762|FG001|Overall Study|Reason Precludes Participation|0|||
126357261|NCT01668537|454599761|FG000|Overall Study|Lost to Follow-up|13|||
126357262|NCT01668537|454599762|FG001|Overall Study|Lost to Follow-up|6|||
126357263|NCT01668537|454599761|FG000|Overall Study|Other|2|||
126357264|NCT01668537|454599762|FG001|Overall Study|Other|3|||
126357265|NCT05064800|454599763|FG000|Period 3|Withdrawal by Subject|0|||
126357266|NCT05064800|454599764|FG001|Period 3|Withdrawal by Subject|0|||
126357267|NCT05064800|454599765|FG002|Period 3|Withdrawal by Subject|0|||
126357268|NCT05064800|454599766|FG003|Period 3|Withdrawal by Subject|0|||
126357269|NCT05064800|454599767|FG004|Period 3|Withdrawal by Subject|1|||
126357270|NCT05064800|454599768|FG005|Period 3|Withdrawal by Subject|0|||
126357271|NCT04477486|454599769|FG000|Overall Study|Death|2|||
126357272|NCT04477486|454599769|FG000|Overall Study|Ongoing at Time of Analysis|11|||
126357273|NCT02497755|454599770|FG000|Overall Study|Protocol Violation|1|||
126357274|NCT02497755|454599771|FG001|Overall Study|Protocol Violation|0|||
126357275|NCT02487199|454599778|FG000|Overall Study|Withdrew Consent|0|||
126357276|NCT02487199|454599779|FG001|Overall Study|Withdrew Consent|1|||
126357277|NCT03554473|454602029|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
126357278|NCT03554473|454602030|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
126357279|NCT03554473|454602031|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
126357280|NCT03554473|454602029|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
126357281|NCT03554473|454602030|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
126357282|NCT03554473|454602031|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
126447335|NCT00862082|454937989|FG000|Overall Study|Sponsor decision to terminate the study|5|||
126447336|NCT00862082|454937990|FG001|Overall Study|Sponsor decision to terminate the study|0|||
126447337|NCT00862082|454937989|FG000|Overall Study|Withdrawal by Subject|0|||
126447338|NCT00862082|454937990|FG001|Overall Study|Withdrawal by Subject|1|||
126447339|NCT00223080|454937991|FG000|Overall Study|Withdrawal by Subject|253|||
126447340|NCT00223080|454937992|FG001|Overall Study|Withdrawal by Subject|232|||
126447341|NCT00223080|454937991|FG000|Overall Study|Required contraindicated med|0|||
126447342|NCT00223080|454937992|FG001|Overall Study|Required contraindicated med|1|||
126357283|NCT03554473|454602029|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
126357284|NCT03554473|454602030|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
126357285|NCT03554473|454602031|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
126447343|NCT00223080|454937991|FG000|Overall Study|Non-compliant|7|||
126447344|NCT00223080|454937992|FG001|Overall Study|Non-compliant|7|||
126694378|NCT00944034|455835076|FG001|Overall Study|Protocol Violation|0|||
126357286|NCT04971837|454602035|FG000|Overall Study|Long Term Illness|1|||
126357287|NCT04971837|454602035|FG000|Overall Study|BMI too low|9|||
126357288|NCT04971837|454602035|FG000|Overall Study|geographic location|1|||
126447345|NCT00223080|454937991|FG000|Overall Study|Moved from study area|37|||
126357289|NCT04971837|454602035|FG000|Overall Study|Discontinued scheduling conflict|1|||
126694379|NCT00944034|455835077|FG002|Overall Study|Protocol Violation|0|||
126694380|NCT00944034|455835078|FG003|Overall Study|Protocol Violation|1|||
126694381|NCT00944034|455835079|FG004|Overall Study|Protocol Violation|2|||
126447346|NCT00223080|454937992|FG001|Overall Study|Moved from study area|47|||
126447347|NCT00223080|454937991|FG000|Overall Study|Lost to Follow-up|259|||
126447348|NCT00223080|454937992|FG001|Overall Study|Lost to Follow-up|284|||
126447349|NCT00223080|454937991|FG000|Overall Study|Death|85|||
126447350|NCT00223080|454937992|FG001|Overall Study|Death|74|||
126447351|NCT00223080|454937991|FG000|Overall Study|Other|14|||
126357290|NCT00382070|454602036|FG000|Overall Study|No follow up data mapped to Other|17|||
126357291|NCT00382070|454602037|FG001|Overall Study|No follow up data mapped to Other|19|||
126357292|NCT00382070|454602036|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
126357293|NCT00382070|454602037|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
126357294|NCT00382070|454602036|FG000|Overall Study|No clinical assessment|9|||
126357295|NCT00382070|454602037|FG001|Overall Study|No clinical assessment|11|||
126357296|NCT00284934|454602043|FG000|Overall Study|Adverse Event|1|||
126357297|NCT00284934|454602044|FG001|Overall Study|Adverse Event|2|||
126357298|NCT00284934|454602043|FG000|Overall Study|Other reasons|3|||
126357299|NCT00284934|454602044|FG001|Overall Study|Other reasons|1|||
126357300|NCT01245751|454602045|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
126357301|NCT01245751|454602046|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
126357302|NCT01245751|454602047|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
126357303|NCT01245751|454602048|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
126357304|NCT01245751|454602045|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
126357305|NCT01245751|454602046|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
126357306|NCT01245751|454602047|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
126357307|NCT01245751|454602048|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
126357308|NCT01245751|454602045|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
126357309|NCT01245751|454602046|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
126357310|NCT01245751|454602047|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
126357311|NCT01245751|454602048|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
126357312|NCT05788328|454602049|FG000|Treatment Period 4 (5 Days)|Other|1|||
126357313|NCT05788328|454602049|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
126357314|NCT02082483|454602050|FG000|Overall Study|Lost to Follow-up|1|||
126357315|NCT02082483|454602051|FG001|Overall Study|Lost to Follow-up|1|||
126357316|NCT02082483|454602050|FG000|Overall Study|Withdrawal by Subject|2|||
126357317|NCT02082483|454602051|FG001|Overall Study|Withdrawal by Subject|1|||
126357318|NCT02082483|454602050|FG000|Overall Study|Physician Decision|1|||
126357319|NCT02082483|454602051|FG001|Overall Study|Physician Decision|1|||
126357320|NCT02082483|454602050|FG000|Overall Study|Death|2|||
126357321|NCT02082483|454602051|FG001|Overall Study|Death|3|||
126357322|NCT00145327|454602053|FG000|Overall Study|Withdrawal by Subject|77|||
126357323|NCT00145327|454602054|FG001|Overall Study|Withdrawal by Subject|72|||
126357324|NCT00145327|454602055|FG002|Overall Study|Withdrawal by Subject|164|||
126357325|NCT00145327|454602053|FG000|Overall Study|Death|26|||
126357326|NCT00145327|454602054|FG001|Overall Study|Death|18|||
126357327|NCT00145327|454602055|FG002|Overall Study|Death|30|||
126357328|NCT00145327|454602053|FG000|Overall Study|Adverse Event|14|||
126357329|NCT00145327|454602054|FG001|Overall Study|Adverse Event|11|||
126357330|NCT00145327|454602055|FG002|Overall Study|Adverse Event|22|||
126357331|NCT00145327|454602053|FG000|Overall Study|Lost to Follow-up|9|||
126357332|NCT00145327|454602054|FG001|Overall Study|Lost to Follow-up|14|||
126357333|NCT00145327|454602055|FG002|Overall Study|Lost to Follow-up|14|||
126357334|NCT00145327|454602053|FG000|Overall Study|Administrative problems|12|||
126357335|NCT00145327|454602054|FG001|Overall Study|Administrative problems|9|||
126357336|NCT00145327|454602055|FG002|Overall Study|Administrative problems|13|||
126357337|NCT00145327|454602053|FG000|Overall Study|Protocol Violation|2|||
126357338|NCT00145327|454602054|FG001|Overall Study|Protocol Violation|0|||
126357339|NCT00145327|454602055|FG002|Overall Study|Protocol Violation|2|||
126447352|NCT00223080|454937992|FG001|Overall Study|Other|11|||
126447353|NCT00223080|454937991|FG000|Overall Study|Reason not provided|141|||
126447354|NCT00223080|454937992|FG001|Overall Study|Reason not provided|140|||
126694382|NCT00944034|455835080|FG005|Overall Study|Protocol Violation|3|||
126694383|NCT00944034|455835081|FG006|Overall Study|Protocol Violation|0|||
126694384|NCT00944034|455835082|FG007|Overall Study|Protocol Violation|1|||
126694385|NCT00944034|455835083|FG008|Overall Study|Protocol Violation|1|||
126694386|NCT00944034|455835084|FG009|Overall Study|Protocol Violation|4|||
126694387|NCT00944034|455835085|FG010|Overall Study|Protocol Violation|0|||
126694388|NCT00944034|455835086|FG011|Overall Study|Protocol Violation|0|||
126694389|NCT00944034|455835075|FG000|Overall Study|Unable to classify|0|||
126694390|NCT00944034|455835076|FG001|Overall Study|Unable to classify|0|||
126694391|NCT00944034|455835077|FG002|Overall Study|Unable to classify|0|||
126694392|NCT00944034|455835078|FG003|Overall Study|Unable to classify|0|||
126694393|NCT00944034|455835079|FG004|Overall Study|Unable to classify|0|||
126694394|NCT00944034|455835080|FG005|Overall Study|Unable to classify|1|||
126694395|NCT00944034|455835081|FG006|Overall Study|Unable to classify|1|||
126694396|NCT00944034|455835082|FG007|Overall Study|Unable to classify|1|||
126357340|NCT00145327|454602053|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126357341|NCT00145327|454602054|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126357342|NCT00145327|454602055|FG002|Overall Study|Abnormal laboratory value(s)|2|||
126357343|NCT00145327|454602053|FG000|Overall Study|Missing - not stated|1|||
126694397|NCT00944034|455835083|FG008|Overall Study|Unable to classify|0|||
126694398|NCT00944034|455835084|FG009|Overall Study|Unable to classify|0|||
126694399|NCT00944034|455835085|FG010|Overall Study|Unable to classify|0|||
126694400|NCT00944034|455835086|FG011|Overall Study|Unable to classify|0|||
126694401|NCT00944034|455835075|FG000|Overall Study|Administrative reason|0|||
126694402|NCT00944034|455835076|FG001|Overall Study|Administrative reason|0|||
126694403|NCT00944034|455835077|FG002|Overall Study|Administrative reason|0|||
126694404|NCT00944034|455835078|FG003|Overall Study|Administrative reason|0|||
126694405|NCT00944034|455835079|FG004|Overall Study|Administrative reason|0|||
126694406|NCT00944034|455835080|FG005|Overall Study|Administrative reason|0|||
126694407|NCT00944034|455835081|FG006|Overall Study|Administrative reason|1|||
126694408|NCT00944034|455835082|FG007|Overall Study|Administrative reason|0|||
126694409|NCT00944034|455835083|FG008|Overall Study|Administrative reason|0|||
126694410|NCT00944034|455835084|FG009|Overall Study|Administrative reason|0|||
126694411|NCT00944034|455835085|FG010|Overall Study|Administrative reason|0|||
126694412|NCT00944034|455835086|FG011|Overall Study|Administrative reason|0|||
126694413|NCT00441792|455835093|FG000|Overall Study|Lost to Follow-up|0|||
126694414|NCT00441792|455835094|FG001|Overall Study|Lost to Follow-up|2|||
126694415|NCT02649634|455835098|FG000|Overall Study|Withdrawal by Subject|3|||
126694416|NCT02649634|455835099|FG001|Overall Study|Withdrawal by Subject|5|||
126694417|NCT02649634|455835098|FG000|Overall Study|Lost to Follow-up|0|||
126357344|NCT00145327|454602054|FG001|Overall Study|Missing - not stated|0|||
126357345|NCT00145327|454602055|FG002|Overall Study|Missing - not stated|1|||
126357346|NCT02802865|454602056|FG000|Overall Study|Pregnancy|1|||
126694418|NCT02649634|455835099|FG001|Overall Study|Lost to Follow-up|1|||
126760955|NCT02309372|456075874|FG000|Overall Study|Lost to Follow-up|3|||
126447355|NCT00223080|454937991|FG000|Overall Study|Adverse Event|0|||
126447356|NCT00223080|454937992|FG001|Overall Study|Adverse Event|1|||
126447357|NCT02598583|454937993|FG000|Extension Period|Withdrawal by Subject|1|||
126447358|NCT02598583|454937994|FG001|Extension Period|Withdrawal by Subject|0|||
126447359|NCT03237286|454937995|FG000|Overall Study|Withdrawal by Subject|1|||
126447360|NCT03237286|454937996|FG001|Overall Study|Withdrawal by Subject|0|||
126447361|NCT03237286|454937997|FG002|Overall Study|Withdrawal by Subject|2|||
126447362|NCT03237286|454937995|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
126447363|NCT03237286|454937996|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
126447364|NCT03237286|454937997|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
126447365|NCT00948441|454937998|FG000|Overall Study|no longer meet inclusion criteria|1|||
126447366|NCT00948441|454937999|FG001|Overall Study|no longer meet inclusion criteria|4|||
126447367|NCT03500224|454938008|FG000|Overall Study|Withdrawal by Subject|2|||
126447368|NCT01324401|454938011|FG000|Overall Study|Withdrawn before any treatment|0|||
126447369|NCT01324401|454938012|FG001|Overall Study|Withdrawn before any treatment|3|||
126447370|NCT01324401|454938011|FG000|Overall Study|Adverse Event|1|||
126447371|NCT01324401|454938012|FG001|Overall Study|Adverse Event|3|||
126447372|NCT01708902|454938014|FG000|Overall Study|Adverse Event|3|||
126447373|NCT01708902|454938015|FG001|Overall Study|Adverse Event|4|||
126694419|NCT01486199|455835100|FG000|Two Year Period Between Study Days|Physician Decision|1|||
126694420|NCT01486199|455835101|FG001|Two Year Period Between Study Days|Physician Decision|0|||
126694421|NCT02211261|455835105|FG000|Overall Study|Withdrawal by Subject|0|||
126694422|NCT02211261|455835106|FG001|Overall Study|Withdrawal by Subject|0|||
126694423|NCT02211261|455835107|FG002|Overall Study|Withdrawal by Subject|1|||
126694424|NCT02211261|455835108|FG003|Overall Study|Withdrawal by Subject|0|||
126694425|NCT02211261|455835109|FG004|Overall Study|Withdrawal by Subject|2|||
126694426|NCT02211261|455835110|FG005|Overall Study|Withdrawal by Subject|0|||
126694427|NCT02211261|455835111|FG006|Overall Study|Withdrawal by Subject|0|||
126694428|NCT02211261|455835112|FG007|Overall Study|Withdrawal by Subject|0|||
126694429|NCT02211261|455835113|FG008|Overall Study|Withdrawal by Subject|0|||
126694430|NCT02211261|455835114|FG009|Overall Study|Withdrawal by Subject|0|||
126694431|NCT02211261|455835115|FG010|Overall Study|Withdrawal by Subject|0|||
126357347|NCT02802865|454602057|FG001|Overall Study|Pregnancy|1|||
126694432|NCT02211261|455835105|FG000|Overall Study|Other|0|||
126694433|NCT02211261|455835106|FG001|Overall Study|Other|0|||
126694434|NCT02211261|455835107|FG002|Overall Study|Other|0|||
126357348|NCT02802865|454602056|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
126357349|NCT02802865|454602057|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
126357350|NCT00985192|454602059|FG000|Overall Study|Withdrawal by Subject|1|||
126357351|NCT00985192|454602059|FG000|Overall Study|Disease Progression|1|||
126357352|NCT00985192|454602059|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
126357353|NCT01454063|454602060|FG000|Randomized|Adverse Event|1|||
126357354|NCT01454063|454602061|FG001|Randomized|Adverse Event|1|||
126357355|NCT01454063|454602060|FG000|Randomized|Protocol Violation|0|||
126357356|NCT01454063|454602061|FG001|Randomized|Protocol Violation|1|||
126357357|NCT00509600|454602065|FG000|Overall Study|Adverse Event|1|||
126357358|NCT03055195|454602066|FG000|Overall Study|Lack of Efficacy|1|||
126357359|NCT03055195|454602067|FG001|Overall Study|Lack of Efficacy|0|||
126357360|NCT03055195|454602066|FG000|Overall Study|Withdrawal by Subject|6|||
126357361|NCT03055195|454602067|FG001|Overall Study|Withdrawal by Subject|7|||
126357362|NCT03055195|454602066|FG000|Overall Study|Study Terminated by Sponsor|2|||
126357363|NCT03055195|454602067|FG001|Overall Study|Study Terminated by Sponsor|6|||
126357364|NCT03055195|454602066|FG000|Overall Study|Protocol Violation|2|||
126357365|NCT03055195|454602067|FG001|Overall Study|Protocol Violation|1|||
126357366|NCT03055195|454602066|FG000|Overall Study|Physician Decision|1|||
126357367|NCT03055195|454602067|FG001|Overall Study|Physician Decision|0|||
126357368|NCT00720083|454602068|FG000|Overall Study|Ineligible|1|||
126357369|NCT00720083|454602069|FG001|Overall Study|Ineligible|2|||
126357370|NCT01960842|454602070|FG000|Overall Study|Adverse Event|1|||
126357371|NCT01960842|454602070|FG000|Overall Study|Withdrawal by Subject|2|||
126357372|NCT02391584|454602071|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
126357373|NCT02391584|454602072|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
126357374|NCT02391584|454602071|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
126357375|NCT02391584|454602072|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
126357376|NCT02391584|454602071|FG000|3 Month|Lost to Follow-up|1|||
126357377|NCT02391584|454602072|FG001|3 Month|Lost to Follow-up|0|||
126357378|NCT02391584|454602071|FG000|6 Month|Withdrawal by Subject|1|||
126357379|NCT02391584|454602072|FG001|6 Month|Withdrawal by Subject|0|||
126545708|NCT02746575|455292420|FG000|Overall Study|Withdrawal by Subject|3|||
126694435|NCT02211261|455835108|FG003|Overall Study|Other|0|||
126694436|NCT02211261|455835109|FG004|Overall Study|Other|0|||
126694437|NCT02211261|455835110|FG005|Overall Study|Other|1|||
126694438|NCT02211261|455835111|FG006|Overall Study|Other|0|||
126694439|NCT02211261|455835112|FG007|Overall Study|Other|0|||
126694440|NCT02211261|455835113|FG008|Overall Study|Other|0|||
126694441|NCT02211261|455835114|FG009|Overall Study|Other|2|||
126694442|NCT02211261|455835115|FG010|Overall Study|Other|0|||
126694443|NCT02211261|455835105|FG000|Overall Study|Lost to Follow-up|0|||
126694444|NCT02211261|455835106|FG001|Overall Study|Lost to Follow-up|0|||
126694445|NCT02211261|455835107|FG002|Overall Study|Lost to Follow-up|0|||
126694446|NCT02211261|455835108|FG003|Overall Study|Lost to Follow-up|0|||
126694447|NCT02211261|455835109|FG004|Overall Study|Lost to Follow-up|0|||
126694448|NCT02211261|455835110|FG005|Overall Study|Lost to Follow-up|0|||
126694449|NCT02211261|455835111|FG006|Overall Study|Lost to Follow-up|0|||
126694450|NCT02211261|455835112|FG007|Overall Study|Lost to Follow-up|1|||
126694451|NCT02211261|455835113|FG008|Overall Study|Lost to Follow-up|0|||
126694452|NCT02211261|455835114|FG009|Overall Study|Lost to Follow-up|0|||
126694453|NCT02211261|455835115|FG010|Overall Study|Lost to Follow-up|0|||
126694454|NCT04897867|455835116|FG000|Overall Study|Withdrawal of Consent|1|||
126694455|NCT04897867|455835116|FG000|Overall Study|Pregnancy|1|||
126694456|NCT04897867|455835116|FG000|Overall Study|Lost to Follow-up|7|||
126694457|NCT04897867|455835116|FG000|Overall Study|Reason not Specified|2|||
126694458|NCT01282229|455835131|FG000|Overall Study|Protocol Violation|2|||
126694459|NCT03094195|455835137|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
126694460|NCT03094195|455835138|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
126694461|NCT03094195|455835139|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
126694462|NCT03094195|455835140|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126694463|NCT03094195|455835141|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126760956|NCT02309372|456075875|FG001|Overall Study|Lost to Follow-up|2|||
126545709|NCT02746575|455292420|FG000|Overall Study|Bradycardia/hypotension|9|||
126545710|NCT02746575|455292420|FG000|Overall Study|Study paused|8|||
126545711|NCT02746575|455292420|FG000|Overall Study|put on beta-blocker|3|||
126545712|NCT02746575|455292420|FG000|Overall Study|type of surgery|1|||
126545713|NCT02746575|455292420|FG000|Overall Study|typ of surgery|1|||
126545714|NCT02746575|455292420|FG000|Overall Study|PI unavailable|1|||
126545715|NCT02746575|455292420|FG000|Overall Study|Unknown history of CVA|1|||
126545716|NCT00957931|455292423|FG000|Overall Study|Death|4|||
126694464|NCT03094195|455835142|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126694465|NCT03094195|455835143|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126694466|NCT03094195|455835144|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126694467|NCT03094195|455835137|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
126357380|NCT02391584|454602071|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
126357381|NCT02391584|454602072|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
126357382|NCT01441414|454602080|FG000|Overall Study|Participant died|9|||
126760957|NCT01590810|456075877|FG000|Overall Study|Physician Decision|0|||
126760958|NCT01590810|456075878|FG001|Overall Study|Physician Decision|1|||
126760959|NCT01590810|456075879|FG002|Overall Study|Physician Decision|1|||
126760960|NCT01590810|456075880|FG003|Overall Study|Physician Decision|0|||
126760961|NCT01590810|456075881|FG004|Overall Study|Physician Decision|0|||
126760962|NCT02400281|456075882|FG000|Overall Study|Adverse Event|0|||
126760963|NCT02400281|456075883|FG001|Overall Study|Adverse Event|0|||
126760964|NCT02400281|456075884|FG002|Overall Study|Adverse Event|1|||
126760965|NCT02400281|456075885|FG003|Overall Study|Adverse Event|0|||
126760966|NCT02400281|456075886|FG004|Overall Study|Adverse Event|1|||
126760967|NCT02400281|456075887|FG005|Overall Study|Adverse Event|0|||
126760968|NCT02400281|456075882|FG000|Overall Study|Physician Decision|0|||
126760969|NCT02400281|456075883|FG001|Overall Study|Physician Decision|0|||
126760970|NCT02400281|456075884|FG002|Overall Study|Physician Decision|1|||
126760971|NCT02400281|456075885|FG003|Overall Study|Physician Decision|0|||
126760972|NCT02400281|456075886|FG004|Overall Study|Physician Decision|0|||
126760973|NCT02400281|456075887|FG005|Overall Study|Physician Decision|0|||
126357383|NCT01441414|454602080|FG000|Overall Study|Other reasons|3|||
126357384|NCT01441414|454602080|FG000|Overall Study|Study terminated by sponsor|2|||
126760974|NCT00412360|456075888|FG000|Overall Study|Lost to Follow-up|0|||
126760975|NCT00412360|456075889|FG001|Overall Study|Lost to Follow-up|1|||
126760976|NCT00412360|456075888|FG000|Overall Study|Not Transplanted|1|||
126760977|NCT00412360|456075889|FG001|Overall Study|Not Transplanted|2|||
126760978|NCT03655951|456075891|FG000|Overall Study|Lost to Follow-up|39|||
126760979|NCT03655951|456075892|FG001|Overall Study|Lost to Follow-up|20|||
126760980|NCT03655951|456075891|FG000|Overall Study|Withdrawal by Subject|0|||
126760981|NCT03655951|456075892|FG001|Overall Study|Withdrawal by Subject|1|||
126760982|NCT02811640|456075893|FG000|Overall Study|Technology malfunction|2|||
126760983|NCT02441517|456075895|FG000|Overall Study|Lost to Follow-up|1|||
126760984|NCT02441517|456075895|FG000|Overall Study|Withdrawal by Subject|2|||
126760985|NCT02441517|456075895|FG000|Overall Study|Study Terminated by Sponsor|1|||
126760986|NCT01393444|456075896|FG000|Overall Study|Withdrawal by Subject|1|||
126760987|NCT01393444|456075896|FG000|Overall Study|Determined ineligible during screening.|2|||
126760988|NCT01349816|456075899|FG000|Overall Study|Withdrawal by Subject|4|||
126760989|NCT01349816|456075899|FG000|Overall Study|Physician Decision|1|||
126357385|NCT01441414|454602080|FG000|Overall Study|Subject refused further follow-up|1|||
126760990|NCT01349816|456075899|FG000|Overall Study|Adverse Event|14|||
126760991|NCT01349816|456075899|FG000|Overall Study|Lost to Follow-up|2|||
126760992|NCT01349816|456075899|FG000|Overall Study|Protocol Violation|1|||
126760993|NCT01349816|456075899|FG000|Overall Study|Protocol-specified criteria|8|||
126760994|NCT02569996|456075900|FG000|Overall Study|Adverse Event|6|||
126760995|NCT02569996|456075900|FG000|Overall Study|Physician Decision|3|||
126760996|NCT02569996|456075900|FG000|Overall Study|Progression of the disease|18|||
126760997|NCT02569996|456075900|FG000|Overall Study|New anti-lymphoma treatment|1|||
126694468|NCT03094195|455835138|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
126357386|NCT01773889|454602087|FG000|Overall Study|lack of funding|2|||
126357387|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
126357388|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
126357389|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
126357390|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
126357391|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
126357392|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
126357393|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
126357394|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
126357395|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
126357396|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
126357397|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
126357398|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
126357399|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
126357400|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
126357401|NCT00976391|454602088|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
126357402|NCT00976391|454602089|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
126357403|NCT00976391|454602088|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
126357404|NCT00976391|454602089|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
126357405|NCT00976391|454602088|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
126357406|NCT00976391|454602089|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
126357407|NCT00976391|454602088|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
126357408|NCT00976391|454602089|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
126357409|NCT00976391|454602088|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
126357410|NCT00976391|454602089|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
126357411|NCT00976391|454602088|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
126357412|NCT00976391|454602089|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
126357413|NCT00976391|454602088|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
126357414|NCT00976391|454602089|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
126357415|NCT02018887|454602090|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
126357416|NCT02018887|454602091|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126447374|NCT01708902|454938016|FG002|Overall Study|Adverse Event|9|||
126447375|NCT01708902|454938017|FG003|Overall Study|Adverse Event|2|||
126447376|NCT01708902|454938018|FG004|Overall Study|Adverse Event|7|||
126447377|NCT01708902|454938019|FG005|Overall Study|Adverse Event|3|||
126447378|NCT01708902|454938020|FG006|Overall Study|Adverse Event|5|||
126447379|NCT01708902|454938014|FG000|Overall Study|Lack of Efficacy|3|||
126447380|NCT01708902|454938015|FG001|Overall Study|Lack of Efficacy|1|||
126447381|NCT01708902|454938016|FG002|Overall Study|Lack of Efficacy|0|||
126447382|NCT01708902|454938017|FG003|Overall Study|Lack of Efficacy|0|||
126447383|NCT01708902|454938018|FG004|Overall Study|Lack of Efficacy|0|||
126447384|NCT01708902|454938019|FG005|Overall Study|Lack of Efficacy|1|||
126447385|NCT01708902|454938020|FG006|Overall Study|Lack of Efficacy|0|||
126447386|NCT01708902|454938014|FG000|Overall Study|Non compliance with protocol|0|||
126447387|NCT01708902|454938015|FG001|Overall Study|Non compliance with protocol|2|||
126447388|NCT01708902|454938016|FG002|Overall Study|Non compliance with protocol|1|||
126447389|NCT01708902|454938017|FG003|Overall Study|Non compliance with protocol|3|||
126447390|NCT01708902|454938018|FG004|Overall Study|Non compliance with protocol|0|||
126447391|NCT01708902|454938019|FG005|Overall Study|Non compliance with protocol|0|||
126694469|NCT03094195|455835139|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
126447392|NCT01708902|454938020|FG006|Overall Study|Non compliance with protocol|0|||
126447393|NCT01708902|454938014|FG000|Overall Study|Lost to Follow-up|2|||
126447394|NCT01708902|454938015|FG001|Overall Study|Lost to Follow-up|1|||
126447395|NCT01708902|454938016|FG002|Overall Study|Lost to Follow-up|2|||
126447396|NCT01708902|454938017|FG003|Overall Study|Lost to Follow-up|2|||
126447397|NCT01708902|454938018|FG004|Overall Study|Lost to Follow-up|0|||
126447398|NCT01708902|454938019|FG005|Overall Study|Lost to Follow-up|0|||
126447399|NCT01708902|454938020|FG006|Overall Study|Lost to Follow-up|1|||
126694470|NCT03094195|455835140|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126760998|NCT02569996|456075900|FG000|Overall Study|Non-compliance|9|||
126447400|NCT01708902|454938014|FG000|Overall Study|Refused to continue trial medication|8|||
126447401|NCT01708902|454938015|FG001|Overall Study|Refused to continue trial medication|0|||
126447402|NCT01708902|454938016|FG002|Overall Study|Refused to continue trial medication|4|||
126357417|NCT02018887|454602092|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357418|NCT02018887|454602093|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357419|NCT02018887|454602094|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357420|NCT02018887|454602095|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357421|NCT02018887|454602096|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357422|NCT02018887|454602097|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357423|NCT02018887|454602098|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357424|NCT02018887|454602099|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357425|NCT02018887|454602100|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
126357426|NCT02018887|454602090|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357427|NCT02018887|454602091|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357428|NCT02018887|454602092|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357429|NCT02018887|454602093|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357430|NCT02018887|454602094|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
126357431|NCT02018887|454602095|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357432|NCT02018887|454602096|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
126694471|NCT03094195|455835141|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126694472|NCT03094195|455835142|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126694473|NCT03094195|455835143|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126694474|NCT03094195|455835144|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126694475|NCT03094195|455835137|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126447403|NCT01708902|454938017|FG003|Overall Study|Refused to continue trial medication|2|||
126447404|NCT01708902|454938018|FG004|Overall Study|Refused to continue trial medication|8|||
126447405|NCT01708902|454938019|FG005|Overall Study|Refused to continue trial medication|1|||
126447406|NCT01708902|454938020|FG006|Overall Study|Refused to continue trial medication|1|||
126447407|NCT01708902|454938014|FG000|Overall Study|Other Reason|1|||
126447408|NCT01708902|454938015|FG001|Overall Study|Other Reason|0|||
126447409|NCT01708902|454938016|FG002|Overall Study|Other Reason|1|||
126447410|NCT01708902|454938017|FG003|Overall Study|Other Reason|1|||
126447411|NCT01708902|454938018|FG004|Overall Study|Other Reason|1|||
126447412|NCT01708902|454938019|FG005|Overall Study|Other Reason|2|||
126447413|NCT01708902|454938020|FG006|Overall Study|Other Reason|0|||
126447414|NCT02152956|454938021|FG000|Overall Study|Adverse Event|0|||
126447415|NCT02152956|454938022|FG001|Overall Study|Adverse Event|0|||
126447416|NCT02152956|454938023|FG002|Overall Study|Adverse Event|0|||
126447417|NCT02152956|454938024|FG003|Overall Study|Adverse Event|0|||
126447418|NCT02152956|454938025|FG004|Overall Study|Adverse Event|0|||
126447419|NCT02152956|454938026|FG005|Overall Study|Adverse Event|0|||
126447420|NCT02152956|454938027|FG006|Overall Study|Adverse Event|0|||
126447421|NCT02152956|454938028|FG007|Overall Study|Adverse Event|0|||
126447422|NCT02152956|454938029|FG008|Overall Study|Adverse Event|0|||
126447423|NCT02152956|454938030|FG009|Overall Study|Adverse Event|0|||
126447424|NCT02152956|454938031|FG010|Overall Study|Adverse Event|0|||
126447425|NCT02152956|454938032|FG011|Overall Study|Adverse Event|4|||
126447426|NCT02152956|454938033|FG012|Overall Study|Adverse Event|0|||
126447427|NCT02152956|454938021|FG000|Overall Study|Death|0|||
126447428|NCT02152956|454938022|FG001|Overall Study|Death|3|||
126447429|NCT02152956|454938023|FG002|Overall Study|Death|3|||
126447430|NCT02152956|454938024|FG003|Overall Study|Death|4|||
126447431|NCT02152956|454938025|FG004|Overall Study|Death|1|||
126447432|NCT02152956|454938026|FG005|Overall Study|Death|2|||
126447433|NCT02152956|454938027|FG006|Overall Study|Death|6|||
126447434|NCT02152956|454938028|FG007|Overall Study|Death|6|||
126447435|NCT02152956|454938029|FG008|Overall Study|Death|4|||
126694476|NCT03094195|455835138|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126447436|NCT02152956|454938030|FG009|Overall Study|Death|5|||
126447437|NCT02152956|454938031|FG010|Overall Study|Death|3|||
126447438|NCT02152956|454938032|FG011|Overall Study|Death|143|||
126447439|NCT02152956|454938033|FG012|Overall Study|Death|12|||
126447440|NCT02152956|454938021|FG000|Overall Study|Lost to Follow-up|0|||
126447441|NCT02152956|454938022|FG001|Overall Study|Lost to Follow-up|1|||
126694477|NCT03094195|455835139|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
126447442|NCT02152956|454938023|FG002|Overall Study|Lost to Follow-up|0|||
126760999|NCT02569996|456075900|FG000|Overall Study|Withdrawal by Subject|5|||
126761000|NCT02569996|456075900|FG000|Overall Study|Lost to Follow-up|5|||
126761001|NCT02569996|456075900|FG000|Overall Study|Complete remission|7|||
126761002|NCT02569996|456075900|FG000|Overall Study|Unknown reason|1|||
126761003|NCT01397409|456075903|FG000|Stage 2|Adverse Event|0|||
126761004|NCT01397409|456075904|FG001|Stage 2|Adverse Event|0|||
126761005|NCT01397409|456075905|FG002|Stage 2|Adverse Event|0|||
126761006|NCT01397409|456075906|FG003|Stage 2|Adverse Event|0|||
126761007|NCT01397409|456075907|FG004|Stage 2|Adverse Event|6|||
126761008|NCT01397409|456075908|FG005|Stage 2|Adverse Event|3|||
126761009|NCT01397409|456075909|FG006|Stage 2|Adverse Event|0|||
126761010|NCT01397409|456075910|FG007|Stage 2|Adverse Event|0|||
126761011|NCT01397409|456075911|FG008|Stage 2|Adverse Event|0|||
126761012|NCT01397409|456075912|FG009|Stage 2|Adverse Event|0|||
126761013|NCT01397409|456075903|FG000|Stage 2|Personal Reasons|0|||
126761014|NCT01397409|456075904|FG001|Stage 2|Personal Reasons|0|||
126761015|NCT01397409|456075905|FG002|Stage 2|Personal Reasons|0|||
126761016|NCT01397409|456075906|FG003|Stage 2|Personal Reasons|0|||
126761017|NCT01397409|456075907|FG004|Stage 2|Personal Reasons|1|||
126761018|NCT01397409|456075908|FG005|Stage 2|Personal Reasons|0|||
126761019|NCT01397409|456075909|FG006|Stage 2|Personal Reasons|0|||
126761020|NCT01397409|456075910|FG007|Stage 2|Personal Reasons|0|||
126761021|NCT01397409|456075911|FG008|Stage 2|Personal Reasons|0|||
126761022|NCT01397409|456075912|FG009|Stage 2|Personal Reasons|0|||
126761023|NCT01397409|456075903|FG000|Stage 2|Other Miscellaneous Reasons|0|||
126761024|NCT01397409|456075904|FG001|Stage 2|Other Miscellaneous Reasons|0|||
126761025|NCT01397409|456075905|FG002|Stage 2|Other Miscellaneous Reasons|0|||
126761026|NCT01397409|456075906|FG003|Stage 2|Other Miscellaneous Reasons|0|||
126761027|NCT01397409|456075907|FG004|Stage 2|Other Miscellaneous Reasons|1|||
126761028|NCT01397409|456075908|FG005|Stage 2|Other Miscellaneous Reasons|1|||
126761029|NCT01397409|456075909|FG006|Stage 2|Other Miscellaneous Reasons|0|||
126761030|NCT01397409|456075910|FG007|Stage 2|Other Miscellaneous Reasons|0|||
126761031|NCT01397409|456075911|FG008|Stage 2|Other Miscellaneous Reasons|0|||
126761032|NCT01397409|456075912|FG009|Stage 2|Other Miscellaneous Reasons|0|||
126761033|NCT01397409|456075903|FG000|Stage 3|Adverse Event|0|||
126761034|NCT01397409|456075904|FG001|Stage 3|Adverse Event|0|||
126761035|NCT01397409|456075905|FG002|Stage 3|Adverse Event|0|||
126761036|NCT01397409|456075906|FG003|Stage 3|Adverse Event|0|||
126761037|NCT01397409|456075907|FG004|Stage 3|Adverse Event|0|||
126761038|NCT01397409|456075908|FG005|Stage 3|Adverse Event|0|||
126761039|NCT01397409|456075909|FG006|Stage 3|Adverse Event|0|||
126761040|NCT01397409|456075910|FG007|Stage 3|Adverse Event|1|||
126761041|NCT01397409|456075911|FG008|Stage 3|Adverse Event|0|||
126761042|NCT01397409|456075912|FG009|Stage 3|Adverse Event|0|||
126761043|NCT01397409|456075903|FG000|Stage 3|Other Miscellaneous Reasons|0|||
126761044|NCT01397409|456075904|FG001|Stage 3|Other Miscellaneous Reasons|0|||
126761045|NCT01397409|456075905|FG002|Stage 3|Other Miscellaneous Reasons|0|||
126761046|NCT01397409|456075906|FG003|Stage 3|Other Miscellaneous Reasons|0|||
126761047|NCT01397409|456075907|FG004|Stage 3|Other Miscellaneous Reasons|0|||
126761048|NCT01397409|456075908|FG005|Stage 3|Other Miscellaneous Reasons|0|||
126761049|NCT01397409|456075909|FG006|Stage 3|Other Miscellaneous Reasons|0|||
126545717|NCT00857805|455292424|FG000|Overall Study|Withdrawal by Subject|1|||
126761050|NCT01397409|456075910|FG007|Stage 3|Other Miscellaneous Reasons|1|||
126761051|NCT01397409|456075911|FG008|Stage 3|Other Miscellaneous Reasons|0|||
126761052|NCT01397409|456075912|FG009|Stage 3|Other Miscellaneous Reasons|0|||
126761053|NCT01207427|456075913|FG000|Double-blind Treatment Period|Adverse Event|0|||
126761054|NCT01207427|456075914|FG001|Double-blind Treatment Period|Adverse Event|1|||
126761055|NCT01207427|456075915|FG002|Double-blind Treatment Period|Adverse Event|0|||
126761056|NCT01207427|456075913|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126761057|NCT01207427|456075914|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
126761058|NCT01207427|456075915|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
126761059|NCT01207427|456075913|FG000|Double-blind Treatment Period|Protocol Violation|2|||
126761060|NCT01207427|456075914|FG001|Double-blind Treatment Period|Protocol Violation|1|||
126761061|NCT01207427|456075915|FG002|Double-blind Treatment Period|Protocol Violation|1|||
126545718|NCT00857805|455292425|FG001|Overall Study|Withdrawal by Subject|1|||
126761062|NCT01207427|456075913|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
126761063|NCT01207427|456075914|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
126545719|NCT04867785|455292426|FG000|Overall Study|Adverse Event|1|||
126761064|NCT01207427|456075915|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126761065|NCT01790633|456075916|FG000|Overall Study|Protocol Violation|1|||
126761066|NCT01790633|456075917|FG001|Overall Study|Protocol Violation|2|||
126447443|NCT02152956|454938024|FG003|Overall Study|Lost to Follow-up|0|||
126761067|NCT01790633|456075916|FG000|Overall Study|Did not have serology performed|47|||
126761068|NCT01790633|456075917|FG001|Overall Study|Did not have serology performed|0|||
126761069|NCT01790633|456075916|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
126761070|NCT01790633|456075917|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
126761071|NCT02930889|456077118|FG000|Overall Study|Lost to Follow-up|2|||
126761072|NCT02930889|456077118|FG000|Overall Study|Withdrawal by Subject|6|||
126761073|NCT02930889|456077118|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
126761074|NCT00198107|456077124|FG000|Double-Blind Period|Adverse Event|1|||
126761075|NCT00198107|456077125|FG001|Double-Blind Period|Adverse Event|1|||
126761076|NCT00198107|456077126|FG002|Double-Blind Period|Adverse Event|0|||
126761077|NCT00198107|456077124|FG000|Double-Blind Period|Lack of Efficacy|2|||
126447444|NCT02152956|454938025|FG004|Overall Study|Lost to Follow-up|0|||
126447445|NCT02152956|454938026|FG005|Overall Study|Lost to Follow-up|0|||
126694478|NCT03094195|455835140|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126694479|NCT03094195|455835141|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126694480|NCT03094195|455835142|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126694481|NCT03094195|455835143|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126694482|NCT03094195|455835144|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126447446|NCT02152956|454938027|FG006|Overall Study|Lost to Follow-up|0|||
126447447|NCT02152956|454938028|FG007|Overall Study|Lost to Follow-up|0|||
126694483|NCT03094195|455835137|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126694484|NCT03094195|455835138|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
126694485|NCT03094195|455835139|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
126694486|NCT03094195|455835140|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126694487|NCT03094195|455835141|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126694488|NCT03094195|455835142|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126694489|NCT03094195|455835143|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126694490|NCT03094195|455835144|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126694491|NCT02440581|455835148|FG000|Overall Study|Death|0|||
126694492|NCT02440581|455835149|FG001|Overall Study|Death|0|||
126694493|NCT02440581|455835150|FG002|Overall Study|Death|7|||
126694494|NCT02440581|455835151|FG003|Overall Study|Death|5|||
126694495|NCT02440581|455835148|FG000|Overall Study|Transplanted|1|||
126694496|NCT02440581|455835149|FG001|Overall Study|Transplanted|0|||
126694497|NCT02440581|455835150|FG002|Overall Study|Transplanted|3|||
126694498|NCT02440581|455835151|FG003|Overall Study|Transplanted|2|||
126694499|NCT02440581|455835148|FG000|Overall Study|Withdrawal by Subject|4|||
126694500|NCT02440581|455835149|FG001|Overall Study|Withdrawal by Subject|11|||
126694501|NCT02440581|455835150|FG002|Overall Study|Withdrawal by Subject|3|||
126761078|NCT00198107|456077125|FG001|Double-Blind Period|Lack of Efficacy|0|||
126761079|NCT00198107|456077126|FG002|Double-Blind Period|Lack of Efficacy|0|||
126761080|NCT00198107|456077124|FG000|Double-Blind Period|Lost to Follow-up|2|||
126761081|NCT00198107|456077125|FG001|Double-Blind Period|Lost to Follow-up|1|||
126761082|NCT00198107|456077126|FG002|Double-Blind Period|Lost to Follow-up|0|||
126761083|NCT00198107|456077124|FG000|Double-Blind Period|Physician Decision|1|||
126761084|NCT00198107|456077125|FG001|Double-Blind Period|Physician Decision|0|||
126761085|NCT00198107|456077126|FG002|Double-Blind Period|Physician Decision|0|||
126761086|NCT00198107|456077124|FG000|Double-Blind Period|Withdrawal by Subject|0|||
126761087|NCT00198107|456077125|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126761088|NCT00198107|456077126|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126761089|NCT00198107|456077124|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
126761090|NCT00198107|456077125|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
126761091|NCT00198107|456077126|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
126761092|NCT00451191|456077135|FG000|Overall Study|withdrawal or received alternate tx|15|||
126761093|NCT00451191|456077136|FG001|Overall Study|withdrawal or received alternate tx|11|||
126761094|NCT03575806|456077138|FG000|Overall Study|Withdrawal by Subject|0|||
126761095|NCT03575806|456077139|FG001|Overall Study|Withdrawal by Subject|2|||
126761096|NCT03575806|456077138|FG000|Overall Study|Protocol Violation|0|||
126761097|NCT03575806|456077139|FG001|Overall Study|Protocol Violation|2|||
126761098|NCT01458535|456077140|FG000|Overall Study|Other|0|||
126761099|NCT01458535|456077141|FG001|Overall Study|Other|0|||
126694502|NCT02440581|455835151|FG003|Overall Study|Withdrawal by Subject|7|||
126694503|NCT01279057|455836441|FG000|Overall Study|Adverse Event|1|||
126694504|NCT01279057|455836442|FG001|Overall Study|Adverse Event|0|||
126694505|NCT01279057|455836443|FG002|Overall Study|Adverse Event|1|||
126694506|NCT01279057|455836441|FG000|Overall Study|Insufficient therapeutic response|0|||
126694507|NCT01279057|455836442|FG001|Overall Study|Insufficient therapeutic response|0|||
126694508|NCT01279057|455836443|FG002|Overall Study|Insufficient therapeutic response|1|||
126694509|NCT01279057|455836441|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
126694510|NCT01279057|455836442|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
126694511|NCT01279057|455836443|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
126694512|NCT01279057|455836441|FG000|Overall Study|Withdrew consent|2|||
126761100|NCT01458535|456077142|FG002|Overall Study|Other|0|||
126761101|NCT01458535|456077143|FG003|Overall Study|Other|0|||
126761102|NCT01458535|456077144|FG004|Overall Study|Other|1|||
126761103|NCT01458535|456077145|FG005|Overall Study|Other|1|||
126761104|NCT01458535|456077140|FG000|Overall Study|Withdrawal by Subject|0|||
126761105|NCT01458535|456077141|FG001|Overall Study|Withdrawal by Subject|0|||
126761106|NCT01458535|456077142|FG002|Overall Study|Withdrawal by Subject|2|||
126761107|NCT01458535|456077143|FG003|Overall Study|Withdrawal by Subject|0|||
126761108|NCT01458535|456077144|FG004|Overall Study|Withdrawal by Subject|1|||
126761109|NCT01458535|456077145|FG005|Overall Study|Withdrawal by Subject|1|||
126761110|NCT01458535|456077140|FG000|Overall Study|Lost to Follow-up|0|||
126761111|NCT01458535|456077141|FG001|Overall Study|Lost to Follow-up|2|||
126761112|NCT01458535|456077142|FG002|Overall Study|Lost to Follow-up|0|||
126761113|NCT01458535|456077143|FG003|Overall Study|Lost to Follow-up|3|||
126761114|NCT01458535|456077144|FG004|Overall Study|Lost to Follow-up|2|||
126761115|NCT01458535|456077145|FG005|Overall Study|Lost to Follow-up|2|||
126761116|NCT01458535|456077140|FG000|Overall Study|Adverse Event|0|||
126761117|NCT01458535|456077141|FG001|Overall Study|Adverse Event|0|||
126761118|NCT01458535|456077142|FG002|Overall Study|Adverse Event|0|||
126761119|NCT01458535|456077143|FG003|Overall Study|Adverse Event|1|||
126761120|NCT01458535|456077144|FG004|Overall Study|Adverse Event|0|||
126761121|NCT01458535|456077145|FG005|Overall Study|Adverse Event|0|||
126761122|NCT01238861|456077146|FG000|Overall Study|Lost to Follow-up|4|||
126761123|NCT01238861|456077147|FG001|Overall Study|Lost to Follow-up|2|||
126761124|NCT01238861|456077148|FG002|Overall Study|Lost to Follow-up|3|||
126761125|NCT01238861|456077149|FG003|Overall Study|Lost to Follow-up|1|||
126761126|NCT01238861|456077150|FG004|Overall Study|Lost to Follow-up|1|||
126545720|NCT04867785|455292427|FG001|Overall Study|Adverse Event|0|||
126694513|NCT01279057|455836442|FG001|Overall Study|Withdrew consent|0|||
126761127|NCT01238861|456077151|FG005|Overall Study|Lost to Follow-up|2|||
126761128|NCT01238861|456077146|FG000|Overall Study|Unplanned surgery|1|||
126761129|NCT01238861|456077147|FG001|Overall Study|Unplanned surgery|0|||
126761130|NCT01238861|456077148|FG002|Overall Study|Unplanned surgery|0|||
126761131|NCT01238861|456077149|FG003|Overall Study|Unplanned surgery|0|||
126761132|NCT01238861|456077150|FG004|Overall Study|Unplanned surgery|0|||
126761133|NCT01238861|456077151|FG005|Overall Study|Unplanned surgery|0|||
126761134|NCT01238861|456077146|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
126545721|NCT04867785|455292428|FG002|Overall Study|Adverse Event|1|||
126545722|NCT04867785|455292429|FG003|Overall Study|Adverse Event|0|||
126761135|NCT01238861|456077147|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
126761136|NCT01238861|456077148|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
126761137|NCT01238861|456077149|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
126761138|NCT01238861|456077150|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
126694514|NCT01279057|455836443|FG002|Overall Study|Withdrew consent|1|||
126694515|NCT01279057|455836441|FG000|Overall Study|Pregnancy|0|||
126694516|NCT01279057|455836442|FG001|Overall Study|Pregnancy|1|||
126694517|NCT01279057|455836443|FG002|Overall Study|Pregnancy|0|||
126694518|NCT01279057|455836441|FG000|Overall Study|Other|3|||
126694519|NCT01279057|455836442|FG001|Overall Study|Other|3|||
126694520|NCT01279057|455836443|FG002|Overall Study|Other|0|||
126694521|NCT01427309|455836445|FG000|Overall Study|Lost to Follow-up|130|||
126694522|NCT01427309|455836446|FG001|Overall Study|Lost to Follow-up|145|||
126694523|NCT01427309|455836447|FG002|Overall Study|Lost to Follow-up|122|||
126694524|NCT01427309|455836448|FG003|Overall Study|Lost to Follow-up|135|||
126694525|NCT01427309|455836445|FG000|Overall Study|Protocol Violation|42|||
126694526|NCT01427309|455836446|FG001|Overall Study|Protocol Violation|69|||
126694527|NCT01427309|455836447|FG002|Overall Study|Protocol Violation|125|||
126694528|NCT01427309|455836448|FG003|Overall Study|Protocol Violation|124|||
126694529|NCT01427309|455836445|FG000|Overall Study|Adverse Event|0|||
126694530|NCT01427309|455836446|FG001|Overall Study|Adverse Event|0|||
126694531|NCT01427309|455836447|FG002|Overall Study|Adverse Event|3|||
126694532|NCT01427309|455836448|FG003|Overall Study|Adverse Event|1|||
126694533|NCT01427309|455836445|FG000|Overall Study|Serious adverse event|52|||
126694534|NCT01427309|455836446|FG001|Overall Study|Serious adverse event|45|||
126694535|NCT01427309|455836447|FG002|Overall Study|Serious adverse event|50|||
126694536|NCT01427309|455836448|FG003|Overall Study|Serious adverse event|61|||
126694537|NCT01427309|455836445|FG000|Overall Study|Withdrawal by Subject|148|||
126694538|NCT01427309|455836446|FG001|Overall Study|Withdrawal by Subject|148|||
126694539|NCT01427309|455836447|FG002|Overall Study|Withdrawal by Subject|61|||
126694540|NCT01427309|455836448|FG003|Overall Study|Withdrawal by Subject|55|||
126694541|NCT00110994|455836449|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
126694542|NCT00110994|455836450|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
126694543|NCT00110994|455836449|FG000|Double-blind (DB) Treatment|Death|1|||
126694544|NCT00110994|455836450|FG001|Double-blind (DB) Treatment|Death|0|||
126694545|NCT00110994|455836449|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
126694546|NCT00110994|455836450|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
126694547|NCT00110994|455836449|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
126694548|NCT00110994|455836450|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
126694549|NCT00110994|455836449|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
126694550|NCT00110994|455836450|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
126694551|NCT00110994|455836449|FG000|Double-blind (DB) Treatment|other reasons|2|||
126694552|NCT00110994|455836450|FG001|Double-blind (DB) Treatment|other reasons|3|||
126694553|NCT00110994|455836449|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
126694554|NCT00110994|455836450|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
126694555|NCT00110994|455836449|FG000|Active Follow-up|Other reasons|0|||
126694556|NCT00110994|455836450|FG001|Active Follow-up|Other reasons|2|||
126694557|NCT00110994|455836449|FG000|Long Term Follow-up|Death|19|||
126694558|NCT00110994|455836450|FG001|Long Term Follow-up|Death|17|||
126694559|NCT00556426|455836451|FG000|Overall Study|Withdrawal by Subject|3|||
126694560|NCT00556426|455836451|FG000|Overall Study|Death|6|||
126694561|NCT00531960|455836455|FG000|Overall Study|Adverse Event|5|||
126694562|NCT00531960|455836456|FG001|Overall Study|Adverse Event|4|||
126694563|NCT00531960|455836455|FG000|Overall Study|Death|3|||
126694564|NCT00531960|455836456|FG001|Overall Study|Death|2|||
126694565|NCT00531960|455836455|FG000|Overall Study|Lack of Efficacy|42|||
126694566|NCT00531960|455836456|FG001|Overall Study|Lack of Efficacy|41|||
126694567|NCT00531960|455836455|FG000|Overall Study|Violation of Selection Criteria|2|||
126694568|NCT00531960|455836456|FG001|Overall Study|Violation of Selection Criteria|0|||
126694569|NCT00531960|455836455|FG000|Overall Study|Refused Treatment|5|||
126694570|NCT00531960|455836456|FG001|Overall Study|Refused Treatment|6|||
126694571|NCT00531960|455836455|FG000|Overall Study|Other|4|||
126694572|NCT00531960|455836456|FG001|Overall Study|Other|10|||
126694573|NCT01500057|455836457|FG000|Overall Study|Lost to Follow-up|6|||
126694574|NCT01500057|455836458|FG001|Overall Study|Lost to Follow-up|4|||
126694575|NCT01318122|455836469|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126694576|NCT01318122|455836470|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126694577|NCT01318122|455836471|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
126694578|NCT01318122|455836472|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
126694579|NCT01318122|455836469|FG000|Enrolled - Long-Term Extension Study|Other|1|||
126694580|NCT01318122|455836470|FG001|Enrolled - Long-Term Extension Study|Other|0|||
126694581|NCT01318122|455836471|FG002|Enrolled - Long-Term Extension Study|Other|0|||
126694582|NCT01318122|455836472|FG003|Enrolled - Long-Term Extension Study|Other|0|||
126447448|NCT02152956|454938029|FG008|Overall Study|Lost to Follow-up|0|||
126447449|NCT02152956|454938030|FG009|Overall Study|Lost to Follow-up|0|||
126447450|NCT02152956|454938031|FG010|Overall Study|Lost to Follow-up|0|||
126694583|NCT01318122|455836469|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
126447451|NCT02152956|454938032|FG011|Overall Study|Lost to Follow-up|3|||
126447452|NCT02152956|454938033|FG012|Overall Study|Lost to Follow-up|0|||
126447453|NCT02152956|454938021|FG000|Overall Study|Withdrawal by Subject|1|||
126694584|NCT01318122|455836470|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
126447454|NCT02152956|454938022|FG001|Overall Study|Withdrawal by Subject|0|||
126447455|NCT02152956|454938023|FG002|Overall Study|Withdrawal by Subject|1|||
126447456|NCT02152956|454938024|FG003|Overall Study|Withdrawal by Subject|0|||
126447457|NCT02152956|454938025|FG004|Overall Study|Withdrawal by Subject|2|||
126447458|NCT02152956|454938026|FG005|Overall Study|Withdrawal by Subject|2|||
126447459|NCT02152956|454938027|FG006|Overall Study|Withdrawal by Subject|0|||
126694585|NCT01318122|455836471|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
126694586|NCT01318122|455836472|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
126447460|NCT02152956|454938028|FG007|Overall Study|Withdrawal by Subject|0|||
126694587|NCT01318122|455836469|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
126447461|NCT02152956|454938029|FG008|Overall Study|Withdrawal by Subject|1|||
126447462|NCT02152956|454938030|FG009|Overall Study|Withdrawal by Subject|0|||
126447463|NCT02152956|454938031|FG010|Overall Study|Withdrawal by Subject|0|||
126447464|NCT02152956|454938032|FG011|Overall Study|Withdrawal by Subject|4|||
126447465|NCT02152956|454938033|FG012|Overall Study|Withdrawal by Subject|0|||
126447466|NCT02152956|454938021|FG000|Overall Study|Physician Decision|0|||
126447467|NCT02152956|454938022|FG001|Overall Study|Physician Decision|0|||
126447468|NCT02152956|454938023|FG002|Overall Study|Physician Decision|0|||
126447469|NCT02152956|454938024|FG003|Overall Study|Physician Decision|0|||
126447470|NCT02152956|454938025|FG004|Overall Study|Physician Decision|0|||
126447471|NCT02152956|454938026|FG005|Overall Study|Physician Decision|0|||
126447472|NCT02152956|454938027|FG006|Overall Study|Physician Decision|0|||
126447473|NCT02152956|454938028|FG007|Overall Study|Physician Decision|0|||
126447474|NCT02152956|454938029|FG008|Overall Study|Physician Decision|0|||
126447475|NCT02152956|454938030|FG009|Overall Study|Physician Decision|0|||
126447476|NCT02152956|454938031|FG010|Overall Study|Physician Decision|0|||
126447477|NCT02152956|454938032|FG011|Overall Study|Physician Decision|1|||
126447478|NCT02152956|454938033|FG012|Overall Study|Physician Decision|0|||
126447479|NCT02152956|454938021|FG000|Overall Study|Study terminated by sponsor|0|||
126447480|NCT02152956|454938022|FG001|Overall Study|Study terminated by sponsor|0|||
126447481|NCT02152956|454938023|FG002|Overall Study|Study terminated by sponsor|0|||
126447482|NCT02152956|454938024|FG003|Overall Study|Study terminated by sponsor|0|||
126447483|NCT02152956|454938025|FG004|Overall Study|Study terminated by sponsor|0|||
126447484|NCT02152956|454938026|FG005|Overall Study|Study terminated by sponsor|0|||
126447485|NCT02152956|454938027|FG006|Overall Study|Study terminated by sponsor|0|||
126447486|NCT02152956|454938028|FG007|Overall Study|Study terminated by sponsor|0|||
126447487|NCT02152956|454938029|FG008|Overall Study|Study terminated by sponsor|0|||
126447488|NCT02152956|454938030|FG009|Overall Study|Study terminated by sponsor|0|||
126694588|NCT01318122|455836470|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126694589|NCT01318122|455836471|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126694590|NCT01318122|455836472|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126694591|NCT01318122|455836469|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126694592|NCT01318122|455836470|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
126694593|NCT01318122|455836471|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126694594|NCT01318122|455836472|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126694595|NCT01318122|455836469|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
126694596|NCT01318122|455836470|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
126694597|NCT01318122|455836471|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
126694598|NCT01318122|455836472|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
126694599|NCT01737931|455836477|FG000|Overall Study|Withdrawal by Subject|0|||
126694600|NCT01737931|455836478|FG001|Overall Study|Withdrawal by Subject|1|||
126694601|NCT01737931|455836479|FG002|Overall Study|Withdrawal by Subject|1|||
126694602|NCT01737931|455836477|FG000|Overall Study|Physician Decision|0|||
126694603|NCT01737931|455836478|FG001|Overall Study|Physician Decision|1|||
126545723|NCT04867785|455292430|FG004|Overall Study|Adverse Event|0|||
126694604|NCT01737931|455836479|FG002|Overall Study|Physician Decision|0|||
126694605|NCT03183128|455836487|FG000|Overall Study|Adverse Event|1|||
126694606|NCT03183128|455836488|FG001|Overall Study|Adverse Event|2|||
126694607|NCT03183128|455836487|FG000|Overall Study|Withdrawal by Subject|1|||
126694608|NCT03183128|455836488|FG001|Overall Study|Withdrawal by Subject|8|||
126694609|NCT03183128|455836487|FG000|Overall Study|Protocol Violation|2|||
126694610|NCT03183128|455836488|FG001|Overall Study|Protocol Violation|0|||
126694611|NCT03183128|455836487|FG000|Overall Study|Lack of Efficacy|4|||
126694612|NCT03183128|455836488|FG001|Overall Study|Lack of Efficacy|27|||
126447489|NCT02152956|454938031|FG010|Overall Study|Study terminated by sponsor|0|||
126447490|NCT02152956|454938032|FG011|Overall Study|Study terminated by sponsor|29|||
126447491|NCT02152956|454938033|FG012|Overall Study|Study terminated by sponsor|0|||
126447492|NCT02152956|454938021|FG000|Overall Study|progressive disease|0|||
126447493|NCT02152956|454938022|FG001|Overall Study|progressive disease|0|||
126447494|NCT02152956|454938023|FG002|Overall Study|progressive disease|0|||
126447495|NCT02152956|454938024|FG003|Overall Study|progressive disease|0|||
126447496|NCT02152956|454938025|FG004|Overall Study|progressive disease|0|||
126447497|NCT02152956|454938026|FG005|Overall Study|progressive disease|0|||
126447498|NCT02152956|454938027|FG006|Overall Study|progressive disease|0|||
126447499|NCT02152956|454938028|FG007|Overall Study|progressive disease|0|||
126447500|NCT02152956|454938029|FG008|Overall Study|progressive disease|1|||
126243729|NCT02409355|454183263|FG000|Overall Study|Withdrawal by Subject|1|||
126243730|NCT02409355|454183264|FG001|Overall Study|Withdrawal by Subject|0|||
126243731|NCT02409355|454183263|FG000|Overall Study|Death|1|||
126243732|NCT02409355|454183264|FG001|Overall Study|Death|1|||
126243733|NCT02409355|454183263|FG000|Overall Study|Study terminated by Sponsor|2|||
126243734|NCT02409355|454183264|FG001|Overall Study|Study terminated by Sponsor|3|||
126243735|NCT01908205|454183265|FG000|Overall Study|Lost to Follow-up|2|||
126357433|NCT02018887|454602097|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
126694613|NCT03183128|455836487|FG000|Overall Study|Lost to Follow-up|1|||
126694614|NCT03183128|455836488|FG001|Overall Study|Lost to Follow-up|0|||
126694615|NCT03183128|455836487|FG000|Overall Study|Death|2|||
126694616|NCT03183128|455836488|FG001|Overall Study|Death|0|||
126694617|NCT03183128|455836487|FG000|Overall Study|Physician Decision|1|||
126694618|NCT03183128|455836488|FG001|Overall Study|Physician Decision|0|||
126694619|NCT00330187|455836491|FG000|Overall Study|Lost to Follow-up|12|||
126694620|NCT00330187|455836492|FG001|Overall Study|Lost to Follow-up|13|||
126694621|NCT00330187|455836493|FG002|Overall Study|Lost to Follow-up|14|||
126694622|NCT00330187|455836494|FG003|Overall Study|Lost to Follow-up|10|||
126694623|NCT00330187|455836491|FG000|Overall Study|Withdrawal by Subject|8|||
126243736|NCT01908205|454183266|FG001|Overall Study|Lost to Follow-up|0|||
126243737|NCT01908205|454183265|FG000|Overall Study|Withdrawal by Subject|3|||
126243738|NCT01908205|454183266|FG001|Overall Study|Withdrawal by Subject|1|||
126243739|NCT03134222|454183271|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
126243740|NCT03134222|454183272|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
126243741|NCT03134222|454183273|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
126243742|NCT03134222|454183274|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
126243743|NCT03134222|454183275|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
126243744|NCT03134222|454183271|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
126243745|NCT03134222|454183272|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
126243746|NCT03134222|454183273|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
126243747|NCT03134222|454183274|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
126694624|NCT00330187|455836492|FG001|Overall Study|Withdrawal by Subject|5|||
126694625|NCT00330187|455836493|FG002|Overall Study|Withdrawal by Subject|4|||
126694626|NCT00330187|455836494|FG003|Overall Study|Withdrawal by Subject|4|||
126694627|NCT03258814|455836497|FG000|Overall Study|Early Termination|4|||
126243748|NCT03134222|454183275|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
126243749|NCT03134222|454183271|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
126243750|NCT03134222|454183272|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
126243751|NCT03134222|454183273|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
126243752|NCT03134222|454183274|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
126243753|NCT03134222|454183275|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
126243754|NCT03134222|454183271|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
126243755|NCT03134222|454183272|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
126243756|NCT03134222|454183273|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
126243757|NCT03134222|454183274|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
126243758|NCT03134222|454183275|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
126243759|NCT03134222|454183271|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
126243760|NCT03134222|454183272|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
126243761|NCT03134222|454183273|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
126243762|NCT03134222|454183274|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
126243763|NCT03134222|454183275|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
126243764|NCT03134222|454183271|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
126243765|NCT03134222|454183272|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
126243766|NCT03134222|454183273|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
126243767|NCT03134222|454183274|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
126243768|NCT03134222|454183275|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
126243769|NCT03134222|454183271|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
126243770|NCT03134222|454183272|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
126243771|NCT03134222|454183273|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
126243772|NCT03134222|454183274|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
126243773|NCT03134222|454183275|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
126243774|NCT03134222|454183271|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
126243775|NCT03134222|454183272|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
126243776|NCT03134222|454183273|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
126243777|NCT03134222|454183274|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
126243778|NCT03134222|454183275|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
126243779|NCT03482882|454183278|FG000|Overall Study|Adverse Event|3|||
126243780|NCT03482882|454183278|FG000|Overall Study|Lost to Follow-up|1|||
126243781|NCT03482882|454183278|FG000|Overall Study|Protocol Violation|2|||
126243782|NCT03482882|454183278|FG000|Overall Study|Not further specified|1|||
126243783|NCT01110005|454183283|FG000|Overall Study|ineligible|1|||
126243784|NCT01110005|454183284|FG001|Overall Study|ineligible|2|||
126243785|NCT01110005|454183283|FG000|Overall Study|missing consent|3|||
126243786|NCT01110005|454183284|FG001|Overall Study|missing consent|2|||
126243787|NCT01110005|454183283|FG000|Overall Study|Withdrawal by Subject|0|||
126243788|NCT01110005|454183284|FG001|Overall Study|Withdrawal by Subject|1|||
126243789|NCT03681470|454183285|FG000|Overall Study|Lack of Efficacy|3|||
126243790|NCT03681470|454183285|FG000|Overall Study|Lost to Follow-up|1|||
126243791|NCT03681470|454183285|FG000|Overall Study|Protocol Violation|3|||
126243792|NCT03681470|454183285|FG000|Overall Study|Withdrawal by Subject|1|||
126243793|NCT01686477|454183286|FG000|Feeding Intervention|Death|1|||
126243794|NCT01686477|454183287|FG001|Feeding Intervention|Death|0|||
126243795|NCT01686477|454183288|FG002|Feeding Intervention|Death|1|||
126243796|NCT01686477|454183286|FG000|Feeding Intervention|Withdrawal by Subject|0|||
126243797|NCT01686477|454183287|FG001|Feeding Intervention|Withdrawal by Subject|6|||
126243798|NCT01686477|454183288|FG002|Feeding Intervention|Withdrawal by Subject|0|||
126243799|NCT01686477|454183286|FG000|Feeding Intervention|Physician Decision|1|||
126243800|NCT01686477|454183287|FG001|Feeding Intervention|Physician Decision|2|||
126243801|NCT01686477|454183288|FG002|Feeding Intervention|Physician Decision|0|||
126243802|NCT01686477|454183286|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
126243803|NCT01686477|454183287|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
126243804|NCT01686477|454183288|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
126447501|NCT02152956|454938030|FG009|Overall Study|progressive disease|0|||
126447502|NCT02152956|454938031|FG010|Overall Study|progressive disease|0|||
126447503|NCT02152956|454938032|FG011|Overall Study|progressive disease|1|||
126447504|NCT02152956|454938033|FG012|Overall Study|progressive disease|0|||
126447505|NCT02445794|454938034|FG000|Overall Study|Adverse Event|0|||
126694628|NCT03258814|455836498|FG001|Overall Study|Early Termination|3|||
126694629|NCT03258814|455836499|FG002|Overall Study|Early Termination|10|||
126243805|NCT01686477|454183286|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
126243806|NCT01686477|454183287|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
126243807|NCT01686477|454183288|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
126447506|NCT02445794|454938035|FG001|Overall Study|Adverse Event|0|||
126447507|NCT02445794|454938036|FG002|Overall Study|Adverse Event|2|||
126694630|NCT01413958|455836500|FG000|Overall Study|Lost to Follow-up|0|||
126447508|NCT02445794|454938037|FG003|Overall Study|Adverse Event|0|||
126447509|NCT00661427|454938040|FG000|Overall Study|Adverse Event|5|||
126447510|NCT00661427|454938041|FG001|Overall Study|Adverse Event|5|||
126447511|NCT00661427|454938040|FG000|Overall Study|Patient not treated|0|||
126447512|NCT00661427|454938041|FG001|Overall Study|Patient not treated|2|||
126447513|NCT04189224|454938044|FG000|Period 2|Adverse Event|0|||
126447514|NCT04189224|454938045|FG001|Period 2|Adverse Event|1|||
126447515|NCT01064947|454938046|FG000|Overall Study|negative culture|41|||
126447516|NCT04198714|454938047|FG000|Overall Study|Physician Decision|0|||
126447517|NCT04198714|454938048|FG001|Overall Study|Physician Decision|1|||
126447518|NCT02970942|454938049|FG000|Overall Study|Death|0|||
126447519|NCT02970942|454938050|FG001|Overall Study|Death|1|||
126447520|NCT02970942|454938051|FG002|Overall Study|Death|0|||
126447521|NCT02970942|454938052|FG003|Overall Study|Death|0|||
126447522|NCT02970942|454938049|FG000|Overall Study|Lost to Follow-up|1|||
126447523|NCT02970942|454938050|FG001|Overall Study|Lost to Follow-up|0|||
126447524|NCT02970942|454938051|FG002|Overall Study|Lost to Follow-up|2|||
126447525|NCT02970942|454938052|FG003|Overall Study|Lost to Follow-up|1|||
126447526|NCT02970942|454938049|FG000|Overall Study|Withdrawal by Subject|3|||
126447527|NCT02970942|454938050|FG001|Overall Study|Withdrawal by Subject|5|||
126447528|NCT02970942|454938051|FG002|Overall Study|Withdrawal by Subject|3|||
126447529|NCT02970942|454938052|FG003|Overall Study|Withdrawal by Subject|2|||
126447530|NCT02529553|454938055|FG000|Overall Study|Progressive Disease|1|||
126447531|NCT02529553|454938056|FG001|Overall Study|Progressive Disease|0|||
126447532|NCT02529553|454938057|FG002|Overall Study|Progressive Disease|1|||
126447533|NCT02529553|454938058|FG003|Overall Study|Progressive Disease|3|||
126447534|NCT02529553|454938059|FG004|Overall Study|Progressive Disease|2|||
126447535|NCT02529553|454938060|FG005|Overall Study|Progressive Disease|3|||
126447536|NCT02529553|454938061|FG006|Overall Study|Progressive Disease|3|||
126447537|NCT02529553|454938062|FG007|Overall Study|Progressive Disease|5|||
126447538|NCT02529553|454938063|FG008|Overall Study|Progressive Disease|3|||
126447539|NCT02529553|454938055|FG000|Overall Study|Physician Decision|0|||
126447540|NCT02529553|454938056|FG001|Overall Study|Physician Decision|1|||
126447541|NCT02529553|454938057|FG002|Overall Study|Physician Decision|0|||
126447542|NCT02529553|454938058|FG003|Overall Study|Physician Decision|0|||
126447543|NCT02529553|454938059|FG004|Overall Study|Physician Decision|1|||
126447544|NCT02529553|454938060|FG005|Overall Study|Physician Decision|0|||
126447545|NCT02529553|454938061|FG006|Overall Study|Physician Decision|0|||
126447546|NCT02529553|454938062|FG007|Overall Study|Physician Decision|0|||
126447547|NCT02529553|454938063|FG008|Overall Study|Physician Decision|0|||
126447548|NCT02529553|454938055|FG000|Overall Study|Withdrawal by Subject|0|||
126447549|NCT02529553|454938056|FG001|Overall Study|Withdrawal by Subject|0|||
126447550|NCT02529553|454938057|FG002|Overall Study|Withdrawal by Subject|0|||
126447551|NCT02529553|454938058|FG003|Overall Study|Withdrawal by Subject|0|||
126447552|NCT02529553|454938059|FG004|Overall Study|Withdrawal by Subject|0|||
126447553|NCT02529553|454938060|FG005|Overall Study|Withdrawal by Subject|1|||
126447554|NCT02529553|454938061|FG006|Overall Study|Withdrawal by Subject|0|||
126447555|NCT02529553|454938062|FG007|Overall Study|Withdrawal by Subject|1|||
126447556|NCT02529553|454938063|FG008|Overall Study|Withdrawal by Subject|0|||
126447557|NCT00488683|454938064|FG000|Overall Study|Withdrawal by Subject|1|||
126447558|NCT00488683|454938065|FG001|Overall Study|Withdrawal by Subject|2|||
126447559|NCT00488683|454938066|FG002|Overall Study|Withdrawal by Subject|2|||
126447560|NCT00488683|454938064|FG000|Overall Study|Lost to Follow-up|5|||
126243808|NCT01686477|454183286|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
126243809|NCT01686477|454183287|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
126243810|NCT01686477|454183288|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
126243811|NCT01686477|454183286|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
126243812|NCT01686477|454183287|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
126243813|NCT01686477|454183288|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
126243814|NCT01686477|454183286|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
126243815|NCT01686477|454183287|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
126243816|NCT01686477|454183288|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
126243817|NCT01686477|454183286|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
126243818|NCT01686477|454183287|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
126447561|NCT00488683|454938065|FG001|Overall Study|Lost to Follow-up|3|||
126447562|NCT00488683|454938066|FG002|Overall Study|Lost to Follow-up|0|||
126447563|NCT00488683|454938064|FG000|Overall Study|Protocol Violation|5|||
126447564|NCT00488683|454938065|FG001|Overall Study|Protocol Violation|1|||
126447565|NCT00488683|454938066|FG002|Overall Study|Protocol Violation|0|||
126447566|NCT00488683|454938064|FG000|Overall Study|Unable to Classify|1|||
126447567|NCT00488683|454938065|FG001|Overall Study|Unable to Classify|0|||
126447568|NCT00488683|454938066|FG002|Overall Study|Unable to Classify|0|||
126447569|NCT04549545|454939483|FG000|Initial Period|Withdrawal by Subject|4|||
126447570|NCT04549545|454939484|FG001|Initial Period|Withdrawal by Subject|0|||
126447571|NCT04549545|454939483|FG000|Initial Period|Additional ENT Procedure|3|||
126447572|NCT04549545|454939484|FG001|Initial Period|Additional ENT Procedure|0|||
126447573|NCT04549545|454939483|FG000|Initial Period|Lost to Follow-up|3|||
126243819|NCT01686477|454183288|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
126243820|NCT01686477|454183286|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
126243821|NCT01686477|454183287|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
126243822|NCT01686477|454183288|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
126243823|NCT03290781|454183290|FG000|Overall Study|Adverse Event|5|||
126447574|NCT04549545|454939484|FG001|Initial Period|Lost to Follow-up|1|||
126447575|NCT04549545|454939483|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
126447576|NCT04549545|454939484|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
126447577|NCT04549545|454939483|FG000|Crossover Period|Additional ENT Procedure|0|||
126447578|NCT04549545|454939484|FG001|Crossover Period|Additional ENT Procedure|6|||
126447579|NCT04549545|454939483|FG000|Crossover Period|Lost to Follow-up|0|||
126447580|NCT04549545|454939484|FG001|Crossover Period|Lost to Follow-up|1|||
126447581|NCT04549545|454939483|FG000|Crossover Period|Withdrawal by Subject|0|||
126447582|NCT04549545|454939484|FG001|Crossover Period|Withdrawal by Subject|4|||
126447583|NCT01006291|454939488|FG000|Overall Study|Adverse Event|2|||
126447584|NCT01006291|454939489|FG001|Overall Study|Adverse Event|1|||
126447585|NCT01006291|454939490|FG002|Overall Study|Adverse Event|2|||
126447586|NCT01006291|454939488|FG000|Overall Study|Lack of Efficacy|2|||
126447587|NCT01006291|454939489|FG001|Overall Study|Lack of Efficacy|2|||
126447588|NCT01006291|454939490|FG002|Overall Study|Lack of Efficacy|1|||
126447589|NCT01006291|454939488|FG000|Overall Study|Protocol Violation|3|||
126447590|NCT01006291|454939489|FG001|Overall Study|Protocol Violation|3|||
126243824|NCT03290781|454183291|FG001|Overall Study|Adverse Event|7|||
126243825|NCT03290781|454183292|FG002|Overall Study|Adverse Event|4|||
126243826|NCT03290781|454183293|FG003|Overall Study|Adverse Event|1|||
126243827|NCT03290781|454183294|FG004|Overall Study|Adverse Event|0|||
126243828|NCT03290781|454183295|FG005|Overall Study|Adverse Event|0|||
126243829|NCT03290781|454183296|FG006|Overall Study|Adverse Event|0|||
126243830|NCT03290781|454183290|FG000|Overall Study|Death|0|||
126243831|NCT03290781|454183291|FG001|Overall Study|Death|0|||
126447591|NCT01006291|454939490|FG002|Overall Study|Protocol Violation|3|||
126447592|NCT01006291|454939488|FG000|Overall Study|Withdrawal criteria|5|||
126447593|NCT01006291|454939489|FG001|Overall Study|Withdrawal criteria|4|||
126447594|NCT01006291|454939490|FG002|Overall Study|Withdrawal criteria|4|||
126243832|NCT03290781|454183292|FG002|Overall Study|Death|1|||
126243833|NCT03290781|454183293|FG003|Overall Study|Death|0|||
126243834|NCT03290781|454183294|FG004|Overall Study|Death|1|||
126243835|NCT03290781|454183295|FG005|Overall Study|Death|0|||
126243836|NCT03290781|454183296|FG006|Overall Study|Death|0|||
126243837|NCT03290781|454183290|FG000|Overall Study|Withdrawal by Subject|6|||
126243838|NCT03290781|454183291|FG001|Overall Study|Withdrawal by Subject|5|||
126243839|NCT03290781|454183292|FG002|Overall Study|Withdrawal by Subject|9|||
126243840|NCT03290781|454183293|FG003|Overall Study|Withdrawal by Subject|10|||
126243841|NCT03290781|454183294|FG004|Overall Study|Withdrawal by Subject|1|||
126243842|NCT03290781|454183295|FG005|Overall Study|Withdrawal by Subject|2|||
126243843|NCT03290781|454183296|FG006|Overall Study|Withdrawal by Subject|0|||
126243844|NCT03290781|454183290|FG000|Overall Study|Physician Decision|0|||
126243845|NCT03290781|454183291|FG001|Overall Study|Physician Decision|1|||
126243846|NCT03290781|454183292|FG002|Overall Study|Physician Decision|0|||
126243847|NCT03290781|454183293|FG003|Overall Study|Physician Decision|0|||
126243848|NCT03290781|454183294|FG004|Overall Study|Physician Decision|0|||
126243849|NCT03290781|454183295|FG005|Overall Study|Physician Decision|0|||
126243850|NCT03290781|454183296|FG006|Overall Study|Physician Decision|0|||
126243851|NCT03290781|454183290|FG000|Overall Study|Site Terminated by Sponsor|1|||
126243852|NCT03290781|454183291|FG001|Overall Study|Site Terminated by Sponsor|0|||
126243853|NCT03290781|454183292|FG002|Overall Study|Site Terminated by Sponsor|2|||
126243854|NCT03290781|454183293|FG003|Overall Study|Site Terminated by Sponsor|1|||
126243855|NCT03290781|454183294|FG004|Overall Study|Site Terminated by Sponsor|0|||
126243856|NCT03290781|454183295|FG005|Overall Study|Site Terminated by Sponsor|0|||
126243857|NCT03290781|454183296|FG006|Overall Study|Site Terminated by Sponsor|0|||
126243858|NCT03290781|454183290|FG000|Overall Study|Lost to Follow-up|0|||
126243859|NCT03290781|454183291|FG001|Overall Study|Lost to Follow-up|0|||
126243860|NCT03290781|454183292|FG002|Overall Study|Lost to Follow-up|0|||
126243861|NCT03290781|454183293|FG003|Overall Study|Lost to Follow-up|1|||
126243862|NCT03290781|454183294|FG004|Overall Study|Lost to Follow-up|0|||
126243863|NCT03290781|454183295|FG005|Overall Study|Lost to Follow-up|0|||
126243864|NCT03290781|454183296|FG006|Overall Study|Lost to Follow-up|0|||
126243865|NCT03290781|454183290|FG000|Overall Study|Protocol Deviation|2|||
126243866|NCT03290781|454183291|FG001|Overall Study|Protocol Deviation|0|||
126243867|NCT03290781|454183292|FG002|Overall Study|Protocol Deviation|0|||
126243868|NCT03290781|454183293|FG003|Overall Study|Protocol Deviation|1|||
126243869|NCT03290781|454183294|FG004|Overall Study|Protocol Deviation|0|||
126243870|NCT03290781|454183295|FG005|Overall Study|Protocol Deviation|0|||
126447595|NCT01006291|454939488|FG000|Overall Study|Other|14|||
126447596|NCT01006291|454939489|FG001|Overall Study|Other|14|||
126243871|NCT03290781|454183296|FG006|Overall Study|Protocol Deviation|0|||
126243872|NCT03290781|454183290|FG000|Overall Study|Disease Relapse|32|||
126447597|NCT01006291|454939490|FG002|Overall Study|Other|17|||
126545724|NCT04867785|455292431|FG005|Overall Study|Adverse Event|0|||
126243873|NCT03290781|454183291|FG001|Overall Study|Disease Relapse|5|||
126243874|NCT03290781|454183292|FG002|Overall Study|Disease Relapse|38|||
126243875|NCT03290781|454183293|FG003|Overall Study|Disease Relapse|7|||
126243876|NCT03290781|454183294|FG004|Overall Study|Disease Relapse|3|||
126243877|NCT03290781|454183295|FG005|Overall Study|Disease Relapse|1|||
126243878|NCT03290781|454183296|FG006|Overall Study|Disease Relapse|4|||
126243879|NCT03290781|454183290|FG000|Overall Study|Other|3|||
126243880|NCT03290781|454183291|FG001|Overall Study|Other|0|||
126243881|NCT03290781|454183292|FG002|Overall Study|Other|2|||
126243882|NCT03290781|454183293|FG003|Overall Study|Other|2|||
126243883|NCT03290781|454183294|FG004|Overall Study|Other|0|||
126243884|NCT03290781|454183295|FG005|Overall Study|Other|0|||
126243885|NCT03290781|454183296|FG006|Overall Study|Other|0|||
126243886|NCT01136174|454183297|FG000|Overall Study|Adverse Event|0|||
126243887|NCT01136174|454183298|FG001|Overall Study|Adverse Event|0|||
126243888|NCT01136174|454183299|FG002|Overall Study|Adverse Event|0|||
126243889|NCT01136174|454183300|FG003|Overall Study|Adverse Event|4|||
126243890|NCT03071575|454184797|FG000|Overall Study|Death|0|||
126243891|NCT03071575|454184798|FG001|Overall Study|Death|1|||
126243892|NCT03071575|454184797|FG000|Overall Study|Lost to Follow-up|5|||
126243893|NCT03071575|454184798|FG001|Overall Study|Lost to Follow-up|11|||
126243894|NCT03071575|454184797|FG000|Overall Study|Withdrawal by Subject|4|||
126243895|NCT03071575|454184798|FG001|Overall Study|Withdrawal by Subject|2|||
126243896|NCT00834795|454184799|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
126243897|NCT00834795|454184800|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
126243898|NCT00834795|454184799|FG000|Second Intervention|Adverse Event|1|||
126243899|NCT00834795|454184800|FG001|Second Intervention|Adverse Event|0|||
126243900|NCT00579345|454184801|FG000|Overall Study|Withdrawal by Subject|2|||
126243901|NCT00579345|454184802|FG001|Overall Study|Withdrawal by Subject|0|||
126243902|NCT00579345|454184803|FG002|Overall Study|Withdrawal by Subject|0|||
126243903|NCT00579345|454184804|FG003|Overall Study|Withdrawal by Subject|0|||
126243904|NCT00579345|454184805|FG004|Overall Study|Withdrawal by Subject|0|||
126243905|NCT00579345|454184806|FG005|Overall Study|Withdrawal by Subject|0|||
126243906|NCT00579345|454184807|FG006|Overall Study|Withdrawal by Subject|0|||
126243907|NCT00579345|454184808|FG007|Overall Study|Withdrawal by Subject|1|||
126761139|NCT01238861|456077151|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
126761140|NCT01238861|456077146|FG000|Overall Study|Incorrect enrollment/randomization|0|||
126761141|NCT01238861|456077147|FG001|Overall Study|Incorrect enrollment/randomization|0|||
126761142|NCT01238861|456077148|FG002|Overall Study|Incorrect enrollment/randomization|1|||
126761143|NCT01238861|456077149|FG003|Overall Study|Incorrect enrollment/randomization|0|||
126761144|NCT01238861|456077150|FG004|Overall Study|Incorrect enrollment/randomization|1|||
126357434|NCT02018887|454602098|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357435|NCT02018887|454602099|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357436|NCT02018887|454602100|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
126357437|NCT02018887|454602090|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
126357438|NCT02018887|454602091|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
126357439|NCT02018887|454602092|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
126357440|NCT02018887|454602093|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
126357441|NCT02018887|454602094|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
126357442|NCT02018887|454602095|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
126761145|NCT01238861|456077151|FG005|Overall Study|Incorrect enrollment/randomization|0|||
126761146|NCT01238861|456077146|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
126761147|NCT01238861|456077147|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
126761148|NCT01238861|456077148|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
126761149|NCT01238861|456077149|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
126761150|NCT01238861|456077150|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
126357443|NCT02018887|454602096|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
126357444|NCT02018887|454602097|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
126357445|NCT02018887|454602098|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
126357446|NCT02018887|454602099|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
126357447|NCT02018887|454602100|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
126357448|NCT02018887|454602090|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
126761151|NCT01238861|456077151|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
126761152|NCT01238861|456077146|FG000|Overall Study|Subject moved out of state/area|0|||
126761153|NCT01238861|456077147|FG001|Overall Study|Subject moved out of state/area|0|||
126243908|NCT00579345|454184801|FG000|Overall Study|Lost to Follow-up|1|||
126761154|NCT01238861|456077148|FG002|Overall Study|Subject moved out of state/area|1|||
126243909|NCT00579345|454184802|FG001|Overall Study|Lost to Follow-up|0|||
126243910|NCT00579345|454184803|FG002|Overall Study|Lost to Follow-up|0|||
126243911|NCT00579345|454184804|FG003|Overall Study|Lost to Follow-up|0|||
126243912|NCT00579345|454184805|FG004|Overall Study|Lost to Follow-up|0|||
126243913|NCT00579345|454184806|FG005|Overall Study|Lost to Follow-up|0|||
126243914|NCT00579345|454184807|FG006|Overall Study|Lost to Follow-up|0|||
126243915|NCT00579345|454184808|FG007|Overall Study|Lost to Follow-up|0|||
126357449|NCT02018887|454602091|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
126357450|NCT02018887|454602092|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
126243916|NCT00579345|454184801|FG000|Overall Study|Adverse Event|0|||
126243917|NCT00579345|454184802|FG001|Overall Study|Adverse Event|0|||
126243918|NCT00579345|454184803|FG002|Overall Study|Adverse Event|1|||
126243919|NCT00579345|454184804|FG003|Overall Study|Adverse Event|0|||
126243920|NCT00579345|454184805|FG004|Overall Study|Adverse Event|0|||
126243921|NCT00579345|454184806|FG005|Overall Study|Adverse Event|0|||
126243922|NCT00579345|454184807|FG006|Overall Study|Adverse Event|0|||
126243923|NCT00579345|454184808|FG007|Overall Study|Adverse Event|0|||
126243924|NCT00579345|454184801|FG000|Overall Study|Protocol Violation|1|||
126243925|NCT00579345|454184802|FG001|Overall Study|Protocol Violation|0|||
126243926|NCT00579345|454184803|FG002|Overall Study|Protocol Violation|0|||
126243927|NCT00579345|454184804|FG003|Overall Study|Protocol Violation|0|||
126243928|NCT00579345|454184805|FG004|Overall Study|Protocol Violation|0|||
126243929|NCT00579345|454184806|FG005|Overall Study|Protocol Violation|0|||
126243930|NCT00579345|454184807|FG006|Overall Study|Protocol Violation|0|||
126243931|NCT00579345|454184808|FG007|Overall Study|Protocol Violation|1|||
126243932|NCT00579345|454184801|FG000|Overall Study|Death|1|||
126243933|NCT00579345|454184802|FG001|Overall Study|Death|1|||
126243934|NCT00579345|454184803|FG002|Overall Study|Death|1|||
126243935|NCT00579345|454184804|FG003|Overall Study|Death|1|||
126243936|NCT00579345|454184805|FG004|Overall Study|Death|0|||
126243937|NCT00579345|454184806|FG005|Overall Study|Death|0|||
126243938|NCT00579345|454184807|FG006|Overall Study|Death|0|||
126243939|NCT00579345|454184808|FG007|Overall Study|Death|0|||
126243940|NCT03255733|454184812|FG000|Overall Study|Lost to Follow-up|4|||
126243941|NCT04299087|454184813|FG000|Overall Study|Lost to Follow-up|2|||
126243942|NCT04299087|454184814|FG001|Overall Study|Lost to Follow-up|1|||
126243943|NCT00594035|454184815|FG000|Overall Study|Lost to Follow-up|1|||
126243944|NCT00594035|454184816|FG001|Overall Study|Lost to Follow-up|1|||
126243945|NCT00594035|454184815|FG000|Overall Study|Withdrawal by Subject|1|||
126243946|NCT00594035|454184816|FG001|Overall Study|Withdrawal by Subject|0|||
126243947|NCT00594035|454184815|FG000|Overall Study|Subject transferred to nursing home|0|||
126243948|NCT00594035|454184816|FG001|Overall Study|Subject transferred to nursing home|1|||
126243949|NCT00594035|454184815|FG000|Overall Study|Subject couldn't return due to job|0|||
126243950|NCT00594035|454184816|FG001|Overall Study|Subject couldn't return due to job|1|||
126243951|NCT00795821|454184817|FG000|Acute Treatment Phase|Adverse Event|23|||
126243952|NCT00795821|454184818|FG001|Acute Treatment Phase|Adverse Event|4|||
126243953|NCT00795821|454184817|FG000|Acute Treatment Phase|Death|1|||
126243954|NCT00795821|454184818|FG001|Acute Treatment Phase|Death|0|||
126243955|NCT00795821|454184817|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
126357451|NCT02018887|454602093|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
126357452|NCT02018887|454602094|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
126357453|NCT02018887|454602095|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
126357454|NCT02018887|454602096|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
126357455|NCT02018887|454602097|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
126357456|NCT02018887|454602098|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
126357457|NCT02018887|454602099|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
126694631|NCT01413958|455836501|FG001|Overall Study|Lost to Follow-up|1|||
126694632|NCT01900002|455836502|FG000|Overall Study|Withdrawal by Subject|2|||
126694633|NCT01900002|455836502|FG000|Overall Study|ineligible for Y-90|4|||
126694634|NCT00364182|455836509|FG000|First Intervention|Secondary prophylaxis|1|||
126694635|NCT00364182|455836510|FG001|First Intervention|Secondary prophylaxis|0|||
126694636|NCT00364182|455836511|FG002|First Intervention|Secondary prophylaxis|0|||
126694637|NCT00364182|455836509|FG000|First Intervention|Withdrawal by Subject|2|||
126694638|NCT00364182|455836510|FG001|First Intervention|Withdrawal by Subject|0|||
126694639|NCT00364182|455836511|FG002|First Intervention|Withdrawal by Subject|0|||
126694640|NCT00364182|455836509|FG000|Second Intervention|non-compliance|0|||
126694641|NCT00364182|455836510|FG001|Second Intervention|non-compliance|1|||
126694642|NCT00364182|455836511|FG002|Second Intervention|non-compliance|1|||
126694643|NCT00364182|455836509|FG000|Second Intervention|Protocol Violation|0|||
126694644|NCT00364182|455836510|FG001|Second Intervention|Protocol Violation|1|||
126694645|NCT00364182|455836511|FG002|Second Intervention|Protocol Violation|0|||
126694646|NCT00364182|455836509|FG000|Second Intervention|Adverse Event|0|||
126694647|NCT00364182|455836510|FG001|Second Intervention|Adverse Event|0|||
126694648|NCT00364182|455836511|FG002|Second Intervention|Adverse Event|1|||
126243956|NCT00795821|454184818|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
126243957|NCT00795821|454184817|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
126243958|NCT00795821|454184818|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
126243959|NCT00795821|454184817|FG000|Acute Treatment Phase|Physician Decision|1|||
126243960|NCT00795821|454184818|FG001|Acute Treatment Phase|Physician Decision|1|||
126243961|NCT00795821|454184817|FG000|Acute Treatment Phase|Protocol Violation|1|||
126243962|NCT00795821|454184818|FG001|Acute Treatment Phase|Protocol Violation|2|||
126243963|NCT00795821|454184817|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
126243964|NCT00795821|454184818|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
126243965|NCT00795821|454184817|FG000|Long-term Extension Phase|Adverse Event|25|||
126243966|NCT00795821|454184818|FG001|Long-term Extension Phase|Adverse Event|32|||
126243967|NCT00795821|454184817|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
126243968|NCT00795821|454184818|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
126243969|NCT00795821|454184817|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
126243970|NCT00795821|454184818|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
126243971|NCT00795821|454184817|FG000|Long-term Extension Phase|Physician Decision|1|||
126243972|NCT00795821|454184818|FG001|Long-term Extension Phase|Physician Decision|2|||
126243973|NCT00795821|454184817|FG000|Long-term Extension Phase|Protocol Violation|3|||
126243974|NCT00795821|454184818|FG001|Long-term Extension Phase|Protocol Violation|5|||
126243975|NCT00795821|454184817|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
126243976|NCT00795821|454184818|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
126243977|NCT00795821|454184817|FG000|Taper Phase|Adverse Event|2|||
126243978|NCT00795821|454184818|FG001|Taper Phase|Adverse Event|0|||
126243979|NCT00795821|454184817|FG000|Taper Phase|Lost to Follow-up|1|||
126243980|NCT00795821|454184818|FG001|Taper Phase|Lost to Follow-up|0|||
126243981|NCT00795821|454184817|FG000|Taper Phase|Physician Decision|2|||
126243982|NCT00795821|454184818|FG001|Taper Phase|Physician Decision|0|||
126243983|NCT00795821|454184817|FG000|Taper Phase|Withdrawal by Subject|4|||
126243984|NCT00795821|454184818|FG001|Taper Phase|Withdrawal by Subject|0|||
126243985|NCT00583453|454184827|FG000|Overall Study|discontinued intervention|0|||
126243986|NCT00583453|454184828|FG001|Overall Study|discontinued intervention|2|||
126243987|NCT03868891|454184833|FG000|Overall Study|Adverse Event|1|||
126243988|NCT03868891|454184834|FG001|Overall Study|Adverse Event|0|||
126243989|NCT03868891|454184833|FG000|Overall Study|Lost to Follow-up|2|||
126243990|NCT03868891|454184834|FG001|Overall Study|Lost to Follow-up|1|||
126243991|NCT03868891|454184833|FG000|Overall Study|COVID-19 Restrictions|1|||
126243992|NCT03868891|454184834|FG001|Overall Study|COVID-19 Restrictions|2|||
126243993|NCT03123094|454184835|FG000|Overall Study|Withdrawal by Subject|0|||
126243994|NCT03123094|454184836|FG001|Overall Study|Withdrawal by Subject|2|||
126243995|NCT03123094|454184837|FG002|Overall Study|Withdrawal by Subject|1|||
126243996|NCT03123094|454184838|FG003|Overall Study|Withdrawal by Subject|0|||
126243997|NCT03123094|454184839|FG004|Overall Study|Withdrawal by Subject|1|||
126243998|NCT03496623|454184842|FG000|Run-In Period (2 Weeks)|Death|1|||
126243999|NCT03496623|454184843|FG001|Run-In Period (2 Weeks)|Death|0|||
126244000|NCT03496623|454184844|FG002|Run-In Period (2 Weeks)|Death|0|||
126244001|NCT03496623|454184845|FG003|Run-In Period (2 Weeks)|Death|0|||
126244002|NCT03496623|454184846|FG004|Run-In Period (2 Weeks)|Death|0|||
126244003|NCT03496623|454184842|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
126244004|NCT03496623|454184843|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
126244005|NCT03496623|454184844|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
126244006|NCT03496623|454184845|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
126244007|NCT03496623|454184846|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
126244008|NCT03496623|454184842|FG000|Period 1 (12 Weeks)|Death|0|||
126244009|NCT03496623|454184843|FG001|Period 1 (12 Weeks)|Death|3|||
126244010|NCT03496623|454184844|FG002|Period 1 (12 Weeks)|Death|0|||
126244011|NCT03496623|454184845|FG003|Period 1 (12 Weeks)|Death|0|||
126244012|NCT03496623|454184846|FG004|Period 1 (12 Weeks)|Death|0|||
126244013|NCT03496623|454184842|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
126244014|NCT03496623|454184843|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
126244015|NCT03496623|454184844|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
126244016|NCT03496623|454184845|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
126244017|NCT03496623|454184846|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
126244018|NCT03496623|454184842|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126244019|NCT03496623|454184843|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
126244020|NCT03496623|454184844|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
126244021|NCT03496623|454184845|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126244022|NCT03496623|454184846|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126244023|NCT03496623|454184842|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
126244024|NCT03496623|454184843|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
126244025|NCT03496623|454184844|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
126244026|NCT03496623|454184845|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
126244027|NCT03496623|454184846|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
126244028|NCT03496623|454184842|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126244029|NCT03496623|454184843|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126244030|NCT03496623|454184844|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
126244031|NCT03496623|454184845|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126244032|NCT03496623|454184846|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126761155|NCT01238861|456077149|FG003|Overall Study|Subject moved out of state/area|1|||
126761156|NCT01238861|456077150|FG004|Overall Study|Subject moved out of state/area|0|||
126761157|NCT01238861|456077151|FG005|Overall Study|Subject moved out of state/area|0|||
126761158|NCT01238861|456077146|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
126761159|NCT01238861|456077147|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
126761160|NCT01238861|456077148|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
126761161|NCT01238861|456077149|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
126545725|NCT04867785|455292432|FG006|Overall Study|Adverse Event|0|||
126545726|NCT04867785|455292433|FG007|Overall Study|Adverse Event|2|||
126244033|NCT03496623|454184842|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
126244034|NCT03496623|454184843|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
126244035|NCT03496623|454184844|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
126244036|NCT03496623|454184845|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
126244037|NCT03496623|454184846|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
126244038|NCT03496623|454184842|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126761162|NCT01238861|456077150|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
126244039|NCT03496623|454184843|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
126244040|NCT03496623|454184844|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126244041|NCT03496623|454184845|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126244042|NCT03496623|454184846|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126244043|NCT00794963|454184847|FG000|Overall Study|Withdrawal by Subject|1|||
126244044|NCT00794963|454184848|FG001|Overall Study|Withdrawal by Subject|4|||
126244045|NCT03181594|454184857|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
126244046|NCT03181594|454184857|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
126244047|NCT03181594|454184857|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
126244048|NCT03181594|454184857|FG000|Initial Study Protocol (12-month FU)|Death|1|||
126761163|NCT01238861|456077151|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
126761164|NCT01238861|456077146|FG000|Overall Study|Personal problems|0|||
126761165|NCT01238861|456077147|FG001|Overall Study|Personal problems|0|||
126761166|NCT01238861|456077148|FG002|Overall Study|Personal problems|0|||
126761167|NCT01238861|456077149|FG003|Overall Study|Personal problems|1|||
126761168|NCT01238861|456077150|FG004|Overall Study|Personal problems|0|||
126761169|NCT01238861|456077151|FG005|Overall Study|Personal problems|0|||
126761170|NCT01238861|456077146|FG000|Overall Study|Unable to continue visits|0|||
126761171|NCT01238861|456077147|FG001|Overall Study|Unable to continue visits|0|||
126761172|NCT01238861|456077148|FG002|Overall Study|Unable to continue visits|0|||
126761173|NCT01238861|456077149|FG003|Overall Study|Unable to continue visits|1|||
126761174|NCT01238861|456077150|FG004|Overall Study|Unable to continue visits|0|||
126761175|NCT01238861|456077151|FG005|Overall Study|Unable to continue visits|1|||
126761176|NCT01238861|456077146|FG000|Overall Study|Serious adverse event|0|||
126761177|NCT01238861|456077147|FG001|Overall Study|Serious adverse event|0|||
126761178|NCT01238861|456077148|FG002|Overall Study|Serious adverse event|0|||
126761179|NCT01238861|456077149|FG003|Overall Study|Serious adverse event|0|||
126761180|NCT01238861|456077150|FG004|Overall Study|Serious adverse event|0|||
126761181|NCT01238861|456077151|FG005|Overall Study|Serious adverse event|1|||
126761182|NCT01238861|456077146|FG000|Overall Study|Lack of compliance|0|||
126761183|NCT01238861|456077147|FG001|Overall Study|Lack of compliance|0|||
126761184|NCT01238861|456077148|FG002|Overall Study|Lack of compliance|0|||
126761185|NCT01238861|456077149|FG003|Overall Study|Lack of compliance|0|||
126761186|NCT01238861|456077150|FG004|Overall Study|Lack of compliance|0|||
126761187|NCT01238861|456077151|FG005|Overall Study|Lack of compliance|1|||
126761188|NCT01238861|456077146|FG000|Overall Study|Adverse Event|0|||
126761189|NCT01238861|456077147|FG001|Overall Study|Adverse Event|1|||
126761190|NCT01238861|456077148|FG002|Overall Study|Adverse Event|0|||
126761191|NCT01238861|456077149|FG003|Overall Study|Adverse Event|0|||
126761192|NCT01238861|456077150|FG004|Overall Study|Adverse Event|0|||
126761193|NCT01238861|456077151|FG005|Overall Study|Adverse Event|0|||
126761194|NCT01238861|456077146|FG000|Overall Study|Withdrawal by Subject|6|||
126761195|NCT01238861|456077147|FG001|Overall Study|Withdrawal by Subject|5|||
126761196|NCT01238861|456077148|FG002|Overall Study|Withdrawal by Subject|4|||
126761197|NCT01238861|456077149|FG003|Overall Study|Withdrawal by Subject|8|||
126761198|NCT01238861|456077150|FG004|Overall Study|Withdrawal by Subject|10|||
126761199|NCT01238861|456077151|FG005|Overall Study|Withdrawal by Subject|9|||
126761200|NCT01269346|456077152|FG000|Treatment Phase|Disease progression|3|||
126761201|NCT01269346|456077152|FG000|Treatment Phase|Adverse Event|3|||
126761202|NCT01269346|456077152|FG000|Treatment Phase|Withdrawal by Subject|1|||
126761203|NCT01269346|456077152|FG000|Treatment Phase|Other|2|||
126761204|NCT01269346|456077152|FG000|Extension Phase|Adverse Event|6|||
126761205|NCT01269346|456077152|FG000|Extension Phase|Withdrawal by Subject|4|||
126761206|NCT01269346|456077152|FG000|Extension Phase|Disease progression|22|||
126761207|NCT01269346|456077152|FG000|Extension Phase|Physician decision or participant choice|9|||
126761208|NCT01269346|456077152|FG000|Extension Phase|Clinical progression|1|||
126761209|NCT01269346|456077152|FG000|Extension Phase|Started a prohibited con med|1|||
126761210|NCT01855607|456077153|FG000|Overall Study|Withdrawal by Subject|1|||
126761211|NCT01855607|456077153|FG000|Overall Study|Study was terminated|11|||
126761212|NCT04001790|456077158|FG000|Overall Study|Withdrawal by Subject|1|||
126761213|NCT04001790|456077159|FG001|Overall Study|Withdrawal by Subject|2|||
126761214|NCT02706327|456077160|FG000|Overall Study|Lost to Follow-up|1|||
126761215|NCT02706327|456077161|FG001|Overall Study|Lost to Follow-up|1|||
126761216|NCT02706327|456077162|FG002|Overall Study|Lost to Follow-up|2|||
126761217|NCT04963231|456077167|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
126761218|NCT04963231|456077168|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
126761219|NCT04963231|456077169|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
126761220|NCT04963231|456077167|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
126545727|NCT04867785|455292426|FG000|Overall Study|Lost to Follow-up|4|||
126545728|NCT04867785|455292427|FG001|Overall Study|Lost to Follow-up|4|||
126694649|NCT00364182|455836509|FG000|Third Intervention|non-compliance|0|||
126694650|NCT00364182|455836510|FG001|Third Intervention|non-compliance|1|||
126694651|NCT00364182|455836511|FG002|Third Intervention|non-compliance|0|||
126694652|NCT00364182|455836509|FG000|Third Intervention|Lost to Follow-up|0|||
126694653|NCT00364182|455836510|FG001|Third Intervention|Lost to Follow-up|0|||
126694654|NCT00364182|455836511|FG002|Third Intervention|Lost to Follow-up|1|||
126694655|NCT02601573|455836515|FG000|Overall Study|Lost to Follow-up|0|||
126694656|NCT02601573|455836516|FG001|Overall Study|Lost to Follow-up|3|||
126694657|NCT02601573|455836517|FG002|Overall Study|Lost to Follow-up|1|||
126694658|NCT02601573|455836518|FG003|Overall Study|Lost to Follow-up|0|||
126694659|NCT02601573|455836519|FG004|Overall Study|Lost to Follow-up|2|||
126694660|NCT02601573|455836515|FG000|Overall Study|Withdrawal by Subject|0|||
126694661|NCT02601573|455836516|FG001|Overall Study|Withdrawal by Subject|1|||
126694662|NCT02601573|455836517|FG002|Overall Study|Withdrawal by Subject|0|||
126694663|NCT02601573|455836518|FG003|Overall Study|Withdrawal by Subject|1|||
126694664|NCT02601573|455836519|FG004|Overall Study|Withdrawal by Subject|0|||
126694665|NCT00974220|455836520|FG000|Treatment Period 1|Adverse Event|2|||
126694666|NCT00974220|455836521|FG001|Treatment Period 1|Adverse Event|1|||
126694667|NCT00974220|455836520|FG000|Treatment Period 1|noncompliant subjects|0|||
126694668|NCT00974220|455836521|FG001|Treatment Period 1|noncompliant subjects|1|||
126694669|NCT02921425|455836522|FG000|Overall Study|Protocol Violation|9|||
126694670|NCT03403400|455836523|FG000|Overall Study|Lost to Follow-up|1|||
126694671|NCT03403400|455836524|FG001|Overall Study|Lost to Follow-up|0|||
126694672|NCT03403400|455836525|FG002|Overall Study|Lost to Follow-up|1|||
126694673|NCT03403400|455836523|FG000|Overall Study|Hospitalization|1|||
126694674|NCT03403400|455836524|FG001|Overall Study|Hospitalization|0|||
126694675|NCT03403400|455836525|FG002|Overall Study|Hospitalization|0|||
126694676|NCT03403400|455836523|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
126694677|NCT03403400|455836524|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
126694678|NCT03403400|455836525|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
126694679|NCT01384292|455836529|FG000|Part B|Severe non-compliance to protocol|1|||
126694680|NCT01384292|455836530|FG001|Part B|Severe non-compliance to protocol|0|||
126694681|NCT01384292|455836531|FG002|Part B|Severe non-compliance to protocol|0|||
126694682|NCT01171612|455836532|FG000|Overall Study|Lost to Follow-up|51|||
126694683|NCT00243659|455836533|FG000|Overall Study|Withdrawal by Subject|1|||
126694684|NCT00243659|455836534|FG001|Overall Study|Withdrawal by Subject|1|||
126694685|NCT00243659|455836533|FG000|Overall Study|Protocol Violation|1|||
126694686|NCT00243659|455836534|FG001|Overall Study|Protocol Violation|2|||
126694687|NCT03310970|455836535|FG000|Overall Study|Withdrawal by Subject|0|||
126694688|NCT03310970|455836536|FG001|Overall Study|Withdrawal by Subject|1|||
126694689|NCT01273064|455836537|FG000|Overall Study|Adverse Event|5|||
126694690|NCT01273064|455836538|FG001|Overall Study|Adverse Event|1|||
126694691|NCT01273064|455836539|FG002|Overall Study|Adverse Event|3|||
126694692|NCT01273064|455836540|FG003|Overall Study|Adverse Event|2|||
126694693|NCT01273064|455836541|FG004|Overall Study|Adverse Event|1|||
126694694|NCT01273064|455836537|FG000|Overall Study|Withdrawal by Subject|4|||
126694695|NCT01273064|455836538|FG001|Overall Study|Withdrawal by Subject|2|||
126694696|NCT01273064|455836539|FG002|Overall Study|Withdrawal by Subject|2|||
126694697|NCT01273064|455836540|FG003|Overall Study|Withdrawal by Subject|2|||
126694698|NCT01273064|455836541|FG004|Overall Study|Withdrawal by Subject|0|||
126694699|NCT01273064|455836537|FG000|Overall Study|Study Termination|13|||
126694700|NCT01273064|455836538|FG001|Overall Study|Study Termination|27|||
126694701|NCT01273064|455836539|FG002|Overall Study|Study Termination|26|||
126694702|NCT01273064|455836540|FG003|Overall Study|Study Termination|16|||
126694703|NCT01273064|455836541|FG004|Overall Study|Study Termination|8|||
126694704|NCT01273064|455836537|FG000|Overall Study|Lost to Follow-up|1|||
126694705|NCT01273064|455836538|FG001|Overall Study|Lost to Follow-up|0|||
126694706|NCT01273064|455836539|FG002|Overall Study|Lost to Follow-up|0|||
126694707|NCT01273064|455836540|FG003|Overall Study|Lost to Follow-up|0|||
126694708|NCT01273064|455836541|FG004|Overall Study|Lost to Follow-up|0|||
126694709|NCT01273064|455836537|FG000|Overall Study|Physician Decision|0|||
126694710|NCT01273064|455836538|FG001|Overall Study|Physician Decision|0|||
126694711|NCT01273064|455836539|FG002|Overall Study|Physician Decision|0|||
126694712|NCT01273064|455836540|FG003|Overall Study|Physician Decision|0|||
126694713|NCT01273064|455836541|FG004|Overall Study|Physician Decision|1|||
126694714|NCT04062214|455836542|FG000|Week 12|Death|1|||
126694715|NCT04062214|455836543|FG001|Week 12|Death|1|||
126694716|NCT04062214|455836542|FG000|Week 12|Withdrawal by Subject|14|||
126694717|NCT04062214|455836543|FG001|Week 12|Withdrawal by Subject|13|||
126694718|NCT04062214|455836542|FG000|Week 12|Lost to Follow-up|55|||
126694719|NCT04062214|455836543|FG001|Week 12|Lost to Follow-up|68|||
126694720|NCT04062214|455836542|FG000|Week 12|Intermittent missing|31|||
126694721|NCT04062214|455836543|FG001|Week 12|Intermittent missing|29|||
126694722|NCT04062214|455836542|FG000|Week 36|Withdrawal by Subject|4|||
126694723|NCT04062214|455836543|FG001|Week 36|Withdrawal by Subject|5|||
126761221|NCT04963231|456077168|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
126761222|NCT04963231|456077169|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
126761223|NCT04963231|456077167|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
126761224|NCT04963231|456077168|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
126761225|NCT04963231|456077169|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
126761226|NCT04963231|456077167|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
126761227|NCT04963231|456077168|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
126761228|NCT04963231|456077169|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
126761229|NCT04963231|456077167|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
126761230|NCT04963231|456077168|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
126761231|NCT04963231|456077169|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
126761232|NCT04963231|456077167|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
126761233|NCT04963231|456077168|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
126761234|NCT04963231|456077169|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
126761235|NCT04963231|456077167|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
126761236|NCT04963231|456077168|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
126761237|NCT04963231|456077169|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
126761238|NCT04576702|456077170|FG000|Overall Study|Death|1|||
126761239|NCT04576702|456077171|FG001|Overall Study|Death|0|||
126761240|NCT04576702|456077172|FG002|Overall Study|Death|0|||
126761241|NCT04576702|456077173|FG003|Overall Study|Death|0|||
126761242|NCT04576702|456077170|FG000|Overall Study|Withdrawal by Subject|0|||
126761243|NCT04576702|456077171|FG001|Overall Study|Withdrawal by Subject|2|||
126761244|NCT04576702|456077172|FG002|Overall Study|Withdrawal by Subject|1|||
126761245|NCT04576702|456077173|FG003|Overall Study|Withdrawal by Subject|0|||
126761246|NCT04576702|456077170|FG000|Overall Study|Lost to Follow-up|3|||
126761247|NCT04576702|456077171|FG001|Overall Study|Lost to Follow-up|3|||
126761248|NCT04576702|456077172|FG002|Overall Study|Lost to Follow-up|3|||
126761249|NCT04576702|456077173|FG003|Overall Study|Lost to Follow-up|4|||
126761250|NCT01319422|456077176|FG000|Overall Study|Withdrawal by Subject|1|||
126761251|NCT01319422|456077177|FG001|Overall Study|Withdrawal by Subject|0|||
126761252|NCT06104423|456077178|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
126761253|NCT06104423|456077179|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
126761254|NCT06104423|456077180|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
126761255|NCT06104423|456077178|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
126761256|NCT06104423|456077179|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
126761257|NCT06104423|456077180|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
126761258|NCT03417245|456077181|FG000|Overall Study|Adverse Event|1|||
126761259|NCT03417245|456077182|FG001|Overall Study|Adverse Event|0|||
126244049|NCT03181594|454184857|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
126244050|NCT03181594|454184857|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
126244051|NCT01527006|454184860|FG000|Core Study|Adverse Event|0|||
126244052|NCT01527006|454184861|FG001|Core Study|Adverse Event|2|||
126244053|NCT01527006|454184860|FG000|Core Study|Lost to Follow-up|0|||
126244054|NCT01527006|454184861|FG001|Core Study|Lost to Follow-up|1|||
126244055|NCT01527006|454184860|FG000|Core Study|Subject Choice|1|||
126244056|NCT01527006|454184861|FG001|Core Study|Subject Choice|0|||
126244057|NCT01527006|454184860|FG000|Core Study|Inadequate Therapeutic Effect|1|||
126244058|NCT01527006|454184861|FG001|Core Study|Inadequate Therapeutic Effect|0|||
126244059|NCT01527006|454184860|FG000|Core Study|Withdrawal by Subject|0|||
126244060|NCT01527006|454184861|FG001|Core Study|Withdrawal by Subject|1|||
126244061|NCT01527006|454184860|FG000|Core Study|Other|0|||
126244062|NCT01527006|454184861|FG001|Core Study|Other|2|||
126244063|NCT01527006|454184860|FG000|Extension Phase|Adverse Event|4|||
126244064|NCT01527006|454184861|FG001|Extension Phase|Adverse Event|2|||
126244065|NCT01527006|454184860|FG000|Extension Phase|Lost to Follow-up|0|||
126244066|NCT01527006|454184861|FG001|Extension Phase|Lost to Follow-up|1|||
126244067|NCT01527006|454184860|FG000|Extension Phase|Subject Choice|1|||
126244068|NCT01527006|454184861|FG001|Extension Phase|Subject Choice|1|||
126244069|NCT01527006|454184860|FG000|Extension Phase|Inadequate therapeutic effect|1|||
126357458|NCT02018887|454602100|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
126761260|NCT03417245|456077181|FG000|Overall Study|Protocol Violation|1|||
126761261|NCT03417245|456077182|FG001|Overall Study|Protocol Violation|0|||
126761262|NCT03417245|456077181|FG000|Overall Study|Withdrawal by Subject|1|||
126761263|NCT03417245|456077182|FG001|Overall Study|Withdrawal by Subject|1|||
126761264|NCT02708524|456077190|FG000|Overall Study|Adverse Event|0|||
126761265|NCT02708524|456077191|FG001|Overall Study|Adverse Event|1|||
126761266|NCT02708524|456077192|FG002|Overall Study|Adverse Event|0|||
126761267|NCT02708524|456077193|FG003|Overall Study|Adverse Event|0|||
126244070|NCT01527006|454184861|FG001|Extension Phase|Inadequate therapeutic effect|1|||
126244071|NCT01527006|454184860|FG000|Extension Phase|Other|0|||
126244072|NCT01527006|454184861|FG001|Extension Phase|Other|3|||
126244073|NCT03247972|454184862|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
126694724|NCT04062214|455836542|FG000|Week 36|Lost to Follow-up|50|||
126244074|NCT03247972|454184862|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
126244075|NCT00123734|454184864|FG000|Overall Study|Death|3|||
126244076|NCT00123734|454184864|FG000|Overall Study|Lost to Follow-up|3|||
126244077|NCT00123734|454184864|FG000|Overall Study|Dropout|1|||
126244078|NCT00123734|454184864|FG000|Overall Study|Withdrawal by Subject|1|||
126244079|NCT00113386|454184865|FG000|Overall Study|Withdrawal by Subject|1|||
126244080|NCT00113386|454184866|FG001|Overall Study|Withdrawal by Subject|0|||
126244081|NCT00113386|454184865|FG000|Overall Study|Physician Decision|0|||
126244082|NCT00113386|454184866|FG001|Overall Study|Physician Decision|1|||
126244083|NCT00113386|454184865|FG000|Overall Study|Toxicity|3|||
126244084|NCT00113386|454184866|FG001|Overall Study|Toxicity|0|||
126244085|NCT00113386|454184865|FG000|Overall Study|Ineligible|1|||
126244086|NCT00113386|454184866|FG001|Overall Study|Ineligible|2|||
126244087|NCT00113386|454184865|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
126244088|NCT00113386|454184866|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
126244089|NCT00834340|454184867|FG000|Washout|Adverse Event|1|||
126244090|NCT00834340|454184868|FG001|Washout|Adverse Event|0|||
126244091|NCT00834340|454184867|FG000|Washout|Withdrawal by Subject|1|||
126244092|NCT00834340|454184868|FG001|Washout|Withdrawal by Subject|0|||
126244093|NCT01175018|454184870|FG000|Overall Study|Adverse Event|3|||
126244094|NCT01175018|454184871|FG001|Overall Study|Adverse Event|1|||
126244095|NCT00840073|454184875|FG000|Second Intervention|Missed 72 hour blood draw|1|||
126244096|NCT00840073|454184876|FG001|Second Intervention|Missed 72 hour blood draw|1|||
126244097|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
126244098|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
126244099|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
126244100|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
126244101|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
126244102|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
126244103|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
126244104|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
126244105|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
126244106|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
126244107|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
126244108|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
126244109|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
126244110|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
126244111|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
126244112|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
126244113|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
126244114|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
126244115|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
126244116|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
126244117|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Death|0|||
126244118|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Death|1|||
126244119|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Death|0|||
126244120|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Death|0|||
126244121|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
126244122|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
126244123|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
126244124|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
126244125|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
126244126|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
126244127|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
126244128|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
126244129|NCT01940341|454184880|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
126244130|NCT01940341|454184881|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
126244131|NCT01940341|454184882|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
126244132|NCT01940341|454184883|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
126244133|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
126244134|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
126694725|NCT04062214|455836543|FG001|Week 36|Lost to Follow-up|46|||
126694726|NCT04062214|455836542|FG000|Week 36|Death|0|||
126244135|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
126244136|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
126244137|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
126244138|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
126244139|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
126244140|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
126694727|NCT04062214|455836543|FG001|Week 36|Death|1|||
126244141|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
126244142|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
126244143|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
126244144|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
126244145|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
126244146|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
126244147|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
126244148|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
126244149|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
126244150|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
126244151|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
126244152|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
126244153|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
126244154|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
126244155|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
126244156|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
126244157|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
126244158|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
126244159|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
126244160|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
126244161|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
126244162|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
126244163|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
126244164|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
126244165|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
126244166|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
126244167|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
126244168|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
126244169|NCT01940341|454184880|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
126244170|NCT01940341|454184881|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
126244171|NCT01940341|454184882|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
126244172|NCT01940341|454184883|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
126244173|NCT00841698|454184888|FG000|First Intervention|Withdrawal by Subject|1|||
126244174|NCT00841698|454184889|FG001|First Intervention|Withdrawal by Subject|0|||
126244175|NCT00185458|454184890|FG000|Contraception Phase|Adverse Event|37|||
126244176|NCT00185458|454184890|FG000|Contraception Phase|Lost to Follow-up|10|||
126244177|NCT00185458|454184890|FG000|Contraception Phase|Protocol Violation|2|||
126244178|NCT00185458|454184890|FG000|Contraception Phase|Physician Decision|2|||
126244179|NCT00185458|454184890|FG000|Contraception Phase|Withdrawal by Subject|7|||
126244180|NCT00185458|454184890|FG000|HRT Phase|Adverse Event|18|||
126244181|NCT00185458|454184890|FG000|HRT Phase|Lost to Follow-up|4|||
126244182|NCT00185458|454184890|FG000|HRT Phase|Protocol Violation|2|||
126244183|NCT00185458|454184890|FG000|HRT Phase|Withdrawal by Subject|3|||
126244184|NCT00251979|454184891|FG000|Overall Study|Protocol Violation|3|||
126244185|NCT00251979|454184892|FG001|Overall Study|Protocol Violation|5|||
126244186|NCT00251979|454184891|FG000|Overall Study|Adverse Event|11|||
126244187|NCT00251979|454184892|FG001|Overall Study|Adverse Event|17|||
126244188|NCT00251979|454184891|FG000|Overall Study|Withdrawal by Subject|13|||
126244189|NCT00251979|454184892|FG001|Overall Study|Withdrawal by Subject|7|||
126244190|NCT00251979|454184891|FG000|Overall Study|Lost to Follow-up|8|||
126244191|NCT00251979|454184892|FG001|Overall Study|Lost to Follow-up|6|||
126244192|NCT00251979|454184891|FG000|Overall Study|Death|3|||
126244193|NCT00251979|454184892|FG001|Overall Study|Death|5|||
126244194|NCT01576042|454184893|FG000|Overall Study|Physician Decision|2|||
126244195|NCT01576042|454184894|FG001|Overall Study|Physician Decision|0|||
126244196|NCT00835536|454184901|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
126244197|NCT00835536|454184902|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
126244198|NCT00657553|454184903|FG000|Overall Study|low accrual, no analysis run|5|||
126244199|NCT00657553|454184904|FG001|Overall Study|low accrual, no analysis run|5|||
126244200|NCT03173547|454184905|FG000|Overall Study|Adverse Event|2|||
126244201|NCT03173547|454184906|FG001|Overall Study|Adverse Event|0|||
126244202|NCT03173547|454184905|FG000|Overall Study|Withdrawal by Subject|2|||
126244203|NCT03173547|454184906|FG001|Overall Study|Withdrawal by Subject|2|||
126244204|NCT00446563|454184907|FG000|Overall Study|Adverse Event|4|||
126244205|NCT00446563|454184908|FG001|Overall Study|Adverse Event|3|||
126244206|NCT00446563|454184907|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126244207|NCT00446563|454184908|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126244208|NCT00446563|454184907|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126357459|NCT01058005|454602101|FG000|Overall Study|Adverse Event|0|||
126244209|NCT00446563|454184908|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126244210|NCT00446563|454184907|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126244211|NCT00446563|454184908|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126244212|NCT00446563|454184907|FG000|Overall Study|Withdrawal by Subject|2|||
126244213|NCT00446563|454184908|FG001|Overall Study|Withdrawal by Subject|1|||
126244214|NCT00446563|454184907|FG000|Overall Study|Administrative problems|0|||
126244215|NCT00446563|454184908|FG001|Overall Study|Administrative problems|1|||
126244216|NCT03769025|454184909|FG000|Overall Study|Withdrawal by Subject|1|||
126244217|NCT03769025|454184910|FG001|Overall Study|Withdrawal by Subject|1|||
126244218|NCT03769025|454184909|FG000|Overall Study|Lost to Follow-up|4|||
126244219|NCT03769025|454184910|FG001|Overall Study|Lost to Follow-up|3|||
126244220|NCT01169558|454184911|FG000|Overall Study|Disease progression|98|||
126244221|NCT01169558|454184911|FG000|Overall Study|Adverse Event|25|||
126244222|NCT01169558|454184911|FG000|Overall Study|Withdrawal of Consent|8|||
126244223|NCT01169558|454184911|FG000|Overall Study|Medical Decision|7|||
126244224|NCT01169558|454184911|FG000|Overall Study|Stable Disease|4|||
126244225|NCT01169558|454184911|FG000|Overall Study|Lost to Follow-up|4|||
126244226|NCT01169558|454184911|FG000|Overall Study|Need for Surgery|4|||
126244227|NCT01169558|454184911|FG000|Overall Study|Non-compliance|2|||
126244228|NCT01169558|454184911|FG000|Overall Study|Protocol Violation|2|||
126244229|NCT01169558|454184911|FG000|Overall Study|Partial response|2|||
126244230|NCT00838539|454184917|FG000|Overall Study|Disease Progression|2|||
126244231|NCT00838539|454184918|FG001|Overall Study|Disease Progression|4|||
126244232|NCT00838539|454184919|FG002|Overall Study|Disease Progression|3|||
126244233|NCT00838539|454184920|FG003|Overall Study|Disease Progression|2|||
126244234|NCT00838539|454184921|FG004|Overall Study|Disease Progression|4|||
126244235|NCT00838539|454184922|FG005|Overall Study|Disease Progression|2|||
126244236|NCT00838539|454184923|FG006|Overall Study|Disease Progression|3|||
126244237|NCT00838539|454184924|FG007|Overall Study|Disease Progression|4|||
126244238|NCT00838539|454184925|FG008|Overall Study|Disease Progression|4|||
126244239|NCT00838539|454184926|FG009|Overall Study|Disease Progression|5|||
126244240|NCT00838539|454184927|FG010|Overall Study|Disease Progression|1|||
126244241|NCT00838539|454184928|FG011|Overall Study|Disease Progression|4|||
126244242|NCT00838539|454184917|FG000|Overall Study|Adverse Event|1|||
126244243|NCT00838539|454184918|FG001|Overall Study|Adverse Event|1|||
126244244|NCT00838539|454184919|FG002|Overall Study|Adverse Event|1|||
126244245|NCT00838539|454184920|FG003|Overall Study|Adverse Event|1|||
126244246|NCT00838539|454184921|FG004|Overall Study|Adverse Event|2|||
126244247|NCT00838539|454184922|FG005|Overall Study|Adverse Event|1|||
126244248|NCT00838539|454184923|FG006|Overall Study|Adverse Event|0|||
126244249|NCT00838539|454184924|FG007|Overall Study|Adverse Event|2|||
126244250|NCT00838539|454184925|FG008|Overall Study|Adverse Event|0|||
126244251|NCT00838539|454184926|FG009|Overall Study|Adverse Event|1|||
126244252|NCT00838539|454184927|FG010|Overall Study|Adverse Event|2|||
126244253|NCT00838539|454184928|FG011|Overall Study|Adverse Event|0|||
126244254|NCT00838539|454184917|FG000|Overall Study|Withdrawal by Subject|0|||
126244255|NCT00838539|454184918|FG001|Overall Study|Withdrawal by Subject|1|||
126447598|NCT02102204|454939491|FG000|Overall Study|Withdrawal by Subject|137|||
126447599|NCT02102204|454939491|FG000|Overall Study|Death|92|||
126447600|NCT02102204|454939491|FG000|Overall Study|Lost to Follow-up|65|||
126447601|NCT02102204|454939491|FG000|Overall Study|Sponsor Decision|5|||
126447602|NCT02102204|454939491|FG000|Overall Study|Ongoing|5|||
126244256|NCT00838539|454184919|FG002|Overall Study|Withdrawal by Subject|0|||
126244257|NCT00838539|454184920|FG003|Overall Study|Withdrawal by Subject|0|||
126244258|NCT00838539|454184921|FG004|Overall Study|Withdrawal by Subject|0|||
126244259|NCT00838539|454184922|FG005|Overall Study|Withdrawal by Subject|0|||
126244260|NCT00838539|454184923|FG006|Overall Study|Withdrawal by Subject|0|||
126447603|NCT01865552|454939492|FG000|Period 1|Adverse Event|1|||
126447604|NCT01865552|454939493|FG001|Period 1|Adverse Event|0|||
126447605|NCT01865552|454939494|FG002|Period 1|Adverse Event|0|||
126447606|NCT01865552|454939495|FG003|Period 1|Adverse Event|1|||
126545729|NCT04867785|455292428|FG002|Overall Study|Lost to Follow-up|3|||
126447607|NCT01865552|454939496|FG004|Period 1|Adverse Event|1|||
126447608|NCT01865552|454939497|FG005|Period 1|Adverse Event|1|||
126447609|NCT01865552|454939492|FG000|Period 1|Pathological lab|0|||
126447610|NCT01865552|454939493|FG001|Period 1|Pathological lab|0|||
126545730|NCT04867785|455292429|FG003|Overall Study|Lost to Follow-up|2|||
126545731|NCT04867785|455292430|FG004|Overall Study|Lost to Follow-up|0|||
126694728|NCT00291551|455836544|FG000|Overall Study|Death|7|||
126694729|NCT00291551|455836544|FG000|Overall Study|Withdrawal by Subject|6|||
126545732|NCT04867785|455292431|FG005|Overall Study|Lost to Follow-up|1|||
126244261|NCT00838539|454184924|FG007|Overall Study|Withdrawal by Subject|0|||
126244262|NCT00838539|454184925|FG008|Overall Study|Withdrawal by Subject|0|||
126244263|NCT00838539|454184926|FG009|Overall Study|Withdrawal by Subject|1|||
126244264|NCT00838539|454184927|FG010|Overall Study|Withdrawal by Subject|2|||
126244265|NCT00838539|454184928|FG011|Overall Study|Withdrawal by Subject|0|||
126244266|NCT00838539|454184917|FG000|Overall Study|Death|0|||
126244267|NCT00838539|454184918|FG001|Overall Study|Death|0|||
126244268|NCT00838539|454184919|FG002|Overall Study|Death|0|||
126545733|NCT04867785|455292432|FG006|Overall Study|Lost to Follow-up|0|||
126244269|NCT00838539|454184920|FG003|Overall Study|Death|0|||
126244270|NCT00838539|454184921|FG004|Overall Study|Death|0|||
126244271|NCT00838539|454184922|FG005|Overall Study|Death|0|||
126244272|NCT00838539|454184923|FG006|Overall Study|Death|1|||
126244273|NCT00838539|454184924|FG007|Overall Study|Death|0|||
126244274|NCT00838539|454184925|FG008|Overall Study|Death|0|||
126244275|NCT00838539|454184926|FG009|Overall Study|Death|0|||
126244276|NCT00838539|454184927|FG010|Overall Study|Death|0|||
126244277|NCT00838539|454184928|FG011|Overall Study|Death|0|||
126244278|NCT00838539|454184917|FG000|Overall Study|Physician Decision|0|||
126244279|NCT00838539|454184918|FG001|Overall Study|Physician Decision|0|||
126244280|NCT00838539|454184919|FG002|Overall Study|Physician Decision|0|||
126244281|NCT00838539|454184920|FG003|Overall Study|Physician Decision|0|||
126244282|NCT00838539|454184921|FG004|Overall Study|Physician Decision|0|||
126244283|NCT00838539|454184922|FG005|Overall Study|Physician Decision|0|||
126244284|NCT00838539|454184923|FG006|Overall Study|Physician Decision|0|||
126244285|NCT00838539|454184924|FG007|Overall Study|Physician Decision|0|||
126244286|NCT00838539|454184925|FG008|Overall Study|Physician Decision|1|||
126244287|NCT00838539|454184926|FG009|Overall Study|Physician Decision|0|||
126244288|NCT00838539|454184927|FG010|Overall Study|Physician Decision|0|||
126244289|NCT00838539|454184928|FG011|Overall Study|Physician Decision|0|||
126244290|NCT00838539|454184917|FG000|Overall Study|Clinical Progression|0|||
126244291|NCT00838539|454184918|FG001|Overall Study|Clinical Progression|0|||
126244292|NCT00838539|454184919|FG002|Overall Study|Clinical Progression|0|||
126244293|NCT00838539|454184920|FG003|Overall Study|Clinical Progression|0|||
126244294|NCT00838539|454184921|FG004|Overall Study|Clinical Progression|0|||
126244295|NCT00838539|454184922|FG005|Overall Study|Clinical Progression|0|||
126244296|NCT00838539|454184923|FG006|Overall Study|Clinical Progression|1|||
126244297|NCT00838539|454184924|FG007|Overall Study|Clinical Progression|0|||
126244298|NCT00838539|454184925|FG008|Overall Study|Clinical Progression|0|||
126244299|NCT00838539|454184926|FG009|Overall Study|Clinical Progression|0|||
126244300|NCT00838539|454184927|FG010|Overall Study|Clinical Progression|0|||
126244301|NCT00838539|454184928|FG011|Overall Study|Clinical Progression|0|||
126244302|NCT00838539|454184917|FG000|Overall Study|Symptomatic Deterioration|0|||
126244303|NCT00838539|454184918|FG001|Overall Study|Symptomatic Deterioration|0|||
126244304|NCT00838539|454184919|FG002|Overall Study|Symptomatic Deterioration|1|||
126244305|NCT00838539|454184920|FG003|Overall Study|Symptomatic Deterioration|1|||
126244306|NCT00838539|454184921|FG004|Overall Study|Symptomatic Deterioration|0|||
126244307|NCT00838539|454184922|FG005|Overall Study|Symptomatic Deterioration|1|||
126244308|NCT00838539|454184923|FG006|Overall Study|Symptomatic Deterioration|0|||
126244309|NCT00838539|454184924|FG007|Overall Study|Symptomatic Deterioration|0|||
126244310|NCT00838539|454184925|FG008|Overall Study|Symptomatic Deterioration|0|||
126244311|NCT00838539|454184926|FG009|Overall Study|Symptomatic Deterioration|1|||
126244312|NCT00838539|454184927|FG010|Overall Study|Symptomatic Deterioration|0|||
126244313|NCT00838539|454184928|FG011|Overall Study|Symptomatic Deterioration|0|||
126244314|NCT03123471|454184929|FG000|Placebo-controlled Phase|Adverse Event|3|||
126244315|NCT03123471|454184930|FG001|Placebo-controlled Phase|Adverse Event|8|||
126244316|NCT03123471|454184929|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
126244317|NCT03123471|454184930|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
126244318|NCT03123471|454184929|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
126244319|NCT03123471|454184930|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
126244320|NCT03123471|454184929|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
126244321|NCT03123471|454184930|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
126244322|NCT03123471|454184929|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
126447611|NCT01865552|454939494|FG002|Period 1|Pathological lab|0|||
126447612|NCT01865552|454939495|FG003|Period 1|Pathological lab|0|||
126447613|NCT01865552|454939496|FG004|Period 1|Pathological lab|1|||
126447614|NCT01865552|454939497|FG005|Period 1|Pathological lab|0|||
126447615|NCT01865552|454939492|FG000|Period 1|Other|0|||
126447616|NCT01865552|454939493|FG001|Period 1|Other|0|||
126447617|NCT01865552|454939494|FG002|Period 1|Other|0|||
126447618|NCT01865552|454939495|FG003|Period 1|Other|0|||
126694730|NCT04666038|455836545|FG000|Overall Study|Progressive Disease|2|||
126694731|NCT04666038|455836546|FG001|Overall Study|Progressive Disease|0|||
126244323|NCT03123471|454184930|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
126244324|NCT03123471|454184929|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
126244325|NCT03123471|454184930|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
126244326|NCT03123471|454184929|FG000|Placebo-controlled Phase|Miscellaneous|0|||
126244327|NCT03123471|454184930|FG001|Placebo-controlled Phase|Miscellaneous|1|||
126244328|NCT03123471|454184929|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
126244329|NCT03123471|454184930|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
126244330|NCT03123471|454184929|FG000|Apremilast Extension Phase|Adverse Event|1|||
126244331|NCT03123471|454184930|FG001|Apremilast Extension Phase|Adverse Event|5|||
126244332|NCT03123471|454184929|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
126244333|NCT03123471|454184930|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
126447619|NCT01865552|454939496|FG004|Period 1|Other|1|||
126447620|NCT01865552|454939497|FG005|Period 1|Other|0|||
126447621|NCT03079102|454939498|FG000|Overall Study|Physician Decision|0|||
126694732|NCT04666038|455836545|FG000|Overall Study|Death|38|||
126447622|NCT03079102|454939499|FG001|Overall Study|Physician Decision|1|||
126447623|NCT02923921|454939500|FG000|Overall Study|Sponsor Decision|39|||
126447624|NCT02923921|454939501|FG001|Overall Study|Sponsor Decision|38|||
126447625|NCT02923921|454939500|FG000|Overall Study|Lost to Follow-up|1|||
126447626|NCT02923921|454939501|FG001|Overall Study|Lost to Follow-up|0|||
126244334|NCT03123471|454184929|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
126244335|NCT03123471|454184930|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
126244336|NCT02957942|454184933|FG000|Overall Study|Withdrawal by Subject|0|||
126244337|NCT02957942|454184934|FG001|Overall Study|Withdrawal by Subject|1|||
126244338|NCT02957942|454184933|FG000|Overall Study|Practicing experiment protocol|0|||
126244339|NCT02957942|454184934|FG001|Overall Study|Practicing experiment protocol|6|||
126244340|NCT03238781|454184935|FG000|Overall Study|Adverse Event|1|||
126244341|NCT03238781|454184936|FG001|Overall Study|Adverse Event|1|||
126244342|NCT03238781|454184937|FG002|Overall Study|Adverse Event|2|||
126244343|NCT03238781|454184935|FG000|Overall Study|Lost to Follow-up|2|||
126244344|NCT03238781|454184936|FG001|Overall Study|Lost to Follow-up|1|||
126244345|NCT03238781|454184937|FG002|Overall Study|Lost to Follow-up|2|||
126244346|NCT03238781|454184935|FG000|Overall Study|Withdrawal by Subject|23|||
126244347|NCT03238781|454184936|FG001|Overall Study|Withdrawal by Subject|14|||
126244348|NCT03238781|454184937|FG002|Overall Study|Withdrawal by Subject|16|||
126244349|NCT03238781|454184935|FG000|Overall Study|Decision by sponsor|0|||
126244350|NCT03238781|454184936|FG001|Overall Study|Decision by sponsor|1|||
126244351|NCT03238781|454184937|FG002|Overall Study|Decision by sponsor|0|||
126244352|NCT01249651|454184941|FG000|Overall Study|Withdrawal by Subject|4|||
126244353|NCT01249651|454184941|FG000|Overall Study|Adverse Event|1|||
126244354|NCT01249651|454184941|FG000|Overall Study|Protocol Violation|1|||
126244355|NCT01249651|454184941|FG000|Overall Study|Sponsor Decision|1|||
126244356|NCT02820350|454184948|FG000|Overall Study|Withdrawal by Subject|3|||
126244357|NCT02820350|454184948|FG000|Overall Study|Death|4|||
126244358|NCT00787254|454184949|FG000|Overall Study|Adverse Event|24|||
126244359|NCT00787254|454184950|FG001|Overall Study|Adverse Event|23|||
126244360|NCT00787254|454184949|FG000|Overall Study|Protocol Violation|26|||
126244361|NCT00787254|454184950|FG001|Overall Study|Protocol Violation|23|||
126244362|NCT00787254|454184949|FG000|Overall Study|Withdrawal by Subject|16|||
126244363|NCT00787254|454184950|FG001|Overall Study|Withdrawal by Subject|11|||
126244364|NCT00787254|454184949|FG000|Overall Study|Lack of Efficacy|4|||
126244365|NCT00787254|454184950|FG001|Overall Study|Lack of Efficacy|15|||
126244366|NCT00787254|454184949|FG000|Overall Study|NSAIDs discontinuation|1|||
126244367|NCT00787254|454184950|FG001|Overall Study|NSAIDs discontinuation|2|||
126244368|NCT00787254|454184949|FG000|Overall Study|Institution closed|1|||
126244369|NCT00787254|454184950|FG001|Overall Study|Institution closed|0|||
126244370|NCT00787254|454184949|FG000|Overall Study|Physician Decision|4|||
126244371|NCT00787254|454184950|FG001|Overall Study|Physician Decision|8|||
126244372|NCT00316186|454184961|FG000|Overall Study|Adverse Event|6|||
126244373|NCT00316186|454184961|FG000|Overall Study|Disease Progression|4|||
126244374|NCT00316186|454184961|FG000|Overall Study|Lost to Follow-up|1|||
126244375|NCT00316186|454184961|FG000|Overall Study|Other|1|||
126244376|NCT02301975|454186887|FG000|Overall Study|Adverse Event|8|||
126244377|NCT02301975|454186888|FG001|Overall Study|Adverse Event|3|||
126244378|NCT02301975|454186889|FG002|Overall Study|Adverse Event|2|||
126244379|NCT02301975|454186887|FG000|Overall Study|Lack of Efficacy|1|||
126244380|NCT02301975|454186888|FG001|Overall Study|Lack of Efficacy|1|||
126244381|NCT02301975|454186889|FG002|Overall Study|Lack of Efficacy|1|||
126244382|NCT02301975|454186887|FG000|Overall Study|Protocol Violation|3|||
126244383|NCT02301975|454186888|FG001|Overall Study|Protocol Violation|5|||
126244384|NCT02301975|454186889|FG002|Overall Study|Protocol Violation|3|||
126244385|NCT02301975|454186887|FG000|Overall Study|Lost to Follow-up|0|||
126244386|NCT02301975|454186888|FG001|Overall Study|Lost to Follow-up|2|||
126244387|NCT02301975|454186889|FG002|Overall Study|Lost to Follow-up|2|||
126244388|NCT02301975|454186887|FG000|Overall Study|Physician Decision|4|||
126244389|NCT02301975|454186888|FG001|Overall Study|Physician Decision|2|||
126244390|NCT02301975|454186889|FG002|Overall Study|Physician Decision|3|||
126244391|NCT02301975|454186887|FG000|Overall Study|Withdrawal by Subject|15|||
126244392|NCT02301975|454186888|FG001|Overall Study|Withdrawal by Subject|12|||
126244393|NCT02301975|454186889|FG002|Overall Study|Withdrawal by Subject|11|||
126244394|NCT03733730|454186890|FG000|Overall Study|Lost to Follow-up|1|||
126244395|NCT03733730|454186891|FG001|Overall Study|Lost to Follow-up|32|||
126447627|NCT02923921|454939500|FG000|Overall Study|Withdrawal by Subject|6|||
126447628|NCT02923921|454939501|FG001|Overall Study|Withdrawal by Subject|13|||
126244396|NCT03733730|454186890|FG000|Overall Study|Other|1|||
126244397|NCT03733730|454186891|FG001|Overall Study|Other|0|||
126447629|NCT02923921|454939500|FG000|Overall Study|Unknown, Not Collected|7|||
126244398|NCT03733730|454186890|FG000|Overall Study|Adverse Event|0|||
126244399|NCT03733730|454186891|FG001|Overall Study|Adverse Event|4|||
126244400|NCT03733730|454186890|FG000|Overall Study|Death|0|||
126244401|NCT03733730|454186891|FG001|Overall Study|Death|5|||
126244402|NCT03733730|454186890|FG000|Overall Study|Withdrawal by Subject|0|||
126244403|NCT03733730|454186891|FG001|Overall Study|Withdrawal by Subject|8|||
126244404|NCT03635320|454186892|FG000|Overall Study|not implanted the device|1|||
126244405|NCT03635320|454186893|FG001|Overall Study|not implanted the device|2|||
126244406|NCT03635320|454186892|FG000|Overall Study|Withdrawal by Subject|11|||
126244407|NCT03635320|454186893|FG001|Overall Study|Withdrawal by Subject|6|||
126244408|NCT00835575|454186896|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
126244409|NCT00835575|454186897|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
126244410|NCT03606174|454186898|FG000|Overall Study|Death|37|||
126244411|NCT03606174|454186899|FG001|Overall Study|Death|15|||
126244412|NCT03606174|454186900|FG002|Overall Study|Death|15|||
126244413|NCT03606174|454186901|FG003|Overall Study|Death|7|||
126244414|NCT03606174|454186902|FG004|Overall Study|Death|35|||
126244415|NCT03606174|454186903|FG005|Overall Study|Death|12|||
126244416|NCT03606174|454186904|FG006|Overall Study|Death|35|||
126244417|NCT03606174|454186905|FG007|Overall Study|Death|8|||
126244418|NCT03606174|454186906|FG008|Overall Study|Death|5|||
126244419|NCT03606174|454186907|FG009|Overall Study|Death|3|||
126244420|NCT03606174|454186908|FG010|Overall Study|Death|0|||
126244421|NCT03606174|454186898|FG000|Overall Study|Lost to Follow-up|0|||
126244422|NCT03606174|454186899|FG001|Overall Study|Lost to Follow-up|0|||
126244423|NCT03606174|454186900|FG002|Overall Study|Lost to Follow-up|0|||
126244424|NCT03606174|454186901|FG003|Overall Study|Lost to Follow-up|0|||
126244425|NCT03606174|454186902|FG004|Overall Study|Lost to Follow-up|1|||
126244426|NCT03606174|454186903|FG005|Overall Study|Lost to Follow-up|1|||
126244427|NCT03606174|454186904|FG006|Overall Study|Lost to Follow-up|0|||
126244428|NCT03606174|454186905|FG007|Overall Study|Lost to Follow-up|0|||
126244429|NCT03606174|454186906|FG008|Overall Study|Lost to Follow-up|0|||
126244430|NCT03606174|454186907|FG009|Overall Study|Lost to Follow-up|0|||
126244431|NCT03606174|454186908|FG010|Overall Study|Lost to Follow-up|0|||
126244432|NCT03606174|454186898|FG000|Overall Study|Withdrawal by Subject|6|||
126244433|NCT03606174|454186899|FG001|Overall Study|Withdrawal by Subject|0|||
126244434|NCT03606174|454186900|FG002|Overall Study|Withdrawal by Subject|0|||
126244435|NCT03606174|454186901|FG003|Overall Study|Withdrawal by Subject|1|||
126244436|NCT03606174|454186902|FG004|Overall Study|Withdrawal by Subject|2|||
126244437|NCT03606174|454186903|FG005|Overall Study|Withdrawal by Subject|1|||
126244438|NCT03606174|454186904|FG006|Overall Study|Withdrawal by Subject|4|||
126244439|NCT03606174|454186905|FG007|Overall Study|Withdrawal by Subject|0|||
126244440|NCT03606174|454186906|FG008|Overall Study|Withdrawal by Subject|0|||
126244441|NCT03606174|454186907|FG009|Overall Study|Withdrawal by Subject|0|||
126244442|NCT03606174|454186908|FG010|Overall Study|Withdrawal by Subject|1|||
126244443|NCT03606174|454186898|FG000|Overall Study|Study Terminated by Sponsor|5|||
126244444|NCT03606174|454186899|FG001|Overall Study|Study Terminated by Sponsor|7|||
126244445|NCT03606174|454186900|FG002|Overall Study|Study Terminated by Sponsor|3|||
126244446|NCT03606174|454186901|FG003|Overall Study|Study Terminated by Sponsor|0|||
126244447|NCT03606174|454186902|FG004|Overall Study|Study Terminated by Sponsor|11|||
126244448|NCT03606174|454186903|FG005|Overall Study|Study Terminated by Sponsor|6|||
126694733|NCT04666038|455836546|FG001|Overall Study|Death|32|||
126694734|NCT04666038|455836545|FG000|Overall Study|Withdrawal by Subject|10|||
126694735|NCT04666038|455836546|FG001|Overall Study|Withdrawal by Subject|19|||
126694736|NCT04666038|455836545|FG000|Overall Study|Lost to Follow-up|0|||
126694737|NCT04666038|455836546|FG001|Overall Study|Lost to Follow-up|2|||
126694738|NCT04666038|455836545|FG000|Overall Study|On Study Treatment|46|||
126694739|NCT04666038|455836546|FG001|Overall Study|On Study Treatment|5|||
126694740|NCT04666038|455836545|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
126694741|NCT04666038|455836546|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
126694742|NCT03887130|455836549|FG000|Overall Study|Progressive disease|23|||
126694743|NCT03887130|455836550|FG001|Overall Study|Progressive disease|14|||
126694744|NCT03887130|455836551|FG002|Overall Study|Progressive disease|7|||
126694745|NCT03887130|455836549|FG000|Overall Study|Protocol Violation|3|||
126694746|NCT03887130|455836550|FG001|Overall Study|Protocol Violation|1|||
126694747|NCT03887130|455836551|FG002|Overall Study|Protocol Violation|2|||
126694748|NCT03887130|455836549|FG000|Overall Study|Drug related toxicity|7|||
126694749|NCT03887130|455836550|FG001|Overall Study|Drug related toxicity|7|||
126694750|NCT03887130|455836551|FG002|Overall Study|Drug related toxicity|13|||
126694751|NCT03887130|455836549|FG000|Overall Study|Non drug related toxicity|3|||
126694752|NCT03887130|455836550|FG001|Overall Study|Non drug related toxicity|0|||
126694753|NCT03887130|455836551|FG002|Overall Study|Non drug related toxicity|0|||
126694754|NCT03887130|455836549|FG000|Overall Study|Death|2|||
126694755|NCT03887130|455836550|FG001|Overall Study|Death|2|||
126694756|NCT03887130|455836551|FG002|Overall Study|Death|1|||
126694757|NCT03887130|455836549|FG000|Overall Study|Withdrawal by Subject|7|||
126694758|NCT03887130|455836550|FG001|Overall Study|Withdrawal by Subject|6|||
126694759|NCT03887130|455836551|FG002|Overall Study|Withdrawal by Subject|11|||
126694760|NCT03887130|455836549|FG000|Overall Study|other reason|6|||
126694761|NCT03887130|455836550|FG001|Overall Study|other reason|20|||
126694762|NCT03887130|455836551|FG002|Overall Study|other reason|17|||
126694763|NCT04082663|455836552|FG000|Overall Study|Adverse Event|6|||
126244449|NCT03606174|454186904|FG006|Overall Study|Study Terminated by Sponsor|12|||
126244450|NCT03606174|454186905|FG007|Overall Study|Study Terminated by Sponsor|1|||
126244451|NCT03606174|454186906|FG008|Overall Study|Study Terminated by Sponsor|3|||
126244452|NCT03606174|454186907|FG009|Overall Study|Study Terminated by Sponsor|1|||
126694764|NCT04082663|455836552|FG000|Overall Study|Lost to Follow-up|1|||
126694765|NCT01752023|455836553|FG000|Overall Study|Physician Decision|2|||
126694766|NCT01752023|455836554|FG001|Overall Study|Physician Decision|1|||
126244453|NCT03606174|454186908|FG010|Overall Study|Study Terminated by Sponsor|2|||
126244454|NCT03606174|454186898|FG000|Overall Study|Miscellaneous|1|||
126244455|NCT03606174|454186899|FG001|Overall Study|Miscellaneous|1|||
126244456|NCT03606174|454186900|FG002|Overall Study|Miscellaneous|0|||
126244457|NCT03606174|454186901|FG003|Overall Study|Miscellaneous|1|||
126244458|NCT03606174|454186902|FG004|Overall Study|Miscellaneous|4|||
126244459|NCT03606174|454186903|FG005|Overall Study|Miscellaneous|7|||
126244460|NCT03606174|454186904|FG006|Overall Study|Miscellaneous|5|||
126244461|NCT03606174|454186905|FG007|Overall Study|Miscellaneous|0|||
126244462|NCT03606174|454186906|FG008|Overall Study|Miscellaneous|0|||
126244463|NCT03606174|454186907|FG009|Overall Study|Miscellaneous|0|||
126244464|NCT03606174|454186908|FG010|Overall Study|Miscellaneous|1|||
126244465|NCT01609257|454186909|FG000|Overall Study|Lost to Follow-up|2|||
126244466|NCT01609257|454186910|FG001|Overall Study|Lost to Follow-up|1|||
126244467|NCT01609257|454186909|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
126244468|NCT01609257|454186910|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
126244469|NCT01609257|454186909|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
126244470|NCT01609257|454186910|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
126244471|NCT03049748|454186911|FG000|Overall Study|Lost to Follow-up|1|||
126244472|NCT03049748|454186912|FG001|Overall Study|Lost to Follow-up|0|||
126244473|NCT03049748|454186911|FG000|Overall Study|Death|3|||
126244474|NCT03049748|454186912|FG001|Overall Study|Death|0|||
126244475|NCT03049748|454186911|FG000|Overall Study|Withdrawal by Subject|0|||
126244476|NCT03049748|454186912|FG001|Overall Study|Withdrawal by Subject|3|||
126244477|NCT03049748|454186911|FG000|Overall Study|Protocol Violation|0|||
126244478|NCT03049748|454186912|FG001|Overall Study|Protocol Violation|2|||
126244479|NCT03049748|454186911|FG000|Overall Study|Moved out of state (relocation)|0|||
126357460|NCT01058005|454602102|FG001|Overall Study|Adverse Event|2|||
126357461|NCT01058005|454602103|FG002|Overall Study|Adverse Event|1|||
126357462|NCT01058005|454602101|FG000|Overall Study|Physician Decision|2|||
126357463|NCT01058005|454602102|FG001|Overall Study|Physician Decision|2|||
126357464|NCT01058005|454602103|FG002|Overall Study|Physician Decision|0|||
126357465|NCT01058005|454602101|FG000|Overall Study|Withdrawal by Subject|4|||
126357466|NCT01058005|454602102|FG001|Overall Study|Withdrawal by Subject|5|||
126357467|NCT01058005|454602103|FG002|Overall Study|Withdrawal by Subject|11|||
126357468|NCT01058005|454602101|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
126357469|NCT01058005|454602102|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
126357470|NCT01058005|454602103|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
126357471|NCT01058005|454602101|FG000|Overall Study|Reason Missing|5|||
126357472|NCT01058005|454602102|FG001|Overall Study|Reason Missing|3|||
126357473|NCT01058005|454602103|FG002|Overall Study|Reason Missing|1|||
126357474|NCT00927186|454602104|FG000|12 Months Primary Study|Adverse Event|5|||
126357475|NCT00927186|454602105|FG001|12 Months Primary Study|Adverse Event|2|||
126357476|NCT00927186|454602104|FG000|12 Months Primary Study|Lost to Follow-up|1|||
126357477|NCT00927186|454602105|FG001|12 Months Primary Study|Lost to Follow-up|0|||
126357478|NCT00927186|454602104|FG000|12 Months Primary Study|Protocol Violation|0|||
126357479|NCT00927186|454602105|FG001|12 Months Primary Study|Protocol Violation|1|||
126357480|NCT00927186|454602104|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
126357481|NCT00927186|454602105|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
126357482|NCT01145222|454602106|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
126357483|NCT01145222|454602107|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
126357484|NCT01145222|454602108|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
126357485|NCT01145222|454602109|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
126357486|NCT01145222|454602106|FG000|Overall Study|Poor bowel preparation|0|||
126357487|NCT01145222|454602107|FG001|Overall Study|Poor bowel preparation|0|||
126357488|NCT01145222|454602108|FG002|Overall Study|Poor bowel preparation|0|||
126357489|NCT01145222|454602109|FG003|Overall Study|Poor bowel preparation|1|||
126357490|NCT01421134|454602110|FG000|Overall Study|Adverse Event|3|||
126357491|NCT01421134|454602111|FG001|Overall Study|Adverse Event|5|||
126357492|NCT01421134|454602110|FG000|Overall Study|Lack of Efficacy|2|||
126357493|NCT01421134|454602111|FG001|Overall Study|Lack of Efficacy|4|||
126357494|NCT01421134|454602110|FG000|Overall Study|Protocol Violation|0|||
126357495|NCT01421134|454602111|FG001|Overall Study|Protocol Violation|3|||
126357496|NCT01421134|454602110|FG000|Overall Study|Withdrawal by Subject|1|||
126357497|NCT01421134|454602111|FG001|Overall Study|Withdrawal by Subject|1|||
126357498|NCT01421134|454602110|FG000|Overall Study|Administrative|0|||
126357499|NCT01421134|454602111|FG001|Overall Study|Administrative|1|||
126357500|NCT01421134|454602110|FG000|Overall Study|Lost to Follow-up|1|||
126357501|NCT01421134|454602111|FG001|Overall Study|Lost to Follow-up|1|||
126357502|NCT01851369|454602116|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357503|NCT01851369|454602117|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126244480|NCT03049748|454186912|FG001|Overall Study|Moved out of state (relocation)|1|||
126244481|NCT04994535|454186916|FG000|Overall Study|Lost to Follow-up|7|||
126244482|NCT04994535|454186917|FG001|Overall Study|Lost to Follow-up|7|||
126244483|NCT04994535|454186916|FG000|Overall Study|Withdrawal by Subject|10|||
126244484|NCT04994535|454186917|FG001|Overall Study|Withdrawal by Subject|7|||
126244485|NCT04994535|454186916|FG000|Overall Study|Other|1|||
126244486|NCT04994535|454186917|FG001|Overall Study|Other|1|||
126244487|NCT01158118|454186918|FG000|Overall Study|Screen failure|1|||
126244488|NCT01158118|454186919|FG001|Overall Study|Screen failure|0|||
126244489|NCT01158118|454186918|FG000|Overall Study|Donor match was a screen failure|0|||
126244490|NCT01158118|454186919|FG001|Overall Study|Donor match was a screen failure|1|||
126244491|NCT01158118|454186918|FG000|Overall Study|Suffered stroke prior to transplant|0|||
126244492|NCT01158118|454186919|FG001|Overall Study|Suffered stroke prior to transplant|1|||
126244493|NCT01158118|454186918|FG000|Overall Study|Death|0|||
126244494|NCT01158118|454186919|FG001|Overall Study|Death|1|||
126244495|NCT00604162|454186920|FG000|Overall Study|Physician Decision|3|||
126244496|NCT00604162|454186920|FG000|Overall Study|Withdrawal by Subject|1|||
126244497|NCT01015287|454186921|FG000|Overall Study|Death|21|||
126244498|NCT01015287|454186922|FG001|Overall Study|Death|16|||
126244499|NCT01015287|454186921|FG000|Overall Study|Adverse Event|1|||
126244500|NCT01015287|454186922|FG001|Overall Study|Adverse Event|0|||
126244501|NCT01015287|454186921|FG000|Overall Study|Sponsor Decision|3|||
126244502|NCT01015287|454186922|FG001|Overall Study|Sponsor Decision|7|||
126244503|NCT01015287|454186921|FG000|Overall Study|Physician Decision|19|||
126244504|NCT01015287|454186922|FG001|Overall Study|Physician Decision|21|||
126244505|NCT01015287|454186921|FG000|Overall Study|Withdrawal by Subject|14|||
126244506|NCT01015287|454186922|FG001|Overall Study|Withdrawal by Subject|19|||
126244507|NCT01015287|454186921|FG000|Overall Study|Entry Criteria not Met|11|||
126244508|NCT01015287|454186922|FG001|Overall Study|Entry Criteria not Met|14|||
126244509|NCT01015287|454186921|FG000|Overall Study|Lost to Follow-up|2|||
126244510|NCT01015287|454186922|FG001|Overall Study|Lost to Follow-up|1|||
126244511|NCT01015287|454186921|FG000|Overall Study|Protocol Violation|1|||
126244512|NCT01015287|454186922|FG001|Overall Study|Protocol Violation|1|||
126244513|NCT00905840|454186923|FG000|Overall Study|Lost to Follow-up|11|||
126244514|NCT00905840|454186923|FG000|Overall Study|Death|3|||
126244515|NCT00905840|454186923|FG000|Overall Study|Withdrawal by Subject|1|||
126244516|NCT00905840|454186923|FG000|Overall Study|Adverse Event|1|||
126244517|NCT01370317|454186924|FG000|Overall Study|Participant withdrew consent|1|||
126244518|NCT01370317|454186925|FG001|Overall Study|Participant withdrew consent|0|||
126244519|NCT01370317|454186924|FG000|Overall Study|Protocol deviation|0|||
126244520|NCT01370317|454186925|FG001|Overall Study|Protocol deviation|1|||
126244521|NCT02849457|454186931|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
126244522|NCT02849457|454186932|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
126244523|NCT02849457|454186933|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
126694767|NCT02899156|455836555|FG000|Overall Study|Death|1|||
126694768|NCT02899156|455836556|FG001|Overall Study|Death|0|||
126244524|NCT02849457|454186934|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
126244525|NCT03673670|454186937|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
126244526|NCT03673670|454186938|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
126244527|NCT03673670|454186939|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
126244528|NCT03673670|454186940|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
126244529|NCT03673670|454186941|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
126244530|NCT03673670|454186942|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
126244531|NCT03673670|454186937|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
126357504|NCT01851369|454602118|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126694769|NCT02899156|455836555|FG000|Overall Study|Physician Decision|0|||
126694770|NCT02899156|455836556|FG001|Overall Study|Physician Decision|1|||
126694771|NCT00787787|455836560|FG000|Overall Study|Lack of Efficacy|4|||
126694772|NCT00787787|455836560|FG000|Overall Study|Adverse Event|3|||
126694773|NCT01412957|455836561|FG000|Overall Study|Withdrawal by Subject|6|||
126694774|NCT01412957|455836562|FG001|Overall Study|Withdrawal by Subject|22|||
126694775|NCT01412957|455836561|FG000|Overall Study|Lost to Follow-up|7|||
126694776|NCT01412957|455836562|FG001|Overall Study|Lost to Follow-up|2|||
126694777|NCT01412957|455836561|FG000|Overall Study|Death|136|||
126694778|NCT01412957|455836562|FG001|Overall Study|Death|133|||
126694779|NCT04722991|455836563|FG000|Overall Study|Adverse Event|12|||
126694780|NCT04722991|455836564|FG001|Overall Study|Adverse Event|4|||
126694781|NCT04722991|455836563|FG000|Overall Study|Death|2|||
126694782|NCT04722991|455836564|FG001|Overall Study|Death|0|||
126761268|NCT02708524|456077190|FG000|Overall Study|Lens Discomfort|1|||
126694783|NCT04722991|455836563|FG000|Overall Study|Lost to Follow-up|1|||
126694784|NCT04722991|455836564|FG001|Overall Study|Lost to Follow-up|1|||
126694785|NCT04722991|455836563|FG000|Overall Study|Withdrawal cirterion met|2|||
126694786|NCT04722991|455836564|FG001|Overall Study|Withdrawal cirterion met|2|||
126244532|NCT03673670|454186938|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
126244533|NCT03673670|454186939|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
126244534|NCT03673670|454186940|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
126244535|NCT03673670|454186941|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
126244536|NCT03673670|454186942|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
126244537|NCT03673670|454186937|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
126244538|NCT03673670|454186938|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
126244539|NCT03673670|454186939|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
126244540|NCT03673670|454186940|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
126244541|NCT03673670|454186941|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
126244542|NCT03673670|454186942|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
126244543|NCT03673670|454186937|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
126244544|NCT03673670|454186938|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
126244545|NCT03673670|454186939|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
126761269|NCT02708524|456077191|FG001|Overall Study|Lens Discomfort|0|||
126244546|NCT03673670|454186940|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
126244547|NCT03673670|454186941|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
126244548|NCT03673670|454186942|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
126244549|NCT03673670|454186937|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
126244550|NCT03673670|454186938|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
126244551|NCT03673670|454186939|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
126244552|NCT03673670|454186940|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
126244553|NCT03673670|454186941|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
126244554|NCT03673670|454186942|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
126244555|NCT03673670|454186937|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
126244556|NCT03673670|454186938|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
126244557|NCT03673670|454186939|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
126244558|NCT03673670|454186940|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
126244559|NCT03673670|454186941|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
126244560|NCT03673670|454186942|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
126244561|NCT03673670|454186937|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
126244562|NCT03673670|454186938|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
126244563|NCT03673670|454186939|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
126244564|NCT03673670|454186940|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
126244565|NCT03673670|454186941|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
126244566|NCT03673670|454186942|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
126244567|NCT04408794|454186943|FG000|Overall Study|Adverse Event|43|||
126244568|NCT04408794|454186943|FG000|Overall Study|Infrequent study drug usage|43|||
126244569|NCT04408794|454186943|FG000|Overall Study|Lack of Efficacy|61|||
126244570|NCT04408794|454186943|FG000|Overall Study|Lost to Follow-up|33|||
126244571|NCT04408794|454186943|FG000|Overall Study|Non-compliance|6|||
126244572|NCT04408794|454186943|FG000|Overall Study|Physician Decision|1|||
126244573|NCT04408794|454186943|FG000|Overall Study|Pregnancy|6|||
126244574|NCT04408794|454186943|FG000|Overall Study|Protocol Deviation|9|||
126244575|NCT04408794|454186943|FG000|Overall Study|Sheehan-STS Result|1|||
126244576|NCT04408794|454186943|FG000|Overall Study|Withdrawal by Subject|57|||
126244577|NCT04408794|454186943|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
126244578|NCT04408794|454186943|FG000|Overall Study|Never Treated Migraine|5|||
126244579|NCT04238754|454186948|FG000|Washout - 1 Week|Lost to Follow-up|1|||
126244580|NCT04238754|454186949|FG001|Washout - 1 Week|Lost to Follow-up|0|||
126244581|NCT01518972|454186953|FG000|Overall Study|Lost to Follow-up|2|||
126244582|NCT01518972|454186954|FG001|Overall Study|Lost to Follow-up|1|||
126244583|NCT01518972|454186953|FG000|Overall Study|Withdrawal by Subject|1|||
126244584|NCT01518972|454186954|FG001|Overall Study|Withdrawal by Subject|0|||
126244585|NCT01518972|454186953|FG000|Overall Study|Moved from area|1|||
126244586|NCT01518972|454186954|FG001|Overall Study|Moved from area|0|||
126244587|NCT01518972|454186953|FG000|Overall Study|Transportation problems|1|||
126244588|NCT01518972|454186954|FG001|Overall Study|Transportation problems|0|||
126761270|NCT02708524|456077192|FG002|Overall Study|Lens Discomfort|1|||
126761271|NCT02708524|456077193|FG003|Overall Study|Lens Discomfort|0|||
126244589|NCT01518972|454186953|FG000|Overall Study|Exclusionary medical condition|1|||
126244590|NCT01518972|454186954|FG001|Overall Study|Exclusionary medical condition|0|||
126244591|NCT01518972|454186953|FG000|Overall Study|Missed safety visits|0|||
126244592|NCT01518972|454186954|FG001|Overall Study|Missed safety visits|1|||
126244593|NCT01518972|454186953|FG000|Overall Study|Exclusionary medication|0|||
126244594|NCT01518972|454186954|FG001|Overall Study|Exclusionary medication|1|||
126244595|NCT01518972|454186953|FG000|Overall Study|Declined medication starting on day 12|0|||
126244596|NCT01518972|454186954|FG001|Overall Study|Declined medication starting on day 12|1|||
126244597|NCT00556322|454186956|FG000|Overall Study|Insufficient therapeutic response|158|||
126244598|NCT00556322|454186957|FG001|Overall Study|Insufficient therapeutic response|168|||
126244599|NCT00556322|454186956|FG000|Overall Study|Adverse Event|7|||
126244600|NCT00556322|454186957|FG001|Overall Study|Adverse Event|4|||
126761272|NCT02708524|456077190|FG000|Overall Study|Lost to Follow-up|1|||
126244601|NCT00556322|454186956|FG000|Overall Study|Other|4|||
126244602|NCT00556322|454186957|FG001|Overall Study|Other|1|||
126244603|NCT00556322|454186956|FG000|Overall Study|Lost to Follow-up|5|||
126244604|NCT00556322|454186957|FG001|Overall Study|Lost to Follow-up|3|||
126244605|NCT00556322|454186956|FG000|Overall Study|Withdrawal by Subject|19|||
126244606|NCT00556322|454186957|FG001|Overall Study|Withdrawal by Subject|7|||
126244607|NCT00556322|454186956|FG000|Overall Study|Protocol Violation|5|||
126244608|NCT00556322|454186957|FG001|Overall Study|Protocol Violation|1|||
126244609|NCT00556322|454186956|FG000|Overall Study|Ongoing at data cutoff|3|||
126244610|NCT00556322|454186957|FG001|Overall Study|Ongoing at data cutoff|5|||
126244611|NCT00556322|454186956|FG000|Overall Study|Death|20|||
126244612|NCT00556322|454186957|FG001|Overall Study|Death|14|||
126244613|NCT03733444|454186958|FG000|Overall Study|Adverse Event|8|||
126244614|NCT03733444|454186959|FG001|Overall Study|Adverse Event|10|||
126447630|NCT02923921|454939501|FG001|Overall Study|Unknown, Not Collected|6|||
126447631|NCT02741518|454939504|FG000|Overall Study|Withdrawal by Subject|1|||
126447632|NCT02741518|454939505|FG001|Overall Study|Withdrawal by Subject|1|||
126447633|NCT01349049|454939506|FG000|Overall Study|Disease progression|3|||
126447634|NCT01349049|454939507|FG001|Overall Study|Disease progression|5|||
126447635|NCT01349049|454939508|FG002|Overall Study|Disease progression|3|||
126447636|NCT01349049|454939509|FG003|Overall Study|Disease progression|2|||
126447637|NCT01349049|454939510|FG004|Overall Study|Disease progression|2|||
126447638|NCT01349049|454939511|FG005|Overall Study|Disease progression|2|||
126447639|NCT01349049|454939512|FG006|Overall Study|Disease progression|3|||
126447640|NCT01349049|454939513|FG007|Overall Study|Disease progression|2|||
126447641|NCT01349049|454939514|FG008|Overall Study|Disease progression|33|||
126447642|NCT01349049|454939506|FG000|Overall Study|Adverse Event|0|||
126447643|NCT01349049|454939507|FG001|Overall Study|Adverse Event|1|||
126447644|NCT01349049|454939508|FG002|Overall Study|Adverse Event|0|||
126447645|NCT01349049|454939509|FG003|Overall Study|Adverse Event|0|||
126447646|NCT01349049|454939510|FG004|Overall Study|Adverse Event|0|||
126447647|NCT01349049|454939511|FG005|Overall Study|Adverse Event|3|||
126447648|NCT01349049|454939512|FG006|Overall Study|Adverse Event|1|||
126447649|NCT01349049|454939513|FG007|Overall Study|Adverse Event|0|||
126447650|NCT01349049|454939514|FG008|Overall Study|Adverse Event|4|||
126447651|NCT01349049|454939506|FG000|Overall Study|Physician Decision|0|||
126447652|NCT01349049|454939507|FG001|Overall Study|Physician Decision|1|||
126447653|NCT01349049|454939508|FG002|Overall Study|Physician Decision|0|||
126447654|NCT01349049|454939509|FG003|Overall Study|Physician Decision|0|||
126447655|NCT01349049|454939510|FG004|Overall Study|Physician Decision|0|||
126447656|NCT01349049|454939511|FG005|Overall Study|Physician Decision|0|||
126447657|NCT01349049|454939512|FG006|Overall Study|Physician Decision|0|||
126447658|NCT01349049|454939513|FG007|Overall Study|Physician Decision|0|||
126447659|NCT01349049|454939514|FG008|Overall Study|Physician Decision|2|||
126447660|NCT01349049|454939506|FG000|Overall Study|Protocol Violation|0|||
126447661|NCT01349049|454939507|FG001|Overall Study|Protocol Violation|0|||
126447662|NCT01349049|454939508|FG002|Overall Study|Protocol Violation|0|||
126447663|NCT01349049|454939509|FG003|Overall Study|Protocol Violation|0|||
126447664|NCT01349049|454939510|FG004|Overall Study|Protocol Violation|0|||
126447665|NCT01349049|454939511|FG005|Overall Study|Protocol Violation|0|||
126447666|NCT01349049|454939512|FG006|Overall Study|Protocol Violation|0|||
126447667|NCT01349049|454939513|FG007|Overall Study|Protocol Violation|0|||
126447668|NCT01349049|454939514|FG008|Overall Study|Protocol Violation|1|||
126447669|NCT01349049|454939506|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
126447670|NCT01349049|454939507|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
126447671|NCT01349049|454939508|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
126447672|NCT01349049|454939509|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
126447673|NCT01349049|454939510|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
126447674|NCT01349049|454939511|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
126447675|NCT01349049|454939512|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
126447676|NCT01349049|454939513|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
126447677|NCT01349049|454939514|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
126447678|NCT01349049|454939506|FG000|Overall Study|Other|0|||
126694787|NCT04722991|455836563|FG000|Overall Study|Other|1|||
126447679|NCT01349049|454939507|FG001|Overall Study|Other|0|||
126447680|NCT01349049|454939508|FG002|Overall Study|Other|0|||
126447681|NCT01349049|454939509|FG003|Overall Study|Other|0|||
126447682|NCT01349049|454939510|FG004|Overall Study|Other|0|||
126447683|NCT01349049|454939511|FG005|Overall Study|Other|1|||
126447684|NCT01349049|454939512|FG006|Overall Study|Other|0|||
126447685|NCT01349049|454939513|FG007|Overall Study|Other|0|||
126244615|NCT03733444|454186960|FG002|Overall Study|Adverse Event|5|||
126447686|NCT01349049|454939514|FG008|Overall Study|Other|4|||
126447687|NCT01349049|454939506|FG000|Overall Study|Death|0|||
126447688|NCT01349049|454939507|FG001|Overall Study|Death|0|||
126244616|NCT03733444|454186958|FG000|Overall Study|Death|20|||
126244617|NCT03733444|454186959|FG001|Overall Study|Death|19|||
126447689|NCT01349049|454939508|FG002|Overall Study|Death|0|||
126447690|NCT01349049|454939509|FG003|Overall Study|Death|0|||
126447691|NCT01349049|454939510|FG004|Overall Study|Death|0|||
126447692|NCT01349049|454939511|FG005|Overall Study|Death|0|||
126694788|NCT04722991|455836564|FG001|Overall Study|Other|0|||
126694789|NCT04722991|455836563|FG000|Overall Study|Non-compliance|0|||
126694790|NCT04722991|455836564|FG001|Overall Study|Non-compliance|1|||
126694791|NCT04722991|455836563|FG000|Overall Study|Withdrawal by Subject|0|||
126694792|NCT04722991|455836564|FG001|Overall Study|Withdrawal by Subject|1|||
126694793|NCT02246621|455836567|FG000|Overall Study|Withdrawal by Subject|28|||
126694794|NCT02246621|455836568|FG001|Overall Study|Withdrawal by Subject|16|||
126694795|NCT02246621|455836567|FG000|Overall Study|Lost to Follow-up|1|||
126694796|NCT02246621|455836568|FG001|Overall Study|Lost to Follow-up|0|||
126694797|NCT02246621|455836567|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
126694798|NCT02246621|455836568|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
126694799|NCT01583374|455836569|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
126694800|NCT01583374|455836570|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
126694801|NCT01583374|455836571|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
126694802|NCT01583374|455836572|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126694803|NCT01583374|455836573|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126244618|NCT03733444|454186960|FG002|Overall Study|Death|11|||
126244619|NCT03733444|454186958|FG000|Overall Study|Lost to Follow-up|3|||
126244620|NCT03733444|454186959|FG001|Overall Study|Lost to Follow-up|0|||
126244621|NCT03733444|454186960|FG002|Overall Study|Lost to Follow-up|1|||
126244622|NCT03733444|454186958|FG000|Overall Study|Lack of Efficacy|0|||
126244623|NCT03733444|454186959|FG001|Overall Study|Lack of Efficacy|1|||
126244624|NCT03733444|454186960|FG002|Overall Study|Lack of Efficacy|1|||
126244625|NCT03733444|454186958|FG000|Overall Study|Physician Decision|2|||
126694804|NCT01583374|455836574|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126694805|NCT01583374|455836575|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126694806|NCT01583374|455836576|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126694807|NCT01583374|455836577|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126694808|NCT01583374|455836569|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
126694809|NCT01583374|455836570|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
126694810|NCT01583374|455836571|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
126694811|NCT01583374|455836572|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126694812|NCT01583374|455836573|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126694813|NCT01583374|455836574|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126694814|NCT01583374|455836575|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126694815|NCT01583374|455836576|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126694816|NCT01583374|455836577|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126694817|NCT01583374|455836569|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
126694818|NCT01583374|455836570|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
126694819|NCT01583374|455836571|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126694820|NCT01583374|455836572|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126694821|NCT01583374|455836573|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126694822|NCT01583374|455836574|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126694823|NCT01583374|455836575|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126694824|NCT01583374|455836576|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126694825|NCT01583374|455836577|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126694826|NCT01583374|455836569|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
126694827|NCT01583374|455836570|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
126694828|NCT01583374|455836571|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
126694829|NCT01583374|455836572|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126694830|NCT01583374|455836573|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126694831|NCT01583374|455836574|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126694832|NCT01583374|455836575|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126694833|NCT01583374|455836576|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126694834|NCT01583374|455836577|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126694835|NCT01583374|455836569|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
126694836|NCT01583374|455836570|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
126244626|NCT03733444|454186959|FG001|Overall Study|Physician Decision|1|||
126244627|NCT03733444|454186960|FG002|Overall Study|Physician Decision|0|||
126244628|NCT03733444|454186958|FG000|Overall Study|Protocol Violation|2|||
126244629|NCT03733444|454186959|FG001|Overall Study|Protocol Violation|1|||
126244630|NCT03733444|454186960|FG002|Overall Study|Protocol Violation|0|||
126244631|NCT03733444|454186958|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
126694837|NCT01583374|455836571|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126357505|NCT01851369|454602119|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126244632|NCT03733444|454186959|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
126244633|NCT03733444|454186960|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
126447693|NCT01349049|454939512|FG006|Overall Study|Death|0|||
126244634|NCT03733444|454186958|FG000|Overall Study|Study Terminated by Sponsor|203|||
126244635|NCT03733444|454186959|FG001|Overall Study|Study Terminated by Sponsor|209|||
126244636|NCT03733444|454186960|FG002|Overall Study|Study Terminated by Sponsor|221|||
126244637|NCT03733444|454186958|FG000|Overall Study|Withdrawal by Subject|19|||
126244638|NCT03733444|454186959|FG001|Overall Study|Withdrawal by Subject|18|||
126244639|NCT03733444|454186960|FG002|Overall Study|Withdrawal by Subject|16|||
126244640|NCT03733444|454186958|FG000|Overall Study|Miscellaneous|1|||
126244641|NCT03733444|454186959|FG001|Overall Study|Miscellaneous|0|||
126244642|NCT03733444|454186960|FG002|Overall Study|Miscellaneous|1|||
126244643|NCT03733444|454186958|FG000|Overall Study|Not Treated|1|||
126244644|NCT03733444|454186959|FG001|Overall Study|Not Treated|2|||
126244645|NCT03733444|454186960|FG002|Overall Study|Not Treated|1|||
126244646|NCT01788423|454186961|FG000|Overall Study|See Comments in Completed (above)|0|||
126244647|NCT01788423|454186962|FG001|Overall Study|See Comments in Completed (above)|4|||
126244648|NCT01788423|454186963|FG002|Overall Study|See Comments in Completed (above)|5|||
126244649|NCT03637764|454186964|FG000|Overall Study|Adverse Event|2|||
126244650|NCT03637764|454186965|FG001|Overall Study|Adverse Event|0|||
126244651|NCT03637764|454186966|FG002|Overall Study|Adverse Event|0|||
126244652|NCT03637764|454186967|FG003|Overall Study|Adverse Event|1|||
126244653|NCT03637764|454186964|FG000|Overall Study|Progressive Disease|23|||
126244654|NCT03637764|454186965|FG001|Overall Study|Progressive Disease|23|||
126244655|NCT03637764|454186966|FG002|Overall Study|Progressive Disease|18|||
126244656|NCT03637764|454186967|FG003|Overall Study|Progressive Disease|31|||
126244657|NCT03637764|454186964|FG000|Overall Study|Withdrawal by Subject|1|||
126244658|NCT03637764|454186965|FG001|Overall Study|Withdrawal by Subject|3|||
126244659|NCT03637764|454186966|FG002|Overall Study|Withdrawal by Subject|0|||
126244660|NCT03637764|454186967|FG003|Overall Study|Withdrawal by Subject|1|||
126244661|NCT02760927|454186972|FG000|Overall Study|Tube Slippage from Device|1|||
126244662|NCT02105272|454186973|FG000|Overall Study|Adverse Event|1|||
126244663|NCT02105272|454186974|FG001|Overall Study|Adverse Event|2|||
126244664|NCT02105272|454186973|FG000|Overall Study|Physician Decision|0|||
126244665|NCT02105272|454186974|FG001|Overall Study|Physician Decision|1|||
126244666|NCT02105272|454186973|FG000|Overall Study|Protocol Violation|2|||
126244667|NCT02105272|454186974|FG001|Overall Study|Protocol Violation|0|||
126244668|NCT02105272|454186973|FG000|Overall Study|Withdrawal by Subject|2|||
126244669|NCT02105272|454186974|FG001|Overall Study|Withdrawal by Subject|0|||
126244670|NCT03190915|454186976|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
126244671|NCT03190915|454186976|FG000|Overall Study|Progressive Disease|3|||
126244672|NCT02964039|454186977|FG000|Overall Study|Medical reason unrelated to study participation|1|||
126244673|NCT02964039|454186978|FG001|Overall Study|Medical reason unrelated to study participation|0|||
126244674|NCT02964039|454186979|FG002|Overall Study|Medical reason unrelated to study participation|3|||
126244675|NCT02964039|454186977|FG000|Overall Study|Research shutdown due to pandemic|2|||
126244676|NCT02964039|454186978|FG001|Overall Study|Research shutdown due to pandemic|0|||
126244677|NCT02964039|454186979|FG002|Overall Study|Research shutdown due to pandemic|1|||
126244678|NCT02964039|454186977|FG000|Overall Study|Withdrawal by Subject|0|||
126244679|NCT02964039|454186978|FG001|Overall Study|Withdrawal by Subject|1|||
126244680|NCT02964039|454186979|FG002|Overall Study|Withdrawal by Subject|0|||
126244681|NCT02964039|454186977|FG000|Overall Study|Lost to Follow-up|1|||
126244682|NCT02964039|454186978|FG001|Overall Study|Lost to Follow-up|0|||
126244683|NCT02964039|454186979|FG002|Overall Study|Lost to Follow-up|1|||
126244684|NCT01103713|454186983|FG000|Overall Study|Lost to Follow-up|2|||
126244685|NCT01103713|454186983|FG000|Overall Study|Withdrawal by Subject|8|||
126244686|NCT01103713|454186983|FG000|Overall Study|Study terminated by sponsor|2|||
126244687|NCT01103713|454186983|FG000|Overall Study|Other|1|||
126244688|NCT03084471|454186988|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
126244689|NCT03084471|454186988|FG000|Overall Study|Condition under investigation worsened|84|||
126244690|NCT03084471|454186988|FG000|Overall Study|Lack of therapeutic response|2|||
126244691|NCT03084471|454186988|FG000|Overall Study|Protocol Violation|1|||
126244692|NCT03084471|454186988|FG000|Overall Study|Adverse Event|73|||
126244693|NCT03084471|454186988|FG000|Overall Study|Withdrawal by Subject|12|||
126244694|NCT03084471|454186988|FG000|Overall Study|Disease relapse|181|||
126244695|NCT03084471|454186988|FG000|Overall Study|Subjective disease progression|359|||
126244696|NCT03084471|454186988|FG000|Overall Study|Other (as recorded)|33|||
126357506|NCT01851369|454602120|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357507|NCT01851369|454602121|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
126357508|NCT01851369|454602122|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357509|NCT01851369|454602123|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357510|NCT01851369|454602124|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126369556|NCT01497197|454650596|FG000|Overall Study|Excessive/lack of response to treatment|1|||
126761273|NCT02708524|456077191|FG001|Overall Study|Lost to Follow-up|1|||
126244697|NCT03084471|454186988|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
126244698|NCT00505622|454186989|FG000|Overall Study|Adverse Event|5|||
126244699|NCT00505622|454186990|FG001|Overall Study|Adverse Event|6|||
126244700|NCT00505622|454186991|FG002|Overall Study|Adverse Event|4|||
126545734|NCT04867785|455292433|FG007|Overall Study|Lost to Follow-up|1|||
126545735|NCT04867785|455292426|FG000|Overall Study|Withdrawal by Subject|6|||
126545736|NCT04867785|455292427|FG001|Overall Study|Withdrawal by Subject|2|||
126545737|NCT04867785|455292428|FG002|Overall Study|Withdrawal by Subject|2|||
126545738|NCT04867785|455292429|FG003|Overall Study|Withdrawal by Subject|1|||
126545739|NCT04867785|455292430|FG004|Overall Study|Withdrawal by Subject|2|||
126545740|NCT04867785|455292431|FG005|Overall Study|Withdrawal by Subject|0|||
126545741|NCT04867785|455292432|FG006|Overall Study|Withdrawal by Subject|2|||
126545742|NCT04867785|455292433|FG007|Overall Study|Withdrawal by Subject|5|||
126545743|NCT04867785|455292426|FG000|Overall Study|Physician Decision|0|||
126545744|NCT04867785|455292427|FG001|Overall Study|Physician Decision|0|||
126545745|NCT04867785|455292428|FG002|Overall Study|Physician Decision|0|||
126545746|NCT04867785|455292429|FG003|Overall Study|Physician Decision|0|||
126545747|NCT04867785|455292430|FG004|Overall Study|Physician Decision|0|||
126545748|NCT04867785|455292431|FG005|Overall Study|Physician Decision|0|||
126545749|NCT04867785|455292432|FG006|Overall Study|Physician Decision|0|||
126545750|NCT04867785|455292433|FG007|Overall Study|Physician Decision|1|||
126545751|NCT04867785|455292426|FG000|Overall Study|Inadvertent Enrollment|0|||
126545752|NCT04867785|455292427|FG001|Overall Study|Inadvertent Enrollment|0|||
126545753|NCT04867785|455292428|FG002|Overall Study|Inadvertent Enrollment|0|||
126545754|NCT04867785|455292429|FG003|Overall Study|Inadvertent Enrollment|1|||
126545755|NCT04867785|455292430|FG004|Overall Study|Inadvertent Enrollment|1|||
126545756|NCT04867785|455292431|FG005|Overall Study|Inadvertent Enrollment|0|||
126545757|NCT04867785|455292432|FG006|Overall Study|Inadvertent Enrollment|0|||
126545758|NCT04867785|455292433|FG007|Overall Study|Inadvertent Enrollment|1|||
126545759|NCT04867785|455292426|FG000|Overall Study|Eligibility Criteria Not Met|0|||
126545760|NCT04867785|455292427|FG001|Overall Study|Eligibility Criteria Not Met|0|||
126545761|NCT04867785|455292428|FG002|Overall Study|Eligibility Criteria Not Met|0|||
126545762|NCT04867785|455292429|FG003|Overall Study|Eligibility Criteria Not Met|0|||
126545763|NCT04867785|455292430|FG004|Overall Study|Eligibility Criteria Not Met|0|||
126545764|NCT04867785|455292431|FG005|Overall Study|Eligibility Criteria Not Met|0|||
126545765|NCT04867785|455292432|FG006|Overall Study|Eligibility Criteria Not Met|0|||
126545766|NCT04867785|455292433|FG007|Overall Study|Eligibility Criteria Not Met|1|||
126545767|NCT01289041|455292434|FG000|Overall Study|Adverse Event|24|||
126545768|NCT01289041|455292434|FG000|Overall Study|Physician Decision|1|||
126545769|NCT01289041|455292434|FG000|Overall Study|Progressive Disease|41|||
126545770|NCT01289041|455292434|FG000|Overall Study|Withdrawal by Subject|3|||
126545771|NCT01289041|455292434|FG000|Overall Study|Death|1|||
126545772|NCT03239873|455292441|FG000|Overall Study|Lost to Follow-up|15|||
126545773|NCT03239873|455292442|FG001|Overall Study|Lost to Follow-up|16|||
126545774|NCT03239873|455292441|FG000|Overall Study|Physician Decision|1|||
126545775|NCT03239873|455292442|FG001|Overall Study|Physician Decision|0|||
126545776|NCT03239873|455292441|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
126545777|NCT03239873|455292442|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
126545778|NCT03239873|455292441|FG000|Overall Study|Withdrawal by Subject|2|||
126545779|NCT03239873|455292442|FG001|Overall Study|Withdrawal by Subject|0|||
126545780|NCT03239873|455292441|FG000|Overall Study|Contraindication to study medication|1|||
126545781|NCT03239873|455292442|FG001|Overall Study|Contraindication to study medication|0|||
126545782|NCT03239873|455292441|FG000|Overall Study|Protocol Violation|1|||
126545783|NCT03239873|455292442|FG001|Overall Study|Protocol Violation|0|||
126545784|NCT00605319|455292447|FG000|Overall Study|Adverse Event|6|||
126545785|NCT01250119|455292448|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
126545786|NCT01250119|455292449|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
126545787|NCT01250119|455292448|FG000|Diagnostic Phase|Participants Not Tested|44|||
126545788|NCT01250119|455292449|FG001|Diagnostic Phase|Participants Not Tested|0|||
126545789|NCT01250119|455292448|FG000|Treatment Phase|Progressive Disease|0|||
126545790|NCT01250119|455292449|FG001|Treatment Phase|Progressive Disease|32|||
126545791|NCT01250119|455292448|FG000|Treatment Phase|Death|0|||
126545792|NCT01250119|455292449|FG001|Treatment Phase|Death|2|||
126545793|NCT01250119|455292448|FG000|Treatment Phase|Withdrawal by Subject|0|||
126244701|NCT00505622|454186989|FG000|Overall Study|Protocol Violation|1|||
126244702|NCT00505622|454186990|FG001|Overall Study|Protocol Violation|1|||
126545794|NCT01250119|455292449|FG001|Treatment Phase|Withdrawal by Subject|1|||
126545795|NCT01250119|455292448|FG000|Treatment Phase|Adverse Event|0|||
126545796|NCT01250119|455292449|FG001|Treatment Phase|Adverse Event|2|||
126545797|NCT01250119|455292448|FG000|Treatment Phase|Unknown reason|0|||
126545798|NCT01250119|455292449|FG001|Treatment Phase|Unknown reason|4|||
126244703|NCT00505622|454186991|FG002|Overall Study|Protocol Violation|0|||
126244704|NCT00505622|454186989|FG000|Overall Study|Withdrawal by Subject|0|||
126545799|NCT02670538|455292450|FG000|Overall Study|Withdrawal of Consent|8|||
126545800|NCT02670538|455292451|FG001|Overall Study|Withdrawal of Consent|6|||
126244705|NCT00505622|454186990|FG001|Overall Study|Withdrawal by Subject|3|||
126545801|NCT02670538|455292452|FG002|Overall Study|Withdrawal of Consent|5|||
126545802|NCT02670538|455292450|FG000|Overall Study|Lost to Follow-up|8|||
126545803|NCT02670538|455292451|FG001|Overall Study|Lost to Follow-up|12|||
126545804|NCT02670538|455292452|FG002|Overall Study|Lost to Follow-up|7|||
126545805|NCT02670538|455292450|FG000|Overall Study|Adverse Event|5|||
126694838|NCT01583374|455836572|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126694839|NCT01583374|455836573|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126244706|NCT00505622|454186991|FG002|Overall Study|Withdrawal by Subject|2|||
126244707|NCT00505622|454186989|FG000|Overall Study|Study termination by sponsor|115|||
126244708|NCT00505622|454186990|FG001|Overall Study|Study termination by sponsor|98|||
126244709|NCT00505622|454186991|FG002|Overall Study|Study termination by sponsor|90|||
126244710|NCT01757392|454186994|FG000|Overall Study|Withdrawal by Subject|1|||
126244711|NCT01757392|454186994|FG000|Overall Study|Screen Fail|3|||
126545806|NCT02670538|455292451|FG001|Overall Study|Adverse Event|5|||
126545807|NCT02670538|455292452|FG002|Overall Study|Adverse Event|11|||
126545808|NCT02670538|455292450|FG000|Overall Study|Lack of Efficacy|7|||
126545809|NCT02670538|455292451|FG001|Overall Study|Lack of Efficacy|1|||
126545810|NCT02670538|455292452|FG002|Overall Study|Lack of Efficacy|2|||
126545811|NCT02670538|455292450|FG000|Overall Study|Protocol Violation|3|||
126545812|NCT02670538|455292451|FG001|Overall Study|Protocol Violation|4|||
126545813|NCT02670538|455292452|FG002|Overall Study|Protocol Violation|1|||
126545814|NCT02670538|455292450|FG000|Overall Study|Noncompliance with Study Drug|1|||
126545815|NCT02670538|455292451|FG001|Overall Study|Noncompliance with Study Drug|3|||
126545816|NCT02670538|455292452|FG002|Overall Study|Noncompliance with Study Drug|2|||
126545817|NCT02670538|455292450|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126545818|NCT02670538|455292451|FG001|Overall Study|Other Miscellaneous Reasons|1|||
126545819|NCT02670538|455292452|FG002|Overall Study|Other Miscellaneous Reasons|2|||
126545820|NCT02887989|455292456|FG000|Overall Study|Withdrawal by Subject|8|||
126545821|NCT02887989|455292457|FG001|Overall Study|Withdrawal by Subject|11|||
126545822|NCT02887989|455292456|FG000|Overall Study|Death|1|||
126545823|NCT02887989|455292457|FG001|Overall Study|Death|0|||
126545824|NCT00674323|455292458|FG000|Overall Study|Adverse Event|0|||
126545825|NCT00674323|455292459|FG001|Overall Study|Adverse Event|1|||
126545826|NCT00674323|455292460|FG002|Overall Study|Adverse Event|0|||
126545827|NCT00674323|455292458|FG000|Overall Study|Protocol Violation|1|||
126545828|NCT00674323|455292459|FG001|Overall Study|Protocol Violation|0|||
126545829|NCT00674323|455292460|FG002|Overall Study|Protocol Violation|0|||
126545830|NCT02045433|455292467|FG000|Overall Study|Withdrawal by Subject|1|||
126545831|NCT01112514|455292468|FG000|Overall Study|Lost to Follow-up|1|||
126545832|NCT02176421|455292469|FG000|Overall Study|Lost to Follow-up|4|||
126545833|NCT02176421|455292469|FG000|Overall Study|Adverse Event|1|||
126545834|NCT02145078|455292472|FG000|Overall Study|Death|1|||
126545835|NCT02145078|455292472|FG000|Overall Study|Reason not given|3|||
126545836|NCT02440594|455292476|FG000|Overall Study|Lost to Follow-up|34|||
126545837|NCT02440594|455292477|FG001|Overall Study|Lost to Follow-up|33|||
126545838|NCT02440594|455292478|FG002|Overall Study|Lost to Follow-up|54|||
126545839|NCT02440594|455292479|FG003|Overall Study|Lost to Follow-up|47|||
126545840|NCT02440594|455292480|FG004|Overall Study|Lost to Follow-up|5|||
126545841|NCT02440594|455292481|FG005|Overall Study|Lost to Follow-up|4|||
126545842|NCT02440594|455292482|FG006|Overall Study|Lost to Follow-up|28|||
126545843|NCT02440594|455292483|FG007|Overall Study|Lost to Follow-up|48|||
126545844|NCT02440594|455292476|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
126545845|NCT02440594|455292477|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
126545846|NCT02440594|455292478|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
126545847|NCT02440594|455292479|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
126545848|NCT02440594|455292480|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
126545849|NCT02440594|455292481|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
126545850|NCT02440594|455292482|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
126545851|NCT02440594|455292483|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
126545852|NCT02440594|455292476|FG000|Overall Study|Withdrawal by Subject|81|||
126694840|NCT01583374|455836574|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126694841|NCT01583374|455836575|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126694842|NCT01583374|455836576|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126694843|NCT01583374|455836577|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
126694844|NCT01583374|455836569|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126694845|NCT01583374|455836570|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126244712|NCT00811655|454187000|FG000|Overall Study|Physician Decision|1|||
126244713|NCT00813592|454187001|FG000|Overall Study|Disease assessment was not completed per|2|||
126244714|NCT03801707|454187006|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
126694846|NCT01583374|455836571|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
126244715|NCT03873272|454187007|FG000|Overall Study|Withdrawal by Subject|2|||
126545853|NCT02440594|455292477|FG001|Overall Study|Withdrawal by Subject|67|||
126244716|NCT03873272|454187008|FG001|Overall Study|Withdrawal by Subject|0|||
126545854|NCT02440594|455292478|FG002|Overall Study|Withdrawal by Subject|59|||
126545855|NCT02440594|455292479|FG003|Overall Study|Withdrawal by Subject|38|||
126545856|NCT02440594|455292480|FG004|Overall Study|Withdrawal by Subject|2|||
126545857|NCT02440594|455292481|FG005|Overall Study|Withdrawal by Subject|2|||
126545858|NCT02440594|455292482|FG006|Overall Study|Withdrawal by Subject|7|||
126545859|NCT02440594|455292483|FG007|Overall Study|Withdrawal by Subject|7|||
126244717|NCT03873272|454187009|FG002|Overall Study|Withdrawal by Subject|1|||
126244718|NCT03873272|454187007|FG000|Overall Study|Death|0|||
126244719|NCT03873272|454187008|FG001|Overall Study|Death|2|||
126244720|NCT03873272|454187009|FG002|Overall Study|Death|1|||
126244721|NCT04852978|454187015|FG000|Overall Study|Physician Decision|0|||
126244722|NCT04852978|454187016|FG001|Overall Study|Physician Decision|1|||
126244723|NCT04852978|454187017|FG002|Overall Study|Physician Decision|0|||
126244724|NCT04852978|454187018|FG003|Overall Study|Physician Decision|0|||
126244725|NCT04852978|454187019|FG004|Overall Study|Physician Decision|0|||
126244726|NCT04852978|454187020|FG005|Overall Study|Physician Decision|0|||
126244727|NCT04852978|454187021|FG006|Overall Study|Physician Decision|0|||
126244728|NCT04852978|454187022|FG007|Overall Study|Physician Decision|2|||
126244729|NCT04852978|454187023|FG008|Overall Study|Physician Decision|0|||
126244730|NCT04852978|454187015|FG000|Overall Study|Sponsor request|0|||
126244731|NCT04852978|454187016|FG001|Overall Study|Sponsor request|0|||
126244732|NCT04852978|454187017|FG002|Overall Study|Sponsor request|1|||
126244733|NCT04852978|454187018|FG003|Overall Study|Sponsor request|0|||
126244734|NCT04852978|454187019|FG004|Overall Study|Sponsor request|0|||
126244735|NCT04852978|454187020|FG005|Overall Study|Sponsor request|0|||
126244736|NCT04852978|454187021|FG006|Overall Study|Sponsor request|0|||
126244737|NCT04852978|454187022|FG007|Overall Study|Sponsor request|0|||
126244738|NCT04852978|454187023|FG008|Overall Study|Sponsor request|0|||
126244739|NCT04852978|454187015|FG000|Overall Study|Death|0|||
126244740|NCT04852978|454187016|FG001|Overall Study|Death|0|||
126694847|NCT01583374|455836572|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126694848|NCT01583374|455836573|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126694849|NCT01583374|455836574|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126694850|NCT01583374|455836575|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126694851|NCT01583374|455836576|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126694852|NCT01583374|455836577|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126694853|NCT01583374|455836569|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
126244741|NCT04852978|454187017|FG002|Overall Study|Death|0|||
126244742|NCT04852978|454187018|FG003|Overall Study|Death|0|||
126244743|NCT04852978|454187019|FG004|Overall Study|Death|0|||
126244744|NCT04852978|454187020|FG005|Overall Study|Death|0|||
126244745|NCT04852978|454187021|FG006|Overall Study|Death|1|||
126244746|NCT04852978|454187022|FG007|Overall Study|Death|0|||
126244747|NCT04852978|454187023|FG008|Overall Study|Death|0|||
126244748|NCT04852978|454187015|FG000|Overall Study|Lost to Follow-up|3|||
126244749|NCT04852978|454187016|FG001|Overall Study|Lost to Follow-up|2|||
126244750|NCT04852978|454187017|FG002|Overall Study|Lost to Follow-up|2|||
126244751|NCT04852978|454187018|FG003|Overall Study|Lost to Follow-up|0|||
126244752|NCT04852978|454187019|FG004|Overall Study|Lost to Follow-up|2|||
126244753|NCT04852978|454187020|FG005|Overall Study|Lost to Follow-up|4|||
126244754|NCT04852978|454187021|FG006|Overall Study|Lost to Follow-up|1|||
126244755|NCT04852978|454187022|FG007|Overall Study|Lost to Follow-up|2|||
126244756|NCT04852978|454187023|FG008|Overall Study|Lost to Follow-up|2|||
126244757|NCT04852978|454187015|FG000|Overall Study|Withdrawal by Subject|4|||
126244758|NCT04852978|454187016|FG001|Overall Study|Withdrawal by Subject|2|||
126244759|NCT04852978|454187017|FG002|Overall Study|Withdrawal by Subject|2|||
126244760|NCT04852978|454187018|FG003|Overall Study|Withdrawal by Subject|1|||
126244761|NCT04852978|454187019|FG004|Overall Study|Withdrawal by Subject|5|||
126244762|NCT04852978|454187020|FG005|Overall Study|Withdrawal by Subject|3|||
126244763|NCT04852978|454187021|FG006|Overall Study|Withdrawal by Subject|2|||
126244764|NCT04852978|454187022|FG007|Overall Study|Withdrawal by Subject|2|||
126244765|NCT04852978|454187023|FG008|Overall Study|Withdrawal by Subject|1|||
126244766|NCT00859430|454187024|FG000|First Intervention|Withdrawal by Subject|0|||
126244767|NCT00859430|454187025|FG001|First Intervention|Withdrawal by Subject|1|||
126244768|NCT04115293|454189267|FG000|Overall Study|Adverse Event|0|||
126694854|NCT01583374|455836570|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
126694855|NCT01583374|455836571|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
126244769|NCT04115293|454189268|FG001|Overall Study|Adverse Event|2|||
126244770|NCT04115293|454189267|FG000|Overall Study|Withdrawal by Subject|2|||
126244771|NCT04115293|454189268|FG001|Overall Study|Withdrawal by Subject|1|||
126244772|NCT04115293|454189267|FG000|Overall Study|Physician Decision|1|||
126244773|NCT04115293|454189268|FG001|Overall Study|Physician Decision|0|||
126244774|NCT04115293|454189267|FG000|Overall Study|Death|1|||
126244775|NCT04115293|454189268|FG001|Overall Study|Death|1|||
126244776|NCT00001703|454189269|FG000|Overall Study|progressed disease|2|||
126244777|NCT00001703|454189269|FG000|Overall Study|No evidence of disease|1|||
126761274|NCT02708524|456077192|FG002|Overall Study|Lost to Follow-up|1|||
126244778|NCT00001703|454189269|FG000|Overall Study|recurrent disease|2|||
126244779|NCT02057835|454189270|FG000|Overall Study|Withdrawal by Subject|0|||
126244780|NCT02057835|454189271|FG001|Overall Study|Withdrawal by Subject|2|||
126244781|NCT02057835|454189272|FG002|Overall Study|Withdrawal by Subject|0|||
126244782|NCT02057835|454189273|FG003|Overall Study|Withdrawal by Subject|0|||
126244783|NCT02057835|454189274|FG004|Overall Study|Withdrawal by Subject|0|||
126244784|NCT02057835|454189275|FG005|Overall Study|Withdrawal by Subject|0|||
126244785|NCT02057835|454189276|FG006|Overall Study|Withdrawal by Subject|0|||
126761275|NCT02708524|456077193|FG003|Overall Study|Lost to Follow-up|0|||
126244786|NCT02057835|454189277|FG007|Overall Study|Withdrawal by Subject|0|||
126244787|NCT02057835|454189278|FG008|Overall Study|Withdrawal by Subject|0|||
126244788|NCT02057835|454189279|FG009|Overall Study|Withdrawal by Subject|0|||
126244789|NCT00712959|454189283|FG000|Overall Study|Protocol Violation|3|||
126244790|NCT00712959|454189284|FG001|Overall Study|Protocol Violation|1|||
126244791|NCT00712959|454189283|FG000|Overall Study|Lost to Follow-up|13|||
126244792|NCT00712959|454189284|FG001|Overall Study|Lost to Follow-up|2|||
126244793|NCT00712959|454189283|FG000|Overall Study|Withdrawal by Subject|3|||
126244794|NCT00712959|454189284|FG001|Overall Study|Withdrawal by Subject|0|||
126244795|NCT01531894|454189289|FG000|Overall Study|Physician Decision|8|||
126244796|NCT01531894|454189289|FG000|Overall Study|Death|1|||
126244797|NCT01440803|454189290|FG000|Overall Study|Met study stopping rule|2|||
126244798|NCT01440803|454189291|FG001|Overall Study|Met study stopping rule|1|||
126244799|NCT01440803|454189290|FG000|Overall Study|Lost to Follow-up|0|||
126244800|NCT01440803|454189291|FG001|Overall Study|Lost to Follow-up|2|||
126244801|NCT01440803|454189290|FG000|Overall Study|Withdrawal by Subject|0|||
126244802|NCT01440803|454189291|FG001|Overall Study|Withdrawal by Subject|1|||
126244803|NCT02125461|454189296|FG000|Overall Study|Withdrawal by Subject|30|||
126244804|NCT02125461|454189297|FG001|Overall Study|Withdrawal by Subject|16|||
126244805|NCT02125461|454189296|FG000|Overall Study|Lost to Follow-up|8|||
126244806|NCT02125461|454189297|FG001|Overall Study|Lost to Follow-up|3|||
126244807|NCT02125461|454189296|FG000|Overall Study|Death|260|||
126244808|NCT02125461|454189297|FG001|Overall Study|Death|149|||
126244809|NCT02125461|454189296|FG000|Overall Study|Missing Termination Reason|0|||
126244810|NCT02125461|454189297|FG001|Overall Study|Missing Termination Reason|1|||
126244811|NCT01244620|454189301|FG000|Overall Study|Study terminated|4|||
126244812|NCT01244620|454189302|FG001|Overall Study|Study terminated|4|||
126244813|NCT01244620|454189303|FG002|Overall Study|Study terminated|4|||
126244814|NCT01244620|454189304|FG003|Overall Study|Study terminated|4|||
126244815|NCT01663233|454189306|FG000|Overall Study|Withdrawal by Subject|3|||
126244816|NCT01663233|454189307|FG001|Overall Study|Withdrawal by Subject|2|||
126244817|NCT01663233|454189306|FG000|Overall Study|Protocol Deviation|1|||
126244818|NCT01663233|454189307|FG001|Overall Study|Protocol Deviation|4|||
126244819|NCT01663233|454189306|FG000|Overall Study|Lost to Follow-up|0|||
126244820|NCT01663233|454189307|FG001|Overall Study|Lost to Follow-up|1|||
126244821|NCT02321098|454189308|FG000|12 Weeks Treament|Lost to Follow-up|1|||
126244822|NCT02321098|454189309|FG001|12 Weeks Treament|Lost to Follow-up|1|||
126244823|NCT02321098|454189310|FG002|12 Weeks Treament|Lost to Follow-up|0|||
126244824|NCT02321098|454189308|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
126244825|NCT02321098|454189309|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
126244826|NCT02321098|454189310|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
126244827|NCT02321098|454189308|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
126244828|NCT02321098|454189309|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
126244829|NCT02321098|454189310|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
126244830|NCT02321098|454189308|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
126244831|NCT02321098|454189309|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
126244832|NCT02321098|454189310|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
126244833|NCT05630885|454189313|FG000|Study Completion|Took prohibited medications|2|||
126244834|NCT05630885|454189314|FG001|Study Completion|Took prohibited medications|0|||
126244835|NCT05630885|454189313|FG000|Study Completion|Non-compliance with study drug|1|||
126244836|NCT05630885|454189314|FG001|Study Completion|Non-compliance with study drug|0|||
126244837|NCT05630885|454189313|FG000|Study Completion|Adverse Event|1|||
126244838|NCT05630885|454189314|FG001|Study Completion|Adverse Event|0|||
126244839|NCT05630885|454189313|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
126244840|NCT05630885|454189314|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
126244841|NCT05630885|454189313|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
126244842|NCT05630885|454189314|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
126244843|NCT01370733|454189315|FG000|Overall Study|Withdrawal by Subject|8|||
126244844|NCT01370733|454189316|FG001|Overall Study|Withdrawal by Subject|8|||
126244845|NCT01370733|454189315|FG000|Overall Study|Lost to Follow-up|3|||
126244846|NCT01370733|454189316|FG001|Overall Study|Lost to Follow-up|0|||
126244847|NCT01370733|454189315|FG000|Overall Study|Adverse Event|2|||
126244848|NCT01370733|454189316|FG001|Overall Study|Adverse Event|4|||
126244849|NCT01370733|454189315|FG000|Overall Study|Lack of Efficacy|3|||
126244850|NCT01370733|454189316|FG001|Overall Study|Lack of Efficacy|5|||
126447694|NCT01349049|454939513|FG007|Overall Study|Death|1|||
126447695|NCT01349049|454939514|FG008|Overall Study|Death|5|||
126447696|NCT01349049|454939506|FG000|Overall Study|Non-compliance|0|||
126244851|NCT01370733|454189315|FG000|Overall Study|Physician Decision|0|||
126244852|NCT01370733|454189316|FG001|Overall Study|Physician Decision|2|||
126244853|NCT01370733|454189315|FG000|Overall Study|Protocol Violation|1|||
126244854|NCT01370733|454189316|FG001|Overall Study|Protocol Violation|3|||
126244855|NCT06539676|454189317|FG000|Overall Study|Early study termination|1|||
126447697|NCT01349049|454939507|FG001|Overall Study|Non-compliance|0|||
126447698|NCT01349049|454939508|FG002|Overall Study|Non-compliance|0|||
126545860|NCT02440594|455292476|FG000|Overall Study|Administratively w/drawn|3|||
126545861|NCT02440594|455292477|FG001|Overall Study|Administratively w/drawn|2|||
126545862|NCT02440594|455292478|FG002|Overall Study|Administratively w/drawn|0|||
126545863|NCT02440594|455292479|FG003|Overall Study|Administratively w/drawn|0|||
126545864|NCT02440594|455292480|FG004|Overall Study|Administratively w/drawn|0|||
126545865|NCT02440594|455292481|FG005|Overall Study|Administratively w/drawn|0|||
126545866|NCT02440594|455292482|FG006|Overall Study|Administratively w/drawn|2|||
126545867|NCT02440594|455292483|FG007|Overall Study|Administratively w/drawn|1|||
126545868|NCT00584805|455292484|FG000|Overall Study|No longer at risk of exposure|39|||
126545869|NCT00584805|455292484|FG000|Overall Study|Relocation|36|||
126545870|NCT00584805|455292484|FG000|Overall Study|Withdrawal by Subject|18|||
126545871|NCT00584805|455292484|FG000|Overall Study|Non-compliance|1|||
126545872|NCT00584805|455292484|FG000|Overall Study|Lost to follow up|3|||
126545873|NCT00584805|455292484|FG000|Overall Study|Screen failures|2|||
126545874|NCT01993823|455292485|FG000|Overall Study|Requested by the patient|6|||
126545875|NCT01993823|455292486|FG001|Overall Study|Requested by the patient|11|||
126545876|NCT01993823|455292485|FG000|Overall Study|Protocol Violation|0|||
126545877|NCT01993823|455292486|FG001|Overall Study|Protocol Violation|1|||
126545878|NCT01993823|455292485|FG000|Overall Study|Lost to Follow-up|1|||
126545879|NCT01993823|455292486|FG001|Overall Study|Lost to Follow-up|4|||
126545880|NCT02341456|455292487|FG000|Overall Study|Disease progression|2|||
126545881|NCT02341456|455292488|FG001|Overall Study|Disease progression|3|||
126545882|NCT02341456|455292489|FG002|Overall Study|Disease progression|1|||
126545883|NCT02341456|455292487|FG000|Overall Study|Death|1|||
126545884|NCT02341456|455292488|FG001|Overall Study|Death|1|||
126545885|NCT02341456|455292489|FG002|Overall Study|Death|1|||
126545886|NCT02341456|455292487|FG000|Overall Study|Withdrawal by Subject|0|||
126545887|NCT02341456|455292488|FG001|Overall Study|Withdrawal by Subject|1|||
126545888|NCT02341456|455292489|FG002|Overall Study|Withdrawal by Subject|1|||
126244856|NCT06539676|454189318|FG001|Overall Study|Early study termination|0|||
126244857|NCT06539676|454189319|FG002|Overall Study|Early study termination|6|||
126244858|NCT02645409|454189320|FG000|Overall Study|Withdrawal by Subject|3|||
126244859|NCT02645409|454189321|FG001|Overall Study|Withdrawal by Subject|0|||
126244860|NCT02645409|454189320|FG000|Overall Study|Physician Decision|1|||
126244861|NCT02645409|454189321|FG001|Overall Study|Physician Decision|0|||
126244862|NCT03419403|454189322|FG000|Overall Study|Withdrawal by Subject|5|||
126244863|NCT03419403|454189323|FG001|Overall Study|Withdrawal by Subject|2|||
126244864|NCT03419403|454189324|FG002|Overall Study|Withdrawal by Subject|5|||
126244865|NCT03419403|454189325|FG003|Overall Study|Withdrawal by Subject|1|||
126244866|NCT03419403|454189322|FG000|Overall Study|Progressive disease (per protocol)|0|||
126244867|NCT03419403|454189323|FG001|Overall Study|Progressive disease (per protocol)|2|||
126244868|NCT03419403|454189324|FG002|Overall Study|Progressive disease (per protocol)|2|||
126244869|NCT03419403|454189325|FG003|Overall Study|Progressive disease (per protocol)|0|||
126244870|NCT03419403|454189322|FG000|Overall Study|Other, not specified|6|||
126244871|NCT03419403|454189323|FG001|Overall Study|Other, not specified|4|||
126244872|NCT03419403|454189324|FG002|Overall Study|Other, not specified|5|||
126244873|NCT03419403|454189325|FG003|Overall Study|Other, not specified|1|||
126244874|NCT03419403|454189322|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
126244875|NCT03419403|454189323|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
126244876|NCT03419403|454189324|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
126244877|NCT03419403|454189325|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
126244878|NCT02089685|454189330|FG000|Overall Study|Adverse Event|1|||
126244879|NCT02089685|454189331|FG001|Overall Study|Adverse Event|0|||
126244880|NCT02089685|454189332|FG002|Overall Study|Adverse Event|0|||
126244881|NCT02089685|454189333|FG003|Overall Study|Adverse Event|0|||
126244882|NCT02089685|454189334|FG004|Overall Study|Adverse Event|1|||
126244883|NCT02089685|454189335|FG005|Overall Study|Adverse Event|0|||
126244884|NCT02089685|454189330|FG000|Overall Study|Clinical Progression|4|||
126244885|NCT02089685|454189331|FG001|Overall Study|Clinical Progression|0|||
126244886|NCT02089685|454189332|FG002|Overall Study|Clinical Progression|0|||
126244887|NCT02089685|454189333|FG003|Overall Study|Clinical Progression|5|||
126244888|NCT02089685|454189334|FG004|Overall Study|Clinical Progression|1|||
126244889|NCT02089685|454189335|FG005|Overall Study|Clinical Progression|2|||
126244890|NCT02089685|454189330|FG000|Overall Study|Excluded Medication|1|||
126244891|NCT02089685|454189331|FG001|Overall Study|Excluded Medication|0|||
126545889|NCT02341456|455292487|FG000|Overall Study|Moved to local access programme.|0|||
126761276|NCT02708524|456077190|FG000|Overall Study|Protocol Violation|0|||
126545890|NCT02341456|455292488|FG001|Overall Study|Moved to local access programme.|1|||
126545891|NCT02341456|455292489|FG002|Overall Study|Moved to local access programme.|1|||
126545892|NCT02341456|455292487|FG000|Overall Study|Physician Decision|1|||
126545893|NCT02341456|455292488|FG001|Overall Study|Physician Decision|0|||
126244892|NCT02089685|454189332|FG002|Overall Study|Excluded Medication|0|||
126545894|NCT02341456|455292489|FG002|Overall Study|Physician Decision|0|||
126545895|NCT01872910|455292492|FG000|Overall Study|Lost to Follow-up|2|||
126545896|NCT01872910|455292493|FG001|Overall Study|Lost to Follow-up|0|||
126545897|NCT01872910|455292494|FG002|Overall Study|Lost to Follow-up|2|||
126545898|NCT01872910|455292495|FG003|Overall Study|Lost to Follow-up|0|||
126244893|NCT02089685|454189333|FG003|Overall Study|Excluded Medication|11|||
126244894|NCT02089685|454189334|FG004|Overall Study|Excluded Medication|2|||
126244895|NCT02089685|454189335|FG005|Overall Study|Excluded Medication|1|||
126244896|NCT02089685|454189330|FG000|Overall Study|Progressive disease|13|||
126244897|NCT02089685|454189331|FG001|Overall Study|Progressive disease|10|||
126244898|NCT02089685|454189332|FG002|Overall Study|Progressive disease|3|||
126244899|NCT02089685|454189333|FG003|Overall Study|Progressive disease|51|||
126244900|NCT02089685|454189334|FG004|Overall Study|Progressive disease|17|||
126244901|NCT02089685|454189335|FG005|Overall Study|Progressive disease|12|||
126244902|NCT02089685|454189330|FG000|Overall Study|Follow up ended by sponsor|2|||
126244903|NCT02089685|454189331|FG001|Overall Study|Follow up ended by sponsor|2|||
126244904|NCT02089685|454189332|FG002|Overall Study|Follow up ended by sponsor|0|||
126244905|NCT02089685|454189333|FG003|Overall Study|Follow up ended by sponsor|70|||
126244906|NCT02089685|454189334|FG004|Overall Study|Follow up ended by sponsor|26|||
126244907|NCT02089685|454189335|FG005|Overall Study|Follow up ended by sponsor|26|||
126244908|NCT02089685|454189330|FG000|Overall Study|Withdrawal by Subject|0|||
126244909|NCT02089685|454189331|FG001|Overall Study|Withdrawal by Subject|2|||
126244910|NCT02089685|454189332|FG002|Overall Study|Withdrawal by Subject|0|||
126244911|NCT02089685|454189333|FG003|Overall Study|Withdrawal by Subject|8|||
126244912|NCT02089685|454189334|FG004|Overall Study|Withdrawal by Subject|1|||
126244913|NCT02089685|454189335|FG005|Overall Study|Withdrawal by Subject|1|||
126244914|NCT02089685|454189330|FG000|Overall Study|Status not recorded|1|||
126244915|NCT02089685|454189331|FG001|Overall Study|Status not recorded|0|||
126244916|NCT02089685|454189332|FG002|Overall Study|Status not recorded|0|||
126244917|NCT02089685|454189333|FG003|Overall Study|Status not recorded|0|||
126244918|NCT02089685|454189334|FG004|Overall Study|Status not recorded|1|||
126244919|NCT02089685|454189335|FG005|Overall Study|Status not recorded|0|||
126761277|NCT02708524|456077191|FG001|Overall Study|Protocol Violation|1|||
126761278|NCT02708524|456077192|FG002|Overall Study|Protocol Violation|0|||
126761279|NCT02708524|456077193|FG003|Overall Study|Protocol Violation|0|||
126761280|NCT02708524|456077190|FG000|Overall Study|Withdrawal by Subject|1|||
126761281|NCT02708524|456077191|FG001|Overall Study|Withdrawal by Subject|1|||
126761282|NCT02708524|456077192|FG002|Overall Study|Withdrawal by Subject|0|||
126761283|NCT02708524|456077193|FG003|Overall Study|Withdrawal by Subject|0|||
126761284|NCT02708524|456077190|FG000|Overall Study|Dispensed incorrect study lens|0|||
126761285|NCT02708524|456077191|FG001|Overall Study|Dispensed incorrect study lens|1|||
126761286|NCT02708524|456077192|FG002|Overall Study|Dispensed incorrect study lens|1|||
126761287|NCT02708524|456077193|FG003|Overall Study|Dispensed incorrect study lens|0|||
126761288|NCT02708524|456077190|FG000|Overall Study|Did not wear lens at final visit|0|||
126761289|NCT02708524|456077191|FG001|Overall Study|Did not wear lens at final visit|1|||
126761290|NCT02708524|456077192|FG002|Overall Study|Did not wear lens at final visit|0|||
126761291|NCT02708524|456077193|FG003|Overall Study|Did not wear lens at final visit|0|||
126761292|NCT02708524|456077190|FG000|Overall Study|Subject lost study lens|1|||
126761293|NCT02708524|456077191|FG001|Overall Study|Subject lost study lens|0|||
126761294|NCT02708524|456077192|FG002|Overall Study|Subject lost study lens|0|||
126761295|NCT02708524|456077193|FG003|Overall Study|Subject lost study lens|0|||
126761296|NCT00229931|456077194|FG000|Overall Study|Death|1|||
126761297|NCT00229931|456077195|FG001|Overall Study|Death|0|||
126761298|NCT00229931|456077194|FG000|Overall Study|Lost to Follow-up|3|||
126761299|NCT00229931|456077195|FG001|Overall Study|Lost to Follow-up|2|||
126761300|NCT00465101|456077196|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
126761301|NCT00465101|456077196|FG000|Overall Study|Change in health precluded follow up|4|||
126761302|NCT00465101|456077196|FG000|Overall Study|Did not meet study criteria|4|||
126761303|NCT00465101|456077196|FG000|Overall Study|Lost to Follow-up|5|||
126761304|NCT00465101|456077196|FG000|Overall Study|Other|6|||
126761305|NCT00465101|456077196|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
126761306|NCT00465101|456077196|FG000|Overall Study|Patient postponed procedure|1|||
126761307|NCT00465101|456077196|FG000|Overall Study|Site closed due to IRB expiration|1|||
126761308|NCT00465101|456077196|FG000|Overall Study|Unable to obtain IRB approval|1|||
126761309|NCT00465101|456077196|FG000|Overall Study|Death|3|||
126761310|NCT00465101|456077196|FG000|Overall Study|Withdrawal by Subject|25|||
126244920|NCT02089685|454189330|FG000|Overall Study|Death|0|||
126244921|NCT02089685|454189331|FG001|Overall Study|Death|0|||
126244922|NCT02089685|454189332|FG002|Overall Study|Death|0|||
126244923|NCT02089685|454189333|FG003|Overall Study|Death|7|||
126244924|NCT02089685|454189334|FG004|Overall Study|Death|2|||
126244925|NCT02089685|454189335|FG005|Overall Study|Death|5|||
126761311|NCT00465101|456077196|FG000|Overall Study|Physician Decision|1|||
126761312|NCT00465101|456077196|FG000|Overall Study|Withdrew consent prior to procedure|3|||
126761313|NCT00361504|456077197|FG000|Overall Study|Withdrawal by Subject|94|||
126761314|NCT00361504|456077198|FG001|Overall Study|Withdrawal by Subject|31|||
126761315|NCT00361504|456077197|FG000|Overall Study|Lost to Follow-up|40|||
126761316|NCT00361504|456077198|FG001|Overall Study|Lost to Follow-up|7|||
126244926|NCT02089685|454189330|FG000|Overall Study|Lost to Follow-up|0|||
126244927|NCT02089685|454189331|FG001|Overall Study|Lost to Follow-up|0|||
126244928|NCT02089685|454189332|FG002|Overall Study|Lost to Follow-up|0|||
126244929|NCT02089685|454189333|FG003|Overall Study|Lost to Follow-up|1|||
126244930|NCT02089685|454189334|FG004|Overall Study|Lost to Follow-up|0|||
126244931|NCT02089685|454189335|FG005|Overall Study|Lost to Follow-up|0|||
126244932|NCT02089685|454189330|FG000|Overall Study|Physician Decision|0|||
126244933|NCT02089685|454189331|FG001|Overall Study|Physician Decision|0|||
126244934|NCT02089685|454189332|FG002|Overall Study|Physician Decision|0|||
126244935|NCT02089685|454189333|FG003|Overall Study|Physician Decision|0|||
126244936|NCT02089685|454189334|FG004|Overall Study|Physician Decision|0|||
126244937|NCT02089685|454189335|FG005|Overall Study|Physician Decision|4|||
126244938|NCT02089685|454189330|FG000|Overall Study|Screen failure|1|||
126244939|NCT02089685|454189331|FG001|Overall Study|Screen failure|0|||
126244940|NCT02089685|454189332|FG002|Overall Study|Screen failure|0|||
126244941|NCT02089685|454189333|FG003|Overall Study|Screen failure|0|||
126244942|NCT02089685|454189334|FG004|Overall Study|Screen failure|0|||
126244943|NCT02089685|454189335|FG005|Overall Study|Screen failure|0|||
126244944|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Adverse Event|11|||
126244945|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Adverse Event|23|||
126244946|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Adverse Event|29|||
126244947|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Adverse Event|2|||
126244948|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Adverse Event|8|||
126244949|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
126244950|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
126244951|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
126244952|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
126244953|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
126244954|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
126244955|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
126244956|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
126244957|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
126244958|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
126244959|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
126244960|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
126244961|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
126244962|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
126244963|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
126244964|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
126244965|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
126244966|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
126244967|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
126244968|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
126244969|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
126244970|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
126244971|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
126244972|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
126244973|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
126244974|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
126244975|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
126244976|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
126244977|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
126244978|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
126244979|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Move|0|||
126244980|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Move|1|||
126244981|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Move|0|||
126447699|NCT01349049|454939509|FG003|Overall Study|Non-compliance|1|||
126447700|NCT01349049|454939510|FG004|Overall Study|Non-compliance|0|||
126447701|NCT01349049|454939511|FG005|Overall Study|Non-compliance|0|||
126447702|NCT01349049|454939512|FG006|Overall Study|Non-compliance|0|||
126447703|NCT01349049|454939513|FG007|Overall Study|Non-compliance|0|||
126447704|NCT01349049|454939514|FG008|Overall Study|Non-compliance|0|||
126447705|NCT01349049|454939506|FG000|Overall Study|Withdrawal by Subject|0|||
126244982|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Move|0|||
126244983|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Move|0|||
126244984|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
126447706|NCT01349049|454939507|FG001|Overall Study|Withdrawal by Subject|0|||
126447707|NCT01349049|454939508|FG002|Overall Study|Withdrawal by Subject|0|||
126447708|NCT01349049|454939509|FG003|Overall Study|Withdrawal by Subject|0|||
126447709|NCT01349049|454939510|FG004|Overall Study|Withdrawal by Subject|0|||
126447710|NCT01349049|454939511|FG005|Overall Study|Withdrawal by Subject|0|||
126447711|NCT01349049|454939512|FG006|Overall Study|Withdrawal by Subject|0|||
126447712|NCT01349049|454939513|FG007|Overall Study|Withdrawal by Subject|0|||
126244985|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
126244986|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
126244987|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
126447713|NCT01349049|454939514|FG008|Overall Study|Withdrawal by Subject|6|||
126447714|NCT02810444|454939519|FG000|Overall Study|Screen Failures|14|||
126545899|NCT01872910|455292496|FG004|Overall Study|Lost to Follow-up|0|||
126244988|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
126244989|NCT00318461|454189336|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
126244990|NCT00318461|454189337|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
126244991|NCT00318461|454189338|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
126244992|NCT00318461|454189339|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
126244993|NCT00318461|454189340|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
126244994|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Work commitment|0|||
126244995|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Work commitment|0|||
126244996|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Work commitment|0|||
126244997|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Work commitment|0|||
126244998|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Work commitment|1|||
126244999|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Investigator decision|0|||
126245000|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Investigator decision|0|||
126245001|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Investigator decision|0|||
126245002|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Investigator decision|0|||
126245003|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Investigator decision|1|||
126245004|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Lack of time|1|||
126245005|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Lack of time|0|||
126245006|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Lack of time|0|||
126245007|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Lack of time|0|||
126245008|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Lack of time|0|||
126245009|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
126245010|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
126245011|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
126245012|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
126245013|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
126245014|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
126245015|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
126245016|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
126245017|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
126245018|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
126245019|NCT00318461|454189336|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
126245020|NCT00318461|454189337|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
126245021|NCT00318461|454189338|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
126245022|NCT00318461|454189339|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
126245023|NCT00318461|454189340|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
126245024|NCT00318461|454189336|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
126245025|NCT00318461|454189337|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
126245026|NCT00318461|454189338|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
126245027|NCT00318461|454189339|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
126245028|NCT00318461|454189340|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
126245029|NCT00318461|454189336|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
126245030|NCT00318461|454189337|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
126245031|NCT00318461|454189338|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
126245032|NCT00318461|454189339|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
126245033|NCT00318461|454189340|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
126245034|NCT00318461|454189336|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
126545900|NCT01872910|455292497|FG005|Overall Study|Lost to Follow-up|0|||
126545901|NCT03101241|455292499|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
126245035|NCT00318461|454189337|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
126245036|NCT00318461|454189338|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
126245037|NCT00318461|454189339|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
126245038|NCT00318461|454189340|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
126245039|NCT00318461|454189336|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
126357511|NCT01851369|454602125|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357512|NCT01851369|454602126|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357513|NCT01851369|454602127|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357514|NCT01851369|454602128|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
126357515|NCT02453191|454602129|FG000|Overall Study|Withdrawal by Subject|1|||
126357516|NCT03364686|454602130|FG000|Overall Study|Physician Decision|2|||
126357517|NCT02336503|454602133|FG000|Overall Study|Lost to Follow-up|0|||
126357518|NCT02336503|454602134|FG001|Overall Study|Lost to Follow-up|3|||
126357519|NCT02336503|454602135|FG002|Overall Study|Lost to Follow-up|0|||
126357520|NCT02336503|454602136|FG003|Overall Study|Lost to Follow-up|2|||
126357521|NCT02336503|454602133|FG000|Overall Study|Withdrawal by Subject|2|||
126357522|NCT02336503|454602134|FG001|Overall Study|Withdrawal by Subject|0|||
126357523|NCT02336503|454602135|FG002|Overall Study|Withdrawal by Subject|0|||
126694856|NCT01583374|455836572|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
126694857|NCT01583374|455836573|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
126694858|NCT01583374|455836574|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
126694859|NCT01583374|455836575|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
126694860|NCT01583374|455836576|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
126694861|NCT01583374|455836577|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
126694862|NCT01583374|455836569|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126694863|NCT01583374|455836570|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126694864|NCT01583374|455836571|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126694865|NCT01583374|455836572|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126694866|NCT01583374|455836573|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126694867|NCT01583374|455836574|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126694868|NCT01583374|455836575|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126694869|NCT01583374|455836576|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
126694870|NCT01583374|455836577|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
126694871|NCT01583374|455836569|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
126694872|NCT01583374|455836570|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
126694873|NCT01583374|455836571|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
126694874|NCT01583374|455836572|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
126694875|NCT01583374|455836573|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
126694876|NCT01583374|455836574|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
126694877|NCT01583374|455836575|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
126694878|NCT01583374|455836576|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
126694879|NCT01583374|455836577|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
126694880|NCT01583374|455836569|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
126694881|NCT01583374|455836570|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
126694882|NCT01583374|455836571|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
126694883|NCT01583374|455836572|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
126694884|NCT01583374|455836573|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
126694885|NCT01583374|455836574|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
126694886|NCT01583374|455836575|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
126694887|NCT01583374|455836576|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
126694888|NCT01583374|455836577|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
126694889|NCT01583374|455836569|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
126694890|NCT01583374|455836570|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
126694891|NCT01583374|455836571|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
126694892|NCT01583374|455836572|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
126694893|NCT01583374|455836573|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
126694894|NCT01583374|455836574|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
126694895|NCT01583374|455836575|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
126694896|NCT01583374|455836576|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
126694897|NCT01583374|455836577|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
126694898|NCT01583374|455836569|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126694899|NCT01583374|455836570|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126694900|NCT01583374|455836571|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
126761317|NCT00361504|456077197|FG000|Overall Study|Adverse Event|203|||
126761318|NCT00361504|456077198|FG001|Overall Study|Adverse Event|82|||
126245040|NCT00318461|454189337|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
126245041|NCT00318461|454189338|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
126245042|NCT00318461|454189339|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
126245043|NCT00318461|454189340|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
126245044|NCT00318461|454189336|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
126245045|NCT00318461|454189337|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
126245046|NCT00318461|454189338|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
126245047|NCT00318461|454189339|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
126245048|NCT00318461|454189340|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
126245049|NCT00796653|454189344|FG000|Overall Study|Adverse Event|19|||
126245050|NCT00796653|454189345|FG001|Overall Study|Adverse Event|16|||
126245051|NCT00796653|454189346|FG002|Overall Study|Adverse Event|16|||
126245052|NCT00796653|454189347|FG003|Overall Study|Adverse Event|16|||
126245053|NCT00796653|454189344|FG000|Overall Study|Lost to Follow-up|2|||
126245054|NCT00796653|454189345|FG001|Overall Study|Lost to Follow-up|1|||
126447715|NCT02810444|454939519|FG000|Overall Study|Withdrawal by Subject|4|||
126447716|NCT02810444|454939519|FG000|Overall Study|Adverse Event|3|||
126447717|NCT02785770|454939520|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
126447718|NCT02785770|454939521|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
126447719|NCT02785770|454939522|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
126245055|NCT00796653|454189346|FG002|Overall Study|Lost to Follow-up|2|||
126245056|NCT00796653|454189347|FG003|Overall Study|Lost to Follow-up|3|||
126245057|NCT00796653|454189344|FG000|Overall Study|Withdrawal by Subject|16|||
126245058|NCT00796653|454189345|FG001|Overall Study|Withdrawal by Subject|8|||
126245059|NCT00796653|454189346|FG002|Overall Study|Withdrawal by Subject|8|||
126245060|NCT00796653|454189347|FG003|Overall Study|Withdrawal by Subject|13|||
126245061|NCT00796653|454189344|FG000|Overall Study|Lack of Efficacy|8|||
126245062|NCT00796653|454189345|FG001|Overall Study|Lack of Efficacy|1|||
126245063|NCT00796653|454189346|FG002|Overall Study|Lack of Efficacy|3|||
126245064|NCT00796653|454189347|FG003|Overall Study|Lack of Efficacy|2|||
126245065|NCT00796653|454189344|FG000|Overall Study|Non compliance with protocol|2|||
126245066|NCT00796653|454189345|FG001|Overall Study|Non compliance with protocol|2|||
126245067|NCT00796653|454189346|FG002|Overall Study|Non compliance with protocol|0|||
126245068|NCT00796653|454189347|FG003|Overall Study|Non compliance with protocol|2|||
126245069|NCT00796653|454189344|FG000|Overall Study|Other reason not described above|4|||
126245070|NCT00796653|454189345|FG001|Overall Study|Other reason not described above|9|||
126245071|NCT00796653|454189346|FG002|Overall Study|Other reason not described above|7|||
126245072|NCT00796653|454189347|FG003|Overall Study|Other reason not described above|4|||
126245073|NCT01848938|454189356|FG000|Overall Study|Lost to Follow-up|1|||
126245074|NCT01848938|454189357|FG001|Overall Study|Lost to Follow-up|1|||
126245075|NCT00207090|454189360|FG000|Overall Study|Study drug toxicity|3|||
126245076|NCT00207090|454189360|FG000|Overall Study|Chest wall mass larger|1|||
126245077|NCT00207090|454189360|FG000|Overall Study|Disease progression/relapse|2|||
126245078|NCT00207090|454189360|FG000|Overall Study|Physician Decision|1|||
126245079|NCT00651820|454189371|FG000|Overall Study|Lost to Follow-up|2|||
126245080|NCT01911676|454189372|FG000|Period 1 of Study|Withdrawal by Subject|4|||
126245081|NCT01911676|454189373|FG001|Period 1 of Study|Withdrawal by Subject|2|||
126245082|NCT01911676|454189374|FG002|Period 1 of Study|Withdrawal by Subject|1|||
126245083|NCT01911676|454189375|FG003|Period 1 of Study|Withdrawal by Subject|2|||
126245084|NCT01911676|454189372|FG000|Period 1 of Study|Physician Decision|2|||
126245085|NCT01911676|454189373|FG001|Period 1 of Study|Physician Decision|0|||
126245086|NCT01911676|454189374|FG002|Period 1 of Study|Physician Decision|0|||
126357524|NCT02336503|454602136|FG003|Overall Study|Withdrawal by Subject|4|||
126447720|NCT02785770|454939523|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
126447721|NCT02785770|454939520|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
126447722|NCT02785770|454939521|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
126447723|NCT02785770|454939522|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
126447724|NCT02785770|454939523|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
126447725|NCT02785770|454939520|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
126447726|NCT02785770|454939521|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
126447727|NCT02785770|454939522|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
126447728|NCT02785770|454939523|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
126447729|NCT04518995|454939524|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
126447730|NCT04518995|454939525|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
126447731|NCT04518995|454939526|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
126447732|NCT04518995|454939524|FG000|Overall Study|Lack of Efficacy|2|||
126447733|NCT04518995|454939525|FG001|Overall Study|Lack of Efficacy|1|||
126447734|NCT04518995|454939526|FG002|Overall Study|Lack of Efficacy|0|||
126447735|NCT04518995|454939524|FG000|Overall Study|Non-compliance With Study Drug|0|||
126447736|NCT04518995|454939525|FG001|Overall Study|Non-compliance With Study Drug|3|||
126447737|NCT04518995|454939526|FG002|Overall Study|Non-compliance With Study Drug|2|||
126447738|NCT04518995|454939524|FG000|Overall Study|Pregnancy|0|||
126447739|NCT04518995|454939525|FG001|Overall Study|Pregnancy|0|||
126447740|NCT04518995|454939526|FG002|Overall Study|Pregnancy|1|||
126447741|NCT04518995|454939524|FG000|Overall Study|Protocol Violation|2|||
126447742|NCT04518995|454939525|FG001|Overall Study|Protocol Violation|0|||
126447743|NCT04518995|454939526|FG002|Overall Study|Protocol Violation|1|||
126447744|NCT04518995|454939524|FG000|Overall Study|Reason not Specified|4|||
126447745|NCT04518995|454939525|FG001|Overall Study|Reason not Specified|11|||
126447746|NCT04518995|454939526|FG002|Overall Study|Reason not Specified|2|||
126447747|NCT04518995|454939524|FG000|Overall Study|Lost to Follow-up|1|||
126447748|NCT04518995|454939525|FG001|Overall Study|Lost to Follow-up|10|||
126447749|NCT04518995|454939526|FG002|Overall Study|Lost to Follow-up|6|||
126447750|NCT02078960|454939529|FG000|Treatment Period|Other|0|||
126245087|NCT01911676|454189375|FG003|Period 1 of Study|Physician Decision|1|||
126357525|NCT02336503|454602133|FG000|Overall Study|Adverse Event|0|||
126357526|NCT02336503|454602134|FG001|Overall Study|Adverse Event|0|||
126357527|NCT02336503|454602135|FG002|Overall Study|Adverse Event|1|||
126357528|NCT02336503|454602136|FG003|Overall Study|Adverse Event|0|||
126357529|NCT01543503|454602137|FG000|Overall Study|Lost to Follow-up|32|||
126357530|NCT01543503|454602138|FG001|Overall Study|Lost to Follow-up|36|||
126357531|NCT01543503|454602137|FG000|Overall Study|Adverse Event|9|||
126357532|NCT01543503|454602138|FG001|Overall Study|Adverse Event|13|||
126357533|NCT01543503|454602137|FG000|Overall Study|Lack of Efficacy|4|||
126357534|NCT01543503|454602138|FG001|Overall Study|Lack of Efficacy|16|||
126245088|NCT01911676|454189372|FG000|Period 2 of Study|Physician Decision|2|||
126245089|NCT01911676|454189373|FG001|Period 2 of Study|Physician Decision|0|||
126245090|NCT01911676|454189374|FG002|Period 2 of Study|Physician Decision|0|||
126245091|NCT01911676|454189375|FG003|Period 2 of Study|Physician Decision|1|||
126245092|NCT01911676|454189372|FG000|Period 2 of Study|Lost to Follow-up|0|||
126245093|NCT01911676|454189373|FG001|Period 2 of Study|Lost to Follow-up|0|||
126245094|NCT01911676|454189374|FG002|Period 2 of Study|Lost to Follow-up|0|||
126245095|NCT01911676|454189375|FG003|Period 2 of Study|Lost to Follow-up|1|||
126245096|NCT01878292|454189376|FG000|Randomized|Protocol Violation|1|||
126245097|NCT01878292|454189377|FG001|Randomized|Protocol Violation|0|||
126245098|NCT01878292|454189378|FG002|Randomized|Protocol Violation|0|||
126245099|NCT01878292|454189376|FG000|Randomized|Lost to Follow-up|1|||
126245100|NCT01878292|454189377|FG001|Randomized|Lost to Follow-up|0|||
126245101|NCT01878292|454189378|FG002|Randomized|Lost to Follow-up|0|||
126245102|NCT01878292|454189376|FG000|Randomized|Adverse Event|1|||
126245103|NCT01878292|454189377|FG001|Randomized|Adverse Event|0|||
126245104|NCT01878292|454189378|FG002|Randomized|Adverse Event|0|||
126245105|NCT01878292|454189376|FG000|Double-blind Treatment Period|Other Reasons|2|||
126245106|NCT01878292|454189377|FG001|Double-blind Treatment Period|Other Reasons|0|||
126245107|NCT01878292|454189378|FG002|Double-blind Treatment Period|Other Reasons|0|||
126245108|NCT01878292|454189376|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
126245109|NCT01878292|454189377|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
126245110|NCT01878292|454189378|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
126245111|NCT01878292|454189376|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
126245112|NCT01878292|454189377|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
126245113|NCT01878292|454189378|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
126245114|NCT01878292|454189376|FG000|Double-blind Treatment Period|Protocol Violation|3|||
126245115|NCT01878292|454189377|FG001|Double-blind Treatment Period|Protocol Violation|4|||
126245116|NCT01878292|454189378|FG002|Double-blind Treatment Period|Protocol Violation|2|||
126245117|NCT01878292|454189376|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
126245118|NCT01878292|454189377|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
126245119|NCT01878292|454189378|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
126245120|NCT01878292|454189376|FG000|Double-blind Treatment Period|Adverse Event|4|||
126245121|NCT01878292|454189377|FG001|Double-blind Treatment Period|Adverse Event|9|||
126245122|NCT01878292|454189378|FG002|Double-blind Treatment Period|Adverse Event|8|||
126245123|NCT01878292|454189376|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
126357535|NCT01543503|454602137|FG000|Overall Study|Participant withdrew informed consent|8|||
126357536|NCT01543503|454602138|FG001|Overall Study|Participant withdrew informed consent|10|||
126357537|NCT01543503|454602137|FG000|Overall Study|Change of jobs|0|||
126357538|NCT01543503|454602138|FG001|Overall Study|Change of jobs|1|||
126357539|NCT01543503|454602137|FG000|Overall Study|Intolerance to the biologic treatment|0|||
126357540|NCT01543503|454602138|FG001|Overall Study|Intolerance to the biologic treatment|1|||
126357541|NCT01543503|454602137|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
126357542|NCT01543503|454602138|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
126357543|NCT01543503|454602137|FG000|Overall Study|Participant did not complete last visit|0|||
126357544|NCT01543503|454602138|FG001|Overall Study|Participant did not complete last visit|2|||
126357545|NCT01543503|454602137|FG000|Overall Study|Refused to continue treatment|7|||
126357546|NCT01543503|454602138|FG001|Overall Study|Refused to continue treatment|0|||
126357547|NCT01543503|454602137|FG000|Overall Study|Incorrect medication received|1|||
126357548|NCT01543503|454602138|FG001|Overall Study|Incorrect medication received|0|||
126357549|NCT01543503|454602137|FG000|Overall Study|Participant moved to another city|2|||
126357550|NCT01543503|454602138|FG001|Overall Study|Participant moved to another city|0|||
126357551|NCT01543503|454602137|FG000|Overall Study|Participant will not return for visits|0|||
126357552|NCT01543503|454602138|FG001|Overall Study|Participant will not return for visits|2|||
126357553|NCT01543503|454602137|FG000|Overall Study|Participant transferred to another city|1|||
126357554|NCT01543503|454602138|FG001|Overall Study|Participant transferred to another city|0|||
126357555|NCT01543503|454602137|FG000|Overall Study|Participant moved to Scotland|1|||
126357556|NCT01543503|454602138|FG001|Overall Study|Participant moved to Scotland|0|||
126357557|NCT01543503|454602137|FG000|Overall Study|Participant decision to stop treatment|1|||
126357558|NCT01543503|454602138|FG001|Overall Study|Participant decision to stop treatment|0|||
126357559|NCT01543503|454602137|FG000|Overall Study|Investigator did not wish to participate|1|||
126357560|NCT01543503|454602138|FG001|Overall Study|Investigator did not wish to participate|1|||
126357561|NCT01543503|454602137|FG000|Overall Study|Participant recruited after closing date|0|||
126357562|NCT01543503|454602138|FG001|Overall Study|Participant recruited after closing date|1|||
126357563|NCT01543503|454602137|FG000|Overall Study|Site stopped participation|5|||
126357564|NCT01543503|454602138|FG001|Overall Study|Site stopped participation|1|||
126357565|NCT01543503|454602137|FG000|Overall Study|Participant did not attend a visit|1|||
126357566|NCT01543503|454602138|FG001|Overall Study|Participant did not attend a visit|0|||
126357567|NCT01543503|454602137|FG000|Overall Study|Moved to other rheumatologic site|0|||
126357568|NCT01543503|454602138|FG001|Overall Study|Moved to other rheumatologic site|1|||
126357569|NCT01543503|454602137|FG000|Overall Study|Participant consented to another study|0|||
126357570|NCT01543503|454602138|FG001|Overall Study|Participant consented to another study|2|||
126357571|NCT01543503|454602137|FG000|Overall Study|Participant went to United States|1|||
126245124|NCT01878292|454189377|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
126245125|NCT01878292|454189378|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
126245126|NCT00773253|454189379|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
126245127|NCT00773253|454189380|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
126245128|NCT01566721|454189381|FG000|Treatment Period|Withdrawal by Subject|35|||
126245129|NCT01566721|454189382|FG001|Treatment Period|Withdrawal by Subject|9|||
126245130|NCT01566721|454189381|FG000|Treatment Period|Disease Progression/Recurrence|37|||
126245131|NCT01566721|454189382|FG001|Treatment Period|Disease Progression/Recurrence|13|||
126245132|NCT01566721|454189381|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
126245133|NCT01566721|454189382|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
126245134|NCT01566721|454189381|FG000|Treatment Period|Other|13|||
126245135|NCT01566721|454189382|FG001|Treatment Period|Other|2|||
126245136|NCT01566721|454189381|FG000|Treatment Period|Lack of Compliance|5|||
126245137|NCT01566721|454189382|FG001|Treatment Period|Lack of Compliance|1|||
126245138|NCT01566721|454189381|FG000|Treatment Period|Adverse Event|100|||
126245139|NCT01566721|454189382|FG001|Treatment Period|Adverse Event|30|||
126245140|NCT01566721|454189381|FG000|Treatment Period|Pregnancy|1|||
126245141|NCT01566721|454189382|FG001|Treatment Period|Pregnancy|0|||
126245142|NCT01566721|454189381|FG000|Safety Follow-up|Physician Decision|6|||
126245143|NCT01566721|454189382|FG001|Safety Follow-up|Physician Decision|4|||
126245144|NCT01566721|454189381|FG000|Safety Follow-up|Lost to Follow-up|101|||
126245145|NCT01566721|454189382|FG001|Safety Follow-up|Lost to Follow-up|48|||
126245146|NCT01566721|454189381|FG000|Safety Follow-up|Withdrawal by Subject|155|||
126245147|NCT01566721|454189382|FG001|Safety Follow-up|Withdrawal by Subject|49|||
126245148|NCT01566721|454189381|FG000|Safety Follow-up|Death|28|||
126245149|NCT01566721|454189382|FG001|Safety Follow-up|Death|4|||
126245150|NCT01566721|454189381|FG000|Safety Follow-up|Non-compliance|7|||
126245151|NCT01566721|454189382|FG001|Safety Follow-up|Non-compliance|3|||
126245152|NCT01566721|454189381|FG000|Safety Follow-up|Protocol Violation|7|||
126245153|NCT01566721|454189382|FG001|Safety Follow-up|Protocol Violation|0|||
126761319|NCT00361504|456077197|FG000|Overall Study|Lack of Efficacy|72|||
126245154|NCT01566721|454189381|FG000|Safety Follow-up|Site closure|2|||
126245155|NCT01566721|454189382|FG001|Safety Follow-up|Site closure|3|||
126245156|NCT01566721|454189381|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
126245157|NCT01566721|454189382|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
126245158|NCT01566721|454189381|FG000|Safety Follow-up|Missing|7|||
126245159|NCT01566721|454189382|FG001|Safety Follow-up|Missing|2|||
126245160|NCT01566721|454189381|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
126245161|NCT01566721|454189382|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
126245162|NCT01566721|454189381|FG000|Safety Follow-up|Sponsor decision|1|||
126245163|NCT01566721|454189382|FG001|Safety Follow-up|Sponsor decision|0|||
126245164|NCT01566721|454189381|FG000|Safety Follow-up|Adverse Event|8|||
126245165|NCT01566721|454189382|FG001|Safety Follow-up|Adverse Event|4|||
126245166|NCT01302548|454189387|FG000|Overall Study|Lost to Follow-up|2|||
126245167|NCT01302548|454189388|FG001|Overall Study|Lost to Follow-up|1|||
126245168|NCT01237054|454189389|FG000|Overall Study|imaging 10C0096|1|||
126245169|NCT02619682|454189390|FG000|Overall Study|Withdrawal by Subject|3|||
126245170|NCT02619682|454189390|FG000|Overall Study|Lack of Efficacy|8|||
126245171|NCT02619682|454189390|FG000|Overall Study|new secondary cancer|1|||
126245172|NCT02619682|454189390|FG000|Overall Study|post surgery complications|2|||
126245173|NCT00268203|454189393|FG000|Overall Study|Lost to Follow-up|92|||
126245174|NCT00268203|454189393|FG000|Overall Study|Withdrawal by Subject|9|||
126245175|NCT00268203|454189393|FG000|Overall Study|Received Other NHL Therapy|7|||
126245176|NCT00268203|454189393|FG000|Overall Study|Progressive Disease|359|||
126245177|NCT00268203|454189393|FG000|Overall Study|Death|84|||
126245178|NCT00268203|454189393|FG000|Overall Study|Reason Not Specified|34|||
126245179|NCT00268203|454189393|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
126245180|NCT00950989|454189394|FG000|Overall Study|Death|0|||
126245181|NCT00950989|454189395|FG001|Overall Study|Death|0|||
126245182|NCT00950989|454189396|FG002|Overall Study|Death|1|||
126357572|NCT01543503|454602138|FG001|Overall Study|Participant went to United States|0|||
126357573|NCT01543503|454602137|FG000|Overall Study|Screen failure|1|||
126357574|NCT01543503|454602138|FG001|Overall Study|Screen failure|0|||
126357575|NCT01936974|454602141|FG000|Overall Study|Physician Decision|2|||
126357576|NCT01936974|454602142|FG001|Overall Study|Physician Decision|5|||
126357577|NCT04584554|454602145|FG000|Overall Study|Withdrawal by Subject|2|||
126357578|NCT04584554|454602146|FG001|Overall Study|Withdrawal by Subject|2|||
126357579|NCT00063999|454602147|FG000|Overall Study|Withdrawal by Subject|1|||
126357580|NCT00063999|454602148|FG001|Overall Study|Withdrawal by Subject|0|||
126357581|NCT00063999|454602147|FG000|Overall Study|Ineligible|44|||
126357582|NCT00063999|454602148|FG001|Overall Study|Ineligible|24|||
126357583|NCT03767894|454602149|FG000|Overall Study|Withdrawal by Subject|1|||
126447751|NCT02078960|454939530|FG001|Treatment Period|Other|0|||
126447752|NCT02078960|454939531|FG002|Treatment Period|Other|1|||
126447753|NCT02078960|454939529|FG000|Treatment Period|Lack of Efficacy|0|||
126447754|NCT02078960|454939530|FG001|Treatment Period|Lack of Efficacy|1|||
126245183|NCT00950989|454189397|FG003|Overall Study|Death|0|||
126447755|NCT02078960|454939531|FG002|Treatment Period|Lack of Efficacy|0|||
126245184|NCT00950989|454189394|FG000|Overall Study|Administrative Decision|0|||
126245185|NCT00950989|454189395|FG001|Overall Study|Administrative Decision|1|||
126245186|NCT00950989|454189396|FG002|Overall Study|Administrative Decision|0|||
126245187|NCT00950989|454189397|FG003|Overall Study|Administrative Decision|0|||
126245188|NCT00950989|454189394|FG000|Overall Study|Disease Progression|0|||
126245189|NCT00950989|454189395|FG001|Overall Study|Disease Progression|0|||
126245190|NCT00950989|454189396|FG002|Overall Study|Disease Progression|1|||
126245191|NCT00950989|454189397|FG003|Overall Study|Disease Progression|0|||
126245192|NCT00950989|454189394|FG000|Overall Study|Withdrawal by Subject|2|||
126245193|NCT00950989|454189395|FG001|Overall Study|Withdrawal by Subject|1|||
126245194|NCT00950989|454189396|FG002|Overall Study|Withdrawal by Subject|0|||
126245195|NCT00950989|454189397|FG003|Overall Study|Withdrawal by Subject|0|||
126245196|NCT00950989|454189394|FG000|Overall Study|Adverse Event|2|||
126245197|NCT00950989|454189395|FG001|Overall Study|Adverse Event|1|||
126245198|NCT00950989|454189396|FG002|Overall Study|Adverse Event|1|||
126245199|NCT00950989|454189397|FG003|Overall Study|Adverse Event|0|||
126245200|NCT02152163|454189398|FG000|Overall Study|Physician Decision|12|||
126245201|NCT02152163|454189399|FG001|Overall Study|Physician Decision|13|||
126245202|NCT00796562|454189403|FG000|Overall Study|Death|49|||
126245203|NCT00424047|454189404|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
126245204|NCT00424047|454189405|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
126245205|NCT00424047|454189404|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
126245206|NCT00424047|454189405|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
126245207|NCT00424047|454189404|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
126245208|NCT00424047|454189405|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
126245209|NCT00424047|454189404|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
126245210|NCT00424047|454189405|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
126245211|NCT00424047|454189404|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
126245212|NCT00424047|454189405|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
126245213|NCT00424047|454189404|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
126245214|NCT00424047|454189405|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
126245215|NCT00424047|454189404|FG000|On Study at Time of Unblinding|Adverse Event|22|||
126245216|NCT00424047|454189405|FG001|On Study at Time of Unblinding|Adverse Event|12|||
126245217|NCT00424047|454189404|FG000|On Study at Time of Unblinding|Progression of disease|92|||
126245218|NCT00424047|454189405|FG001|On Study at Time of Unblinding|Progression of disease|128|||
126245219|NCT00424047|454189404|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
126245220|NCT00424047|454189405|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
126245221|NCT00424047|454189404|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
126245222|NCT00424047|454189405|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
126245223|NCT00424047|454189404|FG000|On Study at Time of Unblinding|Death|11|||
126245224|NCT00424047|454189405|FG001|On Study at Time of Unblinding|Death|11|||
126245225|NCT00424047|454189404|FG000|On Study at Time of Unblinding|Other|5|||
126245226|NCT00424047|454189405|FG001|On Study at Time of Unblinding|Other|4|||
126245227|NCT00424047|454189404|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
126245228|NCT00424047|454189405|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
126245229|NCT00424047|454189404|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
126245230|NCT00424047|454189405|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
126245231|NCT00424047|454189404|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
126245232|NCT00424047|454189405|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
126245233|NCT00424047|454189404|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
126447756|NCT02078960|454939529|FG000|Treatment Period|Disease progression - accelerated phase|0|||
126245234|NCT00424047|454189405|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
126447757|NCT02078960|454939530|FG001|Treatment Period|Disease progression - accelerated phase|1|||
126447758|NCT02078960|454939531|FG002|Treatment Period|Disease progression - accelerated phase|0|||
126447759|NCT02078960|454939529|FG000|Treatment Period|Disease progression - blast phase|1|||
126447760|NCT02078960|454939530|FG001|Treatment Period|Disease progression - blast phase|0|||
126447761|NCT02078960|454939531|FG002|Treatment Period|Disease progression - blast phase|0|||
126447762|NCT02078960|454939529|FG000|Treatment Period|Withdrawal by Subject|0|||
126447763|NCT02078960|454939530|FG001|Treatment Period|Withdrawal by Subject|1|||
126447764|NCT02078960|454939531|FG002|Treatment Period|Withdrawal by Subject|1|||
126245235|NCT00424047|454189404|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
126245236|NCT00424047|454189405|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
126447765|NCT02078960|454939529|FG000|Treatment Period|Adverse Event|1|||
126447766|NCT02078960|454939530|FG001|Treatment Period|Adverse Event|0|||
126447767|NCT02078960|454939531|FG002|Treatment Period|Adverse Event|0|||
126447768|NCT02078960|454939529|FG000|Treatment Period|Death|0|||
126447769|NCT02078960|454939530|FG001|Treatment Period|Death|0|||
126245237|NCT00730691|454189409|FG000|Overall Study|Adverse Event|4|||
126245238|NCT00730691|454189410|FG001|Overall Study|Adverse Event|8|||
126245239|NCT00730691|454189411|FG002|Overall Study|Adverse Event|11|||
126245240|NCT00730691|454189412|FG003|Overall Study|Adverse Event|11|||
126447770|NCT02078960|454939531|FG002|Treatment Period|Death|1|||
126694901|NCT01583374|455836572|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126694902|NCT01583374|455836573|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
126694903|NCT01583374|455836574|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
126694904|NCT01583374|455836575|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126694905|NCT01583374|455836576|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126694906|NCT01583374|455836577|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
126694907|NCT01583374|455836569|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
126694908|NCT01583374|455836570|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
126694909|NCT01583374|455836571|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
126694910|NCT01583374|455836572|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
126694911|NCT01583374|455836573|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
126694912|NCT01583374|455836574|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
126694913|NCT01583374|455836575|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
126694914|NCT01583374|455836576|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
126694915|NCT01583374|455836577|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
126694916|NCT01583374|455836569|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
126694917|NCT01583374|455836570|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
126694918|NCT01583374|455836571|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
126694919|NCT01583374|455836572|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
126694920|NCT01583374|455836573|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
126694921|NCT01583374|455836574|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
126694922|NCT01583374|455836575|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
126694923|NCT01583374|455836576|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
126694924|NCT01583374|455836577|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
126694925|NCT01583374|455836569|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
126694926|NCT01583374|455836570|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
126694927|NCT01583374|455836571|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
126694928|NCT01583374|455836572|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
126694929|NCT01583374|455836573|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
126694930|NCT01583374|455836574|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
126694931|NCT01583374|455836575|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
126694932|NCT01583374|455836576|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
126694933|NCT01583374|455836577|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
126694934|NCT01583374|455836569|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
126694935|NCT01583374|455836570|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
126694936|NCT01583374|455836571|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
126694937|NCT01583374|455836572|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
126694938|NCT01583374|455836573|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
126694939|NCT01583374|455836574|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
126694940|NCT01583374|455836575|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
126694941|NCT01583374|455836576|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
126694942|NCT01583374|455836577|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
126694943|NCT01583374|455836569|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
126694944|NCT01583374|455836570|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
126694945|NCT01583374|455836571|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
126694946|NCT01583374|455836572|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
126694947|NCT01583374|455836573|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
126694948|NCT01583374|455836574|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
126694949|NCT01583374|455836575|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
126694950|NCT01583374|455836576|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
126694951|NCT01583374|455836577|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
126694952|NCT01583374|455836569|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
126694953|NCT01583374|455836570|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
126694954|NCT01583374|455836571|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
126694955|NCT01583374|455836572|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
126694956|NCT01583374|455836573|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
126694957|NCT01583374|455836574|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
126694958|NCT01583374|455836575|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
126694959|NCT01583374|455836576|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
126694960|NCT01583374|455836577|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
126694961|NCT01583374|455836569|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
126694962|NCT01583374|455836570|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
126694963|NCT01583374|455836571|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
126245241|NCT00730691|454189413|FG004|Overall Study|Adverse Event|23|||
126245242|NCT00730691|454189409|FG000|Overall Study|Lack of Efficacy|4|||
126245243|NCT00730691|454189410|FG001|Overall Study|Lack of Efficacy|4|||
126245244|NCT00730691|454189411|FG002|Overall Study|Lack of Efficacy|2|||
126245245|NCT00730691|454189412|FG003|Overall Study|Lack of Efficacy|1|||
126245246|NCT00730691|454189413|FG004|Overall Study|Lack of Efficacy|1|||
126245247|NCT00730691|454189409|FG000|Overall Study|Non-compliance with Study Drug|6|||
126245248|NCT00730691|454189410|FG001|Overall Study|Non-compliance with Study Drug|1|||
126245249|NCT00730691|454189411|FG002|Overall Study|Non-compliance with Study Drug|6|||
126245250|NCT00730691|454189412|FG003|Overall Study|Non-compliance with Study Drug|3|||
126245251|NCT00730691|454189413|FG004|Overall Study|Non-compliance with Study Drug|3|||
126245252|NCT00730691|454189409|FG000|Overall Study|Protocol Deviations|3|||
126245253|NCT00730691|454189410|FG001|Overall Study|Protocol Deviations|5|||
126245254|NCT00730691|454189411|FG002|Overall Study|Protocol Deviations|3|||
126245255|NCT00730691|454189412|FG003|Overall Study|Protocol Deviations|7|||
126245256|NCT00730691|454189413|FG004|Overall Study|Protocol Deviations|5|||
126245257|NCT00730691|454189409|FG000|Overall Study|Withdrawal of Consent|7|||
126245258|NCT00730691|454189410|FG001|Overall Study|Withdrawal of Consent|9|||
126245259|NCT00730691|454189411|FG002|Overall Study|Withdrawal of Consent|3|||
126245260|NCT00730691|454189412|FG003|Overall Study|Withdrawal of Consent|6|||
126245261|NCT00730691|454189413|FG004|Overall Study|Withdrawal of Consent|3|||
126245262|NCT00730691|454189409|FG000|Overall Study|Lost to Follow-up|11|||
126245263|NCT00730691|454189410|FG001|Overall Study|Lost to Follow-up|8|||
126245264|NCT00730691|454189411|FG002|Overall Study|Lost to Follow-up|13|||
126245265|NCT00730691|454189412|FG003|Overall Study|Lost to Follow-up|15|||
126245266|NCT00730691|454189413|FG004|Overall Study|Lost to Follow-up|13|||
126245267|NCT00730691|454189409|FG000|Overall Study|Other|1|||
126245268|NCT00730691|454189410|FG001|Overall Study|Other|1|||
126245269|NCT00730691|454189411|FG002|Overall Study|Other|1|||
126245270|NCT00730691|454189412|FG003|Overall Study|Other|2|||
126245271|NCT00730691|454189413|FG004|Overall Study|Other|2|||
126245272|NCT02178787|454189414|FG000|Overall Study|Lost to Follow-up|1|||
126245273|NCT02178787|454189415|FG001|Overall Study|Lost to Follow-up|0|||
126245274|NCT02178787|454189414|FG000|Overall Study|Withdrawal by Subject|0|||
126245275|NCT02178787|454189415|FG001|Overall Study|Withdrawal by Subject|2|||
126245276|NCT02178787|454189414|FG000|Overall Study|No TCD window|3|||
126245277|NCT02178787|454189415|FG001|Overall Study|No TCD window|7|||
126245278|NCT02178787|454189414|FG000|Overall Study|Physician Decision|1|||
126245279|NCT02178787|454189415|FG001|Overall Study|Physician Decision|0|||
126245280|NCT02554890|454189416|FG000|Double-blind|Adverse Event|45|||
126245281|NCT02554890|454189417|FG001|Double-blind|Adverse Event|51|||
126245282|NCT02554890|454189416|FG000|Double-blind|Death|6|||
126245283|NCT02554890|454189417|FG001|Double-blind|Death|4|||
126245284|NCT02554890|454189416|FG000|Double-blind|Protocol Violation|1|||
126245285|NCT02554890|454189417|FG001|Double-blind|Protocol Violation|1|||
126245286|NCT02554890|454189416|FG000|Double-blind|Physician Decision|4|||
126245287|NCT02554890|454189417|FG001|Double-blind|Physician Decision|3|||
126245288|NCT02554890|454189416|FG000|Double-blind|Subject/Guardian decision|21|||
126245289|NCT02554890|454189417|FG001|Double-blind|Subject/Guardian decision|16|||
126245290|NCT02554890|454189416|FG000|Double-blind|Lost to Follow-up|7|||
126245291|NCT02554890|454189417|FG001|Double-blind|Lost to Follow-up|5|||
126245292|NCT02554890|454189416|FG000|Double-blind|Technical problems|1|||
126245293|NCT02554890|454189417|FG001|Double-blind|Technical problems|0|||
126245294|NCT02554890|454189416|FG000|Double-blind|Withdrawal by Subject|5|||
126245295|NCT02554890|454189417|FG001|Double-blind|Withdrawal by Subject|6|||
126245296|NCT02554890|454189416|FG000|Double-blind|Noncompliance with study treatment|6|||
126245297|NCT02554890|454189417|FG001|Double-blind|Noncompliance with study treatment|5|||
126245298|NCT02554890|454189416|FG000|Open-label|Adverse Event|0|||
126245299|NCT02554890|454189417|FG001|Open-label|Adverse Event|30|||
126245300|NCT02554890|454189416|FG000|Open-label|Death|0|||
126245301|NCT02554890|454189417|FG001|Open-label|Death|1|||
126245302|NCT02554890|454189416|FG000|Open-label|Physician Decision|0|||
126245303|NCT02554890|454189417|FG001|Open-label|Physician Decision|1|||
126447771|NCT02078960|454939529|FG000|Follow-up Period|Death|2|||
126447772|NCT02078960|454939530|FG001|Follow-up Period|Death|0|||
126245304|NCT02554890|454189416|FG000|Open-label|Subject/Guardian decision|0|||
126245305|NCT02554890|454189417|FG001|Open-label|Subject/Guardian decision|11|||
126447773|NCT02078960|454939531|FG002|Follow-up Period|Death|0|||
126447774|NCT02078960|454939529|FG000|Follow-up Period|Lost to Follow-up|0|||
126245306|NCT02554890|454189416|FG000|Open-label|Lost to Follow-up|0|||
126245307|NCT02554890|454189417|FG001|Open-label|Lost to Follow-up|7|||
126245308|NCT02554890|454189416|FG000|Open-label|Technical problems|0|||
126447775|NCT02078960|454939530|FG001|Follow-up Period|Lost to Follow-up|1|||
126245309|NCT02554890|454189417|FG001|Open-label|Technical problems|1|||
126245310|NCT02554890|454189416|FG000|Open-label|Withdrawal by Subject|0|||
126245311|NCT02554890|454189417|FG001|Open-label|Withdrawal by Subject|1|||
126245312|NCT03043872|454189421|FG000|Overall Study|Withdrawal by Subject|6|||
126245313|NCT03043872|454189422|FG001|Overall Study|Withdrawal by Subject|6|||
126245314|NCT03043872|454189423|FG002|Overall Study|Withdrawal by Subject|15|||
126245315|NCT03043872|454189421|FG000|Overall Study|Lost to Follow-up|2|||
126245316|NCT03043872|454189422|FG001|Overall Study|Lost to Follow-up|1|||
126694964|NCT01583374|455836572|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
126694965|NCT01583374|455836573|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
126694966|NCT01583374|455836574|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
126694967|NCT01583374|455836575|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
126694968|NCT01583374|455836576|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
126694969|NCT01583374|455836577|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
126245317|NCT03043872|454189423|FG002|Overall Study|Lost to Follow-up|1|||
126245318|NCT03043872|454189421|FG000|Overall Study|Death|270|||
126245319|NCT03043872|454189422|FG001|Overall Study|Death|269|||
126245320|NCT03043872|454189423|FG002|Overall Study|Death|296|||
126694970|NCT00008385|455838569|FG000|Overall Study|Off treatment reasons not reported|79|||
126245321|NCT03649477|454189424|FG000|Overall Study|Adverse Event|2|||
126245322|NCT03649477|454189425|FG001|Overall Study|Adverse Event|0|||
126245323|NCT03649477|454189426|FG002|Overall Study|Adverse Event|0|||
126245324|NCT02430480|454189427|FG000|Overall Study|Death|1|||
126245325|NCT02430480|454189427|FG000|Overall Study|Anesthesia concerns|1|||
126245326|NCT02430480|454189427|FG000|Overall Study|Progressed on treatment|1|||
126245327|NCT01154231|454189428|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
126245328|NCT01154231|454189428|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
126245329|NCT01097577|454189429|FG000|Overall Study|Adverse Event|0|||
126245330|NCT01097577|454189430|FG001|Overall Study|Adverse Event|1|||
126694971|NCT00008385|455838570|FG001|Overall Study|Off treatment reasons not reported|70|||
126245331|NCT04493684|454189433|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
126245332|NCT04493684|454189434|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245333|NCT04493684|454189435|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
126694972|NCT00008385|455838569|FG000|Overall Study|Progressive disease|52|||
126694973|NCT00008385|455838570|FG001|Overall Study|Progressive disease|117|||
126694974|NCT00008385|455838569|FG000|Overall Study|Adverse Event|8|||
126694975|NCT00008385|455838570|FG001|Overall Study|Adverse Event|20|||
126694976|NCT00008385|455838569|FG000|Overall Study|Death|12|||
126694977|NCT00008385|455838570|FG001|Overall Study|Death|18|||
126694978|NCT00008385|455838569|FG000|Overall Study|Withdrawal by Subject|67|||
126694979|NCT00008385|455838570|FG001|Overall Study|Withdrawal by Subject|157|||
126694980|NCT00008385|455838569|FG000|Overall Study|Start non-protocol therapy|3|||
126694981|NCT00008385|455838570|FG001|Overall Study|Start non-protocol therapy|1|||
126694982|NCT00008385|455838569|FG000|Overall Study|Other complicating disease|17|||
126694983|NCT00008385|455838570|FG001|Overall Study|Other complicating disease|30|||
126694984|NCT00008385|455838569|FG000|Overall Study|Maximum dose reached|0|||
126694985|NCT00008385|455838570|FG001|Overall Study|Maximum dose reached|2|||
126694986|NCT00008385|455838569|FG000|Overall Study|Other|105|||
126694987|NCT00008385|455838570|FG001|Overall Study|Other|212|||
126694988|NCT00008385|455838569|FG000|Overall Study|Not start protocol therapy|44|||
126694989|NCT00008385|455838570|FG001|Overall Study|Not start protocol therapy|175|||
126694990|NCT00365989|455838571|FG000|Overall Study|Withdrawal by Subject|1|||
126694991|NCT00365989|455838571|FG000|Overall Study|Non-compliance|1|||
126694992|NCT02318095|455838572|FG000|Overall Study|Adverse Event|1|||
126694993|NCT00686127|455838573|FG000|Overall Study|Withdrawal by Subject|14|||
126694994|NCT00686127|455838574|FG001|Overall Study|Withdrawal by Subject|6|||
126694995|NCT06441877|455838575|FG000|Overall Study|Withdrawal by Subject|0|||
126694996|NCT06441877|455838576|FG001|Overall Study|Withdrawal by Subject|2|||
126694997|NCT06441877|455838577|FG002|Overall Study|Withdrawal by Subject|0|||
126694998|NCT06441877|455838578|FG003|Overall Study|Withdrawal by Subject|0|||
126694999|NCT00066690|455838579|FG000|Overall Study|Adverse Event|145|||
126695000|NCT00066690|455838580|FG001|Overall Study|Adverse Event|58|||
126695001|NCT00066690|455838581|FG002|Overall Study|Adverse Event|126|||
126695002|NCT00066690|455838579|FG000|Overall Study|Death|3|||
126695003|NCT00066690|455838580|FG001|Overall Study|Death|0|||
126695004|NCT00066690|455838581|FG002|Overall Study|Death|2|||
126695005|NCT00066690|455838579|FG000|Overall Study|Lack of Efficacy|114|||
126695006|NCT00066690|455838580|FG001|Overall Study|Lack of Efficacy|110|||
126695007|NCT00066690|455838581|FG002|Overall Study|Lack of Efficacy|76|||
126695008|NCT00066690|455838579|FG000|Overall Study|Lost to Follow-up|40|||
126695009|NCT00066690|455838580|FG001|Overall Study|Lost to Follow-up|21|||
126695010|NCT00066690|455838581|FG002|Overall Study|Lost to Follow-up|29|||
126695011|NCT00066690|455838579|FG000|Overall Study|Withdrawal by Subject|50|||
126695012|NCT00066690|455838580|FG001|Overall Study|Withdrawal by Subject|55|||
126695013|NCT00066690|455838581|FG002|Overall Study|Withdrawal by Subject|49|||
126695014|NCT00066690|455838579|FG000|Overall Study|Treatment Ongoing|246|||
126695015|NCT00066690|455838580|FG001|Overall Study|Treatment Ongoing|278|||
126695016|NCT00066690|455838581|FG002|Overall Study|Treatment Ongoing|282|||
126695017|NCT03116113|455838585|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126695018|NCT03116113|455838586|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126695019|NCT03116113|455838587|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126695020|NCT03116113|455838588|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126245334|NCT04493684|454189436|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245335|NCT04493684|454189437|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245336|NCT04493684|454189438|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
126245337|NCT04493684|454189439|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245338|NCT04493684|454189440|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245339|NCT04493684|454189441|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245340|NCT04493684|454189442|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245341|NCT04493684|454189443|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245342|NCT04493684|454189444|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245343|NCT04493684|454189445|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245344|NCT04493684|454189446|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245345|NCT04493684|454189447|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245346|NCT04493684|454189448|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245347|NCT04493684|454189449|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
126245348|NCT04493684|454189433|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
126245349|NCT04493684|454189434|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245350|NCT04493684|454189435|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245351|NCT04493684|454189436|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245352|NCT04493684|454189437|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245353|NCT04493684|454189438|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245354|NCT04493684|454189439|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245355|NCT04493684|454189440|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245356|NCT04493684|454189441|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245357|NCT04493684|454189442|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245358|NCT04493684|454189443|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126357584|NCT04243837|454602150|FG000|Overall Study|Adverse Event|2|||
126357585|NCT04243837|454602151|FG001|Overall Study|Adverse Event|1|||
126357586|NCT04243837|454602150|FG000|Overall Study|Withdrawal by Subject|4|||
126357587|NCT04243837|454602151|FG001|Overall Study|Withdrawal by Subject|2|||
126357588|NCT04243837|454602150|FG000|Overall Study|Covid-19 lock down|1|||
126357589|NCT04243837|454602151|FG001|Overall Study|Covid-19 lock down|0|||
126447776|NCT02078960|454939531|FG002|Follow-up Period|Lost to Follow-up|0|||
126447777|NCT04248491|454939532|FG000|Overall Study|Lost to Follow-up|1|||
126447778|NCT04248491|454939533|FG001|Overall Study|Lost to Follow-up|0|||
126447779|NCT02597478|454939542|FG000|Overall Study|Withdrawal by Subject|2|||
126447780|NCT02597478|454939543|FG001|Overall Study|Withdrawal by Subject|0|||
126447781|NCT02597478|454939542|FG000|Overall Study|Change of opioid dose|1|||
126447782|NCT02597478|454939543|FG001|Overall Study|Change of opioid dose|0|||
126447783|NCT02597478|454939542|FG000|Overall Study|Insufficient exertional dyspnea|0|||
126447784|NCT02597478|454939543|FG001|Overall Study|Insufficient exertional dyspnea|1|||
126447785|NCT01652469|454939544|FG000|Overall Study|Withdrawal by Subject|1|||
126447786|NCT01652469|454939545|FG001|Overall Study|Withdrawal by Subject|4|||
126357590|NCT04243837|454602150|FG000|Overall Study|Study Terminated by Sponsor|11|||
126357591|NCT04243837|454602151|FG001|Overall Study|Study Terminated by Sponsor|12|||
126357592|NCT02280499|454602152|FG000|Overall Study|Death|14|||
126357593|NCT02280499|454602152|FG000|Overall Study|Lost to Follow-up|42|||
126761320|NCT00361504|456077198|FG001|Overall Study|Lack of Efficacy|7|||
126761321|NCT00361504|456077197|FG000|Overall Study|Resolution of Pain|2|||
126761322|NCT00361504|456077198|FG001|Overall Study|Resolution of Pain|0|||
126357594|NCT02280499|454602152|FG000|Overall Study|Adverse Event|5|||
126447787|NCT01652469|454939544|FG000|Overall Study|Lost to Follow-up|0|||
126447788|NCT01652469|454939545|FG001|Overall Study|Lost to Follow-up|2|||
126447789|NCT01402102|454939546|FG000|Overall Study|Protocol Violation|1|||
126761323|NCT00361504|456077197|FG000|Overall Study|Study medication non compliant|42|||
126761324|NCT00361504|456077198|FG001|Overall Study|Study medication non compliant|15|||
126761325|NCT00361504|456077197|FG000|Overall Study|All other|28|||
126761326|NCT00361504|456077198|FG001|Overall Study|All other|3|||
126761327|NCT00450814|456077199|FG000|Overall Study|Failed to complete the initial therapy|0|||
126761328|NCT00450814|456077200|FG001|Overall Study|Failed to complete the initial therapy|0|||
126761329|NCT00450814|456077201|FG002|Overall Study|Failed to complete the initial therapy|0|||
126761330|NCT00450814|456077202|FG003|Overall Study|Failed to complete the initial therapy|1|||
126245359|NCT04493684|454189444|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245360|NCT04493684|454189445|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245361|NCT04493684|454189446|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245362|NCT04493684|454189447|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126357595|NCT00977561|454602155|FG000|Overall Study|Death|3|||
126357596|NCT00977561|454602156|FG001|Overall Study|Death|2|||
126357597|NCT00977561|454602155|FG000|Overall Study|Study terminated|0|||
126357598|NCT00977561|454602156|FG001|Overall Study|Study terminated|2|||
126761331|NCT00450814|456077203|FG004|Overall Study|Failed to complete the initial therapy|1|||
126245363|NCT04493684|454189448|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245364|NCT04493684|454189449|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
126245365|NCT04493684|454189433|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245366|NCT04493684|454189434|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245367|NCT04493684|454189435|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245368|NCT04493684|454189436|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245369|NCT04493684|454189437|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245370|NCT04493684|454189438|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245371|NCT04493684|454189439|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
126245372|NCT04493684|454189440|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245373|NCT04493684|454189441|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245374|NCT04493684|454189442|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245375|NCT04493684|454189443|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245376|NCT04493684|454189444|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245377|NCT04493684|454189445|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245378|NCT04493684|454189446|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245379|NCT04493684|454189447|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245380|NCT04493684|454189448|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245381|NCT04493684|454189449|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
126245382|NCT04493684|454189433|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
126245383|NCT04493684|454189434|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245384|NCT04493684|454189435|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245385|NCT04493684|454189436|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245386|NCT04493684|454189437|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245387|NCT04493684|454189438|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245388|NCT04493684|454189439|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245389|NCT04493684|454189440|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245390|NCT04493684|454189441|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245391|NCT04493684|454189442|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245392|NCT04493684|454189443|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245393|NCT04493684|454189444|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245394|NCT04493684|454189445|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245395|NCT04493684|454189446|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245396|NCT04493684|454189447|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245397|NCT04493684|454189448|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245398|NCT04493684|454189449|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
126245399|NCT04493684|454189433|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245400|NCT04493684|454189434|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245401|NCT04493684|454189435|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245402|NCT04493684|454189436|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245403|NCT04493684|454189437|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245404|NCT04493684|454189438|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
126245405|NCT04493684|454189439|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245406|NCT04493684|454189440|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245407|NCT04493684|454189441|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245408|NCT04493684|454189442|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245409|NCT04493684|454189443|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245410|NCT04493684|454189444|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245411|NCT04493684|454189445|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245412|NCT04493684|454189446|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245413|NCT04493684|454189447|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245414|NCT04493684|454189448|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245415|NCT04493684|454189449|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
126245416|NCT04493684|454189433|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245417|NCT04493684|454189434|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245418|NCT04493684|454189435|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245419|NCT04493684|454189436|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245420|NCT04493684|454189437|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245421|NCT04493684|454189438|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245422|NCT04493684|454189439|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245423|NCT04493684|454189440|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126357599|NCT00977561|454602155|FG000|Overall Study|Other|2|||
126357600|NCT00977561|454602156|FG001|Overall Study|Other|0|||
126245424|NCT04493684|454189441|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245425|NCT04493684|454189442|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245426|NCT04493684|454189443|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245427|NCT04493684|454189444|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
126245428|NCT04493684|454189445|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245429|NCT04493684|454189446|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245430|NCT04493684|454189447|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245431|NCT04493684|454189448|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245432|NCT04493684|454189449|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
126245433|NCT04493684|454189433|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245434|NCT04493684|454189434|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245435|NCT04493684|454189435|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245436|NCT04493684|454189436|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245437|NCT04493684|454189437|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245438|NCT04493684|454189438|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245439|NCT04493684|454189439|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245440|NCT04493684|454189440|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245441|NCT04493684|454189441|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245442|NCT04493684|454189442|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245443|NCT04493684|454189443|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245444|NCT04493684|454189444|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245445|NCT04493684|454189445|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245446|NCT04493684|454189446|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245447|NCT04493684|454189447|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245448|NCT04493684|454189448|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
126245449|NCT04493684|454189449|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
126245450|NCT04493684|454189433|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245451|NCT04493684|454189434|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245452|NCT04493684|454189435|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245453|NCT04493684|454189436|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245454|NCT04493684|454189437|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245455|NCT04493684|454189438|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245456|NCT04493684|454189439|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245457|NCT04493684|454189440|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245458|NCT04493684|454189441|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245459|NCT04493684|454189442|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245460|NCT04493684|454189443|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245461|NCT04493684|454189444|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245462|NCT04493684|454189445|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245463|NCT04493684|454189446|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245464|NCT04493684|454189447|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245465|NCT04493684|454189448|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
126245466|NCT04493684|454189449|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
126245467|NCT01963728|454189450|FG000|Overall Study|Study terminated early|0|||
126245468|NCT01963728|454189451|FG001|Overall Study|Study terminated early|1|||
126245469|NCT05152576|454189452|FG000|Overall Study|Lost to Follow-up|3|||
126245470|NCT05152576|454189453|FG001|Overall Study|Lost to Follow-up|0|||
126245471|NCT05152576|454189454|FG002|Overall Study|Lost to Follow-up|0|||
126245472|NCT05152576|454189455|FG003|Overall Study|Lost to Follow-up|1|||
126245473|NCT05152576|454189452|FG000|Overall Study|Withdrawal by Subject|0|||
126245474|NCT05152576|454189453|FG001|Overall Study|Withdrawal by Subject|1|||
126245475|NCT05152576|454189454|FG002|Overall Study|Withdrawal by Subject|0|||
126245476|NCT05152576|454189455|FG003|Overall Study|Withdrawal by Subject|1|||
126245477|NCT05152576|454189452|FG000|Overall Study|Other|2|||
126245478|NCT05152576|454189453|FG001|Overall Study|Other|0|||
126245479|NCT05152576|454189454|FG002|Overall Study|Other|0|||
126695021|NCT03116113|455838589|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126695022|NCT03116113|455838590|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126245480|NCT05152576|454189455|FG003|Overall Study|Other|0|||
126245481|NCT01376037|454191414|FG000|Overall Study|Lost to Follow-up|0|||
126245482|NCT01376037|454191415|FG001|Overall Study|Lost to Follow-up|2|||
126245483|NCT02328040|454191416|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
126245484|NCT02328040|454191417|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
126245485|NCT04278560|454191422|FG000|Overall Study|Adverse Event|1|||
126245486|NCT04278560|454191423|FG001|Overall Study|Adverse Event|2|||
126695023|NCT03116113|455838591|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
126245487|NCT04278560|454191422|FG000|Overall Study|Withdrawal by Subject|0|||
126245488|NCT04278560|454191423|FG001|Overall Study|Withdrawal by Subject|1|||
126245489|NCT02832063|454191424|FG000|Overall Study|Adverse Event|2|||
126245490|NCT02832063|454191425|FG001|Overall Study|Adverse Event|1|||
126245491|NCT02832063|454191424|FG000|Overall Study|Physician Decision|5|||
126245492|NCT02832063|454191425|FG001|Overall Study|Physician Decision|7|||
126245493|NCT02832063|454191424|FG000|Overall Study|Lost to Follow-up|15|||
126245494|NCT02832063|454191425|FG001|Overall Study|Lost to Follow-up|8|||
126245495|NCT02832063|454191424|FG000|Overall Study|Withdrawal by Subject|10|||
126245496|NCT02832063|454191425|FG001|Overall Study|Withdrawal by Subject|21|||
126245497|NCT02832063|454191424|FG000|Overall Study|Other|2|||
126245498|NCT02832063|454191425|FG001|Overall Study|Other|1|||
126245499|NCT03086460|454191430|FG000|Study Participants|Lost to Follow-up|2|||
126245500|NCT03086460|454191430|FG000|Study Participants|Protocol Violation|1|||
126245501|NCT03086460|454191430|FG000|Study Participants|Withdrawal by Subject|6|||
126245502|NCT03086460|454191430|FG000|Treatment A|Lost to Follow-up|1|||
126245503|NCT03086460|454191430|FG000|Treatment A|Protocol Violation|1|||
126245504|NCT03086460|454191430|FG000|Treatment A|Withdrawal by Subject|2|||
126245505|NCT03086460|454191430|FG000|Treatment C|Withdrawal by Subject|2|||
126245506|NCT03086460|454191430|FG000|Treatment E|Lost to Follow-up|1|||
126545902|NCT03101241|455292500|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
126545903|NCT03101241|455292499|FG000|Overall Study|Participant withdrew consent|3|||
126545904|NCT03101241|455292500|FG001|Overall Study|Participant withdrew consent|1|||
126545905|NCT03101241|455292499|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
126545906|NCT03101241|455292500|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
126545907|NCT03101241|455292499|FG000|Overall Study|Lost to Follow-up|2|||
126545908|NCT03101241|455292500|FG001|Overall Study|Lost to Follow-up|0|||
126545909|NCT03101241|455292499|FG000|Overall Study|Lack of Efficacy|0|||
126545910|NCT03101241|455292500|FG001|Overall Study|Lack of Efficacy|1|||
126545911|NCT03101241|455292499|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
126545912|NCT03101241|455292500|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
126545913|NCT03469349|455292501|FG000|Overall Study|Withdrawal by Subject|1|||
126545914|NCT03469349|455292502|FG001|Overall Study|Withdrawal by Subject|3|||
126545915|NCT03469349|455292501|FG000|Overall Study|Progressive Disease|0|||
126545916|NCT03469349|455292502|FG001|Overall Study|Progressive Disease|1|||
126545917|NCT03469349|455292501|FG000|Overall Study|Lost to Follow-up|2|||
126695024|NCT03116113|455838592|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
126695025|NCT03116113|455838593|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
126695026|NCT02159807|455838594|FG000|Overall Study|Adverse Event|0|||
126695027|NCT02159807|455838595|FG001|Overall Study|Adverse Event|0|||
126695028|NCT02159807|455838596|FG002|Overall Study|Adverse Event|1|||
126695029|NCT02159807|455838594|FG000|Overall Study|No CSF|1|||
126695030|NCT02159807|455838595|FG001|Overall Study|No CSF|1|||
126695031|NCT02159807|455838596|FG002|Overall Study|No CSF|1|||
126695032|NCT02159807|455838594|FG000|Overall Study|elevated blood pressure|0|||
126695033|NCT02159807|455838595|FG001|Overall Study|elevated blood pressure|0|||
126695034|NCT02159807|455838596|FG002|Overall Study|elevated blood pressure|1|||
126695035|NCT05195528|455838598|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
126695036|NCT05195528|455838599|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
126695037|NCT05195528|455838600|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
126695038|NCT05195528|455838601|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
126695039|NCT05195528|455838602|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
126695040|NCT05195528|455838598|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
126695041|NCT05195528|455838599|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
126695042|NCT05195528|455838600|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
126245507|NCT03086460|454191430|FG000|Treatment E|Withdrawal by Subject|3|||
126245508|NCT03600805|454191431|FG000|Overall Study|Adverse Event|2|||
126245509|NCT03600805|454191432|FG001|Overall Study|Adverse Event|1|||
126245510|NCT03600805|454191433|FG002|Overall Study|Adverse Event|1|||
126245511|NCT03600805|454191434|FG003|Overall Study|Adverse Event|7|||
126245512|NCT03600805|454191431|FG000|Overall Study|Lack of Efficacy|2|||
126245513|NCT03600805|454191432|FG001|Overall Study|Lack of Efficacy|1|||
126245514|NCT03600805|454191433|FG002|Overall Study|Lack of Efficacy|0|||
126545918|NCT03469349|455292502|FG001|Overall Study|Lost to Follow-up|2|||
126545919|NCT03469349|455292501|FG000|Overall Study|Adverse Event|2|||
126545920|NCT03469349|455292502|FG001|Overall Study|Adverse Event|4|||
126545921|NCT01678820|455292503|FG000|Overall Study|Study Terminated by Sponsor|45|||
126695043|NCT05195528|455838601|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126695044|NCT05195528|455838602|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
126695045|NCT05195528|455838598|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126695046|NCT05195528|455838599|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
126695047|NCT05195528|455838600|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
126695048|NCT05195528|455838601|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126695049|NCT05195528|455838602|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126695050|NCT05195528|455838598|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
126695051|NCT05195528|455838599|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
126695052|NCT05195528|455838600|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
126245515|NCT03600805|454191434|FG003|Overall Study|Lack of Efficacy|0|||
126447790|NCT01402102|454939547|FG001|Overall Study|Protocol Violation|0|||
126695053|NCT05195528|455838601|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
126695054|NCT05195528|455838602|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
126695055|NCT05195528|455838598|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
126695056|NCT05195528|455838599|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
126695057|NCT05195528|455838600|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
126695058|NCT05195528|455838601|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
126447791|NCT01402102|454939546|FG000|Overall Study|Insufficiency of compliance|1|||
126447792|NCT01402102|454939547|FG001|Overall Study|Insufficiency of compliance|1|||
126447793|NCT01402102|454939546|FG000|Overall Study|Withdrawal by Subject|0|||
126447794|NCT01402102|454939547|FG001|Overall Study|Withdrawal by Subject|2|||
126447795|NCT00796978|454939548|FG000|Overall Study|Cardiac adverse event|5|||
126447796|NCT00796978|454939548|FG000|Overall Study|Adverse Event|4|||
126447797|NCT00796978|454939548|FG000|Overall Study|Withdrawal by Subject|3|||
126447798|NCT02364336|454939549|FG000|Overall Study|Adverse Event|0|||
126447799|NCT02364336|454939550|FG001|Overall Study|Adverse Event|1|||
126447800|NCT02136069|454939552|FG000|Overall Study|UC flare-up|1|||
126447801|NCT02136069|454939553|FG001|Overall Study|UC flare-up|0|||
126447802|NCT02136069|454939552|FG000|Overall Study|Adverse Event|6|||
126447803|NCT02136069|454939553|FG001|Overall Study|Adverse Event|8|||
126447804|NCT02136069|454939552|FG000|Overall Study|Death|0|||
126447805|NCT02136069|454939553|FG001|Overall Study|Death|1|||
126447806|NCT02136069|454939552|FG000|Overall Study|Lack of Efficacy|10|||
126447807|NCT02136069|454939553|FG001|Overall Study|Lack of Efficacy|4|||
126447808|NCT02136069|454939552|FG000|Overall Study|Lost to Follow-up|1|||
126447809|NCT02136069|454939553|FG001|Overall Study|Lost to Follow-up|0|||
126447810|NCT02136069|454939552|FG000|Overall Study|Non-Compliance|1|||
126447811|NCT02136069|454939553|FG001|Overall Study|Non-Compliance|0|||
126447812|NCT02136069|454939552|FG000|Overall Study|Physician Decision|5|||
126447813|NCT02136069|454939553|FG001|Overall Study|Physician Decision|4|||
126447814|NCT02136069|454939552|FG000|Overall Study|Withdrawal by Subject|10|||
126447815|NCT02136069|454939553|FG001|Overall Study|Withdrawal by Subject|11|||
126447816|NCT01092546|454939554|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
126447817|NCT00771953|454939555|FG000|Overall Study|Adverse Event|5|||
126447818|NCT00771953|454939556|FG001|Overall Study|Adverse Event|3|||
126447819|NCT00771953|454939555|FG000|Overall Study|Death|2|||
126447820|NCT00771953|454939556|FG001|Overall Study|Death|2|||
126447821|NCT00771953|454939555|FG000|Overall Study|Progression before active Tx|1|||
126447822|NCT00771953|454939556|FG001|Overall Study|Progression before active Tx|2|||
126447823|NCT00771953|454939555|FG000|Overall Study|Sponsor decision|1|||
126447824|NCT00771953|454939556|FG001|Overall Study|Sponsor decision|0|||
126447825|NCT00771953|454939555|FG000|Overall Study|Other complicating disease|1|||
126447826|NCT00771953|454939556|FG001|Overall Study|Other complicating disease|0|||
126447827|NCT00771953|454939555|FG000|Overall Study|Withdrawal by Subject|0|||
126447828|NCT00771953|454939556|FG001|Overall Study|Withdrawal by Subject|3|||
126447829|NCT01667419|454939559|FG000|Overall Study|Reason Not Specified|1|||
126447830|NCT01667419|454939560|FG001|Overall Study|Reason Not Specified|0|||
126447831|NCT01667419|454939561|FG002|Overall Study|Reason Not Specified|0|||
126447832|NCT01667419|454939562|FG003|Overall Study|Reason Not Specified|0|||
126447833|NCT01667419|454939559|FG000|Overall Study|Withdrawal by Subject|16|||
126447834|NCT01667419|454939560|FG001|Overall Study|Withdrawal by Subject|8|||
126447835|NCT01667419|454939561|FG002|Overall Study|Withdrawal by Subject|9|||
126447836|NCT01667419|454939562|FG003|Overall Study|Withdrawal by Subject|8|||
126245516|NCT03600805|454191431|FG000|Overall Study|Withdrawal by Subject|1|||
126245517|NCT03600805|454191432|FG001|Overall Study|Withdrawal by Subject|0|||
126245518|NCT03600805|454191433|FG002|Overall Study|Withdrawal by Subject|0|||
126447837|NCT01667419|454939559|FG000|Overall Study|Non-compliance|0|||
126447838|NCT01667419|454939560|FG001|Overall Study|Non-compliance|0|||
126447839|NCT01667419|454939561|FG002|Overall Study|Non-compliance|0|||
126447840|NCT01667419|454939562|FG003|Overall Study|Non-compliance|1|||
126447841|NCT01667419|454939559|FG000|Overall Study|Protocol Violation|1|||
126447842|NCT01667419|454939560|FG001|Overall Study|Protocol Violation|0|||
126545922|NCT01678820|455292504|FG001|Overall Study|Study Terminated by Sponsor|43|||
126447843|NCT01667419|454939561|FG002|Overall Study|Protocol Violation|0|||
126545923|NCT01678820|455292505|FG002|Overall Study|Study Terminated by Sponsor|43|||
126545924|NCT01678820|455292503|FG000|Overall Study|Withdrawal by Subject|2|||
126447844|NCT01667419|454939562|FG003|Overall Study|Protocol Violation|0|||
126447845|NCT01667419|454939559|FG000|Overall Study|Lost to Follow-up|7|||
126447846|NCT01667419|454939560|FG001|Overall Study|Lost to Follow-up|6|||
126245519|NCT03600805|454191434|FG003|Overall Study|Withdrawal by Subject|1|||
126245520|NCT03600805|454191431|FG000|Overall Study|Other unspecified|14|||
126245521|NCT03600805|454191432|FG001|Overall Study|Other unspecified|6|||
126245522|NCT03600805|454191433|FG002|Overall Study|Other unspecified|7|||
126245523|NCT03600805|454191434|FG003|Overall Study|Other unspecified|11|||
126245524|NCT06195579|454191435|FG000|Overall Study|Withdrawal by Subject|1|||
126245525|NCT02545283|454191436|FG000|Overall Study|Lost to Follow-up|2|||
126245526|NCT02545283|454191437|FG001|Overall Study|Lost to Follow-up|4|||
126245527|NCT02545283|454191436|FG000|Overall Study|Withdrawal by Subject|5|||
126245528|NCT02545283|454191437|FG001|Overall Study|Withdrawal by Subject|9|||
126245529|NCT02545283|454191436|FG000|Overall Study|Death|109|||
126245530|NCT02545283|454191437|FG001|Overall Study|Death|211|||
126245531|NCT02545283|454191436|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
126245532|NCT02545283|454191437|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
126245533|NCT02545283|454191436|FG000|Overall Study|Study Terminated By Sponsor|33|||
126245534|NCT02545283|454191437|FG001|Overall Study|Study Terminated By Sponsor|71|||
126245535|NCT00443651|454191439|FG000|Overall Study|Death|1|||
126245536|NCT00443651|454191440|FG001|Overall Study|Death|5|||
126245537|NCT00443651|454191439|FG000|Overall Study|Adverse Event|5|||
126245538|NCT00443651|454191440|FG001|Overall Study|Adverse Event|6|||
126245539|NCT00443651|454191439|FG000|Overall Study|Lost to Follow-up|18|||
126245540|NCT00443651|454191440|FG001|Overall Study|Lost to Follow-up|12|||
126245541|NCT00443651|454191439|FG000|Overall Study|Patient's/Guardian's Decision|58|||
126245542|NCT00443651|454191440|FG001|Overall Study|Patient's/Guardian's Decision|30|||
126695059|NCT05195528|455838602|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
126695060|NCT05195528|455838598|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
126695061|NCT05195528|455838599|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
126695062|NCT05195528|455838600|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
126695063|NCT05195528|455838601|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
126695064|NCT05195528|455838602|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
126695065|NCT05195528|455838598|FG000|Placebo-controlled Treatment Period|Other|0|||
126695066|NCT05195528|455838599|FG001|Placebo-controlled Treatment Period|Other|0|||
126695067|NCT05195528|455838600|FG002|Placebo-controlled Treatment Period|Other|1|||
126695068|NCT05195528|455838601|FG003|Placebo-controlled Treatment Period|Other|0|||
126695069|NCT05195528|455838602|FG004|Placebo-controlled Treatment Period|Other|0|||
126695070|NCT05195528|455838598|FG000|Extension Period|PTE or AE or SAE|0|||
126245543|NCT00443651|454191439|FG000|Overall Study|Physician Decision|13|||
126245544|NCT00443651|454191440|FG001|Overall Study|Physician Decision|4|||
126245545|NCT00443651|454191439|FG000|Overall Study|Pregnancy|0|||
126245546|NCT00443651|454191440|FG001|Overall Study|Pregnancy|1|||
126447847|NCT01667419|454939561|FG002|Overall Study|Lost to Follow-up|2|||
126447848|NCT01667419|454939562|FG003|Overall Study|Lost to Follow-up|4|||
126447849|NCT01667419|454939559|FG000|Overall Study|Death|18|||
126447850|NCT01667419|454939560|FG001|Overall Study|Death|33|||
126447851|NCT01667419|454939561|FG002|Overall Study|Death|25|||
126447852|NCT01667419|454939562|FG003|Overall Study|Death|26|||
126447853|NCT04364984|454939564|FG000|Overall Study|Death|2|||
126447854|NCT04364984|454939565|FG001|Overall Study|Death|2|||
126447855|NCT04364984|454939566|FG002|Overall Study|Death|0|||
126695071|NCT05195528|455838599|FG001|Extension Period|PTE or AE or SAE|4|||
126695072|NCT05195528|455838600|FG002|Extension Period|PTE or AE or SAE|5|||
126695073|NCT05195528|455838601|FG003|Extension Period|PTE or AE or SAE|4|||
126695074|NCT05195528|455838602|FG004|Extension Period|PTE or AE or SAE|4|||
126695075|NCT05195528|455838598|FG000|Extension Period|Protocol Violation|0|||
126695076|NCT05195528|455838599|FG001|Extension Period|Protocol Violation|2|||
126695077|NCT05195528|455838600|FG002|Extension Period|Protocol Violation|1|||
126695078|NCT05195528|455838601|FG003|Extension Period|Protocol Violation|0|||
126695079|NCT05195528|455838602|FG004|Extension Period|Protocol Violation|1|||
126695080|NCT05195528|455838598|FG000|Extension Period|Lost to Follow-up|0|||
126695081|NCT05195528|455838599|FG001|Extension Period|Lost to Follow-up|6|||
126695082|NCT05195528|455838600|FG002|Extension Period|Lost to Follow-up|13|||
126695083|NCT05195528|455838601|FG003|Extension Period|Lost to Follow-up|3|||
126695084|NCT05195528|455838602|FG004|Extension Period|Lost to Follow-up|7|||
126245547|NCT01547286|454191445|FG000|Overall Study|Did not meet all eligibility criteria|1|||
126245548|NCT01547286|454191445|FG000|Overall Study|Physician Decision|1|||
126245549|NCT03415308|454191446|FG000|Overall Study|Lost to Follow-up|0|||
126245550|NCT03415308|454191447|FG001|Overall Study|Lost to Follow-up|0|||
126245551|NCT03415308|454191448|FG002|Overall Study|Lost to Follow-up|1|||
126245552|NCT03415308|454191446|FG000|Overall Study|Scheduling Conflicts|0|||
126245553|NCT03415308|454191447|FG001|Overall Study|Scheduling Conflicts|0|||
126245554|NCT03415308|454191448|FG002|Overall Study|Scheduling Conflicts|7|||
126245555|NCT01471353|454191450|FG000|Overall Study|remain on study|3|||
126245556|NCT00836472|454191451|FG000|Washout|Adverse Event|1|||
126245557|NCT00836472|454191452|FG001|Washout|Adverse Event|2|||
126447856|NCT05246514|454939567|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
126447857|NCT05246514|454939567|FG000|Overall Study|Withdrawal by Subject|1|||
126447858|NCT05246514|454939567|FG000|Overall Study|Death|13|||
126447859|NCT02910986|454939568|FG000|Overall Study|non-Latina|14|||
126245558|NCT00836472|454191451|FG000|Washout|Withdrawal by Subject|1|||
126245559|NCT00836472|454191452|FG001|Washout|Withdrawal by Subject|1|||
126245560|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
126245561|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
126245562|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
126245563|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
126245564|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245565|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245566|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245567|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245568|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245569|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245570|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245571|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126695085|NCT05195528|455838598|FG000|Extension Period|Withdrawal by Subject|0|||
126245572|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245573|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
126245574|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
126245575|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
126695086|NCT05195528|455838599|FG001|Extension Period|Withdrawal by Subject|12|||
126695087|NCT05195528|455838600|FG002|Extension Period|Withdrawal by Subject|9|||
126695088|NCT05195528|455838601|FG003|Extension Period|Withdrawal by Subject|6|||
126695089|NCT05195528|455838602|FG004|Extension Period|Withdrawal by Subject|5|||
126695090|NCT05195528|455838598|FG000|Extension Period|Lack of Efficacy|0|||
126695091|NCT05195528|455838599|FG001|Extension Period|Lack of Efficacy|3|||
126695092|NCT05195528|455838600|FG002|Extension Period|Lack of Efficacy|0|||
126695093|NCT05195528|455838601|FG003|Extension Period|Lack of Efficacy|0|||
126695094|NCT05195528|455838602|FG004|Extension Period|Lack of Efficacy|2|||
126695095|NCT05195528|455838598|FG000|Extension Period|Not Treated|0|||
126695096|NCT05195528|455838599|FG001|Extension Period|Not Treated|0|||
126695097|NCT05195528|455838600|FG002|Extension Period|Not Treated|2|||
126695098|NCT05195528|455838601|FG003|Extension Period|Not Treated|3|||
126695099|NCT05195528|455838602|FG004|Extension Period|Not Treated|0|||
126695100|NCT05195528|455838598|FG000|Extension Period|Other|0|||
126695101|NCT05195528|455838599|FG001|Extension Period|Other|1|||
126695102|NCT05195528|455838600|FG002|Extension Period|Other|1|||
126695103|NCT05195528|455838601|FG003|Extension Period|Other|0|||
126695104|NCT05195528|455838602|FG004|Extension Period|Other|0|||
126695105|NCT01552902|455838603|FG000|Overall Study|Adverse Event|1|||
126695106|NCT01552902|455838604|FG001|Overall Study|Adverse Event|15|||
126695107|NCT01552902|455838605|FG002|Overall Study|Adverse Event|14|||
126695108|NCT01552902|455838603|FG000|Overall Study|Protocol Violation|3|||
126695109|NCT01552902|455838604|FG001|Overall Study|Protocol Violation|3|||
126695110|NCT01552902|455838605|FG002|Overall Study|Protocol Violation|3|||
126695111|NCT01552902|455838603|FG000|Overall Study|Lack of Efficacy|4|||
126695112|NCT01552902|455838604|FG001|Overall Study|Lack of Efficacy|3|||
126695113|NCT01552902|455838605|FG002|Overall Study|Lack of Efficacy|1|||
126695114|NCT01552902|455838603|FG000|Overall Study|Withdrawal by Subject|1|||
126695115|NCT01552902|455838604|FG001|Overall Study|Withdrawal by Subject|9|||
126695116|NCT01552902|455838605|FG002|Overall Study|Withdrawal by Subject|6|||
126695117|NCT01552902|455838603|FG000|Overall Study|Lost to Follow-up|1|||
126695118|NCT01552902|455838604|FG001|Overall Study|Lost to Follow-up|3|||
126695119|NCT01552902|455838605|FG002|Overall Study|Lost to Follow-up|6|||
126695120|NCT01552902|455838603|FG000|Overall Study|Other|3|||
126695121|NCT01552902|455838604|FG001|Overall Study|Other|4|||
126695122|NCT01552902|455838605|FG002|Overall Study|Other|3|||
126695123|NCT02487108|455838609|FG000|Overall Study|Adverse Event|1|||
126695124|NCT02487108|455838610|FG001|Overall Study|Adverse Event|6|||
126695125|NCT02487108|455838611|FG002|Overall Study|Adverse Event|12|||
126695126|NCT02487108|455838612|FG003|Overall Study|Adverse Event|6|||
126695127|NCT02487108|455838609|FG000|Overall Study|Withdrawal by Subject|8|||
126695128|NCT02487108|455838610|FG001|Overall Study|Withdrawal by Subject|5|||
126245576|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
126245577|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
126695129|NCT02487108|455838611|FG002|Overall Study|Withdrawal by Subject|5|||
126695130|NCT02487108|455838612|FG003|Overall Study|Withdrawal by Subject|0|||
126695131|NCT02487108|455838609|FG000|Overall Study|Non-compliance to study medication|3|||
126695132|NCT02487108|455838610|FG001|Overall Study|Non-compliance to study medication|2|||
126695133|NCT02487108|455838611|FG002|Overall Study|Non-compliance to study medication|5|||
126695134|NCT02487108|455838612|FG003|Overall Study|Non-compliance to study medication|4|||
126695135|NCT02487108|455838609|FG000|Overall Study|Protocol Violation|1|||
126695136|NCT02487108|455838610|FG001|Overall Study|Protocol Violation|1|||
126695137|NCT02487108|455838611|FG002|Overall Study|Protocol Violation|2|||
126245578|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126695138|NCT02487108|455838612|FG003|Overall Study|Protocol Violation|0|||
126695139|NCT02487108|455838609|FG000|Overall Study|Non-compliance to study procedures|0|||
126245579|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245580|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245581|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245582|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245583|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245584|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245585|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245586|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245587|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
126245588|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
126245589|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245590|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
126245591|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245592|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245593|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245594|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245595|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245596|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245597|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245598|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245599|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245600|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245601|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
126245602|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
126245603|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
126245604|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
126245605|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245606|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245607|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245608|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245609|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245610|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245611|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245612|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245613|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245614|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245615|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
126245616|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
126245617|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245618|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
126245619|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245620|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245621|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245622|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245623|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245624|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245625|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245626|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245627|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245628|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245629|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
126245630|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
126245631|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126447860|NCT02910986|454939569|FG001|Overall Study|non-Latina|13|||
126245632|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
126245633|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245634|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245635|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245636|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245637|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245638|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245639|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245640|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245641|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245642|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126447861|NCT02910986|454939570|FG002|Overall Study|non-Latina|12|||
126447862|NCT02910986|454939568|FG000|Overall Study|Failure to return T! survey|72|||
126245643|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
126245644|NCT01695239|454191453|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
126245645|NCT01695239|454191454|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245646|NCT01695239|454191455|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245647|NCT01695239|454191456|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245648|NCT01695239|454191457|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245649|NCT01695239|454191458|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245650|NCT01695239|454191459|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245651|NCT01695239|454191460|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245652|NCT01695239|454191461|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245653|NCT01695239|454191462|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245654|NCT01695239|454191463|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245655|NCT01695239|454191464|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245656|NCT01695239|454191465|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245657|NCT01695239|454191466|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
126245658|NCT01695239|454191453|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245659|NCT01695239|454191454|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245660|NCT01695239|454191455|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245661|NCT01695239|454191456|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245662|NCT01695239|454191457|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245663|NCT01695239|454191458|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245664|NCT01695239|454191459|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245665|NCT01695239|454191460|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
126245666|NCT01695239|454191461|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245667|NCT01695239|454191462|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245668|NCT01695239|454191463|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245669|NCT01695239|454191464|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245670|NCT01695239|454191465|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245671|NCT01695239|454191466|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
126245672|NCT01695239|454191453|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245673|NCT01695239|454191454|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245674|NCT01695239|454191455|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245675|NCT01695239|454191456|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245676|NCT01695239|454191457|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245677|NCT01695239|454191458|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245678|NCT01695239|454191459|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245679|NCT01695239|454191460|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
126245680|NCT01695239|454191461|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245681|NCT01695239|454191462|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245682|NCT01695239|454191463|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245683|NCT01695239|454191464|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245684|NCT01695239|454191465|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245685|NCT01695239|454191466|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
126245686|NCT01695239|454191453|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245687|NCT01695239|454191454|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245688|NCT01695239|454191455|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245689|NCT01695239|454191456|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245690|NCT01695239|454191457|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245691|NCT01695239|454191458|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245692|NCT01695239|454191459|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245693|NCT01695239|454191460|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
126245694|NCT01695239|454191461|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245695|NCT01695239|454191462|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245696|NCT01695239|454191463|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245697|NCT01695239|454191464|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245698|NCT01695239|454191465|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245699|NCT01695239|454191466|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
126245700|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126695140|NCT02487108|455838610|FG001|Overall Study|Non-compliance to study procedures|0|||
126695141|NCT02487108|455838611|FG002|Overall Study|Non-compliance to study procedures|0|||
126695142|NCT02487108|455838612|FG003|Overall Study|Non-compliance to study procedures|1|||
126695143|NCT02487108|455838609|FG000|Overall Study|Other than specified|3|||
126695144|NCT02487108|455838610|FG001|Overall Study|Other than specified|2|||
126695145|NCT02487108|455838611|FG002|Overall Study|Other than specified|2|||
126695146|NCT02487108|455838612|FG003|Overall Study|Other than specified|0|||
126245701|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245702|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245703|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245704|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245705|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245706|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245707|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245708|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
126245709|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
126245710|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245711|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245712|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245713|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
126245714|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
126245715|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
126245716|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
126245717|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
126245718|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
126245719|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
126245720|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
126245721|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
126245722|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
126245723|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
126245724|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
126245725|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
126245726|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
126245727|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
126245728|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245729|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245730|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245731|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245732|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245733|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245734|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245735|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245736|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
126245737|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
126245738|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245739|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245740|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245741|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
126245742|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
126245743|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
126245744|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
126245745|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
126245746|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
126245747|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
126245748|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
126245749|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
126245750|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
126245751|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
126245752|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
126245753|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
126245754|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
126245755|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
126245756|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245757|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245758|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245759|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245760|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126761332|NCT00450814|456077204|FG005|Overall Study|Failed to complete the initial therapy|1|||
126761333|NCT00450814|456077205|FG006|Overall Study|Failed to complete the initial therapy|0|||
126761334|NCT00450814|456077206|FG007|Overall Study|Failed to complete the initial therapy|0|||
126761335|NCT00450814|456077207|FG008|Overall Study|Failed to complete the initial therapy|0|||
126245761|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245762|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245763|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245764|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
126245765|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
126245766|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245767|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245768|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245769|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
126245770|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245771|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245772|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245773|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245774|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245775|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245776|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245777|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245778|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
126245779|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
126245780|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245781|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245782|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245783|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
126245784|NCT01695239|454191453|FG000|Extension Long-Term Extension Periods|Death|0|||
126245785|NCT01695239|454191454|FG001|Extension Long-Term Extension Periods|Death|0|||
126245786|NCT01695239|454191455|FG002|Extension Long-Term Extension Periods|Death|0|||
126245787|NCT01695239|454191456|FG003|Extension Long-Term Extension Periods|Death|0|||
126245788|NCT01695239|454191457|FG004|Extension Long-Term Extension Periods|Death|0|||
126245789|NCT01695239|454191458|FG005|Extension Long-Term Extension Periods|Death|0|||
126245790|NCT01695239|454191459|FG006|Extension Long-Term Extension Periods|Death|0|||
126245791|NCT01695239|454191460|FG007|Extension Long-Term Extension Periods|Death|0|||
126245792|NCT01695239|454191461|FG008|Extension Long-Term Extension Periods|Death|1|||
126245793|NCT01695239|454191462|FG009|Extension Long-Term Extension Periods|Death|0|||
126245794|NCT01695239|454191463|FG010|Extension Long-Term Extension Periods|Death|0|||
126245795|NCT01695239|454191464|FG011|Extension Long-Term Extension Periods|Death|0|||
126245796|NCT01695239|454191465|FG012|Extension Long-Term Extension Periods|Death|0|||
126245797|NCT01695239|454191466|FG013|Extension Long-Term Extension Periods|Death|0|||
126245798|NCT01695239|454191453|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245799|NCT01695239|454191454|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245800|NCT01695239|454191455|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245801|NCT01695239|454191456|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126357601|NCT01968785|454602164|FG000|Overall Study|Withdrawal by Subject|1|||
126357602|NCT01968785|454602165|FG001|Overall Study|Withdrawal by Subject|0|||
126357603|NCT04000724|454602172|FG000|Overall Study|Withdrawal by Subject|5|||
126357604|NCT04000724|454602173|FG001|Overall Study|Withdrawal by Subject|3|||
126357605|NCT04000724|454602174|FG002|Overall Study|Withdrawal by Subject|4|||
126357606|NCT04000724|454602172|FG000|Overall Study|Lost to Follow-up|11|||
126357607|NCT04000724|454602173|FG001|Overall Study|Lost to Follow-up|7|||
126357608|NCT04000724|454602174|FG002|Overall Study|Lost to Follow-up|13|||
126357609|NCT00455455|454602175|FG000|Washout|Withdrawal by Subject|0|||
126357610|NCT00455455|454602176|FG001|Washout|Withdrawal by Subject|1|||
126357611|NCT00455455|454602175|FG000|Washout|Withdrawal by Subject|1|||
126357612|NCT00455455|454602176|FG001|Washout|Withdrawal by Subject|0|||
126357613|NCT01827943|454602177|FG000|Overall Study|Protocol Violation|8|||
126357614|NCT01827943|454602177|FG000|Overall Study|Never treated because of an rapid progression|1|||
126357615|NCT04689009|454602182|FG000|Overall Study|Adverse Event|1|||
126357616|NCT04689009|454602183|FG001|Overall Study|Adverse Event|0|||
126357617|NCT04689009|454602182|FG000|Overall Study|Lost to Follow-up|1|||
126357618|NCT04689009|454602183|FG001|Overall Study|Lost to Follow-up|2|||
126357619|NCT04689009|454602182|FG000|Overall Study|Withdrawal by Subject|4|||
126357620|NCT04689009|454602183|FG001|Overall Study|Withdrawal by Subject|3|||
126357621|NCT04689009|454602182|FG000|Overall Study|Protocol Violation|1|||
126357622|NCT04689009|454602183|FG001|Overall Study|Protocol Violation|0|||
126357623|NCT00545948|454602185|FG000|Overall Study|Not Treated|1|||
126357624|NCT00545948|454602186|FG001|Overall Study|Not Treated|1|||
126357625|NCT00545948|454602187|FG002|Overall Study|Not Treated|7|||
126357626|NCT02187055|454602190|FG000|Overall Study|Lack of Efficacy|10|||
126357627|NCT02187055|454602191|FG001|Overall Study|Lack of Efficacy|3|||
126447863|NCT02910986|454939569|FG001|Overall Study|Failure to return T! survey|84|||
126447864|NCT02910986|454939570|FG002|Overall Study|Failure to return T! survey|72|||
126357628|NCT02187055|454602192|FG002|Overall Study|Lack of Efficacy|7|||
126357629|NCT02187055|454602190|FG000|Overall Study|Lost to Follow-up|2|||
126695147|NCT01254669|455838613|FG000|Overall Study|Withdrawal by Subject|0|||
126695148|NCT01254669|455838614|FG001|Overall Study|Withdrawal by Subject|1|||
126695149|NCT01254669|455838613|FG000|Overall Study|time constraint|2|||
126695150|NCT01254669|455838614|FG001|Overall Study|time constraint|2|||
126695151|NCT01254669|455838613|FG000|Overall Study|called to clinic during intervention|1|||
126695152|NCT01254669|455838614|FG001|Overall Study|called to clinic during intervention|1|||
126695153|NCT02367521|455838615|FG000|Overall Study|severe headache after intervention|2|||
126695154|NCT02367521|455838616|FG001|Overall Study|severe headache after intervention|0|||
126695155|NCT02367521|455838615|FG000|Overall Study|unable to find transportation|2|||
126695156|NCT02367521|455838616|FG001|Overall Study|unable to find transportation|0|||
126695157|NCT00600171|455838617|FG000|Overall Study|Adverse Event|0|||
126695158|NCT00600171|455838618|FG001|Overall Study|Adverse Event|1|||
126695159|NCT00600171|455838619|FG002|Overall Study|Adverse Event|0|||
126695160|NCT00600171|455838620|FG003|Overall Study|Adverse Event|0|||
126695161|NCT00600171|455838621|FG004|Overall Study|Adverse Event|1|||
126695162|NCT00600171|455838622|FG005|Overall Study|Adverse Event|0|||
126695163|NCT00600171|455838617|FG000|Overall Study|Lack of Efficacy|9|||
126761336|NCT00450814|456077208|FG009|Overall Study|Failed to complete the initial therapy|0|||
126761337|NCT00450814|456077209|FG010|Overall Study|Failed to complete the initial therapy|0|||
126761338|NCT00450814|456077199|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
126761339|NCT00450814|456077200|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
126245802|NCT01695239|454191457|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245803|NCT01695239|454191458|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245804|NCT01695239|454191459|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245805|NCT01695239|454191460|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245806|NCT01695239|454191461|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245807|NCT01695239|454191462|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245808|NCT01695239|454191463|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126245809|NCT01695239|454191464|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
126245810|NCT01695239|454191465|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
126245811|NCT01695239|454191466|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
126245812|NCT01695239|454191453|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245813|NCT01695239|454191454|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245814|NCT01695239|454191455|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245815|NCT01695239|454191456|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245816|NCT01695239|454191457|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245817|NCT01695239|454191458|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245818|NCT01695239|454191459|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245819|NCT01695239|454191460|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245820|NCT01695239|454191461|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245821|NCT01695239|454191462|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245822|NCT01695239|454191463|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245823|NCT01695239|454191464|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126245824|NCT01695239|454191465|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
126245825|NCT01695239|454191466|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
126245826|NCT01695239|454191453|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245827|NCT01695239|454191454|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245828|NCT01695239|454191455|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245829|NCT01695239|454191456|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245830|NCT01695239|454191457|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245831|NCT01695239|454191458|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245832|NCT01695239|454191459|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245833|NCT01695239|454191460|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245834|NCT01695239|454191461|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245835|NCT01695239|454191462|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245836|NCT01695239|454191463|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245837|NCT01695239|454191464|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245838|NCT01695239|454191465|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
126245839|NCT01695239|454191466|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
126245840|NCT01695239|454191453|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126761340|NCT00450814|456077201|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
126245841|NCT01695239|454191454|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245842|NCT01695239|454191455|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245843|NCT01695239|454191456|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126357630|NCT02187055|454602191|FG001|Overall Study|Lost to Follow-up|7|||
126695164|NCT00600171|455838618|FG001|Overall Study|Lack of Efficacy|12|||
126695165|NCT00600171|455838619|FG002|Overall Study|Lack of Efficacy|3|||
126695166|NCT00600171|455838620|FG003|Overall Study|Lack of Efficacy|5|||
126761341|NCT00450814|456077202|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
126245844|NCT01695239|454191457|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245845|NCT01695239|454191458|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245846|NCT01695239|454191459|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245847|NCT01695239|454191460|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245848|NCT01695239|454191461|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245849|NCT01695239|454191462|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245850|NCT01695239|454191463|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245851|NCT01695239|454191464|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245852|NCT01695239|454191465|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126245853|NCT01695239|454191466|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
126245854|NCT03502811|454191468|FG000|Overall Study|Death|157|||
126245855|NCT03502811|454191468|FG000|Overall Study|Withdrawal by Subject|105|||
126245856|NCT03502811|454191468|FG000|Overall Study|Lost to Follow-up|26|||
126245857|NCT03502811|454191468|FG000|Overall Study|No Visits (Missed)|31|||
126245858|NCT01735994|454191469|FG000|Overall Study|Withdrawal by Subject|6|||
126245859|NCT01735994|454191470|FG001|Overall Study|Withdrawal by Subject|4|||
126245860|NCT01735994|454191469|FG000|Overall Study|Injury|2|||
126245861|NCT01735994|454191470|FG001|Overall Study|Injury|0|||
126245862|NCT01735994|454191469|FG000|Overall Study|Kicked off team|5|||
126245863|NCT01735994|454191470|FG001|Overall Study|Kicked off team|0|||
126245864|NCT01735994|454191469|FG000|Overall Study|Lost to Follow-up|50|||
126245865|NCT01735994|454191470|FG001|Overall Study|Lost to Follow-up|62|||
126245866|NCT02241551|454191473|FG000|Overall Study|Adverse Event|1|||
126245867|NCT02241551|454191474|FG001|Overall Study|Adverse Event|0|||
126245868|NCT00469898|454191478|FG000|Overall Study|Adverse Event|7|||
126245869|NCT00469898|454191478|FG000|Overall Study|Withdrawal by Subject|4|||
126245870|NCT00469898|454191478|FG000|Overall Study|Death|4|||
126245871|NCT00469898|454191478|FG000|Overall Study|Disease progression|9|||
126245872|NCT00469898|454191478|FG000|Overall Study|Decreased performance status|1|||
126245873|NCT01205035|454191479|FG000|Overall Study|Withdrawal by Subject|1|||
126245874|NCT01205035|454191480|FG001|Overall Study|Withdrawal by Subject|0|||
126245875|NCT01205035|454191479|FG000|Overall Study|Physician Decision|1|||
126245876|NCT01205035|454191480|FG001|Overall Study|Physician Decision|0|||
126245877|NCT00392665|454191482|FG000|Overall Study|Death|16|||
126245878|NCT00392665|454191483|FG001|Overall Study|Death|14|||
126245879|NCT00392665|454191482|FG000|Overall Study|Lost to Follow-up|1|||
126245880|NCT00392665|454191483|FG001|Overall Study|Lost to Follow-up|1|||
126245881|NCT02294786|454191486|FG000|Overall Study|Withdrawal by Subject|0|||
126245882|NCT02294786|454191487|FG001|Overall Study|Withdrawal by Subject|1|||
126245883|NCT02294786|454191486|FG000|Overall Study|Physician Decision|6|||
126245884|NCT02294786|454191487|FG001|Overall Study|Physician Decision|7|||
126245885|NCT02294786|454191486|FG000|Overall Study|Lost to Follow-up|1|||
126245886|NCT02294786|454191487|FG001|Overall Study|Lost to Follow-up|2|||
126245887|NCT02294786|454191486|FG000|Overall Study|Protocol Violation|1|||
126245888|NCT02294786|454191487|FG001|Overall Study|Protocol Violation|0|||
126245889|NCT02294786|454191486|FG000|Overall Study|Adverse Event|1|||
126245890|NCT02294786|454191487|FG001|Overall Study|Adverse Event|1|||
126245891|NCT02294786|454191486|FG000|Overall Study|Death|2|||
126245892|NCT02294786|454191487|FG001|Overall Study|Death|3|||
126245893|NCT01778010|454191488|FG000|Overall Study|Withdrawal by Subject|2|||
126245894|NCT01778010|454191488|FG000|Overall Study|abnormal ECG before meds|1|||
126245895|NCT01778010|454191488|FG000|Overall Study|Arrested|1|||
126245896|NCT01778010|454191488|FG000|Overall Study|rash while on placebo|1|||
126245897|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
126245898|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
126245899|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
126245900|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
126245901|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
126245902|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
126245903|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
126245904|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
126245905|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
126245906|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
126245907|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
126245908|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
126245909|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
126245910|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
126245911|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
126245912|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
126245913|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
126245914|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
126357631|NCT02187055|454602192|FG002|Overall Study|Lost to Follow-up|3|||
126357632|NCT02187055|454602190|FG000|Overall Study|No longer meets eligibility criteria|0|||
126357633|NCT02187055|454602191|FG001|Overall Study|No longer meets eligibility criteria|2|||
126245915|NCT01667679|454191489|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
126245916|NCT01667679|454191490|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
126245917|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
126245918|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
126245919|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
126245920|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
126245921|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
126245922|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
126245923|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
126245924|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
126245925|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
126245926|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
126245927|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
126245928|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
126245929|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
126245930|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
126245931|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
126245932|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
126245933|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
126245934|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
126245935|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
126245936|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
126245937|NCT01667679|454191489|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
126245938|NCT01667679|454191490|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
126245939|NCT02159183|454191491|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
126245940|NCT02159183|454191492|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
126245941|NCT02159183|454191491|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
126245942|NCT02159183|454191492|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
126245943|NCT02159183|454191491|FG000|Analysis After the 36 Months Follow-up|Death|0|||
126245944|NCT02159183|454191492|FG001|Analysis After the 36 Months Follow-up|Death|1|||
126245945|NCT02159183|454191491|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
126245946|NCT02159183|454191492|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
126245947|NCT02159183|454191491|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
126245948|NCT02159183|454191492|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
126245949|NCT01294917|454191496|FG000|Overall Study|Relocation|5|||
126245950|NCT01294917|454191496|FG000|Overall Study|Inconvenience|1|||
126245951|NCT02519348|454191497|FG000|Overall Study|Death|31|||
126245952|NCT02519348|454191498|FG001|Overall Study|Death|74|||
126245953|NCT02519348|454191499|FG002|Overall Study|Death|47|||
126245954|NCT02519348|454191500|FG003|Overall Study|Death|54|||
126245955|NCT02519348|454191501|FG004|Overall Study|Death|63|||
126245956|NCT02519348|454191502|FG005|Overall Study|Death|18|||
126245957|NCT02519348|454191503|FG006|Overall Study|Death|2|||
126245958|NCT02519348|454191504|FG007|Overall Study|Death|5|||
126245959|NCT02519348|454191505|FG008|Overall Study|Death|5|||
126245960|NCT02519348|454191497|FG000|Overall Study|Withdrawal by Subject|4|||
126245961|NCT02519348|454191498|FG001|Overall Study|Withdrawal by Subject|7|||
126245962|NCT02519348|454191499|FG002|Overall Study|Withdrawal by Subject|4|||
126245963|NCT02519348|454191500|FG003|Overall Study|Withdrawal by Subject|3|||
126245964|NCT02519348|454191501|FG004|Overall Study|Withdrawal by Subject|3|||
126245965|NCT02519348|454191502|FG005|Overall Study|Withdrawal by Subject|2|||
126245966|NCT02519348|454191503|FG006|Overall Study|Withdrawal by Subject|0|||
126245967|NCT02519348|454191504|FG007|Overall Study|Withdrawal by Subject|0|||
126245968|NCT02519348|454191505|FG008|Overall Study|Withdrawal by Subject|1|||
126245969|NCT02519348|454191497|FG000|Overall Study|Lost to Follow-up|0|||
126245970|NCT02519348|454191498|FG001|Overall Study|Lost to Follow-up|0|||
126245971|NCT02519348|454191499|FG002|Overall Study|Lost to Follow-up|1|||
126245972|NCT02519348|454191500|FG003|Overall Study|Lost to Follow-up|0|||
126245973|NCT02519348|454191501|FG004|Overall Study|Lost to Follow-up|2|||
126245974|NCT02519348|454191502|FG005|Overall Study|Lost to Follow-up|1|||
126245975|NCT02519348|454191503|FG006|Overall Study|Lost to Follow-up|1|||
126245976|NCT02519348|454191504|FG007|Overall Study|Lost to Follow-up|0|||
126245977|NCT02519348|454191505|FG008|Overall Study|Lost to Follow-up|0|||
126245978|NCT02519348|454191497|FG000|Overall Study|Other|0|||
126245979|NCT02519348|454191498|FG001|Overall Study|Other|3|||
126245980|NCT02519348|454191499|FG002|Overall Study|Other|0|||
126245981|NCT02519348|454191500|FG003|Overall Study|Other|0|||
126245982|NCT02519348|454191501|FG004|Overall Study|Other|1|||
126245983|NCT02519348|454191502|FG005|Overall Study|Other|0|||
126245984|NCT02519348|454191503|FG006|Overall Study|Other|0|||
126245985|NCT02519348|454191504|FG007|Overall Study|Other|0|||
126245986|NCT02519348|454191505|FG008|Overall Study|Other|0|||
126245987|NCT02519348|454191497|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
126695167|NCT00600171|455838621|FG004|Overall Study|Lack of Efficacy|4|||
126245988|NCT02519348|454191498|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
126245989|NCT02519348|454191499|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
126245990|NCT02519348|454191500|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
126245991|NCT02519348|454191501|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
126245992|NCT02519348|454191502|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
126245993|NCT02519348|454191503|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
126245994|NCT02519348|454191504|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
126245995|NCT02519348|454191505|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
126245996|NCT01444378|454191506|FG000|Overall Study|Lost to Follow-up|1|||
126245997|NCT01444378|454191506|FG000|Overall Study|Withdrawal by Subject|1|||
126245998|NCT01444378|454191506|FG000|Overall Study|Death|3|||
126245999|NCT01444378|454191506|FG000|Overall Study|Administrative Closure Of The Study|2|||
126246000|NCT01444378|454191506|FG000|Overall Study|Missed Visits|10|||
126246001|NCT02911792|454191507|FG000|Overall Study|Lost to Follow-up|3|||
126246002|NCT02911792|454191508|FG001|Overall Study|Lost to Follow-up|3|||
126246003|NCT02911792|454191509|FG002|Overall Study|Lost to Follow-up|3|||
126246004|NCT02911792|454191510|FG003|Overall Study|Lost to Follow-up|3|||
126246005|NCT01929863|454191520|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
126246006|NCT01929863|454191521|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
126246007|NCT01929863|454191520|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
126246008|NCT01929863|454191521|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
126246009|NCT01929863|454191520|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
126246010|NCT01929863|454191521|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
126246011|NCT00323882|454191522|FG000|Overall Study|Adverse Event|2|||
126246012|NCT00323882|454191523|FG001|Overall Study|Adverse Event|1|||
126246013|NCT00323882|454191524|FG002|Overall Study|Adverse Event|1|||
126246014|NCT00323882|454191525|FG003|Overall Study|Adverse Event|1|||
126246015|NCT00323882|454191526|FG004|Overall Study|Adverse Event|3|||
126246016|NCT00323882|454191522|FG000|Overall Study|Disease Progression|6|||
126246017|NCT00323882|454191523|FG001|Overall Study|Disease Progression|4|||
126246018|NCT00323882|454191524|FG002|Overall Study|Disease Progression|10|||
126246019|NCT00323882|454191525|FG003|Overall Study|Disease Progression|5|||
126246020|NCT00323882|454191526|FG004|Overall Study|Disease Progression|22|||
126246021|NCT00323882|454191522|FG000|Overall Study|Death|0|||
126246022|NCT00323882|454191523|FG001|Overall Study|Death|1|||
126246023|NCT00323882|454191524|FG002|Overall Study|Death|1|||
126246024|NCT00323882|454191525|FG003|Overall Study|Death|0|||
126246025|NCT00323882|454191526|FG004|Overall Study|Death|5|||
126246026|NCT00323882|454191522|FG000|Overall Study|Lost to Follow-up|0|||
126246027|NCT00323882|454191523|FG001|Overall Study|Lost to Follow-up|0|||
126246028|NCT00323882|454191524|FG002|Overall Study|Lost to Follow-up|1|||
126246029|NCT00323882|454191525|FG003|Overall Study|Lost to Follow-up|0|||
126246030|NCT00323882|454191526|FG004|Overall Study|Lost to Follow-up|1|||
126246031|NCT00323882|454191522|FG000|Overall Study|Other|0|||
126246032|NCT00323882|454191523|FG001|Overall Study|Other|0|||
126246033|NCT00323882|454191524|FG002|Overall Study|Other|0|||
126246034|NCT00323882|454191525|FG003|Overall Study|Other|1|||
126246035|NCT00323882|454191526|FG004|Overall Study|Other|1|||
126246036|NCT02911701|454191527|FG000|Overall Study|Withdrawal by Subject|2|||
126246037|NCT02911701|454191528|FG001|Overall Study|Withdrawal by Subject|4|||
126246038|NCT02911701|454191527|FG000|Overall Study|Adverse Event|1|||
126246039|NCT02911701|454191528|FG001|Overall Study|Adverse Event|0|||
126246040|NCT00830024|454191529|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
126246041|NCT00830024|454191530|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
126246042|NCT01983969|454191531|FG000|Overall Study|Disease Progression|0|||
126246043|NCT01983969|454191532|FG001|Overall Study|Disease Progression|1|||
126246044|NCT01983969|454191533|FG002|Overall Study|Disease Progression|0|||
126246045|NCT00436163|454191534|FG000|Overall Study|Lost to Follow-up|2|||
126246046|NCT00436163|454191534|FG000|Overall Study|Adverse Event|1|||
126246047|NCT02530905|454191535|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
126246048|NCT02530905|454191536|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
126246049|NCT02530905|454191537|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
126246050|NCT01841554|454191539|FG000|Overall Study|Death|7|||
126246051|NCT01841554|454191539|FG000|Overall Study|No Implantation|1|||
126246052|NCT01841554|454191539|FG000|Overall Study|Discontinued Follow Up|5|||
126246053|NCT01841554|454191539|FG000|Overall Study|Study exit due to secondary intervention|6|||
126695168|NCT00600171|455838622|FG005|Overall Study|Lack of Efficacy|0|||
126246054|NCT03804983|454191543|FG000|Overall Study|Adverse Event|0|||
126246055|NCT03804983|454191544|FG001|Overall Study|Adverse Event|1|||
126695169|NCT00600171|455838617|FG000|Overall Study|Protocol Violation|1|||
126695170|NCT00600171|455838618|FG001|Overall Study|Protocol Violation|2|||
126246056|NCT03804983|454191543|FG000|Overall Study|Family Obligation|1|||
126246057|NCT03804983|454191544|FG001|Overall Study|Family Obligation|0|||
126246058|NCT03600376|454191545|FG000|Overall Study|Adverse Event|1|||
126695171|NCT00600171|455838619|FG002|Overall Study|Protocol Violation|0|||
126246059|NCT03600376|454191546|FG001|Overall Study|Adverse Event|1|||
126246060|NCT03600376|454191545|FG000|Overall Study|Transferred to other facility|1|||
126246061|NCT03600376|454191546|FG001|Overall Study|Transferred to other facility|0|||
126246062|NCT03600376|454191545|FG000|Overall Study|Investigator Decision|0|||
126246063|NCT03600376|454191546|FG001|Overall Study|Investigator Decision|4|||
126246064|NCT03600376|454191545|FG000|Overall Study|Determined to be ineligible for study|0|||
126246065|NCT03600376|454191546|FG001|Overall Study|Determined to be ineligible for study|1|||
126246066|NCT00312897|454191549|FG000|Overall Study|Adverse Event|1|||
126246067|NCT00312897|454191550|FG001|Overall Study|Adverse Event|0|||
126246068|NCT00312897|454191549|FG000|Overall Study|Lost to Follow-up|2|||
126246069|NCT00312897|454191550|FG001|Overall Study|Lost to Follow-up|0|||
126246070|NCT00312897|454191549|FG000|Overall Study|Physician Decision|1|||
126246071|NCT00312897|454191550|FG001|Overall Study|Physician Decision|0|||
126246072|NCT00312897|454191549|FG000|Overall Study|Withdrawal by Subject|1|||
126246073|NCT00312897|454191550|FG001|Overall Study|Withdrawal by Subject|3|||
126246074|NCT00312897|454191549|FG000|Overall Study|Pregnancy|1|||
126246075|NCT00312897|454191550|FG001|Overall Study|Pregnancy|0|||
126246076|NCT00312897|454191549|FG000|Overall Study|discontinued prior to getting treatment|0|||
126246077|NCT00312897|454191550|FG001|Overall Study|discontinued prior to getting treatment|3|||
126246078|NCT03100344|454191551|FG000|Overall Study|Adverse Event|0|||
126246079|NCT03100344|454191552|FG001|Overall Study|Adverse Event|3|||
126246080|NCT03100344|454191553|FG002|Overall Study|Adverse Event|2|||
126246081|NCT03100344|454191554|FG003|Overall Study|Adverse Event|3|||
126246082|NCT03100344|454191551|FG000|Overall Study|Lack of Efficacy|2|||
126246083|NCT03100344|454191552|FG001|Overall Study|Lack of Efficacy|0|||
126246084|NCT03100344|454191553|FG002|Overall Study|Lack of Efficacy|0|||
126246085|NCT03100344|454191554|FG003|Overall Study|Lack of Efficacy|0|||
126246086|NCT03100344|454191551|FG000|Overall Study|Protocol Violation|1|||
126246087|NCT03100344|454191552|FG001|Overall Study|Protocol Violation|0|||
126246088|NCT03100344|454191553|FG002|Overall Study|Protocol Violation|0|||
126246089|NCT03100344|454191554|FG003|Overall Study|Protocol Violation|0|||
126246090|NCT03100344|454191551|FG000|Overall Study|Withdrawal by Subject|10|||
126246091|NCT03100344|454191552|FG001|Overall Study|Withdrawal by Subject|7|||
126246092|NCT03100344|454191553|FG002|Overall Study|Withdrawal by Subject|4|||
126246093|NCT03100344|454191554|FG003|Overall Study|Withdrawal by Subject|8|||
126246094|NCT03100344|454191551|FG000|Overall Study|Lost to Follow-up|1|||
126246095|NCT03100344|454191552|FG001|Overall Study|Lost to Follow-up|1|||
126246096|NCT03100344|454191553|FG002|Overall Study|Lost to Follow-up|1|||
126246097|NCT03100344|454191554|FG003|Overall Study|Lost to Follow-up|1|||
126246098|NCT01010503|454191555|FG000|Overall Study|Adverse Event|1|||
126246099|NCT01010503|454191555|FG000|Overall Study|Death|1|||
126246100|NCT04633564|454191556|FG000|Period 1|Adverse Event|28|||
126246101|NCT04633564|454191557|FG001|Period 1|Adverse Event|19|||
126246102|NCT04633564|454191556|FG000|Period 1|Death|8|||
126246103|NCT04633564|454191557|FG001|Period 1|Death|7|||
126246104|NCT04633564|454191556|FG000|Period 1|Lost to Follow-up|3|||
126246105|NCT04633564|454191557|FG001|Period 1|Lost to Follow-up|5|||
126246106|NCT04633564|454191556|FG000|Period 1|Physician Decision|4|||
126246107|NCT04633564|454191557|FG001|Period 1|Physician Decision|12|||
126246108|NCT04633564|454191556|FG000|Period 1|Protocol Violation|0|||
126246109|NCT04633564|454191557|FG001|Period 1|Protocol Violation|1|||
126246110|NCT04633564|454191556|FG000|Period 1|Withdrawal by Subject|10|||
126246111|NCT04633564|454191557|FG001|Period 1|Withdrawal by Subject|8|||
126246112|NCT04633564|454191556|FG000|Period 1|Progressive disease|47|||
126246113|NCT04633564|454191557|FG001|Period 1|Progressive disease|51|||
126246114|NCT04633564|454191556|FG000|Period 1|Terminated by Sponsor|8|||
126246115|NCT04633564|454191557|FG001|Period 1|Terminated by Sponsor|6|||
126246116|NCT04633564|454191556|FG000|Period 2|Adverse Event|3|||
126246117|NCT04633564|454191557|FG001|Period 2|Adverse Event|4|||
126246118|NCT04633564|454191556|FG000|Period 2|Death|0|||
126246119|NCT04633564|454191557|FG001|Period 2|Death|2|||
126246120|NCT04633564|454191556|FG000|Period 2|Lost to Follow-up|0|||
126246121|NCT04633564|454191557|FG001|Period 2|Lost to Follow-up|1|||
126246122|NCT04633564|454191556|FG000|Period 2|Physician Decision|2|||
126246123|NCT04633564|454191557|FG001|Period 2|Physician Decision|4|||
126246124|NCT04633564|454191556|FG000|Period 2|Withdrawal by Subject|5|||
126246125|NCT04633564|454191557|FG001|Period 2|Withdrawal by Subject|1|||
126246126|NCT04633564|454191556|FG000|Period 2|Progressive Disease|74|||
126246127|NCT04633564|454191557|FG001|Period 2|Progressive Disease|82|||
126761342|NCT00450814|456077203|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
126761343|NCT00450814|456077204|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
126246128|NCT04633564|454191556|FG000|Period 2|Terminated by Sponsor|9|||
126761344|NCT00450814|456077205|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
126246129|NCT04633564|454191557|FG001|Period 2|Terminated by Sponsor|3|||
126246130|NCT02267187|454192905|FG000|Overall Study|Physician Decision|2|||
126246131|NCT02267187|454192905|FG000|Overall Study|Screen fail|3|||
126246132|NCT02222818|454192908|FG000|Period 1|Eligibility criteria not met|0|||
126246133|NCT02222818|454192909|FG001|Period 1|Eligibility criteria not met|3|||
126246134|NCT00834717|454192910|FG000|First Intervention|Adverse Event|1|||
126246135|NCT00834717|454192911|FG001|First Intervention|Adverse Event|0|||
126246136|NCT00834717|454192910|FG000|First Intervention|Withdrawal by Subject|0|||
126246137|NCT00834717|454192911|FG001|First Intervention|Withdrawal by Subject|1|||
126246138|NCT01660243|454192912|FG000|Overall Study|Adverse Event|1|||
126246139|NCT01660243|454192913|FG001|Overall Study|Adverse Event|0|||
126246140|NCT01660243|454192914|FG002|Overall Study|Adverse Event|1|||
126246141|NCT01660243|454192915|FG003|Overall Study|Adverse Event|0|||
126246142|NCT01660243|454192912|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
126246143|NCT01660243|454192913|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
126246144|NCT01660243|454192914|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
126246145|NCT01660243|454192915|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
126246146|NCT01660243|454192912|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
126246147|NCT01660243|454192913|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
126246148|NCT01660243|454192914|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
126246149|NCT01660243|454192915|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
126246150|NCT01660243|454192912|FG000|Overall Study|Randomization error|0|||
126246151|NCT01660243|454192913|FG001|Overall Study|Randomization error|0|||
126246152|NCT01660243|454192914|FG002|Overall Study|Randomization error|0|||
126246153|NCT01660243|454192915|FG003|Overall Study|Randomization error|1|||
126246154|NCT03025087|454192916|FG000|Overall Study|Physician Decision|3|||
126246155|NCT03025087|454192917|FG001|Overall Study|Physician Decision|3|||
126246156|NCT03025087|454192918|FG002|Overall Study|Physician Decision|0|||
126246157|NCT03025087|454192919|FG003|Overall Study|Physician Decision|0|||
126246158|NCT03025087|454192920|FG004|Overall Study|Physician Decision|0|||
126246159|NCT03025087|454192916|FG000|Overall Study|Withdrawal by Subject|1|||
126246160|NCT03025087|454192917|FG001|Overall Study|Withdrawal by Subject|1|||
126246161|NCT03025087|454192918|FG002|Overall Study|Withdrawal by Subject|0|||
126246162|NCT03025087|454192919|FG003|Overall Study|Withdrawal by Subject|0|||
126246163|NCT03025087|454192920|FG004|Overall Study|Withdrawal by Subject|0|||
126246164|NCT03025087|454192916|FG000|Overall Study|Unable to complete MRI|2|||
126246165|NCT03025087|454192917|FG001|Overall Study|Unable to complete MRI|2|||
126246166|NCT03025087|454192918|FG002|Overall Study|Unable to complete MRI|0|||
126246167|NCT03025087|454192919|FG003|Overall Study|Unable to complete MRI|0|||
126246168|NCT03025087|454192920|FG004|Overall Study|Unable to complete MRI|0|||
126246169|NCT00508651|454192927|FG000|Overall Study|Lost to Follow-up|3|||
126246170|NCT00508651|454192928|FG001|Overall Study|Lost to Follow-up|1|||
126246171|NCT00508651|454192927|FG000|Overall Study|Withdrawal by Subject|1|||
126246172|NCT00508651|454192928|FG001|Overall Study|Withdrawal by Subject|1|||
126246173|NCT02255149|454192937|FG000|Overall Study|Lost to Follow-up|2|||
126246174|NCT02255149|454192937|FG000|Overall Study|Withdrawal by Subject|1|||
126246175|NCT02255149|454192937|FG000|Overall Study|Withdrawal by PI|1|||
126246176|NCT02255149|454192937|FG000|Overall Study|Implant Failure|1|||
126246177|NCT05710718|454192944|FG000|Overall Study|Withdrawal by Subject|5|||
126246178|NCT05710718|454192945|FG001|Overall Study|Withdrawal by Subject|1|||
126246179|NCT05710718|454192944|FG000|Overall Study|Lost to Follow-up|0|||
126246180|NCT05710718|454192945|FG001|Overall Study|Lost to Follow-up|1|||
126246181|NCT05710718|454192944|FG000|Overall Study|Death|0|||
126246182|NCT05710718|454192945|FG001|Overall Study|Death|1|||
126246183|NCT03121586|454192946|FG000|Overall Study|Study terminated by sponsor|0|||
126246184|NCT03121586|454192947|FG001|Overall Study|Study terminated by sponsor|0|||
126246185|NCT03121586|454192948|FG002|Overall Study|Study terminated by sponsor|99|||
126246186|NCT03121586|454192946|FG000|Overall Study|Withdrawal by Subject|37|||
126695172|NCT00600171|455838620|FG003|Overall Study|Protocol Violation|1|||
126695173|NCT00600171|455838621|FG004|Overall Study|Protocol Violation|0|||
126695174|NCT00600171|455838622|FG005|Overall Study|Protocol Violation|0|||
126246187|NCT03121586|454192947|FG001|Overall Study|Withdrawal by Subject|14|||
126246188|NCT03121586|454192948|FG002|Overall Study|Withdrawal by Subject|9|||
126246189|NCT03121586|454192946|FG000|Overall Study|Not further specified|6|||
126246190|NCT03121586|454192947|FG001|Overall Study|Not further specified|11|||
126246191|NCT03121586|454192948|FG002|Overall Study|Not further specified|10|||
126246192|NCT03121586|454192946|FG000|Overall Study|Adverse Event|16|||
126246193|NCT03121586|454192947|FG001|Overall Study|Adverse Event|5|||
126246194|NCT03121586|454192948|FG002|Overall Study|Adverse Event|6|||
126246195|NCT03121586|454192946|FG000|Overall Study|Protocol Violation|0|||
126246196|NCT03121586|454192947|FG001|Overall Study|Protocol Violation|5|||
126246197|NCT03121586|454192948|FG002|Overall Study|Protocol Violation|0|||
126695175|NCT00600171|455838617|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
126246198|NCT03121586|454192946|FG000|Overall Study|Lack of Efficacy|3|||
126246199|NCT03121586|454192947|FG001|Overall Study|Lack of Efficacy|3|||
126246200|NCT03121586|454192948|FG002|Overall Study|Lack of Efficacy|1|||
126246201|NCT03121586|454192946|FG000|Overall Study|Physician Decision|2|||
126246202|NCT03121586|454192947|FG001|Overall Study|Physician Decision|2|||
126246203|NCT03121586|454192948|FG002|Overall Study|Physician Decision|0|||
126246204|NCT03121586|454192946|FG000|Overall Study|Noncompliance with study drug|5|||
126246205|NCT03121586|454192947|FG001|Overall Study|Noncompliance with study drug|3|||
126246206|NCT03121586|454192948|FG002|Overall Study|Noncompliance with study drug|5|||
126246207|NCT03121586|454192946|FG000|Overall Study|Lost to Follow-up|4|||
126246208|NCT03121586|454192947|FG001|Overall Study|Lost to Follow-up|2|||
126246209|NCT03121586|454192948|FG002|Overall Study|Lost to Follow-up|0|||
126246210|NCT03121586|454192946|FG000|Overall Study|Death|2|||
126246211|NCT03121586|454192947|FG001|Overall Study|Death|0|||
126246212|NCT03121586|454192948|FG002|Overall Study|Death|0|||
126246213|NCT06381102|454192949|FG000|Washout 5 Days|Withdrawal by Subject|0|||
126246214|NCT06381102|454192950|FG001|Washout 5 Days|Withdrawal by Subject|2|||
126246215|NCT01987765|454192951|FG000|Overall Study|Protocol Violation|65|||
126246216|NCT01987765|454192951|FG000|Overall Study|Lost to Follow-up|37|||
126246217|NCT01528696|454192954|FG000|Overall Study|See detailed description|18|||
126246218|NCT01528696|454192955|FG001|Overall Study|See detailed description|19|||
126246219|NCT00859521|454192956|FG000|Washout|Withdrawal by Subject|0|||
126246220|NCT00859521|454192957|FG001|Washout|Withdrawal by Subject|1|||
126246221|NCT05239195|454192964|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
126246222|NCT05239195|454192965|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
126246223|NCT03552484|454192966|FG000|Overall Study|Death|6|||
126246224|NCT03552484|454192967|FG001|Overall Study|Death|4|||
126246225|NCT03552484|454192966|FG000|Overall Study|Lost to Follow-up|0|||
126246226|NCT03552484|454192967|FG001|Overall Study|Lost to Follow-up|16|||
126246227|NCT02663349|454192973|FG000|Overall Study|Withdrawal by Subject|6|||
126246228|NCT01204294|454192974|FG000|Overall Study|Adverse Event|2|||
126246229|NCT01204294|454192975|FG001|Overall Study|Adverse Event|6|||
126246230|NCT01204294|454192976|FG002|Overall Study|Adverse Event|0|||
126246231|NCT01204294|454192977|FG003|Overall Study|Adverse Event|7|||
126246232|NCT01204294|454192978|FG004|Overall Study|Adverse Event|1|||
126246233|NCT01204294|454192979|FG005|Overall Study|Adverse Event|4|||
126246234|NCT01204294|454192980|FG006|Overall Study|Adverse Event|0|||
126246235|NCT01204294|454192974|FG000|Overall Study|Protocol Violation|1|||
126246236|NCT01204294|454192975|FG001|Overall Study|Protocol Violation|0|||
126246237|NCT01204294|454192976|FG002|Overall Study|Protocol Violation|2|||
126246238|NCT01204294|454192977|FG003|Overall Study|Protocol Violation|1|||
126246239|NCT01204294|454192978|FG004|Overall Study|Protocol Violation|0|||
126246240|NCT01204294|454192979|FG005|Overall Study|Protocol Violation|0|||
126246241|NCT01204294|454192980|FG006|Overall Study|Protocol Violation|0|||
126246242|NCT01204294|454192974|FG000|Overall Study|Withdrawal by Subject|0|||
126246243|NCT01204294|454192975|FG001|Overall Study|Withdrawal by Subject|2|||
126246244|NCT01204294|454192976|FG002|Overall Study|Withdrawal by Subject|2|||
126246245|NCT01204294|454192977|FG003|Overall Study|Withdrawal by Subject|1|||
126246246|NCT01204294|454192978|FG004|Overall Study|Withdrawal by Subject|1|||
126246247|NCT01204294|454192979|FG005|Overall Study|Withdrawal by Subject|1|||
126246248|NCT01204294|454192980|FG006|Overall Study|Withdrawal by Subject|2|||
126246249|NCT01204294|454192974|FG000|Overall Study|Lack of Efficacy|0|||
126246250|NCT01204294|454192975|FG001|Overall Study|Lack of Efficacy|0|||
126246251|NCT01204294|454192976|FG002|Overall Study|Lack of Efficacy|0|||
126246252|NCT01204294|454192977|FG003|Overall Study|Lack of Efficacy|2|||
126246253|NCT01204294|454192978|FG004|Overall Study|Lack of Efficacy|0|||
126246254|NCT01204294|454192979|FG005|Overall Study|Lack of Efficacy|0|||
126246255|NCT01204294|454192980|FG006|Overall Study|Lack of Efficacy|0|||
126246256|NCT01204294|454192974|FG000|Overall Study|Other (house moving)|0|||
126246257|NCT01204294|454192975|FG001|Overall Study|Other (house moving)|0|||
126246258|NCT01204294|454192976|FG002|Overall Study|Other (house moving)|1|||
126246259|NCT01204294|454192977|FG003|Overall Study|Other (house moving)|0|||
126246260|NCT01204294|454192978|FG004|Overall Study|Other (house moving)|0|||
126246261|NCT01204294|454192979|FG005|Overall Study|Other (house moving)|0|||
126246262|NCT01204294|454192980|FG006|Overall Study|Other (house moving)|0|||
126246263|NCT03128723|454192983|FG000|Overall Study|Withdrawal by Subject|2|||
126246264|NCT00673660|454192984|FG000|Overall Study|Lost to Follow-up|107|||
126447865|NCT02910986|454939568|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
126246265|NCT01383486|454192985|FG000|Overall Study|Lost to Follow-up|10|||
126246266|NCT01383486|454192985|FG000|Overall Study|Incomplete information for analysis|2|||
126246267|NCT01383486|454192985|FG000|Overall Study|Did not take any product|6|||
126695176|NCT00600171|455838618|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126246268|NCT00245063|454192986|FG000|Overall Study|Adverse Event|6|||
126246269|NCT00245063|454192987|FG001|Overall Study|Adverse Event|5|||
126246270|NCT00245063|454192986|FG000|Overall Study|Death|1|||
126695177|NCT00600171|455838619|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
126246271|NCT00245063|454192987|FG001|Overall Study|Death|0|||
126246272|NCT05099380|454192989|FG000|Overall Study|Subject enrolled in error|1|||
126246273|NCT05099380|454192990|FG001|Overall Study|Subject enrolled in error|0|||
126246274|NCT05099380|454192989|FG000|Overall Study|Study Procedure|1|||
126246275|NCT05099380|454192990|FG001|Overall Study|Study Procedure|0|||
126246276|NCT05099380|454192989|FG000|Overall Study|Protocol Violation|1|||
126246277|NCT05099380|454192990|FG001|Overall Study|Protocol Violation|0|||
126246278|NCT05099380|454192989|FG000|Overall Study|Adverse Event|1|||
126246279|NCT05099380|454192990|FG001|Overall Study|Adverse Event|1|||
126246280|NCT05099380|454192989|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
126246281|NCT05099380|454192990|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
126246282|NCT03276754|454192991|FG000|Overall Study|Withdrawal of informed consent|4|||
126246283|NCT03276754|454192991|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
126246284|NCT03276754|454192991|FG000|Overall Study|Lost to Follow-up|27|||
126246285|NCT03276754|454192991|FG000|Overall Study|No data reported at Month 24|31|||
126246286|NCT03276754|454192991|FG000|Overall Study|Death|39|||
126246287|NCT00927069|454192993|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
126246288|NCT00927069|454192994|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
126246289|NCT00927069|454192995|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
126246290|NCT00927069|454192996|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
126246291|NCT00927069|454192993|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
126246292|NCT00927069|454192994|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
126246293|NCT00927069|454192995|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
126246294|NCT00927069|454192996|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
126246295|NCT00927069|454192993|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
126246296|NCT00927069|454192994|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
126246297|NCT00927069|454192995|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
126246298|NCT00927069|454192996|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
126246299|NCT00927069|454192993|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
126246300|NCT00927069|454192994|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
126246301|NCT00927069|454192995|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
126246302|NCT00927069|454192996|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
126246303|NCT00927069|454192993|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
126246304|NCT00927069|454192994|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
126246305|NCT00927069|454192995|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
126246306|NCT00927069|454192996|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
126246307|NCT02558491|454192997|FG000|First Invention|Withdrawal by Subject|3|||
126246308|NCT02558491|454192998|FG001|First Invention|Withdrawal by Subject|1|||
126246309|NCT02558491|454192997|FG000|First Invention|Data collection issues|1|||
126246310|NCT02558491|454192998|FG001|First Invention|Data collection issues|0|||
126246311|NCT02558491|454192997|FG000|First Invention|Stopping criteria|0|||
126246312|NCT02558491|454192998|FG001|First Invention|Stopping criteria|1|||
126246313|NCT02558491|454192997|FG000|First Invention|Changed parameters during trial|1|||
126246314|NCT02558491|454192998|FG001|First Invention|Changed parameters during trial|0|||
126246315|NCT02558491|454192997|FG000|Second Intervention|Withdrawal by Subject|1|||
126246316|NCT02558491|454192998|FG001|Second Intervention|Withdrawal by Subject|0|||
126246317|NCT02558491|454192997|FG000|Second Intervention|Stopping Criteria|1|||
126246318|NCT02558491|454192998|FG001|Second Intervention|Stopping Criteria|0|||
126246319|NCT00834431|454193001|FG000|First Intervention|Adverse Event|0|||
126246320|NCT00834431|454193002|FG001|First Intervention|Adverse Event|1|||
126246321|NCT00834431|454193001|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
126246322|NCT00834431|454193002|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
126246323|NCT03249454|454193003|FG000|Overall Study|Withdrawal by Subject|0|||
126246324|NCT03249454|454193004|FG001|Overall Study|Withdrawal by Subject|0|||
126246325|NCT03249454|454193005|FG002|Overall Study|Withdrawal by Subject|0|||
126246326|NCT03249454|454193006|FG003|Overall Study|Withdrawal by Subject|0|||
126246327|NCT03249454|454193007|FG004|Overall Study|Withdrawal by Subject|0|||
126246328|NCT03249454|454193008|FG005|Overall Study|Withdrawal by Subject|0|||
126246329|NCT03249454|454193009|FG006|Overall Study|Withdrawal by Subject|0|||
126246330|NCT03249454|454193010|FG007|Overall Study|Withdrawal by Subject|0|||
126246331|NCT03249454|454193011|FG008|Overall Study|Withdrawal by Subject|0|||
126246332|NCT03249454|454193012|FG009|Overall Study|Withdrawal by Subject|1|||
126246333|NCT03249454|454193013|FG010|Overall Study|Withdrawal by Subject|1|||
126246334|NCT01913405|454193014|FG000|Overall Study|Withdrawal by Subject|1|||
126246335|NCT01913405|454193014|FG000|Overall Study|Adverse Event|1|||
126246336|NCT01020474|454193017|FG000|Overall Study|Adverse Event|4|||
126246337|NCT01020474|454193018|FG001|Overall Study|Adverse Event|4|||
126246338|NCT01020474|454193017|FG000|Overall Study|Protocol Violation|0|||
126246339|NCT01020474|454193018|FG001|Overall Study|Protocol Violation|2|||
126246340|NCT01020474|454193017|FG000|Overall Study|Withdrawal by Subject|5|||
126246341|NCT01020474|454193018|FG001|Overall Study|Withdrawal by Subject|7|||
126246342|NCT01020474|454193017|FG000|Overall Study|Other Reasons|1|||
126246343|NCT01020474|454193018|FG001|Overall Study|Other Reasons|1|||
126246344|NCT01020474|454193017|FG000|Overall Study|Insufficient Clinical Response|0|||
126246345|NCT01020474|454193018|FG001|Overall Study|Insufficient Clinical Response|3|||
126246346|NCT03199963|454193021|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
126246347|NCT03199963|454193022|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
126246348|NCT03199963|454193021|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
126246349|NCT03199963|454193022|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
126246350|NCT03199963|454193021|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
126246351|NCT03199963|454193022|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
126306194|NCT03260244|454410221|FG000|Overall Study|Subject Noncompliance|6|||
126246352|NCT03199963|454193021|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
126246353|NCT03199963|454193022|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
126246354|NCT03199963|454193021|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
126246355|NCT03199963|454193022|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
126246356|NCT03199963|454193021|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
126246357|NCT03199963|454193022|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
126246358|NCT00466167|454193023|FG000|Overall Study|Adverse Event|8|||
126246359|NCT00466167|454193024|FG001|Overall Study|Adverse Event|8|||
126246360|NCT00466167|454193025|FG002|Overall Study|Adverse Event|7|||
126246361|NCT00466167|454193023|FG000|Overall Study|Lack of Efficacy|2|||
126246362|NCT00466167|454193024|FG001|Overall Study|Lack of Efficacy|0|||
126246363|NCT00466167|454193025|FG002|Overall Study|Lack of Efficacy|3|||
126246364|NCT00466167|454193023|FG000|Overall Study|Protocol Violation|1|||
126246365|NCT00466167|454193024|FG001|Overall Study|Protocol Violation|1|||
126246366|NCT00466167|454193025|FG002|Overall Study|Protocol Violation|2|||
126246367|NCT00466167|454193023|FG000|Overall Study|Lost to Follow-up|3|||
126246368|NCT00466167|454193024|FG001|Overall Study|Lost to Follow-up|2|||
126246369|NCT00466167|454193025|FG002|Overall Study|Lost to Follow-up|2|||
126246370|NCT00466167|454193023|FG000|Overall Study|Withdrawal by Subject|4|||
126246371|NCT00466167|454193024|FG001|Overall Study|Withdrawal by Subject|1|||
126246372|NCT00466167|454193025|FG002|Overall Study|Withdrawal by Subject|6|||
126246373|NCT00466167|454193023|FG000|Overall Study|patient did not meet inclusion criteria|1|||
126246374|NCT00466167|454193024|FG001|Overall Study|patient did not meet inclusion criteria|0|||
126246375|NCT00466167|454193025|FG002|Overall Study|patient did not meet inclusion criteria|1|||
126246376|NCT00466167|454193023|FG000|Overall Study|Not treated|1|||
126246377|NCT00466167|454193024|FG001|Overall Study|Not treated|0|||
126246378|NCT00466167|454193025|FG002|Overall Study|Not treated|0|||
126246379|NCT01075282|454193034|FG000|Overall Study|Withdrawal by Subject|11|||
126246380|NCT01075282|454193035|FG001|Overall Study|Withdrawal by Subject|7|||
126246381|NCT01075282|454193036|FG002|Overall Study|Withdrawal by Subject|11|||
126246382|NCT01075282|454193034|FG000|Overall Study|Adverse Event|9|||
126246383|NCT01075282|454193035|FG001|Overall Study|Adverse Event|8|||
126246384|NCT01075282|454193036|FG002|Overall Study|Adverse Event|5|||
126246385|NCT01075282|454193034|FG000|Overall Study|Entry Criteria Not Met|3|||
126246386|NCT01075282|454193035|FG001|Overall Study|Entry Criteria Not Met|2|||
126246387|NCT01075282|454193036|FG002|Overall Study|Entry Criteria Not Met|0|||
126246388|NCT01075282|454193034|FG000|Overall Study|Lost to Follow-up|3|||
126246389|NCT01075282|454193035|FG001|Overall Study|Lost to Follow-up|3|||
126246390|NCT01075282|454193036|FG002|Overall Study|Lost to Follow-up|3|||
126246391|NCT01075282|454193034|FG000|Overall Study|Physician Decision|3|||
126246392|NCT01075282|454193035|FG001|Overall Study|Physician Decision|3|||
126246393|NCT01075282|454193036|FG002|Overall Study|Physician Decision|3|||
126246394|NCT01075282|454193034|FG000|Overall Study|Lack of Efficacy|1|||
126246395|NCT01075282|454193035|FG001|Overall Study|Lack of Efficacy|1|||
126246396|NCT01075282|454193036|FG002|Overall Study|Lack of Efficacy|0|||
126246397|NCT01075282|454193034|FG000|Overall Study|Treatment Non-compliance|1|||
126246398|NCT01075282|454193035|FG001|Overall Study|Treatment Non-compliance|2|||
126246399|NCT01075282|454193036|FG002|Overall Study|Treatment Non-compliance|2|||
126246400|NCT01075282|454193034|FG000|Overall Study|Protocol Violation|0|||
126246401|NCT01075282|454193035|FG001|Overall Study|Protocol Violation|2|||
126246402|NCT01075282|454193036|FG002|Overall Study|Protocol Violation|1|||
126246403|NCT01075282|454193034|FG000|Overall Study|Death|0|||
126246404|NCT01075282|454193035|FG001|Overall Study|Death|1|||
126246405|NCT01075282|454193036|FG002|Overall Study|Death|2|||
126246406|NCT01794845|454193038|FG000|Overall Study|Withdrawal by Subject|1|||
126246407|NCT02139826|454193039|FG000|Overall Study|Adverse Event|1|||
126246408|NCT00429416|454193040|FG000|Overall Study|Death|1|||
126246409|NCT01456221|454193041|FG000|Overall Study|Withdrawal by Subject|56|||
126246410|NCT01456221|454193042|FG001|Overall Study|Withdrawal by Subject|49|||
126246411|NCT01456221|454193041|FG000|Overall Study|Lost to Follow-up|1|||
126246412|NCT01456221|454193042|FG001|Overall Study|Lost to Follow-up|4|||
126246413|NCT01456221|454193041|FG000|Overall Study|Received medication|3|||
126246414|NCT01456221|454193042|FG001|Overall Study|Received medication|2|||
126246415|NCT01456221|454193041|FG000|Overall Study|Incomplete data|4|||
126246416|NCT01456221|454193042|FG001|Overall Study|Incomplete data|2|||
126246417|NCT06647173|454193045|FG000|Overall Study|Lost to Follow-up|24|||
126246418|NCT01473953|454193046|FG000|Overall Study|Other|1|||
126246419|NCT01473953|454193047|FG001|Overall Study|Other|0|||
126246420|NCT01473953|454193048|FG002|Overall Study|Other|0|||
126246421|NCT01473953|454193049|FG003|Overall Study|Other|0|||
126246422|NCT01473953|454193050|FG004|Overall Study|Other|0|||
126246423|NCT02358538|454193051|FG000|Through Week 26|Adverse Event|0|||
126246424|NCT02358538|454193052|FG001|Through Week 26|Adverse Event|1|||
126246425|NCT02358538|454193053|FG002|Through Week 26|Adverse Event|1|||
126246426|NCT02358538|454193054|FG003|Through Week 26|Adverse Event|2|||
126246427|NCT02358538|454193051|FG000|Through Week 26|Lack of Efficacy|1|||
126695178|NCT00600171|455838620|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
126695179|NCT00600171|455838621|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
126695180|NCT00600171|455838622|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
126695181|NCT00600171|455838617|FG000|Overall Study|Withdrawal by Subject|3|||
126695182|NCT00600171|455838618|FG001|Overall Study|Withdrawal by Subject|0|||
126695183|NCT00600171|455838619|FG002|Overall Study|Withdrawal by Subject|0|||
126695184|NCT00600171|455838620|FG003|Overall Study|Withdrawal by Subject|1|||
126695185|NCT00600171|455838621|FG004|Overall Study|Withdrawal by Subject|1|||
126695186|NCT00600171|455838622|FG005|Overall Study|Withdrawal by Subject|1|||
126695187|NCT00600171|455838617|FG000|Overall Study|Physician Decision|0|||
126695188|NCT00600171|455838618|FG001|Overall Study|Physician Decision|1|||
126695189|NCT00600171|455838619|FG002|Overall Study|Physician Decision|0|||
126695190|NCT00600171|455838620|FG003|Overall Study|Physician Decision|1|||
126695191|NCT00600171|455838621|FG004|Overall Study|Physician Decision|0|||
126695192|NCT00600171|455838622|FG005|Overall Study|Physician Decision|2|||
126695193|NCT00600171|455838617|FG000|Overall Study|Lost to Follow-up|0|||
126695194|NCT00600171|455838618|FG001|Overall Study|Lost to Follow-up|0|||
126695195|NCT00600171|455838619|FG002|Overall Study|Lost to Follow-up|0|||
126695196|NCT00600171|455838620|FG003|Overall Study|Lost to Follow-up|1|||
126695197|NCT00600171|455838621|FG004|Overall Study|Lost to Follow-up|0|||
126695198|NCT00600171|455838622|FG005|Overall Study|Lost to Follow-up|0|||
126695199|NCT00542191|455838626|FG000|Overall Study|Death|3|||
126695200|NCT00469612|455838627|FG000|Overall Study|Study terminated before data collected|2|||
126695201|NCT00469612|455838628|FG001|Overall Study|Study terminated before data collected|0|||
126695202|NCT04684420|455838629|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126695203|NCT04684420|455838630|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126695204|NCT04684420|455838631|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
126695205|NCT04684420|455838632|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
126695206|NCT04684420|455838629|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
126695207|NCT04684420|455838630|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
126695208|NCT04684420|455838631|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
126695209|NCT04684420|455838632|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
126695210|NCT03480802|455838633|FG000|Overall Study|Lost to Follow-up|5|||
126695211|NCT03480802|455838634|FG001|Overall Study|Lost to Follow-up|1|||
126695212|NCT03480802|455838633|FG000|Overall Study|Withdrawal by Subject|2|||
126695213|NCT03480802|455838634|FG001|Overall Study|Withdrawal by Subject|1|||
126695214|NCT03480802|455838633|FG000|Overall Study|Relocated|0|||
126695215|NCT03480802|455838634|FG001|Overall Study|Relocated|1|||
126695216|NCT03822884|455838635|FG000|Overall Study|Withdrawal by Subject|0|||
126695217|NCT03822884|455838636|FG001|Overall Study|Withdrawal by Subject|0|||
126695218|NCT03822884|455838637|FG002|Overall Study|Withdrawal by Subject|0|||
126695219|NCT03822884|455838638|FG003|Overall Study|Withdrawal by Subject|0|||
126695220|NCT03822884|455838639|FG004|Overall Study|Withdrawal by Subject|1|||
126695221|NCT03822884|455838640|FG005|Overall Study|Withdrawal by Subject|0|||
126695222|NCT00849017|455838645|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
126695223|NCT00849017|455838646|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
126695224|NCT00849017|455838647|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
126695225|NCT00849017|455838645|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
126695226|NCT00849017|455838646|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
126695227|NCT00849017|455838647|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
126695228|NCT00849017|455838645|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
126695229|NCT00849017|455838646|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
126695230|NCT00849017|455838647|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
126695231|NCT00849017|455838645|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
126695232|NCT00849017|455838646|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
126695233|NCT00849017|455838647|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
126695234|NCT00849017|455838645|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
126695235|NCT00849017|455838646|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
126695236|NCT00849017|455838647|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
126695237|NCT00849017|455838645|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
126246428|NCT02358538|454193052|FG001|Through Week 26|Lack of Efficacy|1|||
126246429|NCT02358538|454193053|FG002|Through Week 26|Lack of Efficacy|3|||
126246430|NCT02358538|454193054|FG003|Through Week 26|Lack of Efficacy|3|||
126246431|NCT02358538|454193051|FG000|Through Week 26|Withdrawal by Subject|1|||
126695238|NCT00849017|455838646|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
126695239|NCT00849017|455838647|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
126695240|NCT00849017|455838645|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
126246432|NCT02358538|454193052|FG001|Through Week 26|Withdrawal by Subject|0|||
126761345|NCT00450814|456077206|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
126246433|NCT02358538|454193053|FG002|Through Week 26|Withdrawal by Subject|0|||
126695241|NCT00849017|455838646|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
126695242|NCT00849017|455838647|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
126695243|NCT00849017|455838645|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
126246434|NCT02358538|454193054|FG003|Through Week 26|Withdrawal by Subject|0|||
126246435|NCT02358538|454193051|FG000|Through Week 26|Non-Compliance|0|||
126246436|NCT02358538|454193052|FG001|Through Week 26|Non-Compliance|0|||
126246437|NCT02358538|454193053|FG002|Through Week 26|Non-Compliance|1|||
126246438|NCT02358538|454193054|FG003|Through Week 26|Non-Compliance|0|||
126246439|NCT02358538|454193051|FG000|Through Week 26|Family did not see benefit from IP|1|||
126246440|NCT02358538|454193052|FG001|Through Week 26|Family did not see benefit from IP|0|||
126246441|NCT02358538|454193053|FG002|Through Week 26|Family did not see benefit from IP|0|||
126695244|NCT00849017|455838646|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
126246442|NCT02358538|454193054|FG003|Through Week 26|Family did not see benefit from IP|0|||
126246443|NCT02358538|454193051|FG000|52 Week Extension Period|Lack of Efficacy|0|||
126246444|NCT02358538|454193052|FG001|52 Week Extension Period|Lack of Efficacy|0|||
126246445|NCT02358538|454193053|FG002|52 Week Extension Period|Lack of Efficacy|2|||
126246446|NCT02358538|454193054|FG003|52 Week Extension Period|Lack of Efficacy|4|||
126246447|NCT01494532|454193055|FG000|Overall Study|Adverse Event|4|||
126246448|NCT01494532|454193056|FG001|Overall Study|Adverse Event|1|||
126246449|NCT01494532|454193057|FG002|Overall Study|Adverse Event|8|||
126246450|NCT01494532|454193058|FG003|Overall Study|Adverse Event|6|||
126246451|NCT01494532|454193059|FG004|Overall Study|Adverse Event|5|||
126246452|NCT01494532|454193060|FG005|Overall Study|Adverse Event|0|||
126246453|NCT01494532|454193055|FG000|Overall Study|Lack of Efficacy|0|||
126246454|NCT01494532|454193056|FG001|Overall Study|Lack of Efficacy|0|||
126246455|NCT01494532|454193057|FG002|Overall Study|Lack of Efficacy|0|||
126246456|NCT01494532|454193058|FG003|Overall Study|Lack of Efficacy|0|||
126246457|NCT01494532|454193059|FG004|Overall Study|Lack of Efficacy|2|||
126246458|NCT01494532|454193060|FG005|Overall Study|Lack of Efficacy|0|||
126246459|NCT01494532|454193055|FG000|Overall Study|Protocol deviation|2|||
126246460|NCT01494532|454193056|FG001|Overall Study|Protocol deviation|1|||
126246461|NCT01494532|454193057|FG002|Overall Study|Protocol deviation|3|||
126246462|NCT01494532|454193058|FG003|Overall Study|Protocol deviation|2|||
126246463|NCT01494532|454193059|FG004|Overall Study|Protocol deviation|3|||
126246464|NCT01494532|454193060|FG005|Overall Study|Protocol deviation|0|||
126246465|NCT01494532|454193055|FG000|Overall Study|Protocol-defined stopping criteria|0|||
126246466|NCT01494532|454193056|FG001|Overall Study|Protocol-defined stopping criteria|0|||
126246467|NCT01494532|454193057|FG002|Overall Study|Protocol-defined stopping criteria|1|||
126246468|NCT01494532|454193058|FG003|Overall Study|Protocol-defined stopping criteria|0|||
126246469|NCT01494532|454193059|FG004|Overall Study|Protocol-defined stopping criteria|0|||
126246470|NCT01494532|454193060|FG005|Overall Study|Protocol-defined stopping criteria|0|||
126246471|NCT01494532|454193055|FG000|Overall Study|Lost to Follow-up|1|||
126246472|NCT01494532|454193056|FG001|Overall Study|Lost to Follow-up|0|||
126246473|NCT01494532|454193057|FG002|Overall Study|Lost to Follow-up|0|||
126246474|NCT01494532|454193058|FG003|Overall Study|Lost to Follow-up|2|||
126246475|NCT01494532|454193059|FG004|Overall Study|Lost to Follow-up|0|||
126246476|NCT01494532|454193060|FG005|Overall Study|Lost to Follow-up|0|||
126246477|NCT01494532|454193055|FG000|Overall Study|Physician Decision|0|||
126246478|NCT01494532|454193056|FG001|Overall Study|Physician Decision|1|||
126246479|NCT01494532|454193057|FG002|Overall Study|Physician Decision|1|||
126246480|NCT01494532|454193058|FG003|Overall Study|Physician Decision|2|||
126246481|NCT01494532|454193059|FG004|Overall Study|Physician Decision|0|||
126246482|NCT01494532|454193060|FG005|Overall Study|Physician Decision|0|||
126246483|NCT01494532|454193055|FG000|Overall Study|Withdrawal by Subject|3|||
126246484|NCT01494532|454193056|FG001|Overall Study|Withdrawal by Subject|1|||
126246485|NCT01494532|454193057|FG002|Overall Study|Withdrawal by Subject|4|||
126246486|NCT01494532|454193058|FG003|Overall Study|Withdrawal by Subject|3|||
126246487|NCT01494532|454193059|FG004|Overall Study|Withdrawal by Subject|2|||
126246488|NCT01494532|454193060|FG005|Overall Study|Withdrawal by Subject|0|||
126246489|NCT06999265|454193061|FG000|Overall Study|Lost to Follow-up|1|||
126246490|NCT06999265|454193062|FG001|Overall Study|Lost to Follow-up|1|||
126246491|NCT04025229|454194089|FG000|Overall Study|Adverse Event|1|||
126246492|NCT04025229|454194090|FG001|Overall Study|Adverse Event|0|||
126246493|NCT04025229|454194089|FG000|Overall Study|Withdrawal by Subject|0|||
126246494|NCT04025229|454194090|FG001|Overall Study|Withdrawal by Subject|2|||
126246495|NCT04025229|454194089|FG000|Overall Study|Death|0|||
126246496|NCT04025229|454194090|FG001|Overall Study|Death|1|||
126246497|NCT04025229|454194089|FG000|Overall Study|Physician Decision|0|||
126695245|NCT00849017|455838647|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
126695246|NCT00849017|455838645|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
126246498|NCT04025229|454194090|FG001|Overall Study|Physician Decision|1|||
126246499|NCT02571907|454194091|FG000|Overall Study|Death|4|||
126246500|NCT02571907|454194091|FG000|Overall Study|Lost to Follow-up|3|||
126246501|NCT02571907|454194091|FG000|Overall Study|Withdrawal by Subject|3|||
126246502|NCT02286739|454194096|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
126246503|NCT02286739|454194097|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
126246504|NCT02286739|454194096|FG000|Overall Study|No Verasense type documented|0|||
126246505|NCT02286739|454194097|FG001|Overall Study|No Verasense type documented|23|||
126246506|NCT02286739|454194096|FG000|Overall Study|Adverse Event|1|||
126761346|NCT00450814|456077207|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
126761347|NCT00450814|456077208|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
126761348|NCT00450814|456077209|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
126761349|NCT02067728|456077210|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
126761350|NCT02067728|456077211|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
126761351|NCT02067728|456077210|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
126761352|NCT02067728|456077211|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
126761353|NCT02067728|456077210|FG000|6 Month Measurements|Unable to attend|114|||
126761354|NCT02067728|456077211|FG001|6 Month Measurements|Unable to attend|97|||
126761355|NCT04629534|456077215|FG000|Overall Study|Physician Decision|1|||
126761356|NCT04629534|456077216|FG001|Overall Study|Physician Decision|0|||
126761357|NCT04629534|456077215|FG000|Overall Study|Protocol Violation|0|||
126761358|NCT04629534|456077216|FG001|Overall Study|Protocol Violation|2|||
126761359|NCT02797951|456077217|FG000|Overall Study|Adverse Event|4|||
126761360|NCT02797951|456077217|FG000|Overall Study|Death|1|||
126761361|NCT02797951|456077217|FG000|Overall Study|Lack of Efficacy|19|||
126761362|NCT02797951|456077217|FG000|Overall Study|Lost to Follow-up|4|||
126761363|NCT02797951|456077217|FG000|Overall Study|Physician Decision|6|||
126761364|NCT02797951|456077217|FG000|Overall Study|Withdrawal by Subject|15|||
126761365|NCT00814502|456077218|FG000|Overall Study|Adverse Event|1|||
126761366|NCT00814502|456077219|FG001|Overall Study|Adverse Event|0|||
126761367|NCT00814502|456077218|FG000|Overall Study|Withdrawal by Subject|0|||
126761368|NCT00814502|456077219|FG001|Overall Study|Withdrawal by Subject|2|||
126761369|NCT00234533|456077227|FG000|Overall Study|Withdrawal by Subject|6|||
126761370|NCT00234533|456077227|FG000|Overall Study|Adverse Event|2|||
126761371|NCT00234533|456077227|FG000|Overall Study|Enrolled but not treated|3|||
126761372|NCT01484691|456077228|FG000|Overall Study|Withdrawal by Subject|1|||
126761373|NCT01484691|456077229|FG001|Overall Study|Withdrawal by Subject|1|||
126761374|NCT01484691|456077230|FG002|Overall Study|Withdrawal by Subject|1|||
126761375|NCT01484691|456077228|FG000|Overall Study|Physician Decision|0|||
126761376|NCT01484691|456077229|FG001|Overall Study|Physician Decision|2|||
126761377|NCT01484691|456077230|FG002|Overall Study|Physician Decision|1|||
126246507|NCT02286739|454194097|FG001|Overall Study|Adverse Event|2|||
126246508|NCT02286739|454194096|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
126246509|NCT02286739|454194097|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
126246510|NCT03447353|454194101|FG000|Overall Study|Failure at Screening Visit|2|||
126246511|NCT03447353|454194101|FG000|Overall Study|Lost to Follow-up|4|||
126246512|NCT03447353|454194101|FG000|Overall Study|Scheduling Conflicts|3|||
126246513|NCT03447353|454194101|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
126447866|NCT02910986|454939569|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
126447867|NCT02910986|454939570|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
126447868|NCT02910986|454939568|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
126447869|NCT02910986|454939569|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
126447870|NCT02910986|454939570|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
126447871|NCT01941186|454939571|FG000|Follow-up|Lost to Follow-up|1|||
126447872|NCT01941186|454939572|FG001|Follow-up|Lost to Follow-up|0|||
126447873|NCT04380519|454939573|FG000|Overall Study|Withdrawal by Subject|4|||
126447874|NCT04380519|454939574|FG001|Overall Study|Withdrawal by Subject|0|||
126447875|NCT04380519|454939575|FG002|Overall Study|Withdrawal by Subject|1|||
126447876|NCT04380519|454939573|FG000|Overall Study|Death|14|||
126447877|NCT04380519|454939574|FG001|Overall Study|Death|9|||
126447878|NCT04380519|454939575|FG002|Overall Study|Death|6|||
126447879|NCT04380519|454939573|FG000|Overall Study|Adverse Event|0|||
126447880|NCT04380519|454939574|FG001|Overall Study|Adverse Event|1|||
126447881|NCT04380519|454939575|FG002|Overall Study|Adverse Event|0|||
126447882|NCT04380519|454939573|FG000|Overall Study|relatives' decision|0|||
126447883|NCT04380519|454939574|FG001|Overall Study|relatives' decision|1|||
126447884|NCT04380519|454939575|FG002|Overall Study|relatives' decision|0|||
126447885|NCT01068600|454939576|FG000|Overall Study|Withdrawal by Subject|5|||
126447886|NCT01068600|454939577|FG001|Overall Study|Withdrawal by Subject|6|||
126447887|NCT01068600|454939576|FG000|Overall Study|Adverse Event|3|||
126447888|NCT01068600|454939577|FG001|Overall Study|Adverse Event|3|||
126447889|NCT01068600|454939576|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126447890|NCT01068600|454939577|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126447891|NCT01068600|454939576|FG000|Overall Study|Lost to Follow-up|1|||
126447892|NCT01068600|454939577|FG001|Overall Study|Lost to Follow-up|2|||
126447893|NCT01068600|454939576|FG000|Overall Study|Protocol deviation|1|||
126761378|NCT03205605|456077235|FG000|Overall Study|Withdrawal by Subject|1|||
126761379|NCT00736840|456077236|FG000|Overall Study|Lost to Follow-up|13|||
126761380|NCT00945815|456077237|FG000|Overall Study|Death|3|||
126761381|NCT00945815|456077237|FG000|Overall Study|Not protocol specified|1|||
126761382|NCT00945815|456077237|FG000|Overall Study|Ineligible|3|||
126761383|NCT00945815|456077237|FG000|Overall Study|Did not begin protocol therapy|1|||
126447894|NCT01068600|454939577|FG001|Overall Study|Protocol deviation|1|||
126447895|NCT01068600|454939576|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126695247|NCT00849017|455838646|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
126695248|NCT00849017|455838647|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
126695249|NCT00849017|455838645|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
126695250|NCT00849017|455838646|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
126695251|NCT00849017|455838647|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
126695252|NCT00849017|455838645|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
126695253|NCT00849017|455838646|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
126695254|NCT00849017|455838647|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
126695255|NCT00849017|455838645|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
126695256|NCT00849017|455838646|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
126695257|NCT00849017|455838647|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
126695258|NCT00849017|455838645|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
126695259|NCT00849017|455838646|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
126695260|NCT00849017|455838647|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
126695261|NCT00849017|455838645|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
126695262|NCT00849017|455838646|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
126695263|NCT00849017|455838647|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
126695264|NCT00849017|455838645|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
126695265|NCT00849017|455838646|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
126695266|NCT00849017|455838647|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
126695267|NCT00849017|455838645|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
126695268|NCT00849017|455838646|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
126695269|NCT00849017|455838647|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
126695270|NCT00849017|455838645|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
126695271|NCT00849017|455838646|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
126695272|NCT00849017|455838647|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
126695273|NCT00849017|455838645|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
126695274|NCT00849017|455838646|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
126695275|NCT00849017|455838647|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
126695276|NCT00849017|455838645|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
126695277|NCT00849017|455838646|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
126695278|NCT00849017|455838647|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
126695279|NCT05254418|455838651|FG000|Overall Study|Adverse Event|2|||
126695280|NCT03624946|455838656|FG000|Overall Study|Lost to Follow-up|0|||
126695281|NCT03624946|455838657|FG001|Overall Study|Lost to Follow-up|1|||
126695282|NCT01869348|455838658|FG000|Overall Study|Withdrawal by Subject|1|||
126695283|NCT01869348|455838659|FG001|Overall Study|Withdrawal by Subject|1|||
126695284|NCT00624520|455838661|FG000|Overall Study|Withdrawal by Subject|12|||
126695285|NCT00624520|455838662|FG001|Overall Study|Withdrawal by Subject|7|||
126695286|NCT00624520|455838661|FG000|Overall Study|Death|0|||
126695287|NCT00624520|455838662|FG001|Overall Study|Death|1|||
126695288|NCT03075163|455838663|FG000|Overall Study|not eligible for treatment limb|138|||
126695289|NCT03075163|455838664|FG001|Overall Study|not eligible for treatment limb|138|||
126695290|NCT01925209|455838665|FG000|Treatment Epoch|Physician Decision|1|||
126761384|NCT01314261|456077240|FG000|Overall Study|Adverse Event|1|||
126761385|NCT01314261|456077241|FG001|Overall Study|Adverse Event|0|||
126246514|NCT02642653|454194104|FG000|Overall Study|Adverse Event|2|||
126246515|NCT02642653|454194105|FG001|Overall Study|Adverse Event|0|||
126246516|NCT01319383|454194106|FG000|Overall Study|No ex vivo or in vivo response|4|||
126246517|NCT01319383|454194107|FG001|Overall Study|No ex vivo or in vivo response|0|||
126246518|NCT01319383|454194106|FG000|Overall Study|Physician Decision|3|||
126246519|NCT01319383|454194107|FG001|Overall Study|Physician Decision|0|||
126695291|NCT01925209|455838666|FG001|Treatment Epoch|Physician Decision|0|||
126695292|NCT01925209|455838667|FG002|Treatment Epoch|Physician Decision|0|||
126695293|NCT01925209|455838668|FG003|Treatment Epoch|Physician Decision|0|||
126695294|NCT01925209|455838665|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
126695295|NCT01925209|455838666|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
126695296|NCT01925209|455838667|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
126695297|NCT01925209|455838668|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
126695298|NCT01925209|455838665|FG000|Treatment Epoch|Death|1|||
126695299|NCT01925209|455838666|FG001|Treatment Epoch|Death|0|||
126695300|NCT01925209|455838667|FG002|Treatment Epoch|Death|0|||
126695301|NCT01925209|455838668|FG003|Treatment Epoch|Death|0|||
126695302|NCT01925209|455838665|FG000|Treatment Epoch|Protocol deviation|0|||
126695303|NCT01925209|455838666|FG001|Treatment Epoch|Protocol deviation|0|||
126695304|NCT01925209|455838667|FG002|Treatment Epoch|Protocol deviation|1|||
126695305|NCT01925209|455838668|FG003|Treatment Epoch|Protocol deviation|1|||
126695306|NCT01925209|455838665|FG000|Treatment Epoch|Withdrawal by Subject|4|||
126695307|NCT01925209|455838666|FG001|Treatment Epoch|Withdrawal by Subject|3|||
126695308|NCT01925209|455838667|FG002|Treatment Epoch|Withdrawal by Subject|3|||
126695309|NCT01925209|455838668|FG003|Treatment Epoch|Withdrawal by Subject|2|||
126695310|NCT01925209|455838665|FG000|Treatment Epoch|Adverse Event|3|||
126246520|NCT01319383|454194106|FG000|Overall Study|Lack of Efficacy|5|||
126246521|NCT01319383|454194107|FG001|Overall Study|Lack of Efficacy|9|||
126246522|NCT01319383|454194106|FG000|Overall Study|No in vivo response to interval doses|0|||
126246523|NCT01319383|454194107|FG001|Overall Study|No in vivo response to interval doses|1|||
126246524|NCT00772603|454194108|FG000|Overall Study|Withdrawal by Subject|11|||
126246525|NCT00772603|454194109|FG001|Overall Study|Withdrawal by Subject|10|||
126246526|NCT00772603|454194110|FG002|Overall Study|Withdrawal by Subject|6|||
126246527|NCT00772603|454194108|FG000|Overall Study|Adverse Event|37|||
126246528|NCT00772603|454194109|FG001|Overall Study|Adverse Event|18|||
126246529|NCT00772603|454194110|FG002|Overall Study|Adverse Event|10|||
126246530|NCT00772603|454194108|FG000|Overall Study|Subject Non-compliance|1|||
126246531|NCT00772603|454194109|FG001|Overall Study|Subject Non-compliance|6|||
126246532|NCT00772603|454194110|FG002|Overall Study|Subject Non-compliance|4|||
126246533|NCT00772603|454194108|FG000|Overall Study|Protocol Violation|0|||
126246534|NCT00772603|454194109|FG001|Overall Study|Protocol Violation|1|||
126246535|NCT00772603|454194110|FG002|Overall Study|Protocol Violation|1|||
126246536|NCT00772603|454194108|FG000|Overall Study|Lost to Follow-up|1|||
126246537|NCT00772603|454194109|FG001|Overall Study|Lost to Follow-up|5|||
126246538|NCT00772603|454194110|FG002|Overall Study|Lost to Follow-up|2|||
126246539|NCT00772603|454194108|FG000|Overall Study|Physician Decision|0|||
126246540|NCT00772603|454194109|FG001|Overall Study|Physician Decision|0|||
126246541|NCT00772603|454194110|FG002|Overall Study|Physician Decision|1|||
126447896|NCT01068600|454939577|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
126447897|NCT01068600|454939576|FG000|Overall Study|Administrative problems|0|||
126447898|NCT01068600|454939577|FG001|Overall Study|Administrative problems|1|||
126447899|NCT01727024|454939578|FG000|Period 1|Lost to Follow-up|1|||
126447900|NCT01727024|454939579|FG001|Period 1|Lost to Follow-up|1|||
126447901|NCT01727024|454939578|FG000|Period 1|Withdrawal by Subject|2|||
126447902|NCT01727024|454939579|FG001|Period 1|Withdrawal by Subject|3|||
126447903|NCT00947882|454939593|FG000|Overall Study|Adverse Event|0|||
126447904|NCT00947882|454939594|FG001|Overall Study|Adverse Event|1|||
126447905|NCT00947882|454939595|FG002|Overall Study|Adverse Event|4|||
126447906|NCT00947882|454939596|FG003|Overall Study|Adverse Event|4|||
126447907|NCT00947882|454939593|FG000|Overall Study|Withdrawal by Subject|2|||
126447908|NCT00947882|454939594|FG001|Overall Study|Withdrawal by Subject|0|||
126447909|NCT00947882|454939595|FG002|Overall Study|Withdrawal by Subject|8|||
126447910|NCT00947882|454939596|FG003|Overall Study|Withdrawal by Subject|2|||
126447911|NCT00947882|454939593|FG000|Overall Study|Protocol Violation|0|||
126447912|NCT00947882|454939594|FG001|Overall Study|Protocol Violation|0|||
126447913|NCT00947882|454939595|FG002|Overall Study|Protocol Violation|1|||
126447914|NCT00947882|454939596|FG003|Overall Study|Protocol Violation|0|||
126447915|NCT00947882|454939593|FG000|Overall Study|Lost to Follow-up|0|||
126447916|NCT00947882|454939594|FG001|Overall Study|Lost to Follow-up|2|||
126447917|NCT00947882|454939595|FG002|Overall Study|Lost to Follow-up|1|||
126447918|NCT00947882|454939596|FG003|Overall Study|Lost to Follow-up|0|||
126447919|NCT00947882|454939593|FG000|Overall Study|Other/Unknown|10|||
126447920|NCT00947882|454939594|FG001|Overall Study|Other/Unknown|13|||
126447921|NCT00947882|454939595|FG002|Overall Study|Other/Unknown|3|||
126447922|NCT00947882|454939596|FG003|Overall Study|Other/Unknown|6|||
126447923|NCT00947882|454939593|FG000|Overall Study|Trial Terminated by Sponsor|62|||
126447924|NCT00947882|454939594|FG001|Overall Study|Trial Terminated by Sponsor|61|||
126447925|NCT00947882|454939595|FG002|Overall Study|Trial Terminated by Sponsor|62|||
126447926|NCT00947882|454939596|FG003|Overall Study|Trial Terminated by Sponsor|70|||
126447927|NCT00329797|454939597|FG000|Overall Study|Protocol Violation|1|||
126447928|NCT00329797|454939598|FG001|Overall Study|Protocol Violation|0|||
126447929|NCT00329797|454939597|FG000|Overall Study|Withdrawal by Subject|6|||
126447930|NCT00329797|454939598|FG001|Overall Study|Withdrawal by Subject|6|||
126447931|NCT01396057|454939599|FG000|Overall Study|Adverse Event|2|||
126447932|NCT01396057|454939600|FG001|Overall Study|Adverse Event|6|||
126447933|NCT01396057|454939599|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126447934|NCT01396057|454939600|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
126447935|NCT01396057|454939599|FG000|Overall Study|Protocol deviation|4|||
126447936|NCT01396057|454939600|FG001|Overall Study|Protocol deviation|4|||
126246542|NCT00772603|454194108|FG000|Overall Study|Other|2|||
126246543|NCT00772603|454194109|FG001|Overall Study|Other|0|||
126246544|NCT00772603|454194110|FG002|Overall Study|Other|2|||
126447937|NCT01396057|454939599|FG000|Overall Study|Consent withdrawn|3|||
126447938|NCT01396057|454939600|FG001|Overall Study|Consent withdrawn|2|||
126447939|NCT03037580|454939603|FG000|Overall Study|Withdrawal by Subject|3|||
126447940|NCT03037580|454939604|FG001|Overall Study|Withdrawal by Subject|0|||
126447941|NCT03037580|454939603|FG000|Overall Study|Adverse Event|1|||
126447942|NCT03037580|454939604|FG001|Overall Study|Adverse Event|0|||
126246545|NCT01056484|454194119|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
126246546|NCT01056484|454194120|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
126447943|NCT03037580|454939603|FG000|Overall Study|Study Terminated by Sponsor|12|||
126447944|NCT03037580|454939604|FG001|Overall Study|Study Terminated by Sponsor|15|||
126447945|NCT03037580|454939603|FG000|Overall Study|Death|0|||
126447946|NCT03037580|454939604|FG001|Overall Study|Death|1|||
126695311|NCT01925209|455838666|FG001|Treatment Epoch|Adverse Event|5|||
126761386|NCT01314261|456077242|FG002|Overall Study|Adverse Event|0|||
126447947|NCT02087423|454939605|FG000|Overall Study|Withdrawal by Subject|20|||
126447948|NCT02087423|454939606|FG001|Overall Study|Withdrawal by Subject|20|||
126447949|NCT02087423|454939607|FG002|Overall Study|Withdrawal by Subject|3|||
126761387|NCT01314261|456077243|FG003|Overall Study|Adverse Event|0|||
126761388|NCT01314261|456077240|FG000|Overall Study|Withdrawal by Subject|0|||
126761389|NCT01314261|456077241|FG001|Overall Study|Withdrawal by Subject|3|||
126246547|NCT01056484|454194119|FG000|Randomized Controlled Trial|Physician Decision|1|||
126246548|NCT01056484|454194120|FG001|Randomized Controlled Trial|Physician Decision|0|||
126246549|NCT01056484|454194119|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
126246550|NCT01056484|454194120|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
126246551|NCT00446966|454194123|FG000|Overall Study|Lost to Follow-up|10|||
126246552|NCT00446966|454194124|FG001|Overall Study|Lost to Follow-up|7|||
126246553|NCT01564394|454194125|FG000|Overall Study|Withdrawal by Subject|6|||
126246554|NCT01564394|454194126|FG001|Overall Study|Withdrawal by Subject|10|||
126246555|NCT02888756|454194130|FG000|Analytical Treatment Interruption|Physician Decision|10|||
126246556|NCT02888756|454194131|FG001|Analytical Treatment Interruption|Physician Decision|6|||
126246557|NCT02888756|454194132|FG002|Analytical Treatment Interruption|Physician Decision|5|||
126246558|NCT00488774|454194133|FG000|Overall Study|Withdrawal of consent|2|||
126246559|NCT00488774|454194134|FG001|Overall Study|Withdrawal of consent|2|||
126246560|NCT00488774|454194135|FG002|Overall Study|Withdrawal of consent|2|||
126246561|NCT00488774|454194136|FG003|Overall Study|Withdrawal of consent|0|||
126246562|NCT00488774|454194133|FG000|Overall Study|Other|6|||
126246563|NCT00488774|454194134|FG001|Overall Study|Other|3|||
126246564|NCT00488774|454194135|FG002|Overall Study|Other|2|||
126246565|NCT00488774|454194136|FG003|Overall Study|Other|2|||
126246566|NCT00488774|454194133|FG000|Overall Study|Lost to Follow-up|0|||
126246567|NCT00488774|454194134|FG001|Overall Study|Lost to Follow-up|0|||
126246568|NCT00488774|454194135|FG002|Overall Study|Lost to Follow-up|1|||
126447950|NCT02087423|454939605|FG000|Overall Study|Death|68|||
126246569|NCT00488774|454194136|FG003|Overall Study|Lost to Follow-up|1|||
126447951|NCT02087423|454939606|FG001|Overall Study|Death|207|||
126447952|NCT02087423|454939607|FG002|Overall Study|Death|40|||
126695312|NCT01925209|455838667|FG002|Treatment Epoch|Adverse Event|3|||
126695313|NCT01925209|455838668|FG003|Treatment Epoch|Adverse Event|1|||
126695314|NCT01925209|455838665|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
126695315|NCT01925209|455838666|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
126695316|NCT01925209|455838667|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
126695317|NCT01925209|455838668|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
126695318|NCT01925209|455838665|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
126695319|NCT01925209|455838666|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
126695320|NCT01925209|455838667|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
126695321|NCT01925209|455838668|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
126695322|NCT01925209|455838665|FG000|Follow-up|Adverse Event|1|||
126695323|NCT01925209|455838666|FG001|Follow-up|Adverse Event|4|||
126695324|NCT01925209|455838667|FG002|Follow-up|Adverse Event|0|||
126695325|NCT01925209|455838668|FG003|Follow-up|Adverse Event|1|||
126695326|NCT01925209|455838665|FG000|Follow-up|Physician Decision|0|||
126695327|NCT01925209|455838666|FG001|Follow-up|Physician Decision|0|||
126695328|NCT01925209|455838667|FG002|Follow-up|Physician Decision|1|||
126695329|NCT01925209|455838668|FG003|Follow-up|Physician Decision|0|||
126695330|NCT01925209|455838665|FG000|Follow-up|Non-compliance with study treatment|0|||
126695331|NCT01925209|455838666|FG001|Follow-up|Non-compliance with study treatment|0|||
126695332|NCT01925209|455838667|FG002|Follow-up|Non-compliance with study treatment|0|||
126695333|NCT01925209|455838668|FG003|Follow-up|Non-compliance with study treatment|1|||
126695334|NCT01925209|455838665|FG000|Follow-up|Withdrawal by Subject|0|||
126695335|NCT01925209|455838666|FG001|Follow-up|Withdrawal by Subject|2|||
126695336|NCT01925209|455838667|FG002|Follow-up|Withdrawal by Subject|0|||
126695337|NCT01925209|455838668|FG003|Follow-up|Withdrawal by Subject|2|||
126695338|NCT02796755|455838669|FG000|Overall Study|Adverse Event|2|||
126695339|NCT02796755|455838670|FG001|Overall Study|Adverse Event|0|||
126695340|NCT01950819|455838674|FG000|Overall Study|Graft Loss|35|||
126695341|NCT01950819|455838675|FG001|Overall Study|Graft Loss|30|||
126695342|NCT01950819|455838674|FG000|Overall Study|Death|29|||
126695343|NCT01950819|455838675|FG001|Overall Study|Death|34|||
126695344|NCT01950819|455838674|FG000|Overall Study|Subject / Gardian decision|54|||
126695345|NCT01950819|455838675|FG001|Overall Study|Subject / Gardian decision|51|||
126695346|NCT01950819|455838674|FG000|Overall Study|technical problems|2|||
126695347|NCT01950819|455838675|FG001|Overall Study|technical problems|0|||
126695348|NCT01950819|455838674|FG000|Overall Study|Pregnancy|0|||
126695349|NCT01950819|455838675|FG001|Overall Study|Pregnancy|2|||
126695350|NCT01950819|455838674|FG000|Overall Study|Lost to Follow-up|9|||
126695351|NCT01950819|455838675|FG001|Overall Study|Lost to Follow-up|17|||
126695352|NCT01879410|455838676|FG000|Overall Study|Adverse Event|9|||
126695353|NCT01879410|455838677|FG001|Overall Study|Adverse Event|14|||
126695354|NCT01879410|455838676|FG000|Overall Study|Lack of Efficacy|4|||
126695355|NCT01879410|455838677|FG001|Overall Study|Lack of Efficacy|6|||
126246570|NCT04590027|454194137|FG000|Overall Study|Lost to Follow-up|17|||
126761390|NCT01314261|456077242|FG002|Overall Study|Withdrawal by Subject|1|||
126761391|NCT01314261|456077243|FG003|Overall Study|Withdrawal by Subject|0|||
126761392|NCT01314261|456077240|FG000|Overall Study|Lost to Follow-up|1|||
126761393|NCT01314261|456077241|FG001|Overall Study|Lost to Follow-up|0|||
126761394|NCT01314261|456077242|FG002|Overall Study|Lost to Follow-up|2|||
126761395|NCT01314261|456077243|FG003|Overall Study|Lost to Follow-up|2|||
126761396|NCT01314261|456077240|FG000|Overall Study|Virologic Failure|0|||
126761397|NCT01314261|456077241|FG001|Overall Study|Virologic Failure|1|||
126761398|NCT01314261|456077242|FG002|Overall Study|Virologic Failure|0|||
126761399|NCT01314261|456077243|FG003|Overall Study|Virologic Failure|1|||
126761400|NCT04524507|456077244|FG000|Overall Study|Lost to Follow-up|2|||
126761401|NCT04524507|456077245|FG001|Overall Study|Lost to Follow-up|4|||
126761402|NCT04524507|456077244|FG000|Overall Study|Withdrawal by Subject|2|||
126761403|NCT04524507|456077245|FG001|Overall Study|Withdrawal by Subject|9|||
126761404|NCT04524507|456077244|FG000|Overall Study|Death|2|||
126761405|NCT04524507|456077245|FG001|Overall Study|Death|10|||
126246571|NCT04590027|454194138|FG001|Overall Study|Lost to Follow-up|14|||
126246572|NCT04590027|454194137|FG000|Overall Study|Protocol Violation|0|||
126246573|NCT04590027|454194138|FG001|Overall Study|Protocol Violation|3|||
126246574|NCT02682238|454194139|FG000|Overall Study|Lost to Follow-up|0|||
126246575|NCT02682238|454194140|FG001|Overall Study|Lost to Follow-up|2|||
126246576|NCT02682238|454194139|FG000|Overall Study|Withdrawal by Subject|1|||
126246577|NCT02682238|454194140|FG001|Overall Study|Withdrawal by Subject|0|||
126246578|NCT02682238|454194139|FG000|Overall Study|Adverse Event|1|||
126246579|NCT02682238|454194140|FG001|Overall Study|Adverse Event|0|||
126246580|NCT02682238|454194139|FG000|Overall Study|Non-compliance with Study Drug|1|||
126246581|NCT02682238|454194140|FG001|Overall Study|Non-compliance with Study Drug|0|||
126246582|NCT02682238|454194139|FG000|Overall Study|Non-compliance with Protocol|0|||
126246583|NCT02682238|454194140|FG001|Overall Study|Non-compliance with Protocol|2|||
126246584|NCT02909907|454194141|FG000|Overall Study|Withdrawal by Subject|0|||
126246585|NCT02909907|454194142|FG001|Overall Study|Withdrawal by Subject|1|||
126246586|NCT00075478|454194143|FG000|Overall Study|not eligible|1|||
126246587|NCT00075478|454194144|FG001|Overall Study|not eligible|0|||
126246588|NCT00075478|454194143|FG000|Overall Study|Physician Decision|0|||
126246589|NCT00075478|454194144|FG001|Overall Study|Physician Decision|1|||
126246590|NCT02075463|454194147|FG000|Overall Study|Adverse Event|3|||
126246591|NCT02075463|454194147|FG000|Overall Study|Par. reached stopping criteria|4|||
126246592|NCT02075463|454194147|FG000|Overall Study|Withdrawal by Subject|1|||
126246593|NCT01839279|454194149|FG000|Overall Study|Adverse Event|4|||
126246594|NCT01839279|454194150|FG001|Overall Study|Adverse Event|1|||
126246595|NCT01839279|454194151|FG002|Overall Study|Adverse Event|1|||
126246596|NCT01839279|454194149|FG000|Overall Study|Withdrawal by Subject|4|||
126246597|NCT01839279|454194150|FG001|Overall Study|Withdrawal by Subject|1|||
126246598|NCT01839279|454194151|FG002|Overall Study|Withdrawal by Subject|1|||
126246599|NCT01839279|454194149|FG000|Overall Study|Classified as 'Other'|5|||
126246600|NCT01839279|454194150|FG001|Overall Study|Classified as 'Other'|0|||
126246601|NCT01839279|454194151|FG002|Overall Study|Classified as 'Other'|0|||
126246602|NCT03437265|454194152|FG000|Overall Study|Protocol Violation|6|||
126246603|NCT00316277|454194153|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
126246604|NCT00316277|454194154|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
126246605|NCT00316277|454194153|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
126246606|NCT00316277|454194154|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
126246607|NCT00316277|454194153|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
126761406|NCT02711306|456077246|FG000|Overall Study|Withdrawal by Subject|2|||
126761407|NCT02711306|456077247|FG001|Overall Study|Withdrawal by Subject|2|||
126761408|NCT01383317|456077248|FG000|Overall Study|Lost to Follow-up|2|||
126761409|NCT01383317|456077249|FG001|Overall Study|Lost to Follow-up|1|||
126761410|NCT01383317|456077248|FG000|Overall Study|Death|1|||
126761411|NCT01383317|456077249|FG001|Overall Study|Death|0|||
126761412|NCT01383317|456077248|FG000|Overall Study|Adverse Event|0|||
126761413|NCT01383317|456077249|FG001|Overall Study|Adverse Event|1|||
126761414|NCT00422227|456077250|FG000|Overall Study|Adverse Event|3|||
126761415|NCT00422227|456077251|FG001|Overall Study|Adverse Event|8|||
126761416|NCT00422227|456077250|FG000|Overall Study|Lost to Follow-up|1|||
126761417|NCT00422227|456077251|FG001|Overall Study|Lost to Follow-up|3|||
126761418|NCT00422227|456077250|FG000|Overall Study|Withdrawal by Subject|0|||
126761419|NCT00422227|456077251|FG001|Overall Study|Withdrawal by Subject|4|||
126761420|NCT01396434|456077252|FG000|Overall Study|Lost to Follow-up|1|||
126761421|NCT01396434|456077253|FG001|Overall Study|Lost to Follow-up|0|||
126761422|NCT01396434|456077254|FG002|Overall Study|Lost to Follow-up|0|||
126246608|NCT00316277|454194154|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
126246609|NCT00316277|454194153|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
126545925|NCT01678820|455292504|FG001|Overall Study|Withdrawal by Subject|5|||
126761423|NCT01396434|456077252|FG000|Overall Study|Other|10|||
126246610|NCT00316277|454194154|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
126246611|NCT00316277|454194153|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
126761424|NCT01396434|456077253|FG001|Overall Study|Other|0|||
126246612|NCT00316277|454194154|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
126246613|NCT00835263|454194161|FG000|Second Intervention|Adverse Event|1|||
126246614|NCT00835263|454194162|FG001|Second Intervention|Adverse Event|0|||
126246615|NCT00848536|454194163|FG000|Overall Study|Adverse Event|2|||
126246616|NCT00848536|454194164|FG001|Overall Study|Adverse Event|2|||
126246617|NCT00848536|454194163|FG000|Overall Study|Withdrawal by Subject|0|||
126246618|NCT00848536|454194164|FG001|Overall Study|Withdrawal by Subject|1|||
126246619|NCT00848536|454194163|FG000|Overall Study|Protocol Violation|0|||
126246620|NCT00848536|454194164|FG001|Overall Study|Protocol Violation|1|||
126246621|NCT00848536|454194163|FG000|Overall Study|Noncompliance|1|||
126246622|NCT00848536|454194164|FG001|Overall Study|Noncompliance|0|||
126246623|NCT00848536|454194163|FG000|Overall Study|Inadequate Control of IOP|1|||
126246624|NCT00848536|454194164|FG001|Overall Study|Inadequate Control of IOP|1|||
126246625|NCT00848536|454194163|FG000|Overall Study|Patient Moved|0|||
126246626|NCT00848536|454194164|FG001|Overall Study|Patient Moved|2|||
126246627|NCT03987191|454194165|FG000|Overall Study|COVID-19 related research disruption|0|||
126246628|NCT03987191|454194166|FG001|Overall Study|COVID-19 related research disruption|2|||
126246629|NCT03261167|454194167|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
126246630|NCT03261167|454194168|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
126246631|NCT03261167|454194167|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
126246632|NCT03261167|454194168|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
126246633|NCT03261167|454194167|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
126246634|NCT03261167|454194168|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
126246635|NCT03261167|454194167|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
126246636|NCT03261167|454194168|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
126246637|NCT03261167|454194167|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
126246638|NCT03261167|454194168|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
126246639|NCT00918645|454194169|FG000|Overall Study|Withdrawal by Subject|1|||
126246640|NCT01442155|454194170|FG000|Overall Study|Complete remission|35|||
126246641|NCT01442155|454194170|FG000|Overall Study|Recurrence|26|||
126246642|NCT01442155|454194170|FG000|Overall Study|Adverse Event|2|||
126246643|NCT01442155|454194170|FG000|Overall Study|Lost to Follow-up|2|||
126246644|NCT03669861|454194171|FG000|Overall Study|Disease Flare|5|||
126246645|NCT03669861|454194171|FG000|Overall Study|Lack of Efficacy|2|||
126246646|NCT00705666|454194173|FG000|Overall Study|No post-treatment questionnaire|279|||
126246647|NCT00705666|454194173|FG000|Overall Study|Withdrawal by Subject|21|||
126246648|NCT00705666|454194173|FG000|Overall Study|Physician Decision|7|||
126246649|NCT00705666|454194173|FG000|Overall Study|Lost to Follow-up|5|||
126246650|NCT00705666|454194173|FG000|Overall Study|Death|1|||
126246651|NCT00705666|454194173|FG000|Overall Study|Adverse Event|4|||
126246652|NCT00705666|454194173|FG000|Overall Study|Other|12|||
126246653|NCT00705666|454194173|FG000|Overall Study|Other|2|||
126246654|NCT00705666|454194173|FG000|Overall Study|Lack of data|3|||
126246655|NCT00705666|454194173|FG000|Overall Study|Untreated|5|||
126246656|NCT01590563|454194183|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
126246657|NCT01604941|454194184|FG000|Overall Study|Adverse Event|1|||
126246658|NCT01604941|454194185|FG001|Overall Study|Adverse Event|2|||
126246659|NCT01604941|454194186|FG002|Overall Study|Adverse Event|0|||
126246660|NCT01604941|454194187|FG003|Overall Study|Adverse Event|0|||
126246661|NCT01604941|454194188|FG004|Overall Study|Adverse Event|1|||
126761425|NCT01396434|456077254|FG002|Overall Study|Other|0|||
126761426|NCT00157157|456077255|FG000|Overall Study|Withdrawal by Subject|6|||
126761427|NCT00157157|456077255|FG000|Overall Study|Physician Decision|1|||
126761428|NCT00157157|456077255|FG000|Overall Study|Lost to Follow-up|1|||
126761429|NCT00157157|456077255|FG000|Overall Study|Enrolled in another study|1|||
126761430|NCT00157157|456077255|FG000|Overall Study|Met exclusion criteria|1|||
126761431|NCT00157157|456077255|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
126761432|NCT01018680|456079142|FG000|Overall Study|Adverse Event|23|||
126761433|NCT01018680|456079143|FG001|Overall Study|Adverse Event|40|||
126761434|NCT01018680|456079142|FG000|Overall Study|Withdrawal by Subject|10|||
126761435|NCT01018680|456079143|FG001|Overall Study|Withdrawal by Subject|10|||
126761436|NCT01018680|456079142|FG000|Overall Study|Protocol Violation|5|||
126246662|NCT01604941|454194189|FG005|Overall Study|Adverse Event|5|||
126246663|NCT01604941|454194184|FG000|Overall Study|Non-compliance|1|||
126761437|NCT01018680|456079143|FG001|Overall Study|Protocol Violation|8|||
126761438|NCT01018680|456079142|FG000|Overall Study|Sponsor Decision|6|||
126761439|NCT01018680|456079143|FG001|Overall Study|Sponsor Decision|7|||
126246664|NCT01604941|454194185|FG001|Overall Study|Non-compliance|0|||
126246665|NCT01604941|454194186|FG002|Overall Study|Non-compliance|0|||
126246666|NCT01604941|454194187|FG003|Overall Study|Non-compliance|0|||
126761440|NCT01018680|456079142|FG000|Overall Study|Lack of Efficacy|8|||
126761441|NCT01018680|456079143|FG001|Overall Study|Lack of Efficacy|2|||
126761442|NCT01018680|456079142|FG000|Overall Study|Lost to Follow-up|5|||
126246667|NCT01604941|454194188|FG004|Overall Study|Non-compliance|0|||
126246668|NCT01604941|454194189|FG005|Overall Study|Non-compliance|0|||
126447953|NCT02087423|454939605|FG000|Overall Study|Lost to Follow-up|0|||
126246669|NCT01604941|454194184|FG000|Overall Study|Participant Decision|0|||
126246670|NCT01604941|454194185|FG001|Overall Study|Participant Decision|0|||
126246671|NCT01604941|454194186|FG002|Overall Study|Participant Decision|0|||
126246672|NCT01604941|454194187|FG003|Overall Study|Participant Decision|0|||
126246673|NCT01604941|454194188|FG004|Overall Study|Participant Decision|0|||
126246674|NCT01604941|454194189|FG005|Overall Study|Participant Decision|2|||
126246675|NCT01604941|454194184|FG000|Overall Study|Early Study Termination|9|||
126246676|NCT01604941|454194185|FG001|Overall Study|Early Study Termination|2|||
126246677|NCT01604941|454194186|FG002|Overall Study|Early Study Termination|3|||
126246678|NCT01604941|454194187|FG003|Overall Study|Early Study Termination|3|||
126246679|NCT01604941|454194188|FG004|Overall Study|Early Study Termination|0|||
126246680|NCT01604941|454194189|FG005|Overall Study|Early Study Termination|0|||
126246681|NCT03256695|454194190|FG000|Overall Study|Adverse Event|8|||
126246682|NCT03256695|454194190|FG000|Overall Study|Death|2|||
126246683|NCT03256695|454194190|FG000|Overall Study|Withdrawal by Subject|14|||
126246684|NCT03256695|454194190|FG000|Overall Study|Non-compliance with study drug|1|||
126246685|NCT03256695|454194190|FG000|Overall Study|Lost to Follow-up|3|||
126246686|NCT03256695|454194190|FG000|Overall Study|Lack of Efficacy|3|||
126246687|NCT03256695|454194190|FG000|Overall Study|Protocol Violation|5|||
126246688|NCT03256695|454194190|FG000|Overall Study|Other than specified|3|||
126246689|NCT03366792|454194191|FG000|Overall Study|Withdrawal by Subject|7|||
126246690|NCT03366792|454194191|FG000|Overall Study|Lost to Follow-up|2|||
126246691|NCT03366792|454194191|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
126246692|NCT03366792|454194191|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
126246693|NCT02450539|454194192|FG000|Overall Study|Withdrawal by Subject|12|||
126246694|NCT02450539|454194193|FG001|Overall Study|Withdrawal by Subject|6|||
126246695|NCT02450539|454194192|FG000|Overall Study|Lost to Follow-up|4|||
126246696|NCT02450539|454194193|FG001|Overall Study|Lost to Follow-up|1|||
126246697|NCT00585286|454194194|FG000|Overall Study|Lost to Follow-up|1|||
126246698|NCT05479058|454194195|FG000|Overall Study|Withdrawal by Subject|1|||
126246699|NCT05479058|454194196|FG001|Overall Study|Withdrawal by Subject|1|||
126246700|NCT05479058|454194195|FG000|Overall Study|Study terminated by sponsor|10|||
126246701|NCT05479058|454194196|FG001|Overall Study|Study terminated by sponsor|10|||
126246702|NCT00402103|454194201|FG000|Overall Study|Adverse Event|60|||
126447954|NCT02087423|454939606|FG001|Overall Study|Lost to Follow-up|2|||
126447955|NCT02087423|454939607|FG002|Overall Study|Lost to Follow-up|0|||
126447956|NCT02087423|454939605|FG000|Overall Study|Terminated from study at final DCO|23|||
126447957|NCT02087423|454939606|FG001|Overall Study|Terminated from study at final DCO|36|||
126447958|NCT02087423|454939607|FG002|Overall Study|Terminated from study at final DCO|25|||
126447959|NCT00530816|454939609|FG000|Overall Study|Progressive Disease|16|||
126447960|NCT00530816|454939610|FG001|Overall Study|Progressive Disease|24|||
126447961|NCT00530816|454939611|FG002|Overall Study|Progressive Disease|24|||
126695356|NCT01879410|455838676|FG000|Overall Study|Protocol Violation|1|||
126695357|NCT01879410|455838677|FG001|Overall Study|Protocol Violation|7|||
126695358|NCT01879410|455838676|FG000|Overall Study|Lost to Follow-up|2|||
126695359|NCT01879410|455838677|FG001|Overall Study|Lost to Follow-up|1|||
126695360|NCT01879410|455838676|FG000|Overall Study|Withdrawal by Subject|7|||
126695361|NCT01879410|455838677|FG001|Overall Study|Withdrawal by Subject|8|||
126246703|NCT00402103|454194202|FG001|Overall Study|Adverse Event|7|||
126246704|NCT00402103|454194201|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126246705|NCT00402103|454194202|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126246706|NCT00402103|454194201|FG000|Overall Study|Condition no longer requires study drug|2|||
126246707|NCT00402103|454194202|FG001|Overall Study|Condition no longer requires study drug|0|||
126246708|NCT00402103|454194201|FG000|Overall Study|Protocol Deviation|8|||
126246709|NCT00402103|454194202|FG001|Overall Study|Protocol Deviation|0|||
126246710|NCT00402103|454194201|FG000|Overall Study|Patient withdrew consent|12|||
126246711|NCT00402103|454194202|FG001|Overall Study|Patient withdrew consent|1|||
126447962|NCT00530816|454939609|FG000|Overall Study|Adverse Event|6|||
126447963|NCT00530816|454939610|FG001|Overall Study|Adverse Event|13|||
126447964|NCT00530816|454939611|FG002|Overall Study|Adverse Event|7|||
126447965|NCT00530816|454939609|FG000|Overall Study|Other|3|||
126447966|NCT00530816|454939610|FG001|Overall Study|Other|3|||
126447967|NCT00530816|454939611|FG002|Overall Study|Other|4|||
126447968|NCT00530816|454939609|FG000|Overall Study|Withdrawal by Subject|1|||
126447969|NCT00530816|454939610|FG001|Overall Study|Withdrawal by Subject|2|||
126447970|NCT00530816|454939611|FG002|Overall Study|Withdrawal by Subject|6|||
126447971|NCT01388985|454939614|FG000|Overall Study|Death|0|||
126447972|NCT01388985|454939615|FG001|Overall Study|Death|1|||
126447973|NCT01388985|454939614|FG000|Overall Study|Lost to Follow-up|30|||
126447974|NCT01388985|454939615|FG001|Overall Study|Lost to Follow-up|30|||
126447975|NCT01388985|454939614|FG000|Overall Study|Withdrawal by Subject|13|||
126447976|NCT01388985|454939615|FG001|Overall Study|Withdrawal by Subject|4|||
126447977|NCT01388985|454939614|FG000|Overall Study|Subject unavailable|1|||
126695362|NCT01879410|455838676|FG000|Overall Study|Randomised in Error|1|||
126695363|NCT01879410|455838677|FG001|Overall Study|Randomised in Error|2|||
126695364|NCT01756456|455838678|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
126761443|NCT01018680|456079143|FG001|Overall Study|Lost to Follow-up|3|||
126246712|NCT00402103|454194201|FG000|Overall Study|Lost to Follow-up|6|||
126246713|NCT00402103|454194202|FG001|Overall Study|Lost to Follow-up|3|||
126246714|NCT00402103|454194201|FG000|Overall Study|Administrative problems|2|||
126246715|NCT00402103|454194202|FG001|Overall Study|Administrative problems|0|||
126246716|NCT04078022|454194203|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
126246717|NCT04078022|454194204|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
126246718|NCT01895335|454194209|FG000|Overall Study|Adverse Event|106|||
126246719|NCT01895335|454194209|FG000|Overall Study|Lack of Efficacy|53|||
126246720|NCT01895335|454194209|FG000|Overall Study|Poor Compliance to Protocol|11|||
126246721|NCT01895335|454194209|FG000|Overall Study|Included But Not treated|1|||
126246722|NCT01895335|454194209|FG000|Overall Study|Other than Specified Above|44|||
126246723|NCT00418938|454194210|FG000|Overall Study|Reimbursement|1|||
126246724|NCT00418938|454194211|FG001|Overall Study|Reimbursement|0|||
126246725|NCT00418938|454194210|FG000|Overall Study|Administrative decision|3|||
126246726|NCT00418938|454194211|FG001|Overall Study|Administrative decision|3|||
126246727|NCT00418938|454194210|FG000|Overall Study|Withdrawal by Subject|16|||
126246728|NCT00418938|454194211|FG001|Overall Study|Withdrawal by Subject|15|||
126246729|NCT00418938|454194210|FG000|Overall Study|Lost to Follow-up|1|||
126246730|NCT00418938|454194211|FG001|Overall Study|Lost to Follow-up|3|||
126246731|NCT00418938|454194210|FG000|Overall Study|Adverse Event|1|||
126246732|NCT00418938|454194211|FG001|Overall Study|Adverse Event|1|||
126246733|NCT00418938|454194210|FG000|Overall Study|On-going|1|||
126246734|NCT00418938|454194211|FG001|Overall Study|On-going|1|||
126246735|NCT00418938|454194210|FG000|Overall Study|Ineligibility Determined|1|||
126246736|NCT00418938|454194211|FG001|Overall Study|Ineligibility Determined|0|||
126545926|NCT01678820|455292505|FG002|Overall Study|Withdrawal by Subject|2|||
126545927|NCT01678820|455292503|FG000|Overall Study|Protocol Specified Criteria|2|||
126695365|NCT01756456|455838679|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
126695366|NCT01756456|455838680|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
126695367|NCT01756456|455838681|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
126695368|NCT01756456|455838682|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
126695369|NCT01756456|455838683|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
126695370|NCT01756456|455838678|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
126695371|NCT01756456|455838679|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
126695372|NCT01756456|455838680|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
126695373|NCT01756456|455838681|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
126695374|NCT01756456|455838682|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
126695375|NCT01756456|455838683|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
126695376|NCT01756456|455838678|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
126695377|NCT01756456|455838679|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
126695378|NCT01756456|455838680|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
126695379|NCT01756456|455838681|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
126695380|NCT01756456|455838682|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
126695381|NCT01756456|455838683|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
126695382|NCT01756456|455838678|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
126695383|NCT01756456|455838679|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
126695384|NCT01756456|455838680|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
126695385|NCT01756456|455838681|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
126695386|NCT01756456|455838682|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
126695387|NCT01756456|455838683|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
126695388|NCT01756456|455838678|FG000|Treatment Period: Phase I/II|Other causes|0|||
126695389|NCT01756456|455838679|FG001|Treatment Period: Phase I/II|Other causes|0|||
126695390|NCT01756456|455838680|FG002|Treatment Period: Phase I/II|Other causes|0|||
126695391|NCT01756456|455838681|FG003|Treatment Period: Phase I/II|Other causes|1|||
126695392|NCT01756456|455838682|FG004|Treatment Period: Phase I/II|Other causes|2|||
126695393|NCT01756456|455838683|FG005|Treatment Period: Phase I/II|Other causes|2|||
126695394|NCT01756456|455838678|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
126695395|NCT01756456|455838679|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
126695396|NCT01756456|455838680|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
126695397|NCT01756456|455838681|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
126695398|NCT01756456|455838682|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
126695399|NCT01756456|455838683|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
126695400|NCT01756456|455838678|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
126246737|NCT00463684|454194212|FG000|Overall Study|Withdrawal by Subject|1|||
126246738|NCT00463684|454194212|FG000|Overall Study|Lost to Follow-up|3|||
126246739|NCT00115063|454194213|FG000|Overall Study|Lost to Follow-up|98|||
126246740|NCT00115063|454194214|FG001|Overall Study|Lost to Follow-up|104|||
126246741|NCT00115063|454194213|FG000|Overall Study|Death|1|||
126246742|NCT00115063|454194214|FG001|Overall Study|Death|0|||
126246743|NCT00191815|454194215|FG000|Overall Study|Adverse Event|2|||
126246744|NCT00191815|454194215|FG000|Overall Study|Disease progression or relapse|24|||
126246745|NCT00191815|454194215|FG000|Overall Study|Death|2|||
126246746|NCT00191815|454194215|FG000|Overall Study|Protocol Violation|3|||
126246747|NCT00191815|454194215|FG000|Overall Study|Physician Decision|2|||
126246748|NCT00191815|454194215|FG000|Overall Study|Withdrawal by Subject|7|||
126246749|NCT01316055|454194221|FG000|Overall Study|Lost to Follow-up|1|||
126246750|NCT01316055|454194222|FG001|Overall Study|Lost to Follow-up|0|||
126246751|NCT01316055|454194223|FG002|Overall Study|Lost to Follow-up|0|||
126246752|NCT00003470|454194224|FG000|Overall Study|Not evaluable|6|||
126246753|NCT01825798|454194225|FG000|Overall Study|Adverse Event|1|||
126246754|NCT01825798|454194226|FG001|Overall Study|Adverse Event|5|||
126246755|NCT01825798|454194225|FG000|Overall Study|Lost to Follow-up|1|||
126246756|NCT01825798|454194226|FG001|Overall Study|Lost to Follow-up|0|||
126246757|NCT03500094|454194229|FG000|Overall Study|Withdrawal by Subject|1|||
126246758|NCT03500094|454194229|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
126246759|NCT03500094|454194229|FG000|Overall Study|Lost to Follow-up|1|||
126246760|NCT01030133|454194230|FG000|Overall Study|failed to experience pain at level 7/10|2|||
126246761|NCT01030133|454194231|FG001|Overall Study|failed to experience pain at level 7/10|2|||
126246762|NCT02068794|454195697|FG000|Overall Study|Withdrawal by Subject|0|||
126246763|NCT02068794|454195698|FG001|Overall Study|Withdrawal by Subject|1|||
126246764|NCT02068794|454195699|FG002|Overall Study|Withdrawal by Subject|2|||
126246765|NCT02068794|454195697|FG000|Overall Study|Early Progression|1|||
126246766|NCT02068794|454195698|FG001|Overall Study|Early Progression|0|||
126246767|NCT02068794|454195699|FG002|Overall Study|Early Progression|1|||
126246768|NCT02068794|454195697|FG000|Overall Study|Ineligible|0|||
126695401|NCT01756456|455838679|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
126246769|NCT02068794|454195698|FG001|Overall Study|Ineligible|0|||
126246770|NCT02068794|454195699|FG002|Overall Study|Ineligible|1|||
126246771|NCT02316548|454195701|FG000|Overall Study|Protocol Violation|0|||
126246772|NCT02316548|454195702|FG001|Overall Study|Protocol Violation|1|||
126246773|NCT01958294|454195703|FG000|Overall Study|Clinical Circumstances|2|||
126246774|NCT02566850|454195705|FG000|Overall Study|Protocol Violation|1|||
126447978|NCT01388985|454939615|FG001|Overall Study|Subject unavailable|1|||
126447979|NCT01388985|454939614|FG000|Overall Study|Other (no reason)|0|||
126447980|NCT01388985|454939615|FG001|Overall Study|Other (no reason)|1|||
126447981|NCT01388985|454939614|FG000|Overall Study|Error of nurse|5|||
126447982|NCT01388985|454939615|FG001|Overall Study|Error of nurse|1|||
126447983|NCT01057589|454939616|FG000|Overall Study|Disease Progression|35|||
126695402|NCT01756456|455838680|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
126695403|NCT01756456|455838681|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
126695404|NCT01756456|455838682|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
126695405|NCT01756456|455838683|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
126246775|NCT02635750|454195706|FG000|Part 1, Period 2|Adverse Event|1|||
126246776|NCT02635750|454195707|FG001|Part 1, Period 2|Adverse Event|0|||
126246777|NCT02635750|454195708|FG002|Part 1, Period 2|Adverse Event|0|||
126246778|NCT00830258|454195711|FG000|First Intervention|Adverse Event|1|||
126246779|NCT00830258|454195712|FG001|First Intervention|Adverse Event|0|||
126246780|NCT00830258|454195711|FG000|Washout: 7 Days|Protocol Violation|1|||
126246781|NCT00830258|454195712|FG001|Washout: 7 Days|Protocol Violation|0|||
126246782|NCT00682461|454195716|FG000|Overall Study|Adverse Event|5|||
126246783|NCT00682461|454195717|FG001|Overall Study|Adverse Event|7|||
126246784|NCT00682461|454195716|FG000|Overall Study|Lost to Follow-up|8|||
126246785|NCT00682461|454195717|FG001|Overall Study|Lost to Follow-up|5|||
126695406|NCT01756456|455838678|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
126695407|NCT01756456|455838679|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
126695408|NCT01756456|455838680|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
126695409|NCT01756456|455838681|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
126695410|NCT01756456|455838682|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
126695411|NCT01756456|455838683|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
126695412|NCT01756456|455838678|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
126695413|NCT01756456|455838679|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
126695414|NCT01756456|455838680|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
126695415|NCT01756456|455838681|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
126695416|NCT01756456|455838682|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
126695417|NCT01756456|455838683|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
126695418|NCT01756456|455838678|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
126695419|NCT01756456|455838679|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
126695420|NCT01756456|455838680|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
126695421|NCT01756456|455838681|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
126695422|NCT01756456|455838682|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
126695423|NCT01756456|455838683|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
126695424|NCT01756456|455838678|FG000|Follow Up Period Phase I/II|Other causes|0|||
126695425|NCT01756456|455838679|FG001|Follow Up Period Phase I/II|Other causes|0|||
126761444|NCT01018680|456079142|FG000|Overall Study|Entry Criteria Not Met|1|||
126447984|NCT01057589|454939616|FG000|Overall Study|Adverse Event|10|||
126761445|NCT01018680|456079143|FG001|Overall Study|Entry Criteria Not Met|4|||
126447985|NCT01057589|454939616|FG000|Overall Study|Physician Decision|8|||
126545928|NCT01678820|455292504|FG001|Overall Study|Protocol Specified Criteria|3|||
126545929|NCT01678820|455292505|FG002|Overall Study|Protocol Specified Criteria|1|||
126545930|NCT01678820|455292503|FG000|Overall Study|Adverse Event|2|||
126545931|NCT01678820|455292504|FG001|Overall Study|Adverse Event|2|||
126545932|NCT01678820|455292505|FG002|Overall Study|Adverse Event|2|||
126545933|NCT01678820|455292503|FG000|Overall Study|Lost to Follow-up|7|||
126545934|NCT01678820|455292504|FG001|Overall Study|Lost to Follow-up|2|||
126545935|NCT01678820|455292505|FG002|Overall Study|Lost to Follow-up|2|||
126545936|NCT01678820|455292503|FG000|Overall Study|Non-compliance with study drug|0|||
126545937|NCT01678820|455292504|FG001|Overall Study|Non-compliance with study drug|1|||
126545938|NCT01678820|455292505|FG002|Overall Study|Non-compliance with study drug|0|||
126545939|NCT01678820|455292503|FG000|Overall Study|Physician Decision|0|||
126545940|NCT01678820|455292504|FG001|Overall Study|Physician Decision|0|||
126545941|NCT01678820|455292505|FG002|Overall Study|Physician Decision|1|||
126545942|NCT01678820|455292503|FG000|Overall Study|Protocol Violation|4|||
126545943|NCT01678820|455292504|FG001|Overall Study|Protocol Violation|5|||
126545944|NCT01678820|455292505|FG002|Overall Study|Protocol Violation|4|||
126545945|NCT01678820|455292503|FG000|Overall Study|Not treated with double-blind study drug|0|||
126545946|NCT01678820|455292504|FG001|Overall Study|Not treated with double-blind study drug|2|||
126545947|NCT01678820|455292505|FG002|Overall Study|Not treated with double-blind study drug|2|||
126545948|NCT04488003|455292510|FG000|Assessed for Eligibility|Screen Failure|24|||
126545949|NCT04488003|455292511|FG001|Assessed for Eligibility|Screen Failure|0|||
126545950|NCT04488003|455292512|FG002|Assessed for Eligibility|Screen Failure|0|||
126545951|NCT04488003|455292510|FG000|Assessed for Eligibility|Adverse Event|1|||
126545952|NCT04488003|455292511|FG001|Assessed for Eligibility|Adverse Event|0|||
126545953|NCT04488003|455292512|FG002|Assessed for Eligibility|Adverse Event|0|||
126545954|NCT04488003|455292510|FG000|Assessed for Eligibility|Death|1|||
126545955|NCT04488003|455292511|FG001|Assessed for Eligibility|Death|0|||
126545956|NCT04488003|455292512|FG002|Assessed for Eligibility|Death|0|||
126545957|NCT04488003|455292510|FG000|Assessed for Eligibility|Physician Decision|1|||
126545958|NCT04488003|455292511|FG001|Assessed for Eligibility|Physician Decision|0|||
126545959|NCT04488003|455292512|FG002|Assessed for Eligibility|Physician Decision|0|||
126545960|NCT04488003|455292510|FG000|Allocated to Treatment|Progressive Disease|51|||
126545961|NCT04488003|455292511|FG001|Allocated to Treatment|Progressive Disease|0|||
126545962|NCT04488003|455292512|FG002|Allocated to Treatment|Progressive Disease|0|||
126545963|NCT04488003|455292510|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
126545964|NCT04488003|455292511|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
126545965|NCT04488003|455292512|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
126545966|NCT04488003|455292510|FG000|Allocated to Treatment|Adverse Event|6|||
126545967|NCT04488003|455292511|FG001|Allocated to Treatment|Adverse Event|0|||
126545968|NCT04488003|455292512|FG002|Allocated to Treatment|Adverse Event|0|||
126545969|NCT04488003|455292510|FG000|Allocated to Treatment|Other|5|||
126545970|NCT04488003|455292511|FG001|Allocated to Treatment|Other|0|||
126545971|NCT04488003|455292512|FG002|Allocated to Treatment|Other|0|||
126545972|NCT04488003|455292510|FG000|Allocated to Treatment|Physician Decision|4|||
126545973|NCT04488003|455292511|FG001|Allocated to Treatment|Physician Decision|0|||
126545974|NCT04488003|455292512|FG002|Allocated to Treatment|Physician Decision|0|||
126545975|NCT04488003|455292510|FG000|Allocated to Treatment|Death|4|||
126545976|NCT04488003|455292511|FG001|Allocated to Treatment|Death|0|||
126545977|NCT04488003|455292512|FG002|Allocated to Treatment|Death|0|||
126545978|NCT01350505|455292517|FG000|Overall Study|Lost to Follow-up|4|||
126545979|NCT02357810|455292518|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
126545980|NCT02357810|455292518|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
126545981|NCT02357810|455292518|FG000|Reached 12 Weeks Response|Adverse Event|5|||
126545982|NCT02357810|455292518|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
126545983|NCT02357810|455292518|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
126545984|NCT02357810|455292518|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
126246786|NCT00682461|454195716|FG000|Overall Study|Withdrawal by Subject|12|||
126246787|NCT00682461|454195717|FG001|Overall Study|Withdrawal by Subject|19|||
126246788|NCT04035187|454195720|FG000|Overall Study|Withdrawal by Subject|2|||
126246789|NCT04035187|454195721|FG001|Overall Study|Withdrawal by Subject|1|||
126545985|NCT02357810|455292518|FG000|Reached 12 Weeks Response|Death|1|||
126695426|NCT01756456|455838680|FG002|Follow Up Period Phase I/II|Other causes|0|||
126246790|NCT04035187|454195722|FG002|Overall Study|Withdrawal by Subject|0|||
126246791|NCT04035187|454195723|FG003|Overall Study|Withdrawal by Subject|0|||
126246792|NCT04035187|454195720|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
126545986|NCT02357810|455292518|FG000|Reached 12 Weeks Response|Physician Decision|1|||
126545987|NCT02357810|455292518|FG000|Reached 12 Weeks Response|Other|1|||
126545988|NCT02357810|455292518|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
126545989|NCT02357810|455292518|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
126545990|NCT02357810|455292518|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
126545991|NCT02357810|455292518|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
126545992|NCT02357810|455292518|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
126246793|NCT04035187|454195721|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
126246794|NCT04035187|454195722|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
126246795|NCT04035187|454195723|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
126246796|NCT01116739|454195724|FG000|Overall Study|Child had 2 years of HS|110|||
126246797|NCT01116739|454195725|FG001|Overall Study|Child had 2 years of HS|128|||
126246798|NCT01116739|454195724|FG000|Overall Study|Withdrawal by Subject|6|||
126246799|NCT01116739|454195725|FG001|Overall Study|Withdrawal by Subject|0|||
126246800|NCT01116739|454195724|FG000|Overall Study|child too young|2|||
126246801|NCT01116739|454195725|FG001|Overall Study|child too young|6|||
126246802|NCT01116739|454195724|FG000|Overall Study|child not enrolled in head start|10|||
126246803|NCT01116739|454195725|FG001|Overall Study|child not enrolled in head start|2|||
126246804|NCT01116739|454195724|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
126246805|NCT01116739|454195725|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
126246806|NCT05511935|454195726|FG000|Overall Study|Lost to Follow-up|9|||
126246807|NCT05511935|454195727|FG001|Overall Study|Lost to Follow-up|27|||
126246808|NCT05090839|454195730|FG000|Overall Study|Lost to Follow-up|2|||
126246809|NCT05090839|454195731|FG001|Overall Study|Lost to Follow-up|3|||
126246810|NCT05090839|454195732|FG002|Overall Study|Lost to Follow-up|1|||
126246811|NCT05090839|454195733|FG003|Overall Study|Lost to Follow-up|1|||
126246812|NCT03913377|454195734|FG000|Period 1|Test Article no longer available|0|||
126246813|NCT03913377|454195735|FG001|Period 1|Test Article no longer available|1|||
126246814|NCT03913377|454195736|FG002|Period 1|Test Article no longer available|0|||
126246815|NCT03913377|454195734|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
126246816|NCT03913377|454195735|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
126246817|NCT03913377|454195736|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
126246818|NCT03499353|454195737|FG000|Treatment|Adverse Event|3|||
126246819|NCT03499353|454195737|FG000|Treatment|Progressive Disease|10|||
126246820|NCT03499353|454195737|FG000|Treatment|Other|1|||
126246821|NCT03499353|454195737|FG000|Treatment|Withdrawal by Subject|2|||
126246822|NCT03499353|454195737|FG000|Long-Term Follow-up|Death|2|||
126246823|NCT03499353|454195737|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
126246824|NCT03499353|454195737|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
126246825|NCT01117623|454195738|FG000|Overall Study|Adverse Event|0|||
126246826|NCT01117623|454195739|FG001|Overall Study|Adverse Event|2|||
126246827|NCT01117623|454195740|FG002|Overall Study|Adverse Event|4|||
126246828|NCT01117623|454195741|FG003|Overall Study|Adverse Event|0|||
126246829|NCT01117623|454195742|FG004|Overall Study|Adverse Event|2|||
126246830|NCT01117623|454195743|FG005|Overall Study|Adverse Event|0|||
126246831|NCT01117623|454195744|FG006|Overall Study|Adverse Event|0|||
126246832|NCT01117623|454195745|FG007|Overall Study|Adverse Event|2|||
126246833|NCT01117623|454195738|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
126246834|NCT01117623|454195739|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
126246835|NCT01117623|454195740|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
126246836|NCT01117623|454195741|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
126246837|NCT01117623|454195742|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
126246838|NCT01117623|454195743|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
126246839|NCT01117623|454195744|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
126246840|NCT01117623|454195745|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
126246841|NCT01117623|454195738|FG000|Overall Study|Withdrawal by Subject|0|||
126246842|NCT01117623|454195739|FG001|Overall Study|Withdrawal by Subject|0|||
126246843|NCT01117623|454195740|FG002|Overall Study|Withdrawal by Subject|2|||
126761446|NCT01018680|456079142|FG000|Overall Study|Physician Decision|3|||
126761447|NCT01018680|456079143|FG001|Overall Study|Physician Decision|1|||
126246844|NCT01117623|454195741|FG003|Overall Study|Withdrawal by Subject|0|||
126246845|NCT01117623|454195742|FG004|Overall Study|Withdrawal by Subject|0|||
126246846|NCT01117623|454195743|FG005|Overall Study|Withdrawal by Subject|1|||
126246847|NCT01117623|454195744|FG006|Overall Study|Withdrawal by Subject|1|||
126246848|NCT01117623|454195745|FG007|Overall Study|Withdrawal by Subject|1|||
126246849|NCT01117623|454195738|FG000|Overall Study|Non-compliance with study medication|0|||
126246850|NCT01117623|454195739|FG001|Overall Study|Non-compliance with study medication|0|||
126246851|NCT01117623|454195740|FG002|Overall Study|Non-compliance with study medication|0|||
126246852|NCT01117623|454195741|FG003|Overall Study|Non-compliance with study medication|0|||
126761448|NCT02383966|456079147|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
126761449|NCT02383966|456079148|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
126246853|NCT01117623|454195742|FG004|Overall Study|Non-compliance with study medication|0|||
126246854|NCT01117623|454195743|FG005|Overall Study|Non-compliance with study medication|0|||
126246855|NCT01117623|454195744|FG006|Overall Study|Non-compliance with study medication|0|||
126246856|NCT01117623|454195745|FG007|Overall Study|Non-compliance with study medication|1|||
126246857|NCT01117623|454195738|FG000|Overall Study|Invest. text: completed all planned txs|0|||
126246858|NCT01117623|454195739|FG001|Overall Study|Invest. text: completed all planned txs|0|||
126761450|NCT02383966|456079147|FG000|Overall Study|Randomized, but not treated|1|||
126761451|NCT02383966|456079148|FG001|Overall Study|Randomized, but not treated|3|||
126246859|NCT01117623|454195740|FG002|Overall Study|Invest. text: completed all planned txs|0|||
126246860|NCT01117623|454195741|FG003|Overall Study|Invest. text: completed all planned txs|0|||
126246861|NCT01117623|454195742|FG004|Overall Study|Invest. text: completed all planned txs|0|||
126246862|NCT01117623|454195743|FG005|Overall Study|Invest. text: completed all planned txs|1|||
126246863|NCT01117623|454195744|FG006|Overall Study|Invest. text: completed all planned txs|0|||
126246864|NCT01117623|454195745|FG007|Overall Study|Invest. text: completed all planned txs|0|||
126246865|NCT00736190|454195750|FG000|Overall Study|Pregnancy|1|||
126246866|NCT00736190|454195750|FG000|Overall Study|Withdrawal by Subject|1|||
126246867|NCT00736190|454195750|FG000|Overall Study|Adverse Event|1|||
126246868|NCT01896934|454195752|FG000|Overall Study|Adverse Event|1|||
126246869|NCT01896934|454195752|FG000|Overall Study|Withdrawal by Subject|1|||
126246870|NCT00824291|454195753|FG000|Overall Study|Adverse Event|15|||
126246871|NCT00824291|454195754|FG001|Overall Study|Adverse Event|6|||
126246872|NCT00824291|454195753|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
126246873|NCT00824291|454195754|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
126246874|NCT00824291|454195753|FG000|Overall Study|Lost to Follow-up|11|||
126246875|NCT00824291|454195754|FG001|Overall Study|Lost to Follow-up|9|||
126246876|NCT00824291|454195753|FG000|Overall Study|Non-compliance|1|||
126246877|NCT00824291|454195754|FG001|Overall Study|Non-compliance|1|||
126246878|NCT00824291|454195753|FG000|Overall Study|Protocol Violation|4|||
126246879|NCT00824291|454195754|FG001|Overall Study|Protocol Violation|1|||
126246880|NCT00824291|454195753|FG000|Overall Study|Withdrawal by Subject|14|||
126246881|NCT00824291|454195754|FG001|Overall Study|Withdrawal by Subject|8|||
126246882|NCT00824291|454195753|FG000|Overall Study|Lack of Efficacy|7|||
126246883|NCT00824291|454195754|FG001|Overall Study|Lack of Efficacy|8|||
126246884|NCT00824291|454195753|FG000|Overall Study|Participant on prohibited medication|1|||
126246885|NCT00824291|454195754|FG001|Overall Study|Participant on prohibited medication|0|||
126246886|NCT00933686|454195755|FG000|Overall Study|Protocol Violation|0|||
126246887|NCT00933686|454195756|FG001|Overall Study|Protocol Violation|1|||
126246888|NCT00933686|454195755|FG000|Overall Study|Lost to Follow-up|2|||
126246889|NCT00933686|454195756|FG001|Overall Study|Lost to Follow-up|2|||
126246890|NCT00933686|454195755|FG000|Overall Study|Withdrawal by Subject|6|||
126246891|NCT00933686|454195756|FG001|Overall Study|Withdrawal by Subject|5|||
126246892|NCT00933686|454195755|FG000|Overall Study|Adverse Event|1|||
126246893|NCT00933686|454195756|FG001|Overall Study|Adverse Event|1|||
126246894|NCT00933686|454195755|FG000|Overall Study|Physician Decision|1|||
126246895|NCT00933686|454195756|FG001|Overall Study|Physician Decision|0|||
126246896|NCT00933686|454195755|FG000|Overall Study|Failure to show up at endpoint visits|0|||
126246897|NCT00933686|454195756|FG001|Overall Study|Failure to show up at endpoint visits|2|||
126246898|NCT00840216|454195762|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
126246899|NCT00840216|454195763|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
126246900|NCT05041361|454195764|FG000|Overall Study|Lost to Follow-up|1|||
126246901|NCT05041361|454195765|FG001|Overall Study|Lost to Follow-up|3|||
126246902|NCT01642277|454195766|FG000|Overall Study|Adverse Event|10|||
126246903|NCT01642277|454195767|FG001|Overall Study|Adverse Event|0|||
126246904|NCT01642277|454195766|FG000|Overall Study|Physician Decision|2|||
126246905|NCT01642277|454195767|FG001|Overall Study|Physician Decision|0|||
126246906|NCT01642277|454195766|FG000|Overall Study|Protocol Violation|1|||
126246907|NCT01642277|454195767|FG001|Overall Study|Protocol Violation|0|||
126246908|NCT01642277|454195766|FG000|Overall Study|Withdrawal by Subject|11|||
126246909|NCT01642277|454195767|FG001|Overall Study|Withdrawal by Subject|0|||
126246910|NCT03605342|454195770|FG000|Overall Study|Withdrawal by Subject|9|||
126246911|NCT03605342|454195771|FG001|Overall Study|Withdrawal by Subject|7|||
126246912|NCT03605342|454195770|FG000|Overall Study|Lost to Follow-up|1|||
126246913|NCT03605342|454195771|FG001|Overall Study|Lost to Follow-up|1|||
126246914|NCT00796328|454195772|FG000|Overall Study|experienced hypotension requiring tx|6|||
126246915|NCT01572662|454195780|FG000|Overall Study|Withdrawal by Subject|1|||
126246916|NCT01572662|454195781|FG001|Overall Study|Withdrawal by Subject|0|||
126246917|NCT01572662|454195780|FG000|Overall Study|Physician Decision|0|||
126246918|NCT01572662|454195781|FG001|Overall Study|Physician Decision|1|||
126246919|NCT03364192|454195782|FG000|Overall Study|Ineligible|10|||
126246920|NCT03364192|454195782|FG000|Overall Study|Withdrawal by Subject|5|||
126246921|NCT03364192|454195782|FG000|Overall Study|Lost to Follow-up|1|||
126246922|NCT03446768|454195787|FG000|Overall Study|Withdrawal by Subject|0|||
126246923|NCT03446768|454195788|FG001|Overall Study|Withdrawal by Subject|1|||
126246924|NCT05133180|454195789|FG000|Overall Study|Withdrawal of consent|1|||
126246925|NCT05133180|454195790|FG001|Overall Study|Withdrawal of consent|1|||
126246926|NCT05133180|454195789|FG000|Overall Study|Lost to Follow-up|1|||
126246927|NCT05133180|454195790|FG001|Overall Study|Lost to Follow-up|1|||
126246928|NCT05133180|454195789|FG000|Overall Study|Documented disease progression|0|||
126246929|NCT05133180|454195790|FG001|Overall Study|Documented disease progression|1|||
126246930|NCT00107991|454195791|FG000|Eligibility Assessment|Disease not severe enough|7|||
126246931|NCT00107991|454195791|FG000|Eligibility Assessment|Unwilling to participate|7|||
126246932|NCT00107991|454195791|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
126246933|NCT00107991|454195791|FG000|Eligibility Assessment|Abnormal labs|2|||
126246934|NCT00107991|454195791|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
126545993|NCT02357810|455292518|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
126545994|NCT00980005|455292521|FG000|Overall Study|Withdrawal by Subject|6|||
126545995|NCT00980005|455292522|FG001|Overall Study|Withdrawal by Subject|17|||
126545996|NCT00980005|455292521|FG000|Overall Study|Lost to Follow-up|37|||
126246935|NCT00107991|454195791|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
126545997|NCT00980005|455292522|FG001|Overall Study|Lost to Follow-up|43|||
126246936|NCT00107991|454195791|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
126246937|NCT00107991|454195791|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
126246938|NCT00107991|454195791|FG000|12 Week Treatment Period|Adverse Event|1|||
126246939|NCT00107991|454195791|FG000|12 Week Treatment Period|Protocol Violation|1|||
126246940|NCT00107991|454195791|FG000|12 Week Treatment Period|Incarcerated|1|||
126246941|NCT00107991|454195791|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
126246942|NCT01535222|454195792|FG000|Overall Study|Inclusion/exclusion|0|||
126246943|NCT01535222|454195793|FG001|Overall Study|Inclusion/exclusion|0|||
126246944|NCT01535222|454195794|FG002|Overall Study|Inclusion/exclusion|1|||
126246945|NCT01535222|454195795|FG003|Overall Study|Inclusion/exclusion|0|||
126545998|NCT00980005|455292521|FG000|Overall Study|Other|4|||
126545999|NCT00980005|455292522|FG001|Overall Study|Other|3|||
126546000|NCT00692406|455292523|FG000|Overall Study|PI dropped, bad data|57|||
126546001|NCT04145037|455292524|FG000|Overall Study|Study terminated|2|||
126546002|NCT04145037|455292525|FG001|Overall Study|Study terminated|0|||
126546003|NCT04145037|455292524|FG000|Overall Study|Withdrawal by Subject|1|||
126546004|NCT04145037|455292525|FG001|Overall Study|Withdrawal by Subject|0|||
126546005|NCT04145037|455292524|FG000|Overall Study|Lost to Follow-up|1|||
126546006|NCT04145037|455292525|FG001|Overall Study|Lost to Follow-up|0|||
126546007|NCT02307513|455292528|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
126546008|NCT02307513|455292529|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
126546009|NCT02307513|455292528|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
126546010|NCT02307513|455292529|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
126546011|NCT02307513|455292528|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
126546012|NCT02307513|455292529|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
126546013|NCT02307513|455292528|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
126546014|NCT02307513|455292529|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
126546015|NCT02307513|455292528|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
126546016|NCT02307513|455292529|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
126546017|NCT02307513|455292528|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
126546018|NCT02307513|455292529|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
126546019|NCT02307513|455292528|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
126546020|NCT02307513|455292529|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
126695427|NCT01756456|455838681|FG003|Follow Up Period Phase I/II|Other causes|1|||
126246946|NCT01535222|454195796|FG004|Overall Study|Inclusion/exclusion|0|||
126246947|NCT01535222|454195797|FG005|Overall Study|Inclusion/exclusion|0|||
126246948|NCT00935012|454195798|FG000|Overall Study|Death|19|||
126246949|NCT00935012|454195798|FG000|Overall Study|Withdrawal by Subject|3|||
126246950|NCT00935012|454195798|FG000|Overall Study|Other|5|||
126246951|NCT00935012|454195798|FG000|Overall Study|Adverse Event|2|||
126246952|NCT03930732|454195799|FG000|Overall Study|Adverse Event|9|||
126246953|NCT03930732|454195800|FG001|Overall Study|Adverse Event|7|||
126246954|NCT03930732|454195799|FG000|Overall Study|Poor compliance to protocol|0|||
126546021|NCT02307513|455292528|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
126546022|NCT02307513|455292529|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
126695428|NCT01756456|455838682|FG004|Follow Up Period Phase I/II|Other causes|3|||
126695429|NCT01756456|455838683|FG005|Follow Up Period Phase I/II|Other causes|5|||
126695430|NCT01573910|455838684|FG000|Overall Study|Adverse Event|4|||
126695431|NCT01573910|455838685|FG001|Overall Study|Adverse Event|4|||
126695432|NCT01573910|455838684|FG000|Overall Study|Lost to Follow-up|2|||
126246955|NCT03930732|454195800|FG001|Overall Study|Poor compliance to protocol|1|||
126246956|NCT03930732|454195799|FG000|Overall Study|Withdrawal by Subject|23|||
126546023|NCT02307513|455292528|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
126546024|NCT02307513|455292529|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
126546025|NCT02307513|455292528|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
126546026|NCT02307513|455292529|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
126546027|NCT02307513|455292528|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
126695433|NCT01573910|455838685|FG001|Overall Study|Lost to Follow-up|1|||
126246957|NCT03930732|454195800|FG001|Overall Study|Withdrawal by Subject|11|||
126246958|NCT03930732|454195799|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
126246959|NCT03930732|454195800|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
126246960|NCT03930732|454195799|FG000|Overall Study|Other reason not related to COVID-19|5|||
126546028|NCT02307513|455292529|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
126546029|NCT02307513|455292528|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
126695434|NCT01573910|455838684|FG000|Overall Study|Withdrawal by Subject|0|||
126695435|NCT01573910|455838685|FG001|Overall Study|Withdrawal by Subject|1|||
126246961|NCT03930732|454195800|FG001|Overall Study|Other reason not related to COVID-19|8|||
126246962|NCT03406156|454195801|FG000|Overall Study|Death|9|||
126246963|NCT03406156|454195802|FG001|Overall Study|Death|3|||
126246964|NCT03406156|454195801|FG000|Overall Study|Withdrawal by Subject|1|||
126246965|NCT03406156|454195802|FG001|Overall Study|Withdrawal by Subject|2|||
126246966|NCT03406156|454195801|FG000|Overall Study|COVID-19 infection|1|||
126246967|NCT03406156|454195802|FG001|Overall Study|COVID-19 infection|0|||
126246968|NCT03406156|454195801|FG000|Overall Study|Non-compliance with study procedures|1|||
126246969|NCT03406156|454195802|FG001|Overall Study|Non-compliance with study procedures|1|||
126246970|NCT03406156|454195801|FG000|Overall Study|Lost to Follow-up|0|||
126246971|NCT03406156|454195802|FG001|Overall Study|Lost to Follow-up|2|||
126246972|NCT03406156|454195801|FG000|Overall Study|Other, not specified|72|||
126246973|NCT03406156|454195802|FG001|Overall Study|Other, not specified|28|||
126246974|NCT02699463|454195805|FG000|Overall Study|Lost to Follow-up|11|||
126246975|NCT02699463|454195806|FG001|Overall Study|Lost to Follow-up|8|||
126246976|NCT02699463|454195805|FG000|Overall Study|Withdrawal by Subject|4|||
126246977|NCT02699463|454195806|FG001|Overall Study|Withdrawal by Subject|1|||
126246978|NCT00918684|454195812|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
126246979|NCT00918684|454195812|FG000|Treatment Phase|Lack of Efficacy|6|||
126246980|NCT00918684|454195812|FG000|Treatment Phase|Lost to Follow-up|2|||
126246981|NCT00918684|454195812|FG000|Treatment Phase|Physician Decision|8|||
126246982|NCT00918684|454195812|FG000|Treatment Phase|Protocol Violation|1|||
126246983|NCT00918684|454195812|FG000|Treatment Phase|Withdrawal by Subject|8|||
126246984|NCT00909038|454195813|FG000|Overall Study|Protocol Violation|187|||
126246985|NCT00909038|454195813|FG000|Overall Study|Non-evaluable Subjects|230|||
126246986|NCT00484679|454195814|FG000|Overall Study|Withdrawal by Subject|3|||
126246987|NCT00835692|454195815|FG000|First Intervention|Withdrawal by Subject|1|||
126246988|NCT00835692|454195816|FG001|First Intervention|Withdrawal by Subject|0|||
126246989|NCT04345653|454195819|FG000|Overall Study|Withdrawal by Subject|2|||
126246990|NCT03808376|454195820|FG000|Overall Study|Withdrawal by Subject|10|||
126246991|NCT03644550|454195821|FG000|Overall Study|Withdrawal by Subject|3|||
126246992|NCT03644550|454195821|FG000|Overall Study|Progressive disease|15|||
126246993|NCT01348789|454195824|FG000|Overall Study|Protocol Violation|2|||
126246994|NCT01348789|454195824|FG000|Overall Study|Withdrawal by Subject|2|||
126246995|NCT03503318|454195827|FG000|Overall Study|Death|1|||
126246996|NCT03503318|454195828|FG001|Overall Study|Death|0|||
126246997|NCT03503318|454195829|FG002|Overall Study|Death|4|||
126246998|NCT03503318|454195827|FG000|Overall Study|Adverse Event|3|||
126246999|NCT03503318|454195828|FG001|Overall Study|Adverse Event|4|||
126247000|NCT03503318|454195829|FG002|Overall Study|Adverse Event|2|||
126247001|NCT03503318|454195827|FG000|Overall Study|Withdrawal by Subject|12|||
126247002|NCT03503318|454195828|FG001|Overall Study|Withdrawal by Subject|17|||
126247003|NCT03503318|454195829|FG002|Overall Study|Withdrawal by Subject|16|||
126247004|NCT03503318|454195827|FG000|Overall Study|Protocol Violation|5|||
126247005|NCT03503318|454195828|FG001|Overall Study|Protocol Violation|0|||
126247006|NCT03503318|454195829|FG002|Overall Study|Protocol Violation|3|||
126247007|NCT03503318|454195827|FG000|Overall Study|Lost to Follow-up|17|||
126247008|NCT03503318|454195828|FG001|Overall Study|Lost to Follow-up|15|||
126247009|NCT03503318|454195829|FG002|Overall Study|Lost to Follow-up|12|||
126247010|NCT03503318|454195827|FG000|Overall Study|Other than specified|1|||
126247011|NCT03503318|454195828|FG001|Overall Study|Other than specified|3|||
126247012|NCT03503318|454195829|FG002|Overall Study|Other than specified|3|||
126247013|NCT00834873|454195836|FG000|First Intervention|Adverse Event|0|||
126247014|NCT00834873|454195837|FG001|First Intervention|Adverse Event|1|||
126247015|NCT00477594|454195844|FG000|Year 1 and Year 2|Adverse Event|4|||
126247016|NCT00477594|454195845|FG001|Year 1 and Year 2|Adverse Event|2|||
126247017|NCT00477594|454195844|FG000|Year 1 and Year 2|Physician Decision|2|||
126247018|NCT00477594|454195845|FG001|Year 1 and Year 2|Physician Decision|1|||
126247019|NCT00477594|454195844|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
126247020|NCT00477594|454195845|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
126247021|NCT00477594|454195844|FG000|Year 1 and Year 2|Other|1|||
126247022|NCT00477594|454195845|FG001|Year 1 and Year 2|Other|0|||
126247023|NCT00477594|454195844|FG000|Year 3|Adverse Event|1|||
126761452|NCT02163759|456079149|FG000|Overall Study|Withdrawal by Subject|1|||
126247024|NCT00477594|454195845|FG001|Year 3|Adverse Event|0|||
126247025|NCT00477594|454195844|FG000|Year 3|Withdrawal by Subject|1|||
126247026|NCT00477594|454195845|FG001|Year 3|Withdrawal by Subject|0|||
126247027|NCT00477594|454195844|FG000|Follow-up Period|Withdrawal by Subject|2|||
126247028|NCT00477594|454195845|FG001|Follow-up Period|Withdrawal by Subject|1|||
126247029|NCT00477594|454195844|FG000|Follow-up Period|Other|1|||
126247030|NCT00477594|454195845|FG001|Follow-up Period|Other|0|||
126247031|NCT03114891|454195846|FG000|First Treatment Round|Lost to Follow-up|0|||
126247032|NCT03114891|454195847|FG001|First Treatment Round|Lost to Follow-up|1|||
126247033|NCT03114891|454195848|FG002|First Treatment Round|Lost to Follow-up|1|||
126247034|NCT03114891|454195849|FG003|First Treatment Round|Lost to Follow-up|0|||
126247035|NCT03114891|454195846|FG000|First Treatment Round|Withdrawal by Subject|0|||
126247036|NCT03114891|454195847|FG001|First Treatment Round|Withdrawal by Subject|2|||
126247037|NCT03114891|454195848|FG002|First Treatment Round|Withdrawal by Subject|0|||
126247038|NCT03114891|454195849|FG003|First Treatment Round|Withdrawal by Subject|1|||
126247039|NCT03114891|454195846|FG000|3 Week Break|Lost to Follow-up|1|||
126247040|NCT03114891|454195847|FG001|3 Week Break|Lost to Follow-up|0|||
126247041|NCT03114891|454195848|FG002|3 Week Break|Lost to Follow-up|0|||
126247042|NCT03114891|454195849|FG003|3 Week Break|Lost to Follow-up|1|||
126247043|NCT03114891|454195846|FG000|3 Week Break|Withdrawal by Subject|0|||
126247044|NCT03114891|454195847|FG001|3 Week Break|Withdrawal by Subject|1|||
126247045|NCT03114891|454195848|FG002|3 Week Break|Withdrawal by Subject|0|||
126247046|NCT03114891|454195849|FG003|3 Week Break|Withdrawal by Subject|0|||
126247047|NCT03114891|454195846|FG000|Second Treatment Round|Lost to Follow-up|1|||
126247048|NCT03114891|454195847|FG001|Second Treatment Round|Lost to Follow-up|0|||
126247049|NCT03114891|454195848|FG002|Second Treatment Round|Lost to Follow-up|0|||
126247050|NCT03114891|454195849|FG003|Second Treatment Round|Lost to Follow-up|0|||
126247051|NCT03114891|454195846|FG000|Second Treatment Round|Physician Decision|1|||
126247052|NCT03114891|454195847|FG001|Second Treatment Round|Physician Decision|0|||
126247053|NCT03114891|454195848|FG002|Second Treatment Round|Physician Decision|0|||
126247054|NCT03114891|454195849|FG003|Second Treatment Round|Physician Decision|0|||
126247055|NCT02875392|454198003|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
126247056|NCT02875392|454198004|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
126247057|NCT03599193|454198005|FG000|Overall Study|Adverse Event|0|||
126247058|NCT03599193|454198006|FG001|Overall Study|Adverse Event|2|||
126247059|NCT03599193|454198005|FG000|Overall Study|Withdrawal by Subject|1|||
126247060|NCT03599193|454198006|FG001|Overall Study|Withdrawal by Subject|0|||
126247061|NCT03599193|454198005|FG000|Overall Study|Protocol Violation|1|||
126247062|NCT03599193|454198006|FG001|Overall Study|Protocol Violation|0|||
126247063|NCT03599193|454198005|FG000|Overall Study|Lost to Follow-up|0|||
126247064|NCT03599193|454198006|FG001|Overall Study|Lost to Follow-up|1|||
126447986|NCT01057589|454939616|FG000|Overall Study|Withdrawal by Subject|3|||
126247065|NCT00835705|454198007|FG000|First Intervention|Difficulty with vein|1|||
126247066|NCT00835705|454198008|FG001|First Intervention|Difficulty with vein|0|||
126247067|NCT00835705|454198007|FG000|Second Intervention|Difficulty with vein|1|||
126247068|NCT00835705|454198008|FG001|Second Intervention|Difficulty with vein|0|||
126247069|NCT01750294|454198009|FG000|Overall Study|Withdrawal by Subject|1|||
126247070|NCT01750294|454198009|FG000|Overall Study|Safety Endpoint|1|||
126247071|NCT00665925|454198010|FG000|Overall Study|Lack of Efficacy|10|||
126247072|NCT00665925|454198011|FG001|Overall Study|Lack of Efficacy|8|||
126247073|NCT00665925|454198012|FG002|Overall Study|Lack of Efficacy|9|||
126247074|NCT00665925|454198013|FG003|Overall Study|Lack of Efficacy|8|||
126247075|NCT00665925|454198010|FG000|Overall Study|Lost to Follow-up|1|||
126247076|NCT00665925|454198011|FG001|Overall Study|Lost to Follow-up|2|||
126247077|NCT00665925|454198012|FG002|Overall Study|Lost to Follow-up|2|||
126247078|NCT00665925|454198013|FG003|Overall Study|Lost to Follow-up|2|||
126247079|NCT00665925|454198010|FG000|Overall Study|Withdrawal by Subject|2|||
126247080|NCT00665925|454198011|FG001|Overall Study|Withdrawal by Subject|2|||
126247081|NCT00665925|454198012|FG002|Overall Study|Withdrawal by Subject|3|||
126247082|NCT00665925|454198013|FG003|Overall Study|Withdrawal by Subject|2|||
126247083|NCT00665925|454198010|FG000|Overall Study|Physician Decision|0|||
126247084|NCT00665925|454198011|FG001|Overall Study|Physician Decision|0|||
126247085|NCT00665925|454198012|FG002|Overall Study|Physician Decision|1|||
126247086|NCT00665925|454198013|FG003|Overall Study|Physician Decision|2|||
126247087|NCT00665925|454198010|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
126247088|NCT00665925|454198011|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
126247089|NCT00665925|454198012|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
126247090|NCT00665925|454198013|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
126247091|NCT00665925|454198010|FG000|Overall Study|Adverse Event|1|||
126447987|NCT01057589|454939616|FG000|Overall Study|Sponsor Decision|1|||
126447988|NCT01057589|454939616|FG000|Overall Study|Death|8|||
126247092|NCT00665925|454198011|FG001|Overall Study|Adverse Event|5|||
126247093|NCT00665925|454198012|FG002|Overall Study|Adverse Event|10|||
126247094|NCT00665925|454198013|FG003|Overall Study|Adverse Event|5|||
126247095|NCT00665925|454198010|FG000|Overall Study|Enrolled by mistake|0|||
126247096|NCT00665925|454198011|FG001|Overall Study|Enrolled by mistake|0|||
126247097|NCT00665925|454198012|FG002|Overall Study|Enrolled by mistake|0|||
126447989|NCT01057589|454939616|FG000|Overall Study|Lost to Follow-up|1|||
126247098|NCT00665925|454198013|FG003|Overall Study|Enrolled by mistake|1|||
126447990|NCT00899431|454939619|FG000|Overall Study|Physician Decision|1|||
126447991|NCT00899431|454939620|FG001|Overall Study|Physician Decision|0|||
126447992|NCT00899431|454939621|FG002|Overall Study|Physician Decision|0|||
126247099|NCT00665925|454198010|FG000|Overall Study|Due to exclusion criteria|1|||
126695436|NCT01573910|455838684|FG000|Overall Study|Protocol Violation|3|||
126247100|NCT00665925|454198011|FG001|Overall Study|Due to exclusion criteria|0|||
126247101|NCT00665925|454198012|FG002|Overall Study|Due to exclusion criteria|0|||
126247102|NCT00665925|454198013|FG003|Overall Study|Due to exclusion criteria|0|||
126247103|NCT01592240|454198014|FG000|Overall Study|Adverse Event|1|||
126247104|NCT01592240|454198015|FG001|Overall Study|Adverse Event|0|||
126447993|NCT01253577|454939623|FG000|Overall Study|Lost to Follow-up|3|||
126447994|NCT00334113|454939624|FG000|Overall Study|Lost to Follow-up|2|||
126247105|NCT01592240|454198016|FG002|Overall Study|Adverse Event|0|||
126247106|NCT01592240|454198017|FG003|Overall Study|Adverse Event|1|||
126247107|NCT01592240|454198018|FG004|Overall Study|Adverse Event|1|||
126247108|NCT01592240|454198019|FG005|Overall Study|Adverse Event|0|||
126247109|NCT01592240|454198020|FG006|Overall Study|Adverse Event|0|||
126247110|NCT01592240|454198014|FG000|Overall Study|Death|0|||
126247111|NCT01592240|454198015|FG001|Overall Study|Death|1|||
126247112|NCT01592240|454198016|FG002|Overall Study|Death|0|||
126247113|NCT01592240|454198017|FG003|Overall Study|Death|0|||
126247114|NCT01592240|454198018|FG004|Overall Study|Death|0|||
126247115|NCT01592240|454198019|FG005|Overall Study|Death|0|||
126247116|NCT01592240|454198020|FG006|Overall Study|Death|0|||
126247117|NCT01592240|454198014|FG000|Overall Study|Lost to Follow-up|1|||
126247118|NCT01592240|454198015|FG001|Overall Study|Lost to Follow-up|3|||
126247119|NCT01592240|454198016|FG002|Overall Study|Lost to Follow-up|1|||
126247120|NCT01592240|454198017|FG003|Overall Study|Lost to Follow-up|0|||
126247121|NCT01592240|454198018|FG004|Overall Study|Lost to Follow-up|3|||
126247122|NCT01592240|454198019|FG005|Overall Study|Lost to Follow-up|2|||
126247123|NCT01592240|454198020|FG006|Overall Study|Lost to Follow-up|0|||
126247124|NCT01592240|454198014|FG000|Overall Study|Protocol Violation|0|||
126247125|NCT01592240|454198015|FG001|Overall Study|Protocol Violation|0|||
126247126|NCT01592240|454198016|FG002|Overall Study|Protocol Violation|0|||
126247127|NCT01592240|454198017|FG003|Overall Study|Protocol Violation|0|||
126247128|NCT01592240|454198018|FG004|Overall Study|Protocol Violation|0|||
126247129|NCT01592240|454198019|FG005|Overall Study|Protocol Violation|1|||
126247130|NCT01592240|454198020|FG006|Overall Study|Protocol Violation|0|||
126247131|NCT01592240|454198014|FG000|Overall Study|Withdrawal by Subject|0|||
126247132|NCT01592240|454198015|FG001|Overall Study|Withdrawal by Subject|4|||
126247133|NCT01592240|454198016|FG002|Overall Study|Withdrawal by Subject|4|||
126247134|NCT01592240|454198017|FG003|Overall Study|Withdrawal by Subject|1|||
126247135|NCT01592240|454198018|FG004|Overall Study|Withdrawal by Subject|3|||
126247136|NCT01592240|454198019|FG005|Overall Study|Withdrawal by Subject|0|||
126247137|NCT01592240|454198020|FG006|Overall Study|Withdrawal by Subject|2|||
126247138|NCT01592240|454198014|FG000|Overall Study|Other|0|||
126247139|NCT01592240|454198015|FG001|Overall Study|Other|3|||
126247140|NCT01592240|454198016|FG002|Overall Study|Other|1|||
126247141|NCT01592240|454198017|FG003|Overall Study|Other|1|||
126247142|NCT01592240|454198018|FG004|Overall Study|Other|0|||
126247143|NCT01592240|454198019|FG005|Overall Study|Other|0|||
126247144|NCT01592240|454198020|FG006|Overall Study|Other|1|||
126247145|NCT01592240|454198014|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
126247146|NCT01592240|454198015|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
126247147|NCT01592240|454198016|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
126247148|NCT01592240|454198017|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
126247149|NCT01592240|454198018|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
126247150|NCT01592240|454198019|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
126247151|NCT01592240|454198020|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
126247152|NCT03246503|454198024|FG000|Overall Study|Lost to Follow-up|23|||
126247153|NCT03246503|454198024|FG000|Overall Study|Withdrawal by Subject|20|||
126247154|NCT03246503|454198024|FG000|Overall Study|Physician Decision|5|||
126247155|NCT03246503|454198024|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
126761453|NCT02163759|456079150|FG001|Overall Study|Withdrawal by Subject|5|||
126761454|NCT02163759|456079151|FG002|Overall Study|Withdrawal by Subject|1|||
126761455|NCT02163759|456079149|FG000|Overall Study|Adverse Event|0|||
126761456|NCT02163759|456079150|FG001|Overall Study|Adverse Event|0|||
126761457|NCT02163759|456079151|FG002|Overall Study|Adverse Event|1|||
126761458|NCT02163759|456079149|FG000|Overall Study|Death|0|||
126761459|NCT02163759|456079150|FG001|Overall Study|Death|0|||
126761460|NCT02163759|456079151|FG002|Overall Study|Death|1|||
126761461|NCT03471507|456079164|FG000|Overall Study|Lost to Follow-up|1|||
126761462|NCT03471507|456079165|FG001|Overall Study|Lost to Follow-up|3|||
126761463|NCT03471507|456079164|FG000|Overall Study|Physician Decision|0|||
126761464|NCT03471507|456079165|FG001|Overall Study|Physician Decision|1|||
126761465|NCT03471507|456079164|FG000|Overall Study|Withdrawal by Subject|2|||
126761466|NCT03471507|456079165|FG001|Overall Study|Withdrawal by Subject|1|||
126761467|NCT00750061|456079169|FG000|Overall Study|Adverse Event|2|||
126761468|NCT00750061|456079170|FG001|Overall Study|Adverse Event|0|||
126761469|NCT00750061|456079169|FG000|Overall Study|Withdrawal by Subject|0|||
126247156|NCT02751424|454198025|FG000|Part 2|Adverse Event|0|||
126247157|NCT02751424|454198026|FG001|Part 2|Adverse Event|0|||
126247158|NCT02751424|454198027|FG002|Part 2|Adverse Event|0|||
126247159|NCT02751424|454198028|FG003|Part 2|Adverse Event|0|||
126247160|NCT02751424|454198029|FG004|Part 2|Adverse Event|0|||
126247161|NCT02751424|454198030|FG005|Part 2|Adverse Event|0|||
126247162|NCT02751424|454198031|FG006|Part 2|Adverse Event|0|||
126247163|NCT02751424|454198032|FG007|Part 2|Adverse Event|5|||
126761470|NCT00750061|456079170|FG001|Overall Study|Withdrawal by Subject|1|||
126761471|NCT00750061|456079169|FG000|Overall Study|Physician Decision|0|||
126761472|NCT00750061|456079170|FG001|Overall Study|Physician Decision|1|||
126761473|NCT03246152|456079171|FG000|Overall Study|Lost to Follow-up|2|||
126247164|NCT02751424|454198033|FG008|Part 2|Adverse Event|0|||
126247165|NCT03206749|454198034|FG000|Overall Study|Withdrawal of consent|5|||
126247166|NCT03206749|454198035|FG001|Overall Study|Withdrawal of consent|3|||
126247167|NCT03206749|454198036|FG002|Overall Study|Withdrawal of consent|6|||
126247168|NCT03206749|454198034|FG000|Overall Study|Lost to Follow-up|0|||
126247169|NCT03206749|454198035|FG001|Overall Study|Lost to Follow-up|0|||
126247170|NCT03206749|454198036|FG002|Overall Study|Lost to Follow-up|1|||
126247171|NCT01492439|454198037|FG000|Overall Study|Withdrew from RTE|4|||
126247172|NCT01492439|454198038|FG001|Overall Study|Withdrew from RTE|9|||
126247173|NCT00716625|454198039|FG000|Overall Study|Safety was not Assessable|1|||
126247174|NCT00395694|454198041|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
126247175|NCT00395694|454198042|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
126247176|NCT00395694|454198041|FG000|Continuation Phase|Adverse Event|1|||
126247177|NCT00395694|454198042|FG001|Continuation Phase|Adverse Event|0|||
126247178|NCT00395694|454198041|FG000|Continuation Phase|Lack of Efficacy|12|||
126247179|NCT00395694|454198042|FG001|Continuation Phase|Lack of Efficacy|11|||
126247180|NCT00395694|454198041|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
126247181|NCT00395694|454198042|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
126247182|NCT00395694|454198041|FG000|Continuation Phase|Poor Compliance|1|||
126247183|NCT00395694|454198042|FG001|Continuation Phase|Poor Compliance|0|||
126247184|NCT00395694|454198041|FG000|Continuation Phase|Withdrawal by Subject|0|||
126247185|NCT00395694|454198042|FG001|Continuation Phase|Withdrawal by Subject|2|||
126247186|NCT01648582|454198043|FG000|Overall Study|Adverse Event|6|||
126247187|NCT01648582|454198044|FG001|Overall Study|Adverse Event|11|||
126247188|NCT01648582|454198045|FG002|Overall Study|Adverse Event|2|||
126247189|NCT01648582|454198043|FG000|Overall Study|Lost to Follow-up|9|||
126247190|NCT01648582|454198044|FG001|Overall Study|Lost to Follow-up|6|||
126247191|NCT01648582|454198045|FG002|Overall Study|Lost to Follow-up|8|||
126247192|NCT01648582|454198043|FG000|Overall Study|Protocol Violation|1|||
126247193|NCT01648582|454198044|FG001|Overall Study|Protocol Violation|2|||
126247194|NCT01648582|454198045|FG002|Overall Study|Protocol Violation|1|||
126247195|NCT01648582|454198043|FG000|Overall Study|Withdrawal by Subject|15|||
126761474|NCT03246152|456079171|FG000|Overall Study|Protocol Violation|1|||
126761475|NCT01374516|456079174|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
126761476|NCT01374516|456079175|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
126761477|NCT01374516|456079174|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
126761478|NCT01374516|456079175|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
126761479|NCT01374516|456079174|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
126761480|NCT01374516|456079175|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
126761481|NCT01374516|456079174|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
126761482|NCT01374516|456079175|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
126761483|NCT01374516|456079174|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
126761484|NCT01374516|456079175|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
126761485|NCT01374516|456079174|FG000|Surveillance Expansion Period|Protocol Violation|386|||
126761486|NCT01374516|456079175|FG001|Surveillance Expansion Period|Protocol Violation|217|||
126761487|NCT01374516|456079174|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
126761488|NCT01374516|456079175|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
126761489|NCT01374516|456079174|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
126761490|NCT01374516|456079175|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
126761491|NCT01374516|456079174|FG000|Surveillance Expansion Period|Serious adverse event|20|||
126761492|NCT01374516|456079175|FG001|Surveillance Expansion Period|Serious adverse event|5|||
126761493|NCT03219372|456079181|FG000|Overall Study|Withdrawal by Subject|1|||
126761494|NCT03219372|456079182|FG001|Overall Study|Withdrawal by Subject|0|||
126761495|NCT04145531|456079183|FG000|Part A|Adverse Event|2|||
126761496|NCT04145531|456079184|FG001|Part A|Adverse Event|12|||
126761497|NCT04145531|456079185|FG002|Part A|Adverse Event|6|||
126247196|NCT01648582|454198044|FG001|Overall Study|Withdrawal by Subject|17|||
126247197|NCT01648582|454198045|FG002|Overall Study|Withdrawal by Subject|17|||
126247198|NCT01648582|454198043|FG000|Overall Study|Physician Decision|0|||
126247199|NCT01648582|454198044|FG001|Overall Study|Physician Decision|1|||
126247200|NCT01648582|454198045|FG002|Overall Study|Physician Decision|3|||
126247201|NCT01648582|454198043|FG000|Overall Study|Death|1|||
126247202|NCT01648582|454198044|FG001|Overall Study|Death|0|||
126247203|NCT01648582|454198045|FG002|Overall Study|Death|0|||
126247204|NCT01648582|454198043|FG000|Overall Study|Sponsor Decision|0|||
126247205|NCT01648582|454198044|FG001|Overall Study|Sponsor Decision|1|||
126247206|NCT01648582|454198045|FG002|Overall Study|Sponsor Decision|1|||
126357634|NCT02187055|454602192|FG002|Overall Study|No longer meets eligibility criteria|0|||
126357635|NCT02187055|454602190|FG000|Overall Study|No longer willing to participate|6|||
126761498|NCT04145531|456079186|FG003|Part A|Adverse Event|0|||
126761499|NCT04145531|456079183|FG000|Part A|Death|1|||
126761500|NCT04145531|456079184|FG001|Part A|Death|2|||
126761501|NCT04145531|456079185|FG002|Part A|Death|0|||
126761502|NCT04145531|456079186|FG003|Part A|Death|0|||
126761503|NCT04145531|456079183|FG000|Part A|Physician Decision|2|||
126761504|NCT04145531|456079184|FG001|Part A|Physician Decision|5|||
126247207|NCT02699866|454198046|FG000|Overall Study|Withdrawal by Subject|3|||
126247208|NCT02699866|454198046|FG000|Overall Study|Physician Decision|2|||
126247209|NCT02699866|454198046|FG000|Overall Study|Adverse Event|3|||
126247210|NCT01959672|454198047|FG000|Overall Study|Death|1|||
126247211|NCT01058668|454198048|FG000|Double-blind Treatment Phase|Adverse Event|8|||
126247212|NCT01058668|454198049|FG001|Double-blind Treatment Phase|Adverse Event|15|||
126247213|NCT01058668|454198050|FG002|Double-blind Treatment Phase|Adverse Event|25|||
126247214|NCT01058668|454198048|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
126247215|NCT01058668|454198049|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
126247216|NCT01058668|454198050|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
126247217|NCT01058668|454198048|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
126247218|NCT01058668|454198049|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
126247219|NCT01058668|454198050|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
126247220|NCT01058668|454198048|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
126247221|NCT01058668|454198049|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
126247222|NCT01058668|454198050|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
126247223|NCT01058668|454198048|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
126247224|NCT01058668|454198049|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
126247225|NCT01058668|454198050|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
126247226|NCT01058668|454198048|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
126247227|NCT01058668|454198049|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
126247228|NCT01058668|454198050|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
126247229|NCT02842853|454198059|FG000|Overall Study|Non-compliance with the protocol|3|||
126247230|NCT02842853|454198060|FG001|Overall Study|Non-compliance with the protocol|7|||
126247231|NCT02842853|454198061|FG002|Overall Study|Non-compliance with the protocol|2|||
126247232|NCT02842853|454198062|FG003|Overall Study|Non-compliance with the protocol|5|||
126247233|NCT02842853|454198059|FG000|Overall Study|Subject met exclusion criteria|0|||
126247234|NCT02842853|454198060|FG001|Overall Study|Subject met exclusion criteria|1|||
126247235|NCT02842853|454198061|FG002|Overall Study|Subject met exclusion criteria|0|||
126247236|NCT02842853|454198062|FG003|Overall Study|Subject met exclusion criteria|0|||
126247237|NCT02842853|454198059|FG000|Overall Study|Withdrawal by Subject|11|||
126247238|NCT02842853|454198060|FG001|Overall Study|Withdrawal by Subject|13|||
126247239|NCT02842853|454198061|FG002|Overall Study|Withdrawal by Subject|9|||
126247240|NCT02842853|454198062|FG003|Overall Study|Withdrawal by Subject|8|||
126247241|NCT02842853|454198059|FG000|Overall Study|Lost to Follow-up|9|||
126247242|NCT02842853|454198060|FG001|Overall Study|Lost to Follow-up|13|||
126247243|NCT02842853|454198061|FG002|Overall Study|Lost to Follow-up|10|||
126247244|NCT02842853|454198062|FG003|Overall Study|Lost to Follow-up|11|||
126247245|NCT04089553|454198063|FG000|Overall Study|Death|1|||
126247246|NCT04089553|454198064|FG001|Overall Study|Death|1|||
126247247|NCT04089553|454198063|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
126247248|NCT04089553|454198064|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
126247249|NCT04089553|454198063|FG000|Overall Study|Withdrawal by Subject|3|||
126247250|NCT04089553|454198064|FG001|Overall Study|Withdrawal by Subject|3|||
126247251|NCT04089553|454198063|FG000|Overall Study|Physician Decision|1|||
126247252|NCT04089553|454198064|FG001|Overall Study|Physician Decision|0|||
126247253|NCT04089553|454198063|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
126247254|NCT04089553|454198064|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
126247255|NCT04089553|454198063|FG000|Overall Study|Other|1|||
126247256|NCT04089553|454198064|FG001|Overall Study|Other|0|||
126247257|NCT04089553|454198063|FG000|Overall Study|Adverse Event|1|||
126247258|NCT04089553|454198064|FG001|Overall Study|Adverse Event|1|||
126247259|NCT01403194|454198065|FG000|Overall Study|Screen Failure|2|||
126247260|NCT01403194|454198065|FG000|Overall Study|Lost to Follow-up|8|||
126247261|NCT00506831|454198072|FG000|Overall Study|Death|1|||
126247262|NCT00506831|454198072|FG000|Overall Study|Withdrawal by Subject|1|||
126247263|NCT01808651|454198076|FG000|Study Period 1|Lost to Follow-up|1|||
126247264|NCT01808651|454198077|FG001|Study Period 1|Lost to Follow-up|3|||
126247265|NCT01808651|454198078|FG002|Study Period 1|Lost to Follow-up|0|||
126247266|NCT01808651|454198076|FG000|Study Period 1|Protocol Violation|1|||
126247267|NCT01808651|454198077|FG001|Study Period 1|Protocol Violation|0|||
126247268|NCT01808651|454198078|FG002|Study Period 1|Protocol Violation|1|||
126357636|NCT02187055|454602191|FG001|Overall Study|No longer willing to participate|8|||
126357637|NCT02187055|454602192|FG002|Overall Study|No longer willing to participate|10|||
126357638|NCT02187055|454602190|FG000|Overall Study|Other|5|||
126357639|NCT02187055|454602191|FG001|Overall Study|Other|6|||
126357640|NCT02187055|454602192|FG002|Overall Study|Other|3|||
126357641|NCT02187055|454602190|FG000|Overall Study|Protocol Violation|9|||
126357642|NCT02187055|454602191|FG001|Overall Study|Protocol Violation|9|||
126357643|NCT02187055|454602192|FG002|Overall Study|Protocol Violation|4|||
126357644|NCT02187055|454602190|FG000|Overall Study|Pregnancy|3|||
126357645|NCT02187055|454602191|FG001|Overall Study|Pregnancy|1|||
126357646|NCT02187055|454602192|FG002|Overall Study|Pregnancy|0|||
126357647|NCT02187055|454602190|FG000|Overall Study|Withdrawal by Subject|11|||
126357648|NCT02187055|454602191|FG001|Overall Study|Withdrawal by Subject|11|||
126247269|NCT01808651|454198076|FG000|Study Period 1|Physician Decision|3|||
126247270|NCT01808651|454198077|FG001|Study Period 1|Physician Decision|2|||
126247271|NCT01808651|454198078|FG002|Study Period 1|Physician Decision|0|||
126247272|NCT01808651|454198076|FG000|Study Period 1|Lack of Efficacy|2|||
126247273|NCT01808651|454198077|FG001|Study Period 1|Lack of Efficacy|1|||
126247274|NCT01808651|454198078|FG002|Study Period 1|Lack of Efficacy|0|||
126247275|NCT01808651|454198076|FG000|Study Period 1|Adverse Event|10|||
126247276|NCT01808651|454198077|FG001|Study Period 1|Adverse Event|4|||
126247277|NCT01808651|454198078|FG002|Study Period 1|Adverse Event|1|||
126247278|NCT01808651|454198076|FG000|Study Period 1|Participant Decision|9|||
126247279|NCT01808651|454198077|FG001|Study Period 1|Participant Decision|7|||
126247280|NCT01808651|454198078|FG002|Study Period 1|Participant Decision|3|||
126247281|NCT02488239|454198080|FG000|Overall Study|Death|3|||
126247282|NCT02488239|454198080|FG000|Overall Study|Withdrawal by Subject|3|||
126247283|NCT02488239|454198080|FG000|Overall Study|Physician Decision|2|||
126247284|NCT02488239|454198080|FG000|Overall Study|Consent ineligible|1|||
126247285|NCT02488239|454198080|FG000|Overall Study|Did not undergo implant procedure|1|||
126247286|NCT00608322|454198084|FG000|Overall Study|Death|2|||
126247287|NCT00608322|454198085|FG001|Overall Study|Death|1|||
126247288|NCT00834444|454198086|FG000|First Intervention|Adverse Event|1|||
126247289|NCT00834444|454198087|FG001|First Intervention|Adverse Event|0|||
126247290|NCT00834444|454198086|FG000|First Intervention|Intolerance to Venopuncture|0|||
126247291|NCT00834444|454198087|FG001|First Intervention|Intolerance to Venopuncture|1|||
126247292|NCT00834444|454198086|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
126247293|NCT00834444|454198087|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
126247294|NCT00834444|454198086|FG000|Second Intervention|Adverse Event|1|||
126247295|NCT00834444|454198087|FG001|Second Intervention|Adverse Event|0|||
126247296|NCT00606281|454198090|FG000|Overall Study|Adverse Event|11|||
126247297|NCT00606281|454198091|FG001|Overall Study|Adverse Event|12|||
126247298|NCT00606281|454198090|FG000|Overall Study|Death|1|||
126247299|NCT00606281|454198091|FG001|Overall Study|Death|0|||
126247300|NCT00606281|454198090|FG000|Overall Study|Lack of Efficacy|28|||
126247301|NCT00606281|454198091|FG001|Overall Study|Lack of Efficacy|35|||
126247302|NCT00606281|454198090|FG000|Overall Study|Physician Decision|0|||
126247303|NCT00606281|454198091|FG001|Overall Study|Physician Decision|1|||
126247304|NCT00606281|454198090|FG000|Overall Study|Protocol Violation|3|||
126247305|NCT00606281|454198091|FG001|Overall Study|Protocol Violation|3|||
126247306|NCT00606281|454198090|FG000|Overall Study|Withdrawal by Subject|11|||
126247307|NCT00606281|454198091|FG001|Overall Study|Withdrawal by Subject|13|||
126247308|NCT00606281|454198090|FG000|Overall Study|Progression to depressive phase|1|||
126247309|NCT00606281|454198091|FG001|Overall Study|Progression to depressive phase|1|||
126247310|NCT00606281|454198090|FG000|Overall Study|Change of residence or other commitments|1|||
126247311|NCT00606281|454198091|FG001|Overall Study|Change of residence or other commitments|1|||
126247312|NCT02294981|454198092|FG000|Overall Study|Lost to Follow-up|1|||
126247313|NCT00829712|454198093|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
126247314|NCT00829712|454198094|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
126247315|NCT02213263|454198098|FG000|Overall Study|Insufficient clinical response|4|||
126247316|NCT02213263|454198099|FG001|Overall Study|Insufficient clinical response|3|||
126247317|NCT02213263|454198098|FG000|Overall Study|Lost to Follow-up|0|||
126247318|NCT02213263|454198099|FG001|Overall Study|Lost to Follow-up|1|||
126247319|NCT02213263|454198098|FG000|Overall Study|No longer willing to participate|3|||
126247320|NCT02213263|454198099|FG001|Overall Study|No longer willing to participate|4|||
126247321|NCT02213263|454198098|FG000|Overall Study|Progressive disease|20|||
126247322|NCT02213263|454198099|FG001|Overall Study|Progressive disease|14|||
126247323|NCT02213263|454198098|FG000|Overall Study|Protocol Violation|0|||
126247324|NCT02213263|454198099|FG001|Overall Study|Protocol Violation|1|||
126247325|NCT02213263|454198098|FG000|Overall Study|Adverse Event|1|||
126247326|NCT02213263|454198099|FG001|Overall Study|Adverse Event|3|||
126247327|NCT01188681|454198100|FG000|Overall Study|bladder cancer|0|||
126247328|NCT01188681|454198101|FG001|Overall Study|bladder cancer|0|||
126247329|NCT01188681|454198102|FG002|Overall Study|bladder cancer|1|||
126247330|NCT01188681|454198103|FG003|Overall Study|bladder cancer|0|||
126247331|NCT01188681|454198100|FG000|Overall Study|Withdrawal by Subject|0|||
126447995|NCT00334113|454939625|FG001|Overall Study|Lost to Follow-up|2|||
126447996|NCT00334113|454939624|FG000|Overall Study|Withdrawal by Subject|0|||
126247332|NCT01188681|454198101|FG001|Overall Study|Withdrawal by Subject|0|||
126247333|NCT01188681|454198102|FG002|Overall Study|Withdrawal by Subject|0|||
126247334|NCT01188681|454198103|FG003|Overall Study|Withdrawal by Subject|1|||
126247335|NCT05752721|454198104|FG000|Overall Study|Lost to Follow-up|22|||
126247336|NCT05752721|454198105|FG001|Overall Study|Lost to Follow-up|20|||
126247337|NCT05752721|454198104|FG000|Overall Study|Withdrawal by Subject|15|||
126247338|NCT05752721|454198105|FG001|Overall Study|Withdrawal by Subject|12|||
126247339|NCT02280863|454198106|FG000|Integrated Platform|Met stopping criteria|0|||
126247340|NCT02280863|454198107|FG001|Integrated Platform|Met stopping criteria|1|||
126247341|NCT00263588|454198108|FG000|Overall Study|Death|54|||
126247342|NCT00263588|454198109|FG001|Overall Study|Death|90|||
126247343|NCT00263588|454198108|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
126447997|NCT00334113|454939625|FG001|Overall Study|Withdrawal by Subject|1|||
126247344|NCT00263588|454198109|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
126247345|NCT00263588|454198108|FG000|Overall Study|Lost to Follow-up|7|||
126247346|NCT00263588|454198109|FG001|Overall Study|Lost to Follow-up|10|||
126247347|NCT00263588|454198108|FG000|Overall Study|Withdrawal by Subject|3|||
126247348|NCT00263588|454198109|FG001|Overall Study|Withdrawal by Subject|4|||
126247349|NCT00263588|454198108|FG000|Overall Study|Protocol Violation|0|||
126247350|NCT00263588|454198109|FG001|Overall Study|Protocol Violation|1|||
126247351|NCT00263588|454198108|FG000|Overall Study|Investigator decision|7|||
126247352|NCT00263588|454198109|FG001|Overall Study|Investigator decision|15|||
126247353|NCT00263588|454198108|FG000|Overall Study|Sponsor terminated study|0|||
126247354|NCT00263588|454198109|FG001|Overall Study|Sponsor terminated study|1|||
126247355|NCT03236311|454198110|FG000|Overall Study|Study terminated by sponsor|0|||
126247356|NCT03236311|454198111|FG001|Overall Study|Study terminated by sponsor|2|||
126247357|NCT03236311|454198110|FG000|Overall Study|Adverse Event|0|||
126247358|NCT03236311|454198111|FG001|Overall Study|Adverse Event|1|||
126247359|NCT00700739|454198112|FG000|Overall Study|Lost to Follow-up|4|||
126247360|NCT00700739|454198113|FG001|Overall Study|Lost to Follow-up|4|||
126247361|NCT02336074|454198114|FG000|Overall Study|Adverse Event|0|||
126247362|NCT02336074|454198115|FG001|Overall Study|Adverse Event|2|||
126247363|NCT02679729|454198116|FG000|Overall Study|Lost to Follow-up|0|||
126247364|NCT02679729|454198117|FG001|Overall Study|Lost to Follow-up|1|||
126247365|NCT02679729|454198118|FG002|Overall Study|Lost to Follow-up|0|||
126247366|NCT02679729|454198119|FG003|Overall Study|Lost to Follow-up|0|||
126247367|NCT02679729|454198120|FG004|Overall Study|Lost to Follow-up|1|||
126247368|NCT02679729|454198121|FG005|Overall Study|Lost to Follow-up|0|||
126247369|NCT02679729|454198122|FG006|Overall Study|Lost to Follow-up|0|||
126247370|NCT02679729|454198123|FG007|Overall Study|Lost to Follow-up|0|||
126247371|NCT02679729|454198124|FG008|Overall Study|Lost to Follow-up|0|||
126247372|NCT02679729|454198116|FG000|Overall Study|Participant decision|0|||
126247373|NCT02679729|454198117|FG001|Overall Study|Participant decision|1|||
126247374|NCT02679729|454198118|FG002|Overall Study|Participant decision|0|||
126247375|NCT02679729|454198119|FG003|Overall Study|Participant decision|0|||
126247376|NCT02679729|454198120|FG004|Overall Study|Participant decision|0|||
126247377|NCT02679729|454198121|FG005|Overall Study|Participant decision|0|||
126247378|NCT02679729|454198122|FG006|Overall Study|Participant decision|1|||
126247379|NCT02679729|454198123|FG007|Overall Study|Participant decision|0|||
126247380|NCT02679729|454198124|FG008|Overall Study|Participant decision|0|||
126247381|NCT03488108|454198131|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
126247382|NCT03488108|454198132|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
126247383|NCT03488108|454198131|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
126247384|NCT03488108|454198132|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
126247385|NCT03602339|454198137|FG000|Overall Study|Withdrawal by Subject|9|||
126247386|NCT03602339|454198137|FG000|Overall Study|Physician Decision|2|||
126247387|NCT03602339|454198137|FG000|Overall Study|Other reason|4|||
126247388|NCT01297504|454198138|FG000|Overall Study|Invalid Consent|1|||
126247389|NCT01297504|454198138|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
126247390|NCT01297504|454198138|FG000|Overall Study|No Study Visits|4|||
126247391|NCT01297504|454198138|FG000|Overall Study|Death|3|||
126247392|NCT01297504|454198138|FG000|Overall Study|Lost to Follow-up|43|||
126247393|NCT01297504|454198138|FG000|Overall Study|Withdrawal by Subject|9|||
126247394|NCT01297504|454198138|FG000|Overall Study|Site Closure|3|||
126247395|NCT01297504|454198138|FG000|Overall Study|Protocol Violation|3|||
126247396|NCT04827394|454198140|FG000|Overall Study|Physician Decision|0|||
126247397|NCT04827394|454198141|FG001|Overall Study|Physician Decision|2|||
126247398|NCT00829764|454198144|FG000|First Intervention|Adverse Event|1|||
126247399|NCT00829764|454198145|FG001|First Intervention|Adverse Event|0|||
126247400|NCT00829764|454198144|FG000|First Intervention|Withdrawal by Subject|1|||
126247401|NCT00829764|454198145|FG001|First Intervention|Withdrawal by Subject|1|||
126247402|NCT04594252|454198146|FG000|Overall Study|Adverse Event|0|||
126695437|NCT01573910|455838685|FG001|Overall Study|Protocol Violation|0|||
126247403|NCT04594252|454198147|FG001|Overall Study|Adverse Event|2|||
126247404|NCT01624233|454200254|FG000|Period 2 - Induction|Adverse Event|1|||
126247405|NCT01624233|454200254|FG000|Period 3 - Maintenance|Adverse Event|2|||
126247406|NCT01624233|454200254|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
126247407|NCT01624233|454200254|FG000|Period 3 - Maintenance|Physician Decision|2|||
126247408|NCT01624233|454200254|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
126247409|NCT01624233|454200254|FG000|Period 4 - Drug Free Period|Relapsed|61|||
126247410|NCT01624233|454200254|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
126247411|NCT01624233|454200254|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
126247412|NCT01624233|454200254|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
126247413|NCT01624233|454200254|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
126247414|NCT01624233|454200254|FG000|Period 6: Follow-up|Adverse Event|3|||
126247415|NCT01624233|454200254|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
126247416|NCT01624233|454200254|FG000|Period 6: Follow-up|Physician Decision|1|||
126247417|NCT01624233|454200254|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
126447998|NCT02509026|454939626|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
126761505|NCT04145531|456079185|FG002|Part A|Physician Decision|2|||
126247418|NCT00334815|454200255|FG000|Overall Study|Adverse Event|3|||
126247419|NCT00334815|454200256|FG001|Overall Study|Adverse Event|2|||
126247420|NCT00334815|454200255|FG000|Overall Study|Death|0|||
126247421|NCT00334815|454200256|FG001|Overall Study|Death|2|||
126247422|NCT00334815|454200255|FG000|Overall Study|Progression|1|||
126247423|NCT00334815|454200256|FG001|Overall Study|Progression|0|||
126247424|NCT00334815|454200255|FG000|Overall Study|ineligible|1|||
126247425|NCT00334815|454200256|FG001|Overall Study|ineligible|1|||
126247426|NCT00334815|454200255|FG000|Overall Study|patient refused treatment|0|||
126247427|NCT00334815|454200256|FG001|Overall Study|patient refused treatment|1|||
126247428|NCT00334815|454200255|FG000|Overall Study|Physician Decision|2|||
126247429|NCT00334815|454200256|FG001|Overall Study|Physician Decision|4|||
126247430|NCT02197416|454200257|FG000|Overall Study|Other reasons|0|||
126247431|NCT02197416|454200258|FG001|Overall Study|Other reasons|2|||
126247432|NCT02197416|454200259|FG002|Overall Study|Other reasons|5|||
126247433|NCT02197416|454200257|FG000|Overall Study|Withdrawal by Subject|0|||
126247434|NCT02197416|454200258|FG001|Overall Study|Withdrawal by Subject|2|||
126247435|NCT02197416|454200259|FG002|Overall Study|Withdrawal by Subject|1|||
126247436|NCT02197416|454200257|FG000|Overall Study|Protocol Violation|1|||
126247437|NCT02197416|454200258|FG001|Overall Study|Protocol Violation|0|||
126247438|NCT02197416|454200259|FG002|Overall Study|Protocol Violation|1|||
126247439|NCT02197416|454200257|FG000|Overall Study|Adverse Event|0|||
126247440|NCT02197416|454200258|FG001|Overall Study|Adverse Event|0|||
126247441|NCT02197416|454200259|FG002|Overall Study|Adverse Event|1|||
126247442|NCT02451696|454200260|FG000|Overall Study|Surgery postponed|1|||
126247443|NCT02451696|454200261|FG001|Overall Study|Surgery postponed|0|||
126247444|NCT05014828|454200262|FG000|Overall Study|Study Completed by Sponsor|16|||
126247445|NCT05014828|454200263|FG001|Overall Study|Study Completed by Sponsor|16|||
126247446|NCT05014828|454200264|FG002|Overall Study|Study Completed by Sponsor|3|||
126247447|NCT05014828|454200265|FG003|Overall Study|Study Completed by Sponsor|3|||
126247448|NCT05014828|454200262|FG000|Overall Study|Death|11|||
126247449|NCT05014828|454200263|FG001|Overall Study|Death|6|||
126247450|NCT05014828|454200264|FG002|Overall Study|Death|0|||
126247451|NCT05014828|454200265|FG003|Overall Study|Death|0|||
126247452|NCT05014828|454200262|FG000|Overall Study|Lost to Follow-up|0|||
126247453|NCT05014828|454200263|FG001|Overall Study|Lost to Follow-up|0|||
126247454|NCT05014828|454200264|FG002|Overall Study|Lost to Follow-up|2|||
126247455|NCT05014828|454200265|FG003|Overall Study|Lost to Follow-up|0|||
126247456|NCT05014828|454200262|FG000|Overall Study|Miscellaneous.|0|||
126247457|NCT05014828|454200263|FG001|Overall Study|Miscellaneous.|1|||
126247458|NCT05014828|454200264|FG002|Overall Study|Miscellaneous.|0|||
126247459|NCT05014828|454200265|FG003|Overall Study|Miscellaneous.|0|||
126247460|NCT05523895|454200266|FG000|Overall Study|Adverse Event|2|||
126247461|NCT05523895|454200267|FG001|Overall Study|Adverse Event|1|||
126247462|NCT05523895|454200268|FG002|Overall Study|Adverse Event|1|||
126247463|NCT05523895|454200266|FG000|Overall Study|Lost to Follow-up|0|||
126247464|NCT05523895|454200267|FG001|Overall Study|Lost to Follow-up|1|||
126247465|NCT05523895|454200268|FG002|Overall Study|Lost to Follow-up|2|||
126247466|NCT05523895|454200266|FG000|Overall Study|Noncompliance with study drug|1|||
126247467|NCT05523895|454200267|FG001|Overall Study|Noncompliance with study drug|1|||
126247468|NCT05523895|454200268|FG002|Overall Study|Noncompliance with study drug|1|||
126247469|NCT05523895|454200266|FG000|Overall Study|Protocol Violation|0|||
126247470|NCT05523895|454200267|FG001|Overall Study|Protocol Violation|2|||
126247471|NCT05523895|454200268|FG002|Overall Study|Protocol Violation|0|||
126247472|NCT05523895|454200266|FG000|Overall Study|Withdrawal by Subject|1|||
126247473|NCT05523895|454200267|FG001|Overall Study|Withdrawal by Subject|3|||
126247474|NCT05523895|454200268|FG002|Overall Study|Withdrawal by Subject|1|||
126247475|NCT05523895|454200266|FG000|Overall Study|Not further specified|0|||
126247476|NCT05523895|454200267|FG001|Overall Study|Not further specified|3|||
126247477|NCT05523895|454200268|FG002|Overall Study|Not further specified|1|||
126247478|NCT03674892|454200269|FG000|Overall Study|Lack of Efficacy|5|||
126247479|NCT03674892|454200269|FG000|Overall Study|Lost to Follow-up|3|||
126247480|NCT03674892|454200269|FG000|Overall Study|Migraine|2|||
126247481|NCT03674892|454200269|FG000|Overall Study|Excessive Tearing|1|||
126247482|NCT03674892|454200269|FG000|Overall Study|Increased Eye Pain|1|||
126247483|NCT03674892|454200269|FG000|Overall Study|Increased Facial Pain|1|||
126247484|NCT03674892|454200269|FG000|Overall Study|Sinus Irritation|1|||
126447999|NCT02509026|454939626|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
126448000|NCT02509026|454939626|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
126448001|NCT02509026|454939626|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
126448002|NCT02509026|454939626|FG000|Induction Period (24 Weeks)|Other|2|||
126448003|NCT02509026|454939626|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
126448004|NCT02509026|454939626|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
126448005|NCT02509026|454939626|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
126448006|NCT02509026|454939626|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
126448007|NCT02509026|454939626|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
126247485|NCT03674892|454200269|FG000|Overall Study|Sinus Infection|1|||
126247486|NCT03779334|454200273|FG000|Overall Study|Withdrawal by Subject|3|||
126247487|NCT03779334|454200274|FG001|Overall Study|Withdrawal by Subject|0|||
126247488|NCT03779334|454200275|FG002|Overall Study|Withdrawal by Subject|0|||
126247489|NCT03779334|454200273|FG000|Overall Study|Ongoing in Study|5|||
126247490|NCT03779334|454200274|FG001|Overall Study|Ongoing in Study|13|||
126247491|NCT03779334|454200275|FG002|Overall Study|Ongoing in Study|5|||
126247492|NCT01175135|454200276|FG000|Overall Study|Adverse Event|2|||
126247493|NCT01175135|454200277|FG001|Overall Study|Adverse Event|5|||
126247494|NCT01175135|454200278|FG002|Overall Study|Adverse Event|3|||
126247495|NCT01175135|454200279|FG003|Overall Study|Adverse Event|4|||
126247496|NCT01175135|454200276|FG000|Overall Study|Death|1|||
126247497|NCT01175135|454200277|FG001|Overall Study|Death|0|||
126247498|NCT01175135|454200278|FG002|Overall Study|Death|0|||
126247499|NCT01175135|454200279|FG003|Overall Study|Death|0|||
126247500|NCT01175135|454200276|FG000|Overall Study|Lack of Efficacy|4|||
126247501|NCT01175135|454200277|FG001|Overall Study|Lack of Efficacy|5|||
126247502|NCT01175135|454200278|FG002|Overall Study|Lack of Efficacy|0|||
126247503|NCT01175135|454200279|FG003|Overall Study|Lack of Efficacy|5|||
126247504|NCT01175135|454200276|FG000|Overall Study|Lost to Follow-up|1|||
126247505|NCT01175135|454200277|FG001|Overall Study|Lost to Follow-up|2|||
126247506|NCT01175135|454200278|FG002|Overall Study|Lost to Follow-up|0|||
126247507|NCT01175135|454200279|FG003|Overall Study|Lost to Follow-up|0|||
126247508|NCT01175135|454200276|FG000|Overall Study|Protocol Violation|1|||
126247509|NCT01175135|454200277|FG001|Overall Study|Protocol Violation|1|||
126247510|NCT01175135|454200278|FG002|Overall Study|Protocol Violation|0|||
126247511|NCT01175135|454200279|FG003|Overall Study|Protocol Violation|0|||
126247512|NCT01175135|454200276|FG000|Overall Study|Withdrawal by Subject|4|||
126247513|NCT01175135|454200277|FG001|Overall Study|Withdrawal by Subject|8|||
126247514|NCT01175135|454200278|FG002|Overall Study|Withdrawal by Subject|5|||
126247515|NCT01175135|454200279|FG003|Overall Study|Withdrawal by Subject|5|||
126247516|NCT01175135|454200276|FG000|Overall Study|Other|3|||
126247517|NCT01175135|454200277|FG001|Overall Study|Other|1|||
126247518|NCT01175135|454200278|FG002|Overall Study|Other|3|||
126247519|NCT01175135|454200279|FG003|Overall Study|Other|0|||
126247520|NCT01175135|454200276|FG000|Overall Study|Randomized But Not Treated|0|||
126247521|NCT01175135|454200277|FG001|Overall Study|Randomized But Not Treated|0|||
126247522|NCT01175135|454200278|FG002|Overall Study|Randomized But Not Treated|1|||
126247523|NCT01175135|454200279|FG003|Overall Study|Randomized But Not Treated|0|||
126247524|NCT04692155|454200283|FG000|Overall Study|Death|1|||
126247525|NCT03957551|454200284|FG000|Overall Study|Adverse Event|2|||
126247526|NCT03957551|454200285|FG001|Overall Study|Adverse Event|2|||
126247527|NCT03957551|454200286|FG002|Overall Study|Adverse Event|6|||
126247528|NCT03957551|454200284|FG000|Overall Study|Physician Decision|1|||
126247529|NCT03957551|454200285|FG001|Overall Study|Physician Decision|0|||
126247530|NCT03957551|454200286|FG002|Overall Study|Physician Decision|2|||
126247531|NCT03957551|454200284|FG000|Overall Study|Withdrawal by Subject|1|||
126247532|NCT03957551|454200285|FG001|Overall Study|Withdrawal by Subject|0|||
126247533|NCT03957551|454200286|FG002|Overall Study|Withdrawal by Subject|2|||
126247534|NCT03957551|454200284|FG000|Overall Study|Disease progression|1|||
126247535|NCT03957551|454200285|FG001|Overall Study|Disease progression|0|||
126247536|NCT03957551|454200286|FG002|Overall Study|Disease progression|8|||
126247537|NCT03325881|454200291|FG000|Overall Study|Protocol Violation|0|||
126247538|NCT03325881|454200292|FG001|Overall Study|Protocol Violation|1|||
126247539|NCT03325881|454200291|FG000|Overall Study|Withdrawal by Subject|0|||
126247540|NCT03325881|454200292|FG001|Overall Study|Withdrawal by Subject|2|||
126247541|NCT03325881|454200291|FG000|Overall Study|Lack of Efficacy|2|||
126247542|NCT03325881|454200292|FG001|Overall Study|Lack of Efficacy|0|||
126247543|NCT03325881|454200291|FG000|Overall Study|Not treated|1|||
126247544|NCT03325881|454200292|FG001|Overall Study|Not treated|0|||
126247545|NCT03676634|454200293|FG000|Overall Study|Red blood cell loss|1|||
126247546|NCT03676634|454200293|FG000|Overall Study|Out-of-limit pulse|2|||
126247547|NCT00540423|454200301|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126247548|NCT00540423|454200302|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126247549|NCT00540423|454200303|FG002|Double-Blind Treatment Period|Adverse Event|0|||
126247550|NCT00540423|454200301|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
126247551|NCT00540423|454200302|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
126247552|NCT00540423|454200303|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
126695438|NCT01573910|455838684|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
126695439|NCT01573910|455838685|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
126695440|NCT01227967|455838692|FG000|Overall Study|Protocol Violation|3|||
126695441|NCT01227967|455838693|FG001|Overall Study|Protocol Violation|1|||
126247553|NCT03131895|454200304|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
126247554|NCT03131895|454200305|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
126247555|NCT03131895|454200306|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
126247556|NCT03131895|454200307|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
126247557|NCT03131895|454200304|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
126247558|NCT03131895|454200305|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
126247559|NCT03131895|454200306|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
126695442|NCT01227967|455838692|FG000|Overall Study|Death|0|||
126695443|NCT01227967|455838693|FG001|Overall Study|Death|1|||
126247560|NCT03131895|454200307|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
126247561|NCT03131895|454200304|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126247562|NCT03131895|454200305|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
126247563|NCT03131895|454200306|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126247564|NCT03131895|454200307|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
126247565|NCT03131895|454200304|FG000|Washout Period (at Least 5 Days)|Other|0|||
126247566|NCT03131895|454200305|FG001|Washout Period (at Least 5 Days)|Other|0|||
126247567|NCT03131895|454200306|FG002|Washout Period (at Least 5 Days)|Other|2|||
126247568|NCT03131895|454200307|FG003|Washout Period (at Least 5 Days)|Other|0|||
126247569|NCT03131895|454200304|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
126247570|NCT03131895|454200305|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
126247571|NCT03131895|454200306|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
126247572|NCT03131895|454200307|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
126247573|NCT03131895|454200304|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
126247574|NCT03131895|454200305|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
126247575|NCT03131895|454200306|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
126247576|NCT03131895|454200307|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
126247577|NCT00216736|454200316|FG000|Overall Study|Lost to Follow-up|1|||
126247578|NCT00216736|454200317|FG001|Overall Study|Lost to Follow-up|1|||
126247579|NCT02622386|454200318|FG000|First Assignment|Withdrawal by Subject|3|||
126247580|NCT02622386|454200319|FG001|First Assignment|Withdrawal by Subject|2|||
126247581|NCT02622386|454200318|FG000|Washout|Withdrawal by Subject|4|||
126247582|NCT02622386|454200319|FG001|Washout|Withdrawal by Subject|4|||
126247583|NCT02622386|454200318|FG000|Second Assignment|Withdrawal by Subject|0|||
126247584|NCT02622386|454200319|FG001|Second Assignment|Withdrawal by Subject|2|||
126247585|NCT00909753|454200320|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
126247586|NCT00909753|454200321|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
126247587|NCT00909753|454200320|FG000|Period: Second Intervention|Protocol Violation|1|||
126247588|NCT00909753|454200321|FG001|Period: Second Intervention|Protocol Violation|0|||
126247589|NCT00418145|454200324|FG000|Overall Study|study terminated|6|||
126247590|NCT03214588|454200325|FG000|Overall Study|Adverse Event|1|||
126247591|NCT03214588|454200326|FG001|Overall Study|Adverse Event|0|||
126247592|NCT03214588|454200327|FG002|Overall Study|Adverse Event|2|||
126247593|NCT03214588|454200325|FG000|Overall Study|Reason Not Specified|0|||
126247594|NCT03214588|454200326|FG001|Overall Study|Reason Not Specified|1|||
126247595|NCT03214588|454200327|FG002|Overall Study|Reason Not Specified|0|||
126247596|NCT03480763|454200328|FG000|Overall Study|Withdrawal by Subject|18|||
126247597|NCT03480763|454200329|FG001|Overall Study|Withdrawal by Subject|10|||
126247598|NCT03480763|454200328|FG000|Overall Study|Lost to Follow-up|4|||
126247599|NCT03480763|454200329|FG001|Overall Study|Lost to Follow-up|7|||
126247600|NCT03480763|454200328|FG000|Overall Study|non-study pneumococcal vaccine|1|||
126247601|NCT03480763|454200329|FG001|Overall Study|non-study pneumococcal vaccine|0|||
126247602|NCT03480763|454200328|FG000|Overall Study|oncological treatment|0|||
126247603|NCT03480763|454200329|FG001|Overall Study|oncological treatment|2|||
126247604|NCT03480763|454200328|FG000|Overall Study|pain with vaccination|1|||
126247605|NCT03480763|454200329|FG001|Overall Study|pain with vaccination|0|||
126247606|NCT03629054|454200337|FG000|Period 2 (4 Days)|Not treated|0|||
126247607|NCT03629054|454200338|FG001|Period 2 (4 Days)|Not treated|1|||
126247608|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
126247609|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
126247610|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
126247611|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
126247612|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
126247613|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
126247614|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Death|9|||
126247615|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Death|7|||
126247616|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Death|14|||
126247617|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Death|7|||
126247618|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Death|0|||
126247619|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Death|0|||
126247620|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
126247621|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
126247622|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
126247623|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
126247624|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
126247625|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
126247626|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Other Event|49|||
126247627|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Other Event|52|||
126247628|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Other Event|41|||
126247629|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Other Event|58|||
126247630|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Other Event|0|||
126247631|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Other Event|0|||
126247632|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
126247633|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
126247634|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
126247635|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
126247636|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
126247637|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
126247638|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
126247639|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
126247640|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
126247641|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
126247642|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
126247643|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
126247644|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
126247645|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
126247646|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
126247647|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
126546030|NCT02307513|455292529|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
126546031|NCT02307513|455292528|FG000|Long-term Extension|Physician Decision|1|||
126546032|NCT02307513|455292529|FG001|Long-term Extension|Physician Decision|0|||
126546033|NCT05952297|455292530|FG000|Overall Study|Withdrawal by Subject|1|||
126247648|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
126247649|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
126247650|NCT00205777|454200339|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
126247651|NCT00205777|454200340|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
126247652|NCT00205777|454200341|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
126247653|NCT00205777|454200342|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
126247654|NCT00205777|454200343|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
126247655|NCT00205777|454200344|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
126448008|NCT02509026|454939626|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
126448009|NCT02509026|454939626|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
126448010|NCT02509026|454939626|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
126448011|NCT00721968|454939627|FG000|Overall Study|Lost to Follow-up|2|||
126448012|NCT00721968|454939628|FG001|Overall Study|Lost to Follow-up|0|||
126448013|NCT00479687|454941292|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
126448014|NCT00479687|454941293|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
126448015|NCT00479687|454941294|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
126448016|NCT00479687|454941292|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
126448017|NCT00479687|454941293|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
126448018|NCT00479687|454941294|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
126448019|NCT00479687|454941292|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
126448020|NCT00479687|454941293|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
126448021|NCT00479687|454941294|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
126448022|NCT00479687|454941292|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
126448023|NCT00479687|454941293|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
126448024|NCT00479687|454941294|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
126448025|NCT00479687|454941292|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
126448026|NCT00479687|454941293|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
126448027|NCT00479687|454941294|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
126448028|NCT00479687|454941292|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
126448029|NCT00479687|454941293|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
126448030|NCT00479687|454941294|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
126448031|NCT00479687|454941292|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
126448032|NCT00479687|454941293|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
126448033|NCT00479687|454941294|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
126448034|NCT00479687|454941292|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
126448035|NCT00479687|454941293|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
126448036|NCT00479687|454941294|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
126448037|NCT00479687|454941292|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
126448038|NCT00479687|454941293|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
126448039|NCT00479687|454941294|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
126448040|NCT00295880|454941295|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
126448041|NCT00295880|454941295|FG000|Overall Study|Unit randomization did not occur|1|||
126546034|NCT05952297|455292531|FG001|Overall Study|Withdrawal by Subject|0|||
126546035|NCT00525265|455292534|FG000|Overall Study|Protocol Violation|1|||
126546036|NCT00525265|455292535|FG001|Overall Study|Protocol Violation|0|||
126546037|NCT00744263|455292536|FG000|Overall Study|Death|3006|||
126546038|NCT00744263|455292537|FG001|Overall Study|Death|3005|||
126546039|NCT00744263|455292536|FG000|Overall Study|Lost to Follow-up|2038|||
126247656|NCT00205777|454200339|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
126247657|NCT00205777|454200340|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
126546040|NCT00744263|455292537|FG001|Overall Study|Lost to Follow-up|2135|||
126247658|NCT00205777|454200341|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
126247659|NCT00205777|454200342|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
126247660|NCT00205777|454200343|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
126247661|NCT00205777|454200344|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
126247662|NCT00205777|454200339|FG000|Completed Core Study, Entered SE I|Other Event|52|||
126247663|NCT00205777|454200340|FG001|Completed Core Study, Entered SE I|Other Event|46|||
126247664|NCT00205777|454200341|FG002|Completed Core Study, Entered SE I|Other Event|47|||
126247665|NCT00205777|454200342|FG003|Completed Core Study, Entered SE I|Other Event|50|||
126247666|NCT00205777|454200343|FG004|Completed Core Study, Entered SE I|Other Event|0|||
126247667|NCT00205777|454200344|FG005|Completed Core Study, Entered SE I|Other Event|0|||
126247668|NCT00205777|454200339|FG000|Study Extension I|Adverse Event|57|||
126247669|NCT00205777|454200340|FG001|Study Extension I|Adverse Event|0|||
126247670|NCT00205777|454200341|FG002|Study Extension I|Adverse Event|0|||
126247671|NCT00205777|454200342|FG003|Study Extension I|Adverse Event|61|||
126247672|NCT00205777|454200343|FG004|Study Extension I|Adverse Event|58|||
126247673|NCT00205777|454200344|FG005|Study Extension I|Adverse Event|0|||
126247674|NCT00205777|454200339|FG000|Study Extension I|Death|5|||
126247675|NCT00205777|454200340|FG001|Study Extension I|Death|0|||
126247676|NCT00205777|454200341|FG002|Study Extension I|Death|0|||
126695444|NCT01227967|455838692|FG000|Overall Study|Lost to Follow-up|8|||
126695445|NCT01227967|455838693|FG001|Overall Study|Lost to Follow-up|3|||
126695446|NCT01227967|455838692|FG000|Overall Study|Withdrawal by Subject|4|||
126695447|NCT01227967|455838693|FG001|Overall Study|Withdrawal by Subject|3|||
126695448|NCT01227967|455838692|FG000|Overall Study|Physician Decision|0|||
126247677|NCT00205777|454200342|FG003|Study Extension I|Death|1|||
126247678|NCT00205777|454200343|FG004|Study Extension I|Death|2|||
126247679|NCT00205777|454200344|FG005|Study Extension I|Death|0|||
126695449|NCT01227967|455838693|FG001|Overall Study|Physician Decision|1|||
126695450|NCT01227967|455838692|FG000|Overall Study|Never Started Treatment|0|||
126695451|NCT01227967|455838693|FG001|Overall Study|Never Started Treatment|4|||
126695452|NCT01227967|455838692|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
126695453|NCT01227967|455838693|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
126695454|NCT01763164|455838694|FG000|Treatment Phase|Participant/Guardian decision|26|||
126695455|NCT01763164|455838695|FG001|Treatment Phase|Participant/Guardian decision|14|||
126695456|NCT01763164|455838694|FG000|Treatment Phase|Protocol Violation|1|||
126695457|NCT01763164|455838695|FG001|Treatment Phase|Protocol Violation|1|||
126695458|NCT01763164|455838694|FG000|Treatment Phase|Progressive Disease|142|||
126695459|NCT01763164|455838695|FG001|Treatment Phase|Progressive Disease|76|||
126695460|NCT01763164|455838694|FG000|Treatment Phase|Physician Decision|24|||
126695461|NCT01763164|455838695|FG001|Treatment Phase|Physician Decision|13|||
126695462|NCT01763164|455838694|FG000|Treatment Phase|Death|10|||
126695463|NCT01763164|455838695|FG001|Treatment Phase|Death|1|||
126695464|NCT01763164|455838694|FG000|Treatment Phase|Adverse Event|66|||
126695465|NCT01763164|455838695|FG001|Treatment Phase|Adverse Event|8|||
126695466|NCT01763164|455838694|FG000|Treatment Phase|Randomized but not Treated|0|||
126695467|NCT01763164|455838695|FG001|Treatment Phase|Randomized but not Treated|19|||
126695468|NCT01763164|455838694|FG000|Treatment Phase|Other|0|||
126695469|NCT01763164|455838695|FG001|Treatment Phase|Other|1|||
126695470|NCT01763164|455838694|FG000|Follow up Phase|New therapy for study indication|12|||
126695471|NCT01763164|455838695|FG001|Follow up Phase|New therapy for study indication|3|||
126695472|NCT01763164|455838694|FG000|Follow up Phase|Death|21|||
126695473|NCT01763164|455838695|FG001|Follow up Phase|Death|4|||
126695474|NCT01763164|455838694|FG000|Follow up Phase|Subject/guardian decision|9|||
126695475|NCT01763164|455838695|FG001|Follow up Phase|Subject/guardian decision|2|||
126695476|NCT01763164|455838694|FG000|Follow up Phase|Progressive disease|127|||
126695477|NCT01763164|455838695|FG001|Follow up Phase|Progressive disease|62|||
126695478|NCT01763164|455838694|FG000|Follow up Phase|Physician Decision|10|||
126695479|NCT01763164|455838695|FG001|Follow up Phase|Physician Decision|3|||
126695480|NCT01763164|455838694|FG000|Follow up Phase|Lost to Follow-up|1|||
126695481|NCT01763164|455838695|FG001|Follow up Phase|Lost to Follow-up|0|||
126695482|NCT01763164|455838694|FG000|Follow up Phase|Adverse Event|17|||
126695483|NCT01763164|455838695|FG001|Follow up Phase|Adverse Event|1|||
126695484|NCT02658812|455838696|FG000|Overall Study|Disease Progression|7|||
126695485|NCT02658812|455838696|FG000|Overall Study|Unrelated to study treatment|1|||
126695486|NCT02658812|455838696|FG000|Overall Study|Adverse Event|1|||
126247680|NCT00205777|454200339|FG000|Study Extension I|Withdrawal by Subject|99|||
126247681|NCT00205777|454200340|FG001|Study Extension I|Withdrawal by Subject|0|||
126247682|NCT00205777|454200341|FG002|Study Extension I|Withdrawal by Subject|0|||
126695487|NCT01512264|455838697|FG000|Overall Study|Lost to Follow-up|0|||
126448042|NCT01474239|454941296|FG000|Overall Study|Disease Progression|37|||
126448043|NCT01474239|454941297|FG001|Overall Study|Disease Progression|25|||
126695488|NCT01512264|455838698|FG001|Overall Study|Lost to Follow-up|0|||
126695489|NCT01512264|455838699|FG002|Overall Study|Lost to Follow-up|0|||
126695490|NCT01512264|455838700|FG003|Overall Study|Lost to Follow-up|1|||
126695491|NCT00854828|455838701|FG000|Overall Study|Death|1|||
126695492|NCT00854828|455838702|FG001|Overall Study|Death|0|||
126695493|NCT00854828|455838703|FG002|Overall Study|Death|0|||
126695494|NCT00854828|455838704|FG003|Overall Study|Death|0|||
126546041|NCT00744263|455292536|FG000|Overall Study|Withdrawal by Subject|166|||
126546042|NCT00744263|455292537|FG001|Overall Study|Withdrawal by Subject|150|||
126546043|NCT00744263|455292536|FG000|Overall Study|Physician Decision|20|||
126546044|NCT00744263|455292537|FG001|Overall Study|Physician Decision|23|||
126546045|NCT00744263|455292536|FG000|Overall Study|Protocol Violation|3|||
126546046|NCT00744263|455292537|FG001|Overall Study|Protocol Violation|5|||
126546047|NCT00744263|455292536|FG000|Overall Study|Adverse Event|1|||
126546048|NCT00744263|455292537|FG001|Overall Study|Adverse Event|0|||
126546049|NCT00744263|455292536|FG000|Overall Study|Other|2|||
126546050|NCT00744263|455292537|FG001|Overall Study|Other|2|||
126546051|NCT05796518|455292548|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
126546052|NCT05408468|455292549|FG000|Overall Study|Lost to Follow-up|3|||
126546053|NCT05408468|455292550|FG001|Overall Study|Lost to Follow-up|1|||
126546054|NCT05408468|455292549|FG000|Overall Study|Physician Decision|1|||
126546055|NCT05408468|455292550|FG001|Overall Study|Physician Decision|0|||
126761506|NCT04145531|456079186|FG003|Part A|Physician Decision|0|||
126761507|NCT04145531|456079183|FG000|Part A|Progressive disease|0|||
126761508|NCT04145531|456079184|FG001|Part A|Progressive disease|2|||
126761509|NCT04145531|456079185|FG002|Part A|Progressive disease|1|||
126761510|NCT04145531|456079186|FG003|Part A|Progressive disease|0|||
126247683|NCT00205777|454200342|FG003|Study Extension I|Withdrawal by Subject|106|||
126247684|NCT00205777|454200343|FG004|Study Extension I|Withdrawal by Subject|89|||
126247685|NCT00205777|454200344|FG005|Study Extension I|Withdrawal by Subject|0|||
126247686|NCT00205777|454200339|FG000|Study Extension I|Protocol Violation|4|||
126247687|NCT00205777|454200340|FG001|Study Extension I|Protocol Violation|0|||
126247688|NCT00205777|454200341|FG002|Study Extension I|Protocol Violation|0|||
126247689|NCT00205777|454200342|FG003|Study Extension I|Protocol Violation|8|||
126247690|NCT00205777|454200343|FG004|Study Extension I|Protocol Violation|8|||
126247691|NCT00205777|454200344|FG005|Study Extension I|Protocol Violation|0|||
126247692|NCT00205777|454200339|FG000|Study Extension I|Lack of Efficacy|0|||
126247693|NCT00205777|454200340|FG001|Study Extension I|Lack of Efficacy|0|||
126247694|NCT00205777|454200341|FG002|Study Extension I|Lack of Efficacy|0|||
126247695|NCT00205777|454200342|FG003|Study Extension I|Lack of Efficacy|1|||
126247696|NCT00205777|454200343|FG004|Study Extension I|Lack of Efficacy|2|||
126247697|NCT00205777|454200344|FG005|Study Extension I|Lack of Efficacy|0|||
126247698|NCT00205777|454200339|FG000|Study Extension I|Failed to return|15|||
126247699|NCT00205777|454200340|FG001|Study Extension I|Failed to return|0|||
126247700|NCT00205777|454200341|FG002|Study Extension I|Failed to return|0|||
126247701|NCT00205777|454200342|FG003|Study Extension I|Failed to return|17|||
126247702|NCT00205777|454200343|FG004|Study Extension I|Failed to return|13|||
126247703|NCT00205777|454200344|FG005|Study Extension I|Failed to return|0|||
126247704|NCT00205777|454200339|FG000|Study Extension I|Other Event|34|||
126247705|NCT00205777|454200340|FG001|Study Extension I|Other Event|0|||
126247706|NCT00205777|454200341|FG002|Study Extension I|Other Event|0|||
126247707|NCT00205777|454200342|FG003|Study Extension I|Other Event|34|||
126247708|NCT00205777|454200343|FG004|Study Extension I|Other Event|29|||
126247709|NCT00205777|454200344|FG005|Study Extension I|Other Event|0|||
126247710|NCT00205777|454200339|FG000|Study Extension I|Withdrawn as per protocol|0|||
126247711|NCT00205777|454200340|FG001|Study Extension I|Withdrawn as per protocol|0|||
126247712|NCT00205777|454200341|FG002|Study Extension I|Withdrawn as per protocol|1070|||
126247713|NCT00205777|454200342|FG003|Study Extension I|Withdrawn as per protocol|0|||
126247714|NCT00205777|454200343|FG004|Study Extension I|Withdrawn as per protocol|0|||
126247715|NCT00205777|454200344|FG005|Study Extension I|Withdrawn as per protocol|0|||
126448044|NCT01474239|454941296|FG000|Overall Study|Adverse Event|12|||
126247716|NCT00205777|454200339|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
126247717|NCT00205777|454200340|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
126306195|NCT03260244|454410221|FG000|Overall Study|No inducible Arrhythmia|2|||
126448045|NCT01474239|454941297|FG001|Overall Study|Adverse Event|3|||
126448046|NCT01474239|454941296|FG000|Overall Study|Withdrawal by Subject|1|||
126448047|NCT01474239|454941297|FG001|Overall Study|Withdrawal by Subject|2|||
126448048|NCT01474239|454941296|FG000|Overall Study|Death|1|||
126448049|NCT01474239|454941297|FG001|Overall Study|Death|1|||
126448050|NCT01474239|454941296|FG000|Overall Study|Clinical Disease Progression|7|||
126448051|NCT01474239|454941297|FG001|Overall Study|Clinical Disease Progression|1|||
126448052|NCT01474239|454941296|FG000|Overall Study|Withdrawal for Economic Reason|1|||
126448053|NCT01474239|454941297|FG001|Overall Study|Withdrawal for Economic Reason|0|||
126448054|NCT02175199|454941300|FG000|Overall Study|Withdrawal by Subject|1|||
126448055|NCT02175199|454941301|FG001|Overall Study|Withdrawal by Subject|5|||
126448056|NCT02175199|454941300|FG000|Overall Study|Randomized in Error|1|||
126448057|NCT02175199|454941301|FG001|Overall Study|Randomized in Error|0|||
126448058|NCT02175199|454941300|FG000|Overall Study|Sponsor Decision|1|||
126448059|NCT02175199|454941301|FG001|Overall Study|Sponsor Decision|0|||
126448060|NCT03983317|454941306|FG000|Overall Study|Physician Decision|5|||
126448061|NCT01761162|454941307|FG000|Overall Study|Withdrawal by Subject|3|||
126448062|NCT04681352|454941309|FG000|Overall Study|Lost to Follow-up|2|||
126448063|NCT04681352|454941309|FG000|Overall Study|Withdrawal by Subject|22|||
126448064|NCT01643772|454941310|FG000|Overall Study|Protocol Violation|0|||
126448065|NCT01643772|454941311|FG001|Overall Study|Protocol Violation|0|||
126448066|NCT01643772|454941312|FG002|Overall Study|Protocol Violation|0|||
126448067|NCT01643772|454941313|FG003|Overall Study|Protocol Violation|1|||
126448068|NCT01643772|454941310|FG000|Overall Study|Adverse Event|0|||
126448069|NCT01643772|454941311|FG001|Overall Study|Adverse Event|0|||
126448070|NCT01643772|454941312|FG002|Overall Study|Adverse Event|0|||
126761511|NCT04145531|456079183|FG000|Part A|Protocol deviation|0|||
126761512|NCT04145531|456079184|FG001|Part A|Protocol deviation|0|||
126761513|NCT04145531|456079185|FG002|Part A|Protocol deviation|1|||
126761514|NCT04145531|456079186|FG003|Part A|Protocol deviation|0|||
126761515|NCT04145531|456079183|FG000|Part A|Withdrawal by parent or guardian|1|||
126761516|NCT04145531|456079184|FG001|Part A|Withdrawal by parent or guardian|0|||
126761517|NCT04145531|456079185|FG002|Part A|Withdrawal by parent or guardian|0|||
126761518|NCT04145531|456079186|FG003|Part A|Withdrawal by parent or guardian|0|||
126761519|NCT04145531|456079183|FG000|Part A|Withdrawal by participant|0|||
126247718|NCT00205777|454200341|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
126247719|NCT00205777|454200342|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
126247720|NCT00205777|454200343|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
126247721|NCT00205777|454200344|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
126247722|NCT00205777|454200339|FG000|Study Extension II|Adverse Event|0|||
126247723|NCT00205777|454200340|FG001|Study Extension II|Adverse Event|0|||
126247724|NCT00205777|454200341|FG002|Study Extension II|Adverse Event|0|||
126247725|NCT00205777|454200342|FG003|Study Extension II|Adverse Event|14|||
126247726|NCT00205777|454200343|FG004|Study Extension II|Adverse Event|0|||
126247727|NCT00205777|454200344|FG005|Study Extension II|Adverse Event|30|||
126247728|NCT00205777|454200339|FG000|Study Extension II|Death|0|||
126247729|NCT00205777|454200340|FG001|Study Extension II|Death|0|||
126247730|NCT00205777|454200341|FG002|Study Extension II|Death|0|||
126247731|NCT00205777|454200342|FG003|Study Extension II|Death|2|||
126448071|NCT01643772|454941313|FG003|Overall Study|Adverse Event|1|||
126448072|NCT00798759|454941315|FG000|Overall Study|Adverse Event|3|||
126448073|NCT00798759|454941316|FG001|Overall Study|Adverse Event|3|||
126448074|NCT00798759|454941315|FG000|Overall Study|Lost to Follow-up|1|||
126448075|NCT00798759|454941316|FG001|Overall Study|Lost to Follow-up|1|||
126448076|NCT00798759|454941315|FG000|Overall Study|Protocol Violation|4|||
126448077|NCT00798759|454941316|FG001|Overall Study|Protocol Violation|8|||
126448078|NCT00798759|454941315|FG000|Overall Study|Other|0|||
126448079|NCT00798759|454941316|FG001|Overall Study|Other|1|||
126448080|NCT01754727|454941317|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
126448081|NCT02891070|454941326|FG000|Overall Study|Adverse Event|1|||
126448082|NCT02891070|454941327|FG001|Overall Study|Adverse Event|0|||
126448083|NCT02891070|454941326|FG000|Overall Study|Physician Decision|0|||
126448084|NCT02891070|454941327|FG001|Overall Study|Physician Decision|1|||
126448085|NCT02891070|454941326|FG000|Overall Study|Lost to Follow-up|4|||
126448086|NCT02891070|454941327|FG001|Overall Study|Lost to Follow-up|4|||
126448087|NCT02891070|454941326|FG000|Overall Study|Other|1|||
126448088|NCT02891070|454941327|FG001|Overall Study|Other|0|||
126448089|NCT02891070|454941326|FG000|Overall Study|Protocol Violation|0|||
126448090|NCT02891070|454941327|FG001|Overall Study|Protocol Violation|1|||
126448091|NCT02891070|454941326|FG000|Overall Study|Withdrawal by Subject|1|||
126448092|NCT02891070|454941327|FG001|Overall Study|Withdrawal by Subject|2|||
126448093|NCT02891070|454941326|FG000|Overall Study|Death|3|||
126448094|NCT02891070|454941327|FG001|Overall Study|Death|0|||
126448095|NCT04491604|454941328|FG000|Overall Study|Withdrawal by Subject|3|||
126448096|NCT02934503|454941329|FG000|Overall Study|progression of disease|3|||
126448097|NCT02934503|454941329|FG000|Overall Study|Withdrawal by Subject|1|||
126448098|NCT00724867|454941330|FG000|Overall Study|Adverse Event|25|||
126448099|NCT00724867|454941330|FG000|Overall Study|Lack of Efficacy|14|||
126448100|NCT00724867|454941330|FG000|Overall Study|Lost to Follow-up|12|||
126448101|NCT00724867|454941330|FG000|Overall Study|Non-compliance with study drug|6|||
126448102|NCT00724867|454941330|FG000|Overall Study|Physician Decision|17|||
126247732|NCT00205777|454200343|FG004|Study Extension II|Death|0|||
126448103|NCT00724867|454941330|FG000|Overall Study|Protocol Violation|1|||
126448104|NCT00724867|454941330|FG000|Overall Study|Withdrawal by Subject|31|||
126448105|NCT00724867|454941330|FG000|Overall Study|Sponsor decision to end study|14|||
126448106|NCT00724867|454941330|FG000|Overall Study|Subject incarcerated|1|||
126448107|NCT00724867|454941330|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
126448108|NCT00724867|454941330|FG000|Overall Study|Subject moved out of state|1|||
126448109|NCT00724867|454941330|FG000|Overall Study|Elected to exit due to site closure|2|||
126247733|NCT00205777|454200344|FG005|Study Extension II|Death|5|||
126448110|NCT02881567|454941331|FG000|Overall Study|Adverse Event|1|||
126448111|NCT02881567|454941331|FG000|Overall Study|Lost to Follow-up|3|||
126448112|NCT02881567|454941331|FG000|Overall Study|Consent withdrawn|1|||
126448113|NCT02881567|454941331|FG000|Overall Study|Investigator decision|1|||
126761520|NCT04145531|456079184|FG001|Part A|Withdrawal by participant|0|||
126761521|NCT04145531|456079185|FG002|Part A|Withdrawal by participant|1|||
126761522|NCT04145531|456079186|FG003|Part A|Withdrawal by participant|0|||
126761523|NCT04145531|456079183|FG000|Part A|Other|0|||
126247734|NCT00205777|454200339|FG000|Study Extension II|Withdrawal by Subject|0|||
126247735|NCT00205777|454200340|FG001|Study Extension II|Withdrawal by Subject|0|||
126247736|NCT00205777|454200341|FG002|Study Extension II|Withdrawal by Subject|0|||
126247737|NCT00205777|454200342|FG003|Study Extension II|Withdrawal by Subject|35|||
126247738|NCT00205777|454200343|FG004|Study Extension II|Withdrawal by Subject|0|||
126247739|NCT00205777|454200344|FG005|Study Extension II|Withdrawal by Subject|59|||
126247740|NCT00205777|454200339|FG000|Study Extension II|Protocol Violation|0|||
126247741|NCT00205777|454200340|FG001|Study Extension II|Protocol Violation|0|||
126247742|NCT00205777|454200341|FG002|Study Extension II|Protocol Violation|0|||
126247743|NCT00205777|454200342|FG003|Study Extension II|Protocol Violation|1|||
126247744|NCT00205777|454200343|FG004|Study Extension II|Protocol Violation|0|||
126247745|NCT00205777|454200344|FG005|Study Extension II|Protocol Violation|10|||
126247746|NCT00205777|454200339|FG000|Study Extension II|Lack of Efficacy|0|||
126247747|NCT00205777|454200340|FG001|Study Extension II|Lack of Efficacy|0|||
126247748|NCT00205777|454200341|FG002|Study Extension II|Lack of Efficacy|0|||
126247749|NCT00205777|454200342|FG003|Study Extension II|Lack of Efficacy|0|||
126448114|NCT02881567|454941331|FG000|Overall Study|Study terminated by sponsor|9|||
126448115|NCT02881567|454941331|FG000|Overall Study|Reason not Specified|3|||
126448116|NCT00373113|454941335|FG000|Overall Study|Death|1|||
126448117|NCT00373113|454941336|FG001|Overall Study|Death|7|||
126448118|NCT00373113|454941335|FG000|Overall Study|Adverse Event|38|||
126448119|NCT00373113|454941336|FG001|Overall Study|Adverse Event|24|||
126448120|NCT00373113|454941335|FG000|Overall Study|Study terminated by sponsor|9|||
126546056|NCT05408468|455292549|FG000|Overall Study|Overwhelmed by clinical situation|3|||
126546057|NCT05408468|455292550|FG001|Overall Study|Overwhelmed by clinical situation|0|||
126448121|NCT00373113|454941336|FG001|Overall Study|Study terminated by sponsor|1|||
126448122|NCT00373113|454941335|FG000|Overall Study|Global deterioration of health status|10|||
126448123|NCT00373113|454941336|FG001|Overall Study|Global deterioration of health status|7|||
126546058|NCT05408468|455292549|FG000|Overall Study|Personal illness precluding participation|1|||
126546059|NCT05408468|455292550|FG001|Overall Study|Personal illness precluding participation|0|||
126546060|NCT05408468|455292549|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
126546061|NCT05408468|455292550|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
126546062|NCT04186403|455292551|FG000|Overall Study|Adverse Event|1|||
126546063|NCT04186403|455292552|FG001|Overall Study|Adverse Event|8|||
126546064|NCT04186403|455292551|FG000|Overall Study|Lost to Follow-up|7|||
126546065|NCT04186403|455292552|FG001|Overall Study|Lost to Follow-up|3|||
126546066|NCT04186403|455292551|FG000|Overall Study|Physician Decision|1|||
126546067|NCT04186403|455292552|FG001|Overall Study|Physician Decision|0|||
126546068|NCT04186403|455292551|FG000|Overall Study|Withdrawal by Subject|7|||
126546069|NCT04186403|455292552|FG001|Overall Study|Withdrawal by Subject|8|||
126546070|NCT04186403|455292551|FG000|Overall Study|Other: Not Related to Covid-19|3|||
126546071|NCT04186403|455292552|FG001|Overall Study|Other: Not Related to Covid-19|0|||
126546072|NCT00405639|455292554|FG000|Overall Study|Withdrawal by Subject|1|||
126546073|NCT00405639|455292555|FG001|Overall Study|Withdrawal by Subject|0|||
126546074|NCT00405639|455292554|FG000|Overall Study|Adverse Event|1|||
126546075|NCT00405639|455292555|FG001|Overall Study|Adverse Event|0|||
126546076|NCT00405639|455292554|FG000|Overall Study|Seizure prior to receiving BNP|1|||
126546077|NCT00405639|455292555|FG001|Overall Study|Seizure prior to receiving BNP|0|||
126695495|NCT00854828|455838701|FG000|Overall Study|Withdrawal by Subject|1|||
126695496|NCT00854828|455838702|FG001|Overall Study|Withdrawal by Subject|1|||
126695497|NCT00854828|455838703|FG002|Overall Study|Withdrawal by Subject|0|||
126695498|NCT00854828|455838704|FG003|Overall Study|Withdrawal by Subject|9|||
126695499|NCT00854828|455838701|FG000|Overall Study|Missed 24mo visit|1|||
126695500|NCT00854828|455838702|FG001|Overall Study|Missed 24mo visit|1|||
126695501|NCT00854828|455838703|FG002|Overall Study|Missed 24mo visit|8|||
126695502|NCT00854828|455838704|FG003|Overall Study|Missed 24mo visit|8|||
126695503|NCT04957290|455838705|FG000|Overall Study|Progressive disease|3|||
126695504|NCT04957290|455838706|FG001|Overall Study|Progressive disease|3|||
126695505|NCT04957290|455838707|FG002|Overall Study|Progressive disease|2|||
126695506|NCT04957290|455838708|FG003|Overall Study|Progressive disease|0|||
126695507|NCT04957290|455838709|FG004|Overall Study|Progressive disease|0|||
126695508|NCT04957290|455838710|FG005|Overall Study|Progressive disease|0|||
126695509|NCT04957290|455838705|FG000|Overall Study|Withdrawal by Subject|1|||
126695510|NCT04957290|455838706|FG001|Overall Study|Withdrawal by Subject|0|||
126695511|NCT04957290|455838707|FG002|Overall Study|Withdrawal by Subject|1|||
126695512|NCT04957290|455838708|FG003|Overall Study|Withdrawal by Subject|0|||
126695513|NCT04957290|455838709|FG004|Overall Study|Withdrawal by Subject|0|||
126695514|NCT04957290|455838710|FG005|Overall Study|Withdrawal by Subject|0|||
126695515|NCT04957290|455838705|FG000|Overall Study|Death|0|||
126695516|NCT04957290|455838706|FG001|Overall Study|Death|2|||
126247750|NCT00205777|454200343|FG004|Study Extension II|Lack of Efficacy|0|||
126695517|NCT04957290|455838707|FG002|Overall Study|Death|1|||
126695518|NCT04957290|455838708|FG003|Overall Study|Death|0|||
126695519|NCT04957290|455838709|FG004|Overall Study|Death|0|||
126695520|NCT04957290|455838710|FG005|Overall Study|Death|0|||
126695521|NCT04957290|455838705|FG000|Overall Study|non compliance with study drug|0|||
126357649|NCT02187055|454602192|FG002|Overall Study|Withdrawal by Subject|11|||
126357650|NCT02187055|454602190|FG000|Overall Study|Adverse Event|21|||
126357651|NCT02187055|454602191|FG001|Overall Study|Adverse Event|26|||
126357652|NCT02187055|454602192|FG002|Overall Study|Adverse Event|36|||
126357653|NCT02187055|454602190|FG000|Overall Study|Death|2|||
126357654|NCT02187055|454602191|FG001|Overall Study|Death|0|||
126357655|NCT02187055|454602192|FG002|Overall Study|Death|0|||
126357656|NCT03520387|454602195|FG000|Pre-Randomization|Withdrawal by Subject|1|||
126357657|NCT03520387|454602196|FG001|Pre-Randomization|Withdrawal by Subject|0|||
126357658|NCT03520387|454602197|FG002|Pre-Randomization|Withdrawal by Subject|0|||
126357659|NCT03520387|454602198|FG003|Pre-Randomization|Withdrawal by Subject|0|||
126357660|NCT03520387|454602199|FG004|Pre-Randomization|Withdrawal by Subject|0|||
126357661|NCT03520387|454602195|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
126357662|NCT03520387|454602196|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
126357663|NCT03520387|454602197|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
126357664|NCT03520387|454602198|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
126695522|NCT04957290|455838706|FG001|Overall Study|non compliance with study drug|1|||
126695523|NCT04957290|455838707|FG002|Overall Study|non compliance with study drug|0|||
126695524|NCT04957290|455838708|FG003|Overall Study|non compliance with study drug|0|||
126695525|NCT04957290|455838709|FG004|Overall Study|non compliance with study drug|0|||
126695526|NCT04957290|455838710|FG005|Overall Study|non compliance with study drug|0|||
126695527|NCT04957290|455838705|FG000|Overall Study|none specified.|0|||
126695528|NCT04957290|455838706|FG001|Overall Study|none specified.|1|||
126695529|NCT04957290|455838707|FG002|Overall Study|none specified.|2|||
126695530|NCT04957290|455838708|FG003|Overall Study|none specified.|0|||
126695531|NCT04957290|455838709|FG004|Overall Study|none specified.|0|||
126695532|NCT04957290|455838710|FG005|Overall Study|none specified.|0|||
126695533|NCT04957290|455838705|FG000|Overall Study|unacceptable toxicity|0|||
126695534|NCT04957290|455838706|FG001|Overall Study|unacceptable toxicity|0|||
126695535|NCT04957290|455838707|FG002|Overall Study|unacceptable toxicity|1|||
126695536|NCT04957290|455838708|FG003|Overall Study|unacceptable toxicity|0|||
126695537|NCT04957290|455838709|FG004|Overall Study|unacceptable toxicity|0|||
126695538|NCT04957290|455838710|FG005|Overall Study|unacceptable toxicity|0|||
126695539|NCT04957290|455838705|FG000|Overall Study|Adverse Event|0|||
126695540|NCT04957290|455838706|FG001|Overall Study|Adverse Event|0|||
126695541|NCT04957290|455838707|FG002|Overall Study|Adverse Event|1|||
126695542|NCT04957290|455838708|FG003|Overall Study|Adverse Event|0|||
126695543|NCT04957290|455838709|FG004|Overall Study|Adverse Event|0|||
126695544|NCT04957290|455838710|FG005|Overall Study|Adverse Event|0|||
126695545|NCT04957290|455838705|FG000|Overall Study|study terminated by sponsor|0|||
126695546|NCT04957290|455838706|FG001|Overall Study|study terminated by sponsor|0|||
126695547|NCT04957290|455838707|FG002|Overall Study|study terminated by sponsor|2|||
126695548|NCT04957290|455838708|FG003|Overall Study|study terminated by sponsor|0|||
126695549|NCT04957290|455838709|FG004|Overall Study|study terminated by sponsor|0|||
126695550|NCT04957290|455838710|FG005|Overall Study|study terminated by sponsor|0|||
126695551|NCT02411747|455838711|FG000|Overall Study|Withdrawal by Subject|1|||
126695552|NCT02411747|455838712|FG001|Overall Study|Withdrawal by Subject|0|||
126695553|NCT02411747|455838711|FG000|Overall Study|Protocol Violation|2|||
126695554|NCT02411747|455838712|FG001|Overall Study|Protocol Violation|4|||
126695555|NCT03158220|455838713|FG000|Overall Study|Screen Failure|0|||
126695556|NCT03158220|455838714|FG001|Overall Study|Screen Failure|1|||
126695557|NCT03158220|455838713|FG000|Overall Study|Withdrawal by Subject|8|||
126695558|NCT03158220|455838714|FG001|Overall Study|Withdrawal by Subject|9|||
126695559|NCT03158220|455838713|FG000|Overall Study|Status unknown|0|||
126695560|NCT03158220|455838714|FG001|Overall Study|Status unknown|1|||
126695561|NCT03158220|455838713|FG000|Overall Study|Lost to Follow-up|8|||
126695562|NCT03158220|455838714|FG001|Overall Study|Lost to Follow-up|5|||
126695563|NCT03158220|455838713|FG000|Overall Study|Physician Decision|1|||
126695564|NCT03158220|455838714|FG001|Overall Study|Physician Decision|0|||
126695565|NCT00996203|455838715|FG000|Overall Study|Adverse Event|3|||
126695566|NCT00996203|455838715|FG000|Overall Study|Lost to Follow-up|1|||
126695567|NCT00996203|455838715|FG000|Overall Study|Lack of Efficacy|1|||
126695568|NCT00996203|455838715|FG000|Overall Study|Protocol Violation|2|||
126695569|NCT01671280|455838716|FG000|Overall Study|Withdrawal by Subject|2|||
126695570|NCT03686969|455838718|FG000|Overall Study|Study terminated|1|||
126695571|NCT03686969|455838719|FG001|Overall Study|Study terminated|0|||
126695572|NCT00848120|455838720|FG000|Overall Study|Adverse Event|1|||
126695573|NCT00560755|455838721|FG000|Overall Study|Protocol Violation|15|||
126695574|NCT00560755|455838721|FG000|Overall Study|Withdrawal by Subject|26|||
126357665|NCT03520387|454602199|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
126357666|NCT03336866|454602200|FG000|Overall Study|Lost to Follow-up|2|||
126695575|NCT00560755|455838721|FG000|Overall Study|Lost to Follow-up|9|||
126695576|NCT00560755|455838721|FG000|Overall Study|Adverse Event|8|||
126761524|NCT04145531|456079184|FG001|Part A|Other|0|||
126761525|NCT04145531|456079185|FG002|Part A|Other|1|||
126357667|NCT03336866|454602201|FG001|Overall Study|Lost to Follow-up|0|||
126357668|NCT03336866|454602202|FG002|Overall Study|Lost to Follow-up|3|||
126448124|NCT00373113|454941335|FG000|Overall Study|Lost to Follow-up|1|||
126448125|NCT00373113|454941336|FG001|Overall Study|Lost to Follow-up|3|||
126448126|NCT00373113|454941335|FG000|Overall Study|Objective progression or relapse|150|||
126448127|NCT00373113|454941336|FG001|Overall Study|Objective progression or relapse|169|||
126448128|NCT00373113|454941335|FG000|Overall Study|Other|14|||
126448129|NCT00373113|454941336|FG001|Overall Study|Other|17|||
126448130|NCT00373113|454941335|FG000|Overall Study|Protocol Violation|5|||
126448131|NCT00373113|454941336|FG001|Overall Study|Protocol Violation|1|||
126448132|NCT00373113|454941335|FG000|Overall Study|Withdrawal by Subject|10|||
126448133|NCT00373113|454941336|FG001|Overall Study|Withdrawal by Subject|15|||
126695577|NCT00560755|455838721|FG000|Overall Study|Physician Decision|2|||
126695578|NCT01988090|455838727|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
126695579|NCT01988090|455838728|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
126695580|NCT01988090|455838727|FG000|Start Treament After Randomization|Protocol Violation|0|||
126695581|NCT01988090|455838728|FG001|Start Treament After Randomization|Protocol Violation|1|||
126695582|NCT01988090|455838727|FG000|Complete Study After Start|Withdrawal by Subject|2|||
126695583|NCT01988090|455838728|FG001|Complete Study After Start|Withdrawal by Subject|0|||
126695584|NCT01988090|455838727|FG000|Complete Study After Start|Protocol Violation|1|||
126695585|NCT01988090|455838728|FG001|Complete Study After Start|Protocol Violation|1|||
126695586|NCT01439945|455838733|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
126695587|NCT01439945|455838734|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
126695588|NCT01439945|455838735|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
126695589|NCT01439945|455838736|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
126695590|NCT01439945|455838733|FG000|Double-Blind Treatment Phase|Ineligible|1|||
126695591|NCT01439945|455838734|FG001|Double-Blind Treatment Phase|Ineligible|2|||
126695592|NCT01439945|455838735|FG002|Double-Blind Treatment Phase|Ineligible|0|||
126695593|NCT01439945|455838736|FG003|Double-Blind Treatment Phase|Ineligible|1|||
126546078|NCT00265330|455292556|FG000|Overall Study|Adverse Event|41|||
126546079|NCT00265330|455292556|FG000|Overall Study|Lost to Follow-up|8|||
126546080|NCT00265330|455292556|FG000|Overall Study|Withdrawal by Subject|34|||
126546081|NCT00265330|455292556|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
126695594|NCT00705263|455838737|FG000|Overall Study|Withdrawal by Subject|2|||
126695595|NCT00413959|455838744|FG000|Overall Study|Pt had only one cycle.|1|||
126695596|NCT04343651|455838746|FG000|Overall Study|Physician Decision|2|||
126695597|NCT04343651|455838747|FG001|Overall Study|Physician Decision|1|||
126695598|NCT04343651|455838746|FG000|Overall Study|Lost to Follow-up|2|||
126695599|NCT04343651|455838747|FG001|Overall Study|Lost to Follow-up|1|||
126695600|NCT04343651|455838746|FG000|Overall Study|Protocol Violation|4|||
126695601|NCT04343651|455838747|FG001|Overall Study|Protocol Violation|6|||
126695602|NCT04343651|455838746|FG000|Overall Study|Missing|3|||
126695603|NCT04343651|455838747|FG001|Overall Study|Missing|9|||
126695604|NCT04343651|455838746|FG000|Overall Study|Withdrawal by Subject|0|||
126695605|NCT04343651|455838747|FG001|Overall Study|Withdrawal by Subject|4|||
126695606|NCT04343651|455838746|FG000|Overall Study|Death|0|||
126695607|NCT04343651|455838747|FG001|Overall Study|Death|1|||
126695608|NCT04343651|455838746|FG000|Overall Study|Did not start treatment|1|||
126695609|NCT04343651|455838747|FG001|Overall Study|Did not start treatment|1|||
126695610|NCT04343651|455838746|FG000|Overall Study|Patient did not complete visits 3-6|0|||
126695611|NCT04343651|455838747|FG001|Overall Study|Patient did not complete visits 3-6|1|||
126695612|NCT01292057|455838753|FG000|Overall Study|Protocol Violation|1|||
126695613|NCT01292057|455838754|FG001|Overall Study|Protocol Violation|1|||
126695614|NCT01292057|455838753|FG000|Overall Study|Lost to Follow-up|1|||
126695615|NCT01292057|455838754|FG001|Overall Study|Lost to Follow-up|1|||
126695616|NCT01459614|455838755|FG000|Overall Study|Adverse Event|1|||
126695617|NCT01459614|455838756|FG001|Overall Study|Adverse Event|0|||
126695618|NCT01506882|455838760|FG000|Overall Study|Lack of Efficacy|4|||
126695619|NCT01506882|455838761|FG001|Overall Study|Lack of Efficacy|3|||
126695620|NCT01506882|455838760|FG000|Overall Study|Lost to Follow-up|1|||
126695621|NCT01506882|455838761|FG001|Overall Study|Lost to Follow-up|0|||
126695622|NCT01506882|455838760|FG000|Overall Study|Withdrawal by Subject|9|||
126448134|NCT00975689|454941337|FG000|Overall Study|Adverse Event|0|||
126695623|NCT01506882|455838761|FG001|Overall Study|Withdrawal by Subject|3|||
126695624|NCT01506882|455838760|FG000|Overall Study|SAE, non-fatal|2|||
126695625|NCT01506882|455838761|FG001|Overall Study|SAE, non-fatal|0|||
126695626|NCT01506882|455838760|FG000|Overall Study|AE, non-serious non-fatal|3|||
126695627|NCT01506882|455838761|FG001|Overall Study|AE, non-serious non-fatal|1|||
126695628|NCT01506882|455838760|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
126695629|NCT01506882|455838761|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
126695630|NCT01506882|455838760|FG000|Overall Study|Other Reason|2|||
126695631|NCT01506882|455838761|FG001|Overall Study|Other Reason|0|||
126695632|NCT00821678|455838766|FG000|Overall Study|Withdrawal by Subject|8|||
126448135|NCT00975689|454941338|FG001|Overall Study|Adverse Event|3|||
126448136|NCT00975689|454941337|FG000|Overall Study|Withdrawal by Subject|1|||
126448137|NCT00975689|454941338|FG001|Overall Study|Withdrawal by Subject|0|||
126695633|NCT00821678|455838767|FG001|Overall Study|Withdrawal by Subject|0|||
126448138|NCT00975689|454941337|FG000|Overall Study|Physician Decision|1|||
126695634|NCT00821678|455838766|FG000|Overall Study|Lost to Follow-up|13|||
126695635|NCT00821678|455838767|FG001|Overall Study|Lost to Follow-up|12|||
126695636|NCT00821678|455838766|FG000|Overall Study|Death|0|||
126695637|NCT00821678|455838767|FG001|Overall Study|Death|2|||
126695638|NCT01475734|455840596|FG000|Overall Study|Withdrawal by Subject|1|||
126695639|NCT01475734|455840597|FG001|Overall Study|Withdrawal by Subject|0|||
126695640|NCT01475734|455840596|FG000|Overall Study|Protocol Violation|1|||
126695641|NCT01475734|455840597|FG001|Overall Study|Protocol Violation|0|||
126695642|NCT01475734|455840596|FG000|Overall Study|Physician Decision|0|||
126695643|NCT01475734|455840597|FG001|Overall Study|Physician Decision|1|||
126695644|NCT00376961|455840601|FG000|Initial Registration|Adverse Event|1|||
126695645|NCT00376961|455840602|FG001|Initial Registration|Adverse Event|0|||
126695646|NCT00376961|455840601|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
126761526|NCT04145531|456079186|FG003|Part A|Other|0|||
126761527|NCT04145531|456079183|FG000|Part B|Adverse Event|0|||
126761528|NCT04145531|456079184|FG001|Part B|Adverse Event|0|||
126761529|NCT04145531|456079185|FG002|Part B|Adverse Event|0|||
126761530|NCT04145531|456079186|FG003|Part B|Adverse Event|21|||
126761531|NCT04145531|456079183|FG000|Part B|Physician Decision|0|||
126761532|NCT04145531|456079184|FG001|Part B|Physician Decision|0|||
126761533|NCT04145531|456079185|FG002|Part B|Physician Decision|0|||
126761534|NCT04145531|456079186|FG003|Part B|Physician Decision|7|||
126761535|NCT04145531|456079183|FG000|Part B|Progressive disease|0|||
126761536|NCT04145531|456079184|FG001|Part B|Progressive disease|0|||
126761537|NCT04145531|456079185|FG002|Part B|Progressive disease|0|||
126761538|NCT04145531|456079186|FG003|Part B|Progressive disease|1|||
126761539|NCT04145531|456079183|FG000|Part B|Recurrent disease|0|||
126761540|NCT04145531|456079184|FG001|Part B|Recurrent disease|0|||
126761541|NCT04145531|456079185|FG002|Part B|Recurrent disease|0|||
126761542|NCT04145531|456079186|FG003|Part B|Recurrent disease|1|||
126761543|NCT04145531|456079183|FG000|Part B|Withdrawal by parent or guardian|0|||
126761544|NCT04145531|456079184|FG001|Part B|Withdrawal by parent or guardian|0|||
126761545|NCT04145531|456079185|FG002|Part B|Withdrawal by parent or guardian|0|||
126761546|NCT04145531|456079186|FG003|Part B|Withdrawal by parent or guardian|3|||
126761547|NCT04145531|456079183|FG000|Part B|Withdrawal by participant|0|||
126761548|NCT04145531|456079184|FG001|Part B|Withdrawal by participant|0|||
126761549|NCT04145531|456079185|FG002|Part B|Withdrawal by participant|0|||
126761550|NCT04145531|456079186|FG003|Part B|Withdrawal by participant|1|||
126761551|NCT04145531|456079183|FG000|Part B|Other|0|||
126761552|NCT04145531|456079184|FG001|Part B|Other|0|||
126761553|NCT04145531|456079185|FG002|Part B|Other|0|||
126761554|NCT04145531|456079186|FG003|Part B|Other|1|||
126761555|NCT02985996|456079187|FG000|Overall Study|Withdrawal by Subject|0|||
126761556|NCT02985996|456079188|FG001|Overall Study|Withdrawal by Subject|0|||
126761557|NCT02985996|456079189|FG002|Overall Study|Withdrawal by Subject|1|||
126761558|NCT02985996|456079190|FG003|Overall Study|Withdrawal by Subject|0|||
126761559|NCT02985996|456079191|FG004|Overall Study|Withdrawal by Subject|0|||
126761560|NCT02985996|456079187|FG000|Overall Study|Protocol Violation|0|||
126761561|NCT02985996|456079188|FG001|Overall Study|Protocol Violation|1|||
126761562|NCT02985996|456079189|FG002|Overall Study|Protocol Violation|0|||
126761563|NCT02985996|456079190|FG003|Overall Study|Protocol Violation|0|||
126761564|NCT02985996|456079191|FG004|Overall Study|Protocol Violation|0|||
126761565|NCT00401726|456079192|FG000|Overall Study|Adverse Event|34|||
126761566|NCT00401726|456079193|FG001|Overall Study|Adverse Event|45|||
126761567|NCT00401726|456079192|FG000|Overall Study|Death|0|||
126761568|NCT00401726|456079193|FG001|Overall Study|Death|3|||
126761569|NCT00401726|456079192|FG000|Overall Study|Sponsor Request|0|||
126761570|NCT00401726|456079193|FG001|Overall Study|Sponsor Request|1|||
126761571|NCT00401726|456079192|FG000|Overall Study|Physician Decision|3|||
126761572|NCT00401726|456079193|FG001|Overall Study|Physician Decision|6|||
126761573|NCT00401726|456079192|FG000|Overall Study|Lost to Follow-up|23|||
126761574|NCT00401726|456079193|FG001|Overall Study|Lost to Follow-up|20|||
126761575|NCT00401726|456079192|FG000|Overall Study|Protocol Violation|6|||
126761576|NCT00401726|456079193|FG001|Overall Study|Protocol Violation|3|||
126357669|NCT03336866|454602200|FG000|Overall Study|Withdrawal by Subject|1|||
126357670|NCT03336866|454602201|FG001|Overall Study|Withdrawal by Subject|1|||
126695647|NCT00376961|455840602|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
126761577|NCT00401726|456079192|FG000|Overall Study|Withdrawal by Subject|18|||
126761578|NCT00401726|456079193|FG001|Overall Study|Withdrawal by Subject|24|||
126761579|NCT00401726|456079192|FG000|Overall Study|Lack of Efficacy|4|||
126761580|NCT00401726|456079193|FG001|Overall Study|Lack of Efficacy|6|||
126761581|NCT00401726|456079192|FG000|Overall Study|Protocol Deviation|9|||
126761582|NCT00401726|456079193|FG001|Overall Study|Protocol Deviation|4|||
126761583|NCT00442572|456079194|FG000|Overall Study|Relapse|8|||
126761584|NCT00442572|456079195|FG001|Overall Study|Relapse|1|||
126761585|NCT00442572|456079194|FG000|Overall Study|Lost to Follow-up|0|||
126761586|NCT00442572|456079195|FG001|Overall Study|Lost to Follow-up|1|||
126761587|NCT00442572|456079194|FG000|Overall Study|Withdrawal by Subject|0|||
126761588|NCT00442572|456079195|FG001|Overall Study|Withdrawal by Subject|1|||
126761589|NCT03732534|456079196|FG000|Overall Study|Study terminated by Sponsor|6|||
126761590|NCT03735849|456079200|FG000|Overall Study|Lost to Follow-up|1|||
126761591|NCT03735849|456079201|FG001|Overall Study|Lost to Follow-up|0|||
126247751|NCT00205777|454200344|FG005|Study Extension II|Lack of Efficacy|1|||
126247752|NCT00205777|454200339|FG000|Study Extension II|Failed to return|0|||
126247753|NCT00205777|454200340|FG001|Study Extension II|Failed to return|0|||
126247754|NCT00205777|454200341|FG002|Study Extension II|Failed to return|0|||
126247755|NCT00205777|454200342|FG003|Study Extension II|Failed to return|14|||
126247756|NCT00205777|454200343|FG004|Study Extension II|Failed to return|0|||
126247757|NCT00205777|454200344|FG005|Study Extension II|Failed to return|26|||
126247758|NCT00205777|454200339|FG000|Study Extension II|Other Event|0|||
126247759|NCT00205777|454200340|FG001|Study Extension II|Other Event|0|||
126357671|NCT03336866|454602202|FG002|Overall Study|Withdrawal by Subject|0|||
126357672|NCT03336866|454602200|FG000|Overall Study|Noncompliance with clinic house rules|0|||
126357673|NCT03336866|454602201|FG001|Overall Study|Noncompliance with clinic house rules|0|||
126357674|NCT03336866|454602202|FG002|Overall Study|Noncompliance with clinic house rules|1|||
126357675|NCT00541775|454602203|FG000|Overall Study|Adverse Event|3|||
126357676|NCT00541775|454602204|FG001|Overall Study|Adverse Event|2|||
126357677|NCT00541775|454602205|FG002|Overall Study|Adverse Event|1|||
126357678|NCT00541775|454602203|FG000|Overall Study|Lack of Efficacy|0|||
126357679|NCT00541775|454602204|FG001|Overall Study|Lack of Efficacy|0|||
126357680|NCT00541775|454602205|FG002|Overall Study|Lack of Efficacy|3|||
126357681|NCT00541775|454602203|FG000|Overall Study|Lost to Follow-up|0|||
126357682|NCT00541775|454602204|FG001|Overall Study|Lost to Follow-up|0|||
126357683|NCT00541775|454602205|FG002|Overall Study|Lost to Follow-up|2|||
126357684|NCT00541775|454602203|FG000|Overall Study|Protocol Violation|1|||
126357685|NCT00541775|454602204|FG001|Overall Study|Protocol Violation|0|||
126357686|NCT00541775|454602205|FG002|Overall Study|Protocol Violation|0|||
126357687|NCT00541775|454602203|FG000|Overall Study|Withdrawal by Subject and Other|5|||
126357688|NCT00541775|454602204|FG001|Overall Study|Withdrawal by Subject and Other|0|||
126357689|NCT00541775|454602205|FG002|Overall Study|Withdrawal by Subject and Other|2|||
126357690|NCT00032487|454602206|FG000|Overall Study|Withdrawal by Subject|67|||
126357691|NCT00032487|454602207|FG001|Overall Study|Withdrawal by Subject|43|||
126357692|NCT00032487|454602206|FG000|Overall Study|Adverse Event|3|||
126357693|NCT00032487|454602207|FG001|Overall Study|Adverse Event|7|||
126357694|NCT00032487|454602206|FG000|Overall Study|Lost to Follow-up|57|||
126357695|NCT00032487|454602207|FG001|Overall Study|Lost to Follow-up|58|||
126357696|NCT00032487|454602206|FG000|Overall Study|Had other reason|12|||
126357697|NCT00032487|454602207|FG001|Overall Study|Had other reason|12|||
126357698|NCT04518410|454602209|FG000|Overall Study|Lost to Follow-up|1|||
126357699|NCT04518410|454602210|FG001|Overall Study|Lost to Follow-up|1|||
126357700|NCT04518410|454602211|FG002|Overall Study|Lost to Follow-up|8|||
126357701|NCT04518410|454602212|FG003|Overall Study|Lost to Follow-up|5|||
126357702|NCT04518410|454602213|FG004|Overall Study|Lost to Follow-up|92|||
126357703|NCT04518410|454602214|FG005|Overall Study|Lost to Follow-up|25|||
126357704|NCT04518410|454602215|FG006|Overall Study|Lost to Follow-up|25|||
126357705|NCT04518410|454602216|FG007|Overall Study|Lost to Follow-up|3|||
126357706|NCT04518410|454602217|FG008|Overall Study|Lost to Follow-up|2|||
126357707|NCT04518410|454602218|FG009|Overall Study|Lost to Follow-up|13|||
126357708|NCT04518410|454602219|FG010|Overall Study|Lost to Follow-up|9|||
126357709|NCT04518410|454602220|FG011|Overall Study|Lost to Follow-up|13|||
126357710|NCT04518410|454602221|FG012|Overall Study|Lost to Follow-up|9|||
126357711|NCT04518410|454602222|FG013|Overall Study|Lost to Follow-up|13|||
126357712|NCT04518410|454602223|FG014|Overall Study|Lost to Follow-up|8|||
126357713|NCT04518410|454602224|FG015|Overall Study|Lost to Follow-up|10|||
126357714|NCT04518410|454602225|FG016|Overall Study|Lost to Follow-up|6|||
126357715|NCT04518410|454602226|FG017|Overall Study|Lost to Follow-up|13|||
126357716|NCT04518410|454602227|FG018|Overall Study|Lost to Follow-up|21|||
126357717|NCT04518410|454602228|FG019|Overall Study|Lost to Follow-up|6|||
126357718|NCT04518410|454602229|FG020|Overall Study|Lost to Follow-up|7|||
126357719|NCT04518410|454602230|FG021|Overall Study|Lost to Follow-up|21|||
126357720|NCT04518410|454602231|FG022|Overall Study|Lost to Follow-up|1|||
126357721|NCT04518410|454602232|FG023|Overall Study|Lost to Follow-up|7|||
126357722|NCT04518410|454602233|FG024|Overall Study|Lost to Follow-up|6|||
126357723|NCT04518410|454602209|FG000|Overall Study|Withdrawal by Subject|1|||
126357724|NCT04518410|454602210|FG001|Overall Study|Withdrawal by Subject|2|||
126357725|NCT04518410|454602211|FG002|Overall Study|Withdrawal by Subject|2|||
126357726|NCT04518410|454602212|FG003|Overall Study|Withdrawal by Subject|3|||
126357727|NCT04518410|454602213|FG004|Overall Study|Withdrawal by Subject|20|||
126357728|NCT04518410|454602214|FG005|Overall Study|Withdrawal by Subject|20|||
126357729|NCT04518410|454602215|FG006|Overall Study|Withdrawal by Subject|25|||
126357730|NCT04518410|454602216|FG007|Overall Study|Withdrawal by Subject|6|||
126357731|NCT04518410|454602217|FG008|Overall Study|Withdrawal by Subject|1|||
126357732|NCT04518410|454602218|FG009|Overall Study|Withdrawal by Subject|12|||
126357733|NCT04518410|454602219|FG010|Overall Study|Withdrawal by Subject|5|||
126357734|NCT04518410|454602220|FG011|Overall Study|Withdrawal by Subject|7|||
126357735|NCT04518410|454602221|FG012|Overall Study|Withdrawal by Subject|2|||
126357736|NCT04518410|454602222|FG013|Overall Study|Withdrawal by Subject|13|||
126357737|NCT04518410|454602223|FG014|Overall Study|Withdrawal by Subject|4|||
126357738|NCT04518410|454602224|FG015|Overall Study|Withdrawal by Subject|9|||
126761592|NCT03735849|456079202|FG002|Overall Study|Lost to Follow-up|0|||
126761593|NCT03735849|456079200|FG000|Overall Study|Participant unable to adhere to visit|1|||
126761594|NCT03735849|456079201|FG001|Overall Study|Participant unable to adhere to visit|0|||
126761595|NCT03735849|456079202|FG002|Overall Study|Participant unable to adhere to visit|0|||
126761596|NCT03735849|456079200|FG000|Overall Study|Not Randomized|0|||
126761597|NCT03735849|456079201|FG001|Overall Study|Not Randomized|0|||
126761598|NCT03735849|456079202|FG002|Overall Study|Not Randomized|4|||
126761599|NCT01050998|456079204|FG000|Overall Study|Adverse Event|1|||
126761600|NCT01050998|456079205|FG001|Overall Study|Adverse Event|0|||
126761601|NCT01050998|456079206|FG002|Overall Study|Adverse Event|1|||
126761602|NCT01050998|456079207|FG003|Overall Study|Adverse Event|0|||
126761603|NCT01050998|456079208|FG004|Overall Study|Adverse Event|2|||
126761604|NCT01050998|456079204|FG000|Overall Study|Withdrawal by Subject|0|||
126761605|NCT01050998|456079205|FG001|Overall Study|Withdrawal by Subject|0|||
126761606|NCT01050998|456079206|FG002|Overall Study|Withdrawal by Subject|0|||
126761607|NCT01050998|456079207|FG003|Overall Study|Withdrawal by Subject|1|||
126761608|NCT01050998|456079208|FG004|Overall Study|Withdrawal by Subject|3|||
126761609|NCT01050998|456079204|FG000|Overall Study|Other|3|||
126761610|NCT01050998|456079205|FG001|Overall Study|Other|2|||
126761611|NCT01050998|456079206|FG002|Overall Study|Other|1|||
126761612|NCT01050998|456079207|FG003|Overall Study|Other|1|||
126761613|NCT01050998|456079208|FG004|Overall Study|Other|5|||
126761614|NCT01050998|456079204|FG000|Overall Study|Data integrity issues|0|||
126761615|NCT01050998|456079205|FG001|Overall Study|Data integrity issues|0|||
126761616|NCT01050998|456079206|FG002|Overall Study|Data integrity issues|1|||
126761617|NCT01050998|456079207|FG003|Overall Study|Data integrity issues|1|||
126761618|NCT01050998|456079208|FG004|Overall Study|Data integrity issues|4|||
126761619|NCT04246593|456079215|FG000|Overall Study|Withdrawal by Subject|14|||
126761620|NCT04246593|456079216|FG001|Overall Study|Withdrawal by Subject|13|||
126761621|NCT04246593|456079215|FG000|Overall Study|Lost to Follow-up|124|||
126761622|NCT04246593|456079216|FG001|Overall Study|Lost to Follow-up|71|||
126761623|NCT04246593|456079215|FG000|Overall Study|Moved out of area/became ineligible|3|||
126761624|NCT04246593|456079216|FG001|Overall Study|Moved out of area/became ineligible|1|||
126761625|NCT04246593|456079215|FG000|Overall Study|Reason unknown|4|||
126761626|NCT04246593|456079216|FG001|Overall Study|Reason unknown|2|||
126761627|NCT02369874|456079218|FG000|Overall Study|Lost to Follow-up|2|||
126761628|NCT02369874|456079219|FG001|Overall Study|Lost to Follow-up|2|||
126761629|NCT02369874|456079220|FG002|Overall Study|Lost to Follow-up|2|||
126761630|NCT02369874|456079218|FG000|Overall Study|Withdrawal by Subject|7|||
126761631|NCT02369874|456079219|FG001|Overall Study|Withdrawal by Subject|9|||
126761632|NCT02369874|456079220|FG002|Overall Study|Withdrawal by Subject|27|||
126761633|NCT02369874|456079218|FG000|Overall Study|Miscellaneous|1|||
126761634|NCT02369874|456079219|FG001|Overall Study|Miscellaneous|1|||
126761635|NCT02369874|456079220|FG002|Overall Study|Miscellaneous|0|||
126761636|NCT02369874|456079218|FG000|Overall Study|On Treatment/Off Study|34|||
126761637|NCT02369874|456079219|FG001|Overall Study|On Treatment/Off Study|45|||
126761638|NCT02369874|456079220|FG002|Overall Study|On Treatment/Off Study|32|||
126761639|NCT02058849|456079223|FG000|Overall Study|Hospitalization|1|||
126761640|NCT02058849|456079224|FG001|Overall Study|Hospitalization|1|||
126761641|NCT02058849|456079223|FG000|Overall Study|Death|1|||
126761642|NCT02058849|456079224|FG001|Overall Study|Death|0|||
126761643|NCT02058849|456079223|FG000|Overall Study|Lost to Follow-up|1|||
126761644|NCT02058849|456079224|FG001|Overall Study|Lost to Follow-up|0|||
126761645|NCT02058849|456079223|FG000|Overall Study|Withdrawal by Subject|4|||
126761646|NCT02058849|456079224|FG001|Overall Study|Withdrawal by Subject|0|||
126247760|NCT00205777|454200341|FG002|Study Extension II|Other Event|0|||
126247761|NCT00205777|454200342|FG003|Study Extension II|Other Event|12|||
126247762|NCT00205777|454200343|FG004|Study Extension II|Other Event|0|||
126247763|NCT00205777|454200344|FG005|Study Extension II|Other Event|20|||
126247764|NCT00205777|454200339|FG000|Study Extension II|Enrolled but not treated|0|||
126247765|NCT00205777|454200340|FG001|Study Extension II|Enrolled but not treated|0|||
126247766|NCT00205777|454200341|FG002|Study Extension II|Enrolled but not treated|0|||
126247767|NCT00205777|454200342|FG003|Study Extension II|Enrolled but not treated|71|||
126761647|NCT01012765|456079225|FG000|Treatment Period 1|Adverse Event|1|||
126761648|NCT01012765|456079226|FG001|Treatment Period 1|Adverse Event|0|||
126761649|NCT01012765|456079227|FG002|Treatment Period 1|Adverse Event|1|||
126247768|NCT00205777|454200343|FG004|Study Extension II|Enrolled but not treated|0|||
126761650|NCT01012765|456079228|FG003|Treatment Period 1|Adverse Event|0|||
126247769|NCT00205777|454200344|FG005|Study Extension II|Enrolled but not treated|131|||
126247770|NCT00367133|454200347|FG000|2 Years|Death|20|||
126761651|NCT01012765|456079229|FG004|Treatment Period 1|Adverse Event|0|||
126761652|NCT01012765|456079230|FG005|Treatment Period 1|Adverse Event|0|||
126761653|NCT01012765|456079225|FG000|Treatment Period 1|Withdrawal by Subject|2|||
126761654|NCT01012765|456079226|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126761655|NCT01012765|456079227|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126761656|NCT01012765|456079228|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126761657|NCT01012765|456079229|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126761658|NCT01012765|456079230|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126247771|NCT00367133|454200348|FG001|2 Years|Death|12|||
126247772|NCT00367133|454200349|FG002|2 Years|Death|12|||
126247773|NCT00367133|454200347|FG000|2 Years|Dropped|34|||
126247774|NCT00367133|454200348|FG001|2 Years|Dropped|19|||
126247775|NCT00367133|454200349|FG002|2 Years|Dropped|33|||
126247776|NCT00367133|454200347|FG000|2 Years|Missed visit|4|||
126247777|NCT00367133|454200348|FG001|2 Years|Missed visit|5|||
126247778|NCT00367133|454200349|FG002|2 Years|Missed visit|4|||
126247779|NCT00906399|454200351|FG000|Year 1|Randomized But Not Treated|0|||
126247780|NCT00906399|454200352|FG001|Year 1|Randomized But Not Treated|1|||
126247781|NCT00906399|454200353|FG002|Year 1|Randomized But Not Treated|3|||
126247782|NCT00906399|454200354|FG003|Year 1|Randomized But Not Treated|0|||
126247783|NCT00906399|454200355|FG004|Year 1|Randomized But Not Treated|0|||
126247784|NCT00906399|454200356|FG005|Year 1|Randomized But Not Treated|0|||
126247785|NCT00906399|454200357|FG006|Year 1|Randomized But Not Treated|0|||
126247786|NCT00906399|454200351|FG000|Year 1|Adverse Event|4|||
126247787|NCT00906399|454200352|FG001|Year 1|Adverse Event|22|||
126247788|NCT00906399|454200353|FG002|Year 1|Adverse Event|24|||
126247789|NCT00906399|454200354|FG003|Year 1|Adverse Event|0|||
126247790|NCT00906399|454200355|FG004|Year 1|Adverse Event|0|||
126247791|NCT00906399|454200356|FG005|Year 1|Adverse Event|0|||
126247792|NCT00906399|454200357|FG006|Year 1|Adverse Event|0|||
126247793|NCT00906399|454200351|FG000|Year 1|Lost to Follow-up|4|||
126247794|NCT00906399|454200352|FG001|Year 1|Lost to Follow-up|4|||
126247795|NCT00906399|454200353|FG002|Year 1|Lost to Follow-up|2|||
126247796|NCT00906399|454200354|FG003|Year 1|Lost to Follow-up|0|||
126247797|NCT00906399|454200355|FG004|Year 1|Lost to Follow-up|0|||
126247798|NCT00906399|454200356|FG005|Year 1|Lost to Follow-up|0|||
126247799|NCT00906399|454200357|FG006|Year 1|Lost to Follow-up|0|||
126247800|NCT00906399|454200351|FG000|Year 1|Withdrawal by Subject|30|||
126247801|NCT00906399|454200352|FG001|Year 1|Withdrawal by Subject|32|||
126247802|NCT00906399|454200353|FG002|Year 1|Withdrawal by Subject|36|||
126247803|NCT00906399|454200354|FG003|Year 1|Withdrawal by Subject|0|||
126247804|NCT00906399|454200355|FG004|Year 1|Withdrawal by Subject|0|||
126247805|NCT00906399|454200356|FG005|Year 1|Withdrawal by Subject|0|||
126448139|NCT00975689|454941338|FG001|Overall Study|Physician Decision|0|||
126448140|NCT04335136|454941339|FG000|Overall Study|Death|8|||
126247806|NCT00906399|454200357|FG006|Year 1|Withdrawal by Subject|0|||
126247807|NCT00906399|454200351|FG000|Year 1|Physician Decision|0|||
126247808|NCT00906399|454200352|FG001|Year 1|Physician Decision|1|||
126247809|NCT00906399|454200353|FG002|Year 1|Physician Decision|3|||
126695648|NCT00376961|455840601|FG000|Initial Registration|Progression/relapse|1|||
126695649|NCT00376961|455840602|FG001|Initial Registration|Progression/relapse|0|||
126247810|NCT00906399|454200354|FG003|Year 1|Physician Decision|0|||
126247811|NCT00906399|454200355|FG004|Year 1|Physician Decision|0|||
126247812|NCT00906399|454200356|FG005|Year 1|Physician Decision|0|||
126247813|NCT00906399|454200357|FG006|Year 1|Physician Decision|0|||
126247814|NCT00906399|454200351|FG000|Year 1|Death|2|||
126247815|NCT00906399|454200352|FG001|Year 1|Death|1|||
126247816|NCT00906399|454200353|FG002|Year 1|Death|1|||
126247817|NCT00906399|454200354|FG003|Year 1|Death|0|||
126247818|NCT00906399|454200355|FG004|Year 1|Death|0|||
126247819|NCT00906399|454200356|FG005|Year 1|Death|0|||
126247820|NCT00906399|454200357|FG006|Year 1|Death|0|||
126247821|NCT00906399|454200351|FG000|Year 1|Other|4|||
126247822|NCT00906399|454200352|FG001|Year 1|Other|2|||
126247823|NCT00906399|454200353|FG002|Year 1|Other|7|||
126247824|NCT00906399|454200354|FG003|Year 1|Other|0|||
126247825|NCT00906399|454200355|FG004|Year 1|Other|0|||
126247826|NCT00906399|454200356|FG005|Year 1|Other|0|||
126448141|NCT04335136|454941340|FG001|Overall Study|Death|4|||
126247827|NCT00906399|454200357|FG006|Year 1|Other|0|||
126247828|NCT00906399|454200351|FG000|Year 2|Adverse Event|0|||
126247829|NCT00906399|454200352|FG001|Year 2|Adverse Event|0|||
126247830|NCT00906399|454200353|FG002|Year 2|Adverse Event|0|||
126695650|NCT00376961|455840601|FG000|Initial Registration|Ineligible|3|||
126695651|NCT00376961|455840602|FG001|Initial Registration|Ineligible|0|||
126247831|NCT00906399|454200354|FG003|Year 2|Adverse Event|9|||
126247832|NCT00906399|454200355|FG004|Year 2|Adverse Event|8|||
126247833|NCT00906399|454200356|FG005|Year 2|Adverse Event|11|||
126247834|NCT00906399|454200357|FG006|Year 2|Adverse Event|6|||
126247835|NCT00906399|454200351|FG000|Year 2|Lost to Follow-up|0|||
126247836|NCT00906399|454200352|FG001|Year 2|Lost to Follow-up|0|||
126247837|NCT00906399|454200353|FG002|Year 2|Lost to Follow-up|0|||
126247838|NCT00906399|454200354|FG003|Year 2|Lost to Follow-up|1|||
126247839|NCT00906399|454200355|FG004|Year 2|Lost to Follow-up|4|||
126247840|NCT00906399|454200356|FG005|Year 2|Lost to Follow-up|2|||
126247841|NCT00906399|454200357|FG006|Year 2|Lost to Follow-up|4|||
126247842|NCT00906399|454200351|FG000|Year 2|Withdrawal by Subject|0|||
126247843|NCT00906399|454200352|FG001|Year 2|Withdrawal by Subject|0|||
126247844|NCT00906399|454200353|FG002|Year 2|Withdrawal by Subject|0|||
126247845|NCT00906399|454200354|FG003|Year 2|Withdrawal by Subject|17|||
126247846|NCT00906399|454200355|FG004|Year 2|Withdrawal by Subject|18|||
126247847|NCT00906399|454200356|FG005|Year 2|Withdrawal by Subject|27|||
126247848|NCT00906399|454200357|FG006|Year 2|Withdrawal by Subject|13|||
126247849|NCT00906399|454200351|FG000|Year 2|Physician Decision|0|||
126448142|NCT04335136|454941339|FG000|Overall Study|Lost to Follow-up|2|||
126247850|NCT00906399|454200352|FG001|Year 2|Physician Decision|0|||
126247851|NCT00906399|454200353|FG002|Year 2|Physician Decision|0|||
126247852|NCT00906399|454200354|FG003|Year 2|Physician Decision|0|||
126247853|NCT00906399|454200355|FG004|Year 2|Physician Decision|2|||
126247854|NCT00906399|454200356|FG005|Year 2|Physician Decision|6|||
126247855|NCT00906399|454200357|FG006|Year 2|Physician Decision|3|||
126247856|NCT00906399|454200351|FG000|Year 2|Death|0|||
126247857|NCT00906399|454200352|FG001|Year 2|Death|0|||
126247858|NCT00906399|454200353|FG002|Year 2|Death|0|||
126247859|NCT00906399|454200354|FG003|Year 2|Death|1|||
126695652|NCT00376961|455840601|FG000|Maintenance|Adverse Event|0|||
126695653|NCT00376961|455840602|FG001|Maintenance|Adverse Event|1|||
126695654|NCT00376961|455840601|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
126695655|NCT00376961|455840602|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
126695656|NCT00376961|455840601|FG000|Maintenance|Progression/relapse|0|||
126695657|NCT00376961|455840602|FG001|Maintenance|Progression/relapse|18|||
126695658|NCT00376961|455840601|FG000|Maintenance|Ineligible|0|||
126695659|NCT00376961|455840602|FG001|Maintenance|Ineligible|3|||
126695660|NCT01059448|455840604|FG000|Overall Study|Adverse Event|1|||
126695661|NCT01059448|455840605|FG001|Overall Study|Adverse Event|3|||
126695662|NCT01059448|455840606|FG002|Overall Study|Adverse Event|0|||
126695663|NCT01059448|455840607|FG003|Overall Study|Adverse Event|1|||
126695664|NCT01059448|455840604|FG000|Overall Study|Withdrawal by Subject|2|||
126695665|NCT01059448|455840605|FG001|Overall Study|Withdrawal by Subject|0|||
126695666|NCT01059448|455840606|FG002|Overall Study|Withdrawal by Subject|2|||
126695667|NCT01059448|455840607|FG003|Overall Study|Withdrawal by Subject|4|||
126695668|NCT01059448|455840604|FG000|Overall Study|Disease Progression|2|||
126695669|NCT01059448|455840605|FG001|Overall Study|Disease Progression|1|||
126695670|NCT01059448|455840606|FG002|Overall Study|Disease Progression|4|||
126695671|NCT01059448|455840607|FG003|Overall Study|Disease Progression|2|||
126695672|NCT01059448|455840604|FG000|Overall Study|Administrative Decision|43|||
126695673|NCT01059448|455840605|FG001|Overall Study|Administrative Decision|49|||
126695674|NCT01059448|455840606|FG002|Overall Study|Administrative Decision|45|||
126695675|NCT01059448|455840607|FG003|Overall Study|Administrative Decision|46|||
126695676|NCT01059448|455840604|FG000|Overall Study|Lost to Follow-up|0|||
126695677|NCT01059448|455840605|FG001|Overall Study|Lost to Follow-up|0|||
126695678|NCT01059448|455840606|FG002|Overall Study|Lost to Follow-up|2|||
126695679|NCT01059448|455840607|FG003|Overall Study|Lost to Follow-up|0|||
126695680|NCT01059448|455840604|FG000|Overall Study|Death|0|||
126695681|NCT01059448|455840605|FG001|Overall Study|Death|1|||
126695682|NCT01059448|455840606|FG002|Overall Study|Death|0|||
126695683|NCT01059448|455840607|FG003|Overall Study|Death|0|||
126695684|NCT01059448|455840604|FG000|Overall Study|Other|1|||
126695685|NCT01059448|455840605|FG001|Overall Study|Other|1|||
126695686|NCT01059448|455840606|FG002|Overall Study|Other|0|||
126695687|NCT01059448|455840607|FG003|Overall Study|Other|1|||
126695688|NCT02591615|455840608|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
126695689|NCT02591615|455840609|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
126695690|NCT02591615|455840610|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
126695691|NCT02591615|455840611|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
126695692|NCT02591615|455840608|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
126695693|NCT02591615|455840609|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
126695694|NCT02591615|455840610|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
126695695|NCT02591615|455840611|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
126695696|NCT02591615|455840608|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
126695697|NCT02591615|455840609|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
126695698|NCT02591615|455840610|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
126695699|NCT02591615|455840611|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
126695700|NCT02591615|455840608|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
126695701|NCT02591615|455840609|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
126695702|NCT02591615|455840610|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
126695703|NCT02591615|455840611|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
126695704|NCT02591615|455840608|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
126695705|NCT02591615|455840609|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
126247860|NCT00906399|454200355|FG004|Year 2|Death|0|||
126695706|NCT02591615|455840610|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
126695707|NCT02591615|455840611|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
126695708|NCT02591615|455840608|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
126695709|NCT02591615|455840609|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
126695710|NCT02591615|455840610|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
126695711|NCT02591615|455840611|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
126695712|NCT02591615|455840608|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
126695713|NCT02591615|455840609|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
126247861|NCT00906399|454200356|FG005|Year 2|Death|0|||
126247862|NCT00906399|454200357|FG006|Year 2|Death|3|||
126247863|NCT00906399|454200351|FG000|Year 2|Other|0|||
126247864|NCT00906399|454200352|FG001|Year 2|Other|0|||
126695714|NCT02591615|455840610|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
126695715|NCT02591615|455840611|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
126695716|NCT02591615|455840608|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
126695717|NCT02591615|455840609|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
126695718|NCT02591615|455840610|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
126695719|NCT02591615|455840611|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
126695720|NCT02591615|455840608|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
126695721|NCT02591615|455840609|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
126695722|NCT02591615|455840610|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
126695723|NCT02591615|455840611|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
126695724|NCT02591615|455840608|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
126695725|NCT02591615|455840609|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
126695726|NCT02591615|455840610|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
126695727|NCT02591615|455840611|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
126695728|NCT02591615|455840608|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
126695729|NCT02591615|455840609|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
126695730|NCT02591615|455840610|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
126695731|NCT02591615|455840611|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
126695732|NCT02591615|455840608|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
126695733|NCT02591615|455840609|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
126695734|NCT02591615|455840610|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
126695735|NCT02591615|455840611|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
126695736|NCT02591615|455840608|FG000|Maintenance MK-3475|Adverse Event|0|||
126695737|NCT02591615|455840609|FG001|Maintenance MK-3475|Adverse Event|3|||
126695738|NCT02591615|455840610|FG002|Maintenance MK-3475|Adverse Event|1|||
126695739|NCT02591615|455840611|FG003|Maintenance MK-3475|Adverse Event|2|||
126695740|NCT02591615|455840608|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
126695741|NCT02591615|455840609|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
126695742|NCT02591615|455840610|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
126695743|NCT02591615|455840611|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
126695744|NCT02591615|455840608|FG000|Maintenance MK-3475|Death|0|||
126695745|NCT02591615|455840609|FG001|Maintenance MK-3475|Death|1|||
126695746|NCT02591615|455840610|FG002|Maintenance MK-3475|Death|1|||
126695747|NCT02591615|455840611|FG003|Maintenance MK-3475|Death|0|||
126695748|NCT02591615|455840608|FG000|Maintenance MK-3475|Physician discretion|0|||
126695749|NCT02591615|455840609|FG001|Maintenance MK-3475|Physician discretion|0|||
126695750|NCT02591615|455840610|FG002|Maintenance MK-3475|Physician discretion|1|||
126695751|NCT02591615|455840611|FG003|Maintenance MK-3475|Physician discretion|0|||
126695752|NCT02591615|455840608|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
126695753|NCT02591615|455840609|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
126695754|NCT02591615|455840610|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
126695755|NCT02591615|455840611|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
126695756|NCT02591615|455840608|FG000|Maintenance MK-3475|In active treatment|2|||
126695757|NCT02591615|455840609|FG001|Maintenance MK-3475|In active treatment|0|||
126695758|NCT02591615|455840610|FG002|Maintenance MK-3475|In active treatment|0|||
126695759|NCT02591615|455840611|FG003|Maintenance MK-3475|In active treatment|1|||
126695760|NCT04188197|455840612|FG000|Overall Study|Lost to Follow-up|4|||
126695761|NCT04188197|455840613|FG001|Overall Study|Lost to Follow-up|1|||
126695762|NCT04188197|455840612|FG000|Overall Study|Withdrawal by Subject|1|||
126695763|NCT04188197|455840613|FG001|Overall Study|Withdrawal by Subject|1|||
126695764|NCT04188197|455840612|FG000|Overall Study|Pregnancy|0|||
126695765|NCT04188197|455840613|FG001|Overall Study|Pregnancy|1|||
126695766|NCT02107703|455840614|FG000|Overall Study|Withdrawal by Subject|46|||
126695767|NCT02107703|455840615|FG001|Overall Study|Withdrawal by Subject|21|||
126695768|NCT02107703|455840614|FG000|Overall Study|Lost to Follow-up|20|||
126695769|NCT02107703|455840615|FG001|Overall Study|Lost to Follow-up|9|||
126695770|NCT02107703|455840614|FG000|Overall Study|On study treatment/follow up|48|||
126695771|NCT02107703|455840615|FG001|Overall Study|On study treatment/follow up|5|||
126695772|NCT00809328|455840618|FG000|Overall Study|Lack of Efficacy|18|||
126695773|NCT00809328|455840618|FG000|Overall Study|Adverse Event|6|||
126761659|NCT01012765|456079225|FG000|Treatment Period 1|Administrative problems|0|||
126448143|NCT04335136|454941340|FG001|Overall Study|Lost to Follow-up|0|||
126448144|NCT04335136|454941339|FG000|Overall Study|Protocol Violation|1|||
126448145|NCT04335136|454941340|FG001|Overall Study|Protocol Violation|0|||
126448146|NCT04335136|454941339|FG000|Overall Study|Withdrawal by Subject|1|||
126448147|NCT04335136|454941340|FG001|Overall Study|Withdrawal by Subject|1|||
126448148|NCT04335136|454941339|FG000|Overall Study|Health-threatening condition|0|||
126448149|NCT04335136|454941340|FG001|Overall Study|Health-threatening condition|1|||
126448150|NCT04335136|454941339|FG000|Overall Study|Adverse Event|0|||
126448151|NCT04335136|454941340|FG001|Overall Study|Adverse Event|1|||
126448152|NCT04335136|454941339|FG000|Overall Study|Erroneously randomized|2|||
126448153|NCT04335136|454941340|FG001|Overall Study|Erroneously randomized|0|||
126448154|NCT01305577|454941342|FG000|Overall Study|Adverse Event|2|||
126448155|NCT01305577|454941343|FG001|Overall Study|Adverse Event|2|||
126247865|NCT00906399|454200353|FG002|Year 2|Other|0|||
126247866|NCT00906399|454200354|FG003|Year 2|Other|2|||
126247867|NCT00906399|454200355|FG004|Year 2|Other|3|||
126247868|NCT00906399|454200356|FG005|Year 2|Other|1|||
126448156|NCT01305577|454941344|FG002|Overall Study|Adverse Event|1|||
126448157|NCT01305577|454941342|FG000|Overall Study|Withdrawal by Subject|7|||
126448158|NCT01305577|454941343|FG001|Overall Study|Withdrawal by Subject|5|||
126448159|NCT01305577|454941344|FG002|Overall Study|Withdrawal by Subject|6|||
126448160|NCT01305577|454941342|FG000|Overall Study|Lost to Follow-up|4|||
126448161|NCT01305577|454941343|FG001|Overall Study|Lost to Follow-up|3|||
126448162|NCT01305577|454941344|FG002|Overall Study|Lost to Follow-up|2|||
126448163|NCT01305577|454941342|FG000|Overall Study|Protocol Deviation|0|||
126448164|NCT01305577|454941343|FG001|Overall Study|Protocol Deviation|1|||
126448165|NCT01305577|454941344|FG002|Overall Study|Protocol Deviation|1|||
126448166|NCT00905645|454941345|FG000|Overall Study|Death (not device related)|10|||
126448167|NCT00905645|454941346|FG001|Overall Study|Death (not device related)|4|||
126448168|NCT00905645|454941347|FG002|Overall Study|Death (not device related)|15|||
126448169|NCT00905645|454941348|FG003|Overall Study|Death (not device related)|8|||
126448170|NCT00905645|454941345|FG000|Overall Study|Explantation of study device(s)|78|||
126448171|NCT00905645|454941346|FG001|Overall Study|Explantation of study device(s)|47|||
126448172|NCT00905645|454941347|FG002|Overall Study|Explantation of study device(s)|28|||
126448173|NCT00905645|454941348|FG003|Overall Study|Explantation of study device(s)|21|||
126448174|NCT00905645|454941345|FG000|Overall Study|Subject Request|41|||
126448175|NCT00905645|454941346|FG001|Overall Study|Subject Request|17|||
126448176|NCT00905645|454941347|FG002|Overall Study|Subject Request|13|||
126448177|NCT00905645|454941348|FG003|Overall Study|Subject Request|11|||
126448178|NCT00905645|454941345|FG000|Overall Study|Lost to Follow-up|299|||
126448179|NCT00905645|454941346|FG001|Overall Study|Lost to Follow-up|103|||
126448180|NCT00905645|454941347|FG002|Overall Study|Lost to Follow-up|51|||
126448181|NCT00905645|454941348|FG003|Overall Study|Lost to Follow-up|12|||
126448182|NCT01731938|454941349|FG000|Preliminary Part I|Withdrawal by Subject|2|||
126448183|NCT01731938|454941350|FG001|Preliminary Part I|Withdrawal by Subject|2|||
126448184|NCT01731938|454941349|FG000|Preliminary Part I|Physician Decision|1|||
126448185|NCT01731938|454941350|FG001|Preliminary Part I|Physician Decision|0|||
126448186|NCT01731938|454941349|FG000|Preliminary Part I|Lost to Follow-up|0|||
126448187|NCT01731938|454941350|FG001|Preliminary Part I|Lost to Follow-up|3|||
126448188|NCT01731938|454941349|FG000|Preliminary Part I|Missed Week 6 visit|0|||
126448189|NCT01731938|454941350|FG001|Preliminary Part I|Missed Week 6 visit|3|||
126448190|NCT01731938|454941349|FG000|Primary Part II|Withdrawal by Subject|5|||
126448191|NCT01731938|454941350|FG001|Primary Part II|Withdrawal by Subject|4|||
126448192|NCT01731938|454941349|FG000|Primary Part II|Lost to Follow-up|4|||
126448193|NCT01731938|454941350|FG001|Primary Part II|Lost to Follow-up|5|||
126448194|NCT01731938|454941349|FG000|Primary Part II|Death|2|||
126448195|NCT01731938|454941350|FG001|Primary Part II|Death|1|||
126448196|NCT01731938|454941349|FG000|Primary Part II|Missed Week 6 visit|2|||
126448197|NCT01731938|454941350|FG001|Primary Part II|Missed Week 6 visit|3|||
126448198|NCT04931888|454941351|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
126448199|NCT04931888|454941352|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
126448200|NCT04931888|454941353|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
126448201|NCT04931888|454941354|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
126448202|NCT04538144|454941355|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
126448203|NCT04538144|454941356|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
126448204|NCT04538144|454941357|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
126448205|NCT04538144|454941358|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
126448206|NCT02722304|454941361|FG000|Overall Study|Study Terminated by Sponsor|1|||
126448207|NCT02722304|454941362|FG001|Overall Study|Study Terminated by Sponsor|0|||
126448208|NCT02722304|454941363|FG002|Overall Study|Study Terminated by Sponsor|2|||
126448209|NCT02722304|454941364|FG003|Overall Study|Study Terminated by Sponsor|1|||
126247869|NCT00906399|454200357|FG006|Year 2|Other|0|||
126247870|NCT00858780|454200365|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
126247871|NCT00858780|454200366|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
126448210|NCT02722304|454941365|FG004|Overall Study|Study Terminated by Sponsor|1|||
126448211|NCT02722304|454941361|FG000|Overall Study|Other|0|||
126448212|NCT02722304|454941362|FG001|Overall Study|Other|0|||
126448213|NCT02722304|454941363|FG002|Overall Study|Other|0|||
126448214|NCT02722304|454941364|FG003|Overall Study|Other|1|||
126448215|NCT02722304|454941365|FG004|Overall Study|Other|1|||
126448216|NCT02644109|454941366|FG000|Overall Study|Adverse Event|0|||
126448217|NCT02644109|454941367|FG001|Overall Study|Adverse Event|4|||
126448218|NCT00104520|454941370|FG000|Overall Study|Unrelated adverse event|34|||
126448219|NCT00104520|454941371|FG001|Overall Study|Unrelated adverse event|47|||
126448220|NCT00104520|454941370|FG000|Overall Study|Study drug intolerance|0|||
126448221|NCT00104520|454941371|FG001|Overall Study|Study drug intolerance|1|||
126448222|NCT00104520|454941370|FG000|Overall Study|Related adverse event|13|||
126448223|NCT00104520|454941371|FG001|Overall Study|Related adverse event|15|||
126448224|NCT00104520|454941370|FG000|Overall Study|Lost to Follow-up|1|||
126448225|NCT00104520|454941371|FG001|Overall Study|Lost to Follow-up|0|||
126695774|NCT00809328|455840618|FG000|Overall Study|Protocol Violation|3|||
126695775|NCT00809328|455840618|FG000|Overall Study|Withdrawal by Subject|2|||
126695776|NCT02911688|455840619|FG000|Washout|Lost to Follow-up|1|||
126695777|NCT02911688|455840620|FG001|Washout|Lost to Follow-up|1|||
126695778|NCT02911688|455840619|FG000|Washout|Withdrawal by Subject|0|||
126695779|NCT02911688|455840620|FG001|Washout|Withdrawal by Subject|1|||
126695780|NCT04574999|455840625|FG000|Overall Study|Adverse Event|1|||
126695781|NCT04574999|455840626|FG001|Overall Study|Adverse Event|0|||
126695782|NCT04574999|455840625|FG000|Overall Study|Lack of Efficacy|2|||
126695783|NCT04574999|455840626|FG001|Overall Study|Lack of Efficacy|3|||
126695784|NCT04574999|455840625|FG000|Overall Study|Protocol Violation|1|||
126695785|NCT04574999|455840626|FG001|Overall Study|Protocol Violation|0|||
126695786|NCT04574999|455840625|FG000|Overall Study|Withdrawal by Subject|2|||
126695787|NCT04574999|455840626|FG001|Overall Study|Withdrawal by Subject|2|||
126695788|NCT04574999|455840625|FG000|Overall Study|Lost to Follow-up|1|||
126695789|NCT04574999|455840626|FG001|Overall Study|Lost to Follow-up|0|||
126695790|NCT04574999|455840625|FG000|Overall Study|Personal problems|1|||
126695791|NCT04574999|455840626|FG001|Overall Study|Personal problems|0|||
126247872|NCT00858780|454200367|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
126247873|NCT00858780|454200368|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
126247874|NCT00858780|454200369|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
126247875|NCT00858780|454200365|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
126247876|NCT00858780|454200366|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
126247877|NCT00858780|454200367|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
126247878|NCT00858780|454200368|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
126247879|NCT00858780|454200369|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
126247880|NCT00858780|454200365|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
126247881|NCT00858780|454200366|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
126247882|NCT00858780|454200367|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
126247883|NCT00858780|454200368|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
126247884|NCT00858780|454200369|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
126247885|NCT00858780|454200365|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
126247886|NCT00858780|454200366|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
126247887|NCT00858780|454200367|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
126247888|NCT00858780|454200368|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
126247889|NCT00858780|454200369|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
126247890|NCT00858780|454200365|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
126247891|NCT00858780|454200366|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
126247892|NCT00858780|454200367|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
126247893|NCT00858780|454200368|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
126247894|NCT00858780|454200369|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
126247895|NCT00858780|454200365|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
126247896|NCT00858780|454200366|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
126247897|NCT00858780|454200367|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
126247898|NCT00858780|454200368|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
126247899|NCT00858780|454200369|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
126247900|NCT00863330|454200370|FG000|Overall Study|study terminated early due to administra|6|||
126247901|NCT02615249|454200371|FG000|Overall Study|Withdrawal by Subject|1|||
126247902|NCT00574847|454200372|FG000|Overall Study|Adverse Event|2|||
126247903|NCT00574847|454200373|FG001|Overall Study|Adverse Event|0|||
126247904|NCT00574847|454200372|FG000|Overall Study|Death|1|||
126247905|NCT00574847|454200373|FG001|Overall Study|Death|0|||
126247906|NCT00574847|454200372|FG000|Overall Study|Withdrawal by Subject|2|||
126247907|NCT00574847|454200373|FG001|Overall Study|Withdrawal by Subject|2|||
126247908|NCT00574847|454200372|FG000|Overall Study|Physician Decision|1|||
126695792|NCT04574999|455840625|FG000|Overall Study|Previous planned surgery|1|||
126695793|NCT04574999|455840626|FG001|Overall Study|Previous planned surgery|0|||
126695794|NCT00398112|455840630|FG000|Overall Study|Adverse Event|4|||
126695795|NCT00398112|455840630|FG000|Overall Study|Disease progression|9|||
126695796|NCT00398112|455840630|FG000|Overall Study|Alternative treatment|1|||
126695797|NCT00398112|455840630|FG000|Overall Study|Withdrawal by Subject|3|||
126695798|NCT00398112|455840630|FG000|Overall Study|Death|1|||
126695799|NCT05148884|455840631|FG000|Overall Study|Withdrawal by Subject|3|||
126695800|NCT05148884|455840632|FG001|Overall Study|Withdrawal by Subject|0|||
126695801|NCT05148884|455840631|FG000|Overall Study|Deep brain stimulation operation|0|||
126695802|NCT05148884|455840632|FG001|Overall Study|Deep brain stimulation operation|1|||
126695803|NCT01993888|455840635|FG000|Overall Study|Death|1|||
126695804|NCT01993888|455840636|FG001|Overall Study|Death|1|||
126247909|NCT00574847|454200373|FG001|Overall Study|Physician Decision|0|||
126695805|NCT01993888|455840635|FG000|Overall Study|Lost to Follow-up|1|||
126695806|NCT01993888|455840636|FG001|Overall Study|Lost to Follow-up|1|||
126695807|NCT01993888|455840635|FG000|Overall Study|Withdrawal by Subject|0|||
126695808|NCT01993888|455840636|FG001|Overall Study|Withdrawal by Subject|1|||
126546082|NCT00265330|455292556|FG000|Overall Study|Lack of Efficacy|4|||
126546083|NCT00265330|455292556|FG000|Overall Study|Family Scheduling Conflicts|1|||
126546084|NCT00265330|455292556|FG000|Overall Study|Began Taking Formulary Geodon|1|||
126546085|NCT00265330|455292556|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
126546086|NCT00265330|455292556|FG000|Overall Study|Site Closed by Sponsor|1|||
126546087|NCT00265330|455292556|FG000|Overall Study|Principal Investigators Request|1|||
126546088|NCT00265330|455292556|FG000|Overall Study|Withdrew Consent|1|||
126546089|NCT00265330|455292556|FG000|Overall Study|Protocol Violation|1|||
126546090|NCT03108157|455292557|FG000|Overall Study|Protocol Violation|15|||
126546091|NCT03108157|455292558|FG001|Overall Study|Protocol Violation|4|||
126546092|NCT05067933|455292572|FG000|Overall Study|Withdrawal by Subject|2|||
126546093|NCT05067933|455292573|FG001|Overall Study|Withdrawal by Subject|0|||
126546094|NCT05067933|455292574|FG002|Overall Study|Withdrawal by Subject|0|||
126546095|NCT05067933|455292575|FG003|Overall Study|Withdrawal by Subject|0|||
126695809|NCT00832819|455840638|FG000|Overall Study|Adverse Event|0|||
126695810|NCT00832819|455840639|FG001|Overall Study|Adverse Event|1|||
126695811|NCT00832819|455840640|FG002|Overall Study|Adverse Event|0|||
126695812|NCT00832819|455840638|FG000|Overall Study|Protocol Violation|0|||
126695813|NCT00832819|455840639|FG001|Overall Study|Protocol Violation|0|||
126695814|NCT00832819|455840640|FG002|Overall Study|Protocol Violation|1|||
126695815|NCT00317044|455840641|FG000|Overall Study|Protocol Violation|28|||
126695816|NCT00317044|455840642|FG001|Overall Study|Protocol Violation|22|||
126695817|NCT00317044|455840643|FG002|Overall Study|Protocol Violation|20|||
126695818|NCT00317044|455840641|FG000|Overall Study|Adverse Event|4|||
126695819|NCT00317044|455840642|FG001|Overall Study|Adverse Event|7|||
126695820|NCT00317044|455840643|FG002|Overall Study|Adverse Event|4|||
126695821|NCT00317044|455840641|FG000|Overall Study|Withdrawal by Subject|10|||
126695822|NCT00317044|455840642|FG001|Overall Study|Withdrawal by Subject|7|||
126695823|NCT00317044|455840643|FG002|Overall Study|Withdrawal by Subject|12|||
126695824|NCT00317044|455840641|FG000|Overall Study|Lost to Follow-up|0|||
126695825|NCT00317044|455840642|FG001|Overall Study|Lost to Follow-up|2|||
126695826|NCT00317044|455840643|FG002|Overall Study|Lost to Follow-up|3|||
126695827|NCT00317044|455840641|FG000|Overall Study|Multiple Reasons|6|||
126695828|NCT00317044|455840642|FG001|Overall Study|Multiple Reasons|2|||
126695829|NCT00317044|455840643|FG002|Overall Study|Multiple Reasons|6|||
126695830|NCT05742984|455840644|FG000|Overall Study|Adverse Event|0|||
126695831|NCT05742984|455840645|FG001|Overall Study|Adverse Event|0|||
126695832|NCT05742984|455840646|FG002|Overall Study|Adverse Event|1|||
126695833|NCT05742984|455840647|FG003|Overall Study|Adverse Event|0|||
126695834|NCT05742984|455840648|FG004|Overall Study|Adverse Event|1|||
126695835|NCT05742984|455840649|FG005|Overall Study|Adverse Event|1|||
126695836|NCT05742984|455840644|FG000|Overall Study|Withdrawal by Subject|0|||
126695837|NCT05742984|455840645|FG001|Overall Study|Withdrawal by Subject|1|||
126695838|NCT05742984|455840646|FG002|Overall Study|Withdrawal by Subject|0|||
126695839|NCT05742984|455840647|FG003|Overall Study|Withdrawal by Subject|0|||
126695840|NCT05742984|455840648|FG004|Overall Study|Withdrawal by Subject|0|||
126695841|NCT05742984|455840649|FG005|Overall Study|Withdrawal by Subject|2|||
126695842|NCT00379340|455840650|FG000|Overall Study|Death|0|||
126695843|NCT00379340|455840651|FG001|Overall Study|Death|0|||
126695844|NCT00379340|455840652|FG002|Overall Study|Death|0|||
126695845|NCT00379340|455840653|FG003|Overall Study|Death|2|||
126695846|NCT00379340|455840654|FG004|Overall Study|Death|0|||
126695847|NCT00379340|455840650|FG000|Overall Study|Lack of Efficacy|6|||
126761660|NCT01012765|456079226|FG001|Treatment Period 1|Administrative problems|0|||
126761661|NCT01012765|456079227|FG002|Treatment Period 1|Administrative problems|1|||
126247910|NCT00574847|454200372|FG000|Overall Study|Did not receive medication (declined)|2|||
126247911|NCT00574847|454200373|FG001|Overall Study|Did not receive medication (declined)|5|||
126247912|NCT02055547|454200375|FG000|Overall Study|Protocol Violation|0|||
126247913|NCT02055547|454200376|FG001|Overall Study|Protocol Violation|0|||
126247914|NCT02055547|454200377|FG002|Overall Study|Protocol Violation|1|||
126247915|NCT02055547|454200378|FG003|Overall Study|Protocol Violation|0|||
126247916|NCT02055547|454200379|FG004|Overall Study|Protocol Violation|0|||
126247917|NCT02055547|454200380|FG005|Overall Study|Protocol Violation|0|||
126247918|NCT02055547|454200381|FG006|Overall Study|Protocol Violation|1|||
126247919|NCT02055547|454200382|FG007|Overall Study|Protocol Violation|0|||
126247920|NCT02055547|454200383|FG008|Overall Study|Protocol Violation|0|||
126247921|NCT02055547|454200384|FG009|Overall Study|Protocol Violation|0|||
126247922|NCT02055547|454200385|FG010|Overall Study|Protocol Violation|0|||
126247923|NCT02055547|454200386|FG011|Overall Study|Protocol Violation|0|||
126247924|NCT02055547|454200387|FG012|Overall Study|Protocol Violation|0|||
126247925|NCT02055547|454200388|FG013|Overall Study|Protocol Violation|0|||
126247926|NCT02055547|454200389|FG014|Overall Study|Protocol Violation|0|||
126247927|NCT02055547|454200390|FG015|Overall Study|Protocol Violation|0|||
126247928|NCT02055547|454200391|FG016|Overall Study|Protocol Violation|0|||
126546096|NCT05067933|455292576|FG004|Overall Study|Withdrawal by Subject|0|||
126546097|NCT05067933|455292577|FG005|Overall Study|Withdrawal by Subject|0|||
126695848|NCT00379340|455840651|FG001|Overall Study|Lack of Efficacy|1|||
126695849|NCT00379340|455840652|FG002|Overall Study|Lack of Efficacy|0|||
126695850|NCT00379340|455840653|FG003|Overall Study|Lack of Efficacy|4|||
126695851|NCT00379340|455840654|FG004|Overall Study|Lack of Efficacy|3|||
126695852|NCT00379340|455840650|FG000|Overall Study|Physician Decision|6|||
126695853|NCT00379340|455840651|FG001|Overall Study|Physician Decision|2|||
126695854|NCT00379340|455840652|FG002|Overall Study|Physician Decision|1|||
126695855|NCT00379340|455840653|FG003|Overall Study|Physician Decision|2|||
126695856|NCT00379340|455840654|FG004|Overall Study|Physician Decision|3|||
126695857|NCT00379340|455840650|FG000|Overall Study|Withdrawal by Subject|0|||
126695858|NCT00379340|455840651|FG001|Overall Study|Withdrawal by Subject|0|||
126695859|NCT00379340|455840652|FG002|Overall Study|Withdrawal by Subject|0|||
126448226|NCT00104520|454941370|FG000|Overall Study|Noncompliance|0|||
126695860|NCT00379340|455840653|FG003|Overall Study|Withdrawal by Subject|1|||
126695861|NCT00379340|455840654|FG004|Overall Study|Withdrawal by Subject|0|||
126695862|NCT00379340|455840650|FG000|Overall Study|Refusal of further protocol therapy|1|||
126695863|NCT00379340|455840651|FG001|Overall Study|Refusal of further protocol therapy|0|||
126695864|NCT00379340|455840652|FG002|Overall Study|Refusal of further protocol therapy|1|||
126695865|NCT00379340|455840653|FG003|Overall Study|Refusal of further protocol therapy|1|||
126695866|NCT00379340|455840654|FG004|Overall Study|Refusal of further protocol therapy|7|||
126695867|NCT00379340|455840650|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
126695868|NCT00379340|455840651|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
126695869|NCT00379340|455840652|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
126695870|NCT00379340|455840653|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
126695871|NCT00379340|455840654|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
126695872|NCT00379340|455840650|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
126695873|NCT00379340|455840651|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
126695874|NCT00379340|455840652|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
126695875|NCT00379340|455840653|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
126695876|NCT00379340|455840654|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
126695877|NCT03706365|455840658|FG000|Overall Study|Lost to Follow-up|7|||
126695878|NCT03706365|455840659|FG001|Overall Study|Lost to Follow-up|0|||
126695879|NCT03706365|455840658|FG000|Overall Study|Withdrawal by Subject|17|||
126695880|NCT03706365|455840659|FG001|Overall Study|Withdrawal by Subject|15|||
126695881|NCT03706365|455840658|FG000|Overall Study|On Study Treatment|51|||
126695882|NCT03706365|455840659|FG001|Overall Study|On Study Treatment|51|||
126695883|NCT02162862|455840660|FG000|Overall Study|Lost to Follow-up|0|||
126695884|NCT02162862|455840661|FG001|Overall Study|Lost to Follow-up|11|||
126695885|NCT02162862|455840662|FG002|Overall Study|Lost to Follow-up|0|||
126695886|NCT02162862|455840660|FG000|Overall Study|Subject did not feel the med was needed|0|||
126695887|NCT02162862|455840661|FG001|Overall Study|Subject did not feel the med was needed|0|||
126695888|NCT02162862|455840662|FG002|Overall Study|Subject did not feel the med was needed|4|||
126695889|NCT00103012|455840665|FG000|Overall Study|Withdrawal by Subject|2|||
126695890|NCT00103012|455840666|FG001|Overall Study|Withdrawal by Subject|1|||
126695891|NCT00103012|455840667|FG002|Overall Study|Withdrawal by Subject|2|||
126695892|NCT00103012|455840665|FG000|Overall Study|Pregnancy|1|||
126695893|NCT00103012|455840666|FG001|Overall Study|Pregnancy|0|||
126695894|NCT00103012|455840667|FG002|Overall Study|Pregnancy|0|||
126695895|NCT00103012|455840665|FG000|Overall Study|Adverse Event|0|||
126448227|NCT00104520|454941371|FG001|Overall Study|Noncompliance|2|||
126448228|NCT00104520|454941370|FG000|Overall Study|Personal/administrative|1|||
126448229|NCT00104520|454941371|FG001|Overall Study|Personal/administrative|1|||
126448230|NCT00104520|454941370|FG000|Overall Study|Other|1|||
126448231|NCT00104520|454941371|FG001|Overall Study|Other|5|||
126448232|NCT01026324|454941373|FG000|Follow up/Survival|Withdrawal by Subject|1|||
126448233|NCT01026324|454941374|FG001|Follow up/Survival|Withdrawal by Subject|0|||
126448234|NCT01026324|454941375|FG002|Follow up/Survival|Withdrawal by Subject|0|||
126448235|NCT05188053|454941376|FG000|Overall Study|Lost to Follow-up|23|||
126448236|NCT05188053|454941377|FG001|Overall Study|Lost to Follow-up|30|||
126695896|NCT00103012|455840666|FG001|Overall Study|Adverse Event|0|||
126695897|NCT00103012|455840667|FG002|Overall Study|Adverse Event|1|||
126695898|NCT00103012|455840665|FG000|Overall Study|Subject non-compliant with medications|0|||
126695899|NCT00103012|455840666|FG001|Overall Study|Subject non-compliant with medications|0|||
126695900|NCT00103012|455840667|FG002|Overall Study|Subject non-compliant with medications|1|||
126695901|NCT00430755|455840670|FG000|Overall Study|Withdrawal by Subject|53|||
126695902|NCT05019131|455840674|FG000|Overall Study|Lost to Follow-up|0|||
126695903|NCT05019131|455840675|FG001|Overall Study|Lost to Follow-up|3|||
126695904|NCT01703000|455840677|FG000|Overall Study|Death|1|||
126695905|NCT06118385|455840681|FG000|Overall Study|Protocol Violation|0|||
126695906|NCT06118385|455840682|FG001|Overall Study|Protocol Violation|0|||
126695907|NCT06118385|455840683|FG002|Overall Study|Protocol Violation|0|||
126695908|NCT06118385|455840684|FG003|Overall Study|Protocol Violation|0|||
126761662|NCT01012765|456079228|FG003|Treatment Period 1|Administrative problems|1|||
126448237|NCT05188053|454941376|FG000|Overall Study|Protocol Violation|16|||
126448238|NCT05188053|454941377|FG001|Overall Study|Protocol Violation|16|||
126448239|NCT05188053|454941376|FG000|Overall Study|Physician Decision|3|||
126695909|NCT06118385|455840685|FG004|Overall Study|Protocol Violation|0|||
126695910|NCT06118385|455840686|FG005|Overall Study|Protocol Violation|0|||
126695911|NCT06118385|455840687|FG006|Overall Study|Protocol Violation|0|||
126695912|NCT06118385|455840688|FG007|Overall Study|Protocol Violation|0|||
126695913|NCT06118385|455840689|FG008|Overall Study|Protocol Violation|1|||
126695914|NCT06118385|455840690|FG009|Overall Study|Protocol Violation|0|||
126695915|NCT06118385|455840691|FG010|Overall Study|Protocol Violation|0|||
126695916|NCT06118385|455840692|FG011|Overall Study|Protocol Violation|0|||
126695917|NCT06118385|455840681|FG000|Overall Study|Out-of-range blood tests|0|||
126695918|NCT06118385|455840682|FG001|Overall Study|Out-of-range blood tests|0|||
126695919|NCT06118385|455840683|FG002|Overall Study|Out-of-range blood tests|0|||
126695920|NCT06118385|455840684|FG003|Overall Study|Out-of-range blood tests|0|||
126695921|NCT06118385|455840685|FG004|Overall Study|Out-of-range blood tests|0|||
126695922|NCT06118385|455840686|FG005|Overall Study|Out-of-range blood tests|0|||
126695923|NCT06118385|455840687|FG006|Overall Study|Out-of-range blood tests|0|||
126695924|NCT06118385|455840688|FG007|Overall Study|Out-of-range blood tests|0|||
126695925|NCT06118385|455840689|FG008|Overall Study|Out-of-range blood tests|1|||
126695926|NCT06118385|455840690|FG009|Overall Study|Out-of-range blood tests|0|||
126695927|NCT06118385|455840691|FG010|Overall Study|Out-of-range blood tests|0|||
126695928|NCT06118385|455840692|FG011|Overall Study|Out-of-range blood tests|0|||
126695929|NCT02771522|455840695|FG000|Overall Study|Lost to Follow-up|3|||
126695930|NCT02771522|455840695|FG000|Overall Study|Withdrawal by Subject|2|||
126695931|NCT02771522|455840695|FG000|Overall Study|No white spot lesions|3|||
126695932|NCT01256177|455840698|FG000|Overall Study|Withdrawal by Subject|23|||
126695933|NCT01256177|455840699|FG001|Overall Study|Withdrawal by Subject|22|||
126695934|NCT01256177|455840698|FG000|Overall Study|Lost to Follow-up|2|||
126695935|NCT01256177|455840699|FG001|Overall Study|Lost to Follow-up|2|||
126695936|NCT01256177|455840698|FG000|Overall Study|Adverse Event|8|||
126695937|NCT01256177|455840699|FG001|Overall Study|Adverse Event|9|||
126695938|NCT01256177|455840698|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
126695939|NCT01256177|455840699|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
126695940|NCT01256177|455840698|FG000|Overall Study|Condition under Investigation Worsened|1|||
126761663|NCT01012765|456079229|FG004|Treatment Period 1|Administrative problems|1|||
126761664|NCT01012765|456079230|FG005|Treatment Period 1|Administrative problems|0|||
126448240|NCT05188053|454941377|FG001|Overall Study|Physician Decision|0|||
126448241|NCT05188053|454941376|FG000|Overall Study|Withdrawal by Subject|0|||
126448242|NCT05188053|454941377|FG001|Overall Study|Withdrawal by Subject|1|||
126448243|NCT02447302|454941381|FG000|Overall Study|Physician Decision|1|||
126448244|NCT02447302|454941382|FG001|Overall Study|Physician Decision|0|||
126448245|NCT02447302|454941383|FG002|Overall Study|Physician Decision|0|||
126448246|NCT02447302|454941381|FG000|Overall Study|Adverse Event|4|||
126448247|NCT02447302|454941382|FG001|Overall Study|Adverse Event|3|||
126448248|NCT02447302|454941383|FG002|Overall Study|Adverse Event|0|||
126448249|NCT02447302|454941381|FG000|Overall Study|Withdrawal by Subject|0|||
126448250|NCT02447302|454941382|FG001|Overall Study|Withdrawal by Subject|1|||
126448251|NCT02447302|454941383|FG002|Overall Study|Withdrawal by Subject|5|||
126448252|NCT02447302|454941381|FG000|Overall Study|Sponsor Decision|0|||
126448253|NCT02447302|454941382|FG001|Overall Study|Sponsor Decision|0|||
126448254|NCT02447302|454941383|FG002|Overall Study|Sponsor Decision|1|||
126448255|NCT01456897|454941388|FG000|Overall Study|Adverse Event|19|||
126448256|NCT01456897|454941389|FG001|Overall Study|Adverse Event|22|||
126695941|NCT01256177|455840699|FG001|Overall Study|Condition under Investigation Worsened|0|||
126695942|NCT01256177|455840698|FG000|Overall Study|Lack of Efficacy|11|||
126695943|NCT01256177|455840699|FG001|Overall Study|Lack of Efficacy|2|||
126695944|NCT01256177|455840698|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
126695945|NCT01256177|455840699|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
126695946|NCT00553462|455840700|FG000|Overall Study|Adverse Event|4|||
126695947|NCT00553462|455840700|FG000|Overall Study|Progression|4|||
126695948|NCT00553462|455840700|FG000|Overall Study|Withdrawal by Subject|5|||
126695949|NCT00553462|455840700|FG000|Overall Study|Physician Decision|1|||
126695950|NCT01728779|455840701|FG000|Overall Study|Withdrawal by Subject|1|||
126695951|NCT00675025|455840702|FG000|Overall Study|Study Terminated by Sponsor|38|||
126695952|NCT00675025|455840703|FG001|Overall Study|Study Terminated by Sponsor|42|||
126695953|NCT00675025|455840702|FG000|Overall Study|Adverse Event|6|||
126695954|NCT00675025|455840703|FG001|Overall Study|Adverse Event|11|||
126695955|NCT00675025|455840702|FG000|Overall Study|Lost to Follow-up|6|||
126695956|NCT00675025|455840703|FG001|Overall Study|Lost to Follow-up|4|||
126695957|NCT00675025|455840702|FG000|Overall Study|Withdrawal by Subject|4|||
126448257|NCT01456897|454941388|FG000|Overall Study|Protocol Violation|3|||
126448258|NCT01456897|454941389|FG001|Overall Study|Protocol Violation|4|||
126448259|NCT01456897|454941388|FG000|Overall Study|Physician Decision|5|||
126448260|NCT01456897|454941389|FG001|Overall Study|Physician Decision|3|||
126448261|NCT01456897|454941388|FG000|Overall Study|Withdrawal by Subject|44|||
126448262|NCT01456897|454941389|FG001|Overall Study|Withdrawal by Subject|17|||
126448263|NCT01456897|454941388|FG000|Overall Study|Lack of Efficacy|4|||
126695958|NCT00675025|455840703|FG001|Overall Study|Withdrawal by Subject|6|||
126695959|NCT04398732|455840704|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
126695960|NCT01596257|455840706|FG000|Overall Study|Inadequate Collection|23|||
126695961|NCT01596257|455840707|FG001|Overall Study|Inadequate Collection|19|||
126695962|NCT01570244|455840708|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
126448264|NCT01456897|454941389|FG001|Overall Study|Lack of Efficacy|11|||
126448265|NCT01396070|454941395|FG000|Overall Study|Withdrawal by Subject|2|||
126448266|NCT01396070|454941395|FG000|Overall Study|Death|2|||
126448267|NCT01396070|454941395|FG000|Overall Study|Adverse Event|8|||
126448268|NCT01396070|454941395|FG000|Overall Study|Physician Decision|3|||
126448269|NCT01396070|454941395|FG000|Overall Study|Lack of Efficacy|4|||
126448270|NCT01561313|454941397|FG000|Overall Study|Withdrawal by Subject|1|||
126448271|NCT01561313|454941398|FG001|Overall Study|Withdrawal by Subject|0|||
126448272|NCT01561313|454941397|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
126448273|NCT01561313|454941398|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
126448274|NCT04254913|454941399|FG000|Overall Study|Adverse Event|1|||
126448275|NCT02695420|454941400|FG000|Overall Study|Death|0|||
126448276|NCT02695420|454941401|FG001|Overall Study|Death|1|||
126448277|NCT02695420|454941402|FG002|Overall Study|Death|0|||
126448278|NCT02695420|454941403|FG003|Overall Study|Death|0|||
126448279|NCT04535453|454941404|FG000|Overall Study|Death|0|||
126448280|NCT04535453|454941405|FG001|Overall Study|Death|1|||
126448281|NCT04535453|454941406|FG002|Overall Study|Death|0|||
126448282|NCT04535453|454941407|FG003|Overall Study|Death|0|||
126448283|NCT04535453|454941408|FG004|Overall Study|Death|0|||
126448284|NCT04535453|454941409|FG005|Overall Study|Death|0|||
126448285|NCT04535453|454941410|FG006|Overall Study|Death|0|||
126448286|NCT04535453|454941411|FG007|Overall Study|Death|0|||
126448287|NCT04535453|454941412|FG008|Overall Study|Death|0|||
126448288|NCT04535453|454941413|FG009|Overall Study|Death|0|||
126448289|NCT04535453|454941414|FG010|Overall Study|Death|0|||
126448290|NCT04535453|454941415|FG011|Overall Study|Death|0|||
126448291|NCT04535453|454941404|FG000|Overall Study|Lost to Follow-up|1|||
126448292|NCT04535453|454941405|FG001|Overall Study|Lost to Follow-up|1|||
126448293|NCT04535453|454941406|FG002|Overall Study|Lost to Follow-up|1|||
126448294|NCT04535453|454941407|FG003|Overall Study|Lost to Follow-up|0|||
126448295|NCT04535453|454941408|FG004|Overall Study|Lost to Follow-up|3|||
126448296|NCT04535453|454941409|FG005|Overall Study|Lost to Follow-up|1|||
126448297|NCT04535453|454941410|FG006|Overall Study|Lost to Follow-up|0|||
126448298|NCT04535453|454941411|FG007|Overall Study|Lost to Follow-up|0|||
126448299|NCT04535453|454941412|FG008|Overall Study|Lost to Follow-up|1|||
126448300|NCT04535453|454941413|FG009|Overall Study|Lost to Follow-up|1|||
126448301|NCT04535453|454941414|FG010|Overall Study|Lost to Follow-up|0|||
126448302|NCT04535453|454941415|FG011|Overall Study|Lost to Follow-up|0|||
126448303|NCT04535453|454941404|FG000|Overall Study|Physician Decision|0|||
126448304|NCT04535453|454941405|FG001|Overall Study|Physician Decision|0|||
126448305|NCT04535453|454941406|FG002|Overall Study|Physician Decision|0|||
126448306|NCT04535453|454941407|FG003|Overall Study|Physician Decision|1|||
126448307|NCT04535453|454941408|FG004|Overall Study|Physician Decision|0|||
126448308|NCT04535453|454941409|FG005|Overall Study|Physician Decision|0|||
126448309|NCT04535453|454941410|FG006|Overall Study|Physician Decision|0|||
126448310|NCT04535453|454941411|FG007|Overall Study|Physician Decision|0|||
126448311|NCT04535453|454941412|FG008|Overall Study|Physician Decision|0|||
126448312|NCT04535453|454941413|FG009|Overall Study|Physician Decision|0|||
126448313|NCT04535453|454941414|FG010|Overall Study|Physician Decision|0|||
126448314|NCT04535453|454941415|FG011|Overall Study|Physician Decision|0|||
126448315|NCT04535453|454941404|FG000|Overall Study|Withdrawal by Subject|3|||
126448316|NCT04535453|454941405|FG001|Overall Study|Withdrawal by Subject|6|||
126448317|NCT04535453|454941406|FG002|Overall Study|Withdrawal by Subject|3|||
126448318|NCT04535453|454941407|FG003|Overall Study|Withdrawal by Subject|3|||
126448319|NCT04535453|454941408|FG004|Overall Study|Withdrawal by Subject|2|||
126448320|NCT04535453|454941409|FG005|Overall Study|Withdrawal by Subject|1|||
126448321|NCT04535453|454941410|FG006|Overall Study|Withdrawal by Subject|1|||
126448322|NCT04535453|454941411|FG007|Overall Study|Withdrawal by Subject|1|||
126448323|NCT04535453|454941412|FG008|Overall Study|Withdrawal by Subject|1|||
126448324|NCT04535453|454941413|FG009|Overall Study|Withdrawal by Subject|1|||
126448325|NCT04535453|454941414|FG010|Overall Study|Withdrawal by Subject|0|||
126448326|NCT04535453|454941415|FG011|Overall Study|Withdrawal by Subject|1|||
126448327|NCT04535453|454941404|FG000|Overall Study|Other|0|||
126448328|NCT04535453|454941405|FG001|Overall Study|Other|0|||
126448329|NCT04535453|454941406|FG002|Overall Study|Other|1|||
126448330|NCT04535453|454941407|FG003|Overall Study|Other|0|||
126448331|NCT04535453|454941408|FG004|Overall Study|Other|1|||
126448332|NCT04535453|454941409|FG005|Overall Study|Other|0|||
126448333|NCT04535453|454941410|FG006|Overall Study|Other|1|||
126448334|NCT04535453|454941411|FG007|Overall Study|Other|1|||
126448335|NCT04535453|454941412|FG008|Overall Study|Other|1|||
126448336|NCT04535453|454941413|FG009|Overall Study|Other|0|||
126695963|NCT00792298|455840714|FG000|Treatment Period 1|Adverse Event|0|||
126448337|NCT04535453|454941414|FG010|Overall Study|Other|0|||
126448338|NCT04535453|454941415|FG011|Overall Study|Other|0|||
126448339|NCT00916929|454941416|FG000|Overall Study|Lost to Follow-up|1|||
126448340|NCT00916929|454941417|FG001|Overall Study|Lost to Follow-up|3|||
126448341|NCT00916929|454941416|FG000|Overall Study|Death|5|||
126448342|NCT00916929|454941417|FG001|Overall Study|Death|10|||
126448343|NCT00916929|454941416|FG000|Overall Study|Withdrawal by Subject|1|||
126448344|NCT00916929|454941417|FG001|Overall Study|Withdrawal by Subject|5|||
126695964|NCT00792298|455840715|FG001|Treatment Period 1|Adverse Event|1|||
126695965|NCT00792298|455840716|FG002|Treatment Period 1|Adverse Event|0|||
126695966|NCT00792298|455840717|FG003|Treatment Period 1|Adverse Event|1|||
126695967|NCT00792298|455840718|FG004|Treatment Period 1|Adverse Event|0|||
126695968|NCT00792298|455840719|FG005|Treatment Period 1|Adverse Event|1|||
126695969|NCT00792298|455840720|FG006|Treatment Period 1|Adverse Event|1|||
126695970|NCT00792298|455840721|FG007|Treatment Period 1|Adverse Event|0|||
126695971|NCT00792298|455840714|FG000|Treatment Period 1|Lack of Efficacy|0|||
126695972|NCT00792298|455840715|FG001|Treatment Period 1|Lack of Efficacy|0|||
126695973|NCT00792298|455840716|FG002|Treatment Period 1|Lack of Efficacy|1|||
126695974|NCT00792298|455840717|FG003|Treatment Period 1|Lack of Efficacy|0|||
126695975|NCT00792298|455840718|FG004|Treatment Period 1|Lack of Efficacy|0|||
126695976|NCT00792298|455840719|FG005|Treatment Period 1|Lack of Efficacy|0|||
126695977|NCT00792298|455840720|FG006|Treatment Period 1|Lack of Efficacy|0|||
126695978|NCT00792298|455840721|FG007|Treatment Period 1|Lack of Efficacy|0|||
126695979|NCT00792298|455840714|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126695980|NCT00792298|455840715|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126695981|NCT00792298|455840716|FG002|Treatment Period 1|Withdrawal by Subject|1|||
126695982|NCT00792298|455840717|FG003|Treatment Period 1|Withdrawal by Subject|2|||
126247929|NCT02055547|454200392|FG017|Overall Study|Protocol Violation|0|||
126247930|NCT02055547|454200393|FG018|Overall Study|Protocol Violation|0|||
126247931|NCT02055547|454200375|FG000|Overall Study|Physician Decision|0|||
126247932|NCT02055547|454200376|FG001|Overall Study|Physician Decision|1|||
126247933|NCT02055547|454200377|FG002|Overall Study|Physician Decision|1|||
126247934|NCT02055547|454200378|FG003|Overall Study|Physician Decision|0|||
126247935|NCT02055547|454200379|FG004|Overall Study|Physician Decision|1|||
126247936|NCT02055547|454200380|FG005|Overall Study|Physician Decision|0|||
126247937|NCT02055547|454200381|FG006|Overall Study|Physician Decision|0|||
126247938|NCT02055547|454200382|FG007|Overall Study|Physician Decision|0|||
126247939|NCT02055547|454200383|FG008|Overall Study|Physician Decision|0|||
126247940|NCT02055547|454200384|FG009|Overall Study|Physician Decision|1|||
126247941|NCT02055547|454200385|FG010|Overall Study|Physician Decision|1|||
126247942|NCT02055547|454200386|FG011|Overall Study|Physician Decision|0|||
126247943|NCT02055547|454200387|FG012|Overall Study|Physician Decision|0|||
126247944|NCT02055547|454200388|FG013|Overall Study|Physician Decision|0|||
126247945|NCT02055547|454200389|FG014|Overall Study|Physician Decision|0|||
126247946|NCT02055547|454200390|FG015|Overall Study|Physician Decision|0|||
126247947|NCT02055547|454200391|FG016|Overall Study|Physician Decision|0|||
126247948|NCT02055547|454200392|FG017|Overall Study|Physician Decision|0|||
126247949|NCT02055547|454200393|FG018|Overall Study|Physician Decision|0|||
126247950|NCT02055547|454200375|FG000|Overall Study|Adverse Event|0|||
126247951|NCT02055547|454200376|FG001|Overall Study|Adverse Event|0|||
126247952|NCT02055547|454200377|FG002|Overall Study|Adverse Event|0|||
126448345|NCT00916929|454941416|FG000|Overall Study|Left ventricular epicardial lead|1|||
126448346|NCT00916929|454941417|FG001|Overall Study|Left ventricular epicardial lead|2|||
126448347|NCT00916929|454941416|FG000|Overall Study|Transferred to hospice care|1|||
126448348|NCT00916929|454941417|FG001|Overall Study|Transferred to hospice care|1|||
126448349|NCT00916929|454941416|FG000|Overall Study|System explant|1|||
126448350|NCT00916929|454941417|FG001|Overall Study|System explant|0|||
126448351|NCT00916929|454941416|FG000|Overall Study|Moved to another state|0|||
126448352|NCT00916929|454941417|FG001|Overall Study|Moved to another state|1|||
126448353|NCT00916929|454941416|FG000|Overall Study|Device unable to process impedance data|0|||
126448354|NCT00916929|454941417|FG001|Overall Study|Device unable to process impedance data|7|||
126448355|NCT02929407|454941418|FG000|Overall Study|Adverse Event|1|||
126448356|NCT02442804|454941422|FG000|Overall Study|Withdrawal by Subject|0|||
126448357|NCT02442804|454941423|FG001|Overall Study|Withdrawal by Subject|1|||
126448358|NCT02442804|454941422|FG000|Overall Study|Adverse Event|1|||
126448359|NCT02442804|454941423|FG001|Overall Study|Adverse Event|0|||
126448360|NCT02036853|454941424|FG000|Overall Study|Adverse Event|0|||
126448361|NCT02036853|454941425|FG001|Overall Study|Adverse Event|2|||
126448362|NCT02036853|454941424|FG000|Overall Study|Lack of Efficacy|0|||
126448363|NCT02036853|454941425|FG001|Overall Study|Lack of Efficacy|2|||
126448364|NCT02036853|454941424|FG000|Overall Study|Physician Decision|0|||
126448365|NCT02036853|454941425|FG001|Overall Study|Physician Decision|1|||
126448366|NCT02036853|454941424|FG000|Overall Study|Withdrawal by Subject|0|||
126448367|NCT02036853|454941425|FG001|Overall Study|Withdrawal by Subject|1|||
126448368|NCT01742286|454941426|FG000|Escalation Phase|Administrative problems|1|||
126448369|NCT01742286|454941427|FG001|Escalation Phase|Administrative problems|1|||
126448370|NCT01742286|454941428|FG002|Escalation Phase|Administrative problems|0|||
126695983|NCT00792298|455840718|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126695984|NCT00792298|455840719|FG005|Treatment Period 1|Withdrawal by Subject|2|||
126695985|NCT00792298|455840720|FG006|Treatment Period 1|Withdrawal by Subject|1|||
126695986|NCT00792298|455840721|FG007|Treatment Period 1|Withdrawal by Subject|0|||
126695987|NCT00792298|455840714|FG000|Treatment Period 1|Lost to Follow-up|0|||
126695988|NCT00792298|455840715|FG001|Treatment Period 1|Lost to Follow-up|0|||
126695989|NCT00792298|455840716|FG002|Treatment Period 1|Lost to Follow-up|0|||
126695990|NCT00792298|455840717|FG003|Treatment Period 1|Lost to Follow-up|0|||
126247953|NCT02055547|454200378|FG003|Overall Study|Adverse Event|0|||
126546098|NCT05067933|455292572|FG000|Overall Study|Lost to Follow-up|1|||
126546099|NCT05067933|455292573|FG001|Overall Study|Lost to Follow-up|1|||
126546100|NCT05067933|455292574|FG002|Overall Study|Lost to Follow-up|1|||
126546101|NCT05067933|455292575|FG003|Overall Study|Lost to Follow-up|2|||
126546102|NCT05067933|455292576|FG004|Overall Study|Lost to Follow-up|1|||
126546103|NCT05067933|455292577|FG005|Overall Study|Lost to Follow-up|0|||
126546104|NCT05067933|455292572|FG000|Overall Study|Miscellaneous|1|||
126546105|NCT05067933|455292573|FG001|Overall Study|Miscellaneous|0|||
126546106|NCT05067933|455292574|FG002|Overall Study|Miscellaneous|0|||
126546107|NCT05067933|455292575|FG003|Overall Study|Miscellaneous|0|||
126546108|NCT05067933|455292576|FG004|Overall Study|Miscellaneous|0|||
126546109|NCT05067933|455292577|FG005|Overall Study|Miscellaneous|0|||
126546110|NCT05067933|455292572|FG000|Overall Study|Death|0|||
126546111|NCT05067933|455292573|FG001|Overall Study|Death|0|||
126546112|NCT05067933|455292574|FG002|Overall Study|Death|0|||
126546113|NCT05067933|455292575|FG003|Overall Study|Death|1|||
126546114|NCT05067933|455292576|FG004|Overall Study|Death|0|||
126546115|NCT05067933|455292577|FG005|Overall Study|Death|0|||
126546116|NCT01065350|455292583|FG000|Overall Study|Received incorrect drug allocation|0|||
126546117|NCT01065350|455292584|FG001|Overall Study|Received incorrect drug allocation|1|||
126546118|NCT03443713|455292585|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
126546119|NCT03443713|455292586|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
126546120|NCT03443713|455292587|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
126546121|NCT05879198|455292589|FG000|Overall Study|Lost to Follow-up|1|||
126546122|NCT01693692|455292590|FG000|Overall Study|Withdrawal by Subject|12|||
126546123|NCT01693692|455292591|FG001|Overall Study|Withdrawal by Subject|10|||
126546124|NCT01693692|455292592|FG002|Overall Study|Withdrawal by Subject|11|||
126546125|NCT01693692|455292590|FG000|Overall Study|Adverse Event|7|||
126546126|NCT01693692|455292591|FG001|Overall Study|Adverse Event|14|||
126546127|NCT01693692|455292592|FG002|Overall Study|Adverse Event|9|||
126546128|NCT01693692|455292590|FG000|Overall Study|Physician Decision|0|||
126546129|NCT01693692|455292591|FG001|Overall Study|Physician Decision|0|||
126546130|NCT01693692|455292592|FG002|Overall Study|Physician Decision|1|||
126546131|NCT01693692|455292590|FG000|Overall Study|Protocol Violation|5|||
126546132|NCT01693692|455292591|FG001|Overall Study|Protocol Violation|4|||
126546133|NCT01693692|455292592|FG002|Overall Study|Protocol Violation|6|||
126546134|NCT01693692|455292590|FG000|Overall Study|Lost to Follow-up|2|||
126546135|NCT01693692|455292591|FG001|Overall Study|Lost to Follow-up|2|||
126546136|NCT01693692|455292592|FG002|Overall Study|Lost to Follow-up|3|||
126546137|NCT01693692|455292590|FG000|Overall Study|Other|4|||
126546138|NCT01693692|455292591|FG001|Overall Study|Other|4|||
126546139|NCT01693692|455292592|FG002|Overall Study|Other|6|||
126546140|NCT00663117|455293702|FG000|Overall Study|Lack of Efficacy|1|||
126546141|NCT00663117|455293703|FG001|Overall Study|Lack of Efficacy|0|||
126546142|NCT01992549|455293711|FG000|Overall Study|Lost to Follow-up|2|||
126546143|NCT01992549|455293711|FG000|Overall Study|Serious Adverse Event|1|||
126546144|NCT01992549|455293711|FG000|Overall Study|Product Switch to Extend Half Life|1|||
126546145|NCT01590771|455293712|FG000|Overall Study|Other Protocol Specified Criteria|5|||
126546146|NCT01590771|455293713|FG001|Overall Study|Other Protocol Specified Criteria|14|||
126546147|NCT01590771|455293712|FG000|Overall Study|Withdrawal by Subject|8|||
126546148|NCT01590771|455293713|FG001|Overall Study|Withdrawal by Subject|15|||
126546149|NCT01590771|455293712|FG000|Overall Study|Protocol Violation|1|||
126546150|NCT01590771|455293713|FG001|Overall Study|Protocol Violation|2|||
126546151|NCT01590771|455293712|FG000|Overall Study|Lost to Follow-up|1|||
126546152|NCT01590771|455293713|FG001|Overall Study|Lost to Follow-up|1|||
126546153|NCT01590771|455293712|FG000|Overall Study|Lack of Efficacy|1|||
126546154|NCT01590771|455293713|FG001|Overall Study|Lack of Efficacy|0|||
126546155|NCT01590771|455293712|FG000|Overall Study|Adverse Event|3|||
126546156|NCT01590771|455293713|FG001|Overall Study|Adverse Event|7|||
126546157|NCT00767104|455293719|FG000|Overall Study|Lost to Follow-up|1|||
126546158|NCT00767104|455293720|FG001|Overall Study|Lost to Follow-up|2|||
126546159|NCT04022889|455293721|FG000|Stage 1: Period 1|Adverse Event|1|||
126695991|NCT00792298|455840718|FG004|Treatment Period 1|Lost to Follow-up|0|||
126695992|NCT00792298|455840719|FG005|Treatment Period 1|Lost to Follow-up|0|||
126695993|NCT00792298|455840720|FG006|Treatment Period 1|Lost to Follow-up|1|||
126695994|NCT00792298|455840721|FG007|Treatment Period 1|Lost to Follow-up|0|||
126695995|NCT00792298|455840714|FG000|Treatment Period 1|Physician Decision|0|||
126546160|NCT04022889|455293722|FG001|Stage 1: Period 1|Adverse Event|0|||
126546161|NCT04022889|455293723|FG002|Stage 1: Period 1|Adverse Event|0|||
126546162|NCT04022889|455293721|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
126546163|NCT04022889|455293722|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
126546164|NCT04022889|455293723|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
126546165|NCT04022889|455293721|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
126546166|NCT04022889|455293722|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
126546167|NCT04022889|455293723|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
126546168|NCT04022889|455293721|FG000|Stage 2|Screen Failure|0|||
126546169|NCT04022889|455293722|FG001|Stage 2|Screen Failure|0|||
126546170|NCT04022889|455293723|FG002|Stage 2|Screen Failure|3|||
126695996|NCT00792298|455840715|FG001|Treatment Period 1|Physician Decision|0|||
126695997|NCT00792298|455840716|FG002|Treatment Period 1|Physician Decision|0|||
126695998|NCT00792298|455840717|FG003|Treatment Period 1|Physician Decision|1|||
126695999|NCT00792298|455840718|FG004|Treatment Period 1|Physician Decision|0|||
126696000|NCT00792298|455840719|FG005|Treatment Period 1|Physician Decision|0|||
126696001|NCT00792298|455840720|FG006|Treatment Period 1|Physician Decision|1|||
126696002|NCT00792298|455840721|FG007|Treatment Period 1|Physician Decision|0|||
126696003|NCT00792298|455840714|FG000|Treatment Period 1|Protocol Violation|0|||
126696004|NCT00792298|455840715|FG001|Treatment Period 1|Protocol Violation|0|||
126696005|NCT00792298|455840716|FG002|Treatment Period 1|Protocol Violation|0|||
126696006|NCT00792298|455840717|FG003|Treatment Period 1|Protocol Violation|0|||
126696007|NCT00792298|455840718|FG004|Treatment Period 1|Protocol Violation|0|||
126696008|NCT00792298|455840719|FG005|Treatment Period 1|Protocol Violation|0|||
126247954|NCT02055547|454200379|FG004|Overall Study|Adverse Event|0|||
126247955|NCT02055547|454200380|FG005|Overall Study|Adverse Event|0|||
126247956|NCT02055547|454200381|FG006|Overall Study|Adverse Event|1|||
126247957|NCT02055547|454200382|FG007|Overall Study|Adverse Event|0|||
126247958|NCT02055547|454200383|FG008|Overall Study|Adverse Event|1|||
126247959|NCT02055547|454200384|FG009|Overall Study|Adverse Event|0|||
126247960|NCT02055547|454200385|FG010|Overall Study|Adverse Event|0|||
126247961|NCT02055547|454200386|FG011|Overall Study|Adverse Event|0|||
126247962|NCT02055547|454200387|FG012|Overall Study|Adverse Event|0|||
126247963|NCT02055547|454200388|FG013|Overall Study|Adverse Event|0|||
126247964|NCT02055547|454200389|FG014|Overall Study|Adverse Event|0|||
126247965|NCT02055547|454200390|FG015|Overall Study|Adverse Event|0|||
126247966|NCT02055547|454200391|FG016|Overall Study|Adverse Event|0|||
126247967|NCT02055547|454200392|FG017|Overall Study|Adverse Event|0|||
126247968|NCT02055547|454200393|FG018|Overall Study|Adverse Event|0|||
126247969|NCT02055547|454200375|FG000|Overall Study|Withdrawal by Subject|0|||
126247970|NCT02055547|454200376|FG001|Overall Study|Withdrawal by Subject|0|||
126247971|NCT02055547|454200377|FG002|Overall Study|Withdrawal by Subject|0|||
126247972|NCT02055547|454200378|FG003|Overall Study|Withdrawal by Subject|0|||
126247973|NCT02055547|454200379|FG004|Overall Study|Withdrawal by Subject|0|||
126247974|NCT02055547|454200380|FG005|Overall Study|Withdrawal by Subject|1|||
126247975|NCT02055547|454200381|FG006|Overall Study|Withdrawal by Subject|0|||
126247976|NCT02055547|454200382|FG007|Overall Study|Withdrawal by Subject|0|||
126247977|NCT02055547|454200383|FG008|Overall Study|Withdrawal by Subject|1|||
126247978|NCT02055547|454200384|FG009|Overall Study|Withdrawal by Subject|0|||
126247979|NCT02055547|454200385|FG010|Overall Study|Withdrawal by Subject|0|||
126247980|NCT02055547|454200386|FG011|Overall Study|Withdrawal by Subject|0|||
126247981|NCT02055547|454200387|FG012|Overall Study|Withdrawal by Subject|0|||
126247982|NCT02055547|454200388|FG013|Overall Study|Withdrawal by Subject|1|||
126247983|NCT02055547|454200389|FG014|Overall Study|Withdrawal by Subject|0|||
126247984|NCT02055547|454200390|FG015|Overall Study|Withdrawal by Subject|1|||
126247985|NCT02055547|454200391|FG016|Overall Study|Withdrawal by Subject|0|||
126247986|NCT02055547|454200392|FG017|Overall Study|Withdrawal by Subject|0|||
126247987|NCT02055547|454200393|FG018|Overall Study|Withdrawal by Subject|0|||
126247988|NCT02055547|454200375|FG000|Overall Study|Lost to Follow-up|0|||
126247989|NCT02055547|454200376|FG001|Overall Study|Lost to Follow-up|0|||
126247990|NCT02055547|454200377|FG002|Overall Study|Lost to Follow-up|1|||
126247991|NCT02055547|454200378|FG003|Overall Study|Lost to Follow-up|0|||
126247992|NCT02055547|454200379|FG004|Overall Study|Lost to Follow-up|0|||
126247993|NCT02055547|454200380|FG005|Overall Study|Lost to Follow-up|0|||
126247994|NCT02055547|454200381|FG006|Overall Study|Lost to Follow-up|0|||
126247995|NCT02055547|454200382|FG007|Overall Study|Lost to Follow-up|0|||
126247996|NCT02055547|454200383|FG008|Overall Study|Lost to Follow-up|0|||
126247997|NCT02055547|454200384|FG009|Overall Study|Lost to Follow-up|0|||
126247998|NCT02055547|454200385|FG010|Overall Study|Lost to Follow-up|0|||
126247999|NCT02055547|454200386|FG011|Overall Study|Lost to Follow-up|0|||
126248000|NCT02055547|454200387|FG012|Overall Study|Lost to Follow-up|0|||
126248001|NCT02055547|454200388|FG013|Overall Study|Lost to Follow-up|0|||
126248002|NCT02055547|454200389|FG014|Overall Study|Lost to Follow-up|0|||
126248003|NCT02055547|454200390|FG015|Overall Study|Lost to Follow-up|0|||
126248004|NCT02055547|454200391|FG016|Overall Study|Lost to Follow-up|0|||
126546171|NCT04022889|455293721|FG000|Stage 2|Ineligible for apheresis donation|0|||
126248005|NCT02055547|454200392|FG017|Overall Study|Lost to Follow-up|0|||
126546172|NCT04022889|455293722|FG001|Stage 2|Ineligible for apheresis donation|0|||
126248006|NCT02055547|454200393|FG018|Overall Study|Lost to Follow-up|0|||
126248007|NCT05098743|454200394|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
126248008|NCT05098743|454200395|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
126248009|NCT05098743|454200394|FG000|Overall Study|Lost to Follow-up|1|||
126248010|NCT05098743|454200395|FG001|Overall Study|Lost to Follow-up|2|||
126248011|NCT03719040|454200396|FG000|Overall Study|Withdrawal by Subject|177|||
126696009|NCT00792298|455840720|FG006|Treatment Period 1|Protocol Violation|0|||
126696010|NCT00792298|455840721|FG007|Treatment Period 1|Protocol Violation|1|||
126696011|NCT00792298|455840714|FG000|Washout|Adverse Event|0|||
126696012|NCT00792298|455840715|FG001|Washout|Adverse Event|0|||
126248012|NCT03719040|454200396|FG000|Overall Study|Lost to Follow-up|26|||
126248013|NCT02923349|454200398|FG000|Overall Study|Other|1|||
126248014|NCT02923349|454200399|FG001|Overall Study|Other|2|||
126248015|NCT02923349|454200400|FG002|Overall Study|Other|4|||
126248016|NCT02923349|454200401|FG003|Overall Study|Other|1|||
126248017|NCT02923349|454200402|FG004|Overall Study|Other|3|||
126248018|NCT02923349|454200403|FG005|Overall Study|Other|0|||
126761665|NCT01012765|456079225|FG000|Treatment Period 1|Protocol Violation|0|||
126761666|NCT01012765|456079226|FG001|Treatment Period 1|Protocol Violation|0|||
126761667|NCT01012765|456079227|FG002|Treatment Period 1|Protocol Violation|0|||
126761668|NCT01012765|456079228|FG003|Treatment Period 1|Protocol Violation|2|||
126761669|NCT01012765|456079229|FG004|Treatment Period 1|Protocol Violation|1|||
126761670|NCT01012765|456079230|FG005|Treatment Period 1|Protocol Violation|0|||
126761671|NCT01012765|456079225|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
126761672|NCT01012765|456079226|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
126761673|NCT01012765|456079227|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
126761674|NCT01012765|456079228|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
126761675|NCT01012765|456079229|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
126761676|NCT01012765|456079230|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
126761677|NCT01012765|456079225|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126761678|NCT01012765|456079226|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126761679|NCT01012765|456079227|FG002|Treatment Period 2|Withdrawal by Subject|1|||
126761680|NCT01012765|456079228|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126761681|NCT01012765|456079229|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126761682|NCT01012765|456079230|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126761683|NCT01012765|456079225|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
126761684|NCT01012765|456079226|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
126761685|NCT01012765|456079227|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
126761686|NCT01012765|456079228|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
126761687|NCT01012765|456079229|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
126761688|NCT01012765|456079230|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
126761689|NCT01012765|456079225|FG000|Treatment Period 2|Adverse Event|0|||
126761690|NCT01012765|456079226|FG001|Treatment Period 2|Adverse Event|1|||
126761691|NCT01012765|456079227|FG002|Treatment Period 2|Adverse Event|1|||
126761692|NCT01012765|456079228|FG003|Treatment Period 2|Adverse Event|0|||
126761693|NCT01012765|456079229|FG004|Treatment Period 2|Adverse Event|0|||
126761694|NCT01012765|456079230|FG005|Treatment Period 2|Adverse Event|0|||
126761695|NCT01012765|456079225|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
126761696|NCT01012765|456079226|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
126761697|NCT01012765|456079227|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
126761698|NCT01012765|456079228|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
126761699|NCT01012765|456079229|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
126761700|NCT01012765|456079230|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
126761701|NCT01326312|456079231|FG000|Overall Study|Adverse Event|11|||
126761702|NCT01326312|456079232|FG001|Overall Study|Adverse Event|11|||
126761703|NCT01326312|456079233|FG002|Overall Study|Adverse Event|1|||
126761704|NCT01326312|456079231|FG000|Overall Study|Withdrawal by Subject|1|||
126761705|NCT01326312|456079232|FG001|Overall Study|Withdrawal by Subject|2|||
126761706|NCT01326312|456079233|FG002|Overall Study|Withdrawal by Subject|1|||
126761707|NCT01326312|456079231|FG000|Overall Study|Protocol Violation|0|||
126761708|NCT01326312|456079232|FG001|Overall Study|Protocol Violation|1|||
126761709|NCT01326312|456079233|FG002|Overall Study|Protocol Violation|0|||
126761710|NCT01326312|456079231|FG000|Overall Study|Lack of Efficacy|13|||
126761711|NCT01326312|456079232|FG001|Overall Study|Lack of Efficacy|7|||
126761712|NCT01326312|456079233|FG002|Overall Study|Lack of Efficacy|1|||
126761713|NCT01326312|456079231|FG000|Overall Study|Death|1|||
126761714|NCT01326312|456079232|FG001|Overall Study|Death|0|||
126248019|NCT02923349|454200404|FG006|Overall Study|Other|1|||
126248020|NCT02923349|454200398|FG000|Overall Study|Withdrawal by Subject|2|||
126248021|NCT02923349|454200399|FG001|Overall Study|Withdrawal by Subject|2|||
126248022|NCT02923349|454200400|FG002|Overall Study|Withdrawal by Subject|8|||
126761715|NCT01326312|456079233|FG002|Overall Study|Death|1|||
126761716|NCT01326312|456079231|FG000|Overall Study|progressive disease|0|||
126761717|NCT01326312|456079232|FG001|Overall Study|progressive disease|1|||
126761718|NCT01326312|456079233|FG002|Overall Study|progressive disease|1|||
126761719|NCT01326312|456079231|FG000|Overall Study|Study terminated by Sponsor|8|||
126761720|NCT01326312|456079232|FG001|Overall Study|Study terminated by Sponsor|32|||
126761721|NCT01326312|456079233|FG002|Overall Study|Study terminated by Sponsor|46|||
126761722|NCT01326312|456079231|FG000|Overall Study|Treatment arm terminated|19|||
126761723|NCT01326312|456079232|FG001|Overall Study|Treatment arm terminated|0|||
126761724|NCT01326312|456079233|FG002|Overall Study|Treatment arm terminated|0|||
126761725|NCT01326312|456079231|FG000|Overall Study|QTc > 500|0|||
126761726|NCT01326312|456079232|FG001|Overall Study|QTc > 500|1|||
126761727|NCT01326312|456079233|FG002|Overall Study|QTc > 500|0|||
126761728|NCT02219477|456079234|FG000|Overall Study|Adverse Event|0|||
126761729|NCT02219477|456079235|FG001|Overall Study|Adverse Event|1|||
126696013|NCT00792298|455840716|FG002|Washout|Adverse Event|0|||
126696014|NCT00792298|455840717|FG003|Washout|Adverse Event|0|||
126696015|NCT00792298|455840718|FG004|Washout|Adverse Event|0|||
126696016|NCT00792298|455840719|FG005|Washout|Adverse Event|1|||
126696017|NCT00792298|455840720|FG006|Washout|Adverse Event|0|||
126696018|NCT00792298|455840721|FG007|Washout|Adverse Event|0|||
126696019|NCT00792298|455840714|FG000|Washout|Withdrawal by Subject|0|||
126696020|NCT00792298|455840715|FG001|Washout|Withdrawal by Subject|0|||
126696021|NCT00792298|455840716|FG002|Washout|Withdrawal by Subject|1|||
126696022|NCT00792298|455840717|FG003|Washout|Withdrawal by Subject|0|||
126696023|NCT00792298|455840718|FG004|Washout|Withdrawal by Subject|0|||
126696024|NCT00792298|455840719|FG005|Washout|Withdrawal by Subject|1|||
126696025|NCT00792298|455840720|FG006|Washout|Withdrawal by Subject|0|||
126696026|NCT00792298|455840721|FG007|Washout|Withdrawal by Subject|0|||
126696027|NCT00792298|455840714|FG000|Treatment Period 2|Lack of Efficacy|0|||
126696028|NCT00792298|455840715|FG001|Treatment Period 2|Lack of Efficacy|0|||
126696029|NCT00792298|455840716|FG002|Treatment Period 2|Lack of Efficacy|0|||
126696030|NCT00792298|455840717|FG003|Treatment Period 2|Lack of Efficacy|0|||
126696031|NCT00792298|455840718|FG004|Treatment Period 2|Lack of Efficacy|1|||
126696032|NCT00792298|455840719|FG005|Treatment Period 2|Lack of Efficacy|0|||
126696033|NCT00792298|455840720|FG006|Treatment Period 2|Lack of Efficacy|0|||
126696034|NCT00792298|455840721|FG007|Treatment Period 2|Lack of Efficacy|0|||
126696035|NCT00792298|455840714|FG000|Treatment Period 2|Physician Decision|0|||
126696036|NCT00792298|455840715|FG001|Treatment Period 2|Physician Decision|0|||
126696037|NCT00792298|455840716|FG002|Treatment Period 2|Physician Decision|0|||
126696038|NCT00792298|455840717|FG003|Treatment Period 2|Physician Decision|0|||
126696039|NCT00792298|455840718|FG004|Treatment Period 2|Physician Decision|0|||
126696040|NCT00792298|455840719|FG005|Treatment Period 2|Physician Decision|0|||
126696041|NCT00792298|455840720|FG006|Treatment Period 2|Physician Decision|1|||
126696042|NCT00792298|455840721|FG007|Treatment Period 2|Physician Decision|0|||
126248023|NCT02923349|454200401|FG003|Overall Study|Withdrawal by Subject|10|||
126248024|NCT02923349|454200402|FG004|Overall Study|Withdrawal by Subject|12|||
126248025|NCT02923349|454200403|FG005|Overall Study|Withdrawal by Subject|3|||
126248026|NCT02923349|454200404|FG006|Overall Study|Withdrawal by Subject|0|||
126248027|NCT02923349|454200398|FG000|Overall Study|Physician Decision|0|||
126248028|NCT02923349|454200399|FG001|Overall Study|Physician Decision|0|||
126248029|NCT02923349|454200400|FG002|Overall Study|Physician Decision|0|||
126248030|NCT02923349|454200401|FG003|Overall Study|Physician Decision|1|||
126248031|NCT02923349|454200402|FG004|Overall Study|Physician Decision|1|||
126248032|NCT02923349|454200403|FG005|Overall Study|Physician Decision|0|||
126248033|NCT02923349|454200404|FG006|Overall Study|Physician Decision|2|||
126248034|NCT02923349|454200398|FG000|Overall Study|Lost to Follow-up|0|||
126248035|NCT02923349|454200399|FG001|Overall Study|Lost to Follow-up|0|||
126248036|NCT02923349|454200400|FG002|Overall Study|Lost to Follow-up|3|||
126248037|NCT02923349|454200401|FG003|Overall Study|Lost to Follow-up|0|||
126248038|NCT02923349|454200402|FG004|Overall Study|Lost to Follow-up|1|||
126696043|NCT00792298|455840714|FG000|Treatment Period 2|Pregnancy|0|||
126696044|NCT00792298|455840715|FG001|Treatment Period 2|Pregnancy|0|||
126696045|NCT00792298|455840716|FG002|Treatment Period 2|Pregnancy|1|||
126248039|NCT02923349|454200403|FG005|Overall Study|Lost to Follow-up|1|||
126248040|NCT02923349|454200404|FG006|Overall Study|Lost to Follow-up|0|||
126248041|NCT02923349|454200398|FG000|Overall Study|Death|1|||
126448371|NCT01742286|454941429|FG003|Escalation Phase|Administrative problems|0|||
126448372|NCT01742286|454941430|FG004|Escalation Phase|Administrative problems|0|||
126696046|NCT00792298|455840717|FG003|Treatment Period 2|Pregnancy|0|||
126696047|NCT00792298|455840718|FG004|Treatment Period 2|Pregnancy|0|||
126696048|NCT00792298|455840719|FG005|Treatment Period 2|Pregnancy|0|||
126696049|NCT00792298|455840720|FG006|Treatment Period 2|Pregnancy|0|||
126696050|NCT00792298|455840721|FG007|Treatment Period 2|Pregnancy|0|||
126696051|NCT00792298|455840714|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126696052|NCT00792298|455840715|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126248042|NCT02923349|454200399|FG001|Overall Study|Death|0|||
126248043|NCT02923349|454200400|FG002|Overall Study|Death|2|||
126248044|NCT02923349|454200401|FG003|Overall Study|Death|4|||
126248045|NCT02923349|454200402|FG004|Overall Study|Death|2|||
126248046|NCT02923349|454200403|FG005|Overall Study|Death|3|||
126248047|NCT02923349|454200404|FG006|Overall Study|Death|0|||
126248048|NCT04063878|454200407|FG000|Overall Study|Withdrawal by Subject|2|||
126696053|NCT00792298|455840716|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126696054|NCT00792298|455840717|FG003|Treatment Period 2|Withdrawal by Subject|2|||
126696055|NCT00792298|455840718|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126696056|NCT00792298|455840719|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126696057|NCT00792298|455840720|FG006|Treatment Period 2|Withdrawal by Subject|0|||
126696058|NCT00792298|455840721|FG007|Treatment Period 2|Withdrawal by Subject|2|||
126696059|NCT04258579|455840723|FG000|Overall Study|Withdrawal by Subject|7|||
126696060|NCT04258579|455840723|FG000|Overall Study|Lost to Follow-up|3|||
126696061|NCT04258579|455840723|FG000|Overall Study|Protocol Violation|2|||
126696062|NCT04258579|455840723|FG000|Overall Study|Adverse Event|1|||
126696063|NCT02388295|455840724|FG000|Dose Escalation Week 1|Adverse Event|1|||
126696064|NCT02388295|455840725|FG001|Dose Escalation Week 1|Adverse Event|2|||
126248049|NCT04063878|454200407|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
126248050|NCT02751827|454200408|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
126248051|NCT02751827|454200409|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
126248052|NCT02751827|454200410|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
126248053|NCT01248728|454200411|FG000|Overall Study|Adverse Event|1|||
126248054|NCT01248728|454200412|FG001|Overall Study|Adverse Event|1|||
126357739|NCT04518410|454602225|FG016|Overall Study|Withdrawal by Subject|0|||
126357740|NCT04518410|454602226|FG017|Overall Study|Withdrawal by Subject|15|||
126357741|NCT04518410|454602227|FG018|Overall Study|Withdrawal by Subject|12|||
126357742|NCT04518410|454602228|FG019|Overall Study|Withdrawal by Subject|9|||
126448373|NCT01742286|454941431|FG005|Escalation Phase|Administrative problems|0|||
126357743|NCT04518410|454602229|FG020|Overall Study|Withdrawal by Subject|14|||
126357744|NCT04518410|454602230|FG021|Overall Study|Withdrawal by Subject|3|||
126357745|NCT04518410|454602231|FG022|Overall Study|Withdrawal by Subject|2|||
126357746|NCT04518410|454602232|FG023|Overall Study|Withdrawal by Subject|9|||
126448374|NCT01742286|454941432|FG006|Escalation Phase|Administrative problems|2|||
126448375|NCT01742286|454941426|FG000|Escalation Phase|Adverse Event|0|||
126448376|NCT01742286|454941427|FG001|Escalation Phase|Adverse Event|1|||
126448377|NCT01742286|454941428|FG002|Escalation Phase|Adverse Event|2|||
126448378|NCT01742286|454941429|FG003|Escalation Phase|Adverse Event|0|||
126448379|NCT01742286|454941430|FG004|Escalation Phase|Adverse Event|0|||
126448380|NCT01742286|454941431|FG005|Escalation Phase|Adverse Event|1|||
126448381|NCT01742286|454941432|FG006|Escalation Phase|Adverse Event|0|||
126448382|NCT01742286|454941426|FG000|Escalation Phase|Disease progression|3|||
126448383|NCT01742286|454941427|FG001|Escalation Phase|Disease progression|7|||
126448384|NCT01742286|454941428|FG002|Escalation Phase|Disease progression|4|||
126448385|NCT01742286|454941429|FG003|Escalation Phase|Disease progression|1|||
126448386|NCT01742286|454941430|FG004|Escalation Phase|Disease progression|4|||
126448387|NCT01742286|454941431|FG005|Escalation Phase|Disease progression|3|||
126448388|NCT01742286|454941432|FG006|Escalation Phase|Disease progression|2|||
126448389|NCT01742286|454941426|FG000|Escalation Phase|Death|0|||
126448390|NCT01742286|454941427|FG001|Escalation Phase|Death|0|||
126696065|NCT02388295|455840726|FG002|Dose Escalation Week 1|Adverse Event|1|||
126696066|NCT02388295|455840724|FG000|Dose Escalation Week 1|Determined not eligible|1|||
126696067|NCT02388295|455840725|FG001|Dose Escalation Week 1|Determined not eligible|1|||
126696068|NCT02388295|455840726|FG002|Dose Escalation Week 1|Determined not eligible|1|||
126696069|NCT02388295|455840724|FG000|Dose Escalation Week 2|Protocol Violation|0|||
126696070|NCT02388295|455840725|FG001|Dose Escalation Week 2|Protocol Violation|1|||
126696071|NCT02388295|455840726|FG002|Dose Escalation Week 2|Protocol Violation|0|||
126696072|NCT02388295|455840724|FG000|Dose Escalation Week 2|Determined not eligible|1|||
126696073|NCT02388295|455840725|FG001|Dose Escalation Week 2|Determined not eligible|1|||
126696074|NCT02388295|455840726|FG002|Dose Escalation Week 2|Determined not eligible|1|||
126696075|NCT02388295|455840724|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
126696076|NCT02388295|455840725|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
126696077|NCT02388295|455840726|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
126696078|NCT02076165|455840727|FG000|Overall Study|Lost to Follow-up|7|||
126696079|NCT02076165|455840728|FG001|Overall Study|Lost to Follow-up|5|||
126696080|NCT02076165|455840727|FG000|Overall Study|Refused follow-up assessment|1|||
126696081|NCT02076165|455840728|FG001|Overall Study|Refused follow-up assessment|1|||
126696082|NCT04134494|455840733|FG000|Overall Study|Lost to Follow-up|2|||
126696083|NCT00781365|455840734|FG000|Overall Study|Withdrawal by Subject|13|||
126696084|NCT00781365|455840735|FG001|Overall Study|Withdrawal by Subject|8|||
126696085|NCT00781365|455840734|FG000|Overall Study|Did Not Attend Visit|20|||
126696086|NCT00781365|455840735|FG001|Overall Study|Did Not Attend Visit|28|||
126696087|NCT00781365|455840734|FG000|Overall Study|Language barrier|1|||
126696088|NCT00781365|455840735|FG001|Overall Study|Language barrier|0|||
126696089|NCT01850615|455840736|FG000|Overall Study|Protocol Violation|4|||
126696090|NCT01850615|455840737|FG001|Overall Study|Protocol Violation|1|||
126696091|NCT01850615|455840736|FG000|Overall Study|Adverse Event|2|||
126696092|NCT01850615|455840737|FG001|Overall Study|Adverse Event|1|||
126696093|NCT01850615|455840736|FG000|Overall Study|Withdrawal by Subject|3|||
126696094|NCT01850615|455840737|FG001|Overall Study|Withdrawal by Subject|1|||
126696095|NCT01850615|455840736|FG000|Overall Study|Lost to Follow-up|0|||
126696096|NCT01850615|455840737|FG001|Overall Study|Lost to Follow-up|1|||
126696097|NCT01850615|455840736|FG000|Overall Study|Unclassified|0|||
126248055|NCT01248728|454200411|FG000|Overall Study|Withdrawal by Subject|2|||
126357747|NCT04518410|454602233|FG024|Overall Study|Withdrawal by Subject|8|||
126357748|NCT04518410|454602209|FG000|Overall Study|Other|1|||
126448391|NCT01742286|454941428|FG002|Escalation Phase|Death|0|||
126696098|NCT01850615|455840737|FG001|Overall Study|Unclassified|1|||
126696099|NCT01375764|455840748|FG000|Overall Study|Lost to Follow-up|0|||
126448392|NCT01742286|454941429|FG003|Escalation Phase|Death|0|||
126448393|NCT01742286|454941430|FG004|Escalation Phase|Death|0|||
126696100|NCT01375764|455840749|FG001|Overall Study|Lost to Follow-up|1|||
126696101|NCT01375764|455840750|FG002|Overall Study|Lost to Follow-up|0|||
126248056|NCT01248728|454200412|FG001|Overall Study|Withdrawal by Subject|1|||
126248057|NCT01248728|454200411|FG000|Overall Study|Lack of Efficacy|1|||
126248058|NCT01248728|454200412|FG001|Overall Study|Lack of Efficacy|0|||
126248059|NCT00147498|454200413|FG000|Overall Study|Adverse Event|1|||
126248060|NCT00147498|454200414|FG001|Overall Study|Adverse Event|6|||
126248061|NCT00147498|454200415|FG002|Overall Study|Adverse Event|7|||
126248062|NCT00147498|454200416|FG003|Overall Study|Adverse Event|3|||
126248063|NCT00147498|454200413|FG000|Overall Study|Lack of Efficacy|1|||
126248064|NCT00147498|454200414|FG001|Overall Study|Lack of Efficacy|1|||
126448394|NCT01742286|454941431|FG005|Escalation Phase|Death|1|||
126448395|NCT01742286|454941432|FG006|Escalation Phase|Death|0|||
126448396|NCT01742286|454941426|FG000|Escalation Phase|Physician Decision|0|||
126448397|NCT01742286|454941427|FG001|Escalation Phase|Physician Decision|3|||
126448398|NCT01742286|454941428|FG002|Escalation Phase|Physician Decision|0|||
126448399|NCT01742286|454941429|FG003|Escalation Phase|Physician Decision|1|||
126448400|NCT01742286|454941430|FG004|Escalation Phase|Physician Decision|0|||
126248065|NCT00147498|454200415|FG002|Overall Study|Lack of Efficacy|1|||
126248066|NCT00147498|454200416|FG003|Overall Study|Lack of Efficacy|8|||
126248067|NCT00147498|454200413|FG000|Overall Study|Laboratory abnormality|0|||
126248068|NCT00147498|454200414|FG001|Overall Study|Laboratory abnormality|0|||
126248069|NCT00147498|454200415|FG002|Overall Study|Laboratory abnormality|2|||
126248070|NCT00147498|454200416|FG003|Overall Study|Laboratory abnormality|0|||
126248071|NCT00147498|454200413|FG000|Overall Study|Participant defaulted|0|||
126248072|NCT00147498|454200414|FG001|Overall Study|Participant defaulted|1|||
126248073|NCT00147498|454200415|FG002|Overall Study|Participant defaulted|4|||
126248074|NCT00147498|454200416|FG003|Overall Study|Participant defaulted|3|||
126248075|NCT00147498|454200413|FG000|Overall Study|Other|1|||
126248076|NCT00147498|454200414|FG001|Overall Study|Other|1|||
126248077|NCT00147498|454200415|FG002|Overall Study|Other|3|||
126248078|NCT00147498|454200416|FG003|Overall Study|Other|3|||
126248079|NCT01838681|454200417|FG000|Period A|Adverse Event|39|||
126248080|NCT01838681|454200418|FG001|Period A|Adverse Event|0|||
126248081|NCT01838681|454200419|FG002|Period A|Adverse Event|0|||
126248082|NCT01838681|454200420|FG003|Period A|Adverse Event|0|||
126248083|NCT01838681|454200417|FG000|Period A|Lack of Efficacy|21|||
126248084|NCT01838681|454200418|FG001|Period A|Lack of Efficacy|0|||
126248085|NCT01838681|454200419|FG002|Period A|Lack of Efficacy|0|||
126248086|NCT01838681|454200420|FG003|Period A|Lack of Efficacy|0|||
126248087|NCT01838681|454200417|FG000|Period A|Early response|148|||
126248088|NCT01838681|454200418|FG001|Period A|Early response|0|||
126248089|NCT01838681|454200419|FG002|Period A|Early response|0|||
126248090|NCT01838681|454200420|FG003|Period A|Early response|0|||
126248091|NCT01838681|454200417|FG000|Period A|Withdrawal by Subject|70|||
126248092|NCT01838681|454200418|FG001|Period A|Withdrawal by Subject|0|||
126248093|NCT01838681|454200419|FG002|Period A|Withdrawal by Subject|0|||
126248094|NCT01838681|454200420|FG003|Period A|Withdrawal by Subject|0|||
126248095|NCT01838681|454200417|FG000|Period A|Protocol Violation|16|||
126248096|NCT01838681|454200418|FG001|Period A|Protocol Violation|0|||
126248097|NCT01838681|454200419|FG002|Period A|Protocol Violation|0|||
126248098|NCT01838681|454200420|FG003|Period A|Protocol Violation|0|||
126248099|NCT01838681|454200417|FG000|Period A|Non-compliance with IMP|6|||
126248100|NCT01838681|454200418|FG001|Period A|Non-compliance with IMP|0|||
126248101|NCT01838681|454200419|FG002|Period A|Non-compliance with IMP|0|||
126248102|NCT01838681|454200420|FG003|Period A|Non-compliance with IMP|0|||
126248103|NCT01838681|454200417|FG000|Period A|Lost to Follow-up|4|||
126248104|NCT01838681|454200418|FG001|Period A|Lost to Follow-up|0|||
126248105|NCT01838681|454200419|FG002|Period A|Lost to Follow-up|0|||
126248106|NCT01838681|454200420|FG003|Period A|Lost to Follow-up|0|||
126448401|NCT01742286|454941431|FG005|Escalation Phase|Physician Decision|0|||
126448402|NCT01742286|454941432|FG006|Escalation Phase|Physician Decision|2|||
126448403|NCT01742286|454941426|FG000|Escalation Phase|Subject/guardian decision|1|||
126448404|NCT01742286|454941427|FG001|Escalation Phase|Subject/guardian decision|0|||
126448405|NCT01742286|454941428|FG002|Escalation Phase|Subject/guardian decision|0|||
126448406|NCT01742286|454941429|FG003|Escalation Phase|Subject/guardian decision|0|||
126448407|NCT01742286|454941430|FG004|Escalation Phase|Subject/guardian decision|0|||
126448408|NCT01742286|454941431|FG005|Escalation Phase|Subject/guardian decision|0|||
126448409|NCT01742286|454941432|FG006|Escalation Phase|Subject/guardian decision|0|||
126248107|NCT01838681|454200417|FG000|Period A|Withdrawal before treatment|4|||
126248108|NCT01838681|454200418|FG001|Period A|Withdrawal before treatment|0|||
126248109|NCT01838681|454200419|FG002|Period A|Withdrawal before treatment|0|||
126448410|NCT01742286|454941426|FG000|Expansion Phase|Administrative problems|0|||
126248110|NCT01838681|454200420|FG003|Period A|Withdrawal before treatment|0|||
126248111|NCT01838681|454200417|FG000|Period A|Administrative or other reasons|17|||
126248112|NCT01838681|454200418|FG001|Period A|Administrative or other reasons|0|||
126248113|NCT01838681|454200419|FG002|Period A|Administrative or other reasons|0|||
126248114|NCT01838681|454200420|FG003|Period A|Administrative or other reasons|0|||
126248115|NCT01838681|454200417|FG000|Period B/A+|Adverse Event|0|||
126448411|NCT01742286|454941427|FG001|Expansion Phase|Administrative problems|0|||
126248116|NCT01838681|454200418|FG001|Period B/A+|Adverse Event|13|||
126248117|NCT01838681|454200419|FG002|Period B/A+|Adverse Event|27|||
126248118|NCT01838681|454200420|FG003|Period B/A+|Adverse Event|16|||
126248119|NCT01838681|454200417|FG000|Period B/A+|Lack of Efficacy|0|||
126248120|NCT01838681|454200418|FG001|Period B/A+|Lack of Efficacy|9|||
126248121|NCT01838681|454200419|FG002|Period B/A+|Lack of Efficacy|11|||
126248122|NCT01838681|454200420|FG003|Period B/A+|Lack of Efficacy|6|||
126248123|NCT01838681|454200417|FG000|Period B/A+|Withdrawal by Subject|0|||
126448412|NCT01742286|454941428|FG002|Expansion Phase|Administrative problems|0|||
126448413|NCT01742286|454941429|FG003|Expansion Phase|Administrative problems|0|||
126448414|NCT01742286|454941430|FG004|Expansion Phase|Administrative problems|0|||
126448415|NCT01742286|454941431|FG005|Expansion Phase|Administrative problems|0|||
126448416|NCT01742286|454941432|FG006|Expansion Phase|Administrative problems|5|||
126448417|NCT01742286|454941426|FG000|Expansion Phase|Physician Decision|0|||
126248124|NCT01838681|454200418|FG001|Period B/A+|Withdrawal by Subject|28|||
126248125|NCT01838681|454200419|FG002|Period B/A+|Withdrawal by Subject|35|||
126248126|NCT01838681|454200420|FG003|Period B/A+|Withdrawal by Subject|47|||
126248127|NCT01838681|454200417|FG000|Period B/A+|Protocol Violation|0|||
126248128|NCT01838681|454200418|FG001|Period B/A+|Protocol Violation|1|||
126248129|NCT01838681|454200419|FG002|Period B/A+|Protocol Violation|4|||
126248130|NCT01838681|454200420|FG003|Period B/A+|Protocol Violation|6|||
126248131|NCT01838681|454200417|FG000|Period B/A+|Non-compliance with IMP|0|||
126248132|NCT01838681|454200418|FG001|Period B/A+|Non-compliance with IMP|2|||
126248133|NCT01838681|454200419|FG002|Period B/A+|Non-compliance with IMP|3|||
126248134|NCT01838681|454200420|FG003|Period B/A+|Non-compliance with IMP|3|||
126248135|NCT01838681|454200417|FG000|Period B/A+|Lost to Follow-up|0|||
126248136|NCT01838681|454200418|FG001|Period B/A+|Lost to Follow-up|2|||
126248137|NCT01838681|454200419|FG002|Period B/A+|Lost to Follow-up|5|||
126248138|NCT01838681|454200420|FG003|Period B/A+|Lost to Follow-up|11|||
126248139|NCT01838681|454200417|FG000|Period B/A+|Withdrawal before treatment|0|||
126248140|NCT01838681|454200418|FG001|Period B/A+|Withdrawal before treatment|1|||
126248141|NCT01838681|454200419|FG002|Period B/A+|Withdrawal before treatment|0|||
126248142|NCT01838681|454200420|FG003|Period B/A+|Withdrawal before treatment|0|||
126248143|NCT01838681|454200417|FG000|Period B/A+|Administrative or other reasons|0|||
126248144|NCT01838681|454200418|FG001|Period B/A+|Administrative or other reasons|6|||
126248145|NCT01838681|454200419|FG002|Period B/A+|Administrative or other reasons|10|||
126248146|NCT01838681|454200420|FG003|Period B/A+|Administrative or other reasons|28|||
126248147|NCT01279486|454200421|FG000|Overall Study|Lost to Follow-up|1|||
126248148|NCT04198363|454200423|FG000|Overall Study|Adverse Event|1|||
126248149|NCT04198363|454200424|FG001|Overall Study|Adverse Event|1|||
126248150|NCT04198363|454200423|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
126248151|NCT04198363|454200424|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
126248152|NCT04198363|454200423|FG000|Overall Study|Reason not Specified|1|||
126248153|NCT04198363|454200424|FG001|Overall Study|Reason not Specified|0|||
126448418|NCT01742286|454941427|FG001|Expansion Phase|Physician Decision|0|||
126448419|NCT01742286|454941428|FG002|Expansion Phase|Physician Decision|4|||
126448420|NCT01742286|454941429|FG003|Expansion Phase|Physician Decision|0|||
126448421|NCT01742286|454941430|FG004|Expansion Phase|Physician Decision|0|||
126448422|NCT01742286|454941431|FG005|Expansion Phase|Physician Decision|0|||
126448423|NCT01742286|454941432|FG006|Expansion Phase|Physician Decision|9|||
126448424|NCT01742286|454941426|FG000|Expansion Phase|Adverse Event|0|||
126448425|NCT01742286|454941427|FG001|Expansion Phase|Adverse Event|0|||
126448426|NCT01742286|454941428|FG002|Expansion Phase|Adverse Event|0|||
126448427|NCT01742286|454941429|FG003|Expansion Phase|Adverse Event|0|||
126448428|NCT01742286|454941430|FG004|Expansion Phase|Adverse Event|0|||
126448429|NCT01742286|454941431|FG005|Expansion Phase|Adverse Event|0|||
126448430|NCT01742286|454941432|FG006|Expansion Phase|Adverse Event|6|||
126448431|NCT01742286|454941426|FG000|Expansion Phase|Disease progression|0|||
126448432|NCT01742286|454941427|FG001|Expansion Phase|Disease progression|0|||
126448433|NCT01742286|454941428|FG002|Expansion Phase|Disease progression|3|||
126448434|NCT01742286|454941429|FG003|Expansion Phase|Disease progression|0|||
126448435|NCT01742286|454941430|FG004|Expansion Phase|Disease progression|0|||
126448436|NCT01742286|454941431|FG005|Expansion Phase|Disease progression|0|||
126448437|NCT01742286|454941432|FG006|Expansion Phase|Disease progression|15|||
126448438|NCT01742286|454941426|FG000|Expansion Phase|Withdrawal by Subject|0|||
126448439|NCT01742286|454941427|FG001|Expansion Phase|Withdrawal by Subject|0|||
126248154|NCT03067987|454200426|FG000|Overall Study|Lost to Follow-up|7|||
126248155|NCT03067987|454200427|FG001|Overall Study|Lost to Follow-up|10|||
126248156|NCT03067987|454200426|FG000|Overall Study|Protocol Violation|1|||
126248157|NCT03067987|454200427|FG001|Overall Study|Protocol Violation|2|||
126248158|NCT03067987|454200426|FG000|Overall Study|Withdrawal by Subject|2|||
126248159|NCT03067987|454200427|FG001|Overall Study|Withdrawal by Subject|1|||
126248160|NCT01404988|454200430|FG000|Overall Study|Death|2|||
126248161|NCT01404988|454200431|FG001|Overall Study|Death|0|||
126248162|NCT01404988|454200432|FG002|Overall Study|Death|2|||
126248163|NCT01404988|454200430|FG000|Overall Study|Adverse Event|1|||
126248164|NCT01404988|454200431|FG001|Overall Study|Adverse Event|0|||
126448440|NCT01742286|454941428|FG002|Expansion Phase|Withdrawal by Subject|0|||
126696102|NCT01375764|455840751|FG003|Overall Study|Lost to Follow-up|0|||
126248165|NCT01404988|454200432|FG002|Overall Study|Adverse Event|0|||
126248166|NCT01404988|454200430|FG000|Overall Study|Withdrawal by Subject|2|||
126248167|NCT01404988|454200431|FG001|Overall Study|Withdrawal by Subject|2|||
126248168|NCT01404988|454200432|FG002|Overall Study|Withdrawal by Subject|0|||
126248169|NCT01404988|454200430|FG000|Overall Study|Lost to Follow-up|1|||
126696103|NCT01375764|455840752|FG004|Overall Study|Lost to Follow-up|0|||
126696104|NCT01375764|455840748|FG000|Overall Study|Withdrawal by Subject|2|||
126696105|NCT01375764|455840749|FG001|Overall Study|Withdrawal by Subject|0|||
126696106|NCT01375764|455840750|FG002|Overall Study|Withdrawal by Subject|0|||
126696107|NCT01375764|455840751|FG003|Overall Study|Withdrawal by Subject|0|||
126696108|NCT01375764|455840752|FG004|Overall Study|Withdrawal by Subject|1|||
126696109|NCT01375764|455840748|FG000|Overall Study|Other|0|||
126696110|NCT01375764|455840749|FG001|Overall Study|Other|0|||
126696111|NCT01375764|455840750|FG002|Overall Study|Other|0|||
126696112|NCT01375764|455840751|FG003|Overall Study|Other|1|||
126696113|NCT01375764|455840752|FG004|Overall Study|Other|0|||
126696114|NCT03595280|455840753|FG000|Overall Study|Lost to Follow-up|6|||
126696115|NCT03595280|455840754|FG001|Overall Study|Lost to Follow-up|9|||
126696116|NCT03595280|455840755|FG002|Overall Study|Lost to Follow-up|15|||
126696117|NCT01194440|455840756|FG000|Baseline (First Dose)|Reason not specified|4|||
126696118|NCT01194440|455840756|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
126696119|NCT01194440|455840756|FG000|Baseline (First Dose)|Change in therapy|1|||
126696120|NCT01194440|455840756|FG000|Baseline (First Dose)|Adverse Event|1|||
126696121|NCT01194440|455840756|FG000|6-months (2nd Dose)|Change in therapy|4|||
126696122|NCT00896532|455840758|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696123|NCT00896532|455840759|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696124|NCT00896532|455840760|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696125|NCT00896532|455840761|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
126696126|NCT00896532|455840762|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696127|NCT00896532|455840763|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
126696128|NCT00896532|455840764|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696129|NCT00896532|455840765|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696130|NCT00896532|455840766|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696131|NCT00896532|455840767|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696132|NCT00896532|455840768|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696133|NCT00896532|455840769|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696134|NCT00896532|455840770|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696135|NCT00896532|455840771|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696136|NCT00896532|455840772|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696137|NCT00896532|455840773|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126248170|NCT01404988|454200431|FG001|Overall Study|Lost to Follow-up|2|||
126248171|NCT01404988|454200432|FG002|Overall Study|Lost to Follow-up|1|||
126248172|NCT02588339|454200433|FG000|Overall Study|Withdrawal by Subject|1|||
126248173|NCT02588339|454200433|FG000|Overall Study|GVHD Progression prior to treatment|2|||
126761730|NCT02219477|456079236|FG002|Overall Study|Adverse Event|1|||
126761731|NCT02219477|456079234|FG000|Overall Study|Withdrawal by Subject|0|||
126761732|NCT02219477|456079235|FG001|Overall Study|Withdrawal by Subject|1|||
126761733|NCT02219477|456079236|FG002|Overall Study|Withdrawal by Subject|0|||
126761734|NCT00499694|456079241|FG000|Overall Study|Patient never received treatment.|1|||
126761735|NCT02304484|456079242|FG000|Overall Study|Death|9|||
126761736|NCT02304484|456079242|FG000|Overall Study|Withdrawal by Subject|14|||
126761737|NCT02304484|456079242|FG000|Overall Study|Lost to Follow-up|2|||
126761738|NCT04338685|456079243|FG000|Overall Study|Death|3|||
126761739|NCT04338685|456079244|FG001|Overall Study|Death|4|||
126761740|NCT04338685|456079245|FG002|Overall Study|Death|2|||
126761741|NCT04338685|456079246|FG003|Overall Study|Death|4|||
126248174|NCT00373256|454202156|FG000|Overall Study|Adverse Event (AE)|1|||
126248175|NCT00373256|454202157|FG001|Overall Study|Adverse Event (AE)|5|||
126248176|NCT00373256|454202156|FG000|Overall Study|Lost to Follow-up|2|||
126357749|NCT04518410|454602210|FG001|Overall Study|Other|0|||
126696138|NCT00896532|455840774|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696139|NCT00896532|455840775|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696140|NCT00896532|455840776|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126761742|NCT04338685|456079247|FG004|Overall Study|Death|4|||
126761743|NCT04338685|456079248|FG005|Overall Study|Death|8|||
126761744|NCT04338685|456079249|FG006|Overall Study|Death|1|||
126761745|NCT04338685|456079250|FG007|Overall Study|Death|0|||
126761746|NCT04338685|456079251|FG008|Overall Study|Death|0|||
126761747|NCT04338685|456079243|FG000|Overall Study|Study terminated by Sponsor|0|||
126248177|NCT00373256|454202157|FG001|Overall Study|Lost to Follow-up|1|||
126248178|NCT00373256|454202156|FG000|Overall Study|Death|9|||
126248179|NCT00373256|454202157|FG001|Overall Study|Death|8|||
126248180|NCT00373256|454202156|FG000|Overall Study|Objective Progression or Relapse|111|||
126248181|NCT00373256|454202157|FG001|Overall Study|Objective Progression or Relapse|104|||
126248182|NCT00373256|454202156|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
126761748|NCT04338685|456079244|FG001|Overall Study|Study terminated by Sponsor|0|||
126761749|NCT04338685|456079245|FG002|Overall Study|Study terminated by Sponsor|1|||
126761750|NCT04338685|456079246|FG003|Overall Study|Study terminated by Sponsor|4|||
126761751|NCT04338685|456079247|FG004|Overall Study|Study terminated by Sponsor|0|||
126761752|NCT04338685|456079248|FG005|Overall Study|Study terminated by Sponsor|5|||
126761753|NCT04338685|456079249|FG006|Overall Study|Study terminated by Sponsor|2|||
126761754|NCT04338685|456079250|FG007|Overall Study|Study terminated by Sponsor|4|||
126761755|NCT04338685|456079251|FG008|Overall Study|Study terminated by Sponsor|1|||
126761756|NCT04338685|456079243|FG000|Overall Study|Withdrawal by Subject|1|||
126761757|NCT04338685|456079244|FG001|Overall Study|Withdrawal by Subject|2|||
126761758|NCT04338685|456079245|FG002|Overall Study|Withdrawal by Subject|0|||
126761759|NCT04338685|456079246|FG003|Overall Study|Withdrawal by Subject|2|||
126761760|NCT04338685|456079247|FG004|Overall Study|Withdrawal by Subject|0|||
126761761|NCT04338685|456079248|FG005|Overall Study|Withdrawal by Subject|5|||
126761762|NCT04338685|456079249|FG006|Overall Study|Withdrawal by Subject|1|||
126761763|NCT04338685|456079250|FG007|Overall Study|Withdrawal by Subject|1|||
126761764|NCT04338685|456079251|FG008|Overall Study|Withdrawal by Subject|0|||
126761765|NCT00145795|456079252|FG000|Overall Study|Adverse Event|1|||
126761766|NCT00145795|456079253|FG001|Overall Study|Adverse Event|0|||
126248183|NCT00373256|454202157|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
126248184|NCT00373256|454202156|FG000|Overall Study|Other|73|||
126761767|NCT02967055|456079254|FG000|Overall Study|Excluded|40|||
126761768|NCT02967055|456079254|FG000|Overall Study|Screen fail|3|||
126761769|NCT02967055|456079254|FG000|Overall Study|Lost to Follow-up|2|||
126248185|NCT00373256|454202157|FG001|Overall Study|Other|107|||
126248186|NCT00373256|454202156|FG000|Overall Study|Protocol Violation|0|||
126248187|NCT00373256|454202157|FG001|Overall Study|Protocol Violation|2|||
126248188|NCT00373256|454202156|FG000|Overall Study|Study Terminated by Sponsor|41|||
126248189|NCT00373256|454202157|FG001|Overall Study|Study Terminated by Sponsor|13|||
126248190|NCT04372238|454202158|FG000|Overall Study|Duplicate|3|||
126248191|NCT04372238|454202159|FG001|Overall Study|Duplicate|3|||
126248192|NCT04372238|454202158|FG000|Overall Study|Did not consent for data linkage|6|||
126248193|NCT04372238|454202159|FG001|Overall Study|Did not consent for data linkage|10|||
126248194|NCT05497557|454202171|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
126248195|NCT05497557|454202172|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
126248196|NCT05497557|454202173|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
126248197|NCT02752074|454202174|FG000|Overall Study|Lost to Follow-up|1|||
126248198|NCT02752074|454202175|FG001|Overall Study|Lost to Follow-up|4|||
126248199|NCT02752074|454202174|FG000|Overall Study|Death|146|||
126248200|NCT02752074|454202175|FG001|Overall Study|Death|129|||
126248201|NCT02752074|454202174|FG000|Overall Study|Withdrawal by Subject|9|||
126248202|NCT02752074|454202175|FG001|Overall Study|Withdrawal by Subject|10|||
126248203|NCT02392195|454202178|FG000|Overall Study|Lost to Follow-up|4|||
126248204|NCT02392195|454202178|FG000|Overall Study|Withdrawal by Subject|4|||
126248205|NCT00545792|454202181|FG000|Overall Study|Withdrawal by Subject|1|||
126248206|NCT03679598|454202183|FG000|Overall Study|Adverse Event|2|||
126248207|NCT03679598|454202184|FG001|Overall Study|Adverse Event|0|||
126248208|NCT01701063|454202189|FG000|Overall Study|Lost to Follow-up|0|||
126248209|NCT01701063|454202190|FG001|Overall Study|Lost to Follow-up|1|||
126248210|NCT01701063|454202191|FG002|Overall Study|Lost to Follow-up|0|||
126248211|NCT01701063|454202189|FG000|Overall Study|Withdrawal by Subject|0|||
126248212|NCT01701063|454202190|FG001|Overall Study|Withdrawal by Subject|0|||
126248213|NCT01701063|454202191|FG002|Overall Study|Withdrawal by Subject|1|||
126248214|NCT01701063|454202189|FG000|Overall Study|Other|0|||
126248215|NCT01701063|454202190|FG001|Overall Study|Other|0|||
126248216|NCT01701063|454202191|FG002|Overall Study|Other|1|||
126248217|NCT04474405|454202192|FG000|Overall Study|Withdrawal by Subject|0|||
126248218|NCT04474405|454202193|FG001|Overall Study|Withdrawal by Subject|0|||
126248219|NCT04474405|454202194|FG002|Overall Study|Withdrawal by Subject|1|||
126248220|NCT04474405|454202195|FG003|Overall Study|Withdrawal by Subject|0|||
126248221|NCT04474405|454202196|FG004|Overall Study|Withdrawal by Subject|1|||
126248222|NCT04474405|454202197|FG005|Overall Study|Withdrawal by Subject|0|||
126248223|NCT04474405|454202192|FG000|Overall Study|Other|0|||
126248224|NCT04474405|454202193|FG001|Overall Study|Other|0|||
126357750|NCT04518410|454602211|FG002|Overall Study|Other|0|||
126357751|NCT04518410|454602212|FG003|Overall Study|Other|1|||
126357752|NCT04518410|454602213|FG004|Overall Study|Other|6|||
126357753|NCT04518410|454602214|FG005|Overall Study|Other|6|||
126357754|NCT04518410|454602215|FG006|Overall Study|Other|5|||
126357755|NCT04518410|454602216|FG007|Overall Study|Other|2|||
126357756|NCT04518410|454602217|FG008|Overall Study|Other|0|||
126761770|NCT02967055|456079254|FG000|Overall Study|Stopped due to side effects|3|||
126761771|NCT02967055|456079254|FG000|Overall Study|Stopped due to drug cost|1|||
126761772|NCT00570492|456079255|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
126248225|NCT04474405|454202194|FG002|Overall Study|Other|0|||
126248226|NCT04474405|454202195|FG003|Overall Study|Other|0|||
126248227|NCT04474405|454202196|FG004|Overall Study|Other|3|||
126248228|NCT04474405|454202197|FG005|Overall Study|Other|0|||
126357757|NCT04518410|454602218|FG009|Overall Study|Other|1|||
126761773|NCT00570492|456079256|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
126761774|NCT00570492|456079257|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
126761775|NCT00570492|456079255|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
126761776|NCT00570492|456079256|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
126761777|NCT00570492|456079257|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
126761778|NCT00570492|456079255|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
126761779|NCT00570492|456079256|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
126761780|NCT00570492|456079257|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
126761781|NCT00570492|456079255|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
126761782|NCT00570492|456079256|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
126761783|NCT00570492|456079257|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
126761784|NCT00570492|456079255|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
126761785|NCT00570492|456079256|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
126761786|NCT00570492|456079257|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
126761787|NCT00570492|456079255|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
126761788|NCT00570492|456079256|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
126761789|NCT00570492|456079257|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
126761790|NCT00570492|456079255|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
126761791|NCT00570492|456079256|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
126761792|NCT00570492|456079257|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
126761793|NCT00570492|456079255|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126761794|NCT00570492|456079256|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
126248229|NCT04723693|454202198|FG000|Overall Study|Withdrawal by Subject|2|||
126248230|NCT01410227|454202199|FG000|Overall Study|Adverse Event|1|||
126248231|NCT01410227|454202200|FG001|Overall Study|Adverse Event|0|||
126248232|NCT01410227|454202201|FG002|Overall Study|Adverse Event|0|||
126248233|NCT01410227|454202202|FG003|Overall Study|Adverse Event|0|||
126248234|NCT01410227|454202199|FG000|Overall Study|Withdrawal by Subject|3|||
126248235|NCT01410227|454202200|FG001|Overall Study|Withdrawal by Subject|0|||
126248236|NCT01410227|454202201|FG002|Overall Study|Withdrawal by Subject|1|||
126248237|NCT01410227|454202202|FG003|Overall Study|Withdrawal by Subject|0|||
126248238|NCT01410227|454202199|FG000|Overall Study|Pregnancy|0|||
126248239|NCT01410227|454202200|FG001|Overall Study|Pregnancy|0|||
126248240|NCT01410227|454202201|FG002|Overall Study|Pregnancy|0|||
126248241|NCT01410227|454202202|FG003|Overall Study|Pregnancy|1|||
126248242|NCT01410227|454202199|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
126248243|NCT01410227|454202200|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
126248244|NCT01410227|454202201|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
126248245|NCT01410227|454202202|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
126248246|NCT02890992|454202203|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248247|NCT02890992|454202204|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
126248248|NCT02890992|454202205|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248249|NCT02890992|454202206|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248250|NCT02890992|454202207|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248251|NCT02890992|454202208|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248252|NCT02890992|454202209|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248253|NCT02890992|454202210|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
126248254|NCT02890992|454202203|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
126248255|NCT02890992|454202204|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
126248256|NCT02890992|454202205|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
126248257|NCT02890992|454202206|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
126248258|NCT02890992|454202207|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
126248259|NCT02890992|454202208|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
126248260|NCT02890992|454202209|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
126248261|NCT02890992|454202210|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
126248262|NCT02890992|454202203|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248263|NCT02890992|454202204|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
126248264|NCT02890992|454202205|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248265|NCT02890992|454202206|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248266|NCT02890992|454202207|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248267|NCT02890992|454202208|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248268|NCT02890992|454202209|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248269|NCT02890992|454202210|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
126248270|NCT00669162|454202211|FG000|Overall Study|Withdrawal by Subject|1|||
126248271|NCT00807495|454202212|FG000|Overall Study|Adverse Event|6|||
126248272|NCT00807495|454202213|FG001|Overall Study|Adverse Event|3|||
126248273|NCT00807495|454202214|FG002|Overall Study|Adverse Event|1|||
126248274|NCT00807495|454202215|FG003|Overall Study|Adverse Event|1|||
126248275|NCT00807495|454202216|FG004|Overall Study|Adverse Event|2|||
126248276|NCT00807495|454202212|FG000|Overall Study|Withdrawal by Patient|2|||
126248277|NCT00807495|454202213|FG001|Overall Study|Withdrawal by Patient|0|||
126248278|NCT00807495|454202214|FG002|Overall Study|Withdrawal by Patient|1|||
126696141|NCT00896532|455840777|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696142|NCT00896532|455840778|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696143|NCT00896532|455840779|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696144|NCT00896532|455840780|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
126696145|NCT00896532|455840758|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
126696146|NCT00896532|455840759|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
126696147|NCT00896532|455840760|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
126696148|NCT00896532|455840761|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
126696149|NCT00896532|455840762|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
126696150|NCT00896532|455840763|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
126696151|NCT00896532|455840764|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
126696152|NCT00896532|455840765|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696153|NCT00896532|455840766|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696154|NCT00896532|455840767|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696155|NCT00896532|455840768|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696156|NCT00896532|455840769|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696157|NCT00896532|455840770|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696158|NCT00896532|455840771|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696159|NCT00896532|455840772|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696160|NCT00896532|455840773|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696161|NCT00896532|455840774|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696162|NCT00896532|455840775|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696163|NCT00896532|455840776|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696164|NCT00896532|455840777|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696165|NCT00896532|455840778|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696166|NCT00896532|455840779|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696167|NCT00896532|455840780|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
126696168|NCT00896532|455840758|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
126696169|NCT00896532|455840759|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
126696170|NCT00896532|455840760|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
126696171|NCT00896532|455840761|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
126696172|NCT00896532|455840762|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
126696173|NCT00896532|455840763|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
126696174|NCT00896532|455840764|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
126248279|NCT00807495|454202215|FG003|Overall Study|Withdrawal by Patient|0|||
126248280|NCT00807495|454202216|FG004|Overall Study|Withdrawal by Patient|0|||
126248281|NCT00807495|454202212|FG000|Overall Study|Reason Not Specified|0|||
126248282|NCT00807495|454202213|FG001|Overall Study|Reason Not Specified|3|||
126248283|NCT00807495|454202214|FG002|Overall Study|Reason Not Specified|2|||
126248284|NCT00807495|454202215|FG003|Overall Study|Reason Not Specified|0|||
126248285|NCT00807495|454202216|FG004|Overall Study|Reason Not Specified|3|||
126248286|NCT02412852|454202220|FG000|Overall Study|Withdrawal by Subject|0|||
126248287|NCT02412852|454202221|FG001|Overall Study|Withdrawal by Subject|1|||
126248288|NCT02412852|454202222|FG002|Overall Study|Withdrawal by Subject|0|||
126248289|NCT02412852|454202223|FG003|Overall Study|Withdrawal by Subject|0|||
126248290|NCT02412852|454202220|FG000|Overall Study|Physician Decision|0|||
126248291|NCT02412852|454202221|FG001|Overall Study|Physician Decision|0|||
126448441|NCT01742286|454941429|FG003|Expansion Phase|Withdrawal by Subject|0|||
126448442|NCT01742286|454941430|FG004|Expansion Phase|Withdrawal by Subject|0|||
126448443|NCT01742286|454941431|FG005|Expansion Phase|Withdrawal by Subject|0|||
126448444|NCT01742286|454941432|FG006|Expansion Phase|Withdrawal by Subject|1|||
126448445|NCT02633020|454941433|FG000|Overall Study|Adverse Event|1|||
126448446|NCT02633020|454941434|FG001|Overall Study|Adverse Event|0|||
126448447|NCT01136785|454941435|FG000|Overall Study|Protocol Violation|2|||
126448448|NCT01136785|454941436|FG001|Overall Study|Protocol Violation|1|||
126448449|NCT02954172|454941439|FG000|Overall Study|Protocol Violation|3|||
126546173|NCT04022889|455293723|FG002|Stage 2|Ineligible for apheresis donation|2|||
126248292|NCT02412852|454202222|FG002|Overall Study|Physician Decision|0|||
126248293|NCT02412852|454202223|FG003|Overall Study|Physician Decision|1|||
126248294|NCT05274763|454202224|FG000|Overall Study|Lost to Follow-up|1|||
126248295|NCT01174186|454202225|FG000|Overall Study|Lost to Follow-up|0|||
126248296|NCT01174186|454202226|FG001|Overall Study|Lost to Follow-up|1|||
126448450|NCT02954172|454941440|FG001|Overall Study|Protocol Violation|0|||
126761795|NCT00570492|456079257|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
126761796|NCT00570492|456079255|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
126761797|NCT00570492|456079256|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
126761798|NCT00570492|456079257|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
126761799|NCT00570492|456079255|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
126761800|NCT00570492|456079256|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
126761801|NCT00570492|456079257|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
126761802|NCT00570492|456079255|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
126761803|NCT00570492|456079256|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
126761804|NCT00570492|456079257|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
126761805|NCT00570492|456079255|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
126761806|NCT00570492|456079256|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
126761807|NCT00570492|456079257|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
126761808|NCT00570492|456079255|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
126761809|NCT00570492|456079256|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
126761810|NCT00570492|456079257|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
126761811|NCT00570492|456079255|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
126761812|NCT00570492|456079256|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
126761813|NCT00570492|456079257|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
126761814|NCT00976989|456079258|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
126761815|NCT00976989|456079259|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
126761816|NCT00976989|456079260|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
126761817|NCT00976989|456079258|FG000|Overall Study|Death|5|||
126761818|NCT00976989|456079259|FG001|Overall Study|Death|7|||
126761819|NCT00976989|456079260|FG002|Overall Study|Death|10|||
126761820|NCT00976989|456079258|FG000|Overall Study|Refused Treatment|4|||
126448451|NCT02954172|454941439|FG000|Overall Study|allergic reaction|2|||
126448452|NCT02954172|454941440|FG001|Overall Study|allergic reaction|1|||
126448453|NCT02954172|454941439|FG000|Overall Study|non-measurable lesions at baseline|1|||
126448454|NCT02954172|454941440|FG001|Overall Study|non-measurable lesions at baseline|2|||
126448455|NCT00853567|454941441|FG000|Overall Study|Study prematurely terminated|71|||
126448456|NCT01497366|454941445|FG000|Overall Study|Virologic failure|2|||
126448457|NCT01497366|454941446|FG001|Overall Study|Virologic failure|50|||
126448458|NCT01497366|454941445|FG000|Overall Study|Lost to Follow-up|11|||
126448459|NCT01497366|454941446|FG001|Overall Study|Lost to Follow-up|10|||
126448460|NCT01497366|454941445|FG000|Overall Study|Withdrawal by Subject|6|||
126448461|NCT01497366|454941446|FG001|Overall Study|Withdrawal by Subject|6|||
126448462|NCT01497366|454941445|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
126696175|NCT00896532|455840765|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
126696176|NCT00896532|455840766|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696177|NCT00896532|455840767|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696178|NCT00896532|455840768|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696179|NCT00896532|455840769|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696180|NCT00896532|455840770|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696181|NCT00896532|455840771|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696182|NCT00896532|455840772|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696183|NCT00896532|455840773|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696184|NCT00896532|455840774|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696185|NCT00896532|455840775|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696186|NCT00896532|455840776|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696187|NCT00896532|455840777|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696188|NCT00896532|455840778|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696189|NCT00896532|455840779|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696190|NCT00896532|455840780|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
126696191|NCT00896532|455840758|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696192|NCT00896532|455840759|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696193|NCT00896532|455840760|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
126696194|NCT00896532|455840761|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696195|NCT00896532|455840762|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
126696196|NCT00896532|455840763|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696197|NCT00896532|455840764|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696198|NCT00896532|455840765|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126761821|NCT00976989|456079259|FG001|Overall Study|Refused Treatment|3|||
126761822|NCT00976989|456079260|FG002|Overall Study|Refused Treatment|5|||
126761823|NCT00976989|456079258|FG000|Overall Study|Failure to Return|2|||
126761824|NCT00976989|456079259|FG001|Overall Study|Failure to Return|1|||
126761825|NCT00976989|456079260|FG002|Overall Study|Failure to Return|0|||
126761826|NCT00976989|456079258|FG000|Overall Study|Recurrence of Disease|0|||
126761827|NCT00976989|456079259|FG001|Overall Study|Recurrence of Disease|1|||
126761828|NCT00976989|456079260|FG002|Overall Study|Recurrence of Disease|0|||
126761829|NCT00976989|456079258|FG000|Overall Study|Other|1|||
126761830|NCT00976989|456079259|FG001|Overall Study|Other|0|||
126761831|NCT00976989|456079260|FG002|Overall Study|Other|1|||
126761832|NCT03958045|456079262|FG000|Overall Study|Withdrawal by Subject|1|||
126761833|NCT02283411|456079263|FG000|Overall Study|Withdrawal by Subject|3|||
126761834|NCT02283411|456079263|FG000|Overall Study|Screen Failed|28|||
126248297|NCT01174186|454202225|FG000|Overall Study|Withdrawal by Subject|0|||
126248298|NCT01174186|454202226|FG001|Overall Study|Withdrawal by Subject|2|||
126248299|NCT00841542|454202228|FG000|Period 1|Adverse Event|1|||
126248300|NCT00841542|454202229|FG001|Period 1|Adverse Event|0|||
126248301|NCT01647828|454202230|FG000|Overall Study|Death|3|||
126248302|NCT01647828|454202231|FG001|Overall Study|Death|4|||
126248303|NCT01647828|454202232|FG002|Overall Study|Death|4|||
126248304|NCT01647828|454202233|FG003|Overall Study|Death|5|||
126248305|NCT01647828|454202234|FG004|Overall Study|Death|6|||
126448463|NCT01497366|454941446|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
126448464|NCT01497366|454941445|FG000|Overall Study|Other|5|||
126448465|NCT01497366|454941446|FG001|Overall Study|Other|0|||
126448466|NCT01497366|454941445|FG000|Overall Study|Death|1|||
126448467|NCT01497366|454941446|FG001|Overall Study|Death|1|||
126448468|NCT01497366|454941445|FG000|Overall Study|Randomized but not treated|7|||
126448469|NCT01497366|454941446|FG001|Overall Study|Randomized but not treated|21|||
126448470|NCT02745080|454941460|FG000|Overall Study|Adverse Event|13|||
126448471|NCT02745080|454941461|FG001|Overall Study|Adverse Event|21|||
126448472|NCT02745080|454941460|FG000|Overall Study|Lack of Efficacy|11|||
126448473|NCT02745080|454941461|FG001|Overall Study|Lack of Efficacy|23|||
126546174|NCT04022889|455293721|FG000|Stage 2|Adverse Event|0|||
126546175|NCT04022889|455293722|FG001|Stage 2|Adverse Event|0|||
126546176|NCT04022889|455293723|FG002|Stage 2|Adverse Event|2|||
126546177|NCT04022889|455293721|FG000|Stage 2|Protocol Violation|0|||
126546178|NCT04022889|455293722|FG001|Stage 2|Protocol Violation|0|||
126546179|NCT04022889|455293723|FG002|Stage 2|Protocol Violation|1|||
126546180|NCT04022889|455293721|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
126546181|NCT04022889|455293722|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
126546182|NCT04022889|455293723|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
126546183|NCT01900054|455293731|FG000|Overall Study|Physician Decision|1|||
126546184|NCT01900054|455293731|FG000|Overall Study|Withdrawal by Subject|1|||
126546185|NCT03285295|455293734|FG000|Alinity s HBsAg|Protocol Violation|11|||
126546186|NCT03285295|455293735|FG001|Alinity s HBsAg|Protocol Violation|0|||
126546187|NCT03285295|455293736|FG002|Alinity s HBsAg|Protocol Violation|0|||
126546188|NCT03285295|455293737|FG003|Alinity s HBsAg|Protocol Violation|0|||
126546189|NCT03285295|455293738|FG004|Alinity s HBsAg|Protocol Violation|0|||
126546190|NCT03285295|455293734|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
126761835|NCT04409262|456079265|FG000|Overall Study|Adverse Event|0|||
126761836|NCT04409262|456079266|FG001|Overall Study|Adverse Event|2|||
126761837|NCT04409262|456079265|FG000|Overall Study|Death|55|||
126761838|NCT04409262|456079266|FG001|Overall Study|Death|97|||
126761839|NCT04409262|456079265|FG000|Overall Study|Lost to Follow-up|12|||
126761840|NCT04409262|456079266|FG001|Overall Study|Lost to Follow-up|23|||
126761841|NCT04409262|456079265|FG000|Overall Study|Lack of Staff|0|||
126761842|NCT04409262|456079266|FG001|Overall Study|Lack of Staff|1|||
126761843|NCT04409262|456079265|FG000|Overall Study|Protocol Violation|3|||
126761844|NCT04409262|456079266|FG001|Overall Study|Protocol Violation|1|||
126248306|NCT01647828|454202235|FG005|Overall Study|Death|3|||
126248307|NCT01647828|454202236|FG006|Overall Study|Death|10|||
126248308|NCT01647828|454202237|FG007|Overall Study|Death|60|||
126248309|NCT01647828|454202238|FG008|Overall Study|Death|71|||
126248310|NCT01647828|454202230|FG000|Overall Study|Withdrawal by Subject|2|||
126248311|NCT01647828|454202231|FG001|Overall Study|Withdrawal by Subject|0|||
126448474|NCT02745080|454941460|FG000|Overall Study|Lost to Follow-up|3|||
126448475|NCT02745080|454941461|FG001|Overall Study|Lost to Follow-up|3|||
126448476|NCT02745080|454941460|FG000|Overall Study|Physician Decision|3|||
126761845|NCT04409262|456079265|FG000|Overall Study|Withdrawal by Subject|5|||
126448477|NCT02745080|454941461|FG001|Overall Study|Physician Decision|0|||
126546191|NCT03285295|455293735|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
126546192|NCT03285295|455293736|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
126546193|NCT03285295|455293737|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
126546194|NCT03285295|455293738|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
126761846|NCT04409262|456079266|FG001|Overall Study|Withdrawal by Subject|10|||
126761847|NCT02500732|456079267|FG000|Overall Study|Physician Decision|0|||
126761848|NCT02500732|456079268|FG001|Overall Study|Physician Decision|1|||
126761849|NCT03328325|456079269|FG000|Overall Study|Lost to Follow-up|4|||
126761850|NCT03328325|456079269|FG000|Overall Study|Physician Decision|1|||
126248312|NCT01647828|454202232|FG002|Overall Study|Withdrawal by Subject|0|||
126448478|NCT02745080|454941460|FG000|Overall Study|Protocol Violation|3|||
126248313|NCT01647828|454202233|FG003|Overall Study|Withdrawal by Subject|1|||
126546195|NCT03285295|455293734|FG000|Alinity s HBsAg|No Results Generated|74|||
126248314|NCT01647828|454202234|FG004|Overall Study|Withdrawal by Subject|0|||
126248315|NCT01647828|454202235|FG005|Overall Study|Withdrawal by Subject|0|||
126448479|NCT02745080|454941461|FG001|Overall Study|Protocol Violation|1|||
126448480|NCT02745080|454941460|FG000|Overall Study|Withdrawal by Subject|22|||
126448481|NCT02745080|454941461|FG001|Overall Study|Withdrawal by Subject|41|||
126448482|NCT03818035|454941464|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
126448483|NCT03818035|454941465|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
126448484|NCT03818035|454941466|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
126448485|NCT03818035|454941467|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
126448486|NCT03818035|454941464|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
126448487|NCT03818035|454941465|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
126448488|NCT03818035|454941466|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
126448489|NCT03818035|454941467|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
126448490|NCT03818035|454941464|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
126448491|NCT03818035|454941465|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
126448492|NCT03818035|454941466|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
126448493|NCT03818035|454941467|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
126448494|NCT03818035|454941464|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
126448495|NCT03818035|454941465|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
126448496|NCT03818035|454941466|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
126448497|NCT03818035|454941467|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
126448498|NCT03818035|454941464|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
126448499|NCT03818035|454941465|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
126448500|NCT03818035|454941466|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
126248316|NCT01647828|454202236|FG006|Overall Study|Withdrawal by Subject|1|||
126248317|NCT01647828|454202237|FG007|Overall Study|Withdrawal by Subject|0|||
126248318|NCT01647828|454202238|FG008|Overall Study|Withdrawal by Subject|2|||
126248319|NCT01647828|454202230|FG000|Overall Study|Study terminated by Sponsor|0|||
126248320|NCT01647828|454202231|FG001|Overall Study|Study terminated by Sponsor|0|||
126248321|NCT01647828|454202232|FG002|Overall Study|Study terminated by Sponsor|0|||
126248322|NCT01647828|454202233|FG003|Overall Study|Study terminated by Sponsor|0|||
126248323|NCT01647828|454202234|FG004|Overall Study|Study terminated by Sponsor|0|||
126248324|NCT01647828|454202235|FG005|Overall Study|Study terminated by Sponsor|0|||
126248325|NCT01647828|454202236|FG006|Overall Study|Study terminated by Sponsor|1|||
126248326|NCT01647828|454202237|FG007|Overall Study|Study terminated by Sponsor|26|||
126248327|NCT01647828|454202238|FG008|Overall Study|Study terminated by Sponsor|16|||
126248328|NCT01647828|454202230|FG000|Overall Study|Lost to Follow-up|0|||
126248329|NCT01647828|454202231|FG001|Overall Study|Lost to Follow-up|0|||
126248330|NCT01647828|454202232|FG002|Overall Study|Lost to Follow-up|0|||
126448501|NCT03818035|454941467|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
126448502|NCT03818035|454941464|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
126696199|NCT00896532|455840766|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696200|NCT00896532|455840767|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696201|NCT00896532|455840768|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696202|NCT00896532|455840769|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696203|NCT00896532|455840770|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696204|NCT00896532|455840771|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696205|NCT00896532|455840772|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696206|NCT00896532|455840773|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696207|NCT00896532|455840774|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696208|NCT00896532|455840775|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126248331|NCT01647828|454202233|FG003|Overall Study|Lost to Follow-up|0|||
126248332|NCT01647828|454202234|FG004|Overall Study|Lost to Follow-up|0|||
126248333|NCT01647828|454202235|FG005|Overall Study|Lost to Follow-up|0|||
126248334|NCT01647828|454202236|FG006|Overall Study|Lost to Follow-up|0|||
126248335|NCT01647828|454202237|FG007|Overall Study|Lost to Follow-up|2|||
126248336|NCT01647828|454202238|FG008|Overall Study|Lost to Follow-up|0|||
126248337|NCT01906372|454202239|FG000|Overall Study|Withdrawal by Subject|2|||
126248338|NCT01252953|454202243|FG000|Overall Study|Withdrawal by Subject|16|||
126248339|NCT01252953|454202244|FG001|Overall Study|Withdrawal by Subject|17|||
126248340|NCT01252953|454202243|FG000|Overall Study|Lost to Follow-up|22|||
126248341|NCT01252953|454202244|FG001|Overall Study|Lost to Follow-up|21|||
126248342|NCT00624286|454202245|FG000|Overall Study|Protocol Deviation|7|||
126448503|NCT03818035|454941465|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
126448504|NCT03818035|454941466|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
126448505|NCT03818035|454941467|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
126696209|NCT00896532|455840776|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126248343|NCT00624286|454202246|FG001|Overall Study|Protocol Deviation|9|||
126248344|NCT00624286|454202245|FG000|Overall Study|Adverse Event|6|||
126248345|NCT00624286|454202246|FG001|Overall Study|Adverse Event|3|||
126248346|NCT00624286|454202245|FG000|Overall Study|Withdrawal by Subject|5|||
126248347|NCT00624286|454202246|FG001|Overall Study|Withdrawal by Subject|4|||
126248348|NCT00624286|454202245|FG000|Overall Study|Lost to Follow-up|3|||
126761851|NCT03328325|456079269|FG000|Overall Study|Withdrawal by Subject|3|||
126696210|NCT00896532|455840777|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696211|NCT00896532|455840778|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696212|NCT00896532|455840779|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696213|NCT00896532|455840780|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
126696214|NCT00896532|455840758|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
126248349|NCT00624286|454202246|FG001|Overall Study|Lost to Follow-up|2|||
126248350|NCT00624286|454202245|FG000|Overall Study|Administrative problems|3|||
126248351|NCT00624286|454202246|FG001|Overall Study|Administrative problems|0|||
126248352|NCT00624286|454202245|FG000|Overall Study|Lack of Efficacy|1|||
126248353|NCT00624286|454202246|FG001|Overall Study|Lack of Efficacy|6|||
126248354|NCT00624286|454202245|FG000|Overall Study|Not stated|0|||
126248355|NCT00624286|454202246|FG001|Overall Study|Not stated|1|||
126248356|NCT00624286|454202245|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126248357|NCT00624286|454202246|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126248358|NCT00624286|454202245|FG000|Overall Study|Death|0|||
126248359|NCT00624286|454202246|FG001|Overall Study|Death|1|||
126696215|NCT00896532|455840759|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696216|NCT00896532|455840760|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696217|NCT00896532|455840761|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
126696218|NCT00896532|455840762|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126248360|NCT00841659|454202247|FG000|Washout: 2 Weeks|Protocol Violation|1|||
126248361|NCT00841659|454202248|FG001|Washout: 2 Weeks|Protocol Violation|0|||
126248362|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
126248363|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
126248364|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
126248365|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
126248366|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
126696219|NCT00896532|455840763|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126248367|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
126248368|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
126248369|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
126248370|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
126248371|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
126248372|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
126248373|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
126248374|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
126248375|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
126248376|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
126248377|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
126248378|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
126248379|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
126248380|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
126248381|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
126248382|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
126248383|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
126248384|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
126248385|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
126248386|NCT00073307|454202256|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
126248387|NCT00073307|454202257|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
126248388|NCT00073307|454202258|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
126248389|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
126696220|NCT00896532|455840764|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696221|NCT00896532|455840765|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696222|NCT00896532|455840766|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696223|NCT00896532|455840767|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696224|NCT00896532|455840768|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696225|NCT00896532|455840769|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126761852|NCT03328325|456079269|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
126761853|NCT03759340|456079271|FG000|Overall Study|Adverse Event|2|||
126248390|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
126248391|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
126357758|NCT04518410|454602219|FG010|Overall Study|Other|0|||
126357759|NCT04518410|454602220|FG011|Overall Study|Other|2|||
126357760|NCT04518410|454602221|FG012|Overall Study|Other|0|||
126357761|NCT04518410|454602222|FG013|Overall Study|Other|0|||
126696226|NCT00896532|455840770|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696227|NCT00896532|455840771|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126248392|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
126248393|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
126248394|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
126248395|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
126248396|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
126248397|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
126248398|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
126248399|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
126248400|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
126248401|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
126248402|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
126248403|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
126248404|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
126248405|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
126248406|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
126248407|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
126248408|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
126248409|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
126248410|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
126248411|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
126248412|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
126248413|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
126248414|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
126248415|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
126248416|NCT00073307|454202256|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
126248417|NCT00073307|454202257|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
126248418|NCT00073307|454202258|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
126248419|NCT01438060|454202259|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
126357762|NCT04518410|454602223|FG014|Overall Study|Other|0|||
126357763|NCT04518410|454602224|FG015|Overall Study|Other|3|||
126357764|NCT04518410|454602225|FG016|Overall Study|Other|1|||
126357765|NCT04518410|454602226|FG017|Overall Study|Other|1|||
126357766|NCT04518410|454602227|FG018|Overall Study|Other|1|||
126357767|NCT04518410|454602228|FG019|Overall Study|Other|0|||
126357768|NCT04518410|454602229|FG020|Overall Study|Other|1|||
126546196|NCT03285295|455293735|FG001|Alinity s HBsAg|No Results Generated|6|||
126696228|NCT00896532|455840772|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126248420|NCT01438060|454202260|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
126357769|NCT04518410|454602230|FG021|Overall Study|Other|0|||
126357770|NCT04518410|454602231|FG022|Overall Study|Other|1|||
126357771|NCT04518410|454602232|FG023|Overall Study|Other|2|||
126357772|NCT04518410|454602233|FG024|Overall Study|Other|2|||
126357773|NCT04518410|454602209|FG000|Overall Study|Protocol Violation|0|||
126357774|NCT04518410|454602210|FG001|Overall Study|Protocol Violation|0|||
126357775|NCT04518410|454602211|FG002|Overall Study|Protocol Violation|0|||
126357776|NCT04518410|454602212|FG003|Overall Study|Protocol Violation|2|||
126357777|NCT04518410|454602213|FG004|Overall Study|Protocol Violation|17|||
126357778|NCT04518410|454602214|FG005|Overall Study|Protocol Violation|1|||
126357779|NCT04518410|454602215|FG006|Overall Study|Protocol Violation|2|||
126357780|NCT04518410|454602216|FG007|Overall Study|Protocol Violation|1|||
126357781|NCT04518410|454602217|FG008|Overall Study|Protocol Violation|0|||
126357782|NCT04518410|454602218|FG009|Overall Study|Protocol Violation|0|||
126357783|NCT04518410|454602219|FG010|Overall Study|Protocol Violation|0|||
126357784|NCT04518410|454602220|FG011|Overall Study|Protocol Violation|0|||
126357785|NCT04518410|454602221|FG012|Overall Study|Protocol Violation|0|||
126357786|NCT04518410|454602222|FG013|Overall Study|Protocol Violation|0|||
126357787|NCT04518410|454602223|FG014|Overall Study|Protocol Violation|0|||
126357788|NCT04518410|454602224|FG015|Overall Study|Protocol Violation|0|||
126357789|NCT04518410|454602225|FG016|Overall Study|Protocol Violation|1|||
126357790|NCT04518410|454602226|FG017|Overall Study|Protocol Violation|1|||
126357791|NCT04518410|454602227|FG018|Overall Study|Protocol Violation|0|||
126357792|NCT04518410|454602228|FG019|Overall Study|Protocol Violation|0|||
126357793|NCT04518410|454602229|FG020|Overall Study|Protocol Violation|1|||
126357794|NCT04518410|454602230|FG021|Overall Study|Protocol Violation|2|||
126357795|NCT04518410|454602231|FG022|Overall Study|Protocol Violation|0|||
126357796|NCT04518410|454602232|FG023|Overall Study|Protocol Violation|3|||
126357797|NCT04518410|454602233|FG024|Overall Study|Protocol Violation|0|||
126357798|NCT04518410|454602209|FG000|Overall Study|Death|0|||
126357799|NCT04518410|454602210|FG001|Overall Study|Death|0|||
126357800|NCT04518410|454602211|FG002|Overall Study|Death|0|||
126357801|NCT04518410|454602212|FG003|Overall Study|Death|0|||
126357802|NCT04518410|454602213|FG004|Overall Study|Death|12|||
126248421|NCT01438060|454202259|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
126248422|NCT01438060|454202260|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
126248423|NCT01438060|454202259|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
126248424|NCT01438060|454202260|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
126248425|NCT01438060|454202259|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
126248426|NCT01438060|454202260|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
126248427|NCT01438060|454202259|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
126248428|NCT01438060|454202260|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
126248429|NCT01438060|454202259|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
126248430|NCT01438060|454202260|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
126248431|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
126248432|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
126248433|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
126248434|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
126248435|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
126248436|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
126248437|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
126248438|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
126248439|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
126248440|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
126248441|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
126248442|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
126248443|NCT01438060|454202259|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
126248444|NCT01438060|454202260|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
126248445|NCT01438060|454202259|FG000|On Study Beyond Week 140|Adverse Event|0|||
126248446|NCT01438060|454202260|FG001|On Study Beyond Week 140|Adverse Event|2|||
126248447|NCT01438060|454202259|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
126248448|NCT01438060|454202260|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
126248449|NCT01438060|454202259|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
126248450|NCT01438060|454202260|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
126248451|NCT01438060|454202259|FG000|On Study Beyond Week 140|Death|0|||
126248452|NCT01438060|454202260|FG001|On Study Beyond Week 140|Death|1|||
126248453|NCT01438060|454202259|FG000|On Study Beyond Week 140|Other Reason|0|||
126248454|NCT01438060|454202260|FG001|On Study Beyond Week 140|Other Reason|3|||
126248455|NCT02436200|454202263|FG000|Overall Study|Significant outlier|1|||
126248456|NCT01483820|454202264|FG000|Overall Study|Lack of Efficacy|6|||
126248457|NCT01483820|454202264|FG000|Overall Study|Adverse Event|1|||
126248458|NCT01483820|454202264|FG000|Overall Study|Death|1|||
126248459|NCT00867360|454202265|FG000|Overall Study|Withdrawal by Subject|1|||
126248460|NCT00867360|454202266|FG001|Overall Study|Withdrawal by Subject|0|||
126248461|NCT00867360|454202265|FG000|Overall Study|Physician Decision|0|||
126248462|NCT00867360|454202266|FG001|Overall Study|Physician Decision|1|||
126248463|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
126357803|NCT04518410|454602214|FG005|Overall Study|Death|2|||
126696229|NCT00896532|455840773|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696230|NCT00896532|455840774|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696231|NCT00896532|455840775|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696232|NCT00896532|455840776|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696233|NCT00896532|455840777|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696234|NCT00896532|455840778|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696235|NCT00896532|455840779|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696236|NCT00896532|455840780|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
126696237|NCT00896532|455840758|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696238|NCT00896532|455840759|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696239|NCT00896532|455840760|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
126248464|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
126248465|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
126248466|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
126248467|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
126248468|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248469|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248470|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248471|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248472|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248473|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248474|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248475|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248476|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
126357804|NCT04518410|454602215|FG006|Overall Study|Death|11|||
126357805|NCT04518410|454602216|FG007|Overall Study|Death|0|||
126357806|NCT04518410|454602217|FG008|Overall Study|Death|1|||
126546197|NCT03285295|455293736|FG002|Alinity s HBsAg|No Results Generated|0|||
126546198|NCT03285295|455293737|FG003|Alinity s HBsAg|No Results Generated|0|||
126546199|NCT03285295|455293738|FG004|Alinity s HBsAg|No Results Generated|0|||
126546200|NCT03285295|455293734|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
126248477|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248478|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248479|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
126546201|NCT03285295|455293735|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
126546202|NCT03285295|455293736|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
126546203|NCT03285295|455293737|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
126546204|NCT03285295|455293738|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
126546205|NCT03285295|455293734|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
126546206|NCT03285295|455293735|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
126546207|NCT03285295|455293736|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
126546208|NCT03285295|455293737|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
126546209|NCT03285295|455293738|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
126546210|NCT03285295|455293734|FG000|Alinity s HTLV I/II|No Results Generated|70|||
126546211|NCT03285295|455293735|FG001|Alinity s HTLV I/II|No Results Generated|0|||
126546212|NCT03285295|455293736|FG002|Alinity s HTLV I/II|No Results Generated|0|||
126546213|NCT03285295|455293737|FG003|Alinity s HTLV I/II|No Results Generated|0|||
126546214|NCT03285295|455293738|FG004|Alinity s HTLV I/II|No Results Generated|0|||
126546215|NCT03285295|455293734|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
126546216|NCT03285295|455293735|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
126546217|NCT03285295|455293736|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
126696240|NCT00896532|455840761|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696241|NCT00896532|455840762|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696242|NCT00896532|455840763|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696243|NCT00896532|455840764|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696244|NCT00896532|455840765|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696245|NCT00896532|455840766|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696246|NCT00896532|455840767|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696247|NCT00896532|455840768|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696248|NCT00896532|455840769|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696249|NCT00896532|455840770|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696250|NCT00896532|455840771|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696251|NCT00896532|455840772|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696252|NCT00896532|455840773|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696253|NCT00896532|455840774|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696254|NCT00896532|455840775|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696255|NCT00896532|455840776|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696256|NCT00896532|455840777|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696257|NCT00896532|455840778|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696258|NCT00896532|455840779|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696259|NCT00896532|455840780|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
126696260|NCT00896532|455840758|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696261|NCT00896532|455840759|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696262|NCT00896532|455840760|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
126696263|NCT00896532|455840761|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696264|NCT00896532|455840762|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696265|NCT00896532|455840763|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696266|NCT00896532|455840764|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696267|NCT00896532|455840765|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696268|NCT00896532|455840766|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696269|NCT00896532|455840767|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696270|NCT00896532|455840768|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696271|NCT00896532|455840769|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696272|NCT00896532|455840770|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696273|NCT00896532|455840771|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696274|NCT00896532|455840772|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126761854|NCT03759340|456079271|FG000|Overall Study|Lost to Follow-up|1|||
126761855|NCT03759340|456079271|FG000|Overall Study|Withdrawal by Subject|15|||
126248480|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
126546218|NCT03285295|455293737|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
126546219|NCT03285295|455293738|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
126248481|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
126546220|NCT03285295|455293734|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
126546221|NCT03285295|455293735|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
126761856|NCT03759340|456079271|FG000|Overall Study|Study Terminated by Sponsor|38|||
126761857|NCT03289676|456079272|FG000|Overall Study|Withdrawal by Subject|2|||
126761858|NCT03289676|456079273|FG001|Overall Study|Withdrawal by Subject|0|||
126761859|NCT03289676|456079272|FG000|Overall Study|Protocol Violation|2|||
126761860|NCT03289676|456079273|FG001|Overall Study|Protocol Violation|0|||
126761861|NCT03289676|456079272|FG000|Overall Study|Lost to Follow-up|0|||
126761862|NCT03289676|456079273|FG001|Overall Study|Lost to Follow-up|1|||
126761863|NCT02260804|456079280|FG000|Induction Study Period|Protocol Violation|2|||
126761864|NCT02260804|456079281|FG001|Induction Study Period|Protocol Violation|0|||
126761865|NCT02260804|456079280|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
126761866|NCT02260804|456079281|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
126761867|NCT02260804|456079280|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
126761868|NCT02260804|456079281|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
126761869|NCT02260804|456079280|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
126761870|NCT02260804|456079281|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
126761871|NCT02260804|456079280|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
126761872|NCT02260804|456079281|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
126761873|NCT02260804|456079280|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
126761874|NCT02260804|456079281|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
126761875|NCT02260804|456079280|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
126761876|NCT02260804|456079281|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
126761877|NCT02260804|456079280|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
126761878|NCT02260804|456079281|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
126761879|NCT02260804|456079280|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
126761880|NCT02260804|456079281|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
126761881|NCT02260804|456079280|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
126761882|NCT02260804|456079281|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
126761883|NCT02260804|456079280|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
126761884|NCT02260804|456079281|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
126761885|NCT02207413|456079282|FG000|Overall Study|Withdrawal by Subject|1|||
126761886|NCT02207413|456079283|FG001|Overall Study|Withdrawal by Subject|0|||
126761887|NCT02207413|456079284|FG002|Overall Study|Withdrawal by Subject|0|||
126761888|NCT02207413|456079285|FG003|Overall Study|Withdrawal by Subject|0|||
126761889|NCT02207413|456079286|FG004|Overall Study|Withdrawal by Subject|3|||
126761890|NCT02207413|456079287|FG005|Overall Study|Withdrawal by Subject|7|||
126761891|NCT02207413|456079282|FG000|Overall Study|Lost to Follow-up|0|||
126761892|NCT02207413|456079283|FG001|Overall Study|Lost to Follow-up|0|||
126761893|NCT02207413|456079284|FG002|Overall Study|Lost to Follow-up|0|||
126761894|NCT02207413|456079285|FG003|Overall Study|Lost to Follow-up|1|||
126761895|NCT02207413|456079286|FG004|Overall Study|Lost to Follow-up|1|||
126761896|NCT02207413|456079287|FG005|Overall Study|Lost to Follow-up|5|||
126761897|NCT02207413|456079282|FG000|Overall Study|Adverse Event|0|||
126761898|NCT02207413|456079283|FG001|Overall Study|Adverse Event|0|||
126761899|NCT02207413|456079284|FG002|Overall Study|Adverse Event|0|||
126761900|NCT02207413|456079285|FG003|Overall Study|Adverse Event|0|||
126761901|NCT02207413|456079286|FG004|Overall Study|Adverse Event|2|||
126761902|NCT02207413|456079287|FG005|Overall Study|Adverse Event|1|||
126761903|NCT02207413|456079282|FG000|Overall Study|Migrated/moved from study area|0|||
126761904|NCT02207413|456079283|FG001|Overall Study|Migrated/moved from study area|0|||
126761905|NCT02207413|456079284|FG002|Overall Study|Migrated/moved from study area|0|||
126761906|NCT02207413|456079285|FG003|Overall Study|Migrated/moved from study area|0|||
126248482|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248483|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248484|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248485|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248486|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248487|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
126248488|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
126357807|NCT04518410|454602218|FG009|Overall Study|Death|0|||
126357808|NCT04518410|454602219|FG010|Overall Study|Death|0|||
126546222|NCT03285295|455293736|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
126546223|NCT03285295|455293737|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
126546224|NCT03285295|455293738|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
126546225|NCT03285295|455293734|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
126761907|NCT02207413|456079286|FG004|Overall Study|Migrated/moved from study area|1|||
126761908|NCT02207413|456079287|FG005|Overall Study|Migrated/moved from study area|0|||
126761909|NCT00219349|456081071|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
126761910|NCT00219349|456081071|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
126761911|NCT00219349|456081071|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
126761912|NCT00219349|456081071|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
126761913|NCT02777554|456081072|FG000|Overall Study|Adverse Event|4|||
126761914|NCT02777554|456081073|FG001|Overall Study|Adverse Event|4|||
126248489|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248490|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
126248491|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248492|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248493|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248494|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248495|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248496|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248497|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248498|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248499|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248500|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248501|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248502|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248503|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248504|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248505|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248506|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248507|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248508|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248509|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126546226|NCT03285295|455293735|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
126546227|NCT03285295|455293736|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
126546228|NCT03285295|455293737|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
126546229|NCT03285295|455293738|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
126248510|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248511|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248512|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248513|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248514|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
126248515|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248516|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
126248517|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248518|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248519|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248520|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248521|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248522|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248523|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248524|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126696275|NCT00896532|455840773|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696276|NCT00896532|455840774|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696277|NCT00896532|455840775|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696278|NCT00896532|455840776|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696279|NCT00896532|455840777|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126248525|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248526|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248527|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248528|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248529|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248530|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248531|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248532|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248533|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248534|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126696280|NCT00896532|455840778|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696281|NCT00896532|455840779|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696282|NCT00896532|455840780|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
126696283|NCT00896532|455840758|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696284|NCT00896532|455840759|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696285|NCT00896532|455840760|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126248535|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248536|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126696286|NCT00896532|455840761|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
126248537|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248538|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248539|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248540|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
126248541|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
126248542|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248543|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
126248544|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
126248545|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
126696287|NCT00896532|455840762|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696288|NCT00896532|455840763|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696289|NCT00896532|455840764|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696290|NCT00896532|455840765|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696291|NCT00896532|455840766|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696292|NCT00896532|455840767|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696293|NCT00896532|455840768|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696294|NCT00896532|455840769|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696295|NCT00896532|455840770|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696296|NCT00896532|455840771|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696297|NCT00896532|455840772|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696298|NCT00896532|455840773|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696299|NCT00896532|455840774|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696300|NCT00896532|455840775|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696301|NCT00896532|455840776|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696302|NCT00896532|455840777|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696303|NCT00896532|455840778|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696304|NCT00896532|455840779|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696305|NCT00896532|455840780|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
126696306|NCT00896532|455840758|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696307|NCT00896532|455840759|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
126696308|NCT00896532|455840760|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696309|NCT00896532|455840761|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
126696310|NCT00896532|455840762|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
126696311|NCT00896532|455840763|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696312|NCT00896532|455840764|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696313|NCT00896532|455840765|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696314|NCT00896532|455840766|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696315|NCT00896532|455840767|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696316|NCT00896532|455840768|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696317|NCT00896532|455840769|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696318|NCT00896532|455840770|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696319|NCT00896532|455840771|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696320|NCT00896532|455840772|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696321|NCT00896532|455840773|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696322|NCT00896532|455840774|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696323|NCT00896532|455840775|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696324|NCT00896532|455840776|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696325|NCT00896532|455840777|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696326|NCT00896532|455840778|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696327|NCT00896532|455840779|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696328|NCT00896532|455840780|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
126696329|NCT00896532|455840758|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696330|NCT00896532|455840759|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696331|NCT00896532|455840760|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696332|NCT00896532|455840761|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696333|NCT00896532|455840762|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696334|NCT00896532|455840763|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696335|NCT00896532|455840764|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696336|NCT00896532|455840765|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696337|NCT00896532|455840766|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
126696338|NCT00896532|455840767|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696339|NCT00896532|455840768|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696340|NCT00896532|455840769|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696341|NCT00896532|455840770|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696342|NCT00896532|455840771|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696343|NCT00896532|455840772|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126248546|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248547|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126448506|NCT03818035|454941464|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
126761915|NCT02777554|456081074|FG002|Overall Study|Adverse Event|0|||
126761916|NCT02777554|456081075|FG003|Overall Study|Adverse Event|1|||
126761917|NCT02777554|456081076|FG004|Overall Study|Adverse Event|0|||
126761918|NCT02777554|456081077|FG005|Overall Study|Adverse Event|0|||
126761919|NCT02777554|456081072|FG000|Overall Study|Withdrawal by Subject|3|||
126761920|NCT02777554|456081073|FG001|Overall Study|Withdrawal by Subject|1|||
126761921|NCT02777554|456081074|FG002|Overall Study|Withdrawal by Subject|1|||
126761922|NCT02777554|456081075|FG003|Overall Study|Withdrawal by Subject|0|||
126761923|NCT02777554|456081076|FG004|Overall Study|Withdrawal by Subject|0|||
126761924|NCT02777554|456081077|FG005|Overall Study|Withdrawal by Subject|0|||
126761925|NCT02777554|456081072|FG000|Overall Study|Discharged early due to hurricane|22|||
126761926|NCT02777554|456081073|FG001|Overall Study|Discharged early due to hurricane|20|||
126761927|NCT02777554|456081074|FG002|Overall Study|Discharged early due to hurricane|0|||
126761928|NCT02777554|456081075|FG003|Overall Study|Discharged early due to hurricane|0|||
126761929|NCT02777554|456081076|FG004|Overall Study|Discharged early due to hurricane|0|||
126248548|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248549|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248550|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248551|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248552|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248553|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248554|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248555|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248556|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248557|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248558|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248559|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248560|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248561|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248562|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248563|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248564|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248565|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126761930|NCT02777554|456081077|FG005|Overall Study|Discharged early due to hurricane|0|||
126761931|NCT02777554|456081072|FG000|Overall Study|Other - Miscellaneous|1|||
126761932|NCT02777554|456081073|FG001|Overall Study|Other - Miscellaneous|0|||
126761933|NCT02777554|456081074|FG002|Overall Study|Other - Miscellaneous|0|||
126761934|NCT02777554|456081075|FG003|Overall Study|Other - Miscellaneous|0|||
126761935|NCT02777554|456081076|FG004|Overall Study|Other - Miscellaneous|0|||
126761936|NCT02777554|456081077|FG005|Overall Study|Other - Miscellaneous|0|||
126761937|NCT00270205|456081078|FG000|Overall Study|Lost to Follow-up|1|||
126761938|NCT00270205|456081079|FG001|Overall Study|Lost to Follow-up|0|||
126357809|NCT04518410|454602220|FG011|Overall Study|Death|0|||
126357810|NCT04518410|454602221|FG012|Overall Study|Death|0|||
126761939|NCT00270205|456081080|FG002|Overall Study|Lost to Follow-up|0|||
126761940|NCT00270205|456081081|FG003|Overall Study|Lost to Follow-up|1|||
126248566|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
126248567|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
126357811|NCT04518410|454602222|FG013|Overall Study|Death|1|||
126357812|NCT04518410|454602223|FG014|Overall Study|Death|1|||
126357813|NCT04518410|454602224|FG015|Overall Study|Death|0|||
126357814|NCT04518410|454602225|FG016|Overall Study|Death|0|||
126357815|NCT04518410|454602226|FG017|Overall Study|Death|1|||
126357816|NCT04518410|454602227|FG018|Overall Study|Death|4|||
126357817|NCT04518410|454602228|FG019|Overall Study|Death|4|||
126357818|NCT04518410|454602229|FG020|Overall Study|Death|1|||
126357819|NCT04518410|454602230|FG021|Overall Study|Death|0|||
126357820|NCT04518410|454602231|FG022|Overall Study|Death|0|||
126357821|NCT04518410|454602232|FG023|Overall Study|Death|0|||
126357822|NCT04518410|454602233|FG024|Overall Study|Death|0|||
126357823|NCT04518410|454602209|FG000|Overall Study|Requirement to start alternative therapy|0|||
126357824|NCT04518410|454602210|FG001|Overall Study|Requirement to start alternative therapy|0|||
126357825|NCT04518410|454602211|FG002|Overall Study|Requirement to start alternative therapy|1|||
126357826|NCT04518410|454602212|FG003|Overall Study|Requirement to start alternative therapy|0|||
126357827|NCT04518410|454602213|FG004|Overall Study|Requirement to start alternative therapy|0|||
126357828|NCT04518410|454602214|FG005|Overall Study|Requirement to start alternative therapy|0|||
126357829|NCT04518410|454602215|FG006|Overall Study|Requirement to start alternative therapy|0|||
126357830|NCT04518410|454602216|FG007|Overall Study|Requirement to start alternative therapy|0|||
126448507|NCT03818035|454941465|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
126761941|NCT00066573|456081082|FG000|Overall Study|Did not received protocol treatment|28|||
126761942|NCT00066573|456081083|FG001|Overall Study|Did not received protocol treatment|28|||
126357831|NCT04518410|454602217|FG008|Overall Study|Requirement to start alternative therapy|0|||
126761943|NCT00869362|456081084|FG000|Overall Study|Death|0|||
126357832|NCT04518410|454602218|FG009|Overall Study|Requirement to start alternative therapy|0|||
126248568|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
126248569|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
126248570|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
126248571|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
126248572|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248573|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248574|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248575|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248576|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248577|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248578|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248579|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248580|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248581|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248582|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248583|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248584|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248585|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248586|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248587|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248588|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248589|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248590|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248591|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248592|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
126248593|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|moved|0|||
126248594|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|moved|1|||
126248595|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|moved|1|||
126248596|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|moved|0|||
126248597|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|moved|0|||
126248598|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|moved|0|||
126248599|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|moved|0|||
126248600|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|moved|0|||
126248601|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|moved|0|||
126248602|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|moved|0|||
126248603|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|moved|0|||
126248604|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|moved|0|||
126248605|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|moved|0|||
126248606|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|moved|0|||
126248607|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|moved|0|||
126248608|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|moved|0|||
126248609|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|moved|0|||
126248610|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|moved|0|||
126248611|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|moved|0|||
126248612|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|moved|0|||
126248613|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|moved|0|||
126248614|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|moved|0|||
126761944|NCT00869362|456081085|FG001|Overall Study|Death|2|||
126761945|NCT00869362|456081084|FG000|Overall Study|Lost to Follow-up|1|||
126761946|NCT00869362|456081085|FG001|Overall Study|Lost to Follow-up|3|||
126761947|NCT01241591|456081086|FG000|Overall Study|Lack of Efficacy|5|||
126761948|NCT01241591|456081087|FG001|Overall Study|Lack of Efficacy|2|||
126761949|NCT01241591|456081088|FG002|Overall Study|Lack of Efficacy|2|||
126761950|NCT01241591|456081089|FG003|Overall Study|Lack of Efficacy|3|||
126761951|NCT01241591|456081086|FG000|Overall Study|Protocol Violation|5|||
126761952|NCT01241591|456081087|FG001|Overall Study|Protocol Violation|2|||
126761953|NCT01241591|456081088|FG002|Overall Study|Protocol Violation|3|||
126761954|NCT01241591|456081089|FG003|Overall Study|Protocol Violation|0|||
126761955|NCT01241591|456081086|FG000|Overall Study|Lost to Follow-up|1|||
126761956|NCT01241591|456081087|FG001|Overall Study|Lost to Follow-up|2|||
126761957|NCT01241591|456081088|FG002|Overall Study|Lost to Follow-up|2|||
126761958|NCT01241591|456081089|FG003|Overall Study|Lost to Follow-up|2|||
126761959|NCT01241591|456081086|FG000|Overall Study|Screen Failure|3|||
126761960|NCT01241591|456081087|FG001|Overall Study|Screen Failure|2|||
126761961|NCT01241591|456081088|FG002|Overall Study|Screen Failure|1|||
126761962|NCT01241591|456081089|FG003|Overall Study|Screen Failure|0|||
126248615|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|moved|0|||
126761963|NCT01241591|456081086|FG000|Overall Study|Withdrawal by Subject|6|||
126248616|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|moved|0|||
126761964|NCT01241591|456081087|FG001|Overall Study|Withdrawal by Subject|4|||
126761965|NCT01241591|456081088|FG002|Overall Study|Withdrawal by Subject|2|||
126761966|NCT01241591|456081089|FG003|Overall Study|Withdrawal by Subject|2|||
126761967|NCT01241591|456081086|FG000|Overall Study|Other|0|||
126761968|NCT01241591|456081087|FG001|Overall Study|Other|1|||
126761969|NCT01241591|456081088|FG002|Overall Study|Other|0|||
126761970|NCT01241591|456081089|FG003|Overall Study|Other|1|||
126761971|NCT01241591|456081086|FG000|Overall Study|Adverse Event|3|||
126761972|NCT01241591|456081087|FG001|Overall Study|Adverse Event|11|||
126761973|NCT01241591|456081088|FG002|Overall Study|Adverse Event|12|||
126761974|NCT01241591|456081089|FG003|Overall Study|Adverse Event|4|||
126761975|NCT01945034|456081090|FG000|Overall Study|Medication Error|0|||
126761976|NCT01945034|456081091|FG001|Overall Study|Medication Error|1|||
126761977|NCT01945034|456081092|FG002|Overall Study|Medication Error|0|||
126761978|NCT01945034|456081090|FG000|Overall Study|Withdrawal by Subject|0|||
126761979|NCT01945034|456081091|FG001|Overall Study|Withdrawal by Subject|3|||
126761980|NCT01945034|456081092|FG002|Overall Study|Withdrawal by Subject|1|||
126761981|NCT01945034|456081090|FG000|Overall Study|Other|0|||
126761982|NCT01945034|456081091|FG001|Overall Study|Other|1|||
126761983|NCT01945034|456081092|FG002|Overall Study|Other|3|||
126761984|NCT01945034|456081090|FG000|Overall Study|Lost to Follow-up|0|||
126761985|NCT01945034|456081091|FG001|Overall Study|Lost to Follow-up|0|||
126761986|NCT01945034|456081092|FG002|Overall Study|Lost to Follow-up|2|||
126761987|NCT01945034|456081090|FG000|Overall Study|Protocol Violation|1|||
126761988|NCT01945034|456081091|FG001|Overall Study|Protocol Violation|0|||
126761989|NCT01945034|456081092|FG002|Overall Study|Protocol Violation|1|||
126761990|NCT03053102|456081093|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
126761991|NCT03053102|456081093|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
126761992|NCT02147132|456081094|FG000|Overall Study|Lost to Follow-up|1|||
126761993|NCT02147132|456081095|FG001|Overall Study|Lost to Follow-up|0|||
126761994|NCT02147132|456081096|FG002|Overall Study|Lost to Follow-up|0|||
126761995|NCT02147132|456081097|FG003|Overall Study|Lost to Follow-up|0|||
126761996|NCT01798056|456081098|FG000|Overall Study|Serious Adverse Event|13|||
126761997|NCT01798056|456081099|FG001|Overall Study|Serious Adverse Event|12|||
126761998|NCT01798056|456081098|FG000|Overall Study|Withdrawal by Subject|12|||
126761999|NCT01798056|456081099|FG001|Overall Study|Withdrawal by Subject|9|||
126762000|NCT01798056|456081098|FG000|Overall Study|Migrated/moved from study area|1|||
126762001|NCT01798056|456081099|FG001|Overall Study|Migrated/moved from study area|1|||
126762002|NCT01798056|456081098|FG000|Overall Study|Lost to Follow-up|1|||
126762003|NCT01798056|456081099|FG001|Overall Study|Lost to Follow-up|1|||
126762004|NCT01798056|456081098|FG000|Overall Study|Other|0|||
126762005|NCT01798056|456081099|FG001|Overall Study|Other|2|||
126762006|NCT02842736|456081102|FG000|Overall Study|Lost to Follow-up|13|||
126762007|NCT02842736|456081102|FG000|Overall Study|Intervention for menstrual bleeding|17|||
126762008|NCT02842736|456081102|FG000|Overall Study|Withdrawal by Subject|4|||
126762009|NCT02842736|456081102|FG000|Overall Study|Pregnancy|3|||
126762010|NCT02842736|456081102|FG000|Overall Study|Hysterectomy for fibroids|2|||
126762011|NCT02842736|456081102|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
126762012|NCT02842736|456081102|FG000|Overall Study|IUD: Mirena|1|||
126762013|NCT03323034|456081104|FG000|Overall Study|Lack of Efficacy|5|||
126762014|NCT03323034|456081105|FG001|Overall Study|Lack of Efficacy|5|||
126762015|NCT03323034|456081106|FG002|Overall Study|Lack of Efficacy|6|||
126762016|NCT03323034|456081107|FG003|Overall Study|Lack of Efficacy|5|||
126762017|NCT03323034|456081108|FG004|Overall Study|Lack of Efficacy|5|||
126762018|NCT03323034|456081104|FG000|Overall Study|Physician Decision|0|||
126762019|NCT03323034|456081105|FG001|Overall Study|Physician Decision|0|||
126762020|NCT03323034|456081106|FG002|Overall Study|Physician Decision|0|||
126762021|NCT03323034|456081107|FG003|Overall Study|Physician Decision|0|||
126762022|NCT03323034|456081108|FG004|Overall Study|Physician Decision|1|||
126762023|NCT03323034|456081104|FG000|Overall Study|Withdrawal by Subject|1|||
126762024|NCT03323034|456081105|FG001|Overall Study|Withdrawal by Subject|1|||
126762025|NCT03323034|456081106|FG002|Overall Study|Withdrawal by Subject|0|||
126762026|NCT03323034|456081107|FG003|Overall Study|Withdrawal by Subject|1|||
126357833|NCT04518410|454602219|FG010|Overall Study|Requirement to start alternative therapy|0|||
126762027|NCT03323034|456081108|FG004|Overall Study|Withdrawal by Subject|0|||
126357834|NCT04518410|454602220|FG011|Overall Study|Requirement to start alternative therapy|0|||
126357835|NCT04518410|454602221|FG012|Overall Study|Requirement to start alternative therapy|0|||
126357836|NCT04518410|454602222|FG013|Overall Study|Requirement to start alternative therapy|0|||
126357837|NCT04518410|454602223|FG014|Overall Study|Requirement to start alternative therapy|0|||
126357838|NCT04518410|454602224|FG015|Overall Study|Requirement to start alternative therapy|0|||
126357839|NCT04518410|454602225|FG016|Overall Study|Requirement to start alternative therapy|0|||
126357840|NCT04518410|454602226|FG017|Overall Study|Requirement to start alternative therapy|0|||
126762028|NCT02646566|456081109|FG000|Overall Study|Lost to Follow-up|5|||
126762029|NCT02646566|456081110|FG001|Overall Study|Lost to Follow-up|4|||
126762030|NCT02646566|456081111|FG002|Overall Study|Lost to Follow-up|5|||
126762031|NCT02646566|456081109|FG000|Overall Study|Treatment failure|1|||
126762032|NCT02646566|456081110|FG001|Overall Study|Treatment failure|0|||
126762033|NCT02646566|456081111|FG002|Overall Study|Treatment failure|0|||
126762034|NCT02815540|456081114|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
126762035|NCT02222246|456081115|FG000|Overall Study|No Emergency Department Visits|27|||
126762036|NCT02222246|456081116|FG001|Overall Study|No Emergency Department Visits|26|||
126248617|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|moved|0|||
126248618|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|moved|0|||
126248619|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248620|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248621|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248622|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
126696344|NCT00896532|455840773|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696345|NCT00896532|455840774|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696346|NCT00896532|455840775|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696347|NCT00896532|455840776|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696348|NCT00896532|455840777|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696349|NCT00896532|455840778|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696350|NCT00896532|455840779|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696351|NCT00896532|455840780|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
126696352|NCT00896532|455840758|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696353|NCT00896532|455840759|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696354|NCT00896532|455840760|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696355|NCT00896532|455840761|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696356|NCT00896532|455840762|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696357|NCT00896532|455840763|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696358|NCT00896532|455840764|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696359|NCT00896532|455840765|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696360|NCT00896532|455840766|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696361|NCT00896532|455840767|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696362|NCT00896532|455840768|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696363|NCT00896532|455840769|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696364|NCT00896532|455840770|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
126696365|NCT00896532|455840771|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696366|NCT00896532|455840772|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696367|NCT00896532|455840773|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696368|NCT00896532|455840774|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696369|NCT00896532|455840775|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696370|NCT00896532|455840776|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696371|NCT00896532|455840777|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696372|NCT00896532|455840778|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696373|NCT00896532|455840779|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696374|NCT00896532|455840780|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
126696375|NCT00896532|455840758|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696376|NCT00896532|455840759|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696377|NCT00896532|455840760|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696378|NCT00896532|455840761|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696379|NCT00896532|455840762|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696380|NCT00896532|455840763|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696381|NCT00896532|455840764|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696382|NCT00896532|455840765|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696383|NCT00896532|455840766|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696384|NCT00896532|455840767|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696385|NCT00896532|455840768|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
126696386|NCT00896532|455840769|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696387|NCT00896532|455840770|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
126696388|NCT00896532|455840771|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696389|NCT00896532|455840772|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126248623|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248624|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248625|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248626|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248627|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126696390|NCT00896532|455840773|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696391|NCT00896532|455840774|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696392|NCT00896532|455840775|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696393|NCT00896532|455840776|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696394|NCT00896532|455840777|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696395|NCT00896532|455840778|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696396|NCT00896532|455840779|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126248628|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248629|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248630|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248631|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248632|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248633|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248634|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248635|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248636|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248637|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248638|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126546230|NCT03285295|455293734|FG000|Alinity s Anti-HCV|No Results Generated|71|||
126546231|NCT03285295|455293735|FG001|Alinity s Anti-HCV|No Results Generated|0|||
126546232|NCT03285295|455293736|FG002|Alinity s Anti-HCV|No Results Generated|0|||
126546233|NCT03285295|455293737|FG003|Alinity s Anti-HCV|No Results Generated|0|||
126546234|NCT03285295|455293738|FG004|Alinity s Anti-HCV|No Results Generated|0|||
126546235|NCT03285295|455293734|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
126546236|NCT03285295|455293735|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
126546237|NCT03285295|455293736|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
126546238|NCT03285295|455293737|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
126546239|NCT03285295|455293738|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
126546240|NCT03285295|455293734|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
126546241|NCT03285295|455293735|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
126546242|NCT03285295|455293736|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
126546243|NCT03285295|455293737|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
126546244|NCT03285295|455293738|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
126546245|NCT03285295|455293734|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
126546246|NCT03285295|455293735|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
126546247|NCT03285295|455293736|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
126546248|NCT03285295|455293737|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
126546249|NCT03285295|455293738|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
126546250|NCT03285295|455293734|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
126546251|NCT03285295|455293735|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
126546252|NCT03285295|455293736|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
126546253|NCT03285295|455293737|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
126546254|NCT03285295|455293738|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
126546255|NCT03285295|455293734|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
126546256|NCT03285295|455293735|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
126696397|NCT00896532|455840780|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
126696398|NCT00896532|455840758|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696399|NCT00896532|455840759|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696400|NCT00896532|455840760|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696401|NCT00896532|455840761|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696402|NCT00896532|455840762|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696403|NCT00896532|455840763|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696404|NCT00896532|455840764|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696405|NCT00896532|455840765|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696406|NCT00896532|455840766|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696407|NCT00896532|455840767|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696408|NCT00896532|455840768|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696409|NCT00896532|455840769|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696410|NCT00896532|455840770|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
126696411|NCT00896532|455840771|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
126696412|NCT00896532|455840772|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696413|NCT00896532|455840773|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126248639|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248640|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248641|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248642|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126357841|NCT04518410|454602227|FG018|Overall Study|Requirement to start alternative therapy|0|||
126546257|NCT03285295|455293736|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
126546258|NCT03285295|455293737|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
126248643|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126546259|NCT03285295|455293738|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
126248644|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
126248645|NCT00112437|454202270|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248646|NCT00112437|454202271|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248647|NCT00112437|454202272|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248648|NCT00112437|454202273|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248649|NCT00112437|454202274|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
126248650|NCT00112437|454202275|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248651|NCT00112437|454202276|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248652|NCT00112437|454202277|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248653|NCT00112437|454202278|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248654|NCT00112437|454202279|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248655|NCT00112437|454202280|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248656|NCT00112437|454202281|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248657|NCT00112437|454202282|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248658|NCT00112437|454202283|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248659|NCT00112437|454202284|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248660|NCT00112437|454202285|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248661|NCT00112437|454202286|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248662|NCT00112437|454202287|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248663|NCT00112437|454202288|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248664|NCT00112437|454202289|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248665|NCT00112437|454202290|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248666|NCT00112437|454202291|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248667|NCT00112437|454202292|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248668|NCT00112437|454202293|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248669|NCT00112437|454202294|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248670|NCT00112437|454202295|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
126248671|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
126248672|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
126248673|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
126248674|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
126248675|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
126248676|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
126248677|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
126248678|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
126248679|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
126248680|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
126248681|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
126248682|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
126248683|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
126248684|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
126248685|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
126248686|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
126248687|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
126248688|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
126248689|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
126248690|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
126248691|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
126248692|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
126248693|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
126248694|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
126248695|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
126248696|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
126248697|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248698|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248699|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248700|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248701|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248702|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
126248703|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
126248704|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248705|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248706|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
126248707|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248708|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248709|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248710|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248711|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126696414|NCT00896532|455840774|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696415|NCT00896532|455840775|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696416|NCT00896532|455840776|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696417|NCT00896532|455840777|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696418|NCT00896532|455840778|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696419|NCT00896532|455840779|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696420|NCT00896532|455840780|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
126696421|NCT00896532|455840758|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
126696422|NCT00896532|455840759|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
126696423|NCT00896532|455840760|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
126696424|NCT00896532|455840761|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
126696425|NCT00896532|455840762|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
126696426|NCT00896532|455840763|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
126696427|NCT00896532|455840764|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
126696428|NCT00896532|455840765|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
126696429|NCT00896532|455840766|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
126696430|NCT00896532|455840767|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
126696431|NCT00896532|455840768|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
126696432|NCT00896532|455840769|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
126696433|NCT00896532|455840770|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
126696434|NCT00896532|455840771|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
126696435|NCT00896532|455840772|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
126696436|NCT00896532|455840773|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
126696437|NCT00896532|455840774|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
126696438|NCT00896532|455840775|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
126546260|NCT03285295|455293734|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
126546261|NCT03285295|455293735|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
126546262|NCT03285295|455293736|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
126546263|NCT03285295|455293737|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
126546264|NCT03285295|455293738|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
126696439|NCT00896532|455840776|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
126762037|NCT02222246|456081115|FG000|Overall Study|Physician Decision|0|||
126762038|NCT02222246|456081116|FG001|Overall Study|Physician Decision|1|||
126762039|NCT02660489|456081117|FG000|Overall Study|Lost to Follow-up|1|||
126762040|NCT02660489|456081118|FG001|Overall Study|Lost to Follow-up|1|||
126762041|NCT02660489|456081117|FG000|Overall Study|Adverse Event|1|||
126762042|NCT02660489|456081118|FG001|Overall Study|Adverse Event|3|||
126248712|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248713|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248714|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248715|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248716|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248717|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248718|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248719|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248720|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248721|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248722|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
126248723|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248724|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248725|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248726|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248727|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248728|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248729|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248730|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248731|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
126546265|NCT03285295|455293734|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
126248732|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248733|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248734|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126546266|NCT03285295|455293735|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
126546267|NCT03285295|455293736|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
126696440|NCT00896532|455840777|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
126248735|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248736|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248737|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248738|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248739|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126546268|NCT03285295|455293737|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
126696441|NCT00896532|455840778|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
126696442|NCT00896532|455840779|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
126696443|NCT00896532|455840780|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
126248740|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248741|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248742|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248743|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248744|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248745|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248746|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248747|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248748|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
126248749|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248750|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248751|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248752|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248753|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248754|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
126357842|NCT04518410|454602228|FG019|Overall Study|Requirement to start alternative therapy|0|||
126248755|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248756|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248757|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
126248758|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248759|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248760|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248761|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248762|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248763|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248764|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248765|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248766|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248767|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248768|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248769|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248770|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248771|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248772|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248773|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248774|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
126248775|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248776|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248777|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248778|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126357843|NCT04518410|454602229|FG020|Overall Study|Requirement to start alternative therapy|0|||
126696444|NCT00896532|455840758|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696445|NCT00896532|455840759|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696446|NCT00896532|455840760|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696447|NCT00896532|455840761|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696448|NCT00896532|455840762|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696449|NCT00896532|455840763|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696450|NCT00896532|455840764|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696451|NCT00896532|455840765|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696452|NCT00896532|455840766|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696453|NCT00896532|455840767|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696454|NCT00896532|455840768|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696455|NCT00896532|455840769|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696456|NCT00896532|455840770|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696457|NCT00896532|455840771|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696458|NCT00896532|455840772|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696459|NCT00896532|455840773|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
126696460|NCT00896532|455840774|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
126696461|NCT00896532|455840775|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696462|NCT00896532|455840776|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126248779|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248780|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
126248781|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
126248782|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
126248783|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
126696463|NCT00896532|455840777|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696464|NCT00896532|455840778|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696465|NCT00896532|455840779|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696466|NCT00896532|455840780|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
126696467|NCT00896532|455840758|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696468|NCT00896532|455840759|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696469|NCT00896532|455840760|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696470|NCT00896532|455840761|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696471|NCT00896532|455840762|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696472|NCT00896532|455840763|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126248784|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
126248785|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248786|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248787|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248788|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248789|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248790|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248791|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248792|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248793|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248794|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248795|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248796|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248797|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248798|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248799|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248800|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
126248801|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248802|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248803|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248804|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248805|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248806|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248807|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248808|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248809|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248810|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
126248811|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248812|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248813|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248814|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248815|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248816|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248817|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248818|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126696473|NCT00896532|455840764|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696474|NCT00896532|455840765|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696475|NCT00896532|455840766|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696476|NCT00896532|455840767|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696477|NCT00896532|455840768|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126248819|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248820|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248821|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248822|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248823|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126696478|NCT00896532|455840769|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126762043|NCT02660489|456081117|FG000|Overall Study|no rhinovirus infection|4|||
126248824|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248825|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248826|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
126248827|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248828|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248829|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248830|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
126696479|NCT00896532|455840770|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696480|NCT00896532|455840771|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126248831|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248832|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248833|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248834|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248835|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248836|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
126248837|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248838|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248839|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248840|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248841|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248842|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248843|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248844|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248845|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248846|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248847|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248848|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248849|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248850|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248851|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248852|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
126248853|NCT00112437|454202270|FG000|Year 2 (12-Month Extension)|Moved|0|||
126248854|NCT00112437|454202271|FG001|Year 2 (12-Month Extension)|Moved|0|||
126248855|NCT00112437|454202272|FG002|Year 2 (12-Month Extension)|Moved|0|||
126248856|NCT00112437|454202273|FG003|Year 2 (12-Month Extension)|Moved|0|||
126248857|NCT00112437|454202274|FG004|Year 2 (12-Month Extension)|Moved|0|||
126248858|NCT00112437|454202275|FG005|Year 2 (12-Month Extension)|Moved|0|||
126248859|NCT00112437|454202276|FG006|Year 2 (12-Month Extension)|Moved|0|||
126248860|NCT00112437|454202277|FG007|Year 2 (12-Month Extension)|Moved|0|||
126248861|NCT00112437|454202278|FG008|Year 2 (12-Month Extension)|Moved|0|||
126248862|NCT00112437|454202279|FG009|Year 2 (12-Month Extension)|Moved|1|||
126248863|NCT00112437|454202280|FG010|Year 2 (12-Month Extension)|Moved|0|||
126248864|NCT00112437|454202281|FG011|Year 2 (12-Month Extension)|Moved|0|||
126248865|NCT00112437|454202282|FG012|Year 2 (12-Month Extension)|Moved|0|||
126248866|NCT00112437|454202283|FG013|Year 2 (12-Month Extension)|Moved|0|||
126248867|NCT00112437|454202284|FG014|Year 2 (12-Month Extension)|Moved|0|||
126248868|NCT00112437|454202285|FG015|Year 2 (12-Month Extension)|Moved|0|||
126248869|NCT00112437|454202286|FG016|Year 2 (12-Month Extension)|Moved|0|||
126248870|NCT00112437|454202287|FG017|Year 2 (12-Month Extension)|Moved|0|||
126248871|NCT00112437|454202288|FG018|Year 2 (12-Month Extension)|Moved|0|||
126248872|NCT00112437|454202289|FG019|Year 2 (12-Month Extension)|Moved|0|||
126248873|NCT00112437|454202290|FG020|Year 2 (12-Month Extension)|Moved|0|||
126248874|NCT00112437|454202291|FG021|Year 2 (12-Month Extension)|Moved|0|||
126248875|NCT00112437|454202292|FG022|Year 2 (12-Month Extension)|Moved|0|||
126248876|NCT00112437|454202293|FG023|Year 2 (12-Month Extension)|Moved|0|||
126248877|NCT00112437|454202294|FG024|Year 2 (12-Month Extension)|Moved|0|||
126248878|NCT00112437|454202295|FG025|Year 2 (12-Month Extension)|Moved|0|||
126248879|NCT00112437|454202270|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
126248880|NCT00112437|454202271|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
126248881|NCT00112437|454202272|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
126248882|NCT00112437|454202273|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
126248883|NCT00112437|454202274|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
126696481|NCT00896532|455840772|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696482|NCT00896532|455840773|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
126696483|NCT00896532|455840774|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
126696484|NCT00896532|455840775|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
126696485|NCT00896532|455840776|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126248884|NCT00112437|454202275|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
126696486|NCT00896532|455840777|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126248885|NCT00112437|454202276|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
126248886|NCT00112437|454202277|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
126696487|NCT00896532|455840778|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126248887|NCT00112437|454202278|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
126248888|NCT00112437|454202279|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
126248889|NCT00112437|454202280|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
126248890|NCT00112437|454202281|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
126248891|NCT00112437|454202282|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
126248892|NCT00112437|454202283|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
126696488|NCT00896532|455840779|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696489|NCT00896532|455840780|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
126696490|NCT00896532|455840758|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696491|NCT00896532|455840759|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696492|NCT00896532|455840760|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696493|NCT00896532|455840761|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696494|NCT00896532|455840762|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696495|NCT00896532|455840763|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696496|NCT00896532|455840764|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696497|NCT00896532|455840765|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696498|NCT00896532|455840766|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696499|NCT00896532|455840767|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696500|NCT00896532|455840768|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696501|NCT00896532|455840769|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696502|NCT00896532|455840770|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696503|NCT00896532|455840771|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696504|NCT00896532|455840772|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696505|NCT00896532|455840773|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696506|NCT00896532|455840774|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
126248893|NCT00112437|454202284|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
126248894|NCT00112437|454202285|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
126248895|NCT00112437|454202286|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
126248896|NCT00112437|454202287|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
126248897|NCT00112437|454202288|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
126248898|NCT00112437|454202289|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
126248899|NCT00112437|454202290|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
126248900|NCT00112437|454202291|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
126248901|NCT00112437|454202292|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
126248902|NCT00112437|454202293|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
126248903|NCT00112437|454202294|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
126248904|NCT00112437|454202295|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
126248905|NCT00112437|454202270|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248906|NCT00112437|454202271|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248907|NCT00112437|454202272|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248908|NCT00112437|454202273|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248909|NCT00112437|454202274|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248910|NCT00112437|454202275|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248911|NCT00112437|454202276|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248912|NCT00112437|454202277|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248913|NCT00112437|454202278|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248914|NCT00112437|454202279|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248915|NCT00112437|454202280|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248916|NCT00112437|454202281|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
126248917|NCT00112437|454202282|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248918|NCT00112437|454202283|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
126248919|NCT00112437|454202284|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248920|NCT00112437|454202285|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
126248921|NCT00112437|454202286|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248922|NCT00112437|454202287|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248923|NCT00112437|454202288|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
126248924|NCT00112437|454202289|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126696507|NCT00896532|455840775|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696508|NCT00896532|455840776|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696509|NCT00896532|455840777|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696510|NCT00896532|455840778|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126248925|NCT00112437|454202290|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248926|NCT00112437|454202291|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248927|NCT00112437|454202292|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248928|NCT00112437|454202293|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248929|NCT00112437|454202294|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126248930|NCT00112437|454202295|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
126546269|NCT03285295|455293738|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
126696511|NCT00896532|455840779|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126696512|NCT00896532|455840780|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
126762044|NCT02660489|456081118|FG001|Overall Study|no rhinovirus infection|4|||
126248931|NCT00112437|454202270|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248932|NCT00112437|454202271|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248933|NCT00112437|454202272|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248934|NCT00112437|454202273|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248935|NCT00112437|454202274|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248936|NCT00112437|454202275|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248937|NCT00112437|454202276|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248938|NCT00112437|454202277|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248939|NCT00112437|454202278|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248940|NCT00112437|454202279|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248941|NCT00112437|454202280|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248942|NCT00112437|454202281|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248943|NCT00112437|454202282|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248944|NCT00112437|454202283|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248945|NCT00112437|454202284|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248946|NCT00112437|454202285|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
126248947|NCT00112437|454202286|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248948|NCT00112437|454202287|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248949|NCT00112437|454202288|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248950|NCT00112437|454202289|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248951|NCT00112437|454202290|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248952|NCT00112437|454202291|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248953|NCT00112437|454202292|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248954|NCT00112437|454202293|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248955|NCT00112437|454202294|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248956|NCT00112437|454202295|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
126248957|NCT00112437|454202270|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248958|NCT00112437|454202271|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248959|NCT00112437|454202272|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248960|NCT00112437|454202273|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248961|NCT00112437|454202274|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248962|NCT00112437|454202275|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248963|NCT00112437|454202276|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248964|NCT00112437|454202277|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248965|NCT00112437|454202278|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248966|NCT00112437|454202279|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248967|NCT00112437|454202280|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248968|NCT00112437|454202281|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248969|NCT00112437|454202282|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248970|NCT00112437|454202283|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248971|NCT00112437|454202284|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248972|NCT00112437|454202285|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
126248973|NCT00112437|454202286|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248974|NCT00112437|454202287|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248975|NCT00112437|454202288|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248976|NCT00112437|454202289|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248977|NCT00112437|454202290|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248978|NCT00112437|454202291|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248979|NCT00112437|454202292|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248980|NCT00112437|454202293|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248981|NCT00112437|454202294|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
126357844|NCT04518410|454602230|FG021|Overall Study|Requirement to start alternative therapy|0|||
126357845|NCT04518410|454602231|FG022|Overall Study|Requirement to start alternative therapy|0|||
126357846|NCT04518410|454602232|FG023|Overall Study|Requirement to start alternative therapy|0|||
126357847|NCT04518410|454602233|FG024|Overall Study|Requirement to start alternative therapy|0|||
126357848|NCT04518410|454602209|FG000|Overall Study|Randomized but not treated|0|||
126357849|NCT04518410|454602210|FG001|Overall Study|Randomized but not treated|0|||
126357850|NCT04518410|454602211|FG002|Overall Study|Randomized but not treated|0|||
126357851|NCT04518410|454602212|FG003|Overall Study|Randomized but not treated|2|||
126357852|NCT04518410|454602213|FG004|Overall Study|Randomized but not treated|6|||
126357853|NCT04518410|454602214|FG005|Overall Study|Randomized but not treated|4|||
126357854|NCT04518410|454602215|FG006|Overall Study|Randomized but not treated|3|||
126357855|NCT04518410|454602216|FG007|Overall Study|Randomized but not treated|3|||
126357856|NCT04518410|454602217|FG008|Overall Study|Randomized but not treated|0|||
126357857|NCT04518410|454602218|FG009|Overall Study|Randomized but not treated|4|||
126357858|NCT04518410|454602219|FG010|Overall Study|Randomized but not treated|0|||
126357859|NCT04518410|454602220|FG011|Overall Study|Randomized but not treated|0|||
126357860|NCT04518410|454602221|FG012|Overall Study|Randomized but not treated|1|||
126357861|NCT04518410|454602222|FG013|Overall Study|Randomized but not treated|3|||
126357862|NCT04518410|454602223|FG014|Overall Study|Randomized but not treated|3|||
126357863|NCT04518410|454602224|FG015|Overall Study|Randomized but not treated|3|||
126357864|NCT04518410|454602225|FG016|Overall Study|Randomized but not treated|4|||
126357865|NCT04518410|454602226|FG017|Overall Study|Randomized but not treated|5|||
126357866|NCT04518410|454602227|FG018|Overall Study|Randomized but not treated|4|||
126357867|NCT04518410|454602228|FG019|Overall Study|Randomized but not treated|0|||
126248982|NCT00112437|454202295|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
126248983|NCT00112437|454202270|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248984|NCT00112437|454202271|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248985|NCT00112437|454202272|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248986|NCT00112437|454202273|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248987|NCT00112437|454202274|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248988|NCT00112437|454202275|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248989|NCT00112437|454202276|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248990|NCT00112437|454202277|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248991|NCT00112437|454202278|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248992|NCT00112437|454202279|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248993|NCT00112437|454202280|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248994|NCT00112437|454202281|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
126248995|NCT00112437|454202282|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248996|NCT00112437|454202283|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248997|NCT00112437|454202284|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
126248998|NCT00112437|454202285|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126248999|NCT00112437|454202286|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249000|NCT00112437|454202287|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249001|NCT00112437|454202288|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249002|NCT00112437|454202289|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249003|NCT00112437|454202290|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249004|NCT00112437|454202291|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249005|NCT00112437|454202292|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249006|NCT00112437|454202293|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249007|NCT00112437|454202294|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249008|NCT00112437|454202295|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
126249009|NCT00112437|454202270|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126357868|NCT04518410|454602229|FG020|Overall Study|Randomized but not treated|0|||
126249010|NCT00112437|454202271|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249011|NCT00112437|454202272|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126357869|NCT04518410|454602230|FG021|Overall Study|Randomized but not treated|5|||
126357870|NCT04518410|454602231|FG022|Overall Study|Randomized but not treated|0|||
126357871|NCT04518410|454602232|FG023|Overall Study|Randomized but not treated|3|||
126357872|NCT04518410|454602233|FG024|Overall Study|Randomized but not treated|1|||
126357873|NCT04518410|454602209|FG000|Overall Study|Screen Fail but Randomized|0|||
126357874|NCT04518410|454602210|FG001|Overall Study|Screen Fail but Randomized|0|||
126357875|NCT04518410|454602211|FG002|Overall Study|Screen Fail but Randomized|0|||
126357876|NCT04518410|454602212|FG003|Overall Study|Screen Fail but Randomized|0|||
126357877|NCT04518410|454602213|FG004|Overall Study|Screen Fail but Randomized|2|||
126357878|NCT04518410|454602214|FG005|Overall Study|Screen Fail but Randomized|0|||
126357879|NCT04518410|454602215|FG006|Overall Study|Screen Fail but Randomized|0|||
126357880|NCT04518410|454602216|FG007|Overall Study|Screen Fail but Randomized|0|||
126357881|NCT04518410|454602217|FG008|Overall Study|Screen Fail but Randomized|0|||
126357882|NCT04518410|454602218|FG009|Overall Study|Screen Fail but Randomized|0|||
126357883|NCT04518410|454602219|FG010|Overall Study|Screen Fail but Randomized|0|||
126357884|NCT04518410|454602220|FG011|Overall Study|Screen Fail but Randomized|0|||
126357885|NCT04518410|454602221|FG012|Overall Study|Screen Fail but Randomized|0|||
126357886|NCT04518410|454602222|FG013|Overall Study|Screen Fail but Randomized|0|||
126357887|NCT04518410|454602223|FG014|Overall Study|Screen Fail but Randomized|0|||
126357888|NCT04518410|454602224|FG015|Overall Study|Screen Fail but Randomized|0|||
126357889|NCT04518410|454602225|FG016|Overall Study|Screen Fail but Randomized|0|||
126357890|NCT04518410|454602226|FG017|Overall Study|Screen Fail but Randomized|0|||
126357891|NCT04518410|454602227|FG018|Overall Study|Screen Fail but Randomized|0|||
126357892|NCT04518410|454602228|FG019|Overall Study|Screen Fail but Randomized|0|||
126357893|NCT04518410|454602229|FG020|Overall Study|Screen Fail but Randomized|0|||
126357894|NCT04518410|454602230|FG021|Overall Study|Screen Fail but Randomized|0|||
126357895|NCT04518410|454602231|FG022|Overall Study|Screen Fail but Randomized|0|||
126357896|NCT04518410|454602232|FG023|Overall Study|Screen Fail but Randomized|0|||
126357897|NCT04518410|454602233|FG024|Overall Study|Screen Fail but Randomized|0|||
126357898|NCT04518410|454602209|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357899|NCT04518410|454602210|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357900|NCT04518410|454602211|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357901|NCT04518410|454602212|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357902|NCT04518410|454602213|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
126249012|NCT00112437|454202273|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249013|NCT00112437|454202274|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249014|NCT00112437|454202275|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249015|NCT00112437|454202276|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249016|NCT00112437|454202277|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249017|NCT00112437|454202278|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249018|NCT00112437|454202279|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249019|NCT00112437|454202280|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
126249020|NCT00112437|454202281|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
126249021|NCT00112437|454202282|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249022|NCT00112437|454202283|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249023|NCT00112437|454202284|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249024|NCT00112437|454202285|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249025|NCT00112437|454202286|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249026|NCT00112437|454202287|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249027|NCT00112437|454202288|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249028|NCT00112437|454202289|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249029|NCT00112437|454202290|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249030|NCT00112437|454202291|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249031|NCT00112437|454202292|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249032|NCT00112437|454202293|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249033|NCT00112437|454202294|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249034|NCT00112437|454202295|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
126249035|NCT00112437|454202270|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249036|NCT00112437|454202271|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126448508|NCT03818035|454941466|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
126448509|NCT03818035|454941467|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
126448510|NCT03818035|454941464|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
126448511|NCT03818035|454941465|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
126448512|NCT03818035|454941466|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
126448513|NCT03818035|454941467|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
126448514|NCT03818035|454941464|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
126448515|NCT03818035|454941465|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
126448516|NCT03818035|454941466|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
126249037|NCT00112437|454202272|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249038|NCT00112437|454202273|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126448517|NCT03818035|454941467|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
126448518|NCT03818035|454941464|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
126448519|NCT03818035|454941465|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
126448520|NCT03818035|454941466|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
126448521|NCT03818035|454941467|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
126448522|NCT03818035|454941464|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
126448523|NCT03818035|454941465|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
126448524|NCT03818035|454941466|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
126448525|NCT03818035|454941467|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
126448526|NCT03818035|454941464|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
126448527|NCT03818035|454941465|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
126448528|NCT03818035|454941466|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
126448529|NCT03818035|454941467|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
126448530|NCT03818035|454941464|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
126448531|NCT03818035|454941465|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
126448532|NCT03818035|454941466|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
126448533|NCT03818035|454941467|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
126448534|NCT03818035|454941464|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
126448535|NCT03818035|454941465|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
126448536|NCT03818035|454941466|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
126448537|NCT03818035|454941467|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
126448538|NCT03818035|454941464|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
126448539|NCT03818035|454941465|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
126249039|NCT00112437|454202274|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249040|NCT00112437|454202275|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249041|NCT00112437|454202276|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249042|NCT00112437|454202277|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249043|NCT00112437|454202278|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126696513|NCT00896532|455840758|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
126696514|NCT00896532|455840759|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
126696515|NCT00896532|455840760|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
126696516|NCT00896532|455840761|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
126696517|NCT00896532|455840762|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
126696518|NCT00896532|455840763|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
126696519|NCT00896532|455840764|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
126696520|NCT00896532|455840765|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
126696521|NCT00896532|455840766|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
126696522|NCT00896532|455840767|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
126696523|NCT00896532|455840768|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
126696524|NCT00896532|455840769|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
126696525|NCT00896532|455840770|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
126696526|NCT00896532|455840771|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
126696527|NCT00896532|455840772|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
126696528|NCT00896532|455840773|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
126696529|NCT00896532|455840774|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
126696530|NCT00896532|455840775|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
126696531|NCT00896532|455840776|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
126696532|NCT00896532|455840777|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
126696533|NCT00896532|455840778|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
126696534|NCT00896532|455840779|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
126696535|NCT00896532|455840780|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
126696536|NCT00896532|455840758|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696537|NCT00896532|455840759|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696538|NCT00896532|455840760|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696539|NCT00896532|455840761|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696540|NCT00896532|455840762|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696541|NCT00896532|455840763|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696542|NCT00896532|455840764|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696543|NCT00896532|455840765|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696544|NCT00896532|455840766|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696545|NCT00896532|455840767|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696546|NCT00896532|455840768|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696547|NCT00896532|455840769|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696548|NCT00896532|455840770|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126762045|NCT02064231|456081119|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
126762046|NCT02064231|456081120|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
126249044|NCT00112437|454202279|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249045|NCT00112437|454202280|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249046|NCT00112437|454202281|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249047|NCT00112437|454202282|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249048|NCT00112437|454202283|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249049|NCT00112437|454202284|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249050|NCT00112437|454202285|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249051|NCT00112437|454202286|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249052|NCT00112437|454202287|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249053|NCT00112437|454202288|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249054|NCT00112437|454202289|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249055|NCT00112437|454202290|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
126249056|NCT00112437|454202291|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
126249057|NCT00112437|454202292|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249058|NCT00112437|454202293|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249059|NCT00112437|454202294|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249060|NCT00112437|454202295|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
126249061|NCT00112437|454202270|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249062|NCT00112437|454202271|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249063|NCT00112437|454202272|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249064|NCT00112437|454202273|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249065|NCT00112437|454202274|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126448540|NCT03818035|454941466|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
126448541|NCT03818035|454941467|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
126448542|NCT03374202|454941470|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
126448543|NCT03374202|454941471|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
126448544|NCT03374202|454941472|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
126448545|NCT03374202|454941470|FG000|Five Year Long Term Follow Up|Death|0|||
126448546|NCT03374202|454941471|FG001|Five Year Long Term Follow Up|Death|1|||
126448547|NCT03374202|454941472|FG002|Five Year Long Term Follow Up|Death|0|||
126448548|NCT01395524|454943109|FG000|Overall Study|Non-compliance with study schedule|1|||
126448549|NCT01395524|454943110|FG001|Overall Study|Non-compliance with study schedule|0|||
126448550|NCT01395524|454943111|FG002|Overall Study|Non-compliance with study schedule|1|||
126448551|NCT01395524|454943109|FG000|Overall Study|Lost to Follow-up|3|||
126448552|NCT01395524|454943110|FG001|Overall Study|Lost to Follow-up|1|||
126546270|NCT03285295|455293734|FG000|Alinity s Anti-HBc|No Results Generated|70|||
126546271|NCT03285295|455293735|FG001|Alinity s Anti-HBc|No Results Generated|0|||
126546272|NCT03285295|455293736|FG002|Alinity s Anti-HBc|No Results Generated|0|||
126546273|NCT03285295|455293737|FG003|Alinity s Anti-HBc|No Results Generated|0|||
126546274|NCT03285295|455293738|FG004|Alinity s Anti-HBc|No Results Generated|0|||
126546275|NCT03285295|455293734|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
126546276|NCT03285295|455293735|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
126546277|NCT03285295|455293736|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
126546278|NCT03285295|455293737|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
126546279|NCT03285295|455293738|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
126546280|NCT03285295|455293734|FG000|Alinity s Chagas|Protocol Violation|76|||
126546281|NCT03285295|455293735|FG001|Alinity s Chagas|Protocol Violation|0|||
126546282|NCT03285295|455293736|FG002|Alinity s Chagas|Protocol Violation|0|||
126546283|NCT03285295|455293737|FG003|Alinity s Chagas|Protocol Violation|0|||
126546284|NCT03285295|455293738|FG004|Alinity s Chagas|Protocol Violation|0|||
126546285|NCT03285295|455293734|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
126546286|NCT03285295|455293735|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
126546287|NCT03285295|455293736|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
126546288|NCT03285295|455293737|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
126546289|NCT03285295|455293738|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
126546290|NCT03285295|455293734|FG000|Alinity s Chagas|No Results Generated|105|||
126546291|NCT03285295|455293735|FG001|Alinity s Chagas|No Results Generated|0|||
126546292|NCT03285295|455293736|FG002|Alinity s Chagas|No Results Generated|0|||
126546293|NCT03285295|455293737|FG003|Alinity s Chagas|No Results Generated|0|||
126546294|NCT03285295|455293738|FG004|Alinity s Chagas|No Results Generated|0|||
126546295|NCT03285295|455293734|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
126546296|NCT03285295|455293735|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
126546297|NCT03285295|455293736|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
126546298|NCT03285295|455293737|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
126546299|NCT03285295|455293738|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
126546300|NCT03015116|455293739|FG000|Overall Study|Lost to Follow-up|3|||
126546301|NCT03015116|455293740|FG001|Overall Study|Lost to Follow-up|0|||
126546302|NCT03015116|455293741|FG002|Overall Study|Lost to Follow-up|2|||
126546303|NCT03015116|455293739|FG000|Overall Study|Withdrawal by Subject|3|||
126546304|NCT03015116|455293740|FG001|Overall Study|Withdrawal by Subject|1|||
126546305|NCT03015116|455293741|FG002|Overall Study|Withdrawal by Subject|0|||
126546306|NCT03015116|455293739|FG000|Overall Study|Subject has New Medical Status|1|||
126546307|NCT03015116|455293740|FG001|Overall Study|Subject has New Medical Status|0|||
126546308|NCT03015116|455293741|FG002|Overall Study|Subject has New Medical Status|0|||
126546309|NCT03015116|455293739|FG000|Overall Study|Physician Decision|0|||
126546310|NCT03015116|455293740|FG001|Overall Study|Physician Decision|1|||
126546311|NCT03015116|455293741|FG002|Overall Study|Physician Decision|0|||
126546312|NCT02200939|455293746|FG000|Overall Study|Participant withdrew consent|0|||
126546313|NCT02200939|455293747|FG001|Overall Study|Participant withdrew consent|1|||
126546314|NCT02200939|455293746|FG000|Overall Study|Lost to Follow-up|2|||
126546315|NCT02200939|455293747|FG001|Overall Study|Lost to Follow-up|9|||
126546316|NCT02200939|455293746|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
126546317|NCT02200939|455293747|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
126546318|NCT03066622|455293748|FG000|Overall Study|Lost to Follow-up|24|||
126546319|NCT03066622|455293749|FG001|Overall Study|Lost to Follow-up|25|||
126546320|NCT03066622|455293748|FG000|Overall Study|Withdrawal by Subject|2|||
126546321|NCT03066622|455293749|FG001|Overall Study|Withdrawal by Subject|1|||
126546322|NCT00641719|455293750|FG000|Overall Study|Lack of Efficacy|1|||
126546323|NCT00641719|455293751|FG001|Overall Study|Lack of Efficacy|2|||
126546324|NCT00641719|455293750|FG000|Overall Study|Adverse Event|24|||
126546325|NCT00641719|455293751|FG001|Overall Study|Adverse Event|29|||
126546326|NCT00641719|455293750|FG000|Overall Study|Withdrawal by Subject|4|||
126546327|NCT00641719|455293751|FG001|Overall Study|Withdrawal by Subject|4|||
126546328|NCT00641719|455293750|FG000|Overall Study|Reason Not Specified|1|||
126546329|NCT00641719|455293751|FG001|Overall Study|Reason Not Specified|2|||
126546330|NCT00612534|455293759|FG000|Overall Study|Adverse Event|0|||
126696549|NCT00896532|455840771|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696550|NCT00896532|455840772|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126546331|NCT00612534|455293760|FG001|Overall Study|Adverse Event|4|||
126546332|NCT00612534|455293761|FG002|Overall Study|Adverse Event|2|||
126546333|NCT00612534|455293762|FG003|Overall Study|Adverse Event|1|||
126546334|NCT00612534|455293759|FG000|Overall Study|Lack of Efficacy|13|||
126546335|NCT00612534|455293760|FG001|Overall Study|Lack of Efficacy|12|||
126546336|NCT00612534|455293761|FG002|Overall Study|Lack of Efficacy|5|||
126546337|NCT00612534|455293762|FG003|Overall Study|Lack of Efficacy|16|||
126546338|NCT00612534|455293759|FG000|Overall Study|Other Reason|0|||
126546339|NCT00612534|455293760|FG001|Overall Study|Other Reason|1|||
126546340|NCT00612534|455293761|FG002|Overall Study|Other Reason|0|||
126546341|NCT00612534|455293762|FG003|Overall Study|Other Reason|0|||
126448553|NCT01395524|454943111|FG002|Overall Study|Lost to Follow-up|1|||
126448554|NCT01395524|454943109|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
126448555|NCT01395524|454943110|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
126448556|NCT01395524|454943111|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
126448557|NCT01395524|454943109|FG000|Overall Study|Severe noncompliance with protocol|1|||
126448558|NCT01395524|454943110|FG001|Overall Study|Severe noncompliance with protocol|0|||
126448559|NCT01395524|454943111|FG002|Overall Study|Severe noncompliance with protocol|0|||
126448560|NCT01395524|454943109|FG000|Overall Study|Adverse Event|4|||
126448561|NCT01395524|454943110|FG001|Overall Study|Adverse Event|4|||
126448562|NCT01395524|454943111|FG002|Overall Study|Adverse Event|3|||
126448563|NCT01395524|454943109|FG000|Overall Study|Death|1|||
126249066|NCT00112437|454202275|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249067|NCT00112437|454202276|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249068|NCT00112437|454202277|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249069|NCT00112437|454202278|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249070|NCT00112437|454202279|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249071|NCT00112437|454202280|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249072|NCT00112437|454202281|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126448564|NCT01395524|454943110|FG001|Overall Study|Death|0|||
126448565|NCT01395524|454943111|FG002|Overall Study|Death|0|||
126448566|NCT01395524|454943109|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
126448567|NCT01395524|454943110|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
126448568|NCT01395524|454943111|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
126448569|NCT01395524|454943109|FG000|Overall Study|Withdrawal by Subject|4|||
126448570|NCT01395524|454943110|FG001|Overall Study|Withdrawal by Subject|8|||
126448571|NCT01395524|454943111|FG002|Overall Study|Withdrawal by Subject|8|||
126448572|NCT01395524|454943109|FG000|Overall Study|Did not receive treatment|1|||
126448573|NCT01395524|454943110|FG001|Overall Study|Did not receive treatment|1|||
126448574|NCT01395524|454943111|FG002|Overall Study|Did not receive treatment|3|||
126448575|NCT01395524|454943109|FG000|Overall Study|Subject had spinal surgery|0|||
126448576|NCT01395524|454943110|FG001|Overall Study|Subject had spinal surgery|0|||
126448577|NCT01395524|454943111|FG002|Overall Study|Subject had spinal surgery|1|||
126448578|NCT01657461|454943112|FG000|Overall Study|Death|9|||
126448579|NCT01657461|454943113|FG001|Overall Study|Death|12|||
126448580|NCT01657461|454943112|FG000|Overall Study|Lost to Follow-up|0|||
126448581|NCT01657461|454943113|FG001|Overall Study|Lost to Follow-up|3|||
126448582|NCT01657461|454943112|FG000|Overall Study|Physician Decision|0|||
126448583|NCT01657461|454943113|FG001|Overall Study|Physician Decision|2|||
126448584|NCT01657461|454943112|FG000|Overall Study|Withdrawal by Subject|1|||
126448585|NCT01657461|454943113|FG001|Overall Study|Withdrawal by Subject|3|||
126448586|NCT00843284|454943122|FG000|Overall Study|Adverse Event|39|||
126448587|NCT00843284|454943122|FG000|Overall Study|Lack of Efficacy|5|||
126448588|NCT00843284|454943122|FG000|Overall Study|Lost to Follow-up|11|||
126448589|NCT00843284|454943122|FG000|Overall Study|Other|10|||
126448590|NCT00843284|454943122|FG000|Overall Study|Withdrawal by Subject|4|||
126448591|NCT00843284|454943122|FG000|Overall Study|Death|3|||
126448592|NCT02160899|454943136|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
126448593|NCT02160899|454943137|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
126448594|NCT02160899|454943138|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
126448595|NCT02160899|454943139|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
126448596|NCT02160899|454943140|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
126448597|NCT02160899|454943141|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
126448598|NCT01256294|454943142|FG000|Overall Study|Adverse Event|1|||
126448599|NCT01256294|454943143|FG001|Overall Study|Adverse Event|0|||
126448600|NCT01256294|454943142|FG000|Overall Study|Withdrawal by Subject|1|||
126448601|NCT01256294|454943143|FG001|Overall Study|Withdrawal by Subject|1|||
126448602|NCT01256294|454943142|FG000|Overall Study|Protocol deviation|2|||
126448603|NCT01256294|454943143|FG001|Overall Study|Protocol deviation|1|||
126448604|NCT00724711|454943144|FG000|Overall Study|Adverse Event|7|||
126448605|NCT00724711|454943145|FG001|Overall Study|Adverse Event|3|||
126448606|NCT00724711|454943144|FG000|Overall Study|Pregnancy|0|||
126696551|NCT00896532|455840773|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126249073|NCT00112437|454202282|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249074|NCT00112437|454202283|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126448607|NCT00724711|454943145|FG001|Overall Study|Pregnancy|1|||
126448608|NCT00724711|454943144|FG000|Overall Study|Lack of Efficacy|0|||
126448609|NCT00724711|454943145|FG001|Overall Study|Lack of Efficacy|1|||
126448610|NCT00724711|454943144|FG000|Overall Study|Physician Decision|0|||
126696552|NCT00896532|455840774|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
126696553|NCT00896532|455840775|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126448611|NCT00724711|454943145|FG001|Overall Study|Physician Decision|3|||
126448612|NCT00724711|454943144|FG000|Overall Study|Withdrawal by Subject|5|||
126448613|NCT00724711|454943145|FG001|Overall Study|Withdrawal by Subject|4|||
126696554|NCT00896532|455840776|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696555|NCT00896532|455840777|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696556|NCT00896532|455840778|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696557|NCT00896532|455840779|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696558|NCT00896532|455840780|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
126696559|NCT00896532|455840758|FG000|Months 48-72: Follow-on Phase|Death|0|||
126696560|NCT00896532|455840759|FG001|Months 48-72: Follow-on Phase|Death|0|||
126696561|NCT00896532|455840760|FG002|Months 48-72: Follow-on Phase|Death|0|||
126696562|NCT00896532|455840761|FG003|Months 48-72: Follow-on Phase|Death|0|||
126696563|NCT00896532|455840762|FG004|Months 48-72: Follow-on Phase|Death|0|||
126249075|NCT00112437|454202284|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249076|NCT00112437|454202285|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126696564|NCT00896532|455840763|FG005|Months 48-72: Follow-on Phase|Death|0|||
126696565|NCT00896532|455840764|FG006|Months 48-72: Follow-on Phase|Death|0|||
126696566|NCT00896532|455840765|FG007|Months 48-72: Follow-on Phase|Death|0|||
126249077|NCT00112437|454202286|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249078|NCT00112437|454202287|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249079|NCT00112437|454202288|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249080|NCT00112437|454202289|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249081|NCT00112437|454202290|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
126249082|NCT00112437|454202291|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249083|NCT00112437|454202292|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249084|NCT00112437|454202293|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126249085|NCT00112437|454202294|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126546342|NCT02223754|455293763|FG000|Period 1|Adverse Event|1|||
126546343|NCT02223754|455293764|FG001|Period 1|Adverse Event|0|||
126546344|NCT02223754|455293763|FG000|Period 1|Lost to Follow-up|0|||
126546345|NCT02223754|455293764|FG001|Period 1|Lost to Follow-up|1|||
126546346|NCT02223754|455293763|FG000|Period 1|Protocol Violation|2|||
126546347|NCT02223754|455293764|FG001|Period 1|Protocol Violation|4|||
126546348|NCT02223754|455293763|FG000|Period 1|Withdrawal by Subject|0|||
126546349|NCT02223754|455293764|FG001|Period 1|Withdrawal by Subject|4|||
126546350|NCT02223754|455293763|FG000|Period 1|Test Article No Longer Available|1|||
126546351|NCT02223754|455293764|FG001|Period 1|Test Article No Longer Available|5|||
126546352|NCT02223754|455293763|FG000|Period 1|Unsatisfactory Visual Response|0|||
126546353|NCT02223754|455293764|FG001|Period 1|Unsatisfactory Visual Response|1|||
126546354|NCT02223754|455293763|FG000|Period 2|Adverse Event|0|||
126546355|NCT02223754|455293764|FG001|Period 2|Adverse Event|1|||
126546356|NCT02223754|455293763|FG000|Period 2|Protocol Violation|1|||
126546357|NCT02223754|455293764|FG001|Period 2|Protocol Violation|0|||
126546358|NCT02223754|455293763|FG000|Period 2|Lens Discomfort|1|||
126546359|NCT02223754|455293764|FG001|Period 2|Lens Discomfort|1|||
126546360|NCT02223754|455293763|FG000|Period 2|Lost to Follow-up|1|||
126546361|NCT02223754|455293764|FG001|Period 2|Lost to Follow-up|0|||
126546362|NCT02223754|455293763|FG000|Period 2|Test Article No Longer Available|0|||
126546363|NCT02223754|455293764|FG001|Period 2|Test Article No Longer Available|1|||
126546364|NCT01008475|455293765|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
126546365|NCT01008475|455293766|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
126546366|NCT01008475|455293767|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
126546367|NCT01008475|455293768|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
126546368|NCT01008475|455293769|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
126546369|NCT01008475|455293770|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
126546370|NCT01008475|455293771|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
126546371|NCT03556358|455293772|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
126546372|NCT03556358|455293773|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
126696567|NCT00896532|455840766|FG008|Months 48-72: Follow-on Phase|Death|0|||
126696568|NCT00896532|455840767|FG009|Months 48-72: Follow-on Phase|Death|0|||
126696569|NCT00896532|455840768|FG010|Months 48-72: Follow-on Phase|Death|0|||
126696570|NCT00896532|455840769|FG011|Months 48-72: Follow-on Phase|Death|0|||
126249086|NCT00112437|454202295|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
126546373|NCT03556358|455293772|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
126249087|NCT00112437|454202270|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249088|NCT00112437|454202271|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249089|NCT00112437|454202272|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126546374|NCT03556358|455293773|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
126546375|NCT03556358|455293772|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
126546376|NCT03556358|455293773|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
126546377|NCT03556358|455293772|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
126696571|NCT00896532|455840770|FG012|Months 48-72: Follow-on Phase|Death|0|||
126696572|NCT00896532|455840771|FG013|Months 48-72: Follow-on Phase|Death|0|||
126448614|NCT00724711|454943144|FG000|Overall Study|Lost to Follow-up|4|||
126448615|NCT00724711|454943145|FG001|Overall Study|Lost to Follow-up|5|||
126448616|NCT00724711|454943144|FG000|Overall Study|Protocol Violation|1|||
126448617|NCT00724711|454943145|FG001|Overall Study|Protocol Violation|0|||
126448618|NCT01945710|454943146|FG000|Overall Study|Progressive Disease|5|||
126448619|NCT01945710|454943147|FG001|Overall Study|Progressive Disease|4|||
126448620|NCT01945710|454943148|FG002|Overall Study|Progressive Disease|3|||
126448621|NCT01945710|454943149|FG003|Overall Study|Progressive Disease|2|||
126448622|NCT01945710|454943150|FG004|Overall Study|Progressive Disease|7|||
126448623|NCT01945710|454943151|FG005|Overall Study|Progressive Disease|3|||
126448624|NCT01945710|454943152|FG006|Overall Study|Progressive Disease|19|||
126448625|NCT01945710|454943146|FG000|Overall Study|Adverse Event|0|||
126448626|NCT01945710|454943147|FG001|Overall Study|Adverse Event|1|||
126448627|NCT01945710|454943148|FG002|Overall Study|Adverse Event|0|||
126448628|NCT01945710|454943149|FG003|Overall Study|Adverse Event|0|||
126448629|NCT01945710|454943150|FG004|Overall Study|Adverse Event|0|||
126448630|NCT01945710|454943151|FG005|Overall Study|Adverse Event|0|||
126249090|NCT00112437|454202273|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249091|NCT00112437|454202274|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249092|NCT00112437|454202275|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249093|NCT00112437|454202276|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249094|NCT00112437|454202277|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249095|NCT00112437|454202278|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249096|NCT00112437|454202279|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249097|NCT00112437|454202280|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249098|NCT00112437|454202281|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249099|NCT00112437|454202282|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249100|NCT00112437|454202283|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249101|NCT00112437|454202284|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249102|NCT00112437|454202285|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249103|NCT00112437|454202286|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249104|NCT00112437|454202287|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249105|NCT00112437|454202288|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249106|NCT00112437|454202289|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249107|NCT00112437|454202290|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249108|NCT00112437|454202291|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
126249109|NCT00112437|454202292|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249110|NCT00112437|454202293|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249111|NCT00112437|454202294|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249112|NCT00112437|454202295|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
126249113|NCT00112437|454202270|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249114|NCT00112437|454202271|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249115|NCT00112437|454202272|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249116|NCT00112437|454202273|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249117|NCT00112437|454202274|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249118|NCT00112437|454202275|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249119|NCT00112437|454202276|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249120|NCT00112437|454202277|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249121|NCT00112437|454202278|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249122|NCT00112437|454202279|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249123|NCT00112437|454202280|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249124|NCT00112437|454202281|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249125|NCT00112437|454202282|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249126|NCT00112437|454202283|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249127|NCT00112437|454202284|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249128|NCT00112437|454202285|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249129|NCT00112437|454202286|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249130|NCT00112437|454202287|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249131|NCT00112437|454202288|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249132|NCT00112437|454202289|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249133|NCT00112437|454202290|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249134|NCT00112437|454202291|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
126249135|NCT00112437|454202292|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
126448631|NCT01945710|454943152|FG006|Overall Study|Adverse Event|0|||
126448632|NCT01945710|454943146|FG000|Overall Study|Other|2|||
126448633|NCT01945710|454943147|FG001|Overall Study|Other|0|||
126448634|NCT01945710|454943148|FG002|Overall Study|Other|3|||
126448635|NCT01945710|454943149|FG003|Overall Study|Other|1|||
126249136|NCT00112437|454202293|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249137|NCT00112437|454202294|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
126249138|NCT00112437|454202295|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
126448636|NCT01945710|454943150|FG004|Overall Study|Other|1|||
126448637|NCT01945710|454943151|FG005|Overall Study|Other|0|||
126448638|NCT01945710|454943152|FG006|Overall Study|Other|4|||
126696573|NCT00896532|455840772|FG014|Months 48-72: Follow-on Phase|Death|0|||
126696574|NCT00896532|455840773|FG015|Months 48-72: Follow-on Phase|Death|0|||
126696575|NCT00896532|455840774|FG016|Months 48-72: Follow-on Phase|Death|0|||
126696576|NCT00896532|455840775|FG017|Months 48-72: Follow-on Phase|Death|0|||
126249139|NCT00112437|454202270|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249140|NCT00112437|454202271|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249141|NCT00112437|454202272|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249142|NCT00112437|454202273|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249143|NCT00112437|454202274|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249144|NCT00112437|454202275|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249145|NCT00112437|454202276|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249146|NCT00112437|454202277|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249147|NCT00112437|454202278|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249148|NCT00112437|454202279|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249149|NCT00112437|454202280|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249150|NCT00112437|454202281|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249151|NCT00112437|454202282|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249152|NCT00112437|454202283|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249153|NCT00112437|454202284|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249154|NCT00112437|454202285|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126448639|NCT01945710|454943146|FG000|Overall Study|Withdrawal by Subject|0|||
126448640|NCT01945710|454943147|FG001|Overall Study|Withdrawal by Subject|1|||
126448641|NCT01945710|454943148|FG002|Overall Study|Withdrawal by Subject|1|||
126448642|NCT01945710|454943149|FG003|Overall Study|Withdrawal by Subject|0|||
126448643|NCT01945710|454943150|FG004|Overall Study|Withdrawal by Subject|1|||
126448644|NCT01945710|454943151|FG005|Overall Study|Withdrawal by Subject|0|||
126448645|NCT01945710|454943152|FG006|Overall Study|Withdrawal by Subject|0|||
126448646|NCT00375609|454943153|FG000|Overall Study|Did not receive treatment|1|||
126448647|NCT00375609|454943154|FG001|Overall Study|Did not receive treatment|0|||
126448648|NCT00375609|454943155|FG002|Overall Study|Did not receive treatment|0|||
126448649|NCT00375609|454943153|FG000|Overall Study|Adverse Event|0|||
126448650|NCT00375609|454943154|FG001|Overall Study|Adverse Event|3|||
126448651|NCT00375609|454943155|FG002|Overall Study|Adverse Event|0|||
126448652|NCT00375609|454943153|FG000|Overall Study|Lost to Follow-up|1|||
126448653|NCT00375609|454943154|FG001|Overall Study|Lost to Follow-up|0|||
126448654|NCT00375609|454943155|FG002|Overall Study|Lost to Follow-up|0|||
126448655|NCT00375609|454943153|FG000|Overall Study|Physician Decision|0|||
126448656|NCT00375609|454943154|FG001|Overall Study|Physician Decision|0|||
126448657|NCT00375609|454943155|FG002|Overall Study|Physician Decision|1|||
126448658|NCT00375609|454943153|FG000|Overall Study|Withdrawal by Subject|1|||
126448659|NCT00375609|454943154|FG001|Overall Study|Withdrawal by Subject|4|||
126448660|NCT00375609|454943155|FG002|Overall Study|Withdrawal by Subject|0|||
126448661|NCT00375609|454943153|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
126448662|NCT00375609|454943154|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
126448663|NCT00375609|454943155|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
126448664|NCT01368562|454943156|FG000|Overall Study|Adverse Event|1|||
126448665|NCT01368562|454943156|FG000|Overall Study|Disease progression|1|||
126448666|NCT01368562|454943156|FG000|Overall Study|Lost to Follow-up|1|||
126448667|NCT01368562|454943156|FG000|Overall Study|Death|6|||
126448668|NCT01368562|454943156|FG000|Overall Study|Unresponsive to treatment|5|||
126448669|NCT01368562|454943156|FG000|Overall Study|Other|3|||
126448670|NCT01368562|454943156|FG000|Overall Study|Other than specified|2|||
126448671|NCT02338882|454943161|FG000|Overall Study|Death|1|||
126448672|NCT02338882|454943162|FG001|Overall Study|Death|0|||
126448673|NCT02338882|454943161|FG000|Overall Study|Lost to Follow-up|6|||
126448674|NCT02338882|454943162|FG001|Overall Study|Lost to Follow-up|3|||
126448675|NCT04838977|454943163|FG000|Overall Study|Lost to Follow-up|2|||
126448676|NCT04838977|454943164|FG001|Overall Study|Lost to Follow-up|3|||
126448677|NCT04838977|454943163|FG000|Overall Study|Withdrawal by Subject|1|||
126448678|NCT04838977|454943164|FG001|Overall Study|Withdrawal by Subject|1|||
126448679|NCT02314637|454943168|FG000|Overall Study|Adverse Event|4|||
126448680|NCT02314637|454943169|FG001|Overall Study|Adverse Event|8|||
126249155|NCT00112437|454202286|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249156|NCT00112437|454202287|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126448681|NCT02314637|454943168|FG000|Overall Study|Lack of Efficacy|1|||
126448682|NCT02314637|454943169|FG001|Overall Study|Lack of Efficacy|0|||
126448683|NCT02314637|454943168|FG000|Overall Study|Physician Decision|5|||
126448684|NCT02314637|454943169|FG001|Overall Study|Physician Decision|2|||
126448685|NCT02314637|454943168|FG000|Overall Study|Withdrawal by Subject|5|||
126448686|NCT02314637|454943169|FG001|Overall Study|Withdrawal by Subject|4|||
126448687|NCT02314637|454943168|FG000|Overall Study|Other Reason|1|||
126696577|NCT00896532|455840776|FG018|Months 48-72: Follow-on Phase|Death|1|||
126448688|NCT02314637|454943169|FG001|Overall Study|Other Reason|0|||
126448689|NCT01536067|454943180|FG000|Overall Study|Disease Progression|1|||
126696578|NCT00896532|455840777|FG019|Months 48-72: Follow-on Phase|Death|0|||
126696579|NCT00896532|455840778|FG020|Months 48-72: Follow-on Phase|Death|0|||
126696580|NCT00896532|455840779|FG021|Months 48-72: Follow-on Phase|Death|0|||
126696581|NCT00896532|455840780|FG022|Months 48-72: Follow-on Phase|Death|0|||
126696582|NCT00896532|455840758|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696583|NCT00896532|455840759|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696584|NCT00896532|455840760|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696585|NCT00896532|455840761|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696586|NCT00896532|455840762|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696587|NCT00896532|455840763|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696588|NCT00896532|455840764|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696589|NCT00896532|455840765|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126357903|NCT04518410|454602214|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
126357904|NCT04518410|454602215|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
126357905|NCT04518410|454602216|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
126357906|NCT04518410|454602217|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
126357907|NCT04518410|454602218|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
126357908|NCT04518410|454602219|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
126357909|NCT04518410|454602220|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357910|NCT04518410|454602221|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357911|NCT04518410|454602222|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
126357912|NCT04518410|454602223|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
126357913|NCT04518410|454602224|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
126357914|NCT04518410|454602225|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
126357915|NCT04518410|454602226|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
126357916|NCT04518410|454602227|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
126357917|NCT04518410|454602228|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
126357918|NCT04518410|454602229|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
126357919|NCT04518410|454602230|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
126357920|NCT04518410|454602231|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
126357921|NCT04518410|454602232|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
126357922|NCT04518410|454602233|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
126357923|NCT04518410|454602209|FG000|Overall Study|Dual Enrolled Subject|0|||
126357924|NCT04518410|454602210|FG001|Overall Study|Dual Enrolled Subject|0|||
126357925|NCT04518410|454602211|FG002|Overall Study|Dual Enrolled Subject|0|||
126357926|NCT04518410|454602212|FG003|Overall Study|Dual Enrolled Subject|0|||
126357927|NCT04518410|454602213|FG004|Overall Study|Dual Enrolled Subject|0|||
126357928|NCT04518410|454602214|FG005|Overall Study|Dual Enrolled Subject|0|||
126357929|NCT04518410|454602215|FG006|Overall Study|Dual Enrolled Subject|0|||
126357930|NCT04518410|454602216|FG007|Overall Study|Dual Enrolled Subject|0|||
126357931|NCT04518410|454602217|FG008|Overall Study|Dual Enrolled Subject|0|||
126357932|NCT04518410|454602218|FG009|Overall Study|Dual Enrolled Subject|0|||
126357933|NCT04518410|454602219|FG010|Overall Study|Dual Enrolled Subject|0|||
126357934|NCT04518410|454602220|FG011|Overall Study|Dual Enrolled Subject|0|||
126357935|NCT04518410|454602221|FG012|Overall Study|Dual Enrolled Subject|0|||
126357936|NCT04518410|454602222|FG013|Overall Study|Dual Enrolled Subject|0|||
126357937|NCT04518410|454602223|FG014|Overall Study|Dual Enrolled Subject|0|||
126357938|NCT04518410|454602224|FG015|Overall Study|Dual Enrolled Subject|0|||
126357939|NCT04518410|454602225|FG016|Overall Study|Dual Enrolled Subject|0|||
126357940|NCT04518410|454602226|FG017|Overall Study|Dual Enrolled Subject|1|||
126357941|NCT04518410|454602227|FG018|Overall Study|Dual Enrolled Subject|0|||
126357942|NCT04518410|454602228|FG019|Overall Study|Dual Enrolled Subject|0|||
126357943|NCT04518410|454602229|FG020|Overall Study|Dual Enrolled Subject|0|||
126357944|NCT04518410|454602230|FG021|Overall Study|Dual Enrolled Subject|0|||
126696590|NCT00896532|455840766|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696591|NCT00896532|455840767|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696592|NCT00896532|455840768|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696593|NCT00896532|455840769|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696594|NCT00896532|455840770|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696595|NCT00896532|455840771|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126249157|NCT00112437|454202288|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249158|NCT00112437|454202289|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126696596|NCT00896532|455840772|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696597|NCT00896532|455840773|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696598|NCT00896532|455840774|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696599|NCT00896532|455840775|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696600|NCT00896532|455840776|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696601|NCT00896532|455840777|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696602|NCT00896532|455840778|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126249159|NCT00112437|454202290|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
126249160|NCT00112437|454202291|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
126249161|NCT00112437|454202292|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249162|NCT00112437|454202293|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249163|NCT00112437|454202294|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249164|NCT00112437|454202295|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
126249165|NCT00112437|454202270|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249166|NCT00112437|454202271|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249167|NCT00112437|454202272|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249168|NCT00112437|454202273|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249169|NCT00112437|454202274|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249170|NCT00112437|454202275|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249171|NCT00112437|454202276|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249172|NCT00112437|454202277|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249173|NCT00112437|454202278|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249174|NCT00112437|454202279|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249175|NCT00112437|454202280|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249176|NCT00112437|454202281|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249177|NCT00112437|454202282|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249178|NCT00112437|454202283|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249179|NCT00112437|454202284|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249180|NCT00112437|454202285|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249181|NCT00112437|454202286|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249182|NCT00112437|454202287|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249183|NCT00112437|454202288|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249184|NCT00112437|454202289|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249185|NCT00112437|454202290|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249186|NCT00112437|454202291|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249187|NCT00112437|454202292|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
126249188|NCT00112437|454202293|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
126249189|NCT00112437|454202294|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
126249190|NCT00112437|454202295|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
126249191|NCT00112437|454202270|FG000|Years 6-10 (60-Month Extension)|Death|0|||
126249192|NCT00112437|454202271|FG001|Years 6-10 (60-Month Extension)|Death|0|||
126249193|NCT00112437|454202272|FG002|Years 6-10 (60-Month Extension)|Death|0|||
126249194|NCT00112437|454202273|FG003|Years 6-10 (60-Month Extension)|Death|0|||
126357945|NCT04518410|454602231|FG022|Overall Study|Dual Enrolled Subject|0|||
126357946|NCT04518410|454602232|FG023|Overall Study|Dual Enrolled Subject|0|||
126357947|NCT04518410|454602233|FG024|Overall Study|Dual Enrolled Subject|0|||
126357948|NCT05737745|454602234|FG000|Overall Study|Withdrawal by Subject|0|||
126357949|NCT05737745|454602235|FG001|Overall Study|Withdrawal by Subject|6|||
126357950|NCT05737745|454602236|FG002|Overall Study|Withdrawal by Subject|1|||
126357951|NCT02547935|454602237|FG000|Overall Study|Other|0|||
126357952|NCT02547935|454602238|FG001|Overall Study|Other|1|||
126357953|NCT02547935|454602239|FG002|Overall Study|Other|0|||
126357954|NCT02547935|454602237|FG000|Overall Study|Withdrawal by Subject|2|||
126357955|NCT02547935|454602238|FG001|Overall Study|Withdrawal by Subject|3|||
126357956|NCT02547935|454602239|FG002|Overall Study|Withdrawal by Subject|4|||
126696603|NCT00896532|455840779|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
126249195|NCT00112437|454202274|FG004|Years 6-10 (60-Month Extension)|Death|0|||
126357957|NCT02547935|454602237|FG000|Overall Study|Screen Failure|2|||
126357958|NCT02547935|454602238|FG001|Overall Study|Screen Failure|0|||
126357959|NCT02547935|454602239|FG002|Overall Study|Screen Failure|0|||
126357960|NCT02547935|454602237|FG000|Overall Study|Physician Decision|0|||
126357961|NCT02547935|454602238|FG001|Overall Study|Physician Decision|1|||
126696604|NCT00896532|455840780|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
126696605|NCT00896532|455840758|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126249196|NCT00112437|454202275|FG005|Years 6-10 (60-Month Extension)|Death|0|||
126249197|NCT00112437|454202276|FG006|Years 6-10 (60-Month Extension)|Death|0|||
126357962|NCT02547935|454602239|FG002|Overall Study|Physician Decision|0|||
126357963|NCT02547935|454602237|FG000|Overall Study|Lost to Follow-up|0|||
126357964|NCT02547935|454602238|FG001|Overall Study|Lost to Follow-up|2|||
126357965|NCT02547935|454602239|FG002|Overall Study|Lost to Follow-up|1|||
126249198|NCT00112437|454202277|FG007|Years 6-10 (60-Month Extension)|Death|0|||
126249199|NCT00112437|454202278|FG008|Years 6-10 (60-Month Extension)|Death|0|||
126249200|NCT00112437|454202279|FG009|Years 6-10 (60-Month Extension)|Death|0|||
126249201|NCT00112437|454202280|FG010|Years 6-10 (60-Month Extension)|Death|0|||
126249202|NCT00112437|454202281|FG011|Years 6-10 (60-Month Extension)|Death|0|||
126249203|NCT00112437|454202282|FG012|Years 6-10 (60-Month Extension)|Death|0|||
126249204|NCT00112437|454202283|FG013|Years 6-10 (60-Month Extension)|Death|0|||
126696606|NCT00896532|455840759|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696607|NCT00896532|455840760|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696608|NCT00896532|455840761|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696609|NCT00896532|455840762|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696610|NCT00896532|455840763|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696611|NCT00896532|455840764|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696612|NCT00896532|455840765|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696613|NCT00896532|455840766|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696614|NCT00896532|455840767|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696615|NCT00896532|455840768|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696616|NCT00896532|455840769|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696617|NCT00896532|455840770|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696618|NCT00896532|455840771|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696619|NCT00896532|455840772|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696620|NCT00896532|455840773|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696621|NCT00896532|455840774|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696622|NCT00896532|455840775|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696623|NCT00896532|455840776|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696624|NCT00896532|455840777|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696625|NCT00896532|455840778|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696626|NCT00896532|455840779|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
126696627|NCT00896532|455840780|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
126696628|NCT02149810|455840781|FG000|Overall Study|Physician Decision|1|||
126696629|NCT02149810|455840782|FG001|Overall Study|Physician Decision|2|||
126696630|NCT02149810|455840781|FG000|Overall Study|Lost to Follow-up|2|||
126696631|NCT02149810|455840782|FG001|Overall Study|Lost to Follow-up|1|||
126696632|NCT02149810|455840781|FG000|Overall Study|Withdrawal by Subject|5|||
126696633|NCT02149810|455840782|FG001|Overall Study|Withdrawal by Subject|1|||
126696634|NCT01176916|455840783|FG000|Overall Study|Adverse Event|61|||
126696635|NCT01176916|455840783|FG000|Overall Study|Death|1|||
126249205|NCT00112437|454202284|FG014|Years 6-10 (60-Month Extension)|Death|0|||
126249206|NCT00112437|454202285|FG015|Years 6-10 (60-Month Extension)|Death|0|||
126249207|NCT00112437|454202286|FG016|Years 6-10 (60-Month Extension)|Death|0|||
126249208|NCT00112437|454202287|FG017|Years 6-10 (60-Month Extension)|Death|0|||
126249209|NCT00112437|454202288|FG018|Years 6-10 (60-Month Extension)|Death|0|||
126249210|NCT00112437|454202289|FG019|Years 6-10 (60-Month Extension)|Death|0|||
126249211|NCT00112437|454202290|FG020|Years 6-10 (60-Month Extension)|Death|0|||
126249212|NCT00112437|454202291|FG021|Years 6-10 (60-Month Extension)|Death|0|||
126249213|NCT00112437|454202292|FG022|Years 6-10 (60-Month Extension)|Death|0|||
126249214|NCT00112437|454202293|FG023|Years 6-10 (60-Month Extension)|Death|2|||
126249215|NCT00112437|454202294|FG024|Years 6-10 (60-Month Extension)|Death|0|||
126249216|NCT00112437|454202295|FG025|Years 6-10 (60-Month Extension)|Death|0|||
126249217|NCT00112437|454202270|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249218|NCT00112437|454202271|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249219|NCT00112437|454202272|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249220|NCT00112437|454202273|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249221|NCT00112437|454202274|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249222|NCT00112437|454202275|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249223|NCT00112437|454202276|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249224|NCT00112437|454202277|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249225|NCT00112437|454202278|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249226|NCT00112437|454202279|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126696636|NCT01176916|455840783|FG000|Overall Study|Lost to Follow-up|15|||
126696637|NCT01176916|455840783|FG000|Overall Study|Objective progression or relapse|17|||
126696638|NCT01176916|455840783|FG000|Overall Study|Protocol Violation|24|||
126696639|NCT01176916|455840783|FG000|Overall Study|Withdrawal by Subject|37|||
126249227|NCT00112437|454202280|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249228|NCT00112437|454202281|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249229|NCT00112437|454202282|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249230|NCT00112437|454202283|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249231|NCT00112437|454202284|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249232|NCT00112437|454202285|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249233|NCT00112437|454202286|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249234|NCT00112437|454202287|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126696640|NCT01176916|455840783|FG000|Overall Study|Other|6|||
126696641|NCT01176916|455840783|FG000|Overall Study|Withdrawal prior to Treatment|6|||
126696642|NCT01015833|455840786|FG000|Overall Study|Death|1|||
126696643|NCT01015833|455840787|FG001|Overall Study|Death|0|||
126696644|NCT01015833|455840786|FG000|Overall Study|Withdrawal by Subject|3|||
126249235|NCT00112437|454202288|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249236|NCT00112437|454202289|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249237|NCT00112437|454202290|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126448690|NCT03120351|454943181|FG000|Overall Study|Physician Decision|1|||
126448691|NCT03120351|454943182|FG001|Overall Study|Physician Decision|1|||
126448692|NCT01256190|454943183|FG000|Overall Study|Lost to Follow-up|2|||
126448693|NCT01256190|454943184|FG001|Overall Study|Lost to Follow-up|0|||
126448694|NCT02834793|454943185|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
126448695|NCT02834793|454943186|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
126448696|NCT02834793|454943187|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
126448697|NCT02834793|454943188|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
126448698|NCT02834793|454943185|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
126448699|NCT02834793|454943186|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
126448700|NCT02834793|454943187|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
126448701|NCT02834793|454943188|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
126448702|NCT02834793|454943185|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
126448703|NCT02834793|454943186|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
126448704|NCT02834793|454943187|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
126546378|NCT03556358|455293773|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
126546379|NCT03556358|455293772|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
126696645|NCT01015833|455840787|FG001|Overall Study|Withdrawal by Subject|2|||
126249238|NCT00112437|454202291|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249239|NCT00112437|454202292|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249240|NCT00112437|454202293|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249241|NCT00112437|454202294|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
126249242|NCT00112437|454202295|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
126249243|NCT00112437|454202270|FG000|Years 6-10 (60-Month Extension)|Other|0|||
126249244|NCT00112437|454202271|FG001|Years 6-10 (60-Month Extension)|Other|0|||
126249245|NCT00112437|454202272|FG002|Years 6-10 (60-Month Extension)|Other|0|||
126249246|NCT00112437|454202273|FG003|Years 6-10 (60-Month Extension)|Other|0|||
126249247|NCT00112437|454202274|FG004|Years 6-10 (60-Month Extension)|Other|0|||
126249248|NCT00112437|454202275|FG005|Years 6-10 (60-Month Extension)|Other|0|||
126249249|NCT00112437|454202276|FG006|Years 6-10 (60-Month Extension)|Other|0|||
126249250|NCT00112437|454202277|FG007|Years 6-10 (60-Month Extension)|Other|0|||
126249251|NCT00112437|454202278|FG008|Years 6-10 (60-Month Extension)|Other|0|||
126249252|NCT00112437|454202279|FG009|Years 6-10 (60-Month Extension)|Other|0|||
126249253|NCT00112437|454202280|FG010|Years 6-10 (60-Month Extension)|Other|0|||
126249254|NCT00112437|454202281|FG011|Years 6-10 (60-Month Extension)|Other|0|||
126249255|NCT00112437|454202282|FG012|Years 6-10 (60-Month Extension)|Other|0|||
126249256|NCT00112437|454202283|FG013|Years 6-10 (60-Month Extension)|Other|0|||
126249257|NCT00112437|454202284|FG014|Years 6-10 (60-Month Extension)|Other|0|||
126249258|NCT00112437|454202285|FG015|Years 6-10 (60-Month Extension)|Other|0|||
126249259|NCT00112437|454202286|FG016|Years 6-10 (60-Month Extension)|Other|0|||
126249260|NCT00112437|454202287|FG017|Years 6-10 (60-Month Extension)|Other|0|||
126249261|NCT00112437|454202288|FG018|Years 6-10 (60-Month Extension)|Other|0|||
126249262|NCT00112437|454202289|FG019|Years 6-10 (60-Month Extension)|Other|0|||
126249263|NCT00112437|454202290|FG020|Years 6-10 (60-Month Extension)|Other|0|||
126249264|NCT00112437|454202291|FG021|Years 6-10 (60-Month Extension)|Other|0|||
126249265|NCT00112437|454202292|FG022|Years 6-10 (60-Month Extension)|Other|0|||
126249266|NCT00112437|454202293|FG023|Years 6-10 (60-Month Extension)|Other|0|||
126249267|NCT00112437|454202294|FG024|Years 6-10 (60-Month Extension)|Other|1|||
126249268|NCT00112437|454202295|FG025|Years 6-10 (60-Month Extension)|Other|0|||
126249269|NCT00112437|454202270|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249270|NCT00112437|454202271|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249271|NCT00112437|454202272|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249272|NCT00112437|454202273|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249273|NCT00112437|454202274|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249274|NCT00112437|454202275|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249275|NCT00112437|454202276|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249276|NCT00112437|454202277|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249277|NCT00112437|454202278|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249278|NCT00112437|454202279|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126696646|NCT01015833|455840786|FG000|Overall Study|Adverse Event|0|||
126249279|NCT00112437|454202280|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249280|NCT00112437|454202281|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126696647|NCT01015833|455840787|FG001|Overall Study|Adverse Event|1|||
126696648|NCT01015833|455840786|FG000|Overall Study|Physician Decision|2|||
126357966|NCT02547935|454602237|FG000|Overall Study|Death|1|||
126357967|NCT02547935|454602238|FG001|Overall Study|Death|1|||
126249281|NCT00112437|454202282|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249282|NCT00112437|454202283|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249283|NCT00112437|454202284|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249284|NCT00112437|454202285|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249285|NCT00112437|454202286|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249286|NCT00112437|454202287|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249287|NCT00112437|454202288|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249288|NCT00112437|454202289|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249289|NCT00112437|454202290|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249290|NCT00112437|454202291|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249291|NCT00112437|454202292|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249292|NCT00112437|454202293|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
126249293|NCT00112437|454202294|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249294|NCT00112437|454202295|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
126249295|NCT00112437|454202270|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249296|NCT00112437|454202271|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249297|NCT00112437|454202272|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249298|NCT00112437|454202273|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249299|NCT00112437|454202274|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249300|NCT00112437|454202275|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249301|NCT00112437|454202276|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249302|NCT00112437|454202277|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249303|NCT00112437|454202278|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249304|NCT00112437|454202279|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249305|NCT00112437|454202280|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249306|NCT00112437|454202281|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249307|NCT00112437|454202282|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249308|NCT00112437|454202283|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249309|NCT00112437|454202284|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126357968|NCT02547935|454602239|FG002|Overall Study|Death|0|||
126357969|NCT04289298|454603838|FG000|Overall Study|Lost to Follow-up|5|||
126357970|NCT04289298|454603839|FG001|Overall Study|Lost to Follow-up|0|||
126357971|NCT04289298|454603838|FG000|Overall Study|Withdrawal by Subject|2|||
126357972|NCT04289298|454603839|FG001|Overall Study|Withdrawal by Subject|0|||
126357973|NCT01108796|454603840|FG000|Overall Study|Adverse Event|0|||
126357974|NCT01108796|454603841|FG001|Overall Study|Adverse Event|1|||
126357975|NCT01108796|454603840|FG000|Overall Study|Lost to Follow-up|7|||
126357976|NCT01108796|454603841|FG001|Overall Study|Lost to Follow-up|6|||
126357977|NCT00454142|454603842|FG000|Overall Study|Withdrawal by Subject|1|||
126357978|NCT02545127|454603849|FG000|Overall Study|Lost to Follow-up|1|||
126357979|NCT02545127|454603850|FG001|Overall Study|Lost to Follow-up|0|||
126357980|NCT03315689|454603851|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
126357981|NCT03315689|454603852|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
126696649|NCT01015833|455840787|FG001|Overall Study|Physician Decision|0|||
126696650|NCT01015833|455840786|FG000|Overall Study|Symptomatic deterioration|0|||
126696651|NCT01015833|455840787|FG001|Overall Study|Symptomatic deterioration|1|||
126696652|NCT01015833|455840786|FG000|Overall Study|Other|5|||
126696653|NCT01015833|455840787|FG001|Overall Study|Other|1|||
126696654|NCT01015833|455840786|FG000|Overall Study|Motor Vehicle Accidents|1|||
126696655|NCT01015833|455840787|FG001|Overall Study|Motor Vehicle Accidents|0|||
126696656|NCT01015833|455840786|FG000|Overall Study|Did not start treatment|1|||
126696657|NCT01015833|455840787|FG001|Overall Study|Did not start treatment|0|||
126696658|NCT01959165|455840788|FG000|Overall Study|Adverse Event|0|||
126696659|NCT01959165|455840789|FG001|Overall Study|Adverse Event|0|||
126696660|NCT01959165|455840790|FG002|Overall Study|Adverse Event|0|||
126696661|NCT01959165|455840791|FG003|Overall Study|Adverse Event|1|||
126696662|NCT01959165|455840788|FG000|Overall Study|Lack of Efficacy|1|||
126696663|NCT01959165|455840789|FG001|Overall Study|Lack of Efficacy|0|||
126696664|NCT01959165|455840790|FG002|Overall Study|Lack of Efficacy|0|||
126696665|NCT01959165|455840791|FG003|Overall Study|Lack of Efficacy|0|||
126696666|NCT01959165|455840788|FG000|Overall Study|overdose|0|||
126696667|NCT01959165|455840789|FG001|Overall Study|overdose|0|||
126696668|NCT01959165|455840790|FG002|Overall Study|overdose|0|||
126696669|NCT01959165|455840791|FG003|Overall Study|overdose|1|||
126696670|NCT01959165|455840788|FG000|Overall Study|Welfare recipient|0|||
126696671|NCT01959165|455840789|FG001|Overall Study|Welfare recipient|1|||
126696672|NCT01959165|455840790|FG002|Overall Study|Welfare recipient|0|||
126696673|NCT01959165|455840791|FG003|Overall Study|Welfare recipient|0|||
126696674|NCT00927563|455840804|FG000|Overall Study|Lost to Follow-up|1|||
126696675|NCT00927563|455840804|FG000|Overall Study|Withdrawal by Subject|1|||
126696676|NCT01468987|455840807|FG000|Overall Study|Adverse Event|12|||
126696677|NCT01468987|455840808|FG001|Overall Study|Adverse Event|9|||
126249310|NCT00112437|454202285|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249311|NCT00112437|454202286|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249312|NCT00112437|454202287|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249313|NCT00112437|454202288|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249314|NCT00112437|454202289|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249315|NCT00112437|454202290|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249316|NCT00112437|454202291|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126448705|NCT02834793|454943188|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
126448706|NCT02834793|454943185|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
126448707|NCT02834793|454943186|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
126448708|NCT02834793|454943187|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
126448709|NCT02834793|454943188|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
126448710|NCT02834793|454943185|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
126448711|NCT02834793|454943186|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
126448712|NCT02834793|454943187|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
126448713|NCT02834793|454943188|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
126448714|NCT02834793|454943185|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
126448715|NCT02834793|454943186|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
126448716|NCT02834793|454943187|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
126448717|NCT02834793|454943188|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
126448718|NCT02834793|454943185|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
126448719|NCT02834793|454943186|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
126448720|NCT02834793|454943187|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
126448721|NCT02834793|454943188|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
126448722|NCT02834793|454943185|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
126448723|NCT02834793|454943186|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
126448724|NCT02834793|454943187|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
126448725|NCT02834793|454943188|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
126448726|NCT02834793|454943185|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
126448727|NCT02834793|454943186|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
126448728|NCT02834793|454943187|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
126448729|NCT02834793|454943188|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
126448730|NCT02834793|454943185|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
126448731|NCT02834793|454943186|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
126448732|NCT02834793|454943187|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
126448733|NCT02834793|454943188|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
126448734|NCT02834793|454943185|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
126448735|NCT02834793|454943186|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
126448736|NCT02834793|454943187|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
126448737|NCT02834793|454943188|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
126448738|NCT02834793|454943185|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
126448739|NCT02834793|454943186|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
126448740|NCT02834793|454943187|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
126448741|NCT02834793|454943188|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
126249317|NCT00112437|454202292|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
126249318|NCT00112437|454202293|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
126448742|NCT02834793|454943185|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
126448743|NCT02834793|454943186|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
126448744|NCT02834793|454943187|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
126448745|NCT02834793|454943188|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
126448746|NCT02834793|454943185|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
126448747|NCT02834793|454943186|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
126448748|NCT02834793|454943187|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
126448749|NCT02834793|454943188|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
126448750|NCT02834793|454943185|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
126448751|NCT02834793|454943186|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
126249319|NCT00112437|454202294|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
126249320|NCT00112437|454202295|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
126249321|NCT00842309|454202305|FG000|Overall Study|Withdrawal by Subject|3|||
126249322|NCT00842309|454202306|FG001|Overall Study|Withdrawal by Subject|1|||
126249323|NCT02911025|454202307|FG000|Overall Study|Lost to Follow-up|3|||
126249324|NCT03218787|454202308|FG000|Overall Study|Lost to Follow-up|12|||
126249325|NCT03218787|454202308|FG000|Overall Study|Withdrawal by Subject|72|||
126249326|NCT03218787|454202308|FG000|Overall Study|Physician Decision|11|||
126249327|NCT03218787|454202308|FG000|Overall Study|Death|111|||
126249328|NCT02264977|454202309|FG000|Overall Study|Death|3|||
126448752|NCT02834793|454943187|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
126448753|NCT02834793|454943188|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
126448754|NCT01049009|454943189|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
126249329|NCT02264977|454202309|FG000|Overall Study|Physician Decision|1|||
126249330|NCT02264977|454202309|FG000|Overall Study|Refuse to return|1|||
126249331|NCT03573544|454202310|FG000|Overall Study|Adverse Event|0|||
126249332|NCT03573544|454202311|FG001|Overall Study|Adverse Event|0|||
126249333|NCT03573544|454202312|FG002|Overall Study|Adverse Event|0|||
126249334|NCT03573544|454202313|FG003|Overall Study|Adverse Event|3|||
126249335|NCT03573544|454202314|FG004|Overall Study|Adverse Event|1|||
126249336|NCT03573544|454202315|FG005|Overall Study|Adverse Event|0|||
126357982|NCT03315689|454603851|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
126357983|NCT03315689|454603852|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
126357984|NCT03315689|454603851|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
126696678|NCT01468987|455840807|FG000|Overall Study|Death|4|||
126696679|NCT01468987|455840808|FG001|Overall Study|Death|1|||
126696680|NCT01468987|455840807|FG000|Overall Study|Lost to Follow-up|10|||
126696681|NCT01468987|455840808|FG001|Overall Study|Lost to Follow-up|5|||
126696682|NCT01468987|455840807|FG000|Overall Study|Protocol Violation|8|||
126696683|NCT01468987|455840808|FG001|Overall Study|Protocol Violation|2|||
126696684|NCT01468987|455840807|FG000|Overall Study|Withdrawal by Subject|28|||
126696685|NCT01468987|455840808|FG001|Overall Study|Withdrawal by Subject|28|||
126696686|NCT01468987|455840807|FG000|Overall Study|Physician Decision|8|||
126696687|NCT01468987|455840808|FG001|Overall Study|Physician Decision|15|||
126696688|NCT01468987|455840807|FG000|Overall Study|Sponsor Decision|1|||
126696689|NCT01468987|455840808|FG001|Overall Study|Sponsor Decision|0|||
126696690|NCT05032950|455840809|FG000|Overall Study|Adverse Event|0|||
126696691|NCT05032950|455840810|FG001|Overall Study|Adverse Event|0|||
126696692|NCT05032950|455840811|FG002|Overall Study|Adverse Event|1|||
126696693|NCT05032950|455840812|FG003|Overall Study|Adverse Event|1|||
126696694|NCT05032950|455840813|FG004|Overall Study|Adverse Event|0|||
126696695|NCT05032950|455840814|FG005|Overall Study|Adverse Event|0|||
126696696|NCT01929135|455840823|FG000|Overall Study|Lost to Follow-up|1|||
126696697|NCT01929135|455840824|FG001|Overall Study|Lost to Follow-up|1|||
126696698|NCT02425098|455840825|FG000|Overall Study|Lost to Follow-up|7|||
126696699|NCT02425098|455840826|FG001|Overall Study|Lost to Follow-up|7|||
126696700|NCT02425098|455840825|FG000|Overall Study|Withdrawal by Subject|4|||
126696701|NCT02425098|455840826|FG001|Overall Study|Withdrawal by Subject|8|||
126696702|NCT02425098|455840825|FG000|Overall Study|Pregnancy|2|||
126696703|NCT02425098|455840826|FG001|Overall Study|Pregnancy|0|||
126696704|NCT02425098|455840825|FG000|Overall Study|Reason not Specified|0|||
126696705|NCT02425098|455840826|FG001|Overall Study|Reason not Specified|1|||
126696706|NCT03136107|455840831|FG000|Overall Study|Other (Not specified)|1|||
126696707|NCT00851903|455843151|FG000|Overall Study|Withdrawal by Subject|2|||
126696708|NCT02300129|455843152|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
126696709|NCT02300129|455843153|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
126696710|NCT02300129|455843154|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
126696711|NCT02300129|455843155|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
126696712|NCT02300129|455843152|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
126696713|NCT02300129|455843153|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
126696714|NCT02300129|455843154|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
126696715|NCT02300129|455843155|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
126696716|NCT02300129|455843152|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
126696717|NCT02300129|455843153|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
126696718|NCT02300129|455843154|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
126696719|NCT02300129|455843155|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
126696720|NCT00522392|455843158|FG000|Overall Study|Disease progression|0|||
126696721|NCT00522392|455843159|FG001|Overall Study|Disease progression|3|||
126696722|NCT00522392|455843158|FG000|Overall Study|Adverse Event|7|||
126696723|NCT00522392|455843159|FG001|Overall Study|Adverse Event|7|||
126696724|NCT00522392|455843158|FG000|Overall Study|Withdrawal by Subject|1|||
126696725|NCT00522392|455843159|FG001|Overall Study|Withdrawal by Subject|1|||
126696726|NCT00522392|455843158|FG000|Overall Study|Physician Decision|0|||
126696727|NCT00522392|455843159|FG001|Overall Study|Physician Decision|1|||
126696728|NCT00522392|455843158|FG000|Overall Study|Non-compliance|0|||
126696729|NCT00522392|455843159|FG001|Overall Study|Non-compliance|1|||
126696730|NCT00332709|455843168|FG000|Overall Study|Adverse Event|11|||
126696731|NCT00332709|455843169|FG001|Overall Study|Adverse Event|14|||
126696732|NCT00332709|455843168|FG000|Overall Study|Withdrawal by Subject|2|||
126696733|NCT00332709|455843169|FG001|Overall Study|Withdrawal by Subject|3|||
126696734|NCT00332709|455843168|FG000|Overall Study|Lost to Follow-up|2|||
126696735|NCT00332709|455843169|FG001|Overall Study|Lost to Follow-up|0|||
126696736|NCT00332709|455843168|FG000|Overall Study|Administrative Problems|0|||
126696737|NCT00332709|455843169|FG001|Overall Study|Administrative Problems|3|||
126696738|NCT00332709|455843168|FG000|Overall Study|Abnormal test procedure result|1|||
126696739|NCT00332709|455843169|FG001|Overall Study|Abnormal test procedure result|0|||
126696740|NCT01409928|455843171|FG000|Overall Study|Physician Decision|12|||
126696741|NCT00432237|455843174|FG000|Overall Study|Adverse Event|0|||
126249337|NCT03573544|454202316|FG006|Overall Study|Adverse Event|2|||
126249338|NCT03573544|454202317|FG007|Overall Study|Adverse Event|0|||
126696742|NCT00432237|455843175|FG001|Overall Study|Adverse Event|0|||
126696743|NCT00432237|455843176|FG002|Overall Study|Adverse Event|0|||
126696744|NCT00432237|455843177|FG003|Overall Study|Adverse Event|1|||
126696745|NCT00432237|455843174|FG000|Overall Study|Lack of Efficacy|0|||
126696746|NCT00432237|455843175|FG001|Overall Study|Lack of Efficacy|0|||
126249339|NCT03573544|454202310|FG000|Overall Study|Physician Decision|0|||
126249340|NCT03573544|454202311|FG001|Overall Study|Physician Decision|0|||
126249341|NCT03573544|454202312|FG002|Overall Study|Physician Decision|0|||
126249342|NCT03573544|454202313|FG003|Overall Study|Physician Decision|0|||
126249343|NCT03573544|454202314|FG004|Overall Study|Physician Decision|0|||
126249344|NCT03573544|454202315|FG005|Overall Study|Physician Decision|0|||
126249345|NCT03573544|454202316|FG006|Overall Study|Physician Decision|1|||
126249346|NCT03573544|454202317|FG007|Overall Study|Physician Decision|0|||
126249347|NCT03573544|454202310|FG000|Overall Study|Withdrawal by Subject|2|||
126249348|NCT03573544|454202311|FG001|Overall Study|Withdrawal by Subject|0|||
126249349|NCT03573544|454202312|FG002|Overall Study|Withdrawal by Subject|0|||
126249350|NCT03573544|454202313|FG003|Overall Study|Withdrawal by Subject|1|||
126762047|NCT02064231|456081121|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
126249351|NCT03573544|454202314|FG004|Overall Study|Withdrawal by Subject|1|||
126249352|NCT03573544|454202315|FG005|Overall Study|Withdrawal by Subject|1|||
126249353|NCT03573544|454202316|FG006|Overall Study|Withdrawal by Subject|0|||
126249354|NCT03573544|454202317|FG007|Overall Study|Withdrawal by Subject|1|||
126249355|NCT03573544|454202310|FG000|Overall Study|Disease progression|3|||
126249356|NCT03573544|454202311|FG001|Overall Study|Disease progression|3|||
126249357|NCT03573544|454202312|FG002|Overall Study|Disease progression|6|||
126249358|NCT03573544|454202313|FG003|Overall Study|Disease progression|4|||
126249359|NCT03573544|454202314|FG004|Overall Study|Disease progression|5|||
126249360|NCT03573544|454202315|FG005|Overall Study|Disease progression|7|||
126249361|NCT03573544|454202316|FG006|Overall Study|Disease progression|6|||
126249362|NCT03573544|454202317|FG007|Overall Study|Disease progression|7|||
126249363|NCT00227370|454202318|FG000|Overall Study|Withdrawal by Subject|1|||
126249364|NCT00227370|454202319|FG001|Overall Study|Withdrawal by Subject|2|||
126249365|NCT00227370|454202318|FG000|Overall Study|Death|3|||
126249366|NCT00227370|454202319|FG001|Overall Study|Death|4|||
126249367|NCT00227370|454202318|FG000|Overall Study|Adverse Event|6|||
126249368|NCT00227370|454202319|FG001|Overall Study|Adverse Event|11|||
126249369|NCT00227370|454202318|FG000|Overall Study|Physician Decision|9|||
126249370|NCT00227370|454202319|FG001|Overall Study|Physician Decision|6|||
126249371|NCT00227370|454202318|FG000|Overall Study|Other reasons|2|||
126249372|NCT00227370|454202319|FG001|Overall Study|Other reasons|1|||
126249373|NCT03846193|454202320|FG000|Overall Study|Physician Decision|0|||
126249374|NCT03846193|454202321|FG001|Overall Study|Physician Decision|0|||
126249375|NCT03846193|454202322|FG002|Overall Study|Physician Decision|1|||
126249376|NCT03846193|454202323|FG003|Overall Study|Physician Decision|0|||
126249377|NCT03846193|454202324|FG004|Overall Study|Physician Decision|0|||
126249378|NCT03846193|454202320|FG000|Overall Study|Lost to Follow-up|0|||
126249379|NCT03846193|454202321|FG001|Overall Study|Lost to Follow-up|0|||
126249380|NCT03846193|454202322|FG002|Overall Study|Lost to Follow-up|0|||
126249381|NCT03846193|454202323|FG003|Overall Study|Lost to Follow-up|0|||
126249382|NCT03846193|454202324|FG004|Overall Study|Lost to Follow-up|1|||
126249383|NCT03846193|454202320|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
126249384|NCT03846193|454202321|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
126249385|NCT03846193|454202322|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
126249386|NCT03846193|454202323|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
126249387|NCT03846193|454202324|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
126249388|NCT01229150|454202328|FG000|Overall Study|Toxicity|2|||
126357985|NCT03315689|454603852|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
126357986|NCT01783015|454603853|FG000|Blinded Treatment|Adverse Event|0|||
126357987|NCT01783015|454603854|FG001|Blinded Treatment|Adverse Event|1|||
126357988|NCT01783015|454603855|FG002|Blinded Treatment|Adverse Event|0|||
126696747|NCT00432237|455843176|FG002|Overall Study|Lack of Efficacy|0|||
126696748|NCT00432237|455843177|FG003|Overall Study|Lack of Efficacy|1|||
126696749|NCT00432237|455843174|FG000|Overall Study|Lost to Follow-up|10|||
126696750|NCT00432237|455843175|FG001|Overall Study|Lost to Follow-up|10|||
126696751|NCT00432237|455843176|FG002|Overall Study|Lost to Follow-up|18|||
126696752|NCT00432237|455843177|FG003|Overall Study|Lost to Follow-up|18|||
126696753|NCT00432237|455843174|FG000|Overall Study|Physician Decision|1|||
126696754|NCT00432237|455843175|FG001|Overall Study|Physician Decision|3|||
126696755|NCT00432237|455843176|FG002|Overall Study|Physician Decision|2|||
126696756|NCT00432237|455843177|FG003|Overall Study|Physician Decision|1|||
126696757|NCT00432237|455843174|FG000|Overall Study|Pregnancy|0|||
126249389|NCT01229150|454202329|FG001|Overall Study|Toxicity|2|||
126249390|NCT01229150|454202330|FG002|Overall Study|Toxicity|0|||
126249391|NCT01229150|454202331|FG003|Overall Study|Toxicity|0|||
126249392|NCT02011945|454202332|FG000|Overall Study|Participant requested to Discontinue|0|||
126696758|NCT00432237|455843175|FG001|Overall Study|Pregnancy|1|||
126696759|NCT00432237|455843176|FG002|Overall Study|Pregnancy|0|||
126696760|NCT00432237|455843177|FG003|Overall Study|Pregnancy|0|||
126696761|NCT00432237|455843174|FG000|Overall Study|Protocol Violation|13|||
126696762|NCT00432237|455843175|FG001|Overall Study|Protocol Violation|10|||
126696763|NCT00432237|455843176|FG002|Overall Study|Protocol Violation|11|||
126696764|NCT00432237|455843177|FG003|Overall Study|Protocol Violation|8|||
126448755|NCT01049009|454943190|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
126696765|NCT00432237|455843174|FG000|Overall Study|Withdrawal by Subject|5|||
126696766|NCT00432237|455843175|FG001|Overall Study|Withdrawal by Subject|6|||
126696767|NCT00432237|455843176|FG002|Overall Study|Withdrawal by Subject|9|||
126696768|NCT00432237|455843177|FG003|Overall Study|Withdrawal by Subject|11|||
126696769|NCT00432237|455843174|FG000|Overall Study|Lack of Qualifying Event|38|||
126696770|NCT00432237|455843175|FG001|Overall Study|Lack of Qualifying Event|71|||
126696771|NCT00432237|455843176|FG002|Overall Study|Lack of Qualifying Event|69|||
126696772|NCT00432237|455843177|FG003|Overall Study|Lack of Qualifying Event|84|||
126696773|NCT00603239|455843178|FG000|Overall Study|Adverse Event|4|||
126696774|NCT00603239|455843179|FG001|Overall Study|Adverse Event|1|||
126696775|NCT00603239|455843178|FG000|Overall Study|Entry criteria not met|0|||
126696776|NCT00603239|455843179|FG001|Overall Study|Entry criteria not met|1|||
126696777|NCT00603239|455843178|FG000|Overall Study|Loss of glucose control|3|||
126762048|NCT02064231|456081122|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
126249393|NCT02011945|454202333|FG001|Overall Study|Participant requested to Discontinue|1|||
126249394|NCT02011945|454202334|FG002|Overall Study|Participant requested to Discontinue|1|||
126249395|NCT02011945|454202332|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
126249396|NCT02011945|454202333|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
126249397|NCT02011945|454202334|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
126249398|NCT02011945|454202332|FG000|Overall Study|Study Drug Toxicity|0|||
126249399|NCT02011945|454202333|FG001|Overall Study|Study Drug Toxicity|0|||
126249400|NCT02011945|454202334|FG002|Overall Study|Study Drug Toxicity|1|||
126249401|NCT02011945|454202332|FG000|Overall Study|Treatment Failure|0|||
126249402|NCT02011945|454202333|FG001|Overall Study|Treatment Failure|7|||
126249403|NCT02011945|454202334|FG002|Overall Study|Treatment Failure|6|||
126249404|NCT02011945|454202332|FG000|Overall Study|No Longer Meets Study Criteria|1|||
126249405|NCT02011945|454202333|FG001|Overall Study|No Longer Meets Study Criteria|0|||
126249406|NCT02011945|454202334|FG002|Overall Study|No Longer Meets Study Criteria|0|||
126249407|NCT02011945|454202332|FG000|Overall Study|Proceeded to stem cell transplant|0|||
126249408|NCT02011945|454202333|FG001|Overall Study|Proceeded to stem cell transplant|0|||
126249409|NCT02011945|454202334|FG002|Overall Study|Proceeded to stem cell transplant|1|||
126249410|NCT02011945|454202332|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
126249411|NCT02011945|454202333|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
126249412|NCT02011945|454202334|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
126249413|NCT00902538|454202335|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
126249414|NCT00902538|454202336|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
126249415|NCT00902538|454202337|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
126249416|NCT00902538|454202338|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
126249417|NCT00902538|454202339|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
126249418|NCT00902538|454202340|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
126249419|NCT00902538|454202335|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
126249420|NCT00902538|454202336|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
126249421|NCT00902538|454202337|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
126249422|NCT00902538|454202338|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
126249423|NCT00902538|454202339|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
126357989|NCT01783015|454603853|FG000|Blinded Treatment|Protocol Violation|0|||
126357990|NCT01783015|454603854|FG001|Blinded Treatment|Protocol Violation|1|||
126357991|NCT01783015|454603855|FG002|Blinded Treatment|Protocol Violation|0|||
126357992|NCT01783015|454603853|FG000|Blinded Treatment|Withdrawal by Subject|0|||
126357993|NCT01783015|454603854|FG001|Blinded Treatment|Withdrawal by Subject|1|||
126357994|NCT01783015|454603855|FG002|Blinded Treatment|Withdrawal by Subject|0|||
126357995|NCT01783015|454603853|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
126357996|NCT01783015|454603854|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
126357997|NCT01783015|454603855|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
126357998|NCT01783015|454603853|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
126357999|NCT01783015|454603854|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
126358000|NCT01783015|454603855|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
126762049|NCT02064231|456081119|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
126762050|NCT02064231|456081120|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
126762051|NCT02064231|456081121|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
126762052|NCT02064231|456081122|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
126358001|NCT00669331|454603856|FG000|Randomisation to First Dose|Adverse Event|1|||
126448756|NCT01049009|454943189|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126696778|NCT00603239|455843179|FG001|Overall Study|Loss of glucose control|0|||
126696779|NCT00603239|455843178|FG000|Overall Study|Lost to Follow-up|2|||
126696780|NCT00603239|455843179|FG001|Overall Study|Lost to Follow-up|1|||
126249424|NCT00902538|454202340|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
126448757|NCT01049009|454943190|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
126448758|NCT01049009|454943189|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
126448759|NCT01049009|454943190|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
126696781|NCT00603239|455843178|FG000|Overall Study|Physician Decision|2|||
126696782|NCT00603239|455843179|FG001|Overall Study|Physician Decision|0|||
126696783|NCT00603239|455843178|FG000|Overall Study|Protocol Violation|2|||
126696784|NCT00603239|455843179|FG001|Overall Study|Protocol Violation|0|||
126448760|NCT01049009|454943189|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
126448761|NCT01049009|454943190|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
126249425|NCT00902538|454202335|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
126249426|NCT00902538|454202336|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
126448762|NCT02423902|454943191|FG000|Overall Study|Disease progression|1|||
126448763|NCT02423902|454943192|FG001|Overall Study|Disease progression|4|||
126448764|NCT02350478|454943193|FG000|Overall Study|Lost to Follow-up|5|||
126448765|NCT02350478|454943194|FG001|Overall Study|Lost to Follow-up|1|||
126448766|NCT00622440|454943207|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
126448767|NCT00622440|454943208|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
126448768|NCT00622440|454943207|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
126448769|NCT00622440|454943208|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
126448770|NCT00622440|454943207|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
126448771|NCT00622440|454943208|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
126448772|NCT00622440|454943207|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
126448773|NCT00622440|454943208|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
126448774|NCT01519869|454943209|FG000|Overall Study|Lost to Follow-up|1|||
126696785|NCT00603239|455843178|FG000|Overall Study|Subject decision|2|||
126696786|NCT00603239|455843179|FG001|Overall Study|Subject decision|1|||
126696787|NCT01354132|455843180|FG000|Randomization|Physician Decision|1|||
126249427|NCT00902538|454202337|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
126249428|NCT00902538|454202338|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
126249429|NCT00902538|454202339|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
126249430|NCT00902538|454202340|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
126249431|NCT00902538|454202335|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
126249432|NCT00902538|454202336|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
126249433|NCT00902538|454202337|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
126249434|NCT00902538|454202338|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
126249435|NCT00902538|454202339|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
126249436|NCT00902538|454202340|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
126249437|NCT00902538|454202335|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
126249438|NCT00902538|454202336|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
126249439|NCT00902538|454202337|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
126249440|NCT00902538|454202338|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
126249441|NCT00902538|454202339|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
126249442|NCT00902538|454202340|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
126249443|NCT00902538|454202335|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
126249444|NCT00902538|454202336|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
126249445|NCT00902538|454202337|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
126249446|NCT00902538|454202338|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
126249447|NCT00902538|454202339|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
126249448|NCT00902538|454202340|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
126249449|NCT00902538|454202335|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
126249450|NCT00902538|454202336|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
126249451|NCT00902538|454202337|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
126249452|NCT00902538|454202338|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
126249453|NCT00902538|454202339|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
126249454|NCT00902538|454202340|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
126249455|NCT00902538|454202335|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
126249456|NCT00902538|454202336|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
126249457|NCT00902538|454202337|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
126249458|NCT00902538|454202338|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
126249459|NCT00902538|454202339|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
126249460|NCT00902538|454202340|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
126249461|NCT00902538|454202335|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
126249462|NCT00902538|454202336|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
126546380|NCT03556358|455293773|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
126696788|NCT01354132|455843181|FG001|Randomization|Physician Decision|0|||
126696789|NCT01354132|455843180|FG000|Randomization|Withdrawal by Subject|0|||
126249463|NCT00902538|454202337|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
126249464|NCT00902538|454202338|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
126249465|NCT00902538|454202339|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
126249466|NCT00902538|454202340|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
126249467|NCT00902538|454202335|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
126249468|NCT00902538|454202336|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
126249469|NCT00902538|454202337|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
126249470|NCT00902538|454202338|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
126249471|NCT00902538|454202339|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
126696790|NCT01354132|455843181|FG001|Randomization|Withdrawal by Subject|1|||
126249472|NCT00902538|454202340|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
126249473|NCT00902538|454202335|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
126249474|NCT00902538|454202336|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
126249475|NCT00902538|454202337|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
126249476|NCT00902538|454202338|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
126249477|NCT00902538|454202339|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
126249478|NCT00902538|454202340|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
126249479|NCT00902538|454202335|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
126249480|NCT00902538|454202336|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
126249481|NCT00902538|454202337|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
126249482|NCT00902538|454202338|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
126249483|NCT00902538|454202339|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
126358002|NCT00669331|454603857|FG001|Randomisation to First Dose|Adverse Event|0|||
126448775|NCT03023813|454943210|FG000|Overall Study|Lost to Follow-up|1|||
126696791|NCT01354132|455843180|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
126762053|NCT02064231|456081119|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
126762054|NCT02064231|456081120|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
126762055|NCT02064231|456081121|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
126762056|NCT02064231|456081122|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
126762057|NCT02064231|456081119|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
126762058|NCT02064231|456081120|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
126762059|NCT02064231|456081121|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
126762060|NCT02064231|456081122|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
126762061|NCT04887922|456081123|FG000|1st Randomization|Decided not to have surgery|0|||
126762062|NCT04887922|456081124|FG001|1st Randomization|Decided not to have surgery|1|||
126762063|NCT04887922|456081125|FG002|1st Randomization|Decided not to have surgery|0|||
126762064|NCT04887922|456081126|FG003|1st Randomization|Decided not to have surgery|0|||
126762065|NCT04887922|456081127|FG004|1st Randomization|Decided not to have surgery|0|||
126762066|NCT00718809|456081128|FG000|Overall Study|Disease progression|9|||
126762067|NCT00718809|456081129|FG001|Overall Study|Disease progression|7|||
126762068|NCT00718809|456081128|FG000|Overall Study|Adverse Event|1|||
126762069|NCT00718809|456081129|FG001|Overall Study|Adverse Event|1|||
126762070|NCT00718809|456081128|FG000|Overall Study|Withdrawal by Subject|0|||
126762071|NCT00718809|456081129|FG001|Overall Study|Withdrawal by Subject|1|||
126762072|NCT00718809|456081128|FG000|Overall Study|Lost to Follow-up|1|||
126762073|NCT00718809|456081129|FG001|Overall Study|Lost to Follow-up|0|||
126762074|NCT00718809|456081128|FG000|Overall Study|Noncompliance|1|||
126762075|NCT00718809|456081129|FG001|Overall Study|Noncompliance|0|||
126762076|NCT00536991|456081130|FG000|Overall Study|Withdrawal by Subject|10|||
126762077|NCT00536991|456081130|FG000|Overall Study|Physician Decision|1|||
126762078|NCT00536991|456081130|FG000|Overall Study|patient ineligible|2|||
126762079|NCT04621227|456081131|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
126762080|NCT04621227|456081131|FG000|Period 3 (29 Days)|Adverse Event|1|||
126762081|NCT04621227|456081131|FG000|Period 8 (2 Days)|Adverse Event|1|||
126762082|NCT02204449|456081134|FG000|Overall Study|Lost to Follow-up|7|||
126762083|NCT02204449|456081135|FG001|Overall Study|Lost to Follow-up|9|||
126762084|NCT02204449|456081134|FG000|Overall Study|Death|0|||
126762085|NCT02204449|456081135|FG001|Overall Study|Death|1|||
126762086|NCT02204449|456081134|FG000|Overall Study|Withdrawal by Subject|0|||
126762087|NCT02204449|456081135|FG001|Overall Study|Withdrawal by Subject|1|||
126762088|NCT01342445|456081136|FG000|Overall Study|Experienced side effects|0|||
126696792|NCT01354132|455843181|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
126696793|NCT01354132|455843180|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
126696794|NCT01354132|455843181|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
126696795|NCT01354132|455843180|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
126696796|NCT01354132|455843181|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
126762089|NCT01342445|456081137|FG001|Overall Study|Experienced side effects|2|||
126762090|NCT05299359|456081138|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
126762091|NCT05299359|456081139|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
126762092|NCT05299359|456081138|FG000|Main Part: Day 1 up to Day 366|Other|2|||
126249484|NCT00902538|454202340|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
126762093|NCT05299359|456081139|FG001|Main Part: Day 1 up to Day 366|Other|0|||
126762094|NCT05299359|456081138|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
126762095|NCT05299359|456081139|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
126762096|NCT05299359|456081138|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
126762097|NCT05299359|456081139|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
126762098|NCT05299359|456081138|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
126762099|NCT05299359|456081139|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
126762100|NCT05299359|456081138|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
126762101|NCT05299359|456081139|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
126762102|NCT05299359|456081138|FG000|Extension Part: Day 1 to Day 366|Other|0|||
126762103|NCT05299359|456081139|FG001|Extension Part: Day 1 to Day 366|Other|1|||
126762104|NCT02392078|456081140|FG000|Overall Study|Did not have procedure|32|||
126762105|NCT02392078|456081141|FG001|Overall Study|Did not have procedure|43|||
126762106|NCT02392078|456081142|FG002|Overall Study|Did not have procedure|20|||
126762107|NCT02392078|456081143|FG003|Overall Study|Did not have procedure|1|||
126762108|NCT02652793|456081146|FG000|Overall Study|Adverse Event|1|||
126762109|NCT02652793|456081146|FG000|Overall Study|Lost to Follow-up|2|||
126762110|NCT02652793|456081146|FG000|Overall Study|Withdrawal by Subject|1|||
126762111|NCT03868410|456081147|FG000|Overall Study|Physician Decision|0|||
126762112|NCT03868410|456081148|FG001|Overall Study|Physician Decision|1|||
126762113|NCT01059175|456081149|FG000|Overall Study|Death|17|||
126762114|NCT01059175|456081150|FG001|Overall Study|Death|17|||
126762115|NCT01059175|456081149|FG000|Overall Study|Adverse Event|4|||
126762116|NCT01059175|456081150|FG001|Overall Study|Adverse Event|2|||
126762117|NCT01059175|456081149|FG000|Overall Study|Lost to Follow-up|0|||
126762118|NCT01059175|456081150|FG001|Overall Study|Lost to Follow-up|1|||
126762119|NCT02957149|456081151|FG000|Overall Study|Withdrawal by Subject|5|||
126762120|NCT04579666|456081152|FG000|RTP (Up to Week 52)|Adverse Event|4|||
126762121|NCT04579666|456081153|FG001|RTP (Up to Week 52)|Adverse Event|3|||
126762122|NCT04579666|456081154|FG002|RTP (Up to Week 52)|Adverse Event|0|||
126762123|NCT04579666|456081155|FG003|RTP (Up to Week 52)|Adverse Event|0|||
126762124|NCT04579666|456081152|FG000|RTP (Up to Week 52)|Death|24|||
126762125|NCT04579666|456081153|FG001|RTP (Up to Week 52)|Death|9|||
126762126|NCT04579666|456081154|FG002|RTP (Up to Week 52)|Death|0|||
126762127|NCT04579666|456081155|FG003|RTP (Up to Week 52)|Death|0|||
126762128|NCT04579666|456081152|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
126762129|NCT04579666|456081153|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
126762130|NCT04579666|456081154|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
126762131|NCT04579666|456081155|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
126762132|NCT04579666|456081152|FG000|RTP (Up to Week 52)|Physician Decision|4|||
126762133|NCT04579666|456081153|FG001|RTP (Up to Week 52)|Physician Decision|1|||
126762134|NCT04579666|456081154|FG002|RTP (Up to Week 52)|Physician Decision|0|||
126762135|NCT04579666|456081155|FG003|RTP (Up to Week 52)|Physician Decision|0|||
126762136|NCT04579666|456081152|FG000|RTP (Up to Week 52)|Progressive disease|1|||
126762137|NCT04579666|456081153|FG001|RTP (Up to Week 52)|Progressive disease|0|||
126762138|NCT04579666|456081154|FG002|RTP (Up to Week 52)|Progressive disease|0|||
126762139|NCT04579666|456081155|FG003|RTP (Up to Week 52)|Progressive disease|0|||
126762140|NCT04579666|456081152|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
126762141|NCT04579666|456081153|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
126762142|NCT04579666|456081154|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
126762143|NCT04579666|456081155|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
126762144|NCT04579666|456081152|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
126762145|NCT04579666|456081153|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
126762146|NCT04579666|456081154|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
126762147|NCT04579666|456081155|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
126762148|NCT04579666|456081152|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
126762149|NCT04579666|456081153|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
126762150|NCT04579666|456081154|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
126762151|NCT04579666|456081155|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
126762152|NCT04579666|456081152|FG000|RTP (Up to Week 52)|Other|2|||
126762153|NCT04579666|456081153|FG001|RTP (Up to Week 52)|Other|0|||
126762154|NCT04579666|456081154|FG002|RTP (Up to Week 52)|Other|0|||
126762155|NCT04579666|456081155|FG003|RTP (Up to Week 52)|Other|0|||
126762156|NCT04579666|456081152|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
126762157|NCT04579666|456081153|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
126762158|NCT04579666|456081154|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
126762159|NCT04579666|456081155|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
126762160|NCT04579666|456081152|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
126762161|NCT04579666|456081153|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
126762162|NCT04579666|456081154|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
126762163|NCT04579666|456081155|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
126762164|NCT04579666|456081152|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
126762165|NCT04579666|456081153|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
126762166|NCT04579666|456081154|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
126762167|NCT04579666|456081155|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
126762168|NCT04579666|456081152|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
126762169|NCT04579666|456081153|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
126762170|NCT04579666|456081154|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
126762171|NCT04579666|456081155|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
126762172|NCT04579666|456081152|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
126762173|NCT04579666|456081153|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
126762174|NCT04579666|456081154|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
126762175|NCT04579666|456081155|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
126762176|NCT05450198|456081156|FG000|Overall Study|Withdrawal by Subject|1|||
126762177|NCT05450198|456081157|FG001|Overall Study|Withdrawal by Subject|1|||
126762178|NCT05450198|456081158|FG002|Overall Study|Withdrawal by Subject|2|||
126762179|NCT05450198|456081159|FG003|Overall Study|Withdrawal by Subject|0|||
126762180|NCT05450198|456081156|FG000|Overall Study|Lost to Follow-up|1|||
126762181|NCT05450198|456081157|FG001|Overall Study|Lost to Follow-up|0|||
126762182|NCT05450198|456081158|FG002|Overall Study|Lost to Follow-up|2|||
126762183|NCT05450198|456081159|FG003|Overall Study|Lost to Follow-up|1|||
126762184|NCT00643006|456081161|FG000|Overall Study|Lost to Follow-up|5|||
126762185|NCT00643006|456081162|FG001|Overall Study|Lost to Follow-up|4|||
126762186|NCT01151085|456081164|FG000|Overall Study|Lost to Follow-up|31|||
126762187|NCT01151085|456081164|FG000|Overall Study|Protocol Violation|25|||
126762188|NCT01308476|456081165|FG000|Overall Study|Lost to Follow-up|2|||
126762189|NCT01308476|456081166|FG001|Overall Study|Lost to Follow-up|2|||
126762190|NCT01308476|456081165|FG000|Overall Study|Other|1|||
126762191|NCT01308476|456081166|FG001|Overall Study|Other|0|||
126762192|NCT00812968|456081167|FG000|Overall Study|Relapse after erythroid response|6|||
126762193|NCT00812968|456081167|FG000|Overall Study|Disease progression|1|||
126762194|NCT00812968|456081167|FG000|Overall Study|No further treatment required|1|||
126762195|NCT00812968|456081167|FG000|Overall Study|Study closed due to marketing approval|3|||
126762196|NCT01243762|456081175|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
126762197|NCT01243762|456081176|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
126762198|NCT01243762|456081177|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
126762199|NCT01243762|456081178|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
126762200|NCT01243762|456081179|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
126762201|NCT01243762|456081180|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
126762202|NCT01243762|456081181|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
126762203|NCT01243762|456081175|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
126762204|NCT01243762|456081176|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
126762205|NCT01243762|456081177|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
126762206|NCT01243762|456081178|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
126762207|NCT01243762|456081179|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
126762208|NCT01243762|456081180|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
126762209|NCT01243762|456081181|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
126762210|NCT01243762|456081175|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
126762211|NCT01243762|456081176|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
126762212|NCT01243762|456081177|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
126762213|NCT01243762|456081178|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
126762214|NCT01243762|456081179|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
126762215|NCT01243762|456081180|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
126762216|NCT01243762|456081181|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
126762217|NCT01243762|456081175|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
126762218|NCT01243762|456081176|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
126762219|NCT01243762|456081177|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
126762220|NCT01243762|456081178|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
126762221|NCT01243762|456081179|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
126762222|NCT01243762|456081180|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
126762223|NCT01243762|456081181|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
126762224|NCT01243762|456081175|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
126762225|NCT01243762|456081176|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
126762226|NCT01243762|456081177|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
126762227|NCT01243762|456081178|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
126762228|NCT01243762|456081179|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
126762229|NCT01243762|456081180|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
126762230|NCT01243762|456081181|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
126762231|NCT01243762|456081175|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
126762232|NCT01243762|456081176|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
126762233|NCT01243762|456081177|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
126762234|NCT01243762|456081178|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
126762235|NCT01243762|456081179|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
126249485|NCT00902538|454202335|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
126448776|NCT03023813|454943211|FG001|Overall Study|Lost to Follow-up|2|||
126762236|NCT01243762|456081180|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
126249486|NCT00902538|454202336|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
126249487|NCT00902538|454202337|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
126696797|NCT02357420|455843182|FG000|Overall Study|Adverse Event|3|||
126696798|NCT02357420|455843183|FG001|Overall Study|Adverse Event|3|||
126696799|NCT02357420|455843184|FG002|Overall Study|Adverse Event|8|||
126696800|NCT02357420|455843185|FG003|Overall Study|Adverse Event|9|||
126696801|NCT02357420|455843182|FG000|Overall Study|Investigator Decision|1|||
126696802|NCT02357420|455843183|FG001|Overall Study|Investigator Decision|0|||
126696803|NCT02357420|455843184|FG002|Overall Study|Investigator Decision|0|||
126696804|NCT02357420|455843185|FG003|Overall Study|Investigator Decision|0|||
126696805|NCT02357420|455843182|FG000|Overall Study|Prohibited Medication|1|||
126696806|NCT02357420|455843183|FG001|Overall Study|Prohibited Medication|1|||
126696807|NCT02357420|455843184|FG002|Overall Study|Prohibited Medication|0|||
126696808|NCT02357420|455843185|FG003|Overall Study|Prohibited Medication|0|||
126696809|NCT02357420|455843182|FG000|Overall Study|Protocol Non-compliance|0|||
126696810|NCT02357420|455843183|FG001|Overall Study|Protocol Non-compliance|0|||
126696811|NCT02357420|455843184|FG002|Overall Study|Protocol Non-compliance|0|||
126696812|NCT02357420|455843185|FG003|Overall Study|Protocol Non-compliance|1|||
126696813|NCT02357420|455843182|FG000|Overall Study|Withdrawn Consent|4|||
126696814|NCT02357420|455843183|FG001|Overall Study|Withdrawn Consent|8|||
126696815|NCT02357420|455843184|FG002|Overall Study|Withdrawn Consent|6|||
126696816|NCT02357420|455843185|FG003|Overall Study|Withdrawn Consent|6|||
126696817|NCT02357420|455843182|FG000|Overall Study|Lost to Follow-up|3|||
126696818|NCT02357420|455843183|FG001|Overall Study|Lost to Follow-up|0|||
126696819|NCT02357420|455843184|FG002|Overall Study|Lost to Follow-up|2|||
126696820|NCT02357420|455843185|FG003|Overall Study|Lost to Follow-up|3|||
126696821|NCT00928070|455843188|FG000|Overall Study|Lost to Follow-up|1|||
126696822|NCT00928070|455843189|FG001|Overall Study|Lost to Follow-up|2|||
126696823|NCT00928070|455843188|FG000|Overall Study|Withdrawal by Subject|10|||
126696824|NCT00928070|455843189|FG001|Overall Study|Withdrawal by Subject|3|||
126696825|NCT00928070|455843188|FG000|Overall Study|Adverse Event|14|||
126696826|NCT00928070|455843189|FG001|Overall Study|Adverse Event|26|||
126696827|NCT00928070|455843188|FG000|Overall Study|Lack of Efficacy|9|||
126696828|NCT00928070|455843189|FG001|Overall Study|Lack of Efficacy|5|||
126696829|NCT00928070|455843188|FG000|Overall Study|Did not meet entrance criteria|16|||
126696830|NCT00928070|455843189|FG001|Overall Study|Did not meet entrance criteria|9|||
126696831|NCT00928070|455843188|FG000|Overall Study|Protocol Violation|6|||
126696832|NCT00928070|455843189|FG001|Overall Study|Protocol Violation|5|||
126696833|NCT00928070|455843188|FG000|Overall Study|Randomized but not treated|2|||
126696834|NCT00928070|455843189|FG001|Overall Study|Randomized but not treated|2|||
126696835|NCT00928070|455843188|FG000|Overall Study|Other|5|||
126696836|NCT00928070|455843189|FG001|Overall Study|Other|5|||
126696837|NCT00191854|455843190|FG000|Overall Study|Death|26|||
126696838|NCT00191854|455843191|FG001|Overall Study|Death|23|||
126696839|NCT00191854|455843192|FG002|Overall Study|Death|29|||
126696840|NCT00191854|455843190|FG000|Overall Study|Lost to Follow-up|7|||
126696841|NCT00191854|455843191|FG001|Overall Study|Lost to Follow-up|5|||
126696842|NCT00191854|455843192|FG002|Overall Study|Lost to Follow-up|5|||
126696843|NCT00191854|455843190|FG000|Overall Study|Withdrawal by Subject|4|||
126696844|NCT00191854|455843191|FG001|Overall Study|Withdrawal by Subject|2|||
126696845|NCT00191854|455843192|FG002|Overall Study|Withdrawal by Subject|3|||
126696846|NCT00191854|455843190|FG000|Overall Study|Sponsor Decision|0|||
126696847|NCT00191854|455843191|FG001|Overall Study|Sponsor Decision|0|||
126696848|NCT00191854|455843192|FG002|Overall Study|Sponsor Decision|1|||
126696849|NCT00191854|455843190|FG000|Overall Study|Screen Failure|0|||
126696850|NCT00191854|455843191|FG001|Overall Study|Screen Failure|0|||
126696851|NCT00191854|455843192|FG002|Overall Study|Screen Failure|1|||
126696852|NCT01323478|455843193|FG000|Overall Study|Adverse Event|7|||
126696853|NCT01323478|455843193|FG000|Overall Study|Lack of Efficacy|4|||
126696854|NCT01323478|455843193|FG000|Overall Study|Non-compliance With Study Product|3|||
126696855|NCT01323478|455843193|FG000|Overall Study|Protocol Violation|1|||
126696856|NCT01323478|455843193|FG000|Overall Study|Withdrawal of Consent|1|||
126696857|NCT01323478|455843193|FG000|Overall Study|Administrative or Other Reasons|8|||
126696858|NCT02411448|455843194|FG000|Overall Study|Withdrawal by Subject|1|||
126696859|NCT02411448|455843195|FG001|Overall Study|Withdrawal by Subject|14|||
126696860|NCT02411448|455843196|FG002|Overall Study|Withdrawal by Subject|9|||
126696861|NCT02411448|455843194|FG000|Overall Study|Other|0|||
126696862|NCT02411448|455843195|FG001|Overall Study|Other|2|||
126696863|NCT02411448|455843196|FG002|Overall Study|Other|0|||
126696864|NCT02411448|455843194|FG000|Overall Study|Did not receive study treatment|0|||
126696865|NCT02411448|455843195|FG001|Overall Study|Did not receive study treatment|3|||
126696866|NCT02411448|455843196|FG002|Overall Study|Did not receive study treatment|0|||
126696867|NCT02411448|455843194|FG000|Overall Study|Alive on study treatment|3|||
126696868|NCT02411448|455843195|FG001|Overall Study|Alive on study treatment|64|||
126696869|NCT02411448|455843196|FG002|Overall Study|Alive on study treatment|43|||
126696870|NCT04067518|455843197|FG000|Overall Study|Adverse Event|1|||
126696871|NCT04067518|455843198|FG001|Overall Study|Adverse Event|3|||
126696872|NCT04067518|455843197|FG000|Overall Study|Screen failures|0|||
126546381|NCT03556358|455293772|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
126249488|NCT00902538|454202338|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
126249489|NCT00902538|454202339|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
126249490|NCT00902538|454202340|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
126249491|NCT00902538|454202335|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
126249492|NCT00902538|454202336|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
126249493|NCT00902538|454202337|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
126249494|NCT00902538|454202338|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
126249495|NCT00902538|454202339|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
126249496|NCT00902538|454202340|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
126249497|NCT00902538|454202335|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
126249498|NCT00902538|454202336|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
126249499|NCT00902538|454202337|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
126249500|NCT00902538|454202338|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
126249501|NCT00902538|454202339|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
126249502|NCT00902538|454202340|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
126249503|NCT00902538|454202335|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
126249504|NCT00902538|454202336|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
126249505|NCT00902538|454202337|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
126249506|NCT00902538|454202338|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
126249507|NCT00902538|454202339|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
126249508|NCT00902538|454202340|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
126249509|NCT00902538|454202335|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
126249510|NCT00902538|454202336|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
126249511|NCT00902538|454202337|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
126249512|NCT00902538|454202338|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
126249513|NCT00902538|454202339|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
126249514|NCT00902538|454202340|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
126249515|NCT03531827|454202341|FG000|Overall Study|Adverse Event|2|||
126249516|NCT03531827|454202342|FG001|Overall Study|Adverse Event|0|||
126249517|NCT03531827|454202341|FG000|Overall Study|Progressive disease|1|||
126249518|NCT03531827|454202342|FG001|Overall Study|Progressive disease|0|||
126448777|NCT03023813|454943212|FG002|Overall Study|Lost to Follow-up|0|||
126448778|NCT02433080|454943214|FG000|Overall Study|Lost to Follow-up|1|||
126448779|NCT02433080|454943215|FG001|Overall Study|Lost to Follow-up|2|||
126448780|NCT02433080|454943214|FG000|Overall Study|Withdrawal by Subject|0|||
126448781|NCT02433080|454943215|FG001|Overall Study|Withdrawal by Subject|2|||
126448782|NCT00312195|454943216|FG000|Overall Study|Adverse Event|4|||
126448783|NCT00312195|454943217|FG001|Overall Study|Adverse Event|6|||
126448784|NCT00312195|454943216|FG000|Overall Study|Lost to Follow-up|1|||
126448785|NCT00312195|454943217|FG001|Overall Study|Lost to Follow-up|0|||
126448786|NCT00312195|454943216|FG000|Overall Study|Protocol Violation|1|||
126448787|NCT00312195|454943217|FG001|Overall Study|Protocol Violation|0|||
126696873|NCT04067518|455843198|FG001|Overall Study|Screen failures|1|||
126696874|NCT04067518|455843197|FG000|Overall Study|Enrolled but not treated|0|||
126696875|NCT04067518|455843198|FG001|Overall Study|Enrolled but not treated|1|||
126696876|NCT05655377|455843199|FG000|Overall Study|Withdrawal by Subject|2|||
126696877|NCT00862251|455843201|FG000|Overall Study|Adverse Event|8|||
126696878|NCT00862251|455843202|FG001|Overall Study|Adverse Event|3|||
126696879|NCT00862251|455843203|FG002|Overall Study|Adverse Event|1|||
126696880|NCT00862251|455843201|FG000|Overall Study|Lost to Follow-up|0|||
126696881|NCT00862251|455843202|FG001|Overall Study|Lost to Follow-up|0|||
126696882|NCT00862251|455843203|FG002|Overall Study|Lost to Follow-up|1|||
126696883|NCT00862251|455843201|FG000|Overall Study|Protocol Violation|2|||
126696884|NCT00862251|455843202|FG001|Overall Study|Protocol Violation|0|||
126696885|NCT00862251|455843203|FG002|Overall Study|Protocol Violation|1|||
126696886|NCT00862251|455843201|FG000|Overall Study|Withdrawal by Subject|9|||
126696887|NCT00862251|455843202|FG001|Overall Study|Withdrawal by Subject|2|||
126696888|NCT00862251|455843203|FG002|Overall Study|Withdrawal by Subject|6|||
126696889|NCT02054702|455843209|FG000|Overall Study|Lost to Follow-up|3|||
126696890|NCT02054702|455843210|FG001|Overall Study|Lost to Follow-up|5|||
126696891|NCT02054702|455843209|FG000|Overall Study|Adverse Event|3|||
126696892|NCT02054702|455843210|FG001|Overall Study|Adverse Event|1|||
126696893|NCT02054702|455843209|FG000|Overall Study|Met Withdrawal Criteria|4|||
126696894|NCT02054702|455843210|FG001|Overall Study|Met Withdrawal Criteria|1|||
126696895|NCT02054702|455843209|FG000|Overall Study|Physician Decision|0|||
126696896|NCT02054702|455843210|FG001|Overall Study|Physician Decision|1|||
126696897|NCT02054702|455843209|FG000|Overall Study|Withdrawal by Subject|14|||
126696898|NCT02054702|455843210|FG001|Overall Study|Withdrawal by Subject|4|||
126696899|NCT00934102|455843212|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
126249519|NCT00849797|454202343|FG000|First Intervention|bad veins|1|||
126696900|NCT00934102|455843213|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
126696901|NCT00934102|455843214|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
126696902|NCT02318784|455843215|FG000|Overall Study|Adverse Event|13|||
126696903|NCT02318784|455843215|FG000|Overall Study|Death|2|||
126696904|NCT02318784|455843215|FG000|Overall Study|Progressive Disease|37|||
126696905|NCT02318784|455843215|FG000|Overall Study|Withdrawal by Subject|10|||
126696906|NCT02304926|455843216|FG000|Overall Study|Lost to Follow-up|2|||
126696907|NCT02304926|455843217|FG001|Overall Study|Lost to Follow-up|1|||
126696908|NCT04007159|455843220|FG000|Induction Phase|(missed study visits)|16|||
126696909|NCT04007159|455843220|FG000|Induction Phase|Withdrawal by Subject|4|||
126696910|NCT04007159|455843220|FG000|Induction Phase|Adverse Event|2|||
126696911|NCT04007159|455843220|FG000|Challenge Phase|missed study visits|3|||
126696912|NCT03157531|455843221|FG000|Overall Study|Death|2|||
126696913|NCT03157531|455843221|FG000|Overall Study|Lost to Follow-up|4|||
126696914|NCT00238264|455843226|FG000|Overall Study|Death|7|||
126696915|NCT00238264|455843226|FG000|Overall Study|Lost to Follow-up|18|||
126696916|NCT00238264|455843226|FG000|Overall Study|Withdrawal by Subject|4|||
126696917|NCT00238264|455843226|FG000|Overall Study|Ineligible|7|||
126696918|NCT02706938|455843227|FG000|First Period, 6 Weeks|Adverse Event|8|||
126696919|NCT02706938|455843228|FG001|First Period, 6 Weeks|Adverse Event|0|||
126696920|NCT02706938|455843227|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
126696921|NCT02706938|455843228|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
126696922|NCT02706938|455843227|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
126696923|NCT02706938|455843228|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
126696924|NCT02706938|455843227|FG000|Second Period, 6 Weeks|Adverse Event|0|||
126696925|NCT02706938|455843228|FG001|Second Period, 6 Weeks|Adverse Event|7|||
126696926|NCT02706938|455843227|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
126696927|NCT02706938|455843228|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
126696928|NCT01838044|455843229|FG000|Overall Study|Adverse Event|4|||
126696929|NCT01838044|455843230|FG001|Overall Study|Adverse Event|6|||
126696930|NCT01838044|455843229|FG000|Overall Study|Protocol Violation|3|||
126696931|NCT01838044|455843230|FG001|Overall Study|Protocol Violation|3|||
126696932|NCT01838044|455843229|FG000|Overall Study|Withdrawal by Subject|0|||
126249520|NCT00849797|454202344|FG001|First Intervention|bad veins|0|||
126249521|NCT00849797|454202343|FG000|First Intervention|Adverse Event|0|||
126249522|NCT00849797|454202344|FG001|First Intervention|Adverse Event|1|||
126249523|NCT00849797|454202343|FG000|Washout: One Week|Withdrawal by Subject|0|||
126249524|NCT00849797|454202344|FG001|Washout: One Week|Withdrawal by Subject|2|||
126249525|NCT00679081|454202345|FG000|Overall Study|Lost to Follow-up|1|||
126249526|NCT00725322|454202346|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
126249527|NCT00725322|454202347|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
126249528|NCT00725322|454202346|FG000|Washout (28 Days)|Protocol Violation|0|||
126249529|NCT00725322|454202347|FG001|Washout (28 Days)|Protocol Violation|1|||
126249530|NCT03578809|454204454|FG000|Overall Study|Death|0|||
126249531|NCT03578809|454204455|FG001|Overall Study|Death|2|||
126249532|NCT03578809|454204456|FG002|Overall Study|Death|0|||
126249533|NCT03578809|454204457|FG003|Overall Study|Death|1|||
126249534|NCT03578809|454204454|FG000|Overall Study|Lost to Follow-up|0|||
126249535|NCT03578809|454204455|FG001|Overall Study|Lost to Follow-up|1|||
126696933|NCT01838044|455843230|FG001|Overall Study|Withdrawal by Subject|2|||
126696934|NCT01838044|455843229|FG000|Overall Study|Insufficient clinical response|1|||
126696935|NCT01838044|455843230|FG001|Overall Study|Insufficient clinical response|2|||
126696936|NCT01838044|455843229|FG000|Overall Study|Medication error without associated AE|0|||
126696937|NCT01838044|455843230|FG001|Overall Study|Medication error without associated AE|1|||
126696938|NCT01838044|455843229|FG000|Overall Study|Lost to Follow-up|0|||
126696939|NCT01838044|455843230|FG001|Overall Study|Lost to Follow-up|2|||
126696940|NCT00860470|455843234|FG000|Overall Study|Death|6|||
126696941|NCT00860470|455843235|FG001|Overall Study|Death|10|||
126696942|NCT00860470|455843234|FG000|Overall Study|Moved away|8|||
126696943|NCT00860470|455843235|FG001|Overall Study|Moved away|10|||
126696944|NCT00860470|455843234|FG000|Overall Study|Lost to Follow-up|34|||
126696945|NCT00860470|455843235|FG001|Overall Study|Lost to Follow-up|39|||
126696946|NCT02928952|455843237|FG000|Overall Study|Lost to Follow-up|5|||
126696947|NCT02928952|455843238|FG001|Overall Study|Lost to Follow-up|5|||
126696948|NCT02928952|455843237|FG000|Overall Study|Withdrawal by Subject|5|||
126696949|NCT02928952|455843238|FG001|Overall Study|Withdrawal by Subject|1|||
126696950|NCT02928952|455843237|FG000|Overall Study|Physician Decision|0|||
126762237|NCT01243762|456081181|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
126762238|NCT01243762|456081175|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
126762239|NCT01243762|456081176|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
126249536|NCT03578809|454204456|FG002|Overall Study|Lost to Follow-up|0|||
126249537|NCT03578809|454204457|FG003|Overall Study|Lost to Follow-up|0|||
126249538|NCT03578809|454204454|FG000|Overall Study|Withdrawal by Subject|3|||
126696951|NCT02928952|455843238|FG001|Overall Study|Physician Decision|1|||
126696952|NCT00723957|455843239|FG000|Overall Study|Adverse event unrelated to study drug|1|||
126696953|NCT00723957|455843240|FG001|Overall Study|Adverse event unrelated to study drug|4|||
126696954|NCT00723957|455843239|FG000|Overall Study|Death|3|||
126696955|NCT00723957|455843240|FG001|Overall Study|Death|4|||
126696956|NCT00723957|455843239|FG000|Overall Study|Disease progression|27|||
126249539|NCT03578809|454204455|FG001|Overall Study|Withdrawal by Subject|5|||
126249540|NCT03578809|454204456|FG002|Overall Study|Withdrawal by Subject|2|||
126249541|NCT03578809|454204457|FG003|Overall Study|Withdrawal by Subject|0|||
126249542|NCT03578809|454204454|FG000|Overall Study|Other|3|||
126249543|NCT03578809|454204455|FG001|Overall Study|Other|6|||
126249544|NCT03578809|454204456|FG002|Overall Study|Other|2|||
126249545|NCT03578809|454204457|FG003|Overall Study|Other|8|||
126249546|NCT02302716|454204460|FG000|Overall Study|Adverse Event|1|||
126249547|NCT02302716|454204461|FG001|Overall Study|Adverse Event|1|||
126249548|NCT02302716|454204460|FG000|Overall Study|Death|0|||
126249549|NCT02302716|454204461|FG001|Overall Study|Death|1|||
126249550|NCT02302716|454204460|FG000|Overall Study|Lack of Efficacy|0|||
126249551|NCT02302716|454204461|FG001|Overall Study|Lack of Efficacy|1|||
126249552|NCT02302716|454204460|FG000|Overall Study|Lost to Follow-up|2|||
126249553|NCT02302716|454204461|FG001|Overall Study|Lost to Follow-up|4|||
126249554|NCT02302716|454204460|FG000|Overall Study|Physician Decision|3|||
126249555|NCT02302716|454204461|FG001|Overall Study|Physician Decision|4|||
126249556|NCT02302716|454204460|FG000|Overall Study|Withdrawal by Subject|13|||
126249557|NCT02302716|454204461|FG001|Overall Study|Withdrawal by Subject|7|||
126249558|NCT02302716|454204460|FG000|Overall Study|Protocol Violation|0|||
126249559|NCT02302716|454204461|FG001|Overall Study|Protocol Violation|1|||
126249560|NCT02997176|454204464|FG000|Overall Study|Adverse Event|0|||
126249561|NCT02997176|454204465|FG001|Overall Study|Adverse Event|0|||
126249562|NCT02997176|454204466|FG002|Overall Study|Adverse Event|0|||
126249563|NCT02997176|454204467|FG003|Overall Study|Adverse Event|8|||
126249564|NCT02997176|454204464|FG000|Overall Study|Progressive Disease|1|||
126249565|NCT02997176|454204465|FG001|Overall Study|Progressive Disease|0|||
126249566|NCT02997176|454204466|FG002|Overall Study|Progressive Disease|1|||
126249567|NCT02997176|454204467|FG003|Overall Study|Progressive Disease|1|||
126249568|NCT02997176|454204464|FG000|Overall Study|Death|0|||
126249569|NCT02997176|454204465|FG001|Overall Study|Death|0|||
126249570|NCT02997176|454204466|FG002|Overall Study|Death|1|||
126249571|NCT02997176|454204467|FG003|Overall Study|Death|1|||
126249572|NCT02997176|454204464|FG000|Overall Study|Withdrawal by Subject|0|||
126249573|NCT02997176|454204465|FG001|Overall Study|Withdrawal by Subject|2|||
126249574|NCT02997176|454204466|FG002|Overall Study|Withdrawal by Subject|0|||
126249575|NCT02997176|454204467|FG003|Overall Study|Withdrawal by Subject|1|||
126249576|NCT04241458|454204468|FG000|Overall Study|Withdrawal by Subject|0|||
126249577|NCT04241458|454204469|FG001|Overall Study|Withdrawal by Subject|0|||
126249578|NCT04241458|454204470|FG002|Overall Study|Withdrawal by Subject|0|||
126249579|NCT04241458|454204471|FG003|Overall Study|Withdrawal by Subject|0|||
126249580|NCT04241458|454204472|FG004|Overall Study|Withdrawal by Subject|1|||
126249581|NCT06144424|454204473|FG000|Overall Study|Withdrawal by Subject|2|||
126249582|NCT06144424|454204474|FG001|Overall Study|Withdrawal by Subject|0|||
126249583|NCT06144424|454204473|FG000|Overall Study|Incarceration|1|||
126249584|NCT06144424|454204474|FG001|Overall Study|Incarceration|0|||
126249585|NCT02727192|454204475|FG000|Overall Study|Lost to Follow-up|1|||
126249586|NCT02727192|454204476|FG001|Overall Study|Lost to Follow-up|0|||
126249587|NCT02727192|454204477|FG002|Overall Study|Lost to Follow-up|0|||
126249588|NCT00928057|454204478|FG000|Overall Study|Adverse Event|1|||
126249589|NCT00928057|454204479|FG001|Overall Study|Adverse Event|2|||
126249590|NCT00928057|454204478|FG000|Overall Study|Withdrawal by Subject|1|||
126249591|NCT00928057|454204479|FG001|Overall Study|Withdrawal by Subject|0|||
126249592|NCT00928057|454204478|FG000|Overall Study|Lost to Follow-up|0|||
126249593|NCT00928057|454204479|FG001|Overall Study|Lost to Follow-up|1|||
126249594|NCT00928057|454204478|FG000|Overall Study|Protocol Violation|0|||
126249595|NCT00928057|454204479|FG001|Overall Study|Protocol Violation|1|||
126249596|NCT01380782|454204484|FG000|Overall Study|Adverse Event|0|||
126249597|NCT01380782|454204485|FG001|Overall Study|Adverse Event|1|||
126249598|NCT01380782|454204486|FG002|Overall Study|Adverse Event|0|||
126249599|NCT01380782|454204487|FG003|Overall Study|Adverse Event|0|||
126249600|NCT01380782|454204484|FG000|Overall Study|Death|1|||
126249601|NCT01380782|454204485|FG001|Overall Study|Death|0|||
126249602|NCT01380782|454204486|FG002|Overall Study|Death|0|||
126249603|NCT01380782|454204487|FG003|Overall Study|Death|0|||
126249604|NCT01380782|454204484|FG000|Overall Study|Lack of Efficacy|10|||
126249605|NCT01380782|454204485|FG001|Overall Study|Lack of Efficacy|9|||
126249606|NCT01380782|454204486|FG002|Overall Study|Lack of Efficacy|10|||
126249607|NCT01380782|454204487|FG003|Overall Study|Lack of Efficacy|3|||
126249608|NCT01380782|454204484|FG000|Overall Study|Physician Decision|1|||
126249609|NCT01380782|454204485|FG001|Overall Study|Physician Decision|0|||
126249610|NCT01380782|454204486|FG002|Overall Study|Physician Decision|0|||
126249611|NCT01380782|454204487|FG003|Overall Study|Physician Decision|0|||
126249612|NCT01380782|454204484|FG000|Overall Study|Withdrawal by Subject|0|||
126249613|NCT01380782|454204485|FG001|Overall Study|Withdrawal by Subject|0|||
126249614|NCT01380782|454204486|FG002|Overall Study|Withdrawal by Subject|1|||
126249615|NCT01380782|454204487|FG003|Overall Study|Withdrawal by Subject|1|||
126249616|NCT05387408|454204488|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
126249617|NCT03428750|454204489|FG000|Overall Study|Withdrawal by Subject|11|||
126448788|NCT02511106|454943218|FG000|Overall Study|Lost to Follow-up|6|||
126249618|NCT03428750|454204490|FG001|Overall Study|Withdrawal by Subject|10|||
126249619|NCT03428750|454204489|FG000|Overall Study|Lost to Follow-up|3|||
126249620|NCT03428750|454204490|FG001|Overall Study|Lost to Follow-up|9|||
126249621|NCT03428750|454204489|FG000|Overall Study|Adverse Event|9|||
126249622|NCT03428750|454204490|FG001|Overall Study|Adverse Event|1|||
126249623|NCT03428750|454204489|FG000|Overall Study|Protocol Violation|1|||
126249624|NCT03428750|454204490|FG001|Overall Study|Protocol Violation|0|||
126249625|NCT03428750|454204489|FG000|Overall Study|Administrative|0|||
126249626|NCT03428750|454204490|FG001|Overall Study|Administrative|1|||
126249627|NCT01919112|454204491|FG000|Secondary Analysis-day 30|Death|1|||
126249628|NCT01919112|454204492|FG001|Secondary Analysis-day 30|Death|1|||
126249629|NCT01919112|454204493|FG002|Secondary Analysis-day 30|Death|1|||
126249630|NCT01919112|454204491|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
126249631|NCT01919112|454204492|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
126249632|NCT01919112|454204493|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
126249633|NCT02554877|454204494|FG000|Overall Study|Adverse Event|2|||
126249634|NCT02554877|454204495|FG001|Overall Study|Adverse Event|0|||
126249635|NCT02554877|454204496|FG002|Overall Study|Adverse Event|0|||
126249636|NCT02554877|454204497|FG003|Overall Study|Adverse Event|1|||
126249637|NCT02554877|454204494|FG000|Overall Study|Lost to Follow-up|1|||
126249638|NCT02554877|454204495|FG001|Overall Study|Lost to Follow-up|1|||
126249639|NCT02554877|454204496|FG002|Overall Study|Lost to Follow-up|1|||
126249640|NCT02554877|454204497|FG003|Overall Study|Lost to Follow-up|2|||
126249641|NCT02554877|454204494|FG000|Overall Study|Did not meet entrance criteria|0|||
126249642|NCT02554877|454204495|FG001|Overall Study|Did not meet entrance criteria|0|||
126249643|NCT02554877|454204496|FG002|Overall Study|Did not meet entrance criteria|1|||
126249644|NCT02554877|454204497|FG003|Overall Study|Did not meet entrance criteria|0|||
126249645|NCT02554877|454204494|FG000|Overall Study|No longer met eligibility criteria|1|||
126249646|NCT02554877|454204495|FG001|Overall Study|No longer met eligibility criteria|0|||
126249647|NCT02554877|454204496|FG002|Overall Study|No longer met eligibility criteria|1|||
126249648|NCT02554877|454204497|FG003|Overall Study|No longer met eligibility criteria|1|||
126249649|NCT02554877|454204494|FG000|Overall Study|Protocol Violation|3|||
126249650|NCT02554877|454204495|FG001|Overall Study|Protocol Violation|1|||
126249651|NCT02554877|454204496|FG002|Overall Study|Protocol Violation|1|||
126249652|NCT02554877|454204497|FG003|Overall Study|Protocol Violation|0|||
126249653|NCT02554877|454204494|FG000|Overall Study|Other|1|||
126249654|NCT02554877|454204495|FG001|Overall Study|Other|3|||
126448789|NCT02511106|454943219|FG001|Overall Study|Lost to Follow-up|4|||
126448790|NCT02511106|454943218|FG000|Overall Study|Withdrawal by Subject|24|||
126448791|NCT02511106|454943219|FG001|Overall Study|Withdrawal by Subject|21|||
126448792|NCT02511106|454943218|FG000|Overall Study|Death|42|||
126448793|NCT02511106|454943219|FG001|Overall Study|Death|82|||
126448794|NCT02511106|454943218|FG000|Overall Study|Ongoing study at data cut-off|3|||
126448795|NCT02511106|454943219|FG001|Overall Study|Ongoing study at data cut-off|2|||
126448796|NCT02511106|454943218|FG000|Overall Study|Without specified reason|3|||
126448797|NCT02511106|454943219|FG001|Overall Study|Without specified reason|0|||
126448798|NCT00344487|454943221|FG000|Overall Study|immunologic failure|1|||
126448799|NCT01262820|454943224|FG000|Overall Study|Adverse Event|5|||
126448800|NCT01262820|454943224|FG000|Overall Study|Lack of Efficacy|9|||
126448801|NCT01262820|454943224|FG000|Overall Study|Drug held for 21+ days|1|||
126448802|NCT04530136|454943229|FG000|Overall Study|Lost to Follow-up|2|||
126448803|NCT04530136|454943230|FG001|Overall Study|Lost to Follow-up|3|||
126448804|NCT04530136|454943229|FG000|Overall Study|Withdrawal by Subject|1|||
126448805|NCT04530136|454943230|FG001|Overall Study|Withdrawal by Subject|0|||
126448806|NCT04530136|454943229|FG000|Overall Study|Death|0|||
126448807|NCT04530136|454943230|FG001|Overall Study|Death|1|||
126448808|NCT01309282|454943231|FG000|Overall Study|Lost to Follow-up|1|||
126448809|NCT01387542|454943232|FG000|Overall Study|Adverse Event|3|||
126448810|NCT01387542|454943232|FG000|Overall Study|Withdrawal by Subject|1|||
126249655|NCT02554877|454204496|FG002|Overall Study|Other|0|||
126249656|NCT02554877|454204497|FG003|Overall Study|Other|3|||
126249657|NCT02554877|454204494|FG000|Overall Study|Insufficient clinical response|4|||
126249658|NCT02554877|454204495|FG001|Overall Study|Insufficient clinical response|0|||
126448811|NCT01387542|454943232|FG000|Overall Study|Changed diagnosis|1|||
126448812|NCT01387542|454943232|FG000|Overall Study|Insufficient response|1|||
126448813|NCT01387542|454943232|FG000|Overall Study|Non-compliant|1|||
126448814|NCT01387542|454943232|FG000|Overall Study|Lost to Follow-up|1|||
126448815|NCT01010867|454943233|FG000|Overall Study|< 50% adherence to probiotic|1|||
126448816|NCT00884741|454943236|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
126249659|NCT02554877|454204496|FG002|Overall Study|Insufficient clinical response|0|||
126249660|NCT02554877|454204497|FG003|Overall Study|Insufficient clinical response|0|||
126249661|NCT02554877|454204494|FG000|Overall Study|No longer willing to participate|0|||
126249662|NCT02554877|454204495|FG001|Overall Study|No longer willing to participate|2|||
126249663|NCT02554877|454204496|FG002|Overall Study|No longer willing to participate|2|||
126249664|NCT02554877|454204497|FG003|Overall Study|No longer willing to participate|0|||
126249665|NCT00274651|454204498|FG000|Overall Study|Adverse Event|6|||
126249666|NCT00274651|454204499|FG001|Overall Study|Adverse Event|3|||
126696957|NCT00723957|455843240|FG001|Overall Study|Disease progression|25|||
126696958|NCT00723957|455843239|FG000|Overall Study|Maximum clinical benefit|4|||
126696959|NCT00723957|455843240|FG001|Overall Study|Maximum clinical benefit|5|||
126696960|NCT00723957|455843239|FG000|Overall Study|Investigator decision|1|||
126696961|NCT00723957|455843240|FG001|Overall Study|Investigator decision|1|||
126696962|NCT00723957|455843239|FG000|Overall Study|Study drug toxicity|4|||
126696963|NCT00723957|455843240|FG001|Overall Study|Study drug toxicity|6|||
126696964|NCT00723957|455843239|FG000|Overall Study|Withdrawal by Subject|7|||
126696965|NCT00723957|455843240|FG001|Overall Study|Withdrawal by Subject|5|||
126696966|NCT00723957|455843239|FG000|Overall Study|Reason not analyzed|1|||
126696967|NCT00723957|455843240|FG001|Overall Study|Reason not analyzed|0|||
126696968|NCT00723957|455843239|FG000|Overall Study|Never received treatment|3|||
126696969|NCT00723957|455843240|FG001|Overall Study|Never received treatment|3|||
126696970|NCT00706628|455843241|FG000|Overall Study|Other Adverse Event|16|||
126696971|NCT00706628|455843242|FG001|Overall Study|Other Adverse Event|5|||
126696972|NCT00706628|455843243|FG002|Overall Study|Other Adverse Event|5|||
126696973|NCT00706628|455843244|FG003|Overall Study|Other Adverse Event|2|||
126696974|NCT00706628|455843241|FG000|Overall Study|Non compliant with protocol|0|||
126696975|NCT00706628|455843242|FG001|Overall Study|Non compliant with protocol|1|||
126696976|NCT00706628|455843243|FG002|Overall Study|Non compliant with protocol|0|||
126696977|NCT00706628|455843244|FG003|Overall Study|Non compliant with protocol|0|||
126696978|NCT00706628|455843241|FG000|Overall Study|Consent withdrawn|6|||
126696979|NCT00706628|455843242|FG001|Overall Study|Consent withdrawn|1|||
126696980|NCT00706628|455843243|FG002|Overall Study|Consent withdrawn|3|||
126696981|NCT00706628|455843244|FG003|Overall Study|Consent withdrawn|0|||
126696982|NCT00706628|455843241|FG000|Overall Study|Progressive disease|20|||
126696983|NCT00706628|455843242|FG001|Overall Study|Progressive disease|13|||
126696984|NCT00706628|455843243|FG002|Overall Study|Progressive disease|8|||
126696985|NCT00706628|455843244|FG003|Overall Study|Progressive disease|1|||
126696986|NCT00706628|455843241|FG000|Overall Study|Other than those stated above|4|||
126696987|NCT00706628|455843242|FG001|Overall Study|Other than those stated above|0|||
126696988|NCT00706628|455843243|FG002|Overall Study|Other than those stated above|0|||
126696989|NCT00706628|455843244|FG003|Overall Study|Other than those stated above|0|||
126696990|NCT00706628|455843241|FG000|Overall Study|Not treated|1|||
126696991|NCT00706628|455843242|FG001|Overall Study|Not treated|1|||
126696992|NCT00706628|455843243|FG002|Overall Study|Not treated|0|||
126696993|NCT00706628|455843244|FG003|Overall Study|Not treated|0|||
126696994|NCT01264939|455843245|FG000|Overall Study|Adverse Event|1|||
126696995|NCT01264939|455843246|FG001|Overall Study|Adverse Event|3|||
126696996|NCT01264939|455843245|FG000|Overall Study|Lost to Follow-up|0|||
126696997|NCT01264939|455843246|FG001|Overall Study|Lost to Follow-up|3|||
126696998|NCT01264939|455843245|FG000|Overall Study|Physician Decision|1|||
126696999|NCT01264939|455843246|FG001|Overall Study|Physician Decision|1|||
126546382|NCT03556358|455293773|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
126546383|NCT03556358|455293772|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
126697000|NCT01264939|455843245|FG000|Overall Study|Patient/Guardian Decision|8|||
126697001|NCT01264939|455843246|FG001|Overall Study|Patient/Guardian Decision|10|||
126697002|NCT01264939|455843245|FG000|Overall Study|Disease Progression|8|||
126697003|NCT01264939|455843246|FG001|Overall Study|Disease Progression|11|||
126249667|NCT00274651|454204498|FG000|Overall Study|Lack of Efficacy|13|||
126249668|NCT00274651|454204499|FG001|Overall Study|Lack of Efficacy|6|||
126697004|NCT02266433|455843247|FG000|Overall Study|Lost to Follow-up|54|||
126697005|NCT02266433|455843248|FG001|Overall Study|Lost to Follow-up|46|||
126697006|NCT02266433|455843247|FG000|Overall Study|Withdrawal by Subject|5|||
126697007|NCT02266433|455843248|FG001|Overall Study|Withdrawal by Subject|7|||
126697008|NCT04525703|455843249|FG000|Overall Study|Lost to Follow-up|6|||
126697009|NCT04525703|455843250|FG001|Overall Study|Lost to Follow-up|15|||
126697010|NCT04525703|455843251|FG002|Overall Study|Lost to Follow-up|8|||
126697011|NCT01285349|455843252|FG000|Overall Study|Lost to Follow-up|27|||
126697012|NCT01285349|455843253|FG001|Overall Study|Lost to Follow-up|20|||
126697013|NCT01285349|455843254|FG002|Overall Study|Lost to Follow-up|27|||
126697014|NCT01145560|455843255|FG000|Overall Study|Withdrawal by Subject|2|||
126697015|NCT01145560|455843256|FG001|Overall Study|Withdrawal by Subject|1|||
126697016|NCT01145560|455843257|FG002|Overall Study|Withdrawal by Subject|0|||
126697017|NCT01145560|455843255|FG000|Overall Study|Lost to Follow-up|1|||
126697018|NCT01145560|455843256|FG001|Overall Study|Lost to Follow-up|1|||
126697019|NCT01145560|455843257|FG002|Overall Study|Lost to Follow-up|1|||
126697020|NCT01145560|455843255|FG000|Overall Study|No study drug by 24h after organ failure|1|||
126697021|NCT01145560|455843256|FG001|Overall Study|No study drug by 24h after organ failure|0|||
126697022|NCT01145560|455843257|FG002|Overall Study|No study drug by 24h after organ failure|0|||
126697023|NCT01145560|455843255|FG000|Overall Study|Accidental unblinding of study treatment|0|||
126697024|NCT01145560|455843256|FG001|Overall Study|Accidental unblinding of study treatment|1|||
126697025|NCT01145560|455843257|FG002|Overall Study|Accidental unblinding of study treatment|0|||
126697026|NCT01145560|455843255|FG000|Overall Study|False insurance information|0|||
126697027|NCT01145560|455843256|FG001|Overall Study|False insurance information|1|||
126697028|NCT01145560|455843257|FG002|Overall Study|False insurance information|0|||
126697029|NCT01145560|455843255|FG000|Overall Study|Withdrawal of therapy|0|||
126697030|NCT01145560|455843256|FG001|Overall Study|Withdrawal of therapy|0|||
126697031|NCT01145560|455843257|FG002|Overall Study|Withdrawal of therapy|1|||
126697032|NCT00712348|455843258|FG000|Overall Study|Withdrawal by Subject|1|||
126249669|NCT00274651|454204498|FG000|Overall Study|Death|1|||
126249670|NCT00274651|454204499|FG001|Overall Study|Death|3|||
126249671|NCT00274651|454204498|FG000|Overall Study|Withdrawal by Subject|0|||
126249672|NCT00274651|454204499|FG001|Overall Study|Withdrawal by Subject|1|||
126249673|NCT00274651|454204498|FG000|Overall Study|Physician Decision|8|||
126249674|NCT00274651|454204499|FG001|Overall Study|Physician Decision|7|||
126249675|NCT00635648|454204500|FG000|Overall Study|Adverse Event|12|||
126249676|NCT00635648|454204500|FG000|Overall Study|Withdrawal by Subject|9|||
126249677|NCT00635648|454204500|FG000|Overall Study|Physician Decision|4|||
126249678|NCT00635648|454204500|FG000|Overall Study|Rapid progression of baseline disease|4|||
126249679|NCT00635648|454204500|FG000|Overall Study|Use of other antifungal agent needed|1|||
126249680|NCT00635648|454204500|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
126249681|NCT00635648|454204500|FG000|Overall Study|Noncompliance with protocol|1|||
126249682|NCT00635648|454204500|FG000|Overall Study|Other reason|2|||
126249683|NCT04547192|454204501|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
126249684|NCT04547192|454204502|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
126249685|NCT04547192|454204503|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
126249686|NCT04547192|454204504|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
126249687|NCT04547192|454204501|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
126249688|NCT04547192|454204502|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
126249689|NCT04547192|454204503|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
126249690|NCT04547192|454204504|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
126249691|NCT04547192|454204501|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
126249692|NCT04547192|454204502|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
126249693|NCT04547192|454204503|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
126249694|NCT04547192|454204504|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
126249695|NCT04547192|454204501|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
126249696|NCT04547192|454204502|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
126249697|NCT04547192|454204503|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
126249698|NCT04547192|454204504|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
126249699|NCT04547192|454204501|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
126249700|NCT04547192|454204502|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
126249701|NCT04547192|454204503|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
126249702|NCT04547192|454204504|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
126249703|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
126249704|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
126249705|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
126249706|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
126249707|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
126249708|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
126249709|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
126249710|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
126249711|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
126249712|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
126249713|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
126249714|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
126249715|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
126249716|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
126249717|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
126249718|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
126249719|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
126249720|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
126249721|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
126697033|NCT02452762|455843260|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
126697034|NCT02452762|455843261|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
126697035|NCT02452762|455843260|FG000|Overall Study|Withdrawal by Subject|1|||
126697036|NCT02452762|455843261|FG001|Overall Study|Withdrawal by Subject|0|||
126697037|NCT00584870|455843262|FG000|Overall Study|Adverse Event|4|||
126697038|NCT00584870|455843263|FG001|Overall Study|Adverse Event|3|||
126697039|NCT00584870|455843264|FG002|Overall Study|Adverse Event|2|||
126697040|NCT00584870|455843262|FG000|Overall Study|Lost to Follow-up|4|||
126697041|NCT00584870|455843263|FG001|Overall Study|Lost to Follow-up|1|||
126697042|NCT00584870|455843264|FG002|Overall Study|Lost to Follow-up|1|||
126697043|NCT00584870|455843262|FG000|Overall Study|Lack of Efficacy|7|||
126762240|NCT01243762|456081177|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
126762241|NCT01243762|456081178|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
126697044|NCT00584870|455843263|FG001|Overall Study|Lack of Efficacy|14|||
126697045|NCT00584870|455843264|FG002|Overall Study|Lack of Efficacy|8|||
126697046|NCT00584870|455843262|FG000|Overall Study|Withdrawal by Subject|10|||
126249722|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
126249723|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
126249724|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
126249725|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
126249726|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
126249727|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
126249728|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
126249729|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
126249730|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
126249731|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
126249732|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
126249733|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
126249734|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
126249735|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
126249736|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
126249737|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
126249738|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
126249739|NCT04194801|454204505|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
126249740|NCT04194801|454204506|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
126249741|NCT04194801|454204507|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
126249742|NCT04194801|454204505|FG000|Part Ib/II End of Study|Death|2|||
126249743|NCT04194801|454204506|FG001|Part Ib/II End of Study|Death|3|||
126249744|NCT04194801|454204507|FG002|Part Ib/II End of Study|Death|3|||
126249745|NCT04194801|454204505|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
126249746|NCT04194801|454204506|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
126249747|NCT04194801|454204507|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
126249748|NCT04194801|454204505|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
126249749|NCT04194801|454204506|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
126249750|NCT04194801|454204507|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
126249751|NCT04194801|454204505|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
126249752|NCT04194801|454204506|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
126249753|NCT04194801|454204507|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
126249754|NCT04194801|454204505|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
126249755|NCT04194801|454204506|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
126249756|NCT04194801|454204507|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
126448817|NCT00884741|454943237|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
126448818|NCT00884741|454943238|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
126448819|NCT00884741|454943239|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
126448820|NCT00884741|454943236|FG000|Step 1 Registration: Tissue Screening|Death|3|||
126448821|NCT00884741|454943237|FG001|Step 1 Registration: Tissue Screening|Death|0|||
126448822|NCT00884741|454943238|FG002|Step 1 Registration: Tissue Screening|Death|0|||
126448823|NCT00884741|454943239|FG003|Step 1 Registration: Tissue Screening|Death|0|||
126448824|NCT00884741|454943236|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
126448825|NCT00884741|454943237|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
126448826|NCT00884741|454943238|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
126448827|NCT00884741|454943239|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
126448828|NCT00884741|454943236|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
126448829|NCT00884741|454943237|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
126448830|NCT00884741|454943238|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
126697047|NCT00584870|455843263|FG001|Overall Study|Withdrawal by Subject|5|||
126249757|NCT01923740|454204508|FG000|Overall Study|Lost to Follow-up|4|||
126249758|NCT01923740|454204509|FG001|Overall Study|Lost to Follow-up|9|||
126249759|NCT01923740|454204508|FG000|Overall Study|Withdrawal by Subject|2|||
126249760|NCT01923740|454204509|FG001|Overall Study|Withdrawal by Subject|0|||
126249761|NCT00294047|454204510|FG000|Month 48|Adverse Event|28|||
126249762|NCT00294047|454204511|FG001|Month 48|Adverse Event|13|||
126249763|NCT00294047|454204510|FG000|Month 48|Protocol Violation|4|||
126249764|NCT00294047|454204511|FG001|Month 48|Protocol Violation|4|||
126249765|NCT00294047|454204510|FG000|Month 48|Withdrawal by Subject|111|||
126249766|NCT00294047|454204511|FG001|Month 48|Withdrawal by Subject|115|||
126249767|NCT00294047|454204510|FG000|Month 48|Lost to Follow-up|272|||
126249768|NCT00294047|454204511|FG001|Month 48|Lost to Follow-up|287|||
126249769|NCT00294047|454204510|FG000|Month 48|Other|10|||
126249770|NCT00294047|454204511|FG001|Month 48|Other|14|||
126249771|NCT00294047|454204510|FG000|Month 84|Adverse Event|4|||
126249772|NCT00294047|454204511|FG001|Month 84|Adverse Event|2|||
126249773|NCT00294047|454204510|FG000|Month 84|Protocol Violation|1|||
126249774|NCT00294047|454204511|FG001|Month 84|Protocol Violation|1|||
126249775|NCT00294047|454204510|FG000|Month 84|Withdrawal by Subject|33|||
126697048|NCT00584870|455843264|FG002|Overall Study|Withdrawal by Subject|3|||
126249776|NCT00294047|454204511|FG001|Month 84|Withdrawal by Subject|31|||
126249777|NCT00294047|454204510|FG000|Month 84|Lost to Follow-up|187|||
126249778|NCT00294047|454204511|FG001|Month 84|Lost to Follow-up|190|||
126249779|NCT00294047|454204510|FG000|Month 84|Absent Cervix|2|||
126249780|NCT00294047|454204511|FG001|Month 84|Absent Cervix|0|||
126249781|NCT00294047|454204510|FG000|Month 84|Work related reasons|4|||
126249782|NCT00294047|454204511|FG001|Month 84|Work related reasons|2|||
126249783|NCT00294047|454204510|FG000|Month 84|Center closed, subject did not transfer|1|||
126249784|NCT00294047|454204511|FG001|Month 84|Center closed, subject did not transfer|0|||
126249785|NCT00294047|454204510|FG000|Month 84|Family problems|2|||
126249786|NCT00294047|454204511|FG001|Month 84|Family problems|2|||
126249787|NCT00294047|454204510|FG000|Month 84|Lack of time|3|||
126249788|NCT00294047|454204511|FG001|Month 84|Lack of time|1|||
126249789|NCT00294047|454204510|FG000|Month 84|Personal reason|2|||
126249790|NCT00294047|454204511|FG001|Month 84|Personal reason|4|||
126249791|NCT00294047|454204510|FG000|Month 84|Subject does not want male physician|1|||
126249792|NCT00294047|454204511|FG001|Month 84|Subject does not want male physician|0|||
126249793|NCT00294047|454204510|FG000|Month 84|Transport reimbursement delayed|0|||
126249794|NCT00294047|454204511|FG001|Month 84|Transport reimbursement delayed|1|||
126249795|NCT00294047|454204510|FG000|Month 84|Unable to reach study site|1|||
126249796|NCT00294047|454204511|FG001|Month 84|Unable to reach study site|0|||
126249797|NCT00294047|454204510|FG000|Month 84|Under investigation locally|1|||
126249798|NCT00294047|454204511|FG001|Month 84|Under investigation locally|0|||
126249799|NCT00294047|454204510|FG000|Month 84|Visit missed|0|||
126249800|NCT00294047|454204511|FG001|Month 84|Visit missed|1|||
126249801|NCT00294047|454204510|FG000|Month 84|No consent for Month 84 Follow-up|731|||
126249802|NCT00294047|454204511|FG001|Month 84|No consent for Month 84 Follow-up|754|||
126249803|NCT02157974|454204512|FG000|Overall Study|Withdrawal by Subject|0|||
126249804|NCT02157974|454204513|FG001|Overall Study|Withdrawal by Subject|1|||
126249805|NCT02157974|454204514|FG002|Overall Study|Withdrawal by Subject|0|||
126249806|NCT02157974|454204515|FG003|Overall Study|Withdrawal by Subject|0|||
126249807|NCT02157974|454204516|FG004|Overall Study|Withdrawal by Subject|0|||
126249808|NCT02157974|454204512|FG000|Overall Study|Screen Failure|0|||
126249809|NCT02157974|454204513|FG001|Overall Study|Screen Failure|1|||
126249810|NCT02157974|454204514|FG002|Overall Study|Screen Failure|0|||
126249811|NCT02157974|454204515|FG003|Overall Study|Screen Failure|0|||
126249812|NCT02157974|454204516|FG004|Overall Study|Screen Failure|0|||
126249813|NCT02157974|454204512|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
126249814|NCT02157974|454204513|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
126249815|NCT02157974|454204514|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
126249816|NCT02157974|454204515|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
126249817|NCT02157974|454204516|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
126249818|NCT03497130|454204519|FG000|Overall Study|Lost to Follow-up|1|||
126249819|NCT03497130|454204520|FG001|Overall Study|Lost to Follow-up|1|||
126249820|NCT04002648|454204521|FG000|Overall Study|Lost to Follow-up|2|||
126249821|NCT04002648|454204522|FG001|Overall Study|Lost to Follow-up|0|||
126249822|NCT01484912|454204523|FG000|Overall Study|Withdrawal by Subject|1|||
126249823|NCT01484912|454204524|FG001|Overall Study|Withdrawal by Subject|0|||
126249824|NCT01484912|454204523|FG000|Overall Study|Physician Decision|0|||
126249825|NCT01484912|454204524|FG001|Overall Study|Physician Decision|1|||
126249826|NCT03158727|454204527|FG000|Overall Study|Withdrawal by Subject|2|||
126249827|NCT03158727|454204528|FG001|Overall Study|Withdrawal by Subject|6|||
126249828|NCT03158727|454204527|FG000|Overall Study|Death|11|||
126249829|NCT03158727|454204528|FG001|Overall Study|Death|12|||
126249830|NCT03158727|454204527|FG000|Overall Study|Lost to Follow-up|1|||
126249831|NCT03158727|454204528|FG001|Overall Study|Lost to Follow-up|0|||
126249832|NCT03158727|454204527|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
126249833|NCT03158727|454204528|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
126249834|NCT03158727|454204527|FG000|Overall Study|Visit 11 not done by mistake|0|||
126249835|NCT03158727|454204528|FG001|Overall Study|Visit 11 not done by mistake|1|||
126249836|NCT03158727|454204527|FG000|Overall Study|Enrolled, not treated|1|||
126249837|NCT03158727|454204528|FG001|Overall Study|Enrolled, not treated|0|||
126249838|NCT00985439|454204529|FG000|Overall Study|Adverse Event|0|||
126697049|NCT00584870|455843262|FG000|Overall Study|Protocol Violation|1|||
126697050|NCT00584870|455843263|FG001|Overall Study|Protocol Violation|1|||
126697051|NCT00584870|455843264|FG002|Overall Study|Protocol Violation|2|||
126249839|NCT00985439|454204530|FG001|Overall Study|Adverse Event|0|||
126249840|NCT00985439|454204531|FG002|Overall Study|Adverse Event|1|||
126249841|NCT00985439|454204532|FG003|Overall Study|Adverse Event|0|||
126249842|NCT01051349|454204533|FG000|Overall Study|Adverse Event|88|||
126249843|NCT01051349|454204533|FG000|Overall Study|Consent Withdrawn|54|||
126697052|NCT00584870|455843262|FG000|Overall Study|Did not met entrance criteria|1|||
126697053|NCT00584870|455843263|FG001|Overall Study|Did not met entrance criteria|0|||
126249844|NCT01051349|454204533|FG000|Overall Study|Investigator Decision|6|||
126249845|NCT01051349|454204533|FG000|Overall Study|Lost to Follow-up|6|||
126249846|NCT01051349|454204533|FG000|Overall Study|Subject non-compliance|7|||
126249847|NCT01051349|454204533|FG000|Overall Study|Reason not Specified|12|||
126697054|NCT00584870|455843264|FG002|Overall Study|Did not met entrance criteria|0|||
126249848|NCT00924638|454204540|FG000|Overall Study|Death|3|||
126249849|NCT00924638|454204541|FG001|Overall Study|Death|2|||
126249850|NCT00924638|454204540|FG000|Overall Study|Lost to Follow-up|1|||
126249851|NCT00924638|454204541|FG001|Overall Study|Lost to Follow-up|1|||
126249852|NCT00924638|454204540|FG000|Overall Study|Withdrawal by Subject|5|||
126249853|NCT00924638|454204541|FG001|Overall Study|Withdrawal by Subject|7|||
126249854|NCT00924638|454204540|FG000|Overall Study|Physician Decision|3|||
126249855|NCT00924638|454204541|FG001|Overall Study|Physician Decision|3|||
126249856|NCT00847535|454204542|FG000|Overall Study|Withdrawal by Subject|2|||
126249857|NCT00847535|454204543|FG001|Overall Study|Withdrawal by Subject|1|||
126249858|NCT00847535|454204544|FG002|Overall Study|Withdrawal by Subject|1|||
126249859|NCT00847535|454204542|FG000|Overall Study|Lost to Follow-up|0|||
126249860|NCT00847535|454204543|FG001|Overall Study|Lost to Follow-up|1|||
126249861|NCT00847535|454204544|FG002|Overall Study|Lost to Follow-up|0|||
126249862|NCT05604014|454204548|FG000|Overall Study|Lost to Follow-up|13|||
126249863|NCT04411680|454204557|FG000|Treatment Period|Adverse Event|3|||
126249864|NCT04411680|454204558|FG001|Treatment Period|Adverse Event|0|||
126249865|NCT04411680|454204557|FG000|Treatment Period|Discharged from hospital|18|||
126249866|NCT04411680|454204558|FG001|Treatment Period|Discharged from hospital|7|||
126249867|NCT04411680|454204557|FG000|Treatment Period|Missed 1 or more doses|8|||
126249868|NCT04411680|454204558|FG001|Treatment Period|Missed 1 or more doses|0|||
126249869|NCT04411680|454204557|FG000|Treatment Period|Transferred to another hospital|0|||
126249870|NCT04411680|454204558|FG001|Treatment Period|Transferred to another hospital|1|||
126249871|NCT04411680|454204557|FG000|Follow up Period|Withdrawal by Subject|2|||
126249872|NCT04411680|454204558|FG001|Follow up Period|Withdrawal by Subject|0|||
126249873|NCT04411680|454204557|FG000|Follow up Period|Lost to Follow-up|5|||
126249874|NCT04411680|454204558|FG001|Follow up Period|Lost to Follow-up|6|||
126249875|NCT04411680|454204557|FG000|Follow up Period|Death|11|||
126249876|NCT04411680|454204558|FG001|Follow up Period|Death|8|||
126249877|NCT00748566|454204559|FG000|Overall Study|Adverse Event|49|||
126249878|NCT00748566|454204559|FG000|Overall Study|Death|1|||
126249879|NCT00748566|454204559|FG000|Overall Study|Lack of Efficacy|12|||
126249880|NCT00748566|454204559|FG000|Overall Study|Lost to Follow-up|1|||
126249881|NCT00748566|454204559|FG000|Overall Study|Protocol Violation|13|||
126249882|NCT00748566|454204559|FG000|Overall Study|Withdrawal by Subject|22|||
126249883|NCT00748566|454204559|FG000|Overall Study|Study terminated by sponsor|5|||
126249884|NCT00748566|454204559|FG000|Overall Study|Other|9|||
126249885|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Refused|1|||
126249886|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Refused|3|||
126249887|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Medical|0|||
126249888|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Medical|1|||
126249889|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
126249890|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
126249891|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
126249892|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
126249893|NCT02054715|454204563|FG000|Baseline/Follow-up 1|No Reason|0|||
126249894|NCT02054715|454204564|FG001|Baseline/Follow-up 1|No Reason|1|||
126249895|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
126249896|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
126249897|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Ineligible|3|||
126249898|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Ineligible|0|||
126249899|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Hospitalization|1|||
126249900|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Hospitalization|0|||
126249901|NCT02054715|454204563|FG000|Baseline/Follow-up 1|Changed Mind|1|||
126249902|NCT02054715|454204564|FG001|Baseline/Follow-up 1|Changed Mind|0|||
126249903|NCT02054715|454204563|FG000|Follow-up 2|Lost to Followup|3|||
126249904|NCT02054715|454204564|FG001|Follow-up 2|Lost to Followup|1|||
126249905|NCT02054715|454204563|FG000|Follow-up 2|Refused|3|||
126249906|NCT02054715|454204564|FG001|Follow-up 2|Refused|2|||
126249907|NCT02054715|454204563|FG000|Follow-up 2|Followup Not Completed|3|||
126249908|NCT02054715|454204564|FG001|Follow-up 2|Followup Not Completed|4|||
126249909|NCT02054715|454204563|FG000|Follow-up 2|Ineligible|4|||
126249910|NCT02054715|454204564|FG001|Follow-up 2|Ineligible|5|||
126249911|NCT02054715|454204563|FG000|Follow-up 2|Death|3|||
126249912|NCT02054715|454204564|FG001|Follow-up 2|Death|3|||
126249913|NCT02054715|454204563|FG000|Follow-up 2|Hospitalization|0|||
126249914|NCT02054715|454204564|FG001|Follow-up 2|Hospitalization|2|||
126249915|NCT02054715|454204563|FG000|Follow-up 2|Changed MD/Facility|0|||
126249916|NCT02054715|454204564|FG001|Follow-up 2|Changed MD/Facility|1|||
126249917|NCT02054715|454204563|FG000|Follow-up 2|Changed Mind|0|||
126249918|NCT02054715|454204564|FG001|Follow-up 2|Changed Mind|1|||
126249919|NCT02054715|454204563|FG000|Follow-up 2|No Reason|2|||
126249920|NCT02054715|454204564|FG001|Follow-up 2|No Reason|0|||
126249921|NCT02054715|454204563|FG000|Follow-up 2|Treatment Change or Delay|1|||
126249922|NCT02054715|454204564|FG001|Follow-up 2|Treatment Change or Delay|0|||
126249923|NCT01442376|454204566|FG000|Overall Study|Adverse Event|0|||
126249924|NCT01442376|454204567|FG001|Overall Study|Adverse Event|3|||
126249925|NCT01442376|454204568|FG002|Overall Study|Adverse Event|2|||
126249926|NCT01442376|454204566|FG000|Overall Study|Death|0|||
126249927|NCT01442376|454204567|FG001|Overall Study|Death|1|||
126249928|NCT01442376|454204568|FG002|Overall Study|Death|1|||
126697055|NCT00584870|455843262|FG000|Overall Study|Other|2|||
126697056|NCT00584870|455843263|FG001|Overall Study|Other|0|||
126697057|NCT00584870|455843264|FG002|Overall Study|Other|0|||
126697058|NCT00584870|455843262|FG000|Overall Study|Randomized but not treated|0|||
126249929|NCT01442376|454204566|FG000|Overall Study|Withdrawal of consent|0|||
126249930|NCT01442376|454204567|FG001|Overall Study|Withdrawal of consent|0|||
126249931|NCT01442376|454204568|FG002|Overall Study|Withdrawal of consent|1|||
126249932|NCT01442376|454204566|FG000|Overall Study|Patients not treated|2|||
126249933|NCT01442376|454204567|FG001|Overall Study|Patients not treated|3|||
126249934|NCT01442376|454204568|FG002|Overall Study|Patients not treated|1|||
126249935|NCT01442376|454204566|FG000|Overall Study|Not eligible for subsequent cycles|1|||
126249936|NCT01442376|454204567|FG001|Overall Study|Not eligible for subsequent cycles|2|||
126249937|NCT01442376|454204568|FG002|Overall Study|Not eligible for subsequent cycles|0|||
126697059|NCT00584870|455843263|FG001|Overall Study|Randomized but not treated|1|||
126697060|NCT00584870|455843264|FG002|Overall Study|Randomized but not treated|2|||
126762242|NCT01243762|456081179|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
126249938|NCT03499873|454204569|FG000|Overall Study|Withdrawal by Subject|4|||
126249939|NCT03499873|454204570|FG001|Overall Study|Withdrawal by Subject|6|||
126249940|NCT03499873|454204571|FG002|Overall Study|Withdrawal by Subject|1|||
126249941|NCT03499873|454204569|FG000|Overall Study|Subjects condition worsened|0|||
126249942|NCT03499873|454204570|FG001|Overall Study|Subjects condition worsened|3|||
126249943|NCT03499873|454204571|FG002|Overall Study|Subjects condition worsened|11|||
126249944|NCT03499873|454204569|FG000|Overall Study|Adverse Event|8|||
126249945|NCT03499873|454204570|FG001|Overall Study|Adverse Event|3|||
126249946|NCT03499873|454204571|FG002|Overall Study|Adverse Event|6|||
126249947|NCT03499873|454204569|FG000|Overall Study|Physician Decision|1|||
126249948|NCT03499873|454204570|FG001|Overall Study|Physician Decision|0|||
126249949|NCT03499873|454204571|FG002|Overall Study|Physician Decision|0|||
126249950|NCT03499873|454204569|FG000|Overall Study|Administrative reasons|0|||
126249951|NCT03499873|454204570|FG001|Overall Study|Administrative reasons|1|||
126249952|NCT03499873|454204571|FG002|Overall Study|Administrative reasons|0|||
126249953|NCT03499873|454204569|FG000|Overall Study|Concomitant therapy|5|||
126249954|NCT03499873|454204570|FG001|Overall Study|Concomitant therapy|4|||
126249955|NCT03499873|454204571|FG002|Overall Study|Concomitant therapy|7|||
126249956|NCT03499873|454204569|FG000|Overall Study|Miscellaneous|1|||
126249957|NCT03499873|454204570|FG001|Overall Study|Miscellaneous|2|||
126249958|NCT03499873|454204571|FG002|Overall Study|Miscellaneous|2|||
126249959|NCT03499873|454204569|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
126249960|NCT03499873|454204570|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
126249961|NCT03499873|454204571|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
126249962|NCT01964950|454204572|FG000|Overall Study|Protocol Violation|25|||
126249963|NCT04404725|454204573|FG000|First Intervention|Withdrawal by Subject|0|||
126249964|NCT04404725|454204574|FG001|First Intervention|Withdrawal by Subject|2|||
126249965|NCT04404725|454204573|FG000|Second Intervention|Adverse Event|1|||
126249966|NCT04404725|454204574|FG001|Second Intervention|Adverse Event|1|||
126249967|NCT04404725|454204573|FG000|Second Intervention|Withdrawal by Subject|0|||
126249968|NCT04404725|454204574|FG001|Second Intervention|Withdrawal by Subject|1|||
126249969|NCT01075516|454204575|FG000|Overall Study|Death|5|||
126249970|NCT01075516|454204576|FG001|Overall Study|Death|9|||
126249971|NCT01075516|454204575|FG000|Overall Study|Lost to Follow-up|10|||
126249972|NCT01075516|454204576|FG001|Overall Study|Lost to Follow-up|2|||
126249973|NCT01075516|454204575|FG000|Overall Study|Withdrawal by Subject|3|||
126249974|NCT01075516|454204576|FG001|Overall Study|Withdrawal by Subject|5|||
126249975|NCT02252016|454204579|FG000|Overall Study|Lost to Follow-up|2|||
126249976|NCT02252016|454204580|FG001|Overall Study|Lost to Follow-up|1|||
126249977|NCT02252016|454204579|FG000|Overall Study|Physician Decision|1|||
126249978|NCT02252016|454204580|FG001|Overall Study|Physician Decision|0|||
126249979|NCT02252016|454204579|FG000|Overall Study|Withdrawal by Subject|0|||
126249980|NCT02252016|454204580|FG001|Overall Study|Withdrawal by Subject|2|||
126249981|NCT04631562|454204589|FG000|Overall Study|Withdrawal by Subject|0|||
126249982|NCT04631562|454204590|FG001|Overall Study|Withdrawal by Subject|0|||
126249983|NCT04631562|454204591|FG002|Overall Study|Withdrawal by Subject|0|||
126249984|NCT04631562|454204592|FG003|Overall Study|Withdrawal by Subject|0|||
126249985|NCT04631562|454204593|FG004|Overall Study|Withdrawal by Subject|0|||
126249986|NCT04631562|454204594|FG005|Overall Study|Withdrawal by Subject|0|||
126249987|NCT04631562|454204595|FG006|Overall Study|Withdrawal by Subject|0|||
126249988|NCT04631562|454204596|FG007|Overall Study|Withdrawal by Subject|1|||
126697061|NCT02675075|455843265|FG000|Overall Study|Lost to Follow-up|3|||
126697062|NCT02675075|455843266|FG001|Overall Study|Lost to Follow-up|0|||
126697063|NCT02292212|455843267|FG000|ViE Phase|Withdrawal by Subject|1|||
126249989|NCT04631562|454204597|FG008|Overall Study|Withdrawal by Subject|0|||
126249990|NCT04631562|454204589|FG000|Overall Study|Other|0|||
126249991|NCT04631562|454204590|FG001|Overall Study|Other|0|||
126249992|NCT04631562|454204591|FG002|Overall Study|Other|0|||
126249993|NCT04631562|454204592|FG003|Overall Study|Other|0|||
126697064|NCT02292212|455843267|FG000|ViE Phase|Protocol Violation|2|||
126697065|NCT00675597|455843268|FG000|Overall Study|Withdrawal by Subject|3|||
126697066|NCT00631137|455843269|FG000|Overall Study|Withdrawal by Subject|1|||
126697067|NCT00631137|455843270|FG001|Overall Study|Withdrawal by Subject|0|||
126697068|NCT03682120|455843271|FG000|Overall Study|Lost to Follow-up|11|||
126249994|NCT04631562|454204593|FG004|Overall Study|Other|0|||
126249995|NCT04631562|454204594|FG005|Overall Study|Other|0|||
126249996|NCT04631562|454204595|FG006|Overall Study|Other|0|||
126249997|NCT04631562|454204596|FG007|Overall Study|Other|0|||
126249998|NCT04631562|454204597|FG008|Overall Study|Other|1|||
126249999|NCT04631562|454204589|FG000|Overall Study|Lost to Follow-up|0|||
126250000|NCT04631562|454204590|FG001|Overall Study|Lost to Follow-up|0|||
126250001|NCT04631562|454204591|FG002|Overall Study|Lost to Follow-up|0|||
126250002|NCT04631562|454204592|FG003|Overall Study|Lost to Follow-up|1|||
126250003|NCT04631562|454204593|FG004|Overall Study|Lost to Follow-up|0|||
126250004|NCT04631562|454204594|FG005|Overall Study|Lost to Follow-up|0|||
126250005|NCT04631562|454204595|FG006|Overall Study|Lost to Follow-up|0|||
126250006|NCT04631562|454204596|FG007|Overall Study|Lost to Follow-up|0|||
126250007|NCT04631562|454204597|FG008|Overall Study|Lost to Follow-up|0|||
126250008|NCT04631562|454204589|FG000|Overall Study|Adverse Event|0|||
126250009|NCT04631562|454204590|FG001|Overall Study|Adverse Event|0|||
126250010|NCT04631562|454204591|FG002|Overall Study|Adverse Event|0|||
126250011|NCT04631562|454204592|FG003|Overall Study|Adverse Event|0|||
126250012|NCT04631562|454204593|FG004|Overall Study|Adverse Event|0|||
126250013|NCT04631562|454204594|FG005|Overall Study|Adverse Event|0|||
126250014|NCT04631562|454204595|FG006|Overall Study|Adverse Event|1|||
126250015|NCT04631562|454204596|FG007|Overall Study|Adverse Event|0|||
126250016|NCT04631562|454204597|FG008|Overall Study|Adverse Event|0|||
126250017|NCT01190865|454204603|FG000|Overall Study|Withdrawal by Subject|1|||
126250018|NCT01190865|454204603|FG000|Overall Study|Non-compliance|2|||
126250019|NCT02471807|454204610|FG000|Overall Study|Death|14|||
126250020|NCT02471807|454204610|FG000|Overall Study|Withdrawal by Subject|2|||
126250021|NCT02471807|454204610|FG000|Overall Study|Explant|5|||
126250022|NCT02471807|454204610|FG000|Overall Study|Lost to Follow-up|1|||
126250023|NCT00957021|454204613|FG000|Overall Study|Death|5|||
126250024|NCT00957021|454204613|FG000|Overall Study|Lost to Follow-up|8|||
126250025|NCT00957021|454204613|FG000|Overall Study|Withdrawal by Subject|34|||
126250026|NCT00957021|454204613|FG000|Overall Study|No 2 yr ROM data|35|||
126250027|NCT00957021|454204613|FG000|Overall Study|Revised study component by 2 yr visit|8|||
126250028|NCT00957021|454204613|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
126250029|NCT00957021|454204613|FG000|Overall Study|Surgery Cancelled|9|||
126250030|NCT00957021|454204613|FG000|Overall Study|Termination due to language issue|2|||
126697069|NCT03682120|455843272|FG001|Overall Study|Lost to Follow-up|4|||
126250031|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
126250032|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
126250033|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
126250034|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
126697070|NCT03682120|455843273|FG002|Overall Study|Lost to Follow-up|5|||
126697071|NCT03682120|455843274|FG003|Overall Study|Lost to Follow-up|2|||
126250035|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
126250036|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
126250037|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
126250038|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
126250039|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
126250040|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
126250041|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
126250042|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
126250043|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
126250044|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
126250045|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
126250046|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
126250047|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
126250048|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
126448831|NCT00884741|454943239|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
126448832|NCT00884741|454943236|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
126448833|NCT00884741|454943237|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
126448834|NCT00884741|454943238|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
126697072|NCT03682120|455843271|FG000|Overall Study|Physician Decision|1|||
126250049|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
126697073|NCT03682120|455843272|FG001|Overall Study|Physician Decision|0|||
126697074|NCT03682120|455843273|FG002|Overall Study|Physician Decision|0|||
126250050|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
126250051|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
126250052|NCT02227238|454204626|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
126250053|NCT02227238|454204627|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
126306333|NCT02244463|454410275|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
126250054|NCT02227238|454204628|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
126250055|NCT02227238|454204626|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
126250056|NCT02227238|454204627|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
126250057|NCT02227238|454204628|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
126250058|NCT02227238|454204626|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
126250059|NCT02227238|454204627|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
126250060|NCT02227238|454204628|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
126250061|NCT02227238|454204626|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
126250062|NCT02227238|454204627|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
126250063|NCT02227238|454204628|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
126250064|NCT02227238|454204626|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
126250065|NCT02227238|454204627|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
126250066|NCT02227238|454204628|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
126250067|NCT02227238|454204626|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
126250068|NCT02227238|454204627|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
126250069|NCT02227238|454204628|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
126250070|NCT02227238|454204626|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
126250071|NCT02227238|454204627|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
126250072|NCT02227238|454204628|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
126250073|NCT04025021|454204629|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
126250074|NCT04025021|454204630|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
126250075|NCT03966911|454204631|FG000|Overall Study|Adverse Event|1|||
126250076|NCT03966911|454204632|FG001|Overall Study|Adverse Event|1|||
126250077|NCT03966911|454204631|FG000|Overall Study|Withdrawal by Subject|8|||
126250078|NCT03966911|454204632|FG001|Overall Study|Withdrawal by Subject|2|||
126250079|NCT03966911|454204631|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
126250080|NCT03966911|454204632|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
126250081|NCT00868998|454204633|FG000|Overall Study|Screen Failure|1|||
126250082|NCT00868998|454204633|FG000|Overall Study|Withdrawal by Subject|1|||
126250083|NCT00868998|454204633|FG000|Overall Study|Progression of disease|2|||
126250084|NCT00868998|454204633|FG000|Overall Study|Death|1|||
126250085|NCT01986647|454204634|FG000|Overall Study|Lost to Follow-up|4|||
126250086|NCT01986647|454204635|FG001|Overall Study|Lost to Follow-up|1|||
126250087|NCT01986647|454204636|FG002|Overall Study|Lost to Follow-up|4|||
126250088|NCT01986647|454204637|FG003|Overall Study|Lost to Follow-up|4|||
126250089|NCT01986647|454204634|FG000|Overall Study|Withdrawal by Subject|1|||
126250090|NCT01986647|454204635|FG001|Overall Study|Withdrawal by Subject|3|||
126250091|NCT01986647|454204636|FG002|Overall Study|Withdrawal by Subject|2|||
126250092|NCT01986647|454204637|FG003|Overall Study|Withdrawal by Subject|3|||
126250093|NCT01986647|454204634|FG000|Overall Study|Health|5|||
126250094|NCT01986647|454204635|FG001|Overall Study|Health|3|||
126250095|NCT01986647|454204636|FG002|Overall Study|Health|6|||
126250096|NCT01986647|454204637|FG003|Overall Study|Health|4|||
126250097|NCT03498560|454204641|FG000|Overall Study|Found Ineligible|2|||
126250098|NCT03498560|454204641|FG000|Overall Study|Withdrawal by Subject|14|||
126250099|NCT03498560|454204641|FG000|Overall Study|Lost to Follow-up|4|||
126250100|NCT03498560|454204641|FG000|Overall Study|Death|1|||
126250101|NCT01004510|454204644|FG000|Overall Study|Adverse Event|1|||
126250102|NCT03541252|454204647|FG000|Overall Study|Withdrawal by Subject|1|||
126250103|NCT01960296|454204648|FG000|Overall Study|Postponed surgery|1|||
126250104|NCT01960296|454204649|FG001|Overall Study|Postponed surgery|0|||
126250105|NCT01960296|454204648|FG000|Overall Study|Received different procedure|1|||
126250106|NCT01960296|454204649|FG001|Overall Study|Received different procedure|3|||
126250107|NCT02003391|454204650|FG000|Overall Study|Withdrawal by Subject|2|||
126250108|NCT02003391|454204651|FG001|Overall Study|Withdrawal by Subject|1|||
126250109|NCT02003391|454204650|FG000|Overall Study|Protocol Violation|0|||
126250110|NCT02003391|454204651|FG001|Overall Study|Protocol Violation|1|||
126250111|NCT02003391|454204650|FG000|Overall Study|Adverse Event|1|||
126250112|NCT02003391|454204651|FG001|Overall Study|Adverse Event|0|||
126250113|NCT02272803|454204652|FG000|Overall Study|Disease progression|16|||
126250114|NCT02272803|454204653|FG001|Overall Study|Disease progression|8|||
126250115|NCT02272803|454204652|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
126358003|NCT00669331|454603856|FG000|Randomisation to First Dose|Protocol Violation|1|||
126358004|NCT00669331|454603857|FG001|Randomisation to First Dose|Protocol Violation|0|||
126358005|NCT00669331|454603856|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
126697075|NCT03682120|455843274|FG003|Overall Study|Physician Decision|0|||
126250116|NCT02272803|454204653|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
126250117|NCT02272803|454204652|FG000|Overall Study|Study drug toxicity|4|||
126250118|NCT02272803|454204653|FG001|Overall Study|Study drug toxicity|9|||
126250119|NCT02272803|454204652|FG000|Overall Study|Participant request to discontinue study treatment|3|||
126250120|NCT02272803|454204653|FG001|Overall Study|Participant request to discontinue study treatment|7|||
126250121|NCT02272803|454204652|FG000|Overall Study|Maximum clinical benefit|4|||
126250122|NCT02272803|454204653|FG001|Overall Study|Maximum clinical benefit|2|||
126250123|NCT02272803|454204652|FG000|Overall Study|Poor/non-compliance|2|||
126250124|NCT02272803|454204653|FG001|Overall Study|Poor/non-compliance|2|||
126250125|NCT02272803|454204652|FG000|Overall Study|Withdrawal by Subject|2|||
126250126|NCT02272803|454204653|FG001|Overall Study|Withdrawal by Subject|1|||
126250127|NCT02272803|454204652|FG000|Overall Study|Death|0|||
126250128|NCT02272803|454204653|FG001|Overall Study|Death|1|||
126250129|NCT02272803|454204652|FG000|Overall Study|Other reasons|1|||
126250130|NCT02272803|454204653|FG001|Overall Study|Other reasons|3|||
126250131|NCT02272803|454204652|FG000|Overall Study|Administrative reason by sponsor|5|||
126250132|NCT02272803|454204653|FG001|Overall Study|Administrative reason by sponsor|4|||
126250133|NCT03733145|454204657|FG000|Overall Study|screenfail|3|||
126250134|NCT03733145|454204658|FG001|Overall Study|screenfail|3|||
126250135|NCT03733145|454204659|FG002|Overall Study|screenfail|2|||
126250136|NCT01952691|454205823|FG000|Overall Study|Lost to Follow-up|2|||
126250137|NCT00199901|454205824|FG000|Overall Study|Protocol Violation|2|||
126250138|NCT00199901|454205825|FG001|Overall Study|Protocol Violation|0|||
126250139|NCT00199901|454205824|FG000|Overall Study|Withdrawal by Subject|1|||
126250140|NCT00199901|454205825|FG001|Overall Study|Withdrawal by Subject|0|||
126250141|NCT00199901|454205824|FG000|Overall Study|Progressive Disease|24|||
126250142|NCT00199901|454205825|FG001|Overall Study|Progressive Disease|24|||
126250143|NCT05776901|454205826|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
126250144|NCT00660660|454205830|FG000|Overall Study|Adverse Event|1|||
126250145|NCT00660660|454205831|FG001|Overall Study|Adverse Event|0|||
126250146|NCT00660660|454205830|FG000|Overall Study|Lost to Follow-up|0|||
126250147|NCT00660660|454205831|FG001|Overall Study|Lost to Follow-up|6|||
126250148|NCT00660660|454205830|FG000|Overall Study|Lack of Efficacy|0|||
126250149|NCT00660660|454205831|FG001|Overall Study|Lack of Efficacy|2|||
126250150|NCT00660660|454205830|FG000|Overall Study|Withdrawal by Subject|3|||
126250151|NCT00660660|454205831|FG001|Overall Study|Withdrawal by Subject|0|||
126250152|NCT00660660|454205830|FG000|Overall Study|Incorrect enrollment and other|0|||
126250153|NCT00660660|454205831|FG001|Overall Study|Incorrect enrollment and other|1|||
126250154|NCT00660660|454205830|FG000|Overall Study|New medication after randomization|1|||
126250155|NCT00660660|454205831|FG001|Overall Study|New medication after randomization|0|||
126250156|NCT04523480|454205836|FG000|Overall Study|Lost to Follow-up|30|||
126250157|NCT04523480|454205837|FG001|Overall Study|Lost to Follow-up|35|||
126250158|NCT04523480|454205838|FG002|Overall Study|Lost to Follow-up|0|||
126250159|NCT00081653|454205844|FG000|Overall Study|Adverse Event|23|||
126250160|NCT00081653|454205845|FG001|Overall Study|Adverse Event|17|||
126250161|NCT00081653|454205844|FG000|Overall Study|Lost to Follow-up|2|||
126250162|NCT00081653|454205845|FG001|Overall Study|Lost to Follow-up|4|||
126250163|NCT00081653|454205844|FG000|Overall Study|Refused Treatment|18|||
126697076|NCT03682120|455843271|FG000|Overall Study|Withdrawal by Subject|1|||
126250164|NCT00081653|454205845|FG001|Overall Study|Refused Treatment|14|||
126250165|NCT00081653|454205844|FG000|Overall Study|Low bone mineral density|1|||
126250166|NCT00081653|454205845|FG001|Overall Study|Low bone mineral density|0|||
126250167|NCT00081653|454205844|FG000|Overall Study|Bone loss|2|||
126250168|NCT00081653|454205845|FG001|Overall Study|Bone loss|0|||
126250169|NCT00081653|454205844|FG000|Overall Study|Participant leaving country|1|||
126250170|NCT00081653|454205845|FG001|Overall Study|Participant leaving country|0|||
126250171|NCT00081653|454205844|FG000|Overall Study|Loss of bone mass|0|||
126250172|NCT00081653|454205845|FG001|Overall Study|Loss of bone mass|2|||
126250173|NCT02694536|454205853|FG000|Overall Study|Progressive Disease|40|||
126250174|NCT02694536|454205853|FG000|Overall Study|Lost to Follow-up|1|||
126250175|NCT02694536|454205853|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
126250176|NCT02694536|454205853|FG000|Overall Study|Withdrawal by Subject|8|||
126250177|NCT02694536|454205853|FG000|Overall Study|Death|8|||
126250178|NCT02694536|454205853|FG000|Overall Study|Other|22|||
126250179|NCT00385736|454205854|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
126250180|NCT00385736|454205855|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
126250181|NCT00385736|454205856|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
126250182|NCT00385736|454205854|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
126250183|NCT00385736|454205855|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
126697077|NCT03682120|455843272|FG001|Overall Study|Withdrawal by Subject|2|||
126697078|NCT03682120|455843273|FG002|Overall Study|Withdrawal by Subject|3|||
126697079|NCT03682120|455843274|FG003|Overall Study|Withdrawal by Subject|0|||
126697080|NCT03682120|455843271|FG000|Overall Study|Death|0|||
126697081|NCT03682120|455843272|FG001|Overall Study|Death|1|||
126250184|NCT00385736|454205856|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
126250185|NCT00385736|454205854|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
126250186|NCT00385736|454205855|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
126250187|NCT00385736|454205856|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
126250188|NCT00385736|454205854|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
126250189|NCT00385736|454205855|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
126250190|NCT00385736|454205856|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
126697082|NCT03682120|455843273|FG002|Overall Study|Death|0|||
126697083|NCT03682120|455843274|FG003|Overall Study|Death|0|||
126250191|NCT00385736|454205854|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
126250192|NCT00385736|454205855|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
126250193|NCT00385736|454205856|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
126250194|NCT00385736|454205854|FG000|Efficacy Analysis Set - Induction|Other|0|||
126250195|NCT00385736|454205855|FG001|Efficacy Analysis Set - Induction|Other|0|||
126250196|NCT00385736|454205856|FG002|Efficacy Analysis Set - Induction|Other|1|||
126250197|NCT00385736|454205854|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
126250198|NCT00385736|454205855|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
126250199|NCT00385736|454205856|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
126250200|NCT00385736|454205854|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
126250201|NCT00385736|454205855|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
126250202|NCT00385736|454205856|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
126250203|NCT00385736|454205854|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
126250204|NCT00385736|454205855|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
126250205|NCT00385736|454205856|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
126250206|NCT00385736|454205854|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
126250207|NCT00385736|454205855|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
126250208|NCT00385736|454205856|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
126250209|NCT00385736|454205854|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
126250210|NCT00385736|454205855|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
126250211|NCT00385736|454205856|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
126250212|NCT00385736|454205854|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
126250213|NCT00385736|454205855|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
126250214|NCT00385736|454205856|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
126250215|NCT00385736|454205854|FG000|Safety Analysis Set|Adverse Event|23|||
126250216|NCT00385736|454205855|FG001|Safety Analysis Set|Adverse Event|15|||
126250217|NCT00385736|454205856|FG002|Safety Analysis Set|Adverse Event|23|||
126250218|NCT00385736|454205854|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
126250219|NCT00385736|454205855|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
126250220|NCT00385736|454205856|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
126250221|NCT00385736|454205854|FG000|Safety Analysis Set|Lost to Follow-up|0|||
126250222|NCT00385736|454205855|FG001|Safety Analysis Set|Lost to Follow-up|2|||
126250223|NCT00385736|454205856|FG002|Safety Analysis Set|Lost to Follow-up|2|||
126250224|NCT00385736|454205854|FG000|Safety Analysis Set|Lack of Efficacy|38|||
126250225|NCT00385736|454205855|FG001|Safety Analysis Set|Lack of Efficacy|16|||
126250226|NCT00385736|454205856|FG002|Safety Analysis Set|Lack of Efficacy|31|||
126250227|NCT00385736|454205854|FG000|Safety Analysis Set|Protocol Violation|2|||
126250228|NCT00385736|454205855|FG001|Safety Analysis Set|Protocol Violation|1|||
126250229|NCT00385736|454205856|FG002|Safety Analysis Set|Protocol Violation|6|||
126250230|NCT00385736|454205854|FG000|Safety Analysis Set|Other|1|||
126250231|NCT00385736|454205855|FG001|Safety Analysis Set|Other|4|||
126250232|NCT00385736|454205856|FG002|Safety Analysis Set|Other|4|||
126250233|NCT01911429|454205861|FG000|Overall Study|Adverse Event|5|||
126250234|NCT01911429|454205862|FG001|Overall Study|Adverse Event|3|||
126250235|NCT01911429|454205863|FG002|Overall Study|Adverse Event|9|||
126250236|NCT01911429|454205861|FG000|Overall Study|Lack of Efficacy|1|||
126250237|NCT01911429|454205862|FG001|Overall Study|Lack of Efficacy|2|||
126250238|NCT01911429|454205863|FG002|Overall Study|Lack of Efficacy|4|||
126250239|NCT01911429|454205861|FG000|Overall Study|Lost to Follow-up|0|||
126250240|NCT01911429|454205862|FG001|Overall Study|Lost to Follow-up|0|||
126250241|NCT01911429|454205863|FG002|Overall Study|Lost to Follow-up|1|||
126250242|NCT01911429|454205861|FG000|Overall Study|Protocol Violation|0|||
126250243|NCT01911429|454205862|FG001|Overall Study|Protocol Violation|0|||
126250244|NCT01911429|454205863|FG002|Overall Study|Protocol Violation|1|||
126250245|NCT01911429|454205861|FG000|Overall Study|Withdrawal by Subject|5|||
126250246|NCT01911429|454205862|FG001|Overall Study|Withdrawal by Subject|5|||
126250247|NCT01911429|454205863|FG002|Overall Study|Withdrawal by Subject|4|||
126250248|NCT01911429|454205861|FG000|Overall Study|Accidental randomization|0|||
126250249|NCT01911429|454205862|FG001|Overall Study|Accidental randomization|0|||
126250250|NCT01911429|454205863|FG002|Overall Study|Accidental randomization|1|||
126250251|NCT01911429|454205861|FG000|Overall Study|subject left study|1|||
126250252|NCT01911429|454205862|FG001|Overall Study|subject left study|0|||
126250253|NCT01911429|454205863|FG002|Overall Study|subject left study|0|||
126250254|NCT01557751|454205869|FG000|Overall Study|Physician Decision|3|||
126250255|NCT02043132|454205870|FG000|Overall Study|Lost to Follow-up|1|||
126250256|NCT02043132|454205871|FG001|Overall Study|Lost to Follow-up|1|||
126250257|NCT02043132|454205870|FG000|Overall Study|screen failures|4|||
126250258|NCT02043132|454205871|FG001|Overall Study|screen failures|8|||
126250259|NCT00472212|454205873|FG000|Overall Study|Lost to Follow-up|6|||
126358006|NCT00669331|454603857|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
126697084|NCT03682120|455843271|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
126250260|NCT00472212|454205874|FG001|Overall Study|Lost to Follow-up|4|||
126250261|NCT02462837|454205875|FG000|Overall Study|pt developed hives|1|||
126250262|NCT02462837|454205876|FG001|Overall Study|pt developed hives|0|||
126358007|NCT00669331|454603856|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
126250263|NCT02462837|454205875|FG000|Overall Study|Withdrawal by Subject|1|||
126250264|NCT02462837|454205876|FG001|Overall Study|Withdrawal by Subject|0|||
126250265|NCT00958724|454205877|FG000|Overall Study|Disease Progression|6|||
126250266|NCT00840203|454205895|FG000|First Intervention|Protocol Violation|1|||
126250267|NCT00840203|454205896|FG001|First Intervention|Protocol Violation|1|||
126250268|NCT00840203|454205895|FG000|Washout|Protocol Violation|1|||
126250269|NCT00840203|454205896|FG001|Washout|Protocol Violation|0|||
126250270|NCT02121184|454205900|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
126250271|NCT02121184|454205901|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
126250272|NCT02121184|454205900|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
126250273|NCT02121184|454205901|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
126250274|NCT02121184|454205900|FG000|Overall Study|Emergency cesarean section required|0|||
126250275|NCT02121184|454205901|FG001|Overall Study|Emergency cesarean section required|2|||
126250276|NCT02121184|454205900|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
126250277|NCT02121184|454205901|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
126250278|NCT05562011|454205902|FG000|Overall Study|Withdrawal by Subject|3|||
126250279|NCT05562011|454205902|FG000|Overall Study|Lost to Follow-up|1|||
126250280|NCT05562011|454205902|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
126250281|NCT05562011|454205902|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
126250282|NCT05562011|454205902|FG000|Overall Study|Device malfunction|13|||
126250283|NCT02905435|454205907|FG000|Overall Study|Death|2|||
126250284|NCT02905435|454205907|FG000|Overall Study|Physician Decision|1|||
126250285|NCT02905435|454205907|FG000|Overall Study|Lost to Follow-up|4|||
126250286|NCT01507662|454205908|FG000|Overall Study|Death|26|||
126250287|NCT01507662|454205909|FG001|Overall Study|Death|18|||
126250288|NCT01507662|454205908|FG000|Overall Study|Withdrawal by Subject|290|||
126250289|NCT01507662|454205909|FG001|Overall Study|Withdrawal by Subject|287|||
126250290|NCT01507662|454205908|FG000|Overall Study|Lost to Follow-up|498|||
126250291|NCT01507662|454205909|FG001|Overall Study|Lost to Follow-up|523|||
126250292|NCT01507662|454205908|FG000|Overall Study|Proxy interview done|2|||
126250293|NCT01507662|454205909|FG001|Overall Study|Proxy interview done|3|||
126250294|NCT01395017|454205912|FG000|Overall Study|Lost to Follow-up|1|||
126250295|NCT01395017|454205913|FG001|Overall Study|Lost to Follow-up|0|||
126250296|NCT01395017|454205912|FG000|Overall Study|Adverse Event|26|||
126250297|NCT01395017|454205913|FG001|Overall Study|Adverse Event|12|||
126250298|NCT01395017|454205912|FG000|Overall Study|Physician Decision|11|||
126250299|NCT01395017|454205913|FG001|Overall Study|Physician Decision|15|||
126250300|NCT01395017|454205912|FG000|Overall Study|Withdrawal by Subject|14|||
126250301|NCT01395017|454205913|FG001|Overall Study|Withdrawal by Subject|8|||
126250302|NCT01395017|454205912|FG000|Overall Study|Protocol deviation|1|||
126250303|NCT01395017|454205913|FG001|Overall Study|Protocol deviation|2|||
126250304|NCT01395017|454205912|FG000|Overall Study|Death|4|||
126250305|NCT01395017|454205913|FG001|Overall Study|Death|3|||
126250306|NCT01395017|454205912|FG000|Overall Study|Disease progression|42|||
126250307|NCT01395017|454205913|FG001|Overall Study|Disease progression|58|||
126250308|NCT01395017|454205912|FG000|Overall Study|Sponsor discontinued study|1|||
126250309|NCT01395017|454205913|FG001|Overall Study|Sponsor discontinued study|4|||
126250310|NCT00999687|454205915|FG000|First Intervention|Withdrawal by Subject|1|||
126250311|NCT00999687|454205915|FG000|Second Intervention|Withdrawal by Subject|2|||
126250312|NCT00999687|454205915|FG000|Second Intervention|Lack of Efficacy|1|||
126250313|NCT00474188|454205916|FG000|Overall Study|Withdrawal by Subject|1|||
126250314|NCT00474188|454205916|FG000|Overall Study|Study discontinued by sponsor|5|||
126250315|NCT03684928|454205920|FG000|First Intervention|Lost to Follow-up|0|||
126250316|NCT03684928|454205921|FG001|First Intervention|Lost to Follow-up|1|||
126250317|NCT03684928|454205920|FG000|First Intervention|Withdrawal by Subject|0|||
126250318|NCT03684928|454205921|FG001|First Intervention|Withdrawal by Subject|2|||
126250319|NCT03684928|454205920|FG000|Second Intervention|Soft Tissue Injury|1|||
126250320|NCT03684928|454205921|FG001|Second Intervention|Soft Tissue Injury|0|||
126250321|NCT00557245|454206894|FG000|Overall Study|Lost to Follow-up|7|||
126250322|NCT00557245|454206895|FG001|Overall Study|Lost to Follow-up|8|||
126250323|NCT00557245|454206896|FG002|Overall Study|Lost to Follow-up|10|||
126250324|NCT00557245|454206894|FG000|Overall Study|Ineligible|5|||
126250325|NCT00557245|454206895|FG001|Overall Study|Ineligible|4|||
126250326|NCT00557245|454206896|FG002|Overall Study|Ineligible|2|||
126250327|NCT00798603|454206899|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
126250328|NCT00798603|454206899|FG000|Overall Study|Withdrawal by Subject|10|||
126250329|NCT00798603|454206899|FG000|Overall Study|Adverse Event|22|||
126250330|NCT00798603|454206899|FG000|Overall Study|Physician Decision|1|||
126250331|NCT00798603|454206899|FG000|Overall Study|Lack of insurance coverage|1|||
126250332|NCT02316223|454206902|FG000|Overall Study|Lack of Efficacy|0|||
126250333|NCT02316223|454206903|FG001|Overall Study|Lack of Efficacy|1|||
126250334|NCT02316223|454206904|FG002|Overall Study|Lack of Efficacy|1|||
126250335|NCT02316223|454206902|FG000|Overall Study|Lost to Follow-up|27|||
126250336|NCT02316223|454206903|FG001|Overall Study|Lost to Follow-up|34|||
126250337|NCT02316223|454206904|FG002|Overall Study|Lost to Follow-up|36|||
126250338|NCT02316223|454206902|FG000|Overall Study|COPD Diagnosis|3|||
126250339|NCT02316223|454206903|FG001|Overall Study|COPD Diagnosis|2|||
126250340|NCT02316223|454206904|FG002|Overall Study|COPD Diagnosis|3|||
126250341|NCT02316223|454206902|FG000|Overall Study|Reside outside study area|1|||
126250342|NCT02316223|454206903|FG001|Overall Study|Reside outside study area|1|||
126250343|NCT02316223|454206904|FG002|Overall Study|Reside outside study area|1|||
126250344|NCT02316223|454206902|FG000|Overall Study|No asthma|2|||
126250345|NCT02316223|454206903|FG001|Overall Study|No asthma|0|||
126250346|NCT02316223|454206904|FG002|Overall Study|No asthma|0|||
126250347|NCT02316223|454206902|FG000|Overall Study|Discontinued by PI|11|||
126250348|NCT02316223|454206903|FG001|Overall Study|Discontinued by PI|19|||
126250349|NCT02316223|454206904|FG002|Overall Study|Discontinued by PI|3|||
126250350|NCT00529763|454206906|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
126250351|NCT00529763|454206907|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
126250352|NCT00529763|454206908|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
126250353|NCT00529763|454206906|FG000|Overall Study|Death|1|||
126250354|NCT00529763|454206907|FG001|Overall Study|Death|1|||
126250355|NCT00529763|454206908|FG002|Overall Study|Death|1|||
126250356|NCT00529763|454206906|FG000|Overall Study|Disease Progression|10|||
126250357|NCT00529763|454206907|FG001|Overall Study|Disease Progression|16|||
126250358|NCT00529763|454206908|FG002|Overall Study|Disease Progression|11|||
126250359|NCT00529763|454206906|FG000|Overall Study|Lost to Follow-up|1|||
126250360|NCT00529763|454206907|FG001|Overall Study|Lost to Follow-up|2|||
126250361|NCT00529763|454206908|FG002|Overall Study|Lost to Follow-up|3|||
126250362|NCT00529763|454206906|FG000|Overall Study|Stem Cell Transplant|0|||
126250363|NCT00529763|454206907|FG001|Overall Study|Stem Cell Transplant|3|||
126250364|NCT00529763|454206908|FG002|Overall Study|Stem Cell Transplant|1|||
126250365|NCT00529763|454206906|FG000|Overall Study|Study Drug Toxicity|3|||
126250366|NCT00529763|454206907|FG001|Overall Study|Study Drug Toxicity|6|||
126250367|NCT00529763|454206908|FG002|Overall Study|Study Drug Toxicity|4|||
126250368|NCT00529763|454206906|FG000|Overall Study|Participant Withdrew Consent|2|||
126250369|NCT00529763|454206907|FG001|Overall Study|Participant Withdrew Consent|3|||
126250370|NCT00529763|454206908|FG002|Overall Study|Participant Withdrew Consent|4|||
126250371|NCT00529763|454206906|FG000|Overall Study|Other reasons|2|||
126250372|NCT00529763|454206907|FG001|Overall Study|Other reasons|0|||
126250373|NCT00529763|454206908|FG002|Overall Study|Other reasons|2|||
126250374|NCT00529763|454206906|FG000|Overall Study|Participant request to discontinue treatment|1|||
126250375|NCT00529763|454206907|FG001|Overall Study|Participant request to discontinue treatment|1|||
126250376|NCT00529763|454206908|FG002|Overall Study|Participant request to discontinue treatment|3|||
126250377|NCT03669250|454206909|FG000|Overall Study|Adverse Event|0|||
126250378|NCT03669250|454206910|FG001|Overall Study|Adverse Event|0|||
126250379|NCT03669250|454206911|FG002|Overall Study|Adverse Event|0|||
126250380|NCT03669250|454206912|FG003|Overall Study|Adverse Event|0|||
126250381|NCT03669250|454206913|FG004|Overall Study|Adverse Event|1|||
126250382|NCT03669250|454206914|FG005|Overall Study|Adverse Event|0|||
126250383|NCT03669250|454206909|FG000|Overall Study|Withdrawal by Subject|0|||
126250384|NCT03669250|454206910|FG001|Overall Study|Withdrawal by Subject|1|||
126250385|NCT03669250|454206911|FG002|Overall Study|Withdrawal by Subject|0|||
126250386|NCT03669250|454206912|FG003|Overall Study|Withdrawal by Subject|1|||
126250387|NCT03669250|454206913|FG004|Overall Study|Withdrawal by Subject|0|||
126250388|NCT03669250|454206914|FG005|Overall Study|Withdrawal by Subject|0|||
126250389|NCT00828321|454206915|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
126250390|NCT00828321|454206916|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
126250391|NCT00828321|454206915|FG000|Second Intervention|Protocol Violation|0|||
126250392|NCT00828321|454206916|FG001|Second Intervention|Protocol Violation|1|||
126250393|NCT03234907|454206917|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
126250394|NCT03234907|454206918|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
126250395|NCT03234907|454206919|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
126250396|NCT03234907|454206920|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
126250397|NCT03234907|454206921|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
126250398|NCT03234907|454206922|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
126250399|NCT03234907|454206917|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
126250400|NCT03234907|454206918|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
126250401|NCT03234907|454206919|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
126250402|NCT03234907|454206920|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
126250403|NCT03234907|454206921|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
126250404|NCT03234907|454206922|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
126250405|NCT03234907|454206917|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
126250406|NCT03234907|454206918|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
126250407|NCT03234907|454206919|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
126250408|NCT03234907|454206920|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
126250409|NCT03234907|454206921|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
126250410|NCT03234907|454206922|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
126250411|NCT03234907|454206917|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
126250412|NCT03234907|454206918|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
126250413|NCT03234907|454206919|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
126250414|NCT03234907|454206920|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
126250415|NCT03234907|454206921|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
126250416|NCT03234907|454206922|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
126250417|NCT03234907|454206917|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
126250418|NCT03234907|454206918|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
126250419|NCT03234907|454206919|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
126250420|NCT03234907|454206920|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
126250421|NCT03234907|454206921|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
126250422|NCT03234907|454206922|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
126250423|NCT03234907|454206917|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
126250424|NCT03234907|454206918|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
126250425|NCT03234907|454206919|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
126250426|NCT03234907|454206920|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
126250427|NCT03234907|454206921|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
126250428|NCT03234907|454206922|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
126250429|NCT03234907|454206917|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
126250430|NCT03234907|454206918|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
126250431|NCT03234907|454206919|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
126250432|NCT03234907|454206920|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
126250433|NCT03234907|454206921|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
126250434|NCT03234907|454206922|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
126250435|NCT00642993|454206923|FG000|Overall Study|Adverse Event|85|||
126250436|NCT00642993|454206924|FG001|Overall Study|Adverse Event|4|||
126250437|NCT00642993|454206923|FG000|Overall Study|Lost to Follow-up|8|||
126250438|NCT00642993|454206924|FG001|Overall Study|Lost to Follow-up|4|||
126250439|NCT00642993|454206923|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
126250440|NCT00642993|454206924|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
126250441|NCT00642993|454206923|FG000|Overall Study|Protocol Violation|1|||
126250442|NCT00642993|454206924|FG001|Overall Study|Protocol Violation|4|||
126250443|NCT00642993|454206923|FG000|Overall Study|Did not meet protocol eligibility|0|||
126250444|NCT00642993|454206924|FG001|Overall Study|Did not meet protocol eligibility|1|||
126250445|NCT00642993|454206923|FG000|Overall Study|Administrative|1|||
126250446|NCT00642993|454206924|FG001|Overall Study|Administrative|0|||
126250447|NCT02664415|454206925|FG000|Overall Study|Adverse Event|1|||
126250448|NCT02664415|454206926|FG001|Overall Study|Adverse Event|0|||
126250449|NCT02986139|454206928|FG000|Overall Study|Sponsor Decision|1|||
126250450|NCT02986139|454206929|FG001|Overall Study|Sponsor Decision|2|||
126250451|NCT02986139|454206928|FG000|Overall Study|Withdrawal by Subject|0|||
126250452|NCT02986139|454206929|FG001|Overall Study|Withdrawal by Subject|1|||
126250453|NCT02986139|454206928|FG000|Overall Study|Lost to Follow-up|0|||
126250454|NCT02986139|454206929|FG001|Overall Study|Lost to Follow-up|1|||
126250455|NCT00414726|454206933|FG000|Overall Study|Withdrawal by Subject|0|||
126250456|NCT00414726|454206934|FG001|Overall Study|Withdrawal by Subject|1|||
126250457|NCT02107196|454206935|FG000|12-week Treatment Period|Adverse Event|6|||
126250458|NCT02107196|454206936|FG001|12-week Treatment Period|Adverse Event|3|||
126250459|NCT02107196|454206935|FG000|12-week Treatment Period|Lack of Efficacy|2|||
126250460|NCT02107196|454206936|FG001|12-week Treatment Period|Lack of Efficacy|1|||
126250461|NCT02107196|454206935|FG000|12-week Treatment Period|Lost to Follow-up|3|||
126250462|NCT02107196|454206936|FG001|12-week Treatment Period|Lost to Follow-up|6|||
126250463|NCT02107196|454206935|FG000|12-week Treatment Period|Physician Decision|0|||
126250464|NCT02107196|454206936|FG001|12-week Treatment Period|Physician Decision|1|||
126250465|NCT02107196|454206935|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
126250466|NCT02107196|454206936|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
126250467|NCT02107196|454206935|FG000|12-week Treatment Period|Protocol Violation|7|||
126250468|NCT02107196|454206936|FG001|12-week Treatment Period|Protocol Violation|8|||
126250469|NCT02107196|454206935|FG000|12-week Treatment Period|Reason Missing|11|||
126250470|NCT02107196|454206936|FG001|12-week Treatment Period|Reason Missing|8|||
126250471|NCT02107196|454206935|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
126250472|NCT02107196|454206936|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
126250473|NCT02107196|454206935|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
126250474|NCT02107196|454206936|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
126250475|NCT02107196|454206935|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
126250476|NCT02107196|454206936|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
126250477|NCT02107196|454206935|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
126448835|NCT00884741|454943239|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
126448836|NCT00884741|454943236|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
126250478|NCT02107196|454206936|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
126448837|NCT00884741|454943237|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
126448838|NCT00884741|454943238|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
126448839|NCT00884741|454943239|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
126448840|NCT00884741|454943236|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
126250479|NCT00516295|454206937|FG000|Overall Study|Lack of Efficacy|2|||
126250480|NCT00516295|454206938|FG001|Overall Study|Lack of Efficacy|0|||
126250481|NCT00516295|454206939|FG002|Overall Study|Lack of Efficacy|0|||
126250482|NCT00516295|454206937|FG000|Overall Study|Ineligible|1|||
126250483|NCT00516295|454206938|FG001|Overall Study|Ineligible|0|||
126250484|NCT00516295|454206939|FG002|Overall Study|Ineligible|0|||
126250485|NCT01630616|454206942|FG000|Overall Study|Adverse Event|0|||
126250486|NCT01630616|454206943|FG001|Overall Study|Adverse Event|0|||
126250487|NCT01630616|454206944|FG002|Overall Study|Adverse Event|0|||
126250488|NCT01630616|454206945|FG003|Overall Study|Adverse Event|1|||
126250489|NCT01630616|454206946|FG004|Overall Study|Adverse Event|0|||
126250490|NCT01630616|454206947|FG005|Overall Study|Adverse Event|0|||
126250491|NCT01630616|454206942|FG000|Overall Study|Withdrawal by Subject|0|||
126250492|NCT01630616|454206943|FG001|Overall Study|Withdrawal by Subject|0|||
126250493|NCT01630616|454206944|FG002|Overall Study|Withdrawal by Subject|0|||
126250494|NCT01630616|454206945|FG003|Overall Study|Withdrawal by Subject|2|||
126448841|NCT00884741|454943237|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
126448842|NCT00884741|454943238|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
126448843|NCT00884741|454943239|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
126448844|NCT00884741|454943236|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
126448845|NCT00884741|454943237|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
126448846|NCT00884741|454943238|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
126448847|NCT00884741|454943239|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
126448848|NCT00884741|454943236|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
126448849|NCT00884741|454943237|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
126448850|NCT00884741|454943238|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
126448851|NCT00884741|454943239|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
126448852|NCT00884741|454943236|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
126448853|NCT00884741|454943237|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
126448854|NCT00884741|454943238|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
126448855|NCT00884741|454943239|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
126448856|NCT00884741|454943236|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
126448857|NCT00884741|454943237|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
126250495|NCT01630616|454206946|FG004|Overall Study|Withdrawal by Subject|0|||
126250496|NCT01630616|454206947|FG005|Overall Study|Withdrawal by Subject|0|||
126250497|NCT02218541|454206948|FG000|Overall Study|Lost to Follow-up|2|||
126250498|NCT02218541|454206949|FG001|Overall Study|Lost to Follow-up|1|||
126250499|NCT02218541|454206948|FG000|Overall Study|Implant Failure|4|||
126250500|NCT02218541|454206949|FG001|Overall Study|Implant Failure|1|||
126250501|NCT01993186|454206950|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
126250502|NCT01993186|454206951|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
126250503|NCT01993186|454206950|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
126250504|NCT01993186|454206951|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
126250505|NCT01993186|454206950|FG000|Open-Label Extension Period|Other, Not Specified|0|||
126250506|NCT01993186|454206951|FG001|Open-Label Extension Period|Other, Not Specified|1|||
126250507|NCT01993186|454206950|FG000|Open-Label Extension Period|Adverse Event|1|||
126250508|NCT01993186|454206951|FG001|Open-Label Extension Period|Adverse Event|0|||
126250509|NCT01993186|454206950|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
126250510|NCT01993186|454206951|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
126250511|NCT01993186|454206950|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
126250512|NCT01993186|454206951|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
126250513|NCT01993186|454206950|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
126250514|NCT01993186|454206951|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
126250515|NCT03827395|454206952|FG000|Overall Study|Lost to Follow-up|1|||
126697085|NCT03682120|455843272|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
126697086|NCT03682120|455843273|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
126697087|NCT03682120|455843274|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
126697088|NCT03308188|455843275|FG000|Overall Study|Withdrawal by Subject|0|||
126697089|NCT03308188|455843276|FG001|Overall Study|Withdrawal by Subject|3|||
126697090|NCT03308188|455843275|FG000|Overall Study|Death|0|||
126250516|NCT03827395|454206953|FG001|Overall Study|Lost to Follow-up|0|||
126250517|NCT03827395|454206952|FG000|Overall Study|Protocol Violation|1|||
126250518|NCT03827395|454206953|FG001|Overall Study|Protocol Violation|0|||
126250519|NCT03827395|454206952|FG000|Overall Study|Became ineligible after enrollment|1|||
126250520|NCT03827395|454206953|FG001|Overall Study|Became ineligible after enrollment|2|||
126250521|NCT00731939|454206954|FG000|Overall Study|Adverse Event|6|||
126250522|NCT00731939|454206954|FG000|Overall Study|Lost to Follow-up|15|||
126250523|NCT00731939|454206954|FG000|Overall Study|Not implanted with study device|9|||
126250524|NCT00731939|454206954|FG000|Overall Study|Withdrawal by Subject|2|||
126250525|NCT00731939|454206954|FG000|Overall Study|Did not meet enrollment criteria|2|||
126250526|NCT02072096|454206961|FG000|Overall Study|Lack of Efficacy|18|||
126250527|NCT02072096|454206962|FG001|Overall Study|Lack of Efficacy|29|||
126250528|NCT02072096|454206961|FG000|Overall Study|Protocol Violation|7|||
126250529|NCT02072096|454206962|FG001|Overall Study|Protocol Violation|7|||
126250530|NCT02072096|454206961|FG000|Overall Study|Withdrawal by Subject|5|||
126250531|NCT02072096|454206962|FG001|Overall Study|Withdrawal by Subject|7|||
126250532|NCT02072096|454206961|FG000|Overall Study|Adverse Event|5|||
126250533|NCT02072096|454206962|FG001|Overall Study|Adverse Event|2|||
126250534|NCT02072096|454206961|FG000|Overall Study|No Reason Provided|4|||
126250535|NCT02072096|454206962|FG001|Overall Study|No Reason Provided|2|||
126250536|NCT02072096|454206961|FG000|Overall Study|Death|2|||
126250537|NCT02072096|454206962|FG001|Overall Study|Death|0|||
126250538|NCT02072096|454206961|FG000|Overall Study|Physician Decision|0|||
126250539|NCT02072096|454206962|FG001|Overall Study|Physician Decision|1|||
126250540|NCT02072096|454206961|FG000|Overall Study|Study Terminated by Sponsor|43|||
126250541|NCT02072096|454206962|FG001|Overall Study|Study Terminated by Sponsor|30|||
126250542|NCT02072096|454206961|FG000|Overall Study|Lost to Follow-up|1|||
126448858|NCT00884741|454943238|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
126448859|NCT00884741|454943239|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
126448860|NCT00884741|454943236|FG000|Randomization|Protocol Violation|0|||
126448861|NCT00884741|454943237|FG001|Randomization|Protocol Violation|0|||
126448862|NCT00884741|454943238|FG002|Randomization|Protocol Violation|8|||
126448863|NCT00884741|454943239|FG003|Randomization|Protocol Violation|8|||
126448864|NCT01233232|454943240|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
126448865|NCT01233232|454943241|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
126448866|NCT01233232|454943242|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
126448867|NCT02762370|454943243|FG000|Overall Study|Protocol Violation|1|||
126448868|NCT02762370|454943244|FG001|Overall Study|Protocol Violation|0|||
126448869|NCT00101452|454943249|FG000|Overall Study|Adverse Event|2|||
126448870|NCT00101452|454943250|FG001|Overall Study|Adverse Event|0|||
126448871|NCT00101452|454943251|FG002|Overall Study|Adverse Event|1|||
126448872|NCT00101452|454943249|FG000|Overall Study|Lost to Follow-up|13|||
126448873|NCT00101452|454943250|FG001|Overall Study|Lost to Follow-up|8|||
126448874|NCT00101452|454943251|FG002|Overall Study|Lost to Follow-up|14|||
126448875|NCT00101452|454943249|FG000|Overall Study|Withdrawal by Subject|10|||
126448876|NCT00101452|454943250|FG001|Overall Study|Withdrawal by Subject|14|||
126448877|NCT00101452|454943251|FG002|Overall Study|Withdrawal by Subject|9|||
126448878|NCT00101452|454943249|FG000|Overall Study|Baseline Fail|2|||
126448879|NCT00101452|454943250|FG001|Overall Study|Baseline Fail|1|||
126448880|NCT00101452|454943251|FG002|Overall Study|Baseline Fail|2|||
126448881|NCT00101452|454943249|FG000|Overall Study|Physician Decision|0|||
126448882|NCT00101452|454943250|FG001|Overall Study|Physician Decision|3|||
126448883|NCT00101452|454943251|FG002|Overall Study|Physician Decision|2|||
126448884|NCT00101452|454943249|FG000|Overall Study|Protocol Violation|2|||
126448885|NCT00101452|454943250|FG001|Overall Study|Protocol Violation|1|||
126448886|NCT00101452|454943251|FG002|Overall Study|Protocol Violation|3|||
126448887|NCT00101452|454943249|FG000|Overall Study|Other|15|||
126448888|NCT00101452|454943250|FG001|Overall Study|Other|16|||
126448889|NCT00101452|454943251|FG002|Overall Study|Other|12|||
126448890|NCT00499590|454943252|FG000|Overall Study|Study Terminated|112|||
126448891|NCT00499590|454943253|FG001|Overall Study|Study Terminated|112|||
126448892|NCT00499590|454943254|FG002|Overall Study|Study Terminated|112|||
126697091|NCT03308188|455843276|FG001|Overall Study|Death|1|||
126697092|NCT01791855|455843277|FG000|Overall Study|Adverse Event|0|||
126697093|NCT01791855|455843278|FG001|Overall Study|Adverse Event|0|||
126250543|NCT02072096|454206962|FG001|Overall Study|Lost to Follow-up|0|||
126250544|NCT01168856|454206966|FG000|Overall Study|Lost to Follow-up|4|||
126250545|NCT01168856|454206967|FG001|Overall Study|Lost to Follow-up|34|||
126448893|NCT00499590|454943252|FG000|Overall Study|Not treated|1|||
126448894|NCT00499590|454943253|FG001|Overall Study|Not treated|0|||
126250546|NCT01168856|454206966|FG000|Overall Study|Withdrawal by Subject|6|||
126250547|NCT01168856|454206967|FG001|Overall Study|Withdrawal by Subject|8|||
126250548|NCT01168856|454206966|FG000|Overall Study|Physician Decision|2|||
126250549|NCT01168856|454206967|FG001|Overall Study|Physician Decision|1|||
126448895|NCT00499590|454943254|FG002|Overall Study|Not treated|1|||
126448896|NCT05661851|454943255|FG000|Overall Study|Protocol Violation|1|||
126448897|NCT05661851|454943256|FG001|Overall Study|Protocol Violation|1|||
126250550|NCT01168856|454206966|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
126250551|NCT01168856|454206967|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
126250552|NCT01168856|454206966|FG000|Overall Study|Participant received anti-HCV treatment|1|||
126250553|NCT01168856|454206967|FG001|Overall Study|Participant received anti-HCV treatment|0|||
126250554|NCT01168856|454206966|FG000|Overall Study|Death|0|||
126448898|NCT05661851|454943255|FG000|Overall Study|Covid-19 Related|3|||
126250555|NCT01168856|454206967|FG001|Overall Study|Death|2|||
126250556|NCT01168856|454206966|FG000|Overall Study|Other|1|||
126697094|NCT01791855|455843279|FG002|Overall Study|Adverse Event|0|||
126697095|NCT01791855|455843280|FG003|Overall Study|Adverse Event|1|||
126697096|NCT01791855|455843277|FG000|Overall Study|Randomized, not treated|0|||
126697097|NCT01791855|455843278|FG001|Overall Study|Randomized, not treated|1|||
126697098|NCT01791855|455843279|FG002|Overall Study|Randomized, not treated|0|||
126697099|NCT01791855|455843280|FG003|Overall Study|Randomized, not treated|0|||
126697100|NCT00772447|455843281|FG000|Overall Study|Withdrawal by Subject|9|||
126697101|NCT00772447|455843282|FG001|Overall Study|Withdrawal by Subject|5|||
126697102|NCT00772447|455843281|FG000|Overall Study|Physician Decision|4|||
126697103|NCT00772447|455843282|FG001|Overall Study|Physician Decision|8|||
126697104|NCT00772447|455843281|FG000|Overall Study|Lost to Follow-up|2|||
126697105|NCT00772447|455843282|FG001|Overall Study|Lost to Follow-up|4|||
126697106|NCT00772447|455843281|FG000|Overall Study|incorrect enrolment|3|||
126697107|NCT00772447|455843282|FG001|Overall Study|incorrect enrolment|4|||
126697108|NCT00772447|455843281|FG000|Overall Study|Protocol Violation|0|||
126697109|NCT00772447|455843282|FG001|Overall Study|Protocol Violation|1|||
126697110|NCT00772447|455843281|FG000|Overall Study|all others|2|||
126697111|NCT00772447|455843282|FG001|Overall Study|all others|2|||
126697112|NCT01957137|455843283|FG000|Randomized Portion|Adverse Event|1|||
126697113|NCT01957137|455843283|FG000|Randomized Portion|Withdrawal by Subject|1|||
126697114|NCT02959814|455843285|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
126697115|NCT02959814|455843285|FG000|Overall Study|Excluded based on anatomical criteria|2|||
126697116|NCT02959814|455843285|FG000|Overall Study|Protocol Violation|7|||
126697117|NCT02959814|455843285|FG000|Overall Study|FFR not measured|2|||
126697118|NCT02959814|455843285|FG000|Overall Study|In-procedure QFR not computed|6|||
126697119|NCT02959814|455843285|FG000|Overall Study|Excluded by FFR core-lab|24|||
126697120|NCT02116621|455843288|FG000|Baseline|Withdrawal by Subject|0|||
126697121|NCT02116621|455843289|FG001|Baseline|Withdrawal by Subject|4|||
126697122|NCT02116621|455843288|FG000|Three Month Follow-up|Death|1|||
126697123|NCT02116621|455843289|FG001|Three Month Follow-up|Death|1|||
126697124|NCT02116621|455843288|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
126697125|NCT02116621|455843289|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
126697126|NCT02116621|455843288|FG000|Three Month Follow-up|Lost to Follow-up|0|||
126697127|NCT02116621|455843289|FG001|Three Month Follow-up|Lost to Follow-up|1|||
126697128|NCT02116621|455843288|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
126697129|NCT02116621|455843289|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
126697130|NCT02116621|455843288|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
126697131|NCT02116621|455843289|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
126697132|NCT02116621|455843288|FG000|Six Month Follow-up|Lost to Follow-up|2|||
126697133|NCT02116621|455843289|FG001|Six Month Follow-up|Lost to Follow-up|1|||
126697134|NCT02116621|455843288|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
126697135|NCT02116621|455843289|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
126697136|NCT02116621|455843288|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
126697137|NCT02116621|455843289|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
126697138|NCT02116621|455843288|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
126697139|NCT02116621|455843289|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
126697140|NCT02116621|455843288|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
126250557|NCT01168856|454206967|FG001|Overall Study|Other|291|||
126250558|NCT01168856|454206966|FG000|Overall Study|Protocol Violation|4|||
126250559|NCT01168856|454206967|FG001|Overall Study|Protocol Violation|6|||
126250560|NCT04567329|454206972|FG000|Overall Study|Withdrawal by Subject|5|||
126250561|NCT04567329|454206973|FG001|Overall Study|Withdrawal by Subject|6|||
126250562|NCT04567329|454206972|FG000|Overall Study|Protocol Violation|2|||
126250563|NCT04567329|454206973|FG001|Overall Study|Protocol Violation|3|||
126250564|NCT04567329|454206972|FG000|Overall Study|Discontinued|2|||
126250565|NCT04567329|454206973|FG001|Overall Study|Discontinued|2|||
126250566|NCT04567329|454206972|FG000|Overall Study|Lost to Follow-up|0|||
126250567|NCT04567329|454206973|FG001|Overall Study|Lost to Follow-up|1|||
126250568|NCT04567329|454206972|FG000|Overall Study|Lack of Efficacy|0|||
126448899|NCT05661851|454943256|FG001|Overall Study|Covid-19 Related|4|||
126448900|NCT05661851|454943255|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
126448901|NCT05661851|454943256|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
126448902|NCT05661851|454943255|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
126448903|NCT05661851|454943256|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
126697141|NCT02116621|455843289|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
126697142|NCT02116621|455843288|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
126697143|NCT02116621|455843289|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
126697144|NCT00961961|455843290|FG000|Phase I|Withdrawal by Subject|7|||
126697145|NCT00961961|455843291|FG001|Phase I|Withdrawal by Subject|0|||
126697146|NCT00961961|455843292|FG002|Phase I|Withdrawal by Subject|0|||
126697147|NCT00961961|455843293|FG003|Phase I|Withdrawal by Subject|0|||
126697148|NCT00961961|455843290|FG000|Phase I|Lost to Follow-up|10|||
126697149|NCT00961961|455843291|FG001|Phase I|Lost to Follow-up|0|||
126697150|NCT00961961|455843292|FG002|Phase I|Lost to Follow-up|0|||
126697151|NCT00961961|455843293|FG003|Phase I|Lost to Follow-up|0|||
126697152|NCT00961961|455843290|FG000|Phase I|Lack of Efficacy|94|||
126448904|NCT01014910|454943257|FG000|Overall Study|Withdrawal by Subject|0|||
126448905|NCT01014910|454943258|FG001|Overall Study|Withdrawal by Subject|2|||
126697153|NCT00961961|455843291|FG001|Phase I|Lack of Efficacy|0|||
126250569|NCT04567329|454206973|FG001|Overall Study|Lack of Efficacy|1|||
126250570|NCT00674128|454206975|FG000|Overall Study|Withdrawal by Subject|25|||
126250571|NCT00674128|454206976|FG001|Overall Study|Withdrawal by Subject|23|||
126250572|NCT00829452|454206980|FG000|First Intervention|Withdrawal by Subject|0|||
126250573|NCT00829452|454206981|FG001|First Intervention|Withdrawal by Subject|1|||
126250574|NCT00829452|454206980|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
126250575|NCT00829452|454206981|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
126250576|NCT00829452|454206980|FG000|Second Intervention|Physician Decision|0|||
126250577|NCT00829452|454206981|FG001|Second Intervention|Physician Decision|1|||
126250578|NCT00487435|454206990|FG000|Overall Study|Adverse Event|146|||
126250579|NCT00487435|454206990|FG000|Overall Study|Death|2|||
126250580|NCT00487435|454206990|FG000|Overall Study|Lack of Efficacy|33|||
126250581|NCT00487435|454206990|FG000|Overall Study|Lost to Follow-up|54|||
126250582|NCT00487435|454206990|FG000|Overall Study|Pregnancy|2|||
126250583|NCT00487435|454206990|FG000|Overall Study|Withdrawal by Subject|132|||
126250584|NCT00487435|454206990|FG000|Overall Study|Resolution Of Pain|1|||
126250585|NCT00487435|454206990|FG000|Overall Study|Study Medication Non-Compliant|32|||
126250586|NCT00487435|454206990|FG000|Overall Study|Other|83|||
126250587|NCT01087502|454206991|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
126250588|NCT01087502|454206992|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
126250589|NCT01087502|454206991|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
126250590|NCT01087502|454206992|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
126697154|NCT00961961|455843292|FG002|Phase I|Lack of Efficacy|0|||
126697155|NCT00961961|455843293|FG003|Phase I|Lack of Efficacy|0|||
126697156|NCT00961961|455843290|FG000|Phase I|Adverse Event|7|||
126250591|NCT01087502|454206991|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
126250592|NCT01087502|454206992|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
126250593|NCT01087502|454206991|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
126250594|NCT01087502|454206992|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
126250595|NCT01087502|454206991|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
126250596|NCT01087502|454206992|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
126250597|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
126250598|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
126250599|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
126250600|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
126250601|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
126250602|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
126250603|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
126250604|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
126250605|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
126250606|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
126250607|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
126250608|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
126250609|NCT01087502|454206991|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
126697157|NCT00961961|455843291|FG001|Phase I|Adverse Event|0|||
126697158|NCT00961961|455843292|FG002|Phase I|Adverse Event|0|||
126697159|NCT00961961|455843293|FG003|Phase I|Adverse Event|0|||
126697160|NCT00961961|455843290|FG000|Phase I|Physician Decision|8|||
126697161|NCT00961961|455843291|FG001|Phase I|Physician Decision|0|||
126697162|NCT00961961|455843292|FG002|Phase I|Physician Decision|0|||
126697163|NCT00961961|455843293|FG003|Phase I|Physician Decision|0|||
126697164|NCT00961961|455843290|FG000|Phase II|Lost to Follow-up|0|||
126697165|NCT00961961|455843291|FG001|Phase II|Lost to Follow-up|0|||
126697166|NCT00961961|455843292|FG002|Phase II|Lost to Follow-up|10|||
126697167|NCT00961961|455843293|FG003|Phase II|Lost to Follow-up|7|||
126697168|NCT00961961|455843290|FG000|Phase II|Adverse Event|0|||
126697169|NCT00961961|455843291|FG001|Phase II|Adverse Event|0|||
126697170|NCT00961961|455843292|FG002|Phase II|Adverse Event|0|||
126697171|NCT00961961|455843293|FG003|Phase II|Adverse Event|1|||
126697172|NCT00961961|455843290|FG000|Phase II|Physician Decision|0|||
126697173|NCT00961961|455843291|FG001|Phase II|Physician Decision|0|||
126250610|NCT01087502|454206992|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
126250611|NCT02705716|454206993|FG000|Overall Study|Adverse Event|0|||
126250612|NCT02705716|454206994|FG001|Overall Study|Adverse Event|1|||
126250613|NCT02705716|454206993|FG000|Overall Study|Protocol Violation|3|||
126250614|NCT02705716|454206994|FG001|Overall Study|Protocol Violation|0|||
126448906|NCT00612807|454943259|FG000|Overall Study|Withdrawal by Subject|2|||
126697174|NCT00961961|455843292|FG002|Phase II|Physician Decision|1|||
126697175|NCT00961961|455843293|FG003|Phase II|Physician Decision|0|||
126697176|NCT00961961|455843290|FG000|Phase II|Withdrawal by Subject|0|||
126697177|NCT00961961|455843291|FG001|Phase II|Withdrawal by Subject|0|||
126697178|NCT00961961|455843292|FG002|Phase II|Withdrawal by Subject|1|||
126697179|NCT00961961|455843293|FG003|Phase II|Withdrawal by Subject|0|||
126697180|NCT03437447|455843294|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126697181|NCT03437447|455843295|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126697182|NCT03437447|455843296|FG002|Treatment Period 1|Withdrawal by Subject|1|||
126697183|NCT02764541|455843297|FG000|Overall Study|Withdrawal by Subject|0|||
126697184|NCT02764541|455843298|FG001|Overall Study|Withdrawal by Subject|0|||
126697185|NCT02764541|455843299|FG002|Overall Study|Withdrawal by Subject|0|||
126697186|NCT02764541|455843300|FG003|Overall Study|Withdrawal by Subject|0|||
126697187|NCT02764541|455843301|FG004|Overall Study|Withdrawal by Subject|1|||
126697188|NCT02764541|455843302|FG005|Overall Study|Withdrawal by Subject|1|||
126697189|NCT02764541|455843303|FG006|Overall Study|Withdrawal by Subject|0|||
126697190|NCT02764541|455843304|FG007|Overall Study|Withdrawal by Subject|1|||
126697191|NCT02764541|455843297|FG000|Overall Study|Adverse Event|1|||
126697192|NCT02764541|455843298|FG001|Overall Study|Adverse Event|0|||
126697193|NCT02764541|455843299|FG002|Overall Study|Adverse Event|0|||
126697194|NCT02764541|455843300|FG003|Overall Study|Adverse Event|0|||
126697195|NCT02764541|455843301|FG004|Overall Study|Adverse Event|0|||
126697196|NCT02764541|455843302|FG005|Overall Study|Adverse Event|0|||
126697197|NCT02764541|455843303|FG006|Overall Study|Adverse Event|1|||
126697198|NCT02764541|455843304|FG007|Overall Study|Adverse Event|0|||
126697199|NCT02764541|455843297|FG000|Overall Study|Metastasis|1|||
126762243|NCT01243762|456081180|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
126762244|NCT01243762|456081181|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
126762245|NCT01243762|456081175|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
126762246|NCT01243762|456081176|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
126250615|NCT02705716|454206993|FG000|Overall Study|Withdrawal of Consent|1|||
126250616|NCT02705716|454206994|FG001|Overall Study|Withdrawal of Consent|1|||
126250617|NCT00562718|454206996|FG000|Overall Study|Death|1|||
126250618|NCT00562718|454206996|FG000|Overall Study|Withdrawal by Subject|3|||
126250619|NCT00562718|454206996|FG000|Overall Study|Adverse Event|4|||
126250620|NCT00562718|454206996|FG000|Overall Study|Lack of Efficacy|2|||
126250621|NCT00562718|454206996|FG000|Overall Study|not stated|1|||
126250622|NCT01868243|454206997|FG000|Overall Study|Death|0|||
126250623|NCT01868243|454206998|FG001|Overall Study|Death|1|||
126250624|NCT01451541|454206999|FG000|Overall Study|Adverse Event|4|||
126250625|NCT01451541|454207000|FG001|Overall Study|Adverse Event|3|||
126250626|NCT01451541|454207001|FG002|Overall Study|Adverse Event|6|||
126250627|NCT01451541|454206999|FG000|Overall Study|Lack of Efficacy|2|||
126250628|NCT01451541|454207000|FG001|Overall Study|Lack of Efficacy|0|||
126250629|NCT01451541|454207001|FG002|Overall Study|Lack of Efficacy|0|||
126250630|NCT01451541|454206999|FG000|Overall Study|Lost to Follow-up|4|||
126250631|NCT01451541|454207000|FG001|Overall Study|Lost to Follow-up|4|||
126250632|NCT01451541|454207001|FG002|Overall Study|Lost to Follow-up|7|||
126250633|NCT01451541|454206999|FG000|Overall Study|Withdrawal by Subject|15|||
126250634|NCT01451541|454207000|FG001|Overall Study|Withdrawal by Subject|8|||
126250635|NCT01451541|454207001|FG002|Overall Study|Withdrawal by Subject|6|||
126250636|NCT01451541|454206999|FG000|Overall Study|randomization error, noncompliance|11|||
126250637|NCT01451541|454207000|FG001|Overall Study|randomization error, noncompliance|10|||
126250638|NCT01451541|454207001|FG002|Overall Study|randomization error, noncompliance|8|||
126250639|NCT03961204|454207007|FG000|Overall Study|Withdrawal by Subject|2|||
126250640|NCT03961204|454207007|FG000|Overall Study|Lost to Follow-up|3|||
126250641|NCT03961204|454207007|FG000|Overall Study|Other|1|||
126250642|NCT03961204|454207007|FG000|Overall Study|Missing|1|||
126250643|NCT01566435|454207008|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
126250644|NCT04236596|454207011|FG000|Overall Study|Withdrawal by Subject|1|||
126762247|NCT01243762|456081177|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
126762248|NCT01243762|456081178|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
126762249|NCT01243762|456081179|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
126762250|NCT01243762|456081180|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
126762251|NCT01243762|456081181|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
126762252|NCT02059265|456081182|FG000|Overall Study|Ineligible|4|||
126762253|NCT04753606|456081187|FG000|Overall Study|Adverse Event|1|||
126762254|NCT04753606|456081188|FG001|Overall Study|Adverse Event|0|||
126762255|NCT04753606|456081189|FG002|Overall Study|Adverse Event|0|||
126250645|NCT04236596|454207011|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
126250646|NCT04236596|454207011|FG000|Overall Study|Participants did not receive implant at all|4|||
126250647|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Subject request|8|||
126250648|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Subject request|11|||
126250649|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
126250650|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
126448907|NCT00612807|454943260|FG001|Overall Study|Withdrawal by Subject|0|||
126697200|NCT02764541|455843298|FG001|Overall Study|Metastasis|0|||
126697201|NCT02764541|455843299|FG002|Overall Study|Metastasis|0|||
126697202|NCT02764541|455843300|FG003|Overall Study|Metastasis|0|||
126697203|NCT02764541|455843301|FG004|Overall Study|Metastasis|0|||
126697204|NCT02764541|455843302|FG005|Overall Study|Metastasis|0|||
126697205|NCT02764541|455843303|FG006|Overall Study|Metastasis|0|||
126697206|NCT02764541|455843304|FG007|Overall Study|Metastasis|0|||
126697207|NCT02764541|455843297|FG000|Overall Study|Disease progression|1|||
126697208|NCT02764541|455843298|FG001|Overall Study|Disease progression|1|||
126697209|NCT02764541|455843299|FG002|Overall Study|Disease progression|0|||
126697210|NCT02764541|455843300|FG003|Overall Study|Disease progression|0|||
126697211|NCT02764541|455843301|FG004|Overall Study|Disease progression|0|||
126697212|NCT02764541|455843302|FG005|Overall Study|Disease progression|0|||
126697213|NCT02764541|455843303|FG006|Overall Study|Disease progression|0|||
126697214|NCT02764541|455843304|FG007|Overall Study|Disease progression|1|||
126697215|NCT02764541|455843297|FG000|Overall Study|Protocol Violation|0|||
126697216|NCT02764541|455843298|FG001|Overall Study|Protocol Violation|0|||
126697217|NCT02764541|455843299|FG002|Overall Study|Protocol Violation|0|||
126697218|NCT02764541|455843300|FG003|Overall Study|Protocol Violation|1|||
126697219|NCT02764541|455843301|FG004|Overall Study|Protocol Violation|0|||
126697220|NCT02764541|455843302|FG005|Overall Study|Protocol Violation|1|||
126697221|NCT02764541|455843303|FG006|Overall Study|Protocol Violation|0|||
126697222|NCT02764541|455843304|FG007|Overall Study|Protocol Violation|0|||
126697223|NCT02764541|455843297|FG000|Overall Study|Physician Decision|0|||
126697224|NCT02764541|455843298|FG001|Overall Study|Physician Decision|0|||
126697225|NCT02764541|455843299|FG002|Overall Study|Physician Decision|0|||
126697226|NCT02764541|455843300|FG003|Overall Study|Physician Decision|1|||
126697227|NCT02764541|455843301|FG004|Overall Study|Physician Decision|0|||
126697228|NCT02764541|455843302|FG005|Overall Study|Physician Decision|0|||
126697229|NCT02764541|455843303|FG006|Overall Study|Physician Decision|0|||
126697230|NCT02764541|455843304|FG007|Overall Study|Physician Decision|1|||
126697231|NCT02764541|455843297|FG000|Overall Study|Three Cycles completed before surgery|0|||
126697232|NCT02764541|455843298|FG001|Overall Study|Three Cycles completed before surgery|0|||
126697233|NCT02764541|455843299|FG002|Overall Study|Three Cycles completed before surgery|0|||
126697234|NCT02764541|455843300|FG003|Overall Study|Three Cycles completed before surgery|1|||
126697235|NCT02764541|455843301|FG004|Overall Study|Three Cycles completed before surgery|0|||
126697236|NCT02764541|455843302|FG005|Overall Study|Three Cycles completed before surgery|0|||
126697237|NCT02764541|455843303|FG006|Overall Study|Three Cycles completed before surgery|0|||
126697238|NCT02764541|455843304|FG007|Overall Study|Three Cycles completed before surgery|0|||
126762256|NCT03841331|456081190|FG000|Overall Study|Withdrawal by Subject|4|||
126250651|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
126250652|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
126250653|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
126250654|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
126250655|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
126250656|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
126250657|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
126250658|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
126250659|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Death|1|||
126250660|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Death|0|||
126250661|NCT00521586|454208910|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
126358008|NCT00669331|454603857|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
126358009|NCT00669331|454603856|FG000|Randomisation to First Dose|Death|1|||
126358010|NCT00669331|454603857|FG001|Randomisation to First Dose|Death|0|||
126358011|NCT00669331|454603856|FG000|Randomisation to First Dose|Sponsor decision|0|||
126358012|NCT00669331|454603857|FG001|Randomisation to First Dose|Sponsor decision|1|||
126358013|NCT00669331|454603856|FG000|Randomisation to First Dose|Randomised in error|3|||
126358014|NCT00669331|454603857|FG001|Randomisation to First Dose|Randomised in error|10|||
126358015|NCT00669331|454603856|FG000|Blinded Treatment Period|Adverse Event|16|||
126358016|NCT00669331|454603857|FG001|Blinded Treatment Period|Adverse Event|10|||
126358017|NCT00669331|454603856|FG000|Blinded Treatment Period|Protocol Violation|1|||
126358018|NCT00669331|454603857|FG001|Blinded Treatment Period|Protocol Violation|1|||
126358019|NCT00669331|454603856|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
126358020|NCT00669331|454603857|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
126358021|NCT00669331|454603856|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
126358022|NCT00669331|454603857|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
126358023|NCT00669331|454603856|FG000|Blinded Treatment Period|Death|0|||
126358024|NCT00669331|454603857|FG001|Blinded Treatment Period|Death|2|||
126358025|NCT00669331|454603856|FG000|Blinded Treatment Period|Physician Decision|3|||
126358026|NCT00669331|454603857|FG001|Blinded Treatment Period|Physician Decision|3|||
126358027|NCT00669331|454603856|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
126358028|NCT00669331|454603857|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
126697239|NCT02764541|455843297|FG000|Overall Study|Patient Compliance|0|||
126697240|NCT02764541|455843298|FG001|Overall Study|Patient Compliance|0|||
126697241|NCT02764541|455843299|FG002|Overall Study|Patient Compliance|1|||
126697242|NCT02764541|455843300|FG003|Overall Study|Patient Compliance|0|||
126697243|NCT02764541|455843301|FG004|Overall Study|Patient Compliance|0|||
126697244|NCT02764541|455843302|FG005|Overall Study|Patient Compliance|0|||
126697245|NCT02764541|455843303|FG006|Overall Study|Patient Compliance|0|||
126697246|NCT02764541|455843304|FG007|Overall Study|Patient Compliance|0|||
126697247|NCT02764541|455843297|FG000|Overall Study|Death|0|||
126250662|NCT00521586|454208911|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
126250663|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
126250664|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
126250665|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
126250666|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
126250667|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
126250668|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
126250669|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
126250670|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
126250671|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
126250672|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
126697248|NCT02764541|455843298|FG001|Overall Study|Death|0|||
126697249|NCT02764541|455843299|FG002|Overall Study|Death|0|||
126697250|NCT02764541|455843300|FG003|Overall Study|Death|0|||
126697251|NCT02764541|455843301|FG004|Overall Study|Death|0|||
126697252|NCT02764541|455843302|FG005|Overall Study|Death|0|||
126697253|NCT02764541|455843303|FG006|Overall Study|Death|1|||
126250673|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
126250674|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
126358029|NCT03794544|454603858|FG000|Overall Study|Withdrawal by Subject|1|||
126358030|NCT03794544|454603859|FG001|Overall Study|Withdrawal by Subject|1|||
126358031|NCT03794544|454603860|FG002|Overall Study|Withdrawal by Subject|0|||
126358032|NCT03794544|454603861|FG003|Overall Study|Withdrawal by Subject|0|||
126358033|NCT03794544|454603858|FG000|Overall Study|Death|0|||
126358034|NCT03794544|454603859|FG001|Overall Study|Death|0|||
126358035|NCT03794544|454603860|FG002|Overall Study|Death|0|||
126358036|NCT03794544|454603861|FG003|Overall Study|Death|1|||
126358037|NCT03794544|454603858|FG000|Overall Study|Lost to Follow-up|0|||
126358038|NCT03794544|454603859|FG001|Overall Study|Lost to Follow-up|1|||
126358039|NCT03794544|454603860|FG002|Overall Study|Lost to Follow-up|1|||
126358040|NCT03794544|454603861|FG003|Overall Study|Lost to Follow-up|0|||
126358041|NCT03794544|454603858|FG000|Overall Study|Other|0|||
126358042|NCT03794544|454603859|FG001|Overall Study|Other|1|||
126358043|NCT03794544|454603860|FG002|Overall Study|Other|0|||
126358044|NCT03794544|454603861|FG003|Overall Study|Other|0|||
126358045|NCT00120250|454603865|FG000|Overall Study|Lost to Follow-up|1|||
126358046|NCT00120250|454603866|FG001|Overall Study|Lost to Follow-up|1|||
126358047|NCT00120250|454603865|FG000|Overall Study|Protocol Violation|0|||
126358048|NCT00120250|454603866|FG001|Overall Study|Protocol Violation|1|||
126358049|NCT00710554|454603873|FG000|Overall Study|Adverse Event|24|||
126358050|NCT00710554|454603874|FG001|Overall Study|Adverse Event|7|||
126358051|NCT00710554|454603873|FG000|Overall Study|Withdrawal by Subject|7|||
126358052|NCT00710554|454603874|FG001|Overall Study|Withdrawal by Subject|3|||
126358053|NCT00710554|454603873|FG000|Overall Study|Lost to Follow-up|7|||
126358054|NCT00710554|454603874|FG001|Overall Study|Lost to Follow-up|1|||
126358055|NCT00710554|454603873|FG000|Overall Study|Lack of Efficacy|11|||
126358056|NCT00710554|454603874|FG001|Overall Study|Lack of Efficacy|12|||
126358057|NCT00710554|454603873|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
126358058|NCT00710554|454603874|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
126358059|NCT01433978|454603875|FG000|Core Study|Adverse Event, Non-Fatal|0|||
126358060|NCT01433978|454603876|FG001|Core Study|Adverse Event, Non-Fatal|1|||
126358061|NCT01433978|454603877|FG002|Core Study|Adverse Event, Non-Fatal|0|||
126358062|NCT01433978|454603875|FG000|Core Study|Lack of Efficacy|5|||
126358063|NCT01433978|454603876|FG001|Core Study|Lack of Efficacy|1|||
126358064|NCT01433978|454603877|FG002|Core Study|Lack of Efficacy|0|||
126358065|NCT01433978|454603875|FG000|Core Study|Study Terminated by Sponsor|6|||
126358066|NCT01433978|454603876|FG001|Core Study|Study Terminated by Sponsor|9|||
126358067|NCT01433978|454603877|FG002|Core Study|Study Terminated by Sponsor|0|||
126358068|NCT01433978|454603875|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
126358069|NCT01433978|454603876|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
126358070|NCT01433978|454603877|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
126358071|NCT01433978|454603875|FG000|Extension Phase|Lack of Efficacy|0|||
126358072|NCT01433978|454603876|FG001|Extension Phase|Lack of Efficacy|0|||
126358073|NCT01433978|454603877|FG002|Extension Phase|Lack of Efficacy|1|||
126358074|NCT01433978|454603875|FG000|Extension Phase|Study Terminated by Sponsor|0|||
126358075|NCT01433978|454603876|FG001|Extension Phase|Study Terminated by Sponsor|0|||
126358076|NCT01433978|454603877|FG002|Extension Phase|Study Terminated by Sponsor|4|||
126358077|NCT00378560|454603878|FG000|Overall Study|Adverse Event|1|||
126358078|NCT00378560|454603879|FG001|Overall Study|Adverse Event|0|||
126448908|NCT01215097|454943261|FG000|Overall Study|Adverse Event|1|||
126358079|NCT00378560|454603878|FG000|Overall Study|Lost to Follow-up|24|||
126358080|NCT00378560|454603879|FG001|Overall Study|Lost to Follow-up|29|||
126358081|NCT00378560|454603878|FG000|Overall Study|Protocol Violation|2|||
126358082|NCT00378560|454603879|FG001|Overall Study|Protocol Violation|0|||
126358083|NCT00378560|454603878|FG000|Overall Study|Withdrawal by Subject|17|||
126697254|NCT02764541|455843304|FG007|Overall Study|Death|0|||
126697255|NCT02764541|455843297|FG000|Overall Study|Insurance reasons|0|||
126250675|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
126250676|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
126250677|NCT00521586|454208910|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
126250678|NCT00521586|454208911|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
126250679|NCT00521586|454208910|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
126250680|NCT00521586|454208911|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
126250681|NCT00521586|454208910|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
126250682|NCT00521586|454208911|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
126250683|NCT00521586|454208910|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
126250684|NCT00521586|454208911|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
126250685|NCT02034513|454208914|FG000|Overall Study|Adverse Event|11|||
126250686|NCT02034513|454208915|FG001|Overall Study|Adverse Event|10|||
126250687|NCT02034513|454208914|FG000|Overall Study|Lack of Efficacy|0|||
126250688|NCT02034513|454208915|FG001|Overall Study|Lack of Efficacy|1|||
126250689|NCT02034513|454208914|FG000|Overall Study|Lost to Follow-up|6|||
126250690|NCT02034513|454208915|FG001|Overall Study|Lost to Follow-up|7|||
126250691|NCT02034513|454208914|FG000|Overall Study|Pregnancy|0|||
126250692|NCT02034513|454208915|FG001|Overall Study|Pregnancy|3|||
126250693|NCT02034513|454208914|FG000|Overall Study|Protocol Violation|7|||
126250694|NCT02034513|454208915|FG001|Overall Study|Protocol Violation|10|||
126250695|NCT02034513|454208914|FG000|Overall Study|Withdrawal by Subject|25|||
126250696|NCT02034513|454208915|FG001|Overall Study|Withdrawal by Subject|25|||
126250697|NCT02034513|454208914|FG000|Overall Study|Unclassified|0|||
126250698|NCT02034513|454208915|FG001|Overall Study|Unclassified|1|||
126250699|NCT01243151|454208916|FG000|Overall Study|Adverse Event|0|||
126250700|NCT01243151|454208917|FG001|Overall Study|Adverse Event|1|||
126250701|NCT01243151|454208918|FG002|Overall Study|Adverse Event|0|||
126250702|NCT01243151|454208919|FG003|Overall Study|Adverse Event|0|||
126250703|NCT01243151|454208920|FG004|Overall Study|Adverse Event|0|||
126250704|NCT01243151|454208916|FG000|Overall Study|Protocol Violation|0|||
126250705|NCT01243151|454208917|FG001|Overall Study|Protocol Violation|0|||
126250706|NCT01243151|454208918|FG002|Overall Study|Protocol Violation|1|||
126250707|NCT01243151|454208919|FG003|Overall Study|Protocol Violation|0|||
126250708|NCT01243151|454208920|FG004|Overall Study|Protocol Violation|0|||
126250709|NCT01243151|454208916|FG000|Overall Study|Other|0|||
126250710|NCT01243151|454208917|FG001|Overall Study|Other|0|||
126250711|NCT01243151|454208918|FG002|Overall Study|Other|0|||
126250712|NCT01243151|454208919|FG003|Overall Study|Other|1|||
126250713|NCT01243151|454208920|FG004|Overall Study|Other|0|||
126250714|NCT01243151|454208916|FG000|Overall Study|Randomized but not treated|0|||
126250715|NCT01243151|454208917|FG001|Overall Study|Randomized but not treated|0|||
126250716|NCT01243151|454208918|FG002|Overall Study|Randomized but not treated|0|||
126250717|NCT01243151|454208919|FG003|Overall Study|Randomized but not treated|1|||
126250718|NCT01243151|454208920|FG004|Overall Study|Randomized but not treated|0|||
126250719|NCT03119662|454208921|FG000|Overall Study|Withdrawal by Subject|0|||
126250720|NCT03119662|454208922|FG001|Overall Study|Withdrawal by Subject|1|||
126250721|NCT02308241|454208926|FG000|Overall Study|Withdrawal by Subject|3|||
126250722|NCT04661202|454208928|FG000|Overall Study|Withdrawal by Subject|1|||
126250723|NCT04661202|454208929|FG001|Overall Study|Withdrawal by Subject|1|||
126250724|NCT04661202|454208928|FG000|Overall Study|Lack of Efficacy|2|||
126250725|NCT04661202|454208929|FG001|Overall Study|Lack of Efficacy|0|||
126250726|NCT04158687|454208930|FG000|Overall Study|Adverse Event|2|||
126250727|NCT04158687|454208931|FG001|Overall Study|Adverse Event|3|||
126250728|NCT04158687|454208932|FG002|Overall Study|Adverse Event|0|||
126250729|NCT04158687|454208933|FG003|Overall Study|Adverse Event|3|||
126250730|NCT04158687|454208930|FG000|Overall Study|Lost to Follow-up|5|||
126250731|NCT04158687|454208931|FG001|Overall Study|Lost to Follow-up|12|||
126250732|NCT04158687|454208932|FG002|Overall Study|Lost to Follow-up|4|||
126250733|NCT04158687|454208933|FG003|Overall Study|Lost to Follow-up|5|||
126250734|NCT04158687|454208930|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
126250735|NCT04158687|454208931|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
126250736|NCT04158687|454208932|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
126250737|NCT04158687|454208933|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
126448909|NCT01215097|454943262|FG001|Overall Study|Adverse Event|3|||
126448910|NCT01215097|454943261|FG000|Overall Study|Protocol Violation|0|||
126250738|NCT04158687|454208930|FG000|Overall Study|Non-Compliance with Study Medication|2|||
126250739|NCT04158687|454208931|FG001|Overall Study|Non-Compliance with Study Medication|2|||
126250740|NCT04158687|454208932|FG002|Overall Study|Non-Compliance with Study Medication|3|||
126250741|NCT04158687|454208933|FG003|Overall Study|Non-Compliance with Study Medication|0|||
126250742|NCT04158687|454208930|FG000|Overall Study|Investigator Decision|0|||
126250743|NCT04158687|454208931|FG001|Overall Study|Investigator Decision|0|||
126250744|NCT04158687|454208932|FG002|Overall Study|Investigator Decision|2|||
126250745|NCT04158687|454208933|FG003|Overall Study|Investigator Decision|0|||
126250746|NCT04158687|454208930|FG000|Overall Study|Protocol Violation|0|||
126250747|NCT04158687|454208931|FG001|Overall Study|Protocol Violation|2|||
126250748|NCT04158687|454208932|FG002|Overall Study|Protocol Violation|1|||
126250749|NCT04158687|454208933|FG003|Overall Study|Protocol Violation|0|||
126250750|NCT04158687|454208930|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
126250751|NCT04158687|454208931|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
126250752|NCT04158687|454208932|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
126250753|NCT04158687|454208933|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
126250754|NCT04158687|454208930|FG000|Overall Study|Reason not Specified|3|||
126250755|NCT04158687|454208931|FG001|Overall Study|Reason not Specified|2|||
126250756|NCT04158687|454208932|FG002|Overall Study|Reason not Specified|4|||
126250757|NCT04158687|454208933|FG003|Overall Study|Reason not Specified|4|||
126250758|NCT04102345|454208936|FG000|Overall Study|Withdrawal by Subject|1|||
126250759|NCT04102345|454208937|FG001|Overall Study|Withdrawal by Subject|0|||
126250760|NCT01853176|454208938|FG000|Overall Study|Study terminated|4|||
126250761|NCT01853176|454208939|FG001|Overall Study|Study terminated|0|||
126250762|NCT00198133|454208940|FG000|Overall Study|Disease progression|2|||
126250763|NCT00198133|454208941|FG001|Overall Study|Disease progression|5|||
126250764|NCT00198133|454208940|FG000|Overall Study|Adverse Event|1|||
126250765|NCT00198133|454208941|FG001|Overall Study|Adverse Event|3|||
126250766|NCT00198133|454208940|FG000|Overall Study|Withdrawal by Subject|1|||
126250767|NCT00198133|454208941|FG001|Overall Study|Withdrawal by Subject|0|||
126250768|NCT00198133|454208940|FG000|Overall Study|Physician Decision|1|||
126250769|NCT00198133|454208941|FG001|Overall Study|Physician Decision|0|||
126250770|NCT00835666|454208947|FG000|Washout|Protocol Violation|1|||
126250771|NCT00835666|454208948|FG001|Washout|Protocol Violation|0|||
126250772|NCT00835666|454208947|FG000|Washout|Withdrawal by Subject|1|||
126250773|NCT00835666|454208948|FG001|Washout|Withdrawal by Subject|0|||
126250774|NCT03599362|454208949|FG000|Overall Study|Screen Failure|3|||
126250775|NCT03707587|454208950|FG000|Overall Study|Death|0|||
126250776|NCT03707587|454208951|FG001|Overall Study|Death|1|||
126448911|NCT01215097|454943262|FG001|Overall Study|Protocol Violation|2|||
126448912|NCT01215097|454943261|FG000|Overall Study|Lost to Follow-up|2|||
126448913|NCT01215097|454943262|FG001|Overall Study|Lost to Follow-up|0|||
126448914|NCT01215097|454943261|FG000|Overall Study|Withdrawal by Subject|6|||
126448915|NCT01215097|454943262|FG001|Overall Study|Withdrawal by Subject|3|||
126448916|NCT01215097|454943261|FG000|Overall Study|Lack of Efficacy|0|||
126448917|NCT01215097|454943262|FG001|Overall Study|Lack of Efficacy|3|||
126448918|NCT01215097|454943261|FG000|Overall Study|patient's refusal to come|2|||
126448919|NCT01215097|454943262|FG001|Overall Study|patient's refusal to come|2|||
126448920|NCT01215097|454943261|FG000|Overall Study|patient's private reason|1|||
126448921|NCT01215097|454943262|FG001|Overall Study|patient's private reason|1|||
126448922|NCT02252939|454943263|FG000|Overall Study|Lost to Follow-up|3|||
126448923|NCT00870584|454943264|FG000|Overall Study|Adverse Event|3|||
126448924|NCT00870584|454943265|FG001|Overall Study|Adverse Event|3|||
126448925|NCT00870584|454943264|FG000|Overall Study|Withdrawal by Subject|6|||
126448926|NCT00870584|454943265|FG001|Overall Study|Withdrawal by Subject|7|||
126448927|NCT00870584|454943264|FG000|Overall Study|Lost to Follow-up|5|||
126448928|NCT00870584|454943265|FG001|Overall Study|Lost to Follow-up|1|||
126448929|NCT00870584|454943264|FG000|Overall Study|Protocol Deviation|2|||
126448930|NCT00870584|454943265|FG001|Overall Study|Protocol Deviation|2|||
126448931|NCT01821560|454943266|FG000|Overall Study|Lost to Follow-up|5|||
126448932|NCT01821560|454943267|FG001|Overall Study|Lost to Follow-up|5|||
126448933|NCT01821560|454943266|FG000|Overall Study|Withdrawal by Subject|1|||
126448934|NCT01821560|454943267|FG001|Overall Study|Withdrawal by Subject|1|||
126448935|NCT01821560|454943266|FG000|Overall Study|Protocol Violation|0|||
126448936|NCT01821560|454943267|FG001|Overall Study|Protocol Violation|1|||
126448937|NCT01338298|454943270|FG000|Overall Study|Withdrawal by Subject|1|||
126448938|NCT01338298|454943271|FG001|Overall Study|Withdrawal by Subject|1|||
126448939|NCT01338298|454943270|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
126448940|NCT01338298|454943271|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
126448941|NCT01338298|454943270|FG000|Overall Study|Administrative error|0|||
126448942|NCT01338298|454943271|FG001|Overall Study|Administrative error|1|||
126448943|NCT01338298|454943270|FG000|Overall Study|Positive symptom worsening|1|||
126448944|NCT01338298|454943271|FG001|Overall Study|Positive symptom worsening|0|||
126448945|NCT01338298|454943270|FG000|Overall Study|Depressive symptoms and nausea|1|||
126448946|NCT01338298|454943271|FG001|Overall Study|Depressive symptoms and nausea|0|||
126448947|NCT01338298|454943270|FG000|Overall Study|Non-adherence|1|||
126448948|NCT01338298|454943271|FG001|Overall Study|Non-adherence|0|||
126448949|NCT05601544|454943272|FG000|Phase 2 Period 1|Adverse Event|0|||
126448950|NCT05601544|454943273|FG001|Phase 2 Period 1|Adverse Event|1|||
126448951|NCT05601544|454943274|FG002|Phase 2 Period 1|Adverse Event|0|||
126697256|NCT02764541|455843298|FG001|Overall Study|Insurance reasons|0|||
126250777|NCT01537887|454208952|FG000|Period 1|Physician Decision|0|||
126250778|NCT01537887|454208953|FG001|Period 1|Physician Decision|0|||
126250779|NCT01537887|454208954|FG002|Period 1|Physician Decision|0|||
126250780|NCT01537887|454208955|FG003|Period 1|Physician Decision|0|||
126250781|NCT01537887|454208956|FG004|Period 1|Physician Decision|1|||
126250782|NCT01537887|454208957|FG005|Period 1|Physician Decision|1|||
126448952|NCT05601544|454943275|FG003|Phase 2 Period 1|Adverse Event|0|||
126448953|NCT05601544|454943276|FG004|Phase 2 Period 1|Adverse Event|0|||
126250783|NCT01537887|454208952|FG000|Period 1|Did not receive treatment|0|||
126250784|NCT01537887|454208953|FG001|Period 1|Did not receive treatment|0|||
126250785|NCT01537887|454208954|FG002|Period 1|Did not receive treatment|1|||
126250786|NCT01537887|454208955|FG003|Period 1|Did not receive treatment|0|||
126250787|NCT01537887|454208956|FG004|Period 1|Did not receive treatment|0|||
126250788|NCT01537887|454208957|FG005|Period 1|Did not receive treatment|0|||
126250789|NCT01537887|454208952|FG000|Period 2|Withdrawal by Subject|0|||
126250790|NCT01537887|454208953|FG001|Period 2|Withdrawal by Subject|1|||
126250791|NCT01537887|454208954|FG002|Period 2|Withdrawal by Subject|0|||
126250792|NCT01537887|454208955|FG003|Period 2|Withdrawal by Subject|0|||
126250793|NCT01537887|454208956|FG004|Period 2|Withdrawal by Subject|0|||
126250794|NCT01537887|454208957|FG005|Period 2|Withdrawal by Subject|0|||
126250795|NCT01537887|454208952|FG000|Period 3|Adverse Event|0|||
126250796|NCT01537887|454208953|FG001|Period 3|Adverse Event|0|||
126250797|NCT01537887|454208954|FG002|Period 3|Adverse Event|1|||
126250798|NCT01537887|454208955|FG003|Period 3|Adverse Event|0|||
126250799|NCT01537887|454208956|FG004|Period 3|Adverse Event|0|||
126250800|NCT01537887|454208957|FG005|Period 3|Adverse Event|0|||
126250801|NCT01537887|454208952|FG000|Period 3|Withdrawal by Subject|0|||
126250802|NCT01537887|454208953|FG001|Period 3|Withdrawal by Subject|1|||
126250803|NCT01537887|454208954|FG002|Period 3|Withdrawal by Subject|0|||
126250804|NCT01537887|454208955|FG003|Period 3|Withdrawal by Subject|0|||
126250805|NCT01537887|454208956|FG004|Period 3|Withdrawal by Subject|0|||
126250806|NCT01537887|454208957|FG005|Period 3|Withdrawal by Subject|0|||
126250807|NCT01370083|454208959|FG000|Overall Study|Lost to Follow-up|2|||
126250808|NCT01370083|454208960|FG001|Overall Study|Lost to Follow-up|0|||
126250809|NCT01370083|454208959|FG000|Overall Study|Adverse Event|0|||
126250810|NCT01370083|454208960|FG001|Overall Study|Adverse Event|1|||
126250811|NCT01634139|454208961|FG000|Overall Study|Non compliant with protocol|1|||
126250812|NCT01634139|454208962|FG001|Overall Study|Non compliant with protocol|0|||
126250813|NCT01634139|454208963|FG002|Overall Study|Non compliant with protocol|0|||
126250814|NCT01634139|454208961|FG000|Overall Study|Consent withdrawn not due to AE|4|||
126250815|NCT01634139|454208962|FG001|Overall Study|Consent withdrawn not due to AE|3|||
126250816|NCT01634139|454208963|FG002|Overall Study|Consent withdrawn not due to AE|2|||
126250817|NCT01634139|454208961|FG000|Overall Study|Other|4|||
126250818|NCT01634139|454208962|FG001|Overall Study|Other|0|||
126250819|NCT01634139|454208963|FG002|Overall Study|Other|3|||
126250820|NCT01634139|454208961|FG000|Overall Study|Lost to Follow-up|0|||
126250821|NCT01634139|454208962|FG001|Overall Study|Lost to Follow-up|2|||
126250822|NCT01634139|454208963|FG002|Overall Study|Lost to Follow-up|0|||
126250823|NCT01634139|454208961|FG000|Overall Study|Not treated|1|||
126250824|NCT01634139|454208962|FG001|Overall Study|Not treated|1|||
126250825|NCT01634139|454208963|FG002|Overall Study|Not treated|0|||
126250826|NCT00425308|454208971|FG000|Overall Study|Adverse Event|2|||
126250827|NCT00425308|454208972|FG001|Overall Study|Adverse Event|1|||
126250828|NCT00425308|454208971|FG000|Overall Study|Withdrawal by Subject|1|||
126250829|NCT00425308|454208972|FG001|Overall Study|Withdrawal by Subject|0|||
126250830|NCT00425308|454208971|FG000|Overall Study|Death|1|||
126250831|NCT00425308|454208972|FG001|Overall Study|Death|0|||
126250832|NCT01266902|454208973|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
126250833|NCT01266902|454208974|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
126250834|NCT01266902|454208975|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
126250835|NCT01266902|454208973|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
126250836|NCT01266902|454208974|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
126250837|NCT01266902|454208975|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
126250838|NCT01266902|454208973|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
126250839|NCT01266902|454208974|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
126250840|NCT01266902|454208975|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
126250841|NCT01266902|454208973|FG000|Period 1 (Main Study)|Adverse Event|3|||
126250842|NCT01266902|454208974|FG001|Period 1 (Main Study)|Adverse Event|11|||
126250843|NCT01266902|454208975|FG002|Period 1 (Main Study)|Adverse Event|0|||
126250844|NCT01266902|454208973|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
126250845|NCT01266902|454208974|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
126250846|NCT01266902|454208975|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
126250847|NCT01266902|454208973|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
126250848|NCT01266902|454208974|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
126250849|NCT01266902|454208975|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
126250850|NCT01266902|454208973|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
126250851|NCT01266902|454208974|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
126250852|NCT01266902|454208975|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
126250853|NCT01266902|454208973|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
126250854|NCT01266902|454208974|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
126250855|NCT01266902|454208975|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
126250856|NCT01266902|454208973|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
126250857|NCT01266902|454208974|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
126250858|NCT01266902|454208975|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
126697257|NCT02764541|455843299|FG002|Overall Study|Insurance reasons|0|||
126697258|NCT02764541|455843300|FG003|Overall Study|Insurance reasons|0|||
126697259|NCT02764541|455843301|FG004|Overall Study|Insurance reasons|0|||
126697260|NCT02764541|455843302|FG005|Overall Study|Insurance reasons|0|||
126697261|NCT02764541|455843303|FG006|Overall Study|Insurance reasons|1|||
126697262|NCT02764541|455843304|FG007|Overall Study|Insurance reasons|0|||
126697263|NCT00749190|455843305|FG000|Overall Study|Adverse Event|0|||
126697264|NCT00749190|455843306|FG001|Overall Study|Adverse Event|2|||
126697265|NCT00749190|455843307|FG002|Overall Study|Adverse Event|0|||
126697266|NCT00749190|455843308|FG003|Overall Study|Adverse Event|4|||
126697267|NCT00749190|455843309|FG004|Overall Study|Adverse Event|0|||
126697268|NCT00749190|455843310|FG005|Overall Study|Adverse Event|3|||
126697269|NCT00749190|455843311|FG006|Overall Study|Adverse Event|0|||
126697270|NCT00749190|455843305|FG000|Overall Study|Lack of Efficacy|3|||
126697271|NCT00749190|455843306|FG001|Overall Study|Lack of Efficacy|1|||
126697272|NCT00749190|455843307|FG002|Overall Study|Lack of Efficacy|1|||
126697273|NCT00749190|455843308|FG003|Overall Study|Lack of Efficacy|0|||
126697274|NCT00749190|455843309|FG004|Overall Study|Lack of Efficacy|0|||
126697275|NCT00749190|455843310|FG005|Overall Study|Lack of Efficacy|1|||
126697276|NCT00749190|455843311|FG006|Overall Study|Lack of Efficacy|0|||
126697277|NCT00749190|455843305|FG000|Overall Study|Withdrawal by Subject|2|||
126697278|NCT00749190|455843306|FG001|Overall Study|Withdrawal by Subject|1|||
126697279|NCT00749190|455843307|FG002|Overall Study|Withdrawal by Subject|0|||
126697280|NCT00749190|455843308|FG003|Overall Study|Withdrawal by Subject|0|||
126697281|NCT00749190|455843309|FG004|Overall Study|Withdrawal by Subject|0|||
126697282|NCT00749190|455843310|FG005|Overall Study|Withdrawal by Subject|1|||
126697283|NCT00749190|455843311|FG006|Overall Study|Withdrawal by Subject|0|||
126697284|NCT00749190|455843305|FG000|Overall Study|Protocol Violation|0|||
126697285|NCT00749190|455843306|FG001|Overall Study|Protocol Violation|1|||
126697286|NCT00749190|455843307|FG002|Overall Study|Protocol Violation|0|||
126697287|NCT00749190|455843308|FG003|Overall Study|Protocol Violation|0|||
126697288|NCT00749190|455843309|FG004|Overall Study|Protocol Violation|0|||
126697289|NCT00749190|455843310|FG005|Overall Study|Protocol Violation|0|||
126697290|NCT00749190|455843311|FG006|Overall Study|Protocol Violation|1|||
126697291|NCT00749190|455843305|FG000|Overall Study|Other reason not defined above|0|||
126697292|NCT00749190|455843306|FG001|Overall Study|Other reason not defined above|0|||
126697293|NCT00749190|455843307|FG002|Overall Study|Other reason not defined above|0|||
126697294|NCT00749190|455843308|FG003|Overall Study|Other reason not defined above|1|||
126697295|NCT00749190|455843309|FG004|Overall Study|Other reason not defined above|0|||
126697296|NCT00749190|455843310|FG005|Overall Study|Other reason not defined above|0|||
126697297|NCT00749190|455843311|FG006|Overall Study|Other reason not defined above|0|||
126697298|NCT01245673|455843312|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
126697299|NCT00355121|455843314|FG000|Overall Study|Did not receive study vaccine|1|||
126697300|NCT00355121|455843315|FG001|Overall Study|Did not receive study vaccine|0|||
126697301|NCT00355121|455843316|FG002|Overall Study|Did not receive study vaccine|1|||
126697302|NCT00355121|455843314|FG000|Overall Study|Adverse Event|0|||
126697303|NCT00355121|455843315|FG001|Overall Study|Adverse Event|1|||
126697304|NCT00355121|455843316|FG002|Overall Study|Adverse Event|0|||
126697305|NCT00355121|455843314|FG000|Overall Study|Protocol Violation|7|||
126697306|NCT00355121|455843315|FG001|Overall Study|Protocol Violation|9|||
126697307|NCT00355121|455843316|FG002|Overall Study|Protocol Violation|1|||
126697308|NCT00355121|455843314|FG000|Overall Study|Lost to Follow-up|4|||
126697309|NCT00355121|455843315|FG001|Overall Study|Lost to Follow-up|7|||
126697310|NCT00355121|455843316|FG002|Overall Study|Lost to Follow-up|1|||
126697311|NCT00355121|455843314|FG000|Overall Study|Withdrawal by Subject|9|||
126697312|NCT00355121|455843315|FG001|Overall Study|Withdrawal by Subject|10|||
126697313|NCT00355121|455843316|FG002|Overall Study|Withdrawal by Subject|2|||
126697314|NCT00355121|455843314|FG000|Overall Study|Serious adverse events|0|||
126697315|NCT00355121|455843315|FG001|Overall Study|Serious adverse events|2|||
126697316|NCT00355121|455843316|FG002|Overall Study|Serious adverse events|0|||
126697317|NCT04640766|455843318|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
126697318|NCT00630331|455843319|FG000|Overall Study|Death|2|||
126697319|NCT00630331|455843320|FG001|Overall Study|Death|1|||
126697320|NCT00630331|455843321|FG002|Overall Study|Death|1|||
126697321|NCT00630331|455843319|FG000|Overall Study|Adverse Event|1|||
126697322|NCT00630331|455843320|FG001|Overall Study|Adverse Event|0|||
126697323|NCT00630331|455843321|FG002|Overall Study|Adverse Event|0|||
126697324|NCT00630331|455843319|FG000|Overall Study|Withdrawal by Subject|12|||
126697325|NCT00630331|455843320|FG001|Overall Study|Withdrawal by Subject|7|||
126697326|NCT00630331|455843321|FG002|Overall Study|Withdrawal by Subject|5|||
126697327|NCT00630331|455843319|FG000|Overall Study|Lost to Follow-up|175|||
126697328|NCT00630331|455843320|FG001|Overall Study|Lost to Follow-up|143|||
126697329|NCT00630331|455843321|FG002|Overall Study|Lost to Follow-up|170|||
126697330|NCT00630331|455843319|FG000|Overall Study|Inappropriate enrollment|3|||
126697331|NCT00630331|455843320|FG001|Overall Study|Inappropriate enrollment|6|||
126697332|NCT00630331|455843321|FG002|Overall Study|Inappropriate enrollment|3|||
126697333|NCT00630331|455843319|FG000|Overall Study|Unable to classify|9|||
126697334|NCT00630331|455843320|FG001|Overall Study|Unable to classify|4|||
126697335|NCT00630331|455843321|FG002|Overall Study|Unable to classify|3|||
126697336|NCT00630331|455843319|FG000|Overall Study|Protocol Violation|4|||
126697337|NCT00630331|455843320|FG001|Overall Study|Protocol Violation|5|||
126697338|NCT00630331|455843321|FG002|Overall Study|Protocol Violation|6|||
126697339|NCT01565980|455843323|FG000|Overall Study|Death|1|||
126697340|NCT01565980|455843324|FG001|Overall Study|Death|0|||
126697341|NCT01565980|455843323|FG000|Overall Study|Lost to Follow-up|1|||
126697342|NCT01565980|455843324|FG001|Overall Study|Lost to Follow-up|0|||
126697343|NCT01565980|455843323|FG000|Overall Study|health complications|1|||
126697344|NCT01565980|455843324|FG001|Overall Study|health complications|1|||
126697345|NCT01565980|455843323|FG000|Overall Study|stopped medical treatment|1|||
126697346|NCT01565980|455843324|FG001|Overall Study|stopped medical treatment|0|||
126697347|NCT01565980|455843323|FG000|Overall Study|Withdrawal by Subject|0|||
126697348|NCT01565980|455843324|FG001|Overall Study|Withdrawal by Subject|3|||
126697349|NCT02078219|455843326|FG000|Overall Study|Other|2|||
126697350|NCT02078219|455843327|FG001|Overall Study|Other|2|||
126697351|NCT02078219|455843328|FG002|Overall Study|Other|3|||
126697352|NCT02078219|455843329|FG003|Overall Study|Other|0|||
126697353|NCT02078219|455843330|FG004|Overall Study|Other|1|||
126697354|NCT02078219|455843326|FG000|Overall Study|Withdrawal by Subject|0|||
126697355|NCT02078219|455843327|FG001|Overall Study|Withdrawal by Subject|1|||
126697356|NCT02078219|455843328|FG002|Overall Study|Withdrawal by Subject|0|||
126762257|NCT03841331|456081191|FG001|Overall Study|Withdrawal by Subject|9|||
126762258|NCT03841331|456081190|FG000|Overall Study|Lost to Follow-up|5|||
126762259|NCT03841331|456081191|FG001|Overall Study|Lost to Follow-up|1|||
126762260|NCT02743117|456081192|FG000|Overall Study|Lost to Follow-up|0|||
126762261|NCT02743117|456081193|FG001|Overall Study|Lost to Follow-up|1|||
126250859|NCT01266902|454208973|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
126250860|NCT01266902|454208974|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
126250861|NCT01266902|454208975|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
126250862|NCT04442503|454208976|FG000|Overall Study|Adverse Event|1|||
126250863|NCT04442503|454208977|FG001|Overall Study|Adverse Event|1|||
126250864|NCT04442503|454208976|FG000|Overall Study|Lost to Follow-up|8|||
126250865|NCT04442503|454208977|FG001|Overall Study|Lost to Follow-up|6|||
126250866|NCT04442503|454208976|FG000|Overall Study|Physician Decision|0|||
126250867|NCT04442503|454208977|FG001|Overall Study|Physician Decision|2|||
126250868|NCT04442503|454208976|FG000|Overall Study|Withdrawal by Subject|3|||
126250869|NCT04442503|454208977|FG001|Overall Study|Withdrawal by Subject|4|||
126250870|NCT04442503|454208976|FG000|Overall Study|Reason not Specified|0|||
126250871|NCT04442503|454208977|FG001|Overall Study|Reason not Specified|1|||
126250872|NCT04442503|454208976|FG000|Overall Study|Randomized but not Treated|3|||
126250873|NCT04442503|454208977|FG001|Overall Study|Randomized but not Treated|1|||
126250874|NCT00387153|454208978|FG000|Overall Study|Adverse Event|1|||
126250875|NCT00387153|454208978|FG000|Overall Study|Disease Progression|3|||
126250876|NCT00387153|454208978|FG000|Overall Study|Lack of Response|4|||
126250877|NCT02933060|454208979|FG000|Overall Study|Withdrawal by Subject|0|||
126250878|NCT02933060|454208980|FG001|Overall Study|Withdrawal by Subject|1|||
126250879|NCT01945580|454208981|FG000|Overall Study|Withdrawal by Subject|13|||
126250880|NCT01945580|454208982|FG001|Overall Study|Withdrawal by Subject|35|||
126250881|NCT01945580|454208981|FG000|Overall Study|Physician Decision|3|||
126250882|NCT01945580|454208982|FG001|Overall Study|Physician Decision|2|||
126250883|NCT01945580|454208981|FG000|Overall Study|Lost to Follow-up|26|||
126250884|NCT01945580|454208982|FG001|Overall Study|Lost to Follow-up|39|||
126250885|NCT01945580|454208981|FG000|Overall Study|Death|7|||
126250886|NCT01945580|454208982|FG001|Overall Study|Death|2|||
126697357|NCT02078219|455843329|FG003|Overall Study|Withdrawal by Subject|1|||
126697358|NCT02078219|455843330|FG004|Overall Study|Withdrawal by Subject|1|||
126762262|NCT02743117|456081192|FG000|Overall Study|Other|1|||
126762263|NCT02743117|456081193|FG001|Overall Study|Other|0|||
126762264|NCT03532048|456081195|FG000|Overall Study|Lost to Follow-up|12|||
126762265|NCT03532048|456081196|FG001|Overall Study|Lost to Follow-up|17|||
126250887|NCT01945580|454208981|FG000|Overall Study|Patient moved out of state|0|||
126697359|NCT02078219|455843326|FG000|Overall Study|Protocol Violation|0|||
126697360|NCT02078219|455843327|FG001|Overall Study|Protocol Violation|0|||
126697361|NCT02078219|455843328|FG002|Overall Study|Protocol Violation|0|||
126697362|NCT02078219|455843329|FG003|Overall Study|Protocol Violation|1|||
126250888|NCT01945580|454208982|FG001|Overall Study|Patient moved out of state|1|||
126250889|NCT01945580|454208981|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
126250890|NCT01945580|454208982|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
126448954|NCT05601544|454943277|FG005|Phase 2 Period 1|Adverse Event|0|||
126697363|NCT02078219|455843330|FG004|Overall Study|Protocol Violation|0|||
126697364|NCT02078219|455843326|FG000|Overall Study|Death|0|||
126697365|NCT02078219|455843327|FG001|Overall Study|Death|0|||
126697366|NCT02078219|455843328|FG002|Overall Study|Death|0|||
126762266|NCT03532048|456081195|FG000|Overall Study|Withdrawal by Subject|7|||
126762267|NCT03532048|456081196|FG001|Overall Study|Withdrawal by Subject|0|||
126762268|NCT01901393|456081199|FG000|Overall Study|Adverse Event|1|||
126448955|NCT00122980|454945121|FG000|Overall Study|Death|0|||
126448956|NCT00122980|454945122|FG001|Overall Study|Death|1|||
126448957|NCT00122980|454945121|FG000|Overall Study|Physician Decision|2|||
126448958|NCT00122980|454945122|FG001|Overall Study|Physician Decision|0|||
126448959|NCT00122980|454945121|FG000|Overall Study|Protocol Violation|5|||
126448960|NCT00122980|454945122|FG001|Overall Study|Protocol Violation|1|||
126448961|NCT00122980|454945121|FG000|Overall Study|Withdrawal by Subject|2|||
126448962|NCT00122980|454945122|FG001|Overall Study|Withdrawal by Subject|3|||
126448963|NCT00122980|454945121|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
126448964|NCT00122980|454945122|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
126448965|NCT00122980|454945121|FG000|Overall Study|Study termination|27|||
126250891|NCT01945580|454208981|FG000|Overall Study|Family illness - unable to return|0|||
126448966|NCT00122980|454945122|FG001|Overall Study|Study termination|35|||
126448967|NCT01124864|454945123|FG000|Overall Study|Follow up phase competed as per protocol|18|||
126448968|NCT01124864|454945124|FG001|Overall Study|Follow up phase competed as per protocol|22|||
126448969|NCT01124864|454945125|FG002|Overall Study|Follow up phase competed as per protocol|24|||
126448970|NCT01124864|454945126|FG003|Overall Study|Follow up phase competed as per protocol|18|||
126448971|NCT01124864|454945127|FG004|Overall Study|Follow up phase competed as per protocol|26|||
126448972|NCT01124864|454945128|FG005|Overall Study|Follow up phase competed as per protocol|2|||
126448973|NCT01124864|454945123|FG000|Overall Study|Death|6|||
126448974|NCT01124864|454945124|FG001|Overall Study|Death|9|||
126448975|NCT01124864|454945125|FG002|Overall Study|Death|6|||
126448976|NCT01124864|454945126|FG003|Overall Study|Death|2|||
126448977|NCT01124864|454945127|FG004|Overall Study|Death|1|||
126448978|NCT01124864|454945128|FG005|Overall Study|Death|0|||
126448979|NCT01124864|454945123|FG000|Overall Study|Withdrawal by Subject|2|||
126448980|NCT01124864|454945124|FG001|Overall Study|Withdrawal by Subject|3|||
126448981|NCT01124864|454945125|FG002|Overall Study|Withdrawal by Subject|4|||
126448982|NCT01124864|454945126|FG003|Overall Study|Withdrawal by Subject|0|||
126448983|NCT01124864|454945127|FG004|Overall Study|Withdrawal by Subject|2|||
126448984|NCT01124864|454945128|FG005|Overall Study|Withdrawal by Subject|1|||
126448985|NCT01124864|454945123|FG000|Overall Study|Lost to Follow-up|1|||
126448986|NCT01124864|454945124|FG001|Overall Study|Lost to Follow-up|1|||
126448987|NCT01124864|454945125|FG002|Overall Study|Lost to Follow-up|0|||
126448988|NCT01124864|454945126|FG003|Overall Study|Lost to Follow-up|1|||
126448989|NCT01124864|454945127|FG004|Overall Study|Lost to Follow-up|0|||
126448990|NCT01124864|454945128|FG005|Overall Study|Lost to Follow-up|0|||
126448991|NCT01124864|454945123|FG000|Overall Study|Protocol Violation|1|||
126448992|NCT01124864|454945124|FG001|Overall Study|Protocol Violation|0|||
126448993|NCT01124864|454945125|FG002|Overall Study|Protocol Violation|0|||
126448994|NCT01124864|454945126|FG003|Overall Study|Protocol Violation|0|||
126448995|NCT01124864|454945127|FG004|Overall Study|Protocol Violation|1|||
126448996|NCT01124864|454945128|FG005|Overall Study|Protocol Violation|0|||
126448997|NCT01243242|454945129|FG000|Overall Study|Adverse Event|1|||
126448998|NCT01243242|454945130|FG001|Overall Study|Adverse Event|1|||
126448999|NCT01243242|454945129|FG000|Overall Study|Withdrawal by Subject|1|||
126449000|NCT01243242|454945130|FG001|Overall Study|Withdrawal by Subject|1|||
126449001|NCT01243242|454945129|FG000|Overall Study|Physician Decision|0|||
126449002|NCT01243242|454945130|FG001|Overall Study|Physician Decision|1|||
126449003|NCT01243242|454945129|FG000|Overall Study|sponsor decision|0|||
126250892|NCT01945580|454208982|FG001|Overall Study|Family illness - unable to return|1|||
126250893|NCT01945580|454208981|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
126250894|NCT01945580|454208982|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
126250895|NCT01945580|454208981|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
126250896|NCT01945580|454208982|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
126250897|NCT01945580|454208981|FG000|Overall Study|Noncompliance with 36 month visit|1|||
126250898|NCT01945580|454208982|FG001|Overall Study|Noncompliance with 36 month visit|0|||
126250899|NCT01945580|454208981|FG000|Overall Study|The patient moved.|1|||
126250900|NCT01945580|454208982|FG001|Overall Study|The patient moved.|0|||
126250901|NCT01945580|454208981|FG000|Overall Study|No data available|0|||
126250902|NCT01945580|454208982|FG001|Overall Study|No data available|2|||
126449004|NCT01243242|454945130|FG001|Overall Study|sponsor decision|1|||
126449005|NCT01243242|454945129|FG000|Overall Study|non compliance|1|||
126250903|NCT05034874|454208985|FG000|Overall Study|Withdrawal by Subject|6|||
126250904|NCT05034874|454208986|FG001|Overall Study|Withdrawal by Subject|6|||
126250905|NCT05034874|454208985|FG000|Overall Study|Lost to Follow-up|18|||
126250906|NCT05034874|454208986|FG001|Overall Study|Lost to Follow-up|8|||
126449006|NCT01243242|454945130|FG001|Overall Study|non compliance|0|||
126449007|NCT00669409|454945131|FG000|Part 2|Withdrawal by Subject|0|||
126449008|NCT00669409|454945132|FG001|Part 2|Withdrawal by Subject|0|||
126449009|NCT00669409|454945133|FG002|Part 2|Withdrawal by Subject|0|||
126449010|NCT00669409|454945134|FG003|Part 2|Withdrawal by Subject|0|||
126449011|NCT00669409|454945135|FG004|Part 2|Withdrawal by Subject|0|||
126449012|NCT00669409|454945136|FG005|Part 2|Withdrawal by Subject|0|||
126449013|NCT00669409|454945137|FG006|Part 2|Withdrawal by Subject|0|||
126250907|NCT05034874|454208985|FG000|Overall Study|Physician Decision|0|||
126250908|NCT05034874|454208986|FG001|Overall Study|Physician Decision|1|||
126250909|NCT05034874|454208985|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
126250910|NCT05034874|454208986|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
126250911|NCT00989950|454208987|FG000|Randomized Phase|Protocol Violation|1|||
126250912|NCT00989950|454208988|FG001|Randomized Phase|Protocol Violation|0|||
126250913|NCT00989950|454208989|FG002|Randomized Phase|Protocol Violation|0|||
126250914|NCT00989950|454208990|FG003|Randomized Phase|Protocol Violation|0|||
126250915|NCT00989950|454208987|FG000|Randomized Phase|Adverse Event|0|||
126250916|NCT00989950|454208988|FG001|Randomized Phase|Adverse Event|1|||
126449014|NCT00669409|454945138|FG007|Part 2|Withdrawal by Subject|0|||
126449015|NCT00669409|454945139|FG008|Part 2|Withdrawal by Subject|0|||
126449016|NCT00669409|454945140|FG009|Part 2|Withdrawal by Subject|1|||
126449017|NCT00669409|454945141|FG010|Part 2|Withdrawal by Subject|0|||
126449018|NCT03583385|454945142|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126449019|NCT03583385|454945143|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126449020|NCT03583385|454945142|FG000|Treatment Period 2|Adverse Event|1|||
126449021|NCT03583385|454945143|FG001|Treatment Period 2|Adverse Event|0|||
126449022|NCT00095940|454945144|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
126449023|NCT00095940|454945145|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
126449024|NCT00095940|454945146|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
126449025|NCT00095940|454945147|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
126449026|NCT00095940|454945148|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
126449027|NCT00095940|454945149|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
126449028|NCT00095940|454945150|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
126449029|NCT00095940|454945151|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
126449030|NCT00095940|454945152|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
126449031|NCT00095940|454945144|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
126449032|NCT00095940|454945145|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
126449033|NCT00095940|454945146|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
126449034|NCT00095940|454945147|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
126449035|NCT00095940|454945148|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
126449036|NCT00095940|454945149|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
126449037|NCT00095940|454945150|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
126449038|NCT00095940|454945151|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
126449039|NCT00095940|454945152|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
126449040|NCT00095940|454945144|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
126449041|NCT00095940|454945145|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
126449042|NCT00095940|454945146|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
126449043|NCT00095940|454945147|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
126449044|NCT00095940|454945148|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
126449045|NCT00095940|454945149|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
126449046|NCT00095940|454945150|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
126449047|NCT00095940|454945151|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
126449048|NCT00095940|454945152|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
126449049|NCT03539549|454945154|FG000|Overall Study|Adverse Event|12|||
126449050|NCT03539549|454945154|FG000|Overall Study|Lost to Follow-up|1|||
126449051|NCT03539549|454945154|FG000|Overall Study|Death|2|||
126449052|NCT03539549|454945154|FG000|Overall Study|Progressive Disease|1|||
126449053|NCT03539549|454945154|FG000|Overall Study|Reason not Specified|1|||
126449054|NCT02864862|454945155|FG000|Overall Study|Lost to Follow-up|1|||
126449055|NCT02864862|454945156|FG001|Overall Study|Lost to Follow-up|0|||
126449056|NCT02864862|454945157|FG002|Overall Study|Lost to Follow-up|1|||
126449057|NCT02864862|454945155|FG000|Overall Study|Protocol Violation|0|||
126449058|NCT02864862|454945156|FG001|Overall Study|Protocol Violation|0|||
126449059|NCT02864862|454945157|FG002|Overall Study|Protocol Violation|1|||
126449060|NCT04693234|454945161|FG000|Overall Study|Death|79|||
126449061|NCT04693234|454945162|FG001|Overall Study|Death|19|||
126449062|NCT04693234|454945161|FG000|Overall Study|Sponsor Ended Study|47|||
126697367|NCT02078219|455843329|FG003|Overall Study|Death|1|||
126697368|NCT02078219|455843330|FG004|Overall Study|Death|0|||
126697369|NCT02078219|455843326|FG000|Overall Study|Adverse Event|1|||
126697370|NCT02078219|455843327|FG001|Overall Study|Adverse Event|1|||
126697371|NCT02078219|455843328|FG002|Overall Study|Adverse Event|3|||
126250917|NCT00989950|454208989|FG002|Randomized Phase|Adverse Event|0|||
126250918|NCT00989950|454208990|FG003|Randomized Phase|Adverse Event|0|||
126250919|NCT00101439|454208991|FG000|Period 2|Withdrawal by Subject|0|||
126250920|NCT00101439|454208992|FG001|Period 2|Withdrawal by Subject|2|||
126250921|NCT01867658|454208994|FG000|Overall Study|Withdrawal by Subject|6|||
126449063|NCT04693234|454945162|FG001|Overall Study|Sponsor Ended Study|18|||
126449064|NCT04693234|454945161|FG000|Overall Study|Withdrawal by Subject|10|||
126449065|NCT04693234|454945162|FG001|Overall Study|Withdrawal by Subject|2|||
126449066|NCT04693234|454945161|FG000|Overall Study|Lost to Follow-up|2|||
126449067|NCT04693234|454945162|FG001|Overall Study|Lost to Follow-up|1|||
126697372|NCT02078219|455843329|FG003|Overall Study|Adverse Event|1|||
126250922|NCT01867658|454208994|FG000|Overall Study|Death|2|||
126250923|NCT01867658|454208994|FG000|Overall Study|Subject could not be contacted|1|||
126250924|NCT00840658|454208995|FG000|Overall Study|Death|2|||
126250925|NCT00840658|454208996|FG001|Overall Study|Death|2|||
126250926|NCT00840658|454208997|FG002|Overall Study|Death|3|||
126250927|NCT00840658|454208998|FG003|Overall Study|Death|3|||
126250928|NCT00840658|454208995|FG000|Overall Study|Lost to Follow-up|3|||
126250929|NCT00840658|454208996|FG001|Overall Study|Lost to Follow-up|1|||
126250930|NCT00840658|454208997|FG002|Overall Study|Lost to Follow-up|2|||
126250931|NCT00840658|454208998|FG003|Overall Study|Lost to Follow-up|1|||
126250932|NCT00474058|454208999|FG000|Overall Study|Adverse Event|11|||
126250933|NCT00474058|454209000|FG001|Overall Study|Adverse Event|6|||
126250934|NCT00474058|454208999|FG000|Overall Study|Lack of Efficacy|0|||
126250935|NCT00474058|454209000|FG001|Overall Study|Lack of Efficacy|4|||
126250936|NCT00474058|454208999|FG000|Overall Study|Withdrawal by Subject|11|||
126250937|NCT00474058|454209000|FG001|Overall Study|Withdrawal by Subject|7|||
126250938|NCT00474058|454208999|FG000|Overall Study|Other|2|||
126250939|NCT00474058|454209000|FG001|Overall Study|Other|0|||
126250940|NCT03101358|454209001|FG000|Overall Study|Non-compliance with study schedule|1|||
126250941|NCT03101358|454209002|FG001|Overall Study|Non-compliance with study schedule|0|||
126250942|NCT03101358|454209003|FG002|Overall Study|Non-compliance with study schedule|0|||
126250943|NCT03101358|454209004|FG003|Overall Study|Non-compliance with study schedule|1|||
126250944|NCT03101358|454209001|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
126250945|NCT03101358|454209002|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
126250946|NCT03101358|454209003|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
126250947|NCT03101358|454209004|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
126250948|NCT03101358|454209001|FG000|Overall Study|Physician Decision|1|||
126250949|NCT03101358|454209002|FG001|Overall Study|Physician Decision|0|||
126250950|NCT03101358|454209003|FG002|Overall Study|Physician Decision|0|||
126250951|NCT03101358|454209004|FG003|Overall Study|Physician Decision|3|||
126250952|NCT03101358|454209001|FG000|Overall Study|Adverse Event|0|||
126250953|NCT03101358|454209002|FG001|Overall Study|Adverse Event|0|||
126250954|NCT03101358|454209003|FG002|Overall Study|Adverse Event|1|||
126250955|NCT03101358|454209004|FG003|Overall Study|Adverse Event|0|||
126250956|NCT03101358|454209001|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
126250957|NCT03101358|454209002|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
126250958|NCT03101358|454209003|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
126250959|NCT03101358|454209004|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
126250960|NCT03101358|454209001|FG000|Overall Study|Lost to Follow-up|1|||
126250961|NCT03101358|454209002|FG001|Overall Study|Lost to Follow-up|0|||
126250962|NCT03101358|454209003|FG002|Overall Study|Lost to Follow-up|0|||
126250963|NCT03101358|454209004|FG003|Overall Study|Lost to Follow-up|1|||
126250964|NCT05616728|454209005|FG000|Overall Study|Lost to Follow-up|0|||
126250965|NCT05616728|454209006|FG001|Overall Study|Lost to Follow-up|0|||
126250966|NCT05616728|454209007|FG002|Overall Study|Lost to Follow-up|1|||
126250967|NCT05616728|454209005|FG000|Overall Study|Withdrawal by Subject|1|||
126250968|NCT05616728|454209006|FG001|Overall Study|Withdrawal by Subject|1|||
126250969|NCT05616728|454209007|FG002|Overall Study|Withdrawal by Subject|0|||
126250970|NCT05616728|454209005|FG000|Overall Study|Physician Decision|1|||
126250971|NCT05616728|454209006|FG001|Overall Study|Physician Decision|1|||
126250972|NCT05616728|454209007|FG002|Overall Study|Physician Decision|1|||
126250973|NCT05616728|454209005|FG000|Overall Study|Other|0|||
126250974|NCT05616728|454209006|FG001|Overall Study|Other|2|||
126250975|NCT05616728|454209007|FG002|Overall Study|Other|0|||
126250976|NCT01024855|454209010|FG000|Overall Study|Inclusion/exclusion criteria|1|||
126250977|NCT03306277|454209015|FG000|Overall Study|Death|1|||
126250978|NCT03306277|454209015|FG000|Overall Study|Adverse Event|1|||
126250979|NCT03306277|454209015|FG000|Overall Study|Withdrawal by Subject|1|||
126449068|NCT04643158|454945163|FG000|Overall Study|Study terminated by sponsor|0|||
126449069|NCT04643158|454945164|FG001|Overall Study|Study terminated by sponsor|0|||
126762269|NCT01901393|456081200|FG001|Overall Study|Adverse Event|0|||
126250980|NCT00881751|454209024|FG000|Overall Study|Physician Decision|0|||
126250981|NCT00881751|454209025|FG001|Overall Study|Physician Decision|1|||
126250982|NCT00881751|454209024|FG000|Overall Study|Adverse Event|0|||
126250983|NCT00881751|454209025|FG001|Overall Study|Adverse Event|2|||
126250984|NCT00881751|454209024|FG000|Overall Study|Withdrawal by Subject|0|||
126250985|NCT00881751|454209025|FG001|Overall Study|Withdrawal by Subject|2|||
126250986|NCT02385708|454209026|FG000|Overall Study|Withdrawal by Subject|0|||
126250987|NCT02385708|454209027|FG001|Overall Study|Withdrawal by Subject|2|||
126250988|NCT02385708|454209026|FG000|Overall Study|Withdrawn - surgery canceled|2|||
126250989|NCT02385708|454209027|FG001|Overall Study|Withdrawn - surgery canceled|5|||
126250990|NCT02385708|454209026|FG000|Overall Study|Investigator decision|5|||
126250991|NCT02385708|454209027|FG001|Overall Study|Investigator decision|7|||
126250992|NCT02385708|454209026|FG000|Overall Study|Protocol Violation|1|||
126250993|NCT02385708|454209027|FG001|Overall Study|Protocol Violation|1|||
126697373|NCT02078219|455843330|FG004|Overall Study|Adverse Event|0|||
126697374|NCT03283085|455843333|FG000|Overall Study|Adverse Event|18|||
126697375|NCT03283085|455843334|FG001|Overall Study|Adverse Event|3|||
126697376|NCT03283085|455843335|FG002|Overall Study|Adverse Event|13|||
126697377|NCT03283085|455843336|FG003|Overall Study|Adverse Event|0|||
126697378|NCT03283085|455843337|FG004|Overall Study|Adverse Event|0|||
126697379|NCT03283085|455843338|FG005|Overall Study|Adverse Event|5|||
126697380|NCT03283085|455843333|FG000|Overall Study|Death|0|||
126697381|NCT03283085|455843334|FG001|Overall Study|Death|0|||
126697382|NCT03283085|455843335|FG002|Overall Study|Death|3|||
126697383|NCT03283085|455843336|FG003|Overall Study|Death|1|||
126697384|NCT03283085|455843337|FG004|Overall Study|Death|0|||
126697385|NCT03283085|455843338|FG005|Overall Study|Death|0|||
126697386|NCT03283085|455843333|FG000|Overall Study|Withdrawal by Subject|42|||
126697387|NCT03283085|455843334|FG001|Overall Study|Withdrawal by Subject|21|||
126697388|NCT03283085|455843335|FG002|Overall Study|Withdrawal by Subject|66|||
126697389|NCT03283085|455843336|FG003|Overall Study|Withdrawal by Subject|3|||
126697390|NCT03283085|455843337|FG004|Overall Study|Withdrawal by Subject|3|||
126697391|NCT03283085|455843338|FG005|Overall Study|Withdrawal by Subject|5|||
126697392|NCT03283085|455843333|FG000|Overall Study|Physician Decision|14|||
126697393|NCT03283085|455843334|FG001|Overall Study|Physician Decision|8|||
126697394|NCT03283085|455843335|FG002|Overall Study|Physician Decision|19|||
126697395|NCT03283085|455843336|FG003|Overall Study|Physician Decision|0|||
126697396|NCT03283085|455843337|FG004|Overall Study|Physician Decision|0|||
126250994|NCT01559363|454209029|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
126250995|NCT01559363|454209030|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
126250996|NCT01559363|454209031|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
126250997|NCT01559363|454209032|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
126250998|NCT01559363|454209033|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
126250999|NCT01559363|454209034|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
126251000|NCT01559363|454209029|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
126251001|NCT01559363|454209030|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
126251002|NCT01559363|454209031|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
126251003|NCT01559363|454209032|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
126251004|NCT01559363|454209033|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
126251005|NCT01559363|454209034|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
126251006|NCT01559363|454209029|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
126251007|NCT01559363|454209030|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
126251008|NCT01559363|454209031|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
126251009|NCT01559363|454209032|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
126251010|NCT01559363|454209033|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
126251011|NCT01559363|454209034|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
126251012|NCT01559363|454209029|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
126251013|NCT01559363|454209030|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
126251014|NCT01559363|454209031|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
126251015|NCT01559363|454209032|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
126251016|NCT01559363|454209033|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
126251017|NCT01559363|454209034|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
126251018|NCT01559363|454209029|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
126251019|NCT01559363|454209030|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
126251020|NCT01559363|454209031|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
126251021|NCT01559363|454209032|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
126449070|NCT04643158|454945165|FG002|Overall Study|Study terminated by sponsor|1|||
126449071|NCT04643158|454945166|FG003|Overall Study|Study terminated by sponsor|0|||
126449072|NCT04643158|454945167|FG004|Overall Study|Study terminated by sponsor|0|||
126449073|NCT04643158|454945168|FG005|Overall Study|Study terminated by sponsor|1|||
126697397|NCT03283085|455843338|FG005|Overall Study|Physician Decision|2|||
126697398|NCT03283085|455843333|FG000|Overall Study|Site Terminated by Sponsor|1|||
126697399|NCT03283085|455843334|FG001|Overall Study|Site Terminated by Sponsor|0|||
126697400|NCT03283085|455843335|FG002|Overall Study|Site Terminated by Sponsor|3|||
126697401|NCT03283085|455843336|FG003|Overall Study|Site Terminated by Sponsor|0|||
126697402|NCT03283085|455843337|FG004|Overall Study|Site Terminated by Sponsor|0|||
126697403|NCT03283085|455843338|FG005|Overall Study|Site Terminated by Sponsor|0|||
126697404|NCT03283085|455843333|FG000|Overall Study|Lost to Follow-up|2|||
126697405|NCT03283085|455843334|FG001|Overall Study|Lost to Follow-up|0|||
126697406|NCT03283085|455843335|FG002|Overall Study|Lost to Follow-up|2|||
126697407|NCT03283085|455843336|FG003|Overall Study|Lost to Follow-up|0|||
126697408|NCT03283085|455843337|FG004|Overall Study|Lost to Follow-up|0|||
126697409|NCT03283085|455843338|FG005|Overall Study|Lost to Follow-up|1|||
126697410|NCT03283085|455843333|FG000|Overall Study|Pregnancy|0|||
126251022|NCT01559363|454209033|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
126251023|NCT01559363|454209034|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
126449074|NCT04643158|454945169|FG006|Overall Study|Study terminated by sponsor|0|||
126697411|NCT03283085|455843334|FG001|Overall Study|Pregnancy|0|||
126697412|NCT03283085|455843335|FG002|Overall Study|Pregnancy|1|||
126251024|NCT01559363|454209029|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
126251025|NCT01559363|454209030|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
126251026|NCT01559363|454209031|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
126251027|NCT01559363|454209032|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
126251028|NCT01559363|454209033|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
126251029|NCT01559363|454209034|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
126251030|NCT01559363|454209029|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
126251031|NCT01559363|454209030|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
126251032|NCT01559363|454209031|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
126251033|NCT01559363|454209032|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
126251034|NCT01559363|454209033|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
126251035|NCT01559363|454209034|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
126251036|NCT00672984|454209035|FG000|First Intervention|Adverse Event|5|||
126251037|NCT00672984|454209036|FG001|First Intervention|Adverse Event|0|||
126251038|NCT00672984|454209037|FG002|First Intervention|Adverse Event|0|||
126251039|NCT00672984|454209035|FG000|First Intervention|Withdrawal by Subject|1|||
126251040|NCT00672984|454209036|FG001|First Intervention|Withdrawal by Subject|2|||
126251041|NCT00672984|454209037|FG002|First Intervention|Withdrawal by Subject|2|||
126251042|NCT00672984|454209035|FG000|First Intervention|Sponsor decision|3|||
126251043|NCT00672984|454209036|FG001|First Intervention|Sponsor decision|0|||
126251044|NCT00672984|454209037|FG002|First Intervention|Sponsor decision|0|||
126251045|NCT00672984|454209035|FG000|Second Intervention|Non-compliance with facility policies|0|||
126251046|NCT00672984|454209036|FG001|Second Intervention|Non-compliance with facility policies|2|||
126251047|NCT00672984|454209037|FG002|Second Intervention|Non-compliance with facility policies|0|||
126251048|NCT00672984|454209035|FG000|Second Intervention|Withdrawal by Subject|0|||
126251049|NCT00672984|454209036|FG001|Second Intervention|Withdrawal by Subject|3|||
126251050|NCT00672984|454209037|FG002|Second Intervention|Withdrawal by Subject|0|||
126251051|NCT00672984|454209035|FG000|Second Intervention|Protocol Violation|0|||
126251052|NCT00672984|454209036|FG001|Second Intervention|Protocol Violation|1|||
126251053|NCT00672984|454209037|FG002|Second Intervention|Protocol Violation|1|||
126251054|NCT00672984|454209035|FG000|Third Intervention|Adverse Event|1|||
126251055|NCT00672984|454209036|FG001|Third Intervention|Adverse Event|0|||
126251056|NCT00672984|454209037|FG002|Third Intervention|Adverse Event|1|||
126251057|NCT00645853|454209038|FG000|Overall Study|Adverse Event|18|||
126251058|NCT00645853|454209039|FG001|Overall Study|Adverse Event|7|||
126251059|NCT00645853|454209038|FG000|Overall Study|AZ study closure in Hungary|60|||
126251060|NCT00645853|454209039|FG001|Overall Study|AZ study closure in Hungary|40|||
126251061|NCT00645853|454209038|FG000|Overall Study|Withdrawal by Subject|5|||
126251062|NCT00645853|454209039|FG001|Overall Study|Withdrawal by Subject|2|||
126251063|NCT00645853|454209038|FG000|Overall Study|Protocol Violation|0|||
126251064|NCT00645853|454209039|FG001|Overall Study|Protocol Violation|2|||
126251065|NCT00645853|454209038|FG000|Overall Study|Discontinuation criteria|2|||
126251066|NCT00645853|454209039|FG001|Overall Study|Discontinuation criteria|2|||
126251067|NCT00645853|454209038|FG000|Overall Study|recall of ICF, planned operation, death|7|||
126251068|NCT00645853|454209039|FG001|Overall Study|recall of ICF, planned operation, death|4|||
126251069|NCT04060251|454209040|FG000|Overall Study|Study terminated due to low enrollment.|7|||
126251070|NCT04060251|454209041|FG001|Overall Study|Study terminated due to low enrollment.|5|||
126251071|NCT04060251|454209042|FG002|Overall Study|Study terminated due to low enrollment.|7|||
126251072|NCT04060251|454209040|FG000|Overall Study|Adverse Event|1|||
126449075|NCT04643158|454945163|FG000|Overall Study|Global/country situation|0|||
126697413|NCT03283085|455843336|FG003|Overall Study|Pregnancy|0|||
126251073|NCT04060251|454209041|FG001|Overall Study|Adverse Event|1|||
126251074|NCT04060251|454209042|FG002|Overall Study|Adverse Event|0|||
126251075|NCT01632306|454209043|FG000|Overall Study|Protocol Violation|1|||
126251076|NCT01632306|454209044|FG001|Overall Study|Protocol Violation|0|||
126251077|NCT01632306|454209045|FG002|Overall Study|Protocol Violation|0|||
126697414|NCT03283085|455843337|FG004|Overall Study|Pregnancy|0|||
126697415|NCT03283085|455843338|FG005|Overall Study|Pregnancy|0|||
126697416|NCT03283085|455843333|FG000|Overall Study|Lack of Efficacy|12|||
126697417|NCT03283085|455843334|FG001|Overall Study|Lack of Efficacy|6|||
126697418|NCT03283085|455843335|FG002|Overall Study|Lack of Efficacy|24|||
126697419|NCT03283085|455843336|FG003|Overall Study|Lack of Efficacy|1|||
126697420|NCT03283085|455843337|FG004|Overall Study|Lack of Efficacy|1|||
126697421|NCT03283085|455843338|FG005|Overall Study|Lack of Efficacy|0|||
126697422|NCT03283085|455843333|FG000|Overall Study|Reason not Specified|0|||
126697423|NCT03283085|455843334|FG001|Overall Study|Reason not Specified|4|||
126697424|NCT03283085|455843335|FG002|Overall Study|Reason not Specified|8|||
126697425|NCT03283085|455843336|FG003|Overall Study|Reason not Specified|0|||
126697426|NCT03283085|455843337|FG004|Overall Study|Reason not Specified|0|||
126697427|NCT03283085|455843338|FG005|Overall Study|Reason not Specified|1|||
126697428|NCT02292771|455843342|FG000|Overall Study|Withdrawal by Subject|2|||
126697429|NCT02292771|455843343|FG001|Overall Study|Withdrawal by Subject|1|||
126697430|NCT02292771|455843342|FG000|Overall Study|Lost to Follow-up|2|||
126697431|NCT02292771|455843343|FG001|Overall Study|Lost to Follow-up|1|||
126251078|NCT00985751|454209048|FG000|Overall Study|Adverse Event|0|||
126251079|NCT00985751|454209049|FG001|Overall Study|Adverse Event|0|||
126251080|NCT00985751|454209050|FG002|Overall Study|Adverse Event|0|||
126251081|NCT00985751|454209051|FG003|Overall Study|Adverse Event|0|||
126251082|NCT00985751|454209052|FG004|Overall Study|Adverse Event|1|||
126251083|NCT00380588|454209053|FG000|Overall Study|Unequivocal Disease Progression|25|||
126251084|NCT00380588|454209054|FG001|Overall Study|Unequivocal Disease Progression|34|||
126251085|NCT00380588|454209053|FG000|Overall Study|Next Cycle Not Started|4|||
126251086|NCT00380588|454209054|FG001|Overall Study|Next Cycle Not Started|0|||
126251087|NCT00380588|454209053|FG000|Overall Study|Adverse Event|7|||
126251088|NCT00380588|454209054|FG001|Overall Study|Adverse Event|3|||
126251089|NCT00380588|454209053|FG000|Overall Study|Withdrawal by Subject|1|||
126697432|NCT04025632|455845201|FG000|Overall Study|Adverse Event|1|||
126697433|NCT04025632|455845202|FG001|Overall Study|Adverse Event|1|||
126697434|NCT04025632|455845201|FG000|Overall Study|Withdrawal by Subject|1|||
126697435|NCT04025632|455845202|FG001|Overall Study|Withdrawal by Subject|1|||
126697436|NCT04025632|455845201|FG000|Overall Study|Study Terminated by Sponsor|10|||
126697437|NCT04025632|455845202|FG001|Overall Study|Study Terminated by Sponsor|9|||
126697438|NCT04025632|455845201|FG000|Overall Study|Physician Decision|3|||
126697439|NCT04025632|455845202|FG001|Overall Study|Physician Decision|1|||
126697440|NCT00127127|455845203|FG000|Overall Study|Adverse Event|0|||
126697441|NCT00127127|455845204|FG001|Overall Study|Adverse Event|2|||
126697442|NCT00127127|455845205|FG002|Overall Study|Adverse Event|0|||
126697443|NCT00127127|455845206|FG003|Overall Study|Adverse Event|1|||
126697444|NCT00127127|455845203|FG000|Overall Study|Lack of Efficacy|1|||
126697445|NCT00127127|455845204|FG001|Overall Study|Lack of Efficacy|3|||
126697446|NCT00127127|455845205|FG002|Overall Study|Lack of Efficacy|0|||
126697447|NCT00127127|455845206|FG003|Overall Study|Lack of Efficacy|2|||
126697448|NCT01524991|455845209|FG000|Overall Study|Adverse Event|12|||
126697449|NCT01524991|455845209|FG000|Overall Study|Death|1|||
126697450|NCT01524991|455845209|FG000|Overall Study|Disease ProgressionDu|17|||
126251090|NCT00380588|454209054|FG001|Overall Study|Withdrawal by Subject|3|||
126251091|NCT00380588|454209053|FG000|Overall Study|Physician Decision|2|||
126251092|NCT00380588|454209054|FG001|Overall Study|Physician Decision|0|||
126251093|NCT03366428|454209059|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
126251094|NCT03366428|454209059|FG000|Overall Study|Adverse Event|12|||
126251095|NCT03366428|454209059|FG000|Overall Study|Clinical progression|2|||
126251096|NCT03366428|454209059|FG000|Overall Study|Withdrawal by Subject|4|||
126251097|NCT01120028|454209064|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
126251098|NCT01120028|454209065|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
126251099|NCT01120028|454209066|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
126251100|NCT01120028|454209067|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
126251101|NCT01120028|454209064|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
126251102|NCT01120028|454209065|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
126251103|NCT01120028|454209066|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
126251104|NCT01120028|454209067|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
126251105|NCT03867760|454209068|FG000|Overall Study|Lost to Follow-up|2|||
126251106|NCT03867760|454209069|FG001|Overall Study|Lost to Follow-up|3|||
126251107|NCT03867760|454209068|FG000|Overall Study|Withdrawal by Subject|1|||
126251108|NCT03867760|454209069|FG001|Overall Study|Withdrawal by Subject|2|||
126251109|NCT03867760|454209068|FG000|Overall Study|subject could not meet study logistics|3|||
126251110|NCT03867760|454209069|FG001|Overall Study|subject could not meet study logistics|3|||
126251111|NCT02286466|454209071|FG000|Overall Study|Death|1|||
126251112|NCT02286466|454209072|FG001|Overall Study|Death|3|||
126251113|NCT02286466|454209071|FG000|Overall Study|Withdrawal by Subject|5|||
126251114|NCT02286466|454209072|FG001|Overall Study|Withdrawal by Subject|2|||
126251115|NCT02286466|454209071|FG000|Overall Study|Lost to Follow-up|1|||
126251116|NCT02286466|454209072|FG001|Overall Study|Lost to Follow-up|4|||
126251117|NCT02286466|454209071|FG000|Overall Study|Declined Clinician Assessment|0|||
126251118|NCT02286466|454209072|FG001|Overall Study|Declined Clinician Assessment|1|||
126251119|NCT01018862|454209081|FG000|Overall Study|Adverse Event|2|||
126251120|NCT01018862|454209082|FG001|Overall Study|Adverse Event|0|||
126251121|NCT01018862|454209083|FG002|Overall Study|Adverse Event|6|||
126251122|NCT01018862|454209081|FG000|Overall Study|Lack of Efficacy|1|||
126251123|NCT01018862|454209082|FG001|Overall Study|Lack of Efficacy|0|||
126251124|NCT01018862|454209083|FG002|Overall Study|Lack of Efficacy|2|||
126251125|NCT01018862|454209081|FG000|Overall Study|Lost to Follow-up|3|||
126697451|NCT01524991|455845209|FG000|Overall Study|Other complicating disease|1|||
126697452|NCT01524991|455845209|FG000|Overall Study|Withdrawal by Subject|2|||
126697453|NCT01524991|455845209|FG000|Overall Study|Symptomatic Deterioration|1|||
126697454|NCT01805180|455845212|FG000|Lead-in Donor Phase|screen failure|1|||
126697455|NCT01805180|455845213|FG001|Lead-in Donor Phase|screen failure|0|||
126697456|NCT01805180|455845214|FG002|Lead-in Donor Phase|screen failure|0|||
126697457|NCT00582556|455845218|FG000|Overall Study|Withdrawal by Subject|0|||
126251126|NCT01018862|454209082|FG001|Overall Study|Lost to Follow-up|1|||
126697458|NCT00582556|455845219|FG001|Overall Study|Withdrawal by Subject|1|||
126251127|NCT01018862|454209083|FG002|Overall Study|Lost to Follow-up|0|||
126251128|NCT01018862|454209081|FG000|Overall Study|Protocol Violation|1|||
126251129|NCT01018862|454209082|FG001|Overall Study|Protocol Violation|3|||
126251130|NCT01018862|454209083|FG002|Overall Study|Protocol Violation|3|||
126251131|NCT01018862|454209081|FG000|Overall Study|Withdrawal by Subject|1|||
126251132|NCT01018862|454209082|FG001|Overall Study|Withdrawal by Subject|2|||
126697459|NCT00582556|455845220|FG002|Overall Study|Withdrawal by Subject|1|||
126697460|NCT00582556|455845218|FG000|Overall Study|Physician Decision|0|||
126251133|NCT01018862|454209083|FG002|Overall Study|Withdrawal by Subject|1|||
126697461|NCT00582556|455845219|FG001|Overall Study|Physician Decision|0|||
126697462|NCT00582556|455845220|FG002|Overall Study|Physician Decision|1|||
126697463|NCT01341457|455845221|FG000|Overall Study|Adverse Event|2|||
126697464|NCT01341457|455845222|FG001|Overall Study|Adverse Event|0|||
126697465|NCT03124459|455845223|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
126697466|NCT03124459|455845224|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
126697467|NCT03124459|455845225|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
126697468|NCT03124459|455845226|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
126697469|NCT03124459|455845227|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
126697470|NCT03124459|455845228|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
126251134|NCT01018862|454209081|FG000|Overall Study|administrative problems|5|||
126251135|NCT01018862|454209082|FG001|Overall Study|administrative problems|4|||
126251136|NCT01018862|454209083|FG002|Overall Study|administrative problems|4|||
126251137|NCT01968031|454209084|FG000|Overall Study|Adverse Event|13|||
126251138|NCT01968031|454209085|FG001|Overall Study|Adverse Event|10|||
126251139|NCT01968031|454209086|FG002|Overall Study|Adverse Event|22|||
126251140|NCT01968031|454209084|FG000|Overall Study|Withdrawal by Subject|3|||
126251141|NCT01968031|454209085|FG001|Overall Study|Withdrawal by Subject|7|||
126251142|NCT01968031|454209086|FG002|Overall Study|Withdrawal by Subject|3|||
126251143|NCT01968031|454209084|FG000|Overall Study|Did not meet entry criteria|1|||
126251144|NCT01968031|454209085|FG001|Overall Study|Did not meet entry criteria|1|||
126251145|NCT01968031|454209086|FG002|Overall Study|Did not meet entry criteria|1|||
126251146|NCT01968031|454209084|FG000|Overall Study|Noncompliance|0|||
126251147|NCT01968031|454209085|FG001|Overall Study|Noncompliance|0|||
126251148|NCT01968031|454209086|FG002|Overall Study|Noncompliance|2|||
126251149|NCT01968031|454209084|FG000|Overall Study|Failed inclusion criteria|0|||
126697471|NCT03124459|455845223|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
126697472|NCT03124459|455845224|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
126762270|NCT04585906|456081201|FG000|Overall Study|Lost to Follow-up|8|||
126762271|NCT04585906|456081202|FG001|Overall Study|Lost to Follow-up|5|||
126762272|NCT00634933|456081207|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
126762273|NCT00634933|456081208|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
126762274|NCT00634933|456081209|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
126762275|NCT00634933|456081210|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
126762276|NCT00634933|456081211|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
126762277|NCT00634933|456081207|FG000|Part A: Baseline to Week 24|Death|1|||
126762278|NCT00634933|456081208|FG001|Part A: Baseline to Week 24|Death|0|||
126762279|NCT00634933|456081209|FG002|Part A: Baseline to Week 24|Death|0|||
126762280|NCT00634933|456081210|FG003|Part A: Baseline to Week 24|Death|0|||
126762281|NCT00634933|456081211|FG004|Part A: Baseline to Week 24|Death|0|||
126762282|NCT00634933|456081207|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
126762283|NCT00634933|456081208|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
126762284|NCT00634933|456081209|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
126762285|NCT00634933|456081210|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
126762286|NCT00634933|456081211|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
126762287|NCT00634933|456081207|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
126762288|NCT00634933|456081208|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
126762289|NCT00634933|456081209|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
126762290|NCT00634933|456081210|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
126762291|NCT00634933|456081211|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
126762292|NCT00634933|456081207|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
126251150|NCT01968031|454209085|FG001|Overall Study|Failed inclusion criteria|2|||
126251151|NCT01968031|454209086|FG002|Overall Study|Failed inclusion criteria|0|||
126251152|NCT01968031|454209084|FG000|Overall Study|Death|0|||
126251153|NCT01968031|454209085|FG001|Overall Study|Death|0|||
126251154|NCT01968031|454209086|FG002|Overall Study|Death|1|||
126251155|NCT01968031|454209084|FG000|Overall Study|Prohibited concomitant medication|1|||
126251156|NCT01968031|454209085|FG001|Overall Study|Prohibited concomitant medication|0|||
126251157|NCT01968031|454209086|FG002|Overall Study|Prohibited concomitant medication|0|||
126697473|NCT03124459|455845225|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
126697474|NCT03124459|455845226|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
126762293|NCT00634933|456081208|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
126762294|NCT00634933|456081209|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
126762295|NCT00634933|456081210|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
126762296|NCT00634933|456081211|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
126762297|NCT00634933|456081207|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
126251158|NCT00840879|454209092|FG000|Second Intervention|Withdrawal by Subject|1|||
126251159|NCT00840879|454209093|FG001|Second Intervention|Withdrawal by Subject|0|||
126251160|NCT01253564|454209096|FG000|Overall Study|Disease Progression|22|||
126251161|NCT01253564|454209096|FG000|Overall Study|Withdrawal by Subject|1|||
126251162|NCT01253564|454209096|FG000|Overall Study|Serious Adverse Event|1|||
126251163|NCT02957331|454209101|FG000|Overall Study|Protocol Violation|1|||
126251164|NCT02957331|454209102|FG001|Overall Study|Protocol Violation|0|||
126251165|NCT03247686|454210634|FG000|Overall Study|Withdrawal by Subject|1|||
126251166|NCT03247686|454210635|FG001|Overall Study|Withdrawal by Subject|2|||
126251167|NCT02583048|454210640|FG000|Overall Study|Withdrawal by Subject|0|||
126251168|NCT02583048|454210641|FG001|Overall Study|Withdrawal by Subject|1|||
126251169|NCT02583048|454210642|FG002|Overall Study|Withdrawal by Subject|0|||
126449076|NCT04643158|454945164|FG001|Overall Study|Global/country situation|0|||
126449077|NCT04643158|454945165|FG002|Overall Study|Global/country situation|1|||
126449078|NCT04643158|454945166|FG003|Overall Study|Global/country situation|0|||
126449079|NCT04643158|454945167|FG004|Overall Study|Global/country situation|0|||
126762298|NCT00634933|456081208|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
126762299|NCT00634933|456081209|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
126762300|NCT00634933|456081210|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
126762301|NCT00634933|456081211|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
126762302|NCT00634933|456081207|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
126762303|NCT00634933|456081208|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
126762304|NCT00634933|456081209|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
126762305|NCT00634933|456081210|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
126762306|NCT00634933|456081211|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
126762307|NCT00634933|456081207|FG000|Part A: Baseline to Week 24|Other|1|||
126762308|NCT00634933|456081208|FG001|Part A: Baseline to Week 24|Other|8|||
126762309|NCT00634933|456081209|FG002|Part A: Baseline to Week 24|Other|5|||
126762310|NCT00634933|456081210|FG003|Part A: Baseline to Week 24|Other|0|||
126762311|NCT00634933|456081211|FG004|Part A: Baseline to Week 24|Other|0|||
126762312|NCT00634933|456081207|FG000|Between Part A and Part B|Physician Decision|0|||
126762313|NCT00634933|456081208|FG001|Between Part A and Part B|Physician Decision|1|||
126762314|NCT00634933|456081209|FG002|Between Part A and Part B|Physician Decision|0|||
126762315|NCT00634933|456081210|FG003|Between Part A and Part B|Physician Decision|0|||
126762316|NCT00634933|456081211|FG004|Between Part A and Part B|Physician Decision|0|||
126762317|NCT00634933|456081207|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
126762318|NCT00634933|456081208|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
126762319|NCT00634933|456081209|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
126762320|NCT00634933|456081210|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
126762321|NCT00634933|456081211|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
126762322|NCT00634933|456081207|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
126762323|NCT00634933|456081208|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
126762324|NCT00634933|456081209|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
126762325|NCT00634933|456081210|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
126762326|NCT00634933|456081211|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
126762327|NCT00634933|456081207|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
126762328|NCT00634933|456081208|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
126762329|NCT00634933|456081209|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
126762330|NCT00634933|456081210|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
126762331|NCT00634933|456081211|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
126762332|NCT00634933|456081207|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
126762333|NCT00634933|456081208|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
126762334|NCT00634933|456081209|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
126762335|NCT00634933|456081210|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
126762336|NCT00634933|456081211|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
126762337|NCT00634933|456081207|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
126762338|NCT00634933|456081208|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
126762339|NCT00634933|456081209|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
126762340|NCT00634933|456081210|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
126762341|NCT00634933|456081211|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
126251170|NCT02583048|454210640|FG000|Overall Study|Failed to meet eligibility criterion|0|||
126251171|NCT02583048|454210641|FG001|Overall Study|Failed to meet eligibility criterion|0|||
126251172|NCT02583048|454210642|FG002|Overall Study|Failed to meet eligibility criterion|1|||
126251173|NCT01151280|454210645|FG000|Overall Study|Adverse Event|1|||
126251174|NCT01151280|454210645|FG000|Overall Study|Lack of Efficacy|3|||
126449080|NCT04643158|454945168|FG005|Overall Study|Global/country situation|0|||
126762342|NCT00634933|456081207|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
126762343|NCT00634933|456081208|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
126762344|NCT00634933|456081209|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
126762345|NCT00634933|456081210|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
126762346|NCT00634933|456081211|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
126762347|NCT00634933|456081207|FG000|Part B: Week 24 to Week 52|Other|0|||
126762348|NCT00634933|456081208|FG001|Part B: Week 24 to Week 52|Other|0|||
126762349|NCT00634933|456081209|FG002|Part B: Week 24 to Week 52|Other|5|||
126762350|NCT00634933|456081210|FG003|Part B: Week 24 to Week 52|Other|0|||
126762351|NCT00634933|456081211|FG004|Part B: Week 24 to Week 52|Other|1|||
126762352|NCT01049360|456081212|FG000|Period 1|Adverse Event|0|||
126762353|NCT01049360|456081213|FG001|Period 1|Adverse Event|1|||
126762354|NCT01049360|456081214|FG002|Period 1|Adverse Event|0|||
126762355|NCT01049360|456081215|FG003|Period 1|Adverse Event|1|||
126762356|NCT01049360|456081216|FG004|Period 1|Adverse Event|0|||
126762357|NCT01049360|456081217|FG005|Period 1|Adverse Event|0|||
126762358|NCT01049360|456081218|FG006|Period 1|Adverse Event|0|||
126762359|NCT01049360|456081219|FG007|Period 1|Adverse Event|1|||
126762360|NCT01049360|456081220|FG008|Period 1|Adverse Event|0|||
126762361|NCT01049360|456081221|FG009|Period 1|Adverse Event|0|||
126762362|NCT01049360|456081222|FG010|Period 1|Adverse Event|0|||
126762363|NCT01049360|456081223|FG011|Period 1|Adverse Event|0|||
126762364|NCT01049360|456081224|FG012|Period 1|Adverse Event|1|||
126762365|NCT01049360|456081225|FG013|Period 1|Adverse Event|1|||
126762366|NCT01049360|456081226|FG014|Period 1|Adverse Event|0|||
126762367|NCT01049360|456081227|FG015|Period 1|Adverse Event|0|||
126762368|NCT01049360|456081228|FG016|Period 1|Adverse Event|1|||
126762369|NCT01049360|456081229|FG017|Period 1|Adverse Event|0|||
126762370|NCT01049360|456081230|FG018|Period 1|Adverse Event|1|||
126762371|NCT01049360|456081231|FG019|Period 1|Adverse Event|0|||
126762372|NCT01049360|456081212|FG000|Period 1|Did not meet inc/exc criteria|0|||
126762373|NCT01049360|456081213|FG001|Period 1|Did not meet inc/exc criteria|0|||
126762374|NCT01049360|456081214|FG002|Period 1|Did not meet inc/exc criteria|0|||
126762375|NCT01049360|456081215|FG003|Period 1|Did not meet inc/exc criteria|0|||
126762376|NCT01049360|456081216|FG004|Period 1|Did not meet inc/exc criteria|0|||
126762377|NCT01049360|456081217|FG005|Period 1|Did not meet inc/exc criteria|0|||
126762378|NCT01049360|456081218|FG006|Period 1|Did not meet inc/exc criteria|0|||
126762379|NCT01049360|456081219|FG007|Period 1|Did not meet inc/exc criteria|1|||
126762380|NCT01049360|456081220|FG008|Period 1|Did not meet inc/exc criteria|1|||
126762381|NCT01049360|456081221|FG009|Period 1|Did not meet inc/exc criteria|0|||
126762382|NCT01049360|456081222|FG010|Period 1|Did not meet inc/exc criteria|0|||
126762383|NCT01049360|456081223|FG011|Period 1|Did not meet inc/exc criteria|0|||
126762384|NCT01049360|456081224|FG012|Period 1|Did not meet inc/exc criteria|0|||
126762385|NCT01049360|456081225|FG013|Period 1|Did not meet inc/exc criteria|0|||
126762386|NCT01049360|456081226|FG014|Period 1|Did not meet inc/exc criteria|0|||
126762387|NCT01049360|456081227|FG015|Period 1|Did not meet inc/exc criteria|0|||
126762388|NCT01049360|456081228|FG016|Period 1|Did not meet inc/exc criteria|0|||
126762389|NCT01049360|456081229|FG017|Period 1|Did not meet inc/exc criteria|0|||
126762390|NCT01049360|456081230|FG018|Period 1|Did not meet inc/exc criteria|0|||
126762391|NCT01049360|456081231|FG019|Period 1|Did not meet inc/exc criteria|0|||
126762392|NCT01049360|456081212|FG000|Period 1|Withdrawal by Subject|0|||
126251175|NCT04408924|454210649|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
126251176|NCT04408924|454210649|FG000|Overall Study|Lost to Follow-up|3|||
126251177|NCT04408924|454210649|FG000|Overall Study|Withdrawal by Subject|5|||
126251178|NCT04408924|454210649|FG000|Overall Study|Sponsor Decision|2|||
126251179|NCT00691704|454210650|FG000|Induction Therapy|Disease Progression|1|||
126251180|NCT00691704|454210650|FG000|Induction Therapy|Active Hepatitis|1|||
126251181|NCT00691704|454210650|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
126251182|NCT00691704|454210650|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
126251183|NCT00691704|454210650|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
126251184|NCT02578641|454210651|FG000|Overall Study|Adverse Event|5|||
126251185|NCT02578641|454210652|FG001|Overall Study|Adverse Event|15|||
126251186|NCT02578641|454210651|FG000|Overall Study|Death|16|||
126251187|NCT02578641|454210652|FG001|Overall Study|Death|8|||
126251188|NCT02578641|454210651|FG000|Overall Study|Lost to Follow-up|0|||
126251189|NCT02578641|454210652|FG001|Overall Study|Lost to Follow-up|1|||
126251190|NCT02578641|454210651|FG000|Overall Study|Withdrawal by Subject|14|||
126251191|NCT02578641|454210652|FG001|Overall Study|Withdrawal by Subject|7|||
126251192|NCT02578641|454210651|FG000|Overall Study|Progressive Disease|69|||
126251193|NCT02578641|454210652|FG001|Overall Study|Progressive Disease|21|||
126251194|NCT02578641|454210651|FG000|Overall Study|No Study Drug|2|||
126762393|NCT01049360|456081213|FG001|Period 1|Withdrawal by Subject|0|||
126762394|NCT01049360|456081214|FG002|Period 1|Withdrawal by Subject|0|||
126762395|NCT01049360|456081215|FG003|Period 1|Withdrawal by Subject|0|||
126762396|NCT01049360|456081216|FG004|Period 1|Withdrawal by Subject|0|||
126762397|NCT01049360|456081217|FG005|Period 1|Withdrawal by Subject|0|||
126762398|NCT01049360|456081218|FG006|Period 1|Withdrawal by Subject|0|||
126762399|NCT01049360|456081219|FG007|Period 1|Withdrawal by Subject|0|||
126762400|NCT01049360|456081220|FG008|Period 1|Withdrawal by Subject|1|||
126762401|NCT01049360|456081221|FG009|Period 1|Withdrawal by Subject|0|||
126762402|NCT01049360|456081222|FG010|Period 1|Withdrawal by Subject|1|||
126762403|NCT01049360|456081223|FG011|Period 1|Withdrawal by Subject|0|||
126762404|NCT01049360|456081224|FG012|Period 1|Withdrawal by Subject|1|||
126251195|NCT02578641|454210652|FG001|Overall Study|No Study Drug|0|||
126762405|NCT01049360|456081225|FG013|Period 1|Withdrawal by Subject|0|||
126762406|NCT01049360|456081226|FG014|Period 1|Withdrawal by Subject|0|||
126697475|NCT03124459|455845227|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
126697476|NCT03124459|455845228|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
126697477|NCT03124459|455845223|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
126697478|NCT03124459|455845224|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
126697479|NCT03124459|455845225|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
126697480|NCT03124459|455845226|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
126697481|NCT03124459|455845227|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
126697482|NCT03124459|455845228|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
126697483|NCT03124459|455845223|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
126697484|NCT03124459|455845224|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
126697485|NCT03124459|455845225|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
126697486|NCT03124459|455845226|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
126697487|NCT03124459|455845227|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
126697488|NCT03124459|455845228|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
126697489|NCT03124459|455845223|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
126697490|NCT03124459|455845224|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
126697491|NCT03124459|455845225|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
126697492|NCT03124459|455845226|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
126697493|NCT03124459|455845227|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
126697494|NCT03124459|455845228|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
126697495|NCT03124459|455845223|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
126697496|NCT03124459|455845224|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
126697497|NCT03124459|455845225|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
126697498|NCT03124459|455845226|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
126697499|NCT03124459|455845227|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
126697500|NCT03124459|455845228|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
126697501|NCT00496366|455845229|FG000|Overall Study|Death|1|||
126697502|NCT01717638|455845230|FG000|Overall Study|Lost to Follow-up|0|||
126697503|NCT01717638|455845231|FG001|Overall Study|Lost to Follow-up|0|||
126697504|NCT01717638|455845232|FG002|Overall Study|Lost to Follow-up|0|||
126697505|NCT01717638|455845233|FG003|Overall Study|Lost to Follow-up|0|||
126697506|NCT01717638|455845234|FG004|Overall Study|Lost to Follow-up|0|||
126697507|NCT01717638|455845235|FG005|Overall Study|Lost to Follow-up|1|||
126697508|NCT01717638|455845236|FG006|Overall Study|Lost to Follow-up|0|||
126697509|NCT01717638|455845237|FG007|Overall Study|Lost to Follow-up|0|||
126697510|NCT01717638|455845238|FG008|Overall Study|Lost to Follow-up|0|||
126762407|NCT01049360|456081227|FG015|Period 1|Withdrawal by Subject|0|||
126251196|NCT02578641|454210651|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
126251197|NCT02578641|454210652|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
126251198|NCT02578641|454210651|FG000|Overall Study|Non-compliance with Study Schedule|1|||
126251199|NCT02578641|454210652|FG001|Overall Study|Non-compliance with Study Schedule|0|||
126251200|NCT02578641|454210651|FG000|Overall Study|Other|1|||
126251201|NCT02578641|454210652|FG001|Overall Study|Other|10|||
126251202|NCT02578641|454210651|FG000|Overall Study|Not treated|1|||
126251203|NCT02578641|454210652|FG001|Overall Study|Not treated|4|||
126251204|NCT02313558|454210653|FG000|Overall Study|Withdrawal by Subject|2|||
126251205|NCT02313558|454210654|FG001|Overall Study|Withdrawal by Subject|0|||
126251206|NCT02313558|454210653|FG000|Overall Study|Lost to Follow-up|4|||
126251207|NCT02313558|454210654|FG001|Overall Study|Lost to Follow-up|4|||
126251208|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
126251209|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
126251210|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
126251211|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
126251212|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
126251213|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
126251214|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
126251215|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
126251216|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
126251217|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
126251218|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
126251219|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
126251220|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
126251221|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
126251222|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
126546384|NCT03556358|455293773|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
126697511|NCT01717638|455845239|FG009|Overall Study|Lost to Follow-up|0|||
126697512|NCT01717638|455845240|FG010|Overall Study|Lost to Follow-up|0|||
126697513|NCT01717638|455845241|FG011|Overall Study|Lost to Follow-up|0|||
126762408|NCT01049360|456081228|FG016|Period 1|Withdrawal by Subject|0|||
126762409|NCT01049360|456081229|FG017|Period 1|Withdrawal by Subject|0|||
126251223|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
126251224|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
126251225|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
126251226|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
126251227|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
126251228|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
126251229|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
126251230|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
126697514|NCT01717638|455845242|FG012|Overall Study|Lost to Follow-up|0|||
126697515|NCT01717638|455845230|FG000|Overall Study|Father in hospital|0|||
126697516|NCT01717638|455845231|FG001|Overall Study|Father in hospital|0|||
126697517|NCT01717638|455845232|FG002|Overall Study|Father in hospital|0|||
126697518|NCT01717638|455845233|FG003|Overall Study|Father in hospital|0|||
126697519|NCT01717638|455845234|FG004|Overall Study|Father in hospital|0|||
126697520|NCT01717638|455845235|FG005|Overall Study|Father in hospital|0|||
126697521|NCT01717638|455845236|FG006|Overall Study|Father in hospital|0|||
126697522|NCT01717638|455845237|FG007|Overall Study|Father in hospital|0|||
126697523|NCT01717638|455845238|FG008|Overall Study|Father in hospital|0|||
126697524|NCT01717638|455845239|FG009|Overall Study|Father in hospital|0|||
126697525|NCT01717638|455845240|FG010|Overall Study|Father in hospital|0|||
126697526|NCT01717638|455845241|FG011|Overall Study|Father in hospital|0|||
126697527|NCT01717638|455845242|FG012|Overall Study|Father in hospital|1|||
126697528|NCT01717638|455845230|FG000|Overall Study|Withdrawal by Subject|0|||
126697529|NCT01717638|455845231|FG001|Overall Study|Withdrawal by Subject|1|||
126697530|NCT01717638|455845232|FG002|Overall Study|Withdrawal by Subject|1|||
126697531|NCT01717638|455845233|FG003|Overall Study|Withdrawal by Subject|0|||
126697532|NCT01717638|455845234|FG004|Overall Study|Withdrawal by Subject|1|||
126697533|NCT01717638|455845235|FG005|Overall Study|Withdrawal by Subject|0|||
126697534|NCT01717638|455845236|FG006|Overall Study|Withdrawal by Subject|2|||
126697535|NCT01717638|455845237|FG007|Overall Study|Withdrawal by Subject|1|||
126697536|NCT01717638|455845238|FG008|Overall Study|Withdrawal by Subject|2|||
126697537|NCT01717638|455845239|FG009|Overall Study|Withdrawal by Subject|1|||
126697538|NCT01717638|455845240|FG010|Overall Study|Withdrawal by Subject|0|||
126697539|NCT01717638|455845241|FG011|Overall Study|Withdrawal by Subject|0|||
126697540|NCT01717638|455845242|FG012|Overall Study|Withdrawal by Subject|18|||
126697541|NCT05211336|455845247|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
126449081|NCT04643158|454945169|FG006|Overall Study|Global/country situation|0|||
126449082|NCT04643158|454945163|FG000|Overall Study|Withdrawal by Subject|0|||
126449083|NCT04643158|454945164|FG001|Overall Study|Withdrawal by Subject|0|||
126449084|NCT04643158|454945165|FG002|Overall Study|Withdrawal by Subject|0|||
126449085|NCT04643158|454945166|FG003|Overall Study|Withdrawal by Subject|0|||
126697542|NCT05211336|455845248|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
126251231|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
126251232|NCT01710358|454210656|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
126251233|NCT01710358|454210657|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
126251234|NCT01710358|454210658|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
126251235|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
126251236|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
126251237|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
126251238|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
126251239|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
126251240|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
126251241|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
126251242|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
126251243|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
126251244|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
126251245|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
126251246|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
126251247|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
126251248|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
126251249|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
126251250|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
126251251|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
126697543|NCT05211336|455845247|FG000|Overall Study|Progressive disease|0|||
126697544|NCT05211336|455845248|FG001|Overall Study|Progressive disease|4|||
126697545|NCT05211336|455845247|FG000|Overall Study|Death due to myocardial infarction|0|||
126697546|NCT05211336|455845248|FG001|Overall Study|Death due to myocardial infarction|1|||
126697547|NCT05211336|455845247|FG000|Overall Study|Death due to unknown cause|0|||
126697548|NCT05211336|455845248|FG001|Overall Study|Death due to unknown cause|1|||
126449086|NCT04643158|454945167|FG004|Overall Study|Withdrawal by Subject|0|||
126251252|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
126251253|NCT01710358|454210656|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
126251254|NCT01710358|454210657|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
126251255|NCT01710358|454210658|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
126251256|NCT01710358|454210656|FG000|Rescue Period|Adverse Event|0|||
126251257|NCT01710358|454210657|FG001|Rescue Period|Adverse Event|15|||
126251258|NCT01710358|454210658|FG002|Rescue Period|Adverse Event|0|||
126251259|NCT01710358|454210656|FG000|Rescue Period|Death|0|||
126251260|NCT01710358|454210657|FG001|Rescue Period|Death|1|||
126251261|NCT01710358|454210658|FG002|Rescue Period|Death|0|||
126251262|NCT01710358|454210656|FG000|Rescue Period|Lack of Efficacy|0|||
126251263|NCT01710358|454210657|FG001|Rescue Period|Lack of Efficacy|7|||
126251264|NCT01710358|454210658|FG002|Rescue Period|Lack of Efficacy|0|||
126251265|NCT01710358|454210656|FG000|Rescue Period|Withdrawal by Subject|0|||
126251266|NCT01710358|454210657|FG001|Rescue Period|Withdrawal by Subject|8|||
126251267|NCT01710358|454210658|FG002|Rescue Period|Withdrawal by Subject|0|||
126251268|NCT00084864|454210661|FG000|Overall Study|Adverse Event|1|||
126251269|NCT00084864|454210662|FG001|Overall Study|Adverse Event|0|||
126251270|NCT00084864|454210663|FG002|Overall Study|Adverse Event|0|||
126251271|NCT00084864|454210664|FG003|Overall Study|Adverse Event|0|||
126251272|NCT01741545|454210665|FG000|Treatment Period|Lack of Efficacy|0|||
126251273|NCT01741545|454210666|FG001|Treatment Period|Lack of Efficacy|1|||
126251274|NCT01741545|454210665|FG000|Treatment Period|Adverse event, non-fatal|1|||
126251275|NCT01741545|454210666|FG001|Treatment Period|Adverse event, non-fatal|3|||
126251276|NCT01741545|454210665|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
126251277|NCT01741545|454210666|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
126251278|NCT01741545|454210665|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
126251279|NCT01741545|454210666|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
126251280|NCT01456962|454210667|FG000|Overall Study|Lost to Follow-up|2|||
126251281|NCT01456962|454210668|FG001|Overall Study|Lost to Follow-up|1|||
126251282|NCT03358147|454210677|FG000|Overall Study|Withdrawal by Subject|13|||
126251283|NCT03358147|454210678|FG001|Overall Study|Withdrawal by Subject|19|||
126251284|NCT03358147|454210679|FG002|Overall Study|Withdrawal by Subject|16|||
126251285|NCT03358147|454210680|FG003|Overall Study|Withdrawal by Subject|10|||
126251286|NCT03358147|454210681|FG004|Overall Study|Withdrawal by Subject|5|||
126251287|NCT03358147|454210677|FG000|Overall Study|Adverse Event|3|||
126251288|NCT03358147|454210678|FG001|Overall Study|Adverse Event|9|||
126251289|NCT03358147|454210679|FG002|Overall Study|Adverse Event|7|||
126251290|NCT03358147|454210680|FG003|Overall Study|Adverse Event|5|||
126251291|NCT03358147|454210681|FG004|Overall Study|Adverse Event|2|||
126251292|NCT03358147|454210677|FG000|Overall Study|Lost to Follow-up|4|||
126251293|NCT03358147|454210678|FG001|Overall Study|Lost to Follow-up|3|||
126251294|NCT03358147|454210679|FG002|Overall Study|Lost to Follow-up|7|||
126251295|NCT03358147|454210680|FG003|Overall Study|Lost to Follow-up|6|||
126251296|NCT03358147|454210681|FG004|Overall Study|Lost to Follow-up|4|||
126251297|NCT03358147|454210677|FG000|Overall Study|Major Protocol Deviation|11|||
126251298|NCT03358147|454210678|FG001|Overall Study|Major Protocol Deviation|3|||
126251299|NCT03358147|454210679|FG002|Overall Study|Major Protocol Deviation|2|||
126251300|NCT03358147|454210680|FG003|Overall Study|Major Protocol Deviation|3|||
126251301|NCT03358147|454210681|FG004|Overall Study|Major Protocol Deviation|1|||
126251302|NCT03358147|454210677|FG000|Overall Study|Protocol specified criteria|2|||
126251303|NCT03358147|454210678|FG001|Overall Study|Protocol specified criteria|3|||
126251304|NCT03358147|454210679|FG002|Overall Study|Protocol specified criteria|0|||
126251305|NCT03358147|454210680|FG003|Overall Study|Protocol specified criteria|3|||
126251306|NCT03358147|454210681|FG004|Overall Study|Protocol specified criteria|1|||
126251307|NCT03358147|454210677|FG000|Overall Study|Physician Decision|1|||
126251308|NCT03358147|454210678|FG001|Overall Study|Physician Decision|0|||
126251309|NCT03358147|454210679|FG002|Overall Study|Physician Decision|1|||
126251310|NCT03358147|454210680|FG003|Overall Study|Physician Decision|6|||
126251311|NCT03358147|454210681|FG004|Overall Study|Physician Decision|1|||
126251312|NCT03358147|454210677|FG000|Overall Study|Administrative reasons|0|||
126251313|NCT03358147|454210678|FG001|Overall Study|Administrative reasons|1|||
126251314|NCT03358147|454210679|FG002|Overall Study|Administrative reasons|0|||
126251315|NCT03358147|454210680|FG003|Overall Study|Administrative reasons|3|||
126251316|NCT03358147|454210681|FG004|Overall Study|Administrative reasons|0|||
126251317|NCT03358147|454210677|FG000|Overall Study|Lack of Efficacy|0|||
126251318|NCT03358147|454210678|FG001|Overall Study|Lack of Efficacy|1|||
126251319|NCT03358147|454210679|FG002|Overall Study|Lack of Efficacy|1|||
126251320|NCT03358147|454210680|FG003|Overall Study|Lack of Efficacy|0|||
126251321|NCT03358147|454210681|FG004|Overall Study|Lack of Efficacy|0|||
126251322|NCT02704091|454210682|FG000|Overall Study|Adverse Event|4|||
126251323|NCT02704091|454210683|FG001|Overall Study|Adverse Event|3|||
126251324|NCT02704091|454210682|FG000|Overall Study|Protocol Violation|5|||
126251325|NCT02704091|454210683|FG001|Overall Study|Protocol Violation|3|||
126251326|NCT02704091|454210682|FG000|Overall Study|Consent withdrawn|4|||
126546385|NCT02917941|455293777|FG000|Treatment Period|Adverse Event|11|||
126251327|NCT02704091|454210683|FG001|Overall Study|Consent withdrawn|4|||
126251328|NCT02704091|454210682|FG000|Overall Study|Lost to Follow-up|13|||
126697549|NCT05211336|455845247|FG000|Overall Study|Worsening kidney function and quality of response|0|||
126697550|NCT05211336|455845248|FG001|Overall Study|Worsening kidney function and quality of response|1|||
126697551|NCT03575104|455845250|FG000|Overall Study|Adverse Event|4|||
126697552|NCT03575104|455845251|FG001|Overall Study|Adverse Event|3|||
126251329|NCT02704091|454210683|FG001|Overall Study|Lost to Follow-up|5|||
126251330|NCT02704091|454210682|FG000|Overall Study|Other|2|||
126251331|NCT02704091|454210683|FG001|Overall Study|Other|8|||
126251332|NCT03073798|454210684|FG000|Overall Study|Adverse Event|1|||
126251333|NCT03073798|454210684|FG000|Overall Study|Withdrawal by Subject|1|||
126251334|NCT01186458|454210688|FG000|Overall Study|Adverse Event|1|||
126449087|NCT04643158|454945168|FG005|Overall Study|Withdrawal by Subject|1|||
126449088|NCT04643158|454945169|FG006|Overall Study|Withdrawal by Subject|0|||
126449089|NCT04540198|454945170|FG000|Overall Study|Lost to Follow-up|25|||
126449090|NCT04540198|454945171|FG001|Overall Study|Lost to Follow-up|23|||
126449091|NCT04540198|454945170|FG000|Overall Study|Withdrawal by Subject|15|||
126449092|NCT04540198|454945171|FG001|Overall Study|Withdrawal by Subject|9|||
126449093|NCT04540198|454945170|FG000|Overall Study|Discontinued|1|||
126449094|NCT04540198|454945171|FG001|Overall Study|Discontinued|0|||
126449095|NCT02888119|454945172|FG000|Overall Study|Lost to Follow-up|5|||
126449096|NCT02888119|454945173|FG001|Overall Study|Lost to Follow-up|4|||
126449097|NCT02888119|454945174|FG002|Overall Study|Lost to Follow-up|0|||
126449098|NCT05573386|454945175|FG000|Overall Study|Withdrawal by Subject|3|||
126449099|NCT05573386|454945176|FG001|Overall Study|Withdrawal by Subject|2|||
126449100|NCT03646123|454945177|FG000|Overall Study|Withdrawal by Subject|2|||
126449101|NCT03646123|454945178|FG001|Overall Study|Withdrawal by Subject|2|||
126449102|NCT03646123|454945179|FG002|Overall Study|Withdrawal by Subject|3|||
126449103|NCT03646123|454945177|FG000|Overall Study|Study termination by sponsor|0|||
126449104|NCT03646123|454945178|FG001|Overall Study|Study termination by sponsor|45|||
126697553|NCT03575104|455845252|FG002|Overall Study|Adverse Event|4|||
126697554|NCT03575104|455845250|FG000|Overall Study|Withdrawal by Subject|13|||
126449105|NCT03646123|454945179|FG002|Overall Study|Study termination by sponsor|139|||
126449106|NCT03646123|454945177|FG000|Overall Study|Lost to Follow-up|4|||
126697555|NCT03575104|455845251|FG001|Overall Study|Withdrawal by Subject|16|||
126697556|NCT03575104|455845252|FG002|Overall Study|Withdrawal by Subject|11|||
126697557|NCT03575104|455845250|FG000|Overall Study|Other reasons|6|||
126697558|NCT03575104|455845251|FG001|Overall Study|Other reasons|8|||
126697559|NCT03575104|455845252|FG002|Overall Study|Other reasons|6|||
126697560|NCT03575104|455845250|FG000|Overall Study|Lost to Follow-up|1|||
126697561|NCT03575104|455845251|FG001|Overall Study|Lost to Follow-up|2|||
126697562|NCT03575104|455845252|FG002|Overall Study|Lost to Follow-up|1|||
126697563|NCT00501228|455845256|FG000|Overall Study|Withdrawal by Subject|1|||
126697564|NCT00331006|455845257|FG000|Screening Phase|Withdrawal by Subject|1|||
126697565|NCT00331006|455845257|FG000|Screening Phase|enrollment halted|1|||
126697566|NCT00331006|455845257|FG000|Screening Phase|Lost to Follow-up|1|||
126697567|NCT00331006|455845257|FG000|Screening Phase|Ineligible for treatment phase|4|||
126697568|NCT00331006|455845257|FG000|Treatment Phase|Withdrawal by Subject|1|||
126762410|NCT01049360|456081230|FG018|Period 1|Withdrawal by Subject|0|||
126449107|NCT03646123|454945178|FG001|Overall Study|Lost to Follow-up|10|||
126449108|NCT03646123|454945179|FG002|Overall Study|Lost to Follow-up|10|||
126449109|NCT03646123|454945177|FG000|Overall Study|Death|2|||
126449110|NCT03646123|454945178|FG001|Overall Study|Death|1|||
126449111|NCT03646123|454945179|FG002|Overall Study|Death|1|||
126449112|NCT03646123|454945177|FG000|Overall Study|Other|2|||
126449113|NCT03646123|454945178|FG001|Overall Study|Other|0|||
126449114|NCT03646123|454945179|FG002|Overall Study|Other|2|||
126449115|NCT04195893|454945188|FG000|Second Intervention|Withdrawal by Subject|1|||
126449116|NCT04195893|454945189|FG001|Second Intervention|Withdrawal by Subject|0|||
126449117|NCT01802073|454945194|FG000|Overall Study|Lost to Follow-up|0|||
126449118|NCT01802073|454945195|FG001|Overall Study|Lost to Follow-up|1|||
126449119|NCT01802073|454945194|FG000|Overall Study|Non-compliant|4|||
126697569|NCT00331006|455845257|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
126697570|NCT00331006|455845257|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
126697571|NCT03804684|455845258|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
126251335|NCT02426918|454210695|FG000|Overall Study|Adverse Event|2|||
126251336|NCT02426918|454210696|FG001|Overall Study|Adverse Event|2|||
126251337|NCT02426918|454210697|FG002|Overall Study|Adverse Event|0|||
126251338|NCT02426918|454210695|FG000|Overall Study|Physician Decision|1|||
126697572|NCT03804684|455845259|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
126697573|NCT01756274|455845264|FG000|Overall Study|Protocol Violation|2|||
126251339|NCT02426918|454210696|FG001|Overall Study|Physician Decision|1|||
126251340|NCT02426918|454210697|FG002|Overall Study|Physician Decision|1|||
126251341|NCT02426918|454210695|FG000|Overall Study|Withdrawal by Subject|5|||
126449120|NCT01802073|454945195|FG001|Overall Study|Non-compliant|2|||
126449121|NCT01802073|454945194|FG000|Overall Study|Withdrawal by Subject|1|||
126251342|NCT02426918|454210696|FG001|Overall Study|Withdrawal by Subject|5|||
126449122|NCT01802073|454945195|FG001|Overall Study|Withdrawal by Subject|1|||
126449123|NCT01802073|454945194|FG000|Overall Study|Physician Decision|0|||
126251343|NCT02426918|454210697|FG002|Overall Study|Withdrawal by Subject|4|||
126251344|NCT02426918|454210695|FG000|Overall Study|Other|9|||
126251345|NCT02426918|454210696|FG001|Overall Study|Other|11|||
126251346|NCT02426918|454210697|FG002|Overall Study|Other|9|||
126251347|NCT01496118|454210698|FG000|Overall Study|Disease progression|3|||
126251348|NCT01496118|454210699|FG001|Overall Study|Disease progression|2|||
126251349|NCT01496118|454210700|FG002|Overall Study|Disease progression|3|||
126251350|NCT01496118|454210701|FG003|Overall Study|Disease progression|1|||
126762411|NCT01049360|456081231|FG019|Period 1|Withdrawal by Subject|0|||
126762412|NCT01049360|456081212|FG000|Period 2|Protocol Violation|0|||
126762413|NCT01049360|456081213|FG001|Period 2|Protocol Violation|0|||
126762414|NCT01049360|456081214|FG002|Period 2|Protocol Violation|0|||
126762415|NCT01049360|456081215|FG003|Period 2|Protocol Violation|1|||
126762416|NCT01049360|456081216|FG004|Period 2|Protocol Violation|0|||
126762417|NCT01049360|456081217|FG005|Period 2|Protocol Violation|0|||
126762418|NCT01049360|456081218|FG006|Period 2|Protocol Violation|0|||
126762419|NCT01049360|456081219|FG007|Period 2|Protocol Violation|0|||
126762420|NCT01049360|456081220|FG008|Period 2|Protocol Violation|0|||
126762421|NCT01049360|456081221|FG009|Period 2|Protocol Violation|0|||
126762422|NCT01049360|456081222|FG010|Period 2|Protocol Violation|0|||
126762423|NCT01049360|456081223|FG011|Period 2|Protocol Violation|0|||
126762424|NCT01049360|456081224|FG012|Period 2|Protocol Violation|0|||
126762425|NCT01049360|456081225|FG013|Period 2|Protocol Violation|0|||
126762426|NCT01049360|456081226|FG014|Period 2|Protocol Violation|1|||
126762427|NCT01049360|456081227|FG015|Period 2|Protocol Violation|1|||
126762428|NCT01049360|456081228|FG016|Period 2|Protocol Violation|0|||
126762429|NCT01049360|456081229|FG017|Period 2|Protocol Violation|0|||
126762430|NCT01049360|456081230|FG018|Period 2|Protocol Violation|0|||
126762431|NCT01049360|456081231|FG019|Period 2|Protocol Violation|0|||
126762432|NCT01049360|456081212|FG000|Period 2|Adverse Event|0|||
126762433|NCT01049360|456081213|FG001|Period 2|Adverse Event|1|||
126762434|NCT01049360|456081214|FG002|Period 2|Adverse Event|0|||
126762435|NCT01049360|456081215|FG003|Period 2|Adverse Event|0|||
126762436|NCT01049360|456081216|FG004|Period 2|Adverse Event|0|||
126762437|NCT01049360|456081217|FG005|Period 2|Adverse Event|0|||
126762438|NCT01049360|456081218|FG006|Period 2|Adverse Event|0|||
126762439|NCT01049360|456081219|FG007|Period 2|Adverse Event|0|||
126762440|NCT01049360|456081220|FG008|Period 2|Adverse Event|1|||
126762441|NCT01049360|456081221|FG009|Period 2|Adverse Event|0|||
126762442|NCT01049360|456081222|FG010|Period 2|Adverse Event|0|||
126762443|NCT01049360|456081223|FG011|Period 2|Adverse Event|0|||
126762444|NCT01049360|456081224|FG012|Period 2|Adverse Event|0|||
126762445|NCT01049360|456081225|FG013|Period 2|Adverse Event|0|||
126762446|NCT01049360|456081226|FG014|Period 2|Adverse Event|0|||
126762447|NCT01049360|456081227|FG015|Period 2|Adverse Event|0|||
126762448|NCT01049360|456081228|FG016|Period 2|Adverse Event|0|||
126762449|NCT01049360|456081229|FG017|Period 2|Adverse Event|0|||
126762450|NCT01049360|456081230|FG018|Period 2|Adverse Event|0|||
126762451|NCT01049360|456081231|FG019|Period 2|Adverse Event|1|||
126762452|NCT01049360|456081212|FG000|Period 2|Withdrawal by Subject|0|||
126762453|NCT01049360|456081213|FG001|Period 2|Withdrawal by Subject|0|||
126762454|NCT01049360|456081214|FG002|Period 2|Withdrawal by Subject|0|||
126762455|NCT01049360|456081215|FG003|Period 2|Withdrawal by Subject|1|||
126762456|NCT01049360|456081216|FG004|Period 2|Withdrawal by Subject|0|||
126762457|NCT01049360|456081217|FG005|Period 2|Withdrawal by Subject|0|||
126762458|NCT01049360|456081218|FG006|Period 2|Withdrawal by Subject|0|||
126762459|NCT01049360|456081219|FG007|Period 2|Withdrawal by Subject|0|||
126762460|NCT01049360|456081220|FG008|Period 2|Withdrawal by Subject|0|||
126762461|NCT01049360|456081221|FG009|Period 2|Withdrawal by Subject|0|||
126762462|NCT01049360|456081222|FG010|Period 2|Withdrawal by Subject|0|||
126762463|NCT01049360|456081223|FG011|Period 2|Withdrawal by Subject|0|||
126762464|NCT01049360|456081224|FG012|Period 2|Withdrawal by Subject|0|||
126762465|NCT01049360|456081225|FG013|Period 2|Withdrawal by Subject|0|||
126762466|NCT01049360|456081226|FG014|Period 2|Withdrawal by Subject|1|||
126762467|NCT01049360|456081227|FG015|Period 2|Withdrawal by Subject|0|||
126762468|NCT01049360|456081228|FG016|Period 2|Withdrawal by Subject|0|||
126762469|NCT01049360|456081229|FG017|Period 2|Withdrawal by Subject|0|||
126251351|NCT01496118|454210702|FG004|Overall Study|Disease progression|2|||
126251352|NCT01496118|454210703|FG005|Overall Study|Disease progression|2|||
126251353|NCT01496118|454210704|FG006|Overall Study|Disease progression|14|||
126762470|NCT01049360|456081230|FG018|Period 2|Withdrawal by Subject|0|||
126762471|NCT01049360|456081231|FG019|Period 2|Withdrawal by Subject|1|||
126762472|NCT01049360|456081212|FG000|Period 2|Lack of Efficacy|0|||
126762473|NCT01049360|456081213|FG001|Period 2|Lack of Efficacy|0|||
126762474|NCT01049360|456081214|FG002|Period 2|Lack of Efficacy|0|||
126762475|NCT01049360|456081215|FG003|Period 2|Lack of Efficacy|0|||
126762476|NCT01049360|456081216|FG004|Period 2|Lack of Efficacy|0|||
126762477|NCT01049360|456081217|FG005|Period 2|Lack of Efficacy|1|||
126762478|NCT01049360|456081218|FG006|Period 2|Lack of Efficacy|0|||
126762479|NCT01049360|456081219|FG007|Period 2|Lack of Efficacy|0|||
126762480|NCT01049360|456081220|FG008|Period 2|Lack of Efficacy|0|||
126762481|NCT01049360|456081221|FG009|Period 2|Lack of Efficacy|0|||
126762482|NCT01049360|456081222|FG010|Period 2|Lack of Efficacy|0|||
126762483|NCT01049360|456081223|FG011|Period 2|Lack of Efficacy|0|||
126251354|NCT01496118|454210705|FG007|Overall Study|Disease progression|10|||
126251355|NCT01496118|454210698|FG000|Overall Study|Physician Decision|0|||
126251356|NCT01496118|454210699|FG001|Overall Study|Physician Decision|0|||
126251357|NCT01496118|454210700|FG002|Overall Study|Physician Decision|0|||
126251358|NCT01496118|454210701|FG003|Overall Study|Physician Decision|0|||
126251359|NCT01496118|454210702|FG004|Overall Study|Physician Decision|1|||
126251360|NCT01496118|454210703|FG005|Overall Study|Physician Decision|0|||
126449124|NCT01802073|454945195|FG001|Overall Study|Physician Decision|7|||
126449125|NCT02123472|454945199|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
126449126|NCT02123472|454945200|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
126449127|NCT00918736|454945201|FG000|Overall Study|Withdrawal by Subject|4|||
126449128|NCT01474018|454945202|FG000|Overall Study|Lost to Follow-up|0|||
126449129|NCT01474018|454945203|FG001|Overall Study|Lost to Follow-up|1|||
126449130|NCT01474018|454945202|FG000|Overall Study|Withdrawal by Subject|0|||
126449131|NCT01474018|454945203|FG001|Overall Study|Withdrawal by Subject|2|||
126449132|NCT01137604|454945204|FG000|Overall Study|Adverse Event|3|||
126449133|NCT01137604|454945205|FG001|Overall Study|Adverse Event|6|||
126449134|NCT01137604|454945206|FG002|Overall Study|Adverse Event|9|||
126449135|NCT01137604|454945207|FG003|Overall Study|Adverse Event|9|||
126449136|NCT01137604|454945204|FG000|Overall Study|Participant Choice|0|||
126449137|NCT01137604|454945205|FG001|Overall Study|Participant Choice|2|||
126449138|NCT01137604|454945206|FG002|Overall Study|Participant Choice|2|||
126449139|NCT01137604|454945207|FG003|Overall Study|Participant Choice|0|||
126449140|NCT01137604|454945204|FG000|Overall Study|Withdrawal of consent|0|||
126449141|NCT01137604|454945205|FG001|Overall Study|Withdrawal of consent|0|||
126449142|NCT01137604|454945206|FG002|Overall Study|Withdrawal of consent|0|||
126449143|NCT01137604|454945207|FG003|Overall Study|Withdrawal of consent|2|||
126449144|NCT01137604|454945204|FG000|Overall Study|Clinical progression/deterioration|1|||
126449145|NCT01137604|454945205|FG001|Overall Study|Clinical progression/deterioration|2|||
126449146|NCT01137604|454945206|FG002|Overall Study|Clinical progression/deterioration|2|||
126449147|NCT01137604|454945207|FG003|Overall Study|Clinical progression/deterioration|0|||
126449148|NCT03462511|454945211|FG000|Overall Study|Withdrawal by Subject|2|||
126449149|NCT03462511|454945212|FG001|Overall Study|Withdrawal by Subject|3|||
126449150|NCT02925416|454945213|FG000|Overall Study|Adverse Event|2|||
126449151|NCT02925416|454945214|FG001|Overall Study|Adverse Event|0|||
126449152|NCT03595228|454945215|FG000|Overall Study|Death|2|||
126697574|NCT01756274|455845264|FG000|Overall Study|Laboratory error|1|||
126697575|NCT01147926|455845265|FG000|Overall Study|Subject Withdrew Consent|9|||
126697576|NCT01147926|455845266|FG001|Overall Study|Subject Withdrew Consent|10|||
126697577|NCT01147926|455845265|FG000|Overall Study|Adverse Event|7|||
126697578|NCT01147926|455845266|FG001|Overall Study|Adverse Event|6|||
126697579|NCT01147926|455845265|FG000|Overall Study|Subject Non-Compliant|5|||
126697580|NCT01147926|455845266|FG001|Overall Study|Subject Non-Compliant|4|||
126697581|NCT01147926|455845265|FG000|Overall Study|Principal investigator left hospital|1|||
126697582|NCT01147926|455845266|FG001|Overall Study|Principal investigator left hospital|3|||
126697583|NCT01147926|455845265|FG000|Overall Study|Selection criteria not met|3|||
126697584|NCT01147926|455845266|FG001|Overall Study|Selection criteria not met|1|||
126697585|NCT01147926|455845265|FG000|Overall Study|Lost to Follow-up|0|||
126697586|NCT01147926|455845266|FG001|Overall Study|Lost to Follow-up|2|||
126697587|NCT01147926|455845265|FG000|Overall Study|Sponsor's Decision|0|||
126697588|NCT01147926|455845266|FG001|Overall Study|Sponsor's Decision|1|||
126697589|NCT01147926|455845265|FG000|Overall Study|Lack of Efficacy|1|||
126697590|NCT01147926|455845266|FG001|Overall Study|Lack of Efficacy|0|||
126697591|NCT01147926|455845265|FG000|Overall Study|Too busy, no time for study|1|||
126697592|NCT01147926|455845266|FG001|Overall Study|Too busy, no time for study|0|||
126697593|NCT01147926|455845265|FG000|Overall Study|Went on holiday|0|||
126697594|NCT01147926|455845266|FG001|Overall Study|Went on holiday|1|||
126697595|NCT01147926|455845265|FG000|Overall Study|Colonoscopy result|0|||
126697596|NCT01147926|455845266|FG001|Overall Study|Colonoscopy result|1|||
126697597|NCT03417440|455845270|FG000|Overall Study|Lost to Follow-up|0|||
126697598|NCT03417440|455845271|FG001|Overall Study|Lost to Follow-up|1|||
126697599|NCT03417440|455845272|FG002|Overall Study|Lost to Follow-up|0|||
126697600|NCT03417440|455845273|FG003|Overall Study|Lost to Follow-up|0|||
126697601|NCT03417440|455845274|FG004|Overall Study|Lost to Follow-up|1|||
126697602|NCT03417440|455845275|FG005|Overall Study|Lost to Follow-up|0|||
126697603|NCT03417440|455845276|FG006|Overall Study|Lost to Follow-up|0|||
126697604|NCT03417440|455845277|FG007|Overall Study|Lost to Follow-up|0|||
126697605|NCT03417440|455845270|FG000|Overall Study|Withdrawal by Subject|2|||
126697606|NCT03417440|455845271|FG001|Overall Study|Withdrawal by Subject|0|||
126697607|NCT03417440|455845272|FG002|Overall Study|Withdrawal by Subject|2|||
126697608|NCT03417440|455845273|FG003|Overall Study|Withdrawal by Subject|1|||
126697609|NCT03417440|455845274|FG004|Overall Study|Withdrawal by Subject|1|||
126251361|NCT01496118|454210704|FG006|Overall Study|Physician Decision|3|||
126251362|NCT01496118|454210705|FG007|Overall Study|Physician Decision|6|||
126449153|NCT03595228|454945215|FG000|Overall Study|Lack of Efficacy|13|||
126449154|NCT03595228|454945215|FG000|Overall Study|Withdrawal by Subject|3|||
126697610|NCT03417440|455845275|FG005|Overall Study|Withdrawal by Subject|0|||
126697611|NCT03417440|455845276|FG006|Overall Study|Withdrawal by Subject|0|||
126697612|NCT03417440|455845277|FG007|Overall Study|Withdrawal by Subject|1|||
126697613|NCT03304522|455845280|FG000|Overall Study|Adverse Event|0|||
126697614|NCT03304522|455845281|FG001|Overall Study|Adverse Event|4|||
126697615|NCT03304522|455845280|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
126697616|NCT03304522|455845281|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
126697617|NCT03304522|455845280|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
126697618|NCT03304522|455845281|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
126697619|NCT03304522|455845280|FG000|Overall Study|Other|0|||
126697620|NCT03304522|455845281|FG001|Overall Study|Other|1|||
126697621|NCT00486603|455845284|FG000|Overall Study|Withdrawal by Subject|1|||
126697622|NCT00486603|455845285|FG001|Overall Study|Withdrawal by Subject|0|||
126697623|NCT00486603|455845286|FG002|Overall Study|Withdrawal by Subject|0|||
126251363|NCT01496118|454210698|FG000|Overall Study|Adverse Event|1|||
126251364|NCT01496118|454210699|FG001|Overall Study|Adverse Event|1|||
126251365|NCT01496118|454210700|FG002|Overall Study|Adverse Event|0|||
126251366|NCT01496118|454210701|FG003|Overall Study|Adverse Event|0|||
126251367|NCT01496118|454210702|FG004|Overall Study|Adverse Event|0|||
126251368|NCT01496118|454210703|FG005|Overall Study|Adverse Event|0|||
126251369|NCT01496118|454210704|FG006|Overall Study|Adverse Event|6|||
126251370|NCT01496118|454210705|FG007|Overall Study|Adverse Event|10|||
126251371|NCT01496118|454210698|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251372|NCT01496118|454210699|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251373|NCT01496118|454210700|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251374|NCT01496118|454210701|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251375|NCT01496118|454210702|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251376|NCT01496118|454210703|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251377|NCT01496118|454210704|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
126251378|NCT01496118|454210705|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
126251379|NCT01496118|454210698|FG000|Overall Study|Death|0|||
126251380|NCT01496118|454210699|FG001|Overall Study|Death|0|||
126251381|NCT01496118|454210700|FG002|Overall Study|Death|0|||
126251382|NCT01496118|454210701|FG003|Overall Study|Death|0|||
126251383|NCT01496118|454210702|FG004|Overall Study|Death|0|||
126251384|NCT01496118|454210703|FG005|Overall Study|Death|0|||
126251385|NCT01496118|454210704|FG006|Overall Study|Death|1|||
126251386|NCT01496118|454210705|FG007|Overall Study|Death|1|||
126251387|NCT01496118|454210698|FG000|Overall Study|Withdrawal by Subject|0|||
126251388|NCT01496118|454210699|FG001|Overall Study|Withdrawal by Subject|0|||
126251389|NCT01496118|454210700|FG002|Overall Study|Withdrawal by Subject|0|||
126251390|NCT01496118|454210701|FG003|Overall Study|Withdrawal by Subject|2|||
126251391|NCT01496118|454210702|FG004|Overall Study|Withdrawal by Subject|0|||
126251392|NCT01496118|454210703|FG005|Overall Study|Withdrawal by Subject|1|||
126251393|NCT01496118|454210704|FG006|Overall Study|Withdrawal by Subject|6|||
126251394|NCT01496118|454210705|FG007|Overall Study|Withdrawal by Subject|3|||
126251395|NCT02845336|454210706|FG000|Overall Study|Lost to Follow-up|3|||
126251396|NCT02845336|454210707|FG001|Overall Study|Lost to Follow-up|1|||
126251397|NCT02845336|454210706|FG000|Overall Study|Inability to get medication|2|||
126251398|NCT02845336|454210707|FG001|Overall Study|Inability to get medication|0|||
126251399|NCT02420353|454210714|FG000|Overall Study|Withdrawal by Subject|0|||
126251400|NCT02420353|454210715|FG001|Overall Study|Withdrawal by Subject|1|||
126251401|NCT04608448|454210716|FG000|Overall Study|Withdrawal by Subject|1|||
126251402|NCT04608448|454210716|FG000|Overall Study|Adverse Event|1|||
126251403|NCT01149057|454210717|FG000|Overall Study|Lack of Efficacy|16|||
126251404|NCT01149057|454210717|FG000|Overall Study|Adverse Event|13|||
126251405|NCT01149057|454210717|FG000|Overall Study|Withdrawal by Subject|9|||
126251406|NCT01149057|454210717|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
126251407|NCT01149057|454210717|FG000|Overall Study|B Cell Depletion|4|||
126762484|NCT01049360|456081224|FG012|Period 2|Lack of Efficacy|0|||
126697624|NCT00486603|455845287|FG003|Overall Study|Withdrawal by Subject|0|||
126697625|NCT00486603|455845288|FG004|Overall Study|Withdrawal by Subject|0|||
126697626|NCT00486603|455845284|FG000|Overall Study|Physician Decision|0|||
126697627|NCT00486603|455845285|FG001|Overall Study|Physician Decision|1|||
126697628|NCT00486603|455845286|FG002|Overall Study|Physician Decision|0|||
126697629|NCT00486603|455845287|FG003|Overall Study|Physician Decision|0|||
126697630|NCT00486603|455845288|FG004|Overall Study|Physician Decision|0|||
126697631|NCT01670994|455845289|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
126697632|NCT01670994|455845290|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
126762485|NCT01049360|456081225|FG013|Period 2|Lack of Efficacy|0|||
126762486|NCT01049360|456081226|FG014|Period 2|Lack of Efficacy|0|||
126762487|NCT01049360|456081227|FG015|Period 2|Lack of Efficacy|0|||
126251408|NCT01149057|454210717|FG000|Overall Study|Participant Non-Compliance|2|||
126251409|NCT01149057|454210717|FG000|Overall Study|Lost to Follow-up|1|||
126251410|NCT01149057|454210717|FG000|Overall Study|High Parathyroid Hormone Value|1|||
126251411|NCT01149057|454210717|FG000|Overall Study|Other|6|||
126251412|NCT00654186|454210718|FG000|Overall Study|Withdrawal by Subject|5|||
126251413|NCT00577655|454210719|FG000|Overall Study|Patient Request|0|||
126251414|NCT00577655|454210720|FG001|Overall Study|Patient Request|2|||
126251415|NCT00577655|454210719|FG000|Overall Study|Protocol Violation|0|||
126251416|NCT00577655|454210720|FG001|Overall Study|Protocol Violation|1|||
126251417|NCT00577655|454210719|FG000|Overall Study|Lost to Follow-up|1|||
126251418|NCT00577655|454210720|FG001|Overall Study|Lost to Follow-up|1|||
126251419|NCT00875524|454210722|FG000|Overall Study|Serious adverse event|0|||
126449155|NCT03595228|454945215|FG000|Overall Study|Withdrawal by Sponsor|1|||
126251420|NCT00875524|454210723|FG001|Overall Study|Serious adverse event|1|||
126251421|NCT00875524|454210722|FG000|Overall Study|Protocol Violation|4|||
126251422|NCT00875524|454210723|FG001|Overall Study|Protocol Violation|0|||
126251423|NCT00875524|454210722|FG000|Overall Study|Lost to Follow-up|1|||
126251424|NCT00875524|454210723|FG001|Overall Study|Lost to Follow-up|0|||
126251425|NCT00875524|454210722|FG000|Overall Study|Withdrawal by Subject|3|||
126251426|NCT00875524|454210723|FG001|Overall Study|Withdrawal by Subject|5|||
126251427|NCT01370863|454210724|FG000|Overall Study|Adverse Event|1|||
126251428|NCT01370863|454210725|FG001|Overall Study|Adverse Event|1|||
126251429|NCT01370863|454210724|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
126251430|NCT01370863|454210725|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
126251431|NCT01370863|454210724|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
126251432|NCT01370863|454210725|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
126449156|NCT00200356|454945216|FG000|Overall Study|Lack of Efficacy|3|||
126449157|NCT00200356|454945217|FG001|Overall Study|Lack of Efficacy|3|||
126449158|NCT00200356|454945216|FG000|Overall Study|Protocol Violation|4|||
126449159|NCT00200356|454945217|FG001|Overall Study|Protocol Violation|4|||
126449160|NCT00200356|454945216|FG000|Overall Study|Nontreatment|1|||
126449161|NCT00200356|454945217|FG001|Overall Study|Nontreatment|0|||
126697633|NCT01670994|455845289|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
126697634|NCT01670994|455845290|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
126697635|NCT01670994|455845289|FG000|Overall Study|Patient experienced DLT|0|||
126697636|NCT01670994|455845290|FG001|Overall Study|Patient experienced DLT|1|||
126697637|NCT02013544|455845291|FG000|Overall Study|Adverse Event|5|||
126697638|NCT02013544|455845292|FG001|Overall Study|Adverse Event|5|||
126697639|NCT02013544|455845291|FG000|Overall Study|Lost to Follow-up|2|||
126697640|NCT02013544|455845292|FG001|Overall Study|Lost to Follow-up|3|||
126697641|NCT02013544|455845291|FG000|Overall Study|Withdrawal by Subject|2|||
126697642|NCT02013544|455845292|FG001|Overall Study|Withdrawal by Subject|8|||
126697643|NCT02013544|455845291|FG000|Overall Study|Physician Decision|0|||
126697644|NCT02013544|455845292|FG001|Overall Study|Physician Decision|1|||
126697645|NCT02013544|455845291|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
126697646|NCT02013544|455845292|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
126697647|NCT01295125|455845293|FG000|Overall Study|Study stopped prematurely|9|||
126697648|NCT00885365|455845296|FG000|4 Weeks ON Treatment|Adverse Event|2|||
126697649|NCT00885365|455845297|FG001|4 Weeks ON Treatment|Adverse Event|4|||
126697650|NCT00885365|455845296|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
126697651|NCT00885365|455845297|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
126697652|NCT00885365|455845296|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
126697653|NCT00885365|455845297|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
126697654|NCT01824979|455845298|FG000|Overall Study|Withdrawal by Subject|5|||
126697655|NCT01824979|455845299|FG001|Overall Study|Withdrawal by Subject|0|||
126697656|NCT01824979|455845298|FG000|Overall Study|Physician Decision|2|||
126697657|NCT01824979|455845299|FG001|Overall Study|Physician Decision|0|||
126697658|NCT01824979|455845298|FG000|Overall Study|Protocol Violation|6|||
126697659|NCT01824979|455845299|FG001|Overall Study|Protocol Violation|13|||
126697660|NCT00888238|455845301|FG000|Washout Period After Period 2|Adverse Event|0|||
126697661|NCT00888238|455845302|FG001|Washout Period After Period 2|Adverse Event|0|||
126697662|NCT00888238|455845303|FG002|Washout Period After Period 2|Adverse Event|1|||
126697663|NCT03371355|455845312|FG000|Overall Study|Investigator judgment|0|||
126697664|NCT03371355|455845313|FG001|Overall Study|Investigator judgment|0|||
126697665|NCT03371355|455845314|FG002|Overall Study|Investigator judgment|1|||
126697666|NCT03371355|455845315|FG003|Overall Study|Investigator judgment|1|||
126697667|NCT03371355|455845312|FG000|Overall Study|Voluntary withdrawal|1|||
126697668|NCT03371355|455845313|FG001|Overall Study|Voluntary withdrawal|0|||
126697669|NCT03371355|455845314|FG002|Overall Study|Voluntary withdrawal|1|||
126697670|NCT03371355|455845315|FG003|Overall Study|Voluntary withdrawal|2|||
126251433|NCT00301964|454210726|FG000|Overall Study|Second primary|2|||
126251434|NCT00301964|454210726|FG000|Overall Study|Wrong primary|1|||
126449162|NCT00435045|454945219|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
126697671|NCT03371355|455845312|FG000|Overall Study|Adverse Event|0|||
126697672|NCT03371355|455845313|FG001|Overall Study|Adverse Event|1|||
126697673|NCT03371355|455845314|FG002|Overall Study|Adverse Event|2|||
126251435|NCT00301964|454210726|FG000|Overall Study|Inadequate pathology|1|||
126251436|NCT01143337|454210727|FG000|Overall Study|Adverse Event|3|||
126449163|NCT00435045|454945220|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
126449164|NCT00435045|454945219|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
126251437|NCT01143337|454210728|FG001|Overall Study|Adverse Event|9|||
126251438|NCT01143337|454210729|FG002|Overall Study|Adverse Event|5|||
126251439|NCT01143337|454210727|FG000|Overall Study|Lack of Efficacy|6|||
126251440|NCT01143337|454210728|FG001|Overall Study|Lack of Efficacy|2|||
126251441|NCT01143337|454210729|FG002|Overall Study|Lack of Efficacy|1|||
126251442|NCT01143337|454210727|FG000|Overall Study|Protocol Violation|1|||
126251443|NCT01143337|454210728|FG001|Overall Study|Protocol Violation|0|||
126251444|NCT01143337|454210729|FG002|Overall Study|Protocol Violation|0|||
126251445|NCT01143337|454210727|FG000|Overall Study|Withdrawal by Subject|0|||
126251446|NCT01143337|454210728|FG001|Overall Study|Withdrawal by Subject|0|||
126251447|NCT01143337|454210729|FG002|Overall Study|Withdrawal by Subject|1|||
126251448|NCT01143337|454210727|FG000|Overall Study|Other reason|0|||
126251449|NCT01143337|454210728|FG001|Overall Study|Other reason|0|||
126251450|NCT01143337|454210729|FG002|Overall Study|Other reason|5|||
126251451|NCT02761915|454210730|FG000|Overall Study|Death|3|||
126251452|NCT02761915|454210731|FG001|Overall Study|Death|1|||
126251453|NCT02761915|454210732|FG002|Overall Study|Death|1|||
126251454|NCT02761915|454210733|FG003|Overall Study|Death|1|||
126251455|NCT02761915|454210734|FG004|Overall Study|Death|0|||
126251456|NCT02761915|454210735|FG005|Overall Study|Death|1|||
126251457|NCT02761915|454210730|FG000|Overall Study|Withdrawal by Subject|1|||
126251458|NCT02761915|454210731|FG001|Overall Study|Withdrawal by Subject|0|||
126251459|NCT02761915|454210732|FG002|Overall Study|Withdrawal by Subject|0|||
126251460|NCT02761915|454210733|FG003|Overall Study|Withdrawal by Subject|0|||
126251461|NCT02761915|454210734|FG004|Overall Study|Withdrawal by Subject|1|||
126251462|NCT02761915|454210735|FG005|Overall Study|Withdrawal by Subject|2|||
126251463|NCT02761915|454210730|FG000|Overall Study|Disease Progression|0|||
126251464|NCT02761915|454210731|FG001|Overall Study|Disease Progression|0|||
126251465|NCT02761915|454210732|FG002|Overall Study|Disease Progression|0|||
126251466|NCT02761915|454210733|FG003|Overall Study|Disease Progression|2|||
126697674|NCT03371355|455845315|FG003|Overall Study|Adverse Event|3|||
126697675|NCT03371355|455845312|FG000|Overall Study|Reason not Specified|0|||
126697676|NCT03371355|455845313|FG001|Overall Study|Reason not Specified|1|||
126697677|NCT03371355|455845314|FG002|Overall Study|Reason not Specified|0|||
126697678|NCT03371355|455845315|FG003|Overall Study|Reason not Specified|1|||
126697679|NCT01662648|455845316|FG000|Overall Study|Death|1|||
126697680|NCT01662648|455845317|FG001|Overall Study|Death|3|||
126697681|NCT01662648|455845316|FG000|Overall Study|Adverse Event|40|||
126697682|NCT01662648|455845317|FG001|Overall Study|Adverse Event|37|||
126697683|NCT01662648|455845316|FG000|Overall Study|Lack of Efficacy|17|||
126697684|NCT01662648|455845317|FG001|Overall Study|Lack of Efficacy|16|||
126697685|NCT01662648|455845316|FG000|Overall Study|Participant ineligible to continue trial|1|||
126697686|NCT01662648|455845317|FG001|Overall Study|Participant ineligible to continue trial|1|||
126697687|NCT01662648|455845316|FG000|Overall Study|Lost to Follow-up|24|||
126697688|NCT01662648|455845317|FG001|Overall Study|Lost to Follow-up|36|||
126697689|NCT01662648|455845316|FG000|Overall Study|Withdrawal by Subject|36|||
126697690|NCT01662648|455845317|FG001|Overall Study|Withdrawal by Subject|53|||
126697691|NCT01662648|455845316|FG000|Overall Study|Participant non-compliant|16|||
126697692|NCT01662648|455845317|FG001|Overall Study|Participant non-compliant|20|||
126697693|NCT01662648|455845316|FG000|Overall Study|Other|8|||
126697694|NCT01662648|455845317|FG001|Overall Study|Other|11|||
126697695|NCT01662648|455845316|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
126251467|NCT02761915|454210734|FG004|Overall Study|Disease Progression|2|||
126251468|NCT02761915|454210735|FG005|Overall Study|Disease Progression|2|||
126251469|NCT01151618|454210746|FG000|Overall Study|Adverse Event|2|||
126251470|NCT01151618|454210746|FG000|Overall Study|Withdrawal by Subject|7|||
126251471|NCT03277248|454210747|FG000|Overall Study|Adverse Event|3|||
126251472|NCT03277248|454210748|FG001|Overall Study|Adverse Event|1|||
126251473|NCT03277248|454210747|FG000|Overall Study|Subject Withdrawal of Consent|6|||
126251474|NCT03277248|454210748|FG001|Overall Study|Subject Withdrawal of Consent|23|||
126251475|NCT03277248|454210747|FG000|Overall Study|Investigator/Sponsor Decision|2|||
126251476|NCT03277248|454210748|FG001|Overall Study|Investigator/Sponsor Decision|2|||
126251477|NCT03277248|454210747|FG000|Overall Study|Pregnancy|4|||
126762488|NCT01049360|456081228|FG016|Period 2|Lack of Efficacy|0|||
126251478|NCT03277248|454210748|FG001|Overall Study|Pregnancy|1|||
126449165|NCT00435045|454945220|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
126449166|NCT00435045|454945219|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
126697696|NCT01662648|455845317|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
126697697|NCT01662648|455845316|FG000|Overall Study|LOE and other reason unspecified|1|||
126697698|NCT01662648|455845317|FG001|Overall Study|LOE and other reason unspecified|0|||
126697699|NCT01662648|455845316|FG000|Overall Study|LOE and Participant non-compliant|0|||
126697700|NCT01662648|455845317|FG001|Overall Study|LOE and Participant non-compliant|1|||
126762489|NCT01049360|456081229|FG017|Period 2|Lack of Efficacy|0|||
126251479|NCT03277248|454210747|FG000|Overall Study|Lost to Follow-up|0|||
126251480|NCT03277248|454210748|FG001|Overall Study|Lost to Follow-up|2|||
126251481|NCT03277248|454210747|FG000|Overall Study|Lack of Efficacy|0|||
126251482|NCT03277248|454210748|FG001|Overall Study|Lack of Efficacy|2|||
126251483|NCT03277248|454210747|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
126251484|NCT03277248|454210748|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
126251485|NCT01663896|454210749|FG000|Overall Study|Various reasons|43|||
126251486|NCT01824576|454210753|FG000|Overall Study|Device deficiency|2|||
126251487|NCT01691612|454210754|FG000|Overall Study|deemed ineligible after 1st visit|6|||
126251488|NCT01691612|454210754|FG000|Overall Study|Adverse Event|1|||
126251489|NCT03727139|454210755|FG000|Overall Study|Protocol Violation|60|||
126251490|NCT00566722|454210756|FG000|Overall Study|Adverse Event|0|||
126251491|NCT00566722|454210757|FG001|Overall Study|Adverse Event|1|||
126251492|NCT00566722|454210758|FG002|Overall Study|Adverse Event|0|||
126251493|NCT00566722|454210756|FG000|Overall Study|Withdrawal by Subject|0|||
126251494|NCT00566722|454210757|FG001|Overall Study|Withdrawal by Subject|0|||
126251495|NCT00566722|454210758|FG002|Overall Study|Withdrawal by Subject|1|||
126251496|NCT00566722|454210756|FG000|Overall Study|Lost to Follow-up|1|||
126251497|NCT00566722|454210757|FG001|Overall Study|Lost to Follow-up|1|||
126251498|NCT00566722|454210758|FG002|Overall Study|Lost to Follow-up|1|||
126251499|NCT00566722|454210756|FG000|Overall Study|Lack of Efficacy|1|||
126251500|NCT00566722|454210757|FG001|Overall Study|Lack of Efficacy|2|||
126251501|NCT00566722|454210758|FG002|Overall Study|Lack of Efficacy|4|||
126251502|NCT00566722|454210756|FG000|Overall Study|Did not meet exclusion criteria|0|||
126251503|NCT00566722|454210757|FG001|Overall Study|Did not meet exclusion criteria|0|||
126251504|NCT00566722|454210758|FG002|Overall Study|Did not meet exclusion criteria|2|||
126251505|NCT00566722|454210756|FG000|Overall Study|Serious adverse event|0|||
126251506|NCT00566722|454210757|FG001|Overall Study|Serious adverse event|1|||
126251507|NCT00566722|454210758|FG002|Overall Study|Serious adverse event|0|||
126251508|NCT00566722|454210756|FG000|Overall Study|Noncompliant with drug administration|0|||
126251509|NCT00566722|454210757|FG001|Overall Study|Noncompliant with drug administration|0|||
126251510|NCT00566722|454210758|FG002|Overall Study|Noncompliant with drug administration|1|||
126251511|NCT00858403|454210759|FG000|Overall Study|Withdrawal by Subject|1|||
126251512|NCT00858403|454210759|FG000|Overall Study|Death|3|||
126251513|NCT00858403|454210759|FG000|Overall Study|Disease Progression|1|||
126251514|NCT05315713|454210762|FG000|Overall Study|Death|5|||
126251515|NCT05315713|454210762|FG000|Overall Study|Progressive disease|1|||
126251516|NCT05315713|454210762|FG000|Overall Study|Withdrawal by Subject|1|||
126251517|NCT05315713|454210762|FG000|Overall Study|Study terminated by sponsor|1|||
126251518|NCT00556673|454210763|FG000|Overall Study|Protocol deviation|3|||
126251519|NCT00556673|454210764|FG001|Overall Study|Protocol deviation|2|||
126251520|NCT01131260|454210765|FG000|Overall Study|Randomization error|5|||
126251521|NCT01131260|454210766|FG001|Overall Study|Randomization error|1|||
126251522|NCT01131260|454210765|FG000|Overall Study|Declined to continue participation|8|||
126251523|NCT01131260|454210766|FG001|Overall Study|Declined to continue participation|13|||
126251524|NCT01131260|454210765|FG000|Overall Study|Physician Decision|22|||
126251525|NCT01131260|454210766|FG001|Overall Study|Physician Decision|24|||
126251526|NCT01131260|454210765|FG000|Overall Study|Technical problems|7|||
126251527|NCT01131260|454210766|FG001|Overall Study|Technical problems|6|||
126251528|NCT01131260|454210765|FG000|Overall Study|Staff error|2|||
126251529|NCT01131260|454210766|FG001|Overall Study|Staff error|1|||
126251530|NCT01131260|454210765|FG000|Overall Study|Ineligible|0|||
126251531|NCT01131260|454210766|FG001|Overall Study|Ineligible|2|||
126251532|NCT00874276|454210769|FG000|Overall Study|Withdrawal by Subject|1|||
126251533|NCT00874276|454210770|FG001|Overall Study|Withdrawal by Subject|1|||
126251534|NCT03694197|454210771|FG000|Overall Study|Adverse Event|9|||
126251535|NCT03694197|454210771|FG000|Overall Study|Protocol became inconvenient to participate|1|||
126251536|NCT03694197|454210771|FG000|Overall Study|Physician Decision|4|||
126251537|NCT03694197|454210771|FG000|Overall Study|Study terminated by sponsor|1350|||
126251538|NCT03694197|454210771|FG000|Overall Study|Participant moved|5|||
126251539|NCT03694197|454210771|FG000|Overall Study|Participant withdrew consent|10|||
126251540|NCT03694197|454210771|FG000|Overall Study|Related to IMP administration|1|||
126251541|NCT03694197|454210771|FG000|Overall Study|Not disclosed|5|||
126251542|NCT03506633|454212213|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
126251543|NCT03506633|454212214|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
126251544|NCT01894230|454212215|FG000|Overall Study|Lost to Follow-up|2|||
126251545|NCT01894230|454212216|FG001|Overall Study|Lost to Follow-up|2|||
126251546|NCT01894230|454212215|FG000|Overall Study|Withdrawal by Subject|4|||
126762490|NCT01049360|456081230|FG018|Period 2|Lack of Efficacy|0|||
126251547|NCT01894230|454212216|FG001|Overall Study|Withdrawal by Subject|4|||
126251548|NCT01894230|454212215|FG000|Overall Study|Non-adherent|0|||
126251549|NCT01894230|454212216|FG001|Overall Study|Non-adherent|1|||
126251550|NCT01894230|454212215|FG000|Overall Study|Death|1|||
126251551|NCT01894230|454212216|FG001|Overall Study|Death|0|||
126251552|NCT01109849|454212219|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
126251553|NCT01109849|454212220|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
126251554|NCT01109849|454212221|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
126251555|NCT01109849|454212222|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
126251556|NCT01109849|454212223|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
126251557|NCT01109849|454212219|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
126251558|NCT01109849|454212220|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
126251559|NCT01109849|454212221|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
126251560|NCT01109849|454212222|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
126251561|NCT01109849|454212223|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
126251562|NCT01109849|454212219|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
126251563|NCT01109849|454212220|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
126251564|NCT01109849|454212221|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
126251565|NCT01109849|454212222|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
126251566|NCT01109849|454212223|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
126251567|NCT01109849|454212219|FG000|Initial Randomization: ADHD Treatment|move away|2|||
126251568|NCT01109849|454212220|FG001|Initial Randomization: ADHD Treatment|move away|7|||
126251569|NCT01109849|454212221|FG002|Initial Randomization: ADHD Treatment|move away|0|||
126251570|NCT01109849|454212222|FG003|Initial Randomization: ADHD Treatment|move away|0|||
126251571|NCT01109849|454212223|FG004|Initial Randomization: ADHD Treatment|move away|0|||
126251572|NCT01109849|454212219|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
126449167|NCT00435045|454945220|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
126449168|NCT00435045|454945219|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
126449169|NCT00435045|454945220|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
126449170|NCT00435045|454945219|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
126449171|NCT00435045|454945220|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
126449172|NCT00435045|454945219|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
126449173|NCT00435045|454945220|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
126449174|NCT00435045|454945219|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
126449175|NCT00435045|454945220|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
126449176|NCT00435045|454945219|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
126449177|NCT00435045|454945220|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
126449178|NCT00435045|454945219|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
126697701|NCT03751111|455845319|FG000|Overall Study|Lack of Efficacy|9|||
126697702|NCT03751111|455845320|FG001|Overall Study|Lack of Efficacy|30|||
126697703|NCT03751111|455845319|FG000|Overall Study|Adverse Event|3|||
126697704|NCT03751111|455845320|FG001|Overall Study|Adverse Event|2|||
126697705|NCT03529409|455845331|FG000|Randomized|Lost to Follow-up|0|||
126697706|NCT03529409|455845332|FG001|Randomized|Lost to Follow-up|0|||
126697707|NCT03529409|455845333|FG002|Randomized|Lost to Follow-up|4|||
126697708|NCT03529409|455845331|FG000|Randomized|Excluded|0|||
126697709|NCT03529409|455845332|FG001|Randomized|Excluded|0|||
126697710|NCT03529409|455845333|FG002|Randomized|Excluded|1|||
126697711|NCT03529409|455845331|FG000|Post-treatment Assessment|Death|1|||
126697712|NCT03529409|455845332|FG001|Post-treatment Assessment|Death|0|||
126697713|NCT03529409|455845333|FG002|Post-treatment Assessment|Death|0|||
126697714|NCT03529409|455845331|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
126697715|NCT03529409|455845332|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
126697716|NCT03529409|455845333|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
126697717|NCT03529409|455845331|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
126697718|NCT03529409|455845332|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
126697719|NCT03529409|455845333|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
126697720|NCT03529409|455845331|FG000|Follow-up Assessment|Death|1|||
126251573|NCT01109849|454212220|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
126251574|NCT01109849|454212221|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
126251575|NCT01109849|454212222|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
126251576|NCT01109849|454212223|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
126251577|NCT01109849|454212219|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
126251578|NCT01109849|454212220|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
126449179|NCT00435045|454945220|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
126449180|NCT00435045|454945219|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
126449181|NCT00435045|454945220|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
126449182|NCT00435045|454945219|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
126697721|NCT03529409|455845332|FG001|Follow-up Assessment|Death|0|||
126697722|NCT03529409|455845333|FG002|Follow-up Assessment|Death|0|||
126697723|NCT03529409|455845331|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
126697724|NCT03529409|455845332|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
126251579|NCT01109849|454212221|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
126251580|NCT01109849|454212222|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
126251581|NCT01109849|454212223|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
126697725|NCT03529409|455845333|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
126697726|NCT01497262|455845334|FG000|Overall Study|Abnormal Lab Values|4|||
126697727|NCT01497262|455845334|FG000|Overall Study|Abnormal Test Procedure Result|1|||
126697728|NCT01497262|455845334|FG000|Overall Study|Physician Decision|1|||
126697729|NCT01497262|455845334|FG000|Overall Study|Withdrawal by Subject|2|||
126697730|NCT01497262|455845334|FG000|Overall Study|Adverse Event|2|||
126251582|NCT04364854|454212230|FG000|Overall Study|Withdrawal by Subject|1|||
126251583|NCT04364854|454212231|FG001|Overall Study|Withdrawal by Subject|0|||
126251584|NCT04364854|454212232|FG002|Overall Study|Withdrawal by Subject|1|||
126251585|NCT04364854|454212233|FG003|Overall Study|Withdrawal by Subject|3|||
126449183|NCT00435045|454945220|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
126449184|NCT01297491|454945221|FG000|Overall Study|Adverse Event|11|||
126449185|NCT01297491|454945222|FG001|Overall Study|Adverse Event|6|||
126449186|NCT01297491|454945221|FG000|Overall Study|Physician Decision|3|||
126697731|NCT01497262|455845334|FG000|Overall Study|Protocol Violation|1|||
126697732|NCT02497001|455845337|FG000|Overall Study|Lost to Follow-up|10|||
126697733|NCT02497001|455845338|FG001|Overall Study|Lost to Follow-up|2|||
126697734|NCT02497001|455845339|FG002|Overall Study|Lost to Follow-up|0|||
126697735|NCT02497001|455845340|FG003|Overall Study|Lost to Follow-up|2|||
126697736|NCT02497001|455845337|FG000|Overall Study|Adverse Event|28|||
126697737|NCT02497001|455845338|FG001|Overall Study|Adverse Event|30|||
126697738|NCT02497001|455845339|FG002|Overall Study|Adverse Event|11|||
126697739|NCT02497001|455845340|FG003|Overall Study|Adverse Event|11|||
126697740|NCT02497001|455845337|FG000|Overall Study|Withdrawal by Subject|14|||
126697741|NCT02497001|455845338|FG001|Overall Study|Withdrawal by Subject|37|||
126697742|NCT02497001|455845339|FG002|Overall Study|Withdrawal by Subject|19|||
126697743|NCT02497001|455845340|FG003|Overall Study|Withdrawal by Subject|15|||
126697744|NCT02497001|455845337|FG000|Overall Study|Physician Decision|5|||
126697745|NCT02497001|455845338|FG001|Overall Study|Physician Decision|11|||
126697746|NCT02497001|455845339|FG002|Overall Study|Physician Decision|5|||
126697747|NCT02497001|455845340|FG003|Overall Study|Physician Decision|1|||
126697748|NCT02497001|455845337|FG000|Overall Study|subjects that were not treated|1|||
126697749|NCT02497001|455845338|FG001|Overall Study|subjects that were not treated|2|||
126697750|NCT02497001|455845339|FG002|Overall Study|subjects that were not treated|2|||
126697751|NCT02497001|455845340|FG003|Overall Study|subjects that were not treated|1|||
126697752|NCT02497001|455845337|FG000|Overall Study|Major Protocol Deviation|3|||
126697753|NCT02497001|455845338|FG001|Overall Study|Major Protocol Deviation|4|||
126697754|NCT02497001|455845339|FG002|Overall Study|Major Protocol Deviation|4|||
126697755|NCT02497001|455845340|FG003|Overall Study|Major Protocol Deviation|4|||
126697756|NCT02497001|455845337|FG000|Overall Study|Lack of Efficacy|10|||
126697757|NCT02497001|455845338|FG001|Overall Study|Lack of Efficacy|16|||
126697758|NCT02497001|455845339|FG002|Overall Study|Lack of Efficacy|6|||
126449187|NCT01297491|454945222|FG001|Overall Study|Physician Decision|2|||
126449188|NCT01297491|454945221|FG000|Overall Study|Progressive disease|11|||
126449189|NCT01297491|454945222|FG001|Overall Study|Progressive disease|20|||
126449190|NCT01297491|454945221|FG000|Overall Study|Patient/Guardian decision|3|||
126449191|NCT01297491|454945222|FG001|Overall Study|Patient/Guardian decision|4|||
126449192|NCT01297491|454945221|FG000|Overall Study|Death|2|||
126449193|NCT01297491|454945222|FG001|Overall Study|Death|1|||
126449194|NCT01015638|454945225|FG000|Overall Study|Withdrawal by Subject|1|||
126449195|NCT01015638|454945226|FG001|Overall Study|Withdrawal by Subject|0|||
126449196|NCT03679754|454945233|FG000|Overall Study|Investigator request|1|||
126449197|NCT00964171|454945234|FG000|Overall Study|Death|5|||
126449198|NCT00910299|454945238|FG000|Overall Study|Withdrawal by Subject|16|||
126449199|NCT00910299|454945239|FG001|Overall Study|Withdrawal by Subject|13|||
126449200|NCT00910299|454945238|FG000|Overall Study|Sponsor Decision|58|||
126449201|NCT00910299|454945239|FG001|Overall Study|Sponsor Decision|60|||
126449202|NCT00910299|454945238|FG000|Overall Study|Didn't receive any study drug|2|||
126449203|NCT00910299|454945239|FG001|Overall Study|Didn't receive any study drug|1|||
126449204|NCT00711477|454945240|FG000|Overall Study|Adverse Event|3|||
126697759|NCT02497001|455845340|FG003|Overall Study|Lack of Efficacy|6|||
126697760|NCT02497001|455845337|FG000|Overall Study|Protocol Violation|3|||
126697761|NCT02497001|455845338|FG001|Overall Study|Protocol Violation|1|||
126251586|NCT04364854|454212230|FG000|Overall Study|Death|1|||
126697762|NCT02497001|455845339|FG002|Overall Study|Protocol Violation|3|||
126449205|NCT00711477|454945241|FG001|Overall Study|Adverse Event|1|||
126449206|NCT00711477|454945240|FG000|Overall Study|Lost to Follow-up|0|||
126449207|NCT00711477|454945241|FG001|Overall Study|Lost to Follow-up|1|||
126449208|NCT00711477|454945240|FG000|Overall Study|Noncompliance|0|||
126449209|NCT00711477|454945241|FG001|Overall Study|Noncompliance|1|||
126449210|NCT00145977|454945244|FG000|Overall Study|Lack of Efficacy|0|||
126449211|NCT00145977|454945245|FG001|Overall Study|Lack of Efficacy|4|||
126697763|NCT02497001|455845340|FG003|Overall Study|Protocol Violation|1|||
126697764|NCT03898063|455845343|FG000|Overall Study|Withdrawal by Subject|10|||
126697765|NCT03898063|455845344|FG001|Overall Study|Withdrawal by Subject|8|||
126697766|NCT02949830|455845345|FG000|Overall Study|Adverse Event|1|||
126697767|NCT02949830|455845345|FG000|Overall Study|Withdrawal by Subject|1|||
126697768|NCT00054132|455845346|FG000|Overall Study|Not Treated|1|||
126697769|NCT01290887|455845347|FG000|Overall Study|Adverse Event|6|||
126697770|NCT01290887|455845348|FG001|Overall Study|Adverse Event|11|||
126697771|NCT01290887|455845347|FG000|Overall Study|Lack of Efficacy|4|||
126697772|NCT01290887|455845348|FG001|Overall Study|Lack of Efficacy|5|||
126251587|NCT04364854|454212231|FG001|Overall Study|Death|0|||
126449212|NCT00145977|454945244|FG000|Overall Study|Lost to Follow-up|1|||
126697773|NCT01290887|455845347|FG000|Overall Study|Withdrawal by Subject|26|||
126251588|NCT04364854|454212232|FG002|Overall Study|Death|0|||
126251589|NCT04364854|454212233|FG003|Overall Study|Death|0|||
126251590|NCT04364854|454212230|FG000|Overall Study|Lost to Follow-up|0|||
126251591|NCT04364854|454212231|FG001|Overall Study|Lost to Follow-up|0|||
126251592|NCT04364854|454212232|FG002|Overall Study|Lost to Follow-up|0|||
126251593|NCT04364854|454212233|FG003|Overall Study|Lost to Follow-up|1|||
126697774|NCT01290887|455845348|FG001|Overall Study|Withdrawal by Subject|32|||
126697775|NCT01290887|455845347|FG000|Overall Study|Protocol Violation|2|||
126251594|NCT02435433|454212238|FG000|Overall Study|Withdrawal by Subject|2|||
126251595|NCT02435433|454212239|FG001|Overall Study|Withdrawal by Subject|3|||
126251596|NCT02435433|454212240|FG002|Overall Study|Withdrawal by Subject|1|||
126251597|NCT02435433|454212241|FG003|Overall Study|Withdrawal by Subject|0|||
126251598|NCT02435433|454212242|FG004|Overall Study|Withdrawal by Subject|0|||
126251599|NCT02435433|454212238|FG000|Overall Study|Lost to Follow-up|2|||
126251600|NCT02435433|454212239|FG001|Overall Study|Lost to Follow-up|2|||
126251601|NCT02435433|454212240|FG002|Overall Study|Lost to Follow-up|4|||
126251602|NCT02435433|454212241|FG003|Overall Study|Lost to Follow-up|1|||
126251603|NCT02435433|454212242|FG004|Overall Study|Lost to Follow-up|0|||
126251604|NCT00757705|454212243|FG000|Overall Study|Adverse Event|19|||
126251605|NCT00757705|454212243|FG000|Overall Study|Lost to Follow-up|16|||
126251606|NCT00757705|454212243|FG000|Overall Study|Withdrawal by Subject|25|||
126251607|NCT00757705|454212243|FG000|Overall Study|Insufficient Response|26|||
126251608|NCT00757705|454212243|FG000|Overall Study|Ineligible to continue|8|||
126251609|NCT00757705|454212243|FG000|Overall Study|Non-compliant|9|||
126251610|NCT00757705|454212243|FG000|Overall Study|Other|18|||
126251611|NCT00659815|454212244|FG000|Overall Study|Study related symptoms and complaints|2|||
126251612|NCT00659815|454212245|FG001|Overall Study|Study related symptoms and complaints|1|||
126251613|NCT00659815|454212244|FG000|Overall Study|Inability to maintain wearing schedule|1|||
126251614|NCT00659815|454212245|FG001|Overall Study|Inability to maintain wearing schedule|2|||
126251615|NCT00659815|454212244|FG000|Overall Study|Withdrawal by Subject|1|||
126251616|NCT00659815|454212245|FG001|Overall Study|Withdrawal by Subject|1|||
126251617|NCT00735696|454212250|FG000|Overall Study|Withdrawal by Subject|1|||
126251618|NCT00735696|454212250|FG000|Overall Study|Enrolled but never Treated|1|||
126251619|NCT00640393|454212252|FG000|Part 1|Lost to Follow-up|2|||
126251620|NCT00640393|454212253|FG001|Part 1|Lost to Follow-up|0|||
126251621|NCT00640393|454212254|FG002|Part 1|Lost to Follow-up|0|||
126251622|NCT00640393|454212252|FG000|Part 1|Withdrawal by Subject|3|||
126251623|NCT00640393|454212253|FG001|Part 1|Withdrawal by Subject|0|||
126251624|NCT00640393|454212254|FG002|Part 1|Withdrawal by Subject|0|||
126251625|NCT00640393|454212252|FG000|Randomization|Withdrawn per protocol|17|||
126251626|NCT00640393|454212253|FG001|Randomization|Withdrawn per protocol|0|||
126251627|NCT00640393|454212254|FG002|Randomization|Withdrawn per protocol|0|||
126251628|NCT00640393|454212252|FG000|Randomization|Never randomized by site|2|||
126251629|NCT00640393|454212253|FG001|Randomization|Never randomized by site|0|||
126251630|NCT00640393|454212254|FG002|Randomization|Never randomized by site|0|||
126251631|NCT00640393|454212252|FG000|Part 2|Lost to Follow-up|0|||
126251632|NCT00640393|454212253|FG001|Part 2|Lost to Follow-up|2|||
126251633|NCT00640393|454212254|FG002|Part 2|Lost to Follow-up|2|||
126251634|NCT00640393|454212252|FG000|Part 2|Withdrawal by Subject|0|||
126251635|NCT00640393|454212253|FG001|Part 2|Withdrawal by Subject|6|||
126251636|NCT00640393|454212254|FG002|Part 2|Withdrawal by Subject|1|||
126251637|NCT00640393|454212252|FG000|Part 2|Non-adherence|0|||
126251638|NCT00640393|454212253|FG001|Part 2|Non-adherence|1|||
126251639|NCT00640393|454212254|FG002|Part 2|Non-adherence|0|||
126251640|NCT00640393|454212252|FG000|Part 2|Adverse Event|0|||
126251641|NCT00640393|454212253|FG001|Part 2|Adverse Event|1|||
126251642|NCT00640393|454212254|FG002|Part 2|Adverse Event|0|||
126251643|NCT04406194|454212255|FG000|Period 1|Withdrawal by Subject|0|||
126251644|NCT04406194|454212256|FG001|Period 1|Withdrawal by Subject|1|||
126251645|NCT03540160|454212257|FG000|Overall Study|Protocol Violation|1|||
126251646|NCT03540160|454212257|FG000|Overall Study|Physician Decision|8|||
126697776|NCT01290887|455845348|FG001|Overall Study|Protocol Violation|1|||
126697777|NCT01290887|455845347|FG000|Overall Study|Lost to Follow-up|4|||
126697778|NCT01290887|455845348|FG001|Overall Study|Lost to Follow-up|4|||
126697779|NCT01290887|455845347|FG000|Overall Study|Non-compliance to study procedures|0|||
126697780|NCT01290887|455845348|FG001|Overall Study|Non-compliance to study procedures|1|||
126251647|NCT03540160|454212257|FG000|Overall Study|Lack of Efficacy|60|||
126251648|NCT03540160|454212257|FG000|Overall Study|Pregnancy|1|||
126251649|NCT03540160|454212257|FG000|Overall Study|Adverse Event|20|||
126251650|NCT03540160|454212257|FG000|Overall Study|Withdrawal by Subject|68|||
126251651|NCT03540160|454212257|FG000|Overall Study|COVID-19|2|||
126251652|NCT03540160|454212257|FG000|Overall Study|Study Closure|10|||
126251653|NCT03540160|454212257|FG000|Overall Study|Lost to Follow-up|18|||
126251654|NCT03540160|454212257|FG000|Overall Study|Sponsor decision|191|||
126251655|NCT01664039|454212258|FG000|Overall Study|Adverse Event|3|||
126251656|NCT01664039|454212259|FG001|Overall Study|Adverse Event|4|||
126251657|NCT01664039|454212258|FG000|Overall Study|Lost to Follow-up|1|||
126697781|NCT01290887|455845347|FG000|Overall Study|Non-compliance to study medications|1|||
126697782|NCT01290887|455845348|FG001|Overall Study|Non-compliance to study medications|0|||
126251658|NCT01664039|454212259|FG001|Overall Study|Lost to Follow-up|1|||
126251659|NCT01664039|454212258|FG000|Overall Study|Withdrawal by Subject|1|||
126251660|NCT01664039|454212259|FG001|Overall Study|Withdrawal by Subject|3|||
126251661|NCT01664039|454212258|FG000|Overall Study|Noncompliance|1|||
126251662|NCT01664039|454212259|FG001|Overall Study|Noncompliance|1|||
126251663|NCT02640235|454212263|FG000|Overall Study|Withdrawal by Subject|7|||
126251664|NCT02640235|454212264|FG001|Overall Study|Withdrawal by Subject|6|||
126251665|NCT02640235|454212263|FG000|Overall Study|Lost to Follow-up|4|||
126251666|NCT02640235|454212264|FG001|Overall Study|Lost to Follow-up|3|||
126251667|NCT02640235|454212263|FG000|Overall Study|Death|2|||
126251668|NCT02640235|454212264|FG001|Overall Study|Death|3|||
126251669|NCT02640235|454212263|FG000|Overall Study|Other|1|||
126251670|NCT02640235|454212264|FG001|Overall Study|Other|2|||
126251671|NCT00819169|454212269|FG000|Overall Study|Withdrawal by Subject|2|||
126251672|NCT00819169|454212270|FG001|Overall Study|Withdrawal by Subject|0|||
126251673|NCT00819169|454212271|FG002|Overall Study|Withdrawal by Subject|0|||
126251674|NCT00819169|454212272|FG003|Overall Study|Withdrawal by Subject|1|||
126251675|NCT00819169|454212273|FG004|Overall Study|Withdrawal by Subject|1|||
126251676|NCT00819169|454212274|FG005|Overall Study|Withdrawal by Subject|1|||
126251677|NCT00819169|454212275|FG006|Overall Study|Withdrawal by Subject|5|||
126251678|NCT00819169|454212276|FG007|Overall Study|Withdrawal by Subject|1|||
126251679|NCT00819169|454212277|FG008|Overall Study|Withdrawal by Subject|4|||
126251680|NCT00819169|454212269|FG000|Overall Study|Lost to Follow-up|0|||
126251681|NCT00819169|454212270|FG001|Overall Study|Lost to Follow-up|2|||
126251682|NCT00819169|454212271|FG002|Overall Study|Lost to Follow-up|0|||
126251683|NCT00819169|454212272|FG003|Overall Study|Lost to Follow-up|1|||
126251684|NCT00819169|454212273|FG004|Overall Study|Lost to Follow-up|0|||
126251685|NCT00819169|454212274|FG005|Overall Study|Lost to Follow-up|6|||
126251686|NCT00819169|454212275|FG006|Overall Study|Lost to Follow-up|2|||
126251687|NCT00819169|454212276|FG007|Overall Study|Lost to Follow-up|2|||
126251688|NCT00819169|454212277|FG008|Overall Study|Lost to Follow-up|1|||
126251689|NCT00819169|454212269|FG000|Overall Study|Death|1|||
126251690|NCT00819169|454212270|FG001|Overall Study|Death|1|||
126251691|NCT00819169|454212271|FG002|Overall Study|Death|3|||
126251692|NCT00819169|454212272|FG003|Overall Study|Death|8|||
126251693|NCT00819169|454212273|FG004|Overall Study|Death|5|||
126251694|NCT00819169|454212274|FG005|Overall Study|Death|7|||
126251695|NCT00819169|454212275|FG006|Overall Study|Death|9|||
126251696|NCT00819169|454212276|FG007|Overall Study|Death|4|||
126251697|NCT00819169|454212277|FG008|Overall Study|Death|7|||
126251698|NCT00819169|454212269|FG000|Overall Study|Ineligibility determined|0|||
126251699|NCT00819169|454212270|FG001|Overall Study|Ineligibility determined|0|||
126251700|NCT00819169|454212271|FG002|Overall Study|Ineligibility determined|0|||
126251701|NCT00819169|454212272|FG003|Overall Study|Ineligibility determined|2|||
126251702|NCT00819169|454212273|FG004|Overall Study|Ineligibility determined|0|||
126251703|NCT00819169|454212274|FG005|Overall Study|Ineligibility determined|0|||
126251704|NCT00819169|454212275|FG006|Overall Study|Ineligibility determined|0|||
126251705|NCT00819169|454212276|FG007|Overall Study|Ineligibility determined|0|||
126251706|NCT00819169|454212277|FG008|Overall Study|Ineligibility determined|1|||
126251707|NCT00819169|454212269|FG000|Overall Study|Adverse Event|0|||
126251708|NCT00819169|454212270|FG001|Overall Study|Adverse Event|0|||
126251709|NCT00819169|454212271|FG002|Overall Study|Adverse Event|0|||
126251710|NCT00819169|454212272|FG003|Overall Study|Adverse Event|0|||
126251711|NCT00819169|454212273|FG004|Overall Study|Adverse Event|1|||
126251712|NCT00819169|454212274|FG005|Overall Study|Adverse Event|0|||
126251713|NCT00819169|454212275|FG006|Overall Study|Adverse Event|0|||
126251714|NCT00819169|454212276|FG007|Overall Study|Adverse Event|0|||
126251715|NCT00819169|454212277|FG008|Overall Study|Adverse Event|0|||
126251716|NCT00819169|454212269|FG000|Overall Study|Administrative Decision|0|||
126251717|NCT00819169|454212270|FG001|Overall Study|Administrative Decision|0|||
126251718|NCT00819169|454212271|FG002|Overall Study|Administrative Decision|0|||
126251719|NCT00819169|454212272|FG003|Overall Study|Administrative Decision|0|||
126697783|NCT01290887|455845347|FG000|Overall Study|Sponsor closure of study|420|||
126251720|NCT00819169|454212273|FG004|Overall Study|Administrative Decision|1|||
126251721|NCT00819169|454212274|FG005|Overall Study|Administrative Decision|2|||
126697784|NCT01290887|455845348|FG001|Overall Study|Sponsor closure of study|476|||
126697785|NCT01290887|455845347|FG000|Overall Study|Other|3|||
126697786|NCT01290887|455845348|FG001|Overall Study|Other|6|||
126251722|NCT00819169|454212275|FG006|Overall Study|Administrative Decision|0|||
126697787|NCT01795547|455845349|FG000|Overall Study|Adverse Event|16|||
126697788|NCT01795547|455845350|FG001|Overall Study|Adverse Event|27|||
126697789|NCT01795547|455845349|FG000|Overall Study|Lack of Efficacy|8|||
126697790|NCT01795547|455845350|FG001|Overall Study|Lack of Efficacy|3|||
126251723|NCT00819169|454212276|FG007|Overall Study|Administrative Decision|2|||
126251724|NCT00819169|454212277|FG008|Overall Study|Administrative Decision|0|||
126251725|NCT00406393|454212278|FG000|Overall Study|Did not undergo transplantation|2|||
126251726|NCT00406393|454212279|FG001|Overall Study|Did not undergo transplantation|1|||
126251727|NCT01046084|454212284|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
126449213|NCT00145977|454945245|FG001|Overall Study|Lost to Follow-up|0|||
126697791|NCT01795547|455845349|FG000|Overall Study|Protocol Violation|6|||
126697792|NCT01795547|455845350|FG001|Overall Study|Protocol Violation|4|||
126697793|NCT01795547|455845349|FG000|Overall Study|Lost to Follow-up|2|||
126697794|NCT01795547|455845350|FG001|Overall Study|Lost to Follow-up|5|||
126697795|NCT01795547|455845349|FG000|Overall Study|Withdrawal of consent|7|||
126697796|NCT01795547|455845350|FG001|Overall Study|Withdrawal of consent|12|||
126697797|NCT01795547|455845349|FG000|Overall Study|Not Treated|4|||
126697798|NCT01795547|455845350|FG001|Overall Study|Not Treated|10|||
126697799|NCT01795547|455845349|FG000|Overall Study|Non-compliance with IMP|1|||
126697800|NCT01795547|455845350|FG001|Overall Study|Non-compliance with IMP|1|||
126697801|NCT01795547|455845349|FG000|Overall Study|Others|4|||
126697802|NCT01795547|455845350|FG001|Overall Study|Others|1|||
126697803|NCT01795547|455845349|FG000|Overall Study|Not stated|0|||
126697804|NCT01795547|455845350|FG001|Overall Study|Not stated|1|||
126697805|NCT02040142|455845351|FG000|Overall Study|Lost to Follow-up|5|||
126697806|NCT02040142|455845351|FG000|Overall Study|Death|17|||
126697807|NCT02040142|455845351|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
126697808|NCT01813890|455845354|FG000|Overall Study|Adverse Event|0|||
126697809|NCT01813890|455845355|FG001|Overall Study|Adverse Event|3|||
126697810|NCT01813890|455845356|FG002|Overall Study|Adverse Event|4|||
126697811|NCT01813890|455845354|FG000|Overall Study|Lack of Efficacy|9|||
126697812|NCT01813890|455845355|FG001|Overall Study|Lack of Efficacy|1|||
126697813|NCT01813890|455845356|FG002|Overall Study|Lack of Efficacy|2|||
126697814|NCT03952559|455845357|FG000|Double Blind Treatment Period|Adverse Event|0|||
126697815|NCT03952559|455845358|FG001|Double Blind Treatment Period|Adverse Event|2|||
126697816|NCT03952559|455845359|FG002|Double Blind Treatment Period|Adverse Event|1|||
126697817|NCT03952559|455845360|FG003|Double Blind Treatment Period|Adverse Event|0|||
126697818|NCT03952559|455845361|FG004|Double Blind Treatment Period|Adverse Event|1|||
126697819|NCT03952559|455845357|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
126697820|NCT03952559|455845358|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
126697821|NCT03952559|455845359|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
126697822|NCT03952559|455845360|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
126697823|NCT03952559|455845361|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
126697824|NCT03952559|455845357|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
126697825|NCT03952559|455845358|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
126251728|NCT01046084|454212285|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
126251729|NCT02166606|454212286|FG000|Overall Study|Adverse Event|3|||
126251730|NCT02166606|454212286|FG000|Overall Study|Death|31|||
126251731|NCT02166606|454212286|FG000|Overall Study|Protocol Violation|7|||
126251732|NCT02166606|454212286|FG000|Overall Study|Lost to Follow-up|30|||
126251733|NCT02166606|454212286|FG000|Overall Study|Withdrawal by Subject|1|||
126251734|NCT02166606|454212286|FG000|Overall Study|Physician Decision|1|||
126251735|NCT02166606|454212286|FG000|Overall Study|Device upgrade|1|||
126251736|NCT02166606|454212286|FG000|Overall Study|Enrolled after End of Enrollment|4|||
126251737|NCT00379353|454212289|FG000|Overall Study|Hospitalization|3|||
126251738|NCT00379353|454212290|FG001|Overall Study|Hospitalization|3|||
126251739|NCT00379353|454212289|FG000|Overall Study|Withdrawal by Subject|5|||
126251740|NCT00379353|454212290|FG001|Overall Study|Withdrawal by Subject|2|||
126251741|NCT00379353|454212289|FG000|Overall Study|Death|1|||
126251742|NCT00379353|454212290|FG001|Overall Study|Death|0|||
126251743|NCT00379353|454212289|FG000|Overall Study|Cardiac Tamponade|1|||
126251744|NCT00379353|454212290|FG001|Overall Study|Cardiac Tamponade|0|||
126251745|NCT00379353|454212289|FG000|Overall Study|Non-compliance|1|||
126251746|NCT00379353|454212290|FG001|Overall Study|Non-compliance|0|||
126251747|NCT00379353|454212289|FG000|Overall Study|Conflicting drug treatment|0|||
126251748|NCT00379353|454212290|FG001|Overall Study|Conflicting drug treatment|1|||
126251749|NCT03614728|454212291|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
126251750|NCT03614728|454212292|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
126251751|NCT03614728|454212293|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
126251752|NCT03614728|454212294|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
126251753|NCT03614728|454212291|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
126697826|NCT03952559|455845359|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
126251754|NCT03614728|454212292|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
126251755|NCT03614728|454212293|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
126251756|NCT03614728|454212294|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
126251757|NCT01958476|454212295|FG000|Overall Study|Parent requested exclusion from analysis|1|||
126251758|NCT01958476|454212296|FG001|Overall Study|Parent requested exclusion from analysis|0|||
126251759|NCT05412121|454212301|FG000|Overall Study|Withdrawal by Subject|4|||
126251760|NCT05412121|454212301|FG000|Overall Study|Physician Decision|1|||
126697827|NCT03952559|455845360|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
126762491|NCT01049360|456081231|FG019|Period 2|Lack of Efficacy|0|||
126251761|NCT05412121|454212301|FG000|Overall Study|Lost to Follow-up|5|||
126251762|NCT02670551|454212302|FG000|Overall Study|Adverse Event|4|||
126449214|NCT00145977|454945244|FG000|Overall Study|Withdrawal by Subject|1|||
126697828|NCT03952559|455845361|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
126762492|NCT01049360|456081212|FG000|Period 4|Protocol Violation|0|||
126251763|NCT02670551|454212303|FG001|Overall Study|Adverse Event|7|||
126251764|NCT02670551|454212304|FG002|Overall Study|Adverse Event|9|||
126251765|NCT02670551|454212302|FG000|Overall Study|Lack of Efficacy|2|||
126251766|NCT02670551|454212303|FG001|Overall Study|Lack of Efficacy|0|||
126251767|NCT02670551|454212304|FG002|Overall Study|Lack of Efficacy|3|||
126251768|NCT02670551|454212302|FG000|Overall Study|Withdrawal of Consent|6|||
126251769|NCT02670551|454212303|FG001|Overall Study|Withdrawal of Consent|3|||
126251770|NCT02670551|454212304|FG002|Overall Study|Withdrawal of Consent|8|||
126251771|NCT02670551|454212302|FG000|Overall Study|Lost to Follow-up|5|||
126251772|NCT02670551|454212303|FG001|Overall Study|Lost to Follow-up|7|||
126251773|NCT02670551|454212304|FG002|Overall Study|Lost to Follow-up|6|||
126251774|NCT02670551|454212302|FG000|Overall Study|Protocol Violation|1|||
126251775|NCT02670551|454212303|FG001|Overall Study|Protocol Violation|0|||
126251776|NCT02670551|454212304|FG002|Overall Study|Protocol Violation|0|||
126251777|NCT02670551|454212302|FG000|Overall Study|Noncompliance with study drug|3|||
126251778|NCT02670551|454212303|FG001|Overall Study|Noncompliance with study drug|3|||
126251779|NCT02670551|454212304|FG002|Overall Study|Noncompliance with study drug|2|||
126251780|NCT02670551|454212302|FG000|Overall Study|Other Miscellaneous Reasons|2|||
126251781|NCT02670551|454212303|FG001|Overall Study|Other Miscellaneous Reasons|3|||
126251782|NCT02670551|454212304|FG002|Overall Study|Other Miscellaneous Reasons|3|||
126251783|NCT02670551|454212302|FG000|Overall Study|Did Not Receive Treatment|5|||
126251784|NCT02670551|454212303|FG001|Overall Study|Did Not Receive Treatment|3|||
126251785|NCT02670551|454212304|FG002|Overall Study|Did Not Receive Treatment|0|||
126251786|NCT04476277|454212305|FG000|Overall Study|Withdrawal by Subject|0|||
126251787|NCT04476277|454212306|FG001|Overall Study|Withdrawal by Subject|0|||
126251788|NCT04476277|454212307|FG002|Overall Study|Withdrawal by Subject|1|||
126251789|NCT04476277|454212308|FG003|Overall Study|Withdrawal by Subject|0|||
126251790|NCT01971645|454212309|FG000|Overall Study|Adverse Event|1|||
126251791|NCT01971645|454212310|FG001|Overall Study|Adverse Event|0|||
126251792|NCT01971645|454212311|FG002|Overall Study|Adverse Event|0|||
126251793|NCT01971645|454212309|FG000|Overall Study|Lost to Follow-up|1|||
126251794|NCT01971645|454212310|FG001|Overall Study|Lost to Follow-up|0|||
126251795|NCT01971645|454212311|FG002|Overall Study|Lost to Follow-up|1|||
126251796|NCT01971645|454212309|FG000|Overall Study|Protocol Violation|0|||
126449215|NCT00145977|454945245|FG001|Overall Study|Withdrawal by Subject|0|||
126449216|NCT00782834|454945252|FG000|Treatment Phase|fibrous tumor not GIST|1|||
126449217|NCT02055118|454945253|FG000|Overall Study|Withdrawal by Subject|0|||
126449218|NCT02055118|454945254|FG001|Overall Study|Withdrawal by Subject|2|||
126449219|NCT02055118|454945255|FG002|Overall Study|Withdrawal by Subject|0|||
126449220|NCT02281383|454945256|FG000|Overall Study|Progressive Disease|1|||
126449221|NCT02281383|454945256|FG000|Overall Study|Withdrawal by Subject|6|||
126449222|NCT02281383|454945256|FG000|Overall Study|Protocol Violation|2|||
126449223|NCT02281383|454945256|FG000|Overall Study|Death|1|||
126449224|NCT02281383|454945256|FG000|Overall Study|Adverse Event|2|||
126449225|NCT02560025|454945259|FG000|Overall Study|Ineligible after consent/ registration|3|||
126449226|NCT02703337|454945260|FG000|Period One (Part A)|Withdrawal by Subject|0|||
126449227|NCT02703337|454945261|FG001|Period One (Part A)|Withdrawal by Subject|0|||
126449228|NCT02703337|454945262|FG002|Period One (Part A)|Withdrawal by Subject|0|||
126449229|NCT02703337|454945263|FG003|Period One (Part A)|Withdrawal by Subject|0|||
126762493|NCT01049360|456081213|FG001|Period 4|Protocol Violation|0|||
126251797|NCT01971645|454212310|FG001|Overall Study|Protocol Violation|0|||
126251798|NCT01971645|454212311|FG002|Overall Study|Protocol Violation|1|||
126251799|NCT01962298|454212312|FG000|Overall Study|Protocol Violation|1|||
126251800|NCT01962298|454212313|FG001|Overall Study|Protocol Violation|0|||
126251801|NCT01962298|454212314|FG002|Overall Study|Protocol Violation|1|||
126251802|NCT01962298|454212315|FG003|Overall Study|Protocol Violation|1|||
126251803|NCT01962298|454212316|FG004|Overall Study|Protocol Violation|0|||
126251804|NCT01962298|454212312|FG000|Overall Study|Data quality insufficient|2|||
126251805|NCT01962298|454212313|FG001|Overall Study|Data quality insufficient|0|||
126251806|NCT01962298|454212314|FG002|Overall Study|Data quality insufficient|3|||
126251807|NCT01962298|454212315|FG003|Overall Study|Data quality insufficient|1|||
126251808|NCT01962298|454212316|FG004|Overall Study|Data quality insufficient|4|||
126251809|NCT01962298|454212312|FG000|Overall Study|Insufficient data|0|||
126251810|NCT01962298|454212313|FG001|Overall Study|Insufficient data|2|||
126251811|NCT01962298|454212314|FG002|Overall Study|Insufficient data|1|||
126251812|NCT01962298|454212315|FG003|Overall Study|Insufficient data|0|||
126449230|NCT02703337|454945264|FG004|Period One (Part A)|Withdrawal by Subject|1|||
126449231|NCT02703337|454945265|FG005|Period One (Part A)|Withdrawal by Subject|0|||
126449232|NCT02703337|454945266|FG006|Period One (Part A)|Withdrawal by Subject|0|||
126449233|NCT02703337|454945267|FG007|Period One (Part A)|Withdrawal by Subject|0|||
126762494|NCT01049360|456081214|FG002|Period 4|Protocol Violation|0|||
126251813|NCT01962298|454212316|FG004|Overall Study|Insufficient data|1|||
126251814|NCT01962298|454212312|FG000|Overall Study|Incorrect data recorded|0|||
126251815|NCT01962298|454212313|FG001|Overall Study|Incorrect data recorded|1|||
126251816|NCT01962298|454212314|FG002|Overall Study|Incorrect data recorded|0|||
126251817|NCT01962298|454212315|FG003|Overall Study|Incorrect data recorded|0|||
126251818|NCT01962298|454212316|FG004|Overall Study|Incorrect data recorded|0|||
126251819|NCT01962298|454212312|FG000|Overall Study|Physician Decision|0|||
126251820|NCT01962298|454212313|FG001|Overall Study|Physician Decision|1|||
126251821|NCT01962298|454212314|FG002|Overall Study|Physician Decision|0|||
126251822|NCT01962298|454212315|FG003|Overall Study|Physician Decision|0|||
126251823|NCT01962298|454212316|FG004|Overall Study|Physician Decision|1|||
126251824|NCT00537095|454212317|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
126251825|NCT00537095|454212318|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
126251826|NCT00537095|454212317|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
126251827|NCT00537095|454212318|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
126251828|NCT00537095|454212317|FG000|Randomized Treatment Period (433 Days)|Death|3|||
126251829|NCT00537095|454212318|FG001|Randomized Treatment Period (433 Days)|Death|1|||
126251830|NCT00537095|454212317|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
126251831|NCT00537095|454212318|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
126251832|NCT00537095|454212317|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
126251833|NCT00537095|454212318|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
126251834|NCT00537095|454212317|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
126251835|NCT00537095|454212318|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
126251836|NCT00537095|454212317|FG000|Open-label Period (590 Days)|Adverse Event|2|||
126251837|NCT00537095|454212318|FG001|Open-label Period (590 Days)|Adverse Event|11|||
126251838|NCT00537095|454212317|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
126449234|NCT00282308|454945268|FG000|Treatment Period|Lost to Follow-up|1|||
126449235|NCT00282308|454945269|FG001|Treatment Period|Lost to Follow-up|0|||
126449236|NCT00282308|454945270|FG002|Treatment Period|Lost to Follow-up|0|||
126449237|NCT00282308|454945268|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
126449238|NCT00282308|454945269|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
126449239|NCT00282308|454945270|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
126449240|NCT00282308|454945268|FG000|Treatment Period|Adverse Event|0|||
126449241|NCT00282308|454945269|FG001|Treatment Period|Adverse Event|2|||
126449242|NCT00282308|454945270|FG002|Treatment Period|Adverse Event|0|||
126449243|NCT00282308|454945268|FG000|Treatment Period|Not Treated with Study Drug|1|||
126449244|NCT00282308|454945269|FG001|Treatment Period|Not Treated with Study Drug|0|||
126449245|NCT00282308|454945270|FG002|Treatment Period|Not Treated with Study Drug|0|||
126449246|NCT00282308|454945268|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
126449247|NCT00282308|454945269|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
126449248|NCT00282308|454945270|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
126449249|NCT00282308|454945268|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
126449250|NCT00282308|454945269|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
126449251|NCT00282308|454945270|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
126449252|NCT00282308|454945268|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
126449253|NCT00282308|454945269|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
126449254|NCT00282308|454945270|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
126449255|NCT00282308|454945268|FG000|Safety Follow-up Period|Adverse Event|0|||
126449256|NCT00282308|454945269|FG001|Safety Follow-up Period|Adverse Event|0|||
126449257|NCT00282308|454945270|FG002|Safety Follow-up Period|Adverse Event|1|||
126449258|NCT00282308|454945268|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
126449259|NCT00282308|454945269|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
126449260|NCT00282308|454945270|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
126449261|NCT00282308|454945268|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
126449262|NCT00282308|454945269|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
126449263|NCT00282308|454945270|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
126449264|NCT00282308|454945268|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
126449265|NCT00282308|454945269|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
126449266|NCT00282308|454945270|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
126449267|NCT01001325|454945271|FG000|Overall Study|Lost to Follow-up|16|||
126449268|NCT01001325|454945272|FG001|Overall Study|Lost to Follow-up|10|||
126449269|NCT01001325|454945271|FG000|Overall Study|Protocol Violation|2|||
126449270|NCT01001325|454945272|FG001|Overall Study|Protocol Violation|0|||
126449271|NCT01584440|454945273|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
126449272|NCT01584440|454945274|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
126449273|NCT01584440|454945275|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
126449274|NCT01584440|454945276|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
126546386|NCT02917941|455293777|FG000|Treatment Period|Progressive Disease|11|||
126251839|NCT00537095|454212318|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
126449275|NCT01584440|454945277|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
126449276|NCT01584440|454945273|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
126449277|NCT01584440|454945274|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
126546387|NCT02917941|455293777|FG000|Treatment Period|Reason not Specified|2|||
126546388|NCT02917941|455293777|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
126251840|NCT00537095|454212317|FG000|Open-label Period (590 Days)|Death|2|||
126251841|NCT00537095|454212318|FG001|Open-label Period (590 Days)|Death|2|||
126251842|NCT00537095|454212317|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
126251843|NCT00537095|454212318|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
126251844|NCT00537095|454212317|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
126251845|NCT00537095|454212318|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
126251846|NCT00533507|454212319|FG000|Overall Study|Withdrawal by Subject|1|||
126251847|NCT01576705|454212320|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
126251848|NCT01576705|454212321|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
126251849|NCT01576705|454212322|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
126251850|NCT01576705|454212323|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
126251851|NCT01576705|454212320|FG000|Overall Study|invalid ICF|0|||
126251852|NCT01576705|454212321|FG001|Overall Study|invalid ICF|1|||
126697829|NCT03952559|455845357|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
126697830|NCT03952559|455845358|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
126697831|NCT03952559|455845359|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
126697832|NCT03952559|455845360|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
126251853|NCT01576705|454212322|FG002|Overall Study|invalid ICF|0|||
126251854|NCT01576705|454212323|FG003|Overall Study|invalid ICF|0|||
126251855|NCT02597049|454212324|FG000|Overall Study|Lost to Follow-up|0|||
126251856|NCT02597049|454212325|FG001|Overall Study|Lost to Follow-up|3|||
126251857|NCT02597049|454212326|FG002|Overall Study|Lost to Follow-up|2|||
126251858|NCT02597049|454212324|FG000|Overall Study|Withdrawal by Subject|2|||
126251859|NCT02597049|454212325|FG001|Overall Study|Withdrawal by Subject|2|||
126251860|NCT02597049|454212326|FG002|Overall Study|Withdrawal by Subject|1|||
126251861|NCT02597049|454212324|FG000|Overall Study|Adverse Event|2|||
126251862|NCT02597049|454212325|FG001|Overall Study|Adverse Event|0|||
126697833|NCT03952559|455845361|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
126697834|NCT01870739|455845364|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
126697835|NCT01870739|455845365|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
126697836|NCT01870739|455845364|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
126697837|NCT01870739|455845365|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
126697838|NCT01870739|455845364|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
126251863|NCT02597049|454212326|FG002|Overall Study|Adverse Event|0|||
126251864|NCT02597049|454212324|FG000|Overall Study|Death|2|||
126697839|NCT01870739|455845365|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
126697840|NCT01870739|455845364|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
126697841|NCT01870739|455845365|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
126697842|NCT01870739|455845364|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
126697843|NCT01870739|455845365|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
126697844|NCT01870739|455845364|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
126697845|NCT01870739|455845365|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
126697846|NCT01870739|455845364|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
126697847|NCT01870739|455845365|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
126697848|NCT01986062|455845366|FG000|Overall Study|Lost to Follow-up|1|||
126697849|NCT01986062|455845367|FG001|Overall Study|Lost to Follow-up|0|||
126697850|NCT01986062|455845366|FG000|Overall Study|Withdrawal by Subject|0|||
126697851|NCT01986062|455845367|FG001|Overall Study|Withdrawal by Subject|1|||
126697852|NCT03538743|455845368|FG000|Overall Study|Adverse Event|0|||
126697853|NCT03538743|455845369|FG001|Overall Study|Adverse Event|0|||
126697854|NCT03538743|455845370|FG002|Overall Study|Adverse Event|1|||
126697855|NCT03538743|455845371|FG003|Overall Study|Adverse Event|1|||
126697856|NCT03538743|455845372|FG004|Overall Study|Adverse Event|0|||
126697857|NCT03538743|455845373|FG005|Overall Study|Adverse Event|0|||
126697858|NCT03538743|455845374|FG006|Overall Study|Adverse Event|0|||
126697859|NCT03538743|455845375|FG007|Overall Study|Adverse Event|0|||
126697860|NCT03538743|455845376|FG008|Overall Study|Adverse Event|0|||
126251865|NCT02597049|454212325|FG001|Overall Study|Death|0|||
126251866|NCT02597049|454212326|FG002|Overall Study|Death|0|||
126697861|NCT03538743|455845368|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
126697862|NCT03538743|455845369|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
126697863|NCT03538743|455845370|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
126697864|NCT03538743|455845371|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
126697865|NCT03538743|455845372|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
126697866|NCT03538743|455845373|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
126697867|NCT03538743|455845374|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
126697868|NCT03538743|455845375|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
126762495|NCT01049360|456081215|FG003|Period 4|Protocol Violation|0|||
126251867|NCT02597049|454212324|FG000|Overall Study|Noncompliant with Study Visits|1|||
126251868|NCT02597049|454212325|FG001|Overall Study|Noncompliant with Study Visits|0|||
126251869|NCT02597049|454212326|FG002|Overall Study|Noncompliant with Study Visits|0|||
126251870|NCT00243347|454212329|FG000|Overall Study|Lack of Efficacy|4|||
126251871|NCT00243347|454212329|FG000|Overall Study|Adverse Event|2|||
126251872|NCT00243347|454212329|FG000|Overall Study|Death|1|||
126251873|NCT00243347|454212329|FG000|Overall Study|Withdrawal by Subject|5|||
126251874|NCT00243347|454212329|FG000|Overall Study|Condition worsened|7|||
126251875|NCT01390948|454212331|FG000|Overall Study|End of Study|1|||
126251876|NCT01390948|454212332|FG001|Overall Study|End of Study|0|||
126251877|NCT01390948|454212333|FG002|Overall Study|End of Study|0|||
126251878|NCT01390948|454212331|FG000|Overall Study|Withdrew consent|2|||
126251879|NCT01390948|454212332|FG001|Overall Study|Withdrew consent|2|||
126251880|NCT01390948|454212333|FG002|Overall Study|Withdrew consent|0|||
126251881|NCT01390948|454212331|FG000|Overall Study|Progressive Disease|2|||
126251882|NCT01390948|454212332|FG001|Overall Study|Progressive Disease|5|||
126251883|NCT01390948|454212333|FG002|Overall Study|Progressive Disease|0|||
126251884|NCT01390948|454212331|FG000|Overall Study|Death during follow-up|10|||
126251885|NCT01390948|454212332|FG001|Overall Study|Death during follow-up|11|||
126251886|NCT01390948|454212333|FG002|Overall Study|Death during follow-up|1|||
126251887|NCT01401062|454212336|FG000|Overall Study|Death|9|||
126251888|NCT01401062|454212337|FG001|Overall Study|Death|7|||
126251889|NCT01401062|454212336|FG000|Overall Study|Physician Decision|1|||
126251890|NCT01401062|454212337|FG001|Overall Study|Physician Decision|0|||
126251891|NCT01401062|454212336|FG000|Overall Study|Withdrawal by Subject|1|||
126251892|NCT01401062|454212337|FG001|Overall Study|Withdrawal by Subject|1|||
126251893|NCT00757172|454212340|FG000|Overall Study|Withdrawal by Subject|4|||
126251894|NCT00757172|454212340|FG000|Overall Study|Physician Decision|3|||
126251895|NCT00757172|454212340|FG000|Overall Study|Progression|4|||
126251896|NCT03555695|454212341|FG000|Overall Study|Withdrawal by Subject|1|||
126251897|NCT03555695|454212341|FG000|Overall Study|Lost to Follow-up|1|||
126251898|NCT03555695|454212341|FG000|Overall Study|appendicitis (unrelated)|1|||
126251899|NCT03555695|454212341|FG000|Overall Study|pre-existing sciatica|1|||
126251900|NCT04194151|454212342|FG000|Overall Study|Physician Decision|1|||
126251901|NCT04194151|454212343|FG001|Overall Study|Physician Decision|1|||
126251902|NCT04194151|454212344|FG002|Overall Study|Physician Decision|1|||
126251903|NCT04194151|454212345|FG003|Overall Study|Physician Decision|1|||
126251904|NCT04194151|454212346|FG004|Overall Study|Physician Decision|0|||
126251905|NCT04194151|454212347|FG005|Overall Study|Physician Decision|1|||
126251906|NCT04194151|454212342|FG000|Overall Study|Monitorization problem|0|||
126251907|NCT04194151|454212343|FG001|Overall Study|Monitorization problem|1|||
126251908|NCT04194151|454212344|FG002|Overall Study|Monitorization problem|0|||
126251909|NCT04194151|454212345|FG003|Overall Study|Monitorization problem|0|||
126251910|NCT04194151|454212346|FG004|Overall Study|Monitorization problem|0|||
126251911|NCT04194151|454212347|FG005|Overall Study|Monitorization problem|0|||
126251912|NCT01499043|454212348|FG000|Overall Study|Progressive disease (radiographic)|2|||
126251913|NCT01499043|454212348|FG000|Overall Study|Progressive disease (clinical)|1|||
126251914|NCT01499043|454212348|FG000|Overall Study|Withdrawal by Subject|2|||
126251915|NCT01499043|454212348|FG000|Overall Study|Adverse Event|1|||
126251916|NCT04203823|454212350|FG000|Overall Study|Withdrawal by Subject|2|||
126251917|NCT04203823|454212351|FG001|Overall Study|Withdrawal by Subject|2|||
126251918|NCT04203823|454212350|FG000|Overall Study|Adverse Event|1|||
126251919|NCT04203823|454212351|FG001|Overall Study|Adverse Event|1|||
126251920|NCT04203823|454212350|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126251921|NCT04203823|454212351|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
126251922|NCT00438633|454212352|FG000|Overall Study|Withdrawal by Subject|1|||
126251923|NCT00438633|454212353|FG001|Overall Study|Withdrawal by Subject|0|||
126251924|NCT00438633|454212352|FG000|Overall Study|Lost to Follow-up|15|||
126251925|NCT00438633|454212353|FG001|Overall Study|Lost to Follow-up|17|||
126251926|NCT00835081|454212354|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
126251927|NCT00835081|454212355|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
126251928|NCT00421304|454212356|FG000|Overall Study|Lost to Follow-up|5|||
126251929|NCT00421304|454212357|FG001|Overall Study|Lost to Follow-up|2|||
126251930|NCT00421304|454212358|FG002|Overall Study|Lost to Follow-up|5|||
126251931|NCT00421304|454212356|FG000|Overall Study|Withdrawal by Subject|2|||
126251932|NCT00421304|454212357|FG001|Overall Study|Withdrawal by Subject|2|||
126251933|NCT00421304|454212358|FG002|Overall Study|Withdrawal by Subject|2|||
126251934|NCT00421304|454212356|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
126251935|NCT00421304|454212357|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
126251936|NCT00421304|454212358|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
126251937|NCT00421304|454212356|FG000|Overall Study|Did not attend Day 360 visit|0|||
126251938|NCT00421304|454212357|FG001|Overall Study|Did not attend Day 360 visit|0|||
126251939|NCT00421304|454212358|FG002|Overall Study|Did not attend Day 360 visit|1|||
126251940|NCT03196284|454212359|FG000|Main Part|Withdrawal by Subject|0|||
126251941|NCT03196284|454212360|FG001|Main Part|Withdrawal by Subject|1|||
126251942|NCT03196284|454212361|FG002|Main Part|Withdrawal by Subject|0|||
126251943|NCT03196284|454212359|FG000|Extension Part|Lack of Efficacy|0|||
126251944|NCT03196284|454212360|FG001|Extension Part|Lack of Efficacy|0|||
126251945|NCT03196284|454212361|FG002|Extension Part|Lack of Efficacy|1|||
126251946|NCT03196284|454212359|FG000|Extension Part|Withdrawal by Subject|0|||
126251947|NCT03196284|454212360|FG001|Extension Part|Withdrawal by Subject|0|||
126251948|NCT03196284|454212361|FG002|Extension Part|Withdrawal by Subject|1|||
126251949|NCT03196284|454212359|FG000|Extension Part|Physician Decision|0|||
126251950|NCT03196284|454212360|FG001|Extension Part|Physician Decision|0|||
126251951|NCT03196284|454212361|FG002|Extension Part|Physician Decision|1|||
126251952|NCT01912807|454212362|FG000|Overall Study|Did not meet elegibility criteria|6|||
126251953|NCT01912807|454212363|FG001|Overall Study|Did not meet elegibility criteria|4|||
126251954|NCT01912807|454212362|FG000|Overall Study|Lost to Follow-up|36|||
126251955|NCT01912807|454212363|FG001|Overall Study|Lost to Follow-up|37|||
126251956|NCT02535923|454212364|FG000|Overall Study|Lost to Follow-up|5|||
126251957|NCT02535923|454212365|FG001|Overall Study|Lost to Follow-up|5|||
126251958|NCT02535923|454212364|FG000|Overall Study|Withdrawal by Subject|4|||
126251959|NCT02535923|454212365|FG001|Overall Study|Withdrawal by Subject|3|||
126251960|NCT00754052|454213998|FG000|Overall Study|Study terminated by Sponsor|5|||
126251961|NCT00754052|454213999|FG001|Overall Study|Study terminated by Sponsor|3|||
126251962|NCT02651987|454214000|FG000|Overall Study|Adverse Event|2|||
126251963|NCT02651987|454214001|FG001|Overall Study|Adverse Event|2|||
126251964|NCT02651987|454214000|FG000|Overall Study|Consent Withdrawn|2|||
126251965|NCT02651987|454214001|FG001|Overall Study|Consent Withdrawn|0|||
126251966|NCT02651987|454214000|FG000|Overall Study|Local PD|0|||
126251967|NCT02651987|454214001|FG001|Overall Study|Local PD|2|||
126251968|NCT02651987|454214000|FG000|Overall Study|Investigator Decision|1|||
126251969|NCT02651987|454214001|FG001|Overall Study|Investigator Decision|1|||
126251970|NCT00522041|454214002|FG000|Overall Study|Adverse Event|9|||
126251971|NCT00522041|454214003|FG001|Overall Study|Adverse Event|3|||
126251972|NCT00522041|454214002|FG000|Overall Study|Protocol Violation|2|||
126251973|NCT00522041|454214003|FG001|Overall Study|Protocol Violation|0|||
126251974|NCT00522041|454214002|FG000|Overall Study|Lost to Follow-up|1|||
126251975|NCT00522041|454214003|FG001|Overall Study|Lost to Follow-up|4|||
126251976|NCT00522041|454214002|FG000|Overall Study|Voluntary withdrawal|5|||
126251977|NCT00522041|454214003|FG001|Overall Study|Voluntary withdrawal|4|||
126251978|NCT00522041|454214002|FG000|Overall Study|Did not receive treatment|0|||
126251979|NCT00522041|454214003|FG001|Overall Study|Did not receive treatment|1|||
126251980|NCT00396162|454214004|FG000|Overall Study|Withdrawal by Subject|2|||
126251981|NCT00396162|454214005|FG001|Overall Study|Withdrawal by Subject|3|||
126251982|NCT01944722|454214009|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
126251983|NCT01944722|454214009|FG000|Overall Study|Specimen Shipping Issues|34|||
126251984|NCT01944722|454214009|FG000|Overall Study|Improper Storage/Transport|5|||
126251985|NCT01944722|454214009|FG000|Overall Study|Insufficient Volume for Test|1|||
126251986|NCT01944722|454214009|FG000|Overall Study|Missing Specimens|3|||
126251987|NCT01944722|454214009|FG000|Overall Study|Specimens Mislabeled|2|||
126251988|NCT01944722|454214009|FG000|Overall Study|Withdrawal by Subject|8|||
126251989|NCT01944722|454214009|FG000|Overall Study|NILM Subjects <30 years old|8106|||
126251990|NCT01944722|454214009|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
126251991|NCT01944722|454214009|FG000|Overall Study|>ASCUS Cytology|1122|||
126251992|NCT02854800|454214010|FG000|Overall Study|Protocol Violation|16|||
126251993|NCT02854800|454214011|FG001|Overall Study|Protocol Violation|11|||
126251994|NCT02854800|454214012|FG002|Overall Study|Protocol Violation|3|||
126251995|NCT02854800|454214010|FG000|Overall Study|Withdrawal by Subject|4|||
126251996|NCT02854800|454214011|FG001|Overall Study|Withdrawal by Subject|2|||
126251997|NCT02854800|454214012|FG002|Overall Study|Withdrawal by Subject|3|||
126251998|NCT02627963|454214018|FG000|Overall Study|Randomized but not treated|2|||
126251999|NCT02627963|454214019|FG001|Overall Study|Randomized but not treated|6|||
126252000|NCT00503867|454214023|FG000|Overall Study|Lost to Follow-up|1|||
126252001|NCT00503867|454214023|FG000|Overall Study|Adverse Event|1|||
126252002|NCT00323258|454214024|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
126252003|NCT00323258|454214025|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
126252004|NCT00323258|454214024|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
126252005|NCT00323258|454214025|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
126252006|NCT00323258|454214024|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
126252007|NCT00323258|454214025|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
126252008|NCT00323258|454214024|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
126252009|NCT00323258|454214025|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
126252010|NCT00323258|454214024|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
126252011|NCT00323258|454214025|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
126252012|NCT00323258|454214024|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
126762496|NCT01049360|456081216|FG004|Period 4|Protocol Violation|0|||
126762497|NCT01049360|456081217|FG005|Period 4|Protocol Violation|0|||
126252013|NCT00323258|454214025|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
126252014|NCT00323258|454214024|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
126252015|NCT00323258|454214025|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
126252016|NCT02372006|454214035|FG000|Overall Study|Progressive disease|8|||
126252017|NCT02372006|454214036|FG001|Overall Study|Progressive disease|7|||
126252018|NCT02372006|454214037|FG002|Overall Study|Progressive disease|34|||
126252019|NCT02372006|454214035|FG000|Overall Study|Dose limiting toxicity|0|||
126252020|NCT02372006|454214036|FG001|Overall Study|Dose limiting toxicity|1|||
126252021|NCT02372006|454214037|FG002|Overall Study|Dose limiting toxicity|0|||
126252022|NCT02372006|454214035|FG000|Overall Study|Adverse Event|0|||
126252023|NCT02372006|454214036|FG001|Overall Study|Adverse Event|0|||
126252024|NCT02372006|454214037|FG002|Overall Study|Adverse Event|3|||
126252025|NCT02372006|454214035|FG000|Overall Study|Withdrawal by Subject|0|||
126252026|NCT02372006|454214036|FG001|Overall Study|Withdrawal by Subject|1|||
126252027|NCT02372006|454214037|FG002|Overall Study|Withdrawal by Subject|1|||
126252028|NCT02372006|454214035|FG000|Overall Study|Other reason for not completing|0|||
126252029|NCT02372006|454214036|FG001|Overall Study|Other reason for not completing|0|||
126252030|NCT02372006|454214037|FG002|Overall Study|Other reason for not completing|1|||
126252031|NCT01859598|454214041|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
126252032|NCT00354835|454214042|FG000|Overall Study|Death|1|||
126252033|NCT00354835|454214043|FG001|Overall Study|Death|1|||
126252034|NCT00354835|454214042|FG000|Overall Study|Physician Decision|8|||
126252035|NCT00354835|454214043|FG001|Overall Study|Physician Decision|13|||
126252036|NCT00354835|454214042|FG000|Overall Study|Withdrawal by Subject|2|||
126252037|NCT00354835|454214043|FG001|Overall Study|Withdrawal by Subject|1|||
126252038|NCT00354835|454214042|FG000|Overall Study|Ineligible|17|||
126252039|NCT00354835|454214043|FG001|Overall Study|Ineligible|16|||
126252040|NCT00354835|454214042|FG000|Overall Study|Disease progression or relapse|15|||
126252041|NCT00354835|454214043|FG001|Overall Study|Disease progression or relapse|22|||
126252042|NCT00354835|454214042|FG000|Overall Study|Adverse Event|6|||
126252043|NCT00354835|454214043|FG001|Overall Study|Adverse Event|0|||
126252044|NCT00354835|454214042|FG000|Overall Study|Refusal of further therapy|3|||
126252045|NCT00354835|454214043|FG001|Overall Study|Refusal of further therapy|8|||
126252046|NCT01968551|454214044|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
126252047|NCT01968551|454214045|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
126252048|NCT01968551|454214046|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
126252049|NCT01968551|454214044|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
126252050|NCT01968551|454214045|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
126252051|NCT01968551|454214046|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
126252052|NCT01968551|454214044|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
126252053|NCT01968551|454214045|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
126252054|NCT01968551|454214046|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
126252055|NCT01968551|454214044|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
126252056|NCT01968551|454214045|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
126252057|NCT01968551|454214046|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
126252058|NCT01968551|454214044|FG000|Extension Phase|Adverse Event|0|||
126252059|NCT01968551|454214045|FG001|Extension Phase|Adverse Event|0|||
126252060|NCT01968551|454214046|FG002|Extension Phase|Adverse Event|2|||
126252061|NCT01968551|454214044|FG000|Extension Phase|Death|0|||
126252062|NCT01968551|454214045|FG001|Extension Phase|Death|1|||
126252063|NCT01968551|454214046|FG002|Extension Phase|Death|0|||
126252064|NCT01968551|454214044|FG000|Extension Phase|Withdrew Consent|0|||
126252065|NCT01968551|454214045|FG001|Extension Phase|Withdrew Consent|0|||
126252066|NCT01968551|454214046|FG002|Extension Phase|Withdrew Consent|1|||
126252067|NCT01968551|454214044|FG000|Extension Phase|Lost to Follow-up|1|||
126252068|NCT01968551|454214045|FG001|Extension Phase|Lost to Follow-up|0|||
126252069|NCT01968551|454214046|FG002|Extension Phase|Lost to Follow-up|1|||
126252070|NCT00573313|454214049|FG000|Overall Study|Protocol Violation|5|||
126252071|NCT00573313|454214050|FG001|Overall Study|Protocol Violation|0|||
126252072|NCT00573313|454214051|FG002|Overall Study|Protocol Violation|6|||
126252073|NCT00573313|454214052|FG003|Overall Study|Protocol Violation|0|||
126252074|NCT03255980|454214053|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
126252075|NCT03255980|454214054|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
126252076|NCT03255980|454214055|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
126252077|NCT03255980|454214056|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
126252078|NCT03255980|454214053|FG000|Overall Study|Adverse Event|1|||
126252079|NCT03255980|454214054|FG001|Overall Study|Adverse Event|1|||
126252080|NCT03255980|454214055|FG002|Overall Study|Adverse Event|0|||
126252081|NCT03255980|454214056|FG003|Overall Study|Adverse Event|1|||
126546389|NCT02917941|455293777|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
126252082|NCT03255980|454214053|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
126252083|NCT03255980|454214054|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
126252084|NCT03255980|454214055|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
126252085|NCT03255980|454214056|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
126252086|NCT03255980|454214053|FG000|Overall Study|Lost to Follow-up|1|||
126252087|NCT03255980|454214054|FG001|Overall Study|Lost to Follow-up|1|||
126252088|NCT03255980|454214055|FG002|Overall Study|Lost to Follow-up|0|||
126252089|NCT03255980|454214056|FG003|Overall Study|Lost to Follow-up|3|||
126252090|NCT03255980|454214053|FG000|Overall Study|Withdrawal by Subject|0|||
126252091|NCT03255980|454214054|FG001|Overall Study|Withdrawal by Subject|1|||
126252092|NCT03255980|454214055|FG002|Overall Study|Withdrawal by Subject|0|||
126252093|NCT03255980|454214056|FG003|Overall Study|Withdrawal by Subject|3|||
126252094|NCT01597791|454214063|FG000|Overall Study|Physician Decision|2|||
126546390|NCT01351025|455293778|FG000|Week 0 - 20|Lost to Follow-up|2|||
126252095|NCT01597791|454214064|FG001|Overall Study|Physician Decision|1|||
126252096|NCT01597791|454214063|FG000|Overall Study|Cesarean Section|6|||
126252097|NCT01597791|454214064|FG001|Overall Study|Cesarean Section|7|||
126252098|NCT01597791|454214063|FG000|Overall Study|Subject withdrawal|0|||
126252099|NCT01597791|454214064|FG001|Overall Study|Subject withdrawal|1|||
126252100|NCT01597791|454214063|FG000|Overall Study|Protocol Violation|0|||
126252101|NCT01597791|454214064|FG001|Overall Study|Protocol Violation|1|||
126252102|NCT00467597|454214066|FG000|Overall Study|Withdrawal by Subject|2|||
126252103|NCT00467597|454214067|FG001|Overall Study|Withdrawal by Subject|0|||
126252104|NCT02096705|454214068|FG000|Treatment|Adverse Event|6|||
126252105|NCT02096705|454214069|FG001|Treatment|Adverse Event|3|||
126252106|NCT02096705|454214068|FG000|Treatment|Subject request to discontinue treatment|1|||
126252107|NCT02096705|454214069|FG001|Treatment|Subject request to discontinue treatment|1|||
126252108|NCT02096705|454214068|FG000|Treatment|Withdrawal by Subject|1|||
126252109|NCT02096705|454214069|FG001|Treatment|Withdrawal by Subject|0|||
126252110|NCT02096705|454214068|FG000|Treatment|Other|1|||
126252111|NCT02096705|454214069|FG001|Treatment|Other|1|||
126252112|NCT02096705|454214068|FG000|Follow-up|Withdrawal by Subject|1|||
126252113|NCT02096705|454214069|FG001|Follow-up|Withdrawal by Subject|0|||
126252114|NCT02096705|454214068|FG000|Follow-up|Adverse Event|2|||
126252115|NCT02096705|454214069|FG001|Follow-up|Adverse Event|2|||
126252116|NCT02096705|454214068|FG000|Follow-up|Subjects not reporting status|1|||
126252117|NCT02096705|454214069|FG001|Follow-up|Subjects not reporting status|2|||
126252118|NCT00884390|454214070|FG000|Overall Study|Adverse Event|0|||
126252119|NCT00884390|454214071|FG001|Overall Study|Adverse Event|1|||
126252120|NCT00884390|454214070|FG000|Overall Study|Lost to Follow-up|0|||
126252121|NCT00884390|454214071|FG001|Overall Study|Lost to Follow-up|1|||
126252122|NCT00884390|454214070|FG000|Overall Study|Physician Decision|2|||
126252123|NCT00884390|454214071|FG001|Overall Study|Physician Decision|1|||
126252124|NCT00884390|454214070|FG000|Overall Study|Protocol Violation|4|||
126252125|NCT00884390|454214071|FG001|Overall Study|Protocol Violation|1|||
126252126|NCT00884390|454214070|FG000|Overall Study|Withdrawal by Subject|4|||
126252127|NCT00884390|454214071|FG001|Overall Study|Withdrawal by Subject|1|||
126252128|NCT00884390|454214070|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
126252129|NCT00884390|454214071|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
126252130|NCT00884390|454214070|FG000|Overall Study|Other|11|||
126252131|NCT00884390|454214071|FG001|Overall Study|Other|1|||
126252132|NCT02896296|454214075|FG000|Overall Study|Adverse Event|1|||
126252133|NCT02896296|454214075|FG000|Overall Study|Lost to Follow-up|19|||
126252134|NCT02896296|454214075|FG000|Overall Study|Pregnancy|1|||
126252135|NCT02896296|454214075|FG000|Overall Study|Physician Decision|2|||
126252136|NCT02896296|454214075|FG000|Overall Study|Withdrawal by Subject|10|||
126252137|NCT02896296|454214075|FG000|Overall Study|Site closing|7|||
126252138|NCT02896296|454214075|FG000|Overall Study|Incarceration|1|||
126252139|NCT02896296|454214075|FG000|Overall Study|Relocation|1|||
126252140|NCT01874535|454214076|FG000|Overall Study|Lost to Follow-up|10|||
126252141|NCT01874535|454214077|FG001|Overall Study|Lost to Follow-up|9|||
126252142|NCT01874535|454214076|FG000|Overall Study|incomplete symptom resolution|45|||
126252143|NCT01874535|454214077|FG001|Overall Study|incomplete symptom resolution|35|||
126252144|NCT02611323|454214078|FG000|Overall Study|Death|3|||
126252145|NCT02611323|454214079|FG001|Overall Study|Death|1|||
126252146|NCT02611323|454214080|FG002|Overall Study|Death|0|||
126697869|NCT03538743|455845376|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
126697870|NCT03538743|455845368|FG000|Overall Study|Withdrawal by Subject|0|||
126697871|NCT03538743|455845369|FG001|Overall Study|Withdrawal by Subject|0|||
126697872|NCT03538743|455845370|FG002|Overall Study|Withdrawal by Subject|0|||
126697873|NCT03538743|455845371|FG003|Overall Study|Withdrawal by Subject|1|||
126697874|NCT03538743|455845372|FG004|Overall Study|Withdrawal by Subject|0|||
126697875|NCT03538743|455845373|FG005|Overall Study|Withdrawal by Subject|0|||
126697876|NCT03538743|455845374|FG006|Overall Study|Withdrawal by Subject|0|||
126697877|NCT03538743|455845375|FG007|Overall Study|Withdrawal by Subject|0|||
126697878|NCT03538743|455845376|FG008|Overall Study|Withdrawal by Subject|0|||
126697879|NCT01827384|455845378|FG000|Overall Study|Switched to alternative treatment|0|||
126697880|NCT01827384|455845379|FG001|Overall Study|Switched to alternative treatment|0|||
126697881|NCT01827384|455845380|FG002|Overall Study|Switched to alternative treatment|0|||
126697882|NCT01827384|455845381|FG003|Overall Study|Switched to alternative treatment|0|||
126697883|NCT01827384|455845382|FG004|Overall Study|Switched to alternative treatment|0|||
126697884|NCT01827384|455845383|FG005|Overall Study|Switched to alternative treatment|0|||
126697885|NCT01827384|455845384|FG006|Overall Study|Switched to alternative treatment|0|||
126697886|NCT01827384|455845385|FG007|Overall Study|Switched to alternative treatment|0|||
126697887|NCT01827384|455845386|FG008|Overall Study|Switched to alternative treatment|0|||
126697888|NCT01827384|455845387|FG009|Overall Study|Switched to alternative treatment|0|||
126697889|NCT01827384|455845388|FG010|Overall Study|Switched to alternative treatment|0|||
126697890|NCT01827384|455845389|FG011|Overall Study|Switched to alternative treatment|0|||
126697891|NCT01827384|455845390|FG012|Overall Study|Switched to alternative treatment|0|||
126697892|NCT01827384|455845391|FG013|Overall Study|Switched to alternative treatment|2|||
126697893|NCT01827384|455845378|FG000|Overall Study|Disease progression before treatment|0|||
126697894|NCT01827384|455845379|FG001|Overall Study|Disease progression before treatment|0|||
126762498|NCT01049360|456081218|FG006|Period 4|Protocol Violation|0|||
126762499|NCT01049360|456081219|FG007|Period 4|Protocol Violation|0|||
126762500|NCT01049360|456081220|FG008|Period 4|Protocol Violation|0|||
126762501|NCT01049360|456081221|FG009|Period 4|Protocol Violation|0|||
126762502|NCT01049360|456081222|FG010|Period 4|Protocol Violation|0|||
126762503|NCT01049360|456081223|FG011|Period 4|Protocol Violation|0|||
126762504|NCT01049360|456081224|FG012|Period 4|Protocol Violation|0|||
126762505|NCT01049360|456081225|FG013|Period 4|Protocol Violation|0|||
126762506|NCT01049360|456081226|FG014|Period 4|Protocol Violation|0|||
126762507|NCT01049360|456081227|FG015|Period 4|Protocol Violation|0|||
126762508|NCT01049360|456081228|FG016|Period 4|Protocol Violation|0|||
126762509|NCT01049360|456081229|FG017|Period 4|Protocol Violation|1|||
126762510|NCT01049360|456081230|FG018|Period 4|Protocol Violation|0|||
126762511|NCT01049360|456081231|FG019|Period 4|Protocol Violation|0|||
126762512|NCT01049360|456081212|FG000|Period 4|Withdrawal by Subject|0|||
126762513|NCT01049360|456081213|FG001|Period 4|Withdrawal by Subject|0|||
126762514|NCT01049360|456081214|FG002|Period 4|Withdrawal by Subject|0|||
126762515|NCT01049360|456081215|FG003|Period 4|Withdrawal by Subject|1|||
126762516|NCT01049360|456081216|FG004|Period 4|Withdrawal by Subject|0|||
126762517|NCT01049360|456081217|FG005|Period 4|Withdrawal by Subject|0|||
126762518|NCT01049360|456081218|FG006|Period 4|Withdrawal by Subject|0|||
126762519|NCT01049360|456081219|FG007|Period 4|Withdrawal by Subject|0|||
126762520|NCT01049360|456081220|FG008|Period 4|Withdrawal by Subject|0|||
126762521|NCT01049360|456081221|FG009|Period 4|Withdrawal by Subject|0|||
126762522|NCT01049360|456081222|FG010|Period 4|Withdrawal by Subject|0|||
126762523|NCT01049360|456081223|FG011|Period 4|Withdrawal by Subject|0|||
126762524|NCT01049360|456081224|FG012|Period 4|Withdrawal by Subject|0|||
126762525|NCT01049360|456081225|FG013|Period 4|Withdrawal by Subject|0|||
126762526|NCT01049360|456081226|FG014|Period 4|Withdrawal by Subject|0|||
126762527|NCT01049360|456081227|FG015|Period 4|Withdrawal by Subject|0|||
126762528|NCT01049360|456081228|FG016|Period 4|Withdrawal by Subject|0|||
126762529|NCT01049360|456081229|FG017|Period 4|Withdrawal by Subject|0|||
126762530|NCT01049360|456081230|FG018|Period 4|Withdrawal by Subject|0|||
126697895|NCT01827384|455845380|FG002|Overall Study|Disease progression before treatment|0|||
126252147|NCT02611323|454214081|FG003|Overall Study|Death|0|||
126252148|NCT02611323|454214082|FG004|Overall Study|Death|1|||
126252149|NCT02611323|454214083|FG005|Overall Study|Death|1|||
126252150|NCT02611323|454214084|FG006|Overall Study|Death|8|||
126252151|NCT02611323|454214085|FG007|Overall Study|Death|0|||
126252152|NCT02611323|454214086|FG008|Overall Study|Death|4|||
126252153|NCT02611323|454214087|FG009|Overall Study|Death|6|||
126252154|NCT02611323|454214088|FG010|Overall Study|Death|26|||
126252155|NCT02611323|454214078|FG000|Overall Study|Lost to Follow-up|1|||
126252156|NCT02611323|454214079|FG001|Overall Study|Lost to Follow-up|0|||
126252157|NCT02611323|454214080|FG002|Overall Study|Lost to Follow-up|0|||
126252158|NCT02611323|454214081|FG003|Overall Study|Lost to Follow-up|0|||
126697896|NCT01827384|455845381|FG003|Overall Study|Disease progression before treatment|0|||
126697897|NCT01827384|455845382|FG004|Overall Study|Disease progression before treatment|0|||
126697898|NCT01827384|455845383|FG005|Overall Study|Disease progression before treatment|0|||
126697899|NCT01827384|455845384|FG006|Overall Study|Disease progression before treatment|0|||
126697900|NCT01827384|455845385|FG007|Overall Study|Disease progression before treatment|0|||
126697901|NCT01827384|455845386|FG008|Overall Study|Disease progression before treatment|0|||
126697902|NCT01827384|455845387|FG009|Overall Study|Disease progression before treatment|0|||
126697903|NCT01827384|455845388|FG010|Overall Study|Disease progression before treatment|0|||
126697904|NCT01827384|455845389|FG011|Overall Study|Disease progression before treatment|0|||
126697905|NCT01827384|455845390|FG012|Overall Study|Disease progression before treatment|0|||
126697906|NCT01827384|455845391|FG013|Overall Study|Disease progression before treatment|4|||
126697907|NCT01827384|455845378|FG000|Overall Study|Ineligible|0|||
126697908|NCT01827384|455845379|FG001|Overall Study|Ineligible|0|||
126697909|NCT01827384|455845380|FG002|Overall Study|Ineligible|0|||
126762531|NCT01049360|456081231|FG019|Period 4|Withdrawal by Subject|0|||
126762532|NCT01694849|456081232|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
126762533|NCT01694849|456081233|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
126762534|NCT01694849|456081234|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
126762535|NCT01694849|456081232|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
126762536|NCT01694849|456081233|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
126762537|NCT01694849|456081234|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
126762538|NCT01694849|456081232|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
126762539|NCT01694849|456081233|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
126252159|NCT02611323|454214082|FG004|Overall Study|Lost to Follow-up|0|||
126449278|NCT01584440|454945275|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
126697910|NCT01827384|455845381|FG003|Overall Study|Ineligible|0|||
126252160|NCT02611323|454214083|FG005|Overall Study|Lost to Follow-up|0|||
126697911|NCT01827384|455845382|FG004|Overall Study|Ineligible|0|||
126697912|NCT01827384|455845383|FG005|Overall Study|Ineligible|0|||
126252161|NCT02611323|454214084|FG006|Overall Study|Lost to Follow-up|3|||
126252162|NCT02611323|454214085|FG007|Overall Study|Lost to Follow-up|0|||
126358084|NCT00378560|454603879|FG001|Overall Study|Withdrawal by Subject|21|||
126358085|NCT00378560|454603878|FG000|Overall Study|Moved|4|||
126358086|NCT00378560|454603879|FG001|Overall Study|Moved|3|||
126358087|NCT00378560|454603878|FG000|Overall Study|Pregnancy|7|||
126358088|NCT00378560|454603879|FG001|Overall Study|Pregnancy|5|||
126358089|NCT00378560|454603878|FG000|Overall Study|Laboratory test values abnormal|1|||
126697913|NCT01827384|455845384|FG006|Overall Study|Ineligible|0|||
126697914|NCT01827384|455845385|FG007|Overall Study|Ineligible|0|||
126697915|NCT01827384|455845386|FG008|Overall Study|Ineligible|0|||
126697916|NCT01827384|455845387|FG009|Overall Study|Ineligible|0|||
126697917|NCT01827384|455845388|FG010|Overall Study|Ineligible|0|||
126697918|NCT01827384|455845389|FG011|Overall Study|Ineligible|0|||
126697919|NCT01827384|455845390|FG012|Overall Study|Ineligible|0|||
126697920|NCT01827384|455845391|FG013|Overall Study|Ineligible|19|||
126697921|NCT01827384|455845378|FG000|Overall Study|Participant died before treatment|0|||
126697922|NCT01827384|455845379|FG001|Overall Study|Participant died before treatment|0|||
126697923|NCT01827384|455845380|FG002|Overall Study|Participant died before treatment|0|||
126697924|NCT01827384|455845381|FG003|Overall Study|Participant died before treatment|0|||
126697925|NCT01827384|455845382|FG004|Overall Study|Participant died before treatment|0|||
126697926|NCT01827384|455845383|FG005|Overall Study|Participant died before treatment|0|||
126697927|NCT01827384|455845384|FG006|Overall Study|Participant died before treatment|0|||
126697928|NCT01827384|455845385|FG007|Overall Study|Participant died before treatment|0|||
126697929|NCT01827384|455845386|FG008|Overall Study|Participant died before treatment|0|||
126697930|NCT01827384|455845387|FG009|Overall Study|Participant died before treatment|0|||
126697931|NCT01827384|455845388|FG010|Overall Study|Participant died before treatment|0|||
126697932|NCT01827384|455845389|FG011|Overall Study|Participant died before treatment|0|||
126697933|NCT01827384|455845390|FG012|Overall Study|Participant died before treatment|0|||
126697934|NCT01827384|455845391|FG013|Overall Study|Participant died before treatment|5|||
126697935|NCT01827384|455845378|FG000|Overall Study|Insufficient tumor cells|0|||
126697936|NCT01827384|455845379|FG001|Overall Study|Insufficient tumor cells|0|||
126697937|NCT01827384|455845380|FG002|Overall Study|Insufficient tumor cells|0|||
126697938|NCT01827384|455845381|FG003|Overall Study|Insufficient tumor cells|0|||
126697939|NCT01827384|455845382|FG004|Overall Study|Insufficient tumor cells|0|||
126697940|NCT01827384|455845383|FG005|Overall Study|Insufficient tumor cells|0|||
126697941|NCT01827384|455845384|FG006|Overall Study|Insufficient tumor cells|0|||
126697942|NCT01827384|455845385|FG007|Overall Study|Insufficient tumor cells|0|||
126697943|NCT01827384|455845386|FG008|Overall Study|Insufficient tumor cells|0|||
126697944|NCT01827384|455845387|FG009|Overall Study|Insufficient tumor cells|0|||
126697945|NCT01827384|455845388|FG010|Overall Study|Insufficient tumor cells|0|||
126697946|NCT01827384|455845389|FG011|Overall Study|Insufficient tumor cells|0|||
126697947|NCT01827384|455845390|FG012|Overall Study|Insufficient tumor cells|0|||
126697948|NCT01827384|455845391|FG013|Overall Study|Insufficient tumor cells|13|||
126697949|NCT01827384|455845378|FG000|Overall Study|No actionable mutation|0|||
126697950|NCT01827384|455845379|FG001|Overall Study|No actionable mutation|0|||
126697951|NCT01827384|455845380|FG002|Overall Study|No actionable mutation|0|||
126697952|NCT01827384|455845381|FG003|Overall Study|No actionable mutation|0|||
126697953|NCT01827384|455845382|FG004|Overall Study|No actionable mutation|0|||
126697954|NCT01827384|455845383|FG005|Overall Study|No actionable mutation|0|||
126697955|NCT01827384|455845384|FG006|Overall Study|No actionable mutation|0|||
126697956|NCT01827384|455845385|FG007|Overall Study|No actionable mutation|0|||
126697957|NCT01827384|455845386|FG008|Overall Study|No actionable mutation|0|||
126697958|NCT01827384|455845387|FG009|Overall Study|No actionable mutation|0|||
126697959|NCT01827384|455845388|FG010|Overall Study|No actionable mutation|0|||
126697960|NCT01827384|455845389|FG011|Overall Study|No actionable mutation|0|||
126697961|NCT01827384|455845390|FG012|Overall Study|No actionable mutation|0|||
126697962|NCT01827384|455845391|FG013|Overall Study|No actionable mutation|73|||
126697963|NCT01827384|455845378|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
126697964|NCT01827384|455845379|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
126697965|NCT01827384|455845380|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
126697966|NCT01827384|455845381|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
126697967|NCT01827384|455845382|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
126697968|NCT01827384|455845383|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
126697969|NCT01827384|455845384|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
126697970|NCT01827384|455845385|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
126358090|NCT00378560|454603879|FG001|Overall Study|Laboratory test values abnormal|0|||
126358091|NCT02852434|454603880|FG000|Overall Study|Withdrawal by Subject|0|||
126697971|NCT01827384|455845386|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
126697972|NCT01827384|455845387|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
126697973|NCT01827384|455845388|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
126697974|NCT01827384|455845389|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
126697975|NCT01827384|455845390|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
126252163|NCT02611323|454214086|FG008|Overall Study|Lost to Follow-up|0|||
126252164|NCT02611323|454214087|FG009|Overall Study|Lost to Follow-up|0|||
126252165|NCT02611323|454214088|FG010|Overall Study|Lost to Follow-up|2|||
126252166|NCT02611323|454214078|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252167|NCT02611323|454214079|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252168|NCT02611323|454214080|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252169|NCT02611323|454214081|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252170|NCT02611323|454214082|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252171|NCT02611323|454214083|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252172|NCT02611323|454214084|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252173|NCT02611323|454214085|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
126697976|NCT01827384|455845391|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
126697977|NCT03219164|455846996|FG000|Overall Study|Study Terminated by Sponsor|16|||
126697978|NCT03219164|455846997|FG001|Overall Study|Study Terminated by Sponsor|12|||
126697979|NCT03219164|455846996|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
126252174|NCT02611323|454214086|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252175|NCT02611323|454214087|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
126252176|NCT02611323|454214088|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
126252177|NCT02611323|454214078|FG000|Overall Study|Progressive Disease|0|||
126252178|NCT02611323|454214079|FG001|Overall Study|Progressive Disease|0|||
126252179|NCT02611323|454214080|FG002|Overall Study|Progressive Disease|0|||
126252180|NCT02611323|454214081|FG003|Overall Study|Progressive Disease|0|||
126252181|NCT02611323|454214082|FG004|Overall Study|Progressive Disease|0|||
126252182|NCT02611323|454214083|FG005|Overall Study|Progressive Disease|0|||
126252183|NCT02611323|454214084|FG006|Overall Study|Progressive Disease|0|||
126252184|NCT02611323|454214085|FG007|Overall Study|Progressive Disease|0|||
126252185|NCT02611323|454214086|FG008|Overall Study|Progressive Disease|0|||
126252186|NCT02611323|454214087|FG009|Overall Study|Progressive Disease|0|||
126252187|NCT02611323|454214088|FG010|Overall Study|Progressive Disease|1|||
126252188|NCT02611323|454214078|FG000|Overall Study|Withdrawal by Subject|1|||
126252189|NCT02611323|454214079|FG001|Overall Study|Withdrawal by Subject|0|||
126252190|NCT02611323|454214080|FG002|Overall Study|Withdrawal by Subject|0|||
126252191|NCT02611323|454214081|FG003|Overall Study|Withdrawal by Subject|0|||
126252192|NCT02611323|454214082|FG004|Overall Study|Withdrawal by Subject|0|||
126252193|NCT02611323|454214083|FG005|Overall Study|Withdrawal by Subject|0|||
126252194|NCT02611323|454214084|FG006|Overall Study|Withdrawal by Subject|0|||
126252195|NCT02611323|454214085|FG007|Overall Study|Withdrawal by Subject|1|||
126252196|NCT02611323|454214086|FG008|Overall Study|Withdrawal by Subject|0|||
126252197|NCT02611323|454214087|FG009|Overall Study|Withdrawal by Subject|1|||
126252198|NCT02611323|454214088|FG010|Overall Study|Withdrawal by Subject|0|||
126252199|NCT01215721|454214089|FG000|Overall Study|Adverse Event|2|||
126252200|NCT00045162|454214090|FG000|Overall Study|Ineligible|12|||
126252201|NCT00045162|454214091|FG001|Overall Study|Ineligible|8|||
126252202|NCT00045162|454214090|FG000|Overall Study|Not treated|7|||
126252203|NCT00045162|454214091|FG001|Overall Study|Not treated|2|||
126252204|NCT00045162|454214090|FG000|Overall Study|Adverse Event|55|||
126697980|NCT03219164|455846997|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
126697981|NCT03219164|455846996|FG000|Overall Study|Lost to Follow-up|1|||
126252205|NCT00045162|454214091|FG001|Overall Study|Adverse Event|50|||
126252206|NCT00045162|454214090|FG000|Overall Study|Lack of Efficacy|32|||
126252207|NCT00045162|454214091|FG001|Overall Study|Lack of Efficacy|29|||
126252208|NCT00045162|454214090|FG000|Overall Study|Death|10|||
126252209|NCT00045162|454214091|FG001|Overall Study|Death|10|||
126252210|NCT00045162|454214090|FG000|Overall Study|Withdrawal by Subject|5|||
126252211|NCT00045162|454214091|FG001|Overall Study|Withdrawal by Subject|3|||
126252212|NCT00045162|454214090|FG000|Overall Study|Other|21|||
126252213|NCT00045162|454214091|FG001|Overall Study|Other|16|||
126252214|NCT01044433|454214092|FG000|Overall Study|Lost to Follow-up|3|||
126252215|NCT01044433|454214092|FG000|Overall Study|Withdrawal by Subject|3|||
126252216|NCT01899053|454214094|FG000|Overall Study|Progressive Disease|4|||
126252217|NCT01899053|454214095|FG001|Overall Study|Progressive Disease|0|||
126252218|NCT01899053|454214096|FG002|Overall Study|Progressive Disease|3|||
126252219|NCT01899053|454214097|FG003|Overall Study|Progressive Disease|0|||
126252220|NCT01899053|454214098|FG004|Overall Study|Progressive Disease|3|||
126252221|NCT01899053|454214099|FG005|Overall Study|Progressive Disease|1|||
126252222|NCT01899053|454214100|FG006|Overall Study|Progressive Disease|1|||
126252223|NCT01899053|454214101|FG007|Overall Study|Progressive Disease|1|||
126252224|NCT01899053|454214102|FG008|Overall Study|Progressive Disease|4|||
126252225|NCT01899053|454214103|FG009|Overall Study|Progressive Disease|3|||
126252226|NCT01899053|454214104|FG010|Overall Study|Progressive Disease|12|||
126252227|NCT01899053|454214105|FG011|Overall Study|Progressive Disease|5|||
126252228|NCT01899053|454214106|FG012|Overall Study|Progressive Disease|8|||
126252229|NCT01899053|454214107|FG013|Overall Study|Progressive Disease|17|||
126252230|NCT01899053|454214094|FG000|Overall Study|Adverse Event|1|||
126252231|NCT01899053|454214095|FG001|Overall Study|Adverse Event|1|||
126697982|NCT03219164|455846997|FG001|Overall Study|Lost to Follow-up|1|||
126252232|NCT01899053|454214096|FG002|Overall Study|Adverse Event|1|||
126252233|NCT01899053|454214097|FG003|Overall Study|Adverse Event|3|||
126252234|NCT01899053|454214098|FG004|Overall Study|Adverse Event|1|||
126252235|NCT01899053|454214099|FG005|Overall Study|Adverse Event|1|||
126252236|NCT01899053|454214100|FG006|Overall Study|Adverse Event|1|||
126252237|NCT01899053|454214101|FG007|Overall Study|Adverse Event|0|||
126252238|NCT01899053|454214102|FG008|Overall Study|Adverse Event|2|||
126252239|NCT01899053|454214103|FG009|Overall Study|Adverse Event|0|||
126252240|NCT01899053|454214104|FG010|Overall Study|Adverse Event|3|||
126252241|NCT01899053|454214105|FG011|Overall Study|Adverse Event|1|||
126252242|NCT01899053|454214106|FG012|Overall Study|Adverse Event|2|||
126252243|NCT01899053|454214107|FG013|Overall Study|Adverse Event|2|||
126762540|NCT01694849|456081234|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
126762541|NCT01694849|456081232|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
126762542|NCT01694849|456081233|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
126762543|NCT01694849|456081234|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
126762544|NCT01694849|456081232|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
126762545|NCT01694849|456081233|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
126762546|NCT01694849|456081234|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
126762547|NCT01694849|456081232|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
126762548|NCT01694849|456081233|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
126762549|NCT01694849|456081234|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
126762550|NCT01694849|456081232|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
126762551|NCT01694849|456081233|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
126762552|NCT01694849|456081234|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
126762553|NCT01694849|456081232|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
126762554|NCT01694849|456081233|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
126762555|NCT01694849|456081234|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
126762556|NCT00596466|456081237|FG000|Overall Study|Lack of Efficacy|5|||
126762557|NCT00596466|456081237|FG000|Overall Study|Adverse Event|4|||
126762558|NCT00596466|456081237|FG000|Overall Study|Withdrawal by Subject|2|||
126762559|NCT00596466|456081237|FG000|Overall Study|Protocol Violation|2|||
126762560|NCT00596466|456081237|FG000|Overall Study|Unpecified|2|||
126762561|NCT00596466|456081237|FG000|Overall Study|Enrolled, not treated|2|||
126762562|NCT00908375|456081238|FG000|Overall Study|Withdrawal by Subject|2|||
126252244|NCT01899053|454214094|FG000|Overall Study|Reason Not Specified|0|||
126762563|NCT00908375|456081239|FG001|Overall Study|Withdrawal by Subject|4|||
126762564|NCT00908375|456081238|FG000|Overall Study|Lost to Follow-up|8|||
126252245|NCT01899053|454214095|FG001|Overall Study|Reason Not Specified|0|||
126252246|NCT01899053|454214096|FG002|Overall Study|Reason Not Specified|0|||
126252247|NCT01899053|454214097|FG003|Overall Study|Reason Not Specified|0|||
126252248|NCT01899053|454214098|FG004|Overall Study|Reason Not Specified|0|||
126252249|NCT01899053|454214099|FG005|Overall Study|Reason Not Specified|0|||
126252250|NCT01899053|454214100|FG006|Overall Study|Reason Not Specified|1|||
126252251|NCT01899053|454214101|FG007|Overall Study|Reason Not Specified|0|||
126252252|NCT01899053|454214102|FG008|Overall Study|Reason Not Specified|0|||
126252253|NCT01899053|454214103|FG009|Overall Study|Reason Not Specified|0|||
126252254|NCT01899053|454214104|FG010|Overall Study|Reason Not Specified|0|||
126252255|NCT01899053|454214105|FG011|Overall Study|Reason Not Specified|0|||
126252256|NCT01899053|454214106|FG012|Overall Study|Reason Not Specified|1|||
126252257|NCT01899053|454214107|FG013|Overall Study|Reason Not Specified|0|||
126252258|NCT01899053|454214094|FG000|Overall Study|Withdrawal by Subject|1|||
126252259|NCT01899053|454214095|FG001|Overall Study|Withdrawal by Subject|1|||
126252260|NCT01899053|454214096|FG002|Overall Study|Withdrawal by Subject|2|||
126252261|NCT01899053|454214097|FG003|Overall Study|Withdrawal by Subject|0|||
126252262|NCT01899053|454214098|FG004|Overall Study|Withdrawal by Subject|2|||
126252263|NCT01899053|454214099|FG005|Overall Study|Withdrawal by Subject|0|||
126252264|NCT01899053|454214100|FG006|Overall Study|Withdrawal by Subject|0|||
126252265|NCT01899053|454214101|FG007|Overall Study|Withdrawal by Subject|1|||
126252266|NCT01899053|454214102|FG008|Overall Study|Withdrawal by Subject|0|||
126252267|NCT01899053|454214103|FG009|Overall Study|Withdrawal by Subject|0|||
126252268|NCT01899053|454214104|FG010|Overall Study|Withdrawal by Subject|0|||
126252269|NCT01899053|454214105|FG011|Overall Study|Withdrawal by Subject|0|||
126252270|NCT01899053|454214106|FG012|Overall Study|Withdrawal by Subject|1|||
126252271|NCT01899053|454214107|FG013|Overall Study|Withdrawal by Subject|1|||
126252272|NCT01899053|454214094|FG000|Overall Study|Protocol Violation|0|||
126252273|NCT01899053|454214095|FG001|Overall Study|Protocol Violation|0|||
126252274|NCT01899053|454214096|FG002|Overall Study|Protocol Violation|1|||
126252275|NCT01899053|454214097|FG003|Overall Study|Protocol Violation|0|||
126252276|NCT01899053|454214098|FG004|Overall Study|Protocol Violation|0|||
126252277|NCT01899053|454214099|FG005|Overall Study|Protocol Violation|0|||
126252278|NCT01899053|454214100|FG006|Overall Study|Protocol Violation|0|||
126252279|NCT01899053|454214101|FG007|Overall Study|Protocol Violation|0|||
126252280|NCT01899053|454214102|FG008|Overall Study|Protocol Violation|0|||
126252281|NCT01899053|454214103|FG009|Overall Study|Protocol Violation|0|||
126697983|NCT03219164|455846996|FG000|Overall Study|Adverse Event|1|||
126697984|NCT03219164|455846997|FG001|Overall Study|Adverse Event|0|||
126697985|NCT03219164|455846996|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126697986|NCT03219164|455846997|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126697987|NCT03219164|455846996|FG000|Overall Study|Protocol Violation|0|||
126697988|NCT03219164|455846997|FG001|Overall Study|Protocol Violation|1|||
126697989|NCT03219164|455846996|FG000|Overall Study|Withdrew Assent|1|||
126697990|NCT03219164|455846997|FG001|Overall Study|Withdrew Assent|0|||
126697991|NCT02689492|455846998|FG000|Overall Study|Lost to Follow-up|61|||
126697992|NCT02689492|455846998|FG000|Overall Study|Withdrawal by Subject|11|||
126697993|NCT02689492|455846998|FG000|Overall Study|Death|9|||
126697994|NCT02689492|455846998|FG000|Overall Study|Physician Decision|2|||
126697995|NCT02689492|455846998|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
126697996|NCT02689492|455846998|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
126697997|NCT02689492|455846998|FG000|Overall Study|Other than listed|1|||
126697998|NCT02029976|455846999|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
126697999|NCT02029976|455847000|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
126698000|NCT02029976|455846999|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
126698001|NCT02029976|455847000|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
126698002|NCT02029976|455846999|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
126698003|NCT02029976|455847000|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
126698004|NCT02029976|455846999|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
126698005|NCT02029976|455847000|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
126698006|NCT01750918|455847001|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
126698007|NCT01750918|455847002|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
126252282|NCT01899053|454214104|FG010|Overall Study|Protocol Violation|0|||
126252283|NCT01899053|454214105|FG011|Overall Study|Protocol Violation|0|||
126252284|NCT01899053|454214106|FG012|Overall Study|Protocol Violation|0|||
126252285|NCT01899053|454214107|FG013|Overall Study|Protocol Violation|0|||
126252286|NCT01899053|454214094|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
126252287|NCT01899053|454214095|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
126252288|NCT01899053|454214096|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252289|NCT01899053|454214097|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252290|NCT01899053|454214098|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252291|NCT01899053|454214099|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
126358092|NCT02852434|454603881|FG001|Overall Study|Withdrawal by Subject|1|||
126252292|NCT01899053|454214100|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252293|NCT01899053|454214101|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252294|NCT01899053|454214102|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252295|NCT01899053|454214103|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252296|NCT01899053|454214104|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
126252297|NCT01899053|454214105|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252298|NCT01899053|454214106|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252299|NCT01899053|454214107|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
126252300|NCT01899053|454214094|FG000|Overall Study|Symptomatic Deterioration|0|||
126252301|NCT01899053|454214095|FG001|Overall Study|Symptomatic Deterioration|0|||
126252302|NCT01899053|454214096|FG002|Overall Study|Symptomatic Deterioration|0|||
126252303|NCT01899053|454214097|FG003|Overall Study|Symptomatic Deterioration|0|||
126252304|NCT01899053|454214098|FG004|Overall Study|Symptomatic Deterioration|0|||
126252305|NCT01899053|454214099|FG005|Overall Study|Symptomatic Deterioration|1|||
126252306|NCT01899053|454214100|FG006|Overall Study|Symptomatic Deterioration|0|||
126252307|NCT01899053|454214101|FG007|Overall Study|Symptomatic Deterioration|1|||
126252308|NCT01899053|454214102|FG008|Overall Study|Symptomatic Deterioration|0|||
126252309|NCT01899053|454214103|FG009|Overall Study|Symptomatic Deterioration|0|||
126252310|NCT01899053|454214104|FG010|Overall Study|Symptomatic Deterioration|0|||
126252311|NCT01899053|454214105|FG011|Overall Study|Symptomatic Deterioration|1|||
126252312|NCT01899053|454214106|FG012|Overall Study|Symptomatic Deterioration|2|||
126358093|NCT02852434|454603880|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
126698008|NCT01750918|455847003|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
126698009|NCT01750918|455847004|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
126698010|NCT01750918|455847005|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
126698011|NCT01750918|455847006|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
126698012|NCT01750918|455847007|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
126698013|NCT01750918|455847008|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
126252313|NCT01899053|454214107|FG013|Overall Study|Symptomatic Deterioration|0|||
126252314|NCT03105297|454214108|FG000|Baseline Phase (Day 1)|Other|21|||
126698014|NCT01750918|455847001|FG000|Overall Study|Lost to Follow-up|0|||
126698015|NCT01750918|455847002|FG001|Overall Study|Lost to Follow-up|0|||
126698016|NCT01750918|455847003|FG002|Overall Study|Lost to Follow-up|2|||
126698017|NCT01750918|455847004|FG003|Overall Study|Lost to Follow-up|2|||
126698018|NCT01750918|455847005|FG004|Overall Study|Lost to Follow-up|0|||
126698019|NCT01750918|455847006|FG005|Overall Study|Lost to Follow-up|0|||
126698020|NCT01750918|455847007|FG006|Overall Study|Lost to Follow-up|0|||
126762565|NCT00908375|456081239|FG001|Overall Study|Lost to Follow-up|6|||
126762566|NCT00752206|456081240|FG000|Overall Study|Disease progression|8|||
126762567|NCT00752206|456081241|FG001|Overall Study|Disease progression|11|||
126358094|NCT02852434|454603881|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
126358095|NCT01011283|454603885|FG000|Overall Study|Adverse Event|4|||
126358096|NCT01011283|454603886|FG001|Overall Study|Adverse Event|2|||
126762568|NCT00752206|456081240|FG000|Overall Study|Pregnancy|1|||
126762569|NCT00752206|456081241|FG001|Overall Study|Pregnancy|0|||
126762570|NCT00678652|456081242|FG000|Overall Study|Protocol Violation|2|||
126762571|NCT00678652|456081243|FG001|Overall Study|Protocol Violation|0|||
126762572|NCT00678652|456081244|FG002|Overall Study|Protocol Violation|0|||
126762573|NCT00678652|456081245|FG003|Overall Study|Protocol Violation|0|||
126762574|NCT00678652|456081242|FG000|Overall Study|Pregnancy|0|||
126449279|NCT01584440|454945276|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
126449280|NCT01584440|454945277|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
126449281|NCT01584440|454945273|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
126449282|NCT01584440|454945274|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
126449283|NCT01584440|454945275|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
126762575|NCT00678652|456081243|FG001|Overall Study|Pregnancy|0|||
126762576|NCT00678652|456081244|FG002|Overall Study|Pregnancy|1|||
126762577|NCT00678652|456081245|FG003|Overall Study|Pregnancy|0|||
126762578|NCT00678652|456081242|FG000|Overall Study|Relocation|1|||
126762579|NCT00678652|456081243|FG001|Overall Study|Relocation|0|||
126449284|NCT01584440|454945276|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
126449285|NCT01584440|454945277|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
126449286|NCT01584440|454945273|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
126762580|NCT00678652|456081244|FG002|Overall Study|Relocation|0|||
126762581|NCT00678652|456081245|FG003|Overall Study|Relocation|0|||
126762582|NCT01013207|456082646|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
126762583|NCT00463385|456082651|FG000|Overall Study|Other|4|||
126762584|NCT00463385|456082652|FG001|Overall Study|Other|3|||
126762585|NCT00463385|456082653|FG002|Overall Study|Other|6|||
126762586|NCT00463385|456082654|FG003|Overall Study|Other|4|||
126762587|NCT00463385|456082651|FG000|Overall Study|Adverse Event|5|||
126358097|NCT01011283|454603885|FG000|Overall Study|Progressive Disease|0|||
126358098|NCT01011283|454603886|FG001|Overall Study|Progressive Disease|2|||
126358099|NCT01011283|454603885|FG000|Overall Study|Terminated by Sponsor|5|||
126358100|NCT01011283|454603886|FG001|Overall Study|Terminated by Sponsor|5|||
126358101|NCT01011283|454603885|FG000|Overall Study|Other|2|||
126358102|NCT01011283|454603886|FG001|Overall Study|Other|2|||
126358103|NCT04865978|454603890|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
126358104|NCT04865978|454603891|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
126358105|NCT03835117|454603892|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
126358106|NCT03835117|454603893|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
126358107|NCT00609973|454603897|FG000|Overall Study|Adverse Event|2|||
126358108|NCT00609973|454603898|FG001|Overall Study|Adverse Event|1|||
126358109|NCT00609973|454603897|FG000|Overall Study|Protocol Violation|4|||
126358110|NCT00609973|454603898|FG001|Overall Study|Protocol Violation|3|||
126358111|NCT00609973|454603897|FG000|Overall Study|Lost to Follow-up|2|||
126358112|NCT00609973|454603898|FG001|Overall Study|Lost to Follow-up|1|||
126358113|NCT00609973|454603897|FG000|Overall Study|Withdrawal by Subject|0|||
126358114|NCT00609973|454603898|FG001|Overall Study|Withdrawal by Subject|1|||
126358115|NCT00191152|454603900|FG000|Initial Treatment|Adverse Event|43|||
126358116|NCT00191152|454603901|FG001|Initial Treatment|Adverse Event|67|||
126358117|NCT00191152|454603900|FG000|Initial Treatment|Physician Decision|40|||
126358118|NCT00191152|454603901|FG001|Initial Treatment|Physician Decision|31|||
126358119|NCT00191152|454603900|FG000|Initial Treatment|Withdrawal by Subject|40|||
126358120|NCT00191152|454603901|FG001|Initial Treatment|Withdrawal by Subject|28|||
126358121|NCT00191152|454603900|FG000|Initial Treatment|Lost to Follow-up|0|||
126358122|NCT00191152|454603901|FG001|Initial Treatment|Lost to Follow-up|6|||
126358123|NCT00191152|454603900|FG000|Initial Treatment|Other|18|||
126358124|NCT00191152|454603901|FG001|Initial Treatment|Other|21|||
126358125|NCT00191152|454603900|FG000|Crossover Treatment|Adverse Event|8|||
126358126|NCT00191152|454603901|FG001|Crossover Treatment|Adverse Event|8|||
126546391|NCT01351025|455293779|FG001|Week 0 - 20|Lost to Follow-up|1|||
126762588|NCT00463385|456082652|FG001|Overall Study|Adverse Event|8|||
126762589|NCT00463385|456082653|FG002|Overall Study|Adverse Event|4|||
126762590|NCT00463385|456082654|FG003|Overall Study|Adverse Event|2|||
126762591|NCT00463385|456082651|FG000|Overall Study|Lack of Efficacy|6|||
126762592|NCT00463385|456082652|FG001|Overall Study|Lack of Efficacy|6|||
126762593|NCT00463385|456082653|FG002|Overall Study|Lack of Efficacy|7|||
126762594|NCT00463385|456082654|FG003|Overall Study|Lack of Efficacy|9|||
126762595|NCT00463385|456082651|FG000|Overall Study|Withdrawal by Subject|3|||
126358127|NCT00191152|454603900|FG000|Crossover Treatment|Physician Decision|7|||
126358128|NCT00191152|454603901|FG001|Crossover Treatment|Physician Decision|7|||
126358129|NCT00191152|454603900|FG000|Crossover Treatment|Withdrawal by Subject|6|||
126358130|NCT00191152|454603901|FG001|Crossover Treatment|Withdrawal by Subject|9|||
126358131|NCT00191152|454603900|FG000|Crossover Treatment|Lost to Follow-up|2|||
126449287|NCT01584440|454945274|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
126762596|NCT00463385|456082652|FG001|Overall Study|Withdrawal by Subject|3|||
126762597|NCT00463385|456082653|FG002|Overall Study|Withdrawal by Subject|3|||
126762598|NCT00463385|456082654|FG003|Overall Study|Withdrawal by Subject|4|||
126762599|NCT00463385|456082651|FG000|Overall Study|Lost to Follow-up|0|||
126762600|NCT00463385|456082652|FG001|Overall Study|Lost to Follow-up|0|||
126762601|NCT00463385|456082653|FG002|Overall Study|Lost to Follow-up|0|||
126762602|NCT00463385|456082654|FG003|Overall Study|Lost to Follow-up|1|||
126762603|NCT00463385|456082651|FG000|Overall Study|Death|2|||
126762604|NCT00463385|456082652|FG001|Overall Study|Death|1|||
126762605|NCT00463385|456082653|FG002|Overall Study|Death|2|||
126762606|NCT00463385|456082654|FG003|Overall Study|Death|0|||
126762607|NCT00463385|456082651|FG000|Overall Study|Missing|2|||
126762608|NCT00463385|456082652|FG001|Overall Study|Missing|0|||
126762609|NCT00463385|456082653|FG002|Overall Study|Missing|0|||
126762610|NCT00463385|456082654|FG003|Overall Study|Missing|2|||
126762611|NCT00463385|456082651|FG000|Overall Study|1 participant received commercial drug|0|||
126762612|NCT00463385|456082652|FG001|Overall Study|1 participant received commercial drug|1|||
126762613|NCT00463385|456082653|FG002|Overall Study|1 participant received commercial drug|0|||
126762614|NCT00463385|456082654|FG003|Overall Study|1 participant received commercial drug|0|||
126762615|NCT01600755|456082657|FG000|Overall Study|Withdrawal by Subject|6|||
126762616|NCT01548573|456082662|FG000|Overall Study|Death|3|||
126762617|NCT01548573|456082662|FG000|Overall Study|Withdrawal by Subject|2|||
126762618|NCT01366846|456082663|FG000|Overall Study|Withdrawal by Subject|2|||
126762619|NCT01366846|456082664|FG001|Overall Study|Withdrawal by Subject|0|||
126762620|NCT01366846|456082665|FG002|Overall Study|Withdrawal by Subject|0|||
126762621|NCT01366846|456082666|FG003|Overall Study|Withdrawal by Subject|0|||
126762622|NCT01366846|456082663|FG000|Overall Study|Communication Difficulties|1|||
126762623|NCT01366846|456082664|FG001|Overall Study|Communication Difficulties|4|||
126762624|NCT01366846|456082665|FG002|Overall Study|Communication Difficulties|0|||
126762625|NCT01366846|456082666|FG003|Overall Study|Communication Difficulties|1|||
126762626|NCT01366846|456082663|FG000|Overall Study|Scheduling Conflicts|0|||
126762627|NCT01366846|456082664|FG001|Overall Study|Scheduling Conflicts|0|||
126762628|NCT01366846|456082665|FG002|Overall Study|Scheduling Conflicts|1|||
126762629|NCT01366846|456082666|FG003|Overall Study|Scheduling Conflicts|0|||
126762630|NCT00558831|456082667|FG000|Overall Study|Lost to Follow-up|1|||
126762631|NCT00447265|456082668|FG000|Overall Study|Physician Decision|1|||
126762632|NCT00447265|456082669|FG001|Overall Study|Physician Decision|0|||
126762633|NCT00503035|456082672|FG000|Overall Study|Lost to Follow-up|2|||
126762634|NCT00503035|456082672|FG000|Overall Study|Physician Decision|3|||
126358132|NCT00191152|454603901|FG001|Crossover Treatment|Lost to Follow-up|1|||
126358133|NCT00191152|454603900|FG000|Crossover Treatment|Other|4|||
126358134|NCT00191152|454603901|FG001|Crossover Treatment|Other|3|||
126358135|NCT00114777|454603905|FG000|Randomization to Month 36|Death|10|||
126358136|NCT00114777|454603906|FG001|Randomization to Month 36|Death|4|||
126358137|NCT00114777|454603907|FG002|Randomization to Month 36|Death|3|||
126358138|NCT00114777|454603905|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
126358139|NCT00114777|454603906|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
126358140|NCT00114777|454603907|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
126358141|NCT00114777|454603905|FG000|Randomization to Month 36|Lack of Efficacy|19|||
126358142|NCT00114777|454603906|FG001|Randomization to Month 36|Lack of Efficacy|15|||
126762635|NCT00503035|456082672|FG000|Overall Study|Ineligible|15|||
126762636|NCT04196023|456082675|FG000|Overall Study|Withdrawal by Subject|0|||
126762637|NCT04196023|456082676|FG001|Overall Study|Withdrawal by Subject|1|||
126762638|NCT04196023|456082675|FG000|Overall Study|Adverse Event|3|||
126358143|NCT00114777|454603907|FG002|Randomization to Month 36|Lack of Efficacy|17|||
126358144|NCT00114777|454603905|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
126358145|NCT00114777|454603906|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
126762639|NCT04196023|456082676|FG001|Overall Study|Adverse Event|1|||
126762640|NCT04196023|456082675|FG000|Overall Study|Lost to Follow-up|0|||
126762641|NCT04196023|456082676|FG001|Overall Study|Lost to Follow-up|1|||
126762642|NCT04359758|456082677|FG000|Overall Study|Protocol Violation|3|||
126762643|NCT04359758|456082678|FG001|Overall Study|Protocol Violation|2|||
126762644|NCT03358407|456082679|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126762645|NCT03358407|456082680|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126762646|NCT03358407|456082681|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
126762647|NCT03358407|456082682|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126762648|NCT03358407|456082683|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126762649|NCT03358407|456082684|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126762650|NCT03358407|456082685|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126762651|NCT03358407|456082686|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126762652|NCT03358407|456082687|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126762653|NCT03358407|456082688|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
126358146|NCT00114777|454603907|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
126546392|NCT01351025|455293778|FG000|Week 0 - 20|Withdrawal by Subject|1|||
126762654|NCT03358407|456082679|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126358147|NCT00114777|454603905|FG000|Randomization to Month 36|Adverse Event|34|||
126358148|NCT00114777|454603906|FG001|Randomization to Month 36|Adverse Event|35|||
126358149|NCT00114777|454603907|FG002|Randomization to Month 36|Adverse Event|44|||
126358150|NCT00114777|454603905|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
126358151|NCT00114777|454603906|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
126358152|NCT00114777|454603907|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
126358153|NCT00114777|454603905|FG000|Randomization to Month 36|Other|9|||
126358154|NCT00114777|454603906|FG001|Randomization to Month 36|Other|3|||
126358155|NCT00114777|454603907|FG002|Randomization to Month 36|Other|12|||
126358156|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Death|8|||
126358157|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Death|13|||
126358158|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Death|7|||
126358159|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
126358160|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
126358161|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
126358162|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
126358163|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
126358164|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
126358165|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
126358166|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
126358167|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
126358168|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
126698021|NCT01750918|455847008|FG007|Overall Study|Lost to Follow-up|1|||
126358169|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
126358170|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
126358171|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
126358172|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
126358173|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
126358174|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
126358175|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
126358176|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
126358177|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
126358178|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
126358179|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
126358180|NCT00114777|454603905|FG000|Long-Term Extension to Month 84|Other|2|||
126358181|NCT00114777|454603906|FG001|Long-Term Extension to Month 84|Other|0|||
126358182|NCT00114777|454603907|FG002|Long-Term Extension to Month 84|Other|2|||
126358183|NCT00629239|454603908|FG000|Overall Study|Adverse Event|7|||
126358184|NCT00629239|454603909|FG001|Overall Study|Adverse Event|4|||
126358185|NCT00629239|454603908|FG000|Overall Study|Physician Decision|1|||
126358186|NCT00629239|454603909|FG001|Overall Study|Physician Decision|0|||
126358187|NCT02460380|454603910|FG000|Overall Study|Withdrawal by Subject|10|||
126358188|NCT02460380|454603911|FG001|Overall Study|Withdrawal by Subject|5|||
126358189|NCT03566550|454603917|FG000|Overall Study|Withdrawal by Subject|0|||
126358190|NCT03566550|454603918|FG001|Overall Study|Withdrawal by Subject|1|||
126358191|NCT01210443|454603925|FG000|Overall Study|Study terminated by sponsor|2|||
126358192|NCT00052715|454603926|FG000|Overall Study|wrong histology|1|||
126358193|NCT02807181|454603927|FG000|Overall Study|Death|28|||
126698022|NCT01750918|455847001|FG000|Overall Study|Withdrawal by Subject|0|||
126698023|NCT01750918|455847002|FG001|Overall Study|Withdrawal by Subject|0|||
126698024|NCT01750918|455847003|FG002|Overall Study|Withdrawal by Subject|1|||
126698025|NCT01750918|455847004|FG003|Overall Study|Withdrawal by Subject|2|||
126698026|NCT01750918|455847005|FG004|Overall Study|Withdrawal by Subject|1|||
126698027|NCT01750918|455847006|FG005|Overall Study|Withdrawal by Subject|1|||
126698028|NCT01750918|455847007|FG006|Overall Study|Withdrawal by Subject|2|||
126698029|NCT01750918|455847008|FG007|Overall Study|Withdrawal by Subject|2|||
126698030|NCT02338843|455847013|FG000|Overall Study|Adverse Event|2|||
126698031|NCT02338843|455847014|FG001|Overall Study|Adverse Event|1|||
126698032|NCT02338843|455847013|FG000|Overall Study|Death|40|||
126698033|NCT02338843|455847014|FG001|Overall Study|Death|53|||
126698034|NCT02338843|455847013|FG000|Overall Study|Physician Decision|1|||
126358194|NCT02807181|454603928|FG001|Overall Study|Death|24|||
126546393|NCT01351025|455293779|FG001|Week 0 - 20|Withdrawal by Subject|0|||
126698035|NCT02338843|455847014|FG001|Overall Study|Physician Decision|0|||
126698036|NCT02338843|455847013|FG000|Overall Study|Withdrawal by Subject|0|||
126698037|NCT02338843|455847014|FG001|Overall Study|Withdrawal by Subject|2|||
126698038|NCT02338843|455847013|FG000|Overall Study|Subject Recovered|0|||
126698039|NCT02338843|455847014|FG001|Overall Study|Subject Recovered|2|||
126698040|NCT02338843|455847013|FG000|Overall Study|Discontinued prior to randomizat|1|||
126698041|NCT02338843|455847014|FG001|Overall Study|Discontinued prior to randomizat|0|||
126698042|NCT00023322|455847015|FG000|Overall Study|Lost to Follow-up|1|||
126698043|NCT01793792|455847016|FG000|Overall Study|Death|5|||
126698044|NCT01793792|455847016|FG000|Overall Study|Lost to Follow-up|5|||
126698045|NCT01793792|455847016|FG000|Overall Study|Withdrawal by Subject|1|||
126252315|NCT03105297|454214108|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
126252316|NCT03105297|454214108|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
126252317|NCT05065619|454214109|FG000|Up to Day 42|Lost to Follow-up|1|||
126252318|NCT05065619|454214110|FG001|Up to Day 42|Lost to Follow-up|0|||
126252319|NCT05065619|454214109|FG000|Up to Day 42|Withdrawal by Subject|1|||
126252320|NCT05065619|454214110|FG001|Up to Day 42|Withdrawal by Subject|0|||
126252321|NCT05065619|454214109|FG000|After Day 43|Lost to Follow-up|1|||
126252322|NCT05065619|454214110|FG001|After Day 43|Lost to Follow-up|0|||
126252323|NCT05065619|454214109|FG000|After Day 43|Physician Decision|3|||
126252324|NCT05065619|454214110|FG001|After Day 43|Physician Decision|0|||
126252325|NCT05065619|454214109|FG000|After Day 43|Withdrawal by Subject|1|||
126252326|NCT05065619|454214110|FG001|After Day 43|Withdrawal by Subject|2|||
126252327|NCT05065619|454214109|FG000|After Day 43|Public vaccination|6|||
126252328|NCT05065619|454214110|FG001|After Day 43|Public vaccination|8|||
126252329|NCT05065619|454214109|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
126252330|NCT05065619|454214110|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
126252331|NCT05065619|454214109|FG000|After Day 43|Study Terminated by Sponsor|88|||
126252332|NCT05065619|454214110|FG001|After Day 43|Study Terminated by Sponsor|16|||
126252333|NCT00714051|454214115|FG000|Overall Study|Withdrawal by Subject|1|||
126252334|NCT00714051|454214116|FG001|Overall Study|Withdrawal by Subject|0|||
126252335|NCT00714051|454214115|FG000|Overall Study|Death|0|||
126252336|NCT00714051|454214116|FG001|Overall Study|Death|1|||
126252337|NCT03868631|454214117|FG000|Baseline to Week 6|Adverse Event|0|||
126252338|NCT03868631|454214118|FG001|Baseline to Week 6|Adverse Event|3|||
126252339|NCT03868631|454214117|FG000|Baseline to Week 6|Protocol Violation|1|||
126252340|NCT03868631|454214118|FG001|Baseline to Week 6|Protocol Violation|1|||
126252341|NCT03868631|454214117|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
126252342|NCT03868631|454214118|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
126252343|NCT03868631|454214117|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
126252344|NCT03868631|454214118|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
126252345|NCT03868631|454214117|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
126252346|NCT03868631|454214118|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
126252347|NCT03868631|454214117|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
126252348|NCT03868631|454214118|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
126252349|NCT01929681|454214121|FG000|Overall Study|Withdrawal by Subject|1|||
126252350|NCT01929681|454214122|FG001|Overall Study|Withdrawal by Subject|0|||
126252351|NCT01929681|454214121|FG000|Overall Study|Physician Decision|1|||
126252352|NCT01929681|454214122|FG001|Overall Study|Physician Decision|1|||
126252353|NCT03250117|454214123|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
126252354|NCT03250117|454214124|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
126252355|NCT03250117|454214125|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
126252356|NCT03250117|454214126|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
126252357|NCT02452463|454214129|FG000|Overall Study|Death|1|||
126252358|NCT02452463|454214130|FG001|Overall Study|Death|0|||
126252359|NCT02452463|454214131|FG002|Overall Study|Death|0|||
126252360|NCT02452463|454214129|FG000|Overall Study|Study Suspended|1|||
126252361|NCT02452463|454214130|FG001|Overall Study|Study Suspended|0|||
126252362|NCT02452463|454214131|FG002|Overall Study|Study Suspended|0|||
126252363|NCT02452463|454214129|FG000|Overall Study|Recommended by DSMB|0|||
126252364|NCT02452463|454214130|FG001|Overall Study|Recommended by DSMB|1|||
126252365|NCT02452463|454214131|FG002|Overall Study|Recommended by DSMB|0|||
126252366|NCT02452463|454214129|FG000|Overall Study|Withdrawal by Subject|0|||
126358195|NCT02807181|454603927|FG000|Overall Study|Withdrawal by Subject|1|||
126762655|NCT03358407|456082680|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762656|NCT03358407|456082681|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762657|NCT03358407|456082682|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762658|NCT03358407|456082683|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
126762659|NCT03358407|456082684|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762660|NCT03358407|456082685|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762661|NCT03358407|456082686|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762662|NCT03358407|456082687|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126252367|NCT02452463|454214130|FG001|Overall Study|Withdrawal by Subject|1|||
126252368|NCT02452463|454214131|FG002|Overall Study|Withdrawal by Subject|0|||
126252369|NCT05740098|454214132|FG000|Overall Study|Lost to Follow-up|26|||
126252370|NCT05740098|454214133|FG001|Overall Study|Lost to Follow-up|17|||
126252371|NCT05740098|454214134|FG002|Overall Study|Lost to Follow-up|21|||
126252372|NCT01073631|454214135|FG000|Overall Study|Death|82|||
126252373|NCT01073631|454214135|FG000|Overall Study|Adverse Event|24|||
126252374|NCT01073631|454214135|FG000|Overall Study|Other|63|||
126252375|NCT01528735|454214136|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
126252376|NCT01528735|454214137|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
126358196|NCT02807181|454603928|FG001|Overall Study|Withdrawal by Subject|1|||
126449288|NCT01584440|454945275|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
126449289|NCT01584440|454945276|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
126449290|NCT01584440|454945277|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
126449291|NCT01584440|454945273|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
126449292|NCT01584440|454945274|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
126449293|NCT01584440|454945275|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
126449294|NCT01584440|454945276|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
126449295|NCT01584440|454945277|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
126449296|NCT01584440|454945273|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
126449297|NCT01584440|454945274|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
126449298|NCT01584440|454945275|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
126449299|NCT01584440|454945276|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
126252377|NCT01528735|454214136|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
126252378|NCT01528735|454214137|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
126252379|NCT01971554|454214138|FG000|Overall Study|Lost to Follow-up|1|||
126252380|NCT01971554|454214139|FG001|Overall Study|Lost to Follow-up|0|||
126252381|NCT01971554|454214140|FG002|Overall Study|Lost to Follow-up|0|||
126252382|NCT01971554|454214141|FG003|Overall Study|Lost to Follow-up|0|||
126252383|NCT01426854|454214144|FG000|Overall Study|Adverse Event|1|||
126252384|NCT01426854|454214145|FG001|Overall Study|Adverse Event|5|||
126252385|NCT01426854|454214144|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
126252386|NCT01426854|454214145|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
126252387|NCT01426854|454214144|FG000|Overall Study|Lost to Follow-up|3|||
126252388|NCT01426854|454214145|FG001|Overall Study|Lost to Follow-up|0|||
126252389|NCT01426854|454214144|FG000|Overall Study|Noncompliance|0|||
126252390|NCT01426854|454214145|FG001|Overall Study|Noncompliance|1|||
126252391|NCT01426854|454214144|FG000|Overall Study|Treatment Failure|0|||
126252392|NCT01426854|454214145|FG001|Overall Study|Treatment Failure|16|||
126252393|NCT01426854|454214144|FG000|Overall Study|Protocol Deviation|0|||
126252394|NCT01426854|454214145|FG001|Overall Study|Protocol Deviation|1|||
126252395|NCT01426854|454214144|FG000|Overall Study|Other|3|||
126252396|NCT01426854|454214145|FG001|Overall Study|Other|2|||
126252397|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
126252398|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
126252399|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
126252400|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
126252401|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
126252402|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
126252403|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
126252404|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
126252405|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
126252406|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
126252407|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
126252408|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
126252409|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
126252410|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
126252411|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
126252412|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
126252413|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
126252414|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
126252415|NCT00950300|454214147|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
126252416|NCT00950300|454214148|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
126252417|NCT00950300|454214147|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
126252418|NCT00950300|454214148|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
126252419|NCT00950300|454214147|FG000|TFFU Period|Death|4|||
126252420|NCT00950300|454214148|FG001|TFFU Period|Death|1|||
126252421|NCT00950300|454214147|FG000|TFFU Period|Refused Treatment|10|||
126252422|NCT00950300|454214148|FG001|TFFU Period|Refused Treatment|11|||
126252423|NCT00950300|454214147|FG000|TFFU Period|Failure to Return|16|||
126252424|NCT00950300|454214148|FG001|TFFU Period|Failure to Return|16|||
126252425|NCT00950300|454214147|FG000|TFFU Period|Recurrence of Disease|63|||
126252426|NCT00950300|454214148|FG001|TFFU Period|Recurrence of Disease|72|||
126252427|NCT00950300|454214147|FG000|TFFU Period|Other|4|||
126252428|NCT00950300|454214148|FG001|TFFU Period|Other|3|||
126449300|NCT01584440|454945277|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
126449301|NCT01584440|454945273|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
126449302|NCT01584440|454945274|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
126546394|NCT01351025|455293778|FG000|Week 24 - 44|Lost to Follow-up|0|||
126698046|NCT01793792|455847016|FG000|Overall Study|Device Not Implanted|1|||
126698047|NCT02185521|455847017|FG000|Overall Study|Withdrawal by Subject|1|||
126252429|NCT00950300|454214147|FG000|SFU Period|Death|44|||
126252430|NCT00950300|454214148|FG001|SFU Period|Death|42|||
126252431|NCT00950300|454214147|FG000|SFU Period|Lost to Follow-up|30|||
126762663|NCT03358407|456082688|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762664|NCT03358407|456082679|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126762665|NCT03358407|456082680|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126762666|NCT03358407|456082681|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126762667|NCT03358407|456082682|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126762668|NCT03358407|456082683|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126762669|NCT03358407|456082684|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
126762670|NCT03358407|456082685|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126762671|NCT03358407|456082686|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
126762672|NCT03358407|456082687|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126762673|NCT03358407|456082688|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
126762674|NCT03358407|456082679|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126762675|NCT03358407|456082680|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126762676|NCT03358407|456082681|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126762677|NCT03358407|456082682|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126762678|NCT03358407|456082683|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126762679|NCT03358407|456082684|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
126762680|NCT03358407|456082685|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126762681|NCT03358407|456082686|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
126762682|NCT03358407|456082687|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126762683|NCT03358407|456082688|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
126762684|NCT03358407|456082679|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762685|NCT03358407|456082680|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762686|NCT03358407|456082681|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126358197|NCT02807181|454603927|FG000|Overall Study|Lost to Follow-up|0|||
126358198|NCT02807181|454603928|FG001|Overall Study|Lost to Follow-up|2|||
126358199|NCT02807181|454603927|FG000|Overall Study|Subject decision|1|||
126358200|NCT02807181|454603928|FG001|Overall Study|Subject decision|0|||
126358201|NCT02807181|454603927|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
126358202|NCT02807181|454603928|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
126358203|NCT02807181|454603927|FG000|Overall Study|In Study|3|||
126358204|NCT02807181|454603928|FG001|Overall Study|In Study|3|||
126358205|NCT02807181|454603927|FG000|Overall Study|Post Progression|3|||
126358206|NCT02807181|454603928|FG001|Overall Study|Post Progression|2|||
126358207|NCT01063881|454603929|FG000|Overall Study|Adverse Event|12|||
126358208|NCT01063881|454603930|FG001|Overall Study|Adverse Event|2|||
126358209|NCT01063881|454603931|FG002|Overall Study|Adverse Event|0|||
126358210|NCT01063881|454603929|FG000|Overall Study|Lost to Follow-up|13|||
126358211|NCT01063881|454603930|FG001|Overall Study|Lost to Follow-up|7|||
126358212|NCT01063881|454603931|FG002|Overall Study|Lost to Follow-up|1|||
126358213|NCT01063881|454603929|FG000|Overall Study|Withdrawal by Subject|25|||
126358214|NCT01063881|454603930|FG001|Overall Study|Withdrawal by Subject|1|||
126358215|NCT01063881|454603931|FG002|Overall Study|Withdrawal by Subject|0|||
126358216|NCT01063881|454603929|FG000|Overall Study|Reason for not completed not specified|5|||
126358217|NCT01063881|454603930|FG001|Overall Study|Reason for not completed not specified|1|||
126358218|NCT01063881|454603931|FG002|Overall Study|Reason for not completed not specified|0|||
126358219|NCT01309100|454603932|FG000|Overall Study|Protocol Violation|1|||
126358220|NCT01309100|454603932|FG000|Overall Study|Positive Slit lamp finding|1|||
126358221|NCT03808909|454603939|FG000|Overall Study|Lost to Follow-up|3|||
126358222|NCT03808909|454603940|FG001|Overall Study|Lost to Follow-up|0|||
126358223|NCT03335566|454603941|FG000|Overall Study|Adverse Event|0|||
126358224|NCT03335566|454603942|FG001|Overall Study|Adverse Event|1|||
126358225|NCT03335566|454603941|FG000|Overall Study|Lost to Follow-up|1|||
126358226|NCT03335566|454603942|FG001|Overall Study|Lost to Follow-up|0|||
126762687|NCT03358407|456082682|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126358227|NCT03335566|454603941|FG000|Overall Study|Technical Problems|1|||
126358228|NCT03335566|454603942|FG001|Overall Study|Technical Problems|0|||
126358229|NCT03335566|454603941|FG000|Overall Study|Protocol Violation|1|||
126358230|NCT03335566|454603942|FG001|Overall Study|Protocol Violation|0|||
126358231|NCT03335566|454603941|FG000|Overall Study|Other than specified above|1|||
126358232|NCT03335566|454603942|FG001|Overall Study|Other than specified above|2|||
126358233|NCT01084135|454603943|FG000|20 Week|Physician Decision|0|||
126358234|NCT01084135|454603944|FG001|20 Week|Physician Decision|1|||
126358235|NCT00663351|454603945|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
126358236|NCT00663351|454603946|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
126358237|NCT00663351|454603945|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
126358238|NCT00663351|454603946|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
126358239|NCT00663351|454603945|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
126358240|NCT00663351|454603946|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
126358241|NCT00663351|454603945|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
126546395|NCT01351025|455293779|FG001|Week 24 - 44|Lost to Follow-up|2|||
126698048|NCT02185521|455847017|FG000|Overall Study|Protocol Violation|1|||
126698049|NCT00434967|455847022|FG000|Overall Study|Adverse Event|2|||
126698050|NCT00434967|455847023|FG001|Overall Study|Adverse Event|4|||
126698051|NCT00434967|455847024|FG002|Overall Study|Adverse Event|3|||
126698052|NCT00434967|455847025|FG003|Overall Study|Adverse Event|3|||
126698053|NCT00434967|455847022|FG000|Overall Study|Lost to Follow-up|0|||
126762688|NCT03358407|456082683|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762689|NCT03358407|456082684|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
126762690|NCT03358407|456082685|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
126762691|NCT03358407|456082686|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762692|NCT03358407|456082687|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762693|NCT03358407|456082688|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
126762694|NCT03358407|456082679|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126762695|NCT03358407|456082680|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126762696|NCT03358407|456082681|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126762697|NCT03358407|456082682|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126762698|NCT03358407|456082683|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126762699|NCT03358407|456082684|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
126762700|NCT03358407|456082685|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
126762701|NCT03358407|456082686|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
126762702|NCT03358407|456082687|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126762703|NCT03358407|456082688|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
126762704|NCT03605758|456082689|FG000|Overall Study|Lost to Follow-up|2|||
126762705|NCT03605758|456082690|FG001|Overall Study|Lost to Follow-up|1|||
126762706|NCT03605758|456082689|FG000|Overall Study|Illness|0|||
126762707|NCT03605758|456082690|FG001|Overall Study|Illness|1|||
126762708|NCT03605758|456082689|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
126698054|NCT00434967|455847023|FG001|Overall Study|Lost to Follow-up|0|||
126698055|NCT00434967|455847024|FG002|Overall Study|Lost to Follow-up|1|||
126698056|NCT00434967|455847025|FG003|Overall Study|Lost to Follow-up|0|||
126698057|NCT00434967|455847022|FG000|Overall Study|Withdrawal by Subject|2|||
126698058|NCT00434967|455847023|FG001|Overall Study|Withdrawal by Subject|2|||
126698059|NCT00434967|455847024|FG002|Overall Study|Withdrawal by Subject|4|||
126698060|NCT00434967|455847025|FG003|Overall Study|Withdrawal by Subject|6|||
126698061|NCT00434967|455847022|FG000|Overall Study|Randomized in error|0|||
126698062|NCT00434967|455847023|FG001|Overall Study|Randomized in error|0|||
126698063|NCT00434967|455847024|FG002|Overall Study|Randomized in error|0|||
126698064|NCT00434967|455847025|FG003|Overall Study|Randomized in error|1|||
126698065|NCT00434967|455847022|FG000|Overall Study|Protocol Violation|0|||
126698066|NCT00434967|455847023|FG001|Overall Study|Protocol Violation|1|||
126698067|NCT00434967|455847024|FG002|Overall Study|Protocol Violation|0|||
126698068|NCT00434967|455847025|FG003|Overall Study|Protocol Violation|1|||
126698069|NCT00434967|455847022|FG000|Overall Study|Physician Decision|1|||
126698070|NCT00434967|455847023|FG001|Overall Study|Physician Decision|1|||
126698071|NCT00434967|455847024|FG002|Overall Study|Physician Decision|1|||
126698072|NCT00434967|455847025|FG003|Overall Study|Physician Decision|0|||
126698073|NCT00434967|455847022|FG000|Overall Study|Patient Disposition Challenges|2|||
126698074|NCT00434967|455847023|FG001|Overall Study|Patient Disposition Challenges|0|||
126698075|NCT00434967|455847024|FG002|Overall Study|Patient Disposition Challenges|0|||
126698076|NCT00434967|455847025|FG003|Overall Study|Patient Disposition Challenges|3|||
126698077|NCT00408005|455847026|FG000|Induction|Adverse Event|19|||
126762709|NCT03605758|456082690|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
126762710|NCT00489411|456082691|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
126762711|NCT00489411|456082692|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
126762712|NCT00489411|456082691|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
126762713|NCT00489411|456082692|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
126762714|NCT00489411|456082691|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
126698078|NCT00408005|455847027|FG001|Induction|Adverse Event|3|||
126698079|NCT00408005|455847028|FG002|Induction|Adverse Event|0|||
126698080|NCT00408005|455847029|FG003|Induction|Adverse Event|0|||
126698081|NCT00408005|455847030|FG004|Induction|Adverse Event|0|||
126698082|NCT00408005|455847031|FG005|Induction|Adverse Event|0|||
126698083|NCT00408005|455847032|FG006|Induction|Adverse Event|0|||
126698084|NCT00408005|455847033|FG007|Induction|Adverse Event|0|||
126698085|NCT00408005|455847026|FG000|Induction|Death|6|||
126698086|NCT00408005|455847027|FG001|Induction|Death|0|||
126698087|NCT00408005|455847028|FG002|Induction|Death|0|||
126698088|NCT00408005|455847029|FG003|Induction|Death|0|||
126698089|NCT00408005|455847030|FG004|Induction|Death|0|||
126698090|NCT00408005|455847031|FG005|Induction|Death|0|||
126698091|NCT00408005|455847032|FG006|Induction|Death|0|||
126698092|NCT00408005|455847033|FG007|Induction|Death|0|||
126698093|NCT00408005|455847026|FG000|Induction|Physician Decision|83|||
126698094|NCT00408005|455847027|FG001|Induction|Physician Decision|9|||
126698095|NCT00408005|455847028|FG002|Induction|Physician Decision|0|||
126762715|NCT00489411|456082692|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
126762716|NCT00489411|456082691|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
126762717|NCT00489411|456082692|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
126762718|NCT00489411|456082691|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
126762719|NCT00489411|456082692|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
126762720|NCT01283009|456082693|FG000|Overall Study|Death|83|||
126762721|NCT01283009|456082694|FG001|Overall Study|Death|78|||
126762722|NCT01283009|456082693|FG000|Overall Study|Study ended early|23|||
126762723|NCT01283009|456082694|FG001|Overall Study|Study ended early|26|||
126762724|NCT01283009|456082693|FG000|Overall Study|Withdrawal by Subject|10|||
126762725|NCT01283009|456082694|FG001|Overall Study|Withdrawal by Subject|8|||
126762726|NCT01283009|456082693|FG000|Overall Study|Physician Decision|1|||
126762727|NCT01283009|456082694|FG001|Overall Study|Physician Decision|1|||
126762728|NCT01283009|456082693|FG000|Overall Study|Lost to Follow-up|1|||
126762729|NCT01283009|456082694|FG001|Overall Study|Lost to Follow-up|0|||
126762730|NCT01283009|456082693|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
126762731|NCT01283009|456082694|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
126762732|NCT01748162|456082697|FG000|Overall Study|no additional croup episodes to evaluate|2|||
126762733|NCT01748162|456082698|FG001|Overall Study|no additional croup episodes to evaluate|2|||
126762734|NCT01748162|456082697|FG000|Overall Study|participant consented but did not begin|0|||
126762735|NCT01748162|456082698|FG001|Overall Study|participant consented but did not begin|1|||
126762736|NCT01748162|456082697|FG000|Overall Study|reasons not available|3|||
126762737|NCT01748162|456082698|FG001|Overall Study|reasons not available|2|||
126762738|NCT00505765|456082699|FG000|Overall Study|Withdrawal by Subject|1|||
126762739|NCT00505765|456082700|FG001|Overall Study|Withdrawal by Subject|0|||
126762740|NCT00505765|456082701|FG002|Overall Study|Withdrawal by Subject|0|||
126762741|NCT00505765|456082699|FG000|Overall Study|Adverse Event|1|||
126762742|NCT00505765|456082700|FG001|Overall Study|Adverse Event|2|||
126762743|NCT00505765|456082701|FG002|Overall Study|Adverse Event|0|||
126762744|NCT00505765|456082699|FG000|Overall Study|Noncompliance|0|||
126762745|NCT00505765|456082700|FG001|Overall Study|Noncompliance|1|||
126252432|NCT00950300|454214148|FG001|SFU Period|Lost to Follow-up|28|||
126252433|NCT00950300|454214147|FG000|SFU Period|Withdrawal by Subject|4|||
126252434|NCT00950300|454214148|FG001|SFU Period|Withdrawal by Subject|8|||
126252435|NCT00494013|454214149|FG000|Overall Study|Adverse Event|0|||
126252436|NCT00494013|454214150|FG001|Overall Study|Adverse Event|1|||
126252437|NCT00494013|454214149|FG000|Overall Study|Entry Criteria Not Met|1|||
126252438|NCT00494013|454214150|FG001|Overall Study|Entry Criteria Not Met|4|||
126252439|NCT00494013|454214149|FG000|Overall Study|Lost to Follow-up|5|||
126252440|NCT00494013|454214150|FG001|Overall Study|Lost to Follow-up|6|||
126252441|NCT00494013|454214149|FG000|Overall Study|Physician Decision|3|||
126252442|NCT00494013|454214150|FG001|Overall Study|Physician Decision|5|||
126252443|NCT00494013|454214149|FG000|Overall Study|Protocol Violation|8|||
126252444|NCT00494013|454214150|FG001|Overall Study|Protocol Violation|5|||
126252445|NCT00494013|454214149|FG000|Overall Study|Withdrawal by Subject|13|||
126252446|NCT00494013|454214150|FG001|Overall Study|Withdrawal by Subject|14|||
126252447|NCT00494013|454214149|FG000|Overall Study|Sponsor Decision|0|||
126252448|NCT00494013|454214150|FG001|Overall Study|Sponsor Decision|1|||
126252449|NCT04750239|454214151|FG000|Overall Study|Withdrawal by Subject|2|||
126252450|NCT04750239|454214151|FG000|Overall Study|Trial terminated by sponsor|1|||
126252451|NCT00903877|454214152|FG000|Overall Study|Did not meet study criteria|33|||
126252452|NCT00903877|454214152|FG000|Overall Study|Withdrawal by Subject|3|||
126252453|NCT00903877|454214152|FG000|Overall Study|Adverse Event|2|||
126252454|NCT00903877|454214152|FG000|Overall Study|Lost to Follow-up|1|||
126252455|NCT00903877|454214152|FG000|Overall Study|Participation put on hold|4|||
126252456|NCT00919711|454214153|FG000|Overall Study|Withdrawal by Subject|15|||
126252457|NCT00919711|454214154|FG001|Overall Study|Withdrawal by Subject|7|||
126252458|NCT00919711|454214153|FG000|Overall Study|Adverse Event|13|||
126252459|NCT00919711|454214154|FG001|Overall Study|Adverse Event|3|||
126252460|NCT00919711|454214153|FG000|Overall Study|Other|1|||
126252461|NCT00919711|454214154|FG001|Overall Study|Other|2|||
126252462|NCT00919711|454214153|FG000|Overall Study|Administrative Decision|0|||
126252463|NCT00919711|454214154|FG001|Overall Study|Administrative Decision|1|||
126252464|NCT00919711|454214153|FG000|Overall Study|Lost to Follow-up|2|||
126252465|NCT00919711|454214154|FG001|Overall Study|Lost to Follow-up|0|||
126252466|NCT00919711|454214153|FG000|Overall Study|Death|1|||
126252467|NCT00919711|454214154|FG001|Overall Study|Death|0|||
126252468|NCT00919711|454214153|FG000|Overall Study|Noncompliance|1|||
126762746|NCT00505765|456082701|FG002|Overall Study|Noncompliance|3|||
126762747|NCT01207219|456082702|FG000|Overall Study|changed diagnosis during study period|5|||
126762748|NCT01207219|456082703|FG001|Overall Study|changed diagnosis during study period|3|||
126762749|NCT01207219|456082704|FG002|Overall Study|changed diagnosis during study period|1|||
126762750|NCT01207219|456082702|FG000|Overall Study|Lost to Follow-up|6|||
126762751|NCT01207219|456082703|FG001|Overall Study|Lost to Follow-up|8|||
126762752|NCT01207219|456082704|FG002|Overall Study|Lost to Follow-up|6|||
126762753|NCT00402298|456082708|FG000|Overall Study|Withdrawal by Subject|1|||
126762754|NCT00402298|456082709|FG001|Overall Study|Withdrawal by Subject|0|||
126762755|NCT00480077|456082710|FG000|Overall Study|Death|19|||
126762756|NCT00480077|456082711|FG001|Overall Study|Death|15|||
126762757|NCT00480077|456082710|FG000|Overall Study|early exit|12|||
126762758|NCT00480077|456082711|FG001|Overall Study|early exit|11|||
126762759|NCT04298229|456082716|FG000|Overall Study|Physician Decision|1|||
126762760|NCT04298229|456082717|FG001|Overall Study|Physician Decision|1|||
126762761|NCT04298229|456082716|FG000|Overall Study|Withdrawal by Subject|1|||
126762762|NCT04298229|456082717|FG001|Overall Study|Withdrawal by Subject|1|||
126252469|NCT00919711|454214154|FG001|Overall Study|Noncompliance|0|||
126252470|NCT00685334|454214157|FG000|Overall Study|Withdrawal by Subject|5|||
126252471|NCT00685334|454214158|FG001|Overall Study|Withdrawal by Subject|6|||
126252472|NCT00685334|454214157|FG000|Overall Study|Lost to Follow-up|4|||
126252473|NCT00685334|454214158|FG001|Overall Study|Lost to Follow-up|0|||
126252474|NCT00685334|454214157|FG000|Overall Study|Chose to enter hospital|1|||
126762763|NCT04298229|456082716|FG000|Overall Study|Did not receive IV loop diuretics|2|||
126762764|NCT04298229|456082717|FG001|Overall Study|Did not receive IV loop diuretics|0|||
126762765|NCT00262119|456082719|FG000|Overall Study|Lost to Follow-up|38|||
126252475|NCT00685334|454214158|FG001|Overall Study|Chose to enter hospital|1|||
126252476|NCT01891357|454214159|FG000|Overall Study|Protocol Violation|3|||
126252477|NCT04573309|454215868|FG000|Overall Study|Protocol Violation|1|||
126252478|NCT04573309|454215869|FG001|Overall Study|Protocol Violation|0|||
126252479|NCT02300987|454215870|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
126252480|NCT02300987|454215871|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
126252481|NCT02300987|454215870|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
126252482|NCT02300987|454215871|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
126252483|NCT02300987|454215870|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
126252484|NCT02300987|454215871|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
126252485|NCT02300987|454215870|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
126252486|NCT02300987|454215871|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
126252487|NCT02300987|454215870|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
126252488|NCT02300987|454215871|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
126252489|NCT02488109|454215872|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
126252490|NCT02488109|454215873|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
126252491|NCT02488109|454215872|FG000|12-month Follow-Up|Lost to Follow-up|4|||
126252492|NCT02488109|454215873|FG001|12-month Follow-Up|Lost to Follow-up|7|||
126252493|NCT03969641|454215874|FG000|Overall Study|Lost to Follow-up|5|||
126252494|NCT03969641|454215875|FG001|Overall Study|Lost to Follow-up|3|||
126252495|NCT03969641|454215874|FG000|Overall Study|Withdrawal by Subject|1|||
126252496|NCT03969641|454215875|FG001|Overall Study|Withdrawal by Subject|2|||
126252497|NCT03969641|454215874|FG000|Overall Study|Found to be ineligible|1|||
126252498|NCT03969641|454215875|FG001|Overall Study|Found to be ineligible|1|||
126252499|NCT03969641|454215874|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
126252500|NCT03969641|454215875|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
126252501|NCT03969641|454215874|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
126252502|NCT03969641|454215875|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
126252503|NCT03969641|454215874|FG000|Overall Study|Elective termination|0|||
126252504|NCT03969641|454215875|FG001|Overall Study|Elective termination|1|||
126252505|NCT01541215|454215876|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
126252506|NCT01541215|454215877|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
126252507|NCT01541215|454215876|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
126762766|NCT00262119|456082720|FG001|Overall Study|Lost to Follow-up|51|||
126762767|NCT00262119|456082721|FG002|Overall Study|Lost to Follow-up|42|||
126762768|NCT00262119|456082719|FG000|Overall Study|Death|20|||
126762769|NCT00262119|456082720|FG001|Overall Study|Death|19|||
126762770|NCT00262119|456082721|FG002|Overall Study|Death|16|||
126762771|NCT01683565|456082722|FG000|Overall Study|Lost to Follow-up|2|||
126762772|NCT01683565|456082723|FG001|Overall Study|Lost to Follow-up|0|||
126762773|NCT01683565|456082722|FG000|Overall Study|Discontinued Intervention|1|||
126252508|NCT01541215|454215877|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
126252509|NCT01541215|454215876|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
126252510|NCT01541215|454215877|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
126762774|NCT01683565|456082723|FG001|Overall Study|Discontinued Intervention|1|||
126762775|NCT00859313|456082724|FG000|Overall Study|Lack of Efficacy|2|||
126762776|NCT00859313|456082724|FG000|Overall Study|Adverse Event|1|||
126762777|NCT00859313|456082724|FG000|Overall Study|staff error|1|||
126762778|NCT00071006|456082725|FG000|Overall Study|Lack of Efficacy|7|||
126762779|NCT00071006|456082725|FG000|Overall Study|Adverse Event|1|||
126762780|NCT00071006|456082725|FG000|Overall Study|Withdrawal by Subject|1|||
126252511|NCT01541215|454215876|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
126252512|NCT01541215|454215877|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
126252513|NCT01541215|454215876|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
126252514|NCT01541215|454215877|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
126252515|NCT01541215|454215876|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
126252516|NCT01541215|454215877|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
126698096|NCT00408005|455847029|FG003|Induction|Physician Decision|0|||
126698097|NCT00408005|455847030|FG004|Induction|Physician Decision|0|||
126698098|NCT00408005|455847031|FG005|Induction|Physician Decision|0|||
126698099|NCT00408005|455847032|FG006|Induction|Physician Decision|0|||
126698100|NCT00408005|455847033|FG007|Induction|Physician Decision|0|||
126698101|NCT00408005|455847026|FG000|Induction|Withdrawal by Subject|2|||
126698102|NCT00408005|455847027|FG001|Induction|Withdrawal by Subject|4|||
126698103|NCT00408005|455847028|FG002|Induction|Withdrawal by Subject|0|||
126698104|NCT00408005|455847029|FG003|Induction|Withdrawal by Subject|0|||
126698105|NCT00408005|455847030|FG004|Induction|Withdrawal by Subject|0|||
126698106|NCT00408005|455847031|FG005|Induction|Withdrawal by Subject|0|||
126252517|NCT02658019|454215886|FG000|Overall Study|Adverse Event|1|||
126252518|NCT00820599|454215887|FG000|Overall Study|Death|129|||
126252519|NCT00820599|454215887|FG000|Overall Study|Withdrawal by Subject|2|||
126252520|NCT00960154|454215888|FG000|Overall Study|Study termination|25|||
126252521|NCT00960154|454215889|FG001|Overall Study|Study termination|25|||
126252522|NCT00486434|454215890|FG000|Overall Study|Withdrawal by Subject|34|||
126252523|NCT00486434|454215891|FG001|Overall Study|Withdrawal by Subject|39|||
126252524|NCT00486434|454215890|FG000|Overall Study|Adverse Event|118|||
126252525|NCT00486434|454215891|FG001|Overall Study|Adverse Event|44|||
126252526|NCT00486434|454215890|FG000|Overall Study|Protocol Violation|22|||
126252527|NCT00486434|454215891|FG001|Overall Study|Protocol Violation|21|||
126252528|NCT00486434|454215890|FG000|Overall Study|Lack of Efficacy|12|||
126252529|NCT00486434|454215891|FG001|Overall Study|Lack of Efficacy|19|||
126698107|NCT00408005|455847032|FG006|Induction|Withdrawal by Subject|0|||
126698108|NCT00408005|455847033|FG007|Induction|Withdrawal by Subject|0|||
126698109|NCT00408005|455847026|FG000|Induction|Ineligible|33|||
126698110|NCT00408005|455847027|FG001|Induction|Ineligible|14|||
126698111|NCT00408005|455847028|FG002|Induction|Ineligible|0|||
126252530|NCT00486434|454215890|FG000|Overall Study|Lost to Follow-up|2|||
126252531|NCT00486434|454215891|FG001|Overall Study|Lost to Follow-up|3|||
126252532|NCT00486434|454215890|FG000|Overall Study|Death|1|||
126252533|NCT00486434|454215891|FG001|Overall Study|Death|2|||
126252534|NCT00486434|454215890|FG000|Overall Study|Personal reasons|5|||
126252535|NCT00486434|454215891|FG001|Overall Study|Personal reasons|6|||
126252536|NCT00544167|454215892|FG000|Overall Study|Adverse Event|21|||
126252537|NCT00544167|454215892|FG000|Overall Study|Physician Decision|8|||
126252538|NCT02725515|454215893|FG000|Overall Study|Refused infusion (no study treatment)|1|||
126252539|NCT02725515|454215894|FG001|Overall Study|Refused infusion (no study treatment)|0|||
126252540|NCT02725515|454215893|FG000|Overall Study|Loss of Improvement per Protocol|14|||
126252541|NCT02725515|454215894|FG001|Overall Study|Loss of Improvement per Protocol|25|||
126252542|NCT02725515|454215893|FG000|Overall Study|Withdrawal by Subject|2|||
126252543|NCT02725515|454215894|FG001|Overall Study|Withdrawal by Subject|1|||
126252544|NCT02725515|454215893|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126252545|NCT02725515|454215894|FG001|Overall Study|Non-Compliance With Study Drug|3|||
126252546|NCT02725515|454215893|FG000|Overall Study|Lost to Follow-up|1|||
126252547|NCT02725515|454215894|FG001|Overall Study|Lost to Follow-up|1|||
126252548|NCT02725515|454215893|FG000|Overall Study|Adverse Event|7|||
126252549|NCT02725515|454215894|FG001|Overall Study|Adverse Event|2|||
126252550|NCT02725515|454215893|FG000|Overall Study|No Documented Disease Improvement|0|||
126252551|NCT02725515|454215894|FG001|Overall Study|No Documented Disease Improvement|1|||
126252552|NCT02725515|454215893|FG000|Overall Study|Completed Study Under Original Protocol|0|||
126252553|NCT02725515|454215894|FG001|Overall Study|Completed Study Under Original Protocol|1|||
126252554|NCT02725515|454215893|FG000|Overall Study|Lack of Response|0|||
126252555|NCT02725515|454215894|FG001|Overall Study|Lack of Response|1|||
126252556|NCT00874549|454215895|FG000|Overall Study|Adverse Event|0|||
126252557|NCT00874549|454215896|FG001|Overall Study|Adverse Event|0|||
126252558|NCT00874549|454215897|FG002|Overall Study|Adverse Event|1|||
126252559|NCT00874549|454215898|FG003|Overall Study|Adverse Event|0|||
126252560|NCT00874549|454215895|FG000|Overall Study|Protocol Violation|1|||
126252561|NCT00874549|454215896|FG001|Overall Study|Protocol Violation|0|||
126252562|NCT00874549|454215897|FG002|Overall Study|Protocol Violation|2|||
126252563|NCT00874549|454215898|FG003|Overall Study|Protocol Violation|1|||
126252564|NCT00874549|454215895|FG000|Overall Study|Lost to Follow-up|0|||
126252565|NCT00874549|454215896|FG001|Overall Study|Lost to Follow-up|0|||
126698112|NCT00408005|455847029|FG003|Induction|Ineligible|0|||
126252566|NCT00874549|454215897|FG002|Overall Study|Lost to Follow-up|1|||
126252567|NCT00874549|454215898|FG003|Overall Study|Lost to Follow-up|0|||
126252568|NCT00874549|454215895|FG000|Overall Study|Withdrawal by Subject|0|||
126252569|NCT00874549|454215896|FG001|Overall Study|Withdrawal by Subject|1|||
126252570|NCT00874549|454215897|FG002|Overall Study|Withdrawal by Subject|0|||
126252571|NCT00874549|454215898|FG003|Overall Study|Withdrawal by Subject|1|||
126252572|NCT02998541|454215908|FG000|Overall Study|Adverse Event|4|||
126252573|NCT02998541|454215909|FG001|Overall Study|Adverse Event|5|||
126252574|NCT02998541|454215910|FG002|Overall Study|Adverse Event|1|||
126252575|NCT02998541|454215908|FG000|Overall Study|Protocol Violation|1|||
126698113|NCT00408005|455847030|FG004|Induction|Ineligible|0|||
126698114|NCT00408005|455847031|FG005|Induction|Ineligible|0|||
126698115|NCT00408005|455847032|FG006|Induction|Ineligible|0|||
126252576|NCT02998541|454215909|FG001|Overall Study|Protocol Violation|0|||
126252577|NCT02998541|454215910|FG002|Overall Study|Protocol Violation|0|||
126252578|NCT02998541|454215908|FG000|Overall Study|Withdrawal by Subject|3|||
126252579|NCT02998541|454215909|FG001|Overall Study|Withdrawal by Subject|1|||
126252580|NCT02998541|454215910|FG002|Overall Study|Withdrawal by Subject|0|||
126252581|NCT02998541|454215908|FG000|Overall Study|Lost to Follow-up|0|||
126252582|NCT02998541|454215909|FG001|Overall Study|Lost to Follow-up|3|||
126252583|NCT02998541|454215910|FG002|Overall Study|Lost to Follow-up|1|||
126252584|NCT02998541|454215908|FG000|Overall Study|Physician Decision|0|||
126252585|NCT02998541|454215909|FG001|Overall Study|Physician Decision|0|||
126252586|NCT02998541|454215910|FG002|Overall Study|Physician Decision|3|||
126252587|NCT02998541|454215908|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126252588|NCT02998541|454215909|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126252589|NCT02998541|454215910|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
126252590|NCT03387462|454215918|FG000|Overall Study|Lost to Follow-up|1|||
126252591|NCT01460628|454215921|FG000|Overall Study|Adverse Event|3|||
126252592|NCT01460628|454215921|FG000|Overall Study|Withdrawal by Subject|2|||
126252593|NCT02906917|454215922|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
126252594|NCT02906917|454215923|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
126252595|NCT02906917|454215922|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
126252596|NCT02906917|454215923|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
126252597|NCT02906917|454215922|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
126252598|NCT02906917|454215923|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
126252599|NCT02906917|454215922|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
126252600|NCT02906917|454215923|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
126252601|NCT02906917|454215922|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
126252602|NCT02906917|454215923|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
126252603|NCT02906917|454215922|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
126252604|NCT02906917|454215923|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
126252605|NCT02906917|454215922|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
126252606|NCT02906917|454215923|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
126252607|NCT02906917|454215922|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
126252608|NCT02906917|454215923|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
126252609|NCT00210639|454215924|FG000|Overall Study|Lost to Follow-up|37|||
126252610|NCT00210639|454215925|FG001|Overall Study|Lost to Follow-up|29|||
126252611|NCT00210639|454215924|FG000|Overall Study|Withdrawal by Subject|8|||
126252612|NCT00210639|454215925|FG001|Overall Study|Withdrawal by Subject|1|||
126252613|NCT00210639|454215924|FG000|Overall Study|Other|18|||
126252614|NCT00210639|454215925|FG001|Overall Study|Other|12|||
126252615|NCT00874822|454215927|FG000|Overall Study|excluded by criteria|8|||
126252616|NCT05278858|454215928|FG000|Overall Study|Withdrawal by Subject|1|||
126252617|NCT00152451|454215931|FG000|Overall Study|Adverse Event|4|||
126252618|NCT04697173|454215936|FG000|Overall Study|Withdrawal by Subject|34|||
126252619|NCT04697173|454215937|FG001|Overall Study|Withdrawal by Subject|38|||
126252620|NCT03807440|454215938|FG000|Overall Study|No documentation of index date 2|320|||
126252621|NCT03807440|454215938|FG000|Overall Study|No informed consent for index date 2|117|||
126252622|NCT03504085|454215941|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
126252623|NCT03504085|454215942|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
126252624|NCT03504085|454215941|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
126252625|NCT03504085|454215942|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
126252626|NCT04133311|454215943|FG000|Period 1 Double Masked Treatment Period|Death|1|||
126252627|NCT04133311|454215944|FG001|Period 1 Double Masked Treatment Period|Death|0|||
126252628|NCT04133311|454215945|FG002|Period 1 Double Masked Treatment Period|Death|0|||
126252629|NCT04133311|454215946|FG003|Period 1 Double Masked Treatment Period|Death|0|||
126449303|NCT01584440|454945275|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
126698116|NCT00408005|455847033|FG007|Induction|Ineligible|0|||
126698117|NCT00408005|455847026|FG000|Induction|Refusal of Further Protocol Therapy|225|||
126698118|NCT00408005|455847027|FG001|Induction|Refusal of Further Protocol Therapy|44|||
126698119|NCT00408005|455847028|FG002|Induction|Refusal of Further Protocol Therapy|0|||
126698120|NCT00408005|455847029|FG003|Induction|Refusal of Further Protocol Therapy|0|||
126698121|NCT00408005|455847030|FG004|Induction|Refusal of Further Protocol Therapy|0|||
126698122|NCT00408005|455847031|FG005|Induction|Refusal of Further Protocol Therapy|0|||
126698123|NCT00408005|455847032|FG006|Induction|Refusal of Further Protocol Therapy|0|||
126252630|NCT04133311|454215943|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
126252631|NCT04133311|454215944|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
126252632|NCT04133311|454215945|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
126252633|NCT04133311|454215946|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
126252634|NCT04133311|454215943|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
126252635|NCT04133311|454215944|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
126252636|NCT04133311|454215945|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
126252637|NCT04133311|454215946|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
126698124|NCT00408005|455847033|FG007|Induction|Refusal of Further Protocol Therapy|0|||
126698125|NCT00408005|455847026|FG000|Induction|Entered another COG therapeutic protocol|4|||
126698126|NCT00408005|455847027|FG001|Induction|Entered another COG therapeutic protocol|0|||
126698127|NCT00408005|455847028|FG002|Induction|Entered another COG therapeutic protocol|0|||
126698128|NCT00408005|455847029|FG003|Induction|Entered another COG therapeutic protocol|0|||
126698129|NCT00408005|455847030|FG004|Induction|Entered another COG therapeutic protocol|0|||
126698130|NCT00408005|455847031|FG005|Induction|Entered another COG therapeutic protocol|0|||
126698131|NCT00408005|455847032|FG006|Induction|Entered another COG therapeutic protocol|0|||
126698132|NCT00408005|455847033|FG007|Induction|Entered another COG therapeutic protocol|0|||
126698133|NCT00408005|455847026|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
126698134|NCT00408005|455847027|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
126698135|NCT00408005|455847028|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
126698136|NCT00408005|455847029|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
126698137|NCT00408005|455847030|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
126698138|NCT00408005|455847031|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
126698139|NCT00408005|455847032|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
126698140|NCT00408005|455847033|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
126698141|NCT00408005|455847026|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
126698142|NCT00408005|455847027|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
126698143|NCT00408005|455847028|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
126698144|NCT00408005|455847029|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
126698145|NCT00408005|455847030|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
126698146|NCT00408005|455847031|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
126698147|NCT00408005|455847032|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
126698148|NCT00408005|455847033|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
126698149|NCT00408005|455847026|FG000|Induction|Progressive Disease|0|||
126698150|NCT00408005|455847027|FG001|Induction|Progressive Disease|1|||
126698151|NCT00408005|455847028|FG002|Induction|Progressive Disease|0|||
126698152|NCT00408005|455847029|FG003|Induction|Progressive Disease|0|||
126698153|NCT00408005|455847030|FG004|Induction|Progressive Disease|0|||
126698154|NCT00408005|455847031|FG005|Induction|Progressive Disease|0|||
126698155|NCT00408005|455847032|FG006|Induction|Progressive Disease|0|||
126698156|NCT00408005|455847033|FG007|Induction|Progressive Disease|0|||
126698157|NCT00408005|455847026|FG000|Induction|Inevaluable|18|||
126698158|NCT00408005|455847027|FG001|Induction|Inevaluable|14|||
126698159|NCT00408005|455847028|FG002|Induction|Inevaluable|0|||
126698160|NCT00408005|455847029|FG003|Induction|Inevaluable|0|||
126698161|NCT00408005|455847030|FG004|Induction|Inevaluable|0|||
126698162|NCT00408005|455847031|FG005|Induction|Inevaluable|0|||
126698163|NCT00408005|455847032|FG006|Induction|Inevaluable|0|||
126698164|NCT00408005|455847033|FG007|Induction|Inevaluable|0|||
126698165|NCT00408005|455847026|FG000|Induction|Failed to Complete Randomization|3|||
126698166|NCT00408005|455847027|FG001|Induction|Failed to Complete Randomization|2|||
126698167|NCT00408005|455847028|FG002|Induction|Failed to Complete Randomization|0|||
126698168|NCT00408005|455847029|FG003|Induction|Failed to Complete Randomization|0|||
126698169|NCT00408005|455847030|FG004|Induction|Failed to Complete Randomization|0|||
126762781|NCT00071006|456082725|FG000|Overall Study|Other|3|||
126762782|NCT05261126|456082726|FG000|Overall Study|Death|0|||
126252638|NCT04133311|454215943|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
126252639|NCT04133311|454215944|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
126252640|NCT04133311|454215945|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
126252641|NCT04133311|454215946|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
126252642|NCT04133311|454215943|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
126252643|NCT04133311|454215944|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
126252644|NCT04133311|454215945|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
126252645|NCT04133311|454215946|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
126252646|NCT04133311|454215943|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
126252647|NCT04133311|454215944|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
126252648|NCT04133311|454215945|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
126252649|NCT04133311|454215946|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
126252650|NCT04133311|454215943|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
126252651|NCT04133311|454215944|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
126252652|NCT04133311|454215945|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
126252653|NCT04133311|454215946|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
126252654|NCT04133311|454215943|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
126762783|NCT05261126|456082727|FG001|Overall Study|Death|0|||
126546396|NCT01351025|455293778|FG000|Week 24 - 44|Site closed|0|||
126698170|NCT00408005|455847031|FG005|Induction|Failed to Complete Randomization|0|||
126698171|NCT00408005|455847032|FG006|Induction|Failed to Complete Randomization|0|||
126698172|NCT00408005|455847033|FG007|Induction|Failed to Complete Randomization|0|||
126762784|NCT05261126|456082728|FG002|Overall Study|Death|1|||
126762785|NCT05261126|456082729|FG003|Overall Study|Death|0|||
126252655|NCT04133311|454215944|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
126252656|NCT04133311|454215945|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
126252657|NCT04133311|454215946|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
126252658|NCT00728754|454215949|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
126252659|NCT00728754|454215950|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
126252660|NCT00728754|454215949|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
126252661|NCT00728754|454215950|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
126252662|NCT00728754|454215949|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
126252663|NCT00728754|454215950|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
126252664|NCT01926119|454215951|FG000|Overall Study|Withdrawal by Subject|1|||
126252665|NCT00009945|454215954|FG000|Overall Study|no follow up data|7|||
126252666|NCT00009945|454215955|FG001|Overall Study|no follow up data|5|||
126252667|NCT00295490|454215956|FG000|Overall Study|Protocol Violation|0|||
126252668|NCT00295490|454215957|FG001|Overall Study|Protocol Violation|0|||
126252669|NCT00295490|454215958|FG002|Overall Study|Protocol Violation|3|||
126252670|NCT00295490|454215959|FG003|Overall Study|Protocol Violation|3|||
126252671|NCT00295490|454215956|FG000|Overall Study|Withdrawal by Subject|0|||
126252672|NCT00295490|454215957|FG001|Overall Study|Withdrawal by Subject|2|||
126252673|NCT00295490|454215958|FG002|Overall Study|Withdrawal by Subject|0|||
126252674|NCT00295490|454215959|FG003|Overall Study|Withdrawal by Subject|1|||
126252675|NCT00295490|454215956|FG000|Overall Study|Lost to Follow-up|0|||
126252676|NCT00295490|454215957|FG001|Overall Study|Lost to Follow-up|0|||
126252677|NCT00295490|454215958|FG002|Overall Study|Lost to Follow-up|1|||
126252678|NCT00295490|454215959|FG003|Overall Study|Lost to Follow-up|0|||
126252679|NCT00295490|454215956|FG000|Overall Study|Adverse Event|1|||
126252680|NCT00295490|454215957|FG001|Overall Study|Adverse Event|0|||
126252681|NCT00295490|454215958|FG002|Overall Study|Adverse Event|0|||
126252682|NCT00295490|454215959|FG003|Overall Study|Adverse Event|0|||
126252683|NCT00295490|454215956|FG000|Overall Study|Other|0|||
126252684|NCT00295490|454215957|FG001|Overall Study|Other|2|||
126252685|NCT00295490|454215958|FG002|Overall Study|Other|0|||
126252686|NCT00295490|454215959|FG003|Overall Study|Other|1|||
126252687|NCT01196390|454215966|FG000|Overall Study|Protocol Violation|4|||
126252688|NCT01196390|454215967|FG001|Overall Study|Protocol Violation|5|||
126252689|NCT03141151|454215974|FG000|Overall Study|Lost to Follow-up|3|||
126252690|NCT03141151|454215975|FG001|Overall Study|Lost to Follow-up|2|||
126252691|NCT03141151|454215974|FG000|Overall Study|Withdrawal by Subject|3|||
126252692|NCT03141151|454215975|FG001|Overall Study|Withdrawal by Subject|2|||
126252693|NCT01949532|454215976|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
126252694|NCT01949532|454215977|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
126252695|NCT01050764|454215978|FG000|Overall Study|Death, before HSCT|1|||
126252696|NCT01050764|454215978|FG000|Overall Study|Donor mobilization failure, death|1|||
126252697|NCT01050764|454215978|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
126252698|NCT02119936|454215980|FG000|Overall Study|Lost to Follow-up|10|||
126252699|NCT00570128|454215981|FG000|Overall Study|Adverse Event|1|||
126252700|NCT00570128|454215982|FG001|Overall Study|Adverse Event|0|||
126252701|NCT00570128|454215981|FG000|Overall Study|Lost to Follow-up|1|||
126252702|NCT00570128|454215982|FG001|Overall Study|Lost to Follow-up|0|||
126252703|NCT00570128|454215981|FG000|Overall Study|Withdrawal by Subject|2|||
126252704|NCT00570128|454215982|FG001|Overall Study|Withdrawal by Subject|0|||
126252705|NCT04194008|454215985|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
126252706|NCT04194008|454215985|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
126252707|NCT04194008|454215985|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
126252708|NCT04194008|454215985|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
126252709|NCT04194008|454215985|FG000|Treatment Phase With Nerivio|Missing data|4|||
126252710|NCT04194008|454215985|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
126252711|NCT02218216|454215986|FG000|Overall Study|Study terminated before completed|6|||
126252712|NCT02218216|454215987|FG001|Overall Study|Study terminated before completed|0|||
126252713|NCT02218216|454215988|FG002|Overall Study|Study terminated before completed|0|||
126252714|NCT01942135|454215993|FG000|Overall Study|Adverse Event|21|||
126252715|NCT01942135|454215994|FG001|Overall Study|Adverse Event|7|||
126252716|NCT01942135|454215993|FG000|Overall Study|Global Deterioration of Health Status|9|||
126252717|NCT01942135|454215994|FG001|Overall Study|Global Deterioration of Health Status|6|||
126252718|NCT01942135|454215993|FG000|Overall Study|Randomized Not Treated|2|||
126252719|NCT01942135|454215994|FG001|Overall Study|Randomized Not Treated|2|||
126252720|NCT01942135|454215993|FG000|Overall Study|Death|2|||
126252721|NCT01942135|454215994|FG001|Overall Study|Death|1|||
126546397|NCT01351025|455293779|FG001|Week 24 - 44|Site closed|1|||
126546398|NCT01351025|455293778|FG000|Week 24 - 44|unable to get to clinic|1|||
126252722|NCT01942135|454215993|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
126252723|NCT01942135|454215994|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
126252724|NCT01942135|454215993|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
126252725|NCT01942135|454215994|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
126252726|NCT01942135|454215993|FG000|Overall Study|Withdrawal by Subject|4|||
126252727|NCT01942135|454215994|FG001|Overall Study|Withdrawal by Subject|3|||
126252728|NCT01942135|454215993|FG000|Overall Study|Protocol Violation|1|||
126252729|NCT01942135|454215994|FG001|Overall Study|Protocol Violation|0|||
126252730|NCT01942135|454215993|FG000|Overall Study|Other|19|||
126252731|NCT01942135|454215994|FG001|Overall Study|Other|4|||
126252732|NCT01717040|454215995|FG000|Overall Study|Lost to Follow-up|2|||
126252733|NCT01717040|454215996|FG001|Overall Study|Lost to Follow-up|3|||
126252734|NCT01717040|454215995|FG000|Overall Study|Lack of Efficacy|1|||
126252735|NCT01717040|454215996|FG001|Overall Study|Lack of Efficacy|1|||
126252736|NCT01717040|454215995|FG000|Overall Study|Adverse Event|1|||
126252737|NCT01717040|454215996|FG001|Overall Study|Adverse Event|0|||
126252738|NCT01717040|454215995|FG000|Overall Study|Required Medication Change|0|||
126252739|NCT01717040|454215996|FG001|Overall Study|Required Medication Change|1|||
126252740|NCT01717040|454215995|FG000|Overall Study|New Substance Use Disorder|1|||
126252741|NCT01717040|454215996|FG001|Overall Study|New Substance Use Disorder|0|||
126252742|NCT00087529|454215997|FG000|Overall Study|Death|1|||
126252743|NCT00087529|454215998|FG001|Overall Study|Death|0|||
126252744|NCT00087529|454215997|FG000|Overall Study|Adverse Event|0|||
126252745|NCT00087529|454215998|FG001|Overall Study|Adverse Event|8|||
126252746|NCT00087529|454215997|FG000|Overall Study|Pregnancy|0|||
126252747|NCT00087529|454215998|FG001|Overall Study|Pregnancy|1|||
126252748|NCT00087529|454215997|FG000|Overall Study|Lost to Follow-up|2|||
126252749|NCT00087529|454215998|FG001|Overall Study|Lost to Follow-up|3|||
126252750|NCT00087529|454215997|FG000|Overall Study|Participant Decision|14|||
126252751|NCT00087529|454215998|FG001|Overall Study|Participant Decision|37|||
126252752|NCT00087529|454215997|FG000|Overall Study|Physician Decision|4|||
126252753|NCT00087529|454215998|FG001|Overall Study|Physician Decision|8|||
126252754|NCT00087529|454215997|FG000|Overall Study|Initiation of Excluded Therapy|0|||
126252755|NCT00087529|454215998|FG001|Overall Study|Initiation of Excluded Therapy|1|||
126252756|NCT00087529|454215997|FG000|Overall Study|Participant Noncompliance|0|||
126252757|NCT00087529|454215998|FG001|Overall Study|Participant Noncompliance|1|||
126252758|NCT00087529|454215997|FG000|Overall Study|Disease Progression|5|||
126252759|NCT00087529|454215998|FG001|Overall Study|Disease Progression|4|||
126252760|NCT00087529|454215997|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
126252761|NCT00087529|454215998|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
126252762|NCT01120899|454217298|FG000|Overall Study|Withdrawal by Subject|3|||
126252763|NCT03686215|454217299|FG000|Overall Study|Adverse Event|0|||
126252764|NCT03686215|454217300|FG001|Overall Study|Adverse Event|0|||
126252765|NCT03686215|454217301|FG002|Overall Study|Adverse Event|7|||
126252766|NCT03686215|454217299|FG000|Overall Study|Physician Decision|0|||
126252767|NCT03686215|454217300|FG001|Overall Study|Physician Decision|0|||
126252768|NCT03686215|454217301|FG002|Overall Study|Physician Decision|1|||
126252769|NCT03686215|454217299|FG000|Overall Study|Protocol Violation|0|||
126252770|NCT03686215|454217300|FG001|Overall Study|Protocol Violation|0|||
126252771|NCT03686215|454217301|FG002|Overall Study|Protocol Violation|4|||
126252772|NCT03686215|454217299|FG000|Overall Study|Device issue|1|||
126252773|NCT03686215|454217300|FG001|Overall Study|Device issue|0|||
126252774|NCT03686215|454217301|FG002|Overall Study|Device issue|2|||
126698173|NCT00408005|455847026|FG000|Induction|Protocol Deviation|3|||
126698174|NCT00408005|455847027|FG001|Induction|Protocol Deviation|1|||
126252775|NCT00202839|454217304|FG000|Overall Study|Adverse Event|1|||
126252776|NCT00202839|454217305|FG001|Overall Study|Adverse Event|5|||
126252777|NCT00202839|454217304|FG000|Overall Study|Physician Decision|12|||
126252778|NCT00202839|454217305|FG001|Overall Study|Physician Decision|0|||
126252779|NCT00202839|454217304|FG000|Overall Study|Withdrawal by Subject|6|||
126252780|NCT00202839|454217305|FG001|Overall Study|Withdrawal by Subject|2|||
126252781|NCT00202839|454217304|FG000|Overall Study|Protocol Violation|2|||
126252782|NCT00202839|454217305|FG001|Overall Study|Protocol Violation|1|||
126252783|NCT00202839|454217304|FG000|Overall Study|Lost to Follow-up|3|||
126252784|NCT00202839|454217305|FG001|Overall Study|Lost to Follow-up|2|||
126252785|NCT02485158|454217306|FG000|Overall Study|Withdrawal by Subject|3|||
126252786|NCT02485158|454217306|FG000|Overall Study|expected drug side effect|1|||
126252787|NCT01098851|454217309|FG000|Overall Study|Equipment failure|1|||
126252788|NCT01098851|454217310|FG001|Overall Study|Equipment failure|0|||
126252789|NCT01813435|454217316|FG000|Overall Study|did not finish experimental regimen|1902|||
126252790|NCT01813435|454217317|FG001|Overall Study|did not finish experimental regimen|770|||
126252791|NCT01813435|454217316|FG000|Overall Study|Lost to Follow-up|268|||
126252792|NCT01813435|454217317|FG001|Overall Study|Lost to Follow-up|237|||
126252793|NCT03035890|454217318|FG000|Overall Study|Death|1|||
126252794|NCT00452348|454217319|FG000|Overall Study|Adverse Event|6|||
126252795|NCT00452348|454217320|FG001|Overall Study|Adverse Event|9|||
126252796|NCT00452348|454217319|FG000|Overall Study|Lack of Efficacy|10|||
126252797|NCT00452348|454217320|FG001|Overall Study|Lack of Efficacy|9|||
126252798|NCT00452348|454217319|FG000|Overall Study|Lost to Follow-up|14|||
126252799|NCT00452348|454217320|FG001|Overall Study|Lost to Follow-up|8|||
126252800|NCT00452348|454217319|FG000|Overall Study|Protocol Violation|22|||
126252801|NCT00452348|454217320|FG001|Overall Study|Protocol Violation|28|||
126252802|NCT00452348|454217319|FG000|Overall Study|Withdrawal by Subject|18|||
126252803|NCT00452348|454217320|FG001|Overall Study|Withdrawal by Subject|21|||
126252804|NCT00452348|454217319|FG000|Overall Study|Other|9|||
126252805|NCT00452348|454217320|FG001|Overall Study|Other|9|||
126252806|NCT01490190|454217321|FG000|Overall Study|Withdrawal by Subject|9|||
126252807|NCT01490190|454217321|FG000|Overall Study|Adverse Event|17|||
126252808|NCT01490190|454217321|FG000|Overall Study|Protocol Violation|5|||
126252809|NCT01490190|454217321|FG000|Overall Study|Lost to Follow-up|13|||
126252810|NCT01490190|454217321|FG000|Overall Study|Relocation|1|||
126252811|NCT01490190|454217321|FG000|Overall Study|Inconvenience|1|||
126252812|NCT01490190|454217321|FG000|Overall Study|Ring expulsion|2|||
126252813|NCT02817828|454217327|FG000|Overall Study|Lost to Follow-up|41|||
126252814|NCT02817828|454217327|FG000|Overall Study|Adverse event not related to bleeding|104|||
126252815|NCT02817828|454217327|FG000|Overall Study|Adverse event related to bleeding|53|||
126252816|NCT02817828|454217327|FG000|Overall Study|Protocol Violation|11|||
126252817|NCT02817828|454217327|FG000|Overall Study|Pregnancy|7|||
126252818|NCT02817828|454217327|FG000|Overall Study|Pregnancy wish|15|||
126252819|NCT02817828|454217327|FG000|Overall Study|Withdrawal by Subject|78|||
126252820|NCT02817828|454217327|FG000|Overall Study|Other|26|||
126252821|NCT00377156|454217331|FG000|Overall Study|Death|23|||
126252822|NCT00377156|454217332|FG001|Overall Study|Death|19|||
126252823|NCT00377156|454217331|FG000|Overall Study|Withdrawal by Subject|16|||
126252824|NCT00377156|454217332|FG001|Overall Study|Withdrawal by Subject|24|||
126252825|NCT00377156|454217331|FG000|Overall Study|Had follow-up <90 d|3|||
126252826|NCT00377156|454217332|FG001|Overall Study|Had follow-up <90 d|6|||
126252827|NCT00377156|454217331|FG000|Overall Study|Cancellation|1|||
126252828|NCT00377156|454217332|FG001|Overall Study|Cancellation|0|||
126252829|NCT00377156|454217331|FG000|Overall Study|Refused testing|0|||
126252830|NCT00377156|454217332|FG001|Overall Study|Refused testing|1|||
126252831|NCT00377156|454217331|FG000|Overall Study|Ineligible|0|||
126252832|NCT00377156|454217332|FG001|Overall Study|Ineligible|1|||
126252833|NCT00377156|454217331|FG000|Overall Study|Disability or language problem|0|||
126252834|NCT00377156|454217332|FG001|Overall Study|Disability or language problem|1|||
126252835|NCT00377156|454217331|FG000|Overall Study|Other|5|||
126252836|NCT00377156|454217332|FG001|Overall Study|Other|2|||
126252837|NCT00856349|454217333|FG000|Overall Study|Death|418|||
126252838|NCT00856349|454217333|FG000|Overall Study|Withdrawal by Subject|116|||
126252839|NCT00856349|454217333|FG000|Overall Study|Lost to Follow-up|91|||
126252840|NCT00856349|454217333|FG000|Overall Study|Protocol Violation|38|||
126762786|NCT05261126|456082730|FG004|Overall Study|Death|0|||
126762787|NCT05261126|456082726|FG000|Overall Study|Lost to Follow-up|0|||
126762788|NCT05261126|456082727|FG001|Overall Study|Lost to Follow-up|0|||
126762789|NCT05261126|456082728|FG002|Overall Study|Lost to Follow-up|0|||
126252841|NCT00856349|454217333|FG000|Overall Study|Physician Decision|13|||
126252842|NCT00856349|454217333|FG000|Overall Study|Subject relocation|104|||
126252843|NCT00856349|454217333|FG000|Overall Study|Device explant|33|||
126252844|NCT00856349|454217333|FG000|Overall Study|Site closure|78|||
126252845|NCT00856349|454217333|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
126252846|NCT05061992|454217336|FG000|Overall Study|Excess bowel movements|1|||
126252847|NCT05061992|454217337|FG001|Overall Study|Excess bowel movements|0|||
126252848|NCT05061992|454217336|FG000|Overall Study|Complications of Medical Care|1|||
126252849|NCT05061992|454217337|FG001|Overall Study|Complications of Medical Care|0|||
126252850|NCT05061992|454217336|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
126252851|NCT05061992|454217337|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
126252852|NCT05061992|454217336|FG000|Overall Study|Withdrawal by Subject|0|||
126252853|NCT05061992|454217337|FG001|Overall Study|Withdrawal by Subject|1|||
126252854|NCT02473393|454217338|FG000|Overall Study|Adverse Event|0|||
126252855|NCT02473393|454217339|FG001|Overall Study|Adverse Event|0|||
126252856|NCT02473393|454217340|FG002|Overall Study|Adverse Event|1|||
126252857|NCT02473393|454217341|FG003|Overall Study|Adverse Event|0|||
126252858|NCT02473393|454217338|FG000|Overall Study|Withdrawal by Subject|0|||
126252859|NCT02473393|454217339|FG001|Overall Study|Withdrawal by Subject|0|||
126252860|NCT02473393|454217340|FG002|Overall Study|Withdrawal by Subject|1|||
126252861|NCT02473393|454217341|FG003|Overall Study|Withdrawal by Subject|1|||
126252862|NCT01157234|454217342|FG000|Overall Study|Withdrawal by Subject|1|||
126252863|NCT01157234|454217343|FG001|Overall Study|Withdrawal by Subject|0|||
126252864|NCT01513239|454217344|FG000|Period 1: Main Phase|Adverse Event|1|||
126252865|NCT01513239|454217345|FG001|Period 1: Main Phase|Adverse Event|1|||
126762790|NCT05261126|456082729|FG003|Overall Study|Lost to Follow-up|0|||
126762791|NCT05261126|456082730|FG004|Overall Study|Lost to Follow-up|1|||
126252866|NCT01513239|454217346|FG002|Period 1: Main Phase|Adverse Event|2|||
126252867|NCT01513239|454217347|FG003|Period 1: Main Phase|Adverse Event|0|||
126252868|NCT01513239|454217348|FG004|Period 1: Main Phase|Adverse Event|0|||
126252869|NCT01513239|454217349|FG005|Period 1: Main Phase|Adverse Event|0|||
126252870|NCT01513239|454217344|FG000|Period 1: Main Phase|Death|29|||
126252871|NCT01513239|454217345|FG001|Period 1: Main Phase|Death|22|||
126252872|NCT01513239|454217346|FG002|Period 1: Main Phase|Death|32|||
126252873|NCT01513239|454217347|FG003|Period 1: Main Phase|Death|0|||
126252874|NCT01513239|454217348|FG004|Period 1: Main Phase|Death|0|||
126252875|NCT01513239|454217349|FG005|Period 1: Main Phase|Death|0|||
126762792|NCT05261126|456082726|FG000|Overall Study|Physician Decision|1|||
126252876|NCT01513239|454217344|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
126252877|NCT01513239|454217345|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
126252878|NCT01513239|454217346|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
126252879|NCT01513239|454217347|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
126252880|NCT01513239|454217348|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
126252881|NCT01513239|454217349|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
126252882|NCT01513239|454217344|FG000|Period 1: Main Phase|Physician Decision|4|||
126252883|NCT01513239|454217345|FG001|Period 1: Main Phase|Physician Decision|4|||
126252884|NCT01513239|454217346|FG002|Period 1: Main Phase|Physician Decision|4|||
126252885|NCT01513239|454217347|FG003|Period 1: Main Phase|Physician Decision|0|||
126252886|NCT01513239|454217348|FG004|Period 1: Main Phase|Physician Decision|0|||
126252887|NCT01513239|454217349|FG005|Period 1: Main Phase|Physician Decision|0|||
126252888|NCT01513239|454217344|FG000|Period 1: Main Phase|Protocol Violation|2|||
126252889|NCT01513239|454217345|FG001|Period 1: Main Phase|Protocol Violation|2|||
126252890|NCT01513239|454217346|FG002|Period 1: Main Phase|Protocol Violation|2|||
126252891|NCT01513239|454217347|FG003|Period 1: Main Phase|Protocol Violation|0|||
126252892|NCT01513239|454217348|FG004|Period 1: Main Phase|Protocol Violation|0|||
126252893|NCT01513239|454217349|FG005|Period 1: Main Phase|Protocol Violation|0|||
126252894|NCT01513239|454217344|FG000|Period 1: Main Phase|Technical Problems|1|||
126252895|NCT01513239|454217345|FG001|Period 1: Main Phase|Technical Problems|2|||
126252896|NCT01513239|454217346|FG002|Period 1: Main Phase|Technical Problems|0|||
126252897|NCT01513239|454217347|FG003|Period 1: Main Phase|Technical Problems|0|||
126252898|NCT01513239|454217348|FG004|Period 1: Main Phase|Technical Problems|0|||
126252899|NCT01513239|454217349|FG005|Period 1: Main Phase|Technical Problems|0|||
126252900|NCT01513239|454217344|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
126252901|NCT01513239|454217345|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
126252902|NCT01513239|454217346|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
126252903|NCT01513239|454217347|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
126252904|NCT01513239|454217348|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
126252905|NCT01513239|454217349|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
126252906|NCT01513239|454217344|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
126252907|NCT01513239|454217345|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
126252908|NCT01513239|454217346|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
126252909|NCT01513239|454217347|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
126252910|NCT01513239|454217348|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
126252911|NCT01513239|454217349|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
126252912|NCT01513239|454217344|FG000|Period 2: 9 Month Extension Phase|Death|0|||
126252913|NCT01513239|454217345|FG001|Period 2: 9 Month Extension Phase|Death|0|||
126252914|NCT01513239|454217346|FG002|Period 2: 9 Month Extension Phase|Death|0|||
126252915|NCT01513239|454217347|FG003|Period 2: 9 Month Extension Phase|Death|2|||
126252916|NCT01513239|454217348|FG004|Period 2: 9 Month Extension Phase|Death|5|||
126252917|NCT01513239|454217349|FG005|Period 2: 9 Month Extension Phase|Death|2|||
126252918|NCT01513239|454217344|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
126252919|NCT01513239|454217345|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
126252920|NCT01513239|454217346|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
126252921|NCT01513239|454217347|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
126252922|NCT01513239|454217348|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
126252923|NCT01513239|454217349|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
126252924|NCT01513239|454217344|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
126252925|NCT01513239|454217345|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
126252926|NCT01513239|454217346|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
126252927|NCT01513239|454217347|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
126252928|NCT01513239|454217348|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
126252929|NCT01513239|454217349|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
126252930|NCT01513239|454217344|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
126252931|NCT01513239|454217345|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
126252932|NCT01513239|454217346|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
126252933|NCT01513239|454217347|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
126252934|NCT01513239|454217348|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
126252935|NCT01513239|454217349|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
126252936|NCT03167606|454217352|FG000|Overall Study|Lost to Follow-up|73|||
126252937|NCT03167606|454217353|FG001|Overall Study|Lost to Follow-up|64|||
126252938|NCT03167606|454217352|FG000|Overall Study|Withdrawal by Subject|6|||
126252939|NCT03167606|454217353|FG001|Overall Study|Withdrawal by Subject|5|||
126252940|NCT03167606|454217352|FG000|Overall Study|Withdrawal by Investigator|0|||
126252941|NCT03167606|454217353|FG001|Overall Study|Withdrawal by Investigator|2|||
126252942|NCT00059332|454217354|FG000|Overall Study|Withdrawal by Subject|2|||
126358242|NCT00663351|454603946|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
126358243|NCT00663351|454603945|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
126358244|NCT00663351|454603946|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
126358245|NCT00663351|454603945|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
126252943|NCT00059332|454217355|FG001|Overall Study|Withdrawal by Subject|1|||
126252944|NCT00059332|454217354|FG000|Overall Study|Lost to Follow-up|1|||
126252945|NCT00059332|454217355|FG001|Overall Study|Lost to Follow-up|1|||
126252946|NCT00413049|454217356|FG000|Overall Study|Adverse Event|10|||
126252947|NCT00413049|454217357|FG001|Overall Study|Adverse Event|8|||
126252948|NCT00413049|454217356|FG000|Overall Study|Withdrawal by Subject|7|||
126698175|NCT00408005|455847028|FG002|Induction|Protocol Deviation|0|||
126698176|NCT00408005|455847029|FG003|Induction|Protocol Deviation|0|||
126252949|NCT00413049|454217357|FG001|Overall Study|Withdrawal by Subject|5|||
126252950|NCT00413049|454217356|FG000|Overall Study|Lost to Follow-up|2|||
126252951|NCT00413049|454217357|FG001|Overall Study|Lost to Follow-up|3|||
126252952|NCT00413049|454217356|FG000|Overall Study|Protocol Violation|3|||
126252953|NCT00413049|454217357|FG001|Overall Study|Protocol Violation|1|||
126252954|NCT00413049|454217356|FG000|Overall Study|Subject no longer requires study drug|0|||
126252955|NCT00413049|454217357|FG001|Overall Study|Subject no longer requires study drug|1|||
126252956|NCT00413049|454217356|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126546399|NCT01351025|455293779|FG001|Week 24 - 44|unable to get to clinic|1|||
126546400|NCT00510458|455293796|FG000|Overall Study|5 year not evaluable/missed|21|||
126546401|NCT00510458|455293796|FG000|Overall Study|Death|1|||
126698177|NCT00408005|455847030|FG004|Induction|Protocol Deviation|0|||
126252957|NCT00413049|454217357|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126252958|NCT00413049|454217356|FG000|Overall Study|Lack of Efficacy|1|||
126252959|NCT00413049|454217357|FG001|Overall Study|Lack of Efficacy|0|||
126252960|NCT02587143|454217358|FG000|Overall Study|Adverse Event|1|||
126252961|NCT02587143|454217359|FG001|Overall Study|Adverse Event|0|||
126252962|NCT03314857|454217362|FG000|Overall Study|Death|4|||
126252963|NCT03314857|454217362|FG000|Overall Study|Physician Decision|1|||
126252964|NCT00397254|454217365|FG000|Overall Study|Lost to Follow-up|2|||
126252965|NCT00397254|454217366|FG001|Overall Study|Lost to Follow-up|2|||
126252966|NCT04281472|454217370|FG000|Stage A|Lack of Efficacy|8|||
126252967|NCT04281472|454217371|FG001|Stage A|Lack of Efficacy|0|||
126252968|NCT04281472|454217372|FG002|Stage A|Lack of Efficacy|0|||
126252969|NCT04281472|454217370|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
126252970|NCT04281472|454217371|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
126252971|NCT04281472|454217372|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
126252972|NCT04281472|454217370|FG000|Stage A|Adverse Event|20|||
126252973|NCT04281472|454217371|FG001|Stage A|Adverse Event|0|||
126252974|NCT04281472|454217372|FG002|Stage A|Adverse Event|0|||
126252975|NCT04281472|454217370|FG000|Stage A|Death|1|||
126252976|NCT04281472|454217371|FG001|Stage A|Death|0|||
126252977|NCT04281472|454217372|FG002|Stage A|Death|0|||
126252978|NCT04281472|454217370|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
126252979|NCT04281472|454217371|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
126252980|NCT04281472|454217372|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
126252981|NCT04281472|454217370|FG000|Stage A|Lost to Follow-up|2|||
126252982|NCT04281472|454217371|FG001|Stage A|Lost to Follow-up|0|||
126252983|NCT04281472|454217372|FG002|Stage A|Lost to Follow-up|0|||
126698178|NCT00408005|455847031|FG005|Induction|Protocol Deviation|0|||
126698179|NCT00408005|455847032|FG006|Induction|Protocol Deviation|0|||
126698180|NCT00408005|455847033|FG007|Induction|Protocol Deviation|0|||
126252984|NCT04281472|454217370|FG000|Stage A|Non-compliance with study drug|1|||
126252985|NCT04281472|454217371|FG001|Stage A|Non-compliance with study drug|0|||
126252986|NCT04281472|454217372|FG002|Stage A|Non-compliance with study drug|0|||
126252987|NCT04281472|454217370|FG000|Stage A|Physician Decision|1|||
126252988|NCT04281472|454217371|FG001|Stage A|Physician Decision|0|||
126252989|NCT04281472|454217372|FG002|Stage A|Physician Decision|0|||
126252990|NCT04281472|454217370|FG000|Stage A|Prohibited medications|2|||
126698181|NCT00408005|455847026|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
126698182|NCT00408005|455847027|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
126698183|NCT00408005|455847028|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
126698184|NCT00408005|455847029|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
126698185|NCT00408005|455847030|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
126698186|NCT00408005|455847031|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
126698187|NCT00408005|455847032|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
126762793|NCT05261126|456082727|FG001|Overall Study|Physician Decision|0|||
126252991|NCT04281472|454217371|FG001|Stage A|Prohibited medications|0|||
126252992|NCT04281472|454217372|FG002|Stage A|Prohibited medications|0|||
126252993|NCT04281472|454217370|FG000|Stage A|Withdrawal by Subject|11|||
126252994|NCT04281472|454217371|FG001|Stage A|Withdrawal by Subject|0|||
126252995|NCT04281472|454217372|FG002|Stage A|Withdrawal by Subject|0|||
126252996|NCT04281472|454217370|FG000|Stage A|Other|5|||
126252997|NCT04281472|454217371|FG001|Stage A|Other|0|||
126252998|NCT04281472|454217372|FG002|Stage A|Other|0|||
126252999|NCT04281472|454217370|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
126306334|NCT02244463|454410276|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
126698188|NCT00408005|455847033|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
126698189|NCT00408005|455847026|FG000|Induction|Recurrent leukemia|1|||
126253000|NCT04281472|454217371|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
126253001|NCT04281472|454217372|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
126253002|NCT04281472|454217370|FG000|Stage B|Adverse Event|0|||
126253003|NCT04281472|454217371|FG001|Stage B|Adverse Event|3|||
126253004|NCT04281472|454217372|FG002|Stage B|Adverse Event|0|||
126253005|NCT04281472|454217370|FG000|Stage B|Death|0|||
126253006|NCT04281472|454217371|FG001|Stage B|Death|0|||
126253007|NCT04281472|454217372|FG002|Stage B|Death|1|||
126253008|NCT04281472|454217370|FG000|Stage B|Lack of Efficacy|0|||
126253009|NCT04281472|454217371|FG001|Stage B|Lack of Efficacy|0|||
126253010|NCT04281472|454217372|FG002|Stage B|Lack of Efficacy|1|||
126253011|NCT04281472|454217370|FG000|Stage B|Lost to Follow-up|0|||
126253012|NCT04281472|454217371|FG001|Stage B|Lost to Follow-up|0|||
126253013|NCT04281472|454217372|FG002|Stage B|Lost to Follow-up|2|||
126253014|NCT04281472|454217370|FG000|Stage B|Prohibited medications|0|||
126253015|NCT04281472|454217371|FG001|Stage B|Prohibited medications|2|||
126253016|NCT04281472|454217372|FG002|Stage B|Prohibited medications|1|||
126253017|NCT04281472|454217370|FG000|Stage B|Protocol Violation|0|||
126253018|NCT04281472|454217371|FG001|Stage B|Protocol Violation|1|||
126253019|NCT04281472|454217372|FG002|Stage B|Protocol Violation|1|||
126253020|NCT04281472|454217370|FG000|Stage B|Sponsor decision|0|||
126253021|NCT04281472|454217371|FG001|Stage B|Sponsor decision|0|||
126253022|NCT04281472|454217372|FG002|Stage B|Sponsor decision|1|||
126253023|NCT04281472|454217370|FG000|Stage B|Withdrawal by Subject|0|||
126253024|NCT04281472|454217371|FG001|Stage B|Withdrawal by Subject|3|||
126253025|NCT04281472|454217372|FG002|Stage B|Withdrawal by Subject|3|||
126253026|NCT04281472|454217370|FG000|Stage B|Other|0|||
126253027|NCT04281472|454217371|FG001|Stage B|Other|3|||
126253028|NCT04281472|454217372|FG002|Stage B|Other|0|||
126253029|NCT01055834|454217374|FG000|Treatment Period I|Adverse Event|1|||
126253030|NCT01055834|454217375|FG001|Treatment Period I|Adverse Event|0|||
126253031|NCT01717313|454217376|FG000|Phase A (Weeks 0 to 24)|Death|0|||
126253032|NCT01717313|454217377|FG001|Phase A (Weeks 0 to 24)|Death|1|||
126253033|NCT01717313|454217376|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
126253034|NCT01717313|454217377|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
126253035|NCT01717313|454217376|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
126253036|NCT01717313|454217377|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
126253037|NCT01717313|454217376|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
126253038|NCT01717313|454217377|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
126253039|NCT01717313|454217376|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
126253040|NCT01717313|454217377|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
126253041|NCT01717313|454217376|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
126253042|NCT01717313|454217377|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
126253043|NCT01717313|454217376|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
126253044|NCT01717313|454217377|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
126253045|NCT01717313|454217376|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
126253046|NCT01717313|454217377|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
126253047|NCT01717313|454217376|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
126253048|NCT01717313|454217377|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
126253049|NCT01617096|454217388|FG000|Overall Study|Withdrawal by Subject|96|||
126253050|NCT01617096|454217389|FG001|Overall Study|Withdrawal by Subject|81|||
126253051|NCT01617096|454217388|FG000|Overall Study|Lost to Follow-up|37|||
126253052|NCT01617096|454217389|FG001|Overall Study|Lost to Follow-up|32|||
126253053|NCT01617096|454217388|FG000|Overall Study|Physician Decision|10|||
126253054|NCT01617096|454217389|FG001|Overall Study|Physician Decision|18|||
126253055|NCT01617096|454217388|FG000|Overall Study|Death|4|||
126253056|NCT01617096|454217389|FG001|Overall Study|Death|3|||
126698190|NCT00408005|455847027|FG001|Induction|Recurrent leukemia|0|||
126253057|NCT01617096|454217388|FG000|Overall Study|Other|1|||
126698191|NCT00408005|455847028|FG002|Induction|Recurrent leukemia|0|||
126698192|NCT00408005|455847029|FG003|Induction|Recurrent leukemia|0|||
126698193|NCT00408005|455847030|FG004|Induction|Recurrent leukemia|0|||
126698194|NCT00408005|455847031|FG005|Induction|Recurrent leukemia|0|||
126253058|NCT01617096|454217389|FG001|Overall Study|Other|3|||
126253059|NCT04473326|454217392|FG000|Overall Study|Death|0|||
126253060|NCT04473326|454217393|FG001|Overall Study|Death|1|||
126253061|NCT04473326|454217392|FG000|Overall Study|Withdrawal by Subject|1|||
126253062|NCT04473326|454217393|FG001|Overall Study|Withdrawal by Subject|2|||
126253063|NCT02611362|454217394|FG000|Overall Study|Withdrawal by Subject|7|||
126253064|NCT02611362|454217395|FG001|Overall Study|Withdrawal by Subject|2|||
126253065|NCT02611362|454217394|FG000|Overall Study|Lost to Follow-up|2|||
126253066|NCT02611362|454217395|FG001|Overall Study|Lost to Follow-up|4|||
126253067|NCT01155531|454217396|FG000|Overall Study|Adverse Event|0|||
126253068|NCT01155531|454217397|FG001|Overall Study|Adverse Event|0|||
126253069|NCT01155531|454217398|FG002|Overall Study|Adverse Event|1|||
126253070|NCT01155531|454217399|FG003|Overall Study|Adverse Event|0|||
126253071|NCT01155531|454217396|FG000|Overall Study|Lost to Follow-up|0|||
126698195|NCT00408005|455847032|FG006|Induction|Recurrent leukemia|0|||
126698196|NCT00408005|455847033|FG007|Induction|Recurrent leukemia|0|||
126253072|NCT01155531|454217397|FG001|Overall Study|Lost to Follow-up|0|||
126253073|NCT01155531|454217398|FG002|Overall Study|Lost to Follow-up|0|||
126253074|NCT01155531|454217399|FG003|Overall Study|Lost to Follow-up|1|||
126253075|NCT01155531|454217396|FG000|Overall Study|Withdrawal by Subject|1|||
126253076|NCT01155531|454217397|FG001|Overall Study|Withdrawal by Subject|0|||
126253077|NCT01155531|454217398|FG002|Overall Study|Withdrawal by Subject|1|||
126253078|NCT01155531|454217399|FG003|Overall Study|Withdrawal by Subject|0|||
126253079|NCT00354159|454217400|FG000|Randomized Study Period|Withdrawal by Subject|5|||
126253080|NCT00354159|454217401|FG001|Randomized Study Period|Withdrawal by Subject|3|||
126253081|NCT00354159|454217400|FG000|Randomized Study Period|Physician Decision|6|||
126253082|NCT00354159|454217401|FG001|Randomized Study Period|Physician Decision|10|||
126253083|NCT00354159|454217400|FG000|Randomized Study Period|Lost to Follow-up|4|||
126253084|NCT00354159|454217401|FG001|Randomized Study Period|Lost to Follow-up|0|||
126253085|NCT00354159|454217400|FG000|Randomized Study Period|Death|7|||
126253086|NCT00354159|454217401|FG001|Randomized Study Period|Death|9|||
126253087|NCT00354159|454217400|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
126253088|NCT00354159|454217401|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
126253089|NCT00354159|454217400|FG000|Long-term Follow-up|Physician Decision|127|||
126253090|NCT00354159|454217401|FG001|Long-term Follow-up|Physician Decision|122|||
126253091|NCT00354159|454217400|FG000|Long-term Follow-up|Lost to Follow-up|1|||
126253092|NCT00354159|454217401|FG001|Long-term Follow-up|Lost to Follow-up|0|||
126253093|NCT00354159|454217400|FG000|Long-term Follow-up|Death|14|||
126253094|NCT00354159|454217401|FG001|Long-term Follow-up|Death|11|||
126253095|NCT00354159|454217400|FG000|Long-term Follow-up|Study Closed|29|||
126253096|NCT00354159|454217401|FG001|Long-term Follow-up|Study Closed|34|||
126253097|NCT02046122|454217402|FG000|Overall Study|Physician Decision|8|||
126253098|NCT02046122|454217402|FG000|Overall Study|Withdrawal by Subject|1|||
126253099|NCT01653704|454217403|FG000|Overall Study|Technical failure during recording|1|||
126253100|NCT01653704|454217404|FG001|Overall Study|Technical failure during recording|1|||
126253101|NCT01653704|454217403|FG000|Overall Study|Performance not reflective of training|1|||
126253102|NCT01653704|454217404|FG001|Overall Study|Performance not reflective of training|0|||
126253103|NCT01728116|454217407|FG000|Overall Study|Sponsor Terminated Study|106|||
126253104|NCT01728116|454217408|FG001|Overall Study|Sponsor Terminated Study|35|||
126253105|NCT01728116|454217407|FG000|Overall Study|Withdrawal by Subject|16|||
126253106|NCT01728116|454217408|FG001|Overall Study|Withdrawal by Subject|9|||
126253107|NCT01728116|454217407|FG000|Overall Study|Adverse Event|13|||
126253108|NCT01728116|454217408|FG001|Overall Study|Adverse Event|0|||
126253109|NCT01728116|454217407|FG000|Overall Study|Procedure/device failure|7|||
126253110|NCT01728116|454217408|FG001|Overall Study|Procedure/device failure|0|||
126253111|NCT01728116|454217407|FG000|Overall Study|Lost to Follow-up|9|||
126253112|NCT01728116|454217408|FG001|Overall Study|Lost to Follow-up|2|||
126253113|NCT01728116|454217407|FG000|Overall Study|Physician Decision|2|||
126253114|NCT01728116|454217408|FG001|Overall Study|Physician Decision|0|||
126253115|NCT01728116|454217407|FG000|Overall Study|Subject Non-Compliance|2|||
126253116|NCT01728116|454217408|FG001|Overall Study|Subject Non-Compliance|0|||
126253117|NCT01728116|454217407|FG000|Overall Study|Inter-current finding at procedure|1|||
126253118|NCT01728116|454217408|FG001|Overall Study|Inter-current finding at procedure|0|||
126253119|NCT01728116|454217407|FG000|Overall Study|Incorrectly enrolled in Study|0|||
126253120|NCT01728116|454217408|FG001|Overall Study|Incorrectly enrolled in Study|1|||
126253121|NCT01728116|454217407|FG000|Overall Study|various not noted previously|5|||
126253122|NCT01728116|454217408|FG001|Overall Study|various not noted previously|0|||
126253123|NCT01532908|454217409|FG000|Overall Study|Not Transplanted|1|||
126253124|NCT01532908|454217410|FG001|Overall Study|Not Transplanted|0|||
126253125|NCT02943096|454217411|FG000|Overall Study|Lack of Efficacy|0|||
126253126|NCT02943096|454217412|FG001|Overall Study|Lack of Efficacy|1|||
126253127|NCT00939523|454217417|FG000|Overall Study|Lack of Efficacy|1|||
126253128|NCT00939523|454217417|FG000|Overall Study|Physician Decision|2|||
126253129|NCT00024258|454217418|FG000|Overall Study|Withdrawal by Subject|1|||
126253130|NCT00024258|454217418|FG000|Overall Study|Disease Progression|8|||
126253131|NCT03193021|454217427|FG000|Overall Study|Lost to Follow-up|1|||
126253132|NCT03193021|454217428|FG001|Overall Study|Lost to Follow-up|1|||
126253133|NCT01139762|454217429|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
126253134|NCT01139762|454217430|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
126253135|NCT01139762|454217431|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
126253136|NCT01139762|454217429|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
126253137|NCT01139762|454217430|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
126253138|NCT01139762|454217431|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
126253139|NCT01139762|454217429|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
126253140|NCT01139762|454217430|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
126253141|NCT01139762|454217431|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
126253142|NCT01139762|454217429|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
126253143|NCT01139762|454217430|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
126253144|NCT01139762|454217431|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
126253145|NCT01139762|454217429|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
126253146|NCT01139762|454217430|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
126253147|NCT01139762|454217431|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
126253148|NCT01139762|454217429|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
126253149|NCT01139762|454217430|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
126253150|NCT01139762|454217431|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
126253151|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
126253152|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
126253153|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
126253154|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Death|0|||
126253155|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Death|1|||
126253156|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Death|1|||
126253157|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
126253158|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
126253159|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
126253160|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
126253161|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
126253162|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
126253163|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
126253164|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
126253165|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
126253166|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
126253167|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
126253168|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
126253169|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
126253170|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
126253171|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
126253172|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
126253173|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
126253174|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
126253175|NCT01139762|454217429|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
126253176|NCT01139762|454217430|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
126253177|NCT01139762|454217431|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
126253178|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Adverse Event|8|||
126253179|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Adverse Event|5|||
126253180|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Adverse Event|9|||
126253181|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Adverse Event|0|||
126253182|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Adverse Event|0|||
126253183|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Adverse Event|0|||
126253184|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
126253185|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
126253186|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
126253187|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
126253188|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
126253189|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
126253190|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
126253191|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
126253192|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
126253193|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
126253194|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
126253195|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
126253196|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Physician Decision|4|||
126253197|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Physician Decision|0|||
126253198|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Physician Decision|2|||
126253199|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Physician Decision|0|||
126253200|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Physician Decision|0|||
126253201|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Physician Decision|0|||
126253202|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Pregnancy|1|||
126253203|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Pregnancy|2|||
126253204|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Pregnancy|0|||
126253205|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Pregnancy|0|||
126253206|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Pregnancy|0|||
126253207|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Pregnancy|0|||
126253208|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
126253209|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
126253210|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
126253211|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
126253212|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
126253213|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
126253214|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
126253215|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
126253216|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
126253217|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
126253218|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
126253219|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
126253220|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
126698197|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
126253221|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
126253222|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
126253223|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
126253224|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
126253225|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
126698198|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
126698199|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
126698200|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
126698201|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
126698202|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
126698203|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
126698204|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
126698205|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
126698206|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
126698207|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
126698208|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
126698209|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
126698210|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
126698211|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
126698212|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
126698213|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
126698214|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
126698215|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
126698216|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
126698217|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
126698218|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
126698219|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
126698220|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
126698221|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
126253226|NCT02614196|454217432|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
126253227|NCT02614196|454217433|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
126253228|NCT02614196|454217434|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
126253229|NCT02614196|454217435|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
126253230|NCT02614196|454217436|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
126253231|NCT02614196|454217437|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
126253232|NCT02614196|454217432|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
126253233|NCT02614196|454217433|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
126253234|NCT02614196|454217434|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
126253235|NCT02614196|454217435|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
126253236|NCT02614196|454217436|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
126253237|NCT02614196|454217437|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
126253238|NCT02614196|454217432|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
126253239|NCT02614196|454217433|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
126253240|NCT02614196|454217434|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
126253241|NCT02614196|454217435|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
126253242|NCT02614196|454217436|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
126253243|NCT02614196|454217437|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
126253244|NCT02614196|454217432|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
126253245|NCT02614196|454217433|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
126253246|NCT02614196|454217434|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
126253247|NCT02614196|454217435|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
126253248|NCT02614196|454217436|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
126253249|NCT02614196|454217437|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
126698222|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
126698223|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
126253250|NCT02614196|454217432|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
126253251|NCT02614196|454217433|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
126698224|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
126762794|NCT05261126|456082728|FG002|Overall Study|Physician Decision|0|||
126762795|NCT05261126|456082729|FG003|Overall Study|Physician Decision|0|||
126762796|NCT05261126|456082730|FG004|Overall Study|Physician Decision|0|||
126762797|NCT05261126|456082726|FG000|Overall Study|Screen Failure|0|||
126762798|NCT05261126|456082727|FG001|Overall Study|Screen Failure|0|||
126762799|NCT05261126|456082728|FG002|Overall Study|Screen Failure|0|||
126762800|NCT05261126|456082729|FG003|Overall Study|Screen Failure|0|||
126762801|NCT05261126|456082730|FG004|Overall Study|Screen Failure|1|||
126762802|NCT05261126|456082726|FG000|Overall Study|Withdrawal by Subject|1|||
126762803|NCT05261126|456082727|FG001|Overall Study|Withdrawal by Subject|0|||
126762804|NCT05261126|456082728|FG002|Overall Study|Withdrawal by Subject|1|||
126762805|NCT05261126|456082729|FG003|Overall Study|Withdrawal by Subject|1|||
126762806|NCT05261126|456082730|FG004|Overall Study|Withdrawal by Subject|0|||
126762807|NCT05261126|456082726|FG000|Overall Study|Not Recorded|0|||
126762808|NCT05261126|456082727|FG001|Overall Study|Not Recorded|0|||
126762809|NCT05261126|456082728|FG002|Overall Study|Not Recorded|0|||
126762810|NCT05261126|456082729|FG003|Overall Study|Not Recorded|1|||
126762811|NCT05261126|456082730|FG004|Overall Study|Not Recorded|0|||
126762812|NCT03901274|456082731|FG000|Overall Study|Lost to Follow-up|120|||
126762813|NCT03901274|456082732|FG001|Overall Study|Lost to Follow-up|124|||
126762814|NCT03901274|456082731|FG000|Overall Study|Withdrawal by Subject|0|||
126698225|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
126698226|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
126698227|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
126698228|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
126698229|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
126698230|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
126698231|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
126698232|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
126698233|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
126698234|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
126698235|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
126698236|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
126698237|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
126698238|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
126698239|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
126698240|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
126698241|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
126698242|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
126698243|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
126698244|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
126698245|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126698246|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126698247|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126698248|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126698249|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
126698250|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126698251|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126698252|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
126698253|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
126698254|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
126698255|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
126698256|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
126698257|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
126698258|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
126698259|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
126698260|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
126762815|NCT03901274|456082732|FG001|Overall Study|Withdrawal by Subject|6|||
126762816|NCT05570604|456082733|FG000|Overall Study|Lost to Follow-up|1|||
126762817|NCT05570604|456082734|FG001|Overall Study|Lost to Follow-up|5|||
126762818|NCT05570604|456082733|FG000|Overall Study|Illness|2|||
126762819|NCT05570604|456082734|FG001|Overall Study|Illness|2|||
126762820|NCT00145119|456082737|FG000|Overall Study|Death|45|||
126762821|NCT04527380|456082738|FG000|Overall Study|Lack of Efficacy|0|||
126762822|NCT04527380|456082739|FG001|Overall Study|Lack of Efficacy|1|||
126253252|NCT02614196|454217434|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
126253253|NCT02614196|454217435|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
126253254|NCT02614196|454217436|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
126253255|NCT02614196|454217437|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
126253256|NCT01539239|454217438|FG000|Overall Study|Death|5|||
126253257|NCT01539239|454217439|FG001|Overall Study|Death|5|||
126253258|NCT01539239|454217438|FG000|Overall Study|Lost to Follow-up|7|||
126253259|NCT01539239|454217439|FG001|Overall Study|Lost to Follow-up|12|||
126253260|NCT00640341|454219334|FG000|Overall Study|Adverse Event|0|||
126253261|NCT00640341|454219335|FG001|Overall Study|Adverse Event|0|||
126253262|NCT00640341|454219336|FG002|Overall Study|Adverse Event|1|||
126253263|NCT00640341|454219334|FG000|Overall Study|Positive Slit Lamp Findings|0|||
126253264|NCT00640341|454219335|FG001|Overall Study|Positive Slit Lamp Findings|0|||
126253265|NCT00640341|454219336|FG002|Overall Study|Positive Slit Lamp Findings|1|||
126253266|NCT00640341|454219334|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
126253267|NCT00640341|454219335|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
126253268|NCT00640341|454219336|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
126253269|NCT00640341|454219334|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
126253270|NCT00640341|454219335|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
126253271|NCT00640341|454219336|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
126698261|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
126698262|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
126698263|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
126698264|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
126698265|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
126253272|NCT00640341|454219334|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
126698266|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
126698267|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
126698268|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
126698269|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126698270|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126698271|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126698272|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126698273|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126698274|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
126698275|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126698276|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
126698277|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
126698278|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
126698279|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
126698280|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
126698281|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
126698282|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
126698283|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
126698284|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
126698285|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
126698286|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
126698287|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
126698288|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
126698289|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
126698290|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
126698291|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
126698292|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
126698293|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
126698294|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
126698295|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
126253273|NCT00640341|454219335|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
126253274|NCT00640341|454219336|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
126253275|NCT00640341|454219334|FG000|Overall Study|Lost to Follow-up|2|||
126253276|NCT00640341|454219335|FG001|Overall Study|Lost to Follow-up|0|||
126698296|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
126253277|NCT00640341|454219336|FG002|Overall Study|Lost to Follow-up|0|||
126715185|NCT01052012|455908706|FG000|Overall Study|Withdrawal by Subject|1|||
126253278|NCT00640341|454219334|FG000|Overall Study|Withdrawal by Subject|4|||
126358246|NCT00663351|454603946|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
126698297|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
126698298|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
126253279|NCT00640341|454219335|FG001|Overall Study|Withdrawal by Subject|0|||
126253280|NCT00640341|454219336|FG002|Overall Study|Withdrawal by Subject|1|||
126253281|NCT00640341|454219334|FG000|Overall Study|Unacceptable Lens Movement|1|||
126253282|NCT00640341|454219335|FG001|Overall Study|Unacceptable Lens Movement|0|||
126253283|NCT00640341|454219336|FG002|Overall Study|Unacceptable Lens Movement|0|||
126253284|NCT00640341|454219334|FG000|Overall Study|Poor fit/Uncomfortable|4|||
126253285|NCT00640341|454219335|FG001|Overall Study|Poor fit/Uncomfortable|0|||
126253286|NCT00640341|454219336|FG002|Overall Study|Poor fit/Uncomfortable|0|||
126253287|NCT00640341|454219334|FG000|Overall Study|Ineligable at Baseline|5|||
126253288|NCT00640341|454219335|FG001|Overall Study|Ineligable at Baseline|3|||
126253289|NCT00640341|454219336|FG002|Overall Study|Ineligable at Baseline|2|||
126253290|NCT00640341|454219334|FG000|Overall Study|Adverse event and positive slit lamp|1|||
126253291|NCT00640341|454219335|FG001|Overall Study|Adverse event and positive slit lamp|0|||
126253292|NCT00640341|454219336|FG002|Overall Study|Adverse event and positive slit lamp|0|||
126253293|NCT01520987|454219341|FG000|Overall Study|Withdrawal by Subject|1|||
126253294|NCT01520987|454219342|FG001|Overall Study|Withdrawal by Subject|0|||
126253295|NCT01520987|454219343|FG002|Overall Study|Withdrawal by Subject|0|||
126253296|NCT01520987|454219344|FG003|Overall Study|Withdrawal by Subject|0|||
126253297|NCT01520987|454219345|FG004|Overall Study|Withdrawal by Subject|0|||
126253298|NCT01520987|454219346|FG005|Overall Study|Withdrawal by Subject|1|||
126253299|NCT01520987|454219347|FG006|Overall Study|Withdrawal by Subject|0|||
126253300|NCT01520987|454219348|FG007|Overall Study|Withdrawal by Subject|0|||
126253301|NCT02005562|454219349|FG000|Overall Study|Death|2|||
126253302|NCT02005562|454219350|FG001|Overall Study|Death|2|||
126253303|NCT02005562|454219349|FG000|Overall Study|Graft loss|7|||
126253304|NCT02005562|454219350|FG001|Overall Study|Graft loss|6|||
126253305|NCT02005562|454219349|FG000|Overall Study|Withdrawal by Subject|2|||
126253306|NCT02005562|454219350|FG001|Overall Study|Withdrawal by Subject|2|||
126253307|NCT02005562|454219349|FG000|Overall Study|No transplant|1|||
126253308|NCT02005562|454219350|FG001|Overall Study|No transplant|4|||
126253309|NCT02005562|454219349|FG000|Overall Study|Physician Decision|0|||
126253310|NCT02005562|454219350|FG001|Overall Study|Physician Decision|1|||
126253311|NCT01691430|454219351|FG000|Overall Study|Death|17|||
126253312|NCT01691430|454219352|FG001|Overall Study|Death|16|||
126253313|NCT01691430|454219351|FG000|Overall Study|Withdrawal by Subject|5|||
126253314|NCT01691430|454219352|FG001|Overall Study|Withdrawal by Subject|1|||
126253315|NCT01691430|454219351|FG000|Overall Study|Lost to Follow-up|0|||
126253316|NCT01691430|454219352|FG001|Overall Study|Lost to Follow-up|3|||
126253317|NCT00660387|454219360|FG000|Overall Study|Adverse Event|1|||
126253318|NCT00660387|454219361|FG001|Overall Study|Adverse Event|2|||
126253319|NCT00660387|454219360|FG000|Overall Study|Lack of Efficacy|0|||
126253320|NCT00660387|454219361|FG001|Overall Study|Lack of Efficacy|1|||
126253321|NCT00660387|454219360|FG000|Overall Study|Protocol Violation|1|||
126253322|NCT00660387|454219361|FG001|Overall Study|Protocol Violation|0|||
126253323|NCT04729101|454219362|FG000|Overall Study|Adverse Event|1|||
126253324|NCT04729101|454219363|FG001|Overall Study|Adverse Event|0|||
126253325|NCT04729101|454219362|FG000|Overall Study|Physician Decision|1|||
126253326|NCT04729101|454219363|FG001|Overall Study|Physician Decision|0|||
126253327|NCT04729101|454219362|FG000|Overall Study|Withdrawal by Subject|1|||
126253328|NCT04729101|454219363|FG001|Overall Study|Withdrawal by Subject|0|||
126253329|NCT03086135|454219364|FG000|Overall Study|Adverse Event|1|||
126253330|NCT03086135|454219364|FG000|Overall Study|Lost to Follow-up|2|||
126253331|NCT01023061|454219367|FG000|Overall Study|Withdrawal prior to treatment|2|||
126253332|NCT00762411|454219368|FG000|Initial Treatment|Death|7|||
126253333|NCT00762411|454219369|FG001|Initial Treatment|Death|6|||
126253334|NCT00762411|454219368|FG000|Initial Treatment|Adverse Event|132|||
126253335|NCT00762411|454219369|FG001|Initial Treatment|Adverse Event|40|||
126253336|NCT00762411|454219368|FG000|Initial Treatment|Protocol Violation|4|||
126253337|NCT00762411|454219369|FG001|Initial Treatment|Protocol Violation|1|||
126253338|NCT00762411|454219368|FG000|Initial Treatment|Withdrawal by Subject|65|||
126253339|NCT00762411|454219369|FG001|Initial Treatment|Withdrawal by Subject|52|||
126698299|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
126698300|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
126698301|NCT00408005|455847026|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
126253340|NCT00762411|454219368|FG000|Initial Treatment|Physician Decision|1|||
126253341|NCT00762411|454219369|FG001|Initial Treatment|Physician Decision|0|||
126253342|NCT00762411|454219368|FG000|Initial Treatment|Sponsor Decision|293|||
126253343|NCT00762411|454219369|FG001|Initial Treatment|Sponsor Decision|401|||
126253344|NCT00762411|454219368|FG000|Initial Treatment|Lost to Follow-up|5|||
126358247|NCT03467945|454603947|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126253345|NCT00762411|454219369|FG001|Initial Treatment|Lost to Follow-up|0|||
126253346|NCT00762411|454219368|FG000|Initial Treatment|Caregiver Decision|21|||
126253347|NCT00762411|454219369|FG001|Initial Treatment|Caregiver Decision|16|||
126253348|NCT00762411|454219368|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
126253349|NCT00762411|454219369|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
126253350|NCT00762411|454219368|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
126253351|NCT00762411|454219369|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
126253352|NCT00762411|454219368|FG000|Delayed Start|Adverse Event|0|||
126253353|NCT00762411|454219369|FG001|Delayed Start|Adverse Event|4|||
126253354|NCT00762411|454219368|FG000|Delayed Start|Protocol Violation|0|||
126253355|NCT00762411|454219369|FG001|Delayed Start|Protocol Violation|1|||
126253356|NCT00762411|454219368|FG000|Delayed Start|Sponsor Decision|16|||
126253357|NCT00762411|454219369|FG001|Delayed Start|Sponsor Decision|20|||
126253358|NCT00762411|454219368|FG000|Delayed Start|Caregiver Decision|1|||
126253359|NCT00762411|454219369|FG001|Delayed Start|Caregiver Decision|1|||
126253360|NCT00762411|454219368|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
126253361|NCT00762411|454219369|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
126253362|NCT00762411|454219368|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
126253363|NCT00762411|454219369|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
126253364|NCT00762411|454219368|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
126253365|NCT00762411|454219369|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
126253366|NCT00762411|454219368|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
126253367|NCT00762411|454219369|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
126253368|NCT00762411|454219368|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
126253369|NCT00762411|454219369|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
126253370|NCT00762411|454219368|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
126253371|NCT00762411|454219369|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
126253372|NCT02966340|454219373|FG000|Overall Study|Adverse Event|0|||
126253373|NCT02966340|454219374|FG001|Overall Study|Adverse Event|1|||
126253374|NCT02966340|454219373|FG000|Overall Study|Lost to Follow-up|0|||
126253375|NCT02966340|454219374|FG001|Overall Study|Lost to Follow-up|1|||
126253376|NCT02966340|454219373|FG000|Overall Study|Withdrawal by Subject|1|||
126253377|NCT02966340|454219374|FG001|Overall Study|Withdrawal by Subject|0|||
126253378|NCT02966340|454219373|FG000|Overall Study|data acquisition error|1|||
126253379|NCT02966340|454219374|FG001|Overall Study|data acquisition error|0|||
126253380|NCT02966340|454219373|FG000|Overall Study|startle non-responder|1|||
126253381|NCT02966340|454219374|FG001|Overall Study|startle non-responder|1|||
126253382|NCT01622660|454219375|FG000|Overall Study|Adverse Event|1|||
126253383|NCT02259348|454219376|FG000|Overall Study|Donors|6|||
126253384|NCT02259348|454219376|FG000|Overall Study|Death|4|||
126253385|NCT04812548|454219377|FG000|Overall Study|Adverse Event|2|||
126253386|NCT04812548|454219378|FG001|Overall Study|Adverse Event|7|||
126253387|NCT04812548|454219377|FG000|Overall Study|HSCT Planned|2|||
126253388|NCT04812548|454219378|FG001|Overall Study|HSCT Planned|3|||
126253389|NCT04812548|454219377|FG000|Overall Study|Progressive Disease|0|||
126253390|NCT04812548|454219378|FG001|Overall Study|Progressive Disease|2|||
126253391|NCT04812548|454219377|FG000|Overall Study|Death|0|||
126253392|NCT04812548|454219378|FG001|Overall Study|Death|1|||
126253393|NCT04812548|454219377|FG000|Overall Study|Post Study Access to Treatment|0|||
126253394|NCT04812548|454219378|FG001|Overall Study|Post Study Access to Treatment|1|||
126253395|NCT04812548|454219377|FG000|Overall Study|Withdrawal by Subject|0|||
126253396|NCT04812548|454219378|FG001|Overall Study|Withdrawal by Subject|1|||
126253397|NCT04812548|454219377|FG000|Overall Study|Physician Decision|1|||
126253398|NCT04812548|454219378|FG001|Overall Study|Physician Decision|0|||
126253399|NCT04211766|454219379|FG000|Overall Study|Withdrawal by Subject|5|||
126698302|NCT00408005|455847027|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
126698303|NCT00408005|455847028|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
126698304|NCT00408005|455847029|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
126698305|NCT00408005|455847030|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
126698306|NCT00408005|455847031|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
126698307|NCT00408005|455847032|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
126698308|NCT00408005|455847033|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
126698309|NCT03155997|455847034|FG000|Overall Study|Withdrawal by Subject|119|||
126698310|NCT03155997|455847035|FG001|Overall Study|Withdrawal by Subject|134|||
126698311|NCT03155997|455847034|FG000|Overall Study|Lost to Follow-up|12|||
126698312|NCT03155997|455847035|FG001|Overall Study|Lost to Follow-up|13|||
126698313|NCT03155997|455847034|FG000|Overall Study|Missing disposition data|0|||
126698314|NCT03155997|455847035|FG001|Overall Study|Missing disposition data|1|||
126698315|NCT03155997|455847034|FG000|Overall Study|On study treatment|2027|||
126698316|NCT03155997|455847035|FG001|Overall Study|On study treatment|2074|||
126698317|NCT01848145|455847036|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
126698318|NCT01848145|455847036|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
126253400|NCT04211766|454219380|FG001|Overall Study|Withdrawal by Subject|1|||
126253401|NCT04590781|454219381|FG000|Overall Study|Death|0|||
126253402|NCT04590781|454219382|FG001|Overall Study|Death|2|||
126253403|NCT04590781|454219381|FG000|Overall Study|Withdrawal by Subject|2|||
126253404|NCT04590781|454219382|FG001|Overall Study|Withdrawal by Subject|0|||
126253405|NCT01680016|454219383|FG000|Overall Study|Adverse Event|0|||
126253406|NCT01680016|454219384|FG001|Overall Study|Adverse Event|0|||
126253407|NCT01680016|454219385|FG002|Overall Study|Adverse Event|1|||
126253408|NCT01680016|454219386|FG003|Overall Study|Adverse Event|4|||
126253409|NCT01680016|454219383|FG000|Overall Study|The Subject went out of The Trial|1|||
126253410|NCT01680016|454219384|FG001|Overall Study|The Subject went out of The Trial|0|||
126253411|NCT01680016|454219385|FG002|Overall Study|The Subject went out of The Trial|3|||
126253412|NCT01680016|454219386|FG003|Overall Study|The Subject went out of The Trial|0|||
126253413|NCT01680016|454219383|FG000|Overall Study|Protocol Violation|0|||
126253414|NCT01680016|454219384|FG001|Overall Study|Protocol Violation|1|||
126253415|NCT01680016|454219385|FG002|Overall Study|Protocol Violation|0|||
126253416|NCT01680016|454219386|FG003|Overall Study|Protocol Violation|0|||
126253417|NCT01680016|454219383|FG000|Overall Study|Withdrawal by Subject|5|||
126253418|NCT01680016|454219384|FG001|Overall Study|Withdrawal by Subject|7|||
126253419|NCT01680016|454219385|FG002|Overall Study|Withdrawal by Subject|1|||
126253420|NCT01680016|454219386|FG003|Overall Study|Withdrawal by Subject|1|||
126253421|NCT00442351|454219387|FG000|Overall Study|Administrative|6|||
126253422|NCT00442351|454219388|FG001|Overall Study|Administrative|5|||
126253423|NCT00442351|454219387|FG000|Overall Study|Did not meet protocol eligibility|1|||
126253424|NCT00442351|454219388|FG001|Overall Study|Did not meet protocol eligibility|0|||
126253425|NCT00442351|454219387|FG000|Overall Study|Other|0|||
126253426|NCT00442351|454219388|FG001|Overall Study|Other|1|||
126253427|NCT00288704|454219389|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
126253428|NCT00288704|454219390|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
126253429|NCT00288704|454219391|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
126253430|NCT00288704|454219389|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
126253431|NCT00288704|454219390|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
126253432|NCT00288704|454219391|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
126253433|NCT00288704|454219389|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
126253434|NCT00288704|454219390|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
126253435|NCT00288704|454219391|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
126253436|NCT00288704|454219389|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
126253437|NCT00288704|454219390|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
126253438|NCT00288704|454219391|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
126253439|NCT00288704|454219389|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
126253440|NCT00288704|454219390|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
126253441|NCT00288704|454219391|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
126253442|NCT00288704|454219389|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
126253443|NCT00288704|454219390|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
126253444|NCT00288704|454219391|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
126253445|NCT00288704|454219389|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
126253446|NCT00288704|454219390|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
126253447|NCT00288704|454219391|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
126253448|NCT01579006|454219392|FG000|Overall Study|Lack of Efficacy|10|||
126253449|NCT01579006|454219392|FG000|Overall Study|Adverse Event|13|||
126253450|NCT01579006|454219392|FG000|Overall Study|Withdrawal by Subject|5|||
126253451|NCT01579006|454219392|FG000|Overall Study|Non-compliance|3|||
126253452|NCT01579006|454219392|FG000|Overall Study|Due to participant's health fund|1|||
126253453|NCT01579006|454219392|FG000|Overall Study|Scheduled surgery|1|||
126253454|NCT02697617|454219393|FG000|Overall Study|Withdrawal by Subject|0|||
126253455|NCT02697617|454219394|FG001|Overall Study|Withdrawal by Subject|2|||
126253456|NCT02697617|454219393|FG000|Overall Study|Pregnancy|1|||
126762823|NCT04527380|456082738|FG000|Overall Study|Withdrawal by Subject|1|||
126253457|NCT02697617|454219394|FG001|Overall Study|Pregnancy|0|||
126253458|NCT02460835|454219395|FG000|Overall Study|Disease progression prior to treatment|3|||
126253459|NCT02460835|454219395|FG000|Overall Study|Unable to complete planning scans|2|||
126253460|NCT02460835|454219395|FG000|Overall Study|Decrease in performance status|1|||
126253461|NCT02460835|454219395|FG000|Overall Study|Withdrawal by Subject|3|||
126253462|NCT02460835|454219395|FG000|Overall Study|Underwent fractionated RT|10|||
126253463|NCT02460835|454219395|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
126253464|NCT00517192|454219399|FG000|Overall Study|Adverse Event|1|||
126253465|NCT00517192|454219400|FG001|Overall Study|Adverse Event|1|||
126253466|NCT00517192|454219399|FG000|Overall Study|Lost to Follow-up|1|||
126253467|NCT00517192|454219400|FG001|Overall Study|Lost to Follow-up|1|||
126253468|NCT00517192|454219399|FG000|Overall Study|Withdrawal by Subject|1|||
126253469|NCT00517192|454219400|FG001|Overall Study|Withdrawal by Subject|0|||
126253470|NCT00517192|454219399|FG000|Overall Study|Early termination of the trial|16|||
126253471|NCT00517192|454219400|FG001|Overall Study|Early termination of the trial|18|||
126253472|NCT02733627|454219402|FG000|Overall Study|Adverse Event|0|||
126253473|NCT02733627|454219403|FG001|Overall Study|Adverse Event|1|||
126253474|NCT02733627|454219404|FG002|Overall Study|Adverse Event|1|||
126253475|NCT02733627|454219405|FG003|Overall Study|Adverse Event|0|||
126253476|NCT02733627|454219402|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
126546402|NCT00510458|455293796|FG000|Overall Study|Terminated|14|||
126253477|NCT02733627|454219403|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
126253478|NCT02733627|454219404|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
126253479|NCT02733627|454219405|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
126253480|NCT00183196|454219406|FG000|Overall Study|Withdrawal by Subject|18|||
126253481|NCT00183196|454219407|FG001|Overall Study|Withdrawal by Subject|11|||
126253482|NCT00183196|454219408|FG002|Overall Study|Withdrawal by Subject|13|||
126253483|NCT00183196|454219406|FG000|Overall Study|Adverse Event|1|||
126253484|NCT00183196|454219407|FG001|Overall Study|Adverse Event|2|||
126253485|NCT00183196|454219408|FG002|Overall Study|Adverse Event|2|||
126253486|NCT00183196|454219406|FG000|Overall Study|Legal event|1|||
126253487|NCT00183196|454219407|FG001|Overall Study|Legal event|1|||
126253488|NCT00183196|454219408|FG002|Overall Study|Legal event|1|||
126253489|NCT00183196|454219406|FG000|Overall Study|Required more intensive care|0|||
126253490|NCT00183196|454219407|FG001|Overall Study|Required more intensive care|1|||
126253491|NCT00183196|454219408|FG002|Overall Study|Required more intensive care|2|||
126253492|NCT01119625|454219410|FG000|Overall Study|Lost to Follow-up|1|||
126253493|NCT01119625|454219411|FG001|Overall Study|Lost to Follow-up|2|||
126253494|NCT01119625|454219410|FG000|Overall Study|Withdrawal by Subject|2|||
126253495|NCT01119625|454219411|FG001|Overall Study|Withdrawal by Subject|1|||
126253496|NCT01119625|454219410|FG000|Overall Study|Other|0|||
126253497|NCT01119625|454219411|FG001|Overall Study|Other|1|||
126253498|NCT01721772|454219416|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
126253499|NCT01721772|454219417|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
126253500|NCT01721772|454219416|FG000|Pre-Treatment|Poor/non-compliance|0|||
126253501|NCT01721772|454219417|FG001|Pre-Treatment|Poor/non-compliance|1|||
126253502|NCT01721772|454219416|FG000|Pre-Treatment|Participant withdrew consent|0|||
126253503|NCT01721772|454219417|FG001|Pre-Treatment|Participant withdrew consent|1|||
126253504|NCT01721772|454219416|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
126253505|NCT01721772|454219417|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
126253506|NCT01721772|454219416|FG000|Treatment|Disease progression|119|||
126253507|NCT01721772|454219417|FG001|Treatment|Disease progression|168|||
126253508|NCT01721772|454219416|FG000|Treatment|Study drug toxicity|19|||
126253509|NCT01721772|454219417|FG001|Treatment|Study drug toxicity|10|||
126253510|NCT01721772|454219416|FG000|Treatment|Adverse event unrelated to study drug|7|||
126253511|NCT01721772|454219417|FG001|Treatment|Adverse event unrelated to study drug|7|||
126253512|NCT01721772|454219416|FG000|Treatment|Maximum clinical benefit|16|||
126253513|NCT01721772|454219417|FG001|Treatment|Maximum clinical benefit|4|||
126253514|NCT01721772|454219416|FG000|Treatment|Other|19|||
126253515|NCT01721772|454219417|FG001|Treatment|Other|2|||
126253516|NCT01721772|454219416|FG000|Treatment|Participant withdrew consent|2|||
126253517|NCT01721772|454219417|FG001|Treatment|Participant withdrew consent|5|||
126253518|NCT01721772|454219416|FG000|Treatment|Participant request to discontinue study treatment|21|||
126253519|NCT01721772|454219417|FG001|Treatment|Participant request to discontinue study treatment|8|||
126253520|NCT01721772|454219416|FG000|Treatment|Death|1|||
126253521|NCT01721772|454219417|FG001|Treatment|Death|0|||
126253522|NCT01721772|454219416|FG000|Treatment|Not reported|1|||
126253523|NCT01721772|454219417|FG001|Treatment|Not reported|0|||
126253524|NCT01721772|454219416|FG000|Treatment|Poor/non-compliance|1|||
126253525|NCT01721772|454219417|FG001|Treatment|Poor/non-compliance|0|||
126253526|NCT01721772|454219416|FG000|Treatment|Lost to Follow-up|0|||
126253527|NCT01721772|454219417|FG001|Treatment|Lost to Follow-up|1|||
126253528|NCT02340780|454219425|FG000|Overall Study|Ineligible|1|||
126253529|NCT05004649|454219432|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
126253530|NCT05004649|454219432|FG000|Overall Study|Lost to Follow-up|1|||
126253531|NCT05004649|454219432|FG000|Overall Study|Withdrawal by Subject|2|||
126253532|NCT05004649|454219432|FG000|Overall Study|COVID-19|1|||
126253533|NCT01698554|454219433|FG000|Overall Study|Adverse Event|2|||
126253534|NCT01698554|454219434|FG001|Overall Study|Adverse Event|5|||
126253535|NCT01698554|454219435|FG002|Overall Study|Adverse Event|0|||
126253536|NCT01698554|454219436|FG003|Overall Study|Adverse Event|1|||
126253537|NCT01698554|454219433|FG000|Overall Study|Lost to Follow-up|1|||
126253538|NCT01698554|454219434|FG001|Overall Study|Lost to Follow-up|0|||
126253539|NCT01698554|454219435|FG002|Overall Study|Lost to Follow-up|0|||
126358248|NCT03467945|454603948|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126358249|NCT03467945|454603949|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126253540|NCT01698554|454219436|FG003|Overall Study|Lost to Follow-up|0|||
126253541|NCT01698554|454219433|FG000|Overall Study|Personal Reasons|0|||
126253542|NCT01698554|454219434|FG001|Overall Study|Personal Reasons|5|||
126253543|NCT01698554|454219435|FG002|Overall Study|Personal Reasons|1|||
126253544|NCT01698554|454219436|FG003|Overall Study|Personal Reasons|1|||
126253545|NCT01698554|454219433|FG000|Overall Study|Protocol Violation|2|||
126253546|NCT01698554|454219434|FG001|Overall Study|Protocol Violation|0|||
126253547|NCT01698554|454219435|FG002|Overall Study|Protocol Violation|1|||
126253548|NCT01698554|454219436|FG003|Overall Study|Protocol Violation|0|||
126253549|NCT01698554|454219433|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126253550|NCT01698554|454219434|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126253551|NCT01698554|454219435|FG002|Overall Study|Other Miscellaneous Reasons|0|||
126253552|NCT01698554|454219436|FG003|Overall Study|Other Miscellaneous Reasons|0|||
126253553|NCT02654145|454219437|FG000|Overall Study|Lack of Efficacy|1|||
126253554|NCT02654145|454219437|FG000|Overall Study|Protocol Violation|1|||
126253555|NCT02654145|454219437|FG000|Overall Study|Withdrawal by Subject|5|||
126253556|NCT02637141|454219438|FG000|Overall Study|Adverse Event|1|||
126253557|NCT02637141|454219439|FG001|Overall Study|Adverse Event|1|||
126253558|NCT02637141|454219440|FG002|Overall Study|Adverse Event|0|||
126253559|NCT02637141|454219438|FG000|Overall Study|Withdrawal by Subject|1|||
126253560|NCT02637141|454219439|FG001|Overall Study|Withdrawal by Subject|1|||
126253561|NCT02637141|454219440|FG002|Overall Study|Withdrawal by Subject|1|||
126253562|NCT01943435|454219442|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
126253563|NCT01943435|454219443|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
126253564|NCT01943435|454219444|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
126253565|NCT01943435|454219442|FG000|Intervention Period|Withdrawal by Subject|3|||
126253566|NCT01943435|454219443|FG001|Intervention Period|Withdrawal by Subject|3|||
126253567|NCT01943435|454219444|FG002|Intervention Period|Withdrawal by Subject|4|||
126253568|NCT01943435|454219442|FG000|2 Month Follow up|Lost to Follow-up|2|||
126253569|NCT01943435|454219443|FG001|2 Month Follow up|Lost to Follow-up|3|||
126253570|NCT01943435|454219444|FG002|2 Month Follow up|Lost to Follow-up|0|||
126253571|NCT01943435|454219442|FG000|6 Month Follow up|Lost to Follow-up|12|||
126253572|NCT01943435|454219443|FG001|6 Month Follow up|Lost to Follow-up|7|||
126253573|NCT01943435|454219444|FG002|6 Month Follow up|Lost to Follow-up|15|||
126253574|NCT03885934|454219445|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
126253575|NCT03885934|454219446|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
126253576|NCT03885934|454219447|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
126253577|NCT03885934|454219448|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
126253578|NCT03885934|454219449|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
126253579|NCT03885934|454219450|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
126253580|NCT04535986|454219458|FG000|Overall Study|Death|4|||
126253581|NCT04535986|454219459|FG001|Overall Study|Death|5|||
126253582|NCT04535986|454219458|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
126253583|NCT04535986|454219459|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
126253584|NCT04535986|454219458|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
126253585|NCT04535986|454219459|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
126253586|NCT04535986|454219458|FG000|Overall Study|Adverse Event|10|||
126253587|NCT04535986|454219459|FG001|Overall Study|Adverse Event|1|||
126253588|NCT04535986|454219458|FG000|Overall Study|Lack of Efficacy|3|||
126253589|NCT04535986|454219459|FG001|Overall Study|Lack of Efficacy|2|||
126253590|NCT04535986|454219458|FG000|Overall Study|Investigator discretion|3|||
126253591|NCT04535986|454219459|FG001|Overall Study|Investigator discretion|0|||
126253592|NCT04535986|454219458|FG000|Overall Study|Withdrawal by Subject|32|||
126253593|NCT04535986|454219459|FG001|Overall Study|Withdrawal by Subject|14|||
126253594|NCT04535986|454219458|FG000|Overall Study|Lost to Follow-up|5|||
126253595|NCT04535986|454219459|FG001|Overall Study|Lost to Follow-up|3|||
126253596|NCT04535986|454219458|FG000|Overall Study|Other|7|||
126698319|NCT01848145|455847036|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
126698320|NCT01848145|455847036|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
126698321|NCT01848145|455847036|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
126698322|NCT01848145|455847036|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
126698323|NCT01848145|455847036|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
126698324|NCT02347631|455847037|FG000|First Intervention (2 Months)|Adverse Event|1|||
126698325|NCT02347631|455847038|FG001|First Intervention (2 Months)|Adverse Event|1|||
126698326|NCT02347631|455847037|FG000|First Intervention (2 Months)|Pregnancy|1|||
126698327|NCT02347631|455847038|FG001|First Intervention (2 Months)|Pregnancy|0|||
126698328|NCT02347631|455847037|FG000|First Intervention (2 Months)|Moved out of area|0|||
126698329|NCT02347631|455847038|FG001|First Intervention (2 Months)|Moved out of area|2|||
126698330|NCT02347631|455847037|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
126698331|NCT02347631|455847038|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
126698332|NCT02347631|455847037|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
126698333|NCT02347631|455847038|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
126698334|NCT02347631|455847037|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
126698335|NCT02347631|455847038|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
126698336|NCT02347631|455847037|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
126253597|NCT04535986|454219459|FG001|Overall Study|Other|3|||
126253598|NCT01559116|454219462|FG000|Overall Study|Adverse Event|10|||
126253599|NCT01559116|454219462|FG000|Overall Study|Lack of Efficacy|1|||
126253600|NCT01559116|454219462|FG000|Overall Study|Lost to Follow-up|1|||
126253601|NCT01559116|454219462|FG000|Overall Study|Protocol Violation|1|||
126358250|NCT03467945|454603950|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126546403|NCT00510458|455293796|FG000|Overall Study|Lost to Follow-up|6|||
126253602|NCT01559116|454219462|FG000|Overall Study|Withdrawal by Subject|4|||
126253603|NCT01559116|454219462|FG000|Overall Study|other than stated above|9|||
126253604|NCT04610580|454219463|FG000|Two-way Crossover Period|Adverse Event|1|||
126253605|NCT04610580|454219464|FG001|Two-way Crossover Period|Adverse Event|0|||
126253606|NCT04610580|454219465|FG002|Two-way Crossover Period|Adverse Event|0|||
126253607|NCT04610580|454219466|FG003|Two-way Crossover Period|Adverse Event|0|||
126253608|NCT04610580|454219467|FG004|Two-way Crossover Period|Adverse Event|0|||
126253609|NCT04610580|454219468|FG005|Two-way Crossover Period|Adverse Event|0|||
126253610|NCT04610580|454219463|FG000|Two-way Crossover Period|Physician Decision|1|||
126253611|NCT04610580|454219464|FG001|Two-way Crossover Period|Physician Decision|0|||
126253612|NCT04610580|454219465|FG002|Two-way Crossover Period|Physician Decision|0|||
126253613|NCT04610580|454219466|FG003|Two-way Crossover Period|Physician Decision|0|||
126253614|NCT04610580|454219467|FG004|Two-way Crossover Period|Physician Decision|0|||
126253615|NCT04610580|454219468|FG005|Two-way Crossover Period|Physician Decision|0|||
126253616|NCT04610580|454219463|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
126253617|NCT04610580|454219464|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
126253618|NCT04610580|454219465|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
126253619|NCT04610580|454219466|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
126253620|NCT04610580|454219467|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
126253621|NCT04610580|454219468|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
126253622|NCT04610580|454219463|FG000|Two-way Crossover Period|Other than specified|0|||
126253623|NCT04610580|454219464|FG001|Two-way Crossover Period|Other than specified|1|||
126253624|NCT04610580|454219465|FG002|Two-way Crossover Period|Other than specified|0|||
126253625|NCT04610580|454219466|FG003|Two-way Crossover Period|Other than specified|0|||
126253626|NCT04610580|454219467|FG004|Two-way Crossover Period|Other than specified|0|||
126253627|NCT04610580|454219468|FG005|Two-way Crossover Period|Other than specified|0|||
126253628|NCT04610580|454219463|FG000|Washout Before Extension Period|Other than specified|0|||
126253629|NCT04610580|454219464|FG001|Washout Before Extension Period|Other than specified|1|||
126253630|NCT04610580|454219465|FG002|Washout Before Extension Period|Other than specified|0|||
126253631|NCT04610580|454219466|FG003|Washout Before Extension Period|Other than specified|0|||
126253632|NCT04610580|454219467|FG004|Washout Before Extension Period|Other than specified|0|||
126253633|NCT04610580|454219468|FG005|Washout Before Extension Period|Other than specified|0|||
126253634|NCT04610580|454219463|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
126253635|NCT04610580|454219464|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
126253636|NCT04610580|454219465|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
126253637|NCT04610580|454219466|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
126253638|NCT04610580|454219467|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
126253639|NCT04610580|454219468|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
126253640|NCT04610580|454219463|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
126253641|NCT04610580|454219464|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
126253642|NCT04610580|454219465|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
126253643|NCT04610580|454219466|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
126253644|NCT04610580|454219467|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
126253645|NCT04610580|454219468|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
126253646|NCT01097694|454219469|FG000|Overall Study|Adverse Event|5|||
126253647|NCT01097694|454219470|FG001|Overall Study|Adverse Event|0|||
126253648|NCT01097694|454219469|FG000|Overall Study|Lost to Follow-up|0|||
126253649|NCT01097694|454219470|FG001|Overall Study|Lost to Follow-up|3|||
126253650|NCT01097694|454219469|FG000|Overall Study|Withdrawal by Subject|3|||
126253651|NCT01097694|454219470|FG001|Overall Study|Withdrawal by Subject|1|||
126253652|NCT02377349|454219471|FG000|Overall Study|Serious Adverse Event|1|||
126253653|NCT02377349|454219472|FG001|Overall Study|Serious Adverse Event|0|||
126253654|NCT02377349|454219471|FG000|Overall Study|Protocol Violation|3|||
126253655|NCT02377349|454219472|FG001|Overall Study|Protocol Violation|2|||
126253656|NCT02377349|454219471|FG000|Overall Study|Withdrawal by Subject|5|||
126253657|NCT02377349|454219472|FG001|Overall Study|Withdrawal by Subject|3|||
126253658|NCT02377349|454219471|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
126253659|NCT02377349|454219472|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
126253660|NCT02377349|454219471|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
126253661|NCT02377349|454219472|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
126253662|NCT02377349|454219471|FG000|Overall Study|Other|0|||
126253663|NCT02377349|454219472|FG001|Overall Study|Other|1|||
126253664|NCT03259165|454219473|FG000|Overall Study|COVID 19 pandemic|1|||
126253665|NCT03259165|454219474|FG001|Overall Study|COVID 19 pandemic|1|||
126253666|NCT04320745|454219475|FG000|Overall Study|Adverse Event|26|||
126253667|NCT04320745|454219475|FG000|Overall Study|Withdrawal by Subject|4|||
126253668|NCT04320745|454219475|FG000|Overall Study|Lost to Follow-up|12|||
126253669|NCT04320745|454219475|FG000|Overall Study|Protocol Deviation|2|||
126449304|NCT01584440|454945276|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
126449305|NCT01584440|454945277|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
126253670|NCT04320745|454219475|FG000|Overall Study|Non-compliance With Study Drug|2|||
126253671|NCT04320745|454219475|FG000|Overall Study|Reason Not Specified|1|||
126253672|NCT02004691|454219476|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
126449306|NCT01584440|454945273|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
126449307|NCT01584440|454945274|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
126253673|NCT02004691|454219477|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
126253674|NCT02004691|454219476|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
126253675|NCT02004691|454219477|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
126253676|NCT02004691|454219476|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
126253677|NCT02004691|454219477|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
126253678|NCT02004691|454219476|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
126253679|NCT02004691|454219477|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
126253680|NCT02004691|454219476|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
126253681|NCT02004691|454219477|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
126253682|NCT02004691|454219476|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
126253683|NCT02004691|454219477|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
126253684|NCT01320722|454219478|FG000|Overall Study|Did not Receive Intervention|3|||
126253685|NCT01320722|454219479|FG001|Overall Study|Did not Receive Intervention|2|||
126253686|NCT01320722|454219480|FG002|Overall Study|Did not Receive Intervention|1|||
126253687|NCT01320722|454219481|FG003|Overall Study|Did not Receive Intervention|1|||
126253688|NCT01320722|454219482|FG004|Overall Study|Did not Receive Intervention|2|||
126253689|NCT01320722|454219478|FG000|Overall Study|Lost to Follow-up|0|||
126253690|NCT01320722|454219479|FG001|Overall Study|Lost to Follow-up|1|||
126253691|NCT01320722|454219480|FG002|Overall Study|Lost to Follow-up|0|||
126253692|NCT01320722|454219481|FG003|Overall Study|Lost to Follow-up|1|||
126253693|NCT01320722|454219482|FG004|Overall Study|Lost to Follow-up|3|||
126253694|NCT01320722|454219478|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
126253695|NCT01320722|454219479|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
126253696|NCT01320722|454219480|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
126253697|NCT01320722|454219481|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
126253698|NCT01320722|454219482|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
126253699|NCT01320722|454219478|FG000|Overall Study|Participant Developed a Rash|0|||
126253700|NCT01320722|454219479|FG001|Overall Study|Participant Developed a Rash|0|||
126253701|NCT01320722|454219480|FG002|Overall Study|Participant Developed a Rash|2|||
126253702|NCT01320722|454219481|FG003|Overall Study|Participant Developed a Rash|1|||
126253703|NCT01320722|454219482|FG004|Overall Study|Participant Developed a Rash|1|||
126253704|NCT01320722|454219478|FG000|Overall Study|Non-compliant with Medication|0|||
126253705|NCT01320722|454219479|FG001|Overall Study|Non-compliant with Medication|0|||
126253706|NCT01320722|454219480|FG002|Overall Study|Non-compliant with Medication|1|||
126253707|NCT01320722|454219481|FG003|Overall Study|Non-compliant with Medication|0|||
126253708|NCT01320722|454219482|FG004|Overall Study|Non-compliant with Medication|0|||
126253709|NCT01320722|454219478|FG000|Overall Study|Adverse Event|0|||
126253710|NCT01320722|454219479|FG001|Overall Study|Adverse Event|0|||
126253711|NCT01320722|454219480|FG002|Overall Study|Adverse Event|3|||
126253712|NCT01320722|454219481|FG003|Overall Study|Adverse Event|6|||
126253713|NCT01320722|454219482|FG004|Overall Study|Adverse Event|0|||
126253714|NCT01320722|454219478|FG000|Overall Study|Not Compliant with Study Procedures|0|||
126253715|NCT01320722|454219479|FG001|Overall Study|Not Compliant with Study Procedures|0|||
126253716|NCT01320722|454219480|FG002|Overall Study|Not Compliant with Study Procedures|0|||
126253717|NCT01320722|454219481|FG003|Overall Study|Not Compliant with Study Procedures|4|||
126253718|NCT01320722|454219482|FG004|Overall Study|Not Compliant with Study Procedures|0|||
126253719|NCT01320722|454219478|FG000|Overall Study|Pregnancy|0|||
126253720|NCT01320722|454219479|FG001|Overall Study|Pregnancy|0|||
126253721|NCT01320722|454219480|FG002|Overall Study|Pregnancy|0|||
126253722|NCT01320722|454219481|FG003|Overall Study|Pregnancy|1|||
126253723|NCT01320722|454219482|FG004|Overall Study|Pregnancy|0|||
126253724|NCT01320722|454219478|FG000|Overall Study|Started an Exclusionary Medication|0|||
126253725|NCT01320722|454219479|FG001|Overall Study|Started an Exclusionary Medication|0|||
126253726|NCT01320722|454219480|FG002|Overall Study|Started an Exclusionary Medication|0|||
126253727|NCT01320722|454219481|FG003|Overall Study|Started an Exclusionary Medication|0|||
126253728|NCT01320722|454219482|FG004|Overall Study|Started an Exclusionary Medication|1|||
126253729|NCT01320722|454219478|FG000|Overall Study|Withdrew due to Health Condition|0|||
126253730|NCT01320722|454219479|FG001|Overall Study|Withdrew due to Health Condition|0|||
126698337|NCT02347631|455847038|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
126253731|NCT01320722|454219480|FG002|Overall Study|Withdrew due to Health Condition|0|||
126253732|NCT01320722|454219481|FG003|Overall Study|Withdrew due to Health Condition|0|||
126698338|NCT02347631|455847037|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
126698339|NCT02347631|455847038|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
126698340|NCT03514914|455847040|FG000|Overall Study|Death|3|||
126253733|NCT01320722|454219482|FG004|Overall Study|Withdrew due to Health Condition|1|||
126253734|NCT00021541|454219483|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
126253735|NCT00021541|454219484|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
126253736|NCT00021541|454219483|FG000|Period 1-First Treatment|Adverse Event|2|||
126253737|NCT00021541|454219484|FG001|Period 1-First Treatment|Adverse Event|1|||
126449308|NCT01584440|454945275|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
126449309|NCT01584440|454945276|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
126449310|NCT01584440|454945277|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
126253738|NCT00021541|454219483|FG000|Period 1-First Treatment|non-adherence|3|||
126253739|NCT00021541|454219484|FG001|Period 1-First Treatment|non-adherence|0|||
126253740|NCT00021541|454219483|FG000|Period 1-First Treatment|Death|1|||
126253741|NCT00021541|454219484|FG001|Period 1-First Treatment|Death|0|||
126253742|NCT00021541|454219483|FG000|Period 1-First Treatment|Pts that did not progress|2|||
126253743|NCT00021541|454219484|FG001|Period 1-First Treatment|Pts that did not progress|2|||
126253744|NCT00021541|454219483|FG000|Period 1-First Treatment|Ineligible|0|||
126253745|NCT00021541|454219484|FG001|Period 1-First Treatment|Ineligible|2|||
126253746|NCT00021541|454219483|FG000|Period 2-crossover|refused phase B|2|||
126253747|NCT00021541|454219484|FG001|Period 2-crossover|refused phase B|2|||
126253748|NCT00021541|454219483|FG000|Period 2-crossover|Withdrawal by Subject|3|||
126253749|NCT00021541|454219484|FG001|Period 2-crossover|Withdrawal by Subject|4|||
126253750|NCT00021541|454219483|FG000|Period 2-crossover|Adverse Event|2|||
126253751|NCT00021541|454219484|FG001|Period 2-crossover|Adverse Event|2|||
126253752|NCT00021541|454219483|FG000|Period 2-crossover|non-adherence|1|||
126253753|NCT00021541|454219484|FG001|Period 2-crossover|non-adherence|0|||
126253754|NCT00021541|454219483|FG000|Period 2-crossover|Pts that did not progress|2|||
126253755|NCT00021541|454219484|FG001|Period 2-crossover|Pts that did not progress|3|||
126253756|NCT01547728|454219485|FG000|Overall Study|Change in procedure and equipment|1|||
126253757|NCT01547728|454219485|FG000|Overall Study|Drug not ready for subject|1|||
126253758|NCT01547728|454219485|FG000|Overall Study|Screen failure|39|||
126253759|NCT03828539|454219486|FG000|Overall Study|Adverse Event|3|||
126698341|NCT03514914|455847041|FG001|Overall Study|Death|3|||
126698342|NCT03514914|455847040|FG000|Overall Study|Lost to Follow-up|117|||
126698343|NCT03514914|455847041|FG001|Overall Study|Lost to Follow-up|89|||
126698344|NCT01355289|455847043|FG000|Core Study|Adverse Event, Non-Fatal|1|||
126698345|NCT01355289|455847044|FG001|Core Study|Adverse Event, Non-Fatal|0|||
126698346|NCT01355289|455847045|FG002|Core Study|Adverse Event, Non-Fatal|0|||
126698347|NCT01355289|455847046|FG003|Core Study|Adverse Event, Non-Fatal|0|||
126698348|NCT01355289|455847047|FG004|Core Study|Adverse Event, Non-Fatal|0|||
126698349|NCT01355289|455847043|FG000|Core Study|Inadequate Therapeutic Effect|0|||
126698350|NCT01355289|455847044|FG001|Core Study|Inadequate Therapeutic Effect|0|||
126698351|NCT01355289|455847045|FG002|Core Study|Inadequate Therapeutic Effect|0|||
126698352|NCT01355289|455847046|FG003|Core Study|Inadequate Therapeutic Effect|1|||
126698353|NCT01355289|455847047|FG004|Core Study|Inadequate Therapeutic Effect|0|||
126698354|NCT01355289|455847043|FG000|Core Study|Other|0|||
126698355|NCT01355289|455847044|FG001|Core Study|Other|0|||
126698356|NCT01355289|455847045|FG002|Core Study|Other|0|||
126698357|NCT01355289|455847046|FG003|Core Study|Other|1|||
126698358|NCT01355289|455847047|FG004|Core Study|Other|0|||
126698359|NCT01355289|455847043|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
126698360|NCT01355289|455847044|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
126698361|NCT01355289|455847045|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
126698362|NCT01355289|455847046|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
126698363|NCT01355289|455847047|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
126698364|NCT01355289|455847043|FG000|Open Label Extension|Lost to Follow-up|0|||
126698365|NCT01355289|455847044|FG001|Open Label Extension|Lost to Follow-up|0|||
126698366|NCT01355289|455847045|FG002|Open Label Extension|Lost to Follow-up|0|||
126698367|NCT01355289|455847046|FG003|Open Label Extension|Lost to Follow-up|0|||
126698368|NCT01355289|455847047|FG004|Open Label Extension|Lost to Follow-up|1|||
126698369|NCT01355289|455847043|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
126698370|NCT01355289|455847044|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
126698371|NCT01355289|455847045|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
126698372|NCT01355289|455847046|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
126698373|NCT01355289|455847047|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
126698374|NCT01355289|455847043|FG000|Open Label Extension|Other|0|||
126698375|NCT01355289|455847044|FG001|Open Label Extension|Other|0|||
126698376|NCT01355289|455847045|FG002|Open Label Extension|Other|0|||
126698377|NCT01355289|455847046|FG003|Open Label Extension|Other|0|||
126698378|NCT01355289|455847047|FG004|Open Label Extension|Other|3|||
126698379|NCT04336163|455847048|FG000|Overall Study|Lost to Follow-up|55|||
126698380|NCT04336163|455847049|FG001|Overall Study|Lost to Follow-up|0|||
126698381|NCT01085682|455847050|FG000|Overall Study|Withdrawal by Subject|25|||
126698382|NCT01085682|455847051|FG001|Overall Study|Withdrawal by Subject|25|||
126698383|NCT00813995|455847056|FG000|Overall Study|Clinical adverse event|9|||
126698384|NCT00813995|455847057|FG001|Overall Study|Clinical adverse event|3|||
126698385|NCT00813995|455847056|FG000|Overall Study|Laboratory adverse event|0|||
126253760|NCT03828539|454219487|FG001|Overall Study|Adverse Event|12|||
126253761|NCT03828539|454219486|FG000|Overall Study|Patient's/guardian's decision|3|||
126253762|NCT03828539|454219487|FG001|Overall Study|Patient's/guardian's decision|5|||
126253763|NCT03828539|454219486|FG000|Overall Study|Lost to Follow-up|4|||
126253764|NCT03828539|454219487|FG001|Overall Study|Lost to Follow-up|2|||
126253765|NCT03828539|454219486|FG000|Overall Study|Protocol Violation|3|||
126698386|NCT00813995|455847057|FG001|Overall Study|Laboratory adverse event|2|||
126698387|NCT00813995|455847056|FG000|Overall Study|Lack of Efficacy|1|||
126698388|NCT00813995|455847057|FG001|Overall Study|Lack of Efficacy|0|||
126253766|NCT03828539|454219487|FG001|Overall Study|Protocol Violation|2|||
126253767|NCT03828539|454219486|FG000|Overall Study|Withdrawal of informed consent|2|||
126253768|NCT03828539|454219487|FG001|Overall Study|Withdrawal of informed consent|1|||
126253769|NCT03828539|454219486|FG000|Overall Study|New therapy for study indication|1|||
126253770|NCT03828539|454219487|FG001|Overall Study|New therapy for study indication|0|||
126253771|NCT01341405|454219488|FG000|Overall Study|Adverse Event|0|||
126253772|NCT01341405|454219489|FG001|Overall Study|Adverse Event|1|||
126253773|NCT01341405|454219490|FG002|Overall Study|Adverse Event|1|||
126253774|NCT01341405|454219488|FG000|Overall Study|Withdrawal by Subject|3|||
126253775|NCT01341405|454219489|FG001|Overall Study|Withdrawal by Subject|2|||
126253776|NCT01341405|454219490|FG002|Overall Study|Withdrawal by Subject|1|||
126253777|NCT02616380|454219491|FG000|Overall Study|Lost to Follow-up|1|||
126358251|NCT03467945|454603947|FG000|Treatment Period 3|Withdrawal by Subject|1|||
126358252|NCT03467945|454603948|FG001|Treatment Period 3|Withdrawal by Subject|0|||
126358253|NCT03467945|454603949|FG002|Treatment Period 3|Withdrawal by Subject|2|||
126358254|NCT03467945|454603950|FG003|Treatment Period 3|Withdrawal by Subject|1|||
126546404|NCT00510458|455293796|FG000|Overall Study|Withdrawal by Subject|3|||
126253778|NCT02616380|454219491|FG000|Overall Study|Other|2|||
126546405|NCT00510458|455293796|FG000|Overall Study|Revision|2|||
126546406|NCT01861522|455293797|FG000|Overall Study|Adverse Event|1|||
126253779|NCT00826241|454219492|FG000|Overall Study|Withdrawal from Follow-up|1|||
126253780|NCT00826241|454219492|FG000|Overall Study|Withdrew consent|2|||
126253781|NCT00826241|454219492|FG000|Overall Study|Death|4|||
126253782|NCT00826241|454219492|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
126253783|NCT00826241|454219492|FG000|Overall Study|Non-compliance|1|||
126253784|NCT00826241|454219492|FG000|Overall Study|Progression of disease|1|||
126253785|NCT00826241|454219492|FG000|Overall Study|Patient refused follow-up|3|||
126253786|NCT00826241|454219492|FG000|Overall Study|Lost to Follow-up|9|||
126253787|NCT00826241|454219492|FG000|Overall Study|Could not obtain records|1|||
126253788|NCT00826241|454219492|FG000|Overall Study|Screen failure|2|||
126253789|NCT00826241|454219492|FG000|Overall Study|Pt unable to proceed to registration|1|||
126253790|NCT00826241|454219492|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
126253791|NCT03407729|454219493|FG000|Overall Study|Lost to Follow-up|2|||
126253792|NCT03407729|454219494|FG001|Overall Study|Lost to Follow-up|0|||
126253793|NCT03407729|454219493|FG000|Overall Study|Unable to schedule|0|||
126253794|NCT03407729|454219494|FG001|Overall Study|Unable to schedule|3|||
126253795|NCT04142658|454219495|FG000|Overall Study|Death|2|||
126253796|NCT04142658|454219496|FG001|Overall Study|Death|1|||
126253797|NCT04142658|454219495|FG000|Overall Study|Lost to Follow-up|4|||
126253798|NCT04142658|454219496|FG001|Overall Study|Lost to Follow-up|13|||
126253799|NCT04142658|454219495|FG000|Overall Study|Withdrawal by Subject|9|||
126253800|NCT04142658|454219496|FG001|Overall Study|Withdrawal by Subject|16|||
126546407|NCT01861522|455293798|FG001|Overall Study|Adverse Event|0|||
126546408|NCT01861522|455293797|FG000|Overall Study|Withdrawal by Subject|2|||
126546409|NCT01861522|455293798|FG001|Overall Study|Withdrawal by Subject|0|||
126546410|NCT02716038|455293799|FG000|Overall Study|Not evaluable|1|||
126546411|NCT02716038|455293799|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
126546412|NCT02716038|455293799|FG000|Overall Study|Unresectable|3|||
126546413|NCT03573908|455293800|FG000|Treatment Period|Adverse Event|4|||
126546414|NCT03573908|455293801|FG001|Treatment Period|Adverse Event|9|||
126546415|NCT03573908|455293802|FG002|Treatment Period|Adverse Event|0|||
126546416|NCT03573908|455293803|FG003|Treatment Period|Adverse Event|0|||
126546417|NCT03573908|455293804|FG004|Treatment Period|Adverse Event|0|||
126546418|NCT03573908|455293800|FG000|Treatment Period|Protocol Violation|1|||
126546419|NCT03573908|455293801|FG001|Treatment Period|Protocol Violation|0|||
126546420|NCT03573908|455293802|FG002|Treatment Period|Protocol Violation|0|||
126546421|NCT03573908|455293803|FG003|Treatment Period|Protocol Violation|0|||
126698389|NCT00813995|455847056|FG000|Overall Study|Lost to Follow-up|4|||
126698390|NCT00813995|455847057|FG001|Overall Study|Lost to Follow-up|2|||
126698391|NCT00813995|455847056|FG000|Overall Study|Other reason|2|||
126698392|NCT00813995|455847057|FG001|Overall Study|Other reason|2|||
126698393|NCT00813995|455847056|FG000|Overall Study|Protocol Violation|3|||
126698394|NCT00813995|455847057|FG001|Overall Study|Protocol Violation|2|||
126698395|NCT00813995|455847056|FG000|Overall Study|Subject moved|4|||
126698396|NCT00813995|455847057|FG001|Overall Study|Subject moved|0|||
126698397|NCT00813995|455847056|FG000|Overall Study|Withdrawal by Subject|0|||
126698398|NCT00813995|455847057|FG001|Overall Study|Withdrawal by Subject|5|||
126698399|NCT02507349|455847058|FG000|Overall Study|Death|12|||
126698400|NCT02507349|455847059|FG001|Overall Study|Death|16|||
126698401|NCT02507349|455847058|FG000|Overall Study|Withdrawal by Subject|1|||
126253801|NCT03950674|454219501|FG000|Overall Study|Death|16|||
126358255|NCT02975700|454603951|FG000|Overall Study|Adverse Event|1|||
126546422|NCT03573908|455293804|FG004|Treatment Period|Protocol Violation|0|||
126546423|NCT03573908|455293800|FG000|Treatment Period|Withdrawal by Subject|7|||
126358256|NCT02975700|454603951|FG000|Overall Study|Progressive disease|3|||
126698402|NCT02507349|455847059|FG001|Overall Study|Withdrawal by Subject|1|||
126698403|NCT02507349|455847058|FG000|Overall Study|Lost to Follow-up|174|||
126698404|NCT02507349|455847059|FG001|Overall Study|Lost to Follow-up|144|||
126253802|NCT03950674|454219502|FG001|Overall Study|Death|15|||
126253803|NCT03950674|454219501|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
126253804|NCT03950674|454219502|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
126253805|NCT00830167|454219505|FG000|Overall Study|Lack of Efficacy|26|||
126253806|NCT00830167|454219506|FG001|Overall Study|Lack of Efficacy|10|||
126253807|NCT00830167|454219505|FG000|Overall Study|Adverse Event|8|||
126253808|NCT00830167|454219506|FG001|Overall Study|Adverse Event|24|||
126253809|NCT00830167|454219505|FG000|Overall Study|Not meeting entrance criteria|2|||
126253810|NCT00830167|454219506|FG001|Overall Study|Not meeting entrance criteria|5|||
126253811|NCT00830167|454219505|FG000|Overall Study|Withdrawal by Subject|2|||
126253812|NCT00830167|454219506|FG001|Overall Study|Withdrawal by Subject|0|||
126253813|NCT00830167|454219505|FG000|Overall Study|Lost to Follow-up|0|||
126253814|NCT00830167|454219506|FG001|Overall Study|Lost to Follow-up|1|||
126253815|NCT00830167|454219505|FG000|Overall Study|Protocol Violation|0|||
126253816|NCT00830167|454219506|FG001|Overall Study|Protocol Violation|1|||
126253817|NCT00830167|454219505|FG000|Overall Study|Other|2|||
126253818|NCT00830167|454219506|FG001|Overall Study|Other|2|||
126253819|NCT01223027|454219507|FG000|Overall Study|Adverse Event|20|||
126253820|NCT01223027|454219508|FG001|Overall Study|Adverse Event|10|||
126253821|NCT01223027|454219507|FG000|Overall Study|Death|42|||
126253822|NCT01223027|454219508|FG001|Overall Study|Death|42|||
126253823|NCT01223027|454219507|FG000|Overall Study|Lost to Follow-up|2|||
126253824|NCT01223027|454219508|FG001|Overall Study|Lost to Follow-up|1|||
126253825|NCT01223027|454219507|FG000|Overall Study|Physician Decision|4|||
126253826|NCT01223027|454219508|FG001|Overall Study|Physician Decision|8|||
126253827|NCT01223027|454219507|FG000|Overall Study|Progressive Disease|167|||
126253828|NCT01223027|454219508|FG001|Overall Study|Progressive Disease|183|||
126253829|NCT01223027|454219507|FG000|Overall Study|Protocol Violation|2|||
126253830|NCT01223027|454219508|FG001|Overall Study|Protocol Violation|1|||
126253831|NCT01223027|454219507|FG000|Overall Study|Subject/guardian decicion|18|||
126253832|NCT01223027|454219508|FG001|Overall Study|Subject/guardian decicion|16|||
126253833|NCT01223027|454219507|FG000|Overall Study|New therapy for study indication|17|||
126253834|NCT01223027|454219508|FG001|Overall Study|New therapy for study indication|8|||
126253835|NCT01223027|454219507|FG000|Overall Study|Study terminated by sponsor|2|||
126253836|NCT01223027|454219508|FG001|Overall Study|Study terminated by sponsor|8|||
126253837|NCT03201003|454219512|FG000|Overall Study|Adverse Event|14|||
126253838|NCT03201003|454219513|FG001|Overall Study|Adverse Event|1|||
126253839|NCT03201003|454219512|FG000|Overall Study|Other reasons|5|||
126253840|NCT03201003|454219513|FG001|Overall Study|Other reasons|1|||
126253841|NCT03201003|454219512|FG000|Overall Study|Withdrawal by Subject|4|||
126253842|NCT03201003|454219513|FG001|Overall Study|Withdrawal by Subject|1|||
126253843|NCT03201003|454219512|FG000|Overall Study|Lost to Follow-up|2|||
126253844|NCT03201003|454219513|FG001|Overall Study|Lost to Follow-up|0|||
126253845|NCT03201003|454219512|FG000|Overall Study|Protocol Violation|1|||
126253846|NCT03201003|454219513|FG001|Overall Study|Protocol Violation|0|||
126253847|NCT00834613|454219514|FG000|First Intervention|Protocol Violation|1|||
126253848|NCT00834613|454219515|FG001|First Intervention|Protocol Violation|0|||
126253849|NCT01751087|454219516|FG000|Overall Study|Withdrawal by Subject|1|||
126253850|NCT01751087|454219517|FG001|Overall Study|Withdrawal by Subject|0|||
126253851|NCT01751087|454219518|FG002|Overall Study|Withdrawal by Subject|0|||
126253852|NCT01751087|454219516|FG000|Overall Study|Physician Decision|0|||
126253853|NCT01751087|454219517|FG001|Overall Study|Physician Decision|0|||
126253854|NCT01751087|454219518|FG002|Overall Study|Physician Decision|1|||
126253855|NCT00697619|454219519|FG000|Overall Study|Lack of Efficacy|2|||
126253856|NCT00697619|454219520|FG001|Overall Study|Lack of Efficacy|2|||
126253857|NCT00697619|454219519|FG000|Overall Study|Adverse Event|4|||
126253858|NCT00697619|454219520|FG001|Overall Study|Adverse Event|6|||
126253859|NCT00258856|454220934|FG000|Overall Study|Lost to Follow-up|1|||
126253860|NCT00258856|454220935|FG001|Overall Study|Lost to Follow-up|0|||
126253861|NCT00258856|454220936|FG002|Overall Study|Lost to Follow-up|2|||
126253862|NCT00258856|454220937|FG003|Overall Study|Lost to Follow-up|0|||
126253863|NCT00258856|454220934|FG000|Overall Study|Non-compliance|2|||
126358257|NCT02975700|454603951|FG000|Overall Study|Failed screening criteria|2|||
126253864|NCT00258856|454220935|FG001|Overall Study|Non-compliance|0|||
126253865|NCT00258856|454220936|FG002|Overall Study|Non-compliance|0|||
126253866|NCT00258856|454220937|FG003|Overall Study|Non-compliance|1|||
126253867|NCT02219009|454220940|FG000|Overall Study|Withdrawal by Subject|5|||
126253868|NCT02219009|454220941|FG001|Overall Study|Withdrawal by Subject|1|||
126253869|NCT02219009|454220940|FG000|Overall Study|Adverse Event|2|||
126253870|NCT02219009|454220941|FG001|Overall Study|Adverse Event|4|||
126253871|NCT02219009|454220940|FG000|Overall Study|Lost to Follow-up|2|||
126253872|NCT02219009|454220941|FG001|Overall Study|Lost to Follow-up|2|||
126253873|NCT02219009|454220940|FG000|Overall Study|Protocol deviation|1|||
126253874|NCT02219009|454220941|FG001|Overall Study|Protocol deviation|0|||
126253875|NCT02219009|454220940|FG000|Overall Study|Physician Decision|0|||
126253876|NCT02219009|454220941|FG001|Overall Study|Physician Decision|1|||
126253877|NCT00274625|454220942|FG000|Overall Study|Lost to Follow-up|46|||
126253878|NCT00274625|454220943|FG001|Overall Study|Lost to Follow-up|54|||
126253879|NCT00274625|454220942|FG000|Overall Study|Excluded from analysis|14|||
126253880|NCT00274625|454220943|FG001|Overall Study|Excluded from analysis|8|||
126253881|NCT01754376|454220947|FG000|Overall Study|Adverse Event|1|||
126253882|NCT01754376|454220947|FG000|Overall Study|Lack of Efficacy|2|||
126253883|NCT04556734|454220948|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
126253884|NCT04556734|454220949|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
126253885|NCT04556734|454220950|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
126253886|NCT04556734|454220951|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126253887|NCT04556734|454220952|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126253888|NCT04556734|454220953|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126253889|NCT04556734|454220954|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126253890|NCT04556734|454220955|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126253891|NCT04556734|454220948|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
126253892|NCT04556734|454220949|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253893|NCT04556734|454220950|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253894|NCT04556734|454220951|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253895|NCT04556734|454220952|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253896|NCT04556734|454220953|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253897|NCT04556734|454220954|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253898|NCT04556734|454220955|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126253899|NCT04556734|454220948|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126253900|NCT04556734|454220949|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126253901|NCT04556734|454220950|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126253902|NCT04556734|454220951|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126253903|NCT04556734|454220952|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126253904|NCT04556734|454220953|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126253905|NCT04556734|454220954|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126253906|NCT04556734|454220955|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126253907|NCT04556734|454220948|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
126253908|NCT04556734|454220949|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126698405|NCT01614964|455847060|FG000|Overall Study|Withdrawal by Subject|2|||
126698406|NCT01614964|455847061|FG001|Overall Study|Withdrawal by Subject|0|||
126698407|NCT01614964|455847060|FG000|Overall Study|Lost to Follow-up|3|||
126698408|NCT01614964|455847061|FG001|Overall Study|Lost to Follow-up|0|||
126698409|NCT02700984|455847070|FG000|Overall Study|Death|2|||
126698410|NCT02700984|455847071|FG001|Overall Study|Death|1|||
126253909|NCT04556734|454220950|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126253910|NCT04556734|454220951|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126449311|NCT01584440|454945273|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
126449312|NCT01584440|454945274|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
126698411|NCT02700984|455847070|FG000|Overall Study|Lost to Follow-up|2|||
126698412|NCT02700984|455847071|FG001|Overall Study|Lost to Follow-up|1|||
126698413|NCT02700984|455847070|FG000|Overall Study|Physician Decision|0|||
126698414|NCT02700984|455847071|FG001|Overall Study|Physician Decision|1|||
126698415|NCT02700984|455847070|FG000|Overall Study|Withdrawal by Subject|8|||
126698416|NCT02700984|455847071|FG001|Overall Study|Withdrawal by Subject|9|||
126698417|NCT02700984|455847070|FG000|Overall Study|Reason not specified|3|||
126698418|NCT02700984|455847071|FG001|Overall Study|Reason not specified|2|||
126698419|NCT00473876|455847073|FG000|Overall Study|Lost to Follow-up|3|||
126698420|NCT00473876|455847074|FG001|Overall Study|Lost to Follow-up|1|||
126698421|NCT00348140|455847075|FG000|Overall Study|Adverse Event|46|||
126698422|NCT00348140|455847076|FG001|Overall Study|Adverse Event|49|||
126698423|NCT00348140|455847077|FG002|Overall Study|Adverse Event|78|||
126698424|NCT00348140|455847075|FG000|Overall Study|Lost to Follow-up|4|||
126698425|NCT00348140|455847076|FG001|Overall Study|Lost to Follow-up|4|||
126698426|NCT00348140|455847077|FG002|Overall Study|Lost to Follow-up|4|||
126698427|NCT00348140|455847075|FG000|Overall Study|Protocol Violation|12|||
126698428|NCT00348140|455847076|FG001|Overall Study|Protocol Violation|13|||
126698429|NCT00348140|455847077|FG002|Overall Study|Protocol Violation|14|||
126698430|NCT00348140|455847075|FG000|Overall Study|Withdrawal by Subject|32|||
126698431|NCT00348140|455847076|FG001|Overall Study|Withdrawal by Subject|40|||
126698432|NCT00348140|455847077|FG002|Overall Study|Withdrawal by Subject|40|||
126698433|NCT00348140|455847075|FG000|Overall Study|Non-compliance|8|||
126698434|NCT00348140|455847076|FG001|Overall Study|Non-compliance|13|||
126698435|NCT00348140|455847077|FG002|Overall Study|Non-compliance|5|||
126698436|NCT00348140|455847075|FG000|Overall Study|Participant at risk due to study drug|2|||
126698437|NCT00348140|455847076|FG001|Overall Study|Participant at risk due to study drug|0|||
126698438|NCT00348140|455847077|FG002|Overall Study|Participant at risk due to study drug|0|||
126698439|NCT00348140|455847075|FG000|Overall Study|Conditional medication increased dose|1|||
126698440|NCT00348140|455847076|FG001|Overall Study|Conditional medication increased dose|0|||
126253911|NCT04556734|454220952|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126253912|NCT04556734|454220953|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126253913|NCT04556734|454220954|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126253914|NCT04556734|454220955|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126253915|NCT04556734|454220948|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253916|NCT04556734|454220949|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253917|NCT04556734|454220950|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
126253918|NCT04556734|454220951|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253919|NCT04556734|454220952|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253920|NCT04556734|454220953|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253921|NCT04556734|454220954|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253922|NCT04556734|454220955|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
126253923|NCT04556734|454220948|FG000|OLE Period (28 Weeks)|Not reported|0|||
126253924|NCT04556734|454220949|FG001|OLE Period (28 Weeks)|Not reported|0|||
126253925|NCT04556734|454220950|FG002|OLE Period (28 Weeks)|Not reported|0|||
126253926|NCT04556734|454220951|FG003|OLE Period (28 Weeks)|Not reported|0|||
126253927|NCT04556734|454220952|FG004|OLE Period (28 Weeks)|Not reported|0|||
126253928|NCT04556734|454220953|FG005|OLE Period (28 Weeks)|Not reported|1|||
126253929|NCT04556734|454220954|FG006|OLE Period (28 Weeks)|Not reported|0|||
126253930|NCT04556734|454220955|FG007|OLE Period (28 Weeks)|Not reported|0|||
126253931|NCT04556734|454220948|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253932|NCT04556734|454220949|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253933|NCT04556734|454220950|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253934|NCT04556734|454220951|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253935|NCT04556734|454220952|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253936|NCT04556734|454220953|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253937|NCT04556734|454220954|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126253938|NCT04556734|454220955|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
126253939|NCT04556734|454220948|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
126253940|NCT04556734|454220949|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
126253941|NCT04556734|454220950|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
126253942|NCT04556734|454220951|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
126253943|NCT04556734|454220952|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
126253944|NCT04556734|454220953|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
126253945|NCT04556734|454220954|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
126253946|NCT04556734|454220955|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
126253947|NCT04556734|454220948|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126253948|NCT04556734|454220949|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126253949|NCT04556734|454220950|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126253950|NCT04556734|454220951|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
126253951|NCT04556734|454220952|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
126253952|NCT04556734|454220953|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
126253953|NCT04556734|454220954|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
126253954|NCT04556734|454220955|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126253955|NCT04264819|454220956|FG000|Overall Study|Physician Decision|19|||
126253956|NCT04264819|454220956|FG000|Overall Study|Adverse Event|12|||
126253957|NCT04264819|454220956|FG000|Overall Study|Withdrawal by Subject|11|||
126253958|NCT04264819|454220956|FG000|Overall Study|Lost to Follow-up|2|||
126253959|NCT04264819|454220956|FG000|Overall Study|Death|2|||
126253960|NCT02229084|454220959|FG000|Overall Study|Adverse Event|1|||
126253961|NCT02229084|454220960|FG001|Overall Study|Adverse Event|0|||
126253962|NCT02229084|454220961|FG002|Overall Study|Adverse Event|0|||
126253963|NCT02229084|454220962|FG003|Overall Study|Adverse Event|0|||
126253964|NCT02229084|454220963|FG004|Overall Study|Adverse Event|0|||
126253965|NCT02229084|454220964|FG005|Overall Study|Adverse Event|0|||
126253966|NCT02229084|454220965|FG006|Overall Study|Adverse Event|0|||
126253967|NCT02229084|454220959|FG000|Overall Study|Lost to Follow-up|0|||
126253968|NCT02229084|454220960|FG001|Overall Study|Lost to Follow-up|0|||
126253969|NCT02229084|454220961|FG002|Overall Study|Lost to Follow-up|1|||
126253970|NCT02229084|454220962|FG003|Overall Study|Lost to Follow-up|1|||
126253971|NCT02229084|454220963|FG004|Overall Study|Lost to Follow-up|0|||
126253972|NCT02229084|454220964|FG005|Overall Study|Lost to Follow-up|0|||
126253973|NCT02229084|454220965|FG006|Overall Study|Lost to Follow-up|1|||
126253974|NCT02229084|454220959|FG000|Overall Study|Physician Decision|0|||
126253975|NCT02229084|454220960|FG001|Overall Study|Physician Decision|0|||
126253976|NCT02229084|454220961|FG002|Overall Study|Physician Decision|0|||
126253977|NCT02229084|454220962|FG003|Overall Study|Physician Decision|1|||
126253978|NCT02229084|454220963|FG004|Overall Study|Physician Decision|3|||
126253979|NCT02229084|454220964|FG005|Overall Study|Physician Decision|0|||
126253980|NCT02229084|454220965|FG006|Overall Study|Physician Decision|1|||
126253981|NCT02229084|454220959|FG000|Overall Study|Withdrawal by Subject|0|||
126253982|NCT02229084|454220960|FG001|Overall Study|Withdrawal by Subject|0|||
126253983|NCT02229084|454220961|FG002|Overall Study|Withdrawal by Subject|1|||
126253984|NCT02229084|454220962|FG003|Overall Study|Withdrawal by Subject|0|||
126253985|NCT02229084|454220963|FG004|Overall Study|Withdrawal by Subject|1|||
126253986|NCT02229084|454220964|FG005|Overall Study|Withdrawal by Subject|1|||
126253987|NCT02229084|454220965|FG006|Overall Study|Withdrawal by Subject|1|||
126253988|NCT02229084|454220959|FG000|Overall Study|Death|0|||
126253989|NCT02229084|454220960|FG001|Overall Study|Death|0|||
126253990|NCT02229084|454220961|FG002|Overall Study|Death|0|||
126253991|NCT02229084|454220962|FG003|Overall Study|Death|0|||
126253992|NCT02229084|454220963|FG004|Overall Study|Death|0|||
126253993|NCT02229084|454220964|FG005|Overall Study|Death|0|||
126253994|NCT02229084|454220965|FG006|Overall Study|Death|1|||
126253995|NCT02179190|454220969|FG000|Enrollment|Exit Prior to Device Attempt|11|||
126253996|NCT02179190|454220969|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
126253997|NCT02179190|454220969|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
126253998|NCT02179190|454220969|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
126253999|NCT02179190|454220969|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
126254000|NCT02179190|454220969|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
126254001|NCT00881569|454220972|FG000|Overall Study|Disease progression|1|||
126254002|NCT00881569|454220973|FG001|Overall Study|Disease progression|1|||
126254003|NCT01993940|454220984|FG000|Overall Study|Adverse Event|16|||
126254004|NCT01993940|454220985|FG001|Overall Study|Adverse Event|11|||
126254005|NCT01993940|454220984|FG000|Overall Study|Withdrawal by Subject|15|||
126254006|NCT01993940|454220985|FG001|Overall Study|Withdrawal by Subject|19|||
126254007|NCT01993940|454220984|FG000|Overall Study|Lost to Follow-up|2|||
126254008|NCT01993940|454220985|FG001|Overall Study|Lost to Follow-up|5|||
126254009|NCT01993940|454220984|FG000|Overall Study|Protocol Violation|5|||
126254010|NCT01993940|454220985|FG001|Overall Study|Protocol Violation|8|||
126254011|NCT01993940|454220984|FG000|Overall Study|Death|1|||
126254012|NCT01993940|454220985|FG001|Overall Study|Death|0|||
126254013|NCT01993940|454220984|FG000|Overall Study|Other - Miscellaneous|1|||
126254014|NCT01993940|454220985|FG001|Overall Study|Other - Miscellaneous|1|||
126254015|NCT00550147|454220988|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
126254016|NCT00550147|454220988|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
126254017|NCT00550147|454220988|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
126254018|NCT00550147|454220988|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
126254019|NCT00550147|454220988|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
126254020|NCT01824498|454220989|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
126254021|NCT01824498|454220990|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
126254022|NCT01824498|454220991|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
126254023|NCT01824498|454220992|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
126254024|NCT01824498|454220993|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
126254025|NCT01824498|454220994|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
126254026|NCT01567527|454220995|FG000|Conversion Phase.|Protocol deviation|3|||
126254027|NCT01567527|454220996|FG001|Conversion Phase.|Protocol deviation|0|||
126254028|NCT01567527|454220997|FG002|Conversion Phase.|Protocol deviation|0|||
126254029|NCT01567527|454220998|FG003|Conversion Phase.|Protocol deviation|0|||
126254030|NCT01567527|454220999|FG004|Conversion Phase.|Protocol deviation|0|||
126254031|NCT01567527|454220995|FG000|Conversion Phase.|Met withdrawal criteria|10|||
126254032|NCT01567527|454220996|FG001|Conversion Phase.|Met withdrawal criteria|0|||
126254033|NCT01567527|454220997|FG002|Conversion Phase.|Met withdrawal criteria|0|||
126254034|NCT01567527|454220998|FG003|Conversion Phase.|Met withdrawal criteria|0|||
126254035|NCT01567527|454220999|FG004|Conversion Phase.|Met withdrawal criteria|0|||
126254036|NCT01567527|454220995|FG000|Conversion Phase.|Withdrawal by Subject|32|||
126254037|NCT01567527|454220996|FG001|Conversion Phase.|Withdrawal by Subject|0|||
126254038|NCT01567527|454220997|FG002|Conversion Phase.|Withdrawal by Subject|0|||
126254039|NCT01567527|454220998|FG003|Conversion Phase.|Withdrawal by Subject|0|||
126254040|NCT01567527|454220999|FG004|Conversion Phase.|Withdrawal by Subject|0|||
126254041|NCT01567527|454220995|FG000|Conversion Phase.|Lost to Follow-up|16|||
126254042|NCT01567527|454220996|FG001|Conversion Phase.|Lost to Follow-up|0|||
126254043|NCT01567527|454220997|FG002|Conversion Phase.|Lost to Follow-up|0|||
126254044|NCT01567527|454220998|FG003|Conversion Phase.|Lost to Follow-up|0|||
126254045|NCT01567527|454220999|FG004|Conversion Phase.|Lost to Follow-up|0|||
126254046|NCT01567527|454220995|FG000|Conversion Phase.|Lack of Efficacy|2|||
126254047|NCT01567527|454220996|FG001|Conversion Phase.|Lack of Efficacy|0|||
126254048|NCT01567527|454220997|FG002|Conversion Phase.|Lack of Efficacy|0|||
126254049|NCT01567527|454220998|FG003|Conversion Phase.|Lack of Efficacy|0|||
126254050|NCT01567527|454220999|FG004|Conversion Phase.|Lack of Efficacy|0|||
126254051|NCT01567527|454220995|FG000|Conversion Phase.|Adverse Event|33|||
126254052|NCT01567527|454220996|FG001|Conversion Phase.|Adverse Event|0|||
126254053|NCT01567527|454220997|FG002|Conversion Phase.|Adverse Event|0|||
126254054|NCT01567527|454220998|FG003|Conversion Phase.|Adverse Event|0|||
126254055|NCT01567527|454220999|FG004|Conversion Phase.|Adverse Event|0|||
126254056|NCT01567527|454220995|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
126254057|NCT01567527|454220996|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
126254058|NCT01567527|454220997|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
126254059|NCT01567527|454220998|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
126254060|NCT01567527|454220999|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
126254061|NCT01567527|454220995|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
126254062|NCT01567527|454220996|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
126254063|NCT01567527|454220997|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
126254064|NCT01567527|454220998|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
126254065|NCT01567527|454220999|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
126254066|NCT01567527|454220995|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
126254067|NCT01567527|454220996|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
126254068|NCT01567527|454220997|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
126254069|NCT01567527|454220998|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
126254070|NCT01567527|454220999|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
126254071|NCT01567527|454220995|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
126254072|NCT01567527|454220996|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
126254073|NCT01567527|454220997|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
126254074|NCT01567527|454220998|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
126254075|NCT01567527|454220999|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
126254076|NCT01567527|454220995|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
126254077|NCT01567527|454220996|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
126254078|NCT01567527|454220997|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
126254079|NCT01567527|454220998|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
126254080|NCT01567527|454220999|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
126254081|NCT01567527|454220995|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
126254082|NCT01567527|454220996|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
126254083|NCT01567527|454220997|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
126254084|NCT01567527|454220998|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
126254085|NCT01567527|454220999|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
126254086|NCT01567527|454220995|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
126254087|NCT01567527|454220996|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
126254088|NCT01567527|454220997|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
126254089|NCT01567527|454220998|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
126254090|NCT01567527|454220999|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
126254091|NCT01567527|454220995|FG000|IM Depot Stabilization.|Protocol deviation|0|||
126254092|NCT01567527|454220996|FG001|IM Depot Stabilization.|Protocol deviation|0|||
126254093|NCT01567527|454220997|FG002|IM Depot Stabilization.|Protocol deviation|5|||
126254094|NCT01567527|454220998|FG003|IM Depot Stabilization.|Protocol deviation|0|||
126254095|NCT01567527|454220999|FG004|IM Depot Stabilization.|Protocol deviation|0|||
126254096|NCT01567527|454220995|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
126254097|NCT01567527|454220996|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
126254098|NCT01567527|454220997|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
126254099|NCT01567527|454220998|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
126254100|NCT01567527|454220999|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
126254101|NCT01567527|454220995|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
126254102|NCT01567527|454220996|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
126254103|NCT01567527|454220997|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
126254104|NCT01567527|454220998|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
126254105|NCT01567527|454220999|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
126254106|NCT01567527|454220995|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
126254107|NCT01567527|454220996|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
126254108|NCT01567527|454220997|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
126254109|NCT01567527|454220998|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
126254110|NCT01567527|454220999|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
126254111|NCT01567527|454220995|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
126254112|NCT01567527|454220996|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
126254113|NCT01567527|454220997|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
126254114|NCT01567527|454220998|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
126254115|NCT01567527|454220999|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
126254116|NCT01567527|454220995|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
126254117|NCT01567527|454220996|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
126254118|NCT01567527|454220997|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
126449313|NCT01584440|454945275|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
126449314|NCT01584440|454945276|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
126449315|NCT01584440|454945277|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
126449316|NCT00531427|454945278|FG000|Overall Study|Withdrawal by Subject|7|||
126449317|NCT00531427|454945279|FG001|Overall Study|Withdrawal by Subject|13|||
126698441|NCT00348140|455847077|FG002|Overall Study|Conditional medication increased dose|0|||
126449318|NCT00531427|454945278|FG000|Overall Study|Adverse Event|44|||
126449319|NCT00531427|454945279|FG001|Overall Study|Adverse Event|30|||
126449320|NCT00531427|454945278|FG000|Overall Study|Lost to Follow-up|4|||
126449321|NCT00531427|454945279|FG001|Overall Study|Lost to Follow-up|3|||
126449322|NCT00531427|454945278|FG000|Overall Study|Lack of Efficacy|14|||
126449323|NCT00531427|454945279|FG001|Overall Study|Lack of Efficacy|39|||
126254119|NCT01567527|454220998|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
126254120|NCT01567527|454220999|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
126254121|NCT01567527|454220995|FG000|IM Depot Stabilization.|Adverse Event|0|||
126254122|NCT01567527|454220996|FG001|IM Depot Stabilization.|Adverse Event|0|||
126254123|NCT01567527|454220997|FG002|IM Depot Stabilization.|Adverse Event|37|||
126254124|NCT01567527|454220998|FG003|IM Depot Stabilization.|Adverse Event|0|||
126254125|NCT01567527|454220999|FG004|IM Depot Stabilization.|Adverse Event|0|||
126254126|NCT01567527|454220995|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
126254127|NCT01567527|454220996|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
126254128|NCT01567527|454220997|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
126254129|NCT01567527|454220998|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
126358258|NCT01541254|454603953|FG000|Overall Study|Withdrawal by Subject|1|||
126358259|NCT01541254|454603953|FG000|Overall Study|excluded - metal allergy|1|||
126358260|NCT01541254|454603953|FG000|Overall Study|enrolled after study closed|1|||
126358261|NCT01541254|454603953|FG000|Overall Study|GI bleed prior to procedure|1|||
126254130|NCT01567527|454220999|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
126254131|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
126254132|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
126254133|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
126254134|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
126254135|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
126254136|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
126254137|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
126254138|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
126254139|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
126254140|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
126254141|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
126254142|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
126254143|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
126254144|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
126254145|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
126254146|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
126254147|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
126254148|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
126254149|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
126254150|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
126254151|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
126254152|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
126254153|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
126254154|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
126254155|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
126254156|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
126254157|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
126254158|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
126254159|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
126254160|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
126254161|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
126254162|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
126254163|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
126254164|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
126254165|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
126254166|NCT01567527|454220995|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126254167|NCT01567527|454220996|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126358262|NCT01541254|454603953|FG000|Overall Study|stent not required|1|||
126358263|NCT01541254|454603953|FG000|Overall Study|alternate stent used|1|||
126358264|NCT05660538|454603954|FG000|Overall Study|Adverse Event|0|||
126358265|NCT05660538|454603955|FG001|Overall Study|Adverse Event|0|||
126358266|NCT05660538|454603956|FG002|Overall Study|Adverse Event|1|||
126254168|NCT01567527|454220997|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
126254169|NCT01567527|454220998|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
126358267|NCT05660538|454603957|FG003|Overall Study|Adverse Event|0|||
126358268|NCT05660538|454603954|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
126358269|NCT05660538|454603955|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
126358270|NCT05660538|454603956|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
126358271|NCT05660538|454603957|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
126254170|NCT01567527|454220999|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
126254171|NCT02623218|454221000|FG000|Overall Study|Lost to Follow-up|0|||
126254172|NCT02623218|454221001|FG001|Overall Study|Lost to Follow-up|1|||
126254173|NCT02623218|454221002|FG002|Overall Study|Lost to Follow-up|0|||
126698442|NCT00348140|455847075|FG000|Overall Study|Caregiver related|4|||
126698443|NCT00348140|455847076|FG001|Overall Study|Caregiver related|7|||
126698444|NCT00348140|455847077|FG002|Overall Study|Caregiver related|3|||
126698445|NCT00348140|455847075|FG000|Overall Study|Participant hospitalised|3|||
126698446|NCT00348140|455847076|FG001|Overall Study|Participant hospitalised|0|||
126698447|NCT00348140|455847077|FG002|Overall Study|Participant hospitalised|0|||
126254174|NCT02623218|454221003|FG003|Overall Study|Lost to Follow-up|0|||
126254175|NCT02623218|454221004|FG004|Overall Study|Lost to Follow-up|0|||
126254176|NCT01726803|454221005|FG000|Overall Study|Lost to Follow-up|6|||
126254177|NCT01726803|454221006|FG001|Overall Study|Lost to Follow-up|1|||
126254178|NCT01726803|454221005|FG000|Overall Study|Withdrawal by Subject|1|||
126254179|NCT01726803|454221006|FG001|Overall Study|Withdrawal by Subject|0|||
126254180|NCT01277510|454221010|FG000|Double-blind Phase|Non-compliance|0|||
126254181|NCT01277510|454221011|FG001|Double-blind Phase|Non-compliance|1|||
126254182|NCT01277510|454221010|FG000|Double-blind Phase|Adverse Event|1|||
126254183|NCT01277510|454221011|FG001|Double-blind Phase|Adverse Event|0|||
126254184|NCT01277510|454221010|FG000|Double-blind Phase|Withdrawal by Subject|2|||
126254185|NCT01277510|454221011|FG001|Double-blind Phase|Withdrawal by Subject|0|||
126254186|NCT01277510|454221010|FG000|Double-blind Phase|Administrative decision|7|||
126254187|NCT01277510|454221011|FG001|Double-blind Phase|Administrative decision|9|||
126254188|NCT01277510|454221010|FG000|Double-blind Phase|Death|0|||
126254189|NCT01277510|454221011|FG001|Double-blind Phase|Death|1|||
126254190|NCT01277510|454221010|FG000|Double-blind Phase|Protocol-specified criteria|2|||
126254191|NCT01277510|454221011|FG001|Double-blind Phase|Protocol-specified criteria|6|||
126254192|NCT01277510|454221010|FG000|Double-blind Phase|Other|1|||
126254193|NCT01277510|454221011|FG001|Double-blind Phase|Other|1|||
126254194|NCT01277510|454221010|FG000|Open-label Phase|Administrative decision|4|||
126254195|NCT01277510|454221011|FG001|Open-label Phase|Administrative decision|3|||
126254196|NCT01277510|454221010|FG000|Open-label Phase|Protocol-specified criteria|1|||
126254197|NCT01277510|454221011|FG001|Open-label Phase|Protocol-specified criteria|0|||
126254198|NCT01277510|454221010|FG000|Open-label Phase|Never received investigational product|2|||
126254199|NCT01277510|454221011|FG001|Open-label Phase|Never received investigational product|0|||
126254200|NCT01685008|454221012|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
126254201|NCT01685008|454221013|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
126254202|NCT01685008|454221014|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
126254203|NCT01685008|454221015|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
126254204|NCT01685008|454221012|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
126254205|NCT01685008|454221013|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
126254206|NCT01685008|454221014|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
126254207|NCT01685008|454221015|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
126254208|NCT01685008|454221012|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
126254209|NCT01685008|454221013|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
126254210|NCT01685008|454221014|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
126254211|NCT01685008|454221015|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
126254212|NCT01685008|454221012|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
126254213|NCT01685008|454221013|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
126254214|NCT01685008|454221014|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
126254215|NCT01685008|454221015|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
126254216|NCT01685008|454221012|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
126254217|NCT01685008|454221013|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
126254218|NCT01685008|454221014|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
126254219|NCT01685008|454221015|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
126254220|NCT00057941|454221030|FG000|Overall Study|Death|1|||
126254221|NCT00057941|454221031|FG001|Overall Study|Death|2|||
126254222|NCT00057941|454221030|FG000|Overall Study|Adverse Event|7|||
126358272|NCT05660538|454603954|FG000|Overall Study|Lost to Follow-up|0|||
126698448|NCT00348140|455847075|FG000|Overall Study|Efficacy related|1|||
126254223|NCT00057941|454221031|FG001|Overall Study|Adverse Event|9|||
126358273|NCT05660538|454603955|FG001|Overall Study|Lost to Follow-up|0|||
126698449|NCT00348140|455847076|FG001|Overall Study|Efficacy related|1|||
126698450|NCT00348140|455847077|FG002|Overall Study|Efficacy related|0|||
126254224|NCT00057941|454221030|FG000|Overall Study|Lack of Efficacy|54|||
126254225|NCT00057941|454221031|FG001|Overall Study|Lack of Efficacy|53|||
126254226|NCT00057941|454221030|FG000|Overall Study|Withdrawal by Subject|6|||
126254227|NCT00057941|454221031|FG001|Overall Study|Withdrawal by Subject|1|||
126254228|NCT00057941|454221030|FG000|Overall Study|still on treatment|3|||
126254229|NCT00057941|454221031|FG001|Overall Study|still on treatment|1|||
126254230|NCT00057941|454221030|FG000|Overall Study|insurance, symptomatic deterioration|1|||
126254231|NCT00057941|454221031|FG001|Overall Study|insurance, symptomatic deterioration|3|||
126358274|NCT05660538|454603956|FG002|Overall Study|Lost to Follow-up|1|||
126698451|NCT00348140|455847075|FG000|Overall Study|Administration related|3|||
126254232|NCT00057941|454221030|FG000|Overall Study|Ineligible|2|||
126254233|NCT00057941|454221031|FG001|Overall Study|Ineligible|5|||
126254234|NCT00609154|454221032|FG000|Overall Study|Protocol Violation|1|||
126254235|NCT00609154|454221033|FG001|Overall Study|Protocol Violation|2|||
126254236|NCT00609154|454221032|FG000|Overall Study|Unable to establish IV access|0|||
126254237|NCT00609154|454221033|FG001|Overall Study|Unable to establish IV access|4|||
126254238|NCT00609154|454221032|FG000|Overall Study|Adverse Event|0|||
126254239|NCT00609154|454221033|FG001|Overall Study|Adverse Event|2|||
126254240|NCT02224053|454221034|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
126254241|NCT02224053|454221034|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
126254242|NCT02224053|454221034|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
126254243|NCT02224053|454221034|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
126254244|NCT02224053|454221034|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
126254245|NCT01898598|454221038|FG000|Overall Study|Adverse Event|1|||
126254246|NCT01898598|454221039|FG001|Overall Study|Adverse Event|0|||
126254247|NCT01898598|454221038|FG000|Overall Study|Withdrawal by Subject|3|||
126254248|NCT01898598|454221039|FG001|Overall Study|Withdrawal by Subject|0|||
126254249|NCT01898598|454221038|FG000|Overall Study|Lost to Follow-up|0|||
126254250|NCT01898598|454221039|FG001|Overall Study|Lost to Follow-up|1|||
126254251|NCT01898598|454221038|FG000|Overall Study|Other|0|||
126254252|NCT01898598|454221039|FG001|Overall Study|Other|1|||
126254253|NCT03833427|454221040|FG000|Overall Study|Death|4|||
126254254|NCT03833427|454221041|FG001|Overall Study|Death|2|||
126254255|NCT03833427|454221042|FG002|Overall Study|Death|9|||
126254256|NCT03833427|454221043|FG003|Overall Study|Death|11|||
126254257|NCT03833427|454221044|FG004|Overall Study|Death|0|||
126358275|NCT05660538|454603957|FG003|Overall Study|Lost to Follow-up|1|||
126254258|NCT03833427|454221045|FG005|Overall Study|Death|0|||
126254259|NCT03833427|454221046|FG006|Overall Study|Death|0|||
126254260|NCT03833427|454221040|FG000|Overall Study|Withdrawal by Subject|0|||
126254261|NCT03833427|454221041|FG001|Overall Study|Withdrawal by Subject|1|||
126254262|NCT03833427|454221042|FG002|Overall Study|Withdrawal by Subject|1|||
126254263|NCT03833427|454221043|FG003|Overall Study|Withdrawal by Subject|0|||
126254264|NCT03833427|454221044|FG004|Overall Study|Withdrawal by Subject|0|||
126254265|NCT03833427|454221045|FG005|Overall Study|Withdrawal by Subject|0|||
126254266|NCT03833427|454221046|FG006|Overall Study|Withdrawal by Subject|0|||
126698452|NCT00348140|455847076|FG001|Overall Study|Administration related|1|||
126698453|NCT00348140|455847077|FG002|Overall Study|Administration related|1|||
126698454|NCT00348140|455847075|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
126698455|NCT00348140|455847076|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
126698456|NCT00348140|455847077|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
126698457|NCT00348140|455847075|FG000|Overall Study|Participant unwell|1|||
126698458|NCT00348140|455847076|FG001|Overall Study|Participant unwell|0|||
126698459|NCT00348140|455847077|FG002|Overall Study|Participant unwell|0|||
126698460|NCT00348140|455847075|FG000|Overall Study|Screen failure|1|||
126698461|NCT00348140|455847076|FG001|Overall Study|Screen failure|0|||
126698462|NCT00348140|455847077|FG002|Overall Study|Screen failure|0|||
126698463|NCT00348140|455847075|FG000|Overall Study|Investigator decided to discontinue|4|||
126698464|NCT00348140|455847076|FG001|Overall Study|Investigator decided to discontinue|1|||
126698465|NCT00348140|455847077|FG002|Overall Study|Investigator decided to discontinue|4|||
126698466|NCT00348140|455847075|FG000|Overall Study|Decided to discontinue on their own|1|||
126698467|NCT00348140|455847076|FG001|Overall Study|Decided to discontinue on their own|4|||
126254267|NCT03833427|454221040|FG000|Overall Study|Sponsor Decision|0|||
126254268|NCT03833427|454221041|FG001|Overall Study|Sponsor Decision|0|||
126358276|NCT05660538|454603954|FG000|Overall Study|Death|0|||
126254269|NCT03833427|454221042|FG002|Overall Study|Sponsor Decision|1|||
126254270|NCT03833427|454221043|FG003|Overall Study|Sponsor Decision|3|||
126254271|NCT03833427|454221044|FG004|Overall Study|Sponsor Decision|0|||
126698468|NCT00348140|455847077|FG002|Overall Study|Decided to discontinue on their own|1|||
126698469|NCT00348140|455847075|FG000|Overall Study|Use of prohibited drug|1|||
126698470|NCT00348140|455847076|FG001|Overall Study|Use of prohibited drug|0|||
126698471|NCT00348140|455847077|FG002|Overall Study|Use of prohibited drug|2|||
126698472|NCT00348140|455847075|FG000|Overall Study|Disease progression|1|||
126698473|NCT00348140|455847076|FG001|Overall Study|Disease progression|2|||
126698474|NCT00348140|455847077|FG002|Overall Study|Disease progression|5|||
126358277|NCT05660538|454603955|FG001|Overall Study|Death|0|||
126254272|NCT03833427|454221045|FG005|Overall Study|Sponsor Decision|0|||
126254273|NCT03833427|454221046|FG006|Overall Study|Sponsor Decision|0|||
126254274|NCT01499160|454221047|FG000|Overall Study|Adverse Event|1|||
126254275|NCT01499160|454221047|FG000|Overall Study|Withdrawal by Subject|1|||
126254276|NCT00860262|454221050|FG000|Overall Study|Adverse Event|9|||
126254277|NCT00860262|454221051|FG001|Overall Study|Adverse Event|6|||
126254278|NCT00860262|454221052|FG002|Overall Study|Adverse Event|7|||
126358278|NCT05660538|454603956|FG002|Overall Study|Death|1|||
126698475|NCT00348140|455847075|FG000|Overall Study|Increased risk of cardiac infarction|0|||
126698476|NCT00348140|455847076|FG001|Overall Study|Increased risk of cardiac infarction|1|||
126698477|NCT00348140|455847077|FG002|Overall Study|Increased risk of cardiac infarction|0|||
126698478|NCT00348140|455847075|FG000|Overall Study|Serious adverse event|0|||
126698479|NCT00348140|455847076|FG001|Overall Study|Serious adverse event|1|||
126698480|NCT00348140|455847077|FG002|Overall Study|Serious adverse event|0|||
126698481|NCT00348140|455847075|FG000|Overall Study|Abnormal ECG|0|||
126698482|NCT00348140|455847076|FG001|Overall Study|Abnormal ECG|1|||
126254279|NCT00860262|454221050|FG000|Overall Study|Protocol Violation|0|||
126254280|NCT00860262|454221051|FG001|Overall Study|Protocol Violation|1|||
126698483|NCT00348140|455847077|FG002|Overall Study|Abnormal ECG|3|||
126698484|NCT00348140|455847075|FG000|Overall Study|Participant died|0|||
126698485|NCT00348140|455847076|FG001|Overall Study|Participant died|1|||
126698486|NCT00348140|455847077|FG002|Overall Study|Participant died|0|||
126698487|NCT00348140|455847075|FG000|Overall Study|Exclusion criteria met|0|||
126698488|NCT00348140|455847076|FG001|Overall Study|Exclusion criteria met|0|||
126698489|NCT00348140|455847077|FG002|Overall Study|Exclusion criteria met|1|||
126698490|NCT00348140|455847075|FG000|Overall Study|Memory declined|0|||
126698491|NCT00348140|455847076|FG001|Overall Study|Memory declined|0|||
126698492|NCT00348140|455847077|FG002|Overall Study|Memory declined|1|||
126254281|NCT00860262|454221052|FG002|Overall Study|Protocol Violation|0|||
126254282|NCT00860262|454221050|FG000|Overall Study|Lost to Follow-up|2|||
126254283|NCT00860262|454221051|FG001|Overall Study|Lost to Follow-up|0|||
126254284|NCT00860262|454221052|FG002|Overall Study|Lost to Follow-up|1|||
126254285|NCT00860262|454221050|FG000|Overall Study|Withdrawal by Subject|4|||
126254286|NCT00860262|454221051|FG001|Overall Study|Withdrawal by Subject|8|||
126254287|NCT00860262|454221052|FG002|Overall Study|Withdrawal by Subject|6|||
126254288|NCT00860262|454221050|FG000|Overall Study|Lack of Efficacy|0|||
126254289|NCT00860262|454221051|FG001|Overall Study|Lack of Efficacy|4|||
126254290|NCT00860262|454221052|FG002|Overall Study|Lack of Efficacy|3|||
126254291|NCT00860262|454221050|FG000|Overall Study|Other|5|||
126254292|NCT00860262|454221051|FG001|Overall Study|Other|3|||
126254293|NCT00860262|454221052|FG002|Overall Study|Other|1|||
126254294|NCT00124618|454221053|FG000|Overall Study|Ineligible|1|||
126254295|NCT00593827|454221054|FG000|Overall Study|On Active Treatment/Pending|0|||
126254296|NCT00593827|454221055|FG001|Overall Study|On Active Treatment/Pending|2|||
126254297|NCT01596127|454221056|FG000|Overall Study|Patient Ineligible|1|||
126254298|NCT01675596|454221057|FG000|Overall Study|Death|6|||
126254299|NCT01675596|454221057|FG000|Overall Study|Exit with other reason|1|||
126254300|NCT01675596|454221057|FG000|Overall Study|Missed Visit|1|||
126254301|NCT00688844|454221059|FG000|Overall Study|Lost to Follow-up|10|||
126254302|NCT01374451|454221060|FG000|Overall Study|Administrative problems|1|||
126254303|NCT01374451|454221061|FG001|Overall Study|Administrative problems|0|||
126254304|NCT00663234|454221062|FG000|Overall Study|Not willing to adhere to requirements|1|||
126254305|NCT01709903|454221065|FG000|Overall Study|administrative problems|2|||
126762824|NCT04527380|456082739|FG001|Overall Study|Withdrawal by Subject|0|||
126762825|NCT05437211|456082746|FG000|Overall Study|Patient's decision|1|||
126762826|NCT05437211|456082747|FG001|Overall Study|Patient's decision|1|||
126254306|NCT01709903|454221066|FG001|Overall Study|administrative problems|6|||
126254307|NCT01709903|454221065|FG000|Overall Study|Abnormal test procedure results|1|||
126254308|NCT01709903|454221066|FG001|Overall Study|Abnormal test procedure results|0|||
126698493|NCT01032629|455847078|FG000|Overall Study|Closed Site|21|||
126698494|NCT01032629|455847079|FG001|Overall Study|Closed Site|18|||
126698495|NCT01032629|455847080|FG002|Overall Study|Closed Site|16|||
126698496|NCT01032629|455847078|FG000|Overall Study|Withdrawal by Subject|50|||
126762827|NCT04410991|456082749|FG000|Overall Study|Poor compliance to protocol|5|||
126762828|NCT04410991|456082750|FG001|Overall Study|Poor compliance to protocol|4|||
126254309|NCT01709903|454221065|FG000|Overall Study|In ability to use device|1|||
126254310|NCT01709903|454221066|FG001|Overall Study|In ability to use device|1|||
126254311|NCT01709903|454221065|FG000|Overall Study|no longer needed study drug|0|||
126254312|NCT01709903|454221066|FG001|Overall Study|no longer needed study drug|1|||
126254313|NCT01709903|454221065|FG000|Overall Study|Lost to Follow-up|0|||
126254314|NCT01709903|454221066|FG001|Overall Study|Lost to Follow-up|2|||
126254315|NCT01709903|454221065|FG000|Overall Study|Death|2|||
126254316|NCT01709903|454221066|FG001|Overall Study|Death|0|||
126254317|NCT01709903|454221065|FG000|Overall Study|Protocol Violation|3|||
126254318|NCT01709903|454221066|FG001|Overall Study|Protocol Violation|2|||
126254319|NCT01709903|454221065|FG000|Overall Study|Lack of Efficacy|3|||
126254320|NCT01709903|454221066|FG001|Overall Study|Lack of Efficacy|3|||
126254321|NCT01709903|454221065|FG000|Overall Study|Withdrawal by Subject|6|||
126698497|NCT01032629|455847079|FG001|Overall Study|Withdrawal by Subject|36|||
126698498|NCT01032629|455847080|FG002|Overall Study|Withdrawal by Subject|35|||
126254322|NCT01709903|454221066|FG001|Overall Study|Withdrawal by Subject|6|||
126254323|NCT01709903|454221065|FG000|Overall Study|Adverse Event|11|||
126254324|NCT01709903|454221066|FG001|Overall Study|Adverse Event|18|||
126254325|NCT02061280|454221067|FG000|Overall Study|Protocol Violation|12|||
126254326|NCT02061280|454221068|FG001|Overall Study|Protocol Violation|8|||
126254327|NCT02061280|454221067|FG000|Overall Study|moved out of state|0|||
126254328|NCT02061280|454221068|FG001|Overall Study|moved out of state|1|||
126698499|NCT01032629|455847078|FG000|Overall Study|Lost to Follow-up|74|||
126698500|NCT01032629|455847079|FG001|Overall Study|Lost to Follow-up|47|||
126762829|NCT04410991|456082749|FG000|Overall Study|Withdrawal by Subject|59|||
126254329|NCT02061280|454221067|FG000|Overall Study|Withdrawal by Subject|1|||
126698501|NCT01032629|455847080|FG002|Overall Study|Lost to Follow-up|37|||
126254330|NCT02061280|454221068|FG001|Overall Study|Withdrawal by Subject|2|||
126254331|NCT02061280|454221067|FG000|Overall Study|Lost to Follow-up|5|||
126254332|NCT02061280|454221068|FG001|Overall Study|Lost to Follow-up|1|||
126254333|NCT00724958|454221073|FG000|Overall Study|Adverse Event|28|||
126254334|NCT00724958|454221073|FG000|Overall Study|Loss of Response|40|||
126254335|NCT00724958|454221073|FG000|Overall Study|No Response|18|||
126254336|NCT00724958|454221073|FG000|Overall Study|Remission|7|||
126254337|NCT00724958|454221073|FG000|Overall Study|Other Reason|76|||
126254338|NCT00724958|454221073|FG000|Overall Study|No documentation for end of therapy|13|||
126254339|NCT02940522|454222713|FG000|Overall Study|Lost to Follow-up|1|||
126254340|NCT02940522|454222714|FG001|Overall Study|Lost to Follow-up|2|||
126254341|NCT02940522|454222713|FG000|Overall Study|Withdrawal by Subject|1|||
126254342|NCT02940522|454222714|FG001|Overall Study|Withdrawal by Subject|0|||
126254343|NCT02710214|454222715|FG000|Overall Study|Lost to Follow-up|1|||
126254344|NCT02710214|454222716|FG001|Overall Study|Lost to Follow-up|0|||
126254345|NCT02710214|454222715|FG000|Overall Study|Lack of Efficacy|0|||
126254346|NCT02710214|454222716|FG001|Overall Study|Lack of Efficacy|1|||
126254347|NCT02710214|454222715|FG000|Overall Study|Death|0|||
126254348|NCT02710214|454222716|FG001|Overall Study|Death|1|||
126254349|NCT01188226|454222720|FG000|Overall Study|Withdrawal by Subject|4|||
126254350|NCT02846883|454222721|FG000|Overall Study|Death|0|||
126254351|NCT02846883|454222722|FG001|Overall Study|Death|1|||
126254352|NCT02846883|454222723|FG002|Overall Study|Death|1|||
126254353|NCT02846883|454222721|FG000|Overall Study|Lost to Follow-up|0|||
126698502|NCT00977470|455847084|FG000|Overall Study|Lack of Efficacy|32|||
126698503|NCT00977470|455847085|FG001|Overall Study|Lack of Efficacy|30|||
126698504|NCT00977470|455847084|FG000|Overall Study|Physician Decision|2|||
126698505|NCT00977470|455847085|FG001|Overall Study|Physician Decision|0|||
126254354|NCT02846883|454222722|FG001|Overall Study|Lost to Follow-up|0|||
126254355|NCT02846883|454222723|FG002|Overall Study|Lost to Follow-up|1|||
126254356|NCT02846883|454222721|FG000|Overall Study|Withdrawal by Subject|1|||
126254357|NCT02846883|454222722|FG001|Overall Study|Withdrawal by Subject|0|||
126254358|NCT02846883|454222723|FG002|Overall Study|Withdrawal by Subject|0|||
126254359|NCT02846883|454222721|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
126254360|NCT02846883|454222722|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
126254361|NCT02846883|454222723|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
126254362|NCT02846883|454222721|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
126254363|NCT02846883|454222722|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
126254364|NCT02846883|454222723|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
126254365|NCT00927251|454222724|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
126254366|NCT04768296|454222725|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
126254367|NCT04768296|454222726|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
126254368|NCT03087786|454222729|FG000|Overall Study|Withdrawal by Subject|2|||
126254369|NCT03087786|454222730|FG001|Overall Study|Withdrawal by Subject|0|||
126254370|NCT01453153|454222735|FG000|Overall Study|Physician Decision|0|||
126254371|NCT01453153|454222736|FG001|Overall Study|Physician Decision|0|||
126254372|NCT01453153|454222737|FG002|Overall Study|Physician Decision|1|||
126254373|NCT01453153|454222735|FG000|Overall Study|Progressive Disease|3|||
126254374|NCT01453153|454222736|FG001|Overall Study|Progressive Disease|2|||
126254375|NCT01453153|454222737|FG002|Overall Study|Progressive Disease|16|||
126254376|NCT01453153|454222735|FG000|Overall Study|Withdrawal by Subject|0|||
126254377|NCT01453153|454222736|FG001|Overall Study|Withdrawal by Subject|1|||
126254378|NCT01453153|454222737|FG002|Overall Study|Withdrawal by Subject|2|||
126254379|NCT01453153|454222735|FG000|Overall Study|Adverse Event|1|||
126254380|NCT01453153|454222736|FG001|Overall Study|Adverse Event|1|||
126254381|NCT01453153|454222737|FG002|Overall Study|Adverse Event|1|||
126254382|NCT01802216|454222742|FG000|4 Month Visit|Participant did not show to visit|3|||
126254383|NCT01802216|454222743|FG001|4 Month Visit|Participant did not show to visit|4|||
126254384|NCT01802216|454222742|FG000|8 Month Visit|Participant did not show to visit|3|||
126254385|NCT01802216|454222743|FG001|8 Month Visit|Participant did not show to visit|5|||
126254386|NCT01802216|454222742|FG000|12 Month Visit|Participant did not show to visit|3|||
126254387|NCT01802216|454222743|FG001|12 Month Visit|Participant did not show to visit|4|||
126254388|NCT00799708|454222744|FG000|Overall Study|non-compliance|1|||
126254389|NCT00799708|454222745|FG001|Overall Study|non-compliance|0|||
126254390|NCT00799708|454222746|FG002|Overall Study|non-compliance|0|||
126698506|NCT00977470|455847084|FG000|Overall Study|Adverse Event|1|||
126254391|NCT00880334|454222747|FG000|Randomized Phase|Physician Decision|1|||
126254392|NCT00880334|454222748|FG001|Randomized Phase|Physician Decision|0|||
126698507|NCT00977470|455847085|FG001|Overall Study|Adverse Event|2|||
126254393|NCT00880334|454222747|FG000|Randomized Phase|Withdrawal by Subject|2|||
126254394|NCT00880334|454222748|FG001|Randomized Phase|Withdrawal by Subject|1|||
126254395|NCT00880334|454222747|FG000|Randomized Phase|Inadequate Labs|1|||
126254396|NCT00880334|454222748|FG001|Randomized Phase|Inadequate Labs|1|||
126254397|NCT00880334|454222747|FG000|Randomized Phase|Brain Metastasis|0|||
126254398|NCT00880334|454222748|FG001|Randomized Phase|Brain Metastasis|1|||
126254399|NCT00880334|454222747|FG000|Randomized Phase|Crossover Participants|0|||
126254400|NCT00880334|454222748|FG001|Randomized Phase|Crossover Participants|37|||
126254401|NCT03343639|454222749|FG000|Overall Study|Withdrawal by Subject|10|||
126254402|NCT03343639|454222750|FG001|Overall Study|Withdrawal by Subject|6|||
126254403|NCT03343639|454222749|FG000|Overall Study|Lost to Follow-up|4|||
126254404|NCT03343639|454222750|FG001|Overall Study|Lost to Follow-up|5|||
126254405|NCT03343639|454222749|FG000|Overall Study|Protocol Violation|0|||
126254406|NCT03343639|454222750|FG001|Overall Study|Protocol Violation|1|||
126254407|NCT02274558|454222758|FG000|Overall Study|Adverse Event|2|||
126254408|NCT02274558|454222759|FG001|Overall Study|Adverse Event|4|||
126254409|NCT02274558|454222760|FG002|Overall Study|Adverse Event|2|||
126254410|NCT02274558|454222758|FG000|Overall Study|Non-compliance|2|||
126254411|NCT02274558|454222759|FG001|Overall Study|Non-compliance|1|||
126254412|NCT02274558|454222760|FG002|Overall Study|Non-compliance|0|||
126254413|NCT02274558|454222758|FG000|Overall Study|Withdrawal by Subject|1|||
126254414|NCT02274558|454222759|FG001|Overall Study|Withdrawal by Subject|5|||
126254415|NCT02274558|454222760|FG002|Overall Study|Withdrawal by Subject|4|||
126254416|NCT02274558|454222758|FG000|Overall Study|Death|0|||
126254417|NCT02274558|454222759|FG001|Overall Study|Death|0|||
126254418|NCT02274558|454222760|FG002|Overall Study|Death|1|||
126254419|NCT02274558|454222758|FG000|Overall Study|Lost to Follow-up|2|||
126254420|NCT02274558|454222759|FG001|Overall Study|Lost to Follow-up|1|||
126254421|NCT02274558|454222760|FG002|Overall Study|Lost to Follow-up|1|||
126254422|NCT02274558|454222758|FG000|Overall Study|Physician Decision|0|||
126254423|NCT02274558|454222759|FG001|Overall Study|Physician Decision|2|||
126254424|NCT02274558|454222760|FG002|Overall Study|Physician Decision|1|||
126254425|NCT02655224|454222761|FG000|Overall Study|Adverse Event|1|||
126254426|NCT02655224|454222762|FG001|Overall Study|Adverse Event|1|||
126254427|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
126254428|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
126254429|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
126254430|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
126254431|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
126254432|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
126254433|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
126254434|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
126254435|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
126254436|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
126254437|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
126254438|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
126254439|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
126254440|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
126254441|NCT04592419|454222765|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
126254442|NCT04592419|454222766|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
126254443|NCT04592419|454222765|FG000|Open-Label Extension Period|Adverse Event|1|||
126254444|NCT04592419|454222766|FG001|Open-Label Extension Period|Adverse Event|2|||
126254445|NCT04592419|454222765|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
126254446|NCT04592419|454222766|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
126254447|NCT04592419|454222765|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
126254448|NCT04592419|454222766|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
126254449|NCT04592419|454222765|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
126254450|NCT04592419|454222766|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
126254451|NCT04592419|454222765|FG000|Open-Label Extension Period|Sponsor Request|73|||
126254452|NCT04592419|454222766|FG001|Open-Label Extension Period|Sponsor Request|84|||
126254453|NCT02419573|454222772|FG000|Overall Study|Lost to Follow-up|3|||
126254454|NCT02419573|454222773|FG001|Overall Study|Lost to Follow-up|0|||
126254455|NCT02419573|454222772|FG000|Overall Study|Withdrawal by Subject|1|||
126254456|NCT02419573|454222773|FG001|Overall Study|Withdrawal by Subject|0|||
126254457|NCT05393271|454222774|FG000|Overall Study|Physician Decision|0|||
126254458|NCT05393271|454222775|FG001|Overall Study|Physician Decision|0|||
126254459|NCT05393271|454222776|FG002|Overall Study|Physician Decision|0|||
126254460|NCT05393271|454222777|FG003|Overall Study|Physician Decision|0|||
126254461|NCT05393271|454222778|FG004|Overall Study|Physician Decision|0|||
126254462|NCT05393271|454222779|FG005|Overall Study|Physician Decision|0|||
126254463|NCT05393271|454222780|FG006|Overall Study|Physician Decision|1|||
126254464|NCT05393271|454222781|FG007|Overall Study|Physician Decision|0|||
126254465|NCT05393271|454222782|FG008|Overall Study|Physician Decision|0|||
126762830|NCT04410991|456082750|FG001|Overall Study|Withdrawal by Subject|55|||
126254466|NCT05393271|454222783|FG009|Overall Study|Physician Decision|0|||
126254467|NCT05393271|454222784|FG010|Overall Study|Physician Decision|0|||
126762831|NCT04410991|456082749|FG000|Overall Study|Other|10|||
126254468|NCT02483416|454222785|FG000|Overall Study|Other reason|0|||
126254469|NCT02483416|454222786|FG001|Overall Study|Other reason|1|||
126762832|NCT04410991|456082750|FG001|Overall Study|Other|4|||
126762833|NCT01463631|456082760|FG000|Overall Study|Withdrawal by Subject|0|||
126254470|NCT02483416|454222785|FG000|Overall Study|Treatment stop|3|||
126254471|NCT02483416|454222786|FG001|Overall Study|Treatment stop|0|||
126254472|NCT04968925|454222787|FG000|Phase I- Period 1|COVID-19 related|0|||
126254473|NCT04968925|454222788|FG001|Phase I- Period 1|COVID-19 related|1|||
126254474|NCT04968925|454222789|FG002|Phase I- Period 1|COVID-19 related|0|||
126254475|NCT04968925|454222790|FG003|Phase I- Period 1|COVID-19 related|0|||
126254476|NCT04968925|454222787|FG000|Phase I- Period 1|Subject enrolled in error|1|||
126254477|NCT04968925|454222788|FG001|Phase I- Period 1|Subject enrolled in error|1|||
126254478|NCT04968925|454222789|FG002|Phase I- Period 1|Subject enrolled in error|0|||
126254479|NCT04968925|454222790|FG003|Phase I- Period 1|Subject enrolled in error|0|||
126254480|NCT04968925|454222787|FG000|Phase II- Period 1|COVID-19 Related|0|||
126254481|NCT04968925|454222788|FG001|Phase II- Period 1|COVID-19 Related|0|||
126254482|NCT04968925|454222789|FG002|Phase II- Period 1|COVID-19 Related|6|||
126254483|NCT04968925|454222790|FG003|Phase II- Period 1|COVID-19 Related|6|||
126254484|NCT04968925|454222787|FG000|Phase II- Period 1|Subject enrolled in error|0|||
126254485|NCT04968925|454222788|FG001|Phase II- Period 1|Subject enrolled in error|0|||
126254486|NCT04968925|454222789|FG002|Phase II- Period 1|Subject enrolled in error|1|||
126254487|NCT04968925|454222790|FG003|Phase II- Period 1|Subject enrolled in error|0|||
126254488|NCT04968925|454222787|FG000|Phase II -Period 2|COVID-19 related|0|||
126254489|NCT04968925|454222788|FG001|Phase II -Period 2|COVID-19 related|0|||
126254490|NCT04968925|454222789|FG002|Phase II -Period 2|COVID-19 related|4|||
126254491|NCT04968925|454222790|FG003|Phase II -Period 2|COVID-19 related|3|||
126254492|NCT04968925|454222787|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
126254493|NCT04968925|454222788|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
126254494|NCT04968925|454222789|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
126254495|NCT04968925|454222790|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
126254496|NCT00876265|454222795|FG000|Overall Study|Miscellaneous reasons|4|||
126254497|NCT00876265|454222795|FG000|Overall Study|Lost to Follow-up|6|||
126254498|NCT00876265|454222795|FG000|Overall Study|Withdrawal by Subject|2|||
126254499|NCT01408888|454222796|FG000|First Intervention|Adverse Event|0|||
126254500|NCT01408888|454222797|FG001|First Intervention|Adverse Event|1|||
126254501|NCT01408888|454222796|FG000|First Intervention|Withdrawal by Subject|0|||
126254502|NCT01408888|454222797|FG001|First Intervention|Withdrawal by Subject|2|||
126254503|NCT01408888|454222796|FG000|Second Intervention|Withdrawal by Subject|1|||
126254504|NCT01408888|454222797|FG001|Second Intervention|Withdrawal by Subject|0|||
126254505|NCT01408888|454222796|FG000|Second Intervention|Adverse Event|1|||
126254506|NCT01408888|454222797|FG001|Second Intervention|Adverse Event|0|||
126254507|NCT00695110|454222798|FG000|Treatment Period 1|Adverse Event|1|||
126254508|NCT00695110|454222798|FG000|Treatment Period 1|Withdrawal by Subject|2|||
126254509|NCT00695110|454222798|FG000|Treatment Period 3|Withdrawal by Subject|1|||
126254510|NCT00695110|454222798|FG000|Treatment Period 4|Adverse Event|1|||
126254511|NCT00487695|454222801|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
126254512|NCT00487695|454222802|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
126254513|NCT00487695|454222801|FG000|First Procedure|active wheezing (did not have procedure)|1|||
126254514|NCT00487695|454222802|FG001|First Procedure|active wheezing (did not have procedure)|0|||
126254515|NCT00487695|454222801|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
126254516|NCT00487695|454222802|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
126254517|NCT00487695|454222801|FG000|Second Procedure|active wheezing|0|||
126254518|NCT00487695|454222802|FG001|Second Procedure|active wheezing|1|||
126254519|NCT00487695|454222801|FG000|Second Procedure|Withdrawal by Subject|1|||
126254520|NCT00487695|454222802|FG001|Second Procedure|Withdrawal by Subject|2|||
126254521|NCT04542694|454222803|FG000|Overall Study|The need for prohibited therapy|2|||
126254522|NCT04542694|454222804|FG001|Overall Study|The need for prohibited therapy|0|||
126254523|NCT04542694|454222803|FG000|Overall Study|Adverse Event|1|||
126254524|NCT04542694|454222804|FG001|Overall Study|Adverse Event|0|||
126254525|NCT04542694|454222803|FG000|Overall Study|Protocol Violation|1|||
126254526|NCT04542694|454222804|FG001|Overall Study|Protocol Violation|0|||
126254527|NCT02167594|454222805|FG000|Overall Study|Withdrawal by Subject|2|||
126254528|NCT02167594|454222806|FG001|Overall Study|Withdrawal by Subject|0|||
126254529|NCT02167594|454222807|FG002|Overall Study|Withdrawal by Subject|0|||
126254530|NCT02167594|454222805|FG000|Overall Study|Death|0|||
126254531|NCT02167594|454222806|FG001|Overall Study|Death|1|||
126254532|NCT02167594|454222807|FG002|Overall Study|Death|0|||
126254533|NCT03433703|454222808|FG000|Overall Study|Study terminated by Sponsor|2|||
126254534|NCT01957150|454222809|FG000|Overall Study|Adverse Event|23|||
126254535|NCT01957150|454222810|FG001|Overall Study|Adverse Event|20|||
126254536|NCT01957150|454222809|FG000|Overall Study|Withdrawal by Subject|13|||
126546424|NCT03573908|455293801|FG001|Treatment Period|Withdrawal by Subject|5|||
126546425|NCT03573908|455293802|FG002|Treatment Period|Withdrawal by Subject|0|||
126546426|NCT03573908|455293803|FG003|Treatment Period|Withdrawal by Subject|0|||
126254537|NCT01957150|454222810|FG001|Overall Study|Withdrawal by Subject|17|||
126254538|NCT01957150|454222809|FG000|Overall Study|Physician Decision|3|||
126254539|NCT01957150|454222810|FG001|Overall Study|Physician Decision|6|||
126254540|NCT01957150|454222809|FG000|Overall Study|Lost to Follow-up|4|||
126254541|NCT01957150|454222810|FG001|Overall Study|Lost to Follow-up|4|||
126254542|NCT01957150|454222809|FG000|Overall Study|Protocol Violation|1|||
126254543|NCT01957150|454222810|FG001|Overall Study|Protocol Violation|0|||
126254544|NCT01957150|454222809|FG000|Overall Study|Lack of Efficacy|11|||
126254545|NCT01957150|454222810|FG001|Overall Study|Lack of Efficacy|11|||
126254546|NCT02786953|454222815|FG000|Overall Study|Withdrawal by Subject|3|||
126254547|NCT02786953|454222816|FG001|Overall Study|Withdrawal by Subject|0|||
126254548|NCT02786953|454222815|FG000|Overall Study|Physician Decision|0|||
126254549|NCT02786953|454222816|FG001|Overall Study|Physician Decision|1|||
126254550|NCT01745094|454222819|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
126254551|NCT01745094|454222820|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
126254552|NCT01745094|454222821|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
126254553|NCT01745094|454222822|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
126254554|NCT01745094|454222819|FG000|Overall Study|Adverse Event|0|||
126254555|NCT01745094|454222820|FG001|Overall Study|Adverse Event|0|||
126254556|NCT01745094|454222821|FG002|Overall Study|Adverse Event|3|||
126254557|NCT01745094|454222822|FG003|Overall Study|Adverse Event|0|||
126254558|NCT01745094|454222819|FG000|Overall Study|Withdrawal by Subject|2|||
126254559|NCT01745094|454222820|FG001|Overall Study|Withdrawal by Subject|0|||
126254560|NCT01745094|454222821|FG002|Overall Study|Withdrawal by Subject|1|||
126254561|NCT01745094|454222822|FG003|Overall Study|Withdrawal by Subject|2|||
126254562|NCT01745094|454222819|FG000|Overall Study|Protocol Violation|1|||
126254563|NCT01745094|454222820|FG001|Overall Study|Protocol Violation|0|||
126254564|NCT01745094|454222821|FG002|Overall Study|Protocol Violation|3|||
126254565|NCT01745094|454222822|FG003|Overall Study|Protocol Violation|1|||
126254566|NCT01745094|454222819|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
126254567|NCT01745094|454222820|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
126254568|NCT01745094|454222821|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
126254569|NCT01745094|454222822|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
126254570|NCT01745094|454222819|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
126254571|NCT01745094|454222820|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
126254572|NCT01745094|454222821|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
126254573|NCT01745094|454222822|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
126254574|NCT01745094|454222819|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
126254575|NCT01745094|454222820|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
126254576|NCT01745094|454222821|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
126254577|NCT01745094|454222822|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
126254578|NCT03414034|454222823|FG000|Overall Study|Adverse Event|6|||
126254579|NCT03414034|454222824|FG001|Overall Study|Adverse Event|1|||
126254580|NCT03414034|454222825|FG002|Overall Study|Adverse Event|1|||
126254581|NCT03414034|454222823|FG000|Overall Study|Death|0|||
126254582|NCT03414034|454222824|FG001|Overall Study|Death|0|||
126254583|NCT03414034|454222825|FG002|Overall Study|Death|1|||
126254584|NCT03414034|454222823|FG000|Overall Study|Non-compliance With Study Drug|0|||
126254585|NCT03414034|454222824|FG001|Overall Study|Non-compliance With Study Drug|0|||
126254586|NCT03414034|454222825|FG002|Overall Study|Non-compliance With Study Drug|1|||
126254587|NCT03414034|454222823|FG000|Overall Study|Physician Decision|1|||
126254588|NCT03414034|454222824|FG001|Overall Study|Physician Decision|3|||
126698508|NCT00977470|455847084|FG000|Overall Study|Protocol Violation|1|||
126698509|NCT00977470|455847085|FG001|Overall Study|Protocol Violation|0|||
126254589|NCT03414034|454222825|FG002|Overall Study|Physician Decision|2|||
126254590|NCT03414034|454222823|FG000|Overall Study|Withdrawal of Informed Consent|2|||
126254591|NCT03414034|454222824|FG001|Overall Study|Withdrawal of Informed Consent|1|||
126254592|NCT03414034|454222825|FG002|Overall Study|Withdrawal of Informed Consent|4|||
126254593|NCT03414034|454222823|FG000|Overall Study|Progressive Disease|15|||
126254594|NCT03414034|454222824|FG001|Overall Study|Progressive Disease|15|||
126254595|NCT03414034|454222825|FG002|Overall Study|Progressive Disease|17|||
126254596|NCT03414034|454222823|FG000|Overall Study|Miscellaneous|0|||
126254597|NCT03414034|454222824|FG001|Overall Study|Miscellaneous|0|||
126698510|NCT00977470|455847084|FG000|Overall Study|Withdrawal by Subject|0|||
126254598|NCT03414034|454222825|FG002|Overall Study|Miscellaneous|2|||
126254599|NCT04010227|454222827|FG000|Overall Study|Death|1|||
126254600|NCT04010227|454222828|FG001|Overall Study|Death|2|||
126254601|NCT04010227|454222827|FG000|Overall Study|Medical Reasons|4|||
126254602|NCT04010227|454222828|FG001|Overall Study|Medical Reasons|3|||
126254603|NCT04010227|454222827|FG000|Overall Study|Withdrawal by Subject|2|||
126254604|NCT04010227|454222828|FG001|Overall Study|Withdrawal by Subject|0|||
126254605|NCT04010227|454222827|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
126254606|NCT04010227|454222828|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
126254607|NCT00640926|454222829|FG000|Overall Study|Adverse Event|2|||
126254608|NCT00640926|454222830|FG001|Overall Study|Adverse Event|3|||
126254609|NCT00640926|454222831|FG002|Overall Study|Adverse Event|2|||
126254610|NCT00640926|454222829|FG000|Overall Study|Lack of Efficacy|0|||
126254611|NCT00640926|454222830|FG001|Overall Study|Lack of Efficacy|2|||
126254612|NCT00640926|454222831|FG002|Overall Study|Lack of Efficacy|1|||
126698511|NCT00977470|455847085|FG001|Overall Study|Withdrawal by Subject|2|||
126698512|NCT00977470|455847084|FG000|Overall Study|Death|0|||
126698513|NCT00977470|455847085|FG001|Overall Study|Death|2|||
126698514|NCT00977470|455847084|FG000|Overall Study|clinical decline|0|||
126698515|NCT00977470|455847085|FG001|Overall Study|clinical decline|1|||
126698516|NCT00977470|455847084|FG000|Overall Study|prolonged recovery post-surgery|0|||
126358279|NCT05660538|454603957|FG003|Overall Study|Death|0|||
126358280|NCT05660538|454603954|FG000|Overall Study|Physician Decision|0|||
126358281|NCT05660538|454603955|FG001|Overall Study|Physician Decision|0|||
126358282|NCT05660538|454603956|FG002|Overall Study|Physician Decision|0|||
126358283|NCT05660538|454603957|FG003|Overall Study|Physician Decision|1|||
126358284|NCT05660538|454603954|FG000|Overall Study|Sponsor Decision|1|||
126358285|NCT05660538|454603955|FG001|Overall Study|Sponsor Decision|0|||
126358286|NCT05660538|454603956|FG002|Overall Study|Sponsor Decision|0|||
126358287|NCT05660538|454603957|FG003|Overall Study|Sponsor Decision|0|||
126358288|NCT05660538|454603954|FG000|Overall Study|Other|1|||
126358289|NCT05660538|454603955|FG001|Overall Study|Other|0|||
126358290|NCT05660538|454603956|FG002|Overall Study|Other|0|||
126254613|NCT00640926|454222829|FG000|Overall Study|Protocol Violation|2|||
126254614|NCT00640926|454222830|FG001|Overall Study|Protocol Violation|0|||
126254615|NCT00640926|454222831|FG002|Overall Study|Protocol Violation|2|||
126254616|NCT00640926|454222829|FG000|Overall Study|Lost to Follow-up|3|||
126254617|NCT00640926|454222830|FG001|Overall Study|Lost to Follow-up|1|||
126254618|NCT00640926|454222831|FG002|Overall Study|Lost to Follow-up|2|||
126358291|NCT05660538|454603957|FG003|Overall Study|Other|1|||
126358292|NCT05660538|454603954|FG000|Overall Study|Randomized but did not receive study drug|1|||
126358293|NCT05660538|454603955|FG001|Overall Study|Randomized but did not receive study drug|0|||
126358294|NCT05660538|454603956|FG002|Overall Study|Randomized but did not receive study drug|0|||
126358295|NCT05660538|454603957|FG003|Overall Study|Randomized but did not receive study drug|1|||
126698517|NCT00977470|455847085|FG001|Overall Study|prolonged recovery post-surgery|1|||
126698518|NCT00977470|455847084|FG000|Overall Study|Still on-study|2|||
126698519|NCT00977470|455847085|FG001|Overall Study|Still on-study|0|||
126698520|NCT00737529|455847089|FG000|Overall Study|Disease Progression|95|||
126698521|NCT00737529|455847089|FG000|Overall Study|Adverse Event|24|||
126698522|NCT00737529|455847089|FG000|Overall Study|Withdrawal by Subject|5|||
126698523|NCT00737529|455847089|FG000|Overall Study|Death|4|||
126254619|NCT00640926|454222829|FG000|Overall Study|Withdrawal by Subject|1|||
126358296|NCT05660538|454603954|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
126698524|NCT00737529|455847089|FG000|Overall Study|Protocol Violation|1|||
126358297|NCT05660538|454603955|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
126358298|NCT05660538|454603956|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
126254620|NCT00640926|454222830|FG001|Overall Study|Withdrawal by Subject|0|||
126254621|NCT00640926|454222831|FG002|Overall Study|Withdrawal by Subject|1|||
126254622|NCT03922750|454222832|FG000|Overall Study|Unclassified|0|||
126254623|NCT03922750|454222833|FG001|Overall Study|Unclassified|0|||
126698525|NCT00737529|455847089|FG000|Overall Study|Other|4|||
126698526|NCT01173653|455847096|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
126698527|NCT01173653|455847097|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
126698528|NCT01412229|455847103|FG000|Overall Study|Physician Decision|1|||
126698529|NCT00151892|455847106|FG000|Overall Study|Lack of Efficacy|50|||
126698530|NCT00151892|455847107|FG001|Overall Study|Lack of Efficacy|57|||
126698531|NCT00151892|455847106|FG000|Overall Study|Patient request|10|||
126698532|NCT00151892|455847107|FG001|Overall Study|Patient request|7|||
126762834|NCT01463631|456082761|FG001|Overall Study|Withdrawal by Subject|0|||
126254624|NCT03922750|454222834|FG002|Overall Study|Unclassified|1|||
126254625|NCT03922750|454222832|FG000|Overall Study|Adverse Event|0|||
126254626|NCT03922750|454222833|FG001|Overall Study|Adverse Event|1|||
126254627|NCT03922750|454222834|FG002|Overall Study|Adverse Event|0|||
126254628|NCT02985398|454222835|FG000|Overall Study|Adverse Event|1|||
126254629|NCT02985398|454222835|FG000|Overall Study|Lost to Follow-up|4|||
126254630|NCT02985398|454222835|FG000|Overall Study|Withdrawal by Subject|8|||
126254631|NCT02985398|454222835|FG000|Overall Study|Study Burden|9|||
126254632|NCT01841073|454222836|FG000|Overall Study|Adverse Event|1|||
126762835|NCT01463631|456082762|FG002|Overall Study|Withdrawal by Subject|0|||
126254633|NCT01841073|454222837|FG001|Overall Study|Adverse Event|1|||
126762836|NCT01463631|456082763|FG003|Overall Study|Withdrawal by Subject|1|||
126358299|NCT05660538|454603957|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
126449324|NCT00531427|454945278|FG000|Overall Study|Administrative|4|||
126254634|NCT01841073|454222836|FG000|Overall Study|Physician Decision|1|||
126254635|NCT01841073|454222837|FG001|Overall Study|Physician Decision|0|||
126449325|NCT00531427|454945279|FG001|Overall Study|Administrative|9|||
126698533|NCT00151892|455847106|FG000|Overall Study|Lost to Follow-up|5|||
126698534|NCT00151892|455847107|FG001|Overall Study|Lost to Follow-up|10|||
126698535|NCT00151892|455847106|FG000|Overall Study|Adverse Event|6|||
126698536|NCT00151892|455847107|FG001|Overall Study|Adverse Event|3|||
126254636|NCT01841073|454222836|FG000|Overall Study|Lost to Follow-up|0|||
126254637|NCT01841073|454222837|FG001|Overall Study|Lost to Follow-up|2|||
126762837|NCT01463631|456082760|FG000|Overall Study|Death|0|||
126254638|NCT04164758|454222842|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
126254639|NCT04164758|454222843|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
126254640|NCT04164758|454222844|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
126254641|NCT04164758|454222842|FG000|Overall Study|Adverse Event|0|||
126254642|NCT04164758|454222843|FG001|Overall Study|Adverse Event|1|||
126254643|NCT04164758|454222844|FG002|Overall Study|Adverse Event|0|||
126254644|NCT02858037|454222845|FG000|Overall Study|Death|1|||
126254645|NCT02858037|454222845|FG000|Overall Study|Withdrawal by Subject|18|||
126254646|NCT02858037|454222845|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
126254647|NCT02858037|454222845|FG000|Overall Study|Lost to Follow-up|3|||
126254648|NCT02858037|454222845|FG000|Overall Study|Other|4|||
126254649|NCT01670097|454222848|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
126254650|NCT01670097|454222849|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
126254651|NCT01670097|454222848|FG000|Overall Study|Study burden|1|||
126254652|NCT01670097|454222849|FG001|Overall Study|Study burden|0|||
126254653|NCT01670097|454222848|FG000|Overall Study|COPD exacerbation|0|||
126254654|NCT01670097|454222849|FG001|Overall Study|COPD exacerbation|1|||
126254655|NCT01670097|454222848|FG000|Overall Study|Neutropenia|0|||
126254656|NCT01670097|454222849|FG001|Overall Study|Neutropenia|1|||
126254657|NCT01670097|454222848|FG000|Overall Study|Clinical deterioration|0|||
126254658|NCT01670097|454222849|FG001|Overall Study|Clinical deterioration|1|||
126254659|NCT01670097|454222848|FG000|Overall Study|Disease progression|0|||
126254660|NCT01670097|454222849|FG001|Overall Study|Disease progression|1|||
126254661|NCT00697827|454222850|FG000|Overall Study|enrolled but not treated|2|||
126254662|NCT00697827|454222851|FG001|Overall Study|enrolled but not treated|1|||
126254663|NCT03732833|454222852|FG000|Overall Study|Adverse Event|0|||
126254664|NCT03732833|454222853|FG001|Overall Study|Adverse Event|3|||
126254665|NCT03732833|454222854|FG002|Overall Study|Adverse Event|1|||
126254666|NCT03732833|454222852|FG000|Overall Study|Withdrawal by Subject|11|||
126254667|NCT03732833|454222853|FG001|Overall Study|Withdrawal by Subject|13|||
126254668|NCT03732833|454222854|FG002|Overall Study|Withdrawal by Subject|8|||
126254669|NCT03732833|454222852|FG000|Overall Study|Lost to Follow-up|3|||
126254670|NCT03732833|454222853|FG001|Overall Study|Lost to Follow-up|5|||
126254671|NCT03732833|454222854|FG002|Overall Study|Lost to Follow-up|4|||
126254672|NCT03732833|454222852|FG000|Overall Study|Pregnancy|0|||
126254673|NCT03732833|454222853|FG001|Overall Study|Pregnancy|2|||
126254674|NCT03732833|454222854|FG002|Overall Study|Pregnancy|0|||
126254675|NCT03732833|454222852|FG000|Overall Study|Physician Decision|2|||
126254676|NCT03732833|454222853|FG001|Overall Study|Physician Decision|3|||
126254677|NCT03732833|454222854|FG002|Overall Study|Physician Decision|1|||
126254678|NCT03732833|454222852|FG000|Overall Study|Covid-19 related and other reasons|2|||
126254679|NCT03732833|454222853|FG001|Overall Study|Covid-19 related and other reasons|7|||
126254680|NCT03732833|454222854|FG002|Overall Study|Covid-19 related and other reasons|3|||
126254681|NCT02311894|454222856|FG000|Overall Study|Discontinued in error|1|||
126254682|NCT02311894|454222856|FG000|Overall Study|Lost to Follow-up|1|||
126254683|NCT02311894|454222856|FG000|Overall Study|Adverse Event|1|||
126254684|NCT02311894|454222856|FG000|Overall Study|Withdrawal by Subject|1|||
126254685|NCT00702507|454222859|FG000|Initial Treatment Phase|Adverse Event|2|||
126254686|NCT00702507|454222859|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
126254687|NCT00702507|454222859|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
126254688|NCT00702507|454222859|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
126254689|NCT00702507|454222859|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
126254690|NCT00702507|454222859|FG000|Follow-up Phase|Protocol Violation|2|||
126254691|NCT00702507|454222859|FG000|Follow-up Phase|Lost to Follow-up|23|||
126254692|NCT00702507|454222859|FG000|Follow-up Phase|Late Enrollment|1|||
126254693|NCT00160524|454222860|FG000|Overall Study|Adverse Event|119|||
126254694|NCT00160524|454222860|FG000|Overall Study|Adverse Event and Other|94|||
126254695|NCT00160524|454222860|FG000|Overall Study|Protocol Violation|16|||
126254696|NCT00160524|454222860|FG000|Overall Study|Protocol Violation and Other|2|||
126254697|NCT00160524|454222860|FG000|Overall Study|Withdrawal by Subject|141|||
126254698|NCT00160524|454222860|FG000|Overall Study|Withdrawal by Subject and Other|17|||
126546427|NCT03573908|455293804|FG004|Treatment Period|Withdrawal by Subject|0|||
126698537|NCT00151892|455847106|FG000|Overall Study|Protocol Violation|3|||
126698538|NCT00151892|455847107|FG001|Overall Study|Protocol Violation|3|||
126698539|NCT00151892|455847106|FG000|Overall Study|Non-compliance|0|||
126698540|NCT00151892|455847107|FG001|Overall Study|Non-compliance|1|||
126698541|NCT00151892|455847106|FG000|Overall Study|Pregnancy|0|||
126254699|NCT00160524|454222860|FG000|Overall Study|Physician Decision|27|||
126254700|NCT00160524|454222860|FG000|Overall Study|Physician Decision and Other|6|||
126254701|NCT00160524|454222860|FG000|Overall Study|Lost to Follow-up|13|||
126254702|NCT00160524|454222860|FG000|Overall Study|Lost to Follow-up and Other|1|||
126254703|NCT00160524|454222860|FG000|Overall Study|Lack of Efficacy|21|||
126254704|NCT00160524|454222860|FG000|Overall Study|Lack of Efficacy and Other|1|||
126254705|NCT00160524|454222860|FG000|Overall Study|Other|20|||
126254706|NCT02661022|454222861|FG000|Overall Study|Withdrawal by Subject|3|||
126254707|NCT02661022|454222862|FG001|Overall Study|Withdrawal by Subject|0|||
126254708|NCT02661022|454222861|FG000|Overall Study|Adverse Event|1|||
126698542|NCT00151892|455847107|FG001|Overall Study|Pregnancy|1|||
126254709|NCT02661022|454222862|FG001|Overall Study|Adverse Event|1|||
126254710|NCT02661022|454222861|FG000|Overall Study|Physician Decision|1|||
126254711|NCT02661022|454222862|FG001|Overall Study|Physician Decision|0|||
126254712|NCT02661022|454222861|FG000|Overall Study|Progressive Disease|2|||
126254713|NCT02661022|454222862|FG001|Overall Study|Progressive Disease|1|||
126254714|NCT02387762|454222866|FG000|Overall Study|Withdrawal by Subject|1|||
126254715|NCT02387762|454222867|FG001|Overall Study|Withdrawal by Subject|0|||
126254716|NCT04553406|454222871|FG000|Overall Study|Study Discontinuation|0|||
126254717|NCT04553406|454222872|FG001|Overall Study|Study Discontinuation|1|||
126254718|NCT00772148|454222873|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
126254719|NCT00772148|454222874|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
126254720|NCT00772148|454222873|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
126254721|NCT00772148|454222874|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
126254722|NCT00772148|454222873|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
126254723|NCT00772148|454222874|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
126254724|NCT00772148|454222873|FG000|Maintenance Phase (Week 52)|Death|2|||
126254725|NCT00772148|454222874|FG001|Maintenance Phase (Week 52)|Death|2|||
126254726|NCT00772148|454222873|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
126254727|NCT00772148|454222874|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
126254728|NCT00772148|454222873|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
126254729|NCT00772148|454222874|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
126254730|NCT00772148|454222873|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
126254731|NCT00772148|454222874|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
126254732|NCT00633022|454222877|FG000|Overall Study|Adverse Event|1|||
126254733|NCT00633022|454222878|FG001|Overall Study|Adverse Event|0|||
126254734|NCT00633022|454222879|FG002|Overall Study|Adverse Event|5|||
126254735|NCT00633022|454222877|FG000|Overall Study|Physician Decision|0|||
126254736|NCT00633022|454222878|FG001|Overall Study|Physician Decision|1|||
126254737|NCT00633022|454222879|FG002|Overall Study|Physician Decision|0|||
126254738|NCT03573336|454222880|FG000|Overall Study|Study terminated|2|||
126254739|NCT03573336|454222881|FG001|Overall Study|Study terminated|4|||
126254740|NCT03573336|454222882|FG002|Overall Study|Study terminated|2|||
126254741|NCT04388787|454222883|FG000|Blinded Period|Patient could not follow instructions|1|||
126254742|NCT04388787|454222883|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
126254743|NCT01705717|454224401|FG000|Overall Study|Adverse Event|2|||
126254744|NCT01705717|454224402|FG001|Overall Study|Adverse Event|2|||
126254745|NCT01705717|454224401|FG000|Overall Study|Lack of Efficacy|0|||
126254746|NCT01705717|454224402|FG001|Overall Study|Lack of Efficacy|1|||
126254747|NCT01705717|454224401|FG000|Overall Study|Other|0|||
126254748|NCT01705717|454224402|FG001|Overall Study|Other|2|||
126254749|NCT01662024|454224405|FG000|Overall Study|Pregnancy|2|||
126254750|NCT01662024|454224405|FG000|Overall Study|Withdrawal by Subject|3|||
126254751|NCT04980456|454224406|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
126254752|NCT04980456|454224407|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
126254753|NCT04980456|454224406|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
126254754|NCT04980456|454224407|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
126254755|NCT04980456|454224406|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
126254756|NCT04980456|454224407|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
126254757|NCT04980456|454224406|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
126254758|NCT04980456|454224407|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
126254759|NCT04832971|454224408|FG000|Overall Study|Death|1|||
126254760|NCT04832971|454224409|FG001|Overall Study|Death|0|||
126254761|NCT04832971|454224410|FG002|Overall Study|Death|0|||
126254762|NCT04832971|454224411|FG003|Overall Study|Death|0|||
126358300|NCT03462563|454603958|FG000|Overall Study|Death|1|||
126358301|NCT03462563|454603959|FG001|Overall Study|Death|1|||
126358302|NCT03462563|454603958|FG000|Overall Study|Termination of study|2|||
126546428|NCT03573908|455293800|FG000|Treatment Period|Lost to Follow-up|7|||
126546429|NCT03573908|455293801|FG001|Treatment Period|Lost to Follow-up|6|||
126698543|NCT00151892|455847106|FG000|Overall Study|Did not return for a visit|1|||
126698544|NCT00151892|455847107|FG001|Overall Study|Did not return for a visit|0|||
126698545|NCT00151892|455847106|FG000|Overall Study|Used prohibited corticosteroids|1|||
126254763|NCT04832971|454224408|FG000|Overall Study|Lost to Follow-up|1|||
126254764|NCT04832971|454224409|FG001|Overall Study|Lost to Follow-up|1|||
126254765|NCT04832971|454224410|FG002|Overall Study|Lost to Follow-up|1|||
126254766|NCT04832971|454224411|FG003|Overall Study|Lost to Follow-up|0|||
126254767|NCT04832971|454224408|FG000|Overall Study|Withdrawal by Subject|1|||
126254768|NCT04832971|454224409|FG001|Overall Study|Withdrawal by Subject|3|||
126254769|NCT04832971|454224410|FG002|Overall Study|Withdrawal by Subject|2|||
126254770|NCT04832971|454224411|FG003|Overall Study|Withdrawal by Subject|2|||
126254771|NCT04832971|454224408|FG000|Overall Study|Other, Not Specified|0|||
126254772|NCT04832971|454224409|FG001|Overall Study|Other, Not Specified|0|||
126254773|NCT04832971|454224410|FG002|Overall Study|Other, Not Specified|1|||
126254774|NCT04832971|454224411|FG003|Overall Study|Other, Not Specified|0|||
126358303|NCT03462563|454603959|FG001|Overall Study|Termination of study|1|||
126358304|NCT03462563|454603958|FG000|Overall Study|Adverse Event|1|||
126762838|NCT01463631|456082761|FG001|Overall Study|Death|0|||
126762839|NCT01463631|456082762|FG002|Overall Study|Death|1|||
126762840|NCT01463631|456082763|FG003|Overall Study|Death|0|||
126358305|NCT03462563|454603959|FG001|Overall Study|Adverse Event|3|||
126358306|NCT03462563|454603958|FG000|Overall Study|Unspecified reason|10|||
126358307|NCT03462563|454603959|FG001|Overall Study|Unspecified reason|12|||
126358308|NCT03462563|454603958|FG000|Overall Study|Physician Decision|1|||
126762841|NCT01463631|456082760|FG000|Overall Study|Progressive Disease|0|||
126762842|NCT01463631|456082761|FG001|Overall Study|Progressive Disease|0|||
126762843|NCT01463631|456082762|FG002|Overall Study|Progressive Disease|0|||
126762844|NCT01463631|456082763|FG003|Overall Study|Progressive Disease|5|||
126762845|NCT05966129|456082765|FG000|Overall Study|Death|1|||
126762846|NCT05966129|456082766|FG001|Overall Study|Death|2|||
126762847|NCT05966129|456082765|FG000|Overall Study|Lost to Follow-up|63|||
126762848|NCT05966129|456082766|FG001|Overall Study|Lost to Follow-up|66|||
126762849|NCT05966129|456082765|FG000|Overall Study|Protocol Violation|1|||
126762850|NCT05966129|456082766|FG001|Overall Study|Protocol Violation|0|||
126254775|NCT03687242|454224416|FG000|Overall Study|Adverse Event|1|||
126254776|NCT02943993|454224436|FG000|Overall Study|Withdrawal by Subject|52|||
126254777|NCT02943993|454224436|FG000|Overall Study|Transfer to another institution|6|||
126254778|NCT02943993|454224436|FG000|Overall Study|Lost to Follow-up|135|||
126254779|NCT02943993|454224436|FG000|Overall Study|Death|98|||
126254780|NCT02943993|454224436|FG000|Overall Study|Other reason for premature termination|32|||
126254781|NCT02943993|454224436|FG000|Overall Study|Missing reason for termination|7|||
126254782|NCT02754492|454224440|FG000|Overall Study|Protocol Violation|2|||
126254783|NCT02754492|454224441|FG001|Overall Study|Protocol Violation|2|||
126762851|NCT05966129|456082765|FG000|Overall Study|Withdrawal by Subject|26|||
126254784|NCT02754492|454224442|FG002|Overall Study|Protocol Violation|0|||
126254785|NCT02754492|454224443|FG003|Overall Study|Protocol Violation|1|||
126254786|NCT02754492|454224440|FG000|Overall Study|Withdrawal by Subject|2|||
126358309|NCT03462563|454603959|FG001|Overall Study|Physician Decision|0|||
126358310|NCT05103332|454603960|FG000|Overall Study|Lost to Follow-up|0|||
126358311|NCT05103332|454603961|FG001|Overall Study|Lost to Follow-up|2|||
126254787|NCT02754492|454224441|FG001|Overall Study|Withdrawal by Subject|0|||
126254788|NCT02754492|454224442|FG002|Overall Study|Withdrawal by Subject|0|||
126254789|NCT02754492|454224443|FG003|Overall Study|Withdrawal by Subject|0|||
126254790|NCT02754492|454224440|FG000|Overall Study|Equipment malfuntion|0|||
126254791|NCT02754492|454224441|FG001|Overall Study|Equipment malfuntion|0|||
126254792|NCT02754492|454224442|FG002|Overall Study|Equipment malfuntion|2|||
126254793|NCT02754492|454224443|FG003|Overall Study|Equipment malfuntion|5|||
126254794|NCT02754492|454224440|FG000|Overall Study|Adverse Event|0|||
126254795|NCT02754492|454224441|FG001|Overall Study|Adverse Event|0|||
126254796|NCT02754492|454224442|FG002|Overall Study|Adverse Event|0|||
126254797|NCT02754492|454224443|FG003|Overall Study|Adverse Event|13|||
126358312|NCT05103332|454603962|FG002|Overall Study|Lost to Follow-up|1|||
126358313|NCT05103332|454603963|FG003|Overall Study|Lost to Follow-up|0|||
126254798|NCT02754492|454224440|FG000|Overall Study|Venous access issues not resulting in AE|0|||
126254799|NCT02754492|454224441|FG001|Overall Study|Venous access issues not resulting in AE|0|||
126254800|NCT02754492|454224442|FG002|Overall Study|Venous access issues not resulting in AE|0|||
126254801|NCT02754492|454224443|FG003|Overall Study|Venous access issues not resulting in AE|4|||
126254802|NCT00969124|454224451|FG000|Overall Study|Protocol Violation|2|||
126254803|NCT00969124|454224451|FG000|Overall Study|Inadequate bowel preparation|15|||
126254804|NCT00969124|454224451|FG000|Overall Study|Inability to reach cecum|9|||
126254805|NCT00969124|454224451|FG000|Overall Study|Previously unrecognized disease|3|||
126254806|NCT00969124|454224451|FG000|Overall Study|Technical error|1|||
126254807|NCT00252564|454224452|FG000|Overall Study|Adverse Event|17|||
126254808|NCT00252564|454224453|FG001|Overall Study|Adverse Event|13|||
126254809|NCT00252564|454224452|FG000|Overall Study|Unrelated Complication|2|||
126254810|NCT00252564|454224453|FG001|Overall Study|Unrelated Complication|1|||
126254811|NCT00252564|454224452|FG000|Overall Study|Disease Progression|14|||
126254812|NCT00252564|454224453|FG001|Overall Study|Disease Progression|20|||
126254813|NCT00252564|454224452|FG000|Overall Study|Death|0|||
126254814|NCT00252564|454224453|FG001|Overall Study|Death|3|||
126254815|NCT00252564|454224452|FG000|Overall Study|Physician Decision|1|||
126254816|NCT00252564|454224453|FG001|Overall Study|Physician Decision|0|||
126254817|NCT00252564|454224452|FG000|Overall Study|Lost to Follow-up|1|||
126762852|NCT05966129|456082766|FG001|Overall Study|Withdrawal by Subject|25|||
126254818|NCT00252564|454224453|FG001|Overall Study|Lost to Follow-up|0|||
126254819|NCT00252564|454224452|FG000|Overall Study|Patient Request|4|||
126254820|NCT00252564|454224453|FG001|Overall Study|Patient Request|5|||
126254821|NCT00252564|454224452|FG000|Overall Study|Withdrawal by Subject|0|||
126254822|NCT00252564|454224453|FG001|Overall Study|Withdrawal by Subject|2|||
126254823|NCT04561115|454224455|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
126358314|NCT05103332|454603964|FG004|Overall Study|Lost to Follow-up|0|||
126358315|NCT05103332|454603965|FG005|Overall Study|Lost to Follow-up|2|||
126358316|NCT05103332|454603960|FG000|Overall Study|Physician Decision|0|||
126762853|NCT05966129|456082765|FG000|Overall Study|Surgery not completed|63|||
126762854|NCT05966129|456082766|FG001|Overall Study|Surgery not completed|69|||
126254824|NCT04561115|454224456|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
126254825|NCT04561115|454224455|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
126254826|NCT04561115|454224456|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
126254827|NCT04561115|454224455|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
126254828|NCT04561115|454224456|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
126254829|NCT00743145|454224457|FG000|Overall Study|Withdrawal by Subject|1|||
126254830|NCT00743145|454224457|FG000|Overall Study|Adverse Event|2|||
126254831|NCT00743145|454224457|FG000|Overall Study|Pregnancy|1|||
126254832|NCT01583530|454224458|FG000|Overall Study|Adverse Event|0|||
126254833|NCT01583530|454224459|FG001|Overall Study|Adverse Event|0|||
126254834|NCT01583530|454224460|FG002|Overall Study|Adverse Event|0|||
126254835|NCT01583530|454224461|FG003|Overall Study|Adverse Event|0|||
126254836|NCT01583530|454224462|FG004|Overall Study|Adverse Event|0|||
126254837|NCT01583530|454224463|FG005|Overall Study|Adverse Event|1|||
126254838|NCT01583530|454224458|FG000|Overall Study|Withdrawal by Subject|0|||
126254839|NCT01583530|454224459|FG001|Overall Study|Withdrawal by Subject|3|||
126254840|NCT01583530|454224460|FG002|Overall Study|Withdrawal by Subject|0|||
126254841|NCT01583530|454224461|FG003|Overall Study|Withdrawal by Subject|1|||
126254842|NCT01583530|454224462|FG004|Overall Study|Withdrawal by Subject|1|||
126254843|NCT01583530|454224463|FG005|Overall Study|Withdrawal by Subject|2|||
126254844|NCT01583530|454224458|FG000|Overall Study|Lost to Follow-up|0|||
126254845|NCT01583530|454224459|FG001|Overall Study|Lost to Follow-up|0|||
126254846|NCT01583530|454224460|FG002|Overall Study|Lost to Follow-up|0|||
126254847|NCT01583530|454224461|FG003|Overall Study|Lost to Follow-up|0|||
126254848|NCT01583530|454224462|FG004|Overall Study|Lost to Follow-up|3|||
126254849|NCT01583530|454224463|FG005|Overall Study|Lost to Follow-up|0|||
126254850|NCT01583530|454224458|FG000|Overall Study|Lack of compliance|0|||
126254851|NCT01583530|454224459|FG001|Overall Study|Lack of compliance|0|||
126254852|NCT01583530|454224460|FG002|Overall Study|Lack of compliance|0|||
126254853|NCT01583530|454224461|FG003|Overall Study|Lack of compliance|0|||
126254854|NCT01583530|454224462|FG004|Overall Study|Lack of compliance|1|||
126254855|NCT01583530|454224463|FG005|Overall Study|Lack of compliance|0|||
126254856|NCT02416180|454224464|FG000|Overall Study|Withdrawal by Subject|1|||
126254857|NCT01332968|454224469|FG000|Induction Period|Adverse Event|23|||
126254858|NCT01332968|454224470|FG001|Induction Period|Adverse Event|26|||
126254859|NCT01332968|454224471|FG002|Induction Period|Adverse Event|0|||
126254860|NCT01332968|454224472|FG003|Induction Period|Adverse Event|0|||
126254861|NCT01332968|454224473|FG004|Induction Period|Adverse Event|0|||
126254862|NCT01332968|454224474|FG005|Induction Period|Adverse Event|0|||
126254863|NCT01332968|454224475|FG006|Induction Period|Adverse Event|0|||
126254864|NCT01332968|454224476|FG007|Induction Period|Adverse Event|0|||
126254865|NCT01332968|454224469|FG000|Induction Period|Death|1|||
126254866|NCT01332968|454224470|FG001|Induction Period|Death|4|||
126254867|NCT01332968|454224471|FG002|Induction Period|Death|0|||
126254868|NCT01332968|454224472|FG003|Induction Period|Death|0|||
126254869|NCT01332968|454224473|FG004|Induction Period|Death|0|||
126254870|NCT01332968|454224474|FG005|Induction Period|Death|0|||
126254871|NCT01332968|454224475|FG006|Induction Period|Death|0|||
126254872|NCT01332968|454224476|FG007|Induction Period|Death|0|||
126254873|NCT01332968|454224469|FG000|Induction Period|Non-compliance|1|||
126254874|NCT01332968|454224470|FG001|Induction Period|Non-compliance|0|||
126254875|NCT01332968|454224471|FG002|Induction Period|Non-compliance|0|||
126254876|NCT01332968|454224472|FG003|Induction Period|Non-compliance|0|||
126254877|NCT01332968|454224473|FG004|Induction Period|Non-compliance|0|||
126254878|NCT01332968|454224474|FG005|Induction Period|Non-compliance|0|||
126254879|NCT01332968|454224475|FG006|Induction Period|Non-compliance|0|||
126254880|NCT01332968|454224476|FG007|Induction Period|Non-compliance|0|||
126254881|NCT01332968|454224469|FG000|Induction Period|Other|2|||
126254882|NCT01332968|454224470|FG001|Induction Period|Other|2|||
126254883|NCT01332968|454224471|FG002|Induction Period|Other|0|||
126254884|NCT01332968|454224472|FG003|Induction Period|Other|0|||
126254885|NCT01332968|454224473|FG004|Induction Period|Other|0|||
126254886|NCT01332968|454224474|FG005|Induction Period|Other|0|||
126254887|NCT01332968|454224475|FG006|Induction Period|Other|0|||
126254888|NCT01332968|454224476|FG007|Induction Period|Other|0|||
126254889|NCT01332968|454224469|FG000|Induction Period|Physician Decision|6|||
126254890|NCT01332968|454224470|FG001|Induction Period|Physician Decision|1|||
126254891|NCT01332968|454224471|FG002|Induction Period|Physician Decision|0|||
126254892|NCT01332968|454224472|FG003|Induction Period|Physician Decision|0|||
126254893|NCT01332968|454224473|FG004|Induction Period|Physician Decision|0|||
126254894|NCT01332968|454224474|FG005|Induction Period|Physician Decision|0|||
126254895|NCT01332968|454224475|FG006|Induction Period|Physician Decision|0|||
126254896|NCT01332968|454224476|FG007|Induction Period|Physician Decision|0|||
126254897|NCT01332968|454224469|FG000|Induction Period|Progressive Disease|15|||
126254898|NCT01332968|454224470|FG001|Induction Period|Progressive Disease|7|||
126254899|NCT01332968|454224471|FG002|Induction Period|Progressive Disease|0|||
126358317|NCT05103332|454603961|FG001|Overall Study|Physician Decision|1|||
126254900|NCT01332968|454224472|FG003|Induction Period|Progressive Disease|0|||
126254901|NCT01332968|454224473|FG004|Induction Period|Progressive Disease|0|||
126254902|NCT01332968|454224474|FG005|Induction Period|Progressive Disease|0|||
126254903|NCT01332968|454224475|FG006|Induction Period|Progressive Disease|0|||
126254904|NCT01332968|454224476|FG007|Induction Period|Progressive Disease|0|||
126254905|NCT01332968|454224469|FG000|Induction Period|Protocol Violation|3|||
126254906|NCT01332968|454224470|FG001|Induction Period|Protocol Violation|4|||
126254907|NCT01332968|454224471|FG002|Induction Period|Protocol Violation|0|||
126254908|NCT01332968|454224472|FG003|Induction Period|Protocol Violation|0|||
126254909|NCT01332968|454224473|FG004|Induction Period|Protocol Violation|0|||
126254910|NCT01332968|454224474|FG005|Induction Period|Protocol Violation|0|||
126254911|NCT01332968|454224475|FG006|Induction Period|Protocol Violation|0|||
126254912|NCT01332968|454224476|FG007|Induction Period|Protocol Violation|0|||
126254913|NCT01332968|454224469|FG000|Induction Period|Withdrawal by Subject|3|||
126254914|NCT01332968|454224470|FG001|Induction Period|Withdrawal by Subject|5|||
126254915|NCT01332968|454224471|FG002|Induction Period|Withdrawal by Subject|0|||
126254916|NCT01332968|454224472|FG003|Induction Period|Withdrawal by Subject|0|||
126254917|NCT01332968|454224473|FG004|Induction Period|Withdrawal by Subject|0|||
126254918|NCT01332968|454224474|FG005|Induction Period|Withdrawal by Subject|0|||
126254919|NCT01332968|454224475|FG006|Induction Period|Withdrawal by Subject|0|||
126254920|NCT01332968|454224476|FG007|Induction Period|Withdrawal by Subject|0|||
126254921|NCT01332968|454224469|FG000|Induction Period|Randomised but not treated|4|||
126254922|NCT01332968|454224470|FG001|Induction Period|Randomised but not treated|7|||
126254923|NCT01332968|454224471|FG002|Induction Period|Randomised but not treated|0|||
126254924|NCT01332968|454224472|FG003|Induction Period|Randomised but not treated|0|||
126254925|NCT01332968|454224473|FG004|Induction Period|Randomised but not treated|0|||
126254926|NCT01332968|454224474|FG005|Induction Period|Randomised but not treated|0|||
126254927|NCT01332968|454224475|FG006|Induction Period|Randomised but not treated|0|||
126254928|NCT01332968|454224476|FG007|Induction Period|Randomised but not treated|0|||
126254929|NCT01332968|454224469|FG000|Maintenance/Observation Period|Adverse Event|0|||
126254930|NCT01332968|454224470|FG001|Maintenance/Observation Period|Adverse Event|0|||
126254931|NCT01332968|454224471|FG002|Maintenance/Observation Period|Adverse Event|53|||
126254932|NCT01332968|454224472|FG003|Maintenance/Observation Period|Adverse Event|66|||
126254933|NCT01332968|454224473|FG004|Maintenance/Observation Period|Adverse Event|0|||
126254934|NCT01332968|454224474|FG005|Maintenance/Observation Period|Adverse Event|0|||
126254935|NCT01332968|454224475|FG006|Maintenance/Observation Period|Adverse Event|0|||
126254936|NCT01332968|454224476|FG007|Maintenance/Observation Period|Adverse Event|0|||
126254937|NCT01332968|454224469|FG000|Maintenance/Observation Period|Death|0|||
126254938|NCT01332968|454224470|FG001|Maintenance/Observation Period|Death|0|||
126254939|NCT01332968|454224471|FG002|Maintenance/Observation Period|Death|5|||
126254940|NCT01332968|454224472|FG003|Maintenance/Observation Period|Death|6|||
126254941|NCT01332968|454224473|FG004|Maintenance/Observation Period|Death|0|||
126254942|NCT01332968|454224474|FG005|Maintenance/Observation Period|Death|0|||
126254943|NCT01332968|454224475|FG006|Maintenance/Observation Period|Death|0|||
126254944|NCT01332968|454224476|FG007|Maintenance/Observation Period|Death|0|||
126254945|NCT01332968|454224469|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
126254946|NCT01332968|454224470|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
126254947|NCT01332968|454224471|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
126254948|NCT01332968|454224472|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
126254949|NCT01332968|454224473|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
126254950|NCT01332968|454224474|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
126254951|NCT01332968|454224475|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
126254952|NCT01332968|454224476|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
126254953|NCT01332968|454224469|FG000|Maintenance/Observation Period|Non-compliance|0|||
126254954|NCT01332968|454224470|FG001|Maintenance/Observation Period|Non-compliance|0|||
126254955|NCT01332968|454224471|FG002|Maintenance/Observation Period|Non-compliance|4|||
126254956|NCT01332968|454224472|FG003|Maintenance/Observation Period|Non-compliance|3|||
126254957|NCT01332968|454224473|FG004|Maintenance/Observation Period|Non-compliance|0|||
126254958|NCT01332968|454224474|FG005|Maintenance/Observation Period|Non-compliance|0|||
126254959|NCT01332968|454224475|FG006|Maintenance/Observation Period|Non-compliance|0|||
126254960|NCT01332968|454224476|FG007|Maintenance/Observation Period|Non-compliance|0|||
126254961|NCT01332968|454224469|FG000|Maintenance/Observation Period|Other|0|||
126254962|NCT01332968|454224470|FG001|Maintenance/Observation Period|Other|0|||
126254963|NCT01332968|454224471|FG002|Maintenance/Observation Period|Other|4|||
126254964|NCT01332968|454224472|FG003|Maintenance/Observation Period|Other|7|||
126254965|NCT01332968|454224473|FG004|Maintenance/Observation Period|Other|0|||
126254966|NCT01332968|454224474|FG005|Maintenance/Observation Period|Other|0|||
126254967|NCT01332968|454224475|FG006|Maintenance/Observation Period|Other|0|||
126254968|NCT01332968|454224476|FG007|Maintenance/Observation Period|Other|0|||
126254969|NCT01332968|454224469|FG000|Maintenance/Observation Period|Physician Decision|0|||
126254970|NCT01332968|454224470|FG001|Maintenance/Observation Period|Physician Decision|0|||
126254971|NCT01332968|454224471|FG002|Maintenance/Observation Period|Physician Decision|14|||
126358318|NCT05103332|454603962|FG002|Overall Study|Physician Decision|0|||
126254972|NCT01332968|454224472|FG003|Maintenance/Observation Period|Physician Decision|19|||
126254973|NCT01332968|454224473|FG004|Maintenance/Observation Period|Physician Decision|0|||
126254974|NCT01332968|454224474|FG005|Maintenance/Observation Period|Physician Decision|1|||
126254975|NCT01332968|454224475|FG006|Maintenance/Observation Period|Physician Decision|0|||
126254976|NCT01332968|454224476|FG007|Maintenance/Observation Period|Physician Decision|0|||
126254977|NCT01332968|454224469|FG000|Maintenance/Observation Period|Progressive Disease|0|||
126254978|NCT01332968|454224470|FG001|Maintenance/Observation Period|Progressive Disease|0|||
126254979|NCT01332968|454224471|FG002|Maintenance/Observation Period|Progressive Disease|72|||
126254980|NCT01332968|454224472|FG003|Maintenance/Observation Period|Progressive Disease|40|||
126254981|NCT01332968|454224473|FG004|Maintenance/Observation Period|Progressive Disease|0|||
126254982|NCT01332968|454224474|FG005|Maintenance/Observation Period|Progressive Disease|0|||
126254983|NCT01332968|454224475|FG006|Maintenance/Observation Period|Progressive Disease|0|||
126254984|NCT01332968|454224476|FG007|Maintenance/Observation Period|Progressive Disease|0|||
126254985|NCT01332968|454224469|FG000|Maintenance/Observation Period|Protocol Violation|0|||
126254986|NCT01332968|454224470|FG001|Maintenance/Observation Period|Protocol Violation|0|||
126254987|NCT01332968|454224471|FG002|Maintenance/Observation Period|Protocol Violation|1|||
126254988|NCT01332968|454224472|FG003|Maintenance/Observation Period|Protocol Violation|1|||
126254989|NCT01332968|454224473|FG004|Maintenance/Observation Period|Protocol Violation|0|||
126254990|NCT01332968|454224474|FG005|Maintenance/Observation Period|Protocol Violation|0|||
126254991|NCT01332968|454224475|FG006|Maintenance/Observation Period|Protocol Violation|0|||
126254992|NCT01332968|454224476|FG007|Maintenance/Observation Period|Protocol Violation|0|||
126254993|NCT01332968|454224469|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
126254994|NCT01332968|454224470|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
126254995|NCT01332968|454224471|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
126254996|NCT01332968|454224472|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
126254997|NCT01332968|454224473|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
126254998|NCT01332968|454224474|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
126254999|NCT01332968|454224475|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
126255000|NCT01332968|454224476|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
126255001|NCT01332968|454224469|FG000|Follow-Up Period|Adverse Event|0|||
126255002|NCT01332968|454224470|FG001|Follow-Up Period|Adverse Event|0|||
126255003|NCT01332968|454224471|FG002|Follow-Up Period|Adverse Event|0|||
126255004|NCT01332968|454224472|FG003|Follow-Up Period|Adverse Event|0|||
126255005|NCT01332968|454224473|FG004|Follow-Up Period|Adverse Event|0|||
126255006|NCT01332968|454224474|FG005|Follow-Up Period|Adverse Event|0|||
126255007|NCT01332968|454224475|FG006|Follow-Up Period|Adverse Event|0|||
126255008|NCT01332968|454224476|FG007|Follow-Up Period|Adverse Event|4|||
126255009|NCT01332968|454224469|FG000|Follow-Up Period|Death|0|||
126255010|NCT01332968|454224470|FG001|Follow-Up Period|Death|0|||
126255011|NCT01332968|454224471|FG002|Follow-Up Period|Death|0|||
126255012|NCT01332968|454224472|FG003|Follow-Up Period|Death|0|||
126255013|NCT01332968|454224473|FG004|Follow-Up Period|Death|0|||
126255014|NCT01332968|454224474|FG005|Follow-Up Period|Death|0|||
126255015|NCT01332968|454224475|FG006|Follow-Up Period|Death|27|||
126255016|NCT01332968|454224476|FG007|Follow-Up Period|Death|30|||
126255017|NCT01332968|454224469|FG000|Follow-Up Period|Lost to Follow-up|0|||
126255018|NCT01332968|454224470|FG001|Follow-Up Period|Lost to Follow-up|0|||
126255019|NCT01332968|454224471|FG002|Follow-Up Period|Lost to Follow-up|0|||
126255020|NCT01332968|454224472|FG003|Follow-Up Period|Lost to Follow-up|0|||
126255021|NCT01332968|454224473|FG004|Follow-Up Period|Lost to Follow-up|0|||
126255022|NCT01332968|454224474|FG005|Follow-Up Period|Lost to Follow-up|0|||
126255023|NCT01332968|454224475|FG006|Follow-Up Period|Lost to Follow-up|11|||
126255024|NCT01332968|454224476|FG007|Follow-Up Period|Lost to Follow-up|15|||
126255025|NCT01332968|454224469|FG000|Follow-Up Period|Non-compliance|0|||
126255026|NCT01332968|454224470|FG001|Follow-Up Period|Non-compliance|0|||
126255027|NCT01332968|454224471|FG002|Follow-Up Period|Non-compliance|0|||
126255028|NCT01332968|454224472|FG003|Follow-Up Period|Non-compliance|0|||
126255029|NCT01332968|454224473|FG004|Follow-Up Period|Non-compliance|0|||
126255030|NCT01332968|454224474|FG005|Follow-Up Period|Non-compliance|0|||
126449326|NCT02626624|454945294|FG000|Overall Study|Adverse Event|1|||
126255031|NCT01332968|454224475|FG006|Follow-Up Period|Non-compliance|4|||
126255032|NCT01332968|454224476|FG007|Follow-Up Period|Non-compliance|9|||
126255033|NCT01332968|454224469|FG000|Follow-Up Period|Other|0|||
126255034|NCT01332968|454224470|FG001|Follow-Up Period|Other|0|||
126255035|NCT01332968|454224471|FG002|Follow-Up Period|Other|0|||
126255036|NCT01332968|454224472|FG003|Follow-Up Period|Other|0|||
126255037|NCT01332968|454224473|FG004|Follow-Up Period|Other|0|||
126255038|NCT01332968|454224474|FG005|Follow-Up Period|Other|0|||
126255039|NCT01332968|454224475|FG006|Follow-Up Period|Other|18|||
126255040|NCT01332968|454224476|FG007|Follow-Up Period|Other|21|||
126255041|NCT01332968|454224469|FG000|Follow-Up Period|Physician Decision|0|||
126255042|NCT01332968|454224470|FG001|Follow-Up Period|Physician Decision|0|||
126255043|NCT01332968|454224471|FG002|Follow-Up Period|Physician Decision|0|||
126255044|NCT01332968|454224472|FG003|Follow-Up Period|Physician Decision|0|||
126255045|NCT01332968|454224473|FG004|Follow-Up Period|Physician Decision|0|||
126449327|NCT02626624|454945294|FG000|Overall Study|Lost to Follow-up|3|||
126255046|NCT01332968|454224474|FG005|Follow-Up Period|Physician Decision|0|||
126255047|NCT01332968|454224475|FG006|Follow-Up Period|Physician Decision|12|||
126255048|NCT01332968|454224476|FG007|Follow-Up Period|Physician Decision|15|||
126255049|NCT01332968|454224469|FG000|Follow-Up Period|Progressive Disease|0|||
126255050|NCT01332968|454224470|FG001|Follow-Up Period|Progressive Disease|0|||
126255051|NCT01332968|454224471|FG002|Follow-Up Period|Progressive Disease|0|||
126255052|NCT01332968|454224472|FG003|Follow-Up Period|Progressive Disease|0|||
126255053|NCT01332968|454224473|FG004|Follow-Up Period|Progressive Disease|0|||
126255054|NCT01332968|454224474|FG005|Follow-Up Period|Progressive Disease|0|||
126255055|NCT01332968|454224475|FG006|Follow-Up Period|Progressive Disease|126|||
126255056|NCT01332968|454224476|FG007|Follow-Up Period|Progressive Disease|106|||
126255057|NCT01332968|454224469|FG000|Follow-Up Period|Protocol Violation|0|||
126255058|NCT01332968|454224470|FG001|Follow-Up Period|Protocol Violation|0|||
126255059|NCT01332968|454224471|FG002|Follow-Up Period|Protocol Violation|0|||
126255060|NCT01332968|454224472|FG003|Follow-Up Period|Protocol Violation|0|||
126255061|NCT01332968|454224473|FG004|Follow-Up Period|Protocol Violation|0|||
126255062|NCT01332968|454224474|FG005|Follow-Up Period|Protocol Violation|0|||
126255063|NCT01332968|454224475|FG006|Follow-Up Period|Protocol Violation|1|||
126255064|NCT01332968|454224476|FG007|Follow-Up Period|Protocol Violation|0|||
126255065|NCT01332968|454224469|FG000|Follow-Up Period|Withdrawal by Subject|0|||
126255066|NCT01332968|454224470|FG001|Follow-Up Period|Withdrawal by Subject|0|||
126255067|NCT01332968|454224471|FG002|Follow-Up Period|Withdrawal by Subject|0|||
126255068|NCT01332968|454224472|FG003|Follow-Up Period|Withdrawal by Subject|0|||
126255069|NCT01332968|454224473|FG004|Follow-Up Period|Withdrawal by Subject|0|||
126255070|NCT01332968|454224474|FG005|Follow-Up Period|Withdrawal by Subject|0|||
126255071|NCT01332968|454224475|FG006|Follow-Up Period|Withdrawal by Subject|29|||
126255072|NCT01332968|454224476|FG007|Follow-Up Period|Withdrawal by Subject|32|||
126255073|NCT01332968|454224469|FG000|Follow-Up Period|No reason provided|0|||
126255074|NCT01332968|454224470|FG001|Follow-Up Period|No reason provided|0|||
126255075|NCT01332968|454224471|FG002|Follow-Up Period|No reason provided|0|||
126255076|NCT01332968|454224472|FG003|Follow-Up Period|No reason provided|0|||
126255077|NCT01332968|454224473|FG004|Follow-Up Period|No reason provided|0|||
126255078|NCT01332968|454224474|FG005|Follow-Up Period|No reason provided|0|||
126255079|NCT01332968|454224475|FG006|Follow-Up Period|No reason provided|2|||
126255080|NCT01332968|454224476|FG007|Follow-Up Period|No reason provided|3|||
126255081|NCT03480022|454224477|FG000|Overall Study|Pregnancy|2|||
126255082|NCT03480022|454224478|FG001|Overall Study|Pregnancy|0|||
126255083|NCT03480022|454224477|FG000|Overall Study|Adverse Event|6|||
126255084|NCT03480022|454224478|FG001|Overall Study|Adverse Event|0|||
126255085|NCT03480022|454224477|FG000|Overall Study|Lack of Efficacy|0|||
126255086|NCT03480022|454224478|FG001|Overall Study|Lack of Efficacy|2|||
126255087|NCT03480022|454224477|FG000|Overall Study|Physician Decision|0|||
126255088|NCT03480022|454224478|FG001|Overall Study|Physician Decision|1|||
126255089|NCT03480022|454224477|FG000|Overall Study|Withdrawal by Subject|2|||
126255090|NCT03480022|454224478|FG001|Overall Study|Withdrawal by Subject|0|||
126255091|NCT03480022|454224477|FG000|Overall Study|Medication concerns|1|||
126255092|NCT03480022|454224478|FG001|Overall Study|Medication concerns|0|||
126255093|NCT03480022|454224477|FG000|Overall Study|Family member COVID exposure|0|||
126255094|NCT03480022|454224478|FG001|Overall Study|Family member COVID exposure|1|||
126255095|NCT00668395|454224479|FG000|Overall Study|Withdrawal by Subject|4|||
126255096|NCT00668395|454224480|FG001|Overall Study|Withdrawal by Subject|4|||
126255097|NCT00668395|454224481|FG002|Overall Study|Withdrawal by Subject|1|||
126255098|NCT00668395|454224479|FG000|Overall Study|Adverse Event|1|||
126255099|NCT00668395|454224480|FG001|Overall Study|Adverse Event|1|||
126255100|NCT00668395|454224481|FG002|Overall Study|Adverse Event|0|||
126255101|NCT00668395|454224479|FG000|Overall Study|Physician Decision|1|||
126255102|NCT00668395|454224480|FG001|Overall Study|Physician Decision|1|||
126255103|NCT00668395|454224481|FG002|Overall Study|Physician Decision|0|||
126255104|NCT00283842|454224486|FG000|Overall Study|Adverse Event|8|||
126255105|NCT00283842|454224487|FG001|Overall Study|Adverse Event|7|||
126255106|NCT00283842|454224488|FG002|Overall Study|Adverse Event|21|||
126255107|NCT00283842|454224489|FG003|Overall Study|Adverse Event|21|||
126255108|NCT00283842|454224490|FG004|Overall Study|Adverse Event|5|||
126255109|NCT00283842|454224486|FG000|Overall Study|Protocol Violation|1|||
126255110|NCT00283842|454224487|FG001|Overall Study|Protocol Violation|5|||
126255111|NCT00283842|454224488|FG002|Overall Study|Protocol Violation|4|||
126255112|NCT00283842|454224489|FG003|Overall Study|Protocol Violation|0|||
126255113|NCT00283842|454224490|FG004|Overall Study|Protocol Violation|0|||
126255114|NCT00283842|454224486|FG000|Overall Study|Protocol deviation|0|||
126255115|NCT00283842|454224487|FG001|Overall Study|Protocol deviation|0|||
126255116|NCT00283842|454224488|FG002|Overall Study|Protocol deviation|0|||
126255117|NCT00283842|454224489|FG003|Overall Study|Protocol deviation|0|||
126255118|NCT00283842|454224490|FG004|Overall Study|Protocol deviation|2|||
126255119|NCT00283842|454224486|FG000|Overall Study|Withdrawal by Subject|2|||
126255120|NCT00283842|454224487|FG001|Overall Study|Withdrawal by Subject|1|||
126255121|NCT00283842|454224488|FG002|Overall Study|Withdrawal by Subject|1|||
126255122|NCT00283842|454224489|FG003|Overall Study|Withdrawal by Subject|5|||
126358319|NCT05103332|454603963|FG003|Overall Study|Physician Decision|1|||
126255123|NCT00283842|454224490|FG004|Overall Study|Withdrawal by Subject|4|||
126358320|NCT05103332|454603964|FG004|Overall Study|Physician Decision|0|||
126255124|NCT00283842|454224486|FG000|Overall Study|Lack of Efficacy|1|||
126255125|NCT00283842|454224487|FG001|Overall Study|Lack of Efficacy|3|||
126255126|NCT00283842|454224488|FG002|Overall Study|Lack of Efficacy|1|||
126255127|NCT00283842|454224489|FG003|Overall Study|Lack of Efficacy|0|||
126255128|NCT00283842|454224490|FG004|Overall Study|Lack of Efficacy|3|||
126255129|NCT00283842|454224486|FG000|Overall Study|Lost to Follow-up|0|||
126255130|NCT00283842|454224487|FG001|Overall Study|Lost to Follow-up|2|||
126255131|NCT00283842|454224488|FG002|Overall Study|Lost to Follow-up|4|||
126255132|NCT00283842|454224489|FG003|Overall Study|Lost to Follow-up|1|||
126255133|NCT00283842|454224490|FG004|Overall Study|Lost to Follow-up|1|||
126255134|NCT05665387|454224491|FG000|Overall Study|Withdrawal by Subject|1|||
126255135|NCT05665387|454224492|FG001|Overall Study|Withdrawal by Subject|0|||
126255136|NCT05665387|454224493|FG002|Overall Study|Withdrawal by Subject|1|||
126255137|NCT02472639|454224496|FG000|Overall Study|Physician Decision|4|||
126255138|NCT02472639|454224497|FG001|Overall Study|Physician Decision|3|||
126255139|NCT00751023|454224499|FG000|Overall Study|Lost to Follow-up|11|||
126255140|NCT00751023|454224500|FG001|Overall Study|Lost to Follow-up|7|||
126255141|NCT02308696|454224503|FG000|Overall Study|Lost to Follow-up|28|||
126255142|NCT02308696|454224504|FG001|Overall Study|Lost to Follow-up|21|||
126255143|NCT02308696|454224503|FG000|Overall Study|Death|8|||
126255144|NCT02308696|454224504|FG001|Overall Study|Death|4|||
126255145|NCT02308696|454224503|FG000|Overall Study|Moved to a Higher Level of Care|17|||
126255146|NCT02308696|454224504|FG001|Overall Study|Moved to a Higher Level of Care|6|||
126255147|NCT01211262|454224506|FG000|Overall Study|Progressive Disease|18|||
126255148|NCT01211262|454224507|FG001|Overall Study|Progressive Disease|9|||
126255149|NCT01211262|454224506|FG000|Overall Study|Adverse Event|4|||
126255150|NCT01211262|454224507|FG001|Overall Study|Adverse Event|0|||
126255151|NCT01211262|454224506|FG000|Overall Study|Withdrawal of Consent|1|||
126255152|NCT01211262|454224507|FG001|Overall Study|Withdrawal of Consent|0|||
126255153|NCT01211262|454224506|FG000|Overall Study|Other|0|||
126255154|NCT01211262|454224507|FG001|Overall Study|Other|1|||
126255155|NCT04768114|454224508|FG000|Overall Study|Lost to Follow-up|5|||
126255156|NCT04768114|454224509|FG001|Overall Study|Lost to Follow-up|10|||
126255157|NCT04768114|454224508|FG000|Overall Study|Withdrawal by Subject|0|||
126255158|NCT04768114|454224509|FG001|Overall Study|Withdrawal by Subject|1|||
126255159|NCT04049097|454224513|FG000|Overall Study|Adverse Event|18|||
126255160|NCT04049097|454224513|FG000|Overall Study|Death|2|||
126255161|NCT04049097|454224513|FG000|Overall Study|Lost to Follow-up|1|||
126255162|NCT04049097|454224513|FG000|Overall Study|Physician Decision|2|||
126255163|NCT04049097|454224513|FG000|Overall Study|Withdrawal by Subject|9|||
126255164|NCT04049097|454224513|FG000|Overall Study|Protocol Violation|2|||
126255165|NCT04049097|454224513|FG000|Overall Study|Other|1|||
126358321|NCT05103332|454603965|FG005|Overall Study|Physician Decision|0|||
126255166|NCT04049097|454224513|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
126255167|NCT01970592|454224519|FG000|Overall Study|Withdrawal by Subject|4|||
126255168|NCT01970592|454224519|FG000|Overall Study|Physician Decision|1|||
126255169|NCT01970592|454224519|FG000|Overall Study|Adverse Event|1|||
126255170|NCT03980522|454224520|FG000|Treatment Period|Adverse Event|1|||
126255171|NCT03980522|454224521|FG001|Treatment Period|Adverse Event|0|||
126255172|NCT03980522|454224522|FG002|Treatment Period|Adverse Event|0|||
126255173|NCT03980522|454224523|FG003|Treatment Period|Adverse Event|0|||
126255174|NCT03980522|454224524|FG004|Treatment Period|Adverse Event|0|||
126762855|NCT05966129|456082765|FG000|Overall Study|Surgery logistics issue|2|||
126255175|NCT04892147|454224525|FG000|Overall Study|Withdrawal by Subject|2|||
126255176|NCT04892147|454224526|FG001|Overall Study|Withdrawal by Subject|0|||
126255177|NCT05263505|454224527|FG000|Overall Study|Adverse Event|0|||
126255178|NCT05263505|454224528|FG001|Overall Study|Adverse Event|1|||
126255179|NCT03448692|454224534|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
126255180|NCT03448692|454224535|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
126255181|NCT03448692|454224534|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
126358322|NCT05103332|454603960|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
126358323|NCT05103332|454603961|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
126255182|NCT03448692|454224535|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
126255183|NCT03448692|454224534|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
126255184|NCT03448692|454224535|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
126358324|NCT05103332|454603962|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
126255185|NCT03448692|454224534|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
126255186|NCT03448692|454224535|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
126255187|NCT03448692|454224534|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
126255188|NCT03448692|454224535|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
126255189|NCT01785615|454224541|FG000|Dietary Phase|Lost to Follow-up|0|||
126255190|NCT01785615|454224542|FG001|Dietary Phase|Lost to Follow-up|0|||
126255191|NCT01785615|454224543|FG002|Dietary Phase|Lost to Follow-up|0|||
126255192|NCT01785615|454224544|FG003|Dietary Phase|Lost to Follow-up|24|||
126255193|NCT03428945|454224545|FG000|Overall Study|Lost to Follow-up|5|||
126255194|NCT03428945|454224546|FG001|Overall Study|Lost to Follow-up|3|||
126255195|NCT03428945|454224545|FG000|Overall Study|Withdrawal by Subject|10|||
126255196|NCT03428945|454224546|FG001|Overall Study|Withdrawal by Subject|10|||
126255197|NCT00360490|454224549|FG000|Overall Study|Adverse Event|4|||
126255198|NCT00360490|454224550|FG001|Overall Study|Adverse Event|2|||
126255199|NCT00360490|454224549|FG000|Overall Study|Lost to Follow-up|2|||
126255200|NCT00360490|454224550|FG001|Overall Study|Lost to Follow-up|1|||
126255201|NCT00360490|454224549|FG000|Overall Study|Physician Decision|2|||
126255202|NCT00360490|454224550|FG001|Overall Study|Physician Decision|1|||
126255203|NCT00360490|454224549|FG000|Overall Study|Protocol Violation|0|||
126255204|NCT00360490|454224550|FG001|Overall Study|Protocol Violation|4|||
126255205|NCT00360490|454224549|FG000|Overall Study|Withdrawal by Subject|1|||
126255206|NCT00360490|454224550|FG001|Overall Study|Withdrawal by Subject|3|||
126255207|NCT01598896|454224552|FG000|Overall Study|Withdrawal by Subject|0|||
126255208|NCT01598896|454224553|FG001|Overall Study|Withdrawal by Subject|1|||
126255209|NCT01598896|454224552|FG000|Overall Study|Lack of Efficacy|0|||
126255210|NCT01598896|454224553|FG001|Overall Study|Lack of Efficacy|1|||
126255211|NCT03493919|454224557|FG000|Overall Study|Other|2|||
126255212|NCT03493919|454224558|FG001|Overall Study|Other|0|||
126255213|NCT03493919|454224559|FG002|Overall Study|Other|1|||
126255214|NCT03493919|454224560|FG003|Overall Study|Other|0|||
126255215|NCT03493919|454224557|FG000|Overall Study|Withdrawal by Subject|9|||
126255216|NCT03493919|454224558|FG001|Overall Study|Withdrawal by Subject|3|||
126255217|NCT03493919|454224559|FG002|Overall Study|Withdrawal by Subject|1|||
126255218|NCT03493919|454224560|FG003|Overall Study|Withdrawal by Subject|1|||
126255219|NCT03493919|454224557|FG000|Overall Study|Lost to Follow-up|5|||
126255220|NCT03493919|454224558|FG001|Overall Study|Lost to Follow-up|0|||
126255221|NCT03493919|454224559|FG002|Overall Study|Lost to Follow-up|0|||
126255222|NCT03493919|454224560|FG003|Overall Study|Lost to Follow-up|3|||
126255223|NCT03493919|454224557|FG000|Overall Study|Adverse Event|0|||
126255224|NCT03493919|454224558|FG001|Overall Study|Adverse Event|1|||
126255225|NCT03493919|454224559|FG002|Overall Study|Adverse Event|0|||
126255226|NCT03493919|454224560|FG003|Overall Study|Adverse Event|0|||
126255227|NCT04640194|454224561|FG000|Overall Study|Adverse Event|3|||
126255228|NCT04640194|454224562|FG001|Overall Study|Adverse Event|7|||
126255229|NCT04640194|454224563|FG002|Overall Study|Adverse Event|0|||
126255230|NCT04640194|454224564|FG003|Overall Study|Adverse Event|5|||
126255231|NCT04640194|454224565|FG004|Overall Study|Adverse Event|0|||
126255232|NCT04640194|454224566|FG005|Overall Study|Adverse Event|4|||
126255233|NCT04640194|454224567|FG006|Overall Study|Adverse Event|0|||
126255234|NCT04640194|454224561|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
126255235|NCT04640194|454224562|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
126255236|NCT04640194|454224563|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
126255237|NCT04640194|454224564|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
126255238|NCT04640194|454224565|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
126255239|NCT04640194|454224566|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
126255240|NCT04640194|454224567|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
126255241|NCT04640194|454224561|FG000|Overall Study|fibrinogen level too low|0|||
126255242|NCT04640194|454224562|FG001|Overall Study|fibrinogen level too low|0|||
126255243|NCT04640194|454224563|FG002|Overall Study|fibrinogen level too low|0|||
126255244|NCT04640194|454224564|FG003|Overall Study|fibrinogen level too low|1|||
126255245|NCT04640194|454224565|FG004|Overall Study|fibrinogen level too low|0|||
126255246|NCT04640194|454224566|FG005|Overall Study|fibrinogen level too low|0|||
126255247|NCT04640194|454224567|FG006|Overall Study|fibrinogen level too low|0|||
126255248|NCT04640194|454224561|FG000|Overall Study|mild bleeding|0|||
126255249|NCT04640194|454224562|FG001|Overall Study|mild bleeding|0|||
126358325|NCT05103332|454603963|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
126358326|NCT05103332|454603964|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
126358327|NCT05103332|454603965|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
126255250|NCT04640194|454224563|FG002|Overall Study|mild bleeding|0|||
126358328|NCT05103332|454603960|FG000|Overall Study|Unspeccified|0|||
126358329|NCT05103332|454603961|FG001|Overall Study|Unspeccified|0|||
126255251|NCT04640194|454224564|FG003|Overall Study|mild bleeding|1|||
126255252|NCT04640194|454224565|FG004|Overall Study|mild bleeding|0|||
126255253|NCT04640194|454224566|FG005|Overall Study|mild bleeding|0|||
126255254|NCT04640194|454224567|FG006|Overall Study|mild bleeding|0|||
126255255|NCT04640194|454224561|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
126255256|NCT04640194|454224562|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
126255257|NCT04640194|454224563|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
126255258|NCT04640194|454224564|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
126255259|NCT04640194|454224565|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
126255260|NCT04640194|454224566|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
126255261|NCT04640194|454224567|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
126255262|NCT04428645|454224568|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
126358330|NCT05103332|454603962|FG002|Overall Study|Unspeccified|0|||
126762856|NCT05966129|456082766|FG001|Overall Study|Surgery logistics issue|1|||
126762857|NCT01298323|456082767|FG000|Overall Study|Adverse Event|2|||
126762858|NCT01298323|456082768|FG001|Overall Study|Adverse Event|4|||
126762859|NCT01298323|456082767|FG000|Overall Study|Death|11|||
126762860|NCT01298323|456082768|FG001|Overall Study|Death|16|||
126762861|NCT01298323|456082767|FG000|Overall Study|Lost to Follow-up|1|||
126762862|NCT01298323|456082768|FG001|Overall Study|Lost to Follow-up|0|||
126762863|NCT01298323|456082767|FG000|Overall Study|Withdrawal by Subject|6|||
126762864|NCT01298323|456082768|FG001|Overall Study|Withdrawal by Subject|3|||
126762865|NCT01298323|456082767|FG000|Overall Study|Protocol Violation|1|||
126762866|NCT01298323|456082768|FG001|Overall Study|Protocol Violation|0|||
126762867|NCT01298323|456082767|FG000|Overall Study|Other|10|||
126762868|NCT01298323|456082768|FG001|Overall Study|Other|9|||
126762869|NCT01298323|456082767|FG000|Overall Study|Ongoing|55|||
126762870|NCT01298323|456082768|FG001|Overall Study|Ongoing|55|||
126762871|NCT01298323|456082767|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126762872|NCT01298323|456082768|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126762873|NCT02396849|456082769|FG000|Overall Study|Lost to Follow-up|1|||
126762874|NCT02396849|456082770|FG001|Overall Study|Lost to Follow-up|1|||
126762875|NCT02396849|456082769|FG000|Overall Study|Did not tolerate intervention|1|||
126762876|NCT02396849|456082770|FG001|Overall Study|Did not tolerate intervention|1|||
126762877|NCT04794491|456082775|FG000|Overall Study|Adverse Event|1|||
126762878|NCT04794491|456082775|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
126762879|NCT04794491|456082775|FG000|Overall Study|Noncompliance With Study Intervention|1|||
126762880|NCT04794491|456082775|FG000|Overall Study|Withdrawal by Subject|2|||
126762881|NCT00931515|456082776|FG000|Overall Study|Lost to Follow-up|2|||
126762882|NCT00931515|456082777|FG001|Overall Study|Lost to Follow-up|5|||
126762883|NCT02950831|456082778|FG000|Overall Study|Lost to Follow-up|1|||
126762884|NCT02950831|456082778|FG000|Overall Study|Withdrawal by Subject|3|||
126762885|NCT02950831|456082778|FG000|Overall Study|stimulation trail failure|5|||
126762886|NCT01965600|456082779|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
126762887|NCT01965600|456082780|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
126762888|NCT01965600|456082781|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
126762889|NCT01965600|456082782|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
126762890|NCT01965600|456082779|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
126762891|NCT01965600|456082780|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
126762892|NCT01965600|456082781|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
126762893|NCT01965600|456082782|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
126762894|NCT01965600|456082779|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
126762895|NCT01965600|456082780|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
126762896|NCT01965600|456082781|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
126762897|NCT01965600|456082782|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
126762898|NCT01965600|456082779|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
126762899|NCT01965600|456082780|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
126762900|NCT01965600|456082781|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
126762901|NCT01965600|456082782|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
126762902|NCT01965600|456082779|FG000|Second Intervention|Study terminated by Sponsor|0|||
126255263|NCT04773600|454224573|FG000|Overall Study|Withdrawal by Subject|15|||
126255264|NCT04773600|454224574|FG001|Overall Study|Withdrawal by Subject|9|||
126255265|NCT04773600|454224573|FG000|Overall Study|Lost to Follow-up|10|||
126255266|NCT04773600|454224574|FG001|Overall Study|Lost to Follow-up|6|||
126255267|NCT04773600|454224573|FG000|Overall Study|Adverse Event|8|||
126255268|NCT04773600|454224574|FG001|Overall Study|Adverse Event|2|||
126255269|NCT04773600|454224573|FG000|Overall Study|Lack of Efficacy|2|||
126255270|NCT04773600|454224574|FG001|Overall Study|Lack of Efficacy|3|||
126255271|NCT04773600|454224573|FG000|Overall Study|Noncompliance|2|||
126255272|NCT04773600|454224574|FG001|Overall Study|Noncompliance|0|||
126255273|NCT04773600|454224573|FG000|Overall Study|Protocol Violation|2|||
126255274|NCT04773600|454224574|FG001|Overall Study|Protocol Violation|0|||
126255275|NCT04773600|454224573|FG000|Overall Study|Physician Decision|0|||
126358331|NCT05103332|454603963|FG003|Overall Study|Unspeccified|1|||
126358332|NCT05103332|454603964|FG004|Overall Study|Unspeccified|0|||
126762903|NCT01965600|456082780|FG001|Second Intervention|Study terminated by Sponsor|0|||
126762904|NCT01965600|456082781|FG002|Second Intervention|Study terminated by Sponsor|2|||
126762905|NCT01965600|456082782|FG003|Second Intervention|Study terminated by Sponsor|2|||
126762906|NCT03418727|456082790|FG000|Overall Study|Adverse Event|1|||
126255276|NCT04773600|454224574|FG001|Overall Study|Physician Decision|1|||
126762907|NCT03418727|456082791|FG001|Overall Study|Adverse Event|2|||
126762908|NCT03418727|456082792|FG002|Overall Study|Adverse Event|0|||
126762909|NCT03418727|456082790|FG000|Overall Study|Withdrawal by Subject|0|||
126255277|NCT04773600|454224573|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
126255278|NCT04773600|454224574|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
126255279|NCT04773600|454224573|FG000|Overall Study|Emergency Travel Out of Country|1|||
126255280|NCT04773600|454224574|FG001|Overall Study|Emergency Travel Out of Country|0|||
126255281|NCT05135273|454226318|FG000|Overall Study|Recruited into the army|0|||
126255282|NCT05135273|454226319|FG001|Overall Study|Recruited into the army|0|||
126255283|NCT05135273|454226320|FG002|Overall Study|Recruited into the army|0|||
126255284|NCT05135273|454226321|FG003|Overall Study|Recruited into the army|0|||
126255285|NCT05135273|454226322|FG004|Overall Study|Recruited into the army|1|||
126255286|NCT05135273|454226323|FG005|Overall Study|Recruited into the army|0|||
126255287|NCT05135273|454226324|FG006|Overall Study|Recruited into the army|0|||
126255288|NCT05135273|454226325|FG007|Overall Study|Recruited into the army|0|||
126255289|NCT05135273|454226318|FG000|Overall Study|Moved away from study site|0|||
126358333|NCT05103332|454603965|FG005|Overall Study|Unspeccified|0|||
126358334|NCT02218268|454603966|FG000|24 Hour Washout|Physician Decision|11|||
126358335|NCT02218268|454603967|FG001|24 Hour Washout|Physician Decision|9|||
126358336|NCT03651336|454603968|FG000|Overall Study|Withdrawal by Subject|4|||
126358337|NCT01740427|454603969|FG000|Overall Study|Objective Progression or Relapse|286|||
126358338|NCT01740427|454603970|FG001|Overall Study|Objective Progression or Relapse|172|||
126358339|NCT01740427|454603969|FG000|Overall Study|Adverse Event|32|||
126358340|NCT01740427|454603970|FG001|Overall Study|Adverse Event|9|||
126358341|NCT01740427|454603969|FG000|Overall Study|Global Deterioration of Health Status|28|||
126358342|NCT01740427|454603970|FG001|Overall Study|Global Deterioration of Health Status|12|||
126358343|NCT01740427|454603969|FG000|Overall Study|Participant Refused Continued Treatment|27|||
126358344|NCT01740427|454603970|FG001|Overall Study|Participant Refused Continued Treatment|15|||
126358345|NCT01740427|454603969|FG000|Overall Study|Unspecified reasons|52|||
126358346|NCT01740427|454603970|FG001|Overall Study|Unspecified reasons|8|||
126358347|NCT01740427|454603969|FG000|Overall Study|Death|10|||
126358348|NCT01740427|454603970|FG001|Overall Study|Death|3|||
126358349|NCT01740427|454603969|FG000|Overall Study|Protocol Violation|5|||
126358350|NCT01740427|454603970|FG001|Overall Study|Protocol Violation|3|||
126358351|NCT01740427|454603969|FG000|Overall Study|Lost to Follow-up|3|||
126358352|NCT01740427|454603970|FG001|Overall Study|Lost to Follow-up|0|||
126358353|NCT01740427|454603969|FG000|Overall Study|Site Terminated by Sponsor|1|||
126358354|NCT01740427|454603970|FG001|Overall Study|Site Terminated by Sponsor|0|||
126358355|NCT04796207|454603973|FG000|Overall Study|Lost to Follow-up|7|||
126358356|NCT04796207|454603974|FG001|Overall Study|Lost to Follow-up|2|||
126358357|NCT00362609|454603975|FG000|Overall Study|Withdrawal by Subject|0|||
126358358|NCT00362609|454603976|FG001|Overall Study|Withdrawal by Subject|1|||
126358359|NCT00362609|454603975|FG000|Overall Study|Protocol Violation|0|||
126358360|NCT00362609|454603976|FG001|Overall Study|Protocol Violation|1|||
126358361|NCT01800058|454603985|FG000|Overall Study|Lost to Follow-up|1|||
126358362|NCT02186171|454603986|FG000|Overall Study|Withdrawal by Subject|1|||
126255290|NCT05135273|454226319|FG001|Overall Study|Moved away from study site|0|||
126255291|NCT05135273|454226320|FG002|Overall Study|Moved away from study site|0|||
126255292|NCT05135273|454226321|FG003|Overall Study|Moved away from study site|0|||
126255293|NCT05135273|454226322|FG004|Overall Study|Moved away from study site|0|||
126255294|NCT05135273|454226323|FG005|Overall Study|Moved away from study site|1|||
126255295|NCT05135273|454226324|FG006|Overall Study|Moved away from study site|1|||
126255296|NCT05135273|454226325|FG007|Overall Study|Moved away from study site|0|||
126255297|NCT05135273|454226318|FG000|Overall Study|Travel|0|||
126255298|NCT05135273|454226319|FG001|Overall Study|Travel|0|||
126255299|NCT05135273|454226320|FG002|Overall Study|Travel|0|||
126255300|NCT05135273|454226321|FG003|Overall Study|Travel|0|||
126255301|NCT05135273|454226322|FG004|Overall Study|Travel|0|||
126255302|NCT05135273|454226323|FG005|Overall Study|Travel|0|||
126255303|NCT05135273|454226324|FG006|Overall Study|Travel|0|||
126255304|NCT05135273|454226325|FG007|Overall Study|Travel|1|||
126255305|NCT00500318|454226328|FG000|Overall Study|Adverse Event|3|||
126255306|NCT00500318|454226329|FG001|Overall Study|Adverse Event|8|||
126255307|NCT00500318|454226328|FG000|Overall Study|Protocol Violation|1|||
126255308|NCT00500318|454226329|FG001|Overall Study|Protocol Violation|3|||
126255309|NCT00500318|454226328|FG000|Overall Study|Withdrawal by Subject|1|||
126255310|NCT00500318|454226329|FG001|Overall Study|Withdrawal by Subject|2|||
126255311|NCT00500318|454226328|FG000|Overall Study|Lack of Efficacy|0|||
126255312|NCT00500318|454226329|FG001|Overall Study|Lack of Efficacy|3|||
126255313|NCT00500318|454226328|FG000|Overall Study|Other Reason|0|||
126255314|NCT00500318|454226329|FG001|Overall Study|Other Reason|1|||
126255315|NCT03243396|454226330|FG000|Overall Study|Lost to Follow-up|2|||
126255316|NCT03243396|454226331|FG001|Overall Study|Lost to Follow-up|3|||
126255317|NCT03243396|454226332|FG002|Overall Study|Lost to Follow-up|15|||
126255318|NCT03243396|454226333|FG003|Overall Study|Lost to Follow-up|8|||
126255319|NCT03243396|454226334|FG004|Overall Study|Lost to Follow-up|1|||
126255320|NCT03243396|454226335|FG005|Overall Study|Lost to Follow-up|4|||
126255321|NCT03243396|454226336|FG006|Overall Study|Lost to Follow-up|9|||
126358363|NCT02186171|454603987|FG001|Overall Study|Withdrawal by Subject|9|||
126358364|NCT02186171|454603986|FG000|Overall Study|Lost to Follow-up|2|||
126358365|NCT02186171|454603987|FG001|Overall Study|Lost to Follow-up|2|||
126358366|NCT02186171|454603986|FG000|Overall Study|Death|1|||
126358367|NCT02186171|454603987|FG001|Overall Study|Death|2|||
126358368|NCT02186171|454603986|FG000|Overall Study|Protocol-specified Criteria|0|||
126255322|NCT01257581|454226337|FG000|Overall Study|Early Termination|3|||
126255323|NCT01257581|454226338|FG001|Overall Study|Early Termination|1|||
126255324|NCT01257581|454226339|FG002|Overall Study|Early Termination|2|||
126255325|NCT01257581|454226337|FG000|Overall Study|Death|2|||
126255326|NCT01257581|454226338|FG001|Overall Study|Death|2|||
126255327|NCT01257581|454226339|FG002|Overall Study|Death|4|||
126358369|NCT02186171|454603987|FG001|Overall Study|Protocol-specified Criteria|2|||
126358370|NCT05206604|454605311|FG000|Overall Study|Non-compliance with study drug|0|||
126358371|NCT05206604|454605312|FG001|Overall Study|Non-compliance with study drug|0|||
126358372|NCT05206604|454605313|FG002|Overall Study|Non-compliance with study drug|0|||
126255328|NCT02246764|454226342|FG000|Overall Study|Adverse Event|15|||
126255329|NCT02246764|454226343|FG001|Overall Study|Adverse Event|29|||
126255330|NCT02246764|454226344|FG002|Overall Study|Adverse Event|1|||
126255331|NCT02246764|454226342|FG000|Overall Study|Withdrawal by Subject|0|||
126255332|NCT02246764|454226343|FG001|Overall Study|Withdrawal by Subject|0|||
126255333|NCT02246764|454226344|FG002|Overall Study|Withdrawal by Subject|1|||
126255334|NCT02246764|454226342|FG000|Overall Study|Disallowed Concomitant Medication|1|||
126255335|NCT02246764|454226343|FG001|Overall Study|Disallowed Concomitant Medication|0|||
126255336|NCT02246764|454226344|FG002|Overall Study|Disallowed Concomitant Medication|0|||
126255337|NCT02246764|454226342|FG000|Overall Study|Physician Decision|0|||
126255338|NCT02246764|454226343|FG001|Overall Study|Physician Decision|2|||
126255339|NCT02246764|454226344|FG002|Overall Study|Physician Decision|1|||
126255340|NCT02246764|454226342|FG000|Overall Study|Protocol Violation|2|||
126255341|NCT02246764|454226343|FG001|Overall Study|Protocol Violation|1|||
126255342|NCT02246764|454226344|FG002|Overall Study|Protocol Violation|1|||
126255343|NCT02104817|454226347|FG000|Overall Study|Death|363|||
126255344|NCT02104817|454226348|FG001|Overall Study|Death|330|||
126255345|NCT02104817|454226347|FG000|Overall Study|Lost to Follow-up|3|||
126255346|NCT02104817|454226348|FG001|Overall Study|Lost to Follow-up|2|||
126255347|NCT02104817|454226347|FG000|Overall Study|Protocol Violation|0|||
126255348|NCT02104817|454226348|FG001|Overall Study|Protocol Violation|1|||
126255349|NCT02104817|454226347|FG000|Overall Study|Study terminated by sponsor|5854|||
126255350|NCT02104817|454226348|FG001|Overall Study|Study terminated by sponsor|5901|||
126255351|NCT02104817|454226347|FG000|Overall Study|Withdrawal by Subject|111|||
126255352|NCT02104817|454226348|FG001|Overall Study|Withdrawal by Subject|78|||
126255353|NCT02104817|454226347|FG000|Overall Study|Other reasons|128|||
126255354|NCT02104817|454226348|FG001|Overall Study|Other reasons|135|||
126255355|NCT02575339|454226352|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
126255356|NCT02575339|454226353|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
126255357|NCT02575339|454226354|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
126255358|NCT02575339|454226352|FG000|Study Treatment|Disease Progression|5|||
126255359|NCT02575339|454226353|FG001|Study Treatment|Disease Progression|2|||
126255360|NCT02575339|454226354|FG002|Study Treatment|Disease Progression|0|||
126255361|NCT02575339|454226352|FG000|Study Treatment|Adverse Event|1|||
126255362|NCT02575339|454226353|FG001|Study Treatment|Adverse Event|2|||
126255363|NCT02575339|454226354|FG002|Study Treatment|Adverse Event|0|||
126255364|NCT02575339|454226352|FG000|Follow up|Death|6|||
126255365|NCT02575339|454226353|FG001|Follow up|Death|2|||
126255366|NCT02575339|454226354|FG002|Follow up|Death|0|||
126255367|NCT02575339|454226352|FG000|Follow up|Study Terminated|0|||
126255368|NCT02575339|454226353|FG001|Follow up|Study Terminated|2|||
126255369|NCT02575339|454226354|FG002|Follow up|Study Terminated|0|||
126255370|NCT02575339|454226352|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
126255371|NCT02575339|454226353|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
126255372|NCT02575339|454226354|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
126255373|NCT04633642|454226355|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
126255374|NCT04633642|454226356|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
126255375|NCT04675775|454226357|FG000|Overall Study|Withdrawal by Subject|7|||
126255376|NCT02161549|454226359|FG000|Overall Study|Physician Decision|6|||
126255377|NCT02161549|454226360|FG001|Overall Study|Physician Decision|2|||
126255378|NCT03223909|454226361|FG000|Overall Study|Protocol Violation|48|||
126358373|NCT05206604|454605314|FG003|Overall Study|Non-compliance with study drug|0|||
126358374|NCT05206604|454605315|FG004|Overall Study|Non-compliance with study drug|0|||
126358375|NCT05206604|454605316|FG005|Overall Study|Non-compliance with study drug|1|||
126358376|NCT05206604|454605317|FG006|Overall Study|Non-compliance with study drug|0|||
126358377|NCT05206604|454605318|FG007|Overall Study|Non-compliance with study drug|0|||
126255379|NCT03223909|454226362|FG001|Overall Study|Protocol Violation|45|||
126255380|NCT03223909|454226363|FG002|Overall Study|Protocol Violation|16|||
126255381|NCT01628549|454226368|FG000|Overall Study|Adverse Event|1|||
126255382|NCT01628549|454226369|FG001|Overall Study|Adverse Event|1|||
126255383|NCT01628549|454226370|FG002|Overall Study|Adverse Event|0|||
126255384|NCT01628549|454226371|FG003|Overall Study|Adverse Event|4|||
126255385|NCT01628549|454226368|FG000|Overall Study|Lost to Follow-up|3|||
126255386|NCT01628549|454226369|FG001|Overall Study|Lost to Follow-up|4|||
126255387|NCT01628549|454226370|FG002|Overall Study|Lost to Follow-up|3|||
126358378|NCT03735498|454605319|FG000|Overall Study|Withdrawal by Subject|3|||
126255388|NCT01628549|454226371|FG003|Overall Study|Lost to Follow-up|3|||
126255389|NCT01628549|454226368|FG000|Overall Study|Withdrawal by Subject|3|||
126255390|NCT01628549|454226369|FG001|Overall Study|Withdrawal by Subject|4|||
126255391|NCT01628549|454226370|FG002|Overall Study|Withdrawal by Subject|4|||
126255392|NCT01628549|454226371|FG003|Overall Study|Withdrawal by Subject|1|||
126255393|NCT01628549|454226368|FG000|Overall Study|Protocol Violation|2|||
126255394|NCT01628549|454226369|FG001|Overall Study|Protocol Violation|1|||
126255395|NCT01628549|454226370|FG002|Overall Study|Protocol Violation|1|||
126255396|NCT01628549|454226371|FG003|Overall Study|Protocol Violation|0|||
126255397|NCT01628549|454226368|FG000|Overall Study|withdrawn for noncompliance|0|||
126255398|NCT01628549|454226369|FG001|Overall Study|withdrawn for noncompliance|2|||
126255399|NCT01628549|454226370|FG002|Overall Study|withdrawn for noncompliance|1|||
126255400|NCT01628549|454226371|FG003|Overall Study|withdrawn for noncompliance|0|||
126255401|NCT01628549|454226368|FG000|Overall Study|abnormal laboratory test results|0|||
126255402|NCT01628549|454226369|FG001|Overall Study|abnormal laboratory test results|0|||
126255403|NCT01628549|454226370|FG002|Overall Study|abnormal laboratory test results|1|||
126255404|NCT01628549|454226371|FG003|Overall Study|abnormal laboratory test results|0|||
126255405|NCT01628549|454226368|FG000|Overall Study|positive pregnancy test|0|||
126255406|NCT01628549|454226369|FG001|Overall Study|positive pregnancy test|0|||
126255407|NCT01628549|454226370|FG002|Overall Study|positive pregnancy test|0|||
126255408|NCT01628549|454226371|FG003|Overall Study|positive pregnancy test|1|||
126255409|NCT00177164|454226373|FG000|Overall Study|Protocol Violation|0|||
126255410|NCT00177164|454226374|FG001|Overall Study|Protocol Violation|7|||
126255411|NCT00177164|454226373|FG000|Overall Study|Lost to Follow-up|4|||
126255412|NCT00177164|454226374|FG001|Overall Study|Lost to Follow-up|5|||
126255413|NCT00177164|454226373|FG000|Overall Study|increase in alcohol and drug use|1|||
126255414|NCT00177164|454226374|FG001|Overall Study|increase in alcohol and drug use|2|||
126255415|NCT00177164|454226373|FG000|Overall Study|Adverse Event|1|||
126255416|NCT00177164|454226374|FG001|Overall Study|Adverse Event|0|||
126255417|NCT00177164|454226373|FG000|Overall Study|discharge from hospital|1|||
126255418|NCT00177164|454226374|FG001|Overall Study|discharge from hospital|0|||
126255419|NCT00177164|454226373|FG000|Overall Study|Lack of Efficacy|2|||
126255420|NCT00177164|454226374|FG001|Overall Study|Lack of Efficacy|1|||
126255421|NCT00177164|454226373|FG000|Overall Study|Pregnancy|0|||
126255422|NCT00177164|454226374|FG001|Overall Study|Pregnancy|1|||
126255423|NCT00965757|454226375|FG000|Double-blind Phase|Progression of concomitant disease|1|||
126255424|NCT00965757|454226376|FG001|Double-blind Phase|Progression of concomitant disease|2|||
126255425|NCT00965757|454226377|FG002|Double-blind Phase|Progression of concomitant disease|0|||
126255426|NCT00965757|454226378|FG003|Double-blind Phase|Progression of concomitant disease|0|||
126255427|NCT00965757|454226375|FG000|Double-blind Phase|Adverse drug reaction|2|||
126255428|NCT00965757|454226376|FG001|Double-blind Phase|Adverse drug reaction|1|||
126255429|NCT00965757|454226377|FG002|Double-blind Phase|Adverse drug reaction|0|||
126255430|NCT00965757|454226378|FG003|Double-blind Phase|Adverse drug reaction|0|||
126255431|NCT00965757|454226375|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
126255432|NCT00965757|454226376|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
126255433|NCT00965757|454226377|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
126255434|NCT00965757|454226378|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
126255435|NCT00965757|454226375|FG000|Double-blind Phase|Lack of Efficacy|7|||
126255436|NCT00965757|454226376|FG001|Double-blind Phase|Lack of Efficacy|11|||
126255437|NCT00965757|454226377|FG002|Double-blind Phase|Lack of Efficacy|0|||
126255438|NCT00965757|454226378|FG003|Double-blind Phase|Lack of Efficacy|0|||
126255439|NCT00965757|454226375|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
126255440|NCT00965757|454226376|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
126255441|NCT00965757|454226377|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
126255442|NCT00965757|454226378|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
126255443|NCT00965757|454226375|FG000|Double-blind Phase|Lost to Follow-up|0|||
126255444|NCT00965757|454226376|FG001|Double-blind Phase|Lost to Follow-up|1|||
126255445|NCT00965757|454226377|FG002|Double-blind Phase|Lost to Follow-up|0|||
126255446|NCT00965757|454226378|FG003|Double-blind Phase|Lost to Follow-up|0|||
126546430|NCT03573908|455293802|FG002|Treatment Period|Lost to Follow-up|0|||
126546431|NCT03573908|455293803|FG003|Treatment Period|Lost to Follow-up|0|||
126546432|NCT03573908|455293804|FG004|Treatment Period|Lost to Follow-up|0|||
126255447|NCT00965757|454226375|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
126255448|NCT00965757|454226376|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
126255449|NCT00965757|454226377|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
126255450|NCT00965757|454226378|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
126255451|NCT00965757|454226375|FG000|Double-blind Phase|Other|1|||
126255452|NCT00965757|454226376|FG001|Double-blind Phase|Other|0|||
126255453|NCT00965757|454226377|FG002|Double-blind Phase|Other|0|||
126255454|NCT00965757|454226378|FG003|Double-blind Phase|Other|0|||
126255455|NCT00965757|454226375|FG000|Extension Phase|Progression of concomitant disease|0|||
126255456|NCT00965757|454226376|FG001|Extension Phase|Progression of concomitant disease|0|||
126255457|NCT00965757|454226377|FG002|Extension Phase|Progression of concomitant disease|4|||
126255458|NCT00965757|454226378|FG003|Extension Phase|Progression of concomitant disease|2|||
126255459|NCT00965757|454226375|FG000|Extension Phase|Adverse drug reaction|0|||
126255460|NCT00965757|454226376|FG001|Extension Phase|Adverse drug reaction|0|||
126255461|NCT00965757|454226377|FG002|Extension Phase|Adverse drug reaction|6|||
126255462|NCT00965757|454226378|FG003|Extension Phase|Adverse drug reaction|3|||
126255463|NCT00965757|454226375|FG000|Extension Phase|Abnormal Laboratory Value|0|||
126255464|NCT00965757|454226376|FG001|Extension Phase|Abnormal Laboratory Value|0|||
126255465|NCT00965757|454226377|FG002|Extension Phase|Abnormal Laboratory Value|6|||
126255466|NCT00965757|454226378|FG003|Extension Phase|Abnormal Laboratory Value|1|||
126255467|NCT00965757|454226375|FG000|Extension Phase|Lack of Efficacy|0|||
126255468|NCT00965757|454226376|FG001|Extension Phase|Lack of Efficacy|0|||
126255469|NCT00965757|454226377|FG002|Extension Phase|Lack of Efficacy|8|||
126255470|NCT00965757|454226378|FG003|Extension Phase|Lack of Efficacy|12|||
126255471|NCT00965757|454226375|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
126255472|NCT00965757|454226376|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
126255473|NCT00965757|454226377|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
126255474|NCT00965757|454226378|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
126255475|NCT00965757|454226375|FG000|Extension Phase|Lost to Follow-up|0|||
126255476|NCT00965757|454226376|FG001|Extension Phase|Lost to Follow-up|0|||
126255477|NCT00965757|454226377|FG002|Extension Phase|Lost to Follow-up|0|||
126255478|NCT00965757|454226378|FG003|Extension Phase|Lost to Follow-up|1|||
126255479|NCT00965757|454226375|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
126255480|NCT00965757|454226376|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
126255481|NCT00965757|454226377|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
126255482|NCT00965757|454226378|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
126255483|NCT00965757|454226375|FG000|Extension Phase|Protocol Violation|0|||
126255484|NCT00965757|454226376|FG001|Extension Phase|Protocol Violation|0|||
126255485|NCT00965757|454226377|FG002|Extension Phase|Protocol Violation|0|||
126255486|NCT00965757|454226378|FG003|Extension Phase|Protocol Violation|1|||
126255487|NCT00965757|454226375|FG000|Extension Phase|Other|0|||
126255488|NCT00965757|454226376|FG001|Extension Phase|Other|0|||
126255489|NCT00965757|454226377|FG002|Extension Phase|Other|2|||
126255490|NCT00965757|454226378|FG003|Extension Phase|Other|1|||
126255491|NCT02451358|454226379|FG000|Overall Study|Withdrawal by Subject|1|||
126255492|NCT02451358|454226380|FG001|Overall Study|Withdrawal by Subject|1|||
126255493|NCT02451358|454226381|FG002|Overall Study|Withdrawal by Subject|0|||
126255494|NCT02451358|454226382|FG003|Overall Study|Withdrawal by Subject|0|||
126255495|NCT02451358|454226379|FG000|Overall Study|Protocol Violation|0|||
126255496|NCT02451358|454226380|FG001|Overall Study|Protocol Violation|1|||
126255497|NCT02451358|454226381|FG002|Overall Study|Protocol Violation|1|||
126255498|NCT02451358|454226382|FG003|Overall Study|Protocol Violation|0|||
126255499|NCT01344018|454226393|FG000|Overall Study|Death|22|||
126255500|NCT01344018|454226394|FG001|Overall Study|Death|25|||
126255501|NCT01344018|454226393|FG000|Overall Study|Lost to Follow-up|4|||
126255502|NCT01344018|454226394|FG001|Overall Study|Lost to Follow-up|7|||
126255503|NCT05070754|454226395|FG000|Overall Study|Withdrawal by Subject|0|||
126255504|NCT05070754|454226396|FG001|Overall Study|Withdrawal by Subject|0|||
126255505|NCT05070754|454226397|FG002|Overall Study|Withdrawal by Subject|0|||
126255506|NCT05070754|454226398|FG003|Overall Study|Withdrawal by Subject|1|||
126255507|NCT05070754|454226395|FG000|Overall Study|Protocol Violation|0|||
126255508|NCT05070754|454226396|FG001|Overall Study|Protocol Violation|0|||
126255509|NCT05070754|454226397|FG002|Overall Study|Protocol Violation|0|||
126255510|NCT05070754|454226398|FG003|Overall Study|Protocol Violation|1|||
126255511|NCT01398787|454226399|FG000|Overall Study|Adverse Event|1|||
126255512|NCT02351167|454226400|FG000|Overall Study|Withdrawal by Subject|19|||
126255513|NCT02351167|454226401|FG001|Overall Study|Withdrawal by Subject|18|||
126255514|NCT02351167|454226402|FG002|Overall Study|Withdrawal by Subject|21|||
126255515|NCT00113919|454226405|FG000|Overall Study|Physician Decision|8|||
126255516|NCT00113919|454226405|FG000|Overall Study|Death|6|||
126255517|NCT00715676|454226409|FG000|Overall Study|Adverse Event|3|||
126255518|NCT00715676|454226410|FG001|Overall Study|Adverse Event|5|||
126255519|NCT00715676|454226411|FG002|Overall Study|Adverse Event|21|||
126255520|NCT00715676|454226409|FG000|Overall Study|Withdrawal by Subject|1|||
126255521|NCT00715676|454226410|FG001|Overall Study|Withdrawal by Subject|3|||
126255522|NCT00715676|454226411|FG002|Overall Study|Withdrawal by Subject|8|||
126255523|NCT00715676|454226409|FG000|Overall Study|Lost to Follow-up|1|||
126255524|NCT00715676|454226410|FG001|Overall Study|Lost to Follow-up|2|||
126255525|NCT00715676|454226411|FG002|Overall Study|Lost to Follow-up|1|||
126255526|NCT00715676|454226409|FG000|Overall Study|Terminated by Sponsor|1|||
126255527|NCT00715676|454226410|FG001|Overall Study|Terminated by Sponsor|0|||
126255528|NCT00715676|454226411|FG002|Overall Study|Terminated by Sponsor|0|||
126255529|NCT00715676|454226409|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
126255530|NCT00715676|454226410|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
126255531|NCT00715676|454226411|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
126255532|NCT00715676|454226409|FG000|Overall Study|Use of Exclusionary Medication|0|||
126255533|NCT00715676|454226410|FG001|Overall Study|Use of Exclusionary Medication|0|||
126255534|NCT00715676|454226411|FG002|Overall Study|Use of Exclusionary Medication|1|||
126255535|NCT00715676|454226409|FG000|Overall Study|Elevated Blood Glucose|0|||
126255536|NCT00715676|454226410|FG001|Overall Study|Elevated Blood Glucose|1|||
126255537|NCT00715676|454226411|FG002|Overall Study|Elevated Blood Glucose|0|||
126255538|NCT00372996|454226412|FG000|Overall Study|Death|11|||
126255539|NCT00372996|454226413|FG001|Overall Study|Death|4|||
126255540|NCT00372996|454226414|FG002|Overall Study|Death|8|||
126255541|NCT00372996|454226415|FG003|Overall Study|Death|7|||
126255542|NCT00372996|454226412|FG000|Overall Study|Lost to Follow-up|0|||
126255543|NCT00372996|454226413|FG001|Overall Study|Lost to Follow-up|2|||
126255544|NCT00372996|454226414|FG002|Overall Study|Lost to Follow-up|0|||
126255545|NCT00372996|454226415|FG003|Overall Study|Lost to Follow-up|1|||
126255546|NCT00372996|454226412|FG000|Overall Study|Withdrawal by Subject|12|||
126255547|NCT00372996|454226413|FG001|Overall Study|Withdrawal by Subject|6|||
126255548|NCT00372996|454226414|FG002|Overall Study|Withdrawal by Subject|9|||
126255549|NCT00372996|454226415|FG003|Overall Study|Withdrawal by Subject|5|||
126255550|NCT00372996|454226412|FG000|Overall Study|Study Terminated by Sponsor|4|||
126255551|NCT00372996|454226413|FG001|Overall Study|Study Terminated by Sponsor|0|||
126255552|NCT00372996|454226414|FG002|Overall Study|Study Terminated by Sponsor|4|||
126255553|NCT00372996|454226415|FG003|Overall Study|Study Terminated by Sponsor|0|||
126255554|NCT00372996|454226412|FG000|Overall Study|Other|10|||
126762910|NCT03418727|456082791|FG001|Overall Study|Withdrawal by Subject|0|||
126255555|NCT00372996|454226413|FG001|Overall Study|Other|2|||
126255556|NCT00372996|454226414|FG002|Overall Study|Other|7|||
126255557|NCT00372996|454226415|FG003|Overall Study|Other|7|||
126255558|NCT01091363|454226416|FG000|Overall Study|Withdrawal by Subject|11|||
126255559|NCT01091363|454226417|FG001|Overall Study|Withdrawal by Subject|15|||
126255560|NCT01091363|454226416|FG000|Overall Study|Lost to Follow-up|2|||
126255561|NCT01091363|454226417|FG001|Overall Study|Lost to Follow-up|2|||
126255562|NCT02151149|454226420|FG000|Treatment Period|Death|2|||
126255563|NCT02151149|454226421|FG001|Treatment Period|Death|3|||
126255564|NCT02151149|454226420|FG000|Treatment Period|Adverse Event|17|||
126255565|NCT02151149|454226421|FG001|Treatment Period|Adverse Event|14|||
126255566|NCT02151149|454226420|FG000|Treatment Period|Progressive Disease|25|||
126255567|NCT02151149|454226421|FG001|Treatment Period|Progressive Disease|24|||
126255568|NCT02151149|454226420|FG000|Treatment Period|Symptomatic Deterioration|2|||
126255569|NCT02151149|454226421|FG001|Treatment Period|Symptomatic Deterioration|10|||
126255570|NCT02151149|454226420|FG000|Treatment Period|Withdrawal by Subject|13|||
126255571|NCT02151149|454226421|FG001|Treatment Period|Withdrawal by Subject|11|||
126255572|NCT02151149|454226420|FG000|Treatment Period|Miscellaneous|8|||
126255573|NCT02151149|454226421|FG001|Treatment Period|Miscellaneous|7|||
126255574|NCT02151149|454226420|FG000|Treatment Period|Participants randomized but not treated|3|||
126255575|NCT02151149|454226421|FG001|Treatment Period|Participants randomized but not treated|2|||
126255576|NCT02151149|454226420|FG000|Follow-Up Period|Lost to Follow-up|2|||
126255577|NCT02151149|454226421|FG001|Follow-Up Period|Lost to Follow-up|3|||
126255578|NCT02151149|454226420|FG000|Follow-Up Period|Death|37|||
126255579|NCT02151149|454226421|FG001|Follow-Up Period|Death|34|||
126255580|NCT02760433|454226422|FG000|Overall Study|Lost to Follow-up|1|||
126255581|NCT02760433|454226423|FG001|Overall Study|Lost to Follow-up|0|||
126255582|NCT02760433|454226424|FG002|Overall Study|Lost to Follow-up|1|||
126255583|NCT02760433|454226425|FG003|Overall Study|Lost to Follow-up|0|||
126255584|NCT02760433|454226426|FG004|Overall Study|Lost to Follow-up|0|||
126255585|NCT02760433|454226422|FG000|Overall Study|Withdrawal by Subject|23|||
126255586|NCT02760433|454226423|FG001|Overall Study|Withdrawal by Subject|9|||
126255587|NCT02760433|454226424|FG002|Overall Study|Withdrawal by Subject|0|||
126255588|NCT02760433|454226425|FG003|Overall Study|Withdrawal by Subject|2|||
126255589|NCT02760433|454226426|FG004|Overall Study|Withdrawal by Subject|9|||
126255590|NCT02760433|454226422|FG000|Overall Study|Lack of Response At Week 14|0|||
126762911|NCT03418727|456082792|FG002|Overall Study|Withdrawal by Subject|2|||
126762912|NCT00686894|456082797|FG000|Overall Study|Relapse|2|||
126762913|NCT00686894|456082797|FG000|Overall Study|Protocol Violation|4|||
126255591|NCT02760433|454226423|FG001|Overall Study|Lack of Response At Week 14|0|||
126762914|NCT03145207|456082798|FG000|Overall Study|volunteer started taking allergy shots|1|||
126762915|NCT03145207|456082798|FG000|Overall Study|baseline blood pressure high|1|||
126255592|NCT02760433|454226424|FG002|Overall Study|Lack of Response At Week 14|0|||
126255593|NCT02760433|454226425|FG003|Overall Study|Lack of Response At Week 14|0|||
126255594|NCT02760433|454226426|FG004|Overall Study|Lack of Response At Week 14|1|||
126255595|NCT02760433|454226422|FG000|Overall Study|Subject refused to continue the study|1|||
126255596|NCT02760433|454226423|FG001|Overall Study|Subject refused to continue the study|0|||
126255597|NCT02760433|454226424|FG002|Overall Study|Subject refused to continue the study|0|||
126255598|NCT02760433|454226425|FG003|Overall Study|Subject refused to continue the study|0|||
126255599|NCT02760433|454226426|FG004|Overall Study|Subject refused to continue the study|0|||
126255600|NCT02760433|454226422|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
126255601|NCT02760433|454226423|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
126255602|NCT02760433|454226424|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
126255603|NCT02760433|454226425|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
126449328|NCT02626624|454945294|FG000|Overall Study|Protocol Violation|4|||
126449329|NCT02626624|454945294|FG000|Overall Study|Death|2|||
126255604|NCT02760433|454226426|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
126255605|NCT02760433|454226422|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
126255606|NCT02760433|454226423|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
126255607|NCT02760433|454226424|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
126255608|NCT02760433|454226425|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
126255609|NCT02760433|454226426|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
126255610|NCT05889039|454226432|FG000|Overall Study|error in completing survey|0|||
126255611|NCT05889039|454226433|FG001|Overall Study|error in completing survey|2|||
126255612|NCT05889039|454226434|FG002|Overall Study|error in completing survey|0|||
126255613|NCT05889039|454226435|FG003|Overall Study|error in completing survey|0|||
126255614|NCT05889039|454226432|FG000|Overall Study|Lost to Follow-up|4|||
126255615|NCT05889039|454226433|FG001|Overall Study|Lost to Follow-up|0|||
126255616|NCT05889039|454226434|FG002|Overall Study|Lost to Follow-up|0|||
126255617|NCT05889039|454226435|FG003|Overall Study|Lost to Follow-up|0|||
126255618|NCT00982228|454226436|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
126255619|NCT00982228|454226437|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
126255620|NCT00982228|454226436|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
126255621|NCT00982228|454226437|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
126255622|NCT00982228|454226436|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
126255623|NCT00982228|454226437|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
126255624|NCT00982228|454226436|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
126255625|NCT00982228|454226437|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
126255626|NCT00982228|454226436|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
126255627|NCT00982228|454226437|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
126255628|NCT00982228|454226436|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
126255629|NCT00982228|454226437|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
126255630|NCT00982228|454226436|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
126255631|NCT00982228|454226437|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
126255632|NCT00982228|454226436|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
126255633|NCT00982228|454226437|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
126255634|NCT00982228|454226436|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
126255635|NCT00982228|454226437|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
126255636|NCT00982228|454226436|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
126255637|NCT00982228|454226437|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
126255638|NCT01438476|454226438|FG000|Overall Study|Protocol Violation|1|||
126255639|NCT01438476|454226439|FG001|Overall Study|Protocol Violation|0|||
126255640|NCT01438476|454226438|FG000|Overall Study|Withdrawal by Subject|1|||
126255641|NCT01438476|454226439|FG001|Overall Study|Withdrawal by Subject|0|||
126255642|NCT01438476|454226438|FG000|Overall Study|No Surgery- Disease|8|||
126255643|NCT01438476|454226439|FG001|Overall Study|No Surgery- Disease|10|||
126255644|NCT01438476|454226438|FG000|Overall Study|Communication barrier|0|||
126255645|NCT01438476|454226439|FG001|Overall Study|Communication barrier|1|||
126255646|NCT02058160|454226440|FG000|Overall Study|Randomized but not treated|2|||
126255647|NCT02058160|454226441|FG001|Overall Study|Randomized but not treated|4|||
126255648|NCT02058160|454226440|FG000|Overall Study|Poor compliance to protocol|4|||
126255649|NCT02058160|454226441|FG001|Overall Study|Poor compliance to protocol|1|||
126255650|NCT02058160|454226440|FG000|Overall Study|Adverse Event|12|||
126255651|NCT02058160|454226441|FG001|Overall Study|Adverse Event|3|||
126255652|NCT02058160|454226440|FG000|Overall Study|Lost to Follow-up|1|||
126255653|NCT02058160|454226441|FG001|Overall Study|Lost to Follow-up|0|||
126255654|NCT02058160|454226440|FG000|Overall Study|Other than specified above|12|||
126255655|NCT02058160|454226441|FG001|Overall Study|Other than specified above|6|||
126255656|NCT01517867|454226443|FG000|Overall Study|never started treatment|29|||
126255657|NCT01517867|454226444|FG001|Overall Study|never started treatment|32|||
126255658|NCT01517867|454226443|FG000|Overall Study|Withdrawal by Subject|34|||
126255659|NCT01517867|454226444|FG001|Overall Study|Withdrawal by Subject|30|||
126255660|NCT01517867|454226443|FG000|Overall Study|Still in treatment at study end|0|||
126255661|NCT01517867|454226444|FG001|Overall Study|Still in treatment at study end|3|||
126255662|NCT03294317|454226446|FG000|Overall Study|Physician Decision|1|||
126255663|NCT03294317|454226446|FG000|Overall Study|Withdrawal by Subject|6|||
126255664|NCT03294317|454226446|FG000|Overall Study|Lost to Follow-up|1|||
126255665|NCT03294317|454226446|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
126255666|NCT03294317|454226446|FG000|Overall Study|Failed HB lead implant|8|||
126255667|NCT03294317|454226446|FG000|Overall Study|Received CRT instead|1|||
126449330|NCT01868542|454947063|FG000|Overall Study|Protocol Violation|0|||
126255668|NCT03294317|454226446|FG000|Overall Study|Exited after lead revision|2|||
126255669|NCT01266603|454226447|FG000|Overall Study|Adverse Event|1|||
126255670|NCT01266603|454226447|FG000|Overall Study|Lack of Efficacy|14|||
126255671|NCT01266603|454226447|FG000|Overall Study|Withdrawal by Subject|1|||
126255672|NCT01266603|454226447|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
126255673|NCT01160640|454226448|FG000|Overall Study|Physician Decision|3|||
126255674|NCT01160640|454226449|FG001|Overall Study|Physician Decision|3|||
126255675|NCT01160640|454226448|FG000|Overall Study|Incarceration|1|||
126255676|NCT01160640|454226449|FG001|Overall Study|Incarceration|0|||
126255677|NCT01160640|454226448|FG000|Overall Study|Withdrawal by Subject|0|||
126255678|NCT01160640|454226449|FG001|Overall Study|Withdrawal by Subject|3|||
126255679|NCT01120691|454226454|FG000|Overall Study|Adverse Event|59|||
126255680|NCT01120691|454226455|FG001|Overall Study|Adverse Event|67|||
126255681|NCT01120691|454226456|FG002|Overall Study|Adverse Event|47|||
126255682|NCT01120691|454226454|FG000|Overall Study|Subject withdrew consent|33|||
126255683|NCT01120691|454226455|FG001|Overall Study|Subject withdrew consent|50|||
126255684|NCT01120691|454226456|FG002|Overall Study|Subject withdrew consent|44|||
126255685|NCT01120691|454226454|FG000|Overall Study|Death|21|||
126255686|NCT01120691|454226455|FG001|Overall Study|Death|22|||
126255687|NCT01120691|454226456|FG002|Overall Study|Death|24|||
126255688|NCT01120691|454226454|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
126255689|NCT01120691|454226455|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
126255690|NCT01120691|454226456|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
126255691|NCT01120691|454226454|FG000|Overall Study|Administrative problems|15|||
126255692|NCT01120691|454226455|FG001|Overall Study|Administrative problems|8|||
126255693|NCT01120691|454226456|FG002|Overall Study|Administrative problems|9|||
126255694|NCT01120691|454226454|FG000|Overall Study|Protocol deviation|13|||
126255695|NCT01120691|454226455|FG001|Overall Study|Protocol deviation|12|||
126255696|NCT01120691|454226456|FG002|Overall Study|Protocol deviation|12|||
126255697|NCT01120691|454226454|FG000|Overall Study|Lost to Follow-up|5|||
126255698|NCT01120691|454226455|FG001|Overall Study|Lost to Follow-up|6|||
126255699|NCT01120691|454226456|FG002|Overall Study|Lost to Follow-up|4|||
126255700|NCT01120691|454226454|FG000|Overall Study|Abnormal test procedure result(s)|3|||
126255701|NCT01120691|454226455|FG001|Overall Study|Abnormal test procedure result(s)|2|||
126255702|NCT01120691|454226456|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126255703|NCT01120691|454226454|FG000|Overall Study|Patient's inability to use the device|3|||
126255704|NCT01120691|454226455|FG001|Overall Study|Patient's inability to use the device|1|||
126255705|NCT01120691|454226456|FG002|Overall Study|Patient's inability to use the device|0|||
126255706|NCT01120691|454226454|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126255707|NCT01120691|454226455|FG001|Overall Study|Abnormal laboratory value(s)|3|||
126255708|NCT01120691|454226456|FG002|Overall Study|Abnormal laboratory value(s)|4|||
126255709|NCT00642811|454226457|FG000|Overall Study|Adverse Event|2|||
126255710|NCT00642811|454226458|FG001|Overall Study|Adverse Event|3|||
126255711|NCT00642811|454226459|FG002|Overall Study|Adverse Event|0|||
126255712|NCT00642811|454226460|FG003|Overall Study|Adverse Event|0|||
126255713|NCT00642811|454226461|FG004|Overall Study|Adverse Event|0|||
126255714|NCT00642811|454226462|FG005|Overall Study|Adverse Event|1|||
126255715|NCT00642811|454226457|FG000|Overall Study|Developement of discontinuation criteria|0|||
126255716|NCT00642811|454226458|FG001|Overall Study|Developement of discontinuation criteria|0|||
126255717|NCT00642811|454226459|FG002|Overall Study|Developement of discontinuation criteria|0|||
126255718|NCT00642811|454226460|FG003|Overall Study|Developement of discontinuation criteria|0|||
126255719|NCT00642811|454226461|FG004|Overall Study|Developement of discontinuation criteria|1|||
126255720|NCT00642811|454226462|FG005|Overall Study|Developement of discontinuation criteria|0|||
126255721|NCT00642811|454226457|FG000|Overall Study|Severe Non-compliance to protocol|1|||
126255722|NCT00642811|454226458|FG001|Overall Study|Severe Non-compliance to protocol|0|||
126255723|NCT00642811|454226459|FG002|Overall Study|Severe Non-compliance to protocol|0|||
126255724|NCT00642811|454226460|FG003|Overall Study|Severe Non-compliance to protocol|0|||
126255725|NCT00642811|454226461|FG004|Overall Study|Severe Non-compliance to protocol|0|||
126255726|NCT00642811|454226462|FG005|Overall Study|Severe Non-compliance to protocol|0|||
126255727|NCT00642811|454226457|FG000|Overall Study|Other|0|||
126255728|NCT00642811|454226458|FG001|Overall Study|Other|1|||
126255729|NCT00642811|454226459|FG002|Overall Study|Other|0|||
126255730|NCT00642811|454226460|FG003|Overall Study|Other|1|||
126255731|NCT00642811|454226461|FG004|Overall Study|Other|0|||
126255732|NCT00642811|454226462|FG005|Overall Study|Other|0|||
126255733|NCT03370510|454226466|FG000|Overall Study|COVID-19|2|||
126255734|NCT03370510|454226467|FG001|Overall Study|COVID-19|0|||
126255735|NCT01562613|454226468|FG000|Overall Study|Lost to Follow-up|2|||
126255736|NCT01562613|454226468|FG000|Overall Study|Withdrawal by Subject|2|||
126255737|NCT01525628|454226473|FG000|Overall Study|Adverse Event|1|||
126255738|NCT01525628|454226474|FG001|Overall Study|Adverse Event|1|||
126255739|NCT01525628|454226475|FG002|Overall Study|Adverse Event|2|||
126358379|NCT03735498|454605319|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
126358380|NCT03787212|454605321|FG000|Period 1|Study Termination|2|||
126546433|NCT03573908|455293800|FG000|Treatment Period|Pregnancy|1|||
126546434|NCT03573908|455293801|FG001|Treatment Period|Pregnancy|0|||
126255740|NCT01525628|454226476|FG003|Overall Study|Adverse Event|0|||
126255741|NCT01525628|454226477|FG004|Overall Study|Adverse Event|1|||
126255742|NCT01525628|454226473|FG000|Overall Study|Lack of Efficacy|0|||
126255743|NCT01525628|454226474|FG001|Overall Study|Lack of Efficacy|2|||
126255744|NCT01525628|454226475|FG002|Overall Study|Lack of Efficacy|2|||
126255745|NCT01525628|454226476|FG003|Overall Study|Lack of Efficacy|1|||
126255746|NCT01525628|454226477|FG004|Overall Study|Lack of Efficacy|2|||
126255747|NCT01525628|454226473|FG000|Overall Study|Protocol Violation|0|||
126255748|NCT01525628|454226474|FG001|Overall Study|Protocol Violation|0|||
126255749|NCT01525628|454226475|FG002|Overall Study|Protocol Violation|1|||
126255750|NCT01525628|454226476|FG003|Overall Study|Protocol Violation|0|||
126255751|NCT01525628|454226477|FG004|Overall Study|Protocol Violation|0|||
126255752|NCT01525628|454226473|FG000|Overall Study|Lost to Follow-up|1|||
126255753|NCT01525628|454226474|FG001|Overall Study|Lost to Follow-up|1|||
126255754|NCT01525628|454226475|FG002|Overall Study|Lost to Follow-up|0|||
126255755|NCT01525628|454226476|FG003|Overall Study|Lost to Follow-up|0|||
126255756|NCT01525628|454226477|FG004|Overall Study|Lost to Follow-up|0|||
126255757|NCT01525628|454226473|FG000|Overall Study|Withdrawal by Subject|0|||
126255758|NCT01525628|454226474|FG001|Overall Study|Withdrawal by Subject|1|||
126255759|NCT01525628|454226475|FG002|Overall Study|Withdrawal by Subject|0|||
126255760|NCT01525628|454226476|FG003|Overall Study|Withdrawal by Subject|0|||
126255761|NCT01525628|454226477|FG004|Overall Study|Withdrawal by Subject|0|||
126255762|NCT01525628|454226473|FG000|Overall Study|Other reason not defined above|0|||
126255763|NCT01525628|454226474|FG001|Overall Study|Other reason not defined above|0|||
126255764|NCT01525628|454226475|FG002|Overall Study|Other reason not defined above|0|||
126255765|NCT01525628|454226476|FG003|Overall Study|Other reason not defined above|3|||
126255766|NCT01525628|454226477|FG004|Overall Study|Other reason not defined above|0|||
126255767|NCT00239005|454226478|FG000|Overall Study|Adverse Event|6|||
126255768|NCT00239005|454226479|FG001|Overall Study|Adverse Event|6|||
126255769|NCT00239005|454226478|FG000|Overall Study|Withdrawal by Subject|3|||
126255770|NCT00239005|454226479|FG001|Overall Study|Withdrawal by Subject|4|||
126255771|NCT00239005|454226478|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
126255772|NCT00239005|454226479|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
126255773|NCT00239005|454226478|FG000|Overall Study|Protocol Violation|1|||
126255774|NCT00239005|454226479|FG001|Overall Study|Protocol Violation|0|||
126255775|NCT00239005|454226478|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
126255776|NCT00239005|454226479|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
126255777|NCT00239005|454226478|FG000|Overall Study|Lost to Follow-up|0|||
126255778|NCT00239005|454226479|FG001|Overall Study|Lost to Follow-up|1|||
126255779|NCT02614898|454226480|FG000|Overall Study|Participated until study termination|10|||
126255780|NCT02614898|454226481|FG001|Overall Study|Participated until study termination|26|||
126255781|NCT02614898|454226480|FG000|Overall Study|Lost to Follow-up|0|||
126255782|NCT02614898|454226481|FG001|Overall Study|Lost to Follow-up|2|||
126255783|NCT02614898|454226480|FG000|Overall Study|Physician Decision|1|||
126255784|NCT02614898|454226481|FG001|Overall Study|Physician Decision|8|||
126255785|NCT02614898|454226480|FG000|Overall Study|Study Terminated by Sponsor|3|||
126255786|NCT02614898|454226481|FG001|Overall Study|Study Terminated by Sponsor|0|||
126255787|NCT02614898|454226480|FG000|Overall Study|Withdrawal by Subject|0|||
126255788|NCT02614898|454226481|FG001|Overall Study|Withdrawal by Subject|2|||
126255789|NCT02614898|454226480|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126255790|NCT02614898|454226481|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126255791|NCT02614898|454226480|FG000|Overall Study|Other-Additional Information Unavailable|0|||
126255792|NCT02614898|454226481|FG001|Overall Study|Other-Additional Information Unavailable|11|||
126255793|NCT02614898|454226480|FG000|Overall Study|Missing|0|||
126255794|NCT02614898|454226481|FG001|Overall Study|Missing|1|||
126255795|NCT03382041|454226482|FG000|Overall Study|Consent Form Lost|2|||
126255796|NCT03382041|454226483|FG001|Overall Study|Consent Form Lost|1|||
126255797|NCT03382041|454226482|FG000|Overall Study|Withdrawal by Subject|1|||
126255798|NCT03382041|454226483|FG001|Overall Study|Withdrawal by Subject|4|||
126255799|NCT03382041|454226482|FG000|Overall Study|Lost to Follow-up|1|||
126255800|NCT03382041|454226483|FG001|Overall Study|Lost to Follow-up|4|||
126255801|NCT03108820|454226484|FG000|Overall Study|Lost to Follow-up|30|||
126762916|NCT04678557|456082799|FG000|Overall Study|Withdrawal by Subject|1|||
126762917|NCT04678557|456082800|FG001|Overall Study|Withdrawal by Subject|0|||
126762918|NCT04678557|456082799|FG000|Overall Study|Lack of Efficacy|0|||
126762919|NCT04678557|456082800|FG001|Overall Study|Lack of Efficacy|13|||
126255802|NCT03108820|454226485|FG001|Overall Study|Lost to Follow-up|28|||
126255803|NCT03108820|454226484|FG000|Overall Study|Withdrawal by Subject|32|||
126255804|NCT03108820|454226485|FG001|Overall Study|Withdrawal by Subject|24|||
126255805|NCT03108820|454226484|FG000|Overall Study|Death|6|||
126255806|NCT03108820|454226485|FG001|Overall Study|Death|11|||
126255807|NCT00787605|454226486|FG000|Overall Study|Administrative Problems|3|||
126255808|NCT00787605|454226487|FG001|Overall Study|Administrative Problems|0|||
126255809|NCT00787605|454226486|FG000|Overall Study|Adverse Event|14|||
126255810|NCT00787605|454226487|FG001|Overall Study|Adverse Event|25|||
126255811|NCT00787605|454226486|FG000|Overall Study|Lost to Follow-up|3|||
126762920|NCT04678557|456082799|FG000|Overall Study|Safety Evaluation|0|||
126255812|NCT00787605|454226487|FG001|Overall Study|Lost to Follow-up|6|||
126255813|NCT00787605|454226486|FG000|Overall Study|Protocol Violation|7|||
126255814|NCT00787605|454226487|FG001|Overall Study|Protocol Violation|3|||
126255815|NCT00787605|454226486|FG000|Overall Study|Withdrawal by Subject|6|||
126762921|NCT04678557|456082800|FG001|Overall Study|Safety Evaluation|1|||
126762922|NCT02513732|456084828|FG000|Overall Study|Lost to Follow-up|11|||
126762923|NCT02513732|456084828|FG000|Overall Study|Death|9|||
126762924|NCT02513732|456084828|FG000|Overall Study|Changing hospital|2|||
126762925|NCT01740297|456084829|FG000|Overall Study|Withdrawal by Subject|4|||
126762926|NCT01740297|456084830|FG001|Overall Study|Withdrawal by Subject|16|||
126762927|NCT01740297|456084831|FG002|Overall Study|Withdrawal by Subject|17|||
126762928|NCT01740297|456084829|FG000|Overall Study|Death|8|||
126762929|NCT01740297|456084830|FG001|Overall Study|Death|46|||
126762930|NCT01740297|456084831|FG002|Overall Study|Death|40|||
126255816|NCT00787605|454226487|FG001|Overall Study|Withdrawal by Subject|13|||
126255817|NCT00787605|454226486|FG000|Overall Study|Lack of Efficacy|13|||
126255818|NCT00787605|454226487|FG001|Overall Study|Lack of Efficacy|9|||
126255819|NCT00089973|454226490|FG000|Overall Study|Adverse Event|3|||
126255820|NCT00089973|454226490|FG000|Overall Study|Withdrawal by Subject|1|||
126255821|NCT00089973|454226490|FG000|Overall Study|Disease progression|45|||
126255822|NCT00089973|454226490|FG000|Overall Study|Death|1|||
126255823|NCT01992094|454226492|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
126255824|NCT01992094|454226493|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
126255825|NCT01992094|454226494|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
126762931|NCT01740297|456084829|FG000|Overall Study|Lost to Follow-up|1|||
126762932|NCT01740297|456084830|FG001|Overall Study|Lost to Follow-up|2|||
126762933|NCT01740297|456084831|FG002|Overall Study|Lost to Follow-up|4|||
126762934|NCT00761462|456084836|FG000|Treatment|Subjects never received study medication|23|||
126762935|NCT00761462|456084837|FG001|Treatment|Subjects never received study medication|12|||
126762936|NCT00761462|456084836|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
126762937|NCT00761462|456084837|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
126762938|NCT00761462|456084836|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
126762939|NCT00761462|456084837|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
126762940|NCT00761462|456084836|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
126762941|NCT00761462|456084837|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
126762942|NCT01479777|456084838|FG000|Overall Study|Physician Decision|2|||
126762943|NCT01541644|456084841|FG000|Overall Study|Withdrawal by Subject|3|||
126762944|NCT02389621|456084844|FG000|Treatment Period|Withdrawal by Subject|1|||
126762945|NCT02389621|456084845|FG001|Treatment Period|Withdrawal by Subject|1|||
126762946|NCT02389621|456084844|FG000|Posttreatment Period|Adverse Event|3|||
126762947|NCT02389621|456084845|FG001|Posttreatment Period|Adverse Event|1|||
126358381|NCT03787212|454605322|FG001|Period 1|Study Termination|2|||
126358382|NCT02014103|454605323|FG000|Overall Study|Protocol Violation|7|||
126358383|NCT02014103|454605324|FG001|Overall Study|Protocol Violation|7|||
126255826|NCT01992094|454226492|FG000|Overall Study|Adverse Event|1|||
126255827|NCT01992094|454226493|FG001|Overall Study|Adverse Event|0|||
126255828|NCT01992094|454226494|FG002|Overall Study|Adverse Event|0|||
126255829|NCT01992094|454226492|FG000|Overall Study|Death|5|||
126255830|NCT01992094|454226493|FG001|Overall Study|Death|5|||
126358384|NCT02014103|454605323|FG000|Overall Study|Adverse Event|1|||
126358385|NCT02014103|454605324|FG001|Overall Study|Adverse Event|0|||
126358386|NCT02014103|454605323|FG000|Overall Study|Lost venous access|1|||
126358387|NCT02014103|454605324|FG001|Overall Study|Lost venous access|0|||
126358388|NCT02014103|454605323|FG000|Overall Study|Withdrawal by Subject|0|||
126762948|NCT02389621|456084844|FG000|Posttreatment Period|Withdrawal by Subject|3|||
126762949|NCT02389621|456084845|FG001|Posttreatment Period|Withdrawal by Subject|2|||
126762950|NCT02389621|456084844|FG000|Posttreatment Period|Lost to Follow-up|1|||
126762951|NCT02389621|456084845|FG001|Posttreatment Period|Lost to Follow-up|1|||
126358389|NCT02014103|454605324|FG001|Overall Study|Withdrawal by Subject|2|||
126358390|NCT00620035|454605325|FG000|Overall Study|Adverse Event|106|||
126449331|NCT01868542|454947064|FG001|Overall Study|Protocol Violation|1|||
126255831|NCT01992094|454226494|FG002|Overall Study|Death|2|||
126255832|NCT01992094|454226492|FG000|Overall Study|Lost to Follow-up|26|||
126255833|NCT01992094|454226493|FG001|Overall Study|Lost to Follow-up|9|||
126762952|NCT02389621|456084844|FG000|Posttreatment Period|Other - Miscellaneous|2|||
126762953|NCT02389621|456084845|FG001|Posttreatment Period|Other - Miscellaneous|0|||
126255834|NCT01992094|454226494|FG002|Overall Study|Lost to Follow-up|13|||
126255835|NCT01992094|454226492|FG000|Overall Study|OTHER|4|||
126255836|NCT01992094|454226493|FG001|Overall Study|OTHER|0|||
126762954|NCT00953017|456084860|FG000|Overall Study|DId not show up for colonoscopy|4|||
126255837|NCT01992094|454226494|FG002|Overall Study|OTHER|0|||
126255838|NCT01992094|454226492|FG000|Overall Study|Protocol Violation|1|||
126255839|NCT01992094|454226493|FG001|Overall Study|Protocol Violation|0|||
126255840|NCT01992094|454226494|FG002|Overall Study|Protocol Violation|1|||
126255841|NCT01992094|454226492|FG000|Overall Study|Withdrawal by Subject|7|||
126255842|NCT01992094|454226493|FG001|Overall Study|Withdrawal by Subject|3|||
126762955|NCT00953017|456084861|FG001|Overall Study|DId not show up for colonoscopy|4|||
126255843|NCT01992094|454226494|FG002|Overall Study|Withdrawal by Subject|4|||
126358391|NCT00620035|454605325|FG000|Overall Study|Withdrawal of Informed Consent|1|||
126358392|NCT00620035|454605325|FG000|Overall Study|Other Reason|38|||
126358393|NCT04193176|454605327|FG000|Overall Study|Withdrawal by Subject|6|||
126255844|NCT01214239|454226495|FG000|Overall Study|Adverse Event|3|||
126255845|NCT01214239|454226496|FG001|Overall Study|Adverse Event|4|||
126255846|NCT01214239|454226495|FG000|Overall Study|Protocol Violation|2|||
126255847|NCT01214239|454226496|FG001|Overall Study|Protocol Violation|1|||
126255848|NCT01214239|454226495|FG000|Overall Study|Lost to Follow-up|1|||
126255849|NCT01214239|454226496|FG001|Overall Study|Lost to Follow-up|1|||
126255850|NCT01214239|454226495|FG000|Overall Study|Withdrawal by Subject|4|||
126255851|NCT01214239|454226496|FG001|Overall Study|Withdrawal by Subject|9|||
126255852|NCT01214239|454226495|FG000|Overall Study|Lack of Efficacy|1|||
126255853|NCT01214239|454226496|FG001|Overall Study|Lack of Efficacy|2|||
126255854|NCT01214239|454226495|FG000|Overall Study|patient's private reason|1|||
126255855|NCT01214239|454226496|FG001|Overall Study|patient's private reason|1|||
126255856|NCT01049581|454226497|FG000|Overall Study|Lost to Follow-up|2|||
126255857|NCT01049581|454226498|FG001|Overall Study|Lost to Follow-up|1|||
126255858|NCT03203642|454226499|FG000|Overall Study|Adverse Event|3|||
126255859|NCT03203642|454226500|FG001|Overall Study|Adverse Event|1|||
126255860|NCT03203642|454226499|FG000|Overall Study|Withdrawal by Subject|6|||
126255861|NCT03203642|454226500|FG001|Overall Study|Withdrawal by Subject|6|||
126255862|NCT03203642|454226499|FG000|Overall Study|Lost to Follow-up|2|||
126255863|NCT03203642|454226500|FG001|Overall Study|Lost to Follow-up|1|||
126255864|NCT03203642|454226499|FG000|Overall Study|Termination of the study by sponsor|1|||
126255865|NCT03203642|454226500|FG001|Overall Study|Termination of the study by sponsor|1|||
126255866|NCT03203642|454226499|FG000|Overall Study|Participant moved|0|||
126255867|NCT03203642|454226500|FG001|Overall Study|Participant moved|1|||
126255868|NCT03203642|454226499|FG000|Overall Study|Investigator's decision|3|||
126255869|NCT03203642|454226500|FG001|Overall Study|Investigator's decision|0|||
126255870|NCT03203642|454226499|FG000|Overall Study|Other than above specified|0|||
126255871|NCT03203642|454226500|FG001|Overall Study|Other than above specified|1|||
126255872|NCT05068284|454226513|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
126255873|NCT05068284|454226514|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
126255874|NCT05068284|454226515|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
126255875|NCT05068284|454226516|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
126255876|NCT05068284|454226517|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
126255877|NCT05068284|454226518|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
126255878|NCT05068284|454226519|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
126255879|NCT05068284|454226520|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
126255880|NCT05068284|454226513|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255881|NCT05068284|454226514|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255882|NCT05068284|454226515|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
126255883|NCT05068284|454226516|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255884|NCT05068284|454226517|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255885|NCT05068284|454226518|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255886|NCT05068284|454226519|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255887|NCT05068284|454226520|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
126255888|NCT05068284|454226513|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
126255889|NCT05068284|454226514|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
126255890|NCT05068284|454226515|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
126255891|NCT05068284|454226516|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
126255892|NCT05068284|454226517|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
126255893|NCT05068284|454226518|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
126255894|NCT05068284|454226519|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
126255895|NCT05068284|454226520|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
126255896|NCT05068284|454226513|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
126255897|NCT05068284|454226514|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
126255898|NCT05068284|454226515|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
126255899|NCT05068284|454226516|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
126255900|NCT05068284|454226517|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
126255901|NCT05068284|454226518|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
126255902|NCT05068284|454226519|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
126255903|NCT05068284|454226520|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
126255904|NCT05068284|454226513|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255905|NCT05068284|454226514|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255906|NCT05068284|454226515|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255907|NCT05068284|454226516|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
126255908|NCT05068284|454226517|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255909|NCT05068284|454226518|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255910|NCT05068284|454226519|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255911|NCT05068284|454226520|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
126255912|NCT05068284|454226513|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
126255913|NCT05068284|454226514|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
126255914|NCT05068284|454226515|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
126255915|NCT05068284|454226516|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
126255916|NCT05068284|454226517|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
126255917|NCT05068284|454226518|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
126255918|NCT05068284|454226519|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
126255919|NCT05068284|454226520|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
126255920|NCT05068284|454226513|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255921|NCT05068284|454226514|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255922|NCT05068284|454226515|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
126255923|NCT05068284|454226516|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255924|NCT05068284|454226517|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255925|NCT05068284|454226518|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255926|NCT05068284|454226519|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255927|NCT05068284|454226520|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
126255928|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
126255929|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255930|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255931|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255932|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255933|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255934|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255935|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
126255936|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
126255937|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
126255938|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
126255939|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
126255940|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
126255941|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
126255942|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
126255943|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
126255944|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
126255945|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
126255946|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
126255947|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
126762956|NCT00953017|456084862|FG002|Overall Study|DId not show up for colonoscopy|5|||
126762957|NCT00953017|456084863|FG003|Overall Study|DId not show up for colonoscopy|4|||
126762958|NCT00953017|456084860|FG000|Overall Study|Incomplete data|1|||
126762959|NCT00953017|456084861|FG001|Overall Study|Incomplete data|1|||
126255948|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
126255949|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
126255950|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
126255951|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
126255952|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
126255953|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255954|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255955|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255956|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255957|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255958|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255959|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
126255960|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
126255961|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126255962|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126255963|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126255964|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126255965|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126449332|NCT01868542|454947063|FG000|Overall Study|Unclassified|0|||
126762960|NCT00953017|456084862|FG002|Overall Study|Incomplete data|0|||
126762961|NCT00953017|456084863|FG003|Overall Study|Incomplete data|0|||
126762962|NCT00953017|456084860|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
126762963|NCT00953017|456084861|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
126762964|NCT00953017|456084862|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
126762965|NCT00953017|456084863|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
126762966|NCT00953017|456084860|FG000|Overall Study|Brown stool prior to procedure|0|||
126762967|NCT00953017|456084861|FG001|Overall Study|Brown stool prior to procedure|0|||
126358394|NCT04193176|454605328|FG001|Overall Study|Withdrawal by Subject|10|||
126358395|NCT01629563|454605329|FG000|Overall Study|Adverse Event|16|||
126358396|NCT01629563|454605330|FG001|Overall Study|Adverse Event|16|||
126762968|NCT00953017|456084862|FG002|Overall Study|Brown stool prior to procedure|1|||
126762969|NCT00953017|456084863|FG003|Overall Study|Brown stool prior to procedure|0|||
126762970|NCT00449761|456084866|FG000|Overall Study|Disease progression|12|||
126762971|NCT00449761|456084866|FG000|Overall Study|Death|5|||
126762972|NCT00449761|456084866|FG000|Overall Study|New cancer therapy|1|||
126762973|NCT00344968|456084869|FG000|Overall Study|Adverse Event|5|||
126762974|NCT00344968|456084870|FG001|Overall Study|Adverse Event|4|||
126762975|NCT00344968|456084871|FG002|Overall Study|Adverse Event|15|||
126255966|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126255967|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
126255968|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
126255969|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
126255970|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
126255971|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
126255972|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
126255973|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
126255974|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
126255975|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
126255976|NCT05068284|454226513|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255977|NCT05068284|454226514|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255978|NCT05068284|454226515|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255979|NCT05068284|454226516|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255980|NCT05068284|454226517|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255981|NCT05068284|454226518|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255982|NCT05068284|454226519|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
126255983|NCT05068284|454226520|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
126255984|NCT00965731|454226521|FG000|Overall Study|Death|0|||
126255985|NCT00965731|454226522|FG001|Overall Study|Death|4|||
126255986|NCT00965731|454226521|FG000|Overall Study|Withdrawal by Subject|0|||
126255987|NCT00965731|454226522|FG001|Overall Study|Withdrawal by Subject|1|||
126255988|NCT00965731|454226521|FG000|Overall Study|Other|7|||
126255989|NCT00965731|454226522|FG001|Overall Study|Other|15|||
126255990|NCT01074008|454229146|FG000|Overall Study|Adverse Event|0|||
126255991|NCT01074008|454229147|FG001|Overall Study|Adverse Event|1|||
126255992|NCT01074008|454229148|FG002|Overall Study|Adverse Event|0|||
126762976|NCT00344968|456084869|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126762977|NCT00344968|456084870|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126762978|NCT00344968|456084871|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
126762979|NCT00344968|456084869|FG000|Overall Study|Protocol Violation|2|||
126762980|NCT00344968|456084870|FG001|Overall Study|Protocol Violation|2|||
126255993|NCT01074008|454229149|FG003|Overall Study|Adverse Event|0|||
126255994|NCT01074008|454229150|FG004|Overall Study|Adverse Event|0|||
126255995|NCT01074008|454229151|FG005|Overall Study|Adverse Event|0|||
126255996|NCT01074008|454229152|FG006|Overall Study|Adverse Event|0|||
126255997|NCT01074008|454229153|FG007|Overall Study|Adverse Event|0|||
126255998|NCT01074008|454229154|FG008|Overall Study|Adverse Event|0|||
126255999|NCT01074008|454229146|FG000|Overall Study|Withdrawal by Subject|1|||
126256000|NCT01074008|454229147|FG001|Overall Study|Withdrawal by Subject|1|||
126256001|NCT01074008|454229148|FG002|Overall Study|Withdrawal by Subject|1|||
126256002|NCT01074008|454229149|FG003|Overall Study|Withdrawal by Subject|0|||
126256003|NCT01074008|454229150|FG004|Overall Study|Withdrawal by Subject|1|||
126256004|NCT01074008|454229151|FG005|Overall Study|Withdrawal by Subject|0|||
126256005|NCT01074008|454229152|FG006|Overall Study|Withdrawal by Subject|0|||
126256006|NCT01074008|454229153|FG007|Overall Study|Withdrawal by Subject|0|||
126256007|NCT01074008|454229154|FG008|Overall Study|Withdrawal by Subject|0|||
126256008|NCT01074008|454229146|FG000|Overall Study|Lost to Follow-up|0|||
126256009|NCT01074008|454229147|FG001|Overall Study|Lost to Follow-up|1|||
126256010|NCT01074008|454229148|FG002|Overall Study|Lost to Follow-up|1|||
126256011|NCT01074008|454229149|FG003|Overall Study|Lost to Follow-up|1|||
126358397|NCT01629563|454605329|FG000|Overall Study|Death|2|||
126358398|NCT01629563|454605330|FG001|Overall Study|Death|0|||
126762981|NCT00344968|456084871|FG002|Overall Study|Protocol Violation|5|||
126762982|NCT00344968|456084869|FG000|Overall Study|Withdrawal by Subject|14|||
126762983|NCT00344968|456084870|FG001|Overall Study|Withdrawal by Subject|31|||
126762984|NCT00344968|456084871|FG002|Overall Study|Withdrawal by Subject|27|||
126762985|NCT00344968|456084869|FG000|Overall Study|Lost to Follow-up|24|||
126762986|NCT00344968|456084870|FG001|Overall Study|Lost to Follow-up|37|||
126762987|NCT00344968|456084871|FG002|Overall Study|Lost to Follow-up|37|||
126762988|NCT00344968|456084869|FG000|Overall Study|Death|11|||
126762989|NCT00344968|456084870|FG001|Overall Study|Death|27|||
126762990|NCT00344968|456084871|FG002|Overall Study|Death|31|||
126762991|NCT00344968|456084869|FG000|Overall Study|Other|0|||
126762992|NCT00344968|456084870|FG001|Overall Study|Other|1|||
126762993|NCT00344968|456084871|FG002|Overall Study|Other|0|||
126762994|NCT03735680|456084872|FG000|Overall Study|Withdrawal by Subject|0|||
126762995|NCT03735680|456084873|FG001|Overall Study|Withdrawal by Subject|1|||
126762996|NCT03735680|456084874|FG002|Overall Study|Withdrawal by Subject|0|||
126762997|NCT03735680|456084875|FG003|Overall Study|Withdrawal by Subject|0|||
126762998|NCT03735680|456084876|FG004|Overall Study|Withdrawal by Subject|0|||
126762999|NCT03735680|456084877|FG005|Overall Study|Withdrawal by Subject|1|||
126763000|NCT03735680|456084872|FG000|Overall Study|Patient unable or unwilling to continue|0|||
126763001|NCT03735680|456084873|FG001|Overall Study|Patient unable or unwilling to continue|0|||
126763002|NCT03735680|456084874|FG002|Overall Study|Patient unable or unwilling to continue|1|||
126763003|NCT03735680|456084875|FG003|Overall Study|Patient unable or unwilling to continue|0|||
126763004|NCT03735680|456084876|FG004|Overall Study|Patient unable or unwilling to continue|0|||
126763005|NCT03735680|456084877|FG005|Overall Study|Patient unable or unwilling to continue|0|||
126763006|NCT01422876|456084879|FG000|Week 24|Lost to Follow-up|1|||
126763007|NCT01422876|456084880|FG001|Week 24|Lost to Follow-up|1|||
126763008|NCT01422876|456084881|FG002|Week 24|Lost to Follow-up|2|||
126763009|NCT01422876|456084882|FG003|Week 24|Lost to Follow-up|4|||
126763010|NCT01422876|456084883|FG004|Week 24|Lost to Follow-up|2|||
126256012|NCT01074008|454229150|FG004|Overall Study|Lost to Follow-up|1|||
126256013|NCT01074008|454229151|FG005|Overall Study|Lost to Follow-up|0|||
126256014|NCT01074008|454229152|FG006|Overall Study|Lost to Follow-up|1|||
126256015|NCT01074008|454229153|FG007|Overall Study|Lost to Follow-up|0|||
126256016|NCT01074008|454229154|FG008|Overall Study|Lost to Follow-up|4|||
126256017|NCT02805309|454229155|FG000|Overall Study|Lost to Follow-up|2|||
126256018|NCT02805309|454229156|FG001|Overall Study|Lost to Follow-up|2|||
126256019|NCT02805309|454229157|FG002|Overall Study|Lost to Follow-up|2|||
126256020|NCT02805309|454229155|FG000|Overall Study|Post-Randomization Exclusion|0|||
126256021|NCT02805309|454229156|FG001|Overall Study|Post-Randomization Exclusion|2|||
126256022|NCT02805309|454229157|FG002|Overall Study|Post-Randomization Exclusion|1|||
126256023|NCT01350934|454229160|FG000|Base Study|Adverse Event|6|||
126256024|NCT01350934|454229161|FG001|Base Study|Adverse Event|0|||
126256025|NCT01350934|454229160|FG000|Base Study|Lost to Follow-up|1|||
126256026|NCT01350934|454229161|FG001|Base Study|Lost to Follow-up|0|||
126256027|NCT01350934|454229160|FG000|Base Study|Protocol Violation|1|||
126256028|NCT01350934|454229161|FG001|Base Study|Protocol Violation|1|||
126256029|NCT01350934|454229160|FG000|Base Study|Withdrawal by Subject|1|||
126256030|NCT01350934|454229161|FG001|Base Study|Withdrawal by Subject|2|||
126256031|NCT01350934|454229160|FG000|Base Study|Non-Compliance With Study Drug|2|||
126256032|NCT01350934|454229161|FG001|Base Study|Non-Compliance With Study Drug|0|||
126256033|NCT01350934|454229160|FG000|Extension Study|Adverse Event|2|||
126256034|NCT01350934|454229161|FG001|Extension Study|Adverse Event|1|||
126256035|NCT01350934|454229160|FG000|Extension Study|Lost to Follow-up|2|||
126256036|NCT01350934|454229161|FG001|Extension Study|Lost to Follow-up|0|||
126256037|NCT01350934|454229160|FG000|Extension Study|Protocol Violation|1|||
126256038|NCT01350934|454229161|FG001|Extension Study|Protocol Violation|1|||
126256039|NCT01350934|454229160|FG000|Extension Study|Lack of Efficacy|0|||
126256040|NCT01350934|454229161|FG001|Extension Study|Lack of Efficacy|1|||
126256041|NCT01350934|454229160|FG000|Extension Study|Withdrawal by Subject|0|||
126256042|NCT01350934|454229161|FG001|Extension Study|Withdrawal by Subject|1|||
126256043|NCT04129944|454229164|FG000|Overall Study|Death|0|||
126256044|NCT04129944|454229165|FG001|Overall Study|Death|0|||
126256045|NCT04129944|454229166|FG002|Overall Study|Death|0|||
126256046|NCT04129944|454229167|FG003|Overall Study|Death|1|||
126256047|NCT04129944|454229164|FG000|Overall Study|Lost to Follow-up|1|||
126256048|NCT04129944|454229165|FG001|Overall Study|Lost to Follow-up|0|||
126763011|NCT01422876|456084884|FG005|Week 24|Lost to Follow-up|0|||
126256049|NCT04129944|454229166|FG002|Overall Study|Lost to Follow-up|0|||
126256050|NCT04129944|454229167|FG003|Overall Study|Lost to Follow-up|0|||
126256051|NCT04129944|454229164|FG000|Overall Study|Withdrawal by Subject|1|||
126256052|NCT04129944|454229165|FG001|Overall Study|Withdrawal by Subject|0|||
126256053|NCT04129944|454229166|FG002|Overall Study|Withdrawal by Subject|1|||
126763012|NCT01422876|456084885|FG006|Week 24|Lost to Follow-up|1|||
126763013|NCT01422876|456084886|FG007|Week 24|Lost to Follow-up|3|||
126763014|NCT01422876|456084887|FG008|Week 24|Lost to Follow-up|3|||
126763015|NCT01422876|456084888|FG009|Week 24|Lost to Follow-up|4|||
126763016|NCT01422876|456084879|FG000|Week 24|Consent withdrawn|5|||
126763017|NCT01422876|456084880|FG001|Week 24|Consent withdrawn|1|||
126763018|NCT01422876|456084881|FG002|Week 24|Consent withdrawn|3|||
126763019|NCT01422876|456084882|FG003|Week 24|Consent withdrawn|4|||
126763020|NCT01422876|456084883|FG004|Week 24|Consent withdrawn|5|||
126763021|NCT01422876|456084884|FG005|Week 24|Consent withdrawn|6|||
126763022|NCT01422876|456084885|FG006|Week 24|Consent withdrawn|5|||
126763023|NCT01422876|456084886|FG007|Week 24|Consent withdrawn|4|||
126763024|NCT01422876|456084887|FG008|Week 24|Consent withdrawn|3|||
126763025|NCT01422876|456084888|FG009|Week 24|Consent withdrawn|6|||
126763026|NCT01422876|456084879|FG000|Week 24|Death|0|||
126763027|NCT01422876|456084880|FG001|Week 24|Death|1|||
126763028|NCT01422876|456084881|FG002|Week 24|Death|0|||
126763029|NCT01422876|456084882|FG003|Week 24|Death|0|||
126763030|NCT01422876|456084883|FG004|Week 24|Death|0|||
126763031|NCT01422876|456084884|FG005|Week 24|Death|0|||
126763032|NCT01422876|456084885|FG006|Week 24|Death|0|||
126763033|NCT01422876|456084886|FG007|Week 24|Death|0|||
126763034|NCT01422876|456084887|FG008|Week 24|Death|0|||
126763035|NCT01422876|456084888|FG009|Week 24|Death|0|||
126763036|NCT01422876|456084879|FG000|Week 52|Lost to Follow-up|3|||
126763037|NCT01422876|456084880|FG001|Week 52|Lost to Follow-up|5|||
126763038|NCT01422876|456084881|FG002|Week 52|Lost to Follow-up|7|||
126763039|NCT01422876|456084882|FG003|Week 52|Lost to Follow-up|5|||
126763040|NCT01422876|456084883|FG004|Week 52|Lost to Follow-up|8|||
126763041|NCT01422876|456084884|FG005|Week 52|Lost to Follow-up|5|||
126763042|NCT01422876|456084885|FG006|Week 52|Lost to Follow-up|5|||
126763043|NCT01422876|456084886|FG007|Week 52|Lost to Follow-up|8|||
126763044|NCT01422876|456084887|FG008|Week 52|Lost to Follow-up|7|||
126763045|NCT01422876|456084888|FG009|Week 52|Lost to Follow-up|8|||
126763046|NCT01422876|456084879|FG000|Week 52|Consent withdrawn|9|||
126763047|NCT01422876|456084880|FG001|Week 52|Consent withdrawn|4|||
126763048|NCT01422876|456084881|FG002|Week 52|Consent withdrawn|6|||
126763049|NCT01422876|456084882|FG003|Week 52|Consent withdrawn|12|||
126763050|NCT01422876|456084883|FG004|Week 52|Consent withdrawn|7|||
126763051|NCT01422876|456084884|FG005|Week 52|Consent withdrawn|12|||
126763052|NCT01422876|456084885|FG006|Week 52|Consent withdrawn|10|||
126763053|NCT01422876|456084886|FG007|Week 52|Consent withdrawn|12|||
126763054|NCT01422876|456084887|FG008|Week 52|Consent withdrawn|13|||
126763055|NCT01422876|456084888|FG009|Week 52|Consent withdrawn|9|||
126763056|NCT01422876|456084879|FG000|Week 52|Death|0|||
126763057|NCT01422876|456084880|FG001|Week 52|Death|1|||
126763058|NCT01422876|456084881|FG002|Week 52|Death|0|||
126763059|NCT01422876|456084882|FG003|Week 52|Death|1|||
126763060|NCT01422876|456084883|FG004|Week 52|Death|0|||
126763061|NCT01422876|456084884|FG005|Week 52|Death|0|||
126763062|NCT01422876|456084885|FG006|Week 52|Death|1|||
126763063|NCT01422876|456084886|FG007|Week 52|Death|3|||
126763064|NCT01422876|456084887|FG008|Week 52|Death|1|||
126763065|NCT01422876|456084888|FG009|Week 52|Death|0|||
126763066|NCT00054639|456084898|FG000|Overall Study|Lack of Efficacy|1|||
126763067|NCT00054639|456084898|FG000|Overall Study|Physician Decision|1|||
126763068|NCT05028816|456084910|FG000|Overall Study|Lost to Follow-up|5|||
126763069|NCT05028816|456084911|FG001|Overall Study|Lost to Follow-up|3|||
126763070|NCT05028816|456084910|FG000|Overall Study|Withdrawal by Subject|4|||
126763071|NCT05028816|456084911|FG001|Overall Study|Withdrawal by Subject|1|||
126763072|NCT05028816|456084910|FG000|Overall Study|Physician Decision|1|||
126763073|NCT05028816|456084911|FG001|Overall Study|Physician Decision|0|||
126763074|NCT05064436|456084912|FG000|Overall Study|Other Reasons|1|||
126763075|NCT05064436|456084913|FG001|Overall Study|Other Reasons|0|||
126763076|NCT01711736|456084915|FG000|Overall Study|Lost to Follow-up|4|||
126763077|NCT01711736|456084916|FG001|Overall Study|Lost to Follow-up|1|||
126763078|NCT01711736|456084915|FG000|Overall Study|Withdrawal by Subject|6|||
126763079|NCT01711736|456084916|FG001|Overall Study|Withdrawal by Subject|6|||
126763080|NCT01711736|456084915|FG000|Overall Study|Migrated/moved from study area|2|||
126763081|NCT01711736|456084916|FG001|Overall Study|Migrated/moved from study area|1|||
126763082|NCT02506101|456084917|FG000|Overall Study|Transportation issues|1|||
126358399|NCT01629563|454605329|FG000|Overall Study|Lack of Efficacy|2|||
126763083|NCT02506101|456084918|FG001|Overall Study|Transportation issues|0|||
126763084|NCT02506101|456084917|FG000|Overall Study|No enrollment and staff unavailability|1|||
126763085|NCT02506101|456084918|FG001|Overall Study|No enrollment and staff unavailability|0|||
126763086|NCT04640168|456084919|FG000|Overall Study|Withdrawal by Subject|8|||
126763087|NCT04640168|456084920|FG001|Overall Study|Withdrawal by Subject|7|||
126763088|NCT04640168|456084919|FG000|Overall Study|Lost to Follow-up|1|||
126763089|NCT04640168|456084920|FG001|Overall Study|Lost to Follow-up|0|||
126763090|NCT04640168|456084919|FG000|Overall Study|Enrolled but not treated|12|||
126763091|NCT04640168|456084920|FG001|Overall Study|Enrolled but not treated|12|||
126763092|NCT04366258|456084928|FG000|Baseline Assessments|Screen Failure|21|||
126763093|NCT04366258|456084928|FG000|Baseline Assessments|Early Termination|3|||
126763094|NCT01725217|456084929|FG000|Overall Study|Withdrawal by Subject|1|||
126763095|NCT01725217|456084930|FG001|Overall Study|Withdrawal by Subject|0|||
126763096|NCT01725217|456084931|FG002|Overall Study|Withdrawal by Subject|0|||
126763097|NCT00308555|456084932|FG000|Overall Study|Withdrawal by Subject|1|||
126763098|NCT00308555|456084933|FG001|Overall Study|Withdrawal by Subject|0|||
126763099|NCT00308555|456084932|FG000|Overall Study|Physician Decision|2|||
126763100|NCT00308555|456084933|FG001|Overall Study|Physician Decision|0|||
126763101|NCT00276458|456084934|FG000|Overall Study|Adverse Event|0|||
126763102|NCT00276458|456084935|FG001|Overall Study|Adverse Event|2|||
126256054|NCT04129944|454229167|FG003|Overall Study|Withdrawal by Subject|2|||
126256055|NCT00493792|454229168|FG000|Overall Study|Death|55|||
126256056|NCT00493792|454229169|FG001|Overall Study|Death|50|||
126256057|NCT00493792|454229168|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
126256058|NCT00493792|454229169|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
126256059|NCT00685035|454229170|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
126256060|NCT00685035|454229171|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
126256061|NCT04241133|454229172|FG000|Overall Study|COVID19 Precautions|14|||
126256062|NCT04241133|454229173|FG001|Overall Study|COVID19 Precautions|34|||
126256063|NCT04982445|454229174|FG000|Overall Study|Protocol Violation|1|||
126256064|NCT04982445|454229174|FG000|Overall Study|Withdrawal by Subject|4|||
126256065|NCT04982445|454229174|FG000|Overall Study|Lost to Follow-up|1|||
126256066|NCT00611884|454229176|FG000|Overall Study|Adverse Event|1|||
126256067|NCT00611884|454229177|FG001|Overall Study|Adverse Event|0|||
126256068|NCT00611884|454229178|FG002|Overall Study|Adverse Event|0|||
126256069|NCT00611884|454229179|FG003|Overall Study|Adverse Event|1|||
126256070|NCT00611884|454229176|FG000|Overall Study|Non-Compliance|1|||
126256071|NCT00611884|454229177|FG001|Overall Study|Non-Compliance|4|||
126256072|NCT00611884|454229178|FG002|Overall Study|Non-Compliance|2|||
126256073|NCT00611884|454229179|FG003|Overall Study|Non-Compliance|2|||
126256074|NCT00611884|454229176|FG000|Overall Study|Lack of Efficacy|0|||
126256075|NCT00611884|454229177|FG001|Overall Study|Lack of Efficacy|1|||
126256076|NCT00611884|454229178|FG002|Overall Study|Lack of Efficacy|0|||
126256077|NCT00611884|454229179|FG003|Overall Study|Lack of Efficacy|0|||
126256078|NCT00611884|454229176|FG000|Overall Study|Unclassified|7|||
126256079|NCT00611884|454229177|FG001|Overall Study|Unclassified|4|||
126256080|NCT00611884|454229178|FG002|Overall Study|Unclassified|2|||
126256081|NCT00611884|454229179|FG003|Overall Study|Unclassified|3|||
126256082|NCT00981799|454229180|FG000|Overall Study|Adverse Event|1|||
126256083|NCT00981799|454229181|FG001|Overall Study|Adverse Event|1|||
126256084|NCT00981799|454229182|FG002|Overall Study|Adverse Event|0|||
126256085|NCT00981799|454229183|FG003|Overall Study|Adverse Event|0|||
126256086|NCT00348816|454229184|FG000|Overall Study|Noncompliance with radiation treatment|1|||
126256087|NCT00687739|454229185|FG000|Overall Study|Lost to Follow-up|2|||
126256088|NCT00687739|454229186|FG001|Overall Study|Lost to Follow-up|2|||
126256089|NCT00687739|454229187|FG002|Overall Study|Lost to Follow-up|1|||
126256090|NCT00687739|454229188|FG003|Overall Study|Lost to Follow-up|2|||
126256091|NCT00687739|454229185|FG000|Overall Study|Adverse Event|0|||
126256092|NCT00687739|454229186|FG001|Overall Study|Adverse Event|1|||
126256093|NCT00687739|454229187|FG002|Overall Study|Adverse Event|1|||
126256094|NCT00687739|454229188|FG003|Overall Study|Adverse Event|0|||
126256095|NCT01190930|454229189|FG000|Induction|Adverse Event|17|||
126256096|NCT01190930|454229190|FG001|Induction|Adverse Event|0|||
126256097|NCT01190930|454229191|FG002|Induction|Adverse Event|0|||
126256098|NCT01190930|454229192|FG003|Induction|Adverse Event|0|||
126256099|NCT01190930|454229193|FG004|Induction|Adverse Event|0|||
126256100|NCT01190930|454229194|FG005|Induction|Adverse Event|0|||
126256101|NCT01190930|454229195|FG006|Induction|Adverse Event|0|||
126256102|NCT01190930|454229196|FG007|Induction|Adverse Event|0|||
126256103|NCT01190930|454229197|FG008|Induction|Adverse Event|0|||
126256104|NCT01190930|454229198|FG009|Induction|Adverse Event|0|||
126256105|NCT01190930|454229189|FG000|Induction|Death|34|||
126256106|NCT01190930|454229190|FG001|Induction|Death|0|||
126449333|NCT01868542|454947064|FG001|Overall Study|Unclassified|1|||
126449334|NCT04129151|454947069|FG000|Overall Study|Adverse Event|1|||
126449335|NCT04129151|454947069|FG000|Overall Study|Disease Progression|7|||
126449336|NCT04129151|454947069|FG000|Overall Study|Study closure|1|||
126449337|NCT01703754|454947071|FG000|Overall Study|Clinically significant disease progression|2|||
126449338|NCT01703754|454947072|FG001|Overall Study|Clinically significant disease progression|2|||
126449339|NCT01703754|454947073|FG002|Overall Study|Clinically significant disease progression|1|||
126449340|NCT01703754|454947071|FG000|Overall Study|Adverse Event|1|||
126449341|NCT01703754|454947072|FG001|Overall Study|Adverse Event|1|||
126449342|NCT01703754|454947073|FG002|Overall Study|Adverse Event|0|||
126449343|NCT01703754|454947071|FG000|Overall Study|Withdrawal by Subject|2|||
126449344|NCT01703754|454947072|FG001|Overall Study|Withdrawal by Subject|0|||
126449345|NCT01703754|454947073|FG002|Overall Study|Withdrawal by Subject|0|||
126449346|NCT01989208|454947076|FG000|200 mg (7 Days)|Protocol Violation|0|||
126256107|NCT01190930|454229191|FG002|Induction|Death|0|||
126256108|NCT01190930|454229192|FG003|Induction|Death|0|||
126256109|NCT01190930|454229193|FG004|Induction|Death|0|||
126256110|NCT01190930|454229194|FG005|Induction|Death|0|||
126256111|NCT01190930|454229195|FG006|Induction|Death|0|||
126256112|NCT01190930|454229196|FG007|Induction|Death|0|||
126256113|NCT01190930|454229197|FG008|Induction|Death|0|||
126256114|NCT01190930|454229198|FG009|Induction|Death|0|||
126256115|NCT01190930|454229189|FG000|Induction|Lost to Follow-up|1|||
126256116|NCT01190930|454229190|FG001|Induction|Lost to Follow-up|0|||
126256117|NCT01190930|454229191|FG002|Induction|Lost to Follow-up|0|||
126256118|NCT01190930|454229192|FG003|Induction|Lost to Follow-up|0|||
126256119|NCT01190930|454229193|FG004|Induction|Lost to Follow-up|0|||
126256120|NCT01190930|454229194|FG005|Induction|Lost to Follow-up|0|||
126698546|NCT00151892|455847107|FG001|Overall Study|Used prohibited corticosteroids|0|||
126698547|NCT00151892|455847106|FG000|Overall Study|Lack of study medication at center|0|||
126698548|NCT00151892|455847107|FG001|Overall Study|Lack of study medication at center|1|||
126698549|NCT01889602|455847108|FG000|First Intervention|Adverse Event|1|||
126698550|NCT01889602|455847109|FG001|First Intervention|Adverse Event|1|||
126256121|NCT01190930|454229195|FG006|Induction|Lost to Follow-up|0|||
126256122|NCT01190930|454229196|FG007|Induction|Lost to Follow-up|0|||
126256123|NCT01190930|454229197|FG008|Induction|Lost to Follow-up|0|||
126256124|NCT01190930|454229198|FG009|Induction|Lost to Follow-up|0|||
126256125|NCT01190930|454229189|FG000|Induction|Physician Decision|125|||
126256126|NCT01190930|454229190|FG001|Induction|Physician Decision|3|||
126256127|NCT01190930|454229191|FG002|Induction|Physician Decision|0|||
126256128|NCT01190930|454229192|FG003|Induction|Physician Decision|0|||
126256129|NCT01190930|454229193|FG004|Induction|Physician Decision|0|||
126256130|NCT01190930|454229194|FG005|Induction|Physician Decision|0|||
126256131|NCT01190930|454229195|FG006|Induction|Physician Decision|0|||
126256132|NCT01190930|454229196|FG007|Induction|Physician Decision|0|||
126256133|NCT01190930|454229197|FG008|Induction|Physician Decision|0|||
126256134|NCT01190930|454229198|FG009|Induction|Physician Decision|0|||
126256135|NCT01190930|454229189|FG000|Induction|Withdrawal by Subject|9|||
126256136|NCT01190930|454229190|FG001|Induction|Withdrawal by Subject|0|||
126256137|NCT01190930|454229191|FG002|Induction|Withdrawal by Subject|0|||
126256138|NCT01190930|454229192|FG003|Induction|Withdrawal by Subject|0|||
126256139|NCT01190930|454229193|FG004|Induction|Withdrawal by Subject|0|||
126256140|NCT01190930|454229194|FG005|Induction|Withdrawal by Subject|0|||
126256141|NCT01190930|454229195|FG006|Induction|Withdrawal by Subject|0|||
126256142|NCT01190930|454229196|FG007|Induction|Withdrawal by Subject|0|||
126256143|NCT01190930|454229197|FG008|Induction|Withdrawal by Subject|0|||
126256144|NCT01190930|454229198|FG009|Induction|Withdrawal by Subject|0|||
126256145|NCT01190930|454229189|FG000|Induction|Refusal|235|||
126256146|NCT01190930|454229190|FG001|Induction|Refusal|0|||
126256147|NCT01190930|454229191|FG002|Induction|Refusal|0|||
126256148|NCT01190930|454229192|FG003|Induction|Refusal|0|||
126256149|NCT01190930|454229193|FG004|Induction|Refusal|0|||
126256150|NCT01190930|454229194|FG005|Induction|Refusal|0|||
126256151|NCT01190930|454229195|FG006|Induction|Refusal|0|||
126256152|NCT01190930|454229196|FG007|Induction|Refusal|0|||
126256153|NCT01190930|454229197|FG008|Induction|Refusal|0|||
126256154|NCT01190930|454229198|FG009|Induction|Refusal|0|||
126256155|NCT01190930|454229189|FG000|Induction|Inevaluable|23|||
126256156|NCT01190930|454229190|FG001|Induction|Inevaluable|1|||
126256157|NCT01190930|454229191|FG002|Induction|Inevaluable|0|||
126256158|NCT01190930|454229192|FG003|Induction|Inevaluable|0|||
126256159|NCT01190930|454229193|FG004|Induction|Inevaluable|0|||
126256160|NCT01190930|454229194|FG005|Induction|Inevaluable|0|||
126256161|NCT01190930|454229195|FG006|Induction|Inevaluable|0|||
126256162|NCT01190930|454229196|FG007|Induction|Inevaluable|0|||
126256163|NCT01190930|454229197|FG008|Induction|Inevaluable|0|||
126256164|NCT01190930|454229198|FG009|Induction|Inevaluable|0|||
126256165|NCT01190930|454229189|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
126256166|NCT01190930|454229190|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256167|NCT01190930|454229191|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256168|NCT01190930|454229192|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256169|NCT01190930|454229193|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256170|NCT01190930|454229194|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256171|NCT01190930|454229195|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256172|NCT01190930|454229196|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256173|NCT01190930|454229197|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256174|NCT01190930|454229198|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
126256175|NCT01190930|454229189|FG000|Induction|High Risk Downs|80|||
126256176|NCT01190930|454229190|FG001|Induction|High Risk Downs|0|||
126256177|NCT01190930|454229191|FG002|Induction|High Risk Downs|0|||
126698551|NCT01889602|455847110|FG002|First Intervention|Adverse Event|1|||
126256178|NCT01190930|454229192|FG003|Induction|High Risk Downs|0|||
126256179|NCT01190930|454229193|FG004|Induction|High Risk Downs|0|||
126256180|NCT01190930|454229194|FG005|Induction|High Risk Downs|0|||
126256181|NCT01190930|454229195|FG006|Induction|High Risk Downs|0|||
126256182|NCT01190930|454229196|FG007|Induction|High Risk Downs|0|||
126256183|NCT01190930|454229197|FG008|Induction|High Risk Downs|0|||
126256184|NCT01190930|454229198|FG009|Induction|High Risk Downs|0|||
126256185|NCT01190930|454229189|FG000|Induction|Enrollment onto another COG Protocol|1|||
126256186|NCT01190930|454229190|FG001|Induction|Enrollment onto another COG Protocol|0|||
126256187|NCT01190930|454229191|FG002|Induction|Enrollment onto another COG Protocol|0|||
126256188|NCT01190930|454229192|FG003|Induction|Enrollment onto another COG Protocol|0|||
126256189|NCT01190930|454229193|FG004|Induction|Enrollment onto another COG Protocol|0|||
126256190|NCT01190930|454229194|FG005|Induction|Enrollment onto another COG Protocol|0|||
126256191|NCT01190930|454229195|FG006|Induction|Enrollment onto another COG Protocol|0|||
126256192|NCT01190930|454229196|FG007|Induction|Enrollment onto another COG Protocol|0|||
126256193|NCT01190930|454229197|FG008|Induction|Enrollment onto another COG Protocol|0|||
126256194|NCT01190930|454229198|FG009|Induction|Enrollment onto another COG Protocol|0|||
126256195|NCT01190930|454229189|FG000|Induction|Average Risk|1847|||
126256196|NCT01190930|454229190|FG001|Induction|Average Risk|0|||
126256197|NCT01190930|454229191|FG002|Induction|Average Risk|0|||
126256198|NCT01190930|454229192|FG003|Induction|Average Risk|0|||
126256199|NCT01190930|454229193|FG004|Induction|Average Risk|0|||
126256200|NCT01190930|454229194|FG005|Induction|Average Risk|0|||
126256201|NCT01190930|454229195|FG006|Induction|Average Risk|0|||
126256202|NCT01190930|454229196|FG007|Induction|Average Risk|0|||
126256203|NCT01190930|454229197|FG008|Induction|Average Risk|0|||
126256204|NCT01190930|454229198|FG009|Induction|Average Risk|0|||
126256205|NCT01190930|454229189|FG000|Induction|High Risk|1227|||
126256206|NCT01190930|454229190|FG001|Induction|High Risk|0|||
126256207|NCT01190930|454229191|FG002|Induction|High Risk|0|||
126256208|NCT01190930|454229192|FG003|Induction|High Risk|0|||
126256209|NCT01190930|454229193|FG004|Induction|High Risk|0|||
126256210|NCT01190930|454229194|FG005|Induction|High Risk|0|||
126256211|NCT01190930|454229195|FG006|Induction|High Risk|0|||
126256212|NCT01190930|454229196|FG007|Induction|High Risk|0|||
126256213|NCT01190930|454229197|FG008|Induction|High Risk|0|||
126256214|NCT01190930|454229198|FG009|Induction|High Risk|0|||
126256215|NCT01190930|454229189|FG000|Induction|Low Risk|443|||
126256216|NCT01190930|454229190|FG001|Induction|Low Risk|0|||
126256217|NCT01190930|454229191|FG002|Induction|Low Risk|0|||
126256218|NCT01190930|454229192|FG003|Induction|Low Risk|0|||
126256219|NCT01190930|454229193|FG004|Induction|Low Risk|0|||
126256220|NCT01190930|454229194|FG005|Induction|Low Risk|0|||
126256221|NCT01190930|454229195|FG006|Induction|Low Risk|0|||
126256222|NCT01190930|454229196|FG007|Induction|Low Risk|0|||
126256223|NCT01190930|454229197|FG008|Induction|Low Risk|0|||
126256224|NCT01190930|454229198|FG009|Induction|Low Risk|0|||
126256225|NCT01190930|454229189|FG000|Induction|Very High Risk|1012|||
126256226|NCT01190930|454229190|FG001|Induction|Very High Risk|0|||
126256227|NCT01190930|454229191|FG002|Induction|Very High Risk|0|||
126256228|NCT01190930|454229192|FG003|Induction|Very High Risk|0|||
126256229|NCT01190930|454229193|FG004|Induction|Very High Risk|0|||
126256230|NCT01190930|454229194|FG005|Induction|Very High Risk|0|||
126256231|NCT01190930|454229195|FG006|Induction|Very High Risk|0|||
126256232|NCT01190930|454229196|FG007|Induction|Very High Risk|0|||
126256233|NCT01190930|454229197|FG008|Induction|Very High Risk|0|||
126256234|NCT01190930|454229198|FG009|Induction|Very High Risk|0|||
126256235|NCT01190930|454229189|FG000|Induction|Philadelphia chromosome-positive|99|||
126256236|NCT01190930|454229190|FG001|Induction|Philadelphia chromosome-positive|0|||
126256237|NCT01190930|454229191|FG002|Induction|Philadelphia chromosome-positive|0|||
126256238|NCT01190930|454229192|FG003|Induction|Philadelphia chromosome-positive|0|||
126256239|NCT01190930|454229193|FG004|Induction|Philadelphia chromosome-positive|0|||
126256240|NCT01190930|454229194|FG005|Induction|Philadelphia chromosome-positive|0|||
126256241|NCT01190930|454229195|FG006|Induction|Philadelphia chromosome-positive|0|||
126256242|NCT01190930|454229196|FG007|Induction|Philadelphia chromosome-positive|0|||
126256243|NCT01190930|454229197|FG008|Induction|Philadelphia chromosome-positive|0|||
126256244|NCT01190930|454229198|FG009|Induction|Philadelphia chromosome-positive|0|||
126256245|NCT01190930|454229189|FG000|Induction|Incomplete Induction data|63|||
126256246|NCT01190930|454229190|FG001|Induction|Incomplete Induction data|0|||
126256247|NCT01190930|454229191|FG002|Induction|Incomplete Induction data|0|||
126256248|NCT01190930|454229192|FG003|Induction|Incomplete Induction data|0|||
126256249|NCT01190930|454229193|FG004|Induction|Incomplete Induction data|0|||
126256250|NCT01190930|454229194|FG005|Induction|Incomplete Induction data|0|||
126256251|NCT01190930|454229195|FG006|Induction|Incomplete Induction data|0|||
126256252|NCT01190930|454229196|FG007|Induction|Incomplete Induction data|0|||
126256253|NCT01190930|454229197|FG008|Induction|Incomplete Induction data|0|||
126256254|NCT01190930|454229198|FG009|Induction|Incomplete Induction data|0|||
126256255|NCT01190930|454229189|FG000|Induction|Progressive disease|0|||
126256256|NCT01190930|454229190|FG001|Induction|Progressive disease|1|||
126256257|NCT01190930|454229191|FG002|Induction|Progressive disease|0|||
126763103|NCT00276458|456084934|FG000|Overall Study|Lost to Follow-up|2|||
126256258|NCT01190930|454229192|FG003|Induction|Progressive disease|0|||
126449347|NCT01989208|454947077|FG001|200 mg (7 Days)|Protocol Violation|1|||
126763104|NCT00276458|456084935|FG001|Overall Study|Lost to Follow-up|2|||
126256259|NCT01190930|454229193|FG004|Induction|Progressive disease|0|||
126256260|NCT01190930|454229194|FG005|Induction|Progressive disease|0|||
126256261|NCT01190930|454229195|FG006|Induction|Progressive disease|0|||
126256262|NCT01190930|454229196|FG007|Induction|Progressive disease|0|||
126256263|NCT01190930|454229197|FG008|Induction|Progressive disease|0|||
126256264|NCT01190930|454229198|FG009|Induction|Progressive disease|0|||
126256265|NCT01190930|454229189|FG000|Induction|No treatment|3|||
126256266|NCT01190930|454229190|FG001|Induction|No treatment|0|||
126256267|NCT01190930|454229191|FG002|Induction|No treatment|0|||
126256268|NCT01190930|454229192|FG003|Induction|No treatment|0|||
126256269|NCT01190930|454229193|FG004|Induction|No treatment|0|||
126256270|NCT01190930|454229194|FG005|Induction|No treatment|0|||
126256271|NCT01190930|454229195|FG006|Induction|No treatment|0|||
126256272|NCT01190930|454229196|FG007|Induction|No treatment|0|||
126256273|NCT01190930|454229197|FG008|Induction|No treatment|0|||
126256274|NCT01190930|454229198|FG009|Induction|No treatment|0|||
126763105|NCT00276458|456084934|FG000|Overall Study|Protocol Violation|4|||
126256275|NCT01190930|454229189|FG000|Induction|Ineligible|69|||
126256276|NCT01190930|454229190|FG001|Induction|Ineligible|4|||
126256277|NCT01190930|454229191|FG002|Induction|Ineligible|0|||
126256278|NCT01190930|454229192|FG003|Induction|Ineligible|0|||
126256279|NCT01190930|454229193|FG004|Induction|Ineligible|0|||
126256280|NCT01190930|454229194|FG005|Induction|Ineligible|0|||
126256281|NCT01190930|454229195|FG006|Induction|Ineligible|0|||
126256282|NCT01190930|454229196|FG007|Induction|Ineligible|0|||
126256283|NCT01190930|454229197|FG008|Induction|Ineligible|0|||
126256284|NCT01190930|454229198|FG009|Induction|Ineligible|0|||
126256285|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
126256286|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
126256287|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
126256288|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
126256289|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
126256290|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
126256291|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
126256292|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
126256293|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
126256294|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
126256295|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Death|0|||
126256296|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Death|0|||
126256297|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Death|8|||
126256298|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Death|4|||
126256299|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Death|0|||
126256300|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Death|0|||
126256301|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Death|0|||
126256302|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Death|0|||
126256303|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Death|0|||
126256304|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Death|0|||
126256305|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
126256306|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
126256307|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
126256308|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
126256309|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
126256310|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
126256311|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
126256312|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
126256313|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
126256314|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
126256315|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256316|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
126256317|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
126256318|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
126256319|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256320|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256321|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256322|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256323|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256324|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
126256325|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Refusal|0|||
126256326|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Refusal|2|||
126256327|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Refusal|694|||
126256328|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Refusal|4|||
126256329|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Refusal|0|||
126256330|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Refusal|3|||
126698552|NCT01889602|455847108|FG000|First Intervention|Protocol Violation|0|||
126256331|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Refusal|0|||
126256332|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Refusal|0|||
126256333|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Refusal|0|||
126256334|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Refusal|0|||
126256335|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
126698553|NCT01889602|455847109|FG001|First Intervention|Protocol Violation|1|||
126698554|NCT01889602|455847110|FG002|First Intervention|Protocol Violation|1|||
126698555|NCT01889602|455847108|FG000|First Intervention|Study ending|0|||
126256336|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
126256337|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
126256338|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
126256339|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
126698556|NCT01889602|455847109|FG001|First Intervention|Study ending|1|||
126256340|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
126256341|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
126256342|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
126256343|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
126256344|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
126256345|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256346|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
126256347|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256348|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256349|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256350|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256351|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256352|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256353|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256354|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
126256355|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
126256356|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
126256357|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
126256358|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
126256359|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
126256360|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
126256361|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
126256362|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
126256363|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
126256364|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
126256365|NCT01190930|454229189|FG000|Post Induction Pre-Maintenance|Relapse|0|||
126256366|NCT01190930|454229190|FG001|Post Induction Pre-Maintenance|Relapse|0|||
126256367|NCT01190930|454229191|FG002|Post Induction Pre-Maintenance|Relapse|1|||
126256368|NCT01190930|454229192|FG003|Post Induction Pre-Maintenance|Relapse|0|||
126256369|NCT01190930|454229193|FG004|Post Induction Pre-Maintenance|Relapse|0|||
126256370|NCT01190930|454229194|FG005|Post Induction Pre-Maintenance|Relapse|0|||
126256371|NCT01190930|454229195|FG006|Post Induction Pre-Maintenance|Relapse|0|||
126256372|NCT01190930|454229196|FG007|Post Induction Pre-Maintenance|Relapse|0|||
126256373|NCT01190930|454229197|FG008|Post Induction Pre-Maintenance|Relapse|0|||
126256374|NCT01190930|454229198|FG009|Post Induction Pre-Maintenance|Relapse|0|||
126256375|NCT01190930|454229189|FG000|Maintenance|Adverse Event|0|||
126256376|NCT01190930|454229190|FG001|Maintenance|Adverse Event|0|||
126256377|NCT01190930|454229191|FG002|Maintenance|Adverse Event|0|||
126256378|NCT01190930|454229192|FG003|Maintenance|Adverse Event|0|||
126256379|NCT01190930|454229193|FG004|Maintenance|Adverse Event|0|||
126256380|NCT01190930|454229194|FG005|Maintenance|Adverse Event|1|||
126256381|NCT01190930|454229195|FG006|Maintenance|Adverse Event|1|||
126256382|NCT01190930|454229196|FG007|Maintenance|Adverse Event|3|||
126256383|NCT01190930|454229197|FG008|Maintenance|Adverse Event|3|||
126256384|NCT01190930|454229198|FG009|Maintenance|Adverse Event|0|||
126256385|NCT01190930|454229189|FG000|Maintenance|Death|0|||
126256386|NCT01190930|454229190|FG001|Maintenance|Death|0|||
126698557|NCT01889602|455847110|FG002|First Intervention|Study ending|0|||
126698558|NCT01889602|455847108|FG000|Second Intervention|Adverse Event|0|||
126698559|NCT01889602|455847109|FG001|Second Intervention|Adverse Event|0|||
126698560|NCT01889602|455847110|FG002|Second Intervention|Adverse Event|1|||
126698561|NCT01889602|455847108|FG000|Second Intervention|Study ending|1|||
126698562|NCT01889602|455847109|FG001|Second Intervention|Study ending|0|||
126698563|NCT01889602|455847110|FG002|Second Intervention|Study ending|0|||
126698564|NCT01889602|455847108|FG000|Second Intervention|Withdrawal by Subject|0|||
126698565|NCT01889602|455847109|FG001|Second Intervention|Withdrawal by Subject|0|||
126698566|NCT01889602|455847110|FG002|Second Intervention|Withdrawal by Subject|1|||
126256387|NCT01190930|454229191|FG002|Maintenance|Death|0|||
126256388|NCT01190930|454229192|FG003|Maintenance|Death|1|||
126256389|NCT01190930|454229193|FG004|Maintenance|Death|0|||
126256390|NCT01190930|454229194|FG005|Maintenance|Death|0|||
126256391|NCT01190930|454229195|FG006|Maintenance|Death|2|||
126256392|NCT01190930|454229196|FG007|Maintenance|Death|2|||
126256393|NCT01190930|454229197|FG008|Maintenance|Death|2|||
126256394|NCT01190930|454229198|FG009|Maintenance|Death|2|||
126256395|NCT01190930|454229189|FG000|Maintenance|Lost to Follow-up|0|||
126256396|NCT01190930|454229190|FG001|Maintenance|Lost to Follow-up|0|||
126256397|NCT01190930|454229191|FG002|Maintenance|Lost to Follow-up|0|||
126698567|NCT01889602|455847108|FG000|Third Intervention|Protocol Violation|1|||
126698568|NCT01889602|455847109|FG001|Third Intervention|Protocol Violation|0|||
126698569|NCT01889602|455847110|FG002|Third Intervention|Protocol Violation|0|||
126256398|NCT01190930|454229192|FG003|Maintenance|Lost to Follow-up|0|||
126256399|NCT01190930|454229193|FG004|Maintenance|Lost to Follow-up|0|||
126256400|NCT01190930|454229194|FG005|Maintenance|Lost to Follow-up|0|||
126256401|NCT01190930|454229195|FG006|Maintenance|Lost to Follow-up|1|||
126256402|NCT01190930|454229196|FG007|Maintenance|Lost to Follow-up|1|||
126256403|NCT01190930|454229197|FG008|Maintenance|Lost to Follow-up|1|||
126256404|NCT01190930|454229198|FG009|Maintenance|Lost to Follow-up|0|||
126256405|NCT01190930|454229189|FG000|Maintenance|Physician Decision|0|||
126698570|NCT01889602|455847108|FG000|Third Intervention|Withdrawal by Subject|2|||
126698571|NCT01889602|455847109|FG001|Third Intervention|Withdrawal by Subject|2|||
126698572|NCT01889602|455847110|FG002|Third Intervention|Withdrawal by Subject|0|||
126698573|NCT00404092|455847111|FG000|Overall Study|Death|1|||
126698574|NCT00404092|455847112|FG001|Overall Study|Death|0|||
126698575|NCT00404092|455847113|FG002|Overall Study|Death|0|||
126698576|NCT00404092|455847114|FG003|Overall Study|Death|0|||
126698577|NCT00404092|455847111|FG000|Overall Study|Adverse Event|0|||
126698578|NCT00404092|455847112|FG001|Overall Study|Adverse Event|0|||
126698579|NCT00404092|455847113|FG002|Overall Study|Adverse Event|1|||
126698580|NCT00404092|455847114|FG003|Overall Study|Adverse Event|0|||
126698581|NCT00484315|455847117|FG000|12-Month Clinical Follow-up|Death|6|||
126698582|NCT00484315|455847118|FG001|12-Month Clinical Follow-up|Death|2|||
126698583|NCT00484315|455847117|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
126698584|NCT00484315|455847118|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
126698585|NCT00484315|455847117|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
126698586|NCT00484315|455847118|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
126698587|NCT00484315|455847117|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
126698588|NCT00484315|455847118|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
126698589|NCT00484315|455847117|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
126698590|NCT00484315|455847118|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
126698591|NCT00484315|455847117|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
126698592|NCT00484315|455847118|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
126698593|NCT00484315|455847117|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
126698594|NCT00484315|455847118|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
126256406|NCT01190930|454229190|FG001|Maintenance|Physician Decision|1|||
126256407|NCT01190930|454229191|FG002|Maintenance|Physician Decision|0|||
126256408|NCT01190930|454229192|FG003|Maintenance|Physician Decision|5|||
126256409|NCT01190930|454229193|FG004|Maintenance|Physician Decision|9|||
126256410|NCT01190930|454229194|FG005|Maintenance|Physician Decision|4|||
126256411|NCT01190930|454229195|FG006|Maintenance|Physician Decision|8|||
126256412|NCT01190930|454229196|FG007|Maintenance|Physician Decision|8|||
126256413|NCT01190930|454229197|FG008|Maintenance|Physician Decision|10|||
126256414|NCT01190930|454229198|FG009|Maintenance|Physician Decision|17|||
126256415|NCT01190930|454229189|FG000|Maintenance|Withdrawal by Subject|0|||
126256416|NCT01190930|454229190|FG001|Maintenance|Withdrawal by Subject|0|||
126256417|NCT01190930|454229191|FG002|Maintenance|Withdrawal by Subject|0|||
126256418|NCT01190930|454229192|FG003|Maintenance|Withdrawal by Subject|0|||
126256419|NCT01190930|454229193|FG004|Maintenance|Withdrawal by Subject|0|||
126256420|NCT01190930|454229194|FG005|Maintenance|Withdrawal by Subject|0|||
126256421|NCT01190930|454229195|FG006|Maintenance|Withdrawal by Subject|2|||
126256422|NCT01190930|454229196|FG007|Maintenance|Withdrawal by Subject|1|||
126256423|NCT01190930|454229197|FG008|Maintenance|Withdrawal by Subject|4|||
126256424|NCT01190930|454229198|FG009|Maintenance|Withdrawal by Subject|1|||
126256425|NCT01190930|454229189|FG000|Maintenance|Refusal|0|||
126256426|NCT01190930|454229190|FG001|Maintenance|Refusal|1|||
126256427|NCT01190930|454229191|FG002|Maintenance|Refusal|0|||
126256428|NCT01190930|454229192|FG003|Maintenance|Refusal|2|||
126256429|NCT01190930|454229193|FG004|Maintenance|Refusal|0|||
126256430|NCT01190930|454229194|FG005|Maintenance|Refusal|4|||
126256431|NCT01190930|454229195|FG006|Maintenance|Refusal|5|||
126256432|NCT01190930|454229196|FG007|Maintenance|Refusal|17|||
126256433|NCT01190930|454229197|FG008|Maintenance|Refusal|13|||
126256434|NCT01190930|454229198|FG009|Maintenance|Refusal|6|||
126256435|NCT01190930|454229189|FG000|Maintenance|second malignant neoplasm|0|||
126256436|NCT01190930|454229190|FG001|Maintenance|second malignant neoplasm|0|||
126256437|NCT01190930|454229191|FG002|Maintenance|second malignant neoplasm|0|||
126449348|NCT00566696|454947078|FG000|Overall Study|Met Exclusion Criteria|2|||
126449349|NCT00566696|454947078|FG000|Overall Study|Muromonab not available|1|||
126449350|NCT00566696|454947078|FG000|Overall Study|Health Status Change|1|||
126449351|NCT00566696|454947078|FG000|Overall Study|Physician Decision|1|||
126449352|NCT00566696|454947078|FG000|Overall Study|Non-Patient Donors|37|||
126698595|NCT02500537|455847119|FG000|Overall Study|Death|2|||
126256438|NCT01190930|454229192|FG003|Maintenance|second malignant neoplasm|1|||
126256439|NCT01190930|454229193|FG004|Maintenance|second malignant neoplasm|0|||
126256440|NCT01190930|454229194|FG005|Maintenance|second malignant neoplasm|1|||
126256441|NCT01190930|454229195|FG006|Maintenance|second malignant neoplasm|0|||
126256442|NCT01190930|454229196|FG007|Maintenance|second malignant neoplasm|0|||
126256443|NCT01190930|454229197|FG008|Maintenance|second malignant neoplasm|1|||
126256444|NCT01190930|454229198|FG009|Maintenance|second malignant neoplasm|0|||
126256445|NCT01190930|454229189|FG000|Maintenance|Inevaluable|0|||
126256446|NCT01190930|454229190|FG001|Maintenance|Inevaluable|0|||
126256447|NCT01190930|454229191|FG002|Maintenance|Inevaluable|0|||
126256448|NCT01190930|454229192|FG003|Maintenance|Inevaluable|0|||
126256449|NCT01190930|454229193|FG004|Maintenance|Inevaluable|0|||
126256450|NCT01190930|454229194|FG005|Maintenance|Inevaluable|1|||
126256451|NCT01190930|454229195|FG006|Maintenance|Inevaluable|1|||
126546435|NCT03573908|455293802|FG002|Treatment Period|Pregnancy|0|||
126763106|NCT00276458|456084935|FG001|Overall Study|Protocol Violation|3|||
126256452|NCT01190930|454229196|FG007|Maintenance|Inevaluable|1|||
126256453|NCT01190930|454229197|FG008|Maintenance|Inevaluable|0|||
126256454|NCT01190930|454229198|FG009|Maintenance|Inevaluable|0|||
126256455|NCT01190930|454229189|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
126256456|NCT01190930|454229190|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
126256457|NCT01190930|454229191|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
126256458|NCT01190930|454229192|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
126256459|NCT01190930|454229193|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
126256460|NCT01190930|454229194|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
126256461|NCT01190930|454229195|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
126256462|NCT01190930|454229196|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
126256463|NCT01190930|454229197|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
126256464|NCT01190930|454229198|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
126256465|NCT01190930|454229189|FG000|Maintenance|Relapse|0|||
126256466|NCT01190930|454229190|FG001|Maintenance|Relapse|0|||
126256467|NCT01190930|454229191|FG002|Maintenance|Relapse|0|||
126256468|NCT01190930|454229192|FG003|Maintenance|Relapse|2|||
126256469|NCT01190930|454229193|FG004|Maintenance|Relapse|0|||
126256470|NCT01190930|454229194|FG005|Maintenance|Relapse|1|||
126256471|NCT01190930|454229195|FG006|Maintenance|Relapse|6|||
126256472|NCT01190930|454229196|FG007|Maintenance|Relapse|13|||
126256473|NCT01190930|454229197|FG008|Maintenance|Relapse|11|||
126256474|NCT01190930|454229198|FG009|Maintenance|Relapse|11|||
126256475|NCT01190930|454229189|FG000|Maintenance|Still on therapy|0|||
126256476|NCT01190930|454229190|FG001|Maintenance|Still on therapy|8|||
126256477|NCT01190930|454229191|FG002|Maintenance|Still on therapy|0|||
126256478|NCT01190930|454229192|FG003|Maintenance|Still on therapy|29|||
126256479|NCT01190930|454229193|FG004|Maintenance|Still on therapy|0|||
126256480|NCT01190930|454229194|FG005|Maintenance|Still on therapy|0|||
126256481|NCT01190930|454229195|FG006|Maintenance|Still on therapy|0|||
126256482|NCT01190930|454229196|FG007|Maintenance|Still on therapy|0|||
126256483|NCT01190930|454229197|FG008|Maintenance|Still on therapy|0|||
126256484|NCT01190930|454229198|FG009|Maintenance|Still on therapy|0|||
126256485|NCT00046839|454229203|FG000|Overall Study|Ineligible / No protocol treatment|0|||
126256486|NCT00046839|454229204|FG001|Overall Study|Ineligible / No protocol treatment|2|||
126256487|NCT00046839|454229203|FG000|Overall Study|Withdrawal of consent|1|||
126256488|NCT00046839|454229204|FG001|Overall Study|Withdrawal of consent|0|||
126256489|NCT01292837|454229209|FG000|Overall Study|Adverse Event|1|||
126256490|NCT01292837|454229209|FG000|Overall Study|Further treatment determined|1|||
126256491|NCT04531527|454229210|FG000|Overall Study|Found to be Ineligible|3|||
126256492|NCT01881737|454229216|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
126256493|NCT01881737|454229216|FG000|Overall Study|Withdrawal by Subject|1|||
126256494|NCT01881737|454229216|FG000|Overall Study|Worsening of baseline behavior|1|||
126256495|NCT02250651|454229227|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
126256496|NCT02250651|454229228|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
126256497|NCT02250651|454229229|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
126256498|NCT02250651|454229227|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
126256499|NCT02250651|454229228|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
126256500|NCT02250651|454229229|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
126256501|NCT02250651|454229227|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
126256502|NCT02250651|454229228|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
126256503|NCT02250651|454229229|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
126256504|NCT02250651|454229227|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
126256505|NCT02250651|454229228|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
126256506|NCT02250651|454229229|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
126256507|NCT02250651|454229227|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
126463791|NCT03282565|455000241|FG001|Overall Study|COVID-19 Research Shutdown|2|||
126763107|NCT02940392|456084938|FG000|Overall Study|Lost to Follow-up|3|||
126763108|NCT02940392|456084938|FG000|Overall Study|Retreatment|3|||
126256508|NCT02250651|454229228|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
126256509|NCT02250651|454229229|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
126256510|NCT02250651|454229227|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
126256511|NCT02250651|454229228|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
126256512|NCT02250651|454229229|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
126256513|NCT02250651|454229227|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
126256514|NCT02250651|454229228|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
126256515|NCT02250651|454229229|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
126256516|NCT02250651|454229227|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
126256517|NCT02250651|454229228|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
126256518|NCT02250651|454229229|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
126256519|NCT02250651|454229227|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
126763109|NCT02940392|456084938|FG000|Overall Study|Death|2|||
126256520|NCT02250651|454229228|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
126256521|NCT02250651|454229229|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
126256522|NCT02250651|454229227|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
126256523|NCT02250651|454229228|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
126256524|NCT02250651|454229229|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
126256525|NCT02250651|454229227|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
126256526|NCT02250651|454229228|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
126256527|NCT02250651|454229229|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
126256528|NCT02250651|454229227|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
126256529|NCT02250651|454229228|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
126256530|NCT02250651|454229229|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
126256531|NCT02250651|454229227|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
126256532|NCT02250651|454229228|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
126256533|NCT02250651|454229229|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
126256534|NCT02250651|454229227|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
126256535|NCT02250651|454229228|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
126256536|NCT02250651|454229229|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
126256537|NCT02250651|454229227|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
126256538|NCT02250651|454229228|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
126256539|NCT02250651|454229229|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
126256540|NCT03496298|454229230|FG000|Overall Study|Adverse Event|49|||
126256541|NCT03496298|454229231|FG001|Overall Study|Adverse Event|68|||
126256542|NCT03496298|454229232|FG002|Overall Study|Adverse Event|79|||
126256543|NCT03496298|454229230|FG000|Overall Study|Study terminated by Sponsor|1050|||
126256544|NCT03496298|454229231|FG001|Overall Study|Study terminated by Sponsor|1063|||
126256545|NCT03496298|454229232|FG002|Overall Study|Study terminated by Sponsor|1071|||
126256546|NCT03496298|454229230|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
126256547|NCT03496298|454229231|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
126256548|NCT03496298|454229232|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
126256549|NCT03496298|454229230|FG000|Overall Study|Withdrawal by Subject|176|||
126256550|NCT03496298|454229231|FG001|Overall Study|Withdrawal by Subject|154|||
126256551|NCT03496298|454229232|FG002|Overall Study|Withdrawal by Subject|151|||
126256552|NCT03496298|454229230|FG000|Overall Study|Other|29|||
126256553|NCT03496298|454229231|FG001|Overall Study|Other|20|||
126256554|NCT03496298|454229232|FG002|Overall Study|Other|23|||
126256555|NCT03496298|454229230|FG000|Overall Study|Randomized and not treated|1|||
126256556|NCT03496298|454229231|FG001|Overall Study|Randomized and not treated|1|||
126256557|NCT03496298|454229232|FG002|Overall Study|Randomized and not treated|1|||
126256558|NCT02522780|454229239|FG000|Overall Study|Consent withdrawn by subject|5|||
126256559|NCT02522780|454229240|FG001|Overall Study|Consent withdrawn by subject|7|||
126256560|NCT02522780|454229239|FG000|Overall Study|Protocol deviation|1|||
126256561|NCT02522780|454229240|FG001|Overall Study|Protocol deviation|3|||
126256562|NCT02522780|454229239|FG000|Overall Study|Subject refused endoscopic procedure|0|||
126256563|NCT02522780|454229240|FG001|Overall Study|Subject refused endoscopic procedure|1|||
126256564|NCT02522780|454229239|FG000|Overall Study|Adverse event, non-fatal|11|||
126256565|NCT02522780|454229240|FG001|Overall Study|Adverse event, non-fatal|16|||
126256566|NCT02260635|454229241|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
126256567|NCT02260635|454229242|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
126256568|NCT02260635|454229241|FG000|Open-Label Extension|Study Termination|25|||
126256569|NCT02260635|454229242|FG001|Open-Label Extension|Study Termination|25|||
126256570|NCT02260635|454229241|FG000|Open-Label Extension|Withdrawal by Subject|1|||
126256571|NCT02260635|454229242|FG001|Open-Label Extension|Withdrawal by Subject|0|||
126256572|NCT04106817|454229243|FG000|Overall Study|Lost to Follow-up|1|||
126256573|NCT04106817|454229244|FG001|Overall Study|Lost to Follow-up|0|||
126256574|NCT04106817|454229245|FG002|Overall Study|Lost to Follow-up|0|||
126256575|NCT03310619|454229246|FG000|Pre-Treatment Period|Death|1|||
126256576|NCT03310619|454229247|FG001|Pre-Treatment Period|Death|0|||
126256577|NCT03310619|454229248|FG002|Pre-Treatment Period|Death|0|||
126449353|NCT06338462|454947079|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
126449354|NCT02872935|454947080|FG000|Overall Study|Other|0|||
126449355|NCT02872935|454947081|FG001|Overall Study|Other|1|||
126449356|NCT01276054|454947083|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
126449357|NCT01276054|454947084|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
126449358|NCT02792829|454947085|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
126449359|NCT02792829|454947086|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
126546436|NCT03573908|455293803|FG003|Treatment Period|Pregnancy|0|||
126256578|NCT03310619|454229249|FG003|Pre-Treatment Period|Death|0|||
126256579|NCT03310619|454229250|FG004|Pre-Treatment Period|Death|1|||
126256580|NCT03310619|454229251|FG005|Pre-Treatment Period|Death|0|||
126256581|NCT03310619|454229252|FG006|Pre-Treatment Period|Death|0|||
126256582|NCT03310619|454229253|FG007|Pre-Treatment Period|Death|0|||
126256583|NCT03310619|454229246|FG000|Pre-Treatment Period|Other reasons|2|||
126256584|NCT03310619|454229247|FG001|Pre-Treatment Period|Other reasons|1|||
126256585|NCT03310619|454229248|FG002|Pre-Treatment Period|Other reasons|2|||
126256586|NCT03310619|454229249|FG003|Pre-Treatment Period|Other reasons|0|||
126256587|NCT03310619|454229250|FG004|Pre-Treatment Period|Other reasons|0|||
126256588|NCT03310619|454229251|FG005|Pre-Treatment Period|Other reasons|0|||
126256589|NCT03310619|454229252|FG006|Pre-Treatment Period|Other reasons|2|||
126256590|NCT03310619|454229253|FG007|Pre-Treatment Period|Other reasons|0|||
126256591|NCT03310619|454229246|FG000|Treatment Period|Death|1|||
126256592|NCT03310619|454229247|FG001|Treatment Period|Death|2|||
126256593|NCT03310619|454229248|FG002|Treatment Period|Death|0|||
126256594|NCT03310619|454229249|FG003|Treatment Period|Death|0|||
126256595|NCT03310619|454229250|FG004|Treatment Period|Death|1|||
126256596|NCT03310619|454229251|FG005|Treatment Period|Death|0|||
126256597|NCT03310619|454229252|FG006|Treatment Period|Death|2|||
126256598|NCT03310619|454229253|FG007|Treatment Period|Death|0|||
126256599|NCT03310619|454229246|FG000|Treatment Period|Adverse Event|0|||
126256600|NCT03310619|454229247|FG001|Treatment Period|Adverse Event|1|||
126256601|NCT03310619|454229248|FG002|Treatment Period|Adverse Event|4|||
126256602|NCT03310619|454229249|FG003|Treatment Period|Adverse Event|1|||
126256603|NCT03310619|454229250|FG004|Treatment Period|Adverse Event|0|||
126256604|NCT03310619|454229251|FG005|Treatment Period|Adverse Event|0|||
126256605|NCT03310619|454229252|FG006|Treatment Period|Adverse Event|0|||
126256606|NCT03310619|454229253|FG007|Treatment Period|Adverse Event|0|||
126256607|NCT03310619|454229246|FG000|Treatment Period|Withdrawal by participant|0|||
126256608|NCT03310619|454229247|FG001|Treatment Period|Withdrawal by participant|0|||
126256609|NCT03310619|454229248|FG002|Treatment Period|Withdrawal by participant|1|||
126256610|NCT03310619|454229249|FG003|Treatment Period|Withdrawal by participant|0|||
126256611|NCT03310619|454229250|FG004|Treatment Period|Withdrawal by participant|0|||
126256612|NCT03310619|454229251|FG005|Treatment Period|Withdrawal by participant|0|||
126256613|NCT03310619|454229252|FG006|Treatment Period|Withdrawal by participant|0|||
126256614|NCT03310619|454229253|FG007|Treatment Period|Withdrawal by participant|0|||
126256615|NCT03310619|454229246|FG000|Treatment Period|Lost to Follow-up|0|||
126256616|NCT03310619|454229247|FG001|Treatment Period|Lost to Follow-up|0|||
126256617|NCT03310619|454229248|FG002|Treatment Period|Lost to Follow-up|0|||
126256618|NCT03310619|454229249|FG003|Treatment Period|Lost to Follow-up|0|||
126256619|NCT03310619|454229250|FG004|Treatment Period|Lost to Follow-up|0|||
126256620|NCT03310619|454229251|FG005|Treatment Period|Lost to Follow-up|0|||
126256621|NCT03310619|454229252|FG006|Treatment Period|Lost to Follow-up|0|||
126256622|NCT03310619|454229253|FG007|Treatment Period|Lost to Follow-up|1|||
126256623|NCT03310619|454229246|FG000|Treatment Period|Study terminated by sponsor|0|||
126256624|NCT03310619|454229247|FG001|Treatment Period|Study terminated by sponsor|0|||
126256625|NCT03310619|454229248|FG002|Treatment Period|Study terminated by sponsor|0|||
126256626|NCT03310619|454229249|FG003|Treatment Period|Study terminated by sponsor|0|||
126256627|NCT03310619|454229250|FG004|Treatment Period|Study terminated by sponsor|0|||
126256628|NCT03310619|454229251|FG005|Treatment Period|Study terminated by sponsor|0|||
126256629|NCT03310619|454229252|FG006|Treatment Period|Study terminated by sponsor|0|||
126256630|NCT03310619|454229253|FG007|Treatment Period|Study terminated by sponsor|1|||
126256631|NCT03310619|454229246|FG000|Treatment Period|Physician Decision|0|||
126256632|NCT03310619|454229247|FG001|Treatment Period|Physician Decision|0|||
126256633|NCT03310619|454229248|FG002|Treatment Period|Physician Decision|0|||
126256634|NCT03310619|454229249|FG003|Treatment Period|Physician Decision|0|||
126256635|NCT03310619|454229250|FG004|Treatment Period|Physician Decision|3|||
126256636|NCT03310619|454229251|FG005|Treatment Period|Physician Decision|0|||
126256637|NCT03310619|454229252|FG006|Treatment Period|Physician Decision|0|||
126256638|NCT03310619|454229253|FG007|Treatment Period|Physician Decision|0|||
126256639|NCT03310619|454229246|FG000|Treatment Period|Other reasons|1|||
126256640|NCT03310619|454229247|FG001|Treatment Period|Other reasons|0|||
126256641|NCT03310619|454229248|FG002|Treatment Period|Other reasons|2|||
126256642|NCT03310619|454229249|FG003|Treatment Period|Other reasons|0|||
126256643|NCT03310619|454229250|FG004|Treatment Period|Other reasons|0|||
126256644|NCT03310619|454229251|FG005|Treatment Period|Other reasons|0|||
126256645|NCT03310619|454229252|FG006|Treatment Period|Other reasons|0|||
126256646|NCT03310619|454229253|FG007|Treatment Period|Other reasons|0|||
126256647|NCT00152516|454229254|FG000|Overall Study|Adverse Event|18|||
126256648|NCT00152516|454229254|FG000|Overall Study|Lack and Loss of Efficacy|30|||
126256649|NCT00152516|454229254|FG000|Overall Study|Lost to Follow-up|5|||
126256650|NCT00152516|454229254|FG000|Overall Study|Withdrawal by Subject|8|||
126256651|NCT00152516|454229254|FG000|Overall Study|Protocol Violation|3|||
126256652|NCT00152516|454229254|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
126256653|NCT00152516|454229254|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
126256654|NCT00152516|454229254|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
126256655|NCT00152516|454229254|FG000|Overall Study|Other: Non-Compliance|2|||
126256656|NCT00152516|454229254|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
126256657|NCT00152516|454229254|FG000|Overall Study|Other: Moved Out Of State|1|||
126358400|NCT01629563|454605330|FG001|Overall Study|Lack of Efficacy|3|||
126358401|NCT01629563|454605329|FG000|Overall Study|Lost to Follow-up|1|||
126763110|NCT00910000|456084942|FG000|Overall Study|Adverse Event|0|||
126763111|NCT00910000|456084943|FG001|Overall Study|Adverse Event|3|||
126763112|NCT00910000|456084944|FG002|Overall Study|Adverse Event|2|||
126763113|NCT00910000|456084945|FG003|Overall Study|Adverse Event|2|||
126763114|NCT00910000|456084946|FG004|Overall Study|Adverse Event|0|||
126763115|NCT00910000|456084947|FG005|Overall Study|Adverse Event|1|||
126256658|NCT00152516|454229254|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
126256659|NCT00152516|454229254|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
126256660|NCT02427399|454229255|FG000|Overall Study|Protocol Violation|14|||
126358402|NCT01629563|454605330|FG001|Overall Study|Lost to Follow-up|0|||
126358403|NCT01629563|454605329|FG000|Overall Study|Pregnancy|1|||
126358404|NCT01629563|454605330|FG001|Overall Study|Pregnancy|2|||
126358405|NCT01629563|454605329|FG000|Overall Study|Protocol Violation|0|||
126358406|NCT01629563|454605330|FG001|Overall Study|Protocol Violation|1|||
126358407|NCT01629563|454605329|FG000|Overall Study|Withdrawal by Subject|27|||
126358408|NCT01629563|454605330|FG001|Overall Study|Withdrawal by Subject|20|||
126358409|NCT01629563|454605329|FG000|Overall Study|surgery|0|||
126358410|NCT01629563|454605330|FG001|Overall Study|surgery|3|||
126358411|NCT01629563|454605329|FG000|Overall Study|Lack of return of menses|12|||
126358412|NCT01629563|454605330|FG001|Overall Study|Lack of return of menses|7|||
126358413|NCT01629563|454605329|FG000|Overall Study|Protocol Violation|0|||
126358414|NCT01629563|454605330|FG001|Overall Study|Protocol Violation|1|||
126358415|NCT02370394|454605332|FG000|Overall Study|Lost to Follow-up|2|||
126358416|NCT02370394|454605333|FG001|Overall Study|Lost to Follow-up|1|||
126358417|NCT02370394|454605332|FG000|Overall Study|Withdrawal by Subject|0|||
126358418|NCT02370394|454605333|FG001|Overall Study|Withdrawal by Subject|1|||
126358419|NCT01902303|454605335|FG000|Overall Study|Adverse Event|0|||
126358420|NCT01902303|454605336|FG001|Overall Study|Adverse Event|1|||
126358421|NCT01902303|454605335|FG000|Overall Study|Lost to Follow-up|0|||
126358422|NCT01902303|454605336|FG001|Overall Study|Lost to Follow-up|1|||
126358423|NCT01902303|454605335|FG000|Overall Study|Protocol Violation|2|||
126358424|NCT01902303|454605336|FG001|Overall Study|Protocol Violation|2|||
126358425|NCT01902303|454605335|FG000|Overall Study|subject lost investigational product|0|||
126358426|NCT01902303|454605336|FG001|Overall Study|subject lost investigational product|1|||
126358427|NCT01902303|454605335|FG000|Overall Study|Did not develop a cold sore|21|||
126358428|NCT01902303|454605336|FG001|Overall Study|Did not develop a cold sore|19|||
126358429|NCT02821000|454605337|FG000|Overall Study|Death|89|||
126358430|NCT02821000|454605337|FG000|Overall Study|Sponsor Decision|12|||
126358431|NCT02821000|454605337|FG000|Overall Study|Withdrawal by Subject|2|||
126358432|NCT00394472|454605345|FG000|Overall Study|Protocol Violation|1|||
126358433|NCT00394472|454605346|FG001|Overall Study|Protocol Violation|3|||
126256661|NCT02427399|454229256|FG001|Overall Study|Protocol Violation|16|||
126256662|NCT02427399|454229257|FG002|Overall Study|Protocol Violation|12|||
126256663|NCT02427399|454229258|FG003|Overall Study|Protocol Violation|18|||
126256664|NCT02427399|454229259|FG004|Overall Study|Protocol Violation|15|||
126256665|NCT01115933|454229260|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
126256666|NCT02289820|454229261|FG000|Overall Study|Withdrawal by Subject|2|||
126256667|NCT02289820|454229262|FG001|Overall Study|Withdrawal by Subject|1|||
126256668|NCT02289820|454229263|FG002|Overall Study|Withdrawal by Subject|2|||
126256669|NCT02289820|454229264|FG003|Overall Study|Withdrawal by Subject|1|||
126256670|NCT02289820|454229265|FG004|Overall Study|Withdrawal by Subject|0|||
126256671|NCT02289820|454229266|FG005|Overall Study|Withdrawal by Subject|0|||
126256672|NCT02289820|454229267|FG006|Overall Study|Withdrawal by Subject|1|||
126256673|NCT02289820|454229261|FG000|Overall Study|Death|0|||
126256674|NCT02289820|454229262|FG001|Overall Study|Death|0|||
126358434|NCT00394472|454605345|FG000|Overall Study|incorrect enrolment|4|||
126358435|NCT00394472|454605346|FG001|Overall Study|incorrect enrolment|2|||
126358436|NCT00394472|454605345|FG000|Overall Study|Adverse Event|4|||
126449360|NCT02792829|454947087|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
126763116|NCT00910000|456084942|FG000|Overall Study|Withdrawal by Subject|0|||
126763117|NCT00910000|456084943|FG001|Overall Study|Withdrawal by Subject|0|||
126763118|NCT00910000|456084944|FG002|Overall Study|Withdrawal by Subject|1|||
126256675|NCT02289820|454229263|FG002|Overall Study|Death|1|||
126256676|NCT02289820|454229264|FG003|Overall Study|Death|0|||
126256677|NCT02289820|454229265|FG004|Overall Study|Death|0|||
126358437|NCT00394472|454605346|FG001|Overall Study|Adverse Event|2|||
126358438|NCT00394472|454605345|FG000|Overall Study|Withdrawal by Subject|0|||
126358439|NCT00394472|454605346|FG001|Overall Study|Withdrawal by Subject|2|||
126358440|NCT00394472|454605345|FG000|Overall Study|Physician Decision|0|||
126358441|NCT00394472|454605346|FG001|Overall Study|Physician Decision|1|||
126358442|NCT00394472|454605345|FG000|Overall Study|Lost to Follow-up|0|||
126358443|NCT00394472|454605346|FG001|Overall Study|Lost to Follow-up|1|||
126358444|NCT00520572|454605347|FG000|Overall Study|Adverse Event|9|||
126358445|NCT00520572|454605348|FG001|Overall Study|Adverse Event|3|||
126358446|NCT00520572|454605349|FG002|Overall Study|Adverse Event|6|||
126763119|NCT00910000|456084945|FG003|Overall Study|Withdrawal by Subject|0|||
126763120|NCT00910000|456084946|FG004|Overall Study|Withdrawal by Subject|1|||
126358447|NCT00520572|454605350|FG003|Overall Study|Adverse Event|9|||
126358448|NCT00520572|454605351|FG004|Overall Study|Adverse Event|7|||
126358449|NCT00520572|454605352|FG005|Overall Study|Adverse Event|2|||
126358450|NCT00520572|454605347|FG000|Overall Study|Withdrawal by Subject|0|||
126358451|NCT00520572|454605348|FG001|Overall Study|Withdrawal by Subject|9|||
126358452|NCT00520572|454605349|FG002|Overall Study|Withdrawal by Subject|5|||
126358453|NCT00520572|454605350|FG003|Overall Study|Withdrawal by Subject|2|||
126358454|NCT00520572|454605351|FG004|Overall Study|Withdrawal by Subject|2|||
126358455|NCT00520572|454605352|FG005|Overall Study|Withdrawal by Subject|0|||
126358456|NCT00520572|454605347|FG000|Overall Study|Protocol Violation|0|||
126358457|NCT00520572|454605348|FG001|Overall Study|Protocol Violation|0|||
126358458|NCT00520572|454605349|FG002|Overall Study|Protocol Violation|1|||
126358459|NCT00520572|454605350|FG003|Overall Study|Protocol Violation|0|||
126358460|NCT00520572|454605351|FG004|Overall Study|Protocol Violation|0|||
126358461|NCT00520572|454605352|FG005|Overall Study|Protocol Violation|0|||
126358462|NCT00520572|454605347|FG000|Overall Study|Lack of Efficacy|1|||
126358463|NCT00520572|454605348|FG001|Overall Study|Lack of Efficacy|1|||
126358464|NCT00520572|454605349|FG002|Overall Study|Lack of Efficacy|1|||
126358465|NCT00520572|454605350|FG003|Overall Study|Lack of Efficacy|2|||
126358466|NCT00520572|454605351|FG004|Overall Study|Lack of Efficacy|1|||
126358467|NCT00520572|454605352|FG005|Overall Study|Lack of Efficacy|0|||
126358468|NCT00520572|454605347|FG000|Overall Study|Lost to Follow-up|0|||
126358469|NCT00520572|454605348|FG001|Overall Study|Lost to Follow-up|0|||
126358470|NCT00520572|454605349|FG002|Overall Study|Lost to Follow-up|0|||
126358471|NCT00520572|454605350|FG003|Overall Study|Lost to Follow-up|0|||
126358472|NCT00520572|454605351|FG004|Overall Study|Lost to Follow-up|1|||
126358473|NCT00520572|454605352|FG005|Overall Study|Lost to Follow-up|0|||
126358474|NCT00520572|454605347|FG000|Overall Study|Incorrect enrollment|1|||
126358475|NCT00520572|454605348|FG001|Overall Study|Incorrect enrollment|0|||
126358476|NCT00520572|454605349|FG002|Overall Study|Incorrect enrollment|1|||
126358477|NCT00520572|454605350|FG003|Overall Study|Incorrect enrollment|0|||
126358478|NCT00520572|454605351|FG004|Overall Study|Incorrect enrollment|1|||
126358479|NCT00520572|454605352|FG005|Overall Study|Incorrect enrollment|0|||
126358480|NCT00520572|454605347|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
126358481|NCT00520572|454605348|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
126358482|NCT00520572|454605349|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
126358483|NCT00520572|454605350|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
126358484|NCT00520572|454605351|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
126358485|NCT00520572|454605352|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
126358486|NCT00520572|454605347|FG000|Overall Study|Long break in taking Medication|0|||
126358487|NCT00520572|454605348|FG001|Overall Study|Long break in taking Medication|0|||
126358488|NCT00520572|454605349|FG002|Overall Study|Long break in taking Medication|0|||
126358489|NCT00520572|454605350|FG003|Overall Study|Long break in taking Medication|1|||
126358490|NCT00520572|454605351|FG004|Overall Study|Long break in taking Medication|0|||
126358491|NCT00520572|454605352|FG005|Overall Study|Long break in taking Medication|0|||
126358492|NCT00520572|454605347|FG000|Overall Study|Did not receive Treatment|1|||
126358493|NCT00520572|454605348|FG001|Overall Study|Did not receive Treatment|0|||
126358494|NCT00520572|454605349|FG002|Overall Study|Did not receive Treatment|1|||
126358495|NCT00520572|454605350|FG003|Overall Study|Did not receive Treatment|0|||
126358496|NCT00520572|454605351|FG004|Overall Study|Did not receive Treatment|0|||
126358497|NCT00520572|454605352|FG005|Overall Study|Did not receive Treatment|0|||
126358498|NCT02181621|454605353|FG000|Overall Study|Adverse Event|1|||
126358499|NCT02181621|454605354|FG001|Overall Study|Adverse Event|0|||
126358500|NCT02181621|454605353|FG000|Overall Study|Previously Enrolled|0|||
126358501|NCT02181621|454605354|FG001|Overall Study|Previously Enrolled|1|||
126358502|NCT02181621|454605353|FG000|Overall Study|Enrollment Hold|1|||
126358503|NCT02181621|454605354|FG001|Overall Study|Enrollment Hold|1|||
126358504|NCT00960856|454605355|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
126358505|NCT00960856|454605356|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
126358506|NCT00960856|454605357|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
126358507|NCT00960856|454605358|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
126358508|NCT00960856|454605355|FG000|Washout Period of 7 Days|Adverse Event|0|||
126546437|NCT03573908|455293804|FG004|Treatment Period|Pregnancy|0|||
126698596|NCT02500537|455847120|FG001|Overall Study|Death|0|||
126698597|NCT02500537|455847119|FG000|Overall Study|Lost to Follow-up|0|||
126698598|NCT02500537|455847120|FG001|Overall Study|Lost to Follow-up|1|||
126358509|NCT00960856|454605356|FG001|Washout Period of 7 Days|Adverse Event|0|||
126358510|NCT00960856|454605357|FG002|Washout Period of 7 Days|Adverse Event|1|||
126358511|NCT00960856|454605358|FG003|Washout Period of 7 Days|Adverse Event|0|||
126358512|NCT03387046|454605360|FG000|Overall Study|Adverse Event|1|||
126358513|NCT03387046|454605361|FG001|Overall Study|Adverse Event|1|||
126358514|NCT01964560|454605373|FG000|Overall Study|Adverse Event|23|||
126358515|NCT01964560|454605373|FG000|Overall Study|Lack of Efficacy|46|||
126358516|NCT01964560|454605373|FG000|Overall Study|Protocol deviation|2|||
126358517|NCT01964560|454605373|FG000|Overall Study|Lost to Follow-up|4|||
126358518|NCT01964560|454605373|FG000|Overall Study|Withdrawal by Subject|64|||
126256678|NCT02289820|454229266|FG005|Overall Study|Death|0|||
126256679|NCT02289820|454229267|FG006|Overall Study|Death|0|||
126256680|NCT02289820|454229261|FG000|Overall Study|Lost to Follow-up|0|||
126256681|NCT02289820|454229262|FG001|Overall Study|Lost to Follow-up|0|||
126256682|NCT02289820|454229263|FG002|Overall Study|Lost to Follow-up|3|||
126256683|NCT02289820|454229264|FG003|Overall Study|Lost to Follow-up|1|||
126256684|NCT02289820|454229265|FG004|Overall Study|Lost to Follow-up|0|||
126256685|NCT02289820|454229266|FG005|Overall Study|Lost to Follow-up|1|||
126256686|NCT02289820|454229267|FG006|Overall Study|Lost to Follow-up|1|||
126256687|NCT02289820|454229261|FG000|Overall Study|withdrawal of consent|0|||
126256688|NCT02289820|454229262|FG001|Overall Study|withdrawal of consent|1|||
126256689|NCT02289820|454229263|FG002|Overall Study|withdrawal of consent|0|||
126256690|NCT02289820|454229264|FG003|Overall Study|withdrawal of consent|0|||
126256691|NCT02289820|454229265|FG004|Overall Study|withdrawal of consent|0|||
126256692|NCT02289820|454229266|FG005|Overall Study|withdrawal of consent|0|||
126256693|NCT02289820|454229267|FG006|Overall Study|withdrawal of consent|0|||
126256694|NCT00926367|454229270|FG000|Overall Study|Withdrawal by Subject|0|||
126256695|NCT00926367|454229271|FG001|Overall Study|Withdrawal by Subject|1|||
126256696|NCT00926367|454229270|FG000|Overall Study|Lost to Follow-up|1|||
126256697|NCT00926367|454229271|FG001|Overall Study|Lost to Follow-up|0|||
126256698|NCT00926367|454229270|FG000|Overall Study|Skin Irritation|1|||
126256699|NCT00926367|454229271|FG001|Overall Study|Skin Irritation|2|||
126256700|NCT02725411|454229272|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
126256701|NCT02725411|454229273|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
126256702|NCT02725411|454229274|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
126256703|NCT02725411|454229272|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
126256704|NCT02725411|454229273|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
126256705|NCT02725411|454229274|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
126256706|NCT02725411|454229272|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
126256707|NCT02725411|454229273|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
126256708|NCT02725411|454229274|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
126256709|NCT02725411|454229272|FG000|Treatment Period (56 Weeks)|Other|1|||
126256710|NCT02725411|454229273|FG001|Treatment Period (56 Weeks)|Other|4|||
126256711|NCT02725411|454229274|FG002|Treatment Period (56 Weeks)|Other|5|||
126256712|NCT02725411|454229272|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
126256713|NCT02725411|454229273|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
126256714|NCT02725411|454229274|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
126256715|NCT02725411|454229272|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
126256716|NCT02725411|454229273|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
126256717|NCT02725411|454229274|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
126256718|NCT02725411|454229272|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
126256719|NCT02725411|454229273|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
126256720|NCT02725411|454229274|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
126256721|NCT02725411|454229272|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
126256722|NCT02725411|454229273|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
126256723|NCT02725411|454229274|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
126256724|NCT02725411|454229272|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
126256725|NCT02725411|454229273|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
126256726|NCT02725411|454229274|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
126256727|NCT02725411|454229272|FG000|Follow-up Period (24 Weeks)|Other|1|||
126256728|NCT02725411|454229273|FG001|Follow-up Period (24 Weeks)|Other|4|||
126256729|NCT02725411|454229274|FG002|Follow-up Period (24 Weeks)|Other|2|||
126256730|NCT02725411|454229272|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
126256731|NCT02725411|454229273|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
126256732|NCT02725411|454229274|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
126256733|NCT03847974|454229281|FG000|Overall Study|relocated out of region|3|||
126256734|NCT03847974|454229281|FG000|Overall Study|Withdrawal by Subject|2|||
126256735|NCT03847974|454229281|FG000|Overall Study|Adverse Event|1|||
126256736|NCT01924364|454229282|FG000|Overall Study|Physician Decision|3|||
126256737|NCT02911935|454229283|FG000|Overall Study|Lost to Follow-up|5|||
126256738|NCT02911935|454229284|FG001|Overall Study|Lost to Follow-up|7|||
126256739|NCT01685216|454229287|FG000|Overall Study|Did not receive study drug|1|||
126698599|NCT02500537|455847119|FG000|Overall Study|Withdrawal by Subject|1|||
126256740|NCT00756717|454229288|FG000|Overall Study|Withdrawal by Subject|2|||
126256741|NCT00603512|454229289|FG000|Overall Study|Adverse Event|0|||
126256742|NCT00603512|454229290|FG001|Overall Study|Adverse Event|2|||
126256743|NCT00603512|454229291|FG002|Overall Study|Adverse Event|4|||
126256744|NCT00603512|454229292|FG003|Overall Study|Adverse Event|4|||
126256745|NCT00603512|454229293|FG004|Overall Study|Adverse Event|2|||
126256746|NCT00603512|454229289|FG000|Overall Study|Lack of Efficacy|0|||
126358519|NCT01964560|454605373|FG000|Overall Study|Surgery-hemispherotomy|1|||
126256747|NCT00603512|454229290|FG001|Overall Study|Lack of Efficacy|1|||
126256748|NCT00603512|454229291|FG002|Overall Study|Lack of Efficacy|0|||
126256749|NCT00603512|454229292|FG003|Overall Study|Lack of Efficacy|0|||
126256750|NCT00603512|454229293|FG004|Overall Study|Lack of Efficacy|1|||
126256751|NCT00603512|454229289|FG000|Overall Study|Other|2|||
126256752|NCT00603512|454229290|FG001|Overall Study|Other|1|||
126256753|NCT00603512|454229291|FG002|Overall Study|Other|0|||
126256754|NCT00603512|454229292|FG003|Overall Study|Other|1|||
126256755|NCT00603512|454229293|FG004|Overall Study|Other|1|||
126256756|NCT00603512|454229289|FG000|Overall Study|Withdrawal by Subject|0|||
126256757|NCT00603512|454229290|FG001|Overall Study|Withdrawal by Subject|0|||
126256758|NCT00603512|454229291|FG002|Overall Study|Withdrawal by Subject|0|||
126256759|NCT00603512|454229292|FG003|Overall Study|Withdrawal by Subject|0|||
126256760|NCT00603512|454229293|FG004|Overall Study|Withdrawal by Subject|1|||
126256761|NCT00603512|454229289|FG000|Overall Study|Randomized but not treated|0|||
126256762|NCT00603512|454229290|FG001|Overall Study|Randomized but not treated|1|||
126256763|NCT00603512|454229291|FG002|Overall Study|Randomized but not treated|1|||
126256764|NCT00603512|454229292|FG003|Overall Study|Randomized but not treated|2|||
126256765|NCT00603512|454229293|FG004|Overall Study|Randomized but not treated|0|||
126256766|NCT00685750|454229294|FG000|Overall Study|Tumor sampling failure|0|||
126256767|NCT00685750|454229295|FG001|Overall Study|Tumor sampling failure|0|||
126256768|NCT00685750|454229296|FG002|Overall Study|Tumor sampling failure|1|||
126256769|NCT00685750|454229297|FG003|Overall Study|Tumor sampling failure|0|||
126256770|NCT00685750|454229298|FG004|Overall Study|Tumor sampling failure|0|||
126256771|NCT00685750|454229299|FG005|Overall Study|Tumor sampling failure|0|||
126256772|NCT00685750|454229300|FG006|Overall Study|Tumor sampling failure|0|||
126256773|NCT00685750|454229294|FG000|Overall Study|Patient didn't receive the treatment|0|||
126256774|NCT00685750|454229295|FG001|Overall Study|Patient didn't receive the treatment|0|||
126256775|NCT00685750|454229296|FG002|Overall Study|Patient didn't receive the treatment|0|||
126256776|NCT00685750|454229297|FG003|Overall Study|Patient didn't receive the treatment|0|||
126256777|NCT00685750|454229298|FG004|Overall Study|Patient didn't receive the treatment|0|||
126256778|NCT00685750|454229299|FG005|Overall Study|Patient didn't receive the treatment|0|||
126256779|NCT00685750|454229300|FG006|Overall Study|Patient didn't receive the treatment|1|||
126256780|NCT00685750|454229294|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126256781|NCT00685750|454229295|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126256782|NCT00685750|454229296|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
126256783|NCT00685750|454229297|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
126256784|NCT00685750|454229298|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
126256785|NCT00685750|454229299|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
126256786|NCT00685750|454229300|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
126256787|NCT04979858|454229301|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
126256788|NCT04979858|454229302|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
126256789|NCT02654015|454229303|FG000|Overall Study|Death|12|||
126256790|NCT02654015|454229303|FG000|Overall Study|Lost to Follow-up|3|||
126256791|NCT02418754|454229306|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
126256792|NCT02418754|454229307|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
126256793|NCT02418754|454229308|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
126256794|NCT02418754|454229309|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
126256795|NCT02418754|454229310|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
126256796|NCT02418754|454229306|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
126256797|NCT02418754|454229307|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
126256798|NCT02418754|454229308|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
126256799|NCT02418754|454229309|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
126256800|NCT02418754|454229310|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
126256801|NCT02418754|454229306|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
126256802|NCT02418754|454229307|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
126256803|NCT02418754|454229308|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
126256804|NCT02418754|454229309|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
126256805|NCT02418754|454229310|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
126256806|NCT02418754|454229306|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
126256807|NCT02418754|454229307|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
126256808|NCT02418754|454229308|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
126256809|NCT02418754|454229309|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
126256810|NCT02418754|454229310|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
126256811|NCT02418754|454229306|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
126256812|NCT02418754|454229307|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
126256813|NCT02418754|454229308|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
126256814|NCT02418754|454229309|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
126256815|NCT02418754|454229310|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
126256816|NCT02418754|454229306|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
126358520|NCT01964560|454605373|FG000|Overall Study|Surgery|1|||
126256817|NCT02418754|454229307|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
126256818|NCT02418754|454229308|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
126256819|NCT02418754|454229309|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
126256820|NCT02418754|454229310|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
126256821|NCT02418754|454229306|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
126256822|NCT02418754|454229307|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
126256823|NCT02418754|454229308|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
126256824|NCT02418754|454229309|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
126256825|NCT02418754|454229310|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
126256826|NCT02418754|454229306|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
126256827|NCT02418754|454229307|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
126256828|NCT02418754|454229308|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
126256829|NCT02418754|454229309|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
126256830|NCT02418754|454229310|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
126256831|NCT02418754|454229306|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
126256832|NCT02418754|454229307|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
126256833|NCT02418754|454229308|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
126256834|NCT02418754|454229309|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
126256835|NCT02418754|454229310|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
126256836|NCT02418754|454229306|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
126256837|NCT02418754|454229307|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
126256838|NCT02418754|454229308|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
126256839|NCT02418754|454229309|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
126698600|NCT02500537|455847120|FG001|Overall Study|Withdrawal by Subject|0|||
126698601|NCT01551745|455847121|FG000|Overall Study|Withdrawal by Subject|1|||
126256840|NCT02418754|454229310|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
126256841|NCT02418754|454229306|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
126256842|NCT02418754|454229307|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
126256843|NCT02418754|454229308|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
126256844|NCT02418754|454229309|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
126256845|NCT02418754|454229310|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
126256846|NCT01896505|454229311|FG000|Overall Study|Adverse Event|1|||
126256847|NCT01896505|454229312|FG001|Overall Study|Adverse Event|0|||
126256848|NCT01896505|454229313|FG002|Overall Study|Adverse Event|2|||
126256849|NCT01896505|454229314|FG003|Overall Study|Adverse Event|1|||
126256850|NCT01896505|454229315|FG004|Overall Study|Adverse Event|1|||
126256851|NCT01896505|454229316|FG005|Overall Study|Adverse Event|0|||
126256852|NCT01896505|454229311|FG000|Overall Study|Physician Decision|1|||
126256853|NCT01896505|454229312|FG001|Overall Study|Physician Decision|3|||
126256854|NCT01896505|454229313|FG002|Overall Study|Physician Decision|2|||
126256855|NCT01896505|454229314|FG003|Overall Study|Physician Decision|0|||
126256856|NCT01896505|454229315|FG004|Overall Study|Physician Decision|0|||
126256857|NCT01896505|454229316|FG005|Overall Study|Physician Decision|1|||
126256858|NCT01896505|454229311|FG000|Overall Study|Withdrawal by Subject|1|||
126256859|NCT01896505|454229312|FG001|Overall Study|Withdrawal by Subject|0|||
126256860|NCT01896505|454229313|FG002|Overall Study|Withdrawal by Subject|3|||
126256861|NCT01896505|454229314|FG003|Overall Study|Withdrawal by Subject|1|||
126256862|NCT01896505|454229315|FG004|Overall Study|Withdrawal by Subject|0|||
126256863|NCT01896505|454229316|FG005|Overall Study|Withdrawal by Subject|0|||
126256864|NCT01896505|454229311|FG000|Overall Study|Disease Progression|7|||
126256865|NCT01896505|454229312|FG001|Overall Study|Disease Progression|5|||
126256866|NCT01896505|454229313|FG002|Overall Study|Disease Progression|8|||
126256867|NCT01896505|454229314|FG003|Overall Study|Disease Progression|4|||
126256868|NCT01896505|454229315|FG004|Overall Study|Disease Progression|4|||
126256869|NCT01896505|454229316|FG005|Overall Study|Disease Progression|4|||
126256870|NCT01896505|454229311|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
126256871|NCT01896505|454229312|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
126256872|NCT01896505|454229313|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
126256873|NCT01896505|454229314|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
126256874|NCT01896505|454229315|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
126256875|NCT01896505|454229316|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
126256876|NCT01896505|454229311|FG000|Overall Study|Intercurrent illness|0|||
126256877|NCT01896505|454229312|FG001|Overall Study|Intercurrent illness|1|||
126256878|NCT01896505|454229313|FG002|Overall Study|Intercurrent illness|0|||
126256879|NCT01896505|454229314|FG003|Overall Study|Intercurrent illness|0|||
126256880|NCT01896505|454229315|FG004|Overall Study|Intercurrent illness|0|||
126256881|NCT01896505|454229316|FG005|Overall Study|Intercurrent illness|0|||
126256882|NCT01896505|454229311|FG000|Overall Study|Death|0|||
126256883|NCT01896505|454229312|FG001|Overall Study|Death|0|||
126256884|NCT01896505|454229313|FG002|Overall Study|Death|1|||
126256885|NCT01896505|454229314|FG003|Overall Study|Death|1|||
126256886|NCT01896505|454229315|FG004|Overall Study|Death|0|||
126256887|NCT01896505|454229316|FG005|Overall Study|Death|1|||
126256888|NCT04974580|454229317|FG000|Overall Study|Lost to Follow-up|33|||
126256889|NCT04974580|454229318|FG001|Overall Study|Lost to Follow-up|39|||
126256890|NCT04974580|454229319|FG002|Overall Study|Lost to Follow-up|30|||
126256891|NCT04974580|454229320|FG003|Overall Study|Lost to Follow-up|29|||
126256892|NCT00250705|454229323|FG000|Overall Study|Lack of Efficacy|2|||
126256893|NCT02466386|454229334|FG000|Overall Study|Adverse Event|5|||
126256894|NCT02466386|454229334|FG000|Overall Study|Protocol Violation|2|||
126256895|NCT02466386|454229334|FG000|Overall Study|Withdrawal by Subject|14|||
126256896|NCT02466386|454229334|FG000|Overall Study|Lost to Follow-up|5|||
126256897|NCT02466386|454229334|FG000|Overall Study|Lack of Efficacy|8|||
126256898|NCT02466386|454229334|FG000|Overall Study|Other|10|||
126256899|NCT05317195|454229335|FG000|Randomization|Withdrawal by Subject|1|||
126256900|NCT05317195|454229335|FG000|Randomization|Discontinued|6|||
126256901|NCT05317195|454229335|FG000|Admission|Withdrawal by Subject|2|||
126256902|NCT03919695|454229338|FG000|3-month Follow-up|Death|1|||
126256903|NCT03919695|454229339|FG001|3-month Follow-up|Death|1|||
126256904|NCT03919695|454229338|FG000|3-month Follow-up|unable to contact|0|||
126256905|NCT03919695|454229339|FG001|3-month Follow-up|unable to contact|3|||
126256906|NCT03919695|454229338|FG000|3-month Follow-up|in prison|0|||
126256907|NCT03919695|454229339|FG001|3-month Follow-up|in prison|1|||
126256908|NCT03919695|454229338|FG000|6-month Follow-up|Death|0|||
126256909|NCT03919695|454229339|FG001|6-month Follow-up|Death|1|||
126256910|NCT03919695|454229338|FG000|6-month Follow-up|Lost to Follow-up|1|||
126256911|NCT03919695|454229339|FG001|6-month Follow-up|Lost to Follow-up|2|||
126256912|NCT03919695|454229338|FG000|6-month Follow-up|in prison|0|||
126256913|NCT03919695|454229339|FG001|6-month Follow-up|in prison|2|||
126256914|NCT03919695|454229338|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
126256915|NCT03919695|454229339|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
126256916|NCT03919695|454229338|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
126256917|NCT03919695|454229339|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
126256918|NCT01688882|454229340|FG000|Overall Study|Adverse Event|1|||
126256919|NCT01688882|454229341|FG001|Overall Study|Adverse Event|0|||
126256920|NCT01688882|454229340|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126256921|NCT01688882|454229341|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126256922|NCT01688882|454229340|FG000|Overall Study|Administrative problems|1|||
126256923|NCT01688882|454229341|FG001|Overall Study|Administrative problems|0|||
126256924|NCT03259789|454229342|FG000|Overall Study|Adverse Event|3|||
126256925|NCT03259789|454229343|FG001|Overall Study|Adverse Event|2|||
126256926|NCT03259789|454229344|FG002|Overall Study|Adverse Event|1|||
126256927|NCT03259789|454229342|FG000|Overall Study|Withdrawal by Subject|9|||
126256928|NCT03259789|454229343|FG001|Overall Study|Withdrawal by Subject|5|||
126256929|NCT03259789|454229344|FG002|Overall Study|Withdrawal by Subject|1|||
126256930|NCT03259789|454229342|FG000|Overall Study|Lost to Follow-up|5|||
126256931|NCT03259789|454229343|FG001|Overall Study|Lost to Follow-up|9|||
126256932|NCT03259789|454229344|FG002|Overall Study|Lost to Follow-up|4|||
126256933|NCT03259789|454229342|FG000|Overall Study|Physician Decision|0|||
126256934|NCT03259789|454229343|FG001|Overall Study|Physician Decision|1|||
126256935|NCT03259789|454229344|FG002|Overall Study|Physician Decision|0|||
126256936|NCT02063217|454229346|FG000|Overall Study|Withdrawal by Subject|1|||
126256937|NCT02063217|454229347|FG001|Overall Study|Withdrawal by Subject|0|||
126256938|NCT02063217|454229348|FG002|Overall Study|Withdrawal by Subject|0|||
126256939|NCT00889252|454229349|FG000|Overall Study|Adverse Event|2|||
126256940|NCT00889252|454229350|FG001|Overall Study|Adverse Event|4|||
126256941|NCT00889252|454229349|FG000|Overall Study|Withdrawal by Subject|3|||
126256942|NCT00889252|454229350|FG001|Overall Study|Withdrawal by Subject|0|||
126256943|NCT00889252|454229349|FG000|Overall Study|Protocol Violation|2|||
126256944|NCT00889252|454229350|FG001|Overall Study|Protocol Violation|0|||
126256945|NCT02416934|454229351|FG000|Overall Study|given steroids|1|||
126256946|NCT02416934|454229352|FG001|Overall Study|given steroids|2|||
126256947|NCT02416934|454229351|FG000|Overall Study|Lost to Follow-up|0|||
126256948|NCT02416934|454229352|FG001|Overall Study|Lost to Follow-up|2|||
126256949|NCT02416934|454229351|FG000|Overall Study|Withdrawal by Subject|1|||
126256950|NCT02416934|454229352|FG001|Overall Study|Withdrawal by Subject|0|||
126358521|NCT01964560|454605373|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
126358522|NCT01964560|454605373|FG000|Overall Study|Patient and Investigator choice|1|||
126256951|NCT02416934|454229351|FG000|Overall Study|recruited during continuing renewal proc|0|||
126256952|NCT02416934|454229352|FG001|Overall Study|recruited during continuing renewal proc|1|||
126358523|NCT01964560|454605373|FG000|Overall Study|Patient was prescribed CBD|1|||
126358524|NCT01964560|454605373|FG000|Overall Study|Participant moved to another country|1|||
126358525|NCT01301001|454605374|FG000|First Intervention|Lost to Follow-up|4|||
126358526|NCT01301001|454605375|FG001|First Intervention|Lost to Follow-up|4|||
126256953|NCT02416934|454229351|FG000|Overall Study|Protocol Violation|0|||
126256954|NCT02416934|454229352|FG001|Overall Study|Protocol Violation|1|||
126256955|NCT02416934|454229351|FG000|Overall Study|surgery started late|0|||
126256956|NCT02416934|454229352|FG001|Overall Study|surgery started late|1|||
126256957|NCT02416934|454229351|FG000|Overall Study|re-operation|1|||
126256958|NCT02416934|454229352|FG001|Overall Study|re-operation|0|||
126256959|NCT01020526|454229353|FG000|Overall Study|Withdrawal by Subject|5|||
126256960|NCT01020526|454229353|FG000|Overall Study|Other reasons|3|||
126256961|NCT01020526|454229353|FG000|Overall Study|Insufficient clinical response|3|||
126256962|NCT01020526|454229353|FG000|Overall Study|Lost to Follow-up|1|||
126256963|NCT01020526|454229353|FG000|Overall Study|Adverse Event|2|||
126358527|NCT01301001|454605374|FG000|First Intervention|Withdrawal by Subject|1|||
126358528|NCT01301001|454605375|FG001|First Intervention|Withdrawal by Subject|4|||
126358529|NCT01301001|454605374|FG000|First Intervention|Adverse Event|5|||
126358530|NCT01301001|454605375|FG001|First Intervention|Adverse Event|0|||
126358531|NCT01301001|454605374|FG000|First Intervention|Protocol Violation|0|||
126358532|NCT01301001|454605375|FG001|First Intervention|Protocol Violation|1|||
126358533|NCT01301001|454605374|FG000|Second Intervention|Adverse Event|2|||
126358534|NCT01301001|454605375|FG001|Second Intervention|Adverse Event|0|||
126358535|NCT01301001|454605374|FG000|Second Intervention|Withdrawal by Subject|2|||
126358536|NCT01301001|454605375|FG001|Second Intervention|Withdrawal by Subject|0|||
126358537|NCT01560988|454605376|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
126358538|NCT01560988|454605377|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
126358539|NCT01560988|454605376|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
126358540|NCT01560988|454605377|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
126358541|NCT01560988|454605376|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
126358542|NCT01560988|454605377|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
126358543|NCT01346709|454605378|FG000|Overall Study|Protocol Violation|35|||
126358544|NCT01346709|454605378|FG000|Overall Study|Lost to Follow-up|31|||
126358545|NCT01346709|454605378|FG000|Overall Study|Missing data in candidate risk factor|285|||
126358546|NCT02565186|454605379|FG000|Overall Study|Adverse Event|113|||
126358547|NCT02565186|454605380|FG001|Overall Study|Adverse Event|148|||
126358548|NCT02565186|454605379|FG000|Overall Study|Lost to Follow-up|102|||
126358549|NCT02565186|454605380|FG001|Overall Study|Lost to Follow-up|93|||
126358550|NCT02565186|454605379|FG000|Overall Study|Non-Compliance|57|||
126358551|NCT02565186|454605380|FG001|Overall Study|Non-Compliance|55|||
126358552|NCT02565186|454605379|FG000|Overall Study|Withdrawal by Subject|229|||
126256964|NCT00398073|454229359|FG000|Overall Study|Withdrawal by Subject|1|||
126256965|NCT00398073|454229360|FG001|Overall Study|Withdrawal by Subject|0|||
126256966|NCT01833169|454229366|FG000|Overall Study|Disease Progression|99|||
126256967|NCT01833169|454229366|FG000|Overall Study|Adverse Event|33|||
126256968|NCT01833169|454229366|FG000|Overall Study|Withdrawal by Subject|9|||
126256969|NCT01833169|454229366|FG000|Overall Study|Death|3|||
126256970|NCT01833169|454229366|FG000|Overall Study|Physician Decision|2|||
126256971|NCT00879684|454229367|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
126256972|NCT00879684|454229368|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
126256973|NCT00879684|454229369|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
126256974|NCT00879684|454229370|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
126256975|NCT00879684|454229371|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
126256976|NCT00879684|454229372|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
126256977|NCT00879684|454229373|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
126256978|NCT00879684|454229367|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
126256979|NCT00879684|454229368|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
126256980|NCT00879684|454229369|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
126256981|NCT00879684|454229370|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
126256982|NCT00879684|454229371|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
126256983|NCT00879684|454229372|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
126256984|NCT00879684|454229373|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
126256985|NCT00879684|454229367|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
126256986|NCT00879684|454229368|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
126256987|NCT00879684|454229369|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
126256988|NCT00879684|454229370|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
126256989|NCT00879684|454229371|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
126256990|NCT00879684|454229372|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
126256991|NCT00879684|454229373|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
126256992|NCT00879684|454229367|FG000|Stage 1: Dose Escalation|Death|0|||
126256993|NCT00879684|454229368|FG001|Stage 1: Dose Escalation|Death|0|||
126256994|NCT00879684|454229369|FG002|Stage 1: Dose Escalation|Death|1|||
126256995|NCT00879684|454229370|FG003|Stage 1: Dose Escalation|Death|0|||
126256996|NCT00879684|454229371|FG004|Stage 1: Dose Escalation|Death|0|||
126256997|NCT00879684|454229372|FG005|Stage 1: Dose Escalation|Death|0|||
126256998|NCT00879684|454229373|FG006|Stage 1: Dose Escalation|Death|0|||
126256999|NCT00879684|454229367|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
126257000|NCT00879684|454229368|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
126257001|NCT00879684|454229369|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
126358553|NCT02565186|454605380|FG001|Overall Study|Withdrawal by Subject|214|||
126358554|NCT02565186|454605379|FG000|Overall Study|Physician Decision|18|||
126358555|NCT02565186|454605380|FG001|Overall Study|Physician Decision|16|||
126358556|NCT02565186|454605379|FG000|Overall Study|Sponsor Request|5|||
126358557|NCT02565186|454605380|FG001|Overall Study|Sponsor Request|9|||
126698602|NCT01551745|455847121|FG000|Overall Study|Disease Progression|2|||
126257002|NCT00879684|454229370|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
126257003|NCT00879684|454229371|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
126257004|NCT00879684|454229372|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
126358558|NCT02565186|454605379|FG000|Overall Study|Missing|1|||
126257005|NCT00879684|454229373|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
126257006|NCT00879684|454229367|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
126257007|NCT00879684|454229368|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
126257008|NCT00879684|454229369|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
126257009|NCT00879684|454229370|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
126257010|NCT00879684|454229371|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
126257011|NCT00879684|454229372|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
126257012|NCT00879684|454229373|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
126257013|NCT00879684|454229367|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
126257014|NCT00879684|454229368|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
126257015|NCT00879684|454229369|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
126257016|NCT00879684|454229370|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
126257017|NCT00879684|454229371|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
126257018|NCT00879684|454229372|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
126257019|NCT00879684|454229373|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
126257020|NCT02169336|454229374|FG000|Overall Study|Lack of Efficacy|1|||
126257021|NCT02169336|454229375|FG001|Overall Study|Lack of Efficacy|1|||
126257022|NCT02169336|454229376|FG002|Overall Study|Lack of Efficacy|0|||
126257023|NCT02169336|454229374|FG000|Overall Study|Adverse Event|2|||
126257024|NCT02169336|454229375|FG001|Overall Study|Adverse Event|3|||
126257025|NCT02169336|454229376|FG002|Overall Study|Adverse Event|1|||
126257026|NCT02169336|454229374|FG000|Overall Study|Withdrawal by Subject|1|||
126257027|NCT02169336|454229375|FG001|Overall Study|Withdrawal by Subject|0|||
126257028|NCT02169336|454229376|FG002|Overall Study|Withdrawal by Subject|0|||
126257029|NCT02169336|454229374|FG000|Overall Study|Physician Decision|0|||
126257030|NCT02169336|454229375|FG001|Overall Study|Physician Decision|0|||
126257031|NCT02169336|454229376|FG002|Overall Study|Physician Decision|1|||
126257032|NCT02169336|454229374|FG000|Overall Study|Subject declined to continue dosing|0|||
126257033|NCT02169336|454229375|FG001|Overall Study|Subject declined to continue dosing|0|||
126257034|NCT02169336|454229376|FG002|Overall Study|Subject declined to continue dosing|1|||
126257035|NCT02212457|454229379|FG000|Overall Study|Adverse Event|1|||
126257036|NCT02212457|454229380|FG001|Overall Study|Adverse Event|2|||
126257037|NCT02212457|454229381|FG002|Overall Study|Adverse Event|2|||
126257038|NCT02212457|454229382|FG003|Overall Study|Adverse Event|2|||
126257039|NCT02212457|454229383|FG004|Overall Study|Adverse Event|0|||
126257040|NCT02212457|454229384|FG005|Overall Study|Adverse Event|1|||
126257041|NCT02212457|454229379|FG000|Overall Study|Withdrawal by Subject|8|||
126257042|NCT02212457|454229380|FG001|Overall Study|Withdrawal by Subject|10|||
126257043|NCT02212457|454229381|FG002|Overall Study|Withdrawal by Subject|8|||
126257044|NCT02212457|454229382|FG003|Overall Study|Withdrawal by Subject|6|||
126257045|NCT02212457|454229383|FG004|Overall Study|Withdrawal by Subject|5|||
126257046|NCT02212457|454229384|FG005|Overall Study|Withdrawal by Subject|4|||
126257047|NCT02212457|454229379|FG000|Overall Study|Lost to Follow-up|6|||
126257048|NCT02212457|454229380|FG001|Overall Study|Lost to Follow-up|7|||
126257049|NCT02212457|454229381|FG002|Overall Study|Lost to Follow-up|4|||
126257050|NCT02212457|454229382|FG003|Overall Study|Lost to Follow-up|1|||
126257051|NCT02212457|454229383|FG004|Overall Study|Lost to Follow-up|8|||
126257052|NCT02212457|454229384|FG005|Overall Study|Lost to Follow-up|4|||
126257053|NCT02212457|454229379|FG000|Overall Study|Protocol Violation|2|||
126257054|NCT02212457|454229380|FG001|Overall Study|Protocol Violation|1|||
126257055|NCT02212457|454229381|FG002|Overall Study|Protocol Violation|0|||
126257056|NCT02212457|454229382|FG003|Overall Study|Protocol Violation|1|||
126257057|NCT02212457|454229383|FG004|Overall Study|Protocol Violation|2|||
126257058|NCT02212457|454229384|FG005|Overall Study|Protocol Violation|3|||
126257059|NCT02212457|454229379|FG000|Overall Study|Other|2|||
126257060|NCT02212457|454229380|FG001|Overall Study|Other|1|||
126257061|NCT02212457|454229381|FG002|Overall Study|Other|2|||
126257062|NCT02212457|454229382|FG003|Overall Study|Other|1|||
126257063|NCT02212457|454229383|FG004|Overall Study|Other|0|||
126257064|NCT02212457|454229384|FG005|Overall Study|Other|1|||
126306196|NCT03260244|454410221|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
126306197|NCT03260244|454410221|FG000|Overall Study|Screen Failure|2|||
126306198|NCT03260244|454410221|FG000|Overall Study|Treated Off Label|69|||
126306199|NCT03260244|454410221|FG000|Overall Study|No Radiofrequency Ablation|14|||
126306200|NCT04292912|454410222|FG000|Overall Study|Physician Decision|1|||
126306201|NCT04292912|454410222|FG000|Overall Study|Protocol Violation|6|||
126306202|NCT05338502|454410232|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
126306203|NCT05338502|454410233|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
126306204|NCT05338502|454410234|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
126306205|NCT05338502|454410232|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
126306206|NCT05338502|454410233|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
126306207|NCT05338502|454410234|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
126306208|NCT03575793|454410237|FG000|Overall Study|Withdrawal by Subject|0|||
126306209|NCT03575793|454410238|FG001|Overall Study|Withdrawal by Subject|1|||
126306210|NCT03575793|454410237|FG000|Overall Study|Never Treated|0|||
126306211|NCT03575793|454410238|FG001|Overall Study|Never Treated|2|||
126257065|NCT02832167|454231229|FG000|Treatment Period 1|Disease progression|90|||
126257066|NCT02832167|454231229|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
126257067|NCT02832167|454231229|FG000|Treatment Period 1|Death|2|||
126257068|NCT02832167|454231229|FG000|Treatment Period 1|Study Drug Toxicity|6|||
126257069|NCT02832167|454231229|FG000|Treatment Period 1|Participant request to discontinue|9|||
126257070|NCT02832167|454231229|FG000|Treatment Period 1|No longer meet study criteria|1|||
126257071|NCT02832167|454231229|FG000|Treatment Period 1|Participant withdrew consent|3|||
126257072|NCT02832167|454231229|FG000|Treatment Period 1|Other reasons|6|||
126257073|NCT02832167|454231229|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
126257074|NCT02832167|454231229|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
126257075|NCT02832167|454231229|FG000|Transition From Period 1 to Period 2|Death|2|||
126257076|NCT02832167|454231229|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
126257077|NCT02832167|454231229|FG000|Treatment Period 2|Disease progression|69|||
126257078|NCT02832167|454231229|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
126257079|NCT02832167|454231229|FG000|Treatment Period 2|Maximum clinical benefit|1|||
126257080|NCT02832167|454231229|FG000|Treatment Period 2|Study Drug Toxicity|5|||
126257081|NCT02832167|454231229|FG000|Treatment Period 2|Participant request to discontinue|2|||
126257082|NCT02832167|454231229|FG000|Treatment Period 2|Participant withdrew consent|3|||
126257083|NCT02832167|454231229|FG000|Treatment Period 2|Other reasons|3|||
126257084|NCT02293460|454231230|FG000|Overall Study|Protocol Violation|1|||
126257085|NCT02293460|454231230|FG000|Overall Study|Lack of Efficacy|2|||
126257086|NCT02293460|454231230|FG000|Overall Study|Adverse Event|2|||
126257087|NCT02293460|454231230|FG000|Overall Study|Withdrawal by Subject|1|||
126257088|NCT00224484|454231231|FG000|Overall Study|Serious Adverse Event|1|||
126257089|NCT00224484|454231232|FG001|Overall Study|Serious Adverse Event|1|||
126257090|NCT00224484|454231233|FG002|Overall Study|Serious Adverse Event|0|||
126257091|NCT00224484|454231231|FG000|Overall Study|Non-Serious Adverse Event|5|||
126257092|NCT00224484|454231232|FG001|Overall Study|Non-Serious Adverse Event|7|||
126257093|NCT00224484|454231233|FG002|Overall Study|Non-Serious Adverse Event|3|||
126257094|NCT00224484|454231231|FG000|Overall Study|Protocol Violation|2|||
126257095|NCT00224484|454231232|FG001|Overall Study|Protocol Violation|2|||
126257096|NCT00224484|454231233|FG002|Overall Study|Protocol Violation|0|||
126257097|NCT00224484|454231231|FG000|Overall Study|Withdrawal by Subject|49|||
126257098|NCT00224484|454231232|FG001|Overall Study|Withdrawal by Subject|18|||
126257099|NCT00224484|454231233|FG002|Overall Study|Withdrawal by Subject|16|||
126257100|NCT00224484|454231231|FG000|Overall Study|Migrated/moved from study area|18|||
126257101|NCT00224484|454231232|FG001|Overall Study|Migrated/moved from study area|5|||
126257102|NCT00224484|454231233|FG002|Overall Study|Migrated/moved from study area|5|||
126257103|NCT00224484|454231231|FG000|Overall Study|Lost to Follow-up|66|||
126257104|NCT00224484|454231232|FG001|Overall Study|Lost to Follow-up|28|||
126257105|NCT00224484|454231233|FG002|Overall Study|Lost to Follow-up|36|||
126257106|NCT00224484|454231231|FG000|Overall Study|Reason not specified|5|||
126257107|NCT00224484|454231232|FG001|Overall Study|Reason not specified|4|||
126257108|NCT00224484|454231233|FG002|Overall Study|Reason not specified|2|||
126257109|NCT00108628|454231239|FG000|Overall Study|Withdrawal by Subject|17|||
126257110|NCT00108628|454231240|FG001|Overall Study|Withdrawal by Subject|9|||
126257111|NCT00108628|454231239|FG000|Overall Study|Lack of Efficacy|2|||
126257112|NCT00108628|454231240|FG001|Overall Study|Lack of Efficacy|1|||
126257113|NCT00108628|454231239|FG000|Overall Study|Death|1|||
126257114|NCT00108628|454231240|FG001|Overall Study|Death|0|||
126257115|NCT03547635|454231243|FG000|Overall Study|Adverse Event|5|||
126257116|NCT03547635|454231244|FG001|Overall Study|Adverse Event|2|||
126257117|NCT03547635|454231245|FG002|Overall Study|Adverse Event|3|||
126257118|NCT03547635|454231243|FG000|Overall Study|Lost to Follow-up|1|||
126257119|NCT03547635|454231244|FG001|Overall Study|Lost to Follow-up|3|||
126257120|NCT03547635|454231245|FG002|Overall Study|Lost to Follow-up|4|||
126257121|NCT03547635|454231243|FG000|Overall Study|Withdrawal by Subject|1|||
126257122|NCT03547635|454231244|FG001|Overall Study|Withdrawal by Subject|0|||
126257123|NCT03547635|454231245|FG002|Overall Study|Withdrawal by Subject|0|||
126257124|NCT03547635|454231243|FG000|Overall Study|Withdrawal By PI|0|||
126257125|NCT03547635|454231244|FG001|Overall Study|Withdrawal By PI|1|||
126257126|NCT03547635|454231245|FG002|Overall Study|Withdrawal By PI|0|||
126257127|NCT03547635|454231243|FG000|Overall Study|Withdrawal by Sponsor|0|||
126257128|NCT03547635|454231244|FG001|Overall Study|Withdrawal by Sponsor|0|||
126763121|NCT00910000|456084947|FG005|Overall Study|Withdrawal by Subject|0|||
126763122|NCT04113746|456084948|FG000|Overall Study|Lost to Follow-up|4|||
126257129|NCT03547635|454231245|FG002|Overall Study|Withdrawal by Sponsor|1|||
126257130|NCT03547635|454231243|FG000|Overall Study|Errant Randomization before Treatment|0|||
126257131|NCT03547635|454231244|FG001|Overall Study|Errant Randomization before Treatment|1|||
126257132|NCT03547635|454231245|FG002|Overall Study|Errant Randomization before Treatment|0|||
126257133|NCT03547635|454231243|FG000|Overall Study|Withdrawal by Subject|1|||
126257134|NCT03547635|454231244|FG001|Overall Study|Withdrawal by Subject|0|||
126257135|NCT03547635|454231245|FG002|Overall Study|Withdrawal by Subject|0|||
126257136|NCT02415387|454231253|FG000|Overall Study|Withdrawal by Subject|6|||
126257137|NCT02415387|454231254|FG001|Overall Study|Withdrawal by Subject|1|||
126449361|NCT02792829|454947088|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
126449362|NCT02792829|454947089|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
126449363|NCT02792829|454947090|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
126449364|NCT02792829|454947091|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
126449365|NCT02792829|454947092|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
126449366|NCT02792829|454947085|FG000|Treatment Period 2|Adverse Event|0|||
126449367|NCT02792829|454947086|FG001|Treatment Period 2|Adverse Event|0|||
126449368|NCT02792829|454947087|FG002|Treatment Period 2|Adverse Event|0|||
126449369|NCT02792829|454947088|FG003|Treatment Period 2|Adverse Event|0|||
126449370|NCT02792829|454947089|FG004|Treatment Period 2|Adverse Event|1|||
126449371|NCT02792829|454947090|FG005|Treatment Period 2|Adverse Event|0|||
126449372|NCT02792829|454947091|FG006|Treatment Period 2|Adverse Event|1|||
126449373|NCT02792829|454947092|FG007|Treatment Period 2|Adverse Event|1|||
126449374|NCT02792829|454947085|FG000|Treatment Period 2|Use of proscribed medications|0|||
126449375|NCT02792829|454947086|FG001|Treatment Period 2|Use of proscribed medications|0|||
126449376|NCT02792829|454947087|FG002|Treatment Period 2|Use of proscribed medications|0|||
126449377|NCT02792829|454947088|FG003|Treatment Period 2|Use of proscribed medications|0|||
126449378|NCT02792829|454947089|FG004|Treatment Period 2|Use of proscribed medications|0|||
126449379|NCT02792829|454947090|FG005|Treatment Period 2|Use of proscribed medications|0|||
126698603|NCT04752384|455847122|FG000|Overall Study|Withdrawal by Subject|1|||
126257138|NCT02415387|454231253|FG000|Overall Study|blood draw problem|0|||
126257139|NCT02415387|454231254|FG001|Overall Study|blood draw problem|1|||
126257140|NCT02415387|454231253|FG000|Overall Study|Protocol Violation|1|||
126257141|NCT02415387|454231254|FG001|Overall Study|Protocol Violation|0|||
126257142|NCT00676650|454231255|FG000|Overall Study|Death|45|||
126257143|NCT00676650|454231256|FG001|Overall Study|Death|14|||
126257144|NCT00676650|454231255|FG000|Overall Study|Adverse Event|159|||
126257145|NCT00676650|454231256|FG001|Overall Study|Adverse Event|21|||
126257146|NCT00676650|454231255|FG000|Overall Study|Global deterioration of health status|66|||
126257147|NCT00676650|454231256|FG001|Overall Study|Global deterioration of health status|31|||
126257148|NCT00676650|454231255|FG000|Overall Study|Lost to Follow-up|0|||
126257149|NCT00676650|454231256|FG001|Overall Study|Lost to Follow-up|1|||
126257150|NCT00676650|454231255|FG000|Overall Study|Objective progression or relapse|189|||
126257151|NCT00676650|454231256|FG001|Overall Study|Objective progression or relapse|140|||
126257152|NCT00676650|454231255|FG000|Overall Study|Other|14|||
126257153|NCT00676650|454231256|FG001|Overall Study|Other|10|||
126257154|NCT00676650|454231255|FG000|Overall Study|Protocol Violation|3|||
126257155|NCT00676650|454231256|FG001|Overall Study|Protocol Violation|1|||
126257156|NCT00676650|454231255|FG000|Overall Study|Study terminated by sponsor|57|||
126257157|NCT00676650|454231256|FG001|Overall Study|Study terminated by sponsor|43|||
126257158|NCT00676650|454231255|FG000|Overall Study|Withdrawal by Subject|48|||
126257159|NCT00676650|454231256|FG001|Overall Study|Withdrawal by Subject|24|||
126257160|NCT00676650|454231255|FG000|Overall Study|Randomized but not treated|3|||
126257161|NCT00676650|454231256|FG001|Overall Study|Randomized but not treated|4|||
126257162|NCT02297841|454231260|FG000|Overall Study|Withdrawal by Subject|1|||
126257163|NCT02297841|454231260|FG000|Overall Study|Protocol Violation|7|||
126257164|NCT00683592|454231261|FG000|Overall Study|Adverse Event|12|||
126257165|NCT00683592|454231262|FG001|Overall Study|Adverse Event|4|||
126257166|NCT00683592|454231261|FG000|Overall Study|Withdrawal by Subject|11|||
126257167|NCT00683592|454231262|FG001|Overall Study|Withdrawal by Subject|11|||
126257168|NCT00683592|454231261|FG000|Overall Study|Lost to Follow-up|17|||
126257169|NCT00683592|454231262|FG001|Overall Study|Lost to Follow-up|17|||
126257170|NCT00683592|454231261|FG000|Overall Study|Lack of Efficacy|3|||
126257171|NCT00683592|454231262|FG001|Overall Study|Lack of Efficacy|7|||
126257172|NCT00683592|454231261|FG000|Overall Study|Physician Decision|0|||
126257173|NCT00683592|454231262|FG001|Overall Study|Physician Decision|1|||
126257174|NCT00683592|454231261|FG000|Overall Study|Non-compliance|3|||
126257175|NCT00683592|454231262|FG001|Overall Study|Non-compliance|5|||
126257176|NCT00683592|454231261|FG000|Overall Study|Other|1|||
126257177|NCT00683592|454231262|FG001|Overall Study|Other|1|||
126257178|NCT03431337|454231265|FG000|Overall Study|Lost to Follow-up|21|||
126698604|NCT04752384|455847122|FG000|Overall Study|Death|1|||
126698605|NCT02330419|455847124|FG000|Overall Study|Lost to Follow-up|3|||
126698606|NCT02330419|455847125|FG001|Overall Study|Lost to Follow-up|7|||
126257179|NCT03431337|454231266|FG001|Overall Study|Lost to Follow-up|19|||
126257180|NCT03431337|454231265|FG000|Overall Study|Withdrawal by Subject|8|||
126257181|NCT03431337|454231266|FG001|Overall Study|Withdrawal by Subject|3|||
126698607|NCT01955707|455847131|FG000|Overall Study|Adverse Event|1|||
126257182|NCT04501094|454231267|FG000|Overall Study|Death (unrelated to research)|1|||
126257183|NCT04501094|454231268|FG001|Overall Study|Death (unrelated to research)|0|||
126698608|NCT01955707|455847132|FG001|Overall Study|Adverse Event|2|||
126257184|NCT02050321|454231272|FG000|Overall Study|Withdrawal by Subject|1|||
126257185|NCT02050321|454231272|FG000|Overall Study|Adverse Event|1|||
126257186|NCT02005276|454231273|FG000|Overall Study|No longer interested|5|||
126257187|NCT02005276|454231274|FG001|Overall Study|No longer interested|2|||
126257188|NCT02005276|454231275|FG002|Overall Study|No longer interested|3|||
126257189|NCT02005276|454231276|FG003|Overall Study|No longer interested|3|||
126257190|NCT01963260|454231277|FG000|Overall Study|Withdrawal by Subject|2|||
126257191|NCT01963260|454231278|FG001|Overall Study|Withdrawal by Subject|0|||
126257192|NCT01963260|454231279|FG002|Overall Study|Withdrawal by Subject|0|||
126257193|NCT01963260|454231280|FG003|Overall Study|Withdrawal by Subject|1|||
126257194|NCT01963260|454231281|FG004|Overall Study|Withdrawal by Subject|2|||
126257195|NCT01963260|454231282|FG005|Overall Study|Withdrawal by Subject|0|||
126257196|NCT01963260|454231283|FG006|Overall Study|Withdrawal by Subject|0|||
126257197|NCT01963260|454231284|FG007|Overall Study|Withdrawal by Subject|0|||
126257198|NCT01963260|454231285|FG008|Overall Study|Withdrawal by Subject|0|||
126257199|NCT01963260|454231286|FG009|Overall Study|Withdrawal by Subject|0|||
126257200|NCT04994431|454231287|FG000|Overall Study|Adverse Event|1|||
126257201|NCT04994431|454231288|FG001|Overall Study|Adverse Event|0|||
126257202|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
126257203|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
126257204|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
126257205|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
126257206|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
126257207|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
126257208|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
126257209|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
126257210|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
126257211|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
126257212|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
126257213|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
126257214|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
126257215|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
126257216|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
126449380|NCT02792829|454947091|FG006|Treatment Period 2|Use of proscribed medications|0|||
126449381|NCT02792829|454947092|FG007|Treatment Period 2|Use of proscribed medications|1|||
126449382|NCT00452361|454947093|FG000|Overall Study|Adverse Event|8|||
126449383|NCT00452361|454947094|FG001|Overall Study|Adverse Event|0|||
126449384|NCT00452361|454947093|FG000|Overall Study|Withdrawal by Subject|0|||
126449385|NCT00452361|454947094|FG001|Overall Study|Withdrawal by Subject|1|||
126257217|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
126257218|NCT01067521|454231291|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
126257219|NCT01067521|454231292|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
126257220|NCT01067521|454231291|FG000|Open-Label Period|Death|3|||
126257221|NCT01067521|454231292|FG001|Open-Label Period|Death|1|||
126257222|NCT01067521|454231291|FG000|Open-Label Period|Adverse Event|30|||
126257223|NCT01067521|454231292|FG001|Open-Label Period|Adverse Event|28|||
126257224|NCT01067521|454231291|FG000|Open-Label Period|Withdrawal by Subject|160|||
126257225|NCT01067521|454231292|FG001|Open-Label Period|Withdrawal by Subject|88|||
126257226|NCT01067521|454231291|FG000|Open-Label Period|Physician Decision|13|||
126257227|NCT01067521|454231292|FG001|Open-Label Period|Physician Decision|11|||
126257228|NCT01067521|454231291|FG000|Open-Label Period|Non-compliance with study drug|5|||
126257229|NCT01067521|454231292|FG001|Open-Label Period|Non-compliance with study drug|0|||
126257230|NCT01067521|454231291|FG000|Open-Label Period|Protocol Violation|3|||
126257231|NCT01067521|454231292|FG001|Open-Label Period|Protocol Violation|0|||
126257232|NCT01067521|454231291|FG000|Open-Label Period|Pregnancy|14|||
126257233|NCT01067521|454231292|FG001|Open-Label Period|Pregnancy|8|||
126257234|NCT01067521|454231291|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
126257235|NCT01067521|454231292|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
126257236|NCT01067521|454231291|FG000|Open-Label Period|Lost to Follow-up|21|||
126257237|NCT01067521|454231292|FG001|Open-Label Period|Lost to Follow-up|20|||
126257238|NCT00766493|454231293|FG000|30 Days Post-Procedure|Discontinued|7|||
126257239|NCT00766493|454231293|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
126257240|NCT00766493|454231293|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
126257241|NCT03419962|454231296|FG000|Overall Study|Change to other medication|1|||
126257242|NCT03419962|454231296|FG000|Overall Study|Refusal of continuing with trial drug|1|||
126257243|NCT03419962|454231296|FG000|Overall Study|Lost to Follow-up|3|||
126257244|NCT03419962|454231296|FG000|Overall Study|Difficulty in inhaling the doses|1|||
126257245|NCT03419962|454231296|FG000|Overall Study|Missing completion data|31|||
126257246|NCT02914457|454231297|FG000|Overall Study|Withdrawal by Subject|1|||
126257247|NCT02914457|454231297|FG000|Overall Study|Physician Decision|1|||
126257248|NCT02914457|454231297|FG000|Overall Study|No veins available for lead placement|1|||
126257249|NCT02914457|454231297|FG000|Overall Study|Electrical instability of patient|1|||
126257250|NCT02914457|454231297|FG000|Overall Study|ECG acquisition error due to sweating|1|||
126257251|NCT02914457|454231297|FG000|Overall Study|Protocol Violation|1|||
126257252|NCT01098539|454231298|FG000|Overall Study|Adverse Event|26|||
126257253|NCT01098539|454231299|FG001|Overall Study|Adverse Event|26|||
126257254|NCT01098539|454231298|FG000|Overall Study|Protocol Violation|1|||
126257255|NCT01098539|454231299|FG001|Overall Study|Protocol Violation|4|||
126358559|NCT02565186|454605380|FG001|Overall Study|Missing|0|||
126358560|NCT02565186|454605379|FG000|Overall Study|Did Not Receive Study Drug|55|||
126358561|NCT02565186|454605380|FG001|Overall Study|Did Not Receive Study Drug|86|||
126358562|NCT00337194|454605381|FG000|Overall Study|Adverse Event|5|||
126358563|NCT00337194|454605382|FG001|Overall Study|Adverse Event|1|||
126358564|NCT00337194|454605381|FG000|Overall Study|Death|2|||
126358565|NCT00337194|454605382|FG001|Overall Study|Death|0|||
126358566|NCT00337194|454605381|FG000|Overall Study|Withdrawal by Subject|1|||
126358567|NCT00337194|454605382|FG001|Overall Study|Withdrawal by Subject|0|||
126358568|NCT00337194|454605381|FG000|Overall Study|Disease progression|1|||
126358569|NCT00337194|454605382|FG001|Overall Study|Disease progression|2|||
126358570|NCT00337194|454605381|FG000|Overall Study|Subsequent non-protocol therapy|3|||
126358571|NCT00337194|454605382|FG001|Overall Study|Subsequent non-protocol therapy|1|||
126358572|NCT03188705|454605383|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
126358573|NCT03188705|454605383|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
126358574|NCT01174459|454605384|FG000|Overall Study|case report form (CRF) not collected|5|||
126358575|NCT01623752|454605385|FG000|Phase 1 (78 Weeks)|No Data|249|||
126358576|NCT01623752|454605386|FG001|Phase 1 (78 Weeks)|No Data|66|||
126358577|NCT01623752|454605387|FG002|Phase 1 (78 Weeks)|No Data|2|||
126358578|NCT01623752|454605385|FG000|Phase 1 (78 Weeks)|Other|33|||
126358579|NCT01623752|454605386|FG001|Phase 1 (78 Weeks)|Other|20|||
126358580|NCT01623752|454605387|FG002|Phase 1 (78 Weeks)|Other|0|||
126358581|NCT01623752|454605385|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
126358582|NCT01623752|454605386|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
126358583|NCT01623752|454605387|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
126358584|NCT01623752|454605385|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
126358585|NCT01623752|454605386|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
126358586|NCT01623752|454605387|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
126358587|NCT01623752|454605385|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
126358588|NCT01623752|454605386|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
126358589|NCT01623752|454605387|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
126257256|NCT01098539|454231298|FG000|Overall Study|Noncompliance|3|||
126257257|NCT01098539|454231299|FG001|Overall Study|Noncompliance|5|||
126257258|NCT01098539|454231298|FG000|Overall Study|Lost to Follow-up|4|||
126257259|NCT01098539|454231299|FG001|Overall Study|Lost to Follow-up|4|||
126257260|NCT01098539|454231298|FG000|Overall Study|Withdrawal by Subject|12|||
126257261|NCT01098539|454231299|FG001|Overall Study|Withdrawal by Subject|26|||
126257262|NCT01098539|454231298|FG000|Overall Study|Physician Decision|5|||
126257263|NCT01098539|454231299|FG001|Overall Study|Physician Decision|3|||
126257264|NCT01849458|454231302|FG000|Overall Study|Lost to Follow-up|4|||
126257265|NCT01781234|454231303|FG000|Overall Study|Adverse Event|2|||
126257266|NCT01781234|454231304|FG001|Overall Study|Adverse Event|0|||
126257267|NCT01781234|454231303|FG000|Overall Study|Protocol Violation|3|||
126257268|NCT01781234|454231304|FG001|Overall Study|Protocol Violation|0|||
126257269|NCT01781234|454231303|FG000|Overall Study|Withdrawal by Subject|4|||
126257270|NCT01781234|454231304|FG001|Overall Study|Withdrawal by Subject|3|||
126257271|NCT00721955|454231305|FG000|Overall Study|Adverse Event|0|||
126257272|NCT00721955|454231306|FG001|Overall Study|Adverse Event|0|||
126257273|NCT00721955|454231307|FG002|Overall Study|Adverse Event|2|||
126257274|NCT03439085|454231308|FG000|Overall Study|Death|2|||
126257275|NCT03439085|454231308|FG000|Overall Study|Screen Failure|20|||
126257276|NCT01863433|454231309|FG000|Overall Study|Protocol Violation|1|||
126257277|NCT02174276|454231310|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
126257278|NCT02174276|454231311|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
126257279|NCT02174276|454231312|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
126257280|NCT02174276|454231313|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
126257281|NCT02174276|454231310|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
126257282|NCT02174276|454231311|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
126257283|NCT02174276|454231312|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
126257284|NCT02174276|454231313|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
126358590|NCT01623752|454605385|FG000|Phase 2 (78 Weeks)|Other|5|||
126358591|NCT01623752|454605386|FG001|Phase 2 (78 Weeks)|Other|1|||
126358592|NCT01623752|454605387|FG002|Phase 2 (78 Weeks)|Other|0|||
126358593|NCT01623752|454605385|FG000|Phase 2 (78 Weeks)|No Data|43|||
126358594|NCT01623752|454605386|FG001|Phase 2 (78 Weeks)|No Data|11|||
126449386|NCT00452361|454947093|FG000|Overall Study|Premature termination|13|||
126449387|NCT00452361|454947094|FG001|Overall Study|Premature termination|9|||
126449388|NCT00776919|454947095|FG000|Overall Study|Withdrawal by Subject|16|||
126449389|NCT00776919|454947096|FG001|Overall Study|Withdrawal by Subject|14|||
126449390|NCT00776919|454947097|FG002|Overall Study|Withdrawal by Subject|15|||
126449391|NCT00776919|454947098|FG003|Overall Study|Withdrawal by Subject|26|||
126449392|NCT00776919|454947095|FG000|Overall Study|Lost to Follow-up|8|||
126449393|NCT00776919|454947096|FG001|Overall Study|Lost to Follow-up|12|||
126449394|NCT00776919|454947097|FG002|Overall Study|Lost to Follow-up|11|||
126358595|NCT01623752|454605387|FG002|Phase 2 (78 Weeks)|No Data|0|||
126358596|NCT01623752|454605385|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
126358597|NCT01623752|454605386|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
126358598|NCT01623752|454605387|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
126546438|NCT03573908|455293800|FG000|Treatment Period|Other, Not Specified|4|||
126546439|NCT03573908|455293801|FG001|Treatment Period|Other, Not Specified|6|||
126546440|NCT03573908|455293802|FG002|Treatment Period|Other, Not Specified|0|||
126546441|NCT03573908|455293803|FG003|Treatment Period|Other, Not Specified|0|||
126546442|NCT03573908|455293804|FG004|Treatment Period|Other, Not Specified|0|||
126546443|NCT03573908|455293800|FG000|Randomized Withdrawal Period|Adverse Event|0|||
126546444|NCT03573908|455293801|FG001|Randomized Withdrawal Period|Adverse Event|0|||
126546445|NCT03573908|455293802|FG002|Randomized Withdrawal Period|Adverse Event|3|||
126546446|NCT03573908|455293803|FG003|Randomized Withdrawal Period|Adverse Event|0|||
126546447|NCT03573908|455293804|FG004|Randomized Withdrawal Period|Adverse Event|0|||
126546448|NCT03573908|455293800|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126546449|NCT03573908|455293801|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126257285|NCT02174276|454231310|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
126257286|NCT02174276|454231311|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
126257287|NCT02174276|454231312|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
126257288|NCT02174276|454231313|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
126257289|NCT02174276|454231310|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
126257290|NCT02174276|454231311|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
126257291|NCT02174276|454231312|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
126257292|NCT02174276|454231313|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
126257293|NCT02174276|454231310|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
126257294|NCT02174276|454231311|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
126257295|NCT02174276|454231312|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
126257296|NCT02174276|454231313|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
126257297|NCT02174276|454231310|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
126257298|NCT02174276|454231311|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
126257299|NCT02174276|454231312|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
126257300|NCT02174276|454231313|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
126257301|NCT01206439|454231314|FG000|Overall Study|subject did not meet inclusion criteria|1|||
126257302|NCT00434837|454231326|FG000|Overall Study|Lost to Follow-up|20|||
126257303|NCT00434837|454231327|FG001|Overall Study|Lost to Follow-up|23|||
126257304|NCT00434837|454231328|FG002|Overall Study|Lost to Follow-up|30|||
126257305|NCT01077258|454231329|FG000|Overall Study|Lost to Follow-up|1390|||
126257306|NCT01077258|454231329|FG000|Overall Study|Adverse drug reaction|218|||
126257307|NCT01077258|454231329|FG000|Overall Study|Lack of Efficacy|663|||
126257308|NCT01077258|454231329|FG000|Overall Study|Clinical remission|37|||
126257309|NCT01077258|454231329|FG000|Overall Study|Other reasons|260|||
126257310|NCT00515216|454231330|FG000|Overall Study|Withdrawal by Subject|1|||
126257311|NCT00726895|454231331|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
126257312|NCT00726895|454231332|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126257313|NCT02786927|454231334|FG000|Overall Study|Adverse Event|1|||
126257314|NCT02786927|454231334|FG000|Overall Study|Protocol Violation|4|||
126257315|NCT01801917|454231335|FG000|Period 1 - Randomized|Adverse Event|1|||
126257316|NCT01801917|454231336|FG001|Period 1 - Randomized|Adverse Event|0|||
126257317|NCT01801917|454231337|FG002|Period 1 - Randomized|Adverse Event|1|||
126257318|NCT01801917|454231338|FG003|Period 1 - Randomized|Adverse Event|0|||
126257319|NCT04307849|454231339|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
126257320|NCT04307849|454231340|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
126257321|NCT04307849|454231341|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
126257322|NCT04307849|454231342|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
126257323|NCT04307849|454231343|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
126257324|NCT04307849|454231344|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
126257325|NCT04307849|454231339|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
126257326|NCT04307849|454231340|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
126257327|NCT04307849|454231341|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
126257328|NCT04307849|454231342|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
126257329|NCT04307849|454231343|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
126257330|NCT04307849|454231344|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
126257331|NCT04307849|454231339|FG000|Overall Study|Family member did not want them to continue|0|||
126257332|NCT04307849|454231340|FG001|Overall Study|Family member did not want them to continue|0|||
126257333|NCT04307849|454231341|FG002|Overall Study|Family member did not want them to continue|1|||
126257334|NCT04307849|454231342|FG003|Overall Study|Family member did not want them to continue|0|||
126546450|NCT03573908|455293802|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126546451|NCT03573908|455293803|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126698609|NCT01955707|455847131|FG000|Overall Study|Lost to Follow-up|2|||
126257335|NCT04307849|454231343|FG004|Overall Study|Family member did not want them to continue|0|||
126257336|NCT04307849|454231344|FG005|Overall Study|Family member did not want them to continue|0|||
126546452|NCT03573908|455293804|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
126546453|NCT03573908|455293800|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
126698610|NCT01955707|455847132|FG001|Overall Study|Lost to Follow-up|1|||
126698611|NCT01955707|455847131|FG000|Overall Study|Withdrawal by Subject|0|||
126698612|NCT01955707|455847132|FG001|Overall Study|Withdrawal by Subject|3|||
126698613|NCT01955707|455847131|FG000|Overall Study|Death|13|||
126257337|NCT04307849|454231339|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
126257338|NCT04307849|454231340|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
126257339|NCT04307849|454231341|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
126257340|NCT04307849|454231342|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
126257341|NCT04307849|454231343|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
126257342|NCT04307849|454231344|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
126257343|NCT05467982|454231345|FG000|Overall Study|Death|0|||
126257344|NCT05467982|454231346|FG001|Overall Study|Death|1|||
126257345|NCT05467982|454231345|FG000|Overall Study|Lost to Follow-up|3|||
126257346|NCT05467982|454231346|FG001|Overall Study|Lost to Follow-up|1|||
126257347|NCT00105157|454231362|FG000|Double-Blind (DB)|Never Treated|1|||
126257348|NCT00105157|454231363|FG001|Double-Blind (DB)|Never Treated|0|||
126257349|NCT00105157|454231364|FG002|Double-Blind (DB)|Never Treated|0|||
126257350|NCT00105157|454231365|FG003|Double-Blind (DB)|Never Treated|0|||
126257351|NCT00105157|454231362|FG000|Double-Blind (DB)|Adverse Event|2|||
126257352|NCT00105157|454231363|FG001|Double-Blind (DB)|Adverse Event|0|||
126257353|NCT00105157|454231364|FG002|Double-Blind (DB)|Adverse Event|1|||
126257354|NCT00105157|454231365|FG003|Double-Blind (DB)|Adverse Event|1|||
126257355|NCT00105157|454231362|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
126257356|NCT00105157|454231363|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
126257357|NCT00105157|454231364|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
126257358|NCT00105157|454231365|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
126257359|NCT00105157|454231362|FG000|Open-Label Continuation of DB|Adverse Event|3|||
126257360|NCT00105157|454231363|FG001|Open-Label Continuation of DB|Adverse Event|1|||
126257361|NCT00105157|454231364|FG002|Open-Label Continuation of DB|Adverse Event|0|||
126257362|NCT00105157|454231365|FG003|Open-Label Continuation of DB|Adverse Event|0|||
126257363|NCT00105157|454231362|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
126257364|NCT00105157|454231363|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
126257365|NCT00105157|454231364|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
126257366|NCT00105157|454231365|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
126257367|NCT00105157|454231362|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
126257368|NCT00105157|454231363|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
126257369|NCT00105157|454231364|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
126257370|NCT00105157|454231365|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
126257371|NCT00105157|454231362|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
126257372|NCT00105157|454231363|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
126257373|NCT00105157|454231364|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
126257374|NCT00105157|454231365|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
126257375|NCT00105157|454231362|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
126257376|NCT00105157|454231363|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
126257377|NCT00105157|454231364|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
126257378|NCT00105157|454231365|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
126257379|NCT00105157|454231362|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
126257380|NCT00105157|454231363|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
126257381|NCT00105157|454231364|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
126257382|NCT00105157|454231365|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
126257383|NCT00105157|454231362|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
126257384|NCT00105157|454231363|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
126257385|NCT00105157|454231364|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
126257386|NCT00105157|454231365|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
126257387|NCT00105157|454231362|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
126257388|NCT00105157|454231363|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
126257389|NCT00105157|454231364|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
126257390|NCT00105157|454231365|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
126257391|NCT00105157|454231362|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
126698614|NCT01955707|455847132|FG001|Overall Study|Death|14|||
126698615|NCT01955707|455847131|FG000|Overall Study|Other|4|||
126698616|NCT01955707|455847132|FG001|Overall Study|Other|2|||
126698617|NCT01817790|455847135|FG000|Overall Study|Adverse Event|0|||
126698618|NCT01817790|455847136|FG001|Overall Study|Adverse Event|2|||
126257392|NCT00105157|454231363|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
126257393|NCT00105157|454231364|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
126257394|NCT00105157|454231365|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
126358599|NCT03994120|454605388|FG000|Overall Study|Lost to Follow-up|3|||
126358600|NCT03994120|454605389|FG001|Overall Study|Lost to Follow-up|1|||
126698619|NCT01817790|455847135|FG000|Overall Study|Lost to Follow-up|0|||
126698620|NCT01817790|455847136|FG001|Overall Study|Lost to Follow-up|1|||
126257395|NCT00105157|454231362|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
126257396|NCT00105157|454231363|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
126257397|NCT00105157|454231364|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
126257398|NCT00105157|454231365|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
126257399|NCT00105157|454231362|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
126257400|NCT00105157|454231363|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
126257401|NCT00105157|454231364|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
126257402|NCT00105157|454231365|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
126257403|NCT00127166|454231366|FG000|Period I|Protocol Violation|0|||
126257404|NCT00127166|454231367|FG001|Period I|Protocol Violation|2|||
126257405|NCT00127166|454231366|FG000|Period I|Withdrawal by Subject|2|||
126257406|NCT00127166|454231367|FG001|Period I|Withdrawal by Subject|0|||
126257407|NCT00127166|454231366|FG000|Period I|Patient did not meet inclusion criteria|1|||
126257408|NCT00127166|454231367|FG001|Period I|Patient did not meet inclusion criteria|0|||
126257409|NCT00127166|454231366|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
126257410|NCT00127166|454231367|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
126257411|NCT00127166|454231366|FG000|Period II|Withdrawal by Subject|2|||
126257412|NCT00127166|454231367|FG001|Period II|Withdrawal by Subject|0|||
126257413|NCT00127166|454231366|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
126257414|NCT00127166|454231367|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
126257415|NCT01148225|454231370|FG000|Overall Study|Other|185|||
126257416|NCT00393705|454231371|FG000|Overall Study|Adverse Event|0|||
126257417|NCT00393705|454231372|FG001|Overall Study|Adverse Event|2|||
126257418|NCT00393705|454231371|FG000|Overall Study|Death|0|||
126257419|NCT00393705|454231372|FG001|Overall Study|Death|1|||
126257420|NCT00393705|454231371|FG000|Overall Study|Lost to Follow-up|2|||
126257421|NCT00393705|454231372|FG001|Overall Study|Lost to Follow-up|2|||
126257422|NCT00393705|454231371|FG000|Overall Study|Entry Criteria Not Met|10|||
126257423|NCT00393705|454231372|FG001|Overall Study|Entry Criteria Not Met|10|||
126257424|NCT00393705|454231371|FG000|Overall Study|Protocol Violation|4|||
126257425|NCT00393705|454231372|FG001|Overall Study|Protocol Violation|3|||
126257426|NCT00393705|454231371|FG000|Overall Study|Withdrawal by Subject|5|||
126257427|NCT00393705|454231372|FG001|Overall Study|Withdrawal by Subject|3|||
126257428|NCT00393705|454231371|FG000|Overall Study|Physician Decision|2|||
126257429|NCT00393705|454231372|FG001|Overall Study|Physician Decision|2|||
126257430|NCT02490800|454231373|FG000|Overall Study|Adverse Event|0|||
126257431|NCT02490800|454231374|FG001|Overall Study|Adverse Event|0|||
126257432|NCT02490800|454231375|FG002|Overall Study|Adverse Event|0|||
126257433|NCT02490800|454231376|FG003|Overall Study|Adverse Event|2|||
126257434|NCT02490800|454231377|FG004|Overall Study|Adverse Event|3|||
126257435|NCT02490800|454231378|FG005|Overall Study|Adverse Event|2|||
126257436|NCT02490800|454231379|FG006|Overall Study|Adverse Event|0|||
126257437|NCT02490800|454231380|FG007|Overall Study|Adverse Event|0|||
126257438|NCT02490800|454231381|FG008|Overall Study|Adverse Event|0|||
126257439|NCT02490800|454231382|FG009|Overall Study|Adverse Event|0|||
126257440|NCT02490800|454231383|FG010|Overall Study|Adverse Event|0|||
126257441|NCT02490800|454231384|FG011|Overall Study|Adverse Event|2|||
126257442|NCT02490800|454231385|FG012|Overall Study|Adverse Event|2|||
126257443|NCT02490800|454231373|FG000|Overall Study|Withdrawal by Subject|0|||
126257444|NCT02490800|454231374|FG001|Overall Study|Withdrawal by Subject|0|||
126257445|NCT02490800|454231375|FG002|Overall Study|Withdrawal by Subject|0|||
126257446|NCT02490800|454231376|FG003|Overall Study|Withdrawal by Subject|1|||
126257447|NCT02490800|454231377|FG004|Overall Study|Withdrawal by Subject|0|||
126257448|NCT02490800|454231378|FG005|Overall Study|Withdrawal by Subject|0|||
126257449|NCT02490800|454231379|FG006|Overall Study|Withdrawal by Subject|0|||
126257450|NCT02490800|454231380|FG007|Overall Study|Withdrawal by Subject|0|||
126257451|NCT02490800|454231381|FG008|Overall Study|Withdrawal by Subject|1|||
126449395|NCT00776919|454947098|FG003|Overall Study|Lost to Follow-up|8|||
126449396|NCT00776919|454947095|FG000|Overall Study|Adverse Event|1|||
126449397|NCT00776919|454947096|FG001|Overall Study|Adverse Event|0|||
126449398|NCT00776919|454947097|FG002|Overall Study|Adverse Event|2|||
126449399|NCT00776919|454947098|FG003|Overall Study|Adverse Event|2|||
126763123|NCT04113746|456084949|FG001|Overall Study|Lost to Follow-up|4|||
126257452|NCT02490800|454231382|FG009|Overall Study|Withdrawal by Subject|0|||
126257453|NCT02490800|454231383|FG010|Overall Study|Withdrawal by Subject|0|||
126257454|NCT02490800|454231384|FG011|Overall Study|Withdrawal by Subject|0|||
126257455|NCT02490800|454231385|FG012|Overall Study|Withdrawal by Subject|0|||
126257456|NCT02490800|454231373|FG000|Overall Study|Progressive disease|3|||
126257457|NCT02490800|454231374|FG001|Overall Study|Progressive disease|3|||
126257458|NCT02490800|454231375|FG002|Overall Study|Progressive disease|3|||
126449400|NCT00776919|454947095|FG000|Overall Study|Protocol Violation|1|||
126449401|NCT00776919|454947096|FG001|Overall Study|Protocol Violation|2|||
126257459|NCT02490800|454231376|FG003|Overall Study|Progressive disease|4|||
126257460|NCT02490800|454231377|FG004|Overall Study|Progressive disease|4|||
126257461|NCT02490800|454231378|FG005|Overall Study|Progressive disease|1|||
126449402|NCT00776919|454947097|FG002|Overall Study|Protocol Violation|0|||
126698621|NCT01817790|455847135|FG000|Overall Study|Protocol Violation|2|||
126698622|NCT01817790|455847136|FG001|Overall Study|Protocol Violation|1|||
126698623|NCT01817790|455847135|FG000|Overall Study|Withdrawal by Subject|1|||
126698624|NCT01817790|455847136|FG001|Overall Study|Withdrawal by Subject|3|||
126698625|NCT01817790|455847135|FG000|Overall Study|Other: Could not attend appointment|1|||
126698626|NCT01817790|455847136|FG001|Overall Study|Other: Could not attend appointment|1|||
126698627|NCT01671345|455847137|FG000|Overall Study|Lost to Follow-up|10|||
126698628|NCT01671345|455847138|FG001|Overall Study|Lost to Follow-up|6|||
126257462|NCT02490800|454231379|FG006|Overall Study|Progressive disease|4|||
126257463|NCT02490800|454231380|FG007|Overall Study|Progressive disease|3|||
126257464|NCT02490800|454231381|FG008|Overall Study|Progressive disease|6|||
126257465|NCT02490800|454231382|FG009|Overall Study|Progressive disease|2|||
126257466|NCT02490800|454231383|FG010|Overall Study|Progressive disease|7|||
126257467|NCT02490800|454231384|FG011|Overall Study|Progressive disease|1|||
126257468|NCT02490800|454231385|FG012|Overall Study|Progressive disease|10|||
126257469|NCT02490800|454231373|FG000|Overall Study|Patient enrolled in post-trial access|0|||
126257470|NCT02490800|454231374|FG001|Overall Study|Patient enrolled in post-trial access|0|||
126257471|NCT02490800|454231375|FG002|Overall Study|Patient enrolled in post-trial access|0|||
126257472|NCT02490800|454231376|FG003|Overall Study|Patient enrolled in post-trial access|0|||
126257473|NCT02490800|454231377|FG004|Overall Study|Patient enrolled in post-trial access|0|||
126257474|NCT02490800|454231378|FG005|Overall Study|Patient enrolled in post-trial access|0|||
126257475|NCT02490800|454231379|FG006|Overall Study|Patient enrolled in post-trial access|0|||
126257476|NCT02490800|454231380|FG007|Overall Study|Patient enrolled in post-trial access|0|||
126257477|NCT02490800|454231381|FG008|Overall Study|Patient enrolled in post-trial access|0|||
126257478|NCT02490800|454231382|FG009|Overall Study|Patient enrolled in post-trial access|1|||
126257479|NCT02490800|454231383|FG010|Overall Study|Patient enrolled in post-trial access|1|||
126257480|NCT02490800|454231384|FG011|Overall Study|Patient enrolled in post-trial access|0|||
126257481|NCT02490800|454231385|FG012|Overall Study|Patient enrolled in post-trial access|6|||
126257482|NCT00654641|454231386|FG000|Overall Study|Lost to Follow-up|2|||
126257483|NCT00654641|454231387|FG001|Overall Study|Lost to Follow-up|3|||
126257484|NCT01337596|454231388|FG000|Overall Study|Withdrawal by Subject|0|||
126257485|NCT01337596|454231389|FG001|Overall Study|Withdrawal by Subject|0|||
126257486|NCT01337596|454231390|FG002|Overall Study|Withdrawal by Subject|0|||
126257487|NCT01337596|454231391|FG003|Overall Study|Withdrawal by Subject|0|||
126257488|NCT01337596|454231392|FG004|Overall Study|Withdrawal by Subject|2|||
126257489|NCT01337596|454231393|FG005|Overall Study|Withdrawal by Subject|0|||
126257490|NCT01337596|454231394|FG006|Overall Study|Withdrawal by Subject|0|||
126257491|NCT01337596|454231395|FG007|Overall Study|Withdrawal by Subject|0|||
126257492|NCT01337596|454231396|FG008|Overall Study|Withdrawal by Subject|0|||
126257493|NCT03365791|454231397|FG000|Overall Study|Adverse Event|5|||
126257494|NCT03365791|454231397|FG000|Overall Study|Death|1|||
126257495|NCT03365791|454231397|FG000|Overall Study|Lost to Follow-up|1|||
126257496|NCT03365791|454231397|FG000|Overall Study|Physician Decision|9|||
126257497|NCT03365791|454231397|FG000|Overall Study|Progressive disease|51|||
126257498|NCT03365791|454231397|FG000|Overall Study|Subject/guardian decision|5|||
126257499|NCT03693950|454231398|FG000|Overall Study|Withdrawal by Subject|1|||
126257500|NCT03693950|454231399|FG001|Overall Study|Withdrawal by Subject|0|||
126257501|NCT01475487|454231400|FG000|Overall Study|had to leave early for personal reasons|2|||
126257502|NCT01475487|454231401|FG001|Overall Study|had to leave early for personal reasons|1|||
126257503|NCT00559637|454232666|FG000|Overall Study|Adverse Event|22|||
126257504|NCT00559637|454232666|FG000|Overall Study|Withdrawal by Subject|4|||
126257505|NCT00559637|454232666|FG000|Overall Study|Protocol Violation|6|||
126257506|NCT00559637|454232666|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
126257507|NCT00559637|454232666|FG000|Overall Study|Failure to return|6|||
126257508|NCT00559637|454232666|FG000|Overall Study|Insufficient response|3|||
126257509|NCT00559637|454232666|FG000|Overall Study|Started requiring dialysis after month 7|2|||
126257510|NCT00559637|454232666|FG000|Overall Study|Suspected lung cancer|1|||
126257511|NCT00559637|454232666|FG000|Overall Study|Participation in another study|1|||
126257512|NCT00559637|454232666|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
126257513|NCT00559637|454232666|FG000|Overall Study|Change of center|1|||
126257514|NCT00559637|454232666|FG000|Overall Study|Change of home|1|||
126257515|NCT00559637|454232666|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
126257516|NCT01958060|454232669|FG000|Overall Study|Not treated|2|||
126257517|NCT01958060|454232670|FG001|Overall Study|Not treated|0|||
126257518|NCT01958060|454232671|FG002|Overall Study|Not treated|0|||
126257519|NCT01958060|454232672|FG003|Overall Study|Not treated|0|||
126257520|NCT01958060|454232673|FG004|Overall Study|Not treated|1|||
126257521|NCT01958060|454232674|FG005|Overall Study|Not treated|0|||
126698629|NCT01671345|455847137|FG000|Overall Study|visit with non-participating physician|3|||
126257522|NCT01765270|454232707|FG000|Overall Study|Physician Decision|1|||
126698630|NCT01671345|455847138|FG001|Overall Study|visit with non-participating physician|3|||
126257523|NCT01765270|454232708|FG001|Overall Study|Physician Decision|0|||
126257524|NCT01765270|454232707|FG000|Overall Study|Withdrawal by Subject|0|||
126257525|NCT01765270|454232708|FG001|Overall Study|Withdrawal by Subject|1|||
126257526|NCT00329160|454232709|FG000|Overall Study|Adverse Event|27|||
126257527|NCT00329160|454232709|FG000|Overall Study|Withdrawal by Subject|13|||
126257528|NCT00329160|454232709|FG000|Overall Study|Protocol Violation|2|||
126257529|NCT00329160|454232709|FG000|Overall Study|Did not Receive Study Drug|1|||
126257530|NCT00329160|454232709|FG000|Overall Study|Incomplete IVUS|45|||
126257531|NCT00063258|454232710|FG000|Overall Study|Physician Decision|2|||
126257532|NCT00063258|454232711|FG001|Overall Study|Physician Decision|0|||
126257533|NCT00063258|454232710|FG000|Overall Study|Lack of Efficacy|2|||
126257534|NCT00063258|454232711|FG001|Overall Study|Lack of Efficacy|0|||
126257535|NCT00784979|454232714|FG000|Overall Study|incomplete data|6|||
126257536|NCT00894933|454232715|FG000|Overall Study|Lost to Follow-up|2|||
126257537|NCT00894933|454232715|FG000|Overall Study|Cancelled Procedure|1|||
126257538|NCT00894933|454232715|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
126257539|NCT01235715|454232720|FG000|Overall Study|Physician Decision|0|||
126257540|NCT01235715|454232721|FG001|Overall Study|Physician Decision|2|||
126257541|NCT03619876|454232722|FG000|Overall Study|Withdrawal by Subject|1|||
126257542|NCT03619876|454232723|FG001|Overall Study|Withdrawal by Subject|2|||
126257543|NCT03619876|454232722|FG000|Overall Study|Withdrawal due to incidental finding|0|||
126257544|NCT03619876|454232723|FG001|Overall Study|Withdrawal due to incidental finding|2|||
126257545|NCT00396630|454232726|FG000|Overall Study|Lost to Follow-up|1|||
126257546|NCT00396630|454232727|FG001|Overall Study|Lost to Follow-up|1|||
126257547|NCT00396630|454232726|FG000|Overall Study|Withdrawal by Subject|1|||
126257548|NCT00396630|454232727|FG001|Overall Study|Withdrawal by Subject|1|||
126257549|NCT00396630|454232726|FG000|Overall Study|Not vaccinated at Visit 3|3|||
126257550|NCT00396630|454232727|FG001|Overall Study|Not vaccinated at Visit 3|3|||
126257551|NCT00996437|454232730|FG000|Overall Study|Death|1|||
126257552|NCT00996437|454232731|FG001|Overall Study|Death|0|||
126257553|NCT00996437|454232730|FG000|Overall Study|Dropped|2|||
126257554|NCT00996437|454232731|FG001|Overall Study|Dropped|2|||
126257555|NCT00996437|454232730|FG000|Overall Study|Missed|2|||
126257556|NCT00996437|454232731|FG001|Overall Study|Missed|5|||
126257557|NCT02576717|454232734|FG000|Overall Study|Other Reasons|16|||
126257558|NCT02576717|454232735|FG001|Overall Study|Other Reasons|18|||
126257559|NCT02576717|454232736|FG002|Overall Study|Other Reasons|15|||
126257560|NCT02576717|454232734|FG000|Overall Study|Covid-19 Pandemic|0|||
126257561|NCT02576717|454232735|FG001|Overall Study|Covid-19 Pandemic|1|||
126257562|NCT02576717|454232736|FG002|Overall Study|Covid-19 Pandemic|1|||
126257563|NCT02576717|454232734|FG000|Overall Study|Sponsor Decision|0|||
126257564|NCT02576717|454232735|FG001|Overall Study|Sponsor Decision|0|||
126257565|NCT02576717|454232736|FG002|Overall Study|Sponsor Decision|1|||
126257566|NCT02576717|454232734|FG000|Overall Study|Physician Decision|3|||
126257567|NCT02576717|454232735|FG001|Overall Study|Physician Decision|8|||
126257568|NCT02576717|454232736|FG002|Overall Study|Physician Decision|9|||
126257569|NCT02576717|454232734|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
126257570|NCT02576717|454232735|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
126257571|NCT02576717|454232736|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
126257572|NCT02576717|454232734|FG000|Overall Study|Death|3|||
126257573|NCT02576717|454232735|FG001|Overall Study|Death|5|||
126257574|NCT02576717|454232736|FG002|Overall Study|Death|3|||
126257575|NCT02576717|454232734|FG000|Overall Study|Lost to Follow-up|9|||
126257576|NCT02576717|454232735|FG001|Overall Study|Lost to Follow-up|10|||
126257577|NCT02576717|454232736|FG002|Overall Study|Lost to Follow-up|19|||
126257578|NCT02576717|454232734|FG000|Overall Study|Protocol Violation|4|||
126257579|NCT02576717|454232735|FG001|Overall Study|Protocol Violation|0|||
126257580|NCT02576717|454232736|FG002|Overall Study|Protocol Violation|5|||
126257581|NCT02576717|454232734|FG000|Overall Study|Lack of Efficacy|24|||
126257582|NCT02576717|454232735|FG001|Overall Study|Lack of Efficacy|28|||
126257583|NCT02576717|454232736|FG002|Overall Study|Lack of Efficacy|20|||
126257584|NCT02576717|454232734|FG000|Overall Study|Adverse Event|26|||
126257585|NCT02576717|454232735|FG001|Overall Study|Adverse Event|32|||
126257586|NCT02576717|454232736|FG002|Overall Study|Adverse Event|26|||
126546454|NCT03573908|455293801|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
126257587|NCT01755975|454232737|FG000|Overall Study|Adverse Event|0|||
126257588|NCT01755975|454232738|FG001|Overall Study|Adverse Event|0|||
126257589|NCT01755975|454232739|FG002|Overall Study|Adverse Event|1|||
126257590|NCT01755975|454232740|FG003|Overall Study|Adverse Event|0|||
126257591|NCT01755975|454232741|FG004|Overall Study|Adverse Event|2|||
126257592|NCT00399893|454232742|FG000|Overall Study|Withdrawal by Subject|1|||
126257593|NCT00399893|454232743|FG001|Overall Study|Withdrawal by Subject|0|||
126257594|NCT03653026|454232744|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
126257595|NCT03653026|454232745|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
126257596|NCT03653026|454232746|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
126257597|NCT03653026|454232747|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
126257598|NCT03653026|454232744|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
126257599|NCT03653026|454232745|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
126257600|NCT03653026|454232746|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126257601|NCT03653026|454232747|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126257602|NCT03653026|454232744|FG000|Part 1: Placebo-controlled Period|Other|0|||
126257603|NCT03653026|454232745|FG001|Part 1: Placebo-controlled Period|Other|3|||
126257604|NCT03653026|454232746|FG002|Part 1: Placebo-controlled Period|Other|0|||
126257605|NCT03653026|454232747|FG003|Part 1: Placebo-controlled Period|Other|0|||
126257606|NCT03653026|454232744|FG000|Part 2: Open-label Extension|Adverse Event|0|||
126257607|NCT03653026|454232745|FG001|Part 2: Open-label Extension|Adverse Event|0|||
126257608|NCT03653026|454232746|FG002|Part 2: Open-label Extension|Adverse Event|1|||
126257609|NCT03653026|454232747|FG003|Part 2: Open-label Extension|Adverse Event|1|||
126257610|NCT03653026|454232744|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
126257611|NCT03653026|454232745|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
126257612|NCT03653026|454232746|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
126257613|NCT03653026|454232747|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
126257614|NCT03653026|454232744|FG000|Part 2: Open-label Extension|Other|0|||
126257615|NCT03653026|454232745|FG001|Part 2: Open-label Extension|Other|0|||
126257616|NCT03653026|454232746|FG002|Part 2: Open-label Extension|Other|1|||
126257617|NCT03653026|454232747|FG003|Part 2: Open-label Extension|Other|2|||
126257618|NCT02457819|454232748|FG000|Overall Study|reason not given|8|||
126257619|NCT02457819|454232748|FG000|Overall Study|Withdrawal by Subject|24|||
126257620|NCT02457819|454232748|FG000|Overall Study|Protocol Violation|1|||
126257621|NCT02457819|454232748|FG000|Overall Study|non compliance with study drug|4|||
126257622|NCT02457819|454232748|FG000|Overall Study|Lost to Follow-up|10|||
126257623|NCT02457819|454232748|FG000|Overall Study|Lack of Efficacy|19|||
126257624|NCT02457819|454232748|FG000|Overall Study|Adverse Event|33|||
126257625|NCT03330236|454232751|FG000|Overall Study|Death|2|||
126257626|NCT03330236|454232752|FG001|Overall Study|Death|1|||
126257627|NCT03330236|454232751|FG000|Overall Study|Withdrawal by Subject|2|||
126257628|NCT03330236|454232752|FG001|Overall Study|Withdrawal by Subject|4|||
126257629|NCT03330236|454232751|FG000|Overall Study|Lost to Follow-up|0|||
126257630|NCT03330236|454232752|FG001|Overall Study|Lost to Follow-up|2|||
126257631|NCT03330236|454232751|FG000|Overall Study|Physician Decision|2|||
126257632|NCT03330236|454232752|FG001|Overall Study|Physician Decision|0|||
126257633|NCT03330236|454232751|FG000|Overall Study|Protocol Violation|4|||
126257634|NCT03330236|454232752|FG001|Overall Study|Protocol Violation|3|||
126257635|NCT03330236|454232751|FG000|Overall Study|SedLine malfunction/blinding|19|||
126257636|NCT03330236|454232752|FG001|Overall Study|SedLine malfunction/blinding|14|||
126257637|NCT03330236|454232751|FG000|Overall Study|Volatile anesthetics used|11|||
126257638|NCT03330236|454232752|FG001|Overall Study|Volatile anesthetics used|8|||
126257639|NCT03330236|454232751|FG000|Overall Study|Surgery aborted/converted to open|60|||
126257640|NCT03330236|454232752|FG001|Overall Study|Surgery aborted/converted to open|52|||
126257641|NCT01901848|454232753|FG000|Randomized and Treated|Lost to Follow-up|3|||
126257642|NCT01901848|454232754|FG001|Randomized and Treated|Lost to Follow-up|6|||
126257643|NCT01901848|454232753|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
126257644|NCT01901848|454232754|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
126257645|NCT00763555|454232755|FG000|Overall Study|Adverse Event|2|||
126257646|NCT00763555|454232756|FG001|Overall Study|Adverse Event|1|||
126257647|NCT00763555|454232755|FG000|Overall Study|Withdrawal by Subject|2|||
126257648|NCT00763555|454232756|FG001|Overall Study|Withdrawal by Subject|6|||
126257649|NCT00763555|454232755|FG000|Overall Study|Lost to Follow-up|0|||
126257650|NCT00763555|454232756|FG001|Overall Study|Lost to Follow-up|3|||
126257651|NCT01729026|454232757|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
126257652|NCT01729026|454232758|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
126257653|NCT01729026|454232757|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
126257654|NCT01729026|454232758|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
126257655|NCT03710590|454232759|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
126257656|NCT03710590|454232760|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
126257657|NCT00852917|454232761|FG000|Overall Study|Adverse Event|13|||
126257658|NCT00852917|454232762|FG001|Overall Study|Adverse Event|20|||
126257659|NCT00852917|454232763|FG002|Overall Study|Adverse Event|35|||
126257660|NCT00852917|454232764|FG003|Overall Study|Adverse Event|17|||
126257661|NCT00852917|454232761|FG000|Overall Study|Lack of Efficacy|21|||
126257662|NCT00852917|454232762|FG001|Overall Study|Lack of Efficacy|11|||
126257663|NCT00852917|454232763|FG002|Overall Study|Lack of Efficacy|11|||
126257664|NCT00852917|454232764|FG003|Overall Study|Lack of Efficacy|47|||
126257665|NCT00852917|454232761|FG000|Overall Study|Withdrawal by Subject|4|||
126257666|NCT00852917|454232762|FG001|Overall Study|Withdrawal by Subject|8|||
126257667|NCT00852917|454232763|FG002|Overall Study|Withdrawal by Subject|10|||
126257668|NCT00852917|454232764|FG003|Overall Study|Withdrawal by Subject|9|||
126257669|NCT00852917|454232761|FG000|Overall Study|Physician Decision|6|||
126257670|NCT00852917|454232762|FG001|Overall Study|Physician Decision|7|||
126257671|NCT00852917|454232763|FG002|Overall Study|Physician Decision|2|||
126257672|NCT00852917|454232764|FG003|Overall Study|Physician Decision|19|||
126257673|NCT00852917|454232761|FG000|Overall Study|Death|0|||
126257674|NCT00852917|454232762|FG001|Overall Study|Death|0|||
126257675|NCT00852917|454232763|FG002|Overall Study|Death|0|||
126257676|NCT00852917|454232764|FG003|Overall Study|Death|1|||
126257677|NCT02488824|454232765|FG000|Overall Study|Adverse Event|1|||
126257678|NCT02488824|454232766|FG001|Overall Study|Adverse Event|1|||
126257679|NCT01201759|454232768|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
126257680|NCT01201759|454232769|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
126257681|NCT01201759|454232768|FG000|Visit 3 - Washout|Adverse Event|0|||
126257682|NCT01201759|454232769|FG001|Visit 3 - Washout|Adverse Event|3|||
126257683|NCT01201759|454232768|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
126257684|NCT01201759|454232769|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
126257685|NCT01201759|454232768|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
126257686|NCT01201759|454232769|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
126257687|NCT00906373|454232770|FG000|Overall Study|Withdrawal by Subject|0|||
126257688|NCT00906373|454232771|FG001|Overall Study|Withdrawal by Subject|5|||
126257689|NCT00906373|454232770|FG000|Overall Study|Other|0|||
126257690|NCT00906373|454232771|FG001|Overall Study|Other|1|||
126257691|NCT00906373|454232770|FG000|Overall Study|Still on treatment at cutoff date|0|||
126257692|NCT00906373|454232771|FG001|Overall Study|Still on treatment at cutoff date|2|||
126546455|NCT03573908|455293802|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
126698631|NCT03636906|455847139|FG000|Overall Study|Adverse Event|0|||
126698632|NCT03636906|455847140|FG001|Overall Study|Adverse Event|0|||
126698633|NCT03636906|455847141|FG002|Overall Study|Adverse Event|1|||
126257693|NCT00979212|454232778|FG000|Overall Study|Protocol Violation|1|||
126257694|NCT00979212|454232779|FG001|Overall Study|Protocol Violation|8|||
126358601|NCT03511066|454605390|FG000|Overall Study|Withdrawal by Subject|1|||
126358602|NCT03511066|454605391|FG001|Overall Study|Withdrawal by Subject|2|||
126358603|NCT03511066|454605392|FG002|Overall Study|Withdrawal by Subject|3|||
126358604|NCT03511066|454605390|FG000|Overall Study|Lost to Follow-up|2|||
126358605|NCT03511066|454605391|FG001|Overall Study|Lost to Follow-up|3|||
126358606|NCT03511066|454605392|FG002|Overall Study|Lost to Follow-up|0|||
126358607|NCT04146909|454605395|FG000|Overall Study|Withdrawal by Subject|3|||
126358608|NCT04146909|454605395|FG000|Overall Study|Did not qualify after consented|1|||
126358609|NCT05085405|454605396|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
126358610|NCT05085405|454605397|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
126358611|NCT05085405|454605398|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
126358612|NCT05085405|454605399|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
126358613|NCT05085405|454605400|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
126358614|NCT05085405|454605401|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
126358615|NCT05085405|454605396|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
126358616|NCT05085405|454605397|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
126358617|NCT05085405|454605398|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
126358618|NCT05085405|454605399|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
126358619|NCT05085405|454605400|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
126358620|NCT05085405|454605401|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
126358621|NCT02362412|454605402|FG000|Treatment Period III|Lost to Follow-up|0|||
126358622|NCT02362412|454605403|FG001|Treatment Period III|Lost to Follow-up|1|||
126358623|NCT00165698|454605406|FG000|Overall Study|Adverse Event|2|||
126358624|NCT00165698|454605407|FG001|Overall Study|Adverse Event|10|||
126358625|NCT00165698|454605406|FG000|Overall Study|Lost to Follow-up|2|||
126358626|NCT00165698|454605407|FG001|Overall Study|Lost to Follow-up|2|||
126358627|NCT00165698|454605406|FG000|Overall Study|Withdrawal by Subject|2|||
126358628|NCT00165698|454605407|FG001|Overall Study|Withdrawal by Subject|1|||
126358629|NCT00165698|454605406|FG000|Overall Study|Protocol Violation|1|||
126358630|NCT00165698|454605407|FG001|Overall Study|Protocol Violation|0|||
126358631|NCT00165698|454605406|FG000|Overall Study|Not Taken/Lost the medicine|1|||
126358632|NCT00165698|454605407|FG001|Overall Study|Not Taken/Lost the medicine|2|||
126358633|NCT01107457|454605408|FG000|Part A|Adverse Event|1|||
126358634|NCT01107457|454605409|FG001|Part A|Adverse Event|2|||
126358635|NCT01107457|454605410|FG002|Part A|Adverse Event|1|||
126358636|NCT01107457|454605411|FG003|Part A|Adverse Event|0|||
126358637|NCT01107457|454605412|FG004|Part A|Adverse Event|0|||
126358638|NCT01107457|454605413|FG005|Part A|Adverse Event|0|||
126358639|NCT01107457|454605408|FG000|Part A|Withdrawal by Subject|3|||
126358640|NCT01107457|454605409|FG001|Part A|Withdrawal by Subject|3|||
126358641|NCT01107457|454605410|FG002|Part A|Withdrawal by Subject|0|||
126358642|NCT01107457|454605411|FG003|Part A|Withdrawal by Subject|3|||
126358643|NCT01107457|454605412|FG004|Part A|Withdrawal by Subject|1|||
126358644|NCT01107457|454605413|FG005|Part A|Withdrawal by Subject|0|||
126358645|NCT01107457|454605408|FG000|Part A|Lost to Follow-up|0|||
126358646|NCT01107457|454605409|FG001|Part A|Lost to Follow-up|1|||
126257695|NCT00979212|454232778|FG000|Overall Study|No protocol therapy received|1|||
126257696|NCT00979212|454232779|FG001|Overall Study|No protocol therapy received|0|||
126257697|NCT04886063|454232784|FG000|Overall Study|Adverse Event|50|||
126358647|NCT01107457|454605410|FG002|Part A|Lost to Follow-up|0|||
126358648|NCT01107457|454605411|FG003|Part A|Lost to Follow-up|0|||
126358649|NCT01107457|454605412|FG004|Part A|Lost to Follow-up|0|||
126358650|NCT01107457|454605413|FG005|Part A|Lost to Follow-up|0|||
126358651|NCT01107457|454605408|FG000|Part A|Lack of Efficacy|1|||
126358652|NCT01107457|454605409|FG001|Part A|Lack of Efficacy|0|||
126257698|NCT04886063|454232784|FG000|Overall Study|Lack of Efficacy|31|||
126257699|NCT04886063|454232784|FG000|Overall Study|Withdrawal by Subject|45|||
126257700|NCT04886063|454232784|FG000|Overall Study|Physician Decision|3|||
126257701|NCT04886063|454232784|FG000|Overall Study|Protocol Violation|3|||
126257702|NCT04886063|454232784|FG000|Overall Study|Site closure|4|||
126257703|NCT04886063|454232784|FG000|Overall Study|Nursing home replacement|3|||
126257704|NCT04886063|454232784|FG000|Overall Study|Lost to Follow-up|5|||
126257705|NCT04886063|454232784|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
126257706|NCT04886063|454232784|FG000|Overall Study|>1 reason|20|||
126257707|NCT02448563|454232789|FG000|Overall Study|Lost to Follow-up|16|||
126257708|NCT02448563|454232790|FG001|Overall Study|Lost to Follow-up|10|||
126257709|NCT02448563|454232789|FG000|Overall Study|Withdrawal by Subject|0|||
126257710|NCT02448563|454232790|FG001|Overall Study|Withdrawal by Subject|1|||
126257711|NCT02340962|454232792|FG000|Overall Study|Lost to Follow-up|1|||
126257712|NCT02340962|454232793|FG001|Overall Study|Lost to Follow-up|0|||
126257713|NCT01450800|454232794|FG000|Overall Study|Protocol Violation|1|||
126257714|NCT01450800|454232795|FG001|Overall Study|Protocol Violation|3|||
126257715|NCT00265785|454232796|FG000|Overall Study|Adverse Event|4|||
126257716|NCT00265785|454232796|FG000|Overall Study|Withdrawal by Subject|3|||
126257717|NCT00265785|454232796|FG000|Overall Study|Progression/Relapse|15|||
126449403|NCT00776919|454947098|FG003|Overall Study|Protocol Violation|1|||
126449404|NCT00776919|454947095|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
126449405|NCT00776919|454947096|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
126449406|NCT00776919|454947097|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
126449407|NCT00776919|454947098|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
126449408|NCT03116152|454947099|FG000|Overall Study|Disease Progression|49|||
126449409|NCT03116152|454947100|FG001|Overall Study|Disease Progression|47|||
126449410|NCT03116152|454947099|FG000|Overall Study|Death|5|||
126449411|NCT03116152|454947100|FG001|Overall Study|Death|2|||
126449412|NCT03116152|454947099|FG000|Overall Study|Adverse Event|21|||
126449413|NCT03116152|454947100|FG001|Overall Study|Adverse Event|7|||
126257718|NCT00265785|454232796|FG000|Overall Study|Not protocol specified|2|||
126257719|NCT00265785|454232796|FG000|Overall Study|Ineligible|1|||
126257720|NCT00265785|454232796|FG000|Overall Study|Did not receive protocol treatment|2|||
126257721|NCT01294449|454232799|FG000|Overall Study|Death|11|||
126257722|NCT01294449|454232800|FG001|Overall Study|Death|12|||
126257723|NCT01294449|454232799|FG000|Overall Study|Withdrawal by Subject|1|||
126257724|NCT01294449|454232800|FG001|Overall Study|Withdrawal by Subject|3|||
126449414|NCT03116152|454947099|FG000|Overall Study|Protocol Violation|2|||
126449415|NCT03116152|454947100|FG001|Overall Study|Protocol Violation|2|||
126449416|NCT03116152|454947099|FG000|Overall Study|Withdrawal by Subject|0|||
126449417|NCT03116152|454947100|FG001|Overall Study|Withdrawal by Subject|1|||
126449418|NCT03116152|454947099|FG000|Overall Study|Physician Decision|3|||
126449419|NCT03116152|454947100|FG001|Overall Study|Physician Decision|2|||
126449420|NCT03116152|454947099|FG000|Overall Study|other|11|||
126449421|NCT03116152|454947100|FG001|Overall Study|other|34|||
126449422|NCT03179605|454947101|FG000|Overall Study|Withdrawal by Subject|1|||
126449423|NCT00228553|454947105|FG000|Overall Study|Adverse Event|112|||
126449424|NCT00228553|454947105|FG000|Overall Study|Lack of Efficacy|34|||
126449425|NCT00228553|454947105|FG000|Overall Study|Lost to Follow-up|67|||
126449426|NCT00228553|454947105|FG000|Overall Study|Physician Decision|48|||
126449427|NCT00228553|454947105|FG000|Overall Study|Protocol Violation|6|||
126449428|NCT00228553|454947105|FG000|Overall Study|Withdrawal by Subject|115|||
126449429|NCT00228553|454947105|FG000|Overall Study|Pregnancy|2|||
126449430|NCT00228553|454947105|FG000|Overall Study|Miscellaneous|46|||
126449431|NCT02878798|454947106|FG000|Overall Study|Withdrawal by Subject|5|||
126449432|NCT02878798|454947107|FG001|Overall Study|Withdrawal by Subject|4|||
126449433|NCT02878798|454947106|FG000|Overall Study|Lost to Follow-up|2|||
126449434|NCT02878798|454947107|FG001|Overall Study|Lost to Follow-up|2|||
126449435|NCT02878798|454947106|FG000|Overall Study|Protocol Violation|0|||
126449436|NCT02878798|454947107|FG001|Overall Study|Protocol Violation|1|||
126449437|NCT01536392|454947108|FG000|Overall Study|Adverse Event|2|||
126257725|NCT00708682|454232805|FG000|Infant Series|Adverse Event|1|||
126257726|NCT00708682|454232805|FG000|Infant Series|Lost to Follow-up|4|||
126449438|NCT01536392|454947109|FG001|Overall Study|Adverse Event|2|||
126449439|NCT01536392|454947108|FG000|Overall Study|Physician Decision|2|||
126449440|NCT01536392|454947109|FG001|Overall Study|Physician Decision|3|||
126449441|NCT01536392|454947108|FG000|Overall Study|Withdrawal by Subject|3|||
126449442|NCT01536392|454947109|FG001|Overall Study|Withdrawal by Subject|6|||
126449443|NCT01536392|454947108|FG000|Overall Study|Non Compliance|3|||
126257727|NCT00708682|454232805|FG000|Infant Series|Protocol Violation|1|||
126449444|NCT01536392|454947109|FG001|Overall Study|Non Compliance|4|||
126257728|NCT00708682|454232805|FG000|Infant Series|Parent/legal guardian request|6|||
126257729|NCT00708682|454232805|FG000|Infant Series|Failed to return|2|||
126257730|NCT00708682|454232805|FG000|Infant Series|Other|19|||
126257731|NCT00708682|454232805|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
126449445|NCT01536392|454947108|FG000|Overall Study|Completed therapy early|3|||
126449446|NCT01536392|454947109|FG001|Overall Study|Completed therapy early|0|||
126449447|NCT02873429|454947111|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
126449448|NCT02873429|454947112|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
126449449|NCT02873429|454947111|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
126449450|NCT02873429|454947112|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
126449451|NCT02873429|454947111|FG000|16 Weeks|Lost to Follow-up|3|||
126449452|NCT02873429|454947112|FG001|16 Weeks|Lost to Follow-up|0|||
126449453|NCT02259088|454947113|FG000|Overall Study|Adverse Event|6|||
126449454|NCT02259088|454947114|FG001|Overall Study|Adverse Event|4|||
126449455|NCT02259088|454947113|FG000|Overall Study|Lost to Follow-up|2|||
126449456|NCT02259088|454947114|FG001|Overall Study|Lost to Follow-up|0|||
126449457|NCT02259088|454947113|FG000|Overall Study|Death|2|||
126449458|NCT02259088|454947114|FG001|Overall Study|Death|0|||
126449459|NCT02259088|454947113|FG000|Overall Study|Physician Decision|5|||
126449460|NCT02259088|454947114|FG001|Overall Study|Physician Decision|2|||
126449461|NCT02259088|454947113|FG000|Overall Study|Protocol deviation|5|||
126449462|NCT02259088|454947114|FG001|Overall Study|Protocol deviation|0|||
126449463|NCT02259088|454947113|FG000|Overall Study|Subject/guardian decision|8|||
126449464|NCT02259088|454947114|FG001|Overall Study|Subject/guardian decision|8|||
126449465|NCT01033448|454947116|FG000|Overall Study|Withdrawal by Subject|4|||
126449466|NCT01033448|454947116|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
126449467|NCT01033448|454947116|FG000|Overall Study|Lost to Follow-up|3|||
126449468|NCT01033448|454947116|FG000|Overall Study|Withdrew due to other reasons|3|||
126449469|NCT01033448|454947116|FG000|Overall Study|Unknown disposition|1|||
126449470|NCT01818752|454947117|FG000|Overall Study|Adverse Event|64|||
126449471|NCT01818752|454947118|FG001|Overall Study|Adverse Event|74|||
126449472|NCT01818752|454947117|FG000|Overall Study|Death|14|||
126449473|NCT01818752|454947118|FG001|Overall Study|Death|18|||
126449474|NCT01818752|454947117|FG000|Overall Study|Non-compliance|16|||
126449475|NCT01818752|454947118|FG001|Overall Study|Non-compliance|20|||
126449476|NCT01818752|454947117|FG000|Overall Study|Withdrawal by Subject|15|||
126449477|NCT01818752|454947118|FG001|Overall Study|Withdrawal by Subject|14|||
126449478|NCT01818752|454947117|FG000|Overall Study|Physician Decision|9|||
126449479|NCT01818752|454947118|FG001|Overall Study|Physician Decision|8|||
126449480|NCT01818752|454947117|FG000|Overall Study|Disease Progression|54|||
126449481|NCT01818752|454947118|FG001|Overall Study|Disease Progression|48|||
126449482|NCT01818752|454947117|FG000|Overall Study|Other|7|||
126449483|NCT01818752|454947118|FG001|Overall Study|Other|8|||
126449484|NCT01818752|454947117|FG000|Overall Study|Continuing Treatment|1|||
126449485|NCT01818752|454947118|FG001|Overall Study|Continuing Treatment|4|||
126449486|NCT01818752|454947117|FG000|Overall Study|Randomized but not Dosed|7|||
126449487|NCT01818752|454947118|FG001|Overall Study|Randomized but not Dosed|4|||
126449488|NCT04270370|454947119|FG000|Overall Study|Lost to Follow-up|1|||
126449489|NCT04270370|454947120|FG001|Overall Study|Lost to Follow-up|0|||
126449490|NCT04270370|454947121|FG002|Overall Study|Lost to Follow-up|0|||
126449491|NCT04270370|454947122|FG003|Overall Study|Lost to Follow-up|0|||
126449492|NCT04270370|454947123|FG004|Overall Study|Lost to Follow-up|0|||
126449493|NCT04270370|454947124|FG005|Overall Study|Lost to Follow-up|0|||
126449494|NCT04270370|454947125|FG006|Overall Study|Lost to Follow-up|0|||
126449495|NCT04270370|454947126|FG007|Overall Study|Lost to Follow-up|0|||
126449496|NCT04270370|454947127|FG008|Overall Study|Lost to Follow-up|1|||
126449497|NCT04270370|454947128|FG009|Overall Study|Lost to Follow-up|0|||
126449498|NCT04270370|454947129|FG010|Overall Study|Lost to Follow-up|0|||
126449499|NCT04270370|454947130|FG011|Overall Study|Lost to Follow-up|0|||
126449500|NCT01324141|454947131|FG000|Overall Study|Declined to participate before treatment started|1|||
126449501|NCT01324141|454947131|FG000|Overall Study|Disease progression on study|1|||
126698634|NCT03636906|455847139|FG000|Overall Study|Lost to Follow-up|1|||
126698635|NCT03636906|455847140|FG001|Overall Study|Lost to Follow-up|0|||
126698636|NCT03636906|455847141|FG002|Overall Study|Lost to Follow-up|0|||
126698637|NCT03636906|455847139|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
126698638|NCT03636906|455847140|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
126257732|NCT00708682|454232805|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
126257733|NCT00708682|454232805|FG000|Toddler Dose|Lost to Follow-up|3|||
126257734|NCT00708682|454232805|FG000|Toddler Dose|Failed to Return|4|||
126257735|NCT00420095|454232806|FG000|Overall Study|Adverse Event|1|||
126257736|NCT00420095|454232807|FG001|Overall Study|Adverse Event|0|||
126257737|NCT00420095|454232806|FG000|Overall Study|Protocol Violation|1|||
126257738|NCT00420095|454232807|FG001|Overall Study|Protocol Violation|1|||
126257739|NCT00420095|454232806|FG000|Overall Study|Lost to Follow-up|1|||
126257740|NCT00420095|454232807|FG001|Overall Study|Lost to Follow-up|0|||
126257741|NCT03185741|454232808|FG000|Baseline|Withdrawal by Subject|1|||
126257742|NCT03185741|454232809|FG001|Baseline|Withdrawal by Subject|3|||
126449502|NCT04629066|454947132|FG000|Overall Study|Lost to Follow-up|3|||
126449503|NCT04629066|454947133|FG001|Overall Study|Lost to Follow-up|2|||
126449504|NCT00530504|454947136|FG000|Overall Study|Death|54|||
126449505|NCT00530504|454947136|FG000|Overall Study|Lost to Follow-up|26|||
126449506|NCT00530504|454947136|FG000|Overall Study|Withdrawal by Subject|39|||
126449507|NCT00530504|454947136|FG000|Overall Study|Exited study due to other reasons|33|||
126257743|NCT03185741|454232810|FG002|Baseline|Withdrawal by Subject|2|||
126257744|NCT03185741|454232808|FG000|Baseline|Lost to Follow-up|1|||
126449508|NCT02872285|454947139|FG000|Overall Study|Withdrawal by Subject|2|||
126449509|NCT02872285|454947140|FG001|Overall Study|Withdrawal by Subject|0|||
126449510|NCT02872285|454947139|FG000|Overall Study|Lost to Follow-up|2|||
126449511|NCT02872285|454947140|FG001|Overall Study|Lost to Follow-up|2|||
126449512|NCT02872285|454947139|FG000|Overall Study|Discontinued due to back surgery|1|||
126449513|NCT02872285|454947140|FG001|Overall Study|Discontinued due to back surgery|0|||
126449514|NCT05477108|454947141|FG000|Overall Study|Participants randomized, not treated|1|||
126449515|NCT05477108|454947142|FG001|Overall Study|Participants randomized, not treated|1|||
126698639|NCT03636906|455847141|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
126698640|NCT03636906|455847139|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
126698641|NCT03636906|455847140|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
126698642|NCT03636906|455847141|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
126698643|NCT03636906|455847139|FG000|Overall Study|Other|0|||
126698644|NCT03636906|455847140|FG001|Overall Study|Other|0|||
126698645|NCT03636906|455847141|FG002|Overall Study|Other|1|||
126698646|NCT01291017|455847142|FG000|Overall Study|Lost to Follow-up|2|||
126698647|NCT01291017|455847142|FG000|Overall Study|Withdrawal by Subject|3|||
126763124|NCT01977625|456084950|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
126763125|NCT01977625|456084951|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
126763126|NCT01977625|456084950|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126763127|NCT01977625|456084951|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
126763128|NCT03125382|456084952|FG000|Randomization|screening failure|1|||
126763129|NCT03125382|456084953|FG001|Randomization|screening failure|4|||
126763130|NCT03125382|456084954|FG002|Randomization|screening failure|2|||
126763131|NCT03125382|456084955|FG003|Randomization|screening failure|0|||
126763132|NCT03125382|456084952|FG000|Follow-up|Death|1|||
126257745|NCT03185741|454232809|FG001|Baseline|Lost to Follow-up|2|||
126698648|NCT04980391|455847143|FG000|Overall Study|Death|0|||
126698649|NCT04980391|455847144|FG001|Overall Study|Death|0|||
126698650|NCT04980391|455847145|FG002|Overall Study|Death|1|||
126698651|NCT04980391|455847146|FG003|Overall Study|Death|1|||
126763133|NCT03125382|456084953|FG001|Follow-up|Death|2|||
126257746|NCT03185741|454232810|FG002|Baseline|Lost to Follow-up|3|||
126257747|NCT03185741|454232808|FG000|3Month|Death|1|||
126257748|NCT03185741|454232809|FG001|3Month|Death|1|||
126257749|NCT03185741|454232810|FG002|3Month|Death|2|||
126257750|NCT03185741|454232808|FG000|3Month|Withdrawal by Subject|1|||
126257751|NCT03185741|454232809|FG001|3Month|Withdrawal by Subject|5|||
126257752|NCT03185741|454232810|FG002|3Month|Withdrawal by Subject|1|||
126257753|NCT03185741|454232808|FG000|3Month|Lost to Follow-up|7|||
126257754|NCT03185741|454232809|FG001|3Month|Lost to Follow-up|9|||
126257755|NCT03185741|454232810|FG002|3Month|Lost to Follow-up|8|||
126257756|NCT03185741|454232808|FG000|3Month|Unavailable for 3Month|11|||
126257757|NCT03185741|454232809|FG001|3Month|Unavailable for 3Month|10|||
126257758|NCT03185741|454232810|FG002|3Month|Unavailable for 3Month|11|||
126257759|NCT03185741|454232808|FG000|3Month|Protocol Violation|0|||
126257760|NCT03185741|454232809|FG001|3Month|Protocol Violation|0|||
126257761|NCT03185741|454232810|FG002|3Month|Protocol Violation|3|||
126257762|NCT03185741|454232808|FG000|6Month|Death|1|||
126257763|NCT03185741|454232809|FG001|6Month|Death|1|||
126257764|NCT03185741|454232810|FG002|6Month|Death|2|||
126257765|NCT03185741|454232808|FG000|6Month|Withdrawal by Subject|2|||
126257766|NCT03185741|454232809|FG001|6Month|Withdrawal by Subject|3|||
126257767|NCT03185741|454232810|FG002|6Month|Withdrawal by Subject|1|||
126257768|NCT03185741|454232808|FG000|6Month|Lost to Follow-up|16|||
126257769|NCT03185741|454232809|FG001|6Month|Lost to Follow-up|15|||
126257770|NCT03185741|454232810|FG002|6Month|Lost to Follow-up|16|||
126257771|NCT01634854|454232811|FG000|Overall Study|Cesarean delivery|2|||
126257772|NCT01634854|454232812|FG001|Overall Study|Cesarean delivery|7|||
126257773|NCT01977456|454232813|FG000|Overall Study|Death|5|||
126257774|NCT01142661|454232814|FG000|Overall Study|Adverse Event|2|||
126449516|NCT05477108|454947143|FG002|Overall Study|Participants randomized, not treated|1|||
126698652|NCT04980391|455847143|FG000|Overall Study|Lost to Follow-up|3|||
126698653|NCT04980391|455847144|FG001|Overall Study|Lost to Follow-up|3|||
126763134|NCT03125382|456084954|FG002|Follow-up|Death|1|||
126257775|NCT01142661|454232814|FG000|Overall Study|Withdrawal by Subject|1|||
126698654|NCT04980391|455847145|FG002|Overall Study|Lost to Follow-up|2|||
126698655|NCT04980391|455847146|FG003|Overall Study|Lost to Follow-up|3|||
126763135|NCT03125382|456084955|FG003|Follow-up|Death|2|||
126763136|NCT03125382|456084952|FG000|Follow-up|Lost to Follow-up|1|||
126763137|NCT03125382|456084953|FG001|Follow-up|Lost to Follow-up|4|||
126257776|NCT01142661|454232814|FG000|Overall Study|Physician Decision|1|||
126257777|NCT00434590|454232815|FG000|Overall Study|Administrative problems|5|||
126257778|NCT00434590|454232816|FG001|Overall Study|Administrative problems|5|||
126257779|NCT01011335|454234427|FG000|Overall Study|Lost to Follow-up|0|||
126257780|NCT01011335|454234428|FG001|Overall Study|Lost to Follow-up|0|||
126257781|NCT01011335|454234429|FG002|Overall Study|Lost to Follow-up|1|||
126257782|NCT01011335|454234430|FG003|Overall Study|Lost to Follow-up|1|||
126257783|NCT01011335|454234431|FG004|Overall Study|Lost to Follow-up|1|||
126257784|NCT01011335|454234432|FG005|Overall Study|Lost to Follow-up|1|||
126257785|NCT01011335|454234433|FG006|Overall Study|Lost to Follow-up|2|||
126257786|NCT01011335|454234434|FG007|Overall Study|Lost to Follow-up|2|||
126257787|NCT01011335|454234435|FG008|Overall Study|Lost to Follow-up|1|||
126257788|NCT01011335|454234436|FG009|Overall Study|Lost to Follow-up|0|||
126257789|NCT01011335|454234437|FG010|Overall Study|Lost to Follow-up|0|||
126257790|NCT01011335|454234438|FG011|Overall Study|Lost to Follow-up|1|||
126257791|NCT01011335|454234439|FG012|Overall Study|Lost to Follow-up|2|||
126257792|NCT01011335|454234427|FG000|Overall Study|Protocol Violation|0|||
126257793|NCT01011335|454234428|FG001|Overall Study|Protocol Violation|1|||
126257794|NCT01011335|454234429|FG002|Overall Study|Protocol Violation|0|||
126257795|NCT01011335|454234430|FG003|Overall Study|Protocol Violation|0|||
126257796|NCT01011335|454234431|FG004|Overall Study|Protocol Violation|0|||
126257797|NCT01011335|454234432|FG005|Overall Study|Protocol Violation|0|||
126257798|NCT01011335|454234433|FG006|Overall Study|Protocol Violation|0|||
126257799|NCT01011335|454234434|FG007|Overall Study|Protocol Violation|0|||
126257800|NCT01011335|454234435|FG008|Overall Study|Protocol Violation|0|||
126257801|NCT01011335|454234436|FG009|Overall Study|Protocol Violation|0|||
126257802|NCT01011335|454234437|FG010|Overall Study|Protocol Violation|0|||
126257803|NCT01011335|454234438|FG011|Overall Study|Protocol Violation|0|||
126257804|NCT01011335|454234439|FG012|Overall Study|Protocol Violation|0|||
126257805|NCT01011335|454234427|FG000|Overall Study|Moved/deployed or no booster|1|||
126257806|NCT01011335|454234428|FG001|Overall Study|Moved/deployed or no booster|0|||
126257807|NCT01011335|454234429|FG002|Overall Study|Moved/deployed or no booster|0|||
126698656|NCT04980391|455847143|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
126698657|NCT04980391|455847144|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
126698658|NCT04980391|455847145|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
126698659|NCT04980391|455847146|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
126698660|NCT04980391|455847143|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126698661|NCT04980391|455847144|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126698662|NCT04980391|455847145|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
126698663|NCT04980391|455847146|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126698664|NCT04980391|455847143|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
126698665|NCT04980391|455847144|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
126698666|NCT04980391|455847145|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
126257808|NCT01011335|454234430|FG003|Overall Study|Moved/deployed or no booster|1|||
126698667|NCT04980391|455847146|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
126698668|NCT03690869|455847147|FG000|Overall Study|Adverse Event|0|||
126698669|NCT03690869|455847148|FG001|Overall Study|Adverse Event|0|||
126698670|NCT03690869|455847149|FG002|Overall Study|Adverse Event|0|||
126698671|NCT03690869|455847150|FG003|Overall Study|Adverse Event|1|||
126698672|NCT03690869|455847151|FG004|Overall Study|Adverse Event|0|||
126698673|NCT03690869|455847152|FG005|Overall Study|Adverse Event|0|||
126698674|NCT03690869|455847153|FG006|Overall Study|Adverse Event|0|||
126698675|NCT03690869|455847154|FG007|Overall Study|Adverse Event|1|||
126698676|NCT03690869|455847155|FG008|Overall Study|Adverse Event|0|||
126698677|NCT03690869|455847156|FG009|Overall Study|Adverse Event|1|||
126698678|NCT03690869|455847147|FG000|Overall Study|Death|1|||
126698679|NCT03690869|455847148|FG001|Overall Study|Death|1|||
126698680|NCT03690869|455847149|FG002|Overall Study|Death|1|||
126698681|NCT03690869|455847150|FG003|Overall Study|Death|4|||
126698682|NCT03690869|455847151|FG004|Overall Study|Death|2|||
126698683|NCT03690869|455847152|FG005|Overall Study|Death|5|||
126698684|NCT03690869|455847153|FG006|Overall Study|Death|3|||
126698685|NCT03690869|455847154|FG007|Overall Study|Death|2|||
126698686|NCT03690869|455847155|FG008|Overall Study|Death|0|||
126698687|NCT03690869|455847156|FG009|Overall Study|Death|3|||
126698688|NCT03690869|455847147|FG000|Overall Study|Lost to Follow-up|0|||
126698689|NCT03690869|455847148|FG001|Overall Study|Lost to Follow-up|0|||
126698690|NCT03690869|455847149|FG002|Overall Study|Lost to Follow-up|1|||
126257809|NCT01011335|454234431|FG004|Overall Study|Moved/deployed or no booster|0|||
126257810|NCT01011335|454234432|FG005|Overall Study|Moved/deployed or no booster|0|||
126449517|NCT05477108|454947141|FG000|Overall Study|Physician Decision|0|||
126449518|NCT05477108|454947142|FG001|Overall Study|Physician Decision|0|||
126449519|NCT05477108|454947143|FG002|Overall Study|Physician Decision|1|||
126449520|NCT05477108|454947141|FG000|Overall Study|withdrawn from study|0|||
126449521|NCT05477108|454947142|FG001|Overall Study|withdrawn from study|0|||
126449522|NCT05477108|454947143|FG002|Overall Study|withdrawn from study|1|||
126449523|NCT02660983|454947144|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
126449524|NCT02660983|454947145|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
126449525|NCT02660983|454947144|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
126698691|NCT03690869|455847150|FG003|Overall Study|Lost to Follow-up|0|||
126698692|NCT03690869|455847151|FG004|Overall Study|Lost to Follow-up|0|||
126257811|NCT01011335|454234433|FG006|Overall Study|Moved/deployed or no booster|1|||
126257812|NCT01011335|454234434|FG007|Overall Study|Moved/deployed or no booster|0|||
126257813|NCT01011335|454234435|FG008|Overall Study|Moved/deployed or no booster|1|||
126257814|NCT01011335|454234436|FG009|Overall Study|Moved/deployed or no booster|0|||
126698693|NCT03690869|455847152|FG005|Overall Study|Lost to Follow-up|0|||
126257815|NCT01011335|454234437|FG010|Overall Study|Moved/deployed or no booster|2|||
126257816|NCT01011335|454234438|FG011|Overall Study|Moved/deployed or no booster|0|||
126257817|NCT01011335|454234439|FG012|Overall Study|Moved/deployed or no booster|0|||
126257818|NCT01011335|454234427|FG000|Overall Study|Adverse Event|0|||
126257819|NCT01011335|454234428|FG001|Overall Study|Adverse Event|0|||
126257820|NCT01011335|454234429|FG002|Overall Study|Adverse Event|0|||
126257821|NCT01011335|454234430|FG003|Overall Study|Adverse Event|0|||
126257822|NCT01011335|454234431|FG004|Overall Study|Adverse Event|0|||
126257823|NCT01011335|454234432|FG005|Overall Study|Adverse Event|0|||
126257824|NCT01011335|454234433|FG006|Overall Study|Adverse Event|0|||
126257825|NCT01011335|454234434|FG007|Overall Study|Adverse Event|0|||
126257826|NCT01011335|454234435|FG008|Overall Study|Adverse Event|0|||
126257827|NCT01011335|454234436|FG009|Overall Study|Adverse Event|0|||
126257828|NCT01011335|454234437|FG010|Overall Study|Adverse Event|4|||
126257829|NCT01011335|454234438|FG011|Overall Study|Adverse Event|0|||
126257830|NCT01011335|454234439|FG012|Overall Study|Adverse Event|1|||
126257831|NCT01636934|454234440|FG000|Overall Study|Withdrawal by Subject|3|||
126257832|NCT01636934|454234441|FG001|Overall Study|Withdrawal by Subject|2|||
126257833|NCT01636934|454234440|FG000|Overall Study|Chemo cancel|1|||
126257834|NCT01636934|454234441|FG001|Overall Study|Chemo cancel|0|||
126257835|NCT01636934|454234440|FG000|Overall Study|Too ill to continue|1|||
126257836|NCT01636934|454234441|FG001|Overall Study|Too ill to continue|0|||
126257837|NCT01636934|454234440|FG000|Overall Study|Never started study medication|1|||
126257838|NCT01636934|454234441|FG001|Overall Study|Never started study medication|1|||
126257839|NCT01765751|454234448|FG000|Overall Study|Lost to Follow-up|0|||
126257840|NCT01765751|454234449|FG001|Overall Study|Lost to Follow-up|2|||
126257841|NCT01765751|454234450|FG002|Overall Study|Lost to Follow-up|1|||
126257842|NCT03429049|454234451|FG000|Overall Study|Adverse Event|2|||
126257843|NCT03429049|454234452|FG001|Overall Study|Adverse Event|3|||
126257844|NCT03429049|454234451|FG000|Overall Study|Death|0|||
126257845|NCT03429049|454234452|FG001|Overall Study|Death|1|||
126257846|NCT03429049|454234451|FG000|Overall Study|Lack of Efficacy|4|||
126257847|NCT03429049|454234452|FG001|Overall Study|Lack of Efficacy|2|||
126257848|NCT03429049|454234451|FG000|Overall Study|Lost to Follow-up|9|||
126257849|NCT03429049|454234452|FG001|Overall Study|Lost to Follow-up|8|||
126449526|NCT02660983|454947145|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
126449527|NCT02660983|454947144|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
126449528|NCT02660983|454947145|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
126449529|NCT02660983|454947144|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
126449530|NCT02660983|454947145|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
126449531|NCT02660983|454947144|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
126449532|NCT02660983|454947145|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
126449533|NCT02660983|454947144|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
126449534|NCT02660983|454947145|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
126449535|NCT02660983|454947144|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
126449536|NCT02660983|454947145|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
126449537|NCT01165216|454947153|FG000|Overall Study|Adverse Event|6|||
126449538|NCT01165216|454947154|FG001|Overall Study|Adverse Event|3|||
126449539|NCT01165216|454947153|FG000|Overall Study|Withdrawal by Subject|1|||
126449540|NCT01165216|454947154|FG001|Overall Study|Withdrawal by Subject|1|||
126449541|NCT01165216|454947153|FG000|Overall Study|Disease progression|1|||
126449542|NCT01165216|454947154|FG001|Overall Study|Disease progression|3|||
126449543|NCT04303195|454947156|FG000|Overall Study|Adverse Event|1|||
126449544|NCT04303195|454947157|FG001|Overall Study|Adverse Event|3|||
126449545|NCT04303195|454947158|FG002|Overall Study|Adverse Event|7|||
126449546|NCT04303195|454947159|FG003|Overall Study|Adverse Event|0|||
126449547|NCT04303195|454947156|FG000|Overall Study|Lost to Follow-up|1|||
126449548|NCT04303195|454947157|FG001|Overall Study|Lost to Follow-up|0|||
126449549|NCT04303195|454947158|FG002|Overall Study|Lost to Follow-up|1|||
126449550|NCT04303195|454947159|FG003|Overall Study|Lost to Follow-up|4|||
126449551|NCT04303195|454947156|FG000|Overall Study|Withdrawal by Subject|3|||
126449552|NCT04303195|454947157|FG001|Overall Study|Withdrawal by Subject|1|||
126257850|NCT03429049|454234451|FG000|Overall Study|Physician Decision|1|||
126257851|NCT03429049|454234452|FG001|Overall Study|Physician Decision|0|||
126257852|NCT03429049|454234451|FG000|Overall Study|Protocol Violation|3|||
126698694|NCT03690869|455847153|FG006|Overall Study|Lost to Follow-up|0|||
126257853|NCT03429049|454234452|FG001|Overall Study|Protocol Violation|0|||
126257854|NCT03429049|454234451|FG000|Overall Study|Sponsor Decision|2|||
126257855|NCT03429049|454234452|FG001|Overall Study|Sponsor Decision|0|||
126257856|NCT03429049|454234451|FG000|Overall Study|Withdrawal by Subject|4|||
126257857|NCT03429049|454234452|FG001|Overall Study|Withdrawal by Subject|20|||
126257858|NCT03429049|454234451|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
126257859|NCT03429049|454234452|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
126449553|NCT04303195|454947158|FG002|Overall Study|Withdrawal by Subject|1|||
126449554|NCT04303195|454947159|FG003|Overall Study|Withdrawal by Subject|1|||
126257860|NCT01841060|454234456|FG000|Overall Study|Protocol Violation|10|||
126257861|NCT02459418|454234460|FG000|Overall Study|Exclusion Criteria|4|||
126257862|NCT02459418|454234461|FG001|Overall Study|Exclusion Criteria|0|||
126257863|NCT02459418|454234460|FG000|Overall Study|Protocol Violation|0|||
126257864|NCT02459418|454234461|FG001|Overall Study|Protocol Violation|2|||
126257865|NCT02459418|454234460|FG000|Overall Study|Physician Decision|0|||
126257866|NCT02459418|454234461|FG001|Overall Study|Physician Decision|2|||
126257867|NCT02459418|454234460|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
126257868|NCT02459418|454234461|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
126257869|NCT02459418|454234460|FG000|Overall Study|Adverse Event|0|||
126257870|NCT02459418|454234461|FG001|Overall Study|Adverse Event|1|||
126257871|NCT02459418|454234460|FG000|Overall Study|Withdrawal by Subject|1|||
126257872|NCT02459418|454234461|FG001|Overall Study|Withdrawal by Subject|1|||
126257873|NCT02459418|454234460|FG000|Overall Study|Elevated Creatine Kinase|1|||
126257874|NCT02459418|454234461|FG001|Overall Study|Elevated Creatine Kinase|0|||
126257875|NCT02459418|454234460|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
126257876|NCT02459418|454234461|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
126257877|NCT01872715|454234462|FG000|Overall Study|Adverse Event|1|||
126257878|NCT01872715|454234462|FG000|Overall Study|Protocol Violation|1|||
126257879|NCT01872715|454234462|FG000|Overall Study|Withdrawal by Subject|2|||
126257880|NCT05258630|454234463|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
126257881|NCT05258630|454234464|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
126257882|NCT05258630|454234463|FG000|Overall Study|Lost to Follow-up|0|||
126257883|NCT05258630|454234464|FG001|Overall Study|Lost to Follow-up|2|||
126257884|NCT03303417|454234465|FG000|Overall Study|Withdrawal by Subject|1|||
126257885|NCT03303417|454234466|FG001|Overall Study|Withdrawal by Subject|1|||
126257886|NCT01848210|454234467|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
126257887|NCT01848210|454234468|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
126257888|NCT01848210|454234467|FG000|Overall Study|Lost to Follow-up|24|||
126257889|NCT01848210|454234468|FG001|Overall Study|Lost to Follow-up|12|||
126257890|NCT01848210|454234467|FG000|Overall Study|Protocol Violation|3|||
126257891|NCT01848210|454234468|FG001|Overall Study|Protocol Violation|5|||
126257892|NCT01848210|454234467|FG000|Overall Study|Use of Forbidden Drugs|9|||
126257893|NCT01848210|454234468|FG001|Overall Study|Use of Forbidden Drugs|10|||
126449555|NCT04303195|454947156|FG000|Overall Study|No study drug administered or protocol deviation|0|||
126449556|NCT04303195|454947157|FG001|Overall Study|No study drug administered or protocol deviation|2|||
126449557|NCT04303195|454947158|FG002|Overall Study|No study drug administered or protocol deviation|0|||
126449558|NCT04303195|454947159|FG003|Overall Study|No study drug administered or protocol deviation|2|||
126449559|NCT06457204|454947160|FG000|Washout|Adverse Event|0|||
126449560|NCT06457204|454947161|FG001|Washout|Adverse Event|2|||
126449561|NCT01065454|454947162|FG000|Treatment|Adverse Event|7|||
126449562|NCT01065454|454947163|FG001|Treatment|Adverse Event|4|||
126449563|NCT01065454|454947164|FG002|Treatment|Adverse Event|3|||
126449564|NCT01065454|454947165|FG003|Treatment|Adverse Event|6|||
126449565|NCT01065454|454947162|FG000|Treatment|Death|1|||
126449566|NCT01065454|454947163|FG001|Treatment|Death|0|||
126449567|NCT01065454|454947164|FG002|Treatment|Death|0|||
126449568|NCT01065454|454947165|FG003|Treatment|Death|0|||
126449569|NCT01065454|454947162|FG000|Treatment|Non-compliance|1|||
126449570|NCT01065454|454947163|FG001|Treatment|Non-compliance|0|||
126449571|NCT01065454|454947164|FG002|Treatment|Non-compliance|0|||
126449572|NCT01065454|454947165|FG003|Treatment|Non-compliance|1|||
126449573|NCT01065454|454947162|FG000|Treatment|Protocol Decision|0|||
126449574|NCT01065454|454947163|FG001|Treatment|Protocol Decision|0|||
126449575|NCT01065454|454947164|FG002|Treatment|Protocol Decision|3|||
126449576|NCT01065454|454947165|FG003|Treatment|Protocol Decision|2|||
126449577|NCT01065454|454947162|FG000|Treatment|Protocol Violation|1|||
126449578|NCT01065454|454947163|FG001|Treatment|Protocol Violation|0|||
126449579|NCT01065454|454947164|FG002|Treatment|Protocol Violation|1|||
126449580|NCT01065454|454947165|FG003|Treatment|Protocol Violation|0|||
126449581|NCT01065454|454947162|FG000|Treatment|Withdrawal by Subject|3|||
126449582|NCT01065454|454947163|FG001|Treatment|Withdrawal by Subject|1|||
126449583|NCT01065454|454947164|FG002|Treatment|Withdrawal by Subject|2|||
126257894|NCT01848210|454234467|FG000|Overall Study|Impedition Condition|5|||
126257895|NCT01848210|454234468|FG001|Overall Study|Impedition Condition|9|||
126257896|NCT01848210|454234467|FG000|Overall Study|Adverse Event|7|||
126257897|NCT01848210|454234468|FG001|Overall Study|Adverse Event|9|||
126257898|NCT01848210|454234467|FG000|Overall Study|Discontinuation Criterion|5|||
126257899|NCT01848210|454234468|FG001|Overall Study|Discontinuation Criterion|7|||
126257900|NCT01848210|454234467|FG000|Overall Study|Hypesensitivity|1|||
126257901|NCT01848210|454234468|FG001|Overall Study|Hypesensitivity|0|||
126257902|NCT01848210|454234467|FG000|Overall Study|Hepatic Function Alteration|4|||
126449584|NCT01065454|454947165|FG003|Treatment|Withdrawal by Subject|3|||
126257903|NCT01848210|454234468|FG001|Overall Study|Hepatic Function Alteration|0|||
126449585|NCT01065454|454947162|FG000|Follow up|Adverse Event|1|||
126449586|NCT01065454|454947163|FG001|Follow up|Adverse Event|0|||
126257904|NCT01848210|454234467|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
126449587|NCT01065454|454947164|FG002|Follow up|Adverse Event|0|||
126449588|NCT01065454|454947165|FG003|Follow up|Adverse Event|1|||
126763138|NCT03125382|456084954|FG002|Follow-up|Lost to Follow-up|3|||
126257905|NCT01848210|454234468|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
126257906|NCT01848210|454234467|FG000|Overall Study|Administrative|1|||
126257907|NCT01848210|454234468|FG001|Overall Study|Administrative|0|||
126257908|NCT02994394|454234469|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
126257909|NCT02994394|454234470|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
126257910|NCT02994394|454234471|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
126257911|NCT02994394|454234472|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
126257912|NCT02994394|454234473|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
126257913|NCT02994394|454234474|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
126257914|NCT02994394|454234469|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
126257915|NCT02994394|454234470|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
126257916|NCT02994394|454234471|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
126257917|NCT02994394|454234472|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
126257918|NCT02994394|454234473|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
126546456|NCT03573908|455293803|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
126257919|NCT02994394|454234474|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
126257920|NCT02327325|454234475|FG000|Overall Study|Withdrawal by Subject|1|||
126257921|NCT02327325|454234476|FG001|Overall Study|Withdrawal by Subject|4|||
126257922|NCT02327325|454234477|FG002|Overall Study|Withdrawal by Subject|4|||
126257923|NCT02327325|454234475|FG000|Overall Study|Excluded by Study Team|0|||
126257924|NCT02327325|454234476|FG001|Overall Study|Excluded by Study Team|0|||
126257925|NCT02327325|454234477|FG002|Overall Study|Excluded by Study Team|1|||
126257926|NCT01597479|454234482|FG000|Overall Study|Protocol Violation|1|||
126257927|NCT01597479|454234483|FG001|Overall Study|Protocol Violation|0|||
126257928|NCT01597479|454234482|FG000|Overall Study|Lost to Follow-up|1|||
126257929|NCT01597479|454234483|FG001|Overall Study|Lost to Follow-up|0|||
126257930|NCT01045707|454234484|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
126257931|NCT01045707|454234485|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
126257932|NCT01045707|454234484|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
126257933|NCT01045707|454234485|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
126257934|NCT01045707|454234484|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
126257935|NCT01045707|454234485|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
126257936|NCT01045707|454234484|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
126257937|NCT01045707|454234485|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
126257938|NCT01045707|454234484|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
126257939|NCT01045707|454234485|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
126257940|NCT01045707|454234484|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
126257941|NCT01045707|454234485|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
126257942|NCT01045707|454234484|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
126257943|NCT01045707|454234485|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
126257944|NCT01045707|454234484|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
126257945|NCT01045707|454234485|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
126257946|NCT01045707|454234484|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
126257947|NCT01045707|454234485|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
126257948|NCT00848042|454234486|FG000|Overall Study|Death|1|||
126257949|NCT00848042|454234487|FG001|Overall Study|Death|2|||
126257950|NCT00848042|454234488|FG002|Overall Study|Death|0|||
126257951|NCT00848042|454234486|FG000|Overall Study|Other Therapy|3|||
126257952|NCT00848042|454234487|FG001|Overall Study|Other Therapy|0|||
126257953|NCT00848042|454234488|FG002|Overall Study|Other Therapy|0|||
126257954|NCT04317599|454234489|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
126257955|NCT04317599|454234489|FG000|Overall Study|treatment outside standard of care|4|||
126257956|NCT00809965|454234490|FG000|Overall Study|Death|194|||
126257957|NCT00809965|454234491|FG001|Overall Study|Death|147|||
126257958|NCT00809965|454234492|FG002|Overall Study|Death|196|||
126257959|NCT00809965|454234490|FG000|Overall Study|Lost to Follow-up|17|||
126257960|NCT00809965|454234491|FG001|Overall Study|Lost to Follow-up|10|||
126257961|NCT00809965|454234492|FG002|Overall Study|Lost to Follow-up|18|||
126257962|NCT00809965|454234490|FG000|Overall Study|Withdrawal by Subject|405|||
126257963|NCT00809965|454234491|FG001|Overall Study|Withdrawal by Subject|448|||
126257964|NCT00809965|454234492|FG002|Overall Study|Withdrawal by Subject|441|||
126257965|NCT00809965|454234490|FG000|Overall Study|Other Reason|167|||
126257966|NCT00809965|454234491|FG001|Overall Study|Other Reason|170|||
126257967|NCT00809965|454234492|FG002|Overall Study|Other Reason|189|||
126257968|NCT02315066|454234493|FG000|Overall Study|Lost to Follow-up|0|||
126763139|NCT03125382|456084955|FG003|Follow-up|Lost to Follow-up|1|||
126257969|NCT02315066|454234494|FG001|Overall Study|Lost to Follow-up|1|||
126257970|NCT02315066|454234495|FG002|Overall Study|Lost to Follow-up|1|||
126257971|NCT02315066|454234496|FG003|Overall Study|Lost to Follow-up|0|||
126257972|NCT02315066|454234497|FG004|Overall Study|Lost to Follow-up|1|||
126257973|NCT02315066|454234498|FG005|Overall Study|Lost to Follow-up|0|||
126257974|NCT02315066|454234499|FG006|Overall Study|Lost to Follow-up|2|||
126257975|NCT02315066|454234500|FG007|Overall Study|Lost to Follow-up|1|||
126257976|NCT02315066|454234501|FG008|Overall Study|Lost to Follow-up|0|||
126257977|NCT02315066|454234502|FG009|Overall Study|Lost to Follow-up|0|||
126257978|NCT02315066|454234503|FG010|Overall Study|Lost to Follow-up|1|||
126257979|NCT02315066|454234504|FG011|Overall Study|Lost to Follow-up|2|||
126257980|NCT02315066|454234505|FG012|Overall Study|Lost to Follow-up|0|||
126257981|NCT02315066|454234506|FG013|Overall Study|Lost to Follow-up|4|||
126257982|NCT02315066|454234493|FG000|Overall Study|Death|2|||
126257983|NCT02315066|454234494|FG001|Overall Study|Death|7|||
126257984|NCT02315066|454234495|FG002|Overall Study|Death|6|||
126257985|NCT02315066|454234496|FG003|Overall Study|Death|11|||
126257986|NCT02315066|454234497|FG004|Overall Study|Death|10|||
126257987|NCT02315066|454234498|FG005|Overall Study|Death|3|||
126257988|NCT02315066|454234499|FG006|Overall Study|Death|9|||
126257989|NCT02315066|454234500|FG007|Overall Study|Death|9|||
126257990|NCT02315066|454234501|FG008|Overall Study|Death|10|||
126257991|NCT02315066|454234502|FG009|Overall Study|Death|8|||
126257992|NCT02315066|454234503|FG010|Overall Study|Death|10|||
126257993|NCT02315066|454234504|FG011|Overall Study|Death|7|||
126257994|NCT02315066|454234505|FG012|Overall Study|Death|8|||
126257995|NCT02315066|454234506|FG013|Overall Study|Death|21|||
126257996|NCT02315066|454234493|FG000|Overall Study|Other|0|||
126257997|NCT02315066|454234494|FG001|Overall Study|Other|0|||
126257998|NCT02315066|454234495|FG002|Overall Study|Other|0|||
126257999|NCT02315066|454234496|FG003|Overall Study|Other|0|||
126258000|NCT02315066|454234497|FG004|Overall Study|Other|0|||
126258001|NCT02315066|454234498|FG005|Overall Study|Other|0|||
126258002|NCT02315066|454234499|FG006|Overall Study|Other|0|||
126258003|NCT02315066|454234500|FG007|Overall Study|Other|1|||
126258004|NCT02315066|454234501|FG008|Overall Study|Other|1|||
126258005|NCT02315066|454234502|FG009|Overall Study|Other|2|||
126258006|NCT02315066|454234503|FG010|Overall Study|Other|0|||
126258007|NCT02315066|454234504|FG011|Overall Study|Other|0|||
126258008|NCT02315066|454234505|FG012|Overall Study|Other|0|||
126258009|NCT02315066|454234506|FG013|Overall Study|Other|0|||
126258010|NCT02315066|454234493|FG000|Overall Study|Subject refused further follow-up|0|||
126258011|NCT02315066|454234494|FG001|Overall Study|Subject refused further follow-up|2|||
126258012|NCT02315066|454234495|FG002|Overall Study|Subject refused further follow-up|2|||
126258013|NCT02315066|454234496|FG003|Overall Study|Subject refused further follow-up|0|||
126258014|NCT02315066|454234497|FG004|Overall Study|Subject refused further follow-up|0|||
126258015|NCT02315066|454234498|FG005|Overall Study|Subject refused further follow-up|0|||
126258016|NCT02315066|454234499|FG006|Overall Study|Subject refused further follow-up|2|||
126258017|NCT02315066|454234500|FG007|Overall Study|Subject refused further follow-up|3|||
126258018|NCT02315066|454234501|FG008|Overall Study|Subject refused further follow-up|0|||
126258019|NCT02315066|454234502|FG009|Overall Study|Subject refused further follow-up|1|||
126258020|NCT02315066|454234503|FG010|Overall Study|Subject refused further follow-up|1|||
126258021|NCT02315066|454234504|FG011|Overall Study|Subject refused further follow-up|2|||
126258022|NCT02315066|454234505|FG012|Overall Study|Subject refused further follow-up|2|||
126258023|NCT02315066|454234506|FG013|Overall Study|Subject refused further follow-up|4|||
126258024|NCT02315066|454234493|FG000|Overall Study|Study ongoing at date of cut-off|0|||
126258025|NCT02315066|454234494|FG001|Overall Study|Study ongoing at date of cut-off|0|||
126258026|NCT02315066|454234495|FG002|Overall Study|Study ongoing at date of cut-off|0|||
126258027|NCT02315066|454234496|FG003|Overall Study|Study ongoing at date of cut-off|0|||
126258028|NCT02315066|454234497|FG004|Overall Study|Study ongoing at date of cut-off|0|||
126258029|NCT02315066|454234498|FG005|Overall Study|Study ongoing at date of cut-off|0|||
126258030|NCT02315066|454234499|FG006|Overall Study|Study ongoing at date of cut-off|0|||
126258031|NCT02315066|454234500|FG007|Overall Study|Study ongoing at date of cut-off|0|||
126258032|NCT02315066|454234501|FG008|Overall Study|Study ongoing at date of cut-off|0|||
126258033|NCT02315066|454234502|FG009|Overall Study|Study ongoing at date of cut-off|0|||
126258034|NCT02315066|454234503|FG010|Overall Study|Study ongoing at date of cut-off|0|||
126258035|NCT02315066|454234504|FG011|Overall Study|Study ongoing at date of cut-off|0|||
126258036|NCT02315066|454234505|FG012|Overall Study|Study ongoing at date of cut-off|0|||
126258037|NCT02315066|454234506|FG013|Overall Study|Study ongoing at date of cut-off|1|||
126258038|NCT00112294|454234507|FG000|Overall Study|Still on study|5|||
126258039|NCT00112294|454234508|FG001|Overall Study|Still on study|0|||
126358653|NCT01107457|454605410|FG002|Part A|Lack of Efficacy|0|||
126358654|NCT01107457|454605411|FG003|Part A|Lack of Efficacy|0|||
126258040|NCT01142908|454234509|FG000|Overall Study|Lost to Follow-up|19|||
126258041|NCT01142908|454234510|FG001|Overall Study|Lost to Follow-up|13|||
126258042|NCT01142908|454234509|FG000|Overall Study|Death|1|||
126258043|NCT01142908|454234510|FG001|Overall Study|Death|4|||
126258044|NCT01142908|454234509|FG000|Overall Study|Excluded - did not meet criteria|9|||
126258045|NCT01142908|454234510|FG001|Overall Study|Excluded - did not meet criteria|5|||
126258046|NCT01142908|454234509|FG000|Overall Study|Withdrawal by Subject|3|||
126258047|NCT01142908|454234510|FG001|Overall Study|Withdrawal by Subject|0|||
126258048|NCT00035555|454234511|FG000|Overall Study|Adverse Event|5|||
126258049|NCT00035555|454234512|FG001|Overall Study|Adverse Event|8|||
126258050|NCT00035555|454234513|FG002|Overall Study|Adverse Event|9|||
126258051|NCT00035555|454234511|FG000|Overall Study|Allograft loss|1|||
126258052|NCT00035555|454234512|FG001|Overall Study|Allograft loss|1|||
126358655|NCT01107457|454605412|FG004|Part A|Lack of Efficacy|0|||
126358656|NCT01107457|454605413|FG005|Part A|Lack of Efficacy|0|||
126358657|NCT01107457|454605408|FG000|Part A|Protocol Violation|0|||
126358658|NCT01107457|454605409|FG001|Part A|Protocol Violation|1|||
126358659|NCT01107457|454605410|FG002|Part A|Protocol Violation|0|||
126358660|NCT01107457|454605411|FG003|Part A|Protocol Violation|0|||
126358661|NCT01107457|454605412|FG004|Part A|Protocol Violation|0|||
126358662|NCT01107457|454605413|FG005|Part A|Protocol Violation|0|||
126358663|NCT01107457|454605408|FG000|Part B and C|Adverse Event|0|||
126358664|NCT01107457|454605409|FG001|Part B and C|Adverse Event|0|||
126358665|NCT01107457|454605410|FG002|Part B and C|Adverse Event|0|||
126358666|NCT01107457|454605411|FG003|Part B and C|Adverse Event|0|||
126358667|NCT01107457|454605412|FG004|Part B and C|Adverse Event|0|||
126358668|NCT01107457|454605413|FG005|Part B and C|Adverse Event|12|||
126358669|NCT01107457|454605408|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
126358670|NCT01107457|454605409|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
126358671|NCT01107457|454605410|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
126358672|NCT01107457|454605411|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
126358673|NCT01107457|454605412|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
126449589|NCT01065454|454947162|FG000|Follow up|Death|0|||
126449590|NCT01065454|454947163|FG001|Follow up|Death|1|||
126449591|NCT01065454|454947164|FG002|Follow up|Death|1|||
126449592|NCT01065454|454947165|FG003|Follow up|Death|0|||
126449593|NCT01065454|454947162|FG000|Follow up|Lost to Follow-up|0|||
126449594|NCT01065454|454947163|FG001|Follow up|Lost to Follow-up|0|||
126449595|NCT01065454|454947164|FG002|Follow up|Lost to Follow-up|0|||
126449596|NCT01065454|454947165|FG003|Follow up|Lost to Follow-up|1|||
126449597|NCT01065454|454947162|FG000|Follow up|Progressive disease|0|||
126449598|NCT01065454|454947163|FG001|Follow up|Progressive disease|0|||
126449599|NCT01065454|454947164|FG002|Follow up|Progressive disease|0|||
126449600|NCT01065454|454947165|FG003|Follow up|Progressive disease|1|||
126449601|NCT01065454|454947162|FG000|Follow up|Withdrawal by Subject|1|||
126449602|NCT01065454|454947163|FG001|Follow up|Withdrawal by Subject|1|||
126449603|NCT01065454|454947164|FG002|Follow up|Withdrawal by Subject|1|||
126449604|NCT01065454|454947165|FG003|Follow up|Withdrawal by Subject|0|||
126449605|NCT01065454|454947162|FG000|Follow up|study ongoing|37|||
126449606|NCT01065454|454947163|FG001|Follow up|study ongoing|22|||
126449607|NCT01065454|454947164|FG002|Follow up|study ongoing|15|||
126449608|NCT01065454|454947165|FG003|Follow up|study ongoing|41|||
126449609|NCT01601652|454947166|FG000|Overall Study|Death|1|||
126449610|NCT05688670|454947167|FG000|Overall Study|Change in surgery plan|1|||
126449611|NCT05688670|454947168|FG001|Overall Study|Change in surgery plan|4|||
126449612|NCT05688670|454947167|FG000|Overall Study|Inability to extubate|1|||
126546457|NCT03573908|455293804|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
126258053|NCT00035555|454234513|FG002|Overall Study|Allograft loss|2|||
126258054|NCT00035555|454234511|FG000|Overall Study|Death|0|||
126258055|NCT00035555|454234512|FG001|Overall Study|Death|0|||
126258056|NCT00035555|454234513|FG002|Overall Study|Death|2|||
126258057|NCT00035555|454234511|FG000|Overall Study|Lost to Follow-up|0|||
126258058|NCT00035555|454234512|FG001|Overall Study|Lost to Follow-up|0|||
126258059|NCT00035555|454234513|FG002|Overall Study|Lost to Follow-up|1|||
126258060|NCT00035555|454234511|FG000|Overall Study|Noncompliance|0|||
126258061|NCT00035555|454234512|FG001|Overall Study|Noncompliance|1|||
126258062|NCT00035555|454234513|FG002|Overall Study|Noncompliance|1|||
126258063|NCT00035555|454234511|FG000|Overall Study|Prohibited medication|1|||
126258064|NCT00035555|454234512|FG001|Overall Study|Prohibited medication|1|||
126258065|NCT00035555|454234513|FG002|Overall Study|Prohibited medication|0|||
126258066|NCT00035555|454234511|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
126258067|NCT00035555|454234512|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
126258068|NCT00035555|454234513|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
126258069|NCT00035555|454234511|FG000|Overall Study|Withdrawal by Subject|2|||
126258070|NCT00035555|454234512|FG001|Overall Study|Withdrawal by Subject|0|||
126258071|NCT00035555|454234513|FG002|Overall Study|Withdrawal by Subject|2|||
126258072|NCT00035555|454234511|FG000|Overall Study|Investigator deemed not a good candidate|0|||
126258073|NCT00035555|454234512|FG001|Overall Study|Investigator deemed not a good candidate|0|||
126449613|NCT05688670|454947168|FG001|Overall Study|Inability to extubate|2|||
126449614|NCT05688670|454947167|FG000|Overall Study|Day of surgery cancellation|0|||
126449615|NCT05688670|454947168|FG001|Overall Study|Day of surgery cancellation|1|||
126449616|NCT05688670|454947167|FG000|Overall Study|Reintubated on PCICU arrival|0|||
126546458|NCT03573908|455293800|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
126546459|NCT03573908|455293801|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
126258074|NCT00035555|454234513|FG002|Overall Study|Investigator deemed not a good candidate|1|||
126258075|NCT00035555|454234511|FG000|Overall Study|Received cyclosporin in error|0|||
126258076|NCT00035555|454234512|FG001|Overall Study|Received cyclosporin in error|0|||
126449617|NCT05688670|454947168|FG001|Overall Study|Reintubated on PCICU arrival|1|||
126449618|NCT01808092|454947169|FG000|Overall Study|Death|39|||
126358674|NCT01107457|454605413|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
126358675|NCT01107457|454605408|FG000|Part B and C|Physician Decision|0|||
126358676|NCT01107457|454605409|FG001|Part B and C|Physician Decision|0|||
126358677|NCT01107457|454605410|FG002|Part B and C|Physician Decision|0|||
126258077|NCT00035555|454234513|FG002|Overall Study|Received cyclosporin in error|1|||
126258078|NCT00309985|454234514|FG000|Overall Study|Disease progression|12|||
126258079|NCT00309985|454234515|FG001|Overall Study|Disease progression|0|||
126258080|NCT00309985|454234514|FG000|Overall Study|Adverse Event|30|||
126258081|NCT00309985|454234515|FG001|Overall Study|Adverse Event|0|||
126258082|NCT00309985|454234514|FG000|Overall Study|Death|2|||
126258083|NCT00309985|454234515|FG001|Overall Study|Death|0|||
126258084|NCT00309985|454234514|FG000|Overall Study|Withdrawal by Subject|5|||
126258085|NCT00309985|454234515|FG001|Overall Study|Withdrawal by Subject|1|||
126258086|NCT00309985|454234514|FG000|Overall Study|Physician Decision|3|||
126258087|NCT00309985|454234515|FG001|Overall Study|Physician Decision|0|||
126258088|NCT00309985|454234514|FG000|Overall Study|Never started treatment|7|||
126258089|NCT00309985|454234515|FG001|Overall Study|Never started treatment|0|||
126258090|NCT00309985|454234514|FG000|Overall Study|Complicating disease|1|||
126258091|NCT00309985|454234515|FG001|Overall Study|Complicating disease|0|||
126258092|NCT00309985|454234514|FG000|Overall Study|Non-compliance|1|||
126258093|NCT00309985|454234515|FG001|Overall Study|Non-compliance|0|||
126258094|NCT00309985|454234514|FG000|Overall Study|Chemotherapy discontinued only|1|||
126258095|NCT00309985|454234515|FG001|Overall Study|Chemotherapy discontinued only|0|||
126258096|NCT01186016|454234518|FG000|Overall Study|Withdrawal by Subject|46|||
126258097|NCT01186016|454234519|FG001|Overall Study|Withdrawal by Subject|29|||
126258098|NCT01055886|454234521|FG000|Overall Study|Withdrawal by Subject|4|||
126258099|NCT01055886|454234522|FG001|Overall Study|Withdrawal by Subject|9|||
126258100|NCT01055886|454234521|FG000|Overall Study|Lost to Follow-up|1|||
126258101|NCT01055886|454234522|FG001|Overall Study|Lost to Follow-up|1|||
126258102|NCT01055886|454234521|FG000|Overall Study|Withdrawal by PI|0|||
126258103|NCT01055886|454234522|FG001|Overall Study|Withdrawal by PI|1|||
126258104|NCT02972515|454234525|FG000|Overall Study|Lost to Follow-up|78|||
126258105|NCT01086969|454234530|FG000|Overall Study|Withdrawal by Subject|1|||
126258106|NCT01086969|454234531|FG001|Overall Study|Withdrawal by Subject|2|||
126258107|NCT01086969|454234532|FG002|Overall Study|Withdrawal by Subject|0|||
126258108|NCT00585312|454234548|FG000|Overall Study|Adverse Event|3|||
126258109|NCT00585312|454234549|FG001|Overall Study|Adverse Event|0|||
126258110|NCT00585312|454234548|FG000|Overall Study|Lack of Efficacy|6|||
126258111|NCT00585312|454234549|FG001|Overall Study|Lack of Efficacy|11|||
126258112|NCT00585312|454234548|FG000|Overall Study|Lost to Follow-up|1|||
126258113|NCT00585312|454234549|FG001|Overall Study|Lost to Follow-up|1|||
126258114|NCT00585312|454234548|FG000|Overall Study|Reason not specified|2|||
126258115|NCT00585312|454234549|FG001|Overall Study|Reason not specified|0|||
126258116|NCT00585312|454234548|FG000|Overall Study|Withdrawal by Subject|5|||
126258117|NCT00585312|454234549|FG001|Overall Study|Withdrawal by Subject|1|||
126258118|NCT00585312|454234548|FG000|Overall Study|Study terminated by the sponsor|34|||
126258119|NCT00585312|454234549|FG001|Overall Study|Study terminated by the sponsor|31|||
126258120|NCT04291508|454234553|FG000|Overall Study|Withdrawal by Subject|1|||
126258121|NCT04291508|454234554|FG001|Overall Study|Withdrawal by Subject|0|||
126258122|NCT04291508|454234555|FG002|Overall Study|Withdrawal by Subject|1|||
126258123|NCT04291508|454234556|FG003|Overall Study|Withdrawal by Subject|0|||
126258124|NCT04291508|454234553|FG000|Overall Study|lost to follow up|4|||
126258125|NCT04291508|454234554|FG001|Overall Study|lost to follow up|0|||
126258126|NCT04291508|454234555|FG002|Overall Study|lost to follow up|1|||
126258127|NCT04291508|454234556|FG003|Overall Study|lost to follow up|0|||
126358678|NCT01107457|454605411|FG003|Part B and C|Physician Decision|0|||
126358679|NCT01107457|454605412|FG004|Part B and C|Physician Decision|0|||
126358680|NCT01107457|454605413|FG005|Part B and C|Physician Decision|3|||
126358681|NCT01107457|454605408|FG000|Part B and C|Lack of Efficacy|0|||
126358682|NCT01107457|454605409|FG001|Part B and C|Lack of Efficacy|0|||
126358683|NCT01107457|454605410|FG002|Part B and C|Lack of Efficacy|0|||
126358684|NCT01107457|454605411|FG003|Part B and C|Lack of Efficacy|0|||
126358685|NCT01107457|454605412|FG004|Part B and C|Lack of Efficacy|0|||
126358686|NCT01107457|454605413|FG005|Part B and C|Lack of Efficacy|7|||
126358687|NCT01107457|454605408|FG000|Part B and C|Lost to Follow-up|0|||
126358688|NCT01107457|454605409|FG001|Part B and C|Lost to Follow-up|0|||
126358689|NCT01107457|454605410|FG002|Part B and C|Lost to Follow-up|0|||
126358690|NCT01107457|454605411|FG003|Part B and C|Lost to Follow-up|0|||
126358691|NCT01107457|454605412|FG004|Part B and C|Lost to Follow-up|0|||
126358692|NCT01107457|454605413|FG005|Part B and C|Lost to Follow-up|10|||
126358693|NCT01107457|454605408|FG000|Part B and C|Protocol Violation|0|||
126358694|NCT01107457|454605409|FG001|Part B and C|Protocol Violation|0|||
126358695|NCT01107457|454605410|FG002|Part B and C|Protocol Violation|0|||
126358696|NCT01107457|454605411|FG003|Part B and C|Protocol Violation|0|||
126358697|NCT01107457|454605412|FG004|Part B and C|Protocol Violation|0|||
126358698|NCT01107457|454605413|FG005|Part B and C|Protocol Violation|1|||
126358699|NCT01107457|454605408|FG000|Part B and C|Sponsor Decision|0|||
126258128|NCT04203667|454234557|FG000|Overall Study|Withdrawal by Subject|1|||
126358700|NCT01107457|454605409|FG001|Part B and C|Sponsor Decision|0|||
126358701|NCT01107457|454605410|FG002|Part B and C|Sponsor Decision|0|||
126358702|NCT01107457|454605411|FG003|Part B and C|Sponsor Decision|0|||
126358703|NCT01107457|454605412|FG004|Part B and C|Sponsor Decision|0|||
126358704|NCT01107457|454605413|FG005|Part B and C|Sponsor Decision|66|||
126358705|NCT01107457|454605408|FG000|Part B and C|Withdrawal by Subject|0|||
126358706|NCT01107457|454605409|FG001|Part B and C|Withdrawal by Subject|0|||
126358707|NCT01107457|454605410|FG002|Part B and C|Withdrawal by Subject|0|||
126358708|NCT01107457|454605411|FG003|Part B and C|Withdrawal by Subject|0|||
126358709|NCT01107457|454605412|FG004|Part B and C|Withdrawal by Subject|0|||
126358710|NCT01107457|454605413|FG005|Part B and C|Withdrawal by Subject|16|||
126358711|NCT01107457|454605408|FG000|Part B and C|Clinical Relapse|0|||
126358712|NCT01107457|454605409|FG001|Part B and C|Clinical Relapse|0|||
126358713|NCT01107457|454605410|FG002|Part B and C|Clinical Relapse|0|||
126358714|NCT01107457|454605411|FG003|Part B and C|Clinical Relapse|0|||
126358715|NCT01107457|454605412|FG004|Part B and C|Clinical Relapse|0|||
126358716|NCT01107457|454605413|FG005|Part B and C|Clinical Relapse|4|||
126358717|NCT03679884|454605414|FG000|Overall Study|Other|12|||
126358718|NCT03679884|454605415|FG001|Overall Study|Other|12|||
126358719|NCT03679884|454605416|FG002|Overall Study|Other|12|||
126358720|NCT03679884|454605417|FG003|Overall Study|Other|7|||
126358721|NCT03679884|454605418|FG004|Overall Study|Other|8|||
126358722|NCT03679884|454605414|FG000|Overall Study|Lack of Efficacy|15|||
126358723|NCT03679884|454605415|FG001|Overall Study|Lack of Efficacy|29|||
126358724|NCT03679884|454605416|FG002|Overall Study|Lack of Efficacy|13|||
126358725|NCT03679884|454605417|FG003|Overall Study|Lack of Efficacy|29|||
126358726|NCT03679884|454605418|FG004|Overall Study|Lack of Efficacy|10|||
126358727|NCT03679884|454605414|FG000|Overall Study|Death|1|||
126358728|NCT03679884|454605415|FG001|Overall Study|Death|0|||
126358729|NCT03679884|454605416|FG002|Overall Study|Death|0|||
126358730|NCT03679884|454605417|FG003|Overall Study|Death|0|||
126358731|NCT03679884|454605418|FG004|Overall Study|Death|0|||
126358732|NCT03679884|454605414|FG000|Overall Study|Adverse Event|2|||
126358733|NCT03679884|454605415|FG001|Overall Study|Adverse Event|10|||
126358734|NCT03679884|454605416|FG002|Overall Study|Adverse Event|9|||
126358735|NCT03679884|454605417|FG003|Overall Study|Adverse Event|6|||
126358736|NCT03679884|454605418|FG004|Overall Study|Adverse Event|6|||
126358737|NCT03679884|454605414|FG000|Overall Study|Withdrawal by Subject|12|||
126449619|NCT01808092|454947170|FG001|Overall Study|Death|29|||
126449620|NCT01808092|454947169|FG000|Overall Study|Lost to Follow-up|3|||
126449621|NCT01808092|454947170|FG001|Overall Study|Lost to Follow-up|7|||
126449622|NCT01808092|454947169|FG000|Overall Study|Withdrawal by Subject|9|||
126449623|NCT01808092|454947170|FG001|Overall Study|Withdrawal by Subject|4|||
126449624|NCT01808092|454947169|FG000|Overall Study|Other Eligibility criteria|3|||
126449625|NCT01808092|454947170|FG001|Overall Study|Other Eligibility criteria|5|||
126449626|NCT01097005|454947176|FG000|Overall Study|Case Report Form not collected|18|||
126449627|NCT01097005|454947176|FG000|Overall Study|Subjects cannot visit the hospital|1|||
126449628|NCT01097005|454947176|FG000|Overall Study|Poor medication compliance|1|||
126449629|NCT01097005|454947176|FG000|Overall Study|No examination data available|244|||
126449630|NCT01097005|454947176|FG000|Overall Study|Deviation from exclusion criteria|37|||
126449631|NCT01097005|454947176|FG000|Overall Study|Adverse Event|14|||
126449632|NCT01097005|454947176|FG000|Overall Study|Discontinuance by complication|50|||
126449633|NCT03425253|454947179|FG000|Overall Study|Adverse Event|2|||
126449634|NCT03425253|454947179|FG000|Overall Study|Lost to Follow-up|3|||
126449635|NCT03425253|454947179|FG000|Overall Study|Withdrew Consent|6|||
126449636|NCT03425253|454947179|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
126449637|NCT04614324|454947180|FG000|Overall Study|Lost to Follow-up|3|||
126449638|NCT04614324|454947180|FG000|Overall Study|Physician Decision|1|||
126449639|NCT04614324|454947180|FG000|Overall Study|Withdrawal by Subject|2|||
126449640|NCT04614324|454947180|FG000|Overall Study|Remaining in Follow up|123|||
126449641|NCT05289037|454947181|FG000|Overall Study|Withdrawal by Subject|7|||
126449642|NCT05289037|454947182|FG001|Overall Study|Withdrawal by Subject|0|||
126449643|NCT05289037|454947183|FG002|Overall Study|Withdrawal by Subject|3|||
126449644|NCT05289037|454947184|FG003|Overall Study|Withdrawal by Subject|3|||
126358738|NCT03679884|454605415|FG001|Overall Study|Withdrawal by Subject|23|||
126358739|NCT03679884|454605416|FG002|Overall Study|Withdrawal by Subject|8|||
126358740|NCT03679884|454605417|FG003|Overall Study|Withdrawal by Subject|8|||
126449645|NCT05289037|454947185|FG004|Overall Study|Withdrawal by Subject|1|||
126449646|NCT05289037|454947186|FG005|Overall Study|Withdrawal by Subject|5|||
126449647|NCT05289037|454947187|FG006|Overall Study|Withdrawal by Subject|2|||
126449648|NCT05289037|454947188|FG007|Overall Study|Withdrawal by Subject|1|||
126449649|NCT05289037|454947189|FG008|Overall Study|Withdrawal by Subject|2|||
126763140|NCT02686749|456084956|FG000|Overall Study|terminated for poor enrollment|2|||
126358741|NCT03679884|454605418|FG004|Overall Study|Withdrawal by Subject|9|||
126358742|NCT03679884|454605414|FG000|Overall Study|Lost to Follow-up|1|||
126358743|NCT03679884|454605415|FG001|Overall Study|Lost to Follow-up|4|||
126358744|NCT03679884|454605416|FG002|Overall Study|Lost to Follow-up|2|||
126358745|NCT03679884|454605417|FG003|Overall Study|Lost to Follow-up|0|||
126358746|NCT03679884|454605418|FG004|Overall Study|Lost to Follow-up|3|||
126358747|NCT01227395|454605419|FG000|Overall Study|Protocol Violation|0|||
126358748|NCT01227395|454605420|FG001|Overall Study|Protocol Violation|1|||
126358749|NCT00105508|454605425|FG000|Overall Study|Prephase Dropout|1|||
126358750|NCT00105508|454605426|FG001|Overall Study|Prephase Dropout|0|||
126698695|NCT03690869|455847154|FG007|Overall Study|Lost to Follow-up|0|||
126698696|NCT03690869|455847155|FG008|Overall Study|Lost to Follow-up|0|||
126698697|NCT03690869|455847156|FG009|Overall Study|Lost to Follow-up|0|||
126698698|NCT03690869|455847147|FG000|Overall Study|Other Treatment|1|||
126698699|NCT03690869|455847148|FG001|Overall Study|Other Treatment|1|||
126698700|NCT03690869|455847149|FG002|Overall Study|Other Treatment|1|||
126698701|NCT03690869|455847150|FG003|Overall Study|Other Treatment|2|||
126698702|NCT03690869|455847151|FG004|Overall Study|Other Treatment|3|||
126698703|NCT03690869|455847152|FG005|Overall Study|Other Treatment|1|||
126698704|NCT03690869|455847153|FG006|Overall Study|Other Treatment|2|||
126698705|NCT03690869|455847154|FG007|Overall Study|Other Treatment|7|||
126698706|NCT03690869|455847155|FG008|Overall Study|Other Treatment|0|||
126698707|NCT03690869|455847156|FG009|Overall Study|Other Treatment|3|||
126698708|NCT03690869|455847147|FG000|Overall Study|Physician Decision|0|||
126698709|NCT03690869|455847148|FG001|Overall Study|Physician Decision|1|||
126698710|NCT03690869|455847149|FG002|Overall Study|Physician Decision|0|||
126698711|NCT03690869|455847150|FG003|Overall Study|Physician Decision|0|||
126698712|NCT03690869|455847151|FG004|Overall Study|Physician Decision|0|||
126698713|NCT03690869|455847152|FG005|Overall Study|Physician Decision|0|||
126698714|NCT03690869|455847153|FG006|Overall Study|Physician Decision|0|||
126698715|NCT03690869|455847154|FG007|Overall Study|Physician Decision|0|||
126698716|NCT03690869|455847155|FG008|Overall Study|Physician Decision|0|||
126698717|NCT03690869|455847156|FG009|Overall Study|Physician Decision|0|||
126698718|NCT03690869|455847147|FG000|Overall Study|Progressive Disease|1|||
126698719|NCT03690869|455847148|FG001|Overall Study|Progressive Disease|2|||
126698720|NCT03690869|455847149|FG002|Overall Study|Progressive Disease|0|||
126698721|NCT03690869|455847150|FG003|Overall Study|Progressive Disease|1|||
126698722|NCT03690869|455847151|FG004|Overall Study|Progressive Disease|0|||
126698723|NCT03690869|455847152|FG005|Overall Study|Progressive Disease|0|||
126698724|NCT03690869|455847153|FG006|Overall Study|Progressive Disease|0|||
126698725|NCT03690869|455847154|FG007|Overall Study|Progressive Disease|0|||
126698726|NCT03690869|455847155|FG008|Overall Study|Progressive Disease|1|||
126698727|NCT03690869|455847156|FG009|Overall Study|Progressive Disease|1|||
126698728|NCT03690869|455847147|FG000|Overall Study|Subject Decision|0|||
126698729|NCT03690869|455847148|FG001|Overall Study|Subject Decision|0|||
126698730|NCT03690869|455847149|FG002|Overall Study|Subject Decision|0|||
126698731|NCT03690869|455847150|FG003|Overall Study|Subject Decision|1|||
126698732|NCT03690869|455847151|FG004|Overall Study|Subject Decision|0|||
126698733|NCT03690869|455847152|FG005|Overall Study|Subject Decision|0|||
126698734|NCT03690869|455847153|FG006|Overall Study|Subject Decision|0|||
126698735|NCT03690869|455847154|FG007|Overall Study|Subject Decision|1|||
126698736|NCT03690869|455847155|FG008|Overall Study|Subject Decision|0|||
126698737|NCT03690869|455847156|FG009|Overall Study|Subject Decision|0|||
126698738|NCT04280081|455847158|FG000|Overall Study|Adverse Event|4|||
126698739|NCT04280081|455847158|FG000|Overall Study|Death|2|||
126698740|NCT04280081|455847158|FG000|Overall Study|Progressive Disease|6|||
126698741|NCT01468311|455847159|FG000|Overall Study|mobilization failure|1|||
126258129|NCT04203667|454234557|FG000|Overall Study|Lost to Follow-up|1|||
126258130|NCT04203667|454234557|FG000|Overall Study|Death|1|||
126258131|NCT04203667|454234557|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
126258132|NCT02329431|454234558|FG000|Overall Study|Lost to Follow-up|20|||
126258133|NCT02329431|454234559|FG001|Overall Study|Lost to Follow-up|13|||
126258134|NCT01362296|454234560|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
126258135|NCT01362296|454234561|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
126258136|NCT01362296|454234562|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
126258137|NCT01362296|454234563|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
126698742|NCT01468311|455847159|FG000|Overall Study|Withdrawal by Subject|1|||
126698743|NCT03902080|455848732|FG000|Overall Study|Adverse Event|17|||
126698744|NCT03902080|455848733|FG001|Overall Study|Adverse Event|15|||
126698745|NCT03902080|455848732|FG000|Overall Study|Withdrawal by Subject|28|||
126698746|NCT03902080|455848733|FG001|Overall Study|Withdrawal by Subject|35|||
126698747|NCT03902080|455848732|FG000|Overall Study|Lost to Follow-up|6|||
126698748|NCT03902080|455848733|FG001|Overall Study|Lost to Follow-up|7|||
126698749|NCT03902080|455848732|FG000|Overall Study|Other|3|||
126698750|NCT03902080|455848733|FG001|Overall Study|Other|5|||
126698751|NCT03902080|455848732|FG000|Overall Study|Non compliance|4|||
126698752|NCT03902080|455848733|FG001|Overall Study|Non compliance|3|||
126698753|NCT03902080|455848732|FG000|Overall Study|Physician Decision|5|||
126698754|NCT03902080|455848733|FG001|Overall Study|Physician Decision|1|||
126698755|NCT03902080|455848732|FG000|Overall Study|Protocol Violation|3|||
126698756|NCT03902080|455848733|FG001|Overall Study|Protocol Violation|3|||
126698757|NCT03902080|455848732|FG000|Overall Study|Lack of Efficacy|1|||
126698758|NCT03902080|455848733|FG001|Overall Study|Lack of Efficacy|3|||
126698759|NCT03902080|455848732|FG000|Overall Study|Withdrawn prior to dosing|0|||
126698760|NCT03902080|455848733|FG001|Overall Study|Withdrawn prior to dosing|1|||
126698761|NCT01919307|455848738|FG000|Overall Study|Withdrawal by Subject|9|||
126698762|NCT01701258|455848740|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
126698763|NCT01701258|455848741|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
126698764|NCT01701258|455848742|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
126698765|NCT01701258|455848743|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
126449650|NCT05289037|454947190|FG009|Overall Study|Withdrawal by Subject|2|||
126449651|NCT05289037|454947191|FG010|Overall Study|Withdrawal by Subject|1|||
126449652|NCT05289037|454947192|FG011|Overall Study|Withdrawal by Subject|0|||
126449653|NCT05289037|454947193|FG012|Overall Study|Withdrawal by Subject|1|||
126449654|NCT05289037|454947194|FG013|Overall Study|Withdrawal by Subject|2|||
126449655|NCT05289037|454947195|FG014|Overall Study|Withdrawal by Subject|0|||
126449656|NCT05289037|454947196|FG015|Overall Study|Withdrawal by Subject|3|||
126449657|NCT05289037|454947197|FG016|Overall Study|Withdrawal by Subject|3|||
126449658|NCT05289037|454947181|FG000|Overall Study|Lost to Follow-up|1|||
126449659|NCT05289037|454947182|FG001|Overall Study|Lost to Follow-up|4|||
126449660|NCT05289037|454947183|FG002|Overall Study|Lost to Follow-up|3|||
126449661|NCT05289037|454947184|FG003|Overall Study|Lost to Follow-up|3|||
126449662|NCT05289037|454947185|FG004|Overall Study|Lost to Follow-up|3|||
126449663|NCT05289037|454947186|FG005|Overall Study|Lost to Follow-up|2|||
126449664|NCT05289037|454947187|FG006|Overall Study|Lost to Follow-up|3|||
126449665|NCT05289037|454947188|FG007|Overall Study|Lost to Follow-up|2|||
126449666|NCT05289037|454947189|FG008|Overall Study|Lost to Follow-up|2|||
126449667|NCT05289037|454947190|FG009|Overall Study|Lost to Follow-up|1|||
126449668|NCT05289037|454947191|FG010|Overall Study|Lost to Follow-up|3|||
126449669|NCT05289037|454947192|FG011|Overall Study|Lost to Follow-up|4|||
126449670|NCT05289037|454947193|FG012|Overall Study|Lost to Follow-up|2|||
126449671|NCT05289037|454947194|FG013|Overall Study|Lost to Follow-up|7|||
126449672|NCT05289037|454947195|FG014|Overall Study|Lost to Follow-up|4|||
126449673|NCT05289037|454947196|FG015|Overall Study|Lost to Follow-up|6|||
126449674|NCT05289037|454947197|FG016|Overall Study|Lost to Follow-up|4|||
126449675|NCT05289037|454947181|FG000|Overall Study|Death|0|||
126449676|NCT05289037|454947182|FG001|Overall Study|Death|0|||
126449677|NCT05289037|454947183|FG002|Overall Study|Death|0|||
126449678|NCT05289037|454947184|FG003|Overall Study|Death|0|||
126449679|NCT05289037|454947185|FG004|Overall Study|Death|0|||
126449680|NCT05289037|454947186|FG005|Overall Study|Death|1|||
126449681|NCT05289037|454947187|FG006|Overall Study|Death|0|||
126449682|NCT05289037|454947188|FG007|Overall Study|Death|0|||
126449683|NCT05289037|454947189|FG008|Overall Study|Death|0|||
126449684|NCT05289037|454947190|FG009|Overall Study|Death|0|||
126449685|NCT05289037|454947191|FG010|Overall Study|Death|0|||
126449686|NCT05289037|454947192|FG011|Overall Study|Death|0|||
126449687|NCT05289037|454947193|FG012|Overall Study|Death|0|||
126449688|NCT05289037|454947194|FG013|Overall Study|Death|0|||
126449689|NCT05289037|454947195|FG014|Overall Study|Death|1|||
126449690|NCT05289037|454947196|FG015|Overall Study|Death|0|||
126449691|NCT05289037|454947197|FG016|Overall Study|Death|0|||
126449692|NCT05289037|454947181|FG000|Overall Study|Did not receive vaccine|0|||
126449693|NCT05289037|454947182|FG001|Overall Study|Did not receive vaccine|3|||
126449694|NCT05289037|454947183|FG002|Overall Study|Did not receive vaccine|0|||
126449695|NCT05289037|454947184|FG003|Overall Study|Did not receive vaccine|0|||
126449696|NCT05289037|454947185|FG004|Overall Study|Did not receive vaccine|1|||
126449697|NCT05289037|454947186|FG005|Overall Study|Did not receive vaccine|1|||
126449698|NCT05289037|454947187|FG006|Overall Study|Did not receive vaccine|1|||
126449699|NCT05289037|454947188|FG007|Overall Study|Did not receive vaccine|0|||
126449700|NCT05289037|454947189|FG008|Overall Study|Did not receive vaccine|0|||
126449701|NCT05289037|454947190|FG009|Overall Study|Did not receive vaccine|0|||
126258138|NCT01362296|454234560|FG000|Randomized Phase (RP)|Physician Decision|1|||
126258139|NCT01362296|454234561|FG001|Randomized Phase (RP)|Physician Decision|9|||
126258140|NCT01362296|454234562|FG002|Randomized Phase (RP)|Physician Decision|0|||
126258141|NCT01362296|454234563|FG003|Randomized Phase (RP)|Physician Decision|0|||
126258142|NCT01362296|454234560|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
126258143|NCT01362296|454234561|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
126258144|NCT01362296|454234562|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
126258145|NCT01362296|454234563|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
126449702|NCT05289037|454947191|FG010|Overall Study|Did not receive vaccine|0|||
126449703|NCT05289037|454947192|FG011|Overall Study|Did not receive vaccine|0|||
126449704|NCT05289037|454947193|FG012|Overall Study|Did not receive vaccine|0|||
126449705|NCT05289037|454947194|FG013|Overall Study|Did not receive vaccine|0|||
126449706|NCT05289037|454947195|FG014|Overall Study|Did not receive vaccine|1|||
126449707|NCT05289037|454947196|FG015|Overall Study|Did not receive vaccine|0|||
126449708|NCT05289037|454947197|FG016|Overall Study|Did not receive vaccine|0|||
126449709|NCT05289037|454947181|FG000|Overall Study|Unable to make last visit|0|||
126449710|NCT05289037|454947182|FG001|Overall Study|Unable to make last visit|0|||
126449711|NCT05289037|454947183|FG002|Overall Study|Unable to make last visit|1|||
126258146|NCT01362296|454234560|FG000|Randomized Phase (RP)|Adverse Event|20|||
126258147|NCT01362296|454234561|FG001|Randomized Phase (RP)|Adverse Event|4|||
126449712|NCT05289037|454947184|FG003|Overall Study|Unable to make last visit|0|||
126449713|NCT05289037|454947185|FG004|Overall Study|Unable to make last visit|0|||
126449714|NCT05289037|454947186|FG005|Overall Study|Unable to make last visit|0|||
126449715|NCT05289037|454947187|FG006|Overall Study|Unable to make last visit|0|||
126449716|NCT05289037|454947188|FG007|Overall Study|Unable to make last visit|0|||
126698766|NCT01701258|455848744|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
126698767|NCT01701258|455848745|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
126258148|NCT01362296|454234562|FG002|Randomized Phase (RP)|Adverse Event|0|||
126258149|NCT01362296|454234563|FG003|Randomized Phase (RP)|Adverse Event|0|||
126258150|NCT01362296|454234560|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
126258151|NCT01362296|454234561|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
126258152|NCT01362296|454234562|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
126258153|NCT01362296|454234563|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
126258154|NCT01362296|454234560|FG000|Crossover Phase|PD including Death due to PD|0|||
126258155|NCT01362296|454234561|FG001|Crossover Phase|PD including Death due to PD|0|||
126258156|NCT01362296|454234562|FG002|Crossover Phase|PD including Death due to PD|16|||
126258157|NCT01362296|454234563|FG003|Crossover Phase|PD including Death due to PD|1|||
126258158|NCT01362296|454234560|FG000|Crossover Phase|Withdrawal by Subject|0|||
126258159|NCT01362296|454234561|FG001|Crossover Phase|Withdrawal by Subject|0|||
126258160|NCT01362296|454234562|FG002|Crossover Phase|Withdrawal by Subject|2|||
126258161|NCT01362296|454234563|FG003|Crossover Phase|Withdrawal by Subject|1|||
126258162|NCT01362296|454234560|FG000|Crossover Phase|Adverse Event|0|||
126258163|NCT01362296|454234561|FG001|Crossover Phase|Adverse Event|0|||
126258164|NCT01362296|454234562|FG002|Crossover Phase|Adverse Event|4|||
126258165|NCT01362296|454234563|FG003|Crossover Phase|Adverse Event|0|||
126258166|NCT01362296|454234560|FG000|Crossover Phase|Study Closed/Terminated|0|||
126258167|NCT01362296|454234561|FG001|Crossover Phase|Study Closed/Terminated|0|||
126258168|NCT01362296|454234562|FG002|Crossover Phase|Study Closed/Terminated|1|||
126258169|NCT01362296|454234563|FG003|Crossover Phase|Study Closed/Terminated|0|||
126258170|NCT02625974|454234564|FG000|Part 1|Lost to Follow-up|9|||
126258171|NCT02625974|454234565|FG001|Part 1|Lost to Follow-up|3|||
126698768|NCT01701258|455848746|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
126698769|NCT01701258|455848747|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
126698770|NCT01701258|455848748|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
126258172|NCT02625974|454234564|FG000|Part 2|Lost to Follow-up|4|||
126258173|NCT02625974|454234565|FG001|Part 2|Lost to Follow-up|6|||
126258174|NCT02625974|454234564|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
126258175|NCT02625974|454234565|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
126258176|NCT02129062|454235808|FG000|Overall Study|Death|1|||
126698771|NCT01701258|455848749|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
126258177|NCT02129062|454235808|FG000|Overall Study|Disease Progression|2|||
126258178|NCT02722616|454235809|FG000|Overall Study|Sponsor closed study after one month|2|||
126258179|NCT02722616|454235810|FG001|Overall Study|Sponsor closed study after one month|0|||
126258180|NCT02722616|454235811|FG002|Overall Study|Sponsor closed study after one month|0|||
126258181|NCT01923311|454235812|FG000|Overall Study|Pregnancy|1|||
126258182|NCT01923311|454235813|FG001|Overall Study|Pregnancy|0|||
126258183|NCT01923311|454235812|FG000|Overall Study|Investigator's Discretion|1|||
126258184|NCT01923311|454235813|FG001|Overall Study|Investigator's Discretion|0|||
126258185|NCT01923311|454235812|FG000|Overall Study|Non-Compliance with Study Drug|2|||
126258186|NCT01923311|454235813|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126258187|NCT01923311|454235812|FG000|Overall Study|Withdrew Consent|1|||
126258188|NCT01923311|454235813|FG001|Overall Study|Withdrew Consent|0|||
126258189|NCT01923311|454235812|FG000|Overall Study|Study Terminated by Sponsor|12|||
126258190|NCT01923311|454235813|FG001|Overall Study|Study Terminated by Sponsor|0|||
126258191|NCT02031237|454235814|FG000|Overall Study|Death|1|||
126258192|NCT02031237|454235815|FG001|Overall Study|Death|5|||
126258193|NCT02031237|454235816|FG002|Overall Study|Death|0|||
126258194|NCT02031237|454235814|FG000|Overall Study|Physician Decision|0|||
126258195|NCT02031237|454235815|FG001|Overall Study|Physician Decision|1|||
126258196|NCT02031237|454235816|FG002|Overall Study|Physician Decision|0|||
126258197|NCT02031237|454235814|FG000|Overall Study|Withdrawal by Subject|2|||
126258198|NCT02031237|454235815|FG001|Overall Study|Withdrawal by Subject|2|||
126258199|NCT02031237|454235816|FG002|Overall Study|Withdrawal by Subject|0|||
126258200|NCT02031237|454235814|FG000|Overall Study|Protocol Violation|2|||
126258201|NCT02031237|454235815|FG001|Overall Study|Protocol Violation|6|||
126258202|NCT02031237|454235816|FG002|Overall Study|Protocol Violation|0|||
126258203|NCT02031237|454235814|FG000|Overall Study|Alternate Treatment Given|0|||
126258204|NCT02031237|454235815|FG001|Overall Study|Alternate Treatment Given|0|||
126258205|NCT02031237|454235816|FG002|Overall Study|Alternate Treatment Given|3|||
126258206|NCT00381849|454235817|FG000|Wash Out|Withdrawal by Subject|0|||
126258207|NCT00381849|454235818|FG001|Wash Out|Withdrawal by Subject|1|||
126258208|NCT02426541|454235822|FG000|Overall Study|Protocol Violation|1|||
126258209|NCT02426541|454235823|FG001|Overall Study|Protocol Violation|0|||
126258210|NCT00631007|454235826|FG000|Overall Study|Adverse Event|0|||
126258211|NCT00631007|454235827|FG001|Overall Study|Adverse Event|2|||
126258212|NCT00631007|454235828|FG002|Overall Study|Adverse Event|0|||
126258213|NCT00631007|454235829|FG003|Overall Study|Adverse Event|2|||
126258214|NCT00631007|454235830|FG004|Overall Study|Adverse Event|3|||
126258215|NCT00631007|454235831|FG005|Overall Study|Adverse Event|2|||
126258216|NCT00631007|454235826|FG000|Overall Study|Lost to Follow-up|2|||
126698772|NCT01701258|455848750|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
126698773|NCT01701258|455848751|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
126258217|NCT00631007|454235827|FG001|Overall Study|Lost to Follow-up|1|||
126449717|NCT05289037|454947189|FG008|Overall Study|Unable to make last visit|0|||
126449718|NCT05289037|454947190|FG009|Overall Study|Unable to make last visit|0|||
126449719|NCT05289037|454947191|FG010|Overall Study|Unable to make last visit|0|||
126449720|NCT05289037|454947192|FG011|Overall Study|Unable to make last visit|0|||
126449721|NCT05289037|454947193|FG012|Overall Study|Unable to make last visit|0|||
126449722|NCT05289037|454947194|FG013|Overall Study|Unable to make last visit|0|||
126449723|NCT05289037|454947195|FG014|Overall Study|Unable to make last visit|0|||
126449724|NCT05289037|454947196|FG015|Overall Study|Unable to make last visit|0|||
126449725|NCT05289037|454947197|FG016|Overall Study|Unable to make last visit|0|||
126449726|NCT05289037|454947181|FG000|Overall Study|Protocol deviation|0|||
126449727|NCT05289037|454947182|FG001|Overall Study|Protocol deviation|0|||
126449728|NCT05289037|454947183|FG002|Overall Study|Protocol deviation|0|||
126449729|NCT05289037|454947184|FG003|Overall Study|Protocol deviation|0|||
126449730|NCT05289037|454947185|FG004|Overall Study|Protocol deviation|0|||
126449731|NCT05289037|454947186|FG005|Overall Study|Protocol deviation|0|||
126449732|NCT05289037|454947187|FG006|Overall Study|Protocol deviation|0|||
126449733|NCT05289037|454947188|FG007|Overall Study|Protocol deviation|0|||
126449734|NCT05289037|454947189|FG008|Overall Study|Protocol deviation|0|||
126449735|NCT05289037|454947190|FG009|Overall Study|Protocol deviation|0|||
126449736|NCT05289037|454947191|FG010|Overall Study|Protocol deviation|0|||
126449737|NCT05289037|454947192|FG011|Overall Study|Protocol deviation|0|||
126449738|NCT05289037|454947193|FG012|Overall Study|Protocol deviation|0|||
126449739|NCT05289037|454947194|FG013|Overall Study|Protocol deviation|0|||
126449740|NCT05289037|454947195|FG014|Overall Study|Protocol deviation|0|||
126449741|NCT05289037|454947196|FG015|Overall Study|Protocol deviation|1|||
126449742|NCT05289037|454947197|FG016|Overall Study|Protocol deviation|0|||
126449743|NCT05009979|454947198|FG000|Overall Study|Withdrawal by Subject|1|||
126449744|NCT03844945|454948159|FG000|Overall Study|Adverse Event|1|||
126449745|NCT03844945|454948160|FG001|Overall Study|Adverse Event|1|||
126449746|NCT03844945|454948161|FG002|Overall Study|Adverse Event|4|||
126449747|NCT03844945|454948162|FG003|Overall Study|Adverse Event|0|||
126449748|NCT03844945|454948159|FG000|Overall Study|Withdrawal by Subject|0|||
126449749|NCT03844945|454948160|FG001|Overall Study|Withdrawal by Subject|0|||
126449750|NCT03844945|454948161|FG002|Overall Study|Withdrawal by Subject|1|||
126449751|NCT03844945|454948162|FG003|Overall Study|Withdrawal by Subject|0|||
126449752|NCT03844945|454948159|FG000|Overall Study|Lack of Efficacy|0|||
126449753|NCT03844945|454948160|FG001|Overall Study|Lack of Efficacy|0|||
126449754|NCT03844945|454948161|FG002|Overall Study|Lack of Efficacy|0|||
126449755|NCT03844945|454948162|FG003|Overall Study|Lack of Efficacy|1|||
126449756|NCT04473235|454948165|FG000|Overall Study|Lost to Follow-up|6|||
126449757|NCT04473235|454948166|FG001|Overall Study|Lost to Follow-up|5|||
126449758|NCT04473235|454948165|FG000|Overall Study|Declined continuation|2|||
126449759|NCT04473235|454948166|FG001|Overall Study|Declined continuation|0|||
126449760|NCT04473235|454948165|FG000|Overall Study|Physician Decision|1|||
126449761|NCT04473235|454948166|FG001|Overall Study|Physician Decision|1|||
126449762|NCT04473235|454948165|FG000|Overall Study|Protocol Violation|10|||
126449763|NCT04473235|454948166|FG001|Overall Study|Protocol Violation|6|||
126449764|NCT02051933|454948167|FG000|Overall Study|Physician Decision|0|||
126449765|NCT02051933|454948168|FG001|Overall Study|Physician Decision|1|||
126258218|NCT00631007|454235828|FG002|Overall Study|Lost to Follow-up|2|||
126258219|NCT00631007|454235829|FG003|Overall Study|Lost to Follow-up|4|||
126258220|NCT00631007|454235830|FG004|Overall Study|Lost to Follow-up|5|||
126258221|NCT00631007|454235831|FG005|Overall Study|Lost to Follow-up|3|||
126258222|NCT00631007|454235826|FG000|Overall Study|Physician Decision|1|||
126258223|NCT00631007|454235827|FG001|Overall Study|Physician Decision|0|||
126258224|NCT00631007|454235828|FG002|Overall Study|Physician Decision|1|||
126258225|NCT00631007|454235829|FG003|Overall Study|Physician Decision|0|||
126258226|NCT00631007|454235830|FG004|Overall Study|Physician Decision|0|||
126258227|NCT00631007|454235831|FG005|Overall Study|Physician Decision|2|||
126258228|NCT00631007|454235826|FG000|Overall Study|Persistent Hyperglycemia|2|||
126258229|NCT00631007|454235827|FG001|Overall Study|Persistent Hyperglycemia|2|||
126258230|NCT00631007|454235828|FG002|Overall Study|Persistent Hyperglycemia|5|||
126258231|NCT00631007|454235829|FG003|Overall Study|Persistent Hyperglycemia|1|||
126449766|NCT00588861|454948172|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
126449767|NCT00588861|454948173|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
126449768|NCT00588861|454948172|FG000|6 Months|Patients did not return for follow-up|98|||
126449769|NCT00588861|454948173|FG001|6 Months|Patients did not return for follow-up|73|||
126449770|NCT00588861|454948172|FG000|1 Year|Patients did not return for follow-up|89|||
126449771|NCT00588861|454948173|FG001|1 Year|Patients did not return for follow-up|82|||
126698774|NCT01701258|455848752|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
126449772|NCT00588861|454948172|FG000|2 Years|Patients did not return for follow-up|92|||
126449773|NCT00588861|454948173|FG001|2 Years|Patients did not return for follow-up|87|||
126258232|NCT00631007|454235830|FG004|Overall Study|Persistent Hyperglycemia|2|||
126258233|NCT00631007|454235831|FG005|Overall Study|Persistent Hyperglycemia|5|||
126358751|NCT00105508|454605425|FG000|Overall Study|Adverse Event|16|||
126358752|NCT00105508|454605426|FG001|Overall Study|Adverse Event|19|||
126358753|NCT00105508|454605425|FG000|Overall Study|Insufficient Efficacy|1|||
126358754|NCT00105508|454605426|FG001|Overall Study|Insufficient Efficacy|0|||
126358755|NCT00105508|454605425|FG000|Overall Study|Withdrawal by Subject|10|||
126358756|NCT00105508|454605426|FG001|Overall Study|Withdrawal by Subject|6|||
126358757|NCT00105508|454605425|FG000|Overall Study|Lost to Follow-up|3|||
126358758|NCT00105508|454605426|FG001|Overall Study|Lost to Follow-up|0|||
126358759|NCT00105508|454605425|FG000|Overall Study|Protocol Violation|1|||
126358760|NCT00105508|454605426|FG001|Overall Study|Protocol Violation|2|||
126358761|NCT00105508|454605425|FG000|Overall Study|Other|8|||
126358762|NCT00105508|454605426|FG001|Overall Study|Other|9|||
126358763|NCT00086307|454605427|FG000|Overall Study|Lack of Efficacy|1|||
126358764|NCT00086307|454605428|FG001|Overall Study|Lack of Efficacy|1|||
126358765|NCT00086307|454605429|FG002|Overall Study|Lack of Efficacy|2|||
126358766|NCT00086307|454605427|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
126358767|NCT00086307|454605428|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
126358768|NCT00086307|454605429|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
126358769|NCT00086307|454605427|FG000|Overall Study|Nausea and headaches|0|||
126358770|NCT00086307|454605428|FG001|Overall Study|Nausea and headaches|0|||
126358771|NCT00086307|454605429|FG002|Overall Study|Nausea and headaches|1|||
126358772|NCT00086307|454605427|FG000|Overall Study|Constipation and sleepiness|0|||
126358773|NCT00086307|454605428|FG001|Overall Study|Constipation and sleepiness|0|||
126358774|NCT00086307|454605429|FG002|Overall Study|Constipation and sleepiness|1|||
126358775|NCT00086307|454605427|FG000|Overall Study|Suicidal ideation|0|||
126358776|NCT00086307|454605428|FG001|Overall Study|Suicidal ideation|0|||
126358777|NCT00086307|454605429|FG002|Overall Study|Suicidal ideation|1|||
126358778|NCT00086307|454605427|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
126358779|NCT00086307|454605428|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
126358780|NCT00086307|454605429|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
126358781|NCT00086307|454605427|FG000|Overall Study|Withdrawal by Subject|0|||
126358782|NCT00086307|454605428|FG001|Overall Study|Withdrawal by Subject|0|||
126358783|NCT00086307|454605429|FG002|Overall Study|Withdrawal by Subject|2|||
126358784|NCT00683384|454605430|FG000|Overall Study|Death|1|||
126358785|NCT00683384|454605430|FG000|Overall Study|Adverse Event|1|||
126358786|NCT00120874|454605432|FG000|Overall Study|Death|0|||
126358787|NCT00120874|454605433|FG001|Overall Study|Death|1|||
126358788|NCT00300495|454605440|FG000|Overall Study|Protocol Violation|4|||
126358789|NCT00300495|454605441|FG001|Overall Study|Protocol Violation|1|||
126358790|NCT03632720|454605442|FG000|Overall Study|Adverse Event|2|||
126358791|NCT03632720|454605443|FG001|Overall Study|Adverse Event|0|||
126358792|NCT03632720|454605444|FG002|Overall Study|Adverse Event|0|||
126358793|NCT03632720|454605442|FG000|Overall Study|Lost to Follow-up|0|||
126358794|NCT03632720|454605443|FG001|Overall Study|Lost to Follow-up|1|||
126449774|NCT00588861|454948172|FG000|4 Years|Patients did not return for follow-up|91|||
126449775|NCT00588861|454948173|FG001|4 Years|Patients did not return for follow-up|103|||
126449776|NCT00588861|454948172|FG000|6 Years|Patients did not return for follow-up|104|||
126449777|NCT00588861|454948173|FG001|6 Years|Patients did not return for follow-up|109|||
126449778|NCT00588861|454948172|FG000|8 Years|Patients did not return for follow-up|105|||
126449779|NCT00588861|454948173|FG001|8 Years|Patients did not return for follow-up|114|||
126449780|NCT00588861|454948172|FG000|10 Years|Incomplete due to study termination|107|||
126449781|NCT00588861|454948173|FG001|10 Years|Incomplete due to study termination|114|||
126449782|NCT02730195|454948174|FG000|Overall Study|Withdrawal by Subject|1|||
126449783|NCT02248675|454948176|FG000|Overall Study|Lost to Follow-up|3|||
126449784|NCT02248675|454948177|FG001|Overall Study|Lost to Follow-up|1|||
126449785|NCT00265148|454948179|FG000|Overall Study|Adverse Event|2|||
126449786|NCT00265148|454948180|FG001|Overall Study|Adverse Event|2|||
126449787|NCT00265148|454948179|FG000|Overall Study|Lack of Efficacy|0|||
126698775|NCT01701258|455848740|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
126698776|NCT01701258|455848741|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
126698777|NCT01701258|455848742|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
126449788|NCT00265148|454948180|FG001|Overall Study|Lack of Efficacy|2|||
126449789|NCT00265148|454948179|FG000|Overall Study|Protocol Violation|3|||
126449790|NCT00265148|454948180|FG001|Overall Study|Protocol Violation|2|||
126449791|NCT00265148|454948179|FG000|Overall Study|Lost to Follow-up|0|||
126449792|NCT00265148|454948180|FG001|Overall Study|Lost to Follow-up|1|||
126449793|NCT00265148|454948179|FG000|Overall Study|Withdrawal by Subject|2|||
126358795|NCT03632720|454605444|FG002|Overall Study|Lost to Follow-up|0|||
126358796|NCT03632720|454605442|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
126358797|NCT03632720|454605443|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
126358798|NCT03632720|454605444|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
126358799|NCT03632720|454605442|FG000|Overall Study|Screen failure|0|||
126358800|NCT03632720|454605443|FG001|Overall Study|Screen failure|1|||
126358801|NCT03632720|454605444|FG002|Overall Study|Screen failure|0|||
126358802|NCT00682435|454605445|FG000|Overall Study|Insufficient data|5|||
126449794|NCT00265148|454948180|FG001|Overall Study|Withdrawal by Subject|1|||
126763141|NCT02686749|456084957|FG001|Overall Study|terminated for poor enrollment|2|||
126258234|NCT00631007|454235826|FG000|Overall Study|Withdrawal by Subject|4|||
126258235|NCT00631007|454235827|FG001|Overall Study|Withdrawal by Subject|5|||
126258236|NCT00631007|454235828|FG002|Overall Study|Withdrawal by Subject|2|||
126258237|NCT00631007|454235829|FG003|Overall Study|Withdrawal by Subject|2|||
126258238|NCT00631007|454235830|FG004|Overall Study|Withdrawal by Subject|1|||
126258239|NCT00631007|454235831|FG005|Overall Study|Withdrawal by Subject|3|||
126258240|NCT00631007|454235826|FG000|Overall Study|Other|2|||
126258241|NCT00631007|454235827|FG001|Overall Study|Other|1|||
126449795|NCT00265148|454948179|FG000|Overall Study|Physician Decision|1|||
126449796|NCT00265148|454948180|FG001|Overall Study|Physician Decision|0|||
126449797|NCT00265148|454948179|FG000|Overall Study|Increasing frailty|0|||
126449798|NCT00265148|454948180|FG001|Overall Study|Increasing frailty|1|||
126449799|NCT00265148|454948179|FG000|Overall Study|Subject chose to change of the dose|1|||
126449800|NCT00265148|454948180|FG001|Overall Study|Subject chose to change of the dose|0|||
126449801|NCT00942994|454948185|FG000|Overall Study|Adverse Event|7|||
126449802|NCT00942994|454948186|FG001|Overall Study|Adverse Event|4|||
126449803|NCT00942994|454948185|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126449804|NCT00942994|454948186|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126449805|NCT00942994|454948185|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126449806|NCT00942994|454948186|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126449807|NCT00942994|454948185|FG000|Overall Study|Patient withdrew consent|5|||
126449808|NCT00942994|454948186|FG001|Overall Study|Patient withdrew consent|8|||
126449809|NCT00942994|454948185|FG000|Overall Study|Lost to Follow-up|1|||
126449810|NCT00942994|454948186|FG001|Overall Study|Lost to Follow-up|4|||
126449811|NCT00942994|454948185|FG000|Overall Study|Protocol deviation|1|||
126449812|NCT00942994|454948186|FG001|Overall Study|Protocol deviation|2|||
126449813|NCT01874340|454948189|FG000|Overall Study|Study terminated by Sponsor|6|||
126449814|NCT01874340|454948190|FG001|Overall Study|Study terminated by Sponsor|8|||
126449815|NCT01874340|454948191|FG002|Overall Study|Study terminated by Sponsor|8|||
126449816|NCT01874340|454948192|FG003|Overall Study|Study terminated by Sponsor|4|||
126449817|NCT01874340|454948189|FG000|Overall Study|Withdrawal by Subject|0|||
126449818|NCT01874340|454948190|FG001|Overall Study|Withdrawal by Subject|0|||
126449819|NCT01874340|454948191|FG002|Overall Study|Withdrawal by Subject|0|||
126449820|NCT01874340|454948192|FG003|Overall Study|Withdrawal by Subject|1|||
126449821|NCT01311024|454948200|FG000|Overall Study|Protocol Violation|35|||
126449822|NCT01311024|454948201|FG001|Overall Study|Protocol Violation|22|||
126449823|NCT01523275|454948202|FG000|Overall Study|Lost to Follow-up|1|||
126449824|NCT01523275|454948203|FG001|Overall Study|Lost to Follow-up|2|||
126449825|NCT01523275|454948202|FG000|Overall Study|Withdrawal by Subject|1|||
126449826|NCT01523275|454948203|FG001|Overall Study|Withdrawal by Subject|0|||
126449827|NCT00689117|454948206|FG000|Overall Study|Adverse Event|6|||
126449828|NCT00689117|454948207|FG001|Overall Study|Adverse Event|0|||
126449829|NCT00689117|454948208|FG002|Overall Study|Adverse Event|5|||
126449830|NCT00689117|454948209|FG003|Overall Study|Adverse Event|0|||
126449831|NCT00689117|454948206|FG000|Overall Study|Lost to Follow-up|26|||
126449832|NCT00689117|454948207|FG001|Overall Study|Lost to Follow-up|19|||
126449833|NCT00689117|454948208|FG002|Overall Study|Lost to Follow-up|17|||
126449834|NCT00689117|454948209|FG003|Overall Study|Lost to Follow-up|11|||
126449835|NCT00689117|454948206|FG000|Overall Study|Lack of Efficacy|1|||
126449836|NCT00689117|454948207|FG001|Overall Study|Lack of Efficacy|2|||
126449837|NCT00689117|454948208|FG002|Overall Study|Lack of Efficacy|2|||
126449838|NCT00689117|454948209|FG003|Overall Study|Lack of Efficacy|2|||
126449839|NCT00689117|454948206|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
126449840|NCT00689117|454948207|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
126449841|NCT00689117|454948208|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
126449842|NCT00689117|454948209|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
126449843|NCT00689117|454948206|FG000|Overall Study|Withdrawal by Subject|19|||
126449844|NCT00689117|454948207|FG001|Overall Study|Withdrawal by Subject|18|||
126449845|NCT00689117|454948208|FG002|Overall Study|Withdrawal by Subject|26|||
126449846|NCT00689117|454948209|FG003|Overall Study|Withdrawal by Subject|13|||
126449847|NCT00689117|454948206|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
126763142|NCT05147311|456084960|FG000|Overall Study|Did not complete survey|2|||
126449848|NCT00689117|454948207|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
126449849|NCT00689117|454948208|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
126449850|NCT00689117|454948209|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
126449851|NCT00689117|454948206|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
126449852|NCT00689117|454948207|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
126449853|NCT00689117|454948208|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126449854|NCT00689117|454948209|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126449855|NCT00689117|454948206|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
126763143|NCT05147311|456084961|FG001|Overall Study|Did not complete survey|1|||
126258242|NCT00631007|454235828|FG002|Overall Study|Other|0|||
126258243|NCT00631007|454235829|FG003|Overall Study|Other|0|||
126258244|NCT00631007|454235830|FG004|Overall Study|Other|1|||
126258245|NCT00631007|454235831|FG005|Overall Study|Other|0|||
126546460|NCT03573908|455293802|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
126546461|NCT03573908|455293803|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
126546462|NCT03573908|455293804|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
126546463|NCT04006925|455293805|FG000|Overall Study|Side effects|2|||
126546464|NCT04006925|455293806|FG001|Overall Study|Side effects|0|||
126546465|NCT02669095|455293811|FG000|Overall Study|Adverse Event|1|||
126546466|NCT02669095|455293812|FG001|Overall Study|Adverse Event|0|||
126546467|NCT02669095|455293811|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
126546468|NCT02669095|455293812|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
126546469|NCT02669095|455293811|FG000|Overall Study|Torn Lens|0|||
126546470|NCT02669095|455293812|FG001|Overall Study|Torn Lens|1|||
126546471|NCT02669095|455293811|FG000|Overall Study|Visit 5 assessments not completed|0|||
126546472|NCT02669095|455293812|FG001|Overall Study|Visit 5 assessments not completed|1|||
126546473|NCT01555164|455293814|FG000|Overall Study|Adverse Event|5|||
126546474|NCT01555164|455293815|FG001|Overall Study|Adverse Event|7|||
126546475|NCT01555164|455293814|FG000|Overall Study|Hyperglycemia|0|||
126546476|NCT01555164|455293815|FG001|Overall Study|Hyperglycemia|1|||
126546477|NCT01555164|455293814|FG000|Overall Study|Investigator's Discretion|2|||
126546478|NCT01555164|455293815|FG001|Overall Study|Investigator's Discretion|2|||
126546479|NCT01555164|455293814|FG000|Overall Study|Lost to Follow-up|4|||
126546480|NCT01555164|455293815|FG001|Overall Study|Lost to Follow-up|3|||
126546481|NCT01555164|455293814|FG000|Overall Study|Protocol Violation|9|||
126546482|NCT01555164|455293815|FG001|Overall Study|Protocol Violation|5|||
126546483|NCT01555164|455293814|FG000|Overall Study|Subject Non-compliance|14|||
126546484|NCT01555164|455293815|FG001|Overall Study|Subject Non-compliance|6|||
126546485|NCT01555164|455293814|FG000|Overall Study|Subject Withdrew Consent|6|||
126546486|NCT01555164|455293815|FG001|Overall Study|Subject Withdrew Consent|11|||
126546487|NCT00926003|455293816|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
126546488|NCT00926003|455293817|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
126546489|NCT00926003|455293818|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
126546490|NCT00926003|455293816|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
126546491|NCT00926003|455293817|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
126546492|NCT00926003|455293818|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
126546493|NCT01396317|455293821|FG000|Overall Study|Adverse Event|1|||
126546494|NCT01396317|455293822|FG001|Overall Study|Adverse Event|0|||
126546495|NCT01709305|455293825|FG000|Phase 1|Clinical Adverse Event|80|||
126546496|NCT01709305|455293826|FG001|Phase 1|Clinical Adverse Event|0|||
126546497|NCT01709305|455293827|FG002|Phase 1|Clinical Adverse Event|0|||
126546498|NCT01709305|455293828|FG003|Phase 1|Clinical Adverse Event|0|||
126546499|NCT01709305|455293829|FG004|Phase 1|Clinical Adverse Event|0|||
126546500|NCT01709305|455293825|FG000|Phase 1|Death|2|||
126546501|NCT01709305|455293826|FG001|Phase 1|Death|0|||
126546502|NCT01709305|455293827|FG002|Phase 1|Death|0|||
126546503|NCT01709305|455293828|FG003|Phase 1|Death|0|||
126258246|NCT00683787|454235832|FG000|Overall Study|Progression|3|||
126258247|NCT00683787|454235833|FG001|Overall Study|Progression|3|||
126258248|NCT00683787|454235834|FG002|Overall Study|Progression|0|||
126258249|NCT00683787|454235832|FG000|Overall Study|Adverse Event|0|||
126258250|NCT00683787|454235833|FG001|Overall Study|Adverse Event|0|||
126258251|NCT00683787|454235834|FG002|Overall Study|Adverse Event|2|||
126258252|NCT02674633|454235835|FG000|Overall Study|Lost to Follow-up|3|||
126258253|NCT02674633|454235836|FG001|Overall Study|Lost to Follow-up|2|||
126258254|NCT02674633|454235835|FG000|Overall Study|Physician Decision|1|||
126258255|NCT02674633|454235836|FG001|Overall Study|Physician Decision|0|||
126258256|NCT02674633|454235835|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126258257|NCT02674633|454235836|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
126258258|NCT00460109|454235837|FG000|Overall Study|Death|1|||
126258259|NCT04167618|454235838|FG000|Overall Study|Trial terminated by sponsor|1|||
126258260|NCT04167618|454235839|FG001|Overall Study|Trial terminated by sponsor|1|||
126258261|NCT05996198|454235840|FG000|Overall Study|Withdrawal by Subject|1|||
126258262|NCT05996198|454235841|FG001|Overall Study|Withdrawal by Subject|0|||
126258263|NCT00835796|454235843|FG000|First Intervention|Withdrawal by Subject|0|||
126546504|NCT01709305|455293829|FG004|Phase 1|Death|0|||
126546505|NCT01709305|455293825|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
126258264|NCT00835796|454235844|FG001|First Intervention|Withdrawal by Subject|1|||
126258265|NCT00651183|454235845|FG000|Overall Study|Lack of Efficacy|1|||
126546506|NCT01709305|455293826|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
126546507|NCT01709305|455293827|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
126258266|NCT00651183|454235846|FG001|Overall Study|Lack of Efficacy|0|||
126258267|NCT00651183|454235845|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
126258268|NCT00651183|454235846|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
126258269|NCT00651183|454235845|FG000|Overall Study|Tolerability insufficient|5|||
126546508|NCT01709305|455293828|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
126546509|NCT01709305|455293829|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
126546510|NCT01709305|455293825|FG000|Phase 1|Laboratory Adverse Event|16|||
126546511|NCT01709305|455293826|FG001|Phase 1|Laboratory Adverse Event|0|||
126546512|NCT01709305|455293827|FG002|Phase 1|Laboratory Adverse Event|0|||
126546513|NCT01709305|455293828|FG003|Phase 1|Laboratory Adverse Event|0|||
126358803|NCT00682435|454605445|FG000|Overall Study|Erroneously enrolled twice|2|||
126358804|NCT00290238|454605446|FG000|Overall Study|Study terminated|27|||
126358805|NCT00290238|454605447|FG001|Overall Study|Study terminated|27|||
126358806|NCT00290238|454605446|FG000|Overall Study|Lost to Follow-up|0|||
126358807|NCT00290238|454605447|FG001|Overall Study|Lost to Follow-up|1|||
126358808|NCT00290238|454605446|FG000|Overall Study|Withdrawal by Subject|15|||
126358809|NCT00290238|454605447|FG001|Overall Study|Withdrawal by Subject|13|||
126358810|NCT06868667|454605448|FG000|Overall Study|Death|0|||
126358811|NCT06868667|454605449|FG001|Overall Study|Death|4|||
126358812|NCT06868667|454605448|FG000|Overall Study|Lost to Follow-up|0|||
126358813|NCT06868667|454605449|FG001|Overall Study|Lost to Follow-up|1|||
126358814|NCT06868667|454605448|FG000|Overall Study|Withdrawal by Subject|1|||
126358815|NCT06868667|454605449|FG001|Overall Study|Withdrawal by Subject|0|||
126358816|NCT06868667|454605448|FG000|Overall Study|Ongoing|9|||
126358817|NCT06868667|454605449|FG001|Overall Study|Ongoing|9|||
126358818|NCT05330429|454605450|FG000|Overall Study|Study Terminated by Sponsor|4|||
126358819|NCT05330429|454605451|FG001|Overall Study|Study Terminated by Sponsor|33|||
126358820|NCT05330429|454605452|FG002|Overall Study|Study Terminated by Sponsor|12|||
126358821|NCT05330429|454605450|FG000|Overall Study|Death|5|||
126358822|NCT05330429|454605451|FG001|Overall Study|Death|2|||
126358823|NCT05330429|454605452|FG002|Overall Study|Death|4|||
126358824|NCT05330429|454605450|FG000|Overall Study|Withdrew Consent|0|||
126358825|NCT05330429|454605451|FG001|Overall Study|Withdrew Consent|5|||
126358826|NCT05330429|454605452|FG002|Overall Study|Withdrew Consent|4|||
126358827|NCT05330429|454605450|FG000|Overall Study|Investigator's Discretion|0|||
126358828|NCT05330429|454605451|FG001|Overall Study|Investigator's Discretion|1|||
126358829|NCT05330429|454605452|FG002|Overall Study|Investigator's Discretion|3|||
126698778|NCT01701258|455848743|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
126698779|NCT01701258|455848744|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
126358830|NCT05330429|454605450|FG000|Overall Study|Subject Decision|1|||
126358831|NCT05330429|454605451|FG001|Overall Study|Subject Decision|2|||
126358832|NCT05330429|454605452|FG002|Overall Study|Subject Decision|0|||
126358833|NCT05330429|454605450|FG000|Overall Study|Lost to Follow-up|0|||
126358834|NCT05330429|454605451|FG001|Overall Study|Lost to Follow-up|1|||
126358835|NCT05330429|454605452|FG002|Overall Study|Lost to Follow-up|0|||
126358836|NCT06097273|454605454|FG000|Overall Study|Death|2|||
126358837|NCT06097273|454605455|FG001|Overall Study|Death|1|||
126358838|NCT06097273|454605456|FG002|Overall Study|Death|2|||
126358839|NCT06097273|454605457|FG003|Overall Study|Death|2|||
126358840|NCT06097273|454605454|FG000|Overall Study|Lost to Follow-up|27|||
126358841|NCT06097273|454605455|FG001|Overall Study|Lost to Follow-up|18|||
126449856|NCT00689117|454948207|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
126449857|NCT00689117|454948208|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
126449858|NCT00689117|454948209|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
126449859|NCT00689117|454948206|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
126449860|NCT00689117|454948207|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
126449861|NCT00689117|454948208|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
126449862|NCT00689117|454948209|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
126449863|NCT00689117|454948206|FG000|Overall Study|Use of Prohibitive Medication|2|||
126449864|NCT00689117|454948207|FG001|Overall Study|Use of Prohibitive Medication|1|||
126449865|NCT00689117|454948208|FG002|Overall Study|Use of Prohibitive Medication|3|||
126449866|NCT00689117|454948209|FG003|Overall Study|Use of Prohibitive Medication|0|||
126449867|NCT00689117|454948206|FG000|Overall Study|Pregnancy|0|||
126449868|NCT00689117|454948207|FG001|Overall Study|Pregnancy|2|||
126449869|NCT00689117|454948208|FG002|Overall Study|Pregnancy|0|||
126449870|NCT00689117|454948209|FG003|Overall Study|Pregnancy|2|||
126698780|NCT01701258|455848745|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
126698781|NCT01701258|455848746|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
126698782|NCT01701258|455848747|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
126358842|NCT06097273|454605456|FG002|Overall Study|Lost to Follow-up|36|||
126358843|NCT06097273|454605457|FG003|Overall Study|Lost to Follow-up|31|||
126358844|NCT06097273|454605454|FG000|Overall Study|Physician Decision|0|||
126358845|NCT06097273|454605455|FG001|Overall Study|Physician Decision|1|||
126358846|NCT06097273|454605456|FG002|Overall Study|Physician Decision|0|||
126358847|NCT06097273|454605457|FG003|Overall Study|Physician Decision|3|||
126358848|NCT06097273|454605454|FG000|Overall Study|Protocol Violation|1|||
126449871|NCT00689117|454948206|FG000|Overall Study|Incarceration|2|||
126698783|NCT01701258|455848748|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
126358849|NCT06097273|454605455|FG001|Overall Study|Protocol Violation|1|||
126358850|NCT06097273|454605456|FG002|Overall Study|Protocol Violation|2|||
126358851|NCT06097273|454605457|FG003|Overall Study|Protocol Violation|1|||
126358852|NCT06097273|454605454|FG000|Overall Study|Withdrawal by Subject|14|||
126358853|NCT06097273|454605455|FG001|Overall Study|Withdrawal by Subject|11|||
126358854|NCT06097273|454605456|FG002|Overall Study|Withdrawal by Subject|14|||
126358855|NCT06097273|454605457|FG003|Overall Study|Withdrawal by Subject|15|||
126358856|NCT06097273|454605454|FG000|Overall Study|Other Than Specified|7|||
126358857|NCT06097273|454605455|FG001|Overall Study|Other Than Specified|3|||
126358858|NCT06097273|454605456|FG002|Overall Study|Other Than Specified|11|||
126258270|NCT00651183|454235846|FG001|Overall Study|Tolerability insufficient|2|||
126258271|NCT00651183|454235845|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
126258272|NCT00651183|454235846|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
126258273|NCT00651183|454235845|FG000|Overall Study|Withdrawal by Subject|6|||
126258274|NCT00651183|454235846|FG001|Overall Study|Withdrawal by Subject|3|||
126258275|NCT00651183|454235845|FG000|Overall Study|Lost to Follow-up|3|||
126258276|NCT00651183|454235846|FG001|Overall Study|Lost to Follow-up|1|||
126258277|NCT00651183|454235845|FG000|Overall Study|Other reasons|4|||
126258278|NCT00651183|454235846|FG001|Overall Study|Other reasons|2|||
126258279|NCT00651183|454235845|FG000|Overall Study|missing|1|||
126258280|NCT00651183|454235846|FG001|Overall Study|missing|0|||
126258281|NCT01363011|454235850|FG000|Main Study|Adverse Event|2|||
126258282|NCT01363011|454235851|FG001|Main Study|Adverse Event|3|||
126258283|NCT01363011|454235850|FG000|Main Study|Investigator's Discretion|1|||
126258284|NCT01363011|454235851|FG001|Main Study|Investigator's Discretion|1|||
126258285|NCT01363011|454235850|FG000|Main Study|Withdrew Consent|1|||
126258286|NCT01363011|454235851|FG001|Main Study|Withdrew Consent|4|||
126258287|NCT01363011|454235850|FG000|Main Study|Protocol Violation|0|||
126258288|NCT01363011|454235851|FG001|Main Study|Protocol Violation|1|||
126258289|NCT01363011|454235850|FG000|Extension Phase|Adverse Event|1|||
126449872|NCT00689117|454948207|FG001|Overall Study|Incarceration|0|||
126449873|NCT00689117|454948208|FG002|Overall Study|Incarceration|0|||
126449874|NCT00689117|454948209|FG003|Overall Study|Incarceration|0|||
126449875|NCT00689117|454948206|FG000|Overall Study|Fear of Birth Defects|0|||
126449876|NCT00689117|454948207|FG001|Overall Study|Fear of Birth Defects|0|||
126449877|NCT00689117|454948208|FG002|Overall Study|Fear of Birth Defects|1|||
126449878|NCT00689117|454948209|FG003|Overall Study|Fear of Birth Defects|0|||
126449879|NCT00689117|454948206|FG000|Overall Study|Transportation|1|||
126449880|NCT00689117|454948207|FG001|Overall Study|Transportation|0|||
126449881|NCT00689117|454948208|FG002|Overall Study|Transportation|0|||
126449882|NCT00689117|454948209|FG003|Overall Study|Transportation|0|||
126449883|NCT00689117|454948206|FG000|Overall Study|Patient Withdrew from Study|0|||
126449884|NCT00689117|454948207|FG001|Overall Study|Patient Withdrew from Study|0|||
126449885|NCT00689117|454948208|FG002|Overall Study|Patient Withdrew from Study|0|||
126449886|NCT00689117|454948209|FG003|Overall Study|Patient Withdrew from Study|1|||
126449887|NCT00689117|454948206|FG000|Overall Study|Personal Reason|0|||
126449888|NCT00689117|454948207|FG001|Overall Study|Personal Reason|1|||
126449889|NCT00689117|454948208|FG002|Overall Study|Personal Reason|0|||
126449890|NCT00689117|454948209|FG003|Overall Study|Personal Reason|0|||
126449891|NCT00689117|454948206|FG000|Overall Study|Dispensing Error|0|||
126449892|NCT00689117|454948207|FG001|Overall Study|Dispensing Error|1|||
126449893|NCT00689117|454948208|FG002|Overall Study|Dispensing Error|0|||
126449894|NCT00689117|454948209|FG003|Overall Study|Dispensing Error|0|||
126449895|NCT01206322|454948210|FG000|Overall Study|Adverse Event|0|||
126449896|NCT01206322|454948211|FG001|Overall Study|Adverse Event|0|||
126449897|NCT01206322|454948212|FG002|Overall Study|Adverse Event|0|||
126449898|NCT01206322|454948213|FG003|Overall Study|Adverse Event|1|||
126449899|NCT01086358|454948216|FG000|First Intervention|Lost to Follow-up|9|||
126449900|NCT01086358|454948217|FG001|First Intervention|Lost to Follow-up|4|||
126449901|NCT01086358|454948216|FG000|First Intervention|Withdrawal by Subject|0|||
126449902|NCT01086358|454948217|FG001|First Intervention|Withdrawal by Subject|1|||
126449903|NCT01086358|454948216|FG000|Second Intervention|Lost to Follow-up|4|||
126449904|NCT01086358|454948217|FG001|Second Intervention|Lost to Follow-up|4|||
126449905|NCT02471612|454948220|FG000|Overall Study|Lost to Follow-up|2|||
126449906|NCT03206788|454948221|FG000|Overall Study|Withdrawal by Subject|0|||
126449907|NCT03206788|454948222|FG001|Overall Study|Withdrawal by Subject|1|||
126449908|NCT03206788|454948221|FG000|Overall Study|Adverse Event|0|||
126258290|NCT01363011|454235851|FG001|Extension Phase|Adverse Event|1|||
126258291|NCT01363011|454235850|FG000|Extension Phase|Lack of Efficacy|0|||
126258292|NCT01363011|454235851|FG001|Extension Phase|Lack of Efficacy|1|||
126258293|NCT01363011|454235850|FG000|Extension Phase|Investigator's Discretion|2|||
126258294|NCT01363011|454235851|FG001|Extension Phase|Investigator's Discretion|2|||
126449909|NCT03206788|454948222|FG001|Overall Study|Adverse Event|1|||
126449910|NCT03206788|454948221|FG000|Overall Study|Physician Decision|0|||
126449911|NCT03206788|454948222|FG001|Overall Study|Physician Decision|1|||
126449912|NCT03899805|454948223|FG000|Overall Study|Physician Decision|3|||
126449913|NCT03899805|454948224|FG001|Overall Study|Physician Decision|0|||
126449914|NCT03899805|454948225|FG002|Overall Study|Physician Decision|2|||
126258295|NCT01363011|454235850|FG000|Extension Phase|Withdrew Consent|0|||
126258296|NCT01363011|454235851|FG001|Extension Phase|Withdrew Consent|1|||
126258297|NCT01363011|454235850|FG000|Extension Phase|Lost to Follow-up|0|||
126258298|NCT01363011|454235851|FG001|Extension Phase|Lost to Follow-up|2|||
126258299|NCT01363011|454235850|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
126258300|NCT01363011|454235851|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
126449915|NCT03899805|454948223|FG000|Overall Study|Withdrawal by Subject|1|||
126449916|NCT03899805|454948224|FG001|Overall Study|Withdrawal by Subject|0|||
126449917|NCT03899805|454948225|FG002|Overall Study|Withdrawal by Subject|2|||
126449918|NCT03899805|454948223|FG000|Overall Study|Progressive Disease|10|||
126258301|NCT04412057|454235852|FG000|Overall Study|Death|3|||
126258302|NCT04412057|454235853|FG001|Overall Study|Death|7|||
126258303|NCT04412057|454235852|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
126258304|NCT04412057|454235853|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
126258305|NCT01961882|454235857|FG000|Overall Study|Adverse Event|3|||
126258306|NCT01961882|454235858|FG001|Overall Study|Adverse Event|2|||
126258307|NCT01961882|454235857|FG000|Overall Study|Physician Decision|1|||
126258308|NCT01961882|454235858|FG001|Overall Study|Physician Decision|0|||
126258309|NCT01961882|454235857|FG000|Overall Study|Withdrawal by Subject|4|||
126258310|NCT01961882|454235858|FG001|Overall Study|Withdrawal by Subject|1|||
126258311|NCT01961882|454235857|FG000|Overall Study|Relapse of AML|39|||
126258312|NCT01961882|454235858|FG001|Overall Study|Relapse of AML|37|||
126258313|NCT01961882|454235857|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
126258314|NCT01961882|454235858|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
126258315|NCT01961882|454235857|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
126258316|NCT01961882|454235858|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
126258317|NCT00407745|454235862|FG000|Overall Study|Lack of Efficacy|1|||
126258318|NCT00407745|454235863|FG001|Overall Study|Lack of Efficacy|2|||
126258319|NCT00407745|454235862|FG000|Overall Study|Withdrawal by Subject|3|||
126258320|NCT00407745|454235863|FG001|Overall Study|Withdrawal by Subject|3|||
126258321|NCT00407745|454235862|FG000|Overall Study|Protocol Violation|5|||
126258322|NCT00407745|454235863|FG001|Overall Study|Protocol Violation|3|||
126258323|NCT00407745|454235862|FG000|Overall Study|Adverse Event|8|||
126258324|NCT00407745|454235863|FG001|Overall Study|Adverse Event|8|||
126258325|NCT00407745|454235862|FG000|Overall Study|Other|2|||
126258326|NCT00407745|454235863|FG001|Overall Study|Other|0|||
126258327|NCT00407745|454235862|FG000|Overall Study|Randomized, unknown if treated|0|||
126258328|NCT00407745|454235863|FG001|Overall Study|Randomized, unknown if treated|1|||
126258329|NCT00108082|454235864|FG000|Overall Study|Adverse Event|14|||
126258330|NCT00108082|454235865|FG001|Overall Study|Adverse Event|12|||
126258331|NCT00108082|454235866|FG002|Overall Study|Adverse Event|17|||
126258332|NCT00108082|454235864|FG000|Overall Study|Lost to Follow-up|6|||
126258333|NCT00108082|454235865|FG001|Overall Study|Lost to Follow-up|3|||
126258334|NCT00108082|454235866|FG002|Overall Study|Lost to Follow-up|7|||
126258335|NCT00108082|454235864|FG000|Overall Study|Consent Withdrawn|3|||
126258336|NCT00108082|454235865|FG001|Overall Study|Consent Withdrawn|3|||
126258337|NCT00108082|454235866|FG002|Overall Study|Consent Withdrawn|5|||
126258338|NCT00108082|454235864|FG000|Overall Study|Protocol Violation|1|||
126258339|NCT00108082|454235865|FG001|Overall Study|Protocol Violation|2|||
126258340|NCT00108082|454235866|FG002|Overall Study|Protocol Violation|0|||
126258341|NCT00108082|454235864|FG000|Overall Study|Lack of Efficacy|3|||
126258342|NCT00108082|454235865|FG001|Overall Study|Lack of Efficacy|1|||
126258343|NCT00108082|454235866|FG002|Overall Study|Lack of Efficacy|2|||
126258344|NCT00108082|454235864|FG000|Overall Study|Amendment 4: > Month 12|5|||
126258345|NCT00108082|454235865|FG001|Overall Study|Amendment 4: > Month 12|7|||
126258346|NCT00108082|454235866|FG002|Overall Study|Amendment 4: > Month 12|5|||
126258347|NCT00108082|454235864|FG000|Overall Study|Woman of Child-bearing Potential|2|||
126258348|NCT00108082|454235865|FG001|Overall Study|Woman of Child-bearing Potential|0|||
126449919|NCT03899805|454948224|FG001|Overall Study|Progressive Disease|18|||
126449920|NCT03899805|454948225|FG002|Overall Study|Progressive Disease|12|||
126449921|NCT03899805|454948223|FG000|Overall Study|Adverse Event|3|||
126449922|NCT03899805|454948224|FG001|Overall Study|Adverse Event|1|||
126449923|NCT03899805|454948225|FG002|Overall Study|Adverse Event|0|||
126449924|NCT03899805|454948223|FG000|Overall Study|Death|2|||
126449925|NCT03899805|454948224|FG001|Overall Study|Death|0|||
126449926|NCT03899805|454948225|FG002|Overall Study|Death|0|||
126449927|NCT03899805|454948223|FG000|Overall Study|Came off for surgery|0|||
126449928|NCT03899805|454948224|FG001|Overall Study|Came off for surgery|0|||
126449929|NCT03899805|454948225|FG002|Overall Study|Came off for surgery|1|||
126449930|NCT03317405|454948226|FG000|Overall Study|Withdrawal by Subject|1|||
126449931|NCT03317405|454948227|FG001|Overall Study|Withdrawal by Subject|0|||
126449932|NCT03317405|454948228|FG002|Overall Study|Withdrawal by Subject|0|||
126449933|NCT03317405|454948226|FG000|Overall Study|Physician Decision|0|||
126449934|NCT03317405|454948227|FG001|Overall Study|Physician Decision|0|||
126449935|NCT03317405|454948228|FG002|Overall Study|Physician Decision|1|||
126449936|NCT03317405|454948226|FG000|Overall Study|Surgery Rescheduled|0|||
126449937|NCT03317405|454948227|FG001|Overall Study|Surgery Rescheduled|1|||
126449938|NCT03317405|454948228|FG002|Overall Study|Surgery Rescheduled|0|||
126449939|NCT00984620|454948231|FG000|Overall Study|Adverse Event|5|||
126449940|NCT00984620|454948232|FG001|Overall Study|Adverse Event|5|||
126449941|NCT00984620|454948231|FG000|Overall Study|Lost to Follow-up|1|||
126449942|NCT00984620|454948232|FG001|Overall Study|Lost to Follow-up|1|||
126449943|NCT00984620|454948231|FG000|Overall Study|Withdrawal by Subject|0|||
126449944|NCT00984620|454948232|FG001|Overall Study|Withdrawal by Subject|2|||
126449945|NCT00984620|454948231|FG000|Overall Study|reason other than listed above|0|||
126449946|NCT00984620|454948232|FG001|Overall Study|reason other than listed above|4|||
126449947|NCT01018810|454948233|FG000|Overall Study|Withdrawal by Subject|0|||
126358859|NCT06097273|454605457|FG003|Overall Study|Other Than Specified|6|||
126358860|NCT03882801|454607282|FG000|Period 1|Adverse Event|0|||
126358861|NCT03882801|454607283|FG001|Period 1|Adverse Event|1|||
126358862|NCT03882801|454607282|FG000|Period 1|Non-compliance with study drug|1|||
126358863|NCT03882801|454607283|FG001|Period 1|Non-compliance with study drug|1|||
126358864|NCT03882801|454607282|FG000|Period 1|Never treated with study drug|1|||
126358865|NCT03882801|454607283|FG001|Period 1|Never treated with study drug|0|||
126358866|NCT03882801|454607282|FG000|Washout Period|Physician Decision|0|||
126358867|NCT03882801|454607283|FG001|Washout Period|Physician Decision|1|||
126358868|NCT03882801|454607282|FG000|Period 2|Non-compliance with study drug|0|||
126358869|NCT03882801|454607283|FG001|Period 2|Non-compliance with study drug|1|||
126358870|NCT03548415|454607287|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
126358871|NCT03548415|454607288|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
126358872|NCT03548415|454607289|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
126358873|NCT03548415|454607290|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
126358874|NCT03548415|454607291|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
126358875|NCT01803737|454607292|FG000|Overall Study|Lack of Time|1|||
126358876|NCT01803737|454607293|FG001|Overall Study|Lack of Time|0|||
126358877|NCT01803737|454607292|FG000|Overall Study|Medical Reason|0|||
126358878|NCT01803737|454607293|FG001|Overall Study|Medical Reason|1|||
126358879|NCT01803737|454607292|FG000|Overall Study|Lost to Follow-up|0|||
126358880|NCT01803737|454607293|FG001|Overall Study|Lost to Follow-up|2|||
126358881|NCT01748552|454607294|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
126358882|NCT01748552|454607295|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
126358883|NCT01748552|454607296|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
126358884|NCT01748552|454607297|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
126358885|NCT01748552|454607298|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
126358886|NCT01748552|454607299|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
126358887|NCT01748552|454607300|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
126449948|NCT01018810|454948234|FG001|Overall Study|Withdrawal by Subject|1|||
126449949|NCT01018810|454948235|FG002|Overall Study|Withdrawal by Subject|0|||
126449950|NCT01018810|454948236|FG003|Overall Study|Withdrawal by Subject|0|||
126449951|NCT01018810|454948237|FG004|Overall Study|Withdrawal by Subject|0|||
126449952|NCT01018810|454948233|FG000|Overall Study|Sponsor Decision|2|||
126449953|NCT01018810|454948234|FG001|Overall Study|Sponsor Decision|0|||
126449954|NCT01018810|454948235|FG002|Overall Study|Sponsor Decision|1|||
126449955|NCT01018810|454948236|FG003|Overall Study|Sponsor Decision|1|||
126449956|NCT01018810|454948237|FG004|Overall Study|Sponsor Decision|1|||
126449957|NCT01640314|454948238|FG000|Overall Study|Protocol Violation|0|||
126449958|NCT01640314|454948239|FG001|Overall Study|Protocol Violation|1|||
126449959|NCT04450381|454948241|FG000|Overall Study|Protocol Violation|4|||
126449960|NCT04450381|454948241|FG000|Overall Study|Wrong device setting|2|||
126449961|NCT02424578|454948242|FG000|Overall Study|Withdrawal by Subject|0|||
126449962|NCT02424578|454948243|FG001|Overall Study|Withdrawal by Subject|1|||
126449963|NCT00470834|454948246|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
126449964|NCT00470834|454948247|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
126449965|NCT00470834|454948246|FG000|Treatment Period (18 Months)|Adverse Event|7|||
126449966|NCT00470834|454948247|FG001|Treatment Period (18 Months)|Adverse Event|6|||
126449967|NCT00470834|454948246|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
126449968|NCT00470834|454948247|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
126449969|NCT00470834|454948246|FG000|Treatment Period (18 Months)|Physician Decision|4|||
126449970|NCT00470834|454948247|FG001|Treatment Period (18 Months)|Physician Decision|4|||
126449971|NCT00470834|454948246|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
126449972|NCT00470834|454948247|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
126449973|NCT00470834|454948246|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
126449974|NCT00470834|454948247|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
126449975|NCT00470834|454948246|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
126449976|NCT00470834|454948247|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
126449977|NCT00470834|454948246|FG000|Treatment Period (18 Months)|Non-compliance|1|||
126449978|NCT00470834|454948247|FG001|Treatment Period (18 Months)|Non-compliance|0|||
126449979|NCT00470834|454948246|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
126449980|NCT00470834|454948247|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
126449981|NCT00470834|454948246|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
126449982|NCT00470834|454948247|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
126449983|NCT00470834|454948246|FG000|Extension Period (24 Months)|Adverse Event|3|||
126449984|NCT00470834|454948247|FG001|Extension Period (24 Months)|Adverse Event|4|||
126449985|NCT00470834|454948246|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
126449986|NCT00470834|454948247|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
126449987|NCT00470834|454948246|FG000|Extension Period (24 Months)|Physician Decision|4|||
126546514|NCT01709305|455293829|FG004|Phase 1|Laboratory Adverse Event|0|||
126358888|NCT01748552|454607301|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
126358889|NCT01748552|454607302|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
126449988|NCT00470834|454948247|FG001|Extension Period (24 Months)|Physician Decision|3|||
126449989|NCT00470834|454948246|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
126449990|NCT00470834|454948247|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
126449991|NCT00470834|454948246|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
126449992|NCT00470834|454948247|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
126546515|NCT01709305|455293825|FG000|Phase 1|Lost to Follow-up|147|||
126546516|NCT01709305|455293826|FG001|Phase 1|Lost to Follow-up|0|||
126546517|NCT01709305|455293827|FG002|Phase 1|Lost to Follow-up|0|||
126546518|NCT01709305|455293828|FG003|Phase 1|Lost to Follow-up|0|||
126546519|NCT01709305|455293829|FG004|Phase 1|Lost to Follow-up|0|||
126546520|NCT01709305|455293825|FG000|Phase 1|Travel, moving, etc.|30|||
126546521|NCT01709305|455293826|FG001|Phase 1|Travel, moving, etc.|0|||
126546522|NCT01709305|455293827|FG002|Phase 1|Travel, moving, etc.|0|||
126546523|NCT01709305|455293828|FG003|Phase 1|Travel, moving, etc.|0|||
126546524|NCT01709305|455293829|FG004|Phase 1|Travel, moving, etc.|0|||
126546525|NCT01709305|455293825|FG000|Phase 1|Physician Decision|13|||
126546526|NCT01709305|455293826|FG001|Phase 1|Physician Decision|0|||
126546527|NCT01709305|455293827|FG002|Phase 1|Physician Decision|0|||
126546528|NCT01709305|455293828|FG003|Phase 1|Physician Decision|0|||
126546529|NCT01709305|455293829|FG004|Phase 1|Physician Decision|0|||
126546530|NCT01709305|455293825|FG000|Phase 1|Protocol Violation|118|||
126546531|NCT01709305|455293826|FG001|Phase 1|Protocol Violation|0|||
126546532|NCT01709305|455293827|FG002|Phase 1|Protocol Violation|0|||
126546533|NCT01709305|455293828|FG003|Phase 1|Protocol Violation|0|||
126546534|NCT01709305|455293829|FG004|Phase 1|Protocol Violation|0|||
126546535|NCT01709305|455293825|FG000|Phase 1|Withdrawal by Subject|218|||
126546536|NCT01709305|455293826|FG001|Phase 1|Withdrawal by Subject|0|||
126546537|NCT01709305|455293827|FG002|Phase 1|Withdrawal by Subject|0|||
126546538|NCT01709305|455293828|FG003|Phase 1|Withdrawal by Subject|0|||
126546539|NCT01709305|455293829|FG004|Phase 1|Withdrawal by Subject|0|||
126546540|NCT01709305|455293825|FG000|Phase 2|Clinical Adverse Event|0|||
126546541|NCT01709305|455293826|FG001|Phase 2|Clinical Adverse Event|10|||
126546542|NCT01709305|455293827|FG002|Phase 2|Clinical Adverse Event|10|||
126546543|NCT01709305|455293828|FG003|Phase 2|Clinical Adverse Event|6|||
126546544|NCT01709305|455293829|FG004|Phase 2|Clinical Adverse Event|11|||
126546545|NCT01709305|455293825|FG000|Phase 2|Death|0|||
126546546|NCT01709305|455293826|FG001|Phase 2|Death|0|||
126546547|NCT01709305|455293827|FG002|Phase 2|Death|1|||
126546548|NCT01709305|455293828|FG003|Phase 2|Death|0|||
126546549|NCT01709305|455293829|FG004|Phase 2|Death|0|||
126258349|NCT00108082|454235866|FG002|Overall Study|Woman of Child-bearing Potential|2|||
126258350|NCT00108082|454235864|FG000|Overall Study|Incorrectly Randomized|0|||
126258351|NCT00108082|454235865|FG001|Overall Study|Incorrectly Randomized|0|||
126449993|NCT00470834|454948246|FG000|Extension Period (24 Months)|Non-compliance|0|||
126449994|NCT00470834|454948247|FG001|Extension Period (24 Months)|Non-compliance|1|||
126449995|NCT00470834|454948246|FG000|Extension Period (24 Months)|Disease Progression|0|||
126449996|NCT00470834|454948247|FG001|Extension Period (24 Months)|Disease Progression|1|||
126449997|NCT04973436|454948251|FG000|Overall Study|Lost to Follow-up|3|||
126449998|NCT04973436|454948251|FG000|Overall Study|Withdrawal by Subject|1|||
126449999|NCT04973436|454948251|FG000|Overall Study|Death|2|||
126450000|NCT02379637|454948261|FG000|Overall Study|Protocol Violation|0|||
126450001|NCT02379637|454948262|FG001|Overall Study|Protocol Violation|1|||
126450002|NCT02379637|454948261|FG000|Overall Study|Adverse Event|1|||
126450003|NCT02379637|454948262|FG001|Overall Study|Adverse Event|0|||
126450004|NCT02379637|454948261|FG000|Overall Study|Withdrawal by Subject|1|||
126450005|NCT02379637|454948262|FG001|Overall Study|Withdrawal by Subject|0|||
126450006|NCT00862641|454948263|FG000|Overall Study|Randomized, but drug not received|1|||
126450007|NCT00862641|454948264|FG001|Overall Study|Randomized, but drug not received|4|||
126258352|NCT00108082|454235866|FG002|Overall Study|Incorrectly Randomized|2|||
126258353|NCT00108082|454235864|FG000|Overall Study|Non-compliance|1|||
126258354|NCT00108082|454235865|FG001|Overall Study|Non-compliance|0|||
126258355|NCT00108082|454235866|FG002|Overall Study|Non-compliance|2|||
126258356|NCT00108082|454235864|FG000|Overall Study|Stopped Study Medication|0|||
126258357|NCT00108082|454235865|FG001|Overall Study|Stopped Study Medication|0|||
126450008|NCT00862641|454948265|FG002|Overall Study|Randomized, but drug not received|1|||
126450009|NCT00862641|454948266|FG003|Overall Study|Randomized, but drug not received|4|||
126546550|NCT01709305|455293825|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
126546551|NCT01709305|455293826|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
126546552|NCT01709305|455293827|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
126546553|NCT01709305|455293828|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
126546554|NCT01709305|455293829|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
126546555|NCT01709305|455293825|FG000|Phase 2|Laboratory Adverse Event|0|||
126546556|NCT01709305|455293826|FG001|Phase 2|Laboratory Adverse Event|1|||
126546557|NCT01709305|455293827|FG002|Phase 2|Laboratory Adverse Event|0|||
126546558|NCT01709305|455293828|FG003|Phase 2|Laboratory Adverse Event|1|||
126546559|NCT01709305|455293829|FG004|Phase 2|Laboratory Adverse Event|1|||
126546560|NCT01709305|455293825|FG000|Phase 2|Lost to Follow-up|0|||
126258358|NCT00108082|454235866|FG002|Overall Study|Stopped Study Medication|1|||
126546561|NCT01709305|455293826|FG001|Phase 2|Lost to Follow-up|10|||
126546562|NCT01709305|455293827|FG002|Phase 2|Lost to Follow-up|6|||
126546563|NCT01709305|455293828|FG003|Phase 2|Lost to Follow-up|9|||
126546564|NCT01709305|455293829|FG004|Phase 2|Lost to Follow-up|5|||
126546565|NCT01709305|455293825|FG000|Phase 2|Travel, moving, etc.|0|||
126546566|NCT01709305|455293826|FG001|Phase 2|Travel, moving, etc.|2|||
126546567|NCT01709305|455293827|FG002|Phase 2|Travel, moving, etc.|3|||
126546568|NCT01709305|455293828|FG003|Phase 2|Travel, moving, etc.|3|||
126546569|NCT01709305|455293829|FG004|Phase 2|Travel, moving, etc.|5|||
126546570|NCT01709305|455293825|FG000|Phase 2|Physician Decision|0|||
126546571|NCT01709305|455293826|FG001|Phase 2|Physician Decision|2|||
126258359|NCT00108082|454235864|FG000|Overall Study|Site Closed Study|0|||
126258360|NCT00108082|454235865|FG001|Overall Study|Site Closed Study|2|||
126258361|NCT00108082|454235866|FG002|Overall Study|Site Closed Study|0|||
126258362|NCT00108082|454235864|FG000|Overall Study|Protocol Amendment|0|||
126258363|NCT00108082|454235865|FG001|Overall Study|Protocol Amendment|1|||
126450010|NCT02365480|454948267|FG000|Overall Study|Withdrawal by Subject|2|||
126450011|NCT02365480|454948268|FG001|Overall Study|Withdrawal by Subject|0|||
126450012|NCT00635999|454948269|FG000|Overall Study|Withdrawal by Subject|4|||
126450013|NCT00635999|454948270|FG001|Overall Study|Withdrawal by Subject|2|||
126450014|NCT00635999|454948271|FG002|Overall Study|Withdrawal by Subject|1|||
126450015|NCT03952039|454948274|FG000|Overall Study|Adverse Event|22|||
126450016|NCT03952039|454948275|FG001|Overall Study|Adverse Event|8|||
126450017|NCT03952039|454948274|FG000|Overall Study|Withdrawal by Participant|17|||
126450018|NCT03952039|454948275|FG001|Overall Study|Withdrawal by Participant|12|||
126450019|NCT03952039|454948274|FG000|Overall Study|Death|13|||
126450020|NCT03952039|454948275|FG001|Overall Study|Death|6|||
126450021|NCT03952039|454948274|FG000|Overall Study|Lack of Efficacy|12|||
126450022|NCT03952039|454948275|FG001|Overall Study|Lack of Efficacy|2|||
126450023|NCT03952039|454948274|FG000|Overall Study|Physician Decision|9|||
126450024|NCT03952039|454948275|FG001|Overall Study|Physician Decision|3|||
126450025|NCT03952039|454948274|FG000|Overall Study|Progressive Disease|6|||
126450026|NCT03952039|454948275|FG001|Overall Study|Progressive Disease|4|||
126546572|NCT01709305|455293827|FG002|Phase 2|Physician Decision|0|||
126546573|NCT01709305|455293828|FG003|Phase 2|Physician Decision|1|||
126546574|NCT01709305|455293829|FG004|Phase 2|Physician Decision|2|||
126546575|NCT01709305|455293825|FG000|Phase 2|Protocol Violation|0|||
126546576|NCT01709305|455293826|FG001|Phase 2|Protocol Violation|19|||
126546577|NCT01709305|455293827|FG002|Phase 2|Protocol Violation|19|||
126546578|NCT01709305|455293828|FG003|Phase 2|Protocol Violation|13|||
126546579|NCT01709305|455293829|FG004|Phase 2|Protocol Violation|9|||
126546580|NCT01709305|455293825|FG000|Phase 2|Withdrawal by Subject|0|||
126546581|NCT01709305|455293826|FG001|Phase 2|Withdrawal by Subject|8|||
126546582|NCT01709305|455293827|FG002|Phase 2|Withdrawal by Subject|6|||
126546583|NCT01709305|455293828|FG003|Phase 2|Withdrawal by Subject|15|||
126546584|NCT01709305|455293829|FG004|Phase 2|Withdrawal by Subject|12|||
126698784|NCT01701258|455848749|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
126698785|NCT01701258|455848750|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
126698786|NCT01701258|455848751|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
126698787|NCT01701258|455848752|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
126698788|NCT01701258|455848740|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
126698789|NCT01701258|455848741|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
126546585|NCT00171873|455293834|FG000|Overall Study|Withdrawal by Subject|4|||
126698790|NCT01701258|455848742|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
126698791|NCT01701258|455848743|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
126450027|NCT03952039|454948274|FG000|Overall Study|Other Reasons|12|||
126450028|NCT03952039|454948275|FG001|Overall Study|Other Reasons|4|||
126450029|NCT05141448|454948278|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
126450030|NCT05141448|454948279|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
126450031|NCT05141448|454948280|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
126450032|NCT05141448|454948281|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
126450033|NCT05141448|454948282|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
126450034|NCT05141448|454948283|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
126450035|NCT05141448|454948278|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
126450036|NCT05141448|454948279|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
126450037|NCT05141448|454948280|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
126546586|NCT00171873|455293835|FG001|Overall Study|Withdrawal by Subject|2|||
126763144|NCT05147311|456084960|FG000|Overall Study|Patient too sick|1|||
126546587|NCT00171873|455293834|FG000|Overall Study|Adverse Event|5|||
126546588|NCT00171873|455293835|FG001|Overall Study|Adverse Event|0|||
126763145|NCT05147311|456084961|FG001|Overall Study|Patient too sick|2|||
126450038|NCT05141448|454948281|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
126546589|NCT00171873|455293834|FG000|Overall Study|Switched to Octreotide|0|||
126546590|NCT00171873|455293835|FG001|Overall Study|Switched to Octreotide|1|||
126546591|NCT00539279|455293836|FG000|Treatment|Withdrawal by Subject|10|||
126698792|NCT01701258|455848744|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
126258364|NCT00108082|454235866|FG002|Overall Study|Protocol Amendment|0|||
126358890|NCT01748552|454607303|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
126358891|NCT01748552|454607304|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
126358892|NCT01748552|454607305|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
126358893|NCT01748552|454607294|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358894|NCT01748552|454607295|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358895|NCT01748552|454607296|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358896|NCT01748552|454607297|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358897|NCT01748552|454607298|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358898|NCT01748552|454607299|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358899|NCT01748552|454607300|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
126358900|NCT01748552|454607301|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
126358901|NCT01748552|454607302|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
126358902|NCT01748552|454607303|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358903|NCT01748552|454607304|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358904|NCT01748552|454607305|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
126358905|NCT00004228|454607308|FG000|Overall Study|Adverse Event|0|||
126358906|NCT00004228|454607309|FG001|Overall Study|Adverse Event|1|||
126358907|NCT00004228|454607310|FG002|Overall Study|Adverse Event|0|||
126358908|NCT00004228|454607311|FG003|Overall Study|Adverse Event|0|||
126358909|NCT00004228|454607312|FG004|Overall Study|Adverse Event|1|||
126358910|NCT00004228|454607313|FG005|Overall Study|Adverse Event|0|||
126358911|NCT00004228|454607314|FG006|Overall Study|Adverse Event|0|||
126358912|NCT00004228|454607308|FG000|Overall Study|Death|0|||
126358913|NCT00004228|454607309|FG001|Overall Study|Death|1|||
126358914|NCT00004228|454607310|FG002|Overall Study|Death|2|||
126358915|NCT00004228|454607311|FG003|Overall Study|Death|0|||
126358916|NCT00004228|454607312|FG004|Overall Study|Death|1|||
126358917|NCT00004228|454607313|FG005|Overall Study|Death|0|||
126358918|NCT00004228|454607314|FG006|Overall Study|Death|0|||
126358919|NCT00004228|454607308|FG000|Overall Study|Lack of Efficacy|1|||
126358920|NCT00004228|454607309|FG001|Overall Study|Lack of Efficacy|6|||
126358921|NCT00004228|454607310|FG002|Overall Study|Lack of Efficacy|5|||
126358922|NCT00004228|454607311|FG003|Overall Study|Lack of Efficacy|3|||
126358923|NCT00004228|454607312|FG004|Overall Study|Lack of Efficacy|9|||
126358924|NCT00004228|454607313|FG005|Overall Study|Lack of Efficacy|8|||
126358925|NCT00004228|454607314|FG006|Overall Study|Lack of Efficacy|4|||
126358926|NCT00004228|454607308|FG000|Overall Study|Lost to Follow-up|0|||
126358927|NCT00004228|454607309|FG001|Overall Study|Lost to Follow-up|0|||
126358928|NCT00004228|454607310|FG002|Overall Study|Lost to Follow-up|1|||
126358929|NCT00004228|454607311|FG003|Overall Study|Lost to Follow-up|0|||
126358930|NCT00004228|454607312|FG004|Overall Study|Lost to Follow-up|0|||
126358931|NCT00004228|454607313|FG005|Overall Study|Lost to Follow-up|0|||
126358932|NCT00004228|454607314|FG006|Overall Study|Lost to Follow-up|0|||
126358933|NCT00004228|454607308|FG000|Overall Study|Physician Decision|1|||
126358934|NCT00004228|454607309|FG001|Overall Study|Physician Decision|0|||
126358935|NCT00004228|454607310|FG002|Overall Study|Physician Decision|3|||
126358936|NCT00004228|454607311|FG003|Overall Study|Physician Decision|2|||
126358937|NCT00004228|454607312|FG004|Overall Study|Physician Decision|1|||
126358938|NCT00004228|454607313|FG005|Overall Study|Physician Decision|1|||
126358939|NCT00004228|454607314|FG006|Overall Study|Physician Decision|1|||
126358940|NCT00004228|454607308|FG000|Overall Study|Protocol Violation|0|||
126358941|NCT00004228|454607309|FG001|Overall Study|Protocol Violation|5|||
126358942|NCT00004228|454607310|FG002|Overall Study|Protocol Violation|2|||
126358943|NCT00004228|454607311|FG003|Overall Study|Protocol Violation|1|||
126358944|NCT00004228|454607312|FG004|Overall Study|Protocol Violation|1|||
126358945|NCT00004228|454607313|FG005|Overall Study|Protocol Violation|2|||
126358946|NCT00004228|454607314|FG006|Overall Study|Protocol Violation|0|||
126358947|NCT00004228|454607308|FG000|Overall Study|Withdrawal by Subject|3|||
126358948|NCT00004228|454607309|FG001|Overall Study|Withdrawal by Subject|0|||
126358949|NCT00004228|454607310|FG002|Overall Study|Withdrawal by Subject|1|||
126358950|NCT00004228|454607311|FG003|Overall Study|Withdrawal by Subject|0|||
126358951|NCT00004228|454607312|FG004|Overall Study|Withdrawal by Subject|2|||
126358952|NCT00004228|454607313|FG005|Overall Study|Withdrawal by Subject|1|||
126358953|NCT00004228|454607314|FG006|Overall Study|Withdrawal by Subject|2|||
126358954|NCT00004228|454607308|FG000|Overall Study|Other|0|||
126358955|NCT00004228|454607309|FG001|Overall Study|Other|0|||
126358956|NCT00004228|454607310|FG002|Overall Study|Other|1|||
126358957|NCT00004228|454607311|FG003|Overall Study|Other|0|||
126358958|NCT00004228|454607312|FG004|Overall Study|Other|0|||
126358959|NCT00004228|454607313|FG005|Overall Study|Other|0|||
126358960|NCT00004228|454607314|FG006|Overall Study|Other|0|||
126358961|NCT00004228|454607308|FG000|Overall Study|ineligible|4|||
126358962|NCT00004228|454607309|FG001|Overall Study|ineligible|2|||
126358963|NCT00004228|454607310|FG002|Overall Study|ineligible|4|||
126358964|NCT00004228|454607311|FG003|Overall Study|ineligible|1|||
126358965|NCT00004228|454607312|FG004|Overall Study|ineligible|1|||
126358966|NCT00004228|454607313|FG005|Overall Study|ineligible|2|||
126358967|NCT00004228|454607314|FG006|Overall Study|ineligible|5|||
126258365|NCT00108082|454235864|FG000|Overall Study|Study Medication Not Tapered|0|||
126258366|NCT00108082|454235865|FG001|Overall Study|Study Medication Not Tapered|1|||
126258367|NCT00108082|454235866|FG002|Overall Study|Study Medication Not Tapered|0|||
126258368|NCT00108082|454235864|FG000|Overall Study|Subject Left Site Location|1|||
126258369|NCT00108082|454235865|FG001|Overall Study|Subject Left Site Location|0|||
126258370|NCT00108082|454235866|FG002|Overall Study|Subject Left Site Location|0|||
126258371|NCT00108082|454235864|FG000|Overall Study|Investigator Not at Site|1|||
126258372|NCT00108082|454235865|FG001|Overall Study|Investigator Not at Site|0|||
126258373|NCT00108082|454235866|FG002|Overall Study|Investigator Not at Site|0|||
126258374|NCT00108082|454235864|FG000|Overall Study|Blood Pressure Not Controlled|1|||
126258375|NCT00108082|454235865|FG001|Overall Study|Blood Pressure Not Controlled|0|||
126258376|NCT00108082|454235866|FG002|Overall Study|Blood Pressure Not Controlled|0|||
126258377|NCT01563237|454235867|FG000|Overall Study|Lost to Follow-up|6|||
126258378|NCT01563237|454235868|FG001|Overall Study|Lost to Follow-up|0|||
126258379|NCT01563237|454235867|FG000|Overall Study|Withdrawal by Subject|1|||
126258380|NCT01563237|454235868|FG001|Overall Study|Withdrawal by Subject|0|||
126258381|NCT01563237|454235867|FG000|Overall Study|Adverse Event|1|||
126258382|NCT01563237|454235868|FG001|Overall Study|Adverse Event|0|||
126258383|NCT01563237|454235867|FG000|Overall Study|Medical Reasons|1|||
126258384|NCT01563237|454235868|FG001|Overall Study|Medical Reasons|0|||
126258385|NCT01563237|454235867|FG000|Overall Study|Death|1|||
126258386|NCT01563237|454235868|FG001|Overall Study|Death|0|||
126258387|NCT02940730|454235874|FG000|Intervention 2|Physician Decision|7|||
126258388|NCT02940730|454235875|FG001|Intervention 2|Physician Decision|0|||
126258389|NCT03036839|454235877|FG000|Overall Study|Adverse Event|0|||
126258390|NCT03036839|454235878|FG001|Overall Study|Adverse Event|0|||
126258391|NCT03036839|454235879|FG002|Overall Study|Adverse Event|1|||
126258392|NCT03036839|454235877|FG000|Overall Study|Death|3|||
126358968|NCT02533674|454607315|FG000|Dose Level I|Progressive disease|1|||
126358969|NCT02533674|454607316|FG001|Dose Level I|Progressive disease|0|||
126358970|NCT02533674|454607317|FG002|Dose Level I|Progressive disease|0|||
126358971|NCT02533674|454607318|FG003|Dose Level I|Progressive disease|0|||
126358972|NCT02533674|454607319|FG004|Dose Level I|Progressive disease|0|||
126358973|NCT02533674|454607320|FG005|Dose Level I|Progressive disease|0|||
126358974|NCT02533674|454607321|FG006|Dose Level I|Progressive disease|0|||
126258393|NCT03036839|454235878|FG001|Overall Study|Death|0|||
126258394|NCT03036839|454235879|FG002|Overall Study|Death|3|||
126258395|NCT03036839|454235877|FG000|Overall Study|Withdrew Consent|0|||
126358975|NCT02533674|454607322|FG007|Dose Level I|Progressive disease|0|||
126358976|NCT02533674|454607315|FG000|Dose Level I|Withdrawal by Subject|1|||
126358977|NCT02533674|454607316|FG001|Dose Level I|Withdrawal by Subject|0|||
126358978|NCT02533674|454607317|FG002|Dose Level I|Withdrawal by Subject|0|||
126358979|NCT02533674|454607318|FG003|Dose Level I|Withdrawal by Subject|0|||
126358980|NCT02533674|454607319|FG004|Dose Level I|Withdrawal by Subject|0|||
126358981|NCT02533674|454607320|FG005|Dose Level I|Withdrawal by Subject|0|||
126358982|NCT02533674|454607321|FG006|Dose Level I|Withdrawal by Subject|0|||
126358983|NCT02533674|454607322|FG007|Dose Level I|Withdrawal by Subject|0|||
126358984|NCT02533674|454607315|FG000|Dose Level I|Physician Decision|1|||
126358985|NCT02533674|454607316|FG001|Dose Level I|Physician Decision|0|||
126358986|NCT02533674|454607317|FG002|Dose Level I|Physician Decision|0|||
126358987|NCT02533674|454607318|FG003|Dose Level I|Physician Decision|0|||
126358988|NCT02533674|454607319|FG004|Dose Level I|Physician Decision|0|||
126358989|NCT02533674|454607320|FG005|Dose Level I|Physician Decision|0|||
126358990|NCT02533674|454607321|FG006|Dose Level I|Physician Decision|0|||
126358991|NCT02533674|454607322|FG007|Dose Level I|Physician Decision|0|||
126358992|NCT02533674|454607315|FG000|Dose Level I|Death|1|||
126358993|NCT02533674|454607316|FG001|Dose Level I|Death|0|||
126358994|NCT02533674|454607317|FG002|Dose Level I|Death|0|||
126358995|NCT02533674|454607318|FG003|Dose Level I|Death|0|||
126358996|NCT02533674|454607319|FG004|Dose Level I|Death|0|||
126358997|NCT02533674|454607320|FG005|Dose Level I|Death|0|||
126358998|NCT02533674|454607321|FG006|Dose Level I|Death|0|||
126358999|NCT02533674|454607322|FG007|Dose Level I|Death|0|||
126359000|NCT02533674|454607315|FG000|Dose Level I|Never Treated|1|||
126359001|NCT02533674|454607316|FG001|Dose Level I|Never Treated|0|||
126359002|NCT02533674|454607317|FG002|Dose Level I|Never Treated|0|||
126359003|NCT02533674|454607318|FG003|Dose Level I|Never Treated|0|||
126359004|NCT02533674|454607319|FG004|Dose Level I|Never Treated|0|||
126546592|NCT00539279|455293837|FG001|Treatment|Withdrawal by Subject|8|||
126359005|NCT02533674|454607320|FG005|Dose Level I|Never Treated|0|||
126359006|NCT02533674|454607321|FG006|Dose Level I|Never Treated|0|||
126359007|NCT02533674|454607322|FG007|Dose Level I|Never Treated|0|||
126359008|NCT02533674|454607315|FG000|Dose Level II|Progressive disease|0|||
126258396|NCT03036839|454235878|FG001|Overall Study|Withdrew Consent|0|||
126258397|NCT03036839|454235879|FG002|Overall Study|Withdrew Consent|1|||
126258398|NCT00412737|454235881|FG000|Overall Study|Death|1|||
126258399|NCT00412737|454235882|FG001|Overall Study|Death|0|||
126258400|NCT00412737|454235881|FG000|Overall Study|Adverse Event|3|||
126258401|NCT00412737|454235882|FG001|Overall Study|Adverse Event|2|||
126258402|NCT00412737|454235881|FG000|Overall Study|Refused Treatment|6|||
126698793|NCT01701258|455848745|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
126698794|NCT01701258|455848746|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
126450039|NCT05141448|454948282|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
126450040|NCT05141448|454948283|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
126450041|NCT05141448|454948278|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
126450042|NCT05141448|454948279|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
126450043|NCT05141448|454948280|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
126450044|NCT05141448|454948281|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
126450045|NCT05141448|454948282|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
126450046|NCT05141448|454948283|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
126450047|NCT05141448|454948278|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
126450048|NCT05141448|454948279|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
126450049|NCT05141448|454948280|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
126450050|NCT05141448|454948281|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
126450051|NCT05141448|454948282|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
126450052|NCT05141448|454948283|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
126450053|NCT05141448|454948278|FG000|Period 2|COVID-19 Related|0|||
126450054|NCT05141448|454948279|FG001|Period 2|COVID-19 Related|0|||
126450055|NCT05141448|454948280|FG002|Period 2|COVID-19 Related|0|||
126450056|NCT05141448|454948281|FG003|Period 2|COVID-19 Related|1|||
126450057|NCT05141448|454948282|FG004|Period 2|COVID-19 Related|0|||
126450058|NCT05141448|454948283|FG005|Period 2|COVID-19 Related|1|||
126450059|NCT05141448|454948278|FG000|3|Covid-19 related|2|||
126450060|NCT05141448|454948279|FG001|3|Covid-19 related|0|||
126450061|NCT05141448|454948280|FG002|3|Covid-19 related|0|||
126450062|NCT05141448|454948281|FG003|3|Covid-19 related|0|||
126450063|NCT05141448|454948282|FG004|3|Covid-19 related|0|||
126450064|NCT05141448|454948283|FG005|3|Covid-19 related|1|||
126450065|NCT05141448|454948278|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
126450066|NCT05141448|454948279|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
126450067|NCT05141448|454948280|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
126450068|NCT05141448|454948281|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
126450069|NCT05141448|454948282|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
126450070|NCT05141448|454948283|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
126450071|NCT04627285|454948284|FG000|Overall Study|Adverse Event|0|||
126450072|NCT04627285|454948285|FG001|Overall Study|Adverse Event|2|||
126450073|NCT04627285|454948284|FG000|Overall Study|Lost to Follow-up|1|||
126450074|NCT04627285|454948285|FG001|Overall Study|Lost to Follow-up|0|||
126450075|NCT04627285|454948284|FG000|Overall Study|Withdrawal by Subject|1|||
126450076|NCT04627285|454948285|FG001|Overall Study|Withdrawal by Subject|1|||
126450077|NCT04627285|454948284|FG000|Overall Study|Sponsor decision|5|||
126450078|NCT04627285|454948285|FG001|Overall Study|Sponsor decision|0|||
126450079|NCT04627285|454948284|FG000|Overall Study|Participant left country; aunt informed the site|0|||
126450080|NCT04627285|454948285|FG001|Overall Study|Participant left country; aunt informed the site|1|||
126450081|NCT03703297|454948286|FG000|Overall Study|Death|115|||
126450082|NCT03703297|454948287|FG001|Overall Study|Death|0|||
126450083|NCT03703297|454948288|FG002|Overall Study|Death|144|||
126450084|NCT03703297|454948286|FG000|Overall Study|Withdrawal by Subject|9|||
126450085|NCT03703297|454948287|FG001|Overall Study|Withdrawal by Subject|0|||
126450086|NCT03703297|454948288|FG002|Overall Study|Withdrawal by Subject|11|||
126450087|NCT03703297|454948286|FG000|Overall Study|Ongoing at the time of DCO|140|||
126450088|NCT03703297|454948287|FG001|Overall Study|Ongoing at the time of DCO|200|||
126450089|NCT03703297|454948288|FG002|Overall Study|Ongoing at the time of DCO|111|||
126450090|NCT01217307|454950538|FG000|Overall Study|Withdrawal by Subject|0|||
126450091|NCT01217307|454950539|FG001|Overall Study|Withdrawal by Subject|1|||
126450092|NCT01754402|454950540|FG000|Overall Study|Death|0|||
126450093|NCT01754402|454950541|FG001|Overall Study|Death|0|||
126450094|NCT01754402|454950542|FG002|Overall Study|Death|1|||
126450095|NCT01754402|454950540|FG000|Overall Study|Adverse Event|2|||
126450096|NCT01754402|454950541|FG001|Overall Study|Adverse Event|2|||
126450097|NCT01754402|454950542|FG002|Overall Study|Adverse Event|1|||
126450098|NCT01754402|454950540|FG000|Overall Study|Withdrawal by Subject|0|||
126450099|NCT01754402|454950541|FG001|Overall Study|Withdrawal by Subject|0|||
126450100|NCT01754402|454950542|FG002|Overall Study|Withdrawal by Subject|1|||
126450101|NCT01754402|454950540|FG000|Overall Study|Lack of Efficacy|0|||
126450102|NCT01754402|454950541|FG001|Overall Study|Lack of Efficacy|0|||
126698795|NCT01701258|455848747|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
126450103|NCT01754402|454950542|FG002|Overall Study|Lack of Efficacy|1|||
126450104|NCT01282463|454950543|FG000|Overall Study|Lost to Follow-up|1|||
126546593|NCT00539279|455293836|FG000|Treatment|Death|1|||
126698796|NCT01701258|455848748|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
126698797|NCT01701258|455848749|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
126450105|NCT01282463|454950544|FG001|Overall Study|Lost to Follow-up|0|||
126546594|NCT00539279|455293837|FG001|Treatment|Death|0|||
126698798|NCT01701258|455848750|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
126698799|NCT01701258|455848751|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
126698800|NCT01701258|455848752|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
126359009|NCT02533674|454607316|FG001|Dose Level II|Progressive disease|3|||
126359010|NCT02533674|454607317|FG002|Dose Level II|Progressive disease|0|||
126359011|NCT02533674|454607318|FG003|Dose Level II|Progressive disease|0|||
126359012|NCT02533674|454607319|FG004|Dose Level II|Progressive disease|0|||
126359013|NCT02533674|454607320|FG005|Dose Level II|Progressive disease|0|||
126359014|NCT02533674|454607321|FG006|Dose Level II|Progressive disease|0|||
126359015|NCT02533674|454607322|FG007|Dose Level II|Progressive disease|0|||
126359016|NCT02533674|454607315|FG000|Dose Level II|Withdrawal by Subject|0|||
126359017|NCT02533674|454607316|FG001|Dose Level II|Withdrawal by Subject|1|||
126359018|NCT02533674|454607317|FG002|Dose Level II|Withdrawal by Subject|0|||
126359019|NCT02533674|454607318|FG003|Dose Level II|Withdrawal by Subject|0|||
126359020|NCT02533674|454607319|FG004|Dose Level II|Withdrawal by Subject|0|||
126359021|NCT02533674|454607320|FG005|Dose Level II|Withdrawal by Subject|0|||
126359022|NCT02533674|454607321|FG006|Dose Level II|Withdrawal by Subject|0|||
126359023|NCT02533674|454607322|FG007|Dose Level II|Withdrawal by Subject|0|||
126698801|NCT01701258|455848740|FG000|Assessment and Scheduling|Investigator Terminated|2|||
126698802|NCT01701258|455848741|FG001|Assessment and Scheduling|Investigator Terminated|0|||
126698803|NCT01701258|455848742|FG002|Assessment and Scheduling|Investigator Terminated|0|||
126698804|NCT01701258|455848743|FG003|Assessment and Scheduling|Investigator Terminated|0|||
126698805|NCT01701258|455848744|FG004|Assessment and Scheduling|Investigator Terminated|0|||
126698806|NCT01701258|455848745|FG005|Assessment and Scheduling|Investigator Terminated|0|||
126698807|NCT01701258|455848746|FG006|Assessment and Scheduling|Investigator Terminated|0|||
126698808|NCT01701258|455848747|FG007|Assessment and Scheduling|Investigator Terminated|0|||
126698809|NCT01701258|455848748|FG008|Assessment and Scheduling|Investigator Terminated|0|||
126698810|NCT01701258|455848749|FG009|Assessment and Scheduling|Investigator Terminated|0|||
126698811|NCT01701258|455848750|FG010|Assessment and Scheduling|Investigator Terminated|0|||
126698812|NCT01701258|455848751|FG011|Assessment and Scheduling|Investigator Terminated|0|||
126698813|NCT01701258|455848752|FG012|Assessment and Scheduling|Investigator Terminated|0|||
126698814|NCT02429856|455848755|FG000|Overall Study|Death|12|||
126698815|NCT02429856|455848756|FG001|Overall Study|Death|13|||
126698816|NCT02429856|455848755|FG000|Overall Study|Lost to Follow-up|6|||
126698817|NCT02429856|455848756|FG001|Overall Study|Lost to Follow-up|5|||
126698818|NCT02429856|455848755|FG000|Overall Study|Withdrawal by Subject|1|||
126698819|NCT02429856|455848756|FG001|Overall Study|Withdrawal by Subject|1|||
126698820|NCT01451645|455848765|FG000|Overall Study|Protocol Violation|1|||
126698821|NCT01451645|455848766|FG001|Overall Study|Protocol Violation|0|||
126698822|NCT01451645|455848765|FG000|Overall Study|Adverse Event|0|||
126698823|NCT01451645|455848766|FG001|Overall Study|Adverse Event|3|||
126698824|NCT01451645|455848765|FG000|Overall Study|Withdrawal by Subject|4|||
126698825|NCT01451645|455848766|FG001|Overall Study|Withdrawal by Subject|2|||
126698826|NCT01451645|455848765|FG000|Overall Study|Lost to Follow-up|4|||
126698827|NCT01451645|455848766|FG001|Overall Study|Lost to Follow-up|3|||
126698828|NCT03663166|455848767|FG000|Overall Study|Withdrawal by Subject|1|||
126698829|NCT01686568|455848768|FG000|Main Study|Withdrawal by Subject|1|||
126698830|NCT01686568|455848769|FG001|Main Study|Withdrawal by Subject|3|||
126698831|NCT01686568|455848768|FG000|Main Study|Noncompliance with protocol|0|||
126698832|NCT01686568|455848769|FG001|Main Study|Noncompliance with protocol|1|||
126698833|NCT01686568|455848768|FG000|Main Study|Liver enzymes above range of exclusion|1|||
126698834|NCT01686568|455848769|FG001|Main Study|Liver enzymes above range of exclusion|0|||
126698835|NCT01686568|455848768|FG000|Sub-Study|Not consented for sub-study|2|||
126698836|NCT01686568|455848769|FG001|Sub-Study|Not consented for sub-study|2|||
126698837|NCT02978222|455848770|FG000|Overall Study|Withdrawal by Subject|2|||
126698838|NCT02978222|455848771|FG001|Overall Study|Withdrawal by Subject|2|||
126698839|NCT02978222|455848770|FG000|Overall Study|Physician Decision|2|||
126698840|NCT02978222|455848771|FG001|Overall Study|Physician Decision|0|||
126698841|NCT02978222|455848770|FG000|Overall Study|Adverse Event|0|||
126698842|NCT02978222|455848771|FG001|Overall Study|Adverse Event|1|||
126698843|NCT02978222|455848770|FG000|Overall Study|Death|1|||
126698844|NCT02978222|455848771|FG001|Overall Study|Death|0|||
126698845|NCT02978222|455848770|FG000|Overall Study|Disease Progression|32|||
126698846|NCT02978222|455848771|FG001|Overall Study|Disease Progression|32|||
126698847|NCT02978222|455848770|FG000|Overall Study|Early Study Termination|24|||
126698848|NCT02978222|455848771|FG001|Overall Study|Early Study Termination|21|||
126359024|NCT02533674|454607315|FG000|Dose Level II|Treatment-related AE|0|||
126359025|NCT02533674|454607316|FG001|Dose Level II|Treatment-related AE|1|||
126698849|NCT02868892|455848776|FG000|Overall Study|Investigator left site and no follow-up|6|||
126698850|NCT02393209|455848780|FG000|Overall Study|Study Terminated by Sponsor|1|||
126698851|NCT02393209|455848781|FG001|Overall Study|Study Terminated by Sponsor|1|||
126698852|NCT02393209|455848782|FG002|Overall Study|Study Terminated by Sponsor|0|||
126359026|NCT02533674|454607317|FG002|Dose Level II|Treatment-related AE|0|||
126546595|NCT00539279|455293836|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
126359027|NCT02533674|454607318|FG003|Dose Level II|Treatment-related AE|0|||
126359028|NCT02533674|454607319|FG004|Dose Level II|Treatment-related AE|0|||
126698853|NCT02393209|455848783|FG003|Overall Study|Study Terminated by Sponsor|0|||
126698854|NCT02393209|455848780|FG000|Overall Study|Withdrawal by Patient|1|||
126698855|NCT02393209|455848781|FG001|Overall Study|Withdrawal by Patient|0|||
126698856|NCT02393209|455848782|FG002|Overall Study|Withdrawal by Patient|0|||
126698857|NCT02393209|455848783|FG003|Overall Study|Withdrawal by Patient|0|||
126698858|NCT02393209|455848780|FG000|Overall Study|Death|2|||
126698859|NCT02393209|455848781|FG001|Overall Study|Death|2|||
126698860|NCT02393209|455848782|FG002|Overall Study|Death|0|||
126698861|NCT02393209|455848783|FG003|Overall Study|Death|0|||
126698862|NCT02393209|455848780|FG000|Overall Study|Death due to Disease Progression|2|||
126698863|NCT02393209|455848781|FG001|Overall Study|Death due to Disease Progression|2|||
126698864|NCT02393209|455848782|FG002|Overall Study|Death due to Disease Progression|0|||
126698865|NCT02393209|455848783|FG003|Overall Study|Death due to Disease Progression|0|||
126698866|NCT02393209|455848780|FG000|Overall Study|Death from Legionella Infection|0|||
126698867|NCT02393209|455848781|FG001|Overall Study|Death from Legionella Infection|1|||
126698868|NCT02393209|455848782|FG002|Overall Study|Death from Legionella Infection|0|||
126698869|NCT02393209|455848783|FG003|Overall Study|Death from Legionella Infection|0|||
126698870|NCT02393209|455848780|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
126698871|NCT02393209|455848781|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
126698872|NCT02393209|455848782|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
126698873|NCT02393209|455848783|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
126698874|NCT02393209|455848780|FG000|Overall Study|Lost to Follow-up|0|||
126698875|NCT02393209|455848781|FG001|Overall Study|Lost to Follow-up|1|||
126698876|NCT02393209|455848782|FG002|Overall Study|Lost to Follow-up|0|||
126698877|NCT02393209|455848783|FG003|Overall Study|Lost to Follow-up|0|||
126698878|NCT00619957|455848784|FG000|Month 24 Double-Blind|Adverse Event|9|||
126698879|NCT00619957|455848785|FG001|Month 24 Double-Blind|Adverse Event|7|||
126698880|NCT00619957|455848784|FG000|Month 24 Double-Blind|Protocol Violation|1|||
126698881|NCT00619957|455848785|FG001|Month 24 Double-Blind|Protocol Violation|0|||
126698882|NCT00619957|455848784|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
126698883|NCT00619957|455848785|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
126698884|NCT00619957|455848784|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
126698885|NCT00619957|455848785|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
126698886|NCT00619957|455848784|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
126698887|NCT00619957|455848785|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
126698888|NCT00619957|455848784|FG000|Month 48 Open-Label|Adverse Event|4|||
126698889|NCT00619957|455848785|FG001|Month 48 Open-Label|Adverse Event|4|||
126698890|NCT00619957|455848784|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
126698891|NCT00619957|455848785|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
126698892|NCT00619957|455848784|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
126698893|NCT00619957|455848785|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
126698894|NCT03545282|455848786|FG000|Overall Study|Lost to Follow-up|15|||
126698895|NCT03545282|455848787|FG001|Overall Study|Lost to Follow-up|10|||
126698896|NCT03545282|455848786|FG000|Overall Study|Withdrawal by Subject|2|||
126698897|NCT03545282|455848787|FG001|Overall Study|Withdrawal by Subject|2|||
126698898|NCT00755079|455848788|FG000|Overall Study|Lost to Follow-up|1|||
126698899|NCT00755079|455848789|FG001|Overall Study|Lost to Follow-up|3|||
126698900|NCT00755079|455848788|FG000|Overall Study|Adverse Event|0|||
126698901|NCT00755079|455848789|FG001|Overall Study|Adverse Event|1|||
126698902|NCT00755079|455848788|FG000|Overall Study|Withdrawal by Subject|0|||
126698903|NCT00755079|455848789|FG001|Overall Study|Withdrawal by Subject|2|||
126698904|NCT00868790|455848790|FG000|Period 1|Adverse Event|1|||
126698905|NCT00868790|455848791|FG001|Period 1|Adverse Event|0|||
126698906|NCT00868790|455848792|FG002|Period 1|Adverse Event|0|||
126698907|NCT00868790|455848793|FG003|Period 1|Adverse Event|0|||
126698908|NCT00868790|455848794|FG004|Period 1|Adverse Event|0|||
126698909|NCT00868790|455848795|FG005|Period 1|Adverse Event|0|||
126698910|NCT00868790|455848796|FG006|Period 1|Adverse Event|0|||
126698911|NCT00868790|455848797|FG007|Period 1|Adverse Event|3|||
126698912|NCT00868790|455848798|FG008|Period 1|Adverse Event|1|||
126698913|NCT00868790|455848799|FG009|Period 1|Adverse Event|0|||
126698914|NCT00868790|455848800|FG010|Period 1|Adverse Event|0|||
126698915|NCT00868790|455848801|FG011|Period 1|Adverse Event|0|||
126698916|NCT00868790|455848802|FG012|Period 1|Adverse Event|0|||
126698917|NCT00868790|455848803|FG013|Period 1|Adverse Event|1|||
126698918|NCT00868790|455848790|FG000|Period 1|Protocol Violation|1|||
126698919|NCT00868790|455848791|FG001|Period 1|Protocol Violation|0|||
126698920|NCT00868790|455848792|FG002|Period 1|Protocol Violation|0|||
126698921|NCT00868790|455848793|FG003|Period 1|Protocol Violation|0|||
126698922|NCT00868790|455848794|FG004|Period 1|Protocol Violation|0|||
126698923|NCT00868790|455848795|FG005|Period 1|Protocol Violation|0|||
126698924|NCT00868790|455848796|FG006|Period 1|Protocol Violation|0|||
126698925|NCT00868790|455848797|FG007|Period 1|Protocol Violation|0|||
126698926|NCT00868790|455848798|FG008|Period 1|Protocol Violation|0|||
126698927|NCT00868790|455848799|FG009|Period 1|Protocol Violation|0|||
126698928|NCT00868790|455848800|FG010|Period 1|Protocol Violation|0|||
126698929|NCT00868790|455848801|FG011|Period 1|Protocol Violation|0|||
126698930|NCT00868790|455848802|FG012|Period 1|Protocol Violation|0|||
126450106|NCT01282463|454950545|FG002|Overall Study|Lost to Follow-up|0|||
126450107|NCT01282463|454950543|FG000|Overall Study|Withdrawal by Subject|6|||
126450108|NCT01282463|454950544|FG001|Overall Study|Withdrawal by Subject|2|||
126450109|NCT01282463|454950545|FG002|Overall Study|Withdrawal by Subject|3|||
126450110|NCT01282463|454950543|FG000|Overall Study|"Never Treated Death"|0|||
126450111|NCT01282463|454950544|FG001|Overall Study|"Never Treated Death"|1|||
126450112|NCT01282463|454950545|FG002|Overall Study|"Never Treated Death"|0|||
126450113|NCT01282463|454950543|FG000|Overall Study|"Never Treated PD"|0|||
126450114|NCT01282463|454950544|FG001|Overall Study|"Never Treated PD"|1|||
126450115|NCT01282463|454950545|FG002|Overall Study|"Never Treated PD"|0|||
126450116|NCT01282463|454950543|FG000|Overall Study|Protocol Violation|0|||
126450117|NCT01282463|454950544|FG001|Overall Study|Protocol Violation|0|||
126450118|NCT01282463|454950545|FG002|Overall Study|Protocol Violation|1|||
126450119|NCT01282463|454950543|FG000|Overall Study|Physician Decision|1|||
126450120|NCT01282463|454950544|FG001|Overall Study|Physician Decision|0|||
126450121|NCT01282463|454950545|FG002|Overall Study|Physician Decision|0|||
126450122|NCT01221285|454950548|FG000|Overall Study|Withdrawal by Subject|1|||
126450123|NCT01239992|454950549|FG000|Overall Study|Withdrawal by Subject|2|||
126450124|NCT02848729|454950552|FG000|Overall Study|Withdrawal by Subject|1|||
126450125|NCT02848729|454950553|FG001|Overall Study|Withdrawal by Subject|0|||
126450126|NCT02848729|454950552|FG000|Overall Study|Emesis|15|||
126450127|NCT02848729|454950553|FG001|Overall Study|Emesis|11|||
126450128|NCT01904773|454950554|FG000|Screen|Screen failure|3|||
126450129|NCT01904773|454950555|FG001|Screen|Screen failure|0|||
126450130|NCT01904773|454950556|FG002|Screen|Screen failure|0|||
126450131|NCT01904773|454950557|FG003|Screen|Screen failure|0|||
126450132|NCT01904773|454950558|FG004|Screen|Screen failure|0|||
126450133|NCT01904773|454950559|FG005|Screen|Screen failure|0|||
126450134|NCT01904773|454950560|FG006|Screen|Screen failure|0|||
126450135|NCT01904773|454950561|FG007|Screen|Screen failure|0|||
126450136|NCT01904773|454950562|FG008|Screen|Screen failure|0|||
126450137|NCT01904773|454950554|FG000|Screen|Withdrawal by Subject|1|||
126450138|NCT01904773|454950555|FG001|Screen|Withdrawal by Subject|0|||
126450139|NCT01904773|454950556|FG002|Screen|Withdrawal by Subject|0|||
126450140|NCT01904773|454950557|FG003|Screen|Withdrawal by Subject|0|||
126450141|NCT01904773|454950558|FG004|Screen|Withdrawal by Subject|0|||
126450142|NCT01904773|454950559|FG005|Screen|Withdrawal by Subject|0|||
126450143|NCT01904773|454950560|FG006|Screen|Withdrawal by Subject|0|||
126450144|NCT01904773|454950561|FG007|Screen|Withdrawal by Subject|0|||
126450145|NCT01904773|454950562|FG008|Screen|Withdrawal by Subject|0|||
126450146|NCT01904773|454950554|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
126450147|NCT01904773|454950555|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
126450148|NCT01904773|454950556|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
126450149|NCT01904773|454950557|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
126450150|NCT01904773|454950558|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
126450151|NCT01904773|454950559|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
126450152|NCT01904773|454950560|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
126450153|NCT01904773|454950561|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
126450154|NCT01904773|454950562|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
126450155|NCT01904773|454950554|FG000|First Intervention|Adverse Event|0|||
126450156|NCT01904773|454950555|FG001|First Intervention|Adverse Event|0|||
126450157|NCT01904773|454950556|FG002|First Intervention|Adverse Event|0|||
126450158|NCT01904773|454950557|FG003|First Intervention|Adverse Event|0|||
126450159|NCT01904773|454950558|FG004|First Intervention|Adverse Event|0|||
126450160|NCT01904773|454950559|FG005|First Intervention|Adverse Event|0|||
126450161|NCT01904773|454950560|FG006|First Intervention|Adverse Event|1|||
126450162|NCT01904773|454950561|FG007|First Intervention|Adverse Event|0|||
126450163|NCT01904773|454950562|FG008|First Intervention|Adverse Event|0|||
126450164|NCT01904773|454950554|FG000|Placebo Washout First Intervention|Condition worsened|0|||
126450165|NCT01904773|454950555|FG001|Placebo Washout First Intervention|Condition worsened|1|||
126450166|NCT01904773|454950556|FG002|Placebo Washout First Intervention|Condition worsened|0|||
126450167|NCT01904773|454950557|FG003|Placebo Washout First Intervention|Condition worsened|0|||
126450168|NCT01904773|454950558|FG004|Placebo Washout First Intervention|Condition worsened|0|||
126450169|NCT01904773|454950559|FG005|Placebo Washout First Intervention|Condition worsened|0|||
126450170|NCT01904773|454950560|FG006|Placebo Washout First Intervention|Condition worsened|0|||
126450171|NCT01904773|454950561|FG007|Placebo Washout First Intervention|Condition worsened|0|||
126258403|NCT00412737|454235882|FG001|Overall Study|Refused Treatment|2|||
126450172|NCT01904773|454950562|FG008|Placebo Washout First Intervention|Condition worsened|0|||
126450173|NCT01904773|454950554|FG000|Fifth Intervention|Adverse Event|0|||
126450174|NCT01904773|454950555|FG001|Fifth Intervention|Adverse Event|0|||
126450175|NCT01904773|454950556|FG002|Fifth Intervention|Adverse Event|0|||
126450176|NCT01904773|454950557|FG003|Fifth Intervention|Adverse Event|0|||
126450177|NCT01904773|454950558|FG004|Fifth Intervention|Adverse Event|0|||
126450178|NCT01904773|454950559|FG005|Fifth Intervention|Adverse Event|0|||
126450179|NCT01904773|454950560|FG006|Fifth Intervention|Adverse Event|0|||
126450180|NCT01904773|454950561|FG007|Fifth Intervention|Adverse Event|1|||
126450181|NCT01904773|454950562|FG008|Fifth Intervention|Adverse Event|0|||
126258404|NCT00412737|454235881|FG000|Overall Study|Failure to Return|6|||
126258405|NCT00412737|454235882|FG001|Overall Study|Failure to Return|2|||
126258406|NCT01064531|454235884|FG000|Overall Study|Lost to Follow-up|0|||
126258407|NCT01064531|454235885|FG001|Overall Study|Lost to Follow-up|2|||
126258408|NCT01064531|454235884|FG000|Overall Study|Physician Decision|0|||
126258409|NCT01064531|454235885|FG001|Overall Study|Physician Decision|1|||
126450182|NCT01904773|454950554|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
126450183|NCT01904773|454950555|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
126450184|NCT01904773|454950556|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
126258410|NCT01064531|454235884|FG000|Overall Study|Withdrawal by Subject|2|||
126258411|NCT01064531|454235885|FG001|Overall Study|Withdrawal by Subject|2|||
126258412|NCT01064531|454235884|FG000|Overall Study|Revision due to femoral stem loosening|1|||
126258413|NCT01064531|454235885|FG001|Overall Study|Revision due to femoral stem loosening|0|||
126258414|NCT01064531|454235884|FG000|Overall Study|Revision due to dislocation|0|||
126258415|NCT01064531|454235885|FG001|Overall Study|Revision due to dislocation|1|||
126258416|NCT01064531|454235884|FG000|Overall Study|Death|0|||
126258417|NCT01064531|454235885|FG001|Overall Study|Death|1|||
126258418|NCT02618382|454235891|FG000|Overall Study|Physician Decision|1|||
126258419|NCT02618382|454235891|FG000|Overall Study|Withdrawal by Subject|1|||
126258420|NCT02618382|454235891|FG000|Overall Study|Protocol Violation|1|||
126258421|NCT03843125|454235892|FG000|Overall Study|Adverse Event|17|||
126258422|NCT03843125|454235893|FG001|Overall Study|Adverse Event|13|||
126258423|NCT03843125|454235894|FG002|Overall Study|Adverse Event|5|||
126258424|NCT03843125|454235895|FG003|Overall Study|Adverse Event|9|||
126258425|NCT03843125|454235892|FG000|Overall Study|Death|0|||
126258426|NCT03843125|454235893|FG001|Overall Study|Death|6|||
126450185|NCT01904773|454950557|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
126450186|NCT01904773|454950558|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
126450187|NCT01904773|454950559|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
126450188|NCT01904773|454950560|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
126450189|NCT01904773|454950561|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
126450190|NCT01904773|454950562|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
126450191|NCT00220779|454950566|FG000|Overall Study|Adverse Event|1|||
126450192|NCT00220779|454950567|FG001|Overall Study|Adverse Event|0|||
126450193|NCT00220779|454950568|FG002|Overall Study|Adverse Event|0|||
126450194|NCT00220779|454950566|FG000|Overall Study|Withdrawal by Subject|1|||
126450195|NCT00220779|454950567|FG001|Overall Study|Withdrawal by Subject|4|||
126450196|NCT00220779|454950568|FG002|Overall Study|Withdrawal by Subject|1|||
126450197|NCT00220779|454950566|FG000|Overall Study|Non-compliance|1|||
126450198|NCT00220779|454950567|FG001|Overall Study|Non-compliance|0|||
126450199|NCT00220779|454950568|FG002|Overall Study|Non-compliance|0|||
126450200|NCT00220779|454950566|FG000|Overall Study|Too time consuming|1|||
126450201|NCT00220779|454950567|FG001|Overall Study|Too time consuming|0|||
126450202|NCT00220779|454950568|FG002|Overall Study|Too time consuming|0|||
126450203|NCT00220779|454950566|FG000|Overall Study|Pregnancy|0|||
126450204|NCT00220779|454950567|FG001|Overall Study|Pregnancy|0|||
126450205|NCT00220779|454950568|FG002|Overall Study|Pregnancy|2|||
126450206|NCT00220779|454950566|FG000|Overall Study|Lack of Efficacy|3|||
126450207|NCT00220779|454950567|FG001|Overall Study|Lack of Efficacy|0|||
126450208|NCT00220779|454950568|FG002|Overall Study|Lack of Efficacy|1|||
126450209|NCT00791076|454950569|FG000|Overall Study|Study was terminated,PI left institution|8|||
126450210|NCT03390101|454950572|FG000|Weeks 0-12|Withdrawal by Subject|0|||
126450211|NCT03390101|454950573|FG001|Weeks 0-12|Withdrawal by Subject|1|||
126450212|NCT03390101|454950574|FG002|Weeks 0-12|Withdrawal by Subject|1|||
126450213|NCT03390101|454950572|FG000|Weeks 0-12|Lost to Follow-up|0|||
126450214|NCT03390101|454950573|FG001|Weeks 0-12|Lost to Follow-up|1|||
126450215|NCT03390101|454950574|FG002|Weeks 0-12|Lost to Follow-up|0|||
126698931|NCT00868790|455848803|FG013|Period 1|Protocol Violation|0|||
126698932|NCT00868790|455848790|FG000|Period 1|Withdrawal by Subject|0|||
126698933|NCT00868790|455848791|FG001|Period 1|Withdrawal by Subject|1|||
126698934|NCT00868790|455848792|FG002|Period 1|Withdrawal by Subject|0|||
126698935|NCT00868790|455848793|FG003|Period 1|Withdrawal by Subject|0|||
126698936|NCT00868790|455848794|FG004|Period 1|Withdrawal by Subject|0|||
126258427|NCT03843125|454235894|FG002|Overall Study|Death|2|||
126258428|NCT03843125|454235895|FG003|Overall Study|Death|0|||
126450216|NCT03390101|454950572|FG000|Weeks 12-54|Withdrawal by Subject|0|||
126450217|NCT03390101|454950573|FG001|Weeks 12-54|Withdrawal by Subject|3|||
126450218|NCT03390101|454950574|FG002|Weeks 12-54|Withdrawal by Subject|1|||
126450219|NCT03390101|454950572|FG000|Weeks 12-54|Pregnancy|1|||
126450220|NCT03390101|454950573|FG001|Weeks 12-54|Pregnancy|0|||
126450221|NCT03390101|454950574|FG002|Weeks 12-54|Pregnancy|0|||
126258429|NCT03843125|454235892|FG000|Overall Study|Lack of Efficacy|14|||
126258430|NCT03843125|454235893|FG001|Overall Study|Lack of Efficacy|11|||
126258431|NCT03843125|454235894|FG002|Overall Study|Lack of Efficacy|9|||
126258432|NCT03843125|454235895|FG003|Overall Study|Lack of Efficacy|4|||
126450222|NCT03390101|454950572|FG000|Weeks 12-54|Adverse Event|2|||
126450223|NCT03390101|454950573|FG001|Weeks 12-54|Adverse Event|1|||
126450224|NCT03390101|454950574|FG002|Weeks 12-54|Adverse Event|1|||
126450225|NCT00281658|454950579|FG000|Randomized Phase|Adverse Event|0|||
126450226|NCT00281658|454950580|FG001|Randomized Phase|Adverse Event|2|||
126450227|NCT00281658|454950581|FG002|Randomized Phase|Adverse Event|0|||
126450228|NCT00281658|454950582|FG003|Randomized Phase|Adverse Event|0|||
126450229|NCT00281658|454950579|FG000|Randomized Phase|Lost to Follow-up|34|||
126450230|NCT00281658|454950580|FG001|Randomized Phase|Lost to Follow-up|27|||
126450231|NCT00281658|454950581|FG002|Randomized Phase|Lost to Follow-up|0|||
126450232|NCT00281658|454950582|FG003|Randomized Phase|Lost to Follow-up|0|||
126698937|NCT00868790|455848795|FG005|Period 1|Withdrawal by Subject|0|||
126698938|NCT00868790|455848796|FG006|Period 1|Withdrawal by Subject|0|||
126698939|NCT00868790|455848797|FG007|Period 1|Withdrawal by Subject|0|||
126698940|NCT00868790|455848798|FG008|Period 1|Withdrawal by Subject|0|||
126698941|NCT00868790|455848799|FG009|Period 1|Withdrawal by Subject|0|||
126698942|NCT00868790|455848800|FG010|Period 1|Withdrawal by Subject|0|||
126698943|NCT00868790|455848801|FG011|Period 1|Withdrawal by Subject|0|||
126698944|NCT00868790|455848802|FG012|Period 1|Withdrawal by Subject|0|||
126698945|NCT00868790|455848803|FG013|Period 1|Withdrawal by Subject|1|||
126698946|NCT00868790|455848790|FG000|Period 1|Abnormal Triglycerides|0|||
126698947|NCT00868790|455848791|FG001|Period 1|Abnormal Triglycerides|0|||
126698948|NCT00868790|455848792|FG002|Period 1|Abnormal Triglycerides|0|||
126698949|NCT00868790|455848793|FG003|Period 1|Abnormal Triglycerides|0|||
126698950|NCT00868790|455848794|FG004|Period 1|Abnormal Triglycerides|1|||
126698951|NCT00868790|455848795|FG005|Period 1|Abnormal Triglycerides|0|||
126698952|NCT00868790|455848796|FG006|Period 1|Abnormal Triglycerides|0|||
126698953|NCT00868790|455848797|FG007|Period 1|Abnormal Triglycerides|0|||
126698954|NCT00868790|455848798|FG008|Period 1|Abnormal Triglycerides|0|||
126698955|NCT00868790|455848799|FG009|Period 1|Abnormal Triglycerides|0|||
126698956|NCT00868790|455848800|FG010|Period 1|Abnormal Triglycerides|0|||
126698957|NCT00868790|455848801|FG011|Period 1|Abnormal Triglycerides|0|||
126698958|NCT00868790|455848802|FG012|Period 1|Abnormal Triglycerides|0|||
126698959|NCT00868790|455848803|FG013|Period 1|Abnormal Triglycerides|0|||
126698960|NCT00868790|455848790|FG000|Period 1|Lost to Follow-up|0|||
126698961|NCT00868790|455848791|FG001|Period 1|Lost to Follow-up|0|||
126698962|NCT00868790|455848792|FG002|Period 1|Lost to Follow-up|0|||
126698963|NCT00868790|455848793|FG003|Period 1|Lost to Follow-up|0|||
126698964|NCT00868790|455848794|FG004|Period 1|Lost to Follow-up|0|||
126698965|NCT00868790|455848795|FG005|Period 1|Lost to Follow-up|1|||
126698966|NCT00868790|455848796|FG006|Period 1|Lost to Follow-up|0|||
126698967|NCT00868790|455848797|FG007|Period 1|Lost to Follow-up|0|||
126698968|NCT00868790|455848798|FG008|Period 1|Lost to Follow-up|0|||
126698969|NCT00868790|455848799|FG009|Period 1|Lost to Follow-up|0|||
126698970|NCT00868790|455848800|FG010|Period 1|Lost to Follow-up|0|||
126698971|NCT00868790|455848801|FG011|Period 1|Lost to Follow-up|0|||
126698972|NCT00868790|455848802|FG012|Period 1|Lost to Follow-up|0|||
126698973|NCT00868790|455848803|FG013|Period 1|Lost to Follow-up|0|||
126698974|NCT00868790|455848790|FG000|Period 2|Adverse Event|0|||
126698975|NCT00868790|455848791|FG001|Period 2|Adverse Event|0|||
126698976|NCT00868790|455848792|FG002|Period 2|Adverse Event|0|||
126698977|NCT00868790|455848793|FG003|Period 2|Adverse Event|0|||
126698978|NCT00868790|455848794|FG004|Period 2|Adverse Event|0|||
126698979|NCT00868790|455848795|FG005|Period 2|Adverse Event|0|||
126698980|NCT00868790|455848796|FG006|Period 2|Adverse Event|0|||
126698981|NCT00868790|455848797|FG007|Period 2|Adverse Event|0|||
126698982|NCT00868790|455848798|FG008|Period 2|Adverse Event|1|||
126698983|NCT00868790|455848799|FG009|Period 2|Adverse Event|0|||
126698984|NCT00868790|455848800|FG010|Period 2|Adverse Event|0|||
126698985|NCT00868790|455848801|FG011|Period 2|Adverse Event|0|||
126698986|NCT00868790|455848802|FG012|Period 2|Adverse Event|0|||
126698987|NCT00868790|455848803|FG013|Period 2|Adverse Event|0|||
126698988|NCT00868790|455848790|FG000|Period 2|Lost to Follow-up|0|||
126698989|NCT00868790|455848791|FG001|Period 2|Lost to Follow-up|1|||
126698990|NCT00868790|455848792|FG002|Period 2|Lost to Follow-up|0|||
126698991|NCT00868790|455848793|FG003|Period 2|Lost to Follow-up|0|||
126450233|NCT00281658|454950579|FG000|Randomized Phase|Withdrawal by Subject|8|||
126698992|NCT00868790|455848794|FG004|Period 2|Lost to Follow-up|0|||
126698993|NCT00868790|455848795|FG005|Period 2|Lost to Follow-up|1|||
126698994|NCT00868790|455848796|FG006|Period 2|Lost to Follow-up|0|||
126698995|NCT00868790|455848797|FG007|Period 2|Lost to Follow-up|0|||
126450234|NCT00281658|454950580|FG001|Randomized Phase|Withdrawal by Subject|7|||
126450235|NCT00281658|454950581|FG002|Randomized Phase|Withdrawal by Subject|0|||
126698996|NCT00868790|455848798|FG008|Period 2|Lost to Follow-up|0|||
126698997|NCT00868790|455848799|FG009|Period 2|Lost to Follow-up|0|||
126698998|NCT00868790|455848800|FG010|Period 2|Lost to Follow-up|0|||
126698999|NCT00868790|455848801|FG011|Period 2|Lost to Follow-up|0|||
126699000|NCT00868790|455848802|FG012|Period 2|Lost to Follow-up|0|||
126699001|NCT00868790|455848803|FG013|Period 2|Lost to Follow-up|0|||
126699002|NCT00868790|455848790|FG000|Period 2|Withdrawal by Subject|0|||
126699003|NCT00868790|455848791|FG001|Period 2|Withdrawal by Subject|0|||
126699004|NCT00868790|455848792|FG002|Period 2|Withdrawal by Subject|0|||
126699005|NCT00868790|455848793|FG003|Period 2|Withdrawal by Subject|0|||
126699006|NCT00868790|455848794|FG004|Period 2|Withdrawal by Subject|0|||
126546596|NCT00539279|455293837|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
126546597|NCT00539279|455293836|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
126546598|NCT00539279|455293837|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
126546599|NCT01338012|455293842|FG000|Overall Study|Death|4|||
126546600|NCT01338012|455293842|FG000|Overall Study|Study terminated|4|||
126546601|NCT02073097|455293843|FG000|Overall Study|Adverse Event|0|||
126546602|NCT02073097|455293844|FG001|Overall Study|Adverse Event|0|||
126546603|NCT02073097|455293845|FG002|Overall Study|Adverse Event|0|||
126546604|NCT02073097|455293846|FG003|Overall Study|Adverse Event|0|||
126546605|NCT02073097|455293847|FG004|Overall Study|Adverse Event|0|||
126546606|NCT02073097|455293848|FG005|Overall Study|Adverse Event|0|||
126546607|NCT02073097|455293849|FG006|Overall Study|Adverse Event|0|||
126546608|NCT02073097|455293850|FG007|Overall Study|Adverse Event|2|||
126546609|NCT02073097|455293843|FG000|Overall Study|Withdrawal by Subject|0|||
126699007|NCT00868790|455848795|FG005|Period 2|Withdrawal by Subject|0|||
126699008|NCT00868790|455848796|FG006|Period 2|Withdrawal by Subject|0|||
126258433|NCT03843125|454235892|FG000|Overall Study|Lost to Follow-up|3|||
126258434|NCT03843125|454235893|FG001|Overall Study|Lost to Follow-up|4|||
126258435|NCT03843125|454235894|FG002|Overall Study|Lost to Follow-up|0|||
126258436|NCT03843125|454235895|FG003|Overall Study|Lost to Follow-up|2|||
126258437|NCT03843125|454235892|FG000|Overall Study|Other|12|||
126258438|NCT03843125|454235893|FG001|Overall Study|Other|14|||
126258439|NCT03843125|454235894|FG002|Overall Study|Other|3|||
126258440|NCT03843125|454235895|FG003|Overall Study|Other|4|||
126258441|NCT03843125|454235892|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
126258442|NCT03843125|454235893|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
126258443|NCT03843125|454235894|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
126258444|NCT03843125|454235895|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
126258445|NCT03843125|454235892|FG000|Overall Study|Study Terminated by Sponsor|318|||
126258446|NCT03843125|454235893|FG001|Overall Study|Study Terminated by Sponsor|318|||
126258447|NCT03843125|454235894|FG002|Overall Study|Study Terminated by Sponsor|163|||
126258448|NCT03843125|454235895|FG003|Overall Study|Study Terminated by Sponsor|163|||
126258449|NCT03843125|454235892|FG000|Overall Study|Withdrawal by Subject|23|||
126258450|NCT03843125|454235893|FG001|Overall Study|Withdrawal by Subject|12|||
126258451|NCT03843125|454235894|FG002|Overall Study|Withdrawal by Subject|6|||
126258452|NCT03843125|454235895|FG003|Overall Study|Withdrawal by Subject|9|||
126258453|NCT03843125|454235892|FG000|Overall Study|Missing data|0|||
126258454|NCT03843125|454235893|FG001|Overall Study|Missing data|1|||
126258455|NCT03843125|454235894|FG002|Overall Study|Missing data|1|||
126258456|NCT03843125|454235895|FG003|Overall Study|Missing data|0|||
126258457|NCT03173560|454235896|FG000|Overall Study|Death|70|||
126258458|NCT03173560|454235897|FG001|Overall Study|Death|60|||
126258459|NCT03173560|454235896|FG000|Overall Study|Lost to Follow-up|1|||
126258460|NCT03173560|454235897|FG001|Overall Study|Lost to Follow-up|4|||
126258461|NCT03173560|454235896|FG000|Overall Study|Withdrawal by Subject|10|||
126258462|NCT03173560|454235897|FG001|Overall Study|Withdrawal by Subject|5|||
126258463|NCT03173560|454235896|FG000|Overall Study|Other|0|||
126258464|NCT03173560|454235897|FG001|Overall Study|Other|1|||
126546610|NCT02073097|455293844|FG001|Overall Study|Withdrawal by Subject|0|||
126546611|NCT02073097|455293845|FG002|Overall Study|Withdrawal by Subject|0|||
126546612|NCT02073097|455293846|FG003|Overall Study|Withdrawal by Subject|0|||
126546613|NCT02073097|455293847|FG004|Overall Study|Withdrawal by Subject|0|||
126699009|NCT00868790|455848797|FG007|Period 2|Withdrawal by Subject|0|||
126699010|NCT00868790|455848798|FG008|Period 2|Withdrawal by Subject|1|||
126546614|NCT02073097|455293848|FG005|Overall Study|Withdrawal by Subject|0|||
126699011|NCT00868790|455848799|FG009|Period 2|Withdrawal by Subject|0|||
126699012|NCT00868790|455848800|FG010|Period 2|Withdrawal by Subject|0|||
126699013|NCT00868790|455848801|FG011|Period 2|Withdrawal by Subject|0|||
126699014|NCT00868790|455848802|FG012|Period 2|Withdrawal by Subject|0|||
126699015|NCT00868790|455848803|FG013|Period 2|Withdrawal by Subject|1|||
126699016|NCT00868790|455848790|FG000|Period 3|Adverse Event|0|||
126699017|NCT00868790|455848791|FG001|Period 3|Adverse Event|0|||
126546615|NCT02073097|455293849|FG006|Overall Study|Withdrawal by Subject|0|||
126546616|NCT02073097|455293850|FG007|Overall Study|Withdrawal by Subject|2|||
126546617|NCT02073097|455293843|FG000|Overall Study|Death|0|||
126699018|NCT00868790|455848792|FG002|Period 3|Adverse Event|0|||
126699019|NCT00868790|455848793|FG003|Period 3|Adverse Event|0|||
126763146|NCT05147311|456084960|FG000|Overall Study|Death|0|||
126258465|NCT04254809|454235898|FG000|Overall Study|Lost to Follow-up|5|||
126258466|NCT04254809|454235899|FG001|Overall Study|Lost to Follow-up|10|||
126258467|NCT03023137|454235900|FG000|Overall Study|Multiple pregnancy|2|||
126258468|NCT03023137|454235901|FG001|Overall Study|Multiple pregnancy|4|||
126258469|NCT03023137|454235900|FG000|Overall Study|Lost to Follow-up|1|||
126258470|NCT03023137|454235901|FG001|Overall Study|Lost to Follow-up|1|||
126258471|NCT03023137|454235900|FG000|Overall Study|Protocol Violation|0|||
126258472|NCT03023137|454235901|FG001|Overall Study|Protocol Violation|4|||
126258473|NCT03023137|454235900|FG000|Overall Study|Lost the baby in a car accident|1|||
126699020|NCT00868790|455848794|FG004|Period 3|Adverse Event|0|||
126699021|NCT00868790|455848795|FG005|Period 3|Adverse Event|0|||
126699022|NCT00868790|455848796|FG006|Period 3|Adverse Event|0|||
126258474|NCT03023137|454235901|FG001|Overall Study|Lost the baby in a car accident|0|||
126258475|NCT02795676|454235902|FG000|Overall Study|Adverse Event|2|||
126258476|NCT02795676|454235903|FG001|Overall Study|Adverse Event|0|||
126258477|NCT02795676|454235902|FG000|Overall Study|Withdrawal by Subject|3|||
126258478|NCT02795676|454235903|FG001|Overall Study|Withdrawal by Subject|1|||
126258479|NCT02608476|454235904|FG000|Overall Study|Withdrawal by Subject|30|||
126258480|NCT02608476|454235905|FG001|Overall Study|Withdrawal by Subject|37|||
126258481|NCT02608476|454235904|FG000|Overall Study|Lost to Follow-up|24|||
126258482|NCT02608476|454235905|FG001|Overall Study|Lost to Follow-up|24|||
126258483|NCT02608476|454235904|FG000|Overall Study|Adverse Event|2|||
126258484|NCT02608476|454235905|FG001|Overall Study|Adverse Event|8|||
126258485|NCT02608476|454235904|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
126258486|NCT02608476|454235905|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
126258487|NCT02608476|454235904|FG000|Overall Study|Noncompliance with treatment|1|||
126258488|NCT02608476|454235905|FG001|Overall Study|Noncompliance with treatment|5|||
126258489|NCT02608476|454235904|FG000|Overall Study|Lack of Efficacy|3|||
126258490|NCT02608476|454235905|FG001|Overall Study|Lack of Efficacy|1|||
126258491|NCT02608476|454235904|FG000|Overall Study|Other|0|||
126258492|NCT02608476|454235905|FG001|Overall Study|Other|1|||
126258493|NCT02608476|454235904|FG000|Overall Study|Physician Decision|1|||
126258494|NCT02608476|454235905|FG001|Overall Study|Physician Decision|0|||
126258495|NCT02608476|454235904|FG000|Overall Study|Pregnancy|0|||
126258496|NCT02608476|454235905|FG001|Overall Study|Pregnancy|1|||
126258497|NCT02608476|454235904|FG000|Overall Study|Progressive disease|1|||
126258498|NCT02608476|454235905|FG001|Overall Study|Progressive disease|0|||
126258499|NCT00605176|454235906|FG000|Overall Study|Adverse Event|2|||
126258500|NCT00605176|454235907|FG001|Overall Study|Adverse Event|1|||
126258501|NCT00605176|454235908|FG002|Overall Study|Adverse Event|3|||
126258502|NCT00605176|454235906|FG000|Overall Study|Withdrawal by Subject|4|||
126258503|NCT00605176|454235907|FG001|Overall Study|Withdrawal by Subject|2|||
126258504|NCT00605176|454235908|FG002|Overall Study|Withdrawal by Subject|4|||
126258505|NCT00605176|454235906|FG000|Overall Study|Lost to Follow-up|2|||
126258506|NCT00605176|454235907|FG001|Overall Study|Lost to Follow-up|2|||
126258507|NCT00605176|454235908|FG002|Overall Study|Lost to Follow-up|1|||
126450236|NCT00281658|454950582|FG003|Randomized Phase|Withdrawal by Subject|0|||
126450237|NCT00281658|454950579|FG000|Randomized Phase|Study closed/terminated|1|||
126258508|NCT00605176|454235906|FG000|Overall Study|Non-complicance with study procedures|1|||
126258509|NCT00605176|454235907|FG001|Overall Study|Non-complicance with study procedures|0|||
126258510|NCT00605176|454235908|FG002|Overall Study|Non-complicance with study procedures|0|||
126450238|NCT00281658|454950580|FG001|Randomized Phase|Study closed/terminated|1|||
126450239|NCT00281658|454950581|FG002|Randomized Phase|Study closed/terminated|0|||
126450240|NCT00281658|454950582|FG003|Randomized Phase|Study closed/terminated|0|||
126450241|NCT00281658|454950579|FG000|Randomized Phase|Disease progression|36|||
126450242|NCT00281658|454950580|FG001|Randomized Phase|Disease progression|27|||
126450243|NCT00281658|454950581|FG002|Randomized Phase|Disease progression|0|||
126450244|NCT00281658|454950582|FG003|Randomized Phase|Disease progression|0|||
126450245|NCT00281658|454950579|FG000|Randomized Phase|Physician Decision|1|||
126450246|NCT00281658|454950580|FG001|Randomized Phase|Physician Decision|1|||
126450247|NCT00281658|454950581|FG002|Randomized Phase|Physician Decision|0|||
126450248|NCT00281658|454950582|FG003|Randomized Phase|Physician Decision|0|||
126450249|NCT00281658|454950579|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
126450250|NCT00281658|454950580|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
126450251|NCT00281658|454950581|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
126450252|NCT00281658|454950582|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
126450253|NCT00281658|454950579|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
126450254|NCT00281658|454950580|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
126450255|NCT00281658|454950581|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
126450256|NCT00281658|454950582|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
126450257|NCT00281658|454950579|FG000|Randomized Phase|Treatment ongoing|1|||
126450258|NCT00281658|454950580|FG001|Randomized Phase|Treatment ongoing|0|||
126450259|NCT00281658|454950581|FG002|Randomized Phase|Treatment ongoing|0|||
126450260|NCT00281658|454950582|FG003|Randomized Phase|Treatment ongoing|0|||
126699023|NCT00868790|455848797|FG007|Period 3|Adverse Event|0|||
126258511|NCT00605176|454235906|FG000|Overall Study|Use of concomitant therapy|1|||
126258512|NCT00605176|454235907|FG001|Overall Study|Use of concomitant therapy|0|||
126258513|NCT00605176|454235908|FG002|Overall Study|Use of concomitant therapy|1|||
126258514|NCT00605176|454235906|FG000|Overall Study|Other (not due to AE)|1|||
126258515|NCT00605176|454235907|FG001|Overall Study|Other (not due to AE)|1|||
126258516|NCT00605176|454235908|FG002|Overall Study|Other (not due to AE)|0|||
126258517|NCT04253236|454235920|FG000|Overall Study|Adverse Event|1|||
126258518|NCT04253236|454235921|FG001|Overall Study|Adverse Event|0|||
126258519|NCT04253236|454235920|FG000|Overall Study|Safety Concerns|1|||
126450261|NCT00281658|454950579|FG000|Open Label Phase|Adverse Event|0|||
126450262|NCT00281658|454950580|FG001|Open Label Phase|Adverse Event|0|||
126450263|NCT00281658|454950581|FG002|Open Label Phase|Adverse Event|1|||
126450264|NCT00281658|454950582|FG003|Open Label Phase|Adverse Event|0|||
126546618|NCT02073097|455293844|FG001|Overall Study|Death|0|||
126546619|NCT02073097|455293845|FG002|Overall Study|Death|0|||
126546620|NCT02073097|455293846|FG003|Overall Study|Death|0|||
126546621|NCT02073097|455293847|FG004|Overall Study|Death|0|||
126546622|NCT02073097|455293848|FG005|Overall Study|Death|0|||
126546623|NCT02073097|455293849|FG006|Overall Study|Death|0|||
126546624|NCT02073097|455293850|FG007|Overall Study|Death|1|||
126546625|NCT02073097|455293843|FG000|Overall Study|Physician Decision|0|||
126546626|NCT02073097|455293844|FG001|Overall Study|Physician Decision|0|||
126546627|NCT02073097|455293845|FG002|Overall Study|Physician Decision|0|||
126546628|NCT02073097|455293846|FG003|Overall Study|Physician Decision|0|||
126546629|NCT02073097|455293847|FG004|Overall Study|Physician Decision|0|||
126546630|NCT02073097|455293848|FG005|Overall Study|Physician Decision|0|||
126546631|NCT02073097|455293849|FG006|Overall Study|Physician Decision|0|||
126546632|NCT02073097|455293850|FG007|Overall Study|Physician Decision|1|||
126546633|NCT02769065|455295990|FG000|Overall Study|Voluntary Withdrawal|1|||
126546634|NCT02769065|455295991|FG001|Overall Study|Voluntary Withdrawal|0|||
126546635|NCT02769065|455295992|FG002|Overall Study|Voluntary Withdrawal|0|||
126546636|NCT02769065|455295993|FG003|Overall Study|Voluntary Withdrawal|0|||
126546637|NCT02769065|455295994|FG004|Overall Study|Voluntary Withdrawal|0|||
126546638|NCT02769065|455295995|FG005|Overall Study|Voluntary Withdrawal|0|||
126546639|NCT02769065|455295996|FG006|Overall Study|Voluntary Withdrawal|0|||
126546640|NCT02769065|455295997|FG007|Overall Study|Voluntary Withdrawal|0|||
126546641|NCT02769065|455295998|FG008|Overall Study|Voluntary Withdrawal|0|||
126546642|NCT02769065|455295999|FG009|Overall Study|Voluntary Withdrawal|0|||
126699024|NCT00868790|455848798|FG008|Period 3|Adverse Event|0|||
126699025|NCT00868790|455848799|FG009|Period 3|Adverse Event|1|||
126258520|NCT04253236|454235921|FG001|Overall Study|Safety Concerns|0|||
126258521|NCT04253236|454235920|FG000|Overall Study|Study Terminated by Sponsor|1|||
126258522|NCT04253236|454235921|FG001|Overall Study|Study Terminated by Sponsor|0|||
126258523|NCT00587431|454235922|FG000|Overall Study|Adverse Event|1|||
126258524|NCT00587431|454235923|FG001|Overall Study|Adverse Event|0|||
126258525|NCT00587431|454235922|FG000|Overall Study|Withdrawal by Subject|0|||
126258526|NCT00587431|454235923|FG001|Overall Study|Withdrawal by Subject|1|||
126258527|NCT02169791|454235924|FG000|Overall Study|Death|6|||
126359029|NCT02533674|454607320|FG005|Dose Level II|Treatment-related AE|0|||
126359030|NCT02533674|454607321|FG006|Dose Level II|Treatment-related AE|0|||
126359031|NCT02533674|454607322|FG007|Dose Level II|Treatment-related AE|0|||
126359032|NCT02533674|454607315|FG000|Dose Level II|Physician Decision|0|||
126359033|NCT02533674|454607316|FG001|Dose Level II|Physician Decision|1|||
126359034|NCT02533674|454607317|FG002|Dose Level II|Physician Decision|0|||
126359035|NCT02533674|454607318|FG003|Dose Level II|Physician Decision|0|||
126359036|NCT02533674|454607319|FG004|Dose Level II|Physician Decision|0|||
126359037|NCT02533674|454607320|FG005|Dose Level II|Physician Decision|0|||
126359038|NCT02533674|454607321|FG006|Dose Level II|Physician Decision|0|||
126359039|NCT02533674|454607322|FG007|Dose Level II|Physician Decision|0|||
126359040|NCT02533674|454607315|FG000|Dose Level II|Non-treatment-related AE|0|||
126359041|NCT02533674|454607316|FG001|Dose Level II|Non-treatment-related AE|1|||
126359042|NCT02533674|454607317|FG002|Dose Level II|Non-treatment-related AE|0|||
126359043|NCT02533674|454607318|FG003|Dose Level II|Non-treatment-related AE|0|||
126359044|NCT02533674|454607319|FG004|Dose Level II|Non-treatment-related AE|0|||
126359045|NCT02533674|454607320|FG005|Dose Level II|Non-treatment-related AE|0|||
126359046|NCT02533674|454607321|FG006|Dose Level II|Non-treatment-related AE|0|||
126359047|NCT02533674|454607322|FG007|Dose Level II|Non-treatment-related AE|0|||
126359048|NCT02533674|454607315|FG000|Dose Level III|Progressive disease|0|||
126359049|NCT02533674|454607316|FG001|Dose Level III|Progressive disease|0|||
126359050|NCT02533674|454607317|FG002|Dose Level III|Progressive disease|2|||
126359051|NCT02533674|454607318|FG003|Dose Level III|Progressive disease|0|||
126359052|NCT02533674|454607319|FG004|Dose Level III|Progressive disease|0|||
126359053|NCT02533674|454607320|FG005|Dose Level III|Progressive disease|0|||
126359054|NCT02533674|454607321|FG006|Dose Level III|Progressive disease|0|||
126359055|NCT02533674|454607322|FG007|Dose Level III|Progressive disease|0|||
126359056|NCT02533674|454607315|FG000|Dose Level III|Withdrawal by Subject|0|||
126546643|NCT02769065|455296000|FG010|Overall Study|Voluntary Withdrawal|0|||
126359057|NCT02533674|454607316|FG001|Dose Level III|Withdrawal by Subject|0|||
126546644|NCT02769065|455296001|FG011|Overall Study|Voluntary Withdrawal|0|||
126546645|NCT02769065|455296002|FG012|Overall Study|Voluntary Withdrawal|0|||
126546646|NCT02769065|455296003|FG013|Overall Study|Voluntary Withdrawal|0|||
126546647|NCT02769065|455296004|FG014|Overall Study|Voluntary Withdrawal|0|||
126546648|NCT02769065|455296005|FG015|Overall Study|Voluntary Withdrawal|0|||
126699026|NCT00868790|455848800|FG010|Period 3|Adverse Event|0|||
126258528|NCT02169791|454235924|FG000|Overall Study|patient withdrew consent|1|||
126258529|NCT03566238|454235925|FG000|Overall Study|Adverse Event|0|||
126258530|NCT03566238|454235926|FG001|Overall Study|Adverse Event|1|||
126359058|NCT02533674|454607317|FG002|Dose Level III|Withdrawal by Subject|1|||
126359059|NCT02533674|454607318|FG003|Dose Level III|Withdrawal by Subject|0|||
126359060|NCT02533674|454607319|FG004|Dose Level III|Withdrawal by Subject|0|||
126359061|NCT02533674|454607320|FG005|Dose Level III|Withdrawal by Subject|0|||
126359062|NCT02533674|454607321|FG006|Dose Level III|Withdrawal by Subject|0|||
126359063|NCT02533674|454607322|FG007|Dose Level III|Withdrawal by Subject|0|||
126359064|NCT02533674|454607315|FG000|Dose Level III|Treatment-related AE|0|||
126359065|NCT02533674|454607316|FG001|Dose Level III|Treatment-related AE|0|||
126359066|NCT02533674|454607317|FG002|Dose Level III|Treatment-related AE|1|||
126359067|NCT02533674|454607318|FG003|Dose Level III|Treatment-related AE|0|||
126359068|NCT02533674|454607319|FG004|Dose Level III|Treatment-related AE|0|||
126359069|NCT02533674|454607320|FG005|Dose Level III|Treatment-related AE|0|||
126359070|NCT02533674|454607321|FG006|Dose Level III|Treatment-related AE|0|||
126359071|NCT02533674|454607322|FG007|Dose Level III|Treatment-related AE|0|||
126359072|NCT02533674|454607315|FG000|Dose Level IV|Progressive disease|0|||
126359073|NCT02533674|454607316|FG001|Dose Level IV|Progressive disease|0|||
126359074|NCT02533674|454607317|FG002|Dose Level IV|Progressive disease|0|||
126359075|NCT02533674|454607318|FG003|Dose Level IV|Progressive disease|3|||
126359076|NCT02533674|454607319|FG004|Dose Level IV|Progressive disease|0|||
126359077|NCT02533674|454607320|FG005|Dose Level IV|Progressive disease|0|||
126359078|NCT02533674|454607321|FG006|Dose Level IV|Progressive disease|0|||
126359079|NCT02533674|454607322|FG007|Dose Level IV|Progressive disease|0|||
126359080|NCT02533674|454607315|FG000|Dose Level IV|Withdrawal by Subject|0|||
126359081|NCT02533674|454607316|FG001|Dose Level IV|Withdrawal by Subject|0|||
126359082|NCT02533674|454607317|FG002|Dose Level IV|Withdrawal by Subject|0|||
126359083|NCT02533674|454607318|FG003|Dose Level IV|Withdrawal by Subject|1|||
126359084|NCT02533674|454607319|FG004|Dose Level IV|Withdrawal by Subject|0|||
126359085|NCT02533674|454607320|FG005|Dose Level IV|Withdrawal by Subject|0|||
126359086|NCT02533674|454607321|FG006|Dose Level IV|Withdrawal by Subject|0|||
126359087|NCT02533674|454607322|FG007|Dose Level IV|Withdrawal by Subject|0|||
126359088|NCT02533674|454607315|FG000|Dose Level IV|Physician Decision|0|||
126359089|NCT02533674|454607316|FG001|Dose Level IV|Physician Decision|0|||
126359090|NCT02533674|454607317|FG002|Dose Level IV|Physician Decision|0|||
126359091|NCT02533674|454607318|FG003|Dose Level IV|Physician Decision|1|||
126359092|NCT02533674|454607319|FG004|Dose Level IV|Physician Decision|0|||
126359093|NCT02533674|454607320|FG005|Dose Level IV|Physician Decision|0|||
126359094|NCT02533674|454607321|FG006|Dose Level IV|Physician Decision|0|||
126359095|NCT02533674|454607322|FG007|Dose Level IV|Physician Decision|0|||
126359096|NCT02533674|454607315|FG000|Dose Level V|Progressive disease|0|||
126359097|NCT02533674|454607316|FG001|Dose Level V|Progressive disease|0|||
126359098|NCT02533674|454607317|FG002|Dose Level V|Progressive disease|0|||
126359099|NCT02533674|454607318|FG003|Dose Level V|Progressive disease|0|||
126359100|NCT02533674|454607319|FG004|Dose Level V|Progressive disease|3|||
126359101|NCT02533674|454607320|FG005|Dose Level V|Progressive disease|0|||
126359102|NCT02533674|454607321|FG006|Dose Level V|Progressive disease|0|||
126359103|NCT02533674|454607322|FG007|Dose Level V|Progressive disease|0|||
126359104|NCT02533674|454607315|FG000|Dose Level V|Withdrawal by Subject|0|||
126359105|NCT02533674|454607316|FG001|Dose Level V|Withdrawal by Subject|0|||
126359106|NCT02533674|454607317|FG002|Dose Level V|Withdrawal by Subject|0|||
126359107|NCT02533674|454607318|FG003|Dose Level V|Withdrawal by Subject|0|||
126359108|NCT02533674|454607319|FG004|Dose Level V|Withdrawal by Subject|1|||
126359109|NCT02533674|454607320|FG005|Dose Level V|Withdrawal by Subject|0|||
126359110|NCT02533674|454607321|FG006|Dose Level V|Withdrawal by Subject|0|||
126359111|NCT02533674|454607322|FG007|Dose Level V|Withdrawal by Subject|0|||
126359112|NCT02533674|454607315|FG000|Dose Level V|Physician Decision|0|||
126359113|NCT02533674|454607316|FG001|Dose Level V|Physician Decision|0|||
126359114|NCT02533674|454607317|FG002|Dose Level V|Physician Decision|0|||
126359115|NCT02533674|454607318|FG003|Dose Level V|Physician Decision|0|||
126359116|NCT02533674|454607319|FG004|Dose Level V|Physician Decision|1|||
126359117|NCT02533674|454607320|FG005|Dose Level V|Physician Decision|0|||
126359118|NCT02533674|454607321|FG006|Dose Level V|Physician Decision|0|||
126359119|NCT02533674|454607322|FG007|Dose Level V|Physician Decision|0|||
126450265|NCT00281658|454950579|FG000|Open Label Phase|Lost to Follow-up|0|||
126450266|NCT00281658|454950580|FG001|Open Label Phase|Lost to Follow-up|0|||
126450267|NCT00281658|454950581|FG002|Open Label Phase|Lost to Follow-up|16|||
126450268|NCT00281658|454950582|FG003|Open Label Phase|Lost to Follow-up|2|||
126359120|NCT02533674|454607315|FG000|Dose Level VI|Progressive disease|0|||
126450269|NCT00281658|454950579|FG000|Open Label Phase|Withdrawal by Subject|0|||
126359121|NCT02533674|454607316|FG001|Dose Level VI|Progressive disease|0|||
126359122|NCT02533674|454607317|FG002|Dose Level VI|Progressive disease|0|||
126359123|NCT02533674|454607318|FG003|Dose Level VI|Progressive disease|0|||
126359124|NCT02533674|454607319|FG004|Dose Level VI|Progressive disease|0|||
126359125|NCT02533674|454607320|FG005|Dose Level VI|Progressive disease|7|||
126359126|NCT02533674|454607321|FG006|Dose Level VI|Progressive disease|0|||
126359127|NCT02533674|454607322|FG007|Dose Level VI|Progressive disease|0|||
126359128|NCT02533674|454607315|FG000|Dose Level VI|Withdrawal by Subject|0|||
126359129|NCT02533674|454607316|FG001|Dose Level VI|Withdrawal by Subject|0|||
126359130|NCT02533674|454607317|FG002|Dose Level VI|Withdrawal by Subject|0|||
126359131|NCT02533674|454607318|FG003|Dose Level VI|Withdrawal by Subject|0|||
126359132|NCT02533674|454607319|FG004|Dose Level VI|Withdrawal by Subject|0|||
126359133|NCT02533674|454607320|FG005|Dose Level VI|Withdrawal by Subject|1|||
126450270|NCT00281658|454950580|FG001|Open Label Phase|Withdrawal by Subject|0|||
126359134|NCT02533674|454607321|FG006|Dose Level VI|Withdrawal by Subject|0|||
126359135|NCT02533674|454607322|FG007|Dose Level VI|Withdrawal by Subject|0|||
126359136|NCT02533674|454607315|FG000|Dose Level VI|Treatment-related AE|0|||
126359137|NCT02533674|454607316|FG001|Dose Level VI|Treatment-related AE|0|||
126359138|NCT02533674|454607317|FG002|Dose Level VI|Treatment-related AE|0|||
126359139|NCT02533674|454607318|FG003|Dose Level VI|Treatment-related AE|0|||
126359140|NCT02533674|454607319|FG004|Dose Level VI|Treatment-related AE|0|||
126359141|NCT02533674|454607320|FG005|Dose Level VI|Treatment-related AE|1|||
126359142|NCT02533674|454607321|FG006|Dose Level VI|Treatment-related AE|0|||
126359143|NCT02533674|454607322|FG007|Dose Level VI|Treatment-related AE|0|||
126359144|NCT02533674|454607315|FG000|Dose Level VII|Progressive disease|0|||
126359145|NCT02533674|454607316|FG001|Dose Level VII|Progressive disease|0|||
126359146|NCT02533674|454607317|FG002|Dose Level VII|Progressive disease|0|||
126359147|NCT02533674|454607318|FG003|Dose Level VII|Progressive disease|0|||
126359148|NCT02533674|454607319|FG004|Dose Level VII|Progressive disease|0|||
126359149|NCT02533674|454607320|FG005|Dose Level VII|Progressive disease|0|||
126359150|NCT02533674|454607321|FG006|Dose Level VII|Progressive disease|10|||
126359151|NCT02533674|454607322|FG007|Dose Level VII|Progressive disease|0|||
126359152|NCT02533674|454607315|FG000|Dose Level VII|Withdrawal by Subject|0|||
126359153|NCT02533674|454607316|FG001|Dose Level VII|Withdrawal by Subject|0|||
126359154|NCT02533674|454607317|FG002|Dose Level VII|Withdrawal by Subject|0|||
126359155|NCT02533674|454607318|FG003|Dose Level VII|Withdrawal by Subject|0|||
126359156|NCT02533674|454607319|FG004|Dose Level VII|Withdrawal by Subject|0|||
126359157|NCT02533674|454607320|FG005|Dose Level VII|Withdrawal by Subject|0|||
126359158|NCT02533674|454607321|FG006|Dose Level VII|Withdrawal by Subject|3|||
126359159|NCT02533674|454607322|FG007|Dose Level VII|Withdrawal by Subject|0|||
126359160|NCT02533674|454607315|FG000|Dose Level VII|Treatment-related AE|0|||
126359161|NCT02533674|454607316|FG001|Dose Level VII|Treatment-related AE|0|||
126359162|NCT02533674|454607317|FG002|Dose Level VII|Treatment-related AE|0|||
126450271|NCT00281658|454950581|FG002|Open Label Phase|Withdrawal by Subject|3|||
126450272|NCT00281658|454950582|FG003|Open Label Phase|Withdrawal by Subject|2|||
126450273|NCT00281658|454950579|FG000|Open Label Phase|Disease progression|0|||
126763147|NCT05147311|456084961|FG001|Overall Study|Death|1|||
126763148|NCT05147311|456084960|FG000|Overall Study|Declined survey|1|||
126763149|NCT05147311|456084961|FG001|Overall Study|Declined survey|0|||
126763150|NCT04505592|456084963|FG000|Overall Study|Death|2|||
126763151|NCT04505592|456084964|FG001|Overall Study|Death|1|||
126763152|NCT01015118|456084965|FG000|Overall Study|Protocol Violation|5|||
126763153|NCT01015118|456084966|FG001|Overall Study|Protocol Violation|6|||
126763154|NCT01015118|456084965|FG000|Overall Study|Withdrawal by Subject|103|||
126763155|NCT01015118|456084966|FG001|Overall Study|Withdrawal by Subject|27|||
126763156|NCT01015118|456084965|FG000|Overall Study|Other Adverse Event (AE)|141|||
126763157|NCT01015118|456084966|FG001|Overall Study|Other Adverse Event (AE)|33|||
126763158|NCT01015118|456084965|FG000|Overall Study|Worsening or AE of underlying disease|5|||
126763159|NCT01015118|456084966|FG001|Overall Study|Worsening or AE of underlying disease|4|||
126763160|NCT01015118|456084965|FG000|Overall Study|Progressive disease|364|||
126763161|NCT01015118|456084966|FG001|Overall Study|Progressive disease|229|||
126763162|NCT01015118|456084965|FG000|Overall Study|Not treated|9|||
126763163|NCT01015118|456084966|FG001|Overall Study|Not treated|5|||
126763164|NCT01015118|456084965|FG000|Overall Study|Other than stated above|42|||
126763165|NCT01015118|456084966|FG001|Overall Study|Other than stated above|23|||
126763166|NCT03522506|456084967|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126763167|NCT03522506|456084968|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126763168|NCT03522506|456084969|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126763169|NCT03522506|456084970|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
126763170|NCT03522506|456084967|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126763171|NCT03522506|456084968|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126763172|NCT03522506|456084969|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126763173|NCT03522506|456084970|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
126763174|NCT03480243|456084971|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
126763175|NCT03480243|456084971|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
126763176|NCT04365387|456084985|FG000|Overall Study|Adverse Event|4|||
126763177|NCT04365387|456084986|FG001|Overall Study|Adverse Event|2|||
126763178|NCT04365387|456084985|FG000|Overall Study|Participants request|14|||
126359163|NCT02533674|454607318|FG003|Dose Level VII|Treatment-related AE|0|||
126359164|NCT02533674|454607319|FG004|Dose Level VII|Treatment-related AE|0|||
126359165|NCT02533674|454607320|FG005|Dose Level VII|Treatment-related AE|0|||
126359166|NCT02533674|454607321|FG006|Dose Level VII|Treatment-related AE|1|||
126359167|NCT02533674|454607322|FG007|Dose Level VII|Treatment-related AE|0|||
126359168|NCT02533674|454607315|FG000|Dose Level VII|Death|0|||
126359169|NCT02533674|454607316|FG001|Dose Level VII|Death|0|||
126763179|NCT04365387|456084986|FG001|Overall Study|Participants request|14|||
126763180|NCT04365387|456084985|FG000|Overall Study|Lost to Follow-up|8|||
126763181|NCT04365387|456084986|FG001|Overall Study|Lost to Follow-up|5|||
126763182|NCT04365387|456084985|FG000|Overall Study|Protocol deviation|3|||
126763183|NCT04365387|456084986|FG001|Overall Study|Protocol deviation|4|||
126699027|NCT00868790|455848801|FG011|Period 3|Adverse Event|0|||
126699028|NCT00868790|455848802|FG012|Period 3|Adverse Event|0|||
126699029|NCT00868790|455848803|FG013|Period 3|Adverse Event|0|||
126699030|NCT00868790|455848790|FG000|Period 3|Protocol Violation|0|||
126258531|NCT03566238|454235927|FG002|Overall Study|Adverse Event|0|||
126258532|NCT03566238|454235925|FG000|Overall Study|Lack of Efficacy|4|||
126258533|NCT03566238|454235926|FG001|Overall Study|Lack of Efficacy|2|||
126258534|NCT03566238|454235927|FG002|Overall Study|Lack of Efficacy|5|||
126258535|NCT03566238|454235925|FG000|Overall Study|Other|1|||
126258536|NCT03566238|454235926|FG001|Overall Study|Other|0|||
126258537|NCT03566238|454235927|FG002|Overall Study|Other|0|||
126258538|NCT01183884|454235934|FG000|Overall Study|Progressive Disease|26|||
126258539|NCT01183884|454235934|FG000|Overall Study|Adverse Event|3|||
126258540|NCT01183884|454235934|FG000|Overall Study|Withdrawal by Subject|1|||
126258541|NCT01183884|454235934|FG000|Overall Study|Other Complicating Disease|3|||
126258542|NCT01183884|454235934|FG000|Overall Study|Not Treated|1|||
126258543|NCT01183884|454235934|FG000|Overall Study|Other|4|||
126258544|NCT03689894|454235936|FG000|Overall Study|Adverse Event|1|||
126258545|NCT01169038|454235945|FG000|Overall Study|Death|1|||
126258546|NCT01169038|454235945|FG000|Overall Study|Adverse Event|5|||
126258547|NCT01169038|454235945|FG000|Overall Study|Required antibiotic administration|1|||
126258548|NCT01488448|454235946|FG000|Overall Study|Withdrawal by Subject|3|||
126258549|NCT01488448|454235947|FG001|Overall Study|Withdrawal by Subject|1|||
126258550|NCT01488448|454235946|FG000|Overall Study|Adverse Event|9|||
126258551|NCT01488448|454235947|FG001|Overall Study|Adverse Event|4|||
126258552|NCT01488448|454235946|FG000|Overall Study|Physician Decision|4|||
126258553|NCT01488448|454235947|FG001|Overall Study|Physician Decision|9|||
126258554|NCT01488448|454235946|FG000|Overall Study|Protocol Violation|4|||
126258555|NCT01488448|454235947|FG001|Overall Study|Protocol Violation|3|||
126258556|NCT00857818|454235950|FG000|Overall Study|Lack of Efficacy|1|||
126258557|NCT00857818|454235951|FG001|Overall Study|Lack of Efficacy|0|||
126258558|NCT00857818|454235950|FG000|Overall Study|Adverse Event|3|||
126258559|NCT00857818|454235951|FG001|Overall Study|Adverse Event|0|||
126258560|NCT00857818|454235950|FG000|Overall Study|Withdrawal by Subject|0|||
126258561|NCT00857818|454235951|FG001|Overall Study|Withdrawal by Subject|4|||
126258562|NCT00857818|454235950|FG000|Overall Study|Sponsor terminated study|6|||
126258563|NCT00857818|454235951|FG001|Overall Study|Sponsor terminated study|4|||
126258564|NCT00857818|454235950|FG000|Overall Study|Investigator decision|1|||
126258565|NCT00857818|454235951|FG001|Overall Study|Investigator decision|0|||
126258566|NCT02219308|454235952|FG000|Overall Study|Withdrawal by Subject|1|||
126258567|NCT02219308|454235953|FG001|Overall Study|Withdrawal by Subject|2|||
126450274|NCT00281658|454950580|FG001|Open Label Phase|Disease progression|0|||
126450275|NCT00281658|454950581|FG002|Open Label Phase|Disease progression|18|||
126450276|NCT00281658|454950582|FG003|Open Label Phase|Disease progression|0|||
126450277|NCT00281658|454950579|FG000|Open Label Phase|Physician Decision|0|||
126450278|NCT00281658|454950580|FG001|Open Label Phase|Physician Decision|0|||
126450279|NCT00281658|454950581|FG002|Open Label Phase|Physician Decision|1|||
126450280|NCT00281658|454950582|FG003|Open Label Phase|Physician Decision|0|||
126450281|NCT00281658|454950579|FG000|Open Label Phase|Relocation of patient|0|||
126258568|NCT04149535|454235956|FG000|Overall Study|Death|11|||
126258569|NCT04149535|454235957|FG001|Overall Study|Death|7|||
126699031|NCT00868790|455848791|FG001|Period 3|Protocol Violation|0|||
126699032|NCT00868790|455848792|FG002|Period 3|Protocol Violation|0|||
126699033|NCT00868790|455848793|FG003|Period 3|Protocol Violation|0|||
126258570|NCT04149535|454235956|FG000|Overall Study|Physician Decision|10|||
126258571|NCT04149535|454235957|FG001|Overall Study|Physician Decision|4|||
126258572|NCT04149535|454235956|FG000|Overall Study|Withdrawal by Subject|6|||
126258573|NCT04149535|454235957|FG001|Overall Study|Withdrawal by Subject|7|||
126258574|NCT04149535|454235956|FG000|Overall Study|Not described|2|||
126258575|NCT04149535|454235957|FG001|Overall Study|Not described|0|||
126258576|NCT02175368|454235958|FG000|Overall Study|Lost to Follow-up|1|||
126258577|NCT02875028|454235959|FG000|Washout Period|Withdrawal by Subject|0|||
126258578|NCT02875028|454235960|FG001|Washout Period|Withdrawal by Subject|1|||
126258579|NCT00653159|454237846|FG000|Overall Study|Adverse Event|4|||
126450282|NCT00281658|454950580|FG001|Open Label Phase|Relocation of patient|0|||
126699034|NCT00868790|455848794|FG004|Period 3|Protocol Violation|0|||
126699035|NCT00868790|455848795|FG005|Period 3|Protocol Violation|0|||
126699036|NCT00868790|455848796|FG006|Period 3|Protocol Violation|0|||
126258580|NCT00653159|454237847|FG001|Overall Study|Adverse Event|1|||
126258581|NCT00653159|454237846|FG000|Overall Study|Lost to Follow-up|1|||
126258582|NCT00653159|454237847|FG001|Overall Study|Lost to Follow-up|2|||
126258583|NCT00109837|454237848|FG000|Overall Study|Adverse Event|2|||
126258584|NCT00109837|454237848|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
126258585|NCT00109837|454237848|FG000|Overall Study|Death|1|||
126258586|NCT00109837|454237848|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
126258587|NCT00109837|454237848|FG000|Overall Study|Not treated|1|||
126258588|NCT00109837|454237848|FG000|Overall Study|Ineligible|1|||
126258589|NCT00401245|454237849|FG000|Double Blind Titration Phase|Adverse Event|3|||
126450283|NCT00281658|454950581|FG002|Open Label Phase|Relocation of patient|1|||
126450284|NCT00281658|454950582|FG003|Open Label Phase|Relocation of patient|0|||
126258590|NCT00401245|454237850|FG001|Double Blind Titration Phase|Adverse Event|2|||
126258591|NCT00401245|454237851|FG002|Double Blind Titration Phase|Adverse Event|5|||
126258592|NCT00401245|454237852|FG003|Double Blind Titration Phase|Adverse Event|12|||
126258593|NCT00401245|454237853|FG004|Double Blind Titration Phase|Adverse Event|0|||
126258594|NCT00401245|454237854|FG005|Double Blind Titration Phase|Adverse Event|0|||
126258595|NCT00401245|454237855|FG006|Double Blind Titration Phase|Adverse Event|0|||
126258596|NCT00401245|454237856|FG007|Double Blind Titration Phase|Adverse Event|0|||
126258597|NCT00401245|454237849|FG000|Double Blind Titration Phase|Other|0|||
126258598|NCT00401245|454237850|FG001|Double Blind Titration Phase|Other|0|||
126258599|NCT00401245|454237851|FG002|Double Blind Titration Phase|Other|1|||
126763184|NCT04365387|456084985|FG000|Overall Study|Participant compliance with visit schedule|1|||
126258600|NCT00401245|454237852|FG003|Double Blind Titration Phase|Other|0|||
126258601|NCT00401245|454237853|FG004|Double Blind Titration Phase|Other|0|||
126258602|NCT00401245|454237854|FG005|Double Blind Titration Phase|Other|0|||
126258603|NCT00401245|454237855|FG006|Double Blind Titration Phase|Other|0|||
126258604|NCT00401245|454237856|FG007|Double Blind Titration Phase|Other|0|||
126258605|NCT00401245|454237849|FG000|Double Blind Titration Phase|Protocol Violation|0|||
126258606|NCT00401245|454237850|FG001|Double Blind Titration Phase|Protocol Violation|0|||
126258607|NCT00401245|454237851|FG002|Double Blind Titration Phase|Protocol Violation|0|||
126258608|NCT00401245|454237852|FG003|Double Blind Titration Phase|Protocol Violation|1|||
126258609|NCT00401245|454237853|FG004|Double Blind Titration Phase|Protocol Violation|0|||
126258610|NCT00401245|454237854|FG005|Double Blind Titration Phase|Protocol Violation|0|||
126258611|NCT00401245|454237855|FG006|Double Blind Titration Phase|Protocol Violation|0|||
126258612|NCT00401245|454237856|FG007|Double Blind Titration Phase|Protocol Violation|0|||
126258613|NCT00401245|454237849|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
126258614|NCT00401245|454237850|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
126258615|NCT00401245|454237851|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
126258616|NCT00401245|454237852|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
126258617|NCT00401245|454237853|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
126258618|NCT00401245|454237854|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
126258619|NCT00401245|454237855|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
126258620|NCT00401245|454237856|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
126258621|NCT00401245|454237849|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
126258622|NCT00401245|454237850|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
126258623|NCT00401245|454237851|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
126763185|NCT04365387|456084986|FG001|Overall Study|Participant compliance with visit schedule|0|||
126258624|NCT00401245|454237852|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
126258625|NCT00401245|454237853|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
126258626|NCT00401245|454237854|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
126258627|NCT00401245|454237855|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
126258628|NCT00401245|454237856|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
126258629|NCT00401245|454237849|FG000|Open Label Phase|Adverse Event|5|||
126258630|NCT00401245|454237850|FG001|Open Label Phase|Adverse Event|14|||
126258631|NCT00401245|454237851|FG002|Open Label Phase|Adverse Event|6|||
126258632|NCT00401245|454237852|FG003|Open Label Phase|Adverse Event|7|||
126258633|NCT00401245|454237853|FG004|Open Label Phase|Adverse Event|0|||
126258634|NCT00401245|454237854|FG005|Open Label Phase|Adverse Event|0|||
126258635|NCT00401245|454237855|FG006|Open Label Phase|Adverse Event|0|||
126258636|NCT00401245|454237856|FG007|Open Label Phase|Adverse Event|0|||
126258637|NCT00401245|454237849|FG000|Open Label Phase|Lost to Follow-up|5|||
126258638|NCT00401245|454237850|FG001|Open Label Phase|Lost to Follow-up|7|||
126258639|NCT00401245|454237851|FG002|Open Label Phase|Lost to Follow-up|5|||
126258640|NCT00401245|454237852|FG003|Open Label Phase|Lost to Follow-up|4|||
126258641|NCT00401245|454237853|FG004|Open Label Phase|Lost to Follow-up|0|||
126258642|NCT00401245|454237854|FG005|Open Label Phase|Lost to Follow-up|0|||
126258643|NCT00401245|454237855|FG006|Open Label Phase|Lost to Follow-up|0|||
126258644|NCT00401245|454237856|FG007|Open Label Phase|Lost to Follow-up|0|||
126258645|NCT00401245|454237849|FG000|Open Label Phase|Other|4|||
126258646|NCT00401245|454237850|FG001|Open Label Phase|Other|8|||
126258647|NCT00401245|454237851|FG002|Open Label Phase|Other|7|||
126258648|NCT00401245|454237852|FG003|Open Label Phase|Other|8|||
126258649|NCT00401245|454237853|FG004|Open Label Phase|Other|0|||
126258650|NCT00401245|454237854|FG005|Open Label Phase|Other|0|||
126258651|NCT00401245|454237855|FG006|Open Label Phase|Other|0|||
126258652|NCT00401245|454237856|FG007|Open Label Phase|Other|0|||
126258653|NCT00401245|454237849|FG000|Open Label Phase|Protocol Violation|0|||
126258654|NCT00401245|454237850|FG001|Open Label Phase|Protocol Violation|1|||
126258655|NCT00401245|454237851|FG002|Open Label Phase|Protocol Violation|0|||
126258656|NCT00401245|454237852|FG003|Open Label Phase|Protocol Violation|1|||
126258657|NCT00401245|454237853|FG004|Open Label Phase|Protocol Violation|0|||
126258658|NCT00401245|454237854|FG005|Open Label Phase|Protocol Violation|0|||
126258659|NCT00401245|454237855|FG006|Open Label Phase|Protocol Violation|0|||
126258660|NCT00401245|454237856|FG007|Open Label Phase|Protocol Violation|0|||
126258661|NCT00401245|454237849|FG000|Open Label Phase|Withdrawal by Subject|3|||
126258662|NCT00401245|454237850|FG001|Open Label Phase|Withdrawal by Subject|3|||
126258663|NCT00401245|454237851|FG002|Open Label Phase|Withdrawal by Subject|2|||
126258664|NCT00401245|454237852|FG003|Open Label Phase|Withdrawal by Subject|1|||
126258665|NCT00401245|454237853|FG004|Open Label Phase|Withdrawal by Subject|0|||
126258666|NCT00401245|454237854|FG005|Open Label Phase|Withdrawal by Subject|0|||
126258667|NCT00401245|454237855|FG006|Open Label Phase|Withdrawal by Subject|0|||
126258668|NCT00401245|454237856|FG007|Open Label Phase|Withdrawal by Subject|0|||
126258669|NCT00401245|454237849|FG000|Open Label Phase|Lack of Efficacy|4|||
126258670|NCT00401245|454237850|FG001|Open Label Phase|Lack of Efficacy|2|||
126359170|NCT02533674|454607317|FG002|Dose Level VII|Death|0|||
126450285|NCT00281658|454950579|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
126450286|NCT00281658|454950580|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
126450287|NCT00281658|454950581|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
126450288|NCT00281658|454950582|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
126450289|NCT00813943|454950585|FG000|Overall Study|Ongoing at cut-off date|5|||
126450290|NCT00813943|454950586|FG001|Overall Study|Ongoing at cut-off date|5|||
126450291|NCT00813943|454950587|FG002|Overall Study|Ongoing at cut-off date|3|||
126450292|NCT01343693|454950588|FG000|Overall Study|Lost to Follow-up|9|||
126450293|NCT02704143|454950589|FG000|Overall Study|disease progression|10|||
126450294|NCT01235598|454950590|FG000|Overall Study|Adverse Event|0|||
126450295|NCT01235598|454950591|FG001|Overall Study|Adverse Event|3|||
126450296|NCT01235598|454950590|FG000|Overall Study|Lack of Efficacy|0|||
126450297|NCT01235598|454950591|FG001|Overall Study|Lack of Efficacy|1|||
126450298|NCT01235598|454950590|FG000|Overall Study|Withdrawal by Subject|1|||
126450299|NCT01235598|454950591|FG001|Overall Study|Withdrawal by Subject|0|||
126450300|NCT02151773|454950592|FG000|Overall Study|Protocol Deviation|64|||
126450301|NCT02551991|454950593|FG000|Overall Study|Death|5|||
126450302|NCT02551991|454950594|FG001|Overall Study|Death|7|||
126450303|NCT02551991|454950595|FG002|Overall Study|Death|8|||
126450304|NCT02551991|454950596|FG003|Overall Study|Death|7|||
126450305|NCT02551991|454950597|FG004|Overall Study|Death|17|||
126450306|NCT02551991|454950593|FG000|Overall Study|Withdrawal by Subject|1|||
126450307|NCT02551991|454950594|FG001|Overall Study|Withdrawal by Subject|0|||
126450308|NCT02551991|454950595|FG002|Overall Study|Withdrawal by Subject|0|||
126450309|NCT02551991|454950596|FG003|Overall Study|Withdrawal by Subject|0|||
126450310|NCT02551991|454950597|FG004|Overall Study|Withdrawal by Subject|2|||
126450311|NCT02551991|454950593|FG000|Overall Study|Lost to Follow-up|0|||
126450312|NCT02551991|454950594|FG001|Overall Study|Lost to Follow-up|0|||
126450313|NCT02551991|454950595|FG002|Overall Study|Lost to Follow-up|1|||
126450314|NCT02551991|454950596|FG003|Overall Study|Lost to Follow-up|0|||
126450315|NCT02551991|454950597|FG004|Overall Study|Lost to Follow-up|0|||
126450316|NCT02551991|454950593|FG000|Overall Study|Sponsor Decision|1|||
126450317|NCT02551991|454950594|FG001|Overall Study|Sponsor Decision|0|||
126763186|NCT04365387|456084985|FG000|Overall Study|Participant incarcerated|1|||
126359171|NCT02533674|454607318|FG003|Dose Level VII|Death|0|||
126359172|NCT02533674|454607319|FG004|Dose Level VII|Death|0|||
126359173|NCT02533674|454607320|FG005|Dose Level VII|Death|0|||
126359174|NCT02533674|454607321|FG006|Dose Level VII|Death|2|||
126359175|NCT02533674|454607322|FG007|Dose Level VII|Death|0|||
126359176|NCT02533674|454607315|FG000|Dose Level VIII|Progressive disease|0|||
126359177|NCT02533674|454607316|FG001|Dose Level VIII|Progressive disease|0|||
126359178|NCT02533674|454607317|FG002|Dose Level VIII|Progressive disease|0|||
126359179|NCT02533674|454607318|FG003|Dose Level VIII|Progressive disease|0|||
126359180|NCT02533674|454607319|FG004|Dose Level VIII|Progressive disease|0|||
126359181|NCT02533674|454607320|FG005|Dose Level VIII|Progressive disease|0|||
126359182|NCT02533674|454607321|FG006|Dose Level VIII|Progressive disease|0|||
126359183|NCT02533674|454607322|FG007|Dose Level VIII|Progressive disease|3|||
126359184|NCT02533674|454607315|FG000|Dose Level VIII|Withdrawal by Subject|0|||
126359185|NCT02533674|454607316|FG001|Dose Level VIII|Withdrawal by Subject|0|||
126359186|NCT02533674|454607317|FG002|Dose Level VIII|Withdrawal by Subject|0|||
126359187|NCT02533674|454607318|FG003|Dose Level VIII|Withdrawal by Subject|0|||
126359188|NCT02533674|454607319|FG004|Dose Level VIII|Withdrawal by Subject|0|||
126258671|NCT00401245|454237851|FG002|Open Label Phase|Lack of Efficacy|3|||
126258672|NCT00401245|454237852|FG003|Open Label Phase|Lack of Efficacy|0|||
126359189|NCT02533674|454607320|FG005|Dose Level VIII|Withdrawal by Subject|0|||
126359190|NCT02533674|454607321|FG006|Dose Level VIII|Withdrawal by Subject|0|||
126359191|NCT02533674|454607322|FG007|Dose Level VIII|Withdrawal by Subject|1|||
126359192|NCT02533674|454607315|FG000|Dose Level VIII|Treatment-related AE|0|||
126359193|NCT02533674|454607316|FG001|Dose Level VIII|Treatment-related AE|0|||
126450318|NCT02551991|454950595|FG002|Overall Study|Sponsor Decision|1|||
126450319|NCT02551991|454950596|FG003|Overall Study|Sponsor Decision|0|||
126450320|NCT02551991|454950597|FG004|Overall Study|Sponsor Decision|5|||
126450321|NCT02551991|454950593|FG000|Overall Study|Other|0|||
126450322|NCT02551991|454950594|FG001|Overall Study|Other|0|||
126450323|NCT02551991|454950595|FG002|Overall Study|Other|0|||
126450324|NCT02551991|454950596|FG003|Overall Study|Other|0|||
126258673|NCT00401245|454237853|FG004|Open Label Phase|Lack of Efficacy|0|||
126450325|NCT02551991|454950597|FG004|Overall Study|Other|1|||
126450326|NCT00395343|454950598|FG000|Overall Study|Adverse Event|13|||
126450327|NCT00395343|454950599|FG001|Overall Study|Adverse Event|5|||
126450328|NCT00395343|454950598|FG000|Overall Study|Lack of Efficacy|0|||
126450329|NCT00395343|454950599|FG001|Overall Study|Lack of Efficacy|1|||
126450330|NCT00395343|454950598|FG000|Overall Study|Lost to Follow-up|4|||
126450331|NCT00395343|454950599|FG001|Overall Study|Lost to Follow-up|4|||
126450332|NCT00395343|454950598|FG000|Overall Study|Physician Decision|2|||
126450333|NCT00395343|454950599|FG001|Overall Study|Physician Decision|4|||
126450334|NCT00395343|454950598|FG000|Overall Study|Protocol Violation|6|||
126450335|NCT00395343|454950599|FG001|Overall Study|Protocol Violation|8|||
126450336|NCT00395343|454950598|FG000|Overall Study|Withdrawal by Subject|11|||
126450337|NCT00395343|454950599|FG001|Overall Study|Withdrawal by Subject|12|||
126450338|NCT00395343|454950598|FG000|Overall Study|Other|5|||
126450339|NCT00395343|454950599|FG001|Overall Study|Other|2|||
126450340|NCT01463007|454950600|FG000|Overall Study|Physician Decision|1|||
126450341|NCT00387790|454950602|FG000|Overall Study|Adverse Event|5|||
126450342|NCT00387790|454950602|FG000|Overall Study|Lack of Efficacy|2|||
126450343|NCT00387790|454950602|FG000|Overall Study|Physician Decision|2|||
126450344|NCT00387790|454950602|FG000|Overall Study|Withdrawal by Subject|3|||
126450345|NCT00387790|454950602|FG000|Overall Study|Ineligible for study|2|||
126450346|NCT00444678|454950603|FG000|Overall Study|Toxicity|11|||
126450347|NCT00444678|454950603|FG000|Overall Study|Disease Progression|12|||
126450348|NCT00444678|454950603|FG000|Overall Study|Death|3|||
126450349|NCT00444678|454950603|FG000|Overall Study|Physician Decision|3|||
126450350|NCT00444678|454950603|FG000|Overall Study|Withdrawal by Subject|2|||
126450351|NCT00606905|454950604|FG000|Overall Study|No Pregnancy|9|||
126450352|NCT00606905|454950605|FG001|Overall Study|No Pregnancy|6|||
126450353|NCT00606905|454950604|FG000|Overall Study|Non-Index Pregnancy|1|||
126450354|NCT00606905|454950605|FG001|Overall Study|Non-Index Pregnancy|4|||
126450355|NCT00606905|454950604|FG000|Overall Study|Withdrew|5|||
126258674|NCT00401245|454237854|FG005|Open Label Phase|Lack of Efficacy|0|||
126450356|NCT00606905|454950605|FG001|Overall Study|Withdrew|5|||
126450357|NCT04975438|454950611|FG000|Overall Study|Lost to Follow-up|1|||
126450358|NCT04975438|454950612|FG001|Overall Study|Lost to Follow-up|0|||
126450359|NCT04975438|454950613|FG002|Overall Study|Lost to Follow-up|1|||
126450360|NCT04975438|454950614|FG003|Overall Study|Lost to Follow-up|0|||
126450361|NCT04975438|454950611|FG000|Overall Study|Withdrawal by Subject|1|||
126450362|NCT04975438|454950612|FG001|Overall Study|Withdrawal by Subject|0|||
126450363|NCT04975438|454950613|FG002|Overall Study|Withdrawal by Subject|0|||
126450364|NCT04975438|454950614|FG003|Overall Study|Withdrawal by Subject|0|||
126450365|NCT02640508|454950615|FG000|Overall Study|Death|19|||
126450366|NCT02640508|454950615|FG000|Overall Study|Withdrawal by Subject|8|||
126450367|NCT02640508|454950615|FG000|Overall Study|Physician Decision|1|||
126450368|NCT02640508|454950615|FG000|Overall Study|Lost to Follow-up|1|||
126450369|NCT05405257|454950619|FG000|Overall Study|Withdrawal by Subject|1|||
126450370|NCT00275340|454950620|FG000|Overall Study|Lost to Follow-up|2|||
126450371|NCT00275340|454950621|FG001|Overall Study|Lost to Follow-up|4|||
126450372|NCT03091348|454950623|FG000|Overall Study|Lost to Follow-up|2|||
126450373|NCT03091348|454950624|FG001|Overall Study|Lost to Follow-up|1|||
126450374|NCT02791763|454950625|FG000|Overall Study|Protocol Violation|0|||
126450375|NCT02791763|454950626|FG001|Overall Study|Protocol Violation|0|||
126699037|NCT00868790|455848797|FG007|Period 3|Protocol Violation|0|||
126699038|NCT00868790|455848798|FG008|Period 3|Protocol Violation|0|||
126699039|NCT00868790|455848799|FG009|Period 3|Protocol Violation|0|||
126258675|NCT00401245|454237855|FG006|Open Label Phase|Lack of Efficacy|0|||
126258676|NCT00401245|454237856|FG007|Open Label Phase|Lack of Efficacy|0|||
126258677|NCT00401245|454237849|FG000|Double Blind Tapering Phase|Adverse Event|0|||
126258678|NCT00401245|454237850|FG001|Double Blind Tapering Phase|Adverse Event|0|||
126258679|NCT00401245|454237851|FG002|Double Blind Tapering Phase|Adverse Event|0|||
126258680|NCT00401245|454237852|FG003|Double Blind Tapering Phase|Adverse Event|0|||
126258681|NCT00401245|454237853|FG004|Double Blind Tapering Phase|Adverse Event|1|||
126699040|NCT00868790|455848800|FG010|Period 3|Protocol Violation|1|||
126699041|NCT00868790|455848801|FG011|Period 3|Protocol Violation|0|||
126699042|NCT00868790|455848802|FG012|Period 3|Protocol Violation|0|||
126699043|NCT00868790|455848803|FG013|Period 3|Protocol Violation|0|||
126258682|NCT00401245|454237854|FG005|Double Blind Tapering Phase|Adverse Event|1|||
126258683|NCT00401245|454237855|FG006|Double Blind Tapering Phase|Adverse Event|2|||
126258684|NCT00401245|454237856|FG007|Double Blind Tapering Phase|Adverse Event|4|||
126258685|NCT00401245|454237849|FG000|Double Blind Tapering Phase|Investigator request|0|||
126258686|NCT00401245|454237850|FG001|Double Blind Tapering Phase|Investigator request|0|||
126450376|NCT02791763|454950627|FG002|Overall Study|Protocol Violation|1|||
126450377|NCT02791763|454950625|FG000|Overall Study|Withdrawal by Subject|5|||
126450378|NCT02791763|454950626|FG001|Overall Study|Withdrawal by Subject|1|||
126450379|NCT02791763|454950627|FG002|Overall Study|Withdrawal by Subject|0|||
126450380|NCT02791763|454950625|FG000|Overall Study|Physician Decision|0|||
126450381|NCT02791763|454950626|FG001|Overall Study|Physician Decision|1|||
126450382|NCT02791763|454950627|FG002|Overall Study|Physician Decision|0|||
126699044|NCT00868790|455848790|FG000|Period 3|Study Terminated by Sponsor|0|||
126258687|NCT00401245|454237851|FG002|Double Blind Tapering Phase|Investigator request|0|||
126258688|NCT00401245|454237852|FG003|Double Blind Tapering Phase|Investigator request|0|||
126258689|NCT00401245|454237853|FG004|Double Blind Tapering Phase|Investigator request|0|||
126258690|NCT00401245|454237854|FG005|Double Blind Tapering Phase|Investigator request|0|||
126258691|NCT00401245|454237855|FG006|Double Blind Tapering Phase|Investigator request|0|||
126258692|NCT00401245|454237856|FG007|Double Blind Tapering Phase|Investigator request|1|||
126258693|NCT00401245|454237849|FG000|Double Blind Tapering Phase|Other|0|||
126258694|NCT00401245|454237850|FG001|Double Blind Tapering Phase|Other|0|||
126258695|NCT00401245|454237851|FG002|Double Blind Tapering Phase|Other|0|||
126258696|NCT00401245|454237852|FG003|Double Blind Tapering Phase|Other|0|||
126258697|NCT00401245|454237853|FG004|Double Blind Tapering Phase|Other|1|||
126450383|NCT02791763|454950625|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
126450384|NCT02791763|454950626|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
126450385|NCT02791763|454950627|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
126450386|NCT02791763|454950625|FG000|Overall Study|Cancer event|1|||
126450387|NCT02791763|454950626|FG001|Overall Study|Cancer event|3|||
126450388|NCT02791763|454950627|FG002|Overall Study|Cancer event|0|||
126450389|NCT02791763|454950625|FG000|Overall Study|Participant had renal transplant|3|||
126450390|NCT02791763|454950626|FG001|Overall Study|Participant had renal transplant|0|||
126450391|NCT02791763|454950627|FG002|Overall Study|Participant had renal transplant|0|||
126450392|NCT02791763|454950625|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
126450393|NCT02791763|454950626|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
126450394|NCT02791763|454950627|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
126450395|NCT02791763|454950625|FG000|Overall Study|Adverse Event|12|||
126450396|NCT02791763|454950626|FG001|Overall Study|Adverse Event|13|||
126450397|NCT02791763|454950627|FG002|Overall Study|Adverse Event|7|||
126450398|NCT00706342|454950628|FG000|Overall Study|Adverse Event|3|||
126450399|NCT00706342|454950628|FG000|Overall Study|Not responding to treatment|2|||
126450400|NCT00706342|454950628|FG000|Overall Study|Withdrawn due to failure to respond|1|||
126450401|NCT00706342|454950628|FG000|Overall Study|Death|1|||
126450402|NCT00706342|454950628|FG000|Overall Study|Withdrew from the study on his own.|1|||
126450403|NCT00706342|454950628|FG000|Overall Study|Investigator discretion|2|||
126450404|NCT00706342|454950628|FG000|Overall Study|Non-responder Week 12|1|||
126450405|NCT00706342|454950628|FG000|Overall Study|Ongoing|6|||
126450406|NCT00706342|454950628|FG000|Overall Study|WIthdrawal of consent|1|||
126450407|NCT04534686|454950629|FG000|Baseline Measurement|Lost to Follow-up|4|||
126450408|NCT04534686|454950630|FG001|Baseline Measurement|Lost to Follow-up|6|||
126450409|NCT04534686|454950629|FG000|Baseline Measurement|Withdrawal by Subject|3|||
126450410|NCT04534686|454950630|FG001|Baseline Measurement|Withdrawal by Subject|1|||
126450411|NCT04534686|454950629|FG000|Intervention|Withdrawal by Subject|2|||
126450412|NCT04534686|454950630|FG001|Intervention|Withdrawal by Subject|2|||
126450413|NCT01419197|454950635|FG000|Overall Study|Death|247|||
126450414|NCT01419197|454950636|FG001|Overall Study|Death|122|||
126450415|NCT01419197|454950635|FG000|Overall Study|Physician Decision|4|||
126450416|NCT01419197|454950636|FG001|Overall Study|Physician Decision|4|||
126450417|NCT01419197|454950635|FG000|Overall Study|Non-compliance|3|||
126450418|NCT01419197|454950636|FG001|Overall Study|Non-compliance|1|||
126450419|NCT01419197|454950635|FG000|Overall Study|Withdrawal by Subject|33|||
126450420|NCT01419197|454950636|FG001|Overall Study|Withdrawal by Subject|32|||
126450421|NCT01419197|454950635|FG000|Overall Study|Study Completed by Sponsor|103|||
126450422|NCT01419197|454950636|FG001|Overall Study|Study Completed by Sponsor|34|||
126450423|NCT01419197|454950635|FG000|Overall Study|Reason Not Specified|0|||
126450424|NCT01419197|454950636|FG001|Overall Study|Reason Not Specified|1|||
126450425|NCT01419197|454950635|FG000|Overall Study|Lost to Follow-up|14|||
126450426|NCT01419197|454950636|FG001|Overall Study|Lost to Follow-up|4|||
126450427|NCT01781299|454950637|FG000|Overall Study|Withdrawal by Subject|0|||
126450428|NCT01781299|454950638|FG001|Overall Study|Withdrawal by Subject|1|||
126450429|NCT00146848|454950639|FG000|Pre-randomization|Death|19|||
126450430|NCT00146848|454950640|FG001|Pre-randomization|Death|0|||
126258698|NCT00401245|454237854|FG005|Double Blind Tapering Phase|Other|0|||
126258699|NCT00401245|454237855|FG006|Double Blind Tapering Phase|Other|2|||
126450431|NCT00146848|454950641|FG002|Pre-randomization|Death|0|||
126450432|NCT00146848|454950639|FG000|Pre-randomization|Lost to Follow-up|70|||
126450433|NCT00146848|454950640|FG001|Pre-randomization|Lost to Follow-up|0|||
126450434|NCT00146848|454950641|FG002|Pre-randomization|Lost to Follow-up|0|||
126258700|NCT00401245|454237856|FG007|Double Blind Tapering Phase|Other|2|||
126450435|NCT00146848|454950639|FG000|Pre-randomization|Physician Decision|8|||
126450436|NCT00146848|454950640|FG001|Pre-randomization|Physician Decision|0|||
126450437|NCT00146848|454950641|FG002|Pre-randomization|Physician Decision|0|||
126450438|NCT00146848|454950639|FG000|Pre-randomization|Protocol Violation|172|||
126450439|NCT00146848|454950640|FG001|Pre-randomization|Protocol Violation|0|||
126450440|NCT00146848|454950641|FG002|Pre-randomization|Protocol Violation|0|||
126450441|NCT00146848|454950639|FG000|Pre-randomization|Withdrawal by Subject|40|||
126450442|NCT00146848|454950640|FG001|Pre-randomization|Withdrawal by Subject|0|||
126450443|NCT00146848|454950641|FG002|Pre-randomization|Withdrawal by Subject|0|||
126258701|NCT00401245|454237849|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
126258702|NCT00401245|454237850|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
126258703|NCT00401245|454237851|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
126258704|NCT00401245|454237852|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
126258705|NCT00401245|454237853|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
126258706|NCT00401245|454237854|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
126258707|NCT00401245|454237855|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
126258708|NCT00401245|454237856|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
126258709|NCT00401245|454237849|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
126450444|NCT00146848|454950639|FG000|Post-randomization|Lost to Follow-up|12|||
126450445|NCT00146848|454950640|FG001|Post-randomization|Lost to Follow-up|15|||
126450446|NCT00146848|454950641|FG002|Post-randomization|Lost to Follow-up|12|||
126450447|NCT00146848|454950639|FG000|Post-randomization|Withdrawn|26|||
126450448|NCT00146848|454950640|FG001|Post-randomization|Withdrawn|32|||
126450449|NCT00146848|454950641|FG002|Post-randomization|Withdrawn|27|||
126450450|NCT01798849|454950642|FG000|Overall Study|Physician Decision|0|||
126450451|NCT01798849|454950643|FG001|Overall Study|Physician Decision|0|||
126450452|NCT01798849|454950644|FG002|Overall Study|Physician Decision|1|||
126450453|NCT02636361|454950645|FG000|Period 4|Physician Decision|0|||
126450454|NCT02636361|454950646|FG001|Period 4|Physician Decision|0|||
126450455|NCT02636361|454950647|FG002|Period 4|Physician Decision|0|||
126450456|NCT02636361|454950648|FG003|Period 4|Physician Decision|1|||
126450457|NCT02636361|454950649|FG004|Period 4|Physician Decision|0|||
126450458|NCT02032238|454950650|FG000|Overall Study|Lost to Follow-up|2|||
126450459|NCT02032238|454950651|FG001|Overall Study|Lost to Follow-up|0|||
126450460|NCT02410343|454950652|FG000|Core Period (24 Weeks)|Adverse Event|1|||
126450461|NCT02410343|454950653|FG001|Core Period (24 Weeks)|Adverse Event|0|||
126450462|NCT02410343|454950652|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
126450463|NCT02410343|454950653|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
126450464|NCT02410343|454950652|FG000|Extension Period (12 Months)|Adverse Event|1|||
126450465|NCT02410343|454950653|FG001|Extension Period (12 Months)|Adverse Event|0|||
126450466|NCT02410343|454950652|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
126450467|NCT02410343|454950653|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
126450468|NCT02720042|454950660|FG000|Overall Study|Death|3|||
126450469|NCT02720042|454950660|FG000|Overall Study|Lost to Follow-up|4|||
126450470|NCT02720042|454950660|FG000|Overall Study|Withdrawal by Subject|1|||
126450471|NCT02720042|454950660|FG000|Overall Study|Physician Decision|3|||
126450472|NCT02720042|454950660|FG000|Overall Study|Phasix Mesh explanted|1|||
126450473|NCT02720042|454950660|FG000|Overall Study|unable due to non-study-related illness|3|||
126450474|NCT00246740|454950661|FG000|Initial Enrollment|Death|1|||
126450475|NCT00246740|454950662|FG001|Initial Enrollment|Death|0|||
126450476|NCT00246740|454950661|FG000|Initial Enrollment|Additional surgery scheduled|0|||
126450477|NCT00246740|454950662|FG001|Initial Enrollment|Additional surgery scheduled|2|||
126450478|NCT00246740|454950661|FG000|Initial Enrollment|Surgery schedule change|4|||
126450479|NCT00246740|454950662|FG001|Initial Enrollment|Surgery schedule change|4|||
126450480|NCT00246740|454950661|FG000|Initial Enrollment|Other|1|||
126450481|NCT00246740|454950662|FG001|Initial Enrollment|Other|2|||
126450482|NCT01510769|454950663|FG000|Overall Study|Adverse Event|7|||
126450483|NCT01510769|454950664|FG001|Overall Study|Adverse Event|6|||
126450484|NCT01510769|454950665|FG002|Overall Study|Adverse Event|4|||
126450485|NCT01510769|454950663|FG000|Overall Study|Gout Flare|0|||
126450486|NCT01510769|454950664|FG001|Overall Study|Gout Flare|3|||
126450487|NCT01510769|454950665|FG002|Overall Study|Gout Flare|1|||
126699045|NCT00868790|455848791|FG001|Period 3|Study Terminated by Sponsor|0|||
126699046|NCT00868790|455848792|FG002|Period 3|Study Terminated by Sponsor|0|||
126699047|NCT00868790|455848793|FG003|Period 3|Study Terminated by Sponsor|1|||
126699048|NCT00868790|455848794|FG004|Period 3|Study Terminated by Sponsor|0|||
126699049|NCT00868790|455848795|FG005|Period 3|Study Terminated by Sponsor|0|||
126699050|NCT00868790|455848796|FG006|Period 3|Study Terminated by Sponsor|0|||
126699051|NCT00868790|455848797|FG007|Period 3|Study Terminated by Sponsor|0|||
126699052|NCT00868790|455848798|FG008|Period 3|Study Terminated by Sponsor|0|||
126699053|NCT00868790|455848799|FG009|Period 3|Study Terminated by Sponsor|0|||
126699054|NCT00868790|455848800|FG010|Period 3|Study Terminated by Sponsor|0|||
126699055|NCT00868790|455848801|FG011|Period 3|Study Terminated by Sponsor|0|||
126699056|NCT00868790|455848802|FG012|Period 3|Study Terminated by Sponsor|0|||
126699057|NCT00868790|455848803|FG013|Period 3|Study Terminated by Sponsor|0|||
126699058|NCT00868790|455848790|FG000|Period 4|Adverse Event|0|||
126699059|NCT00868790|455848791|FG001|Period 4|Adverse Event|0|||
126699060|NCT00868790|455848792|FG002|Period 4|Adverse Event|0|||
126699061|NCT00868790|455848793|FG003|Period 4|Adverse Event|0|||
126699062|NCT00868790|455848794|FG004|Period 4|Adverse Event|0|||
126699063|NCT00868790|455848795|FG005|Period 4|Adverse Event|0|||
126699064|NCT00868790|455848796|FG006|Period 4|Adverse Event|0|||
126699065|NCT00868790|455848797|FG007|Period 4|Adverse Event|1|||
126699066|NCT00868790|455848798|FG008|Period 4|Adverse Event|0|||
126699067|NCT00868790|455848799|FG009|Period 4|Adverse Event|0|||
126699068|NCT00868790|455848800|FG010|Period 4|Adverse Event|1|||
126699069|NCT00868790|455848801|FG011|Period 4|Adverse Event|0|||
126258710|NCT00401245|454237850|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
126258711|NCT00401245|454237851|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
126258712|NCT00401245|454237852|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
126258713|NCT00401245|454237853|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
126258714|NCT00401245|454237854|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
126258715|NCT00401245|454237855|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
126258716|NCT00401245|454237856|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
126258717|NCT02344745|454237857|FG000|Overall Study|Data collection sheets were lost|2|||
126258718|NCT02344745|454237858|FG001|Overall Study|Data collection sheets were lost|0|||
126258719|NCT02014441|454237859|FG000|Overall Study|Withdrawal by Subject|12|||
126258720|NCT01933919|454237860|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
126258721|NCT01933919|454237861|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
126258722|NCT01933919|454237860|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
126258723|NCT01933919|454237861|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
126258724|NCT01933919|454237860|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
126258725|NCT01933919|454237861|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
126258726|NCT01933919|454237860|FG000|Open-label Long-term Phase|Adverse Event|2|||
126258727|NCT01933919|454237861|FG001|Open-label Long-term Phase|Adverse Event|0|||
126258728|NCT01933919|454237860|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
126258729|NCT01933919|454237861|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
126258730|NCT01933919|454237860|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
126258731|NCT01933919|454237861|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
126258732|NCT01933919|454237860|FG000|Open-label Long-term Phase|Other|1|||
126258733|NCT01933919|454237861|FG001|Open-label Long-term Phase|Other|2|||
126258734|NCT00991510|454237862|FG000|Period I (Days 1-14)|Adverse Event|1|||
126258735|NCT00991510|454237863|FG001|Period I (Days 1-14)|Adverse Event|0|||
126258736|NCT00991510|454237862|FG000|Period III (Days 29-112)|Adverse Event|1|||
126258737|NCT00991510|454237863|FG001|Period III (Days 29-112)|Adverse Event|1|||
126258738|NCT02510261|454237872|FG000|Overall Study|Adverse Event|5|||
126258739|NCT02510261|454237873|FG001|Overall Study|Adverse Event|8|||
126258740|NCT02510261|454237874|FG002|Overall Study|Adverse Event|0|||
126258741|NCT02510261|454237872|FG000|Overall Study|Physician Decision|1|||
126258742|NCT02510261|454237873|FG001|Overall Study|Physician Decision|5|||
126258743|NCT02510261|454237874|FG002|Overall Study|Physician Decision|0|||
126258744|NCT02510261|454237872|FG000|Overall Study|Death|19|||
126258745|NCT02510261|454237873|FG001|Overall Study|Death|19|||
126258746|NCT02510261|454237874|FG002|Overall Study|Death|0|||
126258747|NCT02510261|454237872|FG000|Overall Study|Withdrawal by Subject|3|||
126258748|NCT02510261|454237873|FG001|Overall Study|Withdrawal by Subject|10|||
126258749|NCT02510261|454237874|FG002|Overall Study|Withdrawal by Subject|3|||
126258750|NCT02443324|454237878|FG000|Overall Study|Death|4|||
126258751|NCT02443324|454237879|FG001|Overall Study|Death|1|||
126258752|NCT02443324|454237880|FG002|Overall Study|Death|0|||
126258753|NCT02443324|454237881|FG003|Overall Study|Death|3|||
126258754|NCT02443324|454237882|FG004|Overall Study|Death|1|||
126258755|NCT02443324|454237883|FG005|Overall Study|Death|3|||
126258756|NCT02443324|454237884|FG006|Overall Study|Death|2|||
126258757|NCT02443324|454237878|FG000|Overall Study|Lost to Follow-up|0|||
126258758|NCT02443324|454237879|FG001|Overall Study|Lost to Follow-up|0|||
126258759|NCT02443324|454237880|FG002|Overall Study|Lost to Follow-up|0|||
126258760|NCT02443324|454237881|FG003|Overall Study|Lost to Follow-up|1|||
126258761|NCT02443324|454237882|FG004|Overall Study|Lost to Follow-up|0|||
126258762|NCT02443324|454237883|FG005|Overall Study|Lost to Follow-up|1|||
126258763|NCT02443324|454237884|FG006|Overall Study|Lost to Follow-up|0|||
126258764|NCT02443324|454237878|FG000|Overall Study|Physician Decision|0|||
126258765|NCT02443324|454237879|FG001|Overall Study|Physician Decision|3|||
126258766|NCT02443324|454237880|FG002|Overall Study|Physician Decision|5|||
126258767|NCT02443324|454237881|FG003|Overall Study|Physician Decision|1|||
126258768|NCT02443324|454237882|FG004|Overall Study|Physician Decision|1|||
126258769|NCT02443324|454237883|FG005|Overall Study|Physician Decision|0|||
126258770|NCT02443324|454237884|FG006|Overall Study|Physician Decision|2|||
126258771|NCT02443324|454237878|FG000|Overall Study|Progressive Disease|20|||
126258772|NCT02443324|454237879|FG001|Overall Study|Progressive Disease|20|||
126258773|NCT02443324|454237880|FG002|Overall Study|Progressive Disease|13|||
126258774|NCT02443324|454237881|FG003|Overall Study|Progressive Disease|10|||
126258775|NCT02443324|454237882|FG004|Overall Study|Progressive Disease|13|||
126258776|NCT02443324|454237883|FG005|Overall Study|Progressive Disease|17|||
126258777|NCT02443324|454237884|FG006|Overall Study|Progressive Disease|10|||
126258778|NCT02443324|454237878|FG000|Overall Study|Withdrawal by Subject|0|||
126258779|NCT02443324|454237879|FG001|Overall Study|Withdrawal by Subject|0|||
126258780|NCT02443324|454237880|FG002|Overall Study|Withdrawal by Subject|3|||
126258781|NCT02443324|454237881|FG003|Overall Study|Withdrawal by Subject|1|||
126258782|NCT02443324|454237882|FG004|Overall Study|Withdrawal by Subject|1|||
126258783|NCT02443324|454237883|FG005|Overall Study|Withdrawal by Subject|0|||
126258784|NCT02443324|454237884|FG006|Overall Study|Withdrawal by Subject|1|||
126258785|NCT02443324|454237878|FG000|Overall Study|Adverse Event|0|||
126258786|NCT02443324|454237879|FG001|Overall Study|Adverse Event|1|||
126258787|NCT02443324|454237880|FG002|Overall Study|Adverse Event|3|||
126258788|NCT02443324|454237881|FG003|Overall Study|Adverse Event|0|||
126258789|NCT02443324|454237882|FG004|Overall Study|Adverse Event|4|||
126258790|NCT02443324|454237883|FG005|Overall Study|Adverse Event|3|||
126258791|NCT02443324|454237884|FG006|Overall Study|Adverse Event|3|||
126258792|NCT02443324|454237878|FG000|Overall Study|Enrolled but Never Treated|0|||
126258793|NCT02443324|454237879|FG001|Overall Study|Enrolled but Never Treated|0|||
126258794|NCT02443324|454237880|FG002|Overall Study|Enrolled but Never Treated|1|||
126258795|NCT02443324|454237881|FG003|Overall Study|Enrolled but Never Treated|0|||
126258796|NCT02443324|454237882|FG004|Overall Study|Enrolled but Never Treated|1|||
126258797|NCT02443324|454237883|FG005|Overall Study|Enrolled but Never Treated|0|||
126258798|NCT02443324|454237884|FG006|Overall Study|Enrolled but Never Treated|1|||
126258799|NCT01091103|454237888|FG000|Overall Study|Adverse Event|1|||
126258800|NCT01091103|454237888|FG000|Overall Study|Progressive Disease|3|||
126258801|NCT03449199|454237889|FG000|Overall Study|Lost to Follow-up|1|||
126258802|NCT03449199|454237890|FG001|Overall Study|Lost to Follow-up|1|||
126258803|NCT03449199|454237891|FG002|Overall Study|Lost to Follow-up|0|||
126258804|NCT03449199|454237889|FG000|Overall Study|Protocol Deviation|0|||
126258805|NCT03449199|454237890|FG001|Overall Study|Protocol Deviation|0|||
126258806|NCT03449199|454237891|FG002|Overall Study|Protocol Deviation|1|||
126258807|NCT03449199|454237889|FG000|Overall Study|Withdrawal by Subject|0|||
126258808|NCT03449199|454237890|FG001|Overall Study|Withdrawal by Subject|0|||
126258809|NCT03449199|454237891|FG002|Overall Study|Withdrawal by Subject|1|||
126258810|NCT01270620|454237892|FG000|Overall Study|Withdrawal by Subject|1|||
126258811|NCT01270620|454237893|FG001|Overall Study|Withdrawal by Subject|3|||
126258812|NCT00684567|454237894|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
126258813|NCT00684567|454237894|FG000|Monotherapy Period|Adverse Event|2|||
126258814|NCT00684567|454237894|FG000|Monotherapy Period|Death|1|||
126258815|NCT00684567|454237894|FG000|Monotherapy Period|Progression of primary disease|11|||
126258816|NCT03136406|454237900|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
126258817|NCT00988208|454237903|FG000|Overall Study|Adverse Event|71|||
126258818|NCT00988208|454237904|FG001|Overall Study|Adverse Event|122|||
126258819|NCT00988208|454237903|FG000|Overall Study|Disease Progression|103|||
126258820|NCT00988208|454237904|FG001|Overall Study|Disease Progression|89|||
126258821|NCT00988208|454237903|FG000|Overall Study|Withdrawal by Subject|50|||
126258822|NCT00988208|454237904|FG001|Overall Study|Withdrawal by Subject|57|||
126258823|NCT00988208|454237903|FG000|Overall Study|Death|9|||
126258824|NCT00988208|454237904|FG001|Overall Study|Death|15|||
126258825|NCT00988208|454237903|FG000|Overall Study|Lost to Follow-up|2|||
126258826|NCT00988208|454237904|FG001|Overall Study|Lost to Follow-up|3|||
126258827|NCT00988208|454237903|FG000|Overall Study|Protocol Violation|9|||
126258828|NCT00988208|454237904|FG001|Overall Study|Protocol Violation|2|||
126258829|NCT00988208|454237903|FG000|Overall Study|Sponsor Decision|102|||
126258830|NCT00988208|454237904|FG001|Overall Study|Sponsor Decision|78|||
126258831|NCT00988208|454237903|FG000|Overall Study|Clinical Progression|17|||
126258832|NCT00988208|454237904|FG001|Overall Study|Clinical Progression|16|||
126258833|NCT00988208|454237903|FG000|Overall Study|Biochemical Progression|21|||
126258834|NCT00988208|454237904|FG001|Overall Study|Biochemical Progression|7|||
126258835|NCT00988208|454237903|FG000|Overall Study|Clinical Deterioration|7|||
126258836|NCT00988208|454237904|FG001|Overall Study|Clinical Deterioration|14|||
126258837|NCT00988208|454237903|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
126359194|NCT02533674|454607317|FG002|Dose Level VIII|Treatment-related AE|0|||
126359195|NCT02533674|454607318|FG003|Dose Level VIII|Treatment-related AE|0|||
126359196|NCT02533674|454607319|FG004|Dose Level VIII|Treatment-related AE|0|||
126359197|NCT02533674|454607320|FG005|Dose Level VIII|Treatment-related AE|0|||
126359198|NCT02533674|454607321|FG006|Dose Level VIII|Treatment-related AE|0|||
126359199|NCT02533674|454607322|FG007|Dose Level VIII|Treatment-related AE|1|||
126359200|NCT02533674|454607315|FG000|Dose Level VIII|Never treated|0|||
126359201|NCT02533674|454607316|FG001|Dose Level VIII|Never treated|0|||
126359202|NCT02533674|454607317|FG002|Dose Level VIII|Never treated|0|||
126359203|NCT02533674|454607318|FG003|Dose Level VIII|Never treated|0|||
126359204|NCT02533674|454607319|FG004|Dose Level VIII|Never treated|0|||
126359205|NCT02533674|454607320|FG005|Dose Level VIII|Never treated|0|||
126699070|NCT00868790|455848802|FG012|Period 4|Adverse Event|1|||
126258838|NCT00988208|454237904|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
126258839|NCT00988208|454237903|FG000|Overall Study|Other|8|||
126258840|NCT00988208|454237904|FG001|Overall Study|Other|3|||
126258841|NCT02780167|454237912|FG000|Overall Study|Adverse Event|9|||
126258842|NCT02780167|454237913|FG001|Overall Study|Adverse Event|8|||
126359206|NCT02533674|454607321|FG006|Dose Level VIII|Never treated|0|||
126450488|NCT01510769|454950663|FG000|Overall Study|Protocol Violation|11|||
126699071|NCT00868790|455848803|FG013|Period 4|Adverse Event|0|||
126258843|NCT02780167|454237914|FG002|Overall Study|Adverse Event|8|||
126258844|NCT02780167|454237915|FG003|Overall Study|Adverse Event|12|||
126258845|NCT02780167|454237916|FG004|Overall Study|Adverse Event|8|||
126258846|NCT02780167|454237912|FG000|Overall Study|Lack of Efficacy|6|||
126258847|NCT02780167|454237913|FG001|Overall Study|Lack of Efficacy|5|||
126258848|NCT02780167|454237914|FG002|Overall Study|Lack of Efficacy|6|||
126699072|NCT00868790|455848790|FG000|Period 4|Lost to Follow-up|0|||
126258849|NCT02780167|454237915|FG003|Overall Study|Lack of Efficacy|1|||
126258850|NCT02780167|454237916|FG004|Overall Study|Lack of Efficacy|0|||
126258851|NCT02780167|454237912|FG000|Overall Study|Lost to Follow-up|2|||
126258852|NCT02780167|454237913|FG001|Overall Study|Lost to Follow-up|0|||
126258853|NCT02780167|454237914|FG002|Overall Study|Lost to Follow-up|1|||
126258854|NCT02780167|454237915|FG003|Overall Study|Lost to Follow-up|0|||
126258855|NCT02780167|454237916|FG004|Overall Study|Lost to Follow-up|0|||
126258856|NCT02780167|454237912|FG000|Overall Study|Does not meet entrance criteria|0|||
126258857|NCT02780167|454237913|FG001|Overall Study|Does not meet entrance criteria|0|||
126258858|NCT02780167|454237914|FG002|Overall Study|Does not meet entrance criteria|1|||
126258859|NCT02780167|454237915|FG003|Overall Study|Does not meet entrance criteria|0|||
126258860|NCT02780167|454237916|FG004|Overall Study|Does not meet entrance criteria|0|||
126258861|NCT02780167|454237912|FG000|Overall Study|No longer meets eligibility criteria|0|||
126258862|NCT02780167|454237913|FG001|Overall Study|No longer meets eligibility criteria|0|||
126258863|NCT02780167|454237914|FG002|Overall Study|No longer meets eligibility criteria|0|||
126258864|NCT02780167|454237915|FG003|Overall Study|No longer meets eligibility criteria|1|||
126258865|NCT02780167|454237916|FG004|Overall Study|No longer meets eligibility criteria|1|||
126450489|NCT01510769|454950664|FG001|Overall Study|Protocol Violation|10|||
126450490|NCT01510769|454950665|FG002|Overall Study|Protocol Violation|9|||
126450491|NCT01510769|454950663|FG000|Overall Study|Lost to Follow-up|5|||
126450492|NCT01510769|454950664|FG001|Overall Study|Lost to Follow-up|1|||
126450493|NCT01510769|454950665|FG002|Overall Study|Lost to Follow-up|5|||
126450494|NCT01510769|454950663|FG000|Overall Study|Withdrawal by Subject|3|||
126450495|NCT01510769|454950664|FG001|Overall Study|Withdrawal by Subject|4|||
126450496|NCT01510769|454950665|FG002|Overall Study|Withdrawal by Subject|3|||
126450497|NCT01510769|454950663|FG000|Overall Study|Death|1|||
126450498|NCT01510769|454950664|FG001|Overall Study|Death|1|||
126450499|NCT01510769|454950665|FG002|Overall Study|Death|0|||
126450500|NCT00335764|454950666|FG000|Overall Study|wrong histology|1|||
126450501|NCT00335764|454950667|FG001|Overall Study|wrong histology|0|||
126450502|NCT00335764|454950668|FG002|Overall Study|wrong histology|0|||
126450503|NCT00335764|454950669|FG003|Overall Study|wrong histology|0|||
126450504|NCT00335764|454950670|FG004|Overall Study|wrong histology|1|||
126763187|NCT04365387|456084986|FG001|Overall Study|Participant incarcerated|0|||
126763188|NCT04365387|456084985|FG000|Overall Study|Participant moved out of town (relocated)|0|||
126763189|NCT04365387|456084986|FG001|Overall Study|Participant moved out of town (relocated)|1|||
126763190|NCT04365387|456084985|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
126258866|NCT02780167|454237912|FG000|Overall Study|Protocol Violation|5|||
126258867|NCT02780167|454237913|FG001|Overall Study|Protocol Violation|5|||
126258868|NCT02780167|454237914|FG002|Overall Study|Protocol Violation|1|||
126258869|NCT02780167|454237915|FG003|Overall Study|Protocol Violation|1|||
126258870|NCT02780167|454237916|FG004|Overall Study|Protocol Violation|2|||
126258871|NCT02780167|454237912|FG000|Overall Study|Withdrawal by Subject|6|||
126258872|NCT02780167|454237913|FG001|Overall Study|Withdrawal by Subject|4|||
126258873|NCT02780167|454237914|FG002|Overall Study|Withdrawal by Subject|4|||
126258874|NCT02780167|454237915|FG003|Overall Study|Withdrawal by Subject|3|||
126258875|NCT02780167|454237916|FG004|Overall Study|Withdrawal by Subject|4|||
126258876|NCT02780167|454237912|FG000|Overall Study|Other|0|||
126258877|NCT02780167|454237913|FG001|Overall Study|Other|0|||
126258878|NCT02780167|454237914|FG002|Overall Study|Other|3|||
126258879|NCT02780167|454237915|FG003|Overall Study|Other|1|||
126258880|NCT02780167|454237916|FG004|Overall Study|Other|2|||
126258881|NCT03180801|454237917|FG000|Overall Study|Physician Decision|3|||
126258882|NCT03180801|454237918|FG001|Overall Study|Physician Decision|3|||
126258883|NCT03180801|454237919|FG002|Overall Study|Physician Decision|1|||
126258884|NCT03180801|454237917|FG000|Overall Study|Non-compliance|1|||
126258885|NCT03180801|454237918|FG001|Overall Study|Non-compliance|4|||
126258886|NCT03180801|454237919|FG002|Overall Study|Non-compliance|0|||
126258887|NCT03180801|454237917|FG000|Overall Study|Inoculation Target Reached|1|||
126258888|NCT03180801|454237918|FG001|Overall Study|Inoculation Target Reached|1|||
126258889|NCT03180801|454237919|FG002|Overall Study|Inoculation Target Reached|3|||
126763191|NCT04365387|456084986|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
126258890|NCT03180801|454237917|FG000|Overall Study|Adverse Event|1|||
126258891|NCT03180801|454237918|FG001|Overall Study|Adverse Event|0|||
126258892|NCT03180801|454237919|FG002|Overall Study|Adverse Event|2|||
126258893|NCT03180801|454237917|FG000|Overall Study|Withdrawal by Subject|2|||
126258894|NCT03180801|454237918|FG001|Overall Study|Withdrawal by Subject|2|||
126258895|NCT03180801|454237919|FG002|Overall Study|Withdrawal by Subject|1|||
126258896|NCT03180801|454237917|FG000|Overall Study|Lost to Follow-up|0|||
126450505|NCT02466659|454950673|FG000|Overall Study|Lost to Follow-up|5|||
126450506|NCT02466659|454950674|FG001|Overall Study|Lost to Follow-up|2|||
126258897|NCT03180801|454237918|FG001|Overall Study|Lost to Follow-up|2|||
126258898|NCT03180801|454237919|FG002|Overall Study|Lost to Follow-up|3|||
126258899|NCT03756883|454237920|FG000|Overall Study|Adverse Event|2|||
126258900|NCT03756883|454237921|FG001|Overall Study|Adverse Event|2|||
126258901|NCT03756883|454237922|FG002|Overall Study|Adverse Event|2|||
126450507|NCT00929643|454950675|FG000|Overall Study|Protocol Violation|2|||
126450508|NCT00934440|454950678|FG000|Overall Study|Lost to Follow-up|1|||
126699073|NCT00868790|455848791|FG001|Period 4|Lost to Follow-up|0|||
126699074|NCT00868790|455848792|FG002|Period 4|Lost to Follow-up|0|||
126258902|NCT03756883|454237920|FG000|Overall Study|Lack of Efficacy|0|||
126258903|NCT03756883|454237921|FG001|Overall Study|Lack of Efficacy|1|||
126258904|NCT03756883|454237922|FG002|Overall Study|Lack of Efficacy|2|||
126258905|NCT03756883|454237920|FG000|Overall Study|Lost to Follow-up|3|||
126258906|NCT03756883|454237921|FG001|Overall Study|Lost to Follow-up|3|||
126258907|NCT03756883|454237922|FG002|Overall Study|Lost to Follow-up|0|||
126258908|NCT03756883|454237920|FG000|Overall Study|Protocol Violation|2|||
126258909|NCT03756883|454237921|FG001|Overall Study|Protocol Violation|0|||
126258910|NCT03756883|454237922|FG002|Overall Study|Protocol Violation|1|||
126258911|NCT03756883|454237920|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
126258912|NCT03756883|454237921|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
126258913|NCT03756883|454237922|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
126258914|NCT03756883|454237920|FG000|Overall Study|Withdrawal by Subject|4|||
126258915|NCT03756883|454237921|FG001|Overall Study|Withdrawal by Subject|1|||
126258916|NCT03756883|454237922|FG002|Overall Study|Withdrawal by Subject|0|||
126258917|NCT03756883|454237920|FG000|Overall Study|Other Reasons|2|||
126258918|NCT03756883|454237921|FG001|Overall Study|Other Reasons|4|||
126258919|NCT03756883|454237922|FG002|Overall Study|Other Reasons|0|||
126258920|NCT03235479|454237925|FG000|Overall Study|Lost to Follow-up|8|||
126258921|NCT03235479|454237926|FG001|Overall Study|Lost to Follow-up|11|||
126258922|NCT03235479|454237925|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
126258923|NCT03235479|454237926|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
126258924|NCT03235479|454237925|FG000|Overall Study|Pregnancy|1|||
126258925|NCT03235479|454237926|FG001|Overall Study|Pregnancy|0|||
126258926|NCT03235479|454237925|FG000|Overall Study|Protocol Deviation|1|||
126258927|NCT03235479|454237926|FG001|Overall Study|Protocol Deviation|3|||
126258928|NCT03235479|454237925|FG000|Overall Study|Technical Problems|3|||
126258929|NCT03235479|454237926|FG001|Overall Study|Technical Problems|2|||
126258930|NCT03235479|454237925|FG000|Overall Study|Withdrawal by Subject|2|||
126258931|NCT03235479|454237926|FG001|Overall Study|Withdrawal by Subject|2|||
126258932|NCT03235479|454237925|FG000|Overall Study|Other Reasons|3|||
126258933|NCT03235479|454237926|FG001|Overall Study|Other Reasons|5|||
126258934|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
126258935|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
126258936|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
126258937|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
126258938|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
126258939|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
126258940|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126258941|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126258942|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
126258943|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
126258944|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
126258945|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
126258946|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
126258947|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
126258948|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
126258949|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
126258950|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Death|2|||
126258951|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Death|1|||
126258952|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Death|0|||
126258953|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Death|0|||
126258954|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
126258955|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
126258956|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
126258957|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
126258958|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
126258959|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
126258960|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
126359207|NCT02533674|454607322|FG007|Dose Level VIII|Never treated|1|||
126699075|NCT00868790|455848793|FG003|Period 4|Lost to Follow-up|0|||
126699076|NCT00868790|455848794|FG004|Period 4|Lost to Follow-up|0|||
126699077|NCT00868790|455848795|FG005|Period 4|Lost to Follow-up|0|||
126699078|NCT00868790|455848796|FG006|Period 4|Lost to Follow-up|0|||
126699079|NCT00868790|455848797|FG007|Period 4|Lost to Follow-up|1|||
126699080|NCT00868790|455848798|FG008|Period 4|Lost to Follow-up|0|||
126699081|NCT00868790|455848799|FG009|Period 4|Lost to Follow-up|0|||
126699082|NCT00868790|455848800|FG010|Period 4|Lost to Follow-up|0|||
126699083|NCT00868790|455848801|FG011|Period 4|Lost to Follow-up|0|||
126699084|NCT00868790|455848802|FG012|Period 4|Lost to Follow-up|0|||
126359208|NCT01292473|454607326|FG000|Overall Study|Adverse Event|1|||
126359209|NCT01292473|454607327|FG001|Overall Study|Adverse Event|0|||
126699085|NCT00868790|455848803|FG013|Period 4|Lost to Follow-up|0|||
126699086|NCT00868790|455848790|FG000|Period 4|Study Terminated by Sponsor|2|||
126699087|NCT00868790|455848791|FG001|Period 4|Study Terminated by Sponsor|0|||
126699088|NCT00868790|455848792|FG002|Period 4|Study Terminated by Sponsor|0|||
126699089|NCT00868790|455848793|FG003|Period 4|Study Terminated by Sponsor|0|||
126699090|NCT00868790|455848794|FG004|Period 4|Study Terminated by Sponsor|0|||
126699091|NCT00868790|455848795|FG005|Period 4|Study Terminated by Sponsor|0|||
126699092|NCT00868790|455848796|FG006|Period 4|Study Terminated by Sponsor|0|||
126699093|NCT00868790|455848797|FG007|Period 4|Study Terminated by Sponsor|1|||
126699094|NCT00868790|455848798|FG008|Period 4|Study Terminated by Sponsor|2|||
126699095|NCT00868790|455848799|FG009|Period 4|Study Terminated by Sponsor|0|||
126699096|NCT00868790|455848800|FG010|Period 4|Study Terminated by Sponsor|2|||
126699097|NCT00868790|455848801|FG011|Period 4|Study Terminated by Sponsor|1|||
126763192|NCT04365387|456084985|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
126763193|NCT04365387|456084986|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
126763194|NCT05770401|456084987|FG000|Overall Study|Lost to Follow-up|5|||
126763195|NCT05770401|456084988|FG001|Overall Study|Lost to Follow-up|4|||
126763196|NCT04784455|456084989|FG000|Overall Study|Death|4|||
126763197|NCT05643573|456084990|FG000|Overall Study|Adverse Event|117|||
126763198|NCT05643573|456084991|FG001|Overall Study|Adverse Event|90|||
126763199|NCT05643573|456084990|FG000|Overall Study|Death|53|||
126763200|NCT05643573|456084991|FG001|Overall Study|Death|57|||
126699098|NCT00868790|455848802|FG012|Period 4|Study Terminated by Sponsor|0|||
126699099|NCT00868790|455848803|FG013|Period 4|Study Terminated by Sponsor|1|||
126699100|NCT00868790|455848790|FG000|Period 4|Abnormal ALT/AST|0|||
126699101|NCT00868790|455848791|FG001|Period 4|Abnormal ALT/AST|0|||
126699102|NCT00868790|455848792|FG002|Period 4|Abnormal ALT/AST|1|||
126699103|NCT00868790|455848793|FG003|Period 4|Abnormal ALT/AST|0|||
126699104|NCT00868790|455848794|FG004|Period 4|Abnormal ALT/AST|0|||
126699105|NCT00868790|455848795|FG005|Period 4|Abnormal ALT/AST|0|||
126699106|NCT00868790|455848796|FG006|Period 4|Abnormal ALT/AST|0|||
126699107|NCT00868790|455848797|FG007|Period 4|Abnormal ALT/AST|0|||
126699108|NCT00868790|455848798|FG008|Period 4|Abnormal ALT/AST|0|||
126699109|NCT00868790|455848799|FG009|Period 4|Abnormal ALT/AST|0|||
126699110|NCT00868790|455848800|FG010|Period 4|Abnormal ALT/AST|0|||
126699111|NCT00868790|455848801|FG011|Period 4|Abnormal ALT/AST|0|||
126699112|NCT00868790|455848802|FG012|Period 4|Abnormal ALT/AST|0|||
126763201|NCT05643573|456084990|FG000|Overall Study|Lost to Follow-up|6|||
126763202|NCT05643573|456084991|FG001|Overall Study|Lost to Follow-up|3|||
126763203|NCT05643573|456084990|FG000|Overall Study|Other|18|||
126763204|NCT05643573|456084991|FG001|Overall Study|Other|15|||
126763205|NCT05643573|456084990|FG000|Overall Study|Outcome event|64|||
126450509|NCT00744042|454950679|FG000|Overall Study|Withdrawal by Subject|1|||
126450510|NCT03158285|454950684|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
126450511|NCT03158285|454950685|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
126450512|NCT03158285|454950686|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
126450513|NCT03158285|454950684|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
126450514|NCT03158285|454950685|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
126450515|NCT03158285|454950686|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
126450516|NCT03158285|454950684|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
126450517|NCT03158285|454950685|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
126450518|NCT03158285|454950686|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
126450519|NCT03158285|454950684|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
126450520|NCT03158285|454950685|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
126450521|NCT03158285|454950686|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
126450522|NCT03158285|454950684|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
126450523|NCT03158285|454950685|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
126450524|NCT03158285|454950686|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
126450525|NCT03158285|454950684|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
126450526|NCT03158285|454950685|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
126450527|NCT03158285|454950686|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
126450528|NCT03158285|454950684|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
126699113|NCT00868790|455848803|FG013|Period 4|Abnormal ALT/AST|0|||
126699114|NCT00868790|455848790|FG000|Post-study|Withdrawal by Subject|0|||
126699115|NCT00868790|455848791|FG001|Post-study|Withdrawal by Subject|0|||
126699116|NCT00868790|455848792|FG002|Post-study|Withdrawal by Subject|0|||
126699117|NCT00868790|455848793|FG003|Post-study|Withdrawal by Subject|0|||
126699118|NCT00868790|455848794|FG004|Post-study|Withdrawal by Subject|1|||
126450529|NCT03158285|454950685|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
126450530|NCT03158285|454950686|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
126699119|NCT00868790|455848795|FG005|Post-study|Withdrawal by Subject|0|||
126699120|NCT00868790|455848796|FG006|Post-study|Withdrawal by Subject|0|||
126699121|NCT00868790|455848797|FG007|Post-study|Withdrawal by Subject|0|||
126763206|NCT05643573|456084991|FG001|Overall Study|Outcome event|36|||
126763207|NCT05643573|456084990|FG000|Overall Study|Physician Decision|33|||
126763208|NCT05643573|456084991|FG001|Overall Study|Physician Decision|19|||
126258961|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
126258962|NCT03110380|454237938|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
126763209|NCT05643573|456084990|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
126763210|NCT05643573|456084991|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
126258963|NCT03110380|454237939|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
126258964|NCT03110380|454237940|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
126258965|NCT03110380|454237941|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
126258966|NCT03110380|454237938|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
126258967|NCT03110380|454237939|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
126258968|NCT03110380|454237940|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
126258969|NCT03110380|454237941|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
126763211|NCT05643573|456084990|FG000|Overall Study|Site terminated by sponsor|10|||
126763212|NCT05643573|456084991|FG001|Overall Study|Site terminated by sponsor|10|||
126763213|NCT05643573|456084990|FG000|Overall Study|Study terminated by sponsor|1|||
126763214|NCT05643573|456084991|FG001|Overall Study|Study terminated by sponsor|0|||
126258970|NCT03110380|454237938|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
126258971|NCT03110380|454237939|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
126258972|NCT03110380|454237940|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
126258973|NCT03110380|454237941|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
126258974|NCT03110380|454237938|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
126258975|NCT03110380|454237939|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
126699122|NCT00868790|455848798|FG008|Post-study|Withdrawal by Subject|0|||
126699123|NCT00868790|455848799|FG009|Post-study|Withdrawal by Subject|0|||
126699124|NCT00868790|455848800|FG010|Post-study|Withdrawal by Subject|0|||
126699125|NCT00868790|455848801|FG011|Post-study|Withdrawal by Subject|0|||
126699126|NCT00868790|455848802|FG012|Post-study|Withdrawal by Subject|0|||
126699127|NCT00868790|455848803|FG013|Post-study|Withdrawal by Subject|0|||
126699128|NCT00868790|455848790|FG000|Post-study|Excluded Medication|0|||
126699129|NCT00868790|455848791|FG001|Post-study|Excluded Medication|0|||
126699130|NCT00868790|455848792|FG002|Post-study|Excluded Medication|0|||
126699131|NCT00868790|455848793|FG003|Post-study|Excluded Medication|0|||
126699132|NCT00868790|455848794|FG004|Post-study|Excluded Medication|0|||
126699133|NCT00868790|455848795|FG005|Post-study|Excluded Medication|0|||
126699134|NCT00868790|455848796|FG006|Post-study|Excluded Medication|0|||
126699135|NCT00868790|455848797|FG007|Post-study|Excluded Medication|2|||
126699136|NCT00868790|455848798|FG008|Post-study|Excluded Medication|0|||
126699137|NCT00868790|455848799|FG009|Post-study|Excluded Medication|1|||
126699138|NCT00868790|455848800|FG010|Post-study|Excluded Medication|0|||
126699139|NCT00868790|455848801|FG011|Post-study|Excluded Medication|0|||
126699140|NCT00868790|455848802|FG012|Post-study|Excluded Medication|0|||
126699141|NCT00868790|455848803|FG013|Post-study|Excluded Medication|0|||
126699142|NCT03377634|455848807|FG000|Study Period|Adverse Event|1|||
126699143|NCT03377634|455848808|FG001|Study Period|Adverse Event|0|||
126699144|NCT03377634|455848807|FG000|Study Period|Withdrawal by Subject|1|||
126699145|NCT03377634|455848808|FG001|Study Period|Withdrawal by Subject|0|||
126699146|NCT03040024|455848810|FG000|Overall Study|Adverse Event|0|||
126699147|NCT03040024|455848811|FG001|Overall Study|Adverse Event|1|||
126699148|NCT03040024|455848812|FG002|Overall Study|Adverse Event|0|||
126699149|NCT03040024|455848810|FG000|Overall Study|Death|0|||
126699150|NCT03040024|455848811|FG001|Overall Study|Death|1|||
126699151|NCT03040024|455848812|FG002|Overall Study|Death|0|||
126699152|NCT03040024|455848810|FG000|Overall Study|Physician Decision|0|||
126699153|NCT03040024|455848811|FG001|Overall Study|Physician Decision|0|||
126699154|NCT03040024|455848812|FG002|Overall Study|Physician Decision|1|||
126699155|NCT01526148|455848814|FG000|Overall Study|Adverse Event|6|||
126699156|NCT01526148|455848815|FG001|Overall Study|Adverse Event|5|||
126699157|NCT01526148|455848814|FG000|Overall Study|Lost to Follow-up|3|||
126699158|NCT01526148|455848815|FG001|Overall Study|Lost to Follow-up|6|||
126699159|NCT01526148|455848814|FG000|Overall Study|Withdrawal by Subject|2|||
126699160|NCT01526148|455848815|FG001|Overall Study|Withdrawal by Subject|0|||
126699161|NCT01526148|455848814|FG000|Overall Study|Unstable Medical Condition|1|||
126699162|NCT01526148|455848815|FG001|Overall Study|Unstable Medical Condition|0|||
126258976|NCT03110380|454237940|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
126699163|NCT01526148|455848814|FG000|Overall Study|Unable to discontinue concomitant med|1|||
126699164|NCT01526148|455848815|FG001|Overall Study|Unable to discontinue concomitant med|0|||
126699165|NCT01526148|455848814|FG000|Overall Study|Moved out of state|1|||
126699166|NCT01526148|455848815|FG001|Overall Study|Moved out of state|0|||
126699167|NCT01526148|455848814|FG000|Overall Study|Incarcerated|0|||
126699168|NCT01526148|455848815|FG001|Overall Study|Incarcerated|2|||
126699169|NCT01818297|455848816|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
126699170|NCT01818297|455848817|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
126699171|NCT01818297|455848816|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
126699172|NCT01818297|455848817|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
126699173|NCT01818297|455848816|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
126763215|NCT05643573|456084990|FG000|Overall Study|Withdrawal by Subject|178|||
126699174|NCT01818297|455848817|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
126699175|NCT01651780|455848818|FG000|Overall Study|Physician decision: No 30-day visit|2|||
126699176|NCT01651780|455848819|FG001|Overall Study|Physician decision: No 30-day visit|1|||
126699177|NCT01651780|455848818|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
126699178|NCT01651780|455848819|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
126699179|NCT01651780|455848818|FG000|Overall Study|Withdrawal by Subject|2|||
126699180|NCT01651780|455848819|FG001|Overall Study|Withdrawal by Subject|0|||
126699181|NCT01651780|455848818|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
126699182|NCT01651780|455848819|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126699183|NCT01651780|455848818|FG000|Overall Study|Lost to Follow-up|1|||
126699184|NCT01651780|455848819|FG001|Overall Study|Lost to Follow-up|2|||
126699185|NCT01651780|455848818|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
126699186|NCT01651780|455848819|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
126699187|NCT02901431|455848824|FG000|PK Part|Adverse Event|0|||
126699188|NCT02901431|455848825|FG001|PK Part|Adverse Event|1|||
126699189|NCT02901431|455848826|FG002|PK Part|Adverse Event|0|||
126699190|NCT02901431|455848827|FG003|PK Part|Adverse Event|0|||
126699191|NCT02901431|455848828|FG004|PK Part|Adverse Event|0|||
126699192|NCT02901431|455848829|FG005|PK Part|Adverse Event|0|||
126699193|NCT02901431|455848830|FG006|PK Part|Adverse Event|0|||
126699194|NCT02901431|455848831|FG007|PK Part|Adverse Event|0|||
126699195|NCT02901431|455848832|FG008|PK Part|Adverse Event|0|||
126699196|NCT02901431|455848833|FG009|PK Part|Adverse Event|0|||
126699197|NCT02901431|455848834|FG010|PK Part|Adverse Event|0|||
126699198|NCT02901431|455848835|FG011|PK Part|Adverse Event|0|||
126699199|NCT02901431|455848836|FG012|PK Part|Adverse Event|0|||
126699200|NCT02901431|455848824|FG000|PK Part|Lost to Follow-up|0|||
126699201|NCT02901431|455848825|FG001|PK Part|Lost to Follow-up|0|||
126699202|NCT02901431|455848826|FG002|PK Part|Lost to Follow-up|1|||
126699203|NCT02901431|455848827|FG003|PK Part|Lost to Follow-up|0|||
126699204|NCT02901431|455848828|FG004|PK Part|Lost to Follow-up|0|||
126699205|NCT02901431|455848829|FG005|PK Part|Lost to Follow-up|0|||
126699206|NCT02901431|455848830|FG006|PK Part|Lost to Follow-up|0|||
126699207|NCT02901431|455848831|FG007|PK Part|Lost to Follow-up|0|||
126699208|NCT02901431|455848832|FG008|PK Part|Lost to Follow-up|0|||
126699209|NCT02901431|455848833|FG009|PK Part|Lost to Follow-up|0|||
126699210|NCT02901431|455848834|FG010|PK Part|Lost to Follow-up|0|||
126699211|NCT02901431|455848835|FG011|PK Part|Lost to Follow-up|0|||
126699212|NCT02901431|455848836|FG012|PK Part|Lost to Follow-up|0|||
126699213|NCT02901431|455848824|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
126699214|NCT02901431|455848825|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126699215|NCT02901431|455848826|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126699216|NCT02901431|455848827|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126699217|NCT02901431|455848828|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126699218|NCT02901431|455848829|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126699219|NCT02901431|455848830|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126699220|NCT02901431|455848831|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126699221|NCT02901431|455848832|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126699222|NCT02901431|455848833|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126699223|NCT02901431|455848834|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126699224|NCT02901431|455848835|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126699225|NCT02901431|455848836|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
126699226|NCT02901431|455848824|FG000|PK Part|Pending dose confirmation|0|||
126699227|NCT02901431|455848825|FG001|PK Part|Pending dose confirmation|1|||
126699228|NCT02901431|455848826|FG002|PK Part|Pending dose confirmation|0|||
126699229|NCT02901431|455848827|FG003|PK Part|Pending dose confirmation|0|||
126699230|NCT02901431|455848828|FG004|PK Part|Pending dose confirmation|0|||
126699231|NCT02901431|455848829|FG005|PK Part|Pending dose confirmation|0|||
126699232|NCT02901431|455848830|FG006|PK Part|Pending dose confirmation|0|||
126699233|NCT02901431|455848831|FG007|PK Part|Pending dose confirmation|0|||
126699234|NCT02901431|455848832|FG008|PK Part|Pending dose confirmation|0|||
126258977|NCT03110380|454237941|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
126258978|NCT04480307|454237942|FG000|Overall Study|Withdrawal by Subject|0|||
126699235|NCT02901431|455848833|FG009|PK Part|Pending dose confirmation|0|||
126699236|NCT02901431|455848834|FG010|PK Part|Pending dose confirmation|0|||
126699237|NCT02901431|455848835|FG011|PK Part|Pending dose confirmation|0|||
126699238|NCT02901431|455848836|FG012|PK Part|Pending dose confirmation|0|||
126699239|NCT02901431|455848824|FG000|PK Part|8 weeks of treatment ran out|2|||
126699240|NCT02901431|455848825|FG001|PK Part|8 weeks of treatment ran out|0|||
126699241|NCT02901431|455848826|FG002|PK Part|8 weeks of treatment ran out|0|||
126699242|NCT02901431|455848827|FG003|PK Part|8 weeks of treatment ran out|0|||
126699243|NCT02901431|455848828|FG004|PK Part|8 weeks of treatment ran out|0|||
126699244|NCT02901431|455848829|FG005|PK Part|8 weeks of treatment ran out|0|||
126699245|NCT02901431|455848830|FG006|PK Part|8 weeks of treatment ran out|0|||
126699246|NCT02901431|455848831|FG007|PK Part|8 weeks of treatment ran out|0|||
126699247|NCT02901431|455848832|FG008|PK Part|8 weeks of treatment ran out|0|||
126699248|NCT02901431|455848833|FG009|PK Part|8 weeks of treatment ran out|0|||
126699249|NCT02901431|455848834|FG010|PK Part|8 weeks of treatment ran out|0|||
126699250|NCT02901431|455848835|FG011|PK Part|8 weeks of treatment ran out|0|||
126450531|NCT03158285|454950684|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
126450532|NCT03158285|454950685|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
126450533|NCT03158285|454950686|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
126450534|NCT03158285|454950684|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
126450535|NCT03158285|454950685|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
126450536|NCT03158285|454950686|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
126450537|NCT03158285|454950684|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
126450538|NCT03158285|454950685|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
126450539|NCT03158285|454950686|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
126450540|NCT03158285|454950684|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
126450541|NCT03158285|454950685|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
126450542|NCT03158285|454950686|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
126450543|NCT03158285|454950684|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
126450544|NCT03158285|454950685|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
126450545|NCT03158285|454950686|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
126450546|NCT03158285|454950684|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
126450547|NCT03158285|454950685|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
126450548|NCT03158285|454950686|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
126450549|NCT03158285|454950684|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
126450550|NCT03158285|454950685|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
126450551|NCT03158285|454950686|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
126450552|NCT03158285|454950684|FG000|Active Treatment Period: Week 52-100|Death|1|||
126450553|NCT03158285|454950685|FG001|Active Treatment Period: Week 52-100|Death|0|||
126450554|NCT03158285|454950686|FG002|Active Treatment Period: Week 52-100|Death|0|||
126450555|NCT03158285|454950684|FG000|Active Treatment Period: Week 52-100|Other|4|||
126450556|NCT03158285|454950685|FG001|Active Treatment Period: Week 52-100|Other|1|||
126450557|NCT03158285|454950686|FG002|Active Treatment Period: Week 52-100|Other|0|||
126450558|NCT01516034|454950689|FG000|Overall Study|Physician Decision|1|||
126450559|NCT01516034|454950689|FG000|Overall Study|Lack of Efficacy|7|||
126450560|NCT02228980|454950690|FG000|Overall Study|Adverse Event|14|||
126450561|NCT02228980|454950691|FG001|Overall Study|Adverse Event|0|||
126450562|NCT02228980|454950692|FG002|Overall Study|Adverse Event|0|||
126450563|NCT02228980|454950693|FG003|Overall Study|Adverse Event|0|||
126450564|NCT02228980|454950690|FG000|Overall Study|Protocol Violation|7|||
126450565|NCT02228980|454950691|FG001|Overall Study|Protocol Violation|0|||
126699251|NCT02901431|455848836|FG012|PK Part|8 weeks of treatment ran out|0|||
126699252|NCT02901431|455848824|FG000|PK Part|Stopped treatment after 8 weeks|1|||
126699253|NCT02901431|455848825|FG001|PK Part|Stopped treatment after 8 weeks|0|||
126699254|NCT02901431|455848826|FG002|PK Part|Stopped treatment after 8 weeks|1|||
126699255|NCT02901431|455848827|FG003|PK Part|Stopped treatment after 8 weeks|0|||
126359210|NCT01292473|454607328|FG002|Overall Study|Adverse Event|1|||
126359211|NCT01292473|454607329|FG003|Overall Study|Adverse Event|1|||
126359212|NCT01292473|454607326|FG000|Overall Study|Lost to Follow-up|1|||
126359213|NCT01292473|454607327|FG001|Overall Study|Lost to Follow-up|1|||
126359214|NCT01292473|454607328|FG002|Overall Study|Lost to Follow-up|2|||
126359215|NCT01292473|454607329|FG003|Overall Study|Lost to Follow-up|2|||
126359216|NCT01292473|454607326|FG000|Overall Study|Withdrawal by Subject|3|||
126359217|NCT01292473|454607327|FG001|Overall Study|Withdrawal by Subject|4|||
126359218|NCT01292473|454607328|FG002|Overall Study|Withdrawal by Subject|3|||
126359219|NCT01292473|454607329|FG003|Overall Study|Withdrawal by Subject|3|||
126359220|NCT01292473|454607326|FG000|Overall Study|Physician Decision|0|||
126359221|NCT01292473|454607327|FG001|Overall Study|Physician Decision|1|||
126359222|NCT01292473|454607328|FG002|Overall Study|Physician Decision|0|||
126359223|NCT01292473|454607329|FG003|Overall Study|Physician Decision|0|||
126359224|NCT01292473|454607326|FG000|Overall Study|Disease Progression|0|||
126359225|NCT01292473|454607327|FG001|Overall Study|Disease Progression|1|||
126359226|NCT01292473|454607328|FG002|Overall Study|Disease Progression|3|||
126359227|NCT01292473|454607329|FG003|Overall Study|Disease Progression|6|||
126359228|NCT00458705|454607336|FG000|Overall Study|Adverse Event|4|||
126359229|NCT00458705|454607336|FG000|Overall Study|Not Treated|1|||
126359230|NCT01717859|454607338|FG000|Overall Study|Adverse Event|5|||
126359231|NCT01717859|454607338|FG000|Overall Study|Moved out of state|1|||
126359232|NCT01717859|454607338|FG000|Overall Study|Patient concerned about mental health|1|||
126359233|NCT01717859|454607338|FG000|Overall Study|Lost to Follow-up|1|||
126359234|NCT01717859|454607338|FG000|Overall Study|Withdrawal by Subject|2|||
126359235|NCT04389671|454607339|FG000|Overall Study|Death|7|||
126699256|NCT02901431|455848828|FG004|PK Part|Stopped treatment after 8 weeks|0|||
126359236|NCT01111292|454607340|FG000|Treatment|Physician Decision|1|||
126359237|NCT01111292|454607341|FG001|Treatment|Physician Decision|1|||
126359238|NCT05463705|454607345|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
126359239|NCT05463705|454607346|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
126450566|NCT02228980|454950692|FG002|Overall Study|Protocol Violation|0|||
126450567|NCT02228980|454950693|FG003|Overall Study|Protocol Violation|0|||
126450568|NCT02228980|454950690|FG000|Overall Study|Withdrawal by Subject|3|||
126699257|NCT02901431|455848829|FG005|PK Part|Stopped treatment after 8 weeks|0|||
126699258|NCT02901431|455848830|FG006|PK Part|Stopped treatment after 8 weeks|0|||
126699259|NCT02901431|455848831|FG007|PK Part|Stopped treatment after 8 weeks|0|||
126699260|NCT02901431|455848832|FG008|PK Part|Stopped treatment after 8 weeks|0|||
126258979|NCT04480307|454237943|FG001|Overall Study|Withdrawal by Subject|1|||
126258980|NCT04480307|454237944|FG002|Overall Study|Withdrawal by Subject|0|||
126450569|NCT02228980|454950691|FG001|Overall Study|Withdrawal by Subject|3|||
126450570|NCT02228980|454950692|FG002|Overall Study|Withdrawal by Subject|2|||
126450571|NCT02228980|454950693|FG003|Overall Study|Withdrawal by Subject|3|||
126450572|NCT03060551|454950694|FG000|Overall Study|Withdrawal by Subject|1|||
126450573|NCT03060551|454950694|FG000|Overall Study|Adverse Event|1|||
126450574|NCT00750152|454950697|FG000|Overall Study|Adverse Event|2|||
126450575|NCT00750152|454950698|FG001|Overall Study|Adverse Event|1|||
126450576|NCT00750152|454950697|FG000|Overall Study|Lost to Follow-up|8|||
126450577|NCT00750152|454950698|FG001|Overall Study|Lost to Follow-up|13|||
126450578|NCT00750152|454950697|FG000|Overall Study|Withdrawal by Subject|3|||
126450579|NCT00750152|454950698|FG001|Overall Study|Withdrawal by Subject|3|||
126450580|NCT00750152|454950697|FG000|Overall Study|Physician Decision|1|||
126450581|NCT00750152|454950698|FG001|Overall Study|Physician Decision|1|||
126450582|NCT00750152|454950697|FG000|Overall Study|Non-compliance|0|||
126450583|NCT00750152|454950698|FG001|Overall Study|Non-compliance|1|||
126450584|NCT00750152|454950697|FG000|Overall Study|Termination by sponsor|1|||
126450585|NCT00750152|454950698|FG001|Overall Study|Termination by sponsor|0|||
126450586|NCT00750152|454950697|FG000|Overall Study|Other|7|||
126450587|NCT00750152|454950698|FG001|Overall Study|Other|8|||
126450588|NCT01642615|454950699|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
126450589|NCT01642615|454950700|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
126450590|NCT01642615|454950701|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
126450591|NCT01642615|454950699|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
126450592|NCT01642615|454950700|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
126450593|NCT01642615|454950701|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
126450594|NCT01642615|454950699|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
126450595|NCT01642615|454950700|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
126450596|NCT01642615|454950701|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
126450597|NCT01642615|454950699|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
126450598|NCT01642615|454950700|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
126450599|NCT01642615|454950701|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
126450600|NCT01642615|454950699|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
126450601|NCT01642615|454950700|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
126450602|NCT01642615|454950701|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
126450603|NCT01642615|454950699|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
126450604|NCT01642615|454950700|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
126450605|NCT01642615|454950701|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
126450606|NCT01642615|454950699|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
126450607|NCT01642615|454950700|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
126450608|NCT01642615|454950701|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
126450609|NCT01642615|454950699|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
126450610|NCT01642615|454950700|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
126450611|NCT01642615|454950701|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
126450612|NCT01642615|454950699|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
126450613|NCT01642615|454950700|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
126450614|NCT01642615|454950701|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
126450615|NCT01028300|454950704|FG000|Overall Study|Study Terminated|4|||
126450616|NCT01214395|454950707|FG000|Overall Study|All patients had infection|5|||
126450617|NCT00715910|454950708|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
126450618|NCT00715910|454950709|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
126450619|NCT00715910|454950710|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
126450620|NCT00715910|454950711|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
126450621|NCT00715910|454950712|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
126450622|NCT00715910|454950713|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
126450623|NCT00715910|454950708|FG000|Booster and ESFU Phase|Other|0|||
126450624|NCT00715910|454950709|FG001|Booster and ESFU Phase|Other|0|||
126450625|NCT00715910|454950710|FG002|Booster and ESFU Phase|Other|0|||
126258981|NCT04480307|454237945|FG003|Overall Study|Withdrawal by Subject|0|||
126450626|NCT00715910|454950711|FG003|Booster and ESFU Phase|Other|5|||
126699261|NCT02901431|455848833|FG009|PK Part|Stopped treatment after 8 weeks|0|||
126699262|NCT02901431|455848834|FG010|PK Part|Stopped treatment after 8 weeks|0|||
126699263|NCT02901431|455848835|FG011|PK Part|Stopped treatment after 8 weeks|0|||
126450627|NCT00715910|454950712|FG004|Booster and ESFU Phase|Other|1|||
126450628|NCT00715910|454950713|FG005|Booster and ESFU Phase|Other|0|||
126450629|NCT02034409|454950717|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
126699264|NCT02901431|455848836|FG012|PK Part|Stopped treatment after 8 weeks|0|||
126763216|NCT05643573|456084991|FG001|Overall Study|Withdrawal by Subject|130|||
126763217|NCT04768881|456084994|FG000|Overall Study|Completed Study Follow-up|0|||
126763218|NCT04768881|456084995|FG001|Overall Study|Completed Study Follow-up|2|||
126763219|NCT04768881|456084994|FG000|Overall Study|Death|3|||
126763220|NCT04768881|456084995|FG001|Overall Study|Death|2|||
126763221|NCT04768881|456084994|FG000|Overall Study|Study Terminated by Sponsor|2|||
126763222|NCT04768881|456084995|FG001|Overall Study|Study Terminated by Sponsor|2|||
126763223|NCT04768881|456084994|FG000|Overall Study|Withdrawal by Subject|2|||
126763224|NCT04768881|456084995|FG001|Overall Study|Withdrawal by Subject|0|||
126763225|NCT04768881|456084994|FG000|Overall Study|Other|2|||
126763226|NCT04768881|456084995|FG001|Overall Study|Other|0|||
126763227|NCT04089566|456084997|FG000|Overall Study|Death|0|||
126763228|NCT04089566|456084998|FG001|Overall Study|Death|6|||
126763229|NCT04089566|456084999|FG002|Overall Study|Death|10|||
126763230|NCT04089566|456085000|FG003|Overall Study|Death|0|||
126763231|NCT04089566|456085001|FG004|Overall Study|Death|0|||
126763232|NCT04089566|456085002|FG005|Overall Study|Death|0|||
126763233|NCT04089566|456084997|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
126763234|NCT04089566|456084998|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
126763235|NCT04089566|456084999|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
126763236|NCT04089566|456085000|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
126763237|NCT04089566|456085001|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
126763238|NCT04089566|456085002|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
126763239|NCT04089566|456084997|FG000|Overall Study|Reason not Specified|0|||
126763240|NCT04089566|456084998|FG001|Overall Study|Reason not Specified|4|||
126763241|NCT04089566|456084999|FG002|Overall Study|Reason not Specified|4|||
126763242|NCT04089566|456085000|FG003|Overall Study|Reason not Specified|1|||
126763243|NCT04089566|456085001|FG004|Overall Study|Reason not Specified|0|||
126763244|NCT04089566|456085002|FG005|Overall Study|Reason not Specified|0|||
126763245|NCT01875731|456085010|FG000|Overall Study|Fail to obtain lab sample|1|||
126763246|NCT01875731|456085011|FG001|Overall Study|Fail to obtain lab sample|0|||
126763247|NCT00223990|456085014|FG000|Overall Study|Moved from area|2|||
126763248|NCT00223990|456085015|FG001|Overall Study|Moved from area|1|||
126763249|NCT00223990|456085014|FG000|Overall Study|Withdrawal by Subject|4|||
126763250|NCT00223990|456085015|FG001|Overall Study|Withdrawal by Subject|8|||
126763251|NCT00223990|456085014|FG000|Overall Study|Lost to Follow-up|1|||
126763252|NCT00223990|456085015|FG001|Overall Study|Lost to Follow-up|0|||
126450630|NCT02034409|454950718|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
126450631|NCT02034409|454950717|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
126546649|NCT02769065|455296006|FG016|Overall Study|Voluntary Withdrawal|0|||
126546650|NCT02769065|455296007|FG017|Overall Study|Voluntary Withdrawal|0|||
126546651|NCT02769065|455296008|FG018|Overall Study|Voluntary Withdrawal|0|||
126546652|NCT02769065|455296009|FG019|Overall Study|Voluntary Withdrawal|0|||
126546653|NCT02769065|455296010|FG020|Overall Study|Voluntary Withdrawal|0|||
126546654|NCT02769065|455296011|FG021|Overall Study|Voluntary Withdrawal|0|||
126546655|NCT02769065|455296012|FG022|Overall Study|Voluntary Withdrawal|0|||
126546656|NCT02769065|455296013|FG023|Overall Study|Voluntary Withdrawal|0|||
126546657|NCT02769065|455296014|FG024|Overall Study|Voluntary Withdrawal|0|||
126546658|NCT02769065|455296015|FG025|Overall Study|Voluntary Withdrawal|0|||
126546659|NCT02769065|455296016|FG026|Overall Study|Voluntary Withdrawal|0|||
126546660|NCT02769065|455296017|FG027|Overall Study|Voluntary Withdrawal|0|||
126546661|NCT02769065|455296018|FG028|Overall Study|Voluntary Withdrawal|0|||
126546662|NCT02769065|455296019|FG029|Overall Study|Voluntary Withdrawal|0|||
126546663|NCT02769065|455295990|FG000|Overall Study|Reason Not Specified|0|||
126546664|NCT02769065|455295991|FG001|Overall Study|Reason Not Specified|0|||
126763253|NCT00437294|456086750|FG000|Overall Study|Adverse Event|5|||
126450632|NCT02034409|454950718|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
126450633|NCT02034409|454950717|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
126450634|NCT02034409|454950718|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
126450635|NCT02034409|454950717|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
126450636|NCT02034409|454950718|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
126450637|NCT02034409|454950717|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
126450638|NCT02034409|454950718|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
126450639|NCT02034409|454950717|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
126763254|NCT00437294|456086751|FG001|Overall Study|Adverse Event|4|||
126763255|NCT00437294|456086750|FG000|Overall Study|Death|5|||
126763256|NCT00437294|456086751|FG001|Overall Study|Death|2|||
126258982|NCT04480307|454237942|FG000|Overall Study|Adverse Event|0|||
126546665|NCT02769065|455295992|FG002|Overall Study|Reason Not Specified|0|||
126546666|NCT02769065|455295993|FG003|Overall Study|Reason Not Specified|0|||
126546667|NCT02769065|455295994|FG004|Overall Study|Reason Not Specified|0|||
126763257|NCT00437294|456086750|FG000|Overall Study|Physician Decision|0|||
126763258|NCT00437294|456086751|FG001|Overall Study|Physician Decision|3|||
126763259|NCT00437294|456086750|FG000|Overall Study|Withdrawal by Subject|5|||
126763260|NCT00437294|456086751|FG001|Overall Study|Withdrawal by Subject|0|||
126763261|NCT00437294|456086750|FG000|Overall Study|Progressive Disease|19|||
126450640|NCT02034409|454950718|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
126450641|NCT01699867|454950719|FG000|Overall Study|Screening Failure|3|||
126450642|NCT05092360|454950721|FG000|Overall Study|Withdrawal by Subject|21|||
126450643|NCT05092360|454950722|FG001|Overall Study|Withdrawal by Subject|4|||
126699265|NCT02901431|455848824|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
126699266|NCT02901431|455848825|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126699267|NCT02901431|455848826|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
126699268|NCT02901431|455848827|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126699269|NCT02901431|455848828|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126699270|NCT02901431|455848829|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126699271|NCT02901431|455848830|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126699272|NCT02901431|455848831|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126699273|NCT02901431|455848832|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126699274|NCT02901431|455848833|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126699275|NCT02901431|455848834|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126699276|NCT02901431|455848835|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126258983|NCT04480307|454237943|FG001|Overall Study|Adverse Event|0|||
126450644|NCT05092360|454950723|FG002|Overall Study|Withdrawal by Subject|9|||
126450645|NCT05092360|454950724|FG003|Overall Study|Withdrawal by Subject|26|||
126450646|NCT05092360|454950721|FG000|Overall Study|Death|97|||
126450647|NCT05092360|454950722|FG001|Overall Study|Death|14|||
126450648|NCT05092360|454950723|FG002|Overall Study|Death|31|||
126450649|NCT05092360|454950724|FG003|Overall Study|Death|101|||
126450650|NCT05092360|454950721|FG000|Overall Study|Lost to Follow-up|1|||
126546668|NCT02769065|455295995|FG005|Overall Study|Reason Not Specified|0|||
126258984|NCT04480307|454237944|FG002|Overall Study|Adverse Event|0|||
126258985|NCT04480307|454237945|FG003|Overall Study|Adverse Event|1|||
126258986|NCT01609582|454237947|FG000|Overall Study|Adverse Event|20|||
126258987|NCT01609582|454237948|FG001|Overall Study|Adverse Event|18|||
126258988|NCT01609582|454237947|FG000|Overall Study|Lost to Follow-up|10|||
126258989|NCT01609582|454237948|FG001|Overall Study|Lost to Follow-up|10|||
126258990|NCT01609582|454237947|FG000|Overall Study|Withdrawal by Subject|21|||
126258991|NCT01609582|454237948|FG001|Overall Study|Withdrawal by Subject|15|||
126258992|NCT01609582|454237947|FG000|Overall Study|Study Terminated by Sponsor|1543|||
126258993|NCT01609582|454237948|FG001|Overall Study|Study Terminated by Sponsor|1548|||
126258994|NCT01609582|454237947|FG000|Overall Study|Other|9|||
126258995|NCT01609582|454237948|FG001|Overall Study|Other|10|||
126258996|NCT01609582|454237947|FG000|Overall Study|Randomized, but not treated|0|||
126258997|NCT01609582|454237948|FG001|Overall Study|Randomized, but not treated|3|||
126258998|NCT00819767|454237949|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126258999|NCT00819767|454237950|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126259000|NCT00808509|454237954|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
126259001|NCT00808509|454237955|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
126259002|NCT00808509|454237954|FG000|Randomized Phase|Reduced methotrexate dose|1|||
126259003|NCT00808509|454237955|FG001|Randomized Phase|Reduced methotrexate dose|2|||
126259004|NCT00808509|454237954|FG000|Randomized Phase|Patient refused rescue therapy|0|||
126259005|NCT00808509|454237955|FG001|Randomized Phase|Patient refused rescue therapy|3|||
126259006|NCT02762994|454237960|FG000|Overall Study|Withdrawal by Subject|0|||
126259007|NCT02762994|454237961|FG001|Overall Study|Withdrawal by Subject|1|||
126259008|NCT02762994|454237962|FG002|Overall Study|Withdrawal by Subject|2|||
126259009|NCT02762994|454237963|FG003|Overall Study|Withdrawal by Subject|0|||
126259010|NCT02762994|454237960|FG000|Overall Study|Protocol Violation|1|||
126259011|NCT02762994|454237961|FG001|Overall Study|Protocol Violation|0|||
126259012|NCT02762994|454237962|FG002|Overall Study|Protocol Violation|0|||
126259013|NCT02762994|454237963|FG003|Overall Study|Protocol Violation|2|||
126546669|NCT02769065|455295996|FG006|Overall Study|Reason Not Specified|1|||
126546670|NCT02769065|455295997|FG007|Overall Study|Reason Not Specified|0|||
126546671|NCT02769065|455295998|FG008|Overall Study|Reason Not Specified|0|||
126259014|NCT04234464|454237964|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
126259015|NCT04234464|454237965|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
126259016|NCT01701973|454237966|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126259017|NCT01701973|454237967|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
126259018|NCT01701973|454237968|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126546672|NCT02769065|455295999|FG009|Overall Study|Reason Not Specified|0|||
126546673|NCT02769065|455296000|FG010|Overall Study|Reason Not Specified|0|||
126450651|NCT05092360|454950722|FG001|Overall Study|Lost to Follow-up|2|||
126450652|NCT05092360|454950723|FG002|Overall Study|Lost to Follow-up|2|||
126546674|NCT02769065|455296001|FG011|Overall Study|Reason Not Specified|0|||
126763262|NCT00437294|456086751|FG001|Overall Study|Progressive Disease|23|||
126259019|NCT01701973|454237969|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126259020|NCT01701973|454237970|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126450653|NCT05092360|454950724|FG003|Overall Study|Lost to Follow-up|2|||
126259021|NCT01701973|454237971|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126259022|NCT01701973|454237972|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126259023|NCT01701973|454237973|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
126259024|NCT02412722|454237976|FG000|Overall Study|Adverse Event|0|||
126259025|NCT02412722|454237977|FG001|Overall Study|Adverse Event|2|||
126450654|NCT05092360|454950721|FG000|Overall Study|Study terminated by sponsor|65|||
126450655|NCT05092360|454950722|FG001|Overall Study|Study terminated by sponsor|7|||
126450656|NCT05092360|454950723|FG002|Overall Study|Study terminated by sponsor|13|||
126450657|NCT05092360|454950724|FG003|Overall Study|Study terminated by sponsor|61|||
126463792|NCT03282565|455000242|FG002|Overall Study|COVID-19 Research Shutdown|2|||
126463793|NCT04163718|455000243|FG000|Overall Study|Study terminated|12|||
126463794|NCT02131532|455000244|FG000|Overall Study|Withdrawal by Subject|1|||
126463795|NCT02131532|455000244|FG000|Overall Study|Physician Decision|1|||
126463796|NCT02131532|455000244|FG000|Overall Study|Other health conditions|2|||
126463797|NCT00450112|455000245|FG000|Overall Study|Other Treatment Required|5|||
126463798|NCT00450112|455000246|FG001|Overall Study|Other Treatment Required|1|||
126463799|NCT00450112|455000245|FG000|Overall Study|Withdrawal by Subject|4|||
126463800|NCT00450112|455000246|FG001|Overall Study|Withdrawal by Subject|1|||
126463801|NCT00450112|455000245|FG000|Overall Study|Lost to Follow-up|2|||
126463802|NCT00450112|455000246|FG001|Overall Study|Lost to Follow-up|1|||
126463803|NCT00450112|455000245|FG000|Overall Study|Others|2|||
126463804|NCT00450112|455000246|FG001|Overall Study|Others|3|||
126463805|NCT01264016|455000247|FG000|Overall Study|Withdrawal by Subject|1|||
126463806|NCT01264016|455000247|FG000|Overall Study|Felt faint at sight of blood|1|||
126463807|NCT00417482|455000248|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
126463808|NCT00417482|455000249|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
126463809|NCT00417482|455000250|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
126463810|NCT00417482|455000248|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
126463811|NCT00417482|455000249|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
126463812|NCT00417482|455000250|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
126463813|NCT00417482|455000248|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
126463814|NCT00417482|455000249|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
126463815|NCT00417482|455000250|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
126463816|NCT00417482|455000248|FG000|Phase B 1st 16 Weeks|Death|1|||
126463817|NCT00417482|455000249|FG001|Phase B 1st 16 Weeks|Death|0|||
126463818|NCT00417482|455000250|FG002|Phase B 1st 16 Weeks|Death|0|||
126463819|NCT00417482|455000248|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
126463820|NCT00417482|455000249|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
126463821|NCT00417482|455000250|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
126463822|NCT00417482|455000248|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
126463823|NCT00417482|455000249|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
126463824|NCT00417482|455000250|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
126463825|NCT00417482|455000248|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
126463826|NCT00417482|455000249|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
126463827|NCT00417482|455000250|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
126463828|NCT00417482|455000248|FG000|Phase B 2nd 16 Weeks|Death|1|||
126463829|NCT00417482|455000249|FG001|Phase B 2nd 16 Weeks|Death|1|||
126463830|NCT00417482|455000250|FG002|Phase B 2nd 16 Weeks|Death|0|||
126463831|NCT06400979|455000253|FG000|Overall Study|Lost to Follow-up|29|||
126463832|NCT06400979|455000253|FG000|Overall Study|Withdrawal by Subject|1|||
126463833|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
126463834|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
126463835|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
126463836|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
126463837|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
126463838|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
126463839|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
126463840|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
126463841|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
126463842|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
126463843|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
126463844|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
126259026|NCT02412722|454237978|FG002|Overall Study|Adverse Event|0|||
126463845|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
126463846|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
126463847|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
126463848|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
126463849|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Program Termination|3|||
126463850|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Program Termination|0|||
126463851|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Program Termination|1|||
126463852|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Program Termination|1|||
126259027|NCT02412722|454237979|FG003|Overall Study|Adverse Event|3|||
126463853|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
126763263|NCT00437294|456086750|FG000|Overall Study|Sponsor Decision|8|||
126259028|NCT02412722|454237980|FG004|Overall Study|Adverse Event|0|||
126699277|NCT02901431|455848836|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
126699278|NCT02901431|455848824|FG000|PK Part|Discontinued per Sponsor|0|||
126259029|NCT02412722|454237981|FG005|Overall Study|Adverse Event|3|||
126259030|NCT02412722|454237976|FG000|Overall Study|Progressive Disease|6|||
126259031|NCT02412722|454237977|FG001|Overall Study|Progressive Disease|4|||
126699279|NCT02901431|455848825|FG001|PK Part|Discontinued per Sponsor|3|||
126699280|NCT02901431|455848826|FG002|PK Part|Discontinued per Sponsor|0|||
126699281|NCT02901431|455848827|FG003|PK Part|Discontinued per Sponsor|0|||
126699282|NCT02901431|455848828|FG004|PK Part|Discontinued per Sponsor|0|||
126699283|NCT02901431|455848829|FG005|PK Part|Discontinued per Sponsor|0|||
126699284|NCT02901431|455848830|FG006|PK Part|Discontinued per Sponsor|0|||
126699285|NCT02901431|455848831|FG007|PK Part|Discontinued per Sponsor|0|||
126699286|NCT02901431|455848832|FG008|PK Part|Discontinued per Sponsor|0|||
126699287|NCT02901431|455848833|FG009|PK Part|Discontinued per Sponsor|0|||
126699288|NCT02901431|455848834|FG010|PK Part|Discontinued per Sponsor|0|||
126699289|NCT02901431|455848835|FG011|PK Part|Discontinued per Sponsor|0|||
126699290|NCT02901431|455848836|FG012|PK Part|Discontinued per Sponsor|0|||
126699291|NCT02901431|455848824|FG000|PK Part|Withdrawal by Subject|1|||
126699292|NCT02901431|455848825|FG001|PK Part|Withdrawal by Subject|1|||
126699293|NCT02901431|455848826|FG002|PK Part|Withdrawal by Subject|3|||
126699294|NCT02901431|455848827|FG003|PK Part|Withdrawal by Subject|0|||
126699295|NCT02901431|455848828|FG004|PK Part|Withdrawal by Subject|0|||
126699296|NCT02901431|455848829|FG005|PK Part|Withdrawal by Subject|0|||
126699297|NCT02901431|455848830|FG006|PK Part|Withdrawal by Subject|0|||
126699298|NCT02901431|455848831|FG007|PK Part|Withdrawal by Subject|0|||
126699299|NCT02901431|455848832|FG008|PK Part|Withdrawal by Subject|0|||
126699300|NCT02901431|455848833|FG009|PK Part|Withdrawal by Subject|0|||
126699301|NCT02901431|455848834|FG010|PK Part|Withdrawal by Subject|0|||
126699302|NCT02901431|455848835|FG011|PK Part|Withdrawal by Subject|0|||
126699303|NCT02901431|455848836|FG012|PK Part|Withdrawal by Subject|0|||
126259032|NCT02412722|454237978|FG002|Overall Study|Progressive Disease|4|||
126259033|NCT02412722|454237979|FG003|Overall Study|Progressive Disease|9|||
126259034|NCT02412722|454237980|FG004|Overall Study|Progressive Disease|3|||
126259035|NCT02412722|454237981|FG005|Overall Study|Progressive Disease|3|||
126359240|NCT05463705|454607347|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
126359241|NCT05463705|454607348|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
126359242|NCT05463705|454607349|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
126359243|NCT05463705|454607350|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
126359244|NCT01530997|454607356|FG000|Overall Study|Physician Decision|1|||
126359245|NCT01530997|454607356|FG000|Overall Study|Withdrawal by Subject|1|||
126359246|NCT02181738|454607359|FG000|Overall Study|Participant Withdrew Consent|2|||
126359247|NCT02181738|454607360|FG001|Overall Study|Participant Withdrew Consent|1|||
126359248|NCT02181738|454607361|FG002|Overall Study|Participant Withdrew Consent|1|||
126359249|NCT02181738|454607362|FG003|Overall Study|Participant Withdrew Consent|1|||
126359250|NCT02181738|454607359|FG000|Overall Study|Lost to Follow-up|1|||
126359251|NCT02181738|454607360|FG001|Overall Study|Lost to Follow-up|2|||
126359252|NCT02181738|454607361|FG002|Overall Study|Lost to Follow-up|1|||
126359253|NCT02181738|454607362|FG003|Overall Study|Lost to Follow-up|1|||
126359254|NCT02181738|454607359|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
126359255|NCT02181738|454607360|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
126359256|NCT02181738|454607361|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
126359257|NCT02181738|454607362|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
126359258|NCT02181738|454607359|FG000|Overall Study|Poor/Non-Compliance|1|||
126359259|NCT02181738|454607360|FG001|Overall Study|Poor/Non-Compliance|0|||
126359260|NCT02181738|454607361|FG002|Overall Study|Poor/Non-Compliance|2|||
126359261|NCT02181738|454607362|FG003|Overall Study|Poor/Non-Compliance|1|||
126359262|NCT02181738|454607359|FG000|Overall Study|Disease Progression|28|||
126359263|NCT02181738|454607360|FG001|Overall Study|Disease Progression|35|||
126359264|NCT02181738|454607361|FG002|Overall Study|Disease Progression|40|||
126359265|NCT02181738|454607362|FG003|Overall Study|Disease Progression|0|||
126359266|NCT02181738|454607359|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
126359267|NCT02181738|454607360|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
126359268|NCT02181738|454607361|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
126699304|NCT02901431|455848824|FG000|Main Treatment Part|Adverse Event|0|||
126699305|NCT02901431|455848825|FG001|Main Treatment Part|Adverse Event|0|||
126699306|NCT02901431|455848826|FG002|Main Treatment Part|Adverse Event|0|||
126699307|NCT02901431|455848827|FG003|Main Treatment Part|Adverse Event|3|||
126699308|NCT02901431|455848828|FG004|Main Treatment Part|Adverse Event|3|||
126699309|NCT02901431|455848829|FG005|Main Treatment Part|Adverse Event|4|||
126699310|NCT02901431|455848830|FG006|Main Treatment Part|Adverse Event|1|||
126699311|NCT02901431|455848831|FG007|Main Treatment Part|Adverse Event|0|||
126699312|NCT02901431|455848832|FG008|Main Treatment Part|Adverse Event|0|||
126699313|NCT02901431|455848833|FG009|Main Treatment Part|Adverse Event|0|||
126259036|NCT02412722|454237976|FG000|Overall Study|Withdrawal by Subject|2|||
126259037|NCT02412722|454237977|FG001|Overall Study|Withdrawal by Subject|0|||
126259038|NCT02412722|454237978|FG002|Overall Study|Withdrawal by Subject|1|||
126450658|NCT03700684|454952297|FG000|Overall Study|COVID-19|0|||
126259039|NCT02412722|454237979|FG003|Overall Study|Withdrawal by Subject|2|||
126259040|NCT02412722|454237980|FG004|Overall Study|Withdrawal by Subject|1|||
126259041|NCT02412722|454237981|FG005|Overall Study|Withdrawal by Subject|1|||
126259042|NCT02412722|454237976|FG000|Overall Study|Lost to Follow-up|0|||
126259043|NCT02412722|454237977|FG001|Overall Study|Lost to Follow-up|0|||
126259044|NCT02412722|454237978|FG002|Overall Study|Lost to Follow-up|0|||
126259045|NCT02412722|454237979|FG003|Overall Study|Lost to Follow-up|0|||
126259046|NCT02412722|454237980|FG004|Overall Study|Lost to Follow-up|1|||
126259047|NCT02412722|454237981|FG005|Overall Study|Lost to Follow-up|0|||
126259048|NCT02412722|454237976|FG000|Overall Study|Received drug in run-in and discontinued|0|||
126259049|NCT02412722|454237977|FG001|Overall Study|Received drug in run-in and discontinued|2|||
126259050|NCT02412722|454237978|FG002|Overall Study|Received drug in run-in and discontinued|0|||
126259051|NCT02412722|454237979|FG003|Overall Study|Received drug in run-in and discontinued|0|||
126259052|NCT02412722|454237980|FG004|Overall Study|Received drug in run-in and discontinued|0|||
126259053|NCT02412722|454237981|FG005|Overall Study|Received drug in run-in and discontinued|0|||
126259054|NCT02412722|454237976|FG000|Overall Study|Reason not Specified|3|||
126259055|NCT02412722|454237977|FG001|Overall Study|Reason not Specified|0|||
126259056|NCT02412722|454237978|FG002|Overall Study|Reason not Specified|2|||
126259057|NCT02412722|454237979|FG003|Overall Study|Reason not Specified|1|||
126259058|NCT02412722|454237980|FG004|Overall Study|Reason not Specified|2|||
126259059|NCT02412722|454237981|FG005|Overall Study|Reason not Specified|6|||
126259060|NCT02941523|454237982|FG000|Monotherapy|Withdrawal by Subject|0|||
126259061|NCT02941523|454237983|FG001|Monotherapy|Withdrawal by Subject|1|||
126259062|NCT02941523|454237982|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
126259063|NCT02941523|454237983|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
126259064|NCT02941523|454237982|FG000|Carboplatin Combination Therapy|Death|1|||
126259065|NCT02941523|454237983|FG001|Carboplatin Combination Therapy|Death|2|||
126259066|NCT02941523|454237982|FG000|Carboplatin Combination Therapy|Disease progression|2|||
126259067|NCT02941523|454237983|FG001|Carboplatin Combination Therapy|Disease progression|0|||
126259068|NCT02941523|454237982|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
126259069|NCT02941523|454237983|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
126259070|NCT04449341|454237984|FG000|Overall Study|Protocol Violation|1|||
126259071|NCT04449341|454237985|FG001|Overall Study|Protocol Violation|0|||
126259072|NCT01899326|454237987|FG000|Overall Study|Withdrawal by Subject|1|||
126259073|NCT01899326|454237987|FG000|Overall Study|Adverse Event|2|||
126259074|NCT01899326|454237987|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
126259075|NCT00373425|454237988|FG000|Overall Study|Relapse of NSCLC|116|||
126259076|NCT00373425|454237989|FG001|Overall Study|Relapse of NSCLC|104|||
126259077|NCT00373425|454237990|FG002|Overall Study|Relapse of NSCLC|19|||
126259078|NCT00373425|454237991|FG003|Overall Study|Relapse of NSCLC|2|||
126259079|NCT00373425|454237992|FG004|Overall Study|Relapse of NSCLC|26|||
126259080|NCT00373425|454237988|FG000|Overall Study|Adverse Event|191|||
126259081|NCT00373425|454237989|FG001|Overall Study|Adverse Event|22|||
126259082|NCT00373425|454237990|FG002|Overall Study|Adverse Event|59|||
126259083|NCT00373425|454237991|FG003|Overall Study|Adverse Event|0|||
126259084|NCT00373425|454237992|FG004|Overall Study|Adverse Event|34|||
126259085|NCT00373425|454237988|FG000|Overall Study|Patient request|35|||
126259086|NCT00373425|454237989|FG001|Overall Study|Patient request|18|||
126259087|NCT00373425|454237990|FG002|Overall Study|Patient request|43|||
126259088|NCT00373425|454237991|FG003|Overall Study|Patient request|6|||
126450659|NCT03700684|454952298|FG001|Overall Study|COVID-19|0|||
126259089|NCT00373425|454237992|FG004|Overall Study|Patient request|7|||
126259090|NCT00373425|454237988|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
126259091|NCT00373425|454237989|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
126450660|NCT03700684|454952299|FG002|Overall Study|COVID-19|2|||
126450661|NCT03319745|454952301|FG000|Overall Study|Death|1|||
126763264|NCT00437294|456086751|FG001|Overall Study|Sponsor Decision|9|||
126259092|NCT00373425|454237990|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
126259093|NCT00373425|454237991|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
126259094|NCT00373425|454237992|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
126259095|NCT00373425|454237988|FG000|Overall Study|Death|7|||
126259096|NCT00373425|454237989|FG001|Overall Study|Death|0|||
126259097|NCT00373425|454237990|FG002|Overall Study|Death|3|||
126259098|NCT00373425|454237991|FG003|Overall Study|Death|1|||
126259099|NCT00373425|454237992|FG004|Overall Study|Death|0|||
126259100|NCT00551616|454237995|FG000|Overall Study|Lost to Follow-up|48|||
126259101|NCT00551616|454237996|FG001|Overall Study|Lost to Follow-up|40|||
126259102|NCT01263561|454237997|FG000|Overall Study|Death|1|||
126259103|NCT01263561|454237998|FG001|Overall Study|Death|2|||
126259104|NCT03942211|454237999|FG000|Overall Study|Death|1|||
126259105|NCT03942211|454238000|FG001|Overall Study|Death|0|||
126259106|NCT03942211|454237999|FG000|Overall Study|Study terminated by sponsor|5|||
126259107|NCT03942211|454238000|FG001|Overall Study|Study terminated by sponsor|3|||
126259108|NCT03942211|454237999|FG000|Overall Study|Adverse Event|0|||
126259109|NCT03942211|454238000|FG001|Overall Study|Adverse Event|1|||
126450662|NCT03319745|454952301|FG000|Overall Study|Toxicity Precluding Surgery|1|||
126546675|NCT02769065|455296002|FG012|Overall Study|Reason Not Specified|0|||
126546676|NCT02769065|455296003|FG013|Overall Study|Reason Not Specified|0|||
126546677|NCT02769065|455296004|FG014|Overall Study|Reason Not Specified|0|||
126546678|NCT02769065|455296005|FG015|Overall Study|Reason Not Specified|0|||
126259110|NCT01396421|454238001|FG000|Overall Study|Lost to Follow-up|0|||
126699314|NCT02901431|455848834|FG010|Main Treatment Part|Adverse Event|0|||
126763265|NCT00437294|456086750|FG000|Overall Study|Protocol Violation|0|||
126763266|NCT00437294|456086751|FG001|Overall Study|Protocol Violation|1|||
126259111|NCT01396421|454238002|FG001|Overall Study|Lost to Follow-up|0|||
126259112|NCT01396421|454238003|FG002|Overall Study|Lost to Follow-up|0|||
126259113|NCT01396421|454238004|FG003|Overall Study|Lost to Follow-up|1|||
126259114|NCT01396421|454238001|FG000|Overall Study|Adverse Event|17|||
126259115|NCT01396421|454238002|FG001|Overall Study|Adverse Event|15|||
126259116|NCT01396421|454238003|FG002|Overall Study|Adverse Event|12|||
126259117|NCT01396421|454238004|FG003|Overall Study|Adverse Event|32|||
126259118|NCT01396421|454238001|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
126259119|NCT01396421|454238002|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
126259120|NCT01396421|454238003|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
126259121|NCT01396421|454238004|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
126259122|NCT01396421|454238001|FG000|Overall Study|Physician Decision|1|||
126259123|NCT01396421|454238002|FG001|Overall Study|Physician Decision|1|||
126259124|NCT01396421|454238003|FG002|Overall Study|Physician Decision|0|||
126259125|NCT01396421|454238004|FG003|Overall Study|Physician Decision|3|||
126259126|NCT01396421|454238001|FG000|Overall Study|Withdrawal by Subject|31|||
126259127|NCT01396421|454238002|FG001|Overall Study|Withdrawal by Subject|24|||
126259128|NCT01396421|454238003|FG002|Overall Study|Withdrawal by Subject|13|||
126259129|NCT01396421|454238004|FG003|Overall Study|Withdrawal by Subject|21|||
126259130|NCT01396421|454238001|FG000|Overall Study|Protocol Deviation|2|||
126259131|NCT01396421|454238002|FG001|Overall Study|Protocol Deviation|1|||
126259132|NCT01396421|454238003|FG002|Overall Study|Protocol Deviation|1|||
126259133|NCT01396421|454238004|FG003|Overall Study|Protocol Deviation|0|||
126259134|NCT01396421|454238001|FG000|Overall Study|Lack of Efficacy|7|||
126259135|NCT01396421|454238002|FG001|Overall Study|Lack of Efficacy|17|||
126259136|NCT01396421|454238003|FG002|Overall Study|Lack of Efficacy|7|||
126259137|NCT01396421|454238004|FG003|Overall Study|Lack of Efficacy|18|||
126259138|NCT00569777|454238008|FG000|Overall Study|Withdrawal by Subject|4|||
126259139|NCT00569777|454238009|FG001|Overall Study|Withdrawal by Subject|0|||
126259140|NCT00569777|454238008|FG000|Overall Study|Adverse Event|3|||
126259141|NCT00569777|454238009|FG001|Overall Study|Adverse Event|0|||
126259142|NCT00569777|454238008|FG000|Overall Study|Lost to Follow-up|1|||
126259143|NCT00569777|454238009|FG001|Overall Study|Lost to Follow-up|0|||
126259144|NCT00569777|454238008|FG000|Overall Study|scheduled eye surgery|0|||
126259145|NCT00569777|454238009|FG001|Overall Study|scheduled eye surgery|1|||
126259146|NCT00569777|454238008|FG000|Overall Study|did not meet exclusion criteria|1|||
126259147|NCT00569777|454238009|FG001|Overall Study|did not meet exclusion criteria|2|||
126259148|NCT00569777|454238008|FG000|Overall Study|pregnant|1|||
126546679|NCT02769065|455296006|FG016|Overall Study|Reason Not Specified|0|||
126546680|NCT02769065|455296007|FG017|Overall Study|Reason Not Specified|0|||
126699315|NCT02901431|455848835|FG011|Main Treatment Part|Adverse Event|0|||
126699316|NCT02901431|455848836|FG012|Main Treatment Part|Adverse Event|0|||
126699317|NCT02901431|455848824|FG000|Main Treatment Part|Lack of Efficacy|0|||
126699318|NCT02901431|455848825|FG001|Main Treatment Part|Lack of Efficacy|0|||
126699319|NCT02901431|455848826|FG002|Main Treatment Part|Lack of Efficacy|0|||
126699320|NCT02901431|455848827|FG003|Main Treatment Part|Lack of Efficacy|1|||
126699321|NCT02901431|455848828|FG004|Main Treatment Part|Lack of Efficacy|0|||
126699322|NCT02901431|455848829|FG005|Main Treatment Part|Lack of Efficacy|0|||
126699323|NCT02901431|455848830|FG006|Main Treatment Part|Lack of Efficacy|0|||
126699324|NCT02901431|455848831|FG007|Main Treatment Part|Lack of Efficacy|0|||
126699325|NCT02901431|455848832|FG008|Main Treatment Part|Lack of Efficacy|0|||
126699326|NCT02901431|455848833|FG009|Main Treatment Part|Lack of Efficacy|0|||
126699327|NCT02901431|455848834|FG010|Main Treatment Part|Lack of Efficacy|0|||
126699328|NCT02901431|455848835|FG011|Main Treatment Part|Lack of Efficacy|0|||
126259149|NCT00569777|454238009|FG001|Overall Study|pregnant|0|||
126699329|NCT02901431|455848836|FG012|Main Treatment Part|Lack of Efficacy|0|||
126546681|NCT02769065|455296008|FG018|Overall Study|Reason Not Specified|0|||
126699330|NCT02901431|455848824|FG000|Main Treatment Part|Lost to Follow-up|0|||
126699331|NCT02901431|455848825|FG001|Main Treatment Part|Lost to Follow-up|0|||
126699332|NCT02901431|455848826|FG002|Main Treatment Part|Lost to Follow-up|0|||
126763267|NCT00437294|456086750|FG000|Overall Study|Entry criteria not met|1|||
126259150|NCT01835548|454238014|FG000|Dose Optimization Period|Adverse Event|0|||
126259151|NCT01835548|454238015|FG001|Dose Optimization Period|Adverse Event|0|||
126259152|NCT01835548|454238016|FG002|Dose Optimization Period|Adverse Event|1|||
126259153|NCT01835548|454238014|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
126259154|NCT01835548|454238015|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
126259155|NCT01835548|454238016|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
126259156|NCT01835548|454238014|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126259157|NCT01835548|454238015|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126259158|NCT01835548|454238016|FG002|Double-Blind Treatment Period|Adverse Event|0|||
126699333|NCT02901431|455848827|FG003|Main Treatment Part|Lost to Follow-up|3|||
126699334|NCT02901431|455848828|FG004|Main Treatment Part|Lost to Follow-up|1|||
126699335|NCT02901431|455848829|FG005|Main Treatment Part|Lost to Follow-up|2|||
126699336|NCT02901431|455848830|FG006|Main Treatment Part|Lost to Follow-up|3|||
126259159|NCT01835548|454238014|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126259160|NCT01835548|454238015|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126259161|NCT01835548|454238016|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126259162|NCT00537017|454238017|FG000|Treatment Phase|Adverse Event|19|||
126259163|NCT00537017|454238017|FG000|Treatment Phase|Withdrawal by Subject|13|||
126259164|NCT00537017|454238017|FG000|Treatment Phase|Protocol Violation|2|||
126259165|NCT00537017|454238017|FG000|Follow-up Phase|Withdrawal by Subject|9|||
126259166|NCT03168906|454238022|FG000|Overall Study|Lack of Efficacy|6|||
126259167|NCT03168906|454238023|FG001|Overall Study|Lack of Efficacy|6|||
126259168|NCT01321697|454238024|FG000|Overall Study|Study Terminated|7|||
126259169|NCT02447887|454239580|FG000|Overall Study|Study was terminated|3|||
126259170|NCT02839798|454239581|FG000|Overall Study|Withdrawal by Subject|2|||
126259171|NCT01989676|454239583|FG000|Overall Study|Death|52|||
126259172|NCT01989676|454239584|FG001|Overall Study|Death|60|||
126259173|NCT01989676|454239583|FG000|Overall Study|Protocol Violation|2|||
126259174|NCT01989676|454239584|FG001|Overall Study|Protocol Violation|1|||
126259175|NCT01989676|454239583|FG000|Overall Study|Lost to Follow-up|8|||
126259176|NCT01989676|454239584|FG001|Overall Study|Lost to Follow-up|18|||
126259177|NCT01989676|454239583|FG000|Overall Study|No longer willing to participate in study|26|||
126259178|NCT01989676|454239584|FG001|Overall Study|No longer willing to participate in study|26|||
126259179|NCT01989676|454239583|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
126259180|NCT01989676|454239584|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
126259181|NCT01989676|454239583|FG000|Overall Study|Other|4|||
126259182|NCT01989676|454239584|FG001|Overall Study|Other|3|||
126259183|NCT03941834|454239585|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
126259184|NCT03941834|454239586|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
126259185|NCT03941834|454239587|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
126259186|NCT03941834|454239585|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
126259187|NCT03941834|454239586|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
126259188|NCT03941834|454239587|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
126259189|NCT03941834|454239585|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
126259190|NCT03941834|454239586|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
126259191|NCT03941834|454239587|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
126259192|NCT03941834|454239585|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
126259193|NCT03941834|454239586|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
126259194|NCT03941834|454239587|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
126259195|NCT03941834|454239585|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
126259196|NCT03941834|454239586|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
126259197|NCT03941834|454239587|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
126259198|NCT03941834|454239585|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
126259199|NCT03941834|454239586|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
126259200|NCT03941834|454239587|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
126259201|NCT01560819|454239591|FG000|Overall Study|Physician Decision|1|||
126259202|NCT01560819|454239592|FG001|Overall Study|Physician Decision|0|||
126259203|NCT02788513|454239593|FG000|Overall Study|Withdrawal by Subject|3|||
126259204|NCT02788513|454239594|FG001|Overall Study|Withdrawal by Subject|0|||
126259205|NCT02788513|454239595|FG002|Overall Study|Withdrawal by Subject|2|||
126259206|NCT02788513|454239596|FG003|Overall Study|Withdrawal by Subject|3|||
126259207|NCT02788513|454239597|FG004|Overall Study|Withdrawal by Subject|1|||
126259208|NCT02788513|454239593|FG000|Overall Study|Lost to Follow-up|1|||
126259209|NCT02788513|454239594|FG001|Overall Study|Lost to Follow-up|0|||
126259210|NCT02788513|454239595|FG002|Overall Study|Lost to Follow-up|0|||
126259211|NCT02788513|454239596|FG003|Overall Study|Lost to Follow-up|0|||
126259212|NCT02788513|454239597|FG004|Overall Study|Lost to Follow-up|1|||
126259213|NCT02788513|454239593|FG000|Overall Study|Adverse Event|5|||
126259214|NCT02788513|454239594|FG001|Overall Study|Adverse Event|8|||
126259215|NCT02788513|454239595|FG002|Overall Study|Adverse Event|4|||
126259216|NCT02788513|454239596|FG003|Overall Study|Adverse Event|2|||
126259217|NCT02788513|454239597|FG004|Overall Study|Adverse Event|2|||
126259218|NCT02788513|454239593|FG000|Overall Study|Protocol Violation|0|||
126259219|NCT02788513|454239594|FG001|Overall Study|Protocol Violation|0|||
126359269|NCT02181738|454607362|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
126359270|NCT02181738|454607359|FG000|Overall Study|Study Drug Toxicity|6|||
126699337|NCT02901431|455848831|FG007|Main Treatment Part|Lost to Follow-up|0|||
126259220|NCT02788513|454239595|FG002|Overall Study|Protocol Violation|1|||
126259221|NCT02788513|454239596|FG003|Overall Study|Protocol Violation|1|||
126259222|NCT02788513|454239597|FG004|Overall Study|Protocol Violation|0|||
126259223|NCT02788513|454239593|FG000|Overall Study|Subject decided to stop taking treatment|0|||
126259224|NCT02788513|454239594|FG001|Overall Study|Subject decided to stop taking treatment|0|||
126450663|NCT00870103|454952302|FG000|Overall Study|Physician Decision|2|||
126450664|NCT00870103|454952302|FG000|Overall Study|Lost to Follow-up|2|||
126450665|NCT01317550|454952303|FG000|Overall Study|Withdrawal by Subject|1|||
126450666|NCT01317550|454952304|FG001|Overall Study|Withdrawal by Subject|0|||
126546682|NCT02769065|455296009|FG019|Overall Study|Reason Not Specified|0|||
126546683|NCT02769065|455296010|FG020|Overall Study|Reason Not Specified|0|||
126546684|NCT02769065|455296011|FG021|Overall Study|Reason Not Specified|0|||
126546685|NCT02769065|455296012|FG022|Overall Study|Reason Not Specified|0|||
126546686|NCT02769065|455296013|FG023|Overall Study|Reason Not Specified|0|||
126546687|NCT02769065|455296014|FG024|Overall Study|Reason Not Specified|0|||
126546688|NCT02769065|455296015|FG025|Overall Study|Reason Not Specified|0|||
126546689|NCT02769065|455296016|FG026|Overall Study|Reason Not Specified|0|||
126546690|NCT02769065|455296017|FG027|Overall Study|Reason Not Specified|0|||
126546691|NCT02769065|455296018|FG028|Overall Study|Reason Not Specified|0|||
126546692|NCT02769065|455296019|FG029|Overall Study|Reason Not Specified|0|||
126546693|NCT02769065|455295990|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546694|NCT02769065|455295991|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546695|NCT02769065|455295992|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546696|NCT02769065|455295993|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546697|NCT02769065|455295994|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546698|NCT02769065|455295995|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546699|NCT02769065|455295996|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546700|NCT02769065|455295997|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546701|NCT02769065|455295998|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546702|NCT02769065|455295999|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546703|NCT02769065|455296000|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
126450667|NCT01317550|454952305|FG002|Overall Study|Withdrawal by Subject|0|||
126450668|NCT01317550|454952306|FG003|Overall Study|Withdrawal by Subject|0|||
126450669|NCT01317550|454952303|FG000|Overall Study|Lack of compliance study med|1|||
126450670|NCT01317550|454952304|FG001|Overall Study|Lack of compliance study med|0|||
126450671|NCT01317550|454952305|FG002|Overall Study|Lack of compliance study med|0|||
126450672|NCT01317550|454952306|FG003|Overall Study|Lack of compliance study med|0|||
126450673|NCT03179202|454952307|FG000|Overall Study|Screen Failure|67|||
126450674|NCT03179202|454952307|FG000|Overall Study|Subject Lost to Follow Up|12|||
126450675|NCT03179202|454952307|FG000|Overall Study|Withdrawal by Subject|7|||
126450676|NCT03179202|454952307|FG000|Overall Study|Adverse Event|3|||
126450677|NCT03179202|454952307|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
126450678|NCT03179202|454952307|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
126450679|NCT03255629|454952308|FG000|Overall Study|Adverse Event|1|||
126450680|NCT03255629|454952309|FG001|Overall Study|Adverse Event|0|||
126450681|NCT03255629|454952308|FG000|Overall Study|did not experience hypoglycemia|2|||
126450682|NCT03255629|454952309|FG001|Overall Study|did not experience hypoglycemia|1|||
126450683|NCT01120782|454952310|FG000|Overall Study|Test article shipping error|11|||
126450684|NCT00859638|454952311|FG000|Overall Study|Lost to Follow-up|6|||
126450685|NCT00859638|454952312|FG001|Overall Study|Lost to Follow-up|1|||
126450686|NCT00859638|454952311|FG000|Overall Study|Withdrawal by Subject|3|||
126546704|NCT02769065|455296001|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546705|NCT02769065|455296002|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
126699338|NCT02901431|455848832|FG008|Main Treatment Part|Lost to Follow-up|0|||
126699339|NCT02901431|455848833|FG009|Main Treatment Part|Lost to Follow-up|0|||
126699340|NCT02901431|455848834|FG010|Main Treatment Part|Lost to Follow-up|0|||
126699341|NCT02901431|455848835|FG011|Main Treatment Part|Lost to Follow-up|0|||
126699342|NCT02901431|455848836|FG012|Main Treatment Part|Lost to Follow-up|0|||
126699343|NCT02901431|455848824|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
126699344|NCT02901431|455848825|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
126699345|NCT02901431|455848826|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
126699346|NCT02901431|455848827|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
126699347|NCT02901431|455848828|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
126699348|NCT02901431|455848829|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
126699349|NCT02901431|455848830|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
126699350|NCT02901431|455848831|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
126699351|NCT02901431|455848832|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
126699352|NCT02901431|455848833|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
126699353|NCT02901431|455848834|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
126699354|NCT02901431|455848835|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
126699355|NCT02901431|455848836|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
126699356|NCT02901431|455848824|FG000|Main Treatment Part|Physician Decision|0|||
126450687|NCT00859638|454952312|FG001|Overall Study|Withdrawal by Subject|2|||
126450688|NCT00859638|454952311|FG000|Overall Study|Ill health|1|||
126450689|NCT00859638|454952312|FG001|Overall Study|Ill health|1|||
126699357|NCT02901431|455848825|FG001|Main Treatment Part|Physician Decision|0|||
126699358|NCT02901431|455848826|FG002|Main Treatment Part|Physician Decision|0|||
126699359|NCT02901431|455848827|FG003|Main Treatment Part|Physician Decision|1|||
126259225|NCT02788513|454239595|FG002|Overall Study|Subject decided to stop taking treatment|1|||
126259226|NCT02788513|454239596|FG003|Overall Study|Subject decided to stop taking treatment|0|||
126259227|NCT02788513|454239597|FG004|Overall Study|Subject decided to stop taking treatment|0|||
126259228|NCT02788513|454239593|FG000|Overall Study|Decision by the study team|0|||
126259229|NCT02788513|454239594|FG001|Overall Study|Decision by the study team|0|||
126259230|NCT02788513|454239595|FG002|Overall Study|Decision by the study team|0|||
126259231|NCT02788513|454239596|FG003|Overall Study|Decision by the study team|0|||
126259232|NCT02788513|454239597|FG004|Overall Study|Decision by the study team|1|||
126259233|NCT00114231|454239599|FG000|Overall Study|No consent|2|||
126259234|NCT00114231|454239600|FG001|Overall Study|No consent|0|||
126259235|NCT00114231|454239599|FG000|Overall Study|QARC requirement not met|1|||
126259236|NCT00114231|454239600|FG001|Overall Study|QARC requirement not met|0|||
126259237|NCT00114231|454239599|FG000|Overall Study|Suspected metastatic disease|1|||
126259238|NCT00114231|454239600|FG001|Overall Study|Suspected metastatic disease|0|||
126259239|NCT00114231|454239599|FG000|Overall Study|No adenocarcinoma|1|||
126259240|NCT00114231|454239600|FG001|Overall Study|No adenocarcinoma|0|||
126259241|NCT00114231|454239599|FG000|Overall Study|Low creatinine clearance|0|||
126259242|NCT00114231|454239600|FG001|Overall Study|Low creatinine clearance|1|||
126259243|NCT00114231|454239599|FG000|Overall Study|Tumor size > 4cm|1|||
126259244|NCT00114231|454239600|FG001|Overall Study|Tumor size > 4cm|0|||
126259245|NCT00114231|454239599|FG000|Overall Study|Tumor fixed on digital exam|0|||
126259246|NCT00114231|454239600|FG001|Overall Study|Tumor fixed on digital exam|1|||
126259247|NCT00114231|454239599|FG000|Overall Study|No Absolute Neutrophil Count|2|||
126259248|NCT00114231|454239600|FG001|Overall Study|No Absolute Neutrophil Count|0|||
126259249|NCT00114231|454239599|FG000|Overall Study|Biopsy done after registration|1|||
126450690|NCT02969408|454952314|FG000|Overall Study|Adverse Event|2|||
126450691|NCT02969408|454952314|FG000|Overall Study|Withdrawal by Subject|8|||
126450692|NCT02969408|454952314|FG000|Overall Study|Lost to Follow-up|4|||
126450693|NCT02969408|454952314|FG000|Overall Study|Protocol Violation|1|||
126450694|NCT02969408|454952314|FG000|Overall Study|Other than specified|1|||
126450695|NCT02779556|454952318|FG000|Baseline|Partial baseline interview completed|1|||
126450696|NCT02779556|454952319|FG001|Baseline|Partial baseline interview completed|0|||
126450697|NCT02779556|454952318|FG000|3 Months|Lost to Follow-up|40|||
126450698|NCT02779556|454952319|FG001|3 Months|Lost to Follow-up|29|||
126450699|NCT02779556|454952318|FG000|3 Months|Missed 3 month clinic visit|27|||
126450700|NCT02779556|454952319|FG001|3 Months|Missed 3 month clinic visit|19|||
126450701|NCT02779556|454952318|FG000|6 Month|Lost to Follow-up|33|||
126450702|NCT02779556|454952319|FG001|6 Month|Lost to Follow-up|39|||
126450703|NCT02779556|454952318|FG000|6 Month HbA1c|No value collected during window|69|||
126450704|NCT02779556|454952319|FG001|6 Month HbA1c|No value collected during window|50|||
126450705|NCT02779556|454952318|FG000|12 Month HbA1c|No value collected during window|138|||
126450706|NCT02779556|454952319|FG001|12 Month HbA1c|No value collected during window|102|||
126450707|NCT03110770|454952323|FG000|Overall Study|Death|1|||
126450708|NCT03110770|454952324|FG001|Overall Study|Death|0|||
126450709|NCT03110770|454952325|FG002|Overall Study|Death|0|||
126450710|NCT03110770|454952326|FG003|Overall Study|Death|1|||
126450711|NCT03110770|454952327|FG004|Overall Study|Death|0|||
126450712|NCT03110770|454952323|FG000|Overall Study|Enrolled but did not receive product|0|||
126450713|NCT03110770|454952324|FG001|Overall Study|Enrolled but did not receive product|0|||
126450714|NCT03110770|454952325|FG002|Overall Study|Enrolled but did not receive product|0|||
126450715|NCT03110770|454952326|FG003|Overall Study|Enrolled but did not receive product|8|||
126450716|NCT03110770|454952327|FG004|Overall Study|Enrolled but did not receive product|7|||
126450717|NCT03110770|454952323|FG000|Overall Study|Lost to Follow-up|0|||
126450718|NCT03110770|454952324|FG001|Overall Study|Lost to Follow-up|0|||
126450719|NCT03110770|454952325|FG002|Overall Study|Lost to Follow-up|0|||
126450720|NCT03110770|454952326|FG003|Overall Study|Lost to Follow-up|53|||
126450721|NCT03110770|454952327|FG004|Overall Study|Lost to Follow-up|45|||
126450722|NCT03110770|454952323|FG000|Overall Study|Investigator Decision|0|||
126763268|NCT00437294|456086751|FG001|Overall Study|Entry criteria not met|1|||
126763269|NCT01473602|456086757|FG000|Overall Study|Adverse Event|1|||
126763270|NCT01473602|456086758|FG001|Overall Study|Adverse Event|2|||
126259250|NCT00114231|454239600|FG001|Overall Study|Biopsy done after registration|0|||
126259251|NCT02356211|454239603|FG000|Overall Study|Withdrawal by Subject|2|||
126259252|NCT02356211|454239604|FG001|Overall Study|Withdrawal by Subject|2|||
126259253|NCT02356211|454239603|FG000|Overall Study|ineligible|1|||
126450723|NCT03110770|454952324|FG001|Overall Study|Investigator Decision|0|||
126259254|NCT02356211|454239604|FG001|Overall Study|ineligible|8|||
126450724|NCT03110770|454952325|FG002|Overall Study|Investigator Decision|0|||
126450725|NCT03110770|454952326|FG003|Overall Study|Investigator Decision|5|||
126450726|NCT03110770|454952327|FG004|Overall Study|Investigator Decision|3|||
126450727|NCT03110770|454952323|FG000|Overall Study|Withdrawal by Subject|0|||
126450728|NCT03110770|454952324|FG001|Overall Study|Withdrawal by Subject|0|||
126450729|NCT03110770|454952325|FG002|Overall Study|Withdrawal by Subject|0|||
126450730|NCT03110770|454952326|FG003|Overall Study|Withdrawal by Subject|24|||
126763271|NCT01473602|456086757|FG000|Overall Study|Death|0|||
126259255|NCT01976728|454239605|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
126763272|NCT01473602|456086758|FG001|Overall Study|Death|1|||
126763273|NCT01473602|456086757|FG000|Overall Study|Lost to Follow-up|1|||
126763274|NCT01473602|456086758|FG001|Overall Study|Lost to Follow-up|1|||
126763275|NCT01473602|456086757|FG000|Overall Study|Withdrawal by Subject|5|||
126763276|NCT01473602|456086758|FG001|Overall Study|Withdrawal by Subject|4|||
126763277|NCT01473602|456086757|FG000|Overall Study|Physician Decision|1|||
126763278|NCT01473602|456086758|FG001|Overall Study|Physician Decision|0|||
126259256|NCT01976728|454239606|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
126259257|NCT01976728|454239607|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
126259258|NCT01976728|454239608|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
126259259|NCT00966381|454239610|FG000|Overall Study|Withdrawal by Subject|2|||
126259260|NCT00966381|454239611|FG001|Overall Study|Withdrawal by Subject|2|||
126259261|NCT01124695|454239612|FG000|Overall Study|Disease progression|77|||
126259262|NCT01124695|454239612|FG000|Overall Study|Adverse Event|11|||
126259263|NCT01124695|454239612|FG000|Overall Study|Death|1|||
126259264|NCT01124695|454239612|FG000|Overall Study|Withdrawal by Subject|7|||
126259265|NCT01124695|454239612|FG000|Overall Study|Physician Decision|3|||
126259266|NCT01124695|454239612|FG000|Overall Study|Alternative therapy|9|||
126259267|NCT01124695|454239612|FG000|Overall Study|No documentation that patient went off treatment|4|||
126259268|NCT01124695|454239612|FG000|Overall Study|Ineligible|9|||
126259269|NCT01124695|454239612|FG000|Overall Study|Ineligible and never start treatment|2|||
126259270|NCT02668822|454239616|FG000|Overall Study|Protocol Violation|2|||
126259271|NCT02668822|454239617|FG001|Overall Study|Protocol Violation|0|||
126259272|NCT02668822|454239616|FG000|Overall Study|Study Terminated by Sponsor|7|||
126259273|NCT02668822|454239617|FG001|Overall Study|Study Terminated by Sponsor|9|||
126259274|NCT01522950|454239618|FG000|Overall Study|Withdrawal by Subject|3|||
126259275|NCT01522950|454239619|FG001|Overall Study|Withdrawal by Subject|2|||
126259276|NCT01522950|454239620|FG002|Overall Study|Withdrawal by Subject|1|||
126259277|NCT01522950|454239618|FG000|Overall Study|Adverse Event|3|||
126259278|NCT01522950|454239619|FG001|Overall Study|Adverse Event|1|||
126259279|NCT01522950|454239620|FG002|Overall Study|Adverse Event|1|||
126259280|NCT01522950|454239618|FG000|Overall Study|Protocol Violation|0|||
126259281|NCT01522950|454239619|FG001|Overall Study|Protocol Violation|0|||
126259282|NCT01522950|454239620|FG002|Overall Study|Protocol Violation|2|||
126259283|NCT01522950|454239618|FG000|Overall Study|Death|0|||
126259284|NCT01522950|454239619|FG001|Overall Study|Death|1|||
126259285|NCT01522950|454239620|FG002|Overall Study|Death|1|||
126259286|NCT01522950|454239618|FG000|Overall Study|Study Medication Sensitivity|0|||
126259287|NCT01522950|454239619|FG001|Overall Study|Study Medication Sensitivity|1|||
126259288|NCT01522950|454239620|FG002|Overall Study|Study Medication Sensitivity|0|||
126259289|NCT00298740|454239623|FG000|Overall Study|Lack of Efficacy|6|||
126259290|NCT00298740|454239623|FG000|Overall Study|Withdrawal by Subject|3|||
126259291|NCT01345318|454239625|FG000|Overall Study|Adverse Event|16|||
126259292|NCT01345318|454239625|FG000|Overall Study|Lack of Efficacy|17|||
126259293|NCT01345318|454239625|FG000|Overall Study|Lost to Follow-up|2|||
126259294|NCT01345318|454239625|FG000|Overall Study|Protocol Violation|1|||
126259295|NCT01345318|454239625|FG000|Overall Study|Withdrawal by Subject|41|||
126259296|NCT01345318|454239625|FG000|Overall Study|Other|3|||
126259297|NCT00317642|454239626|FG000|Overall Study|Not Received Either Study Drug|1|||
126259298|NCT00317642|454239627|FG001|Overall Study|Not Received Either Study Drug|3|||
126259299|NCT00317642|454239626|FG000|Overall Study|Physician Decision|15|||
126259300|NCT00317642|454239627|FG001|Overall Study|Physician Decision|7|||
126259301|NCT00317642|454239626|FG000|Overall Study|Participant declined treatment|14|||
126763279|NCT00003526|456086759|FG000|Overall Study|Not evaluable|6|||
126259302|NCT00317642|454239627|FG001|Overall Study|Participant declined treatment|3|||
126259303|NCT00317642|454239626|FG000|Overall Study|Adverse Event|17|||
126259304|NCT00317642|454239627|FG001|Overall Study|Adverse Event|5|||
126259305|NCT00317642|454239626|FG000|Overall Study|Treatment Failure|56|||
126259306|NCT00317642|454239627|FG001|Overall Study|Treatment Failure|102|||
126259307|NCT00317642|454239626|FG000|Overall Study|Disease Recurrence|1|||
126763280|NCT00779857|456086760|FG000|Overall Study|Death|1|||
126259308|NCT00317642|454239627|FG001|Overall Study|Disease Recurrence|2|||
126259309|NCT00317642|454239626|FG000|Overall Study|Death|14|||
126259310|NCT00317642|454239627|FG001|Overall Study|Death|7|||
126259311|NCT00317642|454239626|FG000|Overall Study|Not Continue to Consolidation|2|||
126259312|NCT00317642|454239627|FG001|Overall Study|Not Continue to Consolidation|0|||
126763281|NCT00779857|456086760|FG000|Overall Study|Withdrawal by Subject|3|||
126763282|NCT00779857|456086760|FG000|Overall Study|Missed Visit|2|||
126763283|NCT00620776|456086761|FG000|Overall Study|Did not receive treatment|3|||
126259313|NCT00317642|454239626|FG000|Overall Study|Withdrawal by Subject|0|||
126259314|NCT00317642|454239627|FG001|Overall Study|Withdrawal by Subject|1|||
126259315|NCT00317642|454239626|FG000|Overall Study|Referred For Transplantation|1|||
126259316|NCT00317642|454239627|FG001|Overall Study|Referred For Transplantation|0|||
126259317|NCT00317642|454239626|FG000|Overall Study|AML Not Centrally Confirmed|1|||
126259318|NCT00317642|454239627|FG001|Overall Study|AML Not Centrally Confirmed|5|||
126259319|NCT01049412|454239629|FG000|Period I|Withdrawal by Subject|4|||
126259320|NCT01049412|454239630|FG001|Period I|Withdrawal by Subject|6|||
126763284|NCT00620776|456086762|FG001|Overall Study|Did not receive treatment|5|||
126763285|NCT00620776|456086761|FG000|Overall Study|Adverse Event|2|||
126763286|NCT00620776|456086762|FG001|Overall Study|Adverse Event|3|||
126763287|NCT00620776|456086761|FG000|Overall Study|Lack of Efficacy|2|||
126763288|NCT00620776|456086762|FG001|Overall Study|Lack of Efficacy|1|||
126763289|NCT00620776|456086761|FG000|Overall Study|Lost to Follow-up|2|||
126763290|NCT00620776|456086762|FG001|Overall Study|Lost to Follow-up|5|||
126763291|NCT00620776|456086761|FG000|Overall Study|Withdrawal by Subject|3|||
126763292|NCT00620776|456086762|FG001|Overall Study|Withdrawal by Subject|2|||
126763293|NCT03205046|456086764|FG000|Overall Study|Death|10|||
126763294|NCT03205046|456086765|FG001|Overall Study|Death|6|||
126763295|NCT03205046|456086764|FG000|Overall Study|Withdrawal by Subject|1|||
126763296|NCT03205046|456086765|FG001|Overall Study|Withdrawal by Subject|2|||
126763297|NCT03205046|456086764|FG000|Overall Study|Lost to Follow-up|0|||
126763298|NCT03205046|456086765|FG001|Overall Study|Lost to Follow-up|1|||
126763299|NCT03205046|456086764|FG000|Overall Study|Study terminated by sponsor|2|||
126763300|NCT03205046|456086765|FG001|Overall Study|Study terminated by sponsor|1|||
126763301|NCT01023815|456086766|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
126763302|NCT01023815|456086767|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
126763303|NCT01023815|456086768|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
126259321|NCT01049412|454239629|FG000|Period I|Lost to Follow-up|2|||
126259322|NCT01049412|454239630|FG001|Period I|Lost to Follow-up|2|||
126259323|NCT01049412|454239629|FG000|Period I|Physician Decision|0|||
126259324|NCT01049412|454239630|FG001|Period I|Physician Decision|3|||
126259325|NCT01049412|454239629|FG000|Period I|Protocol Violation|1|||
126259326|NCT01049412|454239630|FG001|Period I|Protocol Violation|2|||
126359271|NCT02181738|454607360|FG001|Overall Study|Study Drug Toxicity|11|||
126359272|NCT02181738|454607361|FG002|Overall Study|Study Drug Toxicity|8|||
126359273|NCT02181738|454607362|FG003|Overall Study|Study Drug Toxicity|1|||
126359274|NCT02181738|454607359|FG000|Overall Study|Other Reasons|14|||
126359275|NCT02181738|454607360|FG001|Overall Study|Other Reasons|16|||
126359276|NCT02181738|454607361|FG002|Overall Study|Other Reasons|28|||
126359277|NCT02181738|454607362|FG003|Overall Study|Other Reasons|0|||
126359278|NCT02181738|454607359|FG000|Overall Study|Maximum Clinical Benefit|3|||
126359279|NCT02181738|454607360|FG001|Overall Study|Maximum Clinical Benefit|0|||
126450731|NCT03110770|454952327|FG004|Overall Study|Withdrawal by Subject|24|||
126450732|NCT03110770|454952323|FG000|Overall Study|Moved from area|5|||
126450733|NCT03110770|454952324|FG001|Overall Study|Moved from area|0|||
126450734|NCT03110770|454952325|FG002|Overall Study|Moved from area|2|||
126763304|NCT01023815|456086769|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
126763305|NCT01023815|456086766|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
126763306|NCT01023815|456086767|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
126763307|NCT01023815|456086768|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
126763308|NCT01023815|456086769|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
126763309|NCT01023815|456086766|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
126763310|NCT01023815|456086767|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
126763311|NCT01023815|456086768|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
126763312|NCT01023815|456086769|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
126259327|NCT01049412|454239629|FG000|Period I|Adverse Event|1|||
126259328|NCT01049412|454239630|FG001|Period I|Adverse Event|0|||
126259329|NCT01049412|454239629|FG000|Period II|Withdrawal by Subject|2|||
126259330|NCT01049412|454239630|FG001|Period II|Withdrawal by Subject|3|||
126259331|NCT01049412|454239629|FG000|Period II|Adverse Event|1|||
126259332|NCT01049412|454239630|FG001|Period II|Adverse Event|0|||
126259333|NCT01049412|454239629|FG000|Period II|Lost to Follow-up|1|||
126259334|NCT01049412|454239630|FG001|Period II|Lost to Follow-up|0|||
126259335|NCT01355302|454239635|FG000|Phase 1b|Death|4|||
126259336|NCT01355302|454239636|FG001|Phase 1b|Death|0|||
126259337|NCT01355302|454239637|FG002|Phase 1b|Death|0|||
126259338|NCT01355302|454239635|FG000|Phase 1b|Study terminated by sponsor|2|||
126259339|NCT01355302|454239636|FG001|Phase 1b|Study terminated by sponsor|0|||
126259340|NCT01355302|454239637|FG002|Phase 1b|Study terminated by sponsor|0|||
126259341|NCT00693225|454239638|FG000|Overall Study|Lost to Follow-up|1|||
126259342|NCT00693225|454239639|FG001|Overall Study|Lost to Follow-up|2|||
126259343|NCT00693225|454239638|FG000|Overall Study|Adverse Event|1|||
126259344|NCT00693225|454239639|FG001|Overall Study|Adverse Event|3|||
126259345|NCT01315028|454239640|FG000|Overall Study|Lost to Follow-up|1|||
126259346|NCT01315028|454239641|FG001|Overall Study|Lost to Follow-up|0|||
126259347|NCT01315028|454239640|FG000|Overall Study|Death|0|||
126259348|NCT01315028|454239641|FG001|Overall Study|Death|1|||
126259349|NCT02531594|454239642|FG000|Overall Study|Withdrawal by Subject|7|||
126359280|NCT02181738|454607361|FG002|Overall Study|Maximum Clinical Benefit|1|||
126359281|NCT02181738|454607362|FG003|Overall Study|Maximum Clinical Benefit|0|||
126259350|NCT02531594|454239643|FG001|Overall Study|Withdrawal by Subject|8|||
126259351|NCT03750695|454239645|FG000|Overall Study|Lost to Follow-up|0|||
126259352|NCT03750695|454239646|FG001|Overall Study|Lost to Follow-up|1|||
126359282|NCT02181738|454607359|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
126450735|NCT03110770|454952326|FG003|Overall Study|Moved from area|42|||
126699360|NCT02901431|455848828|FG004|Main Treatment Part|Physician Decision|0|||
126699361|NCT02901431|455848829|FG005|Main Treatment Part|Physician Decision|0|||
126699362|NCT02901431|455848830|FG006|Main Treatment Part|Physician Decision|1|||
126699363|NCT02901431|455848831|FG007|Main Treatment Part|Physician Decision|0|||
126699364|NCT02901431|455848832|FG008|Main Treatment Part|Physician Decision|0|||
126699365|NCT02901431|455848833|FG009|Main Treatment Part|Physician Decision|0|||
126699366|NCT02901431|455848834|FG010|Main Treatment Part|Physician Decision|0|||
126699367|NCT02901431|455848835|FG011|Main Treatment Part|Physician Decision|0|||
126699368|NCT02901431|455848836|FG012|Main Treatment Part|Physician Decision|0|||
126699369|NCT02901431|455848824|FG000|Main Treatment Part|Withdrawal by Subject|0|||
126699370|NCT02901431|455848825|FG001|Main Treatment Part|Withdrawal by Subject|0|||
126699371|NCT02901431|455848826|FG002|Main Treatment Part|Withdrawal by Subject|0|||
126699372|NCT02901431|455848827|FG003|Main Treatment Part|Withdrawal by Subject|18|||
126699373|NCT02901431|455848828|FG004|Main Treatment Part|Withdrawal by Subject|3|||
126699374|NCT02901431|455848829|FG005|Main Treatment Part|Withdrawal by Subject|5|||
126699375|NCT02901431|455848830|FG006|Main Treatment Part|Withdrawal by Subject|6|||
126699376|NCT02901431|455848831|FG007|Main Treatment Part|Withdrawal by Subject|0|||
126699377|NCT02901431|455848832|FG008|Main Treatment Part|Withdrawal by Subject|0|||
126699378|NCT02901431|455848833|FG009|Main Treatment Part|Withdrawal by Subject|0|||
126699379|NCT02901431|455848834|FG010|Main Treatment Part|Withdrawal by Subject|0|||
126699380|NCT02901431|455848835|FG011|Main Treatment Part|Withdrawal by Subject|0|||
126699381|NCT02901431|455848836|FG012|Main Treatment Part|Withdrawal by Subject|0|||
126699382|NCT02901431|455848824|FG000|Open Label Part|Adverse Event|0|||
126699383|NCT02901431|455848825|FG001|Open Label Part|Adverse Event|0|||
126699384|NCT02901431|455848826|FG002|Open Label Part|Adverse Event|0|||
126699385|NCT02901431|455848827|FG003|Open Label Part|Adverse Event|0|||
126699386|NCT02901431|455848828|FG004|Open Label Part|Adverse Event|0|||
126699387|NCT02901431|455848829|FG005|Open Label Part|Adverse Event|0|||
126699388|NCT02901431|455848830|FG006|Open Label Part|Adverse Event|0|||
126699389|NCT02901431|455848831|FG007|Open Label Part|Adverse Event|0|||
126699390|NCT02901431|455848832|FG008|Open Label Part|Adverse Event|4|||
126699391|NCT02901431|455848833|FG009|Open Label Part|Adverse Event|4|||
126699392|NCT02901431|455848834|FG010|Open Label Part|Adverse Event|0|||
126699393|NCT02901431|455848835|FG011|Open Label Part|Adverse Event|4|||
126699394|NCT02901431|455848836|FG012|Open Label Part|Adverse Event|1|||
126699395|NCT02901431|455848824|FG000|Open Label Part|Lost to Follow-up|0|||
126699396|NCT02901431|455848825|FG001|Open Label Part|Lost to Follow-up|0|||
126699397|NCT02901431|455848826|FG002|Open Label Part|Lost to Follow-up|0|||
126699398|NCT02901431|455848827|FG003|Open Label Part|Lost to Follow-up|0|||
126699399|NCT02901431|455848828|FG004|Open Label Part|Lost to Follow-up|0|||
126699400|NCT02901431|455848829|FG005|Open Label Part|Lost to Follow-up|0|||
126699401|NCT02901431|455848830|FG006|Open Label Part|Lost to Follow-up|0|||
126699402|NCT02901431|455848831|FG007|Open Label Part|Lost to Follow-up|0|||
126699403|NCT02901431|455848832|FG008|Open Label Part|Lost to Follow-up|2|||
126699404|NCT02901431|455848833|FG009|Open Label Part|Lost to Follow-up|2|||
126699405|NCT02901431|455848834|FG010|Open Label Part|Lost to Follow-up|1|||
126699406|NCT02901431|455848835|FG011|Open Label Part|Lost to Follow-up|1|||
126699407|NCT02901431|455848836|FG012|Open Label Part|Lost to Follow-up|1|||
126699408|NCT02901431|455848824|FG000|Open Label Part|Physician Decision|0|||
126699409|NCT02901431|455848825|FG001|Open Label Part|Physician Decision|0|||
126699410|NCT02901431|455848826|FG002|Open Label Part|Physician Decision|0|||
126699411|NCT02901431|455848827|FG003|Open Label Part|Physician Decision|0|||
126699412|NCT02901431|455848828|FG004|Open Label Part|Physician Decision|0|||
126699413|NCT02901431|455848829|FG005|Open Label Part|Physician Decision|0|||
126699414|NCT02901431|455848830|FG006|Open Label Part|Physician Decision|0|||
126699415|NCT02901431|455848831|FG007|Open Label Part|Physician Decision|0|||
126699416|NCT02901431|455848832|FG008|Open Label Part|Physician Decision|1|||
126699417|NCT02901431|455848833|FG009|Open Label Part|Physician Decision|1|||
126699418|NCT02901431|455848834|FG010|Open Label Part|Physician Decision|0|||
126699419|NCT02901431|455848835|FG011|Open Label Part|Physician Decision|0|||
126699420|NCT02901431|455848836|FG012|Open Label Part|Physician Decision|0|||
126699421|NCT02901431|455848824|FG000|Open Label Part|Study Terminated By Sponsor|0|||
126699422|NCT02901431|455848825|FG001|Open Label Part|Study Terminated By Sponsor|0|||
126699423|NCT02901431|455848826|FG002|Open Label Part|Study Terminated By Sponsor|0|||
126699424|NCT02901431|455848827|FG003|Open Label Part|Study Terminated By Sponsor|0|||
126699425|NCT02901431|455848828|FG004|Open Label Part|Study Terminated By Sponsor|0|||
126699426|NCT02901431|455848829|FG005|Open Label Part|Study Terminated By Sponsor|0|||
126699427|NCT02901431|455848830|FG006|Open Label Part|Study Terminated By Sponsor|0|||
126699428|NCT02901431|455848831|FG007|Open Label Part|Study Terminated By Sponsor|0|||
126450736|NCT03110770|454952327|FG004|Overall Study|Moved from area|43|||
126699429|NCT02901431|455848832|FG008|Open Label Part|Study Terminated By Sponsor|35|||
126699430|NCT02901431|455848833|FG009|Open Label Part|Study Terminated By Sponsor|12|||
126699431|NCT02901431|455848834|FG010|Open Label Part|Study Terminated By Sponsor|21|||
126699432|NCT02901431|455848835|FG011|Open Label Part|Study Terminated By Sponsor|31|||
126699433|NCT02901431|455848836|FG012|Open Label Part|Study Terminated By Sponsor|0|||
126763313|NCT01023815|456086766|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
126763314|NCT01023815|456086767|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
126763315|NCT01023815|456086768|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
126763316|NCT01023815|456086769|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
126763317|NCT01023815|456086766|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
126763318|NCT01023815|456086767|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
126763319|NCT01023815|456086768|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
126763320|NCT01023815|456086769|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
126763321|NCT03253809|456086772|FG000|Overall Study|Unable to obtain study related data|14|||
126763322|NCT03992456|456086773|FG000|Overall Study|Withdrawal by Subject|1|||
126763323|NCT03992456|456086774|FG001|Overall Study|Withdrawal by Subject|0|||
126763324|NCT03992456|456086773|FG000|Overall Study|Disease progression|4|||
126763325|NCT03992456|456086774|FG001|Overall Study|Disease progression|5|||
126763326|NCT03992456|456086773|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
126763327|NCT03992456|456086774|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
126763328|NCT02594384|456086775|FG000|Overall Study|Disease Progression|3|||
126763329|NCT02594384|456086776|FG001|Overall Study|Disease Progression|7|||
126359283|NCT02181738|454607360|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
126359284|NCT02181738|454607361|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
126763330|NCT02594384|456086777|FG002|Overall Study|Disease Progression|0|||
126763331|NCT02594384|456086778|FG003|Overall Study|Disease Progression|2|||
126359285|NCT02181738|454607362|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126359286|NCT01691482|454607366|FG000|Treatment Period 2|Adverse Event|0|||
126359287|NCT01691482|454607367|FG001|Treatment Period 2|Adverse Event|1|||
126359288|NCT01691482|454607366|FG000|Treatment Period 2|Protocol Violation|1|||
126359289|NCT01691482|454607367|FG001|Treatment Period 2|Protocol Violation|1|||
126359290|NCT00183391|454607368|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
126359291|NCT00183391|454607369|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
126359292|NCT00183391|454607368|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
126359293|NCT00183391|454607369|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
126699434|NCT02901431|455848824|FG000|Open Label Part|Withdrawal by Subject|0|||
126699435|NCT02901431|455848825|FG001|Open Label Part|Withdrawal by Subject|0|||
126763332|NCT02594384|456086779|FG004|Overall Study|Disease Progression|2|||
126763333|NCT02594384|456086780|FG005|Overall Study|Disease Progression|12|||
126763334|NCT02594384|456086781|FG006|Overall Study|Disease Progression|5|||
126763335|NCT02594384|456086782|FG007|Overall Study|Disease Progression|5|||
126359294|NCT00395512|454607370|FG000|Overall Study|Adverse Event|3|||
126699436|NCT02901431|455848826|FG002|Open Label Part|Withdrawal by Subject|0|||
126699437|NCT02901431|455848827|FG003|Open Label Part|Withdrawal by Subject|0|||
126699438|NCT02901431|455848828|FG004|Open Label Part|Withdrawal by Subject|0|||
126699439|NCT02901431|455848829|FG005|Open Label Part|Withdrawal by Subject|0|||
126699440|NCT02901431|455848830|FG006|Open Label Part|Withdrawal by Subject|0|||
126699441|NCT02901431|455848831|FG007|Open Label Part|Withdrawal by Subject|0|||
126699442|NCT02901431|455848832|FG008|Open Label Part|Withdrawal by Subject|6|||
126699443|NCT02901431|455848833|FG009|Open Label Part|Withdrawal by Subject|5|||
126699444|NCT02901431|455848834|FG010|Open Label Part|Withdrawal by Subject|7|||
126699445|NCT02901431|455848835|FG011|Open Label Part|Withdrawal by Subject|3|||
126699446|NCT02901431|455848836|FG012|Open Label Part|Withdrawal by Subject|1|||
126699447|NCT04223609|455848839|FG000|Overall Study|Adverse Event|0|||
126699448|NCT04223609|455848840|FG001|Overall Study|Adverse Event|1|||
126699449|NCT04223609|455848839|FG000|Overall Study|Missed last visit|0|||
126699450|NCT04223609|455848840|FG001|Overall Study|Missed last visit|1|||
126699451|NCT01275222|455848843|FG000|Phase l by Treatment|Adverse Event|1|||
126699452|NCT01275222|455848844|FG001|Phase l by Treatment|Adverse Event|4|||
126699453|NCT01275222|455848845|FG002|Phase l by Treatment|Adverse Event|2|||
126699454|NCT01275222|455848846|FG003|Phase l by Treatment|Adverse Event|3|||
126699455|NCT01275222|455848847|FG004|Phase l by Treatment|Adverse Event|0|||
126699456|NCT01275222|455848848|FG005|Phase l by Treatment|Adverse Event|0|||
126699457|NCT01275222|455848843|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
126699458|NCT01275222|455848844|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
126699459|NCT01275222|455848845|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
126699460|NCT01275222|455848846|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
126699461|NCT01275222|455848847|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
126699462|NCT01275222|455848848|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
126699463|NCT01275222|455848843|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
126359295|NCT00395512|454607371|FG001|Overall Study|Adverse Event|8|||
126699464|NCT01275222|455848844|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
126763336|NCT02594384|456086775|FG000|Overall Study|Adverse Event|0|||
126763337|NCT02594384|456086776|FG001|Overall Study|Adverse Event|1|||
126699465|NCT01275222|455848845|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
126699466|NCT01275222|455848846|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
126699467|NCT01275222|455848847|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
126699468|NCT01275222|455848848|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
126259353|NCT01264835|454239649|FG000|Overall Study|Lost to Follow-up|1|||
126259354|NCT01203917|454239650|FG000|Overall Study|Death|29|||
126259355|NCT01203917|454239650|FG000|Overall Study|Lost to Follow-up|2|||
126259356|NCT01203917|454239650|FG000|Overall Study|Withdrawal by Subject|3|||
126259357|NCT01203917|454239650|FG000|Overall Study|Due to objective disease progression|1|||
126259358|NCT01203917|454239650|FG000|Overall Study|Due to EGFR M+I patient|1|||
126259359|NCT04660032|454239658|FG000|Overall Study|Protocol Violation|1|||
126259360|NCT04660032|454239659|FG001|Overall Study|Protocol Violation|1|||
126259361|NCT01466036|454239670|FG000|Overall Study|Death|1|||
126259362|NCT01466036|454239671|FG001|Overall Study|Death|1|||
126259363|NCT01466036|454239670|FG000|Overall Study|Physician Decision|0|||
126259364|NCT01466036|454239671|FG001|Overall Study|Physician Decision|4|||
126259365|NCT01466036|454239670|FG000|Overall Study|Adverse Event|2|||
126259366|NCT01466036|454239671|FG001|Overall Study|Adverse Event|6|||
126259367|NCT01466036|454239670|FG000|Overall Study|Withdrawal by Subject|2|||
126259368|NCT01466036|454239671|FG001|Overall Study|Withdrawal by Subject|8|||
126259369|NCT01466036|454239670|FG000|Overall Study|progression/relapse|14|||
126259370|NCT01466036|454239671|FG001|Overall Study|progression/relapse|21|||
126259371|NCT01466036|454239670|FG000|Overall Study|prolonged treatment delay|1|||
126259372|NCT01466036|454239671|FG001|Overall Study|prolonged treatment delay|1|||
126259373|NCT00985231|454239672|FG000|Overall Study|ineligible|1|||
126259374|NCT00985231|454239673|FG001|Overall Study|ineligible|0|||
126259375|NCT00985231|454239672|FG000|Overall Study|Protocol Violation|1|||
126259376|NCT00985231|454239673|FG001|Overall Study|Protocol Violation|0|||
126259377|NCT00985231|454239672|FG000|Overall Study|Withdrawal by Subject|1|||
126259378|NCT00985231|454239673|FG001|Overall Study|Withdrawal by Subject|0|||
126259379|NCT00985231|454239672|FG000|Overall Study|Lost to Follow-up|0|||
126259380|NCT00985231|454239673|FG001|Overall Study|Lost to Follow-up|1|||
126259381|NCT00985231|454239672|FG000|Overall Study|Study related symptoms & complaints|0|||
126259382|NCT00985231|454239673|FG001|Overall Study|Study related symptoms & complaints|2|||
126259383|NCT05103657|454239674|FG000|Overall Study|Other reasons than listed|9|||
126259384|NCT05103657|454239675|FG001|Overall Study|Other reasons than listed|8|||
126259385|NCT05103657|454239674|FG000|Overall Study|Protocol deviation|2|||
126259386|NCT05103657|454239675|FG001|Overall Study|Protocol deviation|2|||
126259387|NCT05103657|454239674|FG000|Overall Study|No reason available|5|||
126259388|NCT05103657|454239675|FG001|Overall Study|No reason available|4|||
126259389|NCT05103657|454239674|FG000|Overall Study|Burden of study procedures|3|||
126259390|NCT05103657|454239675|FG001|Overall Study|Burden of study procedures|1|||
126259391|NCT05103657|454239674|FG000|Overall Study|Perceived lack of efficacy|1|||
126259392|NCT05103657|454239675|FG001|Overall Study|Perceived lack of efficacy|1|||
126259393|NCT05103657|454239674|FG000|Overall Study|Adverse Event|6|||
126259394|NCT05103657|454239675|FG001|Overall Study|Adverse Event|14|||
126259395|NCT05103657|454239674|FG000|Overall Study|Not Treated|1|||
126259396|NCT05103657|454239675|FG001|Overall Study|Not Treated|1|||
126259397|NCT00109850|454239679|FG000|Overall Study|Adverse Event|1|||
126259398|NCT00109850|454239679|FG000|Overall Study|Death|2|||
126259399|NCT00109850|454239679|FG000|Overall Study|Ineligible|1|||
126259400|NCT00476593|454239680|FG000|Overall Study|Lost to Follow-up|10|||
126259401|NCT00476593|454239681|FG001|Overall Study|Lost to Follow-up|2|||
126259402|NCT00476593|454239682|FG002|Overall Study|Lost to Follow-up|8|||
126259403|NCT00476593|454239683|FG003|Overall Study|Lost to Follow-up|22|||
126259404|NCT03635983|454239684|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
126259405|NCT03635983|454239685|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
126259406|NCT03635983|454239684|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126259407|NCT03635983|454239685|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126450737|NCT03110770|454952323|FG000|Overall Study|Illness/Injury unrelated to product|0|||
126450738|NCT03110770|454952324|FG001|Overall Study|Illness/Injury unrelated to product|0|||
126450739|NCT03110770|454952325|FG002|Overall Study|Illness/Injury unrelated to product|0|||
126259408|NCT03635983|454239684|FG000|Pre-Treatment Period|Other reasons|0|||
126259409|NCT03635983|454239685|FG001|Pre-Treatment Period|Other reasons|1|||
126259410|NCT03635983|454239684|FG000|Pre-Treatment Period|Disease Progression|0|||
126259411|NCT03635983|454239685|FG001|Pre-Treatment Period|Disease Progression|1|||
126259412|NCT03635983|454239684|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
126259413|NCT03635983|454239685|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
126259414|NCT03635983|454239684|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
126259415|NCT03635983|454239685|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
126259416|NCT03635983|454239684|FG000|Treatment Period|Withdrawal by Subject|3|||
126259417|NCT03635983|454239685|FG001|Treatment Period|Withdrawal by Subject|5|||
126259418|NCT03635983|454239684|FG000|Treatment Period|Death|3|||
126259419|NCT03635983|454239685|FG001|Treatment Period|Death|5|||
126259420|NCT03635983|454239684|FG000|Treatment Period|Poor/Non-compliance|2|||
126259421|NCT03635983|454239685|FG001|Treatment Period|Poor/Non-compliance|1|||
126259422|NCT03635983|454239684|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
126259423|NCT03635983|454239685|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
126259424|NCT03635983|454239684|FG000|Treatment Period|Other reasons|7|||
126450740|NCT03110770|454952326|FG003|Overall Study|Illness/Injury unrelated to product|0|||
126259425|NCT03635983|454239685|FG001|Treatment Period|Other reasons|4|||
126259426|NCT03635983|454239684|FG000|Treatment Period|Disease progression|230|||
126259427|NCT03635983|454239685|FG001|Treatment Period|Disease progression|201|||
126259428|NCT03635983|454239684|FG000|Treatment Period|Study drug toxicity|35|||
126259429|NCT03635983|454239685|FG001|Treatment Period|Study drug toxicity|36|||
126259430|NCT03635983|454239684|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
126259431|NCT03635983|454239685|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
126259432|NCT03635983|454239684|FG000|Treatment Period|Maximum clinical benefit|3|||
126259433|NCT03635983|454239685|FG001|Treatment Period|Maximum clinical benefit|5|||
126259434|NCT03635983|454239684|FG000|Treatment Period|Administrative reason by the sponsor|1|||
126259435|NCT03635983|454239685|FG001|Treatment Period|Administrative reason by the sponsor|2|||
126259436|NCT03635983|454239684|FG000|Treatment Period|Lost to Follow-up|0|||
126259437|NCT03635983|454239685|FG001|Treatment Period|Lost to Follow-up|1|||
126259438|NCT03430011|454239686|FG000|Pre-Treatment|Death|1|||
126259439|NCT03430011|454239687|FG001|Pre-Treatment|Death|0|||
126259440|NCT03430011|454239688|FG002|Pre-Treatment|Death|0|||
126259441|NCT03430011|454239689|FG003|Pre-Treatment|Death|0|||
126259442|NCT03430011|454239690|FG004|Pre-Treatment|Death|1|||
126259443|NCT03430011|454239691|FG005|Pre-Treatment|Death|0|||
126259444|NCT03430011|454239692|FG006|Pre-Treatment|Death|1|||
126259445|NCT03430011|454239693|FG007|Pre-Treatment|Death|0|||
126259446|NCT03430011|454239686|FG000|Pre-Treatment|Screen Fail|0|||
126259447|NCT03430011|454239687|FG001|Pre-Treatment|Screen Fail|0|||
126259448|NCT03430011|454239688|FG002|Pre-Treatment|Screen Fail|0|||
126259449|NCT03430011|454239689|FG003|Pre-Treatment|Screen Fail|0|||
126259450|NCT03430011|454239690|FG004|Pre-Treatment|Screen Fail|1|||
126259451|NCT03430011|454239691|FG005|Pre-Treatment|Screen Fail|0|||
126259452|NCT03430011|454239692|FG006|Pre-Treatment|Screen Fail|0|||
126259453|NCT03430011|454239693|FG007|Pre-Treatment|Screen Fail|0|||
126259454|NCT03430011|454239686|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259455|NCT03430011|454239687|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259456|NCT03430011|454239688|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
126259457|NCT03430011|454239689|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259458|NCT03430011|454239690|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259459|NCT03430011|454239691|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259460|NCT03430011|454239692|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259461|NCT03430011|454239693|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
126259462|NCT03430011|454239686|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
126259463|NCT03430011|454239687|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
126259464|NCT03430011|454239688|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
126259465|NCT03430011|454239689|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
126259466|NCT03430011|454239690|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
126259467|NCT03430011|454239691|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
126259468|NCT03430011|454239692|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
126259469|NCT03430011|454239693|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
126259470|NCT03430011|454239686|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
126259471|NCT03430011|454239687|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
126259472|NCT03430011|454239688|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
126259473|NCT03430011|454239689|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
126259474|NCT03430011|454239690|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
126259475|NCT03430011|454239691|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
126259476|NCT03430011|454239692|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
126259477|NCT03430011|454239693|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
126259478|NCT03430011|454239686|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
126259479|NCT03430011|454239687|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
126259480|NCT03430011|454239688|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
126259481|NCT03430011|454239689|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
126259482|NCT03430011|454239690|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
126259483|NCT03430011|454239691|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
126259484|NCT03430011|454239692|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
126259485|NCT03430011|454239693|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
126763338|NCT02594384|456086777|FG002|Overall Study|Adverse Event|4|||
126763339|NCT02594384|456086778|FG003|Overall Study|Adverse Event|1|||
126763340|NCT02594384|456086779|FG004|Overall Study|Adverse Event|0|||
126259486|NCT03430011|454239686|FG000|JCARH125 Treatment|Death|4|||
126359296|NCT00395512|454607372|FG002|Overall Study|Adverse Event|6|||
126763341|NCT02594384|456086780|FG005|Overall Study|Adverse Event|6|||
126259487|NCT03430011|454239687|FG001|JCARH125 Treatment|Death|19|||
126259488|NCT03430011|454239688|FG002|JCARH125 Treatment|Death|10|||
126259489|NCT03430011|454239689|FG003|JCARH125 Treatment|Death|8|||
126259490|NCT03430011|454239690|FG004|JCARH125 Treatment|Death|5|||
126259491|NCT03430011|454239691|FG005|JCARH125 Treatment|Death|3|||
126259492|NCT03430011|454239692|FG006|JCARH125 Treatment|Death|4|||
126259493|NCT03430011|454239693|FG007|JCARH125 Treatment|Death|2|||
126259494|NCT03430011|454239686|FG000|JCARH125 Treatment|Other reasons|1|||
126763342|NCT02594384|456086781|FG006|Overall Study|Adverse Event|1|||
126259495|NCT03430011|454239687|FG001|JCARH125 Treatment|Other reasons|0|||
126259496|NCT03430011|454239688|FG002|JCARH125 Treatment|Other reasons|4|||
126259497|NCT03430011|454239689|FG003|JCARH125 Treatment|Other reasons|2|||
126259498|NCT03430011|454239690|FG004|JCARH125 Treatment|Other reasons|2|||
126259499|NCT03430011|454239691|FG005|JCARH125 Treatment|Other reasons|1|||
126259500|NCT03430011|454239692|FG006|JCARH125 Treatment|Other reasons|3|||
126259501|NCT03430011|454239693|FG007|JCARH125 Treatment|Other reasons|2|||
126259502|NCT04126343|454239695|FG000|Overall Study|Adverse Event|0|||
126259503|NCT04126343|454239696|FG001|Overall Study|Adverse Event|0|||
126259504|NCT04126343|454239697|FG002|Overall Study|Adverse Event|0|||
126259505|NCT04126343|454239698|FG003|Overall Study|Adverse Event|0|||
126259506|NCT04126343|454239699|FG004|Overall Study|Adverse Event|0|||
126259507|NCT04126343|454239700|FG005|Overall Study|Adverse Event|1|||
126259508|NCT04126343|454239695|FG000|Overall Study|Withdrawal by Subject|0|||
126259509|NCT04126343|454239696|FG001|Overall Study|Withdrawal by Subject|0|||
126259510|NCT04126343|454239697|FG002|Overall Study|Withdrawal by Subject|0|||
126259511|NCT04126343|454239698|FG003|Overall Study|Withdrawal by Subject|1|||
126259512|NCT04126343|454239699|FG004|Overall Study|Withdrawal by Subject|0|||
126259513|NCT04126343|454239700|FG005|Overall Study|Withdrawal by Subject|0|||
126259514|NCT04126343|454239695|FG000|Overall Study|Related to COVID-19 pandemic|3|||
126259515|NCT04126343|454239696|FG001|Overall Study|Related to COVID-19 pandemic|4|||
126259516|NCT04126343|454239697|FG002|Overall Study|Related to COVID-19 pandemic|3|||
126259517|NCT04126343|454239698|FG003|Overall Study|Related to COVID-19 pandemic|3|||
126259518|NCT04126343|454239699|FG004|Overall Study|Related to COVID-19 pandemic|3|||
126259519|NCT04126343|454239700|FG005|Overall Study|Related to COVID-19 pandemic|3|||
126259520|NCT01235442|454239701|FG000|Overall Study|Lost to Follow-up|12|||
126259521|NCT01235442|454239702|FG001|Overall Study|Lost to Follow-up|10|||
126259522|NCT01235442|454239701|FG000|Overall Study|Death|0|||
126259523|NCT01235442|454239702|FG001|Overall Study|Death|2|||
126259524|NCT01235442|454239701|FG000|Overall Study|Pregnancy|1|||
126259525|NCT01235442|454239702|FG001|Overall Study|Pregnancy|1|||
126259526|NCT01235442|454239701|FG000|Overall Study|Ineligibility determined|5|||
126259527|NCT01235442|454239702|FG001|Overall Study|Ineligibility determined|4|||
126259528|NCT01235442|454239701|FG000|Overall Study|Protocol Violation|3|||
126259529|NCT01235442|454239702|FG001|Overall Study|Protocol Violation|3|||
126259530|NCT01235442|454239701|FG000|Overall Study|Adverse Event|4|||
126259531|NCT01235442|454239702|FG001|Overall Study|Adverse Event|6|||
126259532|NCT01235442|454239701|FG000|Overall Study|Withdrawal by Subject|15|||
126259533|NCT01235442|454239702|FG001|Overall Study|Withdrawal by Subject|9|||
126259534|NCT01235442|454239701|FG000|Overall Study|Lack of Efficacy|1|||
126259535|NCT01235442|454239702|FG001|Overall Study|Lack of Efficacy|3|||
126259536|NCT01235442|454239701|FG000|Overall Study|Noncompliance|1|||
126259537|NCT01235442|454239702|FG001|Overall Study|Noncompliance|2|||
126259538|NCT01235442|454239701|FG000|Overall Study|Administrative decision|1|||
126259539|NCT01235442|454239702|FG001|Overall Study|Administrative decision|2|||
126259540|NCT01235442|454239701|FG000|Overall Study|Other unspecified|1|||
126259541|NCT01235442|454239702|FG001|Overall Study|Other unspecified|2|||
126259542|NCT00084799|454239703|FG000|Overall Study|Disease Progression|1|||
126259543|NCT00084799|454239704|FG001|Overall Study|Disease Progression|0|||
126259544|NCT03712124|454239707|FG000|Overall Study|Protocol Violation|1|||
126259545|NCT03712124|454239708|FG001|Overall Study|Protocol Violation|0|||
126259546|NCT04499482|454239710|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
126259547|NCT04330157|454239711|FG000|Overall Study|Protocol Violation|4|||
126259548|NCT04330157|454239711|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
126259549|NCT04314843|454239712|FG000|Overall Study|Death|2|||
126259550|NCT04314843|454239713|FG001|Overall Study|Death|2|||
126259551|NCT04314843|454239712|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
126259552|NCT04314843|454239713|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
126259553|NCT04718129|454239714|FG000|Overall Study|Lost to Follow-up|6|||
126259554|NCT04718129|454239715|FG001|Overall Study|Lost to Follow-up|7|||
126259555|NCT01378962|454239716|FG000|Overall Study|Death|14|||
126259556|NCT01378962|454239716|FG000|Overall Study|Lost to Follow-up|1|||
126259557|NCT01378962|454239716|FG000|Overall Study|Other|2|||
126259558|NCT02030535|454239717|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
126259559|NCT01588548|454239718|FG000|Overall Study|Withdrawal by Subject|0|||
126259560|NCT01588548|454239719|FG001|Overall Study|Withdrawal by Subject|1|||
126259561|NCT01588548|454239720|FG002|Overall Study|Withdrawal by Subject|1|||
126259562|NCT01588548|454239721|FG003|Overall Study|Withdrawal by Subject|1|||
126359297|NCT00395512|454607373|FG003|Overall Study|Adverse Event|6|||
126259563|NCT01588548|454239722|FG004|Overall Study|Withdrawal by Subject|2|||
126259564|NCT01588548|454239723|FG005|Overall Study|Withdrawal by Subject|3|||
126259565|NCT01588548|454239718|FG000|Overall Study|Adverse Event|0|||
126259566|NCT01588548|454239719|FG001|Overall Study|Adverse Event|0|||
126359298|NCT00395512|454607370|FG000|Overall Study|Protocol Violation|2|||
126259567|NCT01588548|454239720|FG002|Overall Study|Adverse Event|1|||
126259568|NCT01588548|454239721|FG003|Overall Study|Adverse Event|2|||
126259569|NCT01588548|454239722|FG004|Overall Study|Adverse Event|1|||
126259570|NCT01588548|454239723|FG005|Overall Study|Adverse Event|0|||
126259571|NCT01588548|454239718|FG000|Overall Study|Condition Under Investigation Worsened|3|||
126259572|NCT01588548|454239719|FG001|Overall Study|Condition Under Investigation Worsened|6|||
126259573|NCT01588548|454239720|FG002|Overall Study|Condition Under Investigation Worsened|4|||
126259574|NCT01588548|454239721|FG003|Overall Study|Condition Under Investigation Worsened|4|||
126259575|NCT01588548|454239722|FG004|Overall Study|Condition Under Investigation Worsened|3|||
126259576|NCT01588548|454239723|FG005|Overall Study|Condition Under Investigation Worsened|3|||
126259577|NCT00292227|454239724|FG000|Patch Period|Adverse Event|1|||
126259578|NCT00292227|454239725|FG001|Patch Period|Adverse Event|0|||
126450741|NCT03110770|454952327|FG004|Overall Study|Illness/Injury unrelated to product|1|||
126450742|NCT01767142|454952330|FG000|Overall Study|Lost to Follow-up|3|||
126450743|NCT02082340|454952336|FG000|Overall Study|Lost to Follow-up|1|||
126450744|NCT02082340|454952337|FG001|Overall Study|Lost to Follow-up|1|||
126450745|NCT01625260|454952338|FG000|Overall Study|Adverse Event|3|||
126450746|NCT01625260|454952339|FG001|Overall Study|Adverse Event|0|||
126450747|NCT01625260|454952338|FG000|Overall Study|Study Terminated by Investigator|2|||
126450748|NCT01625260|454952339|FG001|Overall Study|Study Terminated by Investigator|0|||
126450749|NCT01625260|454952338|FG000|Overall Study|Disease Progression|2|||
126450750|NCT01625260|454952339|FG001|Overall Study|Disease Progression|0|||
126450751|NCT01625260|454952338|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
126450752|NCT01625260|454952339|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
126450753|NCT02937584|454952340|FG000|Period 1|Adverse Event|1|||
126450754|NCT02937584|454952341|FG001|Period 1|Adverse Event|2|||
126450755|NCT02937584|454952340|FG000|Washout|Adverse Event|0|||
126450756|NCT02937584|454952341|FG001|Washout|Adverse Event|1|||
126450757|NCT00635219|454952342|FG000|Overall Study|Adverse Event|12|||
126450758|NCT00635219|454952343|FG001|Overall Study|Adverse Event|10|||
126450759|NCT00635219|454952344|FG002|Overall Study|Adverse Event|18|||
126450760|NCT00635219|454952345|FG003|Overall Study|Adverse Event|15|||
126450761|NCT00635219|454952346|FG004|Overall Study|Adverse Event|19|||
126450762|NCT00635219|454952342|FG000|Overall Study|Lack of Efficacy|5|||
126450763|NCT00635219|454952343|FG001|Overall Study|Lack of Efficacy|6|||
126450764|NCT00635219|454952344|FG002|Overall Study|Lack of Efficacy|3|||
126450765|NCT00635219|454952345|FG003|Overall Study|Lack of Efficacy|4|||
126450766|NCT00635219|454952346|FG004|Overall Study|Lack of Efficacy|6|||
126450767|NCT00635219|454952342|FG000|Overall Study|Non-compliance With Study Product|0|||
126450768|NCT00635219|454952343|FG001|Overall Study|Non-compliance With Study Product|0|||
126450769|NCT00635219|454952344|FG002|Overall Study|Non-compliance With Study Product|0|||
126450770|NCT00635219|454952345|FG003|Overall Study|Non-compliance With Study Product|2|||
126450771|NCT00635219|454952346|FG004|Overall Study|Non-compliance With Study Product|1|||
126450772|NCT00635219|454952342|FG000|Overall Study|Protocol Violation|0|||
126450773|NCT00635219|454952343|FG001|Overall Study|Protocol Violation|2|||
126450774|NCT00635219|454952344|FG002|Overall Study|Protocol Violation|3|||
126450775|NCT00635219|454952345|FG003|Overall Study|Protocol Violation|2|||
126450776|NCT00635219|454952346|FG004|Overall Study|Protocol Violation|4|||
126450777|NCT00635219|454952342|FG000|Overall Study|Withdrawal of Consent|8|||
126450778|NCT00635219|454952343|FG001|Overall Study|Withdrawal of Consent|6|||
126450779|NCT00635219|454952344|FG002|Overall Study|Withdrawal of Consent|8|||
126450780|NCT00635219|454952345|FG003|Overall Study|Withdrawal of Consent|11|||
126450781|NCT00635219|454952346|FG004|Overall Study|Withdrawal of Consent|8|||
126450782|NCT00635219|454952342|FG000|Overall Study|Lost to Follow-up|0|||
126450783|NCT00635219|454952343|FG001|Overall Study|Lost to Follow-up|0|||
126450784|NCT00635219|454952344|FG002|Overall Study|Lost to Follow-up|2|||
126450785|NCT00635219|454952345|FG003|Overall Study|Lost to Follow-up|0|||
126450786|NCT00635219|454952346|FG004|Overall Study|Lost to Follow-up|3|||
126450787|NCT00635219|454952342|FG000|Overall Study|Administrative or Other Reasons|0|||
126450788|NCT00635219|454952343|FG001|Overall Study|Administrative or Other Reasons|1|||
126450789|NCT00635219|454952344|FG002|Overall Study|Administrative or Other Reasons|1|||
126450790|NCT00635219|454952345|FG003|Overall Study|Administrative or Other Reasons|0|||
126450791|NCT00635219|454952346|FG004|Overall Study|Administrative or Other Reasons|1|||
126450792|NCT04075734|454952355|FG000|Overall Study|Lost to Follow-up|1|||
126450793|NCT04075734|454952356|FG001|Overall Study|Lost to Follow-up|1|||
126450794|NCT04075734|454952357|FG002|Overall Study|Lost to Follow-up|0|||
126450795|NCT04075734|454952355|FG000|Overall Study|Withdrawal by Subject|3|||
126450796|NCT04075734|454952356|FG001|Overall Study|Withdrawal by Subject|0|||
126450797|NCT04075734|454952357|FG002|Overall Study|Withdrawal by Subject|0|||
126450798|NCT01598129|454952358|FG000|Overall Study|Disease progression|6|||
126450799|NCT01598129|454952358|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
126450800|NCT01598129|454952358|FG000|Overall Study|Withdrawal by Subject|1|||
126450801|NCT00591318|454952359|FG000|Overall Study|Lack of Efficacy|2|||
126450802|NCT00591318|454952360|FG001|Overall Study|Lack of Efficacy|0|||
126450803|NCT00591318|454952359|FG000|Overall Study|Adverse Event|2|||
126450804|NCT00591318|454952360|FG001|Overall Study|Adverse Event|0|||
126450805|NCT03615040|454952361|FG000|Overall Study|Withdrawal by Subject|2|||
126259579|NCT00292227|454239726|FG002|Patch Period|Adverse Event|2|||
126450806|NCT03615040|454952362|FG001|Overall Study|Withdrawal by Subject|1|||
126699469|NCT01275222|455848843|FG000|Phase l by Treatment|Disease progression|12|||
126699470|NCT01275222|455848844|FG001|Phase l by Treatment|Disease progression|8|||
126699471|NCT01275222|455848845|FG002|Phase l by Treatment|Disease progression|2|||
126699472|NCT01275222|455848846|FG003|Phase l by Treatment|Disease progression|5|||
126699473|NCT01275222|455848847|FG004|Phase l by Treatment|Disease progression|0|||
126699474|NCT01275222|455848848|FG005|Phase l by Treatment|Disease progression|0|||
126699475|NCT01275222|455848843|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
126699476|NCT01275222|455848844|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
126699477|NCT01275222|455848845|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
126699478|NCT01275222|455848846|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
126699479|NCT01275222|455848847|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
126699480|NCT01275222|455848848|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
126699481|NCT01275222|455848843|FG000|Phase l by Treatment|Death|0|||
126699482|NCT01275222|455848844|FG001|Phase l by Treatment|Death|1|||
126699483|NCT01275222|455848845|FG002|Phase l by Treatment|Death|0|||
126699484|NCT01275222|455848846|FG003|Phase l by Treatment|Death|1|||
126699485|NCT01275222|455848847|FG004|Phase l by Treatment|Death|0|||
126699486|NCT01275222|455848848|FG005|Phase l by Treatment|Death|0|||
126699487|NCT01275222|455848843|FG000|Phase ll by Stratum|Adverse Event|0|||
126699488|NCT01275222|455848844|FG001|Phase ll by Stratum|Adverse Event|0|||
126699489|NCT01275222|455848845|FG002|Phase ll by Stratum|Adverse Event|0|||
126699490|NCT01275222|455848846|FG003|Phase ll by Stratum|Adverse Event|0|||
126699491|NCT01275222|455848847|FG004|Phase ll by Stratum|Adverse Event|2|||
126699492|NCT01275222|455848848|FG005|Phase ll by Stratum|Adverse Event|10|||
126699493|NCT01275222|455848843|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
126699494|NCT01275222|455848844|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
126699495|NCT01275222|455848845|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
126699496|NCT01275222|455848846|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
126699497|NCT01275222|455848847|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
126699498|NCT01275222|455848848|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
126699499|NCT01275222|455848843|FG000|Phase ll by Stratum|Disease progression|0|||
126699500|NCT01275222|455848844|FG001|Phase ll by Stratum|Disease progression|0|||
126699501|NCT01275222|455848845|FG002|Phase ll by Stratum|Disease progression|0|||
126699502|NCT01275222|455848846|FG003|Phase ll by Stratum|Disease progression|0|||
126699503|NCT01275222|455848847|FG004|Phase ll by Stratum|Disease progression|23|||
126699504|NCT01275222|455848848|FG005|Phase ll by Stratum|Disease progression|31|||
126699505|NCT01275222|455848843|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
126699506|NCT01275222|455848844|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
126699507|NCT01275222|455848845|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
126699508|NCT01275222|455848846|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
126699509|NCT01275222|455848847|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
126699510|NCT01275222|455848848|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
126699511|NCT01275222|455848843|FG000|Phase ll by Stratum|Death|0|||
126699512|NCT01275222|455848844|FG001|Phase ll by Stratum|Death|0|||
126699513|NCT01275222|455848845|FG002|Phase ll by Stratum|Death|0|||
126699514|NCT01275222|455848846|FG003|Phase ll by Stratum|Death|0|||
126699515|NCT01275222|455848847|FG004|Phase ll by Stratum|Death|1|||
126699516|NCT01275222|455848848|FG005|Phase ll by Stratum|Death|1|||
126699517|NCT03440944|455848849|FG000|Overall Study|Physician Decision|1|||
126699518|NCT03440944|455848850|FG001|Overall Study|Physician Decision|0|||
126699519|NCT03440944|455848849|FG000|Overall Study|No Acceptable Vasculature|0|||
126699520|NCT03440944|455848850|FG001|Overall Study|No Acceptable Vasculature|1|||
126699521|NCT00591734|455848851|FG000|Overall Study|Lack of Efficacy|35|||
126699522|NCT00591734|455848851|FG000|Overall Study|Adverse Event|5|||
126699523|NCT00591734|455848851|FG000|Overall Study|Physician Decision|5|||
126699524|NCT00591734|455848851|FG000|Overall Study|Intercurrent Illness|8|||
126699525|NCT00943683|455848852|FG000|Overall Study|Adverse Event|3|||
126699526|NCT00943683|455848853|FG001|Overall Study|Adverse Event|3|||
126699527|NCT00943683|455848852|FG000|Overall Study|Lost to Follow-up|1|||
126699528|NCT00943683|455848853|FG001|Overall Study|Lost to Follow-up|1|||
126259580|NCT00292227|454239724|FG000|Patch Period|Withdrawal by Subject|0|||
126259581|NCT00292227|454239725|FG001|Patch Period|Withdrawal by Subject|0|||
126699529|NCT00943683|455848852|FG000|Overall Study|Protocol Violation|1|||
126699530|NCT00943683|455848853|FG001|Overall Study|Protocol Violation|2|||
126699531|NCT00943683|455848852|FG000|Overall Study|Withdrawal by Subject|1|||
126699532|NCT00943683|455848853|FG001|Overall Study|Withdrawal by Subject|0|||
126699533|NCT00943683|455848852|FG000|Overall Study|Patient Moved|1|||
126699534|NCT00943683|455848853|FG001|Overall Study|Patient Moved|0|||
126699535|NCT04672083|455848854|FG000|Overall Study|Lost to Follow-up|1|||
126699536|NCT04672083|455848855|FG001|Overall Study|Lost to Follow-up|0|||
126699537|NCT04672083|455848856|FG002|Overall Study|Lost to Follow-up|0|||
126699538|NCT04672083|455848857|FG003|Overall Study|Lost to Follow-up|0|||
126699539|NCT04672083|455848858|FG004|Overall Study|Lost to Follow-up|0|||
126699540|NCT01661790|455848859|FG000|Overall Study|Lost to Follow-up|0|||
126699541|NCT01661790|455848860|FG001|Overall Study|Lost to Follow-up|2|||
126699542|NCT02048904|455848865|FG000|Overall Study|Withdrawal by Subject|7|||
126763343|NCT02594384|456086782|FG007|Overall Study|Adverse Event|1|||
126699543|NCT02048904|455848865|FG000|Overall Study|Physician Decision|70|||
126259582|NCT00292227|454239726|FG002|Patch Period|Withdrawal by Subject|1|||
126259583|NCT03257254|454239727|FG000|Overall Study|Withdrawal by Subject|7|||
126259584|NCT03257254|454239727|FG000|Overall Study|Lost to Follow-up|9|||
126259585|NCT03257254|454239727|FG000|Overall Study|Study discontinued by sponsor|5|||
126259586|NCT00442546|454239728|FG000|Overall Study|Adverse Event|11|||
126259587|NCT00442546|454239729|FG001|Overall Study|Adverse Event|17|||
126259588|NCT00442546|454239730|FG002|Overall Study|Adverse Event|13|||
126259589|NCT00442546|454239728|FG000|Overall Study|Lost to Follow-up|1|||
126259590|NCT00442546|454239729|FG001|Overall Study|Lost to Follow-up|2|||
126259591|NCT00442546|454239730|FG002|Overall Study|Lost to Follow-up|1|||
126259592|NCT00442546|454239728|FG000|Overall Study|Other|4|||
126259593|NCT00442546|454239729|FG001|Overall Study|Other|9|||
126546706|NCT02769065|455296003|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546707|NCT02769065|455296004|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546708|NCT02769065|455296005|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546709|NCT02769065|455296006|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546710|NCT02769065|455296007|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546711|NCT02769065|455296008|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546712|NCT02769065|455296009|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546713|NCT02769065|455296010|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546714|NCT02769065|455296011|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546715|NCT02769065|455296012|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546716|NCT02769065|455296013|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546717|NCT02769065|455296014|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546718|NCT02769065|455296015|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546719|NCT02769065|455296016|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546720|NCT02769065|455296017|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546721|NCT02769065|455296018|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546722|NCT02769065|455296019|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
126546723|NCT02764775|455296022|FG000|Overall Study|Death|1|||
126546724|NCT02764775|455296022|FG000|Overall Study|Lost to Follow-up|2|||
126546725|NCT02764775|455296022|FG000|Overall Study|Withdrawal by Subject|3|||
126546726|NCT01186328|455296023|FG000|Overall Study|Death|1|||
126546727|NCT01186328|455296024|FG001|Overall Study|Death|0|||
126546728|NCT01186328|455296025|FG002|Overall Study|Death|0|||
126546729|NCT02762981|455296028|FG000|Overall Study|Adverse Event|2|||
126546730|NCT02762981|455296029|FG001|Overall Study|Adverse Event|3|||
126546731|NCT02762981|455296030|FG002|Overall Study|Adverse Event|1|||
126546732|NCT02762981|455296031|FG003|Overall Study|Adverse Event|1|||
126546733|NCT02762981|455296032|FG004|Overall Study|Adverse Event|3|||
126546734|NCT02762981|455296028|FG000|Overall Study|Physician Decision|0|||
126546735|NCT02762981|455296029|FG001|Overall Study|Physician Decision|1|||
126546736|NCT02762981|455296030|FG002|Overall Study|Physician Decision|0|||
126546737|NCT02762981|455296031|FG003|Overall Study|Physician Decision|0|||
126546738|NCT02762981|455296032|FG004|Overall Study|Physician Decision|1|||
126699544|NCT00784758|455848873|FG000|Overall Study|Withdrawal by Subject|3|||
126699545|NCT00784758|455848874|FG001|Overall Study|Withdrawal by Subject|0|||
126699546|NCT00784758|455848873|FG000|Overall Study|Adverse Event|1|||
126699547|NCT00784758|455848874|FG001|Overall Study|Adverse Event|0|||
126699548|NCT04439123|455848878|FG000|Overall Study|Adverse Event|11|||
126699549|NCT04439123|455848878|FG000|Overall Study|Death|1|||
126699550|NCT04439123|455848878|FG000|Overall Study|Disease progression|19|||
126699551|NCT04439123|455848878|FG000|Overall Study|Withdrawal by Subject|2|||
126699552|NCT04439123|455848878|FG000|Overall Study|Still on treatment|2|||
126699553|NCT06119191|455848886|FG000|Overall Study|Adverse Event|0|||
126699554|NCT06119191|455848887|FG001|Overall Study|Adverse Event|1|||
126699555|NCT06119191|455848886|FG000|Overall Study|Protocol Violation|1|||
126699556|NCT06119191|455848887|FG001|Overall Study|Protocol Violation|0|||
126699557|NCT02732951|455851198|FG000|Overall Study|Other than listed|1|||
126699558|NCT02732951|455851199|FG001|Overall Study|Other than listed|0|||
126699559|NCT02732951|455851198|FG000|Overall Study|Lost to Follow-up|0|||
126699560|NCT02732951|455851199|FG001|Overall Study|Lost to Follow-up|1|||
126699561|NCT02732951|455851198|FG000|Overall Study|Adverse Event|4|||
126699562|NCT02732951|455851199|FG001|Overall Study|Adverse Event|4|||
126699563|NCT02732951|455851198|FG000|Overall Study|Protocol Violation|0|||
126699564|NCT02732951|455851199|FG001|Overall Study|Protocol Violation|1|||
126699565|NCT03263806|455851200|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
126699566|NCT03263806|455851201|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
126699567|NCT03263806|455851200|FG000|Overall Study|Withdrawal by Subject|0|||
126699568|NCT03263806|455851201|FG001|Overall Study|Withdrawal by Subject|1|||
126699569|NCT03263806|455851200|FG000|Overall Study|Study Termination|5|||
126699570|NCT03263806|455851201|FG001|Overall Study|Study Termination|6|||
126259594|NCT00442546|454239730|FG002|Overall Study|Other|6|||
126699571|NCT01412879|455851204|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
126699572|NCT01412879|455851205|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
126699573|NCT01412879|455851206|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
126763344|NCT02594384|456086775|FG000|Overall Study|Withdrawal by Subject|0|||
126699574|NCT01412879|455851204|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
126699575|NCT01412879|455851205|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
126699576|NCT01412879|455851206|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
126699577|NCT01412879|455851204|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
126699578|NCT01412879|455851205|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
126699579|NCT01412879|455851206|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
126699580|NCT01412879|455851204|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
126699581|NCT01412879|455851205|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
126699582|NCT01412879|455851206|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
126699583|NCT01412879|455851204|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
126699584|NCT01412879|455851205|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
126699585|NCT01412879|455851206|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
126699586|NCT04840667|455851207|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
126699587|NCT01445171|455851208|FG000|Overall Study|Lost to Follow-up|11|||
126699588|NCT01445171|455851208|FG000|Overall Study|Withdrawal by Subject|16|||
126699589|NCT01445171|455851208|FG000|Overall Study|Death|51|||
126699590|NCT01445171|455851208|FG000|Overall Study|Subjects declined to return for followup|9|||
126699591|NCT01445171|455851208|FG000|Overall Study|Consented but did not receive device|8|||
126699592|NCT03195894|455851215|FG000|Overall Study|"An example is Started other treatment."|4|||
126699593|NCT03195894|455851216|FG001|Overall Study|"An example is Started other treatment."|5|||
126699594|NCT03195894|455851215|FG000|Overall Study|Withdrawal by Subject|15|||
126259595|NCT00442546|454239728|FG000|Overall Study|Withdrawal by Subject|5|||
126259596|NCT00442546|454239729|FG001|Overall Study|Withdrawal by Subject|5|||
126259597|NCT00442546|454239730|FG002|Overall Study|Withdrawal by Subject|7|||
126259598|NCT00442546|454239728|FG000|Overall Study|Randomized But Not Treated|5|||
126259599|NCT00442546|454239729|FG001|Overall Study|Randomized But Not Treated|4|||
126259600|NCT00442546|454239730|FG002|Overall Study|Randomized But Not Treated|6|||
126259601|NCT03840382|454239731|FG000|Overall Study|Lost to Follow-up|11|||
126259602|NCT03180528|454240728|FG000|Overall Study|Adverse Event|1|||
126259603|NCT03180528|454240728|FG000|Overall Study|Withdrawal by Subject|1|||
126259604|NCT03180528|454240728|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
126259605|NCT04703855|454240729|FG000|Overall Study|Heart Transplant|1|||
126259606|NCT00097786|454240733|FG000|Overall Study|lost to follow-up for all-cause death|296|||
126259607|NCT00097786|454240734|FG001|Overall Study|lost to follow-up for all-cause death|292|||
126259608|NCT00097786|454240735|FG002|Overall Study|lost to follow-up for all-cause death|313|||
126259609|NCT00097786|454240736|FG003|Overall Study|lost to follow-up for all-cause death|310|||
126259610|NCT02000531|454240737|FG000|Overall Study|Lost to Follow-up|1|||
126259611|NCT02000531|454240738|FG001|Overall Study|Lost to Follow-up|0|||
126259612|NCT02000531|454240737|FG000|Overall Study|Discontinued due to data cut-off|3|||
126259613|NCT02000531|454240738|FG001|Overall Study|Discontinued due to data cut-off|8|||
126259614|NCT01239472|454240741|FG000|Overall Study|Withdrawal by Subject|5|||
126259615|NCT01239472|454240742|FG001|Overall Study|Withdrawal by Subject|1|||
126259616|NCT01239472|454240741|FG000|Overall Study|Adverse Event|0|||
126259617|NCT01239472|454240742|FG001|Overall Study|Adverse Event|1|||
126259618|NCT01239472|454240741|FG000|Overall Study|Lack of Efficacy|0|||
126259619|NCT01239472|454240742|FG001|Overall Study|Lack of Efficacy|1|||
126259620|NCT01280617|454240747|FG000|Overall Study|Adverse Event|0|||
126259621|NCT01280617|454240748|FG001|Overall Study|Adverse Event|1|||
126259622|NCT05966090|454240749|FG000|Overall Study|Lost to Follow-up|6|||
126259623|NCT05966090|454240750|FG001|Overall Study|Lost to Follow-up|6|||
126259624|NCT05966090|454240749|FG000|Overall Study|Adverse Event|1|||
126259625|NCT05966090|454240750|FG001|Overall Study|Adverse Event|1|||
126259626|NCT05966090|454240749|FG000|Overall Study|Withdrawal by Subject|1|||
126259627|NCT05966090|454240750|FG001|Overall Study|Withdrawal by Subject|1|||
126259628|NCT05966090|454240749|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126259629|NCT05966090|454240750|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
126259630|NCT05966090|454240749|FG000|Overall Study|Other|1|||
126259631|NCT05966090|454240750|FG001|Overall Study|Other|1|||
126259632|NCT00337428|454240751|FG000|Overall Study|Withdrawal by Subject|1|||
126259633|NCT00337428|454240752|FG001|Overall Study|Withdrawal by Subject|2|||
126259634|NCT00337428|454240751|FG000|Overall Study|Lack of Time|1|||
126259635|NCT00337428|454240752|FG001|Overall Study|Lack of Time|1|||
126259636|NCT00337428|454240751|FG000|Overall Study|Unwilling to Continue|1|||
126259637|NCT00337428|454240752|FG001|Overall Study|Unwilling to Continue|0|||
126259638|NCT00337428|454240751|FG000|Overall Study|Anorexia|1|||
126259639|NCT00337428|454240752|FG001|Overall Study|Anorexia|0|||
126259640|NCT02001051|454240753|FG000|Overall Study|Deemed not eligible following enrollment|0|||
126359299|NCT00395512|454607371|FG001|Overall Study|Protocol Violation|3|||
126359300|NCT00395512|454607372|FG002|Overall Study|Protocol Violation|6|||
126359301|NCT00395512|454607373|FG003|Overall Study|Protocol Violation|7|||
126359302|NCT00395512|454607370|FG000|Overall Study|Lost to Follow-up|2|||
126699595|NCT03195894|455851216|FG001|Overall Study|Withdrawal by Subject|4|||
126699596|NCT03195894|455851215|FG000|Overall Study|Lost to Follow-up|14|||
126699597|NCT03195894|455851216|FG001|Overall Study|Lost to Follow-up|19|||
126699598|NCT00162773|455851220|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
126699599|NCT05047523|455851235|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
126699600|NCT05047523|455851236|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
126699601|NCT05047523|455851237|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
126699602|NCT05047523|455851238|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
126699603|NCT05047523|455851239|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
126699604|NCT05047523|455851240|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
126699605|NCT05047523|455851235|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126699606|NCT05047523|455851236|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
126699607|NCT05047523|455851237|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126699608|NCT05047523|455851238|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126699609|NCT05047523|455851239|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126699610|NCT05047523|455851240|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
126699611|NCT05047523|455851235|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
126699612|NCT05047523|455851236|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
126699613|NCT05047523|455851237|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
126699614|NCT05047523|455851238|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
126699615|NCT05047523|455851239|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
126699616|NCT05047523|455851240|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
126699617|NCT05047523|455851235|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
126699618|NCT05047523|455851236|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126699619|NCT05047523|455851237|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126699620|NCT05047523|455851238|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126699621|NCT05047523|455851239|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126699622|NCT05047523|455851240|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
126699623|NCT05047523|455851235|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
126699624|NCT05047523|455851236|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
126259641|NCT02001051|454240754|FG001|Overall Study|Deemed not eligible following enrollment|1|||
126259642|NCT04205162|454240760|FG000|Overall Study|Lost to Follow-up|1|||
126259643|NCT04205162|454240761|FG001|Overall Study|Lost to Follow-up|0|||
126259644|NCT04205162|454240760|FG000|Overall Study|Withdrawal by Subject|2|||
126259645|NCT04205162|454240761|FG001|Overall Study|Withdrawal by Subject|0|||
126259646|NCT04205162|454240760|FG000|Overall Study|University closure due to COVID-19|1|||
126699625|NCT05047523|455851237|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
126699626|NCT05047523|455851238|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
126699627|NCT05047523|455851239|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
126699628|NCT05047523|455851240|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
126699629|NCT05047523|455851235|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
126699630|NCT05047523|455851236|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
126699631|NCT05047523|455851237|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
126699632|NCT05047523|455851238|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
126699633|NCT05047523|455851239|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
126699634|NCT05047523|455851240|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
126699635|NCT03658889|455851241|FG000|Overall Study|Protocol Violation|2|||
126699636|NCT03658889|455851242|FG001|Overall Study|Protocol Violation|0|||
126699637|NCT01903876|455851250|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
126699638|NCT01903876|455851251|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
126699639|NCT01903876|455851250|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
126699640|NCT01903876|455851251|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
126259647|NCT04205162|454240761|FG001|Overall Study|University closure due to COVID-19|0|||
126699641|NCT04317690|455851254|FG000|Overall Study|did not have complete information for primary outcome|0|||
126699642|NCT04317690|455851255|FG001|Overall Study|did not have complete information for primary outcome|4|||
126699643|NCT04317690|455851256|FG002|Overall Study|did not have complete information for primary outcome|0|||
126699644|NCT04317690|455851257|FG003|Overall Study|did not have complete information for primary outcome|2|||
126699645|NCT04317690|455851258|FG004|Overall Study|did not have complete information for primary outcome|0|||
126259648|NCT01011556|454240763|FG000|Overall Study|Adverse Event|1|||
126450807|NCT03615040|454952361|FG000|Overall Study|Physician Decision|2|||
126450808|NCT03615040|454952362|FG001|Overall Study|Physician Decision|2|||
126450809|NCT03615040|454952361|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
126450810|NCT03615040|454952362|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
126450811|NCT03615040|454952361|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
126259649|NCT01011556|454240764|FG001|Overall Study|Adverse Event|3|||
126259650|NCT01011556|454240765|FG002|Overall Study|Adverse Event|2|||
126699646|NCT02612909|455851259|FG000|Phase 2|Withdrawal by Subject|2|||
126259651|NCT01011556|454240766|FG003|Overall Study|Adverse Event|1|||
126450812|NCT03615040|454952362|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
126450813|NCT03615040|454952361|FG000|Overall Study|Death|0|||
126450814|NCT03615040|454952362|FG001|Overall Study|Death|2|||
126450815|NCT01776307|454952365|FG000|Overall Study|Not dosed|0|||
126450816|NCT01776307|454952366|FG001|Overall Study|Not dosed|0|||
126450817|NCT01776307|454952367|FG002|Overall Study|Not dosed|1|||
126450818|NCT04074161|454952373|FG000|Overall Study|Withdrawal by Subject|2|||
126450819|NCT04074161|454952374|FG001|Overall Study|Withdrawal by Subject|4|||
126450820|NCT04074161|454952375|FG002|Overall Study|Withdrawal by Subject|1|||
126450821|NCT04074161|454952373|FG000|Overall Study|Lost to Follow-up|4|||
126450822|NCT04074161|454952374|FG001|Overall Study|Lost to Follow-up|5|||
126450823|NCT04074161|454952375|FG002|Overall Study|Lost to Follow-up|3|||
126450824|NCT01024309|454952383|FG000|Overall Study|Physician Decision|4|||
126450825|NCT01024309|454952384|FG001|Overall Study|Physician Decision|0|||
126450826|NCT01024309|454952383|FG000|Overall Study|Withdrawal by Subject|4|||
126450827|NCT01024309|454952384|FG001|Overall Study|Withdrawal by Subject|4|||
126450828|NCT05194579|454952389|FG000|Overall Study|Lost to Follow-up|2|||
126450829|NCT05194579|454952390|FG001|Overall Study|Lost to Follow-up|3|||
126450830|NCT05194579|454952389|FG000|Overall Study|Withdrawal by Subject|3|||
126450831|NCT05194579|454952390|FG001|Overall Study|Withdrawal by Subject|4|||
126450832|NCT05194579|454952389|FG000|Overall Study|Refused further study procedures|0|||
126450833|NCT05194579|454952390|FG001|Overall Study|Refused further study procedures|1|||
126450834|NCT05194579|454952389|FG000|Overall Study|Protocol deviation|1|||
126450835|NCT05194579|454952390|FG001|Overall Study|Protocol deviation|0|||
126450836|NCT03890666|454952391|FG000|Overall Study|Withdrawal by Subject|0|||
126450837|NCT03890666|454952392|FG001|Overall Study|Withdrawal by Subject|1|||
126450838|NCT03890666|454952391|FG000|Overall Study|Protocol deviation|1|||
126450839|NCT03890666|454952392|FG001|Overall Study|Protocol deviation|4|||
126450840|NCT03890666|454952391|FG000|Overall Study|Lost to Follow-up|2|||
126450841|NCT03890666|454952392|FG001|Overall Study|Lost to Follow-up|5|||
126450842|NCT03890666|454952391|FG000|Overall Study|Other than specified|1|||
126450843|NCT03890666|454952392|FG001|Overall Study|Other than specified|8|||
126450844|NCT01639729|454952393|FG000|Overall Study|Withdrawal by Subject|1|||
126450845|NCT01639729|454952394|FG001|Overall Study|Withdrawal by Subject|0|||
126450846|NCT01639729|454952395|FG002|Overall Study|Withdrawal by Subject|1|||
126450847|NCT01639729|454952396|FG003|Overall Study|Withdrawal by Subject|1|||
126450848|NCT01639729|454952397|FG004|Overall Study|Withdrawal by Subject|0|||
126450849|NCT01639729|454952398|FG005|Overall Study|Withdrawal by Subject|0|||
126450850|NCT00567255|454952399|FG000|Overall Study|Adverse Event|241|||
126450851|NCT00567255|454952400|FG001|Overall Study|Adverse Event|68|||
126450852|NCT00567255|454952399|FG000|Overall Study|Lost to Follow-up|77|||
126450853|NCT00567255|454952400|FG001|Overall Study|Lost to Follow-up|48|||
126450854|NCT00567255|454952399|FG000|Overall Study|Withdrawal by Subject|75|||
126450855|NCT00567255|454952400|FG001|Overall Study|Withdrawal by Subject|56|||
126450856|NCT00567255|454952399|FG000|Overall Study|Lack of Efficacy|19|||
126450857|NCT00567255|454952400|FG001|Overall Study|Lack of Efficacy|33|||
126450858|NCT00567255|454952399|FG000|Overall Study|Protocol Violation|20|||
126450859|NCT00567255|454952400|FG001|Overall Study|Protocol Violation|8|||
126450860|NCT00567255|454952399|FG000|Overall Study|Pregnancy|6|||
126450861|NCT00567255|454952400|FG001|Overall Study|Pregnancy|0|||
126450862|NCT00567255|454952399|FG000|Overall Study|Drug noncompliance,moved,other|25|||
126450863|NCT00567255|454952400|FG001|Overall Study|Drug noncompliance,moved,other|15|||
126450864|NCT03052426|454952401|FG000|Overall Study|Withdrawal by Subject|0|||
126450865|NCT03052426|454952402|FG001|Overall Study|Withdrawal by Subject|1|||
126450866|NCT03052426|454952403|FG002|Overall Study|Withdrawal by Subject|0|||
126450867|NCT03052426|454952401|FG000|Overall Study|Lost to Follow-up|2|||
126450868|NCT03052426|454952402|FG001|Overall Study|Lost to Follow-up|0|||
126450869|NCT03052426|454952403|FG002|Overall Study|Lost to Follow-up|1|||
126450870|NCT03083990|454952406|FG000|Overall Study|Adverse Event|1|||
126450871|NCT03083990|454952407|FG001|Overall Study|Adverse Event|0|||
126450872|NCT04145219|454952408|FG000|Overall Study|Adverse Event|18|||
126450873|NCT04145219|454952409|FG001|Overall Study|Adverse Event|6|||
126450874|NCT04145219|454952408|FG000|Overall Study|Lost to Follow-up|2|||
126450875|NCT04145219|454952409|FG001|Overall Study|Lost to Follow-up|3|||
126450876|NCT04145219|454952408|FG000|Overall Study|Physician Decision|0|||
126450877|NCT04145219|454952409|FG001|Overall Study|Physician Decision|2|||
126450878|NCT04145219|454952408|FG000|Overall Study|Withdrawal by Subject|12|||
126450879|NCT04145219|454952409|FG001|Overall Study|Withdrawal by Subject|8|||
126450880|NCT04145219|454952408|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
126450881|NCT04145219|454952409|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
126450882|NCT03672097|454952410|FG000|Period 1|Withdrawal by Subject|2|||
126450883|NCT03672097|454952410|FG000|Period 1|Adverse Event|1|||
126450884|NCT03672097|454952410|FG000|Period 1|Did not receive treatment|1|||
126450885|NCT03672097|454952410|FG000|Period 2|Withdrawal by Subject|3|||
126450886|NCT03672097|454952410|FG000|Period 2|Other|1|||
126450887|NCT01290796|454952411|FG000|Overall Study|Lost to Follow-up|21|||
126450888|NCT01290796|454952411|FG000|Overall Study|Withdrawal by Subject|4|||
126450889|NCT01290796|454952411|FG000|Overall Study|Physician Decision|2|||
126259652|NCT01011556|454240763|FG000|Overall Study|Lost to Follow-up|1|||
126259653|NCT01011556|454240764|FG001|Overall Study|Lost to Follow-up|0|||
126259654|NCT01011556|454240765|FG002|Overall Study|Lost to Follow-up|0|||
126259655|NCT01011556|454240766|FG003|Overall Study|Lost to Follow-up|0|||
126259656|NCT01011556|454240763|FG000|Overall Study|Physician Decision|1|||
126259657|NCT01011556|454240764|FG001|Overall Study|Physician Decision|0|||
126259658|NCT01011556|454240765|FG002|Overall Study|Physician Decision|0|||
126259659|NCT01011556|454240766|FG003|Overall Study|Physician Decision|1|||
126259660|NCT01011556|454240763|FG000|Overall Study|Protocol Violation|0|||
126259661|NCT01011556|454240764|FG001|Overall Study|Protocol Violation|1|||
126259662|NCT01011556|454240765|FG002|Overall Study|Protocol Violation|0|||
126259663|NCT01011556|454240766|FG003|Overall Study|Protocol Violation|0|||
126259664|NCT01011556|454240763|FG000|Overall Study|Withdrawal by Subject|1|||
126259665|NCT01011556|454240764|FG001|Overall Study|Withdrawal by Subject|2|||
126259666|NCT01011556|454240765|FG002|Overall Study|Withdrawal by Subject|4|||
126259667|NCT01011556|454240766|FG003|Overall Study|Withdrawal by Subject|4|||
126259668|NCT01011556|454240763|FG000|Overall Study|Sponsor decision|0|||
126259669|NCT01011556|454240764|FG001|Overall Study|Sponsor decision|1|||
126259670|NCT01011556|454240765|FG002|Overall Study|Sponsor decision|1|||
126259671|NCT01011556|454240766|FG003|Overall Study|Sponsor decision|2|||
126259672|NCT01011556|454240763|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
126259673|NCT01011556|454240764|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
126259674|NCT01011556|454240765|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
126259675|NCT01011556|454240766|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
126259676|NCT01546519|454240771|FG000|Overall Study|Adverse Event|0|||
126450890|NCT01290796|454952411|FG000|Overall Study|Secondary Surgical Intervention|2|||
126450891|NCT01290796|454952411|FG000|Overall Study|Withdrawal by Sponsor|1|||
126450892|NCT01950013|454952415|FG000|Overall Study|Withdrawal by Subject|0|||
126450893|NCT01950013|454952416|FG001|Overall Study|Withdrawal by Subject|2|||
126450894|NCT01950013|454952417|FG002|Overall Study|Withdrawal by Subject|0|||
126450895|NCT00271505|454952421|FG000|Overall Study|Screen Failure|3|||
126450896|NCT00271505|454952421|FG000|Overall Study|Adverse Event|1|||
126450897|NCT00271505|454952421|FG000|Overall Study|Death|1|||
126450898|NCT04556383|454952422|FG000|PCP|Lack of Efficacy|28|||
126450899|NCT04556383|454952423|FG001|PCP|Lack of Efficacy|23|||
126450900|NCT04556383|454952424|FG002|PCP|Lack of Efficacy|23|||
126450901|NCT04556383|454952425|FG003|PCP|Lack of Efficacy|0|||
126450902|NCT04556383|454952422|FG000|PCP|Study terminated by sponsor|15|||
126450903|NCT04556383|454952423|FG001|PCP|Study terminated by sponsor|13|||
126450904|NCT04556383|454952424|FG002|PCP|Study terminated by sponsor|16|||
126450905|NCT04556383|454952425|FG003|PCP|Study terminated by sponsor|0|||
126450906|NCT04556383|454952422|FG000|PCP|Withdrawal by Subject|8|||
126450907|NCT04556383|454952423|FG001|PCP|Withdrawal by Subject|6|||
126450908|NCT04556383|454952424|FG002|PCP|Withdrawal by Subject|6|||
126450909|NCT04556383|454952425|FG003|PCP|Withdrawal by Subject|0|||
126450910|NCT04556383|454952422|FG000|PCP|Adverse Event|1|||
126450911|NCT04556383|454952423|FG001|PCP|Adverse Event|7|||
126450912|NCT04556383|454952424|FG002|PCP|Adverse Event|7|||
126450913|NCT04556383|454952425|FG003|PCP|Adverse Event|0|||
126450914|NCT04556383|454952422|FG000|PCP|Other, Not Specified|1|||
126450915|NCT04556383|454952423|FG001|PCP|Other, Not Specified|2|||
126450916|NCT04556383|454952424|FG002|PCP|Other, Not Specified|1|||
126450917|NCT04556383|454952425|FG003|PCP|Other, Not Specified|0|||
126450918|NCT04556383|454952422|FG000|PCP|Protocol Violation|1|||
126450919|NCT04556383|454952423|FG001|PCP|Protocol Violation|0|||
126450920|NCT04556383|454952424|FG002|PCP|Protocol Violation|1|||
126259677|NCT01546519|454240772|FG001|Overall Study|Adverse Event|0|||
126259678|NCT01546519|454240773|FG002|Overall Study|Adverse Event|1|||
126259679|NCT01546519|454240774|FG003|Overall Study|Adverse Event|1|||
126259680|NCT01546519|454240771|FG000|Overall Study|Death|0|||
126259681|NCT01546519|454240772|FG001|Overall Study|Death|1|||
126259682|NCT01546519|454240773|FG002|Overall Study|Death|3|||
126259683|NCT01546519|454240774|FG003|Overall Study|Death|1|||
126259684|NCT01546519|454240771|FG000|Overall Study|related to disease progression|2|||
126450921|NCT04556383|454952425|FG003|PCP|Protocol Violation|0|||
126450922|NCT04556383|454952422|FG000|PCP|Lost to Follow-up|1|||
126259685|NCT01546519|454240772|FG001|Overall Study|related to disease progression|2|||
126259686|NCT01546519|454240773|FG002|Overall Study|related to disease progression|2|||
126259687|NCT01546519|454240774|FG003|Overall Study|related to disease progression|1|||
126259688|NCT01546519|454240771|FG000|Overall Study|Physician Decision|6|||
126450923|NCT04556383|454952423|FG001|PCP|Lost to Follow-up|0|||
126450924|NCT04556383|454952424|FG002|PCP|Lost to Follow-up|0|||
126450925|NCT04556383|454952425|FG003|PCP|Lost to Follow-up|0|||
126450926|NCT04556383|454952422|FG000|PCP|Physician Decision|0|||
126450927|NCT04556383|454952423|FG001|PCP|Physician Decision|1|||
126450928|NCT04556383|454952424|FG002|PCP|Physician Decision|0|||
126450929|NCT04556383|454952425|FG003|PCP|Physician Decision|0|||
126450930|NCT04556383|454952422|FG000|PCP|Site terminated by sponsor|0|||
126450931|NCT04556383|454952423|FG001|PCP|Site terminated by sponsor|1|||
126450932|NCT04556383|454952424|FG002|PCP|Site terminated by sponsor|0|||
126450933|NCT04556383|454952425|FG003|PCP|Site terminated by sponsor|0|||
126450934|NCT04556383|454952422|FG000|OLE|Study terminated by sponsor|0|||
126259689|NCT01546519|454240772|FG001|Overall Study|Physician Decision|5|||
126259690|NCT01546519|454240773|FG002|Overall Study|Physician Decision|2|||
126259691|NCT01546519|454240774|FG003|Overall Study|Physician Decision|3|||
126259692|NCT01546519|454240771|FG000|Overall Study|Withdrawal by Subject|1|||
126259693|NCT01546519|454240772|FG001|Overall Study|Withdrawal by Subject|0|||
126259694|NCT01546519|454240773|FG002|Overall Study|Withdrawal by Subject|0|||
126259695|NCT01546519|454240774|FG003|Overall Study|Withdrawal by Subject|0|||
126359303|NCT00395512|454607371|FG001|Overall Study|Lost to Follow-up|6|||
126359304|NCT00395512|454607372|FG002|Overall Study|Lost to Follow-up|5|||
126546739|NCT02762981|455296028|FG000|Overall Study|Disease progression|11|||
126546740|NCT02762981|455296029|FG001|Overall Study|Disease progression|23|||
126546741|NCT02762981|455296030|FG002|Overall Study|Disease progression|4|||
126546742|NCT02762981|455296031|FG003|Overall Study|Disease progression|10|||
126546743|NCT02762981|455296032|FG004|Overall Study|Disease progression|1|||
126546744|NCT02762981|455296028|FG000|Overall Study|Enrolled not treated|1|||
126546745|NCT02762981|455296029|FG001|Overall Study|Enrolled not treated|5|||
126546746|NCT02762981|455296030|FG002|Overall Study|Enrolled not treated|0|||
126546747|NCT02762981|455296031|FG003|Overall Study|Enrolled not treated|2|||
126546748|NCT02762981|455296032|FG004|Overall Study|Enrolled not treated|0|||
126259696|NCT00263887|454240777|FG000|Overall Study|Withdrawal by Subject|1|||
126359305|NCT00395512|454607373|FG003|Overall Study|Lost to Follow-up|5|||
126359306|NCT00395512|454607370|FG000|Overall Study|Withdrawal by Subject|6|||
126359307|NCT00395512|454607371|FG001|Overall Study|Withdrawal by Subject|5|||
126359308|NCT00395512|454607372|FG002|Overall Study|Withdrawal by Subject|5|||
126359309|NCT00395512|454607373|FG003|Overall Study|Withdrawal by Subject|12|||
126359310|NCT00395512|454607370|FG000|Overall Study|Physician Decision|6|||
126359311|NCT00395512|454607371|FG001|Overall Study|Physician Decision|4|||
126359312|NCT00395512|454607372|FG002|Overall Study|Physician Decision|2|||
126359313|NCT00395512|454607373|FG003|Overall Study|Physician Decision|2|||
126359314|NCT00395512|454607370|FG000|Overall Study|Other|1|||
126359315|NCT00395512|454607371|FG001|Overall Study|Other|1|||
126359316|NCT00395512|454607372|FG002|Overall Study|Other|0|||
126359317|NCT00395512|454607373|FG003|Overall Study|Other|0|||
126359318|NCT00395512|454607370|FG000|Overall Study|Hyperglycemic Rescue|18|||
126359319|NCT00395512|454607371|FG001|Overall Study|Hyperglycemic Rescue|10|||
126546749|NCT02762981|455296028|FG000|Overall Study|Other|2|||
126546750|NCT02762981|455296029|FG001|Overall Study|Other|3|||
126699647|NCT02612909|455851260|FG001|Phase 2|Withdrawal by Subject|5|||
126699648|NCT02612909|455851261|FG002|Phase 2|Withdrawal by Subject|0|||
126699649|NCT02612909|455851262|FG003|Phase 2|Withdrawal by Subject|0|||
126259697|NCT00263887|454240778|FG001|Overall Study|Withdrawal by Subject|1|||
126259698|NCT00263887|454240777|FG000|Overall Study|Lung transplantation|1|||
126259699|NCT00263887|454240778|FG001|Overall Study|Lung transplantation|2|||
126259700|NCT00263887|454240777|FG000|Overall Study|Too ill to attend visit|1|||
126259701|NCT00263887|454240778|FG001|Overall Study|Too ill to attend visit|0|||
126259702|NCT00263887|454240777|FG000|Overall Study|Adverse Event|0|||
126259703|NCT00263887|454240778|FG001|Overall Study|Adverse Event|2|||
126259704|NCT00263887|454240777|FG000|Overall Study|Disease progression|0|||
126259705|NCT00263887|454240778|FG001|Overall Study|Disease progression|1|||
126259706|NCT00263887|454240777|FG000|Overall Study|Lack of Efficacy|0|||
126259707|NCT00263887|454240778|FG001|Overall Study|Lack of Efficacy|1|||
126259708|NCT00779402|454240779|FG000|Treatment Phase 1|Disease Progression|1|||
126259709|NCT00779402|454240780|FG001|Treatment Phase 1|Disease Progression|0|||
126259710|NCT00779402|454240779|FG000|Treatment Phase 1|Adverse Event|2|||
126259711|NCT00779402|454240780|FG001|Treatment Phase 1|Adverse Event|0|||
126259712|NCT00779402|454240779|FG000|Treatment Phase 1|Protocol Violation|1|||
126259713|NCT00779402|454240780|FG001|Treatment Phase 1|Protocol Violation|0|||
126259714|NCT00779402|454240779|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
126259715|NCT00779402|454240780|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
126259716|NCT00779402|454240779|FG000|Treatment Phase 1|Lost to Follow-up|0|||
126259717|NCT00779402|454240780|FG001|Treatment Phase 1|Lost to Follow-up|1|||
126259718|NCT00779402|454240779|FG000|Treatment Phase 1|Death|0|||
126259719|NCT00779402|454240780|FG001|Treatment Phase 1|Death|1|||
126259720|NCT00779402|454240779|FG000|Treatment Phase 1|Intercurrent Illness|1|||
126259721|NCT00779402|454240780|FG001|Treatment Phase 1|Intercurrent Illness|1|||
126259722|NCT00779402|454240779|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
126259723|NCT00779402|454240780|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
126259724|NCT00779402|454240779|FG000|Treatment Phase 1|Other|4|||
126259725|NCT00779402|454240780|FG001|Treatment Phase 1|Other|2|||
126259726|NCT00779402|454240779|FG000|Treatment Phase 1|Closure of Study|3|||
126259727|NCT00779402|454240780|FG001|Treatment Phase 1|Closure of Study|2|||
126259728|NCT00779402|454240779|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
126259729|NCT00779402|454240780|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
126259730|NCT00779402|454240779|FG000|Surveillance Phase|Protocol Violation|0|||
126699650|NCT02612909|455851263|FG004|Phase 2|Withdrawal by Subject|0|||
126259731|NCT00779402|454240780|FG001|Surveillance Phase|Protocol Violation|1|||
126259732|NCT00779402|454240779|FG000|Surveillance Phase|Patient refused to continue|22|||
126359320|NCT00395512|454607372|FG002|Overall Study|Hyperglycemic Rescue|4|||
126450935|NCT04556383|454952423|FG001|OLE|Study terminated by sponsor|0|||
126450936|NCT04556383|454952424|FG002|OLE|Study terminated by sponsor|0|||
126450937|NCT04556383|454952425|FG003|OLE|Study terminated by sponsor|68|||
126450938|NCT04556383|454952422|FG000|OLE|Withdrawal by Subject|0|||
126450939|NCT04556383|454952423|FG001|OLE|Withdrawal by Subject|0|||
126450940|NCT04556383|454952424|FG002|OLE|Withdrawal by Subject|0|||
126450941|NCT04556383|454952425|FG003|OLE|Withdrawal by Subject|10|||
126450942|NCT04556383|454952422|FG000|OLE|Lack of Efficacy|0|||
126450943|NCT04556383|454952423|FG001|OLE|Lack of Efficacy|0|||
126450944|NCT04556383|454952424|FG002|OLE|Lack of Efficacy|0|||
126450945|NCT04556383|454952425|FG003|OLE|Lack of Efficacy|7|||
126450946|NCT04556383|454952422|FG000|OLE|Adverse Event|0|||
126450947|NCT04556383|454952423|FG001|OLE|Adverse Event|0|||
126450948|NCT04556383|454952424|FG002|OLE|Adverse Event|0|||
126450949|NCT04556383|454952425|FG003|OLE|Adverse Event|2|||
126450950|NCT04556383|454952422|FG000|OLE|Other, Not Specified|0|||
126450951|NCT04556383|454952423|FG001|OLE|Other, Not Specified|0|||
126450952|NCT04556383|454952424|FG002|OLE|Other, Not Specified|0|||
126450953|NCT04556383|454952425|FG003|OLE|Other, Not Specified|2|||
126450954|NCT04556383|454952422|FG000|OLE|Death|0|||
126450955|NCT04556383|454952423|FG001|OLE|Death|0|||
126450956|NCT04556383|454952424|FG002|OLE|Death|0|||
126450957|NCT04556383|454952425|FG003|OLE|Death|1|||
126450958|NCT04556383|454952422|FG000|OLE|Lost to Follow-up|0|||
126450959|NCT04556383|454952423|FG001|OLE|Lost to Follow-up|0|||
126450960|NCT04556383|454952424|FG002|OLE|Lost to Follow-up|0|||
126450961|NCT04556383|454952425|FG003|OLE|Lost to Follow-up|1|||
126450962|NCT00119678|454952431|FG000|Double-blind Treatment Period|Death|1|||
126450963|NCT00119678|454952432|FG001|Double-blind Treatment Period|Death|0|||
126450964|NCT00119678|454952431|FG000|Double-blind Treatment Period|Adverse Event|7|||
126450965|NCT00119678|454952432|FG001|Double-blind Treatment Period|Adverse Event|1|||
126450966|NCT00119678|454952431|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
126450967|NCT00119678|454952432|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
126450968|NCT00119678|454952431|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
126450969|NCT00119678|454952432|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
126450970|NCT00119678|454952431|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
126450971|NCT00119678|454952432|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
126450972|NCT00119678|454952431|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
126450973|NCT00119678|454952432|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
126450974|NCT00119678|454952431|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
126450975|NCT00119678|454952432|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
126450976|NCT00119678|454952431|FG000|Double-blind Treatment Period|Pregnancy|0|||
126450977|NCT00119678|454952432|FG001|Double-blind Treatment Period|Pregnancy|2|||
126450978|NCT00119678|454952431|FG000|Double-blind Treatment Period|Not treated|1|||
126450979|NCT00119678|454952432|FG001|Double-blind Treatment Period|Not treated|2|||
126450980|NCT00119678|454952431|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
126450981|NCT00119678|454952432|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
126450982|NCT00119678|454952431|FG000|Open-label Treatment Period|Death|1|||
126450983|NCT00119678|454952432|FG001|Open-label Treatment Period|Death|0|||
126450984|NCT00119678|454952431|FG000|Open-label Treatment Period|Adverse Event|3|||
126450985|NCT00119678|454952432|FG001|Open-label Treatment Period|Adverse Event|0|||
126450986|NCT00119678|454952431|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
126450987|NCT00119678|454952432|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
126763345|NCT02594384|456086776|FG001|Overall Study|Withdrawal by Subject|0|||
126259733|NCT00779402|454240780|FG001|Surveillance Phase|Patient refused to continue|14|||
126259734|NCT00779402|454240779|FG000|Surveillance Phase|Lost to Follow-up|2|||
126259735|NCT00779402|454240780|FG001|Surveillance Phase|Lost to Follow-up|1|||
126259736|NCT00779402|454240779|FG000|Surveillance Phase|Death|0|||
126259737|NCT00779402|454240780|FG001|Surveillance Phase|Death|1|||
126259738|NCT00779402|454240779|FG000|Surveillance Phase|Intercurrent Illness|2|||
126259739|NCT00779402|454240780|FG001|Surveillance Phase|Intercurrent Illness|0|||
126259740|NCT00779402|454240779|FG000|Surveillance Phase|Other|5|||
126259741|NCT00779402|454240780|FG001|Surveillance Phase|Other|5|||
126259742|NCT00779402|454240779|FG000|Surveillance Phase|Withdrawal by Subject|4|||
126259743|NCT00779402|454240780|FG001|Surveillance Phase|Withdrawal by Subject|1|||
126259744|NCT00779402|454240779|FG000|Surveillance Phase|Closure of study|5|||
126259745|NCT00779402|454240780|FG001|Surveillance Phase|Closure of study|6|||
126450988|NCT00119678|454952431|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
126450989|NCT00119678|454952432|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
126450990|NCT00119678|454952431|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
126450991|NCT00119678|454952432|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
126450992|NCT00119678|454952431|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
126450993|NCT00119678|454952432|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
126450994|NCT00119678|454952431|FG000|Open-label Treatment Period|Pregnancy|1|||
126259746|NCT00779402|454240779|FG000|Surveillance Phase|Completed Protocol Visits|3|||
126450995|NCT00119678|454952432|FG001|Open-label Treatment Period|Pregnancy|0|||
126450996|NCT00119678|454952431|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
126450997|NCT00119678|454952432|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
126450998|NCT01761240|454952433|FG000|Overall Study|Progressive disease:radiology assessment|3|||
126450999|NCT01761240|454952434|FG001|Overall Study|Progressive disease:radiology assessment|3|||
126451000|NCT01761240|454952435|FG002|Overall Study|Progressive disease:radiology assessment|0|||
126451001|NCT01761240|454952436|FG003|Overall Study|Progressive disease:radiology assessment|0|||
126451002|NCT01761240|454952437|FG004|Overall Study|Progressive disease:radiology assessment|0|||
126451003|NCT01761240|454952433|FG000|Overall Study|Progressive disease:clinical assessment|0|||
126451004|NCT01761240|454952434|FG001|Overall Study|Progressive disease:clinical assessment|0|||
126451005|NCT01761240|454952435|FG002|Overall Study|Progressive disease:clinical assessment|3|||
126451006|NCT01761240|454952436|FG003|Overall Study|Progressive disease:clinical assessment|1|||
126451007|NCT01761240|454952437|FG004|Overall Study|Progressive disease:clinical assessment|0|||
126451008|NCT01761240|454952433|FG000|Overall Study|Withdrawal by Subject|0|||
126451009|NCT01761240|454952434|FG001|Overall Study|Withdrawal by Subject|0|||
126451010|NCT01761240|454952435|FG002|Overall Study|Withdrawal by Subject|0|||
126451011|NCT01761240|454952436|FG003|Overall Study|Withdrawal by Subject|3|||
126451012|NCT01761240|454952437|FG004|Overall Study|Withdrawal by Subject|1|||
126451013|NCT01761240|454952433|FG000|Overall Study|Adverse Event|0|||
126451014|NCT01761240|454952434|FG001|Overall Study|Adverse Event|0|||
126451015|NCT01761240|454952435|FG002|Overall Study|Adverse Event|0|||
126259747|NCT00779402|454240780|FG001|Surveillance Phase|Completed Protocol Visits|2|||
126259748|NCT00779402|454240779|FG000|Long-term Follow-up|Patient refused to continue|2|||
126259749|NCT00779402|454240780|FG001|Long-term Follow-up|Patient refused to continue|0|||
126259750|NCT00779402|454240779|FG000|Long-term Follow-up|Other|5|||
126259751|NCT00779402|454240780|FG001|Long-term Follow-up|Other|0|||
126259752|NCT00779402|454240779|FG000|Long-term Follow-up|Closure of Study|8|||
126259753|NCT00779402|454240780|FG001|Long-term Follow-up|Closure of Study|4|||
126259754|NCT00779402|454240779|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
126259755|NCT00779402|454240780|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
126259756|NCT01519947|454240785|FG000|Overall Study|Death|0|||
126259757|NCT01519947|454240786|FG001|Overall Study|Death|0|||
126259758|NCT01519947|454240787|FG002|Overall Study|Death|0|||
126259759|NCT01519947|454240788|FG003|Overall Study|Death|1|||
126259760|NCT01519947|454240785|FG000|Overall Study|Protocol Violation|0|||
126259761|NCT01519947|454240786|FG001|Overall Study|Protocol Violation|0|||
126259762|NCT01519947|454240787|FG002|Overall Study|Protocol Violation|2|||
126259763|NCT01519947|454240788|FG003|Overall Study|Protocol Violation|1|||
126259764|NCT01519947|454240785|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
126259765|NCT01519947|454240786|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
126259766|NCT01519947|454240787|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
126259767|NCT01519947|454240788|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
126259768|NCT01519947|454240785|FG000|Overall Study|Development of Anemia|0|||
126259769|NCT01519947|454240786|FG001|Overall Study|Development of Anemia|1|||
126259770|NCT01519947|454240787|FG002|Overall Study|Development of Anemia|0|||
126259771|NCT01519947|454240788|FG003|Overall Study|Development of Anemia|1|||
126259772|NCT01519947|454240785|FG000|Overall Study|Blood Transfusion|0|||
126259773|NCT01519947|454240786|FG001|Overall Study|Blood Transfusion|1|||
126259774|NCT01519947|454240787|FG002|Overall Study|Blood Transfusion|1|||
126259775|NCT01519947|454240788|FG003|Overall Study|Blood Transfusion|0|||
126259776|NCT01519947|454240785|FG000|Overall Study|Withdrawal by Subject|0|||
126259777|NCT01519947|454240786|FG001|Overall Study|Withdrawal by Subject|1|||
126259778|NCT01519947|454240787|FG002|Overall Study|Withdrawal by Subject|0|||
126259779|NCT01519947|454240788|FG003|Overall Study|Withdrawal by Subject|1|||
126259780|NCT01519947|454240785|FG000|Overall Study|Lost to Follow-up|0|||
126259781|NCT01519947|454240786|FG001|Overall Study|Lost to Follow-up|0|||
126259782|NCT01519947|454240787|FG002|Overall Study|Lost to Follow-up|3|||
126259783|NCT01519947|454240788|FG003|Overall Study|Lost to Follow-up|2|||
126259784|NCT01519947|454240785|FG000|Overall Study|Poor Response|1|||
126259785|NCT01519947|454240786|FG001|Overall Study|Poor Response|0|||
126259786|NCT01519947|454240787|FG002|Overall Study|Poor Response|0|||
126451016|NCT01761240|454952436|FG003|Overall Study|Adverse Event|1|||
126259787|NCT01519947|454240788|FG003|Overall Study|Poor Response|1|||
126259788|NCT01519947|454240785|FG000|Overall Study|Adverse Event|1|||
126259789|NCT01519947|454240786|FG001|Overall Study|Adverse Event|0|||
126699651|NCT02612909|455851259|FG000|Phase 2|Pregnancy|0|||
126259790|NCT01519947|454240787|FG002|Overall Study|Adverse Event|1|||
126259791|NCT01519947|454240788|FG003|Overall Study|Adverse Event|1|||
126259792|NCT00707434|454240793|FG000|Overall Study|Adverse Event|1|||
126259793|NCT04364763|454240794|FG000|Overall Study|Death|1|||
126259794|NCT04364763|454240795|FG001|Overall Study|Death|2|||
126259795|NCT04364763|454240794|FG000|Overall Study|Lost to Follow-up|1|||
126259796|NCT04364763|454240795|FG001|Overall Study|Lost to Follow-up|0|||
126451017|NCT01761240|454952437|FG004|Overall Study|Adverse Event|6|||
126451018|NCT01761240|454952433|FG000|Overall Study|Death|0|||
126259797|NCT01386125|454240796|FG000|Overall Study|Lost to Follow-up|3|||
126259798|NCT01386125|454240797|FG001|Overall Study|Lost to Follow-up|9|||
126259799|NCT01386125|454240796|FG000|Overall Study|Physician Decision|0|||
126259800|NCT01386125|454240797|FG001|Overall Study|Physician Decision|1|||
126359321|NCT00395512|454607373|FG003|Overall Study|Hyperglycemic Rescue|6|||
126359322|NCT01986751|454607374|FG000|Overall Study|improperly consented|10|||
126359323|NCT01986751|454607375|FG001|Overall Study|improperly consented|2|||
126359324|NCT01478087|454607376|FG000|Overall Study|due to sponsor closing study|1|||
126359325|NCT04576949|454607377|FG000|Overall Study|Adverse Event|1|||
126359326|NCT04576949|454607378|FG001|Overall Study|Adverse Event|3|||
126359327|NCT04576949|454607379|FG002|Overall Study|Adverse Event|2|||
126359328|NCT04576949|454607377|FG000|Overall Study|Withdrawal by Subject|41|||
126359329|NCT04576949|454607378|FG001|Overall Study|Withdrawal by Subject|26|||
126359330|NCT04576949|454607379|FG002|Overall Study|Withdrawal by Subject|18|||
126359331|NCT04576949|454607377|FG000|Overall Study|Physician Decision|3|||
126359332|NCT04576949|454607378|FG001|Overall Study|Physician Decision|0|||
126359333|NCT04576949|454607379|FG002|Overall Study|Physician Decision|0|||
126359334|NCT04576949|454607377|FG000|Overall Study|Death|0|||
126359335|NCT04576949|454607378|FG001|Overall Study|Death|1|||
126359336|NCT04576949|454607379|FG002|Overall Study|Death|0|||
126359337|NCT04576949|454607377|FG000|Overall Study|Lost to Follow-up|29|||
126359338|NCT04576949|454607378|FG001|Overall Study|Lost to Follow-up|37|||
126359339|NCT04576949|454607379|FG002|Overall Study|Lost to Follow-up|24|||
126359340|NCT04576949|454607377|FG000|Overall Study|Other, Not Specified|2|||
126359341|NCT04576949|454607378|FG001|Overall Study|Other, Not Specified|3|||
126359342|NCT04576949|454607379|FG002|Overall Study|Other, Not Specified|1|||
126359343|NCT04576949|454607377|FG000|Overall Study|Other|1|||
126359344|NCT04576949|454607378|FG001|Overall Study|Other|0|||
126359345|NCT04576949|454607379|FG002|Overall Study|Other|0|||
126359346|NCT00407030|454607380|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
126359347|NCT00407030|454607381|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
126359348|NCT00407030|454607382|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
126359349|NCT00407030|454607380|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
126359350|NCT00407030|454607381|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
126359351|NCT00407030|454607382|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
126359352|NCT00407030|454607380|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
126359353|NCT00407030|454607381|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
126451019|NCT01761240|454952434|FG001|Overall Study|Death|1|||
126451020|NCT01761240|454952435|FG002|Overall Study|Death|1|||
126451021|NCT01761240|454952436|FG003|Overall Study|Death|2|||
126451022|NCT01761240|454952437|FG004|Overall Study|Death|1|||
126451023|NCT01761240|454952433|FG000|Overall Study|Non-compliance|0|||
126451024|NCT01761240|454952434|FG001|Overall Study|Non-compliance|0|||
126451025|NCT01761240|454952435|FG002|Overall Study|Non-compliance|1|||
126451026|NCT01761240|454952436|FG003|Overall Study|Non-compliance|0|||
126451027|NCT01761240|454952437|FG004|Overall Study|Non-compliance|0|||
126451028|NCT04002908|454952442|FG000|Overall Study|Death|41|||
126451029|NCT04002908|454952443|FG001|Overall Study|Death|0|||
126451030|NCT04002908|454952444|FG002|Overall Study|Death|0|||
126451031|NCT04002908|454952445|FG003|Overall Study|Death|0|||
126451032|NCT04002908|454952442|FG000|Overall Study|Withdrawal by Subject|112|||
126451033|NCT04002908|454952443|FG001|Overall Study|Withdrawal by Subject|0|||
126451034|NCT04002908|454952444|FG002|Overall Study|Withdrawal by Subject|0|||
126451035|NCT04002908|454952445|FG003|Overall Study|Withdrawal by Subject|0|||
126451036|NCT04002908|454952442|FG000|Overall Study|Lost to Follow-up|72|||
126451037|NCT04002908|454952443|FG001|Overall Study|Lost to Follow-up|0|||
126451038|NCT04002908|454952444|FG002|Overall Study|Lost to Follow-up|0|||
126451039|NCT04002908|454952445|FG003|Overall Study|Lost to Follow-up|0|||
126451040|NCT04002908|454952442|FG000|Overall Study|Infant died, so mother withdrawn|34|||
126451041|NCT04002908|454952443|FG001|Overall Study|Infant died, so mother withdrawn|0|||
126451042|NCT04002908|454952444|FG002|Overall Study|Infant died, so mother withdrawn|0|||
126451043|NCT04002908|454952445|FG003|Overall Study|Infant died, so mother withdrawn|0|||
126451044|NCT00006289|454952448|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
126699652|NCT02612909|455851260|FG001|Phase 2|Pregnancy|0|||
126359354|NCT00407030|454607382|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
126359355|NCT00407030|454607380|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
126451045|NCT00006289|454952449|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
126451046|NCT00006289|454952448|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
126359356|NCT00407030|454607381|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
126359357|NCT00407030|454607382|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
126359358|NCT00407030|454607380|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
126451047|NCT00006289|454952449|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
126451048|NCT04359901|454952459|FG000|Overall Study|Withdrawal by Subject|0|||
126451049|NCT04359901|454952460|FG001|Overall Study|Withdrawal by Subject|1|||
126451050|NCT04359901|454952459|FG000|Overall Study|Death|6|||
126451051|NCT04359901|454952460|FG001|Overall Study|Death|2|||
126451052|NCT01888432|454954490|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
126451053|NCT01888432|454954491|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
126451054|NCT01888432|454954490|FG000|12-month Analysis (FAS)|Physician Decision|1|||
126699653|NCT02612909|455851261|FG002|Phase 2|Pregnancy|1|||
126359359|NCT00407030|454607381|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
126699654|NCT02612909|455851262|FG003|Phase 2|Pregnancy|0|||
126451055|NCT01888432|454954491|FG001|12-month Analysis (FAS)|Physician Decision|1|||
126451056|NCT01888432|454954490|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
126451057|NCT01888432|454954491|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
126451058|NCT01888432|454954490|FG000|12-month Analysis (FAS)|Death|4|||
126451059|NCT01888432|454954491|FG001|12-month Analysis (FAS)|Death|3|||
126451060|NCT01888432|454954490|FG000|24-month Analysis (FAS)|Graft loss|0|||
126451061|NCT01888432|454954491|FG001|24-month Analysis (FAS)|Graft loss|1|||
126451062|NCT01888432|454954490|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
126451063|NCT01888432|454954491|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
126451064|NCT01888432|454954490|FG000|24-month Analysis (FAS)|Physician Decision|2|||
126451065|NCT01888432|454954491|FG001|24-month Analysis (FAS)|Physician Decision|4|||
126451066|NCT01888432|454954490|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
126451067|NCT01888432|454954491|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
126451068|NCT01888432|454954490|FG000|24-month Analysis (FAS)|Death|8|||
126451069|NCT01888432|454954491|FG001|24-month Analysis (FAS)|Death|4|||
126451070|NCT01888432|454954490|FG000|36-month Analysis (Extension)|Death|1|||
126451071|NCT01888432|454954491|FG001|36-month Analysis (Extension)|Death|0|||
126451072|NCT00130247|454954494|FG000|Overall Study|Pregnancy|1|||
126451073|NCT00130247|454954495|FG001|Overall Study|Pregnancy|0|||
126451074|NCT00130247|454954494|FG000|Overall Study|Post-randomization exclusion|1|||
126451075|NCT00130247|454954495|FG001|Overall Study|Post-randomization exclusion|2|||
126451076|NCT00130247|454954494|FG000|Overall Study|Not compliant with DOT|0|||
126451077|NCT00130247|454954495|FG001|Overall Study|Not compliant with DOT|2|||
126451078|NCT02123251|454954496|FG000|Overall Study|Death|1|||
126451079|NCT02123251|454954497|FG001|Overall Study|Death|1|||
126451080|NCT02123251|454954496|FG000|Overall Study|Withdrawal by Subject|0|||
126451081|NCT02123251|454954497|FG001|Overall Study|Withdrawal by Subject|3|||
126451082|NCT02123251|454954496|FG000|Overall Study|Lost Medicaid eligibility|29|||
126451083|NCT02123251|454954497|FG001|Overall Study|Lost Medicaid eligibility|22|||
126451084|NCT02123251|454954496|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
126451085|NCT02123251|454954497|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
126451086|NCT00966875|454954501|FG000|Part A|Adverse Event|2|||
126451087|NCT00966875|454954502|FG001|Part A|Adverse Event|1|||
126451088|NCT00966875|454954503|FG002|Part A|Adverse Event|0|||
126451089|NCT00966875|454954504|FG003|Part A|Adverse Event|1|||
126451090|NCT00966875|454954505|FG004|Part A|Adverse Event|0|||
126451091|NCT00966875|454954506|FG005|Part A|Adverse Event|1|||
126451092|NCT00966875|454954507|FG006|Part A|Adverse Event|0|||
126451093|NCT00966875|454954508|FG007|Part A|Adverse Event|3|||
126451094|NCT00966875|454954509|FG008|Part A|Adverse Event|3|||
126451095|NCT00966875|454954501|FG000|Part A|Entry Criteria|0|||
126451096|NCT00966875|454954502|FG001|Part A|Entry Criteria|0|||
126451097|NCT00966875|454954503|FG002|Part A|Entry Criteria|0|||
126451098|NCT00966875|454954504|FG003|Part A|Entry Criteria|0|||
126451099|NCT00966875|454954505|FG004|Part A|Entry Criteria|0|||
126451100|NCT00966875|454954506|FG005|Part A|Entry Criteria|2|||
126451101|NCT00966875|454954507|FG006|Part A|Entry Criteria|0|||
126451102|NCT00966875|454954508|FG007|Part A|Entry Criteria|0|||
126451103|NCT00966875|454954509|FG008|Part A|Entry Criteria|0|||
126451104|NCT00966875|454954501|FG000|Part A|Lack of Efficacy|0|||
126451105|NCT00966875|454954502|FG001|Part A|Lack of Efficacy|1|||
126451106|NCT00966875|454954503|FG002|Part A|Lack of Efficacy|0|||
126451107|NCT00966875|454954504|FG003|Part A|Lack of Efficacy|0|||
126451108|NCT00966875|454954505|FG004|Part A|Lack of Efficacy|0|||
126451109|NCT00966875|454954506|FG005|Part A|Lack of Efficacy|0|||
126451110|NCT00966875|454954507|FG006|Part A|Lack of Efficacy|4|||
126451111|NCT00966875|454954508|FG007|Part A|Lack of Efficacy|0|||
126451112|NCT00966875|454954509|FG008|Part A|Lack of Efficacy|0|||
126451113|NCT00966875|454954501|FG000|Part A|Lost to Follow-up|2|||
126451114|NCT00966875|454954502|FG001|Part A|Lost to Follow-up|0|||
126451115|NCT00966875|454954503|FG002|Part A|Lost to Follow-up|0|||
126451116|NCT00966875|454954504|FG003|Part A|Lost to Follow-up|0|||
126451117|NCT00966875|454954505|FG004|Part A|Lost to Follow-up|0|||
126451118|NCT00966875|454954506|FG005|Part A|Lost to Follow-up|1|||
126451119|NCT00966875|454954507|FG006|Part A|Lost to Follow-up|0|||
126451120|NCT00966875|454954508|FG007|Part A|Lost to Follow-up|0|||
126451121|NCT00966875|454954509|FG008|Part A|Lost to Follow-up|0|||
126451122|NCT00966875|454954501|FG000|Part A|Parent/Caregiver Decision|0|||
126451123|NCT00966875|454954502|FG001|Part A|Parent/Caregiver Decision|0|||
126546751|NCT02762981|455296030|FG002|Overall Study|Other|1|||
126699655|NCT02612909|455851263|FG004|Phase 2|Pregnancy|0|||
126699656|NCT02612909|455851259|FG000|Phase 3|Withdrawal by Subject|0|||
126451124|NCT00966875|454954503|FG002|Part A|Parent/Caregiver Decision|0|||
126451125|NCT00966875|454954504|FG003|Part A|Parent/Caregiver Decision|1|||
126451126|NCT00966875|454954505|FG004|Part A|Parent/Caregiver Decision|0|||
126451127|NCT00966875|454954506|FG005|Part A|Parent/Caregiver Decision|0|||
126451128|NCT00966875|454954507|FG006|Part A|Parent/Caregiver Decision|0|||
126451129|NCT00966875|454954508|FG007|Part A|Parent/Caregiver Decision|0|||
126451130|NCT00966875|454954509|FG008|Part A|Parent/Caregiver Decision|0|||
126451131|NCT00966875|454954501|FG000|Part A|Physician Decision|0|||
126451132|NCT00966875|454954502|FG001|Part A|Physician Decision|0|||
126451133|NCT00966875|454954503|FG002|Part A|Physician Decision|0|||
126259801|NCT01386125|454240796|FG000|Overall Study|Protocol Violation|5|||
126259802|NCT01386125|454240797|FG001|Overall Study|Protocol Violation|7|||
126259803|NCT01386125|454240796|FG000|Overall Study|Disease Progress|1|||
126259804|NCT01386125|454240797|FG001|Overall Study|Disease Progress|2|||
126259805|NCT01386125|454240796|FG000|Overall Study|Withdrawal by Subject|13|||
126259806|NCT01386125|454240797|FG001|Overall Study|Withdrawal by Subject|12|||
126259807|NCT01386125|454240796|FG000|Overall Study|Adverse Event|2|||
126259808|NCT01386125|454240797|FG001|Overall Study|Adverse Event|5|||
126259809|NCT01386125|454240796|FG000|Overall Study|Lack of Efficacy|0|||
126259810|NCT01386125|454240797|FG001|Overall Study|Lack of Efficacy|1|||
126259811|NCT01386125|454240796|FG000|Overall Study|Participant Leaving Country|1|||
126259812|NCT01386125|454240797|FG001|Overall Study|Participant Leaving Country|0|||
126259813|NCT02359864|454240799|FG000|Overall Study|Withdrawal by Subject|1|||
126259814|NCT02359864|454240800|FG001|Overall Study|Withdrawal by Subject|0|||
126259815|NCT00725764|454240801|FG000|Overall Study|Withdrawal by Subject|2|||
126259816|NCT00725764|454240801|FG000|Overall Study|Physician Decision|1|||
126259817|NCT00725764|454240801|FG000|Overall Study|Progressive Disease|7|||
126259818|NCT00725764|454240801|FG000|Overall Study|Lost to Follow-up|1|||
126259819|NCT00725764|454240801|FG000|Overall Study|Death|1|||
126259820|NCT00725764|454240801|FG000|Overall Study|Participant non compliant with protocol|1|||
126259821|NCT00725764|454240801|FG000|Overall Study|Decline in performance status|1|||
126259822|NCT01928615|454240802|FG000|Overall Study|Study Terminated by Sponsor|2|||
126259823|NCT00732160|454240806|FG000|Overall Study|Adverse Event|1|||
126259824|NCT00732160|454240807|FG001|Overall Study|Adverse Event|0|||
126259825|NCT00732160|454240808|FG002|Overall Study|Adverse Event|1|||
126259826|NCT00732160|454240809|FG003|Overall Study|Adverse Event|1|||
126259827|NCT00732160|454240806|FG000|Overall Study|scheduling|4|||
126259828|NCT00732160|454240807|FG001|Overall Study|scheduling|4|||
126259829|NCT00732160|454240808|FG002|Overall Study|scheduling|2|||
126259830|NCT00732160|454240809|FG003|Overall Study|scheduling|1|||
126259831|NCT00090753|454240813|FG000|First Treatment Period|Adverse Event|20|||
126259832|NCT00090753|454240814|FG001|First Treatment Period|Adverse Event|8|||
126259833|NCT00090753|454240813|FG000|First Treatment Period|Death|88|||
126259834|NCT00090753|454240814|FG001|First Treatment Period|Death|62|||
126259835|NCT00090753|454240813|FG000|First Treatment Period|Lack of Efficacy|2|||
126259836|NCT00090753|454240814|FG001|First Treatment Period|Lack of Efficacy|1|||
126259837|NCT00090753|454240813|FG000|First Treatment Period|Refused Treatment|32|||
126259838|NCT00090753|454240814|FG001|First Treatment Period|Refused Treatment|25|||
126259839|NCT00090753|454240813|FG000|First Treatment Period|Lost to Follow-up|4|||
126259840|NCT00090753|454240814|FG001|First Treatment Period|Lost to Follow-up|4|||
126259841|NCT00090753|454240813|FG000|First Treatment Period|Renal Transplant|70|||
126259842|NCT00090753|454240814|FG001|First Treatment Period|Renal Transplant|50|||
126259843|NCT00090753|454240813|FG000|First Treatment Period|Mircera Commercialization|1|||
126259844|NCT00090753|454240814|FG001|First Treatment Period|Mircera Commercialization|0|||
126259845|NCT00090753|454240813|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
126259846|NCT00090753|454240814|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
126259847|NCT00090753|454240813|FG000|Extended Treatment Period|Adverse Event|11|||
126259848|NCT00090753|454240814|FG001|Extended Treatment Period|Adverse Event|0|||
126259849|NCT00090753|454240813|FG000|Extended Treatment Period|Death|58|||
126259850|NCT00090753|454240814|FG001|Extended Treatment Period|Death|30|||
126259851|NCT00090753|454240813|FG000|Extended Treatment Period|Lack of Efficacy|1|||
126259852|NCT00090753|454240814|FG001|Extended Treatment Period|Lack of Efficacy|0|||
126259853|NCT00090753|454240813|FG000|Extended Treatment Period|Refused Treatment|18|||
126259854|NCT00090753|454240814|FG001|Extended Treatment Period|Refused Treatment|12|||
126259855|NCT00090753|454240813|FG000|Extended Treatment Period|Lost to Follow-up|3|||
126259856|NCT00090753|454240814|FG001|Extended Treatment Period|Lost to Follow-up|1|||
126259857|NCT00090753|454240813|FG000|Extended Treatment Period|Renal Transplant|15|||
126259858|NCT00090753|454240814|FG001|Extended Treatment Period|Renal Transplant|12|||
126259859|NCT00090753|454240813|FG000|Extended Treatment Period|Mircera Commercialization|188|||
126259860|NCT00090753|454240814|FG001|Extended Treatment Period|Mircera Commercialization|93|||
126259861|NCT00090753|454240813|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
126259862|NCT00090753|454240814|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
126259863|NCT01256060|454240819|FG000|Overall Study|Lost to Follow-up|0|||
126259864|NCT01256060|454240820|FG001|Overall Study|Lost to Follow-up|1|||
126259865|NCT01256060|454240821|FG002|Overall Study|Lost to Follow-up|0|||
126259866|NCT01256060|454240822|FG003|Overall Study|Lost to Follow-up|0|||
126259867|NCT01808248|454240831|FG000|Overall Study|Lack of Efficacy|3|||
126259868|NCT01808248|454240831|FG000|Overall Study|Withdrawal by Subject|1|||
126259869|NCT01808248|454240831|FG000|Overall Study|Lost to Follow-up|1|||
126259870|NCT00436917|454240832|FG000|Overall Study|Withdrawal by Subject|13|||
126259871|NCT00436917|454240832|FG000|Overall Study|Adverse Event|2|||
126259872|NCT00436917|454240832|FG000|Overall Study|Physician Decision|1|||
126259873|NCT00436917|454240832|FG000|Overall Study|Death|1|||
126259874|NCT00436917|454240832|FG000|Overall Study|Lost to Follow-up|1|||
126259875|NCT00436917|454240832|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
126259876|NCT00436917|454240832|FG000|Overall Study|Increased creatinine|1|||
126359360|NCT00407030|454607382|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
126359361|NCT00407030|454607380|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
126763346|NCT02594384|456086777|FG002|Overall Study|Withdrawal by Subject|0|||
126763347|NCT02594384|456086778|FG003|Overall Study|Withdrawal by Subject|1|||
126763348|NCT02594384|456086779|FG004|Overall Study|Withdrawal by Subject|0|||
126359362|NCT00407030|454607381|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
126359363|NCT00407030|454607382|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
126359364|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
126359365|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
126359366|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
126359367|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
126359368|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
126359369|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
126359370|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
126359371|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
126359372|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
126359373|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
126359374|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
126359375|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
126359376|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
126359377|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
126359378|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
126359379|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
126359380|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
126359381|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
126451134|NCT00966875|454954504|FG003|Part A|Physician Decision|0|||
126451135|NCT00966875|454954505|FG004|Part A|Physician Decision|1|||
126451136|NCT00966875|454954506|FG005|Part A|Physician Decision|0|||
126451137|NCT00966875|454954507|FG006|Part A|Physician Decision|1|||
126451138|NCT00966875|454954508|FG007|Part A|Physician Decision|0|||
126451139|NCT00966875|454954509|FG008|Part A|Physician Decision|2|||
126451140|NCT00966875|454954501|FG000|Part A|Sponsor Decision|0|||
126451141|NCT00966875|454954502|FG001|Part A|Sponsor Decision|0|||
126451142|NCT00966875|454954503|FG002|Part A|Sponsor Decision|1|||
126451143|NCT00966875|454954504|FG003|Part A|Sponsor Decision|0|||
126451144|NCT00966875|454954505|FG004|Part A|Sponsor Decision|1|||
126451145|NCT00966875|454954506|FG005|Part A|Sponsor Decision|0|||
126451146|NCT00966875|454954507|FG006|Part A|Sponsor Decision|0|||
126451147|NCT00966875|454954508|FG007|Part A|Sponsor Decision|2|||
126451148|NCT00966875|454954509|FG008|Part A|Sponsor Decision|1|||
126451149|NCT00966875|454954501|FG000|Part A|Withdrawal by Subject|2|||
126451150|NCT00966875|454954502|FG001|Part A|Withdrawal by Subject|2|||
126451151|NCT00966875|454954503|FG002|Part A|Withdrawal by Subject|1|||
126451152|NCT00966875|454954504|FG003|Part A|Withdrawal by Subject|1|||
126451153|NCT00966875|454954505|FG004|Part A|Withdrawal by Subject|3|||
126451154|NCT00966875|454954506|FG005|Part A|Withdrawal by Subject|0|||
126451155|NCT00966875|454954507|FG006|Part A|Withdrawal by Subject|5|||
126451156|NCT00966875|454954508|FG007|Part A|Withdrawal by Subject|1|||
126451157|NCT00966875|454954509|FG008|Part A|Withdrawal by Subject|1|||
126451158|NCT00966875|454954501|FG000|Part A|Protocol Violation|0|||
126451159|NCT00966875|454954502|FG001|Part A|Protocol Violation|0|||
126451160|NCT00966875|454954503|FG002|Part A|Protocol Violation|0|||
126451161|NCT00966875|454954504|FG003|Part A|Protocol Violation|0|||
126451162|NCT00966875|454954505|FG004|Part A|Protocol Violation|0|||
126451163|NCT00966875|454954506|FG005|Part A|Protocol Violation|0|||
126451164|NCT00966875|454954507|FG006|Part A|Protocol Violation|2|||
126451165|NCT00966875|454954508|FG007|Part A|Protocol Violation|1|||
126451166|NCT00966875|454954509|FG008|Part A|Protocol Violation|1|||
126451167|NCT00966875|454954501|FG000|Part B|Adverse Event|0|||
126451168|NCT00966875|454954502|FG001|Part B|Adverse Event|1|||
126359382|NCT00407030|454607380|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
126359383|NCT00407030|454607381|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
126451169|NCT00966875|454954503|FG002|Part B|Adverse Event|1|||
126451170|NCT00966875|454954504|FG003|Part B|Adverse Event|0|||
126451171|NCT00966875|454954505|FG004|Part B|Adverse Event|1|||
126451172|NCT00966875|454954506|FG005|Part B|Adverse Event|0|||
126451173|NCT00966875|454954507|FG006|Part B|Adverse Event|5|||
126451174|NCT00966875|454954508|FG007|Part B|Adverse Event|2|||
126451175|NCT00966875|454954509|FG008|Part B|Adverse Event|2|||
126451176|NCT00966875|454954501|FG000|Part B|Death|0|||
126451177|NCT00966875|454954502|FG001|Part B|Death|0|||
126451178|NCT00966875|454954503|FG002|Part B|Death|1|||
126451179|NCT00966875|454954504|FG003|Part B|Death|0|||
126451180|NCT00966875|454954505|FG004|Part B|Death|0|||
126451181|NCT00966875|454954506|FG005|Part B|Death|0|||
126451182|NCT00966875|454954507|FG006|Part B|Death|0|||
126451183|NCT00966875|454954508|FG007|Part B|Death|1|||
126451184|NCT00966875|454954509|FG008|Part B|Death|0|||
126451185|NCT00966875|454954501|FG000|Part B|Lack of Efficacy|2|||
126451186|NCT00966875|454954502|FG001|Part B|Lack of Efficacy|1|||
126359384|NCT00407030|454607382|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
126359385|NCT01489358|454607383|FG000|Overall Study|Lost to Follow-up|0|||
126359386|NCT01489358|454607384|FG001|Overall Study|Lost to Follow-up|0|||
126359387|NCT01489358|454607385|FG002|Overall Study|Lost to Follow-up|2|||
126359388|NCT00736476|454607386|FG000|Overall Study|Adverse Event|1|||
126359389|NCT00736476|454607387|FG001|Overall Study|Adverse Event|0|||
126359390|NCT03518203|454607392|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
126359391|NCT03518203|454607392|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
126359392|NCT02829957|454607393|FG000|Overall Study|Lost to Follow-up|2|||
126359393|NCT02829957|454607394|FG001|Overall Study|Lost to Follow-up|1|||
126359394|NCT04560309|454607396|FG000|Overall Study|Meet drop out criteria|1|||
126359395|NCT04560309|454607397|FG001|Overall Study|Meet drop out criteria|1|||
126359396|NCT01370538|454607400|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
126359397|NCT01370538|454607401|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
126359398|NCT01370538|454607400|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126451187|NCT00966875|454954503|FG002|Part B|Lack of Efficacy|1|||
126451188|NCT00966875|454954504|FG003|Part B|Lack of Efficacy|1|||
126451189|NCT00966875|454954505|FG004|Part B|Lack of Efficacy|2|||
126451190|NCT00966875|454954506|FG005|Part B|Lack of Efficacy|3|||
126451191|NCT00966875|454954507|FG006|Part B|Lack of Efficacy|12|||
126451192|NCT00966875|454954508|FG007|Part B|Lack of Efficacy|9|||
126451193|NCT00966875|454954509|FG008|Part B|Lack of Efficacy|6|||
126451194|NCT00966875|454954501|FG000|Part B|Lost to Follow-up|0|||
126451195|NCT00966875|454954502|FG001|Part B|Lost to Follow-up|0|||
126451196|NCT00966875|454954503|FG002|Part B|Lost to Follow-up|0|||
126451197|NCT00966875|454954504|FG003|Part B|Lost to Follow-up|1|||
126451198|NCT00966875|454954505|FG004|Part B|Lost to Follow-up|0|||
126451199|NCT00966875|454954506|FG005|Part B|Lost to Follow-up|0|||
126451200|NCT00966875|454954507|FG006|Part B|Lost to Follow-up|0|||
126451201|NCT00966875|454954508|FG007|Part B|Lost to Follow-up|0|||
126451202|NCT00966875|454954509|FG008|Part B|Lost to Follow-up|1|||
126451203|NCT00966875|454954501|FG000|Part B|Physician Decision|0|||
126451204|NCT00966875|454954502|FG001|Part B|Physician Decision|0|||
126451205|NCT00966875|454954503|FG002|Part B|Physician Decision|1|||
126451206|NCT00966875|454954504|FG003|Part B|Physician Decision|0|||
126451207|NCT00966875|454954505|FG004|Part B|Physician Decision|2|||
126451208|NCT00966875|454954506|FG005|Part B|Physician Decision|1|||
126451209|NCT00966875|454954507|FG006|Part B|Physician Decision|0|||
126451210|NCT00966875|454954508|FG007|Part B|Physician Decision|0|||
126451211|NCT00966875|454954509|FG008|Part B|Physician Decision|2|||
126451212|NCT00966875|454954501|FG000|Part B|Sponsor Decision|1|||
126451213|NCT00966875|454954502|FG001|Part B|Sponsor Decision|0|||
126451214|NCT00966875|454954503|FG002|Part B|Sponsor Decision|0|||
126451215|NCT00966875|454954504|FG003|Part B|Sponsor Decision|0|||
126451216|NCT00966875|454954505|FG004|Part B|Sponsor Decision|0|||
126451217|NCT00966875|454954506|FG005|Part B|Sponsor Decision|1|||
126451218|NCT00966875|454954507|FG006|Part B|Sponsor Decision|0|||
126451219|NCT00966875|454954508|FG007|Part B|Sponsor Decision|2|||
126451220|NCT00966875|454954509|FG008|Part B|Sponsor Decision|1|||
126451221|NCT00966875|454954501|FG000|Part B|Withdrawal by Subject|2|||
126451222|NCT00966875|454954502|FG001|Part B|Withdrawal by Subject|1|||
126451223|NCT00966875|454954503|FG002|Part B|Withdrawal by Subject|2|||
126451224|NCT00966875|454954504|FG003|Part B|Withdrawal by Subject|1|||
126451225|NCT00966875|454954505|FG004|Part B|Withdrawal by Subject|2|||
126451226|NCT00966875|454954506|FG005|Part B|Withdrawal by Subject|1|||
126451227|NCT00966875|454954507|FG006|Part B|Withdrawal by Subject|4|||
126359399|NCT01370538|454607401|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126359400|NCT01370538|454607400|FG000|Overall Study|Adverse Event|1|||
126359401|NCT01370538|454607401|FG001|Overall Study|Adverse Event|0|||
126451228|NCT00966875|454954508|FG007|Part B|Withdrawal by Subject|5|||
126451229|NCT00966875|454954509|FG008|Part B|Withdrawal by Subject|5|||
126451230|NCT00966875|454954501|FG000|Part B|Entry Criteria|0|||
126451231|NCT00966875|454954502|FG001|Part B|Entry Criteria|0|||
126451232|NCT00966875|454954503|FG002|Part B|Entry Criteria|0|||
126451233|NCT00966875|454954504|FG003|Part B|Entry Criteria|0|||
126451234|NCT00966875|454954505|FG004|Part B|Entry Criteria|0|||
126451235|NCT00966875|454954506|FG005|Part B|Entry Criteria|0|||
126451236|NCT00966875|454954507|FG006|Part B|Entry Criteria|1|||
126451237|NCT00966875|454954508|FG007|Part B|Entry Criteria|0|||
126451238|NCT00966875|454954509|FG008|Part B|Entry Criteria|1|||
126451239|NCT02386189|454954512|FG000|Overall Study|Lost to Follow-up|2|||
126451240|NCT02386189|454954513|FG001|Overall Study|Lost to Follow-up|3|||
126451241|NCT02386189|454954512|FG000|Overall Study|Withdrawal by Subject|1|||
126451242|NCT02386189|454954513|FG001|Overall Study|Withdrawal by Subject|0|||
126451243|NCT02386189|454954512|FG000|Overall Study|Death|1|||
126451244|NCT02386189|454954513|FG001|Overall Study|Death|0|||
126451245|NCT04657666|454954514|FG000|Period 1|Withdrawal of participant consent|2|||
126451246|NCT04657666|454954515|FG001|Period 1|Withdrawal of participant consent|1|||
126451247|NCT04657666|454954514|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
126451248|NCT04657666|454954515|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
126451249|NCT04657666|454954514|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
126259877|NCT00436917|454240832|FG000|Overall Study|Personal conflicts of patient|1|||
126259878|NCT00761176|454240837|FG000|Overall Study|Death|1|||
126259879|NCT00761176|454240838|FG001|Overall Study|Death|0|||
126259880|NCT00761176|454240837|FG000|Overall Study|Withdrawal by Subject|1|||
126259881|NCT00761176|454240838|FG001|Overall Study|Withdrawal by Subject|1|||
126259882|NCT01083680|454240843|FG000|Overall Study|Lost to Follow-up|2758|||
126259883|NCT01083680|454240843|FG000|Overall Study|Withdrawal by Subject|1086|||
126259884|NCT05766787|454240844|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
126259885|NCT05766787|454240845|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
126259886|NCT05766787|454240844|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
126259887|NCT05766787|454240845|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
126259888|NCT05766787|454240844|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
126259889|NCT05766787|454240845|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
126259890|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
126259891|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
126259892|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
126259893|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
126259894|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
126259895|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
126259896|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
126259897|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
126259898|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
126259899|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
126259900|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
126259901|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
126259902|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
126259903|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
126259904|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
126259905|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
126259906|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
126259907|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
126259908|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
126259909|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
126259910|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
126259911|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
126259912|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
126259913|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
126259914|NCT01435928|454240846|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
126259915|NCT01435928|454240847|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
126259916|NCT01435928|454240848|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
126259917|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
126259918|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
126259919|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
126259920|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
126259921|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
126259922|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
126259923|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
126259924|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
126259925|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
126259926|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
126259927|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
126259928|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
126259929|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
126259930|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
126259931|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
126259932|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
126259933|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
126259934|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
126259935|NCT01435928|454240846|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
126259936|NCT01435928|454240847|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
126259937|NCT01435928|454240848|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
126259938|NCT02124902|454242285|FG000|Overall Study|Adverse Event|7|||
126546752|NCT02762981|455296031|FG003|Overall Study|Other|0|||
126546753|NCT02762981|455296032|FG004|Overall Study|Other|0|||
126546754|NCT02762981|455296028|FG000|Overall Study|Missing|1|||
126546755|NCT02762981|455296029|FG001|Overall Study|Missing|0|||
126546756|NCT02762981|455296030|FG002|Overall Study|Missing|0|||
126546757|NCT02762981|455296031|FG003|Overall Study|Missing|0|||
126546758|NCT02762981|455296032|FG004|Overall Study|Missing|0|||
126259939|NCT02124902|454242286|FG001|Overall Study|Adverse Event|2|||
126259940|NCT02124902|454242285|FG000|Overall Study|Went to alternative treatment|4|||
126259941|NCT02124902|454242286|FG001|Overall Study|Went to alternative treatment|0|||
126259942|NCT02124902|454242285|FG000|Overall Study|Withdrawal by Subject|2|||
126259943|NCT02124902|454242286|FG001|Overall Study|Withdrawal by Subject|1|||
126259944|NCT02124902|454242285|FG000|Overall Study|Physician Decision|2|||
126259945|NCT02124902|454242286|FG001|Overall Study|Physician Decision|0|||
126259946|NCT02124902|454242285|FG000|Overall Study|Not eligible|1|||
126546759|NCT02762981|455296028|FG000|Overall Study|Withdrawal by Subject|0|||
126546760|NCT02762981|455296029|FG001|Overall Study|Withdrawal by Subject|5|||
126546761|NCT02762981|455296030|FG002|Overall Study|Withdrawal by Subject|1|||
126763349|NCT02594384|456086780|FG005|Overall Study|Withdrawal by Subject|0|||
126259947|NCT02124902|454242286|FG001|Overall Study|Not eligible|0|||
126259948|NCT02124902|454242285|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
126259949|NCT02124902|454242286|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
126259950|NCT00802178|454242287|FG000|Overall Study|Lack of Efficacy|36|||
126359402|NCT01370538|454607400|FG000|Overall Study|Protocol Violation|8|||
126359403|NCT01370538|454607401|FG001|Overall Study|Protocol Violation|5|||
126359404|NCT01370538|454607400|FG000|Overall Study|Development of study specific withdrawal|1|||
126359405|NCT01370538|454607401|FG001|Overall Study|Development of study specific withdrawal|1|||
126359406|NCT01370538|454607400|FG000|Overall Study|Lost to follow up|6|||
126359407|NCT01370538|454607401|FG001|Overall Study|Lost to follow up|10|||
126359408|NCT04193527|454607402|FG000|Overall Study|Other|1|||
126359409|NCT04193527|454607403|FG001|Overall Study|Other|1|||
126359410|NCT04193527|454607404|FG002|Overall Study|Other|0|||
126359411|NCT02366130|454607405|FG000|Overall Study|Withdrawal by Subject|3|||
126359412|NCT02366130|454607405|FG000|Overall Study|Ineligible|6|||
126359413|NCT00567112|454607406|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
126359414|NCT00567112|454607407|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
126359415|NCT00567112|454607408|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
126359416|NCT00567112|454607406|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
126359417|NCT00567112|454607407|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
126359418|NCT00567112|454607408|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
126359419|NCT00567112|454607406|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
126359420|NCT00567112|454607407|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
126359421|NCT00567112|454607408|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
126359422|NCT01945242|454607419|FG000|Overall Study|Physician Decision|3|||
126359423|NCT01945242|454607420|FG001|Overall Study|Physician Decision|3|||
126359424|NCT05661734|454607421|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
126359425|NCT05661734|454607421|FG000|Overall Study|Lost to Follow-up|13|||
126359426|NCT05661734|454607421|FG000|Overall Study|Enrolled but not dosed|2|||
126359427|NCT01125748|454607422|FG000|Overall Study|Adverse Event|0|||
126359428|NCT01125748|454607423|FG001|Overall Study|Adverse Event|2|||
126359429|NCT01125748|454607422|FG000|Overall Study|Lost to Follow-up|0|||
126359430|NCT01125748|454607423|FG001|Overall Study|Lost to Follow-up|1|||
126359431|NCT01125748|454607422|FG000|Overall Study|Physician Decision|8|||
126359432|NCT01125748|454607423|FG001|Overall Study|Physician Decision|7|||
126359433|NCT01125748|454607422|FG000|Overall Study|Patient Decision to Withdraw|2|||
126359434|NCT01125748|454607423|FG001|Overall Study|Patient Decision to Withdraw|4|||
126359435|NCT02405962|454607424|FG000|Overall Study|Lost to Follow-up|1|||
126359436|NCT02405962|454607425|FG001|Overall Study|Lost to Follow-up|4|||
126359437|NCT02405962|454607424|FG000|Overall Study|A participant has moved to another place|0|||
126359438|NCT02405962|454607425|FG001|Overall Study|A participant has moved to another place|1|||
126359439|NCT01028391|454607426|FG000|Overall Study|Adverse Event|4|||
126359440|NCT01028391|454607427|FG001|Overall Study|Adverse Event|0|||
126359441|NCT01028391|454607426|FG000|Overall Study|Lack of Efficacy|0|||
126359442|NCT01028391|454607427|FG001|Overall Study|Lack of Efficacy|2|||
126359443|NCT01028391|454607426|FG000|Overall Study|Lost to Follow-up|3|||
126359444|NCT01028391|454607427|FG001|Overall Study|Lost to Follow-up|4|||
126359445|NCT01028391|454607426|FG000|Overall Study|Physician Decision|0|||
126359446|NCT01028391|454607427|FG001|Overall Study|Physician Decision|1|||
126359447|NCT01028391|454607426|FG000|Overall Study|Withdrawal by Subject|6|||
126359448|NCT01028391|454607427|FG001|Overall Study|Withdrawal by Subject|3|||
126359449|NCT01028391|454607426|FG000|Overall Study|Needed excluded medication|1|||
126359450|NCT01028391|454607427|FG001|Overall Study|Needed excluded medication|1|||
126359451|NCT01026038|454607428|FG000|Overall Study|Lost to Follow-up|1|||
126359452|NCT01026038|454607429|FG001|Overall Study|Lost to Follow-up|1|||
126359453|NCT01026038|454607430|FG002|Overall Study|Lost to Follow-up|0|||
126359454|NCT03601052|454607431|FG000|Overall Study|Lost to Follow-up|2|||
126359455|NCT00837330|454607432|FG000|Overall Study|Lost to Follow-up|1|||
126359456|NCT00837330|454607433|FG001|Overall Study|Lost to Follow-up|3|||
126359457|NCT01184118|454607434|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
126359458|NCT01184118|454607434|FG000|Overall Study|No physiologic confirmation of asthma|8|||
126359459|NCT01184118|454607434|FG000|Overall Study|FEV1 <60% predicted|2|||
126359460|NCT01184118|454607434|FG000|Overall Study|Exclusionary medical condition|2|||
126359461|NCT01184118|454607434|FG000|Overall Study|Withdrawal by Subject|5|||
126259951|NCT00802178|454242287|FG000|Overall Study|Insufficient tolerability (IT)|17|||
126259952|NCT00802178|454242287|FG000|Overall Study|Withdrawal by Subject|18|||
126259953|NCT00802178|454242287|FG000|Overall Study|Other|32|||
126259954|NCT00802178|454242287|FG000|Overall Study|Lack of efficacy and patient wish|1|||
126259955|NCT00802178|454242287|FG000|Overall Study|IT and patient wish|8|||
126259956|NCT00802178|454242287|FG000|Overall Study|Patients wish and other reason|1|||
126259957|NCT04100096|454242288|FG000|Overall Study|Adverse Event|19|||
126259958|NCT04100096|454242289|FG001|Overall Study|Adverse Event|7|||
126259959|NCT04100096|454242288|FG000|Overall Study|Lack of Efficacy|0|||
126259960|NCT04100096|454242289|FG001|Overall Study|Lack of Efficacy|1|||
126259961|NCT04100096|454242288|FG000|Overall Study|Lost to Follow-up|13|||
126259962|NCT04100096|454242289|FG001|Overall Study|Lost to Follow-up|11|||
126259963|NCT04100096|454242288|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126259964|NCT04100096|454242289|FG001|Overall Study|Non-Compliance With Study Drug|3|||
126259965|NCT04100096|454242288|FG000|Overall Study|Protocol Deviation|1|||
126259966|NCT04100096|454242289|FG001|Overall Study|Protocol Deviation|1|||
126259967|NCT04100096|454242288|FG000|Overall Study|Withdrawal by Participant|13|||
126259968|NCT04100096|454242289|FG001|Overall Study|Withdrawal by Participant|15|||
126259969|NCT00831233|454242293|FG000|Overall Study|Adverse Event|0|||
126259970|NCT00831233|454242294|FG001|Overall Study|Adverse Event|1|||
126259971|NCT00831233|454242293|FG000|Overall Study|Protocol Violation|1|||
126259972|NCT00831233|454242294|FG001|Overall Study|Protocol Violation|0|||
126259973|NCT00831233|454242293|FG000|Overall Study|Selection Criteria Not Met|2|||
126259974|NCT00831233|454242294|FG001|Overall Study|Selection Criteria Not Met|0|||
126259975|NCT02211014|454242295|FG000|Overall Study|Adverse Event|0|||
126259976|NCT02211014|454242296|FG001|Overall Study|Adverse Event|2|||
126259977|NCT02211014|454242295|FG000|Overall Study|Physician Decision|1|||
126259978|NCT02211014|454242296|FG001|Overall Study|Physician Decision|2|||
126259979|NCT02211014|454242295|FG000|Overall Study|Started another cancer therapy|1|||
126259980|NCT02211014|454242296|FG001|Overall Study|Started another cancer therapy|0|||
126259981|NCT02211014|454242295|FG000|Overall Study|Withdrawal by Subject|0|||
126259982|NCT02211014|454242296|FG001|Overall Study|Withdrawal by Subject|1|||
126259983|NCT02211014|454242295|FG000|Overall Study|In agreement with patient, no benefit|0|||
126259984|NCT02211014|454242296|FG001|Overall Study|In agreement with patient, no benefit|1|||
126259985|NCT02916693|454242297|FG000|Overall Study|Lost to Follow-up|7|||
126259986|NCT00529217|454242298|FG000|Overall Study|Lack of Efficacy|2|||
126259987|NCT00529217|454242298|FG000|Overall Study|Unable to adhere to study schedule|2|||
126259988|NCT01098110|454242300|FG000|Overall Study|Withdrawal by Subject|14|||
126259989|NCT01098110|454242301|FG001|Overall Study|Withdrawal by Subject|24|||
126259990|NCT01098110|454242302|FG002|Overall Study|Withdrawal by Subject|19|||
126259991|NCT01098110|454242300|FG000|Overall Study|Adverse Event|30|||
126259992|NCT01098110|454242301|FG001|Overall Study|Adverse Event|32|||
126259993|NCT01098110|454242302|FG002|Overall Study|Adverse Event|43|||
126259994|NCT01098110|454242300|FG000|Overall Study|Lack of Efficacy|13|||
126259995|NCT01098110|454242301|FG001|Overall Study|Lack of Efficacy|9|||
126259996|NCT01098110|454242302|FG002|Overall Study|Lack of Efficacy|27|||
126259997|NCT01098110|454242300|FG000|Overall Study|Other|4|||
126259998|NCT01098110|454242301|FG001|Overall Study|Other|7|||
126259999|NCT01098110|454242302|FG002|Overall Study|Other|5|||
126260000|NCT01098110|454242300|FG000|Overall Study|Untreated|1|||
126260001|NCT01098110|454242301|FG001|Overall Study|Untreated|1|||
126260002|NCT01098110|454242302|FG002|Overall Study|Untreated|0|||
126260003|NCT01999894|454242303|FG000|Overall Study|Adverse Event|9|||
126260004|NCT01999894|454242303|FG000|Overall Study|Lack of Efficacy|5|||
126260005|NCT01999894|454242303|FG000|Overall Study|Protocol Violation|1|||
126260006|NCT01999894|454242303|FG000|Overall Study|Withdrawal by Subject|7|||
126260007|NCT01999894|454242303|FG000|Overall Study|Lost to Follow-up|10|||
126260008|NCT01999894|454242303|FG000|Overall Study|Other Reason|3|||
126260009|NCT01999894|454242303|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
126260010|NCT02147587|454242304|FG000|Overall Study|Adverse Event|9|||
126260011|NCT02147587|454242305|FG001|Overall Study|Adverse Event|4|||
126260012|NCT02147587|454242304|FG000|Overall Study|Lack of Efficacy|2|||
126260013|NCT02147587|454242305|FG001|Overall Study|Lack of Efficacy|1|||
126359462|NCT01049828|454607440|FG000|Overall Study|Claustrophibia and Frustration|2|||
126359463|NCT02946996|454607441|FG000|Overall Study|non-evaluable|3|||
126359464|NCT02946996|454607442|FG001|Overall Study|non-evaluable|6|||
126359465|NCT02946996|454607443|FG002|Overall Study|non-evaluable|5|||
126359466|NCT03572218|454607446|FG000|Overall Study|Lost to Follow-up|3|||
126260014|NCT02274948|454242308|FG000|Overall Study|Lost to Follow-up|28|||
126260015|NCT02274948|454242309|FG001|Overall Study|Lost to Follow-up|25|||
126260016|NCT02274948|454242308|FG000|Overall Study|Withdrawal by Subject|64|||
126260017|NCT02274948|454242309|FG001|Overall Study|Withdrawal by Subject|58|||
126260018|NCT02274948|454242308|FG000|Overall Study|Stopped on family Practitioner advice|2|||
126260019|NCT02274948|454242309|FG001|Overall Study|Stopped on family Practitioner advice|5|||
126260020|NCT02274948|454242308|FG000|Overall Study|Left the area|4|||
126359467|NCT03572218|454607447|FG001|Overall Study|Lost to Follow-up|2|||
126260021|NCT02274948|454242309|FG001|Overall Study|Left the area|3|||
126260022|NCT00530348|454242310|FG000|Overall Study|Adverse Event|5|||
126260023|NCT00530348|454242311|FG001|Overall Study|Adverse Event|1|||
126260024|NCT00530348|454242310|FG000|Overall Study|Death|0|||
126260025|NCT00530348|454242311|FG001|Overall Study|Death|1|||
126260026|NCT00530348|454242310|FG000|Overall Study|Lack of Efficacy|2|||
126260027|NCT00530348|454242311|FG001|Overall Study|Lack of Efficacy|0|||
126260028|NCT00530348|454242310|FG000|Overall Study|Lost to Follow-up|0|||
126260029|NCT00530348|454242311|FG001|Overall Study|Lost to Follow-up|2|||
126260030|NCT00530348|454242310|FG000|Overall Study|Physician Decision|1|||
126260031|NCT00530348|454242311|FG001|Overall Study|Physician Decision|2|||
126260032|NCT00530348|454242310|FG000|Overall Study|Pregnancy|1|||
126260033|NCT00530348|454242311|FG001|Overall Study|Pregnancy|0|||
126260034|NCT00530348|454242310|FG000|Overall Study|Withdrawal by Subject|12|||
126260035|NCT00530348|454242311|FG001|Overall Study|Withdrawal by Subject|12|||
126260036|NCT00530348|454242310|FG000|Overall Study|Randomised in error|1|||
126260037|NCT00530348|454242311|FG001|Overall Study|Randomised in error|0|||
126260038|NCT00530348|454242310|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
126260039|NCT00530348|454242311|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
126260040|NCT00676494|454242312|FG000|Overall Study|Missed Visit|8|||
126260041|NCT00676494|454242312|FG000|Overall Study|Withdrawal by Subject|6|||
126260042|NCT01740791|454242313|FG000|Overall Study|Randomized but never treated|5|||
126260043|NCT01740791|454242314|FG001|Overall Study|Randomized but never treated|3|||
126260044|NCT01740791|454242315|FG002|Overall Study|Randomized but never treated|2|||
126260045|NCT01740791|454242316|FG003|Overall Study|Randomized but never treated|2|||
126260046|NCT01740791|454242317|FG004|Overall Study|Randomized but never treated|1|||
126260047|NCT01740791|454242318|FG005|Overall Study|Randomized but never treated|3|||
126260048|NCT01740791|454242313|FG000|Overall Study|Lost to Follow-up|2|||
126260049|NCT01740791|454242314|FG001|Overall Study|Lost to Follow-up|0|||
126260050|NCT01740791|454242315|FG002|Overall Study|Lost to Follow-up|2|||
126260051|NCT01740791|454242316|FG003|Overall Study|Lost to Follow-up|3|||
126260052|NCT01740791|454242317|FG004|Overall Study|Lost to Follow-up|2|||
126260053|NCT01740791|454242318|FG005|Overall Study|Lost to Follow-up|3|||
126260054|NCT01740791|454242313|FG000|Overall Study|Withdrew Consent|4|||
126260055|NCT01740791|454242314|FG001|Overall Study|Withdrew Consent|0|||
126260056|NCT01740791|454242315|FG002|Overall Study|Withdrew Consent|1|||
126260057|NCT01740791|454242316|FG003|Overall Study|Withdrew Consent|2|||
126260058|NCT01740791|454242317|FG004|Overall Study|Withdrew Consent|0|||
126260059|NCT01740791|454242318|FG005|Overall Study|Withdrew Consent|3|||
126260060|NCT01740791|454242313|FG000|Overall Study|Investigator's discretion|1|||
126260061|NCT01740791|454242314|FG001|Overall Study|Investigator's discretion|0|||
126260062|NCT01740791|454242315|FG002|Overall Study|Investigator's discretion|1|||
126260063|NCT01740791|454242316|FG003|Overall Study|Investigator's discretion|0|||
126260064|NCT01740791|454242317|FG004|Overall Study|Investigator's discretion|0|||
126260065|NCT01740791|454242318|FG005|Overall Study|Investigator's discretion|1|||
126260066|NCT01740791|454242313|FG000|Overall Study|Adverse Event|0|||
126260067|NCT01740791|454242314|FG001|Overall Study|Adverse Event|0|||
126260068|NCT01740791|454242315|FG002|Overall Study|Adverse Event|0|||
126260069|NCT01740791|454242316|FG003|Overall Study|Adverse Event|0|||
126260070|NCT01740791|454242317|FG004|Overall Study|Adverse Event|0|||
126260071|NCT01740791|454242318|FG005|Overall Study|Adverse Event|1|||
126260072|NCT01463982|454242319|FG000|Overall Study|Withdrawal by Subject|0|||
126260073|NCT01463982|454242320|FG001|Overall Study|Withdrawal by Subject|1|||
126260074|NCT01463982|454242321|FG002|Overall Study|Withdrawal by Subject|1|||
126260075|NCT01463982|454242322|FG003|Overall Study|Withdrawal by Subject|0|||
126260076|NCT01463982|454242319|FG000|Overall Study|Treatment delay over 5 week|0|||
126260077|NCT01463982|454242320|FG001|Overall Study|Treatment delay over 5 week|0|||
126260078|NCT01463982|454242321|FG002|Overall Study|Treatment delay over 5 week|1|||
126260079|NCT01463982|454242322|FG003|Overall Study|Treatment delay over 5 week|0|||
126260080|NCT04220775|454242323|FG000|Overall Study|Adverse Event|1|||
126260081|NCT04220775|454242324|FG001|Overall Study|Adverse Event|0|||
126260082|NCT04220775|454242323|FG000|Overall Study|Disease Progression|1|||
126260083|NCT04220775|454242324|FG001|Overall Study|Disease Progression|0|||
126260084|NCT00931463|454242325|FG000|Overall Study|Death|8|||
126260085|NCT00931463|454242326|FG001|Overall Study|Death|4|||
126260086|NCT00931463|454242325|FG000|Overall Study|Withdrawal by Subject|5|||
126260087|NCT00931463|454242326|FG001|Overall Study|Withdrawal by Subject|0|||
126260088|NCT00931463|454242325|FG000|Overall Study|Lost to Follow-up|4|||
126260089|NCT00931463|454242326|FG001|Overall Study|Lost to Follow-up|1|||
126260090|NCT03170869|454242327|FG000|Overall Study|Protocol Violation|5|||
126260091|NCT03170869|454242327|FG000|Overall Study|Early study termination|3|||
126260092|NCT00220727|454242330|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
126260093|NCT00220727|454242331|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
126260094|NCT02020967|454242332|FG000|Overall Study|Withdrawal by Subject|51|||
126260095|NCT03507686|454242333|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
126260096|NCT03507686|454242334|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
126260097|NCT03507686|454242333|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
126260098|NCT03507686|454242334|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
126699657|NCT02612909|455851260|FG001|Phase 3|Withdrawal by Subject|0|||
126451250|NCT04657666|454954515|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
126451251|NCT04657666|454954514|FG000|Period 2|Other|2|||
126451252|NCT04657666|454954515|FG001|Period 2|Other|0|||
126451253|NCT04657666|454954514|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
126451254|NCT04657666|454954515|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
126451255|NCT00640224|454954516|FG000|Overall Study|Lost to Follow-up|5|||
126451256|NCT00640224|454954517|FG001|Overall Study|Lost to Follow-up|2|||
126451257|NCT00640224|454954518|FG002|Overall Study|Lost to Follow-up|0|||
126451258|NCT00640224|454954519|FG003|Overall Study|Lost to Follow-up|0|||
126451259|NCT00640224|454954516|FG000|Overall Study|Withdrawal by Subject|1|||
126451260|NCT00640224|454954517|FG001|Overall Study|Withdrawal by Subject|0|||
126451261|NCT00640224|454954518|FG002|Overall Study|Withdrawal by Subject|0|||
126546762|NCT02762981|455296031|FG003|Overall Study|Withdrawal by Subject|3|||
126546763|NCT02762981|455296032|FG004|Overall Study|Withdrawal by Subject|0|||
126260099|NCT03507686|454242333|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
126260100|NCT03507686|454242334|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
126260101|NCT03507686|454242333|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
126260102|NCT03507686|454242334|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
126260103|NCT03507686|454242333|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
126260104|NCT03507686|454242334|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
126260105|NCT03507686|454242333|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
126260106|NCT03507686|454242334|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
126260107|NCT02508116|454242337|FG000|Overall Study|Lost to Follow-up|2|||
126260108|NCT02508116|454242338|FG001|Overall Study|Lost to Follow-up|3|||
126260109|NCT02508116|454242337|FG000|Overall Study|Withdrawal by Subject|3|||
126260110|NCT02508116|454242338|FG001|Overall Study|Withdrawal by Subject|2|||
126260111|NCT02508116|454242337|FG000|Overall Study|Protocol Violation|1|||
126260112|NCT02508116|454242338|FG001|Overall Study|Protocol Violation|2|||
126260113|NCT02508116|454242337|FG000|Overall Study|Physician Decision|2|||
126260114|NCT02508116|454242338|FG001|Overall Study|Physician Decision|0|||
126260115|NCT00983528|454242339|FG000|Overall Study|Death|4|||
126260116|NCT00983528|454242339|FG000|Overall Study|Lost to Follow-up|1|||
126260117|NCT00983528|454242339|FG000|Overall Study|Study Terminated|1|||
126260118|NCT00575380|454242340|FG000|Overall Study|Withdrawal by Subject|1|||
126260119|NCT00575380|454242341|FG001|Overall Study|Withdrawal by Subject|0|||
126260120|NCT00575380|454242340|FG000|Overall Study|Adverse Event|0|||
126260121|NCT00575380|454242341|FG001|Overall Study|Adverse Event|1|||
126260122|NCT00575380|454242340|FG000|Overall Study|Various|0|||
126260123|NCT00575380|454242341|FG001|Overall Study|Various|2|||
126260124|NCT00559364|454242342|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
126260125|NCT00559364|454242343|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
126260126|NCT00330460|454242346|FG000|Overall Study|Physician Decision|1|||
126260127|NCT00330460|454242347|FG001|Overall Study|Physician Decision|0|||
126260128|NCT00330460|454242346|FG000|Overall Study|Adverse Event|10|||
126260129|NCT00330460|454242347|FG001|Overall Study|Adverse Event|8|||
126260130|NCT00330460|454242346|FG000|Overall Study|Withdrawal by Subject|18|||
126260131|NCT00330460|454242347|FG001|Overall Study|Withdrawal by Subject|17|||
126260132|NCT00330460|454242346|FG000|Overall Study|Death|1|||
126260133|NCT00330460|454242347|FG001|Overall Study|Death|1|||
126260134|NCT00330460|454242346|FG000|Overall Study|Ineligibility determined|1|||
126260135|NCT00330460|454242347|FG001|Overall Study|Ineligibility determined|3|||
126260136|NCT00330460|454242346|FG000|Overall Study|Lost to Follow-up|8|||
126260137|NCT00330460|454242347|FG001|Overall Study|Lost to Follow-up|3|||
126260138|NCT00330460|454242346|FG000|Overall Study|Noncompliance|2|||
126260139|NCT00330460|454242347|FG001|Overall Study|Noncompliance|1|||
126260140|NCT00330460|454242346|FG000|Overall Study|Other|1|||
126260141|NCT00330460|454242347|FG001|Overall Study|Other|0|||
126260142|NCT02663882|454242352|FG000|Overall Study|Lost to Follow-up|4|||
126260143|NCT02663882|454242353|FG001|Overall Study|Lost to Follow-up|2|||
126260144|NCT00602537|454242354|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
126260145|NCT00602537|454242355|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
126260146|NCT00602537|454242354|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
126260147|NCT00602537|454242355|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
126546764|NCT00976482|455296035|FG000|Overall Study|Death|208|||
126763350|NCT02594384|456086781|FG006|Overall Study|Withdrawal by Subject|0|||
126260148|NCT00602537|454242354|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
126260149|NCT00602537|454242355|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
126260150|NCT00602537|454242354|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
126260151|NCT00602537|454242355|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
126260152|NCT00602537|454242354|FG000|Follow Up Study Comparison|Adverse Event|1|||
126260153|NCT00602537|454242355|FG001|Follow Up Study Comparison|Adverse Event|0|||
126260154|NCT00602537|454242354|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
126451262|NCT00640224|454954519|FG003|Overall Study|Withdrawal by Subject|0|||
126451263|NCT00640224|454954516|FG000|Overall Study|Headaches|0|||
126451264|NCT00640224|454954517|FG001|Overall Study|Headaches|1|||
126451265|NCT00640224|454954518|FG002|Overall Study|Headaches|0|||
126451266|NCT00640224|454954519|FG003|Overall Study|Headaches|0|||
126451267|NCT04224688|454954524|FG000|Overall Study|Withdrawal by Subject|1|||
126451268|NCT04224688|454954525|FG001|Overall Study|Withdrawal by Subject|3|||
126451269|NCT04224688|454954524|FG000|Overall Study|Lack of Efficacy|1|||
126451270|NCT04224688|454954525|FG001|Overall Study|Lack of Efficacy|1|||
126451271|NCT04224688|454954524|FG000|Overall Study|Adverse event, not fatal|0|||
126451272|NCT04224688|454954525|FG001|Overall Study|Adverse event, not fatal|2|||
126451273|NCT04224688|454954524|FG000|Overall Study|COVID-19|0|||
126451274|NCT04224688|454954525|FG001|Overall Study|COVID-19|1|||
126451275|NCT03232333|454954531|FG000|Overall Study|Infection or Osteomyelitis|9|||
126451276|NCT03232333|454954531|FG000|Overall Study|Lost to Follow-up|4|||
126451277|NCT03232333|454954531|FG000|Overall Study|Withdrawal by Subject|2|||
126451278|NCT00653432|454954535|FG000|Overall Study|Adverse Event|4|||
126451279|NCT00653432|454954536|FG001|Overall Study|Adverse Event|1|||
126451280|NCT00653432|454954535|FG000|Overall Study|Withdrawal by Subject|4|||
126451281|NCT00653432|454954536|FG001|Overall Study|Withdrawal by Subject|5|||
126451282|NCT00653432|454954535|FG000|Overall Study|Lost to Follow-up|7|||
126451283|NCT00653432|454954536|FG001|Overall Study|Lost to Follow-up|6|||
126451284|NCT00653432|454954535|FG000|Overall Study|Use/Need of Con Therapy|2|||
126451285|NCT00653432|454954536|FG001|Overall Study|Use/Need of Con Therapy|1|||
126451286|NCT00653432|454954535|FG000|Overall Study|Other - Reason Not Provided|5|||
126451287|NCT00653432|454954536|FG001|Overall Study|Other - Reason Not Provided|3|||
126451288|NCT03087617|454954541|FG000|Overall Study|Lost to Follow-up|32|||
126451289|NCT03087617|454954542|FG001|Overall Study|Lost to Follow-up|30|||
126451290|NCT03087617|454954543|FG002|Overall Study|Lost to Follow-up|30|||
126451291|NCT03087617|454954544|FG003|Overall Study|Lost to Follow-up|39|||
126451292|NCT02343549|454954545|FG000|Overall Study|Death|11|||
126451293|NCT02343549|454954545|FG000|Overall Study|Withdrawal by Subject|2|||
126451294|NCT00787267|454954549|FG000|Overall Study|Screen failure/Ineligible|10|||
126451295|NCT00787267|454954549|FG000|Overall Study|No Reason Provided|1|||
126451296|NCT00787267|454954549|FG000|Overall Study|Withdrawal by Subject|1|||
126451297|NCT04343235|454954550|FG000|Overall Study|Lost to Follow-up|3|||
126451298|NCT04343235|454954551|FG001|Overall Study|Lost to Follow-up|2|||
126451299|NCT00865280|454954552|FG000|Overall Study|Withdrawal by Subject|4|||
126451300|NCT00865280|454954553|FG001|Overall Study|Withdrawal by Subject|1|||
126451301|NCT00865280|454954552|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
126451302|NCT00865280|454954553|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
126451303|NCT00865280|454954552|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
126451304|NCT00865280|454954553|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
126451305|NCT00865280|454954552|FG000|Overall Study|Exclusion Condition|1|||
126451306|NCT00865280|454954553|FG001|Overall Study|Exclusion Condition|0|||
126451307|NCT00865280|454954552|FG000|Overall Study|Adverse Event|0|||
126451308|NCT00865280|454954553|FG001|Overall Study|Adverse Event|1|||
126451309|NCT01788215|454954554|FG000|Overall Study|Withdrawal by Subject|0|||
126451310|NCT01788215|454954555|FG001|Overall Study|Withdrawal by Subject|1|||
126451311|NCT01788215|454954554|FG000|Overall Study|Lost to Follow-up|2|||
126546765|NCT00976482|455296035|FG000|Overall Study|Withdrawal by Subject|45|||
126699658|NCT02612909|455851261|FG002|Phase 3|Withdrawal by Subject|0|||
126699659|NCT02612909|455851262|FG003|Phase 3|Withdrawal by Subject|1|||
126260155|NCT00602537|454242355|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
126260156|NCT00602537|454242354|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
126260157|NCT00602537|454242355|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
126260158|NCT00388037|454242356|FG000|Overall Study|Protocol Violation|1|||
126260159|NCT00869440|454242359|FG000|Overall Study|Withdrawal by Subject|1|||
126260160|NCT00869440|454242360|FG001|Overall Study|Withdrawal by Subject|0|||
126260161|NCT00869440|454242361|FG002|Overall Study|Withdrawal by Subject|0|||
126260162|NCT00869440|454242362|FG003|Overall Study|Withdrawal by Subject|0|||
126260163|NCT00869440|454242359|FG000|Overall Study|Physician Decision|1|||
126260164|NCT00869440|454242360|FG001|Overall Study|Physician Decision|1|||
126260165|NCT00869440|454242361|FG002|Overall Study|Physician Decision|0|||
126260166|NCT00869440|454242362|FG003|Overall Study|Physician Decision|0|||
126260167|NCT03573817|454242363|FG000|Overall Study|Adverse Event|0|||
126699660|NCT02612909|455851263|FG004|Phase 3|Withdrawal by Subject|0|||
126699661|NCT03323749|455851264|FG000|Double-blind Period|Lost to Follow-up|4|||
126699662|NCT03323749|455851265|FG001|Double-blind Period|Lost to Follow-up|5|||
126699663|NCT03323749|455851264|FG000|Double-blind Period|Adverse Event|3|||
126260168|NCT03573817|454242364|FG001|Overall Study|Adverse Event|2|||
126260169|NCT03573817|454242363|FG000|Overall Study|Protocol Violation|0|||
126260170|NCT03573817|454242364|FG001|Overall Study|Protocol Violation|1|||
126260171|NCT03573817|454242363|FG000|Overall Study|Withdrawal by Subject|1|||
126451312|NCT01788215|454954555|FG001|Overall Study|Lost to Follow-up|0|||
126451313|NCT00612105|454954564|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
126451314|NCT00612105|454954565|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
126451315|NCT00612105|454954564|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
126699664|NCT03323749|455851265|FG001|Double-blind Period|Adverse Event|1|||
126699665|NCT03323749|455851264|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
126260172|NCT03573817|454242364|FG001|Overall Study|Withdrawal by Subject|1|||
126260173|NCT02013531|454242365|FG000|Overall Study|Lost to Follow-up|3|||
126260174|NCT02013531|454242365|FG000|Overall Study|Met Withdrawal Criteria|1|||
126260175|NCT02013531|454242365|FG000|Overall Study|Withdrawal by Subject|1|||
126260176|NCT03546647|454242366|FG000|Overall Study|Adverse Event|1|||
126260177|NCT03546647|454242367|FG001|Overall Study|Adverse Event|0|||
126260178|NCT02400476|454242368|FG000|Overall Study|Adverse Event|57|||
126260179|NCT02400476|454242369|FG001|Overall Study|Adverse Event|10|||
126260180|NCT02400476|454242370|FG002|Overall Study|Adverse Event|22|||
126260181|NCT02400476|454242371|FG003|Overall Study|Adverse Event|19|||
126260182|NCT02400476|454242372|FG004|Overall Study|Adverse Event|5|||
126260183|NCT02400476|454242373|FG005|Overall Study|Adverse Event|8|||
126260184|NCT02400476|454242368|FG000|Overall Study|Withdrawal by Subject|4|||
126260185|NCT02400476|454242369|FG001|Overall Study|Withdrawal by Subject|1|||
126260186|NCT02400476|454242370|FG002|Overall Study|Withdrawal by Subject|12|||
126260187|NCT02400476|454242371|FG003|Overall Study|Withdrawal by Subject|7|||
126260188|NCT02400476|454242372|FG004|Overall Study|Withdrawal by Subject|5|||
126260189|NCT02400476|454242373|FG005|Overall Study|Withdrawal by Subject|5|||
126260190|NCT02400476|454242368|FG000|Overall Study|Lost to Follow-up|0|||
126260191|NCT02400476|454242369|FG001|Overall Study|Lost to Follow-up|0|||
126260192|NCT02400476|454242370|FG002|Overall Study|Lost to Follow-up|0|||
126763351|NCT02594384|456086782|FG007|Overall Study|Withdrawal by Subject|1|||
126260193|NCT02400476|454242371|FG003|Overall Study|Lost to Follow-up|1|||
126260194|NCT02400476|454242372|FG004|Overall Study|Lost to Follow-up|3|||
126260195|NCT02400476|454242373|FG005|Overall Study|Lost to Follow-up|1|||
126260196|NCT02400476|454242368|FG000|Overall Study|Physician Decision|0|||
126451316|NCT00612105|454954565|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
126451317|NCT00612105|454954564|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
126451318|NCT00612105|454954565|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
126451319|NCT00612105|454954564|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
126451320|NCT00612105|454954565|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
126451321|NCT00612105|454954564|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
126451322|NCT00612105|454954565|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
126451323|NCT00612105|454954564|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
126451324|NCT00612105|454954565|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
126451325|NCT00612105|454954564|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
126451326|NCT00612105|454954565|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
126451327|NCT00612105|454954564|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
126451328|NCT00612105|454954565|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
126451329|NCT00612105|454954564|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
126451330|NCT00612105|454954565|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
126451331|NCT00612105|454954564|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
126451332|NCT00612105|454954565|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
126451333|NCT00612105|454954564|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
126451334|NCT00612105|454954565|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
126451335|NCT00612105|454954564|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
126451336|NCT00612105|454954565|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
126451337|NCT00509145|454954566|FG000|Overall Study|Death|0|||
126451338|NCT00509145|454954567|FG001|Overall Study|Death|2|||
126451339|NCT00509145|454954566|FG000|Overall Study|Adverse Event|42|||
126451340|NCT00509145|454954567|FG001|Overall Study|Adverse Event|28|||
126451341|NCT00509145|454954566|FG000|Overall Study|Withdrawal by Subject|32|||
126451342|NCT00509145|454954567|FG001|Overall Study|Withdrawal by Subject|38|||
126451343|NCT00509145|454954566|FG000|Overall Study|Physician Decision|11|||
126451344|NCT00509145|454954567|FG001|Overall Study|Physician Decision|14|||
126451345|NCT00509145|454954566|FG000|Overall Study|Protocol Violation|1|||
126451346|NCT00509145|454954567|FG001|Overall Study|Protocol Violation|6|||
126451347|NCT00509145|454954566|FG000|Overall Study|Pregnancy|3|||
126451348|NCT00509145|454954567|FG001|Overall Study|Pregnancy|8|||
126451349|NCT00509145|454954566|FG000|Overall Study|Lost to Follow-up|6|||
126451350|NCT00509145|454954567|FG001|Overall Study|Lost to Follow-up|5|||
126451351|NCT00509145|454954566|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
126451352|NCT00509145|454954567|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
126546766|NCT00976482|455296035|FG000|Overall Study|Center terminated|1|||
126260197|NCT02400476|454242369|FG001|Overall Study|Physician Decision|0|||
126260198|NCT02400476|454242370|FG002|Overall Study|Physician Decision|1|||
126260199|NCT02400476|454242371|FG003|Overall Study|Physician Decision|1|||
126260200|NCT02400476|454242372|FG004|Overall Study|Physician Decision|0|||
126260201|NCT02400476|454242373|FG005|Overall Study|Physician Decision|1|||
126260202|NCT02400476|454242368|FG000|Overall Study|Other, Disease Progression|0|||
126260203|NCT02400476|454242369|FG001|Overall Study|Other, Disease Progression|1|||
126451353|NCT00509145|454954566|FG000|Overall Study|Other|6|||
126451354|NCT00509145|454954567|FG001|Overall Study|Other|6|||
126546767|NCT00976482|455296035|FG000|Overall Study|Protocol Violation|5|||
126451355|NCT01994889|454954568|FG000|Overall Study|Adverse Event|5|||
126451356|NCT01994889|454954569|FG001|Overall Study|Adverse Event|12|||
126451357|NCT01994889|454954570|FG002|Overall Study|Adverse Event|11|||
126451358|NCT01994889|454954568|FG000|Overall Study|Cardiac Device Implantation|0|||
126451359|NCT01994889|454954569|FG001|Overall Study|Cardiac Device Implantation|2|||
126451360|NCT01994889|454954570|FG002|Overall Study|Cardiac Device Implantation|0|||
126451361|NCT01994889|454954568|FG000|Overall Study|Organ Transplantation|1|||
126451362|NCT01994889|454954569|FG001|Overall Study|Organ Transplantation|5|||
126451363|NCT01994889|454954570|FG002|Overall Study|Organ Transplantation|5|||
126451364|NCT01994889|454954568|FG000|Overall Study|No longer willing to participate|8|||
126451365|NCT01994889|454954569|FG001|Overall Study|No longer willing to participate|17|||
126451366|NCT01994889|454954570|FG002|Overall Study|No longer willing to participate|37|||
126451367|NCT01994889|454954568|FG000|Overall Study|Lost to Follow-up|0|||
126451368|NCT01994889|454954569|FG001|Overall Study|Lost to Follow-up|1|||
126451369|NCT01994889|454954570|FG002|Overall Study|Lost to Follow-up|0|||
126451370|NCT01994889|454954568|FG000|Overall Study|Protocol Violation|0|||
126451371|NCT01994889|454954569|FG001|Overall Study|Protocol Violation|1|||
126451372|NCT01994889|454954570|FG002|Overall Study|Protocol Violation|1|||
126451373|NCT01994889|454954568|FG000|Overall Study|Death|14|||
126451374|NCT01994889|454954569|FG001|Overall Study|Death|25|||
126451375|NCT01994889|454954570|FG002|Overall Study|Death|38|||
126451376|NCT02969655|454954572|FG000|Overall Study|Withdrawal by Subject|3|||
126451377|NCT02969655|454954573|FG001|Overall Study|Withdrawal by Subject|2|||
126451378|NCT02969655|454954572|FG000|Overall Study|Physician Decision|4|||
126451379|NCT02969655|454954573|FG001|Overall Study|Physician Decision|3|||
126451380|NCT02969655|454954572|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
126451381|NCT02969655|454954573|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
126451382|NCT02969655|454954572|FG000|Overall Study|Adverse Event|10|||
126451383|NCT02969655|454954573|FG001|Overall Study|Adverse Event|8|||
126451384|NCT02674204|454954574|FG000|Overall Study|Adverse Event|1|||
126451385|NCT02674204|454954575|FG001|Overall Study|Adverse Event|0|||
126451386|NCT00486811|454954579|FG000|Overall Study|Adverse Event|28|||
126451387|NCT00486811|454954580|FG001|Overall Study|Adverse Event|60|||
126451388|NCT00486811|454954581|FG002|Overall Study|Adverse Event|135|||
126451389|NCT00486811|454954579|FG000|Overall Study|Lack of Efficacy|34|||
126451390|NCT00486811|454954580|FG001|Overall Study|Lack of Efficacy|14|||
126451391|NCT00486811|454954581|FG002|Overall Study|Lack of Efficacy|7|||
126451392|NCT00486811|454954579|FG000|Overall Study|Lost to Follow-up|4|||
126451393|NCT00486811|454954580|FG001|Overall Study|Lost to Follow-up|6|||
126451394|NCT00486811|454954581|FG002|Overall Study|Lost to Follow-up|4|||
126451395|NCT00486811|454954579|FG000|Overall Study|Withdrawal by Subject|33|||
126451396|NCT00486811|454954580|FG001|Overall Study|Withdrawal by Subject|44|||
126451397|NCT00486811|454954581|FG002|Overall Study|Withdrawal by Subject|58|||
126451398|NCT00486811|454954579|FG000|Overall Study|Study drug non-compliant|5|||
126451399|NCT00486811|454954580|FG001|Overall Study|Study drug non-compliant|6|||
126451400|NCT00486811|454954581|FG002|Overall Study|Study drug non-compliant|3|||
126451401|NCT00486811|454954579|FG000|Overall Study|All other|18|||
126451402|NCT00486811|454954580|FG001|Overall Study|All other|11|||
126451403|NCT00486811|454954581|FG002|Overall Study|All other|7|||
126451404|NCT01711216|454954585|FG000|Overall Study|Adverse Event|4|||
126451405|NCT01711216|454954585|FG000|Overall Study|Pregnancy|56|||
126451406|NCT01711216|454954585|FG000|Overall Study|Withdrawal by Subject|6|||
126451407|NCT01711216|454954585|FG000|Overall Study|Lost to Follow-up|46|||
126451408|NCT01711216|454954585|FG000|Overall Study|variety of other minor reasons|83|||
126451409|NCT01711216|454954585|FG000|Overall Study|no reason specified|22|||
126451410|NCT02929498|454954586|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
126451411|NCT02929498|454954587|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
126260204|NCT02400476|454242370|FG002|Overall Study|Other, Disease Progression|2|||
126260205|NCT02400476|454242371|FG003|Overall Study|Other, Disease Progression|1|||
126260206|NCT02400476|454242372|FG004|Overall Study|Other, Disease Progression|2|||
126260207|NCT02400476|454242373|FG005|Overall Study|Other, Disease Progression|1|||
126260208|NCT02400476|454242368|FG000|Overall Study|Other, Decreased Quality of Life|0|||
126260209|NCT02400476|454242369|FG001|Overall Study|Other, Decreased Quality of Life|0|||
126260210|NCT02400476|454242370|FG002|Overall Study|Other, Decreased Quality of Life|2|||
126451412|NCT02929498|454954588|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
126260211|NCT02400476|454242371|FG003|Overall Study|Other, Decreased Quality of Life|0|||
126451413|NCT02929498|454954586|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
126451414|NCT02929498|454954587|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
126451415|NCT02929498|454954588|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
126451416|NCT02744040|454954589|FG000|Overall Study|Withdrawal by Subject|3|||
126451417|NCT02744040|454954590|FG001|Overall Study|Withdrawal by Subject|2|||
126451418|NCT02744040|454954591|FG002|Overall Study|Withdrawal by Subject|2|||
126451419|NCT02744040|454954589|FG000|Overall Study|Physician Decision|0|||
126451420|NCT02744040|454954590|FG001|Overall Study|Physician Decision|8|||
126451421|NCT02744040|454954591|FG002|Overall Study|Physician Decision|13|||
126451422|NCT02744040|454954589|FG000|Overall Study|Lost to Follow-up|3|||
126451423|NCT02744040|454954590|FG001|Overall Study|Lost to Follow-up|1|||
126451424|NCT02744040|454954591|FG002|Overall Study|Lost to Follow-up|7|||
126451425|NCT00096356|454954592|FG000|Overall Study|Adverse Event|11|||
126451426|NCT00096356|454954593|FG001|Overall Study|Adverse Event|9|||
126451427|NCT00096356|454954592|FG000|Overall Study|Physician Decision|5|||
126451428|NCT00096356|454954593|FG001|Overall Study|Physician Decision|3|||
126451429|NCT00096356|454954592|FG000|Overall Study|Withdrawal by Subject|17|||
126451430|NCT00096356|454954593|FG001|Overall Study|Withdrawal by Subject|23|||
126451431|NCT00096356|454954592|FG000|Overall Study|Lack of Efficacy|1|||
126451432|NCT00096356|454954593|FG001|Overall Study|Lack of Efficacy|0|||
126451433|NCT00096356|454954592|FG000|Overall Study|multiple reasons|10|||
126451434|NCT00096356|454954593|FG001|Overall Study|multiple reasons|18|||
126451435|NCT03698591|454954597|FG000|Overall Study|Withdrawal by Subject|2|||
126451436|NCT03698591|454954598|FG001|Overall Study|Withdrawal by Subject|2|||
126451437|NCT03698591|454954597|FG000|Overall Study|Failed drug screen|1|||
126451438|NCT03698591|454954598|FG001|Overall Study|Failed drug screen|1|||
126451439|NCT03698591|454954597|FG000|Overall Study|Failed health screen|0|||
126451440|NCT03698591|454954598|FG001|Overall Study|Failed health screen|1|||
126451441|NCT03698591|454954597|FG000|Overall Study|Ineligible for financial compensation|1|||
126451442|NCT03698591|454954598|FG001|Overall Study|Ineligible for financial compensation|0|||
126451443|NCT03698591|454954597|FG000|Overall Study|Equipment Error|1|||
126451444|NCT03698591|454954598|FG001|Overall Study|Equipment Error|0|||
126451445|NCT03698591|454954597|FG000|Overall Study|Could not establish TMS dosage|0|||
126451446|NCT03698591|454954598|FG001|Overall Study|Could not establish TMS dosage|1|||
126451447|NCT00557856|454954601|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
126451448|NCT00557856|454954602|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
126451449|NCT00557856|454954603|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
126451450|NCT00557856|454954604|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
126451451|NCT00557856|454954605|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
126451452|NCT00557856|454954606|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
126451453|NCT00557856|454954607|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
126451454|NCT00557856|454954608|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
126451455|NCT00557856|454954609|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
126451456|NCT00557856|454954601|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
126451457|NCT00557856|454954602|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
126451458|NCT00557856|454954603|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
126451459|NCT00557856|454954604|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
126451460|NCT00557856|454954605|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
126451461|NCT00557856|454954606|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
126451462|NCT00557856|454954607|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
126451463|NCT00557856|454954608|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
126451464|NCT00557856|454954609|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
126451465|NCT00557856|454954601|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
126451466|NCT00557856|454954602|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
126451467|NCT00557856|454954603|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
126451468|NCT00557856|454954604|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
126451469|NCT00557856|454954605|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
126451470|NCT00557856|454954606|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
126451471|NCT00557856|454954607|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
126451472|NCT00557856|454954608|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
126451473|NCT00557856|454954609|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
126451474|NCT00557856|454954601|FG000|Part 1: Dose Escalation Phase|Other|0|||
126451475|NCT00557856|454954602|FG001|Part 1: Dose Escalation Phase|Other|0|||
126451476|NCT00557856|454954603|FG002|Part 1: Dose Escalation Phase|Other|1|||
126451477|NCT00557856|454954604|FG003|Part 1: Dose Escalation Phase|Other|1|||
126451478|NCT00557856|454954605|FG004|Part 1: Dose Escalation Phase|Other|0|||
126451479|NCT00557856|454954606|FG005|Part 1: Dose Escalation Phase|Other|0|||
126451480|NCT00557856|454954607|FG006|Part 1: Dose Escalation Phase|Other|0|||
126451481|NCT00557856|454954608|FG007|Part 1: Dose Escalation Phase|Other|1|||
126451482|NCT00557856|454954609|FG008|Part 1: Dose Escalation Phase|Other|0|||
126451483|NCT00557856|454954601|FG000|Part 1: Dose Escalation Phase|Death|0|||
126451484|NCT00557856|454954602|FG001|Part 1: Dose Escalation Phase|Death|0|||
126546768|NCT00720902|455296036|FG000|Overall Study|Withdrawal by Subject|1|||
126546769|NCT00720902|455296037|FG001|Overall Study|Withdrawal by Subject|0|||
126546770|NCT00720902|455296036|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
126546771|NCT00720902|455296037|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
126451485|NCT00557856|454954603|FG002|Part 1: Dose Escalation Phase|Death|0|||
126451486|NCT00557856|454954604|FG003|Part 1: Dose Escalation Phase|Death|0|||
126451487|NCT00557856|454954605|FG004|Part 1: Dose Escalation Phase|Death|0|||
126451488|NCT00557856|454954606|FG005|Part 1: Dose Escalation Phase|Death|1|||
126451489|NCT00557856|454954607|FG006|Part 1: Dose Escalation Phase|Death|0|||
126451490|NCT00557856|454954608|FG007|Part 1: Dose Escalation Phase|Death|0|||
126451491|NCT00557856|454954609|FG008|Part 1: Dose Escalation Phase|Death|0|||
126451492|NCT00557856|454954601|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
126451493|NCT00557856|454954602|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
126451494|NCT00557856|454954603|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
126451495|NCT00557856|454954604|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
126451496|NCT00557856|454954605|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
126451497|NCT00557856|454954606|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
126451498|NCT00557856|454954607|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
126451499|NCT00557856|454954608|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
126451500|NCT00557856|454954609|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
126451501|NCT00557856|454954601|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
126451502|NCT00557856|454954602|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
126451503|NCT00557856|454954603|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
126451504|NCT00557856|454954604|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
126451505|NCT00557856|454954605|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
126451506|NCT00557856|454954606|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
126451507|NCT00557856|454954607|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
126451508|NCT00557856|454954608|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
126451509|NCT00557856|454954609|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
126451510|NCT00557856|454954601|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
126451511|NCT00557856|454954602|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
126451512|NCT00557856|454954603|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
126451513|NCT00557856|454954604|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
126451514|NCT00557856|454954605|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
126260212|NCT02400476|454242372|FG004|Overall Study|Other, Decreased Quality of Life|0|||
126260213|NCT02400476|454242373|FG005|Overall Study|Other, Decreased Quality of Life|0|||
126260214|NCT02400476|454242368|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
126451515|NCT00557856|454954606|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
126451516|NCT00557856|454954607|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
126451517|NCT00557856|454954608|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
126451518|NCT00557856|454954609|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
126451519|NCT00557856|454954601|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
126451520|NCT00557856|454954602|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
126260215|NCT02400476|454242369|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
126260216|NCT02400476|454242370|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
126260217|NCT02400476|454242371|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
126451521|NCT00557856|454954603|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
126451522|NCT00557856|454954604|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
126451523|NCT00557856|454954605|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
126451524|NCT00557856|454954606|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
126451525|NCT00557856|454954607|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
126451526|NCT00557856|454954608|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
126451527|NCT00557856|454954609|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
126451528|NCT00557856|454954601|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
126451529|NCT00557856|454954602|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
126451530|NCT00557856|454954603|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
126451531|NCT00557856|454954604|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
126451532|NCT00557856|454954605|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
126451533|NCT00557856|454954606|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
126451534|NCT00557856|454954607|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
126451535|NCT00557856|454954608|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
126451536|NCT00557856|454954609|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
126451537|NCT00557856|454954601|FG000|Part 2: Exploratory Phase|Other|0|||
126451538|NCT00557856|454954602|FG001|Part 2: Exploratory Phase|Other|0|||
126451539|NCT00557856|454954603|FG002|Part 2: Exploratory Phase|Other|0|||
126451540|NCT00557856|454954604|FG003|Part 2: Exploratory Phase|Other|0|||
126451541|NCT00557856|454954605|FG004|Part 2: Exploratory Phase|Other|0|||
126763352|NCT02594384|456086775|FG000|Overall Study|Physician Decision|0|||
126260218|NCT02400476|454242372|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
126451542|NCT00557856|454954606|FG005|Part 2: Exploratory Phase|Other|0|||
126260219|NCT02400476|454242373|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
126260220|NCT00612677|454242378|FG000|Overall Study|study closed before treatment started|1|||
126260221|NCT00613730|454242387|FG000|Overall Study|Disease progression|2|||
126451543|NCT00557856|454954607|FG006|Part 2: Exploratory Phase|Other|0|||
126451544|NCT00557856|454954608|FG007|Part 2: Exploratory Phase|Other|0|||
126451545|NCT00557856|454954609|FG008|Part 2: Exploratory Phase|Other|1|||
126451546|NCT00557856|454954601|FG000|Part 2: Exploratory Phase|Death|0|||
126451547|NCT00557856|454954602|FG001|Part 2: Exploratory Phase|Death|0|||
126451548|NCT00557856|454954603|FG002|Part 2: Exploratory Phase|Death|0|||
126451549|NCT00557856|454954604|FG003|Part 2: Exploratory Phase|Death|0|||
126451550|NCT00557856|454954605|FG004|Part 2: Exploratory Phase|Death|0|||
126451551|NCT00557856|454954606|FG005|Part 2: Exploratory Phase|Death|0|||
126260222|NCT00613730|454242387|FG000|Overall Study|Administrative decision|1|||
126260223|NCT00479388|454242388|FG000|Overall Study|Adverse Event|90|||
126451552|NCT00557856|454954607|FG006|Part 2: Exploratory Phase|Death|0|||
126451553|NCT00557856|454954608|FG007|Part 2: Exploratory Phase|Death|0|||
126451554|NCT00557856|454954609|FG008|Part 2: Exploratory Phase|Death|2|||
126451555|NCT00557856|454954601|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
126451556|NCT00557856|454954602|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
126451557|NCT00557856|454954603|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
126451558|NCT00557856|454954604|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
126451559|NCT00557856|454954605|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
126451560|NCT00557856|454954606|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
126451561|NCT00557856|454954607|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
126451562|NCT00557856|454954608|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
126451563|NCT00557856|454954609|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
126451564|NCT01675167|454954610|FG000|Open-label Titration Phase|Adverse Event|81|||
126451565|NCT01675167|454954611|FG001|Open-label Titration Phase|Adverse Event|0|||
126451566|NCT01675167|454954612|FG002|Open-label Titration Phase|Adverse Event|0|||
126451567|NCT01675167|454954610|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
126451568|NCT01675167|454954611|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
126451569|NCT01675167|454954612|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
126451570|NCT01675167|454954610|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
126451571|NCT01675167|454954611|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
126451572|NCT01675167|454954612|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
126451573|NCT01675167|454954610|FG000|Open-label Titration Phase|Protocol Violation|43|||
126451574|NCT01675167|454954611|FG001|Open-label Titration Phase|Protocol Violation|0|||
126451575|NCT01675167|454954612|FG002|Open-label Titration Phase|Protocol Violation|0|||
126451576|NCT01675167|454954610|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
126451577|NCT01675167|454954611|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
126451578|NCT01675167|454954612|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
126451579|NCT01675167|454954610|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
126451580|NCT01675167|454954611|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
126451581|NCT01675167|454954612|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
126451582|NCT01675167|454954610|FG000|Open-label Titration Phase|Other|55|||
126451583|NCT01675167|454954611|FG001|Open-label Titration Phase|Other|0|||
126451584|NCT01675167|454954612|FG002|Open-label Titration Phase|Other|0|||
126451585|NCT01675167|454954610|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
126451586|NCT01675167|454954611|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
126451587|NCT01675167|454954612|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
126451588|NCT01675167|454954610|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126451589|NCT01675167|454954611|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
126451590|NCT01675167|454954612|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
126451591|NCT01675167|454954610|FG000|Double-blind Treatment Phase|Adverse Event|0|||
126451592|NCT01675167|454954611|FG001|Double-blind Treatment Phase|Adverse Event|5|||
126451593|NCT01675167|454954612|FG002|Double-blind Treatment Phase|Adverse Event|13|||
126451594|NCT01675167|454954610|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
126451595|NCT01675167|454954611|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
126451596|NCT01675167|454954612|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
126451597|NCT01675167|454954610|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
126451598|NCT01675167|454954611|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
126451599|NCT01675167|454954612|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
126451600|NCT01675167|454954610|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
126260224|NCT00479388|454242389|FG001|Overall Study|Adverse Event|45|||
126260225|NCT00479388|454242388|FG000|Overall Study|Lost to Follow-up|0|||
126260226|NCT00479388|454242389|FG001|Overall Study|Lost to Follow-up|2|||
126260227|NCT00479388|454242388|FG000|Overall Study|Protocol Violation|10|||
126260228|NCT00479388|454242389|FG001|Overall Study|Protocol Violation|9|||
126451601|NCT01675167|454954611|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
126451602|NCT01675167|454954612|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
126451603|NCT01675167|454954610|FG000|Double-blind Treatment Phase|Other|0|||
126260229|NCT00479388|454242388|FG000|Overall Study|Withdrawal by Subject|32|||
126260230|NCT00479388|454242389|FG001|Overall Study|Withdrawal by Subject|17|||
126260231|NCT01876368|454242392|FG000|Overall Study|Adverse Event|2|||
126451604|NCT01675167|454954611|FG001|Double-blind Treatment Phase|Other|7|||
126451605|NCT01675167|454954612|FG002|Double-blind Treatment Phase|Other|5|||
126451606|NCT01525225|454954613|FG000|Enrollment|No longer met study criteria|1|||
126451607|NCT01525225|454954613|FG000|Enrollment|Other|1|||
126546772|NCT02254408|455296041|FG000|Overall Study|Randomized But Not Treated|1|||
126451608|NCT00243841|454954616|FG000|Overall Study|Physician Decision|0|||
126451609|NCT00243841|454954617|FG001|Overall Study|Physician Decision|0|||
126451610|NCT00243841|454954618|FG002|Overall Study|Physician Decision|1|||
126451611|NCT00243841|454954619|FG003|Overall Study|Physician Decision|0|||
126451612|NCT00243841|454954620|FG004|Overall Study|Physician Decision|0|||
126451613|NCT00243841|454954621|FG005|Overall Study|Physician Decision|2|||
126451614|NCT00363545|454954622|FG000|Overall Study|Serious Adverse Event|0|||
126451615|NCT00363545|454954623|FG001|Overall Study|Serious Adverse Event|1|||
126451616|NCT00363545|454954622|FG000|Overall Study|Withdrawal by Subject|12|||
126451617|NCT00363545|454954623|FG001|Overall Study|Withdrawal by Subject|15|||
126451618|NCT00363545|454954622|FG000|Overall Study|Migrated/moved from study area|3|||
126451619|NCT00363545|454954623|FG001|Overall Study|Migrated/moved from study area|6|||
126451620|NCT00363545|454954622|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
126451621|NCT00363545|454954623|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
126451622|NCT00363545|454954622|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
126451623|NCT00363545|454954623|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
126451624|NCT00363545|454954622|FG000|Overall Study|Others|1|||
126451625|NCT00363545|454954623|FG001|Overall Study|Others|0|||
126451626|NCT01182844|454954624|FG000|Overall Study|Withdrawal by Subject|0|||
126451627|NCT01182844|454954625|FG001|Overall Study|Withdrawal by Subject|2|||
126451628|NCT01379508|454954626|FG000|Treatment to Week 104|Adverse Event|2|||
126451629|NCT01379508|454954627|FG001|Treatment to Week 104|Adverse Event|0|||
126451630|NCT01379508|454954628|FG002|Treatment to Week 104|Adverse Event|5|||
126451631|NCT01379508|454954629|FG003|Treatment to Week 104|Adverse Event|0|||
126451632|NCT01379508|454954626|FG000|Treatment to Week 104|Abnormal lab value|1|||
126451633|NCT01379508|454954627|FG001|Treatment to Week 104|Abnormal lab value|0|||
126451634|NCT01379508|454954628|FG002|Treatment to Week 104|Abnormal lab value|0|||
126451635|NCT01379508|454954629|FG003|Treatment to Week 104|Abnormal lab value|0|||
126451636|NCT01379508|454954626|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
126451637|NCT01379508|454954627|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
126451638|NCT01379508|454954628|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
126451639|NCT01379508|454954629|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
126451640|NCT01379508|454954626|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
126451641|NCT01379508|454954627|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
126451642|NCT01379508|454954628|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
126451643|NCT01379508|454954629|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
126451644|NCT01379508|454954626|FG000|Treatment to Week 104|Lost to Follow-up|5|||
126451645|NCT01379508|454954627|FG001|Treatment to Week 104|Lost to Follow-up|0|||
126699666|NCT03323749|455851265|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
126699667|NCT03323749|455851264|FG000|Open-Label Period|Adverse Event|3|||
126699668|NCT03323749|455851265|FG001|Open-Label Period|Adverse Event|10|||
126699669|NCT03323749|455851264|FG000|Open-Label Period|Withdrawal by Subject|7|||
126699670|NCT03323749|455851265|FG001|Open-Label Period|Withdrawal by Subject|5|||
126699671|NCT01719757|455851267|FG000|Overall Study|Adverse Event|38|||
126260232|NCT01876368|454242393|FG001|Overall Study|Adverse Event|5|||
126260233|NCT01876368|454242392|FG000|Overall Study|Lack of Efficacy|1|||
126546773|NCT02254408|455296042|FG001|Overall Study|Randomized But Not Treated|3|||
126546774|NCT02254408|455296041|FG000|Overall Study|Adverse Event|1|||
126546775|NCT02254408|455296042|FG001|Overall Study|Adverse Event|0|||
126546776|NCT02254408|455296041|FG000|Overall Study|Death|2|||
126546777|NCT02254408|455296042|FG001|Overall Study|Death|3|||
126260234|NCT01876368|454242393|FG001|Overall Study|Lack of Efficacy|0|||
126260235|NCT01876368|454242392|FG000|Overall Study|Lost to Follow-up|0|||
126260236|NCT01876368|454242393|FG001|Overall Study|Lost to Follow-up|1|||
126260237|NCT01876368|454242392|FG000|Overall Study|Non-compliance with study treatment|0|||
126260238|NCT01876368|454242393|FG001|Overall Study|Non-compliance with study treatment|1|||
126451646|NCT01379508|454954628|FG002|Treatment to Week 104|Lost to Follow-up|3|||
126451647|NCT01379508|454954629|FG003|Treatment to Week 104|Lost to Follow-up|0|||
126451648|NCT01379508|454954626|FG000|Treatment to Week 104|Administrative problems|3|||
126451649|NCT01379508|454954627|FG001|Treatment to Week 104|Administrative problems|1|||
126546778|NCT02254408|455296041|FG000|Overall Study|Investigator's Discretion|0|||
126546779|NCT02254408|455296042|FG001|Overall Study|Investigator's Discretion|1|||
126260239|NCT01876368|454242392|FG000|Overall Study|Physician Decision|0|||
126260240|NCT01876368|454242393|FG001|Overall Study|Physician Decision|2|||
126260241|NCT01876368|454242392|FG000|Overall Study|Protocol deviation|3|||
126451650|NCT01379508|454954628|FG002|Treatment to Week 104|Administrative problems|0|||
126451651|NCT01379508|454954629|FG003|Treatment to Week 104|Administrative problems|0|||
126451652|NCT01379508|454954626|FG000|Treatment to Week 104|Protocol Violation|1|||
126451653|NCT01379508|454954627|FG001|Treatment to Week 104|Protocol Violation|1|||
126451654|NCT01379508|454954628|FG002|Treatment to Week 104|Protocol Violation|1|||
126451655|NCT01379508|454954629|FG003|Treatment to Week 104|Protocol Violation|0|||
126546780|NCT02254408|455296041|FG000|Overall Study|Withdrawal by Subject|3|||
126451656|NCT01379508|454954626|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
126451657|NCT01379508|454954627|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
126546781|NCT02254408|455296042|FG001|Overall Study|Withdrawal by Subject|3|||
126699672|NCT01719757|455851267|FG000|Overall Study|Withdrawal by Subject|15|||
126699673|NCT01719757|455851267|FG000|Overall Study|Lost to Follow-up|20|||
126699674|NCT01719757|455851267|FG000|Overall Study|Protocol Violation|1|||
126699675|NCT01719757|455851267|FG000|Overall Study|well controlled pain|27|||
126260242|NCT01876368|454242393|FG001|Overall Study|Protocol deviation|3|||
126260243|NCT01876368|454242392|FG000|Overall Study|Subject/guardian decision|3|||
126260244|NCT01876368|454242393|FG001|Overall Study|Subject/guardian decision|1|||
126260245|NCT01955044|454242394|FG000|Overall Study|Death|1|||
126260246|NCT01955044|454242395|FG001|Overall Study|Death|1|||
126260247|NCT01955044|454242396|FG002|Overall Study|Death|0|||
126260248|NCT01644149|454242397|FG000|Overall Study|Withdrawal by Subject|1|||
126260249|NCT01644149|454242398|FG001|Overall Study|Withdrawal by Subject|0|||
126260250|NCT01644149|454242397|FG000|Overall Study|Lost to Follow-up|3|||
126260251|NCT01644149|454242398|FG001|Overall Study|Lost to Follow-up|1|||
126260252|NCT02093923|454242401|FG000|Overall Study|Lost to Follow-up|0|||
126260253|NCT02093923|454242402|FG001|Overall Study|Lost to Follow-up|0|||
126260254|NCT02093923|454242403|FG002|Overall Study|Lost to Follow-up|0|||
126260255|NCT02093923|454242404|FG003|Overall Study|Lost to Follow-up|1|||
126260256|NCT02093923|454242405|FG004|Overall Study|Lost to Follow-up|0|||
126260257|NCT02093923|454242401|FG000|Overall Study|Screen failure after randomization|0|||
126260258|NCT02093923|454242402|FG001|Overall Study|Screen failure after randomization|0|||
126260259|NCT02093923|454242403|FG002|Overall Study|Screen failure after randomization|0|||
126260260|NCT02093923|454242404|FG003|Overall Study|Screen failure after randomization|1|||
126260261|NCT02093923|454242405|FG004|Overall Study|Screen failure after randomization|0|||
126260262|NCT00248170|454242406|FG000|Overall Study|Withdrawal by Subject|71|||
126359468|NCT03572218|454607446|FG000|Overall Study|No longer available for study visits|2|||
126359469|NCT03572218|454607447|FG001|Overall Study|No longer available for study visits|1|||
126359470|NCT03572218|454607446|FG000|Overall Study|No longer interested|1|||
126359471|NCT03572218|454607447|FG001|Overall Study|No longer interested|2|||
126359472|NCT00286455|454607448|FG000|Overall Study|Hyperglycemia rescue|19|||
126359473|NCT00286455|454607449|FG001|Overall Study|Hyperglycemia rescue|13|||
126359474|NCT00286455|454607450|FG002|Overall Study|Hyperglycemia rescue|10|||
126359475|NCT00286455|454607448|FG000|Overall Study|Adverse Event|1|||
126359476|NCT00286455|454607449|FG001|Overall Study|Adverse Event|3|||
126359477|NCT00286455|454607450|FG002|Overall Study|Adverse Event|2|||
126359478|NCT00286455|454607448|FG000|Overall Study|Lost to Follow-up|0|||
126359479|NCT00286455|454607449|FG001|Overall Study|Lost to Follow-up|3|||
126359480|NCT00286455|454607450|FG002|Overall Study|Lost to Follow-up|3|||
126359481|NCT00286455|454607448|FG000|Overall Study|Physician Decision|3|||
126359482|NCT00286455|454607449|FG001|Overall Study|Physician Decision|0|||
126359483|NCT00286455|454607450|FG002|Overall Study|Physician Decision|2|||
126359484|NCT00286455|454607448|FG000|Overall Study|Protocol Violation|1|||
126359485|NCT00286455|454607449|FG001|Overall Study|Protocol Violation|1|||
126359486|NCT00286455|454607450|FG002|Overall Study|Protocol Violation|0|||
126359487|NCT00286455|454607448|FG000|Overall Study|Participant Non-compliance|1|||
126359488|NCT00286455|454607449|FG001|Overall Study|Participant Non-compliance|0|||
126359489|NCT00286455|454607450|FG002|Overall Study|Participant Non-compliance|0|||
126359490|NCT00286455|454607448|FG000|Overall Study|Withdrawal by Subject|0|||
126359491|NCT00286455|454607449|FG001|Overall Study|Withdrawal by Subject|8|||
126359492|NCT00286455|454607450|FG002|Overall Study|Withdrawal by Subject|7|||
126359493|NCT04359680|454608977|FG000|Overall Study|Withdrawal by Subject|29|||
126359494|NCT04359680|454608978|FG001|Overall Study|Withdrawal by Subject|24|||
126359495|NCT04359680|454608977|FG000|Overall Study|Adverse Event|6|||
126359496|NCT04359680|454608978|FG001|Overall Study|Adverse Event|2|||
126359497|NCT04359680|454608977|FG000|Overall Study|Lost to Follow-up|56|||
126359498|NCT04359680|454608978|FG001|Overall Study|Lost to Follow-up|59|||
126359499|NCT04359680|454608977|FG000|Overall Study|Protocol Violation|3|||
126359500|NCT04359680|454608978|FG001|Overall Study|Protocol Violation|5|||
126359501|NCT04359680|454608977|FG000|Overall Study|Physician Decision|1|||
126359502|NCT04359680|454608978|FG001|Overall Study|Physician Decision|1|||
126359503|NCT04359680|454608977|FG000|Overall Study|Sponsor Decision|0|||
126359504|NCT04359680|454608978|FG001|Overall Study|Sponsor Decision|1|||
126359505|NCT03931785|454608980|FG000|Overall Study|Lost to Follow-up|4|||
126359506|NCT03931785|454608981|FG001|Overall Study|Lost to Follow-up|1|||
126359507|NCT03931785|454608982|FG002|Overall Study|Lost to Follow-up|4|||
126359508|NCT03931785|454608983|FG003|Overall Study|Lost to Follow-up|3|||
126359509|NCT03931785|454608980|FG000|Overall Study|Adverse Event|1|||
126359510|NCT03931785|454608981|FG001|Overall Study|Adverse Event|0|||
126359511|NCT03931785|454608982|FG002|Overall Study|Adverse Event|3|||
126359512|NCT03931785|454608983|FG003|Overall Study|Adverse Event|4|||
126359513|NCT03931785|454608980|FG000|Overall Study|Protocol Violation|0|||
126359514|NCT03931785|454608981|FG001|Overall Study|Protocol Violation|1|||
126359515|NCT03931785|454608982|FG002|Overall Study|Protocol Violation|0|||
126359516|NCT03931785|454608983|FG003|Overall Study|Protocol Violation|0|||
126359517|NCT03931785|454608980|FG000|Overall Study|Noncompliance With Study drug|0|||
126359518|NCT03931785|454608981|FG001|Overall Study|Noncompliance With Study drug|1|||
126546782|NCT02254408|455296041|FG000|Overall Study|Lost to Follow-up|1|||
126451658|NCT01379508|454954628|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
126451659|NCT01379508|454954629|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
126451660|NCT01379508|454954626|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
126451661|NCT01379508|454954627|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
126451662|NCT01379508|454954628|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
126451663|NCT01379508|454954629|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
126451664|NCT01379508|454954626|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
126451665|NCT01379508|454954627|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
126699676|NCT02626338|455851268|FG000|Overall Study|Lack of Efficacy|3|||
126699677|NCT02626338|455851269|FG001|Overall Study|Lack of Efficacy|2|||
126699678|NCT02626338|455851270|FG002|Overall Study|Lack of Efficacy|0|||
126699679|NCT01901224|455851271|FG000|Overall Study|study was not funded and terminated|2|||
126699680|NCT00450580|455851272|FG000|Overall Study|Adverse Event|5|||
126699681|NCT00450580|455851273|FG001|Overall Study|Adverse Event|7|||
126699682|NCT00450580|455851272|FG000|Overall Study|Lost to Follow-up|4|||
126699683|NCT00450580|455851273|FG001|Overall Study|Lost to Follow-up|5|||
126699684|NCT00450580|455851272|FG000|Overall Study|Withdrawal by Subject|2|||
126699685|NCT00450580|455851273|FG001|Overall Study|Withdrawal by Subject|2|||
126699686|NCT00450580|455851272|FG000|Overall Study|Protocol Violation|1|||
126699687|NCT00450580|455851273|FG001|Overall Study|Protocol Violation|1|||
126699688|NCT00450580|455851272|FG000|Overall Study|Protocol-defined virologic failure|1|||
126699689|NCT00450580|455851273|FG001|Overall Study|Protocol-defined virologic failure|0|||
126699690|NCT00450580|455851272|FG000|Overall Study|Could not comply with scheduled visits|1|||
126699691|NCT00450580|455851273|FG001|Overall Study|Could not comply with scheduled visits|0|||
126699692|NCT00450580|455851272|FG000|Overall Study|Patient went to Brazil|1|||
126699693|NCT00450580|455851273|FG001|Overall Study|Patient went to Brazil|0|||
126699694|NCT00450580|455851272|FG000|Overall Study|Patient could not swallow Norvir|1|||
126699695|NCT00450580|455851273|FG001|Overall Study|Patient could not swallow Norvir|0|||
126699696|NCT00450580|455851272|FG000|Overall Study|Withdrawal due to pregnancy|0|||
126699697|NCT00450580|455851273|FG001|Overall Study|Withdrawal due to pregnancy|1|||
126699698|NCT00393718|455851274|FG000|Overall Study|Adverse Event|20|||
126699699|NCT00393718|455851275|FG001|Overall Study|Adverse Event|8|||
126699700|NCT00393718|455851274|FG000|Overall Study|Protocol Violation|1|||
126699701|NCT00393718|455851275|FG001|Overall Study|Protocol Violation|2|||
126699702|NCT00393718|455851274|FG000|Overall Study|Lack of Efficacy|10|||
126699703|NCT00393718|455851275|FG001|Overall Study|Lack of Efficacy|9|||
126699704|NCT00393718|455851274|FG000|Overall Study|Hypoglycaemia|3|||
126699705|NCT00393718|455851275|FG001|Overall Study|Hypoglycaemia|2|||
126699706|NCT00393718|455851274|FG000|Overall Study|Subject decision|5|||
126699707|NCT00393718|455851275|FG001|Overall Study|Subject decision|0|||
126699708|NCT00393718|455851274|FG000|Overall Study|Withdrawal of consent|2|||
126699709|NCT00393718|455851275|FG001|Overall Study|Withdrawal of consent|1|||
126699710|NCT00393718|455851274|FG000|Overall Study|Missed measurement|1|||
126699711|NCT00393718|455851275|FG001|Overall Study|Missed measurement|0|||
126699712|NCT00393718|455851274|FG000|Overall Study|Move|1|||
126699713|NCT00393718|455851275|FG001|Overall Study|Move|0|||
126699714|NCT04938648|455851276|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
126699715|NCT04938648|455851277|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
126699716|NCT04938648|455851276|FG000|Overall Study|Patient too ill|0|||
126699717|NCT04938648|455851277|FG001|Overall Study|Patient too ill|1|||
126699718|NCT04938648|455851276|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
126699719|NCT04938648|455851277|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
126699720|NCT04938648|455851276|FG000|Overall Study|Patient did not have memory problems|1|||
126699721|NCT04938648|455851277|FG001|Overall Study|Patient did not have memory problems|1|||
126260263|NCT00248170|454242407|FG001|Overall Study|Withdrawal by Subject|79|||
126260264|NCT00248170|454242406|FG000|Overall Study|Protocol Violation|35|||
126260265|NCT00248170|454242407|FG001|Overall Study|Protocol Violation|30|||
126260266|NCT00248170|454242406|FG000|Overall Study|Lost to Follow-up|28|||
126451666|NCT01379508|454954628|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
126699722|NCT04938648|455851276|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
126699723|NCT04938648|455851277|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
126699724|NCT04938648|455851276|FG000|Overall Study|Care partner could not be reached|0|||
126699725|NCT04938648|455851277|FG001|Overall Study|Care partner could not be reached|1|||
126260267|NCT00248170|454242407|FG001|Overall Study|Lost to Follow-up|35|||
126451667|NCT01379508|454954629|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
126451668|NCT01379508|454954626|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
126699726|NCT04938648|455851276|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
126699727|NCT04938648|455851277|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
126699728|NCT04938648|455851276|FG000|Overall Study|Withdrawal by Subject|2|||
126699729|NCT04938648|455851277|FG001|Overall Study|Withdrawal by Subject|1|||
126260268|NCT00248170|454242406|FG000|Overall Study|Disease progression|196|||
126699730|NCT03293654|455851278|FG000|Overall Study|Lost to Follow-up|0|||
126699731|NCT03293654|455851279|FG001|Overall Study|Lost to Follow-up|1|||
126699732|NCT03293654|455851280|FG002|Overall Study|Lost to Follow-up|0|||
126260269|NCT00248170|454242407|FG001|Overall Study|Disease progression|216|||
126260270|NCT00248170|454242406|FG000|Overall Study|Death|28|||
126260271|NCT00248170|454242407|FG001|Overall Study|Death|47|||
126260272|NCT00248170|454242406|FG000|Overall Study|Adverse Event|311|||
126260273|NCT00248170|454242407|FG001|Overall Study|Adverse Event|296|||
126260274|NCT00248170|454242406|FG000|Overall Study|Administrative problems|22|||
126260275|NCT00248170|454242407|FG001|Overall Study|Administrative problems|25|||
126260276|NCT00248170|454242406|FG000|Overall Study|Abnormal test procedure(s) result|49|||
126260277|NCT00248170|454242407|FG001|Overall Study|Abnormal test procedure(s) result|61|||
126260278|NCT00248170|454242406|FG000|Overall Study|Abnormal laboratory values|4|||
126260279|NCT00248170|454242407|FG001|Overall Study|Abnormal laboratory values|0|||
126260280|NCT00248170|454242406|FG000|Overall Study|Protocol deviation|17|||
126260281|NCT00248170|454242407|FG001|Overall Study|Protocol deviation|19|||
126260282|NCT01557582|454242408|FG000|Overall Study|Protocol Violation|4|||
126260283|NCT01557582|454242408|FG000|Overall Study|Operator error|2|||
126260284|NCT02843659|454242409|FG000|Overall Study|Subject Withdrew Consent|0|||
126260285|NCT02843659|454242410|FG001|Overall Study|Subject Withdrew Consent|0|||
126260286|NCT02843659|454242411|FG002|Overall Study|Subject Withdrew Consent|1|||
126260287|NCT02843659|454242409|FG000|Overall Study|Administrative Reason by Sponsor|4|||
126260288|NCT02843659|454242410|FG001|Overall Study|Administrative Reason by Sponsor|5|||
126260289|NCT02843659|454242411|FG002|Overall Study|Administrative Reason by Sponsor|4|||
126260290|NCT02843659|454242409|FG000|Overall Study|Adverse Event|0|||
126260291|NCT02843659|454242410|FG001|Overall Study|Adverse Event|1|||
126260292|NCT02843659|454242411|FG002|Overall Study|Adverse Event|0|||
126260293|NCT02413294|454242415|FG000|Overall Study|Withdrawal by Subject|1|||
126260294|NCT01253317|454242422|FG000|Overall Study|Adverse Event|2|||
126260295|NCT01619579|454245373|FG000|Overall Study|Withdrawal by Subject|0|||
126260296|NCT01619579|454245374|FG001|Overall Study|Withdrawal by Subject|3|||
126260297|NCT02012452|454245378|FG000|Overall Study|Lost to Follow-up|2|||
126260298|NCT02012452|454245379|FG001|Overall Study|Lost to Follow-up|1|||
126260299|NCT02012452|454245378|FG000|Overall Study|Withdrawal by Subject|4|||
126260300|NCT02012452|454245379|FG001|Overall Study|Withdrawal by Subject|0|||
126260301|NCT02688387|454245380|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260302|NCT02688387|454245381|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260303|NCT02688387|454245382|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
126260304|NCT02688387|454245383|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260305|NCT02688387|454245384|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260306|NCT02688387|454245385|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260307|NCT02688387|454245386|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260308|NCT02688387|454245387|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260309|NCT02688387|454245388|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260310|NCT02688387|454245389|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260311|NCT02688387|454245390|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260312|NCT02688387|454245391|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260313|NCT02688387|454245392|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260314|NCT02688387|454245393|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260315|NCT02688387|454245394|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260316|NCT02688387|454245395|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260317|NCT02688387|454245396|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260318|NCT02688387|454245397|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260319|NCT02688387|454245398|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260320|NCT02688387|454245399|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260321|NCT02688387|454245400|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260322|NCT02688387|454245401|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
126260323|NCT02688387|454245380|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260324|NCT02688387|454245381|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260325|NCT02688387|454245382|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260326|NCT02688387|454245383|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
126260327|NCT02688387|454245384|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260328|NCT02688387|454245385|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260329|NCT02688387|454245386|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260330|NCT02688387|454245387|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260331|NCT02688387|454245388|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126451669|NCT01379508|454954627|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
126451670|NCT01379508|454954628|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
126260332|NCT02688387|454245389|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260333|NCT02688387|454245390|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260334|NCT02688387|454245391|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260335|NCT02688387|454245392|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260336|NCT02688387|454245393|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260337|NCT02688387|454245394|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260338|NCT02688387|454245395|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126451671|NCT01379508|454954629|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
126451672|NCT01457352|454954630|FG000|Period 1|Adverse Event|2|||
126260339|NCT02688387|454245396|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260340|NCT02688387|454245397|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126451673|NCT01457352|454954631|FG001|Period 1|Adverse Event|0|||
126451674|NCT01457352|454954630|FG000|Period 1|Withdrawal by Subject|2|||
126451675|NCT01457352|454954631|FG001|Period 1|Withdrawal by Subject|0|||
126451676|NCT01457352|454954630|FG000|Period 1|Physician Decision|2|||
126451677|NCT01457352|454954631|FG001|Period 1|Physician Decision|0|||
126451678|NCT01457352|454954630|FG000|Period 1|MS related disease progression|1|||
126451679|NCT01457352|454954631|FG001|Period 1|MS related disease progression|0|||
126451680|NCT01457352|454954630|FG000|Period 1|Withdrawn|1|||
126451681|NCT01457352|454954631|FG001|Period 1|Withdrawn|0|||
126451682|NCT01457352|454954630|FG000|Period 1|withdrew per sponsor|1|||
126451683|NCT01457352|454954631|FG001|Period 1|withdrew per sponsor|0|||
126451684|NCT01457352|454954630|FG000|Period 1|Protocol Violation|4|||
126451685|NCT01457352|454954631|FG001|Period 1|Protocol Violation|0|||
126451686|NCT01457352|454954630|FG000|Period 1|Did not meet eligibility criteria|3|||
126451687|NCT01457352|454954631|FG001|Period 1|Did not meet eligibility criteria|0|||
126260341|NCT02688387|454245398|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260342|NCT02688387|454245399|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260343|NCT02688387|454245400|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260344|NCT02688387|454245401|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260345|NCT02688387|454245380|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260346|NCT02688387|454245381|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
126260347|NCT02688387|454245382|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260348|NCT02688387|454245383|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260349|NCT02688387|454245384|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260350|NCT02688387|454245385|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260351|NCT02688387|454245386|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260352|NCT02688387|454245387|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260353|NCT02688387|454245388|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260354|NCT02688387|454245389|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260355|NCT02688387|454245390|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260356|NCT02688387|454245391|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260357|NCT02688387|454245392|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260358|NCT02688387|454245393|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260359|NCT02688387|454245394|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260360|NCT02688387|454245395|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260361|NCT02688387|454245396|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260362|NCT02688387|454245397|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260363|NCT02688387|454245398|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260364|NCT02688387|454245399|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260365|NCT02688387|454245400|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260366|NCT02688387|454245401|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
126260367|NCT02688387|454245380|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260368|NCT02688387|454245381|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260369|NCT02688387|454245382|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
126260370|NCT02688387|454245383|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260371|NCT02688387|454245384|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
126451688|NCT01457352|454954630|FG000|Period 2|Withdrawal by Subject|23|||
126451689|NCT01457352|454954631|FG001|Period 2|Withdrawal by Subject|0|||
126451690|NCT01457352|454954630|FG000|Period 2|Adverse Event|22|||
126451691|NCT01457352|454954631|FG001|Period 2|Adverse Event|0|||
126451692|NCT01457352|454954630|FG000|Period 2|no analysis|10|||
126451693|NCT01457352|454954631|FG001|Period 2|no analysis|0|||
126451694|NCT01457352|454954630|FG000|Period 2|Lack of Efficacy|8|||
126451695|NCT01457352|454954631|FG001|Period 2|Lack of Efficacy|0|||
126451696|NCT01457352|454954630|FG000|Period 2|Protocol Violation|4|||
126451697|NCT01457352|454954631|FG001|Period 2|Protocol Violation|0|||
126451698|NCT01457352|454954630|FG000|Period 2|Sponsor's withdrawal|7|||
126451699|NCT01457352|454954631|FG001|Period 2|Sponsor's withdrawal|0|||
126451700|NCT01457352|454954630|FG000|Period 2|Lost to Follow-up|1|||
126451701|NCT01457352|454954631|FG001|Period 2|Lost to Follow-up|0|||
126451702|NCT01457352|454954630|FG000|Period 2|dose change|1|||
126451703|NCT01457352|454954631|FG001|Period 2|dose change|0|||
126451704|NCT01457352|454954630|FG000|Period 2|Physician Decision|1|||
126451705|NCT01457352|454954631|FG001|Period 2|Physician Decision|0|||
126451706|NCT01457352|454954630|FG000|Period 2|Did not meet eligibility criteria|3|||
126546783|NCT02254408|455296042|FG001|Overall Study|Lost to Follow-up|0|||
126546784|NCT02914184|455296043|FG000|Overall Study|Lost to Follow-up|7|||
126546785|NCT02914184|455296044|FG001|Overall Study|Lost to Follow-up|10|||
126546786|NCT02914184|455296045|FG002|Overall Study|Lost to Follow-up|8|||
126546787|NCT02914184|455296046|FG003|Overall Study|Lost to Follow-up|7|||
126763353|NCT02594384|456086776|FG001|Overall Study|Physician Decision|0|||
126763354|NCT02594384|456086777|FG002|Overall Study|Physician Decision|0|||
126763355|NCT02594384|456086778|FG003|Overall Study|Physician Decision|0|||
126763356|NCT02594384|456086779|FG004|Overall Study|Physician Decision|0|||
126763357|NCT02594384|456086780|FG005|Overall Study|Physician Decision|1|||
126763358|NCT02594384|456086781|FG006|Overall Study|Physician Decision|2|||
126763359|NCT02594384|456086782|FG007|Overall Study|Physician Decision|0|||
126763360|NCT02594384|456086775|FG000|Overall Study|Progressive Leukocytosis|0|||
126763361|NCT02594384|456086776|FG001|Overall Study|Progressive Leukocytosis|0|||
126763362|NCT02594384|456086777|FG002|Overall Study|Progressive Leukocytosis|1|||
126763363|NCT02594384|456086778|FG003|Overall Study|Progressive Leukocytosis|0|||
126763364|NCT02594384|456086779|FG004|Overall Study|Progressive Leukocytosis|0|||
126763365|NCT02594384|456086780|FG005|Overall Study|Progressive Leukocytosis|0|||
126763366|NCT02594384|456086781|FG006|Overall Study|Progressive Leukocytosis|0|||
126763367|NCT02594384|456086782|FG007|Overall Study|Progressive Leukocytosis|0|||
126763368|NCT02594384|456086775|FG000|Overall Study|Lack of Efficacy|0|||
126546788|NCT02914184|455296043|FG000|Overall Study|Withdrawal by Subject|4|||
126546789|NCT02914184|455296044|FG001|Overall Study|Withdrawal by Subject|2|||
126546790|NCT02914184|455296045|FG002|Overall Study|Withdrawal by Subject|7|||
126546791|NCT02914184|455296046|FG003|Overall Study|Withdrawal by Subject|3|||
126546792|NCT02914184|455296043|FG000|Overall Study|Other|1|||
126546793|NCT02914184|455296044|FG001|Overall Study|Other|0|||
126546794|NCT02914184|455296045|FG002|Overall Study|Other|0|||
126546795|NCT02914184|455296046|FG003|Overall Study|Other|0|||
126546796|NCT02914184|455296043|FG000|Overall Study|Migrated/moved from the study area|2|||
126546797|NCT02914184|455296044|FG001|Overall Study|Migrated/moved from the study area|1|||
126546798|NCT02914184|455296045|FG002|Overall Study|Migrated/moved from the study area|2|||
126546799|NCT02914184|455296046|FG003|Overall Study|Migrated/moved from the study area|1|||
126546800|NCT00798174|455296047|FG000|Overall Study|inability to implant azygos coil|3|||
126546801|NCT00798174|455296048|FG001|Overall Study|inability to implant azygos coil|3|||
126546802|NCT00798174|455296047|FG000|Overall Study|Inability to sedate for DFT testing|1|||
126546803|NCT00798174|455296048|FG001|Overall Study|Inability to sedate for DFT testing|0|||
126546804|NCT01478113|455296049|FG000|Overall Study|Withdrawal by Subject|0|||
126546805|NCT01478113|455296050|FG001|Overall Study|Withdrawal by Subject|1|||
126546806|NCT01478113|455296049|FG000|Overall Study|Physician Decision|1|||
126546807|NCT01478113|455296050|FG001|Overall Study|Physician Decision|0|||
126546808|NCT03093428|455296056|FG000|Overall Study|Not eligible for treatment|2|||
126546809|NCT03093428|455296057|FG001|Overall Study|Not eligible for treatment|1|||
126546810|NCT03093428|455296056|FG000|Overall Study|Progression|14|||
126546811|NCT03093428|455296057|FG001|Overall Study|Progression|4|||
126546812|NCT03093428|455296056|FG000|Overall Study|Death|1|||
126546813|NCT03093428|455296057|FG001|Overall Study|Death|0|||
126546814|NCT03093428|455296056|FG000|Overall Study|Adverse Event|1|||
126546815|NCT03093428|455296057|FG001|Overall Study|Adverse Event|0|||
126546816|NCT03093428|455296056|FG000|Overall Study|Withdrawal by Subject|1|||
126763369|NCT02594384|456086776|FG001|Overall Study|Lack of Efficacy|0|||
126763370|NCT02594384|456086777|FG002|Overall Study|Lack of Efficacy|0|||
126763371|NCT02594384|456086778|FG003|Overall Study|Lack of Efficacy|0|||
126763372|NCT02594384|456086779|FG004|Overall Study|Lack of Efficacy|1|||
126763373|NCT02594384|456086780|FG005|Overall Study|Lack of Efficacy|0|||
126763374|NCT02594384|456086781|FG006|Overall Study|Lack of Efficacy|0|||
126763375|NCT02594384|456086782|FG007|Overall Study|Lack of Efficacy|0|||
126763376|NCT02594384|456086775|FG000|Overall Study|Substantial noncompliance|0|||
126763377|NCT02594384|456086776|FG001|Overall Study|Substantial noncompliance|0|||
126763378|NCT02594384|456086777|FG002|Overall Study|Substantial noncompliance|0|||
126763379|NCT02594384|456086778|FG003|Overall Study|Substantial noncompliance|0|||
126763380|NCT02594384|456086779|FG004|Overall Study|Substantial noncompliance|0|||
126763381|NCT02594384|456086780|FG005|Overall Study|Substantial noncompliance|0|||
126763382|NCT02594384|456086781|FG006|Overall Study|Substantial noncompliance|1|||
126763383|NCT02594384|456086782|FG007|Overall Study|Substantial noncompliance|0|||
126763384|NCT03919669|456086785|FG000|Overall Study|Withdrawal by Subject|1|||
126763385|NCT03919669|456086786|FG001|Overall Study|Withdrawal by Subject|0|||
126763386|NCT03919669|456086787|FG002|Overall Study|Withdrawal by Subject|0|||
126763387|NCT04964960|456086788|FG000|Overall Study|Withdrawal by Subject|1|||
126546817|NCT03093428|455296057|FG001|Overall Study|Withdrawal by Subject|1|||
126546818|NCT03980184|455296058|FG000|Overall Study|Dropped out before treatment|2|||
126546819|NCT03980184|455296059|FG001|Overall Study|Dropped out before treatment|2|||
126763388|NCT02319642|456086789|FG000|Overall Study|Adverse Event|2|||
126546820|NCT03980184|455296058|FG000|Overall Study|Lost to Follow-up|11|||
126546821|NCT03980184|455296059|FG001|Overall Study|Lost to Follow-up|13|||
126546822|NCT01118455|455296061|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
126763389|NCT02319642|456086790|FG001|Overall Study|Adverse Event|4|||
126763390|NCT02319642|456086789|FG000|Overall Study|Lack of Efficacy|1|||
126763391|NCT02319642|456086790|FG001|Overall Study|Lack of Efficacy|1|||
126763392|NCT02319642|456086789|FG000|Overall Study|Withdrawal by Subject|1|||
126763393|NCT02319642|456086790|FG001|Overall Study|Withdrawal by Subject|1|||
126763394|NCT00483119|456086791|FG000|Overall Study|Adverse Event|0|||
126763395|NCT00483119|456086792|FG001|Overall Study|Adverse Event|1|||
126763396|NCT00483119|456086791|FG000|Overall Study|Physician Decision|1|||
126451707|NCT01457352|454954631|FG001|Period 2|Did not meet eligibility criteria|0|||
126451708|NCT01457352|454954630|FG000|Period 3|Adverse Event|1|||
126260372|NCT02688387|454245385|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260373|NCT02688387|454245386|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260374|NCT02688387|454245387|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260375|NCT02688387|454245388|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260376|NCT02688387|454245389|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260377|NCT02688387|454245390|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260378|NCT02688387|454245391|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260379|NCT02688387|454245392|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260380|NCT02688387|454245393|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260381|NCT02688387|454245394|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260382|NCT02688387|454245395|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260383|NCT02688387|454245396|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260384|NCT02688387|454245397|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260385|NCT02688387|454245398|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260386|NCT02688387|454245399|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260387|NCT02688387|454245400|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260388|NCT02688387|454245401|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
126260389|NCT02688387|454245380|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
126260390|NCT02688387|454245381|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260391|NCT02688387|454245382|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260392|NCT02688387|454245383|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260393|NCT02688387|454245384|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260394|NCT02688387|454245385|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260395|NCT02688387|454245386|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260396|NCT02688387|454245387|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260397|NCT02688387|454245388|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260398|NCT02688387|454245389|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260399|NCT02688387|454245390|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260400|NCT02688387|454245391|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260401|NCT02688387|454245392|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260402|NCT02688387|454245393|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260403|NCT02688387|454245394|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260404|NCT02688387|454245395|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260405|NCT02688387|454245396|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260406|NCT02688387|454245397|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260407|NCT02688387|454245398|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126451709|NCT01457352|454954631|FG001|Period 3|Adverse Event|1|||
126451710|NCT01457352|454954630|FG000|Period 3|Withdrawal by Subject|0|||
126451711|NCT01457352|454954631|FG001|Period 3|Withdrawal by Subject|2|||
126451712|NCT01457352|454954630|FG000|Period 3|incorrect treatment|0|||
126451713|NCT01457352|454954631|FG001|Period 3|incorrect treatment|1|||
126451714|NCT01457352|454954630|FG000|Period 3|Sponsor's withdrawal|0|||
126451715|NCT01457352|454954631|FG001|Period 3|Sponsor's withdrawal|1|||
126451716|NCT02537015|454954632|FG000|Overall Study|Adverse Event|3|||
126451717|NCT02537015|454954632|FG000|Overall Study|Withdrawal by Subject|2|||
126451718|NCT02537015|454954632|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126546823|NCT01118455|455296062|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
126763397|NCT00483119|456086792|FG001|Overall Study|Physician Decision|0|||
126763398|NCT04668066|456086793|FG000|Part 1: Treatment Phase|Adverse Event|0|||
126763399|NCT04668066|456086794|FG001|Part 1: Treatment Phase|Adverse Event|0|||
126763400|NCT04668066|456086795|FG002|Part 1: Treatment Phase|Adverse Event|0|||
126763401|NCT04668066|456086796|FG003|Part 1: Treatment Phase|Adverse Event|0|||
126763402|NCT04668066|456086797|FG004|Part 1: Treatment Phase|Adverse Event|0|||
126763403|NCT04668066|456086798|FG005|Part 1: Treatment Phase|Adverse Event|0|||
126260408|NCT02688387|454245399|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260409|NCT02688387|454245400|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126260410|NCT02688387|454245401|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
126451719|NCT04174365|454954633|FG000|Overall Study|Lost to Follow-up|1|||
126451720|NCT04174365|454954634|FG001|Overall Study|Lost to Follow-up|2|||
126763404|NCT04668066|456086799|FG006|Part 1: Treatment Phase|Adverse Event|0|||
126260411|NCT02688387|454245380|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260412|NCT02688387|454245381|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260413|NCT02688387|454245382|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126763405|NCT04668066|456086800|FG007|Part 1: Treatment Phase|Adverse Event|0|||
126763406|NCT04668066|456086801|FG008|Part 1: Treatment Phase|Adverse Event|0|||
126260414|NCT02688387|454245383|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260415|NCT02688387|454245384|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260416|NCT02688387|454245385|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260417|NCT02688387|454245386|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260418|NCT02688387|454245387|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260419|NCT02688387|454245388|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260420|NCT02688387|454245389|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260421|NCT02688387|454245390|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
126260422|NCT02688387|454245391|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260423|NCT02688387|454245392|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260424|NCT02688387|454245393|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260425|NCT02688387|454245394|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260426|NCT02688387|454245395|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260427|NCT02688387|454245396|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260428|NCT02688387|454245397|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260429|NCT02688387|454245398|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260430|NCT02688387|454245399|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260431|NCT02688387|454245400|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126546824|NCT03327402|455296063|FG000|Overall Study|Withdrawal by Subject|1|||
126763407|NCT04668066|456086802|FG009|Part 1: Treatment Phase|Adverse Event|0|||
126763408|NCT04668066|456086803|FG010|Part 1: Treatment Phase|Adverse Event|0|||
126763409|NCT04668066|456086804|FG011|Part 1: Treatment Phase|Adverse Event|1|||
126763410|NCT04668066|456086805|FG012|Part 1: Treatment Phase|Adverse Event|1|||
126763411|NCT04668066|456086806|FG013|Part 1: Treatment Phase|Adverse Event|0|||
126763412|NCT04668066|456086807|FG014|Part 1: Treatment Phase|Adverse Event|0|||
126763413|NCT04668066|456086808|FG015|Part 1: Treatment Phase|Adverse Event|0|||
126763414|NCT04668066|456086809|FG016|Part 1: Treatment Phase|Adverse Event|0|||
126763415|NCT04668066|456086810|FG017|Part 1: Treatment Phase|Adverse Event|0|||
126763416|NCT04668066|456086811|FG018|Part 1: Treatment Phase|Adverse Event|0|||
126763417|NCT04668066|456086793|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763418|NCT04668066|456086794|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763419|NCT04668066|456086795|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
126763420|NCT04668066|456086796|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763421|NCT04668066|456086797|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763422|NCT04668066|456086798|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763423|NCT04668066|456086799|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763424|NCT04668066|456086800|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763425|NCT04668066|456086801|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763426|NCT04668066|456086802|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763427|NCT04668066|456086803|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763428|NCT04668066|456086804|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763429|NCT04668066|456086805|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763430|NCT04668066|456086806|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763431|NCT04668066|456086807|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763432|NCT04668066|456086808|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763433|NCT04668066|456086809|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763434|NCT04668066|456086810|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763435|NCT04668066|456086811|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
126763436|NCT04668066|456086793|FG000|Part 1: Treatment Phase|Other|0|||
126763437|NCT04668066|456086794|FG001|Part 1: Treatment Phase|Other|0|||
126763438|NCT04668066|456086795|FG002|Part 1: Treatment Phase|Other|0|||
126763439|NCT04668066|456086796|FG003|Part 1: Treatment Phase|Other|0|||
126763440|NCT04668066|456086797|FG004|Part 1: Treatment Phase|Other|0|||
126763441|NCT04668066|456086798|FG005|Part 1: Treatment Phase|Other|0|||
126763442|NCT04668066|456086799|FG006|Part 1: Treatment Phase|Other|0|||
126763443|NCT04668066|456086800|FG007|Part 1: Treatment Phase|Other|0|||
126763444|NCT04668066|456086801|FG008|Part 1: Treatment Phase|Other|0|||
126763445|NCT04668066|456086802|FG009|Part 1: Treatment Phase|Other|0|||
126763446|NCT04668066|456086803|FG010|Part 1: Treatment Phase|Other|0|||
126260432|NCT02688387|454245401|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
126260433|NCT02688387|454245380|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260434|NCT02688387|454245381|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126763447|NCT04668066|456086804|FG011|Part 1: Treatment Phase|Other|1|||
126260435|NCT02688387|454245382|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260436|NCT02688387|454245383|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126763448|NCT04668066|456086805|FG012|Part 1: Treatment Phase|Other|0|||
126763449|NCT04668066|456086806|FG013|Part 1: Treatment Phase|Other|0|||
126763450|NCT04668066|456086807|FG014|Part 1: Treatment Phase|Other|0|||
126763451|NCT04668066|456086808|FG015|Part 1: Treatment Phase|Other|0|||
126451721|NCT04174365|454954633|FG000|Overall Study|Adverse Event|2|||
126451722|NCT04174365|454954634|FG001|Overall Study|Adverse Event|1|||
126451723|NCT04174365|454954633|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
126451724|NCT04174365|454954634|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
126451725|NCT04174365|454954633|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
126451726|NCT04174365|454954634|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
126451727|NCT04174365|454954633|FG000|Overall Study|Protocol Deviation|1|||
126451728|NCT04174365|454954634|FG001|Overall Study|Protocol Deviation|0|||
126451729|NCT04174365|454954633|FG000|Overall Study|Lack of Efficacy|0|||
126451730|NCT04174365|454954634|FG001|Overall Study|Lack of Efficacy|2|||
126451731|NCT04174365|454954633|FG000|Overall Study|Disease Relapse|1|||
126451732|NCT04174365|454954634|FG001|Overall Study|Disease Relapse|0|||
126451733|NCT04174365|454954633|FG000|Overall Study|Reason Not Specified|0|||
126451734|NCT04174365|454954634|FG001|Overall Study|Reason Not Specified|1|||
126451735|NCT01925131|454957057|FG000|Overall Study|Death|0|||
126451736|NCT01925131|454957058|FG001|Overall Study|Death|0|||
126451737|NCT01925131|454957059|FG002|Overall Study|Death|1|||
126451738|NCT01925131|454957060|FG003|Overall Study|Death|0|||
126451739|NCT01925131|454957061|FG004|Overall Study|Death|0|||
126763452|NCT04668066|456086809|FG016|Part 1: Treatment Phase|Other|0|||
126260437|NCT02688387|454245384|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260438|NCT02688387|454245385|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260439|NCT02688387|454245386|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260440|NCT02688387|454245387|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260441|NCT02688387|454245388|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260442|NCT02688387|454245389|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260443|NCT02688387|454245390|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260444|NCT02688387|454245391|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260445|NCT02688387|454245392|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260446|NCT02688387|454245393|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260447|NCT02688387|454245394|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
126260448|NCT02688387|454245395|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260449|NCT02688387|454245396|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260450|NCT02688387|454245397|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260451|NCT02688387|454245398|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260452|NCT02688387|454245399|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260453|NCT02688387|454245400|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260454|NCT02688387|454245401|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
126260455|NCT02688387|454245380|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260456|NCT02688387|454245381|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260457|NCT02688387|454245382|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260458|NCT02688387|454245383|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260459|NCT02688387|454245384|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260460|NCT02688387|454245385|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260461|NCT02688387|454245386|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260462|NCT02688387|454245387|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260463|NCT02688387|454245388|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260464|NCT02688387|454245389|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260465|NCT02688387|454245390|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260466|NCT02688387|454245391|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260467|NCT02688387|454245392|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260468|NCT02688387|454245393|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260469|NCT02688387|454245394|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260470|NCT02688387|454245395|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260471|NCT02688387|454245396|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260472|NCT02688387|454245397|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260473|NCT02688387|454245398|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260474|NCT02688387|454245399|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126260475|NCT02688387|454245400|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
126451740|NCT01925131|454957062|FG005|Overall Study|Death|0|||
126260476|NCT02688387|454245401|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
126451741|NCT01925131|454957057|FG000|Overall Study|Progression/Relapse|1|||
126451742|NCT01925131|454957058|FG001|Overall Study|Progression/Relapse|1|||
126763453|NCT04668066|456086810|FG017|Part 1: Treatment Phase|Other|0|||
126260477|NCT02688387|454245380|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126451743|NCT01925131|454957059|FG002|Overall Study|Progression/Relapse|4|||
126451744|NCT01925131|454957060|FG003|Overall Study|Progression/Relapse|0|||
126451745|NCT01925131|454957061|FG004|Overall Study|Progression/Relapse|0|||
126451746|NCT01925131|454957062|FG005|Overall Study|Progression/Relapse|1|||
126451747|NCT01925131|454957057|FG000|Overall Study|Patient Refusal|1|||
126451748|NCT01925131|454957058|FG001|Overall Study|Patient Refusal|0|||
126451749|NCT01925131|454957059|FG002|Overall Study|Patient Refusal|0|||
126451750|NCT01925131|454957060|FG003|Overall Study|Patient Refusal|0|||
126451751|NCT01925131|454957061|FG004|Overall Study|Patient Refusal|0|||
126451752|NCT01925131|454957062|FG005|Overall Study|Patient Refusal|0|||
126451753|NCT01925131|454957057|FG000|Overall Study|Adverse Event|0|||
126451754|NCT01925131|454957058|FG001|Overall Study|Adverse Event|0|||
126451755|NCT01925131|454957059|FG002|Overall Study|Adverse Event|2|||
126451756|NCT01925131|454957060|FG003|Overall Study|Adverse Event|0|||
126451757|NCT01925131|454957061|FG004|Overall Study|Adverse Event|1|||
126451758|NCT01925131|454957062|FG005|Overall Study|Adverse Event|3|||
126451759|NCT01925131|454957057|FG000|Overall Study|Other - Not Protocol Specified|3|||
126451760|NCT01925131|454957058|FG001|Overall Study|Other - Not Protocol Specified|1|||
126451761|NCT01925131|454957059|FG002|Overall Study|Other - Not Protocol Specified|2|||
126451762|NCT01925131|454957060|FG003|Overall Study|Other - Not Protocol Specified|5|||
126451763|NCT01925131|454957061|FG004|Overall Study|Other - Not Protocol Specified|10|||
126451764|NCT01925131|454957062|FG005|Overall Study|Other - Not Protocol Specified|6|||
126451765|NCT01696929|454957066|FG000|Overall Study|Physician Decision|1|||
126451766|NCT02522624|454957067|FG000|Overall Study|Technical failure|1|||
126546825|NCT03327402|455296063|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
126546826|NCT03810313|455296064|FG000|Overall Study|Study terminated by sponsor|164|||
126546827|NCT03810313|455296065|FG001|Overall Study|Study terminated by sponsor|159|||
126546828|NCT03810313|455296064|FG000|Overall Study|Subject decision|10|||
126546829|NCT03810313|455296065|FG001|Overall Study|Subject decision|11|||
126546830|NCT03810313|455296064|FG000|Overall Study|Lost to Follow-up|3|||
126546831|NCT03810313|455296065|FG001|Overall Study|Lost to Follow-up|3|||
126546832|NCT03810313|455296064|FG000|Overall Study|Adverse Event|2|||
126546833|NCT03810313|455296065|FG001|Overall Study|Adverse Event|1|||
126260478|NCT02688387|454245381|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260479|NCT02688387|454245382|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260480|NCT02688387|454245383|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260481|NCT02688387|454245384|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260482|NCT02688387|454245385|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260483|NCT02688387|454245386|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260484|NCT02688387|454245387|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260485|NCT02688387|454245388|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260486|NCT02688387|454245389|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260487|NCT02688387|454245390|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260488|NCT02688387|454245391|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260489|NCT02688387|454245392|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260490|NCT02688387|454245393|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260491|NCT02688387|454245394|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260492|NCT02688387|454245395|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260493|NCT02688387|454245396|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260494|NCT02688387|454245397|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260495|NCT02688387|454245398|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
126260496|NCT02688387|454245399|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260497|NCT02688387|454245400|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
126260498|NCT02688387|454245401|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
126260499|NCT02688387|454245380|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126546834|NCT03810313|455296064|FG000|Overall Study|Death|2|||
126260500|NCT02688387|454245381|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260501|NCT02688387|454245382|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126451767|NCT02522624|454957068|FG001|Overall Study|Technical failure|0|||
126451768|NCT02156271|454957069|FG000|Overall Study|Physician Decision|4|||
126451769|NCT02156271|454957070|FG001|Overall Study|Physician Decision|3|||
126451770|NCT00109590|454957071|FG000|Overall Study|Lost to Follow-up|1|||
126260502|NCT02688387|454245383|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260503|NCT02688387|454245384|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260504|NCT02688387|454245385|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260505|NCT02688387|454245386|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260506|NCT02688387|454245387|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260507|NCT02688387|454245388|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260508|NCT02688387|454245389|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260509|NCT02688387|454245390|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260510|NCT02688387|454245391|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260511|NCT02688387|454245392|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260512|NCT02688387|454245393|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260513|NCT02688387|454245394|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126546835|NCT03810313|455296065|FG001|Overall Study|Death|1|||
126546836|NCT03810313|455296064|FG000|Overall Study|Physician Decision|0|||
126546837|NCT03810313|455296065|FG001|Overall Study|Physician Decision|1|||
126546838|NCT03029780|455296066|FG000|Overall Study|Disease Progression|20|||
126260514|NCT02688387|454245395|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126451771|NCT00109590|454957072|FG001|Overall Study|Lost to Follow-up|0|||
126451772|NCT00109590|454957073|FG002|Overall Study|Lost to Follow-up|1|||
126260515|NCT02688387|454245396|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260516|NCT02688387|454245397|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260517|NCT02688387|454245398|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260518|NCT02688387|454245399|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
126260519|NCT02688387|454245400|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260520|NCT02688387|454245401|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
126260521|NCT02938442|454245404|FG000|Overall Study|Death|0|||
126260522|NCT02938442|454245405|FG001|Overall Study|Death|1|||
126451773|NCT00109590|454957071|FG000|Overall Study|Never Started Treatment|1|||
126451774|NCT00109590|454957072|FG001|Overall Study|Never Started Treatment|2|||
126451775|NCT00109590|454957073|FG002|Overall Study|Never Started Treatment|3|||
126451776|NCT02617485|454957091|FG000|Treatment and Observation Period|Adverse Event|9|||
126260523|NCT02938442|454245404|FG000|Overall Study|Lost to Follow-up|0|||
126260524|NCT02938442|454245405|FG001|Overall Study|Lost to Follow-up|1|||
126260525|NCT02938442|454245404|FG000|Overall Study|Physician Decision|0|||
126260526|NCT02938442|454245405|FG001|Overall Study|Physician Decision|1|||
126260527|NCT02938442|454245404|FG000|Overall Study|Withdrawal by Subject|2|||
126260528|NCT02938442|454245405|FG001|Overall Study|Withdrawal by Subject|0|||
126260529|NCT04403399|454245407|FG000|Period 2|Physician Decision|0|||
126260530|NCT04403399|454245408|FG001|Period 2|Physician Decision|1|||
126260531|NCT01606228|454245409|FG000|Overall Study|Lost to Follow-up|20|||
126260532|NCT01606228|454245409|FG000|Overall Study|Withdrawal by Subject|3|||
126260533|NCT01606228|454245409|FG000|Overall Study|Non-compliant|3|||
126260534|NCT01606228|454245409|FG000|Overall Study|Lack of Efficacy|2|||
126260535|NCT01606228|454245409|FG000|Overall Study|Adverse Event|1|||
126260536|NCT00546910|454245410|FG000|Overall Study|Adverse Event|2|||
126260537|NCT00546910|454245411|FG001|Overall Study|Adverse Event|3|||
126260538|NCT00546910|454245410|FG000|Overall Study|Lack of Efficacy|5|||
126260539|NCT00546910|454245411|FG001|Overall Study|Lack of Efficacy|7|||
126260540|NCT00546910|454245410|FG000|Overall Study|Physician Decision|0|||
126260541|NCT00546910|454245411|FG001|Overall Study|Physician Decision|1|||
126260542|NCT00546910|454245410|FG000|Overall Study|Withdrawal by Subject|2|||
126260543|NCT00546910|454245411|FG001|Overall Study|Withdrawal by Subject|0|||
126260544|NCT01115855|454245412|FG000|Overall Study|Adverse Event|16|||
126260545|NCT01115855|454245413|FG001|Overall Study|Adverse Event|18|||
126260546|NCT01115855|454245412|FG000|Overall Study|Death|6|||
126260547|NCT01115855|454245413|FG001|Overall Study|Death|5|||
126260548|NCT01115855|454245412|FG000|Overall Study|Lab Abnormality|1|||
126260549|NCT01115855|454245413|FG001|Overall Study|Lab Abnormality|1|||
126260550|NCT01115855|454245412|FG000|Overall Study|Protocol Violation|0|||
126260551|NCT01115855|454245413|FG001|Overall Study|Protocol Violation|1|||
126260552|NCT01115855|454245412|FG000|Overall Study|Withdrawal by Subject|5|||
126260553|NCT01115855|454245413|FG001|Overall Study|Withdrawal by Subject|5|||
126260554|NCT01115855|454245412|FG000|Overall Study|Other|8|||
126260555|NCT01115855|454245413|FG001|Overall Study|Other|6|||
126260556|NCT01915940|454245415|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
126260557|NCT01915940|454245416|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
126260558|NCT01915940|454245417|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
126260559|NCT01915940|454245415|FG000|Treatment Period|Decision of Participant|0|||
126260560|NCT01915940|454245416|FG001|Treatment Period|Decision of Participant|1|||
126260561|NCT01915940|454245417|FG002|Treatment Period|Decision of Participant|3|||
126260562|NCT01915940|454245415|FG000|Treatment Period|Adverse Event|0|||
126260563|NCT01915940|454245416|FG001|Treatment Period|Adverse Event|9|||
126260564|NCT01915940|454245417|FG002|Treatment Period|Adverse Event|1|||
126260565|NCT01915940|454245415|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
126260566|NCT01915940|454245416|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
126260567|NCT01915940|454245417|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
126260568|NCT02960438|454245418|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
126260569|NCT02960438|454245419|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
126260570|NCT02960438|454245420|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
126260571|NCT02960438|454245421|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
126451777|NCT02617485|454957092|FG001|Treatment and Observation Period|Adverse Event|1|||
126451778|NCT02617485|454957091|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
126260572|NCT02960438|454245418|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
126260573|NCT02960438|454245419|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
126260574|NCT02960438|454245420|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
126260575|NCT02960438|454245421|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
126260576|NCT02960438|454245418|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
126260577|NCT02960438|454245419|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
126260578|NCT02960438|454245420|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
126260579|NCT02960438|454245421|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
126260580|NCT02960438|454245418|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
126260581|NCT02960438|454245419|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
126260582|NCT02960438|454245420|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
126260583|NCT02960438|454245421|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
126260584|NCT02960438|454245418|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
126260585|NCT02960438|454245419|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
126260586|NCT02960438|454245420|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
126260587|NCT02960438|454245421|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
126260588|NCT02960438|454245418|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
126260589|NCT02960438|454245419|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
126260590|NCT02960438|454245420|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
126260591|NCT02960438|454245421|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
126260592|NCT02960438|454245418|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
126260593|NCT02960438|454245419|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
126260594|NCT02960438|454245420|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
126260595|NCT02960438|454245421|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
126260596|NCT02960438|454245418|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
126260597|NCT02960438|454245419|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
126260598|NCT02960438|454245420|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
126260599|NCT02960438|454245421|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
126260600|NCT02960438|454245418|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
126260601|NCT02960438|454245419|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
126260602|NCT02960438|454245420|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
126260603|NCT02960438|454245421|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
126260604|NCT02960438|454245418|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
126260605|NCT02960438|454245419|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
126260606|NCT02960438|454245420|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
126260607|NCT02960438|454245421|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
126260608|NCT02960438|454245418|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
126260609|NCT02960438|454245419|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
126260610|NCT02960438|454245420|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
126260611|NCT02960438|454245421|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
126260612|NCT02960438|454245418|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
126260613|NCT02960438|454245419|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
126260614|NCT02960438|454245420|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
126260615|NCT02960438|454245421|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
126260616|NCT01647711|454245423|FG000|Overall Study|Progressive disease|6|||
126260617|NCT01647711|454245424|FG001|Overall Study|Progressive disease|2|||
126260618|NCT01647711|454245425|FG002|Overall Study|Progressive disease|6|||
126260619|NCT01647711|454245426|FG003|Overall Study|Progressive disease|8|||
126260620|NCT01647711|454245427|FG004|Overall Study|Progressive disease|2|||
126260621|NCT01647711|454245423|FG000|Overall Study|Other adverse event|0|||
126260622|NCT01647711|454245424|FG001|Overall Study|Other adverse event|0|||
126260623|NCT01647711|454245425|FG002|Overall Study|Other adverse event|2|||
126260624|NCT01647711|454245426|FG003|Overall Study|Other adverse event|0|||
126260625|NCT01647711|454245427|FG004|Overall Study|Other adverse event|2|||
126260626|NCT01647711|454245423|FG000|Overall Study|Protocol Violation|0|||
126260627|NCT01647711|454245424|FG001|Overall Study|Protocol Violation|0|||
126260628|NCT01647711|454245425|FG002|Overall Study|Protocol Violation|0|||
126260629|NCT01647711|454245426|FG003|Overall Study|Protocol Violation|0|||
126260630|NCT01647711|454245427|FG004|Overall Study|Protocol Violation|1|||
126260631|NCT01647711|454245423|FG000|Overall Study|Refused to continue taking medication|0|||
126699733|NCT00391976|455851281|FG000|Overall Study|Adverse Event|0|||
126699734|NCT00391976|455851282|FG001|Overall Study|Adverse Event|0|||
126699735|NCT00391976|455851283|FG002|Overall Study|Adverse Event|1|||
126260632|NCT01647711|454245424|FG001|Overall Study|Refused to continue taking medication|0|||
126260633|NCT01647711|454245425|FG002|Overall Study|Refused to continue taking medication|0|||
126260634|NCT01647711|454245426|FG003|Overall Study|Refused to continue taking medication|2|||
126260635|NCT01647711|454245427|FG004|Overall Study|Refused to continue taking medication|1|||
126260636|NCT01647711|454245423|FG000|Overall Study|Other reason not defined|0|||
126260637|NCT01647711|454245424|FG001|Overall Study|Other reason not defined|1|||
126260638|NCT01647711|454245425|FG002|Overall Study|Other reason not defined|1|||
126260639|NCT01647711|454245426|FG003|Overall Study|Other reason not defined|1|||
126260640|NCT01647711|454245427|FG004|Overall Study|Other reason not defined|0|||
126260641|NCT01796964|454245445|FG000|Overall Study|Adverse Event|1|||
126699736|NCT00391976|455851281|FG000|Overall Study|Withdrawal of consent|0|||
126699737|NCT00391976|455851282|FG001|Overall Study|Withdrawal of consent|1|||
126699738|NCT00391976|455851283|FG002|Overall Study|Withdrawal of consent|1|||
126699739|NCT00391976|455851281|FG000|Overall Study|Lost to Follow-up|1|||
126699740|NCT00391976|455851282|FG001|Overall Study|Lost to Follow-up|2|||
126699741|NCT00391976|455851283|FG002|Overall Study|Lost to Follow-up|0|||
126699742|NCT00391976|455851281|FG000|Overall Study|Inappropriate enrollment|1|||
126260642|NCT01796964|454245446|FG001|Overall Study|Adverse Event|1|||
126260643|NCT01796964|454245445|FG000|Overall Study|Death|1|||
126260644|NCT01796964|454245446|FG001|Overall Study|Death|0|||
126260645|NCT01796964|454245445|FG000|Overall Study|Protocol Violation|0|||
126260646|NCT01796964|454245446|FG001|Overall Study|Protocol Violation|1|||
126260647|NCT01796964|454245445|FG000|Overall Study|Withdrawal by Subject|1|||
126260648|NCT01796964|454245446|FG001|Overall Study|Withdrawal by Subject|1|||
126260649|NCT04025684|454245447|FG000|Overall Study|Withdrawal by Subject|1|||
126260650|NCT04025684|454245448|FG001|Overall Study|Withdrawal by Subject|1|||
126260651|NCT04025684|454245449|FG002|Overall Study|Withdrawal by Subject|0|||
126260652|NCT04025684|454245450|FG003|Overall Study|Withdrawal by Subject|0|||
126260653|NCT04025684|454245447|FG000|Overall Study|Multiple reasons|1|||
126260654|NCT04025684|454245448|FG001|Overall Study|Multiple reasons|3|||
126260655|NCT04025684|454245449|FG002|Overall Study|Multiple reasons|0|||
126260656|NCT04025684|454245450|FG003|Overall Study|Multiple reasons|1|||
126260657|NCT01844531|454245451|FG000|Overall Study|Withdrawal by Subject|0|||
126260658|NCT01844531|454245452|FG001|Overall Study|Withdrawal by Subject|1|||
126260659|NCT01844531|454245453|FG002|Overall Study|Withdrawal by Subject|0|||
126260660|NCT01844531|454245454|FG003|Overall Study|Withdrawal by Subject|0|||
126260661|NCT02744755|454245455|FG000|Study Period 1|Protocol Violation|2|||
126260662|NCT02744755|454245456|FG001|Study Period 1|Protocol Violation|1|||
126260663|NCT02744755|454245455|FG000|Study Period 1|not defined|0|||
126260664|NCT02744755|454245456|FG001|Study Period 1|not defined|1|||
126260665|NCT02744755|454245455|FG000|Study Period 1|Pregnancy|1|||
126260666|NCT02744755|454245456|FG001|Study Period 1|Pregnancy|0|||
126260667|NCT02744755|454245455|FG000|Study Period 1|Adverse Event|1|||
126260668|NCT02744755|454245456|FG001|Study Period 1|Adverse Event|1|||
126260669|NCT02744755|454245455|FG000|Study Period 1|Lost to Follow-up|1|||
126260670|NCT02744755|454245456|FG001|Study Period 1|Lost to Follow-up|1|||
126260671|NCT02744755|454245455|FG000|Study Period 1|Lack of Efficacy|1|||
126260672|NCT02744755|454245456|FG001|Study Period 1|Lack of Efficacy|0|||
126260673|NCT02744755|454245455|FG000|Study Period 1|Withdrawal by Subject|8|||
126260674|NCT02744755|454245456|FG001|Study Period 1|Withdrawal by Subject|4|||
126260675|NCT02744755|454245455|FG000|Study Period 2|Adverse Event|5|||
126260676|NCT02744755|454245456|FG001|Study Period 2|Adverse Event|0|||
126260677|NCT02744755|454245455|FG000|Study Period 2|Protocol Violation|1|||
126260678|NCT02744755|454245456|FG001|Study Period 2|Protocol Violation|0|||
126260679|NCT02744755|454245455|FG000|Study Period 2|not defined|3|||
126260680|NCT02744755|454245456|FG001|Study Period 2|not defined|2|||
126260681|NCT02744755|454245455|FG000|Study Period 2|Lost to Follow-up|0|||
126260682|NCT02744755|454245456|FG001|Study Period 2|Lost to Follow-up|2|||
126260683|NCT02744755|454245455|FG000|Study Period 2|Withdrawal by Subject|2|||
126260684|NCT02744755|454245456|FG001|Study Period 2|Withdrawal by Subject|2|||
126260685|NCT02744755|454245455|FG000|Study Period 2|Lack of Efficacy|3|||
126260686|NCT02744755|454245456|FG001|Study Period 2|Lack of Efficacy|2|||
126260687|NCT00089076|454245460|FG000|Overall Study|Alternate Therapy|1|||
126260688|NCT00089076|454245460|FG000|Overall Study|Withdrawal by Subject|2|||
126260689|NCT00089076|454245460|FG000|Overall Study|Progression|7|||
126260690|NCT01009515|454245461|FG000|Overall Study|Withdrawal by Subject|3|||
126260691|NCT00983476|454245466|FG000|Overall Study|Did not receive intervention|17|||
126260692|NCT00983476|454245467|FG001|Overall Study|Did not receive intervention|22|||
126260693|NCT00983476|454245468|FG002|Overall Study|Did not receive intervention|0|||
126260694|NCT01175473|454245470|FG000|Overall Study|Adverse Event|2|||
126260695|NCT01175473|454245471|FG001|Overall Study|Adverse Event|2|||
126260696|NCT02539368|454245474|FG000|Overall Study|Death|4|||
126260697|NCT02539368|454245475|FG001|Overall Study|Death|2|||
126260698|NCT02539368|454245476|FG002|Overall Study|Death|1|||
126699743|NCT00391976|455851282|FG001|Overall Study|Inappropriate enrollment|1|||
126699744|NCT00391976|455851283|FG002|Overall Study|Inappropriate enrollment|0|||
126260699|NCT02539368|454245477|FG003|Overall Study|Death|0|||
126260700|NCT02539368|454245478|FG004|Overall Study|Death|0|||
126260701|NCT02539368|454245474|FG000|Overall Study|Withdrawal by Subject|44|||
126699745|NCT00391976|455851281|FG000|Overall Study|Protocol deviation/violation|4|||
126699746|NCT00391976|455851282|FG001|Overall Study|Protocol deviation/violation|2|||
126699747|NCT00391976|455851283|FG002|Overall Study|Protocol deviation/violation|1|||
126260702|NCT02539368|454245475|FG001|Overall Study|Withdrawal by Subject|35|||
126260703|NCT02539368|454245476|FG002|Overall Study|Withdrawal by Subject|9|||
126260704|NCT02539368|454245477|FG003|Overall Study|Withdrawal by Subject|1|||
126260705|NCT02539368|454245478|FG004|Overall Study|Withdrawal by Subject|3|||
126260706|NCT02539368|454245474|FG000|Overall Study|Physician Decision|49|||
126260707|NCT02539368|454245475|FG001|Overall Study|Physician Decision|15|||
126260708|NCT02539368|454245476|FG002|Overall Study|Physician Decision|7|||
126260709|NCT02539368|454245477|FG003|Overall Study|Physician Decision|0|||
126260710|NCT02539368|454245478|FG004|Overall Study|Physician Decision|2|||
126260711|NCT02539368|454245474|FG000|Overall Study|Lost to Follow-up|96|||
126699748|NCT00391976|455851281|FG000|Overall Study|Recurrence/no eradication of infection|21|||
126699749|NCT00391976|455851282|FG001|Overall Study|Recurrence/no eradication of infection|19|||
126699750|NCT00391976|455851283|FG002|Overall Study|Recurrence/no eradication of infection|0|||
126260712|NCT02539368|454245475|FG001|Overall Study|Lost to Follow-up|21|||
126260713|NCT02539368|454245476|FG002|Overall Study|Lost to Follow-up|16|||
126260714|NCT02539368|454245477|FG003|Overall Study|Lost to Follow-up|4|||
126260715|NCT02539368|454245478|FG004|Overall Study|Lost to Follow-up|3|||
126260716|NCT02539368|454245474|FG000|Overall Study|Adverse Event|44|||
126260717|NCT02539368|454245475|FG001|Overall Study|Adverse Event|5|||
126260718|NCT02539368|454245476|FG002|Overall Study|Adverse Event|9|||
126260719|NCT02539368|454245477|FG003|Overall Study|Adverse Event|0|||
126260720|NCT02539368|454245478|FG004|Overall Study|Adverse Event|3|||
126260721|NCT02539368|454245474|FG000|Overall Study|Participant Non-compliant|13|||
126260722|NCT02539368|454245475|FG001|Overall Study|Participant Non-compliant|2|||
126260723|NCT02539368|454245476|FG002|Overall Study|Participant Non-compliant|1|||
126260724|NCT02539368|454245477|FG003|Overall Study|Participant Non-compliant|1|||
126260725|NCT02539368|454245478|FG004|Overall Study|Participant Non-compliant|0|||
126260726|NCT02539368|454245474|FG000|Overall Study|Other|145|||
126260727|NCT02539368|454245475|FG001|Overall Study|Other|18|||
126260728|NCT02539368|454245476|FG002|Overall Study|Other|24|||
126260729|NCT02539368|454245477|FG003|Overall Study|Other|1|||
126260730|NCT02539368|454245478|FG004|Overall Study|Other|3|||
126260731|NCT02539368|454245474|FG000|Overall Study|Missing|10|||
126260732|NCT02539368|454245475|FG001|Overall Study|Missing|3|||
126260733|NCT02539368|454245476|FG002|Overall Study|Missing|0|||
126260734|NCT02539368|454245477|FG003|Overall Study|Missing|0|||
126260735|NCT02539368|454245478|FG004|Overall Study|Missing|0|||
126260736|NCT03558139|454245481|FG000|Overall Study|Consent Withdrawn|1|||
126260737|NCT03558139|454245482|FG001|Overall Study|Consent Withdrawn|1|||
126260738|NCT03558139|454245483|FG002|Overall Study|Consent Withdrawn|4|||
126260739|NCT03558139|454245481|FG000|Overall Study|Death|5|||
126260740|NCT03558139|454245482|FG001|Overall Study|Death|3|||
126260741|NCT03558139|454245483|FG002|Overall Study|Death|8|||
126260742|NCT03558139|454245481|FG000|Overall Study|Lost to Follow-up|0|||
126260743|NCT03558139|454245482|FG001|Overall Study|Lost to Follow-up|0|||
126260744|NCT03558139|454245483|FG002|Overall Study|Lost to Follow-up|3|||
126260745|NCT03558139|454245481|FG000|Overall Study|Study Ended Per Protocol|0|||
126260746|NCT03558139|454245482|FG001|Overall Study|Study Ended Per Protocol|3|||
126260747|NCT03558139|454245483|FG002|Overall Study|Study Ended Per Protocol|6|||
126260748|NCT02752802|454245484|FG000|Overall Study|Contrast Volume Not Collected|1|||
126260749|NCT02752802|454245485|FG001|Overall Study|Contrast Volume Not Collected|0|||
126260750|NCT02808819|454245486|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
126260751|NCT02808819|454245487|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
126260752|NCT02808819|454245486|FG000|Overall Study|Withdrawal by Subject|10|||
126260753|NCT02808819|454245487|FG001|Overall Study|Withdrawal by Subject|13|||
126260754|NCT02808819|454245486|FG000|Overall Study|Site terminated by sponsor|2|||
126699751|NCT00391976|455851281|FG000|Overall Study|Unable to classify|0|||
126260755|NCT02808819|454245487|FG001|Overall Study|Site terminated by sponsor|0|||
126260756|NCT02808819|454245486|FG000|Overall Study|Pregnancy|1|||
126260757|NCT02808819|454245487|FG001|Overall Study|Pregnancy|0|||
126260758|NCT02808819|454245486|FG000|Overall Study|Lost to Follow-up|1|||
126260759|NCT02808819|454245487|FG001|Overall Study|Lost to Follow-up|6|||
126260760|NCT02808819|454245486|FG000|Overall Study|Protocol Violation|0|||
126260761|NCT02808819|454245487|FG001|Overall Study|Protocol Violation|1|||
126260762|NCT02808819|454245486|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
126260763|NCT02808819|454245487|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
126260764|NCT02808819|454245486|FG000|Overall Study|Death|1|||
126260765|NCT02808819|454245487|FG001|Overall Study|Death|0|||
126260766|NCT02808819|454245486|FG000|Overall Study|Adverse Event|3|||
126260767|NCT02808819|454245487|FG001|Overall Study|Adverse Event|4|||
126260768|NCT00588731|454245488|FG000|Overall Study|Withdrawal by Subject|3|||
126260769|NCT00588731|454245489|FG001|Overall Study|Withdrawal by Subject|2|||
126260770|NCT03417830|454245490|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
126260771|NCT03417830|454245491|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
126260772|NCT00823199|454245492|FG000|Overall Study|Withdrawal by Subject|2|||
126546839|NCT03029780|455296067|FG001|Overall Study|Disease Progression|22|||
126699752|NCT00391976|455851282|FG001|Overall Study|Unable to classify|0|||
126260773|NCT00268892|454245493|FG000|Overall Study|Adverse Event|14|||
126260774|NCT00268892|454245494|FG001|Overall Study|Adverse Event|17|||
126260775|NCT00268892|454245495|FG002|Overall Study|Adverse Event|20|||
126260776|NCT00268892|454245493|FG000|Overall Study|Lack of Efficacy|1|||
126260777|NCT00268892|454245494|FG001|Overall Study|Lack of Efficacy|3|||
126260778|NCT00268892|454245495|FG002|Overall Study|Lack of Efficacy|0|||
126260779|NCT00268892|454245493|FG000|Overall Study|Withdrawal by Subject|14|||
126260780|NCT00268892|454245494|FG001|Overall Study|Withdrawal by Subject|15|||
126260781|NCT00268892|454245495|FG002|Overall Study|Withdrawal by Subject|13|||
126260782|NCT00268892|454245493|FG000|Overall Study|Physician Decision|0|||
126260783|NCT00268892|454245494|FG001|Overall Study|Physician Decision|1|||
126260784|NCT00268892|454245495|FG002|Overall Study|Physician Decision|0|||
126699753|NCT00391976|455851283|FG002|Overall Study|Unable to classify|1|||
126699754|NCT00391976|455851281|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
126699755|NCT00391976|455851282|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
126699756|NCT00391976|455851283|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
126699757|NCT03093402|455851288|FG000|Overall Study|Lost to Follow-up|1|||
126699758|NCT03093402|455851289|FG001|Overall Study|Lost to Follow-up|0|||
126699759|NCT03093402|455851290|FG002|Overall Study|Lost to Follow-up|0|||
126699760|NCT03093402|455851291|FG003|Overall Study|Lost to Follow-up|0|||
126699761|NCT03093402|455851288|FG000|Overall Study|Withdrawal by Subject|3|||
126699762|NCT03093402|455851289|FG001|Overall Study|Withdrawal by Subject|3|||
126699763|NCT03093402|455851290|FG002|Overall Study|Withdrawal by Subject|0|||
126699764|NCT03093402|455851291|FG003|Overall Study|Withdrawal by Subject|1|||
126699765|NCT03093402|455851288|FG000|Overall Study|Withdrew prior to dosing|2|||
126699766|NCT03093402|455851289|FG001|Overall Study|Withdrew prior to dosing|1|||
126699767|NCT03093402|455851290|FG002|Overall Study|Withdrew prior to dosing|2|||
126699768|NCT03093402|455851291|FG003|Overall Study|Withdrew prior to dosing|3|||
126699769|NCT03093402|455851288|FG000|Overall Study|Ineligible for study|1|||
126699770|NCT03093402|455851289|FG001|Overall Study|Ineligible for study|0|||
126699771|NCT03093402|455851290|FG002|Overall Study|Ineligible for study|0|||
126699772|NCT03093402|455851291|FG003|Overall Study|Ineligible for study|0|||
126699773|NCT03093402|455851288|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
126699774|NCT03093402|455851289|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
126699775|NCT03093402|455851290|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
126699776|NCT03093402|455851291|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
126699777|NCT02886702|455851292|FG000|Overall Study|Other|4|||
126699778|NCT02886702|455851293|FG001|Overall Study|Other|3|||
126699779|NCT02886702|455851294|FG002|Overall Study|Other|9|||
126699780|NCT02886702|455851292|FG000|Overall Study|Withdrawal by Subject|24|||
126699781|NCT02886702|455851293|FG001|Overall Study|Withdrawal by Subject|18|||
126699782|NCT02886702|455851294|FG002|Overall Study|Withdrawal by Subject|22|||
126699783|NCT02886702|455851292|FG000|Overall Study|Significant Worsening of Condition|0|||
126699784|NCT02886702|455851293|FG001|Overall Study|Significant Worsening of Condition|1|||
126699785|NCT02886702|455851294|FG002|Overall Study|Significant Worsening of Condition|0|||
126699786|NCT02886702|455851292|FG000|Overall Study|Protocol Violation|2|||
126699787|NCT02886702|455851293|FG001|Overall Study|Protocol Violation|2|||
126699788|NCT02886702|455851294|FG002|Overall Study|Protocol Violation|1|||
126699789|NCT02886702|455851292|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126699790|NCT02886702|455851293|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126699791|NCT02886702|455851294|FG002|Overall Study|Non-Compliance With Study Drug|4|||
126699792|NCT02886702|455851292|FG000|Overall Study|Lost to Follow-up|11|||
126699793|NCT02886702|455851293|FG001|Overall Study|Lost to Follow-up|13|||
126260785|NCT00268892|454245493|FG000|Overall Study|Lost to Follow-up|5|||
126260786|NCT00268892|454245494|FG001|Overall Study|Lost to Follow-up|2|||
126260787|NCT00268892|454245495|FG002|Overall Study|Lost to Follow-up|4|||
126260788|NCT00268892|454245493|FG000|Overall Study|Protocol Violation|0|||
126260789|NCT00268892|454245494|FG001|Overall Study|Protocol Violation|1|||
126260790|NCT00268892|454245495|FG002|Overall Study|Protocol Violation|0|||
126260791|NCT00268892|454245493|FG000|Overall Study|Disease Progression|1|||
126260792|NCT00268892|454245494|FG001|Overall Study|Disease Progression|1|||
126260793|NCT00268892|454245495|FG002|Overall Study|Disease Progression|0|||
126260794|NCT00268892|454245493|FG000|Overall Study|Trial Site Closed|4|||
126260795|NCT00268892|454245494|FG001|Overall Study|Trial Site Closed|2|||
126260796|NCT00268892|454245495|FG002|Overall Study|Trial Site Closed|2|||
126260797|NCT01640184|454245496|FG000|Overall Study|Death|1|||
126260798|NCT01640184|454245497|FG001|Overall Study|Death|0|||
126260799|NCT01640184|454245498|FG002|Overall Study|Death|0|||
126260800|NCT01640184|454245496|FG000|Overall Study|Lost to Follow-up|4|||
126260801|NCT01640184|454245497|FG001|Overall Study|Lost to Follow-up|1|||
126260802|NCT01640184|454245498|FG002|Overall Study|Lost to Follow-up|0|||
126260803|NCT01640184|454245496|FG000|Overall Study|Physician Decision|3|||
126260804|NCT01640184|454245497|FG001|Overall Study|Physician Decision|0|||
126260805|NCT01640184|454245498|FG002|Overall Study|Physician Decision|0|||
126260806|NCT01640184|454245496|FG000|Overall Study|Withdrawal by Subject|0|||
126260807|NCT01640184|454245497|FG001|Overall Study|Withdrawal by Subject|1|||
126260808|NCT01640184|454245498|FG002|Overall Study|Withdrawal by Subject|1|||
126260809|NCT01640184|454245496|FG000|Overall Study|Protocol Violation|0|||
126260810|NCT01640184|454245497|FG001|Overall Study|Protocol Violation|0|||
126260811|NCT01640184|454245498|FG002|Overall Study|Protocol Violation|1|||
126260812|NCT01684878|454245499|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
126260813|NCT01684878|454245500|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
126260814|NCT01684878|454245501|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
126260815|NCT01684878|454245502|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
126260816|NCT01684878|454245499|FG000|Part 1: Safety Run in Phase|Death|15|||
126260817|NCT01684878|454245500|FG001|Part 1: Safety Run in Phase|Death|20|||
126699794|NCT02886702|455851294|FG002|Overall Study|Lost to Follow-up|8|||
126699795|NCT02886702|455851292|FG000|Overall Study|Lack of Efficacy|3|||
126260818|NCT01684878|454245501|FG002|Part 1: Safety Run in Phase|Death|0|||
126260819|NCT01684878|454245502|FG003|Part 1: Safety Run in Phase|Death|0|||
126260820|NCT01684878|454245499|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
126451779|NCT02617485|454957092|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
126451780|NCT02617485|454957091|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
126451781|NCT02617485|454957092|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
126260821|NCT01684878|454245500|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
126260822|NCT01684878|454245501|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
126260823|NCT01684878|454245502|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
126260824|NCT01684878|454245499|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
126260825|NCT01684878|454245500|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
126260826|NCT01684878|454245501|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
126260827|NCT01684878|454245502|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
126260828|NCT01684878|454245499|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
126260829|NCT01684878|454245500|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
126260830|NCT01684878|454245501|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
126260831|NCT01684878|454245502|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
126260832|NCT01684878|454245499|FG000|Part 2: Randomized Phase|Death|0|||
126260833|NCT01684878|454245500|FG001|Part 2: Randomized Phase|Death|0|||
126260834|NCT01684878|454245501|FG002|Part 2: Randomized Phase|Death|62|||
126260835|NCT01684878|454245502|FG003|Part 2: Randomized Phase|Death|68|||
126260836|NCT01684878|454245499|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
126260837|NCT01684878|454245500|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
126260838|NCT01684878|454245501|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
126260839|NCT01684878|454245502|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
126451782|NCT02617485|454957091|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
126451783|NCT02617485|454957092|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
126451784|NCT02617485|454957091|FG000|Treatment and Observation Period|Physician Decision|0|||
126451785|NCT02617485|454957092|FG001|Treatment and Observation Period|Physician Decision|1|||
126451786|NCT02617485|454957091|FG000|Follow-up Period|Adverse Event|1|||
126451787|NCT02617485|454957092|FG001|Follow-up Period|Adverse Event|0|||
126451788|NCT02617485|454957091|FG000|Follow-up Period|Withdrawal by Subject|1|||
126451789|NCT02617485|454957092|FG001|Follow-up Period|Withdrawal by Subject|0|||
126451790|NCT02617485|454957091|FG000|Follow-up Period|Disease progression|2|||
126451791|NCT02617485|454957092|FG001|Follow-up Period|Disease progression|1|||
126451792|NCT02617485|454957091|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
126451793|NCT02617485|454957092|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
126451794|NCT02617485|454957091|FG000|Follow-up Period|Patient needed radiotherapy|9|||
126451795|NCT02617485|454957092|FG001|Follow-up Period|Patient needed radiotherapy|5|||
126451796|NCT02617485|454957091|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
126546840|NCT03029780|455296066|FG000|Overall Study|Study Drug Toxicity|15|||
126699796|NCT02886702|455851293|FG001|Overall Study|Lack of Efficacy|4|||
126260840|NCT01684878|454245499|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
126260841|NCT01684878|454245500|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
126260842|NCT01684878|454245501|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
126260843|NCT01684878|454245502|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
126260844|NCT02692482|454245506|FG000|Overall Study|Death|2|||
126260845|NCT02692482|454245507|FG001|Overall Study|Death|2|||
126260846|NCT02692482|454245506|FG000|Overall Study|Withdrawal by Subject|1|||
126260847|NCT02692482|454245507|FG001|Overall Study|Withdrawal by Subject|2|||
126260848|NCT01435031|454245508|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
126260849|NCT01435031|454245508|FG000|ITT at 1 Month|Death|1|||
126260850|NCT01435031|454245508|FG000|ITT at 1 Month|Lost to Follow-up|4|||
126260851|NCT01435031|454245508|FG000|ITT at 6 Months|Death|2|||
126260852|NCT01435031|454245508|FG000|ITT at 6 Months|Lost to Follow-up|3|||
126260853|NCT01435031|454245508|FG000|ITT at 1 Year|Death|1|||
126260854|NCT01435031|454245508|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
126260855|NCT01435031|454245508|FG000|ITT at 1 Year|Lost to Follow-up|6|||
126260856|NCT01435031|454245508|FG000|ITT at 2 Years|Death|7|||
126260857|NCT01435031|454245508|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
126260858|NCT01435031|454245508|FG000|ITT at 2 Years|Lost to Follow-up|4|||
126260859|NCT01435031|454245508|FG000|ITT at 3 Years|Death|5|||
126260860|NCT01435031|454245508|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
126260861|NCT01435031|454245508|FG000|ITT at 3 Years|Lost to Follow-up|4|||
126260862|NCT01435031|454245508|FG000|ITT at 4 Years|Death|4|||
126260863|NCT01435031|454245508|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
126260864|NCT01435031|454245508|FG000|ITT at 4 Years|Lost to Follow-up|1|||
126260865|NCT02927834|454245509|FG000|Overall Study|Lost to Follow-up|1|||
126260866|NCT02927834|454245510|FG001|Overall Study|Lost to Follow-up|2|||
126260867|NCT02927834|454245511|FG002|Overall Study|Lost to Follow-up|2|||
126260868|NCT02260258|454245514|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
126260869|NCT02260258|454245515|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
126260870|NCT01610063|454245516|FG000|Overall Study|Lost to Follow-up|42|||
126451797|NCT02617485|454957092|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
126451798|NCT00409331|454957093|FG000|Overall Study|Physician Decision|1|||
126260871|NCT01610063|454245517|FG001|Overall Study|Lost to Follow-up|20|||
126260872|NCT04405739|454245518|FG000|Overall Study|Adverse Event|0|||
126260873|NCT04405739|454245519|FG001|Overall Study|Adverse Event|1|||
126260874|NCT04405739|454245520|FG002|Overall Study|Adverse Event|0|||
126260875|NCT04405739|454245521|FG003|Overall Study|Adverse Event|0|||
126260876|NCT04405739|454245518|FG000|Overall Study|Lost to Follow-up|0|||
126260877|NCT04405739|454245519|FG001|Overall Study|Lost to Follow-up|2|||
126260878|NCT04405739|454245520|FG002|Overall Study|Lost to Follow-up|1|||
126260879|NCT04405739|454245521|FG003|Overall Study|Lost to Follow-up|3|||
126260880|NCT04405739|454245518|FG000|Overall Study|Withdrawal by Subject|0|||
126451799|NCT01511055|454957098|FG000|Overall Study|Withdrawal by Subject|6|||
126451800|NCT04590248|454957099|FG000|Overall Study|Lost to Follow-up|1|||
126451801|NCT04590248|454957099|FG000|Overall Study|Withdrawal by Subject|16|||
126451802|NCT04590248|454957099|FG000|Overall Study|Other|2|||
126451803|NCT02052414|454957102|FG000|Overall Study|Adverse Event|12|||
126451804|NCT02052414|454957102|FG000|Overall Study|Lack of Efficacy|2|||
126451805|NCT02052414|454957102|FG000|Overall Study|Withdrawal by Subject|3|||
126451806|NCT04605991|454957105|FG000|Overall Study|Adverse Event|5|||
126451807|NCT04605991|454957105|FG000|Overall Study|Lack of Efficacy|1|||
126451808|NCT04605991|454957105|FG000|Overall Study|Lost to Follow-up|8|||
126260881|NCT04405739|454245519|FG001|Overall Study|Withdrawal by Subject|2|||
126260882|NCT04405739|454245520|FG002|Overall Study|Withdrawal by Subject|1|||
126260883|NCT04405739|454245521|FG003|Overall Study|Withdrawal by Subject|1|||
126260884|NCT04405739|454245518|FG000|Overall Study|Death|0|||
126260885|NCT04405739|454245519|FG001|Overall Study|Death|0|||
126260886|NCT04405739|454245520|FG002|Overall Study|Death|1|||
126260887|NCT04405739|454245521|FG003|Overall Study|Death|0|||
126260888|NCT04405739|454245518|FG000|Overall Study|Transferred to rehab|0|||
126260889|NCT04405739|454245519|FG001|Overall Study|Transferred to rehab|0|||
126260890|NCT04405739|454245520|FG002|Overall Study|Transferred to rehab|0|||
126260891|NCT04405739|454245521|FG003|Overall Study|Transferred to rehab|1|||
126260892|NCT04405739|454245518|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
126260893|NCT04405739|454245519|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
126260894|NCT04405739|454245520|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
126260895|NCT04405739|454245521|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
126260896|NCT01436643|454245522|FG000|2-week Pre-treatment|Abnormal test result|0|||
126260897|NCT01436643|454245523|FG001|2-week Pre-treatment|Abnormal test result|0|||
126260898|NCT01436643|454245524|FG002|2-week Pre-treatment|Abnormal test result|0|||
126260899|NCT01436643|454245525|FG003|2-week Pre-treatment|Abnormal test result|1|||
126260900|NCT01436643|454245522|FG000|2-week Pre-treatment|Adverse Event|0|||
126260901|NCT01436643|454245523|FG001|2-week Pre-treatment|Adverse Event|0|||
126260902|NCT01436643|454245524|FG002|2-week Pre-treatment|Adverse Event|0|||
126260903|NCT01436643|454245525|FG003|2-week Pre-treatment|Adverse Event|5|||
126451809|NCT04605991|454957105|FG000|Overall Study|Physician Decision|4|||
126451810|NCT04605991|454957105|FG000|Overall Study|Withdrawal by Subject|14|||
126451811|NCT04605991|454957105|FG000|Overall Study|Non-compliance with study|1|||
126451812|NCT03263702|454957106|FG000|Overall Study|Lost to Follow-up|2|||
126451813|NCT03263702|454957107|FG001|Overall Study|Lost to Follow-up|2|||
126451814|NCT03263702|454957106|FG000|Overall Study|Withdrawal by Subject|1|||
126451815|NCT03263702|454957107|FG001|Overall Study|Withdrawal by Subject|2|||
126451816|NCT02527200|454957108|FG000|Overall Study|Withdrawal by Subject|3|||
126451817|NCT02527200|454957109|FG001|Overall Study|Withdrawal by Subject|2|||
126451818|NCT02527200|454957110|FG002|Overall Study|Withdrawal by Subject|1|||
126451819|NCT02527200|454957111|FG003|Overall Study|Withdrawal by Subject|0|||
126451820|NCT02527200|454957108|FG000|Overall Study|Unclassified|0|||
126451821|NCT02527200|454957109|FG001|Overall Study|Unclassified|1|||
126451822|NCT02527200|454957110|FG002|Overall Study|Unclassified|0|||
126451823|NCT02527200|454957111|FG003|Overall Study|Unclassified|0|||
126451824|NCT02527200|454957108|FG000|Overall Study|Lost to Follow-up|0|||
126451825|NCT02527200|454957109|FG001|Overall Study|Lost to Follow-up|0|||
126260904|NCT01436643|454245522|FG000|2-week Pre-treatment|Protocol Violation|0|||
126451826|NCT02527200|454957110|FG002|Overall Study|Lost to Follow-up|1|||
126451827|NCT02527200|454957111|FG003|Overall Study|Lost to Follow-up|0|||
126260905|NCT01436643|454245523|FG001|2-week Pre-treatment|Protocol Violation|0|||
126260906|NCT01436643|454245524|FG002|2-week Pre-treatment|Protocol Violation|0|||
126451828|NCT01659554|454957112|FG000|Overall Study|Study Termination|4|||
126260907|NCT01436643|454245525|FG003|2-week Pre-treatment|Protocol Violation|4|||
126260908|NCT01436643|454245522|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
126260909|NCT01436643|454245523|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
126260910|NCT01436643|454245524|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
126260911|NCT01436643|454245525|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
126260912|NCT01436643|454245522|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
126546841|NCT03029780|455296067|FG001|Overall Study|Study Drug Toxicity|11|||
126260913|NCT01436643|454245523|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
126451829|NCT01022398|454957113|FG000|Overall Study|Study terminated|2|||
126451830|NCT01022398|454957114|FG001|Overall Study|Study terminated|2|||
126260914|NCT01436643|454245524|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
126260915|NCT01436643|454245525|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
126260916|NCT01436643|454245522|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
126260917|NCT01436643|454245523|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
126260918|NCT01436643|454245524|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
126260919|NCT01436643|454245525|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
126260920|NCT01867606|454245526|FG000|Overall Study|Withdrawal by Subject|10|||
126260921|NCT01867606|454245527|FG001|Overall Study|Withdrawal by Subject|14|||
126260922|NCT01867606|454245526|FG000|Overall Study|Protocol Violation|0|||
126260923|NCT01867606|454245527|FG001|Overall Study|Protocol Violation|1|||
126260924|NCT02056652|454245533|FG000|Overall Study|Withdrawal by Subject|1|||
126260925|NCT02056652|454245534|FG001|Overall Study|Withdrawal by Subject|0|||
126260926|NCT02056652|454245533|FG000|Overall Study|Lost to Follow-up|0|||
126260927|NCT02056652|454245534|FG001|Overall Study|Lost to Follow-up|3|||
126260928|NCT03234608|454245541|FG000|Overall Study|Lost to Follow-up|23|||
126260929|NCT03234608|454245542|FG001|Overall Study|Lost to Follow-up|21|||
126260930|NCT02105701|454245543|FG000|Overall Study|Lost to Follow-up|1|||
126260931|NCT02105701|454245544|FG001|Overall Study|Lost to Follow-up|0|||
126260932|NCT02105701|454245545|FG002|Overall Study|Lost to Follow-up|2|||
126260933|NCT02105701|454245546|FG003|Overall Study|Lost to Follow-up|1|||
126260934|NCT02105701|454245543|FG000|Overall Study|Protocol Violation|0|||
126260935|NCT02105701|454245544|FG001|Overall Study|Protocol Violation|0|||
126260936|NCT02105701|454245545|FG002|Overall Study|Protocol Violation|1|||
126260937|NCT02105701|454245546|FG003|Overall Study|Protocol Violation|0|||
126260938|NCT02105701|454245543|FG000|Overall Study|Withdrawal by Subject|2|||
126260939|NCT02105701|454245544|FG001|Overall Study|Withdrawal by Subject|1|||
126260940|NCT02105701|454245545|FG002|Overall Study|Withdrawal by Subject|0|||
126260941|NCT02105701|454245546|FG003|Overall Study|Withdrawal by Subject|1|||
126260942|NCT02105701|454245543|FG000|Overall Study|Death|1|||
126260943|NCT02105701|454245544|FG001|Overall Study|Death|0|||
126260944|NCT02105701|454245545|FG002|Overall Study|Death|0|||
126260945|NCT02105701|454245546|FG003|Overall Study|Death|0|||
126260946|NCT04230876|454245547|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
126260947|NCT04230876|454245548|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
126260948|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
126260949|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260950|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260951|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260952|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260953|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260954|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260955|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260956|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
126260957|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
126260958|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260959|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260960|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260961|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260962|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260963|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260964|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260965|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
126260966|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
126260967|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260968|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260969|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260970|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260971|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260972|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260973|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260974|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
126260975|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
126260976|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260977|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260978|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260979|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260980|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260981|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126359519|NCT03931785|454608982|FG002|Overall Study|Noncompliance With Study drug|0|||
126699797|NCT02886702|455851294|FG002|Overall Study|Lack of Efficacy|5|||
126699798|NCT02886702|455851292|FG000|Overall Study|Adverse Event|4|||
126763454|NCT04668066|456086811|FG018|Part 1: Treatment Phase|Other|0|||
126763455|NCT04668066|456086793|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763456|NCT04668066|456086794|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763457|NCT04668066|456086795|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763458|NCT04668066|456086796|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763459|NCT04668066|456086797|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763460|NCT04668066|456086798|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763461|NCT04668066|456086799|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763462|NCT04668066|456086800|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763463|NCT04668066|456086801|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763464|NCT04668066|456086802|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763465|NCT04668066|456086803|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126699799|NCT02886702|455851293|FG001|Overall Study|Adverse Event|9|||
126699800|NCT02886702|455851294|FG002|Overall Study|Adverse Event|3|||
126699801|NCT02886702|455851292|FG000|Overall Study|Administrative Reasons|0|||
126763466|NCT04668066|456086804|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763467|NCT04668066|456086805|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
126763468|NCT04668066|456086806|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763469|NCT04668066|456086807|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763470|NCT04668066|456086808|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
126763471|NCT04668066|456086809|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763472|NCT04668066|456086810|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126763473|NCT04668066|456086811|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
126699802|NCT02886702|455851293|FG001|Overall Study|Administrative Reasons|0|||
126699803|NCT02886702|455851294|FG002|Overall Study|Administrative Reasons|1|||
126699804|NCT00763009|455851295|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
126699805|NCT00891735|455851297|FG000|Overall Study|Adverse Event|2|||
126699806|NCT00891735|455851298|FG001|Overall Study|Adverse Event|0|||
126699807|NCT00891735|455851299|FG002|Overall Study|Adverse Event|2|||
126699808|NCT00891735|455851300|FG003|Overall Study|Adverse Event|0|||
126699809|NCT00891735|455851297|FG000|Overall Study|Death|8|||
126699810|NCT00891735|455851298|FG001|Overall Study|Death|5|||
126699811|NCT00891735|455851299|FG002|Overall Study|Death|4|||
126699812|NCT00891735|455851300|FG003|Overall Study|Death|5|||
126699813|NCT00891735|455851297|FG000|Overall Study|Lost to Follow-up|2|||
126699814|NCT00891735|455851298|FG001|Overall Study|Lost to Follow-up|2|||
126699815|NCT00891735|455851299|FG002|Overall Study|Lost to Follow-up|2|||
126699816|NCT00891735|455851300|FG003|Overall Study|Lost to Follow-up|2|||
126699817|NCT00891735|455851297|FG000|Overall Study|Physician's decision to withdraw patient|1|||
126699818|NCT00891735|455851298|FG001|Overall Study|Physician's decision to withdraw patient|0|||
126699819|NCT00891735|455851299|FG002|Overall Study|Physician's decision to withdraw patient|0|||
126699820|NCT00891735|455851300|FG003|Overall Study|Physician's decision to withdraw patient|0|||
126699821|NCT00891735|455851297|FG000|Overall Study|Patient's decision to withdraw|4|||
126699822|NCT00891735|455851298|FG001|Overall Study|Patient's decision to withdraw|9|||
126699823|NCT00891735|455851299|FG002|Overall Study|Patient's decision to withdraw|4|||
126699824|NCT00891735|455851300|FG003|Overall Study|Patient's decision to withdraw|8|||
126699825|NCT03838484|455851307|FG000|Overall Study|Lost to Follow-up|0|||
126699826|NCT03838484|455851308|FG001|Overall Study|Lost to Follow-up|1|||
126699827|NCT03838484|455851309|FG002|Overall Study|Lost to Follow-up|0|||
126699828|NCT03838484|455851310|FG003|Overall Study|Lost to Follow-up|0|||
126699829|NCT00158184|455851316|FG000|Overall Study|personal issues|3|||
126699830|NCT00158184|455851317|FG001|Overall Study|personal issues|1|||
126699831|NCT00158184|455851316|FG000|Overall Study|failed for follow unit/study rules|2|||
126699832|NCT00158184|455851317|FG001|Overall Study|failed for follow unit/study rules|0|||
126699833|NCT00158184|455851316|FG000|Overall Study|Adverse Event|1|||
126699834|NCT00158184|455851317|FG001|Overall Study|Adverse Event|1|||
126699835|NCT05340504|455851318|FG000|Overall Study|Withdrawal by Subject|1|||
126699836|NCT05340504|455851319|FG001|Overall Study|Withdrawal by Subject|0|||
126699837|NCT00481065|455851320|FG000|Overall Study|Adverse event or death|1|||
126699838|NCT00481065|455851321|FG001|Overall Study|Adverse event or death|1|||
126763474|NCT04668066|456086793|FG000|Part 1: Follow-Up|Adverse Event|0|||
126763475|NCT04668066|456086794|FG001|Part 1: Follow-Up|Adverse Event|0|||
126763476|NCT04668066|456086795|FG002|Part 1: Follow-Up|Adverse Event|0|||
126260982|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260983|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
126260984|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
126260985|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260986|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260987|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126451831|NCT00361634|454957116|FG000|Overall Study|Lost to Follow-up|1|||
126699839|NCT00481065|455851322|FG002|Overall Study|Adverse event or death|3|||
126699840|NCT00481065|455851323|FG003|Overall Study|Adverse event or death|0|||
126260988|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260989|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260990|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260991|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260992|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
126260993|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
126260994|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126260995|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126260996|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126260997|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126260998|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126260999|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126261000|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126261001|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
126261002|NCT00739973|454245554|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
126261003|NCT00739973|454245555|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261004|NCT00739973|454245556|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261005|NCT00739973|454245557|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261006|NCT00739973|454245558|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261007|NCT00739973|454245559|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261008|NCT00739973|454245560|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261009|NCT00739973|454245561|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261010|NCT00739973|454245562|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
126261011|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
126261012|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
126261013|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
126261014|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
126261015|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
126261016|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
126261017|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
126261018|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
126261019|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
126261020|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261021|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261022|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261023|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261024|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
126261025|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261026|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261027|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
126261028|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
126261029|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
126261030|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
126261031|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261032|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261033|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261034|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261035|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261036|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261037|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
126261038|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
126261039|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
126261040|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
126261041|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
126261042|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
126261043|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
126261044|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
126261045|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
126451832|NCT00361634|454957116|FG000|Overall Study|Withdrawal by Subject|1|||
126451833|NCT00833417|454957117|FG000|Overall Study|Adverse Event|5|||
126451834|NCT00833417|454957118|FG001|Overall Study|Adverse Event|16|||
126451835|NCT00833417|454957117|FG000|Overall Study|Death|1|||
126261046|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
126261047|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261048|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261049|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
126261050|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261051|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126699841|NCT00481065|455851324|FG004|Overall Study|Adverse event or death|2|||
126699842|NCT00481065|455851325|FG005|Overall Study|Adverse event or death|0|||
126699843|NCT00481065|455851326|FG006|Overall Study|Adverse event or death|1|||
126699844|NCT00481065|455851327|FG007|Overall Study|Adverse event or death|1|||
126261052|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261053|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261054|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261055|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
126261056|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
126261057|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
126451836|NCT00833417|454957118|FG001|Overall Study|Death|3|||
126451837|NCT00833417|454957117|FG000|Overall Study|Lost to Follow-up|1|||
126451838|NCT00833417|454957118|FG001|Overall Study|Lost to Follow-up|2|||
126451839|NCT00833417|454957117|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
126451840|NCT00833417|454957118|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
126451841|NCT00833417|454957117|FG000|Overall Study|Patient Decision to Withdraw|4|||
126451842|NCT00833417|454957118|FG001|Overall Study|Patient Decision to Withdraw|23|||
126451843|NCT00833417|454957117|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
126451844|NCT00833417|454957118|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
126451845|NCT00833417|454957117|FG000|Overall Study|Disease Progression|18|||
126451846|NCT00833417|454957118|FG001|Overall Study|Disease Progression|17|||
126261058|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
126261059|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
126261060|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
126261061|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
126261062|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
126261063|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
126261064|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
126261065|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
126261066|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
126261067|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
126261068|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
126261069|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
126261070|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
126261071|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
126261072|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
126261073|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
126261074|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261075|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126451847|NCT00833417|454957117|FG000|Overall Study|Reason Not Specified|0|||
126451848|NCT00833417|454957118|FG001|Overall Study|Reason Not Specified|1|||
126451849|NCT03330002|454957119|FG000|Overall Study|Lost to Follow-up|15|||
126451850|NCT03330002|454957119|FG000|Overall Study|Death|7|||
126451851|NCT00505076|454957120|FG000|Overall Study|Adverse Event|1|||
126699845|NCT00481065|455851320|FG000|Overall Study|Withdrawal by Subject|11|||
126699846|NCT00481065|455851321|FG001|Overall Study|Withdrawal by Subject|12|||
126699847|NCT00481065|455851322|FG002|Overall Study|Withdrawal by Subject|7|||
126699848|NCT00481065|455851323|FG003|Overall Study|Withdrawal by Subject|11|||
126699849|NCT00481065|455851324|FG004|Overall Study|Withdrawal by Subject|13|||
126699850|NCT00481065|455851325|FG005|Overall Study|Withdrawal by Subject|12|||
126699851|NCT00481065|455851326|FG006|Overall Study|Withdrawal by Subject|9|||
126699852|NCT00481065|455851327|FG007|Overall Study|Withdrawal by Subject|10|||
126699853|NCT00481065|455851320|FG000|Overall Study|Lost to Follow-up|4|||
126699854|NCT00481065|455851321|FG001|Overall Study|Lost to Follow-up|2|||
126699855|NCT00481065|455851322|FG002|Overall Study|Lost to Follow-up|4|||
126699856|NCT00481065|455851323|FG003|Overall Study|Lost to Follow-up|3|||
126699857|NCT00481065|455851324|FG004|Overall Study|Lost to Follow-up|3|||
126699858|NCT00481065|455851325|FG005|Overall Study|Lost to Follow-up|3|||
126699859|NCT00481065|455851326|FG006|Overall Study|Lost to Follow-up|2|||
126699860|NCT00481065|455851327|FG007|Overall Study|Lost to Follow-up|5|||
126699861|NCT00481065|455851320|FG000|Overall Study|Inappropriate enrollment|4|||
126699862|NCT00481065|455851321|FG001|Overall Study|Inappropriate enrollment|0|||
126451852|NCT00505076|454957121|FG001|Overall Study|Adverse Event|0|||
126451853|NCT00505076|454957122|FG002|Overall Study|Adverse Event|1|||
126451854|NCT00505076|454957120|FG000|Overall Study|Protocol Violation|2|||
126261076|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261077|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261078|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261079|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261080|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
126261081|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261082|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
126261083|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
126261084|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
126261085|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
126261086|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
126261087|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
126261088|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
126261089|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
126261090|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
126261091|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
126261092|NCT00739973|454245554|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261093|NCT00739973|454245555|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
126261094|NCT00739973|454245556|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261095|NCT00739973|454245557|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261096|NCT00739973|454245558|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261097|NCT00739973|454245559|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261098|NCT00739973|454245560|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
126261099|NCT00739973|454245561|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261100|NCT00739973|454245562|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
126261101|NCT01662362|454245563|FG000|Overall Study|Lost to Follow-up|38|||
126261102|NCT03078478|454245568|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
126261103|NCT03078478|454245569|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
126261104|NCT03078478|454245568|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
126261105|NCT03078478|454245569|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
126261106|NCT03078478|454245568|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
126261107|NCT03078478|454245569|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
126261108|NCT03078478|454245568|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
126261109|NCT03078478|454245569|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
126261110|NCT03078478|454245568|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
126261111|NCT03078478|454245569|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
126261112|NCT03078478|454245568|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
126261113|NCT03078478|454245569|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
126261114|NCT03078478|454245568|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
126261115|NCT03078478|454245569|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
126261116|NCT03078478|454245568|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
126261117|NCT03078478|454245569|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
126451855|NCT00505076|454957121|FG001|Overall Study|Protocol Violation|1|||
126451856|NCT00505076|454957122|FG002|Overall Study|Protocol Violation|2|||
126451857|NCT00505076|454957120|FG000|Overall Study|Withdrawal by Subject|0|||
126451858|NCT00505076|454957121|FG001|Overall Study|Withdrawal by Subject|1|||
126451859|NCT00505076|454957122|FG002|Overall Study|Withdrawal by Subject|2|||
126451860|NCT02745145|454957123|FG000|Overall Study|Adverse Event|1|||
126451861|NCT02745145|454957124|FG001|Overall Study|Adverse Event|0|||
126451862|NCT02745145|454957125|FG002|Overall Study|Adverse Event|0|||
126451863|NCT02745145|454957123|FG000|Overall Study|Death|0|||
126451864|NCT02745145|454957124|FG001|Overall Study|Death|1|||
126451865|NCT02745145|454957125|FG002|Overall Study|Death|0|||
126451866|NCT02745145|454957123|FG000|Overall Study|Progressive disease|0|||
126451867|NCT02745145|454957124|FG001|Overall Study|Progressive disease|0|||
126451868|NCT02745145|454957125|FG002|Overall Study|Progressive disease|1|||
126451869|NCT02745145|454957123|FG000|Overall Study|Withdrew consent|1|||
126451870|NCT02745145|454957124|FG001|Overall Study|Withdrew consent|1|||
126451871|NCT02745145|454957125|FG002|Overall Study|Withdrew consent|1|||
126451872|NCT02745145|454957123|FG000|Overall Study|Study Termination|8|||
126451873|NCT02745145|454957124|FG001|Overall Study|Study Termination|3|||
126451874|NCT02745145|454957125|FG002|Overall Study|Study Termination|7|||
126763477|NCT04668066|456086796|FG003|Part 1: Follow-Up|Adverse Event|0|||
126451875|NCT00388583|454957126|FG000|Overall Study|Protocol Violation|1|||
126763478|NCT04668066|456086797|FG004|Part 1: Follow-Up|Adverse Event|0|||
126763479|NCT04668066|456086798|FG005|Part 1: Follow-Up|Adverse Event|0|||
126261118|NCT01181531|454245570|FG000|Overall Study|Other|17|||
126261119|NCT01181531|454245571|FG001|Overall Study|Other|12|||
126451876|NCT00388583|454957127|FG001|Overall Study|Protocol Violation|0|||
126451877|NCT00388583|454957126|FG000|Overall Study|Withdrawal by Subject|3|||
126451878|NCT00388583|454957127|FG001|Overall Study|Withdrawal by Subject|3|||
126451879|NCT00388583|454957126|FG000|Overall Study|Serious Adverse Event|2|||
126451880|NCT00388583|454957127|FG001|Overall Study|Serious Adverse Event|0|||
126451881|NCT00388583|454957126|FG000|Overall Study|Did not receive vaccine|0|||
126451882|NCT00388583|454957127|FG001|Overall Study|Did not receive vaccine|1|||
126451883|NCT00322621|454957128|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
126451884|NCT00322621|454957129|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
126451885|NCT00322621|454957130|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
126451886|NCT00322621|454957128|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
126451887|NCT00322621|454957129|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
126451888|NCT00322621|454957130|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
126451889|NCT00322621|454957128|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
126451890|NCT00322621|454957129|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
126451891|NCT00322621|454957130|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
126451892|NCT00322621|454957128|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
126451893|NCT00322621|454957129|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
126451894|NCT00322621|454957130|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
126451895|NCT00322621|454957128|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
126451896|NCT00322621|454957129|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
126451897|NCT00322621|454957130|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
126451898|NCT00322621|454957128|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
126451899|NCT00322621|454957129|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
126451900|NCT00322621|454957130|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
126451901|NCT00322621|454957128|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
126451902|NCT00322621|454957129|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
126451903|NCT00322621|454957130|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
126451904|NCT00322621|454957128|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
126261120|NCT01181531|454245570|FG000|Overall Study|Partial consent by subject withdrawn|0|||
126261121|NCT01181531|454245571|FG001|Overall Study|Partial consent by subject withdrawn|1|||
126261122|NCT01181531|454245570|FG000|Overall Study|Physician Decision|3|||
126261123|NCT01181531|454245571|FG001|Overall Study|Physician Decision|1|||
126261124|NCT01181531|454245570|FG000|Overall Study|Noncompliance|2|||
126261125|NCT01181531|454245571|FG001|Overall Study|Noncompliance|2|||
126261126|NCT01181531|454245570|FG000|Overall Study|Ineligibility determined|1|||
126261127|NCT01181531|454245571|FG001|Overall Study|Ineligibility determined|2|||
126261128|NCT01181531|454245570|FG000|Overall Study|Protocol Specified Criteria|15|||
126261129|NCT01181531|454245571|FG001|Overall Study|Protocol Specified Criteria|8|||
126261130|NCT01181531|454245570|FG000|Overall Study|Pregnancy|0|||
126261131|NCT01181531|454245571|FG001|Overall Study|Pregnancy|1|||
126261132|NCT01181531|454245570|FG000|Overall Study|Withdrawal by Subject|8|||
126261133|NCT01181531|454245571|FG001|Overall Study|Withdrawal by Subject|7|||
126261134|NCT01181531|454245570|FG000|Overall Study|Protocol Violation|6|||
126261135|NCT01181531|454245571|FG001|Overall Study|Protocol Violation|6|||
126261136|NCT01181531|454245570|FG000|Overall Study|Death|9|||
126261137|NCT01181531|454245571|FG001|Overall Study|Death|12|||
126261138|NCT01181531|454245570|FG000|Overall Study|Adverse Event|0|||
126261139|NCT01181531|454245571|FG001|Overall Study|Adverse Event|1|||
126261140|NCT00987831|454245573|FG000|Overall Study|Never flared in 12 months|1|||
126261141|NCT00987831|454245574|FG001|Overall Study|Never flared in 12 months|0|||
126261142|NCT00987831|454245575|FG002|Overall Study|Never flared in 12 months|0|||
126261143|NCT00987831|454245573|FG000|Overall Study|Lost to Follow-up|0|||
126261144|NCT00987831|454245574|FG001|Overall Study|Lost to Follow-up|3|||
126261145|NCT00987831|454245575|FG002|Overall Study|Lost to Follow-up|0|||
126261146|NCT03253094|454245576|FG000|Overall Study|Adverse Event|2|||
126261147|NCT03253094|454245577|FG001|Overall Study|Adverse Event|0|||
126451905|NCT00322621|454957129|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
126699863|NCT00481065|455851322|FG002|Overall Study|Inappropriate enrollment|2|||
126699864|NCT00481065|455851323|FG003|Overall Study|Inappropriate enrollment|0|||
126699865|NCT00481065|455851324|FG004|Overall Study|Inappropriate enrollment|2|||
126699866|NCT00481065|455851325|FG005|Overall Study|Inappropriate enrollment|1|||
126261148|NCT03253094|454245578|FG002|Overall Study|Adverse Event|0|||
126261149|NCT03253094|454245579|FG003|Overall Study|Adverse Event|0|||
126261150|NCT03253094|454245580|FG004|Overall Study|Adverse Event|0|||
126261151|NCT03253094|454245581|FG005|Overall Study|Adverse Event|0|||
126261152|NCT03253094|454245576|FG000|Overall Study|Lack of Efficacy|0|||
126261153|NCT03253094|454245577|FG001|Overall Study|Lack of Efficacy|0|||
126261154|NCT03253094|454245578|FG002|Overall Study|Lack of Efficacy|2|||
126261155|NCT03253094|454245579|FG003|Overall Study|Lack of Efficacy|1|||
126261156|NCT03253094|454245580|FG004|Overall Study|Lack of Efficacy|2|||
126261157|NCT03253094|454245581|FG005|Overall Study|Lack of Efficacy|1|||
126763480|NCT04668066|456086799|FG006|Part 1: Follow-Up|Adverse Event|0|||
126763481|NCT04668066|456086800|FG007|Part 1: Follow-Up|Adverse Event|0|||
126763482|NCT04668066|456086801|FG008|Part 1: Follow-Up|Adverse Event|0|||
126763483|NCT04668066|456086802|FG009|Part 1: Follow-Up|Adverse Event|0|||
126763484|NCT04668066|456086803|FG010|Part 1: Follow-Up|Adverse Event|0|||
126763485|NCT04668066|456086804|FG011|Part 1: Follow-Up|Adverse Event|1|||
126763486|NCT04668066|456086805|FG012|Part 1: Follow-Up|Adverse Event|0|||
126763487|NCT04668066|456086806|FG013|Part 1: Follow-Up|Adverse Event|0|||
126763488|NCT04668066|456086807|FG014|Part 1: Follow-Up|Adverse Event|0|||
126763489|NCT04668066|456086808|FG015|Part 1: Follow-Up|Adverse Event|0|||
126763490|NCT04668066|456086809|FG016|Part 1: Follow-Up|Adverse Event|0|||
126763491|NCT04668066|456086810|FG017|Part 1: Follow-Up|Adverse Event|0|||
126763492|NCT04668066|456086811|FG018|Part 1: Follow-Up|Adverse Event|0|||
126763493|NCT04668066|456086793|FG000|Part 1: Follow-Up|Other|0|||
126763494|NCT04668066|456086794|FG001|Part 1: Follow-Up|Other|0|||
126763495|NCT04668066|456086795|FG002|Part 1: Follow-Up|Other|0|||
126763496|NCT04668066|456086796|FG003|Part 1: Follow-Up|Other|0|||
126359520|NCT03931785|454608983|FG003|Overall Study|Noncompliance With Study drug|0|||
126359521|NCT03931785|454608980|FG000|Overall Study|Other Not specified|0|||
126359522|NCT03931785|454608981|FG001|Overall Study|Other Not specified|2|||
126359523|NCT03931785|454608982|FG002|Overall Study|Other Not specified|2|||
126359524|NCT03931785|454608983|FG003|Overall Study|Other Not specified|2|||
126359525|NCT03931785|454608980|FG000|Overall Study|Withdrawal by Subject|0|||
126359526|NCT03931785|454608981|FG001|Overall Study|Withdrawal by Subject|2|||
126359527|NCT03931785|454608982|FG002|Overall Study|Withdrawal by Subject|4|||
126359528|NCT03931785|454608983|FG003|Overall Study|Withdrawal by Subject|1|||
126359529|NCT03931785|454608980|FG000|Overall Study|Pregnancy|0|||
126359530|NCT03931785|454608981|FG001|Overall Study|Pregnancy|0|||
126359531|NCT03931785|454608982|FG002|Overall Study|Pregnancy|0|||
126359532|NCT03931785|454608983|FG003|Overall Study|Pregnancy|1|||
126359533|NCT04605588|454608986|FG000|Overall Study|Withdrawal by Subject|1|||
126359534|NCT04605588|454608987|FG001|Overall Study|Withdrawal by Subject|0|||
126359535|NCT01230814|454608988|FG000|Overall Study|Lost to Follow-up|11|||
126359536|NCT01230814|454608989|FG001|Overall Study|Lost to Follow-up|3|||
126359537|NCT01230814|454608988|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
126359538|NCT01230814|454608989|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
126359539|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
126359540|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
126359541|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
126359542|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
126359543|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
126359544|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
126359545|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
126359546|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
126359547|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
126359548|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
126359549|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
126359550|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
126359551|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
126359552|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
126699867|NCT00481065|455851326|FG006|Overall Study|Inappropriate enrollment|0|||
126699868|NCT00481065|455851327|FG007|Overall Study|Inappropriate enrollment|1|||
126699869|NCT00481065|455851320|FG000|Overall Study|Administrative reason|0|||
126699870|NCT00481065|455851321|FG001|Overall Study|Administrative reason|0|||
126699871|NCT00481065|455851322|FG002|Overall Study|Administrative reason|0|||
126699872|NCT00481065|455851323|FG003|Overall Study|Administrative reason|0|||
126699873|NCT00481065|455851324|FG004|Overall Study|Administrative reason|0|||
126699874|NCT00481065|455851325|FG005|Overall Study|Administrative reason|2|||
126699875|NCT00481065|455851326|FG006|Overall Study|Administrative reason|1|||
126699876|NCT00481065|455851327|FG007|Overall Study|Administrative reason|0|||
126699877|NCT00481065|455851320|FG000|Overall Study|Protocol Violation|2|||
126699878|NCT00481065|455851321|FG001|Overall Study|Protocol Violation|1|||
126699879|NCT00481065|455851322|FG002|Overall Study|Protocol Violation|1|||
126699880|NCT00481065|455851323|FG003|Overall Study|Protocol Violation|1|||
126699881|NCT00481065|455851324|FG004|Overall Study|Protocol Violation|2|||
126699882|NCT00481065|455851325|FG005|Overall Study|Protocol Violation|6|||
126763497|NCT04668066|456086797|FG004|Part 1: Follow-Up|Other|0|||
126763498|NCT04668066|456086798|FG005|Part 1: Follow-Up|Other|0|||
126359553|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
126359554|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
126359555|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
126699883|NCT00481065|455851326|FG006|Overall Study|Protocol Violation|3|||
126699884|NCT00481065|455851327|FG007|Overall Study|Protocol Violation|2|||
126699885|NCT00481065|455851320|FG000|Overall Study|Unable to classify|0|||
126763499|NCT04668066|456086799|FG006|Part 1: Follow-Up|Other|0|||
126763500|NCT04668066|456086800|FG007|Part 1: Follow-Up|Other|0|||
126359556|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
126359557|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
126359558|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
126359559|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
126359560|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
126359561|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
126359562|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
126359563|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
126359564|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
126359565|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
126359566|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
126359567|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
126359568|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
126359569|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
126359570|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
126359571|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
126359572|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
126359573|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
126359574|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
126359575|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
126359576|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
126359577|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
126451906|NCT00322621|454957130|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
126451907|NCT00322621|454957128|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
126359578|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
126359579|NCT02596893|454608994|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
126359580|NCT02596893|454608995|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
126359581|NCT02596893|454608996|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
126359582|NCT02596893|454608997|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
126359583|NCT01529112|454609000|FG000|Overall Study|Adverse Event|2|||
126359584|NCT01529112|454609001|FG001|Overall Study|Adverse Event|0|||
126359585|NCT01529112|454609000|FG000|Overall Study|Death|59|||
126359586|NCT01529112|454609001|FG001|Overall Study|Death|38|||
126451908|NCT00322621|454957129|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
126451909|NCT00322621|454957130|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
126451910|NCT00322621|454957128|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
126451911|NCT00322621|454957129|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
126451912|NCT00322621|454957130|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
126451913|NCT00322621|454957128|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
126451914|NCT00322621|454957129|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
126451915|NCT00322621|454957130|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
126451916|NCT02709538|454957132|FG000|Overall Study|Adverse Event|13|||
126451917|NCT02709538|454957133|FG001|Overall Study|Adverse Event|2|||
126451918|NCT02709538|454957134|FG002|Overall Study|Adverse Event|3|||
126451919|NCT02709538|454957132|FG000|Overall Study|Lack of Efficacy|1|||
126451920|NCT02709538|454957133|FG001|Overall Study|Lack of Efficacy|0|||
126451921|NCT02709538|454957134|FG002|Overall Study|Lack of Efficacy|0|||
126451922|NCT02709538|454957132|FG000|Overall Study|Lost to Follow-up|24|||
126451923|NCT02709538|454957133|FG001|Overall Study|Lost to Follow-up|8|||
126451924|NCT02709538|454957134|FG002|Overall Study|Lost to Follow-up|4|||
126451925|NCT02709538|454957132|FG000|Overall Study|Physician Decision|1|||
126451926|NCT02709538|454957133|FG001|Overall Study|Physician Decision|0|||
126451927|NCT02709538|454957134|FG002|Overall Study|Physician Decision|0|||
126451928|NCT02709538|454957132|FG000|Overall Study|Withdrawal by Subject|40|||
126451929|NCT02709538|454957133|FG001|Overall Study|Withdrawal by Subject|7|||
126451930|NCT02709538|454957134|FG002|Overall Study|Withdrawal by Subject|4|||
126359587|NCT01529112|454609000|FG000|Overall Study|Protocol Violation|1|||
126359588|NCT01529112|454609001|FG001|Overall Study|Protocol Violation|0|||
126359589|NCT01529112|454609000|FG000|Overall Study|Withdrawal by Subject|7|||
126359590|NCT01529112|454609001|FG001|Overall Study|Withdrawal by Subject|3|||
126359591|NCT02255279|454609002|FG000|Overall Study|Lost to Follow-up|2|||
126763501|NCT04668066|456086801|FG008|Part 1: Follow-Up|Other|0|||
126359592|NCT02255279|454609003|FG001|Overall Study|Lost to Follow-up|2|||
126359593|NCT02255279|454609002|FG000|Overall Study|Protocol Violation|0|||
126359594|NCT02255279|454609003|FG001|Overall Study|Protocol Violation|1|||
126451931|NCT02709538|454957132|FG000|Overall Study|Non-compliance with study procedures|5|||
126451932|NCT02709538|454957133|FG001|Overall Study|Non-compliance with study procedures|0|||
126451933|NCT02709538|454957134|FG002|Overall Study|Non-compliance with study procedures|0|||
126359595|NCT02255279|454609002|FG000|Overall Study|Withdrawal by Subject|3|||
126451934|NCT02709538|454957132|FG000|Overall Study|Non-compliance with study drug|2|||
126763502|NCT04668066|456086802|FG009|Part 1: Follow-Up|Other|0|||
126261158|NCT03253094|454245576|FG000|Overall Study|Lost to Follow-up|0|||
126261159|NCT03253094|454245577|FG001|Overall Study|Lost to Follow-up|0|||
126261160|NCT03253094|454245578|FG002|Overall Study|Lost to Follow-up|1|||
126261161|NCT03253094|454245579|FG003|Overall Study|Lost to Follow-up|1|||
126261162|NCT03253094|454245580|FG004|Overall Study|Lost to Follow-up|0|||
126261163|NCT03253094|454245581|FG005|Overall Study|Lost to Follow-up|1|||
126261164|NCT03253094|454245576|FG000|Overall Study|Physician Decision|1|||
126546842|NCT03029780|455296066|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
126546843|NCT03029780|455296067|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
126261165|NCT03253094|454245577|FG001|Overall Study|Physician Decision|0|||
126261166|NCT03253094|454245578|FG002|Overall Study|Physician Decision|0|||
126261167|NCT03253094|454245579|FG003|Overall Study|Physician Decision|1|||
126261168|NCT03253094|454245580|FG004|Overall Study|Physician Decision|0|||
126261169|NCT03253094|454245581|FG005|Overall Study|Physician Decision|2|||
126261170|NCT03253094|454245576|FG000|Overall Study|Withdrawal by Subject|1|||
126261171|NCT03253094|454245577|FG001|Overall Study|Withdrawal by Subject|2|||
126261172|NCT03253094|454245578|FG002|Overall Study|Withdrawal by Subject|1|||
126261173|NCT03253094|454245579|FG003|Overall Study|Withdrawal by Subject|0|||
126261174|NCT03253094|454245580|FG004|Overall Study|Withdrawal by Subject|3|||
126261175|NCT03253094|454245581|FG005|Overall Study|Withdrawal by Subject|0|||
126261176|NCT03253094|454245576|FG000|Overall Study|Other|0|||
126261177|NCT03253094|454245577|FG001|Overall Study|Other|1|||
126261178|NCT03253094|454245578|FG002|Overall Study|Other|2|||
126261179|NCT03253094|454245579|FG003|Overall Study|Other|1|||
126261180|NCT03253094|454245580|FG004|Overall Study|Other|0|||
126261181|NCT03253094|454245581|FG005|Overall Study|Other|0|||
126261182|NCT02339090|454245582|FG000|Overall Study|Adverse Event|1|||
126261183|NCT02339090|454245583|FG001|Overall Study|Adverse Event|0|||
126261184|NCT02339090|454245582|FG000|Overall Study|Lost to Follow-up|0|||
126261185|NCT02339090|454245583|FG001|Overall Study|Lost to Follow-up|1|||
126261186|NCT02339090|454245582|FG000|Overall Study|Non-compliance With Study Drug|0|||
126261187|NCT02339090|454245583|FG001|Overall Study|Non-compliance With Study Drug|1|||
126261188|NCT02339090|454245582|FG000|Overall Study|Withdrawal by Subject|2|||
126261189|NCT02339090|454245583|FG001|Overall Study|Withdrawal by Subject|1|||
126261190|NCT02339090|454245582|FG000|Overall Study|Poor Growth|3|||
126261191|NCT02339090|454245583|FG001|Overall Study|Poor Growth|0|||
126261192|NCT02339090|454245582|FG000|Overall Study|Randomized but not treated|0|||
126261193|NCT02339090|454245583|FG001|Overall Study|Randomized but not treated|2|||
126261194|NCT02737592|454245586|FG000|Overall Study|Withdrawal by Subject|1|||
126261195|NCT00576303|454245588|FG000|Dose Titration Period|Early withdrawal|17|||
126261196|NCT00576303|454245588|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
126261197|NCT00576303|454245588|FG000|Long Term Safety Period|Early withdrawal|16|||
126261198|NCT00810602|454245589|FG000|Overall Study|Withdrawal by Subject|8|||
126261199|NCT00810602|454245590|FG001|Overall Study|Withdrawal by Subject|3|||
126261200|NCT02792218|454245591|FG000|Overall Study|Patient/guardian decision|15|||
126261201|NCT02792218|454245592|FG001|Overall Study|Patient/guardian decision|42|||
126261202|NCT02792218|454245591|FG000|Overall Study|Adverse Event|15|||
126261203|NCT02792218|454245592|FG001|Overall Study|Adverse Event|14|||
126261204|NCT02792218|454245591|FG000|Overall Study|Lost to Follow-up|10|||
126261205|NCT02792218|454245592|FG001|Overall Study|Lost to Follow-up|5|||
126261206|NCT02792218|454245591|FG000|Overall Study|Lack of Efficacy|1|||
126261207|NCT02792218|454245592|FG001|Overall Study|Lack of Efficacy|12|||
126261208|NCT02792218|454245591|FG000|Overall Study|Physician Decision|4|||
126261209|NCT02792218|454245592|FG001|Overall Study|Physician Decision|4|||
126261210|NCT02792218|454245591|FG000|Overall Study|Protocol deviation|3|||
126261211|NCT02792218|454245592|FG001|Overall Study|Protocol deviation|2|||
126261212|NCT02792218|454245591|FG000|Overall Study|New therapy for study indication|0|||
126261213|NCT02792218|454245592|FG001|Overall Study|New therapy for study indication|1|||
126261214|NCT02792218|454245591|FG000|Overall Study|Non-compliance with study treatment|0|||
126261215|NCT02792218|454245592|FG001|Overall Study|Non-compliance with study treatment|1|||
126261216|NCT02792218|454245591|FG000|Overall Study|Pregnancy|1|||
126261217|NCT02792218|454245592|FG001|Overall Study|Pregnancy|0|||
126261218|NCT00824369|454245593|FG000|Overall Study|Nolonger willing to participate in study|1|||
126261219|NCT00824369|454245594|FG001|Overall Study|Nolonger willing to participate in study|0|||
126261220|NCT00824369|454245595|FG002|Overall Study|Nolonger willing to participate in study|1|||
126261221|NCT00824369|454245596|FG003|Overall Study|Nolonger willing to participate in study|2|||
126261222|NCT00824369|454245597|FG004|Overall Study|Nolonger willing to participate in study|0|||
126261223|NCT00824369|454245598|FG005|Overall Study|Nolonger willing to participate in study|1|||
126261224|NCT00824369|454245593|FG000|Overall Study|Lost to Follow-up|0|||
126261225|NCT00824369|454245594|FG001|Overall Study|Lost to Follow-up|0|||
126261226|NCT00824369|454245595|FG002|Overall Study|Lost to Follow-up|0|||
126261227|NCT00824369|454245596|FG003|Overall Study|Lost to Follow-up|0|||
126261228|NCT00824369|454245597|FG004|Overall Study|Lost to Follow-up|1|||
126261229|NCT00824369|454245598|FG005|Overall Study|Lost to Follow-up|0|||
126261230|NCT04034355|454245626|FG000|Overall Study|Study terminated by Sponsor|10|||
126261231|NCT04034355|454245627|FG001|Overall Study|Study terminated by Sponsor|17|||
126261232|NCT04034355|454245626|FG000|Overall Study|Withdrawal by Subject|12|||
126261233|NCT04034355|454245627|FG001|Overall Study|Withdrawal by Subject|11|||
126261234|NCT04034355|454245626|FG000|Overall Study|Site terminated by Sponsor|4|||
126261235|NCT04034355|454245627|FG001|Overall Study|Site terminated by Sponsor|5|||
126261236|NCT04034355|454245626|FG000|Overall Study|Adverse Event|2|||
126261237|NCT04034355|454245627|FG001|Overall Study|Adverse Event|0|||
126261238|NCT04034355|454245626|FG000|Overall Study|Death|1|||
126261239|NCT04034355|454245627|FG001|Overall Study|Death|1|||
126261240|NCT04034355|454245626|FG000|Overall Study|Not reported|2|||
126261241|NCT04034355|454245627|FG001|Overall Study|Not reported|0|||
126261242|NCT04034355|454245626|FG000|Overall Study|Lost to Follow-up|1|||
126261243|NCT04034355|454245627|FG001|Overall Study|Lost to Follow-up|0|||
126261244|NCT04034355|454245626|FG000|Overall Study|Physician Decision|1|||
126261245|NCT04034355|454245627|FG001|Overall Study|Physician Decision|0|||
126261246|NCT04034355|454245626|FG000|Overall Study|Protocol Violation|0|||
126261247|NCT04034355|454245627|FG001|Overall Study|Protocol Violation|1|||
126261248|NCT04034355|454245626|FG000|Overall Study|Progressive disease|1|||
126261249|NCT04034355|454245627|FG001|Overall Study|Progressive disease|0|||
126261250|NCT02190279|454248119|FG000|Overall Study|Withdrawal consent|1|||
126261251|NCT02190279|454248120|FG001|Overall Study|Withdrawal consent|0|||
126261252|NCT02190279|454248121|FG002|Overall Study|Withdrawal consent|1|||
126261253|NCT02190279|454248119|FG000|Overall Study|Lost to Follow-up|2|||
126261254|NCT02190279|454248120|FG001|Overall Study|Lost to Follow-up|0|||
126261255|NCT02190279|454248121|FG002|Overall Study|Lost to Follow-up|0|||
126261256|NCT02190279|454248119|FG000|Overall Study|Refused further treatment|0|||
126261257|NCT02190279|454248120|FG001|Overall Study|Refused further treatment|0|||
126261258|NCT02190279|454248121|FG002|Overall Study|Refused further treatment|1|||
126261259|NCT02190279|454248119|FG000|Overall Study|Screening failure|0|||
126261260|NCT02190279|454248120|FG001|Overall Study|Screening failure|0|||
126261261|NCT02190279|454248121|FG002|Overall Study|Screening failure|1|||
126261262|NCT01467479|454248122|FG000|Overall Study|No Study Medication|1|||
126261263|NCT01467479|454248123|FG001|Overall Study|No Study Medication|0|||
126261264|NCT01467479|454248124|FG002|Overall Study|No Study Medication|2|||
126261265|NCT01467479|454248122|FG000|Overall Study|Adverse Event|1|||
126261266|NCT01467479|454248123|FG001|Overall Study|Adverse Event|2|||
126261267|NCT01467479|454248124|FG002|Overall Study|Adverse Event|0|||
126261268|NCT01467479|454248122|FG000|Overall Study|Death|0|||
126261269|NCT01467479|454248123|FG001|Overall Study|Death|0|||
126261270|NCT01467479|454248124|FG002|Overall Study|Death|1|||
126261271|NCT01467479|454248122|FG000|Overall Study|Lost to Follow-up|2|||
126261272|NCT01467479|454248123|FG001|Overall Study|Lost to Follow-up|5|||
126261273|NCT01467479|454248124|FG002|Overall Study|Lost to Follow-up|3|||
126261274|NCT01467479|454248122|FG000|Overall Study|Withdrawal of Consent|3|||
126261275|NCT01467479|454248123|FG001|Overall Study|Withdrawal of Consent|7|||
126261276|NCT01467479|454248124|FG002|Overall Study|Withdrawal of Consent|7|||
126261277|NCT01467479|454248122|FG000|Overall Study|Study Terminated by Sponsor|1|||
126261278|NCT01467479|454248123|FG001|Overall Study|Study Terminated by Sponsor|3|||
126261279|NCT01467479|454248124|FG002|Overall Study|Study Terminated by Sponsor|3|||
126261280|NCT01467479|454248122|FG000|Overall Study|Other|1|||
126261281|NCT01467479|454248123|FG001|Overall Study|Other|0|||
126261282|NCT01467479|454248124|FG002|Overall Study|Other|0|||
126261283|NCT01197417|454248137|FG000|Overall Study|Physician Decision|3|||
126261284|NCT01197417|454248138|FG001|Overall Study|Physician Decision|2|||
126261285|NCT01197417|454248137|FG000|Overall Study|Withdrawal by Subject|2|||
126261286|NCT01197417|454248138|FG001|Overall Study|Withdrawal by Subject|4|||
126261287|NCT01197417|454248137|FG000|Overall Study|Site miscommunication|0|||
126261288|NCT01197417|454248138|FG001|Overall Study|Site miscommunication|1|||
126261289|NCT01197417|454248137|FG000|Overall Study|Subject transferred to intensive care|0|||
126261290|NCT01197417|454248138|FG001|Overall Study|Subject transferred to intensive care|1|||
126261291|NCT01197417|454248137|FG000|Overall Study|Not consented in time to receive drug|0|||
126261292|NCT01197417|454248138|FG001|Overall Study|Not consented in time to receive drug|1|||
126261293|NCT01197417|454248137|FG000|Overall Study|Hypotension|1|||
126261294|NCT01197417|454248138|FG001|Overall Study|Hypotension|2|||
126261295|NCT01197417|454248137|FG000|Overall Study|Found to be ineligible|2|||
126261296|NCT01197417|454248138|FG001|Overall Study|Found to be ineligible|5|||
126261297|NCT01197417|454248137|FG000|Overall Study|No 25-hour magnesium level|0|||
126261298|NCT01197417|454248138|FG001|Overall Study|No 25-hour magnesium level|2|||
126261299|NCT02070757|454248139|FG000|Overall Study|Adverse Event|107|||
126261300|NCT02070757|454248140|FG001|Overall Study|Adverse Event|99|||
126261301|NCT02070757|454248139|FG000|Overall Study|Lost to Follow-up|7|||
126261302|NCT02070757|454248140|FG001|Overall Study|Lost to Follow-up|4|||
126261303|NCT02070757|454248139|FG000|Overall Study|Protocol Violation|0|||
126261304|NCT02070757|454248140|FG001|Overall Study|Protocol Violation|4|||
126261305|NCT02070757|454248139|FG000|Overall Study|Withdrawal by Subject|1|||
126261306|NCT02070757|454248140|FG001|Overall Study|Withdrawal by Subject|3|||
126261307|NCT02070757|454248139|FG000|Overall Study|Investigator Decision|0|||
126261308|NCT02070757|454248140|FG001|Overall Study|Investigator Decision|2|||
126261309|NCT02070757|454248139|FG000|Overall Study|Discharged from Study Hospital|2|||
126261310|NCT02070757|454248140|FG001|Overall Study|Discharged from Study Hospital|2|||
126261311|NCT01546922|454248141|FG000|First Period of 10 Weeks|Protocol Violation|3|||
126451935|NCT02709538|454957133|FG001|Overall Study|Non-compliance with study drug|0|||
126451936|NCT02709538|454957134|FG002|Overall Study|Non-compliance with study drug|0|||
126451937|NCT02709538|454957132|FG000|Overall Study|Protocol deviation|10|||
126451938|NCT02709538|454957133|FG001|Overall Study|Protocol deviation|4|||
126451939|NCT02709538|454957134|FG002|Overall Study|Protocol deviation|4|||
126451940|NCT02709538|454957132|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
126451941|NCT02709538|454957133|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
126451942|NCT02709538|454957134|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
126451943|NCT02709538|454957132|FG000|Overall Study|Other|16|||
126451944|NCT02709538|454957133|FG001|Overall Study|Other|7|||
126699886|NCT00481065|455851321|FG001|Overall Study|Unable to classify|1|||
126699887|NCT00481065|455851322|FG002|Overall Study|Unable to classify|2|||
126699888|NCT00481065|455851323|FG003|Overall Study|Unable to classify|0|||
126699889|NCT00481065|455851324|FG004|Overall Study|Unable to classify|1|||
126699890|NCT00481065|455851325|FG005|Overall Study|Unable to classify|0|||
126261312|NCT01546922|454248142|FG001|First Period of 10 Weeks|Protocol Violation|1|||
126261313|NCT01546922|454248141|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
126261314|NCT01546922|454248142|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
126261315|NCT01546922|454248141|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
126261316|NCT01546922|454248142|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
126261317|NCT01546922|454248141|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
126451945|NCT02709538|454957134|FG002|Overall Study|Other|5|||
126451946|NCT02160041|454957135|FG000|Overall Study|Adverse Event|11|||
126451947|NCT02160041|454957135|FG000|Overall Study|Death|2|||
126451948|NCT02160041|454957135|FG000|Overall Study|disease progression|57|||
126451949|NCT02160041|454957135|FG000|Overall Study|Protocol Violation|1|||
126451950|NCT02160041|454957135|FG000|Overall Study|non-compliance with study|1|||
126451951|NCT02160041|454957135|FG000|Overall Study|Physician Decision|3|||
126451952|NCT02160041|454957135|FG000|Overall Study|Withdrawal by Subject|8|||
126451953|NCT02160041|454957135|FG000|Overall Study|study terminated by by sponsor|1|||
126451954|NCT01090323|454957136|FG000|Overall Study|Adverse Event|12|||
126451955|NCT01090323|454957137|FG001|Overall Study|Adverse Event|2|||
126451956|NCT01090323|454957136|FG000|Overall Study|Abnormal Lab Values|3|||
126451957|NCT01090323|454957137|FG001|Overall Study|Abnormal Lab Values|1|||
126451958|NCT01090323|454957136|FG000|Overall Study|Abnormal Test Procedure Results|2|||
126451959|NCT01090323|454957137|FG001|Overall Study|Abnormal Test Procedure Results|0|||
126451960|NCT01090323|454957136|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126451961|NCT01090323|454957137|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126451962|NCT01090323|454957136|FG000|Overall Study|Condition no longer requires drug|5|||
126451963|NCT01090323|454957137|FG001|Overall Study|Condition no longer requires drug|4|||
126451964|NCT01090323|454957136|FG000|Overall Study|Protocol Violation|2|||
126451965|NCT01090323|454957137|FG001|Overall Study|Protocol Violation|1|||
126451966|NCT01090323|454957136|FG000|Overall Study|Withdrew consent|33|||
126451967|NCT01090323|454957137|FG001|Overall Study|Withdrew consent|11|||
126451968|NCT01090323|454957136|FG000|Overall Study|Lost to Follow-up|11|||
126451969|NCT01090323|454957137|FG001|Overall Study|Lost to Follow-up|6|||
126451970|NCT01090323|454957136|FG000|Overall Study|Administrative problems|6|||
126451971|NCT01090323|454957137|FG001|Overall Study|Administrative problems|4|||
126451972|NCT01090323|454957136|FG000|Overall Study|Death|1|||
126451973|NCT01090323|454957137|FG001|Overall Study|Death|2|||
126451974|NCT01090323|454957136|FG000|Overall Study|Stopped end of core|7|||
126451975|NCT01090323|454957137|FG001|Overall Study|Stopped end of core|0|||
126451976|NCT01090323|454957136|FG000|Overall Study|Stopped end of extension 1#|3|||
126451977|NCT01090323|454957137|FG001|Overall Study|Stopped end of extension 1#|1|||
126451978|NCT01864005|454957138|FG000|Overall Study|Protocol Violation|0|||
126451979|NCT01864005|454957139|FG001|Overall Study|Protocol Violation|1|||
126451980|NCT01864005|454957138|FG000|Overall Study|Withdrawal by Subject|0|||
126699891|NCT00481065|455851326|FG006|Overall Study|Unable to classify|0|||
126699892|NCT00481065|455851327|FG007|Overall Study|Unable to classify|0|||
126699893|NCT01709331|455851330|FG000|Overall Study|Adverse Event|1|||
126699894|NCT03029832|455851333|FG000|Overall Study|Safety Follow-Up Completed|2|||
126699895|NCT03029832|455851334|FG001|Overall Study|Safety Follow-Up Completed|0|||
126699896|NCT03029832|455851333|FG000|Overall Study|Death due to Disease Progression|1|||
126699897|NCT03029832|455851334|FG001|Overall Study|Death due to Disease Progression|0|||
126699898|NCT03029832|455851333|FG000|Overall Study|Study Terminated By Sponsor|1|||
126699899|NCT03029832|455851334|FG001|Overall Study|Study Terminated By Sponsor|1|||
126699900|NCT01628926|455851335|FG000|Overall Study|Adverse Event|13|||
126699901|NCT01628926|455851336|FG001|Overall Study|Adverse Event|11|||
126699902|NCT01628926|455851337|FG002|Overall Study|Adverse Event|9|||
126699903|NCT01628926|455851335|FG000|Overall Study|Lack of Efficacy|2|||
126699904|NCT01628926|455851336|FG001|Overall Study|Lack of Efficacy|1|||
126699905|NCT01628926|455851337|FG002|Overall Study|Lack of Efficacy|5|||
126699906|NCT01628926|455851335|FG000|Overall Study|Withdrawal by Subject|6|||
126699907|NCT01628926|455851336|FG001|Overall Study|Withdrawal by Subject|4|||
126699908|NCT01628926|455851337|FG002|Overall Study|Withdrawal by Subject|2|||
126763503|NCT04668066|456086803|FG010|Part 1: Follow-Up|Other|0|||
126699909|NCT01628926|455851335|FG000|Overall Study|Protocol Violation|0|||
126261318|NCT01546922|454248142|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
126261319|NCT01546922|454248141|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
126261320|NCT01546922|454248142|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
126261321|NCT01613378|454248148|FG000|Overall Study|Lack of Efficacy|13|||
126261322|NCT01613378|454248148|FG000|Overall Study|Adverse Event|11|||
126261323|NCT01613378|454248148|FG000|Overall Study|Withdrawal by Subject|8|||
126261324|NCT01613378|454248148|FG000|Overall Study|Death|2|||
126261325|NCT01613378|454248148|FG000|Overall Study|Lost to Follow-up|1|||
126261326|NCT01613378|454248148|FG000|Overall Study|Other Reason|4|||
126261327|NCT00792623|454248158|FG000|Overall Study|Adverse Event|2|||
126261328|NCT00792623|454248158|FG000|Overall Study|Withdrawal by Subject|5|||
126261329|NCT00880087|454248159|FG000|Overall Study|Lost to Follow-up|0|||
126261330|NCT00880087|454248160|FG001|Overall Study|Lost to Follow-up|2|||
126261331|NCT01311557|454248161|FG000|Overall Study|Serious adverse event|0|||
126261332|NCT01311557|454248162|FG001|Overall Study|Serious adverse event|1|||
126261333|NCT01311557|454248161|FG000|Overall Study|Protocol Violation|4|||
126261334|NCT01311557|454248162|FG001|Overall Study|Protocol Violation|2|||
126261335|NCT01311557|454248161|FG000|Overall Study|Lost to Follow-up|0|||
126261336|NCT01311557|454248162|FG001|Overall Study|Lost to Follow-up|1|||
126261337|NCT01311557|454248161|FG000|Overall Study|Withdrawal by Subject|1|||
126261338|NCT01311557|454248162|FG001|Overall Study|Withdrawal by Subject|2|||
126261339|NCT00572039|454248163|FG000|Overall Study|Withdrawal by Subject|9|||
126261340|NCT00572039|454248164|FG001|Overall Study|Withdrawal by Subject|6|||
126261341|NCT00572039|454248163|FG000|Overall Study|Death|2|||
126261342|NCT00572039|454248164|FG001|Overall Study|Death|3|||
126261343|NCT00572039|454248163|FG000|Overall Study|Ill|5|||
126261344|NCT00572039|454248164|FG001|Overall Study|Ill|1|||
126261345|NCT01470417|454248167|FG000|Overall Study|Disease progression|0|||
126261346|NCT01470417|454248168|FG001|Overall Study|Disease progression|2|||
126261347|NCT02418455|454248169|FG000|48-Week Treatment Period|Other- Not Specified|1|||
126261348|NCT02418455|454248169|FG000|Continuation Period|Sponsor Decision|7|||
126261349|NCT02973321|454248170|FG000|Overall Study|Other than specified|0|||
126261350|NCT02973321|454248171|FG001|Overall Study|Other than specified|5|||
126261351|NCT02973321|454248172|FG002|Overall Study|Other than specified|3|||
126261352|NCT02973321|454248173|FG003|Overall Study|Other than specified|3|||
126261353|NCT02973321|454248174|FG004|Overall Study|Other than specified|1|||
126261354|NCT02973321|454248170|FG000|Overall Study|Lack of Efficacy|0|||
126261355|NCT02973321|454248171|FG001|Overall Study|Lack of Efficacy|0|||
126261356|NCT02973321|454248172|FG002|Overall Study|Lack of Efficacy|0|||
126261357|NCT02973321|454248173|FG003|Overall Study|Lack of Efficacy|0|||
126261358|NCT02973321|454248174|FG004|Overall Study|Lack of Efficacy|1|||
126261359|NCT02973321|454248170|FG000|Overall Study|Adverse Event|1|||
126261360|NCT02973321|454248171|FG001|Overall Study|Adverse Event|10|||
126261361|NCT02973321|454248172|FG002|Overall Study|Adverse Event|11|||
126261362|NCT02973321|454248173|FG003|Overall Study|Adverse Event|13|||
126261363|NCT02973321|454248174|FG004|Overall Study|Adverse Event|3|||
126451981|NCT01864005|454957139|FG001|Overall Study|Withdrawal by Subject|1|||
126451982|NCT01864005|454957138|FG000|Overall Study|Incorrect enrolment|1|||
126699910|NCT01628926|455851336|FG001|Overall Study|Protocol Violation|1|||
126699911|NCT01628926|455851337|FG002|Overall Study|Protocol Violation|0|||
126699912|NCT01628926|455851335|FG000|Overall Study|Discontinuation criteria|3|||
126699913|NCT01628926|455851336|FG001|Overall Study|Discontinuation criteria|4|||
126699914|NCT01628926|455851337|FG002|Overall Study|Discontinuation criteria|0|||
126699915|NCT01628926|455851335|FG000|Overall Study|Physician Decision|2|||
126699916|NCT01628926|455851336|FG001|Overall Study|Physician Decision|2|||
126699917|NCT01628926|455851337|FG002|Overall Study|Physician Decision|1|||
126699918|NCT02875223|455851339|FG000|Overall Study|Other reasons|0|||
126699919|NCT02875223|455851340|FG001|Overall Study|Other reasons|0|||
126699920|NCT02875223|455851341|FG002|Overall Study|Other reasons|1|||
126699921|NCT02875223|455851342|FG003|Overall Study|Other reasons|0|||
126699922|NCT02875223|455851343|FG004|Overall Study|Other reasons|1|||
126699923|NCT02875223|455851344|FG005|Overall Study|Other reasons|2|||
126763504|NCT04668066|456086804|FG011|Part 1: Follow-Up|Other|1|||
126261364|NCT01790113|454248181|FG000|Overall Study|Adverse Event|2|||
126261365|NCT01790113|454248182|FG001|Overall Study|Adverse Event|7|||
126261366|NCT01790113|454248181|FG000|Overall Study|Study ended due to FDA clearance|1|||
126261367|NCT01790113|454248182|FG001|Overall Study|Study ended due to FDA clearance|68|||
126261368|NCT00194792|454248183|FG000|Overall Study|Withdrawal by Subject|1|||
126699924|NCT02875223|455851345|FG006|Overall Study|Other reasons|0|||
126261369|NCT01714739|454248184|FG000|Overall Study|Disease progression|3|||
126261370|NCT01714739|454248185|FG001|Overall Study|Disease progression|5|||
126261371|NCT01714739|454248186|FG002|Overall Study|Disease progression|5|||
126261372|NCT01714739|454248187|FG003|Overall Study|Disease progression|204|||
126261373|NCT01714739|454248188|FG004|Overall Study|Disease progression|1|||
126261374|NCT01714739|454248189|FG005|Overall Study|Disease progression|3|||
126261375|NCT01714739|454248190|FG006|Overall Study|Disease progression|5|||
126699925|NCT02875223|455851346|FG007|Overall Study|Other reasons|2|||
126699926|NCT02875223|455851347|FG008|Overall Study|Other reasons|0|||
126699927|NCT02875223|455851348|FG009|Overall Study|Other reasons|0|||
126699928|NCT02875223|455851349|FG010|Overall Study|Other reasons|0|||
126699929|NCT02875223|455851350|FG011|Overall Study|Other reasons|0|||
126699930|NCT02875223|455851351|FG012|Overall Study|Other reasons|0|||
126699931|NCT02875223|455851339|FG000|Overall Study|Withdrawal by Subject|0|||
126699932|NCT02875223|455851340|FG001|Overall Study|Withdrawal by Subject|0|||
126699933|NCT02875223|455851341|FG002|Overall Study|Withdrawal by Subject|0|||
126699934|NCT02875223|455851342|FG003|Overall Study|Withdrawal by Subject|0|||
126699935|NCT02875223|455851343|FG004|Overall Study|Withdrawal by Subject|1|||
126699936|NCT02875223|455851344|FG005|Overall Study|Withdrawal by Subject|1|||
126699937|NCT02875223|455851345|FG006|Overall Study|Withdrawal by Subject|0|||
126699938|NCT02875223|455851346|FG007|Overall Study|Withdrawal by Subject|0|||
126699939|NCT02875223|455851347|FG008|Overall Study|Withdrawal by Subject|1|||
126699940|NCT02875223|455851348|FG009|Overall Study|Withdrawal by Subject|0|||
126699941|NCT02875223|455851349|FG010|Overall Study|Withdrawal by Subject|0|||
126699942|NCT02875223|455851350|FG011|Overall Study|Withdrawal by Subject|0|||
126699943|NCT02875223|455851351|FG012|Overall Study|Withdrawal by Subject|0|||
126699944|NCT02875223|455851339|FG000|Overall Study|Progressive disease|0|||
126699945|NCT02875223|455851340|FG001|Overall Study|Progressive disease|0|||
126699946|NCT02875223|455851341|FG002|Overall Study|Progressive disease|1|||
126699947|NCT02875223|455851342|FG003|Overall Study|Progressive disease|0|||
126699948|NCT02875223|455851343|FG004|Overall Study|Progressive disease|0|||
126699949|NCT02875223|455851344|FG005|Overall Study|Progressive disease|0|||
126699950|NCT02875223|455851345|FG006|Overall Study|Progressive disease|0|||
126699951|NCT02875223|455851346|FG007|Overall Study|Progressive disease|0|||
126699952|NCT02875223|455851347|FG008|Overall Study|Progressive disease|0|||
126699953|NCT02875223|455851348|FG009|Overall Study|Progressive disease|12|||
126699954|NCT02875223|455851349|FG010|Overall Study|Progressive disease|2|||
126699955|NCT02875223|455851350|FG011|Overall Study|Progressive disease|3|||
126699956|NCT02875223|455851351|FG012|Overall Study|Progressive disease|6|||
126699957|NCT02875223|455851339|FG000|Overall Study|Death|4|||
126699958|NCT02875223|455851340|FG001|Overall Study|Death|4|||
126699959|NCT02875223|455851341|FG002|Overall Study|Death|3|||
126699960|NCT02875223|455851342|FG003|Overall Study|Death|4|||
126699961|NCT02875223|455851343|FG004|Overall Study|Death|2|||
126699962|NCT02875223|455851344|FG005|Overall Study|Death|3|||
126699963|NCT02875223|455851345|FG006|Overall Study|Death|5|||
126699964|NCT02875223|455851346|FG007|Overall Study|Death|7|||
126699965|NCT02875223|455851347|FG008|Overall Study|Death|3|||
126699966|NCT02875223|455851348|FG009|Overall Study|Death|2|||
126699967|NCT02875223|455851349|FG010|Overall Study|Death|0|||
126699968|NCT02875223|455851350|FG011|Overall Study|Death|0|||
126699969|NCT02875223|455851351|FG012|Overall Study|Death|0|||
126699970|NCT02875223|455851339|FG000|Overall Study|Lost to Follow-up|0|||
126699971|NCT02875223|455851340|FG001|Overall Study|Lost to Follow-up|1|||
126699972|NCT02875223|455851341|FG002|Overall Study|Lost to Follow-up|1|||
126699973|NCT02875223|455851342|FG003|Overall Study|Lost to Follow-up|0|||
126699974|NCT02875223|455851343|FG004|Overall Study|Lost to Follow-up|1|||
126699975|NCT02875223|455851344|FG005|Overall Study|Lost to Follow-up|0|||
126699976|NCT02875223|455851345|FG006|Overall Study|Lost to Follow-up|1|||
126699977|NCT02875223|455851346|FG007|Overall Study|Lost to Follow-up|1|||
126699978|NCT02875223|455851347|FG008|Overall Study|Lost to Follow-up|0|||
126261376|NCT01714739|454248184|FG000|Overall Study|Study drug toxicity|1|||
126261377|NCT01714739|454248185|FG001|Overall Study|Study drug toxicity|1|||
126261378|NCT01714739|454248186|FG002|Overall Study|Study drug toxicity|1|||
126261379|NCT01714739|454248187|FG003|Overall Study|Study drug toxicity|15|||
126699979|NCT02875223|455851348|FG009|Overall Study|Lost to Follow-up|0|||
126699980|NCT02875223|455851349|FG010|Overall Study|Lost to Follow-up|0|||
126699981|NCT02875223|455851350|FG011|Overall Study|Lost to Follow-up|0|||
126763505|NCT04668066|456086805|FG012|Part 1: Follow-Up|Other|1|||
126261380|NCT01714739|454248188|FG004|Overall Study|Study drug toxicity|0|||
126261381|NCT01714739|454248189|FG005|Overall Study|Study drug toxicity|0|||
126699982|NCT02875223|455851351|FG012|Overall Study|Lost to Follow-up|0|||
126699983|NCT01707992|455851354|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
126699984|NCT01707992|455851355|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
126699985|NCT01707992|455851356|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
126699986|NCT01707992|455851357|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
126699987|NCT01707992|455851358|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
126699988|NCT01707992|455851359|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
126261382|NCT01714739|454248190|FG006|Overall Study|Study drug toxicity|5|||
126699989|NCT01707992|455851354|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
126699990|NCT01707992|455851355|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
126699991|NCT01707992|455851356|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
126699992|NCT01707992|455851357|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
126699993|NCT01707992|455851358|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
126699994|NCT01707992|455851359|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
126261383|NCT01714739|454248184|FG000|Overall Study|Death|0|||
126699995|NCT01707992|455851354|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
126763506|NCT04668066|456086806|FG013|Part 1: Follow-Up|Other|0|||
126261384|NCT01714739|454248185|FG001|Overall Study|Death|0|||
126261385|NCT01714739|454248186|FG002|Overall Study|Death|0|||
126261386|NCT01714739|454248187|FG003|Overall Study|Death|1|||
126261387|NCT01714739|454248188|FG004|Overall Study|Death|0|||
126261388|NCT01714739|454248189|FG005|Overall Study|Death|0|||
126261389|NCT01714739|454248190|FG006|Overall Study|Death|0|||
126261390|NCT01714739|454248184|FG000|Overall Study|Adverse Event unrelated to drug|0|||
126261391|NCT01714739|454248185|FG001|Overall Study|Adverse Event unrelated to drug|0|||
126261392|NCT01714739|454248186|FG002|Overall Study|Adverse Event unrelated to drug|3|||
126261393|NCT01714739|454248187|FG003|Overall Study|Adverse Event unrelated to drug|21|||
126261394|NCT01714739|454248188|FG004|Overall Study|Adverse Event unrelated to drug|0|||
126261395|NCT01714739|454248189|FG005|Overall Study|Adverse Event unrelated to drug|0|||
126261396|NCT01714739|454248190|FG006|Overall Study|Adverse Event unrelated to drug|0|||
126261397|NCT01714739|454248184|FG000|Overall Study|Participant request to stop therapy|0|||
126261398|NCT01714739|454248185|FG001|Overall Study|Participant request to stop therapy|1|||
126261399|NCT01714739|454248186|FG002|Overall Study|Participant request to stop therapy|0|||
126261400|NCT01714739|454248187|FG003|Overall Study|Participant request to stop therapy|6|||
126261401|NCT01714739|454248188|FG004|Overall Study|Participant request to stop therapy|0|||
126261402|NCT01714739|454248189|FG005|Overall Study|Participant request to stop therapy|0|||
126261403|NCT01714739|454248190|FG006|Overall Study|Participant request to stop therapy|0|||
126261404|NCT01714739|454248184|FG000|Overall Study|Participant withdrew consent|0|||
126261405|NCT01714739|454248185|FG001|Overall Study|Participant withdrew consent|1|||
126261406|NCT01714739|454248186|FG002|Overall Study|Participant withdrew consent|0|||
126261407|NCT01714739|454248187|FG003|Overall Study|Participant withdrew consent|8|||
126261408|NCT01714739|454248188|FG004|Overall Study|Participant withdrew consent|0|||
126261409|NCT01714739|454248189|FG005|Overall Study|Participant withdrew consent|0|||
126261410|NCT01714739|454248190|FG006|Overall Study|Participant withdrew consent|0|||
126261411|NCT01714739|454248184|FG000|Overall Study|Lost to Follow-up|0|||
126261412|NCT01714739|454248185|FG001|Overall Study|Lost to Follow-up|0|||
126261413|NCT01714739|454248186|FG002|Overall Study|Lost to Follow-up|0|||
126261414|NCT01714739|454248187|FG003|Overall Study|Lost to Follow-up|1|||
126261415|NCT01714739|454248188|FG004|Overall Study|Lost to Follow-up|0|||
126261416|NCT01714739|454248189|FG005|Overall Study|Lost to Follow-up|0|||
126261417|NCT01714739|454248190|FG006|Overall Study|Lost to Follow-up|0|||
126261418|NCT01714739|454248184|FG000|Overall Study|Maximum clinical benefit|0|||
126261419|NCT01714739|454248185|FG001|Overall Study|Maximum clinical benefit|1|||
126261420|NCT01714739|454248186|FG002|Overall Study|Maximum clinical benefit|1|||
126261421|NCT01714739|454248187|FG003|Overall Study|Maximum clinical benefit|3|||
126261422|NCT01714739|454248188|FG004|Overall Study|Maximum clinical benefit|0|||
126261423|NCT01714739|454248189|FG005|Overall Study|Maximum clinical benefit|0|||
126261424|NCT01714739|454248190|FG006|Overall Study|Maximum clinical benefit|0|||
126261425|NCT01714739|454248184|FG000|Overall Study|Poor/non-comliance|0|||
126261426|NCT01714739|454248185|FG001|Overall Study|Poor/non-comliance|1|||
126261427|NCT01714739|454248186|FG002|Overall Study|Poor/non-comliance|0|||
126261428|NCT01714739|454248187|FG003|Overall Study|Poor/non-comliance|1|||
126261429|NCT01714739|454248188|FG004|Overall Study|Poor/non-comliance|0|||
126699996|NCT01707992|455851355|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
126699997|NCT01707992|455851356|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
126699998|NCT01707992|455851357|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
126699999|NCT01707992|455851358|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
126700000|NCT01707992|455851359|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
126261430|NCT01714739|454248189|FG005|Overall Study|Poor/non-comliance|0|||
126261431|NCT01714739|454248190|FG006|Overall Study|Poor/non-comliance|0|||
126261432|NCT01714739|454248184|FG000|Overall Study|No longer meets study criteria|0|||
126261433|NCT01714739|454248185|FG001|Overall Study|No longer meets study criteria|0|||
126261434|NCT01714739|454248186|FG002|Overall Study|No longer meets study criteria|0|||
126261435|NCT01714739|454248187|FG003|Overall Study|No longer meets study criteria|1|||
126261436|NCT01714739|454248188|FG004|Overall Study|No longer meets study criteria|0|||
126261437|NCT01714739|454248189|FG005|Overall Study|No longer meets study criteria|0|||
126261438|NCT01714739|454248190|FG006|Overall Study|No longer meets study criteria|0|||
126261439|NCT01714739|454248184|FG000|Overall Study|Other reason|0|||
126261440|NCT01714739|454248185|FG001|Overall Study|Other reason|0|||
126261441|NCT01714739|454248186|FG002|Overall Study|Other reason|0|||
126261442|NCT01714739|454248187|FG003|Overall Study|Other reason|3|||
126261443|NCT01714739|454248188|FG004|Overall Study|Other reason|1|||
126261444|NCT01714739|454248189|FG005|Overall Study|Other reason|0|||
126261445|NCT01714739|454248190|FG006|Overall Study|Other reason|0|||
126261446|NCT03585959|454248191|FG000|Overall Study|Physician Decision|1|||
126700001|NCT01707992|455851354|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
126700002|NCT01707992|455851355|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
126261447|NCT03585959|454248191|FG000|Overall Study|Unsuccessful Procedure|2|||
126261448|NCT00865514|454248192|FG000|Overall Study|Infusion cost exceeded funding|2|||
126261449|NCT03920280|454248193|FG000|Overall Study|Adverse Event|2|||
126261450|NCT03920280|454248194|FG001|Overall Study|Adverse Event|3|||
126261451|NCT03920280|454248193|FG000|Overall Study|Lost to Follow-up|0|||
126261452|NCT03920280|454248194|FG001|Overall Study|Lost to Follow-up|1|||
126261453|NCT03920280|454248193|FG000|Overall Study|Withdrawal by Subject|1|||
126261454|NCT03920280|454248194|FG001|Overall Study|Withdrawal by Subject|1|||
126261455|NCT03920280|454248193|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
126261456|NCT03920280|454248194|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
126261457|NCT01857206|454248196|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
126261458|NCT01857206|454248197|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
126261459|NCT01857206|454248196|FG000|Overall Study|Lost to Follow-up|9|||
126261460|NCT01857206|454248197|FG001|Overall Study|Lost to Follow-up|6|||
126261461|NCT01857206|454248196|FG000|Overall Study|Unclassified|3|||
126261462|NCT01857206|454248197|FG001|Overall Study|Unclassified|3|||
126261463|NCT01857206|454248196|FG000|Overall Study|Withdrawal by Subject|1|||
126261464|NCT01857206|454248197|FG001|Overall Study|Withdrawal by Subject|0|||
126261465|NCT01857973|454248199|FG000|Overall Study|Subject did not meet required BG range|3|||
126261466|NCT01857973|454248199|FG000|Overall Study|drop out after 3 failed attempts|1|||
126261467|NCT01857973|454248199|FG000|Overall Study|Physician Decision|1|||
126261468|NCT01731886|454248208|FG000|Overall Study|Death|1|||
126261469|NCT01731886|454248209|FG001|Overall Study|Death|0|||
126261470|NCT01731886|454248208|FG000|Overall Study|Never started treatment|0|||
126261471|NCT01731886|454248209|FG001|Overall Study|Never started treatment|1|||
126261472|NCT01731886|454248208|FG000|Overall Study|Non-compliant|1|||
126261473|NCT01731886|454248209|FG001|Overall Study|Non-compliant|0|||
126261474|NCT00129116|454248210|FG000|Primary Phase|Lost to Follow-up|1|||
126261475|NCT00129116|454248211|FG001|Primary Phase|Lost to Follow-up|1|||
126261476|NCT00129116|454248212|FG002|Primary Phase|Lost to Follow-up|0|||
126261477|NCT00129116|454248213|FG003|Primary Phase|Lost to Follow-up|1|||
126261478|NCT00129116|454248214|FG004|Primary Phase|Lost to Follow-up|1|||
126261479|NCT00129116|454248210|FG000|Primary Phase|Protocol Violation|0|||
126261480|NCT00129116|454248211|FG001|Primary Phase|Protocol Violation|1|||
126261481|NCT00129116|454248212|FG002|Primary Phase|Protocol Violation|0|||
126261482|NCT00129116|454248213|FG003|Primary Phase|Protocol Violation|0|||
126261483|NCT00129116|454248214|FG004|Primary Phase|Protocol Violation|0|||
126261484|NCT00129116|454248210|FG000|Primary Phase|Adverse Event|1|||
126261485|NCT00129116|454248211|FG001|Primary Phase|Adverse Event|1|||
126261486|NCT00129116|454248212|FG002|Primary Phase|Adverse Event|0|||
126261487|NCT00129116|454248213|FG003|Primary Phase|Adverse Event|0|||
126261488|NCT00129116|454248214|FG004|Primary Phase|Adverse Event|0|||
126261489|NCT00129116|454248210|FG000|Primary Phase|Withdrawal by Subject|0|||
126261490|NCT00129116|454248211|FG001|Primary Phase|Withdrawal by Subject|1|||
126261491|NCT00129116|454248212|FG002|Primary Phase|Withdrawal by Subject|0|||
126261492|NCT00129116|454248213|FG003|Primary Phase|Withdrawal by Subject|0|||
126261493|NCT00129116|454248214|FG004|Primary Phase|Withdrawal by Subject|0|||
126451983|NCT01864005|454957139|FG001|Overall Study|Incorrect enrolment|0|||
126451984|NCT01864005|454957138|FG000|Overall Study|Disease need|1|||
126451985|NCT01864005|454957139|FG001|Overall Study|Disease need|1|||
126451986|NCT01864005|454957138|FG000|Overall Study|Need GP IIb/IIIa|1|||
126451987|NCT01864005|454957139|FG001|Overall Study|Need GP IIb/IIIa|3|||
126451988|NCT00763698|454957140|FG000|Overall Study|Unsuccessful Implant|5|||
126451989|NCT00763698|454957140|FG000|Overall Study|Death|4|||
126451990|NCT00763698|454957140|FG000|Overall Study|Withdrawal by Subject|1|||
126451991|NCT02059291|454957141|FG000|Epoch 2|Lack of Efficacy|0|||
126451992|NCT02059291|454957142|FG001|Epoch 2|Lack of Efficacy|0|||
126451993|NCT02059291|454957143|FG002|Epoch 2|Lack of Efficacy|0|||
126451994|NCT02059291|454957144|FG003|Epoch 2|Lack of Efficacy|1|||
126451995|NCT02059291|454957145|FG004|Epoch 2|Lack of Efficacy|0|||
126451996|NCT02059291|454957146|FG005|Epoch 2|Lack of Efficacy|1|||
126451997|NCT02059291|454957147|FG006|Epoch 2|Lack of Efficacy|0|||
126763507|NCT04668066|456086807|FG014|Part 1: Follow-Up|Other|0|||
126451998|NCT02059291|454957148|FG007|Epoch 2|Lack of Efficacy|0|||
126451999|NCT02059291|454957149|FG008|Epoch 2|Lack of Efficacy|0|||
126261494|NCT00129116|454248210|FG000|Primary Phase|Other|0|||
126261495|NCT00129116|454248211|FG001|Primary Phase|Other|0|||
126261496|NCT00129116|454248212|FG002|Primary Phase|Other|1|||
126261497|NCT00129116|454248213|FG003|Primary Phase|Other|0|||
126261498|NCT00129116|454248214|FG004|Primary Phase|Other|0|||
126261499|NCT00129116|454248210|FG000|Booster Phase|Lost to Follow-up|2|||
126261500|NCT00129116|454248211|FG001|Booster Phase|Lost to Follow-up|0|||
126261501|NCT00129116|454248212|FG002|Booster Phase|Lost to Follow-up|0|||
126261502|NCT00129116|454248213|FG003|Booster Phase|Lost to Follow-up|0|||
126261503|NCT00129116|454248214|FG004|Booster Phase|Lost to Follow-up|1|||
126261504|NCT00271024|454248215|FG000|Overall Study|Lost Interest|3|||
126261505|NCT00271024|454248216|FG001|Overall Study|Lost Interest|4|||
126261506|NCT00271024|454248217|FG002|Overall Study|Lost Interest|2|||
126261507|NCT00271024|454248218|FG003|Overall Study|Lost Interest|3|||
126261508|NCT00271024|454248215|FG000|Overall Study|Unknown/Unspecified|11|||
126452000|NCT02059291|454957150|FG009|Epoch 2|Lack of Efficacy|0|||
126261509|NCT00271024|454248216|FG001|Overall Study|Unknown/Unspecified|11|||
126261510|NCT00271024|454248217|FG002|Overall Study|Unknown/Unspecified|8|||
126452001|NCT02059291|454957151|FG010|Epoch 2|Lack of Efficacy|0|||
126452002|NCT02059291|454957152|FG011|Epoch 2|Lack of Efficacy|0|||
126763508|NCT04668066|456086808|FG015|Part 1: Follow-Up|Other|0|||
126763509|NCT04668066|456086809|FG016|Part 1: Follow-Up|Other|0|||
126763510|NCT04668066|456086810|FG017|Part 1: Follow-Up|Other|0|||
126763511|NCT04668066|456086811|FG018|Part 1: Follow-Up|Other|0|||
126763512|NCT04668066|456086793|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763513|NCT04668066|456086794|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763514|NCT04668066|456086795|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763515|NCT04668066|456086796|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763516|NCT04668066|456086797|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763517|NCT04668066|456086798|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763518|NCT04668066|456086799|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763519|NCT04668066|456086800|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763520|NCT04668066|456086801|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763521|NCT04668066|456086802|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763522|NCT04668066|456086803|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763523|NCT04668066|456086804|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763524|NCT04668066|456086805|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
126763525|NCT04668066|456086806|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763526|NCT04668066|456086807|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763527|NCT04668066|456086808|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
126763528|NCT04668066|456086809|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763529|NCT04668066|456086810|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
126261511|NCT00271024|454248218|FG003|Overall Study|Unknown/Unspecified|4|||
126261512|NCT00271024|454248215|FG000|Overall Study|Protocol Violation|1|||
126261513|NCT00271024|454248216|FG001|Overall Study|Protocol Violation|6|||
126261514|NCT00271024|454248217|FG002|Overall Study|Protocol Violation|5|||
126261515|NCT00271024|454248218|FG003|Overall Study|Protocol Violation|11|||
126261516|NCT00271024|454248215|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
126261517|NCT00271024|454248216|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
126261518|NCT00271024|454248217|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
126261519|NCT00271024|454248218|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
126261520|NCT00271024|454248215|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
126261521|NCT00271024|454248216|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
126261522|NCT00271024|454248217|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
126261523|NCT00271024|454248218|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
126261524|NCT02487082|454248222|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
126261525|NCT02487082|454248223|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
126261526|NCT02487082|454248222|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
126261527|NCT02487082|454248223|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
126261528|NCT00003531|454248224|FG000|Overall Study|Not evaluable|10|||
126261529|NCT00251316|454248225|FG000|Overall Study|Physician Decision|2|||
126261530|NCT00251316|454248226|FG001|Overall Study|Physician Decision|3|||
126261531|NCT00346164|454248227|FG000|Overall Study|Adverse Event|0|||
126261532|NCT00346164|454248228|FG001|Overall Study|Adverse Event|0|||
126261533|NCT00346164|454248229|FG002|Overall Study|Adverse Event|0|||
126261534|NCT00346164|454248230|FG003|Overall Study|Adverse Event|1|||
126261535|NCT00346164|454248227|FG000|Overall Study|Lack of Efficacy|0|||
126261536|NCT00346164|454248228|FG001|Overall Study|Lack of Efficacy|1|||
126261537|NCT00346164|454248229|FG002|Overall Study|Lack of Efficacy|7|||
126261538|NCT00346164|454248230|FG003|Overall Study|Lack of Efficacy|25|||
126261539|NCT00346164|454248227|FG000|Overall Study|Physician Decision|0|||
126261540|NCT00346164|454248228|FG001|Overall Study|Physician Decision|1|||
126261541|NCT00346164|454248229|FG002|Overall Study|Physician Decision|2|||
126261542|NCT00346164|454248230|FG003|Overall Study|Physician Decision|27|||
126261543|NCT00346164|454248227|FG000|Overall Study|Protocol Violation|6|||
126261544|NCT00346164|454248228|FG001|Overall Study|Protocol Violation|2|||
126452003|NCT02059291|454957153|FG012|Epoch 2|Lack of Efficacy|0|||
126452004|NCT02059291|454957154|FG013|Epoch 2|Lack of Efficacy|0|||
126452005|NCT02059291|454957155|FG014|Epoch 2|Lack of Efficacy|0|||
126452006|NCT02059291|454957156|FG015|Epoch 2|Lack of Efficacy|0|||
126452007|NCT02059291|454957157|FG016|Epoch 2|Lack of Efficacy|0|||
126452008|NCT02059291|454957158|FG017|Epoch 2|Lack of Efficacy|0|||
126452009|NCT02059291|454957159|FG018|Epoch 2|Lack of Efficacy|0|||
126763530|NCT04668066|456086811|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
126763531|NCT04668066|456086793|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763532|NCT04668066|456086794|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763533|NCT04668066|456086795|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763534|NCT04668066|456086796|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126261545|NCT00346164|454248229|FG002|Overall Study|Protocol Violation|10|||
126261546|NCT00346164|454248230|FG003|Overall Study|Protocol Violation|4|||
126261547|NCT00346164|454248227|FG000|Overall Study|Withdrawal by Subject|0|||
126452010|NCT02059291|454957160|FG019|Epoch 2|Lack of Efficacy|0|||
126261548|NCT00346164|454248228|FG001|Overall Study|Withdrawal by Subject|0|||
126261549|NCT00346164|454248229|FG002|Overall Study|Withdrawal by Subject|2|||
126261550|NCT00346164|454248230|FG003|Overall Study|Withdrawal by Subject|0|||
126261551|NCT00346164|454248227|FG000|Overall Study|Ineligible|11|||
126452011|NCT02059291|454957161|FG020|Epoch 2|Lack of Efficacy|0|||
126763535|NCT04668066|456086797|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126700003|NCT01707992|455851356|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
126700004|NCT01707992|455851357|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
126700005|NCT01707992|455851358|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
126700006|NCT01707992|455851359|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
126700007|NCT01707992|455851354|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
126700008|NCT01707992|455851355|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
126700009|NCT01707992|455851356|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
126700010|NCT01707992|455851357|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
126700011|NCT01707992|455851358|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
126700012|NCT01707992|455851359|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
126700013|NCT01707992|455851354|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
126700014|NCT01707992|455851355|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
126700015|NCT01707992|455851356|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
126700016|NCT01707992|455851357|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
126700017|NCT01707992|455851358|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
126700018|NCT01707992|455851359|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
126700019|NCT01707992|455851354|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
126700020|NCT01707992|455851355|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
126700021|NCT01707992|455851356|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
126700022|NCT01707992|455851357|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
126700023|NCT01707992|455851358|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
126700024|NCT01707992|455851359|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
126700025|NCT01707992|455851354|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
126700026|NCT01707992|455851355|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
126700027|NCT01707992|455851356|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
126700028|NCT01707992|455851357|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
126700029|NCT01707992|455851358|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
126700030|NCT01707992|455851359|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
126700031|NCT01707992|455851354|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
126700032|NCT01707992|455851355|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
126700033|NCT01707992|455851356|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
126700034|NCT01707992|455851357|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
126700035|NCT01707992|455851358|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
126700036|NCT01707992|455851359|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
126700037|NCT01707992|455851354|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
126700038|NCT01707992|455851355|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
126700039|NCT01707992|455851356|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
126700040|NCT01707992|455851357|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
126700041|NCT01707992|455851358|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
126700042|NCT01707992|455851359|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
126700043|NCT01707992|455851354|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
126700044|NCT01707992|455851355|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
126700045|NCT01707992|455851356|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
126700046|NCT01707992|455851357|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
126700047|NCT01707992|455851358|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
126700048|NCT01707992|455851359|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
126700049|NCT01707992|455851354|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
126700050|NCT01707992|455851355|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
126700051|NCT01707992|455851356|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
126700052|NCT01707992|455851357|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
126700053|NCT01707992|455851358|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
126700054|NCT01707992|455851359|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
126700055|NCT01707992|455851354|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
126700056|NCT01707992|455851355|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
126700057|NCT01707992|455851356|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
126700058|NCT01707992|455851357|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
126700059|NCT01707992|455851358|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
126700060|NCT01707992|455851359|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
126700061|NCT01707992|455851354|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
126700062|NCT01707992|455851355|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
126700063|NCT01707992|455851356|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
126700064|NCT01707992|455851357|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
126261552|NCT00346164|454248228|FG001|Overall Study|Ineligible|2|||
126700065|NCT01707992|455851358|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
126763536|NCT04668066|456086798|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126452012|NCT02059291|454957162|FG021|Epoch 2|Lack of Efficacy|0|||
126700066|NCT01707992|455851359|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
126700067|NCT01707992|455851354|FG000|Active Treatment Phase (24 Months)|Death|0|||
126700068|NCT01707992|455851355|FG001|Active Treatment Phase (24 Months)|Death|0|||
126700069|NCT01707992|455851356|FG002|Active Treatment Phase (24 Months)|Death|0|||
126700070|NCT01707992|455851357|FG003|Active Treatment Phase (24 Months)|Death|2|||
126700071|NCT01707992|455851358|FG004|Active Treatment Phase (24 Months)|Death|0|||
126700072|NCT01707992|455851359|FG005|Active Treatment Phase (24 Months)|Death|0|||
126700073|NCT01707992|455851354|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
126700074|NCT01707992|455851355|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
126700075|NCT01707992|455851356|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
126700076|NCT01707992|455851357|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
126700077|NCT01707992|455851358|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
126700078|NCT01707992|455851359|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
126700079|NCT01707992|455851354|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
126700080|NCT01707992|455851355|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
126700081|NCT01707992|455851356|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
126700082|NCT01707992|455851357|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
126700083|NCT01707992|455851358|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
126700084|NCT01707992|455851359|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
126700085|NCT01707992|455851354|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
126700086|NCT01707992|455851355|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
126700087|NCT01707992|455851356|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
126700088|NCT01707992|455851357|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
126700089|NCT01707992|455851358|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
126700090|NCT01707992|455851359|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
126700091|NCT01707992|455851354|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
126700092|NCT01707992|455851355|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
126700093|NCT01707992|455851356|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
126700094|NCT01707992|455851357|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
126700095|NCT01707992|455851358|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
126700096|NCT01707992|455851359|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
126700097|NCT00891202|455851363|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
126700098|NCT00891202|455851364|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
126700099|NCT00891202|455851365|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
126700100|NCT00891202|455851366|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
126700101|NCT00891202|455851363|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
126700102|NCT00891202|455851364|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
126700103|NCT00891202|455851365|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
126700104|NCT00891202|455851366|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
126700105|NCT00891202|455851363|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
126700106|NCT00891202|455851364|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
126700107|NCT00891202|455851365|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
126700108|NCT00891202|455851366|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
126700109|NCT00891202|455851363|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
126700110|NCT00891202|455851364|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
126700111|NCT00891202|455851365|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
126700112|NCT00891202|455851366|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
126700113|NCT03313050|455851370|FG000|Stage 2: 12 Months|Adverse Event|0|||
126700114|NCT03313050|455851371|FG001|Stage 2: 12 Months|Adverse Event|0|||
126700115|NCT03313050|455851372|FG002|Stage 2: 12 Months|Adverse Event|0|||
126700116|NCT03313050|455851373|FG003|Stage 2: 12 Months|Adverse Event|1|||
126700117|NCT03313050|455851370|FG000|Stage 2: 12 Months|Death|0|||
126700118|NCT03313050|455851371|FG001|Stage 2: 12 Months|Death|0|||
126700119|NCT03313050|455851372|FG002|Stage 2: 12 Months|Death|3|||
126700120|NCT03313050|455851373|FG003|Stage 2: 12 Months|Death|0|||
126700121|NCT03313050|455851370|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
126700122|NCT03313050|455851371|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
126700123|NCT03313050|455851372|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
126700124|NCT03313050|455851373|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
126700125|NCT03313050|455851370|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
126700126|NCT03313050|455851371|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
126700127|NCT03313050|455851372|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
126700128|NCT03313050|455851373|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
126700129|NCT03313050|455851370|FG000|Stage 2: 12 Months|Protocol deviation|0|||
126700130|NCT03313050|455851371|FG001|Stage 2: 12 Months|Protocol deviation|0|||
126700131|NCT03313050|455851372|FG002|Stage 2: 12 Months|Protocol deviation|7|||
126700132|NCT03313050|455851373|FG003|Stage 2: 12 Months|Protocol deviation|7|||
126700133|NCT03313050|455851370|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
126546844|NCT03029780|455296066|FG000|Overall Study|Participant request to discontinue study treatment|4|||
126261553|NCT00346164|454248229|FG002|Overall Study|Ineligible|2|||
126261554|NCT00346164|454248230|FG003|Overall Study|Ineligible|23|||
126261555|NCT00346164|454248227|FG000|Overall Study|Refusal of further protocol therapy|0|||
126261556|NCT00346164|454248228|FG001|Overall Study|Refusal of further protocol therapy|1|||
126261557|NCT00346164|454248229|FG002|Overall Study|Refusal of further protocol therapy|3|||
126261558|NCT00346164|454248230|FG003|Overall Study|Refusal of further protocol therapy|15|||
126261559|NCT00346164|454248227|FG000|Overall Study|Inability to start week 16 tx on time|0|||
126359596|NCT02255279|454609003|FG001|Overall Study|Withdrawal by Subject|6|||
126261560|NCT00346164|454248228|FG001|Overall Study|Inability to start week 16 tx on time|0|||
126261561|NCT00346164|454248229|FG002|Overall Study|Inability to start week 16 tx on time|0|||
126261562|NCT00346164|454248230|FG003|Overall Study|Inability to start week 16 tx on time|11|||
126261563|NCT00467831|454248231|FG000|Overall Study|Death|2|||
126261564|NCT00467831|454248231|FG000|Overall Study|Withdrawal by Subject|1|||
126261565|NCT01198873|454248232|FG000|Overall Study|Adverse Event|4|||
126261566|NCT01198873|454248233|FG001|Overall Study|Adverse Event|7|||
126261567|NCT01198873|454248232|FG000|Overall Study|Study closure|29|||
126261568|NCT01198873|454248233|FG001|Overall Study|Study closure|23|||
126261569|NCT01198873|454248232|FG000|Overall Study|Other than above|4|||
126261570|NCT01198873|454248233|FG001|Overall Study|Other than above|2|||
126261571|NCT03139240|454248234|FG000|Overall Study|Lost to Follow-up|0|||
126261572|NCT03139240|454248235|FG001|Overall Study|Lost to Follow-up|1|||
126261573|NCT03139240|454248236|FG002|Overall Study|Lost to Follow-up|1|||
126261574|NCT03139240|454248237|FG003|Overall Study|Lost to Follow-up|0|||
126261575|NCT00171340|454248238|FG000|Overall Study|Adverse Event|46|||
126261576|NCT00171340|454248239|FG001|Overall Study|Adverse Event|42|||
126261577|NCT00171340|454248238|FG000|Overall Study|Lack of Efficacy|29|||
126261578|NCT00171340|454248239|FG001|Overall Study|Lack of Efficacy|41|||
126261579|NCT00171340|454248238|FG000|Overall Study|Protocol Violation|7|||
126261580|NCT00171340|454248239|FG001|Overall Study|Protocol Violation|8|||
126261581|NCT00171340|454248238|FG000|Overall Study|Withdrawal by Subject|22|||
126261582|NCT00171340|454248239|FG001|Overall Study|Withdrawal by Subject|19|||
126261583|NCT00171340|454248238|FG000|Overall Study|Lost to Follow-up|0|||
126261584|NCT00171340|454248239|FG001|Overall Study|Lost to Follow-up|5|||
126261585|NCT00171340|454248238|FG000|Overall Study|Abnormal Laboratory Results|2|||
126261586|NCT00171340|454248239|FG001|Overall Study|Abnormal Laboratory Results|0|||
126261587|NCT00171340|454248238|FG000|Overall Study|Abnormal Test Procedure Results|6|||
126261588|NCT00171340|454248239|FG001|Overall Study|Abnormal Test Procedure Results|11|||
126261589|NCT00171340|454248238|FG000|Overall Study|No Longer Required Study Drug|1|||
126261590|NCT00171340|454248239|FG001|Overall Study|No Longer Required Study Drug|1|||
126261591|NCT00171340|454248238|FG000|Overall Study|Administrative Problems|5|||
126261592|NCT00171340|454248239|FG001|Overall Study|Administrative Problems|2|||
126261593|NCT00171340|454248238|FG000|Overall Study|Death|6|||
126261594|NCT00171340|454248239|FG001|Overall Study|Death|6|||
126261595|NCT01998243|454248240|FG000|Overall Study|Pregnancy|0|||
126261596|NCT01998243|454248241|FG001|Overall Study|Pregnancy|1|||
126261597|NCT01998243|454248240|FG000|Overall Study|Protocol Violation|5|||
126261598|NCT01998243|454248241|FG001|Overall Study|Protocol Violation|2|||
126261599|NCT01998243|454248240|FG000|Overall Study|Withdrawal by Subject|3|||
126261600|NCT01998243|454248241|FG001|Overall Study|Withdrawal by Subject|4|||
126261601|NCT04569786|454248242|FG000|Overall Study|Lost to Follow-up|1|||
126261602|NCT04569786|454248243|FG001|Overall Study|Lost to Follow-up|0|||
126261603|NCT04569786|454248244|FG002|Overall Study|Lost to Follow-up|4|||
126261604|NCT04569786|454248245|FG003|Overall Study|Lost to Follow-up|1|||
126261605|NCT04569786|454248246|FG004|Overall Study|Lost to Follow-up|0|||
126261606|NCT04569786|454248242|FG000|Overall Study|Withdrawal by Subject|0|||
126261607|NCT04569786|454248243|FG001|Overall Study|Withdrawal by Subject|0|||
126359597|NCT03607695|454609004|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
126359598|NCT03607695|454609004|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
126359599|NCT02741193|454609005|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
126359600|NCT02741193|454609005|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
126359601|NCT02502383|454609006|FG000|Overall Study|Lost to Follow-up|130|||
126359602|NCT02502383|454609007|FG001|Overall Study|Lost to Follow-up|131|||
126359603|NCT02502383|454609006|FG000|Overall Study|Withdrawal by Subject|31|||
126359604|NCT02502383|454609007|FG001|Overall Study|Withdrawal by Subject|24|||
126359605|NCT00363467|454609008|FG000|Overall Study|Physician Decision|1|||
126359606|NCT00527748|454609011|FG000|Overall Study|Other|3|||
126359607|NCT01093885|454609015|FG000|Overall Study|Adverse Event|4|||
126359608|NCT01093885|454609015|FG000|Overall Study|Lost to Follow-up|1|||
126359609|NCT04621786|454609016|FG000|Overall Study|Lost to Follow-up|9|||
126261608|NCT04569786|454248244|FG002|Overall Study|Withdrawal by Subject|0|||
126261609|NCT04569786|454248245|FG003|Overall Study|Withdrawal by Subject|5|||
126261610|NCT04569786|454248246|FG004|Overall Study|Withdrawal by Subject|1|||
126261611|NCT04569786|454248242|FG000|Overall Study|Physician Decision|0|||
126261612|NCT04569786|454248243|FG001|Overall Study|Physician Decision|0|||
126261613|NCT04569786|454248244|FG002|Overall Study|Physician Decision|0|||
126261614|NCT04569786|454248245|FG003|Overall Study|Physician Decision|1|||
126261615|NCT04569786|454248246|FG004|Overall Study|Physician Decision|0|||
126261616|NCT02563769|454248253|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
126261617|NCT02563769|454248254|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
126261618|NCT02563769|454248255|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
126261619|NCT00690482|454248256|FG000|Overall Study|Adverse Event|2|||
126261620|NCT00690482|454248257|FG001|Overall Study|Adverse Event|1|||
126261621|NCT00690482|454248256|FG000|Overall Study|Incorrect enrolment|0|||
126261622|NCT00690482|454248257|FG001|Overall Study|Incorrect enrolment|1|||
126261623|NCT00690482|454248256|FG000|Overall Study|Study-specific discontinuation criteria|1|||
126261624|NCT00690482|454248257|FG001|Overall Study|Study-specific discontinuation criteria|0|||
126261625|NCT00690482|454248256|FG000|Overall Study|Intake of prohibited medicine|1|||
126261626|NCT00690482|454248257|FG001|Overall Study|Intake of prohibited medicine|0|||
126261627|NCT00690482|454248256|FG000|Overall Study|withdrew consent at rand.day|0|||
126261628|NCT00690482|454248257|FG001|Overall Study|withdrew consent at rand.day|1|||
126261629|NCT02820740|454248258|FG000|Overall Study|Did not have procedure|2|||
126261630|NCT03718117|454248262|FG000|Overall Study|Death|12|||
126261631|NCT03718117|454248263|FG001|Overall Study|Death|11|||
126261632|NCT03718117|454248264|FG002|Overall Study|Death|0|||
126261633|NCT03718117|454248262|FG000|Overall Study|Other|0|||
126261634|NCT03718117|454248263|FG001|Overall Study|Other|1|||
126261635|NCT03718117|454248264|FG002|Overall Study|Other|0|||
126261636|NCT03718117|454248262|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
126261637|NCT03718117|454248263|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
126261638|NCT03718117|454248264|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
126261639|NCT03718117|454248262|FG000|Overall Study|Participant not met eligibility criteria|0|||
126261640|NCT03718117|454248263|FG001|Overall Study|Participant not met eligibility criteria|0|||
126261641|NCT03718117|454248264|FG002|Overall Study|Participant not met eligibility criteria|2|||
126261642|NCT03069417|454248265|FG000|Overall Study|Lost to Follow-up|2|||
126261643|NCT03069417|454248266|FG001|Overall Study|Lost to Follow-up|0|||
126261644|NCT03069417|454248265|FG000|Overall Study|Reason Unknown|4|||
126261645|NCT03069417|454248266|FG001|Overall Study|Reason Unknown|7|||
126261646|NCT04117945|454248267|FG000|Overall Study|Death|1|||
126261647|NCT04117945|454248268|FG001|Overall Study|Death|0|||
126261648|NCT04117945|454248267|FG000|Overall Study|Withdrawal by Subject|3|||
126261649|NCT04117945|454248268|FG001|Overall Study|Withdrawal by Subject|1|||
126261650|NCT04117945|454248267|FG000|Overall Study|Disease Progression|0|||
126261651|NCT04117945|454248268|FG001|Overall Study|Disease Progression|2|||
126261652|NCT04117945|454248267|FG000|Overall Study|Ineligible|8|||
126261653|NCT04117945|454248268|FG001|Overall Study|Ineligible|7|||
126261654|NCT00402025|454248269|FG000|Overall Study|Adverse Event|0|||
126261655|NCT00402025|454248270|FG001|Overall Study|Adverse Event|0|||
126261656|NCT00402025|454248271|FG002|Overall Study|Adverse Event|2|||
126261657|NCT00402025|454248269|FG000|Overall Study|Death|0|||
126261658|NCT00402025|454248270|FG001|Overall Study|Death|1|||
126261659|NCT00402025|454248271|FG002|Overall Study|Death|5|||
126261660|NCT00402025|454248269|FG000|Overall Study|Disease Progression|1|||
126261661|NCT00402025|454248270|FG001|Overall Study|Disease Progression|1|||
126261662|NCT00402025|454248271|FG002|Overall Study|Disease Progression|2|||
126261663|NCT00402025|454248269|FG000|Overall Study|Physician Decision|1|||
126261664|NCT00402025|454248270|FG001|Overall Study|Physician Decision|1|||
126261665|NCT00402025|454248271|FG002|Overall Study|Physician Decision|0|||
126261666|NCT00402025|454248269|FG000|Overall Study|Participant Decision|0|||
126261667|NCT00402025|454248270|FG001|Overall Study|Participant Decision|0|||
126261668|NCT00402025|454248271|FG002|Overall Study|Participant Decision|1|||
126261669|NCT01917968|454248273|FG000|Overall Study|Death|3|||
126261670|NCT01917968|454248274|FG001|Overall Study|Death|2|||
126261671|NCT01917968|454248273|FG000|Overall Study|Lost to Follow-up|21|||
126359610|NCT04621786|454609016|FG000|Overall Study|Protocol Violation|3|||
126261672|NCT01917968|454248274|FG001|Overall Study|Lost to Follow-up|39|||
126261673|NCT01917968|454248273|FG000|Overall Study|Physician Decision|1|||
126261674|NCT01917968|454248274|FG001|Overall Study|Physician Decision|2|||
126261675|NCT01917968|454248273|FG000|Overall Study|Withdrawal by Subject|20|||
126261676|NCT01917968|454248274|FG001|Overall Study|Withdrawal by Subject|35|||
126261677|NCT01917968|454248273|FG000|Overall Study|Subject Relocation|5|||
126261678|NCT01917968|454248274|FG001|Overall Study|Subject Relocation|1|||
126261679|NCT01917968|454248273|FG000|Overall Study|36M Missed Visit|3|||
126261680|NCT01917968|454248274|FG001|Overall Study|36M Missed Visit|2|||
126261681|NCT01917968|454248273|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
126261682|NCT01917968|454248274|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
126261683|NCT01917968|454248273|FG000|Overall Study|Change in Family Circumstances|0|||
126261684|NCT01917968|454248274|FG001|Overall Study|Change in Family Circumstances|1|||
126261685|NCT01917968|454248273|FG000|Overall Study|No Data Available|0|||
126261686|NCT01917968|454248274|FG001|Overall Study|No Data Available|2|||
126261687|NCT02148445|454248279|FG000|Overall Study|Death|1|||
126261688|NCT02148445|454248280|FG001|Overall Study|Death|3|||
126261689|NCT03450629|454248281|FG000|Overall Study|Adverse Event|15|||
126261690|NCT03450629|454248282|FG001|Overall Study|Adverse Event|14|||
126261691|NCT03450629|454248281|FG000|Overall Study|Physician Decision|2|||
126261692|NCT03450629|454248282|FG001|Overall Study|Physician Decision|2|||
126261693|NCT03450629|454248281|FG000|Overall Study|Lack of Efficacy|2|||
126261694|NCT03450629|454248282|FG001|Overall Study|Lack of Efficacy|0|||
126261695|NCT03450629|454248281|FG000|Overall Study|Lost to Follow-up|4|||
126261696|NCT03450629|454248282|FG001|Overall Study|Lost to Follow-up|2|||
126261697|NCT03450629|454248281|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
126261698|NCT03450629|454248282|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
126261699|NCT03450629|454248281|FG000|Overall Study|Non-Compliance With Study Drug|2|||
126261700|NCT03450629|454248282|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126261701|NCT03450629|454248281|FG000|Overall Study|Protocol Violation|11|||
126261702|NCT03450629|454248282|FG001|Overall Study|Protocol Violation|8|||
126261703|NCT03450629|454248281|FG000|Overall Study|Withdrawal by Subject|12|||
126261704|NCT03450629|454248282|FG001|Overall Study|Withdrawal by Subject|6|||
126261705|NCT03438006|454248283|FG000|Overall Study|Adverse Event|1|||
126261706|NCT03438006|454248283|FG000|Overall Study|Lost to Follow-up|67|||
126261707|NCT03438006|454248283|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
126261708|NCT03438006|454248283|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
126261709|NCT00955721|454248294|FG000|Overall Study|Physician Decision|1|||
126261710|NCT00955721|454248295|FG001|Overall Study|Physician Decision|0|||
126261711|NCT00955721|454248294|FG000|Overall Study|Death|1|||
126261712|NCT00955721|454248295|FG001|Overall Study|Death|0|||
126261713|NCT00955721|454248294|FG000|Overall Study|Withdrawal by Subject|1|||
126261714|NCT00955721|454248295|FG001|Overall Study|Withdrawal by Subject|0|||
126261715|NCT00749411|454248299|FG000|Overall Study|Adverse Event|0|||
126261716|NCT00749411|454248300|FG001|Overall Study|Adverse Event|2|||
126261717|NCT00749411|454248299|FG000|Overall Study|Lack of Efficacy|0|||
126261718|NCT00749411|454248300|FG001|Overall Study|Lack of Efficacy|1|||
126261719|NCT00749411|454248299|FG000|Overall Study|Protocol Violation|1|||
126261720|NCT00749411|454248300|FG001|Overall Study|Protocol Violation|1|||
126261721|NCT00749411|454248299|FG000|Overall Study|Protocol-defined stopping criteria|0|||
126261722|NCT00749411|454248300|FG001|Overall Study|Protocol-defined stopping criteria|1|||
126261723|NCT03183141|454248302|FG000|Overall Study|Withdrawal by Subject|2|||
126261724|NCT03183141|454248303|FG001|Overall Study|Withdrawal by Subject|4|||
126261725|NCT03183141|454248302|FG000|Overall Study|Death|0|||
126261726|NCT03183141|454248303|FG001|Overall Study|Death|8|||
126261727|NCT02756637|454248305|FG000|Overall Study|Not eligible for initial SWOG study|10|||
126261728|NCT02756637|454248306|FG001|Overall Study|Not eligible for initial SWOG study|10|||
126261729|NCT02756637|454248305|FG000|Overall Study|No available NLR value|44|||
126261730|NCT02756637|454248306|FG001|Overall Study|No available NLR value|44|||
126261731|NCT02756637|454248305|FG000|Overall Study|Did not complete curative therapy|33|||
126261732|NCT02756637|454248306|FG001|Overall Study|Did not complete curative therapy|0|||
126261733|NCT01507090|454248307|FG000|Overall Study|incomplete dataset|18|||
126261734|NCT03581188|454249603|FG000|Overall Study|Inclusion criteria not met|3|||
126261735|NCT03581188|454249604|FG001|Overall Study|Inclusion criteria not met|2|||
126261736|NCT03581188|454249603|FG000|Overall Study|Lost to Follow-up|5|||
126261737|NCT03581188|454249604|FG001|Overall Study|Lost to Follow-up|5|||
126261738|NCT03581188|454249603|FG000|Overall Study|Discontinued intervention|11|||
126261739|NCT03581188|454249604|FG001|Overall Study|Discontinued intervention|8|||
126261740|NCT01937351|454249605|FG000|Overall Study|Withdrawal by Subject|4|||
126261741|NCT01937351|454249606|FG001|Overall Study|Withdrawal by Subject|2|||
126763537|NCT04668066|456086799|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763538|NCT04668066|456086800|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763539|NCT04668066|456086801|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126261742|NCT01937351|454249605|FG000|Overall Study|Death|1|||
126261743|NCT01937351|454249606|FG001|Overall Study|Death|0|||
126261744|NCT01937351|454249605|FG000|Overall Study|Not treated w device, per protocol fail|4|||
126261745|NCT01937351|454249606|FG001|Overall Study|Not treated w device, per protocol fail|0|||
126261746|NCT01961687|454249607|FG000|Overall Study|Lost to Follow-up|19|||
126261747|NCT01961687|454249607|FG000|Overall Study|Re-operation|17|||
126359611|NCT02123511|454609017|FG000|Overall Study|Cancelled treatment|1|||
126261748|NCT01961687|454249607|FG000|Overall Study|Death|7|||
126261749|NCT01961687|454249607|FG000|Overall Study|Withdrawal by Subject|6|||
126261750|NCT01961687|454249607|FG000|Overall Study|Adverse Event|6|||
126261751|NCT01961687|454249607|FG000|Overall Study|Moved to area without study site|2|||
126261752|NCT01961687|454249607|FG000|Overall Study|Sponsor decision|2|||
126261753|NCT01961687|454249607|FG000|Overall Study|Physician Decision|1|||
126261754|NCT01961687|454249607|FG000|Overall Study|Unable to meet follow-up requirements|1|||
126261755|NCT02284347|454249608|FG000|Overall Study|Lost to Follow-up|2|||
126261756|NCT02284347|454249608|FG000|Overall Study|Withdrawn prior to treatment|1|||
126359612|NCT02123511|454609018|FG001|Overall Study|Cancelled treatment|0|||
126261757|NCT02999984|454249609|FG000|Overall Study|Treatment Failure|1|||
126261758|NCT01316419|454249610|FG000|Overall Study|Not treated|103|||
126261759|NCT01316419|454249610|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
126261760|NCT01316419|454249610|FG000|Overall Study|Lost to Follow-up|19|||
126261761|NCT00754013|454249613|FG000|Overall Study|Lost to Follow-up|1|||
126261762|NCT00754013|454249614|FG001|Overall Study|Lost to Follow-up|1|||
126261763|NCT00754013|454249613|FG000|Overall Study|didn't return after study termed|3|||
126261764|NCT00754013|454249614|FG001|Overall Study|didn't return after study termed|4|||
126261765|NCT04039919|454249615|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126261766|NCT04039919|454249616|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126261767|NCT04039919|454249617|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126261768|NCT04039919|454249618|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126261769|NCT04039919|454249619|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126261770|NCT04039919|454249615|FG000|Treatment Period 1|Sponsor's decision|0|||
126261771|NCT04039919|454249616|FG001|Treatment Period 1|Sponsor's decision|0|||
126261772|NCT04039919|454249617|FG002|Treatment Period 1|Sponsor's decision|0|||
126261773|NCT04039919|454249618|FG003|Treatment Period 1|Sponsor's decision|0|||
126261774|NCT04039919|454249619|FG004|Treatment Period 1|Sponsor's decision|16|||
126261775|NCT04039919|454249615|FG000|Treatment Period 5|Withdrawal by Subject|1|||
126261776|NCT04039919|454249616|FG001|Treatment Period 5|Withdrawal by Subject|0|||
126261777|NCT04039919|454249617|FG002|Treatment Period 5|Withdrawal by Subject|0|||
126261778|NCT04039919|454249618|FG003|Treatment Period 5|Withdrawal by Subject|0|||
126261779|NCT04039919|454249619|FG004|Treatment Period 5|Withdrawal by Subject|0|||
126261780|NCT02310789|454249620|FG000|Overall Study|Adverse Event|1|||
126261781|NCT00983918|454249621|FG000|Overall Study|conversion to open cholecystectomy|0|||
126261782|NCT00983918|454249622|FG001|Overall Study|conversion to open cholecystectomy|2|||
126261783|NCT00983918|454249623|FG002|Overall Study|conversion to open cholecystectomy|2|||
126261784|NCT00983918|454249624|FG003|Overall Study|conversion to open cholecystectomy|2|||
126261785|NCT00794417|454249625|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
126261786|NCT00794417|454249626|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
126261787|NCT00794417|454249627|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
126261788|NCT00794417|454249628|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
126261789|NCT00794417|454249625|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
126261790|NCT00794417|454249626|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
126261791|NCT00794417|454249627|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
126261792|NCT00794417|454249628|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
126261793|NCT00794417|454249625|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
126261794|NCT00794417|454249626|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
126261795|NCT00794417|454249627|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
126261796|NCT00794417|454249628|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
126261797|NCT00794417|454249625|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
126261798|NCT00794417|454249626|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
126261799|NCT00794417|454249627|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
126261800|NCT00794417|454249628|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
126261801|NCT00794417|454249625|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
126261802|NCT00794417|454249626|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
126261803|NCT00794417|454249627|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
126261804|NCT00794417|454249628|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
126261805|NCT00794417|454249625|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
126261806|NCT00794417|454249626|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
126261807|NCT00794417|454249627|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
126261808|NCT00794417|454249628|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
126261809|NCT01652729|454249629|FG000|Overall Study|Withdrawal by Subject|14|||
126261810|NCT01652729|454249630|FG001|Overall Study|Withdrawal by Subject|7|||
126261811|NCT01652729|454249631|FG002|Overall Study|Withdrawal by Subject|7|||
126261812|NCT01652729|454249629|FG000|Overall Study|Adverse Event|4|||
126261813|NCT01652729|454249630|FG001|Overall Study|Adverse Event|0|||
126261814|NCT01652729|454249631|FG002|Overall Study|Adverse Event|3|||
126261815|NCT01652729|454249629|FG000|Overall Study|Physician Decision|1|||
126261816|NCT01652729|454249630|FG001|Overall Study|Physician Decision|0|||
126452013|NCT02059291|454957163|FG022|Epoch 2|Lack of Efficacy|0|||
126261817|NCT01652729|454249631|FG002|Overall Study|Physician Decision|1|||
126261818|NCT01652729|454249629|FG000|Overall Study|Protocol Violation|1|||
126261819|NCT01652729|454249630|FG001|Overall Study|Protocol Violation|0|||
126261820|NCT01652729|454249631|FG002|Overall Study|Protocol Violation|0|||
126261821|NCT01652729|454249629|FG000|Overall Study|Lost to Follow-up|6|||
126261822|NCT01652729|454249630|FG001|Overall Study|Lost to Follow-up|6|||
126261823|NCT01652729|454249631|FG002|Overall Study|Lost to Follow-up|3|||
126261824|NCT01652729|454249629|FG000|Overall Study|Administrative|1|||
126261825|NCT01652729|454249630|FG001|Overall Study|Administrative|0|||
126261826|NCT01652729|454249631|FG002|Overall Study|Administrative|0|||
126452014|NCT02059291|454957164|FG023|Epoch 2|Lack of Efficacy|0|||
126452015|NCT02059291|454957165|FG024|Epoch 2|Lack of Efficacy|0|||
126452016|NCT02059291|454957141|FG000|Epoch 2|Adverse Event|0|||
126261827|NCT00483548|454249632|FG000|Overall Study|Randomized; not treated with study drug|1|||
126261828|NCT00483548|454249633|FG001|Overall Study|Randomized; not treated with study drug|3|||
126261829|NCT00483548|454249632|FG000|Overall Study|Adverse Event|25|||
126452017|NCT02059291|454957142|FG001|Epoch 2|Adverse Event|0|||
126261830|NCT00483548|454249633|FG001|Overall Study|Adverse Event|14|||
126261831|NCT00483548|454249632|FG000|Overall Study|Laboratory abnormality|1|||
126700134|NCT03313050|455851371|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
126700135|NCT03313050|455851372|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
126700136|NCT03313050|455851373|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
126700137|NCT03313050|455851370|FG000|Stage 2: 12 Months|Other|0|||
126700138|NCT03313050|455851371|FG001|Stage 2: 12 Months|Other|0|||
126700139|NCT03313050|455851372|FG002|Stage 2: 12 Months|Other|0|||
126700140|NCT03313050|455851373|FG003|Stage 2: 12 Months|Other|1|||
126700141|NCT04211337|455851374|FG000|Overall Study|On Treatment|175|||
126700142|NCT04211337|455851375|FG001|Overall Study|On Treatment|40|||
126700143|NCT04211337|455851374|FG000|Overall Study|Withdrawal by Subject|0|||
126700144|NCT04211337|455851375|FG001|Overall Study|Withdrawal by Subject|2|||
126700145|NCT02847598|455851380|FG000|Overall Study|Adverse Event|0|||
126700146|NCT02847598|455851381|FG001|Overall Study|Adverse Event|0|||
126700147|NCT02847598|455851382|FG002|Overall Study|Adverse Event|0|||
126700148|NCT02847598|455851383|FG003|Overall Study|Adverse Event|0|||
126700149|NCT02847598|455851384|FG004|Overall Study|Adverse Event|0|||
126700150|NCT02847598|455851385|FG005|Overall Study|Adverse Event|0|||
126700151|NCT02847598|455851386|FG006|Overall Study|Adverse Event|0|||
126700152|NCT02847598|455851387|FG007|Overall Study|Adverse Event|1|||
126700153|NCT02847598|455851380|FG000|Overall Study|Consent withdrawn|2|||
126700154|NCT02847598|455851381|FG001|Overall Study|Consent withdrawn|0|||
126700155|NCT02847598|455851382|FG002|Overall Study|Consent withdrawn|0|||
126700156|NCT02847598|455851383|FG003|Overall Study|Consent withdrawn|4|||
126700157|NCT02847598|455851384|FG004|Overall Study|Consent withdrawn|3|||
126700158|NCT02847598|455851385|FG005|Overall Study|Consent withdrawn|2|||
126700159|NCT02847598|455851386|FG006|Overall Study|Consent withdrawn|1|||
126700160|NCT02847598|455851387|FG007|Overall Study|Consent withdrawn|3|||
126700161|NCT02847598|455851380|FG000|Overall Study|Death|3|||
126700162|NCT02847598|455851381|FG001|Overall Study|Death|0|||
126700163|NCT02847598|455851382|FG002|Overall Study|Death|0|||
126700164|NCT02847598|455851383|FG003|Overall Study|Death|0|||
126700165|NCT02847598|455851384|FG004|Overall Study|Death|0|||
126700166|NCT02847598|455851385|FG005|Overall Study|Death|0|||
126700167|NCT02847598|455851386|FG006|Overall Study|Death|0|||
126700168|NCT02847598|455851387|FG007|Overall Study|Death|0|||
126700169|NCT02847598|455851380|FG000|Overall Study|Lost to Follow-up|0|||
126700170|NCT02847598|455851381|FG001|Overall Study|Lost to Follow-up|0|||
126700171|NCT02847598|455851382|FG002|Overall Study|Lost to Follow-up|0|||
126700172|NCT02847598|455851383|FG003|Overall Study|Lost to Follow-up|0|||
126700173|NCT02847598|455851384|FG004|Overall Study|Lost to Follow-up|0|||
126700174|NCT02847598|455851385|FG005|Overall Study|Lost to Follow-up|1|||
126700175|NCT02847598|455851386|FG006|Overall Study|Lost to Follow-up|1|||
126700176|NCT02847598|455851387|FG007|Overall Study|Lost to Follow-up|0|||
126700177|NCT02848833|455851388|FG000|Overall Study|subject who are duplicated|1|||
126700178|NCT02848833|455851388|FG000|Overall Study|have not taken the study drug|11|||
126700179|NCT02848833|455851388|FG000|Overall Study|follow-up failure|6|||
126700180|NCT02848833|455851388|FG000|Overall Study|Protocol Violation|119|||
126700181|NCT04167345|455851389|FG000|Overall Study|Other|1|||
126700182|NCT04167345|455851390|FG001|Overall Study|Other|1|||
126700183|NCT04167345|455851391|FG002|Overall Study|Other|0|||
126700184|NCT04167345|455851392|FG003|Overall Study|Other|0|||
126700185|NCT04167345|455851393|FG004|Overall Study|Other|0|||
126700186|NCT01609933|455853491|FG000|Overall Study|Adverse Event|1|||
126700187|NCT01609933|455853491|FG000|Overall Study|Withdrawal by Subject|3|||
126700188|NCT00224016|455853492|FG000|Titration Period|Withdrawal by Subject|0|||
126700189|NCT00224016|455853493|FG001|Titration Period|Withdrawal by Subject|1|||
126700190|NCT00224016|455853492|FG000|Titration Period|Lost to Follow-up|1|||
126700191|NCT00224016|455853493|FG001|Titration Period|Lost to Follow-up|0|||
126700192|NCT00224016|455853492|FG000|Maintenance Period|Withdrawal by Subject|2|||
126700193|NCT00224016|455853493|FG001|Maintenance Period|Withdrawal by Subject|0|||
126700194|NCT00224016|455853492|FG000|Maintenance Period|Lost to Follow-up|0|||
126700195|NCT00224016|455853493|FG001|Maintenance Period|Lost to Follow-up|1|||
126700196|NCT01252966|455853494|FG000|Overall Study|Lost to Follow-up|16|||
126700197|NCT01252966|455853495|FG001|Overall Study|Lost to Follow-up|10|||
126700198|NCT01252966|455853494|FG000|Overall Study|Withdrawal by Subject|7|||
126700199|NCT01252966|455853495|FG001|Overall Study|Withdrawal by Subject|3|||
126700200|NCT00206726|455853502|FG000|Overall Study|Delayed recovery of blood counts|1|||
126700201|NCT00206726|455853502|FG000|Overall Study|Progressive disease or relapsed disease|18|||
126700202|NCT00206726|455853502|FG000|Overall Study|Placed on new protocol|1|||
126700203|NCT00206726|455853502|FG000|Overall Study|Bone marrow transplant|1|||
126700204|NCT00206726|455853502|FG000|Overall Study|Adverse Event|17|||
126700205|NCT00206726|455853502|FG000|Overall Study|Death|4|||
126700206|NCT00206726|455853502|FG000|Overall Study|Protocol Violation|1|||
126700207|NCT00206726|455853502|FG000|Overall Study|Withdrawal by Subject|8|||
126700208|NCT01028352|455853505|FG000|Overall Study|Ineligible due to baseline average pain|5|||
126700209|NCT01028352|455853505|FG000|Overall Study|Withdrawal by Subject|1|||
126700210|NCT02468193|455853506|FG000|Overall Study|Adverse Event|4|||
126700211|NCT02468193|455853506|FG000|Overall Study|Subject/ Guardian decision|2|||
126763540|NCT04668066|456086802|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763541|NCT04668066|456086803|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763542|NCT04668066|456086804|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763543|NCT04668066|456086805|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763544|NCT04668066|456086806|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763545|NCT04668066|456086807|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763546|NCT04668066|456086808|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763547|NCT04668066|456086809|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763548|NCT04668066|456086810|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
126763549|NCT04668066|456086811|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
126763550|NCT04668066|456086793|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763551|NCT04668066|456086794|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763552|NCT04668066|456086795|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
126261832|NCT00483548|454249633|FG001|Overall Study|Laboratory abnormality|2|||
126261833|NCT00483548|454249632|FG000|Overall Study|Lack of Efficacy|4|||
126261834|NCT00483548|454249633|FG001|Overall Study|Lack of Efficacy|8|||
126261835|NCT00483548|454249632|FG000|Overall Study|Protocol Violation|11|||
126261836|NCT00483548|454249633|FG001|Overall Study|Protocol Violation|7|||
126261837|NCT00483548|454249632|FG000|Overall Study|Pregnancy|1|||
126261838|NCT00483548|454249633|FG001|Overall Study|Pregnancy|0|||
126261839|NCT00483548|454249632|FG000|Overall Study|Protocol required discontinuation|6|||
126261840|NCT00483548|454249633|FG001|Overall Study|Protocol required discontinuation|6|||
126261841|NCT00483548|454249632|FG000|Overall Study|Unable to comply with protocol schedule|1|||
126261842|NCT00483548|454249633|FG001|Overall Study|Unable to comply with protocol schedule|0|||
126261843|NCT00483548|454249632|FG000|Overall Study|Non-compliance with medication|2|||
126261844|NCT00483548|454249633|FG001|Overall Study|Non-compliance with medication|0|||
126261845|NCT00483548|454249632|FG000|Overall Study|Lost to Follow-up|3|||
126261846|NCT00483548|454249633|FG001|Overall Study|Lost to Follow-up|4|||
126261847|NCT00483548|454249632|FG000|Overall Study|Withdrawal by Subject|5|||
126261848|NCT00483548|454249633|FG001|Overall Study|Withdrawal by Subject|2|||
126261849|NCT02694549|454249636|FG000|Overall Study|screen failures|2|||
126359613|NCT02123511|454609017|FG000|Overall Study|Incomplete data|1|||
126359614|NCT02123511|454609018|FG001|Overall Study|Incomplete data|3|||
126359615|NCT02123511|454609017|FG000|Overall Study|Ineligible|0|||
126359616|NCT02123511|454609018|FG001|Overall Study|Ineligible|1|||
126700212|NCT01887912|455853507|FG000|Overall Study|Serious adverse event|400|||
126700213|NCT01887912|455853508|FG001|Overall Study|Serious adverse event|198|||
126700214|NCT01887912|455853507|FG000|Overall Study|Other Adverse Event|34|||
126700215|NCT01887912|455853508|FG001|Overall Study|Other Adverse Event|15|||
126700216|NCT01887912|455853507|FG000|Overall Study|Protocol Violation|67|||
126359617|NCT01975285|454609021|FG000|Overall Study|Failed Block and follow up|2|||
126359618|NCT01975285|454609022|FG001|Overall Study|Failed Block and follow up|2|||
126359619|NCT01750281|454609023|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
126700217|NCT01887912|455853508|FG001|Overall Study|Protocol Violation|37|||
126700218|NCT01887912|455853507|FG000|Overall Study|Lost to Follow-up|163|||
126700219|NCT01887912|455853508|FG001|Overall Study|Lost to Follow-up|74|||
126700220|NCT01887912|455853507|FG000|Overall Study|Withdrawal by Subject|606|||
126700221|NCT01887912|455853508|FG001|Overall Study|Withdrawal by Subject|349|||
126700222|NCT01887912|455853507|FG000|Overall Study|Other|122|||
126700223|NCT01887912|455853508|FG001|Overall Study|Other|58|||
126700224|NCT05067127|455853509|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
126700225|NCT05067127|455853510|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
126700226|NCT05067127|455853511|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
126700227|NCT05067127|455853512|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
126763553|NCT04668066|456086796|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
126261850|NCT01534078|454249637|FG000|Overall Study|Death|1|||
126359620|NCT01750281|454609024|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
126359621|NCT01750281|454609025|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
126359622|NCT01750281|454609023|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
126359623|NCT01750281|454609024|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
126359624|NCT01750281|454609025|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
126359625|NCT01750281|454609023|FG000|Overall Study|Did not receive treatment|0|||
126359626|NCT01750281|454609024|FG001|Overall Study|Did not receive treatment|1|||
126359627|NCT01750281|454609025|FG002|Overall Study|Did not receive treatment|0|||
126359628|NCT01122680|454609027|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
126359629|NCT01122680|454609028|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
126359630|NCT01122680|454609029|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
126359631|NCT01122680|454609030|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
126700228|NCT05067127|455853509|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
126763554|NCT04668066|456086797|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
126261851|NCT01534078|454249637|FG000|Overall Study|Withdrawal by Subject|1|||
126700229|NCT05067127|455853510|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
126261852|NCT01223235|454249638|FG000|Overall Study|Withdrawal by Subject|1|||
126261853|NCT04364737|454249642|FG000|Overall Study|Withdrawal by Subject|4|||
126763555|NCT04668066|456086798|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763556|NCT04668066|456086799|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763557|NCT04668066|456086800|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763558|NCT04668066|456086801|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763559|NCT04668066|456086802|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
126261854|NCT04364737|454249643|FG001|Overall Study|Withdrawal by Subject|9|||
126261855|NCT04364737|454249642|FG000|Overall Study|Lost to Follow-up|1|||
126261856|NCT04364737|454249643|FG001|Overall Study|Lost to Follow-up|1|||
126261857|NCT01220609|454249644|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
126261858|NCT01220609|454249644|FG000|Overall Study|Ineligible- Wrong cell type|1|||
126261859|NCT01220609|454249644|FG000|Overall Study|Ineligible-Never treated|1|||
126261860|NCT02225665|454249645|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
126261861|NCT02225665|454249646|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
126261862|NCT02225665|454249645|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
126261863|NCT02225665|454249646|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
126261864|NCT00614822|454249652|FG000|Overall Study|Adverse Event|3|||
126261865|NCT01557920|454249653|FG000|Overall Study|Withdrawal by Subject|2|||
126261866|NCT01557920|454249654|FG001|Overall Study|Withdrawal by Subject|3|||
126261867|NCT01557920|454249653|FG000|Overall Study|Lack of Efficacy|1|||
126261868|NCT01557920|454249654|FG001|Overall Study|Lack of Efficacy|0|||
126261869|NCT02674386|454249659|FG000|Overall Study|Lost to Follow-up|0|||
126261870|NCT02674386|454249660|FG001|Overall Study|Lost to Follow-up|1|||
126261871|NCT02674386|454249661|FG002|Overall Study|Lost to Follow-up|1|||
126763560|NCT04668066|456086803|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763561|NCT04668066|456086804|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763562|NCT04668066|456086805|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
126261872|NCT02674386|454249659|FG000|Overall Study|Withdrawal by Subject|0|||
126261873|NCT02674386|454249660|FG001|Overall Study|Withdrawal by Subject|4|||
126261874|NCT02674386|454249661|FG002|Overall Study|Withdrawal by Subject|0|||
126261875|NCT02674386|454249659|FG000|Overall Study|Other|0|||
126261876|NCT02674386|454249660|FG001|Overall Study|Other|1|||
126261877|NCT02674386|454249661|FG002|Overall Study|Other|0|||
126261878|NCT02674386|454249659|FG000|Overall Study|Enrolled but not evaluated|0|||
126261879|NCT02674386|454249660|FG001|Overall Study|Enrolled but not evaluated|4|||
126261880|NCT02674386|454249661|FG002|Overall Study|Enrolled but not evaluated|0|||
126261881|NCT01439724|454249666|FG000|Overall Study|missing consultation|9|||
126261882|NCT01439724|454249667|FG001|Overall Study|missing consultation|8|||
126261883|NCT01040793|454249672|FG000|Overall Study|Adverse Event|5|||
126261884|NCT01040793|454249673|FG001|Overall Study|Adverse Event|3|||
126763563|NCT04668066|456086806|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763564|NCT04668066|456086807|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763565|NCT04668066|456086808|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763566|NCT04668066|456086809|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763567|NCT04668066|456086810|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
126763568|NCT04668066|456086811|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
126763569|NCT04668066|456086793|FG000|Part 2: Treatment Phase|Other|0|||
126763570|NCT04668066|456086794|FG001|Part 2: Treatment Phase|Other|0|||
126763571|NCT04668066|456086795|FG002|Part 2: Treatment Phase|Other|0|||
126763572|NCT04668066|456086796|FG003|Part 2: Treatment Phase|Other|0|||
126763573|NCT04668066|456086797|FG004|Part 2: Treatment Phase|Other|0|||
126763574|NCT04668066|456086798|FG005|Part 2: Treatment Phase|Other|0|||
126763575|NCT04668066|456086799|FG006|Part 2: Treatment Phase|Other|0|||
126763576|NCT04668066|456086800|FG007|Part 2: Treatment Phase|Other|0|||
126763577|NCT04668066|456086801|FG008|Part 2: Treatment Phase|Other|0|||
126763578|NCT04668066|456086802|FG009|Part 2: Treatment Phase|Other|0|||
126763579|NCT04668066|456086803|FG010|Part 2: Treatment Phase|Other|0|||
126763580|NCT04668066|456086804|FG011|Part 2: Treatment Phase|Other|0|||
126763581|NCT04668066|456086805|FG012|Part 2: Treatment Phase|Other|0|||
126763582|NCT04668066|456086806|FG013|Part 2: Treatment Phase|Other|0|||
126763583|NCT04668066|456086807|FG014|Part 2: Treatment Phase|Other|0|||
126261885|NCT01040793|454249674|FG002|Overall Study|Adverse Event|0|||
126261886|NCT01040793|454249675|FG003|Overall Study|Adverse Event|2|||
126261887|NCT01040793|454249676|FG004|Overall Study|Adverse Event|2|||
126261888|NCT01040793|454249677|FG005|Overall Study|Adverse Event|1|||
126763584|NCT04668066|456086808|FG015|Part 2: Treatment Phase|Other|0|||
126763585|NCT04668066|456086809|FG016|Part 2: Treatment Phase|Other|0|||
126261889|NCT01040793|454249672|FG000|Overall Study|Protocol Violation|1|||
126261890|NCT01040793|454249673|FG001|Overall Study|Protocol Violation|1|||
126261891|NCT01040793|454249674|FG002|Overall Study|Protocol Violation|1|||
126261892|NCT01040793|454249675|FG003|Overall Study|Protocol Violation|0|||
126261893|NCT01040793|454249676|FG004|Overall Study|Protocol Violation|1|||
126261894|NCT01040793|454249677|FG005|Overall Study|Protocol Violation|0|||
126359632|NCT01122680|454609027|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
126763586|NCT04668066|456086810|FG017|Part 2: Treatment Phase|Other|0|||
126763587|NCT04668066|456086811|FG018|Part 2: Treatment Phase|Other|1|||
126763588|NCT04668066|456086793|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
126261895|NCT01040793|454249672|FG000|Overall Study|Lost to Follow-up|0|||
126261896|NCT01040793|454249673|FG001|Overall Study|Lost to Follow-up|1|||
126261897|NCT01040793|454249674|FG002|Overall Study|Lost to Follow-up|1|||
126261898|NCT01040793|454249675|FG003|Overall Study|Lost to Follow-up|0|||
126261899|NCT01040793|454249676|FG004|Overall Study|Lost to Follow-up|0|||
126261900|NCT01040793|454249677|FG005|Overall Study|Lost to Follow-up|0|||
126261901|NCT01040793|454249672|FG000|Overall Study|Withdrawal by Subject|0|||
126261902|NCT01040793|454249673|FG001|Overall Study|Withdrawal by Subject|0|||
126261903|NCT01040793|454249674|FG002|Overall Study|Withdrawal by Subject|0|||
126261904|NCT01040793|454249675|FG003|Overall Study|Withdrawal by Subject|2|||
126261905|NCT01040793|454249676|FG004|Overall Study|Withdrawal by Subject|0|||
126261906|NCT01040793|454249677|FG005|Overall Study|Withdrawal by Subject|0|||
126261907|NCT01040793|454249672|FG000|Overall Study|Other reasons not listed above|0|||
126261908|NCT01040793|454249673|FG001|Overall Study|Other reasons not listed above|0|||
126261909|NCT01040793|454249674|FG002|Overall Study|Other reasons not listed above|1|||
126261910|NCT01040793|454249675|FG003|Overall Study|Other reasons not listed above|0|||
126261911|NCT01040793|454249676|FG004|Overall Study|Other reasons not listed above|1|||
126261912|NCT01040793|454249677|FG005|Overall Study|Other reasons not listed above|0|||
126261913|NCT00939627|454249682|FG000|Overall Study|Disease Progression|16|||
126261914|NCT00939627|454249683|FG001|Overall Study|Disease Progression|12|||
126700230|NCT05067127|455853511|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
126261915|NCT00939627|454249684|FG002|Overall Study|Disease Progression|0|||
126261916|NCT00939627|454249682|FG000|Overall Study|Adverse Event|6|||
126261917|NCT00939627|454249683|FG001|Overall Study|Adverse Event|7|||
126261918|NCT00939627|454249684|FG002|Overall Study|Adverse Event|0|||
126261919|NCT00939627|454249682|FG000|Overall Study|Death|0|||
126261920|NCT00939627|454249683|FG001|Overall Study|Death|2|||
126261921|NCT00939627|454249684|FG002|Overall Study|Death|0|||
126261922|NCT00939627|454249682|FG000|Overall Study|Withdrawal by Subject|2|||
126261923|NCT00939627|454249683|FG001|Overall Study|Withdrawal by Subject|4|||
126261924|NCT00939627|454249684|FG002|Overall Study|Withdrawal by Subject|0|||
126261925|NCT00939627|454249682|FG000|Overall Study|Other complicating disease|1|||
126261926|NCT00939627|454249683|FG001|Overall Study|Other complicating disease|1|||
126261927|NCT00939627|454249684|FG002|Overall Study|Other complicating disease|0|||
126261928|NCT00939627|454249682|FG000|Overall Study|Not compliant|2|||
126261929|NCT00939627|454249683|FG001|Overall Study|Not compliant|0|||
126261930|NCT00939627|454249684|FG002|Overall Study|Not compliant|0|||
126261931|NCT00939627|454249682|FG000|Overall Study|No off-tx reason given|0|||
126261932|NCT00939627|454249683|FG001|Overall Study|No off-tx reason given|2|||
126261933|NCT00939627|454249684|FG002|Overall Study|No off-tx reason given|0|||
126261934|NCT03297294|454249685|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
126261935|NCT03297294|454249686|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
126261936|NCT03297294|454249687|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126261937|NCT03297294|454249688|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126261938|NCT03297294|454249689|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
126261939|NCT03297294|454249685|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
126261940|NCT03297294|454249686|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
126261941|NCT03297294|454249687|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126261942|NCT03297294|454249688|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126261943|NCT03297294|454249689|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
126261944|NCT03297294|454249685|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
126261945|NCT03297294|454249686|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
126261946|NCT03297294|454249687|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126261947|NCT03297294|454249688|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126261948|NCT03297294|454249689|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
126261949|NCT03297294|454249685|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
126261950|NCT03297294|454249686|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
126261951|NCT03297294|454249687|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126261952|NCT03297294|454249688|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126261953|NCT03297294|454249689|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
126261954|NCT03297294|454249685|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
126261955|NCT03297294|454249686|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
126261956|NCT03297294|454249687|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
126261957|NCT03297294|454249688|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
126261958|NCT03297294|454249689|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
126261959|NCT02039063|454249692|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
126261960|NCT02039063|454249693|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
126261961|NCT02039063|454249694|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
126261962|NCT02039063|454249695|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
126261963|NCT02039063|454249692|FG000|Treatment Phase|Progression of disease|0|||
126261964|NCT02039063|454249693|FG001|Treatment Phase|Progression of disease|0|||
126261965|NCT02039063|454249694|FG002|Treatment Phase|Progression of disease|1|||
126261966|NCT02039063|454249695|FG003|Treatment Phase|Progression of disease|1|||
126261967|NCT02039063|454249692|FG000|Extension Phase|Inadequate therapeutic effect|0|||
126261968|NCT02039063|454249693|FG001|Extension Phase|Inadequate therapeutic effect|1|||
126261969|NCT02039063|454249694|FG002|Extension Phase|Inadequate therapeutic effect|2|||
126261970|NCT02039063|454249695|FG003|Extension Phase|Inadequate therapeutic effect|0|||
126261971|NCT02039063|454249692|FG000|Extension Phase|Progression of disease|0|||
126261972|NCT02039063|454249693|FG001|Extension Phase|Progression of disease|0|||
126261973|NCT02039063|454249694|FG002|Extension Phase|Progression of disease|0|||
126261974|NCT02039063|454249695|FG003|Extension Phase|Progression of disease|1|||
126261975|NCT02039063|454249692|FG000|Extension Phase|Adverse Event|0|||
126261976|NCT02039063|454249693|FG001|Extension Phase|Adverse Event|0|||
126261977|NCT02039063|454249694|FG002|Extension Phase|Adverse Event|1|||
126261978|NCT02039063|454249695|FG003|Extension Phase|Adverse Event|0|||
126261979|NCT01056640|454249696|FG000|Overall Study|Withdrawal by Subject|11|||
126261980|NCT01056640|454249697|FG001|Overall Study|Withdrawal by Subject|8|||
126261981|NCT01056640|454249696|FG000|Overall Study|Death|15|||
126261982|NCT01056640|454249697|FG001|Overall Study|Death|4|||
126261983|NCT02492841|454249698|FG000|Overall Study|Lost to Follow-up|34|||
126261984|NCT02492841|454249699|FG001|Overall Study|Lost to Follow-up|31|||
126261985|NCT02492841|454249700|FG002|Overall Study|Lost to Follow-up|35|||
126261986|NCT00104247|454249710|FG000|Overall Study|Withdrawal by Subject|1|||
126261987|NCT00104247|454249711|FG001|Overall Study|Withdrawal by Subject|0|||
126261988|NCT00104247|454249710|FG000|Overall Study|Noncompliant with dosing|0|||
126261989|NCT00104247|454249711|FG001|Overall Study|Noncompliant with dosing|1|||
126261990|NCT00063882|454249717|FG000|Overall Study|Protocol Violation|3|||
126261991|NCT00063882|454249718|FG001|Overall Study|Protocol Violation|3|||
126261992|NCT00063882|454249717|FG000|Overall Study|Withdrawal by Subject|2|||
126261993|NCT00063882|454249718|FG001|Overall Study|Withdrawal by Subject|1|||
126261994|NCT01930175|454249719|FG000|Core Study|Lost to Follow-up|0|||
126261995|NCT01930175|454249720|FG001|Core Study|Lost to Follow-up|1|||
126261996|NCT01930175|454249721|FG002|Core Study|Lost to Follow-up|0|||
126261997|NCT01930175|454249719|FG000|Core Study|Adverse Event|0|||
126261998|NCT01930175|454249720|FG001|Core Study|Adverse Event|0|||
126261999|NCT01930175|454249721|FG002|Core Study|Adverse Event|1|||
126262000|NCT00834899|454249722|FG000|Overall Study|Withdrawal by Subject|1|||
126262001|NCT00834899|454249723|FG001|Overall Study|Withdrawal by Subject|1|||
126262002|NCT03314662|454249724|FG000|Overall Study|Withdrawal by Subject|1|||
126262003|NCT03314662|454249725|FG001|Overall Study|Withdrawal by Subject|1|||
126262004|NCT03314662|454249726|FG002|Overall Study|Withdrawal by Subject|1|||
126262005|NCT03314662|454249724|FG000|Overall Study|Lost to Follow-up|5|||
126262006|NCT03314662|454249725|FG001|Overall Study|Lost to Follow-up|4|||
126262007|NCT03314662|454249726|FG002|Overall Study|Lost to Follow-up|4|||
126262008|NCT03314662|454249724|FG000|Overall Study|Death|2|||
126262009|NCT03314662|454249725|FG001|Overall Study|Death|0|||
126262010|NCT03314662|454249726|FG002|Overall Study|Death|0|||
126262011|NCT00925301|454249731|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
126262012|NCT00925301|454249732|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
126262013|NCT00925301|454249733|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
126262014|NCT00925301|454249734|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
126262015|NCT00925301|454249731|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
126262016|NCT00925301|454249732|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
126262017|NCT00925301|454249733|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
126262018|NCT00925301|454249734|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
126262019|NCT00925301|454249731|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
126262020|NCT00925301|454249732|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
126262021|NCT00925301|454249733|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
126262022|NCT00925301|454249734|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
126262023|NCT00925301|454249731|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
126262024|NCT00925301|454249732|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
126452018|NCT02059291|454957143|FG002|Epoch 2|Adverse Event|1|||
126452019|NCT02059291|454957144|FG003|Epoch 2|Adverse Event|1|||
126452020|NCT02059291|454957145|FG004|Epoch 2|Adverse Event|0|||
126452021|NCT02059291|454957146|FG005|Epoch 2|Adverse Event|0|||
126452022|NCT02059291|454957147|FG006|Epoch 2|Adverse Event|0|||
126452023|NCT02059291|454957148|FG007|Epoch 2|Adverse Event|1|||
126262025|NCT00925301|454249733|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
126262026|NCT00925301|454249734|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
126262027|NCT00925301|454249731|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
126452024|NCT02059291|454957149|FG008|Epoch 2|Adverse Event|1|||
126262028|NCT00925301|454249732|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
126262029|NCT00925301|454249733|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
126262030|NCT00925301|454249734|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
126262031|NCT00925301|454249731|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
126262032|NCT00925301|454249732|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
126262033|NCT00925301|454249733|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
126262034|NCT00925301|454249734|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
126763589|NCT04668066|456086794|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763590|NCT04668066|456086795|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763591|NCT04668066|456086796|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763592|NCT04668066|456086797|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763593|NCT04668066|456086798|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763594|NCT04668066|456086799|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763595|NCT04668066|456086800|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763596|NCT04668066|456086801|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763597|NCT04668066|456086802|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763598|NCT04668066|456086803|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763599|NCT04668066|456086804|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763600|NCT04668066|456086805|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763601|NCT04668066|456086806|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763602|NCT04668066|456086807|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763603|NCT04668066|456086808|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763604|NCT04668066|456086809|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763605|NCT04668066|456086810|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
126763606|NCT04668066|456086811|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
126763607|NCT02388906|456086819|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
126763608|NCT02388906|456086820|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
126763609|NCT02388906|456086819|FG000|Treatment Period|Disease progression|121|||
126763610|NCT02388906|456086820|FG001|Treatment Period|Disease progression|100|||
126763611|NCT02388906|456086819|FG000|Treatment Period|Study drug toxicity|41|||
126763612|NCT02388906|456086820|FG001|Treatment Period|Study drug toxicity|208|||
126763613|NCT02388906|456086819|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
126763614|NCT02388906|456086820|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
126763615|NCT02388906|456086819|FG000|Treatment Period|Participant request to stop treatment|5|||
126763616|NCT02388906|456086820|FG001|Treatment Period|Participant request to stop treatment|9|||
126763617|NCT02388906|456086819|FG000|Treatment Period|Participant withdrew consent|2|||
126763618|NCT02388906|456086820|FG001|Treatment Period|Participant withdrew consent|3|||
126763619|NCT02388906|456086819|FG000|Treatment Period|Poor/non-compliance|0|||
126763620|NCT02388906|456086820|FG001|Treatment Period|Poor/non-compliance|1|||
126763621|NCT02388906|456086819|FG000|Treatment Period|Participant no longer meets study criteria|0|||
126763622|NCT02388906|456086820|FG001|Treatment Period|Participant no longer meets study criteria|1|||
126763623|NCT02388906|456086819|FG000|Treatment Period|Other reasons|3|||
126763624|NCT02388906|456086820|FG001|Treatment Period|Other reasons|3|||
126763625|NCT05048875|456086823|FG000|Overall Study|Withdrawal by Subject|1|||
126763626|NCT05048875|456086824|FG001|Overall Study|Withdrawal by Subject|0|||
126763627|NCT05048875|456086825|FG002|Overall Study|Withdrawal by Subject|0|||
126763628|NCT05048875|456086826|FG003|Overall Study|Withdrawal by Subject|0|||
126763629|NCT05048875|456086827|FG004|Overall Study|Withdrawal by Subject|0|||
126763630|NCT05048875|456086828|FG005|Overall Study|Withdrawal by Subject|0|||
126763631|NCT05048875|456086829|FG006|Overall Study|Withdrawal by Subject|0|||
126262035|NCT00925301|454249731|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
126262036|NCT00925301|454249732|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
126262037|NCT00925301|454249733|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
126262038|NCT00925301|454249734|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
126262039|NCT01117766|454249735|FG000|First Intervention|Adverse Event|0|||
126262040|NCT01117766|454249736|FG001|First Intervention|Adverse Event|1|||
126262041|NCT01117766|454249735|FG000|First Intervention|Protocol Violation|1|||
126452025|NCT02059291|454957150|FG009|Epoch 2|Adverse Event|0|||
126452026|NCT02059291|454957151|FG010|Epoch 2|Adverse Event|0|||
126452027|NCT02059291|454957152|FG011|Epoch 2|Adverse Event|0|||
126452028|NCT02059291|454957153|FG012|Epoch 2|Adverse Event|0|||
126452029|NCT02059291|454957154|FG013|Epoch 2|Adverse Event|0|||
126452030|NCT02059291|454957155|FG014|Epoch 2|Adverse Event|0|||
126452031|NCT02059291|454957156|FG015|Epoch 2|Adverse Event|0|||
126452032|NCT02059291|454957157|FG016|Epoch 2|Adverse Event|0|||
126452033|NCT02059291|454957158|FG017|Epoch 2|Adverse Event|0|||
126452034|NCT02059291|454957159|FG018|Epoch 2|Adverse Event|0|||
126452035|NCT02059291|454957160|FG019|Epoch 2|Adverse Event|0|||
126452036|NCT02059291|454957161|FG020|Epoch 2|Adverse Event|0|||
126452037|NCT02059291|454957162|FG021|Epoch 2|Adverse Event|0|||
126452038|NCT02059291|454957163|FG022|Epoch 2|Adverse Event|0|||
126452039|NCT02059291|454957164|FG023|Epoch 2|Adverse Event|0|||
126452040|NCT02059291|454957165|FG024|Epoch 2|Adverse Event|0|||
126452041|NCT02059291|454957141|FG000|Epoch 2|Withdrawal by Subject|0|||
126452042|NCT02059291|454957142|FG001|Epoch 2|Withdrawal by Subject|1|||
126452043|NCT02059291|454957143|FG002|Epoch 2|Withdrawal by Subject|0|||
126452044|NCT02059291|454957144|FG003|Epoch 2|Withdrawal by Subject|0|||
126763632|NCT05048875|456086830|FG007|Overall Study|Withdrawal by Subject|0|||
126763633|NCT05048875|456086823|FG000|Overall Study|Adverse Event|0|||
126763634|NCT05048875|456086824|FG001|Overall Study|Adverse Event|0|||
126763635|NCT05048875|456086825|FG002|Overall Study|Adverse Event|0|||
126452045|NCT02059291|454957145|FG004|Epoch 2|Withdrawal by Subject|0|||
126452046|NCT02059291|454957146|FG005|Epoch 2|Withdrawal by Subject|1|||
126546845|NCT03029780|455296067|FG001|Overall Study|Participant request to discontinue study treatment|1|||
126262042|NCT01117766|454249736|FG001|First Intervention|Protocol Violation|0|||
126262043|NCT01117766|454249735|FG000|Washout Period|Protocol Violation|0|||
126262044|NCT01117766|454249736|FG001|Washout Period|Protocol Violation|2|||
126262045|NCT01117766|454249735|FG000|Second Intervention|Lost to Follow-up|1|||
126262046|NCT01117766|454249736|FG001|Second Intervention|Lost to Follow-up|0|||
126262047|NCT01117766|454249735|FG000|Second Intervention|Other|1|||
126262048|NCT01117766|454249736|FG001|Second Intervention|Other|2|||
126262049|NCT01117766|454249735|FG000|Second Intervention|Adverse Event|0|||
126262050|NCT01117766|454249736|FG001|Second Intervention|Adverse Event|2|||
126262051|NCT01117766|454249735|FG000|Second Intervention|Withdrawal by Subject|0|||
126262052|NCT01117766|454249736|FG001|Second Intervention|Withdrawal by Subject|1|||
126262053|NCT01117987|454249737|FG000|Overall Study|Protocol deviation|0|||
126262054|NCT01117987|454249738|FG001|Overall Study|Protocol deviation|1|||
126262055|NCT01117987|454249737|FG000|Overall Study|Subject no longer requires study drug|1|||
126262056|NCT01117987|454249738|FG001|Overall Study|Subject no longer requires study drug|0|||
126262057|NCT01117987|454249737|FG000|Overall Study|Lost to Follow-up|1|||
126262058|NCT01117987|454249738|FG001|Overall Study|Lost to Follow-up|1|||
126262059|NCT01117987|454249737|FG000|Overall Study|Abnormal test procedure result|2|||
126262060|NCT01117987|454249738|FG001|Overall Study|Abnormal test procedure result|0|||
126262061|NCT01117987|454249737|FG000|Overall Study|Lack of Efficacy|3|||
126262062|NCT01117987|454249738|FG001|Overall Study|Lack of Efficacy|4|||
126262063|NCT01117987|454249737|FG000|Overall Study|Death|5|||
126262064|NCT01117987|454249738|FG001|Overall Study|Death|10|||
126262065|NCT01117987|454249737|FG000|Overall Study|Withdrawal by Subject|5|||
126262066|NCT01117987|454249738|FG001|Overall Study|Withdrawal by Subject|10|||
126262067|NCT01117987|454249737|FG000|Overall Study|Adverse Event|19|||
126262068|NCT01117987|454249738|FG001|Overall Study|Adverse Event|26|||
126262069|NCT01117987|454249737|FG000|Overall Study|Administrative problems|25|||
126262070|NCT01117987|454249738|FG001|Overall Study|Administrative problems|22|||
126262071|NCT02244424|454249739|FG000|Overall Study|Lost to Follow-up|20|||
126262072|NCT02244424|454249740|FG001|Overall Study|Lost to Follow-up|10|||
126262073|NCT04232540|454249741|FG000|Overall Study|Lost to Follow-up|1|||
126262074|NCT04232540|454249742|FG001|Overall Study|Lost to Follow-up|0|||
126262075|NCT03064438|454251147|FG000|Overall Study|Lost to Follow-up|1|||
126262076|NCT03064438|454251148|FG001|Overall Study|Lost to Follow-up|0|||
126262077|NCT03064438|454251147|FG000|Overall Study|Withdrawal by Subject|0|||
126262078|NCT03064438|454251148|FG001|Overall Study|Withdrawal by Subject|1|||
126262079|NCT01684215|454251152|FG000|Phase 1, Part 1|Adverse Event|1|||
126262080|NCT01684215|454251153|FG001|Phase 1, Part 1|Adverse Event|0|||
126262081|NCT01684215|454251154|FG002|Phase 1, Part 1|Adverse Event|0|||
126262082|NCT01684215|454251155|FG003|Phase 1, Part 1|Adverse Event|0|||
126262083|NCT01684215|454251152|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
126262084|NCT01684215|454251153|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
126262085|NCT01684215|454251154|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
126262086|NCT01684215|454251155|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
126262087|NCT01684215|454251152|FG000|Phase 1, Part 2|Adverse Event|0|||
126262088|NCT01684215|454251153|FG001|Phase 1, Part 2|Adverse Event|0|||
126262089|NCT01684215|454251154|FG002|Phase 1, Part 2|Adverse Event|1|||
126262090|NCT01684215|454251155|FG003|Phase 1, Part 2|Adverse Event|0|||
126262091|NCT01684215|454251152|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
126262092|NCT01684215|454251153|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
126262093|NCT01684215|454251154|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
126700231|NCT05067127|455853512|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
126262094|NCT01684215|454251155|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
126546846|NCT03029780|455296066|FG000|Overall Study|Maximum clinical benefit|1|||
126262095|NCT01684215|454251152|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
126262096|NCT01684215|454251153|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
126262097|NCT01684215|454251154|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
126262098|NCT01684215|454251155|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
126262099|NCT01684215|454251152|FG000|Phase 2|Death|0|||
126262100|NCT01684215|454251153|FG001|Phase 2|Death|0|||
126262101|NCT01684215|454251154|FG002|Phase 2|Death|0|||
126262102|NCT01684215|454251155|FG003|Phase 2|Death|8|||
126262103|NCT01684215|454251152|FG000|Phase 2|Study terminated by sponsor|0|||
126262104|NCT01684215|454251153|FG001|Phase 2|Study terminated by sponsor|0|||
126262105|NCT01684215|454251154|FG002|Phase 2|Study terminated by sponsor|0|||
126262106|NCT01684215|454251155|FG003|Phase 2|Study terminated by sponsor|30|||
126262107|NCT01684215|454251152|FG000|Phase 2|Enrolled but not treated|0|||
126262108|NCT01684215|454251153|FG001|Phase 2|Enrolled but not treated|0|||
126262109|NCT01684215|454251154|FG002|Phase 2|Enrolled but not treated|0|||
126262110|NCT01684215|454251155|FG003|Phase 2|Enrolled but not treated|1|||
126262111|NCT01684215|454251152|FG000|Phase 2|Lost to Follow-up|0|||
126262112|NCT01684215|454251153|FG001|Phase 2|Lost to Follow-up|0|||
126262113|NCT01684215|454251154|FG002|Phase 2|Lost to Follow-up|0|||
126262114|NCT01684215|454251155|FG003|Phase 2|Lost to Follow-up|4|||
126262115|NCT01301482|454251156|FG000|Overall Study|Withdrawal by Subject|1|||
126262116|NCT00480324|454251159|FG000|Overall Study|Adverse Event|1|||
126359633|NCT01122680|454609028|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
126700232|NCT05067127|455853509|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
126700233|NCT05067127|455853510|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
126700234|NCT05067127|455853511|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
126700235|NCT05067127|455853512|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
126700236|NCT05067127|455853509|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
126700237|NCT05067127|455853510|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
126700238|NCT05067127|455853511|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
126700239|NCT05067127|455853512|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
126700240|NCT05067127|455853509|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
126700241|NCT05067127|455853510|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
126700242|NCT05067127|455853511|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
126700243|NCT05067127|455853512|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
126700244|NCT05067127|455853509|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
126700245|NCT05067127|455853510|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
126700246|NCT05067127|455853511|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
126700247|NCT05067127|455853512|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
126700248|NCT05067127|455853509|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
126700249|NCT05067127|455853510|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
126700250|NCT05067127|455853511|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
126700251|NCT05067127|455853512|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
126700252|NCT04462536|455853513|FG000|Overall Study|Withdrawal by Subject|3|||
126700253|NCT04462536|455853514|FG001|Overall Study|Withdrawal by Subject|9|||
126700254|NCT04462536|455853513|FG000|Overall Study|Lost to Follow-up|2|||
126700255|NCT04462536|455853514|FG001|Overall Study|Lost to Follow-up|4|||
126700256|NCT01154101|455853520|FG000|Overall Study|Adverse Event|0|||
126700257|NCT01154101|455853521|FG001|Overall Study|Adverse Event|2|||
126700258|NCT01154101|455853522|FG002|Overall Study|Adverse Event|1|||
126700259|NCT01154101|455853523|FG003|Overall Study|Adverse Event|1|||
126700260|NCT01154101|455853524|FG004|Overall Study|Adverse Event|0|||
126700261|NCT01154101|455853520|FG000|Overall Study|Lost to Follow-up|0|||
126700262|NCT01154101|455853521|FG001|Overall Study|Lost to Follow-up|1|||
126700263|NCT01154101|455853522|FG002|Overall Study|Lost to Follow-up|0|||
126700264|NCT01154101|455853523|FG003|Overall Study|Lost to Follow-up|1|||
126700265|NCT01154101|455853524|FG004|Overall Study|Lost to Follow-up|0|||
126700266|NCT01154101|455853520|FG000|Overall Study|Withdrawal by Subject|0|||
126700267|NCT01154101|455853521|FG001|Overall Study|Withdrawal by Subject|1|||
126700268|NCT01154101|455853522|FG002|Overall Study|Withdrawal by Subject|2|||
126700269|NCT01154101|455853523|FG003|Overall Study|Withdrawal by Subject|0|||
126700270|NCT01154101|455853524|FG004|Overall Study|Withdrawal by Subject|1|||
126700271|NCT04125680|455853526|FG000|Overall Study|Lost to Follow-up|15|||
126700272|NCT01562028|455853527|FG000|Overall Study|Withdrawal by Subject|1|||
126700273|NCT01562028|455853528|FG001|Overall Study|Withdrawal by Subject|1|||
126700274|NCT01562028|455853527|FG000|Overall Study|Lost to Follow-up|2|||
126700275|NCT01562028|455853528|FG001|Overall Study|Lost to Follow-up|1|||
126700276|NCT02360098|455853529|FG000|Overall Study|Physician Decision|7|||
126700277|NCT02731742|455853536|FG000|Overall Study|Death|1|||
126700278|NCT02731742|455853537|FG001|Overall Study|Death|2|||
126700279|NCT02731742|455853538|FG002|Overall Study|Death|5|||
126700280|NCT02731742|455853539|FG003|Overall Study|Death|0|||
126700281|NCT02731742|455853536|FG000|Overall Study|Physician Decision|0|||
126700282|NCT02731742|455853537|FG001|Overall Study|Physician Decision|0|||
126700283|NCT02731742|455853538|FG002|Overall Study|Physician Decision|0|||
126700284|NCT02731742|455853539|FG003|Overall Study|Physician Decision|1|||
126700285|NCT02731742|455853536|FG000|Overall Study|Study Terminated by Sponsor|2|||
126700286|NCT02731742|455853537|FG001|Overall Study|Study Terminated by Sponsor|1|||
126700287|NCT02731742|455853538|FG002|Overall Study|Study Terminated by Sponsor|1|||
126700288|NCT02731742|455853539|FG003|Overall Study|Study Terminated by Sponsor|1|||
126700289|NCT02786901|455853540|FG000|Overall Study|Adverse Event|1|||
126700290|NCT02786901|455853541|FG001|Overall Study|Adverse Event|1|||
126359634|NCT01122680|454609029|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
126359635|NCT01122680|454609030|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
126359636|NCT01122680|454609027|FG000|Period 1 (4 Weeks)|Other|1|||
126700291|NCT02786901|455853542|FG002|Overall Study|Adverse Event|2|||
126700292|NCT02786901|455853540|FG000|Overall Study|Physician Decision|1|||
126700293|NCT02786901|455853541|FG001|Overall Study|Physician Decision|0|||
126700294|NCT02786901|455853542|FG002|Overall Study|Physician Decision|0|||
126700295|NCT02786901|455853540|FG000|Overall Study|Rescue Therapy Use|71|||
126700296|NCT02786901|455853541|FG001|Overall Study|Rescue Therapy Use|49|||
126700297|NCT02786901|455853542|FG002|Overall Study|Rescue Therapy Use|33|||
126700298|NCT02786901|455853540|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
126700299|NCT02786901|455853541|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
126700300|NCT02786901|455853542|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
126700301|NCT02786901|455853540|FG000|Overall Study|Disallowed medication|1|||
126359637|NCT01122680|454609028|FG001|Period 1 (4 Weeks)|Other|1|||
126359638|NCT01122680|454609029|FG002|Period 1 (4 Weeks)|Other|0|||
126359639|NCT01122680|454609030|FG003|Period 1 (4 Weeks)|Other|0|||
126359640|NCT01122680|454609027|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
126359641|NCT01122680|454609028|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
126359642|NCT01122680|454609029|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
126359643|NCT01122680|454609030|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
126359644|NCT01122680|454609027|FG000|Period 2 (4 Weeks)|Other|1|||
126359645|NCT01122680|454609028|FG001|Period 2 (4 Weeks)|Other|0|||
126359646|NCT01122680|454609029|FG002|Period 2 (4 Weeks)|Other|0|||
126262117|NCT00480324|454251160|FG001|Overall Study|Adverse Event|1|||
126262118|NCT00480324|454251159|FG000|Overall Study|Protocol Violation|0|||
126262119|NCT00480324|454251160|FG001|Overall Study|Protocol Violation|1|||
126262120|NCT00480324|454251159|FG000|Overall Study|Withdrawal by Subject|14|||
126262121|NCT00480324|454251160|FG001|Overall Study|Withdrawal by Subject|5|||
126262122|NCT00480324|454251159|FG000|Overall Study|Lost to Follow-up|17|||
126262123|NCT00480324|454251160|FG001|Overall Study|Lost to Follow-up|8|||
126262124|NCT00480324|454251159|FG000|Overall Study|Subject's mother pregnant|0|||
126262125|NCT00480324|454251160|FG001|Overall Study|Subject's mother pregnant|1|||
126262126|NCT01552369|454251161|FG000|Overall Study|Did not consent to extended follow up|8|||
126262127|NCT01552369|454251162|FG001|Overall Study|Did not consent to extended follow up|9|||
126262128|NCT00977548|454251164|FG000|Overall Study|Ineligible|4|||
126262129|NCT00977548|454251164|FG000|Overall Study|Adverse Event|8|||
126262130|NCT00977548|454251164|FG000|Overall Study|Withdrawal by Subject|1|||
126262131|NCT04086641|454251166|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
126262132|NCT04086641|454251167|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
126262133|NCT03438539|454251175|FG000|Overall Study|Lost to Follow-up|8|||
126262134|NCT03438539|454251176|FG001|Overall Study|Lost to Follow-up|4|||
126262135|NCT03438539|454251177|FG002|Overall Study|Lost to Follow-up|10|||
126262136|NCT03438539|454251178|FG003|Overall Study|Lost to Follow-up|9|||
126262137|NCT03438539|454251179|FG004|Overall Study|Lost to Follow-up|3|||
126262138|NCT03438539|454251180|FG005|Overall Study|Lost to Follow-up|8|||
126262139|NCT04213209|454251181|FG000|Overall Study|Protocol Violation|1|||
126262140|NCT04213209|454251182|FG001|Overall Study|Protocol Violation|0|||
126262141|NCT04213209|454251183|FG002|Overall Study|Protocol Violation|0|||
126262142|NCT04213209|454251184|FG003|Overall Study|Protocol Violation|0|||
126262143|NCT04213209|454251185|FG004|Overall Study|Protocol Violation|0|||
126262144|NCT04213209|454251186|FG005|Overall Study|Protocol Violation|0|||
126262145|NCT02065713|454251191|FG000|Overall Study|Adverse Event|0|||
126262146|NCT02065713|454251192|FG001|Overall Study|Adverse Event|1|||
126262147|NCT02065713|454251191|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126262148|NCT02065713|454251192|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126262149|NCT00126126|454251195|FG000|Overall Study|Lost to Follow-up|0|||
126262150|NCT00126126|454251196|FG001|Overall Study|Lost to Follow-up|2|||
126262151|NCT02459665|454251197|FG000|Overall Study|Withdrawal by Subject|0|||
126262152|NCT02459665|454251198|FG001|Overall Study|Withdrawal by Subject|1|||
126262153|NCT02459665|454251199|FG002|Overall Study|Withdrawal by Subject|1|||
126262154|NCT02459665|454251200|FG003|Overall Study|Withdrawal by Subject|2|||
126262155|NCT00868296|454251201|FG000|Overall Study|Adverse Event|0|||
126262156|NCT00868296|454251202|FG001|Overall Study|Adverse Event|2|||
126262157|NCT00868296|454251201|FG000|Overall Study|Withdrawal by Subject|0|||
126262158|NCT00868296|454251202|FG001|Overall Study|Withdrawal by Subject|1|||
126262159|NCT00986570|454251207|FG000|Overall Study|Lost to Follow-up|6|||
126262160|NCT00986570|454251207|FG000|Overall Study|Potential bias for objective assessment|1|||
126262161|NCT00804141|454251208|FG000|Overall Study|Adverse Event|157|||
126262162|NCT00804141|454251208|FG000|Overall Study|Death|4|||
126359647|NCT01122680|454609030|FG003|Period 2 (4 Weeks)|Other|0|||
126359648|NCT01122680|454609027|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
126359649|NCT01122680|454609028|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
126700302|NCT02786901|455853541|FG001|Overall Study|Disallowed medication|1|||
126262163|NCT00804141|454251208|FG000|Overall Study|Failed to return|96|||
126262164|NCT00804141|454251208|FG000|Overall Study|Investigator request|8|||
126262165|NCT00804141|454251208|FG000|Overall Study|Protocol Violation|85|||
126262166|NCT00804141|454251208|FG000|Overall Study|Withdrawal by Subject|131|||
126262167|NCT00804141|454251208|FG000|Overall Study|Lack of Efficacy|46|||
126262168|NCT00804141|454251208|FG000|Overall Study|Other than specified|30|||
126262169|NCT00804141|454251208|FG000|Overall Study|Enrolled but not treated|6|||
126359650|NCT01122680|454609029|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
126359651|NCT01122680|454609030|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
126262170|NCT01501110|454251209|FG000|Overall Study|Death|0|||
126359652|NCT01122680|454609027|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126359653|NCT01122680|454609028|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
126262171|NCT01501110|454251210|FG001|Overall Study|Death|1|||
126262172|NCT02075606|454251211|FG000|Overall Study|Adverse Event|5|||
126262173|NCT02075606|454251211|FG000|Overall Study|Withdrawal by Subject|1|||
126262174|NCT02075606|454251211|FG000|Overall Study|Death|1|||
126262175|NCT02075606|454251211|FG000|Overall Study|Investigator's decision|1|||
126262176|NCT02075606|454251211|FG000|Overall Study|Symptom management|1|||
126359654|NCT01122680|454609029|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126262177|NCT02075606|454251211|FG000|Overall Study|Increasing Symptoms|1|||
126262178|NCT02462486|454251212|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
126262179|NCT02462486|454251213|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
126262180|NCT02462486|454251214|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
126262181|NCT02462486|454251212|FG000|Overall Study|Adverse Event|53|||
126262182|NCT02462486|454251213|FG001|Overall Study|Adverse Event|48|||
126452047|NCT02059291|454957147|FG006|Epoch 2|Withdrawal by Subject|0|||
126452048|NCT02059291|454957148|FG007|Epoch 2|Withdrawal by Subject|0|||
126452049|NCT02059291|454957149|FG008|Epoch 2|Withdrawal by Subject|1|||
126452050|NCT02059291|454957150|FG009|Epoch 2|Withdrawal by Subject|0|||
126452051|NCT02059291|454957151|FG010|Epoch 2|Withdrawal by Subject|0|||
126452052|NCT02059291|454957152|FG011|Epoch 2|Withdrawal by Subject|0|||
126452053|NCT02059291|454957153|FG012|Epoch 2|Withdrawal by Subject|0|||
126452054|NCT02059291|454957154|FG013|Epoch 2|Withdrawal by Subject|0|||
126452055|NCT02059291|454957155|FG014|Epoch 2|Withdrawal by Subject|0|||
126262183|NCT02462486|454251214|FG002|Overall Study|Adverse Event|21|||
126262184|NCT02462486|454251212|FG000|Overall Study|Lack of Efficacy|6|||
126262185|NCT02462486|454251213|FG001|Overall Study|Lack of Efficacy|12|||
126262186|NCT02462486|454251214|FG002|Overall Study|Lack of Efficacy|3|||
126262187|NCT02462486|454251212|FG000|Overall Study|Lost to Follow-up|3|||
126262188|NCT02462486|454251213|FG001|Overall Study|Lost to Follow-up|4|||
126262189|NCT02462486|454251214|FG002|Overall Study|Lost to Follow-up|2|||
126262190|NCT02462486|454251212|FG000|Overall Study|Withdrawal by Subject|25|||
126262191|NCT02462486|454251213|FG001|Overall Study|Withdrawal by Subject|22|||
126262192|NCT02462486|454251214|FG002|Overall Study|Withdrawal by Subject|19|||
126262193|NCT02462486|454251212|FG000|Overall Study|Protocol Violation|3|||
126262194|NCT02462486|454251213|FG001|Overall Study|Protocol Violation|1|||
126262195|NCT02462486|454251214|FG002|Overall Study|Protocol Violation|1|||
126262196|NCT02462486|454251212|FG000|Overall Study|Reason not Specified|3|||
126262197|NCT02462486|454251213|FG001|Overall Study|Reason not Specified|4|||
126262198|NCT02462486|454251214|FG002|Overall Study|Reason not Specified|3|||
126262199|NCT02310763|454251215|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
126262200|NCT02310763|454251216|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
126262201|NCT02310763|454251217|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
126359655|NCT01122680|454609030|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126359656|NCT01550965|454609031|FG000|Overall Study|Adverse Event|26|||
126359657|NCT01550965|454609031|FG000|Overall Study|Withdrawal by Subject|10|||
126359658|NCT01550965|454609031|FG000|Overall Study|Lost to Follow-up|2|||
126359659|NCT01550965|454609031|FG000|Overall Study|Lack of Efficacy|59|||
126359660|NCT01550965|454609031|FG000|Overall Study|Other|13|||
126359661|NCT03016403|454609034|FG000|Baseline|Death|5|||
126359662|NCT03016403|454609035|FG001|Baseline|Death|8|||
126359663|NCT03016403|454609036|FG002|Baseline|Death|1|||
126359664|NCT03016403|454609037|FG003|Baseline|Death|0|||
126359665|NCT03016403|454609034|FG000|Baseline|Withdrawal by Subject|2|||
126359666|NCT03016403|454609035|FG001|Baseline|Withdrawal by Subject|8|||
126359667|NCT03016403|454609036|FG002|Baseline|Withdrawal by Subject|4|||
126359668|NCT03016403|454609037|FG003|Baseline|Withdrawal by Subject|10|||
126359669|NCT03016403|454609034|FG000|Baseline|Lost to Follow-up|9|||
126359670|NCT03016403|454609035|FG001|Baseline|Lost to Follow-up|11|||
126359671|NCT03016403|454609036|FG002|Baseline|Lost to Follow-up|6|||
126359672|NCT03016403|454609037|FG003|Baseline|Lost to Follow-up|24|||
126359673|NCT03016403|454609034|FG000|6-week Follow-up|Death|1|||
126359674|NCT03016403|454609035|FG001|6-week Follow-up|Death|4|||
126359675|NCT03016403|454609036|FG002|6-week Follow-up|Death|0|||
126359676|NCT03016403|454609037|FG003|6-week Follow-up|Death|0|||
126359677|NCT03016403|454609034|FG000|6-week Follow-up|Lost to Follow-up|2|||
126359678|NCT03016403|454609035|FG001|6-week Follow-up|Lost to Follow-up|7|||
126359679|NCT03016403|454609036|FG002|6-week Follow-up|Lost to Follow-up|4|||
126359680|NCT03016403|454609037|FG003|6-week Follow-up|Lost to Follow-up|8|||
126359681|NCT03016403|454609034|FG000|6-week Follow-up|Withdrawal by Subject|0|||
126359682|NCT03016403|454609035|FG001|6-week Follow-up|Withdrawal by Subject|2|||
126359683|NCT03016403|454609036|FG002|6-week Follow-up|Withdrawal by Subject|0|||
126359684|NCT03016403|454609037|FG003|6-week Follow-up|Withdrawal by Subject|1|||
126359685|NCT03016403|454609034|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
126359686|NCT03016403|454609035|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
126359687|NCT03016403|454609036|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
126359688|NCT03016403|454609037|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
126262202|NCT02310763|454251215|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
126359689|NCT03016403|454609034|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
126359690|NCT03016403|454609035|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
126359691|NCT03016403|454609036|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
126359692|NCT03016403|454609037|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
126359693|NCT03016403|454609034|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
126452056|NCT02059291|454957156|FG015|Epoch 2|Withdrawal by Subject|0|||
126452057|NCT02059291|454957157|FG016|Epoch 2|Withdrawal by Subject|0|||
126452058|NCT02059291|454957158|FG017|Epoch 2|Withdrawal by Subject|0|||
126452059|NCT02059291|454957159|FG018|Epoch 2|Withdrawal by Subject|0|||
126700303|NCT02786901|455853542|FG002|Overall Study|Disallowed medication|0|||
126700304|NCT02786901|455853540|FG000|Overall Study|Randomized in error|2|||
126700305|NCT02786901|455853541|FG001|Overall Study|Randomized in error|0|||
126700306|NCT02786901|455853542|FG002|Overall Study|Randomized in error|1|||
126700307|NCT03367871|455853543|FG000|Overall Study|Lost to Follow-up|1|||
126700308|NCT01157117|455853544|FG000|Overall Study|Dosing Symptoms|0|||
126700309|NCT01157117|455853545|FG001|Overall Study|Dosing Symptoms|4|||
126262203|NCT02310763|454251216|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
126262204|NCT02310763|454251217|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
126262205|NCT02310763|454251215|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
126262206|NCT02310763|454251216|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
126262207|NCT02310763|454251217|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
126262208|NCT02310763|454251215|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
126262209|NCT02310763|454251216|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
126262210|NCT02310763|454251217|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
126262211|NCT02310763|454251215|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
126262212|NCT02310763|454251216|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
126262213|NCT02310763|454251217|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
126262214|NCT03877926|454251222|FG000|Overall Study|Adverse Event|1|||
126262215|NCT03877926|454251223|FG001|Overall Study|Adverse Event|0|||
126262216|NCT03877926|454251224|FG002|Overall Study|Adverse Event|0|||
126262217|NCT03877926|454251225|FG003|Overall Study|Adverse Event|0|||
126262218|NCT03877926|454251222|FG000|Overall Study|Death|2|||
126262219|NCT03877926|454251223|FG001|Overall Study|Death|2|||
126262220|NCT03877926|454251224|FG002|Overall Study|Death|2|||
126262221|NCT03877926|454251225|FG003|Overall Study|Death|0|||
126262222|NCT03877926|454251222|FG000|Overall Study|Lost to Follow-up|41|||
126262223|NCT03877926|454251223|FG001|Overall Study|Lost to Follow-up|52|||
126262224|NCT03877926|454251224|FG002|Overall Study|Lost to Follow-up|45|||
126262225|NCT03877926|454251225|FG003|Overall Study|Lost to Follow-up|17|||
126262226|NCT03877926|454251222|FG000|Overall Study|Physician Decision|2|||
126262227|NCT03877926|454251223|FG001|Overall Study|Physician Decision|0|||
126262228|NCT03877926|454251224|FG002|Overall Study|Physician Decision|2|||
126262229|NCT03877926|454251225|FG003|Overall Study|Physician Decision|0|||
126262230|NCT03877926|454251222|FG000|Overall Study|Withdrawal by Subject|18|||
126262231|NCT03877926|454251223|FG001|Overall Study|Withdrawal by Subject|21|||
126262232|NCT03877926|454251224|FG002|Overall Study|Withdrawal by Subject|12|||
126262233|NCT03877926|454251225|FG003|Overall Study|Withdrawal by Subject|4|||
126262234|NCT03877926|454251222|FG000|Overall Study|Other - Various|4|||
126262235|NCT03877926|454251223|FG001|Overall Study|Other - Various|1|||
126262236|NCT03877926|454251224|FG002|Overall Study|Other - Various|1|||
126262237|NCT03877926|454251225|FG003|Overall Study|Other - Various|0|||
126700310|NCT01157117|455853546|FG002|Overall Study|Dosing Symptoms|0|||
126700311|NCT01157117|455853544|FG000|Overall Study|Withdrawal by Subject|4|||
126700312|NCT01157117|455853545|FG001|Overall Study|Withdrawal by Subject|1|||
126700313|NCT01157117|455853546|FG002|Overall Study|Withdrawal by Subject|1|||
126700314|NCT01157117|455853544|FG000|Overall Study|Lack of Efficacy|1|||
126700315|NCT01157117|455853545|FG001|Overall Study|Lack of Efficacy|1|||
126700316|NCT01157117|455853546|FG002|Overall Study|Lack of Efficacy|0|||
126700317|NCT01157117|455853544|FG000|Overall Study|Lost to Follow-up|0|||
126700318|NCT01157117|455853545|FG001|Overall Study|Lost to Follow-up|0|||
126700319|NCT01157117|455853546|FG002|Overall Study|Lost to Follow-up|1|||
126700320|NCT01157117|455853544|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
126700321|NCT01157117|455853545|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
126700322|NCT01157117|455853546|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
126700323|NCT02207907|455853552|FG000|Overall Study|Lost to Follow-up|3|||
126700324|NCT02207907|455853553|FG001|Overall Study|Lost to Follow-up|1|||
126700325|NCT02207907|455853552|FG000|Overall Study|Withdrawal by Subject|5|||
126700326|NCT02207907|455853553|FG001|Overall Study|Withdrawal by Subject|6|||
126700327|NCT02207907|455853552|FG000|Overall Study|Did not meet study criteria|3|||
126700328|NCT02207907|455853553|FG001|Overall Study|Did not meet study criteria|0|||
126700329|NCT02207907|455853552|FG000|Overall Study|Pregnancy|0|||
126700330|NCT02207907|455853553|FG001|Overall Study|Pregnancy|1|||
126262238|NCT03877926|454251222|FG000|Overall Study|Not Treated|3|||
126262239|NCT03877926|454251223|FG001|Overall Study|Not Treated|1|||
126262240|NCT03877926|454251224|FG002|Overall Study|Not Treated|1|||
126262241|NCT03877926|454251225|FG003|Overall Study|Not Treated|0|||
126262242|NCT03554317|454251227|FG000|Overall Study|Withdrawal by Subject|1|||
126262243|NCT03554317|454251227|FG000|Overall Study|PSA Progression|3|||
126262244|NCT03554317|454251227|FG000|Overall Study|Radiographic Progression|4|||
126262245|NCT00124462|454251230|FG000|Overall Study|Lost to Follow-up|3|||
126262246|NCT00124462|454251231|FG001|Overall Study|Lost to Follow-up|3|||
126262247|NCT00124462|454251230|FG000|Overall Study|Physician Decision|3|||
126700331|NCT02620020|455853554|FG000|Overall Study|Adverse Event|8|||
126700332|NCT02620020|455853555|FG001|Overall Study|Adverse Event|4|||
126700333|NCT02620020|455853556|FG002|Overall Study|Adverse Event|3|||
126700334|NCT02620020|455853557|FG003|Overall Study|Adverse Event|5|||
126700335|NCT02620020|455853554|FG000|Overall Study|Lost to Follow-up|4|||
126262248|NCT00124462|454251231|FG001|Overall Study|Physician Decision|4|||
126452060|NCT02059291|454957160|FG019|Epoch 2|Withdrawal by Subject|0|||
126452061|NCT02059291|454957161|FG020|Epoch 2|Withdrawal by Subject|0|||
126452062|NCT02059291|454957162|FG021|Epoch 2|Withdrawal by Subject|0|||
126452063|NCT02059291|454957163|FG022|Epoch 2|Withdrawal by Subject|0|||
126452064|NCT02059291|454957164|FG023|Epoch 2|Withdrawal by Subject|0|||
126452065|NCT02059291|454957165|FG024|Epoch 2|Withdrawal by Subject|0|||
126452066|NCT02059291|454957141|FG000|Epoch 3|Physician Decision|0|||
126452067|NCT02059291|454957142|FG001|Epoch 3|Physician Decision|0|||
126452068|NCT02059291|454957143|FG002|Epoch 3|Physician Decision|0|||
126452069|NCT02059291|454957144|FG003|Epoch 3|Physician Decision|0|||
126452070|NCT02059291|454957145|FG004|Epoch 3|Physician Decision|0|||
126262249|NCT00124462|454251230|FG000|Overall Study|Withdrawal by Subject|4|||
126262250|NCT00124462|454251231|FG001|Overall Study|Withdrawal by Subject|5|||
126262251|NCT00124462|454251230|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
126262252|NCT00124462|454251231|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
126262253|NCT00537199|454251232|FG000|Overall Study|Study Terminated|1|||
126262254|NCT02776553|454251237|FG000|Overall Study|Lost to Follow-up|1|||
126262255|NCT02776553|454251238|FG001|Overall Study|Lost to Follow-up|0|||
126262256|NCT02776553|454251237|FG000|Overall Study|got liver transplant|1|||
126262257|NCT02776553|454251238|FG001|Overall Study|got liver transplant|2|||
126262258|NCT02776553|454251237|FG000|Overall Study|had other surgery|1|||
126262259|NCT02776553|454251238|FG001|Overall Study|had other surgery|0|||
126262260|NCT02776553|454251237|FG000|Overall Study|Protocol Violation|0|||
126262261|NCT02776553|454251238|FG001|Overall Study|Protocol Violation|1|||
126262262|NCT00941720|454251240|FG000|Overall Study|Withdrawal by Subject|1|||
126262263|NCT00941720|454251240|FG000|Overall Study|Insurance denied participation|11|||
126262264|NCT00941720|454251240|FG000|Overall Study|ineligible|2|||
126262265|NCT01682148|454251241|FG000|Overall Study|Withdrawal by Subject|2|||
126262266|NCT01682148|454251242|FG001|Overall Study|Withdrawal by Subject|0|||
126262267|NCT01682148|454251241|FG000|Overall Study|Lost to Follow-up|1|||
126262268|NCT01682148|454251242|FG001|Overall Study|Lost to Follow-up|2|||
126262269|NCT01682148|454251241|FG000|Overall Study|Protocol Violation|1|||
126262270|NCT01682148|454251242|FG001|Overall Study|Protocol Violation|1|||
126262271|NCT02087176|454251246|FG000|Overall Study|Withdrawal by Subject|1|||
126262272|NCT02087176|454251246|FG000|Overall Study|Death|10|||
126262273|NCT02087176|454251246|FG000|Overall Study|Censored|19|||
126262274|NCT02087176|454251246|FG000|Overall Study|Study Terminated by Sponsor|2|||
126262275|NCT03648879|454251247|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
126262276|NCT03812991|454251250|FG000|Overall Study|Lost to Follow-up|3|||
126262277|NCT03812991|454251251|FG001|Overall Study|Lost to Follow-up|1|||
126262278|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
126262279|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
126262280|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
126262281|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
126262282|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
126262283|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
126262284|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
126262285|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
126262286|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
126262287|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
126262288|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
126262289|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
126262290|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
126262291|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
126262292|NCT04740931|454251252|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
126262293|NCT04740931|454251253|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
126262294|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
126262295|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
126262296|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
126262297|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
126262298|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
126262299|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
126262300|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
126262301|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
126452071|NCT02059291|454957146|FG005|Epoch 3|Physician Decision|0|||
126262302|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
126262303|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
126262304|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
126262305|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
126262306|NCT04740931|454251252|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
126452072|NCT02059291|454957147|FG006|Epoch 3|Physician Decision|0|||
126452073|NCT02059291|454957148|FG007|Epoch 3|Physician Decision|0|||
126452074|NCT02059291|454957149|FG008|Epoch 3|Physician Decision|0|||
126452075|NCT02059291|454957150|FG009|Epoch 3|Physician Decision|0|||
126700336|NCT02620020|455853555|FG001|Overall Study|Lost to Follow-up|8|||
126700337|NCT02620020|455853556|FG002|Overall Study|Lost to Follow-up|1|||
126700338|NCT02620020|455853557|FG003|Overall Study|Lost to Follow-up|4|||
126700339|NCT02620020|455853554|FG000|Overall Study|Physician Decision|7|||
126700340|NCT02620020|455853555|FG001|Overall Study|Physician Decision|4|||
126700341|NCT02620020|455853556|FG002|Overall Study|Physician Decision|3|||
126700342|NCT02620020|455853557|FG003|Overall Study|Physician Decision|4|||
126700343|NCT02620020|455853554|FG000|Overall Study|Protocol Violation|5|||
126700344|NCT02620020|455853555|FG001|Overall Study|Protocol Violation|2|||
126700345|NCT02620020|455853556|FG002|Overall Study|Protocol Violation|1|||
126700346|NCT02620020|455853557|FG003|Overall Study|Protocol Violation|1|||
126700347|NCT02620020|455853554|FG000|Overall Study|Withdrawal by Subject|20|||
126700348|NCT02620020|455853555|FG001|Overall Study|Withdrawal by Subject|16|||
126700349|NCT02620020|455853556|FG002|Overall Study|Withdrawal by Subject|17|||
126700350|NCT02620020|455853557|FG003|Overall Study|Withdrawal by Subject|12|||
126700351|NCT02620020|455853554|FG000|Overall Study|Death|0|||
126700352|NCT02620020|455853555|FG001|Overall Study|Death|1|||
126700353|NCT02620020|455853556|FG002|Overall Study|Death|0|||
126700354|NCT02620020|455853557|FG003|Overall Study|Death|0|||
126700355|NCT02582671|455853558|FG000|Overall Study|Failure to return|1|||
126700356|NCT02582671|455853558|FG000|Overall Study|Other, not specified|1|||
126700357|NCT01287104|455853559|FG000|Overall Study|Patient developed progressive disease|1|||
126700358|NCT01287104|455853560|FG001|Overall Study|Patient developed progressive disease|1|||
126700359|NCT01287104|455853561|FG002|Overall Study|Patient developed progressive disease|3|||
126700360|NCT01287104|455853562|FG003|Overall Study|Patient developed progressive disease|2|||
126700361|NCT01287104|455853559|FG000|Overall Study|Donor anaphylaxis|0|||
126700362|NCT01287104|455853560|FG001|Overall Study|Donor anaphylaxis|1|||
126700363|NCT01287104|455853561|FG002|Overall Study|Donor anaphylaxis|0|||
126700364|NCT01287104|455853562|FG003|Overall Study|Donor anaphylaxis|1|||
126700365|NCT01287104|455853559|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
126700366|NCT01287104|455853560|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
126700367|NCT01287104|455853561|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
126700368|NCT01287104|455853562|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
126700369|NCT01287104|455853559|FG000|Overall Study|Low donor chimerism|0|||
126700370|NCT01287104|455853560|FG001|Overall Study|Low donor chimerism|1|||
126700371|NCT01287104|455853561|FG002|Overall Study|Low donor chimerism|0|||
126700372|NCT01287104|455853562|FG003|Overall Study|Low donor chimerism|0|||
126700373|NCT01287104|455853559|FG000|Overall Study|NK cells did not meet release criteria|0|||
126700374|NCT01287104|455853560|FG001|Overall Study|NK cells did not meet release criteria|1|||
126700375|NCT01287104|455853561|FG002|Overall Study|NK cells did not meet release criteria|0|||
126700376|NCT01287104|455853562|FG003|Overall Study|NK cells did not meet release criteria|0|||
126700377|NCT03068715|455853567|FG000|Overall Study|No longer met inclusion criteria|1|||
126700378|NCT03068715|455853568|FG001|Overall Study|No longer met inclusion criteria|0|||
126700379|NCT01276288|455853569|FG000|Overall Study|Adverse Event|1|||
126700380|NCT01276288|455853570|FG001|Overall Study|Adverse Event|1|||
126700381|NCT01276288|455853571|FG002|Overall Study|Adverse Event|0|||
126700382|NCT01276288|455853572|FG003|Overall Study|Adverse Event|0|||
126700383|NCT01276288|455853569|FG000|Overall Study|not treated|1|||
126700384|NCT01276288|455853570|FG001|Overall Study|not treated|0|||
126700385|NCT01276288|455853571|FG002|Overall Study|not treated|0|||
126700386|NCT01276288|455853572|FG003|Overall Study|not treated|0|||
126700387|NCT02537678|455853573|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
126700388|NCT02537678|455853574|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
126700389|NCT02537678|455853573|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
126700390|NCT02537678|455853574|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
126700391|NCT02537678|455853573|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
126700392|NCT02537678|455853574|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
126700393|NCT02537678|455853573|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
126700394|NCT02537678|455853574|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
126700395|NCT02537678|455853573|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
126700396|NCT02537678|455853574|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
126700397|NCT02537678|455853573|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
126700398|NCT02537678|455853574|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
126700399|NCT02537678|455853573|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
126359694|NCT03016403|454609035|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
126359695|NCT03016403|454609036|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
126359696|NCT03016403|454609037|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
126359697|NCT00225758|454609038|FG000|Overall Study|Adverse Event|4|||
126359698|NCT00564070|454609039|FG000|Overall Study|Lost to Follow-up|9|||
126359699|NCT00564070|454609040|FG001|Overall Study|Lost to Follow-up|7|||
126700400|NCT02537678|455853574|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
126452076|NCT02059291|454957151|FG010|Epoch 3|Physician Decision|0|||
126546847|NCT03029780|455296067|FG001|Overall Study|Maximum clinical benefit|0|||
126546848|NCT03029780|455296066|FG000|Overall Study|Participant no longer meets study criteria|0|||
126546849|NCT03029780|455296067|FG001|Overall Study|Participant no longer meets study criteria|1|||
126546850|NCT03029780|455296066|FG000|Overall Study|Other reasons|6|||
126546851|NCT03029780|455296067|FG001|Overall Study|Other reasons|6|||
126546852|NCT03029780|455296066|FG000|Overall Study|Not reported|1|||
126546853|NCT03029780|455296067|FG001|Overall Study|Not reported|1|||
126546854|NCT03029780|455296066|FG000|Overall Study|Death|2|||
126546855|NCT03029780|455296067|FG001|Overall Study|Death|6|||
126546856|NCT01460160|455296068|FG000|Treatment Phase|Lack of Efficacy|3|||
126546857|NCT01460160|455296068|FG000|Treatment Phase|Study Drug Toxicity|2|||
126546858|NCT01460160|455296068|FG000|Treatment Phase|Adverse Event|8|||
126546859|NCT01460160|455296068|FG000|Treatment Phase|Withdrawal by Subject|4|||
126546860|NCT01460160|455296068|FG000|Treatment Phase|Death|2|||
126546861|NCT01460160|455296068|FG000|Treatment Phase|Other reasons|9|||
126546862|NCT01460160|455296068|FG000|Follow-up Phase|Withdrawal by Subject|4|||
126452077|NCT02059291|454957152|FG011|Epoch 3|Physician Decision|0|||
126452078|NCT02059291|454957153|FG012|Epoch 3|Physician Decision|0|||
126452079|NCT02059291|454957154|FG013|Epoch 3|Physician Decision|1|||
126452080|NCT02059291|454957155|FG014|Epoch 3|Physician Decision|0|||
126452081|NCT02059291|454957156|FG015|Epoch 3|Physician Decision|1|||
126452082|NCT02059291|454957157|FG016|Epoch 3|Physician Decision|0|||
126546863|NCT01460160|455296068|FG000|Follow-up Phase|Death|14|||
126262307|NCT04740931|454251253|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
126262308|NCT00895037|454251254|FG000|Overall Study|Death|0|||
126262309|NCT00895037|454251255|FG001|Overall Study|Death|2|||
126262310|NCT00895037|454251256|FG002|Overall Study|Death|1|||
126262311|NCT01029392|454251259|FG000|Overall Study|Withdrawal by Subject|18|||
126262312|NCT01029392|454251260|FG001|Overall Study|Withdrawal by Subject|11|||
126262313|NCT01029392|454251259|FG000|Overall Study|Physician Decision|2|||
126262314|NCT01029392|454251260|FG001|Overall Study|Physician Decision|0|||
126262315|NCT01103479|454251261|FG000|Overall Study|Up to date with CRC screening|1|||
126262316|NCT01103479|454251262|FG001|Overall Study|Up to date with CRC screening|9|||
126262317|NCT01103479|454251263|FG002|Overall Study|Up to date with CRC screening|12|||
126262318|NCT01103479|454251261|FG000|Overall Study|Family history of CRC|1|||
126262319|NCT01103479|454251262|FG001|Overall Study|Family history of CRC|0|||
126262320|NCT01103479|454251263|FG002|Overall Study|Family history of CRC|2|||
126262321|NCT01103479|454251261|FG000|Overall Study|Active cancer|1|||
126262322|NCT01103479|454251262|FG001|Overall Study|Active cancer|0|||
126262323|NCT01103479|454251263|FG002|Overall Study|Active cancer|0|||
126262324|NCT01103479|454251261|FG000|Overall Study|Saw non-study physician|2|||
126262325|NCT01103479|454251262|FG001|Overall Study|Saw non-study physician|0|||
126262326|NCT01103479|454251263|FG002|Overall Study|Saw non-study physician|0|||
126262327|NCT00605917|454251264|FG000|Overall Study|Protocol Violation|79|||
126262328|NCT00890552|454251265|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
126262329|NCT00890552|454251265|FG000|On-treatment|Early prog disease/ death|10|||
126262330|NCT00724373|454251268|FG000|Overall Study|Adverse Event|41|||
126262331|NCT00724373|454251268|FG000|Overall Study|Lack of Efficacy|82|||
126262332|NCT00724373|454251268|FG000|Overall Study|Lost to Follow-up|7|||
126262333|NCT00724373|454251268|FG000|Overall Study|Non-compliance|2|||
126262334|NCT00724373|454251268|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
126262335|NCT00724373|454251268|FG000|Overall Study|Participant moved away|1|||
126262336|NCT00724373|454251268|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
126262337|NCT00724373|454251268|FG000|Overall Study|Only to have 24 week regimen|1|||
126262338|NCT00724373|454251268|FG000|Overall Study|Viral Relapse|1|||
126262339|NCT00724373|454251268|FG000|Overall Study|Acute HCV infection|1|||
126262340|NCT00724373|454251268|FG000|Overall Study|Drug Relapse|1|||
126262341|NCT00724373|454251268|FG000|Overall Study|Tolerability|23|||
126262342|NCT02549573|454251269|FG000|Overall Study|Withdrawal by Subject|0|||
126262343|NCT02549573|454251270|FG001|Overall Study|Withdrawal by Subject|2|||
126262344|NCT02549573|454251269|FG000|Overall Study|Protocol Violation|0|||
126262345|NCT02549573|454251270|FG001|Overall Study|Protocol Violation|1|||
126262346|NCT03043560|454251271|FG000|Overall Study|Discontinued Intervention|1|||
126262347|NCT03043560|454251272|FG001|Overall Study|Discontinued Intervention|2|||
126262348|NCT03043560|454251271|FG000|Overall Study|Lost to Follow-up|0|||
126262349|NCT03043560|454251272|FG001|Overall Study|Lost to Follow-up|1|||
126546864|NCT01460160|455296068|FG000|Follow-up Phase|Lost to Follow-up|7|||
126546865|NCT01460160|455296068|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
126262350|NCT00438659|454251273|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
126546866|NCT01460160|455296068|FG000|Follow-up Phase|Other and not reported reasons|5|||
126546867|NCT01616771|455296069|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
126262351|NCT00438659|454251274|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
126262352|NCT00438659|454251273|FG000|Overall Study|Cancel|5|||
126452083|NCT02059291|454957158|FG017|Epoch 3|Physician Decision|0|||
126452084|NCT02059291|454957159|FG018|Epoch 3|Physician Decision|0|||
126452085|NCT02059291|454957160|FG019|Epoch 3|Physician Decision|0|||
126546868|NCT00100932|455296070|FG000|Overall Study|Adverse Event|11|||
126262353|NCT00438659|454251274|FG001|Overall Study|Cancel|2|||
126262354|NCT03366194|454251278|FG000|Overall Study|Lost to Follow-up|2|||
126262355|NCT03123783|454251279|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
126262356|NCT03123783|454251280|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
126262357|NCT03123783|454251281|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
126262358|NCT03123783|454251282|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
126262359|NCT03123783|454251283|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
126262360|NCT03123783|454251284|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
126262361|NCT03123783|454251285|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
126262362|NCT03123783|454251279|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
126262363|NCT03123783|454251280|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
126262364|NCT03123783|454251281|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
126262365|NCT03123783|454251282|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
126262366|NCT03123783|454251283|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
126262367|NCT03123783|454251284|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
126262368|NCT03123783|454251285|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
126262369|NCT03123783|454251279|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
126262370|NCT03123783|454251280|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
126262371|NCT03123783|454251281|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
126262372|NCT03123783|454251282|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
126262373|NCT03123783|454251283|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
126262374|NCT03123783|454251284|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
126262375|NCT03123783|454251285|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
126262376|NCT03123783|454251279|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
126262377|NCT03123783|454251280|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
126262378|NCT03123783|454251281|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
126262379|NCT03123783|454251282|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
126262380|NCT03123783|454251283|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
126262381|NCT03123783|454251284|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
126262382|NCT03123783|454251285|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
126262383|NCT01730040|454252773|FG000|Overall Study|Randomized but not treated|0|||
126262384|NCT01730040|454252774|FG001|Overall Study|Randomized but not treated|0|||
126262385|NCT01730040|454252775|FG002|Overall Study|Randomized but not treated|0|||
126262386|NCT01730040|454252776|FG003|Overall Study|Randomized but not treated|0|||
126262387|NCT01730040|454252777|FG004|Overall Study|Randomized but not treated|0|||
126262388|NCT01730040|454252778|FG005|Overall Study|Randomized but not treated|1|||
126262389|NCT01730040|454252779|FG006|Overall Study|Randomized but not treated|0|||
126262390|NCT01730040|454252773|FG000|Overall Study|Subject moved|0|||
126262391|NCT01730040|454252774|FG001|Overall Study|Subject moved|0|||
126262392|NCT01730040|454252775|FG002|Overall Study|Subject moved|1|||
126262393|NCT01730040|454252776|FG003|Overall Study|Subject moved|0|||
126262394|NCT01730040|454252777|FG004|Overall Study|Subject moved|0|||
126262395|NCT01730040|454252778|FG005|Overall Study|Subject moved|0|||
126262396|NCT01730040|454252779|FG006|Overall Study|Subject moved|1|||
126262397|NCT01730040|454252773|FG000|Overall Study|Physician Decision|0|||
126262398|NCT01730040|454252774|FG001|Overall Study|Physician Decision|0|||
126262399|NCT01730040|454252775|FG002|Overall Study|Physician Decision|0|||
126262400|NCT01730040|454252776|FG003|Overall Study|Physician Decision|0|||
126262401|NCT01730040|454252777|FG004|Overall Study|Physician Decision|0|||
126262402|NCT01730040|454252778|FG005|Overall Study|Physician Decision|1|||
126262403|NCT01730040|454252779|FG006|Overall Study|Physician Decision|1|||
126262404|NCT01730040|454252773|FG000|Overall Study|Other than specified|7|||
126262405|NCT01730040|454252774|FG001|Overall Study|Other than specified|8|||
126262406|NCT01730040|454252775|FG002|Overall Study|Other than specified|5|||
126262407|NCT01730040|454252776|FG003|Overall Study|Other than specified|5|||
126262408|NCT01730040|454252777|FG004|Overall Study|Other than specified|5|||
126262409|NCT01730040|454252778|FG005|Overall Study|Other than specified|4|||
126262410|NCT01730040|454252779|FG006|Overall Study|Other than specified|4|||
126546869|NCT00100932|455296071|FG001|Overall Study|Adverse Event|2|||
126546870|NCT00100932|455296070|FG000|Overall Study|Withdrawal by Subject|6|||
126546871|NCT00100932|455296071|FG001|Overall Study|Withdrawal by Subject|0|||
126546872|NCT00100932|455296070|FG000|Overall Study|Progressive Disease|44|||
126262411|NCT01730040|454252773|FG000|Overall Study|Adverse Event|4|||
126262412|NCT01730040|454252774|FG001|Overall Study|Adverse Event|3|||
126262413|NCT01730040|454252775|FG002|Overall Study|Adverse Event|5|||
126262414|NCT01730040|454252776|FG003|Overall Study|Adverse Event|3|||
126262415|NCT01730040|454252777|FG004|Overall Study|Adverse Event|1|||
126546873|NCT00100932|455296071|FG001|Overall Study|Progressive Disease|18|||
126700401|NCT03168867|455853576|FG000|Overall Study|Withdrawal by Subject|1|||
126262416|NCT01730040|454252778|FG005|Overall Study|Adverse Event|1|||
126262417|NCT01730040|454252779|FG006|Overall Study|Adverse Event|2|||
126262418|NCT01730040|454252773|FG000|Overall Study|Poor compliance to protocol|2|||
126262419|NCT01730040|454252774|FG001|Overall Study|Poor compliance to protocol|4|||
126262420|NCT01730040|454252775|FG002|Overall Study|Poor compliance to protocol|0|||
126262421|NCT01730040|454252776|FG003|Overall Study|Poor compliance to protocol|0|||
126262422|NCT01730040|454252777|FG004|Overall Study|Poor compliance to protocol|0|||
126262423|NCT01730040|454252778|FG005|Overall Study|Poor compliance to protocol|0|||
126262424|NCT01730040|454252779|FG006|Overall Study|Poor compliance to protocol|1|||
126262425|NCT03346070|454252782|FG000|Overall Study|Death|0|||
126262426|NCT03346070|454252783|FG001|Overall Study|Death|0|||
126262427|NCT03346070|454252784|FG002|Overall Study|Death|0|||
126262428|NCT03346070|454252785|FG003|Overall Study|Death|0|||
126262429|NCT03346070|454252786|FG004|Overall Study|Death|1|||
126262430|NCT03346070|454252782|FG000|Overall Study|Lost to Follow-up|0|||
126262431|NCT03346070|454252783|FG001|Overall Study|Lost to Follow-up|1|||
126262432|NCT03346070|454252784|FG002|Overall Study|Lost to Follow-up|2|||
126262433|NCT03346070|454252785|FG003|Overall Study|Lost to Follow-up|0|||
126262434|NCT03346070|454252786|FG004|Overall Study|Lost to Follow-up|0|||
126262435|NCT03346070|454252782|FG000|Overall Study|Physician Decision|0|||
126262436|NCT03346070|454252783|FG001|Overall Study|Physician Decision|0|||
126262437|NCT03346070|454252784|FG002|Overall Study|Physician Decision|0|||
126262438|NCT03346070|454252785|FG003|Overall Study|Physician Decision|1|||
126262439|NCT03346070|454252786|FG004|Overall Study|Physician Decision|1|||
126262440|NCT03346070|454252782|FG000|Overall Study|Withdrawal by Subject|1|||
126452086|NCT02059291|454957161|FG020|Epoch 3|Physician Decision|0|||
126452087|NCT02059291|454957162|FG021|Epoch 3|Physician Decision|0|||
126452088|NCT02059291|454957163|FG022|Epoch 3|Physician Decision|0|||
126452089|NCT02059291|454957164|FG023|Epoch 3|Physician Decision|0|||
126452090|NCT02059291|454957165|FG024|Epoch 3|Physician Decision|0|||
126452091|NCT02059291|454957141|FG000|Epoch 3|Adverse Event|0|||
126262441|NCT03346070|454252783|FG001|Overall Study|Withdrawal by Subject|0|||
126262442|NCT03346070|454252784|FG002|Overall Study|Withdrawal by Subject|0|||
126262443|NCT03346070|454252785|FG003|Overall Study|Withdrawal by Subject|1|||
126262444|NCT03346070|454252786|FG004|Overall Study|Withdrawal by Subject|0|||
126262445|NCT03346070|454252782|FG000|Overall Study|Study medication not received as planned|2|||
126262446|NCT03346070|454252783|FG001|Overall Study|Study medication not received as planned|3|||
126262447|NCT03346070|454252784|FG002|Overall Study|Study medication not received as planned|2|||
126262448|NCT03346070|454252785|FG003|Overall Study|Study medication not received as planned|3|||
126262449|NCT03346070|454252786|FG004|Overall Study|Study medication not received as planned|2|||
126262450|NCT03346070|454252782|FG000|Overall Study|Screen Failure|0|||
126262451|NCT03346070|454252783|FG001|Overall Study|Screen Failure|0|||
126262452|NCT03346070|454252784|FG002|Overall Study|Screen Failure|0|||
126262453|NCT03346070|454252785|FG003|Overall Study|Screen Failure|1|||
126262454|NCT03346070|454252786|FG004|Overall Study|Screen Failure|1|||
126262455|NCT01042535|454252787|FG000|Overall Study|disease progression prior to treatment|3|||
126262456|NCT01042535|454252787|FG000|Overall Study|disease progression during treatment|3|||
126262457|NCT01042535|454252787|FG000|Overall Study|complications from other disease|2|||
126262458|NCT01546142|454252788|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
126262459|NCT01546142|454252789|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
126262460|NCT01546142|454252788|FG000|Overall Study|Subject Noncompliance|1|||
126262461|NCT01546142|454252789|FG001|Overall Study|Subject Noncompliance|1|||
126262462|NCT01546142|454252788|FG000|Overall Study|Adverse Event|6|||
126262463|NCT01546142|454252789|FG001|Overall Study|Adverse Event|3|||
126262464|NCT01546142|454252788|FG000|Overall Study|Lost to Follow-up|20|||
126262465|NCT01546142|454252789|FG001|Overall Study|Lost to Follow-up|15|||
126262466|NCT01546142|454252788|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
126262467|NCT01546142|454252789|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
126262468|NCT01546142|454252788|FG000|Overall Study|Subject Randomized but Not Treated|1|||
126262469|NCT01546142|454252789|FG001|Overall Study|Subject Randomized but Not Treated|0|||
126262470|NCT03919448|454252793|FG000|Overall Study|Withdrawal by Subject|1|||
126262471|NCT03919448|454252794|FG001|Overall Study|Withdrawal by Subject|0|||
126262472|NCT03919448|454252795|FG002|Overall Study|Withdrawal by Subject|0|||
126262473|NCT01286558|454252801|FG000|Overall Study|Adverse Event|1|||
126262474|NCT01286558|454252802|FG001|Overall Study|Adverse Event|1|||
126262475|NCT01286558|454252801|FG000|Overall Study|Withdrawal by Subject|0|||
126452092|NCT02059291|454957142|FG001|Epoch 3|Adverse Event|0|||
126452093|NCT02059291|454957143|FG002|Epoch 3|Adverse Event|0|||
126452094|NCT02059291|454957144|FG003|Epoch 3|Adverse Event|0|||
126452095|NCT02059291|454957145|FG004|Epoch 3|Adverse Event|0|||
126262476|NCT01286558|454252802|FG001|Overall Study|Withdrawal by Subject|1|||
126262477|NCT01005329|454252807|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
126262478|NCT01272921|454252810|FG000|Overall Study|Protocol Violation|2|||
126262479|NCT01272921|454252811|FG001|Overall Study|Protocol Violation|1|||
126262480|NCT01132664|454252812|FG000|Phase lb|Adverse Event|0|||
126452096|NCT02059291|454957146|FG005|Epoch 3|Adverse Event|0|||
126452097|NCT02059291|454957147|FG006|Epoch 3|Adverse Event|0|||
126262481|NCT01132664|454252813|FG001|Phase lb|Adverse Event|1|||
126262482|NCT01132664|454252814|FG002|Phase lb|Adverse Event|0|||
126262483|NCT01132664|454252815|FG003|Phase lb|Adverse Event|0|||
126262484|NCT01132664|454252816|FG004|Phase lb|Adverse Event|0|||
126262485|NCT01132664|454252812|FG000|Phase lb|Withdrawal by Subject|1|||
126262486|NCT01132664|454252813|FG001|Phase lb|Withdrawal by Subject|2|||
126262487|NCT01132664|454252814|FG002|Phase lb|Withdrawal by Subject|0|||
126262488|NCT01132664|454252815|FG003|Phase lb|Withdrawal by Subject|0|||
126262489|NCT01132664|454252816|FG004|Phase lb|Withdrawal by Subject|0|||
126262490|NCT01132664|454252812|FG000|Phase lb|Disease Progression|4|||
126262491|NCT01132664|454252813|FG001|Phase lb|Disease Progression|9|||
126262492|NCT01132664|454252814|FG002|Phase lb|Disease Progression|0|||
126262493|NCT01132664|454252815|FG003|Phase lb|Disease Progression|0|||
126262494|NCT01132664|454252816|FG004|Phase lb|Disease Progression|0|||
126262495|NCT01132664|454252812|FG000|Phase ll|Death|0|||
126262496|NCT01132664|454252813|FG001|Phase ll|Death|0|||
126262497|NCT01132664|454252814|FG002|Phase ll|Death|2|||
126262498|NCT01132664|454252815|FG003|Phase ll|Death|0|||
126262499|NCT01132664|454252816|FG004|Phase ll|Death|0|||
126262500|NCT01132664|454252812|FG000|Phase ll|Adverse Event|0|||
126262501|NCT01132664|454252813|FG001|Phase ll|Adverse Event|0|||
126262502|NCT01132664|454252814|FG002|Phase ll|Adverse Event|10|||
126262503|NCT01132664|454252815|FG003|Phase ll|Adverse Event|0|||
126262504|NCT01132664|454252816|FG004|Phase ll|Adverse Event|0|||
126262505|NCT01132664|454252812|FG000|Phase ll|Withdrawal by Subject|0|||
126262506|NCT01132664|454252813|FG001|Phase ll|Withdrawal by Subject|0|||
126262507|NCT01132664|454252814|FG002|Phase ll|Withdrawal by Subject|3|||
126262508|NCT01132664|454252815|FG003|Phase ll|Withdrawal by Subject|0|||
126262509|NCT01132664|454252816|FG004|Phase ll|Withdrawal by Subject|0|||
126262510|NCT01132664|454252812|FG000|Phase ll|Disease progression|0|||
126262511|NCT01132664|454252813|FG001|Phase ll|Disease progression|0|||
126262512|NCT01132664|454252814|FG002|Phase ll|Disease progression|35|||
126262513|NCT01132664|454252815|FG003|Phase ll|Disease progression|0|||
126262514|NCT01132664|454252816|FG004|Phase ll|Disease progression|0|||
126262515|NCT01132664|454252812|FG000|BM Cohort|Disease progression|0|||
126262516|NCT01132664|454252813|FG001|BM Cohort|Disease progression|0|||
126262517|NCT01132664|454252814|FG002|BM Cohort|Disease progression|0|||
126262518|NCT01132664|454252815|FG003|BM Cohort|Disease progression|3|||
126262519|NCT01132664|454252816|FG004|BM Cohort|Disease progression|4|||
126262520|NCT01132664|454252812|FG000|BM Cohort|Adverse Event|0|||
126262521|NCT01132664|454252813|FG001|BM Cohort|Adverse Event|0|||
126262522|NCT01132664|454252814|FG002|BM Cohort|Adverse Event|0|||
126262523|NCT01132664|454252815|FG003|BM Cohort|Adverse Event|0|||
126262524|NCT01132664|454252816|FG004|BM Cohort|Adverse Event|1|||
126262525|NCT01132664|454252812|FG000|BM Cohort|Withdrawal by Subject|0|||
126262526|NCT01132664|454252813|FG001|BM Cohort|Withdrawal by Subject|0|||
126262527|NCT01132664|454252814|FG002|BM Cohort|Withdrawal by Subject|0|||
126262528|NCT01132664|454252815|FG003|BM Cohort|Withdrawal by Subject|0|||
126262529|NCT01132664|454252816|FG004|BM Cohort|Withdrawal by Subject|1|||
126262530|NCT00655850|454252817|FG000|Overall Study|Death|2|||
126262531|NCT00655850|454252817|FG000|Overall Study|Withdrawal by Subject|1|||
126262532|NCT01567826|454252820|FG000|Overall Study|Lost to Follow-up|3|||
126262533|NCT01567826|454252821|FG001|Overall Study|Lost to Follow-up|2|||
126262534|NCT00573170|454252827|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
126262535|NCT00573170|454252828|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
126262536|NCT00573170|454252829|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
126262537|NCT00573170|454252830|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
126262538|NCT00573170|454252831|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
126262539|NCT00573170|454252832|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
126262540|NCT00573170|454252827|FG000|First Washout Period|Adverse Event|1|||
126262541|NCT00573170|454252828|FG001|First Washout Period|Adverse Event|1|||
126262542|NCT00573170|454252829|FG002|First Washout Period|Adverse Event|0|||
126262543|NCT00573170|454252830|FG003|First Washout Period|Adverse Event|0|||
126262544|NCT00573170|454252831|FG004|First Washout Period|Adverse Event|0|||
126262545|NCT00573170|454252832|FG005|First Washout Period|Adverse Event|1|||
126359700|NCT00564070|454609039|FG000|Overall Study|Worsening depression, referred to care|3|||
126359701|NCT00564070|454609040|FG001|Overall Study|Worsening depression, referred to care|0|||
126359702|NCT03142334|454609044|FG000|Overall Study|Death|18|||
126262546|NCT00573170|454252827|FG000|First Washout Period|Lack of Efficacy|0|||
126262547|NCT00573170|454252828|FG001|First Washout Period|Lack of Efficacy|0|||
126262548|NCT00573170|454252829|FG002|First Washout Period|Lack of Efficacy|0|||
126262549|NCT00573170|454252830|FG003|First Washout Period|Lack of Efficacy|0|||
126262550|NCT00573170|454252831|FG004|First Washout Period|Lack of Efficacy|0|||
126262551|NCT00573170|454252832|FG005|First Washout Period|Lack of Efficacy|1|||
126262552|NCT00573170|454252827|FG000|First Washout Period|Lost to Follow-up|1|||
126262553|NCT00573170|454252828|FG001|First Washout Period|Lost to Follow-up|1|||
126262554|NCT00573170|454252829|FG002|First Washout Period|Lost to Follow-up|0|||
126262555|NCT00573170|454252830|FG003|First Washout Period|Lost to Follow-up|2|||
126262556|NCT00573170|454252831|FG004|First Washout Period|Lost to Follow-up|0|||
126262557|NCT00573170|454252832|FG005|First Washout Period|Lost to Follow-up|2|||
126546874|NCT00100932|455296070|FG000|Overall Study|Physician Decision|7|||
126546875|NCT00100932|455296071|FG001|Overall Study|Physician Decision|5|||
126763636|NCT05048875|456086826|FG003|Overall Study|Adverse Event|1|||
126763637|NCT05048875|456086827|FG004|Overall Study|Adverse Event|0|||
126763638|NCT05048875|456086828|FG005|Overall Study|Adverse Event|0|||
126763639|NCT05048875|456086829|FG006|Overall Study|Adverse Event|0|||
126763640|NCT05048875|456086830|FG007|Overall Study|Adverse Event|0|||
126763641|NCT02255422|456086835|FG000|Overall Study|Withdrawal by Subject|0|||
126763642|NCT02255422|456086836|FG001|Overall Study|Withdrawal by Subject|0|||
126763643|NCT02255422|456086837|FG002|Overall Study|Withdrawal by Subject|0|||
126763644|NCT02255422|456086838|FG003|Overall Study|Withdrawal by Subject|0|||
126763645|NCT02255422|456086839|FG004|Overall Study|Withdrawal by Subject|0|||
126763646|NCT02255422|456086840|FG005|Overall Study|Withdrawal by Subject|0|||
126763647|NCT02255422|456086841|FG006|Overall Study|Withdrawal by Subject|2|||
126763648|NCT02255422|456086835|FG000|Overall Study|Lost to Follow-up|0|||
126763649|NCT02255422|456086836|FG001|Overall Study|Lost to Follow-up|0|||
126763650|NCT02255422|456086837|FG002|Overall Study|Lost to Follow-up|1|||
126763651|NCT02255422|456086838|FG003|Overall Study|Lost to Follow-up|0|||
126763652|NCT02255422|456086839|FG004|Overall Study|Lost to Follow-up|0|||
126763653|NCT02255422|456086840|FG005|Overall Study|Lost to Follow-up|0|||
126763654|NCT02255422|456086841|FG006|Overall Study|Lost to Follow-up|0|||
126763655|NCT04411641|456086842|FG000|DB Period|Other|7|||
126763656|NCT04411641|456086843|FG001|DB Period|Other|27|||
126763657|NCT04411641|456086844|FG002|DB Period|Other|0|||
126763658|NCT04411641|456086845|FG003|DB Period|Other|0|||
126763659|NCT04411641|456086842|FG000|DB Period|Withdrawal by Subject|67|||
126763660|NCT04411641|456086843|FG001|DB Period|Withdrawal by Subject|122|||
126763661|NCT04411641|456086844|FG002|DB Period|Withdrawal by Subject|0|||
126359703|NCT03142334|454609045|FG001|Overall Study|Death|33|||
126359704|NCT03142334|454609044|FG000|Overall Study|Withdrawal by Subject|15|||
126763662|NCT04411641|456086845|FG003|DB Period|Withdrawal by Subject|0|||
126763663|NCT04411641|456086842|FG000|DB Period|Progressive disease|76|||
126763664|NCT04411641|456086843|FG001|DB Period|Progressive disease|116|||
126359705|NCT03142334|454609045|FG001|Overall Study|Withdrawal by Subject|11|||
126359706|NCT03142334|454609044|FG000|Overall Study|Ongoing on trial follow up|463|||
126359707|NCT03142334|454609045|FG001|Overall Study|Ongoing on trial follow up|454|||
126359708|NCT03071965|454609046|FG000|Overall Study|Adverse Event|0|||
126359709|NCT03071965|454609047|FG001|Overall Study|Adverse Event|0|||
126359710|NCT03071965|454609048|FG002|Overall Study|Adverse Event|1|||
126359711|NCT03071965|454609049|FG003|Overall Study|Adverse Event|0|||
126359712|NCT03071965|454609046|FG000|Overall Study|Death|0|||
126359713|NCT03071965|454609047|FG001|Overall Study|Death|0|||
126359714|NCT03071965|454609048|FG002|Overall Study|Death|1|||
126359715|NCT03071965|454609049|FG003|Overall Study|Death|1|||
126359716|NCT03071965|454609046|FG000|Overall Study|COVID-19|0|||
126359717|NCT03071965|454609047|FG001|Overall Study|COVID-19|1|||
126359718|NCT03071965|454609048|FG002|Overall Study|COVID-19|0|||
126359719|NCT03071965|454609049|FG003|Overall Study|COVID-19|1|||
126359720|NCT03071965|454609046|FG000|Overall Study|Other Health Reason|0|||
126452098|NCT02059291|454957148|FG007|Epoch 3|Adverse Event|0|||
126452099|NCT02059291|454957149|FG008|Epoch 3|Adverse Event|0|||
126763665|NCT04411641|456086844|FG002|DB Period|Progressive disease|0|||
126763666|NCT04411641|456086845|FG003|DB Period|Progressive disease|0|||
126763667|NCT04411641|456086842|FG000|DB Period|Poor compliance to protocol|1|||
126763668|NCT04411641|456086843|FG001|DB Period|Poor compliance to protocol|5|||
126763669|NCT04411641|456086844|FG002|DB Period|Poor compliance to protocol|0|||
126763670|NCT04411641|456086845|FG003|DB Period|Poor compliance to protocol|0|||
126763671|NCT04411641|456086842|FG000|DB Period|Lack of Efficacy|19|||
126359721|NCT03071965|454609047|FG001|Overall Study|Other Health Reason|0|||
126359722|NCT03071965|454609048|FG002|Overall Study|Other Health Reason|0|||
126359723|NCT03071965|454609049|FG003|Overall Study|Other Health Reason|1|||
126452100|NCT02059291|454957150|FG009|Epoch 3|Adverse Event|0|||
126452101|NCT02059291|454957151|FG010|Epoch 3|Adverse Event|0|||
126452102|NCT02059291|454957152|FG011|Epoch 3|Adverse Event|0|||
126452103|NCT02059291|454957153|FG012|Epoch 3|Adverse Event|0|||
126452104|NCT02059291|454957154|FG013|Epoch 3|Adverse Event|0|||
126452105|NCT02059291|454957155|FG014|Epoch 3|Adverse Event|0|||
126452106|NCT02059291|454957156|FG015|Epoch 3|Adverse Event|1|||
126452107|NCT02059291|454957157|FG016|Epoch 3|Adverse Event|0|||
126546876|NCT00100932|455296070|FG000|Overall Study|Other|5|||
126763672|NCT04411641|456086843|FG001|DB Period|Lack of Efficacy|19|||
126763673|NCT04411641|456086844|FG002|DB Period|Lack of Efficacy|0|||
126763674|NCT04411641|456086845|FG003|DB Period|Lack of Efficacy|0|||
126763675|NCT04411641|456086842|FG000|DB Period|Adverse Event|13|||
126763676|NCT04411641|456086843|FG001|DB Period|Adverse Event|29|||
126763677|NCT04411641|456086844|FG002|DB Period|Adverse Event|0|||
126763678|NCT04411641|456086845|FG003|DB Period|Adverse Event|0|||
126359724|NCT01217047|454609050|FG000|Overall Study|Lost to Follow-up|0|||
126452108|NCT02059291|454957158|FG017|Epoch 3|Adverse Event|0|||
126452109|NCT02059291|454957159|FG018|Epoch 3|Adverse Event|0|||
126452110|NCT02059291|454957160|FG019|Epoch 3|Adverse Event|0|||
126452111|NCT02059291|454957161|FG020|Epoch 3|Adverse Event|0|||
126546877|NCT00100932|455296071|FG001|Overall Study|Other|2|||
126262558|NCT00573170|454252827|FG000|First Washout Period|Withdrawal by Subject|2|||
126262559|NCT00573170|454252828|FG001|First Washout Period|Withdrawal by Subject|0|||
126262560|NCT00573170|454252829|FG002|First Washout Period|Withdrawal by Subject|0|||
126262561|NCT00573170|454252830|FG003|First Washout Period|Withdrawal by Subject|2|||
126262562|NCT00573170|454252831|FG004|First Washout Period|Withdrawal by Subject|3|||
126262563|NCT00573170|454252832|FG005|First Washout Period|Withdrawal by Subject|3|||
126262564|NCT00573170|454252827|FG000|First Washout Period|Other|4|||
126262565|NCT00573170|454252828|FG001|First Washout Period|Other|0|||
126262566|NCT00573170|454252829|FG002|First Washout Period|Other|1|||
126262567|NCT00573170|454252830|FG003|First Washout Period|Other|1|||
126262568|NCT00573170|454252831|FG004|First Washout Period|Other|0|||
126262569|NCT00573170|454252832|FG005|First Washout Period|Other|0|||
126262570|NCT00573170|454252827|FG000|Second Washout Period|Adverse Event|1|||
126262571|NCT00573170|454252828|FG001|Second Washout Period|Adverse Event|0|||
126262572|NCT00573170|454252829|FG002|Second Washout Period|Adverse Event|0|||
126262573|NCT00573170|454252830|FG003|Second Washout Period|Adverse Event|0|||
126262574|NCT00573170|454252831|FG004|Second Washout Period|Adverse Event|1|||
126262575|NCT00573170|454252832|FG005|Second Washout Period|Adverse Event|0|||
126262576|NCT00573170|454252827|FG000|Second Washout Period|Protocol Violation|2|||
126262577|NCT00573170|454252828|FG001|Second Washout Period|Protocol Violation|1|||
126262578|NCT00573170|454252829|FG002|Second Washout Period|Protocol Violation|1|||
126262579|NCT00573170|454252830|FG003|Second Washout Period|Protocol Violation|0|||
126262580|NCT00573170|454252831|FG004|Second Washout Period|Protocol Violation|0|||
126262581|NCT00573170|454252832|FG005|Second Washout Period|Protocol Violation|0|||
126262582|NCT00573170|454252827|FG000|Second Washout Period|Withdrawal by Subject|1|||
126262583|NCT00573170|454252828|FG001|Second Washout Period|Withdrawal by Subject|1|||
126262584|NCT00573170|454252829|FG002|Second Washout Period|Withdrawal by Subject|2|||
126262585|NCT00573170|454252830|FG003|Second Washout Period|Withdrawal by Subject|0|||
126262586|NCT00573170|454252831|FG004|Second Washout Period|Withdrawal by Subject|1|||
126262587|NCT00573170|454252832|FG005|Second Washout Period|Withdrawal by Subject|0|||
126262588|NCT00573170|454252827|FG000|Second Washout Period|Lost to Follow-up|0|||
126262589|NCT00573170|454252828|FG001|Second Washout Period|Lost to Follow-up|0|||
126262590|NCT00573170|454252829|FG002|Second Washout Period|Lost to Follow-up|0|||
126262591|NCT00573170|454252830|FG003|Second Washout Period|Lost to Follow-up|1|||
126262592|NCT00573170|454252831|FG004|Second Washout Period|Lost to Follow-up|0|||
126262593|NCT00573170|454252832|FG005|Second Washout Period|Lost to Follow-up|0|||
126262594|NCT00573170|454252827|FG000|Second Washout Period|Other|1|||
126262595|NCT00573170|454252828|FG001|Second Washout Period|Other|2|||
126262596|NCT00573170|454252829|FG002|Second Washout Period|Other|1|||
126262597|NCT00573170|454252830|FG003|Second Washout Period|Other|4|||
126262598|NCT00573170|454252831|FG004|Second Washout Period|Other|6|||
126262599|NCT00573170|454252832|FG005|Second Washout Period|Other|2|||
126262600|NCT00573170|454252827|FG000|Third Treatment Period|Withdrawal by Subject|1|||
126262601|NCT00573170|454252828|FG001|Third Treatment Period|Withdrawal by Subject|0|||
126262602|NCT00573170|454252829|FG002|Third Treatment Period|Withdrawal by Subject|0|||
126700402|NCT03168867|455853577|FG001|Overall Study|Withdrawal by Subject|5|||
126700403|NCT04348851|455853578|FG000|Post-Test 1|Withdrawal by Subject|0|||
126700404|NCT04348851|455853579|FG001|Post-Test 1|Withdrawal by Subject|1|||
126700405|NCT04348851|455853580|FG002|Post-Test 1|Withdrawal by Subject|0|||
126700406|NCT04348851|455853581|FG003|Post-Test 1|Withdrawal by Subject|0|||
126700407|NCT04348851|455853578|FG000|Post-Test 1|Lost to Follow-up|0|||
126262603|NCT00573170|454252830|FG003|Third Treatment Period|Withdrawal by Subject|0|||
126262604|NCT00573170|454252831|FG004|Third Treatment Period|Withdrawal by Subject|0|||
126359725|NCT01217047|454609051|FG001|Overall Study|Lost to Follow-up|1|||
126359726|NCT01217047|454609052|FG002|Overall Study|Lost to Follow-up|0|||
126359727|NCT05529173|454609053|FG000|Overall Study|Physician Decision|3|||
126359728|NCT05529173|454609054|FG001|Overall Study|Physician Decision|6|||
126359729|NCT05529173|454609053|FG000|Overall Study|Sample shipment delay more than one day|4|||
126359730|NCT05529173|454609054|FG001|Overall Study|Sample shipment delay more than one day|0|||
126359731|NCT05587998|454609055|FG000|Overall Study|Withdrawal by Subject|1|||
126359732|NCT05587998|454609056|FG001|Overall Study|Withdrawal by Subject|1|||
126359733|NCT05587998|454609055|FG000|Overall Study|Not treated|3|||
126359734|NCT05587998|454609056|FG001|Overall Study|Not treated|1|||
126359735|NCT05587998|454609055|FG000|Overall Study|Non-compliance with study procedures|0|||
126700408|NCT04348851|455853579|FG001|Post-Test 1|Lost to Follow-up|1|||
126700409|NCT04348851|455853580|FG002|Post-Test 1|Lost to Follow-up|0|||
126700410|NCT04348851|455853581|FG003|Post-Test 1|Lost to Follow-up|0|||
126700411|NCT04348851|455853578|FG000|Post-Test 2|Stroke survivor death|0|||
126700412|NCT04348851|455853579|FG001|Post-Test 2|Stroke survivor death|1|||
126262605|NCT00573170|454252832|FG005|Third Treatment Period|Withdrawal by Subject|0|||
126262606|NCT00573170|454252827|FG000|Third Treatment Period|Lost to Follow-up|0|||
126262607|NCT00573170|454252828|FG001|Third Treatment Period|Lost to Follow-up|0|||
126262608|NCT00573170|454252829|FG002|Third Treatment Period|Lost to Follow-up|0|||
126262609|NCT00573170|454252830|FG003|Third Treatment Period|Lost to Follow-up|0|||
126262610|NCT00573170|454252831|FG004|Third Treatment Period|Lost to Follow-up|0|||
126262611|NCT00573170|454252832|FG005|Third Treatment Period|Lost to Follow-up|2|||
126700413|NCT04348851|455853580|FG002|Post-Test 2|Stroke survivor death|0|||
126700414|NCT04348851|455853581|FG003|Post-Test 2|Stroke survivor death|1|||
126262612|NCT00608517|454252834|FG000|Overall Study|Death|1|||
126262613|NCT00608517|454252835|FG001|Overall Study|Death|0|||
126262614|NCT00608517|454252836|FG002|Overall Study|Death|0|||
126262615|NCT00493454|454252838|FG000|Overall Study|Withdrawal by Subject|1|||
126262616|NCT00103038|454252839|FG000|Overall Study|Withdrawal by Subject|8|||
126262617|NCT00103038|454252839|FG000|Overall Study|Screen failure|3|||
126262618|NCT00103038|454252839|FG000|Overall Study|Death|1|||
126262619|NCT00103038|454252839|FG000|Overall Study|Physician Decision|1|||
126262620|NCT03649412|454252846|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
126262621|NCT03649412|454252847|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
126262622|NCT03649412|454252846|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
126262623|NCT03649412|454252847|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
126700415|NCT02965378|455853582|FG000|Overall Study|Progression|16|||
126700416|NCT02965378|455853583|FG001|Overall Study|Progression|4|||
126700417|NCT02965378|455853582|FG000|Overall Study|Adverse Event|5|||
126700418|NCT02965378|455853583|FG001|Overall Study|Adverse Event|2|||
126700419|NCT02965378|455853582|FG000|Overall Study|Death|2|||
126700420|NCT02965378|455853583|FG001|Overall Study|Death|0|||
126700421|NCT02965378|455853582|FG000|Overall Study|Refusal|2|||
126700422|NCT02965378|455853583|FG001|Overall Study|Refusal|1|||
126700423|NCT02965378|455853582|FG000|Overall Study|Not protocol specified|0|||
126700424|NCT02965378|455853583|FG001|Overall Study|Not protocol specified|2|||
126700425|NCT00629083|455853588|FG000|Overall Study|Adverse Event|0|||
126700426|NCT00629083|455853589|FG001|Overall Study|Adverse Event|2|||
126700427|NCT00629083|455853588|FG000|Overall Study|Lack of Efficacy|3|||
126700428|NCT00629083|455853589|FG001|Overall Study|Lack of Efficacy|1|||
126763679|NCT04411641|456086842|FG000|DB Period|Randomized and not treated|2|||
126763680|NCT04411641|456086843|FG001|DB Period|Randomized and not treated|2|||
126763681|NCT04411641|456086844|FG002|DB Period|Randomized and not treated|0|||
126763682|NCT04411641|456086845|FG003|DB Period|Randomized and not treated|0|||
126763683|NCT04411641|456086842|FG000|OL|Withdrawal by Subject|0|||
126763684|NCT04411641|456086843|FG001|OL|Withdrawal by Subject|0|||
126763685|NCT04411641|456086844|FG002|OL|Withdrawal by Subject|6|||
126763686|NCT04411641|456086845|FG003|OL|Withdrawal by Subject|17|||
126763687|NCT04411641|456086842|FG000|OL|Progressive disease|0|||
126262624|NCT03649412|454252846|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
126700429|NCT00629083|455853588|FG000|Overall Study|Withdrawal by Subject|10|||
126700430|NCT00629083|455853589|FG001|Overall Study|Withdrawal by Subject|2|||
126700431|NCT00629083|455853588|FG000|Overall Study|Lost to Follow-up|12|||
126700432|NCT00629083|455853589|FG001|Overall Study|Lost to Follow-up|8|||
126700433|NCT00629083|455853588|FG000|Overall Study|Moved out of country/state|2|||
126700434|NCT00629083|455853589|FG001|Overall Study|Moved out of country/state|1|||
126700435|NCT00629083|455853588|FG000|Overall Study|Refused to return for 12 month visit|1|||
126700436|NCT00629083|455853589|FG001|Overall Study|Refused to return for 12 month visit|0|||
126700437|NCT02909153|455853590|FG000|Overall Study|Withdrawal by Subject|0|||
126700438|NCT02909153|455853591|FG001|Overall Study|Withdrawal by Subject|1|||
126700439|NCT02909153|455853592|FG002|Overall Study|Withdrawal by Subject|0|||
126700440|NCT02909153|455853593|FG003|Overall Study|Withdrawal by Subject|0|||
126700441|NCT02909153|455853594|FG004|Overall Study|Withdrawal by Subject|0|||
126700442|NCT01193686|455853595|FG000|Overall Study|Withdrawal by Subject|4|||
126700443|NCT01193686|455853596|FG001|Overall Study|Withdrawal by Subject|1|||
126700444|NCT01193686|455853595|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
126700445|NCT01193686|455853596|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
126700446|NCT03401749|455853597|FG000|Overall Study|Lost to Follow-up|20|||
126700447|NCT03401749|455853598|FG001|Overall Study|Lost to Follow-up|16|||
126700448|NCT03401749|455853599|FG002|Overall Study|Lost to Follow-up|26|||
126700449|NCT01147809|455853602|FG000|Phase I (168 Days)|Adverse Event|0|||
126700450|NCT01147809|455853603|FG001|Phase I (168 Days)|Adverse Event|0|||
126700451|NCT01147809|455853604|FG002|Phase I (168 Days)|Adverse Event|0|||
126700452|NCT01147809|455853605|FG003|Phase I (168 Days)|Adverse Event|1|||
126262625|NCT03649412|454252847|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126262626|NCT03649412|454252846|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
126262627|NCT03649412|454252847|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
126262628|NCT03649412|454252846|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
126262629|NCT03649412|454252847|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
126262630|NCT03649412|454252846|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
126700453|NCT01147809|455853606|FG004|Phase I (168 Days)|Adverse Event|0|||
126763688|NCT04411641|456086843|FG001|OL|Progressive disease|0|||
126763689|NCT04411641|456086844|FG002|OL|Progressive disease|1|||
126763690|NCT04411641|456086845|FG003|OL|Progressive disease|2|||
126262631|NCT03649412|454252847|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
126700454|NCT01147809|455853607|FG005|Phase I (168 Days)|Adverse Event|0|||
126700455|NCT01147809|455853602|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
126700456|NCT01147809|455853603|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
126763691|NCT04411641|456086842|FG000|OL|Poor compliance to protocol|0|||
126763692|NCT04411641|456086843|FG001|OL|Poor compliance to protocol|0|||
126763693|NCT04411641|456086844|FG002|OL|Poor compliance to protocol|1|||
126763694|NCT04411641|456086845|FG003|OL|Poor compliance to protocol|0|||
126262632|NCT02865395|454252848|FG000|Overall Study|Physician Decision|6|||
126262633|NCT02865395|454252849|FG001|Overall Study|Physician Decision|10|||
126262634|NCT02865395|454252850|FG002|Overall Study|Physician Decision|7|||
126262635|NCT01483625|454252851|FG000|Overall Study|Adverse Event|1|||
126262636|NCT01483625|454252852|FG001|Overall Study|Adverse Event|1|||
126262637|NCT01483625|454252851|FG000|Overall Study|Refused to continue medication|2|||
126262638|NCT01483625|454252852|FG001|Overall Study|Refused to continue medication|1|||
126262639|NCT01483625|454252851|FG000|Overall Study|Due to other reason|1|||
126262640|NCT01483625|454252852|FG001|Overall Study|Due to other reason|0|||
126262641|NCT04019054|454252856|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
126262642|NCT04019054|454252857|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
126262643|NCT04019054|454252856|FG000|Overall Study|Withdrawal by Subject|3|||
126262644|NCT04019054|454252857|FG001|Overall Study|Withdrawal by Subject|1|||
126262645|NCT05444543|454252858|FG000|Overall Study|Withdrawal by Subject|1|||
126262646|NCT05444543|454252859|FG001|Overall Study|Withdrawal by Subject|0|||
126262647|NCT05444543|454252858|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
126262648|NCT05444543|454252859|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
126262649|NCT05444543|454252858|FG000|Overall Study|Adverse Event|0|||
126262650|NCT05444543|454252859|FG001|Overall Study|Adverse Event|1|||
126262651|NCT05444543|454252858|FG000|Overall Study|Family relocating at a distance from study site|0|||
126262652|NCT05444543|454252859|FG001|Overall Study|Family relocating at a distance from study site|1|||
126262653|NCT01261624|454252860|FG000|Week 0 to Week 12|Disease Progression|1|||
126262654|NCT01261624|454252861|FG001|Week 0 to Week 12|Disease Progression|1|||
126262655|NCT01261624|454252860|FG000|Week 0 to Week 12|Insufficient Response|0|||
126262656|NCT01261624|454252861|FG001|Week 0 to Week 12|Insufficient Response|2|||
126262657|NCT01261624|454252860|FG000|Week 13 to Week 24|Insufficient Response|0|||
126262658|NCT01261624|454252861|FG001|Week 13 to Week 24|Insufficient Response|1|||
126262659|NCT01719562|454252864|FG000|Overall Study|Lost to Follow-up|1|||
126262660|NCT01719562|454252865|FG001|Overall Study|Lost to Follow-up|0|||
126262661|NCT01719562|454252864|FG000|Overall Study|Death|1|||
126262662|NCT01719562|454252865|FG001|Overall Study|Death|0|||
126262663|NCT01719562|454252864|FG000|Overall Study|New cancer diagnosis|1|||
126262664|NCT01719562|454252865|FG001|Overall Study|New cancer diagnosis|0|||
126262665|NCT00860743|454252868|FG000|Overall Study|Withdrawal by Subject|3|||
126262666|NCT00860743|454252869|FG001|Overall Study|Withdrawal by Subject|0|||
126262667|NCT03827018|454252870|FG000|Overall Study|Adverse Event|1|||
126262668|NCT03827018|454252871|FG001|Overall Study|Adverse Event|0|||
126262669|NCT03827018|454252870|FG000|Overall Study|Withdrawal by Subject|2|||
126262670|NCT03827018|454252871|FG001|Overall Study|Withdrawal by Subject|2|||
126262671|NCT03827018|454252870|FG000|Overall Study|Lack of Efficacy|0|||
126262672|NCT03827018|454252871|FG001|Overall Study|Lack of Efficacy|1|||
126763695|NCT04411641|456086842|FG000|OL|Adverse Event|0|||
126763696|NCT04411641|456086843|FG001|OL|Adverse Event|0|||
126763697|NCT04411641|456086844|FG002|OL|Adverse Event|1|||
126763698|NCT04411641|456086845|FG003|OL|Adverse Event|0|||
126262673|NCT00775528|454252876|FG000|Overall Study|Protocol Violation|1|||
126262674|NCT00350402|454252877|FG000|Overall Study|Lost to Follow-up|1|||
126262675|NCT00350402|454252878|FG001|Overall Study|Lost to Follow-up|1|||
126262676|NCT01884688|454252881|FG000|Overall Study|Screen Failure|2|||
126262677|NCT04099641|454252885|FG000|Overall Study|Death|46|||
126262678|NCT04099641|454252886|FG001|Overall Study|Death|12|||
126262679|NCT04099641|454252885|FG000|Overall Study|Lost to Follow-up|1|||
126262680|NCT04099641|454252886|FG001|Overall Study|Lost to Follow-up|0|||
126262681|NCT04099641|454252885|FG000|Overall Study|Withdrawal by Subject|2|||
126262682|NCT04099641|454252886|FG001|Overall Study|Withdrawal by Subject|0|||
126262683|NCT04798482|454252902|FG000|Overall Study|Physician Decision|1|||
126262684|NCT04798482|454252902|FG000|Overall Study|Lost eligibility|1|||
126262685|NCT01192399|454252903|FG000|Overall Study|Lack of Efficacy|2|||
126262686|NCT01534637|454252904|FG000|Overall Study|Physician Decision|3|||
126262687|NCT01534637|454252904|FG000|Overall Study|Lack of Efficacy|3|||
126763699|NCT04411641|456086842|FG000|OL|Other|0|||
126763700|NCT04411641|456086843|FG001|OL|Other|0|||
126262688|NCT01534637|454252904|FG000|Overall Study|Withdrawal by Subject|1|||
126262689|NCT01534637|454252904|FG000|Overall Study|Adverse Event|1|||
126262690|NCT01534637|454252904|FG000|Overall Study|Liver Mets before treatment|1|||
126262691|NCT03903159|454252906|FG000|Overall Study|Discharged with Staff Approval|2|||
126262692|NCT03903159|454252906|FG000|Overall Study|Discharged at Staff Request|2|||
126262693|NCT03903159|454252906|FG000|Overall Study|Discharged Against Staff Advice|1|||
126262694|NCT02443545|454252907|FG000|Overall Study|Adverse Event|1|||
126262695|NCT02443545|454252908|FG001|Overall Study|Adverse Event|1|||
126262696|NCT02443545|454252907|FG000|Overall Study|Lost to Follow-up|0|||
126262697|NCT02443545|454252908|FG001|Overall Study|Lost to Follow-up|2|||
126262698|NCT02443545|454252907|FG000|Overall Study|Physician Decision|3|||
126262699|NCT02443545|454252908|FG001|Overall Study|Physician Decision|0|||
126763701|NCT04411641|456086844|FG002|OL|Other|0|||
126763702|NCT04411641|456086845|FG003|OL|Other|6|||
126452112|NCT02059291|454957162|FG021|Epoch 3|Adverse Event|0|||
126452113|NCT02059291|454957163|FG022|Epoch 3|Adverse Event|0|||
126452114|NCT02059291|454957164|FG023|Epoch 3|Adverse Event|0|||
126452115|NCT02059291|454957165|FG024|Epoch 3|Adverse Event|0|||
126452116|NCT02059291|454957141|FG000|Epoch 3|Lack of Efficacy|0|||
126452117|NCT02059291|454957142|FG001|Epoch 3|Lack of Efficacy|0|||
126452118|NCT02059291|454957143|FG002|Epoch 3|Lack of Efficacy|0|||
126452119|NCT02059291|454957144|FG003|Epoch 3|Lack of Efficacy|0|||
126452120|NCT02059291|454957145|FG004|Epoch 3|Lack of Efficacy|0|||
126452121|NCT02059291|454957146|FG005|Epoch 3|Lack of Efficacy|0|||
126452122|NCT02059291|454957147|FG006|Epoch 3|Lack of Efficacy|0|||
126452123|NCT02059291|454957148|FG007|Epoch 3|Lack of Efficacy|0|||
126452124|NCT02059291|454957149|FG008|Epoch 3|Lack of Efficacy|0|||
126452125|NCT02059291|454957150|FG009|Epoch 3|Lack of Efficacy|0|||
126452126|NCT02059291|454957151|FG010|Epoch 3|Lack of Efficacy|0|||
126452127|NCT02059291|454957152|FG011|Epoch 3|Lack of Efficacy|0|||
126452128|NCT02059291|454957153|FG012|Epoch 3|Lack of Efficacy|0|||
126452129|NCT02059291|454957154|FG013|Epoch 3|Lack of Efficacy|0|||
126452130|NCT02059291|454957155|FG014|Epoch 3|Lack of Efficacy|0|||
126452131|NCT02059291|454957156|FG015|Epoch 3|Lack of Efficacy|3|||
126452132|NCT02059291|454957157|FG016|Epoch 3|Lack of Efficacy|0|||
126452133|NCT02059291|454957158|FG017|Epoch 3|Lack of Efficacy|0|||
126452134|NCT02059291|454957159|FG018|Epoch 3|Lack of Efficacy|0|||
126452135|NCT02059291|454957160|FG019|Epoch 3|Lack of Efficacy|0|||
126452136|NCT02059291|454957161|FG020|Epoch 3|Lack of Efficacy|0|||
126452137|NCT02059291|454957162|FG021|Epoch 3|Lack of Efficacy|0|||
126452138|NCT02059291|454957163|FG022|Epoch 3|Lack of Efficacy|0|||
126452139|NCT02059291|454957164|FG023|Epoch 3|Lack of Efficacy|0|||
126452140|NCT02059291|454957165|FG024|Epoch 3|Lack of Efficacy|0|||
126452141|NCT02059291|454957141|FG000|Epoch 3|Withdrawal by Subject|0|||
126452142|NCT02059291|454957142|FG001|Epoch 3|Withdrawal by Subject|0|||
126700457|NCT01147809|455853604|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
126700458|NCT01147809|455853605|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
126700459|NCT01147809|455853606|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
126700460|NCT01147809|455853607|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
126700461|NCT01147809|455853602|FG000|Phase I (168 Days)|Physician Decision|0|||
126700462|NCT01147809|455853603|FG001|Phase I (168 Days)|Physician Decision|1|||
126700463|NCT01147809|455853604|FG002|Phase I (168 Days)|Physician Decision|2|||
126700464|NCT01147809|455853605|FG003|Phase I (168 Days)|Physician Decision|0|||
126700465|NCT01147809|455853606|FG004|Phase I (168 Days)|Physician Decision|0|||
126700466|NCT01147809|455853607|FG005|Phase I (168 Days)|Physician Decision|0|||
126700467|NCT01147809|455853602|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
126700468|NCT01147809|455853603|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
126700469|NCT01147809|455853604|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
126700470|NCT01147809|455853605|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
126700471|NCT01147809|455853606|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
126700472|NCT01147809|455853607|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
126700473|NCT01147809|455853602|FG000|Phase II (168 Days)|Adverse Event|0|||
126700474|NCT01147809|455853603|FG001|Phase II (168 Days)|Adverse Event|0|||
126700475|NCT01147809|455853604|FG002|Phase II (168 Days)|Adverse Event|0|||
126700476|NCT01147809|455853605|FG003|Phase II (168 Days)|Adverse Event|0|||
126700477|NCT01147809|455853606|FG004|Phase II (168 Days)|Adverse Event|3|||
126700478|NCT01147809|455853607|FG005|Phase II (168 Days)|Adverse Event|6|||
126700479|NCT01147809|455853602|FG000|Phase II (168 Days)|Protocol Violation|0|||
126700480|NCT01147809|455853603|FG001|Phase II (168 Days)|Protocol Violation|0|||
126700481|NCT01147809|455853604|FG002|Phase II (168 Days)|Protocol Violation|0|||
126700482|NCT01147809|455853605|FG003|Phase II (168 Days)|Protocol Violation|0|||
126700483|NCT01147809|455853606|FG004|Phase II (168 Days)|Protocol Violation|0|||
126700484|NCT01147809|455853607|FG005|Phase II (168 Days)|Protocol Violation|1|||
126700485|NCT01147809|455853602|FG000|Phase II (168 Days)|Physician Decision|0|||
126700486|NCT01147809|455853603|FG001|Phase II (168 Days)|Physician Decision|0|||
126700487|NCT01147809|455853604|FG002|Phase II (168 Days)|Physician Decision|0|||
126700488|NCT01147809|455853605|FG003|Phase II (168 Days)|Physician Decision|0|||
126700489|NCT01147809|455853606|FG004|Phase II (168 Days)|Physician Decision|5|||
126700490|NCT01147809|455853607|FG005|Phase II (168 Days)|Physician Decision|11|||
126700491|NCT01147809|455853602|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
126700492|NCT01147809|455853603|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
126700493|NCT01147809|455853604|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
126700494|NCT01147809|455853605|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
126700495|NCT01147809|455853606|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
126700496|NCT01147809|455853607|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
126262700|NCT02443545|454252907|FG000|Overall Study|Protocol Violation|8|||
126452143|NCT02059291|454957143|FG002|Epoch 3|Withdrawal by Subject|0|||
126452144|NCT02059291|454957144|FG003|Epoch 3|Withdrawal by Subject|0|||
126452145|NCT02059291|454957145|FG004|Epoch 3|Withdrawal by Subject|0|||
126452146|NCT02059291|454957146|FG005|Epoch 3|Withdrawal by Subject|0|||
126452147|NCT02059291|454957147|FG006|Epoch 3|Withdrawal by Subject|0|||
126452148|NCT02059291|454957148|FG007|Epoch 3|Withdrawal by Subject|0|||
126452149|NCT02059291|454957149|FG008|Epoch 3|Withdrawal by Subject|0|||
126452150|NCT02059291|454957150|FG009|Epoch 3|Withdrawal by Subject|0|||
126452151|NCT02059291|454957151|FG010|Epoch 3|Withdrawal by Subject|0|||
126546878|NCT00744328|455296072|FG000|Overall Study|Lost to Follow-up|2|||
126546879|NCT00744328|455296073|FG001|Overall Study|Lost to Follow-up|5|||
126546880|NCT00744328|455296074|FG002|Overall Study|Lost to Follow-up|3|||
126546881|NCT00744328|455296072|FG000|Overall Study|Withdrawal by Subject|5|||
126546882|NCT00744328|455296073|FG001|Overall Study|Withdrawal by Subject|3|||
126546883|NCT00744328|455296074|FG002|Overall Study|Withdrawal by Subject|4|||
126546884|NCT00744328|455296072|FG000|Overall Study|Found ineligible after randomization|0|||
126546885|NCT00744328|455296073|FG001|Overall Study|Found ineligible after randomization|0|||
126546886|NCT00744328|455296074|FG002|Overall Study|Found ineligible after randomization|1|||
126546887|NCT02387216|455296077|FG000|Overall Study|Progressive disease|2|||
126546888|NCT02387216|455296078|FG001|Overall Study|Progressive disease|0|||
126546889|NCT02387216|455296077|FG000|Overall Study|Withdrawal by Subject|3|||
126546890|NCT02387216|455296078|FG001|Overall Study|Withdrawal by Subject|5|||
126546891|NCT02387216|455296077|FG000|Overall Study|Physician Decision|2|||
126546892|NCT02387216|455296078|FG001|Overall Study|Physician Decision|0|||
126546893|NCT02387216|455296077|FG000|Overall Study|Sponsor Decision|28|||
126546894|NCT02387216|455296078|FG001|Overall Study|Sponsor Decision|12|||
126546895|NCT02387216|455296077|FG000|Overall Study|Death|60|||
126546896|NCT02387216|455296078|FG001|Overall Study|Death|23|||
126546897|NCT02387216|455296077|FG000|Overall Study|Other|5|||
126546898|NCT02387216|455296078|FG001|Overall Study|Other|4|||
126546899|NCT02387216|455296077|FG000|Overall Study|Lost to Follow-up|0|||
126546900|NCT02387216|455296078|FG001|Overall Study|Lost to Follow-up|3|||
126546901|NCT04498247|455296079|FG000|Overall Study|Lost to Follow-up|0|||
126546902|NCT04498247|455296080|FG001|Overall Study|Lost to Follow-up|0|||
126546903|NCT04498247|455296081|FG002|Overall Study|Lost to Follow-up|0|||
126546904|NCT04498247|455296082|FG003|Overall Study|Lost to Follow-up|1|||
126546905|NCT04498247|455296083|FG004|Overall Study|Lost to Follow-up|0|||
126546906|NCT04498247|455296084|FG005|Overall Study|Lost to Follow-up|0|||
126546907|NCT04498247|455296085|FG006|Overall Study|Lost to Follow-up|0|||
126546908|NCT04498247|455296086|FG007|Overall Study|Lost to Follow-up|0|||
126546909|NCT04498247|455296079|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
126546910|NCT04498247|455296080|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
126546911|NCT04498247|455296081|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
126546912|NCT04498247|455296082|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
126546913|NCT04498247|455296083|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
126546914|NCT04498247|455296084|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
126763703|NCT03282123|456086850|FG000|Overall Study|Withdrawal by Subject|5|||
126763704|NCT00938366|456086851|FG000|Overall Study|Withdrawal by Subject|1|||
126763705|NCT00938366|456086852|FG001|Overall Study|Withdrawal by Subject|0|||
126763706|NCT01195662|456086853|FG000|Double Blind Treatment Period|Adverse Event|4|||
126763707|NCT01195662|456086854|FG001|Double Blind Treatment Period|Adverse Event|1|||
126763708|NCT01195662|456086855|FG002|Double Blind Treatment Period|Adverse Event|2|||
126763709|NCT01195662|456086853|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
126763710|NCT01195662|456086854|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
126763711|NCT01195662|456086855|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
126262701|NCT02443545|454252908|FG001|Overall Study|Protocol Violation|1|||
126262702|NCT02443545|454252907|FG000|Overall Study|Pregnancy|1|||
126262703|NCT02443545|454252908|FG001|Overall Study|Pregnancy|1|||
126262704|NCT02443545|454252907|FG000|Overall Study|Withdrawal by Subject|6|||
126262705|NCT02443545|454252908|FG001|Overall Study|Withdrawal by Subject|3|||
126262706|NCT02443545|454252907|FG000|Overall Study|Termination of study|20|||
126262707|NCT02443545|454252908|FG001|Overall Study|Termination of study|11|||
126262708|NCT00536484|454252909|FG000|Overall Study|Adverse Event|21|||
126262709|NCT00536484|454252910|FG001|Overall Study|Adverse Event|34|||
126262710|NCT00536484|454252909|FG000|Overall Study|Withdrawal by Subject|11|||
126262711|NCT00536484|454252910|FG001|Overall Study|Withdrawal by Subject|11|||
126262712|NCT00536484|454252909|FG000|Overall Study|Lost to Follow-up|8|||
126262713|NCT00536484|454252910|FG001|Overall Study|Lost to Follow-up|6|||
126262714|NCT00536484|454252909|FG000|Overall Study|Lack of Efficacy|16|||
126262715|NCT00536484|454252910|FG001|Overall Study|Lack of Efficacy|5|||
126262716|NCT00536484|454252909|FG000|Overall Study|Other|4|||
126262717|NCT00536484|454252910|FG001|Overall Study|Other|0|||
126262718|NCT01506908|454252911|FG000|Overall Study|Adverse Event|1|||
126359736|NCT05587998|454609056|FG001|Overall Study|Non-compliance with study procedures|1|||
126262719|NCT01506908|454252912|FG001|Overall Study|Adverse Event|0|||
126546915|NCT04498247|455296085|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
126546916|NCT04498247|455296086|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
126546917|NCT04498247|455296079|FG000|Overall Study|Withdrawal by Subject|0|||
126262720|NCT00440115|454252916|FG000|Overall Study|Death|7|||
126262721|NCT00440115|454252917|FG001|Overall Study|Death|9|||
126262722|NCT00440115|454252918|FG002|Overall Study|Death|5|||
126262723|NCT00440115|454252916|FG000|Overall Study|Incarceration|0|||
126262724|NCT00440115|454252917|FG001|Overall Study|Incarceration|2|||
126546918|NCT04498247|455296080|FG001|Overall Study|Withdrawal by Subject|8|||
126546919|NCT04498247|455296081|FG002|Overall Study|Withdrawal by Subject|0|||
126546920|NCT04498247|455296082|FG003|Overall Study|Withdrawal by Subject|7|||
126700497|NCT01147809|455853602|FG000|Phase II (168 Days)|Ongoing|0|||
126262725|NCT00440115|454252918|FG002|Overall Study|Incarceration|1|||
126262726|NCT00206102|454252920|FG000|Overall Study|Adverse Event|119|||
126262727|NCT00206102|454252921|FG001|Overall Study|Adverse Event|82|||
126262728|NCT00206102|454252920|FG000|Overall Study|Protocol Violation|0|||
126262729|NCT00206102|454252921|FG001|Overall Study|Protocol Violation|2|||
126262730|NCT00206102|454252920|FG000|Overall Study|Lack of therapeutic response|16|||
126262731|NCT00206102|454252921|FG001|Overall Study|Lack of therapeutic response|11|||
126262732|NCT00206102|454252920|FG000|Overall Study|Lost to Follow-up|95|||
126262733|NCT00206102|454252921|FG001|Overall Study|Lost to Follow-up|66|||
126262734|NCT00206102|454252920|FG000|Overall Study|Withdrawal by Subject|118|||
126262735|NCT00206102|454252921|FG001|Overall Study|Withdrawal by Subject|101|||
126262736|NCT00206102|454252920|FG000|Overall Study|Study-specific discontinuation criteria|18|||
126262737|NCT00206102|454252921|FG001|Overall Study|Study-specific discontinuation criteria|17|||
126262738|NCT00206102|454252920|FG000|Overall Study|None of those categories|42|||
126262739|NCT00206102|454252921|FG001|Overall Study|None of those categories|36|||
126262740|NCT02953678|454252922|FG000|Overall Study|Adverse Event|20|||
126262741|NCT02953678|454252922|FG000|Overall Study|Death|7|||
126262742|NCT02953678|454252922|FG000|Overall Study|Physician Decision|23|||
126262743|NCT02953678|454252922|FG000|Overall Study|Progressive Disease of GVHD|7|||
126262744|NCT02953678|454252922|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
126262745|NCT02953678|454252922|FG000|Overall Study|Withdrawal by participant|3|||
126262746|NCT02953678|454252922|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
126262747|NCT02953678|454252922|FG000|Overall Study|Participants were transferred to commercial product.|3|||
126262748|NCT04678817|454254467|FG000|Overall Study|Lost to Follow-up|28|||
126262749|NCT04678817|454254468|FG001|Overall Study|Lost to Follow-up|0|||
126262750|NCT04678817|454254469|FG002|Overall Study|Lost to Follow-up|0|||
126262751|NCT00784134|454254476|FG000|Overall Study|Lost to Follow-up|3|||
126262752|NCT00784134|454254477|FG001|Overall Study|Lost to Follow-up|6|||
126262753|NCT03785145|454254478|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
126262754|NCT03785145|454254479|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
126262755|NCT03785145|454254478|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
126262756|NCT03785145|454254479|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
126262757|NCT03785145|454254478|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
126262758|NCT03785145|454254479|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
126262759|NCT03785145|454254478|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
126262760|NCT03785145|454254479|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
126262761|NCT03785145|454254478|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
126262762|NCT03785145|454254479|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
126262763|NCT03785145|454254478|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
126262764|NCT03785145|454254479|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
126262765|NCT03785145|454254478|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
126262766|NCT03785145|454254479|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
126262767|NCT03785145|454254478|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
126262768|NCT03785145|454254479|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
126262769|NCT03785145|454254478|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
126262770|NCT03785145|454254479|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
126262771|NCT03785145|454254478|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
126262772|NCT03785145|454254479|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
126262773|NCT03785145|454254478|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
126262774|NCT03785145|454254479|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
126262775|NCT03686150|454254480|FG000|Overall Study|Withdrawal by Subject|1|||
126262776|NCT03686150|454254481|FG001|Overall Study|Withdrawal by Subject|1|||
126262777|NCT03686150|454254482|FG002|Overall Study|Withdrawal by Subject|1|||
126262778|NCT03686150|454254483|FG003|Overall Study|Withdrawal by Subject|0|||
126262779|NCT03686150|454254484|FG004|Overall Study|Withdrawal by Subject|1|||
126262780|NCT03686150|454254485|FG005|Overall Study|Withdrawal by Subject|2|||
126262781|NCT03686150|454254480|FG000|Overall Study|Physician Decision|1|||
126262782|NCT03686150|454254481|FG001|Overall Study|Physician Decision|0|||
126262783|NCT03686150|454254482|FG002|Overall Study|Physician Decision|0|||
126700498|NCT01147809|455853603|FG001|Phase II (168 Days)|Ongoing|0|||
126700499|NCT01147809|455853604|FG002|Phase II (168 Days)|Ongoing|0|||
126700500|NCT01147809|455853605|FG003|Phase II (168 Days)|Ongoing|0|||
126700501|NCT01147809|455853606|FG004|Phase II (168 Days)|Ongoing|1|||
126262784|NCT03686150|454254483|FG003|Overall Study|Physician Decision|0|||
126262785|NCT03686150|454254484|FG004|Overall Study|Physician Decision|0|||
126262786|NCT03686150|454254485|FG005|Overall Study|Physician Decision|1|||
126262787|NCT03686150|454254480|FG000|Overall Study|Lost to Follow-up|0|||
126262788|NCT03686150|454254481|FG001|Overall Study|Lost to Follow-up|1|||
126262789|NCT03686150|454254482|FG002|Overall Study|Lost to Follow-up|0|||
126700502|NCT01147809|455853607|FG005|Phase II (168 Days)|Ongoing|0|||
126763712|NCT01195662|456086853|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
126763713|NCT01195662|456086854|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
126763714|NCT01195662|456086855|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
126763715|NCT01195662|456086853|FG000|Double Blind Treatment Period|Administrative reason|2|||
126763716|NCT01195662|456086854|FG001|Double Blind Treatment Period|Administrative reason|1|||
126763717|NCT01195662|456086855|FG002|Double Blind Treatment Period|Administrative reason|1|||
126763718|NCT01195662|456086853|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
126546921|NCT04498247|455296083|FG004|Overall Study|Withdrawal by Subject|0|||
126546922|NCT04498247|455296084|FG005|Overall Study|Withdrawal by Subject|0|||
126546923|NCT04498247|455296085|FG006|Overall Study|Withdrawal by Subject|1|||
126546924|NCT04498247|455296086|FG007|Overall Study|Withdrawal by Subject|0|||
126546925|NCT04498247|455296079|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
126546926|NCT04498247|455296080|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
126546927|NCT04498247|455296081|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
126546928|NCT04498247|455296082|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
126700503|NCT01307423|455853608|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
126700504|NCT01307423|455853609|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
126700505|NCT01307423|455853610|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
126700506|NCT01307423|455853611|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126700507|NCT01307423|455853612|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126700508|NCT01307423|455853613|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126700509|NCT01307423|455853614|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126700510|NCT01307423|455853615|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126700511|NCT01307423|455853616|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126700512|NCT01307423|455853608|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
126700513|NCT01307423|455853609|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
126700514|NCT01307423|455853610|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
126700515|NCT01307423|455853611|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126700516|NCT01307423|455853612|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126700517|NCT01307423|455853613|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126700518|NCT01307423|455853614|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126700519|NCT01307423|455853615|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126700520|NCT01307423|455853616|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126700521|NCT01307423|455853608|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
126700522|NCT01307423|455853609|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
126700523|NCT01307423|455853610|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
126700524|NCT01307423|455853611|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126700525|NCT01307423|455853612|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126700526|NCT01307423|455853613|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126700527|NCT01307423|455853614|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126700528|NCT01307423|455853615|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126700529|NCT01307423|455853616|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126700530|NCT01307423|455853608|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126700531|NCT01307423|455853609|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126700532|NCT01307423|455853610|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
126700533|NCT01307423|455853611|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126700534|NCT01307423|455853612|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126700535|NCT01307423|455853613|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126700536|NCT01307423|455853614|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126700537|NCT01307423|455853615|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126700538|NCT01307423|455853616|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126262790|NCT03686150|454254483|FG003|Overall Study|Lost to Follow-up|0|||
126262791|NCT03686150|454254484|FG004|Overall Study|Lost to Follow-up|0|||
126262792|NCT03686150|454254485|FG005|Overall Study|Lost to Follow-up|0|||
126262793|NCT03250299|454254488|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
126262794|NCT03250299|454254489|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
126262795|NCT03250299|454254490|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
126262796|NCT03250299|454254491|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
126262797|NCT03250299|454254492|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
126262798|NCT03250299|454254488|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
126262799|NCT03250299|454254489|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
126262800|NCT03250299|454254490|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
126262801|NCT03250299|454254491|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
126262802|NCT03250299|454254492|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
126262803|NCT03250299|454254488|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
126262804|NCT03250299|454254489|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
126262805|NCT03250299|454254490|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
126700539|NCT01307423|455853608|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
126700540|NCT01307423|455853609|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
126700541|NCT01307423|455853610|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
126700542|NCT01307423|455853611|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126700543|NCT01307423|455853612|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126262806|NCT03250299|454254491|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
126262807|NCT03250299|454254492|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
126262808|NCT03250299|454254488|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
126262809|NCT03250299|454254489|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
126262810|NCT03250299|454254490|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
126262811|NCT03250299|454254491|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
126262812|NCT03250299|454254492|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
126262813|NCT01213836|454254506|FG000|Period 1, First Intervention|Adverse Event|2|||
126262814|NCT01213836|454254507|FG001|Period 1, First Intervention|Adverse Event|1|||
126262815|NCT01213836|454254506|FG000|Period 1, First Intervention|Protocol Violation|0|||
126262816|NCT01213836|454254507|FG001|Period 1, First Intervention|Protocol Violation|1|||
126262817|NCT01213836|454254506|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
126262818|NCT01213836|454254507|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
126262819|NCT00255151|454254508|FG000|Overall Study|Adverse Event|10|||
126262820|NCT00255151|454254509|FG001|Overall Study|Adverse Event|6|||
126262821|NCT00255151|454254510|FG002|Overall Study|Adverse Event|9|||
126262822|NCT00255151|454254508|FG000|Overall Study|Lost to Follow-up|4|||
126262823|NCT00255151|454254509|FG001|Overall Study|Lost to Follow-up|3|||
126262824|NCT00255151|454254510|FG002|Overall Study|Lost to Follow-up|4|||
126262825|NCT00255151|454254508|FG000|Overall Study|Withdrawal by Subject|18|||
126262826|NCT00255151|454254509|FG001|Overall Study|Withdrawal by Subject|17|||
126262827|NCT00255151|454254510|FG002|Overall Study|Withdrawal by Subject|8|||
126262828|NCT00255151|454254508|FG000|Overall Study|Noncompliance|0|||
126262829|NCT00255151|454254509|FG001|Overall Study|Noncompliance|1|||
126262830|NCT00255151|454254510|FG002|Overall Study|Noncompliance|2|||
126262831|NCT00255151|454254508|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
126262832|NCT00255151|454254509|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
126262833|NCT00255151|454254510|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
126262834|NCT00255151|454254508|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
126262835|NCT00255151|454254509|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
126262836|NCT00255151|454254510|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
126262837|NCT00255151|454254508|FG000|Overall Study|Possible Barrett's Esophagus|1|||
126262838|NCT00255151|454254509|FG001|Overall Study|Possible Barrett's Esophagus|3|||
126262839|NCT00255151|454254510|FG002|Overall Study|Possible Barrett's Esophagus|8|||
126262840|NCT00255151|454254508|FG000|Overall Study|Esophageal Stricture|0|||
126262841|NCT00255151|454254509|FG001|Overall Study|Esophageal Stricture|0|||
126262842|NCT00255151|454254510|FG002|Overall Study|Esophageal Stricture|1|||
126262843|NCT00255151|454254508|FG000|Overall Study|Therapeutic Failure|11|||
126262844|NCT00255151|454254509|FG001|Overall Study|Therapeutic Failure|2|||
126262845|NCT00255151|454254510|FG002|Overall Study|Therapeutic Failure|3|||
126262846|NCT02676284|454254511|FG000|Overall Study|Withdrawal by Subject|1|||
126262847|NCT01685073|454254512|FG000|Overall Study|Lost to Follow-up|6|||
126262848|NCT01685073|454254513|FG001|Overall Study|Lost to Follow-up|8|||
126262849|NCT01685073|454254512|FG000|Overall Study|Withdrawal by Subject|24|||
126262850|NCT01685073|454254513|FG001|Overall Study|Withdrawal by Subject|24|||
126262851|NCT00107042|454254518|FG000|Overall Study|Lost to Follow-up|9|||
126262852|NCT00107042|454254519|FG001|Overall Study|Lost to Follow-up|7|||
126262853|NCT00107042|454254518|FG000|Overall Study|Withdrawal by Subject|6|||
126262854|NCT00107042|454254519|FG001|Overall Study|Withdrawal by Subject|1|||
126262855|NCT00107042|454254518|FG000|Overall Study|Moved out of area|5|||
126262856|NCT00107042|454254519|FG001|Overall Study|Moved out of area|3|||
126262857|NCT00107042|454254518|FG000|Overall Study|Pregnancy|1|||
126262858|NCT00107042|454254519|FG001|Overall Study|Pregnancy|1|||
126262859|NCT00107042|454254518|FG000|Overall Study|Inadvertent enrollment|0|||
126700544|NCT01307423|455853613|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126700545|NCT01307423|455853614|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126763719|NCT01195662|456086854|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
126763720|NCT01195662|456086855|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
126700546|NCT01307423|455853615|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126262860|NCT00107042|454254519|FG001|Overall Study|Inadvertent enrollment|1|||
126359737|NCT03892915|454609060|FG000|Overall Study|Lost to Follow-up|6|||
126262861|NCT00107042|454254518|FG000|Overall Study|vaccinated outside window|1|||
126262862|NCT00107042|454254519|FG001|Overall Study|vaccinated outside window|1|||
126262863|NCT00107042|454254518|FG000|Overall Study|Disallowed medications|0|||
126262864|NCT00107042|454254519|FG001|Overall Study|Disallowed medications|2|||
126262865|NCT01221090|454254521|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
126262866|NCT01221090|454254522|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
126262867|NCT01221090|454254523|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
126359738|NCT03892915|454609061|FG001|Overall Study|Lost to Follow-up|12|||
126700547|NCT01307423|455853616|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126700548|NCT01307423|455853608|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
126700549|NCT01307423|455853609|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126452152|NCT02059291|454957152|FG011|Epoch 3|Withdrawal by Subject|0|||
126452153|NCT02059291|454957153|FG012|Epoch 3|Withdrawal by Subject|0|||
126452154|NCT02059291|454957154|FG013|Epoch 3|Withdrawal by Subject|0|||
126452155|NCT02059291|454957155|FG014|Epoch 3|Withdrawal by Subject|0|||
126452156|NCT02059291|454957156|FG015|Epoch 3|Withdrawal by Subject|1|||
126452157|NCT02059291|454957157|FG016|Epoch 3|Withdrawal by Subject|0|||
126452158|NCT02059291|454957158|FG017|Epoch 3|Withdrawal by Subject|0|||
126452159|NCT02059291|454957159|FG018|Epoch 3|Withdrawal by Subject|0|||
126452160|NCT02059291|454957160|FG019|Epoch 3|Withdrawal by Subject|0|||
126452161|NCT02059291|454957161|FG020|Epoch 3|Withdrawal by Subject|0|||
126452162|NCT02059291|454957162|FG021|Epoch 3|Withdrawal by Subject|0|||
126452163|NCT02059291|454957163|FG022|Epoch 3|Withdrawal by Subject|0|||
126452164|NCT02059291|454957164|FG023|Epoch 3|Withdrawal by Subject|0|||
126452165|NCT02059291|454957165|FG024|Epoch 3|Withdrawal by Subject|0|||
126452166|NCT02059291|454957141|FG000|Epoch 4|Adverse Event|0|||
126452167|NCT02059291|454957142|FG001|Epoch 4|Adverse Event|0|||
126452168|NCT02059291|454957143|FG002|Epoch 4|Adverse Event|0|||
126700550|NCT01307423|455853610|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126700551|NCT01307423|455853611|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126700552|NCT01307423|455853612|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126700553|NCT01307423|455853613|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126700554|NCT01307423|455853614|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126700555|NCT01307423|455853615|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126700556|NCT01307423|455853616|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126700557|NCT01307423|455853608|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
126700558|NCT01307423|455853609|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
126700559|NCT01307423|455853610|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126700560|NCT01307423|455853611|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126763721|NCT01195662|456086853|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
126763722|NCT01195662|456086854|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
126262868|NCT01221090|454254524|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
126262869|NCT01221090|454254521|FG000|Overall Study|Withdrawal by Subject|0|||
126262870|NCT01221090|454254522|FG001|Overall Study|Withdrawal by Subject|22|||
126262871|NCT01221090|454254523|FG002|Overall Study|Withdrawal by Subject|27|||
126262872|NCT01221090|454254524|FG003|Overall Study|Withdrawal by Subject|2|||
126262873|NCT00708708|454254525|FG000|Overall Study|Another therapy instead of Enbrel|141|||
126262874|NCT00708708|454254525|FG000|Overall Study|Lost to Follow-up|52|||
126262875|NCT00708708|454254525|FG000|Overall Study|Withdrawal by Subject|51|||
126262876|NCT00708708|454254525|FG000|Overall Study|Intolerance|42|||
126262877|NCT00708708|454254525|FG000|Overall Study|Another therapy along with Enbrel|15|||
126262878|NCT00708708|454254525|FG000|Overall Study|Other unspecified|11|||
126262879|NCT00708708|454254525|FG000|Overall Study|Good effectiveness|9|||
126262880|NCT00708708|454254525|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
126262881|NCT00708708|454254525|FG000|Overall Study|Administrative reasons|7|||
126262882|NCT00708708|454254525|FG000|Overall Study|Lack of effectiveness|4|||
126262883|NCT00708708|454254525|FG000|Overall Study|Lack of compliance|3|||
126262884|NCT00708708|454254525|FG000|Overall Study|Pregnancy|3|||
126262885|NCT00708708|454254525|FG000|Overall Study|Adverse Event|3|||
126262886|NCT00708708|454254525|FG000|Overall Study|Missing values|392|||
126262887|NCT04776746|454254529|FG000|Overall Study|Study terminated by sponsor|61|||
126262888|NCT04776746|454254529|FG000|Overall Study|Adverse Event|5|||
126262889|NCT04776746|454254529|FG000|Overall Study|Death|4|||
126262890|NCT04776746|454254529|FG000|Overall Study|Lack of Efficacy|3|||
126262891|NCT04776746|454254529|FG000|Overall Study|Noncompliance with study drug|2|||
126262892|NCT04776746|454254529|FG000|Overall Study|Not related to COVID-19|2|||
126262893|NCT00440466|454254530|FG000|Overall Study|Death|3|||
126262894|NCT00440466|454254531|FG001|Overall Study|Death|2|||
126452169|NCT02059291|454957144|FG003|Epoch 4|Adverse Event|0|||
126262895|NCT00440466|454254532|FG002|Overall Study|Death|9|||
126452170|NCT02059291|454957145|FG004|Epoch 4|Adverse Event|0|||
126452171|NCT02059291|454957146|FG005|Epoch 4|Adverse Event|0|||
126452172|NCT02059291|454957147|FG006|Epoch 4|Adverse Event|0|||
126546929|NCT04498247|455296083|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
126262896|NCT00440466|454254530|FG000|Overall Study|Adverse Event|3|||
126262897|NCT00440466|454254531|FG001|Overall Study|Adverse Event|4|||
126262898|NCT00440466|454254532|FG002|Overall Study|Adverse Event|11|||
126262899|NCT00440466|454254530|FG000|Overall Study|Lost to Follow-up|1|||
126262900|NCT00440466|454254531|FG001|Overall Study|Lost to Follow-up|0|||
126262901|NCT00440466|454254532|FG002|Overall Study|Lost to Follow-up|2|||
126452173|NCT02059291|454957148|FG007|Epoch 4|Adverse Event|0|||
126452174|NCT02059291|454957149|FG008|Epoch 4|Adverse Event|0|||
126452175|NCT02059291|454957150|FG009|Epoch 4|Adverse Event|0|||
126452176|NCT02059291|454957151|FG010|Epoch 4|Adverse Event|0|||
126452177|NCT02059291|454957152|FG011|Epoch 4|Adverse Event|0|||
126262902|NCT00440466|454254530|FG000|Overall Study|Physician Decision|2|||
126262903|NCT00440466|454254531|FG001|Overall Study|Physician Decision|0|||
126262904|NCT00440466|454254532|FG002|Overall Study|Physician Decision|1|||
126262905|NCT00440466|454254530|FG000|Overall Study|Protocol Violation|2|||
126262906|NCT00440466|454254531|FG001|Overall Study|Protocol Violation|0|||
126262907|NCT00440466|454254532|FG002|Overall Study|Protocol Violation|4|||
126262908|NCT00440466|454254530|FG000|Overall Study|Withdrawal by Subject|2|||
126262909|NCT00440466|454254531|FG001|Overall Study|Withdrawal by Subject|5|||
126262910|NCT00440466|454254532|FG002|Overall Study|Withdrawal by Subject|9|||
126262911|NCT00440466|454254530|FG000|Overall Study|Began Dialysis|0|||
126262912|NCT00440466|454254531|FG001|Overall Study|Began Dialysis|0|||
126262913|NCT00440466|454254532|FG002|Overall Study|Began Dialysis|1|||
126262914|NCT00440466|454254530|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
126262915|NCT00440466|454254531|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
126262916|NCT00440466|454254532|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
126262917|NCT00743509|454254533|FG000|Overall Study|Withdrawal by Subject|2|||
126262918|NCT03768726|454254538|FG000|Treatment Phase|Adverse Event|2|||
126262919|NCT03768726|454254539|FG001|Treatment Phase|Adverse Event|2|||
126262920|NCT03768726|454254538|FG000|Treatment Phase|Lost to Follow-up|1|||
126262921|NCT03768726|454254539|FG001|Treatment Phase|Lost to Follow-up|0|||
126262922|NCT03768726|454254538|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
126262923|NCT03768726|454254539|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
126262924|NCT03768726|454254538|FG000|Treatment Phase|Withdrawal by Subject|3|||
126262925|NCT03768726|454254539|FG001|Treatment Phase|Withdrawal by Subject|1|||
126262926|NCT03768726|454254538|FG000|Follow-Up|Adverse Event|2|||
126262927|NCT03768726|454254539|FG001|Follow-Up|Adverse Event|2|||
126262928|NCT03768726|454254538|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
126262929|NCT03768726|454254539|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
126262930|NCT03768726|454254538|FG000|Follow-Up|Withdrawal by Subject|2|||
126262931|NCT03768726|454254539|FG001|Follow-Up|Withdrawal by Subject|0|||
126262932|NCT03768726|454254538|FG000|Follow-Up|Other|1|||
126262933|NCT03768726|454254539|FG001|Follow-Up|Other|0|||
126262934|NCT01787279|454254540|FG000|Overall Study|Lost to Follow-up|2|||
126262935|NCT01787279|454254540|FG000|Overall Study|Lack of Efficacy|1|||
126262936|NCT00418522|454254541|FG000|Overall Study|Adverse Event|7|||
126262937|NCT00418522|454254542|FG001|Overall Study|Adverse Event|1|||
126262938|NCT00418522|454254541|FG000|Overall Study|Lack of Efficacy|1|||
126262939|NCT00418522|454254542|FG001|Overall Study|Lack of Efficacy|3|||
126262940|NCT00418522|454254541|FG000|Overall Study|Lost to Follow-up|10|||
126262941|NCT00418522|454254542|FG001|Overall Study|Lost to Follow-up|4|||
126262942|NCT00418522|454254541|FG000|Overall Study|Withdrawal by Subject|31|||
126262943|NCT00418522|454254542|FG001|Overall Study|Withdrawal by Subject|7|||
126262944|NCT00418522|454254541|FG000|Overall Study|Other|27|||
126262945|NCT00418522|454254542|FG001|Overall Study|Other|23|||
126262946|NCT00418522|454254541|FG000|Overall Study|Randomized but did not receive treatment|7|||
126262947|NCT00418522|454254542|FG001|Overall Study|Randomized but did not receive treatment|4|||
126262948|NCT02695719|454254543|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
126262949|NCT02695719|454254544|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
126262950|NCT02695719|454254543|FG000|Overall Study|Significant Protocol Deviation|0|||
126262951|NCT02695719|454254544|FG001|Overall Study|Significant Protocol Deviation|1|||
126262952|NCT02695719|454254543|FG000|Overall Study|Voluntary Withdrawal|1|||
126262953|NCT02695719|454254544|FG001|Overall Study|Voluntary Withdrawal|0|||
126262954|NCT04109313|454254548|FG000|Overall Study|Pregnancy|1|||
126262955|NCT04109313|454254548|FG000|Overall Study|Adverse Event|11|||
126262956|NCT04109313|454254548|FG000|Overall Study|Lack of Efficacy|11|||
126262957|NCT04109313|454254548|FG000|Overall Study|Lost to Follow-up|1|||
126262958|NCT04109313|454254548|FG000|Overall Study|Physician Decision|2|||
126262959|NCT04109313|454254548|FG000|Overall Study|Subject Decision|13|||
126262960|NCT04109313|454254548|FG000|Overall Study|Covid-19 situation|2|||
126262961|NCT00892281|454254552|FG000|Overall Study|Adverse Event|65|||
126262962|NCT00892281|454254553|FG001|Overall Study|Adverse Event|8|||
126262963|NCT00892281|454254552|FG000|Overall Study|Lost to Follow-up|81|||
126262964|NCT00892281|454254553|FG001|Overall Study|Lost to Follow-up|8|||
126262965|NCT00892281|454254552|FG000|Overall Study|Pregnancy|1|||
126262966|NCT00892281|454254553|FG001|Overall Study|Pregnancy|0|||
126262967|NCT00892281|454254552|FG000|Overall Study|Protocol Violation|7|||
126262968|NCT00892281|454254553|FG001|Overall Study|Protocol Violation|2|||
126262969|NCT00892281|454254552|FG000|Overall Study|Withdrawal by Subject|86|||
126262970|NCT00892281|454254553|FG001|Overall Study|Withdrawal by Subject|14|||
126262971|NCT00892281|454254552|FG000|Overall Study|Subject failed to return for final visit|2|||
126262972|NCT00892281|454254553|FG001|Overall Study|Subject failed to return for final visit|0|||
126359739|NCT03892915|454609060|FG000|Overall Study|Death|0|||
126359740|NCT03892915|454609061|FG001|Overall Study|Death|2|||
126359741|NCT03892915|454609060|FG000|Overall Study|Withdrawal by Subject|1|||
126359742|NCT03892915|454609061|FG001|Overall Study|Withdrawal by Subject|1|||
126359743|NCT03892915|454609060|FG000|Overall Study|unsuccessful delivery|13|||
126359744|NCT03892915|454609061|FG001|Overall Study|unsuccessful delivery|18|||
126359745|NCT01181128|454609062|FG000|Overall Study|Withdrawal by Subject|2|||
126763723|NCT01195662|456086855|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
126763724|NCT01195662|456086853|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
126763725|NCT01195662|456086854|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
126763726|NCT01195662|456086855|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
126763727|NCT01195662|456086853|FG000|Double Blind Treatment Period|Non-specified|3|||
126763728|NCT01195662|456086854|FG001|Double Blind Treatment Period|Non-specified|0|||
126763729|NCT01195662|456086855|FG002|Double Blind Treatment Period|Non-specified|0|||
126763730|NCT01195662|456086853|FG000|Double Blind Treatment Period|Missing disposition information|0|||
126700561|NCT01307423|455853612|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126700562|NCT01307423|455853613|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126700563|NCT01307423|455853614|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126700564|NCT01307423|455853615|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126700565|NCT01307423|455853616|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126700566|NCT01307423|455853608|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126763731|NCT01195662|456086854|FG001|Double Blind Treatment Period|Missing disposition information|1|||
126763732|NCT01195662|456086855|FG002|Double Blind Treatment Period|Missing disposition information|1|||
126763733|NCT01195662|456086853|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
126763734|NCT01195662|456086854|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
126763735|NCT01195662|456086855|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
126763736|NCT01195662|456086853|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
126763737|NCT01195662|456086854|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
126763738|NCT01195662|456086855|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
126763739|NCT01215968|456086856|FG000|Overall Study|Adverse Event|0|||
126763740|NCT01215968|456086857|FG001|Overall Study|Adverse Event|2|||
126763741|NCT01215968|456086856|FG000|Overall Study|Protocol Violation|2|||
126763742|NCT01215968|456086857|FG001|Overall Study|Protocol Violation|4|||
126763743|NCT01215968|456086856|FG000|Overall Study|Not received study drug|0|||
126763744|NCT01215968|456086857|FG001|Overall Study|Not received study drug|1|||
126763745|NCT01250418|456086864|FG000|Overall Study|monitor data failure|1|||
126763746|NCT01250418|456086865|FG001|Overall Study|monitor data failure|1|||
126763747|NCT01761565|456086866|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
126763748|NCT05182840|456086869|FG000|Run-in Period|Not treated|0|||
126763749|NCT05182840|456086870|FG001|Run-in Period|Not treated|1|||
126763750|NCT05182840|456086871|FG002|Run-in Period|Not treated|0|||
126763751|NCT05182840|456086872|FG003|Run-in Period|Not treated|0|||
126763752|NCT05182840|456086873|FG004|Run-in Period|Not treated|0|||
126452178|NCT02059291|454957153|FG012|Epoch 4|Adverse Event|0|||
126452179|NCT02059291|454957154|FG013|Epoch 4|Adverse Event|0|||
126700567|NCT01307423|455853609|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
126700568|NCT01307423|455853610|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
126700569|NCT01307423|455853611|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126700570|NCT01307423|455853612|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126700571|NCT01307423|455853613|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126700572|NCT01307423|455853614|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126700573|NCT01307423|455853615|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126700574|NCT01307423|455853616|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
126700575|NCT01307423|455853608|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
126700576|NCT01307423|455853609|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
126700577|NCT01307423|455853610|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
126700578|NCT01307423|455853611|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
126700579|NCT01307423|455853612|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
126700580|NCT01307423|455853613|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
126700581|NCT01307423|455853614|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
126700582|NCT01307423|455853615|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
126700583|NCT01307423|455853616|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
126452180|NCT02059291|454957155|FG014|Epoch 4|Adverse Event|0|||
126452181|NCT02059291|454957156|FG015|Epoch 4|Adverse Event|0|||
126452182|NCT02059291|454957157|FG016|Epoch 4|Adverse Event|1|||
126452183|NCT02059291|454957158|FG017|Epoch 4|Adverse Event|0|||
126452184|NCT02059291|454957159|FG018|Epoch 4|Adverse Event|0|||
126452185|NCT02059291|454957160|FG019|Epoch 4|Adverse Event|0|||
126452186|NCT02059291|454957161|FG020|Epoch 4|Adverse Event|0|||
126452187|NCT02059291|454957162|FG021|Epoch 4|Adverse Event|0|||
126452188|NCT02059291|454957163|FG022|Epoch 4|Adverse Event|1|||
126546930|NCT04498247|455296084|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
126700584|NCT01307423|455853608|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
126700585|NCT01307423|455853609|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
126452189|NCT02059291|454957164|FG023|Epoch 4|Adverse Event|0|||
126452190|NCT02059291|454957165|FG024|Epoch 4|Adverse Event|0|||
126452191|NCT02059291|454957141|FG000|Epoch 4|Pregnancy|0|||
126452192|NCT02059291|454957142|FG001|Epoch 4|Pregnancy|0|||
126452193|NCT02059291|454957143|FG002|Epoch 4|Pregnancy|0|||
126262973|NCT00892281|454254552|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
126262974|NCT00892281|454254553|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
126262975|NCT00892281|454254552|FG000|Overall Study|Final visit completed 4 weeks late|0|||
126262976|NCT00892281|454254553|FG001|Overall Study|Final visit completed 4 weeks late|1|||
126262977|NCT00892281|454254552|FG000|Overall Study|Subject completed day after study closed|1|||
126262978|NCT00892281|454254553|FG001|Overall Study|Subject completed day after study closed|0|||
126262979|NCT00892281|454254552|FG000|Overall Study|Family emergency|1|||
126262980|NCT00892281|454254553|FG001|Overall Study|Family emergency|0|||
126262981|NCT00892281|454254552|FG000|Overall Study|Last visit not done - death in family|1|||
126262982|NCT00892281|454254553|FG001|Overall Study|Last visit not done - death in family|0|||
126262983|NCT00892281|454254552|FG000|Overall Study|Did not meet incl/excl criteria|1|||
126262984|NCT00892281|454254553|FG001|Overall Study|Did not meet incl/excl criteria|0|||
126262985|NCT00892281|454254552|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
126262986|NCT00892281|454254553|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
126262987|NCT00892281|454254552|FG000|Overall Study|Unable to redeem the drug voucher|1|||
126262988|NCT00892281|454254553|FG001|Overall Study|Unable to redeem the drug voucher|0|||
126262989|NCT00892281|454254552|FG000|Overall Study|Subject not good candidate for study|1|||
126262990|NCT00892281|454254553|FG001|Overall Study|Subject not good candidate for study|0|||
126262991|NCT00892281|454254552|FG000|Overall Study|Subject did not return for any visits|1|||
126262992|NCT00892281|454254553|FG001|Overall Study|Subject did not return for any visits|0|||
126262993|NCT00892281|454254552|FG000|Overall Study|Subject missed several visits/lost meds|1|||
126262994|NCT00892281|454254553|FG001|Overall Study|Subject missed several visits/lost meds|0|||
126262995|NCT00892281|454254552|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
126262996|NCT00892281|454254553|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
126262997|NCT00892281|454254552|FG000|Overall Study|Scheduled for knee replacement|0|||
126262998|NCT00892281|454254553|FG001|Overall Study|Scheduled for knee replacement|1|||
126262999|NCT00892281|454254552|FG000|Overall Study|PI complained of inadequate compensation|3|||
126263000|NCT00892281|454254553|FG001|Overall Study|PI complained of inadequate compensation|0|||
126263001|NCT00892281|454254552|FG000|Overall Study|Subject lost interest in program|0|||
126263002|NCT00892281|454254553|FG001|Overall Study|Subject lost interest in program|1|||
126263003|NCT00892281|454254552|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
126263004|NCT00892281|454254553|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
126263005|NCT00892281|454254552|FG000|Overall Study|Death in family|1|||
126263006|NCT00892281|454254553|FG001|Overall Study|Death in family|0|||
126263007|NCT00892281|454254552|FG000|Overall Study|Lack of efficacy of study product|2|||
126263008|NCT00892281|454254553|FG001|Overall Study|Lack of efficacy of study product|0|||
126263009|NCT00892281|454254552|FG000|Overall Study|Subject not seen by PI at final visit|1|||
126263010|NCT00892281|454254553|FG001|Overall Study|Subject not seen by PI at final visit|0|||
126263011|NCT00892281|454254552|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
126263012|NCT00892281|454254553|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
126263013|NCT00892281|454254552|FG000|Overall Study|Missed multiple visits|1|||
126263014|NCT00892281|454254553|FG001|Overall Study|Missed multiple visits|0|||
126263015|NCT00892281|454254552|FG000|Overall Study|Missed visits rescheduled out of window|1|||
126263016|NCT00892281|454254553|FG001|Overall Study|Missed visits rescheduled out of window|0|||
126263017|NCT00892281|454254552|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
126263018|NCT00892281|454254553|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
126263019|NCT00892281|454254552|FG000|Overall Study|Subject had history of drug abuse|1|||
126263020|NCT00892281|454254553|FG001|Overall Study|Subject had history of drug abuse|0|||
126263021|NCT00892281|454254552|FG000|Overall Study|Rash on hand|1|||
126263022|NCT00892281|454254553|FG001|Overall Study|Rash on hand|0|||
126263023|NCT00892281|454254552|FG000|Overall Study|Visit 4 date out of window|1|||
126263024|NCT00892281|454254553|FG001|Overall Study|Visit 4 date out of window|0|||
126263025|NCT00865098|454254556|FG000|Overall Study|Progressive disease|1|||
126263026|NCT03702049|454254563|FG000|Overall Study|Lost to Follow-up|4|||
126263027|NCT03702049|454254563|FG000|Overall Study|Physician Decision|1|||
126263028|NCT01833533|454254564|FG000|Overall Study|Adverse Event|0|||
126263029|NCT01833533|454254565|FG001|Overall Study|Adverse Event|1|||
126359746|NCT01181128|454609063|FG001|Overall Study|Withdrawal by Subject|2|||
126263030|NCT01833533|454254564|FG000|Overall Study|Lost to Follow-up|4|||
126359747|NCT01181128|454609064|FG002|Overall Study|Withdrawal by Subject|0|||
126359748|NCT01181128|454609062|FG000|Overall Study|Death|1|||
126359749|NCT01181128|454609063|FG001|Overall Study|Death|0|||
126359750|NCT01181128|454609064|FG002|Overall Study|Death|0|||
126263031|NCT01833533|454254565|FG001|Overall Study|Lost to Follow-up|9|||
126263032|NCT01833533|454254564|FG000|Overall Study|To Enter an Extension Study|0|||
126263033|NCT01833533|454254565|FG001|Overall Study|To Enter an Extension Study|4|||
126263034|NCT01833533|454254564|FG000|Overall Study|Other|2|||
126263035|NCT01833533|454254565|FG001|Overall Study|Other|7|||
126263036|NCT01048502|454254566|FG000|Overall Study|Lost to Follow-up|2|||
126263037|NCT01048502|454254567|FG001|Overall Study|Lost to Follow-up|0|||
126359751|NCT01181128|454609062|FG000|Overall Study|Physician Decision|2|||
126700586|NCT01307423|455853610|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
126763753|NCT05182840|456086874|FG005|Run-in Period|Not treated|0|||
126763754|NCT05182840|456086875|FG006|Run-in Period|Not treated|0|||
126763755|NCT05182840|456086876|FG007|Run-in Period|Not treated|0|||
126763756|NCT05182840|456086877|FG008|Run-in Period|Not treated|0|||
126763757|NCT05182840|456086878|FG009|Run-in Period|Not treated|0|||
126763758|NCT05182840|456086869|FG000|Run-in Period|Other reason but not sponsor termination|14|||
126763759|NCT05182840|456086870|FG001|Run-in Period|Other reason but not sponsor termination|18|||
126763760|NCT05182840|456086871|FG002|Run-in Period|Other reason but not sponsor termination|0|||
126763761|NCT05182840|456086872|FG003|Run-in Period|Other reason but not sponsor termination|0|||
126763762|NCT05182840|456086873|FG004|Run-in Period|Other reason but not sponsor termination|0|||
126763763|NCT05182840|456086874|FG005|Run-in Period|Other reason but not sponsor termination|0|||
126359752|NCT01181128|454609063|FG001|Overall Study|Physician Decision|0|||
126359753|NCT01181128|454609064|FG002|Overall Study|Physician Decision|0|||
126359754|NCT01181128|454609062|FG000|Overall Study|Adverse Event|0|||
126359755|NCT01181128|454609063|FG001|Overall Study|Adverse Event|2|||
126359756|NCT01181128|454609064|FG002|Overall Study|Adverse Event|0|||
126359757|NCT01181128|454609062|FG000|Overall Study|Other|1|||
126359758|NCT01181128|454609063|FG001|Overall Study|Other|1|||
126359759|NCT01181128|454609064|FG002|Overall Study|Other|1|||
126359760|NCT01362270|454609067|FG000|Overall Study|Withdrawal by Subject|1|||
126452194|NCT02059291|454957144|FG003|Epoch 4|Pregnancy|0|||
126452195|NCT02059291|454957145|FG004|Epoch 4|Pregnancy|0|||
126452196|NCT02059291|454957146|FG005|Epoch 4|Pregnancy|0|||
126452197|NCT02059291|454957147|FG006|Epoch 4|Pregnancy|0|||
126452198|NCT02059291|454957148|FG007|Epoch 4|Pregnancy|0|||
126452199|NCT02059291|454957149|FG008|Epoch 4|Pregnancy|0|||
126452200|NCT02059291|454957150|FG009|Epoch 4|Pregnancy|0|||
126452201|NCT02059291|454957151|FG010|Epoch 4|Pregnancy|0|||
126452202|NCT02059291|454957152|FG011|Epoch 4|Pregnancy|0|||
126452203|NCT02059291|454957153|FG012|Epoch 4|Pregnancy|0|||
126452204|NCT02059291|454957154|FG013|Epoch 4|Pregnancy|0|||
126452205|NCT02059291|454957155|FG014|Epoch 4|Pregnancy|0|||
126452206|NCT02059291|454957156|FG015|Epoch 4|Pregnancy|0|||
126452207|NCT02059291|454957157|FG016|Epoch 4|Pregnancy|1|||
126452208|NCT02059291|454957158|FG017|Epoch 4|Pregnancy|0|||
126452209|NCT02059291|454957159|FG018|Epoch 4|Pregnancy|0|||
126452210|NCT02059291|454957160|FG019|Epoch 4|Pregnancy|0|||
126452211|NCT02059291|454957161|FG020|Epoch 4|Pregnancy|0|||
126452212|NCT02059291|454957162|FG021|Epoch 4|Pregnancy|0|||
126452213|NCT02059291|454957163|FG022|Epoch 4|Pregnancy|0|||
126452214|NCT02059291|454957164|FG023|Epoch 4|Pregnancy|0|||
126452215|NCT02059291|454957165|FG024|Epoch 4|Pregnancy|0|||
126452216|NCT02059291|454957141|FG000|Epoch 4|Withdrawal by Subject|0|||
126452217|NCT02059291|454957142|FG001|Epoch 4|Withdrawal by Subject|0|||
126700587|NCT01307423|455853611|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
126700588|NCT01307423|455853612|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
126700589|NCT01307423|455853613|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
126700590|NCT01307423|455853614|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
126700591|NCT01307423|455853615|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
126700592|NCT01307423|455853616|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
126700593|NCT01307423|455853608|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126700594|NCT01307423|455853609|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126700595|NCT01307423|455853610|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126700596|NCT01307423|455853611|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126700597|NCT01307423|455853612|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126700598|NCT01307423|455853613|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
126700599|NCT01307423|455853614|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126700600|NCT01307423|455853615|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126700601|NCT01307423|455853616|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
126700602|NCT01307423|455853608|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
126700603|NCT01307423|455853609|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
126763764|NCT05182840|456086875|FG006|Run-in Period|Other reason but not sponsor termination|0|||
126763765|NCT05182840|456086876|FG007|Run-in Period|Other reason but not sponsor termination|0|||
126359761|NCT01362270|454609068|FG001|Overall Study|Withdrawal by Subject|0|||
126359762|NCT01362270|454609067|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
126359763|NCT01362270|454609068|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
126452218|NCT02059291|454957143|FG002|Epoch 4|Withdrawal by Subject|0|||
126452219|NCT02059291|454957144|FG003|Epoch 4|Withdrawal by Subject|0|||
126452220|NCT02059291|454957145|FG004|Epoch 4|Withdrawal by Subject|0|||
126452221|NCT02059291|454957146|FG005|Epoch 4|Withdrawal by Subject|0|||
126452222|NCT02059291|454957147|FG006|Epoch 4|Withdrawal by Subject|0|||
126452223|NCT02059291|454957148|FG007|Epoch 4|Withdrawal by Subject|0|||
126452224|NCT02059291|454957149|FG008|Epoch 4|Withdrawal by Subject|0|||
126452225|NCT02059291|454957150|FG009|Epoch 4|Withdrawal by Subject|0|||
126452226|NCT02059291|454957151|FG010|Epoch 4|Withdrawal by Subject|0|||
126452227|NCT02059291|454957152|FG011|Epoch 4|Withdrawal by Subject|0|||
126452228|NCT02059291|454957153|FG012|Epoch 4|Withdrawal by Subject|0|||
126763766|NCT05182840|456086877|FG008|Run-in Period|Other reason but not sponsor termination|0|||
126763767|NCT05182840|456086878|FG009|Run-in Period|Other reason but not sponsor termination|0|||
126763768|NCT05182840|456086869|FG000|Run-in Period|No reason available|2|||
126763769|NCT05182840|456086870|FG001|Run-in Period|No reason available|2|||
126763770|NCT05182840|456086871|FG002|Run-in Period|No reason available|0|||
126763771|NCT05182840|456086872|FG003|Run-in Period|No reason available|0|||
126763772|NCT05182840|456086873|FG004|Run-in Period|No reason available|0|||
126763773|NCT05182840|456086874|FG005|Run-in Period|No reason available|0|||
126763774|NCT05182840|456086875|FG006|Run-in Period|No reason available|0|||
126763775|NCT05182840|456086876|FG007|Run-in Period|No reason available|0|||
126763776|NCT05182840|456086877|FG008|Run-in Period|No reason available|0|||
126763777|NCT05182840|456086878|FG009|Run-in Period|No reason available|0|||
126763778|NCT05182840|456086869|FG000|Run-in Period|Burden of study procedures|2|||
126763779|NCT05182840|456086870|FG001|Run-in Period|Burden of study procedures|2|||
126763780|NCT05182840|456086871|FG002|Run-in Period|Burden of study procedures|0|||
126763781|NCT05182840|456086872|FG003|Run-in Period|Burden of study procedures|0|||
126763782|NCT05182840|456086873|FG004|Run-in Period|Burden of study procedures|0|||
126763783|NCT05182840|456086874|FG005|Run-in Period|Burden of study procedures|0|||
126763784|NCT05182840|456086875|FG006|Run-in Period|Burden of study procedures|0|||
126763785|NCT05182840|456086876|FG007|Run-in Period|Burden of study procedures|0|||
126763786|NCT05182840|456086877|FG008|Run-in Period|Burden of study procedures|0|||
126263038|NCT01048502|454254568|FG002|Overall Study|Lost to Follow-up|0|||
126263039|NCT01048502|454254569|FG003|Overall Study|Lost to Follow-up|0|||
126263040|NCT01048502|454254566|FG000|Overall Study|Adverse Event|1|||
126263041|NCT01048502|454254567|FG001|Overall Study|Adverse Event|0|||
126263042|NCT01048502|454254568|FG002|Overall Study|Adverse Event|0|||
126263043|NCT01048502|454254569|FG003|Overall Study|Adverse Event|0|||
126263044|NCT01048502|454254566|FG000|Overall Study|Withdrawal by Subject|1|||
126263045|NCT01048502|454254567|FG001|Overall Study|Withdrawal by Subject|4|||
126263046|NCT01048502|454254568|FG002|Overall Study|Withdrawal by Subject|5|||
126263047|NCT01048502|454254569|FG003|Overall Study|Withdrawal by Subject|3|||
126263048|NCT01048502|454254566|FG000|Overall Study|Physician Decision|0|||
126263049|NCT01048502|454254567|FG001|Overall Study|Physician Decision|3|||
126452229|NCT02059291|454957154|FG013|Epoch 4|Withdrawal by Subject|0|||
126452230|NCT02059291|454957155|FG014|Epoch 4|Withdrawal by Subject|0|||
126452231|NCT02059291|454957156|FG015|Epoch 4|Withdrawal by Subject|0|||
126452232|NCT02059291|454957157|FG016|Epoch 4|Withdrawal by Subject|0|||
126452233|NCT02059291|454957158|FG017|Epoch 4|Withdrawal by Subject|0|||
126452234|NCT02059291|454957159|FG018|Epoch 4|Withdrawal by Subject|0|||
126452235|NCT02059291|454957160|FG019|Epoch 4|Withdrawal by Subject|0|||
126452236|NCT02059291|454957161|FG020|Epoch 4|Withdrawal by Subject|1|||
126452237|NCT02059291|454957162|FG021|Epoch 4|Withdrawal by Subject|0|||
126452238|NCT02059291|454957163|FG022|Epoch 4|Withdrawal by Subject|0|||
126452239|NCT02059291|454957164|FG023|Epoch 4|Withdrawal by Subject|0|||
126452240|NCT02059291|454957165|FG024|Epoch 4|Withdrawal by Subject|0|||
126452241|NCT02059291|454957141|FG000|Epoch 4|Lack of Efficacy|0|||
126452242|NCT02059291|454957142|FG001|Epoch 4|Lack of Efficacy|0|||
126452243|NCT02059291|454957143|FG002|Epoch 4|Lack of Efficacy|0|||
126452244|NCT02059291|454957144|FG003|Epoch 4|Lack of Efficacy|0|||
126452245|NCT02059291|454957145|FG004|Epoch 4|Lack of Efficacy|0|||
126452246|NCT02059291|454957146|FG005|Epoch 4|Lack of Efficacy|0|||
126452247|NCT02059291|454957147|FG006|Epoch 4|Lack of Efficacy|0|||
126452248|NCT02059291|454957148|FG007|Epoch 4|Lack of Efficacy|0|||
126452249|NCT02059291|454957149|FG008|Epoch 4|Lack of Efficacy|0|||
126452250|NCT02059291|454957150|FG009|Epoch 4|Lack of Efficacy|0|||
126452251|NCT02059291|454957151|FG010|Epoch 4|Lack of Efficacy|0|||
126452252|NCT02059291|454957152|FG011|Epoch 4|Lack of Efficacy|0|||
126452253|NCT02059291|454957153|FG012|Epoch 4|Lack of Efficacy|0|||
126452254|NCT02059291|454957154|FG013|Epoch 4|Lack of Efficacy|0|||
126452255|NCT02059291|454957155|FG014|Epoch 4|Lack of Efficacy|0|||
126452256|NCT02059291|454957156|FG015|Epoch 4|Lack of Efficacy|0|||
126452257|NCT02059291|454957157|FG016|Epoch 4|Lack of Efficacy|0|||
126263050|NCT01048502|454254568|FG002|Overall Study|Physician Decision|0|||
126263051|NCT01048502|454254569|FG003|Overall Study|Physician Decision|1|||
126263052|NCT01138826|454254570|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
126452258|NCT02059291|454957158|FG017|Epoch 4|Lack of Efficacy|0|||
126763787|NCT05182840|456086878|FG009|Run-in Period|Burden of study procedures|0|||
126763788|NCT05182840|456086869|FG000|Run-in Period|Change of residence|1|||
126263053|NCT01138826|454254571|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
126263054|NCT01138826|454254572|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
126452259|NCT02059291|454957159|FG018|Epoch 4|Lack of Efficacy|0|||
126452260|NCT02059291|454957160|FG019|Epoch 4|Lack of Efficacy|0|||
126452261|NCT02059291|454957161|FG020|Epoch 4|Lack of Efficacy|0|||
126452262|NCT02059291|454957162|FG021|Epoch 4|Lack of Efficacy|0|||
126452263|NCT02059291|454957163|FG022|Epoch 4|Lack of Efficacy|0|||
126452264|NCT02059291|454957164|FG023|Epoch 4|Lack of Efficacy|1|||
126452265|NCT02059291|454957165|FG024|Epoch 4|Lack of Efficacy|0|||
126452266|NCT01433289|454957166|FG000|Overall Study|Pregnancy|0|||
126452267|NCT01433289|454957167|FG001|Overall Study|Pregnancy|1|||
126452268|NCT01433289|454957168|FG002|Overall Study|Pregnancy|0|||
126452269|NCT01433289|454957169|FG003|Overall Study|Pregnancy|0|||
126763789|NCT05182840|456086870|FG001|Run-in Period|Change of residence|0|||
126763790|NCT05182840|456086871|FG002|Run-in Period|Change of residence|0|||
126763791|NCT05182840|456086872|FG003|Run-in Period|Change of residence|0|||
126763792|NCT05182840|456086873|FG004|Run-in Period|Change of residence|0|||
126763793|NCT05182840|456086874|FG005|Run-in Period|Change of residence|0|||
126763794|NCT05182840|456086875|FG006|Run-in Period|Change of residence|0|||
126763795|NCT05182840|456086876|FG007|Run-in Period|Change of residence|0|||
126263055|NCT01138826|454254573|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
126263056|NCT01138826|454254574|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
126263057|NCT01138826|454254575|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
126263058|NCT05206448|454254576|FG000|Overall Study|Lost to Follow-up|2|||
126263059|NCT05206448|454254577|FG001|Overall Study|Lost to Follow-up|2|||
126263060|NCT05206448|454254576|FG000|Overall Study|Withdrawal by Subject|2|||
126263061|NCT05206448|454254577|FG001|Overall Study|Withdrawal by Subject|0|||
126263062|NCT05206448|454254576|FG000|Overall Study|found ineligible after randomization|1|||
126263063|NCT05206448|454254577|FG001|Overall Study|found ineligible after randomization|1|||
126263064|NCT05206448|454254576|FG000|Overall Study|unable to complete study due to personal constraints|1|||
126263065|NCT05206448|454254577|FG001|Overall Study|unable to complete study due to personal constraints|0|||
126263066|NCT05206448|454254576|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
126263067|NCT05206448|454254577|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
126263068|NCT01333072|454254581|FG000|Overall Study|Lost to Follow-up|3|||
126263069|NCT01333072|454254582|FG001|Overall Study|Lost to Follow-up|0|||
126263070|NCT01333072|454254581|FG000|Overall Study|Adverse Event|2|||
126263071|NCT01333072|454254582|FG001|Overall Study|Adverse Event|4|||
126263072|NCT01333072|454254581|FG000|Overall Study|Physician Decision|1|||
126263073|NCT01333072|454254582|FG001|Overall Study|Physician Decision|0|||
126263074|NCT02457611|454254584|FG000|Overall Study|Lost to Follow-up|3|||
126263075|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
126263076|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
126359764|NCT01362270|454609067|FG000|Overall Study|Met excl. criteria before 1st session|1|||
126359765|NCT01362270|454609068|FG001|Overall Study|Met excl. criteria before 1st session|1|||
126359766|NCT02318277|454609069|FG000|Overall Study|Physician Decision|0|||
126359767|NCT02318277|454609070|FG001|Overall Study|Physician Decision|0|||
126359768|NCT02318277|454609071|FG002|Overall Study|Physician Decision|0|||
126359769|NCT02318277|454609072|FG003|Overall Study|Physician Decision|0|||
126359770|NCT02318277|454609073|FG004|Overall Study|Physician Decision|0|||
126359771|NCT02318277|454609074|FG005|Overall Study|Physician Decision|0|||
126359772|NCT02318277|454609075|FG006|Overall Study|Physician Decision|0|||
126359773|NCT02318277|454609076|FG007|Overall Study|Physician Decision|1|||
126359774|NCT02318277|454609069|FG000|Overall Study|Other|0|||
126359775|NCT02318277|454609070|FG001|Overall Study|Other|0|||
126359776|NCT02318277|454609071|FG002|Overall Study|Other|0|||
126359777|NCT02318277|454609072|FG003|Overall Study|Other|0|||
126359778|NCT02318277|454609073|FG004|Overall Study|Other|0|||
126359779|NCT02318277|454609074|FG005|Overall Study|Other|0|||
126359780|NCT02318277|454609075|FG006|Overall Study|Other|1|||
126359781|NCT02318277|454609076|FG007|Overall Study|Other|0|||
126359782|NCT02318277|454609069|FG000|Overall Study|Withdrawal by Subject|0|||
126359783|NCT02318277|454609070|FG001|Overall Study|Withdrawal by Subject|0|||
126359784|NCT02318277|454609071|FG002|Overall Study|Withdrawal by Subject|1|||
126359785|NCT02318277|454609072|FG003|Overall Study|Withdrawal by Subject|0|||
126359786|NCT02318277|454609073|FG004|Overall Study|Withdrawal by Subject|1|||
126359787|NCT02318277|454609074|FG005|Overall Study|Withdrawal by Subject|1|||
126359788|NCT02318277|454609075|FG006|Overall Study|Withdrawal by Subject|6|||
126359789|NCT02318277|454609076|FG007|Overall Study|Withdrawal by Subject|14|||
126359790|NCT02318277|454609069|FG000|Overall Study|Participant trial terminated by sponsor|0|||
126359791|NCT02318277|454609070|FG001|Overall Study|Participant trial terminated by sponsor|0|||
126359792|NCT02318277|454609071|FG002|Overall Study|Participant trial terminated by sponsor|1|||
126359793|NCT02318277|454609072|FG003|Overall Study|Participant trial terminated by sponsor|0|||
126359794|NCT02318277|454609073|FG004|Overall Study|Participant trial terminated by sponsor|1|||
126359795|NCT02318277|454609074|FG005|Overall Study|Participant trial terminated by sponsor|2|||
126359796|NCT02318277|454609075|FG006|Overall Study|Participant trial terminated by sponsor|5|||
126359797|NCT02318277|454609076|FG007|Overall Study|Participant trial terminated by sponsor|16|||
126359798|NCT02318277|454609069|FG000|Overall Study|Lost to Follow-up|1|||
126359799|NCT02318277|454609070|FG001|Overall Study|Lost to Follow-up|0|||
126359800|NCT02318277|454609071|FG002|Overall Study|Lost to Follow-up|1|||
126452270|NCT03241368|454957170|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
126452271|NCT03241368|454957170|FG000|Overall Study|Lost to Follow-up|1|||
126452272|NCT03241368|454957170|FG000|Overall Study|Physician Decision|6|||
126452273|NCT03241368|454957170|FG000|Overall Study|Withdrawal by Subject|6|||
126763796|NCT05182840|456086877|FG008|Run-in Period|Change of residence|0|||
126263077|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
126359801|NCT02318277|454609072|FG003|Overall Study|Lost to Follow-up|0|||
126359802|NCT02318277|454609073|FG004|Overall Study|Lost to Follow-up|0|||
126359803|NCT02318277|454609074|FG005|Overall Study|Lost to Follow-up|0|||
126546931|NCT04498247|455296085|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
126263078|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
126263079|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
126263080|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
126263081|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
126263082|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
126263083|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
126700604|NCT01307423|455853610|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
126700605|NCT01307423|455853611|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
126700606|NCT01307423|455853612|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
126700607|NCT01307423|455853613|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
126700608|NCT01307423|455853614|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
126700609|NCT01307423|455853615|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
126700610|NCT01307423|455853616|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
126700611|NCT01307423|455853608|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126263084|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
126263085|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
126263086|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
126263087|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
126263088|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
126263089|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
126263090|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
126263091|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
126263092|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
126263093|NCT00384293|454254585|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
126263094|NCT00384293|454254586|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
126263095|NCT00384293|454254587|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
126263096|NCT00384293|454254585|FG000|Post-randomization Period|Adverse Event|0|||
126263097|NCT00384293|454254586|FG001|Post-randomization Period|Adverse Event|23|||
126263098|NCT00384293|454254587|FG002|Post-randomization Period|Adverse Event|7|||
126263099|NCT00384293|454254585|FG000|Post-randomization Period|Lost to Follow-up|0|||
126263100|NCT00384293|454254586|FG001|Post-randomization Period|Lost to Follow-up|2|||
126263101|NCT00384293|454254587|FG002|Post-randomization Period|Lost to Follow-up|1|||
126263102|NCT00384293|454254585|FG000|Post-randomization Period|Protocol Violation|0|||
126263103|NCT00384293|454254586|FG001|Post-randomization Period|Protocol Violation|1|||
126263104|NCT00384293|454254587|FG002|Post-randomization Period|Protocol Violation|0|||
126263105|NCT00384293|454254585|FG000|Post-randomization Period|Withdrawal by Subject|0|||
126263106|NCT00384293|454254586|FG001|Post-randomization Period|Withdrawal by Subject|8|||
126263107|NCT00384293|454254587|FG002|Post-randomization Period|Withdrawal by Subject|6|||
126263108|NCT00384293|454254585|FG000|Post-randomization Period|Trial Termination|0|||
126263109|NCT00384293|454254586|FG001|Post-randomization Period|Trial Termination|180|||
126263110|NCT00384293|454254587|FG002|Post-randomization Period|Trial Termination|204|||
126263111|NCT00384293|454254585|FG000|Post-randomization Period|Patient Randomized in Error|0|||
126263112|NCT00384293|454254586|FG001|Post-randomization Period|Patient Randomized in Error|0|||
126263113|NCT00384293|454254587|FG002|Post-randomization Period|Patient Randomized in Error|1|||
126263114|NCT00619359|454254588|FG000|Overall Study|Adverse Event|32|||
126263115|NCT00619359|454254589|FG001|Overall Study|Adverse Event|36|||
126263116|NCT00619359|454254588|FG000|Overall Study|Lost to Follow-up|12|||
126263117|NCT00619359|454254589|FG001|Overall Study|Lost to Follow-up|16|||
126263118|NCT00619359|454254588|FG000|Overall Study|Physician Decision|0|||
126263119|NCT00619359|454254589|FG001|Overall Study|Physician Decision|7|||
126263120|NCT00619359|454254588|FG000|Overall Study|Protocol Violation|1|||
126359804|NCT02318277|454609075|FG006|Overall Study|Lost to Follow-up|3|||
126359805|NCT02318277|454609076|FG007|Overall Study|Lost to Follow-up|4|||
126359806|NCT02318277|454609069|FG000|Overall Study|Death|5|||
126359807|NCT02318277|454609070|FG001|Overall Study|Death|3|||
126359808|NCT02318277|454609071|FG002|Overall Study|Death|1|||
126359809|NCT02318277|454609072|FG003|Overall Study|Death|4|||
126359810|NCT02318277|454609073|FG004|Overall Study|Death|6|||
126359811|NCT02318277|454609074|FG005|Overall Study|Death|5|||
126359812|NCT02318277|454609075|FG006|Overall Study|Death|34|||
126359813|NCT02318277|454609076|FG007|Overall Study|Death|58|||
126359814|NCT02318277|454609069|FG000|Overall Study|Transitioned to Hospice|0|||
126359815|NCT02318277|454609070|FG001|Overall Study|Transitioned to Hospice|0|||
126359816|NCT02318277|454609071|FG002|Overall Study|Transitioned to Hospice|0|||
126359817|NCT02318277|454609072|FG003|Overall Study|Transitioned to Hospice|0|||
126359818|NCT02318277|454609073|FG004|Overall Study|Transitioned to Hospice|0|||
126546932|NCT04498247|455296086|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
126700612|NCT01307423|455853609|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126263121|NCT00619359|454254589|FG001|Overall Study|Protocol Violation|1|||
126263122|NCT00619359|454254588|FG000|Overall Study|Withdrawal by Subject|19|||
126263123|NCT00619359|454254589|FG001|Overall Study|Withdrawal by Subject|20|||
126263124|NCT00619359|454254588|FG000|Overall Study|Progressive Disease|3|||
126263125|NCT00619359|454254589|FG001|Overall Study|Progressive Disease|1|||
126263126|NCT02502734|454254590|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
126263127|NCT02502734|454254591|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
126263128|NCT02502734|454254590|FG000|Washout Period|Adverse Event|1|||
126263129|NCT02502734|454254591|FG001|Washout Period|Adverse Event|0|||
126263130|NCT02280187|454254594|FG000|Overall Study|Lost to Follow-up|218|||
126263131|NCT02094261|454254595|FG000|Overall Study|Death|24|||
126263132|NCT02094261|454254595|FG000|Overall Study|Lost to Follow-up|1|||
126263133|NCT02094261|454254595|FG000|Overall Study|Withdrawal by Subject|4|||
126263134|NCT02094261|454254595|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
126263135|NCT04668274|454254596|FG000|Part 1 Study Period 1|Adverse Event|3|||
126263136|NCT04668274|454254597|FG001|Part 1 Study Period 1|Adverse Event|0|||
126263137|NCT04668274|454254598|FG002|Part 1 Study Period 1|Adverse Event|0|||
126263138|NCT04668274|454254599|FG003|Part 1 Study Period 1|Adverse Event|0|||
126263139|NCT04668274|454254596|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
126263140|NCT04668274|454254597|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
126263141|NCT04668274|454254598|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
126263142|NCT04668274|454254599|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
126263143|NCT04668274|454254596|FG000|Part 1 Study Period 2|Other|0|||
126263144|NCT04668274|454254597|FG001|Part 1 Study Period 2|Other|1|||
126263145|NCT04668274|454254598|FG002|Part 1 Study Period 2|Other|0|||
126263146|NCT04668274|454254599|FG003|Part 1 Study Period 2|Other|0|||
126263147|NCT04668274|454254596|FG000|Part 1 Study Period 3|Adverse Event|0|||
126263148|NCT04668274|454254597|FG001|Part 1 Study Period 3|Adverse Event|0|||
126263149|NCT04668274|454254598|FG002|Part 1 Study Period 3|Adverse Event|1|||
126263150|NCT04668274|454254599|FG003|Part 1 Study Period 3|Adverse Event|0|||
126263151|NCT04668274|454254596|FG000|Part 1 Study Period 3|Other|0|||
126263152|NCT04668274|454254597|FG001|Part 1 Study Period 3|Other|0|||
126263153|NCT04668274|454254598|FG002|Part 1 Study Period 3|Other|2|||
126263154|NCT04668274|454254599|FG003|Part 1 Study Period 3|Other|0|||
126263155|NCT04668274|454254596|FG000|Part 2 Study Period 4|Other|0|||
126263156|NCT04668274|454254597|FG001|Part 2 Study Period 4|Other|0|||
126263157|NCT04668274|454254598|FG002|Part 2 Study Period 4|Other|0|||
126263158|NCT04668274|454254599|FG003|Part 2 Study Period 4|Other|1|||
126263159|NCT02363439|454254600|FG000|Overall Study|Lack of Efficacy|4|||
126263160|NCT00508027|454254601|FG000|Dose Level 1|Lost to Follow-up|4|||
126263161|NCT00508027|454254601|FG000|Dose Level 1|Withdrawal by Subject|2|||
126263162|NCT00508027|454254601|FG000|Dose Level 1|Physician Decision|2|||
126263163|NCT00508027|454254601|FG000|Dose Level 2|Lost to Follow-up|2|||
126263164|NCT00508027|454254601|FG000|Dose Level 2|Withdrawal by Subject|2|||
126263165|NCT01832402|454254604|FG000|Overall Study|Lost to Follow-up|2|||
126263166|NCT01832402|454254605|FG001|Overall Study|Lost to Follow-up|0|||
126263167|NCT01832402|454254604|FG000|Overall Study|Withdrawal by Subject|3|||
126263168|NCT01832402|454254605|FG001|Overall Study|Withdrawal by Subject|3|||
126263169|NCT01832402|454254604|FG000|Overall Study|Declining Performance status|2|||
126263170|NCT01832402|454254605|FG001|Overall Study|Declining Performance status|1|||
126263171|NCT01202877|454254606|FG000|Overall Study|Disease Progression|0|||
126263172|NCT01202877|454254607|FG001|Overall Study|Disease Progression|1|||
126263173|NCT01202877|454254608|FG002|Overall Study|Disease Progression|2|||
126263174|NCT01202877|454254606|FG000|Overall Study|Adverse Event|0|||
126263175|NCT01202877|454254607|FG001|Overall Study|Adverse Event|0|||
126263176|NCT01202877|454254608|FG002|Overall Study|Adverse Event|2|||
126263177|NCT01202877|454254606|FG000|Overall Study|Withdrawal by Subject|0|||
126263178|NCT01202877|454254607|FG001|Overall Study|Withdrawal by Subject|0|||
126263179|NCT01202877|454254608|FG002|Overall Study|Withdrawal by Subject|1|||
126263180|NCT01202877|454254606|FG000|Overall Study|Death|0|||
126263181|NCT01202877|454254607|FG001|Overall Study|Death|0|||
126263182|NCT01202877|454254608|FG002|Overall Study|Death|1|||
126263183|NCT00396331|454254609|FG000|Overall Study|Failed to mobilize - no transplant|8|||
126263184|NCT00396331|454254609|FG000|Overall Study|Did not go on to transplant|5|||
126263185|NCT00396331|454254609|FG000|Overall Study|Lost to Follow-up|3|||
126263186|NCT00396331|454254609|FG000|Overall Study|Death|16|||
126263187|NCT01382251|454254610|FG000|Overall Study|Surgeries cancelled or delayed|16|||
126263188|NCT01382251|454254611|FG001|Overall Study|Surgeries cancelled or delayed|16|||
126263189|NCT01382251|454254610|FG000|Overall Study|Lost to Follow-up|4|||
126263190|NCT01382251|454254611|FG001|Overall Study|Lost to Follow-up|4|||
126263191|NCT01382251|454254610|FG000|Overall Study|Contacted after study closed|1|||
126263192|NCT01382251|454254611|FG001|Overall Study|Contacted after study closed|1|||
126263193|NCT00562120|454254612|FG000|First Intervention Period|Adverse Event|1|||
126263194|NCT00562120|454254613|FG001|First Intervention Period|Adverse Event|0|||
126263195|NCT00562120|454254614|FG002|First Intervention Period|Adverse Event|0|||
126263196|NCT00562120|454254615|FG003|First Intervention Period|Adverse Event|0|||
126263197|NCT00562120|454254612|FG000|First Intervention Period|Randomized but not Treated|1|||
126263198|NCT00562120|454254613|FG001|First Intervention Period|Randomized but not Treated|0|||
126263199|NCT00562120|454254614|FG002|First Intervention Period|Randomized but not Treated|0|||
126263200|NCT00562120|454254615|FG003|First Intervention Period|Randomized but not Treated|0|||
126263201|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
126263202|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
126263203|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
126263204|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
126263205|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
126263206|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
126263207|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
126263208|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
126263209|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
126263210|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
126263211|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
126263212|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
126263213|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Death|0|||
126263214|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Death|1|||
126700613|NCT01307423|455853610|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126763797|NCT05182840|456086878|FG009|Run-in Period|Change of residence|0|||
126263215|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Death|0|||
126263216|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Death|0|||
126263217|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
126263218|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
126263219|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
126263220|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
126263221|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
126263222|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
126263223|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
126263224|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
126263225|NCT00545688|454254618|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
126263226|NCT00545688|454254619|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
126263227|NCT00545688|454254620|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
126263228|NCT00545688|454254621|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
126263229|NCT00545688|454254618|FG000|Adjuvant Treatment Period|Disease Progression|3|||
126263230|NCT00545688|454254619|FG001|Adjuvant Treatment Period|Disease Progression|3|||
126263231|NCT00545688|454254620|FG002|Adjuvant Treatment Period|Disease Progression|0|||
126263232|NCT00545688|454254621|FG003|Adjuvant Treatment Period|Disease Progression|7|||
126263233|NCT00545688|454254618|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
126263234|NCT00545688|454254619|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
126263235|NCT00545688|454254620|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
126263236|NCT00545688|454254621|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
126263237|NCT00545688|454254618|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
126263238|NCT00545688|454254619|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
126263239|NCT00545688|454254620|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
126263240|NCT00545688|454254621|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
126263241|NCT00545688|454254618|FG000|Adjuvant Treatment Period|Adverse Event|0|||
126263242|NCT00545688|454254619|FG001|Adjuvant Treatment Period|Adverse Event|3|||
126263243|NCT00545688|454254620|FG002|Adjuvant Treatment Period|Adverse Event|2|||
126263244|NCT00545688|454254621|FG003|Adjuvant Treatment Period|Adverse Event|2|||
126263245|NCT00545688|454254618|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
126263246|NCT00545688|454254619|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
126263247|NCT00545688|454254620|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
126263248|NCT00545688|454254621|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
126263249|NCT00545688|454254618|FG000|Follow-Up Period|Death|4|||
126263250|NCT00545688|454254619|FG001|Follow-Up Period|Death|2|||
126263251|NCT00545688|454254620|FG002|Follow-Up Period|Death|2|||
126263252|NCT00545688|454254621|FG003|Follow-Up Period|Death|6|||
126263253|NCT00545688|454254618|FG000|Follow-Up Period|Disease Progression|6|||
126263254|NCT00545688|454254619|FG001|Follow-Up Period|Disease Progression|5|||
126263255|NCT00545688|454254620|FG002|Follow-Up Period|Disease Progression|9|||
126263256|NCT00545688|454254621|FG003|Follow-Up Period|Disease Progression|9|||
126263257|NCT00545688|454254618|FG000|Follow-Up Period|Refused Treatment|6|||
126263258|NCT00545688|454254619|FG001|Follow-Up Period|Refused Treatment|2|||
126263259|NCT00545688|454254620|FG002|Follow-Up Period|Refused Treatment|0|||
126263260|NCT00545688|454254621|FG003|Follow-Up Period|Refused Treatment|2|||
126263261|NCT00545688|454254618|FG000|Follow-Up Period|Lost to Follow-up|3|||
126263262|NCT00545688|454254619|FG001|Follow-Up Period|Lost to Follow-up|3|||
126263263|NCT00545688|454254620|FG002|Follow-Up Period|Lost to Follow-up|3|||
126452274|NCT03241368|454957170|FG000|Overall Study|Protocol Violation|1|||
126452275|NCT00080899|454957173|FG000|Overall Study|Adverse Event|1|||
126452276|NCT01763996|454957175|FG000|Treatment Period 2|Adverse Event|0|||
126452277|NCT01763996|454957176|FG001|Treatment Period 2|Adverse Event|1|||
126452278|NCT01616693|454957177|FG000|Evaluated for Safety|Physician Decision|1|||
126263264|NCT00545688|454254621|FG003|Follow-Up Period|Lost to Follow-up|1|||
126263265|NCT00545688|454254618|FG000|Follow-Up Period|Unspecified Reason|2|||
126263266|NCT00545688|454254619|FG001|Follow-Up Period|Unspecified Reason|5|||
126263267|NCT00545688|454254620|FG002|Follow-Up Period|Unspecified Reason|6|||
126263268|NCT00545688|454254621|FG003|Follow-Up Period|Unspecified Reason|8|||
126263269|NCT00545688|454254618|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
126263270|NCT00545688|454254619|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
126263271|NCT00545688|454254620|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
126263272|NCT00545688|454254621|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
126263273|NCT00952276|454254624|FG000|Overall Study|Withdrawal by Subject|1|||
126263274|NCT00952276|454254625|FG001|Overall Study|Withdrawal by Subject|0|||
126263275|NCT00952276|454254626|FG002|Overall Study|Withdrawal by Subject|0|||
126263276|NCT00952276|454254627|FG003|Overall Study|Withdrawal by Subject|1|||
126263277|NCT00952276|454254628|FG004|Overall Study|Withdrawal by Subject|0|||
126263278|NCT01010126|454256291|FG000|Overall Study|Withdrawal by Subject|1|||
126263279|NCT01010126|454256292|FG001|Overall Study|Withdrawal by Subject|0|||
126263280|NCT01010126|454256293|FG002|Overall Study|Withdrawal by Subject|1|||
126263281|NCT01010126|454256294|FG003|Overall Study|Withdrawal by Subject|0|||
126263282|NCT01010126|454256295|FG004|Overall Study|Withdrawal by Subject|3|||
126263283|NCT01010126|454256296|FG005|Overall Study|Withdrawal by Subject|0|||
126263284|NCT00595335|454256299|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
126263285|NCT00595335|454256300|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
126263286|NCT00595335|454256299|FG000|Baseline to Six Months|Disease Progression|1|||
126263287|NCT00595335|454256300|FG001|Baseline to Six Months|Disease Progression|1|||
126263288|NCT00595335|454256299|FG000|Baseline to Six Months|Adverse Event|1|||
126263289|NCT00595335|454256300|FG001|Baseline to Six Months|Adverse Event|0|||
126263290|NCT00595335|454256299|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
126263291|NCT00595335|454256300|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
126263292|NCT00595335|454256299|FG000|Six Months to Twelve Months|Disease Progression|1|||
126263293|NCT00595335|454256300|FG001|Six Months to Twelve Months|Disease Progression|0|||
126263294|NCT01647958|454256308|FG000|Initial Study|Lost to Follow-up|2|||
126263295|NCT01647958|454256309|FG001|Initial Study|Lost to Follow-up|3|||
126263296|NCT01647958|454256308|FG000|Continuation Phase|treatment received during Overall Study|39|||
126263297|NCT01647958|454256309|FG001|Continuation Phase|treatment received during Overall Study|0|||
126263298|NCT01647958|454256308|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
126263299|NCT01647958|454256309|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
126263300|NCT00544817|454256310|FG000|Combined Modality|Lack of Efficacy|2|||
126263301|NCT00544817|454256310|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
126263302|NCT00544817|454256310|FG000|Combined Modality|Adverse Event|2|||
126263303|NCT00544817|454256310|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
126263304|NCT00544817|454256310|FG000|No Treatment Interval|Lack of Efficacy|8|||
126263305|NCT00544817|454256310|FG000|No Treatment Interval|Physician Decision|3|||
126263306|NCT00544817|454256310|FG000|No Treatment Interval|Adverse Event|1|||
126263307|NCT00544817|454256310|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
126263308|NCT00544817|454256310|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
126263309|NCT00544817|454256310|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
126263310|NCT01131299|454256311|FG000|Overall Study|Withdrawal by Subject|4|||
126263311|NCT01131299|454256312|FG001|Overall Study|Withdrawal by Subject|7|||
126263312|NCT00140413|454256319|FG000|Overall Study|Lost to Follow-up|1|||
126263313|NCT00140413|454256320|FG001|Overall Study|Lost to Follow-up|0|||
126263314|NCT00140413|454256319|FG000|Overall Study|Withdrawal by Subject|2|||
126263315|NCT00140413|454256320|FG001|Overall Study|Withdrawal by Subject|0|||
126263316|NCT01360866|454256325|FG000|Overall Study|Lost to Follow-up|11|||
126263317|NCT01360866|454256326|FG001|Overall Study|Lost to Follow-up|28|||
126263318|NCT01360866|454256327|FG002|Overall Study|Lost to Follow-up|41|||
126263319|NCT01360866|454256328|FG003|Overall Study|Lost to Follow-up|0|||
126263320|NCT01360866|454256325|FG000|Overall Study|Adverse Event|56|||
126263321|NCT01360866|454256326|FG001|Overall Study|Adverse Event|61|||
126263322|NCT01360866|454256327|FG002|Overall Study|Adverse Event|134|||
126263323|NCT01360866|454256328|FG003|Overall Study|Adverse Event|6|||
126263324|NCT01360866|454256325|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
126263325|NCT01360866|454256326|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
126263326|NCT01360866|454256327|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
126452279|NCT01616693|454957178|FG001|Evaluated for Safety|Physician Decision|0|||
126263327|NCT01360866|454256328|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
126263328|NCT01360866|454256325|FG000|Overall Study|Withdrawn by Investigator|9|||
126263329|NCT01360866|454256326|FG001|Overall Study|Withdrawn by Investigator|8|||
126263330|NCT01360866|454256327|FG002|Overall Study|Withdrawn by Investigator|31|||
126263331|NCT01360866|454256328|FG003|Overall Study|Withdrawn by Investigator|2|||
126763798|NCT05182840|456086869|FG000|Run-in Period|Adverse Event|5|||
126263332|NCT01360866|454256325|FG000|Overall Study|Withdrawal by participant|79|||
126263333|NCT01360866|454256326|FG001|Overall Study|Withdrawal by participant|89|||
126263334|NCT01360866|454256327|FG002|Overall Study|Withdrawal by participant|168|||
126763799|NCT05182840|456086870|FG001|Run-in Period|Adverse Event|5|||
126452280|NCT01616693|454957179|FG002|Evaluated for Safety|Physician Decision|1|||
126452281|NCT01616693|454957180|FG003|Evaluated for Safety|Physician Decision|0|||
126263335|NCT01360866|454256328|FG003|Overall Study|Withdrawal by participant|8|||
126263336|NCT01360866|454256325|FG000|Overall Study|Protocol Deviation|25|||
126263337|NCT01360866|454256326|FG001|Overall Study|Protocol Deviation|33|||
126263338|NCT01360866|454256327|FG002|Overall Study|Protocol Deviation|61|||
126263339|NCT01360866|454256328|FG003|Overall Study|Protocol Deviation|2|||
126263340|NCT01360866|454256325|FG000|Overall Study|Lack of Efficacy|30|||
126263341|NCT01360866|454256326|FG001|Overall Study|Lack of Efficacy|40|||
126263342|NCT01360866|454256327|FG002|Overall Study|Lack of Efficacy|30|||
126263343|NCT01360866|454256328|FG003|Overall Study|Lack of Efficacy|4|||
126263344|NCT01304693|454256329|FG000|Overall Study|Adverse Event|0|||
126263345|NCT01304693|454256330|FG001|Overall Study|Adverse Event|0|||
126263346|NCT01304693|454256331|FG002|Overall Study|Adverse Event|0|||
126263347|NCT01304693|454256332|FG003|Overall Study|Adverse Event|0|||
126263348|NCT01304693|454256333|FG004|Overall Study|Adverse Event|1|||
126263349|NCT01304693|454256329|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
126263350|NCT01304693|454256330|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
126263351|NCT01304693|454256331|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
126263352|NCT01304693|454256332|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
126263353|NCT01304693|454256333|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
126263354|NCT02129647|454256334|FG000|Overall Study|Adverse Event|2|||
126263355|NCT02129647|454256334|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
126263356|NCT01715896|454256335|FG000|Overall Study|Lost to Follow-up|0|||
126263357|NCT01715896|454256336|FG001|Overall Study|Lost to Follow-up|2|||
126263358|NCT01715896|454256335|FG000|Overall Study|Withdrawal by Subject|1|||
126263359|NCT01715896|454256336|FG001|Overall Study|Withdrawal by Subject|4|||
126263360|NCT01715896|454256335|FG000|Overall Study|Other|2|||
126263361|NCT01715896|454256336|FG001|Overall Study|Other|5|||
126263362|NCT01173471|454256342|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126263363|NCT01173471|454256343|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126263364|NCT01173471|454256344|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
126263365|NCT01173471|454256345|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
126263366|NCT01173471|454256342|FG000|Overall Study|Condition under investigation worsened|2|||
126263367|NCT01173471|454256343|FG001|Overall Study|Condition under investigation worsened|0|||
126263368|NCT01173471|454256344|FG002|Overall Study|Condition under investigation worsened|0|||
126263369|NCT01173471|454256345|FG003|Overall Study|Condition under investigation worsened|0|||
126263370|NCT01173471|454256342|FG000|Overall Study|Lost to Follow-up|0|||
126263371|NCT01173471|454256343|FG001|Overall Study|Lost to Follow-up|0|||
126263372|NCT01173471|454256344|FG002|Overall Study|Lost to Follow-up|1|||
126263373|NCT01173471|454256345|FG003|Overall Study|Lost to Follow-up|0|||
126263374|NCT01173471|454256342|FG000|Overall Study|Reason given as Other|0|||
126263375|NCT01173471|454256343|FG001|Overall Study|Reason given as Other|0|||
126263376|NCT01173471|454256344|FG002|Overall Study|Reason given as Other|1|||
126263377|NCT01173471|454256345|FG003|Overall Study|Reason given as Other|0|||
126263378|NCT03028740|454256346|FG000|Overall Study|Did not Receive Study Drug|4|||
126263379|NCT03028740|454256347|FG001|Overall Study|Did not Receive Study Drug|5|||
126263380|NCT03028740|454256346|FG000|Overall Study|Adverse Event|8|||
126263381|NCT03028740|454256347|FG001|Overall Study|Adverse Event|26|||
126263382|NCT03028740|454256346|FG000|Overall Study|Lack of Efficacy|0|||
126263383|NCT03028740|454256347|FG001|Overall Study|Lack of Efficacy|1|||
126263384|NCT03028740|454256346|FG000|Overall Study|Withdrawal by Subject|48|||
126263385|NCT03028740|454256347|FG001|Overall Study|Withdrawal by Subject|101|||
126263386|NCT03028740|454256346|FG000|Overall Study|Lost to Follow-up|30|||
126263387|NCT03028740|454256347|FG001|Overall Study|Lost to Follow-up|54|||
126263388|NCT03028740|454256346|FG000|Overall Study|Physician Decision|4|||
126263389|NCT03028740|454256347|FG001|Overall Study|Physician Decision|11|||
126263390|NCT03028740|454256346|FG000|Overall Study|Protocol Violation|4|||
126263391|NCT03028740|454256347|FG001|Overall Study|Protocol Violation|8|||
126263392|NCT03028740|454256346|FG000|Overall Study|Non-compliance with Study Drug|0|||
126452282|NCT01616693|454957177|FG000|Received Both Vaccines|Adverse Event|2|||
126452283|NCT01616693|454957178|FG001|Received Both Vaccines|Adverse Event|0|||
126452284|NCT01616693|454957179|FG002|Received Both Vaccines|Adverse Event|0|||
126263393|NCT03028740|454256347|FG001|Overall Study|Non-compliance with Study Drug|2|||
126263394|NCT03028740|454256346|FG000|Overall Study|Study Terminated by Sponsor|467|||
126263395|NCT03028740|454256347|FG001|Overall Study|Study Terminated by Sponsor|917|||
126263396|NCT03028740|454256346|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
126263397|NCT03028740|454256347|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
126263398|NCT03028740|454256346|FG000|Overall Study|Reason not Specified|1|||
126263399|NCT03028740|454256347|FG001|Overall Study|Reason not Specified|5|||
126263400|NCT00685802|454256353|FG000|Washout Period of 7 Days|Protocol Violation|2|||
126263401|NCT00685802|454256354|FG001|Washout Period of 7 Days|Protocol Violation|0|||
126263402|NCT00685802|454256353|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
126263403|NCT00685802|454256354|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126263404|NCT03336242|454256355|FG000|Overall Study|Adverse Event|0|||
126263405|NCT03336242|454256356|FG001|Overall Study|Adverse Event|1|||
126263406|NCT02224573|454256358|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
126263407|NCT02224573|454256359|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
126263408|NCT02224573|454256358|FG000|Treatment Phase|Started on Other IMP|1|||
126263409|NCT02224573|454256359|FG001|Treatment Phase|Started on Other IMP|0|||
126263410|NCT02224573|454256358|FG000|Treatment Phase|Participant Discontinued IMP|0|||
126263411|NCT02224573|454256359|FG001|Treatment Phase|Participant Discontinued IMP|1|||
126263412|NCT02224573|454256358|FG000|Treatment Phase|Lack of Efficacy|15|||
126263413|NCT02224573|454256359|FG001|Treatment Phase|Lack of Efficacy|8|||
126263414|NCT02224573|454256358|FG000|Treatment Phase|Began Commercial Product|1|||
126263415|NCT02224573|454256359|FG001|Treatment Phase|Began Commercial Product|0|||
126263416|NCT02224573|454256358|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
126263417|NCT02224573|454256359|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
126263418|NCT02224573|454256358|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
126263419|NCT02224573|454256359|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
126263420|NCT02224573|454256358|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
126263421|NCT02224573|454256359|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
126263422|NCT02224573|454256358|FG000|Treatment Phase|Continued Compassionate Use|1|||
126263423|NCT02224573|454256359|FG001|Treatment Phase|Continued Compassionate Use|0|||
126263424|NCT02224573|454256358|FG000|Treatment Phase|Lack of Efficiency|2|||
126263425|NCT02224573|454256359|FG001|Treatment Phase|Lack of Efficiency|1|||
126263426|NCT02224573|454256358|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
126263427|NCT02224573|454256359|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
126263428|NCT02224573|454256358|FG000|Treatment Phase|Participant Moved|2|||
126263429|NCT02224573|454256359|FG001|Treatment Phase|Participant Moved|0|||
126263430|NCT02224573|454256358|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
126263431|NCT02224573|454256359|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
126263432|NCT02224573|454256358|FG000|Treatment Phase|Refused Medication|1|||
126263433|NCT02224573|454256359|FG001|Treatment Phase|Refused Medication|1|||
126263434|NCT02224573|454256358|FG000|Treatment Phase|Adverse Event|26|||
126263435|NCT02224573|454256359|FG001|Treatment Phase|Adverse Event|38|||
126263436|NCT02224573|454256358|FG000|Treatment Phase|Placed in Group Home|0|||
126263437|NCT02224573|454256359|FG001|Treatment Phase|Placed in Group Home|1|||
126263438|NCT02224573|454256358|FG000|Treatment Phase|Pursued Other Trials|1|||
126263439|NCT02224573|454256359|FG001|Treatment Phase|Pursued Other Trials|0|||
126263440|NCT02224573|454256358|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
126263441|NCT02224573|454256359|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
126263442|NCT02224573|454256358|FG000|Treatment Phase|Lost to Follow-up|2|||
126263443|NCT02224573|454256359|FG001|Treatment Phase|Lost to Follow-up|1|||
126263444|NCT02224573|454256358|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
126263445|NCT02224573|454256359|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
126263446|NCT02224573|454256358|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
126263447|NCT02224573|454256359|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
126263448|NCT02224573|454256358|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
126263449|NCT02224573|454256359|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
126263450|NCT02224573|454256358|FG000|Taper Phase|Adverse Event|1|||
126263451|NCT02224573|454256359|FG001|Taper Phase|Adverse Event|1|||
126263452|NCT02546362|454256360|FG000|4-week Treatment Period|Lost to Follow-up|1|||
126263453|NCT02546362|454256360|FG000|4-week Treatment Period|Change in medication|2|||
126263454|NCT02546362|454256360|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
126263455|NCT02546362|454256360|FG000|12-week Treatment Period|Lost to Follow-up|2|||
126263456|NCT02546362|454256360|FG000|12-week Treatment Period|Change in medication|1|||
126263457|NCT01557842|454256361|FG000|Overall Study|Lost to Follow-up|0|||
126263458|NCT01557842|454256362|FG001|Overall Study|Lost to Follow-up|1|||
126263459|NCT01557842|454256361|FG000|Overall Study|Death|1|||
126263460|NCT01557842|454256362|FG001|Overall Study|Death|0|||
126263461|NCT01557842|454256361|FG000|Overall Study|Lack of Efficacy|0|||
126263462|NCT01557842|454256362|FG001|Overall Study|Lack of Efficacy|1|||
126263463|NCT01557842|454256361|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
126263464|NCT01557842|454256362|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
126263465|NCT01557842|454256361|FG000|Overall Study|Study Terminated by Sponsor|3|||
126263466|NCT01557842|454256362|FG001|Overall Study|Study Terminated by Sponsor|4|||
126263467|NCT01557842|454256361|FG000|Overall Study|Not Ablated|2|||
126263468|NCT01557842|454256362|FG001|Overall Study|Not Ablated|0|||
126263469|NCT03005067|454256366|FG000|Overall Study|Withdrawal by Subject|3|||
126263470|NCT03005067|454256367|FG001|Overall Study|Withdrawal by Subject|2|||
126263471|NCT03005067|454256366|FG000|Overall Study|Adverse Event|4|||
126263472|NCT03005067|454256367|FG001|Overall Study|Adverse Event|3|||
126263473|NCT03005067|454256366|FG000|Overall Study|Other (reason not specified)|3|||
126263474|NCT03005067|454256367|FG001|Overall Study|Other (reason not specified)|1|||
126263475|NCT03005067|454256366|FG000|Overall Study|Protocol Violation|0|||
126263476|NCT03005067|454256367|FG001|Overall Study|Protocol Violation|1|||
126263477|NCT01661881|454256373|FG000|Overall Study|Disease Progression|1|||
126263478|NCT00949988|454256378|FG000|Overall Study|Withdrawal by Subject|3|||
126263479|NCT05212883|454256381|FG000|Overall Study|Invalid test result|125|||
126263480|NCT03891329|454256394|FG000|Overall Study|Death|5|||
126263481|NCT03891329|454256394|FG000|Overall Study|Lost to Follow-up|4|||
126263482|NCT03891329|454256394|FG000|Overall Study|Physician Decision|4|||
126263483|NCT03891329|454256394|FG000|Overall Study|Device explanted|3|||
126263484|NCT03891329|454256394|FG000|Overall Study|No study device implanted|3|||
126263485|NCT01803269|454256397|FG000|Overall Study|Withdrawal by Subject|3|||
126263486|NCT01803269|454256398|FG001|Overall Study|Withdrawal by Subject|0|||
126263487|NCT01803269|454256399|FG002|Overall Study|Withdrawal by Subject|0|||
126263488|NCT01351350|454256400|FG000|Overall Study|Disease Progression|5|||
126263489|NCT01351350|454256401|FG001|Overall Study|Disease Progression|13|||
126263490|NCT01351350|454256402|FG002|Overall Study|Disease Progression|6|||
126263491|NCT01351350|454256403|FG003|Overall Study|Disease Progression|8|||
126263492|NCT01351350|454256404|FG004|Overall Study|Disease Progression|5|||
126263493|NCT01351350|454256400|FG000|Overall Study|Adverse Event|1|||
126263494|NCT01351350|454256401|FG001|Overall Study|Adverse Event|10|||
126263495|NCT01351350|454256402|FG002|Overall Study|Adverse Event|1|||
126263496|NCT01351350|454256403|FG003|Overall Study|Adverse Event|2|||
126263497|NCT01351350|454256404|FG004|Overall Study|Adverse Event|0|||
126263498|NCT01351350|454256400|FG000|Overall Study|Participant Decision|2|||
126263499|NCT01351350|454256401|FG001|Overall Study|Participant Decision|6|||
126263500|NCT01351350|454256402|FG002|Overall Study|Participant Decision|3|||
126263501|NCT01351350|454256403|FG003|Overall Study|Participant Decision|3|||
126263502|NCT01351350|454256404|FG004|Overall Study|Participant Decision|2|||
126263503|NCT01351350|454256400|FG000|Overall Study|Enrolled but not Treated|0|||
126263504|NCT01351350|454256401|FG001|Overall Study|Enrolled but not Treated|0|||
126263505|NCT01351350|454256402|FG002|Overall Study|Enrolled but not Treated|1|||
126263506|NCT01351350|454256403|FG003|Overall Study|Enrolled but not Treated|0|||
126263507|NCT01351350|454256404|FG004|Overall Study|Enrolled but not Treated|0|||
126263508|NCT04647383|454256407|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
126263509|NCT04647383|454256408|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
126263510|NCT04647383|454256409|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
126263511|NCT04647383|454256410|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
126263512|NCT00873119|454256411|FG000|Overall Study|Patient request|4|||
126263513|NCT00873119|454256412|FG001|Overall Study|Patient request|2|||
126263514|NCT00873119|454256411|FG000|Overall Study|Adverse Event|8|||
126263515|NCT00873119|454256412|FG001|Overall Study|Adverse Event|0|||
126263516|NCT00873119|454256411|FG000|Overall Study|Progressive disease|26|||
126263517|NCT00873119|454256412|FG001|Overall Study|Progressive disease|18|||
126263518|NCT00873119|454256411|FG000|Overall Study|Death|2|||
126263519|NCT00873119|454256412|FG001|Overall Study|Death|1|||
126263520|NCT00873119|454256411|FG000|Overall Study|Other|2|||
126263521|NCT00873119|454256412|FG001|Overall Study|Other|5|||
126263522|NCT00873119|454256411|FG000|Overall Study|Not treated|2|||
126263523|NCT00873119|454256412|FG001|Overall Study|Not treated|0|||
126263524|NCT02339740|454256415|FG000|Overall Study|Death|1|||
126263525|NCT02339740|454256416|FG001|Overall Study|Death|0|||
126263526|NCT02339740|454256415|FG000|Overall Study|Physician Decision|0|||
126263527|NCT02339740|454256416|FG001|Overall Study|Physician Decision|2|||
126263528|NCT02339740|454256415|FG000|Overall Study|Withdrawal by Subject|5|||
126263529|NCT02339740|454256416|FG001|Overall Study|Withdrawal by Subject|1|||
126263530|NCT02339740|454256415|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
126263531|NCT02339740|454256416|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
126263532|NCT02096588|454256417|FG000|Overall Study|Lack of Efficacy|2|||
126263533|NCT02096588|454256418|FG001|Overall Study|Lack of Efficacy|0|||
126263534|NCT02096588|454256417|FG000|Overall Study|Withdrawal by Subject|0|||
126263535|NCT02096588|454256418|FG001|Overall Study|Withdrawal by Subject|1|||
126263536|NCT01258101|454256419|FG000|Overall Study|Adverse Event|5|||
126263537|NCT01258101|454256420|FG001|Overall Study|Adverse Event|6|||
126263538|NCT01258101|454256421|FG002|Overall Study|Adverse Event|0|||
126263539|NCT01258101|454256422|FG003|Overall Study|Adverse Event|0|||
126263540|NCT01258101|454256419|FG000|Overall Study|Extra exclusion criterion amended|2|||
126263541|NCT01258101|454256420|FG001|Overall Study|Extra exclusion criterion amended|1|||
126263542|NCT01258101|454256421|FG002|Overall Study|Extra exclusion criterion amended|1|||
126263543|NCT01258101|454256422|FG003|Overall Study|Extra exclusion criterion amended|1|||
126263544|NCT01258101|454256419|FG000|Overall Study|Informed consent has been withdrawn|2|||
126263545|NCT01258101|454256420|FG001|Overall Study|Informed consent has been withdrawn|2|||
126263546|NCT01258101|454256421|FG002|Overall Study|Informed consent has been withdrawn|1|||
126263547|NCT01258101|454256422|FG003|Overall Study|Informed consent has been withdrawn|1|||
126359819|NCT02318277|454609074|FG005|Overall Study|Transitioned to Hospice|1|||
126359820|NCT02318277|454609075|FG006|Overall Study|Transitioned to Hospice|0|||
126359821|NCT02318277|454609076|FG007|Overall Study|Transitioned to Hospice|0|||
126359822|NCT01520714|454609077|FG000|Overall Study|Protocol Violation|0|||
126359823|NCT01520714|454609078|FG001|Overall Study|Protocol Violation|3|||
126359824|NCT01520714|454609077|FG000|Overall Study|Adverse Event|0|||
126359825|NCT01520714|454609078|FG001|Overall Study|Adverse Event|2|||
126359826|NCT01520714|454609077|FG000|Overall Study|Lack of Efficacy|0|||
126263548|NCT01258101|454256419|FG000|Overall Study|Patient is not able to attend visits|8|||
126263549|NCT01258101|454256420|FG001|Overall Study|Patient is not able to attend visits|9|||
126263550|NCT01258101|454256421|FG002|Overall Study|Patient is not able to attend visits|7|||
126263551|NCT01258101|454256422|FG003|Overall Study|Patient is not able to attend visits|6|||
126263552|NCT01258101|454256419|FG000|Overall Study|Patient´s compliance|4|||
126263553|NCT01258101|454256420|FG001|Overall Study|Patient´s compliance|3|||
126263554|NCT01258101|454256421|FG002|Overall Study|Patient´s compliance|1|||
126263555|NCT01258101|454256422|FG003|Overall Study|Patient´s compliance|2|||
126263556|NCT01258101|454256419|FG000|Overall Study|Lost to Follow-up|5|||
126263557|NCT01258101|454256420|FG001|Overall Study|Lost to Follow-up|5|||
126263558|NCT01258101|454256421|FG002|Overall Study|Lost to Follow-up|0|||
126263559|NCT01258101|454256422|FG003|Overall Study|Lost to Follow-up|6|||
126263560|NCT01258101|454256419|FG000|Overall Study|PCR positive at week 24|0|||
126263561|NCT01258101|454256420|FG001|Overall Study|PCR positive at week 24|0|||
126263562|NCT01258101|454256421|FG002|Overall Study|PCR positive at week 24|0|||
126263563|NCT01258101|454256422|FG003|Overall Study|PCR positive at week 24|1|||
126263564|NCT01258101|454256419|FG000|Overall Study|Other reason|7|||
126263565|NCT01258101|454256420|FG001|Overall Study|Other reason|8|||
126263566|NCT01258101|454256421|FG002|Overall Study|Other reason|1|||
126263567|NCT01258101|454256422|FG003|Overall Study|Other reason|8|||
126263568|NCT00303667|454256423|FG000|Overall Study|Death|0|||
126263569|NCT00303667|454256424|FG001|Overall Study|Death|4|||
126263570|NCT01298778|454256425|FG000|Overall Study|Lost to Follow-up|2|||
126263571|NCT01298778|454256426|FG001|Overall Study|Lost to Follow-up|3|||
126263572|NCT01298778|454256425|FG000|Overall Study|Incorrect use of VAS|1|||
126263573|NCT01298778|454256426|FG001|Overall Study|Incorrect use of VAS|0|||
126263574|NCT01298778|454256425|FG000|Overall Study|Withdrawal by Subject|0|||
126263575|NCT01298778|454256426|FG001|Overall Study|Withdrawal by Subject|1|||
126263576|NCT01298778|454256425|FG000|Overall Study|Protocol Violation|0|||
126263577|NCT01298778|454256426|FG001|Overall Study|Protocol Violation|1|||
126263578|NCT01298778|454256425|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
126263579|NCT01298778|454256426|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
126263580|NCT04965389|454256427|FG000|Overall Study|Other reasons|1|||
126263581|NCT04965389|454256428|FG001|Overall Study|Other reasons|0|||
126263582|NCT04965389|454256429|FG002|Overall Study|Other reasons|0|||
126263583|NCT04965389|454256430|FG003|Overall Study|Other reasons|0|||
126263584|NCT04965389|454256427|FG000|Overall Study|Participant withdrew consent|0|||
126263585|NCT04965389|454256428|FG001|Overall Study|Participant withdrew consent|1|||
126263586|NCT04965389|454256429|FG002|Overall Study|Participant withdrew consent|0|||
126263587|NCT04965389|454256430|FG003|Overall Study|Participant withdrew consent|0|||
126263588|NCT04965389|454256427|FG000|Overall Study|Poor/Non-compliance|0|||
126263589|NCT04965389|454256428|FG001|Overall Study|Poor/Non-compliance|1|||
126263590|NCT04965389|454256429|FG002|Overall Study|Poor/Non-compliance|0|||
126263591|NCT04965389|454256430|FG003|Overall Study|Poor/Non-compliance|0|||
126263592|NCT02377921|454256433|FG000|Overall Study|Subject non-compliance|1|||
126263593|NCT02377921|454256434|FG001|Overall Study|Subject non-compliance|1|||
126263594|NCT00706355|454256440|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
126263595|NCT00706355|454256441|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
126263596|NCT00706355|454256442|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
126263597|NCT00706355|454256443|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
126263598|NCT00706355|454256440|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
126263599|NCT00706355|454256441|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
126263600|NCT00706355|454256442|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
126263601|NCT00706355|454256443|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
126263602|NCT00706355|454256440|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
126263603|NCT00706355|454256441|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
126263604|NCT00706355|454256442|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
126263605|NCT00706355|454256443|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
126263606|NCT00706355|454256440|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
126263607|NCT00706355|454256441|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
126263608|NCT00706355|454256442|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
126263609|NCT00706355|454256443|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
126263610|NCT00706355|454256440|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
126263611|NCT00706355|454256441|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
126263612|NCT00706355|454256442|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
126263613|NCT00706355|454256443|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
126263614|NCT00706355|454256440|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
126263615|NCT00706355|454256441|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
126263616|NCT00706355|454256442|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
126263617|NCT00706355|454256443|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
126263618|NCT00706355|454256440|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
126359827|NCT01520714|454609078|FG001|Overall Study|Lack of Efficacy|1|||
126263619|NCT00706355|454256441|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
126263620|NCT00706355|454256442|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
126263621|NCT00706355|454256443|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
126263622|NCT00706355|454256440|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
126263623|NCT00706355|454256441|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
126263624|NCT00706355|454256442|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
126263625|NCT00706355|454256443|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
126263626|NCT00706355|454256440|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
126263627|NCT00706355|454256441|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
126263628|NCT00706355|454256442|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
126263629|NCT00706355|454256443|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
126263630|NCT01020799|454256446|FG000|Overall Study|Adverse Event|4|||
126263631|NCT01020799|454256447|FG001|Overall Study|Adverse Event|3|||
126263632|NCT01020799|454256448|FG002|Overall Study|Adverse Event|2|||
126263633|NCT01020799|454256446|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
126263634|NCT01020799|454256447|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
126263635|NCT01020799|454256448|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
126263636|NCT01020799|454256446|FG000|Overall Study|Protocol Violation|3|||
126263637|NCT01020799|454256447|FG001|Overall Study|Protocol Violation|2|||
126263638|NCT01020799|454256448|FG002|Overall Study|Protocol Violation|0|||
126263639|NCT01020799|454256446|FG000|Overall Study|Withdrawal by Subject|2|||
126263640|NCT01020799|454256447|FG001|Overall Study|Withdrawal by Subject|2|||
126263641|NCT01020799|454256448|FG002|Overall Study|Withdrawal by Subject|3|||
126263642|NCT01020799|454256446|FG000|Overall Study|Lost to Follow-up|6|||
126263643|NCT01020799|454256447|FG001|Overall Study|Lost to Follow-up|4|||
126263644|NCT01020799|454256448|FG002|Overall Study|Lost to Follow-up|2|||
126263645|NCT01425528|454256451|FG000|Overall Study|Withdrawal by Subject|1|||
126263646|NCT01425528|454256452|FG001|Overall Study|Withdrawal by Subject|1|||
126263647|NCT02985879|454256455|FG000|Overall Study|Adverse Event|7|||
126263648|NCT02985879|454256456|FG001|Overall Study|Adverse Event|9|||
126263649|NCT02985879|454256457|FG002|Overall Study|Adverse Event|7|||
126263650|NCT02985879|454256455|FG000|Overall Study|Withdrew consent|6|||
126263651|NCT02985879|454256456|FG001|Overall Study|Withdrew consent|8|||
126263652|NCT02985879|454256457|FG002|Overall Study|Withdrew consent|10|||
126263653|NCT02985879|454256455|FG000|Overall Study|Lost to Follow-up|1|||
126263654|NCT02985879|454256456|FG001|Overall Study|Lost to Follow-up|0|||
126263655|NCT02985879|454256457|FG002|Overall Study|Lost to Follow-up|2|||
126263656|NCT02985879|454256455|FG000|Overall Study|Other, not specified|62|||
126263657|NCT02985879|454256456|FG001|Overall Study|Other, not specified|58|||
126263658|NCT02985879|454256457|FG002|Overall Study|Other, not specified|58|||
126263659|NCT02658487|454258261|FG000|Overall Study|Death|2|||
126263660|NCT02658487|454258261|FG000|Overall Study|Disease progression|10|||
126263661|NCT02658487|454258261|FG000|Overall Study|Alternative therapy|1|||
126263662|NCT02658487|454258261|FG000|Overall Study|Adverse Event|1|||
126263663|NCT02658487|454258261|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
126263664|NCT02658487|454258261|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
126263665|NCT01885182|454258262|FG000|Overall Study|Adverse Event|11|||
126263666|NCT01885182|454258263|FG001|Overall Study|Adverse Event|13|||
126263667|NCT01885182|454258262|FG000|Overall Study|Withdrawal by Subject|13|||
126263668|NCT01885182|454258263|FG001|Overall Study|Withdrawal by Subject|6|||
126263669|NCT01885182|454258262|FG000|Overall Study|Lost to Follow-up|2|||
126263670|NCT01885182|454258263|FG001|Overall Study|Lost to Follow-up|2|||
126263671|NCT01885182|454258262|FG000|Overall Study|Lack of Efficacy|8|||
126263672|NCT01885182|454258263|FG001|Overall Study|Lack of Efficacy|1|||
126263673|NCT00614926|454258270|FG000|Overall Study|Burden of travel|1|||
126263674|NCT00614926|454258271|FG001|Overall Study|Burden of travel|0|||
126263675|NCT00614926|454258270|FG000|Overall Study|Adverse Event|3|||
126263676|NCT00614926|454258271|FG001|Overall Study|Adverse Event|0|||
126263677|NCT01207440|454258272|FG000|Overall Study|Adverse Event|46|||
126263678|NCT01207440|454258273|FG001|Overall Study|Adverse Event|11|||
126263679|NCT01207440|454258274|FG002|Overall Study|Adverse Event|7|||
126263680|NCT01207440|454258275|FG003|Overall Study|Adverse Event|2|||
126263681|NCT01207440|454258276|FG004|Overall Study|Adverse Event|6|||
126263682|NCT01207440|454258277|FG005|Overall Study|Adverse Event|6|||
126263683|NCT01207440|454258278|FG006|Overall Study|Adverse Event|2|||
126263684|NCT01207440|454258272|FG000|Overall Study|Death|6|||
126359828|NCT00754559|454609082|FG000|Overall Study|Adverse Event|15|||
126263685|NCT01207440|454258273|FG001|Overall Study|Death|3|||
126263686|NCT01207440|454258274|FG002|Overall Study|Death|2|||
126263687|NCT01207440|454258275|FG003|Overall Study|Death|2|||
126263688|NCT01207440|454258276|FG004|Overall Study|Death|7|||
126263689|NCT01207440|454258277|FG005|Overall Study|Death|5|||
126263690|NCT01207440|454258278|FG006|Overall Study|Death|1|||
126263691|NCT01207440|454258272|FG000|Overall Study|Lack of Efficacy|13|||
126263692|NCT01207440|454258273|FG001|Overall Study|Lack of Efficacy|2|||
126263693|NCT01207440|454258274|FG002|Overall Study|Lack of Efficacy|5|||
126263694|NCT01207440|454258275|FG003|Overall Study|Lack of Efficacy|1|||
126359829|NCT00754559|454609082|FG000|Overall Study|Protocol Violation|11|||
126359830|NCT00754559|454609082|FG000|Overall Study|Lack of Efficacy|10|||
126359831|NCT00754559|454609082|FG000|Overall Study|Lost to Follow-up|2|||
126359832|NCT00754559|454609082|FG000|Overall Study|Administrative reason|1|||
126359833|NCT00754559|454609082|FG000|Overall Study|Other|5|||
126359834|NCT00754559|454609082|FG000|Overall Study|Withdrawal by Subject|3|||
126359835|NCT01663987|454609083|FG000|Overall Study|Adverse Event|7|||
126359836|NCT01663987|454609084|FG001|Overall Study|Adverse Event|2|||
126359837|NCT01663987|454609083|FG000|Overall Study|Lost to Follow-up|1|||
126359838|NCT01663987|454609084|FG001|Overall Study|Lost to Follow-up|1|||
126359839|NCT01663987|454609083|FG000|Overall Study|Withdrawal by Subject|2|||
126359840|NCT01663987|454609084|FG001|Overall Study|Withdrawal by Subject|3|||
126359841|NCT01663987|454609083|FG000|Overall Study|Other reason not defined above|3|||
126359842|NCT01663987|454609084|FG001|Overall Study|Other reason not defined above|0|||
126359843|NCT03721965|454609086|FG000|Overall Study|Death|1|||
126359844|NCT03721965|454609086|FG000|Overall Study|Study Terminated by Sponsor|1|||
126359845|NCT04595370|454609087|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
126359846|NCT04595370|454609088|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
126359847|NCT04595370|454609089|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
126359848|NCT04595370|454609090|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
126359849|NCT04595370|454609091|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
126359850|NCT04595370|454609092|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
126359851|NCT04595370|454609087|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
126359852|NCT04595370|454609088|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
126359853|NCT04595370|454609089|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
126359854|NCT04595370|454609090|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
126359855|NCT04595370|454609091|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
126359856|NCT04595370|454609092|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
126359857|NCT04595370|454609087|FG000|Overall Study|Adverse Event|0|||
126359858|NCT04595370|454609088|FG001|Overall Study|Adverse Event|4|||
126359859|NCT04595370|454609089|FG002|Overall Study|Adverse Event|3|||
126359860|NCT04595370|454609090|FG003|Overall Study|Adverse Event|1|||
126359861|NCT04595370|454609091|FG004|Overall Study|Adverse Event|1|||
126359862|NCT04595370|454609092|FG005|Overall Study|Adverse Event|1|||
126359863|NCT04595370|454609087|FG000|Overall Study|Withdrawal of Consent|1|||
126359864|NCT04595370|454609088|FG001|Overall Study|Withdrawal of Consent|1|||
126359865|NCT04595370|454609089|FG002|Overall Study|Withdrawal of Consent|1|||
126359866|NCT04595370|454609090|FG003|Overall Study|Withdrawal of Consent|0|||
126359867|NCT04595370|454609091|FG004|Overall Study|Withdrawal of Consent|0|||
126359868|NCT04595370|454609092|FG005|Overall Study|Withdrawal of Consent|0|||
126359869|NCT04595370|454609087|FG000|Overall Study|Death|0|||
126359870|NCT04595370|454609088|FG001|Overall Study|Death|1|||
126359871|NCT04595370|454609089|FG002|Overall Study|Death|0|||
126359872|NCT04595370|454609090|FG003|Overall Study|Death|0|||
126359873|NCT04595370|454609091|FG004|Overall Study|Death|1|||
126359874|NCT04595370|454609092|FG005|Overall Study|Death|0|||
126359875|NCT04595370|454609087|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126359876|NCT04595370|454609088|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126359877|NCT04595370|454609089|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
126359878|NCT04595370|454609090|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126359879|NCT04595370|454609091|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126359880|NCT04595370|454609092|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126359881|NCT04595370|454609087|FG000|Overall Study|Withdrawal by Subject|0|||
126359882|NCT04595370|454609088|FG001|Overall Study|Withdrawal by Subject|0|||
126359883|NCT04595370|454609089|FG002|Overall Study|Withdrawal by Subject|1|||
126359884|NCT04595370|454609090|FG003|Overall Study|Withdrawal by Subject|0|||
126359885|NCT04595370|454609091|FG004|Overall Study|Withdrawal by Subject|2|||
126359886|NCT04595370|454609092|FG005|Overall Study|Withdrawal by Subject|0|||
126700614|NCT01307423|455853611|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
126700615|NCT01307423|455853612|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126700616|NCT01307423|455853613|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126700617|NCT01307423|455853614|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126359887|NCT04595370|454609087|FG000|Overall Study|Lost to Follow-up|0|||
126359888|NCT04595370|454609088|FG001|Overall Study|Lost to Follow-up|0|||
126359889|NCT04595370|454609089|FG002|Overall Study|Lost to Follow-up|0|||
126452285|NCT01616693|454957180|FG003|Received Both Vaccines|Adverse Event|0|||
126452286|NCT01616693|454957177|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
126452287|NCT01616693|454957178|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
126452288|NCT01616693|454957179|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
126359890|NCT04595370|454609090|FG003|Overall Study|Lost to Follow-up|0|||
126359891|NCT04595370|454609091|FG004|Overall Study|Lost to Follow-up|1|||
126359892|NCT04595370|454609092|FG005|Overall Study|Lost to Follow-up|0|||
126452289|NCT01616693|454957180|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
126452290|NCT01616693|454957177|FG000|Received Both Vaccines|Lost to Follow-up|4|||
126452291|NCT01616693|454957178|FG001|Received Both Vaccines|Lost to Follow-up|3|||
126452292|NCT01616693|454957179|FG002|Received Both Vaccines|Lost to Follow-up|4|||
126452293|NCT01616693|454957180|FG003|Received Both Vaccines|Lost to Follow-up|4|||
126452294|NCT01616693|454957177|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
126452295|NCT01616693|454957178|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
126263695|NCT01207440|454258276|FG004|Overall Study|Lack of Efficacy|2|||
126263696|NCT01207440|454258277|FG005|Overall Study|Lack of Efficacy|3|||
126263697|NCT01207440|454258278|FG006|Overall Study|Lack of Efficacy|0|||
126263698|NCT01207440|454258272|FG000|Overall Study|Lost to Follow-up|0|||
126263699|NCT01207440|454258273|FG001|Overall Study|Lost to Follow-up|0|||
126263700|NCT01207440|454258274|FG002|Overall Study|Lost to Follow-up|2|||
126263701|NCT01207440|454258275|FG003|Overall Study|Lost to Follow-up|1|||
126263702|NCT01207440|454258276|FG004|Overall Study|Lost to Follow-up|0|||
126263703|NCT01207440|454258277|FG005|Overall Study|Lost to Follow-up|0|||
126263704|NCT01207440|454258278|FG006|Overall Study|Lost to Follow-up|0|||
126263705|NCT01207440|454258272|FG000|Overall Study|Non-compliance with Study Drug|3|||
126263706|NCT01207440|454258273|FG001|Overall Study|Non-compliance with Study Drug|0|||
126263707|NCT01207440|454258274|FG002|Overall Study|Non-compliance with Study Drug|1|||
126263708|NCT01207440|454258275|FG003|Overall Study|Non-compliance with Study Drug|0|||
126263709|NCT01207440|454258276|FG004|Overall Study|Non-compliance with Study Drug|0|||
126263710|NCT01207440|454258277|FG005|Overall Study|Non-compliance with Study Drug|0|||
126263711|NCT01207440|454258278|FG006|Overall Study|Non-compliance with Study Drug|0|||
126263712|NCT01207440|454258272|FG000|Overall Study|Physician Decision|6|||
126263713|NCT01207440|454258273|FG001|Overall Study|Physician Decision|5|||
126263714|NCT01207440|454258274|FG002|Overall Study|Physician Decision|5|||
126263715|NCT01207440|454258275|FG003|Overall Study|Physician Decision|0|||
126263716|NCT01207440|454258276|FG004|Overall Study|Physician Decision|1|||
126263717|NCT01207440|454258277|FG005|Overall Study|Physician Decision|0|||
126263718|NCT01207440|454258278|FG006|Overall Study|Physician Decision|0|||
126263719|NCT01207440|454258272|FG000|Overall Study|Progressive Disease|19|||
126263720|NCT01207440|454258273|FG001|Overall Study|Progressive Disease|10|||
126263721|NCT01207440|454258274|FG002|Overall Study|Progressive Disease|19|||
126263722|NCT01207440|454258275|FG003|Overall Study|Progressive Disease|7|||
126263723|NCT01207440|454258276|FG004|Overall Study|Progressive Disease|23|||
126263724|NCT01207440|454258277|FG005|Overall Study|Progressive Disease|27|||
126263725|NCT01207440|454258278|FG006|Overall Study|Progressive Disease|0|||
126263726|NCT01207440|454258272|FG000|Overall Study|Protocol Violation|2|||
126263727|NCT01207440|454258273|FG001|Overall Study|Protocol Violation|0|||
126263728|NCT01207440|454258274|FG002|Overall Study|Protocol Violation|0|||
126263729|NCT01207440|454258275|FG003|Overall Study|Protocol Violation|0|||
126263730|NCT01207440|454258276|FG004|Overall Study|Protocol Violation|0|||
126263731|NCT01207440|454258277|FG005|Overall Study|Protocol Violation|0|||
126263732|NCT01207440|454258278|FG006|Overall Study|Protocol Violation|0|||
126263733|NCT01207440|454258272|FG000|Overall Study|Site Terminated by Sponsor|69|||
126263734|NCT01207440|454258273|FG001|Overall Study|Site Terminated by Sponsor|19|||
126263735|NCT01207440|454258274|FG002|Overall Study|Site Terminated by Sponsor|12|||
126263736|NCT01207440|454258275|FG003|Overall Study|Site Terminated by Sponsor|2|||
126263737|NCT01207440|454258276|FG004|Overall Study|Site Terminated by Sponsor|3|||
126263738|NCT01207440|454258277|FG005|Overall Study|Site Terminated by Sponsor|0|||
126263739|NCT01207440|454258278|FG006|Overall Study|Site Terminated by Sponsor|2|||
126263740|NCT01207440|454258272|FG000|Overall Study|Withdrawal by Subject|29|||
126263741|NCT01207440|454258273|FG001|Overall Study|Withdrawal by Subject|4|||
126263742|NCT01207440|454258274|FG002|Overall Study|Withdrawal by Subject|5|||
126263743|NCT01207440|454258275|FG003|Overall Study|Withdrawal by Subject|3|||
126263744|NCT01207440|454258276|FG004|Overall Study|Withdrawal by Subject|2|||
126263745|NCT01207440|454258277|FG005|Overall Study|Withdrawal by Subject|2|||
126263746|NCT01207440|454258278|FG006|Overall Study|Withdrawal by Subject|0|||
126263747|NCT01207440|454258272|FG000|Overall Study|Reason Not Specified|10|||
126546933|NCT04041440|455296087|FG000|Overall Study|Withdrawal by Subject|0|||
126263748|NCT01207440|454258273|FG001|Overall Study|Reason Not Specified|10|||
126263749|NCT01207440|454258274|FG002|Overall Study|Reason Not Specified|7|||
126263750|NCT01207440|454258275|FG003|Overall Study|Reason Not Specified|0|||
126263751|NCT01207440|454258276|FG004|Overall Study|Reason Not Specified|4|||
126263752|NCT01207440|454258277|FG005|Overall Study|Reason Not Specified|3|||
126263753|NCT01207440|454258278|FG006|Overall Study|Reason Not Specified|0|||
126263754|NCT03341000|454258279|FG000|Overall Study|Adverse Event|1|||
126263755|NCT02813421|454258282|FG000|Overall Study|Withdrawal by Subject|1|||
126263756|NCT02813421|454258283|FG001|Overall Study|Withdrawal by Subject|2|||
126263757|NCT02813421|454258282|FG000|Overall Study|Lost to Follow-up|1|||
126263758|NCT02813421|454258283|FG001|Overall Study|Lost to Follow-up|1|||
126263759|NCT03135899|454258284|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
126263760|NCT03135899|454258285|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
126263761|NCT03135899|454258286|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
126263762|NCT03135899|454258287|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
126359893|NCT04595370|454609087|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
126359894|NCT04595370|454609088|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
126359895|NCT04595370|454609089|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
126359896|NCT04595370|454609090|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
126359897|NCT04595370|454609091|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
126359898|NCT04595370|454609092|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
126359899|NCT04913675|454609093|FG000|Main Study (Up to Week 36)|Death|0|||
126359900|NCT04913675|454609094|FG001|Main Study (Up to Week 36)|Death|2|||
126359901|NCT04913675|454609095|FG002|Main Study (Up to Week 36)|Death|2|||
126359902|NCT04913675|454609096|FG003|Main Study (Up to Week 36)|Death|0|||
126359903|NCT04913675|454609093|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
126359904|NCT04913675|454609094|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
126359905|NCT04913675|454609095|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
126359906|NCT04913675|454609096|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
126263763|NCT03135899|454258288|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
126263764|NCT03135899|454258289|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
126263765|NCT03135899|454258290|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
126263766|NCT03135899|454258291|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
126263767|NCT03135899|454258284|FG000|Overall Study|Withdrawal by Subject|0|||
126263768|NCT03135899|454258285|FG001|Overall Study|Withdrawal by Subject|0|||
126263769|NCT03135899|454258286|FG002|Overall Study|Withdrawal by Subject|0|||
126263770|NCT03135899|454258287|FG003|Overall Study|Withdrawal by Subject|0|||
126263771|NCT03135899|454258288|FG004|Overall Study|Withdrawal by Subject|0|||
126263772|NCT03135899|454258289|FG005|Overall Study|Withdrawal by Subject|2|||
126263773|NCT03135899|454258290|FG006|Overall Study|Withdrawal by Subject|0|||
126263774|NCT03135899|454258291|FG007|Overall Study|Withdrawal by Subject|0|||
126263775|NCT04146363|454258300|FG000|Induction Period|Adverse Event|1|||
126263776|NCT04146363|454258301|FG001|Induction Period|Adverse Event|2|||
126263777|NCT04146363|454258302|FG002|Induction Period|Adverse Event|0|||
126263778|NCT04146363|454258303|FG003|Induction Period|Adverse Event|0|||
126263779|NCT04146363|454258304|FG004|Induction Period|Adverse Event|0|||
126263780|NCT04146363|454258305|FG005|Induction Period|Adverse Event|0|||
126263781|NCT04146363|454258306|FG006|Induction Period|Adverse Event|0|||
126263782|NCT04146363|454258307|FG007|Induction Period|Adverse Event|0|||
126263783|NCT04146363|454258308|FG008|Induction Period|Adverse Event|0|||
126263784|NCT04146363|454258309|FG009|Induction Period|Adverse Event|0|||
126263785|NCT04146363|454258310|FG010|Induction Period|Adverse Event|0|||
126263786|NCT04146363|454258300|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
126263787|NCT04146363|454258301|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
126263788|NCT04146363|454258302|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
126263789|NCT04146363|454258303|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
126263790|NCT04146363|454258304|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
126263791|NCT04146363|454258305|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
126263792|NCT04146363|454258306|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
126263793|NCT04146363|454258307|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
126263794|NCT04146363|454258308|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
126263795|NCT04146363|454258309|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
126263796|NCT04146363|454258310|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
126263797|NCT04146363|454258300|FG000|Induction Period|Lack of Efficacy|7|||
126263798|NCT04146363|454258301|FG001|Induction Period|Lack of Efficacy|2|||
126359907|NCT04913675|454609093|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
126359908|NCT04913675|454609094|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
126359909|NCT04913675|454609095|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
126359910|NCT04913675|454609096|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
126452296|NCT01616693|454957179|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
126452297|NCT01616693|454957180|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
126452298|NCT00653939|454957181|FG000|Overall Study|Adverse Event|1|||
126452299|NCT00653939|454957182|FG001|Overall Study|Adverse Event|3|||
126263799|NCT04146363|454258302|FG002|Induction Period|Lack of Efficacy|0|||
126263800|NCT04146363|454258303|FG003|Induction Period|Lack of Efficacy|0|||
126263801|NCT04146363|454258304|FG004|Induction Period|Lack of Efficacy|0|||
126263802|NCT04146363|454258305|FG005|Induction Period|Lack of Efficacy|0|||
126263803|NCT04146363|454258306|FG006|Induction Period|Lack of Efficacy|0|||
126263804|NCT04146363|454258307|FG007|Induction Period|Lack of Efficacy|0|||
126263805|NCT04146363|454258308|FG008|Induction Period|Lack of Efficacy|0|||
126263806|NCT04146363|454258309|FG009|Induction Period|Lack of Efficacy|0|||
126263807|NCT04146363|454258310|FG010|Induction Period|Lack of Efficacy|0|||
126263808|NCT04146363|454258300|FG000|Induction Period|Lost to Follow-up|1|||
126263809|NCT04146363|454258301|FG001|Induction Period|Lost to Follow-up|4|||
126263810|NCT04146363|454258302|FG002|Induction Period|Lost to Follow-up|0|||
126263811|NCT04146363|454258303|FG003|Induction Period|Lost to Follow-up|0|||
126263812|NCT04146363|454258304|FG004|Induction Period|Lost to Follow-up|0|||
126263813|NCT04146363|454258305|FG005|Induction Period|Lost to Follow-up|0|||
126359911|NCT04913675|454609093|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
126359912|NCT04913675|454609094|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
126359913|NCT04913675|454609095|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
126359914|NCT04913675|454609096|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
126359915|NCT04913675|454609093|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
126359916|NCT04913675|454609094|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
126359917|NCT04913675|454609095|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
126359918|NCT04913675|454609096|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
126359919|NCT01341990|454609099|FG000|Overall Study|Adverse Event|0|||
126359920|NCT01341990|454609100|FG001|Overall Study|Adverse Event|1|||
126359921|NCT01341990|454609099|FG000|Overall Study|Torn Study Lens|1|||
126359922|NCT01341990|454609100|FG001|Overall Study|Torn Study Lens|0|||
126359923|NCT01341990|454609099|FG000|Overall Study|Withdrawal by Subject|2|||
126359924|NCT01341990|454609100|FG001|Overall Study|Withdrawal by Subject|0|||
126359925|NCT02489045|454609101|FG000|Overall Study|unable to collect usable data|53|||
126359926|NCT02489045|454609101|FG000|Follow-up|Lost to Follow-up|10|||
126359927|NCT01751685|454609103|FG000|6-mo Followup|Missed study visit|1|||
126359928|NCT01751685|454609104|FG001|6-mo Followup|Missed study visit|0|||
126359929|NCT01751685|454609103|FG000|6-mo Followup|Withdrawal by Subject|2|||
126359930|NCT01751685|454609104|FG001|6-mo Followup|Withdrawal by Subject|2|||
126359931|NCT01751685|454609103|FG000|6-mo Followup|Lost to Follow-up|0|||
126359932|NCT01751685|454609104|FG001|6-mo Followup|Lost to Follow-up|1|||
126359933|NCT01751685|454609103|FG000|12-mo Followup|Lost to Follow-up|5|||
126263814|NCT04146363|454258306|FG006|Induction Period|Lost to Follow-up|0|||
126263815|NCT04146363|454258307|FG007|Induction Period|Lost to Follow-up|0|||
126263816|NCT04146363|454258308|FG008|Induction Period|Lost to Follow-up|0|||
126263817|NCT04146363|454258309|FG009|Induction Period|Lost to Follow-up|0|||
126263818|NCT04146363|454258310|FG010|Induction Period|Lost to Follow-up|0|||
126263819|NCT04146363|454258300|FG000|Induction Period|Positive quantiferon test|0|||
126263820|NCT04146363|454258301|FG001|Induction Period|Positive quantiferon test|1|||
126263821|NCT04146363|454258302|FG002|Induction Period|Positive quantiferon test|0|||
126263822|NCT04146363|454258303|FG003|Induction Period|Positive quantiferon test|0|||
126263823|NCT04146363|454258304|FG004|Induction Period|Positive quantiferon test|0|||
126263824|NCT04146363|454258305|FG005|Induction Period|Positive quantiferon test|0|||
126263825|NCT04146363|454258306|FG006|Induction Period|Positive quantiferon test|0|||
126263826|NCT04146363|454258307|FG007|Induction Period|Positive quantiferon test|0|||
126263827|NCT04146363|454258308|FG008|Induction Period|Positive quantiferon test|0|||
126263828|NCT04146363|454258309|FG009|Induction Period|Positive quantiferon test|0|||
126263829|NCT04146363|454258310|FG010|Induction Period|Positive quantiferon test|0|||
126263830|NCT04146363|454258300|FG000|Induction Period|Protocol Deviation|5|||
126263831|NCT04146363|454258301|FG001|Induction Period|Protocol Deviation|6|||
126263832|NCT04146363|454258302|FG002|Induction Period|Protocol Deviation|0|||
126263833|NCT04146363|454258303|FG003|Induction Period|Protocol Deviation|0|||
126263834|NCT04146363|454258304|FG004|Induction Period|Protocol Deviation|0|||
126263835|NCT04146363|454258305|FG005|Induction Period|Protocol Deviation|0|||
126263836|NCT04146363|454258306|FG006|Induction Period|Protocol Deviation|0|||
126263837|NCT04146363|454258307|FG007|Induction Period|Protocol Deviation|0|||
126263838|NCT04146363|454258308|FG008|Induction Period|Protocol Deviation|0|||
126263839|NCT04146363|454258309|FG009|Induction Period|Protocol Deviation|0|||
126263840|NCT04146363|454258310|FG010|Induction Period|Protocol Deviation|0|||
126263841|NCT04146363|454258300|FG000|Induction Period|Withdrawal by Subject|6|||
126263842|NCT04146363|454258301|FG001|Induction Period|Withdrawal by Subject|3|||
126263843|NCT04146363|454258302|FG002|Induction Period|Withdrawal by Subject|0|||
126263844|NCT04146363|454258303|FG003|Induction Period|Withdrawal by Subject|0|||
126263845|NCT04146363|454258304|FG004|Induction Period|Withdrawal by Subject|0|||
126263846|NCT04146363|454258305|FG005|Induction Period|Withdrawal by Subject|0|||
126263847|NCT04146363|454258306|FG006|Induction Period|Withdrawal by Subject|0|||
126263848|NCT04146363|454258307|FG007|Induction Period|Withdrawal by Subject|0|||
126263849|NCT04146363|454258308|FG008|Induction Period|Withdrawal by Subject|0|||
126452300|NCT00653939|454957181|FG000|Overall Study|Withdrawal by Subject|3|||
126452301|NCT00653939|454957182|FG001|Overall Study|Withdrawal by Subject|3|||
126452302|NCT00653939|454957181|FG000|Overall Study|Physician Decision|4|||
126452303|NCT00653939|454957182|FG001|Overall Study|Physician Decision|0|||
126452304|NCT00653939|454957181|FG000|Overall Study|Disease Progression|2|||
126452305|NCT00653939|454957182|FG001|Overall Study|Disease Progression|3|||
126452306|NCT00653939|454957181|FG000|Overall Study|Other|2|||
126263850|NCT04146363|454258309|FG009|Induction Period|Withdrawal by Subject|0|||
126263851|NCT04146363|454258310|FG010|Induction Period|Withdrawal by Subject|0|||
126263852|NCT04146363|454258300|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
126359934|NCT01751685|454609104|FG001|12-mo Followup|Lost to Follow-up|0|||
126359935|NCT01348490|454609111|FG000|Overall Study|Death|1|||
126359936|NCT01348490|454609111|FG000|Overall Study|Adverse Event|3|||
126359937|NCT01348490|454609111|FG000|Overall Study|Consent withdrawn|7|||
126452307|NCT00653939|454957182|FG001|Overall Study|Other|6|||
126263853|NCT04146363|454258301|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263854|NCT04146363|454258302|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263855|NCT04146363|454258303|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263856|NCT04146363|454258304|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263857|NCT04146363|454258305|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263858|NCT04146363|454258306|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
126263859|NCT04146363|454258307|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
126263860|NCT04146363|454258308|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263861|NCT04146363|454258309|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263862|NCT04146363|454258310|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
126263863|NCT04146363|454258300|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263864|NCT04146363|454258301|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263865|NCT04146363|454258302|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263866|NCT04146363|454258303|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263867|NCT04146363|454258304|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263868|NCT04146363|454258305|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263869|NCT04146363|454258306|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263870|NCT04146363|454258307|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
126263871|NCT04146363|454258308|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263872|NCT04146363|454258309|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263873|NCT04146363|454258310|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
126263874|NCT04146363|454258300|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263875|NCT04146363|454258301|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263876|NCT04146363|454258302|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263877|NCT04146363|454258303|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263878|NCT04146363|454258304|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263879|NCT04146363|454258305|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263880|NCT04146363|454258306|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
126263881|NCT04146363|454258307|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
126263882|NCT04146363|454258308|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263883|NCT04146363|454258309|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263884|NCT04146363|454258310|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
126263885|NCT04146363|454258300|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263886|NCT04146363|454258301|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263887|NCT04146363|454258302|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
126263888|NCT04146363|454258303|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263889|NCT04146363|454258304|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263890|NCT04146363|454258305|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
126263891|NCT04146363|454258306|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263892|NCT04146363|454258307|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263893|NCT04146363|454258308|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263894|NCT04146363|454258309|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263895|NCT04146363|454258310|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
126263896|NCT04146363|454258300|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126263897|NCT04146363|454258301|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126263898|NCT04146363|454258302|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126263899|NCT04146363|454258303|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126263900|NCT04146363|454258304|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
126263901|NCT04146363|454258305|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
126263902|NCT04146363|454258306|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
126263903|NCT04146363|454258307|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
126263904|NCT04146363|454258308|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126263905|NCT04146363|454258309|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126452308|NCT01105767|454957183|FG000|Overall Study|Lost to Follow-up|1160|||
126452309|NCT01105767|454957184|FG001|Overall Study|Lost to Follow-up|1614|||
126452310|NCT01105767|454957185|FG002|Overall Study|Lost to Follow-up|1184|||
126452311|NCT00743106|454957186|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
126452312|NCT00743106|454957187|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
126452313|NCT03704636|454957192|FG000|Overall Study|Inadequate Venous Flow|3|||
126452314|NCT00539188|454957195|FG000|Overall Study|Withdrawal by Subject|1|||
126700618|NCT01307423|455853615|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126700619|NCT01307423|455853616|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
126700620|NCT01307423|455853608|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
126263906|NCT04146363|454258310|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
126263907|NCT04146363|454258300|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126452315|NCT00539188|454957196|FG001|Overall Study|Withdrawal by Subject|0|||
126700621|NCT01307423|455853609|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
126546934|NCT04041440|455296088|FG001|Overall Study|Withdrawal by Subject|1|||
126763800|NCT05182840|456086871|FG002|Run-in Period|Adverse Event|0|||
126263908|NCT04146363|454258301|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126263909|NCT04146363|454258302|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
126263910|NCT04146363|454258303|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126263911|NCT04146363|454258304|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126263912|NCT04146363|454258305|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
126263913|NCT04146363|454258306|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
126263914|NCT04146363|454258307|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
126263915|NCT04146363|454258308|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126263916|NCT04146363|454258309|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126263917|NCT04146363|454258310|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
126263918|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263919|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263920|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263921|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263922|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263923|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263924|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263925|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263926|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
126263927|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
126263928|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
126263929|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263930|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263931|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263932|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263933|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263934|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263935|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263936|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126263937|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
126263938|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
126263939|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
126263940|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263941|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263942|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263943|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263944|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263945|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263946|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263947|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263948|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
126263949|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
126263950|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126263951|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263952|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263953|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263954|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263955|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263956|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263957|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263958|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263959|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
126263960|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
126263961|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
126263962|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263963|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263964|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263965|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263966|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263967|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263968|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263969|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126263970|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
126263971|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
126546935|NCT04041440|455296087|FG000|Overall Study|Lost to Follow-up|0|||
126263972|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
126263973|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263974|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263975|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263976|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263977|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263978|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
126763801|NCT05182840|456086872|FG003|Run-in Period|Adverse Event|0|||
126263979|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263980|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263981|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263982|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
126263983|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
126263984|NCT04146363|454258300|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263985|NCT04146363|454258301|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263986|NCT04146363|454258302|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263987|NCT04146363|454258303|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263988|NCT04146363|454258304|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263989|NCT04146363|454258305|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263990|NCT04146363|454258306|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263991|NCT04146363|454258307|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263992|NCT04146363|454258308|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263993|NCT04146363|454258309|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
126263994|NCT04146363|454258310|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
126263995|NCT02914236|454258311|FG000|Overall Study|Lost to Follow-up|1|||
126263996|NCT00706095|454258312|FG000|Overall Study|Progressive Disease|4|||
126263997|NCT00706095|454258313|FG001|Overall Study|Progressive Disease|5|||
126263998|NCT00706095|454258314|FG002|Overall Study|Progressive Disease|3|||
126263999|NCT00706095|454258312|FG000|Overall Study|Clinical Progression|1|||
126264000|NCT00706095|454258313|FG001|Overall Study|Clinical Progression|2|||
126264001|NCT00706095|454258314|FG002|Overall Study|Clinical Progression|2|||
126264002|NCT00706095|454258312|FG000|Overall Study|Withdrawal by Subject|1|||
126264003|NCT00706095|454258313|FG001|Overall Study|Withdrawal by Subject|0|||
126264004|NCT00706095|454258314|FG002|Overall Study|Withdrawal by Subject|0|||
126264005|NCT00856830|454258315|FG000|Irinotecan & Bendamustine|Death|0|||
126264006|NCT00856830|454258316|FG001|Irinotecan & Bendamustine|Death|0|||
126264007|NCT00856830|454258317|FG002|Irinotecan & Bendamustine|Death|0|||
126264008|NCT00856830|454258318|FG003|Irinotecan & Bendamustine|Death|2|||
126264009|NCT00856830|454258315|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
126264010|NCT00856830|454258316|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
126264011|NCT00856830|454258317|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
126264012|NCT00856830|454258318|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
126264013|NCT00918463|454258320|FG000|Overall Study|Death|1|||
126264014|NCT00918463|454258320|FG000|Overall Study|Lack of Efficacy|1|||
126264015|NCT01014624|454258324|FG000|Overall Study|Adverse Event|0|||
126264016|NCT01014624|454258325|FG001|Overall Study|Adverse Event|1|||
126264017|NCT01014624|454258324|FG000|Overall Study|Protocol Violation|1|||
126264018|NCT01014624|454258325|FG001|Overall Study|Protocol Violation|0|||
126264019|NCT01014624|454258324|FG000|Overall Study|Withdrawal by Subject|1|||
126264020|NCT01014624|454258325|FG001|Overall Study|Withdrawal by Subject|0|||
126264021|NCT02954159|454258327|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
126264022|NCT02954159|454258328|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
126264023|NCT02954159|454258327|FG000|Overall Study|Withdrawal by Subject|0|||
126264024|NCT02954159|454258328|FG001|Overall Study|Withdrawal by Subject|1|||
126264025|NCT01117337|454258332|FG000|Overall Study|Lost to Follow-up|4|||
126264026|NCT01117337|454258333|FG001|Overall Study|Lost to Follow-up|0|||
126264027|NCT03575871|454258334|FG000|Overall Study|Adverse Event|5|||
126264028|NCT03575871|454258335|FG001|Overall Study|Adverse Event|5|||
126264029|NCT03575871|454258336|FG002|Overall Study|Adverse Event|8|||
126264030|NCT03575871|454258334|FG000|Overall Study|Death|1|||
126264031|NCT03575871|454258335|FG001|Overall Study|Death|0|||
126264032|NCT03575871|454258336|FG002|Overall Study|Death|0|||
126264033|NCT03575871|454258334|FG000|Overall Study|Lack of Efficacy|5|||
126264034|NCT03575871|454258335|FG001|Overall Study|Lack of Efficacy|4|||
126264035|NCT03575871|454258336|FG002|Overall Study|Lack of Efficacy|7|||
126264036|NCT03575871|454258334|FG000|Overall Study|Lost to Follow-up|1|||
126264037|NCT03575871|454258335|FG001|Overall Study|Lost to Follow-up|1|||
126264038|NCT03575871|454258336|FG002|Overall Study|Lost to Follow-up|1|||
126264039|NCT03575871|454258334|FG000|Overall Study|Protocol Deviation|1|||
126359938|NCT01348490|454609111|FG000|Overall Study|Disease progression|3|||
126359939|NCT01348490|454609111|FG000|Overall Study|Lost to Follow-up|1|||
126359940|NCT01348490|454609111|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
126359941|NCT01348490|454609111|FG000|Overall Study|Other Unspecified|8|||
126359942|NCT01117350|454609116|FG000|Comparative Period|Not Treated|5|||
126359943|NCT01117350|454609117|FG001|Comparative Period|Not Treated|8|||
126264040|NCT03575871|454258335|FG001|Overall Study|Protocol Deviation|1|||
126264041|NCT03575871|454258336|FG002|Overall Study|Protocol Deviation|1|||
126264042|NCT03575871|454258334|FG000|Overall Study|Withdrawal by Subject|6|||
126264043|NCT03575871|454258335|FG001|Overall Study|Withdrawal by Subject|1|||
126264044|NCT03575871|454258336|FG002|Overall Study|Withdrawal by Subject|9|||
126264045|NCT03575871|454258334|FG000|Overall Study|Other than specified|2|||
126264046|NCT03575871|454258335|FG001|Overall Study|Other than specified|2|||
126264047|NCT03575871|454258336|FG002|Overall Study|Other than specified|0|||
126264048|NCT01744093|454258340|FG000|Overall Study|Withdrawal by Subject|6|||
126264049|NCT01744093|454258341|FG001|Overall Study|Withdrawal by Subject|1|||
126264050|NCT01570283|454258342|FG000|Cohort 1: Dose Level 1|Death|0|||
126264051|NCT01570283|454258343|FG001|Cohort 1: Dose Level 1|Death|1|||
126264052|NCT01570283|454258344|FG002|Cohort 1: Dose Level 1|Death|0|||
126264053|NCT01570283|454258345|FG003|Cohort 1: Dose Level 1|Death|0|||
126264054|NCT01570283|454258346|FG004|Cohort 1: Dose Level 1|Death|0|||
126264055|NCT01570283|454258347|FG005|Cohort 1: Dose Level 1|Death|0|||
126264056|NCT01570283|454258342|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
126264057|NCT01570283|454258343|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
126264058|NCT01570283|454258344|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
126264059|NCT01570283|454258345|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
126264060|NCT01570283|454258346|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
126264061|NCT01570283|454258347|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
126264062|NCT01570283|454258342|FG000|Cohort 2: Dose Level 2|Death|0|||
126264063|NCT01570283|454258343|FG001|Cohort 2: Dose Level 2|Death|0|||
126264064|NCT01570283|454258344|FG002|Cohort 2: Dose Level 2|Death|1|||
126264065|NCT01570283|454258345|FG003|Cohort 2: Dose Level 2|Death|0|||
126264066|NCT01570283|454258346|FG004|Cohort 2: Dose Level 2|Death|0|||
126264067|NCT01570283|454258347|FG005|Cohort 2: Dose Level 2|Death|0|||
126264068|NCT01570283|454258342|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
126264069|NCT01570283|454258343|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
126264070|NCT01570283|454258344|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
126264071|NCT01570283|454258345|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
126264072|NCT01570283|454258346|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
126264073|NCT01570283|454258347|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
126264074|NCT01570283|454258342|FG000|Cohort 3: Dose Level 3|Death|0|||
126264075|NCT01570283|454258343|FG001|Cohort 3: Dose Level 3|Death|0|||
126264076|NCT01570283|454258344|FG002|Cohort 3: Dose Level 3|Death|0|||
126264077|NCT01570283|454258345|FG003|Cohort 3: Dose Level 3|Death|0|||
126264078|NCT01570283|454258346|FG004|Cohort 3: Dose Level 3|Death|0|||
126264079|NCT01570283|454258347|FG005|Cohort 3: Dose Level 3|Death|1|||
126264080|NCT01570283|454258342|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
126264081|NCT01570283|454258343|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
126264082|NCT01570283|454258344|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
126264083|NCT01570283|454258345|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
126264084|NCT01570283|454258346|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
126264085|NCT01570283|454258347|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
126264086|NCT00355472|454258360|FG000|Overall Study|Physician Decision|1|||
126264087|NCT03095118|454258361|FG000|Overall Study|Adverse Event|1|||
126264088|NCT03095118|454258361|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
126264089|NCT03847194|454258362|FG000|Overall Study|Lost to Follow-up|2|||
126264090|NCT03847194|454258363|FG001|Overall Study|Lost to Follow-up|5|||
126264091|NCT03847194|454258362|FG000|Overall Study|Withdrawal by Subject|1|||
126264092|NCT03847194|454258363|FG001|Overall Study|Withdrawal by Subject|2|||
126264093|NCT03847194|454258362|FG000|Overall Study|Death|0|||
126700622|NCT01307423|455853610|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
126264094|NCT03847194|454258363|FG001|Overall Study|Death|1|||
126264095|NCT02408120|454258364|FG000|Overall Study|Withdrawal by Subject|0|||
126264096|NCT02408120|454258365|FG001|Overall Study|Withdrawal by Subject|1|||
126264097|NCT02408120|454258364|FG000|Overall Study|Treatment Refusal|1|||
126264098|NCT02408120|454258365|FG001|Overall Study|Treatment Refusal|0|||
126264099|NCT02408120|454258364|FG000|Overall Study|Received Steroids|1|||
126264100|NCT02408120|454258365|FG001|Overall Study|Received Steroids|1|||
126264101|NCT02408120|454258364|FG000|Overall Study|Discharged same day|1|||
126264102|NCT02408120|454258365|FG001|Overall Study|Discharged same day|1|||
126264103|NCT02408120|454258364|FG000|Overall Study|Did not receive insulin|1|||
126264104|NCT02408120|454258365|FG001|Overall Study|Did not receive insulin|2|||
126264105|NCT00680186|454258370|FG000|Overall Study|Adverse Event|47|||
126264106|NCT00680186|454258371|FG001|Overall Study|Adverse Event|44|||
126264107|NCT00680186|454258370|FG000|Overall Study|Protocol Violation|31|||
126264108|NCT00680186|454258371|FG001|Overall Study|Protocol Violation|26|||
126264109|NCT00680186|454258370|FG000|Overall Study|Lost to Follow-up|11|||
126264110|NCT00680186|454258371|FG001|Overall Study|Lost to Follow-up|6|||
126264111|NCT00680186|454258370|FG000|Overall Study|Withdrawal by Subject|32|||
126264112|NCT00680186|454258371|FG001|Overall Study|Withdrawal by Subject|39|||
126700623|NCT01307423|455853611|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
126264113|NCT00680186|454258370|FG000|Overall Study|Other|4|||
126264114|NCT00680186|454258371|FG001|Overall Study|Other|1|||
126264115|NCT00285584|454258379|FG000|Month 3|Lost to Follow-up|3|||
126264116|NCT00285584|454258380|FG001|Month 3|Lost to Follow-up|3|||
126264117|NCT00285584|454258379|FG000|Month 3|Withdrawal by Subject|1|||
126264118|NCT00285584|454258380|FG001|Month 3|Withdrawal by Subject|0|||
126264119|NCT00285584|454258379|FG000|Month 6|Lost to Follow-up|0|||
126264120|NCT00285584|454258380|FG001|Month 6|Lost to Follow-up|1|||
126264121|NCT00466726|454258381|FG000|Overall Study|Not evaluable for response|14|||
126264122|NCT01376310|454258382|FG000|Overall Study|Study closed/terminated|1|||
126264123|NCT01376310|454258383|FG001|Overall Study|Study closed/terminated|2|||
126264124|NCT01376310|454258382|FG000|Overall Study|Withdrawal by Subject|8|||
126264125|NCT01376310|454258383|FG001|Overall Study|Withdrawal by Subject|2|||
126264126|NCT01376310|454258382|FG000|Overall Study|Physician Decision|26|||
126264127|NCT01376310|454258383|FG001|Overall Study|Physician Decision|7|||
126264128|NCT01376310|454258382|FG000|Overall Study|Lost to Follow-up|1|||
126264129|NCT01376310|454258383|FG001|Overall Study|Lost to Follow-up|0|||
126264130|NCT00645944|454258384|FG000|Randomized|Withdrawal by Subject|1|||
126264131|NCT00645944|454258385|FG001|Randomized|Withdrawal by Subject|2|||
126264132|NCT00645944|454258384|FG000|Received Medication|Adverse Event|2|||
126264133|NCT00645944|454258385|FG001|Received Medication|Adverse Event|1|||
126264134|NCT00645944|454258384|FG000|Received Medication|Withdrawal by Subject|1|||
126264135|NCT00645944|454258385|FG001|Received Medication|Withdrawal by Subject|1|||
126264136|NCT00645944|454258384|FG000|Received Medication|Lost to Follow-up|1|||
126264137|NCT00645944|454258385|FG001|Received Medication|Lost to Follow-up|0|||
126264138|NCT00645944|454258384|FG000|Received Medication|Protocol Violation|2|||
126264139|NCT00645944|454258385|FG001|Received Medication|Protocol Violation|1|||
126264140|NCT01807117|454258387|FG000|Overall Study|Physician Decision|2|||
126264141|NCT01807117|454258387|FG000|Overall Study|Disease diagnosis not a study disease|1|||
126264142|NCT01523587|454258388|FG000|Overall Study|Other than listed|5|||
126264143|NCT01523587|454258389|FG001|Overall Study|Other than listed|5|||
126264144|NCT01523587|454258388|FG000|Overall Study|Worsening of underlying cancer disease|19|||
126264145|NCT01523587|454258389|FG001|Overall Study|Worsening of underlying cancer disease|34|||
126264146|NCT01523587|454258388|FG000|Overall Study|Adverse Event|68|||
126264147|NCT01523587|454258389|FG001|Overall Study|Adverse Event|52|||
126264148|NCT01523587|454258388|FG000|Overall Study|Protocol Violation|5|||
126264149|NCT01523587|454258389|FG001|Overall Study|Protocol Violation|3|||
126264150|NCT01523587|454258388|FG000|Overall Study|Lost to Follow-up|2|||
126264151|NCT01523587|454258389|FG001|Overall Study|Lost to Follow-up|2|||
126264152|NCT01523587|454258388|FG000|Overall Study|Withdrawal by Subject|28|||
126264153|NCT01523587|454258389|FG001|Overall Study|Withdrawal by Subject|20|||
126264154|NCT01523587|454258388|FG000|Overall Study|Withdrew due to Progressive disease|265|||
126264155|NCT01523587|454258389|FG001|Overall Study|Withdrew due to Progressive disease|279|||
126264156|NCT01523587|454258388|FG000|Overall Study|Randomised but bot treated|6|||
126264157|NCT01523587|454258389|FG001|Overall Study|Randomised but bot treated|2|||
126264158|NCT02709486|454258390|FG000|Overall Study|Adverse Event|2|||
126264159|NCT02709486|454258391|FG001|Overall Study|Adverse Event|5|||
126264160|NCT02709486|454258392|FG002|Overall Study|Adverse Event|3|||
126264161|NCT02709486|454258390|FG000|Overall Study|Death|0|||
126264162|NCT02709486|454258391|FG001|Overall Study|Death|0|||
126264163|NCT02709486|454258392|FG002|Overall Study|Death|2|||
126264164|NCT02709486|454258390|FG000|Overall Study|Insufficient clinical response|7|||
126264165|NCT02709486|454258391|FG001|Overall Study|Insufficient clinical response|3|||
126264166|NCT02709486|454258392|FG002|Overall Study|Insufficient clinical response|3|||
126264167|NCT02709486|454258390|FG000|Overall Study|Lost to Follow-up|3|||
126264168|NCT02709486|454258391|FG001|Overall Study|Lost to Follow-up|2|||
126264169|NCT02709486|454258392|FG002|Overall Study|Lost to Follow-up|2|||
126264170|NCT02709486|454258390|FG000|Overall Study|Other|0|||
126264171|NCT02709486|454258391|FG001|Overall Study|Other|2|||
126264172|NCT02709486|454258392|FG002|Overall Study|Other|3|||
126264173|NCT02709486|454258390|FG000|Overall Study|Withdrawal by Subject|32|||
126264174|NCT02709486|454258391|FG001|Overall Study|Withdrawal by Subject|22|||
126264175|NCT02709486|454258392|FG002|Overall Study|Withdrawal by Subject|32|||
126700624|NCT01307423|455853612|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
126700625|NCT01307423|455853613|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
126264176|NCT04179019|454258402|FG000|Overall Study|Lost to Follow-up|2|||
126264177|NCT04179019|454258402|FG000|Overall Study|Physician Decision|2|||
126264178|NCT04179019|454258402|FG000|Overall Study|Withdrawal by Subject|5|||
126264179|NCT04179019|454258402|FG000|Overall Study|Adverse Event|4|||
126264180|NCT02610816|454258403|FG000|Phase 1|Withdrawal by Subject|2|||
126264181|NCT02610816|454258404|FG001|Phase 1|Withdrawal by Subject|6|||
126264182|NCT02610816|454258405|FG002|Phase 1|Withdrawal by Subject|0|||
126264183|NCT02610816|454258406|FG003|Phase 1|Withdrawal by Subject|0|||
126700626|NCT01307423|455853614|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
126264184|NCT02610816|454258403|FG000|Phase 1|Lost to Follow-up|2|||
126264185|NCT02610816|454258404|FG001|Phase 1|Lost to Follow-up|1|||
126264186|NCT02610816|454258405|FG002|Phase 1|Lost to Follow-up|0|||
126264187|NCT02610816|454258406|FG003|Phase 1|Lost to Follow-up|0|||
126264188|NCT02610816|454258403|FG000|Phase 1|Physician Decision|0|||
126264189|NCT02610816|454258404|FG001|Phase 1|Physician Decision|1|||
126264190|NCT02610816|454258405|FG002|Phase 1|Physician Decision|0|||
126264191|NCT02610816|454258406|FG003|Phase 1|Physician Decision|0|||
126264192|NCT02610816|454258403|FG000|Phase 2|Withdrawal by Subject|0|||
126264193|NCT02610816|454258404|FG001|Phase 2|Withdrawal by Subject|0|||
126264194|NCT02610816|454258405|FG002|Phase 2|Withdrawal by Subject|9|||
126264195|NCT02610816|454258406|FG003|Phase 2|Withdrawal by Subject|3|||
126264196|NCT02610816|454258403|FG000|Phase 2|Lost to Follow-up|0|||
126264197|NCT02610816|454258404|FG001|Phase 2|Lost to Follow-up|0|||
126264198|NCT02610816|454258405|FG002|Phase 2|Lost to Follow-up|2|||
126264199|NCT02610816|454258406|FG003|Phase 2|Lost to Follow-up|0|||
126264200|NCT02610816|454258403|FG000|Phase 2|Physician Decision|0|||
126264201|NCT02610816|454258404|FG001|Phase 2|Physician Decision|0|||
126264202|NCT02610816|454258405|FG002|Phase 2|Physician Decision|0|||
126264203|NCT02610816|454258406|FG003|Phase 2|Physician Decision|2|||
126264204|NCT02610816|454258403|FG000|Phase 2|Pregnancy|0|||
126264205|NCT02610816|454258404|FG001|Phase 2|Pregnancy|0|||
126264206|NCT02610816|454258405|FG002|Phase 2|Pregnancy|0|||
126264207|NCT02610816|454258406|FG003|Phase 2|Pregnancy|1|||
126264208|NCT01855048|454258407|FG000|Overall Study|Withdrawal by Subject|0|||
126264209|NCT01855048|454258408|FG001|Overall Study|Withdrawal by Subject|1|||
126264210|NCT01855048|454258409|FG002|Overall Study|Withdrawal by Subject|0|||
126264211|NCT01855048|454258410|FG003|Overall Study|Withdrawal by Subject|0|||
126264212|NCT01855048|454258411|FG004|Overall Study|Withdrawal by Subject|1|||
126264213|NCT01855048|454258412|FG005|Overall Study|Withdrawal by Subject|0|||
126264214|NCT02691741|454258413|FG000|Overall Study|Adverse Event|0|||
126264215|NCT02691741|454258414|FG001|Overall Study|Adverse Event|2|||
126264216|NCT02691741|454258413|FG000|Overall Study|Lost to Follow-up|1|||
126264217|NCT02691741|454258414|FG001|Overall Study|Lost to Follow-up|0|||
126264218|NCT02691741|454258413|FG000|Overall Study|Physician Decision|0|||
126264219|NCT02691741|454258414|FG001|Overall Study|Physician Decision|1|||
126264220|NCT02691741|454258413|FG000|Overall Study|Withdrawal by Subject|0|||
126264221|NCT02691741|454258414|FG001|Overall Study|Withdrawal by Subject|4|||
126264222|NCT02139124|454258415|FG000|Overall Study|Adverse Event|2|||
126264223|NCT02139124|454258416|FG001|Overall Study|Adverse Event|0|||
126264224|NCT02139124|454258417|FG002|Overall Study|Adverse Event|1|||
126264225|NCT02139124|454258418|FG003|Overall Study|Adverse Event|2|||
126264226|NCT02139124|454258419|FG004|Overall Study|Adverse Event|5|||
126264227|NCT02139124|454258415|FG000|Overall Study|Withdrawal by Subject|2|||
126264228|NCT02139124|454258416|FG001|Overall Study|Withdrawal by Subject|2|||
126264229|NCT02139124|454258417|FG002|Overall Study|Withdrawal by Subject|2|||
126264230|NCT02139124|454258418|FG003|Overall Study|Withdrawal by Subject|2|||
126264231|NCT02139124|454258419|FG004|Overall Study|Withdrawal by Subject|3|||
126264232|NCT02139124|454258415|FG000|Overall Study|Protocol Violation|0|||
126264233|NCT02139124|454258416|FG001|Overall Study|Protocol Violation|0|||
126264234|NCT02139124|454258417|FG002|Overall Study|Protocol Violation|0|||
126264235|NCT02139124|454258418|FG003|Overall Study|Protocol Violation|1|||
126264236|NCT02139124|454258419|FG004|Overall Study|Protocol Violation|1|||
126264237|NCT02139124|454258415|FG000|Overall Study|non-compliant|1|||
126264238|NCT02139124|454258416|FG001|Overall Study|non-compliant|0|||
126264239|NCT02139124|454258417|FG002|Overall Study|non-compliant|0|||
126264240|NCT02139124|454258418|FG003|Overall Study|non-compliant|2|||
126264241|NCT02139124|454258419|FG004|Overall Study|non-compliant|0|||
126264242|NCT02139124|454258415|FG000|Overall Study|incarceration|0|||
126264243|NCT02139124|454258416|FG001|Overall Study|incarceration|0|||
126264244|NCT02139124|454258417|FG002|Overall Study|incarceration|1|||
126264245|NCT02139124|454258418|FG003|Overall Study|incarceration|0|||
126264246|NCT02139124|454258419|FG004|Overall Study|incarceration|0|||
126264247|NCT02139124|454258415|FG000|Overall Study|subject moved|1|||
126264248|NCT02139124|454258416|FG001|Overall Study|subject moved|0|||
126264249|NCT02139124|454258417|FG002|Overall Study|subject moved|0|||
126264250|NCT02139124|454258418|FG003|Overall Study|subject moved|0|||
126264251|NCT02139124|454258419|FG004|Overall Study|subject moved|0|||
126264252|NCT02139124|454258415|FG000|Overall Study|Lost to Follow-up|3|||
126264253|NCT02139124|454258416|FG001|Overall Study|Lost to Follow-up|2|||
126264254|NCT02139124|454258417|FG002|Overall Study|Lost to Follow-up|0|||
126264255|NCT02139124|454258418|FG003|Overall Study|Lost to Follow-up|5|||
126264256|NCT02139124|454258419|FG004|Overall Study|Lost to Follow-up|4|||
126264257|NCT03465436|454258420|FG000|Period 1|Protocol Violation|0|||
126264258|NCT03465436|454258421|FG001|Period 1|Protocol Violation|0|||
126264259|NCT03465436|454258422|FG002|Period 1|Protocol Violation|1|||
126264260|NCT03465436|454258423|FG003|Period 1|Protocol Violation|0|||
126264261|NCT03465436|454258420|FG000|Period 2|Protocol Violation|0|||
126264262|NCT03465436|454258421|FG001|Period 2|Protocol Violation|1|||
126264263|NCT03465436|454258422|FG002|Period 2|Protocol Violation|0|||
126264264|NCT03465436|454258423|FG003|Period 2|Protocol Violation|0|||
126264265|NCT03465436|454258420|FG000|Period 3|Protocol Violation|1|||
126264266|NCT03465436|454258421|FG001|Period 3|Protocol Violation|1|||
126264267|NCT03465436|454258422|FG002|Period 3|Protocol Violation|0|||
126264268|NCT03465436|454258423|FG003|Period 3|Protocol Violation|0|||
126264269|NCT03465436|454258420|FG000|Period 4|Protocol Violation|0|||
126264270|NCT03465436|454258421|FG001|Period 4|Protocol Violation|0|||
126264271|NCT03465436|454258422|FG002|Period 4|Protocol Violation|1|||
126264272|NCT03465436|454258423|FG003|Period 4|Protocol Violation|0|||
126264273|NCT02697773|454258424|FG000|Overall Study|Adverse Event|2|||
126264274|NCT02697773|454258425|FG001|Overall Study|Adverse Event|1|||
126264275|NCT02697773|454258426|FG002|Overall Study|Adverse Event|2|||
126264276|NCT02697773|454258424|FG000|Overall Study|Death|0|||
126264277|NCT02697773|454258425|FG001|Overall Study|Death|0|||
126264278|NCT02697773|454258426|FG002|Overall Study|Death|2|||
126264279|NCT02697773|454258424|FG000|Overall Study|Lack of Efficacy|4|||
126264280|NCT02697773|454258425|FG001|Overall Study|Lack of Efficacy|6|||
126264281|NCT02697773|454258426|FG002|Overall Study|Lack of Efficacy|6|||
126264282|NCT02697773|454258424|FG000|Overall Study|Lost to Follow-up|5|||
126264283|NCT02697773|454258425|FG001|Overall Study|Lost to Follow-up|5|||
126264284|NCT02697773|454258426|FG002|Overall Study|Lost to Follow-up|7|||
126264285|NCT02697773|454258424|FG000|Overall Study|Other|15|||
126264286|NCT02697773|454258425|FG001|Overall Study|Other|11|||
126264287|NCT02697773|454258426|FG002|Overall Study|Other|10|||
126264288|NCT02697773|454258424|FG000|Overall Study|Protocol Violation|1|||
126264289|NCT02697773|454258425|FG001|Overall Study|Protocol Violation|1|||
126264290|NCT02697773|454258426|FG002|Overall Study|Protocol Violation|0|||
126264291|NCT02697773|454258424|FG000|Overall Study|Withdrawal by Subject|10|||
126264292|NCT02697773|454258425|FG001|Overall Study|Withdrawal by Subject|13|||
126264293|NCT02697773|454258426|FG002|Overall Study|Withdrawal by Subject|13|||
126264294|NCT02697773|454258424|FG000|Overall Study|Randomized but not treated|1|||
126264295|NCT02697773|454258425|FG001|Overall Study|Randomized but not treated|1|||
126264296|NCT02697773|454258426|FG002|Overall Study|Randomized but not treated|0|||
126264297|NCT00613834|454258427|FG000|Overall Study|Withdrawal by Subject|0|||
126264298|NCT00613834|454258428|FG001|Overall Study|Withdrawal by Subject|3|||
126264299|NCT00842530|454258429|FG000|Overall Study|Serious adverse event|0|||
126264300|NCT00842530|454258430|FG001|Overall Study|Serious adverse event|6|||
126264301|NCT00842530|454258429|FG000|Overall Study|Other adverse event|6|||
126264302|NCT00842530|454258430|FG001|Overall Study|Other adverse event|1|||
126264303|NCT00842530|454258429|FG000|Overall Study|Protocol Violation|32|||
126264304|NCT00842530|454258430|FG001|Overall Study|Protocol Violation|14|||
126264305|NCT00842530|454258429|FG000|Overall Study|Lost to Follow-up|6|||
126264306|NCT00842530|454258430|FG001|Overall Study|Lost to Follow-up|8|||
126264307|NCT00842530|454258429|FG000|Overall Study|Withdrawal by Subject|73|||
126264308|NCT00842530|454258430|FG001|Overall Study|Withdrawal by Subject|28|||
126264309|NCT02939950|454258433|FG000|Overall Study|Lost to Follow-up|13|||
126264310|NCT02939950|454258434|FG001|Overall Study|Lost to Follow-up|16|||
126264311|NCT02939950|454258433|FG000|Overall Study|Positive slit lamp findings|0|||
126264312|NCT02939950|454258434|FG001|Overall Study|Positive slit lamp findings|1|||
126264313|NCT02939950|454258433|FG000|Overall Study|Chalazion upper lid|0|||
126264314|NCT02939950|454258434|FG001|Overall Study|Chalazion upper lid|1|||
126264315|NCT02939950|454258433|FG000|Overall Study|Lack of motivation|0|||
126264316|NCT02939950|454258434|FG001|Overall Study|Lack of motivation|2|||
126264317|NCT02939950|454258433|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
126264318|NCT02939950|454258434|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
126264319|NCT02939950|454258433|FG000|Overall Study|Military orders|1|||
126264320|NCT02939950|454258434|FG001|Overall Study|Military orders|0|||
126264321|NCT02939950|454258433|FG000|Overall Study|Participant Relocated|5|||
126264322|NCT02939950|454258434|FG001|Overall Study|Participant Relocated|3|||
126264323|NCT02939950|454258433|FG000|Overall Study|Study related symptoms|8|||
126264324|NCT02939950|454258434|FG001|Overall Study|Study related symptoms|8|||
126264325|NCT02939950|454258433|FG000|Overall Study|Unacceptable lens movement|2|||
126264326|NCT02939950|454258434|FG001|Overall Study|Unacceptable lens movement|0|||
126264327|NCT02939950|454258433|FG000|Overall Study|Protocol Violation|6|||
126264328|NCT02939950|454258434|FG001|Overall Study|Protocol Violation|3|||
126264329|NCT02939950|454258433|FG000|Overall Study|Physician Decision|2|||
126264330|NCT02939950|454258434|FG001|Overall Study|Physician Decision|0|||
126264331|NCT02939950|454258433|FG000|Overall Study|Pregnancy|6|||
126264332|NCT02939950|454258434|FG001|Overall Study|Pregnancy|7|||
126264333|NCT02939950|454258433|FG000|Overall Study|Withdrawal by Subject|12|||
126264334|NCT02939950|454258434|FG001|Overall Study|Withdrawal by Subject|28|||
126264335|NCT02939950|454258433|FG000|Overall Study|Adverse Event|7|||
126452316|NCT00539188|454957195|FG000|Overall Study|Lost to Follow-up|2|||
126452317|NCT00539188|454957196|FG001|Overall Study|Lost to Follow-up|1|||
126452318|NCT01546623|454957197|FG000|Overall Study|Adverse Event|2|||
126700627|NCT01307423|455853615|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
126264336|NCT02939950|454258434|FG001|Overall Study|Adverse Event|3|||
126264337|NCT02939950|454258433|FG000|Overall Study|Randomized, not dispensed|1|||
126264338|NCT02939950|454258434|FG001|Overall Study|Randomized, not dispensed|0|||
126264339|NCT02939950|454258433|FG000|Overall Study|Ineligible at Baseline|2|||
126264340|NCT02939950|454258434|FG001|Overall Study|Ineligible at Baseline|8|||
126264341|NCT02243293|454258438|FG000|Overall Study|Adverse Event|1|||
126264342|NCT02243293|454258439|FG001|Overall Study|Adverse Event|0|||
126264343|NCT02243293|454258440|FG002|Overall Study|Adverse Event|0|||
126452319|NCT01546623|454957198|FG001|Overall Study|Adverse Event|3|||
126763802|NCT05182840|456086873|FG004|Run-in Period|Adverse Event|0|||
126763803|NCT05182840|456086874|FG005|Run-in Period|Adverse Event|0|||
126264344|NCT02243293|454258441|FG003|Overall Study|Adverse Event|0|||
126264345|NCT02243293|454258442|FG004|Overall Study|Adverse Event|0|||
126264346|NCT02243293|454258443|FG005|Overall Study|Adverse Event|0|||
126264347|NCT02243293|454258444|FG006|Overall Study|Adverse Event|0|||
126264348|NCT02243293|454258445|FG007|Overall Study|Adverse Event|0|||
126264349|NCT02243293|454258446|FG008|Overall Study|Adverse Event|0|||
126264350|NCT02243293|454258447|FG009|Overall Study|Adverse Event|0|||
126264351|NCT02243293|454258448|FG010|Overall Study|Adverse Event|0|||
126264352|NCT02243293|454258449|FG011|Overall Study|Adverse Event|0|||
126264353|NCT02243293|454258450|FG012|Overall Study|Adverse Event|0|||
126264354|NCT02243293|454258451|FG013|Overall Study|Adverse Event|0|||
126264355|NCT02243293|454258452|FG014|Overall Study|Adverse Event|0|||
126264356|NCT02243293|454258453|FG015|Overall Study|Adverse Event|1|||
126264357|NCT02243293|454258454|FG016|Overall Study|Adverse Event|0|||
126264358|NCT02243293|454258455|FG017|Overall Study|Adverse Event|0|||
126264359|NCT02243293|454258456|FG018|Overall Study|Adverse Event|0|||
126264360|NCT02243293|454258457|FG019|Overall Study|Adverse Event|0|||
126264361|NCT02243293|454258458|FG020|Overall Study|Adverse Event|1|||
126264362|NCT02243293|454258459|FG021|Overall Study|Adverse Event|0|||
126264363|NCT02243293|454258438|FG000|Overall Study|Withdrawal by Subject|1|||
126264364|NCT02243293|454258439|FG001|Overall Study|Withdrawal by Subject|0|||
126264365|NCT02243293|454258440|FG002|Overall Study|Withdrawal by Subject|0|||
126264366|NCT02243293|454258441|FG003|Overall Study|Withdrawal by Subject|0|||
126264367|NCT02243293|454258442|FG004|Overall Study|Withdrawal by Subject|0|||
126264368|NCT02243293|454258443|FG005|Overall Study|Withdrawal by Subject|0|||
126264369|NCT02243293|454258444|FG006|Overall Study|Withdrawal by Subject|0|||
126264370|NCT02243293|454258445|FG007|Overall Study|Withdrawal by Subject|0|||
126264371|NCT02243293|454258446|FG008|Overall Study|Withdrawal by Subject|0|||
126264372|NCT02243293|454258447|FG009|Overall Study|Withdrawal by Subject|1|||
126264373|NCT02243293|454258448|FG010|Overall Study|Withdrawal by Subject|0|||
126264374|NCT02243293|454258449|FG011|Overall Study|Withdrawal by Subject|1|||
126264375|NCT02243293|454258450|FG012|Overall Study|Withdrawal by Subject|0|||
126264376|NCT02243293|454258451|FG013|Overall Study|Withdrawal by Subject|0|||
126264377|NCT02243293|454258452|FG014|Overall Study|Withdrawal by Subject|0|||
126264378|NCT02243293|454258453|FG015|Overall Study|Withdrawal by Subject|0|||
126264379|NCT02243293|454258454|FG016|Overall Study|Withdrawal by Subject|0|||
126264380|NCT02243293|454258455|FG017|Overall Study|Withdrawal by Subject|0|||
126264381|NCT02243293|454258456|FG018|Overall Study|Withdrawal by Subject|0|||
126264382|NCT02243293|454258457|FG019|Overall Study|Withdrawal by Subject|0|||
126264383|NCT02243293|454258458|FG020|Overall Study|Withdrawal by Subject|0|||
126264384|NCT02243293|454258459|FG021|Overall Study|Withdrawal by Subject|1|||
126264385|NCT02243293|454258438|FG000|Overall Study|Lost to Follow-up|0|||
126264386|NCT02243293|454258439|FG001|Overall Study|Lost to Follow-up|1|||
126264387|NCT02243293|454258440|FG002|Overall Study|Lost to Follow-up|1|||
126264388|NCT02243293|454258441|FG003|Overall Study|Lost to Follow-up|1|||
126264389|NCT02243293|454258442|FG004|Overall Study|Lost to Follow-up|0|||
126264390|NCT02243293|454258443|FG005|Overall Study|Lost to Follow-up|0|||
126264391|NCT02243293|454258444|FG006|Overall Study|Lost to Follow-up|3|||
126264392|NCT02243293|454258445|FG007|Overall Study|Lost to Follow-up|0|||
126264393|NCT02243293|454258446|FG008|Overall Study|Lost to Follow-up|0|||
126264394|NCT02243293|454258447|FG009|Overall Study|Lost to Follow-up|0|||
126264395|NCT02243293|454258448|FG010|Overall Study|Lost to Follow-up|0|||
126264396|NCT02243293|454258449|FG011|Overall Study|Lost to Follow-up|2|||
126264397|NCT02243293|454258450|FG012|Overall Study|Lost to Follow-up|0|||
126264398|NCT02243293|454258451|FG013|Overall Study|Lost to Follow-up|0|||
126264399|NCT02243293|454258452|FG014|Overall Study|Lost to Follow-up|0|||
126264400|NCT02243293|454258453|FG015|Overall Study|Lost to Follow-up|0|||
126264401|NCT02243293|454258454|FG016|Overall Study|Lost to Follow-up|3|||
126264402|NCT02243293|454258455|FG017|Overall Study|Lost to Follow-up|1|||
126264403|NCT02243293|454258456|FG018|Overall Study|Lost to Follow-up|0|||
126264404|NCT02243293|454258457|FG019|Overall Study|Lost to Follow-up|0|||
126264405|NCT02243293|454258458|FG020|Overall Study|Lost to Follow-up|1|||
126264406|NCT02243293|454258459|FG021|Overall Study|Lost to Follow-up|2|||
126264407|NCT02243293|454258438|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
126264408|NCT02243293|454258439|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
126264409|NCT02243293|454258440|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
126264410|NCT02243293|454258441|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
126264411|NCT02243293|454258442|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
126264412|NCT02243293|454258443|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
126264413|NCT02243293|454258444|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
126264414|NCT02243293|454258445|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
126763804|NCT05182840|456086875|FG006|Run-in Period|Adverse Event|0|||
126763805|NCT05182840|456086876|FG007|Run-in Period|Adverse Event|0|||
126264415|NCT02243293|454258446|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
126264416|NCT02243293|454258447|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
126264417|NCT02243293|454258448|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
126264418|NCT02243293|454258449|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
126264419|NCT02243293|454258450|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
126264420|NCT02243293|454258451|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
126264421|NCT02243293|454258452|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
126264422|NCT02243293|454258453|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
126264423|NCT02243293|454258454|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
126264424|NCT02243293|454258455|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
126264425|NCT02243293|454258456|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
126264426|NCT02243293|454258457|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
126264427|NCT02243293|454258458|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
126264428|NCT02243293|454258459|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
126264429|NCT02243293|454258438|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
126264430|NCT02243293|454258439|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
126264431|NCT02243293|454258440|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
126264432|NCT02243293|454258441|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
126264433|NCT02243293|454258442|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
126264434|NCT02243293|454258443|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
126264435|NCT02243293|454258444|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
126264436|NCT02243293|454258445|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
126264437|NCT02243293|454258446|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
126264438|NCT02243293|454258447|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
126264439|NCT02243293|454258448|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
126264440|NCT02243293|454258449|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
126264441|NCT02243293|454258450|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
126264442|NCT02243293|454258451|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
126359944|NCT01117350|454609116|FG000|Comparative Period|Adverse Event|6|||
126359945|NCT01117350|454609117|FG001|Comparative Period|Adverse Event|33|||
126359946|NCT01117350|454609116|FG000|Comparative Period|Lost to Follow-up|11|||
126359947|NCT01117350|454609117|FG001|Comparative Period|Lost to Follow-up|7|||
126700628|NCT01307423|455853616|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
126700629|NCT01307423|455853608|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126700630|NCT01307423|455853609|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126700631|NCT01307423|455853610|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126763806|NCT05182840|456086877|FG008|Run-in Period|Adverse Event|0|||
126763807|NCT05182840|456086878|FG009|Run-in Period|Adverse Event|0|||
126763808|NCT05182840|456086869|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
126763809|NCT05182840|456086870|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
126763810|NCT05182840|456086871|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126763811|NCT05182840|456086872|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126763812|NCT05182840|456086873|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126700632|NCT01307423|455853611|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126700633|NCT01307423|455853612|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126359948|NCT01117350|454609116|FG000|Comparative Period|Withdrawal by Subject|9|||
126700634|NCT01307423|455853613|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
126700635|NCT01307423|455853614|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126700636|NCT01307423|455853615|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126700637|NCT01307423|455853616|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
126700638|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126700639|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
126700640|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
126700641|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126700642|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126700643|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126700644|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
126700645|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
126700646|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
126700647|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126700648|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
126700649|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
126700650|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126700651|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126700652|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126700653|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
126700654|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
126700655|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
126700656|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126700657|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126700658|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
126700659|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126700660|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126700661|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126700662|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126700663|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126700664|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
126700665|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126700666|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
126700667|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
126700668|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126700669|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126700670|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126700671|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126700672|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
126700673|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
126700674|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126700675|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
126700676|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126700677|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126700678|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126700679|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126700680|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
126700681|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
126700682|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
126700683|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126700684|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
126700685|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
126700686|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126700687|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126700688|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126700689|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
126700690|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
126700691|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
126700692|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126700693|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
126700694|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
126700695|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126700696|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126700697|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126700698|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
126700699|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
126700700|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
126700701|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126700702|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
126700703|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
126700704|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126700705|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126700706|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126700707|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126700708|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126700709|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
126700710|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126700711|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
126700712|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
126700713|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126700714|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126700715|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126700716|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126452320|NCT01546623|454957197|FG000|Overall Study|Major Protocol Deviation|1|||
126700717|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
126700718|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
126700719|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126700720|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
126700721|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
126700722|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126700723|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126700724|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126700725|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
126700726|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
126700727|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
126700728|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126700729|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
126700730|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126700731|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126700732|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126700733|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126700734|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126700735|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
126700736|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
126700737|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126700738|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
126700739|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126700740|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126700741|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126700742|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126700743|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126700744|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126700745|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
126700746|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126700747|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
126700748|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126700749|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126700750|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126700751|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126700752|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126700753|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
126700754|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
126700755|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126700756|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
126700757|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
126700758|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126700759|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126700760|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126700761|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126700762|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
126700763|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
126700764|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126700765|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126700766|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
126700767|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126700768|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126700769|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126700770|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126700771|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126700772|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
126700773|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126700774|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126700775|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126700776|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126700777|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126700778|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126700779|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126700780|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
126700781|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
126700782|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126700783|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
126700784|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
126700785|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126700786|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126264443|NCT02243293|454258452|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
126264444|NCT02243293|454258453|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
126264445|NCT02243293|454258454|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
126546936|NCT04041440|455296088|FG001|Overall Study|Lost to Follow-up|1|||
126700787|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126700788|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126700789|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
126700790|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
126700791|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126700792|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
126700793|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
126700794|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126700795|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126700796|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126700797|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126700798|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126700799|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
126700800|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126700801|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
126700802|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
126700803|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126700804|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126700805|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126700806|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126700807|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126700808|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
126700809|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126700810|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
126700811|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126700812|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126700813|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126700814|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126700815|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126700816|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126700817|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
126700818|NCT01307423|455853608|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126700819|NCT01307423|455853609|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126700820|NCT01307423|455853610|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
126700821|NCT01307423|455853611|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126700822|NCT01307423|455853612|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126700823|NCT01307423|455853613|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126700824|NCT01307423|455853614|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
126546937|NCT01381874|455296089|FG000|Overall Study|Lost to Follow-up|1|||
126546938|NCT01381874|455296090|FG001|Overall Study|Lost to Follow-up|1|||
126546939|NCT01381874|455296091|FG002|Overall Study|Lost to Follow-up|0|||
126546940|NCT01381874|455296089|FG000|Overall Study|Withdrawal by Subject|9|||
126546941|NCT01381874|455296090|FG001|Overall Study|Withdrawal by Subject|10|||
126546942|NCT01381874|455296091|FG002|Overall Study|Withdrawal by Subject|9|||
126546943|NCT01381874|455296089|FG000|Overall Study|Other|67|||
126546944|NCT01381874|455296090|FG001|Overall Study|Other|52|||
126546945|NCT01381874|455296091|FG002|Overall Study|Other|67|||
126546946|NCT02247804|455296092|FG000|Treatment Period 1|Adverse Event|9|||
126546947|NCT02247804|455296093|FG001|Treatment Period 1|Adverse Event|2|||
126546948|NCT02247804|455296094|FG002|Treatment Period 1|Adverse Event|0|||
126546949|NCT02247804|455296092|FG000|Treatment Period 1|Lack of Efficacy|0|||
126546950|NCT02247804|455296093|FG001|Treatment Period 1|Lack of Efficacy|0|||
126546951|NCT02247804|455296094|FG002|Treatment Period 1|Lack of Efficacy|2|||
126546952|NCT02247804|455296092|FG000|Treatment Period 1|Lost to Follow-up|1|||
126546953|NCT02247804|455296093|FG001|Treatment Period 1|Lost to Follow-up|0|||
126546954|NCT02247804|455296094|FG002|Treatment Period 1|Lost to Follow-up|2|||
126700825|NCT01307423|455853615|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
126546955|NCT02247804|455296092|FG000|Treatment Period 1|Personal Reasons|7|||
126546956|NCT02247804|455296093|FG001|Treatment Period 1|Personal Reasons|1|||
126546957|NCT02247804|455296094|FG002|Treatment Period 1|Personal Reasons|2|||
126700826|NCT01307423|455853616|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
126700827|NCT00190775|455853617|FG000|Overall Study|Adverse Event|57|||
126700828|NCT00190775|455853618|FG001|Overall Study|Adverse Event|22|||
126264446|NCT02243293|454258455|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
126264447|NCT02243293|454258456|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
126264448|NCT02243293|454258457|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
126264449|NCT02243293|454258458|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
126546958|NCT02247804|455296092|FG000|Treatment Period 1|Protocol Deviation|0|||
126546959|NCT02247804|455296093|FG001|Treatment Period 1|Protocol Deviation|0|||
126546960|NCT02247804|455296094|FG002|Treatment Period 1|Protocol Deviation|1|||
126700829|NCT00190775|455853617|FG000|Overall Study|Satisfactory Response|1|||
126700830|NCT00190775|455853618|FG001|Overall Study|Satisfactory Response|0|||
126700831|NCT00190775|455853617|FG000|Overall Study|Lack of Efficacy|28|||
126700832|NCT00190775|455853618|FG001|Overall Study|Lack of Efficacy|32|||
126700833|NCT00190775|455853617|FG000|Overall Study|Lost to Follow-up|31|||
126546961|NCT02247804|455296092|FG000|Treatment Period 1|Randomized but not Treated|5|||
126452321|NCT01546623|454957198|FG001|Overall Study|Major Protocol Deviation|1|||
126452322|NCT01546623|454957197|FG000|Overall Study|High Prostate specific antigen|2|||
126452323|NCT01546623|454957198|FG001|Overall Study|High Prostate specific antigen|1|||
126452324|NCT01546623|454957197|FG000|Overall Study|Did Not Receive Study Drug|1|||
126452325|NCT01546623|454957198|FG001|Overall Study|Did Not Receive Study Drug|1|||
126452326|NCT01134705|454957199|FG000|Overall Study|Adverse Event|1|||
126452327|NCT01134705|454957200|FG001|Overall Study|Adverse Event|7|||
126452328|NCT01134705|454957199|FG000|Overall Study|Withdrawal by Subject|6|||
126452329|NCT01134705|454957200|FG001|Overall Study|Withdrawal by Subject|6|||
126452330|NCT01134705|454957199|FG000|Overall Study|Pregnancy|1|||
126452331|NCT01134705|454957200|FG001|Overall Study|Pregnancy|0|||
126452332|NCT01134705|454957199|FG000|Overall Study|Lost to Follow-up|5|||
126452333|NCT01134705|454957200|FG001|Overall Study|Lost to Follow-up|2|||
126452334|NCT01134705|454957199|FG000|Overall Study|Protocol Violation|1|||
126452335|NCT01134705|454957200|FG001|Overall Study|Protocol Violation|1|||
126452336|NCT01134705|454957199|FG000|Overall Study|Other|1|||
126452337|NCT01134705|454957200|FG001|Overall Study|Other|6|||
126452338|NCT02874144|454957203|FG000|Overall Study|Lost to Follow-up|3|||
126452339|NCT02874144|454957204|FG001|Overall Study|Lost to Follow-up|5|||
126452340|NCT03753789|454957206|FG000|Overall Study|Withdrawal by Subject|2|||
126452341|NCT01578850|454957210|FG000|Period 1|Insufficient Clinical Response|1|||
126452342|NCT01578850|454957211|FG001|Period 1|Insufficient Clinical Response|0|||
126452343|NCT01578850|454957212|FG002|Period 1|Insufficient Clinical Response|0|||
126452344|NCT01578850|454957210|FG000|Period 1|Adverse Event|11|||
126452345|NCT01578850|454957211|FG001|Period 1|Adverse Event|0|||
126452346|NCT01578850|454957212|FG002|Period 1|Adverse Event|0|||
126452347|NCT01578850|454957210|FG000|Period 1|Death|1|||
126452348|NCT01578850|454957211|FG001|Period 1|Death|0|||
126452349|NCT01578850|454957212|FG002|Period 1|Death|0|||
126452350|NCT01578850|454957210|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
126452351|NCT01578850|454957211|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
126452352|NCT01578850|454957212|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
126452353|NCT01578850|454957210|FG000|Period 1|Withdrawal by Subject|9|||
126452354|NCT01578850|454957211|FG001|Period 1|Withdrawal by Subject|0|||
126452355|NCT01578850|454957212|FG002|Period 1|Withdrawal by Subject|0|||
126452356|NCT01578850|454957210|FG000|Period 1|Study Terminated by Sponsor|3|||
126452357|NCT01578850|454957211|FG001|Period 1|Study Terminated by Sponsor|0|||
126452358|NCT01578850|454957212|FG002|Period 1|Study Terminated by Sponsor|0|||
126452359|NCT01578850|454957210|FG000|Period 2|Insufficient Clinical Response|0|||
126452360|NCT01578850|454957211|FG001|Period 2|Insufficient Clinical Response|1|||
126452361|NCT01578850|454957212|FG002|Period 2|Insufficient Clinical Response|0|||
126452362|NCT01578850|454957210|FG000|Period 2|Adverse Event|0|||
126452363|NCT01578850|454957211|FG001|Period 2|Adverse Event|3|||
126452364|NCT01578850|454957212|FG002|Period 2|Adverse Event|6|||
126452365|NCT01578850|454957210|FG000|Period 2|Lost to Follow-up|0|||
126452366|NCT01578850|454957211|FG001|Period 2|Lost to Follow-up|1|||
126452367|NCT01578850|454957212|FG002|Period 2|Lost to Follow-up|2|||
126452368|NCT01578850|454957210|FG000|Period 2|Withdrawal by Subject|0|||
126452369|NCT01578850|454957211|FG001|Period 2|Withdrawal by Subject|2|||
126546962|NCT02247804|455296093|FG001|Treatment Period 1|Randomized but not Treated|1|||
126546963|NCT02247804|455296094|FG002|Treatment Period 1|Randomized but not Treated|1|||
126546964|NCT02247804|455296092|FG000|Treatment Period 2|Adverse Event|6|||
126700834|NCT00190775|455853618|FG001|Overall Study|Lost to Follow-up|23|||
126700835|NCT00190775|455853617|FG000|Overall Study|Participant Moved|0|||
126700836|NCT00190775|455853618|FG001|Overall Study|Participant Moved|1|||
126700837|NCT00190775|455853617|FG000|Overall Study|Withdrawal by Subject|24|||
126700838|NCT00190775|455853618|FG001|Overall Study|Withdrawal by Subject|13|||
126264450|NCT02243293|454258459|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
126264451|NCT01118117|454258460|FG000|Overall Study|Death|8|||
126264452|NCT01118117|454258461|FG001|Overall Study|Death|0|||
126452370|NCT01578850|454957212|FG002|Period 2|Withdrawal by Subject|2|||
126452371|NCT01578850|454957210|FG000|Period 2|Study Terminated by Sponsor|0|||
126452372|NCT01578850|454957211|FG001|Period 2|Study Terminated by Sponsor|5|||
126452373|NCT01578850|454957212|FG002|Period 2|Study Terminated by Sponsor|4|||
126452374|NCT01578850|454957210|FG000|Period 2|Unspecified Reasons|0|||
126452375|NCT01578850|454957211|FG001|Period 2|Unspecified Reasons|1|||
126452376|NCT01578850|454957212|FG002|Period 2|Unspecified Reasons|0|||
126452377|NCT01008423|454957213|FG000|Overall Study|Adverse Event|13|||
126452378|NCT01008423|454957214|FG001|Overall Study|Adverse Event|6|||
126452379|NCT01008423|454957213|FG000|Overall Study|Withdrawal by Subject|4|||
126264453|NCT01118117|454258460|FG000|Overall Study|Lost to Follow-up|6|||
126452380|NCT01008423|454957214|FG001|Overall Study|Withdrawal by Subject|7|||
126452381|NCT01008423|454957213|FG000|Overall Study|Lost to Follow-up|0|||
126452382|NCT01008423|454957214|FG001|Overall Study|Lost to Follow-up|2|||
126452383|NCT01008423|454957213|FG000|Overall Study|Low Cortisol|0|||
126700839|NCT00190775|455853617|FG000|Overall Study|Sponsor Decision|1|||
126700840|NCT00190775|455853618|FG001|Overall Study|Sponsor Decision|0|||
126700841|NCT00190775|455853617|FG000|Overall Study|Physician Decision|3|||
126700842|NCT00190775|455853618|FG001|Overall Study|Physician Decision|0|||
126700843|NCT00190775|455853617|FG000|Overall Study|Noncompliance|3|||
126700844|NCT00190775|455853618|FG001|Overall Study|Noncompliance|5|||
126700845|NCT00190775|455853617|FG000|Overall Study|Protocol Violation|0|||
126700846|NCT00190775|455853618|FG001|Overall Study|Protocol Violation|1|||
126700847|NCT00190775|455853617|FG000|Overall Study|Exclusion Criteria Met|1|||
126700848|NCT00190775|455853618|FG001|Overall Study|Exclusion Criteria Met|3|||
126700849|NCT00519077|455853619|FG000|Overall Study|Death|6|||
126700850|NCT00519077|455853619|FG000|Overall Study|Other|2|||
126700851|NCT01967225|455853620|FG000|Overall Study|Adverse Event|3|||
126700852|NCT01967225|455853621|FG001|Overall Study|Adverse Event|1|||
126700853|NCT01967225|455853620|FG000|Overall Study|Withdrawal by Subject|2|||
126700854|NCT01967225|455853621|FG001|Overall Study|Withdrawal by Subject|1|||
126700855|NCT01967225|455853620|FG000|Overall Study|Lack of Efficacy|1|||
126700856|NCT01967225|455853621|FG001|Overall Study|Lack of Efficacy|1|||
126700857|NCT01967225|455853620|FG000|Overall Study|Switching to other therapy|2|||
126700858|NCT01967225|455853621|FG001|Overall Study|Switching to other therapy|0|||
126700859|NCT01967225|455853620|FG000|Overall Study|Protocol driven decision point|1|||
126700860|NCT01967225|455853621|FG001|Overall Study|Protocol driven decision point|0|||
126700861|NCT01967225|455853620|FG000|Overall Study|Logistical difficulties|1|||
126700862|NCT01967225|455853621|FG001|Overall Study|Logistical difficulties|0|||
126700863|NCT01967225|455853620|FG000|Overall Study|Protocol Violation|2|||
126700864|NCT01967225|455853621|FG001|Overall Study|Protocol Violation|0|||
126700865|NCT03896295|455853622|FG000|Overall Study|Adverse Event|0|||
126700866|NCT03896295|455853623|FG001|Overall Study|Adverse Event|1|||
126700867|NCT03896295|455853622|FG000|Overall Study|COVID-19|7|||
126700868|NCT03896295|455853623|FG001|Overall Study|COVID-19|29|||
126700869|NCT00700804|455853624|FG000|Overall Study|Withdrawal by Subject|1|||
126700870|NCT00700804|455853625|FG001|Overall Study|Withdrawal by Subject|2|||
126700871|NCT00700804|455853624|FG000|Overall Study|Protocol Violation|1|||
126700872|NCT00700804|455853625|FG001|Overall Study|Protocol Violation|1|||
126700873|NCT00700804|455853624|FG000|Overall Study|Loose Stools|1|||
126700874|NCT00700804|455853625|FG001|Overall Study|Loose Stools|1|||
126700875|NCT01511445|455853626|FG000|Overall Study|Lost to Follow-up|3|||
126700876|NCT01511445|455853627|FG001|Overall Study|Lost to Follow-up|1|||
126700877|NCT01511445|455853626|FG000|Overall Study|Protocol Violation|1|||
126700878|NCT01511445|455853627|FG001|Overall Study|Protocol Violation|3|||
126700879|NCT01511445|455853626|FG000|Overall Study|Protocol Violation|1|||
126700880|NCT01511445|455853627|FG001|Overall Study|Protocol Violation|0|||
126700881|NCT04696861|455853628|FG000|Overall Study|Death|1|||
126700882|NCT04696861|455853629|FG001|Overall Study|Death|0|||
126700883|NCT04696861|455853628|FG000|Overall Study|Lost to Follow-up|3|||
126700884|NCT04696861|455853629|FG001|Overall Study|Lost to Follow-up|0|||
126700885|NCT02382133|455853630|FG000|Overall Study|Death|22|||
126700886|NCT02382133|455853630|FG000|Overall Study|transfer out of ICU|4|||
126700887|NCT02382133|455853630|FG000|Overall Study|Physician Decision|2|||
126700888|NCT02382133|455853630|FG000|Overall Study|arterial catheter loss|4|||
126700889|NCT02382133|455853630|FG000|Overall Study|pressure injury both sites|1|||
126700890|NCT04906707|455853631|FG000|Overall Study|Withdrawal by Subject|2|||
126700891|NCT04906707|455853632|FG001|Overall Study|Withdrawal by Subject|0|||
126700892|NCT04906707|455853631|FG000|Overall Study|Withdrawal due to PI decision|1|||
126700893|NCT04906707|455853632|FG001|Overall Study|Withdrawal due to PI decision|0|||
126700894|NCT04906707|455853631|FG000|Overall Study|Lost to Follow-up|0|||
126700895|NCT04906707|455853632|FG001|Overall Study|Lost to Follow-up|1|||
126700896|NCT01976806|455853633|FG000|Overall Study|Lost to Follow-up|1|||
126700897|NCT01976806|455853634|FG001|Overall Study|Lost to Follow-up|4|||
126700898|NCT01976806|455853633|FG000|Overall Study|Adverse Event|1|||
126700899|NCT01976806|455853634|FG001|Overall Study|Adverse Event|1|||
126700900|NCT01976806|455853633|FG000|Overall Study|Withdrawal by Subject|1|||
126700901|NCT01976806|455853634|FG001|Overall Study|Withdrawal by Subject|1|||
126700902|NCT02654002|455853639|FG000|Overall Study|Adverse Event|0|||
126700903|NCT02654002|455853640|FG001|Overall Study|Adverse Event|0|||
126700904|NCT02654002|455853641|FG002|Overall Study|Adverse Event|0|||
126700905|NCT02654002|455853642|FG003|Overall Study|Adverse Event|0|||
126700906|NCT02654002|455853643|FG004|Overall Study|Adverse Event|0|||
126700907|NCT02654002|455853644|FG005|Overall Study|Adverse Event|0|||
126700908|NCT02654002|455853645|FG006|Overall Study|Adverse Event|1|||
126700909|NCT02654002|455853646|FG007|Overall Study|Adverse Event|0|||
126700910|NCT02654002|455853647|FG008|Overall Study|Adverse Event|0|||
126700911|NCT02654002|455853639|FG000|Overall Study|Withdrew Consent|0|||
126700912|NCT02654002|455853640|FG001|Overall Study|Withdrew Consent|0|||
126700913|NCT02654002|455853641|FG002|Overall Study|Withdrew Consent|0|||
126700914|NCT02654002|455853642|FG003|Overall Study|Withdrew Consent|0|||
126700915|NCT02654002|455853643|FG004|Overall Study|Withdrew Consent|0|||
126700916|NCT02654002|455853644|FG005|Overall Study|Withdrew Consent|1|||
126700917|NCT02654002|455853645|FG006|Overall Study|Withdrew Consent|0|||
126700918|NCT02654002|455853646|FG007|Overall Study|Withdrew Consent|1|||
126700919|NCT02654002|455853647|FG008|Overall Study|Withdrew Consent|0|||
126359949|NCT01117350|454609117|FG001|Comparative Period|Withdrawal by Subject|13|||
126359950|NCT01117350|454609116|FG000|Comparative Period|Protocol Violation|8|||
126359951|NCT01117350|454609117|FG001|Comparative Period|Protocol Violation|12|||
126359952|NCT01117350|454609116|FG000|Comparative Period|Lack of Efficacy|1|||
126359953|NCT01117350|454609117|FG001|Comparative Period|Lack of Efficacy|0|||
126359954|NCT01117350|454609116|FG000|Comparative Period|Physician Decision|0|||
126359955|NCT01117350|454609117|FG001|Comparative Period|Physician Decision|1|||
126359956|NCT01117350|454609116|FG000|Comparative Period|Move to another city/country|2|||
126359957|NCT01117350|454609117|FG001|Comparative Period|Move to another city/country|1|||
126359958|NCT01117350|454609116|FG000|Extension Period|Not included in extension, not treated|0|||
126359959|NCT01117350|454609117|FG001|Extension Period|Not included in extension, not treated|50|||
126359960|NCT01117350|454609116|FG000|Extension Period|Adverse Event|0|||
126359961|NCT01117350|454609117|FG001|Extension Period|Adverse Event|2|||
126359962|NCT01117350|454609116|FG000|Extension Period|Protocol Violation|0|||
126359963|NCT01117350|454609117|FG001|Extension Period|Protocol Violation|2|||
126359964|NCT01117350|454609116|FG000|Extension Period|Lost to Follow-up|0|||
126359965|NCT01117350|454609117|FG001|Extension Period|Lost to Follow-up|2|||
126359966|NCT01117350|454609116|FG000|Extension Period|Withdrawal by Subject|0|||
126359967|NCT01117350|454609117|FG001|Extension Period|Withdrawal by Subject|3|||
126359968|NCT01117350|454609116|FG000|Extension Period|Lack of Efficacy|0|||
126359969|NCT01117350|454609117|FG001|Extension Period|Lack of Efficacy|2|||
126359970|NCT01117350|454609116|FG000|Extension Period|Inclusion criteria not respected|0|||
126359971|NCT01117350|454609117|FG001|Extension Period|Inclusion criteria not respected|1|||
126359972|NCT01117350|454609116|FG000|Extension Period|Prohibited medication|0|||
126359973|NCT01117350|454609117|FG001|Extension Period|Prohibited medication|1|||
126359974|NCT00800384|454609118|FG000|Overall Study|Withdrawal by Subject|24|||
126359975|NCT00800384|454609119|FG001|Overall Study|Withdrawal by Subject|17|||
126359976|NCT00800384|454609118|FG000|Overall Study|Lost to Follow-up|17|||
126359977|NCT00800384|454609119|FG001|Overall Study|Lost to Follow-up|26|||
126700920|NCT01523873|455853648|FG000|Overall Study|Protocol Violation|422|||
126700921|NCT03946449|455853655|FG000|Treatment Extension II|Rolled over to another study|0|||
126763813|NCT05182840|456086874|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126763814|NCT05182840|456086875|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126763815|NCT05182840|456086876|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126763816|NCT05182840|456086877|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126763817|NCT05182840|456086878|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
126763818|NCT05182840|456086869|FG000|Treatment Period|Reason missing|0|||
126763819|NCT05182840|456086870|FG001|Treatment Period|Reason missing|0|||
126700922|NCT03946449|455853656|FG001|Treatment Extension II|Rolled over to another study|0|||
126700923|NCT03946449|455853657|FG002|Treatment Extension II|Rolled over to another study|2|||
126700924|NCT03946449|455853655|FG000|Treatment Extension II|Withdrawal by Subject|0|||
126700925|NCT03946449|455853656|FG001|Treatment Extension II|Withdrawal by Subject|0|||
126700926|NCT03946449|455853657|FG002|Treatment Extension II|Withdrawal by Subject|1|||
126700927|NCT03896581|455856621|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
126700928|NCT03896581|455856622|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
126700929|NCT03896581|455856621|FG000|Overall Study|Withdrawal by Subject|4|||
126700930|NCT03896581|455856622|FG001|Overall Study|Withdrawal by Subject|1|||
126700931|NCT03896581|455856621|FG000|Overall Study|Lost to Follow-up|1|||
126700932|NCT03896581|455856622|FG001|Overall Study|Lost to Follow-up|0|||
126700933|NCT03896581|455856621|FG000|Overall Study|Lack of Efficacy|2|||
126700934|NCT03896581|455856622|FG001|Overall Study|Lack of Efficacy|1|||
126700935|NCT03896581|455856621|FG000|Overall Study|Adverse event, non-fatal|0|||
126700936|NCT03896581|455856622|FG001|Overall Study|Adverse event, non-fatal|2|||
126700937|NCT04375761|455856623|FG000|Overall Study|Death|1|||
126700938|NCT04375761|455856624|FG001|Overall Study|Death|2|||
126700939|NCT04375761|455856623|FG000|Overall Study|Lost to Follow-up|203|||
126700940|NCT04375761|455856624|FG001|Overall Study|Lost to Follow-up|380|||
126700941|NCT04375761|455856623|FG000|Overall Study|Withdrawal by Subject|47|||
126700942|NCT04375761|455856624|FG001|Overall Study|Withdrawal by Subject|98|||
126700943|NCT04375761|455856623|FG000|Overall Study|Noncompliance with study procedure|121|||
126763820|NCT05182840|456086871|FG002|Treatment Period|Reason missing|1|||
126763821|NCT05182840|456086872|FG003|Treatment Period|Reason missing|0|||
126763822|NCT05182840|456086873|FG004|Treatment Period|Reason missing|0|||
126700944|NCT04375761|455856624|FG001|Overall Study|Noncompliance with study procedure|251|||
126359978|NCT01027754|454610707|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
126359979|NCT01027754|454610708|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
126359980|NCT01027754|454610707|FG000|Overall Study|Withdrawal by Subject|0|||
126359981|NCT01027754|454610708|FG001|Overall Study|Withdrawal by Subject|5|||
126359982|NCT00326495|454610709|FG000|Overall Study|Switched to alternative treatment|1|||
126359983|NCT00326495|454610709|FG000|Overall Study|Disease progression before treatment|1|||
126359984|NCT00326495|454610709|FG000|Overall Study|Refused further treatment|2|||
126452384|NCT01008423|454957214|FG001|Overall Study|Low Cortisol|1|||
126452385|NCT01008423|454957213|FG000|Overall Study|Lack of Efficacy|0|||
126452386|NCT01008423|454957214|FG001|Overall Study|Lack of Efficacy|5|||
126452387|NCT01008423|454957213|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
126452388|NCT01008423|454957214|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
126452389|NCT01008423|454957213|FG000|Overall Study|Personal Conflict|1|||
126452390|NCT01008423|454957214|FG001|Overall Study|Personal Conflict|0|||
126452391|NCT01008423|454957213|FG000|Overall Study|Other|0|||
126452392|NCT01008423|454957214|FG001|Overall Study|Other|1|||
126452393|NCT03288142|454957216|FG000|Overall Study|Lost to Follow-up|22|||
126452394|NCT03288142|454957217|FG001|Overall Study|Lost to Follow-up|15|||
126700945|NCT04375761|455856623|FG000|Overall Study|Reimbursement not enough|1|||
126700946|NCT04375761|455856624|FG001|Overall Study|Reimbursement not enough|2|||
126700947|NCT04375761|455856623|FG000|Overall Study|Unforeseen family circumstances|1|||
126700948|NCT04375761|455856624|FG001|Overall Study|Unforeseen family circumstances|3|||
126700949|NCT04375761|455856623|FG000|Overall Study|Test too painful|1|||
126700950|NCT04375761|455856624|FG001|Overall Study|Test too painful|1|||
126700951|NCT04375761|455856623|FG000|Overall Study|Moved|0|||
126700952|NCT04375761|455856624|FG001|Overall Study|Moved|2|||
126700953|NCT04375761|455856623|FG000|Overall Study|Nonresponsive|0|||
126700954|NCT04375761|455856624|FG001|Overall Study|Nonresponsive|5|||
126700955|NCT03797001|455856625|FG000|Overall Study|Withdrawn due to COVID19|4|||
126700956|NCT03797001|455856626|FG001|Overall Study|Withdrawn due to COVID19|0|||
126700957|NCT03797001|455856625|FG000|Overall Study|Withdrawal by Subject|7|||
126700958|NCT03797001|455856626|FG001|Overall Study|Withdrawal by Subject|6|||
126700959|NCT03797001|455856625|FG000|Overall Study|Adverse Event|0|||
126700960|NCT03797001|455856626|FG001|Overall Study|Adverse Event|1|||
126700961|NCT05630846|455856629|FG000|Overall Study|Death|1|||
126700962|NCT05630846|455856630|FG001|Overall Study|Death|0|||
126700963|NCT05630846|455856631|FG002|Overall Study|Death|0|||
126700964|NCT05630846|455856632|FG003|Overall Study|Death|0|||
126700965|NCT05630846|455856629|FG000|Overall Study|Withdrawal by Subject|3|||
126700966|NCT05630846|455856630|FG001|Overall Study|Withdrawal by Subject|3|||
126700967|NCT05630846|455856631|FG002|Overall Study|Withdrawal by Subject|4|||
126700968|NCT05630846|455856632|FG003|Overall Study|Withdrawal by Subject|1|||
126700969|NCT05630846|455856629|FG000|Overall Study|Lost to Follow-up|6|||
126700970|NCT05630846|455856630|FG001|Overall Study|Lost to Follow-up|5|||
126700971|NCT05630846|455856631|FG002|Overall Study|Lost to Follow-up|2|||
126700972|NCT05630846|455856632|FG003|Overall Study|Lost to Follow-up|5|||
126700973|NCT05630846|455856629|FG000|Overall Study|Other|1|||
126700974|NCT05630846|455856630|FG001|Overall Study|Other|0|||
126700975|NCT05630846|455856631|FG002|Overall Study|Other|0|||
126700976|NCT05630846|455856632|FG003|Overall Study|Other|0|||
126700977|NCT00960076|455856644|FG000|Overall Study|Adverse Event|1|||
126700978|NCT00960076|455856645|FG001|Overall Study|Adverse Event|7|||
126700979|NCT00960076|455856644|FG000|Overall Study|No longer met study criteria|1|||
126700980|NCT00960076|455856645|FG001|Overall Study|No longer met study criteria|5|||
126700981|NCT00960076|455856644|FG000|Overall Study|Withdrawal by Subject|1|||
126700982|NCT00960076|455856645|FG001|Overall Study|Withdrawal by Subject|2|||
126700983|NCT00960076|455856644|FG000|Overall Study|Lost to Follow-up|3|||
126700984|NCT00960076|455856645|FG001|Overall Study|Lost to Follow-up|3|||
126700985|NCT00960076|455856644|FG000|Overall Study|Severe non-compliance to protocol|1|||
126700986|NCT00960076|455856645|FG001|Overall Study|Severe non-compliance to protocol|2|||
126700987|NCT00960076|455856644|FG000|Overall Study|Hyperglycemia|1|||
126700988|NCT00960076|455856645|FG001|Overall Study|Hyperglycemia|5|||
126700989|NCT00960076|455856644|FG000|Overall Study|Did not attend the termination visit|0|||
126700990|NCT00960076|455856645|FG001|Overall Study|Did not attend the termination visit|1|||
126700991|NCT00500266|455856646|FG000|Overall Study|Death|3|||
126700992|NCT00500266|455856646|FG000|Overall Study|Lost to Follow-up|3|||
126700993|NCT00500266|455856646|FG000|Overall Study|Withdrawal by Subject|3|||
126700994|NCT00500266|455856646|FG000|Overall Study|Assigned, not treated|4|||
126700995|NCT01431287|455856647|FG000|Overall Study|not treated|0|||
126700996|NCT01431287|455856648|FG001|Overall Study|not treated|0|||
126700997|NCT01431287|455856649|FG002|Overall Study|not treated|1|||
126700998|NCT01431287|455856650|FG003|Overall Study|not treated|0|||
126700999|NCT01431287|455856651|FG004|Overall Study|not treated|0|||
126452395|NCT00946153|454957218|FG000|Phase 2|Adverse Event|0|||
126701000|NCT01431287|455856647|FG000|Overall Study|Adverse Event|59|||
126701001|NCT01431287|455856648|FG001|Overall Study|Adverse Event|57|||
126701002|NCT01431287|455856649|FG002|Overall Study|Adverse Event|53|||
126701003|NCT01431287|455856650|FG003|Overall Study|Adverse Event|33|||
126452396|NCT00946153|454957219|FG001|Phase 2|Adverse Event|0|||
126452397|NCT00946153|454957220|FG002|Phase 2|Adverse Event|0|||
126452398|NCT00946153|454957221|FG003|Phase 2|Adverse Event|0|||
126452399|NCT00946153|454957222|FG004|Phase 2|Adverse Event|6|||
126452400|NCT00946153|454957218|FG000|Phase 2|Need more reduction of dose|0|||
126546965|NCT02247804|455296093|FG001|Treatment Period 2|Adverse Event|3|||
126701004|NCT01431287|455856651|FG004|Overall Study|Adverse Event|41|||
126701005|NCT01431287|455856647|FG000|Overall Study|Non compliant with protocol|6|||
126701006|NCT01431287|455856648|FG001|Overall Study|Non compliant with protocol|6|||
126701007|NCT01431287|455856649|FG002|Overall Study|Non compliant with protocol|5|||
126701008|NCT01431287|455856650|FG003|Overall Study|Non compliant with protocol|6|||
126701009|NCT01431287|455856651|FG004|Overall Study|Non compliant with protocol|5|||
126701010|NCT01431287|455856647|FG000|Overall Study|Lost to Follow-up|0|||
126701011|NCT01431287|455856648|FG001|Overall Study|Lost to Follow-up|3|||
126701012|NCT01431287|455856649|FG002|Overall Study|Lost to Follow-up|2|||
126701013|NCT01431287|455856650|FG003|Overall Study|Lost to Follow-up|3|||
126701014|NCT01431287|455856651|FG004|Overall Study|Lost to Follow-up|1|||
126701015|NCT01431287|455856647|FG000|Overall Study|Consent withdrawn not due to AE|29|||
126701016|NCT01431287|455856648|FG001|Overall Study|Consent withdrawn not due to AE|30|||
126701017|NCT01431287|455856649|FG002|Overall Study|Consent withdrawn not due to AE|34|||
126701018|NCT01431287|455856650|FG003|Overall Study|Consent withdrawn not due to AE|19|||
126701019|NCT01431287|455856651|FG004|Overall Study|Consent withdrawn not due to AE|29|||
126701020|NCT01431287|455856647|FG000|Overall Study|not stated above|4|||
126701021|NCT01431287|455856648|FG001|Overall Study|not stated above|2|||
126701022|NCT01431287|455856649|FG002|Overall Study|not stated above|2|||
126701023|NCT01431287|455856650|FG003|Overall Study|not stated above|2|||
126701024|NCT01431287|455856651|FG004|Overall Study|not stated above|1|||
126701025|NCT02109029|455856652|FG000|Part B|Adverse Event|0|||
126701026|NCT02109029|455856653|FG001|Part B|Adverse Event|0|||
126701027|NCT02109029|455856654|FG002|Part B|Adverse Event|0|||
126701028|NCT02109029|455856655|FG003|Part B|Adverse Event|0|||
126701029|NCT02109029|455856656|FG004|Part B|Adverse Event|1|||
126701030|NCT02109029|455856657|FG005|Part B|Adverse Event|1|||
126701031|NCT00110305|455856658|FG000|Overall Study|Adverse Event|46|||
126701032|NCT00110305|455856659|FG001|Overall Study|Adverse Event|13|||
126701033|NCT00110305|455856658|FG000|Overall Study|Sponsors Decision|1|||
126701034|NCT00110305|455856659|FG001|Overall Study|Sponsors Decision|0|||
126701035|NCT00110305|455856658|FG000|Overall Study|Subject Non-Compliant|9|||
126701036|NCT00110305|455856659|FG001|Overall Study|Subject Non-Compliant|2|||
126701037|NCT00110305|455856658|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
126701038|NCT00110305|455856659|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
126701039|NCT00110305|455856658|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
126701040|NCT00110305|455856659|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
126701041|NCT00110305|455856658|FG000|Overall Study|Protocol Violation|0|||
126701042|NCT00110305|455856659|FG001|Overall Study|Protocol Violation|1|||
126701043|NCT00110305|455856658|FG000|Overall Study|Withdrawal by Subject|7|||
126701044|NCT00110305|455856659|FG001|Overall Study|Withdrawal by Subject|7|||
126701045|NCT00110305|455856658|FG000|Overall Study|Lost to Follow-up|20|||
126701046|NCT00110305|455856659|FG001|Overall Study|Lost to Follow-up|3|||
126701047|NCT00110305|455856658|FG000|Overall Study|Other|8|||
126701048|NCT00110305|455856659|FG001|Overall Study|Other|2|||
126701049|NCT02251743|455856662|FG000|Overall Study|Withdrawal by Subject|1|||
126701050|NCT02251743|455856663|FG001|Overall Study|Withdrawal by Subject|1|||
126701051|NCT00768222|455856664|FG000|Overall Study|Lost to Follow-up|1|||
126701052|NCT00768222|455856665|FG001|Overall Study|Lost to Follow-up|1|||
126701053|NCT00768222|455856664|FG000|Overall Study|Withdrawal by Subject|3|||
126701054|NCT00768222|455856665|FG001|Overall Study|Withdrawal by Subject|1|||
126701055|NCT00768222|455856664|FG000|Overall Study|Protocol Violation|0|||
126701056|NCT00768222|455856665|FG001|Overall Study|Protocol Violation|2|||
126701057|NCT03312218|455856666|FG000|Overall Study|Never signed in to access the app|54|||
126701058|NCT03312218|455856667|FG001|Overall Study|Never signed in to access the app|58|||
126701059|NCT05040971|455856672|FG000|Overall Study|Withdrawal by Subject|0|||
126701060|NCT05040971|455856673|FG001|Overall Study|Withdrawal by Subject|2|||
126701061|NCT05040971|455856672|FG000|Overall Study|Lost to Follow-up|8|||
126701062|NCT05040971|455856673|FG001|Overall Study|Lost to Follow-up|3|||
126701063|NCT05040971|455856672|FG000|Overall Study|Death|2|||
126701064|NCT05040971|455856673|FG001|Overall Study|Death|0|||
126701065|NCT06161012|455856674|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
126701066|NCT06161012|455856675|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
126452401|NCT00946153|454957219|FG001|Phase 2|Need more reduction of dose|0|||
126452402|NCT00946153|454957220|FG002|Phase 2|Need more reduction of dose|0|||
126452403|NCT00946153|454957221|FG003|Phase 2|Need more reduction of dose|0|||
126701067|NCT02601950|455856676|FG000|Overall Study|Participant enrolled in rollover study|0|||
126701068|NCT02601950|455856677|FG001|Overall Study|Participant enrolled in rollover study|0|||
126701069|NCT02601950|455856678|FG002|Overall Study|Participant enrolled in rollover study|1|||
126701070|NCT02601950|455856679|FG003|Overall Study|Participant enrolled in rollover study|0|||
126701071|NCT02601950|455856680|FG004|Overall Study|Participant enrolled in rollover study|1|||
126701072|NCT02601950|455856681|FG005|Overall Study|Participant enrolled in rollover study|1|||
126701073|NCT02601950|455856682|FG006|Overall Study|Participant enrolled in rollover study|1|||
126701074|NCT02601950|455856683|FG007|Overall Study|Participant enrolled in rollover study|0|||
126701075|NCT02601950|455856676|FG000|Overall Study|Disease progression - radiological|21|||
126701076|NCT02601950|455856677|FG001|Overall Study|Disease progression - radiological|26|||
126701077|NCT02601950|455856678|FG002|Overall Study|Disease progression - radiological|22|||
126452404|NCT00946153|454957222|FG004|Phase 2|Need more reduction of dose|2|||
126452405|NCT00946153|454957218|FG000|Phase 2|Physician Decision|0|||
126701078|NCT02601950|455856679|FG003|Overall Study|Disease progression - radiological|11|||
126701079|NCT02601950|455856680|FG004|Overall Study|Disease progression - radiological|46|||
126701080|NCT02601950|455856681|FG005|Overall Study|Disease progression - radiological|52|||
126701081|NCT02601950|455856682|FG006|Overall Study|Disease progression - radiological|7|||
126701082|NCT02601950|455856683|FG007|Overall Study|Disease progression - radiological|5|||
126701083|NCT02601950|455856676|FG000|Overall Study|Disease progression - clinical|3|||
126701084|NCT02601950|455856677|FG001|Overall Study|Disease progression - clinical|5|||
126701085|NCT02601950|455856678|FG002|Overall Study|Disease progression - clinical|4|||
126701086|NCT02601950|455856679|FG003|Overall Study|Disease progression - clinical|2|||
126701087|NCT02601950|455856680|FG004|Overall Study|Disease progression - clinical|6|||
126701088|NCT02601950|455856681|FG005|Overall Study|Disease progression - clinical|6|||
126701089|NCT02601950|455856682|FG006|Overall Study|Disease progression - clinical|5|||
126701090|NCT02601950|455856683|FG007|Overall Study|Disease progression - clinical|1|||
126701091|NCT02601950|455856676|FG000|Overall Study|Death|6|||
126701092|NCT02601950|455856677|FG001|Overall Study|Death|0|||
126701093|NCT02601950|455856678|FG002|Overall Study|Death|3|||
126701094|NCT02601950|455856679|FG003|Overall Study|Death|1|||
126701095|NCT02601950|455856680|FG004|Overall Study|Death|4|||
126701096|NCT02601950|455856681|FG005|Overall Study|Death|1|||
126701097|NCT02601950|455856682|FG006|Overall Study|Death|0|||
126701098|NCT02601950|455856683|FG007|Overall Study|Death|0|||
126701099|NCT02601950|455856676|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126701100|NCT02601950|455856677|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126701101|NCT02601950|455856678|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126701102|NCT02601950|455856679|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126701103|NCT02601950|455856680|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126701104|NCT02601950|455856681|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
126701105|NCT02601950|455856682|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126701106|NCT02601950|455856683|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
126701107|NCT02601950|455856676|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
126701108|NCT02601950|455856677|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
126701109|NCT02601950|455856678|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
126701110|NCT02601950|455856679|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
126701111|NCT02601950|455856680|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
126701112|NCT02601950|455856681|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
126701113|NCT02601950|455856682|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
126701114|NCT02601950|455856683|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
126701115|NCT02601950|455856676|FG000|Overall Study|Non-compliance|0|||
126701116|NCT02601950|455856677|FG001|Overall Study|Non-compliance|1|||
126701117|NCT02601950|455856678|FG002|Overall Study|Non-compliance|0|||
126701118|NCT02601950|455856679|FG003|Overall Study|Non-compliance|0|||
126701119|NCT02601950|455856680|FG004|Overall Study|Non-compliance|0|||
126701120|NCT02601950|455856681|FG005|Overall Study|Non-compliance|1|||
126701121|NCT02601950|455856682|FG006|Overall Study|Non-compliance|1|||
126701122|NCT02601950|455856683|FG007|Overall Study|Non-compliance|0|||
126701123|NCT02601950|455856676|FG000|Overall Study|Participant refused further study treatment|0|||
126701124|NCT02601950|455856677|FG001|Overall Study|Participant refused further study treatment|1|||
126452406|NCT00946153|454957219|FG001|Phase 2|Physician Decision|0|||
126701125|NCT02601950|455856678|FG002|Overall Study|Participant refused further study treatment|1|||
126701126|NCT02601950|455856679|FG003|Overall Study|Participant refused further study treatment|0|||
126701127|NCT02601950|455856680|FG004|Overall Study|Participant refused further study treatment|2|||
126701128|NCT02601950|455856681|FG005|Overall Study|Participant refused further study treatment|2|||
126701129|NCT02601950|455856682|FG006|Overall Study|Participant refused further study treatment|2|||
126701130|NCT02601950|455856683|FG007|Overall Study|Participant refused further study treatment|1|||
126701131|NCT02601950|455856676|FG000|Overall Study|Investigator discretion|1|||
126701132|NCT02601950|455856677|FG001|Overall Study|Investigator discretion|0|||
126701133|NCT02601950|455856678|FG002|Overall Study|Investigator discretion|1|||
126701134|NCT02601950|455856679|FG003|Overall Study|Investigator discretion|0|||
126701135|NCT02601950|455856680|FG004|Overall Study|Investigator discretion|1|||
126701136|NCT02601950|455856681|FG005|Overall Study|Investigator discretion|1|||
126701137|NCT02601950|455856682|FG006|Overall Study|Investigator discretion|1|||
126701138|NCT02601950|455856683|FG007|Overall Study|Investigator discretion|0|||
126452407|NCT00946153|454957220|FG002|Phase 2|Physician Decision|0|||
126701139|NCT02601950|455856676|FG000|Overall Study|Other|0|||
126701140|NCT02601950|455856677|FG001|Overall Study|Other|0|||
126701141|NCT02601950|455856678|FG002|Overall Study|Other|0|||
126701142|NCT02601950|455856679|FG003|Overall Study|Other|0|||
126701143|NCT02601950|455856680|FG004|Overall Study|Other|2|||
126701144|NCT02601950|455856681|FG005|Overall Study|Other|2|||
126701145|NCT02601950|455856682|FG006|Overall Study|Other|1|||
126701146|NCT02601950|455856683|FG007|Overall Study|Other|0|||
126701147|NCT05817045|455856690|FG000|Overall Study|Protocol Violation|0|||
126452408|NCT00946153|454957221|FG003|Phase 2|Physician Decision|0|||
126701148|NCT05817045|455856691|FG001|Overall Study|Protocol Violation|3|||
126701149|NCT05817045|455856690|FG000|Overall Study|Withdrawal by Subject|10|||
126701150|NCT05817045|455856691|FG001|Overall Study|Withdrawal by Subject|7|||
126701151|NCT05817045|455856690|FG000|Overall Study|Physician Decision|3|||
126701152|NCT05817045|455856691|FG001|Overall Study|Physician Decision|0|||
126701153|NCT05817045|455856690|FG000|Overall Study|Lost to Follow-up|0|||
126701154|NCT05817045|455856691|FG001|Overall Study|Lost to Follow-up|1|||
126701155|NCT05817045|455856690|FG000|Overall Study|Device Deficiency|1|||
126701156|NCT05817045|455856691|FG001|Overall Study|Device Deficiency|0|||
126701157|NCT05817045|455856690|FG000|Overall Study|System Error|1|||
126701158|NCT05817045|455856691|FG001|Overall Study|System Error|0|||
126701159|NCT04889209|455856692|FG000|All Cohorts Except 15E|Adverse Event|0|||
126701160|NCT04889209|455856693|FG001|All Cohorts Except 15E|Adverse Event|0|||
126701161|NCT04889209|455856694|FG002|All Cohorts Except 15E|Adverse Event|0|||
126701162|NCT04889209|455856695|FG003|All Cohorts Except 15E|Adverse Event|0|||
126701163|NCT04889209|455856696|FG004|All Cohorts Except 15E|Adverse Event|0|||
126701164|NCT04889209|455856697|FG005|All Cohorts Except 15E|Adverse Event|0|||
126701165|NCT04889209|455856698|FG006|All Cohorts Except 15E|Adverse Event|1|||
126701166|NCT04889209|455856699|FG007|All Cohorts Except 15E|Adverse Event|0|||
126701167|NCT04889209|455856700|FG008|All Cohorts Except 15E|Adverse Event|0|||
126701168|NCT04889209|455856701|FG009|All Cohorts Except 15E|Adverse Event|0|||
126701169|NCT04889209|455856702|FG010|All Cohorts Except 15E|Adverse Event|0|||
126701170|NCT04889209|455856703|FG011|All Cohorts Except 15E|Adverse Event|0|||
126701171|NCT04889209|455856704|FG012|All Cohorts Except 15E|Adverse Event|0|||
126701172|NCT04889209|455856705|FG013|All Cohorts Except 15E|Adverse Event|0|||
126701173|NCT04889209|455856706|FG014|All Cohorts Except 15E|Adverse Event|0|||
126701174|NCT04889209|455856707|FG015|All Cohorts Except 15E|Adverse Event|0|||
126701175|NCT04889209|455856708|FG016|All Cohorts Except 15E|Adverse Event|0|||
126701176|NCT04889209|455856709|FG017|All Cohorts Except 15E|Adverse Event|0|||
126701177|NCT04889209|455856692|FG000|All Cohorts Except 15E|Death|0|||
126701178|NCT04889209|455856693|FG001|All Cohorts Except 15E|Death|1|||
126701179|NCT04889209|455856694|FG002|All Cohorts Except 15E|Death|0|||
126701180|NCT04889209|455856695|FG003|All Cohorts Except 15E|Death|0|||
126701181|NCT04889209|455856696|FG004|All Cohorts Except 15E|Death|0|||
126701182|NCT04889209|455856697|FG005|All Cohorts Except 15E|Death|0|||
126701183|NCT04889209|455856698|FG006|All Cohorts Except 15E|Death|0|||
126701184|NCT04889209|455856699|FG007|All Cohorts Except 15E|Death|0|||
126701185|NCT04889209|455856700|FG008|All Cohorts Except 15E|Death|0|||
126701186|NCT04889209|455856701|FG009|All Cohorts Except 15E|Death|0|||
126701187|NCT04889209|455856702|FG010|All Cohorts Except 15E|Death|0|||
126701188|NCT04889209|455856703|FG011|All Cohorts Except 15E|Death|0|||
126701189|NCT04889209|455856704|FG012|All Cohorts Except 15E|Death|0|||
126701190|NCT04889209|455856705|FG013|All Cohorts Except 15E|Death|0|||
126701191|NCT04889209|455856706|FG014|All Cohorts Except 15E|Death|0|||
126701192|NCT04889209|455856707|FG015|All Cohorts Except 15E|Death|0|||
126701193|NCT04889209|455856708|FG016|All Cohorts Except 15E|Death|0|||
126701194|NCT04889209|455856709|FG017|All Cohorts Except 15E|Death|0|||
126701195|NCT04889209|455856692|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
126701196|NCT04889209|455856693|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
126701197|NCT04889209|455856694|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
126701198|NCT04889209|455856695|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
126701199|NCT04889209|455856696|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
126701200|NCT04889209|455856697|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
126701201|NCT04889209|455856698|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
126452409|NCT00946153|454957222|FG004|Phase 2|Physician Decision|1|||
126452410|NCT00946153|454957218|FG000|Phase 2|14 days washout for recovery due to AE|0|||
126452411|NCT00946153|454957219|FG001|Phase 2|14 days washout for recovery due to AE|0|||
126701202|NCT04889209|455856699|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
126701203|NCT04889209|455856700|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
126701204|NCT04889209|455856701|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
126701205|NCT04889209|455856702|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
126701206|NCT04889209|455856703|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
126701207|NCT04889209|455856704|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
126701208|NCT04889209|455856705|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
126701209|NCT04889209|455856706|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
126701210|NCT04889209|455856707|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
126701211|NCT04889209|455856708|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
126701212|NCT04889209|455856709|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
126452412|NCT00946153|454957220|FG002|Phase 2|14 days washout for recovery due to AE|0|||
126701213|NCT04889209|455856692|FG000|All Cohorts Except 15E|Physician Decision|0|||
126701214|NCT04889209|455856693|FG001|All Cohorts Except 15E|Physician Decision|0|||
126452413|NCT00946153|454957221|FG003|Phase 2|14 days washout for recovery due to AE|0|||
126701215|NCT04889209|455856694|FG002|All Cohorts Except 15E|Physician Decision|0|||
126701216|NCT04889209|455856695|FG003|All Cohorts Except 15E|Physician Decision|0|||
126701217|NCT04889209|455856696|FG004|All Cohorts Except 15E|Physician Decision|1|||
126701218|NCT04889209|455856697|FG005|All Cohorts Except 15E|Physician Decision|0|||
126701219|NCT04889209|455856698|FG006|All Cohorts Except 15E|Physician Decision|0|||
126701220|NCT04889209|455856699|FG007|All Cohorts Except 15E|Physician Decision|1|||
126701221|NCT04889209|455856700|FG008|All Cohorts Except 15E|Physician Decision|0|||
126701222|NCT04889209|455856701|FG009|All Cohorts Except 15E|Physician Decision|1|||
126701223|NCT04889209|455856702|FG010|All Cohorts Except 15E|Physician Decision|0|||
126701224|NCT04889209|455856703|FG011|All Cohorts Except 15E|Physician Decision|1|||
126701225|NCT04889209|455856704|FG012|All Cohorts Except 15E|Physician Decision|1|||
126701226|NCT04889209|455856705|FG013|All Cohorts Except 15E|Physician Decision|0|||
126701227|NCT04889209|455856706|FG014|All Cohorts Except 15E|Physician Decision|0|||
126701228|NCT04889209|455856707|FG015|All Cohorts Except 15E|Physician Decision|0|||
126701229|NCT04889209|455856708|FG016|All Cohorts Except 15E|Physician Decision|0|||
126701230|NCT04889209|455856709|FG017|All Cohorts Except 15E|Physician Decision|0|||
126359985|NCT00326495|454610709|FG000|Overall Study|Subject off study before assessment|1|||
126359986|NCT03280615|454610711|FG000|Overall Study|Lost to Follow-up|1|||
126359987|NCT03280615|454610712|FG001|Overall Study|Lost to Follow-up|2|||
126359988|NCT03280615|454610711|FG000|Overall Study|Adverse Event|1|||
126359989|NCT03280615|454610712|FG001|Overall Study|Adverse Event|1|||
126359990|NCT03280615|454610711|FG000|Overall Study|Withdrawal by Subject|2|||
126359991|NCT03280615|454610712|FG001|Overall Study|Withdrawal by Subject|2|||
126359992|NCT00432991|454610715|FG000|Overall Study|Protocol Violation|7|||
126701231|NCT04889209|455856692|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
126701232|NCT04889209|455856693|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
126701233|NCT04889209|455856694|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
126701234|NCT04889209|455856695|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
126701235|NCT04889209|455856696|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
126701236|NCT04889209|455856697|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
126701237|NCT04889209|455856698|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
126701238|NCT04889209|455856699|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
126701239|NCT04889209|455856700|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
126701240|NCT04889209|455856701|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
126701241|NCT04889209|455856702|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
126701242|NCT04889209|455856703|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
126701243|NCT04889209|455856704|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
126701244|NCT04889209|455856705|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
126701245|NCT04889209|455856706|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
126701246|NCT04889209|455856707|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
126701247|NCT04889209|455856708|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
126701248|NCT04889209|455856709|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
126701249|NCT04889209|455856692|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
126701250|NCT04889209|455856693|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
126701251|NCT04889209|455856694|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126701252|NCT04889209|455856695|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126701253|NCT04889209|455856696|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126701254|NCT04889209|455856697|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
126701255|NCT04889209|455856698|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126701256|NCT04889209|455856699|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
126701257|NCT04889209|455856700|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126701258|NCT04889209|455856701|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
126701259|NCT04889209|455856702|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126701260|NCT04889209|455856703|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126701261|NCT04889209|455856704|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126701262|NCT04889209|455856705|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126701263|NCT04889209|455856706|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126701264|NCT04889209|455856707|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126701265|NCT04889209|455856708|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
126701266|NCT04889209|455856709|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
126701267|NCT04889209|455856692|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701268|NCT04889209|455856693|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701269|NCT04889209|455856694|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701270|NCT04889209|455856695|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
126701271|NCT04889209|455856696|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701272|NCT04889209|455856697|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701273|NCT04889209|455856698|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126763823|NCT05182840|456086874|FG005|Treatment Period|Reason missing|0|||
126359993|NCT00432991|454610716|FG001|Overall Study|Protocol Violation|12|||
126359994|NCT00903344|454610717|FG000|Overall Study|Pregnancy|2|||
126359995|NCT00903344|454610718|FG001|Overall Study|Pregnancy|3|||
126701274|NCT04889209|455856699|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701275|NCT04889209|455856700|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701276|NCT04889209|455856701|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701277|NCT04889209|455856702|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701278|NCT04889209|455856703|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701279|NCT04889209|455856704|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701280|NCT04889209|455856705|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701281|NCT04889209|455856706|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701282|NCT04889209|455856707|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701283|NCT04889209|455856708|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701284|NCT04889209|455856709|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
126701285|NCT04889209|455856692|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126701286|NCT04889209|455856693|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126701287|NCT04889209|455856694|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126701288|NCT04889209|455856695|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126701289|NCT04889209|455856696|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126701290|NCT04889209|455856697|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126701291|NCT04889209|455856698|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126701292|NCT04889209|455856699|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126701293|NCT04889209|455856700|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126701294|NCT04889209|455856701|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126701295|NCT04889209|455856702|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126701296|NCT04889209|455856703|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126701297|NCT04889209|455856704|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126701298|NCT04889209|455856705|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126701299|NCT04889209|455856706|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126701300|NCT04889209|455856707|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126701301|NCT04889209|455856708|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
126701302|NCT04889209|455856709|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
126701303|NCT04889209|455856692|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701304|NCT04889209|455856693|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701305|NCT04889209|455856694|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701306|NCT04889209|455856695|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701307|NCT04889209|455856696|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701308|NCT04889209|455856697|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701309|NCT04889209|455856698|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701310|NCT04889209|455856699|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701311|NCT04889209|455856700|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701312|NCT04889209|455856701|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701313|NCT04889209|455856702|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701314|NCT04889209|455856703|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701315|NCT04889209|455856704|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701316|NCT04889209|455856705|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701317|NCT04889209|455856706|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701318|NCT04889209|455856707|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701319|NCT04889209|455856708|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
126701320|NCT04889209|455856709|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
126701321|NCT04889209|455856692|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701322|NCT04889209|455856693|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701323|NCT04889209|455856694|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701324|NCT04889209|455856695|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701325|NCT04889209|455856696|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701326|NCT04889209|455856697|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701327|NCT04889209|455856698|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701328|NCT04889209|455856699|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701329|NCT04889209|455856700|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701330|NCT04889209|455856701|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701331|NCT04889209|455856702|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701332|NCT04889209|455856703|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701333|NCT04889209|455856704|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701334|NCT04889209|455856705|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701335|NCT04889209|455856706|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701336|NCT04889209|455856707|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701337|NCT04889209|455856708|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
126701338|NCT04889209|455856709|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
126701339|NCT04889209|455856692|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701340|NCT04889209|455856693|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701341|NCT04889209|455856694|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701342|NCT04889209|455856695|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701343|NCT04889209|455856696|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701344|NCT04889209|455856697|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701345|NCT04889209|455856698|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701346|NCT04889209|455856699|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701347|NCT04889209|455856700|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701348|NCT04889209|455856701|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701349|NCT04889209|455856702|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701350|NCT04889209|455856703|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701351|NCT04889209|455856704|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701352|NCT04889209|455856705|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701353|NCT04889209|455856706|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
126701354|NCT04889209|455856707|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701355|NCT04889209|455856708|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701356|NCT04889209|455856709|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
126701357|NCT01725165|455856716|FG000|Overall Study|Death|11|||
126701358|NCT01725165|455856717|FG001|Overall Study|Death|18|||
126701359|NCT05113940|455856720|FG000|Part A (18 Days)|Adverse Event|0|||
126701360|NCT05113940|455856721|FG001|Part A (18 Days)|Adverse Event|0|||
126701361|NCT05113940|455856722|FG002|Part A (18 Days)|Adverse Event|1|||
126701362|NCT05113940|455856723|FG003|Part A (18 Days)|Adverse Event|1|||
126701363|NCT05113940|455856724|FG004|Part A (18 Days)|Adverse Event|1|||
126701364|NCT05113940|455856725|FG005|Part A (18 Days)|Adverse Event|0|||
126701365|NCT05113940|455856726|FG006|Part A (18 Days)|Adverse Event|0|||
126701366|NCT05113940|455856727|FG007|Part A (18 Days)|Adverse Event|0|||
126701367|NCT05113940|455856728|FG008|Part A (18 Days)|Adverse Event|0|||
126701368|NCT05113940|455856729|FG009|Part A (18 Days)|Adverse Event|0|||
126701369|NCT05113940|455856730|FG010|Part A (18 Days)|Adverse Event|0|||
126701370|NCT05113940|455856731|FG011|Part A (18 Days)|Adverse Event|2|||
126701371|NCT05113940|455856732|FG012|Part A (18 Days)|Adverse Event|0|||
126701372|NCT05113940|455856733|FG013|Part A (18 Days)|Adverse Event|0|||
126701373|NCT05113940|455856734|FG014|Part A (18 Days)|Adverse Event|0|||
126701374|NCT05113940|455856720|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701375|NCT05113940|455856721|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701376|NCT05113940|455856722|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701377|NCT05113940|455856723|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701378|NCT05113940|455856724|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701379|NCT05113940|455856725|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701380|NCT05113940|455856726|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701381|NCT05113940|455856727|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701382|NCT05113940|455856728|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701383|NCT05113940|455856729|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701384|NCT05113940|455856730|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701385|NCT05113940|455856731|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701386|NCT05113940|455856732|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701387|NCT05113940|455856733|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
126701388|NCT05113940|455856734|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
126701389|NCT02688647|455856735|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
126701390|NCT02688647|455856736|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
126701391|NCT02688647|455856735|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
126701392|NCT02688647|455856736|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
126701393|NCT02688647|455856735|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
126701394|NCT02688647|455856736|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
126701395|NCT02688647|455856735|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
126701396|NCT02688647|455856736|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
126701397|NCT02688647|455856735|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
126452414|NCT00946153|454957222|FG004|Phase 2|14 days washout for recovery due to AE|4|||
126701398|NCT02688647|455856736|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
126701399|NCT02688647|455856735|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
126701400|NCT02688647|455856736|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
126701401|NCT02688647|455856735|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
126701402|NCT02688647|455856736|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
126701403|NCT03619213|455856737|FG000|Overall Study|Lost to Follow-up|2|||
126701404|NCT03619213|455856738|FG001|Overall Study|Lost to Follow-up|1|||
126701405|NCT03619213|455856737|FG000|Overall Study|Withdrawal by Subject|8|||
126701406|NCT03619213|455856738|FG001|Overall Study|Withdrawal by Subject|10|||
126701407|NCT00382967|455856739|FG000|Overall Study|Protocol Violation|1|||
126701408|NCT00382967|455856740|FG001|Overall Study|Protocol Violation|1|||
126701409|NCT02542267|455856742|FG000|Overall Study|Withdrawal by Subject|10|||
126701410|NCT02542267|455856742|FG000|Overall Study|Physician Decision|6|||
126701411|NCT02542267|455856742|FG000|Overall Study|Lost to Follow-up|4|||
126546966|NCT02247804|455296094|FG002|Treatment Period 2|Adverse Event|3|||
126546967|NCT02247804|455296092|FG000|Treatment Period 2|Lack of Efficacy|0|||
126701412|NCT02542267|455856742|FG000|Overall Study|Death|13|||
126701413|NCT02542267|455856742|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
126701414|NCT02542267|455856742|FG000|Overall Study|Other|9|||
126701415|NCT03049449|455856745|FG000|Overall Study|Did not receive treatment.|0|||
126701416|NCT03049449|455856746|FG001|Overall Study|Did not receive treatment.|0|||
126701417|NCT03049449|455856747|FG002|Overall Study|Did not receive treatment.|0|||
126701418|NCT03049449|455856748|FG003|Overall Study|Did not receive treatment.|0|||
126701419|NCT03049449|455856749|FG004|Overall Study|Did not receive treatment.|0|||
126701420|NCT03049449|455856750|FG005|Overall Study|Did not receive treatment.|0|||
126701421|NCT03049449|455856751|FG006|Overall Study|Did not receive treatment.|0|||
126701422|NCT03049449|455856752|FG007|Overall Study|Did not receive treatment.|0|||
126701423|NCT03049449|455856753|FG008|Overall Study|Did not receive treatment.|1|||
126701424|NCT03049449|455856754|FG009|Overall Study|Did not receive treatment.|0|||
126701425|NCT03049449|455856745|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
126701426|NCT03049449|455856746|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
126701427|NCT03049449|455856747|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
126701428|NCT03049449|455856748|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
126701429|NCT03049449|455856749|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
126701430|NCT03049449|455856750|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
126701431|NCT03049449|455856751|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
126701432|NCT03049449|455856752|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
126701433|NCT03049449|455856753|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
126701434|NCT03049449|455856754|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
126701435|NCT03049449|455856745|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126701436|NCT03049449|455856746|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126701437|NCT03049449|455856747|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126701438|NCT03049449|455856748|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126701439|NCT03049449|455856749|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126701440|NCT03049449|455856750|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126701441|NCT03049449|455856751|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126701442|NCT03049449|455856752|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
126701443|NCT03049449|455856753|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
126701444|NCT03049449|455856754|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
126701445|NCT00474240|455856755|FG000|Overall Study|Withdrawal by Subject|1|||
126701446|NCT00474240|455856756|FG001|Overall Study|Withdrawal by Subject|1|||
126701447|NCT00474240|455856757|FG002|Overall Study|Withdrawal by Subject|0|||
126701448|NCT00474240|455856758|FG003|Overall Study|Withdrawal by Subject|2|||
126701449|NCT00474240|455856759|FG004|Overall Study|Withdrawal by Subject|3|||
126701450|NCT00474240|455856760|FG005|Overall Study|Withdrawal by Subject|1|||
126701451|NCT00474240|455856755|FG000|Overall Study|Adverse Event|0|||
126701452|NCT00474240|455856756|FG001|Overall Study|Adverse Event|0|||
126701453|NCT00474240|455856757|FG002|Overall Study|Adverse Event|9|||
126701454|NCT00474240|455856758|FG003|Overall Study|Adverse Event|14|||
126701455|NCT00474240|455856759|FG004|Overall Study|Adverse Event|5|||
126701456|NCT00474240|455856760|FG005|Overall Study|Adverse Event|16|||
126701457|NCT00474240|455856755|FG000|Overall Study|Removed due to lab value|0|||
126701458|NCT00474240|455856756|FG001|Overall Study|Removed due to lab value|0|||
126701459|NCT00474240|455856757|FG002|Overall Study|Removed due to lab value|0|||
126701460|NCT00474240|455856758|FG003|Overall Study|Removed due to lab value|0|||
126701461|NCT00474240|455856759|FG004|Overall Study|Removed due to lab value|0|||
126701462|NCT00474240|455856760|FG005|Overall Study|Removed due to lab value|1|||
126701463|NCT01147497|455856761|FG000|Overall Study|failed insertion|2|||
126701464|NCT01147497|455856762|FG001|Overall Study|failed insertion|0|||
126701465|NCT01974323|455856765|FG000|Overall Study|Other Reasons|25|||
126701466|NCT01974323|455856766|FG001|Overall Study|Other Reasons|28|||
126701467|NCT01974323|455856765|FG000|Overall Study|Protocol Violation|2|||
126264454|NCT01118117|454258461|FG001|Overall Study|Lost to Follow-up|0|||
126701468|NCT01974323|455856766|FG001|Overall Study|Protocol Violation|2|||
126701469|NCT01974323|455856765|FG000|Overall Study|Personal Reasons|15|||
126701470|NCT01974323|455856766|FG001|Overall Study|Personal Reasons|19|||
126701471|NCT01974323|455856765|FG000|Overall Study|Lost to Follow-up|45|||
126701472|NCT01974323|455856766|FG001|Overall Study|Lost to Follow-up|40|||
126701473|NCT01974323|455856765|FG000|Overall Study|Pregnancy|2|||
126701474|NCT01974323|455856766|FG001|Overall Study|Pregnancy|1|||
126701475|NCT01974323|455856765|FG000|Overall Study|Lack of Efficacy|1|||
126701476|NCT01974323|455856766|FG001|Overall Study|Lack of Efficacy|1|||
126701477|NCT01974323|455856765|FG000|Overall Study|Adverse Event|2|||
126701478|NCT01974323|455856766|FG001|Overall Study|Adverse Event|2|||
126701479|NCT00331760|455856767|FG000|Overall Study|Ineligible / no protocol treatment|15|||
126701480|NCT00331760|455856768|FG001|Overall Study|Ineligible / no protocol treatment|8|||
126701481|NCT03093155|455856770|FG000|Overall Study|Not Eligible|1|||
126701482|NCT03093155|455856771|FG001|Overall Study|Not Eligible|0|||
126701483|NCT03093155|455856770|FG000|Overall Study|Withdrawal by Subject|0|||
126701484|NCT03093155|455856771|FG001|Overall Study|Withdrawal by Subject|1|||
126701485|NCT00619229|455856772|FG000|Overall Study|Withdrawal by Subject|1|||
126701486|NCT00619229|455856773|FG001|Overall Study|Withdrawal by Subject|1|||
126701487|NCT00619229|455856772|FG000|Overall Study|Lost to Follow-up|1|||
126701488|NCT00619229|455856773|FG001|Overall Study|Lost to Follow-up|0|||
126701489|NCT00619229|455856772|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
126701490|NCT00619229|455856773|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
126701491|NCT00619229|455856772|FG000|Overall Study|Investigator planned Cataract Operation|1|||
126701492|NCT00619229|455856773|FG001|Overall Study|Investigator planned Cataract Operation|0|||
126701493|NCT01075178|455856774|FG000|Subject Matching|eligible but not matched|130|||
126701494|NCT01075178|455856775|FG001|Subject Matching|eligible but not matched|403|||
126701495|NCT01075178|455856774|FG000|Subject Chart Review|died before chart review period|0|||
126701496|NCT01075178|455856775|FG001|Subject Chart Review|died before chart review period|2|||
126701497|NCT01075178|455856774|FG000|Subject Chart Review|no data collected due to site closure|3|||
126701498|NCT01075178|455856775|FG001|Subject Chart Review|no data collected due to site closure|4|||
126701499|NCT01075178|455856774|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
126701500|NCT01075178|455856775|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
126701501|NCT02983604|455856776|FG000|Overall Study|Enrolled but not Treated|0|||
126701502|NCT02983604|455856777|FG001|Overall Study|Enrolled but not Treated|0|||
126701503|NCT02983604|455856778|FG002|Overall Study|Enrolled but not Treated|1|||
126701504|NCT02983604|455856779|FG003|Overall Study|Enrolled but not Treated|0|||
126701505|NCT01111604|455856780|FG000|Overall Study|Lost to Follow-up|0|||
126701506|NCT01111604|455856781|FG001|Overall Study|Lost to Follow-up|0|||
126701507|NCT01111604|455856782|FG002|Overall Study|Lost to Follow-up|1|||
126701508|NCT01111604|455856780|FG000|Overall Study|Withdrew Consent|3|||
126701509|NCT01111604|455856781|FG001|Overall Study|Withdrew Consent|0|||
126701510|NCT01111604|455856782|FG002|Overall Study|Withdrew Consent|2|||
126701511|NCT01111604|455856780|FG000|Overall Study|Withdrawal by Subject|2|||
126701512|NCT01111604|455856781|FG001|Overall Study|Withdrawal by Subject|0|||
126701513|NCT01111604|455856782|FG002|Overall Study|Withdrawal by Subject|0|||
126701514|NCT01111604|455856780|FG000|Overall Study|Death|1|||
126701515|NCT01111604|455856781|FG001|Overall Study|Death|0|||
126701516|NCT01111604|455856782|FG002|Overall Study|Death|0|||
126701517|NCT01111604|455856780|FG000|Overall Study|Met Exclusion Criteria|2|||
126701518|NCT01111604|455856781|FG001|Overall Study|Met Exclusion Criteria|0|||
126701519|NCT01111604|455856782|FG002|Overall Study|Met Exclusion Criteria|0|||
126701520|NCT00316264|455856784|FG000|Overall Study|Lost to Follow-up|0|||
126701521|NCT00316264|455856785|FG001|Overall Study|Lost to Follow-up|1|||
126701522|NCT00316264|455856786|FG002|Overall Study|Lost to Follow-up|0|||
126701523|NCT00316264|455856784|FG000|Overall Study|Withdrawal of Consent|3|||
126701524|NCT00316264|455856785|FG001|Overall Study|Withdrawal of Consent|5|||
126701525|NCT00316264|455856786|FG002|Overall Study|Withdrawal of Consent|6|||
126701526|NCT00316264|455856784|FG000|Overall Study|Death|2|||
126701527|NCT00316264|455856785|FG001|Overall Study|Death|0|||
126701528|NCT00316264|455856786|FG002|Overall Study|Death|0|||
126701529|NCT00316264|455856784|FG000|Overall Study|Other|1|||
126701530|NCT00316264|455856785|FG001|Overall Study|Other|1|||
126701531|NCT00316264|455856786|FG002|Overall Study|Other|0|||
126701532|NCT00607048|455856787|FG000|Overall Study|Adverse Event|0|||
126701533|NCT00607048|455856788|FG001|Overall Study|Adverse Event|1|||
126701534|NCT00607048|455856789|FG002|Overall Study|Adverse Event|0|||
126701535|NCT00607048|455856790|FG003|Overall Study|Adverse Event|0|||
126701536|NCT00607048|455856791|FG004|Overall Study|Adverse Event|4|||
126701537|NCT00607048|455856792|FG005|Overall Study|Adverse Event|0|||
126701538|NCT00607048|455856787|FG000|Overall Study|Global deterioration of health|1|||
126701539|NCT00607048|455856788|FG001|Overall Study|Global deterioration of health|0|||
126701540|NCT00607048|455856789|FG002|Overall Study|Global deterioration of health|0|||
126701541|NCT00607048|455856790|FG003|Overall Study|Global deterioration of health|0|||
126701542|NCT00607048|455856791|FG004|Overall Study|Global deterioration of health|0|||
126701543|NCT00607048|455856792|FG005|Overall Study|Global deterioration of health|0|||
126701544|NCT00607048|455856787|FG000|Overall Study|Objective disease progression - relapse|1|||
126701545|NCT00607048|455856788|FG001|Overall Study|Objective disease progression - relapse|2|||
126701546|NCT00607048|455856789|FG002|Overall Study|Objective disease progression - relapse|4|||
126701547|NCT00607048|455856790|FG003|Overall Study|Objective disease progression - relapse|2|||
126701548|NCT00607048|455856791|FG004|Overall Study|Objective disease progression - relapse|2|||
126701549|NCT00607048|455856792|FG005|Overall Study|Objective disease progression - relapse|2|||
126701550|NCT00607048|455856787|FG000|Overall Study|Withdrawal by Subject|0|||
126701551|NCT00607048|455856788|FG001|Overall Study|Withdrawal by Subject|0|||
126701552|NCT00607048|455856789|FG002|Overall Study|Withdrawal by Subject|0|||
126701553|NCT00607048|455856790|FG003|Overall Study|Withdrawal by Subject|1|||
126701554|NCT00607048|455856791|FG004|Overall Study|Withdrawal by Subject|0|||
126701555|NCT00607048|455856792|FG005|Overall Study|Withdrawal by Subject|2|||
126701556|NCT00607048|455856787|FG000|Overall Study|Other|1|||
126701557|NCT00607048|455856788|FG001|Overall Study|Other|1|||
126701558|NCT00607048|455856789|FG002|Overall Study|Other|0|||
126701559|NCT00607048|455856790|FG003|Overall Study|Other|0|||
126701560|NCT00607048|455856791|FG004|Overall Study|Other|0|||
126701561|NCT00607048|455856792|FG005|Overall Study|Other|1|||
126701562|NCT00355264|455856793|FG000|Extension (Variable Duration)|Adverse Event|1|||
126701563|NCT00355264|455856793|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
126701564|NCT00826514|455856794|FG000|Overall Study|Adverse Event|1|||
126701565|NCT00826514|455856795|FG001|Overall Study|Adverse Event|1|||
126701566|NCT00826514|455856794|FG000|Overall Study|Lack of Efficacy|0|||
126701567|NCT00826514|455856795|FG001|Overall Study|Lack of Efficacy|1|||
126701568|NCT00826514|455856794|FG000|Overall Study|Withdrawal by Subject|2|||
126701569|NCT00826514|455856795|FG001|Overall Study|Withdrawal by Subject|3|||
126701570|NCT03926143|455856797|FG000|Overall Study|Physician Decision|3|||
126701571|NCT03926143|455856797|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
126701572|NCT03926143|455856797|FG000|Overall Study|Adverse Event|2|||
126701573|NCT03926143|455856797|FG000|Overall Study|Progressive disease|3|||
126701574|NCT02561156|455856798|FG000|Part 2|Adverse Event|0|||
126701575|NCT02561156|455856799|FG001|Part 2|Adverse Event|0|||
126701576|NCT02561156|455856800|FG002|Part 2|Adverse Event|0|||
126701577|NCT02561156|455856801|FG003|Part 2|Adverse Event|0|||
126701578|NCT02561156|455856802|FG004|Part 2|Adverse Event|0|||
126701579|NCT02561156|455856803|FG005|Part 2|Adverse Event|0|||
126701580|NCT02561156|455856804|FG006|Part 2|Adverse Event|0|||
126701581|NCT02561156|455856805|FG007|Part 2|Adverse Event|0|||
126701582|NCT02561156|455856806|FG008|Part 2|Adverse Event|0|||
126701583|NCT02561156|455856807|FG009|Part 2|Adverse Event|0|||
126701584|NCT02561156|455856808|FG010|Part 2|Adverse Event|0|||
126701585|NCT02561156|455856809|FG011|Part 2|Adverse Event|1|||
126701586|NCT02561156|455856810|FG012|Part 2|Adverse Event|0|||
126701587|NCT01071070|455856814|FG000|Overall Study|Adverse Event|0|||
126701588|NCT01071070|455856815|FG001|Overall Study|Adverse Event|3|||
126701589|NCT01071070|455856814|FG000|Overall Study|Withdrawal by Subject|1|||
126701590|NCT01071070|455856815|FG001|Overall Study|Withdrawal by Subject|0|||
126701591|NCT01071070|455856814|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
126701592|NCT01071070|455856815|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
126701593|NCT01071070|455856814|FG000|Overall Study|Hypercalcemia|1|||
126701594|NCT01071070|455856815|FG001|Overall Study|Hypercalcemia|0|||
126701595|NCT02209506|455856821|FG000|Overall Study|Withdrawal by Subject|0|||
126701596|NCT02209506|455856822|FG001|Overall Study|Withdrawal by Subject|0|||
126701597|NCT02209506|455856823|FG002|Overall Study|Withdrawal by Subject|0|||
126701598|NCT02209506|455856824|FG003|Overall Study|Withdrawal by Subject|0|||
126452415|NCT01030666|454957223|FG000|Overall Study|Lost to Follow-up|3|||
126452416|NCT01030666|454957224|FG001|Overall Study|Lost to Follow-up|2|||
126701599|NCT02209506|455856825|FG004|Overall Study|Withdrawal by Subject|1|||
126701600|NCT00098787|455856826|FG000|Overall Study|Never started treatment|3|||
126701601|NCT00098787|455856827|FG001|Overall Study|Never started treatment|2|||
126701602|NCT00098787|455856828|FG002|Overall Study|Never started treatment|1|||
126701603|NCT00098787|455856826|FG000|Overall Study|Ineligible|9|||
126701604|NCT00098787|455856827|FG001|Overall Study|Ineligible|7|||
126701605|NCT00098787|455856828|FG002|Overall Study|Ineligible|3|||
126701606|NCT00098787|455856826|FG000|Overall Study|Disease progression|28|||
126701607|NCT00098787|455856827|FG001|Overall Study|Disease progression|17|||
126701608|NCT00098787|455856828|FG002|Overall Study|Disease progression|23|||
126701609|NCT00098787|455856826|FG000|Overall Study|Adverse Event|8|||
126701610|NCT00098787|455856827|FG001|Overall Study|Adverse Event|17|||
126701611|NCT00098787|455856828|FG002|Overall Study|Adverse Event|8|||
126701612|NCT00098787|455856826|FG000|Overall Study|Death|6|||
126701613|NCT00098787|455856827|FG001|Overall Study|Death|1|||
126701614|NCT00098787|455856828|FG002|Overall Study|Death|0|||
126701615|NCT00098787|455856826|FG000|Overall Study|Withdrawal by Subject|4|||
126701616|NCT00098787|455856827|FG001|Overall Study|Withdrawal by Subject|12|||
126701617|NCT00098787|455856828|FG002|Overall Study|Withdrawal by Subject|6|||
126701618|NCT00098787|455856826|FG000|Overall Study|Alternative therapy|8|||
126452417|NCT00934843|454957225|FG000|Overall Study|Protocol Violation|0|||
126701619|NCT00098787|455856827|FG001|Overall Study|Alternative therapy|13|||
126763824|NCT05182840|456086875|FG006|Treatment Period|Reason missing|0|||
126763825|NCT05182840|456086876|FG007|Treatment Period|Reason missing|0|||
126763826|NCT05182840|456086877|FG008|Treatment Period|Reason missing|0|||
126763827|NCT05182840|456086878|FG009|Treatment Period|Reason missing|0|||
126763828|NCT05182840|456086869|FG000|Treatment Period|Other but not sponsor termination|0|||
126763829|NCT05182840|456086870|FG001|Treatment Period|Other but not sponsor termination|0|||
126763830|NCT05182840|456086871|FG002|Treatment Period|Other but not sponsor termination|8|||
126763831|NCT05182840|456086872|FG003|Treatment Period|Other but not sponsor termination|6|||
126763832|NCT05182840|456086873|FG004|Treatment Period|Other but not sponsor termination|6|||
126763833|NCT05182840|456086874|FG005|Treatment Period|Other but not sponsor termination|7|||
126763834|NCT05182840|456086875|FG006|Treatment Period|Other but not sponsor termination|5|||
126763835|NCT05182840|456086876|FG007|Treatment Period|Other but not sponsor termination|8|||
126763836|NCT05182840|456086877|FG008|Treatment Period|Other but not sponsor termination|7|||
126763837|NCT05182840|456086878|FG009|Treatment Period|Other but not sponsor termination|2|||
126763838|NCT05182840|456086869|FG000|Treatment Period|Protocol deviation|0|||
126763839|NCT05182840|456086870|FG001|Treatment Period|Protocol deviation|0|||
126763840|NCT05182840|456086871|FG002|Treatment Period|Protocol deviation|0|||
126763841|NCT05182840|456086872|FG003|Treatment Period|Protocol deviation|0|||
126763842|NCT05182840|456086873|FG004|Treatment Period|Protocol deviation|0|||
126763843|NCT05182840|456086874|FG005|Treatment Period|Protocol deviation|0|||
126763844|NCT05182840|456086875|FG006|Treatment Period|Protocol deviation|0|||
126763845|NCT05182840|456086876|FG007|Treatment Period|Protocol deviation|0|||
126763846|NCT05182840|456086877|FG008|Treatment Period|Protocol deviation|1|||
126763847|NCT05182840|456086878|FG009|Treatment Period|Protocol deviation|0|||
126763848|NCT05182840|456086869|FG000|Treatment Period|No reason available|0|||
126763849|NCT05182840|456086870|FG001|Treatment Period|No reason available|0|||
126763850|NCT05182840|456086871|FG002|Treatment Period|No reason available|0|||
126763851|NCT05182840|456086872|FG003|Treatment Period|No reason available|1|||
126763852|NCT05182840|456086873|FG004|Treatment Period|No reason available|0|||
126763853|NCT05182840|456086874|FG005|Treatment Period|No reason available|2|||
126763854|NCT05182840|456086875|FG006|Treatment Period|No reason available|0|||
126763855|NCT05182840|456086876|FG007|Treatment Period|No reason available|1|||
126763856|NCT05182840|456086877|FG008|Treatment Period|No reason available|0|||
126763857|NCT05182840|456086878|FG009|Treatment Period|No reason available|0|||
126763858|NCT05182840|456086869|FG000|Treatment Period|Burden of study procedures|0|||
126763859|NCT05182840|456086870|FG001|Treatment Period|Burden of study procedures|0|||
126763860|NCT05182840|456086871|FG002|Treatment Period|Burden of study procedures|0|||
126763861|NCT05182840|456086872|FG003|Treatment Period|Burden of study procedures|0|||
126763862|NCT05182840|456086873|FG004|Treatment Period|Burden of study procedures|1|||
126763863|NCT05182840|456086874|FG005|Treatment Period|Burden of study procedures|0|||
126763864|NCT05182840|456086875|FG006|Treatment Period|Burden of study procedures|0|||
126763865|NCT05182840|456086876|FG007|Treatment Period|Burden of study procedures|0|||
126763866|NCT05182840|456086877|FG008|Treatment Period|Burden of study procedures|0|||
126763867|NCT05182840|456086878|FG009|Treatment Period|Burden of study procedures|0|||
126763868|NCT05182840|456086869|FG000|Treatment Period|Change of residence|0|||
126763869|NCT05182840|456086870|FG001|Treatment Period|Change of residence|0|||
126763870|NCT05182840|456086871|FG002|Treatment Period|Change of residence|0|||
126763871|NCT05182840|456086872|FG003|Treatment Period|Change of residence|0|||
126763872|NCT05182840|456086873|FG004|Treatment Period|Change of residence|0|||
126763873|NCT05182840|456086874|FG005|Treatment Period|Change of residence|1|||
126763874|NCT05182840|456086875|FG006|Treatment Period|Change of residence|0|||
126763875|NCT05182840|456086876|FG007|Treatment Period|Change of residence|0|||
126763876|NCT05182840|456086877|FG008|Treatment Period|Change of residence|0|||
126763877|NCT05182840|456086878|FG009|Treatment Period|Change of residence|0|||
126763878|NCT05182840|456086869|FG000|Treatment Period|Adverse Event|0|||
126763879|NCT05182840|456086870|FG001|Treatment Period|Adverse Event|0|||
126763880|NCT05182840|456086871|FG002|Treatment Period|Adverse Event|4|||
126763881|NCT05182840|456086872|FG003|Treatment Period|Adverse Event|16|||
126763882|NCT05182840|456086873|FG004|Treatment Period|Adverse Event|12|||
126763883|NCT05182840|456086874|FG005|Treatment Period|Adverse Event|6|||
126763884|NCT05182840|456086875|FG006|Treatment Period|Adverse Event|4|||
126763885|NCT05182840|456086876|FG007|Treatment Period|Adverse Event|8|||
126763886|NCT05182840|456086877|FG008|Treatment Period|Adverse Event|16|||
126763887|NCT05182840|456086878|FG009|Treatment Period|Adverse Event|5|||
126763888|NCT05182840|456086869|FG000|Treatment Period|Not treated with study drug|0|||
126763889|NCT05182840|456086870|FG001|Treatment Period|Not treated with study drug|0|||
126763890|NCT05182840|456086871|FG002|Treatment Period|Not treated with study drug|0|||
126763891|NCT05182840|456086872|FG003|Treatment Period|Not treated with study drug|1|||
126763892|NCT05182840|456086873|FG004|Treatment Period|Not treated with study drug|0|||
126763893|NCT05182840|456086874|FG005|Treatment Period|Not treated with study drug|0|||
126763894|NCT05182840|456086875|FG006|Treatment Period|Not treated with study drug|1|||
126763895|NCT05182840|456086876|FG007|Treatment Period|Not treated with study drug|1|||
126763896|NCT05182840|456086877|FG008|Treatment Period|Not treated with study drug|0|||
126701620|NCT00098787|455856828|FG002|Overall Study|Alternative therapy|13|||
126701621|NCT00098787|455856826|FG000|Overall Study|Other|7|||
126701622|NCT00098787|455856827|FG001|Overall Study|Other|6|||
126701623|NCT00098787|455856828|FG002|Overall Study|Other|9|||
126701624|NCT02203149|455856831|FG000|Part 1|Adverse Event|0|||
126701625|NCT02203149|455856832|FG001|Part 1|Adverse Event|1|||
126701626|NCT02203149|455856833|FG002|Part 1|Adverse Event|0|||
126701627|NCT02203149|455856834|FG003|Part 1|Adverse Event|0|||
126701628|NCT02203149|455856835|FG004|Part 1|Adverse Event|0|||
126701629|NCT02203149|455856831|FG000|Part 2|Death|0|||
126701630|NCT02203149|455856832|FG001|Part 2|Death|0|||
126701631|NCT02203149|455856833|FG002|Part 2|Death|1|||
126701632|NCT02203149|455856834|FG003|Part 2|Death|1|||
126701633|NCT02203149|455856835|FG004|Part 2|Death|0|||
126701634|NCT02203149|455856831|FG000|Part 2|Withdrawal by Subject|0|||
126701635|NCT02203149|455856832|FG001|Part 2|Withdrawal by Subject|0|||
126701636|NCT02203149|455856833|FG002|Part 2|Withdrawal by Subject|0|||
126701637|NCT02203149|455856834|FG003|Part 2|Withdrawal by Subject|1|||
126701638|NCT02203149|455856835|FG004|Part 2|Withdrawal by Subject|0|||
126701639|NCT02203149|455856831|FG000|Part 2|Adverse Event|0|||
126701640|NCT02203149|455856832|FG001|Part 2|Adverse Event|0|||
126701641|NCT02203149|455856833|FG002|Part 2|Adverse Event|0|||
126452418|NCT00934843|454957226|FG001|Overall Study|Protocol Violation|1|||
126452419|NCT01144299|454957229|FG000|Overall Study|Lost to Follow-up|1|||
126452420|NCT01144299|454957230|FG001|Overall Study|Lost to Follow-up|0|||
126452421|NCT01144299|454957229|FG000|Overall Study|Withdrawal by Subject|1|||
126452422|NCT01144299|454957230|FG001|Overall Study|Withdrawal by Subject|0|||
126452423|NCT00831493|454957239|FG000|Overall Study|Intractable nausea and vomiting|1|||
126452424|NCT03976648|454957246|FG000|Overall Study|Adverse Event|0|||
126452425|NCT03976648|454957247|FG001|Overall Study|Adverse Event|2|||
126452426|NCT03976648|454957246|FG000|Overall Study|Study terminated by sponsor|21|||
126452427|NCT03976648|454957247|FG001|Overall Study|Study terminated by sponsor|8|||
126452428|NCT00881868|454957248|FG000|Overall Study|Adverse Event|0|||
126452429|NCT00881868|454957249|FG001|Overall Study|Adverse Event|1|||
126452430|NCT00881868|454957248|FG000|Overall Study|Lost to Follow-up|2|||
126452431|NCT00881868|454957249|FG001|Overall Study|Lost to Follow-up|1|||
126452432|NCT00881868|454957248|FG000|Overall Study|Physician Decision|4|||
126452433|NCT00881868|454957249|FG001|Overall Study|Physician Decision|0|||
126452434|NCT00881868|454957248|FG000|Overall Study|Protocol Violation|2|||
126452435|NCT00881868|454957249|FG001|Overall Study|Protocol Violation|0|||
126452436|NCT03255083|454957250|FG000|Overall Study|Clinical progression|1|||
126452437|NCT03255083|454957251|FG001|Overall Study|Clinical progression|0|||
126452438|NCT03255083|454957252|FG002|Overall Study|Clinical progression|0|||
126452439|NCT03255083|454957253|FG003|Overall Study|Clinical progression|0|||
126452440|NCT03255083|454957250|FG000|Overall Study|Adverse Event|0|||
126452441|NCT03255083|454957251|FG001|Overall Study|Adverse Event|1|||
126452442|NCT03255083|454957252|FG002|Overall Study|Adverse Event|0|||
126452443|NCT03255083|454957253|FG003|Overall Study|Adverse Event|0|||
126452444|NCT03255083|454957250|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
126452445|NCT03255083|454957251|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
126452446|NCT03255083|454957252|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
126452447|NCT03255083|454957253|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
126452448|NCT03255083|454957250|FG000|Overall Study|Withdrawal by Subject|1|||
126452449|NCT03255083|454957251|FG001|Overall Study|Withdrawal by Subject|1|||
126452450|NCT03255083|454957252|FG002|Overall Study|Withdrawal by Subject|1|||
126452451|NCT03255083|454957253|FG003|Overall Study|Withdrawal by Subject|0|||
126452452|NCT01981551|454957254|FG000|Overall Study|Refused further treatment|8|||
126701642|NCT02203149|455856834|FG003|Part 2|Adverse Event|1|||
126701643|NCT02203149|455856835|FG004|Part 2|Adverse Event|1|||
126701644|NCT01360996|455856836|FG000|Overall Study|Withdrawal by Subject|4|||
126701645|NCT01360996|455856837|FG001|Overall Study|Withdrawal by Subject|3|||
126701646|NCT01360996|455856838|FG002|Overall Study|Withdrawal by Subject|2|||
126701647|NCT01360996|455856836|FG000|Overall Study|Noncompliant|2|||
126701648|NCT01360996|455856837|FG001|Overall Study|Noncompliant|0|||
126452453|NCT01981551|454957254|FG000|Overall Study|Adverse Event|1|||
126452454|NCT01794338|454958911|FG000|Overall Study|Death|2|||
126452455|NCT01794338|454958912|FG001|Overall Study|Death|0|||
126452456|NCT01794338|454958911|FG000|Overall Study|Lost to Follow-up|6|||
126452457|NCT01794338|454958912|FG001|Overall Study|Lost to Follow-up|9|||
126701649|NCT01360996|455856838|FG002|Overall Study|Noncompliant|0|||
126701650|NCT01454076|455856839|FG000|Overall Study|Other|2|||
126452458|NCT00535288|454958913|FG000|Overall Study|Adverse Event|20|||
126452459|NCT00535288|454958914|FG001|Overall Study|Adverse Event|19|||
126452460|NCT00535288|454958915|FG002|Overall Study|Adverse Event|25|||
126452461|NCT00535288|454958916|FG003|Overall Study|Adverse Event|20|||
126452462|NCT00535288|454958917|FG004|Overall Study|Adverse Event|30|||
126452463|NCT00535288|454958913|FG000|Overall Study|Lost to Follow-up|0|||
126452464|NCT00535288|454958914|FG001|Overall Study|Lost to Follow-up|3|||
126701651|NCT01454076|455856840|FG001|Overall Study|Other|0|||
126701652|NCT01454076|455856841|FG002|Overall Study|Other|0|||
126701653|NCT01454076|455856842|FG003|Overall Study|Other|1|||
126701654|NCT01454076|455856843|FG004|Overall Study|Other|2|||
126701655|NCT01454076|455856839|FG000|Overall Study|Withdrawal by Subject|3|||
126701656|NCT01454076|455856840|FG001|Overall Study|Withdrawal by Subject|4|||
126701657|NCT01454076|455856841|FG002|Overall Study|Withdrawal by Subject|2|||
126701658|NCT01454076|455856842|FG003|Overall Study|Withdrawal by Subject|1|||
126701659|NCT01454076|455856843|FG004|Overall Study|Withdrawal by Subject|2|||
126701660|NCT01454076|455856839|FG000|Overall Study|Adverse Event|8|||
126701661|NCT01454076|455856840|FG001|Overall Study|Adverse Event|2|||
126701662|NCT01454076|455856841|FG002|Overall Study|Adverse Event|7|||
126701663|NCT01454076|455856842|FG003|Overall Study|Adverse Event|0|||
126701664|NCT01454076|455856843|FG004|Overall Study|Adverse Event|2|||
126701665|NCT04964258|455856844|FG000|Overall Study|Lost to Follow-up|1|||
126701666|NCT04964258|455856845|FG001|Overall Study|Lost to Follow-up|0|||
126701667|NCT04964258|455856846|FG002|Overall Study|Lost to Follow-up|0|||
126701668|NCT04964258|455856847|FG003|Overall Study|Lost to Follow-up|0|||
126701669|NCT04964258|455856848|FG004|Overall Study|Lost to Follow-up|0|||
126701670|NCT04964258|455856849|FG005|Overall Study|Lost to Follow-up|1|||
126701671|NCT04964258|455856850|FG006|Overall Study|Lost to Follow-up|0|||
126701672|NCT04964258|455856851|FG007|Overall Study|Lost to Follow-up|0|||
126701673|NCT04964258|455856852|FG008|Overall Study|Lost to Follow-up|0|||
126701674|NCT04964258|455856853|FG009|Overall Study|Lost to Follow-up|0|||
126701675|NCT04964258|455856854|FG010|Overall Study|Lost to Follow-up|0|||
126701676|NCT01478958|455856855|FG000|Overall Study|Withdrawal by Subject|1|||
126701677|NCT01478958|455856856|FG001|Overall Study|Withdrawal by Subject|1|||
126701678|NCT01478958|455856857|FG002|Overall Study|Withdrawal by Subject|1|||
126701679|NCT01478958|455856855|FG000|Overall Study|Weight loss|1|||
126701680|NCT01478958|455856856|FG001|Overall Study|Weight loss|0|||
126701681|NCT01478958|455856857|FG002|Overall Study|Weight loss|0|||
126701682|NCT01478958|455856855|FG000|Overall Study|Re-located|0|||
126701683|NCT01478958|455856856|FG001|Overall Study|Re-located|1|||
126701684|NCT01478958|455856857|FG002|Overall Study|Re-located|0|||
126701685|NCT01478958|455856855|FG000|Overall Study|Unable to comply|0|||
126701686|NCT01478958|455856856|FG001|Overall Study|Unable to comply|0|||
126701687|NCT01478958|455856857|FG002|Overall Study|Unable to comply|2|||
126701688|NCT03075839|455856858|FG000|Overall Study|Lost to Follow-up|4|||
126701689|NCT01499290|455856859|FG000|Overall Study|Withdrawal by Subject|22|||
126701690|NCT01499290|455856860|FG001|Overall Study|Withdrawal by Subject|15|||
126701691|NCT01499290|455856859|FG000|Overall Study|Not specified in study report|11|||
126701692|NCT01499290|455856860|FG001|Overall Study|Not specified in study report|5|||
126701693|NCT01499290|455856859|FG000|Overall Study|Condition improved/subject recovered|1|||
126701694|NCT01499290|455856860|FG001|Overall Study|Condition improved/subject recovered|0|||
126701695|NCT01499290|455856859|FG000|Overall Study|Lack of Efficacy|7|||
126701696|NCT01499290|455856860|FG001|Overall Study|Lack of Efficacy|8|||
126701697|NCT01499290|455856859|FG000|Overall Study|Adverse Event|14|||
126701698|NCT01499290|455856860|FG001|Overall Study|Adverse Event|7|||
126701699|NCT04052139|455856861|FG000|Overall Study|Lost to Follow-up|2|||
126701700|NCT04052139|455856862|FG001|Overall Study|Lost to Follow-up|0|||
126701701|NCT04052139|455856863|FG002|Overall Study|Lost to Follow-up|0|||
126701702|NCT04052139|455856861|FG000|Overall Study|Withdrawal by Subject|1|||
126701703|NCT04052139|455856862|FG001|Overall Study|Withdrawal by Subject|0|||
126701704|NCT04052139|455856863|FG002|Overall Study|Withdrawal by Subject|0|||
126701705|NCT02305563|455856864|FG000|Treatment Period|Disease progression|0|||
126701706|NCT02305563|455856865|FG001|Treatment Period|Disease progression|0|||
126701707|NCT02305563|455856866|FG002|Treatment Period|Disease progression|15|||
126701708|NCT02305563|455856867|FG003|Treatment Period|Disease progression|6|||
126701709|NCT02305563|455856868|FG004|Treatment Period|Disease progression|6|||
126701710|NCT02305563|455856864|FG000|Treatment Period|Study drug toxicity|0|||
126701711|NCT02305563|455856865|FG001|Treatment Period|Study drug toxicity|0|||
126701712|NCT02305563|455856866|FG002|Treatment Period|Study drug toxicity|0|||
126701713|NCT02305563|455856867|FG003|Treatment Period|Study drug toxicity|1|||
126701714|NCT02305563|455856868|FG004|Treatment Period|Study drug toxicity|2|||
126701715|NCT02305563|455856864|FG000|Treatment Period|Death|0|||
126701716|NCT02305563|455856865|FG001|Treatment Period|Death|0|||
126701717|NCT02305563|455856866|FG002|Treatment Period|Death|1|||
126701718|NCT02305563|455856867|FG003|Treatment Period|Death|2|||
126701719|NCT02305563|455856868|FG004|Treatment Period|Death|1|||
126701720|NCT02305563|455856864|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
126701721|NCT02305563|455856865|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
126701722|NCT02305563|455856866|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
126701723|NCT02305563|455856867|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
126701724|NCT02305563|455856868|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
126701725|NCT02305563|455856864|FG000|Treatment Period|Participant request to stop therapy|0|||
126701726|NCT02305563|455856865|FG001|Treatment Period|Participant request to stop therapy|2|||
126701727|NCT02305563|455856866|FG002|Treatment Period|Participant request to stop therapy|0|||
126701728|NCT02305563|455856867|FG003|Treatment Period|Participant request to stop therapy|1|||
126701729|NCT02305563|455856868|FG004|Treatment Period|Participant request to stop therapy|0|||
126701730|NCT02305563|455856864|FG000|Treatment Period|Participant withdrew consent|0|||
126701731|NCT02305563|455856865|FG001|Treatment Period|Participant withdrew consent|0|||
126701732|NCT02305563|455856866|FG002|Treatment Period|Participant withdrew consent|1|||
126701733|NCT02305563|455856867|FG003|Treatment Period|Participant withdrew consent|1|||
126701734|NCT02305563|455856868|FG004|Treatment Period|Participant withdrew consent|1|||
126701735|NCT02305563|455856864|FG000|Treatment Period|Maximum clinical benefit|0|||
126701736|NCT02305563|455856865|FG001|Treatment Period|Maximum clinical benefit|0|||
126701737|NCT02305563|455856866|FG002|Treatment Period|Maximum clinical benefit|0|||
126701738|NCT02305563|455856867|FG003|Treatment Period|Maximum clinical benefit|0|||
126701739|NCT02305563|455856868|FG004|Treatment Period|Maximum clinical benefit|1|||
126701740|NCT02305563|455856864|FG000|Treatment Period|Poor/non-compliance|0|||
126701741|NCT02305563|455856865|FG001|Treatment Period|Poor/non-compliance|0|||
126701742|NCT02305563|455856866|FG002|Treatment Period|Poor/non-compliance|0|||
126701743|NCT02305563|455856867|FG003|Treatment Period|Poor/non-compliance|0|||
126701744|NCT02305563|455856868|FG004|Treatment Period|Poor/non-compliance|1|||
126701745|NCT02305563|455856864|FG000|Treatment Period|Administrative reason by Sponsor|0|||
126701746|NCT02305563|455856865|FG001|Treatment Period|Administrative reason by Sponsor|0|||
126701747|NCT02305563|455856866|FG002|Treatment Period|Administrative reason by Sponsor|0|||
126701748|NCT02305563|455856867|FG003|Treatment Period|Administrative reason by Sponsor|0|||
126701749|NCT02305563|455856868|FG004|Treatment Period|Administrative reason by Sponsor|1|||
126701750|NCT02305563|455856864|FG000|Treatment Period|other reason|2|||
126701751|NCT02305563|455856865|FG001|Treatment Period|other reason|0|||
126701752|NCT02305563|455856866|FG002|Treatment Period|other reason|2|||
126701753|NCT02305563|455856867|FG003|Treatment Period|other reason|2|||
126701754|NCT02305563|455856868|FG004|Treatment Period|other reason|1|||
126701755|NCT02305563|455856864|FG000|Treatment Period|Randomized but not treated|0|||
126701756|NCT02305563|455856865|FG001|Treatment Period|Randomized but not treated|0|||
126701757|NCT02305563|455856866|FG002|Treatment Period|Randomized but not treated|0|||
126701758|NCT02305563|455856867|FG003|Treatment Period|Randomized but not treated|0|||
126701759|NCT02305563|455856868|FG004|Treatment Period|Randomized but not treated|2|||
126701760|NCT02305563|455856864|FG000|Treatment Period|added ULO, then disease progression|0|||
126701761|NCT02305563|455856865|FG001|Treatment Period|added ULO, then disease progression|0|||
126701762|NCT02305563|455856866|FG002|Treatment Period|added ULO, then disease progression|0|||
126701763|NCT02305563|455856867|FG003|Treatment Period|added ULO, then disease progression|0|||
126701764|NCT02305563|455856868|FG004|Treatment Period|added ULO, then disease progression|4|||
126701765|NCT02305563|455856864|FG000|Treatment Period|added ULO; then other reason|0|||
126701766|NCT02305563|455856865|FG001|Treatment Period|added ULO; then other reason|0|||
126701767|NCT02305563|455856866|FG002|Treatment Period|added ULO; then other reason|0|||
126701768|NCT02305563|455856867|FG003|Treatment Period|added ULO; then other reason|0|||
126701769|NCT02305563|455856868|FG004|Treatment Period|added ULO; then other reason|1|||
126701770|NCT02305563|455856864|FG000|Treatment Period|added ULO, then request to stop|0|||
126701771|NCT02305563|455856865|FG001|Treatment Period|added ULO, then request to stop|0|||
126701772|NCT02305563|455856866|FG002|Treatment Period|added ULO, then request to stop|0|||
126701773|NCT02305563|455856867|FG003|Treatment Period|added ULO, then request to stop|0|||
126701774|NCT02305563|455856868|FG004|Treatment Period|added ULO, then request to stop|1|||
126701775|NCT02305563|455856864|FG000|Follow-up Period|Death|0|||
126701776|NCT02305563|455856865|FG001|Follow-up Period|Death|0|||
126701777|NCT02305563|455856866|FG002|Follow-up Period|Death|5|||
126701778|NCT02305563|455856867|FG003|Follow-up Period|Death|4|||
126701779|NCT02305563|455856868|FG004|Follow-up Period|Death|7|||
126701780|NCT02305563|455856864|FG000|Follow-up Period|Participant withdrew consent|0|||
126701781|NCT02305563|455856865|FG001|Follow-up Period|Participant withdrew consent|0|||
126701782|NCT02305563|455856866|FG002|Follow-up Period|Participant withdrew consent|2|||
126701783|NCT02305563|455856867|FG003|Follow-up Period|Participant withdrew consent|1|||
126701784|NCT02305563|455856868|FG004|Follow-up Period|Participant withdrew consent|0|||
126701785|NCT02305563|455856864|FG000|Follow-up Period|other reason|0|||
126701786|NCT02305563|455856865|FG001|Follow-up Period|other reason|0|||
126701787|NCT02305563|455856866|FG002|Follow-up Period|other reason|0|||
126701788|NCT02305563|455856867|FG003|Follow-up Period|other reason|0|||
126701789|NCT02305563|455856868|FG004|Follow-up Period|other reason|1|||
126701790|NCT02305563|455856864|FG000|Follow-up Period|Followup no longer required per protocol|3|||
126701791|NCT02305563|455856865|FG001|Follow-up Period|Followup no longer required per protocol|3|||
126701792|NCT02305563|455856866|FG002|Follow-up Period|Followup no longer required per protocol|4|||
126701793|NCT02305563|455856867|FG003|Follow-up Period|Followup no longer required per protocol|1|||
126701794|NCT02305563|455856868|FG004|Follow-up Period|Followup no longer required per protocol|4|||
126701795|NCT01926626|455856871|FG000|Overall Study|Withdrawal by Subject|15|||
126701796|NCT01926626|455856871|FG000|Overall Study|Lost to Follow-up|7|||
126701797|NCT00655928|455856872|FG000|Overall Study|Withdrawal by Subject|2|||
126701798|NCT00655928|455856873|FG001|Overall Study|Withdrawal by Subject|1|||
126701799|NCT00655928|455856872|FG000|Overall Study|Physician Decision|1|||
126701800|NCT00655928|455856873|FG001|Overall Study|Physician Decision|1|||
126701801|NCT00998738|455856874|FG000|Overall Study|Uknown|1|||
126715186|NCT01052012|455908707|FG001|Overall Study|Withdrawal by Subject|1|||
126715187|NCT01052012|455908708|FG002|Overall Study|Withdrawal by Subject|0|||
126701802|NCT00075881|455858781|FG000|Overall Study|Lack of Efficacy|18|||
126701803|NCT00075881|455858781|FG000|Overall Study|Adverse Event|7|||
126701804|NCT00075881|455858781|FG000|Overall Study|Death|1|||
126701805|NCT00075881|455858781|FG000|Overall Study|Withdrawal by Subject|2|||
126701806|NCT00075881|455858781|FG000|Overall Study|Protocol Violation|4|||
126701807|NCT00075881|455858781|FG000|Overall Study|other complicating disease|3|||
126701808|NCT00075881|455858781|FG000|Overall Study|other|4|||
126701809|NCT00075881|455858781|FG000|Overall Study|missing data|2|||
126701810|NCT00075881|455858781|FG000|Overall Study|Ineligible|1|||
126701811|NCT00075881|455858781|FG000|Overall Study|never start protocol therapy|1|||
126701812|NCT02224664|455858782|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
126701813|NCT02224664|455858783|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
126701814|NCT02224664|455858784|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
126701815|NCT02224664|455858785|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
126701816|NCT02224664|455858786|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
126701817|NCT02224664|455858782|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
126701818|NCT02224664|455858783|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
126701819|NCT02224664|455858784|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
126701820|NCT02224664|455858785|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
126701821|NCT02224664|455858786|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
126701822|NCT02224664|455858782|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
126701823|NCT02224664|455858783|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
126701824|NCT02224664|455858784|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
126701825|NCT02224664|455858785|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
126701826|NCT02224664|455858786|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
126701827|NCT03019549|455858787|FG000|Washout|DId not meet genotype criteria|11|||
126701828|NCT03019549|455858787|FG000|Period 2|Adverse Event|2|||
126701829|NCT03019549|455858787|FG000|Period 2|Physician Decision|2|||
126701830|NCT03019549|455858787|FG000|Period 2|Withdrawal by Subject|1|||
126701831|NCT00215150|455858791|FG000|Open Label Phase|Lost to Follow-up|7|||
126701832|NCT00215150|455858791|FG000|Open Label Phase|Withdrawal by Subject|1|||
126701833|NCT00215150|455858791|FG000|Open Label Phase|Did not complete a post base visit|13|||
126701834|NCT00215150|455858791|FG000|Open Label Phase|Did not meet randomization criteria|9|||
126701835|NCT00215150|455858791|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
126701836|NCT00215150|455858791|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
126701837|NCT00215150|455858791|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
126701838|NCT00260208|455858795|FG000|Overall Study|Subject withdrew consent|11|||
126701839|NCT00260208|455858796|FG001|Overall Study|Subject withdrew consent|7|||
126701840|NCT00260208|455858795|FG000|Overall Study|Lost to Follow-up|6|||
126701841|NCT00260208|455858796|FG001|Overall Study|Lost to Follow-up|1|||
126701842|NCT00260208|455858795|FG000|Overall Study|Death|12|||
126701843|NCT00260208|455858796|FG001|Overall Study|Death|10|||
126701844|NCT00260208|455858795|FG000|Overall Study|Missing|18|||
126701845|NCT00260208|455858796|FG001|Overall Study|Missing|16|||
126701846|NCT02091440|455858797|FG000|Overall Study|Death|2|||
126701847|NCT00278629|455858804|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
126701848|NCT03263091|455858806|FG000|OL Component|Withdrawal by Subject|1|||
126701849|NCT03263091|455858807|FG001|OL Component|Withdrawal by Subject|1|||
126701850|NCT03263091|455858808|FG002|OL Component|Withdrawal by Subject|0|||
126701851|NCT03263091|455858809|FG003|OL Component|Withdrawal by Subject|0|||
126701852|NCT03263091|455858810|FG004|OL Component|Withdrawal by Subject|0|||
126701853|NCT03263091|455858811|FG005|OL Component|Withdrawal by Subject|0|||
126701854|NCT03263091|455858806|FG000|OL Component|Physician Decision|0|||
126701855|NCT03263091|455858807|FG001|OL Component|Physician Decision|1|||
126701856|NCT03263091|455858808|FG002|OL Component|Physician Decision|2|||
126701857|NCT03263091|455858809|FG003|OL Component|Physician Decision|0|||
126701858|NCT03263091|455858810|FG004|OL Component|Physician Decision|0|||
126701859|NCT03263091|455858811|FG005|OL Component|Physician Decision|0|||
126701860|NCT03263091|455858806|FG000|OL Component|Death|1|||
126701861|NCT03263091|455858807|FG001|OL Component|Death|0|||
126701862|NCT03263091|455858808|FG002|OL Component|Death|0|||
126701863|NCT03263091|455858809|FG003|OL Component|Death|0|||
126701864|NCT03263091|455858810|FG004|OL Component|Death|0|||
126701865|NCT03263091|455858811|FG005|OL Component|Death|0|||
126701866|NCT03263091|455858806|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
126701867|NCT03263091|455858807|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
126701868|NCT03263091|455858808|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
126701869|NCT03263091|455858809|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
126701870|NCT03263091|455858810|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
126701871|NCT03263091|455858811|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
126701872|NCT03263091|455858806|FG000|OL High-EPO Component|Physician Decision|0|||
126359996|NCT00903344|454610717|FG000|Overall Study|Lost to Follow-up|3|||
126701873|NCT03263091|455858807|FG001|OL High-EPO Component|Physician Decision|0|||
126701874|NCT03263091|455858808|FG002|OL High-EPO Component|Physician Decision|0|||
126763897|NCT05182840|456086878|FG009|Treatment Period|Not treated with study drug|0|||
126701875|NCT03263091|455858809|FG003|OL High-EPO Component|Physician Decision|1|||
126701876|NCT03263091|455858810|FG004|OL High-EPO Component|Physician Decision|0|||
126701877|NCT03263091|455858811|FG005|OL High-EPO Component|Physician Decision|0|||
126701878|NCT03263091|455858806|FG000|OL High-EPO Component|Death|0|||
126701879|NCT03263091|455858807|FG001|OL High-EPO Component|Death|0|||
126701880|NCT03263091|455858808|FG002|OL High-EPO Component|Death|0|||
126701881|NCT03263091|455858809|FG003|OL High-EPO Component|Death|3|||
126701882|NCT03263091|455858810|FG004|OL High-EPO Component|Death|0|||
126701883|NCT03263091|455858811|FG005|OL High-EPO Component|Death|0|||
126701884|NCT03263091|455858806|FG000|DB Component|Withdrawal by Subject|0|||
126701885|NCT03263091|455858807|FG001|DB Component|Withdrawal by Subject|0|||
126701886|NCT03263091|455858808|FG002|DB Component|Withdrawal by Subject|0|||
126701887|NCT03263091|455858809|FG003|DB Component|Withdrawal by Subject|0|||
126701888|NCT03263091|455858810|FG004|DB Component|Withdrawal by Subject|22|||
126701889|NCT03263091|455858811|FG005|DB Component|Withdrawal by Subject|8|||
126701890|NCT03263091|455858806|FG000|DB Component|Physician Decision|0|||
126701891|NCT03263091|455858807|FG001|DB Component|Physician Decision|0|||
126701892|NCT03263091|455858808|FG002|DB Component|Physician Decision|0|||
126701893|NCT03263091|455858809|FG003|DB Component|Physician Decision|0|||
126701894|NCT03263091|455858810|FG004|DB Component|Physician Decision|3|||
126701895|NCT03263091|455858811|FG005|DB Component|Physician Decision|1|||
126701896|NCT03263091|455858806|FG000|DB Component|Adverse Event|0|||
126701897|NCT03263091|455858807|FG001|DB Component|Adverse Event|0|||
126701898|NCT03263091|455858808|FG002|DB Component|Adverse Event|0|||
126701899|NCT03263091|455858809|FG003|DB Component|Adverse Event|0|||
126701900|NCT03263091|455858810|FG004|DB Component|Adverse Event|2|||
126701901|NCT03263091|455858811|FG005|DB Component|Adverse Event|1|||
126701902|NCT03263091|455858806|FG000|DB Component|Lost to Follow-up|0|||
126701903|NCT03263091|455858807|FG001|DB Component|Lost to Follow-up|0|||
126701904|NCT03263091|455858808|FG002|DB Component|Lost to Follow-up|0|||
126701905|NCT03263091|455858809|FG003|DB Component|Lost to Follow-up|0|||
126701906|NCT03263091|455858810|FG004|DB Component|Lost to Follow-up|2|||
126701907|NCT03263091|455858811|FG005|DB Component|Lost to Follow-up|1|||
126701908|NCT03263091|455858806|FG000|DB Component|Death|0|||
126701909|NCT03263091|455858807|FG001|DB Component|Death|0|||
126701910|NCT03263091|455858808|FG002|DB Component|Death|0|||
126701911|NCT03263091|455858809|FG003|DB Component|Death|0|||
126701912|NCT03263091|455858810|FG004|DB Component|Death|7|||
126701913|NCT03263091|455858811|FG005|DB Component|Death|4|||
126701914|NCT03263091|455858806|FG000|DB Component|Other than specified|0|||
126701915|NCT03263091|455858807|FG001|DB Component|Other than specified|0|||
126701916|NCT03263091|455858808|FG002|DB Component|Other than specified|0|||
126701917|NCT03263091|455858809|FG003|DB Component|Other than specified|0|||
126701918|NCT03263091|455858810|FG004|DB Component|Other than specified|8|||
126701919|NCT03263091|455858811|FG005|DB Component|Other than specified|6|||
126701920|NCT00742781|455858812|FG000|Overall Study|Withdrawal by Subject|3|||
126701921|NCT00826748|455858813|FG000|Overall Study|Withdrawal by Subject|0|||
126701922|NCT00826748|455858814|FG001|Overall Study|Withdrawal by Subject|0|||
126701923|NCT00826748|455858815|FG002|Overall Study|Withdrawal by Subject|2|||
126701924|NCT00826748|455858813|FG000|Overall Study|Physician Decision|0|||
126701925|NCT00826748|455858814|FG001|Overall Study|Physician Decision|0|||
126701926|NCT00826748|455858815|FG002|Overall Study|Physician Decision|1|||
126359997|NCT00903344|454610718|FG001|Overall Study|Lost to Follow-up|0|||
126546968|NCT02247804|455296093|FG001|Treatment Period 2|Lack of Efficacy|0|||
126546969|NCT02247804|455296094|FG002|Treatment Period 2|Lack of Efficacy|1|||
126701927|NCT00826748|455858813|FG000|Overall Study|Samples Did Not pass QC|0|||
126701928|NCT00826748|455858814|FG001|Overall Study|Samples Did Not pass QC|0|||
126701929|NCT00826748|455858815|FG002|Overall Study|Samples Did Not pass QC|1|||
126701930|NCT02443402|455858824|FG000|Overall Study|Withdrawal by Subject|3|||
126701931|NCT02443402|455858825|FG001|Overall Study|Withdrawal by Subject|1|||
126701932|NCT02443402|455858824|FG000|Overall Study|Screen Failure|1|||
126701933|NCT02443402|455858825|FG001|Overall Study|Screen Failure|2|||
126701934|NCT01552057|455858842|FG000|Overall Study|Adverse Event|14|||
126701935|NCT01552057|455858843|FG001|Overall Study|Adverse Event|15|||
126701936|NCT01552057|455858842|FG000|Overall Study|Lack of Efficacy|8|||
126701937|NCT01552057|455858843|FG001|Overall Study|Lack of Efficacy|23|||
126701938|NCT01552057|455858842|FG000|Overall Study|Withdrawal by Subject|5|||
126701939|NCT01552057|455858843|FG001|Overall Study|Withdrawal by Subject|8|||
126546970|NCT02247804|455296092|FG000|Treatment Period 2|Lost to Follow-up|0|||
126701940|NCT01552057|455858842|FG000|Overall Study|Entry Criteria Not Met|2|||
126701941|NCT01552057|455858843|FG001|Overall Study|Entry Criteria Not Met|2|||
126701942|NCT01552057|455858842|FG000|Overall Study|Physician Decision|1|||
126701943|NCT01552057|455858843|FG001|Overall Study|Physician Decision|0|||
126701944|NCT01389245|455858845|FG000|Overall Study|Protocol Violation|10|||
126701945|NCT01389245|455858845|FG000|Overall Study|Lost to Follow-up|3|||
126701946|NCT01389245|455858845|FG000|Overall Study|Withdrawal by Subject|2|||
126701947|NCT05127486|455858846|FG000|Overall Study|Adverse Event|2|||
126701948|NCT05127486|455858847|FG001|Overall Study|Adverse Event|4|||
126701949|NCT05127486|455858846|FG000|Overall Study|Lack of Efficacy|1|||
126701950|NCT05127486|455858847|FG001|Overall Study|Lack of Efficacy|0|||
126701951|NCT05127486|455858846|FG000|Overall Study|Pregnancy|0|||
126701952|NCT05127486|455858847|FG001|Overall Study|Pregnancy|1|||
126701953|NCT05127486|455858846|FG000|Overall Study|Physician Decision|4|||
126701954|NCT05127486|455858847|FG001|Overall Study|Physician Decision|1|||
126701955|NCT05127486|455858846|FG000|Overall Study|Withdrawal by Subject|14|||
126701956|NCT05127486|455858847|FG001|Overall Study|Withdrawal by Subject|13|||
126701957|NCT05127486|455858846|FG000|Overall Study|Lost to Follow-up|5|||
126701958|NCT05127486|455858847|FG001|Overall Study|Lost to Follow-up|8|||
126701959|NCT01287754|455858848|FG000|Overall Study|Death|2|||
126701960|NCT01287754|455858849|FG001|Overall Study|Death|12|||
126701961|NCT01287754|455858848|FG000|Overall Study|Lost to Follow-up|1|||
126701962|NCT01287754|455858849|FG001|Overall Study|Lost to Follow-up|6|||
126701963|NCT01287754|455858848|FG000|Overall Study|Protocol Violation|0|||
126701964|NCT01287754|455858849|FG001|Overall Study|Protocol Violation|3|||
126701965|NCT04439266|455858860|FG000|Overall Study|Ineligible|1|||
126701966|NCT04439266|455858860|FG000|Overall Study|Adverse Event|1|||
126701967|NCT04439266|455858860|FG000|Overall Study|Death|1|||
126701968|NCT04439266|455858860|FG000|Overall Study|Disease progression|1|||
126701969|NCT04439266|455858860|FG000|Overall Study|Still on treatment|1|||
126701970|NCT04971226|455858861|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
126701971|NCT04971226|455858862|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
126701972|NCT04971226|455858863|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
126701973|NCT04971226|455858864|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
126701974|NCT04971226|455858861|FG000|Overall Study|Adverse Event|6|||
126701975|NCT04971226|455858862|FG001|Overall Study|Adverse Event|5|||
126701976|NCT04971226|455858863|FG002|Overall Study|Adverse Event|11|||
126701977|NCT04971226|455858864|FG003|Overall Study|Adverse Event|10|||
126701978|NCT04971226|455858861|FG000|Overall Study|Progressive disease|2|||
126701979|NCT04971226|455858862|FG001|Overall Study|Progressive disease|0|||
126701980|NCT04971226|455858863|FG002|Overall Study|Progressive disease|3|||
126701981|NCT04971226|455858864|FG003|Overall Study|Progressive disease|1|||
126701982|NCT04971226|455858861|FG000|Overall Study|Protocol Deviation|1|||
126701983|NCT04971226|455858862|FG001|Overall Study|Protocol Deviation|0|||
126701984|NCT04971226|455858863|FG002|Overall Study|Protocol Deviation|1|||
126701985|NCT04971226|455858864|FG003|Overall Study|Protocol Deviation|1|||
126701986|NCT04971226|455858861|FG000|Overall Study|Subject Decision|0|||
126701987|NCT04971226|455858862|FG001|Overall Study|Subject Decision|1|||
126701988|NCT04971226|455858863|FG002|Overall Study|Subject Decision|1|||
126701989|NCT04971226|455858864|FG003|Overall Study|Subject Decision|1|||
126701990|NCT04971226|455858861|FG000|Overall Study|Pregnancy|0|||
126701991|NCT04971226|455858862|FG001|Overall Study|Pregnancy|0|||
126701992|NCT04971226|455858863|FG002|Overall Study|Pregnancy|0|||
126701993|NCT04971226|455858864|FG003|Overall Study|Pregnancy|1|||
126701994|NCT04971226|455858861|FG000|Overall Study|Participants not treated|1|||
126701995|NCT04971226|455858862|FG001|Overall Study|Participants not treated|0|||
126701996|NCT04971226|455858863|FG002|Overall Study|Participants not treated|2|||
126701997|NCT04971226|455858864|FG003|Overall Study|Participants not treated|1|||
126701998|NCT00001337|455858866|FG000|Overall Study|Switched to alternate treatment|2|||
126701999|NCT00001337|455858867|FG001|Overall Study|Switched to alternate treatment|2|||
126702000|NCT00001337|455858868|FG002|Overall Study|Switched to alternate treatment|0|||
126264455|NCT01118117|454258460|FG000|Overall Study|Missed 12 Month Visit|7|||
126702001|NCT00001337|455858866|FG000|Overall Study|Refused further treatment|2|||
126702002|NCT00001337|455858867|FG001|Overall Study|Refused further treatment|1|||
126702003|NCT00001337|455858868|FG002|Overall Study|Refused further treatment|0|||
126702004|NCT00001337|455858866|FG000|Overall Study|Began other Tx|1|||
126702005|NCT00001337|455858867|FG001|Overall Study|Began other Tx|0|||
126702006|NCT00001337|455858868|FG002|Overall Study|Began other Tx|0|||
126702007|NCT00001337|455858866|FG000|Overall Study|Physician Decision|3|||
126702008|NCT00001337|455858867|FG001|Overall Study|Physician Decision|1|||
126702009|NCT00001337|455858868|FG002|Overall Study|Physician Decision|0|||
126264456|NCT01118117|454258461|FG001|Overall Study|Missed 12 Month Visit|0|||
126264457|NCT02181296|454258467|FG000|Overall Study|Lost to Follow-up|7|||
126264458|NCT02181296|454258468|FG001|Overall Study|Lost to Follow-up|6|||
126264459|NCT02149121|454258469|FG000|Main Study Period|Lack of Efficacy|2|||
126264460|NCT02149121|454258470|FG001|Main Study Period|Lack of Efficacy|2|||
126264461|NCT02149121|454258471|FG002|Main Study Period|Lack of Efficacy|1|||
126264462|NCT02149121|454258472|FG003|Main Study Period|Lack of Efficacy|0|||
126264463|NCT02149121|454258473|FG004|Main Study Period|Lack of Efficacy|0|||
126264464|NCT02149121|454258474|FG005|Main Study Period|Lack of Efficacy|0|||
126264465|NCT02149121|454258475|FG006|Main Study Period|Lack of Efficacy|0|||
126264466|NCT02149121|454258469|FG000|Main Study Period|Withdrawal by Subject|9|||
126264467|NCT02149121|454258470|FG001|Main Study Period|Withdrawal by Subject|5|||
126702010|NCT00001337|455858866|FG000|Overall Study|Doesn't have NHL|0|||
126702011|NCT00001337|455858867|FG001|Overall Study|Doesn't have NHL|1|||
126702012|NCT00001337|455858868|FG002|Overall Study|Doesn't have NHL|0|||
126702013|NCT00001337|455858866|FG000|Overall Study|Non protocol tx needed|3|||
126702014|NCT00001337|455858867|FG001|Overall Study|Non protocol tx needed|1|||
126264468|NCT02149121|454258471|FG002|Main Study Period|Withdrawal by Subject|1|||
126264469|NCT02149121|454258472|FG003|Main Study Period|Withdrawal by Subject|0|||
126452465|NCT00535288|454958915|FG002|Overall Study|Lost to Follow-up|0|||
126452466|NCT00535288|454958916|FG003|Overall Study|Lost to Follow-up|0|||
126702015|NCT00001337|455858868|FG002|Overall Study|Non protocol tx needed|0|||
126702016|NCT00001337|455858866|FG000|Overall Study|Protocol change|1|||
126702017|NCT00001337|455858867|FG001|Overall Study|Protocol change|0|||
126702018|NCT00001337|455858868|FG002|Overall Study|Protocol change|0|||
126702019|NCT00001337|455858866|FG000|Overall Study|2nd primary disease|0|||
126702020|NCT00001337|455858867|FG001|Overall Study|2nd primary disease|0|||
126702021|NCT00001337|455858868|FG002|Overall Study|2nd primary disease|1|||
126702022|NCT00001337|455858866|FG000|Overall Study|Death during follow up period|9|||
126702023|NCT00001337|455858867|FG001|Overall Study|Death during follow up period|4|||
126702024|NCT00001337|455858868|FG002|Overall Study|Death during follow up period|0|||
126702025|NCT00001337|455858866|FG000|Overall Study|Death on study|19|||
126702026|NCT00001337|455858867|FG001|Overall Study|Death on study|9|||
126702027|NCT00001337|455858868|FG002|Overall Study|Death on study|0|||
126702028|NCT00001337|455858866|FG000|Overall Study|Disease progression during follow-up period|3|||
126702029|NCT00001337|455858867|FG001|Overall Study|Disease progression during follow-up period|1|||
126702030|NCT00001337|455858868|FG002|Overall Study|Disease progression during follow-up period|0|||
126702031|NCT00001337|455858866|FG000|Overall Study|Disease progression on study|33|||
126702032|NCT00001337|455858867|FG001|Overall Study|Disease progression on study|41|||
126702033|NCT00001337|455858868|FG002|Overall Study|Disease progression on study|0|||
126702034|NCT00001337|455858866|FG000|Overall Study|Lost to further follow-up|10|||
126702035|NCT00001337|455858867|FG001|Overall Study|Lost to further follow-up|6|||
126702036|NCT00001337|455858868|FG002|Overall Study|Lost to further follow-up|0|||
126702037|NCT00001337|455858866|FG000|Overall Study|2nd malignancy|1|||
126702038|NCT00001337|455858867|FG001|Overall Study|2nd malignancy|0|||
126702039|NCT00001337|455858868|FG002|Overall Study|2nd malignancy|0|||
126702040|NCT00001337|455858866|FG000|Overall Study|Treatment for second lymphoma|0|||
126702041|NCT00001337|455858867|FG001|Overall Study|Treatment for second lymphoma|1|||
126702042|NCT00001337|455858868|FG002|Overall Study|Treatment for second lymphoma|0|||
126702043|NCT00001337|455858866|FG000|Overall Study|Transfer to transplant|0|||
126702044|NCT00001337|455858867|FG001|Overall Study|Transfer to transplant|1|||
126702045|NCT00001337|455858868|FG002|Overall Study|Transfer to transplant|0|||
126702046|NCT00442598|455858869|FG000|Overall Study|Adverse Event|1|||
126702047|NCT00442598|455858870|FG001|Overall Study|Adverse Event|0|||
126702048|NCT00442598|455858871|FG002|Overall Study|Adverse Event|0|||
126702049|NCT00442598|455858869|FG000|Overall Study|Tumor progression|3|||
126702050|NCT00442598|455858870|FG001|Overall Study|Tumor progression|4|||
126702051|NCT00442598|455858871|FG002|Overall Study|Tumor progression|0|||
126702052|NCT00442598|455858869|FG000|Overall Study|Clinical deterioration|1|||
126702053|NCT00442598|455858870|FG001|Overall Study|Clinical deterioration|2|||
126702054|NCT00442598|455858871|FG002|Overall Study|Clinical deterioration|0|||
126702055|NCT00442598|455858869|FG000|Overall Study|CA125 progression|0|||
126702056|NCT00442598|455858870|FG001|Overall Study|CA125 progression|1|||
126702057|NCT00442598|455858871|FG002|Overall Study|CA125 progression|0|||
126702058|NCT00442598|455858869|FG000|Overall Study|Reduced creatinine clearance|1|||
126702059|NCT00442598|455858870|FG001|Overall Study|Reduced creatinine clearance|0|||
126702060|NCT00442598|455858871|FG002|Overall Study|Reduced creatinine clearance|0|||
126702061|NCT00442598|455858869|FG000|Overall Study|Death|0|||
126702062|NCT00442598|455858870|FG001|Overall Study|Death|1|||
126702063|NCT00442598|455858871|FG002|Overall Study|Death|0|||
126702064|NCT01262898|455858875|FG000|Overall Study|Protocol Violation|1|||
126702065|NCT01262898|455858876|FG001|Overall Study|Protocol Violation|1|||
126702066|NCT01262898|455858877|FG002|Overall Study|Protocol Violation|0|||
126452467|NCT00535288|454958917|FG004|Overall Study|Lost to Follow-up|0|||
126452468|NCT00535288|454958913|FG000|Overall Study|Lack of Efficacy|26|||
126452469|NCT00535288|454958914|FG001|Overall Study|Lack of Efficacy|3|||
126452470|NCT00535288|454958915|FG002|Overall Study|Lack of Efficacy|4|||
126452471|NCT00535288|454958916|FG003|Overall Study|Lack of Efficacy|4|||
126452472|NCT00535288|454958917|FG004|Overall Study|Lack of Efficacy|7|||
126452473|NCT00535288|454958913|FG000|Overall Study|Unwilling to cooperate|6|||
126452474|NCT00535288|454958914|FG001|Overall Study|Unwilling to cooperate|6|||
126452475|NCT00535288|454958915|FG002|Overall Study|Unwilling to cooperate|3|||
126452476|NCT00535288|454958916|FG003|Overall Study|Unwilling to cooperate|3|||
126452477|NCT00535288|454958917|FG004|Overall Study|Unwilling to cooperate|4|||
126702067|NCT01262898|455858878|FG003|Overall Study|Protocol Violation|0|||
126702068|NCT01262898|455858875|FG000|Overall Study|Lost to Follow-up|1|||
126702069|NCT01262898|455858876|FG001|Overall Study|Lost to Follow-up|0|||
126702070|NCT01262898|455858877|FG002|Overall Study|Lost to Follow-up|0|||
126702071|NCT01262898|455858878|FG003|Overall Study|Lost to Follow-up|0|||
126702072|NCT01262898|455858875|FG000|Overall Study|Withdrawal by Subject|1|||
126702073|NCT01262898|455858876|FG001|Overall Study|Withdrawal by Subject|1|||
126702074|NCT01262898|455858877|FG002|Overall Study|Withdrawal by Subject|0|||
126702075|NCT01262898|455858878|FG003|Overall Study|Withdrawal by Subject|0|||
126452478|NCT00535288|454958913|FG000|Overall Study|Other|2|||
126452479|NCT00535288|454958914|FG001|Overall Study|Other|1|||
126452480|NCT00535288|454958915|FG002|Overall Study|Other|1|||
126546971|NCT02247804|455296093|FG001|Treatment Period 2|Lost to Follow-up|1|||
126546972|NCT02247804|455296094|FG002|Treatment Period 2|Lost to Follow-up|1|||
126546973|NCT02247804|455296092|FG000|Treatment Period 2|Personal Reasons|2|||
126546974|NCT02247804|455296093|FG001|Treatment Period 2|Personal Reasons|1|||
126546975|NCT02247804|455296094|FG002|Treatment Period 2|Personal Reasons|1|||
126546976|NCT02247804|455296092|FG000|Treatment Period 2|Reason not Specified|0|||
126546977|NCT02247804|455296093|FG001|Treatment Period 2|Reason not Specified|0|||
126546978|NCT02247804|455296094|FG002|Treatment Period 2|Reason not Specified|2|||
126546979|NCT02247804|455296092|FG000|Treatment Period 3|Adverse Event|4|||
126546980|NCT02247804|455296093|FG001|Treatment Period 3|Adverse Event|3|||
126546981|NCT02247804|455296094|FG002|Treatment Period 3|Adverse Event|3|||
126546982|NCT02247804|455296092|FG000|Treatment Period 3|Lack of Efficacy|0|||
126546983|NCT02247804|455296093|FG001|Treatment Period 3|Lack of Efficacy|1|||
126546984|NCT02247804|455296094|FG002|Treatment Period 3|Lack of Efficacy|0|||
126546985|NCT02247804|455296092|FG000|Treatment Period 3|Lost to Follow-up|1|||
126546986|NCT02247804|455296093|FG001|Treatment Period 3|Lost to Follow-up|2|||
126546987|NCT02247804|455296094|FG002|Treatment Period 3|Lost to Follow-up|2|||
126546988|NCT02247804|455296092|FG000|Treatment Period 3|Personal Reasons|4|||
126546989|NCT02247804|455296093|FG001|Treatment Period 3|Personal Reasons|3|||
126546990|NCT02247804|455296094|FG002|Treatment Period 3|Personal Reasons|2|||
126546991|NCT02247804|455296092|FG000|Treatment Period 3|Reason not Specified|2|||
126546992|NCT02247804|455296093|FG001|Treatment Period 3|Reason not Specified|1|||
126546993|NCT02247804|455296094|FG002|Treatment Period 3|Reason not Specified|3|||
126546994|NCT02917265|455296100|FG000|Overall Study|Physician Decision|1|||
126546995|NCT02917265|455296101|FG001|Overall Study|Physician Decision|0|||
126546996|NCT02917265|455296100|FG000|Overall Study|Withdrawal by Subject|1|||
126546997|NCT02917265|455296101|FG001|Overall Study|Withdrawal by Subject|0|||
126546998|NCT01737996|455296103|FG000|Overall Study|Adverse Event|0|||
126546999|NCT01737996|455296104|FG001|Overall Study|Adverse Event|1|||
126547000|NCT01737996|455296105|FG002|Overall Study|Adverse Event|1|||
126547001|NCT01737996|455296103|FG000|Overall Study|Withdrawal by Subject|0|||
126547002|NCT01737996|455296104|FG001|Overall Study|Withdrawal by Subject|0|||
126547003|NCT01737996|455296105|FG002|Overall Study|Withdrawal by Subject|1|||
126547004|NCT00452413|455296106|FG000|Overall Study|Progressive Disease|4|||
126547005|NCT00452413|455296107|FG001|Overall Study|Progressive Disease|11|||
126547006|NCT00452413|455296108|FG002|Overall Study|Progressive Disease|30|||
126547007|NCT00452413|455296106|FG000|Overall Study|Withdrawal by Subject|0|||
126547008|NCT00452413|455296107|FG001|Overall Study|Withdrawal by Subject|1|||
126547009|NCT00452413|455296108|FG002|Overall Study|Withdrawal by Subject|4|||
126547010|NCT00452413|455296106|FG000|Overall Study|Adverse Event|0|||
126547011|NCT00452413|455296107|FG001|Overall Study|Adverse Event|0|||
126547012|NCT00452413|455296108|FG002|Overall Study|Adverse Event|5|||
126547013|NCT00452413|455296106|FG000|Overall Study|Physician Decision|0|||
126547014|NCT00452413|455296107|FG001|Overall Study|Physician Decision|0|||
126547015|NCT00452413|455296108|FG002|Overall Study|Physician Decision|4|||
126547016|NCT00452413|455296106|FG000|Overall Study|Death due to study disease|0|||
126547017|NCT00452413|455296107|FG001|Overall Study|Death due to study disease|0|||
126547018|NCT00452413|455296108|FG002|Overall Study|Death due to study disease|2|||
126547019|NCT00452413|455296106|FG000|Overall Study|Death due to adverse event (AE)|0|||
126547020|NCT00452413|455296107|FG001|Overall Study|Death due to adverse event (AE)|0|||
126547021|NCT00452413|455296108|FG002|Overall Study|Death due to adverse event (AE)|1|||
126547022|NCT00452413|455296106|FG000|Overall Study|On treatment|0|||
126547023|NCT00452413|455296107|FG001|Overall Study|On treatment|0|||
126547024|NCT00452413|455296108|FG002|Overall Study|On treatment|3|||
126547025|NCT01248962|455296109|FG000|Overall Study|Withdrawal by Subject|1|||
126763898|NCT02161380|456086879|FG000|Overall Study|Lost to Follow-up|0|||
126763899|NCT02161380|456086880|FG001|Overall Study|Lost to Follow-up|1|||
126547026|NCT01248962|455296110|FG001|Overall Study|Withdrawal by Subject|1|||
126547027|NCT01248962|455296109|FG000|Overall Study|Adverse Event|2|||
126547028|NCT01248962|455296110|FG001|Overall Study|Adverse Event|1|||
126547029|NCT01248962|455296109|FG000|Overall Study|Complete Response after 4 Cycles|1|||
126547030|NCT01248962|455296110|FG001|Overall Study|Complete Response after 4 Cycles|0|||
126547031|NCT01248962|455296109|FG000|Overall Study|Complete Response after 3 Cycles|0|||
126547032|NCT01248962|455296110|FG001|Overall Study|Complete Response after 3 Cycles|1|||
126547033|NCT01248962|455296109|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
126547034|NCT01248962|455296110|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
126547035|NCT03119610|455296111|FG000|Overall Study|Adverse Event|1|||
126547036|NCT03119610|455296112|FG001|Overall Study|Adverse Event|0|||
126547037|NCT03119610|455296111|FG000|Overall Study|Lost to Follow-up|0|||
126547038|NCT03119610|455296112|FG001|Overall Study|Lost to Follow-up|1|||
126547039|NCT00114634|455296113|FG000|Overall Study|failure to return forms|3|||
126547040|NCT03283696|455296114|FG000|Overall Study|Physician Decision|5|||
126547041|NCT03283696|455296115|FG001|Overall Study|Physician Decision|6|||
126547042|NCT03283696|455296114|FG000|Overall Study|Withdrawal by Subject|2|||
126547043|NCT03283696|455296115|FG001|Overall Study|Withdrawal by Subject|0|||
126547044|NCT00557622|455296119|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
126763900|NCT02161380|456086881|FG002|Overall Study|Lost to Follow-up|0|||
126702076|NCT04026568|455858879|FG000|Overall Study|study terminated|0|||
126702077|NCT04026568|455858880|FG001|Overall Study|study terminated|1|||
126702078|NCT02197377|455858881|FG000|Overall Study|Insertion Failure|0|||
126702079|NCT02197377|455858882|FG001|Overall Study|Insertion Failure|3|||
126702080|NCT00502840|455858883|FG000|Overall Study|Adverse Event|5|||
126702081|NCT00502840|455858883|FG000|Overall Study|Additional or changed therapy|48|||
126702082|NCT00502840|455858883|FG000|Overall Study|Lack of Efficacy|11|||
126702083|NCT00502840|455858883|FG000|Overall Study|Protocol Violation|4|||
126702084|NCT00502840|455858883|FG000|Overall Study|Withdrawal by Subject|5|||
126702085|NCT00502840|455858883|FG000|Overall Study|Lost to Follow-up|6|||
126702086|NCT00502840|455858883|FG000|Overall Study|Administrative problems|1|||
126702087|NCT00502840|455858883|FG000|Overall Study|Other|20|||
126702088|NCT00461175|455858884|FG000|Overall Study|Protocol Violation|522|||
126702089|NCT00461175|455858885|FG001|Overall Study|Protocol Violation|365|||
126702090|NCT01700829|455858886|FG000|Overall Study|Withdrawal by Subject|1|||
126702091|NCT01700829|455858887|FG001|Overall Study|Withdrawal by Subject|1|||
126702092|NCT03406962|455858888|FG000|Overall Study|Death|2|||
126702093|NCT03406962|455858888|FG000|Overall Study|Adverse Event|1|||
126702094|NCT00327444|455858889|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
126702095|NCT00327444|455858890|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
126702096|NCT00327444|455858889|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
126702097|NCT00327444|455858890|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
126702098|NCT00327444|455858889|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
126702099|NCT00327444|455858890|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
126702100|NCT00327444|455858889|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
126702101|NCT00327444|455858890|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
126702102|NCT00327444|455858889|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
126702103|NCT00327444|455858890|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
126702104|NCT00327444|455858889|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
126702105|NCT00327444|455858890|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
126702106|NCT00327444|455858889|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
126702107|NCT00327444|455858890|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
126702108|NCT00327444|455858889|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
126702109|NCT00327444|455858890|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
126702110|NCT04439344|455858891|FG000|Overall Study|Never started threapy|3|||
126702111|NCT04439344|455858891|FG000|Overall Study|Ineligible|3|||
126702112|NCT04439344|455858891|FG000|Overall Study|Adverse Event|13|||
126702113|NCT04439344|455858891|FG000|Overall Study|Death|2|||
126702114|NCT04439344|455858891|FG000|Overall Study|Disease progression|29|||
126702115|NCT04439344|455858891|FG000|Overall Study|Withdrawal by Subject|2|||
126702116|NCT04439344|455858891|FG000|Overall Study|Alternative therapy|1|||
126702117|NCT00552110|455858892|FG000|Overall Study|Serious or Life-Threatening AE|0|||
126702118|NCT00552110|455858893|FG001|Overall Study|Serious or Life-Threatening AE|0|||
126702119|NCT00552110|455858894|FG002|Overall Study|Serious or Life-Threatening AE|1|||
126702120|NCT00552110|455858895|FG003|Overall Study|Serious or Life-Threatening AE|0|||
126702121|NCT00552110|455858896|FG004|Overall Study|Serious or Life-Threatening AE|0|||
126702122|NCT00552110|455858892|FG000|Overall Study|Lack of Efficacy|1|||
126702123|NCT00552110|455858893|FG001|Overall Study|Lack of Efficacy|0|||
126702124|NCT00552110|455858894|FG002|Overall Study|Lack of Efficacy|0|||
126702125|NCT00552110|455858895|FG003|Overall Study|Lack of Efficacy|1|||
126702126|NCT00552110|455858896|FG004|Overall Study|Lack of Efficacy|4|||
126763901|NCT02161380|456086882|FG003|Overall Study|Lost to Follow-up|0|||
126452481|NCT00535288|454958916|FG003|Overall Study|Other|2|||
126452482|NCT00535288|454958917|FG004|Overall Study|Other|1|||
126452483|NCT00745849|454958918|FG000|First Intervention|Withdrawal by Subject|0|||
126452484|NCT00745849|454958919|FG001|First Intervention|Withdrawal by Subject|1|||
126452485|NCT00745849|454958918|FG000|First Intervention|Lost to Follow-up|1|||
126452486|NCT00745849|454958919|FG001|First Intervention|Lost to Follow-up|1|||
126452487|NCT00745849|454958918|FG000|Second Intervention|Lost to Follow-up|2|||
126452488|NCT00745849|454958919|FG001|Second Intervention|Lost to Follow-up|1|||
126452489|NCT01129583|454958920|FG000|Overall Study|Death|1|||
126452490|NCT01129583|454958921|FG001|Overall Study|Death|0|||
126452491|NCT01129583|454958920|FG000|Overall Study|Lost to Follow-up|1|||
126547045|NCT00557622|455296120|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
126702127|NCT00552110|455858892|FG000|Overall Study|Withdrawal by Subject|0|||
126702128|NCT00552110|455858893|FG001|Overall Study|Withdrawal by Subject|2|||
126702129|NCT00552110|455858894|FG002|Overall Study|Withdrawal by Subject|0|||
126702130|NCT00552110|455858895|FG003|Overall Study|Withdrawal by Subject|3|||
126702131|NCT00552110|455858896|FG004|Overall Study|Withdrawal by Subject|2|||
126702132|NCT00552110|455858892|FG000|Overall Study|Lost to Follow-up|0|||
126702133|NCT00552110|455858893|FG001|Overall Study|Lost to Follow-up|0|||
126702134|NCT00552110|455858894|FG002|Overall Study|Lost to Follow-up|0|||
126702135|NCT00552110|455858895|FG003|Overall Study|Lost to Follow-up|1|||
126547046|NCT00557622|455296119|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
126452492|NCT01129583|454958921|FG001|Overall Study|Lost to Follow-up|1|||
126702136|NCT00552110|455858896|FG004|Overall Study|Lost to Follow-up|1|||
126702137|NCT00552110|455858892|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
126702138|NCT00552110|455858893|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
126702139|NCT00552110|455858894|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
126702140|NCT00552110|455858895|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
126702141|NCT00552110|455858896|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
126702142|NCT00552110|455858892|FG000|Overall Study|Withdrawn per Sponsor|0|||
126702143|NCT00552110|455858893|FG001|Overall Study|Withdrawn per Sponsor|1|||
126702144|NCT00552110|455858894|FG002|Overall Study|Withdrawn per Sponsor|0|||
126702145|NCT00552110|455858895|FG003|Overall Study|Withdrawn per Sponsor|0|||
126702146|NCT00552110|455858896|FG004|Overall Study|Withdrawn per Sponsor|1|||
126702147|NCT00552110|455858892|FG000|Overall Study|Use of Prohibited Medication|1|||
126702148|NCT00552110|455858893|FG001|Overall Study|Use of Prohibited Medication|1|||
126702149|NCT00552110|455858894|FG002|Overall Study|Use of Prohibited Medication|0|||
126702150|NCT00552110|455858895|FG003|Overall Study|Use of Prohibited Medication|0|||
126702151|NCT00552110|455858896|FG004|Overall Study|Use of Prohibited Medication|0|||
126702152|NCT00552110|455858892|FG000|Overall Study|Delay of Study due to Relabeling|0|||
126702153|NCT00552110|455858893|FG001|Overall Study|Delay of Study due to Relabeling|0|||
126702154|NCT00552110|455858894|FG002|Overall Study|Delay of Study due to Relabeling|0|||
126702155|NCT00552110|455858895|FG003|Overall Study|Delay of Study due to Relabeling|1|||
126702156|NCT00552110|455858896|FG004|Overall Study|Delay of Study due to Relabeling|0|||
126702157|NCT00552110|455858892|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
126702158|NCT00552110|455858893|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
126702159|NCT00552110|455858894|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
126702160|NCT00552110|455858895|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
126702161|NCT00552110|455858896|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
126702162|NCT00552110|455858892|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
126702163|NCT00552110|455858893|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
126702164|NCT00552110|455858894|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
126702165|NCT00552110|455858895|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
126702166|NCT00552110|455858896|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
126702167|NCT02700451|455858897|FG000|Overall Study|Protocol Violation|2|||
126702168|NCT02700451|455858898|FG001|Overall Study|Protocol Violation|2|||
126702169|NCT02700451|455858899|FG002|Overall Study|Protocol Violation|3|||
126702170|NCT02700451|455858897|FG000|Overall Study|Discontinued intervention|14|||
126702171|NCT02700451|455858898|FG001|Overall Study|Discontinued intervention|15|||
126702172|NCT02700451|455858899|FG002|Overall Study|Discontinued intervention|14|||
126702173|NCT04373460|455858900|FG000|Overall Study|Did not receive tranfusion|18|||
126702174|NCT04373460|455858901|FG001|Overall Study|Did not receive tranfusion|26|||
126702175|NCT00454207|455858902|FG000|Overall Study|Adverse Event|3|||
126702176|NCT00454207|455858903|FG001|Overall Study|Adverse Event|1|||
126702177|NCT00454207|455858902|FG000|Overall Study|Lack of Efficacy|1|||
126702178|NCT00454207|455858903|FG001|Overall Study|Lack of Efficacy|0|||
126702179|NCT00454207|455858902|FG000|Overall Study|Protocol Violation|0|||
126702180|NCT00454207|455858903|FG001|Overall Study|Protocol Violation|1|||
126702181|NCT01672957|455858904|FG000|Overall Study|Protocol Violation|48|||
126702182|NCT01672957|455858904|FG000|Overall Study|Death|2|||
126702183|NCT01672957|455858904|FG000|Overall Study|ICF Signed After Transplantation|5|||
126702184|NCT02115308|455858906|FG000|Overall Study|Safety Screening|2|||
126702185|NCT02115308|455858907|FG001|Overall Study|Safety Screening|2|||
126702186|NCT00642642|455858908|FG000|Treatment & Follow Up|Adverse Event|2|||
126702187|NCT00642642|455858908|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
126702188|NCT00642642|455858908|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
126702189|NCT02272790|455858911|FG000|Overall Study|Physician Decision|0|||
126702190|NCT02272790|455858912|FG001|Overall Study|Physician Decision|1|||
126702191|NCT02272790|455858913|FG002|Overall Study|Physician Decision|0|||
126702192|NCT02272790|455858914|FG003|Overall Study|Physician Decision|0|||
126702193|NCT02272790|455858915|FG004|Overall Study|Physician Decision|0|||
126702194|NCT02272790|455858916|FG005|Overall Study|Physician Decision|0|||
126702195|NCT00332202|455858917|FG000|Overall Study|Adverse Event|72|||
126702196|NCT00332202|455858918|FG001|Overall Study|Adverse Event|28|||
126702197|NCT00332202|455858917|FG000|Overall Study|Lost to Follow-up|2|||
126702198|NCT00332202|455858918|FG001|Overall Study|Lost to Follow-up|1|||
126702199|NCT00332202|455858917|FG000|Overall Study|Physician Decision|6|||
126702200|NCT00332202|455858918|FG001|Overall Study|Physician Decision|8|||
126702201|NCT00332202|455858917|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
126702202|NCT00332202|455858918|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
126702203|NCT00332202|455858917|FG000|Overall Study|Protocol Violation|7|||
126702204|NCT00332202|455858918|FG001|Overall Study|Protocol Violation|2|||
126702205|NCT00332202|455858917|FG000|Overall Study|Sponsor Decision|1|||
126702206|NCT00332202|455858918|FG001|Overall Study|Sponsor Decision|2|||
126702207|NCT00332202|455858917|FG000|Overall Study|Withdrawal by Subject|36|||
126702208|NCT00332202|455858918|FG001|Overall Study|Withdrawal by Subject|17|||
126702209|NCT00332202|455858917|FG000|Overall Study|Progressive Disease|106|||
126763902|NCT02268214|456086889|FG000|Overall Study|Subject no longer meets study criteria|0|||
126702210|NCT00332202|455858918|FG001|Overall Study|Progressive Disease|60|||
126702211|NCT00332202|455858917|FG000|Overall Study|Death|5|||
126702212|NCT00332202|455858918|FG001|Overall Study|Death|2|||
126702213|NCT03871491|455858919|FG000|Overall Study|Withdrawal by Subject|14|||
126702214|NCT03871491|455858920|FG001|Overall Study|Withdrawal by Subject|14|||
126702215|NCT03871491|455858921|FG002|Overall Study|Withdrawal by Subject|14|||
126702216|NCT03871491|455858922|FG003|Overall Study|Withdrawal by Subject|14|||
126702217|NCT03871491|455858919|FG000|Overall Study|Physician Decision|0|||
126702218|NCT03871491|455858920|FG001|Overall Study|Physician Decision|0|||
126702219|NCT03871491|455858921|FG002|Overall Study|Physician Decision|1|||
126702220|NCT03871491|455858922|FG003|Overall Study|Physician Decision|1|||
126702221|NCT03871491|455858919|FG000|Overall Study|Lost to Follow-up|50|||
126702222|NCT03871491|455858920|FG001|Overall Study|Lost to Follow-up|15|||
126702223|NCT03871491|455858921|FG002|Overall Study|Lost to Follow-up|36|||
126702224|NCT03871491|455858922|FG003|Overall Study|Lost to Follow-up|11|||
126702225|NCT04439331|455858923|FG000|Overall Study|Never Start Protocol Therapy|2|||
126702226|NCT04439331|455858923|FG000|Overall Study|Ineligible|2|||
126702227|NCT04439331|455858923|FG000|Overall Study|Mutation Status Not Confirmed|1|||
126702228|NCT04439331|455858923|FG000|Overall Study|Adverse Event|1|||
126702229|NCT04439331|455858923|FG000|Overall Study|Death|1|||
126702230|NCT04439331|455858923|FG000|Overall Study|Disease Progression|20|||
126702231|NCT04439331|455858923|FG000|Overall Study|Withdrawal by Subject|6|||
126702232|NCT04439331|455858923|FG000|Overall Study|Physician Decision|1|||
126702233|NCT04439331|455858923|FG000|Overall Study|Other Complicating Disease|1|||
126702234|NCT00490542|455858926|FG000|Overall Study|Lost to Follow-up|3|||
126702235|NCT00490542|455858927|FG001|Overall Study|Lost to Follow-up|0|||
126702236|NCT00490542|455858926|FG000|Overall Study|Adverse Event|3|||
126702237|NCT00490542|455858927|FG001|Overall Study|Adverse Event|3|||
126702238|NCT00490542|455858926|FG000|Overall Study|Lack of Efficacy|1|||
126702239|NCT00490542|455858927|FG001|Overall Study|Lack of Efficacy|1|||
126702240|NCT00818259|455858931|FG000|Part I|Withdrawal by Subject|1|||
126702241|NCT00818259|455858932|FG001|Part I|Withdrawal by Subject|0|||
126702242|NCT00818259|455858933|FG002|Part I|Withdrawal by Subject|0|||
126702243|NCT00818259|455858934|FG003|Part I|Withdrawal by Subject|0|||
126702244|NCT00818259|455858935|FG004|Part I|Withdrawal by Subject|0|||
126702245|NCT00818259|455858936|FG005|Part I|Withdrawal by Subject|0|||
126702246|NCT00818259|455858937|FG006|Part I|Withdrawal by Subject|0|||
126702247|NCT00818259|455858938|FG007|Part I|Withdrawal by Subject|0|||
126702248|NCT00818259|455858939|FG008|Part I|Withdrawal by Subject|0|||
126702249|NCT00818259|455858931|FG000|Part II|Physician Decision|0|||
126702250|NCT00818259|455858932|FG001|Part II|Physician Decision|0|||
126702251|NCT00818259|455858933|FG002|Part II|Physician Decision|1|||
126702252|NCT00818259|455858934|FG003|Part II|Physician Decision|0|||
126702253|NCT00818259|455858935|FG004|Part II|Physician Decision|0|||
126702254|NCT00818259|455858936|FG005|Part II|Physician Decision|0|||
126702255|NCT00818259|455858937|FG006|Part II|Physician Decision|0|||
126702256|NCT00818259|455858938|FG007|Part II|Physician Decision|0|||
126702257|NCT00818259|455858939|FG008|Part II|Physician Decision|0|||
126702258|NCT00818259|455858931|FG000|Part II|Lack of Efficacy|0|||
126702259|NCT00818259|455858932|FG001|Part II|Lack of Efficacy|0|||
126702260|NCT00818259|455858933|FG002|Part II|Lack of Efficacy|0|||
126702261|NCT00818259|455858934|FG003|Part II|Lack of Efficacy|1|||
126702262|NCT00818259|455858935|FG004|Part II|Lack of Efficacy|0|||
126702263|NCT00818259|455858936|FG005|Part II|Lack of Efficacy|0|||
126702264|NCT00818259|455858937|FG006|Part II|Lack of Efficacy|0|||
126702265|NCT00818259|455858938|FG007|Part II|Lack of Efficacy|0|||
126702266|NCT00818259|455858939|FG008|Part II|Lack of Efficacy|0|||
126702267|NCT00818259|455858931|FG000|Part II|Not Treated|0|||
126702268|NCT00818259|455858932|FG001|Part II|Not Treated|0|||
126702269|NCT00818259|455858933|FG002|Part II|Not Treated|0|||
126702270|NCT00818259|455858934|FG003|Part II|Not Treated|1|||
126452493|NCT01129583|454958920|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
126452494|NCT01129583|454958921|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
126452495|NCT02600871|454958922|FG000|Overall Study|Lost to Follow-up|13|||
126702271|NCT00818259|455858935|FG004|Part II|Not Treated|0|||
126702272|NCT00818259|455858936|FG005|Part II|Not Treated|0|||
126702273|NCT00818259|455858937|FG006|Part II|Not Treated|0|||
126763903|NCT02268214|456086890|FG001|Overall Study|Subject no longer meets study criteria|2|||
126702274|NCT00818259|455858938|FG007|Part II|Not Treated|0|||
126702275|NCT00818259|455858939|FG008|Part II|Not Treated|0|||
126702276|NCT00818259|455858931|FG000|Part IV|Physician Decision|0|||
126702277|NCT00818259|455858932|FG001|Part IV|Physician Decision|0|||
126702278|NCT00818259|455858933|FG002|Part IV|Physician Decision|0|||
126452496|NCT02600871|454958923|FG001|Overall Study|Lost to Follow-up|10|||
126702279|NCT00818259|455858934|FG003|Part IV|Physician Decision|0|||
126702280|NCT00818259|455858935|FG004|Part IV|Physician Decision|0|||
126702281|NCT00818259|455858936|FG005|Part IV|Physician Decision|1|||
126702282|NCT00818259|455858937|FG006|Part IV|Physician Decision|0|||
126702283|NCT00818259|455858938|FG007|Part IV|Physician Decision|0|||
126702284|NCT00818259|455858939|FG008|Part IV|Physician Decision|0|||
126702285|NCT00818259|455858931|FG000|Part V|Adverse Event|0|||
126702286|NCT00818259|455858932|FG001|Part V|Adverse Event|0|||
126702287|NCT00818259|455858933|FG002|Part V|Adverse Event|0|||
126702288|NCT00818259|455858934|FG003|Part V|Adverse Event|0|||
126702289|NCT00818259|455858935|FG004|Part V|Adverse Event|0|||
126702290|NCT00818259|455858936|FG005|Part V|Adverse Event|0|||
126702291|NCT00818259|455858937|FG006|Part V|Adverse Event|0|||
126702292|NCT00818259|455858938|FG007|Part V|Adverse Event|1|||
126702293|NCT00818259|455858939|FG008|Part V|Adverse Event|0|||
126702294|NCT01053429|455858943|FG000|Overall Study|Adverse Event|64|||
126702295|NCT01053429|455858943|FG000|Overall Study|Other|309|||
126702296|NCT01237951|455858944|FG000|Overall Study|Death|1|||
126702297|NCT00666562|455858947|FG000|Overall Study|Withdrawal by Subject|0|||
126702298|NCT00666562|455858948|FG001|Overall Study|Withdrawal by Subject|1|||
126702299|NCT00666562|455858949|FG002|Overall Study|Withdrawal by Subject|0|||
126702300|NCT00666562|455858947|FG000|Overall Study|Concomitant Medication|0|||
126702301|NCT00666562|455858948|FG001|Overall Study|Concomitant Medication|1|||
126702302|NCT00666562|455858949|FG002|Overall Study|Concomitant Medication|0|||
126702303|NCT04429022|455858951|FG000|Overall Study|Protocol Violation|18|||
126702304|NCT04429022|455858952|FG001|Overall Study|Protocol Violation|1|||
126702305|NCT02582658|455858957|FG000|Overall Study|Failure to Return|10|||
126702306|NCT02582658|455858957|FG000|Overall Study|Insufficient Virological Response|2|||
126702307|NCT02582658|455858957|FG000|Overall Study|Withdrawn Consent|1|||
126702308|NCT02582658|455858957|FG000|Overall Study|Death|1|||
126702309|NCT02582658|455858957|FG000|Overall Study|Not further specified|11|||
126702310|NCT05556616|455860643|FG000|Overall Study|Withdrawal by Subject|1|||
126702311|NCT05556616|455860644|FG001|Overall Study|Withdrawal by Subject|0|||
126702312|NCT05556616|455860645|FG002|Overall Study|Withdrawal by Subject|0|||
126702313|NCT05556616|455860646|FG003|Overall Study|Withdrawal by Subject|0|||
126702314|NCT05556616|455860647|FG004|Overall Study|Withdrawal by Subject|0|||
126702315|NCT05556616|455860648|FG005|Overall Study|Withdrawal by Subject|0|||
126702316|NCT05556616|455860649|FG006|Overall Study|Withdrawal by Subject|0|||
126702317|NCT05556616|455860643|FG000|Overall Study|Death|0|||
126702318|NCT05556616|455860644|FG001|Overall Study|Death|0|||
126702319|NCT05556616|455860645|FG002|Overall Study|Death|2|||
126702320|NCT05556616|455860646|FG003|Overall Study|Death|1|||
126702321|NCT05556616|455860647|FG004|Overall Study|Death|0|||
126702322|NCT05556616|455860648|FG005|Overall Study|Death|0|||
126702323|NCT05556616|455860649|FG006|Overall Study|Death|0|||
126702324|NCT05556616|455860643|FG000|Overall Study|Study Terminated by Sponsor|0|||
126702325|NCT05556616|455860644|FG001|Overall Study|Study Terminated by Sponsor|3|||
126702326|NCT05556616|455860645|FG002|Overall Study|Study Terminated by Sponsor|0|||
126702327|NCT05556616|455860646|FG003|Overall Study|Study Terminated by Sponsor|0|||
126702328|NCT05556616|455860647|FG004|Overall Study|Study Terminated by Sponsor|0|||
126702329|NCT05556616|455860648|FG005|Overall Study|Study Terminated by Sponsor|0|||
126702330|NCT05556616|455860649|FG006|Overall Study|Study Terminated by Sponsor|0|||
126702331|NCT03539432|455860650|FG000|Overall Study|Lost to Follow-up|0|||
126702332|NCT03539432|455860651|FG001|Overall Study|Lost to Follow-up|1|||
126702333|NCT00824564|455860653|FG000|Overall Study|Lost to Follow-up|5|||
126702334|NCT00824564|455860654|FG001|Overall Study|Lost to Follow-up|7|||
126702335|NCT00824564|455860653|FG000|Overall Study|Withdrawal by Subject|1|||
126702336|NCT00824564|455860654|FG001|Overall Study|Withdrawal by Subject|1|||
126702337|NCT00824564|455860653|FG000|Overall Study|Other|1|||
126702338|NCT00824564|455860654|FG001|Overall Study|Other|2|||
126702339|NCT00824564|455860653|FG000|Overall Study|Randomized, but not treated|1|||
126702340|NCT00824564|455860654|FG001|Overall Study|Randomized, but not treated|0|||
126702341|NCT00476086|455860655|FG000|Overall Study|Alternative therapy|1|||
126702342|NCT00476086|455860655|FG000|Overall Study|Progressive Disease|4|||
126702343|NCT04178590|455860656|FG000|Overall Study|Pregnancy|1|||
126702344|NCT04178590|455860656|FG000|Overall Study|Lost to Follow-up|1|||
126702345|NCT02292849|455860657|FG000|Overall Study|Lost to Follow-up|0|||
126702346|NCT02292849|455860658|FG001|Overall Study|Lost to Follow-up|2|||
126702347|NCT02292849|455860659|FG002|Overall Study|Lost to Follow-up|2|||
126702348|NCT02292849|455860657|FG000|Overall Study|Physician Decision|4|||
126702349|NCT02292849|455860658|FG001|Overall Study|Physician Decision|0|||
126702350|NCT02292849|455860659|FG002|Overall Study|Physician Decision|0|||
126702351|NCT00886938|455860660|FG000|Overall Study|Adverse Event|1|||
126702352|NCT00886938|455860660|FG000|Overall Study|Withdrawal by Subject|1|||
126702353|NCT00364793|455860661|FG000|Overall Study|Adverse Event|2|||
126702354|NCT00364793|455860662|FG001|Overall Study|Adverse Event|0|||
126702355|NCT00364793|455860663|FG002|Overall Study|Adverse Event|0|||
126702356|NCT00364793|455860664|FG003|Overall Study|Adverse Event|0|||
126702357|NCT00364793|455860661|FG000|Overall Study|Death|1|||
126702358|NCT00364793|455860662|FG001|Overall Study|Death|0|||
126702359|NCT00364793|455860663|FG002|Overall Study|Death|1|||
126702360|NCT00364793|455860664|FG003|Overall Study|Death|0|||
126763904|NCT02268214|456086891|FG002|Overall Study|Subject no longer meets study criteria|0|||
126763905|NCT02268214|456086889|FG000|Overall Study|Pregnancy|2|||
126702361|NCT00364793|455860661|FG000|Overall Study|Lack of Efficacy|3|||
126702362|NCT00364793|455860662|FG001|Overall Study|Lack of Efficacy|3|||
126702363|NCT00364793|455860663|FG002|Overall Study|Lack of Efficacy|1|||
126702364|NCT00364793|455860664|FG003|Overall Study|Lack of Efficacy|1|||
126702365|NCT00364793|455860661|FG000|Overall Study|Lost to Follow-up|1|||
126702366|NCT00364793|455860662|FG001|Overall Study|Lost to Follow-up|0|||
126702367|NCT00364793|455860663|FG002|Overall Study|Lost to Follow-up|2|||
126702368|NCT00364793|455860664|FG003|Overall Study|Lost to Follow-up|0|||
126702369|NCT00364793|455860661|FG000|Overall Study|Poor or non-compliance|1|||
126702370|NCT00364793|455860662|FG001|Overall Study|Poor or non-compliance|1|||
126702371|NCT00364793|455860663|FG002|Overall Study|Poor or non-compliance|0|||
126702372|NCT00364793|455860664|FG003|Overall Study|Poor or non-compliance|1|||
126702373|NCT00364793|455860661|FG000|Overall Study|No longer meets criteria|0|||
126702374|NCT00364793|455860662|FG001|Overall Study|No longer meets criteria|0|||
126702375|NCT00364793|455860663|FG002|Overall Study|No longer meets criteria|0|||
126702376|NCT00364793|455860664|FG003|Overall Study|No longer meets criteria|1|||
126702377|NCT00364793|455860661|FG000|Overall Study|Withdrawal by Subject|0|||
126702378|NCT00364793|455860662|FG001|Overall Study|Withdrawal by Subject|1|||
126702379|NCT00364793|455860663|FG002|Overall Study|Withdrawal by Subject|0|||
126702380|NCT00364793|455860664|FG003|Overall Study|Withdrawal by Subject|0|||
126702381|NCT00363415|455860667|FG000|Overall Study|Progressive Disease|196|||
126702382|NCT00363415|455860668|FG001|Overall Study|Progressive Disease|107|||
126702383|NCT00363415|455860667|FG000|Overall Study|Sponsor Decision|67|||
126702384|NCT00363415|455860668|FG001|Overall Study|Sponsor Decision|31|||
126702385|NCT00363415|455860667|FG000|Overall Study|Death|32|||
126702386|NCT00363415|455860668|FG001|Overall Study|Death|29|||
126702387|NCT00363415|455860667|FG000|Overall Study|Adverse Event|24|||
126702388|NCT00363415|455860668|FG001|Overall Study|Adverse Event|15|||
126702389|NCT00363415|455860667|FG000|Overall Study|Physician Decision|18|||
126702390|NCT00363415|455860668|FG001|Overall Study|Physician Decision|35|||
126702391|NCT00363415|455860667|FG000|Overall Study|Entry Criteria Not Met|11|||
126702392|NCT00363415|455860668|FG001|Overall Study|Entry Criteria Not Met|10|||
126702393|NCT00363415|455860667|FG000|Overall Study|Withdrawal by Subject|9|||
126702394|NCT00363415|455860668|FG001|Overall Study|Withdrawal by Subject|15|||
126702395|NCT00363415|455860667|FG000|Overall Study|Lost to Follow-up|3|||
126702396|NCT00363415|455860668|FG001|Overall Study|Lost to Follow-up|3|||
126702397|NCT00363415|455860667|FG000|Overall Study|Protocol Violation|1|||
126702398|NCT00363415|455860668|FG001|Overall Study|Protocol Violation|4|||
126702399|NCT00870688|455860671|FG000|Overall Study|Lost to Follow-up|2|||
126702400|NCT00870688|455860671|FG000|Overall Study|Death, Unrelated|1|||
126702401|NCT00870688|455860671|FG000|Overall Study|Granules in the Stools|1|||
126702402|NCT05027802|455860672|FG000|Overall Study|Adverse Event|2|||
126702403|NCT05027802|455860672|FG000|Overall Study|Withdrawal by Subject|18|||
126702404|NCT05027802|455860672|FG000|Overall Study|Death|2|||
126702405|NCT05027802|455860672|FG000|Overall Study|Other|1|||
126702406|NCT03872180|455860681|FG000|Overall Study|Adverse Event|4|||
126702407|NCT03872180|455860681|FG000|Overall Study|Lack of Efficacy|2|||
126702408|NCT01506141|455860682|FG000|Overall Study|Adverse Event|0|||
126702409|NCT01506141|455860683|FG001|Overall Study|Adverse Event|2|||
126702410|NCT01506141|455860682|FG000|Overall Study|Participation Terminated by Investigator|1|||
126452497|NCT00830869|454958927|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
126452498|NCT00830869|454958928|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
126452499|NCT00830869|454958929|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
126452500|NCT00830869|454958930|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
126452501|NCT00830869|454958931|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
126452502|NCT00830869|454958932|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
126452503|NCT00830869|454958933|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
126452504|NCT00830869|454958934|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
126452505|NCT00830869|454958935|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
126452506|NCT00830869|454958936|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
126452507|NCT00830869|454958937|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
126452508|NCT00830869|454958938|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
126452509|NCT00830869|454958927|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
126452510|NCT00830869|454958928|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
126452511|NCT00830869|454958929|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
126452512|NCT00830869|454958930|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
126452513|NCT00830869|454958931|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
126452514|NCT00830869|454958932|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
126702411|NCT01506141|455860683|FG001|Overall Study|Participation Terminated by Investigator|1|||
126452515|NCT00830869|454958933|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
126702412|NCT01506141|455860682|FG000|Overall Study|Site Terminated by Sponsor|2|||
126702413|NCT01506141|455860683|FG001|Overall Study|Site Terminated by Sponsor|0|||
126702414|NCT01506141|455860682|FG000|Overall Study|Reason Not Specified|4|||
126702415|NCT01506141|455860683|FG001|Overall Study|Reason Not Specified|2|||
126702416|NCT04607408|455860684|FG000|Overall Study|Lost to Follow-up|0|||
126702417|NCT04607408|455860685|FG001|Overall Study|Lost to Follow-up|0|||
126702418|NCT04607408|455860686|FG002|Overall Study|Lost to Follow-up|0|||
126702419|NCT04607408|455860687|FG003|Overall Study|Lost to Follow-up|1|||
126702420|NCT04607408|455860688|FG004|Overall Study|Lost to Follow-up|0|||
126702421|NCT04607408|455860684|FG000|Overall Study|Withdrawal by Subject|0|||
126452516|NCT00830869|454958934|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
126452517|NCT00830869|454958935|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
126547047|NCT00557622|455296120|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
126547048|NCT00557622|455296119|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
126547049|NCT00557622|455296120|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
126547050|NCT01539863|455296121|FG000|Overall Study|Lost to Follow-up|5|||
126547051|NCT01539863|455296122|FG001|Overall Study|Lost to Follow-up|4|||
126547052|NCT02765490|455296125|FG000|Overall Study|Lost to Follow-up|1|||
126547053|NCT02765490|455296126|FG001|Overall Study|Lost to Follow-up|1|||
126547054|NCT02765490|455296125|FG000|Overall Study|Other|0|||
126547055|NCT02765490|455296126|FG001|Overall Study|Other|1|||
126547056|NCT02765490|455296125|FG000|Overall Study|Death|0|||
126702422|NCT04607408|455860685|FG001|Overall Study|Withdrawal by Subject|1|||
126702423|NCT04607408|455860686|FG002|Overall Study|Withdrawal by Subject|0|||
126702424|NCT04607408|455860687|FG003|Overall Study|Withdrawal by Subject|1|||
126702425|NCT04607408|455860688|FG004|Overall Study|Withdrawal by Subject|0|||
126702426|NCT02725788|455860689|FG000|Overall Study|Lost to Follow-up|1|||
126702427|NCT02725788|455860690|FG001|Overall Study|Lost to Follow-up|1|||
126702428|NCT02725788|455860689|FG000|Overall Study|Protocol Violation|0|||
126702429|NCT02725788|455860690|FG001|Overall Study|Protocol Violation|1|||
126702430|NCT05590377|455860691|FG000|Overall Study|Death|1|||
126702431|NCT05590377|455860692|FG001|Overall Study|Death|1|||
126702432|NCT05590377|455860693|FG002|Overall Study|Death|2|||
126702433|NCT05590377|455860694|FG003|Overall Study|Death|0|||
126702434|NCT05590377|455860695|FG004|Overall Study|Death|0|||
126702435|NCT05590377|455860691|FG000|Overall Study|Study Terminated by Sponsor|1|||
126702436|NCT05590377|455860692|FG001|Overall Study|Study Terminated by Sponsor|5|||
126702437|NCT05590377|455860693|FG002|Overall Study|Study Terminated by Sponsor|4|||
126702438|NCT05590377|455860694|FG003|Overall Study|Study Terminated by Sponsor|0|||
126702439|NCT05590377|455860695|FG004|Overall Study|Study Terminated by Sponsor|0|||
126702440|NCT05590377|455860691|FG000|Overall Study|Withdrawal by Subject|1|||
126702441|NCT05590377|455860692|FG001|Overall Study|Withdrawal by Subject|0|||
126702442|NCT05590377|455860693|FG002|Overall Study|Withdrawal by Subject|0|||
126702443|NCT05590377|455860694|FG003|Overall Study|Withdrawal by Subject|0|||
126702444|NCT05590377|455860695|FG004|Overall Study|Withdrawal by Subject|0|||
126702445|NCT00828464|455860696|FG000|Overall Study|Withdrawal by Subject|1|||
126702446|NCT00809133|455860697|FG000|Overall Study|Progressive disease|2|||
126702447|NCT00809133|455860698|FG001|Overall Study|Progressive disease|5|||
126702448|NCT00809133|455860699|FG002|Overall Study|Progressive disease|5|||
126702449|NCT00809133|455860700|FG003|Overall Study|Progressive disease|3|||
126702450|NCT00809133|455860701|FG004|Overall Study|Progressive disease|4|||
126702451|NCT00809133|455860702|FG005|Overall Study|Progressive disease|1|||
126702452|NCT00809133|455860703|FG006|Overall Study|Progressive disease|3|||
126702453|NCT00809133|455860704|FG007|Overall Study|Progressive disease|3|||
126702454|NCT00809133|455860705|FG008|Overall Study|Progressive disease|3|||
126702455|NCT00809133|455860706|FG009|Overall Study|Progressive disease|9|||
126702456|NCT00809133|455860707|FG010|Overall Study|Progressive disease|5|||
126702457|NCT00809133|455860708|FG011|Overall Study|Progressive disease|7|||
126702458|NCT00809133|455860709|FG012|Overall Study|Progressive disease|5|||
126702459|NCT00809133|455860710|FG013|Overall Study|Progressive disease|4|||
126702460|NCT00809133|455860697|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126702461|NCT00809133|455860698|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126702462|NCT00809133|455860699|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126702463|NCT00809133|455860700|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126702464|NCT00809133|455860701|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126702465|NCT00809133|455860702|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
126702466|NCT00809133|455860703|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
126702467|NCT00809133|455860704|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
126702468|NCT00809133|455860705|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126702469|NCT00809133|455860706|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126702470|NCT00809133|455860707|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126452518|NCT00830869|454958936|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
126452519|NCT00830869|454958937|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
126452520|NCT00830869|454958938|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
126452521|NCT00830869|454958927|FG000|Period 1: Part 1|Adverse Event|0|||
126452522|NCT00830869|454958928|FG001|Period 1: Part 1|Adverse Event|0|||
126452523|NCT00830869|454958929|FG002|Period 1: Part 1|Adverse Event|0|||
126452524|NCT00830869|454958930|FG003|Period 1: Part 1|Adverse Event|0|||
126452525|NCT00830869|454958931|FG004|Period 1: Part 1|Adverse Event|0|||
126452526|NCT00830869|454958932|FG005|Period 1: Part 1|Adverse Event|1|||
126452527|NCT00830869|454958933|FG006|Period 1: Part 1|Adverse Event|1|||
126452528|NCT00830869|454958934|FG007|Period 1: Part 1|Adverse Event|0|||
126547057|NCT02765490|455296126|FG001|Overall Study|Death|1|||
126547058|NCT01468922|455296127|FG000|Overall Study|Screening failure|0|||
126702471|NCT00809133|455860708|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126702472|NCT00809133|455860709|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126763906|NCT02268214|456086890|FG001|Overall Study|Pregnancy|2|||
126452529|NCT00830869|454958935|FG008|Period 1: Part 1|Adverse Event|0|||
126452530|NCT00830869|454958936|FG009|Period 1: Part 1|Adverse Event|0|||
126547059|NCT01468922|455296128|FG001|Overall Study|Screening failure|0|||
126702473|NCT00809133|455860710|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
126702474|NCT00809133|455860697|FG000|Overall Study|Other adverse event|1|||
126702475|NCT00809133|455860698|FG001|Overall Study|Other adverse event|1|||
126702476|NCT00809133|455860699|FG002|Overall Study|Other adverse event|1|||
126702477|NCT00809133|455860700|FG003|Overall Study|Other adverse event|0|||
126702478|NCT00809133|455860701|FG004|Overall Study|Other adverse event|0|||
126702479|NCT00809133|455860702|FG005|Overall Study|Other adverse event|3|||
126702480|NCT00809133|455860703|FG006|Overall Study|Other adverse event|2|||
126702481|NCT00809133|455860704|FG007|Overall Study|Other adverse event|4|||
126702482|NCT00809133|455860705|FG008|Overall Study|Other adverse event|0|||
126702483|NCT00809133|455860706|FG009|Overall Study|Other adverse event|0|||
126702484|NCT00809133|455860707|FG010|Overall Study|Other adverse event|1|||
126702485|NCT00809133|455860708|FG011|Overall Study|Other adverse event|1|||
126702486|NCT00809133|455860709|FG012|Overall Study|Other adverse event|0|||
126702487|NCT00809133|455860710|FG013|Overall Study|Other adverse event|1|||
126702488|NCT00809133|455860697|FG000|Overall Study|Lost to Follow-up|0|||
126702489|NCT00809133|455860698|FG001|Overall Study|Lost to Follow-up|0|||
126702490|NCT00809133|455860699|FG002|Overall Study|Lost to Follow-up|0|||
126702491|NCT00809133|455860700|FG003|Overall Study|Lost to Follow-up|0|||
126702492|NCT00809133|455860701|FG004|Overall Study|Lost to Follow-up|0|||
126702493|NCT00809133|455860702|FG005|Overall Study|Lost to Follow-up|1|||
126702494|NCT00809133|455860703|FG006|Overall Study|Lost to Follow-up|0|||
126702495|NCT00809133|455860704|FG007|Overall Study|Lost to Follow-up|0|||
126702496|NCT00809133|455860705|FG008|Overall Study|Lost to Follow-up|0|||
126702497|NCT00809133|455860706|FG009|Overall Study|Lost to Follow-up|0|||
126702498|NCT00809133|455860707|FG010|Overall Study|Lost to Follow-up|0|||
126702499|NCT00809133|455860708|FG011|Overall Study|Lost to Follow-up|0|||
126702500|NCT00809133|455860709|FG012|Overall Study|Lost to Follow-up|0|||
126702501|NCT00809133|455860710|FG013|Overall Study|Lost to Follow-up|0|||
126702502|NCT00809133|455860697|FG000|Overall Study|Consent withdrawn|0|||
126702503|NCT00809133|455860698|FG001|Overall Study|Consent withdrawn|0|||
126702504|NCT00809133|455860699|FG002|Overall Study|Consent withdrawn|0|||
126702505|NCT00809133|455860700|FG003|Overall Study|Consent withdrawn|0|||
126702506|NCT00809133|455860701|FG004|Overall Study|Consent withdrawn|1|||
126702507|NCT00809133|455860702|FG005|Overall Study|Consent withdrawn|0|||
126702508|NCT00809133|455860703|FG006|Overall Study|Consent withdrawn|0|||
126702509|NCT00809133|455860704|FG007|Overall Study|Consent withdrawn|0|||
126702510|NCT00809133|455860705|FG008|Overall Study|Consent withdrawn|0|||
126702511|NCT00809133|455860706|FG009|Overall Study|Consent withdrawn|0|||
126702512|NCT00809133|455860707|FG010|Overall Study|Consent withdrawn|0|||
126702513|NCT00809133|455860708|FG011|Overall Study|Consent withdrawn|0|||
126702514|NCT00809133|455860709|FG012|Overall Study|Consent withdrawn|0|||
126702515|NCT00809133|455860710|FG013|Overall Study|Consent withdrawn|0|||
126702516|NCT00809133|455860697|FG000|Overall Study|Other not mentioned above|0|||
126702517|NCT00809133|455860698|FG001|Overall Study|Other not mentioned above|1|||
126702518|NCT00809133|455860699|FG002|Overall Study|Other not mentioned above|0|||
126702519|NCT00809133|455860700|FG003|Overall Study|Other not mentioned above|0|||
126702520|NCT00809133|455860701|FG004|Overall Study|Other not mentioned above|0|||
126702521|NCT00809133|455860702|FG005|Overall Study|Other not mentioned above|1|||
126702522|NCT00809133|455860703|FG006|Overall Study|Other not mentioned above|0|||
126702523|NCT00809133|455860704|FG007|Overall Study|Other not mentioned above|0|||
126702524|NCT00809133|455860705|FG008|Overall Study|Other not mentioned above|0|||
126702525|NCT00809133|455860706|FG009|Overall Study|Other not mentioned above|0|||
126702526|NCT00809133|455860707|FG010|Overall Study|Other not mentioned above|0|||
126702527|NCT00809133|455860708|FG011|Overall Study|Other not mentioned above|0|||
126702528|NCT00809133|455860709|FG012|Overall Study|Other not mentioned above|0|||
126702529|NCT00809133|455860710|FG013|Overall Study|Other not mentioned above|0|||
126702530|NCT04433117|455860711|FG000|Overall Study|Withdrawal by Subject|1|||
126702531|NCT04433117|455860712|FG001|Overall Study|Withdrawal by Subject|0|||
126702532|NCT01051739|455860713|FG000|Overall Study|Death|3|||
126702533|NCT01051739|455860714|FG001|Overall Study|Death|3|||
126702534|NCT01051739|455860713|FG000|Overall Study|Withdrawal by Subject|25|||
126702535|NCT01051739|455860714|FG001|Overall Study|Withdrawal by Subject|10|||
126452531|NCT00830869|454958937|FG010|Period 1: Part 1|Adverse Event|0|||
126452532|NCT00830869|454958938|FG011|Period 1: Part 1|Adverse Event|0|||
126452533|NCT00830869|454958927|FG000|Period 1: Part 1|Progressive disease|1|||
126452534|NCT00830869|454958928|FG001|Period 1: Part 1|Progressive disease|0|||
126702536|NCT00707577|455860715|FG000|Overall Study|Withdrawal by Subject|3|||
126702537|NCT00707577|455860716|FG001|Overall Study|Withdrawal by Subject|2|||
126702538|NCT00707577|455860715|FG000|Overall Study|Lost to Follow-up|34|||
126702539|NCT00707577|455860716|FG001|Overall Study|Lost to Follow-up|25|||
126702540|NCT00707577|455860715|FG000|Overall Study|Left employment|13|||
126702541|NCT00707577|455860716|FG001|Overall Study|Left employment|10|||
126702542|NCT00707577|455860715|FG000|Overall Study|Pregnancy|4|||
126702543|NCT00707577|455860716|FG001|Overall Study|Pregnancy|1|||
126702544|NCT03853694|455860717|FG000|Overall Study|Protocol Violation|3|||
126702545|NCT03853694|455860718|FG001|Overall Study|Protocol Violation|5|||
126452535|NCT00830869|454958929|FG002|Period 1: Part 1|Progressive disease|1|||
126702546|NCT03853694|455860719|FG002|Overall Study|Protocol Violation|3|||
126702547|NCT03853694|455860717|FG000|Overall Study|Delivered early|0|||
126547060|NCT01468922|455296129|FG002|Overall Study|Screening failure|0|||
126547061|NCT01468922|455296130|FG003|Overall Study|Screening failure|0|||
126547062|NCT01468922|455296131|FG004|Overall Study|Screening failure|0|||
126547063|NCT01468922|455296132|FG005|Overall Study|Screening failure|0|||
126547064|NCT01468922|455296133|FG006|Overall Study|Screening failure|0|||
126547065|NCT01468922|455296134|FG007|Overall Study|Screening failure|0|||
126547066|NCT01468922|455296135|FG008|Overall Study|Screening failure|1|||
126547067|NCT01468922|455296127|FG000|Overall Study|Per patient choice|1|||
126547068|NCT01468922|455296128|FG001|Overall Study|Per patient choice|0|||
126547069|NCT01468922|455296129|FG002|Overall Study|Per patient choice|0|||
126547070|NCT01468922|455296130|FG003|Overall Study|Per patient choice|0|||
126547071|NCT01468922|455296131|FG004|Overall Study|Per patient choice|0|||
126547072|NCT01468922|455296132|FG005|Overall Study|Per patient choice|0|||
126547073|NCT01468922|455296133|FG006|Overall Study|Per patient choice|0|||
126547074|NCT01468922|455296134|FG007|Overall Study|Per patient choice|0|||
126547075|NCT01468922|455296135|FG008|Overall Study|Per patient choice|0|||
126547076|NCT01468922|455296127|FG000|Overall Study|Switched to alternative treatment|1|||
126547077|NCT01468922|455296128|FG001|Overall Study|Switched to alternative treatment|0|||
126547078|NCT01468922|455296129|FG002|Overall Study|Switched to alternative treatment|0|||
126547079|NCT01468922|455296130|FG003|Overall Study|Switched to alternative treatment|0|||
126547080|NCT01468922|455296131|FG004|Overall Study|Switched to alternative treatment|1|||
126547081|NCT01468922|455296132|FG005|Overall Study|Switched to alternative treatment|0|||
126547082|NCT01468922|455296133|FG006|Overall Study|Switched to alternative treatment|0|||
126547083|NCT01468922|455296134|FG007|Overall Study|Switched to alternative treatment|0|||
126547084|NCT01468922|455296135|FG008|Overall Study|Switched to alternative treatment|0|||
126547085|NCT01468922|455296127|FG000|Overall Study|Enrolled on new protocol|0|||
126547086|NCT01468922|455296128|FG001|Overall Study|Enrolled on new protocol|0|||
126547087|NCT01468922|455296129|FG002|Overall Study|Enrolled on new protocol|0|||
126547088|NCT01468922|455296130|FG003|Overall Study|Enrolled on new protocol|0|||
126547089|NCT01468922|455296131|FG004|Overall Study|Enrolled on new protocol|1|||
126547090|NCT01468922|455296132|FG005|Overall Study|Enrolled on new protocol|0|||
126547091|NCT01468922|455296133|FG006|Overall Study|Enrolled on new protocol|0|||
126547092|NCT01468922|455296134|FG007|Overall Study|Enrolled on new protocol|0|||
126547093|NCT01468922|455296135|FG008|Overall Study|Enrolled on new protocol|0|||
126547094|NCT01468922|455296127|FG000|Overall Study|Adverse Event|0|||
126547095|NCT01468922|455296128|FG001|Overall Study|Adverse Event|0|||
126452536|NCT00830869|454958930|FG003|Period 1: Part 1|Progressive disease|6|||
126452537|NCT00830869|454958931|FG004|Period 1: Part 1|Progressive disease|4|||
126452538|NCT00830869|454958932|FG005|Period 1: Part 1|Progressive disease|4|||
126452539|NCT00830869|454958933|FG006|Period 1: Part 1|Progressive disease|1|||
126452540|NCT00830869|454958934|FG007|Period 1: Part 1|Progressive disease|0|||
126452541|NCT00830869|454958935|FG008|Period 1: Part 1|Progressive disease|0|||
126452542|NCT00830869|454958936|FG009|Period 1: Part 1|Progressive disease|0|||
126452543|NCT00830869|454958937|FG010|Period 1: Part 1|Progressive disease|0|||
126452544|NCT00830869|454958938|FG011|Period 1: Part 1|Progressive disease|0|||
126452545|NCT00830869|454958927|FG000|Period 2: Part 2|Protocol Violation|0|||
126452546|NCT00830869|454958928|FG001|Period 2: Part 2|Protocol Violation|0|||
126452547|NCT00830869|454958929|FG002|Period 2: Part 2|Protocol Violation|0|||
126452548|NCT00830869|454958930|FG003|Period 2: Part 2|Protocol Violation|0|||
126452549|NCT00830869|454958931|FG004|Period 2: Part 2|Protocol Violation|0|||
126452550|NCT00830869|454958932|FG005|Period 2: Part 2|Protocol Violation|0|||
126452551|NCT00830869|454958933|FG006|Period 2: Part 2|Protocol Violation|0|||
126452552|NCT00830869|454958934|FG007|Period 2: Part 2|Protocol Violation|1|||
126452553|NCT00830869|454958935|FG008|Period 2: Part 2|Protocol Violation|0|||
126452554|NCT00830869|454958936|FG009|Period 2: Part 2|Protocol Violation|1|||
126547096|NCT01468922|455296129|FG002|Overall Study|Adverse Event|0|||
126547097|NCT01468922|455296130|FG003|Overall Study|Adverse Event|0|||
126702548|NCT03853694|455860718|FG001|Overall Study|Delivered early|1|||
126702549|NCT03853694|455860719|FG002|Overall Study|Delivered early|0|||
126702550|NCT03853694|455860717|FG000|Overall Study|not suitable to proceed|0|||
126702551|NCT03853694|455860718|FG001|Overall Study|not suitable to proceed|1|||
126702552|NCT03853694|455860719|FG002|Overall Study|not suitable to proceed|0|||
126702553|NCT03853694|455860717|FG000|Overall Study|difficult surgery|0|||
126452555|NCT00830869|454958937|FG010|Period 2: Part 2|Protocol Violation|0|||
126452556|NCT00830869|454958938|FG011|Period 2: Part 2|Protocol Violation|0|||
126547098|NCT01468922|455296131|FG004|Overall Study|Adverse Event|0|||
126547099|NCT01468922|455296132|FG005|Overall Study|Adverse Event|0|||
126702554|NCT03853694|455860718|FG001|Overall Study|difficult surgery|0|||
126702555|NCT03853694|455860719|FG002|Overall Study|difficult surgery|1|||
126547100|NCT01468922|455296133|FG006|Overall Study|Adverse Event|0|||
126547101|NCT01468922|455296134|FG007|Overall Study|Adverse Event|1|||
126547102|NCT01468922|455296135|FG008|Overall Study|Adverse Event|0|||
126547103|NCT01468922|455296127|FG000|Overall Study|Infection of blood|0|||
126547104|NCT01468922|455296128|FG001|Overall Study|Infection of blood|0|||
126452557|NCT00830869|454958927|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
126452558|NCT00830869|454958928|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
126452559|NCT00830869|454958929|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
126702556|NCT03853694|455860717|FG000|Overall Study|Lost to Follow-up|0|||
126702557|NCT03853694|455860718|FG001|Overall Study|Lost to Follow-up|1|||
126702558|NCT03853694|455860719|FG002|Overall Study|Lost to Follow-up|0|||
126702559|NCT03853694|455860717|FG000|Overall Study|Withdrawal by Subject|0|||
126702560|NCT03853694|455860718|FG001|Overall Study|Withdrawal by Subject|1|||
126702561|NCT03853694|455860719|FG002|Overall Study|Withdrawal by Subject|0|||
126702562|NCT02499952|455860720|FG000|Overall Study|Lost to Follow-up|1|||
126702563|NCT02499952|455860720|FG000|Overall Study|Death|9|||
126702564|NCT05089708|455860721|FG000|Overall Study|Lost to Follow-up|9|||
126702565|NCT05089708|455860722|FG001|Overall Study|Lost to Follow-up|7|||
126702566|NCT05089708|455860721|FG000|Overall Study|Withdrawal by Subject|3|||
126702567|NCT05089708|455860722|FG001|Overall Study|Withdrawal by Subject|1|||
126702568|NCT05089708|455860721|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
126702569|NCT05089708|455860722|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
126702570|NCT05089708|455860721|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
126702571|NCT05089708|455860722|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
126702572|NCT02209766|455860724|FG000|Overall Study|Withdrawal by Subject|0|||
126702573|NCT02209766|455860725|FG001|Overall Study|Withdrawal by Subject|0|||
126702574|NCT02209766|455860726|FG002|Overall Study|Withdrawal by Subject|0|||
126702575|NCT02209766|455860727|FG003|Overall Study|Withdrawal by Subject|1|||
126702576|NCT02209766|455860728|FG004|Overall Study|Withdrawal by Subject|0|||
126702577|NCT00064701|455860729|FG000|One Year Post-transplant|Did not receive study drug|7|||
126702578|NCT00064701|455860730|FG001|One Year Post-transplant|Did not receive study drug|12|||
126702579|NCT00064701|455860731|FG002|One Year Post-transplant|Did not receive study drug|11|||
126702580|NCT00064701|455860729|FG000|One Year Post-transplant|Adverse Event|23|||
126702581|NCT00064701|455860730|FG001|One Year Post-transplant|Adverse Event|19|||
126702582|NCT00064701|455860731|FG002|One Year Post-transplant|Adverse Event|37|||
126702583|NCT00064701|455860729|FG000|One Year Post-transplant|Rejection|0|||
126702584|NCT00064701|455860730|FG001|One Year Post-transplant|Rejection|1|||
126702585|NCT00064701|455860731|FG002|One Year Post-transplant|Rejection|16|||
126702586|NCT00064701|455860729|FG000|One Year Post-transplant|Non-compliance|4|||
126702587|NCT00064701|455860730|FG001|One Year Post-transplant|Non-compliance|2|||
126702588|NCT00064701|455860731|FG002|One Year Post-transplant|Non-compliance|5|||
126702589|NCT00064701|455860729|FG000|One Year Post-transplant|Graft Failure|3|||
126702590|NCT00064701|455860730|FG001|One Year Post-transplant|Graft Failure|2|||
126702591|NCT00064701|455860731|FG002|One Year Post-transplant|Graft Failure|1|||
126702592|NCT00064701|455860729|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
126702593|NCT00064701|455860730|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
126702594|NCT00064701|455860731|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
126702595|NCT00064701|455860729|FG000|One Year Post-transplant|Lost to Follow-up|1|||
126452560|NCT00830869|454958930|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
126452561|NCT00830869|454958931|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
126452562|NCT00830869|454958932|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
126452563|NCT00830869|454958933|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
126452564|NCT00830869|454958934|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
126452565|NCT00830869|454958935|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
126452566|NCT00830869|454958936|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
126452567|NCT00830869|454958937|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
126452568|NCT00830869|454958938|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
126452569|NCT00830869|454958927|FG000|Period 2: Part 2|Adverse Event|0|||
126452570|NCT00830869|454958928|FG001|Period 2: Part 2|Adverse Event|0|||
126452571|NCT00830869|454958929|FG002|Period 2: Part 2|Adverse Event|0|||
126452572|NCT00830869|454958930|FG003|Period 2: Part 2|Adverse Event|0|||
126452573|NCT00830869|454958931|FG004|Period 2: Part 2|Adverse Event|0|||
126452574|NCT00830869|454958932|FG005|Period 2: Part 2|Adverse Event|0|||
126452575|NCT00830869|454958933|FG006|Period 2: Part 2|Adverse Event|0|||
126452576|NCT00830869|454958934|FG007|Period 2: Part 2|Adverse Event|4|||
126452577|NCT00830869|454958935|FG008|Period 2: Part 2|Adverse Event|3|||
126452578|NCT00830869|454958936|FG009|Period 2: Part 2|Adverse Event|2|||
126702596|NCT00064701|455860730|FG001|One Year Post-transplant|Lost to Follow-up|0|||
126452579|NCT00830869|454958937|FG010|Period 2: Part 2|Adverse Event|2|||
126702597|NCT00064701|455860731|FG002|One Year Post-transplant|Lost to Follow-up|0|||
126702598|NCT00064701|455860729|FG000|One Year Post-transplant|Converted to rapamycin|1|||
126702599|NCT00064701|455860730|FG001|One Year Post-transplant|Converted to rapamycin|0|||
126702600|NCT00064701|455860731|FG002|One Year Post-transplant|Converted to rapamycin|0|||
126702601|NCT00064701|455860729|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
126702602|NCT00064701|455860730|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
126702603|NCT00064701|455860731|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
126452580|NCT00830869|454958938|FG011|Period 2: Part 2|Adverse Event|0|||
126452581|NCT00830869|454958927|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
126452582|NCT00830869|454958928|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
126452583|NCT00830869|454958929|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
126452584|NCT00830869|454958930|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
126452585|NCT00830869|454958931|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
126452586|NCT00830869|454958932|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
126452587|NCT00830869|454958933|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
126452588|NCT00830869|454958934|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
126452589|NCT00830869|454958935|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
126452590|NCT00830869|454958936|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
126452591|NCT00830869|454958937|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
126452592|NCT00830869|454958938|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
126452593|NCT00830869|454958927|FG000|Period 2: Part 2|Progressive disease|0|||
126452594|NCT00830869|454958928|FG001|Period 2: Part 2|Progressive disease|0|||
126452595|NCT00830869|454958929|FG002|Period 2: Part 2|Progressive disease|0|||
126452596|NCT00830869|454958930|FG003|Period 2: Part 2|Progressive disease|0|||
126452597|NCT00830869|454958931|FG004|Period 2: Part 2|Progressive disease|0|||
126452598|NCT00830869|454958932|FG005|Period 2: Part 2|Progressive disease|0|||
126452599|NCT00830869|454958933|FG006|Period 2: Part 2|Progressive disease|0|||
126452600|NCT00830869|454958934|FG007|Period 2: Part 2|Progressive disease|14|||
126452601|NCT00830869|454958935|FG008|Period 2: Part 2|Progressive disease|11|||
126452602|NCT00830869|454958936|FG009|Period 2: Part 2|Progressive disease|12|||
126452603|NCT00830869|454958937|FG010|Period 2: Part 2|Progressive disease|8|||
126452604|NCT00830869|454958938|FG011|Period 2: Part 2|Progressive disease|15|||
126452605|NCT00830869|454958927|FG000|Period 2: Part 2|Other|0|||
126452606|NCT00830869|454958928|FG001|Period 2: Part 2|Other|0|||
126452607|NCT00830869|454958929|FG002|Period 2: Part 2|Other|0|||
126452608|NCT00830869|454958930|FG003|Period 2: Part 2|Other|0|||
126452609|NCT00830869|454958931|FG004|Period 2: Part 2|Other|0|||
126452610|NCT00830869|454958932|FG005|Period 2: Part 2|Other|0|||
126452611|NCT00830869|454958933|FG006|Period 2: Part 2|Other|0|||
126452612|NCT00830869|454958934|FG007|Period 2: Part 2|Other|0|||
126452613|NCT00830869|454958935|FG008|Period 2: Part 2|Other|0|||
126452614|NCT00830869|454958936|FG009|Period 2: Part 2|Other|1|||
126452615|NCT00830869|454958937|FG010|Period 2: Part 2|Other|0|||
126452616|NCT00830869|454958938|FG011|Period 2: Part 2|Other|0|||
126452617|NCT00617669|454958939|FG000|Overall Study|Withdrawal by Subject|71|||
126452618|NCT00617669|454958940|FG001|Overall Study|Withdrawal by Subject|77|||
126452619|NCT00617669|454958939|FG000|Overall Study|Lost to Follow-up|3|||
126452620|NCT00617669|454958940|FG001|Overall Study|Lost to Follow-up|2|||
126452621|NCT00617669|454958939|FG000|Overall Study|Adverse Event|87|||
126452622|NCT00617669|454958940|FG001|Overall Study|Adverse Event|76|||
126452623|NCT00617669|454958939|FG000|Overall Study|Protocol Violation|2|||
126452624|NCT00617669|454958940|FG001|Overall Study|Protocol Violation|3|||
126452625|NCT00617669|454958939|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
126452626|NCT00617669|454958940|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
126452627|NCT00617669|454958939|FG000|Overall Study|Patients randomized but not treated|2|||
126452628|NCT00617669|454958940|FG001|Overall Study|Patients randomized but not treated|3|||
126452629|NCT03745820|454958941|FG000|Overall Study|Adverse Event|0|||
126452630|NCT03745820|454958942|FG001|Overall Study|Adverse Event|3|||
126452631|NCT03745820|454958943|FG002|Overall Study|Adverse Event|2|||
126452632|NCT03745820|454958941|FG000|Overall Study|Non-Compliance with Study Drug|4|||
126452633|NCT03745820|454958942|FG001|Overall Study|Non-Compliance with Study Drug|3|||
126452634|NCT03745820|454958943|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126452635|NCT03745820|454958941|FG000|Overall Study|Withdrawal by Subject|4|||
126452636|NCT03745820|454958942|FG001|Overall Study|Withdrawal by Subject|4|||
126452637|NCT03745820|454958943|FG002|Overall Study|Withdrawal by Subject|4|||
126452638|NCT03745820|454958941|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
126452639|NCT03745820|454958942|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
126452640|NCT03745820|454958943|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
126452641|NCT03745820|454958941|FG000|Overall Study|Lost to Follow-up|2|||
126452642|NCT03745820|454958942|FG001|Overall Study|Lost to Follow-up|0|||
126452643|NCT03745820|454958943|FG002|Overall Study|Lost to Follow-up|3|||
126452644|NCT03745820|454958941|FG000|Overall Study|Reason not Specified|2|||
126452645|NCT03745820|454958942|FG001|Overall Study|Reason not Specified|4|||
126452646|NCT03745820|454958943|FG002|Overall Study|Reason not Specified|1|||
126452647|NCT03680742|454958944|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
126452648|NCT02894502|454958947|FG000|Baseline|Withdrawal by Subject|24|||
126452649|NCT02894502|454958948|FG001|Baseline|Withdrawal by Subject|31|||
126452650|NCT02894502|454958949|FG002|Baseline|Withdrawal by Subject|36|||
126452651|NCT02894502|454958947|FG000|Baseline|Death|3|||
126452652|NCT02894502|454958948|FG001|Baseline|Death|1|||
126452653|NCT02894502|454958949|FG002|Baseline|Death|9|||
126452654|NCT02894502|454958947|FG000|First Follow up|Withdrawal by Subject|32|||
126452655|NCT02894502|454958948|FG001|First Follow up|Withdrawal by Subject|29|||
126452656|NCT02894502|454958949|FG002|First Follow up|Withdrawal by Subject|37|||
126452657|NCT02894502|454958947|FG000|First Follow up|Death|2|||
126452658|NCT02894502|454958948|FG001|First Follow up|Death|2|||
126452659|NCT02894502|454958949|FG002|First Follow up|Death|3|||
126452660|NCT02894502|454958947|FG000|Second Follow up|Withdrawal by Subject|13|||
126452661|NCT02894502|454958948|FG001|Second Follow up|Withdrawal by Subject|15|||
126452662|NCT02894502|454958949|FG002|Second Follow up|Withdrawal by Subject|13|||
126702604|NCT00064701|455860729|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
126452663|NCT02894502|454958947|FG000|Second Follow up|Death|2|||
126452664|NCT02894502|454958948|FG001|Second Follow up|Death|3|||
126452665|NCT02894502|454958949|FG002|Second Follow up|Death|1|||
126452666|NCT02894502|454958947|FG000|Third Follow up|Withdrawal by Subject|5|||
126452667|NCT02894502|454958948|FG001|Third Follow up|Withdrawal by Subject|6|||
126452668|NCT02894502|454958949|FG002|Third Follow up|Withdrawal by Subject|3|||
126452669|NCT02894502|454958947|FG000|Third Follow up|Death|1|||
126452670|NCT02894502|454958948|FG001|Third Follow up|Death|1|||
126452671|NCT02894502|454958949|FG002|Third Follow up|Death|0|||
126452672|NCT01410357|454958950|FG000|Overall Study|Death|2|||
126452673|NCT01410357|454958951|FG001|Overall Study|Death|1|||
126452674|NCT01410357|454958950|FG000|Overall Study|Withdrawal by Subject|1|||
126452675|NCT01410357|454958951|FG001|Overall Study|Withdrawal by Subject|2|||
126452676|NCT01410357|454958950|FG000|Overall Study|Lost to Follow-up|23|||
126452677|NCT01410357|454958951|FG001|Overall Study|Lost to Follow-up|21|||
126452678|NCT00615901|454958952|FG000|Overall Study|Withdrawal by Subject|2|||
126452679|NCT00615901|454958952|FG000|Overall Study|Adverse Event|7|||
126452680|NCT03598114|454958953|FG000|Overall Study|Staff turnover/left the program|3|||
126452681|NCT03598114|454958954|FG001|Overall Study|Staff turnover/left the program|39|||
126452682|NCT01589653|454958958|FG000|Overall Study|Protocol Violation|3|||
126452683|NCT01589653|454958959|FG001|Overall Study|Protocol Violation|1|||
126702605|NCT00064701|455860730|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
126702606|NCT00064701|455860731|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
126452684|NCT01589653|454958958|FG000|Overall Study|Withdrawal criteria|4|||
126452685|NCT01589653|454958959|FG001|Overall Study|Withdrawal criteria|7|||
126452686|NCT01589653|454958958|FG000|Overall Study|Unclassified|0|||
126452687|NCT01589653|454958959|FG001|Overall Study|Unclassified|3|||
126452688|NCT00668733|454958960|FG000|Overall Study|Lost to Follow-up|2|||
126452689|NCT00668733|454958961|FG001|Overall Study|Lost to Follow-up|3|||
126452690|NCT00668733|454958960|FG000|Overall Study|Withdrawal by Subject|0|||
126452691|NCT00668733|454958961|FG001|Overall Study|Withdrawal by Subject|4|||
126452692|NCT01909791|454958962|FG000|Overall Study|Death|9|||
126452693|NCT01909791|454958963|FG001|Overall Study|Death|8|||
126452694|NCT01909791|454958964|FG002|Overall Study|Death|4|||
126452695|NCT01909791|454958962|FG000|Overall Study|Withdrawal by Subject|5|||
126452696|NCT01909791|454958963|FG001|Overall Study|Withdrawal by Subject|9|||
126452697|NCT01909791|454958964|FG002|Overall Study|Withdrawal by Subject|13|||
126452698|NCT01909791|454958962|FG000|Overall Study|Lost to Follow-up|5|||
126452699|NCT01909791|454958963|FG001|Overall Study|Lost to Follow-up|11|||
126452700|NCT01909791|454958964|FG002|Overall Study|Lost to Follow-up|10|||
126452701|NCT01909791|454958962|FG000|Overall Study|Missed Visit|2|||
126452702|NCT01909791|454958963|FG001|Overall Study|Missed Visit|0|||
126452703|NCT01909791|454958964|FG002|Overall Study|Missed Visit|1|||
126452704|NCT00945906|454958967|FG000|Overall Study|Withdrawal by Subject|1|||
126452705|NCT00945906|454958967|FG000|Overall Study|Did not want to return for last visit|2|||
126452706|NCT00945906|454958967|FG000|Overall Study|Unable to return for last visit|2|||
126452707|NCT00945906|454958967|FG000|Overall Study|Moved to another country|2|||
126452708|NCT04250077|454958969|FG000|Overall Study|Withdrawal by Subject|0|||
126452709|NCT04250077|454958970|FG001|Overall Study|Withdrawal by Subject|1|||
126452710|NCT04250077|454958971|FG002|Overall Study|Withdrawal by Subject|0|||
126452711|NCT04250077|454958969|FG000|Overall Study|Lost to Follow-up|2|||
126452712|NCT04250077|454958970|FG001|Overall Study|Lost to Follow-up|3|||
126452713|NCT04250077|454958971|FG002|Overall Study|Lost to Follow-up|0|||
126452714|NCT01883453|454958972|FG000|Overall Study|No episode of common cold|25|||
126452715|NCT01883453|454958973|FG001|Overall Study|No episode of common cold|23|||
126452716|NCT00647270|454958974|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
126452717|NCT00647270|454958975|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
126452718|NCT00647270|454958976|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
126452719|NCT00647270|454958974|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
126452720|NCT00647270|454958975|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
126452721|NCT00647270|454958976|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
126452722|NCT00647270|454958974|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
126452723|NCT00647270|454958975|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
126452724|NCT00647270|454958976|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
126452725|NCT00647270|454958974|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
126452726|NCT00647270|454958975|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
126452727|NCT00647270|454958976|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
126452728|NCT00647270|454958974|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
126452729|NCT00647270|454958975|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
126452730|NCT00647270|454958976|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
126452731|NCT00647270|454958974|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
126452732|NCT00647270|454958975|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
126452733|NCT00647270|454958976|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
126547105|NCT01468922|455296129|FG002|Overall Study|Infection of blood|0|||
126702607|NCT00064701|455860729|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
126702608|NCT00064701|455860730|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
126702609|NCT00064701|455860731|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
126702610|NCT00064701|455860729|FG000|One Year Post-transplant|Poor absorption|0|||
126702611|NCT00064701|455860730|FG001|One Year Post-transplant|Poor absorption|1|||
126702612|NCT00064701|455860731|FG002|One Year Post-transplant|Poor absorption|0|||
126702613|NCT00064701|455860729|FG000|One Year Post-transplant|Pancreas transplant|0|||
126702614|NCT00064701|455860730|FG001|One Year Post-transplant|Pancreas transplant|0|||
126702615|NCT00064701|455860731|FG002|One Year Post-transplant|Pancreas transplant|1|||
126702616|NCT00064701|455860729|FG000|Clinical Continuation Phase|Adverse Event|12|||
126702617|NCT00064701|455860730|FG001|Clinical Continuation Phase|Adverse Event|21|||
126702618|NCT00064701|455860731|FG002|Clinical Continuation Phase|Adverse Event|14|||
126702619|NCT00064701|455860729|FG000|Clinical Continuation Phase|Non-compliance|8|||
126702620|NCT00064701|455860730|FG001|Clinical Continuation Phase|Non-compliance|6|||
126702621|NCT00064701|455860731|FG002|Clinical Continuation Phase|Non-compliance|7|||
126702622|NCT00064701|455860729|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
126702623|NCT00064701|455860730|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
126702624|NCT00064701|455860731|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
126702625|NCT00064701|455860729|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
126702626|NCT00064701|455860730|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
126702627|NCT00064701|455860731|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
126702628|NCT00064701|455860729|FG000|Clinical Continuation Phase|Graft Failure|5|||
126702629|NCT00064701|455860730|FG001|Clinical Continuation Phase|Graft Failure|5|||
126702630|NCT00064701|455860731|FG002|Clinical Continuation Phase|Graft Failure|2|||
126702631|NCT00064701|455860729|FG000|Clinical Continuation Phase|Rejection|1|||
126702632|NCT00064701|455860730|FG001|Clinical Continuation Phase|Rejection|2|||
126702633|NCT00064701|455860731|FG002|Clinical Continuation Phase|Rejection|2|||
126702634|NCT00064701|455860729|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
126702635|NCT00064701|455860730|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
126702636|NCT00064701|455860731|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
126702637|NCT00064701|455860729|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
126702638|NCT00064701|455860730|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
126702639|NCT00064701|455860731|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
126702640|NCT00064701|455860729|FG000|Clinical Continuation Phase|Physician Decision|1|||
126702641|NCT00064701|455860730|FG001|Clinical Continuation Phase|Physician Decision|3|||
126702642|NCT00064701|455860731|FG002|Clinical Continuation Phase|Physician Decision|0|||
126702643|NCT00064701|455860729|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
126702644|NCT00064701|455860730|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
126702645|NCT00064701|455860731|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
126702646|NCT00064701|455860729|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
126702647|NCT00064701|455860730|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
126702648|NCT00064701|455860731|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
126702649|NCT00064701|455860729|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
126702650|NCT00064701|455860730|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
126702651|NCT00064701|455860731|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
126702652|NCT00064701|455860729|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
126702653|NCT00064701|455860730|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
126702654|NCT00064701|455860731|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
126702655|NCT00064701|455860729|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
126702656|NCT00064701|455860730|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
126702657|NCT00064701|455860731|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
126702658|NCT00064701|455860729|FG000|Clinical Continuation Phase|Patient opted out|0|||
126702659|NCT00064701|455860730|FG001|Clinical Continuation Phase|Patient opted out|0|||
126702660|NCT00064701|455860731|FG002|Clinical Continuation Phase|Patient opted out|1|||
126702661|NCT01491945|455860733|FG000|Overall Study|Death|30|||
126702662|NCT01491945|455860733|FG000|Overall Study|Withdrwan/LTF|16|||
126702663|NCT01491945|455860733|FG000|Overall Study|Conversion|4|||
126763907|NCT02268214|456086891|FG002|Overall Study|Pregnancy|1|||
126763908|NCT02268214|456086889|FG000|Overall Study|Lost to Follow-up|3|||
126359998|NCT01524705|454610719|FG000|Overall Study|Adverse Event|2|||
126702664|NCT01491945|455860733|FG000|Overall Study|Missed Visit|1|||
126702665|NCT03770403|455860734|FG000|Overall Study|Adverse Event|8|||
126702666|NCT03770403|455860734|FG000|Overall Study|Death|5|||
126702667|NCT03770403|455860734|FG000|Overall Study|Physician Decision|1|||
126702668|NCT03770403|455860734|FG000|Overall Study|Sponsor decision|1|||
126702669|NCT03770403|455860734|FG000|Overall Study|Study terminated by Sponsor|1|||
126763909|NCT02268214|456086890|FG001|Overall Study|Lost to Follow-up|3|||
126763910|NCT02268214|456086891|FG002|Overall Study|Lost to Follow-up|4|||
126359999|NCT01524705|454610720|FG001|Overall Study|Adverse Event|0|||
126702670|NCT03770403|455860734|FG000|Overall Study|Withdrawal by Subject|13|||
126763911|NCT02268214|456086889|FG000|Overall Study|Lack of Efficacy|1|||
126763912|NCT02268214|456086890|FG001|Overall Study|Lack of Efficacy|0|||
126763913|NCT02268214|456086891|FG002|Overall Study|Lack of Efficacy|2|||
126763914|NCT02268214|456086889|FG000|Overall Study|Adverse Event|11|||
126763915|NCT02268214|456086890|FG001|Overall Study|Adverse Event|14|||
126763916|NCT02268214|456086891|FG002|Overall Study|Adverse Event|9|||
126763917|NCT02268214|456086889|FG000|Overall Study|Withdrawal by Subject|4|||
126763918|NCT02268214|456086890|FG001|Overall Study|Withdrawal by Subject|5|||
126763919|NCT02268214|456086891|FG002|Overall Study|Withdrawal by Subject|10|||
126763920|NCT02268214|456086889|FG000|Overall Study|Subject request to discontinue treatment|10|||
126763921|NCT02268214|456086890|FG001|Overall Study|Subject request to discontinue treatment|8|||
126763922|NCT02268214|456086891|FG002|Overall Study|Subject request to discontinue treatment|6|||
126763923|NCT02268214|456086889|FG000|Overall Study|Poor/non-compliance|2|||
126763924|NCT02268214|456086890|FG001|Overall Study|Poor/non-compliance|1|||
126763925|NCT02268214|456086891|FG002|Overall Study|Poor/non-compliance|2|||
126763926|NCT02268214|456086889|FG000|Overall Study|Other reasons|7|||
126763927|NCT02268214|456086890|FG001|Overall Study|Other reasons|3|||
126763928|NCT02268214|456086891|FG002|Overall Study|Other reasons|3|||
126763929|NCT02268214|456086889|FG000|Overall Study|Not entering long-term period|2|||
126763930|NCT02268214|456086890|FG001|Overall Study|Not entering long-term period|3|||
126763931|NCT02268214|456086891|FG002|Overall Study|Not entering long-term period|5|||
126763932|NCT04342390|456086894|FG000|Overall Study|Lost to Follow-up|3|||
126763933|NCT04342390|456086895|FG001|Overall Study|Lost to Follow-up|0|||
126763934|NCT01083121|456086905|FG000|Overall Study|Use of Humira outside the approved label|81|||
126763935|NCT01958619|456086908|FG000|Overall Study|Protocol Violation|2|||
126763936|NCT01958619|456086909|FG001|Overall Study|Protocol Violation|0|||
126763937|NCT01958619|456086910|FG002|Overall Study|Protocol Violation|1|||
126763938|NCT01958619|456086911|FG003|Overall Study|Protocol Violation|0|||
126763939|NCT05403502|456086912|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
126763940|NCT05403502|456086912|FG000|Humalog Lead-In Period|Physician Decision|2|||
126763941|NCT05403502|456086912|FG000|Humalog Lead-In Period|Protocol Violation|1|||
126763942|NCT05403502|456086912|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
126763943|NCT05403502|456086912|FG000|Lyumjev Treatment Period|Physician Decision|2|||
126763944|NCT01054443|456086913|FG000|Overall Study|Withdrawal by Subject|0|||
126763945|NCT01054443|456086914|FG001|Overall Study|Withdrawal by Subject|0|||
126763946|NCT01054443|456086915|FG002|Overall Study|Withdrawal by Subject|0|||
126763947|NCT01054443|456086916|FG003|Overall Study|Withdrawal by Subject|1|||
126763948|NCT00985114|456086917|FG000|Overall Study|Adverse Event|1|||
126763949|NCT00985114|456086918|FG001|Overall Study|Adverse Event|0|||
126763950|NCT00985114|456086917|FG000|Overall Study|Withdrawal by Subject|0|||
126763951|NCT00985114|456086918|FG001|Overall Study|Withdrawal by Subject|2|||
126763952|NCT01119118|456086919|FG000|Overall Study|Adverse Event|1|||
126763953|NCT01003691|456086920|FG000|Overall Study|Adverse Event|0|||
126763954|NCT01003691|456086921|FG001|Overall Study|Adverse Event|0|||
126763955|NCT01003691|456086922|FG002|Overall Study|Adverse Event|0|||
126763956|NCT01003691|456086923|FG003|Overall Study|Adverse Event|1|||
126763957|NCT00167414|456086925|FG000|Overall Study|Death|10|||
126763958|NCT01593761|456086928|FG000|Overall Study|Lost to Follow-up|1|||
126763959|NCT01593761|456086928|FG000|Overall Study|culture negative for MRSA at baseline|5|||
126763960|NCT01593761|456086928|FG000|Overall Study|positive for hepatitis C virus|1|||
126763961|NCT01593761|456086928|FG000|Overall Study|secondary cellulitis|1|||
126763962|NCT01302366|456089016|FG000|Overall Study|patient choice or noncompliance|5|||
126763963|NCT00509223|456089017|FG000|Overall Study|Lost to Follow-up|1|||
126763964|NCT00509223|456089018|FG001|Overall Study|Lost to Follow-up|1|||
126763965|NCT00509223|456089017|FG000|Overall Study|Adverse Event|1|||
126763966|NCT00509223|456089018|FG001|Overall Study|Adverse Event|1|||
126763967|NCT00509223|456089017|FG000|Overall Study|Withdrawal by Subject|25|||
126763968|NCT00509223|456089018|FG001|Overall Study|Withdrawal by Subject|6|||
126763969|NCT00509223|456089017|FG000|Overall Study|Including: subject change of address|5|||
126763970|NCT00509223|456089018|FG001|Overall Study|Including: subject change of address|2|||
126763971|NCT00509223|456089017|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
126763972|NCT00509223|456089018|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
126763973|NCT00467051|456089019|FG000|Overall Study|Adverse Event|2|||
126763974|NCT00934661|456089020|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
126763975|NCT00934661|456089021|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
126763976|NCT00122954|456089024|FG000|Overall Study|Withdrawal by Subject|2|||
126763977|NCT00122954|456089025|FG001|Overall Study|Withdrawal by Subject|2|||
126763978|NCT00122954|456089024|FG000|Overall Study|Protocol Violation|0|||
126360000|NCT01524705|454610719|FG000|Overall Study|Death|1|||
126360001|NCT01524705|454610720|FG001|Overall Study|Death|0|||
126360002|NCT01524705|454610719|FG000|Overall Study|Lost to Follow-up|0|||
126360003|NCT01524705|454610720|FG001|Overall Study|Lost to Follow-up|1|||
126763979|NCT00122954|456089025|FG001|Overall Study|Protocol Violation|1|||
126763980|NCT05279807|456089029|FG000|Overall Study|Withdrawal by Subject|1|||
126763981|NCT05279807|456089030|FG001|Overall Study|Withdrawal by Subject|0|||
126763982|NCT05279807|456089029|FG000|Overall Study|Adverse Event|0|||
126547106|NCT01468922|455296130|FG003|Overall Study|Infection of blood|0|||
126547107|NCT01468922|455296131|FG004|Overall Study|Infection of blood|0|||
126547108|NCT01468922|455296132|FG005|Overall Study|Infection of blood|0|||
126547109|NCT01468922|455296133|FG006|Overall Study|Infection of blood|0|||
126547110|NCT01468922|455296134|FG007|Overall Study|Infection of blood|1|||
126547111|NCT01468922|455296135|FG008|Overall Study|Infection of blood|0|||
126547112|NCT01468922|455296127|FG000|Overall Study|Patient choice - surgery|0|||
126547113|NCT01468922|455296128|FG001|Overall Study|Patient choice - surgery|0|||
126702671|NCT03770403|455860734|FG000|Overall Study|Other|88|||
126702672|NCT02344576|455860764|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
126702673|NCT02344576|455860765|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
126702674|NCT02344576|455860766|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
126702675|NCT02344576|455860767|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
126702676|NCT02344576|455860764|FG000|1-Month Follow-Up|Death|13|||
126702677|NCT02344576|455860765|FG001|1-Month Follow-Up|Death|8|||
126702678|NCT02344576|455860766|FG002|1-Month Follow-Up|Death|0|||
126702679|NCT02344576|455860767|FG003|1-Month Follow-Up|Death|0|||
126702680|NCT02344576|455860764|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
126702681|NCT02344576|455860765|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
126702682|NCT02344576|455860766|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
126702683|NCT02344576|455860767|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
126702684|NCT02344576|455860764|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
126702685|NCT02344576|455860765|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
126702686|NCT02344576|455860766|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
126702687|NCT02344576|455860767|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
126702688|NCT02344576|455860764|FG000|6-Month Follow-Up|Death|14|||
126702689|NCT02344576|455860765|FG001|6-Month Follow-Up|Death|14|||
126702690|NCT02344576|455860766|FG002|6-Month Follow-Up|Death|0|||
126702691|NCT02344576|455860767|FG003|6-Month Follow-Up|Death|0|||
126702692|NCT02344576|455860764|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
126702693|NCT02344576|455860765|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
126702694|NCT02344576|455860766|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
126702695|NCT02344576|455860767|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
126702696|NCT02344576|455860764|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
126702697|NCT02344576|455860765|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
126702698|NCT02344576|455860766|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
126702699|NCT02344576|455860767|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
126702700|NCT02337387|455860768|FG000|Overall Study|Adverse Event|0|||
126702701|NCT02337387|455860769|FG001|Overall Study|Adverse Event|1|||
126702702|NCT02337387|455860770|FG002|Overall Study|Adverse Event|0|||
126702703|NCT02337387|455860771|FG003|Overall Study|Adverse Event|0|||
126702704|NCT02337387|455860768|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
126702705|NCT02337387|455860769|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
126702706|NCT02337387|455860770|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
126702707|NCT02337387|455860771|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
126702708|NCT05202808|455860772|FG000|Overall Study|Lost to Follow-up|3|||
126702709|NCT05202808|455860773|FG001|Overall Study|Lost to Follow-up|1|||
126702710|NCT02495948|455860774|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
126702711|NCT02495948|455860775|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
126702712|NCT02495948|455860774|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
126702713|NCT02495948|455860775|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
126702714|NCT02747004|455860777|FG000|Overall Study|Withdrawal by Subject|8|||
126702715|NCT02747004|455860778|FG001|Overall Study|Withdrawal by Subject|5|||
126702716|NCT02747004|455860779|FG002|Overall Study|Withdrawal by Subject|4|||
126360004|NCT01524705|454610719|FG000|Overall Study|Withdrawal by Subject|0|||
126702717|NCT02747004|455860777|FG000|Overall Study|Lost to Follow-up|1|||
126702718|NCT02747004|455860778|FG001|Overall Study|Lost to Follow-up|2|||
126702719|NCT02747004|455860779|FG002|Overall Study|Lost to Follow-up|2|||
126702720|NCT02747004|455860777|FG000|Overall Study|on study treatment/follow-up|48|||
126702721|NCT02747004|455860778|FG001|Overall Study|on study treatment/follow-up|42|||
126702722|NCT02747004|455860779|FG002|Overall Study|on study treatment/follow-up|41|||
126702723|NCT06218251|455860780|FG000|Overall Study|Lost to Follow-up|4|||
126702724|NCT05087030|455860781|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
126702725|NCT05087030|455860782|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
126547114|NCT01468922|455296129|FG002|Overall Study|Patient choice - surgery|0|||
126702726|NCT05087030|455860783|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
126702727|NCT05087030|455860784|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
126702728|NCT05087030|455860785|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
126702729|NCT05087030|455860781|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
126702730|NCT05087030|455860782|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
126702731|NCT05087030|455860783|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
126702732|NCT05087030|455860784|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
126702733|NCT05087030|455860785|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
126360005|NCT01524705|454610720|FG001|Overall Study|Withdrawal by Subject|1|||
126547115|NCT01468922|455296130|FG003|Overall Study|Patient choice - surgery|0|||
126547116|NCT01468922|455296131|FG004|Overall Study|Patient choice - surgery|0|||
126547117|NCT01468922|455296132|FG005|Overall Study|Patient choice - surgery|0|||
126547118|NCT01468922|455296133|FG006|Overall Study|Patient choice - surgery|0|||
126547119|NCT01468922|455296134|FG007|Overall Study|Patient choice - surgery|1|||
126547120|NCT01468922|455296135|FG008|Overall Study|Patient choice - surgery|0|||
126547121|NCT01468922|455296127|FG000|Overall Study|Refused further treatment|0|||
126547122|NCT01468922|455296128|FG001|Overall Study|Refused further treatment|0|||
126547123|NCT01468922|455296129|FG002|Overall Study|Refused further treatment|0|||
126547124|NCT01468922|455296130|FG003|Overall Study|Refused further treatment|0|||
126547125|NCT01468922|455296131|FG004|Overall Study|Refused further treatment|0|||
126547126|NCT01468922|455296132|FG005|Overall Study|Refused further treatment|0|||
126547127|NCT01468922|455296133|FG006|Overall Study|Refused further treatment|0|||
126547128|NCT01468922|455296134|FG007|Overall Study|Refused further treatment|1|||
126547129|NCT01468922|455296135|FG008|Overall Study|Refused further treatment|0|||
126547130|NCT00007475|455296142|FG000|Overall Study|Withdrawal by Subject|1|||
126547131|NCT00007475|455296143|FG001|Overall Study|Withdrawal by Subject|0|||
126547132|NCT00007475|455296144|FG002|Overall Study|Withdrawal by Subject|0|||
126547133|NCT00007475|455296145|FG003|Overall Study|Withdrawal by Subject|0|||
126547134|NCT00007475|455296142|FG000|Overall Study|Adverse Event|3|||
126547135|NCT00007475|455296143|FG001|Overall Study|Adverse Event|0|||
126702734|NCT05087030|455860781|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
126702735|NCT05087030|455860782|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
126702736|NCT05087030|455860783|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
126702737|NCT05087030|455860784|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
126702738|NCT05087030|455860785|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
126702739|NCT05087030|455860781|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
126702740|NCT05087030|455860782|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
126702741|NCT05087030|455860783|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
126702742|NCT05087030|455860784|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
126702743|NCT05087030|455860785|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
126702744|NCT05087030|455860781|FG000|Main Period (Week 0 to Week 52)|Death|0|||
126702745|NCT05087030|455860782|FG001|Main Period (Week 0 to Week 52)|Death|1|||
126702746|NCT05087030|455860783|FG002|Main Period (Week 0 to Week 52)|Death|0|||
126702747|NCT05087030|455860784|FG003|Main Period (Week 0 to Week 52)|Death|0|||
126702748|NCT05087030|455860785|FG004|Main Period (Week 0 to Week 52)|Death|0|||
126702749|NCT05087030|455860781|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
126702750|NCT05087030|455860782|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
126702751|NCT05087030|455860783|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
126702752|NCT05087030|455860784|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
126702753|NCT05087030|455860785|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
126702754|NCT05087030|455860781|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
126702755|NCT05087030|455860782|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
126702756|NCT05087030|455860783|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
126702757|NCT05087030|455860784|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
126702758|NCT05087030|455860785|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
126702759|NCT05087030|455860781|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
126702760|NCT05087030|455860782|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
126702761|NCT05087030|455860783|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
126702762|NCT05087030|455860784|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
126702763|NCT05087030|455860785|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
126702764|NCT05087030|455860781|FG000|Main Period (Week 0 to Week 52)|Other|1|||
126702765|NCT05087030|455860782|FG001|Main Period (Week 0 to Week 52)|Other|2|||
126702766|NCT05087030|455860783|FG002|Main Period (Week 0 to Week 52)|Other|0|||
126702767|NCT05087030|455860784|FG003|Main Period (Week 0 to Week 52)|Other|0|||
126702768|NCT05087030|455860785|FG004|Main Period (Week 0 to Week 52)|Other|0|||
126702769|NCT05087030|455860781|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
126702770|NCT05087030|455860782|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
126702771|NCT05087030|455860783|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
126702772|NCT05087030|455860784|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
126702773|NCT05087030|455860785|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
126547136|NCT00007475|455296144|FG002|Overall Study|Adverse Event|0|||
126702774|NCT01444300|455860786|FG000|Overall Study|Adverse Event|4|||
126547137|NCT00007475|455296145|FG003|Overall Study|Adverse Event|0|||
126547138|NCT01512745|455296147|FG000|Overall Study|Adverse Event|22|||
126702775|NCT01444300|455860787|FG001|Overall Study|Adverse Event|0|||
126702776|NCT00752986|455860788|FG000|Overall Study|Withdrawal by Subject|2|||
126702777|NCT00752986|455860789|FG001|Overall Study|Withdrawal by Subject|1|||
126547139|NCT01512745|455296148|FG001|Overall Study|Adverse Event|3|||
126547140|NCT01512745|455296147|FG000|Overall Study|Death|9|||
126547141|NCT01512745|455296148|FG001|Overall Study|Death|13|||
126702778|NCT00752986|455860790|FG002|Overall Study|Withdrawal by Subject|2|||
126702779|NCT00752986|455860788|FG000|Overall Study|Protocol Violation|3|||
126702780|NCT00752986|455860789|FG001|Overall Study|Protocol Violation|0|||
126702781|NCT00752986|455860790|FG002|Overall Study|Protocol Violation|0|||
126702782|NCT00924703|455860794|FG000|Overall Study|Withdrawal by Subject|11|||
126702783|NCT00924703|455860794|FG000|Overall Study|Physician Decision|5|||
126702784|NCT00924703|455860794|FG000|Overall Study|Lost to Follow-up|3|||
126702785|NCT00924703|455860794|FG000|Overall Study|Adverse Event|2|||
126702786|NCT00924703|455860794|FG000|Overall Study|Withdrawal by Sponsor|1|||
126702787|NCT02370121|455860795|FG000|Overall Study|Lost to Follow-up|1|||
126702788|NCT02370121|455860796|FG001|Overall Study|Lost to Follow-up|1|||
126702789|NCT01587989|455860798|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
126702790|NCT01587989|455860799|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
126702791|NCT01587989|455860800|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
126702792|NCT01587989|455860798|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
126702793|NCT01587989|455860799|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
126702794|NCT01587989|455860800|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
126702795|NCT01587989|455860798|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
126702796|NCT01587989|455860799|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
126702797|NCT01587989|455860800|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
126702798|NCT01587989|455860798|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
126702799|NCT01587989|455860799|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
126702800|NCT01587989|455860800|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
126702801|NCT01587989|455860798|FG000|Randomized Study Treatment|Screening failure|0|||
126702802|NCT01587989|455860799|FG001|Randomized Study Treatment|Screening failure|1|||
126702803|NCT01587989|455860800|FG002|Randomized Study Treatment|Screening failure|0|||
126702804|NCT01587989|455860798|FG000|Randomized Study Treatment|Physician Decision|0|||
126702805|NCT01587989|455860799|FG001|Randomized Study Treatment|Physician Decision|0|||
126702806|NCT01587989|455860800|FG002|Randomized Study Treatment|Physician Decision|1|||
126702807|NCT00275561|455860803|FG000|Overall Study|Withdrawal by Subject|0|||
126702808|NCT00275561|455860804|FG001|Overall Study|Withdrawal by Subject|1|||
126702809|NCT00275561|455860803|FG000|Overall Study|Travel|1|||
126702810|NCT00275561|455860804|FG001|Overall Study|Travel|1|||
126702811|NCT00275561|455860803|FG000|Overall Study|Scheduling|1|||
126264470|NCT02149121|454258473|FG004|Main Study Period|Withdrawal by Subject|0|||
126264471|NCT02149121|454258474|FG005|Main Study Period|Withdrawal by Subject|0|||
126264472|NCT02149121|454258475|FG006|Main Study Period|Withdrawal by Subject|0|||
126264473|NCT02149121|454258469|FG000|Main Study Period|Adverse Event|2|||
126264474|NCT02149121|454258470|FG001|Main Study Period|Adverse Event|5|||
126264475|NCT02149121|454258471|FG002|Main Study Period|Adverse Event|1|||
126264476|NCT02149121|454258472|FG003|Main Study Period|Adverse Event|0|||
126264477|NCT02149121|454258473|FG004|Main Study Period|Adverse Event|0|||
126264478|NCT02149121|454258474|FG005|Main Study Period|Adverse Event|0|||
126264479|NCT02149121|454258475|FG006|Main Study Period|Adverse Event|0|||
126264480|NCT02149121|454258469|FG000|Main Study Period|Protocol Violation|2|||
126264481|NCT02149121|454258470|FG001|Main Study Period|Protocol Violation|0|||
126264482|NCT02149121|454258471|FG002|Main Study Period|Protocol Violation|0|||
126264483|NCT02149121|454258472|FG003|Main Study Period|Protocol Violation|0|||
126264484|NCT02149121|454258473|FG004|Main Study Period|Protocol Violation|0|||
126264485|NCT02149121|454258474|FG005|Main Study Period|Protocol Violation|0|||
126264486|NCT02149121|454258475|FG006|Main Study Period|Protocol Violation|0|||
126264487|NCT02149121|454258469|FG000|Main Study Period|Lost to Follow-up|2|||
126264488|NCT02149121|454258470|FG001|Main Study Period|Lost to Follow-up|1|||
126264489|NCT02149121|454258471|FG002|Main Study Period|Lost to Follow-up|0|||
126264490|NCT02149121|454258472|FG003|Main Study Period|Lost to Follow-up|0|||
126264491|NCT02149121|454258473|FG004|Main Study Period|Lost to Follow-up|0|||
126264492|NCT02149121|454258474|FG005|Main Study Period|Lost to Follow-up|0|||
126264493|NCT02149121|454258475|FG006|Main Study Period|Lost to Follow-up|0|||
126264494|NCT02149121|454258469|FG000|Main Study Period|Death|1|||
126264495|NCT02149121|454258470|FG001|Main Study Period|Death|0|||
126702812|NCT00275561|455860804|FG001|Overall Study|Scheduling|2|||
126702813|NCT00275561|455860803|FG000|Overall Study|Family Issues|0|||
126702814|NCT00275561|455860804|FG001|Overall Study|Family Issues|2|||
126702815|NCT01769105|455860805|FG000|First Intervention|Protocol Violation|2|||
126264496|NCT02149121|454258471|FG002|Main Study Period|Death|0|||
126264497|NCT02149121|454258472|FG003|Main Study Period|Death|0|||
126264498|NCT02149121|454258473|FG004|Main Study Period|Death|0|||
126264499|NCT02149121|454258474|FG005|Main Study Period|Death|0|||
126360006|NCT01524705|454610719|FG000|Overall Study|Pancreatic Cancer|0|||
126360007|NCT01524705|454610720|FG001|Overall Study|Pancreatic Cancer|1|||
126360008|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
126360009|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
126360010|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
126360011|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
126360012|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
126360013|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
126763983|NCT05279807|456089030|FG001|Overall Study|Adverse Event|1|||
126763984|NCT05279807|456089029|FG000|Overall Study|Laboratory Abnormal Results|1|||
126763985|NCT05279807|456089030|FG001|Overall Study|Laboratory Abnormal Results|0|||
126763986|NCT03110107|456089031|FG000|Treatment Period|Disease Progression|3|||
126763987|NCT03110107|456089032|FG001|Treatment Period|Disease Progression|9|||
126763988|NCT03110107|456089033|FG002|Treatment Period|Disease Progression|8|||
126763989|NCT03110107|456089034|FG003|Treatment Period|Disease Progression|11|||
126763990|NCT03110107|456089035|FG004|Treatment Period|Disease Progression|8|||
126763991|NCT03110107|456089036|FG005|Treatment Period|Disease Progression|4|||
126763992|NCT03110107|456089037|FG006|Treatment Period|Disease Progression|6|||
126763993|NCT03110107|456089038|FG007|Treatment Period|Disease Progression|7|||
126763994|NCT03110107|456089039|FG008|Treatment Period|Disease Progression|2|||
126763995|NCT03110107|456089040|FG009|Treatment Period|Disease Progression|10|||
126763996|NCT03110107|456089041|FG010|Treatment Period|Disease Progression|5|||
126763997|NCT03110107|456089042|FG011|Treatment Period|Disease Progression|2|||
126763998|NCT03110107|456089043|FG012|Treatment Period|Disease Progression|0|||
126763999|NCT03110107|456089044|FG013|Treatment Period|Disease Progression|5|||
126764000|NCT03110107|456089045|FG014|Treatment Period|Disease Progression|14|||
126764001|NCT03110107|456089046|FG015|Treatment Period|Disease Progression|14|||
126764002|NCT03110107|456089047|FG016|Treatment Period|Disease Progression|4|||
126764003|NCT03110107|456089048|FG017|Treatment Period|Disease Progression|3|||
126764004|NCT03110107|456089049|FG018|Treatment Period|Disease Progression|16|||
126764005|NCT03110107|456089050|FG019|Treatment Period|Disease Progression|14|||
126764006|NCT03110107|456089051|FG020|Treatment Period|Disease Progression|12|||
126764007|NCT03110107|456089052|FG021|Treatment Period|Disease Progression|16|||
126764008|NCT03110107|456089053|FG022|Treatment Period|Disease Progression|18|||
126764009|NCT03110107|456089054|FG023|Treatment Period|Disease Progression|13|||
126764010|NCT03110107|456089055|FG024|Treatment Period|Disease Progression|16|||
126764011|NCT03110107|456089056|FG025|Treatment Period|Disease Progression|31|||
126764012|NCT03110107|456089031|FG000|Treatment Period|Study drug toxicity|1|||
126764013|NCT03110107|456089032|FG001|Treatment Period|Study drug toxicity|0|||
126764014|NCT03110107|456089033|FG002|Treatment Period|Study drug toxicity|1|||
126764015|NCT03110107|456089034|FG003|Treatment Period|Study drug toxicity|2|||
126764016|NCT03110107|456089035|FG004|Treatment Period|Study drug toxicity|0|||
126764017|NCT03110107|456089036|FG005|Treatment Period|Study drug toxicity|3|||
126764018|NCT03110107|456089037|FG006|Treatment Period|Study drug toxicity|1|||
126764019|NCT03110107|456089038|FG007|Treatment Period|Study drug toxicity|1|||
126764020|NCT03110107|456089039|FG008|Treatment Period|Study drug toxicity|3|||
126764021|NCT03110107|456089040|FG009|Treatment Period|Study drug toxicity|2|||
126764022|NCT03110107|456089041|FG010|Treatment Period|Study drug toxicity|0|||
126764023|NCT03110107|456089042|FG011|Treatment Period|Study drug toxicity|2|||
126764024|NCT03110107|456089043|FG012|Treatment Period|Study drug toxicity|0|||
126764025|NCT03110107|456089044|FG013|Treatment Period|Study drug toxicity|0|||
126764026|NCT03110107|456089045|FG014|Treatment Period|Study drug toxicity|2|||
126764027|NCT03110107|456089046|FG015|Treatment Period|Study drug toxicity|3|||
126764028|NCT03110107|456089047|FG016|Treatment Period|Study drug toxicity|3|||
126764029|NCT03110107|456089048|FG017|Treatment Period|Study drug toxicity|3|||
126764030|NCT03110107|456089049|FG018|Treatment Period|Study drug toxicity|1|||
126764031|NCT03110107|456089050|FG019|Treatment Period|Study drug toxicity|2|||
126764032|NCT03110107|456089051|FG020|Treatment Period|Study drug toxicity|2|||
126764033|NCT03110107|456089052|FG021|Treatment Period|Study drug toxicity|0|||
126764034|NCT03110107|456089053|FG022|Treatment Period|Study drug toxicity|2|||
126764035|NCT03110107|456089054|FG023|Treatment Period|Study drug toxicity|6|||
126764036|NCT03110107|456089055|FG024|Treatment Period|Study drug toxicity|7|||
126764037|NCT03110107|456089056|FG025|Treatment Period|Study drug toxicity|6|||
126764038|NCT03110107|456089031|FG000|Treatment Period|Death|0|||
126764039|NCT03110107|456089032|FG001|Treatment Period|Death|0|||
126764040|NCT03110107|456089033|FG002|Treatment Period|Death|0|||
126764041|NCT03110107|456089034|FG003|Treatment Period|Death|0|||
126764042|NCT03110107|456089035|FG004|Treatment Period|Death|0|||
126764043|NCT03110107|456089036|FG005|Treatment Period|Death|0|||
126764044|NCT03110107|456089037|FG006|Treatment Period|Death|0|||
126764045|NCT03110107|456089038|FG007|Treatment Period|Death|0|||
126452734|NCT00647270|454958974|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
126452735|NCT00647270|454958975|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
126452736|NCT00647270|454958976|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
126452737|NCT03337490|454958977|FG000|Overall Study|Withdrawal by Subject|1|||
126452738|NCT03337490|454958978|FG001|Overall Study|Withdrawal by Subject|0|||
126452739|NCT03337490|454958979|FG002|Overall Study|Withdrawal by Subject|0|||
126764046|NCT03110107|456089039|FG008|Treatment Period|Death|0|||
126764047|NCT03110107|456089040|FG009|Treatment Period|Death|0|||
126764048|NCT03110107|456089041|FG010|Treatment Period|Death|0|||
126764049|NCT03110107|456089042|FG011|Treatment Period|Death|0|||
126452740|NCT03337490|454958977|FG000|Overall Study|Lack of Efficacy|10|||
126452741|NCT03337490|454958978|FG001|Overall Study|Lack of Efficacy|12|||
126764050|NCT03110107|456089043|FG012|Treatment Period|Death|1|||
126764051|NCT03110107|456089044|FG013|Treatment Period|Death|0|||
126764052|NCT03110107|456089045|FG014|Treatment Period|Death|0|||
126764053|NCT03110107|456089046|FG015|Treatment Period|Death|0|||
126764054|NCT03110107|456089047|FG016|Treatment Period|Death|0|||
126764055|NCT03110107|456089048|FG017|Treatment Period|Death|0|||
126764056|NCT03110107|456089049|FG018|Treatment Period|Death|0|||
126764057|NCT03110107|456089050|FG019|Treatment Period|Death|0|||
126764058|NCT03110107|456089051|FG020|Treatment Period|Death|0|||
126764059|NCT03110107|456089052|FG021|Treatment Period|Death|0|||
126764060|NCT03110107|456089053|FG022|Treatment Period|Death|0|||
126764061|NCT03110107|456089054|FG023|Treatment Period|Death|0|||
126764062|NCT03110107|456089055|FG024|Treatment Period|Death|0|||
126764063|NCT03110107|456089056|FG025|Treatment Period|Death|0|||
126764064|NCT03110107|456089031|FG000|Treatment Period|Adverse Event|0|||
126264500|NCT02149121|454258475|FG006|Main Study Period|Death|0|||
126764065|NCT03110107|456089032|FG001|Treatment Period|Adverse Event|0|||
126764066|NCT03110107|456089033|FG002|Treatment Period|Adverse Event|1|||
126264501|NCT02149121|454258469|FG000|Main Study Period|Physician Decision|1|||
126264502|NCT02149121|454258470|FG001|Main Study Period|Physician Decision|0|||
126264503|NCT02149121|454258471|FG002|Main Study Period|Physician Decision|0|||
126264504|NCT02149121|454258472|FG003|Main Study Period|Physician Decision|0|||
126264505|NCT02149121|454258473|FG004|Main Study Period|Physician Decision|0|||
126264506|NCT02149121|454258474|FG005|Main Study Period|Physician Decision|0|||
126264507|NCT02149121|454258475|FG006|Main Study Period|Physician Decision|0|||
126264508|NCT02149121|454258469|FG000|Main Study Period|Developed any malignancy|0|||
126264509|NCT02149121|454258470|FG001|Main Study Period|Developed any malignancy|1|||
126264510|NCT02149121|454258471|FG002|Main Study Period|Developed any malignancy|1|||
126264511|NCT02149121|454258472|FG003|Main Study Period|Developed any malignancy|0|||
126264512|NCT02149121|454258473|FG004|Main Study Period|Developed any malignancy|0|||
126264513|NCT02149121|454258474|FG005|Main Study Period|Developed any malignancy|0|||
126264514|NCT02149121|454258475|FG006|Main Study Period|Developed any malignancy|0|||
126264515|NCT02149121|454258469|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
126264516|NCT02149121|454258470|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
126264517|NCT02149121|454258471|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
126264518|NCT02149121|454258472|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
126264519|NCT02149121|454258473|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
126264520|NCT02149121|454258474|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
126264521|NCT02149121|454258475|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
126264522|NCT02149121|454258469|FG000|Main Study Period|Disease progression|0|||
126264523|NCT02149121|454258470|FG001|Main Study Period|Disease progression|1|||
126264524|NCT02149121|454258471|FG002|Main Study Period|Disease progression|0|||
126264525|NCT02149121|454258472|FG003|Main Study Period|Disease progression|0|||
126264526|NCT02149121|454258473|FG004|Main Study Period|Disease progression|0|||
126264527|NCT02149121|454258474|FG005|Main Study Period|Disease progression|0|||
126264528|NCT02149121|454258475|FG006|Main Study Period|Disease progression|0|||
126264529|NCT02149121|454258469|FG000|Extension Study Period|Withdrawal by Subject|0|||
126264530|NCT02149121|454258470|FG001|Extension Study Period|Withdrawal by Subject|0|||
126264531|NCT02149121|454258471|FG002|Extension Study Period|Withdrawal by Subject|0|||
126264532|NCT02149121|454258472|FG003|Extension Study Period|Withdrawal by Subject|1|||
126264533|NCT02149121|454258473|FG004|Extension Study Period|Withdrawal by Subject|0|||
126264534|NCT02149121|454258474|FG005|Extension Study Period|Withdrawal by Subject|2|||
126264535|NCT02149121|454258475|FG006|Extension Study Period|Withdrawal by Subject|0|||
126264536|NCT03166124|454258476|FG000|Treatment Period 1|Adverse Event|0|||
126264537|NCT03166124|454258477|FG001|Treatment Period 1|Adverse Event|0|||
126264538|NCT03166124|454258478|FG002|Treatment Period 1|Adverse Event|1|||
126264539|NCT03166124|454258479|FG003|Treatment Period 1|Adverse Event|0|||
126264540|NCT03166124|454258476|FG000|Wash-out Period|Withdrawal by Subject|0|||
126264541|NCT03166124|454258477|FG001|Wash-out Period|Withdrawal by Subject|1|||
126264542|NCT03166124|454258478|FG002|Wash-out Period|Withdrawal by Subject|0|||
126264543|NCT03166124|454258479|FG003|Wash-out Period|Withdrawal by Subject|1|||
126264544|NCT03166124|454258476|FG000|Wash-out Period|Adverse Event|0|||
126264545|NCT03166124|454258477|FG001|Wash-out Period|Adverse Event|1|||
126264546|NCT03166124|454258478|FG002|Wash-out Period|Adverse Event|1|||
126264547|NCT03166124|454258479|FG003|Wash-out Period|Adverse Event|0|||
126264548|NCT00766831|454258480|FG000|Overall Study|Withdrawal by Subject|4|||
126264549|NCT00766831|454258480|FG000|Overall Study|Lost to Follow-up|3|||
126264550|NCT00766831|454258480|FG000|Overall Study|Adverse Event|20|||
126264551|NCT00766831|454258480|FG000|Overall Study|Protocol Violation|15|||
126764067|NCT03110107|456089034|FG003|Treatment Period|Adverse Event|0|||
126764068|NCT03110107|456089035|FG004|Treatment Period|Adverse Event|0|||
126764069|NCT03110107|456089036|FG005|Treatment Period|Adverse Event|2|||
126264552|NCT00766831|454258480|FG000|Overall Study|Physician Decision|5|||
126264553|NCT00766831|454258480|FG000|Overall Study|Withdrawal of consent|26|||
126264554|NCT00766831|454258480|FG000|Overall Study|Non cooperation by participants|14|||
126264555|NCT00766831|454258480|FG000|Overall Study|Other|28|||
126264556|NCT04974619|454260596|FG000|Overall Study|Lost to Follow-up|0|||
126264557|NCT04974619|454260597|FG001|Overall Study|Lost to Follow-up|0|||
126264558|NCT04974619|454260598|FG002|Overall Study|Lost to Follow-up|1|||
126264559|NCT04974619|454260596|FG000|Overall Study|Withdrawal by Subject|0|||
126264560|NCT04974619|454260597|FG001|Overall Study|Withdrawal by Subject|0|||
126264561|NCT04974619|454260598|FG002|Overall Study|Withdrawal by Subject|1|||
126264562|NCT04974619|454260596|FG000|Overall Study|Protocol Violation|0|||
126264563|NCT04974619|454260597|FG001|Overall Study|Protocol Violation|1|||
126264564|NCT04974619|454260598|FG002|Overall Study|Protocol Violation|0|||
126264565|NCT00493779|454260599|FG000|Overall Study|Logistical issue at site|1|||
126264566|NCT01475253|454260603|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
126264567|NCT01475253|454260604|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
126264568|NCT01475253|454260605|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
126264569|NCT01475253|454260606|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
126264570|NCT01475253|454260603|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
126264571|NCT01475253|454260604|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
126264572|NCT01475253|454260605|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
126264573|NCT01475253|454260606|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
126264574|NCT02148913|454260608|FG000|Overall Study|Death|0|||
126264575|NCT02148913|454260609|FG001|Overall Study|Death|1|||
126264576|NCT02148913|454260610|FG002|Overall Study|Death|0|||
126264577|NCT02148913|454260611|FG003|Overall Study|Death|0|||
126264578|NCT01045993|454260618|FG000|Overall Study|Treated-later found eligibility not met|0|||
126264579|NCT01045993|454260619|FG001|Overall Study|Treated-later found eligibility not met|1|||
126264580|NCT01045993|454260620|FG002|Overall Study|Treated-later found eligibility not met|0|||
126264581|NCT01045993|454260621|FG003|Overall Study|Treated-later found eligibility not met|0|||
126264582|NCT05506358|454260622|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
126264583|NCT05506358|454260623|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
126264584|NCT05506358|454260624|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
126264585|NCT05506358|454260625|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
126264586|NCT05506358|454260626|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
126264587|NCT05506358|454260622|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
126264588|NCT05506358|454260623|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
126264589|NCT05506358|454260624|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
126264590|NCT05506358|454260625|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
126264591|NCT05506358|454260626|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
126264592|NCT05506358|454260622|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
126264593|NCT05506358|454260623|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
126264594|NCT05506358|454260624|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
126264595|NCT05506358|454260625|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
126264596|NCT05506358|454260626|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
126264597|NCT05506358|454260622|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
126264598|NCT05506358|454260623|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
126264599|NCT05506358|454260624|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
126264600|NCT05506358|454260625|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
126264601|NCT05506358|454260626|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
126264602|NCT05506358|454260622|FG000|Overall Study|HbE trait|0|||
126264603|NCT05506358|454260623|FG001|Overall Study|HbE trait|0|||
126264604|NCT05506358|454260624|FG002|Overall Study|HbE trait|0|||
126264605|NCT05506358|454260625|FG003|Overall Study|HbE trait|1|||
126264606|NCT05506358|454260626|FG004|Overall Study|HbE trait|0|||
126264607|NCT01659736|454260627|FG000|Treatment Period|Adverse Event|1|||
126264608|NCT01659736|454260628|FG001|Treatment Period|Adverse Event|1|||
126264609|NCT01659736|454260627|FG000|Treatment Period|Protocol Violation|3|||
126264610|NCT01659736|454260628|FG001|Treatment Period|Protocol Violation|1|||
126264611|NCT01659736|454260627|FG000|Treatment Period|Withdrawal by Subject|1|||
126264612|NCT01659736|454260628|FG001|Treatment Period|Withdrawal by Subject|0|||
126264613|NCT01659736|454260627|FG000|3-month Follow-up|Lost to Follow-up|0|||
126452742|NCT03337490|454958979|FG002|Overall Study|Lack of Efficacy|35|||
126452743|NCT03337490|454958977|FG000|Overall Study|Physician Decision|0|||
126452744|NCT03337490|454958978|FG001|Overall Study|Physician Decision|1|||
126452745|NCT03337490|454958979|FG002|Overall Study|Physician Decision|0|||
126452746|NCT03337490|454958977|FG000|Overall Study|Lost to Follow-up|0|||
126452747|NCT03337490|454958978|FG001|Overall Study|Lost to Follow-up|1|||
126264614|NCT01659736|454260628|FG001|3-month Follow-up|Lost to Follow-up|1|||
126264615|NCT02791893|454260636|FG000|Blinded Phase|Lost to Follow-up|2|||
126264616|NCT02791893|454260637|FG001|Blinded Phase|Lost to Follow-up|2|||
126264617|NCT02791893|454260636|FG000|Blinded Phase|Withdrawal by Subject|1|||
126264618|NCT02791893|454260637|FG001|Blinded Phase|Withdrawal by Subject|2|||
126264619|NCT02791893|454260636|FG000|Open Label Phase|Lost to Follow-up|3|||
126264620|NCT02791893|454260637|FG001|Open Label Phase|Lost to Follow-up|0|||
126452748|NCT03337490|454958979|FG002|Overall Study|Lost to Follow-up|0|||
126452749|NCT00233454|454958980|FG000|Overall Study|Death|6|||
126264621|NCT02791893|454260636|FG000|Open Label Phase|Withdrawal by Subject|0|||
126264622|NCT02791893|454260637|FG001|Open Label Phase|Withdrawal by Subject|2|||
126264623|NCT00262041|454260638|FG000|Overall Study|Withdrawal by Subject|0|||
126264624|NCT00262041|454260639|FG001|Overall Study|Withdrawal by Subject|3|||
126264625|NCT00262041|454260640|FG002|Overall Study|Withdrawal by Subject|1|||
126264626|NCT00262041|454260638|FG000|Overall Study|Lost to Follow-up|1|||
126264627|NCT00262041|454260639|FG001|Overall Study|Lost to Follow-up|1|||
126264628|NCT00262041|454260640|FG002|Overall Study|Lost to Follow-up|5|||
126264629|NCT00262041|454260638|FG000|Overall Study|Unable to classify|1|||
126264630|NCT00262041|454260639|FG001|Overall Study|Unable to classify|0|||
126264631|NCT00262041|454260640|FG002|Overall Study|Unable to classify|0|||
126264632|NCT02384941|454260643|FG000|Overall Study|Adverse Event|11|||
126264633|NCT02384941|454260644|FG001|Overall Study|Adverse Event|13|||
126264634|NCT02384941|454260645|FG002|Overall Study|Adverse Event|17|||
126264635|NCT02384941|454260643|FG000|Overall Study|Lost to Follow-up|3|||
126264636|NCT02384941|454260644|FG001|Overall Study|Lost to Follow-up|2|||
126264637|NCT02384941|454260645|FG002|Overall Study|Lost to Follow-up|1|||
126264638|NCT02384941|454260643|FG000|Overall Study|Non-Compliance With Study Drug|2|||
126264639|NCT02384941|454260644|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126264640|NCT02384941|454260645|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126264641|NCT02384941|454260643|FG000|Overall Study|Physician Decision|1|||
126264642|NCT02384941|454260644|FG001|Overall Study|Physician Decision|1|||
126264643|NCT02384941|454260645|FG002|Overall Study|Physician Decision|0|||
126264644|NCT02384941|454260643|FG000|Overall Study|Protocol Violation|3|||
126264645|NCT02384941|454260644|FG001|Overall Study|Protocol Violation|0|||
126264646|NCT02384941|454260645|FG002|Overall Study|Protocol Violation|0|||
126264647|NCT02384941|454260643|FG000|Overall Study|Withdrawal by Subject|26|||
126264648|NCT02384941|454260644|FG001|Overall Study|Withdrawal by Subject|19|||
126264649|NCT02384941|454260645|FG002|Overall Study|Withdrawal by Subject|20|||
126264650|NCT02384941|454260643|FG000|Overall Study|Pregnancy|0|||
126264651|NCT02384941|454260644|FG001|Overall Study|Pregnancy|0|||
126264652|NCT02384941|454260645|FG002|Overall Study|Pregnancy|1|||
126264653|NCT02384941|454260643|FG000|Overall Study|Other than specified above|4|||
126264654|NCT02384941|454260644|FG001|Overall Study|Other than specified above|0|||
126264655|NCT02384941|454260645|FG002|Overall Study|Other than specified above|1|||
126264656|NCT00252174|454260648|FG000|Overall Study|Withdrawal by Subject|0|||
126264657|NCT00252174|454260649|FG001|Overall Study|Withdrawal by Subject|1|||
126264658|NCT00252174|454260650|FG002|Overall Study|Withdrawal by Subject|0|||
126264659|NCT02025010|454260651|FG000|Overall Study|Symptomatic or radiographic progression|36|||
126264660|NCT02025010|454260651|FG000|Overall Study|Adverse Event|6|||
126264661|NCT02025010|454260651|FG000|Overall Study|Physician Decision|7|||
126264662|NCT02025010|454260651|FG000|Overall Study|Withdrawal by Subject|3|||
126264663|NCT02025010|454260651|FG000|Overall Study|Intercurrent illness|3|||
126264664|NCT02025010|454260651|FG000|Overall Study|Patients still on treatment|3|||
126264665|NCT02025010|454260651|FG000|Overall Study|Never initiate the treatment|2|||
126264666|NCT00484419|454260656|FG000|Overall Study|Adverse Event|3|||
126264667|NCT00484419|454260657|FG001|Overall Study|Adverse Event|0|||
126264668|NCT00484419|454260658|FG002|Overall Study|Adverse Event|0|||
126264669|NCT00484419|454260656|FG000|Overall Study|Lost to Follow-up|1|||
126264670|NCT00484419|454260657|FG001|Overall Study|Lost to Follow-up|0|||
126264671|NCT00484419|454260658|FG002|Overall Study|Lost to Follow-up|2|||
126264672|NCT00484419|454260656|FG000|Overall Study|Withdrawal by Subject|3|||
126264673|NCT00484419|454260657|FG001|Overall Study|Withdrawal by Subject|1|||
126264674|NCT00484419|454260658|FG002|Overall Study|Withdrawal by Subject|1|||
126264675|NCT00484419|454260656|FG000|Overall Study|subject met discontinuation criteria|2|||
126264676|NCT00484419|454260657|FG001|Overall Study|subject met discontinuation criteria|2|||
126264677|NCT00484419|454260658|FG002|Overall Study|subject met discontinuation criteria|4|||
126264678|NCT00484419|454260656|FG000|Overall Study|required restricted medication|1|||
126264679|NCT00484419|454260657|FG001|Overall Study|required restricted medication|0|||
126264680|NCT00484419|454260658|FG002|Overall Study|required restricted medication|1|||
126264681|NCT00484419|454260656|FG000|Overall Study|Physician Decision|1|||
126264682|NCT00484419|454260657|FG001|Overall Study|Physician Decision|1|||
126264683|NCT00484419|454260658|FG002|Overall Study|Physician Decision|1|||
126264684|NCT00484419|454260656|FG000|Overall Study|subject unable to receive medication|1|||
126264685|NCT00484419|454260657|FG001|Overall Study|subject unable to receive medication|0|||
126264686|NCT00484419|454260658|FG002|Overall Study|subject unable to receive medication|0|||
126264687|NCT00484419|454260656|FG000|Overall Study|subject relocated|0|||
126264688|NCT00484419|454260657|FG001|Overall Study|subject relocated|1|||
126264689|NCT00484419|454260658|FG002|Overall Study|subject relocated|0|||
126264690|NCT00484419|454260656|FG000|Overall Study|sponsor decision, randomized in error|0|||
126264691|NCT00484419|454260657|FG001|Overall Study|sponsor decision, randomized in error|0|||
126264692|NCT00484419|454260658|FG002|Overall Study|sponsor decision, randomized in error|2|||
126264693|NCT00102687|454260659|FG000|Initial Period|Withdrawal by Subject|6|||
126264694|NCT00102687|454260660|FG001|Initial Period|Withdrawal by Subject|3|||
126264695|NCT00102687|454260661|FG002|Initial Period|Withdrawal by Subject|5|||
126264696|NCT00102687|454260662|FG003|Initial Period|Withdrawal by Subject|0|||
126264697|NCT00102687|454260663|FG004|Initial Period|Withdrawal by Subject|0|||
126264698|NCT00102687|454260659|FG000|Initial Period|Adverse Event|4|||
126264699|NCT00102687|454260660|FG001|Initial Period|Adverse Event|7|||
126264700|NCT00102687|454260661|FG002|Initial Period|Adverse Event|9|||
126264701|NCT00102687|454260662|FG003|Initial Period|Adverse Event|0|||
126264702|NCT00102687|454260663|FG004|Initial Period|Adverse Event|0|||
126264703|NCT00102687|454260659|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
126264704|NCT00102687|454260660|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
126264705|NCT00102687|454260661|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
126264706|NCT00102687|454260662|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
126264707|NCT00102687|454260663|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
126264708|NCT00102687|454260659|FG000|Initial Period|Protocol Violation|0|||
126264709|NCT00102687|454260660|FG001|Initial Period|Protocol Violation|0|||
126264710|NCT00102687|454260661|FG002|Initial Period|Protocol Violation|2|||
126264711|NCT00102687|454260662|FG003|Initial Period|Protocol Violation|0|||
126264712|NCT00102687|454260663|FG004|Initial Period|Protocol Violation|0|||
126264713|NCT00102687|454260659|FG000|Initial Period|Physician Decision|2|||
126764070|NCT03110107|456089037|FG006|Treatment Period|Adverse Event|0|||
126764071|NCT03110107|456089038|FG007|Treatment Period|Adverse Event|2|||
126764072|NCT03110107|456089039|FG008|Treatment Period|Adverse Event|0|||
126764073|NCT03110107|456089040|FG009|Treatment Period|Adverse Event|1|||
126764074|NCT03110107|456089041|FG010|Treatment Period|Adverse Event|0|||
126764075|NCT03110107|456089042|FG011|Treatment Period|Adverse Event|0|||
126764076|NCT03110107|456089043|FG012|Treatment Period|Adverse Event|0|||
126764077|NCT03110107|456089044|FG013|Treatment Period|Adverse Event|0|||
126764078|NCT03110107|456089045|FG014|Treatment Period|Adverse Event|0|||
126764079|NCT03110107|456089046|FG015|Treatment Period|Adverse Event|2|||
126764080|NCT03110107|456089047|FG016|Treatment Period|Adverse Event|0|||
126764081|NCT03110107|456089048|FG017|Treatment Period|Adverse Event|1|||
126764082|NCT03110107|456089049|FG018|Treatment Period|Adverse Event|2|||
126764083|NCT03110107|456089050|FG019|Treatment Period|Adverse Event|1|||
126764084|NCT03110107|456089051|FG020|Treatment Period|Adverse Event|4|||
126764085|NCT03110107|456089052|FG021|Treatment Period|Adverse Event|2|||
126764086|NCT03110107|456089053|FG022|Treatment Period|Adverse Event|2|||
126764087|NCT03110107|456089054|FG023|Treatment Period|Adverse Event|2|||
126764088|NCT03110107|456089055|FG024|Treatment Period|Adverse Event|2|||
126764089|NCT03110107|456089056|FG025|Treatment Period|Adverse Event|4|||
126764090|NCT03110107|456089031|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
126764091|NCT03110107|456089032|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
126764092|NCT03110107|456089033|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
126764093|NCT03110107|456089034|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
126764094|NCT03110107|456089035|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
126764095|NCT03110107|456089036|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
126764096|NCT03110107|456089037|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
126764097|NCT03110107|456089038|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
126764098|NCT03110107|456089039|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
126764099|NCT03110107|456089040|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
126764100|NCT03110107|456089041|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
126764101|NCT03110107|456089042|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
126764102|NCT03110107|456089043|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
126764103|NCT03110107|456089044|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
126764104|NCT03110107|456089045|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
126264714|NCT00102687|454260660|FG001|Initial Period|Physician Decision|9|||
126264715|NCT00102687|454260661|FG002|Initial Period|Physician Decision|6|||
126264716|NCT00102687|454260662|FG003|Initial Period|Physician Decision|0|||
126264717|NCT00102687|454260663|FG004|Initial Period|Physician Decision|0|||
126264718|NCT00102687|454260659|FG000|Initial Period|Sponsor's decision|0|||
126264719|NCT00102687|454260660|FG001|Initial Period|Sponsor's decision|1|||
126264720|NCT00102687|454260661|FG002|Initial Period|Sponsor's decision|1|||
126264721|NCT00102687|454260662|FG003|Initial Period|Sponsor's decision|0|||
126264722|NCT00102687|454260663|FG004|Initial Period|Sponsor's decision|0|||
126264723|NCT00102687|454260659|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
126360014|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
126360015|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
126360016|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
126360017|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
126360018|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
126360019|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
126360020|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
126764105|NCT03110107|456089046|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
126264724|NCT00102687|454260660|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
126264725|NCT00102687|454260661|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
126264726|NCT00102687|454260662|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
126264727|NCT00102687|454260663|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
126264728|NCT00102687|454260659|FG000|Initial Period|Death|1|||
126264729|NCT00102687|454260660|FG001|Initial Period|Death|1|||
126264730|NCT00102687|454260661|FG002|Initial Period|Death|1|||
126264731|NCT00102687|454260662|FG003|Initial Period|Death|0|||
126264732|NCT00102687|454260663|FG004|Initial Period|Death|0|||
126264733|NCT00102687|454260659|FG000|Maintenance Period|Withdrawal by Subject|4|||
126264734|NCT00102687|454260660|FG001|Maintenance Period|Withdrawal by Subject|0|||
126264735|NCT00102687|454260661|FG002|Maintenance Period|Withdrawal by Subject|2|||
126264736|NCT00102687|454260662|FG003|Maintenance Period|Withdrawal by Subject|3|||
126264737|NCT00102687|454260663|FG004|Maintenance Period|Withdrawal by Subject|1|||
126264738|NCT00102687|454260659|FG000|Maintenance Period|Adverse Event|1|||
126264739|NCT00102687|454260660|FG001|Maintenance Period|Adverse Event|0|||
126264740|NCT00102687|454260661|FG002|Maintenance Period|Adverse Event|0|||
126264741|NCT00102687|454260662|FG003|Maintenance Period|Adverse Event|1|||
126264742|NCT00102687|454260663|FG004|Maintenance Period|Adverse Event|3|||
126264743|NCT00102687|454260659|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
126264744|NCT00102687|454260660|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
126264745|NCT00102687|454260661|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
126264746|NCT00102687|454260662|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
126264747|NCT00102687|454260663|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
126264748|NCT00102687|454260659|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
126264749|NCT00102687|454260660|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
126264750|NCT00102687|454260661|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
126264751|NCT00102687|454260662|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
126547142|NCT01512745|455296147|FG000|Overall Study|Withdrawal by Subject|2|||
126547143|NCT01512745|455296148|FG001|Overall Study|Withdrawal by Subject|2|||
126547144|NCT01512745|455296147|FG000|Overall Study|Lost to Follow-up|4|||
126547145|NCT01512745|455296148|FG001|Overall Study|Lost to Follow-up|0|||
126547146|NCT01512745|455296147|FG000|Overall Study|Lack of Efficacy|2|||
126547147|NCT01512745|455296148|FG001|Overall Study|Lack of Efficacy|2|||
126547148|NCT01512745|455296147|FG000|Overall Study|Protocol Violation|1|||
126547149|NCT01512745|455296148|FG001|Overall Study|Protocol Violation|0|||
126547150|NCT00936221|455296149|FG000|Overall Study|Withdrawal by Subject|1|||
126547151|NCT00936221|455296150|FG001|Overall Study|Withdrawal by Subject|1|||
126547152|NCT03820323|455296151|FG000|Overall Study|Lost to Follow-up|2|||
126547153|NCT03820323|455296152|FG001|Overall Study|Lost to Follow-up|1|||
126547154|NCT03820323|455296151|FG000|Overall Study|Missed 12-month visit|22|||
126547155|NCT03820323|455296152|FG001|Overall Study|Missed 12-month visit|14|||
126547156|NCT03820323|455296151|FG000|Overall Study|Death|2|||
126547157|NCT03820323|455296152|FG001|Overall Study|Death|1|||
126547158|NCT03820323|455296151|FG000|Overall Study|Transferred out|13|||
126547159|NCT03820323|455296152|FG001|Overall Study|Transferred out|11|||
126547160|NCT03820323|455296151|FG000|Overall Study|Terminated|0|||
126547161|NCT03820323|455296152|FG001|Overall Study|Terminated|3|||
126547162|NCT03820323|455296151|FG000|Overall Study|Withdrawal by Subject|1|||
126547163|NCT03820323|455296152|FG001|Overall Study|Withdrawal by Subject|6|||
126547164|NCT03151395|455296153|FG000|Overall Study|Adverse Event|2|||
126702816|NCT01769105|455860806|FG001|First Intervention|Protocol Violation|2|||
126702817|NCT01769105|455860805|FG000|Cross-over|Lost to Follow-up|5|||
126264752|NCT00102687|454260663|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
126264753|NCT00102687|454260659|FG000|Maintenance Period|Death|0|||
126264754|NCT00102687|454260660|FG001|Maintenance Period|Death|0|||
126264755|NCT00102687|454260661|FG002|Maintenance Period|Death|0|||
126264756|NCT00102687|454260662|FG003|Maintenance Period|Death|1|||
126264757|NCT00102687|454260663|FG004|Maintenance Period|Death|1|||
126264758|NCT00102687|454260659|FG000|Maintenance Period|Physician Decision|1|||
126264759|NCT00102687|454260660|FG001|Maintenance Period|Physician Decision|2|||
126264760|NCT00102687|454260661|FG002|Maintenance Period|Physician Decision|3|||
126264761|NCT00102687|454260662|FG003|Maintenance Period|Physician Decision|0|||
126264762|NCT00102687|454260663|FG004|Maintenance Period|Physician Decision|4|||
126264763|NCT01341587|454260664|FG000|Overall Study|Lost to Follow-up|2|||
126264764|NCT01341587|454260665|FG001|Overall Study|Lost to Follow-up|0|||
126264765|NCT01341587|454260664|FG000|Overall Study|stopped using the meters|2|||
126264766|NCT01341587|454260665|FG001|Overall Study|stopped using the meters|10|||
126264767|NCT01144403|454260666|FG000|Overall Study|Lost to Follow-up|3|||
126264768|NCT01144403|454260666|FG000|Overall Study|Death|1|||
126264769|NCT01144403|454260666|FG000|Overall Study|Adverse Event|1|||
126264770|NCT03176784|454260667|FG000|Overall Study|Lost to Follow-up|77|||
126264771|NCT03176784|454260668|FG001|Overall Study|Lost to Follow-up|79|||
126264772|NCT03176784|454260669|FG002|Overall Study|Lost to Follow-up|79|||
126264773|NCT03176784|454260670|FG003|Overall Study|Lost to Follow-up|49|||
126547165|NCT03151395|455296153|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
126547166|NCT03151395|455296153|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
126547167|NCT03151395|455296153|FG000|Overall Study|Unspecified reason|4|||
126264774|NCT03176784|454260667|FG000|Overall Study|Withdrawal by Subject|28|||
126264775|NCT03176784|454260668|FG001|Overall Study|Withdrawal by Subject|34|||
126264776|NCT03176784|454260669|FG002|Overall Study|Withdrawal by Subject|34|||
126264777|NCT03176784|454260670|FG003|Overall Study|Withdrawal by Subject|21|||
126264778|NCT01825837|454260671|FG000|PART I|Withdrawal by Subject|0|||
126264779|NCT01825837|454260672|FG001|PART I|Withdrawal by Subject|0|||
126264780|NCT01825837|454260673|FG002|PART I|Withdrawal by Subject|0|||
126264781|NCT01825837|454260674|FG003|PART I|Withdrawal by Subject|6|||
126264782|NCT01825837|454260671|FG000|PART I|Patient non-compliance|0|||
126264783|NCT01825837|454260672|FG001|PART I|Patient non-compliance|0|||
126264784|NCT01825837|454260673|FG002|PART I|Patient non-compliance|0|||
126264785|NCT01825837|454260674|FG003|PART I|Patient non-compliance|1|||
126264786|NCT01825837|454260671|FG000|PART I|Treatment failure|0|||
126264787|NCT01825837|454260672|FG001|PART I|Treatment failure|0|||
126264788|NCT01825837|454260673|FG002|PART I|Treatment failure|0|||
126264789|NCT01825837|454260674|FG003|PART I|Treatment failure|7|||
126264790|NCT01825837|454260671|FG000|PART I|reason unspecified|0|||
126264791|NCT01825837|454260672|FG001|PART I|reason unspecified|0|||
126264792|NCT01825837|454260673|FG002|PART I|reason unspecified|0|||
126264793|NCT01825837|454260674|FG003|PART I|reason unspecified|3|||
126264794|NCT01825837|454260671|FG000|PART II|Withdrawal by Subject|3|||
126264795|NCT01825837|454260672|FG001|PART II|Withdrawal by Subject|3|||
126264796|NCT01825837|454260673|FG002|PART II|Withdrawal by Subject|7|||
126264797|NCT01825837|454260674|FG003|PART II|Withdrawal by Subject|0|||
126264798|NCT01825837|454260671|FG000|PART II|Patient non-compliance|5|||
126264799|NCT01825837|454260672|FG001|PART II|Patient non-compliance|2|||
126264800|NCT01825837|454260673|FG002|PART II|Patient non-compliance|4|||
126264801|NCT01825837|454260674|FG003|PART II|Patient non-compliance|0|||
126264802|NCT01825837|454260671|FG000|PART II|Adverse Event|3|||
126264803|NCT01825837|454260672|FG001|PART II|Adverse Event|3|||
126264804|NCT01825837|454260673|FG002|PART II|Adverse Event|1|||
126264805|NCT01825837|454260674|FG003|PART II|Adverse Event|0|||
126264806|NCT01825837|454260671|FG000|PART II|Treatment failure|6|||
126264807|NCT01825837|454260672|FG001|PART II|Treatment failure|4|||
126264808|NCT01825837|454260673|FG002|PART II|Treatment failure|5|||
126264809|NCT01825837|454260674|FG003|PART II|Treatment failure|0|||
126264810|NCT01825837|454260671|FG000|PART II|reason unspecified|2|||
126264811|NCT01825837|454260672|FG001|PART II|reason unspecified|2|||
126452750|NCT02366091|454958981|FG000|Overall Study|Withdrawal by Subject|3|||
126452751|NCT02366091|454958982|FG001|Overall Study|Withdrawal by Subject|7|||
126452752|NCT02366091|454958983|FG002|Overall Study|Withdrawal by Subject|3|||
126452753|NCT02366091|454958984|FG003|Overall Study|Withdrawal by Subject|1|||
126452754|NCT01155011|454958985|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
126452755|NCT01155011|454958986|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
126452756|NCT01155011|454958985|FG000|Baseline to 6 Months|investigator decision, moved|4|||
126452757|NCT01155011|454958986|FG001|Baseline to 6 Months|investigator decision, moved|5|||
126452758|NCT01155011|454958985|FG000|Baseline to 6 Months|Death|0|||
126452759|NCT01155011|454958986|FG001|Baseline to 6 Months|Death|1|||
126452760|NCT01155011|454958985|FG000|6 to 12 Months|Withdrawal by Subject|8|||
126452761|NCT01155011|454958986|FG001|6 to 12 Months|Withdrawal by Subject|5|||
126452762|NCT01155011|454958985|FG000|6 to 12 Months|Death|1|||
126452763|NCT01155011|454958986|FG001|6 to 12 Months|Death|5|||
126452764|NCT01743001|454958987|FG000|Overall Study|Physician Decision|1|||
126452765|NCT01743001|454958988|FG001|Overall Study|Physician Decision|0|||
126452766|NCT01743001|454958987|FG000|Overall Study|Pregnancy|1|||
126452767|NCT01743001|454958988|FG001|Overall Study|Pregnancy|0|||
126452768|NCT01743001|454958987|FG000|Overall Study|Death|1|||
126452769|NCT01743001|454958988|FG001|Overall Study|Death|0|||
126452770|NCT01565343|454958989|FG000|Overall Study|Administrative decision/technical issues|1|||
126452771|NCT01565343|454958990|FG001|Overall Study|Administrative decision/technical issues|0|||
126452772|NCT01565343|454958991|FG002|Overall Study|Administrative decision/technical issues|0|||
126452773|NCT01853839|454958996|FG000|Overall Study|Violated inclusion criteria|2|||
126452774|NCT01853839|454958996|FG000|Overall Study|Not meet ITT population definition|58|||
126452775|NCT01853839|454958996|FG000|Overall Study|End of treatment visit too early|33|||
126452776|NCT01853839|454958996|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
126452777|NCT00835211|454958997|FG000|First Intervention|Withdrawal by Subject|0|||
126452778|NCT00835211|454958998|FG001|First Intervention|Withdrawal by Subject|1|||
126452779|NCT00835211|454958997|FG000|Washout: 7 Days|Adverse Event|2|||
126452780|NCT00835211|454958998|FG001|Washout: 7 Days|Adverse Event|1|||
126452781|NCT00835211|454958997|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
126452782|NCT00835211|454958998|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
126452783|NCT01403948|454958999|FG000|Overall Study|Progressive disease|0|||
126452784|NCT01403948|454959000|FG001|Overall Study|Progressive disease|2|||
126452785|NCT01403948|454959001|FG002|Overall Study|Progressive disease|2|||
126452786|NCT01403948|454959002|FG003|Overall Study|Progressive disease|4|||
126452787|NCT01403948|454959003|FG004|Overall Study|Progressive disease|2|||
126452788|NCT01403948|454959004|FG005|Overall Study|Progressive disease|6|||
126452789|NCT01403948|454959005|FG006|Overall Study|Progressive disease|2|||
126452790|NCT01403948|454959006|FG007|Overall Study|Progressive disease|4|||
126547168|NCT00879996|455296154|FG000|Overall Study|Lost to Follow-up|7|||
126547169|NCT00879996|455296155|FG001|Overall Study|Lost to Follow-up|6|||
126547170|NCT00879996|455296154|FG000|Overall Study|non-compliance|6|||
126547171|NCT00879996|455296155|FG001|Overall Study|non-compliance|4|||
126547172|NCT00879996|455296154|FG000|Overall Study|Physician Decision|1|||
126547173|NCT00879996|455296155|FG001|Overall Study|Physician Decision|2|||
126547174|NCT00879996|455296154|FG000|Overall Study|psychiatric problem|0|||
126547175|NCT00879996|455296155|FG001|Overall Study|psychiatric problem|1|||
126547176|NCT00879996|455296154|FG000|Overall Study|put on parole|1|||
126547177|NCT00879996|455296155|FG001|Overall Study|put on parole|0|||
126547178|NCT02597933|455296157|FG000|Overall Study|Withdrawal by Subject|7|||
126547179|NCT02597933|455296158|FG001|Overall Study|Withdrawal by Subject|5|||
126547180|NCT02597933|455296157|FG000|Overall Study|Protocol Violation|2|||
126547181|NCT02597933|455296158|FG001|Overall Study|Protocol Violation|2|||
126547182|NCT02597933|455296157|FG000|Overall Study|Adverse Event|20|||
126547183|NCT02597933|455296158|FG001|Overall Study|Adverse Event|28|||
126547184|NCT02597933|455296157|FG000|Overall Study|Not treated|2|||
126547185|NCT02597933|455296158|FG001|Overall Study|Not treated|2|||
126547186|NCT02597933|455296157|FG000|Overall Study|Other than stated above|7|||
126547187|NCT02597933|455296158|FG001|Overall Study|Other than stated above|14|||
126547188|NCT01617005|455296161|FG000|Overall Study|Pregnancy|1|||
126547189|NCT01617005|455296161|FG000|Overall Study|Lack of motivation for treatment|1|||
126547190|NCT01107743|455296165|FG000|Overall Study|Protocol Violation|46|||
126547191|NCT00308737|455296166|FG000|Overall Study|Adverse Event|104|||
126547192|NCT00308737|455296167|FG001|Overall Study|Adverse Event|9|||
126547193|NCT00308737|455296168|FG002|Overall Study|Adverse Event|0|||
126547194|NCT00308737|455296166|FG000|Overall Study|Death|4|||
126547195|NCT00308737|455296167|FG001|Overall Study|Death|3|||
126547196|NCT00308737|455296168|FG002|Overall Study|Death|0|||
126547197|NCT00308737|455296166|FG000|Overall Study|Lost to Follow-up|56|||
126547198|NCT00308737|455296167|FG001|Overall Study|Lost to Follow-up|80|||
126547199|NCT00308737|455296168|FG002|Overall Study|Lost to Follow-up|5|||
126547200|NCT00308737|455296166|FG000|Overall Study|Physician Decision|15|||
126547201|NCT00308737|455296167|FG001|Overall Study|Physician Decision|2|||
126547202|NCT00308737|455296168|FG002|Overall Study|Physician Decision|1|||
126547203|NCT00308737|455296166|FG000|Overall Study|Protocol Violation|34|||
126547204|NCT00308737|455296167|FG001|Overall Study|Protocol Violation|9|||
126547205|NCT00308737|455296168|FG002|Overall Study|Protocol Violation|5|||
126547206|NCT00308737|455296166|FG000|Overall Study|Withdrawal by Subject|218|||
126547207|NCT00308737|455296167|FG001|Overall Study|Withdrawal by Subject|166|||
126547208|NCT00308737|455296168|FG002|Overall Study|Withdrawal by Subject|18|||
126547209|NCT00308737|455296166|FG000|Overall Study|Various|32|||
126547210|NCT00308737|455296167|FG001|Overall Study|Various|20|||
126547211|NCT00308737|455296168|FG002|Overall Study|Various|8|||
126547212|NCT01225822|455296180|FG000|Overall Study|Adverse Event|13|||
126547213|NCT01225822|455296181|FG001|Overall Study|Adverse Event|31|||
126547214|NCT01225822|455296182|FG002|Overall Study|Adverse Event|18|||
126547215|NCT01225822|455296183|FG003|Overall Study|Adverse Event|23|||
126547216|NCT01225822|455296184|FG004|Overall Study|Adverse Event|14|||
126547217|NCT01225822|455296180|FG000|Overall Study|Protocol Violation|6|||
126702818|NCT01769105|455860806|FG001|Cross-over|Lost to Follow-up|0|||
126702819|NCT00963807|455860811|FG000|Overall Study|Physician Decision|2|||
126702820|NCT00963807|455860811|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
126702821|NCT00963807|455860811|FG000|Overall Study|Disease progression|15|||
126264812|NCT01825837|454260673|FG002|PART II|reason unspecified|2|||
126264813|NCT01825837|454260674|FG003|PART II|reason unspecified|0|||
126264814|NCT00904748|454260675|FG000|Overall Study|Withdrawal by Subject|1|||
126264815|NCT00904748|454260676|FG001|Overall Study|Withdrawal by Subject|1|||
126264816|NCT00904748|454260677|FG002|Overall Study|Withdrawal by Subject|1|||
126702822|NCT00684177|455860812|FG000|Overall Study|Adverse Event|4|||
126702823|NCT00684177|455860813|FG001|Overall Study|Adverse Event|3|||
126264817|NCT00904748|454260678|FG003|Overall Study|Withdrawal by Subject|2|||
126264818|NCT00904748|454260679|FG004|Overall Study|Withdrawal by Subject|0|||
126264819|NCT00904748|454260680|FG005|Overall Study|Withdrawal by Subject|0|||
126264820|NCT00904748|454260675|FG000|Overall Study|Adverse Event|0|||
126547218|NCT01225822|455296181|FG001|Overall Study|Protocol Violation|8|||
126547219|NCT01225822|455296182|FG002|Overall Study|Protocol Violation|6|||
126702824|NCT00684177|455860812|FG000|Overall Study|Lack of Efficacy|10|||
126702825|NCT00684177|455860813|FG001|Overall Study|Lack of Efficacy|15|||
126360021|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
126360022|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
126360023|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
126547220|NCT01225822|455296183|FG003|Overall Study|Protocol Violation|7|||
126547221|NCT01225822|455296184|FG004|Overall Study|Protocol Violation|4|||
126547222|NCT01225822|455296180|FG000|Overall Study|Lost to Follow-up|0|||
126547223|NCT01225822|455296181|FG001|Overall Study|Lost to Follow-up|0|||
126547224|NCT01225822|455296182|FG002|Overall Study|Lost to Follow-up|0|||
126547225|NCT01225822|455296183|FG003|Overall Study|Lost to Follow-up|1|||
126702826|NCT00684177|455860812|FG000|Overall Study|Protocol Violation|1|||
126702827|NCT00684177|455860813|FG001|Overall Study|Protocol Violation|0|||
126264821|NCT00904748|454260676|FG001|Overall Study|Adverse Event|0|||
126264822|NCT00904748|454260677|FG002|Overall Study|Adverse Event|0|||
126264823|NCT00904748|454260678|FG003|Overall Study|Adverse Event|0|||
126264824|NCT00904748|454260679|FG004|Overall Study|Adverse Event|1|||
126264825|NCT00904748|454260680|FG005|Overall Study|Adverse Event|0|||
126264826|NCT00700817|454260687|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
126264827|NCT00700817|454260688|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
126264828|NCT00700817|454260689|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
126264829|NCT00700817|454260690|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
126264830|NCT00700817|454260691|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
126264831|NCT00700817|454260687|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
126264832|NCT00700817|454260688|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
126264833|NCT00700817|454260689|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
126264834|NCT00700817|454260690|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
126264835|NCT00700817|454260691|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
126264836|NCT00700817|454260687|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
126264837|NCT00700817|454260688|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
126264838|NCT00700817|454260689|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
126264839|NCT00700817|454260690|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
126264840|NCT00700817|454260691|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
126264841|NCT00700817|454260687|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
126264842|NCT00700817|454260688|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
126264843|NCT00700817|454260689|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
126264844|NCT00700817|454260690|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
126264845|NCT00700817|454260691|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
126264846|NCT00700817|454260687|FG000|Week 0-26 (Main Period)|Unclassified|14|||
126264847|NCT00700817|454260688|FG001|Week 0-26 (Main Period)|Unclassified|4|||
126264848|NCT00700817|454260689|FG002|Week 0-26 (Main Period)|Unclassified|8|||
126264849|NCT00700817|454260690|FG003|Week 0-26 (Main Period)|Unclassified|0|||
126264850|NCT00700817|454260691|FG004|Week 0-26 (Main Period)|Unclassified|0|||
126264851|NCT00700817|454260687|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
126264852|NCT00700817|454260688|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
126264853|NCT00700817|454260689|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
126264854|NCT00700817|454260690|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
126264855|NCT00700817|454260691|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
126264856|NCT00700817|454260687|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
126264857|NCT00700817|454260688|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
126264858|NCT00700817|454260689|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
126264859|NCT00700817|454260690|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
126264860|NCT00700817|454260691|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
126264861|NCT00700817|454260687|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
126264862|NCT00700817|454260688|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
126264863|NCT00700817|454260689|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
126452791|NCT01403948|454959007|FG008|Overall Study|Progressive disease|5|||
126452792|NCT01403948|454959008|FG009|Overall Study|Progressive disease|5|||
126452793|NCT01403948|454958999|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
126452794|NCT01403948|454959000|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
126452795|NCT01403948|454959001|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
126452796|NCT01403948|454959002|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
126452797|NCT01403948|454959003|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
126452798|NCT01403948|454959004|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
126452799|NCT01403948|454959005|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
126452800|NCT01403948|454959006|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
126452801|NCT01403948|454959007|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
126452802|NCT01403948|454959008|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
126452803|NCT01403948|454958999|FG000|Overall Study|Lost to Follow-up|0|||
126452804|NCT01403948|454959000|FG001|Overall Study|Lost to Follow-up|0|||
126452805|NCT01403948|454959001|FG002|Overall Study|Lost to Follow-up|0|||
126547226|NCT01225822|455296184|FG004|Overall Study|Lost to Follow-up|0|||
126547227|NCT01225822|455296180|FG000|Overall Study|Withdrawal by Subject|6|||
126702828|NCT00684177|455860812|FG000|Overall Study|Lost to Follow-up|2|||
126702829|NCT00684177|455860813|FG001|Overall Study|Lost to Follow-up|1|||
126702830|NCT00684177|455860812|FG000|Overall Study|Physician Decision|2|||
126264864|NCT00700817|454260690|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
126264865|NCT00700817|454260691|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
126264866|NCT00700817|454260687|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
126264867|NCT00700817|454260688|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
126264868|NCT00700817|454260689|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
126264869|NCT00700817|454260690|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
126452806|NCT01403948|454959002|FG003|Overall Study|Lost to Follow-up|0|||
126452807|NCT01403948|454959003|FG004|Overall Study|Lost to Follow-up|0|||
126452808|NCT01403948|454959004|FG005|Overall Study|Lost to Follow-up|0|||
126264870|NCT00700817|454260691|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
126264871|NCT00700817|454260687|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
126264872|NCT00700817|454260688|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
126264873|NCT00700817|454260689|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
126264874|NCT00700817|454260690|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
126264875|NCT00700817|454260691|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
126264876|NCT00700817|454260687|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
126264877|NCT00700817|454260688|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
126264878|NCT00700817|454260689|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
126264879|NCT00700817|454260690|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
126264880|NCT00700817|454260691|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
126264881|NCT00700817|454260687|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
126264882|NCT00700817|454260688|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
126264883|NCT00700817|454260689|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
126264884|NCT00700817|454260690|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
126264885|NCT00700817|454260691|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
126264886|NCT00700817|454260687|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
126264887|NCT00700817|454260688|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
126264888|NCT00700817|454260689|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
126264889|NCT00700817|454260690|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
126264890|NCT00700817|454260691|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
126264891|NCT00700817|454260687|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
126264892|NCT00700817|454260688|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
126264893|NCT00700817|454260689|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
126264894|NCT00700817|454260690|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
126264895|NCT00700817|454260691|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
126264896|NCT00700817|454260687|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
126264897|NCT00700817|454260688|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
126264898|NCT00700817|454260689|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
126264899|NCT00700817|454260690|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
126264900|NCT00700817|454260691|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
126264901|NCT00767520|454260699|FG000|Overall Study|Participants still on treatment|11|||
126264902|NCT00767520|454260700|FG001|Overall Study|Participants still on treatment|15|||
126264903|NCT00767520|454260699|FG000|Overall Study|Randomized in error and Never treated|0|||
126264904|NCT00767520|454260700|FG001|Overall Study|Randomized in error and Never treated|2|||
126264905|NCT00606502|454260703|FG000|Randomization|Randomized but not treated|3|||
126264906|NCT00606502|454260704|FG001|Randomization|Randomized but not treated|0|||
126264907|NCT00606502|454260703|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
126264908|NCT00606502|454260704|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
126264909|NCT00958126|454260707|FG000|Overall Study|Serious Adverse Event|0|||
126264910|NCT00958126|454260708|FG001|Overall Study|Serious Adverse Event|2|||
126264911|NCT00958126|454260709|FG002|Overall Study|Serious Adverse Event|0|||
126264912|NCT00958126|454260710|FG003|Overall Study|Serious Adverse Event|0|||
126264913|NCT00958126|454260711|FG004|Overall Study|Serious Adverse Event|0|||
126264914|NCT00958126|454260712|FG005|Overall Study|Serious Adverse Event|0|||
126264915|NCT00958126|454260713|FG006|Overall Study|Serious Adverse Event|1|||
126264916|NCT00958126|454260714|FG007|Overall Study|Serious Adverse Event|0|||
126264917|NCT00958126|454260707|FG000|Overall Study|Withdrawal by Subject|0|||
126264918|NCT00958126|454260708|FG001|Overall Study|Withdrawal by Subject|2|||
126264919|NCT00958126|454260709|FG002|Overall Study|Withdrawal by Subject|0|||
126264920|NCT00958126|454260710|FG003|Overall Study|Withdrawal by Subject|0|||
126264921|NCT00958126|454260711|FG004|Overall Study|Withdrawal by Subject|0|||
126264922|NCT00958126|454260712|FG005|Overall Study|Withdrawal by Subject|0|||
126264923|NCT00958126|454260713|FG006|Overall Study|Withdrawal by Subject|0|||
126264924|NCT00958126|454260714|FG007|Overall Study|Withdrawal by Subject|0|||
126264925|NCT00958126|454260707|FG000|Overall Study|Moved away from study area|0|||
126264926|NCT00958126|454260708|FG001|Overall Study|Moved away from study area|0|||
126452809|NCT01403948|454959005|FG006|Overall Study|Lost to Follow-up|0|||
126764106|NCT03110107|456089047|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
126764107|NCT03110107|456089048|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
126764108|NCT03110107|456089049|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
126264927|NCT00958126|454260709|FG002|Overall Study|Moved away from study area|1|||
126264928|NCT00958126|454260710|FG003|Overall Study|Moved away from study area|1|||
126264929|NCT00958126|454260711|FG004|Overall Study|Moved away from study area|0|||
126264930|NCT00958126|454260712|FG005|Overall Study|Moved away from study area|0|||
126264931|NCT00958126|454260713|FG006|Overall Study|Moved away from study area|0|||
126264932|NCT00958126|454260714|FG007|Overall Study|Moved away from study area|0|||
126264933|NCT00958126|454260707|FG000|Overall Study|Lost to Follow-up|1|||
126264934|NCT00958126|454260708|FG001|Overall Study|Lost to Follow-up|5|||
126264935|NCT00958126|454260709|FG002|Overall Study|Lost to Follow-up|9|||
126452810|NCT01403948|454959006|FG007|Overall Study|Lost to Follow-up|0|||
126264936|NCT00958126|454260710|FG003|Overall Study|Lost to Follow-up|8|||
126264937|NCT00958126|454260711|FG004|Overall Study|Lost to Follow-up|0|||
126264938|NCT00958126|454260712|FG005|Overall Study|Lost to Follow-up|0|||
126264939|NCT00958126|454260713|FG006|Overall Study|Lost to Follow-up|0|||
126264940|NCT00958126|454260714|FG007|Overall Study|Lost to Follow-up|0|||
126264941|NCT00958126|454260707|FG000|Overall Study|Sponsor/Investigator decision|0|||
126264942|NCT00958126|454260708|FG001|Overall Study|Sponsor/Investigator decision|0|||
126264943|NCT00958126|454260709|FG002|Overall Study|Sponsor/Investigator decision|0|||
126264944|NCT00958126|454260710|FG003|Overall Study|Sponsor/Investigator decision|1|||
126264945|NCT00958126|454260711|FG004|Overall Study|Sponsor/Investigator decision|0|||
126264946|NCT00958126|454260712|FG005|Overall Study|Sponsor/Investigator decision|0|||
126264947|NCT00958126|454260713|FG006|Overall Study|Sponsor/Investigator decision|0|||
126264948|NCT00958126|454260714|FG007|Overall Study|Sponsor/Investigator decision|0|||
126264949|NCT00958126|454260707|FG000|Overall Study|Other Reason|0|||
126264950|NCT00958126|454260708|FG001|Overall Study|Other Reason|0|||
126264951|NCT00958126|454260709|FG002|Overall Study|Other Reason|0|||
126264952|NCT00958126|454260710|FG003|Overall Study|Other Reason|1|||
126764109|NCT03110107|456089050|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
126764110|NCT03110107|456089051|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
126764111|NCT03110107|456089052|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
126764112|NCT03110107|456089053|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
126764113|NCT03110107|456089054|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
126764114|NCT03110107|456089055|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
126264953|NCT00958126|454260711|FG004|Overall Study|Other Reason|0|||
126264954|NCT00958126|454260712|FG005|Overall Study|Other Reason|1|||
126264955|NCT00958126|454260713|FG006|Overall Study|Other Reason|0|||
126264956|NCT00958126|454260714|FG007|Overall Study|Other Reason|0|||
126264957|NCT03401073|454260715|FG000|Overall Study|Lost to Follow-up|1|||
126264958|NCT03401073|454260716|FG001|Overall Study|Lost to Follow-up|2|||
126264959|NCT01470612|454260717|FG000|Overall Study|Adverse Event|20|||
126264960|NCT01470612|454260718|FG001|Overall Study|Adverse Event|80|||
126264961|NCT01470612|454260717|FG000|Overall Study|Death|0|||
126264962|NCT01470612|454260718|FG001|Overall Study|Death|1|||
126264963|NCT01470612|454260717|FG000|Overall Study|Lack of Efficacy|20|||
126264964|NCT01470612|454260718|FG001|Overall Study|Lack of Efficacy|326|||
126264965|NCT01470612|454260717|FG000|Overall Study|Lost to Follow-up|2|||
126264966|NCT01470612|454260718|FG001|Overall Study|Lost to Follow-up|5|||
126264967|NCT01470612|454260717|FG000|Overall Study|Did not meet entrance criteria|0|||
126264968|NCT01470612|454260718|FG001|Overall Study|Did not meet entrance criteria|1|||
126264969|NCT01470612|454260717|FG000|Overall Study|Pregnancy|2|||
126264970|NCT01470612|454260718|FG001|Overall Study|Pregnancy|10|||
126264971|NCT01470612|454260717|FG000|Overall Study|Protocol Violation|2|||
126264972|NCT01470612|454260718|FG001|Overall Study|Protocol Violation|7|||
126264973|NCT01470612|454260717|FG000|Overall Study|Withdrawal by Subject|24|||
126264974|NCT01470612|454260718|FG001|Overall Study|Withdrawal by Subject|79|||
126264975|NCT01470612|454260717|FG000|Overall Study|Other|14|||
126264976|NCT01470612|454260718|FG001|Overall Study|Other|156|||
126264977|NCT02083926|454260722|FG000|Overall Study|Withdrawal by Subject|1|||
126264978|NCT02083926|454260723|FG001|Overall Study|Withdrawal by Subject|0|||
126264979|NCT03438227|454260724|FG000|Overall Study|Withdrawal by Subject|10|||
126264980|NCT03438227|454260725|FG001|Overall Study|Withdrawal by Subject|5|||
126264981|NCT01813071|454260726|FG000|Overall Study|Protocol Violation|0|||
126264982|NCT01813071|454260727|FG001|Overall Study|Protocol Violation|0|||
126264983|NCT01813071|454260728|FG002|Overall Study|Protocol Violation|0|||
126264984|NCT01813071|454260729|FG003|Overall Study|Protocol Violation|0|||
126264985|NCT01813071|454260730|FG004|Overall Study|Protocol Violation|1|||
126264986|NCT01813071|454260731|FG005|Overall Study|Protocol Violation|4|||
126264987|NCT01813071|454260732|FG006|Overall Study|Protocol Violation|2|||
126264988|NCT01813071|454260733|FG007|Overall Study|Protocol Violation|4|||
126264989|NCT01813071|454260734|FG008|Overall Study|Protocol Violation|2|||
126264990|NCT01813071|454260726|FG000|Overall Study|Withdrawal by Subject|0|||
126264991|NCT01813071|454260727|FG001|Overall Study|Withdrawal by Subject|0|||
126264992|NCT01813071|454260728|FG002|Overall Study|Withdrawal by Subject|0|||
126264993|NCT01813071|454260729|FG003|Overall Study|Withdrawal by Subject|0|||
126264994|NCT01813071|454260730|FG004|Overall Study|Withdrawal by Subject|0|||
126264995|NCT01813071|454260731|FG005|Overall Study|Withdrawal by Subject|1|||
126264996|NCT01813071|454260732|FG006|Overall Study|Withdrawal by Subject|0|||
126264997|NCT01813071|454260733|FG007|Overall Study|Withdrawal by Subject|0|||
126264998|NCT01813071|454260734|FG008|Overall Study|Withdrawal by Subject|0|||
126264999|NCT01813071|454260726|FG000|Overall Study|Adverse Event|0|||
126265000|NCT01813071|454260727|FG001|Overall Study|Adverse Event|0|||
126265001|NCT01813071|454260728|FG002|Overall Study|Adverse Event|0|||
126265002|NCT01813071|454260729|FG003|Overall Study|Adverse Event|0|||
126265003|NCT01813071|454260730|FG004|Overall Study|Adverse Event|0|||
126265004|NCT01813071|454260731|FG005|Overall Study|Adverse Event|1|||
126265005|NCT01813071|454260732|FG006|Overall Study|Adverse Event|0|||
126265006|NCT01813071|454260733|FG007|Overall Study|Adverse Event|0|||
126265007|NCT01813071|454260734|FG008|Overall Study|Adverse Event|0|||
126265008|NCT01813071|454260726|FG000|Overall Study|Physician Decision|0|||
126265009|NCT01813071|454260727|FG001|Overall Study|Physician Decision|0|||
126265010|NCT01813071|454260728|FG002|Overall Study|Physician Decision|0|||
126265011|NCT01813071|454260729|FG003|Overall Study|Physician Decision|0|||
126265012|NCT01813071|454260730|FG004|Overall Study|Physician Decision|0|||
126265013|NCT01813071|454260731|FG005|Overall Study|Physician Decision|0|||
126265014|NCT01813071|454260732|FG006|Overall Study|Physician Decision|1|||
126265015|NCT01813071|454260733|FG007|Overall Study|Physician Decision|0|||
126265016|NCT01813071|454260734|FG008|Overall Study|Physician Decision|0|||
126265017|NCT01813071|454260726|FG000|Overall Study|Met inc/exc criteria|0|||
126265018|NCT01813071|454260727|FG001|Overall Study|Met inc/exc criteria|0|||
126265019|NCT01813071|454260728|FG002|Overall Study|Met inc/exc criteria|0|||
126265020|NCT01813071|454260729|FG003|Overall Study|Met inc/exc criteria|0|||
126265021|NCT01813071|454260730|FG004|Overall Study|Met inc/exc criteria|0|||
126265022|NCT01813071|454260731|FG005|Overall Study|Met inc/exc criteria|1|||
126265023|NCT01813071|454260732|FG006|Overall Study|Met inc/exc criteria|0|||
126265024|NCT01813071|454260733|FG007|Overall Study|Met inc/exc criteria|1|||
126265025|NCT01813071|454260734|FG008|Overall Study|Met inc/exc criteria|1|||
126265026|NCT01660022|454260735|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
126265027|NCT01660022|454260736|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
126265028|NCT01660022|454260737|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
126265029|NCT01660022|454260738|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
126265030|NCT01660022|454260739|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
126265031|NCT01660022|454260740|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
126265032|NCT01660022|454260735|FG000|First Sequence (7 Days)|Adverse Event|0|||
126265033|NCT01660022|454260736|FG001|First Sequence (7 Days)|Adverse Event|0|||
126265034|NCT01660022|454260737|FG002|First Sequence (7 Days)|Adverse Event|0|||
126265035|NCT01660022|454260738|FG003|First Sequence (7 Days)|Adverse Event|0|||
126265036|NCT01660022|454260739|FG004|First Sequence (7 Days)|Adverse Event|1|||
126265037|NCT01660022|454260740|FG005|First Sequence (7 Days)|Adverse Event|3|||
126265038|NCT01660022|454260735|FG000|First Sequence (7 Days)|Protocol Violation|0|||
126265039|NCT01660022|454260736|FG001|First Sequence (7 Days)|Protocol Violation|0|||
126265040|NCT01660022|454260737|FG002|First Sequence (7 Days)|Protocol Violation|0|||
126265041|NCT01660022|454260738|FG003|First Sequence (7 Days)|Protocol Violation|0|||
126265042|NCT01660022|454260739|FG004|First Sequence (7 Days)|Protocol Violation|0|||
126265043|NCT01660022|454260740|FG005|First Sequence (7 Days)|Protocol Violation|1|||
126265044|NCT00094094|454260744|FG000|Overall Study|Death|2|||
126265045|NCT00094094|454260744|FG000|Overall Study|Lack of Efficacy|23|||
126265046|NCT00094094|454260744|FG000|Overall Study|Adverse Event|7|||
126265047|NCT01592721|454262784|FG000|Long-term Follow-up|Death|1|||
126265048|NCT02516410|454262785|FG000|Overall Study|Adverse Event|0|||
126265049|NCT02516410|454262786|FG001|Overall Study|Adverse Event|1|||
126265050|NCT02516410|454262785|FG000|Overall Study|Withdrawal by Subject|0|||
126265051|NCT02516410|454262786|FG001|Overall Study|Withdrawal by Subject|1|||
126265052|NCT01432574|454262787|FG000|Overall Study|Moved|2|||
126265053|NCT01432574|454262787|FG000|Overall Study|Not interested|1|||
126265054|NCT02698865|454262796|FG000|Overall Study|Other|11|||
126265055|NCT02698865|454262797|FG001|Overall Study|Other|11|||
126265056|NCT02698865|454262796|FG000|Overall Study|Withdrawal by Subject|20|||
126265057|NCT02698865|454262797|FG001|Overall Study|Withdrawal by Subject|16|||
126265058|NCT02698865|454262796|FG000|Overall Study|Physician Decision|0|||
126265059|NCT02698865|454262797|FG001|Overall Study|Physician Decision|4|||
126265060|NCT02698865|454262796|FG000|Overall Study|Lost to Follow-up|4|||
126265061|NCT02698865|454262797|FG001|Overall Study|Lost to Follow-up|2|||
126265062|NCT03861481|454262798|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
126265063|NCT03861481|454262799|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
126702831|NCT00684177|455860813|FG001|Overall Study|Physician Decision|0|||
126702832|NCT00684177|455860812|FG000|Overall Study|Withdrawal by Subject|1|||
126702833|NCT00684177|455860813|FG001|Overall Study|Withdrawal by Subject|2|||
126702834|NCT00684177|455860812|FG000|Overall Study|Other|1|||
126702835|NCT00684177|455860813|FG001|Overall Study|Other|2|||
126702836|NCT02031679|455863637|FG000|Overall Study|Protocol Violation|0|||
126702837|NCT02031679|455863638|FG001|Overall Study|Protocol Violation|1|||
126702838|NCT02031679|455863637|FG000|Overall Study|Lack of Efficacy|0|||
126265064|NCT03861481|454262798|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
126265065|NCT03861481|454262799|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
126265066|NCT03861481|454262798|FG000|Overall Study|Relapse|1|||
126265067|NCT03861481|454262799|FG001|Overall Study|Relapse|0|||
126265068|NCT03861481|454262798|FG000|Overall Study|Withdrawal by Subject|0|||
126265069|NCT03861481|454262799|FG001|Overall Study|Withdrawal by Subject|1|||
126265070|NCT03861481|454262798|FG000|Overall Study|Lack of Efficacy|4|||
126265071|NCT03861481|454262799|FG001|Overall Study|Lack of Efficacy|5|||
126265072|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
126702839|NCT02031679|455863638|FG001|Overall Study|Lack of Efficacy|1|||
126702840|NCT04030195|455863639|FG000|Overall Study|Withdrawal by Subject|2|||
126265073|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
126265074|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
126265075|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
126265076|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
126265077|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
126265078|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
126265079|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
126265080|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
126265081|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
126265082|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
126265083|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
126265084|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
126265085|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
126265086|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
126265087|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
126265088|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
126265089|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
126265090|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
126265091|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
126265092|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
126265093|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
126265094|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
126265095|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
126265096|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
126265097|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
126265098|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
126265099|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
126265100|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
126265101|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
126265102|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
126265103|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
126265104|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
126265105|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
126265106|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
126265107|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
126265108|NCT00773734|454262800|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
126265109|NCT00773734|454262801|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
126265110|NCT00773734|454262802|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
126265111|NCT00773734|454262803|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
126265112|NCT00773734|454262804|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
126265113|NCT00773734|454262805|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
126265114|NCT00773734|454262800|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
126265115|NCT00773734|454262801|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
126265116|NCT00773734|454262802|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
126265117|NCT00773734|454262803|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
126265118|NCT00773734|454262804|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
126265119|NCT00773734|454262805|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
126265120|NCT00773734|454262800|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
126265121|NCT00773734|454262801|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
126265122|NCT00773734|454262802|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
126265123|NCT00773734|454262803|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
126265124|NCT00773734|454262804|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
126265125|NCT00773734|454262805|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
126265126|NCT00773734|454262800|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
126265127|NCT00773734|454262801|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
126265128|NCT00773734|454262802|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
126265129|NCT00773734|454262803|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
126265130|NCT00773734|454262804|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
126265131|NCT00773734|454262805|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
126265132|NCT00773734|454262800|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
126360024|NCT01755156|454610721|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
126360025|NCT01755156|454610722|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
126265133|NCT00773734|454262801|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
126265134|NCT00773734|454262802|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
126764115|NCT03110107|456089056|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
126764116|NCT03110107|456089031|FG000|Treatment Period|Participant withdrew consent|0|||
126764117|NCT03110107|456089032|FG001|Treatment Period|Participant withdrew consent|0|||
126764118|NCT03110107|456089033|FG002|Treatment Period|Participant withdrew consent|1|||
126764119|NCT03110107|456089034|FG003|Treatment Period|Participant withdrew consent|0|||
126764120|NCT03110107|456089035|FG004|Treatment Period|Participant withdrew consent|4|||
126764121|NCT03110107|456089036|FG005|Treatment Period|Participant withdrew consent|3|||
126764122|NCT03110107|456089037|FG006|Treatment Period|Participant withdrew consent|0|||
126764123|NCT03110107|456089038|FG007|Treatment Period|Participant withdrew consent|0|||
126764124|NCT03110107|456089039|FG008|Treatment Period|Participant withdrew consent|0|||
126764125|NCT03110107|456089040|FG009|Treatment Period|Participant withdrew consent|1|||
126764126|NCT03110107|456089041|FG010|Treatment Period|Participant withdrew consent|0|||
126764127|NCT03110107|456089042|FG011|Treatment Period|Participant withdrew consent|0|||
126764128|NCT03110107|456089043|FG012|Treatment Period|Participant withdrew consent|0|||
126764129|NCT03110107|456089044|FG013|Treatment Period|Participant withdrew consent|0|||
126764130|NCT03110107|456089045|FG014|Treatment Period|Participant withdrew consent|0|||
126764131|NCT03110107|456089046|FG015|Treatment Period|Participant withdrew consent|0|||
126764132|NCT03110107|456089047|FG016|Treatment Period|Participant withdrew consent|0|||
126764133|NCT03110107|456089048|FG017|Treatment Period|Participant withdrew consent|0|||
126764134|NCT03110107|456089049|FG018|Treatment Period|Participant withdrew consent|0|||
126764135|NCT03110107|456089050|FG019|Treatment Period|Participant withdrew consent|1|||
126764136|NCT03110107|456089051|FG020|Treatment Period|Participant withdrew consent|0|||
126764137|NCT03110107|456089052|FG021|Treatment Period|Participant withdrew consent|2|||
126764138|NCT03110107|456089053|FG022|Treatment Period|Participant withdrew consent|0|||
126764139|NCT03110107|456089054|FG023|Treatment Period|Participant withdrew consent|0|||
126764140|NCT03110107|456089055|FG024|Treatment Period|Participant withdrew consent|0|||
126764141|NCT03110107|456089056|FG025|Treatment Period|Participant withdrew consent|2|||
126764142|NCT03110107|456089031|FG000|Treatment Period|Participants no longer meets study criteria|0|||
126764143|NCT03110107|456089032|FG001|Treatment Period|Participants no longer meets study criteria|0|||
126764144|NCT03110107|456089033|FG002|Treatment Period|Participants no longer meets study criteria|0|||
126764145|NCT03110107|456089034|FG003|Treatment Period|Participants no longer meets study criteria|0|||
126764146|NCT03110107|456089035|FG004|Treatment Period|Participants no longer meets study criteria|0|||
126764147|NCT03110107|456089036|FG005|Treatment Period|Participants no longer meets study criteria|0|||
126764148|NCT03110107|456089037|FG006|Treatment Period|Participants no longer meets study criteria|0|||
126764149|NCT03110107|456089038|FG007|Treatment Period|Participants no longer meets study criteria|0|||
126764150|NCT03110107|456089039|FG008|Treatment Period|Participants no longer meets study criteria|0|||
126452811|NCT01403948|454959007|FG008|Overall Study|Lost to Follow-up|0|||
126452812|NCT01403948|454959008|FG009|Overall Study|Lost to Follow-up|1|||
126452813|NCT01403948|454958999|FG000|Overall Study|Refused cont. medication|0|||
126452814|NCT01403948|454959000|FG001|Overall Study|Refused cont. medication|0|||
126452815|NCT01403948|454959001|FG002|Overall Study|Refused cont. medication|0|||
126452816|NCT01403948|454959002|FG003|Overall Study|Refused cont. medication|0|||
126764151|NCT03110107|456089040|FG009|Treatment Period|Participants no longer meets study criteria|0|||
126764152|NCT03110107|456089041|FG010|Treatment Period|Participants no longer meets study criteria|0|||
126764153|NCT03110107|456089042|FG011|Treatment Period|Participants no longer meets study criteria|0|||
126764154|NCT03110107|456089043|FG012|Treatment Period|Participants no longer meets study criteria|0|||
126764155|NCT03110107|456089044|FG013|Treatment Period|Participants no longer meets study criteria|0|||
126764156|NCT03110107|456089045|FG014|Treatment Period|Participants no longer meets study criteria|0|||
126764157|NCT03110107|456089046|FG015|Treatment Period|Participants no longer meets study criteria|0|||
126764158|NCT03110107|456089047|FG016|Treatment Period|Participants no longer meets study criteria|0|||
126265135|NCT00773734|454262803|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
126265136|NCT00773734|454262804|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
126265137|NCT00773734|454262805|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
126452817|NCT01403948|454959003|FG004|Overall Study|Refused cont. medication|1|||
126265138|NCT00773734|454262800|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
126265139|NCT00773734|454262801|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
126265140|NCT00773734|454262802|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
126265141|NCT00773734|454262803|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
126265142|NCT00773734|454262804|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
126265143|NCT00773734|454262805|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
126265144|NCT00773734|454262800|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
126265145|NCT00773734|454262801|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
126265146|NCT00773734|454262802|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
126265147|NCT00773734|454262803|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
126265148|NCT00773734|454262804|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
126265149|NCT00773734|454262805|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
126452818|NCT01403948|454959004|FG005|Overall Study|Refused cont. medication|0|||
126360026|NCT01755156|454610721|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
126360027|NCT01755156|454610722|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
126360028|NCT01755156|454610721|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
126360029|NCT01755156|454610722|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
126360030|NCT00090402|454610723|FG000|Overall Study|Death|1|||
126360031|NCT00090402|454610724|FG001|Overall Study|Death|1|||
126360032|NCT00090402|454610725|FG002|Overall Study|Death|0|||
126360033|NCT00090402|454610723|FG000|Overall Study|subject moved|0|||
126360034|NCT00090402|454610724|FG001|Overall Study|subject moved|1|||
126360035|NCT00090402|454610725|FG002|Overall Study|subject moved|0|||
126360036|NCT00090402|454610723|FG000|Overall Study|stopped taking study medication|1|||
126360037|NCT00090402|454610724|FG001|Overall Study|stopped taking study medication|0|||
126360038|NCT00090402|454610725|FG002|Overall Study|stopped taking study medication|1|||
126360039|NCT01530256|454610728|FG000|Overall Study|Death|2|||
126360040|NCT02004275|454610730|FG000|Phase 1|Ineligible|0|||
126360041|NCT02004275|454610731|FG001|Phase 1|Ineligible|0|||
126360042|NCT02004275|454610732|FG002|Phase 1|Ineligible|0|||
126360043|NCT02004275|454610733|FG003|Phase 1|Ineligible|1|||
126360044|NCT02004275|454610734|FG004|Phase 1|Ineligible|1|||
126360045|NCT02004275|454610735|FG005|Phase 1|Ineligible|0|||
126360046|NCT02004275|454610730|FG000|Phase 1|Protocol Violation|0|||
126360047|NCT02004275|454610731|FG001|Phase 1|Protocol Violation|0|||
126360048|NCT02004275|454610732|FG002|Phase 1|Protocol Violation|0|||
126360049|NCT02004275|454610733|FG003|Phase 1|Protocol Violation|1|||
126360050|NCT02004275|454610734|FG004|Phase 1|Protocol Violation|0|||
126360051|NCT02004275|454610735|FG005|Phase 1|Protocol Violation|5|||
126360052|NCT02004275|454610730|FG000|Phase 2 Part 1|Ineligible|6|||
126360053|NCT02004275|454610731|FG001|Phase 2 Part 1|Ineligible|9|||
126360054|NCT02004275|454610732|FG002|Phase 2 Part 1|Ineligible|0|||
126360055|NCT02004275|454610733|FG003|Phase 2 Part 1|Ineligible|0|||
126360056|NCT02004275|454610734|FG004|Phase 2 Part 1|Ineligible|0|||
126360057|NCT02004275|454610735|FG005|Phase 2 Part 1|Ineligible|0|||
126360058|NCT02004275|454610730|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
126360059|NCT02004275|454610731|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
126360060|NCT02004275|454610732|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
126360061|NCT02004275|454610733|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
126360062|NCT02004275|454610734|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
126702841|NCT04030195|455863640|FG001|Overall Study|Withdrawal by Subject|0|||
126702842|NCT04030195|455863641|FG002|Overall Study|Withdrawal by Subject|0|||
126702843|NCT01024244|455863642|FG000|Overall Study|Adverse Event|1|||
126702844|NCT01024244|455863643|FG001|Overall Study|Adverse Event|2|||
126702845|NCT01024244|455863644|FG002|Overall Study|Adverse Event|0|||
126702846|NCT01024244|455863645|FG003|Overall Study|Adverse Event|1|||
126702847|NCT01024244|455863646|FG004|Overall Study|Adverse Event|2|||
126702848|NCT01024244|455863642|FG000|Overall Study|Entry Criteria Not Met|0|||
126702849|NCT01024244|455863643|FG001|Overall Study|Entry Criteria Not Met|1|||
126702850|NCT01024244|455863644|FG002|Overall Study|Entry Criteria Not Met|0|||
126702851|NCT01024244|455863645|FG003|Overall Study|Entry Criteria Not Met|0|||
126702852|NCT01024244|455863646|FG004|Overall Study|Entry Criteria Not Met|0|||
126702853|NCT01024244|455863642|FG000|Overall Study|Lack of Efficacy|1|||
126702854|NCT01024244|455863643|FG001|Overall Study|Lack of Efficacy|0|||
126702855|NCT01024244|455863644|FG002|Overall Study|Lack of Efficacy|0|||
126702856|NCT01024244|455863645|FG003|Overall Study|Lack of Efficacy|0|||
126702857|NCT01024244|455863646|FG004|Overall Study|Lack of Efficacy|0|||
126702858|NCT01024244|455863642|FG000|Overall Study|Protocol Violation|1|||
126702859|NCT01024244|455863643|FG001|Overall Study|Protocol Violation|0|||
126702860|NCT01024244|455863644|FG002|Overall Study|Protocol Violation|0|||
126702861|NCT01024244|455863645|FG003|Overall Study|Protocol Violation|0|||
126702862|NCT01024244|455863646|FG004|Overall Study|Protocol Violation|2|||
126702863|NCT01024244|455863642|FG000|Overall Study|Sponsor Decision|14|||
126702864|NCT01024244|455863643|FG001|Overall Study|Sponsor Decision|7|||
126702865|NCT01024244|455863644|FG002|Overall Study|Sponsor Decision|14|||
126702866|NCT01024244|455863645|FG003|Overall Study|Sponsor Decision|12|||
126702867|NCT01024244|455863646|FG004|Overall Study|Sponsor Decision|10|||
126702868|NCT01024244|455863642|FG000|Overall Study|Withdrawal by Subject|0|||
126702869|NCT01024244|455863643|FG001|Overall Study|Withdrawal by Subject|1|||
126702870|NCT01024244|455863644|FG002|Overall Study|Withdrawal by Subject|0|||
126360063|NCT02004275|454610735|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
126360064|NCT00292370|454610736|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
126360065|NCT00292370|454610737|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
126360066|NCT00292370|454610738|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
126360067|NCT00292370|454610736|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
126702871|NCT01024244|455863645|FG003|Overall Study|Withdrawal by Subject|0|||
126702872|NCT01024244|455863646|FG004|Overall Study|Withdrawal by Subject|0|||
126702873|NCT02660580|455863650|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
126360068|NCT00292370|454610737|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
126360069|NCT00292370|454610738|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
126702874|NCT02660580|455863651|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
126547228|NCT01225822|455296181|FG001|Overall Study|Withdrawal by Subject|7|||
126547229|NCT01225822|455296182|FG002|Overall Study|Withdrawal by Subject|7|||
126547230|NCT01225822|455296183|FG003|Overall Study|Withdrawal by Subject|11|||
126764159|NCT03110107|456089048|FG017|Treatment Period|Participants no longer meets study criteria|0|||
126764160|NCT03110107|456089049|FG018|Treatment Period|Participants no longer meets study criteria|0|||
126265150|NCT00773734|454262800|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
126265151|NCT00773734|454262801|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
126265152|NCT00773734|454262802|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
126265153|NCT00773734|454262803|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
126265154|NCT00773734|454262804|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
126265155|NCT00773734|454262805|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
126265156|NCT00773734|454262800|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
126265157|NCT00773734|454262801|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
126265158|NCT00773734|454262802|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
126265159|NCT00773734|454262803|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
126265160|NCT00773734|454262804|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
126265161|NCT00773734|454262805|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
126265162|NCT00773734|454262800|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
126265163|NCT00773734|454262801|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
126265164|NCT00773734|454262802|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
126265165|NCT00773734|454262803|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
126265166|NCT00773734|454262804|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
126265167|NCT00773734|454262805|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
126265168|NCT00773734|454262800|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
126265169|NCT00773734|454262801|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
126265170|NCT00773734|454262802|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
126265171|NCT00773734|454262803|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
126265172|NCT00773734|454262804|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
126265173|NCT00773734|454262805|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
126265174|NCT00773734|454262800|FG000|Extension: Active Treatment Week 24-52|Other|0|||
126265175|NCT00773734|454262801|FG001|Extension: Active Treatment Week 24-52|Other|0|||
126265176|NCT00773734|454262802|FG002|Extension: Active Treatment Week 24-52|Other|1|||
126265177|NCT00773734|454262803|FG003|Extension: Active Treatment Week 24-52|Other|2|||
126265178|NCT00773734|454262804|FG004|Extension: Active Treatment Week 24-52|Other|0|||
126265179|NCT00773734|454262805|FG005|Extension: Active Treatment Week 24-52|Other|1|||
126265180|NCT00773734|454262800|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
126265181|NCT00773734|454262801|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
126265182|NCT00773734|454262802|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
126265183|NCT00773734|454262803|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
126265184|NCT00773734|454262804|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
126265185|NCT00773734|454262805|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
126265186|NCT00773734|454262800|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
126265187|NCT00773734|454262801|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
126265188|NCT00773734|454262802|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
126265189|NCT00773734|454262803|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
126265190|NCT00773734|454262804|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
126265191|NCT00773734|454262805|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
126265192|NCT00773734|454262800|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
126265193|NCT00773734|454262801|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
126265194|NCT00773734|454262802|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
126265195|NCT00773734|454262803|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
126265196|NCT00773734|454262804|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
126360070|NCT00292370|454610736|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
126764161|NCT03110107|456089050|FG019|Treatment Period|Participants no longer meets study criteria|0|||
126764162|NCT03110107|456089051|FG020|Treatment Period|Participants no longer meets study criteria|0|||
126764163|NCT03110107|456089052|FG021|Treatment Period|Participants no longer meets study criteria|0|||
126764164|NCT03110107|456089053|FG022|Treatment Period|Participants no longer meets study criteria|0|||
126265197|NCT00773734|454262805|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
126265198|NCT00773734|454262800|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
126265199|NCT00773734|454262801|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
126265200|NCT00773734|454262802|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
126265201|NCT00773734|454262803|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
126360071|NCT00292370|454610737|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
126360072|NCT00292370|454610738|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
126265202|NCT00773734|454262804|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
126265203|NCT00773734|454262805|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
126265204|NCT01220297|454262808|FG000|Overall Study|Death|2|||
126702875|NCT02660580|455863652|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
126702876|NCT02660580|455863653|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
126702877|NCT02660580|455863654|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
126702878|NCT02660580|455863650|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
126702879|NCT02660580|455863651|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
126702880|NCT02660580|455863652|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
126702881|NCT02660580|455863653|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
126702882|NCT02660580|455863654|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
126702883|NCT02660580|455863650|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
126702884|NCT02660580|455863651|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
126702885|NCT02660580|455863652|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
126702886|NCT02660580|455863653|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
126702887|NCT02660580|455863654|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
126702888|NCT02660580|455863650|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
126702889|NCT02660580|455863651|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
126702890|NCT02660580|455863652|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
126702891|NCT02660580|455863653|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
126702892|NCT02660580|455863654|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
126702893|NCT02660580|455863650|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
126702894|NCT02660580|455863651|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
126702895|NCT02660580|455863652|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
126702896|NCT02660580|455863653|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
126702897|NCT02660580|455863654|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
126702898|NCT02660580|455863650|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
126702899|NCT02660580|455863651|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
126702900|NCT02660580|455863652|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
126702901|NCT02660580|455863653|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
126702902|NCT02660580|455863654|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
126702903|NCT02660580|455863650|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
126265205|NCT01220297|454262808|FG000|Overall Study|Lost to Follow-up|1|||
126265206|NCT01287039|454262809|FG000|Overall Study|Noncompliance with study procedures|0|||
126265207|NCT01287039|454262810|FG001|Overall Study|Noncompliance with study procedures|1|||
126265208|NCT01287039|454262809|FG000|Overall Study|Change of location/residence|0|||
126265209|NCT01287039|454262810|FG001|Overall Study|Change of location/residence|3|||
126265210|NCT01287039|454262809|FG000|Overall Study|Elective surgery|0|||
126265211|NCT01287039|454262810|FG001|Overall Study|Elective surgery|1|||
126265212|NCT01287039|454262809|FG000|Overall Study|Protocol Violation|2|||
126265213|NCT01287039|454262810|FG001|Overall Study|Protocol Violation|3|||
126265214|NCT01287039|454262809|FG000|Overall Study|Excluded medication taken|1|||
126265215|NCT01287039|454262810|FG001|Overall Study|Excluded medication taken|0|||
126265216|NCT01287039|454262809|FG000|Overall Study|Noncompliance with study medication|0|||
126265217|NCT01287039|454262810|FG001|Overall Study|Noncompliance with study medication|1|||
126265218|NCT01287039|454262809|FG000|Overall Study|Problem with travel|0|||
126265219|NCT01287039|454262810|FG001|Overall Study|Problem with travel|1|||
126265220|NCT01287039|454262809|FG000|Overall Study|Death|1|||
126265221|NCT01287039|454262810|FG001|Overall Study|Death|0|||
126265222|NCT01287039|454262809|FG000|Overall Study|Change of residence|1|||
126265223|NCT01287039|454262810|FG001|Overall Study|Change of residence|0|||
126265224|NCT01287039|454262809|FG000|Overall Study|Adverse Event|7|||
126265225|NCT01287039|454262810|FG001|Overall Study|Adverse Event|4|||
126265226|NCT01287039|454262809|FG000|Overall Study|Withdrawal by Subject|14|||
126265227|NCT01287039|454262810|FG001|Overall Study|Withdrawal by Subject|11|||
126265228|NCT01287039|454262809|FG000|Overall Study|Lost to Follow-up|3|||
126265229|NCT01287039|454262810|FG001|Overall Study|Lost to Follow-up|2|||
126265230|NCT00099268|454262811|FG000|Overall Study|Withdrawal by Subject|46|||
126265231|NCT00099268|454262812|FG001|Overall Study|Withdrawal by Subject|28|||
126265232|NCT00099268|454262811|FG000|Overall Study|Adverse Event|19|||
126265233|NCT00099268|454262812|FG001|Overall Study|Adverse Event|19|||
126265234|NCT00099268|454262811|FG000|Overall Study|Protocol Violation|9|||
126702904|NCT02660580|455863651|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
126702905|NCT02660580|455863652|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
126764165|NCT03110107|456089054|FG023|Treatment Period|Participants no longer meets study criteria|1|||
126547231|NCT01225822|455296184|FG004|Overall Study|Withdrawal by Subject|6|||
126547232|NCT01225822|455296180|FG000|Overall Study|Other|13|||
126265235|NCT00099268|454262812|FG001|Overall Study|Protocol Violation|8|||
126265236|NCT00099268|454262811|FG000|Overall Study|Lost to Follow-up|6|||
126265237|NCT00099268|454262812|FG001|Overall Study|Lost to Follow-up|4|||
126265238|NCT00099268|454262811|FG000|Overall Study|Lack of Efficacy|5|||
126265239|NCT00099268|454262812|FG001|Overall Study|Lack of Efficacy|18|||
126265240|NCT00099268|454262811|FG000|Overall Study|Administrative problems|4|||
126547233|NCT01225822|455296181|FG001|Overall Study|Other|10|||
126452819|NCT01403948|454959005|FG006|Overall Study|Refused cont. medication|0|||
126265241|NCT00099268|454262812|FG001|Overall Study|Administrative problems|4|||
126265242|NCT00099268|454262811|FG000|Overall Study|Death|3|||
126265243|NCT00099268|454262812|FG001|Overall Study|Death|1|||
126265244|NCT05016622|454262813|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
126265245|NCT05016622|454262813|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
126265246|NCT02581163|454262815|FG000|Overall Study|Failure to return|15|||
126265247|NCT02581163|454262815|FG000|Overall Study|Insufficient virological response|3|||
126265248|NCT02581163|454262815|FG000|Overall Study|Withdrew consent|1|||
126265249|NCT02581163|454262815|FG000|Overall Study|Death|1|||
126265250|NCT02581163|454262815|FG000|Overall Study|Other, not specified|9|||
126265251|NCT03438396|454262816|FG000|Overall Study|Reason Not Specified|9|||
126265252|NCT03438396|454262816|FG000|Overall Study|Withdrawal by Subject|5|||
126265253|NCT03438396|454262816|FG000|Overall Study|Lost to Follow-up|2|||
126265254|NCT03438396|454262816|FG000|Overall Study|Death|85|||
126265255|NCT03438396|454262816|FG000|Overall Study|Not treated|1|||
126265256|NCT02006628|454262817|FG000|Overall Study|Adverse Event|1|||
126265257|NCT02006628|454262818|FG001|Overall Study|Adverse Event|1|||
126265258|NCT02006628|454262817|FG000|Overall Study|Withdrawal by Subject|2|||
126265259|NCT02006628|454262818|FG001|Overall Study|Withdrawal by Subject|1|||
126265260|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
126265261|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
126265262|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
126265263|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
126265264|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
126265265|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
126265266|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
126265267|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
126265268|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
126265269|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
126265270|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
126452820|NCT01403948|454959006|FG007|Overall Study|Refused cont. medication|0|||
126452821|NCT01403948|454959007|FG008|Overall Study|Refused cont. medication|0|||
126452822|NCT01403948|454959008|FG009|Overall Study|Refused cont. medication|1|||
126452823|NCT01403948|454958999|FG000|Overall Study|other than above|1|||
126452824|NCT01403948|454959000|FG001|Overall Study|other than above|2|||
126452825|NCT01403948|454959001|FG002|Overall Study|other than above|1|||
126452826|NCT01403948|454959002|FG003|Overall Study|other than above|0|||
126452827|NCT01403948|454959003|FG004|Overall Study|other than above|1|||
126452828|NCT01403948|454959004|FG005|Overall Study|other than above|1|||
126452829|NCT01403948|454959005|FG006|Overall Study|other than above|2|||
126452830|NCT01403948|454959006|FG007|Overall Study|other than above|0|||
126452831|NCT01403948|454959007|FG008|Overall Study|other than above|0|||
126452832|NCT01403948|454959008|FG009|Overall Study|other than above|0|||
126452833|NCT05498701|454959009|FG000|Period 3|Adverse Event|1|||
126547234|NCT01225822|455296182|FG002|Overall Study|Other|7|||
126547235|NCT01225822|455296183|FG003|Overall Study|Other|10|||
126547236|NCT01225822|455296184|FG004|Overall Study|Other|7|||
126547237|NCT04078035|455296185|FG000|Session 2|Lost to Follow-up|3|||
126547238|NCT04078035|455296186|FG001|Session 2|Lost to Follow-up|1|||
126547239|NCT04078035|455296185|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
126702906|NCT02660580|455863653|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
126702907|NCT02660580|455863654|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
126702908|NCT02660580|455863650|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
126702909|NCT02660580|455863651|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
126702910|NCT02660580|455863652|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
126702911|NCT02660580|455863653|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
126702912|NCT02660580|455863654|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
126702913|NCT02660580|455863650|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
126702914|NCT02660580|455863651|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
126702915|NCT02660580|455863652|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
126702916|NCT02660580|455863653|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
126764166|NCT03110107|456089055|FG024|Treatment Period|Participants no longer meets study criteria|0|||
126265271|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
126265272|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
126265273|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
126265274|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
126265275|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
126265276|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
126452834|NCT05498701|454959010|FG001|Period 3|Adverse Event|0|||
126452835|NCT00006409|454959014|FG000|Baseline|Protocol Violation|48|||
126452836|NCT00006409|454959015|FG001|Baseline|Protocol Violation|70|||
126452837|NCT00006409|454959016|FG002|Baseline|Protocol Violation|0|||
126702917|NCT02660580|455863654|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
126702918|NCT02660580|455863650|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
126702919|NCT02660580|455863651|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
126702920|NCT02660580|455863652|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
126702921|NCT02660580|455863653|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
126702922|NCT02660580|455863654|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
126702923|NCT02660580|455863650|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
126702924|NCT02660580|455863651|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
126702925|NCT02660580|455863652|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
126702926|NCT02660580|455863653|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
126702927|NCT02660580|455863654|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
126702928|NCT02660580|455863650|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
126702929|NCT02660580|455863651|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
126702930|NCT02660580|455863652|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
126702931|NCT02660580|455863653|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
126702932|NCT02660580|455863654|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
126702933|NCT02660580|455863650|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
126702934|NCT02660580|455863651|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
126702935|NCT02660580|455863652|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
126702936|NCT02660580|455863653|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
126702937|NCT02660580|455863654|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
126702938|NCT00377962|455863655|FG000|Core Study: 0-12 Months|Adverse Event|18|||
126702939|NCT00377962|455863656|FG001|Core Study: 0-12 Months|Adverse Event|2|||
126702940|NCT00377962|455863655|FG000|Core Study: 0-12 Months|Death|3|||
126702941|NCT00377962|455863656|FG001|Core Study: 0-12 Months|Death|0|||
126265277|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
126265278|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
126702942|NCT00377962|455863655|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
126702943|NCT00377962|455863656|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
126702944|NCT00377962|455863655|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
126702945|NCT00377962|455863656|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
126702946|NCT00377962|455863655|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
126702947|NCT00377962|455863656|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
126702948|NCT00377962|455863655|FG000|Extension Study: 12-24 Months|Death|1|||
126265279|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
126265280|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
126265281|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
126265282|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
126265283|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
126265284|NCT01421342|454262819|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
126265285|NCT01421342|454262820|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
126265286|NCT01421342|454262821|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
126265287|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
126265288|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
126702949|NCT00377962|455863656|FG001|Extension Study: 12-24 Months|Death|1|||
126702950|NCT00377962|455863655|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
126702951|NCT00377962|455863656|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
126702952|NCT00377962|455863655|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
126702953|NCT00377962|455863656|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
126702954|NCT00377962|455863655|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
126702955|NCT00377962|455863656|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
126702956|NCT01381094|455863662|FG000|Overall Study|Adverse Event|1|||
126702957|NCT01381094|455863663|FG001|Overall Study|Adverse Event|2|||
126702958|NCT01381094|455863664|FG002|Overall Study|Adverse Event|0|||
126702959|NCT01381094|455863665|FG003|Overall Study|Adverse Event|1|||
126702960|NCT01381094|455863666|FG004|Overall Study|Adverse Event|0|||
126702961|NCT01381094|455863662|FG000|Overall Study|Lost to Follow-up|0|||
126702962|NCT01381094|455863663|FG001|Overall Study|Lost to Follow-up|0|||
126702963|NCT01381094|455863664|FG002|Overall Study|Lost to Follow-up|0|||
126702964|NCT01381094|455863665|FG003|Overall Study|Lost to Follow-up|0|||
126702965|NCT01381094|455863666|FG004|Overall Study|Lost to Follow-up|1|||
126702966|NCT01381094|455863662|FG000|Overall Study|Withdrawal of informed consent|0|||
126702967|NCT01381094|455863663|FG001|Overall Study|Withdrawal of informed consent|1|||
126702968|NCT01381094|455863664|FG002|Overall Study|Withdrawal of informed consent|0|||
126702969|NCT01381094|455863665|FG003|Overall Study|Withdrawal of informed consent|0|||
126702970|NCT01381094|455863666|FG004|Overall Study|Withdrawal of informed consent|0|||
126265289|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
126702971|NCT01381094|455863662|FG000|Overall Study|Participant given Aranesp injection|1|||
126702972|NCT01381094|455863663|FG001|Overall Study|Participant given Aranesp injection|0|||
126764167|NCT03110107|456089056|FG025|Treatment Period|Participants no longer meets study criteria|0|||
126764168|NCT03110107|456089031|FG000|Treatment Period|Other Reasons|0|||
126764169|NCT03110107|456089032|FG001|Treatment Period|Other Reasons|0|||
126360073|NCT00292370|454610736|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
126360074|NCT00292370|454610737|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
126360075|NCT00292370|454610738|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
126360076|NCT00292370|454610736|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
126360077|NCT00292370|454610737|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
126360078|NCT00292370|454610738|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
126360079|NCT00292370|454610736|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
126360080|NCT00292370|454610737|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
126360081|NCT00292370|454610738|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
126360082|NCT04821245|454610740|FG000|Overall Study|Withdrawal by Subject|3|||
126360083|NCT04821245|454610740|FG000|Overall Study|Physician Decision|1|||
126360084|NCT04821245|454610740|FG000|Overall Study|Protocol Violation|5|||
126360085|NCT01133977|454610743|FG000|Overall Study|Adverse Event|0|||
126360086|NCT01133977|454610744|FG001|Overall Study|Adverse Event|0|||
126360087|NCT01133977|454610745|FG002|Overall Study|Adverse Event|1|||
126360088|NCT01133977|454610746|FG003|Overall Study|Adverse Event|0|||
126360089|NCT01133977|454610747|FG004|Overall Study|Adverse Event|0|||
126360090|NCT01133977|454610743|FG000|Overall Study|Death|1|||
126547240|NCT04078035|455296186|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
126547241|NCT05644353|455296189|FG000|Overall Study|Physician Decision|1|||
126547242|NCT05644353|455296190|FG001|Overall Study|Physician Decision|0|||
126547243|NCT05644353|455296191|FG002|Overall Study|Physician Decision|0|||
126547244|NCT05644353|455296192|FG003|Overall Study|Physician Decision|0|||
126547245|NCT05644353|455296193|FG004|Overall Study|Physician Decision|0|||
126547246|NCT05644353|455296194|FG005|Overall Study|Physician Decision|0|||
126547247|NCT05644353|455296189|FG000|Overall Study|Protocol Violation|1|||
126547248|NCT05644353|455296190|FG001|Overall Study|Protocol Violation|0|||
126547249|NCT05644353|455296191|FG002|Overall Study|Protocol Violation|0|||
126547250|NCT05644353|455296192|FG003|Overall Study|Protocol Violation|0|||
126547251|NCT05644353|455296193|FG004|Overall Study|Protocol Violation|0|||
126547252|NCT05644353|455296194|FG005|Overall Study|Protocol Violation|0|||
126547253|NCT05644353|455296189|FG000|Overall Study|Withdrawal by Subject|0|||
126547254|NCT05644353|455296190|FG001|Overall Study|Withdrawal by Subject|2|||
126547255|NCT05644353|455296191|FG002|Overall Study|Withdrawal by Subject|0|||
126547256|NCT05644353|455296192|FG003|Overall Study|Withdrawal by Subject|0|||
126547257|NCT05644353|455296193|FG004|Overall Study|Withdrawal by Subject|1|||
126547258|NCT05644353|455296194|FG005|Overall Study|Withdrawal by Subject|0|||
126547259|NCT05644353|455296189|FG000|Overall Study|Lost to Follow-up|0|||
126547260|NCT05644353|455296190|FG001|Overall Study|Lost to Follow-up|0|||
126547261|NCT05644353|455296191|FG002|Overall Study|Lost to Follow-up|1|||
126547262|NCT05644353|455296192|FG003|Overall Study|Lost to Follow-up|0|||
126547263|NCT05644353|455296193|FG004|Overall Study|Lost to Follow-up|0|||
126360091|NCT01133977|454610744|FG001|Overall Study|Death|1|||
126360092|NCT01133977|454610745|FG002|Overall Study|Death|1|||
126360093|NCT01133977|454610746|FG003|Overall Study|Death|7|||
126360094|NCT01133977|454610747|FG004|Overall Study|Death|3|||
126360095|NCT01133977|454610743|FG000|Overall Study|Started a New Line of Therapy|2|||
126360096|NCT01133977|454610744|FG001|Overall Study|Started a New Line of Therapy|6|||
126360097|NCT01133977|454610745|FG002|Overall Study|Started a New Line of Therapy|4|||
126360098|NCT01133977|454610746|FG003|Overall Study|Started a New Line of Therapy|25|||
126360099|NCT01133977|454610747|FG004|Overall Study|Started a New Line of Therapy|33|||
126360100|NCT01133977|454610743|FG000|Overall Study|Lost to Follow-up|0|||
126360101|NCT01133977|454610744|FG001|Overall Study|Lost to Follow-up|0|||
126360102|NCT01133977|454610745|FG002|Overall Study|Lost to Follow-up|0|||
126547264|NCT05644353|455296194|FG005|Overall Study|Lost to Follow-up|0|||
126547265|NCT01407354|455296195|FG000|First Intervention|Withdrawal by Subject|0|||
126547266|NCT01407354|455296196|FG001|First Intervention|Withdrawal by Subject|2|||
126547267|NCT01407354|455296195|FG000|First Intervention|Adverse Event|1|||
126764170|NCT03110107|456089033|FG002|Treatment Period|Other Reasons|1|||
126764171|NCT03110107|456089034|FG003|Treatment Period|Other Reasons|1|||
126764172|NCT03110107|456089035|FG004|Treatment Period|Other Reasons|0|||
126360103|NCT01133977|454610746|FG003|Overall Study|Lost to Follow-up|2|||
126360104|NCT01133977|454610747|FG004|Overall Study|Lost to Follow-up|1|||
126360105|NCT01133977|454610743|FG000|Overall Study|Withdrawal by Subject|0|||
126547268|NCT01407354|455296196|FG001|First Intervention|Adverse Event|0|||
126547269|NCT01407354|455296195|FG000|First Intervention|Physician Decision|1|||
126360106|NCT01133977|454610744|FG001|Overall Study|Withdrawal by Subject|0|||
126764173|NCT03110107|456089036|FG005|Treatment Period|Other Reasons|1|||
126360107|NCT01133977|454610745|FG002|Overall Study|Withdrawal by Subject|0|||
126360108|NCT01133977|454610746|FG003|Overall Study|Withdrawal by Subject|5|||
126547270|NCT01407354|455296196|FG001|First Intervention|Physician Decision|0|||
126547271|NCT02204579|455296197|FG000|Overall Study|Screen failures|2|||
126764174|NCT03110107|456089037|FG006|Treatment Period|Other Reasons|0|||
126702973|NCT01381094|455863664|FG002|Overall Study|Participant given Aranesp injection|0|||
126702974|NCT01381094|455863665|FG003|Overall Study|Participant given Aranesp injection|0|||
126702975|NCT01381094|455863666|FG004|Overall Study|Participant given Aranesp injection|0|||
126702976|NCT02665689|455863667|FG000|Overall Study|Adverse Event|1|||
126702977|NCT02665689|455863668|FG001|Overall Study|Adverse Event|0|||
126702978|NCT02665689|455863667|FG000|Overall Study|Trial termination|1|||
126702979|NCT02665689|455863668|FG001|Overall Study|Trial termination|1|||
126702980|NCT02665689|455863667|FG000|Overall Study|Lost to Follow-up|0|||
126702981|NCT02665689|455863668|FG001|Overall Study|Lost to Follow-up|1|||
126702982|NCT00486902|455863669|FG000|Overall Study|Withdrawal by Subject|1|||
126702983|NCT00486902|455863670|FG001|Overall Study|Withdrawal by Subject|2|||
126702984|NCT00486902|455863669|FG000|Overall Study|decision for postpartum tubal ligation|3|||
126702985|NCT00486902|455863670|FG001|Overall Study|decision for postpartum tubal ligation|1|||
126702986|NCT00486902|455863669|FG000|Overall Study|spinal anesthetic protocal violation|1|||
126702987|NCT00486902|455863670|FG001|Overall Study|spinal anesthetic protocal violation|1|||
126702988|NCT00486902|455863669|FG000|Overall Study|Did not meet inclusion criteria|1|||
126702989|NCT00486902|455863670|FG001|Overall Study|Did not meet inclusion criteria|0|||
126702990|NCT00486902|455863669|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
126702991|NCT00486902|455863670|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
126702992|NCT00541307|455863673|FG000|Overall Study|Death|5|||
126702993|NCT00541307|455863673|FG000|Overall Study|Physician Decision|3|||
126702994|NCT00541307|455863673|FG000|Overall Study|Withdrawal by Subject|6|||
126702995|NCT00541307|455863673|FG000|Overall Study|Lost to Follow-up|4|||
126702996|NCT00541307|455863673|FG000|Overall Study|Subject returned early (outside window)|1|||
126702997|NCT00541307|455863673|FG000|Overall Study|Surgical Bypass|5|||
126702998|NCT02455557|455863674|FG000|Overall Study|Withdrawal by Subject|2|||
126702999|NCT03615222|455863675|FG000|Overall Study|Ineligible|26|||
126703000|NCT03615222|455863675|FG000|Overall Study|Withdrawal by Subject|7|||
126703001|NCT03615222|455863675|FG000|Overall Study|Death|1|||
126703002|NCT02900092|455863676|FG000|Overall Study|Adverse Event|1|||
126703003|NCT03895203|455863677|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
126703004|NCT03895203|455863678|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
126703005|NCT03895203|455863679|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
126703006|NCT03895203|455863680|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
126703007|NCT03895203|455863681|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
126265290|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
126265291|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
126265292|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
126265293|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
126265294|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
126265295|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
126265296|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
126547272|NCT02778399|455296198|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
126547273|NCT02778399|455296199|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
126360109|NCT01133977|454610747|FG004|Overall Study|Withdrawal by Subject|1|||
126360110|NCT00662038|454610752|FG000|Overall Study|Reason not specified|3|||
126547274|NCT02778399|455296200|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
126547275|NCT02778399|455296201|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
126547276|NCT02778399|455296202|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
126547277|NCT02778399|455296203|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
126547278|NCT02778399|455296198|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
126547279|NCT02778399|455296199|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
126547280|NCT02778399|455296200|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
126547281|NCT02778399|455296201|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
126547282|NCT02778399|455296202|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
126547283|NCT02778399|455296203|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
126547284|NCT02778399|455296198|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
126547285|NCT02778399|455296199|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
126547286|NCT02778399|455296200|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
126547287|NCT02778399|455296201|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
126547288|NCT02778399|455296202|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
126547289|NCT02778399|455296203|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
126547290|NCT02778399|455296198|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
126547291|NCT02778399|455296199|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
126703008|NCT03895203|455863682|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
126703009|NCT03895203|455863677|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
126360111|NCT00662038|454610752|FG000|Overall Study|Withdrawn consent|22|||
126360112|NCT00662038|454610752|FG000|Overall Study|Withdrawal by Subject|83|||
126360113|NCT00662038|454610752|FG000|Overall Study|Sponsor decision|1|||
126703010|NCT03895203|455863678|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
126703011|NCT03895203|455863679|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
126703012|NCT03895203|455863680|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
126703013|NCT03895203|455863681|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
126703014|NCT03895203|455863682|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
126703015|NCT03895203|455863677|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
126703016|NCT03895203|455863678|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
126703017|NCT03895203|455863679|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
126703018|NCT03895203|455863680|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
126703019|NCT03895203|455863681|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
126703020|NCT03895203|455863682|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
126703021|NCT03895203|455863677|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
126703022|NCT03895203|455863678|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
126703023|NCT03895203|455863679|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
126703024|NCT03895203|455863680|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
126703025|NCT03895203|455863681|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
126703026|NCT03895203|455863682|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
126703027|NCT03895203|455863677|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
126703028|NCT03895203|455863678|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
126703029|NCT03895203|455863679|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
126703030|NCT03895203|455863680|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
126703031|NCT03895203|455863681|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
126703032|NCT03895203|455863682|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
126703033|NCT03895203|455863677|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
126703034|NCT03895203|455863678|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
126703035|NCT03895203|455863679|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
126703036|NCT03895203|455863680|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
126703037|NCT03895203|455863681|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
126703038|NCT03895203|455863682|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
126703039|NCT03895203|455863677|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
126703040|NCT03895203|455863678|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
126703041|NCT03895203|455863679|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
126703042|NCT03895203|455863680|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
126703043|NCT03895203|455863681|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
126703044|NCT03895203|455863682|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
126703045|NCT03895203|455863677|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
126703046|NCT03895203|455863678|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
126703047|NCT03895203|455863679|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
126703048|NCT03895203|455863680|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
126703049|NCT03895203|455863681|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
126703050|NCT03895203|455863682|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
126703051|NCT03895203|455863677|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
126703052|NCT03895203|455863678|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
126703053|NCT03895203|455863679|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
126703054|NCT03895203|455863680|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
126703055|NCT03895203|455863681|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
126703056|NCT03895203|455863682|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
126703057|NCT03895203|455863677|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
126703058|NCT03895203|455863678|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
126703059|NCT03895203|455863679|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
126703060|NCT03895203|455863680|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
126703061|NCT03895203|455863681|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
126703062|NCT03895203|455863682|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
126703063|NCT03895203|455863677|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
126703064|NCT03895203|455863678|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
126703065|NCT03895203|455863679|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
126703066|NCT03895203|455863680|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
126703067|NCT03895203|455863681|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
126703068|NCT03895203|455863682|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
126703069|NCT03895203|455863677|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
126452838|NCT00006409|454959017|FG003|Baseline|Protocol Violation|0|||
126452839|NCT00006409|454959018|FG004|Baseline|Protocol Violation|0|||
126452840|NCT00006409|454959019|FG005|Baseline|Protocol Violation|0|||
126265297|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
126265298|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
126265299|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
126452841|NCT00006409|454959014|FG000|Post-2 Year Intervention|Protocol Violation|0|||
126547292|NCT02778399|455296200|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
126547293|NCT02778399|455296201|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
126547294|NCT02778399|455296202|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
126547295|NCT02778399|455296203|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
126547296|NCT02778399|455296198|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
126547297|NCT02778399|455296199|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
126547298|NCT02778399|455296200|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
126547299|NCT02778399|455296201|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
126547300|NCT02778399|455296202|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
126547301|NCT02778399|455296203|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
126547302|NCT02778399|455296198|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
126265300|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
126265301|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
126265302|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
126265303|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
126265304|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
126265305|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
126265306|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
126265307|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
126265308|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
126265309|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
126265310|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
126265311|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
126265312|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
126265313|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
126547303|NCT02778399|455296199|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
126547304|NCT02778399|455296200|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
126547305|NCT02778399|455296201|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
126360114|NCT00662038|454610752|FG000|Overall Study|Physician Decision|19|||
126360115|NCT00662038|454610752|FG000|Overall Study|Lung transplantation|44|||
126360116|NCT00662038|454610752|FG000|Overall Study|Lost to Follow-up|1|||
126360117|NCT00662038|454610752|FG000|Overall Study|Death|95|||
126360118|NCT00662038|454610752|FG000|Overall Study|Adverse Event|358|||
126360119|NCT00662038|454610752|FG000|Overall Study|Continued treatment|5|||
126547306|NCT02778399|455296202|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
126547307|NCT02778399|455296203|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
126547308|NCT02778399|455296198|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
126360120|NCT00397046|454610753|FG000|Overall Study|Disease Progression|3|||
126547309|NCT02778399|455296199|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
126547310|NCT02778399|455296200|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
126547311|NCT02778399|455296201|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
126547312|NCT02778399|455296202|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
126547313|NCT02778399|455296203|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
126547314|NCT02778399|455296198|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
126703070|NCT03895203|455863678|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
126703071|NCT03895203|455863679|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
126703072|NCT03895203|455863680|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
126703073|NCT03895203|455863681|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
126703074|NCT03895203|455863682|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
126703075|NCT03895203|455863677|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
126703076|NCT03895203|455863678|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
126703077|NCT03895203|455863679|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
126703078|NCT03895203|455863680|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
126703079|NCT03895203|455863681|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
126703080|NCT03895203|455863682|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
126703081|NCT03895203|455863677|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
126703082|NCT03895203|455863678|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
126703083|NCT03895203|455863679|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
126703084|NCT03895203|455863680|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
126703085|NCT03895203|455863681|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
126703086|NCT03895203|455863682|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
126703087|NCT00996840|455863683|FG000|Overall Study|Adverse Event|0|||
126703088|NCT00996840|455863684|FG001|Overall Study|Adverse Event|1|||
126703089|NCT00996840|455863685|FG002|Overall Study|Adverse Event|0|||
126703090|NCT00996840|455863686|FG003|Overall Study|Adverse Event|0|||
126265314|NCT01421342|454262819|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
126265315|NCT01421342|454262820|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
126265316|NCT01421342|454262821|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
126265317|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
126265318|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
126265319|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
126265320|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
126265321|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
126265322|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
126265323|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
126265324|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
126265325|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
126265326|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
126265327|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
126265328|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
126265329|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
126265330|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
126265331|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
126265332|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
126265333|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
126265334|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
126265335|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
126265336|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
126265337|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
126265338|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
126265339|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
126265340|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
126265341|NCT01421342|454262819|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
126265342|NCT01421342|454262820|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
126265343|NCT01421342|454262821|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
126265344|NCT03578237|454262822|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
126265345|NCT03578237|454262823|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
126265346|NCT02488330|454262824|FG000|Overall Study|Adverse Event|1|||
126265347|NCT02488330|454262824|FG000|Overall Study|Physician Decision|2|||
126265348|NCT02488330|454262824|FG000|Overall Study|Death|2|||
126265349|NCT02488330|454262824|FG000|Overall Study|Disease Progression|3|||
126265350|NCT02488330|454262824|FG000|Overall Study|Study Termination by Sponsor|4|||
126265351|NCT01206816|454262826|FG000|Overall Study|Protocol Violation|0|||
126265352|NCT01206816|454262827|FG001|Overall Study|Protocol Violation|0|||
126265353|NCT01206816|454262828|FG002|Overall Study|Protocol Violation|1|||
126265354|NCT01206816|454262829|FG003|Overall Study|Protocol Violation|0|||
126452842|NCT00006409|454959015|FG001|Post-2 Year Intervention|Protocol Violation|0|||
126452843|NCT00006409|454959016|FG002|Post-2 Year Intervention|Protocol Violation|251|||
126452844|NCT00006409|454959017|FG003|Post-2 Year Intervention|Protocol Violation|168|||
126452845|NCT00006409|454959018|FG004|Post-2 Year Intervention|Protocol Violation|0|||
126452846|NCT00006409|454959019|FG005|Post-2 Year Intervention|Protocol Violation|0|||
126452847|NCT00006409|454959014|FG000|Post-3 Year Intervention|Protocol Violation|0|||
126703091|NCT00996840|455863687|FG004|Overall Study|Adverse Event|0|||
126703092|NCT00996840|455863683|FG000|Overall Study|Physician Decision|0|||
126703093|NCT00996840|455863684|FG001|Overall Study|Physician Decision|0|||
126703094|NCT00996840|455863685|FG002|Overall Study|Physician Decision|1|||
126703095|NCT00996840|455863686|FG003|Overall Study|Physician Decision|1|||
126703096|NCT00996840|455863687|FG004|Overall Study|Physician Decision|2|||
126703097|NCT00996840|455863683|FG000|Overall Study|Withdrawal by Subject|1|||
126703098|NCT00996840|455863684|FG001|Overall Study|Withdrawal by Subject|1|||
126703099|NCT00996840|455863685|FG002|Overall Study|Withdrawal by Subject|0|||
126703100|NCT00996840|455863686|FG003|Overall Study|Withdrawal by Subject|0|||
126703101|NCT00996840|455863687|FG004|Overall Study|Withdrawal by Subject|0|||
126703102|NCT04645797|455863688|FG000|Overall Study|Disease Progression|3|||
126703103|NCT04645797|455863689|FG001|Overall Study|Disease Progression|3|||
126703104|NCT04645797|455863690|FG002|Overall Study|Disease Progression|1|||
126703105|NCT04645797|455863691|FG003|Overall Study|Disease Progression|0|||
126452848|NCT00006409|454959015|FG001|Post-3 Year Intervention|Protocol Violation|0|||
126452849|NCT00006409|454959016|FG002|Post-3 Year Intervention|Protocol Violation|0|||
126703106|NCT04645797|455863692|FG004|Overall Study|Disease Progression|0|||
126703107|NCT04645797|455863693|FG005|Overall Study|Disease Progression|0|||
126703108|NCT04645797|455863694|FG006|Overall Study|Disease Progression|0|||
126703109|NCT04645797|455863688|FG000|Overall Study|Death|3|||
126703110|NCT04645797|455863689|FG001|Overall Study|Death|1|||
126360121|NCT00397046|454610754|FG001|Overall Study|Disease Progression|3|||
126360122|NCT00397046|454610755|FG002|Overall Study|Disease Progression|10|||
126360123|NCT00397046|454610756|FG003|Overall Study|Disease Progression|5|||
126360124|NCT00604383|454610765|FG000|Overall Study|Withdrawal by Subject|33|||
126360125|NCT00604383|454610766|FG001|Overall Study|Withdrawal by Subject|31|||
126360126|NCT00604383|454610765|FG000|Overall Study|Lost to Follow-up|24|||
126360127|NCT00604383|454610766|FG001|Overall Study|Lost to Follow-up|19|||
126360128|NCT00604383|454610765|FG000|Overall Study|Death|14|||
126360129|NCT00604383|454610766|FG001|Overall Study|Death|22|||
126452850|NCT00006409|454959017|FG003|Post-3 Year Intervention|Protocol Violation|0|||
126452851|NCT00006409|454959018|FG004|Post-3 Year Intervention|Protocol Violation|62|||
126452852|NCT00006409|454959019|FG005|Post-3 Year Intervention|Protocol Violation|62|||
126764175|NCT03110107|456089038|FG007|Treatment Period|Other Reasons|0|||
126764176|NCT03110107|456089039|FG008|Treatment Period|Other Reasons|0|||
126764177|NCT03110107|456089040|FG009|Treatment Period|Other Reasons|0|||
126764178|NCT03110107|456089041|FG010|Treatment Period|Other Reasons|0|||
126764179|NCT03110107|456089042|FG011|Treatment Period|Other Reasons|0|||
126764180|NCT03110107|456089043|FG012|Treatment Period|Other Reasons|0|||
126764181|NCT03110107|456089044|FG013|Treatment Period|Other Reasons|0|||
126764182|NCT03110107|456089045|FG014|Treatment Period|Other Reasons|0|||
126764183|NCT03110107|456089046|FG015|Treatment Period|Other Reasons|0|||
126764184|NCT03110107|456089047|FG016|Treatment Period|Other Reasons|0|||
126764185|NCT03110107|456089048|FG017|Treatment Period|Other Reasons|0|||
126764186|NCT03110107|456089049|FG018|Treatment Period|Other Reasons|0|||
126764187|NCT03110107|456089050|FG019|Treatment Period|Other Reasons|0|||
126764188|NCT03110107|456089051|FG020|Treatment Period|Other Reasons|0|||
126764189|NCT03110107|456089052|FG021|Treatment Period|Other Reasons|0|||
126764190|NCT03110107|456089053|FG022|Treatment Period|Other Reasons|0|||
126764191|NCT03110107|456089054|FG023|Treatment Period|Other Reasons|0|||
126764192|NCT03110107|456089055|FG024|Treatment Period|Other Reasons|1|||
126764193|NCT03110107|456089056|FG025|Treatment Period|Other Reasons|0|||
126764194|NCT03526549|456089058|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
126764195|NCT03526549|456089059|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
126764196|NCT03526549|456089058|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
126764197|NCT03526549|456089059|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
126764198|NCT03526549|456089058|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
126764199|NCT03526549|456089059|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
126764200|NCT03526549|456089058|FG000|Open-label Phase|Adverse Event|4|||
126764201|NCT03526549|456089059|FG001|Open-label Phase|Adverse Event|0|||
126764202|NCT03526549|456089058|FG000|Open-label Phase|Withdrawal by Subject|54|||
126764203|NCT03526549|456089059|FG001|Open-label Phase|Withdrawal by Subject|0|||
126764204|NCT03526549|456089058|FG000|Open-label Phase|Lost to Follow-up|35|||
126764205|NCT03526549|456089059|FG001|Open-label Phase|Lost to Follow-up|0|||
126764206|NCT03526549|456089058|FG000|Open-label Phase|Other than Specified|5|||
126764207|NCT03526549|456089059|FG001|Open-label Phase|Other than Specified|0|||
126764208|NCT05981365|456089066|FG000|Period 1|Adverse Event|1|||
126764209|NCT05981365|456089067|FG001|Period 1|Adverse Event|0|||
126764210|NCT04780776|456089068|FG000|Titration Week 1-5|Lost to Follow-up|2|||
126764211|NCT04780776|456089069|FG001|Titration Week 1-5|Lost to Follow-up|8|||
126764212|NCT04780776|456089068|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
126764213|NCT04780776|456089069|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
126764214|NCT04780776|456089068|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
126764215|NCT04780776|456089069|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
126764216|NCT03113760|456089070|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
126764217|NCT03113760|456089071|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
126452853|NCT00638183|454959020|FG000|Overall Study|Adverse Event|23|||
126452854|NCT00638183|454959020|FG000|Overall Study|Lack of Efficacy|14|||
126452855|NCT00638183|454959020|FG000|Overall Study|Physician Decision|9|||
126452856|NCT00638183|454959020|FG000|Overall Study|Lost to Follow-up|46|||
126452857|NCT00638183|454959020|FG000|Overall Study|Other reason not defined above|27|||
126452858|NCT02350764|454959021|FG000|Overall Study|Adverse Event|4|||
126764218|NCT03113760|456089072|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
126764219|NCT03113760|456089073|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
126764220|NCT03113760|456089070|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
126360130|NCT00604383|454610765|FG000|Overall Study|Adverse Event|16|||
126360131|NCT00604383|454610766|FG001|Overall Study|Adverse Event|9|||
126360132|NCT00604383|454610765|FG000|Overall Study|Physician Decision|0|||
126360133|NCT00604383|454610766|FG001|Overall Study|Physician Decision|3|||
126360134|NCT00474968|454610769|FG000|Overall Study|Withdrawal by Subject|8|||
126360135|NCT00474968|454610770|FG001|Overall Study|Withdrawal by Subject|7|||
126764221|NCT03113760|456089071|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
126764222|NCT03113760|456089072|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
126764223|NCT03113760|456089073|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
126764224|NCT03113760|456089070|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
126360136|NCT00474968|454610769|FG000|Overall Study|Protocol Violation|9|||
126452859|NCT02350764|454959021|FG000|Overall Study|Death|3|||
126265355|NCT01206816|454262830|FG004|Overall Study|Protocol Violation|0|||
126265356|NCT01206816|454262831|FG005|Overall Study|Protocol Violation|0|||
126265357|NCT01206816|454262832|FG006|Overall Study|Protocol Violation|0|||
126265358|NCT01206816|454262826|FG000|Overall Study|Withdrawal by Subject|0|||
126265359|NCT01206816|454262827|FG001|Overall Study|Withdrawal by Subject|0|||
126265360|NCT01206816|454262828|FG002|Overall Study|Withdrawal by Subject|1|||
126265361|NCT01206816|454262829|FG003|Overall Study|Withdrawal by Subject|0|||
126265362|NCT01206816|454262830|FG004|Overall Study|Withdrawal by Subject|0|||
126265363|NCT01206816|454262831|FG005|Overall Study|Withdrawal by Subject|0|||
126265364|NCT01206816|454262832|FG006|Overall Study|Withdrawal by Subject|0|||
126265365|NCT01206816|454262826|FG000|Overall Study|Progressive disease|3|||
126265366|NCT01206816|454262827|FG001|Overall Study|Progressive disease|3|||
126265367|NCT01206816|454262828|FG002|Overall Study|Progressive disease|13|||
126265368|NCT01206816|454262829|FG003|Overall Study|Progressive disease|3|||
126265369|NCT01206816|454262830|FG004|Overall Study|Progressive disease|3|||
126265370|NCT01206816|454262831|FG005|Overall Study|Progressive disease|16|||
126265371|NCT01206816|454262832|FG006|Overall Study|Progressive disease|3|||
126265372|NCT01206816|454262826|FG000|Overall Study|Other AE|0|||
126265373|NCT01206816|454262827|FG001|Overall Study|Other AE|0|||
126265374|NCT01206816|454262828|FG002|Overall Study|Other AE|4|||
126265375|NCT01206816|454262829|FG003|Overall Study|Other AE|0|||
126265376|NCT01206816|454262830|FG004|Overall Study|Other AE|0|||
126265377|NCT01206816|454262831|FG005|Overall Study|Other AE|3|||
126265378|NCT01206816|454262832|FG006|Overall Study|Other AE|2|||
126265379|NCT01206816|454262826|FG000|Overall Study|other than stated above|0|||
126265380|NCT01206816|454262827|FG001|Overall Study|other than stated above|0|||
126265381|NCT01206816|454262828|FG002|Overall Study|other than stated above|1|||
126265382|NCT01206816|454262829|FG003|Overall Study|other than stated above|0|||
126703111|NCT04645797|455863690|FG002|Overall Study|Death|0|||
126265383|NCT01206816|454262830|FG004|Overall Study|other than stated above|0|||
126265384|NCT01206816|454262831|FG005|Overall Study|other than stated above|0|||
126265385|NCT01206816|454262832|FG006|Overall Study|other than stated above|1|||
126265386|NCT02493777|454262835|FG000|Overall Study|Lost to Follow-up|0|||
126265387|NCT02493777|454262836|FG001|Overall Study|Lost to Follow-up|1|||
126265388|NCT01642914|454262837|FG000|Overall Study|Adverse Event|11|||
126265389|NCT01642914|454262838|FG001|Overall Study|Adverse Event|7|||
126265390|NCT01642914|454262839|FG002|Overall Study|Adverse Event|15|||
126265391|NCT01642914|454262837|FG000|Overall Study|Lack of Efficacy|9|||
126265392|NCT01642914|454262838|FG001|Overall Study|Lack of Efficacy|4|||
126265393|NCT01642914|454262839|FG002|Overall Study|Lack of Efficacy|2|||
126265394|NCT01642914|454262837|FG000|Overall Study|Protocol Violation|15|||
126265395|NCT01642914|454262838|FG001|Overall Study|Protocol Violation|13|||
126265396|NCT01642914|454262839|FG002|Overall Study|Protocol Violation|6|||
126265397|NCT01642914|454262837|FG000|Overall Study|Withdrawal by Subject|5|||
126265398|NCT01642914|454262838|FG001|Overall Study|Withdrawal by Subject|5|||
126265399|NCT01642914|454262839|FG002|Overall Study|Withdrawal by Subject|10|||
126265400|NCT01642914|454262837|FG000|Overall Study|Lost to Follow-up|5|||
126265401|NCT01642914|454262838|FG001|Overall Study|Lost to Follow-up|3|||
126265402|NCT01642914|454262839|FG002|Overall Study|Lost to Follow-up|7|||
126265403|NCT01642914|454262837|FG000|Overall Study|Other Reason|1|||
126265404|NCT01642914|454262838|FG001|Overall Study|Other Reason|0|||
126265405|NCT01642914|454262839|FG002|Overall Study|Other Reason|0|||
126360137|NCT00474968|454610770|FG001|Overall Study|Protocol Violation|8|||
126360138|NCT00474968|454610769|FG000|Overall Study|Sample not collected|1|||
126360139|NCT00474968|454610770|FG001|Overall Study|Sample not collected|1|||
126360140|NCT00281580|454610771|FG000|Overall Study|Adverse Event|2|||
126360141|NCT00281580|454610772|FG001|Overall Study|Adverse Event|0|||
126360142|NCT00281580|454610773|FG002|Overall Study|Adverse Event|2|||
126360143|NCT00281580|454610774|FG003|Overall Study|Adverse Event|4|||
126360144|NCT00281580|454610775|FG004|Overall Study|Adverse Event|1|||
126360145|NCT00281580|454610776|FG005|Overall Study|Adverse Event|0|||
126360146|NCT00281580|454610777|FG006|Overall Study|Adverse Event|1|||
126360147|NCT00281580|454610778|FG007|Overall Study|Adverse Event|0|||
126360148|NCT00281580|454610779|FG008|Overall Study|Adverse Event|1|||
126360149|NCT00281580|454610780|FG009|Overall Study|Adverse Event|6|||
126360150|NCT00281580|454610781|FG010|Overall Study|Adverse Event|0|||
126360151|NCT00281580|454610782|FG011|Overall Study|Adverse Event|5|||
126360152|NCT00281580|454610783|FG012|Overall Study|Adverse Event|8|||
126360153|NCT00281580|454610784|FG013|Overall Study|Adverse Event|2|||
126360154|NCT00281580|454610785|FG014|Overall Study|Adverse Event|3|||
126360155|NCT00281580|454610786|FG015|Overall Study|Adverse Event|3|||
126360156|NCT00281580|454610771|FG000|Overall Study|Protocol Violation|0|||
126360157|NCT00281580|454610772|FG001|Overall Study|Protocol Violation|0|||
126360158|NCT00281580|454610773|FG002|Overall Study|Protocol Violation|1|||
126360159|NCT00281580|454610774|FG003|Overall Study|Protocol Violation|1|||
126360160|NCT00281580|454610775|FG004|Overall Study|Protocol Violation|0|||
126360161|NCT00281580|454610776|FG005|Overall Study|Protocol Violation|0|||
126360162|NCT00281580|454610777|FG006|Overall Study|Protocol Violation|1|||
126360163|NCT00281580|454610778|FG007|Overall Study|Protocol Violation|0|||
126360164|NCT00281580|454610779|FG008|Overall Study|Protocol Violation|2|||
126265406|NCT01705236|454262840|FG000|Overall Study|Lost to Follow-up|1|||
126265407|NCT01705236|454262840|FG000|Overall Study|Administrative problems|2|||
126265408|NCT01705236|454262840|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
126265409|NCT01705236|454262840|FG000|Overall Study|Protocol Violation|3|||
126265410|NCT01705236|454262840|FG000|Overall Study|Abnormal test procedure result(s)|4|||
126265411|NCT01705236|454262840|FG000|Overall Study|Abnormal laboratory value(s)|4|||
126265412|NCT01705236|454262840|FG000|Overall Study|Withdrawal by Subject|5|||
126265413|NCT01705236|454262840|FG000|Overall Study|Adverse Event|5|||
126265414|NCT00171301|454262841|FG000|Overall Study|Death|1|||
126265415|NCT00171301|454262842|FG001|Overall Study|Death|2|||
126265416|NCT00171301|454262841|FG000|Overall Study|Adverse Event|1|||
126265417|NCT00171301|454262842|FG001|Overall Study|Adverse Event|2|||
126265418|NCT00171301|454262841|FG000|Overall Study|Lost to Follow-up|6|||
126265419|NCT00171301|454262842|FG001|Overall Study|Lost to Follow-up|2|||
126265420|NCT00171301|454262841|FG000|Overall Study|Protocol Violation|0|||
126265421|NCT00171301|454262842|FG001|Overall Study|Protocol Violation|2|||
126265422|NCT00171301|454262841|FG000|Overall Study|Withdrawal by Subject|0|||
126265423|NCT00171301|454262842|FG001|Overall Study|Withdrawal by Subject|1|||
126265424|NCT04319159|454262843|FG000|Overall Study|Screening failure|13|||
126265425|NCT04319159|454262843|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
126265426|NCT04319159|454262843|FG000|Overall Study|Withdrawal by Subject|1|||
126452860|NCT02350764|454959021|FG000|Overall Study|Physician Decision|2|||
126452861|NCT02350764|454959021|FG000|Overall Study|Withdrawal by Subject|2|||
126452862|NCT03531632|454959022|FG000|Overall Study|Adverse Event|0|||
126452863|NCT03531632|454959023|FG001|Overall Study|Adverse Event|0|||
126703112|NCT04645797|455863691|FG003|Overall Study|Death|0|||
126703113|NCT04645797|455863692|FG004|Overall Study|Death|0|||
126703114|NCT04645797|455863693|FG005|Overall Study|Death|0|||
126703115|NCT04645797|455863694|FG006|Overall Study|Death|0|||
126703116|NCT01485614|455863696|FG000|Randomization|Not Treated|1|||
126703117|NCT01485614|455863697|FG001|Randomization|Not Treated|0|||
126703118|NCT01485614|455863698|FG002|Randomization|Not Treated|0|||
126703119|NCT01485614|455863699|FG003|Randomization|Not Treated|0|||
126703120|NCT01485614|455863696|FG000|Weeks 0-20|Lost to Follow-up|2|||
126703121|NCT01485614|455863697|FG001|Weeks 0-20|Lost to Follow-up|0|||
126703122|NCT01485614|455863698|FG002|Weeks 0-20|Lost to Follow-up|0|||
126703123|NCT01485614|455863699|FG003|Weeks 0-20|Lost to Follow-up|0|||
126703124|NCT01485614|455863696|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
126703125|NCT01485614|455863697|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
126703126|NCT01485614|455863698|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
126703127|NCT01485614|455863699|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
126703128|NCT01485614|455863696|FG000|Weeks 0-20|Withdrawal by Subject|3|||
126703129|NCT01485614|455863697|FG001|Weeks 0-20|Withdrawal by Subject|2|||
126703130|NCT01485614|455863698|FG002|Weeks 0-20|Withdrawal by Subject|1|||
126703131|NCT01485614|455863699|FG003|Weeks 0-20|Withdrawal by Subject|0|||
126703132|NCT01485614|455863696|FG000|Weeks 20-54|Lost to Follow-up|4|||
126703133|NCT01485614|455863697|FG001|Weeks 20-54|Lost to Follow-up|3|||
126703134|NCT01485614|455863698|FG002|Weeks 20-54|Lost to Follow-up|1|||
126703135|NCT01485614|455863699|FG003|Weeks 20-54|Lost to Follow-up|0|||
126703136|NCT01485614|455863696|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
126703137|NCT01485614|455863697|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
126703138|NCT01485614|455863698|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
126703139|NCT01485614|455863699|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
126703140|NCT01485614|455863696|FG000|Weeks 20-54|Withdrawal by Subject|5|||
126703141|NCT01485614|455863697|FG001|Weeks 20-54|Withdrawal by Subject|3|||
126703142|NCT01485614|455863698|FG002|Weeks 20-54|Withdrawal by Subject|0|||
126703143|NCT01485614|455863699|FG003|Weeks 20-54|Withdrawal by Subject|0|||
126703144|NCT02582515|455863700|FG000|Overall Study|Withdrawal by Subject|0|||
126703145|NCT02582515|455863701|FG001|Overall Study|Withdrawal by Subject|1|||
126703146|NCT00775021|455863702|FG000|First Intervention|Lost to Follow-up|1|||
126703147|NCT00775021|455863703|FG001|First Intervention|Lost to Follow-up|0|||
126703148|NCT00775021|455863702|FG000|Second Intervention|Adverse Event|0|||
126703149|NCT00775021|455863703|FG001|Second Intervention|Adverse Event|1|||
126703150|NCT00833092|455863708|FG000|Overall Study|Withdrawal by Subject|2|||
126703151|NCT00833092|455863709|FG001|Overall Study|Withdrawal by Subject|3|||
126703152|NCT00833092|455863708|FG000|Overall Study|Protocol Violation|2|||
126703153|NCT00833092|455863709|FG001|Overall Study|Protocol Violation|1|||
126703154|NCT00833092|455863708|FG000|Overall Study|Diarrhea|0|||
126703155|NCT00833092|455863709|FG001|Overall Study|Diarrhea|2|||
126703156|NCT00833092|455863708|FG000|Overall Study|constipation|0|||
126703157|NCT00833092|455863709|FG001|Overall Study|constipation|1|||
126265427|NCT02100319|454262844|FG000|Overall Study|Case Report Forms Uncollected|11|||
126265428|NCT02100319|454262844|FG000|Overall Study|Protocol Deviation|5|||
126265429|NCT02370914|454262845|FG000|Overall Study|Protocol Violation|2|||
126265430|NCT00754442|454262846|FG000|Overall Study|Withdrawal by Subject|5|||
126265431|NCT00754442|454262847|FG001|Overall Study|Withdrawal by Subject|3|||
126452864|NCT03531632|454959024|FG002|Overall Study|Adverse Event|1|||
126703158|NCT00699192|455863710|FG000|Overall Study|Missing|1|||
126703159|NCT00699192|455863711|FG001|Overall Study|Missing|1|||
126703160|NCT00699192|455863712|FG002|Overall Study|Missing|1|||
126547315|NCT02778399|455296199|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
126703161|NCT00699192|455863710|FG000|Overall Study|Adverse Event|9|||
126703162|NCT00699192|455863711|FG001|Overall Study|Adverse Event|4|||
126703163|NCT00699192|455863712|FG002|Overall Study|Adverse Event|3|||
126703164|NCT00699192|455863710|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126703165|NCT00699192|455863711|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126703166|NCT00699192|455863712|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126703167|NCT00699192|455863710|FG000|Overall Study|Lack of Efficacy|0|||
126703168|NCT00699192|455863711|FG001|Overall Study|Lack of Efficacy|0|||
126703169|NCT00699192|455863712|FG002|Overall Study|Lack of Efficacy|1|||
126703170|NCT00699192|455863710|FG000|Overall Study|Withdrawal by Subject|3|||
126703171|NCT00699192|455863711|FG001|Overall Study|Withdrawal by Subject|2|||
126703172|NCT00699192|455863712|FG002|Overall Study|Withdrawal by Subject|4|||
126703173|NCT00699192|455863710|FG000|Overall Study|Administrative problems|1|||
126703174|NCT00699192|455863711|FG001|Overall Study|Administrative problems|3|||
126703175|NCT00699192|455863712|FG002|Overall Study|Administrative problems|1|||
126703176|NCT00699192|455863710|FG000|Overall Study|Protocol Violation|2|||
126703177|NCT00699192|455863711|FG001|Overall Study|Protocol Violation|2|||
126703178|NCT00699192|455863712|FG002|Overall Study|Protocol Violation|0|||
126703179|NCT04919564|455863717|FG000|Overall Study|Lost to Follow-up|1|||
126703180|NCT04919564|455863718|FG001|Overall Study|Lost to Follow-up|0|||
126703181|NCT04919564|455863717|FG000|Overall Study|Physician Decision|1|||
126703182|NCT04919564|455863718|FG001|Overall Study|Physician Decision|1|||
126703183|NCT01241786|455863719|FG000|Overall Study|Lack of Efficacy|5|||
126703184|NCT01025635|455863727|FG000|Overall Study|Withdrawal by Subject|6|||
126703185|NCT01025635|455863728|FG001|Overall Study|Withdrawal by Subject|7|||
126703186|NCT01025635|455863727|FG000|Overall Study|Protocol Violation|4|||
126703187|NCT01025635|455863728|FG001|Overall Study|Protocol Violation|2|||
126703188|NCT01025635|455863727|FG000|Overall Study|Lack of Efficacy|0|||
126703189|NCT01025635|455863728|FG001|Overall Study|Lack of Efficacy|1|||
126703190|NCT01025635|455863727|FG000|Overall Study|Lost to Follow-up|9|||
126703191|NCT01025635|455863728|FG001|Overall Study|Lost to Follow-up|13|||
126703192|NCT01025635|455863727|FG000|Overall Study|Reason not known|4|||
126703193|NCT01025635|455863728|FG001|Overall Study|Reason not known|2|||
126703194|NCT00727402|455863729|FG000|Overall Study|Physician Decision|116|||
126703195|NCT00929240|455863730|FG000|Initial Treatment Phase|Adverse Event|31|||
126703196|NCT00929240|455863731|FG001|Initial Treatment Phase|Adverse Event|0|||
126703197|NCT00929240|455863732|FG002|Initial Treatment Phase|Adverse Event|0|||
126703198|NCT00929240|455863730|FG000|Initial Treatment Phase|Disease progression|41|||
126703199|NCT00929240|455863731|FG001|Initial Treatment Phase|Disease progression|0|||
126703200|NCT00929240|455863732|FG002|Initial Treatment Phase|Disease progression|0|||
126703201|NCT00929240|455863730|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
126703202|NCT00929240|455863731|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
126703203|NCT00929240|455863732|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
126703204|NCT00929240|455863730|FG000|Initial Treatment Phase|Protocol Violation|5|||
126703205|NCT00929240|455863731|FG001|Initial Treatment Phase|Protocol Violation|0|||
126703206|NCT00929240|455863732|FG002|Initial Treatment Phase|Protocol Violation|0|||
126703207|NCT00929240|455863730|FG000|Initial Treatment Phase|Death|2|||
126703208|NCT00929240|455863731|FG001|Initial Treatment Phase|Death|0|||
126703209|NCT00929240|455863732|FG002|Initial Treatment Phase|Death|0|||
126703210|NCT00929240|455863730|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
126703211|NCT00929240|455863731|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
126703212|NCT00929240|455863732|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
126703213|NCT00929240|455863730|FG000|Initial Treatment Phase|Physician Decision|4|||
126703214|NCT00929240|455863731|FG001|Initial Treatment Phase|Physician Decision|0|||
126703215|NCT00929240|455863732|FG002|Initial Treatment Phase|Physician Decision|0|||
126703216|NCT00929240|455863730|FG000|Maintenance Phase|Disease progression|0|||
126360165|NCT00281580|454610780|FG009|Overall Study|Protocol Violation|0|||
126360166|NCT00281580|454610781|FG010|Overall Study|Protocol Violation|1|||
126360167|NCT00281580|454610782|FG011|Overall Study|Protocol Violation|2|||
126360168|NCT00281580|454610783|FG012|Overall Study|Protocol Violation|0|||
126360169|NCT00281580|454610784|FG013|Overall Study|Protocol Violation|1|||
126360170|NCT00281580|454610785|FG014|Overall Study|Protocol Violation|1|||
126360171|NCT00281580|454610786|FG015|Overall Study|Protocol Violation|3|||
126360172|NCT00281580|454610771|FG000|Overall Study|Withdrawal by Subject|3|||
126360173|NCT00281580|454610772|FG001|Overall Study|Withdrawal by Subject|0|||
126360174|NCT00281580|454610773|FG002|Overall Study|Withdrawal by Subject|1|||
126360175|NCT00281580|454610774|FG003|Overall Study|Withdrawal by Subject|1|||
126703217|NCT00929240|455863731|FG001|Maintenance Phase|Disease progression|73|||
126703218|NCT00929240|455863732|FG002|Maintenance Phase|Disease progression|60|||
126703219|NCT00929240|455863730|FG000|Maintenance Phase|Adverse Event|0|||
126703220|NCT00929240|455863731|FG001|Maintenance Phase|Adverse Event|9|||
126360176|NCT00281580|454610775|FG004|Overall Study|Withdrawal by Subject|1|||
126360177|NCT00281580|454610776|FG005|Overall Study|Withdrawal by Subject|2|||
126703221|NCT00929240|455863732|FG002|Maintenance Phase|Adverse Event|12|||
126703222|NCT00929240|455863730|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126764225|NCT03113760|456089071|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
126764226|NCT03113760|456089072|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
126764227|NCT03113760|456089073|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
126764228|NCT03927989|456089074|FG000|Overall Study|Withdrawal by Subject|0|||
126764229|NCT03927989|456089075|FG001|Overall Study|Withdrawal by Subject|1|||
126764230|NCT01012609|456089081|FG000|Overall Study|Withdrawal by Subject|1|||
126764231|NCT01012609|456089082|FG001|Overall Study|Withdrawal by Subject|1|||
126764232|NCT01453296|456089083|FG000|Treatment Period 1|Adverse Event|0|||
126764233|NCT01453296|456089084|FG001|Treatment Period 1|Adverse Event|1|||
126764234|NCT01453296|456089083|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
126764235|NCT01453296|456089084|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
126764236|NCT01453296|456089083|FG000|Treatment Period 2|Adverse Event|1|||
126764237|NCT01453296|456089084|FG001|Treatment Period 2|Adverse Event|0|||
126764238|NCT01453296|456089083|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126764239|NCT01453296|456089084|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126764240|NCT03557775|456089085|FG000|Overall Study|Withdrawal by Subject|1|||
126764241|NCT03557775|456089086|FG001|Overall Study|Withdrawal by Subject|2|||
126764242|NCT03557775|456089087|FG002|Overall Study|Withdrawal by Subject|4|||
126764243|NCT03557775|456089085|FG000|Overall Study|Physician Decision|0|||
126764244|NCT03557775|456089086|FG001|Overall Study|Physician Decision|1|||
126764245|NCT03557775|456089087|FG002|Overall Study|Physician Decision|0|||
126764246|NCT03426995|456089095|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764247|NCT03426995|456089096|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764248|NCT03426995|456089097|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
126764249|NCT03426995|456089098|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764250|NCT03426995|456089099|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764251|NCT03426995|456089100|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764252|NCT03426995|456089101|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764253|NCT03426995|456089102|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764254|NCT03426995|456089103|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764255|NCT03426995|456089104|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764256|NCT03426995|456089105|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764257|NCT03426995|456089106|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764258|NCT03426995|456089107|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764259|NCT03426995|456089108|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764260|NCT03426995|456089109|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764261|NCT03426995|456089110|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764262|NCT03426995|456089111|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764263|NCT03426995|456089112|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764264|NCT03426995|456089113|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
126764265|NCT03426995|456089095|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764266|NCT03426995|456089096|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764267|NCT03426995|456089097|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764268|NCT03426995|456089098|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764269|NCT03426995|456089099|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764270|NCT03426995|456089100|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
126764271|NCT03426995|456089101|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764272|NCT03426995|456089102|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764273|NCT03426995|456089103|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764274|NCT03426995|456089104|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764275|NCT03426995|456089105|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764276|NCT03426995|456089106|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764277|NCT03426995|456089107|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764278|NCT03426995|456089108|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764279|NCT03426995|456089109|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764280|NCT03426995|456089110|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764281|NCT03426995|456089111|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764282|NCT03426995|456089112|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764283|NCT03426995|456089113|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
126764284|NCT03426995|456089095|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764285|NCT03426995|456089096|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764286|NCT03426995|456089097|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764287|NCT03426995|456089098|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764288|NCT03426995|456089099|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
126764289|NCT03426995|456089100|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
126547316|NCT02778399|455296200|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
126764290|NCT03426995|456089101|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764291|NCT03426995|456089102|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764292|NCT03426995|456089103|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764293|NCT03426995|456089104|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764294|NCT03426995|456089105|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764295|NCT03426995|456089106|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126265432|NCT00296491|454262848|FG000|Overall Study|Low Pollen Counts|18|||
126265433|NCT00296491|454262849|FG001|Overall Study|Low Pollen Counts|26|||
126265434|NCT00296491|454262850|FG002|Overall Study|Low Pollen Counts|25|||
126265435|NCT00296491|454262851|FG003|Overall Study|Low Pollen Counts|16|||
126265436|NCT00296491|454262848|FG000|Overall Study|Protocol Violation|4|||
126265437|NCT00296491|454262849|FG001|Overall Study|Protocol Violation|6|||
126265438|NCT00296491|454262850|FG002|Overall Study|Protocol Violation|2|||
126265439|NCT00296491|454262851|FG003|Overall Study|Protocol Violation|3|||
126265440|NCT00296491|454262848|FG000|Overall Study|Adverse Event|1|||
126265441|NCT00296491|454262849|FG001|Overall Study|Adverse Event|3|||
126265442|NCT00296491|454262850|FG002|Overall Study|Adverse Event|1|||
126265443|NCT00296491|454262851|FG003|Overall Study|Adverse Event|4|||
126265444|NCT00296491|454262848|FG000|Overall Study|Withdrawn due to Asthma|0|||
126265445|NCT00296491|454262849|FG001|Overall Study|Withdrawn due to Asthma|0|||
126265446|NCT00296491|454262850|FG002|Overall Study|Withdrawn due to Asthma|0|||
126265447|NCT00296491|454262851|FG003|Overall Study|Withdrawn due to Asthma|4|||
126265448|NCT00296491|454262848|FG000|Overall Study|Withdrawal by Subject|7|||
126265449|NCT00296491|454262849|FG001|Overall Study|Withdrawal by Subject|3|||
126265450|NCT00296491|454262850|FG002|Overall Study|Withdrawal by Subject|3|||
126265451|NCT00296491|454262851|FG003|Overall Study|Withdrawal by Subject|2|||
126265452|NCT00296491|454262848|FG000|Overall Study|Non-Compliance|12|||
126265453|NCT00296491|454262849|FG001|Overall Study|Non-Compliance|13|||
126265454|NCT00296491|454262850|FG002|Overall Study|Non-Compliance|10|||
126265455|NCT00296491|454262851|FG003|Overall Study|Non-Compliance|14|||
126265456|NCT00296491|454262848|FG000|Overall Study|Lost to Follow-up|0|||
126265457|NCT00296491|454262849|FG001|Overall Study|Lost to Follow-up|2|||
126265458|NCT00296491|454262850|FG002|Overall Study|Lost to Follow-up|2|||
126265459|NCT00296491|454262851|FG003|Overall Study|Lost to Follow-up|0|||
126265460|NCT01300052|454262852|FG000|Overall Study|Adverse Event|3|||
126265461|NCT01300052|454262853|FG001|Overall Study|Adverse Event|0|||
126265462|NCT01300052|454262852|FG000|Overall Study|Withdrawal by Subject|2|||
126265463|NCT01300052|454262853|FG001|Overall Study|Withdrawal by Subject|2|||
126265464|NCT01300052|454262852|FG000|Overall Study|Protocol Violation|1|||
126265465|NCT01300052|454262853|FG001|Overall Study|Protocol Violation|1|||
126265466|NCT01231373|454262854|FG000|Overall Study|Withdrew consent prior to randomization|2|||
126265467|NCT01231373|454262855|FG001|Overall Study|Withdrew consent prior to randomization|1|||
126265468|NCT01231373|454262856|FG002|Overall Study|Withdrew consent prior to randomization|0|||
126265469|NCT01231373|454262857|FG003|Overall Study|Withdrew consent prior to randomization|0|||
126265470|NCT01231373|454262854|FG000|Overall Study|Lost to Follow-up|0|||
126265471|NCT01231373|454262855|FG001|Overall Study|Lost to Follow-up|0|||
126265472|NCT01231373|454262856|FG002|Overall Study|Lost to Follow-up|0|||
126265473|NCT01231373|454262857|FG003|Overall Study|Lost to Follow-up|1|||
126265474|NCT01231373|454262854|FG000|Overall Study|Withdrew Consent|1|||
126265475|NCT01231373|454262855|FG001|Overall Study|Withdrew Consent|0|||
126265476|NCT01231373|454262856|FG002|Overall Study|Withdrew Consent|0|||
126265477|NCT01231373|454262857|FG003|Overall Study|Withdrew Consent|0|||
126265478|NCT03451006|454262858|FG000|Overall Study|Withdrawal by Subject|2|||
126265479|NCT03451006|454262859|FG001|Overall Study|Withdrawal by Subject|2|||
126265480|NCT01929395|454262860|FG000|Overall Study|Did not complete - non-related toxicity|1|||
126265481|NCT01929395|454262861|FG001|Overall Study|Did not complete - non-related toxicity|0|||
126265482|NCT01929395|454262862|FG002|Overall Study|Did not complete - non-related toxicity|0|||
126265483|NCT01929395|454262860|FG000|Overall Study|Withdrawal by Subject|0|||
126265484|NCT01929395|454262861|FG001|Overall Study|Withdrawal by Subject|1|||
126265485|NCT01929395|454262862|FG002|Overall Study|Withdrawal by Subject|0|||
126265486|NCT01929395|454262860|FG000|Overall Study|Screen Fail|0|||
126265487|NCT01929395|454262861|FG001|Overall Study|Screen Fail|0|||
126265488|NCT01929395|454262862|FG002|Overall Study|Screen Fail|1|||
126265489|NCT02547766|454262863|FG000|Overall Study|Withdrawal by Subject|1|||
126265490|NCT00351351|454262866|FG000|Overall Study|surgical access pbs; device issues|9|||
126265491|NCT00351351|454262867|FG001|Overall Study|surgical access pbs; device issues|4|||
126265492|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
126265493|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
126265494|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
126265495|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
126265496|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
126265497|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
126265498|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
126265499|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
126265500|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
126452865|NCT03531632|454959022|FG000|Overall Study|Death|4|||
126703223|NCT00929240|455863731|FG001|Maintenance Phase|Withdrawal by Subject|2|||
126703224|NCT00929240|455863732|FG002|Maintenance Phase|Withdrawal by Subject|6|||
126703225|NCT00929240|455863730|FG000|Maintenance Phase|Protocol Violation|0|||
126703226|NCT00929240|455863731|FG001|Maintenance Phase|Protocol Violation|1|||
126703227|NCT00929240|455863732|FG002|Maintenance Phase|Protocol Violation|0|||
126703228|NCT00929240|455863730|FG000|Maintenance Phase|Health authority/Study termination|0|||
126703229|NCT00929240|455863731|FG001|Maintenance Phase|Health authority/Study termination|1|||
126703230|NCT00929240|455863732|FG002|Maintenance Phase|Health authority/Study termination|2|||
126360178|NCT00281580|454610777|FG006|Overall Study|Withdrawal by Subject|2|||
126703231|NCT00929240|455863730|FG000|Maintenance Phase|Physician Decision|0|||
126703232|NCT00929240|455863731|FG001|Maintenance Phase|Physician Decision|2|||
126703233|NCT00929240|455863732|FG002|Maintenance Phase|Physician Decision|1|||
126703234|NCT00929240|455863730|FG000|Maintenance Phase|Change of treatment|0|||
126703235|NCT00929240|455863731|FG001|Maintenance Phase|Change of treatment|4|||
126703236|NCT00929240|455863732|FG002|Maintenance Phase|Change of treatment|0|||
126703237|NCT00929240|455863730|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
126703238|NCT00929240|455863731|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
126703239|NCT00929240|455863732|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
126703240|NCT00929240|455863730|FG000|Maintenance Phase|Participant not treated|0|||
126703241|NCT00929240|455863731|FG001|Maintenance Phase|Participant not treated|2|||
126703242|NCT00929240|455863732|FG002|Maintenance Phase|Participant not treated|0|||
126703243|NCT05292755|455863733|FG000|Overall Study|Lost to Follow-up|5|||
126703244|NCT05292755|455863734|FG001|Overall Study|Lost to Follow-up|9|||
126703245|NCT00432809|455863736|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
126703246|NCT00432809|455863737|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
126703247|NCT00432809|455863738|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
126703248|NCT00432809|455863736|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
126703249|NCT00432809|455863737|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
126703250|NCT00432809|455863738|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
126703251|NCT02371629|455863739|FG000|Overall Study|Patient decision|14|||
126360179|NCT00281580|454610778|FG007|Overall Study|Withdrawal by Subject|0|||
126360180|NCT00281580|454610779|FG008|Overall Study|Withdrawal by Subject|1|||
126360181|NCT00281580|454610780|FG009|Overall Study|Withdrawal by Subject|4|||
126360182|NCT00281580|454610781|FG010|Overall Study|Withdrawal by Subject|1|||
126360183|NCT00281580|454610782|FG011|Overall Study|Withdrawal by Subject|1|||
126360184|NCT00281580|454610783|FG012|Overall Study|Withdrawal by Subject|2|||
126360185|NCT00281580|454610784|FG013|Overall Study|Withdrawal by Subject|2|||
126360186|NCT00281580|454610785|FG014|Overall Study|Withdrawal by Subject|1|||
126360187|NCT00281580|454610786|FG015|Overall Study|Withdrawal by Subject|5|||
126360188|NCT00281580|454610771|FG000|Overall Study|Lack of Efficacy|2|||
126360189|NCT00281580|454610772|FG001|Overall Study|Lack of Efficacy|1|||
126360190|NCT00281580|454610773|FG002|Overall Study|Lack of Efficacy|1|||
126360191|NCT00281580|454610774|FG003|Overall Study|Lack of Efficacy|6|||
126360192|NCT00281580|454610775|FG004|Overall Study|Lack of Efficacy|2|||
126360193|NCT00281580|454610776|FG005|Overall Study|Lack of Efficacy|0|||
126360194|NCT00281580|454610777|FG006|Overall Study|Lack of Efficacy|0|||
126360195|NCT00281580|454610778|FG007|Overall Study|Lack of Efficacy|0|||
126360196|NCT00281580|454610779|FG008|Overall Study|Lack of Efficacy|0|||
126360197|NCT00281580|454610780|FG009|Overall Study|Lack of Efficacy|0|||
126360198|NCT00281580|454610781|FG010|Overall Study|Lack of Efficacy|0|||
126360199|NCT00281580|454610782|FG011|Overall Study|Lack of Efficacy|1|||
126360200|NCT00281580|454610783|FG012|Overall Study|Lack of Efficacy|0|||
126360201|NCT00281580|454610784|FG013|Overall Study|Lack of Efficacy|2|||
126360202|NCT00281580|454610785|FG014|Overall Study|Lack of Efficacy|1|||
126360203|NCT00281580|454610786|FG015|Overall Study|Lack of Efficacy|0|||
126360204|NCT00281580|454610771|FG000|Overall Study|Lost to Follow-up|0|||
126360205|NCT00281580|454610772|FG001|Overall Study|Lost to Follow-up|0|||
126360206|NCT00281580|454610773|FG002|Overall Study|Lost to Follow-up|0|||
126360207|NCT00281580|454610774|FG003|Overall Study|Lost to Follow-up|3|||
126360208|NCT00281580|454610775|FG004|Overall Study|Lost to Follow-up|0|||
126360209|NCT00281580|454610776|FG005|Overall Study|Lost to Follow-up|1|||
126360210|NCT00281580|454610777|FG006|Overall Study|Lost to Follow-up|0|||
126360211|NCT00281580|454610778|FG007|Overall Study|Lost to Follow-up|1|||
126360212|NCT00281580|454610779|FG008|Overall Study|Lost to Follow-up|2|||
126360213|NCT00281580|454610780|FG009|Overall Study|Lost to Follow-up|1|||
126360214|NCT00281580|454610781|FG010|Overall Study|Lost to Follow-up|1|||
126360215|NCT00281580|454610782|FG011|Overall Study|Lost to Follow-up|0|||
126360216|NCT00281580|454610783|FG012|Overall Study|Lost to Follow-up|1|||
126360217|NCT00281580|454610784|FG013|Overall Study|Lost to Follow-up|0|||
126703252|NCT02371629|455863740|FG001|Overall Study|Patient decision|10|||
126703253|NCT02371629|455863739|FG000|Overall Study|Adverse Event|8|||
126360218|NCT00281580|454610785|FG014|Overall Study|Lost to Follow-up|0|||
126360219|NCT00281580|454610786|FG015|Overall Study|Lost to Follow-up|0|||
126360220|NCT00281580|454610771|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
126360221|NCT00281580|454610772|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
126360222|NCT00281580|454610773|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
126764296|NCT03426995|456089107|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764297|NCT03426995|456089108|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764298|NCT03426995|456089109|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764299|NCT03426995|456089110|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764300|NCT03426995|456089111|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764301|NCT03426995|456089112|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764302|NCT03426995|456089113|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
126764303|NCT03426995|456089095|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764304|NCT03426995|456089096|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764305|NCT03426995|456089097|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764306|NCT03426995|456089098|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764307|NCT03426995|456089099|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764308|NCT03426995|456089100|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764309|NCT03426995|456089101|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764310|NCT03426995|456089102|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764311|NCT03426995|456089103|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764312|NCT03426995|456089104|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764313|NCT03426995|456089105|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
126764314|NCT03426995|456089106|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764315|NCT03426995|456089107|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764316|NCT03426995|456089108|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764317|NCT03426995|456089109|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764318|NCT03426995|456089110|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764319|NCT03426995|456089111|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764320|NCT03426995|456089112|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764321|NCT03426995|456089113|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
126764322|NCT03426995|456089095|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764323|NCT03426995|456089096|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764324|NCT03426995|456089097|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764325|NCT03426995|456089098|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764326|NCT03426995|456089099|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764327|NCT03426995|456089100|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764328|NCT03426995|456089101|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764329|NCT03426995|456089102|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
126764330|NCT03426995|456089103|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764331|NCT03426995|456089104|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764332|NCT03426995|456089105|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764333|NCT03426995|456089106|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764334|NCT03426995|456089107|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764335|NCT03426995|456089108|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764336|NCT03426995|456089109|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764337|NCT03426995|456089110|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764338|NCT03426995|456089111|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764339|NCT03426995|456089112|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764340|NCT03426995|456089113|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
126764341|NCT03426995|456089095|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764342|NCT03426995|456089096|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764343|NCT03426995|456089097|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764344|NCT03426995|456089098|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764345|NCT03426995|456089099|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764346|NCT03426995|456089100|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764347|NCT03426995|456089101|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764348|NCT03426995|456089102|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764349|NCT03426995|456089103|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764350|NCT03426995|456089104|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764351|NCT03426995|456089105|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126265501|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
126265502|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
126265503|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
126265504|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
126265505|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
126265506|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
126265507|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
126265508|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
126452866|NCT03531632|454959023|FG001|Overall Study|Death|0|||
126452867|NCT03531632|454959024|FG002|Overall Study|Death|14|||
126265509|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
126703254|NCT02371629|455863740|FG001|Overall Study|Adverse Event|8|||
126703255|NCT02371629|455863739|FG000|Overall Study|Physician Decision|2|||
126703256|NCT02371629|455863740|FG001|Overall Study|Physician Decision|3|||
126703257|NCT02371629|455863739|FG000|Overall Study|Death|1|||
126703258|NCT02371629|455863740|FG001|Overall Study|Death|1|||
126703259|NCT02371629|455863739|FG000|Overall Study|Noncompliance with study treatment|1|||
126703260|NCT02371629|455863740|FG001|Overall Study|Noncompliance with study treatment|0|||
126703261|NCT02371629|455863739|FG000|Overall Study|Lack of Efficacy|0|||
126703262|NCT02371629|455863740|FG001|Overall Study|Lack of Efficacy|2|||
126703263|NCT02371629|455863739|FG000|Overall Study|Protocol deviation|0|||
126703264|NCT02371629|455863740|FG001|Overall Study|Protocol deviation|1|||
126703265|NCT00805207|455863741|FG000|Overall Study|Protocol Violation|0|||
126703266|NCT00805207|455863742|FG001|Overall Study|Protocol Violation|0|||
126703267|NCT00805207|455863743|FG002|Overall Study|Protocol Violation|1|||
126703268|NCT00805207|455863744|FG003|Overall Study|Protocol Violation|0|||
126703269|NCT00805207|455863745|FG004|Overall Study|Protocol Violation|0|||
126703270|NCT00805207|455863746|FG005|Overall Study|Protocol Violation|0|||
126703271|NCT00805207|455863747|FG006|Overall Study|Protocol Violation|0|||
126703272|NCT00805207|455863748|FG007|Overall Study|Protocol Violation|0|||
126703273|NCT00805207|455863749|FG008|Overall Study|Protocol Violation|0|||
126703274|NCT00805207|455863741|FG000|Overall Study|Physician Decision|0|||
126703275|NCT00805207|455863742|FG001|Overall Study|Physician Decision|1|||
126703276|NCT00805207|455863743|FG002|Overall Study|Physician Decision|0|||
126703277|NCT00805207|455863744|FG003|Overall Study|Physician Decision|0|||
126703278|NCT00805207|455863745|FG004|Overall Study|Physician Decision|0|||
126703279|NCT00805207|455863746|FG005|Overall Study|Physician Decision|1|||
126703280|NCT00805207|455863747|FG006|Overall Study|Physician Decision|0|||
126703281|NCT00805207|455863748|FG007|Overall Study|Physician Decision|0|||
126703282|NCT00805207|455863749|FG008|Overall Study|Physician Decision|0|||
126703283|NCT00805207|455863741|FG000|Overall Study|Withdrawal by Subject|0|||
126703284|NCT00805207|455863742|FG001|Overall Study|Withdrawal by Subject|1|||
126703285|NCT00805207|455863743|FG002|Overall Study|Withdrawal by Subject|0|||
126703286|NCT00805207|455863744|FG003|Overall Study|Withdrawal by Subject|0|||
126703287|NCT00805207|455863745|FG004|Overall Study|Withdrawal by Subject|1|||
126703288|NCT00805207|455863746|FG005|Overall Study|Withdrawal by Subject|2|||
126703289|NCT00805207|455863747|FG006|Overall Study|Withdrawal by Subject|0|||
126703290|NCT00805207|455863748|FG007|Overall Study|Withdrawal by Subject|0|||
126703291|NCT00805207|455863749|FG008|Overall Study|Withdrawal by Subject|0|||
126703292|NCT02469246|455863750|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
126703293|NCT02469246|455863751|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
126703294|NCT02469246|455863750|FG000|Double-Blind Phase|Adverse Event|12|||
126703295|NCT02469246|455863751|FG001|Double-Blind Phase|Adverse Event|9|||
126703296|NCT02469246|455863750|FG000|Double-Blind Phase|Death|2|||
126703297|NCT02469246|455863751|FG001|Double-Blind Phase|Death|0|||
126703298|NCT02469246|455863750|FG000|Double-Blind Phase|Lack of Efficacy|2|||
126703299|NCT02469246|455863751|FG001|Double-Blind Phase|Lack of Efficacy|1|||
126703300|NCT02469246|455863750|FG000|Double-Blind Phase|Investigator's Discretion|8|||
126703301|NCT02469246|455863751|FG001|Double-Blind Phase|Investigator's Discretion|8|||
126703302|NCT02469246|455863750|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
126703303|NCT02469246|455863751|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
126703304|NCT02469246|455863750|FG000|Double-Blind Phase|Protocol Violation|1|||
126703305|NCT02469246|455863751|FG001|Double-Blind Phase|Protocol Violation|1|||
126703306|NCT02469246|455863750|FG000|Double-Blind Phase|Withdrew Consent|25|||
126703307|NCT02469246|455863751|FG001|Double-Blind Phase|Withdrew Consent|25|||
126703308|NCT02469246|455863750|FG000|Double-Blind Phase|Lost to Follow-up|9|||
126703309|NCT02469246|455863751|FG001|Double-Blind Phase|Lost to Follow-up|5|||
126703310|NCT05681715|455863755|FG000|Training Period (6-weeks)|Adverse Event|3|||
126703311|NCT05681715|455863756|FG001|Training Period (6-weeks)|Adverse Event|0|||
126703312|NCT05681715|455863757|FG002|Training Period (6-weeks)|Adverse Event|0|||
126703313|NCT05681715|455863755|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
126703314|NCT05681715|455863756|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
126703315|NCT05681715|455863757|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
126703316|NCT05681715|455863755|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
126703317|NCT05681715|455863756|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
126703318|NCT05681715|455863757|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
126703319|NCT05681715|455863755|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
126703320|NCT05681715|455863756|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
126703321|NCT05681715|455863757|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
126703322|NCT05681715|455863755|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
126703323|NCT05681715|455863756|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
126703324|NCT05681715|455863757|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
126703325|NCT05681715|455863755|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
126703326|NCT05681715|455863756|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
126703327|NCT05681715|455863757|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
126703328|NCT05681715|455863755|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
126703329|NCT05681715|455863756|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
126703330|NCT05681715|455863757|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
126703331|NCT05681715|455863755|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
126703332|NCT05681715|455863756|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
126703333|NCT05681715|455863757|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
126703334|NCT05564052|455863758|FG000|Overall Study|Withdrawal by Subject|0|||
126703335|NCT05564052|455863759|FG001|Overall Study|Withdrawal by Subject|0|||
126703336|NCT05564052|455863760|FG002|Overall Study|Withdrawal by Subject|0|||
126764352|NCT03426995|456089106|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764353|NCT03426995|456089107|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764354|NCT03426995|456089108|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764355|NCT03426995|456089109|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
126764356|NCT03426995|456089110|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
126764357|NCT03426995|456089111|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764358|NCT03426995|456089112|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764359|NCT03426995|456089113|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
126764360|NCT03426995|456089095|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764361|NCT03426995|456089096|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764362|NCT03426995|456089097|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764363|NCT03426995|456089098|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764364|NCT03426995|456089099|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764365|NCT03426995|456089100|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764366|NCT03426995|456089101|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764367|NCT03426995|456089102|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764368|NCT03426995|456089103|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764369|NCT03426995|456089104|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764370|NCT03426995|456089105|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764371|NCT03426995|456089106|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764372|NCT03426995|456089107|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764373|NCT03426995|456089108|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764374|NCT03426995|456089109|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
126764375|NCT03426995|456089110|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
126764376|NCT03426995|456089111|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764377|NCT03426995|456089112|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764378|NCT03426995|456089113|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
126764379|NCT05939388|456089114|FG000|Overall Study|Lost to Follow-up|1|||
126764380|NCT00885677|456089120|FG000|Overall Study|Death|40|||
126764381|NCT00885677|456089121|FG001|Overall Study|Death|34|||
126764382|NCT00885677|456089120|FG000|Overall Study|Lost to Follow-up|15|||
126764383|NCT00885677|456089121|FG001|Overall Study|Lost to Follow-up|13|||
126764384|NCT00885677|456089120|FG000|Overall Study|Protocol Violation|54|||
126764385|NCT00885677|456089121|FG001|Overall Study|Protocol Violation|54|||
126764386|NCT00885677|456089120|FG000|Overall Study|premature study closure|41|||
126764387|NCT00885677|456089121|FG001|Overall Study|premature study closure|44|||
126764388|NCT00885677|456089120|FG000|Overall Study|device/lead revision or replacement|7|||
126764389|NCT00885677|456089121|FG001|Overall Study|device/lead revision or replacement|6|||
126764390|NCT00885677|456089120|FG000|Overall Study|Heart transplantation|1|||
126764391|NCT00885677|456089121|FG001|Overall Study|Heart transplantation|0|||
126764392|NCT00885677|456089120|FG000|Overall Study|Inclusion/exclusion not met|25|||
126764393|NCT00885677|456089121|FG001|Overall Study|Inclusion/exclusion not met|27|||
126360223|NCT00281580|454610774|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
126360224|NCT00281580|454610775|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
126360225|NCT00281580|454610776|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
126360226|NCT00281580|454610777|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
126360227|NCT00281580|454610778|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
126360228|NCT00281580|454610779|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
126360229|NCT00281580|454610780|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
126360230|NCT00281580|454610781|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
126360231|NCT00281580|454610782|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
126360232|NCT00281580|454610783|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
126360233|NCT00281580|454610784|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
126360234|NCT00281580|454610785|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
126265510|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
126703337|NCT05564052|455863761|FG003|Overall Study|Withdrawal by Subject|1|||
126703338|NCT05564052|455863758|FG000|Overall Study|Ongoing|8|||
126703339|NCT05564052|455863759|FG001|Overall Study|Ongoing|5|||
126703340|NCT05564052|455863760|FG002|Overall Study|Ongoing|4|||
126703341|NCT05564052|455863761|FG003|Overall Study|Ongoing|1|||
126703342|NCT04325503|455863779|FG000|Overall Study|Withdrawal by Subject|1|||
126703343|NCT04325503|455863779|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
126265511|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
126452868|NCT03531632|454959022|FG000|Overall Study|Study Terminated|1|||
126452869|NCT03531632|454959023|FG001|Overall Study|Study Terminated|3|||
126452870|NCT03531632|454959024|FG002|Overall Study|Study Terminated|11|||
126452871|NCT00600119|454959025|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
126452872|NCT00600119|454959026|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
126452873|NCT00600119|454959027|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
126452874|NCT00600119|454959028|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
126452875|NCT00600119|454959029|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
126452876|NCT00600119|454959030|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
126452877|NCT00600119|454959025|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
126452878|NCT00600119|454959026|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
126452879|NCT00600119|454959027|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
126452880|NCT00600119|454959028|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
126452881|NCT00600119|454959029|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
126452882|NCT00600119|454959030|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
126703344|NCT03832387|455863780|FG000|Overall Study|Protocol Violation|2|||
126703345|NCT03832387|455863781|FG001|Overall Study|Protocol Violation|6|||
126703346|NCT03832387|455863780|FG000|Overall Study|EXCLUSION CRITERIA|3|||
126703347|NCT03832387|455863781|FG001|Overall Study|EXCLUSION CRITERIA|1|||
126703348|NCT01856114|455863782|FG000|Overall Study|Withdrawal by Subject|1|||
126703349|NCT01856114|455863783|FG001|Overall Study|Withdrawal by Subject|0|||
126703350|NCT01856114|455863782|FG000|Overall Study|Adverse Event|1|||
126703351|NCT01856114|455863783|FG001|Overall Study|Adverse Event|0|||
126703352|NCT00144170|455863784|FG000|Overall Study|Adverse Event|84|||
126703353|NCT00144170|455863785|FG001|Overall Study|Adverse Event|41|||
126703354|NCT00144170|455863784|FG000|Overall Study|Protocol Violation|23|||
126703355|NCT00144170|455863785|FG001|Overall Study|Protocol Violation|16|||
126703356|NCT00144170|455863784|FG000|Overall Study|Lost to Follow-up|5|||
126703357|NCT00144170|455863785|FG001|Overall Study|Lost to Follow-up|10|||
126703358|NCT00144170|455863784|FG000|Overall Study|Withdrawal by Subject|29|||
126703359|NCT00144170|455863785|FG001|Overall Study|Withdrawal by Subject|13|||
126703360|NCT00144170|455863784|FG000|Overall Study|Other reason not defined above|211|||
126703361|NCT00144170|455863785|FG001|Overall Study|Other reason not defined above|316|||
126703362|NCT00981526|455863786|FG000|Overall Study|Withdrawal by Subject|0|||
126703363|NCT00981526|455863787|FG001|Overall Study|Withdrawal by Subject|2|||
126703364|NCT00981526|455863786|FG000|Overall Study|Physician Decision|4|||
126703365|NCT00981526|455863787|FG001|Overall Study|Physician Decision|4|||
126703366|NCT01564784|455863788|FG000|Overall Study|Other|1|||
126703367|NCT01564784|455863789|FG001|Overall Study|Other|0|||
126703368|NCT01564784|455863788|FG000|Overall Study|Subject refused further follow-up|1|||
126703369|NCT01564784|455863789|FG001|Overall Study|Subject refused further follow-up|6|||
126703370|NCT01564784|455863788|FG000|Overall Study|Lost to Follow-up|1|||
126703371|NCT01564784|455863789|FG001|Overall Study|Lost to Follow-up|1|||
126703372|NCT01564784|455863788|FG000|Overall Study|Death|131|||
126703373|NCT01564784|455863789|FG001|Overall Study|Death|126|||
126703374|NCT04238819|455863790|FG000|Overall Study|Ongoing Treatment|0|||
126703375|NCT04238819|455863791|FG001|Overall Study|Ongoing Treatment|0|||
126703376|NCT04238819|455863792|FG002|Overall Study|Ongoing Treatment|0|||
126703377|NCT04238819|455863793|FG003|Overall Study|Ongoing Treatment|0|||
126703378|NCT04238819|455863794|FG004|Overall Study|Ongoing Treatment|1|||
126703379|NCT04238819|455863795|FG005|Overall Study|Ongoing Treatment|4|||
126703380|NCT04238819|455863796|FG006|Overall Study|Ongoing Treatment|0|||
126703381|NCT04238819|455863790|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
126703382|NCT04238819|455863791|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
126703383|NCT04238819|455863792|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
126703384|NCT04238819|455863793|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
126703385|NCT04238819|455863794|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
126703386|NCT04238819|455863795|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
126703387|NCT04238819|455863796|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
126452883|NCT00600119|454959025|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
126703388|NCT00045032|455863799|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
126703389|NCT00045032|455863800|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
126703390|NCT00045032|455863801|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
126703391|NCT00045032|455863799|FG000|Overall Study|Death|22|||
126703392|NCT00045032|455863800|FG001|Overall Study|Death|24|||
126452884|NCT00600119|454959026|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
126452885|NCT00600119|454959027|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
126452886|NCT00600119|454959028|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
126452887|NCT00600119|454959029|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
126452888|NCT00600119|454959030|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
126452889|NCT00600119|454959025|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
126452890|NCT00600119|454959026|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
126452891|NCT00600119|454959027|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
126452892|NCT00600119|454959028|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
126452893|NCT00600119|454959029|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
126452894|NCT00600119|454959030|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
126452895|NCT00600119|454959025|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
126452896|NCT00600119|454959026|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
126452897|NCT00600119|454959027|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
126452898|NCT00600119|454959028|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
126452899|NCT00600119|454959029|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
126452900|NCT00600119|454959030|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
126452901|NCT00600119|454959025|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
126452902|NCT00600119|454959026|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
126452903|NCT00600119|454959027|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
126452904|NCT00600119|454959028|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
126452905|NCT00600119|454959029|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
126703393|NCT00045032|455863801|FG002|Overall Study|Death|17|||
126703394|NCT00045032|455863799|FG000|Overall Study|Insufficient Therapeutic Response|542|||
126703395|NCT00045032|455863800|FG001|Overall Study|Insufficient Therapeutic Response|437|||
126703396|NCT00045032|455863801|FG002|Overall Study|Insufficient Therapeutic Response|445|||
126703397|NCT00045032|455863799|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
126703398|NCT00045032|455863800|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
126703399|NCT00045032|455863801|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
126703400|NCT00045032|455863799|FG000|Overall Study|Other Protocol Violation|2|||
126703401|NCT00045032|455863800|FG001|Overall Study|Other Protocol Violation|0|||
126703402|NCT00045032|455863801|FG002|Overall Study|Other Protocol Violation|1|||
126703403|NCT00045032|455863799|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
126703404|NCT00045032|455863800|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
126703405|NCT00045032|455863801|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
126703406|NCT00045032|455863799|FG000|Overall Study|Failure to Return|57|||
126703407|NCT00045032|455863800|FG001|Overall Study|Failure to Return|62|||
126703408|NCT00045032|455863801|FG002|Overall Study|Failure to Return|61|||
126703409|NCT00045032|455863799|FG000|Overall Study|Other|93|||
126703410|NCT00045032|455863800|FG001|Overall Study|Other|84|||
126703411|NCT00045032|455863801|FG002|Overall Study|Other|105|||
126703412|NCT02581995|455863809|FG000|Overall Study|Unspecified other|3|||
126703413|NCT02581995|455863809|FG000|Overall Study|Adverse Event|6|||
126703414|NCT02581995|455863809|FG000|Overall Study|Lost to Follow-up|5|||
126703415|NCT02581995|455863809|FG000|Overall Study|Withdrawal by participant|12|||
126703416|NCT02581995|455863809|FG000|Overall Study|Physician Decision|1|||
126703417|NCT02581995|455863809|FG000|Overall Study|Death|4|||
126703418|NCT03095703|455865418|FG000|Overall Study|Withdrawal by Subject|1|||
126703419|NCT01934504|455865421|FG000|Overall Study|Protocol Deviation|0|||
126703420|NCT01934504|455865422|FG001|Overall Study|Protocol Deviation|0|||
126703421|NCT01934504|455865423|FG002|Overall Study|Protocol Deviation|0|||
126703422|NCT01934504|455865424|FG003|Overall Study|Protocol Deviation|2|||
126452906|NCT00600119|454959030|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
126452907|NCT00600119|454959025|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
126452908|NCT00600119|454959026|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
126703423|NCT01934504|455865421|FG000|Overall Study|Study Terminated by Sponsor|1|||
126703424|NCT01934504|455865422|FG001|Overall Study|Study Terminated by Sponsor|0|||
126703425|NCT01934504|455865423|FG002|Overall Study|Study Terminated by Sponsor|5|||
126703426|NCT01934504|455865424|FG003|Overall Study|Study Terminated by Sponsor|5|||
126703427|NCT00733902|455865425|FG000|Overall Study|Death|0|||
126703428|NCT00733902|455865426|FG001|Overall Study|Death|0|||
126703429|NCT00733902|455865427|FG002|Overall Study|Death|0|||
126703430|NCT00733902|455865428|FG003|Overall Study|Death|1|||
126703431|NCT00733902|455865425|FG000|Overall Study|Adverse Event|3|||
126703432|NCT00733902|455865426|FG001|Overall Study|Adverse Event|4|||
126703433|NCT00733902|455865427|FG002|Overall Study|Adverse Event|7|||
126703434|NCT00733902|455865428|FG003|Overall Study|Adverse Event|11|||
126703435|NCT00733902|455865425|FG000|Overall Study|Lack of Efficacy|56|||
126703436|NCT00733902|455865426|FG001|Overall Study|Lack of Efficacy|21|||
126703437|NCT00733902|455865427|FG002|Overall Study|Lack of Efficacy|34|||
126703438|NCT00733902|455865428|FG003|Overall Study|Lack of Efficacy|23|||
126703439|NCT00733902|455865425|FG000|Overall Study|Protocol Violation|4|||
126703440|NCT00733902|455865426|FG001|Overall Study|Protocol Violation|6|||
126703441|NCT00733902|455865427|FG002|Overall Study|Protocol Violation|3|||
126703442|NCT00733902|455865428|FG003|Overall Study|Protocol Violation|3|||
126703443|NCT00733902|455865425|FG000|Overall Study|Withdrawal by Subject|10|||
126703444|NCT00733902|455865426|FG001|Overall Study|Withdrawal by Subject|5|||
126703445|NCT00733902|455865427|FG002|Overall Study|Withdrawal by Subject|4|||
126703446|NCT00733902|455865428|FG003|Overall Study|Withdrawal by Subject|16|||
126703447|NCT00733902|455865425|FG000|Overall Study|Entered extension study|89|||
126703448|NCT00733902|455865426|FG001|Overall Study|Entered extension study|124|||
126703449|NCT00733902|455865427|FG002|Overall Study|Entered extension study|111|||
126703450|NCT00733902|455865428|FG003|Overall Study|Entered extension study|109|||
126703451|NCT00733902|455865425|FG000|Overall Study|Randomized but not treated|2|||
126703452|NCT00733902|455865426|FG001|Overall Study|Randomized but not treated|2|||
126703453|NCT00733902|455865427|FG002|Overall Study|Randomized but not treated|2|||
126703454|NCT00733902|455865428|FG003|Overall Study|Randomized but not treated|1|||
126703455|NCT02210780|455865429|FG000|Overall Study|Adverse Event|0|||
126703456|NCT02210780|455865430|FG001|Overall Study|Adverse Event|5|||
126703457|NCT02210780|455865429|FG000|Overall Study|Lost to Follow-up|2|||
126703458|NCT02210780|455865430|FG001|Overall Study|Lost to Follow-up|1|||
126703459|NCT02210780|455865429|FG000|Overall Study|Withdrawal by Subject|1|||
126703460|NCT02210780|455865430|FG001|Overall Study|Withdrawal by Subject|1|||
126703461|NCT02210780|455865429|FG000|Overall Study|Physician Decision|1|||
126703462|NCT02210780|455865430|FG001|Overall Study|Physician Decision|0|||
126703463|NCT02210780|455865429|FG000|Overall Study|Protocol Violation|1|||
126703464|NCT02210780|455865430|FG001|Overall Study|Protocol Violation|0|||
126703465|NCT02210780|455865429|FG000|Overall Study|Other than specified above|0|||
126703466|NCT02210780|455865430|FG001|Overall Study|Other than specified above|1|||
126703467|NCT00049127|455865431|FG000|Overall Study|Withdrawal by Subject|0|||
126703468|NCT00049127|455865432|FG001|Overall Study|Withdrawal by Subject|0|||
126703469|NCT00049127|455865433|FG002|Overall Study|Withdrawal by Subject|1|||
126703470|NCT00049127|455865434|FG003|Overall Study|Withdrawal by Subject|0|||
126703471|NCT00049127|455865435|FG004|Overall Study|Withdrawal by Subject|0|||
126703472|NCT02599402|455865436|FG000|Overall Study|Disease progression|153|||
126703473|NCT02599402|455865436|FG000|Overall Study|Study drug toxicity|201|||
126703474|NCT02599402|455865436|FG000|Overall Study|Death|26|||
126703475|NCT02599402|455865436|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
126703476|NCT02599402|455865436|FG000|Overall Study|Participant request to discontinue study treatment|13|||
126703477|NCT02599402|455865436|FG000|Overall Study|Participant withdrew consent|5|||
126703478|NCT02599402|455865436|FG000|Overall Study|Lost to Follow-up|1|||
126703479|NCT02599402|455865436|FG000|Overall Study|Maximum Clinical Benefit|7|||
126703480|NCT02599402|455865436|FG000|Overall Study|Poor/non-compliance|1|||
126703481|NCT02599402|455865436|FG000|Overall Study|Pregnancy|1|||
126703482|NCT02599402|455865436|FG000|Overall Study|Participant no longer met study criteria|7|||
126703483|NCT02599402|455865436|FG000|Overall Study|Other Reasons|95|||
126703484|NCT01773473|455865437|FG000|Overall Study|Adverse Event|3|||
126703485|NCT01773473|455865438|FG001|Overall Study|Adverse Event|2|||
126703486|NCT01773473|455865437|FG000|Overall Study|Protocol Violation|0|||
126703487|NCT01773473|455865438|FG001|Overall Study|Protocol Violation|4|||
126360235|NCT00281580|454610786|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
126360236|NCT00621322|454610787|FG000|Overall Study|Lost to Follow-up|0|||
126360237|NCT00621322|454610788|FG001|Overall Study|Lost to Follow-up|0|||
126360238|NCT00621322|454610789|FG002|Overall Study|Lost to Follow-up|0|||
126360239|NCT00621322|454610790|FG003|Overall Study|Lost to Follow-up|0|||
126360240|NCT00621322|454610791|FG004|Overall Study|Lost to Follow-up|1|||
126360241|NCT00621322|454610792|FG005|Overall Study|Lost to Follow-up|0|||
126360242|NCT00621322|454610787|FG000|Overall Study|Physician Decision|0|||
126360243|NCT00621322|454610788|FG001|Overall Study|Physician Decision|0|||
126360244|NCT00621322|454610789|FG002|Overall Study|Physician Decision|1|||
126360245|NCT00621322|454610790|FG003|Overall Study|Physician Decision|1|||
126360246|NCT00621322|454610791|FG004|Overall Study|Physician Decision|0|||
126360247|NCT00621322|454610792|FG005|Overall Study|Physician Decision|0|||
126360248|NCT00621322|454610787|FG000|Overall Study|Withdrawal by Subject|0|||
126360249|NCT00621322|454610788|FG001|Overall Study|Withdrawal by Subject|0|||
126360250|NCT00621322|454610789|FG002|Overall Study|Withdrawal by Subject|0|||
126360251|NCT00621322|454610790|FG003|Overall Study|Withdrawal by Subject|1|||
126360252|NCT00621322|454610791|FG004|Overall Study|Withdrawal by Subject|0|||
126360253|NCT00621322|454610792|FG005|Overall Study|Withdrawal by Subject|2|||
126360254|NCT00621322|454610787|FG000|Overall Study|Migrated/moved from study area|1|||
126360255|NCT00621322|454610788|FG001|Overall Study|Migrated/moved from study area|0|||
126360256|NCT00621322|454610789|FG002|Overall Study|Migrated/moved from study area|1|||
126360257|NCT00621322|454610790|FG003|Overall Study|Migrated/moved from study area|1|||
126360258|NCT00621322|454610791|FG004|Overall Study|Migrated/moved from study area|0|||
126703488|NCT01773473|455865437|FG000|Overall Study|Physician Decision|3|||
126703489|NCT01773473|455865438|FG001|Overall Study|Physician Decision|5|||
126703490|NCT01773473|455865437|FG000|Overall Study|Sponsor Decision|2|||
126360259|NCT00621322|454610792|FG005|Overall Study|Migrated/moved from study area|2|||
126360260|NCT00576407|454610793|FG000|Overall Study|Death|7|||
126360261|NCT00576407|454610793|FG000|Overall Study|Physician Decision|1|||
126547317|NCT02778399|455296201|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
126764394|NCT00972309|456089122|FG000|Overall Study|Switched to alternative treatment|0|||
126764395|NCT00972309|456089123|FG001|Overall Study|Switched to alternative treatment|2|||
126764396|NCT00972309|456089122|FG000|Overall Study|Refused further treatment|0|||
126764397|NCT00972309|456089123|FG001|Overall Study|Refused further treatment|1|||
126764398|NCT00972309|456089122|FG000|Overall Study|Late determination of ineligibility|0|||
126764399|NCT00972309|456089123|FG001|Overall Study|Late determination of ineligibility|1|||
126764400|NCT00972309|456089122|FG000|Overall Study|Second malignancy|1|||
126764401|NCT00972309|456089123|FG001|Overall Study|Second malignancy|1|||
126764402|NCT00972309|456089122|FG000|Overall Study|Visa issues|0|||
126764403|NCT00972309|456089123|FG001|Overall Study|Visa issues|1|||
126764404|NCT00972309|456089122|FG000|Overall Study|Secondary cancer (SCC)|0|||
126764405|NCT00972309|456089123|FG001|Overall Study|Secondary cancer (SCC)|1|||
126764406|NCT00972309|456089122|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
126764407|NCT00972309|456089123|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
126764408|NCT00972309|456089122|FG000|Overall Study|Lost to Follow-up|1|||
126764409|NCT00972309|456089123|FG001|Overall Study|Lost to Follow-up|1|||
126764410|NCT00972309|456089122|FG000|Overall Study|Disease progression on study|10|||
126764411|NCT00972309|456089123|FG001|Overall Study|Disease progression on study|4|||
126764412|NCT00948896|456089124|FG000|Randomization to 24 Months of Age|Death|1|||
126764413|NCT00948896|456089125|FG001|Randomization to 24 Months of Age|Death|0|||
126764414|NCT00948896|456089126|FG002|Randomization to 24 Months of Age|Death|0|||
126764415|NCT00948896|456089127|FG003|Randomization to 24 Months of Age|Death|0|||
126764416|NCT00948896|456089128|FG004|Randomization to 24 Months of Age|Death|2|||
126764417|NCT00948896|456089129|FG005|Randomization to 24 Months of Age|Death|1|||
126764418|NCT00948896|456089130|FG006|Randomization to 24 Months of Age|Death|2|||
126764419|NCT00948896|456089131|FG007|Randomization to 24 Months of Age|Death|1|||
126764420|NCT00948896|456089124|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
126764421|NCT00948896|456089125|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
126764422|NCT00948896|456089126|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
126764423|NCT00948896|456089127|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
126764424|NCT00948896|456089128|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
126764425|NCT00948896|456089129|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
126764426|NCT00948896|456089130|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
126764427|NCT00948896|456089131|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
126764428|NCT00948896|456089124|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
126764429|NCT00948896|456089125|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
126764430|NCT00948896|456089126|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
126764431|NCT00948896|456089127|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
126764432|NCT00948896|456089128|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
126764433|NCT00948896|456089129|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
126764434|NCT00948896|456089130|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
126764435|NCT00948896|456089131|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
126764436|NCT00948896|456089124|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
126764437|NCT00948896|456089125|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
126764438|NCT00948896|456089126|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
126764439|NCT00948896|456089127|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
126764440|NCT00948896|456089128|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
126764441|NCT00948896|456089129|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
126764442|NCT00948896|456089130|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
126764443|NCT00948896|456089131|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
126547318|NCT02778399|455296202|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
126764444|NCT00948896|456089124|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
126764445|NCT00948896|456089125|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
126764446|NCT00948896|456089126|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
126360262|NCT00756444|454610794|FG000|Overall Study|Adverse Event|1|||
126360263|NCT00756444|454610795|FG001|Overall Study|Adverse Event|1|||
126360264|NCT00756444|454610794|FG000|Overall Study|Withdrawal by Subject|6|||
126360265|NCT00756444|454610795|FG001|Overall Study|Withdrawal by Subject|8|||
126360266|NCT00756444|454610794|FG000|Overall Study|Lost to Follow-up|0|||
126360267|NCT00756444|454610795|FG001|Overall Study|Lost to Follow-up|1|||
126360268|NCT00756444|454610794|FG000|Overall Study|Death|5|||
126360269|NCT00756444|454610795|FG001|Overall Study|Death|4|||
126360270|NCT00756444|454610794|FG000|Overall Study|Disease Progression|2|||
126360271|NCT00756444|454610795|FG001|Overall Study|Disease Progression|7|||
126360272|NCT00756444|454610794|FG000|Overall Study|Ineligibility Determined|1|||
126360273|NCT00756444|454610795|FG001|Overall Study|Ineligibility Determined|0|||
126764447|NCT00948896|456089127|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
126360274|NCT01655069|454610799|FG000|Overall Study|Physician Decision|0|||
126360275|NCT01655069|454610800|FG001|Overall Study|Physician Decision|0|||
126360276|NCT01655069|454610801|FG002|Overall Study|Physician Decision|0|||
126703491|NCT01773473|455865438|FG001|Overall Study|Sponsor Decision|0|||
126703492|NCT01773473|455865437|FG000|Overall Study|Lack of Efficacy|0|||
126703493|NCT01773473|455865438|FG001|Overall Study|Lack of Efficacy|1|||
126703494|NCT01773473|455865437|FG000|Overall Study|Non-Compliance with study drug|1|||
126703495|NCT01773473|455865438|FG001|Overall Study|Non-Compliance with study drug|4|||
126703496|NCT01773473|455865437|FG000|Overall Study|Withdrawal by Subject|5|||
126703497|NCT01773473|455865438|FG001|Overall Study|Withdrawal by Subject|3|||
126703498|NCT01773473|455865437|FG000|Overall Study|Lost to Follow-up|2|||
126703499|NCT01773473|455865438|FG001|Overall Study|Lost to Follow-up|0|||
126703500|NCT04927312|455865439|FG000|Overall Study|Adverse Event|1|||
126703501|NCT04927312|455865439|FG000|Overall Study|Death|1|||
126703502|NCT04927312|455865439|FG000|Overall Study|Withdrawal by Subject|1|||
126703503|NCT04927312|455865439|FG000|Overall Study|Other|1|||
126703504|NCT01440101|455865440|FG000|Overall Study|Adverse Event|2|||
126703505|NCT01440101|455865441|FG001|Overall Study|Adverse Event|0|||
126703506|NCT01440101|455865442|FG002|Overall Study|Adverse Event|0|||
126703507|NCT01440101|455865440|FG000|Overall Study|Withdrawal by Subject|0|||
126703508|NCT01440101|455865441|FG001|Overall Study|Withdrawal by Subject|3|||
126703509|NCT01440101|455865442|FG002|Overall Study|Withdrawal by Subject|1|||
126703510|NCT01440101|455865440|FG000|Overall Study|Other|0|||
126703511|NCT01440101|455865441|FG001|Overall Study|Other|1|||
126703512|NCT01440101|455865442|FG002|Overall Study|Other|0|||
126703513|NCT00201851|455865443|FG000|Overall Study|Lost to Follow-up|2|||
126265512|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
126265513|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
126703514|NCT00201851|455865444|FG001|Overall Study|Lost to Follow-up|1|||
126703515|NCT00201851|455865445|FG002|Overall Study|Lost to Follow-up|0|||
126703516|NCT00201851|455865443|FG000|Overall Study|Ineligible post enrollment|6|||
126703517|NCT00201851|455865444|FG001|Overall Study|Ineligible post enrollment|1|||
126703518|NCT00201851|455865445|FG002|Overall Study|Ineligible post enrollment|1|||
126703519|NCT00636818|455865446|FG000|Overall Study|Adverse Event|1|||
126703520|NCT00636818|455865446|FG000|Overall Study|Lost to Follow-up|2|||
126703521|NCT00636818|455865446|FG000|Overall Study|Entry Criteria Exclusion|3|||
126703522|NCT00636818|455865446|FG000|Overall Study|Protocol Violation|1|||
126703523|NCT00636818|455865446|FG000|Overall Study|Withdrawal by Subject|4|||
126703524|NCT00074958|455865447|FG000|Overall Study|Adverse Event|1|||
126703525|NCT01658514|455865451|FG000|Overall Study|Protocol Violation|1|||
126703526|NCT01658514|455865452|FG001|Overall Study|Protocol Violation|0|||
126703527|NCT01658514|455865453|FG002|Overall Study|Protocol Violation|2|||
126703528|NCT02853760|455865454|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
126703529|NCT02853760|455865455|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
126703530|NCT02853760|455865456|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
126703531|NCT02853760|455865457|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
126703532|NCT02853760|455865458|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
126703533|NCT02853760|455865459|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
126703534|NCT01243268|455865460|FG000|Overall Study|Lost to Follow-up|4|||
126703535|NCT01243268|455865460|FG000|Overall Study|Protocol Violation|51|||
126703536|NCT01243268|455865460|FG000|Overall Study|Deviation with contract date|7|||
126703537|NCT01243268|455865460|FG000|Overall Study|Duplicate subject|2|||
126703538|NCT00957853|455865461|FG000|Overall Study|Withdrawal by Subject|1|||
126703539|NCT00957853|455865462|FG001|Overall Study|Withdrawal by Subject|0|||
126703540|NCT00957853|455865463|FG002|Overall Study|Withdrawal by Subject|0|||
126703541|NCT00004980|455865464|FG000|Overall Study|Withdrawal by Subject|1|||
126703542|NCT00004980|455865465|FG001|Overall Study|Withdrawal by Subject|0|||
126703543|NCT00004980|455865464|FG000|Overall Study|memory difficulties|1|||
126703544|NCT00004980|455865465|FG001|Overall Study|memory difficulties|1|||
126703545|NCT00004980|455865464|FG000|Overall Study|Physician Decision|0|||
126703546|NCT00004980|455865465|FG001|Overall Study|Physician Decision|1|||
126703547|NCT00702143|455865466|FG000|Overall Study|Lost to Follow-up|0|||
126703548|NCT00702143|455865467|FG001|Overall Study|Lost to Follow-up|0|||
126703549|NCT00702143|455865468|FG002|Overall Study|Lost to Follow-up|1|||
126703550|NCT01822561|455865475|FG000|Overall Study|Withdrawal by Subject|2|||
126265514|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
126265515|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
126703551|NCT04826900|455865476|FG000|Overall Study|Family factor|1|||
126703552|NCT04826900|455865477|FG001|Overall Study|Family factor|1|||
126703553|NCT03372941|455865478|FG000|Overall Study|Lost to Follow-up|2|||
126703554|NCT03372941|455865479|FG001|Overall Study|Lost to Follow-up|4|||
126703555|NCT00741819|455865480|FG000|Overall Study|Adverse Event|3|||
126703556|NCT00741819|455865480|FG000|Overall Study|Withdrawal by Subject|3|||
126703557|NCT00741819|455865480|FG000|Overall Study|Death|1|||
126265516|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
126265517|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
126265518|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
126265519|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
126360277|NCT01655069|454610802|FG003|Overall Study|Physician Decision|1|||
126703558|NCT00741819|455865480|FG000|Overall Study|Disease progression|1|||
126452909|NCT00600119|454959027|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126452910|NCT00600119|454959028|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
126452911|NCT00600119|454959029|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
126452912|NCT00600119|454959030|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
126452913|NCT00600119|454959025|FG000|Double-blind Treatment Period|Other|0|||
126452914|NCT00600119|454959026|FG001|Double-blind Treatment Period|Other|0|||
126452915|NCT00600119|454959027|FG002|Double-blind Treatment Period|Other|0|||
126452916|NCT00600119|454959028|FG003|Double-blind Treatment Period|Other|0|||
126452917|NCT00600119|454959029|FG004|Double-blind Treatment Period|Other|2|||
126452918|NCT00600119|454959030|FG005|Double-blind Treatment Period|Other|1|||
126452919|NCT00600119|454959025|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
126452920|NCT00600119|454959026|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
126547319|NCT02778399|455296203|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
126703559|NCT01126580|455865481|FG000|Overall Study|Adverse Event|14|||
126703560|NCT01126580|455865482|FG001|Overall Study|Adverse Event|8|||
126703561|NCT01126580|455865483|FG002|Overall Study|Adverse Event|12|||
126703562|NCT01126580|455865481|FG000|Overall Study|Withdrawal by Subject|11|||
126703563|NCT01126580|455865482|FG001|Overall Study|Withdrawal by Subject|19|||
126703564|NCT01126580|455865483|FG002|Overall Study|Withdrawal by Subject|14|||
126703565|NCT01126580|455865481|FG000|Overall Study|Sponsor Decision|5|||
126703566|NCT01126580|455865482|FG001|Overall Study|Sponsor Decision|4|||
126703567|NCT01126580|455865483|FG002|Overall Study|Sponsor Decision|7|||
126703568|NCT01126580|455865481|FG000|Overall Study|Physician Decision|1|||
126703569|NCT01126580|455865482|FG001|Overall Study|Physician Decision|1|||
126703570|NCT01126580|455865483|FG002|Overall Study|Physician Decision|2|||
126703571|NCT01126580|455865481|FG000|Overall Study|Entry Criteria Not Met|1|||
126703572|NCT01126580|455865482|FG001|Overall Study|Entry Criteria Not Met|1|||
126703573|NCT01126580|455865483|FG002|Overall Study|Entry Criteria Not Met|2|||
126703574|NCT01126580|455865481|FG000|Overall Study|Lack of Efficacy|2|||
126703575|NCT01126580|455865482|FG001|Overall Study|Lack of Efficacy|3|||
126703576|NCT01126580|455865483|FG002|Overall Study|Lack of Efficacy|4|||
126703577|NCT01126580|455865481|FG000|Overall Study|Protocol Violation|0|||
126703578|NCT01126580|455865482|FG001|Overall Study|Protocol Violation|1|||
126703579|NCT01126580|455865483|FG002|Overall Study|Protocol Violation|2|||
126703580|NCT01126580|455865481|FG000|Overall Study|Lost to Follow-up|15|||
126703581|NCT01126580|455865482|FG001|Overall Study|Lost to Follow-up|13|||
126703582|NCT01126580|455865483|FG002|Overall Study|Lost to Follow-up|9|||
126703583|NCT01126580|455865481|FG000|Overall Study|Treatment Non-compliance|0|||
126703584|NCT01126580|455865482|FG001|Overall Study|Treatment Non-compliance|2|||
126703585|NCT01126580|455865483|FG002|Overall Study|Treatment Non-compliance|3|||
126703586|NCT00609622|455865484|FG000|Overall Study|Adverse Event|14|||
126703587|NCT00609622|455865485|FG001|Overall Study|Adverse Event|10|||
126703588|NCT00609622|455865484|FG000|Overall Study|Withdrawal by Subject|4|||
126703589|NCT00609622|455865485|FG001|Overall Study|Withdrawal by Subject|20|||
126703590|NCT00609622|455865484|FG000|Overall Study|Death|1|||
126703591|NCT00609622|455865485|FG001|Overall Study|Death|4|||
126703592|NCT00609622|455865484|FG000|Overall Study|Protocol Violation|1|||
126703593|NCT00609622|455865485|FG001|Overall Study|Protocol Violation|1|||
126703594|NCT00609622|455865484|FG000|Overall Study|Objective progression or relapse|47|||
126703595|NCT00609622|455865485|FG001|Overall Study|Objective progression or relapse|41|||
126703596|NCT00609622|455865484|FG000|Overall Study|Study terminated by sponsor|16|||
126703597|NCT00609622|455865485|FG001|Overall Study|Study terminated by sponsor|3|||
126703598|NCT00609622|455865484|FG000|Overall Study|Other|7|||
126703599|NCT00609622|455865485|FG001|Overall Study|Other|14|||
126703600|NCT00609622|455865484|FG000|Overall Study|Global deterioration of health status|6|||
126703601|NCT00609622|455865485|FG001|Overall Study|Global deterioration of health status|2|||
126703602|NCT00686543|455865486|FG000|Overall Study|Adverse Event|9|||
126703603|NCT00686543|455865487|FG001|Overall Study|Adverse Event|1|||
126703604|NCT00686543|455865488|FG002|Overall Study|Adverse Event|3|||
126703605|NCT00686543|455865489|FG003|Overall Study|Adverse Event|2|||
126703606|NCT00686543|455865486|FG000|Overall Study|Withdrawal by Subject|2|||
126703607|NCT00686543|455865487|FG001|Overall Study|Withdrawal by Subject|0|||
126703608|NCT00686543|455865488|FG002|Overall Study|Withdrawal by Subject|0|||
126703609|NCT00686543|455865489|FG003|Overall Study|Withdrawal by Subject|0|||
126547320|NCT02778399|455296198|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
126703610|NCT00686543|455865486|FG000|Overall Study|Protocol Violation|3|||
126703611|NCT00686543|455865487|FG001|Overall Study|Protocol Violation|0|||
126703612|NCT00686543|455865488|FG002|Overall Study|Protocol Violation|2|||
126703613|NCT00686543|455865489|FG003|Overall Study|Protocol Violation|1|||
126703614|NCT01708057|455865493|FG000|Overall Study|Withdrawal due to study termination.|1|||
126265520|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Death|0|||
126703615|NCT01708057|455865494|FG001|Overall Study|Withdrawal due to study termination.|1|||
126703616|NCT01708057|455865495|FG002|Overall Study|Withdrawal due to study termination.|1|||
126703617|NCT00947349|455865498|FG000|Triple Treatment Combination Period|Adverse Event|0|||
126703618|NCT00947349|455865499|FG001|Triple Treatment Combination Period|Adverse Event|1|||
126703619|NCT00947349|455865500|FG002|Triple Treatment Combination Period|Adverse Event|0|||
126703620|NCT00947349|455865501|FG003|Triple Treatment Combination Period|Adverse Event|0|||
126703621|NCT00947349|455865498|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
126703622|NCT00947349|455865499|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
126703623|NCT00947349|455865500|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
126703624|NCT00947349|455865501|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
126703625|NCT00947349|455865498|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
126703626|NCT00947349|455865499|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
126703627|NCT00947349|455865500|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
126703628|NCT00947349|455865501|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
126703629|NCT00947349|455865498|FG000|Overall Study Standard of Care|Other|0|||
126703630|NCT00947349|455865499|FG001|Overall Study Standard of Care|Other|0|||
126703631|NCT00947349|455865500|FG002|Overall Study Standard of Care|Other|0|||
126703632|NCT00947349|455865501|FG003|Overall Study Standard of Care|Other|1|||
126703633|NCT00538681|455865502|FG000|Overall Study|Progressive Disease|7|||
126703634|NCT00538681|455865503|FG001|Overall Study|Progressive Disease|0|||
126764448|NCT00948896|456089128|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
126764449|NCT00948896|456089129|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
126764450|NCT00948896|456089130|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
126764451|NCT00948896|456089131|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
126764452|NCT00948896|456089124|FG000|24 Months of Age to 36 Months of Age|Death|0|||
126764453|NCT00948896|456089125|FG001|24 Months of Age to 36 Months of Age|Death|2|||
126764454|NCT00948896|456089126|FG002|24 Months of Age to 36 Months of Age|Death|2|||
126265521|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Death|1|||
126265522|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Death|0|||
126265523|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Death|0|||
126265524|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
126265525|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
126265526|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
126265527|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
126265528|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
126265529|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
126265530|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
126265531|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
126265532|NCT02990806|454262868|FG000|Stage 1 (22 Weeks)|Other|1|||
126265533|NCT02990806|454262869|FG001|Stage 1 (22 Weeks)|Other|3|||
126265534|NCT02990806|454262870|FG002|Stage 1 (22 Weeks)|Other|0|||
126265535|NCT02990806|454262871|FG003|Stage 1 (22 Weeks)|Other|0|||
126265536|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
126265537|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
126265538|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
126265539|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
126265540|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Death|1|||
126265541|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Death|0|||
126265542|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Death|0|||
126265543|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Death|0|||
126265544|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
126265545|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
126265546|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
126265547|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
126265548|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
126360278|NCT01655069|454610799|FG000|Overall Study|Adverse Event|6|||
126360279|NCT01655069|454610800|FG001|Overall Study|Adverse Event|7|||
126360280|NCT01655069|454610801|FG002|Overall Study|Adverse Event|2|||
126360281|NCT01655069|454610802|FG003|Overall Study|Adverse Event|3|||
126360282|NCT01655069|454610799|FG000|Overall Study|Lack of Efficacy|0|||
126360283|NCT01655069|454610800|FG001|Overall Study|Lack of Efficacy|1|||
126360284|NCT01655069|454610801|FG002|Overall Study|Lack of Efficacy|0|||
126360285|NCT01655069|454610802|FG003|Overall Study|Lack of Efficacy|0|||
126360286|NCT01655069|454610799|FG000|Overall Study|No Treatment Needed|0|||
126360287|NCT01655069|454610800|FG001|Overall Study|No Treatment Needed|1|||
126360288|NCT01655069|454610801|FG002|Overall Study|No Treatment Needed|0|||
126360289|NCT01655069|454610802|FG003|Overall Study|No Treatment Needed|0|||
126360290|NCT01655069|454610799|FG000|Overall Study|Withdrawal by Subject|2|||
126360291|NCT01655069|454610800|FG001|Overall Study|Withdrawal by Subject|3|||
126360292|NCT01655069|454610801|FG002|Overall Study|Withdrawal by Subject|0|||
126360293|NCT01655069|454610802|FG003|Overall Study|Withdrawal by Subject|0|||
126360294|NCT06399471|454610803|FG000|Overall Study|Withdrawal by Subject|1|||
126360295|NCT03225989|454610804|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
126360296|NCT03225989|454610805|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
126360297|NCT03225989|454610806|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
126265549|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
126265550|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
126265551|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
126703635|NCT00538681|455865504|FG002|Overall Study|Progressive Disease|1|||
126764455|NCT00948896|456089127|FG003|24 Months of Age to 36 Months of Age|Death|0|||
126764456|NCT00948896|456089128|FG004|24 Months of Age to 36 Months of Age|Death|0|||
126764457|NCT00948896|456089129|FG005|24 Months of Age to 36 Months of Age|Death|1|||
126764458|NCT00948896|456089130|FG006|24 Months of Age to 36 Months of Age|Death|0|||
126764459|NCT00948896|456089131|FG007|24 Months of Age to 36 Months of Age|Death|0|||
126764460|NCT00948896|456089124|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
126764461|NCT00948896|456089125|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
126764462|NCT00948896|456089126|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
126764463|NCT00948896|456089127|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
126764464|NCT00948896|456089128|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
126764465|NCT00948896|456089129|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
126764466|NCT00948896|456089130|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
126764467|NCT00948896|456089131|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
126764468|NCT00948896|456089124|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
126764469|NCT00948896|456089125|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
126764470|NCT00948896|456089126|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
126764471|NCT00948896|456089127|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
126764472|NCT00948896|456089128|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
126764473|NCT00948896|456089129|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
126764474|NCT00948896|456089130|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
126764475|NCT00948896|456089131|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
126764476|NCT00948896|456089124|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
126764477|NCT00948896|456089125|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
126764478|NCT00948896|456089126|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
126764479|NCT00948896|456089127|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
126764480|NCT00948896|456089128|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
126764481|NCT00948896|456089129|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
126764482|NCT00948896|456089130|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
126764483|NCT00948896|456089131|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
126764484|NCT00948896|456089124|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126764485|NCT00948896|456089125|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126764486|NCT00948896|456089126|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126764487|NCT00948896|456089127|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
126764488|NCT00948896|456089128|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126764489|NCT00948896|456089129|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126764490|NCT00948896|456089130|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126764491|NCT00948896|456089131|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
126764492|NCT03795233|456089132|FG000|Overall Study|Withdrawal by Subject|2|||
126452921|NCT00600119|454959027|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
126764493|NCT03795233|456089133|FG001|Overall Study|Withdrawal by Subject|1|||
126452922|NCT00600119|454959028|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
126452923|NCT00600119|454959029|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
126452924|NCT00600119|454959030|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
126452925|NCT00600119|454959025|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
126452926|NCT00600119|454959026|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
126452927|NCT00600119|454959027|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
126452928|NCT00600119|454959028|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
126452929|NCT00600119|454959029|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
126452930|NCT00600119|454959030|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
126452931|NCT00600119|454959025|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
126452932|NCT00600119|454959026|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
126547321|NCT02778399|455296199|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
126547322|NCT02778399|455296200|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
126547323|NCT02778399|455296201|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
126764494|NCT03795233|456089132|FG000|Overall Study|Lost to Follow-up|1|||
126764495|NCT03795233|456089133|FG001|Overall Study|Lost to Follow-up|0|||
126764496|NCT03795233|456089132|FG000|Overall Study|Death|1|||
126764497|NCT03795233|456089133|FG001|Overall Study|Death|0|||
126764498|NCT01869959|456089137|FG000|Randomization Period|Physician Decision|0|||
126764499|NCT01869959|456089138|FG001|Randomization Period|Physician Decision|0|||
126764500|NCT01869959|456089139|FG002|Randomization Period|Physician Decision|0|||
126764501|NCT01869959|456089140|FG003|Randomization Period|Physician Decision|0|||
126764502|NCT01869959|456089141|FG004|Randomization Period|Physician Decision|1|||
126764503|NCT01869959|456089137|FG000|Treatment Period|Adverse Event|1|||
126764504|NCT01869959|456089138|FG001|Treatment Period|Adverse Event|0|||
126547324|NCT02778399|455296202|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
126703636|NCT00538681|455865505|FG003|Overall Study|Progressive Disease|0|||
126703637|NCT00538681|455865502|FG000|Overall Study|Sponsor Decision|1|||
126703638|NCT00538681|455865503|FG001|Overall Study|Sponsor Decision|3|||
126703639|NCT00538681|455865504|FG002|Overall Study|Sponsor Decision|8|||
126703640|NCT00538681|455865505|FG003|Overall Study|Sponsor Decision|9|||
126703641|NCT00538681|455865502|FG000|Overall Study|Adverse Event|1|||
126703642|NCT00538681|455865503|FG001|Overall Study|Adverse Event|1|||
126703643|NCT00538681|455865504|FG002|Overall Study|Adverse Event|1|||
126703644|NCT00538681|455865505|FG003|Overall Study|Adverse Event|0|||
126703645|NCT00538681|455865502|FG000|Overall Study|Death|0|||
126703646|NCT00538681|455865503|FG001|Overall Study|Death|0|||
126703647|NCT00538681|455865504|FG002|Overall Study|Death|1|||
126703648|NCT00538681|455865505|FG003|Overall Study|Death|1|||
126703649|NCT00538681|455865502|FG000|Overall Study|Investigator Decision|0|||
126703650|NCT00538681|455865503|FG001|Overall Study|Investigator Decision|0|||
126703651|NCT00538681|455865504|FG002|Overall Study|Investigator Decision|0|||
126703652|NCT00538681|455865505|FG003|Overall Study|Investigator Decision|1|||
126703653|NCT02970929|455865506|FG000|Overall Study|Adverse Event|18|||
126703654|NCT02970929|455865506|FG000|Overall Study|Lack of Efficacy|8|||
126703655|NCT02970929|455865506|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
126703656|NCT02970929|455865506|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
126703657|NCT02970929|455865506|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
126703658|NCT02970929|455865506|FG000|Overall Study|LOST TO FOLLOWUP|6|||
126703659|NCT02970929|455865506|FG000|Overall Study|MOVED OUT OF STATE|1|||
126703660|NCT02970929|455865506|FG000|Overall Study|Withdrawal by Subject|16|||
126703661|NCT03929250|455865515|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
126703662|NCT03929250|455865516|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
126703663|NCT04321343|455865521|FG000|Overall Study|Adverse Event|0|||
126703664|NCT04321343|455865522|FG001|Overall Study|Adverse Event|0|||
126703665|NCT04321343|455865523|FG002|Overall Study|Adverse Event|1|||
126703666|NCT04321343|455865524|FG003|Overall Study|Adverse Event|0|||
126703667|NCT04321343|455865521|FG000|Overall Study|Death|0|||
126703668|NCT04321343|455865522|FG001|Overall Study|Death|0|||
126703669|NCT04321343|455865523|FG002|Overall Study|Death|0|||
126703670|NCT04321343|455865524|FG003|Overall Study|Death|1|||
126703671|NCT04321343|455865521|FG000|Overall Study|Pregnancy|1|||
126703672|NCT04321343|455865522|FG001|Overall Study|Pregnancy|0|||
126703673|NCT04321343|455865523|FG002|Overall Study|Pregnancy|0|||
126703674|NCT04321343|455865524|FG003|Overall Study|Pregnancy|0|||
126703675|NCT04321343|455865521|FG000|Overall Study|Protocol Violation|1|||
126703676|NCT04321343|455865522|FG001|Overall Study|Protocol Violation|1|||
126703677|NCT04321343|455865523|FG002|Overall Study|Protocol Violation|1|||
126703678|NCT04321343|455865524|FG003|Overall Study|Protocol Violation|1|||
126703679|NCT04321343|455865521|FG000|Overall Study|Withdrawal by Subject|0|||
126764505|NCT01869959|456089139|FG002|Treatment Period|Adverse Event|3|||
126764506|NCT01869959|456089140|FG003|Treatment Period|Adverse Event|1|||
126764507|NCT01869959|456089141|FG004|Treatment Period|Adverse Event|0|||
126764508|NCT01869959|456089137|FG000|Treatment Period|Sponsor decision|0|||
126764509|NCT01869959|456089138|FG001|Treatment Period|Sponsor decision|1|||
126764510|NCT01869959|456089139|FG002|Treatment Period|Sponsor decision|0|||
126764511|NCT01869959|456089140|FG003|Treatment Period|Sponsor decision|1|||
126764512|NCT01869959|456089141|FG004|Treatment Period|Sponsor decision|0|||
126764513|NCT01869959|456089137|FG000|Treatment Period|Withdrawal by Subject|0|||
126764514|NCT01869959|456089138|FG001|Treatment Period|Withdrawal by Subject|1|||
126764515|NCT01869959|456089139|FG002|Treatment Period|Withdrawal by Subject|0|||
126764516|NCT01869959|456089140|FG003|Treatment Period|Withdrawal by Subject|0|||
126764517|NCT01869959|456089141|FG004|Treatment Period|Withdrawal by Subject|0|||
126265552|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
126265553|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
126265554|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
126265555|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
126703680|NCT04321343|455865522|FG001|Overall Study|Withdrawal by Subject|6|||
126703681|NCT04321343|455865523|FG002|Overall Study|Withdrawal by Subject|0|||
126703682|NCT04321343|455865524|FG003|Overall Study|Withdrawal by Subject|2|||
126703683|NCT04321343|455865521|FG000|Overall Study|Lost to Follow-up|2|||
126764518|NCT00828009|456089142|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
126703684|NCT04321343|455865522|FG001|Overall Study|Lost to Follow-up|2|||
126764519|NCT00828009|456089142|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
126764520|NCT00828009|456089142|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
126703685|NCT04321343|455865523|FG002|Overall Study|Lost to Follow-up|1|||
126703686|NCT04321343|455865524|FG003|Overall Study|Lost to Follow-up|3|||
126703687|NCT04194944|455865525|FG000|Overall Study|Lost to Follow-up|3|||
126703688|NCT04194944|455865526|FG001|Overall Study|Lost to Follow-up|0|||
126703689|NCT04194944|455865525|FG000|Overall Study|Withdrawal by Subject|2|||
126703690|NCT04194944|455865526|FG001|Overall Study|Withdrawal by Subject|2|||
126764521|NCT00828009|456089142|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
126265556|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
126265557|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
126265558|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
126265559|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
126265560|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
126265561|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
126265562|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
126265563|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
126265564|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
126265565|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
126265566|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
126265567|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
126265568|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
126265569|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
126265570|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
126265571|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
126265572|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
126265573|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
126265574|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
126265575|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
126265576|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
126265577|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
126360298|NCT03225989|454610804|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
126360299|NCT03225989|454610805|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
126360300|NCT03225989|454610806|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
126360301|NCT03225989|454610804|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
126360302|NCT03225989|454610805|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
126360303|NCT03225989|454610806|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
126360304|NCT03225989|454610804|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
126360305|NCT03225989|454610805|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
126360306|NCT03225989|454610806|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
126360307|NCT03225989|454610804|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
126360308|NCT03225989|454610805|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
126360309|NCT03225989|454610806|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
126360310|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
126360311|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
126360312|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
126360313|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
126360314|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
126360315|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
126360316|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
126703691|NCT04194944|455865525|FG000|Overall Study|On Treatment|93|||
126703692|NCT04194944|455865526|FG001|Overall Study|On Treatment|30|||
126703693|NCT03277196|455865538|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
126703694|NCT03277196|455865538|FG000|Overall Study|Lost to Follow-up|3|||
126703695|NCT03277196|455865538|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
126703696|NCT03277196|455865538|FG000|Overall Study|Other|2|||
126703697|NCT05224258|455866525|FG000|Overall Study|Withdrawal by Subject|1|||
126703698|NCT05224258|455866526|FG001|Overall Study|Withdrawal by Subject|1|||
126703699|NCT05224258|455866525|FG000|Overall Study|Physician Decision|1|||
126703700|NCT05224258|455866526|FG001|Overall Study|Physician Decision|1|||
126703701|NCT05224258|455866525|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126703702|NCT05224258|455866526|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126703703|NCT05224258|455866525|FG000|Overall Study|Study Product No Longer in Use|1|||
126703704|NCT05224258|455866526|FG001|Overall Study|Study Product No Longer in Use|0|||
126703705|NCT05224258|455866525|FG000|Overall Study|Adverse Event|0|||
126703706|NCT05224258|455866526|FG001|Overall Study|Adverse Event|1|||
126703707|NCT05224258|455866525|FG000|Overall Study|Protocol Deviation|0|||
126703708|NCT05224258|455866526|FG001|Overall Study|Protocol Deviation|1|||
126703709|NCT01122927|455866528|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
126703710|NCT01122927|455866529|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
126703711|NCT01122927|455866528|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
126703712|NCT01122927|455866529|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
126703713|NCT01122927|455866528|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
126703714|NCT01122927|455866529|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
126703715|NCT01122927|455866528|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
126703716|NCT01122927|455866529|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
126703717|NCT01122927|455866528|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
126703718|NCT01122927|455866529|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
126703719|NCT01122927|455866528|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
126703720|NCT01122927|455866529|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
126703721|NCT01122927|455866528|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
126703722|NCT01122927|455866529|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
126703723|NCT01122927|455866528|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
126703724|NCT01122927|455866529|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
126703725|NCT01122927|455866528|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
126703726|NCT01122927|455866529|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
126703727|NCT01122927|455866528|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
126703728|NCT01122927|455866529|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
126703729|NCT01122927|455866528|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
126703730|NCT01122927|455866529|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
126703731|NCT01122927|455866528|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
126703732|NCT01122927|455866529|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
126703733|NCT00684814|455866530|FG000|Washout Period of 7 Days|Adverse Event|1|||
126703734|NCT00684814|455866531|FG001|Washout Period of 7 Days|Adverse Event|2|||
126703735|NCT00684814|455866530|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
126703736|NCT00684814|455866531|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
126703737|NCT00684814|455866530|FG000|Second Intervention|Adverse Event|1|||
126703738|NCT00684814|455866531|FG001|Second Intervention|Adverse Event|0|||
126265578|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
126265579|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
126265580|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Other|3|||
126265581|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Other|0|||
126265582|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Other|4|||
126265583|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Other|1|||
126265584|NCT02990806|454262868|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
126265585|NCT02990806|454262869|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
126265586|NCT02990806|454262870|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
126265587|NCT02990806|454262871|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
126265588|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
126265589|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
126265590|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
126265591|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
126265592|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
126265593|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
126265594|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
126265595|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
126265596|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
126265597|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
126265598|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
126265599|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
126265600|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
126265601|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
126703739|NCT01676961|455866534|FG000|Overall Study|Death|3|||
126703740|NCT01676961|455866534|FG000|Overall Study|Lost to Follow-up|1|||
126703741|NCT01676961|455866534|FG000|Overall Study|Withdrawal by Subject|1|||
126703742|NCT00117312|455866535|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
126703743|NCT00117312|455866536|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
126703744|NCT00117312|455866537|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
126703745|NCT00117312|455866538|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
126703746|NCT00117312|455866535|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
126703747|NCT00117312|455866536|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
126265602|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
126265603|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
126265604|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
126265605|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
126703748|NCT00117312|455866537|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
126764522|NCT00828009|456089142|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
126265606|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
126265607|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
126265608|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
126265609|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
126703749|NCT00117312|455866538|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
126703750|NCT00117312|455866535|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
126703751|NCT00117312|455866536|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
126703752|NCT00117312|455866537|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
126703753|NCT00117312|455866538|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
126703754|NCT00117312|455866535|FG000|Overall Study|Other|0|||
126703755|NCT00117312|455866536|FG001|Overall Study|Other|1|||
126703756|NCT00117312|455866537|FG002|Overall Study|Other|3|||
126703757|NCT00117312|455866538|FG003|Overall Study|Other|1|||
126703758|NCT00117312|455866535|FG000|Overall Study|Patient choice|0|||
126703759|NCT00117312|455866536|FG001|Overall Study|Patient choice|0|||
126703760|NCT00117312|455866537|FG002|Overall Study|Patient choice|2|||
126764523|NCT00828009|456089142|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
126764524|NCT00828009|456089142|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
126764525|NCT00828009|456089142|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
126764526|NCT00828009|456089142|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
126764527|NCT00828009|456089142|FG000|Step 2 - Maintenance Therapy|Death|1|||
126764528|NCT00828009|456089142|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
126764529|NCT00828009|456089142|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
126764530|NCT00828009|456089142|FG000|Step 2 - Maintenance Therapy|Other|1|||
126764531|NCT00157820|456089151|FG000|Randomized|Physician Decision|4|||
126764532|NCT00157820|456089152|FG001|Randomized|Physician Decision|2|||
126764533|NCT00157820|456089153|FG002|Randomized|Physician Decision|3|||
126764534|NCT00157820|456089151|FG000|Randomized|Withdrawal by Subject|1|||
126764535|NCT00157820|456089152|FG001|Randomized|Withdrawal by Subject|2|||
126764536|NCT00157820|456089153|FG002|Randomized|Withdrawal by Subject|3|||
126764537|NCT00157820|456089151|FG000|Randomized|Protocol Violation|2|||
126764538|NCT00157820|456089152|FG001|Randomized|Protocol Violation|1|||
126764539|NCT00157820|456089153|FG002|Randomized|Protocol Violation|2|||
126764540|NCT00157820|456089151|FG000|1st 8 Month|Death|7|||
126265610|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
126265611|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
126764541|NCT00157820|456089152|FG001|1st 8 Month|Death|8|||
126764542|NCT00157820|456089153|FG002|1st 8 Month|Death|3|||
126764543|NCT00157820|456089151|FG000|1st 8 Month|Lost to Follow-up|1|||
126764544|NCT00157820|456089152|FG001|1st 8 Month|Lost to Follow-up|2|||
126764545|NCT00157820|456089153|FG002|1st 8 Month|Lost to Follow-up|1|||
126764546|NCT00157820|456089151|FG000|1st 8 Month|Premature cross-over|0|||
126764547|NCT00157820|456089152|FG001|1st 8 Month|Premature cross-over|2|||
126764548|NCT00157820|456089153|FG002|1st 8 Month|Premature cross-over|2|||
126764549|NCT00157820|456089151|FG000|2nd 8 Months|Death|3|||
126764550|NCT00157820|456089152|FG001|2nd 8 Months|Death|1|||
126764551|NCT00157820|456089153|FG002|2nd 8 Months|Death|3|||
126764552|NCT00157820|456089151|FG000|2nd 8 Months|Lost to Follow-up|1|||
126764553|NCT00157820|456089152|FG001|2nd 8 Months|Lost to Follow-up|5|||
126764554|NCT00157820|456089153|FG002|2nd 8 Months|Lost to Follow-up|2|||
126764555|NCT00157820|456089151|FG000|2nd 8 Months|Premature cross-over|1|||
126764556|NCT00157820|456089152|FG001|2nd 8 Months|Premature cross-over|7|||
126265612|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
126265613|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
126265614|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
126265615|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
126265616|NCT02990806|454262868|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
126265617|NCT02990806|454262869|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
126265618|NCT02990806|454262870|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
126764557|NCT00157820|456089153|FG002|2nd 8 Months|Premature cross-over|9|||
126360317|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
126764558|NCT01721369|456089154|FG000|Overall Study|Not initial etiological diagnosis|12|||
126360318|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
126360319|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
126360320|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
126360321|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
126360322|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
126360323|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
126360324|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
126360325|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
126360326|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
126360327|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
126360328|NCT03225989|454610804|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
126703761|NCT00117312|455866538|FG003|Overall Study|Patient choice|1|||
126703762|NCT00117312|455866535|FG000|Overall Study|Adverse Event|0|||
126764559|NCT00563706|456090909|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
126764560|NCT00563706|456090910|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
126764561|NCT00563706|456090911|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
126764562|NCT00563706|456090912|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
126764563|NCT00563706|456090913|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
126265619|NCT02990806|454262871|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
126265620|NCT03739138|454262873|FG000|Overall Study|Death|0|||
126265621|NCT03739138|454262874|FG001|Overall Study|Death|7|||
126265622|NCT03739138|454262875|FG002|Overall Study|Death|4|||
126265623|NCT03739138|454262876|FG003|Overall Study|Death|13|||
126265624|NCT03739138|454262877|FG004|Overall Study|Death|0|||
126265625|NCT03739138|454262873|FG000|Overall Study|Lost to Follow-up|0|||
126265626|NCT03739138|454262874|FG001|Overall Study|Lost to Follow-up|0|||
126265627|NCT03739138|454262875|FG002|Overall Study|Lost to Follow-up|1|||
126265628|NCT03739138|454262876|FG003|Overall Study|Lost to Follow-up|0|||
126265629|NCT03739138|454262877|FG004|Overall Study|Lost to Follow-up|0|||
126265630|NCT03739138|454262873|FG000|Overall Study|Study Terminated By Sponsor|0|||
126265631|NCT03739138|454262874|FG001|Overall Study|Study Terminated By Sponsor|0|||
126265632|NCT03739138|454262875|FG002|Overall Study|Study Terminated By Sponsor|0|||
126265633|NCT03739138|454262876|FG003|Overall Study|Study Terminated By Sponsor|4|||
126265634|NCT03739138|454262877|FG004|Overall Study|Study Terminated By Sponsor|0|||
126265635|NCT03739138|454262873|FG000|Overall Study|Withdrawal by Subject|0|||
126703763|NCT00117312|455866536|FG001|Overall Study|Adverse Event|2|||
126703764|NCT00117312|455866537|FG002|Overall Study|Adverse Event|0|||
126703765|NCT00117312|455866538|FG003|Overall Study|Adverse Event|0|||
126703766|NCT00117312|455866535|FG000|Overall Study|Protocol Violation|0|||
126703767|NCT00117312|455866536|FG001|Overall Study|Protocol Violation|1|||
126703768|NCT00117312|455866537|FG002|Overall Study|Protocol Violation|3|||
126703769|NCT00117312|455866538|FG003|Overall Study|Protocol Violation|0|||
126703770|NCT00117312|455866535|FG000|Overall Study|PSA decrease <=50%|0|||
126703771|NCT00117312|455866536|FG001|Overall Study|PSA decrease <=50%|2|||
126703772|NCT00117312|455866537|FG002|Overall Study|PSA decrease <=50%|2|||
126703773|NCT00117312|455866538|FG003|Overall Study|PSA decrease <=50%|4|||
126703774|NCT00117312|455866535|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
126703775|NCT00117312|455866536|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
126703776|NCT00117312|455866537|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
126703777|NCT00117312|455866538|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
126703778|NCT00117312|455866535|FG000|Overall Study|Hepatic abnormality|0|||
126703779|NCT00117312|455866536|FG001|Overall Study|Hepatic abnormality|1|||
126703780|NCT00117312|455866537|FG002|Overall Study|Hepatic abnormality|0|||
126703781|NCT00117312|455866538|FG003|Overall Study|Hepatic abnormality|1|||
126703782|NCT00117312|455866535|FG000|Overall Study|Withdrawal by Subject|0|||
126703783|NCT00117312|455866536|FG001|Overall Study|Withdrawal by Subject|2|||
126703784|NCT00117312|455866537|FG002|Overall Study|Withdrawal by Subject|0|||
126703785|NCT00117312|455866538|FG003|Overall Study|Withdrawal by Subject|0|||
126703786|NCT00195650|455866539|FG000|Overall Study|Adverse Event|194|||
126703787|NCT00195650|455866539|FG000|Overall Study|Lack of Efficacy|99|||
126703788|NCT00195650|455866539|FG000|Overall Study|Withdrawal by Subject|67|||
126703789|NCT00195650|455866539|FG000|Overall Study|Lost to Follow-up|44|||
126703790|NCT00195650|455866539|FG000|Overall Study|Death|23|||
126703791|NCT00195650|455866539|FG000|Overall Study|Protocol Violation|15|||
126703792|NCT00195650|455866539|FG000|Overall Study|Administrative reasons|83|||
126703793|NCT03375320|455866540|FG000|Overall Study|Adverse Event|34|||
126703794|NCT03375320|455866541|FG001|Overall Study|Adverse Event|9|||
126703795|NCT03375320|455866542|FG002|Overall Study|Adverse Event|10|||
126703796|NCT03375320|455866543|FG003|Overall Study|Adverse Event|0|||
126703797|NCT03375320|455866540|FG000|Overall Study|Death|6|||
126703798|NCT03375320|455866541|FG001|Overall Study|Death|3|||
126703799|NCT03375320|455866542|FG002|Overall Study|Death|0|||
126703800|NCT03375320|455866543|FG003|Overall Study|Death|0|||
126703801|NCT03375320|455866540|FG000|Overall Study|Withdrawal by Subject|7|||
126703802|NCT03375320|455866541|FG001|Overall Study|Withdrawal by Subject|4|||
126703803|NCT03375320|455866542|FG002|Overall Study|Withdrawal by Subject|5|||
126703804|NCT03375320|455866543|FG003|Overall Study|Withdrawal by Subject|4|||
126703805|NCT03375320|455866540|FG000|Overall Study|Progressive disease|55|||
126703806|NCT03375320|455866541|FG001|Overall Study|Progressive disease|41|||
126265636|NCT03739138|454262874|FG001|Overall Study|Withdrawal by Subject|0|||
126547325|NCT02778399|455296203|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
126703807|NCT03375320|455866542|FG002|Overall Study|Progressive disease|29|||
126703808|NCT03375320|455866543|FG003|Overall Study|Progressive disease|24|||
126265637|NCT03739138|454262875|FG002|Overall Study|Withdrawal by Subject|0|||
126265638|NCT03739138|454262876|FG003|Overall Study|Withdrawal by Subject|1|||
126265639|NCT03739138|454262877|FG004|Overall Study|Withdrawal by Subject|0|||
126265640|NCT04403763|454262878|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
126703809|NCT03375320|455866540|FG000|Overall Study|Alternative treatment|6|||
126703810|NCT03375320|455866541|FG001|Overall Study|Alternative treatment|1|||
126703811|NCT03375320|455866542|FG002|Overall Study|Alternative treatment|1|||
126703812|NCT03375320|455866543|FG003|Overall Study|Alternative treatment|0|||
126703813|NCT03375320|455866540|FG000|Overall Study|Other disease|1|||
126703814|NCT03375320|455866541|FG001|Overall Study|Other disease|1|||
126703815|NCT03375320|455866542|FG002|Overall Study|Other disease|3|||
126703816|NCT03375320|455866543|FG003|Overall Study|Other disease|0|||
126703817|NCT03375320|455866540|FG000|Overall Study|Withdrawal prior to initiation|2|||
126703818|NCT03375320|455866541|FG001|Overall Study|Withdrawal prior to initiation|2|||
126703819|NCT03375320|455866542|FG002|Overall Study|Withdrawal prior to initiation|1|||
126703820|NCT03375320|455866543|FG003|Overall Study|Withdrawal prior to initiation|0|||
126764564|NCT00563706|456090914|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
126764565|NCT00563706|456090915|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
126764566|NCT00563706|456090916|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
126764567|NCT00563706|456090917|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
126764568|NCT00563706|456090909|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
126764569|NCT00563706|456090910|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
126764570|NCT00563706|456090911|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
126764571|NCT00563706|456090912|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
126764572|NCT00563706|456090913|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
126764573|NCT00563706|456090914|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
126764574|NCT00563706|456090915|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
126764575|NCT00563706|456090916|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
126764576|NCT00563706|456090917|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
126764577|NCT00563706|456090909|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
126764578|NCT00563706|456090910|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
126764579|NCT00563706|456090911|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
126764580|NCT00563706|456090912|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
126764581|NCT00563706|456090913|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
126764582|NCT00563706|456090914|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
126764583|NCT00563706|456090915|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
126764584|NCT00563706|456090916|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
126764585|NCT00563706|456090917|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
126764586|NCT00563706|456090909|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
126764587|NCT00563706|456090910|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126764588|NCT00563706|456090911|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126764589|NCT00563706|456090912|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126764590|NCT00563706|456090913|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126764591|NCT00563706|456090914|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126764592|NCT00563706|456090915|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126764593|NCT00563706|456090916|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
126764594|NCT00563706|456090917|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
126764595|NCT00563706|456090909|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126764596|NCT00563706|456090910|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126764597|NCT00563706|456090911|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126764598|NCT00563706|456090912|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126764599|NCT00563706|456090913|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126764600|NCT00563706|456090914|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126764601|NCT00563706|456090915|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
126764602|NCT00563706|456090916|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
126764603|NCT00563706|456090917|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
126764604|NCT00822237|456090918|FG000|Dose 1 Vaccination|Not vaccinated|3|||
126764605|NCT00822237|456090919|FG001|Dose 1 Vaccination|Not vaccinated|0|||
126764606|NCT00822237|456090918|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
126764607|NCT00822237|456090919|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
126764608|NCT00822237|456090918|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
126764609|NCT00822237|456090919|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
126764610|NCT00822237|456090918|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
126764611|NCT00822237|456090919|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
126703821|NCT03375320|455866540|FG000|Overall Study|Physician Decision|1|||
126703822|NCT03375320|455866541|FG001|Overall Study|Physician Decision|1|||
126703823|NCT03375320|455866542|FG002|Overall Study|Physician Decision|1|||
126703824|NCT03375320|455866543|FG003|Overall Study|Physician Decision|1|||
126703825|NCT03375320|455866540|FG000|Overall Study|Non-compliance|1|||
126703826|NCT03375320|455866541|FG001|Overall Study|Non-compliance|0|||
126703827|NCT03375320|455866542|FG002|Overall Study|Non-compliance|0|||
126703828|NCT03375320|455866543|FG003|Overall Study|Non-compliance|0|||
126703829|NCT01128387|455866544|FG000|Overall Study|Physician Decision|0|||
126703830|NCT01128387|455866545|FG001|Overall Study|Physician Decision|1|||
126703831|NCT01535235|455866546|FG000|Overall Study|Adverse Event|1|||
126764612|NCT00822237|456090918|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
126764613|NCT00822237|456090919|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
126452933|NCT00600119|454959027|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
126265641|NCT04403763|454262879|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
126703832|NCT01535235|455866547|FG001|Overall Study|Adverse Event|0|||
126703833|NCT01794780|455866553|FG000|Overall Study|Adverse Event|0|||
126452934|NCT00600119|454959028|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
126452935|NCT00600119|454959029|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
126452936|NCT00600119|454959030|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
126452937|NCT00600119|454959025|FG000|Double-blind Treatment Period|Physician Decision|2|||
126452938|NCT00600119|454959026|FG001|Double-blind Treatment Period|Physician Decision|0|||
126452939|NCT00600119|454959027|FG002|Double-blind Treatment Period|Physician Decision|0|||
126452940|NCT00600119|454959028|FG003|Double-blind Treatment Period|Physician Decision|0|||
126452941|NCT00600119|454959029|FG004|Double-blind Treatment Period|Physician Decision|0|||
126703834|NCT01794780|455866554|FG001|Overall Study|Adverse Event|1|||
126703835|NCT01794780|455866555|FG002|Overall Study|Adverse Event|2|||
126703836|NCT01794780|455866556|FG003|Overall Study|Adverse Event|0|||
126703837|NCT01794780|455866557|FG004|Overall Study|Adverse Event|0|||
126703838|NCT01794780|455866558|FG005|Overall Study|Adverse Event|0|||
126703839|NCT01794780|455866559|FG006|Overall Study|Adverse Event|0|||
126703840|NCT01794780|455866560|FG007|Overall Study|Adverse Event|0|||
126703841|NCT01794780|455866553|FG000|Overall Study|Death|0|||
126703842|NCT01794780|455866554|FG001|Overall Study|Death|2|||
126703843|NCT01794780|455866555|FG002|Overall Study|Death|14|||
126703844|NCT01794780|455866556|FG003|Overall Study|Death|1|||
126703845|NCT01794780|455866557|FG004|Overall Study|Death|0|||
126703846|NCT01794780|455866558|FG005|Overall Study|Death|9|||
126703847|NCT01794780|455866559|FG006|Overall Study|Death|4|||
126703848|NCT01794780|455866560|FG007|Overall Study|Death|0|||
126703849|NCT01794780|455866553|FG000|Overall Study|Lost to Follow-up|10|||
126703850|NCT01794780|455866554|FG001|Overall Study|Lost to Follow-up|64|||
126703851|NCT01794780|455866555|FG002|Overall Study|Lost to Follow-up|165|||
126703852|NCT01794780|455866556|FG003|Overall Study|Lost to Follow-up|53|||
126703853|NCT01794780|455866557|FG004|Overall Study|Lost to Follow-up|2|||
126703854|NCT01794780|455866558|FG005|Overall Study|Lost to Follow-up|99|||
126703855|NCT01794780|455866559|FG006|Overall Study|Lost to Follow-up|30|||
126703856|NCT01794780|455866560|FG007|Overall Study|Lost to Follow-up|5|||
126703857|NCT01794780|455866553|FG000|Overall Study|Withdrew informed consent|7|||
126703858|NCT01794780|455866554|FG001|Overall Study|Withdrew informed consent|17|||
126703859|NCT01794780|455866555|FG002|Overall Study|Withdrew informed consent|36|||
126703860|NCT01794780|455866556|FG003|Overall Study|Withdrew informed consent|9|||
126703861|NCT01794780|455866557|FG004|Overall Study|Withdrew informed consent|0|||
126703862|NCT01794780|455866558|FG005|Overall Study|Withdrew informed consent|48|||
126703863|NCT01794780|455866559|FG006|Overall Study|Withdrew informed consent|4|||
126703864|NCT01794780|455866560|FG007|Overall Study|Withdrew informed consent|3|||
126703865|NCT01794780|455866553|FG000|Overall Study|Other|0|||
126703866|NCT01794780|455866554|FG001|Overall Study|Other|12|||
126703867|NCT01794780|455866555|FG002|Overall Study|Other|25|||
126703868|NCT01794780|455866556|FG003|Overall Study|Other|20|||
126703869|NCT01794780|455866557|FG004|Overall Study|Other|1|||
126703870|NCT01794780|455866558|FG005|Overall Study|Other|24|||
126703871|NCT01794780|455866559|FG006|Overall Study|Other|4|||
126703872|NCT01794780|455866560|FG007|Overall Study|Other|1|||
126703873|NCT02286102|455866561|FG000|Overall Study|Screen Failure|1|||
126703874|NCT02286102|455866562|FG001|Overall Study|Screen Failure|1|||
126703875|NCT02690701|455866566|FG000|Treatment Period 1|Adverse Event|2|||
126703876|NCT02690701|455866567|FG001|Treatment Period 1|Adverse Event|2|||
126703877|NCT02690701|455866566|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126703878|NCT02690701|455866567|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126703879|NCT02690701|455866566|FG000|Treatment Period 2|Adverse Event|2|||
126703880|NCT02690701|455866567|FG001|Treatment Period 2|Adverse Event|0|||
126703881|NCT02690701|455866566|FG000|Treatment Period 2|Lack of Efficacy|1|||
126703882|NCT02690701|455866567|FG001|Treatment Period 2|Lack of Efficacy|0|||
126703883|NCT02690701|455866566|FG000|Treatment Period 2|Lost to Follow-up|0|||
126703884|NCT02690701|455866567|FG001|Treatment Period 2|Lost to Follow-up|2|||
126703885|NCT02690701|455866566|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126703886|NCT02690701|455866567|FG001|Treatment Period 2|Withdrawal by Subject|2|||
126703887|NCT02690701|455866566|FG000|Treatment Period 2|Protocol Violation|0|||
126703888|NCT02690701|455866567|FG001|Treatment Period 2|Protocol Violation|1|||
126703889|NCT01442181|455866568|FG000|Overall Study|patient refused surgery|1|||
126703890|NCT01442181|455866569|FG001|Overall Study|patient refused surgery|0|||
126703891|NCT01442181|455866568|FG000|Overall Study|no insurance for surgery|1|||
126703892|NCT01442181|455866569|FG001|Overall Study|no insurance for surgery|0|||
126703893|NCT01442181|455866568|FG000|Overall Study|low ejection factor|0|||
126703894|NCT01442181|455866569|FG001|Overall Study|low ejection factor|1|||
126703895|NCT01442181|455866568|FG000|Overall Study|Lost to Follow-up|1|||
126703896|NCT01442181|455866569|FG001|Overall Study|Lost to Follow-up|1|||
126452942|NCT00600119|454959030|FG005|Double-blind Treatment Period|Physician Decision|0|||
126452943|NCT00600119|454959025|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126703897|NCT01442181|455866568|FG000|Overall Study|patient in an additional study|1|||
126703898|NCT01442181|455866569|FG001|Overall Study|patient in an additional study|0|||
126703899|NCT01442181|455866568|FG000|Overall Study|atrial fibrillation not noted|0|||
126703900|NCT01442181|455866569|FG001|Overall Study|atrial fibrillation not noted|1|||
126703901|NCT00749203|455866570|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
126265642|NCT04403763|454262880|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
126452944|NCT00600119|454959026|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
126452945|NCT00600119|454959027|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
126452946|NCT00600119|454959028|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
126452947|NCT00600119|454959029|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
126452948|NCT00600119|454959030|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
126452949|NCT00600119|454959025|FG000|Double-blind Treatment Period|Adverse Event|1|||
126452950|NCT00600119|454959026|FG001|Double-blind Treatment Period|Adverse Event|1|||
126452951|NCT00600119|454959027|FG002|Double-blind Treatment Period|Adverse Event|0|||
126452952|NCT00600119|454959028|FG003|Double-blind Treatment Period|Adverse Event|1|||
126452953|NCT00600119|454959029|FG004|Double-blind Treatment Period|Adverse Event|2|||
126452954|NCT00600119|454959030|FG005|Double-blind Treatment Period|Adverse Event|10|||
126452955|NCT00600119|454959025|FG000|Follow-up Period|Adverse Event|0|||
126452956|NCT00600119|454959026|FG001|Follow-up Period|Adverse Event|0|||
126452957|NCT00600119|454959027|FG002|Follow-up Period|Adverse Event|0|||
126452958|NCT00600119|454959028|FG003|Follow-up Period|Adverse Event|0|||
126452959|NCT00600119|454959029|FG004|Follow-up Period|Adverse Event|0|||
126452960|NCT00600119|454959030|FG005|Follow-up Period|Adverse Event|1|||
126452961|NCT00600119|454959025|FG000|Follow-up Period|Other|1|||
126452962|NCT00600119|454959026|FG001|Follow-up Period|Other|0|||
126452963|NCT00600119|454959027|FG002|Follow-up Period|Other|0|||
126452964|NCT00600119|454959028|FG003|Follow-up Period|Other|0|||
126452965|NCT00600119|454959029|FG004|Follow-up Period|Other|0|||
126452966|NCT00600119|454959030|FG005|Follow-up Period|Other|0|||
126452967|NCT00729469|454959031|FG000|Overall Study|Adverse Event|14|||
126452968|NCT00729469|454959032|FG001|Overall Study|Adverse Event|25|||
126452969|NCT00729469|454959031|FG000|Overall Study|Lost to Follow-up|9|||
126452970|NCT00729469|454959032|FG001|Overall Study|Lost to Follow-up|9|||
126452971|NCT00729469|454959031|FG000|Overall Study|Protocol Violation|2|||
126703902|NCT00749203|455866571|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
126703903|NCT00749203|455866570|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
126703904|NCT00749203|455866571|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
126703905|NCT00749203|455866570|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
126703906|NCT00749203|455866571|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
126703907|NCT00749203|455866570|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
126703908|NCT00749203|455866571|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
126703909|NCT00749203|455866570|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
126703910|NCT00749203|455866571|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
126703911|NCT00749203|455866570|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
126703912|NCT00749203|455866571|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
126703913|NCT01642212|455866573|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
126703914|NCT01642212|455866574|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
126703915|NCT01642212|455866575|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
126703916|NCT01642212|455866576|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
126703917|NCT01642212|455866577|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
126703918|NCT01642212|455866573|FG000|Double-blind Treatment|Other|0|||
126703919|NCT01642212|455866574|FG001|Double-blind Treatment|Other|2|||
126703920|NCT01642212|455866575|FG002|Double-blind Treatment|Other|1|||
126703921|NCT01642212|455866576|FG003|Double-blind Treatment|Other|0|||
126703922|NCT01642212|455866577|FG004|Double-blind Treatment|Other|0|||
126703923|NCT01642212|455866573|FG000|Double-blind Treatment|Non-compliance|0|||
126703924|NCT01642212|455866574|FG001|Double-blind Treatment|Non-compliance|1|||
126764614|NCT00299546|456090920|FG000|Overall Study|Death|3|||
126764615|NCT00299546|456090921|FG001|Overall Study|Death|2|||
126265643|NCT04403763|454262881|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
126265644|NCT04403763|454262882|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
126265645|NCT04403763|454262883|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
126265646|NCT04403763|454262884|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
126265647|NCT04403763|454262878|FG000|Stage 1|Early termination due to PK tube failure|0|||
126265648|NCT04403763|454262879|FG001|Stage 1|Early termination due to PK tube failure|0|||
126265649|NCT04403763|454262880|FG002|Stage 1|Early termination due to PK tube failure|1|||
126265650|NCT04403763|454262881|FG003|Stage 1|Early termination due to PK tube failure|0|||
126265651|NCT04403763|454262882|FG004|Stage 1|Early termination due to PK tube failure|0|||
126360329|NCT03225989|454610805|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
126703925|NCT01642212|455866575|FG002|Double-blind Treatment|Non-compliance|0|||
126764616|NCT00299546|456090922|FG002|Overall Study|Death|0|||
126360330|NCT03225989|454610806|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
126360331|NCT00601107|454610807|FG000|Overall Study|Adverse Event|0|||
126360332|NCT00601107|454610808|FG001|Overall Study|Adverse Event|1|||
126360333|NCT00601107|454610809|FG002|Overall Study|Adverse Event|3|||
126360334|NCT00601107|454610810|FG003|Overall Study|Adverse Event|0|||
126360335|NCT00601107|454610807|FG000|Overall Study|Withdrawal by Subject|5|||
126360336|NCT00601107|454610808|FG001|Overall Study|Withdrawal by Subject|4|||
126360337|NCT00601107|454610809|FG002|Overall Study|Withdrawal by Subject|7|||
126764617|NCT00299546|456090920|FG000|Overall Study|Lost to Follow-up|2|||
126764618|NCT00299546|456090921|FG001|Overall Study|Lost to Follow-up|2|||
126764619|NCT00299546|456090922|FG002|Overall Study|Lost to Follow-up|5|||
126764620|NCT00299546|456090920|FG000|Overall Study|Adverse Event|37|||
126764621|NCT00299546|456090921|FG001|Overall Study|Adverse Event|22|||
126764622|NCT00299546|456090922|FG002|Overall Study|Adverse Event|27|||
126764623|NCT00299546|456090920|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
126764624|NCT00299546|456090921|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
126764625|NCT00299546|456090922|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
126764626|NCT00299546|456090920|FG000|Overall Study|Other|24|||
126764627|NCT00299546|456090921|FG001|Overall Study|Other|26|||
126764628|NCT00299546|456090922|FG002|Overall Study|Other|19|||
126764629|NCT00299546|456090920|FG000|Overall Study|Not treated|0|||
126764630|NCT00299546|456090921|FG001|Overall Study|Not treated|1|||
126764631|NCT00299546|456090922|FG002|Overall Study|Not treated|1|||
126764632|NCT03099265|456090923|FG000|Overall Study|Adverse Event|1|||
126764633|NCT02526017|456090927|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126764634|NCT02526017|456090928|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126764635|NCT02526017|456090929|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126360338|NCT00601107|454610810|FG003|Overall Study|Withdrawal by Subject|4|||
126360339|NCT00601107|454610807|FG000|Overall Study|Lost to Follow-up|3|||
126360340|NCT00601107|454610808|FG001|Overall Study|Lost to Follow-up|3|||
126360341|NCT00601107|454610809|FG002|Overall Study|Lost to Follow-up|0|||
126452972|NCT00729469|454959032|FG001|Overall Study|Protocol Violation|1|||
126452973|NCT00729469|454959031|FG000|Overall Study|Withdrawal by Subject|19|||
126452974|NCT00729469|454959032|FG001|Overall Study|Withdrawal by Subject|8|||
126452975|NCT00729469|454959031|FG000|Overall Study|Other-Not mentioned|9|||
126452976|NCT00729469|454959032|FG001|Overall Study|Other-Not mentioned|4|||
126703926|NCT01642212|455866576|FG003|Double-blind Treatment|Non-compliance|0|||
126703927|NCT01642212|455866577|FG004|Double-blind Treatment|Non-compliance|0|||
126703928|NCT01642212|455866573|FG000|Double-blind Treatment|Adverse Event|0|||
126452977|NCT01270802|454959035|FG000|Overall Study|Withdrawal by Subject|1|||
126452978|NCT01270802|454959036|FG001|Overall Study|Withdrawal by Subject|0|||
126452979|NCT01270802|454959035|FG000|Overall Study|Adverse Event|1|||
126452980|NCT01270802|454959036|FG001|Overall Study|Adverse Event|0|||
126452981|NCT01270802|454959035|FG000|Overall Study|Lost to Follow-up|0|||
126703929|NCT01642212|455866574|FG001|Double-blind Treatment|Adverse Event|0|||
126703930|NCT01642212|455866575|FG002|Double-blind Treatment|Adverse Event|1|||
126703931|NCT01642212|455866576|FG003|Double-blind Treatment|Adverse Event|0|||
126703932|NCT01642212|455866577|FG004|Double-blind Treatment|Adverse Event|0|||
126703933|NCT01642212|455866573|FG000|Open-label Extension|Adverse Event|0|||
126703934|NCT01642212|455866574|FG001|Open-label Extension|Adverse Event|0|||
126703935|NCT01642212|455866575|FG002|Open-label Extension|Adverse Event|0|||
126703936|NCT01642212|455866576|FG003|Open-label Extension|Adverse Event|3|||
126703937|NCT01642212|455866577|FG004|Open-label Extension|Adverse Event|0|||
126764636|NCT02526017|456090930|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126764637|NCT02526017|456090931|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
126764638|NCT02526017|456090932|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126360342|NCT00601107|454610810|FG003|Overall Study|Lost to Follow-up|3|||
126360343|NCT00601107|454610807|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
126360344|NCT00601107|454610808|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
126360345|NCT00601107|454610809|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
126360346|NCT00601107|454610810|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
126360347|NCT00601107|454610807|FG000|Overall Study|Worsening of Psoriasis|4|||
126360348|NCT00601107|454610808|FG001|Overall Study|Worsening of Psoriasis|1|||
126360349|NCT00601107|454610809|FG002|Overall Study|Worsening of Psoriasis|1|||
126360350|NCT00601107|454610810|FG003|Overall Study|Worsening of Psoriasis|4|||
126360351|NCT00601107|454610807|FG000|Overall Study|Undefined|1|||
126360352|NCT00601107|454610808|FG001|Overall Study|Undefined|0|||
126360353|NCT00601107|454610809|FG002|Overall Study|Undefined|1|||
126360354|NCT00601107|454610810|FG003|Overall Study|Undefined|0|||
126360355|NCT00147537|454610812|FG000|Phase 1b|Death|0|||
126360356|NCT00147537|454610813|FG001|Phase 1b|Death|1|||
126360357|NCT00147537|454610814|FG002|Phase 1b|Death|2|||
126360358|NCT00147537|454610815|FG003|Phase 1b|Death|1|||
126452982|NCT01270802|454959036|FG001|Overall Study|Lost to Follow-up|1|||
126452983|NCT00832624|454959042|FG000|Overall Study|Study Terminated|10|||
126452984|NCT02395172|454959043|FG000|Overall Study|Participants randomized but not treated|3|||
126764639|NCT02526017|456090933|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126360359|NCT00147537|454610816|FG004|Phase 1b|Death|2|||
126360360|NCT00147537|454610817|FG005|Phase 1b|Death|2|||
126360361|NCT00147537|454610818|FG006|Phase 1b|Death|1|||
126360362|NCT00147537|454610819|FG007|Phase 1b|Death|3|||
126360363|NCT00147537|454610820|FG008|Phase 1b|Death|9|||
126703938|NCT01642212|455866573|FG000|Open-label Extension|Sponsor Decision|0|||
126703939|NCT01642212|455866574|FG001|Open-label Extension|Sponsor Decision|0|||
126703940|NCT01642212|455866575|FG002|Open-label Extension|Sponsor Decision|0|||
126703941|NCT01642212|455866576|FG003|Open-label Extension|Sponsor Decision|7|||
126452985|NCT02395172|454959044|FG001|Overall Study|Participants randomized but not treated|31|||
126703942|NCT01642212|455866577|FG004|Open-label Extension|Sponsor Decision|4|||
126703943|NCT01642212|455866573|FG000|Open-label Extension|Consent Withdrawn|0|||
126703944|NCT01642212|455866574|FG001|Open-label Extension|Consent Withdrawn|0|||
126703945|NCT01642212|455866575|FG002|Open-label Extension|Consent Withdrawn|0|||
126703946|NCT01642212|455866576|FG003|Open-label Extension|Consent Withdrawn|0|||
126703947|NCT01642212|455866577|FG004|Open-label Extension|Consent Withdrawn|2|||
126703948|NCT01642212|455866573|FG000|Open-label Extension|Lost to Follow-up|0|||
126703949|NCT01642212|455866574|FG001|Open-label Extension|Lost to Follow-up|0|||
126703950|NCT01642212|455866575|FG002|Open-label Extension|Lost to Follow-up|0|||
126703951|NCT01642212|455866576|FG003|Open-label Extension|Lost to Follow-up|0|||
126703952|NCT01642212|455866577|FG004|Open-label Extension|Lost to Follow-up|1|||
126703953|NCT01642212|455866573|FG000|Open-label Extension|Other|0|||
126703954|NCT01642212|455866574|FG001|Open-label Extension|Other|0|||
126703955|NCT01642212|455866575|FG002|Open-label Extension|Other|0|||
126703956|NCT01642212|455866576|FG003|Open-label Extension|Other|0|||
126703957|NCT01642212|455866577|FG004|Open-label Extension|Other|1|||
126703958|NCT01299025|455866578|FG000|Overall Study|Withdrawal by Subject|2|||
126703959|NCT01299025|455866579|FG001|Overall Study|Withdrawal by Subject|1|||
126703960|NCT01299025|455866578|FG000|Overall Study|Lost to Follow-up|1|||
126703961|NCT01299025|455866579|FG001|Overall Study|Lost to Follow-up|0|||
126703962|NCT03577990|455866580|FG000|Overall Study|Lost to Follow-up|4|||
126703963|NCT03577990|455866581|FG001|Overall Study|Lost to Follow-up|6|||
126703964|NCT03577990|455866580|FG000|Overall Study|Withdrawal by Subject|4|||
126703965|NCT03577990|455866581|FG001|Overall Study|Withdrawal by Subject|7|||
126703966|NCT04996797|455866582|FG000|Overall Study|Adverse Event|0|||
126703967|NCT04996797|455866583|FG001|Overall Study|Adverse Event|2|||
126703968|NCT04996797|455866584|FG002|Overall Study|Adverse Event|0|||
126703969|NCT04996797|455866585|FG003|Overall Study|Adverse Event|1|||
126703970|NCT04996797|455866582|FG000|Overall Study|Lack of Efficacy|0|||
126703971|NCT04996797|455866583|FG001|Overall Study|Lack of Efficacy|2|||
126703972|NCT04996797|455866584|FG002|Overall Study|Lack of Efficacy|0|||
126703973|NCT04996797|455866585|FG003|Overall Study|Lack of Efficacy|0|||
126703974|NCT04996797|455866582|FG000|Overall Study|Prohibited Medication|0|||
126703975|NCT04996797|455866583|FG001|Overall Study|Prohibited Medication|1|||
126703976|NCT04996797|455866584|FG002|Overall Study|Prohibited Medication|0|||
126703977|NCT04996797|455866585|FG003|Overall Study|Prohibited Medication|0|||
126703978|NCT04996797|455866582|FG000|Overall Study|Ongoing|68|||
126703979|NCT04996797|455866583|FG001|Overall Study|Ongoing|60|||
126703980|NCT04996797|455866584|FG002|Overall Study|Ongoing|22|||
126703981|NCT04996797|455866585|FG003|Overall Study|Ongoing|20|||
126703982|NCT04996797|455866582|FG000|Overall Study|Withdrawal by Subject|0|||
126703983|NCT04996797|455866583|FG001|Overall Study|Withdrawal by Subject|2|||
126703984|NCT04996797|455866584|FG002|Overall Study|Withdrawal by Subject|0|||
126703985|NCT04996797|455866585|FG003|Overall Study|Withdrawal by Subject|0|||
126703986|NCT02793544|455866586|FG000|Overall Study|Death|10|||
126703987|NCT02793544|455866587|FG001|Overall Study|Death|8|||
126703988|NCT02793544|455866586|FG000|Overall Study|Lost to Follow-up|2|||
126703989|NCT02793544|455866587|FG001|Overall Study|Lost to Follow-up|0|||
126703990|NCT02793544|455866586|FG000|Overall Study|Withdrawal by Subject|1|||
126703991|NCT02793544|455866587|FG001|Overall Study|Withdrawal by Subject|0|||
126703992|NCT00100048|455866588|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
126703993|NCT00100048|455866589|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
126265652|NCT04403763|454262883|FG005|Stage 1|Early termination due to PK tube failure|0|||
126265653|NCT04403763|454262884|FG006|Stage 1|Early termination due to PK tube failure|0|||
126265654|NCT04403763|454262878|FG000|Stage 2A|Adverse Event|0|||
126265655|NCT04403763|454262879|FG001|Stage 2A|Adverse Event|0|||
126265656|NCT04403763|454262880|FG002|Stage 2A|Adverse Event|0|||
126265657|NCT04403763|454262881|FG003|Stage 2A|Adverse Event|0|||
126265658|NCT04403763|454262882|FG004|Stage 2A|Adverse Event|0|||
126265659|NCT04403763|454262883|FG005|Stage 2A|Adverse Event|0|||
126265660|NCT04403763|454262884|FG006|Stage 2A|Adverse Event|1|||
126265661|NCT02470091|454262885|FG000|Overall Study|Withdrawal by Subject|1|||
126452986|NCT00717236|454959045|FG000|Double-Blind Period|Adverse Event|33|||
126703994|NCT00100048|455866590|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
126703995|NCT00100048|455866591|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
126703996|NCT00100048|455866592|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
126703997|NCT00100048|455866593|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
126703998|NCT00100048|455866588|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
126703999|NCT00100048|455866589|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
126704000|NCT00100048|455866590|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
126265662|NCT02470091|454262886|FG001|Overall Study|Withdrawal by Subject|0|||
126265663|NCT02470091|454262885|FG000|Overall Study|Ineligible|0|||
126265664|NCT02470091|454262886|FG001|Overall Study|Ineligible|2|||
126265665|NCT02903238|454262888|FG000|Overall Study|Lost to Follow-up|4|||
126265666|NCT00720226|454262890|FG000|Overall Study|Withdrawal by Subject|7|||
126704001|NCT00100048|455866591|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
126704002|NCT00100048|455866592|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
126704003|NCT00100048|455866593|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
126704004|NCT00100048|455866588|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
126704005|NCT00100048|455866589|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
126704006|NCT00100048|455866590|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
126704007|NCT00100048|455866591|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
126704008|NCT00100048|455866592|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
126704009|NCT00100048|455866593|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
126704010|NCT00100048|455866588|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
126704011|NCT00100048|455866589|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
126704012|NCT00100048|455866590|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
126704013|NCT00100048|455866591|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
126704014|NCT00100048|455866592|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
126704015|NCT00100048|455866593|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
126704016|NCT00100048|455866588|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
126704017|NCT00100048|455866589|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
126704018|NCT00100048|455866590|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
126704019|NCT00100048|455866591|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
126704020|NCT00100048|455866592|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
126704021|NCT00100048|455866593|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
126704022|NCT00100048|455866588|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
126704023|NCT00100048|455866589|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
126704024|NCT00100048|455866590|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
126704025|NCT00100048|455866591|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
126704026|NCT00100048|455866592|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
126704027|NCT00100048|455866593|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
126704028|NCT00100048|455866588|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
126704029|NCT00100048|455866589|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
126704030|NCT00100048|455866590|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
126704031|NCT00100048|455866591|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
126704032|NCT00100048|455866592|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
126704033|NCT00100048|455866593|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
126704034|NCT00100048|455866588|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
126704035|NCT00100048|455866589|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
126704036|NCT00100048|455866590|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
126704037|NCT00100048|455866591|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
126704038|NCT00100048|455866592|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
126704039|NCT00100048|455866593|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
126704040|NCT01624142|455866595|FG000|Overall Study|Withdrawal by Subject|14|||
126704041|NCT01624142|455866596|FG001|Overall Study|Withdrawal by Subject|4|||
126704042|NCT01624142|455866595|FG000|Overall Study|Death|3|||
126704043|NCT01624142|455866596|FG001|Overall Study|Death|6|||
126704044|NCT01624142|455866595|FG000|Overall Study|Study Closure|12|||
126704045|NCT01624142|455866596|FG001|Overall Study|Study Closure|6|||
126704046|NCT01624142|455866595|FG000|Overall Study|Lost to Follow-up|2|||
126704047|NCT01624142|455866596|FG001|Overall Study|Lost to Follow-up|0|||
126704048|NCT01624142|455866595|FG000|Overall Study|Other|1|||
126704049|NCT01624142|455866596|FG001|Overall Study|Other|0|||
126704050|NCT02597062|455866599|FG000|Overall Study|Ineligible|1|||
126704051|NCT01697345|455866602|FG000|Overall Study|Withdrawal by Subject|1|||
126704052|NCT05369806|455866603|FG000|Overall Study|Lost to Follow-up|1|||
126704053|NCT00140855|455866604|FG000|Overall Study|Progressive disease|2|||
126704054|NCT01392183|455866605|FG000|First Drug Administration|Adverse Event|3|||
126704055|NCT01392183|455866606|FG001|First Drug Administration|Adverse Event|2|||
126704056|NCT01392183|455866605|FG000|First Drug Administration|Death|1|||
126704057|NCT01392183|455866606|FG001|First Drug Administration|Death|0|||
126704058|NCT01392183|455866605|FG000|First Drug Administration|Withdrawal by Subject|10|||
126704059|NCT01392183|455866606|FG001|First Drug Administration|Withdrawal by Subject|17|||
126704060|NCT03430310|455866607|FG000|Overall Study|Protocol Violation|2|||
126704061|NCT03430310|455866608|FG001|Overall Study|Protocol Violation|0|||
126704062|NCT03430310|455866607|FG000|Overall Study|Withdrawal by Subject|3|||
126704063|NCT03430310|455866608|FG001|Overall Study|Withdrawal by Subject|2|||
126704064|NCT03430310|455866607|FG000|Overall Study|COVID shutdown March 2020|0|||
126704065|NCT03430310|455866608|FG001|Overall Study|COVID shutdown March 2020|1|||
126704066|NCT03476239|455866610|FG000|Overall Study|Withdrawal by Subject|10|||
126704067|NCT03476239|455866610|FG000|Overall Study|Death|80|||
126704068|NCT03476239|455866610|FG000|Overall Study|Lost to Follow-up|8|||
126704069|NCT01331161|455866614|FG000|Overall Study|Physician Decision|1|||
126704070|NCT01331161|455866615|FG001|Overall Study|Physician Decision|0|||
126704071|NCT01331161|455866614|FG000|Overall Study|Lost to Follow-up|0|||
126704072|NCT01331161|455866615|FG001|Overall Study|Lost to Follow-up|1|||
126704073|NCT01331161|455866614|FG000|Overall Study|Pregnancy|0|||
126704074|NCT01331161|455866615|FG001|Overall Study|Pregnancy|1|||
126704075|NCT01097044|455866616|FG000|Overall Study|Withdrawal by Subject|4|||
126704076|NCT01097044|455866617|FG001|Overall Study|Withdrawal by Subject|4|||
126704077|NCT01097044|455866616|FG000|Overall Study|Lost to Follow-up|1|||
126704078|NCT01097044|455866617|FG001|Overall Study|Lost to Follow-up|0|||
126704079|NCT01097044|455866616|FG000|Overall Study|Withdrawal by Sponsor|0|||
126360364|NCT00147537|454610821|FG009|Phase 1b|Death|0|||
126704080|NCT01097044|455866617|FG001|Overall Study|Withdrawal by Sponsor|1|||
126704081|NCT01682044|455866618|FG000|Overall Study|Death|1|||
126704082|NCT01682044|455866618|FG000|Overall Study|Progression|3|||
126704083|NCT01659151|455866619|FG000|Overall Study|Inadequate TIL growth|1|||
126704084|NCT04865731|455866620|FG000|Overall Study|Physician Decision|2|||
126704085|NCT04865731|455866621|FG001|Overall Study|Physician Decision|1|||
126704086|NCT04865731|455866620|FG000|Overall Study|Adverse Event|1|||
126704087|NCT04865731|455866621|FG001|Overall Study|Adverse Event|0|||
126704088|NCT04865731|455866620|FG000|Overall Study|Withdrawal by Subject|0|||
126704089|NCT04865731|455866621|FG001|Overall Study|Withdrawal by Subject|1|||
126704090|NCT02770807|455866622|FG000|Overall Study|Adverse Event|3|||
126704091|NCT02770807|455866623|FG001|Overall Study|Adverse Event|3|||
126704092|NCT02770807|455866624|FG002|Overall Study|Adverse Event|1|||
126704093|NCT02770807|455866622|FG000|Overall Study|Withdrawal by Subject|7|||
126704094|NCT02770807|455866623|FG001|Overall Study|Withdrawal by Subject|3|||
126704095|NCT02770807|455866624|FG002|Overall Study|Withdrawal by Subject|4|||
126704096|NCT02770807|455866622|FG000|Overall Study|Other|0|||
126704097|NCT02770807|455866623|FG001|Overall Study|Other|1|||
126704098|NCT02770807|455866624|FG002|Overall Study|Other|0|||
126704099|NCT02770807|455866622|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
126704100|NCT02770807|455866623|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
126704101|NCT02770807|455866624|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
126704102|NCT02770807|455866622|FG000|Overall Study|Physician Decision|0|||
126704103|NCT02770807|455866623|FG001|Overall Study|Physician Decision|0|||
126704104|NCT02770807|455866624|FG002|Overall Study|Physician Decision|1|||
126704105|NCT01826214|455868194|FG000|Overall Study|Adverse Event|7|||
126704106|NCT01826214|455868195|FG001|Overall Study|Adverse Event|6|||
126704107|NCT01826214|455868194|FG000|Overall Study|Death|3|||
126704108|NCT01826214|455868195|FG001|Overall Study|Death|1|||
126704109|NCT01826214|455868194|FG000|Overall Study|Lost to Follow-up|1|||
126704110|NCT01826214|455868195|FG001|Overall Study|Lost to Follow-up|0|||
126704111|NCT01826214|455868194|FG000|Overall Study|Physician Decision|0|||
126704112|NCT01826214|455868195|FG001|Overall Study|Physician Decision|2|||
126704113|NCT01826214|455868194|FG000|Overall Study|Progressive disease|22|||
126704114|NCT01826214|455868195|FG001|Overall Study|Progressive disease|21|||
126704115|NCT01826214|455868194|FG000|Overall Study|Study terminated by Sponsor|0|||
126704116|NCT01826214|455868195|FG001|Overall Study|Study terminated by Sponsor|1|||
126704117|NCT01826214|455868194|FG000|Overall Study|Subject/guardian decision|2|||
126704118|NCT01826214|455868195|FG001|Overall Study|Subject/guardian decision|3|||
126704119|NCT01056107|455868208|FG000|Overall Study|Withdrawal by Subject|0|||
126704120|NCT01056107|455868209|FG001|Overall Study|Withdrawal by Subject|1|||
126704121|NCT01056107|455868210|FG002|Overall Study|Withdrawal by Subject|3|||
126704122|NCT01056107|455868211|FG003|Overall Study|Withdrawal by Subject|0|||
126704123|NCT02017444|455868212|FG000|Overall Study|Physician Decision|1|||
126704124|NCT02017444|455868213|FG001|Overall Study|Physician Decision|0|||
126704125|NCT02017444|455868212|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
126704126|NCT02017444|455868213|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
126704127|NCT01614457|455868214|FG000|Overall Study|Non-Compliance|1|||
126704128|NCT01614457|455868215|FG001|Overall Study|Non-Compliance|0|||
126704129|NCT01614457|455868214|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
126704130|NCT01614457|455868215|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
126704131|NCT00374556|455868216|FG000|Overall Study|Lost to Follow-up|1|||
126704132|NCT00374556|455868217|FG001|Overall Study|Lost to Follow-up|0|||
126704133|NCT00374556|455868216|FG000|Overall Study|Removed at baseline due to medical cond|0|||
126704134|NCT00374556|455868217|FG001|Overall Study|Removed at baseline due to medical cond|1|||
126704135|NCT00473694|455868222|FG000|Overall Study|Adverse Event|0|||
126704136|NCT00473694|455868223|FG001|Overall Study|Adverse Event|1|||
126704137|NCT00473694|455868224|FG002|Overall Study|Adverse Event|0|||
126704138|NCT00473694|455868225|FG003|Overall Study|Adverse Event|0|||
126704139|NCT00473694|455868222|FG000|Overall Study|Participants did not receive treatment|11|||
126704140|NCT00473694|455868223|FG001|Overall Study|Participants did not receive treatment|3|||
126704141|NCT00473694|455868224|FG002|Overall Study|Participants did not receive treatment|5|||
126704142|NCT00473694|455868225|FG003|Overall Study|Participants did not receive treatment|6|||
126360365|NCT00147537|454610822|FG010|Phase 1b|Death|0|||
126704143|NCT00473694|455868222|FG000|Overall Study|Lost to Follow-up|0|||
126764640|NCT02526017|456090934|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126764641|NCT02526017|456090935|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
126764642|NCT02674568|456090940|FG000|Overall Study|Withdrawal by Subject|5|||
126764643|NCT02674568|456090940|FG000|Overall Study|Death|303|||
126764644|NCT02674568|456090940|FG000|Overall Study|Physician Decision|2|||
126764645|NCT02674568|456090940|FG000|Overall Study|Lost to Follow-up|9|||
126764646|NCT02674568|456090940|FG000|Overall Study|Other, Not Specified|20|||
126764647|NCT00968539|456090941|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
126764648|NCT00968539|456090942|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
126764649|NCT00457249|456090943|FG000|Overall Study|Lost to Follow-up|3|||
126764650|NCT00457249|456090944|FG001|Overall Study|Lost to Follow-up|0|||
126764651|NCT00457249|456090943|FG000|Overall Study|Protocol Violation|4|||
126764652|NCT00457249|456090944|FG001|Overall Study|Protocol Violation|1|||
126764653|NCT00457249|456090943|FG000|Overall Study|Withdrawal by Subject|3|||
126764654|NCT00457249|456090944|FG001|Overall Study|Withdrawal by Subject|1|||
126764655|NCT00457249|456090943|FG000|Overall Study|Serious Adverse Events|2|||
126764656|NCT00457249|456090944|FG001|Overall Study|Serious Adverse Events|0|||
126764657|NCT00396318|456090945|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
126764658|NCT00326118|456090946|FG000|Active Phase|Withdrawal by Subject|4|||
126764659|NCT00326118|456090947|FG001|Active Phase|Withdrawal by Subject|1|||
126764660|NCT00938392|456090948|FG000|Overall Study|Adverse Event|0|||
126764661|NCT00938392|456090949|FG001|Overall Study|Adverse Event|1|||
126764662|NCT00938392|456090948|FG000|Overall Study|Withdrawal by Subject|0|||
126764663|NCT00938392|456090949|FG001|Overall Study|Withdrawal by Subject|1|||
126764664|NCT00938392|456090948|FG000|Overall Study|Lost to Follow-up|2|||
126764665|NCT00938392|456090949|FG001|Overall Study|Lost to Follow-up|2|||
126764666|NCT02916056|456090950|FG000|Overall Study|Adverse Event|6|||
126764667|NCT02916056|456090950|FG000|Overall Study|Lost to Follow-up|1|||
126764668|NCT02916056|456090950|FG000|Overall Study|Other|12|||
126764669|NCT02916056|456090950|FG000|Overall Study|Protocol Violation|1|||
126764670|NCT02916056|456090950|FG000|Overall Study|Withdrawal by Subject|8|||
126764671|NCT02916056|456090950|FG000|Overall Study|Study Terminated by Sponsor|269|||
126764672|NCT00290511|456090951|FG000|Overall Study|Adverse Event|1|||
126764673|NCT00290511|456090951|FG000|Overall Study|Death|1|||
126764674|NCT00290511|456090951|FG000|Overall Study|Physician Decision|1|||
126764675|NCT00290511|456090951|FG000|Overall Study|Withdrawal by Subject|1|||
126764676|NCT00124709|456090952|FG000|Overall Study|Randomized but did not take medication|3|||
126764677|NCT00124709|456090953|FG001|Overall Study|Randomized but did not take medication|1|||
126764678|NCT00124709|456090952|FG000|Overall Study|Adverse Event|3|||
126764679|NCT00124709|456090953|FG001|Overall Study|Adverse Event|0|||
126764680|NCT00124709|456090952|FG000|Overall Study|Lack of Efficacy|5|||
126764681|NCT00124709|456090953|FG001|Overall Study|Lack of Efficacy|10|||
126764682|NCT00124709|456090952|FG000|Overall Study|Protocol Violation|3|||
126764683|NCT00124709|456090953|FG001|Overall Study|Protocol Violation|5|||
126764684|NCT00124709|456090952|FG000|Overall Study|Withdrawal by Subject|127|||
126764685|NCT00124709|456090953|FG001|Overall Study|Withdrawal by Subject|136|||
126764686|NCT00124709|456090952|FG000|Overall Study|Lost to Follow-up|114|||
126764687|NCT00124709|456090953|FG001|Overall Study|Lost to Follow-up|120|||
126764688|NCT01728376|456090954|FG000|Overall Study|Adverse Event|1|||
126764689|NCT01728376|456090955|FG001|Overall Study|Adverse Event|1|||
126265667|NCT00720226|454262891|FG001|Overall Study|Withdrawal by Subject|4|||
126265668|NCT00733369|454262894|FG000|Overall Study|Lost to Follow-up|2|||
126265669|NCT00733369|454262895|FG001|Overall Study|Lost to Follow-up|1|||
126265670|NCT00733369|454262894|FG000|Overall Study|Adverse Event|4|||
126265671|NCT00733369|454262895|FG001|Overall Study|Adverse Event|4|||
126265672|NCT00733369|454262894|FG000|Overall Study|Protocol Violation|4|||
126265673|NCT00733369|454262895|FG001|Overall Study|Protocol Violation|4|||
126265674|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
126265675|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
126764690|NCT01728376|456090956|FG002|Overall Study|Adverse Event|1|||
126265676|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
126764691|NCT01728376|456090957|FG003|Overall Study|Adverse Event|1|||
126764692|NCT01728376|456090958|FG004|Overall Study|Adverse Event|1|||
126764693|NCT01728376|456090959|FG005|Overall Study|Adverse Event|0|||
126764694|NCT01728376|456090954|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
126764695|NCT01728376|456090955|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
126764696|NCT01728376|456090956|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
126764697|NCT01728376|456090957|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
126265677|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
126265678|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
126265679|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
126265680|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
126265681|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
126265682|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
126764698|NCT01728376|456090958|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
126265683|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
126265684|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
126265685|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
126265686|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
126265687|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
126265688|NCT02510014|454262896|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
126265689|NCT02510014|454262897|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
126265690|NCT02510014|454262896|FG000|Treatment Period|Adverse Event|11|||
126265691|NCT02510014|454262897|FG001|Treatment Period|Adverse Event|4|||
126265692|NCT02510014|454262896|FG000|Treatment Period|Withdrawal symptoms|3|||
126265693|NCT02510014|454262897|FG001|Treatment Period|Withdrawal symptoms|0|||
126265694|NCT02510014|454262896|FG000|Treatment Period|Lost to Follow-up|80|||
126265695|NCT02510014|454262897|FG001|Treatment Period|Lost to Follow-up|19|||
126265696|NCT02510014|454262896|FG000|Treatment Period|Physician Decision|5|||
126265697|NCT02510014|454262897|FG001|Treatment Period|Physician Decision|0|||
126265698|NCT02510014|454262896|FG000|Treatment Period|Withdrawal by Subject|67|||
126265699|NCT02510014|454262897|FG001|Treatment Period|Withdrawal by Subject|24|||
126265700|NCT02510014|454262896|FG000|Treatment Period|Withdrawn by the investigator|7|||
126265701|NCT02510014|454262897|FG001|Treatment Period|Withdrawn by the investigator|1|||
126265702|NCT02510014|454262896|FG000|Treatment Period|Protocol Violation|4|||
126265703|NCT02510014|454262897|FG001|Treatment Period|Protocol Violation|4|||
126265704|NCT02510014|454262896|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
126265705|NCT02510014|454262897|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
126265706|NCT01875471|454262901|FG000|Overall Study|Adverse Event|0|||
126704144|NCT00473694|455868223|FG001|Overall Study|Lost to Follow-up|0|||
126704145|NCT00473694|455868224|FG002|Overall Study|Lost to Follow-up|0|||
126704146|NCT00473694|455868225|FG003|Overall Study|Lost to Follow-up|1|||
126704147|NCT03874234|455868235|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126704148|NCT03874234|455868236|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126704149|NCT03874234|455868237|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126704150|NCT03874234|455868238|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
126704151|NCT03874234|455868239|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126704152|NCT03874234|455868240|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126704153|NCT03874234|455868241|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126704154|NCT03874234|455868242|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126704155|NCT03874234|455868243|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126704156|NCT03874234|455868244|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126704157|NCT03874234|455868245|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126704158|NCT03874234|455868246|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126704159|NCT03874234|455868247|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
126704160|NCT03874234|455868235|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
126704161|NCT03874234|455868236|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126704162|NCT03874234|455868237|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126704163|NCT03874234|455868238|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126704164|NCT03874234|455868239|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126704165|NCT03874234|455868240|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126704166|NCT03874234|455868241|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126704167|NCT03874234|455868242|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126704168|NCT03874234|455868243|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126704169|NCT03874234|455868244|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126704170|NCT03874234|455868245|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126704171|NCT03874234|455868246|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126704172|NCT03874234|455868247|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
126704173|NCT03874234|455868235|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126704174|NCT03874234|455868236|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126704175|NCT03874234|455868237|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126704176|NCT03874234|455868238|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
126704177|NCT03874234|455868239|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126704178|NCT03874234|455868240|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126704179|NCT03874234|455868241|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126704180|NCT03874234|455868242|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126704181|NCT03874234|455868243|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126265707|NCT01875471|454262902|FG001|Overall Study|Adverse Event|1|||
126704182|NCT03874234|455868244|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126704183|NCT03874234|455868245|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126704184|NCT03874234|455868246|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126704185|NCT03874234|455868247|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
126265708|NCT01875471|454262901|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
126265709|NCT01875471|454262902|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
126265710|NCT01949116|454262906|FG000|Overall Study|Death|2|||
126452987|NCT00717236|454959046|FG001|Double-Blind Period|Adverse Event|6|||
126452988|NCT00717236|454959045|FG000|Double-Blind Period|Lack of Efficacy|6|||
126452989|NCT00717236|454959046|FG001|Double-Blind Period|Lack of Efficacy|6|||
126452990|NCT00717236|454959045|FG000|Double-Blind Period|Lost to Follow-up|3|||
126452991|NCT00717236|454959046|FG001|Double-Blind Period|Lost to Follow-up|5|||
126452992|NCT00717236|454959045|FG000|Double-Blind Period|Withdrawal by Subject|10|||
126452993|NCT00717236|454959046|FG001|Double-Blind Period|Withdrawal by Subject|2|||
126452994|NCT00717236|454959045|FG000|Double-Blind Period|Loss of efficacy|3|||
126452995|NCT00717236|454959046|FG001|Double-Blind Period|Loss of efficacy|0|||
126452996|NCT00717236|454959045|FG000|Double-Blind Period|Other: Death|1|||
126452997|NCT00717236|454959046|FG001|Double-Blind Period|Other: Death|0|||
126452998|NCT00717236|454959045|FG000|Double-Blind Period|Other: Pregnancy|1|||
126704186|NCT03874234|455868235|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126764699|NCT01728376|456090959|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
126764700|NCT01728376|456090954|FG000|Overall Study|No relevant bacteria|2|||
126265711|NCT01949116|454262907|FG001|Overall Study|Death|0|||
126265712|NCT01949116|454262906|FG000|Overall Study|Lost to Follow-up|1|||
126265713|NCT01949116|454262907|FG001|Overall Study|Lost to Follow-up|3|||
126265714|NCT01949116|454262906|FG000|Overall Study|Withdrawal by Subject|5|||
126265715|NCT01949116|454262907|FG001|Overall Study|Withdrawal by Subject|3|||
126265716|NCT03407118|454262908|FG000|Period 2|Withdrawal by Subject|1|||
126265717|NCT03407118|454262909|FG001|Period 2|Withdrawal by Subject|0|||
126265718|NCT02556307|454262910|FG000|Overall Study|Premature treatment interruption|11|||
126265719|NCT02556307|454262910|FG000|Overall Study|Lost to Follow-up|36|||
126265720|NCT02556307|454262910|FG000|Overall Study|Change to triple therapy|4|||
126265721|NCT02556307|454262910|FG000|Overall Study|Enrolled but not treated|2|||
126265722|NCT00384176|454262914|FG000|Overall Study|Death|239|||
126265723|NCT00384176|454262915|FG001|Overall Study|Death|247|||
126265724|NCT00384176|454262916|FG002|Overall Study|Death|105|||
126265725|NCT00384176|454262914|FG000|Overall Study|Withdrawal by Subject|52|||
126265726|NCT00384176|454262915|FG001|Overall Study|Withdrawal by Subject|48|||
126265727|NCT00384176|454262916|FG002|Overall Study|Withdrawal by Subject|22|||
126265728|NCT00384176|454262914|FG000|Overall Study|Lost to Follow-up|16|||
126265729|NCT00384176|454262915|FG001|Overall Study|Lost to Follow-up|18|||
126265730|NCT00384176|454262916|FG002|Overall Study|Lost to Follow-up|4|||
126265731|NCT00384176|454262914|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
126265732|NCT00384176|454262915|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
126265733|NCT00384176|454262916|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
126265734|NCT00384176|454262914|FG000|Overall Study|Longer QTC as Visit 1|1|||
126265735|NCT00384176|454262915|FG001|Overall Study|Longer QTC as Visit 1|0|||
126265736|NCT00384176|454262916|FG002|Overall Study|Longer QTC as Visit 1|0|||
126265737|NCT00384176|454262914|FG000|Overall Study|Toxicity of treatment|1|||
126265738|NCT00384176|454262915|FG001|Overall Study|Toxicity of treatment|0|||
126265739|NCT00384176|454262916|FG002|Overall Study|Toxicity of treatment|0|||
126265740|NCT00384176|454262914|FG000|Overall Study|Did not receive study treatment|0|||
126265741|NCT00384176|454262915|FG001|Overall Study|Did not receive study treatment|1|||
126452999|NCT00717236|454959046|FG001|Double-Blind Period|Other: Pregnancy|0|||
126453000|NCT00717236|454959045|FG000|Double-Blind Period|Other: Protocol Violation|2|||
126704187|NCT03874234|455868236|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126704188|NCT03874234|455868237|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126704189|NCT03874234|455868238|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126704190|NCT03874234|455868239|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
126704191|NCT03874234|455868240|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126704192|NCT03874234|455868241|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126704193|NCT03874234|455868242|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126704194|NCT03874234|455868243|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126704195|NCT03874234|455868244|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126704196|NCT03874234|455868245|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126704197|NCT03874234|455868246|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126704198|NCT03874234|455868247|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
126704199|NCT03874234|455868235|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126704200|NCT03874234|455868236|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126704201|NCT03874234|455868237|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126704202|NCT03874234|455868238|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126704203|NCT03874234|455868239|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126764701|NCT01728376|456090955|FG001|Overall Study|No relevant bacteria|0|||
126265742|NCT00384176|454262916|FG002|Overall Study|Did not receive study treatment|1|||
126265743|NCT00384176|454262914|FG000|Overall Study|Physician Decision|0|||
126265744|NCT00384176|454262915|FG001|Overall Study|Physician Decision|2|||
126265745|NCT00384176|454262916|FG002|Overall Study|Physician Decision|0|||
126265746|NCT00384176|454262914|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
126265747|NCT00384176|454262915|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
126265748|NCT00384176|454262916|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
126704204|NCT03874234|455868240|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126704205|NCT03874234|455868241|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126704206|NCT03874234|455868242|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
126704207|NCT03874234|455868243|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126704208|NCT03874234|455868244|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126704209|NCT03874234|455868245|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126704210|NCT03874234|455868246|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126704211|NCT03874234|455868247|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
126704212|NCT03874234|455868235|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126704213|NCT03874234|455868236|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126704214|NCT03874234|455868237|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126704215|NCT03874234|455868238|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126704216|NCT03874234|455868239|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
126704217|NCT03874234|455868240|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
126704218|NCT03874234|455868241|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126704219|NCT03874234|455868242|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126704220|NCT03874234|455868243|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126704221|NCT03874234|455868244|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126704222|NCT03874234|455868245|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126704223|NCT03874234|455868246|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126704224|NCT03874234|455868247|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
126704225|NCT03874234|455868235|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126704226|NCT03874234|455868236|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126704227|NCT03874234|455868237|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126704228|NCT03874234|455868238|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126704229|NCT03874234|455868239|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126704230|NCT03874234|455868240|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126704231|NCT03874234|455868241|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
126704232|NCT03874234|455868242|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126704233|NCT03874234|455868243|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126704234|NCT03874234|455868244|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126704235|NCT03874234|455868245|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126704236|NCT03874234|455868246|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126704237|NCT03874234|455868247|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
126704238|NCT03874234|455868235|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126704239|NCT03874234|455868236|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126704240|NCT03874234|455868237|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126704241|NCT03874234|455868238|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126704242|NCT03874234|455868239|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
126704243|NCT03874234|455868240|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126704244|NCT03874234|455868241|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126704245|NCT03874234|455868242|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126704246|NCT03874234|455868243|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126704247|NCT03874234|455868244|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126704248|NCT03874234|455868245|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126704249|NCT03874234|455868246|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126704250|NCT03874234|455868247|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
126704251|NCT00783289|455868248|FG000|Overall Study|Protocol Violation|0|||
126704252|NCT00783289|455868249|FG001|Overall Study|Protocol Violation|1|||
126704253|NCT00783289|455868250|FG002|Overall Study|Protocol Violation|0|||
126704254|NCT00783289|455868251|FG003|Overall Study|Protocol Violation|0|||
126704255|NCT00506389|455868252|FG000|In-treatment Period|Other|3|||
126265749|NCT00049842|454262917|FG000|Treatment Phase|Adverse Event|47|||
126265750|NCT00049842|454262918|FG001|Treatment Phase|Adverse Event|12|||
126265751|NCT00049842|454262917|FG000|Treatment Phase|Withdrawal by Subject|35|||
126265752|NCT00049842|454262918|FG001|Treatment Phase|Withdrawal by Subject|46|||
126265753|NCT00049842|454262917|FG000|Treatment Phase|Non-compliance with protocol|7|||
126265754|NCT00049842|454262918|FG001|Treatment Phase|Non-compliance with protocol|8|||
126265755|NCT00049842|454262917|FG000|Treatment Phase|Lost to Follow-up|4|||
126265756|NCT00049842|454262918|FG001|Treatment Phase|Lost to Follow-up|8|||
126265757|NCT00049842|454262917|FG000|Treatment Phase|Administrative|0|||
126265758|NCT00049842|454262918|FG001|Treatment Phase|Administrative|3|||
126704256|NCT00506389|455868253|FG001|In-treatment Period|Other|3|||
126704257|NCT00506389|455868254|FG002|In-treatment Period|Other|4|||
126704258|NCT00506389|455868252|FG000|In-treatment Period|Lost to Follow-up|0|||
126704259|NCT00506389|455868253|FG001|In-treatment Period|Lost to Follow-up|0|||
126265759|NCT00049842|454262917|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
126265760|NCT00049842|454262918|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
126265761|NCT00049842|454262917|FG000|Follow-up Phase|Adverse Event|6|||
126704260|NCT00506389|455868254|FG002|In-treatment Period|Lost to Follow-up|1|||
126265762|NCT00049842|454262918|FG001|Follow-up Phase|Adverse Event|1|||
126704261|NCT00506389|455868252|FG000|In-treatment Period|Lack of compliance|1|||
126265763|NCT00049842|454262917|FG000|Follow-up Phase|Other|1|||
126265764|NCT00049842|454262918|FG001|Follow-up Phase|Other|4|||
126265765|NCT00854373|454262919|FG000|Overall Study|Withdrawal by Subject|1|||
126265766|NCT00854373|454262920|FG001|Overall Study|Withdrawal by Subject|3|||
126265767|NCT00854373|454262919|FG000|Overall Study|Forgot to take study drug|1|||
126265768|NCT00854373|454262920|FG001|Overall Study|Forgot to take study drug|1|||
126265769|NCT00307931|454262921|FG000|Overall Study|Adverse Event|1|||
126265770|NCT00293202|454262922|FG000|Overall Study|Withdrawal by Subject|1|||
126265771|NCT00293202|454262923|FG001|Overall Study|Withdrawal by Subject|2|||
126265772|NCT00293202|454262922|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
126265773|NCT00293202|454262923|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
126265774|NCT00293202|454262922|FG000|Overall Study|on-hold due to fistula maturation time|1|||
126265775|NCT00293202|454262923|FG001|Overall Study|on-hold due to fistula maturation time|0|||
126265776|NCT02442271|454262924|FG000|Overall Study|Adverse Event|1|||
126265777|NCT02442271|454262924|FG000|Overall Study|Withdrew Consent|1|||
126265778|NCT02442271|454262924|FG000|Overall Study|Lost to Follow-up|1|||
126265779|NCT02442271|454262924|FG000|Overall Study|Other|1|||
126265780|NCT01560507|454262926|FG000|Overall Study|Lost to Follow-up|3|||
126265781|NCT01560507|454262927|FG001|Overall Study|Lost to Follow-up|1|||
126265782|NCT01560507|454262928|FG002|Overall Study|Lost to Follow-up|2|||
126265783|NCT01560507|454262926|FG000|Overall Study|Withdrawal by Subject|1|||
126265784|NCT01560507|454262927|FG001|Overall Study|Withdrawal by Subject|1|||
126265785|NCT01560507|454262928|FG002|Overall Study|Withdrawal by Subject|0|||
126265786|NCT02080832|454262929|FG000|Overall Study|Excluded from analysis by MRI|9|||
126265787|NCT02080832|454262930|FG001|Overall Study|Excluded from analysis by MRI|10|||
126265788|NCT02080832|454262931|FG002|Overall Study|Excluded from analysis by MRI|14|||
126265789|NCT02080832|454262929|FG000|Overall Study|Lost to Follow-up|0|||
126265790|NCT02080832|454262930|FG001|Overall Study|Lost to Follow-up|2|||
126265791|NCT02080832|454262931|FG002|Overall Study|Lost to Follow-up|2|||
126265792|NCT02427984|454262932|FG000|Overall Study|Lost to Follow-up|13|||
126265793|NCT02427984|454262933|FG001|Overall Study|Lost to Follow-up|5|||
126265794|NCT02427984|454262934|FG002|Overall Study|Lost to Follow-up|18|||
126265795|NCT00788593|454262935|FG000|Placebo Run-in Phase|Adverse Event|2|||
126265796|NCT00788593|454262936|FG001|Placebo Run-in Phase|Adverse Event|0|||
126265797|NCT00788593|454262937|FG002|Placebo Run-in Phase|Adverse Event|0|||
126265798|NCT00788593|454262935|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
126265799|NCT00788593|454262936|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
126265800|NCT00788593|454262937|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
126265801|NCT00788593|454262935|FG000|Placebo Run-in Phase|Protocol Violation|2|||
126265802|NCT00788593|454262936|FG001|Placebo Run-in Phase|Protocol Violation|0|||
126265803|NCT00788593|454262937|FG002|Placebo Run-in Phase|Protocol Violation|0|||
126265804|NCT00788593|454262935|FG000|First Intervention Period|Adverse Event|0|||
126265805|NCT00788593|454262936|FG001|First Intervention Period|Adverse Event|1|||
126265806|NCT00788593|454262937|FG002|First Intervention Period|Adverse Event|0|||
126265807|NCT00788593|454262935|FG000|Second Intervention Period|Lost to Follow-up|0|||
126265808|NCT00788593|454262936|FG001|Second Intervention Period|Lost to Follow-up|1|||
126265809|NCT00788593|454262937|FG002|Second Intervention Period|Lost to Follow-up|0|||
126265810|NCT00788593|454262935|FG000|Second Intervention Period|Other|0|||
126265811|NCT00788593|454262936|FG001|Second Intervention Period|Other|0|||
126265812|NCT00788593|454262937|FG002|Second Intervention Period|Other|1|||
126265813|NCT00515034|454262940|FG000|Overall Study|Adverse Event|2|||
126265814|NCT00515034|454262941|FG001|Overall Study|Adverse Event|0|||
126265815|NCT00515034|454262942|FG002|Overall Study|Adverse Event|1|||
126547326|NCT02778399|455296198|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
126704262|NCT00506389|455868253|FG001|In-treatment Period|Lack of compliance|0|||
126704263|NCT00506389|455868254|FG002|In-treatment Period|Lack of compliance|0|||
126704264|NCT00506389|455868252|FG000|In-treatment Period|Reasons not related to trial|4|||
126704265|NCT00506389|455868253|FG001|In-treatment Period|Reasons not related to trial|1|||
126704266|NCT00506389|455868254|FG002|In-treatment Period|Reasons not related to trial|0|||
126704267|NCT00506389|455868252|FG000|In-treatment Period|Withdrawal by Subject|3|||
126265816|NCT00515034|454262943|FG003|Overall Study|Adverse Event|0|||
126265817|NCT00515034|454262940|FG000|Overall Study|Death|4|||
126265818|NCT00515034|454262941|FG001|Overall Study|Death|2|||
126265819|NCT00515034|454262942|FG002|Overall Study|Death|1|||
126265820|NCT00515034|454262943|FG003|Overall Study|Death|3|||
126265821|NCT00515034|454262940|FG000|Overall Study|Withdrawal by Subject|1|||
126265822|NCT00515034|454262941|FG001|Overall Study|Withdrawal by Subject|0|||
126547327|NCT02778399|455296199|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
126265823|NCT00515034|454262942|FG002|Overall Study|Withdrawal by Subject|3|||
126265824|NCT00515034|454262943|FG003|Overall Study|Withdrawal by Subject|0|||
126265825|NCT00515034|454262940|FG000|Overall Study|Physician Decision|0|||
126265826|NCT00515034|454262941|FG001|Overall Study|Physician Decision|0|||
126265827|NCT00515034|454262942|FG002|Overall Study|Physician Decision|1|||
126360366|NCT00147537|454610812|FG000|Phase 1b|Lost to Follow-up|2|||
126360367|NCT00147537|454610813|FG001|Phase 1b|Lost to Follow-up|1|||
126360368|NCT00147537|454610814|FG002|Phase 1b|Lost to Follow-up|0|||
126704268|NCT00506389|455868253|FG001|In-treatment Period|Withdrawal by Subject|3|||
126764702|NCT01728376|456090956|FG002|Overall Study|No relevant bacteria|0|||
126764703|NCT01728376|456090957|FG003|Overall Study|No relevant bacteria|0|||
126764704|NCT01728376|456090958|FG004|Overall Study|No relevant bacteria|1|||
126764705|NCT01728376|456090959|FG005|Overall Study|No relevant bacteria|1|||
126764706|NCT01728376|456090954|FG000|Overall Study|Did not receive treatment|0|||
126764707|NCT01728376|456090955|FG001|Overall Study|Did not receive treatment|1|||
126764708|NCT01728376|456090956|FG002|Overall Study|Did not receive treatment|0|||
126764709|NCT01728376|456090957|FG003|Overall Study|Did not receive treatment|0|||
126764710|NCT01728376|456090958|FG004|Overall Study|Did not receive treatment|0|||
126764711|NCT01728376|456090959|FG005|Overall Study|Did not receive treatment|0|||
126764712|NCT01728376|456090954|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
126764713|NCT01728376|456090955|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
126764714|NCT01728376|456090956|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
126764715|NCT01728376|456090957|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
126764716|NCT01728376|456090958|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
126764717|NCT01728376|456090959|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
126764718|NCT04341727|456090974|FG000|Overall Study|Withdrawal by Subject|0|||
126764719|NCT04341727|456090975|FG001|Overall Study|Withdrawal by Subject|0|||
126764720|NCT04341727|456090976|FG002|Overall Study|Withdrawal by Subject|1|||
126764721|NCT04341727|456090977|FG003|Overall Study|Withdrawal by Subject|0|||
126764722|NCT04341727|456090974|FG000|Overall Study|Lost to Follow-up|0|||
126764723|NCT04341727|456090975|FG001|Overall Study|Lost to Follow-up|0|||
126764724|NCT04341727|456090976|FG002|Overall Study|Lost to Follow-up|0|||
126764725|NCT04341727|456090977|FG003|Overall Study|Lost to Follow-up|1|||
126764726|NCT05604521|456090978|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
126764727|NCT05604521|456090979|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
126764728|NCT05604521|456090978|FG000|Overall Study|Adverse Event|1|||
126764729|NCT05604521|456090979|FG001|Overall Study|Adverse Event|0|||
126764730|NCT01491737|456090980|FG000|Overall Study|Withdrawal by Subject|20|||
126764731|NCT01491737|456090981|FG001|Overall Study|Withdrawal by Subject|17|||
126764732|NCT01491737|456090980|FG000|Overall Study|Lost to Follow-up|2|||
126764733|NCT01491737|456090981|FG001|Overall Study|Lost to Follow-up|10|||
126764734|NCT01491737|456090980|FG000|Overall Study|Death|63|||
126764735|NCT01491737|456090981|FG001|Overall Study|Death|57|||
126764736|NCT01491737|456090980|FG000|Overall Study|Study Termination by Sponsor|36|||
126764737|NCT01491737|456090981|FG001|Overall Study|Study Termination by Sponsor|36|||
126764738|NCT01491737|456090980|FG000|Overall Study|Reason Not Specified|8|||
126764739|NCT01491737|456090981|FG001|Overall Study|Reason Not Specified|9|||
126764740|NCT04311411|456090982|FG000|Overall Study|Adverse Event|2|||
126764741|NCT04311411|456090983|FG001|Overall Study|Adverse Event|3|||
126764742|NCT04311411|456090984|FG002|Overall Study|Adverse Event|2|||
126764743|NCT04311411|456090982|FG000|Overall Study|Withdrawal by Subject|3|||
126764744|NCT04311411|456090983|FG001|Overall Study|Withdrawal by Subject|3|||
126764745|NCT04311411|456090984|FG002|Overall Study|Withdrawal by Subject|0|||
126764746|NCT01976663|456090985|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
126764747|NCT01976663|456090985|FG000|Overall Study|Personal Reasons|6|||
126764748|NCT01976663|456090985|FG000|Overall Study|Withdrawal by Subject|4|||
126360369|NCT00147537|454610815|FG003|Phase 1b|Lost to Follow-up|0|||
126360370|NCT00147537|454610816|FG004|Phase 1b|Lost to Follow-up|0|||
126360371|NCT00147537|454610817|FG005|Phase 1b|Lost to Follow-up|0|||
126360372|NCT00147537|454610818|FG006|Phase 1b|Lost to Follow-up|2|||
126360373|NCT00147537|454610819|FG007|Phase 1b|Lost to Follow-up|0|||
126360374|NCT00147537|454610820|FG008|Phase 1b|Lost to Follow-up|1|||
126704269|NCT00506389|455868254|FG002|In-treatment Period|Withdrawal by Subject|4|||
126704270|NCT00506389|455868252|FG000|In-treatment Period|Lack of Efficacy|0|||
126704271|NCT00506389|455868253|FG001|In-treatment Period|Lack of Efficacy|2|||
126704272|NCT00506389|455868254|FG002|In-treatment Period|Lack of Efficacy|0|||
126704273|NCT00506389|455868252|FG000|In-treatment Period|Adverse Event|11|||
126704274|NCT00506389|455868253|FG001|In-treatment Period|Adverse Event|5|||
126704275|NCT00506389|455868254|FG002|In-treatment Period|Adverse Event|2|||
126704276|NCT00506389|455868252|FG000|In-treatment Period|Randomized but not treated|4|||
126704277|NCT00506389|455868253|FG001|In-treatment Period|Randomized but not treated|1|||
126360375|NCT00147537|454610821|FG009|Phase 1b|Lost to Follow-up|0|||
126704278|NCT00506389|455868254|FG002|In-treatment Period|Randomized but not treated|1|||
126704279|NCT00283387|455868260|FG000|First Intervention|Subject non-compliant|1|||
126360376|NCT00147537|454610822|FG010|Phase 1b|Lost to Follow-up|0|||
126360377|NCT00147537|454610812|FG000|Phase 1b|Other|0|||
126704280|NCT00283387|455868261|FG001|First Intervention|Subject non-compliant|1|||
126764749|NCT01976663|456090985|FG000|Overall Study|Screen Failure|3|||
126764750|NCT01976663|456090985|FG000|Overall Study|Adverse Event|2|||
126764751|NCT01976663|456090985|FG000|Overall Study|Lost to Follow-up|3|||
126265828|NCT00515034|454262943|FG003|Overall Study|Physician Decision|1|||
126265829|NCT00515034|454262940|FG000|Overall Study|Other|1|||
126265830|NCT00515034|454262941|FG001|Overall Study|Other|0|||
126265831|NCT00515034|454262942|FG002|Overall Study|Other|2|||
126265832|NCT00515034|454262943|FG003|Overall Study|Other|1|||
126265833|NCT01392326|454262948|FG000|Overall Study|Death|2|||
126265834|NCT01392326|454262949|FG001|Overall Study|Death|0|||
126265835|NCT01392326|454262950|FG002|Overall Study|Death|0|||
126265836|NCT01392326|454262948|FG000|Overall Study|Withdrawal by Subject|12|||
126265837|NCT01392326|454262949|FG001|Overall Study|Withdrawal by Subject|11|||
126265838|NCT01392326|454262950|FG002|Overall Study|Withdrawal by Subject|15|||
126265839|NCT01392326|454262948|FG000|Overall Study|Protocol Violation|2|||
126265840|NCT01392326|454262949|FG001|Overall Study|Protocol Violation|0|||
126265841|NCT01392326|454262950|FG002|Overall Study|Protocol Violation|0|||
126265842|NCT01392326|454262948|FG000|Overall Study|Pregnancy|0|||
126265843|NCT01392326|454262949|FG001|Overall Study|Pregnancy|0|||
126265844|NCT01392326|454262950|FG002|Overall Study|Pregnancy|1|||
126265845|NCT01392326|454262948|FG000|Overall Study|Physician Decision|7|||
126265846|NCT01392326|454262949|FG001|Overall Study|Physician Decision|5|||
126704281|NCT00283387|455868260|FG000|First Intervention|Withdrawal by Subject|0|||
126704282|NCT00283387|455868261|FG001|First Intervention|Withdrawal by Subject|1|||
126704283|NCT00446030|455868271|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
126704284|NCT00446030|455868272|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
126704285|NCT00446030|455868271|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
126704286|NCT00446030|455868272|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
126704287|NCT00446030|455868271|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
126704288|NCT00446030|455868272|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
126704289|NCT00446030|455868271|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
126704290|NCT00446030|455868272|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
126704291|NCT00446030|455868271|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
126704292|NCT00446030|455868272|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
126704293|NCT00446030|455868271|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
126704294|NCT00446030|455868272|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
126704295|NCT00446030|455868271|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
126704296|NCT00446030|455868272|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
126704297|NCT00446030|455868271|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
126704298|NCT00446030|455868272|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
126704299|NCT00446030|455868271|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
126704300|NCT00446030|455868272|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
126704301|NCT00446030|455868271|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
126704302|NCT00446030|455868272|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
126704303|NCT00446030|455868271|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
126704304|NCT00446030|455868272|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
126704305|NCT00446030|455868271|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
126704306|NCT00446030|455868272|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
126704307|NCT00446030|455868271|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
126704308|NCT00446030|455868272|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
126704309|NCT00446030|455868271|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
126704310|NCT00446030|455868272|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
126704311|NCT00446030|455868271|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
126704312|NCT00446030|455868272|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
126704313|NCT00446030|455868271|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
126704314|NCT00446030|455868272|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
126704315|NCT00446030|455868271|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
126704316|NCT00446030|455868272|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
126704317|NCT00446030|455868271|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
126704318|NCT00446030|455868272|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
126704319|NCT00446030|455868271|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
126704320|NCT00446030|455868272|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
126704321|NCT02886715|455868273|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126704322|NCT02886715|455868274|FG001|Overall Study|Non-Compliance With Study Drug|2|||
126704323|NCT02886715|455868275|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126704324|NCT02886715|455868273|FG000|Overall Study|Adverse Event|4|||
126704325|NCT02886715|455868274|FG001|Overall Study|Adverse Event|2|||
126704326|NCT02886715|455868275|FG002|Overall Study|Adverse Event|0|||
126704327|NCT02886715|455868273|FG000|Overall Study|Lack of Efficacy|0|||
126704328|NCT02886715|455868274|FG001|Overall Study|Lack of Efficacy|2|||
126704329|NCT02886715|455868275|FG002|Overall Study|Lack of Efficacy|1|||
126265847|NCT01392326|454262950|FG002|Overall Study|Physician Decision|2|||
126265848|NCT01392326|454262948|FG000|Overall Study|Lost to Follow-up|1|||
126265849|NCT01392326|454262949|FG001|Overall Study|Lost to Follow-up|3|||
126265850|NCT01392326|454262950|FG002|Overall Study|Lost to Follow-up|4|||
126265851|NCT01392326|454262948|FG000|Overall Study|Lack of Efficacy|14|||
126704330|NCT02886715|455868273|FG000|Overall Study|Lost to Follow-up|29|||
126704331|NCT02886715|455868274|FG001|Overall Study|Lost to Follow-up|26|||
126704332|NCT02886715|455868275|FG002|Overall Study|Lost to Follow-up|10|||
126704333|NCT02886715|455868273|FG000|Overall Study|Pregnancy|1|||
126704334|NCT02886715|455868274|FG001|Overall Study|Pregnancy|1|||
126704335|NCT02886715|455868275|FG002|Overall Study|Pregnancy|1|||
126704336|NCT02886715|455868273|FG000|Overall Study|Protocol Violation|3|||
126704337|NCT02886715|455868274|FG001|Overall Study|Protocol Violation|2|||
126704338|NCT02886715|455868275|FG002|Overall Study|Protocol Violation|1|||
126704339|NCT02886715|455868273|FG000|Overall Study|Withdrawal by Subject|20|||
126704340|NCT02886715|455868274|FG001|Overall Study|Withdrawal by Subject|18|||
126704341|NCT02886715|455868275|FG002|Overall Study|Withdrawal by Subject|5|||
126704342|NCT02886715|455868273|FG000|Overall Study|missing|7|||
126704343|NCT02886715|455868274|FG001|Overall Study|missing|2|||
126704344|NCT02886715|455868275|FG002|Overall Study|missing|2|||
126704345|NCT00503399|455868278|FG000|Overall Study|Death|2|||
126704346|NCT00503399|455868279|FG001|Overall Study|Death|1|||
126704347|NCT00503399|455868278|FG000|Overall Study|Protocol Violation|1|||
126704348|NCT00503399|455868279|FG001|Overall Study|Protocol Violation|0|||
126704349|NCT00503399|455868278|FG000|Overall Study|Withdrawal by Subject|4|||
126704350|NCT00503399|455868279|FG001|Overall Study|Withdrawal by Subject|2|||
126704351|NCT00503399|455868278|FG000|Overall Study|Adverse Event|0|||
126704352|NCT00503399|455868279|FG001|Overall Study|Adverse Event|3|||
126704353|NCT00503399|455868278|FG000|Overall Study|Lost to Follow-up|0|||
126704354|NCT00503399|455868279|FG001|Overall Study|Lost to Follow-up|2|||
126704355|NCT03812510|455868280|FG000|Overall Study|Lost to Follow-up|39|||
126704356|NCT03812510|455868280|FG000|Overall Study|Withdrawal by Subject|42|||
126704357|NCT03812510|455868280|FG000|Overall Study|Physician Decision|2|||
126704358|NCT03812510|455868280|FG000|Overall Study|Study Terminated by Sponsor|9|||
126704359|NCT03812510|455868280|FG000|Overall Study|Did Not Start Study Medication|55|||
126704360|NCT03812510|455868280|FG000|Overall Study|Adverse Event|5|||
126704361|NCT00768560|455868281|FG000|Intervention Set 1|Adverse Event|0|||
126704362|NCT00768560|455868282|FG001|Intervention Set 1|Adverse Event|1|||
126764752|NCT01817764|456090986|FG000|Overall Study|Adverse Event|7|||
126764753|NCT01817764|456090987|FG001|Overall Study|Adverse Event|10|||
126764754|NCT01817764|456090986|FG000|Overall Study|Lack of Efficacy|9|||
126764755|NCT01817764|456090987|FG001|Overall Study|Lack of Efficacy|7|||
126764756|NCT01817764|456090986|FG000|Overall Study|Protocol Violation|7|||
126764757|NCT01817764|456090987|FG001|Overall Study|Protocol Violation|5|||
126764758|NCT01817764|456090986|FG000|Overall Study|Lost to Follow-up|1|||
126764759|NCT01817764|456090987|FG001|Overall Study|Lost to Follow-up|4|||
126764760|NCT01817764|456090986|FG000|Overall Study|Withdrawal by Subject|10|||
126764761|NCT01817764|456090987|FG001|Overall Study|Withdrawal by Subject|12|||
126764762|NCT04888377|456090988|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
126764763|NCT04888377|456090989|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
126764764|NCT04888377|456090988|FG000|Overall Study|Physician Decision|6|||
126764765|NCT04888377|456090989|FG001|Overall Study|Physician Decision|6|||
126764766|NCT04888377|456090988|FG000|Overall Study|Withdrawal by Subject|7|||
126764767|NCT04888377|456090989|FG001|Overall Study|Withdrawal by Subject|3|||
126764768|NCT00526162|456090990|FG000|Overall Study|Device not implanted|3|||
126764769|NCT05993299|456090991|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
126764770|NCT05993299|456090991|FG000|Overall Study|Ongoing|4|||
126764771|NCT05644756|456090992|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
126764772|NCT05644756|456090992|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
126764773|NCT03985982|456090993|FG000|Double-Blind Phase|Lost to Follow-up|4|||
126764774|NCT03985982|456090994|FG001|Double-Blind Phase|Lost to Follow-up|3|||
126764775|NCT03985982|456090995|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126764776|NCT03985982|456090993|FG000|Double-Blind Phase|Physician Decision|1|||
126764777|NCT03985982|456090994|FG001|Double-Blind Phase|Physician Decision|0|||
126764778|NCT03985982|456090995|FG002|Double-Blind Phase|Physician Decision|0|||
126764779|NCT03985982|456090993|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
126453001|NCT00717236|454959046|FG001|Double-Blind Period|Other: Protocol Violation|0|||
126453002|NCT00717236|454959045|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
126704363|NCT00768560|455868283|FG002|Intervention Set 1|Adverse Event|0|||
126764780|NCT03985982|456090994|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
126764781|NCT03985982|456090995|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
126704364|NCT00768560|455868284|FG003|Intervention Set 1|Adverse Event|0|||
126704365|NCT00768560|455868285|FG004|Intervention Set 1|Adverse Event|0|||
126704366|NCT00768560|455868286|FG005|Intervention Set 1|Adverse Event|0|||
126704367|NCT01120626|455868287|FG000|Overall Study|Withdrawal by Subject|1|||
126704368|NCT01120626|455868288|FG001|Overall Study|Withdrawal by Subject|0|||
126704369|NCT02635204|455868289|FG000|Overall Study|Adverse Event|1|||
126704370|NCT02635204|455868290|FG001|Overall Study|Adverse Event|0|||
126704371|NCT02635204|455868289|FG000|Overall Study|Lost to Follow-up|1|||
126704372|NCT02635204|455868290|FG001|Overall Study|Lost to Follow-up|1|||
126764782|NCT03985982|456090993|FG000|Double-Blind Phase|COVID-19|1|||
126764783|NCT03985982|456090994|FG001|Double-Blind Phase|COVID-19|0|||
126764784|NCT03985982|456090995|FG002|Double-Blind Phase|COVID-19|0|||
126764785|NCT03985982|456090993|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
126764786|NCT03985982|456090994|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
126764787|NCT03985982|456090995|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
126764788|NCT03985982|456090993|FG000|Open-Label Phase|Lost to Follow-up|0|||
126764789|NCT03985982|456090994|FG001|Open-Label Phase|Lost to Follow-up|0|||
126764790|NCT03985982|456090995|FG002|Open-Label Phase|Lost to Follow-up|13|||
126764791|NCT03985982|456090993|FG000|Open-Label Phase|Physician Decision|0|||
126764792|NCT03985982|456090994|FG001|Open-Label Phase|Physician Decision|0|||
126764793|NCT03985982|456090995|FG002|Open-Label Phase|Physician Decision|2|||
126764794|NCT03985982|456090993|FG000|Open-Label Phase|Withdrawal by Subject|0|||
126764795|NCT03985982|456090994|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126764796|NCT03985982|456090995|FG002|Open-Label Phase|Withdrawal by Subject|11|||
126764797|NCT00478933|456091000|FG000|Overall Study|Protocol Violation|22|||
126265852|NCT01392326|454262949|FG001|Overall Study|Lack of Efficacy|10|||
126265853|NCT01392326|454262950|FG002|Overall Study|Lack of Efficacy|15|||
126265854|NCT01392326|454262948|FG000|Overall Study|Adverse Event|9|||
126265855|NCT01392326|454262949|FG001|Overall Study|Adverse Event|6|||
126265856|NCT01392326|454262950|FG002|Overall Study|Adverse Event|11|||
126265857|NCT04553913|454262953|FG000|Overall Study|patient's block resolved prior to PACU|1|||
126265858|NCT04553913|454262953|FG000|Overall Study|did not use the device properly|5|||
126265859|NCT00710749|454262955|FG000|First Intervention|Withdrawal by Subject|1|||
126265860|NCT00710749|454262956|FG001|First Intervention|Withdrawal by Subject|0|||
126265861|NCT05626803|454265066|FG000|Overall Study|Lost to Follow-up|0|||
126265862|NCT05626803|454265067|FG001|Overall Study|Lost to Follow-up|1|||
126265863|NCT05626803|454265068|FG002|Overall Study|Lost to Follow-up|0|||
126265864|NCT05626803|454265069|FG003|Overall Study|Lost to Follow-up|0|||
126265865|NCT01000610|454265075|FG000|Overall Study|Adverse Event|1|||
126265866|NCT01000610|454265075|FG000|Overall Study|Lost to Follow-up|4|||
126265867|NCT01000610|454265075|FG000|Overall Study|Treatment failure|1|||
126265868|NCT00493246|454265076|FG000|Overall Study|Withdrawal by Subject|0|||
126265869|NCT00493246|454265077|FG001|Overall Study|Withdrawal by Subject|0|||
126265870|NCT00493246|454265078|FG002|Overall Study|Withdrawal by Subject|0|||
126265871|NCT00493246|454265079|FG003|Overall Study|Withdrawal by Subject|0|||
126265872|NCT00493246|454265080|FG004|Overall Study|Withdrawal by Subject|1|||
126265873|NCT00493246|454265081|FG005|Overall Study|Withdrawal by Subject|0|||
126265874|NCT00493246|454265082|FG006|Overall Study|Withdrawal by Subject|0|||
126265875|NCT00493246|454265083|FG007|Overall Study|Withdrawal by Subject|0|||
126265876|NCT00493246|454265076|FG000|Overall Study|No access to draw blood|0|||
126265877|NCT00493246|454265077|FG001|Overall Study|No access to draw blood|0|||
126265878|NCT00493246|454265078|FG002|Overall Study|No access to draw blood|0|||
126265879|NCT00493246|454265079|FG003|Overall Study|No access to draw blood|0|||
126265880|NCT00493246|454265080|FG004|Overall Study|No access to draw blood|0|||
126265881|NCT00493246|454265081|FG005|Overall Study|No access to draw blood|1|||
126265882|NCT00493246|454265082|FG006|Overall Study|No access to draw blood|0|||
126265883|NCT00493246|454265083|FG007|Overall Study|No access to draw blood|0|||
126265884|NCT00493246|454265076|FG000|Overall Study|Lost to Follow-up|0|||
126265885|NCT00493246|454265077|FG001|Overall Study|Lost to Follow-up|0|||
126265886|NCT00493246|454265078|FG002|Overall Study|Lost to Follow-up|0|||
126265887|NCT00493246|454265079|FG003|Overall Study|Lost to Follow-up|0|||
126265888|NCT00493246|454265080|FG004|Overall Study|Lost to Follow-up|0|||
126265889|NCT00493246|454265081|FG005|Overall Study|Lost to Follow-up|0|||
126265890|NCT00493246|454265082|FG006|Overall Study|Lost to Follow-up|1|||
126265891|NCT00493246|454265083|FG007|Overall Study|Lost to Follow-up|0|||
126265892|NCT02631876|454265090|FG000|Overall Study|Death|96|||
126265893|NCT02631876|454265091|FG001|Overall Study|Death|50|||
126265894|NCT02631876|454265090|FG000|Overall Study|Investigator's discretion|1|||
126265895|NCT02631876|454265091|FG001|Overall Study|Investigator's discretion|0|||
126265896|NCT02631876|454265090|FG000|Overall Study|Lost to Follow-up|2|||
126265897|NCT02631876|454265091|FG001|Overall Study|Lost to Follow-up|0|||
126265898|NCT02631876|454265090|FG000|Overall Study|Withdrawal by Subject|16|||
126265899|NCT02631876|454265091|FG001|Overall Study|Withdrawal by Subject|9|||
126265900|NCT02631876|454265090|FG000|Overall Study|Other than specified|4|||
126265901|NCT02631876|454265091|FG001|Overall Study|Other than specified|4|||
126265902|NCT01408563|454265096|FG000|Overall Study|Ineligible after consent/ registration|2|||
126265903|NCT02054130|454265099|FG000|Overall Study|Withdrawal by Subject|4|||
126764798|NCT00478933|456091000|FG000|Overall Study|Informed consent not verified|3|||
126764799|NCT00478933|456091000|FG000|Overall Study|Inadequate data available|53|||
126764800|NCT03772574|456091001|FG000|Overall Study|Protocol Violation|2|||
126265904|NCT02054130|454265100|FG001|Overall Study|Withdrawal by Subject|4|||
126265905|NCT02054130|454265101|FG002|Overall Study|Withdrawal by Subject|7|||
126265906|NCT02054130|454265102|FG003|Overall Study|Withdrawal by Subject|10|||
126265907|NCT02054130|454265099|FG000|Overall Study|Death|0|||
126265908|NCT02054130|454265100|FG001|Overall Study|Death|1|||
126265909|NCT02054130|454265101|FG002|Overall Study|Death|0|||
126265910|NCT02054130|454265102|FG003|Overall Study|Death|0|||
126265911|NCT02054130|454265099|FG000|Overall Study|Lost to Follow-up|0|||
126764801|NCT03772574|456091002|FG001|Overall Study|Protocol Violation|0|||
126764802|NCT03772574|456091003|FG002|Overall Study|Protocol Violation|0|||
126764803|NCT03772574|456091001|FG000|Overall Study|Discomfort|0|||
126764804|NCT03772574|456091002|FG001|Overall Study|Discomfort|5|||
126764805|NCT03772574|456091003|FG002|Overall Study|Discomfort|4|||
126764806|NCT03586427|456091006|FG000|Overall Study|Lost to Follow-up|0|||
126764807|NCT03586427|456091007|FG001|Overall Study|Lost to Follow-up|3|||
126764808|NCT03586427|456091008|FG002|Overall Study|Lost to Follow-up|1|||
126764809|NCT03586427|456091009|FG003|Overall Study|Lost to Follow-up|3|||
126764810|NCT03586427|456091010|FG004|Overall Study|Lost to Follow-up|3|||
126764811|NCT03586427|456091006|FG000|Overall Study|Withdrawal by Subject|0|||
126764812|NCT03586427|456091007|FG001|Overall Study|Withdrawal by Subject|1|||
126764813|NCT03586427|456091008|FG002|Overall Study|Withdrawal by Subject|2|||
126764814|NCT03586427|456091009|FG003|Overall Study|Withdrawal by Subject|1|||
126764815|NCT03586427|456091010|FG004|Overall Study|Withdrawal by Subject|1|||
126764816|NCT03586427|456091006|FG000|Overall Study|Adverse Event|0|||
126764817|NCT03586427|456091007|FG001|Overall Study|Adverse Event|0|||
126764818|NCT03586427|456091008|FG002|Overall Study|Adverse Event|1|||
126764819|NCT03586427|456091009|FG003|Overall Study|Adverse Event|0|||
126764820|NCT03586427|456091010|FG004|Overall Study|Adverse Event|0|||
126547328|NCT02778399|455296200|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
126547329|NCT02778399|455296201|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
126547330|NCT02778399|455296202|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
126547331|NCT02778399|455296203|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
126764821|NCT03586427|456091006|FG000|Overall Study|Protocol Violation|0|||
126764822|NCT03586427|456091007|FG001|Overall Study|Protocol Violation|0|||
126764823|NCT03586427|456091008|FG002|Overall Study|Protocol Violation|1|||
126764824|NCT03586427|456091009|FG003|Overall Study|Protocol Violation|0|||
126764825|NCT03586427|456091010|FG004|Overall Study|Protocol Violation|1|||
126764826|NCT03586427|456091006|FG000|Overall Study|Noncompliance with study drug|0|||
126764827|NCT03586427|456091007|FG001|Overall Study|Noncompliance with study drug|0|||
126764828|NCT03586427|456091008|FG002|Overall Study|Noncompliance with study drug|1|||
126764829|NCT03586427|456091009|FG003|Overall Study|Noncompliance with study drug|0|||
126764830|NCT03586427|456091010|FG004|Overall Study|Noncompliance with study drug|0|||
126764831|NCT03193996|456091011|FG000|Overall Study|Withdrawal by Subject|4|||
126764832|NCT03193996|456091011|FG000|Overall Study|Lost to Follow-up|4|||
126764833|NCT03193996|456091011|FG000|Overall Study|Physician Decision|2|||
126764834|NCT03193996|456091011|FG000|Overall Study|Pregnancy|1|||
126764835|NCT03193996|456091011|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
126265912|NCT02054130|454265100|FG001|Overall Study|Lost to Follow-up|0|||
126265913|NCT02054130|454265101|FG002|Overall Study|Lost to Follow-up|1|||
126265914|NCT02054130|454265102|FG003|Overall Study|Lost to Follow-up|2|||
126265915|NCT02054130|454265099|FG000|Overall Study|Missed dose|4|||
126265916|NCT02054130|454265100|FG001|Overall Study|Missed dose|6|||
126265917|NCT02054130|454265101|FG002|Overall Study|Missed dose|7|||
126265918|NCT02054130|454265102|FG003|Overall Study|Missed dose|10|||
126265919|NCT00094458|454265103|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
126265920|NCT00094458|454265104|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
126265921|NCT00094458|454265105|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
126265922|NCT00094458|454265106|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
126265923|NCT00094458|454265107|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
126265924|NCT00094458|454265108|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
126265925|NCT00094458|454265103|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
126265926|NCT00094458|454265104|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
126265927|NCT00094458|454265105|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
126265928|NCT00094458|454265106|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
126265929|NCT00094458|454265107|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
126265930|NCT00094458|454265108|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
126265931|NCT00094458|454265103|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
126265932|NCT00094458|454265104|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
126265933|NCT00094458|454265105|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
126265934|NCT00094458|454265106|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
126265935|NCT00094458|454265107|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
126265936|NCT00094458|454265108|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
126265937|NCT00094458|454265103|FG000|Main Study: Through Week 30|Adverse Event|38|||
126265938|NCT00094458|454265104|FG001|Main Study: Through Week 30|Adverse Event|20|||
126265939|NCT00094458|454265105|FG002|Main Study: Through Week 30|Adverse Event|28|||
126265940|NCT00094458|454265106|FG003|Main Study: Through Week 30|Adverse Event|0|||
126265941|NCT00094458|454265107|FG004|Main Study: Through Week 30|Adverse Event|0|||
126265942|NCT00094458|454265108|FG005|Main Study: Through Week 30|Adverse Event|0|||
126265943|NCT00094458|454265103|FG000|Main Study: Through Week 30|Death|1|||
126764836|NCT03193996|456091011|FG000|Overall Study|Complicating disease|1|||
126764837|NCT00494234|456091012|FG000|Overall Study|Withdrawal by Subject|1|||
126764838|NCT00494234|456091013|FG001|Overall Study|Withdrawal by Subject|0|||
126764839|NCT00494234|456091012|FG000|Overall Study|Disease progression|11|||
126764840|NCT00494234|456091013|FG001|Overall Study|Disease progression|8|||
126764841|NCT00494234|456091012|FG000|Overall Study|Death|2|||
126764842|NCT00494234|456091013|FG001|Overall Study|Death|1|||
126764843|NCT00423137|456091014|FG000|Overall Study|Lost to Follow-up|0|||
126764844|NCT00423137|456091015|FG001|Overall Study|Lost to Follow-up|0|||
126764845|NCT00423137|456091016|FG002|Overall Study|Lost to Follow-up|1|||
126764846|NCT00423137|456091017|FG003|Overall Study|Lost to Follow-up|0|||
126764847|NCT00423137|456091014|FG000|Overall Study|Protocol Violation|0|||
126764848|NCT00423137|456091015|FG001|Overall Study|Protocol Violation|0|||
126764849|NCT00423137|456091016|FG002|Overall Study|Protocol Violation|0|||
126764850|NCT00423137|456091017|FG003|Overall Study|Protocol Violation|1|||
126764851|NCT00423137|456091014|FG000|Overall Study|Adverse Event Study disease worse|1|||
126764852|NCT00423137|456091015|FG001|Overall Study|Adverse Event Study disease worse|0|||
126764853|NCT00423137|456091016|FG002|Overall Study|Adverse Event Study disease worse|3|||
126764854|NCT00423137|456091017|FG003|Overall Study|Adverse Event Study disease worse|1|||
126764855|NCT00423137|456091014|FG000|Overall Study|Adverse Event Other|0|||
126764856|NCT00423137|456091015|FG001|Overall Study|Adverse Event Other|0|||
126764857|NCT00423137|456091016|FG002|Overall Study|Adverse Event Other|2|||
126764858|NCT00423137|456091017|FG003|Overall Study|Adverse Event Other|0|||
126764859|NCT00593385|456091019|FG000|Overall Study|Death|14|||
126764860|NCT00593385|456091019|FG000|Overall Study|Lost to Follow-up|17|||
126764861|NCT00593385|456091019|FG000|Overall Study|Withdrawal by Subject|9|||
126764862|NCT01471197|456091020|FG000|Overall Study|Disease Progression|4|||
126764863|NCT01471197|456091021|FG001|Overall Study|Disease Progression|2|||
126764864|NCT01471197|456091020|FG000|Overall Study|Death|1|||
126764865|NCT01471197|456091021|FG001|Overall Study|Death|0|||
126764866|NCT01471197|456091020|FG000|Overall Study|Study Drug Toxicity|1|||
126764867|NCT01471197|456091021|FG001|Overall Study|Study Drug Toxicity|0|||
126764868|NCT00924313|456091027|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
126764869|NCT00491322|456091029|FG000|Overall Study|Protocol Violation|1|||
126764870|NCT00491322|456091030|FG001|Overall Study|Protocol Violation|0|||
126764871|NCT00491322|456091029|FG000|Overall Study|Pregnancy|0|||
126764872|NCT00491322|456091030|FG001|Overall Study|Pregnancy|1|||
126764873|NCT02331680|456091031|FG000|Overall Study|Adverse Event|3|||
126764874|NCT02331680|456091032|FG001|Overall Study|Adverse Event|0|||
126764875|NCT02331680|456091033|FG002|Overall Study|Adverse Event|2|||
126764876|NCT02331680|456091031|FG000|Overall Study|Physician Decision|1|||
126764877|NCT02331680|456091032|FG001|Overall Study|Physician Decision|1|||
126764878|NCT02331680|456091033|FG002|Overall Study|Physician Decision|2|||
126764879|NCT02331680|456091031|FG000|Overall Study|Withdrawal by Subject|0|||
126764880|NCT02331680|456091032|FG001|Overall Study|Withdrawal by Subject|1|||
126764881|NCT02331680|456091033|FG002|Overall Study|Withdrawal by Subject|2|||
126764882|NCT02331680|456091031|FG000|Overall Study|Met withdrawal criteria|2|||
126764883|NCT02331680|456091032|FG001|Overall Study|Met withdrawal criteria|2|||
126764884|NCT02331680|456091033|FG002|Overall Study|Met withdrawal criteria|5|||
126764885|NCT02331680|456091031|FG000|Overall Study|Non-compliance with study drug|0|||
126764886|NCT02331680|456091032|FG001|Overall Study|Non-compliance with study drug|0|||
126764887|NCT02331680|456091033|FG002|Overall Study|Non-compliance with study drug|1|||
126764888|NCT02331680|456091031|FG000|Overall Study|Protocol Violation|0|||
126764889|NCT02331680|456091032|FG001|Overall Study|Protocol Violation|0|||
126764890|NCT02331680|456091033|FG002|Overall Study|Protocol Violation|3|||
126764891|NCT00602667|456091034|FG000|Overall Study|Still on Therapy|0|||
126764892|NCT00602667|456091035|FG001|Overall Study|Still on Therapy|2|||
126265944|NCT00094458|454265104|FG001|Main Study: Through Week 30|Death|0|||
126265945|NCT00094458|454265105|FG002|Main Study: Through Week 30|Death|0|||
126265946|NCT00094458|454265106|FG003|Main Study: Through Week 30|Death|0|||
126265947|NCT00094458|454265107|FG004|Main Study: Through Week 30|Death|0|||
126265948|NCT00094458|454265108|FG005|Main Study: Through Week 30|Death|0|||
126265949|NCT00094458|454265103|FG000|Main Study: Through Week 30|Other|19|||
126265950|NCT00094458|454265104|FG001|Main Study: Through Week 30|Other|16|||
126265951|NCT00094458|454265105|FG002|Main Study: Through Week 30|Other|9|||
126265952|NCT00094458|454265106|FG003|Main Study: Through Week 30|Other|0|||
126265953|NCT00094458|454265107|FG004|Main Study: Through Week 30|Other|0|||
126265954|NCT00094458|454265108|FG005|Main Study: Through Week 30|Other|0|||
126265955|NCT00094458|454265103|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
126265956|NCT00094458|454265104|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
126764893|NCT00602667|456091036|FG002|Overall Study|Still on Therapy|2|||
126764894|NCT00602667|456091034|FG000|Overall Study|Death|0|||
126265957|NCT00094458|454265105|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
126265958|NCT00094458|454265106|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
126265959|NCT00094458|454265107|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
126764895|NCT00602667|456091035|FG001|Overall Study|Death|1|||
126764896|NCT00602667|456091036|FG002|Overall Study|Death|1|||
126764897|NCT00602667|456091034|FG000|Overall Study|Family request|3|||
126764898|NCT00602667|456091035|FG001|Overall Study|Family request|25|||
126764899|NCT00602667|456091036|FG002|Overall Study|Family request|6|||
126764900|NCT00602667|456091034|FG000|Overall Study|Excessive toxicity|1|||
126764901|NCT00602667|456091035|FG001|Overall Study|Excessive toxicity|1|||
126764902|NCT00602667|456091036|FG002|Overall Study|Excessive toxicity|0|||
126265960|NCT00094458|454265108|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
126265961|NCT00094458|454265103|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
126265962|NCT00094458|454265104|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
126265963|NCT00094458|454265105|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
126265964|NCT00094458|454265106|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
126265965|NCT00094458|454265107|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
126265966|NCT00094458|454265108|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
126265967|NCT00094458|454265103|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
126265968|NCT00094458|454265104|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
126265969|NCT00094458|454265105|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
126265970|NCT00094458|454265106|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
126265971|NCT00094458|454265107|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
126265972|NCT00094458|454265108|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
126265973|NCT00094458|454265103|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
126265974|NCT00094458|454265104|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
126265975|NCT00094458|454265105|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
126265976|NCT00094458|454265106|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
126265977|NCT00094458|454265107|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
126265978|NCT00094458|454265108|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
126265979|NCT00094458|454265103|FG000|OLE: Open-Label Extension|Adverse Event|0|||
126265980|NCT00094458|454265104|FG001|OLE: Open-Label Extension|Adverse Event|0|||
126265981|NCT00094458|454265105|FG002|OLE: Open-Label Extension|Adverse Event|0|||
126265982|NCT00094458|454265106|FG003|OLE: Open-Label Extension|Adverse Event|0|||
126265983|NCT00094458|454265107|FG004|OLE: Open-Label Extension|Adverse Event|3|||
126265984|NCT00094458|454265108|FG005|OLE: Open-Label Extension|Adverse Event|4|||
126265985|NCT00094458|454265103|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
126265986|NCT00094458|454265104|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
126265987|NCT00094458|454265105|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
126265988|NCT00094458|454265106|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
126265989|NCT00094458|454265107|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
126265990|NCT00094458|454265108|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
126265991|NCT00094458|454265103|FG000|OLE: Open-Label Extension|Patient decision|0|||
126265992|NCT00094458|454265104|FG001|OLE: Open-Label Extension|Patient decision|0|||
126265993|NCT00094458|454265105|FG002|OLE: Open-Label Extension|Patient decision|0|||
126265994|NCT00094458|454265106|FG003|OLE: Open-Label Extension|Patient decision|0|||
126265995|NCT00094458|454265107|FG004|OLE: Open-Label Extension|Patient decision|1|||
126265996|NCT00094458|454265108|FG005|OLE: Open-Label Extension|Patient decision|0|||
126265997|NCT02017860|454265113|FG000|Overall Study|Adverse Event|1|||
126265998|NCT02017860|454265113|FG000|Overall Study|Withdrawal by Subject|1|||
126265999|NCT03604341|454265116|FG000|Overall Study|Withdrawal by Subject|1|||
126266000|NCT03604341|454265117|FG001|Overall Study|Withdrawal by Subject|1|||
126266001|NCT03604341|454265116|FG000|Overall Study|Adverse Event|1|||
126764903|NCT00602667|456091034|FG000|Overall Study|Second malignancy|0|||
126764904|NCT00602667|456091035|FG001|Overall Study|Second malignancy|1|||
126764905|NCT00602667|456091036|FG002|Overall Study|Second malignancy|0|||
126764906|NCT00602667|456091034|FG000|Overall Study|Physician Decision|2|||
126764907|NCT00602667|456091035|FG001|Overall Study|Physician Decision|3|||
126764908|NCT00602667|456091036|FG002|Overall Study|Physician Decision|8|||
126764909|NCT00602667|456091034|FG000|Overall Study|Progressive disease|13|||
126764910|NCT00602667|456091035|FG001|Overall Study|Progressive disease|48|||
126764911|NCT00602667|456091036|FG002|Overall Study|Progressive disease|45|||
126764912|NCT00602667|456091034|FG000|Overall Study|Progressive disease prior to therapy|0|||
126764913|NCT00602667|456091035|FG001|Overall Study|Progressive disease prior to therapy|0|||
126764914|NCT00602667|456091036|FG002|Overall Study|Progressive disease prior to therapy|1|||
126764915|NCT04410978|456091042|FG000|Overall Study|Poor compliance to protocol|2|||
126764916|NCT04410978|456091043|FG001|Overall Study|Poor compliance to protocol|4|||
126764917|NCT04410978|456091042|FG000|Overall Study|Withdrawal by Subject|64|||
126764918|NCT04410978|456091043|FG001|Overall Study|Withdrawal by Subject|66|||
126764919|NCT04410978|456091042|FG000|Overall Study|Other|6|||
126764920|NCT04410978|456091043|FG001|Overall Study|Other|7|||
126266002|NCT03604341|454265117|FG001|Overall Study|Adverse Event|0|||
126266003|NCT03604341|454265116|FG000|Overall Study|Protocol Violation|0|||
126266004|NCT03604341|454265117|FG001|Overall Study|Protocol Violation|1|||
126266005|NCT01829113|454265121|FG000|Overall Study|Disease Progression|37|||
126266006|NCT01829113|454265122|FG001|Overall Study|Disease Progression|48|||
126266007|NCT01829113|454265121|FG000|Overall Study|Adverse Event|14|||
126266008|NCT01829113|454265122|FG001|Overall Study|Adverse Event|10|||
126266009|NCT01829113|454265121|FG000|Overall Study|Withdrawal by Subject|17|||
126360378|NCT00147537|454610813|FG001|Phase 1b|Other|0|||
126360379|NCT00147537|454610814|FG002|Phase 1b|Other|2|||
126764921|NCT04410978|456091042|FG000|Overall Study|Missing study status|1|||
126764922|NCT04410978|456091043|FG001|Overall Study|Missing study status|0|||
126764923|NCT04115488|456091045|FG000|Overall Study|Adverse Event|8|||
126266010|NCT01829113|454265122|FG001|Overall Study|Withdrawal by Subject|10|||
126266011|NCT01829113|454265121|FG000|Overall Study|Death|4|||
126266012|NCT01829113|454265122|FG001|Overall Study|Death|6|||
126266013|NCT01829113|454265121|FG000|Overall Study|Sponsor Decision|1|||
126266014|NCT01829113|454265122|FG001|Overall Study|Sponsor Decision|1|||
126266015|NCT01829113|454265121|FG000|Overall Study|No Study Treatment Received|3|||
126266016|NCT01829113|454265122|FG001|Overall Study|No Study Treatment Received|2|||
126266017|NCT01829113|454265121|FG000|Overall Study|Physician Decision|1|||
126266018|NCT01829113|454265122|FG001|Overall Study|Physician Decision|1|||
126764924|NCT04115488|456091046|FG001|Overall Study|Adverse Event|4|||
126764925|NCT04115488|456091045|FG000|Overall Study|Withdrawal by Subject|3|||
126764926|NCT04115488|456091046|FG001|Overall Study|Withdrawal by Subject|6|||
126764927|NCT04115488|456091045|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
126764928|NCT04115488|456091046|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
126764929|NCT04115488|456091045|FG000|Overall Study|Patient 's location change|1|||
126764930|NCT04115488|456091046|FG001|Overall Study|Patient 's location change|0|||
126764931|NCT04115488|456091045|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
126764932|NCT04115488|456091046|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
126764933|NCT02576951|456091051|FG000|Overall Study|Lost to Follow-up|0|||
126764934|NCT02576951|456091052|FG001|Overall Study|Lost to Follow-up|0|||
126764935|NCT02576951|456091053|FG002|Overall Study|Lost to Follow-up|2|||
126764936|NCT02576951|456091054|FG003|Overall Study|Lost to Follow-up|2|||
126764937|NCT02576951|456091051|FG000|Overall Study|Withdrawal by Subject|1|||
126764938|NCT02576951|456091052|FG001|Overall Study|Withdrawal by Subject|0|||
126764939|NCT02576951|456091053|FG002|Overall Study|Withdrawal by Subject|0|||
126764940|NCT02576951|456091054|FG003|Overall Study|Withdrawal by Subject|2|||
126266019|NCT00897949|454265123|FG000|Overall Study|Adverse Event|1|||
126266020|NCT00897949|454265124|FG001|Overall Study|Adverse Event|1|||
126266021|NCT00897949|454265125|FG002|Overall Study|Adverse Event|0|||
126266022|NCT00897949|454265123|FG000|Overall Study|Lost to Follow-up|0|||
126266023|NCT00897949|454265124|FG001|Overall Study|Lost to Follow-up|2|||
126266024|NCT00897949|454265125|FG002|Overall Study|Lost to Follow-up|1|||
126266025|NCT00897949|454265123|FG000|Overall Study|Protocol Violation|6|||
126266026|NCT00897949|454265124|FG001|Overall Study|Protocol Violation|3|||
126266027|NCT00897949|454265125|FG002|Overall Study|Protocol Violation|1|||
126266028|NCT00897949|454265123|FG000|Overall Study|Withdrawal by Subject|1|||
126266029|NCT00897949|454265124|FG001|Overall Study|Withdrawal by Subject|2|||
126266030|NCT00897949|454265125|FG002|Overall Study|Withdrawal by Subject|0|||
126266031|NCT00897949|454265123|FG000|Overall Study|Patient Uncoorperative|0|||
126266032|NCT00897949|454265124|FG001|Overall Study|Patient Uncoorperative|2|||
126266033|NCT00897949|454265125|FG002|Overall Study|Patient Uncoorperative|1|||
126764941|NCT02576951|456091051|FG000|Overall Study|Protocol Violation|0|||
126764942|NCT02576951|456091052|FG001|Overall Study|Protocol Violation|0|||
126764943|NCT02576951|456091053|FG002|Overall Study|Protocol Violation|0|||
126764944|NCT02576951|456091054|FG003|Overall Study|Protocol Violation|1|||
126764945|NCT03280628|456092608|FG000|Overall Study|Lost to Follow-up|8|||
126764946|NCT03280628|456092609|FG001|Overall Study|Lost to Follow-up|6|||
126764947|NCT03280628|456092610|FG002|Overall Study|Lost to Follow-up|11|||
126764948|NCT01361308|456092613|FG000|Overall Study|Withdrawal by Subject|9|||
126764949|NCT01361308|456092614|FG001|Overall Study|Withdrawal by Subject|13|||
126764950|NCT01361308|456092613|FG000|Overall Study|Physician Decision|3|||
126764951|NCT01361308|456092614|FG001|Overall Study|Physician Decision|3|||
126764952|NCT01361308|456092613|FG000|Overall Study|Lack of Efficacy|2|||
126764953|NCT01361308|456092614|FG001|Overall Study|Lack of Efficacy|0|||
126764954|NCT01361308|456092613|FG000|Overall Study|Protocol Violation|1|||
126764955|NCT01361308|456092614|FG001|Overall Study|Protocol Violation|0|||
126764956|NCT01361308|456092613|FG000|Overall Study|Lost to Follow-up|5|||
126764957|NCT01361308|456092614|FG001|Overall Study|Lost to Follow-up|4|||
126764958|NCT01361308|456092613|FG000|Overall Study|Adverse Event|8|||
126764959|NCT01361308|456092614|FG001|Overall Study|Adverse Event|4|||
126764960|NCT01361308|456092613|FG000|Overall Study|Eligibility Criteria Not Met|2|||
126764961|NCT01361308|456092614|FG001|Overall Study|Eligibility Criteria Not Met|3|||
126764962|NCT01361308|456092613|FG000|Overall Study|Failed C-SSRS|5|||
126764963|NCT01361308|456092614|FG001|Overall Study|Failed C-SSRS|2|||
126764964|NCT01361308|456092613|FG000|Overall Study|Other|0|||
126764965|NCT01361308|456092614|FG001|Overall Study|Other|1|||
126266034|NCT00897949|454265123|FG000|Overall Study|Lost to Follow-up|30|||
126266035|NCT00897949|454265124|FG001|Overall Study|Lost to Follow-up|23|||
126266036|NCT00897949|454265125|FG002|Overall Study|Lost to Follow-up|17|||
126266037|NCT00897949|454265123|FG000|Overall Study|Withdrawal by Subject|24|||
126266038|NCT00897949|454265124|FG001|Overall Study|Withdrawal by Subject|31|||
126360380|NCT00147537|454610815|FG003|Phase 1b|Other|1|||
126360381|NCT00147537|454610816|FG004|Phase 1b|Other|1|||
126266039|NCT00897949|454265125|FG002|Overall Study|Withdrawal by Subject|17|||
126764966|NCT03839693|456092619|FG000|Overall Study|Lost to Follow-up|0|||
126764967|NCT03839693|456092620|FG001|Overall Study|Lost to Follow-up|2|||
126764968|NCT03839693|456092621|FG002|Overall Study|Lost to Follow-up|2|||
126764969|NCT03839693|456092619|FG000|Overall Study|Withdrawal by Subject|1|||
126764970|NCT03839693|456092620|FG001|Overall Study|Withdrawal by Subject|0|||
126360382|NCT00147537|454610817|FG005|Phase 1b|Other|1|||
126360383|NCT00147537|454610818|FG006|Phase 1b|Other|14|||
126360384|NCT00147537|454610819|FG007|Phase 1b|Other|4|||
126360385|NCT00147537|454610820|FG008|Phase 1b|Other|4|||
126360386|NCT00147537|454610821|FG009|Phase 1b|Other|0|||
126360387|NCT00147537|454610822|FG010|Phase 1b|Other|0|||
126360388|NCT00147537|454610812|FG000|Phase 1b|Withdrawal by Subject|0|||
126266040|NCT00897949|454265123|FG000|Overall Study|Abnormal Prestudy Labs|2|||
126266041|NCT00897949|454265124|FG001|Overall Study|Abnormal Prestudy Labs|3|||
126266042|NCT00897949|454265125|FG002|Overall Study|Abnormal Prestudy Labs|4|||
126266043|NCT00897949|454265123|FG000|Overall Study|Abnormal Baseline ECG|2|||
126266044|NCT00897949|454265124|FG001|Overall Study|Abnormal Baseline ECG|2|||
126266045|NCT00897949|454265125|FG002|Overall Study|Abnormal Baseline ECG|4|||
126266046|NCT00897949|454265123|FG000|Overall Study|Need for Concom. Med.|0|||
126266047|NCT00897949|454265124|FG001|Overall Study|Need for Concom. Med.|1|||
126266048|NCT00897949|454265125|FG002|Overall Study|Need for Concom. Med.|1|||
126266049|NCT00897949|454265123|FG000|Overall Study|Lack of Migraine Attack|29|||
126266050|NCT00897949|454265124|FG001|Overall Study|Lack of Migraine Attack|30|||
126266051|NCT00897949|454265125|FG002|Overall Study|Lack of Migraine Attack|19|||
126266052|NCT00897949|454265123|FG000|Overall Study|Did not take study drug|9|||
126266053|NCT00897949|454265124|FG001|Overall Study|Did not take study drug|3|||
126266054|NCT00897949|454265125|FG002|Overall Study|Did not take study drug|4|||
126266055|NCT01553747|454265126|FG000|Overall Study|Protocol Violation|0|||
126266056|NCT01553747|454265127|FG001|Overall Study|Protocol Violation|2|||
126266057|NCT01553747|454265128|FG002|Overall Study|Protocol Violation|0|||
126266058|NCT01553747|454265126|FG000|Overall Study|Voluntarily withdrew|70|||
126360389|NCT00147537|454610813|FG001|Phase 1b|Withdrawal by Subject|0|||
126360390|NCT00147537|454610814|FG002|Phase 1b|Withdrawal by Subject|0|||
126360391|NCT00147537|454610815|FG003|Phase 1b|Withdrawal by Subject|0|||
126360392|NCT00147537|454610816|FG004|Phase 1b|Withdrawal by Subject|0|||
126360393|NCT00147537|454610817|FG005|Phase 1b|Withdrawal by Subject|0|||
126360394|NCT00147537|454610818|FG006|Phase 1b|Withdrawal by Subject|0|||
126360395|NCT00147537|454610819|FG007|Phase 1b|Withdrawal by Subject|0|||
126360396|NCT00147537|454610820|FG008|Phase 1b|Withdrawal by Subject|2|||
126360397|NCT00147537|454610821|FG009|Phase 1b|Withdrawal by Subject|0|||
126704373|NCT00858832|455868292|FG000|Overall Study|became ineligible: delivered vaginally|1|||
126704374|NCT00858832|455868293|FG001|Overall Study|became ineligible: delivered vaginally|0|||
126704375|NCT00858832|455868292|FG000|Overall Study|Adverse Event|0|||
126704376|NCT00858832|455868293|FG001|Overall Study|Adverse Event|1|||
126704377|NCT00389207|455868294|FG000|Overall Study|Adverse Event|26|||
126704378|NCT00389207|455868295|FG001|Overall Study|Adverse Event|32|||
126704379|NCT00389207|455868296|FG002|Overall Study|Adverse Event|10|||
126704380|NCT00389207|455868294|FG000|Overall Study|Protocol Violation|3|||
126704381|NCT00389207|455868295|FG001|Overall Study|Protocol Violation|1|||
126704382|NCT00389207|455868296|FG002|Overall Study|Protocol Violation|4|||
126704383|NCT00389207|455868294|FG000|Overall Study|Lost to Follow-up|12|||
126704384|NCT00389207|455868295|FG001|Overall Study|Lost to Follow-up|9|||
126704385|NCT00389207|455868296|FG002|Overall Study|Lost to Follow-up|7|||
126704386|NCT00389207|455868294|FG000|Overall Study|Withdrawal by Subject|5|||
126704387|NCT00389207|455868295|FG001|Overall Study|Withdrawal by Subject|7|||
126704388|NCT00389207|455868296|FG002|Overall Study|Withdrawal by Subject|11|||
126704389|NCT00389207|455868294|FG000|Overall Study|Other|17|||
126704390|NCT00389207|455868295|FG001|Overall Study|Other|23|||
126704391|NCT00389207|455868296|FG002|Overall Study|Other|9|||
126704392|NCT01073943|455868300|FG000|Overall Study|Withdrawal by Subject|8|||
126704393|NCT01073943|455868301|FG001|Overall Study|Withdrawal by Subject|2|||
126704394|NCT01073943|455868300|FG000|Overall Study|Protocol Violation|2|||
126704395|NCT01073943|455868301|FG001|Overall Study|Protocol Violation|1|||
126704396|NCT01073943|455868300|FG000|Overall Study|Adverse Event|1|||
126266059|NCT01553747|454265127|FG001|Overall Study|Voluntarily withdrew|66|||
126266060|NCT01553747|454265128|FG002|Overall Study|Voluntarily withdrew|74|||
126266061|NCT01553747|454265126|FG000|Overall Study|Adverse event or SAE|32|||
126360398|NCT00147537|454610822|FG010|Phase 1b|Withdrawal by Subject|0|||
126360399|NCT00147537|454610812|FG000|Phase 1b|Randomized but not treated|0|||
126360400|NCT00147537|454610813|FG001|Phase 1b|Randomized but not treated|0|||
126360401|NCT00147537|454610814|FG002|Phase 1b|Randomized but not treated|0|||
126360402|NCT00147537|454610815|FG003|Phase 1b|Randomized but not treated|0|||
126360403|NCT00147537|454610816|FG004|Phase 1b|Randomized but not treated|0|||
126704397|NCT01073943|455868301|FG001|Overall Study|Adverse Event|1|||
126704398|NCT01073943|455868300|FG000|Overall Study|Lost to Follow-up|0|||
126704399|NCT01073943|455868301|FG001|Overall Study|Lost to Follow-up|2|||
126704400|NCT01073943|455868300|FG000|Overall Study|Power outage; colonoscopy not done|1|||
126266062|NCT01553747|454265127|FG001|Overall Study|Adverse event or SAE|28|||
126704401|NCT01073943|455868301|FG001|Overall Study|Power outage; colonoscopy not done|0|||
126704402|NCT01073943|455868300|FG000|Overall Study|Subject forgot|0|||
126704403|NCT01073943|455868301|FG001|Overall Study|Subject forgot|1|||
126266063|NCT01553747|454265128|FG002|Overall Study|Adverse event or SAE|19|||
126266064|NCT01553747|454265126|FG000|Overall Study|Physician decision: other|10|||
126266065|NCT01553747|454265127|FG001|Overall Study|Physician decision: other|8|||
126764971|NCT03839693|456092621|FG002|Overall Study|Withdrawal by Subject|2|||
126764972|NCT03839693|456092619|FG000|Overall Study|subject moved out of the area|1|||
126764973|NCT03839693|456092620|FG001|Overall Study|subject moved out of the area|0|||
126764974|NCT03839693|456092621|FG002|Overall Study|subject moved out of the area|0|||
126764975|NCT00700115|456092630|FG000|Overall Study|Withdrawal by Subject|1|||
126266066|NCT01553747|454265128|FG002|Overall Study|Physician decision: other|7|||
126266067|NCT01553747|454265126|FG000|Overall Study|Lost to Follow-up|11|||
126266068|NCT01553747|454265127|FG001|Overall Study|Lost to Follow-up|5|||
126266069|NCT01553747|454265128|FG002|Overall Study|Lost to Follow-up|6|||
126266070|NCT01553747|454265126|FG000|Overall Study|Sponsor decision, specify|7|||
126266071|NCT01553747|454265127|FG001|Overall Study|Sponsor decision, specify|5|||
126266072|NCT01553747|454265128|FG002|Overall Study|Sponsor decision, specify|0|||
126266073|NCT01553747|454265126|FG000|Overall Study|Physician decision: lack of efficacy|1|||
126266074|NCT01553747|454265127|FG001|Overall Study|Physician decision: lack of efficacy|5|||
126266075|NCT01553747|454265128|FG002|Overall Study|Physician decision: lack of efficacy|3|||
126266076|NCT02010255|454265137|FG000|Overall Study|Death|0|||
126266077|NCT02010255|454265138|FG001|Overall Study|Death|1|||
126266078|NCT02010255|454265139|FG002|Overall Study|Death|4|||
126266079|NCT02010255|454265140|FG003|Overall Study|Death|4|||
126266080|NCT02010255|454265141|FG004|Overall Study|Death|2|||
126266081|NCT02010255|454265142|FG005|Overall Study|Death|0|||
126266082|NCT02010255|454265143|FG006|Overall Study|Death|1|||
126266083|NCT02010255|454265144|FG007|Overall Study|Death|1|||
126266084|NCT02010255|454265145|FG008|Overall Study|Death|1|||
126266085|NCT02010255|454265146|FG009|Overall Study|Death|0|||
126266086|NCT02010255|454265147|FG010|Overall Study|Death|1|||
126266087|NCT02010255|454265148|FG011|Overall Study|Death|1|||
126266088|NCT02010255|454265149|FG012|Overall Study|Death|0|||
126266089|NCT02010255|454265150|FG013|Overall Study|Death|0|||
126266090|NCT02010255|454265137|FG000|Overall Study|Lack of Efficacy|4|||
126266091|NCT02010255|454265138|FG001|Overall Study|Lack of Efficacy|1|||
126266092|NCT02010255|454265139|FG002|Overall Study|Lack of Efficacy|2|||
126266093|NCT02010255|454265140|FG003|Overall Study|Lack of Efficacy|1|||
126266094|NCT02010255|454265141|FG004|Overall Study|Lack of Efficacy|1|||
126266095|NCT02010255|454265142|FG005|Overall Study|Lack of Efficacy|0|||
126266096|NCT02010255|454265143|FG006|Overall Study|Lack of Efficacy|0|||
126266097|NCT02010255|454265144|FG007|Overall Study|Lack of Efficacy|0|||
126266098|NCT02010255|454265145|FG008|Overall Study|Lack of Efficacy|0|||
126266099|NCT02010255|454265146|FG009|Overall Study|Lack of Efficacy|0|||
126266100|NCT02010255|454265147|FG010|Overall Study|Lack of Efficacy|1|||
126266101|NCT02010255|454265148|FG011|Overall Study|Lack of Efficacy|0|||
126266102|NCT02010255|454265149|FG012|Overall Study|Lack of Efficacy|0|||
126266103|NCT02010255|454265150|FG013|Overall Study|Lack of Efficacy|0|||
126266104|NCT02010255|454265137|FG000|Overall Study|Withdrew Consent|1|||
126266105|NCT02010255|454265138|FG001|Overall Study|Withdrew Consent|0|||
126266106|NCT02010255|454265139|FG002|Overall Study|Withdrew Consent|0|||
126266107|NCT02010255|454265140|FG003|Overall Study|Withdrew Consent|1|||
126266108|NCT02010255|454265141|FG004|Overall Study|Withdrew Consent|0|||
126266109|NCT02010255|454265142|FG005|Overall Study|Withdrew Consent|0|||
126266110|NCT02010255|454265143|FG006|Overall Study|Withdrew Consent|0|||
126266111|NCT02010255|454265144|FG007|Overall Study|Withdrew Consent|0|||
126266112|NCT02010255|454265145|FG008|Overall Study|Withdrew Consent|0|||
126266113|NCT02010255|454265146|FG009|Overall Study|Withdrew Consent|0|||
126266114|NCT02010255|454265147|FG010|Overall Study|Withdrew Consent|0|||
126266115|NCT02010255|454265148|FG011|Overall Study|Withdrew Consent|0|||
126266116|NCT02010255|454265149|FG012|Overall Study|Withdrew Consent|0|||
126266117|NCT02010255|454265150|FG013|Overall Study|Withdrew Consent|0|||
126266118|NCT02010255|454265137|FG000|Overall Study|Adverse Event|1|||
126266119|NCT02010255|454265138|FG001|Overall Study|Adverse Event|0|||
126266120|NCT02010255|454265139|FG002|Overall Study|Adverse Event|0|||
126266121|NCT02010255|454265140|FG003|Overall Study|Adverse Event|0|||
126266122|NCT02010255|454265141|FG004|Overall Study|Adverse Event|0|||
126266123|NCT02010255|454265142|FG005|Overall Study|Adverse Event|0|||
126764976|NCT00700115|456092631|FG001|Overall Study|Withdrawal by Subject|0|||
126764977|NCT00700115|456092630|FG000|Overall Study|Lost to Follow-up|0|||
126764978|NCT00700115|456092631|FG001|Overall Study|Lost to Follow-up|1|||
126266124|NCT02010255|454265143|FG006|Overall Study|Adverse Event|0|||
126266125|NCT02010255|454265144|FG007|Overall Study|Adverse Event|0|||
126764979|NCT02983305|456092636|FG000|Overall Study|incomplete data|2|||
126266126|NCT02010255|454265145|FG008|Overall Study|Adverse Event|0|||
126266127|NCT02010255|454265146|FG009|Overall Study|Adverse Event|0|||
126266128|NCT02010255|454265147|FG010|Overall Study|Adverse Event|0|||
126266129|NCT02010255|454265148|FG011|Overall Study|Adverse Event|0|||
126266130|NCT02010255|454265149|FG012|Overall Study|Adverse Event|0|||
126266131|NCT02010255|454265150|FG013|Overall Study|Adverse Event|0|||
126266132|NCT02010255|454265137|FG000|Overall Study|Lost to Follow-up|0|||
126266133|NCT02010255|454265138|FG001|Overall Study|Lost to Follow-up|0|||
126266134|NCT02010255|454265139|FG002|Overall Study|Lost to Follow-up|1|||
126266135|NCT02010255|454265140|FG003|Overall Study|Lost to Follow-up|0|||
126266136|NCT02010255|454265141|FG004|Overall Study|Lost to Follow-up|1|||
126266137|NCT02010255|454265142|FG005|Overall Study|Lost to Follow-up|0|||
126266138|NCT02010255|454265143|FG006|Overall Study|Lost to Follow-up|0|||
126266139|NCT02010255|454265144|FG007|Overall Study|Lost to Follow-up|0|||
126266140|NCT02010255|454265145|FG008|Overall Study|Lost to Follow-up|0|||
126266141|NCT02010255|454265146|FG009|Overall Study|Lost to Follow-up|0|||
126266142|NCT02010255|454265147|FG010|Overall Study|Lost to Follow-up|0|||
126266143|NCT02010255|454265148|FG011|Overall Study|Lost to Follow-up|0|||
126704404|NCT01073943|455868300|FG000|Overall Study|Unable to return for follow-up|0|||
126704405|NCT01073943|455868301|FG001|Overall Study|Unable to return for follow-up|1|||
126704406|NCT01073943|455868300|FG000|Overall Study|Could not tolerate prep|1|||
126704407|NCT01073943|455868301|FG001|Overall Study|Could not tolerate prep|0|||
126704408|NCT03527043|455868310|FG000|Overall Study|Withdrawal by Subject|1|||
126704409|NCT03527043|455868311|FG001|Overall Study|Withdrawal by Subject|0|||
126704410|NCT03830281|455868312|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
126704411|NCT03830281|455868313|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
126704412|NCT03830281|455868312|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
126704413|NCT03830281|455868313|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
126704414|NCT03830281|455868312|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
126704415|NCT03830281|455868313|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
126704416|NCT03830281|455868312|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
126704417|NCT03830281|455868313|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
126704418|NCT03830281|455868312|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
126704419|NCT03830281|455868313|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
126704420|NCT03830281|455868312|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
126704421|NCT03830281|455868313|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
126704422|NCT03830281|455868312|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
126704423|NCT03830281|455868313|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
126704424|NCT03830281|455868312|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
126704425|NCT03830281|455868313|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
126704426|NCT03830281|455868312|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
126704427|NCT03830281|455868313|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
126704428|NCT01985321|455868314|FG000|Overall Study|Protocol Violation|4|||
126704429|NCT01985321|455868315|FG001|Overall Study|Protocol Violation|3|||
126704430|NCT01985321|455868314|FG000|Overall Study|Withdrawal by Subject|1|||
126704431|NCT01985321|455868315|FG001|Overall Study|Withdrawal by Subject|0|||
126704432|NCT01985321|455868314|FG000|Overall Study|Lost to Follow-up|5|||
126704433|NCT01985321|455868315|FG001|Overall Study|Lost to Follow-up|2|||
126704434|NCT01985321|455868314|FG000|Overall Study|Subject treated wrong type of sore|1|||
126704435|NCT01985321|455868315|FG001|Overall Study|Subject treated wrong type of sore|0|||
126704436|NCT03293680|455868316|FG000|Overall Study|Death|1|||
126704437|NCT03293680|455868316|FG000|Overall Study|Did not meet inclusion criteria|8|||
126704438|NCT02201940|455868317|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
126704439|NCT02201940|455868318|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
126704440|NCT02201940|455868317|FG000|Overall Study|Lack of Efficacy|2|||
126704441|NCT02201940|455868318|FG001|Overall Study|Lack of Efficacy|113|||
126704442|NCT02201940|455868317|FG000|Overall Study|Lost to Follow-up|5|||
126704443|NCT02201940|455868318|FG001|Overall Study|Lost to Follow-up|0|||
126704444|NCT02201940|455868317|FG000|Overall Study|Withdrew Consent|2|||
126704445|NCT02201940|455868318|FG001|Overall Study|Withdrew Consent|1|||
126704446|NCT02201940|455868317|FG000|Overall Study|Investigator's Discretion|1|||
126704447|NCT02201940|455868318|FG001|Overall Study|Investigator's Discretion|1|||
126704448|NCT02201940|455868317|FG000|Overall Study|Death|1|||
126704449|NCT02201940|455868318|FG001|Overall Study|Death|0|||
126704450|NCT02201940|455868317|FG000|Overall Study|Adverse Event|0|||
126704451|NCT02201940|455868318|FG001|Overall Study|Adverse Event|1|||
126704452|NCT03192904|455868319|FG000|Overall Study|Physician Decision|3|||
126704453|NCT03192904|455868320|FG001|Overall Study|Physician Decision|1|||
126704454|NCT03192904|455868319|FG000|Overall Study|Lost to Follow-up|0|||
126704455|NCT03192904|455868320|FG001|Overall Study|Lost to Follow-up|1|||
126704456|NCT01309737|455868321|FG000|Week 0 to 16|Death|1|||
126704457|NCT01309737|455868322|FG001|Week 0 to 16|Death|0|||
126704458|NCT01309737|455868323|FG002|Week 0 to 16|Death|1|||
126704459|NCT01309737|455868324|FG003|Week 0 to 16|Death|0|||
126704460|NCT01309737|455868325|FG004|Week 0 to 16|Death|0|||
126704461|NCT01309737|455868321|FG000|Week 0 to 16|Adverse Event|11|||
126704462|NCT01309737|455868322|FG001|Week 0 to 16|Adverse Event|10|||
126704463|NCT01309737|455868323|FG002|Week 0 to 16|Adverse Event|5|||
126704464|NCT01309737|455868324|FG003|Week 0 to 16|Adverse Event|0|||
126704465|NCT01309737|455868325|FG004|Week 0 to 16|Adverse Event|0|||
126704466|NCT01309737|455868321|FG000|Week 0 to 16|Lack of Efficacy|15|||
126704467|NCT01309737|455868322|FG001|Week 0 to 16|Lack of Efficacy|2|||
126704468|NCT01309737|455868323|FG002|Week 0 to 16|Lack of Efficacy|24|||
126704469|NCT01309737|455868324|FG003|Week 0 to 16|Lack of Efficacy|0|||
126704470|NCT01309737|455868325|FG004|Week 0 to 16|Lack of Efficacy|0|||
126704471|NCT01309737|455868321|FG000|Week 0 to 16|Lost to Follow-up|7|||
126266144|NCT02010255|454265149|FG012|Overall Study|Lost to Follow-up|0|||
126704472|NCT01309737|455868322|FG001|Week 0 to 16|Lost to Follow-up|8|||
126266145|NCT02010255|454265150|FG013|Overall Study|Lost to Follow-up|0|||
126360404|NCT00147537|454610817|FG005|Phase 1b|Randomized but not treated|0|||
126764980|NCT02983305|456092637|FG001|Overall Study|incomplete data|0|||
126764981|NCT01646268|456092638|FG000|Overall Study|Adverse Event|6|||
126764982|NCT01646268|456092639|FG001|Overall Study|Adverse Event|7|||
126764983|NCT01646268|456092638|FG000|Overall Study|Lack of Efficacy|1|||
126764984|NCT01646268|456092639|FG001|Overall Study|Lack of Efficacy|3|||
126764985|NCT01646268|456092638|FG000|Overall Study|Protocol Violation|0|||
126764986|NCT01646268|456092639|FG001|Overall Study|Protocol Violation|1|||
126764987|NCT01646268|456092638|FG000|Overall Study|Withdrawal by Subject|2|||
126764988|NCT01646268|456092639|FG001|Overall Study|Withdrawal by Subject|5|||
126764989|NCT01646268|456092638|FG000|Overall Study|Other|2|||
126764990|NCT01646268|456092639|FG001|Overall Study|Other|0|||
126764991|NCT01519635|456092644|FG000|Overall Study|Withdrawal by Subject|0|||
126764992|NCT01519635|456092645|FG001|Overall Study|Withdrawal by Subject|1|||
126764993|NCT01519635|456092644|FG000|Overall Study|No possibility to put a catheter|1|||
126764994|NCT01519635|456092645|FG001|Overall Study|No possibility to put a catheter|2|||
126764995|NCT01300741|456092646|FG000|Overall Study|Lens deposits|1|||
126764996|NCT01300741|456092646|FG000|Overall Study|Lost to Follow-up|1|||
126764997|NCT01300741|456092646|FG000|Overall Study|Discomfort|1|||
126764998|NCT02325414|456092647|FG000|Overall Study|Withdrawal by Subject|3|||
126764999|NCT02325414|456092648|FG001|Overall Study|Withdrawal by Subject|1|||
126765000|NCT02325414|456092647|FG000|Overall Study|Lost to Follow-up|5|||
126765001|NCT02325414|456092648|FG001|Overall Study|Lost to Follow-up|5|||
126765002|NCT00726882|456092650|FG000|Overall Study|Withdrawal by Subject|5|||
126765003|NCT00726882|456092650|FG000|Overall Study|Lost to Follow-up|7|||
126765004|NCT00726882|456092650|FG000|Overall Study|Other|10|||
126765005|NCT00560573|456092651|FG000|Overall Study|Death|4|||
126765006|NCT00560573|456092652|FG001|Overall Study|Death|1|||
126765007|NCT00560573|456092653|FG002|Overall Study|Death|4|||
126765008|NCT00560573|456092654|FG003|Overall Study|Death|5|||
126765009|NCT00560573|456092655|FG004|Overall Study|Death|1|||
126765010|NCT00560573|456092656|FG005|Overall Study|Death|10|||
126765011|NCT00560573|456092651|FG000|Overall Study|Lost to Follow-up|0|||
126765012|NCT00560573|456092652|FG001|Overall Study|Lost to Follow-up|0|||
126765013|NCT00560573|456092653|FG002|Overall Study|Lost to Follow-up|0|||
126360405|NCT00147537|454610818|FG006|Phase 1b|Randomized but not treated|1|||
126360406|NCT00147537|454610819|FG007|Phase 1b|Randomized but not treated|0|||
126360407|NCT00147537|454610820|FG008|Phase 1b|Randomized but not treated|1|||
126360408|NCT00147537|454610821|FG009|Phase 1b|Randomized but not treated|0|||
126360409|NCT00147537|454610822|FG010|Phase 1b|Randomized but not treated|0|||
126360410|NCT00147537|454610812|FG000|Phase 2|Death|0|||
126360411|NCT00147537|454610813|FG001|Phase 2|Death|0|||
126360412|NCT00147537|454610814|FG002|Phase 2|Death|0|||
126360413|NCT00147537|454610815|FG003|Phase 2|Death|0|||
126360414|NCT00147537|454610816|FG004|Phase 2|Death|0|||
126765014|NCT00560573|456092654|FG003|Overall Study|Lost to Follow-up|1|||
126765015|NCT00560573|456092655|FG004|Overall Study|Lost to Follow-up|1|||
126765016|NCT00560573|456092656|FG005|Overall Study|Lost to Follow-up|0|||
126765017|NCT00560573|456092651|FG000|Overall Study|Withdrawal by Subject|0|||
126765018|NCT00560573|456092652|FG001|Overall Study|Withdrawal by Subject|0|||
126765019|NCT00560573|456092653|FG002|Overall Study|Withdrawal by Subject|0|||
126765020|NCT00560573|456092654|FG003|Overall Study|Withdrawal by Subject|1|||
126765021|NCT00560573|456092655|FG004|Overall Study|Withdrawal by Subject|1|||
126765022|NCT00560573|456092656|FG005|Overall Study|Withdrawal by Subject|0|||
126765023|NCT00560573|456092651|FG000|Overall Study|Other|2|||
126765024|NCT00560573|456092652|FG001|Overall Study|Other|2|||
126765025|NCT00560573|456092653|FG002|Overall Study|Other|2|||
126765026|NCT00560573|456092654|FG003|Overall Study|Other|3|||
126765027|NCT00560573|456092655|FG004|Overall Study|Other|3|||
126765028|NCT00560573|456092656|FG005|Overall Study|Other|3|||
126765029|NCT00560573|456092651|FG000|Overall Study|Enrolled, not treated|0|||
126765030|NCT00560573|456092652|FG001|Overall Study|Enrolled, not treated|0|||
126765031|NCT00560573|456092653|FG002|Overall Study|Enrolled, not treated|0|||
126765032|NCT00560573|456092654|FG003|Overall Study|Enrolled, not treated|0|||
126765033|NCT00560573|456092655|FG004|Overall Study|Enrolled, not treated|1|||
126765034|NCT00560573|456092656|FG005|Overall Study|Enrolled, not treated|0|||
126765035|NCT01339273|456092657|FG000|Overall Study|Lost to Follow-up|8|||
126765036|NCT01339273|456092658|FG001|Overall Study|Lost to Follow-up|8|||
126765037|NCT00347776|456092659|FG000|1.5 Month Follow-up|Death|2|||
126765038|NCT00347776|456092660|FG001|1.5 Month Follow-up|Death|0|||
126360415|NCT00147537|454610817|FG005|Phase 2|Death|0|||
126360416|NCT00147537|454610818|FG006|Phase 2|Death|0|||
126360417|NCT00147537|454610819|FG007|Phase 2|Death|0|||
126360418|NCT00147537|454610820|FG008|Phase 2|Death|0|||
126765039|NCT00347776|456092661|FG002|1.5 Month Follow-up|Death|0|||
126765040|NCT00347776|456092659|FG000|1.5 Month Follow-up|reached the endpoint|12|||
126765041|NCT00347776|456092660|FG001|1.5 Month Follow-up|reached the endpoint|8|||
126765042|NCT00347776|456092661|FG002|1.5 Month Follow-up|reached the endpoint|12|||
126765043|NCT00347776|456092659|FG000|6 Month Follow-up|Death|2|||
126765044|NCT00347776|456092660|FG001|6 Month Follow-up|Death|1|||
126765045|NCT00347776|456092661|FG002|6 Month Follow-up|Death|3|||
126360419|NCT00147537|454610821|FG009|Phase 2|Death|85|||
126266146|NCT02010255|454265137|FG000|Overall Study|Randomized but Not Treated|0|||
126266147|NCT02010255|454265138|FG001|Overall Study|Randomized but Not Treated|0|||
126266148|NCT02010255|454265139|FG002|Overall Study|Randomized but Not Treated|0|||
126360420|NCT00147537|454610822|FG010|Phase 2|Death|31|||
126360421|NCT00147537|454610812|FG000|Phase 2|Lost to Follow-up|0|||
126704473|NCT01309737|455868323|FG002|Week 0 to 16|Lost to Follow-up|3|||
126704474|NCT01309737|455868324|FG003|Week 0 to 16|Lost to Follow-up|0|||
126266149|NCT02010255|454265140|FG003|Overall Study|Randomized but Not Treated|0|||
126266150|NCT02010255|454265141|FG004|Overall Study|Randomized but Not Treated|0|||
126266151|NCT02010255|454265142|FG005|Overall Study|Randomized but Not Treated|0|||
126266152|NCT02010255|454265143|FG006|Overall Study|Randomized but Not Treated|0|||
126266153|NCT02010255|454265144|FG007|Overall Study|Randomized but Not Treated|0|||
126266154|NCT02010255|454265145|FG008|Overall Study|Randomized but Not Treated|0|||
126266155|NCT02010255|454265146|FG009|Overall Study|Randomized but Not Treated|0|||
126266156|NCT02010255|454265147|FG010|Overall Study|Randomized but Not Treated|0|||
126266157|NCT02010255|454265148|FG011|Overall Study|Randomized but Not Treated|0|||
126266158|NCT02010255|454265149|FG012|Overall Study|Randomized but Not Treated|0|||
126266159|NCT02010255|454265150|FG013|Overall Study|Randomized but Not Treated|1|||
126266160|NCT01134627|454265151|FG000|Overall Study|Adverse Event|47|||
126266161|NCT01134627|454265152|FG001|Overall Study|Adverse Event|31|||
126266162|NCT01134627|454265151|FG000|Overall Study|Lost to Follow-up|1|||
126266163|NCT01134627|454265152|FG001|Overall Study|Lost to Follow-up|2|||
126266164|NCT01134627|454265151|FG000|Overall Study|Protocol Violation|3|||
126266165|NCT01134627|454265152|FG001|Overall Study|Protocol Violation|5|||
126266166|NCT01134627|454265151|FG000|Overall Study|Lack of Efficacy|2|||
126266167|NCT01134627|454265152|FG001|Overall Study|Lack of Efficacy|12|||
126266168|NCT01134627|454265151|FG000|Overall Study|Withdrawal by Subject|4|||
126266169|NCT01134627|454265152|FG001|Overall Study|Withdrawal by Subject|3|||
126266170|NCT01134627|454265151|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
126266171|NCT01134627|454265152|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
126266172|NCT01134627|454265151|FG000|Overall Study|Other|11|||
126266173|NCT01134627|454265152|FG001|Overall Study|Other|14|||
126266174|NCT00977431|454265158|FG000|Overall Study|Other than listed|1|||
126266175|NCT00977431|454265159|FG001|Overall Study|Other than listed|0|||
126266176|NCT00977431|454265160|FG002|Overall Study|Other than listed|0|||
126266177|NCT00977431|454265161|FG003|Overall Study|Other than listed|0|||
126266178|NCT00977431|454265162|FG004|Overall Study|Other than listed|2|||
126266179|NCT00977431|454265158|FG000|Overall Study|Protocol Violation|0|||
126266180|NCT00977431|454265159|FG001|Overall Study|Protocol Violation|0|||
126266181|NCT00977431|454265160|FG002|Overall Study|Protocol Violation|1|||
126266182|NCT00977431|454265161|FG003|Overall Study|Protocol Violation|0|||
126266183|NCT00977431|454265162|FG004|Overall Study|Protocol Violation|0|||
126266184|NCT00977431|454265158|FG000|Overall Study|Adverse Event|3|||
126266185|NCT00977431|454265159|FG001|Overall Study|Adverse Event|0|||
126266186|NCT00977431|454265160|FG002|Overall Study|Adverse Event|4|||
126266187|NCT00977431|454265161|FG003|Overall Study|Adverse Event|0|||
126266188|NCT00977431|454265162|FG004|Overall Study|Adverse Event|6|||
126266189|NCT00977431|454265158|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
126266190|NCT00977431|454265159|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
126704475|NCT01309737|455868325|FG004|Week 0 to 16|Lost to Follow-up|0|||
126704476|NCT01309737|455868321|FG000|Week 0 to 16|Withdrawal by Subject|7|||
126704477|NCT01309737|455868322|FG001|Week 0 to 16|Withdrawal by Subject|6|||
126704478|NCT01309737|455868323|FG002|Week 0 to 16|Withdrawal by Subject|7|||
126704479|NCT01309737|455868324|FG003|Week 0 to 16|Withdrawal by Subject|0|||
126704480|NCT01309737|455868325|FG004|Week 0 to 16|Withdrawal by Subject|0|||
126704481|NCT01309737|455868321|FG000|Week 0 to 16|Other|10|||
126704482|NCT01309737|455868322|FG001|Week 0 to 16|Other|14|||
126704483|NCT01309737|455868323|FG002|Week 0 to 16|Other|4|||
126704484|NCT01309737|455868324|FG003|Week 0 to 16|Other|0|||
126704485|NCT01309737|455868325|FG004|Week 0 to 16|Other|0|||
126704486|NCT01309737|455868321|FG000|Week 0 to 16|Randomized, but not treated|1|||
126704487|NCT01309737|455868322|FG001|Week 0 to 16|Randomized, but not treated|0|||
126704488|NCT01309737|455868323|FG002|Week 0 to 16|Randomized, but not treated|0|||
126704489|NCT01309737|455868324|FG003|Week 0 to 16|Randomized, but not treated|0|||
126266191|NCT00977431|454265160|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
126266192|NCT00977431|454265161|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
126266193|NCT00977431|454265162|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
126704490|NCT01309737|455868325|FG004|Week 0 to 16|Randomized, but not treated|0|||
126704491|NCT01309737|455868321|FG000|Week 16 to 52|Death|0|||
126765046|NCT00347776|456092659|FG000|6 Month Follow-up|reached endpont|20|||
126266194|NCT00977431|454265158|FG000|Overall Study|Progressive disease|2|||
126266195|NCT00977431|454265159|FG001|Overall Study|Progressive disease|6|||
126266196|NCT00977431|454265160|FG002|Overall Study|Progressive disease|1|||
126266197|NCT00977431|454265161|FG003|Overall Study|Progressive disease|3|||
126266198|NCT00977431|454265162|FG004|Overall Study|Progressive disease|5|||
126266199|NCT01010750|454265163|FG000|Second Intervention|Adverse Event|0|||
126704492|NCT01309737|455868322|FG001|Week 16 to 52|Death|0|||
126704493|NCT01309737|455868323|FG002|Week 16 to 52|Death|0|||
126704494|NCT01309737|455868324|FG003|Week 16 to 52|Death|0|||
126765047|NCT00347776|456092660|FG001|6 Month Follow-up|reached endpont|12|||
126765048|NCT00347776|456092661|FG002|6 Month Follow-up|reached endpont|15|||
126765049|NCT00347776|456092659|FG000|12 Month Follow-up|Lost to Follow-up|7|||
126765050|NCT00347776|456092660|FG001|12 Month Follow-up|Lost to Follow-up|6|||
126765051|NCT00347776|456092661|FG002|12 Month Follow-up|Lost to Follow-up|6|||
126765052|NCT00347776|456092659|FG000|12 Month Follow-up|Death|3|||
126765053|NCT00347776|456092660|FG001|12 Month Follow-up|Death|4|||
126765054|NCT00347776|456092661|FG002|12 Month Follow-up|Death|4|||
126765055|NCT00347776|456092659|FG000|12 Month Follow-up|Reached endpoint|13|||
126765056|NCT00347776|456092660|FG001|12 Month Follow-up|Reached endpoint|6|||
126765057|NCT00347776|456092661|FG002|12 Month Follow-up|Reached endpoint|9|||
126765058|NCT00518531|456092662|FG000|Treatment Period 1|Adverse Event|5|||
126765059|NCT00518531|456092663|FG001|Treatment Period 1|Adverse Event|0|||
126765060|NCT00518531|456092662|FG000|Treatment Period 1|Lost to Follow-up|5|||
126765061|NCT00518531|456092663|FG001|Treatment Period 1|Lost to Follow-up|3|||
126765062|NCT00518531|456092662|FG000|Treatment Period 1|Physician Decision|1|||
126765063|NCT00518531|456092663|FG001|Treatment Period 1|Physician Decision|0|||
126765064|NCT00518531|456092662|FG000|Treatment Period 1|Protocol Violation|2|||
126765065|NCT00518531|456092663|FG001|Treatment Period 1|Protocol Violation|0|||
126765066|NCT00518531|456092662|FG000|Treatment Period 1|Withdrawal by Subject|4|||
126765067|NCT00518531|456092663|FG001|Treatment Period 1|Withdrawal by Subject|6|||
126765068|NCT00518531|456092662|FG000|Treatment Period 1|Early crossover|1|||
126765069|NCT00518531|456092663|FG001|Treatment Period 1|Early crossover|3|||
126765070|NCT00518531|456092662|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126765071|NCT00518531|456092663|FG001|Treatment Period 2|Withdrawal by Subject|8|||
126765072|NCT00518531|456092662|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
126765073|NCT00518531|456092663|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
126765074|NCT00518531|456092662|FG000|Treatment Period 2|Adverse Event|1|||
126765075|NCT00518531|456092663|FG001|Treatment Period 2|Adverse Event|7|||
126765076|NCT00518531|456092662|FG000|Treatment Period 2|Protocol-specified criteria|0|||
126765077|NCT00518531|456092663|FG001|Treatment Period 2|Protocol-specified criteria|1|||
126765078|NCT00518531|456092662|FG000|Treatment Period 2|Non-compliance|1|||
126765079|NCT00518531|456092663|FG001|Treatment Period 2|Non-compliance|2|||
126765080|NCT00602927|456092666|FG000|Period 1: 13 Days|Protocol Violation|2|||
126765081|NCT00602927|456092667|FG001|Period 1: 13 Days|Protocol Violation|4|||
126765082|NCT00602927|456092666|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
126765083|NCT00602927|456092667|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
126765084|NCT00602927|456092666|FG000|Period 1: 13 Days|Time|1|||
126765085|NCT00602927|456092667|FG001|Period 1: 13 Days|Time|0|||
126765086|NCT00602927|456092666|FG000|Period 1: 13 Days|Claustrophobia|0|||
126765087|NCT00602927|456092667|FG001|Period 1: 13 Days|Claustrophobia|1|||
126765088|NCT00602927|456092666|FG000|Period 2: 14 Days|Protocol Violation|0|||
126765089|NCT00602927|456092667|FG001|Period 2: 14 Days|Protocol Violation|2|||
126765090|NCT00602927|456092666|FG000|Period 3: 13 Days|Protocol Violation|0|||
126266200|NCT01010750|454265164|FG001|Second Intervention|Adverse Event|1|||
126266201|NCT01010750|454265165|FG002|Second Intervention|Adverse Event|0|||
126266202|NCT01010750|454265166|FG003|Second Intervention|Adverse Event|0|||
126266203|NCT01010750|454265167|FG004|Second Intervention|Adverse Event|0|||
126266204|NCT01010750|454265168|FG005|Second Intervention|Adverse Event|0|||
126266205|NCT02654587|454265169|FG000|Overall Study|patient alive at end of study|22|||
126266206|NCT02654587|454265170|FG001|Overall Study|patient alive at end of study|8|||
126266207|NCT02654587|454265169|FG000|Overall Study|Withdrawal by Subject|1|||
126266208|NCT02654587|454265170|FG001|Overall Study|Withdrawal by Subject|7|||
126266209|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
126266210|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
126266211|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
126266212|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
126266213|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
126266214|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
126266215|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
126266216|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
126266217|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
126266218|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
126266219|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Subject decision|1|||
126266220|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Subject decision|1|||
126266221|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
126266222|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
126266223|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
126266224|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
126765091|NCT00602927|456092667|FG001|Period 3: 13 Days|Protocol Violation|1|||
126765092|NCT00602927|456092666|FG000|Period 3: 13 Days|MRI data quality|2|||
126765093|NCT00602927|456092667|FG001|Period 3: 13 Days|MRI data quality|2|||
126765094|NCT03722849|456092677|FG000|Overall Study|Withdrawal by Subject|1|||
126765095|NCT03722849|456092678|FG001|Overall Study|Withdrawal by Subject|1|||
126765096|NCT00348348|456092683|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
126765097|NCT00348348|456092684|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
126266225|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
126266226|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
126266227|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
126266228|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
126266229|NCT00518882|454265173|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
126266230|NCT00518882|454265174|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
126547332|NCT02778399|455296198|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
126547333|NCT02778399|455296199|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
126704495|NCT01309737|455868325|FG004|Week 16 to 52|Death|1|||
126704496|NCT01309737|455868321|FG000|Week 16 to 52|Adverse Event|7|||
126704497|NCT01309737|455868322|FG001|Week 16 to 52|Adverse Event|7|||
126704498|NCT01309737|455868323|FG002|Week 16 to 52|Adverse Event|0|||
126704499|NCT01309737|455868324|FG003|Week 16 to 52|Adverse Event|6|||
126704500|NCT01309737|455868325|FG004|Week 16 to 52|Adverse Event|5|||
126704501|NCT01309737|455868321|FG000|Week 16 to 52|Lack of Efficacy|107|||
126704502|NCT01309737|455868322|FG001|Week 16 to 52|Lack of Efficacy|76|||
126704503|NCT01309737|455868323|FG002|Week 16 to 52|Lack of Efficacy|0|||
126704504|NCT01309737|455868324|FG003|Week 16 to 52|Lack of Efficacy|25|||
126704505|NCT01309737|455868325|FG004|Week 16 to 52|Lack of Efficacy|21|||
126704506|NCT01309737|455868321|FG000|Week 16 to 52|Lost to Follow-up|4|||
126704507|NCT01309737|455868322|FG001|Week 16 to 52|Lost to Follow-up|2|||
126704508|NCT01309737|455868323|FG002|Week 16 to 52|Lost to Follow-up|0|||
126704509|NCT01309737|455868324|FG003|Week 16 to 52|Lost to Follow-up|1|||
126704510|NCT01309737|455868325|FG004|Week 16 to 52|Lost to Follow-up|4|||
126704511|NCT01309737|455868321|FG000|Week 16 to 52|Withdrawal by Subject|5|||
126704512|NCT01309737|455868322|FG001|Week 16 to 52|Withdrawal by Subject|6|||
126704513|NCT01309737|455868323|FG002|Week 16 to 52|Withdrawal by Subject|0|||
126704514|NCT01309737|455868324|FG003|Week 16 to 52|Withdrawal by Subject|0|||
126704515|NCT01309737|455868325|FG004|Week 16 to 52|Withdrawal by Subject|2|||
126704516|NCT01309737|455868321|FG000|Week 16 to 52|Other|10|||
126704517|NCT01309737|455868322|FG001|Week 16 to 52|Other|12|||
126704518|NCT01309737|455868323|FG002|Week 16 to 52|Other|0|||
126704519|NCT01309737|455868324|FG003|Week 16 to 52|Other|2|||
126704520|NCT01309737|455868325|FG004|Week 16 to 52|Other|0|||
126704521|NCT00709202|455868326|FG000|Overall Study|Withdrawal by Subject|6|||
126704522|NCT00709202|455868327|FG001|Overall Study|Withdrawal by Subject|6|||
126704523|NCT03934684|455868331|FG000|Overall Study|Participants continuing in study|11|||
126704524|NCT03934684|455868332|FG001|Overall Study|Participants continuing in study|4|||
126704525|NCT03934684|455868331|FG000|Overall Study|Discontinuation of carfilzomib|20|||
126704526|NCT03934684|455868332|FG001|Overall Study|Discontinuation of carfilzomib|30|||
126704527|NCT03934684|455868331|FG000|Overall Study|Death|2|||
126704528|NCT03934684|455868332|FG001|Overall Study|Death|2|||
126704529|NCT03934684|455868331|FG000|Overall Study|Lost to Follow-up|2|||
126704530|NCT03934684|455868332|FG001|Overall Study|Lost to Follow-up|5|||
126704531|NCT03934684|455868331|FG000|Overall Study|Withdrawal by Subject|7|||
126704532|NCT03934684|455868332|FG001|Overall Study|Withdrawal by Subject|8|||
126704533|NCT04091217|455868333|FG000|Overall Study|Lost to Follow-up|2|||
126704534|NCT05662332|455868334|FG000|Overall Study|Death|3|||
126704535|NCT05662332|455868335|FG001|Overall Study|Death|3|||
126704536|NCT05662332|455868334|FG000|Overall Study|Lost to Follow-up|3|||
126704537|NCT05662332|455868335|FG001|Overall Study|Lost to Follow-up|8|||
126704538|NCT05662332|455868334|FG000|Overall Study|Physician Decision|1|||
126704539|NCT05662332|455868335|FG001|Overall Study|Physician Decision|2|||
126704540|NCT05662332|455868334|FG000|Overall Study|Protocol Deviation|2|||
126704541|NCT05662332|455868335|FG001|Overall Study|Protocol Deviation|1|||
126704542|NCT05662332|455868334|FG000|Overall Study|Withdrawal by Subject|14|||
126704543|NCT05662332|455868335|FG001|Overall Study|Withdrawal by Subject|14|||
126704544|NCT05662332|455868334|FG000|Overall Study|Assigned Treatment by Mistake|5|||
126704545|NCT05662332|455868335|FG001|Overall Study|Assigned Treatment by Mistake|7|||
126704546|NCT05662332|455868334|FG000|Overall Study|Non-compliance with study drug|4|||
126704547|NCT05662332|455868335|FG001|Overall Study|Non-compliance with study drug|1|||
126704548|NCT05662332|455868334|FG000|Overall Study|Due to Bariatric surgery|1|||
126704549|NCT05662332|455868335|FG001|Overall Study|Due to Bariatric surgery|0|||
126704550|NCT05662332|455868334|FG000|Overall Study|Subject Moving out of State|0|||
126704551|NCT05662332|455868335|FG001|Overall Study|Subject Moving out of State|1|||
126704552|NCT05662332|455868334|FG000|Overall Study|Subject Missed the Schedule|1|||
126704553|NCT05662332|455868335|FG001|Overall Study|Subject Missed the Schedule|0|||
126704554|NCT05662332|455868334|FG000|Overall Study|The Patient Moved to Another City|1|||
126704555|NCT05662332|455868335|FG001|Overall Study|The Patient Moved to Another City|0|||
126704556|NCT05262764|455868337|FG000|Overall Study|Case report form not collected|9|||
126704557|NCT05262764|455868337|FG000|Overall Study|No patient visits after entry|23|||
126704558|NCT05262764|455868337|FG000|Overall Study|Registration rule not followed|2|||
126704559|NCT05262764|455868337|FG000|Overall Study|Patient of non-chronic heart failure|1|||
126704560|NCT01446809|455868338|FG000|Overall Study|Adverse Event|0|||
126704561|NCT01446809|455868339|FG001|Overall Study|Adverse Event|0|||
126360422|NCT00147537|454610813|FG001|Phase 2|Lost to Follow-up|0|||
126704562|NCT01446809|455868340|FG002|Overall Study|Adverse Event|1|||
126765098|NCT00348348|456092683|FG000|Overall Study|Lack of Efficacy|1|||
126765099|NCT00348348|456092684|FG001|Overall Study|Lack of Efficacy|1|||
126765100|NCT00348348|456092683|FG000|Overall Study|Lost to Follow-up|8|||
126765101|NCT00348348|456092684|FG001|Overall Study|Lost to Follow-up|10|||
126765102|NCT00348348|456092683|FG000|Overall Study|Withdrawal by Subject|4|||
126765103|NCT00348348|456092684|FG001|Overall Study|Withdrawal by Subject|1|||
126765104|NCT00348348|456092683|FG000|Overall Study|Other|7|||
126765105|NCT00348348|456092684|FG001|Overall Study|Other|4|||
126765106|NCT00348348|456092683|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
126765107|NCT00348348|456092684|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
126765108|NCT00348348|456092683|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
126765109|NCT00348348|456092684|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
126765110|NCT00348348|456092683|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
126765111|NCT00348348|456092684|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
126765112|NCT00348348|456092683|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
126765113|NCT00348348|456092684|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
126765114|NCT00348348|456092683|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
126765115|NCT00348348|456092684|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
126765116|NCT00348348|456092683|FG000|Overall Study|Adverse event probably related to study|1|||
126765117|NCT00348348|456092684|FG001|Overall Study|Adverse event probably related to study|0|||
126765118|NCT01298362|456092687|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
126765119|NCT01298362|456092688|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
126765120|NCT00762073|456092697|FG000|Overall Study|Lack of Efficacy|1|||
126765121|NCT00762073|456092698|FG001|Overall Study|Lack of Efficacy|1|||
126765122|NCT00762073|456092699|FG002|Overall Study|Lack of Efficacy|0|||
126765123|NCT00762073|456092700|FG003|Overall Study|Lack of Efficacy|0|||
126765124|NCT00762073|456092697|FG000|Overall Study|Adverse Event|1|||
126765125|NCT00762073|456092698|FG001|Overall Study|Adverse Event|0|||
126765126|NCT00762073|456092699|FG002|Overall Study|Adverse Event|1|||
126765127|NCT00762073|456092700|FG003|Overall Study|Adverse Event|1|||
126765128|NCT00762073|456092697|FG000|Overall Study|Significant Subject Noncompliance|0|||
126765129|NCT00762073|456092698|FG001|Overall Study|Significant Subject Noncompliance|1|||
126765130|NCT00762073|456092699|FG002|Overall Study|Significant Subject Noncompliance|0|||
126765131|NCT00762073|456092700|FG003|Overall Study|Significant Subject Noncompliance|1|||
126765132|NCT00762073|456092697|FG000|Overall Study|Withdrawal by Subject|1|||
126765133|NCT00762073|456092698|FG001|Overall Study|Withdrawal by Subject|2|||
126765134|NCT00762073|456092699|FG002|Overall Study|Withdrawal by Subject|1|||
126765135|NCT00762073|456092700|FG003|Overall Study|Withdrawal by Subject|1|||
126765136|NCT00762073|456092697|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
126765137|NCT00762073|456092698|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
126765138|NCT00762073|456092699|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
126765139|NCT00762073|456092700|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
126765140|NCT00326625|456092701|FG000|Overall Study|Adverse Event|20|||
126765141|NCT00326625|456092702|FG001|Overall Study|Adverse Event|9|||
126765142|NCT00326625|456092701|FG000|Overall Study|Withdrawal by Subject|15|||
126765143|NCT00326625|456092702|FG001|Overall Study|Withdrawal by Subject|12|||
126765144|NCT00326625|456092701|FG000|Overall Study|Death|18|||
126765145|NCT00326625|456092702|FG001|Overall Study|Death|16|||
126765146|NCT00326625|456092701|FG000|Overall Study|Lost to Follow-up|1|||
126765147|NCT00326625|456092702|FG001|Overall Study|Lost to Follow-up|0|||
126765148|NCT00326625|456092701|FG000|Overall Study|prescheduled medical intervention|0|||
126765149|NCT00326625|456092702|FG001|Overall Study|prescheduled medical intervention|1|||
126765150|NCT01265875|456092703|FG000|Overall Study|Uncooperative/unreliable|1|||
126765151|NCT05275673|456092704|FG000|Overall Study|Study Termination by Sponsor|2|||
126765152|NCT05275673|456092705|FG001|Overall Study|Study Termination by Sponsor|3|||
126765153|NCT05275673|456092704|FG000|Overall Study|Death|1|||
126765154|NCT05275673|456092705|FG001|Overall Study|Death|0|||
126266231|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
126266232|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
126266233|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
126266234|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
126266235|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
126266236|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
126266237|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
126266238|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
126765155|NCT05275673|456092704|FG000|Overall Study|Withdrawal by Subject|1|||
126765156|NCT05275673|456092705|FG001|Overall Study|Withdrawal by Subject|0|||
126765157|NCT04456998|456092706|FG000|Overall Study|Adverse Event|0|||
126765158|NCT04456998|456092707|FG001|Overall Study|Adverse Event|4|||
126765159|NCT04456998|456092706|FG000|Overall Study|Protocol Deviation|0|||
126765160|NCT04456998|456092707|FG001|Overall Study|Protocol Deviation|1|||
126765161|NCT04456998|456092706|FG000|Overall Study|Withdrawal by Subject|0|||
126765162|NCT04456998|456092707|FG001|Overall Study|Withdrawal by Subject|1|||
126765163|NCT04882085|456092708|FG000|Overall Study|Death|6|||
126453003|NCT00717236|454959046|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
126453004|NCT00717236|454959045|FG000|Double-Blind Period|Other: Site withdrew|2|||
126453005|NCT00717236|454959046|FG001|Double-Blind Period|Other: Site withdrew|0|||
126453006|NCT00717236|454959045|FG000|Double-Blind Period|Other: Screening failure|1|||
126704563|NCT01446809|455868338|FG000|Overall Study|Failure to complete study procedures|0|||
126704564|NCT01446809|455868339|FG001|Overall Study|Failure to complete study procedures|0|||
126266239|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
126266240|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
126266241|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
126266242|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
126266243|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
126266244|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
126453007|NCT00717236|454959046|FG001|Double-Blind Period|Other: Screening failure|0|||
126704565|NCT01446809|455868340|FG002|Overall Study|Failure to complete study procedures|1|||
126704566|NCT00785577|455868341|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
126704567|NCT00785577|455868342|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
126704568|NCT00785577|455868343|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
126704569|NCT00785577|455868344|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
126704570|NCT00785577|455868345|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
126704571|NCT00785577|455868341|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
126704572|NCT00785577|455868342|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
126704573|NCT00785577|455868343|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
126704574|NCT00785577|455868344|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
126704575|NCT00785577|455868345|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
126266245|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
126266246|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
126266247|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
126266248|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
126266249|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
126704576|NCT00785577|455868341|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
126704577|NCT00785577|455868342|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
126704578|NCT00785577|455868343|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
126704579|NCT00785577|455868344|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
126704580|NCT00785577|455868345|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
126704581|NCT00785577|455868341|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
126704582|NCT00785577|455868342|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
126704583|NCT00785577|455868343|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
126704584|NCT00785577|455868344|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
126704585|NCT00785577|455868345|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
126704586|NCT00785577|455868341|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
126704587|NCT00785577|455868342|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
126704588|NCT00785577|455868343|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
126704589|NCT00785577|455868344|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
126704590|NCT00785577|455868345|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
126704591|NCT00785577|455868341|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
126704592|NCT00785577|455868342|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
126704593|NCT00785577|455868343|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
126704594|NCT00785577|455868344|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
126704595|NCT00785577|455868345|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
126704596|NCT00785577|455868341|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
126704597|NCT00785577|455868342|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
126704598|NCT00785577|455868343|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
126704599|NCT00785577|455868344|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
126704600|NCT00785577|455868345|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
126704601|NCT00785577|455868341|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
126704602|NCT00785577|455868342|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
126704603|NCT00785577|455868343|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
126704604|NCT00785577|455868344|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
126704605|NCT00785577|455868345|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
126266250|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
126453008|NCT00717236|454959045|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
126704606|NCT00785577|455868341|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
126704607|NCT00785577|455868342|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
126704608|NCT00785577|455868343|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
126704609|NCT00785577|455868344|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
126704610|NCT00785577|455868345|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
126266251|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
126266252|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
126266253|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
126266254|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
126266255|NCT00518882|454265173|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
126266256|NCT00518882|454265174|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
126266257|NCT00567476|454265178|FG000|Overall Study|Adverse Event|2|||
126266258|NCT00567476|454265179|FG001|Overall Study|Adverse Event|0|||
126266259|NCT00567476|454265178|FG000|Overall Study|Pregnancy|1|||
126266260|NCT00567476|454265179|FG001|Overall Study|Pregnancy|0|||
126266261|NCT00567476|454265178|FG000|Overall Study|Protocol Violation|4|||
126266262|NCT00567476|454265179|FG001|Overall Study|Protocol Violation|1|||
126266263|NCT00567476|454265178|FG000|Overall Study|Lost to Follow-up|0|||
126266264|NCT00567476|454265179|FG001|Overall Study|Lost to Follow-up|1|||
126266265|NCT00567476|454265178|FG000|Overall Study|Administrative issues|1|||
126266266|NCT00567476|454265179|FG001|Overall Study|Administrative issues|0|||
126266267|NCT00567476|454265178|FG000|Overall Study|Medical Decision|0|||
126266268|NCT00567476|454265179|FG001|Overall Study|Medical Decision|1|||
126266269|NCT00567476|454265178|FG000|Overall Study|Non-adherence to protocol|0|||
126266270|NCT00567476|454265179|FG001|Overall Study|Non-adherence to protocol|1|||
126266271|NCT02696031|454265180|FG000|Up to Week 24|Adverse Event|2|||
126266272|NCT02696031|454265181|FG001|Up to Week 24|Adverse Event|4|||
126266273|NCT02696031|454265182|FG002|Up to Week 24|Adverse Event|2|||
126266274|NCT02696031|454265183|FG003|Up to Week 24|Adverse Event|0|||
126266275|NCT02696031|454265184|FG004|Up to Week 24|Adverse Event|0|||
126266276|NCT02696031|454265185|FG005|Up to Week 24|Adverse Event|0|||
126266277|NCT02696031|454265180|FG000|Up to Week 24|Lack of Efficacy|2|||
126266278|NCT02696031|454265181|FG001|Up to Week 24|Lack of Efficacy|1|||
126266279|NCT02696031|454265182|FG002|Up to Week 24|Lack of Efficacy|2|||
126266280|NCT02696031|454265183|FG003|Up to Week 24|Lack of Efficacy|0|||
126266281|NCT02696031|454265184|FG004|Up to Week 24|Lack of Efficacy|0|||
126266282|NCT02696031|454265185|FG005|Up to Week 24|Lack of Efficacy|0|||
126266283|NCT02696031|454265180|FG000|Up to Week 24|Lost to Follow-up|0|||
126266284|NCT02696031|454265181|FG001|Up to Week 24|Lost to Follow-up|1|||
126704611|NCT00785577|455868341|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
126704612|NCT00785577|455868342|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
126704613|NCT00785577|455868343|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
126704614|NCT00785577|455868344|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
126704615|NCT00785577|455868345|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
126704616|NCT03972488|455868349|FG000|Overall Study|Progressive disease|42|||
126704617|NCT03972488|455868350|FG001|Overall Study|Progressive disease|44|||
126704618|NCT03972488|455868349|FG000|Overall Study|Physician Decision|13|||
126704619|NCT03972488|455868350|FG001|Overall Study|Physician Decision|7|||
126704620|NCT03972488|455868349|FG000|Overall Study|Adverse Event|8|||
126704621|NCT03972488|455868350|FG001|Overall Study|Adverse Event|1|||
126266285|NCT02696031|454265182|FG002|Up to Week 24|Lost to Follow-up|1|||
126266286|NCT02696031|454265183|FG003|Up to Week 24|Lost to Follow-up|0|||
126266287|NCT02696031|454265184|FG004|Up to Week 24|Lost to Follow-up|0|||
126266288|NCT02696031|454265185|FG005|Up to Week 24|Lost to Follow-up|0|||
126266289|NCT02696031|454265180|FG000|Up to Week 24|Physician Decision|1|||
126266290|NCT02696031|454265181|FG001|Up to Week 24|Physician Decision|0|||
126266291|NCT02696031|454265182|FG002|Up to Week 24|Physician Decision|1|||
126704622|NCT03972488|455868349|FG000|Overall Study|Death|4|||
126704623|NCT03972488|455868350|FG001|Overall Study|Death|4|||
126704624|NCT03972488|455868349|FG000|Overall Study|Withdrawal by Subject|3|||
126704625|NCT03972488|455868350|FG001|Overall Study|Withdrawal by Subject|4|||
126704626|NCT03972488|455868349|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
126704627|NCT03972488|455868350|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
126704628|NCT00942162|455869853|FG000|Overall Study|Death|45|||
126266292|NCT02696031|454265183|FG003|Up to Week 24|Physician Decision|0|||
126266293|NCT02696031|454265184|FG004|Up to Week 24|Physician Decision|0|||
126266294|NCT02696031|454265185|FG005|Up to Week 24|Physician Decision|0|||
126266295|NCT02696031|454265180|FG000|Up to Week 24|Protocol Violation|1|||
126266296|NCT02696031|454265181|FG001|Up to Week 24|Protocol Violation|0|||
126266297|NCT02696031|454265182|FG002|Up to Week 24|Protocol Violation|0|||
126360423|NCT00147537|454610814|FG002|Phase 2|Lost to Follow-up|0|||
126360424|NCT00147537|454610815|FG003|Phase 2|Lost to Follow-up|0|||
126360425|NCT00147537|454610816|FG004|Phase 2|Lost to Follow-up|0|||
126360426|NCT00147537|454610817|FG005|Phase 2|Lost to Follow-up|0|||
126704629|NCT00942162|455869854|FG001|Overall Study|Death|35|||
126704630|NCT00942162|455869855|FG002|Overall Study|Death|0|||
126704631|NCT00942162|455869853|FG000|Overall Study|Withdrawal by Subject|7|||
126704632|NCT00942162|455869854|FG001|Overall Study|Withdrawal by Subject|2|||
126704633|NCT00942162|455869855|FG002|Overall Study|Withdrawal by Subject|0|||
126266298|NCT02696031|454265183|FG003|Up to Week 24|Protocol Violation|0|||
126266299|NCT02696031|454265184|FG004|Up to Week 24|Protocol Violation|0|||
126266300|NCT02696031|454265185|FG005|Up to Week 24|Protocol Violation|0|||
126266301|NCT02696031|454265180|FG000|Up to Week 24|Withdrawal by Subject|4|||
126266302|NCT02696031|454265181|FG001|Up to Week 24|Withdrawal by Subject|1|||
126360427|NCT00147537|454610818|FG006|Phase 2|Lost to Follow-up|0|||
126266303|NCT02696031|454265182|FG002|Up to Week 24|Withdrawal by Subject|5|||
126266304|NCT02696031|454265183|FG003|Up to Week 24|Withdrawal by Subject|0|||
126266305|NCT02696031|454265184|FG004|Up to Week 24|Withdrawal by Subject|0|||
126266306|NCT02696031|454265185|FG005|Up to Week 24|Withdrawal by Subject|0|||
126266307|NCT02696031|454265180|FG000|Up to Week 52|Adverse Event|4|||
126266308|NCT02696031|454265181|FG001|Up to Week 52|Adverse Event|5|||
126266309|NCT02696031|454265182|FG002|Up to Week 52|Adverse Event|3|||
126266310|NCT02696031|454265183|FG003|Up to Week 52|Adverse Event|0|||
126266311|NCT02696031|454265184|FG004|Up to Week 52|Adverse Event|0|||
126266312|NCT02696031|454265185|FG005|Up to Week 52|Adverse Event|0|||
126765164|NCT04882085|456092709|FG001|Overall Study|Death|9|||
126765165|NCT04882085|456092708|FG000|Overall Study|Withdrawal by Subject|0|||
126765166|NCT04882085|456092709|FG001|Overall Study|Withdrawal by Subject|3|||
126765167|NCT04882085|456092708|FG000|Overall Study|Randomized not treated|1|||
126765168|NCT04882085|456092709|FG001|Overall Study|Randomized not treated|0|||
126765169|NCT00400985|456092710|FG000|Overall Study|Withdrawal by Subject|5|||
126765170|NCT00400985|456092710|FG000|Overall Study|system modification|8|||
126765171|NCT00400985|456092710|FG000|Overall Study|Death|30|||
126765172|NCT00400985|456092710|FG000|Overall Study|Lost to Follow-up|9|||
126765173|NCT03792633|456092715|FG000|Overall Study|Alternative Treatment|17|||
126765174|NCT03792633|456092716|FG001|Overall Study|Alternative Treatment|19|||
126765175|NCT03792633|456092715|FG000|Overall Study|Death|2|||
126765176|NCT03792633|456092716|FG001|Overall Study|Death|0|||
126765177|NCT03792633|456092715|FG000|Overall Study|Disease progression|8|||
126765178|NCT03792633|456092716|FG001|Overall Study|Disease progression|9|||
126765179|NCT03792633|456092715|FG000|Overall Study|Lost to Follow-up|1|||
126765180|NCT03792633|456092716|FG001|Overall Study|Lost to Follow-up|1|||
126765181|NCT03792633|456092715|FG000|Overall Study|Screen fail|1|||
126765182|NCT03792633|456092716|FG001|Overall Study|Screen fail|0|||
126765183|NCT03792633|456092715|FG000|Overall Study|Second malignancy|0|||
126765184|NCT03792633|456092716|FG001|Overall Study|Second malignancy|1|||
126765185|NCT03179462|456092719|FG000|Overall Study|screening failure|1|||
126765186|NCT03179462|456092720|FG001|Overall Study|screening failure|2|||
126765187|NCT03179462|456092721|FG002|Overall Study|screening failure|0|||
126765188|NCT00816166|456092722|FG000|Overall Study|Lost to Follow-up|6|||
126765189|NCT00816166|456092723|FG001|Overall Study|Lost to Follow-up|10|||
126765190|NCT00816166|456092722|FG000|Overall Study|Death|4|||
126765191|NCT00816166|456092723|FG001|Overall Study|Death|2|||
126765192|NCT05153629|456092724|FG000|Overall Study|Withdrawal by Subject|0|||
126765193|NCT05153629|456092725|FG001|Overall Study|Withdrawal by Subject|2|||
126765194|NCT03743571|456092728|FG000|Overall Study|Withdrawal by Subject|1|||
126765195|NCT03743571|456092729|FG001|Overall Study|Withdrawal by Subject|1|||
126765196|NCT03743571|456092728|FG000|Overall Study|Lost to Follow-up|1|||
126765197|NCT03743571|456092729|FG001|Overall Study|Lost to Follow-up|2|||
126266313|NCT02696031|454265180|FG000|Up to Week 52|Lack of Efficacy|10|||
126266314|NCT02696031|454265181|FG001|Up to Week 52|Lack of Efficacy|7|||
126266315|NCT02696031|454265182|FG002|Up to Week 52|Lack of Efficacy|11|||
126266316|NCT02696031|454265183|FG003|Up to Week 52|Lack of Efficacy|0|||
126266317|NCT02696031|454265184|FG004|Up to Week 52|Lack of Efficacy|0|||
126266318|NCT02696031|454265185|FG005|Up to Week 52|Lack of Efficacy|0|||
126266319|NCT02696031|454265180|FG000|Up to Week 52|Lost to Follow-up|1|||
126266320|NCT02696031|454265181|FG001|Up to Week 52|Lost to Follow-up|1|||
126765198|NCT01233284|456092741|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
126765199|NCT01233284|456092742|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126765200|NCT01233284|456092743|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126765201|NCT01233284|456092744|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126765202|NCT01233284|456092745|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126765203|NCT01233284|456092741|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126765204|NCT01233284|456092742|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
126765205|NCT01233284|456092743|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126266321|NCT02696031|454265182|FG002|Up to Week 52|Lost to Follow-up|1|||
126266322|NCT02696031|454265183|FG003|Up to Week 52|Lost to Follow-up|0|||
126266323|NCT02696031|454265184|FG004|Up to Week 52|Lost to Follow-up|0|||
126266324|NCT02696031|454265185|FG005|Up to Week 52|Lost to Follow-up|0|||
126266325|NCT02696031|454265180|FG000|Up to Week 52|Physician Decision|1|||
126765206|NCT01233284|456092744|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126765207|NCT01233284|456092745|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
126765208|NCT01233284|456092741|FG000|Period 1 (4 Weeks)|Other|0|||
126765209|NCT01233284|456092742|FG001|Period 1 (4 Weeks)|Other|0|||
126765210|NCT01233284|456092743|FG002|Period 1 (4 Weeks)|Other|1|||
126765211|NCT01233284|456092744|FG003|Period 1 (4 Weeks)|Other|0|||
126765212|NCT01233284|456092745|FG004|Period 1 (4 Weeks)|Other|0|||
126765213|NCT01233284|456092741|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126765214|NCT01233284|456092742|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126765215|NCT01233284|456092743|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
126266326|NCT02696031|454265181|FG001|Up to Week 52|Physician Decision|1|||
126266327|NCT02696031|454265182|FG002|Up to Week 52|Physician Decision|2|||
126266328|NCT02696031|454265183|FG003|Up to Week 52|Physician Decision|0|||
126266329|NCT02696031|454265184|FG004|Up to Week 52|Physician Decision|0|||
126765216|NCT01233284|456092744|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126765217|NCT01233284|456092745|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126765218|NCT01233284|456092741|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126765219|NCT01233284|456092742|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126765220|NCT01233284|456092743|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
126765221|NCT01233284|456092744|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126765222|NCT01233284|456092745|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
126765223|NCT01233284|456092741|FG000|Period 3 (4 Weeks)|Other|0|||
126765224|NCT01233284|456092742|FG001|Period 3 (4 Weeks)|Other|0|||
126765225|NCT01233284|456092743|FG002|Period 3 (4 Weeks)|Other|0|||
126765226|NCT01233284|456092744|FG003|Period 3 (4 Weeks)|Other|1|||
126765227|NCT01233284|456092745|FG004|Period 3 (4 Weeks)|Other|0|||
126765228|NCT01233284|456092741|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
126765229|NCT01233284|456092742|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
126765230|NCT01233284|456092743|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
126765231|NCT01233284|456092744|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
126765232|NCT01233284|456092745|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
126765233|NCT01233284|456092741|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
126266330|NCT02696031|454265185|FG005|Up to Week 52|Physician Decision|0|||
126266331|NCT02696031|454265180|FG000|Up to Week 52|Pregnancy|0|||
126266332|NCT02696031|454265181|FG001|Up to Week 52|Pregnancy|2|||
126266333|NCT02696031|454265182|FG002|Up to Week 52|Pregnancy|0|||
126266334|NCT02696031|454265183|FG003|Up to Week 52|Pregnancy|0|||
126266335|NCT02696031|454265184|FG004|Up to Week 52|Pregnancy|0|||
126266336|NCT02696031|454265185|FG005|Up to Week 52|Pregnancy|0|||
126266337|NCT02696031|454265180|FG000|Up to Week 52|Protocol Violation|1|||
126266338|NCT02696031|454265181|FG001|Up to Week 52|Protocol Violation|0|||
126266339|NCT02696031|454265182|FG002|Up to Week 52|Protocol Violation|0|||
126266340|NCT02696031|454265183|FG003|Up to Week 52|Protocol Violation|0|||
126266341|NCT02696031|454265184|FG004|Up to Week 52|Protocol Violation|0|||
126266342|NCT02696031|454265185|FG005|Up to Week 52|Protocol Violation|0|||
126266343|NCT02696031|454265180|FG000|Up to Week 52|Withdrawal by Subject|12|||
126266344|NCT02696031|454265181|FG001|Up to Week 52|Withdrawal by Subject|3|||
126266345|NCT02696031|454265182|FG002|Up to Week 52|Withdrawal by Subject|9|||
126266346|NCT02696031|454265183|FG003|Up to Week 52|Withdrawal by Subject|0|||
126266347|NCT02696031|454265184|FG004|Up to Week 52|Withdrawal by Subject|0|||
126266348|NCT02696031|454265185|FG005|Up to Week 52|Withdrawal by Subject|0|||
126266349|NCT02696031|454265180|FG000|Up to Week 104|Pregnancy|0|||
126266350|NCT02696031|454265181|FG001|Up to Week 104|Pregnancy|2|||
126266351|NCT02696031|454265182|FG002|Up to Week 104|Pregnancy|1|||
126266352|NCT02696031|454265183|FG003|Up to Week 104|Pregnancy|0|||
126266353|NCT02696031|454265184|FG004|Up to Week 104|Pregnancy|0|||
126266354|NCT02696031|454265185|FG005|Up to Week 104|Pregnancy|0|||
126266355|NCT02696031|454265180|FG000|Up to Week 104|Withdrawal by Subject|15|||
126266356|NCT02696031|454265181|FG001|Up to Week 104|Withdrawal by Subject|10|||
126266357|NCT02696031|454265182|FG002|Up to Week 104|Withdrawal by Subject|16|||
126266358|NCT02696031|454265183|FG003|Up to Week 104|Withdrawal by Subject|0|||
126266359|NCT02696031|454265184|FG004|Up to Week 104|Withdrawal by Subject|0|||
126453009|NCT00717236|454959046|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
126453010|NCT00717236|454959045|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
126453011|NCT00717236|454959046|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
126266360|NCT02696031|454265185|FG005|Up to Week 104|Withdrawal by Subject|0|||
126266361|NCT02696031|454265180|FG000|Up to Week 104|Protocol Violation|1|||
126266362|NCT02696031|454265181|FG001|Up to Week 104|Protocol Violation|0|||
126266363|NCT02696031|454265182|FG002|Up to Week 104|Protocol Violation|0|||
126266364|NCT02696031|454265183|FG003|Up to Week 104|Protocol Violation|0|||
126266365|NCT02696031|454265184|FG004|Up to Week 104|Protocol Violation|0|||
126266366|NCT02696031|454265185|FG005|Up to Week 104|Protocol Violation|0|||
126266367|NCT02696031|454265180|FG000|Up to Week 104|Physician Decision|1|||
126266368|NCT02696031|454265181|FG001|Up to Week 104|Physician Decision|2|||
126266369|NCT02696031|454265182|FG002|Up to Week 104|Physician Decision|3|||
126453012|NCT00717236|454959045|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
126266370|NCT02696031|454265183|FG003|Up to Week 104|Physician Decision|0|||
126266371|NCT02696031|454265184|FG004|Up to Week 104|Physician Decision|0|||
126266372|NCT02696031|454265185|FG005|Up to Week 104|Physician Decision|0|||
126765234|NCT01233284|456092742|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
126765235|NCT01233284|456092743|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
126765236|NCT01233284|456092744|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
126765237|NCT01233284|456092745|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
126266373|NCT02696031|454265180|FG000|Up to Week 104|Lost to Follow-up|2|||
126266374|NCT02696031|454265181|FG001|Up to Week 104|Lost to Follow-up|3|||
126266375|NCT02696031|454265182|FG002|Up to Week 104|Lost to Follow-up|1|||
126266376|NCT02696031|454265183|FG003|Up to Week 104|Lost to Follow-up|0|||
126266377|NCT02696031|454265184|FG004|Up to Week 104|Lost to Follow-up|0|||
126266378|NCT02696031|454265185|FG005|Up to Week 104|Lost to Follow-up|0|||
126266379|NCT02696031|454265180|FG000|Up to Week 104|Lack of Efficacy|13|||
126266380|NCT02696031|454265181|FG001|Up to Week 104|Lack of Efficacy|12|||
126266381|NCT02696031|454265182|FG002|Up to Week 104|Lack of Efficacy|11|||
126266382|NCT02696031|454265183|FG003|Up to Week 104|Lack of Efficacy|0|||
126266383|NCT02696031|454265184|FG004|Up to Week 104|Lack of Efficacy|0|||
126765238|NCT01058707|456092747|FG000|Overall Study|Disease Progression|15|||
126266384|NCT02696031|454265185|FG005|Up to Week 104|Lack of Efficacy|0|||
126266385|NCT02696031|454265180|FG000|Up to Week 104|Adverse Event|7|||
126266386|NCT02696031|454265181|FG001|Up to Week 104|Adverse Event|11|||
126266387|NCT02696031|454265182|FG002|Up to Week 104|Adverse Event|5|||
126266388|NCT02696031|454265183|FG003|Up to Week 104|Adverse Event|0|||
126266389|NCT02696031|454265184|FG004|Up to Week 104|Adverse Event|0|||
126266390|NCT02696031|454265185|FG005|Up to Week 104|Adverse Event|0|||
126704634|NCT00942162|455869853|FG000|Overall Study|Lost to Follow-up|4|||
126704635|NCT00942162|455869854|FG001|Overall Study|Lost to Follow-up|0|||
126704636|NCT00942162|455869855|FG002|Overall Study|Lost to Follow-up|0|||
126704637|NCT00942162|455869853|FG000|Overall Study|Other|14|||
126704638|NCT00942162|455869854|FG001|Overall Study|Other|13|||
126704639|NCT00942162|455869855|FG002|Overall Study|Other|2|||
126704640|NCT02799381|455869865|FG000|Overall Study|Withdrew consent|3|||
126704641|NCT02799381|455869866|FG001|Overall Study|Withdrew consent|2|||
126704642|NCT02799381|455869865|FG000|Overall Study|Adverse Event|0|||
126704643|NCT02799381|455869866|FG001|Overall Study|Adverse Event|1|||
126704644|NCT02799381|455869865|FG000|Overall Study|Participant did not take any study drug|1|||
126704645|NCT02799381|455869866|FG001|Overall Study|Participant did not take any study drug|0|||
126704646|NCT01821963|455869867|FG000|Overall Study|Adverse Event|1|||
126704647|NCT03952130|455869868|FG000|Overall Study|Adverse Event|0|||
126704648|NCT03952130|455869869|FG001|Overall Study|Adverse Event|1|||
126704649|NCT03952130|455869868|FG000|Overall Study|Lost to Follow-up|1|||
126704650|NCT03952130|455869869|FG001|Overall Study|Lost to Follow-up|0|||
126704651|NCT03952130|455869868|FG000|Overall Study|Withdrawal by Subject|1|||
126704652|NCT03952130|455869869|FG001|Overall Study|Withdrawal by Subject|5|||
126704653|NCT01713348|455869870|FG000|Overall Study|Withdrawal by Subject|3|||
126704654|NCT01713348|455869871|FG001|Overall Study|Withdrawal by Subject|2|||
126704655|NCT01713348|455869872|FG002|Overall Study|Withdrawal by Subject|2|||
126704656|NCT01713348|455869873|FG003|Overall Study|Withdrawal by Subject|0|||
126704657|NCT01713348|455869870|FG000|Overall Study|Lost to Follow-up|1|||
126704658|NCT01713348|455869871|FG001|Overall Study|Lost to Follow-up|0|||
126704659|NCT01713348|455869872|FG002|Overall Study|Lost to Follow-up|0|||
126704660|NCT01713348|455869873|FG003|Overall Study|Lost to Follow-up|0|||
126704661|NCT01896232|455869874|FG000|Overall Study|Death|6|||
126704662|NCT01896232|455869875|FG001|Overall Study|Death|10|||
126704663|NCT01896232|455869874|FG000|Overall Study|Withdrawal by Subject|32|||
126704664|NCT01896232|455869875|FG001|Overall Study|Withdrawal by Subject|31|||
126704665|NCT01896232|455869874|FG000|Overall Study|Sponsor Decision|2|||
126704666|NCT01896232|455869875|FG001|Overall Study|Sponsor Decision|0|||
126704667|NCT01896232|455869874|FG000|Overall Study|Lost to Follow-up|9|||
126704668|NCT01896232|455869875|FG001|Overall Study|Lost to Follow-up|12|||
126704669|NCT00686205|455869884|FG000|Overall Study|Protocol Violation|127|||
126704670|NCT00686205|455869885|FG001|Overall Study|Protocol Violation|0|||
126704671|NCT00686205|455869884|FG000|Overall Study|Withdrawal by Subject|2|||
126704672|NCT00686205|455869885|FG001|Overall Study|Withdrawal by Subject|0|||
126704673|NCT00686205|455869884|FG000|Overall Study|Specimen handling procedure altered|5878|||
126704674|NCT00686205|455869885|FG001|Overall Study|Specimen handling procedure altered|0|||
126704675|NCT00686205|455869884|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
126704676|NCT00686205|455869885|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
126704677|NCT00265941|455869886|FG000|Overall Study|Protocol Violation|22|||
126704678|NCT00265941|455869887|FG001|Overall Study|Protocol Violation|25|||
126704679|NCT00265941|455869886|FG000|Overall Study|Lost to Follow-up|1|||
126704680|NCT00265941|455869887|FG001|Overall Study|Lost to Follow-up|1|||
126704681|NCT03816995|455869890|FG000|Overall Study|Withdrawal by Subject|3|||
126704682|NCT03816995|455869891|FG001|Overall Study|Withdrawal by Subject|1|||
126704683|NCT03816995|455869890|FG000|Overall Study|Cancelled Surgery|8|||
126704684|NCT03816995|455869891|FG001|Overall Study|Cancelled Surgery|12|||
126704685|NCT03816995|455869890|FG000|Overall Study|No wound protector used|11|||
126704686|NCT03816995|455869891|FG001|Overall Study|No wound protector used|17|||
126704687|NCT03816995|455869890|FG000|Overall Study|Protocol Violation|2|||
126266391|NCT02696031|454265180|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
126360428|NCT00147537|454610819|FG007|Phase 2|Lost to Follow-up|0|||
126704688|NCT03816995|455869891|FG001|Overall Study|Protocol Violation|3|||
126704689|NCT05882890|455869893|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
126704690|NCT00613314|455869896|FG000|Overall Study|Adverse Event|5|||
126704691|NCT00613314|455869896|FG000|Overall Study|Protocol Violation|14|||
126704692|NCT00613314|455869896|FG000|Overall Study|Lost to Follow-up|46|||
126704693|NCT00613314|455869896|FG000|Overall Study|Other reason not defined above|90|||
126266392|NCT02696031|454265181|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
126360429|NCT00147537|454610820|FG008|Phase 2|Lost to Follow-up|0|||
126704694|NCT03090191|455869901|FG000|Overall Study|Adverse Event|90|||
126704695|NCT03090191|455869902|FG001|Overall Study|Adverse Event|72|||
126704696|NCT03090191|455869901|FG000|Overall Study|Death|365|||
126704697|NCT03090191|455869902|FG001|Overall Study|Death|358|||
126704698|NCT03090191|455869901|FG000|Overall Study|Lost to Follow-up|382|||
126704699|NCT03090191|455869902|FG001|Overall Study|Lost to Follow-up|394|||
126704700|NCT03090191|455869901|FG000|Overall Study|Physician Decision|77|||
126704701|NCT03090191|455869902|FG001|Overall Study|Physician Decision|66|||
126704702|NCT03090191|455869901|FG000|Overall Study|Protocol Violation|43|||
126704703|NCT03090191|455869902|FG001|Overall Study|Protocol Violation|52|||
126704704|NCT03090191|455869901|FG000|Overall Study|Withdrawal by Subject|2160|||
126704705|NCT03090191|455869902|FG001|Overall Study|Withdrawal by Subject|2133|||
126704706|NCT03090191|455869901|FG000|Overall Study|Site terminated|7|||
126704707|NCT03090191|455869902|FG001|Overall Study|Site terminated|8|||
126704708|NCT03090191|455869901|FG000|Overall Study|Other|66|||
126704709|NCT03090191|455869902|FG001|Overall Study|Other|60|||
126704710|NCT03090191|455869901|FG000|Overall Study|Withdrawn before any study vaccination|43|||
126704711|NCT03090191|455869902|FG001|Overall Study|Withdrawn before any study vaccination|52|||
126704712|NCT02432807|455869903|FG000|Overall Study|Adverse Event|0|||
126704713|NCT02432807|455869904|FG001|Overall Study|Adverse Event|2|||
126704714|NCT02432807|455869903|FG000|Overall Study|Lost to Follow-up|1|||
126704715|NCT02432807|455869904|FG001|Overall Study|Lost to Follow-up|0|||
126704716|NCT02432807|455869903|FG000|Overall Study|Withdrawal by Subject|1|||
126704717|NCT02432807|455869904|FG001|Overall Study|Withdrawal by Subject|1|||
126704718|NCT02432807|455869903|FG000|Overall Study|Other|1|||
126704719|NCT02432807|455869904|FG001|Overall Study|Other|1|||
126704720|NCT01845025|455869905|FG000|Overall Study|Adverse Event|6|||
126704721|NCT01845025|455869906|FG001|Overall Study|Adverse Event|3|||
126704722|NCT01845025|455869905|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126704723|NCT01845025|455869906|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126704724|NCT01845025|455869905|FG000|Overall Study|Withdrawal by Subject|48|||
126704725|NCT01845025|455869906|FG001|Overall Study|Withdrawal by Subject|44|||
126704726|NCT01845025|455869905|FG000|Overall Study|Lost to Follow-up|13|||
126704727|NCT01845025|455869906|FG001|Overall Study|Lost to Follow-up|13|||
126704728|NCT01845025|455869905|FG000|Overall Study|Administrative problems|8|||
126704729|NCT01845025|455869906|FG001|Overall Study|Administrative problems|8|||
126704730|NCT01845025|455869905|FG000|Overall Study|Death|2|||
126704731|NCT01845025|455869906|FG001|Overall Study|Death|0|||
126704732|NCT01845025|455869905|FG000|Overall Study|Protocol deviation|3|||
126704733|NCT01845025|455869906|FG001|Overall Study|Protocol deviation|6|||
126704734|NCT01845025|455869905|FG000|Overall Study|Missing|1|||
126704735|NCT01845025|455869906|FG001|Overall Study|Missing|1|||
126704736|NCT03976401|455869907|FG000|Overall Study|Adverse Event|2|||
126704737|NCT03976401|455869908|FG001|Overall Study|Adverse Event|0|||
126704738|NCT03976401|455869909|FG002|Overall Study|Adverse Event|4|||
126704739|NCT03976401|455869910|FG003|Overall Study|Adverse Event|1|||
126704740|NCT03976401|455869911|FG004|Overall Study|Adverse Event|1|||
126704741|NCT03976401|455869912|FG005|Overall Study|Adverse Event|0|||
126704742|NCT03976401|455869907|FG000|Overall Study|Withdrawal by Subject|0|||
126704743|NCT03976401|455869908|FG001|Overall Study|Withdrawal by Subject|1|||
126704744|NCT03976401|455869909|FG002|Overall Study|Withdrawal by Subject|0|||
126704745|NCT03976401|455869910|FG003|Overall Study|Withdrawal by Subject|0|||
126704746|NCT03976401|455869911|FG004|Overall Study|Withdrawal by Subject|0|||
126704747|NCT03976401|455869912|FG005|Overall Study|Withdrawal by Subject|1|||
126704748|NCT03976401|455869907|FG000|Overall Study|Physician Decision|0|||
126704749|NCT03976401|455869908|FG001|Overall Study|Physician Decision|0|||
126704750|NCT03976401|455869909|FG002|Overall Study|Physician Decision|1|||
126704751|NCT03976401|455869910|FG003|Overall Study|Physician Decision|0|||
126704752|NCT03976401|455869911|FG004|Overall Study|Physician Decision|0|||
126704753|NCT03976401|455869912|FG005|Overall Study|Physician Decision|0|||
126704754|NCT03976401|455869907|FG000|Overall Study|Lost to Follow-up|1|||
126704755|NCT03976401|455869908|FG001|Overall Study|Lost to Follow-up|2|||
126704756|NCT03976401|455869909|FG002|Overall Study|Lost to Follow-up|0|||
126704757|NCT03976401|455869910|FG003|Overall Study|Lost to Follow-up|0|||
126704758|NCT03976401|455869911|FG004|Overall Study|Lost to Follow-up|0|||
126704759|NCT03976401|455869912|FG005|Overall Study|Lost to Follow-up|0|||
126704760|NCT03976401|455869907|FG000|Overall Study|Protocol Violation|0|||
126704761|NCT03976401|455869908|FG001|Overall Study|Protocol Violation|1|||
126704762|NCT03976401|455869909|FG002|Overall Study|Protocol Violation|0|||
126704763|NCT03976401|455869910|FG003|Overall Study|Protocol Violation|0|||
126704764|NCT03976401|455869911|FG004|Overall Study|Protocol Violation|0|||
126266393|NCT02696031|454265182|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
126266394|NCT02696031|454265183|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
126704765|NCT03976401|455869912|FG005|Overall Study|Protocol Violation|0|||
126704766|NCT03976401|455869907|FG000|Overall Study|Withdrew Consent|0|||
126704767|NCT03976401|455869908|FG001|Overall Study|Withdrew Consent|0|||
126360430|NCT00147537|454610821|FG009|Phase 2|Lost to Follow-up|12|||
126704768|NCT03976401|455869909|FG002|Overall Study|Withdrew Consent|0|||
126704769|NCT03976401|455869910|FG003|Overall Study|Withdrew Consent|1|||
126704770|NCT03976401|455869911|FG004|Overall Study|Withdrew Consent|0|||
126704771|NCT03976401|455869912|FG005|Overall Study|Withdrew Consent|0|||
126704772|NCT01324830|455869913|FG000|Overall Study|Progressive Disease|3|||
126704773|NCT01324830|455869914|FG001|Overall Study|Progressive Disease|2|||
126704774|NCT01324830|455869915|FG002|Overall Study|Progressive Disease|3|||
126704775|NCT01324830|455869916|FG003|Overall Study|Progressive Disease|3|||
126704776|NCT01324830|455869917|FG004|Overall Study|Progressive Disease|6|||
126266395|NCT02696031|454265184|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
126266396|NCT02696031|454265185|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
126266397|NCT02696031|454265180|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
126765239|NCT01058707|456092748|FG001|Overall Study|Disease Progression|20|||
126765240|NCT01058707|456092749|FG002|Overall Study|Disease Progression|20|||
126765241|NCT01058707|456092750|FG003|Overall Study|Disease Progression|15|||
126765242|NCT01058707|456092751|FG004|Overall Study|Disease Progression|23|||
126765243|NCT01058707|456092752|FG005|Overall Study|Disease Progression|10|||
126765244|NCT01058707|456092753|FG006|Overall Study|Disease Progression|12|||
126765245|NCT01058707|456092747|FG000|Overall Study|Adverse Event|11|||
126765246|NCT01058707|456092748|FG001|Overall Study|Adverse Event|4|||
126765247|NCT01058707|456092749|FG002|Overall Study|Adverse Event|7|||
126765248|NCT01058707|456092750|FG003|Overall Study|Adverse Event|6|||
126765249|NCT01058707|456092751|FG004|Overall Study|Adverse Event|7|||
126765250|NCT01058707|456092752|FG005|Overall Study|Adverse Event|3|||
126266398|NCT02696031|454265181|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
126266399|NCT02696031|454265182|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
126266400|NCT02696031|454265183|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
126266401|NCT02696031|454265184|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
126266402|NCT02696031|454265185|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
126765251|NCT01058707|456092753|FG006|Overall Study|Adverse Event|1|||
126765252|NCT01058707|456092747|FG000|Overall Study|Subject Decision|5|||
126765253|NCT01058707|456092748|FG001|Overall Study|Subject Decision|3|||
126765254|NCT01058707|456092749|FG002|Overall Study|Subject Decision|3|||
126765255|NCT01058707|456092750|FG003|Overall Study|Subject Decision|1|||
126765256|NCT01058707|456092751|FG004|Overall Study|Subject Decision|2|||
126765257|NCT01058707|456092752|FG005|Overall Study|Subject Decision|3|||
126765258|NCT01058707|456092753|FG006|Overall Study|Subject Decision|6|||
126765259|NCT01058707|456092747|FG000|Overall Study|Lost to Follow-up|0|||
126765260|NCT01058707|456092748|FG001|Overall Study|Lost to Follow-up|0|||
126765261|NCT01058707|456092749|FG002|Overall Study|Lost to Follow-up|1|||
126765262|NCT01058707|456092750|FG003|Overall Study|Lost to Follow-up|0|||
126765263|NCT01058707|456092751|FG004|Overall Study|Lost to Follow-up|0|||
126765264|NCT01058707|456092752|FG005|Overall Study|Lost to Follow-up|0|||
126765265|NCT01058707|456092753|FG006|Overall Study|Lost to Follow-up|0|||
126765266|NCT01058707|456092747|FG000|Overall Study|Reason Not Specified|0|||
126765267|NCT01058707|456092748|FG001|Overall Study|Reason Not Specified|3|||
126765268|NCT01058707|456092749|FG002|Overall Study|Reason Not Specified|2|||
126765269|NCT01058707|456092750|FG003|Overall Study|Reason Not Specified|0|||
126765270|NCT01058707|456092751|FG004|Overall Study|Reason Not Specified|7|||
126765271|NCT01058707|456092752|FG005|Overall Study|Reason Not Specified|1|||
126765272|NCT01058707|456092753|FG006|Overall Study|Reason Not Specified|7|||
126765273|NCT01821391|456092754|FG000|Overall Study|Adverse Event|1|||
126765274|NCT01821391|456092755|FG001|Overall Study|Adverse Event|0|||
126765275|NCT04880850|456092764|FG000|Overall Study|Death|2|||
126765276|NCT04880850|456092765|FG001|Overall Study|Death|1|||
126765277|NCT04880850|456092764|FG000|Overall Study|Lost to Follow-up|3|||
126765278|NCT04880850|456092765|FG001|Overall Study|Lost to Follow-up|6|||
126765279|NCT04880850|456092764|FG000|Overall Study|Physician Decision|2|||
126765280|NCT04880850|456092765|FG001|Overall Study|Physician Decision|1|||
126266403|NCT02696031|454265180|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
126266404|NCT02696031|454265181|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
126266405|NCT02696031|454265182|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
126266406|NCT02696031|454265183|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
126266407|NCT02696031|454265184|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
126360431|NCT00147537|454610822|FG010|Phase 2|Lost to Follow-up|4|||
126360432|NCT00147537|454610812|FG000|Phase 2|Other|0|||
126360433|NCT00147537|454610813|FG001|Phase 2|Other|0|||
126360434|NCT00147537|454610814|FG002|Phase 2|Other|0|||
126765281|NCT04880850|456092764|FG000|Overall Study|Withdrawal by Subject|9|||
126765282|NCT04880850|456092765|FG001|Overall Study|Withdrawal by Subject|10|||
126765283|NCT01608321|456092766|FG000|Overall Study|Withdrawal by Subject|1|||
126765284|NCT01608321|456092767|FG001|Overall Study|Withdrawal by Subject|0|||
126360435|NCT00147537|454610815|FG003|Phase 2|Other|0|||
126360436|NCT00147537|454610816|FG004|Phase 2|Other|0|||
126360437|NCT00147537|454610817|FG005|Phase 2|Other|0|||
126360438|NCT00147537|454610818|FG006|Phase 2|Other|0|||
126360439|NCT00147537|454610819|FG007|Phase 2|Other|0|||
126360440|NCT00147537|454610820|FG008|Phase 2|Other|0|||
126360441|NCT00147537|454610821|FG009|Phase 2|Other|47|||
126360442|NCT00147537|454610822|FG010|Phase 2|Other|12|||
126360443|NCT00147537|454610812|FG000|Phase 2|Withdrawal by Subject|0|||
126360444|NCT00147537|454610813|FG001|Phase 2|Withdrawal by Subject|0|||
126360445|NCT00147537|454610814|FG002|Phase 2|Withdrawal by Subject|0|||
126360446|NCT00147537|454610815|FG003|Phase 2|Withdrawal by Subject|0|||
126765285|NCT03417102|456092768|FG000|Overall Study|Adverse Event|0|||
126765286|NCT03417102|456092769|FG001|Overall Study|Adverse Event|1|||
126765287|NCT03417102|456092768|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
126765288|NCT03417102|456092769|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
126765289|NCT03417102|456092768|FG000|Overall Study|Other|0|||
126765290|NCT03417102|456092769|FG001|Overall Study|Other|1|||
126765291|NCT02062385|456092770|FG000|Overall Study|Adverse Event|19|||
126765292|NCT02062385|456092771|FG001|Overall Study|Adverse Event|13|||
126765293|NCT02062385|456092772|FG002|Overall Study|Adverse Event|1|||
126765294|NCT02062385|456092773|FG003|Overall Study|Adverse Event|0|||
126765295|NCT02062385|456092770|FG000|Overall Study|Protocol Violation|1|||
126765296|NCT02062385|456092771|FG001|Overall Study|Protocol Violation|0|||
126765297|NCT02062385|456092772|FG002|Overall Study|Protocol Violation|0|||
126765298|NCT02062385|456092773|FG003|Overall Study|Protocol Violation|0|||
126765299|NCT02062385|456092770|FG000|Overall Study|Incomplete EPI by database lock|2|||
126765300|NCT02062385|456092771|FG001|Overall Study|Incomplete EPI by database lock|0|||
126765301|NCT02062385|456092772|FG002|Overall Study|Incomplete EPI by database lock|0|||
126765302|NCT02062385|456092773|FG003|Overall Study|Incomplete EPI by database lock|0|||
126765303|NCT02062385|456092770|FG000|Overall Study|Moved|10|||
126765304|NCT02062385|456092771|FG001|Overall Study|Moved|11|||
126765305|NCT02062385|456092772|FG002|Overall Study|Moved|1|||
126765306|NCT02062385|456092773|FG003|Overall Study|Moved|0|||
126765307|NCT02062385|456092770|FG000|Overall Study|Withdrawn by parent/guardian|46|||
126765308|NCT02062385|456092771|FG001|Overall Study|Withdrawn by parent/guardian|41|||
126765309|NCT02062385|456092772|FG002|Overall Study|Withdrawn by parent/guardian|9|||
126765310|NCT02062385|456092773|FG003|Overall Study|Withdrawn by parent/guardian|8|||
126765311|NCT02062385|456092770|FG000|Overall Study|Death|0|||
126765312|NCT02062385|456092771|FG001|Overall Study|Death|0|||
126765313|NCT02062385|456092772|FG002|Overall Study|Death|0|||
126765314|NCT02062385|456092773|FG003|Overall Study|Death|1|||
126765315|NCT02062385|456092770|FG000|Overall Study|Lost to Follow-up|0|||
126765316|NCT02062385|456092771|FG001|Overall Study|Lost to Follow-up|0|||
126765317|NCT02062385|456092772|FG002|Overall Study|Lost to Follow-up|1|||
126765318|NCT02062385|456092773|FG003|Overall Study|Lost to Follow-up|0|||
126765319|NCT02503215|456094469|FG000|Overall Study|Unable to wear compression stockings|1|||
126765320|NCT02503215|456094469|FG000|Overall Study|Unable to use positive airway pressure|2|||
126765321|NCT00706901|456094470|FG000|Overall Study|Lost to Follow-up|2|||
126765322|NCT00706901|456094471|FG001|Overall Study|Lost to Follow-up|3|||
126765323|NCT00706901|456094472|FG002|Overall Study|Lost to Follow-up|2|||
126765324|NCT00706901|456094470|FG000|Overall Study|Withdrawal by Subject|4|||
126765325|NCT00706901|456094471|FG001|Overall Study|Withdrawal by Subject|2|||
126765326|NCT00706901|456094472|FG002|Overall Study|Withdrawal by Subject|5|||
126765327|NCT00706901|456094470|FG000|Overall Study|In Jail|1|||
126765328|NCT00706901|456094471|FG001|Overall Study|In Jail|0|||
126765329|NCT00706901|456094472|FG002|Overall Study|In Jail|1|||
126765330|NCT00706901|456094470|FG000|Overall Study|Death|1|||
126765331|NCT00706901|456094471|FG001|Overall Study|Death|0|||
126765332|NCT00706901|456094472|FG002|Overall Study|Death|0|||
126765333|NCT03433482|456094473|FG000|Overall Study|Lost to Follow-up|1|||
126765334|NCT03433482|456094474|FG001|Overall Study|Lost to Follow-up|0|||
126765335|NCT03433482|456094475|FG002|Overall Study|Lost to Follow-up|1|||
126765336|NCT03433482|456094476|FG003|Overall Study|Lost to Follow-up|1|||
126765337|NCT03433482|456094473|FG000|Overall Study|Withdrawal by Subject|0|||
126765338|NCT03433482|456094474|FG001|Overall Study|Withdrawal by Subject|0|||
126765339|NCT03433482|456094475|FG002|Overall Study|Withdrawal by Subject|1|||
126765340|NCT03433482|456094476|FG003|Overall Study|Withdrawal by Subject|0|||
126765341|NCT03433482|456094473|FG000|Overall Study|Unknown reason|0|||
126765342|NCT03433482|456094474|FG001|Overall Study|Unknown reason|0|||
126765343|NCT03433482|456094475|FG002|Overall Study|Unknown reason|2|||
126765344|NCT03433482|456094476|FG003|Overall Study|Unknown reason|0|||
126765345|NCT00594568|456094477|FG000|Initial Treatment|Adverse Event|51|||
126765346|NCT00594568|456094478|FG001|Initial Treatment|Adverse Event|121|||
126765347|NCT00594568|456094479|FG002|Initial Treatment|Adverse Event|144|||
126765348|NCT00594568|456094477|FG000|Initial Treatment|Death|6|||
126765349|NCT00594568|456094478|FG001|Initial Treatment|Death|11|||
126765350|NCT00594568|456094479|FG002|Initial Treatment|Death|15|||
126765351|NCT00594568|456094477|FG000|Initial Treatment|Lost to Follow-up|4|||
126765352|NCT00594568|456094478|FG001|Initial Treatment|Lost to Follow-up|1|||
126765353|NCT00594568|456094479|FG002|Initial Treatment|Lost to Follow-up|4|||
126765354|NCT00594568|456094477|FG000|Initial Treatment|Physician Decision|3|||
126765355|NCT00594568|456094478|FG001|Initial Treatment|Physician Decision|2|||
126765356|NCT00594568|456094479|FG002|Initial Treatment|Physician Decision|4|||
126765357|NCT00594568|456094477|FG000|Initial Treatment|Protocol Violation|2|||
126765358|NCT00594568|456094478|FG001|Initial Treatment|Protocol Violation|2|||
126765359|NCT00594568|456094479|FG002|Initial Treatment|Protocol Violation|5|||
126765360|NCT00594568|456094477|FG000|Initial Treatment|Withdrawal by Subject|25|||
126360447|NCT00147537|454610816|FG004|Phase 2|Withdrawal by Subject|0|||
126360448|NCT00147537|454610817|FG005|Phase 2|Withdrawal by Subject|0|||
126360449|NCT00147537|454610818|FG006|Phase 2|Withdrawal by Subject|0|||
126360450|NCT00147537|454610819|FG007|Phase 2|Withdrawal by Subject|0|||
126360451|NCT00147537|454610820|FG008|Phase 2|Withdrawal by Subject|0|||
126360452|NCT00147537|454610821|FG009|Phase 2|Withdrawal by Subject|16|||
126266408|NCT02696031|454265185|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
126266409|NCT02696031|454265180|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
126266410|NCT02696031|454265181|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
126266411|NCT02696031|454265182|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
126266412|NCT02696031|454265183|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
126266413|NCT02696031|454265184|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
126266414|NCT02696031|454265185|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
126266415|NCT02696031|454265180|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
126266416|NCT02696031|454265181|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
126266417|NCT02696031|454265182|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
126266418|NCT02696031|454265183|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
126266419|NCT02696031|454265184|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
126266420|NCT02696031|454265185|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
126266421|NCT02696031|454265180|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
126453013|NCT00717236|454959046|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
126704777|NCT01324830|455869918|FG005|Overall Study|Progressive Disease|6|||
126704778|NCT01324830|455869919|FG006|Overall Study|Progressive Disease|3|||
126704779|NCT01324830|455869920|FG007|Overall Study|Progressive Disease|3|||
126704780|NCT01324830|455869921|FG008|Overall Study|Progressive Disease|3|||
126704781|NCT01324830|455869922|FG009|Overall Study|Progressive Disease|6|||
126704782|NCT01324830|455869923|FG010|Overall Study|Progressive Disease|2|||
126704783|NCT01324830|455869924|FG011|Overall Study|Progressive Disease|1|||
126704784|NCT01324830|455869925|FG012|Overall Study|Progressive Disease|1|||
126704785|NCT01324830|455869926|FG013|Overall Study|Progressive Disease|1|||
126704786|NCT01324830|455869927|FG014|Overall Study|Progressive Disease|1|||
126704787|NCT01324830|455869928|FG015|Overall Study|Progressive Disease|3|||
126704788|NCT01324830|455869929|FG016|Overall Study|Progressive Disease|2|||
126704789|NCT01324830|455869930|FG017|Overall Study|Progressive Disease|3|||
126704790|NCT01324830|455869931|FG018|Overall Study|Progressive Disease|4|||
126704791|NCT01324830|455869913|FG000|Overall Study|Dose limiting toxicity|0|||
126704792|NCT01324830|455869914|FG001|Overall Study|Dose limiting toxicity|0|||
126704793|NCT01324830|455869915|FG002|Overall Study|Dose limiting toxicity|0|||
126704794|NCT01324830|455869916|FG003|Overall Study|Dose limiting toxicity|0|||
126704795|NCT01324830|455869917|FG004|Overall Study|Dose limiting toxicity|1|||
126704796|NCT01324830|455869918|FG005|Overall Study|Dose limiting toxicity|0|||
126704797|NCT01324830|455869919|FG006|Overall Study|Dose limiting toxicity|0|||
126704798|NCT01324830|455869920|FG007|Overall Study|Dose limiting toxicity|0|||
126704799|NCT01324830|455869921|FG008|Overall Study|Dose limiting toxicity|0|||
126704800|NCT01324830|455869922|FG009|Overall Study|Dose limiting toxicity|0|||
126704801|NCT01324830|455869923|FG010|Overall Study|Dose limiting toxicity|0|||
126704802|NCT01324830|455869924|FG011|Overall Study|Dose limiting toxicity|0|||
126704803|NCT01324830|455869925|FG012|Overall Study|Dose limiting toxicity|0|||
126704804|NCT01324830|455869926|FG013|Overall Study|Dose limiting toxicity|0|||
126704805|NCT01324830|455869927|FG014|Overall Study|Dose limiting toxicity|0|||
126704806|NCT01324830|455869928|FG015|Overall Study|Dose limiting toxicity|0|||
126704807|NCT01324830|455869929|FG016|Overall Study|Dose limiting toxicity|1|||
126704808|NCT01324830|455869930|FG017|Overall Study|Dose limiting toxicity|1|||
126704809|NCT01324830|455869931|FG018|Overall Study|Dose limiting toxicity|1|||
126704810|NCT01324830|455869913|FG000|Overall Study|Reason not mentioned above|0|||
126704811|NCT01324830|455869914|FG001|Overall Study|Reason not mentioned above|0|||
126704812|NCT01324830|455869915|FG002|Overall Study|Reason not mentioned above|0|||
126704813|NCT01324830|455869916|FG003|Overall Study|Reason not mentioned above|0|||
126704814|NCT01324830|455869917|FG004|Overall Study|Reason not mentioned above|0|||
126704815|NCT01324830|455869918|FG005|Overall Study|Reason not mentioned above|0|||
126704816|NCT01324830|455869919|FG006|Overall Study|Reason not mentioned above|0|||
126704817|NCT01324830|455869920|FG007|Overall Study|Reason not mentioned above|0|||
126704818|NCT01324830|455869921|FG008|Overall Study|Reason not mentioned above|0|||
126704819|NCT01324830|455869922|FG009|Overall Study|Reason not mentioned above|0|||
126704820|NCT01324830|455869923|FG010|Overall Study|Reason not mentioned above|0|||
126704821|NCT01324830|455869924|FG011|Overall Study|Reason not mentioned above|0|||
126704822|NCT01324830|455869925|FG012|Overall Study|Reason not mentioned above|0|||
126704823|NCT01324830|455869926|FG013|Overall Study|Reason not mentioned above|0|||
126704824|NCT01324830|455869927|FG014|Overall Study|Reason not mentioned above|0|||
126704825|NCT01324830|455869928|FG015|Overall Study|Reason not mentioned above|0|||
126704826|NCT01324830|455869929|FG016|Overall Study|Reason not mentioned above|0|||
126765361|NCT00594568|456094478|FG001|Initial Treatment|Withdrawal by Subject|31|||
126704827|NCT01324830|455869930|FG017|Overall Study|Reason not mentioned above|1|||
126704828|NCT01324830|455869931|FG018|Overall Study|Reason not mentioned above|0|||
126704829|NCT01324830|455869913|FG000|Overall Study|Adverse Event, serious fatal|0|||
126704830|NCT01324830|455869914|FG001|Overall Study|Adverse Event, serious fatal|1|||
126704831|NCT01324830|455869915|FG002|Overall Study|Adverse Event, serious fatal|0|||
126704832|NCT01324830|455869916|FG003|Overall Study|Adverse Event, serious fatal|0|||
126765362|NCT00594568|456094479|FG002|Initial Treatment|Withdrawal by Subject|46|||
126453014|NCT00717236|454959045|FG000|Double-Blind Period|Other: History of cancer|1|||
126453015|NCT00717236|454959046|FG001|Double-Blind Period|Other: History of cancer|0|||
126453016|NCT00717236|454959045|FG000|Double-Blind Period|Other: Sponsor request|1|||
126765363|NCT00594568|456094477|FG000|Initial Treatment|Sponsor decision|193|||
126765364|NCT00594568|456094478|FG001|Initial Treatment|Sponsor decision|142|||
126765365|NCT00594568|456094479|FG002|Initial Treatment|Sponsor decision|147|||
126765366|NCT00594568|456094477|FG000|Initial Treatment|Caregiver decision|21|||
126765367|NCT00594568|456094478|FG001|Initial Treatment|Caregiver decision|36|||
126765368|NCT00594568|456094479|FG002|Initial Treatment|Caregiver decision|36|||
126765369|NCT00594568|456094477|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
126765370|NCT00594568|456094478|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
126765371|NCT00594568|456094479|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
126765372|NCT00594568|456094477|FG000|Initial Treatment|Entry criteria exclusion|0|||
126765373|NCT00594568|456094478|FG001|Initial Treatment|Entry criteria exclusion|1|||
126765374|NCT00594568|456094479|FG002|Initial Treatment|Entry criteria exclusion|1|||
126765375|NCT00594568|456094477|FG000|Delayed Start|Death|0|||
126765376|NCT00594568|456094478|FG001|Delayed Start|Death|0|||
126765377|NCT00594568|456094479|FG002|Delayed Start|Death|1|||
126765378|NCT00594568|456094477|FG000|Delayed Start|Adverse Event|12|||
126765379|NCT00594568|456094478|FG001|Delayed Start|Adverse Event|2|||
126765380|NCT00594568|456094479|FG002|Delayed Start|Adverse Event|2|||
126765381|NCT00594568|456094477|FG000|Delayed Start|Withdrawal by Subject|4|||
126765382|NCT00594568|456094478|FG001|Delayed Start|Withdrawal by Subject|3|||
126765383|NCT00594568|456094479|FG002|Delayed Start|Withdrawal by Subject|0|||
126765384|NCT00594568|456094477|FG000|Delayed Start|Physician Decision|0|||
126765385|NCT00594568|456094478|FG001|Delayed Start|Physician Decision|0|||
126765386|NCT00594568|456094479|FG002|Delayed Start|Physician Decision|1|||
126765387|NCT00594568|456094477|FG000|Delayed Start|Lost to Follow-up|0|||
126765388|NCT00594568|456094478|FG001|Delayed Start|Lost to Follow-up|0|||
126765389|NCT00594568|456094479|FG002|Delayed Start|Lost to Follow-up|1|||
126765390|NCT00594568|456094477|FG000|Delayed Start|Caregiver Decision|5|||
126765391|NCT00594568|456094478|FG001|Delayed Start|Caregiver Decision|6|||
126765392|NCT00594568|456094479|FG002|Delayed Start|Caregiver Decision|2|||
126765393|NCT00594568|456094477|FG000|Delayed Start|Sponsor Decision|77|||
126765394|NCT00594568|456094478|FG001|Delayed Start|Sponsor Decision|66|||
126765395|NCT00594568|456094479|FG002|Delayed Start|Sponsor Decision|59|||
126765396|NCT00594568|456094477|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
126765397|NCT00594568|456094478|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
126765398|NCT00594568|456094479|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
126765399|NCT00594568|456094477|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
126765400|NCT00594568|456094478|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
126765401|NCT00594568|456094479|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
126765402|NCT00594568|456094477|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
126765403|NCT00594568|456094478|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
126765404|NCT00594568|456094479|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
126765405|NCT00594568|456094477|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
126765406|NCT00594568|456094478|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
126765407|NCT00594568|456094479|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
126765408|NCT00594568|456094477|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
126765409|NCT00594568|456094478|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
126765410|NCT00594568|456094479|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
126765411|NCT00594568|456094477|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
126765412|NCT00594568|456094478|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
126765413|NCT00594568|456094479|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
126765414|NCT04478994|456094480|FG000|Overall Study|Withdrawal by Subject|1|||
126765415|NCT04478994|456094481|FG001|Overall Study|Withdrawal by Subject|1|||
126266422|NCT02696031|454265181|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
126266423|NCT02696031|454265182|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
126266424|NCT02696031|454265183|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
126453017|NCT00717236|454959046|FG001|Double-Blind Period|Other: Sponsor request|0|||
126453018|NCT00717236|454959045|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
126765416|NCT01100073|456094482|FG000|Overall Study|Lack of Efficacy|4|||
126266425|NCT02696031|454265184|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
126765417|NCT01100073|456094482|FG000|Overall Study|Insufficient Tolerability|21|||
126765418|NCT01100073|456094482|FG000|Overall Study|Withdrawal by Subject|13|||
126765419|NCT01100073|456094482|FG000|Overall Study|Lost to Follow-up|39|||
126765420|NCT01100073|456094482|FG000|Overall Study|Lack of effect + patient's wish|2|||
126765421|NCT01100073|456094482|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
126765422|NCT01100073|456094482|FG000|Overall Study|Other|8|||
126765423|NCT01100073|456094482|FG000|Overall Study|Missing|5|||
126765424|NCT01656850|456094483|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
126765425|NCT01656850|456094484|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
126765426|NCT01741259|456094490|FG000|Overall Study|Protocol Violation|6|||
126765427|NCT01741259|456094491|FG001|Overall Study|Protocol Violation|4|||
126266426|NCT02696031|454265185|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
126266427|NCT02696031|454265180|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
126266428|NCT02696031|454265181|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
126266429|NCT02696031|454265182|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
126266430|NCT02696031|454265183|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
126266431|NCT02696031|454265184|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
126266432|NCT02696031|454265185|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
126266433|NCT02777918|454265186|FG000|Overall Study|Medical reasons|1|||
126266434|NCT02777918|454265187|FG001|Overall Study|Medical reasons|2|||
126266435|NCT02777918|454265186|FG000|Overall Study|Too busy / stressed|1|||
126266436|NCT02777918|454265187|FG001|Overall Study|Too busy / stressed|1|||
126266437|NCT02777918|454265186|FG000|Overall Study|Withdrawal by Subject|1|||
126266438|NCT02777918|454265187|FG001|Overall Study|Withdrawal by Subject|1|||
126266439|NCT01338987|454265188|FG000|Overall Study|enrolled on new protocol|0|||
126266440|NCT01338987|454265189|FG001|Overall Study|enrolled on new protocol|0|||
126266441|NCT01338987|454265190|FG002|Overall Study|enrolled on new protocol|1|||
126266442|NCT01338987|454265191|FG003|Overall Study|enrolled on new protocol|0|||
126266443|NCT01338987|454265192|FG004|Overall Study|enrolled on new protocol|0|||
126266444|NCT01338987|454265188|FG000|Overall Study|Disease progression on study|2|||
126266445|NCT01338987|454265189|FG001|Overall Study|Disease progression on study|1|||
126266446|NCT01338987|454265190|FG002|Overall Study|Disease progression on study|1|||
126266447|NCT01338987|454265191|FG003|Overall Study|Disease progression on study|0|||
126453019|NCT00717236|454959046|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
126453020|NCT00717236|454959045|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
126453021|NCT00717236|454959046|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
126453022|NCT00717236|454959045|FG000|Double-Blind Period|Other: Subject moved|1|||
126453023|NCT00717236|454959046|FG001|Double-Blind Period|Other: Subject moved|1|||
126453024|NCT00717236|454959045|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
126453025|NCT00717236|454959046|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
126453026|NCT00717236|454959045|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
126453027|NCT00717236|454959046|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
126453028|NCT00717236|454959045|FG000|Double-Blind Period|Other: Transportation problems|0|||
126547334|NCT02778399|455296200|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
126266448|NCT01338987|454265192|FG004|Overall Study|Disease progression on study|0|||
126266449|NCT00058214|454265193|FG000|Overall Study|Adverse Event|1|||
126266450|NCT03856593|454265206|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
126266451|NCT03856593|454265207|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
126266452|NCT01491035|454265209|FG000|Overall Study|Lost to Follow-up|0|||
126266453|NCT01491035|454265210|FG001|Overall Study|Lost to Follow-up|0|||
126266454|NCT01491035|454265211|FG002|Overall Study|Lost to Follow-up|0|||
126266455|NCT01491035|454265212|FG003|Overall Study|Lost to Follow-up|0|||
126266456|NCT01491035|454265213|FG004|Overall Study|Lost to Follow-up|1|||
126453029|NCT00717236|454959046|FG001|Double-Blind Period|Other: Transportation problems|1|||
126704833|NCT01324830|455869917|FG004|Overall Study|Adverse Event, serious fatal|0|||
126704834|NCT01324830|455869918|FG005|Overall Study|Adverse Event, serious fatal|0|||
126704835|NCT01324830|455869919|FG006|Overall Study|Adverse Event, serious fatal|0|||
126704836|NCT01324830|455869920|FG007|Overall Study|Adverse Event, serious fatal|0|||
126704837|NCT01324830|455869921|FG008|Overall Study|Adverse Event, serious fatal|0|||
126704838|NCT01324830|455869922|FG009|Overall Study|Adverse Event, serious fatal|0|||
126704839|NCT01324830|455869923|FG010|Overall Study|Adverse Event, serious fatal|0|||
126704840|NCT01324830|455869924|FG011|Overall Study|Adverse Event, serious fatal|0|||
126704841|NCT01324830|455869925|FG012|Overall Study|Adverse Event, serious fatal|0|||
126704842|NCT01324830|455869926|FG013|Overall Study|Adverse Event, serious fatal|0|||
126704843|NCT01324830|455869927|FG014|Overall Study|Adverse Event, serious fatal|0|||
126704844|NCT01324830|455869928|FG015|Overall Study|Adverse Event, serious fatal|0|||
126704845|NCT01324830|455869929|FG016|Overall Study|Adverse Event, serious fatal|0|||
126704846|NCT01324830|455869930|FG017|Overall Study|Adverse Event, serious fatal|0|||
126704847|NCT01324830|455869931|FG018|Overall Study|Adverse Event, serious fatal|0|||
126704848|NCT01324830|455869913|FG000|Overall Study|Adverse Event, non-fatal|0|||
126704849|NCT01324830|455869914|FG001|Overall Study|Adverse Event, non-fatal|0|||
126704850|NCT01324830|455869915|FG002|Overall Study|Adverse Event, non-fatal|0|||
126765428|NCT01741259|456094490|FG000|Overall Study|Withdrawal by Subject|0|||
126765429|NCT01741259|456094491|FG001|Overall Study|Withdrawal by Subject|2|||
126765430|NCT00057330|456094497|FG000|Overall Study|Adverse Event|9|||
126453030|NCT00717236|454959045|FG000|Double-Blind Period|Other: Investigator Decision|0|||
126765431|NCT00057330|456094498|FG001|Overall Study|Adverse Event|12|||
126266457|NCT01491035|454265214|FG005|Overall Study|Lost to Follow-up|0|||
126266458|NCT01491035|454265215|FG006|Overall Study|Lost to Follow-up|0|||
126453031|NCT00717236|454959046|FG001|Double-Blind Period|Other: Investigator Decision|1|||
126453032|NCT00717236|454959045|FG000|Open-Label Period|Adverse Event|29|||
126453033|NCT00717236|454959046|FG001|Open-Label Period|Adverse Event|4|||
126453034|NCT00717236|454959045|FG000|Open-Label Period|Lack of Efficacy|30|||
126704851|NCT01324830|455869916|FG003|Overall Study|Adverse Event, non-fatal|0|||
126704852|NCT01324830|455869917|FG004|Overall Study|Adverse Event, non-fatal|0|||
126704853|NCT01324830|455869918|FG005|Overall Study|Adverse Event, non-fatal|0|||
126704854|NCT01324830|455869919|FG006|Overall Study|Adverse Event, non-fatal|0|||
126704855|NCT01324830|455869920|FG007|Overall Study|Adverse Event, non-fatal|0|||
126704856|NCT01324830|455869921|FG008|Overall Study|Adverse Event, non-fatal|2|||
126704857|NCT01324830|455869922|FG009|Overall Study|Adverse Event, non-fatal|0|||
126704858|NCT01324830|455869923|FG010|Overall Study|Adverse Event, non-fatal|1|||
126704859|NCT01324830|455869924|FG011|Overall Study|Adverse Event, non-fatal|0|||
126704860|NCT01324830|455869925|FG012|Overall Study|Adverse Event, non-fatal|0|||
126704861|NCT01324830|455869926|FG013|Overall Study|Adverse Event, non-fatal|0|||
126704862|NCT01324830|455869927|FG014|Overall Study|Adverse Event, non-fatal|0|||
126704863|NCT01324830|455869928|FG015|Overall Study|Adverse Event, non-fatal|0|||
126704864|NCT01324830|455869929|FG016|Overall Study|Adverse Event, non-fatal|0|||
126704865|NCT01324830|455869930|FG017|Overall Study|Adverse Event, non-fatal|1|||
126704866|NCT01324830|455869931|FG018|Overall Study|Adverse Event, non-fatal|0|||
126704867|NCT01324830|455869913|FG000|Overall Study|Withdrawal by Subject|0|||
126704868|NCT01324830|455869914|FG001|Overall Study|Withdrawal by Subject|0|||
126704869|NCT01324830|455869915|FG002|Overall Study|Withdrawal by Subject|0|||
126704870|NCT01324830|455869916|FG003|Overall Study|Withdrawal by Subject|0|||
126704871|NCT01324830|455869917|FG004|Overall Study|Withdrawal by Subject|0|||
126704872|NCT01324830|455869918|FG005|Overall Study|Withdrawal by Subject|1|||
126704873|NCT01324830|455869919|FG006|Overall Study|Withdrawal by Subject|0|||
126704874|NCT01324830|455869920|FG007|Overall Study|Withdrawal by Subject|0|||
126704875|NCT01324830|455869921|FG008|Overall Study|Withdrawal by Subject|0|||
126704876|NCT01324830|455869922|FG009|Overall Study|Withdrawal by Subject|0|||
126704877|NCT01324830|455869923|FG010|Overall Study|Withdrawal by Subject|1|||
126704878|NCT01324830|455869924|FG011|Overall Study|Withdrawal by Subject|0|||
126704879|NCT01324830|455869925|FG012|Overall Study|Withdrawal by Subject|0|||
126704880|NCT01324830|455869926|FG013|Overall Study|Withdrawal by Subject|0|||
126704881|NCT01324830|455869927|FG014|Overall Study|Withdrawal by Subject|0|||
126704882|NCT01324830|455869928|FG015|Overall Study|Withdrawal by Subject|0|||
126704883|NCT01324830|455869929|FG016|Overall Study|Withdrawal by Subject|0|||
126704884|NCT01324830|455869930|FG017|Overall Study|Withdrawal by Subject|0|||
126704885|NCT01324830|455869931|FG018|Overall Study|Withdrawal by Subject|1|||
126704886|NCT01973283|455869932|FG000|Overall Study|Lost to Follow-up|4|||
126704887|NCT00942409|455869933|FG000|Overall Study|Lack of Efficacy|1|||
126704888|NCT00942409|455869933|FG000|Overall Study|study drug unavailable|2|||
126704889|NCT01503021|455869938|FG000|Overall Study|Adverse Event|7|||
126704890|NCT01503021|455869939|FG001|Overall Study|Adverse Event|6|||
126704891|NCT01503021|455869938|FG000|Overall Study|Death|0|||
126704892|NCT01503021|455869939|FG001|Overall Study|Death|2|||
126704893|NCT01503021|455869938|FG000|Overall Study|Lost to Follow-up|2|||
126704894|NCT01503021|455869939|FG001|Overall Study|Lost to Follow-up|0|||
126704895|NCT01503021|455869938|FG000|Overall Study|Physician Decision|3|||
126704896|NCT01503021|455869939|FG001|Overall Study|Physician Decision|0|||
126704897|NCT01503021|455869938|FG000|Overall Study|Protocol Violation|1|||
126704898|NCT01503021|455869939|FG001|Overall Study|Protocol Violation|3|||
126704899|NCT01503021|455869938|FG000|Overall Study|Withdrawal by Subject|9|||
126704900|NCT01503021|455869939|FG001|Overall Study|Withdrawal by Subject|8|||
126704901|NCT01503021|455869938|FG000|Overall Study|Moved, received transplant, etc.|5|||
126704902|NCT01503021|455869939|FG001|Overall Study|Moved, received transplant, etc.|7|||
126704903|NCT00817414|455869940|FG000|Overall Study|Adverse Event|1|||
126704904|NCT00817414|455869941|FG001|Overall Study|Adverse Event|1|||
126704905|NCT00817414|455869942|FG002|Overall Study|Adverse Event|1|||
126704906|NCT00817414|455869943|FG003|Overall Study|Adverse Event|0|||
126704907|NCT00817414|455869944|FG004|Overall Study|Adverse Event|0|||
126704908|NCT00817414|455869940|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
126704909|NCT00817414|455869941|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
126704910|NCT00817414|455869942|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
126704911|NCT00817414|455869943|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
126704912|NCT00817414|455869944|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
126704913|NCT00817414|455869940|FG000|Overall Study|Withdrawal by Subject|1|||
126704914|NCT00817414|455869941|FG001|Overall Study|Withdrawal by Subject|1|||
126704915|NCT00817414|455869942|FG002|Overall Study|Withdrawal by Subject|0|||
126704916|NCT00817414|455869943|FG003|Overall Study|Withdrawal by Subject|0|||
126704917|NCT00817414|455869944|FG004|Overall Study|Withdrawal by Subject|0|||
126704918|NCT00817414|455869940|FG000|Overall Study|Lost to Follow-up|0|||
126704919|NCT00817414|455869941|FG001|Overall Study|Lost to Follow-up|0|||
126704920|NCT00817414|455869942|FG002|Overall Study|Lost to Follow-up|1|||
126704921|NCT00817414|455869943|FG003|Overall Study|Lost to Follow-up|1|||
126704922|NCT00817414|455869944|FG004|Overall Study|Lost to Follow-up|1|||
126453035|NCT00717236|454959046|FG001|Open-Label Period|Lack of Efficacy|8|||
126453036|NCT00717236|454959045|FG000|Open-Label Period|Lost to Follow-up|28|||
126453037|NCT00717236|454959046|FG001|Open-Label Period|Lost to Follow-up|4|||
126453038|NCT00717236|454959045|FG000|Open-Label Period|Withdrawal by Subject|20|||
126453039|NCT00717236|454959046|FG001|Open-Label Period|Withdrawal by Subject|2|||
126453040|NCT00717236|454959045|FG000|Open-Label Period|Loss of Efficacy|6|||
126453041|NCT00717236|454959046|FG001|Open-Label Period|Loss of Efficacy|1|||
126453042|NCT00717236|454959045|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
126453043|NCT00717236|454959046|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
126453044|NCT00717236|454959045|FG000|Open-Label Period|Other: Lack of Compliance|1|||
126453045|NCT00717236|454959046|FG001|Open-Label Period|Other: Lack of Compliance|1|||
126453046|NCT00717236|454959045|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
126453047|NCT00717236|454959046|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
126453048|NCT00717236|454959045|FG000|Open-Label Period|Other: Moved|1|||
126453049|NCT00717236|454959046|FG001|Open-Label Period|Other: Moved|0|||
126453050|NCT00717236|454959045|FG000|Open-Label Period|Other: Investigator Decision|1|||
126453051|NCT00717236|454959046|FG001|Open-Label Period|Other: Investigator Decision|0|||
126453052|NCT00717236|454959045|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
126453053|NCT00717236|454959046|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
126453054|NCT00717236|454959045|FG000|Open-Label Period|Other: Sponsor Request|3|||
126453055|NCT00717236|454959046|FG001|Open-Label Period|Other: Sponsor Request|0|||
126453056|NCT00717236|454959045|FG000|Open-Label Period|Other: Cataract Surgery|1|||
126453057|NCT00717236|454959046|FG001|Open-Label Period|Other: Cataract Surgery|0|||
126453058|NCT00717236|454959045|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
126453059|NCT00717236|454959046|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
126453060|NCT00717236|454959045|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
126453061|NCT00717236|454959046|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
126453062|NCT00717236|454959045|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
126453063|NCT00717236|454959046|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
126453064|NCT00475982|454959047|FG000|Overall Study|surgery rescheduled|7|||
126453065|NCT00475982|454959048|FG001|Overall Study|surgery rescheduled|3|||
126453066|NCT00783198|454959053|FG000|Overall Study|Adverse Event|15|||
126453067|NCT00783198|454959054|FG001|Overall Study|Adverse Event|19|||
126453068|NCT00783198|454959055|FG002|Overall Study|Adverse Event|3|||
126453069|NCT00783198|454959053|FG000|Overall Study|Lost to Follow-up|11|||
126453070|NCT00783198|454959054|FG001|Overall Study|Lost to Follow-up|1|||
126453071|NCT00783198|454959055|FG002|Overall Study|Lost to Follow-up|7|||
126453072|NCT00783198|454959053|FG000|Overall Study|Withdrawal by Subject|22|||
126453073|NCT00783198|454959054|FG001|Overall Study|Withdrawal by Subject|14|||
126453074|NCT00783198|454959055|FG002|Overall Study|Withdrawal by Subject|20|||
126453075|NCT00783198|454959053|FG000|Overall Study|Noncompliance with protocol|7|||
126453076|NCT00783198|454959054|FG001|Overall Study|Noncompliance with protocol|7|||
126704923|NCT00817414|455869940|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
126704924|NCT00817414|455869941|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
126704925|NCT00817414|455869942|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
126704926|NCT00817414|455869943|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
126704927|NCT00817414|455869944|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
126704928|NCT00817414|455869940|FG000|Overall Study|Protocol Violation|0|||
126704929|NCT00817414|455869941|FG001|Overall Study|Protocol Violation|0|||
126704930|NCT00817414|455869942|FG002|Overall Study|Protocol Violation|0|||
126704931|NCT00817414|455869943|FG003|Overall Study|Protocol Violation|0|||
126704932|NCT00817414|455869944|FG004|Overall Study|Protocol Violation|1|||
126704933|NCT00097539|455869947|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
126704934|NCT00097539|455869948|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
126704935|NCT00097539|455869949|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
126704936|NCT00097539|455869950|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
126704937|NCT00097539|455869951|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
126704938|NCT00097539|455869952|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
126704939|NCT00097539|455869953|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
126704940|NCT00097539|455869947|FG000|Overall Study|Withdrawal by Subject|925|||
126704941|NCT00097539|455869948|FG001|Overall Study|Withdrawal by Subject|323|||
126704942|NCT00097539|455869949|FG002|Overall Study|Withdrawal by Subject|346|||
126704943|NCT00097539|455869950|FG003|Overall Study|Withdrawal by Subject|217|||
126704944|NCT00097539|455869951|FG004|Overall Study|Withdrawal by Subject|68|||
126704945|NCT00097539|455869952|FG005|Overall Study|Withdrawal by Subject|229|||
126453077|NCT00783198|454959055|FG002|Overall Study|Noncompliance with protocol|10|||
126453078|NCT00783198|454959053|FG000|Overall Study|Did not meet protocol eligibility|0|||
126453079|NCT00783198|454959054|FG001|Overall Study|Did not meet protocol eligibility|1|||
126453080|NCT00783198|454959055|FG002|Overall Study|Did not meet protocol eligibility|0|||
126453081|NCT00783198|454959053|FG000|Overall Study|Administrative|2|||
126453082|NCT00783198|454959054|FG001|Overall Study|Administrative|1|||
126453083|NCT00783198|454959055|FG002|Overall Study|Administrative|2|||
126453084|NCT04784442|454959056|FG000|Overall Study|Adverse Event|1|||
126547335|NCT02778399|455296201|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
126704946|NCT00097539|455869953|FG006|Overall Study|Withdrawal by Subject|3|||
126704947|NCT00097539|455869947|FG000|Overall Study|Participant Non-compliant|2140|||
126704948|NCT00097539|455869948|FG001|Overall Study|Participant Non-compliant|567|||
126704949|NCT00097539|455869949|FG002|Overall Study|Participant Non-compliant|1067|||
126704950|NCT00097539|455869950|FG003|Overall Study|Participant Non-compliant|353|||
126704951|NCT00097539|455869951|FG004|Overall Study|Participant Non-compliant|136|||
126704952|NCT00097539|455869952|FG005|Overall Study|Participant Non-compliant|543|||
126704953|NCT00097539|455869953|FG006|Overall Study|Participant Non-compliant|18|||
126704954|NCT00097539|455869947|FG000|Overall Study|Lack of Efficacy|249|||
126704955|NCT00097539|455869948|FG001|Overall Study|Lack of Efficacy|122|||
126704956|NCT00097539|455869949|FG002|Overall Study|Lack of Efficacy|202|||
126704957|NCT00097539|455869950|FG003|Overall Study|Lack of Efficacy|105|||
126704958|NCT00097539|455869951|FG004|Overall Study|Lack of Efficacy|45|||
126704959|NCT00097539|455869952|FG005|Overall Study|Lack of Efficacy|228|||
126704960|NCT00097539|455869953|FG006|Overall Study|Lack of Efficacy|5|||
126704961|NCT00097539|455869947|FG000|Overall Study|Adverse Event|78|||
126704962|NCT00097539|455869948|FG001|Overall Study|Adverse Event|133|||
126704963|NCT00097539|455869949|FG002|Overall Study|Adverse Event|37|||
126704964|NCT00097539|455869950|FG003|Overall Study|Adverse Event|27|||
126704965|NCT00097539|455869951|FG004|Overall Study|Adverse Event|30|||
126704966|NCT00097539|455869952|FG005|Overall Study|Adverse Event|59|||
126704967|NCT00097539|455869953|FG006|Overall Study|Adverse Event|1|||
126704968|NCT00097539|455869947|FG000|Overall Study|Death|2|||
126704969|NCT00097539|455869948|FG001|Overall Study|Death|7|||
126704970|NCT00097539|455869949|FG002|Overall Study|Death|0|||
126704971|NCT00097539|455869950|FG003|Overall Study|Death|0|||
126704972|NCT00097539|455869951|FG004|Overall Study|Death|1|||
126704973|NCT00097539|455869952|FG005|Overall Study|Death|3|||
126704974|NCT00097539|455869953|FG006|Overall Study|Death|0|||
126704975|NCT00097539|455869947|FG000|Overall Study|Reasons Other Than Above|3602|||
126704976|NCT00097539|455869948|FG001|Overall Study|Reasons Other Than Above|1382|||
126704977|NCT00097539|455869949|FG002|Overall Study|Reasons Other Than Above|1757|||
126704978|NCT00097539|455869950|FG003|Overall Study|Reasons Other Than Above|692|||
126704979|NCT00097539|455869951|FG004|Overall Study|Reasons Other Than Above|361|||
126704980|NCT00097539|455869952|FG005|Overall Study|Reasons Other Than Above|1244|||
126704981|NCT00097539|455869953|FG006|Overall Study|Reasons Other Than Above|34|||
126704982|NCT00097539|455869947|FG000|Overall Study|Reason not Specified|111|||
126704983|NCT00097539|455869948|FG001|Overall Study|Reason not Specified|49|||
126360453|NCT00147537|454610822|FG010|Phase 2|Withdrawal by Subject|4|||
126360454|NCT00147537|454610812|FG000|Phase 2|Randomized but not treated|0|||
126360455|NCT00147537|454610813|FG001|Phase 2|Randomized but not treated|0|||
126360456|NCT00147537|454610814|FG002|Phase 2|Randomized but not treated|0|||
126360457|NCT00147537|454610815|FG003|Phase 2|Randomized but not treated|0|||
126360458|NCT00147537|454610816|FG004|Phase 2|Randomized but not treated|0|||
126360459|NCT00147537|454610817|FG005|Phase 2|Randomized but not treated|0|||
126360460|NCT00147537|454610818|FG006|Phase 2|Randomized but not treated|0|||
126360461|NCT00147537|454610819|FG007|Phase 2|Randomized but not treated|0|||
126360462|NCT00147537|454610820|FG008|Phase 2|Randomized but not treated|0|||
126704984|NCT00097539|455869949|FG002|Overall Study|Reason not Specified|53|||
126704985|NCT00097539|455869950|FG003|Overall Study|Reason not Specified|21|||
126704986|NCT00097539|455869951|FG004|Overall Study|Reason not Specified|11|||
126704987|NCT00097539|455869952|FG005|Overall Study|Reason not Specified|40|||
126704988|NCT00097539|455869953|FG006|Overall Study|Reason not Specified|2|||
126704989|NCT02966314|455869954|FG000|Overall Study|Lost to Follow-up|1|||
126704990|NCT02966314|455869955|FG001|Overall Study|Lost to Follow-up|0|||
126704991|NCT03941548|455869957|FG000|Overall Study|Adverse Event|0|||
126704992|NCT03941548|455869958|FG001|Overall Study|Adverse Event|1|||
126704993|NCT03941548|455869957|FG000|Overall Study|Lost to Follow-up|0|||
126704994|NCT03941548|455869958|FG001|Overall Study|Lost to Follow-up|1|||
126704995|NCT03941548|455869957|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
126704996|NCT03941548|455869958|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
126704997|NCT02015819|455869961|FG000|Overall Study|Rickham catheter was misaligned|0|||
126704998|NCT02015819|455869962|FG001|Overall Study|Rickham catheter was misaligned|0|||
126360463|NCT00147537|454610821|FG009|Phase 2|Randomized but not treated|1|||
126360464|NCT00147537|454610822|FG010|Phase 2|Randomized but not treated|1|||
126360465|NCT02006654|454610824|FG000|Overall Study|Withdrawal before treatment|4|||
126360466|NCT02006654|454610825|FG001|Overall Study|Withdrawal before treatment|2|||
126360467|NCT02006654|454610824|FG000|Overall Study|Adverse Event|16|||
126704999|NCT02015819|455869963|FG002|Overall Study|Rickham catheter was misaligned|0|||
126705000|NCT02015819|455869964|FG003|Overall Study|Rickham catheter was misaligned|1|||
126705001|NCT02945657|455869965|FG000|Overall Study|Adverse Event|1|||
126705002|NCT02945657|455869965|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
126360468|NCT02006654|454610825|FG001|Overall Study|Adverse Event|17|||
126705003|NCT00811252|455869973|FG000|Overall Study|Adverse Event|6|||
126705004|NCT00811252|455869974|FG001|Overall Study|Adverse Event|10|||
126705005|NCT00811252|455869975|FG002|Overall Study|Adverse Event|15|||
126705006|NCT00811252|455869973|FG000|Overall Study|Lack of Efficacy|7|||
126705007|NCT00811252|455869974|FG001|Overall Study|Lack of Efficacy|2|||
126705008|NCT00811252|455869975|FG002|Overall Study|Lack of Efficacy|0|||
126705009|NCT00811252|455869973|FG000|Overall Study|Protocol Violation|3|||
126705010|NCT00811252|455869974|FG001|Overall Study|Protocol Violation|3|||
126705011|NCT00811252|455869975|FG002|Overall Study|Protocol Violation|2|||
126765432|NCT00057330|456094497|FG000|Overall Study|Death|1|||
126765433|NCT00057330|456094498|FG001|Overall Study|Death|0|||
126765434|NCT00057330|456094497|FG000|Overall Study|Protocol Violation|1|||
126765435|NCT00057330|456094498|FG001|Overall Study|Protocol Violation|1|||
126765436|NCT00057330|456094497|FG000|Overall Study|Withdrawal by Subject|115|||
126765437|NCT00057330|456094498|FG001|Overall Study|Withdrawal by Subject|84|||
126765438|NCT00057330|456094497|FG000|Overall Study|Lost to Follow-up|745|||
126765439|NCT00057330|456094498|FG001|Overall Study|Lost to Follow-up|617|||
126765440|NCT00057330|456094497|FG000|Overall Study|Physician Decision|1|||
126765441|NCT00057330|456094498|FG001|Overall Study|Physician Decision|0|||
126765442|NCT00057330|456094497|FG000|Overall Study|Other|260|||
126765443|NCT00057330|456094498|FG001|Overall Study|Other|206|||
126765444|NCT04633434|456094501|FG000|Overall Study|Lost to Follow-up|32|||
126765445|NCT04633434|456094502|FG001|Overall Study|Lost to Follow-up|32|||
126765446|NCT01605370|456094510|FG000|Overall Study|Adverse Event|1|||
126765447|NCT01605370|456094511|FG001|Overall Study|Adverse Event|0|||
126765448|NCT00585468|456094515|FG000|First Intervention|Withdrawal by Subject|1|||
126765449|NCT00585468|456094516|FG001|First Intervention|Withdrawal by Subject|1|||
126765450|NCT00943826|456094519|FG000|Concurrent Phase|Adverse Event|50|||
126547336|NCT02778399|455296202|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
126547337|NCT02778399|455296203|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
126547338|NCT03916744|455296204|FG000|Overall Study|Withdrawal by Subject|0|||
126547339|NCT03916744|455296205|FG001|Overall Study|Withdrawal by Subject|1|||
126547340|NCT03916744|455296206|FG002|Overall Study|Withdrawal by Subject|2|||
126547341|NCT03757234|455296207|FG000|Overall Study|Adverse Event|0|||
126547342|NCT03757234|455296208|FG001|Overall Study|Adverse Event|0|||
126547343|NCT03757234|455296209|FG002|Overall Study|Adverse Event|0|||
126705012|NCT00811252|455869973|FG000|Overall Study|Withdrawal of Consent|1|||
126705013|NCT00811252|455869974|FG001|Overall Study|Withdrawal of Consent|2|||
126705014|NCT00811252|455869975|FG002|Overall Study|Withdrawal of Consent|2|||
126705015|NCT00811252|455869973|FG000|Overall Study|Lost to Follow-up|0|||
126765451|NCT00943826|456094520|FG001|Concurrent Phase|Adverse Event|27|||
126765452|NCT00943826|456094519|FG000|Concurrent Phase|Withdrew consent|3|||
126765453|NCT00943826|456094520|FG001|Concurrent Phase|Withdrew consent|7|||
126765454|NCT00943826|456094519|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
126765455|NCT00943826|456094520|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
126765456|NCT00943826|456094519|FG000|Concurrent Phase|Administrative reasons|2|||
126765457|NCT00943826|456094520|FG001|Concurrent Phase|Administrative reasons|1|||
126765458|NCT00943826|456094519|FG000|Concurrent Phase|Protocol Violation|1|||
126765459|NCT00943826|456094520|FG001|Concurrent Phase|Protocol Violation|0|||
126765460|NCT00943826|456094519|FG000|Maintenance Phase|Adverse Event|31|||
126765461|NCT00943826|456094520|FG001|Maintenance Phase|Adverse Event|30|||
126705016|NCT00811252|455869974|FG001|Overall Study|Lost to Follow-up|0|||
126705017|NCT00811252|455869975|FG002|Overall Study|Lost to Follow-up|2|||
126705018|NCT00811252|455869973|FG000|Overall Study|Administrative or Other Reasons|0|||
126705019|NCT00811252|455869974|FG001|Overall Study|Administrative or Other Reasons|3|||
126765462|NCT00943826|456094519|FG000|Maintenance Phase|Withdrew consent|2|||
126765463|NCT00943826|456094520|FG001|Maintenance Phase|Withdrew consent|4|||
126765464|NCT00943826|456094519|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
126765465|NCT00943826|456094520|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
126765466|NCT00943826|456094519|FG000|Maintenance Phase|Administrative reasons|4|||
126765467|NCT00943826|456094520|FG001|Maintenance Phase|Administrative reasons|1|||
126765468|NCT00943826|456094519|FG000|Maintenance Phase|Failure to return|0|||
126765469|NCT00943826|456094520|FG001|Maintenance Phase|Failure to return|1|||
126765470|NCT00943826|456094519|FG000|Monotherapy Phase|Adverse Event|42|||
126765471|NCT00943826|456094520|FG001|Monotherapy Phase|Adverse Event|5|||
126266459|NCT01491035|454265216|FG007|Overall Study|Lost to Follow-up|0|||
126705020|NCT00811252|455869975|FG002|Overall Study|Administrative or Other Reasons|2|||
126765472|NCT00943826|456094519|FG000|Monotherapy Phase|Administrative reasons|11|||
126765473|NCT00943826|456094520|FG001|Monotherapy Phase|Administrative reasons|5|||
126765474|NCT00943826|456094519|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
126705021|NCT01486264|455869976|FG000|Overall Study|Death|1|||
126705022|NCT01486264|455869977|FG001|Overall Study|Death|1|||
126547344|NCT03757234|455296210|FG003|Overall Study|Adverse Event|0|||
126547345|NCT03757234|455296211|FG004|Overall Study|Adverse Event|1|||
126765475|NCT00943826|456094520|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
126765476|NCT00943826|456094519|FG000|Monotherapy Phase|Withdrew Consent|2|||
126765477|NCT00943826|456094520|FG001|Monotherapy Phase|Withdrew Consent|3|||
126765478|NCT00943826|456094519|FG000|Monotherapy Phase|Failure to return|2|||
126765479|NCT00943826|456094520|FG001|Monotherapy Phase|Failure to return|1|||
126765480|NCT00943826|456094519|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
126266460|NCT01277718|454265221|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
126266461|NCT01277718|454265222|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
126266462|NCT01277718|454265221|FG000|Period 2 - Second Intervention|Physician Decision|0|||
126266463|NCT01277718|454265222|FG001|Period 2 - Second Intervention|Physician Decision|2|||
126266464|NCT01524913|454265223|FG000|Overall Study|Lost to Follow-up|4|||
126266465|NCT01524913|454265224|FG001|Overall Study|Lost to Follow-up|0|||
126266466|NCT01524913|454265225|FG002|Overall Study|Lost to Follow-up|0|||
126266467|NCT03351231|454265239|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
126266468|NCT03351231|454265239|FG000|Combination Therapy Period|Disease progression|2|||
126266469|NCT03351231|454265239|FG000|Combination Therapy Period|Study drug toxicity|1|||
126266470|NCT03351231|454265239|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
126266471|NCT03351231|454265239|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
126266472|NCT03351231|454265239|FG000|Safety Follow-Up Period|Other reason|2|||
126266473|NCT02858726|454265240|FG000|Overall Study|Adverse Event|4|||
126266474|NCT02858726|454265241|FG001|Overall Study|Adverse Event|4|||
126705023|NCT01486264|455869976|FG000|Overall Study|Adverse Event|3|||
126705024|NCT01486264|455869977|FG001|Overall Study|Adverse Event|3|||
126705025|NCT01486264|455869976|FG000|Overall Study|Lack of Efficacy|6|||
126705026|NCT01486264|455869977|FG001|Overall Study|Lack of Efficacy|10|||
126765481|NCT00943826|456094520|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
126705027|NCT01486264|455869976|FG000|Overall Study|Withdrawal by Subject|7|||
126705028|NCT01486264|455869977|FG001|Overall Study|Withdrawal by Subject|18|||
126705029|NCT01486264|455869976|FG000|Overall Study|Physician Decision|1|||
126705030|NCT01486264|455869977|FG001|Overall Study|Physician Decision|1|||
126705031|NCT01486264|455869976|FG000|Overall Study|Protocol Violation|3|||
126705032|NCT01486264|455869977|FG001|Overall Study|Protocol Violation|0|||
126705033|NCT01486264|455869976|FG000|Overall Study|Lost to Follow-up|3|||
126705034|NCT01486264|455869977|FG001|Overall Study|Lost to Follow-up|2|||
126705035|NCT01486264|455869976|FG000|Overall Study|Other|5|||
126705036|NCT01486264|455869977|FG001|Overall Study|Other|11|||
126705037|NCT01486264|455869976|FG000|Overall Study|Not treated|0|||
126705038|NCT01486264|455869977|FG001|Overall Study|Not treated|1|||
126705039|NCT00813748|455869978|FG000|Skin Test Substudy|Physician Decision|0|||
126705040|NCT00813748|455869979|FG001|Skin Test Substudy|Physician Decision|1|||
126705041|NCT01931865|455869980|FG000|Overall Study|Lost to Follow-up|2|||
126705042|NCT01931865|455869980|FG000|Overall Study|Withdrawal by Subject|2|||
126705043|NCT03584009|455869985|FG000|Overall Study|Death|25|||
126705044|NCT03584009|455869986|FG001|Overall Study|Death|18|||
126705045|NCT03584009|455869985|FG000|Overall Study|Lost to Follow-up|0|||
126705046|NCT03584009|455869986|FG001|Overall Study|Lost to Follow-up|1|||
126705047|NCT03584009|455869985|FG000|Overall Study|Physician Decision|1|||
126705048|NCT03584009|455869986|FG001|Overall Study|Physician Decision|1|||
126705049|NCT03584009|455869985|FG000|Overall Study|Study Terminated by Sponsor|22|||
126705050|NCT03584009|455869986|FG001|Overall Study|Study Terminated by Sponsor|30|||
126705051|NCT03584009|455869985|FG000|Overall Study|Withdrawal by Subject|3|||
126705052|NCT03584009|455869986|FG001|Overall Study|Withdrawal by Subject|2|||
126705053|NCT00222105|455869987|FG000|Overall Study|Removed due to wrong diagnosis|1|||
126705054|NCT00222105|455869987|FG000|Overall Study|Withdrawal by Subject|1|||
126705055|NCT00222105|455869987|FG000|Overall Study|Adverse Event|8|||
126705056|NCT00222105|455869987|FG000|Overall Study|Treatment delays|2|||
126705057|NCT00222105|455869987|FG000|Overall Study|Death|2|||
126705058|NCT00824421|455870001|FG000|Overall Study|Adverse Event|6|||
126705059|NCT00824421|455870002|FG001|Overall Study|Adverse Event|6|||
126705060|NCT00824421|455870003|FG002|Overall Study|Adverse Event|6|||
126705061|NCT00824421|455870001|FG000|Overall Study|Death|0|||
126705062|NCT00824421|455870002|FG001|Overall Study|Death|1|||
126705063|NCT00824421|455870003|FG002|Overall Study|Death|0|||
126705064|NCT00824421|455870001|FG000|Overall Study|Lack of Efficacy|5|||
126705065|NCT00824421|455870002|FG001|Overall Study|Lack of Efficacy|7|||
126705066|NCT00824421|455870003|FG002|Overall Study|Lack of Efficacy|4|||
126705067|NCT00824421|455870001|FG000|Overall Study|Lost to Follow-up|2|||
126705068|NCT00824421|455870002|FG001|Overall Study|Lost to Follow-up|3|||
126705069|NCT00824421|455870003|FG002|Overall Study|Lost to Follow-up|0|||
126705070|NCT00824421|455870001|FG000|Overall Study|Pregnancy|1|||
126266475|NCT02858726|454265242|FG002|Overall Study|Adverse Event|9|||
126705071|NCT00824421|455870002|FG001|Overall Study|Pregnancy|0|||
126705072|NCT00824421|455870003|FG002|Overall Study|Pregnancy|1|||
126705073|NCT00824421|455870001|FG000|Overall Study|Withdrawal by Subject|2|||
126266476|NCT02858726|454265243|FG003|Overall Study|Adverse Event|1|||
126266477|NCT02858726|454265240|FG000|Overall Study|Physician Decision|0|||
126360469|NCT02006654|454610824|FG000|Overall Study|Death|1|||
126705074|NCT00824421|455870002|FG001|Overall Study|Withdrawal by Subject|3|||
126360470|NCT02006654|454610825|FG001|Overall Study|Death|0|||
126705075|NCT00824421|455870003|FG002|Overall Study|Withdrawal by Subject|3|||
126266478|NCT02858726|454265241|FG001|Overall Study|Physician Decision|0|||
126705076|NCT00824421|455870001|FG000|Overall Study|Randomized but not Treated|1|||
126705077|NCT00824421|455870002|FG001|Overall Study|Randomized but not Treated|1|||
126705078|NCT00824421|455870003|FG002|Overall Study|Randomized but not Treated|0|||
126705079|NCT00824421|455870001|FG000|Overall Study|Other|0|||
126266479|NCT02858726|454265242|FG002|Overall Study|Physician Decision|1|||
126266480|NCT02858726|454265243|FG003|Overall Study|Physician Decision|0|||
126266481|NCT02858726|454265240|FG000|Overall Study|Protocol Violation|0|||
126266482|NCT02858726|454265241|FG001|Overall Study|Protocol Violation|0|||
126266483|NCT02858726|454265242|FG002|Overall Study|Protocol Violation|0|||
126266484|NCT02858726|454265243|FG003|Overall Study|Protocol Violation|1|||
126266485|NCT02858726|454265240|FG000|Overall Study|Study Terminated by Sponsor|0|||
126266486|NCT02858726|454265241|FG001|Overall Study|Study Terminated by Sponsor|0|||
126266487|NCT02858726|454265242|FG002|Overall Study|Study Terminated by Sponsor|0|||
126266488|NCT02858726|454265243|FG003|Overall Study|Study Terminated by Sponsor|1|||
126266489|NCT02858726|454265240|FG000|Overall Study|Withdrawal by Subject|1|||
126266490|NCT02858726|454265241|FG001|Overall Study|Withdrawal by Subject|2|||
126266491|NCT02858726|454265242|FG002|Overall Study|Withdrawal by Subject|1|||
126266492|NCT02858726|454265243|FG003|Overall Study|Withdrawal by Subject|0|||
126266493|NCT02858726|454265240|FG000|Overall Study|Noncompliance|0|||
126266494|NCT02858726|454265241|FG001|Overall Study|Noncompliance|1|||
126266495|NCT02858726|454265242|FG002|Overall Study|Noncompliance|0|||
126266496|NCT02858726|454265243|FG003|Overall Study|Noncompliance|0|||
126266497|NCT00233987|454265248|FG000|Overall Study|Withdrawal by Subject|1|||
126266498|NCT00233987|454265248|FG000|Overall Study|Lack of Efficacy|2|||
126266499|NCT00233987|454265248|FG000|Overall Study|Reason Under Review|1|||
126266500|NCT00233987|454265248|FG000|Overall Study|Other - Not Protocol Specified|5|||
126266501|NCT00233987|454265248|FG000|Overall Study|Eligible but No Treatment Received|2|||
126266502|NCT00233987|454265248|FG000|Overall Study|Ineligible|4|||
126266503|NCT00518622|454265249|FG000|Overall Study|Lost to Follow-up|0|||
126266504|NCT00518622|454265250|FG001|Overall Study|Lost to Follow-up|0|||
126266505|NCT00518622|454265251|FG002|Overall Study|Lost to Follow-up|1|||
126266506|NCT00518622|454265252|FG003|Overall Study|Lost to Follow-up|0|||
126266507|NCT00518622|454265253|FG004|Overall Study|Lost to Follow-up|0|||
126266508|NCT00518622|454265254|FG005|Overall Study|Lost to Follow-up|0|||
126266509|NCT00518622|454265255|FG006|Overall Study|Lost to Follow-up|0|||
126266510|NCT00518622|454265256|FG007|Overall Study|Lost to Follow-up|0|||
126266511|NCT00518622|454265249|FG000|Overall Study|Study medication taken incorrectly|0|||
126266512|NCT00518622|454265250|FG001|Overall Study|Study medication taken incorrectly|1|||
126266513|NCT00518622|454265251|FG002|Overall Study|Study medication taken incorrectly|0|||
126266514|NCT00518622|454265252|FG003|Overall Study|Study medication taken incorrectly|0|||
126266515|NCT00518622|454265253|FG004|Overall Study|Study medication taken incorrectly|0|||
126266516|NCT00518622|454265254|FG005|Overall Study|Study medication taken incorrectly|0|||
126266517|NCT00518622|454265255|FG006|Overall Study|Study medication taken incorrectly|0|||
126266518|NCT00518622|454265256|FG007|Overall Study|Study medication taken incorrectly|0|||
126266519|NCT01688726|454265257|FG000|Overall Study|Adverse Event|1|||
126266520|NCT01688726|454265258|FG001|Overall Study|Adverse Event|0|||
126266521|NCT01688726|454265257|FG000|Overall Study|Relocated abroad|0|||
126266522|NCT01688726|454265258|FG001|Overall Study|Relocated abroad|1|||
126266523|NCT04920916|454267344|FG000|Phase IIa 60 Day Study|Death|2|||
126266524|NCT04920916|454267345|FG001|Phase IIa 60 Day Study|Death|5|||
126266525|NCT04920916|454267344|FG000|1 Year Follow up (Phone Call)|Death|1|||
126266526|NCT04920916|454267345|FG001|1 Year Follow up (Phone Call)|Death|3|||
126266527|NCT04920916|454267344|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
126266528|NCT04920916|454267345|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
126266529|NCT00973765|454267346|FG000|Overall Study|Lost to Follow-up|8|||
126266530|NCT00973765|454267347|FG001|Overall Study|Lost to Follow-up|14|||
126266531|NCT02011113|454267348|FG000|Overall Study|Adverse Event|4|||
126266532|NCT02011113|454267348|FG000|Overall Study|Disease Progression (DP)|16|||
126266533|NCT02011113|454267348|FG000|Overall Study|Death|1|||
126266534|NCT02011113|454267348|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
126705080|NCT00824421|455870002|FG001|Overall Study|Other|1|||
126705081|NCT00824421|455870003|FG002|Overall Study|Other|0|||
126705082|NCT02120417|455870005|FG000|Overall Study|Death|5|||
126705083|NCT02120417|455870006|FG001|Overall Study|Death|1|||
126705084|NCT02120417|455870005|FG000|Overall Study|Adverse Event|3|||
126705085|NCT02120417|455870006|FG001|Overall Study|Adverse Event|9|||
126705086|NCT02120417|455870005|FG000|Overall Study|Participant decision|4|||
126266535|NCT02011113|454267348|FG000|Overall Study|Investigator's judgement- DP|3|||
126266536|NCT02011113|454267348|FG000|Overall Study|Study terminated by sponsor|11|||
126266537|NCT01892657|454267351|FG000|Overall Study|Withdrawal by Subject|6|||
126266538|NCT01892657|454267351|FG000|Overall Study|Protocol Violation|12|||
126266539|NCT00468728|454267362|FG000|Treatment|criteria for mITT population|4|||
126266540|NCT00468728|454267363|FG001|Treatment|criteria for mITT population|11|||
126266541|NCT00468728|454267362|FG000|Follow-up|mITT failure|34|||
126266542|NCT00468728|454267363|FG001|Follow-up|mITT failure|31|||
126266543|NCT03251963|454267364|FG000|Overall Study|inappropriate Xa level timing|6|||
126266544|NCT03251963|454267365|FG001|Overall Study|inappropriate Xa level timing|3|||
126266545|NCT03251963|454267364|FG000|Overall Study|no peak Xa level drawn|2|||
126266546|NCT03251963|454267365|FG001|Overall Study|no peak Xa level drawn|0|||
126547346|NCT03757234|455296207|FG000|Overall Study|Lost to Follow-up|1|||
126705087|NCT02120417|455870006|FG001|Overall Study|Participant decision|4|||
126705088|NCT02120417|455870005|FG000|Overall Study|Disease progression|41|||
126705089|NCT02120417|455870006|FG001|Overall Study|Disease progression|45|||
126705090|NCT02120417|455870005|FG000|Overall Study|Noncompliance with study treatment|0|||
126705091|NCT02120417|455870006|FG001|Overall Study|Noncompliance with study treatment|2|||
126266547|NCT03251963|454267364|FG000|Overall Study|bled prior to Xa level|1|||
126266548|NCT03251963|454267365|FG001|Overall Study|bled prior to Xa level|2|||
126266549|NCT04505293|454267366|FG000|Overall Study|Lost to Follow-up|2|||
126266550|NCT04505293|454267366|FG000|Overall Study|Withdrawal by Subject|6|||
126266551|NCT04505293|454267366|FG000|Overall Study|CT scan unreadable|277|||
126266552|NCT02712333|454267369|FG000|First Period|Withdrawal by Subject|3|||
126266553|NCT02712333|454267370|FG001|First Period|Withdrawal by Subject|2|||
126266554|NCT03463993|454267371|FG000|Overall Study|Lost to Follow-up|7|||
126266555|NCT03463993|454267372|FG001|Overall Study|Lost to Follow-up|8|||
126266556|NCT03463993|454267371|FG000|Overall Study|Withdrawal by Subject|2|||
126266557|NCT03463993|454267372|FG001|Overall Study|Withdrawal by Subject|0|||
126266558|NCT03463993|454267371|FG000|Overall Study|Protocol Violation|4|||
126266559|NCT03463993|454267372|FG001|Overall Study|Protocol Violation|1|||
126266560|NCT03463993|454267371|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
126266561|NCT03463993|454267372|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
126266562|NCT03463993|454267371|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
126266563|NCT03463993|454267372|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
126266564|NCT01478828|454267373|FG000|Overall Study|Adverse Event|1|||
126266565|NCT00757848|454267388|FG000|Overall Study|Voluntary discontinuation|1|||
126266566|NCT00757848|454267389|FG001|Overall Study|Voluntary discontinuation|0|||
126266567|NCT00757848|454267388|FG000|Overall Study|Adverse Event|1|||
126266568|NCT00757848|454267389|FG001|Overall Study|Adverse Event|2|||
126266569|NCT00757848|454267388|FG000|Overall Study|Incorrect enrolment|1|||
126266570|NCT00757848|454267389|FG001|Overall Study|Incorrect enrolment|0|||
126266571|NCT03978091|454267392|FG000|Overall Study|Lost to Follow-up|0|||
126266572|NCT03978091|454267393|FG001|Overall Study|Lost to Follow-up|0|||
126266573|NCT03978091|454267394|FG002|Overall Study|Lost to Follow-up|1|||
126266574|NCT03978091|454267395|FG003|Overall Study|Lost to Follow-up|0|||
126266575|NCT03978091|454267396|FG004|Overall Study|Lost to Follow-up|0|||
126266576|NCT03978091|454267397|FG005|Overall Study|Lost to Follow-up|0|||
126266577|NCT03978091|454267392|FG000|Overall Study|Withdrawal by Subject|0|||
126266578|NCT03978091|454267393|FG001|Overall Study|Withdrawal by Subject|0|||
126266579|NCT03978091|454267394|FG002|Overall Study|Withdrawal by Subject|0|||
126266580|NCT03978091|454267395|FG003|Overall Study|Withdrawal by Subject|1|||
126266581|NCT03978091|454267396|FG004|Overall Study|Withdrawal by Subject|1|||
126266582|NCT03978091|454267397|FG005|Overall Study|Withdrawal by Subject|0|||
126266583|NCT02595008|454267402|FG000|Overall Study|Enrolled In Error|1|||
126266584|NCT02595008|454267403|FG001|Overall Study|Enrolled In Error|0|||
126266585|NCT03078582|454267406|FG000|Overall Study|Adverse Event|0|||
126266586|NCT03078582|454267407|FG001|Overall Study|Adverse Event|8|||
126266587|NCT01843348|454267410|FG000|Overall Study|Withdrawal by Subject|4|||
126266588|NCT01843348|454267411|FG001|Overall Study|Withdrawal by Subject|16|||
126266589|NCT01843348|454267412|FG002|Overall Study|Withdrawal by Subject|18|||
126266590|NCT01843348|454267410|FG000|Overall Study|Lost to Follow-up|5|||
126266591|NCT01843348|454267411|FG001|Overall Study|Lost to Follow-up|4|||
126266592|NCT01843348|454267412|FG002|Overall Study|Lost to Follow-up|2|||
126266593|NCT01843348|454267410|FG000|Overall Study|Death|5|||
126266594|NCT01843348|454267411|FG001|Overall Study|Death|3|||
126266595|NCT01843348|454267412|FG002|Overall Study|Death|4|||
126266596|NCT01843348|454267410|FG000|Overall Study|Graft loss/retransplantation|5|||
126266597|NCT01843348|454267411|FG001|Overall Study|Graft loss/retransplantation|8|||
126266598|NCT01843348|454267412|FG002|Overall Study|Graft loss/retransplantation|11|||
126266599|NCT01843348|454267410|FG000|Overall Study|Various reasons|4|||
126266600|NCT01843348|454267411|FG001|Overall Study|Various reasons|9|||
126266601|NCT01843348|454267412|FG002|Overall Study|Various reasons|6|||
126266602|NCT02039414|454267421|FG000|Overall Study|Delivered|1|||
126266603|NCT02039414|454267422|FG001|Overall Study|Delivered|1|||
126266604|NCT02039414|454267421|FG000|Overall Study|Lost to Follow-up|2|||
126266605|NCT02039414|454267422|FG001|Overall Study|Lost to Follow-up|0|||
126705092|NCT02120417|455870005|FG000|Overall Study|Physician Decision|2|||
126705093|NCT02120417|455870006|FG001|Overall Study|Physician Decision|3|||
126266606|NCT02039414|454267421|FG000|Overall Study|Protocol Violation|3|||
126266607|NCT02039414|454267422|FG001|Overall Study|Protocol Violation|1|||
126266608|NCT02972502|454267425|FG000|Overall Study|Lost to Follow-up|3|||
126266609|NCT02972502|454267426|FG001|Overall Study|Lost to Follow-up|1|||
126266610|NCT02972502|454267425|FG000|Overall Study|Withdrawal by Subject|1|||
126266611|NCT02972502|454267426|FG001|Overall Study|Withdrawal by Subject|1|||
126266612|NCT01347866|454267429|FG000|Overall Study|Death|0|||
126266613|NCT01347866|454267430|FG001|Overall Study|Death|0|||
126266614|NCT01347866|454267431|FG002|Overall Study|Death|0|||
126705094|NCT02120417|455870005|FG000|Overall Study|Other unspecified|5|||
126266615|NCT01347866|454267432|FG003|Overall Study|Death|1|||
126266616|NCT01347866|454267433|FG004|Overall Study|Death|2|||
126266617|NCT01347866|454267434|FG005|Overall Study|Death|2|||
126266618|NCT01347866|454267435|FG006|Overall Study|Death|1|||
126705095|NCT02120417|455870006|FG001|Overall Study|Other unspecified|4|||
126705096|NCT00927485|455870007|FG000|Overall Study|Adverse Event|4|||
126705097|NCT00927485|455870008|FG001|Overall Study|Adverse Event|2|||
126705098|NCT00927485|455870007|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
126705099|NCT00927485|455870008|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
126705100|NCT02604264|455870010|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
126705101|NCT02604264|455870011|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
126705102|NCT04885257|455870017|FG000|Overall Study|Withdrawal by Subject|1|||
126266619|NCT01347866|454267436|FG007|Overall Study|Death|0|||
126266620|NCT01347866|454267437|FG008|Overall Study|Death|4|||
126266621|NCT01347866|454267438|FG009|Overall Study|Death|1|||
126266622|NCT01347866|454267439|FG010|Overall Study|Death|3|||
126266623|NCT01347866|454267440|FG011|Overall Study|Death|1|||
126266624|NCT01347866|454267441|FG012|Overall Study|Death|2|||
126266625|NCT01347866|454267442|FG013|Overall Study|Death|0|||
126266626|NCT01347866|454267443|FG014|Overall Study|Death|0|||
126266627|NCT01347866|454267444|FG015|Overall Study|Death|1|||
126266628|NCT01347866|454267445|FG016|Overall Study|Death|0|||
126266629|NCT01347866|454267429|FG000|Overall Study|Lost to Follow-up|0|||
126266630|NCT01347866|454267430|FG001|Overall Study|Lost to Follow-up|0|||
126266631|NCT01347866|454267431|FG002|Overall Study|Lost to Follow-up|0|||
126266632|NCT01347866|454267432|FG003|Overall Study|Lost to Follow-up|0|||
126266633|NCT01347866|454267433|FG004|Overall Study|Lost to Follow-up|0|||
126266634|NCT01347866|454267434|FG005|Overall Study|Lost to Follow-up|0|||
126266635|NCT01347866|454267435|FG006|Overall Study|Lost to Follow-up|0|||
126266636|NCT01347866|454267436|FG007|Overall Study|Lost to Follow-up|1|||
126266637|NCT01347866|454267437|FG008|Overall Study|Lost to Follow-up|1|||
126266638|NCT01347866|454267438|FG009|Overall Study|Lost to Follow-up|0|||
126266639|NCT01347866|454267439|FG010|Overall Study|Lost to Follow-up|0|||
126266640|NCT01347866|454267440|FG011|Overall Study|Lost to Follow-up|0|||
126266641|NCT01347866|454267441|FG012|Overall Study|Lost to Follow-up|0|||
126266642|NCT01347866|454267442|FG013|Overall Study|Lost to Follow-up|0|||
126266643|NCT01347866|454267443|FG014|Overall Study|Lost to Follow-up|0|||
126266644|NCT01347866|454267444|FG015|Overall Study|Lost to Follow-up|0|||
126266645|NCT01347866|454267445|FG016|Overall Study|Lost to Follow-up|0|||
126266646|NCT01347866|454267429|FG000|Overall Study|Other|3|||
126266647|NCT01347866|454267430|FG001|Overall Study|Other|1|||
126266648|NCT01347866|454267431|FG002|Overall Study|Other|1|||
126266649|NCT01347866|454267432|FG003|Overall Study|Other|4|||
126266650|NCT01347866|454267433|FG004|Overall Study|Other|5|||
126266651|NCT01347866|454267434|FG005|Overall Study|Other|0|||
126266652|NCT01347866|454267435|FG006|Overall Study|Other|5|||
126266653|NCT01347866|454267436|FG007|Overall Study|Other|3|||
126266654|NCT01347866|454267437|FG008|Overall Study|Other|22|||
126266655|NCT01347866|454267438|FG009|Overall Study|Other|5|||
126266656|NCT01347866|454267439|FG010|Overall Study|Other|0|||
126266657|NCT01347866|454267440|FG011|Overall Study|Other|3|||
126266658|NCT01347866|454267441|FG012|Overall Study|Other|4|||
126266659|NCT01347866|454267442|FG013|Overall Study|Other|4|||
126266660|NCT01347866|454267443|FG014|Overall Study|Other|2|||
126266661|NCT01347866|454267444|FG015|Overall Study|Other|3|||
126266662|NCT01347866|454267445|FG016|Overall Study|Other|0|||
126266663|NCT01347866|454267429|FG000|Overall Study|Subject refused further follow-up|2|||
126266664|NCT01347866|454267430|FG001|Overall Study|Subject refused further follow-up|0|||
126765482|NCT00943826|456094519|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
126765483|NCT00943826|456094520|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
126765484|NCT00943826|456094519|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
126705103|NCT04885257|455870018|FG001|Overall Study|Withdrawal by Subject|0|||
126705104|NCT00256295|455870019|FG000|Overall Study|Withdrawal by Subject|3|||
126765485|NCT00943826|456094520|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
126705105|NCT00256295|455870019|FG000|Overall Study|Death|1|||
126705106|NCT01731002|455870029|FG000|Overall Study|Adverse Event|0|||
126765486|NCT00943826|456094519|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
126765487|NCT00943826|456094520|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
126765488|NCT00455923|456094525|FG000|Overall Study|Pregnancy|0|||
126266665|NCT01347866|454267431|FG002|Overall Study|Subject refused further follow-up|0|||
126705107|NCT01731002|455870030|FG001|Overall Study|Adverse Event|2|||
126705108|NCT01731002|455870031|FG002|Overall Study|Adverse Event|2|||
126765489|NCT00455923|456094526|FG001|Overall Study|Pregnancy|2|||
126266666|NCT01347866|454267432|FG003|Overall Study|Subject refused further follow-up|2|||
126266667|NCT01347866|454267433|FG004|Overall Study|Subject refused further follow-up|0|||
126266668|NCT01347866|454267434|FG005|Overall Study|Subject refused further follow-up|1|||
126266669|NCT01347866|454267435|FG006|Overall Study|Subject refused further follow-up|0|||
126266670|NCT01347866|454267436|FG007|Overall Study|Subject refused further follow-up|0|||
126705109|NCT01731002|455870029|FG000|Overall Study|Non-Compliant|0|||
126266671|NCT01347866|454267437|FG008|Overall Study|Subject refused further follow-up|4|||
126266672|NCT01347866|454267438|FG009|Overall Study|Subject refused further follow-up|1|||
126266673|NCT01347866|454267439|FG010|Overall Study|Subject refused further follow-up|0|||
126266674|NCT01347866|454267440|FG011|Overall Study|Subject refused further follow-up|0|||
126705110|NCT01731002|455870030|FG001|Overall Study|Non-Compliant|1|||
126705111|NCT01731002|455870031|FG002|Overall Study|Non-Compliant|0|||
126705112|NCT01731002|455870029|FG000|Overall Study|Lost to Follow-up|1|||
126705113|NCT01731002|455870030|FG001|Overall Study|Lost to Follow-up|0|||
126705114|NCT01731002|455870031|FG002|Overall Study|Lost to Follow-up|0|||
126705115|NCT01731002|455870029|FG000|Overall Study|Test Agent Discontinuation|0|||
126705116|NCT01731002|455870030|FG001|Overall Study|Test Agent Discontinuation|1|||
126705117|NCT01731002|455870031|FG002|Overall Study|Test Agent Discontinuation|0|||
126705118|NCT01731002|455870029|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
126705119|NCT01731002|455870030|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
126705120|NCT01731002|455870031|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
126705121|NCT01731002|455870029|FG000|Overall Study|Elevated IOP|1|||
126705122|NCT01731002|455870030|FG001|Overall Study|Elevated IOP|0|||
126705123|NCT01731002|455870031|FG002|Overall Study|Elevated IOP|0|||
126705124|NCT01731002|455870029|FG000|Overall Study|Inappropriate use of study medications|0|||
126705125|NCT01731002|455870030|FG001|Overall Study|Inappropriate use of study medications|0|||
126266675|NCT01347866|454267441|FG012|Overall Study|Subject refused further follow-up|1|||
126266676|NCT01347866|454267442|FG013|Overall Study|Subject refused further follow-up|3|||
126266677|NCT01347866|454267443|FG014|Overall Study|Subject refused further follow-up|1|||
126266678|NCT01347866|454267444|FG015|Overall Study|Subject refused further follow-up|0|||
126266679|NCT01347866|454267445|FG016|Overall Study|Subject refused further follow-up|2|||
126266680|NCT00430950|454267446|FG000|Overall Study|Adverse Event|7|||
126266681|NCT00430950|454267447|FG001|Overall Study|Adverse Event|6|||
126266682|NCT00430950|454267446|FG000|Overall Study|Withdrawal by Subject|1|||
126266683|NCT00430950|454267447|FG001|Overall Study|Withdrawal by Subject|0|||
126266684|NCT00430950|454267446|FG000|Overall Study|concomitant medication,etc.|5|||
126266685|NCT00430950|454267447|FG001|Overall Study|concomitant medication,etc.|7|||
126266686|NCT02429934|454267450|FG000|Overall Study|Withdrawal by Subject|0|||
126266687|NCT02429934|454267451|FG001|Overall Study|Withdrawal by Subject|2|||
126266688|NCT02429934|454267450|FG000|Overall Study|Adverse Event|2|||
126266689|NCT02429934|454267451|FG001|Overall Study|Adverse Event|0|||
126266690|NCT02429934|454267450|FG000|Overall Study|Lost to Follow-up|1|||
126266691|NCT02429934|454267451|FG001|Overall Study|Lost to Follow-up|1|||
126266692|NCT02429934|454267450|FG000|Overall Study|Physician Decision|1|||
126266693|NCT02429934|454267451|FG001|Overall Study|Physician Decision|0|||
126266694|NCT00869024|454267452|FG000|Overall Study|Death|2|||
126266695|NCT00869024|454267453|FG001|Overall Study|Death|3|||
126266696|NCT00869024|454267452|FG000|Overall Study|Lost to Follow-up|0|||
126266697|NCT00869024|454267453|FG001|Overall Study|Lost to Follow-up|1|||
126266698|NCT00869024|454267452|FG000|Overall Study|Protocol Violation|0|||
126266699|NCT00869024|454267453|FG001|Overall Study|Protocol Violation|1|||
126266700|NCT00831623|454267458|FG000|Overall Study|Withdrawal by Subject|9|||
126266701|NCT00831623|454267458|FG000|Overall Study|Lost to Follow-up|1|||
126266702|NCT00831623|454267458|FG000|Overall Study|Not 2 years post-treatment|12|||
126266703|NCT01564459|454267459|FG000|Run-In|Adverse Event|7|||
126266704|NCT01564459|454267460|FG001|Run-In|Adverse Event|0|||
126266705|NCT01564459|454267461|FG002|Run-In|Adverse Event|0|||
126266706|NCT01564459|454267459|FG000|Run-In|Lost to Follow-up|1|||
126266707|NCT01564459|454267460|FG001|Run-In|Lost to Follow-up|0|||
126266708|NCT01564459|454267461|FG002|Run-In|Lost to Follow-up|0|||
126266709|NCT01564459|454267459|FG000|Run-In|Non-compliance with study drug|2|||
126266710|NCT01564459|454267460|FG001|Run-In|Non-compliance with study drug|0|||
126266711|NCT01564459|454267461|FG002|Run-In|Non-compliance with study drug|0|||
126266712|NCT01564459|454267459|FG000|Run-In|Protocol Violation|1|||
126266713|NCT01564459|454267460|FG001|Run-In|Protocol Violation|0|||
126266714|NCT01564459|454267461|FG002|Run-In|Protocol Violation|0|||
126266715|NCT01564459|454267459|FG000|Run-In|Withdrawal by Subject|1|||
126266716|NCT01564459|454267460|FG001|Run-In|Withdrawal by Subject|0|||
126266717|NCT01564459|454267461|FG002|Run-In|Withdrawal by Subject|0|||
126266718|NCT01564459|454267459|FG000|Double-blind Treatment|Adverse Event|0|||
126360471|NCT02006654|454610824|FG000|Overall Study|Withdrawal by Subject|14|||
126705126|NCT01731002|455870031|FG002|Overall Study|Inappropriate use of study medications|1|||
126705127|NCT03542682|455870034|FG000|Overall Study|COVID-19 Protocol|0|||
126705128|NCT03542682|455870035|FG001|Overall Study|COVID-19 Protocol|1|||
126266719|NCT01564459|454267460|FG001|Double-blind Treatment|Adverse Event|0|||
126266720|NCT01564459|454267461|FG002|Double-blind Treatment|Adverse Event|1|||
126705129|NCT00853632|455871656|FG000|Overall Study|Death|88|||
126705130|NCT00853632|455871656|FG000|Overall Study|Withdrawal by Subject|45|||
126705131|NCT00853632|455871656|FG000|Overall Study|Lost to Follow-up|30|||
126705132|NCT00853632|455871656|FG000|Overall Study|Reoperation/Explant|17|||
126266721|NCT00706992|454267469|FG000|Overall Study|Study termination|5|||
126266722|NCT00706992|454267470|FG001|Overall Study|Study termination|5|||
126705133|NCT00853632|455871656|FG000|Overall Study|Exit with other reason|22|||
126705134|NCT00886821|455871662|FG000|Stage 2|Adverse Event|0|||
126705135|NCT00886821|455871663|FG001|Stage 2|Adverse Event|0|||
126705136|NCT00886821|455871664|FG002|Stage 2|Adverse Event|0|||
126705137|NCT00886821|455871665|FG003|Stage 2|Adverse Event|0|||
126705138|NCT00886821|455871666|FG004|Stage 2|Adverse Event|0|||
126705139|NCT00886821|455871667|FG005|Stage 2|Adverse Event|0|||
126266723|NCT00706992|454267471|FG002|Overall Study|Study termination|6|||
126266724|NCT00706992|454267472|FG003|Overall Study|Study termination|2|||
126266725|NCT00706992|454267473|FG004|Overall Study|Study termination|3|||
126266726|NCT00706992|454267474|FG005|Overall Study|Study termination|2|||
126266727|NCT00706992|454267475|FG006|Overall Study|Study termination|3|||
126266728|NCT00706992|454267469|FG000|Overall Study|Disease progression before treatment|0|||
126266729|NCT00706992|454267470|FG001|Overall Study|Disease progression before treatment|0|||
126266730|NCT00706992|454267471|FG002|Overall Study|Disease progression before treatment|0|||
126266731|NCT00706992|454267472|FG003|Overall Study|Disease progression before treatment|0|||
126266732|NCT00706992|454267473|FG004|Overall Study|Disease progression before treatment|1|||
126266733|NCT00706992|454267474|FG005|Overall Study|Disease progression before treatment|0|||
126266734|NCT00706992|454267475|FG006|Overall Study|Disease progression before treatment|0|||
126266735|NCT03545191|454267476|FG000|Overall Study|Death|1|||
126266736|NCT03545191|454267477|FG001|Overall Study|Death|0|||
126266737|NCT03545191|454267478|FG002|Overall Study|Death|0|||
126266738|NCT03545191|454267476|FG000|Overall Study|Adverse Event|4|||
126266739|NCT03545191|454267477|FG001|Overall Study|Adverse Event|2|||
126266740|NCT03545191|454267478|FG002|Overall Study|Adverse Event|7|||
126266741|NCT03545191|454267476|FG000|Overall Study|Other reasons|3|||
126266742|NCT03545191|454267477|FG001|Overall Study|Other reasons|11|||
126266743|NCT03545191|454267478|FG002|Overall Study|Other reasons|8|||
126266744|NCT03545191|454267476|FG000|Overall Study|Withdrawal by Subject|13|||
126266745|NCT03545191|454267477|FG001|Overall Study|Withdrawal by Subject|10|||
126266746|NCT03545191|454267478|FG002|Overall Study|Withdrawal by Subject|12|||
126266747|NCT03545191|454267476|FG000|Overall Study|Lost to Follow-up|1|||
126266748|NCT03545191|454267477|FG001|Overall Study|Lost to Follow-up|2|||
126266749|NCT03545191|454267478|FG002|Overall Study|Lost to Follow-up|3|||
126266750|NCT02377063|454267482|FG000|Overall Study|Non-compliance|5|||
126266751|NCT02746627|454267488|FG000|Overall Study|Withdrawal by Subject|1|||
126266752|NCT02746627|454267489|FG001|Overall Study|Withdrawal by Subject|1|||
126266753|NCT02746627|454267490|FG002|Overall Study|Withdrawal by Subject|1|||
126266754|NCT02340221|454267493|FG000|Overall Study|Death|100|||
126266755|NCT02340221|454267494|FG001|Overall Study|Death|197|||
126266756|NCT02340221|454267493|FG000|Overall Study|Withdrawal by Participant|24|||
126266757|NCT02340221|454267494|FG001|Overall Study|Withdrawal by Participant|37|||
126266758|NCT02340221|454267493|FG000|Overall Study|Lost to Follow-up|4|||
126266759|NCT02340221|454267494|FG001|Overall Study|Lost to Follow-up|15|||
126266760|NCT02340221|454267493|FG000|Overall Study|Reason Not Specified|85|||
126266761|NCT02340221|454267494|FG001|Overall Study|Reason Not Specified|165|||
126266762|NCT02340221|454267493|FG000|Overall Study|Study Terminated by Sponsor|1|||
126266763|NCT02340221|454267494|FG001|Overall Study|Study Terminated by Sponsor|3|||
126266764|NCT03499119|454267495|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
126266765|NCT03499119|454267496|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
126266766|NCT03499119|454267497|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
126266767|NCT03499119|454267498|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
126266768|NCT03499119|454267495|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
126266769|NCT03499119|454267496|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
126266770|NCT03499119|454267497|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
126266771|NCT03499119|454267498|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
126266772|NCT03499119|454267495|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
126266773|NCT03499119|454267496|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
126266774|NCT03499119|454267497|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
126266775|NCT03499119|454267498|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
126266776|NCT03499119|454267495|FG000|Optional Extension Phase|Lost to Follow-up|0|||
126266777|NCT03499119|454267496|FG001|Optional Extension Phase|Lost to Follow-up|0|||
126266778|NCT03499119|454267497|FG002|Optional Extension Phase|Lost to Follow-up|0|||
126266779|NCT03499119|454267498|FG003|Optional Extension Phase|Lost to Follow-up|1|||
126266780|NCT03499119|454267495|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
126266781|NCT03499119|454267496|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
126266782|NCT03499119|454267497|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
126266783|NCT03499119|454267498|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
126705140|NCT00886821|455871668|FG006|Stage 2|Adverse Event|0|||
126266784|NCT03499119|454267495|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
126266785|NCT03499119|454267496|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
126266786|NCT03499119|454267497|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
126266787|NCT03499119|454267498|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
126266788|NCT00588640|454267499|FG000|Overall Study|Physician Decision|1|||
126453085|NCT04784442|454959057|FG001|Overall Study|Adverse Event|0|||
126705141|NCT00886821|455871669|FG007|Stage 2|Adverse Event|0|||
126266789|NCT00588640|454267499|FG000|Overall Study|Ineligible Patient|1|||
126266790|NCT01481324|454267500|FG000|Overall Study|Missing Data|0|||
126266791|NCT01481324|454267501|FG001|Overall Study|Missing Data|2|||
126266792|NCT01481324|454267502|FG002|Overall Study|Missing Data|2|||
126266793|NCT01172821|454267503|FG000|Overall Study|Adverse Event|5|||
126705142|NCT00886821|455871670|FG008|Stage 2|Adverse Event|0|||
126453086|NCT04784442|454959058|FG002|Overall Study|Adverse Event|2|||
126453087|NCT04784442|454959059|FG003|Overall Study|Adverse Event|1|||
126453088|NCT04784442|454959056|FG000|Overall Study|Protocol Violation|1|||
126453089|NCT04784442|454959057|FG001|Overall Study|Protocol Violation|0|||
126453090|NCT04784442|454959058|FG002|Overall Study|Protocol Violation|0|||
126453091|NCT04784442|454959059|FG003|Overall Study|Protocol Violation|0|||
126266794|NCT01172821|454267504|FG001|Overall Study|Adverse Event|2|||
126266795|NCT01172821|454267505|FG002|Overall Study|Adverse Event|2|||
126266796|NCT01172821|454267506|FG003|Overall Study|Adverse Event|7|||
126266797|NCT01172821|454267503|FG000|Overall Study|Protocol Violation|0|||
126266798|NCT01172821|454267504|FG001|Overall Study|Protocol Violation|2|||
126266799|NCT01172821|454267505|FG002|Overall Study|Protocol Violation|1|||
126266800|NCT01172821|454267506|FG003|Overall Study|Protocol Violation|2|||
126266801|NCT01172821|454267503|FG000|Overall Study|Lost to Follow-up|4|||
126266802|NCT01172821|454267504|FG001|Overall Study|Lost to Follow-up|1|||
126266803|NCT01172821|454267505|FG002|Overall Study|Lost to Follow-up|2|||
126266804|NCT01172821|454267506|FG003|Overall Study|Lost to Follow-up|2|||
126266805|NCT01172821|454267503|FG000|Overall Study|Withdrawal by Subject|2|||
126266806|NCT01172821|454267504|FG001|Overall Study|Withdrawal by Subject|3|||
126266807|NCT01172821|454267505|FG002|Overall Study|Withdrawal by Subject|3|||
126266808|NCT01172821|454267506|FG003|Overall Study|Withdrawal by Subject|3|||
126266809|NCT01172821|454267503|FG000|Overall Study|Other|3|||
126266810|NCT01172821|454267504|FG001|Overall Study|Other|4|||
126266811|NCT01172821|454267505|FG002|Overall Study|Other|5|||
126266812|NCT01172821|454267506|FG003|Overall Study|Other|3|||
126266813|NCT00003138|454269210|FG000|Step 1|Reasons off treatment not documented|60|||
126266814|NCT00003138|454269211|FG001|Step 1|Reasons off treatment not documented|57|||
126266815|NCT00003138|454269210|FG000|Step 1|Never started treatment|1|||
126266816|NCT00003138|454269211|FG001|Step 1|Never started treatment|0|||
126266817|NCT00003138|454269210|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
126266818|NCT00003138|454269211|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
126266819|NCT00003138|454269210|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
126266820|NCT00003138|454269211|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
126266821|NCT00003138|454269210|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
126266822|NCT00003138|454269211|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
126266823|NCT00003138|454269210|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
126266824|NCT00003138|454269211|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
126266825|NCT04495283|454269213|FG000|Overall Study|Physician Decision|0|||
126266826|NCT04495283|454269214|FG001|Overall Study|Physician Decision|0|||
126266827|NCT04495283|454269215|FG002|Overall Study|Physician Decision|1|||
126266828|NCT04495283|454269213|FG000|Overall Study|Withdrawal by Subject|0|||
126266829|NCT04495283|454269214|FG001|Overall Study|Withdrawal by Subject|1|||
126266830|NCT04495283|454269215|FG002|Overall Study|Withdrawal by Subject|1|||
126266831|NCT04495283|454269213|FG000|Overall Study|Other|1|||
126266832|NCT04495283|454269214|FG001|Overall Study|Other|0|||
126266833|NCT04495283|454269215|FG002|Overall Study|Other|1|||
126266834|NCT05142566|454269218|FG000|Overall Study|Protocol Violation|1|||
126266835|NCT02246439|454269219|FG000|Overall Study|Adverse Event|3|||
126266836|NCT02246439|454269220|FG001|Overall Study|Adverse Event|0|||
126266837|NCT02246439|454269219|FG000|Overall Study|Lost to Follow-up|7|||
126266838|NCT02246439|454269220|FG001|Overall Study|Lost to Follow-up|5|||
126266839|NCT02246439|454269219|FG000|Overall Study|Protocol Violation|0|||
126266840|NCT02246439|454269220|FG001|Overall Study|Protocol Violation|2|||
126266841|NCT02246439|454269219|FG000|Overall Study|Physician Decision|0|||
126266842|NCT02246439|454269220|FG001|Overall Study|Physician Decision|1|||
126266843|NCT02246439|454269219|FG000|Overall Study|Unkonwn|1|||
126266844|NCT02246439|454269220|FG001|Overall Study|Unkonwn|3|||
126266845|NCT02246439|454269219|FG000|Overall Study|Withdrawal by Subject|1|||
126266846|NCT02246439|454269220|FG001|Overall Study|Withdrawal by Subject|0|||
126266847|NCT01553279|454269221|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
126266848|NCT01553279|454269222|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
126266849|NCT01553279|454269221|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
126266850|NCT01553279|454269222|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
126266851|NCT01553279|454269221|FG000|Interim Period|Withdrawal by Subject|2|||
126266852|NCT01553279|454269222|FG001|Interim Period|Withdrawal by Subject|2|||
126266853|NCT01553279|454269221|FG000|Interim Period|Lost to Follow-up|1|||
126266854|NCT01553279|454269222|FG001|Interim Period|Lost to Follow-up|0|||
126266855|NCT01553279|454269221|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
126266856|NCT01553279|454269222|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
126266857|NCT01553279|454269221|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
126266858|NCT01553279|454269222|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
126266859|NCT00380692|454269223|FG000|Study Period II - Double Blind|Adverse Event|1|||
126266860|NCT00380692|454269224|FG001|Study Period II - Double Blind|Adverse Event|0|||
126453092|NCT04784442|454959056|FG000|Overall Study|Non-compliance with study drug|1|||
126453093|NCT04784442|454959057|FG001|Overall Study|Non-compliance with study drug|0|||
126453094|NCT04784442|454959058|FG002|Overall Study|Non-compliance with study drug|0|||
126266861|NCT00380692|454269223|FG000|Study Period II - Double Blind|Protocol Violation|2|||
126266862|NCT00380692|454269224|FG001|Study Period II - Double Blind|Protocol Violation|2|||
126266863|NCT00380692|454269223|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
126266864|NCT00380692|454269224|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
126266865|NCT00380692|454269223|FG000|Study Period II - Double Blind|Physician Decision|0|||
126266866|NCT00380692|454269224|FG001|Study Period II - Double Blind|Physician Decision|1|||
126266867|NCT00380692|454269223|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
126266868|NCT00380692|454269224|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
126266869|NCT00380692|454269223|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
126266870|NCT00380692|454269224|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
126266871|NCT00380692|454269223|FG000|Study Period III - Open Label|Adverse Event|5|||
126266872|NCT00380692|454269224|FG001|Study Period III - Open Label|Adverse Event|3|||
126266873|NCT00380692|454269223|FG000|Study Period III - Open Label|Protocol Violation|0|||
126266874|NCT00380692|454269224|FG001|Study Period III - Open Label|Protocol Violation|0|||
126266875|NCT00380692|454269223|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
126266876|NCT00380692|454269224|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
126266877|NCT00380692|454269223|FG000|Study Period III - Open Label|Physician Decision|0|||
126266878|NCT00380692|454269224|FG001|Study Period III - Open Label|Physician Decision|3|||
126266879|NCT00380692|454269223|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
126266880|NCT00380692|454269224|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
126266881|NCT00380692|454269223|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
126266882|NCT00380692|454269224|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
126266883|NCT03955471|454269225|FG000|Overall Study|Death|22|||
126266884|NCT03955471|454269225|FG000|Overall Study|Lost to Follow-up|1|||
126266885|NCT03955471|454269225|FG000|Overall Study|Withdrawal by Subject|6|||
126266886|NCT03955471|454269225|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
126266887|NCT02177136|454269240|FG000|DB Phase|Withdrawal by Subject|2|||
126266888|NCT02177136|454269241|FG001|DB Phase|Withdrawal by Subject|0|||
126266889|NCT02177136|454269242|FG002|DB Phase|Withdrawal by Subject|0|||
126266890|NCT02177136|454269243|FG003|DB Phase|Withdrawal by Subject|0|||
126266891|NCT02177136|454269240|FG000|DB Phase|Discontinued Due to Pruritus|1|||
126266892|NCT02177136|454269241|FG001|DB Phase|Discontinued Due to Pruritus|3|||
126266893|NCT02177136|454269242|FG002|DB Phase|Discontinued Due to Pruritus|0|||
126266894|NCT02177136|454269243|FG003|DB Phase|Discontinued Due to Pruritus|0|||
126266895|NCT02177136|454269240|FG000|DB Phase|Adverse Event|3|||
126266896|NCT02177136|454269241|FG001|DB Phase|Adverse Event|2|||
126266897|NCT02177136|454269242|FG002|DB Phase|Adverse Event|3|||
126266898|NCT02177136|454269243|FG003|DB Phase|Adverse Event|0|||
126266899|NCT02177136|454269240|FG000|DB Phase|Protocol Violation|0|||
126266900|NCT02177136|454269241|FG001|DB Phase|Protocol Violation|0|||
126266901|NCT02177136|454269242|FG002|DB Phase|Protocol Violation|1|||
126266902|NCT02177136|454269243|FG003|DB Phase|Protocol Violation|0|||
126266903|NCT02177136|454269240|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
126266904|NCT02177136|454269241|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
126266905|NCT02177136|454269242|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
126266906|NCT02177136|454269243|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
126266907|NCT02177136|454269240|FG000|LTSE Phase|Withdrawal by Subject|0|||
126266908|NCT02177136|454269241|FG001|LTSE Phase|Withdrawal by Subject|0|||
126266909|NCT02177136|454269242|FG002|LTSE Phase|Withdrawal by Subject|0|||
126266910|NCT02177136|454269243|FG003|LTSE Phase|Withdrawal by Subject|6|||
126266911|NCT02177136|454269240|FG000|LTSE Phase|Adverse Event|0|||
126266912|NCT02177136|454269241|FG001|LTSE Phase|Adverse Event|0|||
126266913|NCT02177136|454269242|FG002|LTSE Phase|Adverse Event|0|||
126266914|NCT02177136|454269243|FG003|LTSE Phase|Adverse Event|10|||
126453095|NCT04784442|454959059|FG003|Overall Study|Non-compliance with study drug|0|||
126453096|NCT01590758|454959062|FG000|Overall Study|Withdrawal by Subject|0|||
126453097|NCT01590758|454959063|FG001|Overall Study|Withdrawal by Subject|3|||
126453098|NCT01590758|454959062|FG000|Overall Study|Physician Decision|1|||
126705143|NCT00886821|455871671|FG009|Stage 2|Adverse Event|0|||
126705144|NCT00886821|455871672|FG010|Stage 2|Adverse Event|0|||
126705145|NCT00886821|455871673|FG011|Stage 2|Adverse Event|1|||
126705146|NCT00886821|455871674|FG012|Stage 2|Adverse Event|3|||
126266915|NCT02177136|454269240|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
126266916|NCT02177136|454269241|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
126266917|NCT02177136|454269242|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
126266918|NCT02177136|454269243|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
126266919|NCT02177136|454269240|FG000|LTSE Phase|Physician Decision|0|||
126266920|NCT02177136|454269241|FG001|LTSE Phase|Physician Decision|0|||
126266921|NCT02177136|454269242|FG002|LTSE Phase|Physician Decision|0|||
126266922|NCT02177136|454269243|FG003|LTSE Phase|Physician Decision|2|||
126266923|NCT02177136|454269240|FG000|LTSE Phase|Lost to Follow-up|0|||
126266924|NCT02177136|454269241|FG001|LTSE Phase|Lost to Follow-up|0|||
126266925|NCT02177136|454269242|FG002|LTSE Phase|Lost to Follow-up|0|||
126266926|NCT02177136|454269243|FG003|LTSE Phase|Lost to Follow-up|1|||
126266927|NCT02177136|454269240|FG000|LTSE Phase|Participant Moved|0|||
126453099|NCT01590758|454959063|FG001|Overall Study|Physician Decision|2|||
126705147|NCT00886821|455871675|FG013|Stage 2|Adverse Event|0|||
126266928|NCT02177136|454269241|FG001|LTSE Phase|Participant Moved|0|||
126266929|NCT02177136|454269242|FG002|LTSE Phase|Participant Moved|0|||
126266930|NCT02177136|454269243|FG003|LTSE Phase|Participant Moved|1|||
126266931|NCT01386684|454269244|FG000|Overall Study|Lost to Follow-up|51|||
126266932|NCT01386684|454269244|FG000|Overall Study|Other|51|||
126266933|NCT01386684|454269244|FG000|Overall Study|Death|47|||
126266934|NCT01386684|454269244|FG000|Overall Study|Withdrawal of Consent|44|||
126266935|NCT01386684|454269244|FG000|Overall Study|Alternative Therapy Required|37|||
126266936|NCT01386684|454269244|FG000|Overall Study|Disease Progression|28|||
126266937|NCT01386684|454269244|FG000|Overall Study|Adverse Event|20|||
126266938|NCT01386684|454269244|FG000|Overall Study|Noncompliance|8|||
126266939|NCT01386684|454269244|FG000|Overall Study|Protocol Violation|4|||
126266940|NCT01386684|454269244|FG000|Overall Study|Missing|3|||
126266941|NCT01032018|454269245|FG000|Overall Study|Lost to Follow-up|6|||
126266942|NCT01032018|454269246|FG001|Overall Study|Lost to Follow-up|5|||
126266943|NCT01032018|454269245|FG000|Overall Study|Death|0|||
126266944|NCT01032018|454269246|FG001|Overall Study|Death|1|||
126266945|NCT03247517|454269253|FG000|Overall Study|Adverse Event|0|||
126266946|NCT03247517|454269254|FG001|Overall Study|Adverse Event|4|||
126266947|NCT03247517|454269255|FG002|Overall Study|Adverse Event|2|||
126266948|NCT03247517|454269253|FG000|Overall Study|Lost to Follow-up|2|||
126266949|NCT03247517|454269254|FG001|Overall Study|Lost to Follow-up|6|||
126266950|NCT03247517|454269255|FG002|Overall Study|Lost to Follow-up|4|||
126266951|NCT03247517|454269253|FG000|Overall Study|Consent withdrawn by caregiver|1|||
126266952|NCT03247517|454269254|FG001|Overall Study|Consent withdrawn by caregiver|4|||
126266953|NCT03247517|454269255|FG002|Overall Study|Consent withdrawn by caregiver|7|||
126266954|NCT03247517|454269253|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
126266955|NCT03247517|454269254|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
126266956|NCT03247517|454269255|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
126266957|NCT03247517|454269253|FG000|Overall Study|Protocol Violation|0|||
126266958|NCT03247517|454269254|FG001|Overall Study|Protocol Violation|2|||
126266959|NCT03247517|454269255|FG002|Overall Study|Protocol Violation|0|||
126266960|NCT03247517|454269253|FG000|Overall Study|Multiple reasons|3|||
126266961|NCT03247517|454269254|FG001|Overall Study|Multiple reasons|1|||
126266962|NCT03247517|454269255|FG002|Overall Study|Multiple reasons|0|||
126266963|NCT03265288|454269256|FG000|Overall Study|Adverse Event|0|||
126266964|NCT03265288|454269257|FG001|Overall Study|Adverse Event|1|||
126266965|NCT03265288|454269256|FG000|Overall Study|Withdrawal by Subject|13|||
126266966|NCT03265288|454269257|FG001|Overall Study|Withdrawal by Subject|5|||
126266967|NCT03265288|454269256|FG000|Overall Study|Drug Withdrawn|3|||
126266968|NCT03265288|454269257|FG001|Overall Study|Drug Withdrawn|3|||
126266969|NCT03265288|454269256|FG000|Overall Study|Any Other Reason|7|||
126266970|NCT03265288|454269257|FG001|Overall Study|Any Other Reason|3|||
126266971|NCT03197558|454269258|FG000|Overall Study|Tubes not placed|1|||
126266972|NCT02072148|454269269|FG000|Overall Study|withdrew prior to surgery|23|||
126266973|NCT02072148|454269270|FG001|Overall Study|withdrew prior to surgery|0|||
126266974|NCT02072148|454269271|FG002|Overall Study|withdrew prior to surgery|0|||
126266975|NCT02072148|454269269|FG000|Overall Study|Death|0|||
126266976|NCT02072148|454269270|FG001|Overall Study|Death|0|||
126266977|NCT02072148|454269271|FG002|Overall Study|Death|1|||
126266978|NCT02072148|454269269|FG000|Overall Study|Withdrawal by Subject|0|||
126266979|NCT02072148|454269270|FG001|Overall Study|Withdrawal by Subject|13|||
126266980|NCT02072148|454269271|FG002|Overall Study|Withdrawal by Subject|12|||
126266981|NCT00158756|454269277|FG000|Overall Study|Withdrawal by Subject|5|||
126266982|NCT00158756|454269278|FG001|Overall Study|Withdrawal by Subject|0|||
126266983|NCT00158756|454269279|FG002|Overall Study|Withdrawal by Subject|6|||
126360472|NCT02006654|454610825|FG001|Overall Study|Withdrawal by Subject|12|||
126360473|NCT02006654|454610824|FG000|Overall Study|Protocol Violation|5|||
126360474|NCT02006654|454610825|FG001|Overall Study|Protocol Violation|8|||
126360475|NCT02006654|454610824|FG000|Overall Study|Lost to Follow-up|1|||
126360476|NCT02006654|454610825|FG001|Overall Study|Lost to Follow-up|0|||
126360477|NCT02006654|454610824|FG000|Overall Study|patient's will|2|||
126360478|NCT02006654|454610825|FG001|Overall Study|patient's will|1|||
126360479|NCT02006654|454610824|FG000|Overall Study|insufficient compliance|1|||
126360480|NCT02006654|454610825|FG001|Overall Study|insufficient compliance|0|||
126266984|NCT00158756|454269280|FG003|Overall Study|Withdrawal by Subject|1|||
126266985|NCT00158756|454269281|FG004|Overall Study|Withdrawal by Subject|3|||
126266986|NCT00158756|454269277|FG000|Overall Study|Adverse Event|0|||
126266987|NCT00158756|454269278|FG001|Overall Study|Adverse Event|0|||
126266988|NCT00158756|454269279|FG002|Overall Study|Adverse Event|1|||
126266989|NCT00158756|454269280|FG003|Overall Study|Adverse Event|0|||
126266990|NCT00158756|454269281|FG004|Overall Study|Adverse Event|0|||
126266991|NCT00158756|454269277|FG000|Overall Study|Serious adverse event|0|||
126266992|NCT00158756|454269278|FG001|Overall Study|Serious adverse event|0|||
126266993|NCT00158756|454269279|FG002|Overall Study|Serious adverse event|1|||
126266994|NCT00158756|454269280|FG003|Overall Study|Serious adverse event|0|||
126266995|NCT00158756|454269281|FG004|Overall Study|Serious adverse event|0|||
126266996|NCT04132336|454269282|FG000|Overall Study|Investigator Decision|0|||
126360481|NCT02006654|454610824|FG000|Overall Study|worsening cognitive condition|0|||
126453100|NCT01590758|454959062|FG000|Overall Study|Lost to Follow-up|4|||
126453101|NCT01590758|454959063|FG001|Overall Study|Lost to Follow-up|2|||
126453102|NCT02756806|454959064|FG000|Overall Study|Study terminated early|5|||
126453103|NCT02717832|454959065|FG000|Overall Study|Inability to place IV|3|||
126453104|NCT00960570|454959068|FG000|21 Day Washout Period|Adverse Event|1|||
126266997|NCT04132336|454269283|FG001|Overall Study|Investigator Decision|1|||
126266998|NCT04132336|454269284|FG002|Overall Study|Investigator Decision|0|||
126266999|NCT04132336|454269285|FG003|Overall Study|Investigator Decision|0|||
126453105|NCT00960570|454959068|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
126453106|NCT00960570|454959068|FG000|1 Day Period Between Dosing|Adverse Event|2|||
126453107|NCT00960570|454959068|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
126453108|NCT01451437|454959069|FG000|Overall Study|Adverse Event|0|||
126453109|NCT01451437|454959070|FG001|Overall Study|Adverse Event|0|||
126453110|NCT01451437|454959071|FG002|Overall Study|Adverse Event|0|||
126453111|NCT01451437|454959072|FG003|Overall Study|Adverse Event|0|||
126453112|NCT01451437|454959073|FG004|Overall Study|Adverse Event|0|||
126453113|NCT01451437|454959074|FG005|Overall Study|Adverse Event|1|||
126453114|NCT01451437|454959075|FG006|Overall Study|Adverse Event|1|||
126547347|NCT03757234|455296208|FG001|Overall Study|Lost to Follow-up|0|||
126547348|NCT03757234|455296209|FG002|Overall Study|Lost to Follow-up|0|||
126267000|NCT04132336|454269286|FG004|Overall Study|Investigator Decision|0|||
126267001|NCT04132336|454269287|FG005|Overall Study|Investigator Decision|0|||
126267002|NCT04132336|454269288|FG006|Overall Study|Investigator Decision|0|||
126267003|NCT02528123|454269289|FG000|Overall Study|Lost to Follow-up|1|||
126267004|NCT01939496|454269291|FG000|Overall Study|Adverse Event|2|||
126267005|NCT01939496|454269292|FG001|Overall Study|Adverse Event|0|||
126267006|NCT01939496|454269293|FG002|Overall Study|Adverse Event|0|||
126267007|NCT01939496|454269291|FG000|Overall Study|Lost to Follow-up|1|||
126267008|NCT01939496|454269292|FG001|Overall Study|Lost to Follow-up|1|||
126267009|NCT01939496|454269293|FG002|Overall Study|Lost to Follow-up|0|||
126267010|NCT01939496|454269291|FG000|Overall Study|Physician Decision|1|||
126267011|NCT01939496|454269292|FG001|Overall Study|Physician Decision|0|||
126267012|NCT01939496|454269293|FG002|Overall Study|Physician Decision|0|||
126267013|NCT01939496|454269291|FG000|Overall Study|Protocol Violation|3|||
126267014|NCT01939496|454269292|FG001|Overall Study|Protocol Violation|0|||
126267015|NCT01939496|454269293|FG002|Overall Study|Protocol Violation|0|||
126267016|NCT01939496|454269291|FG000|Overall Study|Withdrawal by Subject|0|||
126267017|NCT01939496|454269292|FG001|Overall Study|Withdrawal by Subject|1|||
126267018|NCT01939496|454269293|FG002|Overall Study|Withdrawal by Subject|1|||
126267019|NCT01939496|454269291|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
126267020|NCT01939496|454269292|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
126267021|NCT01939496|454269293|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
126267022|NCT01939496|454269291|FG000|Overall Study|Other|2|||
126267023|NCT01939496|454269292|FG001|Overall Study|Other|0|||
126267024|NCT01939496|454269293|FG002|Overall Study|Other|1|||
126267025|NCT03052322|454269294|FG000|Overall Study|Other un-specified|1|||
126267026|NCT03052322|454269295|FG001|Overall Study|Other un-specified|2|||
126267027|NCT03052322|454269294|FG000|Overall Study|Withdrawal by Subject|10|||
126267028|NCT03052322|454269295|FG001|Overall Study|Withdrawal by Subject|9|||
126267029|NCT03052322|454269294|FG000|Overall Study|Death|0|||
126267030|NCT03052322|454269295|FG001|Overall Study|Death|2|||
126267031|NCT03052322|454269294|FG000|Overall Study|Lack of Efficacy|1|||
126267032|NCT03052322|454269295|FG001|Overall Study|Lack of Efficacy|2|||
126267033|NCT03052322|454269294|FG000|Overall Study|Protocol Violation|1|||
126267034|NCT03052322|454269295|FG001|Overall Study|Protocol Violation|0|||
126267035|NCT03052322|454269294|FG000|Overall Study|Lost to Follow-up|2|||
126267036|NCT03052322|454269295|FG001|Overall Study|Lost to Follow-up|4|||
126267037|NCT03052322|454269294|FG000|Overall Study|Adverse Event|6|||
126267038|NCT03052322|454269295|FG001|Overall Study|Adverse Event|13|||
126267039|NCT00136318|454269298|FG000|Overall Study|Adverse Event|5|||
126267040|NCT00136318|454269299|FG001|Overall Study|Adverse Event|5|||
126267041|NCT00136318|454269298|FG000|Overall Study|Withdrawal by Subject|2|||
126267042|NCT00136318|454269299|FG001|Overall Study|Withdrawal by Subject|2|||
126267043|NCT00775606|454269302|FG000|Overall Study|Study sponsor terminated funding|3|||
126267044|NCT00775606|454269303|FG001|Overall Study|Study sponsor terminated funding|0|||
126267045|NCT02278718|454269304|FG000|Overall Study|Adverse Event|1|||
126453115|NCT01451437|454959076|FG007|Overall Study|Adverse Event|2|||
126547349|NCT03757234|455296210|FG003|Overall Study|Lost to Follow-up|0|||
126267046|NCT02278718|454269305|FG001|Overall Study|Adverse Event|0|||
126267047|NCT02278718|454269304|FG000|Overall Study|Lost to Follow-up|2|||
126267048|NCT02278718|454269305|FG001|Overall Study|Lost to Follow-up|4|||
126267049|NCT02278718|454269304|FG000|Overall Study|Withdrawal by Subject|1|||
126267050|NCT02278718|454269305|FG001|Overall Study|Withdrawal by Subject|4|||
126267051|NCT02278718|454269304|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
126453116|NCT01451437|454959077|FG008|Overall Study|Adverse Event|1|||
126453117|NCT01451437|454959069|FG000|Overall Study|Physician Decision|1|||
126453118|NCT01451437|454959070|FG001|Overall Study|Physician Decision|1|||
126453119|NCT01451437|454959071|FG002|Overall Study|Physician Decision|2|||
126267052|NCT02278718|454269305|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
126267053|NCT02278718|454269304|FG000|Overall Study|Missing|0|||
126267054|NCT02278718|454269305|FG001|Overall Study|Missing|1|||
126267055|NCT01546649|454269306|FG000|Overall Study|Adverse Event|4|||
126267056|NCT01546649|454269307|FG001|Overall Study|Adverse Event|5|||
126267057|NCT01546649|454269306|FG000|Overall Study|Protocol Violation|1|||
126267058|NCT01546649|454269307|FG001|Overall Study|Protocol Violation|0|||
126267059|NCT01546649|454269306|FG000|Overall Study|Lack of Efficacy|1|||
126267060|NCT01546649|454269307|FG001|Overall Study|Lack of Efficacy|0|||
126267061|NCT01546649|454269306|FG000|Overall Study|Recurrence|1|||
126267062|NCT01546649|454269307|FG001|Overall Study|Recurrence|1|||
126267063|NCT01546649|454269306|FG000|Overall Study|Discovery of secondary cancer|0|||
126267064|NCT01546649|454269307|FG001|Overall Study|Discovery of secondary cancer|1|||
126267065|NCT01546649|454269306|FG000|Overall Study|Withdrawal by Subject|1|||
126267066|NCT01546649|454269307|FG001|Overall Study|Withdrawal by Subject|2|||
126267067|NCT04440449|454269308|FG000|Overall Study|Lost to Follow-up|2|||
126267068|NCT04440449|454269309|FG001|Overall Study|Lost to Follow-up|0|||
126267069|NCT03212794|454269310|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
126267070|NCT03212794|454269311|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
126267071|NCT03212794|454269310|FG000|Overall Study|Lost to Follow-up|5|||
126267072|NCT03212794|454269311|FG001|Overall Study|Lost to Follow-up|6|||
126267073|NCT03212794|454269310|FG000|Overall Study|Incarcerated; unable to participate|2|||
126267074|NCT03212794|454269311|FG001|Overall Study|Incarcerated; unable to participate|0|||
126267075|NCT03212794|454269310|FG000|Overall Study|Withdrawal by Subject|1|||
126267076|NCT03212794|454269311|FG001|Overall Study|Withdrawal by Subject|0|||
126267077|NCT03212794|454269310|FG000|Overall Study|Death|0|||
126267078|NCT03212794|454269311|FG001|Overall Study|Death|1|||
126267079|NCT03212794|454269310|FG000|Overall Study|Found to be ineligible after allocation|0|||
126267080|NCT03212794|454269311|FG001|Overall Study|Found to be ineligible after allocation|1|||
126267081|NCT03212794|454269310|FG000|Overall Study|Relocated out of area|2|||
126267082|NCT03212794|454269311|FG001|Overall Study|Relocated out of area|0|||
126267083|NCT01763918|454269312|FG000|Overall Study|Withdrawal by Subject|2|||
126267084|NCT01763918|454269313|FG001|Overall Study|Withdrawal by Subject|1|||
126267085|NCT01763918|454269314|FG002|Overall Study|Withdrawal by Subject|1|||
126267086|NCT01763918|454269315|FG003|Overall Study|Withdrawal by Subject|2|||
126267087|NCT01763918|454269312|FG000|Overall Study|Sponsor Decision|4|||
126267088|NCT01763918|454269313|FG001|Overall Study|Sponsor Decision|0|||
126267089|NCT01763918|454269314|FG002|Overall Study|Sponsor Decision|9|||
126267090|NCT01763918|454269315|FG003|Overall Study|Sponsor Decision|0|||
126267091|NCT03395639|454269316|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
126267092|NCT03395639|454269317|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
126267093|NCT03395639|454269318|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
126267094|NCT03395639|454269316|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
126267095|NCT03395639|454269317|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
126267096|NCT03395639|454269318|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
126267097|NCT03395639|454269316|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
126267098|NCT03395639|454269317|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
126267099|NCT03395639|454269318|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
126267100|NCT03395639|454269316|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
126267101|NCT03395639|454269317|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
126267102|NCT03395639|454269318|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
126267103|NCT03395639|454269316|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
126267104|NCT03395639|454269317|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
126267105|NCT03395639|454269318|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
126267106|NCT00942331|454269319|FG000|Overall Study|Did not start treatment|15|||
126267107|NCT00942331|454269320|FG001|Overall Study|Did not start treatment|22|||
126267108|NCT00597116|454269323|FG000|Overall Study|Adverse Event|2|||
126267109|NCT00597116|454269324|FG001|Overall Study|Adverse Event|1|||
126267110|NCT00597116|454269323|FG000|Overall Study|Withdrawal by Subject|0|||
126267111|NCT00597116|454269324|FG001|Overall Study|Withdrawal by Subject|2|||
126267112|NCT00597116|454269323|FG000|Overall Study|Physician Decision|0|||
126267113|NCT00597116|454269324|FG001|Overall Study|Physician Decision|1|||
126267114|NCT00597116|454269323|FG000|Overall Study|Death|0|||
126267115|NCT00597116|454269324|FG001|Overall Study|Death|1|||
126267116|NCT00597116|454269323|FG000|Overall Study|Lost to Follow-up|1|||
126267117|NCT00597116|454269324|FG001|Overall Study|Lost to Follow-up|0|||
126267118|NCT00597116|454269323|FG000|Overall Study|Progressive disease|11|||
126267119|NCT00597116|454269324|FG001|Overall Study|Progressive disease|6|||
126267120|NCT03832738|454269326|FG000|Overall Study|Withdrawal by Subject|6|||
126267121|NCT03832738|454269327|FG001|Overall Study|Withdrawal by Subject|7|||
126267122|NCT03832738|454269328|FG002|Overall Study|Withdrawal by Subject|16|||
126267123|NCT03832738|454269326|FG000|Overall Study|Physician Decision|0|||
126267124|NCT03832738|454269327|FG001|Overall Study|Physician Decision|1|||
126267125|NCT03832738|454269328|FG002|Overall Study|Physician Decision|2|||
126267126|NCT03832738|454269326|FG000|Overall Study|Adverse Event|2|||
126267127|NCT03832738|454269327|FG001|Overall Study|Adverse Event|3|||
126267128|NCT03832738|454269328|FG002|Overall Study|Adverse Event|1|||
126267129|NCT03832738|454269326|FG000|Overall Study|Pregnancy|0|||
126267130|NCT03832738|454269327|FG001|Overall Study|Pregnancy|1|||
126267131|NCT03832738|454269328|FG002|Overall Study|Pregnancy|0|||
126267132|NCT03977701|454269329|FG000|Overall Study|COVID-19 pandemic|0|||
126267133|NCT03977701|454269330|FG001|Overall Study|COVID-19 pandemic|0|||
126267134|NCT03977701|454269331|FG002|Overall Study|COVID-19 pandemic|0|||
126267135|NCT03977701|454269332|FG003|Overall Study|COVID-19 pandemic|0|||
126267136|NCT03977701|454269333|FG004|Overall Study|COVID-19 pandemic|0|||
126267137|NCT03977701|454269334|FG005|Overall Study|COVID-19 pandemic|1|||
126267138|NCT03977701|454269335|FG006|Overall Study|COVID-19 pandemic|0|||
126453120|NCT01451437|454959072|FG003|Overall Study|Physician Decision|0|||
126453121|NCT01451437|454959073|FG004|Overall Study|Physician Decision|0|||
126453122|NCT01451437|454959074|FG005|Overall Study|Physician Decision|0|||
126453123|NCT01451437|454959075|FG006|Overall Study|Physician Decision|0|||
126453124|NCT01451437|454959076|FG007|Overall Study|Physician Decision|0|||
126453125|NCT01451437|454959077|FG008|Overall Study|Physician Decision|0|||
126453126|NCT01451437|454959069|FG000|Overall Study|Disease Progression|0|||
126453127|NCT01451437|454959070|FG001|Overall Study|Disease Progression|0|||
126453128|NCT01451437|454959071|FG002|Overall Study|Disease Progression|1|||
126453129|NCT01451437|454959072|FG003|Overall Study|Disease Progression|1|||
126453130|NCT01451437|454959073|FG004|Overall Study|Disease Progression|3|||
126453131|NCT01451437|454959074|FG005|Overall Study|Disease Progression|2|||
126453132|NCT01451437|454959075|FG006|Overall Study|Disease Progression|3|||
126453133|NCT01451437|454959076|FG007|Overall Study|Disease Progression|1|||
126453134|NCT01451437|454959077|FG008|Overall Study|Disease Progression|3|||
126453135|NCT01451437|454959069|FG000|Overall Study|Protocol Violation|0|||
126453136|NCT01451437|454959070|FG001|Overall Study|Protocol Violation|0|||
126453137|NCT01451437|454959071|FG002|Overall Study|Protocol Violation|0|||
126453138|NCT01451437|454959072|FG003|Overall Study|Protocol Violation|0|||
126453139|NCT01451437|454959073|FG004|Overall Study|Protocol Violation|0|||
126453140|NCT01451437|454959074|FG005|Overall Study|Protocol Violation|0|||
126453141|NCT01451437|454959075|FG006|Overall Study|Protocol Violation|1|||
126453142|NCT01451437|454959076|FG007|Overall Study|Protocol Violation|0|||
126453143|NCT01451437|454959077|FG008|Overall Study|Protocol Violation|0|||
126453144|NCT01451437|454959069|FG000|Overall Study|Withdrawal by Subject|0|||
126453145|NCT01451437|454959070|FG001|Overall Study|Withdrawal by Subject|0|||
126453146|NCT01451437|454959071|FG002|Overall Study|Withdrawal by Subject|0|||
126453147|NCT01451437|454959072|FG003|Overall Study|Withdrawal by Subject|0|||
126453148|NCT01451437|454959073|FG004|Overall Study|Withdrawal by Subject|1|||
126453149|NCT01451437|454959074|FG005|Overall Study|Withdrawal by Subject|0|||
126453150|NCT01451437|454959075|FG006|Overall Study|Withdrawal by Subject|1|||
126453151|NCT01451437|454959076|FG007|Overall Study|Withdrawal by Subject|0|||
126453152|NCT01451437|454959077|FG008|Overall Study|Withdrawal by Subject|0|||
126453153|NCT03472547|454959083|FG000|Overall Study|Withdrawal by Subject|30|||
126453154|NCT04236141|454961343|FG000|Overall Study|Death|18|||
126453155|NCT04236141|454961344|FG001|Overall Study|Death|10|||
126453156|NCT04236141|454961343|FG000|Overall Study|Withdrawal by Participant|1|||
126453157|NCT04236141|454961344|FG001|Overall Study|Withdrawal by Participant|0|||
126453158|NCT04236141|454961343|FG000|Overall Study|Reason not Specified|1|||
126453159|NCT04236141|454961344|FG001|Overall Study|Reason not Specified|0|||
126453160|NCT04236141|454961343|FG000|Overall Study|Study terminated by Sponsor|8|||
126453161|NCT04236141|454961344|FG001|Overall Study|Study terminated by Sponsor|4|||
126453162|NCT01948193|454961345|FG000|Overall Study|Serious event|2|||
126453163|NCT01948193|454961345|FG000|Overall Study|Lost to Follow-up|7|||
126453164|NCT01954927|454961346|FG000|Overall Study|Withdrawal by Subject|3|||
126453165|NCT01954927|454961347|FG001|Overall Study|Withdrawal by Subject|1|||
126453166|NCT03320824|454961348|FG000|Overall Study|Withdrawal by Subject|8|||
126267139|NCT03977701|454269336|FG007|Overall Study|COVID-19 pandemic|1|||
126267140|NCT03977701|454269337|FG008|Overall Study|COVID-19 pandemic|0|||
126453167|NCT03320824|454961349|FG001|Overall Study|Withdrawal by Subject|1|||
126453168|NCT03320824|454961348|FG000|Overall Study|Lost to Follow-up|10|||
126267141|NCT03977701|454269338|FG009|Overall Study|COVID-19 pandemic|0|||
126267142|NCT00702208|454269339|FG000|Overall Study|Lost to Follow-up|28|||
126267143|NCT00702208|454269339|FG000|Overall Study|Did not self-lavage|1|||
126453169|NCT03320824|454961349|FG001|Overall Study|Lost to Follow-up|1|||
126453170|NCT03320824|454961348|FG000|Overall Study|moved out of state|0|||
126453171|NCT03320824|454961349|FG001|Overall Study|moved out of state|1|||
126453172|NCT03320824|454961348|FG000|Overall Study|could not complete final visit|0|||
126453173|NCT03320824|454961349|FG001|Overall Study|could not complete final visit|1|||
126453174|NCT00955305|454961350|FG000|Overall Study|Disease progression|39|||
126453175|NCT00955305|454961351|FG001|Overall Study|Disease progression|41|||
126453176|NCT00955305|454961350|FG000|Overall Study|Adverse Event|22|||
126453177|NCT00955305|454961351|FG001|Overall Study|Adverse Event|22|||
126453178|NCT00955305|454961350|FG000|Overall Study|Death|2|||
126453179|NCT00955305|454961351|FG001|Overall Study|Death|1|||
126765490|NCT00455923|456094525|FG000|Overall Study|Other|3|||
126765491|NCT00455923|456094526|FG001|Overall Study|Other|1|||
126765492|NCT02279888|456094530|FG000|Overall Study|Death|326|||
126765493|NCT02279888|456094530|FG000|Overall Study|Withdrawal by Subject|38|||
126765494|NCT02279888|456094530|FG000|Overall Study|Lost to Follow-up|21|||
126765495|NCT02279888|456094530|FG000|Overall Study|Physician Decision|62|||
126765496|NCT02279888|456094530|FG000|Overall Study|Subject Non-compliance|43|||
126765497|NCT02279888|456094530|FG000|Overall Study|Not implanted|14|||
126765498|NCT02279888|456094530|FG000|Overall Study|Visit not performed|26|||
126765499|NCT02335411|456094531|FG000|Overall Study|Death|223|||
126765500|NCT02335411|456094532|FG001|Overall Study|Death|22|||
126765501|NCT02335411|456094533|FG002|Overall Study|Death|26|||
126765502|NCT02335411|456094531|FG000|Overall Study|Physician Decision|3|||
126765503|NCT02335411|456094532|FG001|Overall Study|Physician Decision|0|||
126765504|NCT02335411|456094533|FG002|Overall Study|Physician Decision|0|||
126765505|NCT02335411|456094531|FG000|Overall Study|Protocol Violation|1|||
126765506|NCT02335411|456094532|FG001|Overall Study|Protocol Violation|0|||
126453180|NCT00955305|454961350|FG000|Overall Study|Withdrawal by Subject|5|||
126453181|NCT00955305|454961351|FG001|Overall Study|Withdrawal by Subject|4|||
126453182|NCT00955305|454961350|FG000|Overall Study|Alternative therapy|4|||
126453183|NCT00955305|454961351|FG001|Overall Study|Alternative therapy|0|||
126453184|NCT00955305|454961350|FG000|Overall Study|Other complicating disease|2|||
126453185|NCT00955305|454961351|FG001|Overall Study|Other complicating disease|4|||
126453186|NCT00955305|454961350|FG000|Overall Study|Physician Decision|1|||
126453187|NCT00955305|454961351|FG001|Overall Study|Physician Decision|0|||
126453188|NCT00955305|454961350|FG000|Overall Study|Continued presence of residual disease|0|||
126453189|NCT00955305|454961351|FG001|Overall Study|Continued presence of residual disease|1|||
126453190|NCT00955305|454961350|FG000|Overall Study|Functional decline|2|||
126453191|NCT00955305|454961351|FG001|Overall Study|Functional decline|0|||
126453192|NCT00955305|454961350|FG000|Overall Study|Maximum response achieved|0|||
126453193|NCT00955305|454961351|FG001|Overall Study|Maximum response achieved|1|||
126453194|NCT00955305|454961350|FG000|Overall Study|Lost to Follow-up|0|||
126453195|NCT00955305|454961351|FG001|Overall Study|Lost to Follow-up|1|||
126453196|NCT00955305|454961350|FG000|Overall Study|No off-treatment reason submitted|1|||
126453197|NCT00955305|454961351|FG001|Overall Study|No off-treatment reason submitted|0|||
126453198|NCT00955305|454961350|FG000|Overall Study|Never started protocol treatment|5|||
126453199|NCT00955305|454961351|FG001|Overall Study|Never started protocol treatment|5|||
126453200|NCT00955305|454961350|FG000|Overall Study|Ineligible|5|||
126453201|NCT00955305|454961351|FG001|Overall Study|Ineligible|7|||
126267144|NCT00702208|454269339|FG000|Overall Study|Unsatisfactory colposcopy|2|||
126267145|NCT02220725|454269340|FG000|Overall Study|Lost to Follow-up|0|||
126267146|NCT02220725|454269341|FG001|Overall Study|Lost to Follow-up|0|||
126267147|NCT02220725|454269342|FG002|Overall Study|Lost to Follow-up|0|||
126267148|NCT02220725|454269343|FG003|Overall Study|Lost to Follow-up|1|||
126267149|NCT02220725|454269340|FG000|Overall Study|Withdrawal by Subject|0|||
126267150|NCT02220725|454269341|FG001|Overall Study|Withdrawal by Subject|0|||
126267151|NCT02220725|454269342|FG002|Overall Study|Withdrawal by Subject|0|||
126267152|NCT02220725|454269343|FG003|Overall Study|Withdrawal by Subject|1|||
126267153|NCT03487848|454269344|FG000|Overall Study|Lost to Follow-up|1|||
126267154|NCT00731549|454269345|FG000|Overall Study|Lost to Follow-up|19|||
126267155|NCT00731549|454269345|FG000|Overall Study|Met withdrawal criteria|24|||
126267156|NCT00731549|454269345|FG000|Overall Study|Physician Decision|16|||
126267157|NCT00731549|454269345|FG000|Overall Study|Withdrawal by Subject|89|||
126267158|NCT00731549|454269345|FG000|Overall Study|Protocol deviation|1|||
126267159|NCT00731549|454269345|FG000|Overall Study|Adverse Event|31|||
126267160|NCT00731549|454269345|FG000|Overall Study|Lack of efficacy with AE|37|||
126267161|NCT00731549|454269345|FG000|Overall Study|Lack of efficacy without AE|6|||
126267162|NCT01393730|454269346|FG000|Overall Study|Withdrawal by Subject|3|||
126453202|NCT03387111|454961352|FG000|Overall Study|Progressive Disease|3|||
126267163|NCT01393730|454269346|FG000|Overall Study|Other|2|||
126453203|NCT03387111|454961352|FG000|Overall Study|Other|1|||
126547350|NCT03757234|455296211|FG004|Overall Study|Lost to Follow-up|1|||
126547351|NCT03757234|455296207|FG000|Overall Study|Withdrawal by Subject|1|||
126765507|NCT02335411|456094533|FG002|Overall Study|Protocol Violation|0|||
126765508|NCT02335411|456094531|FG000|Overall Study|Withdrawal by Subject|11|||
126267164|NCT01393730|454269346|FG000|Overall Study|Adverse Event|1|||
126267165|NCT00103402|454269347|FG000|Overall Study|Adverse Event|3|||
126267166|NCT00103402|454269348|FG001|Overall Study|Adverse Event|4|||
126267167|NCT00103402|454269347|FG000|Overall Study|Lost to Follow-up|8|||
126267168|NCT00103402|454269348|FG001|Overall Study|Lost to Follow-up|7|||
126267169|NCT00103402|454269347|FG000|Overall Study|Dissatisfied/No longer interested|6|||
126453204|NCT03254108|454961356|FG000|Overall Study|Adverse Event|0|||
126453205|NCT03254108|454961357|FG001|Overall Study|Adverse Event|2|||
126453206|NCT03254108|454961358|FG002|Overall Study|Adverse Event|0|||
126453207|NCT03254108|454961359|FG003|Overall Study|Adverse Event|1|||
126453208|NCT03254108|454961360|FG004|Overall Study|Adverse Event|1|||
126547352|NCT03757234|455296208|FG001|Overall Study|Withdrawal by Subject|1|||
126765509|NCT02335411|456094532|FG001|Overall Study|Withdrawal by Subject|0|||
126765510|NCT02335411|456094533|FG002|Overall Study|Withdrawal by Subject|3|||
126360482|NCT02006654|454610825|FG001|Overall Study|worsening cognitive condition|1|||
126360483|NCT02006654|454610824|FG000|Overall Study|faecal incontinence|0|||
126360484|NCT02006654|454610825|FG001|Overall Study|faecal incontinence|1|||
126360485|NCT02006654|454610824|FG000|Overall Study|mood disorder|0|||
126360486|NCT02006654|454610825|FG001|Overall Study|mood disorder|1|||
126360487|NCT02006654|454610824|FG000|Overall Study|disallowed medication|1|||
126360488|NCT02006654|454610825|FG001|Overall Study|disallowed medication|0|||
126360489|NCT02006654|454610824|FG000|Overall Study|moving out of state|0|||
126360490|NCT02006654|454610825|FG001|Overall Study|moving out of state|1|||
126360491|NCT00478140|454610826|FG000|Overall Study|Clinical Disease Progression|1|||
126360492|NCT00676689|454610829|FG000|Overall Study|Screen Failure|2|||
126360493|NCT00676689|454610829|FG000|Overall Study|Death|2|||
126360494|NCT00676689|454610829|FG000|Overall Study|Lost to Follow-up|4|||
126360495|NCT00676689|454610829|FG000|Overall Study|Physician Decision|1|||
126360496|NCT00676689|454610829|FG000|Overall Study|Withdrawal by Subject|3|||
126453209|NCT03254108|454961356|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
126453210|NCT03254108|454961357|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
126453211|NCT03254108|454961358|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
126453212|NCT03254108|454961359|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
126453213|NCT03254108|454961360|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
126705148|NCT00886821|455871662|FG000|Stage 2|Lost to Follow-up|0|||
126705149|NCT00886821|455871663|FG001|Stage 2|Lost to Follow-up|0|||
126705150|NCT00886821|455871664|FG002|Stage 2|Lost to Follow-up|0|||
126705151|NCT00886821|455871665|FG003|Stage 2|Lost to Follow-up|0|||
126705152|NCT00886821|455871666|FG004|Stage 2|Lost to Follow-up|0|||
126705153|NCT00886821|455871667|FG005|Stage 2|Lost to Follow-up|0|||
126705154|NCT00886821|455871668|FG006|Stage 2|Lost to Follow-up|0|||
126705155|NCT00886821|455871669|FG007|Stage 2|Lost to Follow-up|0|||
126705156|NCT00886821|455871670|FG008|Stage 2|Lost to Follow-up|0|||
126705157|NCT00886821|455871671|FG009|Stage 2|Lost to Follow-up|0|||
126705158|NCT00886821|455871672|FG010|Stage 2|Lost to Follow-up|0|||
126705159|NCT00886821|455871673|FG011|Stage 2|Lost to Follow-up|0|||
126705160|NCT00886821|455871674|FG012|Stage 2|Lost to Follow-up|2|||
126705161|NCT00886821|455871675|FG013|Stage 2|Lost to Follow-up|1|||
126705162|NCT00914628|455871676|FG000|Overall Study|Death|35|||
126705163|NCT00914628|455871677|FG001|Overall Study|Death|17|||
126705164|NCT00914628|455871676|FG000|Overall Study|Medical decision|4|||
126705165|NCT00914628|455871677|FG001|Overall Study|Medical decision|0|||
126705166|NCT00914628|455871676|FG000|Overall Study|Protocol Violation|1|||
126705167|NCT00914628|455871677|FG001|Overall Study|Protocol Violation|0|||
126705168|NCT00914628|455871676|FG000|Overall Study|Lack of Efficacy|1|||
126705169|NCT00914628|455871677|FG001|Overall Study|Lack of Efficacy|0|||
126705170|NCT00914628|455871676|FG000|Overall Study|non-randomized|1|||
126705171|NCT00914628|455871677|FG001|Overall Study|non-randomized|0|||
126705172|NCT00914628|455871676|FG000|Overall Study|Relapse|1|||
126705173|NCT00914628|455871677|FG001|Overall Study|Relapse|2|||
126705174|NCT00914628|455871676|FG000|Overall Study|Study terminated by Sponsor|14|||
126705175|NCT00914628|455871677|FG001|Overall Study|Study terminated by Sponsor|8|||
126705176|NCT00914628|455871676|FG000|Overall Study|Patients who did not receive a single dose|7|||
126705177|NCT00914628|455871677|FG001|Overall Study|Patients who did not receive a single dose|1|||
126705178|NCT03404960|455871678|FG000|Overall Study|Adverse Event|0|||
126705179|NCT03404960|455871679|FG001|Overall Study|Adverse Event|2|||
126705180|NCT03404960|455871678|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
126705181|NCT03404960|455871679|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
126705182|NCT03404960|455871678|FG000|Overall Study|Bowel obstruction|0|||
126705183|NCT03404960|455871679|FG001|Overall Study|Bowel obstruction|1|||
126705184|NCT03404960|455871678|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
126705185|NCT03404960|455871679|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
126705186|NCT03311126|455871680|FG000|Induction|Death|1|||
126705187|NCT03311126|455871680|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
126705188|NCT00469079|455871681|FG000|Overall Study|Lack of Efficacy|3|||
126705189|NCT00469079|455871682|FG001|Overall Study|Lack of Efficacy|8|||
126705190|NCT00469079|455871683|FG002|Overall Study|Lack of Efficacy|5|||
126360497|NCT00676689|454610829|FG000|Overall Study|Continuing FU|49|||
126453214|NCT00490529|454961368|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
126453215|NCT00490529|454961368|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
126360498|NCT03438656|454610830|FG000|Overall Study|Lost to Follow-up|2|||
126547353|NCT03757234|455296209|FG002|Overall Study|Withdrawal by Subject|0|||
126705191|NCT00469079|455871681|FG000|Overall Study|Adverse Event|1|||
126705192|NCT00469079|455871682|FG001|Overall Study|Adverse Event|3|||
126705193|NCT00469079|455871683|FG002|Overall Study|Adverse Event|2|||
126705194|NCT00469079|455871681|FG000|Overall Study|Lost to Follow-up|4|||
126705195|NCT00469079|455871682|FG001|Overall Study|Lost to Follow-up|8|||
126705196|NCT00469079|455871683|FG002|Overall Study|Lost to Follow-up|10|||
126705197|NCT00469079|455871681|FG000|Overall Study|Withdrawal by Subject|1|||
126705198|NCT00469079|455871682|FG001|Overall Study|Withdrawal by Subject|2|||
126705199|NCT00469079|455871683|FG002|Overall Study|Withdrawal by Subject|2|||
126267170|NCT00103402|454269348|FG001|Overall Study|Dissatisfied/No longer interested|6|||
126267171|NCT00103402|454269347|FG000|Overall Study|Personal constraints/Other|5|||
126267172|NCT00103402|454269348|FG001|Overall Study|Personal constraints/Other|0|||
126267173|NCT02333487|454269349|FG000|Overall Study|Adverse Event|0|||
126267174|NCT02333487|454269350|FG001|Overall Study|Adverse Event|2|||
126267175|NCT02333487|454269351|FG002|Overall Study|Adverse Event|0|||
126267176|NCT01583218|454269353|FG000|Overall Study|Withdrawal by Subject|43|||
126267177|NCT01583218|454269354|FG001|Overall Study|Withdrawal by Subject|29|||
126267178|NCT01583218|454269353|FG000|Overall Study|Death|206|||
126267179|NCT01583218|454269354|FG001|Overall Study|Death|211|||
126267180|NCT01583218|454269353|FG000|Overall Study|Lost to Follow-up|11|||
126267181|NCT01583218|454269354|FG001|Overall Study|Lost to Follow-up|17|||
126267182|NCT01583218|454269353|FG000|Overall Study|Adverse event or serious adverse event|3|||
126267183|NCT01583218|454269354|FG001|Overall Study|Adverse event or serious adverse event|3|||
126267184|NCT01583218|454269353|FG000|Overall Study|Patient /Family decision|3|||
126267185|NCT01583218|454269354|FG001|Overall Study|Patient /Family decision|0|||
126267186|NCT01583218|454269353|FG000|Overall Study|Cannot contact patient directly|1|||
126267187|NCT01583218|454269354|FG001|Overall Study|Cannot contact patient directly|2|||
126267188|NCT01583218|454269353|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
126267189|NCT01583218|454269354|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
126267190|NCT01583218|454269353|FG000|Overall Study|Patient did not wish to attend visits|0|||
126267191|NCT01583218|454269354|FG001|Overall Study|Patient did not wish to attend visits|1|||
126267192|NCT01583218|454269353|FG000|Overall Study|Patient randomized but not dosed|17|||
126267193|NCT01583218|454269354|FG001|Overall Study|Patient randomized but not dosed|16|||
126267194|NCT01583218|454269353|FG000|Overall Study|Patient was assessed via phone in person|1|||
126267195|NCT01583218|454269354|FG001|Overall Study|Patient was assessed via phone in person|0|||
126267196|NCT01583218|454269353|FG000|Overall Study|Patient deemed ineligible after random|2|||
126267197|NCT01583218|454269354|FG001|Overall Study|Patient deemed ineligible after random|0|||
126267198|NCT01583218|454269353|FG000|Overall Study|Patient was early terminated from study|0|||
126267199|NCT01583218|454269354|FG001|Overall Study|Patient was early terminated from study|1|||
126267200|NCT01583218|454269353|FG000|Overall Study|Patient was randomized due to mistake|1|||
126267201|NCT01583218|454269354|FG001|Overall Study|Patient was randomized due to mistake|0|||
126267202|NCT01583218|454269353|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
126267203|NCT01583218|454269354|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
126267204|NCT01583218|454269353|FG000|Overall Study|Withdraw of consent on day of random|1|||
126267205|NCT01583218|454269354|FG001|Overall Study|Withdraw of consent on day of random|0|||
126267206|NCT00712985|454269357|FG000|Overall Study|1 withdrew prior to start of drug|1|||
126267207|NCT00712985|454269357|FG000|Overall Study|1 patient moved out of state|1|||
126267208|NCT00712985|454269357|FG000|Overall Study|Lack of Efficacy|3|||
126267209|NCT01299805|454269360|FG000|Overall Study|Adverse Event|2|||
126267210|NCT01299805|454269361|FG001|Overall Study|Adverse Event|0|||
126267211|NCT00123955|454269365|FG000|Overall Study|Adverse Event|1|||
126267212|NCT00123955|454269366|FG001|Overall Study|Adverse Event|0|||
126267213|NCT00123955|454269365|FG000|Overall Study|Withdrawal by Subject|4|||
126267214|NCT00123955|454269366|FG001|Overall Study|Withdrawal by Subject|3|||
126267215|NCT00123955|454269365|FG000|Overall Study|Death|0|||
126267216|NCT00123955|454269366|FG001|Overall Study|Death|1|||
126267217|NCT03334721|454269367|FG000|Overall Study|Withdrawal by Subject|1|||
126267218|NCT03334721|454269368|FG001|Overall Study|Withdrawal by Subject|0|||
126267219|NCT03334721|454269367|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
126267220|NCT03334721|454269368|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
126267221|NCT01663727|454269370|FG000|Overall Study|Death|161|||
126267222|NCT01663727|454269371|FG001|Overall Study|Death|155|||
126267223|NCT01663727|454269370|FG000|Overall Study|Lost to Follow-up|10|||
126267224|NCT01663727|454269371|FG001|Overall Study|Lost to Follow-up|8|||
126267225|NCT01663727|454269370|FG000|Overall Study|Withdrawal by Subject|18|||
126267226|NCT01663727|454269371|FG001|Overall Study|Withdrawal by Subject|25|||
126360499|NCT00563316|454610833|FG000|Overall Study|Adverse Event|2|||
126360500|NCT00563316|454610833|FG000|Overall Study|Physician Decision|1|||
126360501|NCT00563316|454610833|FG000|Overall Study|Lost to Follow-up|2|||
126360502|NCT00563316|454610833|FG000|Overall Study|Death|1|||
126360503|NCT00563316|454610833|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
126360504|NCT00563316|454610833|FG000|Overall Study|Other|1|||
126360505|NCT04401293|454610839|FG000|Overall Study|Withdrawal by Subject|1|||
126360506|NCT04401293|454610840|FG001|Overall Study|Withdrawal by Subject|3|||
126360507|NCT00694161|454610841|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
126360508|NCT00694161|454610841|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
126360509|NCT00694161|454610841|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
126360510|NCT03111732|454610842|FG000|Overall Study|Enrolled in different study|1|||
126360511|NCT03111732|454610842|FG000|Overall Study|Progressive disease|3|||
126360512|NCT03111732|454610842|FG000|Overall Study|Withdrawal by Subject|1|||
126360513|NCT01108055|454610843|FG000|Overall Study|Ineligible|11|||
126360514|NCT01108055|454610843|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
126705200|NCT00469079|455871681|FG000|Overall Study|Ineligible|0|||
126453216|NCT00490529|454961368|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
126267227|NCT01663727|454269370|FG000|Overall Study|Study Terminated|51|||
126267228|NCT01663727|454269371|FG001|Overall Study|Study Terminated|50|||
126267229|NCT01663727|454269370|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
126267230|NCT01663727|454269371|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
126267231|NCT01663727|454269370|FG000|Overall Study|Withdrawal prior to dosing.|1|||
126267232|NCT01663727|454269371|FG001|Overall Study|Withdrawal prior to dosing.|0|||
126267233|NCT04969861|454269373|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
126267234|NCT04969861|454269374|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
126267235|NCT04718194|454270843|FG000|Overall Study|Withdrawal by Subject|3|||
126267236|NCT04718194|454270844|FG001|Overall Study|Withdrawal by Subject|0|||
126267237|NCT04718194|454270843|FG000|Overall Study|Lost to Follow-up|3|||
126267238|NCT04718194|454270844|FG001|Overall Study|Lost to Follow-up|0|||
126267239|NCT02091141|454270846|FG000|Overall Study|Death|280|||
126267240|NCT02091141|454270847|FG001|Overall Study|Death|118|||
126267241|NCT02091141|454270848|FG002|Overall Study|Death|46|||
126267242|NCT02091141|454270849|FG003|Overall Study|Death|13|||
126267243|NCT02091141|454270850|FG004|Overall Study|Death|31|||
126267244|NCT02091141|454270851|FG005|Overall Study|Death|16|||
126267245|NCT02091141|454270852|FG006|Overall Study|Death|12|||
126267246|NCT02091141|454270846|FG000|Overall Study|Withdrawal by Subject|21|||
126267247|NCT02091141|454270847|FG001|Overall Study|Withdrawal by Subject|13|||
126267248|NCT02091141|454270848|FG002|Overall Study|Withdrawal by Subject|3|||
126267249|NCT02091141|454270849|FG003|Overall Study|Withdrawal by Subject|2|||
126267250|NCT02091141|454270850|FG004|Overall Study|Withdrawal by Subject|2|||
126267251|NCT02091141|454270851|FG005|Overall Study|Withdrawal by Subject|3|||
126267252|NCT02091141|454270852|FG006|Overall Study|Withdrawal by Subject|0|||
126267253|NCT02091141|454270846|FG000|Overall Study|Lost to Follow-up|21|||
126267254|NCT02091141|454270847|FG001|Overall Study|Lost to Follow-up|5|||
126267255|NCT02091141|454270848|FG002|Overall Study|Lost to Follow-up|1|||
126267256|NCT02091141|454270849|FG003|Overall Study|Lost to Follow-up|0|||
126267257|NCT02091141|454270850|FG004|Overall Study|Lost to Follow-up|1|||
126267258|NCT02091141|454270851|FG005|Overall Study|Lost to Follow-up|2|||
126267259|NCT02091141|454270852|FG006|Overall Study|Lost to Follow-up|0|||
126267260|NCT02091141|454270846|FG000|Overall Study|Reason Not Specified|6|||
126267261|NCT02091141|454270847|FG001|Overall Study|Reason Not Specified|5|||
126267262|NCT02091141|454270848|FG002|Overall Study|Reason Not Specified|2|||
126267263|NCT02091141|454270849|FG003|Overall Study|Reason Not Specified|0|||
126267264|NCT02091141|454270850|FG004|Overall Study|Reason Not Specified|0|||
126267265|NCT02091141|454270851|FG005|Overall Study|Reason Not Specified|0|||
126267266|NCT02091141|454270852|FG006|Overall Study|Reason Not Specified|1|||
126267267|NCT02091141|454270846|FG000|Overall Study|Study Ended by Sponsor|1|||
126267268|NCT02091141|454270847|FG001|Overall Study|Study Ended by Sponsor|9|||
126267269|NCT02091141|454270848|FG002|Overall Study|Study Ended by Sponsor|0|||
126267270|NCT02091141|454270849|FG003|Overall Study|Study Ended by Sponsor|0|||
126267271|NCT02091141|454270850|FG004|Overall Study|Study Ended by Sponsor|0|||
126267272|NCT02091141|454270851|FG005|Overall Study|Study Ended by Sponsor|0|||
126267273|NCT02091141|454270852|FG006|Overall Study|Study Ended by Sponsor|0|||
126267274|NCT02091141|454270846|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
126267275|NCT02091141|454270847|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
126267276|NCT02091141|454270848|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
126267277|NCT02091141|454270849|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
126267278|NCT02091141|454270850|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
126267279|NCT02091141|454270851|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
126267280|NCT02091141|454270852|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
126267281|NCT00605865|454270853|FG000|Overall Study|Protocol Violation|115|||
126267282|NCT02119286|454270854|FG000|Overall Study|Adverse Event|9|||
126267283|NCT02119286|454270855|FG001|Overall Study|Adverse Event|7|||
126267284|NCT02119286|454270856|FG002|Overall Study|Adverse Event|2|||
126267285|NCT02119286|454270854|FG000|Overall Study|Lack of Efficacy|11|||
126267286|NCT02119286|454270855|FG001|Overall Study|Lack of Efficacy|3|||
126267287|NCT02119286|454270856|FG002|Overall Study|Lack of Efficacy|4|||
126453217|NCT00490529|454961368|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
126267288|NCT02119286|454270854|FG000|Overall Study|Lost to Follow-up|2|||
126267289|NCT02119286|454270855|FG001|Overall Study|Lost to Follow-up|0|||
126267290|NCT02119286|454270856|FG002|Overall Study|Lost to Follow-up|1|||
126267291|NCT02119286|454270854|FG000|Overall Study|Withdrawal by Subject|4|||
126267292|NCT02119286|454270855|FG001|Overall Study|Withdrawal by Subject|1|||
126267293|NCT02119286|454270856|FG002|Overall Study|Withdrawal by Subject|0|||
126267294|NCT00619112|454270857|FG000|Overall Study|Adverse Event|1|||
126267295|NCT00619112|454270858|FG001|Overall Study|Adverse Event|2|||
126267296|NCT01996332|454270859|FG000|Overall Study|Adverse Event|117|||
126267297|NCT01996332|454270859|FG000|Overall Study|Lack of Efficacy|1245|||
126267298|NCT01996332|454270859|FG000|Overall Study|Death|264|||
126267299|NCT01996332|454270859|FG000|Overall Study|Protocol Violation|9|||
126267300|NCT01996332|454270859|FG000|Overall Study|Withdrawal by Subject|71|||
126267301|NCT01996332|454270859|FG000|Overall Study|Other|20|||
126267302|NCT01996332|454270859|FG000|Overall Study|Clinical Deterioration|28|||
126267303|NCT01996332|454270859|FG000|Overall Study|Physician Decision|17|||
126267304|NCT01996332|454270859|FG000|Overall Study|Lost to Follow-up|34|||
126267305|NCT02113189|454270860|FG000|Overall Study|Lost to follow up|2|||
126267306|NCT02113189|454270861|FG001|Overall Study|Lost to follow up|1|||
126267307|NCT02113189|454270862|FG002|Overall Study|Lost to follow up|3|||
126267308|NCT01388166|454270863|FG000|Overall Study|Adverse Event|16|||
126267309|NCT01388166|454270863|FG000|Overall Study|Lost to Follow-up|30|||
126267310|NCT01388166|454270863|FG000|Overall Study|Others than specified above|13|||
126267311|NCT00430495|454270864|FG000|Overall Study|Adverse Event|2|||
126267312|NCT00430495|454270865|FG001|Overall Study|Adverse Event|3|||
126267313|NCT00430495|454270866|FG002|Overall Study|Adverse Event|2|||
126267314|NCT00430495|454270867|FG003|Overall Study|Adverse Event|0|||
126267315|NCT00430495|454270864|FG000|Overall Study|Death|0|||
126267316|NCT00430495|454270865|FG001|Overall Study|Death|0|||
126267317|NCT00430495|454270866|FG002|Overall Study|Death|1|||
126267318|NCT00430495|454270867|FG003|Overall Study|Death|0|||
126267319|NCT00430495|454270864|FG000|Overall Study|Lost to Follow-up|0|||
126267320|NCT00430495|454270865|FG001|Overall Study|Lost to Follow-up|1|||
126267321|NCT00430495|454270866|FG002|Overall Study|Lost to Follow-up|4|||
126267322|NCT00430495|454270867|FG003|Overall Study|Lost to Follow-up|0|||
126267323|NCT00430495|454270864|FG000|Overall Study|Protocol Violation|1|||
126267324|NCT00430495|454270865|FG001|Overall Study|Protocol Violation|0|||
126267325|NCT00430495|454270866|FG002|Overall Study|Protocol Violation|1|||
126267326|NCT00430495|454270867|FG003|Overall Study|Protocol Violation|0|||
126267327|NCT00430495|454270864|FG000|Overall Study|Disease Progression|1|||
126267328|NCT00430495|454270865|FG001|Overall Study|Disease Progression|1|||
126267329|NCT00430495|454270866|FG002|Overall Study|Disease Progression|0|||
126267330|NCT00430495|454270867|FG003|Overall Study|Disease Progression|0|||
126267331|NCT00430495|454270864|FG000|Overall Study|Other|8|||
126267332|NCT00430495|454270865|FG001|Overall Study|Other|2|||
126267333|NCT00430495|454270866|FG002|Overall Study|Other|5|||
126267334|NCT00430495|454270867|FG003|Overall Study|Other|4|||
126267335|NCT00430495|454270864|FG000|Overall Study|Randomized but not Treated|2|||
126267336|NCT00430495|454270865|FG001|Overall Study|Randomized but not Treated|0|||
126267337|NCT00430495|454270866|FG002|Overall Study|Randomized but not Treated|0|||
126267338|NCT00430495|454270867|FG003|Overall Study|Randomized but not Treated|0|||
126267339|NCT02751359|454270868|FG000|Overall Study|Lost to Follow-up|1|||
126267340|NCT02400671|454270869|FG000|Overall Study|Death|5|||
126267341|NCT02400671|454270870|FG001|Overall Study|Death|3|||
126267342|NCT02400671|454270871|FG002|Overall Study|Death|4|||
126267343|NCT02400671|454270869|FG000|Overall Study|Lost to Follow-up|20|||
126267344|NCT02400671|454270870|FG001|Overall Study|Lost to Follow-up|27|||
126267345|NCT02400671|454270871|FG002|Overall Study|Lost to Follow-up|24|||
126267346|NCT02400671|454270869|FG000|Overall Study|Withdrawal by Subject|2|||
126267347|NCT02400671|454270870|FG001|Overall Study|Withdrawal by Subject|2|||
126267348|NCT02400671|454270871|FG002|Overall Study|Withdrawal by Subject|0|||
126267349|NCT02145026|454270872|FG000|Overall Study|Adverse Event|2|||
126267350|NCT02145026|454270872|FG000|Overall Study|Death|4|||
126267351|NCT02145026|454270872|FG000|Overall Study|Withdrawal by Subject|2|||
126267352|NCT02145026|454270872|FG000|Overall Study|Physician Decision|4|||
126267353|NCT01429051|454270873|FG000|Titration Phase|Death|1|||
126267354|NCT01429051|454270873|FG000|Titration Phase|Withdrawal by Subject|7|||
126453218|NCT00490529|454961368|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
126453219|NCT00490529|454961368|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
126453220|NCT03254459|454961369|FG000|Overall Study|Adverse Event|7|||
126453221|NCT03254459|454961370|FG001|Overall Study|Adverse Event|20|||
126453222|NCT03254459|454961369|FG000|Overall Study|Withdrawal by Subject Consent|3|||
126453223|NCT03254459|454961370|FG001|Overall Study|Withdrawal by Subject Consent|1|||
126267355|NCT01429051|454270873|FG000|Titration Phase|Physician Decision|1|||
126267356|NCT01429051|454270873|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
126267357|NCT01429051|454270873|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
126267358|NCT01429051|454270873|FG000|Efficacy Phase|Adverse Event|1|||
126267359|NCT01429051|454270873|FG000|Efficacy Phase|Death|1|||
126267360|NCT01429051|454270873|FG000|Tolerability Phase|Death|5|||
126267361|NCT01429051|454270873|FG000|Tolerability Phase|Adverse Event|2|||
126267362|NCT01429051|454270873|FG000|Tolerability Phase|Withdrawal by Subject|5|||
126267363|NCT01429051|454270873|FG000|Tolerability Phase|Physician Decision|1|||
126267364|NCT01429051|454270873|FG000|Tolerability Phase|Other|2|||
126267365|NCT00857792|454270874|FG000|Overall Study|inadequate image quality for analysis|12|||
126267366|NCT01797835|454270875|FG000|Overall Study|Lost to Follow-up|31|||
126267367|NCT01797835|454270876|FG001|Overall Study|Lost to Follow-up|27|||
126267368|NCT04295135|454270884|FG000|Overall Study|Withdrawal by Subject|2|||
126267369|NCT04295135|454270885|FG001|Overall Study|Withdrawal by Subject|1|||
126267370|NCT04295135|454270884|FG000|Overall Study|Subject left organization|8|||
126267371|NCT04295135|454270885|FG001|Overall Study|Subject left organization|4|||
126267372|NCT03484117|454270886|FG000|Overall Study|Lost to Follow-up|1|||
126267373|NCT03484117|454270887|FG001|Overall Study|Lost to Follow-up|3|||
126267374|NCT03484117|454270886|FG000|Overall Study|Declined participation in exit assess|1|||
126267375|NCT03484117|454270887|FG001|Overall Study|Declined participation in exit assess|1|||
126267376|NCT00289874|454270888|FG000|Overall Study|Adverse Event|1|||
126267377|NCT00289874|454270889|FG001|Overall Study|Adverse Event|5|||
126267378|NCT00289874|454270888|FG000|Overall Study|Lost to Follow-up|1|||
126267379|NCT00289874|454270889|FG001|Overall Study|Lost to Follow-up|1|||
126267380|NCT00289874|454270888|FG000|Overall Study|Protocol Violation|3|||
126267381|NCT00289874|454270889|FG001|Overall Study|Protocol Violation|2|||
126267382|NCT00289874|454270888|FG000|Overall Study|Did not meet eligibility|1|||
126765511|NCT02335411|456094531|FG000|Overall Study|Sponsor Decision|12|||
126765512|NCT02335411|456094532|FG001|Overall Study|Sponsor Decision|3|||
126765513|NCT02335411|456094533|FG002|Overall Study|Sponsor Decision|2|||
126267383|NCT00289874|454270889|FG001|Overall Study|Did not meet eligibility|0|||
126267384|NCT03835325|454270890|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
126267385|NCT03835325|454270890|FG000|Overall Study|Selection failure|1|||
126267386|NCT01901874|454270891|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
126267387|NCT01901874|454270891|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
126267388|NCT01901874|454270891|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
126267389|NCT01901874|454270891|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
126267390|NCT01901874|454270891|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
126267391|NCT01901874|454270891|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
126267392|NCT00770692|454270898|FG000|Overall Study|Withdrawal by Subject|7|||
126267393|NCT00770692|454270899|FG001|Overall Study|Withdrawal by Subject|9|||
126267394|NCT00770692|454270900|FG002|Overall Study|Withdrawal by Subject|9|||
126267395|NCT00770692|454270901|FG003|Overall Study|Withdrawal by Subject|6|||
126267396|NCT00770692|454270898|FG000|Overall Study|Adverse Event|3|||
126267397|NCT00770692|454270899|FG001|Overall Study|Adverse Event|0|||
126267398|NCT00770692|454270900|FG002|Overall Study|Adverse Event|4|||
126267399|NCT00770692|454270901|FG003|Overall Study|Adverse Event|4|||
126267400|NCT00770692|454270898|FG000|Overall Study|Investigator judgment|2|||
126267401|NCT00770692|454270899|FG001|Overall Study|Investigator judgment|0|||
126267402|NCT00770692|454270900|FG002|Overall Study|Investigator judgment|1|||
126267403|NCT00770692|454270901|FG003|Overall Study|Investigator judgment|1|||
126267404|NCT01138111|454270903|FG000|Overall Study|Withdrawal by Subject|5|||
126267405|NCT01138111|454270903|FG000|Overall Study|Adverse Event|1|||
126267406|NCT01138111|454270903|FG000|Overall Study|Death|1|||
126267407|NCT01138111|454270903|FG000|Overall Study|Lost to Follow-up|2|||
126267408|NCT00560937|454270906|FG000|Overall Study|Withdrawal by Subject|0|||
126267409|NCT00560937|454270907|FG001|Overall Study|Withdrawal by Subject|1|||
126267410|NCT00560937|454270906|FG000|Overall Study|Physician Decision|1|||
126267411|NCT00560937|454270907|FG001|Overall Study|Physician Decision|1|||
126267412|NCT03629028|454270908|FG000|Overall Study|Lost to Follow-up|26|||
126267413|NCT03629028|454270909|FG001|Overall Study|Lost to Follow-up|23|||
126267414|NCT03629028|454270908|FG000|Overall Study|Pregnancy|4|||
126267415|NCT03629028|454270909|FG001|Overall Study|Pregnancy|2|||
126267416|NCT03629028|454270908|FG000|Overall Study|intolerance to examination|2|||
126267417|NCT03629028|454270909|FG001|Overall Study|intolerance to examination|0|||
126267418|NCT02025751|454270912|FG000|Overall Study|Lost to Follow-up|1|||
126267419|NCT02025751|454270913|FG001|Overall Study|Lost to Follow-up|0|||
126267420|NCT02025751|454270912|FG000|Overall Study|Adverse Event|0|||
126267421|NCT02025751|454270913|FG001|Overall Study|Adverse Event|1|||
126267422|NCT02025751|454270912|FG000|Overall Study|Physician Decision|0|||
126267423|NCT02025751|454270913|FG001|Overall Study|Physician Decision|1|||
126267424|NCT02025751|454270912|FG000|Overall Study|Withdrawal by Subject|0|||
126267425|NCT02025751|454270913|FG001|Overall Study|Withdrawal by Subject|1|||
126267426|NCT00653991|454270914|FG000|3 Month Follow-up|Participant would not respond|150|||
126267427|NCT00653991|454270915|FG001|3 Month Follow-up|Participant would not respond|157|||
126267428|NCT00653991|454270914|FG000|6 Month Follow-up|Participant would not respond|133|||
126267429|NCT00653991|454270915|FG001|6 Month Follow-up|Participant would not respond|141|||
126360515|NCT03339453|454610846|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
126765514|NCT02335411|456094531|FG000|Overall Study|Adverse Event|9|||
126267430|NCT01846273|454270916|FG000|Overall Study|Adverse Event|9|||
126267431|NCT01846273|454270917|FG001|Overall Study|Adverse Event|7|||
126267432|NCT01846273|454270918|FG002|Overall Study|Adverse Event|0|||
126267433|NCT01846273|454270916|FG000|Overall Study|Subject withdrew consent|5|||
126267434|NCT01846273|454270917|FG001|Overall Study|Subject withdrew consent|8|||
126267435|NCT01846273|454270918|FG002|Overall Study|Subject withdrew consent|0|||
126267436|NCT01846273|454270916|FG000|Overall Study|Lost to Follow-up|2|||
126267437|NCT01846273|454270917|FG001|Overall Study|Lost to Follow-up|1|||
126267438|NCT01846273|454270918|FG002|Overall Study|Lost to Follow-up|0|||
126267439|NCT01846273|454270916|FG000|Overall Study|Administrative problems|1|||
126267440|NCT01846273|454270917|FG001|Overall Study|Administrative problems|0|||
126267441|NCT01846273|454270918|FG002|Overall Study|Administrative problems|0|||
126360516|NCT03339453|454610847|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
126765515|NCT02335411|456094532|FG001|Overall Study|Adverse Event|0|||
126267442|NCT01846273|454270916|FG000|Overall Study|Death|2|||
126267443|NCT01846273|454270917|FG001|Overall Study|Death|1|||
126267444|NCT01846273|454270918|FG002|Overall Study|Death|0|||
126267445|NCT01846273|454270916|FG000|Overall Study|Disease Progression|0|||
126267446|NCT01846273|454270917|FG001|Overall Study|Disease Progression|4|||
126267447|NCT01846273|454270918|FG002|Overall Study|Disease Progression|0|||
126267448|NCT01846273|454270916|FG000|Overall Study|Protocol Deviation|2|||
126267449|NCT01846273|454270917|FG001|Overall Study|Protocol Deviation|3|||
126267450|NCT01846273|454270918|FG002|Overall Study|Protocol Deviation|0|||
126267451|NCT01846273|454270916|FG000|Overall Study|Physician Decision|1|||
126267452|NCT01846273|454270917|FG001|Overall Study|Physician Decision|2|||
126267453|NCT01846273|454270918|FG002|Overall Study|Physician Decision|0|||
126267454|NCT00891839|454270919|FG000|Overall Study|Adverse Event|2|||
126267455|NCT00891839|454270919|FG000|Overall Study|Withdrawal by Subject|2|||
126267456|NCT00891839|454270919|FG000|Overall Study|Disease progression|3|||
126267457|NCT00456495|454270922|FG000|Overall Study|Physician Decision|2|||
126267458|NCT02939014|454270923|FG000|Overall Study|Lost to Follow-up|1|||
126267459|NCT02939014|454270924|FG001|Overall Study|Lost to Follow-up|0|||
126267460|NCT02939014|454270923|FG000|Overall Study|Death|4|||
126267461|NCT02939014|454270924|FG001|Overall Study|Death|3|||
126267462|NCT03864042|454270925|FG000|DDI Phase|Adverse Event|2|||
126267463|NCT03864042|454270926|FG001|DDI Phase|Adverse Event|0|||
126267464|NCT03864042|454270927|FG002|DDI Phase|Adverse Event|0|||
126267465|NCT03864042|454270925|FG000|DDI Phase|Physician Decision|1|||
126267466|NCT03864042|454270926|FG001|DDI Phase|Physician Decision|0|||
126267467|NCT03864042|454270927|FG002|DDI Phase|Physician Decision|0|||
126267468|NCT03864042|454270925|FG000|DDI Phase|Progressive Disease|1|||
126267469|NCT03864042|454270926|FG001|DDI Phase|Progressive Disease|0|||
126267470|NCT03864042|454270927|FG002|DDI Phase|Progressive Disease|0|||
126267471|NCT03864042|454270925|FG000|Post-DDI Phase|Adverse Event|5|||
126267472|NCT03864042|454270926|FG001|Post-DDI Phase|Adverse Event|3|||
126267473|NCT03864042|454270927|FG002|Post-DDI Phase|Adverse Event|2|||
126267474|NCT03864042|454270925|FG000|Post-DDI Phase|Progressive Disease|11|||
126267475|NCT03864042|454270926|FG001|Post-DDI Phase|Progressive Disease|6|||
126267476|NCT03864042|454270927|FG002|Post-DDI Phase|Progressive Disease|13|||
126267477|NCT03864042|454270925|FG000|Post-DDI Phase|Discretion of investigator|1|||
126267478|NCT03864042|454270926|FG001|Post-DDI Phase|Discretion of investigator|1|||
126267479|NCT03864042|454270927|FG002|Post-DDI Phase|Discretion of investigator|0|||
126267480|NCT03864042|454270925|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
126267481|NCT03864042|454270926|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
126267482|NCT03864042|454270927|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
126267483|NCT03864042|454270925|FG000|Post-DDI Phase|Withdrawal of consent|1|||
126267484|NCT03864042|454270926|FG001|Post-DDI Phase|Withdrawal of consent|2|||
126267485|NCT03864042|454270927|FG002|Post-DDI Phase|Withdrawal of consent|0|||
126267486|NCT05069155|454270928|FG000|Overall Study|Withdrawal by Subject|1|||
126267487|NCT05069155|454270929|FG001|Overall Study|Withdrawal by Subject|3|||
126267488|NCT01297322|454270930|FG000|Overall Study|Lost to Follow-up|1|||
126267489|NCT01297322|454270931|FG001|Overall Study|Lost to Follow-up|0|||
126267490|NCT01297322|454270930|FG000|Overall Study|Withdrawal by Subject|0|||
126267491|NCT01297322|454270931|FG001|Overall Study|Withdrawal by Subject|1|||
126267492|NCT01297322|454270930|FG000|Overall Study|Protocol Violation|0|||
126267493|NCT01297322|454270931|FG001|Overall Study|Protocol Violation|3|||
126267494|NCT01111019|454270932|FG000|Overall Study|Withdrew Prematurely|2|||
126267495|NCT01111019|454270932|FG000|Overall Study|Other|1|||
126267496|NCT02674061|454270935|FG000|Overall Study|Death|229|||
126267497|NCT02674061|454270936|FG001|Overall Study|Death|77|||
126267498|NCT02674061|454270935|FG000|Overall Study|Lost to Follow-up|3|||
126267499|NCT02674061|454270936|FG001|Overall Study|Lost to Follow-up|3|||
126267500|NCT02674061|454270935|FG000|Overall Study|Withdrawal by Subject|9|||
126267501|NCT02674061|454270936|FG001|Overall Study|Withdrawal by Subject|1|||
126267502|NCT02674061|454270935|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
126267503|NCT02674061|454270936|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
126267504|NCT01558297|454270942|FG000|Overall Study|Withdrawal by Subject|2|||
126267505|NCT01558297|454270943|FG001|Overall Study|Withdrawal by Subject|2|||
126267506|NCT01558297|454270944|FG002|Overall Study|Withdrawal by Subject|1|||
126267507|NCT01334710|454270945|FG000|Overall Study|Trial was terminated|3|||
126267508|NCT00375492|454270946|FG000|Overall Study|Adverse Event|4|||
126267509|NCT00375492|454270947|FG001|Overall Study|Adverse Event|5|||
126267510|NCT00375492|454270946|FG000|Overall Study|Entry Criteria Not Met|0|||
126267511|NCT00375492|454270947|FG001|Overall Study|Entry Criteria Not Met|1|||
126267512|NCT00375492|454270946|FG000|Overall Study|Loss of Glucose Control|0|||
126267513|NCT00375492|454270947|FG001|Overall Study|Loss of Glucose Control|1|||
126267514|NCT00375492|454270946|FG000|Overall Study|Lost to Follow-up|10|||
126267515|NCT00375492|454270947|FG001|Overall Study|Lost to Follow-up|5|||
126267516|NCT00375492|454270946|FG000|Overall Study|Physician Decision|0|||
126267517|NCT00375492|454270947|FG001|Overall Study|Physician Decision|4|||
126267518|NCT00375492|454270946|FG000|Overall Study|Protocol Violation|6|||
126267519|NCT00375492|454270947|FG001|Overall Study|Protocol Violation|3|||
126267520|NCT00375492|454270946|FG000|Overall Study|Sponsor Decision|0|||
126360517|NCT02151604|454610850|FG000|Overall Study|Lost to Follow-up|3|||
126360518|NCT02151604|454610850|FG000|Overall Study|Withdrawal by Subject|2|||
126360519|NCT02151604|454610850|FG000|Overall Study|Physician Decision|3|||
126360520|NCT02151604|454610850|FG000|Overall Study|Death|1|||
126360521|NCT04495478|454610851|FG000|Overall Study|Withdrawal by Subject|0|||
126360522|NCT04495478|454610852|FG001|Overall Study|Withdrawal by Subject|0|||
126360523|NCT04495478|454610853|FG002|Overall Study|Withdrawal by Subject|0|||
126360524|NCT04495478|454610854|FG003|Overall Study|Withdrawal by Subject|1|||
126360525|NCT04495478|454610855|FG004|Overall Study|Withdrawal by Subject|0|||
126360526|NCT04495478|454610856|FG005|Overall Study|Withdrawal by Subject|0|||
126360527|NCT04495478|454610857|FG006|Overall Study|Withdrawal by Subject|0|||
126360528|NCT04495478|454610851|FG000|Overall Study|Physician Decision|0|||
126360529|NCT04495478|454610852|FG001|Overall Study|Physician Decision|1|||
126360530|NCT04495478|454610853|FG002|Overall Study|Physician Decision|0|||
126360531|NCT04495478|454610854|FG003|Overall Study|Physician Decision|0|||
126360532|NCT04495478|454610855|FG004|Overall Study|Physician Decision|1|||
126360533|NCT04495478|454610856|FG005|Overall Study|Physician Decision|0|||
126267521|NCT00375492|454270947|FG001|Overall Study|Sponsor Decision|1|||
126267522|NCT00375492|454270946|FG000|Overall Study|Withdrawal by Subject|6|||
126267523|NCT00375492|454270947|FG001|Overall Study|Withdrawal by Subject|6|||
126267524|NCT01902628|454270948|FG000|Overall Study|Withdrawal of participant's consent|7|||
126267525|NCT01902628|454270948|FG000|Overall Study|Adverse Event|41|||
126267526|NCT01902628|454270948|FG000|Overall Study|Lost to Follow-up|35|||
126267527|NCT01232491|454270949|FG000|Overall Study|Adverse Event|13|||
126267528|NCT01232491|454270950|FG001|Overall Study|Adverse Event|8|||
126267529|NCT01232491|454270949|FG000|Overall Study|Lack of Efficacy|1|||
126267530|NCT01232491|454270950|FG001|Overall Study|Lack of Efficacy|5|||
126267531|NCT01232491|454270949|FG000|Overall Study|Protocol Violation|13|||
126267532|NCT01232491|454270950|FG001|Overall Study|Protocol Violation|11|||
126267533|NCT01232491|454270949|FG000|Overall Study|Withdrawal Criteria|12|||
126267534|NCT01232491|454270950|FG001|Overall Study|Withdrawal Criteria|21|||
126267535|NCT01232491|454270949|FG000|Overall Study|Other|21|||
126267536|NCT01232491|454270950|FG001|Overall Study|Other|18|||
126267537|NCT02522403|454272376|FG000|Overall Study|Lost to Follow-up|2|||
126267538|NCT02522403|454272377|FG001|Overall Study|Lost to Follow-up|2|||
126267539|NCT02522403|454272376|FG000|Overall Study|Withdrawal by Subject|2|||
126267540|NCT02522403|454272377|FG001|Overall Study|Withdrawal by Subject|4|||
126267541|NCT03340064|454272378|FG000|First Period|Adverse Event, non-fatal|2|||
126267542|NCT03340064|454272379|FG001|First Period|Adverse Event, non-fatal|0|||
126267543|NCT03340064|454272378|FG000|First Period|Lack of Efficacy|3|||
126267544|NCT03340064|454272379|FG001|First Period|Lack of Efficacy|0|||
126267545|NCT03340064|454272378|FG000|Second Period|Adverse Event, non-fatal|1|||
126267546|NCT03340064|454272379|FG001|Second Period|Adverse Event, non-fatal|1|||
126267547|NCT03340064|454272378|FG000|Second Period|Lack of Efficacy|11|||
126267548|NCT03340064|454272379|FG001|Second Period|Lack of Efficacy|0|||
126267549|NCT03340064|454272378|FG000|Second Period|Physician Decision|3|||
126267550|NCT03340064|454272379|FG001|Second Period|Physician Decision|0|||
126267551|NCT03340064|454272378|FG000|Second Period|Withdrawal by Subject|2|||
126267552|NCT03340064|454272379|FG001|Second Period|Withdrawal by Subject|1|||
126267553|NCT03340064|454272378|FG000|Second Period|Approved Drug Available For Indication|1|||
126267554|NCT03340064|454272379|FG001|Second Period|Approved Drug Available For Indication|0|||
126267555|NCT03340064|454272378|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
126267556|NCT03340064|454272379|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
126267557|NCT00856973|454272382|FG000|Overall Study|Adverse Event|5|||
126267558|NCT00856973|454272383|FG001|Overall Study|Adverse Event|5|||
126267559|NCT00856973|454272384|FG002|Overall Study|Adverse Event|3|||
126267560|NCT00856973|454272382|FG000|Overall Study|Lost to Follow-up|6|||
126267561|NCT00856973|454272383|FG001|Overall Study|Lost to Follow-up|3|||
126267562|NCT00856973|454272384|FG002|Overall Study|Lost to Follow-up|5|||
126360534|NCT04495478|454610857|FG006|Overall Study|Physician Decision|0|||
126360535|NCT03312114|454612646|FG000|Overall Study|All the five enrolled dropped out of the|5|||
126360536|NCT00944645|454612647|FG000|Period 2|Adverse Event|1|||
126267563|NCT00856973|454272382|FG000|Overall Study|Physician Decision|0|||
126360537|NCT00944645|454612648|FG001|Period 2|Adverse Event|0|||
126267564|NCT00856973|454272383|FG001|Overall Study|Physician Decision|3|||
126360538|NCT00944645|454612647|FG000|Period 2|Lost to Follow-up|0|||
126360539|NCT00944645|454612648|FG001|Period 2|Lost to Follow-up|3|||
126360540|NCT00944645|454612647|FG000|Period 2|Withdrawal by Subject|7|||
126267565|NCT00856973|454272384|FG002|Overall Study|Physician Decision|1|||
126267566|NCT00856973|454272382|FG000|Overall Study|Protocol Violation|1|||
126267567|NCT00856973|454272383|FG001|Overall Study|Protocol Violation|2|||
126360541|NCT00944645|454612648|FG001|Period 2|Withdrawal by Subject|6|||
126360542|NCT03537729|454612649|FG000|Overall Study|Death|2|||
126360543|NCT03537729|454612650|FG001|Overall Study|Death|2|||
126267568|NCT00856973|454272384|FG002|Overall Study|Protocol Violation|1|||
126267569|NCT00856973|454272382|FG000|Overall Study|Withdrawal by Subject|13|||
126267570|NCT00856973|454272383|FG001|Overall Study|Withdrawal by Subject|16|||
126360544|NCT03537729|454612651|FG002|Overall Study|Death|7|||
126360545|NCT03537729|454612649|FG000|Overall Study|Withdrawal by Subject|3|||
126267571|NCT00856973|454272384|FG002|Overall Study|Withdrawal by Subject|15|||
126267572|NCT00856973|454272382|FG000|Overall Study|Other|11|||
126267573|NCT00856973|454272383|FG001|Overall Study|Other|12|||
126267574|NCT00856973|454272384|FG002|Overall Study|Other|13|||
126267575|NCT04556552|454272386|FG000|Overall Study|Lost to Follow-up|1|||
126267576|NCT04556552|454272387|FG001|Overall Study|Lost to Follow-up|0|||
126267577|NCT04556552|454272386|FG000|Overall Study|Claustrophobia|0|||
126267578|NCT04556552|454272387|FG001|Overall Study|Claustrophobia|1|||
126267579|NCT04556552|454272386|FG000|Overall Study|Inability to continue|0|||
126267580|NCT04556552|454272387|FG001|Overall Study|Inability to continue|1|||
126267581|NCT03439852|454272388|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
126267582|NCT03439852|454272389|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
126267583|NCT03439852|454272388|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
126267584|NCT03439852|454272389|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
126267585|NCT03439852|454272388|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
126267586|NCT03439852|454272389|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
126267587|NCT01215513|454272390|FG000|Overall Study|Not completed CS42|9|||
126267588|NCT01215513|454272390|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
126267589|NCT01215513|454272390|FG000|Overall Study|Adverse event (CS42A)|2|||
126267590|NCT01215513|454272390|FG000|Overall Study|Physician decision (CS42A)|6|||
126267591|NCT01215513|454272390|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
126267592|NCT01215513|454272390|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
126267593|NCT02858492|454272391|FG000|Overall Study|Withdrawal by Subject|0|||
126267594|NCT02858492|454272392|FG001|Overall Study|Withdrawal by Subject|1|||
126267595|NCT02858492|454272393|FG002|Overall Study|Withdrawal by Subject|0|||
126267596|NCT02858492|454272394|FG003|Overall Study|Withdrawal by Subject|1|||
126267597|NCT02858492|454272391|FG000|Overall Study|Adverse Event|0|||
126267598|NCT02858492|454272392|FG001|Overall Study|Adverse Event|0|||
126267599|NCT02858492|454272393|FG002|Overall Study|Adverse Event|0|||
126267600|NCT02858492|454272394|FG003|Overall Study|Adverse Event|3|||
126267601|NCT02858492|454272391|FG000|Overall Study|Lack of Efficacy|0|||
126267602|NCT02858492|454272392|FG001|Overall Study|Lack of Efficacy|0|||
126267603|NCT02858492|454272393|FG002|Overall Study|Lack of Efficacy|0|||
126267604|NCT02858492|454272394|FG003|Overall Study|Lack of Efficacy|1|||
126267605|NCT02858492|454272391|FG000|Overall Study|Protocol defined stopping criteria|0|||
126267606|NCT02858492|454272392|FG001|Overall Study|Protocol defined stopping criteria|0|||
126267607|NCT02858492|454272393|FG002|Overall Study|Protocol defined stopping criteria|0|||
126267608|NCT02858492|454272394|FG003|Overall Study|Protocol defined stopping criteria|1|||
126267609|NCT02040779|454272397|FG000|Overall Study|Adverse Event|1|||
126267610|NCT02040779|454272398|FG001|Overall Study|Adverse Event|0|||
126267611|NCT02040779|454272399|FG002|Overall Study|Adverse Event|0|||
126267612|NCT02040779|454272397|FG000|Overall Study|Withdrawal by Subject|4|||
126267613|NCT02040779|454272398|FG001|Overall Study|Withdrawal by Subject|1|||
126267614|NCT02040779|454272399|FG002|Overall Study|Withdrawal by Subject|3|||
126267615|NCT02040779|454272397|FG000|Overall Study|Non-compliance|0|||
126267616|NCT02040779|454272398|FG001|Overall Study|Non-compliance|1|||
126267617|NCT02040779|454272399|FG002|Overall Study|Non-compliance|0|||
126267618|NCT02040779|454272397|FG000|Overall Study|Protocol Violation|2|||
126267619|NCT02040779|454272398|FG001|Overall Study|Protocol Violation|1|||
126267620|NCT02040779|454272399|FG002|Overall Study|Protocol Violation|0|||
126267621|NCT02040779|454272397|FG000|Overall Study|Lost to Follow-up|1|||
126267622|NCT02040779|454272398|FG001|Overall Study|Lost to Follow-up|2|||
126267623|NCT02040779|454272399|FG002|Overall Study|Lost to Follow-up|1|||
126360546|NCT03537729|454612650|FG001|Overall Study|Withdrawal by Subject|3|||
126360547|NCT03537729|454612651|FG002|Overall Study|Withdrawal by Subject|0|||
126360548|NCT03537729|454612649|FG000|Overall Study|Subject Moved|8|||
126360549|NCT03537729|454612650|FG001|Overall Study|Subject Moved|5|||
126360550|NCT03537729|454612651|FG002|Overall Study|Subject Moved|4|||
126360551|NCT03537729|454612649|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
126360552|NCT03537729|454612650|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
126360553|NCT03537729|454612651|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
126360554|NCT03537729|454612649|FG000|Overall Study|COVID-19 Site Restrictions|11|||
126360555|NCT03537729|454612650|FG001|Overall Study|COVID-19 Site Restrictions|15|||
126360556|NCT03537729|454612651|FG002|Overall Study|COVID-19 Site Restrictions|18|||
126360557|NCT03537729|454612649|FG000|Overall Study|Decline in Health|5|||
126360558|NCT03537729|454612650|FG001|Overall Study|Decline in Health|9|||
126360559|NCT03537729|454612651|FG002|Overall Study|Decline in Health|4|||
126360560|NCT03537729|454612649|FG000|Overall Study|Determined Ineligible|0|||
126360561|NCT03537729|454612650|FG001|Overall Study|Determined Ineligible|0|||
126360562|NCT03537729|454612651|FG002|Overall Study|Determined Ineligible|1|||
126360563|NCT02562040|454612653|FG000|Overall Study|Lost to Follow-up|20|||
126360564|NCT02562040|454612654|FG001|Overall Study|Lost to Follow-up|28|||
126360565|NCT02562040|454612653|FG000|Overall Study|Withdrawal by Subject|8|||
126360566|NCT02562040|454612654|FG001|Overall Study|Withdrawal by Subject|7|||
126360567|NCT02562040|454612653|FG000|Overall Study|Adverse Event|1|||
126267624|NCT02040779|454272397|FG000|Overall Study|Lack of Efficacy|4|||
126267625|NCT02040779|454272398|FG001|Overall Study|Lack of Efficacy|2|||
126267626|NCT02040779|454272399|FG002|Overall Study|Lack of Efficacy|0|||
126267627|NCT02132637|454272400|FG000|Study Period 1|Withdrawal by Subject|0|||
126267628|NCT02132637|454272401|FG001|Study Period 1|Withdrawal by Subject|4|||
126267629|NCT02132637|454272400|FG000|Study Period 1|Physician Decision|1|||
126267630|NCT02132637|454272401|FG001|Study Period 1|Physician Decision|0|||
126267631|NCT02132637|454272400|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
126267632|NCT02132637|454272401|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
126267633|NCT02132637|454272400|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
126267634|NCT02132637|454272401|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
126267635|NCT00652028|454272402|FG000|Overall Study|Adverse Event|1|||
126267636|NCT00652028|454272403|FG001|Overall Study|Adverse Event|0|||
126267637|NCT00652028|454272404|FG002|Overall Study|Adverse Event|0|||
126267638|NCT00652028|454272405|FG003|Overall Study|Adverse Event|0|||
126267639|NCT00652028|454272402|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
126267640|NCT00652028|454272403|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
126267641|NCT00652028|454272404|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
126267642|NCT00652028|454272405|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
126267643|NCT00652028|454272402|FG000|Overall Study|Physician Decision|0|||
126267644|NCT00652028|454272403|FG001|Overall Study|Physician Decision|0|||
126267645|NCT00652028|454272404|FG002|Overall Study|Physician Decision|1|||
126267646|NCT00652028|454272405|FG003|Overall Study|Physician Decision|0|||
126267647|NCT00931268|454272409|FG000|Overall Study|Lost to Follow-up|6|||
126267648|NCT03656874|454272415|FG000|Overall Study|Lost to Follow-up|3|||
126267649|NCT03656874|454272416|FG001|Overall Study|Lost to Follow-up|17|||
126267650|NCT00584844|454272417|FG000|Overall Study|Withdrawal by Subject|59|||
126267651|NCT00584844|454272417|FG000|Overall Study|Screen Failure|20|||
126267652|NCT03001219|454272422|FG000|Proof of Concept|Study Termination by Sponsor|0|||
126267653|NCT03001219|454272423|FG001|Proof of Concept|Study Termination by Sponsor|1|||
126267654|NCT03001219|454272422|FG000|Proof of Concept|Withdrawal by Subject|0|||
126267655|NCT03001219|454272423|FG001|Proof of Concept|Withdrawal by Subject|4|||
126267656|NCT03001219|454272422|FG000|Proof of Concept|Protocol Deviation|0|||
126360568|NCT02562040|454612654|FG001|Overall Study|Adverse Event|0|||
126360569|NCT01654250|454612655|FG000|Overall Study|Lost to Follow-up|1|||
126360570|NCT01654250|454612656|FG001|Overall Study|Lost to Follow-up|0|||
126360571|NCT01862029|454612657|FG000|Overall Study|Physician Decision|1|||
126360572|NCT00504556|454612658|FG000|Overall Study|Adverse Event|11|||
126360573|NCT00504556|454612659|FG001|Overall Study|Adverse Event|11|||
126360574|NCT00504556|454612660|FG002|Overall Study|Adverse Event|14|||
126360575|NCT00504556|454612661|FG003|Overall Study|Adverse Event|13|||
126360576|NCT00504556|454612662|FG004|Overall Study|Adverse Event|5|||
126360577|NCT00504556|454612658|FG000|Overall Study|Death|3|||
126360578|NCT00504556|454612659|FG001|Overall Study|Death|3|||
126360579|NCT00504556|454612660|FG002|Overall Study|Death|1|||
126360580|NCT00504556|454612661|FG003|Overall Study|Death|0|||
126360581|NCT00504556|454612662|FG004|Overall Study|Death|2|||
126360582|NCT00504556|454612658|FG000|Overall Study|Protocol Violation|1|||
126360583|NCT00504556|454612659|FG001|Overall Study|Protocol Violation|3|||
126360584|NCT00504556|454612660|FG002|Overall Study|Protocol Violation|2|||
126360585|NCT00504556|454612661|FG003|Overall Study|Protocol Violation|1|||
126360586|NCT00504556|454612662|FG004|Overall Study|Protocol Violation|2|||
126360587|NCT00504556|454612658|FG000|Overall Study|Lost to Follow-up|0|||
126360588|NCT00504556|454612659|FG001|Overall Study|Lost to Follow-up|0|||
126360589|NCT00504556|454612660|FG002|Overall Study|Lost to Follow-up|1|||
126360590|NCT00504556|454612661|FG003|Overall Study|Lost to Follow-up|1|||
126360591|NCT00504556|454612662|FG004|Overall Study|Lost to Follow-up|1|||
126360592|NCT00504556|454612658|FG000|Overall Study|Withdrawal by Subject|16|||
126360593|NCT00504556|454612659|FG001|Overall Study|Withdrawal by Subject|16|||
126360594|NCT00504556|454612660|FG002|Overall Study|Withdrawal by Subject|7|||
126360595|NCT00504556|454612661|FG003|Overall Study|Withdrawal by Subject|8|||
126360596|NCT00504556|454612662|FG004|Overall Study|Withdrawal by Subject|12|||
126360597|NCT00504556|454612658|FG000|Overall Study|administrative reasons|0|||
126360598|NCT00504556|454612659|FG001|Overall Study|administrative reasons|2|||
126360599|NCT00504556|454612660|FG002|Overall Study|administrative reasons|2|||
126360600|NCT00504556|454612661|FG003|Overall Study|administrative reasons|1|||
126360601|NCT00504556|454612662|FG004|Overall Study|administrative reasons|2|||
126360602|NCT00504556|454612658|FG000|Overall Study|did not meet entry criteria|2|||
126360603|NCT00504556|454612659|FG001|Overall Study|did not meet entry criteria|0|||
126360604|NCT00504556|454612660|FG002|Overall Study|did not meet entry criteria|1|||
126360605|NCT00504556|454612661|FG003|Overall Study|did not meet entry criteria|1|||
126360606|NCT00504556|454612662|FG004|Overall Study|did not meet entry criteria|0|||
126360607|NCT00504556|454612658|FG000|Overall Study|data monitor committee decision|0|||
126360608|NCT00504556|454612659|FG001|Overall Study|data monitor committee decision|0|||
126360609|NCT00504556|454612660|FG002|Overall Study|data monitor committee decision|0|||
126360610|NCT00504556|454612661|FG003|Overall Study|data monitor committee decision|100|||
126360611|NCT00504556|454612662|FG004|Overall Study|data monitor committee decision|0|||
126360612|NCT00504556|454612658|FG000|Overall Study|Other|2|||
126360613|NCT00504556|454612659|FG001|Overall Study|Other|2|||
126360614|NCT00504556|454612660|FG002|Overall Study|Other|2|||
126360615|NCT00504556|454612661|FG003|Overall Study|Other|3|||
126360616|NCT00504556|454612662|FG004|Overall Study|Other|0|||
126360617|NCT00504556|454612658|FG000|Overall Study|not in safety analysis set|0|||
126360618|NCT00504556|454612659|FG001|Overall Study|not in safety analysis set|1|||
126360619|NCT00504556|454612660|FG002|Overall Study|not in safety analysis set|1|||
126360620|NCT00504556|454612661|FG003|Overall Study|not in safety analysis set|0|||
126360621|NCT00504556|454612662|FG004|Overall Study|not in safety analysis set|1|||
126360622|NCT01013870|454612663|FG000|Overall Study|Lost to Follow-up|1|||
126360623|NCT01013870|454612664|FG001|Overall Study|Lost to Follow-up|3|||
126360624|NCT01386645|454612665|FG000|Overall Study|Physician Decision|0|||
126360625|NCT01386645|454612666|FG001|Overall Study|Physician Decision|0|||
126360626|NCT01386645|454612667|FG002|Overall Study|Physician Decision|1|||
126360627|NCT01386645|454612665|FG000|Overall Study|Withdrawal by Subject|0|||
126267657|NCT03001219|454272423|FG001|Proof of Concept|Protocol Deviation|1|||
126267658|NCT03001219|454272422|FG000|Proof of Concept|Adverse Event|1|||
126267659|NCT03001219|454272423|FG001|Proof of Concept|Adverse Event|1|||
126267660|NCT03001219|454272422|FG000|Proof of Concept|Physician Decision|1|||
126267661|NCT03001219|454272423|FG001|Proof of Concept|Physician Decision|0|||
126267662|NCT03001219|454272422|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
126267663|NCT03001219|454272423|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
126267664|NCT03001219|454272422|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
126267665|NCT03001219|454272423|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
126267666|NCT03001219|454272422|FG000|Extension Period Analysis|Physician Decision|0|||
126267667|NCT03001219|454272423|FG001|Extension Period Analysis|Physician Decision|1|||
126267668|NCT03001219|454272422|FG000|Extension Period Analysis|Adverse Event|1|||
126267669|NCT03001219|454272423|FG001|Extension Period Analysis|Adverse Event|1|||
126267670|NCT03001219|454272422|FG000|Extension Period Analysis|Protocol Deviation|0|||
126267671|NCT03001219|454272423|FG001|Extension Period Analysis|Protocol Deviation|1|||
126267672|NCT03001219|454272422|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
126267673|NCT03001219|454272423|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
126267674|NCT01195103|454272424|FG000|Overall Study|Withdrawal by Subject|1|||
126267675|NCT01195103|454272425|FG001|Overall Study|Withdrawal by Subject|0|||
126267676|NCT01195103|454272426|FG002|Overall Study|Withdrawal by Subject|0|||
126267677|NCT03733210|454272427|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
126267678|NCT03733210|454272428|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
126267679|NCT03760250|454272429|FG000|Overall Study|Withdrawal by Subject|1|||
126267680|NCT03760250|454272429|FG000|Overall Study|Physician Decision|1|||
126267681|NCT04421586|454272430|FG000|Overall Study|Death|0|||
126267682|NCT04421586|454272431|FG001|Overall Study|Death|1|||
126267683|NCT04421586|454272430|FG000|Overall Study|Lost to Follow-up|2|||
126267684|NCT04421586|454272431|FG001|Overall Study|Lost to Follow-up|2|||
126267685|NCT04421586|454272430|FG000|Overall Study|Withdrawn by PI|1|||
126267686|NCT04421586|454272431|FG001|Overall Study|Withdrawn by PI|0|||
126267687|NCT04421586|454272430|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
126267688|NCT04421586|454272431|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
126267689|NCT05065983|454272433|FG000|Overall Study|Lost to Follow-up|2|||
126267690|NCT00986180|454272434|FG000|Overall Study|Adverse Event|21|||
126267691|NCT00986180|454272435|FG001|Overall Study|Adverse Event|23|||
126267692|NCT00986180|454272434|FG000|Overall Study|Lack of Efficacy|4|||
126267693|NCT00986180|454272435|FG001|Overall Study|Lack of Efficacy|3|||
126267694|NCT00986180|454272434|FG000|Overall Study|Lost to Follow-up|5|||
126267695|NCT00986180|454272435|FG001|Overall Study|Lost to Follow-up|7|||
126360628|NCT01386645|454612666|FG001|Overall Study|Withdrawal by Subject|1|||
126360629|NCT01386645|454612667|FG002|Overall Study|Withdrawal by Subject|1|||
126360630|NCT03142451|454612677|FG000|Overall Study|Adverse Event|5|||
126360631|NCT03142451|454612678|FG001|Overall Study|Adverse Event|2|||
126360632|NCT03142451|454612677|FG000|Overall Study|Lost to Follow-up|25|||
126360633|NCT03142451|454612678|FG001|Overall Study|Lost to Follow-up|8|||
126360634|NCT03142451|454612677|FG000|Overall Study|Participant request|24|||
126360635|NCT03142451|454612678|FG001|Overall Study|Participant request|12|||
126360636|NCT03142451|454612677|FG000|Overall Study|Protocol Violation|3|||
126360637|NCT03142451|454612678|FG001|Overall Study|Protocol Violation|1|||
126453224|NCT03254459|454961369|FG000|Overall Study|Lost to Follow-up|0|||
126453225|NCT03254459|454961370|FG001|Overall Study|Lost to Follow-up|1|||
126360638|NCT03142451|454612677|FG000|Overall Study|Other|1|||
126267696|NCT00986180|454272434|FG000|Overall Study|Physician Decision|1|||
126360639|NCT03142451|454612678|FG001|Overall Study|Other|1|||
126360640|NCT03048019|454612679|FG000|Overall Study|Adverse Event|1|||
126267697|NCT00986180|454272435|FG001|Overall Study|Physician Decision|3|||
126267698|NCT00986180|454272434|FG000|Overall Study|Protocol Violation|2|||
126267699|NCT00986180|454272435|FG001|Overall Study|Protocol Violation|0|||
126267700|NCT00986180|454272434|FG000|Overall Study|Withdrawal by Subject|1|||
126360641|NCT03048019|454612680|FG001|Overall Study|Adverse Event|0|||
126267701|NCT00986180|454272435|FG001|Overall Study|Withdrawal by Subject|9|||
126267702|NCT00986180|454272434|FG000|Overall Study|Miscellanies|10|||
126267703|NCT00986180|454272435|FG001|Overall Study|Miscellanies|11|||
126267704|NCT01765582|454272436|FG000|Overall Study|Other|3|||
126267705|NCT01765582|454272437|FG001|Overall Study|Other|6|||
126267706|NCT01765582|454272438|FG002|Overall Study|Other|9|||
126267707|NCT01765582|454272436|FG000|Overall Study|Lost to Follow-up|2|||
126267708|NCT01765582|454272437|FG001|Overall Study|Lost to Follow-up|2|||
126267709|NCT01765582|454272438|FG002|Overall Study|Lost to Follow-up|1|||
126267710|NCT01765582|454272436|FG000|Overall Study|Death|31|||
126267711|NCT01765582|454272437|FG001|Overall Study|Death|36|||
126267712|NCT01765582|454272438|FG002|Overall Study|Death|33|||
126267713|NCT01765582|454272436|FG000|Overall Study|Sponsor Decision|46|||
126267714|NCT01765582|454272437|FG001|Overall Study|Sponsor Decision|42|||
126267715|NCT01765582|454272438|FG002|Overall Study|Sponsor Decision|42|||
126267716|NCT01765582|454272436|FG000|Overall Study|Withdrawal of Consent|11|||
126267717|NCT01765582|454272437|FG001|Overall Study|Withdrawal of Consent|6|||
126267718|NCT01765582|454272438|FG002|Overall Study|Withdrawal of Consent|10|||
126267719|NCT01691820|454272439|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
126267720|NCT01691820|454272440|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
126267721|NCT01691820|454272439|FG000|Overall Study|Migrated/moved from study area|7|||
126267722|NCT01691820|454272440|FG001|Overall Study|Migrated/moved from study area|4|||
126453226|NCT03254459|454961369|FG000|Overall Study|Miscellaneous|0|||
126453227|NCT03254459|454961370|FG001|Overall Study|Miscellaneous|1|||
126453228|NCT00727441|454961371|FG000|Overall Study|Disease Progression|11|||
126453229|NCT00727441|454961372|FG001|Overall Study|Disease Progression|14|||
126453230|NCT00727441|454961373|FG002|Overall Study|Disease Progression|17|||
126453231|NCT00727441|454961371|FG000|Overall Study|Eligibility|7|||
126453232|NCT00727441|454961372|FG001|Overall Study|Eligibility|5|||
126453233|NCT00727441|454961373|FG002|Overall Study|Eligibility|7|||
126453234|NCT00727441|454961371|FG000|Overall Study|Death|0|||
126267723|NCT01691820|454272439|FG000|Overall Study|Lost to Follow-up|6|||
126267724|NCT01691820|454272440|FG001|Overall Study|Lost to Follow-up|17|||
126267725|NCT01691820|454272439|FG000|Overall Study|Other (unspecified)|4|||
126267726|NCT01691820|454272440|FG001|Overall Study|Other (unspecified)|1|||
126267727|NCT00076804|454272445|FG000|Overall Study|Death|9|||
126267728|NCT00076804|454272446|FG001|Overall Study|Death|20|||
126267729|NCT00076804|454272445|FG000|Overall Study|Lost to Follow-up|9|||
126267730|NCT00076804|454272446|FG001|Overall Study|Lost to Follow-up|9|||
126267731|NCT00076804|454272445|FG000|Overall Study|Withdrawal by Subject|10|||
126267732|NCT00076804|454272446|FG001|Overall Study|Withdrawal by Subject|8|||
126267733|NCT00076804|454272445|FG000|Overall Study|Early study Closure|32|||
126267734|NCT00076804|454272446|FG001|Overall Study|Early study Closure|32|||
126267735|NCT01615263|454272448|FG000|Overall Study|Post-randomization exclusion|0|||
126267736|NCT01615263|454272449|FG001|Overall Study|Post-randomization exclusion|2|||
126267737|NCT00857259|454272450|FG000|Overall Study|Protocol Violation|1|||
126267738|NCT00857259|454272451|FG001|Overall Study|Protocol Violation|0|||
126267739|NCT00857259|454272452|FG002|Overall Study|Protocol Violation|1|||
126267740|NCT02701413|454272453|FG000|Overall Study|Withdrawal by Subject|7|||
126267741|NCT02701413|454272454|FG001|Overall Study|Withdrawal by Subject|11|||
126267742|NCT01370213|454272455|FG000|Overall Study|Early Death|1|||
126267743|NCT01370213|454272456|FG001|Overall Study|Early Death|0|||
126267744|NCT01370213|454272457|FG002|Overall Study|Early Death|0|||
126267745|NCT01370213|454272455|FG000|Overall Study|Not evaluable|0|||
126267746|NCT01370213|454272456|FG001|Overall Study|Not evaluable|2|||
126267747|NCT01370213|454272457|FG002|Overall Study|Not evaluable|0|||
126267748|NCT01321008|454272463|FG000|Overall Study|Early Study Termination|1|||
126267749|NCT03852459|454272468|FG000|Overall Study|Adverse Event|2|||
126267750|NCT03852459|454272469|FG001|Overall Study|Adverse Event|2|||
126267751|NCT03852459|454272468|FG000|Overall Study|Withdrawal by Subject|1|||
126267752|NCT03852459|454272469|FG001|Overall Study|Withdrawal by Subject|1|||
126267753|NCT00257920|454272471|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
126267754|NCT00257920|454272472|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
126267755|NCT00257920|454272471|FG000|Period: Second Intervention|Other|2|||
126267756|NCT00257920|454272472|FG001|Period: Second Intervention|Other|1|||
126267757|NCT03097588|454272477|FG000|Overall Study|Adverse Event|1|||
126267758|NCT02687360|454272478|FG000|Overall Study|Withdrawal by Subject|3|||
126267759|NCT02687360|454272479|FG001|Overall Study|Withdrawal by Subject|0|||
126267760|NCT03456960|454272480|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
126453235|NCT00727441|454961372|FG001|Overall Study|Death|1|||
126765516|NCT02335411|456094533|FG002|Overall Study|Adverse Event|0|||
126267761|NCT03456960|454272481|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
126267762|NCT03456960|454272482|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
126267763|NCT03456960|454272483|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
126267764|NCT03456960|454272484|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
126267765|NCT03456960|454272485|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
126267766|NCT03456960|454272480|FG000|Period 2 (1 Day)|Adverse Event|1|||
126453236|NCT00727441|454961373|FG002|Overall Study|Death|1|||
126765517|NCT01891669|456094534|FG000|Overall Study|Death|0|||
126360642|NCT01716559|454612688|FG000|Overall Study|Adverse Event|11|||
126360643|NCT01716559|454612688|FG000|Overall Study|Death|21|||
126360644|NCT01716559|454612688|FG000|Overall Study|Withdrawal by Subject|4|||
126360645|NCT01716559|454612688|FG000|Overall Study|Other withdrawal reason|75|||
126360646|NCT02773537|454612697|FG000|Overall Study|Lost to Follow-up|0|||
126547354|NCT03757234|455296210|FG003|Overall Study|Withdrawal by Subject|1|||
126267767|NCT03456960|454272481|FG001|Period 2 (1 Day)|Adverse Event|0|||
126267768|NCT03456960|454272482|FG002|Period 2 (1 Day)|Adverse Event|0|||
126267769|NCT03456960|454272483|FG003|Period 2 (1 Day)|Adverse Event|1|||
126267770|NCT03456960|454272484|FG004|Period 2 (1 Day)|Adverse Event|0|||
126267771|NCT03456960|454272485|FG005|Period 2 (1 Day)|Adverse Event|0|||
126267772|NCT02989168|454272486|FG000|Overall Study|Withdrawal by Subject|2|||
126267773|NCT02989168|454272487|FG001|Overall Study|Withdrawal by Subject|0|||
126267774|NCT02989168|454272486|FG000|Overall Study|Physician Decision|0|||
126267775|NCT02989168|454272487|FG001|Overall Study|Physician Decision|1|||
126267776|NCT02989168|454272486|FG000|Overall Study|Adverse Event|1|||
126267777|NCT02989168|454272487|FG001|Overall Study|Adverse Event|2|||
126267778|NCT02989168|454272486|FG000|Overall Study|Sponsor stopped study.|1|||
126267779|NCT02989168|454272487|FG001|Overall Study|Sponsor stopped study.|0|||
126267780|NCT03828448|454272488|FG000|Overall Study|Sponsor's Discretion|34|||
126267781|NCT02037165|454272489|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
126267782|NCT02037165|454272490|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
126267783|NCT02037165|454272491|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
126267784|NCT02037165|454272492|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
126267785|NCT02037165|454272493|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
126267786|NCT00532935|454272494|FG000|Overall Study|Adverse Event|11|||
126267787|NCT00532935|454272495|FG001|Overall Study|Adverse Event|12|||
126267788|NCT00532935|454272494|FG000|Overall Study|Lack of Efficacy|0|||
126267789|NCT00532935|454272495|FG001|Overall Study|Lack of Efficacy|3|||
126267790|NCT00532935|454272494|FG000|Overall Study|Lost to Follow-up|10|||
126267791|NCT00532935|454272495|FG001|Overall Study|Lost to Follow-up|6|||
126267792|NCT00532935|454272494|FG000|Overall Study|Physician Decision|4|||
126267793|NCT00532935|454272495|FG001|Overall Study|Physician Decision|5|||
126267794|NCT00532935|454272494|FG000|Overall Study|Pregnancy|1|||
126267795|NCT00532935|454272495|FG001|Overall Study|Pregnancy|0|||
126267796|NCT00532935|454272494|FG000|Overall Study|Protocol Violation|4|||
126267797|NCT00532935|454272495|FG001|Overall Study|Protocol Violation|2|||
126267798|NCT00532935|454272494|FG000|Overall Study|Withdrawal by Subject|10|||
126267799|NCT00532935|454272495|FG001|Overall Study|Withdrawal by Subject|9|||
126267800|NCT00532935|454272494|FG000|Overall Study|Protocol Specific Criteria|11|||
126267801|NCT00532935|454272495|FG001|Overall Study|Protocol Specific Criteria|15|||
126267802|NCT01300923|454272496|FG000|Overall Study|Physician Decision|0|||
126267803|NCT01300923|454272497|FG001|Overall Study|Physician Decision|2|||
126267804|NCT01568866|454272498|FG000|Overall Study|Disease Progression|208|||
126267805|NCT01568866|454272499|FG001|Overall Study|Disease Progression|183|||
126267806|NCT01568866|454272498|FG000|Overall Study|Adverse Event|94|||
126267807|NCT01568866|454272499|FG001|Overall Study|Adverse Event|96|||
126267808|NCT01568866|454272498|FG000|Overall Study|Patient Request|55|||
126267809|NCT01568866|454272499|FG001|Overall Study|Patient Request|71|||
126267810|NCT01568866|454272498|FG000|Overall Study|Physician Decision|40|||
126267811|NCT01568866|454272499|FG001|Overall Study|Physician Decision|32|||
126267812|NCT01568866|454272498|FG000|Overall Study|Withdrawal by Subject|19|||
126267813|NCT01568866|454272499|FG001|Overall Study|Withdrawal by Subject|11|||
126267814|NCT01568866|454272498|FG000|Overall Study|Death|10|||
126267815|NCT01568866|454272499|FG001|Overall Study|Death|18|||
126267816|NCT01568866|454272498|FG000|Overall Study|Protocol Non-compliance|2|||
126267817|NCT01568866|454272499|FG001|Overall Study|Protocol Non-compliance|4|||
126267818|NCT01568866|454272498|FG000|Overall Study|Lost to Follow-up|1|||
126267819|NCT01568866|454272499|FG001|Overall Study|Lost to Follow-up|0|||
126267820|NCT01568866|454272498|FG000|Overall Study|Randomized but Not Dosed|9|||
126267821|NCT01568866|454272499|FG001|Overall Study|Randomized but Not Dosed|1|||
126267822|NCT01698775|454272500|FG000|Phase A|Adverse Event|2|||
126267823|NCT01698775|454272501|FG001|Phase A|Adverse Event|1|||
126360647|NCT02773537|454612698|FG001|Overall Study|Lost to Follow-up|1|||
126360648|NCT02773537|454612699|FG002|Overall Study|Lost to Follow-up|4|||
126360649|NCT01840163|454612700|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
126360650|NCT01840163|454612701|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
126360651|NCT01840163|454612700|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
126360652|NCT01840163|454612701|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
126360653|NCT01840163|454612700|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
126360654|NCT01840163|454612701|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
126360655|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
126360656|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
126267824|NCT01698775|454272500|FG000|Phase A|Death|1|||
126267825|NCT01698775|454272501|FG001|Phase A|Death|1|||
126267826|NCT01698775|454272500|FG000|Phase A|Lack of Efficacy|1|||
126267827|NCT01698775|454272501|FG001|Phase A|Lack of Efficacy|0|||
126267828|NCT01698775|454272500|FG000|Phase A|Lost to Follow-up|1|||
126765518|NCT01891669|456094535|FG001|Overall Study|Death|0|||
126765519|NCT01891669|456094536|FG002|Overall Study|Death|0|||
126765520|NCT01891669|456094537|FG003|Overall Study|Death|0|||
126765521|NCT01891669|456094538|FG004|Overall Study|Death|0|||
126765522|NCT01891669|456094539|FG005|Overall Study|Death|0|||
126765523|NCT01891669|456094540|FG006|Overall Study|Death|0|||
126765524|NCT01891669|456094541|FG007|Overall Study|Death|1|||
126765525|NCT01891669|456094542|FG008|Overall Study|Death|0|||
126765526|NCT01891669|456094543|FG009|Overall Study|Death|1|||
126765527|NCT01891669|456094534|FG000|Overall Study|Withdrawal by Subject|1|||
126765528|NCT01891669|456094535|FG001|Overall Study|Withdrawal by Subject|1|||
126765529|NCT01891669|456094536|FG002|Overall Study|Withdrawal by Subject|0|||
126765530|NCT01891669|456094537|FG003|Overall Study|Withdrawal by Subject|0|||
126765531|NCT01891669|456094538|FG004|Overall Study|Withdrawal by Subject|0|||
126765532|NCT01891669|456094539|FG005|Overall Study|Withdrawal by Subject|0|||
126765533|NCT01891669|456094540|FG006|Overall Study|Withdrawal by Subject|1|||
126765534|NCT01891669|456094541|FG007|Overall Study|Withdrawal by Subject|2|||
126765535|NCT01891669|456094542|FG008|Overall Study|Withdrawal by Subject|1|||
126765536|NCT01891669|456094543|FG009|Overall Study|Withdrawal by Subject|1|||
126765537|NCT01891669|456094534|FG000|Overall Study|Other|1|||
126765538|NCT01891669|456094535|FG001|Overall Study|Other|0|||
126267829|NCT01698775|454272501|FG001|Phase A|Lost to Follow-up|2|||
126267830|NCT01698775|454272500|FG000|Phase A|Protocol Violation|1|||
126267831|NCT01698775|454272501|FG001|Phase A|Protocol Violation|0|||
126267832|NCT01698775|454272500|FG000|Phase A|Withdrawal by Subject|3|||
126267833|NCT01698775|454272501|FG001|Phase A|Withdrawal by Subject|4|||
126267834|NCT01698775|454272500|FG000|Phase A|Kidney [transplant]|0|||
126267835|NCT01698775|454272501|FG001|Phase A|Kidney [transplant]|1|||
126267836|NCT01698775|454272500|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
126267837|NCT01698775|454272501|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
126267838|NCT01698775|454272500|FG000|Phase B|Adverse Event|6|||
126267839|NCT01698775|454272501|FG001|Phase B|Adverse Event|3|||
126267840|NCT01698775|454272500|FG000|Phase B|Death|0|||
126267841|NCT01698775|454272501|FG001|Phase B|Death|1|||
126267842|NCT01698775|454272500|FG000|Phase B|Lack of Efficacy|0|||
126267843|NCT01698775|454272501|FG001|Phase B|Lack of Efficacy|1|||
126267844|NCT01698775|454272500|FG000|Phase B|Lost to Follow-up|0|||
126267845|NCT01698775|454272501|FG001|Phase B|Lost to Follow-up|1|||
126267846|NCT01698775|454272500|FG000|Phase B|Physician Decision|1|||
126267847|NCT01698775|454272501|FG001|Phase B|Physician Decision|1|||
126267848|NCT01698775|454272500|FG000|Phase B|Protocol Violation|1|||
126267849|NCT01698775|454272501|FG001|Phase B|Protocol Violation|1|||
126267850|NCT01698775|454272500|FG000|Phase B|Withdrawal by Subject|6|||
126267851|NCT01698775|454272501|FG001|Phase B|Withdrawal by Subject|2|||
126267852|NCT01244061|454272504|FG000|Overall Study|Death|1|||
126267853|NCT01244061|454272505|FG001|Overall Study|Death|0|||
126267854|NCT01244061|454272504|FG000|Overall Study|Did not meet entrance criteria|1|||
126267855|NCT01244061|454272505|FG001|Overall Study|Did not meet entrance criteria|0|||
126267856|NCT01244061|454272504|FG000|Overall Study|Lack of Efficacy|1|||
126267857|NCT01244061|454272505|FG001|Overall Study|Lack of Efficacy|3|||
126267858|NCT01244061|454272504|FG000|Overall Study|Lost to Follow-up|34|||
126267859|NCT01244061|454272505|FG001|Overall Study|Lost to Follow-up|30|||
126267860|NCT01244061|454272504|FG000|Overall Study|Withdrawal by Subject|29|||
126267861|NCT01244061|454272505|FG001|Overall Study|Withdrawal by Subject|46|||
126267862|NCT01244061|454272504|FG000|Overall Study|Other|8|||
126267863|NCT01244061|454272505|FG001|Overall Study|Other|19|||
126267864|NCT01244061|454272504|FG000|Overall Study|Protocol Violation|1|||
126267865|NCT01244061|454272505|FG001|Overall Study|Protocol Violation|1|||
126267866|NCT01244061|454272504|FG000|Overall Study|Adverse Event|5|||
126360657|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
126360658|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
126360659|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
126360660|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
126360661|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
126765539|NCT01891669|456094536|FG002|Overall Study|Other|0|||
126765540|NCT01891669|456094537|FG003|Overall Study|Other|0|||
126765541|NCT01891669|456094538|FG004|Overall Study|Other|0|||
126267867|NCT01244061|454272505|FG001|Overall Study|Adverse Event|2|||
126267868|NCT01244061|454272504|FG000|Overall Study|Randomized but not treated|2|||
126267869|NCT01244061|454272505|FG001|Overall Study|Randomized but not treated|2|||
126267870|NCT02384850|454272506|FG000|Overall Study|Withdrawal by Subject|2|||
126267871|NCT02384850|454272507|FG001|Overall Study|Withdrawal by Subject|2|||
126267872|NCT02013375|454272508|FG000|Overall Study|Did not engraft|1|||
126267873|NCT02013375|454272508|FG000|Overall Study|Did not engraft|1|||
126267874|NCT02932228|454272512|FG000|Overall Study|Death|8|||
126267875|NCT02932228|454272513|FG001|Overall Study|Death|23|||
126765542|NCT01891669|456094539|FG005|Overall Study|Other|0|||
126765543|NCT01891669|456094540|FG006|Overall Study|Other|0|||
126765544|NCT01891669|456094541|FG007|Overall Study|Other|1|||
126765545|NCT01891669|456094542|FG008|Overall Study|Other|0|||
126765546|NCT01891669|456094543|FG009|Overall Study|Other|0|||
126765547|NCT03075826|456094545|FG000|Overall Study|Withdrawal by Subject|1|||
126453237|NCT00727441|454961371|FG000|Overall Study|Physician Decision|0|||
126453238|NCT00727441|454961372|FG001|Overall Study|Physician Decision|1|||
126267876|NCT02932228|454272512|FG000|Overall Study|not eligible upon chart review|2|||
126267877|NCT02932228|454272513|FG001|Overall Study|not eligible upon chart review|5|||
126267878|NCT00793780|454273828|FG000|Overall Study|Withdrawal by Subject|2|||
126267879|NCT00793780|454273829|FG001|Overall Study|Withdrawal by Subject|1|||
126267880|NCT03310411|454273832|FG000|Period 1|Adverse Event|0|||
126267881|NCT03310411|454273833|FG001|Period 1|Adverse Event|0|||
126267882|NCT03310411|454273834|FG002|Period 1|Adverse Event|0|||
126267883|NCT03310411|454273835|FG003|Period 1|Adverse Event|1|||
126267884|NCT03623386|454273838|FG000|Overall Study|Protocol Violation|3|||
126267885|NCT03623386|454273839|FG001|Overall Study|Protocol Violation|2|||
126267886|NCT03623386|454273840|FG002|Overall Study|Protocol Violation|0|||
126267887|NCT03623386|454273838|FG000|Overall Study|Physician Decision|1|||
126267888|NCT03623386|454273839|FG001|Overall Study|Physician Decision|1|||
126267889|NCT03623386|454273840|FG002|Overall Study|Physician Decision|0|||
126267890|NCT03623386|454273838|FG000|Overall Study|Lost to Follow-up|0|||
126267891|NCT03623386|454273839|FG001|Overall Study|Lost to Follow-up|2|||
126267892|NCT03623386|454273840|FG002|Overall Study|Lost to Follow-up|0|||
126267893|NCT03623386|454273838|FG000|Overall Study|COVID-19|0|||
126267894|NCT03623386|454273839|FG001|Overall Study|COVID-19|1|||
126267895|NCT03623386|454273840|FG002|Overall Study|COVID-19|0|||
126267896|NCT04271735|454273845|FG000|Overall Study|Physician Decision|2|||
126267897|NCT04271735|454273846|FG001|Overall Study|Physician Decision|0|||
126267898|NCT00515541|454273847|FG000|Overall Study|Physician Decision|0|||
126267899|NCT00515541|454273848|FG001|Overall Study|Physician Decision|2|||
126267900|NCT00515541|454273849|FG002|Overall Study|Physician Decision|0|||
126267901|NCT00515541|454273850|FG003|Overall Study|Physician Decision|1|||
126267902|NCT00515541|454273847|FG000|Overall Study|No show for appointments|0|||
126267903|NCT00515541|454273848|FG001|Overall Study|No show for appointments|1|||
126267904|NCT00515541|454273849|FG002|Overall Study|No show for appointments|0|||
126267905|NCT00515541|454273850|FG003|Overall Study|No show for appointments|2|||
126267906|NCT00515541|454273847|FG000|Overall Study|Withdrawal by Subject|0|||
126267907|NCT00515541|454273848|FG001|Overall Study|Withdrawal by Subject|2|||
126267908|NCT00515541|454273849|FG002|Overall Study|Withdrawal by Subject|0|||
126267909|NCT00515541|454273850|FG003|Overall Study|Withdrawal by Subject|2|||
126267910|NCT00922272|454273854|FG000|Open-label Phase|Adverse Event|5|||
126267911|NCT00922272|454273855|FG001|Open-label Phase|Adverse Event|0|||
126267912|NCT00922272|454273854|FG000|Open-label Phase|Protocol Violation|1|||
126267913|NCT00922272|454273855|FG001|Open-label Phase|Protocol Violation|0|||
126267914|NCT00922272|454273854|FG000|Open-label Phase|Withdrawal by Subject|11|||
126267915|NCT00922272|454273855|FG001|Open-label Phase|Withdrawal by Subject|0|||
126267916|NCT00922272|454273854|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
126267917|NCT00922272|454273855|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
126267918|NCT00922272|454273854|FG000|Open-label Phase|Withdrawal criteria met|5|||
126267919|NCT00922272|454273855|FG001|Open-label Phase|Withdrawal criteria met|0|||
126267920|NCT00922272|454273854|FG000|Double-blind Phase|Adverse Event|1|||
126267921|NCT00922272|454273855|FG001|Double-blind Phase|Adverse Event|1|||
126267922|NCT00922272|454273854|FG000|Double-blind Phase|Withdrawal by Subject|1|||
126267923|NCT00922272|454273855|FG001|Double-blind Phase|Withdrawal by Subject|1|||
126267924|NCT00922272|454273854|FG000|Double-blind Phase|Lost to Follow-up|2|||
126267925|NCT00922272|454273855|FG001|Double-blind Phase|Lost to Follow-up|1|||
126267926|NCT00922272|454273854|FG000|Double-blind Phase|Withdrawal criteria met|1|||
126267927|NCT00922272|454273855|FG001|Double-blind Phase|Withdrawal criteria met|1|||
126267928|NCT00922272|454273854|FG000|Double-blind Phase|Noncompliance|1|||
126267929|NCT00922272|454273855|FG001|Double-blind Phase|Noncompliance|1|||
126267930|NCT00922272|454273854|FG000|Double-blind Phase|Positive urine drug screen|1|||
126267931|NCT00922272|454273855|FG001|Double-blind Phase|Positive urine drug screen|1|||
126267932|NCT02588950|454273856|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
126267933|NCT02588950|454273857|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
126267934|NCT02588950|454273858|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
126267935|NCT02588950|454273859|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
126267936|NCT02588950|454273856|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
126267937|NCT02588950|454273857|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
126267938|NCT02588950|454273858|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
126267939|NCT02588950|454273859|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
126267940|NCT03188718|454273860|FG000|Overall Study|Participant noncompliance|4|||
126267941|NCT03188718|454273860|FG000|Overall Study|Withdrawal by Subject|1|||
126267942|NCT03188718|454273860|FG000|Overall Study|Device failure|3|||
126267943|NCT02072824|454273863|FG000|Overall Study|Insufficient clinical response|1|||
126267944|NCT02072824|454273864|FG001|Overall Study|Insufficient clinical response|0|||
126267945|NCT02072824|454273865|FG002|Overall Study|Insufficient clinical response|1|||
126267946|NCT02072824|454273863|FG000|Overall Study|No longer willing to participate|1|||
126267947|NCT02072824|454273864|FG001|Overall Study|No longer willing to participate|0|||
126267948|NCT02072824|454273865|FG002|Overall Study|No longer willing to participate|1|||
126267949|NCT02072824|454273863|FG000|Overall Study|Medication error|0|||
126267950|NCT02072824|454273864|FG001|Overall Study|Medication error|1|||
126267951|NCT02072824|454273865|FG002|Overall Study|Medication error|0|||
126267952|NCT02072824|454273863|FG000|Overall Study|Adverse Event|0|||
126267953|NCT02072824|454273864|FG001|Overall Study|Adverse Event|0|||
126267954|NCT02072824|454273865|FG002|Overall Study|Adverse Event|1|||
126267955|NCT03084367|454273866|FG000|Overall Study|Lost to Follow-up|32|||
126267956|NCT03084367|454273866|FG000|Overall Study|Withdrawal by Subject|4|||
126267957|NCT03084367|454273866|FG000|Overall Study|Other|1|||
126267958|NCT00841906|454273867|FG000|Overall Study|Withdrawal by Subject|2|||
126267959|NCT00841906|454273868|FG001|Overall Study|Withdrawal by Subject|0|||
126267960|NCT02667288|454273871|FG000|Overall Study|Protocol Violation|5|||
126267961|NCT02667288|454273871|FG000|Overall Study|Lost to Follow-up|3|||
126267962|NCT02667288|454273871|FG000|Overall Study|Withdrawal by Subject|5|||
126267963|NCT00912093|454273872|FG000|The Controlled Phase|Death|0|||
126267964|NCT00912093|454273873|FG001|The Controlled Phase|Death|1|||
126267965|NCT00912093|454273874|FG002|The Controlled Phase|Death|0|||
126267966|NCT00912093|454273875|FG003|The Controlled Phase|Death|0|||
126267967|NCT00912093|454273876|FG004|The Controlled Phase|Death|0|||
126453239|NCT00727441|454961373|FG002|Overall Study|Physician Decision|0|||
126453240|NCT00727441|454961371|FG000|Overall Study|Withdrawal by Subject|0|||
126453241|NCT00727441|454961372|FG001|Overall Study|Withdrawal by Subject|1|||
126453242|NCT00727441|454961373|FG002|Overall Study|Withdrawal by Subject|0|||
126267968|NCT00912093|454273872|FG000|The Controlled Phase|Medical Condition|0|||
126267969|NCT00912093|454273873|FG001|The Controlled Phase|Medical Condition|1|||
126267970|NCT00912093|454273874|FG002|The Controlled Phase|Medical Condition|0|||
126267971|NCT00912093|454273875|FG003|The Controlled Phase|Medical Condition|0|||
126267972|NCT00912093|454273876|FG004|The Controlled Phase|Medical Condition|0|||
126267973|NCT00912093|454273872|FG000|The Controlled Phase|Lost to Follow-up|0|||
126267974|NCT00912093|454273873|FG001|The Controlled Phase|Lost to Follow-up|0|||
126267975|NCT00912093|454273874|FG002|The Controlled Phase|Lost to Follow-up|0|||
126267976|NCT00912093|454273875|FG003|The Controlled Phase|Lost to Follow-up|0|||
126267977|NCT00912093|454273876|FG004|The Controlled Phase|Lost to Follow-up|1|||
126267978|NCT00127036|454273877|FG000|Overall Study|Insufficient Data for Analysis|6|||
126267979|NCT00127036|454273878|FG001|Overall Study|Insufficient Data for Analysis|11|||
126267980|NCT00127036|454273877|FG000|Overall Study|Screen Failure|2|||
126267981|NCT00127036|454273878|FG001|Overall Study|Screen Failure|0|||
126267982|NCT04397445|454273881|FG000|Overall Study|Withdrawal by Subject|1|||
126267983|NCT04397445|454273882|FG001|Overall Study|Withdrawal by Subject|0|||
126267984|NCT04397445|454273883|FG002|Overall Study|Withdrawal by Subject|0|||
126267985|NCT04397445|454273884|FG003|Overall Study|Withdrawal by Subject|0|||
126267986|NCT03921151|454273885|FG000|Overall Study|Withdrawal by Subject|11|||
126267987|NCT03921151|454273886|FG001|Overall Study|Withdrawal by Subject|16|||
126267988|NCT00270257|454273890|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
126267989|NCT00270257|454273891|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
126267990|NCT02621034|454273892|FG000|Overall Study|Lost to Follow-up|3|||
126267991|NCT02621034|454273893|FG001|Overall Study|Lost to Follow-up|2|||
126267992|NCT02621034|454273894|FG002|Overall Study|Lost to Follow-up|5|||
126267993|NCT02963441|454273895|FG000|Overall Study|Protocol violation or withdrawn|8|||
126267994|NCT02963441|454273895|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
126267995|NCT02963441|454273895|FG000|Overall Study|IDx-DR insufficient quality|33|||
126267996|NCT02669940|454273898|FG000|Overall Study|Failure to return|0|||
126267997|NCT02669940|454273899|FG001|Overall Study|Failure to return|3|||
126267998|NCT02669940|454273898|FG000|Overall Study|Insufficient follow-up data|1|||
126267999|NCT02669940|454273899|FG001|Overall Study|Insufficient follow-up data|0|||
126268000|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Adverse Event|9|||
126268001|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Adverse Event|4|||
126268002|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Adverse Event|5|||
126268003|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Adverse Event|9|||
126268004|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Adverse Event|8|||
126268005|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Adverse Event|0|||
126268006|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Adverse Event|0|||
126268007|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
126453243|NCT00507728|454961380|FG000|Randomization to Month 3|Lost to Follow-up|15|||
126453244|NCT00507728|454961381|FG001|Randomization to Month 3|Lost to Follow-up|14|||
126268008|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
126268009|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
126268010|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
126268011|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
126268012|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
126268013|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
126268014|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Death|1|||
126268015|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Death|1|||
126268016|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Death|1|||
126268017|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Death|1|||
126268018|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Death|0|||
126268019|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Death|0|||
126705201|NCT00469079|455871682|FG001|Overall Study|Ineligible|1|||
126705202|NCT00469079|455871683|FG002|Overall Study|Ineligible|0|||
126705203|NCT02698410|455871684|FG000|Overall Study|Adverse Event|2|||
126268020|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Death|0|||
126268021|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
126268022|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
126268023|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
126268024|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
126268025|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
126268026|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
126268027|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
126268028|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
126268029|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
126268030|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
126268031|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
126268032|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
126268033|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
126268034|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
126268035|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
126268036|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
126268037|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
126268038|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
126268039|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
126268040|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
126268041|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
126268042|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Other|2|||
126268043|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Other|9|||
126268044|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Other|9|||
126268045|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Other|3|||
126268046|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Other|2|||
126268047|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Other|0|||
126268048|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Other|0|||
126268049|NCT00361335|454273900|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
126268050|NCT00361335|454273901|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
126268051|NCT00361335|454273902|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
126268052|NCT00361335|454273903|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
126268053|NCT00361335|454273904|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
126268054|NCT00361335|454273905|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
126268055|NCT00361335|454273906|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
126268056|NCT00361335|454273900|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
126268057|NCT00361335|454273901|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
126268058|NCT00361335|454273902|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
126268059|NCT00361335|454273903|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
126268060|NCT00361335|454273904|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
126268061|NCT00361335|454273905|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
126268062|NCT00361335|454273906|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
126268063|NCT00361335|454273900|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
126268064|NCT00361335|454273901|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
126268065|NCT00361335|454273902|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
126268066|NCT00361335|454273903|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
126268067|NCT00361335|454273904|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
126268068|NCT00361335|454273905|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
126268069|NCT00361335|454273906|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
126268070|NCT00361335|454273900|FG000|SC Period: Week E0 to Week E24|Death|0|||
126268071|NCT00361335|454273901|FG001|SC Period: Week E0 to Week E24|Death|0|||
126268072|NCT00361335|454273902|FG002|SC Period: Week E0 to Week E24|Death|0|||
126268073|NCT00361335|454273903|FG003|SC Period: Week E0 to Week E24|Death|0|||
126268074|NCT00361335|454273904|FG004|SC Period: Week E0 to Week E24|Death|0|||
126268075|NCT00361335|454273905|FG005|SC Period: Week E0 to Week E24|Death|0|||
126268076|NCT00361335|454273906|FG006|SC Period: Week E0 to Week E24|Death|1|||
126268077|NCT00361335|454273900|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
126268078|NCT00361335|454273901|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
126268079|NCT00361335|454273902|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
126268080|NCT00361335|454273903|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
126268081|NCT00361335|454273904|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
126268082|NCT00361335|454273905|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
126705204|NCT02698410|455871684|FG000|Overall Study|Withdrawal by Subject|1|||
126705205|NCT02698410|455871684|FG000|Overall Study|Other|1|||
126268083|NCT00361335|454273906|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
126705206|NCT01584024|455871685|FG000|Overall Study|Lost to Follow-up|10|||
126268084|NCT00361335|454273900|FG000|SC Period: Week E0 to Week E24|Other|1|||
126268085|NCT00361335|454273901|FG001|SC Period: Week E0 to Week E24|Other|0|||
126268086|NCT00361335|454273902|FG002|SC Period: Week E0 to Week E24|Other|0|||
126268087|NCT00361335|454273903|FG003|SC Period: Week E0 to Week E24|Other|1|||
126268088|NCT00361335|454273904|FG004|SC Period: Week E0 to Week E24|Other|0|||
126268089|NCT00361335|454273905|FG005|SC Period: Week E0 to Week E24|Other|1|||
126268090|NCT00361335|454273906|FG006|SC Period: Week E0 to Week E24|Other|2|||
126268091|NCT00361335|454273900|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
126268092|NCT00361335|454273901|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
126268093|NCT00361335|454273902|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
126268094|NCT00361335|454273903|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
126268095|NCT00361335|454273904|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
126268096|NCT00361335|454273905|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
126268097|NCT00361335|454273906|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
126268098|NCT00616941|454273907|FG000|Overall Study|Progressive Disease|1|||
126268099|NCT00616941|454273908|FG001|Overall Study|Progressive Disease|2|||
126268100|NCT00616941|454273909|FG002|Overall Study|Progressive Disease|1|||
126268101|NCT00616941|454273907|FG000|Overall Study|Adverse Event|0|||
126268102|NCT00616941|454273908|FG001|Overall Study|Adverse Event|1|||
126268103|NCT00616941|454273909|FG002|Overall Study|Adverse Event|1|||
126547355|NCT03757234|455296211|FG004|Overall Study|Withdrawal by Subject|2|||
126547356|NCT03757234|455296207|FG000|Overall Study|Other|1|||
126765548|NCT03075826|456094545|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
126765549|NCT00650806|456094546|FG000|Overall Study|Adverse Event|0|||
126268104|NCT00616941|454273907|FG000|Overall Study|Subject Non-compliance|0|||
126268105|NCT00616941|454273908|FG001|Overall Study|Subject Non-compliance|0|||
126268106|NCT00616941|454273909|FG002|Overall Study|Subject Non-compliance|1|||
126268107|NCT00616941|454273907|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
126268108|NCT00616941|454273908|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
126268109|NCT00616941|454273909|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
126268110|NCT00616941|454273907|FG000|Overall Study|Vaccination Suspended|0|||
126268111|NCT00616941|454273908|FG001|Overall Study|Vaccination Suspended|0|||
126268112|NCT00616941|454273909|FG002|Overall Study|Vaccination Suspended|3|||
126268113|NCT02372071|454273910|FG000|Overall Study|Protocol Violation|18|||
126268114|NCT00714493|454273911|FG000|Overall Study|Adverse Event|11|||
126268115|NCT00714493|454273911|FG000|Overall Study|Death|3|||
126268116|NCT00714493|454273911|FG000|Overall Study|Lack of Efficacy|10|||
126268117|NCT00714493|454273911|FG000|Overall Study|Lost to Follow-up|3|||
126268118|NCT00714493|454273911|FG000|Overall Study|Protocol Violation|12|||
126268119|NCT00714493|454273911|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
126268120|NCT00714493|454273911|FG000|Overall Study|OTHER|2|||
126268121|NCT00506129|454273912|FG000|Overall Study|Disease Progression/Relapse|15|||
126268122|NCT00506129|454273912|FG000|Overall Study|Death|7|||
126268123|NCT01400919|454273913|FG000|Overall Study|Withdrawal by Subject|4|||
126268124|NCT01400919|454273913|FG000|Overall Study|Lost to Follow-up|2|||
126268125|NCT01400919|454273913|FG000|Overall Study|Missed visit|2|||
126268126|NCT00251719|454273914|FG000|Overall Study|Adverse Event|14|||
126268127|NCT00251719|454273915|FG001|Overall Study|Adverse Event|8|||
126268128|NCT00251719|454273916|FG002|Overall Study|Adverse Event|7|||
126268129|NCT00251719|454273914|FG000|Overall Study|Protocol Violation|1|||
126268130|NCT00251719|454273915|FG001|Overall Study|Protocol Violation|1|||
126268131|NCT00251719|454273916|FG002|Overall Study|Protocol Violation|1|||
126268132|NCT00251719|454273914|FG000|Overall Study|Lost to Follow-up|5|||
126268133|NCT00251719|454273915|FG001|Overall Study|Lost to Follow-up|11|||
126268134|NCT00251719|454273916|FG002|Overall Study|Lost to Follow-up|8|||
126268135|NCT00251719|454273914|FG000|Overall Study|Withdrawal by Subject|14|||
126268136|NCT00251719|454273915|FG001|Overall Study|Withdrawal by Subject|12|||
126268137|NCT00251719|454273916|FG002|Overall Study|Withdrawal by Subject|11|||
126268138|NCT00251719|454273914|FG000|Overall Study|Lack of Efficacy|2|||
126268139|NCT00251719|454273915|FG001|Overall Study|Lack of Efficacy|1|||
126268140|NCT00251719|454273916|FG002|Overall Study|Lack of Efficacy|0|||
126268141|NCT00251719|454273914|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
126268142|NCT00251719|454273915|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
126268143|NCT00251719|454273916|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
126268144|NCT00251719|454273914|FG000|Overall Study|Investigator decision|1|||
126268145|NCT00251719|454273915|FG001|Overall Study|Investigator decision|1|||
126765550|NCT00650806|456094547|FG001|Overall Study|Adverse Event|5|||
126765551|NCT00650806|456094548|FG002|Overall Study|Adverse Event|3|||
126765552|NCT00650806|456094549|FG003|Overall Study|Adverse Event|4|||
126765553|NCT00650806|456094546|FG000|Overall Study|Lost to Follow-up|7|||
126765554|NCT00650806|456094547|FG001|Overall Study|Lost to Follow-up|6|||
126765555|NCT00650806|456094548|FG002|Overall Study|Lost to Follow-up|11|||
126268146|NCT00251719|454273916|FG002|Overall Study|Investigator decision|0|||
126268147|NCT00251719|454273914|FG000|Overall Study|Noncompliance|2|||
126268148|NCT00251719|454273915|FG001|Overall Study|Noncompliance|3|||
126268149|NCT00251719|454273916|FG002|Overall Study|Noncompliance|1|||
126268150|NCT00251719|454273914|FG000|Overall Study|Barrett's esophagus|2|||
126765556|NCT00650806|456094549|FG003|Overall Study|Lost to Follow-up|10|||
126268151|NCT00251719|454273915|FG001|Overall Study|Barrett's esophagus|2|||
126453245|NCT00507728|454961382|FG002|Randomization to Month 3|Lost to Follow-up|20|||
126453246|NCT00507728|454961380|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
126453247|NCT00507728|454961381|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
126453248|NCT00507728|454961382|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
126453249|NCT01964755|454961383|FG000|Overall Study|Death|2|||
126453250|NCT01332799|454961387|FG000|Overall Study|Insufficient funding|10|||
126453251|NCT01332799|454961388|FG001|Overall Study|Insufficient funding|10|||
126453252|NCT02168387|454961391|FG000|Overall Study|Planned exubation|6|||
126453253|NCT02168387|454961392|FG001|Overall Study|Planned exubation|3|||
126765557|NCT00650806|456094546|FG000|Overall Study|Protocol Violation|0|||
126765558|NCT00650806|456094547|FG001|Overall Study|Protocol Violation|0|||
126765559|NCT00650806|456094548|FG002|Overall Study|Protocol Violation|0|||
126765560|NCT00650806|456094549|FG003|Overall Study|Protocol Violation|1|||
126765561|NCT00650806|456094546|FG000|Overall Study|Pregnancy|0|||
126765562|NCT00650806|456094547|FG001|Overall Study|Pregnancy|0|||
126765563|NCT00650806|456094548|FG002|Overall Study|Pregnancy|0|||
126268152|NCT00251719|454273916|FG002|Overall Study|Barrett's esophagus|0|||
126268153|NCT04392583|454273919|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
126268154|NCT02408068|454273920|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
126268155|NCT02408068|454273921|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
126268156|NCT02408068|454273922|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
126268157|NCT02408068|454273923|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
126268158|NCT02408068|454273924|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
126268159|NCT02408068|454273925|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
126268160|NCT02303041|454273929|FG000|Overall Study|Adverse Event|1|||
126268161|NCT02303041|454273930|FG001|Overall Study|Adverse Event|2|||
126268162|NCT01621191|454273933|FG000|Overall Study|Adverse Event|9|||
126268163|NCT01621191|454273933|FG000|Overall Study|Withdrawal by Subject|8|||
126268164|NCT01621191|454273933|FG000|Overall Study|Lack of Efficacy|6|||
126268165|NCT01621191|454273933|FG000|Overall Study|Lost to Follow-up|1|||
126268166|NCT01621191|454273933|FG000|Overall Study|Site Removed From Study|1|||
126268167|NCT00706381|454273934|FG000|Overall Study|Lost to Follow-up|0|||
126268168|NCT00706381|454273935|FG001|Overall Study|Lost to Follow-up|1|||
126268169|NCT00706381|454273936|FG002|Overall Study|Lost to Follow-up|1|||
126268170|NCT00706381|454273937|FG003|Overall Study|Lost to Follow-up|0|||
126268171|NCT01782482|454273945|FG000|Overall Study|Adverse Event|2|||
126268172|NCT01782482|454273946|FG001|Overall Study|Adverse Event|1|||
126268173|NCT01782482|454273945|FG000|Overall Study|Lost to Follow-up|2|||
126268174|NCT01782482|454273946|FG001|Overall Study|Lost to Follow-up|3|||
126360662|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
126360663|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
126360664|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
126360665|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
126360666|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
126360667|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Other|6|||
126360668|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Other|3|||
126360669|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Other|0|||
126360670|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
126360671|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
126360672|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
126360673|NCT03636269|454612703|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
126360674|NCT03636269|454612704|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
126360675|NCT03636269|454612705|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
126360676|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Adverse Event|0|||
126360677|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Adverse Event|0|||
126360678|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Adverse Event|21|||
126360679|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
126360680|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
126360681|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
126360682|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
126360683|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
126360684|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
126360685|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
126453254|NCT02168387|454961391|FG000|Overall Study|Death|1|||
126453255|NCT02168387|454961392|FG001|Overall Study|Death|0|||
126268175|NCT01782482|454273945|FG000|Overall Study|Physician Decision|1|||
126453256|NCT03467152|454961393|FG000|Overall Study|Adverse Event|4|||
126765564|NCT00650806|456094549|FG003|Overall Study|Pregnancy|1|||
126765565|NCT00650806|456094546|FG000|Overall Study|Withdrawal by Subject|7|||
126268176|NCT01782482|454273946|FG001|Overall Study|Physician Decision|0|||
126268177|NCT01782482|454273945|FG000|Overall Study|Protocol Violation|1|||
126268178|NCT01782482|454273946|FG001|Overall Study|Protocol Violation|0|||
126268179|NCT01782482|454273945|FG000|Overall Study|Withdrawal by Subject|2|||
126268180|NCT01782482|454273946|FG001|Overall Study|Withdrawal by Subject|3|||
126268181|NCT01782482|454273945|FG000|Overall Study|Randomized in Error|2|||
126360686|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
126360687|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
126360688|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Administrative|0|||
126360689|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Administrative|0|||
126360690|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Administrative|36|||
126360691|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Other|0|||
126360692|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Other|0|||
126360693|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Other|9|||
126360694|NCT03636269|454612703|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
126360695|NCT03636269|454612704|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
126360696|NCT03636269|454612705|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
126360697|NCT03774810|454612710|FG000|Phase 1|Lack of Efficacy|21|||
126360698|NCT03774810|454612711|FG001|Phase 1|Lack of Efficacy|0|||
126360699|NCT03774810|454612712|FG002|Phase 1|Lack of Efficacy|0|||
126360700|NCT03774810|454612713|FG003|Phase 1|Lack of Efficacy|0|||
126360701|NCT03774810|454612714|FG004|Phase 1|Lack of Efficacy|0|||
126360702|NCT03774810|454612710|FG000|Phase 1|Withdrawal by Subject|9|||
126360703|NCT03774810|454612711|FG001|Phase 1|Withdrawal by Subject|0|||
126360704|NCT03774810|454612712|FG002|Phase 1|Withdrawal by Subject|0|||
126360705|NCT03774810|454612713|FG003|Phase 1|Withdrawal by Subject|0|||
126360706|NCT03774810|454612714|FG004|Phase 1|Withdrawal by Subject|0|||
126360707|NCT03774810|454612710|FG000|Phase 1|Lost to Follow-up|2|||
126360708|NCT03774810|454612711|FG001|Phase 1|Lost to Follow-up|0|||
126360709|NCT03774810|454612712|FG002|Phase 1|Lost to Follow-up|0|||
126360710|NCT03774810|454612713|FG003|Phase 1|Lost to Follow-up|0|||
126360711|NCT03774810|454612714|FG004|Phase 1|Lost to Follow-up|0|||
126360712|NCT03774810|454612710|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
126360713|NCT03774810|454612711|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
126360714|NCT03774810|454612712|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
126360715|NCT03774810|454612713|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
126360716|NCT03774810|454612714|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
126360717|NCT03774810|454612710|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
126360718|NCT03774810|454612711|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
126360719|NCT03774810|454612712|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
126360720|NCT03774810|454612713|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
126360721|NCT03774810|454612714|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
126360722|NCT03774810|454612710|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
126360723|NCT03774810|454612711|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
126360724|NCT03774810|454612712|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
126360725|NCT03774810|454612713|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
126360726|NCT03774810|454612714|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
126360727|NCT03774810|454612710|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
126360728|NCT03774810|454612711|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
126360729|NCT03774810|454612712|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
126360730|NCT03774810|454612713|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
126360731|NCT03774810|454612714|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
126360732|NCT03774810|454612710|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
126360733|NCT03774810|454612711|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
126360734|NCT03774810|454612712|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
126360735|NCT03774810|454612713|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
126360736|NCT03774810|454612714|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
126360737|NCT03774810|454612710|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
126360738|NCT03774810|454612711|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
126360739|NCT03774810|454612712|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
126360740|NCT03774810|454612713|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
126360741|NCT03774810|454612714|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
126360742|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
126360743|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
126360744|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
126360745|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
126360746|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
126360747|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
126360748|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
126360749|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
126360750|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
126360751|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
126360752|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
126360753|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
126360754|NCT00290758|454612715|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
126360755|NCT00290758|454612716|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
126360756|NCT00290758|454612715|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
126360757|NCT00290758|454612716|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
126360758|NCT04914000|454612717|FG000|Overall Study|Lost to Follow-up|8|||
126360759|NCT04914000|454612717|FG000|Overall Study|Withdrawal by Subject|1|||
126360760|NCT01429623|454612718|FG000|Overall Study|Death|1|||
126360761|NCT01429623|454612719|FG001|Overall Study|Death|0|||
126360762|NCT01429623|454612718|FG000|Overall Study|Adverse Event|7|||
126268182|NCT01782482|454273946|FG001|Overall Study|Randomized in Error|2|||
126268183|NCT01782482|454273945|FG000|Overall Study|Habitually wearing toric lens OS|0|||
126268184|NCT01782482|454273946|FG001|Overall Study|Habitually wearing toric lens OS|1|||
126268185|NCT00038649|454273948|FG000|Overall Study|Adverse Event|9|||
126268186|NCT00995085|454273949|FG000|Overall Study|Withdrawal by Subject|5|||
126268187|NCT03096847|454273955|FG000|Overall Study|Other|2|||
126268188|NCT03096847|454273956|FG001|Overall Study|Other|1|||
126268189|NCT03096847|454273957|FG002|Overall Study|Other|2|||
126268190|NCT03096847|454273955|FG000|Overall Study|Lost to Follow-up|1|||
126268191|NCT03096847|454273956|FG001|Overall Study|Lost to Follow-up|0|||
126268192|NCT03096847|454273957|FG002|Overall Study|Lost to Follow-up|1|||
126268193|NCT03096847|454273955|FG000|Overall Study|Death|6|||
126268194|NCT03096847|454273956|FG001|Overall Study|Death|0|||
126268195|NCT03096847|454273957|FG002|Overall Study|Death|2|||
126268196|NCT03096847|454273955|FG000|Overall Study|Protocol Violation|3|||
126268197|NCT03096847|454273956|FG001|Overall Study|Protocol Violation|0|||
126268198|NCT03096847|454273957|FG002|Overall Study|Protocol Violation|6|||
126268199|NCT03096847|454273955|FG000|Overall Study|Physician Decision|12|||
126268200|NCT03096847|454273956|FG001|Overall Study|Physician Decision|2|||
126268201|NCT03096847|454273957|FG002|Overall Study|Physician Decision|8|||
126268202|NCT03096847|454273955|FG000|Overall Study|Withdrawal by Subject|24|||
126268203|NCT03096847|454273956|FG001|Overall Study|Withdrawal by Subject|1|||
126360763|NCT01429623|454612719|FG001|Overall Study|Adverse Event|14|||
126360764|NCT01429623|454612718|FG000|Overall Study|Withdrawal by Subject|19|||
126360765|NCT01429623|454612719|FG001|Overall Study|Withdrawal by Subject|13|||
126360766|NCT01429623|454612718|FG000|Overall Study|Physician Decision|2|||
126360767|NCT01429623|454612719|FG001|Overall Study|Physician Decision|3|||
126360768|NCT01429623|454612718|FG000|Overall Study|Protocol Violation|3|||
126453257|NCT03467152|454961394|FG001|Overall Study|Adverse Event|5|||
126453258|NCT03467152|454961395|FG002|Overall Study|Adverse Event|0|||
126453259|NCT03467152|454961393|FG000|Overall Study|Subject Choice|1|||
126453260|NCT03467152|454961394|FG001|Overall Study|Subject Choice|3|||
126360769|NCT01429623|454612719|FG001|Overall Study|Protocol Violation|2|||
126360770|NCT01429623|454612718|FG000|Overall Study|Assorted|1|||
126360771|NCT01429623|454612719|FG001|Overall Study|Assorted|2|||
126360772|NCT01429623|454612718|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
126360773|NCT01429623|454612719|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
126360774|NCT01429623|454612718|FG000|Overall Study|No post baseline data|4|||
126360775|NCT01429623|454612719|FG001|Overall Study|No post baseline data|4|||
126360776|NCT01896986|454612721|FG000|Overall Study|samples lost|14|||
126360777|NCT01896986|454612722|FG001|Overall Study|samples lost|23|||
126360778|NCT04189588|454612727|FG000|Overall Study|Death|0|||
126360779|NCT04189588|454612728|FG001|Overall Study|Death|1|||
126360780|NCT04189588|454612727|FG000|Overall Study|Lost to Follow-up|0|||
126453261|NCT03467152|454961395|FG002|Overall Study|Subject Choice|0|||
126453262|NCT03467152|454961393|FG000|Overall Study|Lost to Follow-up|1|||
126453263|NCT03467152|454961394|FG001|Overall Study|Lost to Follow-up|0|||
126453264|NCT03467152|454961395|FG002|Overall Study|Lost to Follow-up|0|||
126453265|NCT03467152|454961393|FG000|Overall Study|Withdrawal by Subject|4|||
126765566|NCT00650806|456094547|FG001|Overall Study|Withdrawal by Subject|5|||
126765567|NCT00650806|456094548|FG002|Overall Study|Withdrawal by Subject|8|||
126765568|NCT00650806|456094549|FG003|Overall Study|Withdrawal by Subject|6|||
126765569|NCT00650806|456094546|FG000|Overall Study|Noncompliance with study drug regimen|1|||
126268204|NCT03096847|454273957|FG002|Overall Study|Withdrawal by Subject|12|||
126360781|NCT04189588|454612728|FG001|Overall Study|Lost to Follow-up|1|||
126360782|NCT01061710|454612730|FG000|Overall Study|Protocol Violation|14|||
126360783|NCT03757715|454612731|FG000|Overall Study|Lost to Follow-up|4|||
126360784|NCT03757715|454612732|FG001|Overall Study|Lost to Follow-up|9|||
126360785|NCT03757715|454612731|FG000|Overall Study|Withdrawal by Subject|1|||
126360786|NCT03757715|454612732|FG001|Overall Study|Withdrawal by Subject|1|||
126360787|NCT03156621|454612733|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
126360788|NCT03156621|454612734|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
126765570|NCT00650806|456094547|FG001|Overall Study|Noncompliance with study drug regimen|1|||
126268205|NCT03096847|454273955|FG000|Overall Study|Adverse Event|72|||
126268206|NCT03096847|454273956|FG001|Overall Study|Adverse Event|6|||
126268207|NCT03096847|454273957|FG002|Overall Study|Adverse Event|28|||
126268208|NCT03096847|454273955|FG000|Overall Study|Progressive disease|97|||
126268209|NCT03096847|454273956|FG001|Overall Study|Progressive disease|10|||
126268210|NCT03096847|454273957|FG002|Overall Study|Progressive disease|78|||
126360789|NCT03156621|454612733|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
126360790|NCT03156621|454612734|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
126360791|NCT03302936|454612735|FG000|Overall Study|Protocol Violation|3|||
126360792|NCT03302936|454612736|FG001|Overall Study|Protocol Violation|4|||
126705207|NCT01584024|455871685|FG000|Overall Study|Withdrawal by Subject|3|||
126705208|NCT01217606|455871686|FG000|Initial Treatment Phase|Other Reasons|0|||
126268211|NCT03096847|454273955|FG000|Overall Study|Non-compliance with study medication|1|||
126268212|NCT03096847|454273956|FG001|Overall Study|Non-compliance with study medication|0|||
126268213|NCT03096847|454273957|FG002|Overall Study|Non-compliance with study medication|0|||
126268214|NCT03096847|454273955|FG000|Overall Study|New therapy for study indication|1|||
126268215|NCT03096847|454273956|FG001|Overall Study|New therapy for study indication|0|||
126268216|NCT03096847|454273957|FG002|Overall Study|New therapy for study indication|1|||
126268217|NCT02749292|454273958|FG000|Overall Study|Physician Decision|1|||
126268218|NCT02749292|454273959|FG001|Overall Study|Physician Decision|0|||
126268219|NCT02749292|454273958|FG000|Overall Study|Withdrawal by Subject|5|||
126268220|NCT02749292|454273959|FG001|Overall Study|Withdrawal by Subject|7|||
126268221|NCT02749292|454273958|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
126268222|NCT02749292|454273959|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
126268223|NCT02749292|454273958|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
126268224|NCT02749292|454273959|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
126268225|NCT02749292|454273958|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
126268226|NCT02749292|454273959|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
126268227|NCT02749292|454273958|FG000|Overall Study|Adverse Event|4|||
126268228|NCT02749292|454273959|FG001|Overall Study|Adverse Event|1|||
126268229|NCT02749292|454273958|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
126268230|NCT02749292|454273959|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
126268231|NCT02749292|454273958|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
126268232|NCT02749292|454273959|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
126268233|NCT02749292|454273958|FG000|Overall Study|Requiring glucocorticoids|0|||
126268234|NCT02749292|454273959|FG001|Overall Study|Requiring glucocorticoids|3|||
126268235|NCT02749292|454273958|FG000|Overall Study|Cancer|1|||
126268236|NCT02749292|454273959|FG001|Overall Study|Cancer|0|||
126268237|NCT02458092|454273960|FG000|Overall Study|Withdrawal by Subject|1|||
126268238|NCT02458092|454273961|FG001|Overall Study|Withdrawal by Subject|0|||
126705209|NCT01217606|455871687|FG001|Initial Treatment Phase|Other Reasons|2|||
126705210|NCT01217606|455871686|FG000|Initial Treatment Phase|Protocol Violation|3|||
126268239|NCT00251641|454273964|FG000|Overall Study|Adverse Event|80|||
126268240|NCT00251641|454273965|FG001|Overall Study|Adverse Event|8|||
126268241|NCT00251641|454273964|FG000|Overall Study|Lack of Efficacy|2|||
126268242|NCT00251641|454273965|FG001|Overall Study|Lack of Efficacy|1|||
126268243|NCT00251641|454273964|FG000|Overall Study|Progression of Disease|0|||
126268244|NCT00251641|454273965|FG001|Overall Study|Progression of Disease|2|||
126268245|NCT00251641|454273964|FG000|Overall Study|Lost to Follow-up|3|||
126268246|NCT00251641|454273965|FG001|Overall Study|Lost to Follow-up|3|||
126268247|NCT00251641|454273964|FG000|Overall Study|Withdrawal by Subject|6|||
126268248|NCT00251641|454273965|FG001|Overall Study|Withdrawal by Subject|8|||
126268249|NCT00251641|454273964|FG000|Overall Study|Protocol Violation|10|||
126268250|NCT00251641|454273965|FG001|Overall Study|Protocol Violation|2|||
126268251|NCT00251641|454273964|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
126268252|NCT00251641|454273965|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
126268253|NCT00251641|454273964|FG000|Overall Study|Switched Treatment|9|||
126268254|NCT00251641|454273965|FG001|Overall Study|Switched Treatment|63|||
126268255|NCT02093221|454273968|FG000|Overall Study|Adverse Event|1|||
126268256|NCT02093221|454273969|FG001|Overall Study|Adverse Event|0|||
126268257|NCT02093221|454273970|FG002|Overall Study|Adverse Event|0|||
126268258|NCT02093221|454273971|FG003|Overall Study|Adverse Event|0|||
126268259|NCT02093221|454273972|FG004|Overall Study|Adverse Event|0|||
126268260|NCT02093221|454273968|FG000|Overall Study|Withdrawal by Subject|1|||
126360793|NCT01259024|454612739|FG000|Overall Study|Physician Decision|1|||
126360794|NCT01657500|454612740|FG000|Overall Study|set impropperly matched|3|||
126360795|NCT01657500|454612741|FG001|Overall Study|set impropperly matched|3|||
126360796|NCT01657500|454612740|FG000|Overall Study|Lost to Follow-up|2|||
126360797|NCT01657500|454612741|FG001|Overall Study|Lost to Follow-up|2|||
126360798|NCT00986102|454612745|FG000|Overall Study|Lost to Follow-up|0|||
126360799|NCT00986102|454612746|FG001|Overall Study|Lost to Follow-up|1|||
126360800|NCT00986102|454612747|FG002|Overall Study|Lost to Follow-up|0|||
126705211|NCT01217606|455871687|FG001|Initial Treatment Phase|Protocol Violation|2|||
126268261|NCT02093221|454273969|FG001|Overall Study|Withdrawal by Subject|1|||
126268262|NCT02093221|454273970|FG002|Overall Study|Withdrawal by Subject|4|||
126268263|NCT02093221|454273971|FG003|Overall Study|Withdrawal by Subject|1|||
126360801|NCT00986102|454612748|FG003|Overall Study|Lost to Follow-up|1|||
126360802|NCT00986102|454612745|FG000|Overall Study|Withdrawal by Subject|1|||
126360803|NCT00986102|454612746|FG001|Overall Study|Withdrawal by Subject|1|||
126360804|NCT00986102|454612747|FG002|Overall Study|Withdrawal by Subject|0|||
126547357|NCT03757234|455296208|FG001|Overall Study|Other|1|||
126705212|NCT01217606|455871686|FG000|Initial Treatment Phase|Personal Reasons|0|||
126268264|NCT02093221|454273972|FG004|Overall Study|Withdrawal by Subject|1|||
126268265|NCT02093221|454273968|FG000|Overall Study|Lost to Follow-up|2|||
126268266|NCT02093221|454273969|FG001|Overall Study|Lost to Follow-up|0|||
126765571|NCT00650806|456094548|FG002|Overall Study|Noncompliance with study drug regimen|0|||
126268267|NCT02093221|454273970|FG002|Overall Study|Lost to Follow-up|1|||
126268268|NCT02093221|454273971|FG003|Overall Study|Lost to Follow-up|1|||
126268269|NCT02093221|454273972|FG004|Overall Study|Lost to Follow-up|0|||
126268270|NCT02093221|454273968|FG000|Overall Study|Death|0|||
126268271|NCT02093221|454273969|FG001|Overall Study|Death|1|||
126268272|NCT02093221|454273970|FG002|Overall Study|Death|0|||
126268273|NCT02093221|454273971|FG003|Overall Study|Death|0|||
126268274|NCT02093221|454273972|FG004|Overall Study|Death|0|||
126268275|NCT02093221|454273968|FG000|Overall Study|Protocol Violation|0|||
126268276|NCT02093221|454273969|FG001|Overall Study|Protocol Violation|1|||
126268277|NCT02093221|454273970|FG002|Overall Study|Protocol Violation|0|||
126268278|NCT02093221|454273971|FG003|Overall Study|Protocol Violation|0|||
126268279|NCT02093221|454273972|FG004|Overall Study|Protocol Violation|0|||
126268280|NCT02093221|454273968|FG000|Overall Study|Study termination|6|||
126360805|NCT00986102|454612748|FG003|Overall Study|Withdrawal by Subject|0|||
126360806|NCT06083493|454612749|FG000|Overall Study|Technical issues with the interventional device|2|||
126360807|NCT06083493|454612750|FG001|Overall Study|Technical issues with the interventional device|2|||
126360808|NCT06083493|454612749|FG000|Overall Study|Performed incorrect visual task|1|||
126360809|NCT06083493|454612750|FG001|Overall Study|Performed incorrect visual task|0|||
126360810|NCT06083493|454612749|FG000|Overall Study|Insufficient baseline performance|0|||
126360811|NCT06083493|454612750|FG001|Overall Study|Insufficient baseline performance|1|||
126360812|NCT04034056|454612751|FG000|Overall Study|Withdrawal by Subject|2|||
126360813|NCT04034056|454612751|FG000|Overall Study|Reason Not Specified|13|||
126360814|NCT04034056|454612751|FG000|Overall Study|Adverse Event|56|||
126360815|NCT01260311|454612761|FG000|Overall Study|Adverse Event|11|||
126360816|NCT01260311|454612761|FG000|Overall Study|Lack of Efficacy|4|||
126360817|NCT01260311|454612761|FG000|Overall Study|Lost to Follow-up|25|||
126360818|NCT01260311|454612761|FG000|Overall Study|Withdrawal by Subject|6|||
126360819|NCT01260311|454612761|FG000|Overall Study|Financial Constraints|77|||
126360820|NCT01260311|454612761|FG000|Overall Study|Gone to Province|2|||
126360821|NCT01260311|454612761|FG000|Overall Study|Medication Stopped|1|||
126360822|NCT01260311|454612761|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
126360823|NCT01452789|454612762|FG000|Overall Study|Withdrawal by Subject|3|||
126360824|NCT01452789|454612763|FG001|Overall Study|Withdrawal by Subject|2|||
126360825|NCT00066170|454612764|FG000|Overall Study|Adverse Event|2|||
126360826|NCT00066170|454612765|FG001|Overall Study|Adverse Event|4|||
126360827|NCT00066170|454612766|FG002|Overall Study|Adverse Event|1|||
126360828|NCT00066170|454612767|FG003|Overall Study|Adverse Event|7|||
126360829|NCT00066170|454612764|FG000|Overall Study|Serious Adverse Event|0|||
126360830|NCT00066170|454612765|FG001|Overall Study|Serious Adverse Event|0|||
126360831|NCT00066170|454612766|FG002|Overall Study|Serious Adverse Event|1|||
126360832|NCT00066170|454612767|FG003|Overall Study|Serious Adverse Event|1|||
126360833|NCT00066170|454612764|FG000|Overall Study|Lost to Follow-up|0|||
126360834|NCT00066170|454612765|FG001|Overall Study|Lost to Follow-up|1|||
126360835|NCT00066170|454612766|FG002|Overall Study|Lost to Follow-up|0|||
126360836|NCT00066170|454612767|FG003|Overall Study|Lost to Follow-up|0|||
126360837|NCT00066170|454612764|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
126360838|NCT00066170|454612765|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
126360839|NCT00066170|454612766|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
126360840|NCT00066170|454612767|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
126360841|NCT00066170|454612764|FG000|Overall Study|Protocol Violation|3|||
126360842|NCT00066170|454612765|FG001|Overall Study|Protocol Violation|0|||
126360843|NCT00066170|454612766|FG002|Overall Study|Protocol Violation|0|||
126360844|NCT00066170|454612767|FG003|Overall Study|Protocol Violation|0|||
126360845|NCT00066170|454612764|FG000|Overall Study|Other|1|||
126360846|NCT00066170|454612765|FG001|Overall Study|Other|5|||
126360847|NCT00066170|454612766|FG002|Overall Study|Other|2|||
126360848|NCT00066170|454612767|FG003|Overall Study|Other|0|||
126360849|NCT03722030|454612768|FG000|Overall Study|Withdrawal by Subject|1|||
126360850|NCT03722030|454612769|FG001|Overall Study|Withdrawal by Subject|0|||
126360851|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Adverse Event|14|||
126360852|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Adverse Event|27|||
126360853|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Adverse Event|60|||
126360854|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Adverse Event|0|||
126360855|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Adverse Event|0|||
126360856|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Pregnancy|0|||
126360857|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Pregnancy|7|||
126360858|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Pregnancy|9|||
126360859|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Pregnancy|0|||
126360860|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Pregnancy|0|||
126268281|NCT02093221|454273969|FG001|Overall Study|Study termination|5|||
126268282|NCT02093221|454273970|FG002|Overall Study|Study termination|4|||
126268283|NCT02093221|454273971|FG003|Overall Study|Study termination|6|||
126268284|NCT02093221|454273972|FG004|Overall Study|Study termination|7|||
126360861|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
126360862|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
126268285|NCT04932941|454273980|FG000|Overall Study|Lost to Follow-up|3|||
126268286|NCT04932941|454273981|FG001|Overall Study|Lost to Follow-up|1|||
126268287|NCT04932941|454273980|FG000|Overall Study|Withdrawal by Subject|7|||
126268288|NCT04932941|454273981|FG001|Overall Study|Withdrawal by Subject|4|||
126268289|NCT04932941|454273980|FG000|Overall Study|Other|4|||
126268290|NCT04932941|454273981|FG001|Overall Study|Other|2|||
126268291|NCT01929031|454273984|FG000|Overall Study|Adverse Event|3|||
126268292|NCT01929031|454273985|FG001|Overall Study|Adverse Event|1|||
126268293|NCT01929031|454273986|FG002|Overall Study|Adverse Event|1|||
126268294|NCT01929031|454273987|FG003|Overall Study|Adverse Event|0|||
126268295|NCT01929031|454273988|FG004|Overall Study|Adverse Event|0|||
126268296|NCT01929031|454273989|FG005|Overall Study|Adverse Event|0|||
126268297|NCT01929031|454273984|FG000|Overall Study|Protocol Violation|1|||
126268298|NCT01929031|454273985|FG001|Overall Study|Protocol Violation|0|||
126268299|NCT01929031|454273986|FG002|Overall Study|Protocol Violation|0|||
126268300|NCT01929031|454273987|FG003|Overall Study|Protocol Violation|0|||
126268301|NCT01929031|454273988|FG004|Overall Study|Protocol Violation|0|||
126268302|NCT01929031|454273989|FG005|Overall Study|Protocol Violation|1|||
126268303|NCT01929031|454273984|FG000|Overall Study|Reason other than specified above|0|||
126268304|NCT01929031|454273985|FG001|Overall Study|Reason other than specified above|1|||
126268305|NCT01929031|454273986|FG002|Overall Study|Reason other than specified above|0|||
126268306|NCT01929031|454273987|FG003|Overall Study|Reason other than specified above|0|||
126268307|NCT01929031|454273988|FG004|Overall Study|Reason other than specified above|1|||
126268308|NCT01929031|454273989|FG005|Overall Study|Reason other than specified above|0|||
126268309|NCT02394730|454273995|FG000|Overall Study|Lost to Follow-up|1|||
126268310|NCT02394730|454273996|FG001|Overall Study|Lost to Follow-up|0|||
126268311|NCT02394730|454273995|FG000|Overall Study|Withdrawal by Subject|0|||
126268312|NCT02394730|454273996|FG001|Overall Study|Withdrawal by Subject|1|||
126268313|NCT04905290|454275790|FG000|Overall Study|Adverse Event|4|||
126268314|NCT04905290|454275790|FG000|Overall Study|Death|2|||
126268315|NCT04905290|454275790|FG000|Overall Study|Withdrawal by Subject|4|||
126268316|NCT04905290|454275790|FG000|Overall Study|Physician Decision|2|||
126268317|NCT04905290|454275790|FG000|Overall Study|Lost to Follow-up|2|||
126268318|NCT04905290|454275790|FG000|Overall Study|Screen Failure|2|||
126268319|NCT04905290|454275790|FG000|Overall Study|Unsuccessful Procedure|2|||
126268320|NCT00821873|454275791|FG000|Overall Study|Lost to Follow-up|4|||
126268321|NCT01995266|454275793|FG000|Overall Study|Death|1|||
126268322|NCT01995266|454275793|FG000|Overall Study|Lack of Efficacy|6|||
126268323|NCT01995266|454275793|FG000|Overall Study|Adverse Event|2|||
126268324|NCT03596151|454275794|FG000|Overall Study|Withdrawal by Subject|1|||
126268325|NCT00729248|454275796|FG000|Overall Study|Physician Decision|2|||
126268326|NCT03222583|454275801|FG000|Overall Study|Withdrawal by Subject|3|||
126268327|NCT03222583|454275802|FG001|Overall Study|Withdrawal by Subject|3|||
126268328|NCT03222583|454275801|FG000|Overall Study|Lost to Follow-up|1|||
126268329|NCT03222583|454275802|FG001|Overall Study|Lost to Follow-up|0|||
126268330|NCT03222583|454275801|FG000|Overall Study|Other|1|||
126268331|NCT03222583|454275802|FG001|Overall Study|Other|3|||
126268332|NCT03573505|454275803|FG000|Overall Study|Adverse Event|1|||
126268333|NCT03573505|454275804|FG001|Overall Study|Adverse Event|1|||
126268334|NCT03573505|454275803|FG000|Overall Study|Consent withdrawn|0|||
126268335|NCT03573505|454275804|FG001|Overall Study|Consent withdrawn|1|||
126268336|NCT03573505|454275803|FG000|Overall Study|Disease progression|0|||
126268337|NCT03573505|454275804|FG001|Overall Study|Disease progression|1|||
126268338|NCT03573505|454275803|FG000|Overall Study|Site Terminated by Sponsor|1|||
126360863|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
126360864|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
126360865|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
126360866|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
126360867|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
126360868|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
126360869|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
126360870|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
126360871|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Death|1|||
126268339|NCT03573505|454275804|FG001|Overall Study|Site Terminated by Sponsor|1|||
126268340|NCT03573505|454275803|FG000|Overall Study|Study terminated by sponsor|50|||
126268341|NCT03573505|454275804|FG001|Overall Study|Study terminated by sponsor|45|||
126268342|NCT03573505|454275803|FG000|Overall Study|Reason not specified|0|||
126268343|NCT03573505|454275804|FG001|Overall Study|Reason not specified|1|||
126360872|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Death|2|||
126360873|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Death|2|||
126268344|NCT03573505|454275803|FG000|Overall Study|Death|0|||
126268345|NCT03573505|454275804|FG001|Overall Study|Death|4|||
126268346|NCT04280705|454275805|FG000|Overall Study|Enrolled but not treated|4|||
126268347|NCT04280705|454275806|FG001|Overall Study|Enrolled but not treated|10|||
126268348|NCT04280705|454275805|FG000|Overall Study|Physician Decision|1|||
126268349|NCT04280705|454275806|FG001|Overall Study|Physician Decision|0|||
126268350|NCT04280705|454275805|FG000|Overall Study|Withdrawal by Subject|7|||
126268351|NCT04280705|454275806|FG001|Overall Study|Withdrawal by Subject|9|||
126268352|NCT04280705|454275805|FG000|Overall Study|Adverse Event|0|||
126268353|NCT04280705|454275806|FG001|Overall Study|Adverse Event|4|||
126268354|NCT04280705|454275805|FG000|Overall Study|Transferred to another hospital|1|||
126268355|NCT04280705|454275806|FG001|Overall Study|Transferred to another hospital|1|||
126268356|NCT04268316|454275809|FG000|Overall Study|Withdrawal by Subject|2|||
126268357|NCT04268316|454275810|FG001|Overall Study|Withdrawal by Subject|1|||
126268358|NCT04268316|454275811|FG002|Overall Study|Withdrawal by Subject|0|||
126268359|NCT04032158|454275818|FG000|Overall Study|Study Termination|2|||
126268360|NCT04032158|454275819|FG001|Overall Study|Study Termination|1|||
126268361|NCT01196078|454275820|FG000|Overall Study|Withdrawal by Subject|3|||
126268362|NCT01196078|454275821|FG001|Overall Study|Withdrawal by Subject|5|||
126268363|NCT01196078|454275820|FG000|Overall Study|Adverse Event|4|||
126268364|NCT01196078|454275821|FG001|Overall Study|Adverse Event|4|||
126268365|NCT01196078|454275820|FG000|Overall Study|Protocol Violation|2|||
126268366|NCT01196078|454275821|FG001|Overall Study|Protocol Violation|1|||
126268367|NCT01196078|454275820|FG000|Overall Study|Lack of Efficacy|17|||
126268368|NCT01196078|454275821|FG001|Overall Study|Lack of Efficacy|23|||
126268369|NCT01196078|454275820|FG000|Overall Study|Lost to Follow-up|1|||
126268370|NCT01196078|454275821|FG001|Overall Study|Lost to Follow-up|0|||
126268371|NCT01196078|454275820|FG000|Overall Study|Death|6|||
126268372|NCT01196078|454275821|FG001|Overall Study|Death|4|||
126268373|NCT01403064|454275822|FG000|Overall Study|Death|0|||
126268374|NCT01403064|454275823|FG001|Overall Study|Death|0|||
126268375|NCT01403064|454275824|FG002|Overall Study|Death|1|||
126268376|NCT01403064|454275825|FG003|Overall Study|Death|1|||
126268377|NCT01403064|454275822|FG000|Overall Study|Withdrawal by Subject|0|||
126268378|NCT01403064|454275823|FG001|Overall Study|Withdrawal by Subject|0|||
126268379|NCT01403064|454275824|FG002|Overall Study|Withdrawal by Subject|1|||
126268380|NCT01403064|454275825|FG003|Overall Study|Withdrawal by Subject|1|||
126268381|NCT01403064|454275822|FG000|Overall Study|Other|1|||
126268382|NCT01403064|454275823|FG001|Overall Study|Other|0|||
126268383|NCT01403064|454275824|FG002|Overall Study|Other|2|||
126268384|NCT01403064|454275825|FG003|Overall Study|Other|1|||
126268385|NCT04688931|454275837|FG000|Overall Study|Adverse Event|4|||
126268386|NCT04688931|454275838|FG001|Overall Study|Adverse Event|1|||
126268387|NCT04688931|454275837|FG000|Overall Study|Withdrawal by Subject|5|||
126268388|NCT04688931|454275838|FG001|Overall Study|Withdrawal by Subject|16|||
126268389|NCT04688931|454275837|FG000|Overall Study|Physician Decision|3|||
126268390|NCT04688931|454275838|FG001|Overall Study|Physician Decision|5|||
126268391|NCT04688931|454275837|FG000|Overall Study|Noncompliance|0|||
126268392|NCT04688931|454275838|FG001|Overall Study|Noncompliance|1|||
126268393|NCT04688931|454275837|FG000|Overall Study|Lost to Follow-up|1|||
126268394|NCT04688931|454275838|FG001|Overall Study|Lost to Follow-up|3|||
126268395|NCT04688931|454275837|FG000|Overall Study|Randomization Error|3|||
126268396|NCT04688931|454275838|FG001|Overall Study|Randomization Error|0|||
126268397|NCT04688931|454275837|FG000|Overall Study|Not Eligible|1|||
126268398|NCT04688931|454275838|FG001|Overall Study|Not Eligible|3|||
126268399|NCT04688931|454275837|FG000|Overall Study|Disease Progression|0|||
126268400|NCT04688931|454275838|FG001|Overall Study|Disease Progression|2|||
126268401|NCT04688931|454275837|FG000|Overall Study|Sponsor Requirement|1|||
126268402|NCT04688931|454275838|FG001|Overall Study|Sponsor Requirement|1|||
126268403|NCT04688931|454275837|FG000|Overall Study|Other Reason|1|||
126268404|NCT04688931|454275838|FG001|Overall Study|Other Reason|2|||
126268405|NCT00450619|454275839|FG000|Overall Study|refused treatment after randomization|2|||
126268406|NCT00450619|454275840|FG001|Overall Study|refused treatment after randomization|0|||
126268407|NCT00450619|454275839|FG000|Overall Study|did not progress; refused further trmt|1|||
126268408|NCT00450619|454275840|FG001|Overall Study|did not progress; refused further trmt|1|||
126268409|NCT00450619|454275839|FG000|Overall Study|Adverse Event|1|||
126268410|NCT00450619|454275840|FG001|Overall Study|Adverse Event|0|||
126268411|NCT01968694|454275860|FG000|Washout (1 Month)|Lost to Follow-up|0|||
126268412|NCT01968694|454275861|FG001|Washout (1 Month)|Lost to Follow-up|1|||
126268413|NCT02836496|454275864|FG000|Overall Study|Adverse Event|2|||
126268414|NCT02836496|454275865|FG001|Overall Study|Adverse Event|1|||
126268415|NCT02836496|454275864|FG000|Overall Study|Withdrawal by Subject|0|||
126268416|NCT02836496|454275865|FG001|Overall Study|Withdrawal by Subject|1|||
126268417|NCT00354341|454275866|FG000|Overall Study|Adverse Event|1|||
126268418|NCT00354341|454275867|FG001|Overall Study|Adverse Event|0|||
126268419|NCT00354341|454275866|FG000|Overall Study|Death|0|||
126268420|NCT00354341|454275867|FG001|Overall Study|Death|2|||
126268421|NCT00354341|454275866|FG000|Overall Study|Refused treatment|1|||
126268422|NCT00354341|454275867|FG001|Overall Study|Refused treatment|2|||
126268423|NCT00354341|454275866|FG000|Overall Study|Failure to return|0|||
126268424|NCT00354341|454275867|FG001|Overall Study|Failure to return|1|||
126268425|NCT00354341|454275866|FG000|Overall Study|Other|1|||
126268426|NCT00354341|454275867|FG001|Overall Study|Other|2|||
126268427|NCT03822832|454275868|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
126268428|NCT03822832|454275869|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
126268429|NCT03822832|454275868|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
126268430|NCT03822832|454275869|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
126268431|NCT03822832|454275868|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
126268432|NCT03822832|454275869|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
126268433|NCT03822832|454275868|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
126268434|NCT03822832|454275869|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
126268435|NCT03822832|454275868|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
126268436|NCT03822832|454275869|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
126268437|NCT03822832|454275868|FG000|Re-allocation|Not re-allocated to open label period|2|||
126268438|NCT03822832|454275869|FG001|Re-allocation|Not re-allocated to open label period|6|||
126268439|NCT03822832|454275868|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
126268440|NCT03822832|454275869|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
126268441|NCT03822832|454275868|FG000|Period 2 - Open Label Period|Adverse Event|0|||
126268442|NCT03822832|454275869|FG001|Period 2 - Open Label Period|Adverse Event|3|||
126268443|NCT01732874|454275870|FG000|Overall Study|Withdrawal by Subject|5|||
126268444|NCT01732874|454275871|FG001|Overall Study|Withdrawal by Subject|1|||
126268445|NCT01732874|454275870|FG000|Overall Study|Death of Infant|3|||
126268446|NCT01732874|454275871|FG001|Overall Study|Death of Infant|2|||
126268447|NCT00557076|454275878|FG000|Overall Study|Unblinding|0|||
126268448|NCT00557076|454275879|FG001|Overall Study|Unblinding|1|||
126268449|NCT00688376|454275880|FG000|Double-Blind Phase|Adverse Event|4|||
126268450|NCT00688376|454275881|FG001|Double-Blind Phase|Adverse Event|4|||
126268451|NCT00688376|454275880|FG000|Double-Blind Phase|Protocol Violation|1|||
126268452|NCT00688376|454275881|FG001|Double-Blind Phase|Protocol Violation|2|||
126268453|NCT00688376|454275880|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
126268454|NCT00688376|454275881|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
126268455|NCT00688376|454275880|FG000|Double-Blind Phase|Not treated|0|||
126268456|NCT00688376|454275881|FG001|Double-Blind Phase|Not treated|1|||
126268457|NCT00688376|454275880|FG000|Blinded Extension Phase|Adverse Event|3|||
126360874|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Death|0|||
126360875|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Death|0|||
126360876|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
126360877|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
126360878|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
126360879|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
126360880|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
126360881|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
126360882|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
126360883|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
126360884|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
126360885|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
126360886|NCT00098293|454612770|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
126360887|NCT00098293|454612771|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
126360888|NCT00098293|454612772|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
126360889|NCT00098293|454612773|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
126360890|NCT00098293|454612774|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
126360891|NCT00098293|454612770|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
126360892|NCT00098293|454612771|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
126360893|NCT00098293|454612772|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
126360894|NCT00098293|454612773|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
126360895|NCT00098293|454612774|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
126360896|NCT00098293|454612770|FG000|Open-label (OL) Phase|Adverse Event|0|||
126360897|NCT00098293|454612771|FG001|Open-label (OL) Phase|Adverse Event|3|||
126360898|NCT00098293|454612772|FG002|Open-label (OL) Phase|Adverse Event|7|||
126360899|NCT00098293|454612773|FG003|Open-label (OL) Phase|Adverse Event|6|||
126360900|NCT00098293|454612774|FG004|Open-label (OL) Phase|Adverse Event|0|||
126453266|NCT03467152|454961394|FG001|Overall Study|Withdrawal by Subject|2|||
126453267|NCT03467152|454961395|FG002|Overall Study|Withdrawal by Subject|0|||
126453268|NCT03467152|454961393|FG000|Overall Study|Others|3|||
126453269|NCT03467152|454961394|FG001|Overall Study|Others|0|||
126453270|NCT03467152|454961395|FG002|Overall Study|Others|0|||
126268458|NCT00688376|454275881|FG001|Blinded Extension Phase|Adverse Event|4|||
126268459|NCT00688376|454275880|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
126268460|NCT00688376|454275881|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
126268461|NCT00688376|454275880|FG000|Blinded Extension Phase|Physician Decision|1|||
126268462|NCT00688376|454275881|FG001|Blinded Extension Phase|Physician Decision|0|||
126360901|NCT00098293|454612770|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
126360902|NCT00098293|454612771|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
126360903|NCT00098293|454612772|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
126453271|NCT03467152|454961393|FG000|Overall Study|Not treated|3|||
126453272|NCT03467152|454961394|FG001|Overall Study|Not treated|1|||
126453273|NCT03467152|454961395|FG002|Overall Study|Not treated|6|||
126268463|NCT00688376|454275880|FG000|Blinded Extension Phase|Other|1|||
126268464|NCT00688376|454275881|FG001|Blinded Extension Phase|Other|0|||
126268465|NCT00846521|454275883|FG000|Overall Study|Withdrawal by Subject|5|||
126268466|NCT00846521|454275883|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
126705213|NCT01217606|455871687|FG001|Initial Treatment Phase|Personal Reasons|2|||
126705214|NCT01217606|455871686|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
126705215|NCT01217606|455871687|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
126705216|NCT01217606|455871686|FG000|Initial Treatment Phase|Adverse Event|10|||
126705217|NCT01217606|455871687|FG001|Initial Treatment Phase|Adverse Event|6|||
126705218|NCT01217606|455871686|FG000|9-Month Masked Extension|Adverse Event|3|||
126705219|NCT01217606|455871687|FG001|9-Month Masked Extension|Adverse Event|6|||
126705220|NCT01217606|455871686|FG000|9-Month Masked Extension|Other Reasons|4|||
126705221|NCT01217606|455871687|FG001|9-Month Masked Extension|Other Reasons|4|||
126268467|NCT00846521|454275883|FG000|Overall Study|Protocol Violation|1|||
126268468|NCT01246011|454275885|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
126268469|NCT01246011|454275886|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
126268470|NCT01246011|454275887|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
126268471|NCT01246011|454275885|FG000|Overall Study|Withdrawal by Subject|0|||
126268472|NCT01246011|454275886|FG001|Overall Study|Withdrawal by Subject|0|||
126705222|NCT01217606|455871686|FG000|9-Month Masked Extension|Personal Reasons|2|||
126268473|NCT01246011|454275887|FG002|Overall Study|Withdrawal by Subject|1|||
126268474|NCT01780987|454275890|FG000|Overall Study|Adverse Event|0|||
126268475|NCT01780987|454275891|FG001|Overall Study|Adverse Event|4|||
126268476|NCT01780987|454275890|FG000|Overall Study|Withdrawal by Subject|2|||
126268477|NCT01780987|454275891|FG001|Overall Study|Withdrawal by Subject|0|||
126268478|NCT01780987|454275890|FG000|Overall Study|Request of Changing Hospital|0|||
126268479|NCT01780987|454275891|FG001|Overall Study|Request of Changing Hospital|1|||
126268480|NCT01780987|454275890|FG000|Overall Study|Changing Residence|1|||
126268481|NCT01780987|454275891|FG001|Overall Study|Changing Residence|0|||
126268482|NCT01780987|454275890|FG000|Overall Study|Not Receiving any Study Medication|0|||
126268483|NCT01780987|454275891|FG001|Overall Study|Not Receiving any Study Medication|1|||
126268484|NCT02138136|454275895|FG000|Overall Study|Protocol Violation|4|||
126268485|NCT02138136|454275895|FG000|Overall Study|Physician Decision|7|||
126268486|NCT02138136|454275895|FG000|Overall Study|Lack of Efficacy|35|||
126268487|NCT02138136|454275895|FG000|Overall Study|Pregnancy|2|||
126268488|NCT02138136|454275895|FG000|Overall Study|Adverse Event|18|||
126268489|NCT02138136|454275895|FG000|Overall Study|Withdrawal by Subject|36|||
126268490|NCT02138136|454275895|FG000|Overall Study|Lost to Follow-up|32|||
126268491|NCT02138136|454275895|FG000|Overall Study|Withdrawn by Sponsor|5|||
126268492|NCT03979820|454275898|FG000|Overall Study|Protocol Violation|1|||
126268493|NCT03979820|454275899|FG001|Overall Study|Protocol Violation|0|||
126268494|NCT03979820|454275900|FG002|Overall Study|Protocol Violation|0|||
126268495|NCT03979820|454275901|FG003|Overall Study|Protocol Violation|0|||
126268496|NCT03979820|454275898|FG000|Overall Study|Withdrawal by Subject|0|||
126360904|NCT00098293|454612773|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
126360905|NCT00098293|454612774|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
126360906|NCT00098293|454612770|FG000|Open-label (OL) Phase|Pregnancy|0|||
126705223|NCT01217606|455871687|FG001|9-Month Masked Extension|Personal Reasons|1|||
126268497|NCT03979820|454275899|FG001|Overall Study|Withdrawal by Subject|0|||
126268498|NCT03979820|454275900|FG002|Overall Study|Withdrawal by Subject|1|||
126268499|NCT03979820|454275901|FG003|Overall Study|Withdrawal by Subject|0|||
126268500|NCT03979820|454275898|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
126360907|NCT00098293|454612771|FG001|Open-label (OL) Phase|Pregnancy|1|||
126360908|NCT00098293|454612772|FG002|Open-label (OL) Phase|Pregnancy|0|||
126360909|NCT00098293|454612773|FG003|Open-label (OL) Phase|Pregnancy|3|||
126360910|NCT00098293|454612774|FG004|Open-label (OL) Phase|Pregnancy|0|||
126360911|NCT00098293|454612770|FG000|Open-label (OL) Phase|Protocol Violation|0|||
126360912|NCT00098293|454612771|FG001|Open-label (OL) Phase|Protocol Violation|6|||
126360913|NCT00098293|454612772|FG002|Open-label (OL) Phase|Protocol Violation|13|||
126360914|NCT00098293|454612773|FG003|Open-label (OL) Phase|Protocol Violation|16|||
126360915|NCT00098293|454612774|FG004|Open-label (OL) Phase|Protocol Violation|0|||
126360916|NCT00098293|454612770|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
126360917|NCT00098293|454612771|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
126360918|NCT00098293|454612772|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
126360919|NCT00098293|454612773|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
126360920|NCT00098293|454612774|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
126360921|NCT00098293|454612770|FG000|Open-label (OL) Phase|Death|0|||
126705224|NCT01217606|455871686|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
126268501|NCT03979820|454275899|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
126268502|NCT03979820|454275900|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
126268503|NCT03979820|454275901|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
126268504|NCT00160641|454275902|FG000|Overall Study|Adverse Event|102|||
126268505|NCT00160641|454275902|FG000|Overall Study|Withdrawal by Subject|87|||
126360922|NCT00098293|454612771|FG001|Open-label (OL) Phase|Death|2|||
126705225|NCT01217606|455871687|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
126360923|NCT00098293|454612772|FG002|Open-label (OL) Phase|Death|3|||
126360924|NCT00098293|454612773|FG003|Open-label (OL) Phase|Death|0|||
126360925|NCT00098293|454612774|FG004|Open-label (OL) Phase|Death|0|||
126268506|NCT00160641|454275902|FG000|Overall Study|Lost to Follow-up|8|||
126268507|NCT00160641|454275902|FG000|Overall Study|Lack of Efficacy|12|||
126268508|NCT00160641|454275902|FG000|Overall Study|Protocol Violation|3|||
126268509|NCT00160641|454275902|FG000|Overall Study|Other|9|||
126268510|NCT01640873|454275903|FG000|Overall Study|Protocol Violation|2|||
126268511|NCT01640873|454275904|FG001|Overall Study|Protocol Violation|1|||
126268512|NCT02192164|454275918|FG000|Overall Study|Other|8|||
126268513|NCT02192164|454275918|FG000|Overall Study|Withdrawal by Subject|1|||
126268514|NCT02192164|454275918|FG000|Overall Study|Physician Decision|4|||
126268515|NCT02192164|454275918|FG000|Overall Study|Did not meet the exclusion criteria|1|||
126268516|NCT00359788|454275921|FG000|Overall Study|Adverse Event|11|||
126268517|NCT00359788|454275922|FG001|Overall Study|Adverse Event|10|||
126268518|NCT00359788|454275921|FG000|Overall Study|Lack of Efficacy|1|||
126268519|NCT00359788|454275922|FG001|Overall Study|Lack of Efficacy|2|||
126268520|NCT00359788|454275921|FG000|Overall Study|Lost to Follow-up|3|||
126268521|NCT00359788|454275922|FG001|Overall Study|Lost to Follow-up|2|||
126268522|NCT00359788|454275921|FG000|Overall Study|Withdrawal by Subject|4|||
126268523|NCT00359788|454275922|FG001|Overall Study|Withdrawal by Subject|1|||
126268524|NCT00359788|454275921|FG000|Overall Study|Protocol Violation|4|||
126268525|NCT00359788|454275922|FG001|Overall Study|Protocol Violation|2|||
126268526|NCT02143583|454275923|FG000|Overall Study|Withdrawal by Subject|1|||
126268527|NCT02143583|454275924|FG001|Overall Study|Withdrawal by Subject|0|||
126268528|NCT02143583|454275925|FG002|Overall Study|Withdrawal by Subject|1|||
126268529|NCT02143583|454275923|FG000|Overall Study|husband illness|0|||
126268530|NCT02143583|454275924|FG001|Overall Study|husband illness|0|||
126268531|NCT02143583|454275925|FG002|Overall Study|husband illness|1|||
126268532|NCT00673933|454275926|FG000|Overall Study|Withdrawal by Subject|2|||
126268533|NCT00673933|454275926|FG000|Overall Study|Lost to Follow-up|1|||
126268534|NCT01366443|454275927|FG000|Overall Study|Lost to Follow-up|2|||
126268535|NCT01366443|454275927|FG000|Overall Study|Under 18 yo|1|||
126268536|NCT05816200|454275928|FG000|Overall Study|Lost to Follow-up|2|||
126268537|NCT05816200|454275929|FG001|Overall Study|Lost to Follow-up|1|||
126268538|NCT00369382|454275930|FG000|Overall Study|Death|0|||
126268539|NCT00369382|454275931|FG001|Overall Study|Death|2|||
126268540|NCT00369382|454275930|FG000|Overall Study|Physician Decision|2|||
126268541|NCT00369382|454275931|FG001|Overall Study|Physician Decision|1|||
126268542|NCT00369382|454275930|FG000|Overall Study|Withdrawal by Subject|5|||
126268543|NCT00369382|454275931|FG001|Overall Study|Withdrawal by Subject|0|||
126268544|NCT00369382|454275930|FG000|Overall Study|Randomized, not treated|2|||
126268545|NCT00369382|454275931|FG001|Overall Study|Randomized, not treated|0|||
126268546|NCT00369382|454275930|FG000|Overall Study|Other|1|||
126268547|NCT00369382|454275931|FG001|Overall Study|Other|0|||
126268548|NCT01673698|454275934|FG000|Overall Study|Lost to Follow-up|51|||
126268549|NCT01673698|454275935|FG001|Overall Study|Lost to Follow-up|13|||
126360926|NCT00098293|454612770|FG000|Supplemental Phase (SP)|Death|0|||
126360927|NCT00098293|454612771|FG001|Supplemental Phase (SP)|Death|0|||
126360928|NCT00098293|454612772|FG002|Supplemental Phase (SP)|Death|0|||
126360929|NCT00098293|454612773|FG003|Supplemental Phase (SP)|Death|0|||
126360930|NCT00098293|454612774|FG004|Supplemental Phase (SP)|Death|1|||
126360931|NCT00098293|454612770|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
126360932|NCT00098293|454612771|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
126360933|NCT00098293|454612772|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
126360934|NCT00098293|454612773|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
126360935|NCT00098293|454612774|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
126360936|NCT00098293|454612770|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
126360937|NCT00098293|454612771|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
126360938|NCT00098293|454612772|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
126360939|NCT00098293|454612773|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
126360940|NCT00098293|454612774|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
126360941|NCT00098293|454612770|FG000|Supplemental Phase (SP)|Other|0|||
126360942|NCT00098293|454612771|FG001|Supplemental Phase (SP)|Other|0|||
126360943|NCT00098293|454612772|FG002|Supplemental Phase (SP)|Other|0|||
126360944|NCT00098293|454612773|FG003|Supplemental Phase (SP)|Other|0|||
126360945|NCT00098293|454612774|FG004|Supplemental Phase (SP)|Other|22|||
126360946|NCT01370642|454612775|FG000|Overall Study|Adverse Event|2|||
126360947|NCT01370642|454612776|FG001|Overall Study|Adverse Event|1|||
126360948|NCT01370642|454612777|FG002|Overall Study|Adverse Event|1|||
126360949|NCT01370642|454612775|FG000|Overall Study|Detectable HCV RNA|0|||
126705226|NCT01217606|455871686|FG000|9-Month Masked Extension|Pregnancy|1|||
126268550|NCT00507546|454275936|FG000|Overall Study|Withdrawal by Subject|1|||
126268551|NCT00507546|454275937|FG001|Overall Study|Withdrawal by Subject|0|||
126268552|NCT00507546|454275936|FG000|Overall Study|Protocol Violation|1|||
126268553|NCT00507546|454275937|FG001|Overall Study|Protocol Violation|0|||
126268554|NCT00507546|454275936|FG000|Overall Study|Physician Decision|0|||
126268555|NCT00507546|454275937|FG001|Overall Study|Physician Decision|1|||
126268556|NCT00448136|454275938|FG000|Overall Study|Death|3|||
126360950|NCT01370642|454612776|FG001|Overall Study|Detectable HCV RNA|0|||
126360951|NCT01370642|454612777|FG002|Overall Study|Detectable HCV RNA|22|||
126360952|NCT01370642|454612775|FG000|Overall Study|Lost to Follow-up|0|||
126268557|NCT00448136|454275939|FG001|Overall Study|Death|8|||
126268558|NCT00448136|454275938|FG000|Overall Study|Investigator's decision (progression)|1|||
126268559|NCT00448136|454275939|FG001|Overall Study|Investigator's decision (progression)|0|||
126268560|NCT00609466|454275940|FG000|Overall Study|Withdrawal by Subject|0|||
126268561|NCT00609466|454275941|FG001|Overall Study|Withdrawal by Subject|1|||
126268562|NCT00609466|454275942|FG002|Overall Study|Withdrawal by Subject|1|||
126268563|NCT00609466|454275940|FG000|Overall Study|Adverse Event|2|||
126268564|NCT00609466|454275941|FG001|Overall Study|Adverse Event|3|||
126268565|NCT00609466|454275942|FG002|Overall Study|Adverse Event|1|||
126268566|NCT00609466|454275940|FG000|Overall Study|Lack of Efficacy|0|||
126268567|NCT00609466|454275941|FG001|Overall Study|Lack of Efficacy|2|||
126268568|NCT00609466|454275942|FG002|Overall Study|Lack of Efficacy|2|||
126268569|NCT03512262|454275943|FG000|Overall Study|Adverse Event|8|||
126268570|NCT03512262|454275944|FG001|Overall Study|Adverse Event|3|||
126268571|NCT03512262|454275943|FG000|Overall Study|Death (non-treatment emergent)|1|||
126268572|NCT03512262|454275944|FG001|Overall Study|Death (non-treatment emergent)|0|||
126268573|NCT03512262|454275943|FG000|Overall Study|Withdrawal by Subject|17|||
126268574|NCT03512262|454275944|FG001|Overall Study|Withdrawal by Subject|9|||
126268575|NCT03512262|454275943|FG000|Overall Study|Lost to Follow-up|7|||
126268576|NCT03512262|454275944|FG001|Overall Study|Lost to Follow-up|1|||
126268577|NCT03512262|454275943|FG000|Overall Study|Other than Specified|2|||
126268578|NCT03512262|454275944|FG001|Overall Study|Other than Specified|2|||
126268579|NCT03407430|454275947|FG000|Washout|Protocol Violation|1|||
126268580|NCT03407430|454275948|FG001|Washout|Protocol Violation|0|||
126268581|NCT03510182|454275949|FG000|Overall Study|Withdrawal by Subject|2|||
126268582|NCT01195272|454275950|FG000|Overall Study|Adverse Event|1|||
126268583|NCT01195272|454275950|FG000|Overall Study|Lack of Efficacy|3|||
126268584|NCT03295318|454277420|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
126268585|NCT03295318|454277421|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
126268586|NCT03295318|454277422|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
126268587|NCT03295318|454277420|FG000|Overall Study|Death|1|||
126268588|NCT03295318|454277421|FG001|Overall Study|Death|1|||
126268589|NCT03295318|454277422|FG002|Overall Study|Death|1|||
126268590|NCT03295318|454277420|FG000|Overall Study|Protocol Violation|4|||
126268591|NCT03295318|454277421|FG001|Overall Study|Protocol Violation|3|||
126268592|NCT03295318|454277422|FG002|Overall Study|Protocol Violation|3|||
126268593|NCT03295318|454277420|FG000|Overall Study|Withdrawal by Subject|0|||
126268594|NCT03295318|454277421|FG001|Overall Study|Withdrawal by Subject|0|||
126268595|NCT03295318|454277422|FG002|Overall Study|Withdrawal by Subject|1|||
126268596|NCT03295318|454277420|FG000|Overall Study|Subject discontinued due to travel|0|||
126268597|NCT03295318|454277421|FG001|Overall Study|Subject discontinued due to travel|1|||
126268598|NCT03295318|454277422|FG002|Overall Study|Subject discontinued due to travel|0|||
126268599|NCT04319718|454277423|FG000|Overall Study|Adverse Event|0|||
126268600|NCT04319718|454277424|FG001|Overall Study|Adverse Event|2|||
126268601|NCT04319718|454277423|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
126268602|NCT04319718|454277424|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
126268603|NCT01288053|454277425|FG000|Overall Study|Death|1|||
126268604|NCT00144781|454277426|FG000|Overall Study|Adverse Event|0|||
126268605|NCT00144781|454277427|FG001|Overall Study|Adverse Event|1|||
126268606|NCT00144781|454277428|FG002|Overall Study|Adverse Event|0|||
126268607|NCT00144781|454277429|FG003|Overall Study|Adverse Event|0|||
126268608|NCT00144781|454277426|FG000|Overall Study|Non-compliant|0|||
126268609|NCT00144781|454277427|FG001|Overall Study|Non-compliant|1|||
126268610|NCT00144781|454277428|FG002|Overall Study|Non-compliant|0|||
126268611|NCT00144781|454277429|FG003|Overall Study|Non-compliant|0|||
126268612|NCT02068092|454277430|FG000|Overall Study|Physician Decision|2|||
126268613|NCT02068092|454277430|FG000|Overall Study|Adverse Event|2|||
126268614|NCT02068092|454277430|FG000|Overall Study|Lost to Follow-up|4|||
126268615|NCT02068092|454277430|FG000|Overall Study|Withdrawal by Subject|2|||
126705227|NCT01217606|455871687|FG001|9-Month Masked Extension|Pregnancy|0|||
126705228|NCT01217606|455871686|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
126705229|NCT01217606|455871687|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
126268616|NCT03502707|454277431|FG000|Overall Study|Adverse Event|0|||
126268617|NCT03502707|454277432|FG001|Overall Study|Adverse Event|0|||
126268618|NCT03502707|454277433|FG002|Overall Study|Adverse Event|0|||
126268619|NCT03502707|454277434|FG003|Overall Study|Adverse Event|0|||
126268620|NCT03502707|454277435|FG004|Overall Study|Adverse Event|0|||
126268621|NCT03502707|454277436|FG005|Overall Study|Adverse Event|0|||
126268622|NCT03502707|454277437|FG006|Overall Study|Adverse Event|0|||
126268623|NCT03502707|454277438|FG007|Overall Study|Adverse Event|0|||
126268624|NCT03502707|454277439|FG008|Overall Study|Adverse Event|0|||
126268625|NCT03502707|454277440|FG009|Overall Study|Adverse Event|0|||
126268626|NCT03502707|454277441|FG010|Overall Study|Adverse Event|0|||
126268627|NCT03502707|454277442|FG011|Overall Study|Adverse Event|0|||
126268628|NCT03502707|454277443|FG012|Overall Study|Adverse Event|0|||
126268629|NCT03502707|454277444|FG013|Overall Study|Adverse Event|0|||
126705230|NCT00719810|455871695|FG000|Overall Study|Adverse Event|0|||
126268630|NCT03502707|454277445|FG014|Overall Study|Adverse Event|0|||
126268631|NCT03502707|454277446|FG015|Overall Study|Adverse Event|1|||
126268632|NCT03502707|454277447|FG016|Overall Study|Adverse Event|5|||
126268633|NCT03502707|454277448|FG017|Overall Study|Adverse Event|0|||
126268634|NCT03502707|454277431|FG000|Overall Study|Death|0|||
126268635|NCT03502707|454277432|FG001|Overall Study|Death|0|||
126268636|NCT03502707|454277433|FG002|Overall Study|Death|0|||
126268637|NCT03502707|454277434|FG003|Overall Study|Death|1|||
126268638|NCT03502707|454277435|FG004|Overall Study|Death|0|||
126268639|NCT03502707|454277436|FG005|Overall Study|Death|0|||
126268640|NCT03502707|454277437|FG006|Overall Study|Death|0|||
126268641|NCT03502707|454277438|FG007|Overall Study|Death|0|||
126268642|NCT03502707|454277439|FG008|Overall Study|Death|1|||
126268643|NCT03502707|454277440|FG009|Overall Study|Death|1|||
126268644|NCT03502707|454277441|FG010|Overall Study|Death|0|||
126268645|NCT03502707|454277442|FG011|Overall Study|Death|0|||
126268646|NCT03502707|454277443|FG012|Overall Study|Death|1|||
126268647|NCT03502707|454277444|FG013|Overall Study|Death|0|||
126268648|NCT03502707|454277445|FG014|Overall Study|Death|0|||
126268649|NCT03502707|454277446|FG015|Overall Study|Death|1|||
126268650|NCT03502707|454277447|FG016|Overall Study|Death|0|||
126268651|NCT03502707|454277448|FG017|Overall Study|Death|0|||
126268652|NCT03502707|454277431|FG000|Overall Study|Lost to Follow-up|0|||
126268653|NCT03502707|454277432|FG001|Overall Study|Lost to Follow-up|0|||
126268654|NCT03502707|454277433|FG002|Overall Study|Lost to Follow-up|0|||
126268655|NCT03502707|454277434|FG003|Overall Study|Lost to Follow-up|0|||
126268656|NCT03502707|454277435|FG004|Overall Study|Lost to Follow-up|0|||
126268657|NCT03502707|454277436|FG005|Overall Study|Lost to Follow-up|0|||
126268658|NCT03502707|454277437|FG006|Overall Study|Lost to Follow-up|0|||
126268659|NCT03502707|454277438|FG007|Overall Study|Lost to Follow-up|5|||
126268660|NCT03502707|454277439|FG008|Overall Study|Lost to Follow-up|0|||
126268661|NCT03502707|454277440|FG009|Overall Study|Lost to Follow-up|2|||
126268662|NCT03502707|454277441|FG010|Overall Study|Lost to Follow-up|1|||
126268663|NCT03502707|454277442|FG011|Overall Study|Lost to Follow-up|2|||
126268664|NCT03502707|454277443|FG012|Overall Study|Lost to Follow-up|1|||
126268665|NCT03502707|454277444|FG013|Overall Study|Lost to Follow-up|1|||
126268666|NCT03502707|454277445|FG014|Overall Study|Lost to Follow-up|0|||
126268667|NCT03502707|454277446|FG015|Overall Study|Lost to Follow-up|4|||
126268668|NCT03502707|454277447|FG016|Overall Study|Lost to Follow-up|9|||
126268669|NCT03502707|454277448|FG017|Overall Study|Lost to Follow-up|2|||
126268670|NCT03502707|454277431|FG000|Overall Study|Physician Decision|0|||
126268671|NCT03502707|454277432|FG001|Overall Study|Physician Decision|0|||
126268672|NCT03502707|454277433|FG002|Overall Study|Physician Decision|0|||
126268673|NCT03502707|454277434|FG003|Overall Study|Physician Decision|0|||
126268674|NCT03502707|454277435|FG004|Overall Study|Physician Decision|0|||
126268675|NCT03502707|454277436|FG005|Overall Study|Physician Decision|0|||
126268676|NCT03502707|454277437|FG006|Overall Study|Physician Decision|0|||
126268677|NCT03502707|454277438|FG007|Overall Study|Physician Decision|0|||
126268678|NCT03502707|454277439|FG008|Overall Study|Physician Decision|2|||
126268679|NCT03502707|454277440|FG009|Overall Study|Physician Decision|1|||
126268680|NCT03502707|454277441|FG010|Overall Study|Physician Decision|0|||
126268681|NCT03502707|454277442|FG011|Overall Study|Physician Decision|0|||
126268682|NCT03502707|454277443|FG012|Overall Study|Physician Decision|0|||
126268683|NCT03502707|454277444|FG013|Overall Study|Physician Decision|0|||
126360953|NCT01370642|454612776|FG001|Overall Study|Lost to Follow-up|0|||
126360954|NCT01370642|454612777|FG002|Overall Study|Lost to Follow-up|1|||
126360955|NCT01370642|454612775|FG000|Overall Study|Physician Decision|4|||
126360956|NCT01370642|454612776|FG001|Overall Study|Physician Decision|1|||
126705231|NCT00719810|455871696|FG001|Overall Study|Adverse Event|2|||
126705232|NCT00719810|455871697|FG002|Overall Study|Adverse Event|3|||
126268684|NCT03502707|454277445|FG014|Overall Study|Physician Decision|1|||
126268685|NCT03502707|454277446|FG015|Overall Study|Physician Decision|3|||
126268686|NCT03502707|454277447|FG016|Overall Study|Physician Decision|0|||
126268687|NCT03502707|454277448|FG017|Overall Study|Physician Decision|0|||
126268688|NCT03502707|454277431|FG000|Overall Study|Protocol Violation|0|||
126268689|NCT03502707|454277432|FG001|Overall Study|Protocol Violation|0|||
126268690|NCT03502707|454277433|FG002|Overall Study|Protocol Violation|0|||
126268691|NCT03502707|454277434|FG003|Overall Study|Protocol Violation|0|||
126268692|NCT03502707|454277435|FG004|Overall Study|Protocol Violation|0|||
126268693|NCT03502707|454277436|FG005|Overall Study|Protocol Violation|0|||
126268694|NCT03502707|454277437|FG006|Overall Study|Protocol Violation|0|||
126360957|NCT01370642|454612777|FG002|Overall Study|Physician Decision|2|||
126360958|NCT01370642|454612775|FG000|Overall Study|Withdrawal by Subject|2|||
126705233|NCT00719810|455871695|FG000|Overall Study|Lost to Follow-up|2|||
126268695|NCT03502707|454277438|FG007|Overall Study|Protocol Violation|0|||
126268696|NCT03502707|454277439|FG008|Overall Study|Protocol Violation|0|||
126268697|NCT03502707|454277440|FG009|Overall Study|Protocol Violation|0|||
126268698|NCT03502707|454277441|FG010|Overall Study|Protocol Violation|0|||
126268699|NCT03502707|454277442|FG011|Overall Study|Protocol Violation|0|||
126268700|NCT03502707|454277443|FG012|Overall Study|Protocol Violation|0|||
126268701|NCT03502707|454277444|FG013|Overall Study|Protocol Violation|0|||
126268702|NCT03502707|454277445|FG014|Overall Study|Protocol Violation|0|||
126705234|NCT00719810|455871696|FG001|Overall Study|Lost to Follow-up|0|||
126268703|NCT03502707|454277446|FG015|Overall Study|Protocol Violation|1|||
126268704|NCT03502707|454277447|FG016|Overall Study|Protocol Violation|0|||
126268705|NCT03502707|454277448|FG017|Overall Study|Protocol Violation|0|||
126268706|NCT03502707|454277431|FG000|Overall Study|Withdrawal by Subject|1|||
126268707|NCT03502707|454277432|FG001|Overall Study|Withdrawal by Subject|1|||
126268708|NCT03502707|454277433|FG002|Overall Study|Withdrawal by Subject|0|||
126268709|NCT03502707|454277434|FG003|Overall Study|Withdrawal by Subject|0|||
126268710|NCT03502707|454277435|FG004|Overall Study|Withdrawal by Subject|0|||
126268711|NCT03502707|454277436|FG005|Overall Study|Withdrawal by Subject|2|||
126268712|NCT03502707|454277437|FG006|Overall Study|Withdrawal by Subject|0|||
126268713|NCT03502707|454277438|FG007|Overall Study|Withdrawal by Subject|3|||
126268714|NCT03502707|454277439|FG008|Overall Study|Withdrawal by Subject|1|||
126268715|NCT03502707|454277440|FG009|Overall Study|Withdrawal by Subject|2|||
126268716|NCT03502707|454277441|FG010|Overall Study|Withdrawal by Subject|12|||
126268717|NCT03502707|454277442|FG011|Overall Study|Withdrawal by Subject|23|||
126268718|NCT03502707|454277443|FG012|Overall Study|Withdrawal by Subject|5|||
126268719|NCT03502707|454277444|FG013|Overall Study|Withdrawal by Subject|3|||
126268720|NCT03502707|454277445|FG014|Overall Study|Withdrawal by Subject|3|||
126268721|NCT03502707|454277446|FG015|Overall Study|Withdrawal by Subject|43|||
126268722|NCT03502707|454277447|FG016|Overall Study|Withdrawal by Subject|44|||
126268723|NCT03502707|454277448|FG017|Overall Study|Withdrawal by Subject|18|||
126268724|NCT03502707|454277431|FG000|Overall Study|Sponsor's Decision|1|||
126268725|NCT03502707|454277432|FG001|Overall Study|Sponsor's Decision|0|||
126268726|NCT03502707|454277433|FG002|Overall Study|Sponsor's Decision|0|||
126268727|NCT03502707|454277434|FG003|Overall Study|Sponsor's Decision|0|||
126268728|NCT03502707|454277435|FG004|Overall Study|Sponsor's Decision|0|||
126268729|NCT03502707|454277436|FG005|Overall Study|Sponsor's Decision|0|||
126268730|NCT03502707|454277437|FG006|Overall Study|Sponsor's Decision|0|||
126268731|NCT03502707|454277438|FG007|Overall Study|Sponsor's Decision|0|||
126268732|NCT03502707|454277439|FG008|Overall Study|Sponsor's Decision|0|||
126268733|NCT03502707|454277440|FG009|Overall Study|Sponsor's Decision|1|||
126268734|NCT03502707|454277441|FG010|Overall Study|Sponsor's Decision|0|||
126268735|NCT03502707|454277442|FG011|Overall Study|Sponsor's Decision|0|||
126268736|NCT03502707|454277443|FG012|Overall Study|Sponsor's Decision|0|||
126268737|NCT03502707|454277444|FG013|Overall Study|Sponsor's Decision|0|||
126268738|NCT03502707|454277445|FG014|Overall Study|Sponsor's Decision|0|||
126268739|NCT03502707|454277446|FG015|Overall Study|Sponsor's Decision|2|||
126268740|NCT03502707|454277447|FG016|Overall Study|Sponsor's Decision|1|||
126268741|NCT03502707|454277448|FG017|Overall Study|Sponsor's Decision|0|||
126268742|NCT03502707|454277431|FG000|Overall Study|Initiated Prohibited Medication|0|||
126268743|NCT03502707|454277432|FG001|Overall Study|Initiated Prohibited Medication|0|||
126268744|NCT03502707|454277433|FG002|Overall Study|Initiated Prohibited Medication|0|||
126268745|NCT03502707|454277434|FG003|Overall Study|Initiated Prohibited Medication|0|||
126268746|NCT03502707|454277435|FG004|Overall Study|Initiated Prohibited Medication|0|||
126268747|NCT03502707|454277436|FG005|Overall Study|Initiated Prohibited Medication|0|||
126268748|NCT03502707|454277437|FG006|Overall Study|Initiated Prohibited Medication|0|||
126268749|NCT03502707|454277438|FG007|Overall Study|Initiated Prohibited Medication|0|||
126268750|NCT03502707|454277439|FG008|Overall Study|Initiated Prohibited Medication|0|||
126268751|NCT03502707|454277440|FG009|Overall Study|Initiated Prohibited Medication|0|||
126268752|NCT03502707|454277441|FG010|Overall Study|Initiated Prohibited Medication|0|||
126268753|NCT03502707|454277442|FG011|Overall Study|Initiated Prohibited Medication|0|||
126268754|NCT03502707|454277443|FG012|Overall Study|Initiated Prohibited Medication|0|||
126268755|NCT03502707|454277444|FG013|Overall Study|Initiated Prohibited Medication|0|||
126268756|NCT03502707|454277445|FG014|Overall Study|Initiated Prohibited Medication|0|||
126268757|NCT03502707|454277446|FG015|Overall Study|Initiated Prohibited Medication|0|||
126268758|NCT03502707|454277447|FG016|Overall Study|Initiated Prohibited Medication|1|||
126268759|NCT03502707|454277448|FG017|Overall Study|Initiated Prohibited Medication|0|||
126268760|NCT03502707|454277431|FG000|Overall Study|Other|0|||
126268761|NCT03502707|454277432|FG001|Overall Study|Other|0|||
126268762|NCT03502707|454277433|FG002|Overall Study|Other|0|||
126268763|NCT03502707|454277434|FG003|Overall Study|Other|0|||
126268764|NCT03502707|454277435|FG004|Overall Study|Other|0|||
126268765|NCT03502707|454277436|FG005|Overall Study|Other|0|||
126268766|NCT03502707|454277437|FG006|Overall Study|Other|0|||
126268767|NCT03502707|454277438|FG007|Overall Study|Other|0|||
126268768|NCT03502707|454277439|FG008|Overall Study|Other|1|||
126268769|NCT03502707|454277440|FG009|Overall Study|Other|1|||
126268770|NCT03502707|454277441|FG010|Overall Study|Other|2|||
126268771|NCT03502707|454277442|FG011|Overall Study|Other|0|||
126268772|NCT03502707|454277443|FG012|Overall Study|Other|0|||
126268773|NCT03502707|454277444|FG013|Overall Study|Other|0|||
126268774|NCT03502707|454277445|FG014|Overall Study|Other|0|||
126268775|NCT03502707|454277446|FG015|Overall Study|Other|4|||
126268776|NCT03502707|454277447|FG016|Overall Study|Other|1|||
126268777|NCT03502707|454277448|FG017|Overall Study|Other|0|||
126268778|NCT03502707|454277431|FG000|Overall Study|Randomized but not vaccinated|0|||
126268779|NCT03502707|454277432|FG001|Overall Study|Randomized but not vaccinated|0|||
126268780|NCT03502707|454277433|FG002|Overall Study|Randomized but not vaccinated|0|||
126705235|NCT00719810|455871697|FG002|Overall Study|Lost to Follow-up|3|||
126360959|NCT01370642|454612776|FG001|Overall Study|Withdrawal by Subject|4|||
126360960|NCT01370642|454612777|FG002|Overall Study|Withdrawal by Subject|3|||
126360961|NCT01796470|454612784|FG000|Overall Study|Adverse Event|4|||
126360962|NCT01796470|454612785|FG001|Overall Study|Adverse Event|2|||
126360963|NCT01796470|454612786|FG002|Overall Study|Adverse Event|2|||
126360964|NCT01796470|454612787|FG003|Overall Study|Adverse Event|1|||
126360965|NCT01796470|454612788|FG004|Overall Study|Adverse Event|3|||
126360966|NCT01796470|454612784|FG000|Overall Study|Death|2|||
126360967|NCT01796470|454612785|FG001|Overall Study|Death|0|||
126360968|NCT01796470|454612786|FG002|Overall Study|Death|0|||
126360969|NCT01796470|454612787|FG003|Overall Study|Death|0|||
126360970|NCT01796470|454612788|FG004|Overall Study|Death|1|||
126360971|NCT01796470|454612784|FG000|Overall Study|Initiated New Therapy|9|||
126360972|NCT01796470|454612785|FG001|Overall Study|Initiated New Therapy|0|||
126360973|NCT01796470|454612786|FG002|Overall Study|Initiated New Therapy|0|||
126360974|NCT01796470|454612787|FG003|Overall Study|Initiated New Therapy|0|||
126360975|NCT01796470|454612788|FG004|Overall Study|Initiated New Therapy|2|||
126453274|NCT01236547|454961396|FG000|Overall Study|Protocol Violation|0|||
126453275|NCT01236547|454961397|FG001|Overall Study|Protocol Violation|1|||
126453276|NCT01236547|454961398|FG002|Overall Study|Protocol Violation|1|||
126453277|NCT01236547|454961399|FG003|Overall Study|Protocol Violation|6|||
126453278|NCT01236547|454961400|FG004|Overall Study|Protocol Violation|12|||
126453279|NCT00910624|454961401|FG000|Treatment Phase|Adverse Event|2|||
126453280|NCT00910624|454961402|FG001|Treatment Phase|Adverse Event|6|||
126453281|NCT00910624|454961403|FG002|Treatment Phase|Adverse Event|6|||
126453282|NCT00910624|454961404|FG003|Treatment Phase|Adverse Event|0|||
126453283|NCT00910624|454961401|FG000|Treatment Phase|Treatment Failure|23|||
126453284|NCT00910624|454961402|FG001|Treatment Phase|Treatment Failure|10|||
126453285|NCT00910624|454961403|FG002|Treatment Phase|Treatment Failure|0|||
126453286|NCT00910624|454961404|FG003|Treatment Phase|Treatment Failure|0|||
126453287|NCT00910624|454961401|FG000|Treatment Phase|Lost to Follow-up|0|||
126453288|NCT00910624|454961402|FG001|Treatment Phase|Lost to Follow-up|0|||
126453289|NCT00910624|454961403|FG002|Treatment Phase|Lost to Follow-up|1|||
126453290|NCT00910624|454961404|FG003|Treatment Phase|Lost to Follow-up|0|||
126453291|NCT00910624|454961401|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
126453292|NCT00910624|454961402|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
126453293|NCT00910624|454961403|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
126453294|NCT00910624|454961404|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
126453295|NCT00910624|454961401|FG000|Treatment Phase|Withdrawal by Subject|2|||
126453296|NCT00910624|454961402|FG001|Treatment Phase|Withdrawal by Subject|1|||
126453297|NCT00910624|454961403|FG002|Treatment Phase|Withdrawal by Subject|0|||
126453298|NCT00910624|454961404|FG003|Treatment Phase|Withdrawal by Subject|0|||
126453299|NCT00910624|454961401|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
126453300|NCT00910624|454961402|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
126453301|NCT00910624|454961403|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
126453302|NCT00910624|454961404|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
126453303|NCT00910624|454961401|FG000|Follow-Up Phase|Adverse Event|0|||
126453304|NCT00910624|454961402|FG001|Follow-Up Phase|Adverse Event|0|||
126453305|NCT00910624|454961403|FG002|Follow-Up Phase|Adverse Event|1|||
126453306|NCT00910624|454961404|FG003|Follow-Up Phase|Adverse Event|0|||
126453307|NCT00910624|454961401|FG000|Follow-Up Phase|Lost to Follow-up|3|||
126453308|NCT00910624|454961402|FG001|Follow-Up Phase|Lost to Follow-up|1|||
126453309|NCT00910624|454961403|FG002|Follow-Up Phase|Lost to Follow-up|2|||
126453310|NCT00910624|454961404|FG003|Follow-Up Phase|Lost to Follow-up|0|||
126453311|NCT00910624|454961401|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
126705236|NCT00719810|455871695|FG000|Overall Study|Physician Decision|0|||
126705237|NCT00719810|455871696|FG001|Overall Study|Physician Decision|1|||
126705238|NCT00719810|455871697|FG002|Overall Study|Physician Decision|0|||
126360976|NCT01796470|454612784|FG000|Overall Study|Lost to Follow-up|0|||
126360977|NCT01796470|454612785|FG001|Overall Study|Lost to Follow-up|1|||
126360978|NCT01796470|454612786|FG002|Overall Study|Lost to Follow-up|0|||
126360979|NCT01796470|454612787|FG003|Overall Study|Lost to Follow-up|0|||
126360980|NCT01796470|454612788|FG004|Overall Study|Lost to Follow-up|0|||
126453312|NCT00910624|454961402|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
126453313|NCT00910624|454961403|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
126453314|NCT00910624|454961404|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
126360981|NCT01796470|454612784|FG000|Overall Study|Physician Decision|5|||
126360982|NCT01796470|454612785|FG001|Overall Study|Physician Decision|4|||
126453315|NCT00910624|454961401|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
126453316|NCT00910624|454961402|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
126453317|NCT00910624|454961403|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
126453318|NCT00910624|454961404|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
126453319|NCT00910624|454961401|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
126360983|NCT01796470|454612786|FG002|Overall Study|Physician Decision|1|||
126360984|NCT01796470|454612787|FG003|Overall Study|Physician Decision|0|||
126360985|NCT01796470|454612788|FG004|Overall Study|Physician Decision|1|||
126453320|NCT00910624|454961402|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
126453321|NCT00910624|454961403|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
126453322|NCT00910624|454961404|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
126453323|NCT00910624|454961401|FG000|Follow-Up Phase|Administrative|0|||
126705239|NCT00719810|455871695|FG000|Overall Study|Withdrawal by Subject|1|||
126705240|NCT00719810|455871696|FG001|Overall Study|Withdrawal by Subject|1|||
126705241|NCT00719810|455871697|FG002|Overall Study|Withdrawal by Subject|2|||
126705242|NCT00893789|455871698|FG000|Overall Study|Withdrawal by Subject|3|||
126705243|NCT00893789|455871699|FG001|Overall Study|Withdrawal by Subject|1|||
126705244|NCT00893789|455871700|FG002|Overall Study|Withdrawal by Subject|3|||
126268781|NCT03502707|454277434|FG003|Overall Study|Randomized but not vaccinated|0|||
126268782|NCT03502707|454277435|FG004|Overall Study|Randomized but not vaccinated|0|||
126268783|NCT03502707|454277436|FG005|Overall Study|Randomized but not vaccinated|0|||
126268784|NCT03502707|454277437|FG006|Overall Study|Randomized but not vaccinated|0|||
126268785|NCT03502707|454277438|FG007|Overall Study|Randomized but not vaccinated|0|||
126268786|NCT03502707|454277439|FG008|Overall Study|Randomized but not vaccinated|0|||
126268787|NCT03502707|454277440|FG009|Overall Study|Randomized but not vaccinated|0|||
126268788|NCT03502707|454277441|FG010|Overall Study|Randomized but not vaccinated|0|||
126268789|NCT03502707|454277442|FG011|Overall Study|Randomized but not vaccinated|1|||
126268790|NCT03502707|454277443|FG012|Overall Study|Randomized but not vaccinated|0|||
126268791|NCT03502707|454277444|FG013|Overall Study|Randomized but not vaccinated|0|||
126268792|NCT03502707|454277445|FG014|Overall Study|Randomized but not vaccinated|0|||
126268793|NCT03502707|454277446|FG015|Overall Study|Randomized but not vaccinated|0|||
126268794|NCT03502707|454277447|FG016|Overall Study|Randomized but not vaccinated|0|||
126268795|NCT03502707|454277448|FG017|Overall Study|Randomized but not vaccinated|1|||
126268796|NCT01045421|454277449|FG000|Phase 1|Progressive Disease|0|||
126268797|NCT01045421|454277450|FG001|Phase 1|Progressive Disease|0|||
126268798|NCT01045421|454277451|FG002|Phase 1|Progressive Disease|0|||
126268799|NCT01045421|454277452|FG003|Phase 1|Progressive Disease|0|||
126268800|NCT01045421|454277453|FG004|Phase 1|Progressive Disease|1|||
126268801|NCT01045421|454277454|FG005|Phase 1|Progressive Disease|0|||
126268802|NCT01045421|454277455|FG006|Phase 1|Progressive Disease|0|||
126268803|NCT01045421|454277456|FG007|Phase 1|Progressive Disease|0|||
126268804|NCT01045421|454277457|FG008|Phase 1|Progressive Disease|0|||
126268805|NCT01045421|454277458|FG009|Phase 1|Progressive Disease|0|||
126268806|NCT01045421|454277459|FG010|Phase 1|Progressive Disease|0|||
126268807|NCT01045421|454277449|FG000|Phase 1|Withdrawal by Subject|0|||
126268808|NCT01045421|454277450|FG001|Phase 1|Withdrawal by Subject|0|||
126268809|NCT01045421|454277451|FG002|Phase 1|Withdrawal by Subject|0|||
126268810|NCT01045421|454277452|FG003|Phase 1|Withdrawal by Subject|1|||
126268811|NCT01045421|454277453|FG004|Phase 1|Withdrawal by Subject|0|||
126268812|NCT01045421|454277454|FG005|Phase 1|Withdrawal by Subject|0|||
126268813|NCT01045421|454277455|FG006|Phase 1|Withdrawal by Subject|0|||
126268814|NCT01045421|454277456|FG007|Phase 1|Withdrawal by Subject|0|||
126268815|NCT01045421|454277457|FG008|Phase 1|Withdrawal by Subject|0|||
126268816|NCT01045421|454277458|FG009|Phase 1|Withdrawal by Subject|0|||
126268817|NCT01045421|454277459|FG010|Phase 1|Withdrawal by Subject|0|||
126268818|NCT01045421|454277449|FG000|Phase 2|Progressive Disease|0|||
126268819|NCT01045421|454277450|FG001|Phase 2|Progressive Disease|0|||
126268820|NCT01045421|454277451|FG002|Phase 2|Progressive Disease|0|||
126268821|NCT01045421|454277452|FG003|Phase 2|Progressive Disease|0|||
126268822|NCT01045421|454277453|FG004|Phase 2|Progressive Disease|0|||
126268823|NCT01045421|454277454|FG005|Phase 2|Progressive Disease|0|||
126268824|NCT01045421|454277455|FG006|Phase 2|Progressive Disease|0|||
126268825|NCT01045421|454277456|FG007|Phase 2|Progressive Disease|1|||
126268826|NCT01045421|454277457|FG008|Phase 2|Progressive Disease|1|||
126268827|NCT01045421|454277458|FG009|Phase 2|Progressive Disease|1|||
126268828|NCT01045421|454277459|FG010|Phase 2|Progressive Disease|1|||
126268829|NCT01045421|454277449|FG000|Phase 2|Death|0|||
126268830|NCT01045421|454277450|FG001|Phase 2|Death|0|||
126268831|NCT01045421|454277451|FG002|Phase 2|Death|0|||
126268832|NCT01045421|454277452|FG003|Phase 2|Death|0|||
126268833|NCT01045421|454277453|FG004|Phase 2|Death|0|||
126268834|NCT01045421|454277454|FG005|Phase 2|Death|0|||
126268835|NCT01045421|454277455|FG006|Phase 2|Death|0|||
126268836|NCT01045421|454277456|FG007|Phase 2|Death|1|||
126705245|NCT00893789|455871701|FG003|Overall Study|Withdrawal by Subject|1|||
126705246|NCT00893789|455871698|FG000|Overall Study|Noncompliance With Study Drug|1|||
126268837|NCT01045421|454277457|FG008|Phase 2|Death|1|||
126268838|NCT01045421|454277458|FG009|Phase 2|Death|2|||
126268839|NCT01045421|454277459|FG010|Phase 2|Death|0|||
126268840|NCT01045421|454277449|FG000|Phase 2|Other|0|||
126268841|NCT01045421|454277450|FG001|Phase 2|Other|0|||
126268842|NCT01045421|454277451|FG002|Phase 2|Other|0|||
126268843|NCT01045421|454277452|FG003|Phase 2|Other|0|||
126268844|NCT01045421|454277453|FG004|Phase 2|Other|0|||
126268845|NCT01045421|454277454|FG005|Phase 2|Other|0|||
126268846|NCT01045421|454277455|FG006|Phase 2|Other|0|||
126268847|NCT01045421|454277456|FG007|Phase 2|Other|3|||
126268848|NCT01045421|454277457|FG008|Phase 2|Other|0|||
126268849|NCT01045421|454277458|FG009|Phase 2|Other|0|||
126268850|NCT01045421|454277459|FG010|Phase 2|Other|1|||
126268851|NCT02221037|454277460|FG000|Overall Study|Physician Decision|0|||
126268852|NCT02221037|454277461|FG001|Overall Study|Physician Decision|0|||
126268853|NCT02221037|454277462|FG002|Overall Study|Physician Decision|1|||
126268854|NCT02221037|454277463|FG003|Overall Study|Physician Decision|0|||
126268855|NCT04551911|454277464|FG000|Overall Study|Lost to Follow-up|2|||
126268856|NCT04551911|454277465|FG001|Overall Study|Lost to Follow-up|1|||
126268857|NCT04551911|454277464|FG000|Overall Study|Withdrawal by Subject|10|||
126268858|NCT04551911|454277465|FG001|Overall Study|Withdrawal by Subject|10|||
126268859|NCT04551911|454277464|FG000|Overall Study|Did not receive the study drug|3|||
126268860|NCT04551911|454277465|FG001|Overall Study|Did not receive the study drug|4|||
126268861|NCT01030341|454277466|FG000|Overall Study|Withdrawal by Subject|1|||
126268862|NCT01030341|454277466|FG000|Overall Study|Lost to Follow-up|2|||
126268863|NCT01884311|454277467|FG000|Overall Study|Withdrawal by Subject|3|||
126268864|NCT01884311|454277467|FG000|Overall Study|withdrew consent due to AEs|1|||
126268865|NCT01884311|454277467|FG000|Overall Study|Precautionary measure|1|||
126268866|NCT02307266|454277468|FG000|Overall Study|Adverse Event|3|||
126268867|NCT02307266|454277469|FG001|Overall Study|Adverse Event|1|||
126268868|NCT02307266|454277470|FG002|Overall Study|Adverse Event|5|||
126268869|NCT02307266|454277468|FG000|Overall Study|Withdrawal by Subject|2|||
126268870|NCT02307266|454277469|FG001|Overall Study|Withdrawal by Subject|0|||
126268871|NCT02307266|454277470|FG002|Overall Study|Withdrawal by Subject|1|||
126268872|NCT02307266|454277468|FG000|Overall Study|Lost to Follow-up|3|||
126268873|NCT02307266|454277469|FG001|Overall Study|Lost to Follow-up|0|||
126268874|NCT02307266|454277470|FG002|Overall Study|Lost to Follow-up|0|||
126268875|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Death|89|||
126268876|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Death|193|||
126268877|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Death|198|||
126268878|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
126268879|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
126268880|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
126268881|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
126268882|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
126268883|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
126268884|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
126268885|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
126268886|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
126268887|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
126268888|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
126268889|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
126268890|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
126268891|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
126268892|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
126268893|NCT02031458|454277483|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
126268894|NCT02031458|454277484|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
126268895|NCT02031458|454277485|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
126268896|NCT02031458|454277483|FG000|Baseline to May 8, 2015|Death|36|||
126268897|NCT02031458|454277484|FG001|Baseline to May 8, 2015|Death|87|||
126268898|NCT02031458|454277485|FG002|Baseline to May 8, 2015|Death|100|||
126268899|NCT02031458|454277483|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
126268900|NCT02031458|454277484|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
126268901|NCT02031458|454277485|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
126268902|NCT02031458|454277483|FG000|Baseline to May 8, 2015|Physician Decision|0|||
126268903|NCT02031458|454277484|FG001|Baseline to May 8, 2015|Physician Decision|1|||
126268904|NCT02031458|454277485|FG002|Baseline to May 8, 2015|Physician Decision|0|||
126268905|NCT02031458|454277483|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
126453324|NCT00910624|454961402|FG001|Follow-Up Phase|Administrative|1|||
126453325|NCT00910624|454961403|FG002|Follow-Up Phase|Administrative|1|||
126453326|NCT00910624|454961404|FG003|Follow-Up Phase|Administrative|0|||
126453327|NCT01713933|454961405|FG000|Overall Study|Lost to Follow-up|2|||
126268906|NCT02031458|454277484|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
126268907|NCT02031458|454277485|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
126268908|NCT02031458|454277483|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
126268909|NCT02031458|454277484|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
126268910|NCT02031458|454277485|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
126268911|NCT02031458|454277483|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
126268912|NCT02031458|454277484|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
126453328|NCT01713933|454961405|FG000|Overall Study|Withdrawal by Subject|3|||
126268913|NCT02031458|454277485|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
126268914|NCT02031458|454277483|FG000|Baseline to May 8, 2015|On Treatment|43|||
126268915|NCT02031458|454277484|FG001|Baseline to May 8, 2015|On Treatment|81|||
126453329|NCT01713933|454961405|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
126268916|NCT02031458|454277485|FG002|Baseline to May 8, 2015|On Treatment|73|||
126268917|NCT02031458|454277483|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
126268918|NCT02031458|454277484|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
126268919|NCT02031458|454277485|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
126268920|NCT05855616|454277486|FG000|Overall Study|Lost to Follow-up|1|||
126268921|NCT05855616|454277487|FG001|Overall Study|Lost to Follow-up|2|||
126268922|NCT00059787|454277488|FG000|Overall Study|Adverse Event|13|||
126268923|NCT00059787|454277488|FG000|Overall Study|disease progression|2|||
126268924|NCT00059787|454277488|FG000|Overall Study|ineligible|1|||
126268925|NCT00059787|454277488|FG000|Overall Study|Other|4|||
126268926|NCT00103311|454277495|FG000|Overall Study|Lost to Follow-up|1|||
126268927|NCT00103311|454277496|FG001|Overall Study|Lost to Follow-up|0|||
126268928|NCT00103311|454277495|FG000|Overall Study|Withdrawal by Subject|2|||
126268929|NCT00103311|454277496|FG001|Overall Study|Withdrawal by Subject|1|||
126268930|NCT00103311|454277495|FG000|Overall Study|Adverse Event|1|||
126268931|NCT00103311|454277496|FG001|Overall Study|Adverse Event|0|||
126268932|NCT00974974|454277498|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
126268933|NCT00974974|454277499|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
126268934|NCT00974974|454277498|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
126268935|NCT00974974|454277499|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
126268936|NCT00974974|454277498|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
126268937|NCT00974974|454277499|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
126268938|NCT00974974|454277498|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
126268939|NCT00974974|454277499|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
126453330|NCT00412373|454961406|FG000|Overall Study|Adverse Event|8|||
126453331|NCT00412373|454961407|FG001|Overall Study|Adverse Event|13|||
126453332|NCT00412373|454961406|FG000|Overall Study|Lack of Efficacy|16|||
126453333|NCT00412373|454961407|FG001|Overall Study|Lack of Efficacy|22|||
126453334|NCT00412373|454961406|FG000|Overall Study|Lost to Follow-up|7|||
126453335|NCT00412373|454961407|FG001|Overall Study|Lost to Follow-up|13|||
126453336|NCT00412373|454961406|FG000|Overall Study|Withdrawal by Subject|8|||
126453337|NCT00412373|454961407|FG001|Overall Study|Withdrawal by Subject|27|||
126453338|NCT00412373|454961406|FG000|Overall Study|Other|2|||
126705247|NCT00893789|455871699|FG001|Overall Study|Noncompliance With Study Drug|0|||
126705248|NCT00893789|455871700|FG002|Overall Study|Noncompliance With Study Drug|1|||
126705249|NCT00893789|455871701|FG003|Overall Study|Noncompliance With Study Drug|2|||
126705250|NCT00893789|455871698|FG000|Overall Study|Noncompliance With Study Procedures|1|||
126705251|NCT00893789|455871699|FG001|Overall Study|Noncompliance With Study Procedures|0|||
126705252|NCT00893789|455871700|FG002|Overall Study|Noncompliance With Study Procedures|0|||
126705253|NCT00893789|455871701|FG003|Overall Study|Noncompliance With Study Procedures|0|||
126705254|NCT00893789|455871698|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
126705255|NCT00893789|455871699|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
126705256|NCT00893789|455871700|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
126705257|NCT00893789|455871701|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
126705258|NCT00893789|455871698|FG000|Overall Study|Adverse Event|0|||
126268940|NCT00974974|454277498|FG000|IR CD-LD Dose Adjustment|Various|0|||
126268941|NCT00974974|454277499|FG001|IR CD-LD Dose Adjustment|Various|9|||
126268942|NCT00974974|454277498|FG000|IPX066 Dose Conversion|Adverse Event|23|||
126268943|NCT00974974|454277499|FG001|IPX066 Dose Conversion|Adverse Event|0|||
126268944|NCT00974974|454277498|FG000|IPX066 Dose Conversion|Death|2|||
126268945|NCT00974974|454277499|FG001|IPX066 Dose Conversion|Death|0|||
126268946|NCT00974974|454277498|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
126268947|NCT00974974|454277499|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
126268948|NCT00974974|454277498|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
126268949|NCT00974974|454277499|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
126268950|NCT00974974|454277498|FG000|IPX066 Dose Conversion|Various|3|||
126268951|NCT00974974|454277499|FG001|IPX066 Dose Conversion|Various|0|||
126268952|NCT00974974|454277498|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
126268953|NCT00974974|454277499|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
126268954|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
126268955|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
126268956|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
126268957|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
126268958|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
126268959|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
126268960|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
126268961|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
126268962|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
126268963|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
126268964|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
126268965|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
126268966|NCT00974974|454277498|FG000|Maintenance - Double Blind Treatment|Various|4|||
126453339|NCT00412373|454961407|FG001|Overall Study|Other|2|||
126547358|NCT03757234|455296209|FG002|Overall Study|Other|0|||
126268967|NCT00974974|454277499|FG001|Maintenance - Double Blind Treatment|Various|0|||
126268968|NCT01959035|454277500|FG000|Overall Study|Adverse Event|5|||
126268969|NCT01959035|454277500|FG000|Overall Study|Withdrawal by Subject|4|||
126268970|NCT01959035|454277500|FG000|Overall Study|Lost to Follow-up|1|||
126268971|NCT01959035|454277500|FG000|Overall Study|Other (no primary reason given)|1|||
126268972|NCT02034058|454277501|FG000|Overall Study|Death|3|||
126268973|NCT03254602|454277502|FG000|Overall Study|Lost to Follow-up|4|||
126268974|NCT02963311|454277507|FG000|Overall Study|Withdrawal by Subject|1|||
126268975|NCT02963311|454277507|FG000|Overall Study|Screen Failure|4|||
126268976|NCT04492020|454277514|FG000|Overall Study|Adverse Event|1|||
126268977|NCT04492020|454277515|FG001|Overall Study|Adverse Event|3|||
126268978|NCT04492020|454277514|FG000|Overall Study|Withdrawal by Subject|4|||
126268979|NCT04492020|454277515|FG001|Overall Study|Withdrawal by Subject|3|||
126268980|NCT04492020|454277514|FG000|Overall Study|Lost to Follow-up|4|||
126268981|NCT04492020|454277515|FG001|Overall Study|Lost to Follow-up|3|||
126268982|NCT04492020|454277514|FG000|Overall Study|Protocol Violation|5|||
126268983|NCT04492020|454277515|FG001|Overall Study|Protocol Violation|2|||
126268984|NCT04492020|454277514|FG000|Overall Study|Lack of Qualifying Event|25|||
126453340|NCT04022733|454961411|FG000|Overall Study|conversion to open surgery|3|||
126453341|NCT04022733|454961412|FG001|Overall Study|conversion to open surgery|2|||
126453342|NCT04022733|454961411|FG000|Overall Study|bradycardia|0|||
126453343|NCT04022733|454961412|FG001|Overall Study|bradycardia|1|||
126453344|NCT00797966|454961413|FG000|Phase A|Lost to Follow-up|0|||
126453345|NCT00797966|454961414|FG001|Phase A|Lost to Follow-up|0|||
126453346|NCT00797966|454961415|FG002|Phase A|Lost to Follow-up|0|||
126453347|NCT00797966|454961416|FG003|Phase A|Lost to Follow-up|0|||
126453348|NCT00797966|454961417|FG004|Phase A|Lost to Follow-up|33|||
126453349|NCT00797966|454961418|FG005|Phase A|Lost to Follow-up|0|||
126453350|NCT00797966|454961413|FG000|Phase A|Adverse Event|0|||
126453351|NCT00797966|454961414|FG001|Phase A|Adverse Event|0|||
126453352|NCT00797966|454961415|FG002|Phase A|Adverse Event|0|||
126453353|NCT00797966|454961416|FG003|Phase A|Adverse Event|0|||
126268985|NCT04492020|454277515|FG001|Overall Study|Lack of Qualifying Event|27|||
126268986|NCT04492020|454277514|FG000|Overall Study|Non-compliance with Study Drug|2|||
126268987|NCT04492020|454277515|FG001|Overall Study|Non-compliance with Study Drug|1|||
126268988|NCT02792959|454277520|FG000|Overall Study|Protocol Violation|1|||
126268989|NCT03914950|454277524|FG000|Overall Study|Physician Decision|54|||
126268990|NCT00003875|454277531|FG000|Overall Study|Screen Failed|1|||
126268991|NCT04168190|454277532|FG000|Overall Study|Lost to Follow-up|0|||
126268992|NCT04168190|454277533|FG001|Overall Study|Lost to Follow-up|1|||
126268993|NCT04168190|454277534|FG002|Overall Study|Lost to Follow-up|0|||
126268994|NCT04168190|454277535|FG003|Overall Study|Lost to Follow-up|7|||
126268995|NCT04168190|454277536|FG004|Overall Study|Lost to Follow-up|5|||
126268996|NCT04168190|454277532|FG000|Overall Study|Withdrawal by Subject|1|||
126268997|NCT04168190|454277533|FG001|Overall Study|Withdrawal by Subject|0|||
126268998|NCT04168190|454277534|FG002|Overall Study|Withdrawal by Subject|0|||
126268999|NCT04168190|454277535|FG003|Overall Study|Withdrawal by Subject|2|||
126269000|NCT04168190|454277536|FG004|Overall Study|Withdrawal by Subject|4|||
126269001|NCT04168190|454277532|FG000|Overall Study|Death|0|||
126269002|NCT04168190|454277533|FG001|Overall Study|Death|0|||
126269003|NCT04168190|454277534|FG002|Overall Study|Death|0|||
126269004|NCT04168190|454277535|FG003|Overall Study|Death|1|||
126269005|NCT04168190|454277536|FG004|Overall Study|Death|0|||
126269006|NCT01070771|454277537|FG000|Overall Study|Adverse Event|2|||
126269007|NCT01070771|454277537|FG000|Overall Study|Protocol Violation|1|||
126269008|NCT00629265|454277538|FG000|Overall Study|Lost to Follow-up|4|||
126269009|NCT00629265|454277539|FG001|Overall Study|Lost to Follow-up|5|||
126269010|NCT00629265|454277538|FG000|Overall Study|Withdrawal by Subject|11|||
126269011|NCT00629265|454277539|FG001|Overall Study|Withdrawal by Subject|8|||
126269012|NCT00629265|454277538|FG000|Overall Study|Death|1|||
126269013|NCT00629265|454277539|FG001|Overall Study|Death|0|||
126269014|NCT00629265|454277538|FG000|Overall Study|Adverse Event|2|||
126269015|NCT00629265|454277539|FG001|Overall Study|Adverse Event|0|||
126269016|NCT00629265|454277538|FG000|Overall Study|HNC Recurrence|4|||
126269017|NCT00629265|454277539|FG001|Overall Study|HNC Recurrence|0|||
126269018|NCT00629265|454277538|FG000|Overall Study|Other CA Requiring Treatment|1|||
126269019|NCT00629265|454277539|FG001|Overall Study|Other CA Requiring Treatment|3|||
126269020|NCT00629265|454277538|FG000|Overall Study|Needed Esophageal Dilation|4|||
126269021|NCT00629265|454277539|FG001|Overall Study|Needed Esophageal Dilation|1|||
126269022|NCT00629265|454277538|FG000|Overall Study|Unrelated Medical Complications|3|||
126269023|NCT00629265|454277539|FG001|Overall Study|Unrelated Medical Complications|1|||
126269024|NCT00629265|454277538|FG000|Overall Study|Unknown Reason|2|||
126269025|NCT00629265|454277539|FG001|Overall Study|Unknown Reason|2|||
126269026|NCT04465630|454277540|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
126269027|NCT04465630|454277540|FG000|Overall Study|Screen failure|8|||
126453354|NCT00797966|454961417|FG004|Phase A|Adverse Event|46|||
126453355|NCT00797966|454961418|FG005|Phase A|Adverse Event|0|||
126453356|NCT00797966|454961413|FG000|Phase A|Met withdrawal criteria|0|||
126269028|NCT04465630|454277540|FG000|Overall Study|Baseline failure|16|||
126453357|NCT00797966|454961414|FG001|Phase A|Met withdrawal criteria|0|||
126360986|NCT01796470|454612784|FG000|Overall Study|Progressive Disease|7|||
126360987|NCT01796470|454612785|FG001|Overall Study|Progressive Disease|7|||
126360988|NCT01796470|454612786|FG002|Overall Study|Progressive Disease|3|||
126360989|NCT01796470|454612787|FG003|Overall Study|Progressive Disease|2|||
126360990|NCT01796470|454612788|FG004|Overall Study|Progressive Disease|0|||
126360991|NCT01796470|454612784|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
126360992|NCT01796470|454612785|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
126360993|NCT01796470|454612786|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
126360994|NCT01796470|454612787|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
126360995|NCT01796470|454612788|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
126360996|NCT01796470|454612784|FG000|Overall Study|Withdrawal by Subject|7|||
126360997|NCT01796470|454612785|FG001|Overall Study|Withdrawal by Subject|0|||
126360998|NCT01796470|454612786|FG002|Overall Study|Withdrawal by Subject|0|||
126360999|NCT01796470|454612787|FG003|Overall Study|Withdrawal by Subject|0|||
126361000|NCT01796470|454612788|FG004|Overall Study|Withdrawal by Subject|1|||
126361001|NCT01927861|454612789|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
126361002|NCT01927861|454612790|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
126361003|NCT01927861|454612789|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
126361004|NCT01927861|454612790|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
126361005|NCT00987935|454612791|FG000|Overall Study|Progressive disease|3|||
126361006|NCT00987935|454612792|FG001|Overall Study|Progressive disease|2|||
126269029|NCT04355663|454277541|FG000|Overall Study|Physician Decision|2|||
126269030|NCT04355663|454277542|FG001|Overall Study|Physician Decision|7|||
126269031|NCT04355663|454277543|FG002|Overall Study|Physician Decision|0|||
126269032|NCT04355663|454277541|FG000|Overall Study|Adverse Event|0|||
126269033|NCT04355663|454277542|FG001|Overall Study|Adverse Event|0|||
126269034|NCT04355663|454277543|FG002|Overall Study|Adverse Event|1|||
126269035|NCT04355663|454277541|FG000|Overall Study|Withdrawal by Subject|0|||
126269036|NCT04355663|454277542|FG001|Overall Study|Withdrawal by Subject|8|||
126269037|NCT04355663|454277543|FG002|Overall Study|Withdrawal by Subject|3|||
126269038|NCT01230892|454277544|FG000|Overall Study|Withdrawal by Subject|1|||
126269039|NCT01230892|454277545|FG001|Overall Study|Withdrawal by Subject|1|||
126269040|NCT01230892|454277544|FG000|Overall Study|Lost to Follow-up|2|||
126269041|NCT01230892|454277545|FG001|Overall Study|Lost to Follow-up|0|||
126269042|NCT00679913|454277546|FG000|Overall Study|Protocol Violation|18|||
126269043|NCT00679913|454277547|FG001|Overall Study|Protocol Violation|13|||
126269044|NCT01144364|454277551|FG000|Induction Phase|Disease progression|14|||
126269045|NCT01144364|454277552|FG001|Induction Phase|Disease progression|0|||
126269046|NCT01144364|454277553|FG002|Induction Phase|Disease progression|0|||
126269047|NCT01144364|454277551|FG000|Induction Phase|Adverse Event|9|||
126269048|NCT01144364|454277552|FG001|Induction Phase|Adverse Event|0|||
126269049|NCT01144364|454277553|FG002|Induction Phase|Adverse Event|0|||
126269050|NCT01144364|454277551|FG000|Induction Phase|Death|1|||
126269051|NCT01144364|454277552|FG001|Induction Phase|Death|0|||
126269052|NCT01144364|454277553|FG002|Induction Phase|Death|0|||
126269053|NCT01144364|454277551|FG000|Induction Phase|Withdrawal by Subject|1|||
126269054|NCT01144364|454277552|FG001|Induction Phase|Withdrawal by Subject|0|||
126269055|NCT01144364|454277553|FG002|Induction Phase|Withdrawal by Subject|0|||
126269056|NCT01144364|454277551|FG000|Induction Phase|Lost to Follow-up|2|||
126269057|NCT01144364|454277552|FG001|Induction Phase|Lost to Follow-up|0|||
126269058|NCT01144364|454277553|FG002|Induction Phase|Lost to Follow-up|0|||
126269059|NCT01144364|454277551|FG000|Induction Phase|Physician Decision|1|||
126269060|NCT01144364|454277552|FG001|Induction Phase|Physician Decision|0|||
126269061|NCT01144364|454277553|FG002|Induction Phase|Physician Decision|0|||
126269062|NCT01144364|454277551|FG000|Induction Phase|Stable disease|2|||
126269063|NCT01144364|454277552|FG001|Induction Phase|Stable disease|0|||
126269064|NCT01144364|454277553|FG002|Induction Phase|Stable disease|0|||
126269065|NCT01144364|454277551|FG000|Induction Phase|Secondary neoplasia|1|||
126269066|NCT01144364|454277552|FG001|Induction Phase|Secondary neoplasia|0|||
126269067|NCT01144364|454277553|FG002|Induction Phase|Secondary neoplasia|0|||
126361007|NCT00987935|454612793|FG002|Overall Study|Progressive disease|3|||
126361008|NCT00987935|454612794|FG003|Overall Study|Progressive disease|2|||
126361009|NCT00987935|454612795|FG004|Overall Study|Progressive disease|5|||
126361010|NCT00987935|454612796|FG005|Overall Study|Progressive disease|3|||
126269068|NCT01144364|454277551|FG000|Induction Phase|Protocol Violation|1|||
126269069|NCT01144364|454277552|FG001|Induction Phase|Protocol Violation|0|||
126269070|NCT01144364|454277553|FG002|Induction Phase|Protocol Violation|0|||
126269071|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
126361011|NCT00987935|454612797|FG006|Overall Study|Progressive disease|9|||
126361012|NCT00987935|454612798|FG007|Overall Study|Progressive disease|48|||
126361013|NCT00987935|454612799|FG008|Overall Study|Progressive disease|23|||
126361014|NCT00987935|454612791|FG000|Overall Study|Adverse Event|0|||
126361015|NCT00987935|454612792|FG001|Overall Study|Adverse Event|1|||
126361016|NCT00987935|454612793|FG002|Overall Study|Adverse Event|0|||
126269072|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
126269073|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
126269074|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
126361017|NCT00987935|454612794|FG003|Overall Study|Adverse Event|1|||
126705259|NCT00893789|455871699|FG001|Overall Study|Adverse Event|2|||
126705260|NCT00893789|455871700|FG002|Overall Study|Adverse Event|1|||
126705261|NCT00893789|455871701|FG003|Overall Study|Adverse Event|5|||
126361018|NCT00987935|454612795|FG004|Overall Study|Adverse Event|1|||
126361019|NCT00987935|454612796|FG005|Overall Study|Adverse Event|0|||
126361020|NCT00987935|454612797|FG006|Overall Study|Adverse Event|2|||
126361021|NCT00987935|454612798|FG007|Overall Study|Adverse Event|10|||
126361022|NCT00987935|454612799|FG008|Overall Study|Adverse Event|6|||
126361023|NCT00987935|454612791|FG000|Overall Study|Refused to continue taking trial med.|1|||
126361024|NCT00987935|454612792|FG001|Overall Study|Refused to continue taking trial med.|0|||
126361025|NCT00987935|454612793|FG002|Overall Study|Refused to continue taking trial med.|0|||
126361026|NCT00987935|454612794|FG003|Overall Study|Refused to continue taking trial med.|0|||
126361027|NCT00987935|454612795|FG004|Overall Study|Refused to continue taking trial med.|1|||
126361028|NCT00987935|454612796|FG005|Overall Study|Refused to continue taking trial med.|0|||
126361029|NCT00987935|454612797|FG006|Overall Study|Refused to continue taking trial med.|4|||
126361030|NCT00987935|454612798|FG007|Overall Study|Refused to continue taking trial med.|4|||
126361031|NCT00987935|454612799|FG008|Overall Study|Refused to continue taking trial med.|2|||
126705262|NCT00893789|455871698|FG000|Overall Study|Protocol Violation|0|||
126705263|NCT00893789|455871699|FG001|Overall Study|Protocol Violation|1|||
126705264|NCT00893789|455871700|FG002|Overall Study|Protocol Violation|1|||
126361032|NCT00987935|454612791|FG000|Overall Study|Reason other than those specified above|0|||
126361033|NCT00987935|454612792|FG001|Overall Study|Reason other than those specified above|0|||
126453358|NCT00797966|454961415|FG002|Phase A|Met withdrawal criteria|0|||
126453359|NCT00797966|454961416|FG003|Phase A|Met withdrawal criteria|0|||
126453360|NCT00797966|454961417|FG004|Phase A|Met withdrawal criteria|4|||
126453361|NCT00797966|454961418|FG005|Phase A|Met withdrawal criteria|0|||
126453362|NCT00797966|454961413|FG000|Phase A|Physician Decision|0|||
126453363|NCT00797966|454961414|FG001|Phase A|Physician Decision|0|||
126453364|NCT00797966|454961415|FG002|Phase A|Physician Decision|0|||
126453365|NCT00797966|454961416|FG003|Phase A|Physician Decision|0|||
126453366|NCT00797966|454961417|FG004|Phase A|Physician Decision|13|||
126453367|NCT00797966|454961418|FG005|Phase A|Physician Decision|0|||
126453368|NCT00797966|454961413|FG000|Phase A|Withdrawal by Subject|0|||
126453369|NCT00797966|454961414|FG001|Phase A|Withdrawal by Subject|0|||
126453370|NCT00797966|454961415|FG002|Phase A|Withdrawal by Subject|0|||
126453371|NCT00797966|454961416|FG003|Phase A|Withdrawal by Subject|0|||
126453372|NCT00797966|454961417|FG004|Phase A|Withdrawal by Subject|33|||
126453373|NCT00797966|454961418|FG005|Phase A|Withdrawal by Subject|0|||
126453374|NCT00797966|454961413|FG000|Phase A|Protocol deviation|0|||
126453375|NCT00797966|454961414|FG001|Phase A|Protocol deviation|0|||
126453376|NCT00797966|454961415|FG002|Phase A|Protocol deviation|0|||
126453377|NCT00797966|454961416|FG003|Phase A|Protocol deviation|0|||
126453378|NCT00797966|454961417|FG004|Phase A|Protocol deviation|56|||
126453379|NCT00797966|454961418|FG005|Phase A|Protocol deviation|0|||
126453380|NCT00797966|454961413|FG000|Phase B|Lost to Follow-up|0|||
126453381|NCT00797966|454961414|FG001|Phase B|Lost to Follow-up|1|||
126453382|NCT00797966|454961415|FG002|Phase B|Lost to Follow-up|3|||
126453383|NCT00797966|454961416|FG003|Phase B|Lost to Follow-up|0|||
126453384|NCT00797966|454961417|FG004|Phase B|Lost to Follow-up|0|||
126453385|NCT00797966|454961418|FG005|Phase B|Lost to Follow-up|0|||
126705265|NCT00893789|455871701|FG003|Overall Study|Protocol Violation|4|||
126705266|NCT00893789|455871698|FG000|Overall Study|Lost to Follow-up|0|||
126705267|NCT00893789|455871699|FG001|Overall Study|Lost to Follow-up|0|||
126705268|NCT00893789|455871700|FG002|Overall Study|Lost to Follow-up|0|||
126705269|NCT00893789|455871701|FG003|Overall Study|Lost to Follow-up|1|||
126705270|NCT04723537|455871702|FG000|Overall Study|Withdrawal by Subject|3|||
126453386|NCT00797966|454961413|FG000|Phase B|Adverse Event|2|||
126453387|NCT00797966|454961414|FG001|Phase B|Adverse Event|1|||
126453388|NCT00797966|454961415|FG002|Phase B|Adverse Event|3|||
126453389|NCT00797966|454961416|FG003|Phase B|Adverse Event|1|||
126453390|NCT00797966|454961417|FG004|Phase B|Adverse Event|0|||
126453391|NCT00797966|454961418|FG005|Phase B|Adverse Event|0|||
126453392|NCT00797966|454961413|FG000|Phase B|Met Withdrawal Criteria|3|||
126453393|NCT00797966|454961414|FG001|Phase B|Met Withdrawal Criteria|3|||
126361034|NCT00987935|454612793|FG002|Overall Study|Reason other than those specified above|0|||
126361035|NCT00987935|454612794|FG003|Overall Study|Reason other than those specified above|0|||
126361036|NCT00987935|454612795|FG004|Overall Study|Reason other than those specified above|0|||
126361037|NCT00987935|454612796|FG005|Overall Study|Reason other than those specified above|0|||
126361038|NCT00987935|454612797|FG006|Overall Study|Reason other than those specified above|0|||
126453394|NCT00797966|454961415|FG002|Phase B|Met Withdrawal Criteria|6|||
126453395|NCT00797966|454961416|FG003|Phase B|Met Withdrawal Criteria|1|||
126453396|NCT00797966|454961417|FG004|Phase B|Met Withdrawal Criteria|0|||
126453397|NCT00797966|454961418|FG005|Phase B|Met Withdrawal Criteria|0|||
126453398|NCT00797966|454961413|FG000|Phase B|Physician Decision|1|||
126453399|NCT00797966|454961414|FG001|Phase B|Physician Decision|0|||
126705271|NCT04723537|455871703|FG001|Overall Study|Withdrawal by Subject|0|||
126705272|NCT04723537|455871704|FG002|Overall Study|Withdrawal by Subject|0|||
126705273|NCT04723537|455871702|FG000|Overall Study|Physician Decision|0|||
126705274|NCT04723537|455871703|FG001|Overall Study|Physician Decision|0|||
126705275|NCT04723537|455871704|FG002|Overall Study|Physician Decision|1|||
126705276|NCT04723537|455871702|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
126705277|NCT04723537|455871703|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
126705278|NCT04723537|455871704|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
126705279|NCT05408858|455871705|FG000|Overall Study|no longer met eligibility criteria|1|||
126705280|NCT04419506|455871706|FG000|Overall Study|Adverse Event|0|||
126269075|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
126269076|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
126269077|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Death|0|||
126269078|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Death|2|||
126269079|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Death|0|||
126269080|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
126269081|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
126269082|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
126269083|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
126269084|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
126269085|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
126269086|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
126269087|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
126269088|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
126269089|NCT01144364|454277551|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
126269090|NCT01144364|454277552|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
126269091|NCT01144364|454277553|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
126269092|NCT01301508|454277556|FG000|Overall Study|Withdrawal by Subject|1|||
126269093|NCT01301508|454277557|FG001|Overall Study|Withdrawal by Subject|2|||
126269094|NCT01301508|454277556|FG000|Overall Study|Lost to Follow-up|0|||
126269095|NCT01301508|454277557|FG001|Overall Study|Lost to Follow-up|1|||
126269096|NCT00851643|454277558|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
126269097|NCT00851643|454277559|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
126269098|NCT00851643|454277560|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
126269099|NCT00851643|454277561|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
126269100|NCT00851643|454277562|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
126269101|NCT00851643|454277563|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
126269102|NCT00851643|454277558|FG000|Base Study (Up to 12 Months)|Other|0|||
126269103|NCT00851643|454277559|FG001|Base Study (Up to 12 Months)|Other|0|||
126269104|NCT00851643|454277560|FG002|Base Study (Up to 12 Months)|Other|0|||
126269105|NCT00851643|454277561|FG003|Base Study (Up to 12 Months)|Other|0|||
126269106|NCT00851643|454277562|FG004|Base Study (Up to 12 Months)|Other|0|||
126269107|NCT00851643|454277563|FG005|Base Study (Up to 12 Months)|Other|1|||
126269108|NCT00851643|454277558|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
126269109|NCT00851643|454277559|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
126269110|NCT00851643|454277560|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
126269111|NCT00851643|454277561|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
126269112|NCT00851643|454277562|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
126269113|NCT00851643|454277563|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
126269114|NCT00851643|454277558|FG000|Extension Study (Up to 36 Months)|Moved|0|||
126269115|NCT00851643|454277559|FG001|Extension Study (Up to 36 Months)|Moved|2|||
126269116|NCT00851643|454277560|FG002|Extension Study (Up to 36 Months)|Moved|1|||
126269117|NCT00851643|454277561|FG003|Extension Study (Up to 36 Months)|Moved|1|||
126269118|NCT00851643|454277562|FG004|Extension Study (Up to 36 Months)|Moved|0|||
126269119|NCT00851643|454277563|FG005|Extension Study (Up to 36 Months)|Moved|1|||
126269120|NCT02707861|454277566|FG000|Overall Study|Went onto commercial drug|30|||
126269121|NCT02707861|454277567|FG001|Overall Study|Went onto commercial drug|23|||
126269122|NCT02707861|454277566|FG000|Overall Study|Adverse Event|2|||
126269123|NCT02707861|454277567|FG001|Overall Study|Adverse Event|3|||
126269124|NCT02707861|454277566|FG000|Overall Study|Death|5|||
126269125|NCT02707861|454277567|FG001|Overall Study|Death|2|||
126269126|NCT02707861|454277566|FG000|Overall Study|Lack of Efficacy|0|||
126269127|NCT02707861|454277567|FG001|Overall Study|Lack of Efficacy|2|||
126269128|NCT02707861|454277566|FG000|Overall Study|Physician Decision|1|||
126269129|NCT02707861|454277567|FG001|Overall Study|Physician Decision|4|||
126705281|NCT04419506|455871707|FG001|Overall Study|Adverse Event|10|||
126269130|NCT02707861|454277566|FG000|Overall Study|Withdrawal by Subject|2|||
126269131|NCT02707861|454277567|FG001|Overall Study|Withdrawal by Subject|1|||
126269132|NCT02707861|454277566|FG000|Overall Study|Lost to Follow-up|1|||
126269133|NCT02707861|454277567|FG001|Overall Study|Lost to Follow-up|3|||
126269134|NCT01940497|454277568|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
126269135|NCT01940497|454277569|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
126269136|NCT01940497|454277568|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
126269137|NCT01940497|454277569|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
126269138|NCT01940497|454277568|FG000|Overall Study|Violation of Entry Criteria|1|||
126705282|NCT04419506|455871708|FG002|Overall Study|Adverse Event|0|||
126269139|NCT01940497|454277569|FG001|Overall Study|Violation of Entry Criteria|1|||
126269140|NCT01940497|454277568|FG000|Overall Study|Refused Treatment|1|||
126269141|NCT01940497|454277569|FG001|Overall Study|Refused Treatment|3|||
126269142|NCT01940497|454277568|FG000|Overall Study|Withdrew Consent|6|||
126269143|NCT01940497|454277569|FG001|Overall Study|Withdrew Consent|2|||
126269144|NCT01940497|454277568|FG000|Overall Study|Administrative/Other|1|||
126269145|NCT01940497|454277569|FG001|Overall Study|Administrative/Other|1|||
126269146|NCT01641133|454277570|FG000|Overall Study|Protocol Violation|0|||
126269147|NCT01641133|454277571|FG001|Overall Study|Protocol Violation|1|||
126269148|NCT01641133|454277572|FG002|Overall Study|Protocol Violation|1|||
126269149|NCT01641133|454277570|FG000|Overall Study|Migrated/moved from study area|5|||
126269150|NCT01641133|454277571|FG001|Overall Study|Migrated/moved from study area|3|||
126269151|NCT01641133|454277572|FG002|Overall Study|Migrated/moved from study area|1|||
126269152|NCT01641133|454277570|FG000|Overall Study|Adverse Event|0|||
126269153|NCT01641133|454277571|FG001|Overall Study|Adverse Event|0|||
126269154|NCT01641133|454277572|FG002|Overall Study|Adverse Event|1|||
126269155|NCT01641133|454277570|FG000|Overall Study|Withdrawal by Subject|5|||
126269156|NCT01641133|454277571|FG001|Overall Study|Withdrawal by Subject|3|||
126269157|NCT01641133|454277572|FG002|Overall Study|Withdrawal by Subject|3|||
126269158|NCT01641133|454277570|FG000|Overall Study|Lost to Follow-up|0|||
126269159|NCT01641133|454277571|FG001|Overall Study|Lost to Follow-up|2|||
126269160|NCT01641133|454277572|FG002|Overall Study|Lost to Follow-up|2|||
126269161|NCT03123861|454277573|FG000|Overall Study|Protocol Violation|1|||
126269162|NCT03123861|454277574|FG001|Overall Study|Protocol Violation|1|||
126269163|NCT03123861|454277573|FG000|Overall Study|Withdrawal by Subject|2|||
126269164|NCT03123861|454277574|FG001|Overall Study|Withdrawal by Subject|2|||
126269165|NCT02206620|454277575|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
126269166|NCT02206620|454277576|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
126269167|NCT02206620|454277575|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
126269168|NCT02206620|454277576|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
126269169|NCT00807248|454279014|FG000|Overall Study|Adverse Event|1|||
126269170|NCT00807248|454279015|FG001|Overall Study|Adverse Event|2|||
126269171|NCT00807248|454279016|FG002|Overall Study|Adverse Event|2|||
126269172|NCT00807248|454279017|FG003|Overall Study|Adverse Event|6|||
126269173|NCT00807248|454279014|FG000|Overall Study|Lack of Efficacy|14|||
126269174|NCT00807248|454279015|FG001|Overall Study|Lack of Efficacy|4|||
126269175|NCT00807248|454279016|FG002|Overall Study|Lack of Efficacy|8|||
126269176|NCT00807248|454279017|FG003|Overall Study|Lack of Efficacy|3|||
126269177|NCT00807248|454279014|FG000|Overall Study|Protocol Violation|0|||
126269178|NCT00807248|454279015|FG001|Overall Study|Protocol Violation|1|||
126269179|NCT00807248|454279016|FG002|Overall Study|Protocol Violation|1|||
126269180|NCT00807248|454279017|FG003|Overall Study|Protocol Violation|0|||
126269181|NCT00807248|454279014|FG000|Overall Study|Withdrawal of Consent|5|||
126269182|NCT00807248|454279015|FG001|Overall Study|Withdrawal of Consent|5|||
126269183|NCT00807248|454279016|FG002|Overall Study|Withdrawal of Consent|5|||
126269184|NCT00807248|454279017|FG003|Overall Study|Withdrawal of Consent|5|||
126269185|NCT00807248|454279014|FG000|Overall Study|Lost to Follow-up|1|||
126269186|NCT00807248|454279015|FG001|Overall Study|Lost to Follow-up|0|||
126269187|NCT00807248|454279016|FG002|Overall Study|Lost to Follow-up|0|||
126269188|NCT00807248|454279017|FG003|Overall Study|Lost to Follow-up|0|||
126269189|NCT00807248|454279014|FG000|Overall Study|Other Reason|0|||
126269190|NCT00807248|454279015|FG001|Overall Study|Other Reason|0|||
126361039|NCT00987935|454612798|FG007|Overall Study|Reason other than those specified above|0|||
126361040|NCT00987935|454612799|FG008|Overall Study|Reason other than those specified above|1|||
126361041|NCT01089543|454612800|FG000|Overall Study|Withdrawal by Subject|2|||
126361042|NCT01089543|454612801|FG001|Overall Study|Withdrawal by Subject|3|||
126361043|NCT01089543|454612802|FG002|Overall Study|Withdrawal by Subject|3|||
126361044|NCT01089543|454612803|FG003|Overall Study|Withdrawal by Subject|1|||
126361045|NCT01089543|454612800|FG000|Overall Study|Physician Decision|1|||
126361046|NCT01089543|454612801|FG001|Overall Study|Physician Decision|0|||
126269191|NCT00807248|454279016|FG002|Overall Study|Other Reason|2|||
126269192|NCT00807248|454279017|FG003|Overall Study|Other Reason|0|||
126269193|NCT00609518|454279019|FG000|Overall Study|Death from Study Disease|32|||
126269194|NCT00609518|454279020|FG001|Overall Study|Death from Study Disease|32|||
126269195|NCT00609518|454279019|FG000|Overall Study|Withdrawal by Subject|5|||
126269196|NCT00609518|454279020|FG001|Overall Study|Withdrawal by Subject|3|||
126269197|NCT00609518|454279019|FG000|Overall Study|Lost to Follow-up|3|||
126269198|NCT00609518|454279020|FG001|Overall Study|Lost to Follow-up|0|||
126269199|NCT00609518|454279019|FG000|Overall Study|Physician Decision|1|||
126269200|NCT00609518|454279020|FG001|Overall Study|Physician Decision|3|||
126269201|NCT00609518|454279019|FG000|Overall Study|Death from Adverse Event|2|||
126269202|NCT00609518|454279020|FG001|Overall Study|Death from Adverse Event|2|||
126269203|NCT00292188|454279024|FG000|Single-Blind|Adverse Event|14|||
126269204|NCT00292188|454279025|FG001|Single-Blind|Adverse Event|0|||
126269205|NCT00292188|454279026|FG002|Single-Blind|Adverse Event|0|||
126269206|NCT00292188|454279024|FG000|Single-Blind|Lack of Efficacy|2|||
126269207|NCT00292188|454279025|FG001|Single-Blind|Lack of Efficacy|0|||
126361047|NCT01089543|454612802|FG002|Overall Study|Physician Decision|0|||
126361048|NCT01089543|454612803|FG003|Overall Study|Physician Decision|1|||
126361049|NCT01089543|454612800|FG000|Overall Study|Adverse Event|0|||
126361050|NCT01089543|454612801|FG001|Overall Study|Adverse Event|1|||
126361051|NCT01089543|454612802|FG002|Overall Study|Adverse Event|0|||
126361052|NCT01089543|454612803|FG003|Overall Study|Adverse Event|0|||
126361053|NCT00345592|454612805|FG000|Overall Study|Death|14|||
126361054|NCT00345592|454612806|FG001|Overall Study|Death|16|||
126361055|NCT00345592|454612805|FG000|Overall Study|Withdrawal by Subject|11|||
126361056|NCT00345592|454612806|FG001|Overall Study|Withdrawal by Subject|8|||
126361057|NCT01248468|454612807|FG000|Overall Study|Administrative problem|1|||
126361058|NCT01248468|454612808|FG001|Overall Study|Administrative problem|0|||
126361059|NCT01248468|454612809|FG002|Overall Study|Administrative problem|0|||
126361060|NCT01248468|454612807|FG000|Overall Study|Lost to Follow-up|9|||
126361061|NCT01248468|454612808|FG001|Overall Study|Lost to Follow-up|12|||
126361062|NCT01248468|454612809|FG002|Overall Study|Lost to Follow-up|4|||
126361063|NCT01248468|454612807|FG000|Overall Study|Pregnancy|1|||
126361064|NCT01248468|454612808|FG001|Overall Study|Pregnancy|0|||
126361065|NCT01248468|454612809|FG002|Overall Study|Pregnancy|0|||
126361066|NCT01248468|454612807|FG000|Overall Study|Withdrawal by Subject|4|||
126361067|NCT01248468|454612808|FG001|Overall Study|Withdrawal by Subject|2|||
126361068|NCT01248468|454612809|FG002|Overall Study|Withdrawal by Subject|0|||
126361069|NCT02176525|454612811|FG000|Overall Study|Adverse Event|0|||
126361070|NCT02176525|454612812|FG001|Overall Study|Adverse Event|0|||
126361071|NCT02176525|454612813|FG002|Overall Study|Adverse Event|0|||
126361072|NCT02176525|454612814|FG003|Overall Study|Adverse Event|1|||
126361073|NCT02176525|454612815|FG004|Overall Study|Adverse Event|1|||
126361074|NCT02176525|454612816|FG005|Overall Study|Adverse Event|0|||
126361075|NCT02176525|454612817|FG006|Overall Study|Adverse Event|1|||
126361076|NCT02176525|454612818|FG007|Overall Study|Adverse Event|0|||
126361077|NCT02176525|454612811|FG000|Overall Study|not treated|1|||
126361078|NCT02176525|454612812|FG001|Overall Study|not treated|0|||
126361079|NCT02176525|454612813|FG002|Overall Study|not treated|0|||
126361080|NCT02176525|454612814|FG003|Overall Study|not treated|0|||
126361081|NCT02176525|454612815|FG004|Overall Study|not treated|0|||
126361082|NCT02176525|454612816|FG005|Overall Study|not treated|1|||
126361083|NCT02176525|454612817|FG006|Overall Study|not treated|0|||
126361084|NCT02176525|454612818|FG007|Overall Study|not treated|0|||
126361085|NCT00468546|454612819|FG000|Week 24 Analysis|Lack of Efficacy|83|||
126361086|NCT00468546|454612820|FG001|Week 24 Analysis|Lack of Efficacy|37|||
126361087|NCT00468546|454612819|FG000|Week 24 Analysis|Refused treatment|5|||
126361088|NCT00468546|454612820|FG001|Week 24 Analysis|Refused treatment|5|||
126361089|NCT00468546|454612819|FG000|Week 24 Analysis|Adverse Event|1|||
126361090|NCT00468546|454612820|FG001|Week 24 Analysis|Adverse Event|8|||
126361091|NCT00468546|454612819|FG000|Week 24 Analysis|Failure to return|3|||
126361092|NCT00468546|454612820|FG001|Week 24 Analysis|Failure to return|4|||
126361093|NCT00468546|454612819|FG000|Week 24 Analysis|Rescue therapy|2|||
126361094|NCT00468546|454612820|FG001|Week 24 Analysis|Rescue therapy|0|||
126361095|NCT00468546|454612819|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
126361096|NCT00468546|454612820|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
126361097|NCT00468546|454612819|FG000|Week 24 Analysis|Due to clinical hold|1|||
126361098|NCT00468546|454612820|FG001|Week 24 Analysis|Due to clinical hold|0|||
126361099|NCT00468546|454612819|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
126361100|NCT00468546|454612820|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
126361101|NCT00468546|454612819|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
126361102|NCT00468546|454612820|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
126361103|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
126361104|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
126361105|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Death|1|||
126361106|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Death|0|||
126361107|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
126361108|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
126361109|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
126361110|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
126361111|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
126361112|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
126361113|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
126361114|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
126361115|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
126361116|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
126361117|NCT00468546|454612819|FG000|Week 24 to Week 104 Analysis|Other|17|||
126361118|NCT00468546|454612820|FG001|Week 24 to Week 104 Analysis|Other|14|||
126361119|NCT01245049|454612826|FG000|Overall Study|Migrated/moved from study area|0|||
126361120|NCT01245049|454612827|FG001|Overall Study|Migrated/moved from study area|1|||
126361121|NCT01245049|454612826|FG000|Overall Study|Withdrawal by Subject|0|||
126361122|NCT01245049|454612827|FG001|Overall Study|Withdrawal by Subject|1|||
126361123|NCT01245049|454612826|FG000|Overall Study|Lost to Follow-up|1|||
126705283|NCT04419506|455871709|FG003|Overall Study|Adverse Event|3|||
126269208|NCT00292188|454279026|FG002|Single-Blind|Lack of Efficacy|0|||
126269209|NCT00292188|454279024|FG000|Single-Blind|Laboratory Abnormality|5|||
126269210|NCT00292188|454279025|FG001|Single-Blind|Laboratory Abnormality|0|||
126269211|NCT00292188|454279026|FG002|Single-Blind|Laboratory Abnormality|0|||
126705284|NCT04419506|455871706|FG000|Overall Study|Withdrawal by Subject|0|||
126705285|NCT04419506|455871707|FG001|Overall Study|Withdrawal by Subject|0|||
126705286|NCT04419506|455871708|FG002|Overall Study|Withdrawal by Subject|0|||
126705287|NCT04419506|455871709|FG003|Overall Study|Withdrawal by Subject|1|||
126705288|NCT04419506|455871706|FG000|Overall Study|poor-compliance|0|||
126705289|NCT04419506|455871707|FG001|Overall Study|poor-compliance|0|||
126705290|NCT04419506|455871708|FG002|Overall Study|poor-compliance|0|||
126705291|NCT04419506|455871709|FG003|Overall Study|poor-compliance|1|||
126705292|NCT03717922|455871717|FG000|Overall Study|Lost to Follow-up|2|||
126705293|NCT03717922|455871718|FG001|Overall Study|Lost to Follow-up|2|||
126705294|NCT01242111|455871719|FG000|Overall Study|Adverse Event|1|||
126705295|NCT01242111|455871719|FG000|Overall Study|Withdrawal by Subject|1|||
126705296|NCT01242111|455871719|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
126705297|NCT01021007|455871722|FG000|Overall Study|Lost to Follow-up|1|||
126705298|NCT01021007|455871723|FG001|Overall Study|Lost to Follow-up|1|||
126705299|NCT01021007|455871722|FG000|Overall Study|Adverse Event|1|||
126705300|NCT01021007|455871723|FG001|Overall Study|Adverse Event|3|||
126705301|NCT00087438|455871724|FG000|Overall Study|Ineligible / No protocol treatment|4|||
126705302|NCT00466505|455871725|FG000|Overall Study|disease progression|13|||
126705303|NCT00466505|455871725|FG000|Overall Study|Adverse Event|4|||
126705304|NCT00594399|455871728|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
126705305|NCT00594399|455871729|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
126705306|NCT00594399|455871730|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
126705307|NCT00594399|455871728|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
126705308|NCT00594399|455871729|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
126269212|NCT00292188|454279024|FG000|Single-Blind|Lost to Follow-up|3|||
126269213|NCT00292188|454279025|FG001|Single-Blind|Lost to Follow-up|0|||
126269214|NCT00292188|454279026|FG002|Single-Blind|Lost to Follow-up|0|||
126269215|NCT00292188|454279024|FG000|Single-Blind|Other|77|||
126269216|NCT00292188|454279025|FG001|Single-Blind|Other|0|||
126269217|NCT00292188|454279026|FG002|Single-Blind|Other|0|||
126269218|NCT00292188|454279024|FG000|Single-Blind|Withdrawal by Subject|12|||
126269219|NCT00292188|454279025|FG001|Single-Blind|Withdrawal by Subject|0|||
126269220|NCT00292188|454279026|FG002|Single-Blind|Withdrawal by Subject|0|||
126269221|NCT00292188|454279024|FG000|Single-Blind|Did not receive treatment|1|||
126269222|NCT00292188|454279025|FG001|Single-Blind|Did not receive treatment|0|||
126269223|NCT00292188|454279026|FG002|Single-Blind|Did not receive treatment|0|||
126269224|NCT00292188|454279024|FG000|Double-Blind|Adverse Event|0|||
126269225|NCT00292188|454279025|FG001|Double-Blind|Adverse Event|25|||
126269226|NCT00292188|454279026|FG002|Double-Blind|Adverse Event|9|||
126269227|NCT00292188|454279024|FG000|Double-Blind|Lack of Efficacy|0|||
126269228|NCT00292188|454279025|FG001|Double-Blind|Lack of Efficacy|2|||
126269229|NCT00292188|454279026|FG002|Double-Blind|Lack of Efficacy|12|||
126269230|NCT00292188|454279024|FG000|Double-Blind|Lost to Follow-up|0|||
126269231|NCT00292188|454279025|FG001|Double-Blind|Lost to Follow-up|1|||
126269232|NCT00292188|454279026|FG002|Double-Blind|Lost to Follow-up|0|||
126269233|NCT00292188|454279024|FG000|Double-Blind|Other|0|||
126269234|NCT00292188|454279025|FG001|Double-Blind|Other|3|||
126269235|NCT00292188|454279026|FG002|Double-Blind|Other|4|||
126269236|NCT00292188|454279024|FG000|Double-Blind|Withdrawal by Subject|0|||
126269237|NCT00292188|454279025|FG001|Double-Blind|Withdrawal by Subject|0|||
126269238|NCT00292188|454279026|FG002|Double-Blind|Withdrawal by Subject|3|||
126269239|NCT00292188|454279024|FG000|Double-Blind|Laboratory Abnormality|0|||
126269240|NCT00292188|454279025|FG001|Double-Blind|Laboratory Abnormality|0|||
126269241|NCT00292188|454279026|FG002|Double-Blind|Laboratory Abnormality|1|||
126269242|NCT00824616|454279027|FG000|Overall Study|Adverse Event|2|||
126269243|NCT00824616|454279028|FG001|Overall Study|Adverse Event|1|||
126269244|NCT00824616|454279027|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
126269245|NCT00824616|454279028|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
126269246|NCT00824616|454279027|FG000|Overall Study|Hyperglycemia|1|||
126269247|NCT00824616|454279028|FG001|Overall Study|Hyperglycemia|1|||
126269248|NCT00824616|454279027|FG000|Overall Study|Lack of Efficacy|2|||
126269249|NCT00824616|454279028|FG001|Overall Study|Lack of Efficacy|1|||
126361124|NCT01245049|454612827|FG001|Overall Study|Lost to Follow-up|2|||
126361125|NCT00450749|454612828|FG000|Overall Study|Withdrawal by Subject|0|||
126361126|NCT00450749|454612829|FG001|Overall Study|Withdrawal by Subject|0|||
126361127|NCT00450749|454612830|FG002|Overall Study|Withdrawal by Subject|2|||
126361128|NCT00450749|454612828|FG000|Overall Study|Noncompliant|0|||
126705309|NCT00594399|455871730|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
126705310|NCT00594399|455871728|FG000|Initial 3 Month Counseling|Personal issues|2|||
126705311|NCT00594399|455871729|FG001|Initial 3 Month Counseling|Personal issues|0|||
126705312|NCT00594399|455871730|FG002|Initial 3 Month Counseling|Personal issues|0|||
126705313|NCT00594399|455871728|FG000|Initial 3 Month Counseling|Too busy|7|||
126361129|NCT00450749|454612829|FG001|Overall Study|Noncompliant|1|||
126361130|NCT00450749|454612830|FG002|Overall Study|Noncompliant|0|||
126361131|NCT01213251|454615171|FG000|Overall Study|Death|2|||
126361132|NCT01213251|454615172|FG001|Overall Study|Death|1|||
126361133|NCT01213251|454615173|FG002|Overall Study|Death|2|||
126361134|NCT01213251|454615171|FG000|Overall Study|Exit|3|||
126361135|NCT01213251|454615172|FG001|Overall Study|Exit|2|||
126361136|NCT01213251|454615173|FG002|Overall Study|Exit|8|||
126361137|NCT01213251|454615171|FG000|Overall Study|Protocol Violation|1|||
126361138|NCT01213251|454615172|FG001|Overall Study|Protocol Violation|1|||
126361139|NCT01213251|454615173|FG002|Overall Study|Protocol Violation|0|||
126361140|NCT01213251|454615171|FG000|Overall Study|Missed 18-Month Follow-up|0|||
126361141|NCT01213251|454615172|FG001|Overall Study|Missed 18-Month Follow-up|0|||
126361142|NCT01213251|454615173|FG002|Overall Study|Missed 18-Month Follow-up|1|||
126361143|NCT02529488|454615174|FG000|Overall Study|Adverse Event|1|||
126361144|NCT02529488|454615174|FG000|Overall Study|Death|3|||
126361145|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
126361146|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
126361147|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
126361148|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
126361149|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
126361150|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
126361151|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
126361152|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
126361153|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
126361154|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
126361155|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
126361156|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
126361157|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
126361158|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
126361159|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
126361160|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
126453400|NCT00797966|454961415|FG002|Phase B|Physician Decision|3|||
126453401|NCT00797966|454961416|FG003|Phase B|Physician Decision|1|||
126453402|NCT00797966|454961417|FG004|Phase B|Physician Decision|0|||
126453403|NCT00797966|454961418|FG005|Phase B|Physician Decision|0|||
126453404|NCT00797966|454961413|FG000|Phase B|Withdrawal by Subject|1|||
126453405|NCT00797966|454961414|FG001|Phase B|Withdrawal by Subject|4|||
126453406|NCT00797966|454961415|FG002|Phase B|Withdrawal by Subject|3|||
126453407|NCT00797966|454961416|FG003|Phase B|Withdrawal by Subject|3|||
126453408|NCT00797966|454961417|FG004|Phase B|Withdrawal by Subject|0|||
126453409|NCT00797966|454961418|FG005|Phase B|Withdrawal by Subject|0|||
126453410|NCT00797966|454961413|FG000|Phase B|Protocol Deviation|4|||
126453411|NCT00797966|454961414|FG001|Phase B|Protocol Deviation|8|||
126453412|NCT00797966|454961415|FG002|Phase B|Protocol Deviation|2|||
126453413|NCT00797966|454961416|FG003|Phase B|Protocol Deviation|6|||
126453414|NCT00797966|454961417|FG004|Phase B|Protocol Deviation|0|||
126453415|NCT00797966|454961418|FG005|Phase B|Protocol Deviation|0|||
126453416|NCT00797966|454961413|FG000|Phase B|Lack of Efficacy|0|||
126453417|NCT00797966|454961414|FG001|Phase B|Lack of Efficacy|1|||
126453418|NCT00797966|454961415|FG002|Phase B|Lack of Efficacy|1|||
126453419|NCT00797966|454961416|FG003|Phase B|Lack of Efficacy|4|||
126453420|NCT00797966|454961417|FG004|Phase B|Lack of Efficacy|0|||
126453421|NCT00797966|454961418|FG005|Phase B|Lack of Efficacy|0|||
126453422|NCT00797966|454961413|FG000|Phase A+|Lost to Follow-up|0|||
126453423|NCT00797966|454961414|FG001|Phase A+|Lost to Follow-up|0|||
126453424|NCT00797966|454961415|FG002|Phase A+|Lost to Follow-up|0|||
126705314|NCT00594399|455871729|FG001|Initial 3 Month Counseling|Too busy|1|||
126705315|NCT00594399|455871730|FG002|Initial 3 Month Counseling|Too busy|0|||
126705316|NCT00594399|455871728|FG000|Initial 3 Month Counseling|Pain|2|||
126705317|NCT00594399|455871729|FG001|Initial 3 Month Counseling|Pain|0|||
126361161|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
126361162|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
126453425|NCT00797966|454961416|FG003|Phase A+|Lost to Follow-up|0|||
126453426|NCT00797966|454961417|FG004|Phase A+|Lost to Follow-up|0|||
126453427|NCT00797966|454961418|FG005|Phase A+|Lost to Follow-up|9|||
126453428|NCT00797966|454961413|FG000|Phase A+|Met withdrawal criteria|0|||
126453429|NCT00797966|454961414|FG001|Phase A+|Met withdrawal criteria|0|||
126453430|NCT00797966|454961415|FG002|Phase A+|Met withdrawal criteria|0|||
126453431|NCT00797966|454961416|FG003|Phase A+|Met withdrawal criteria|0|||
126705318|NCT00594399|455871730|FG002|Initial 3 Month Counseling|Pain|0|||
126705319|NCT00594399|455871728|FG000|Initial 3 Month Counseling|Moved|1|||
126453432|NCT00797966|454961417|FG004|Phase A+|Met withdrawal criteria|0|||
126453433|NCT00797966|454961418|FG005|Phase A+|Met withdrawal criteria|5|||
126453434|NCT00797966|454961413|FG000|Phase A+|Withdrawal by Subject|0|||
126453435|NCT00797966|454961414|FG001|Phase A+|Withdrawal by Subject|0|||
126453436|NCT00797966|454961415|FG002|Phase A+|Withdrawal by Subject|0|||
126269250|NCT00824616|454279027|FG000|Overall Study|Lost to Follow-up|0|||
126269251|NCT00824616|454279028|FG001|Overall Study|Lost to Follow-up|1|||
126269252|NCT00824616|454279027|FG000|Overall Study|Withdrawal by Subject|1|||
126269253|NCT00824616|454279028|FG001|Overall Study|Withdrawal by Subject|1|||
126269254|NCT02923674|454279035|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
126269255|NCT02923674|454279036|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
126269256|NCT02923674|454279037|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
126269257|NCT02923674|454279035|FG000|Overall Study|Lost to Follow-up|7|||
126269258|NCT02923674|454279036|FG001|Overall Study|Lost to Follow-up|12|||
126269259|NCT02923674|454279037|FG002|Overall Study|Lost to Follow-up|7|||
126269260|NCT02923674|454279035|FG000|Overall Study|Problem with intervention|2|||
126269261|NCT02923674|454279036|FG001|Overall Study|Problem with intervention|2|||
126269262|NCT02923674|454279037|FG002|Overall Study|Problem with intervention|1|||
126269263|NCT02923674|454279035|FG000|Overall Study|Adverse Event|3|||
126269264|NCT02923674|454279036|FG001|Overall Study|Adverse Event|1|||
126269265|NCT02923674|454279037|FG002|Overall Study|Adverse Event|1|||
126269266|NCT02923674|454279035|FG000|Overall Study|Withdrawal by Subject|2|||
126269267|NCT02923674|454279036|FG001|Overall Study|Withdrawal by Subject|2|||
126269268|NCT02923674|454279037|FG002|Overall Study|Withdrawal by Subject|2|||
126269269|NCT01055132|454279038|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
126269270|NCT01055132|454279039|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
126269271|NCT01055132|454279038|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
126269272|NCT01055132|454279039|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
126269273|NCT00158600|454279040|FG000|Overall Study|unable to commit time to study|0|||
126269274|NCT00158600|454279041|FG001|Overall Study|unable to commit time to study|1|||
126269275|NCT00158600|454279040|FG000|Overall Study|Adverse Event|2|||
126269276|NCT00158600|454279041|FG001|Overall Study|Adverse Event|1|||
126269277|NCT00158600|454279040|FG000|Overall Study|Death|1|||
126269278|NCT00158600|454279041|FG001|Overall Study|Death|0|||
126269279|NCT00158600|454279040|FG000|Overall Study|Withdrawal by Subject|2|||
126269280|NCT00158600|454279041|FG001|Overall Study|Withdrawal by Subject|2|||
126269281|NCT02618408|454279042|FG000|Overall Study|Withdrawal by Subject|1|||
126269282|NCT02618408|454279043|FG001|Overall Study|Withdrawal by Subject|0|||
126269283|NCT02618408|454279044|FG002|Overall Study|Withdrawal by Subject|4|||
126269284|NCT02618408|454279042|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
126269285|NCT02618408|454279043|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
126269286|NCT02618408|454279044|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
126269287|NCT02618408|454279042|FG000|Overall Study|Lost to Follow-up|4|||
126269288|NCT02618408|454279043|FG001|Overall Study|Lost to Follow-up|2|||
126269289|NCT02618408|454279044|FG002|Overall Study|Lost to Follow-up|6|||
126269290|NCT02618408|454279042|FG000|Overall Study|Adverse Event|4|||
126269291|NCT02618408|454279043|FG001|Overall Study|Adverse Event|0|||
126269292|NCT02618408|454279044|FG002|Overall Study|Adverse Event|10|||
126269293|NCT02618408|454279042|FG000|Overall Study|Physician Decision|1|||
126269294|NCT02618408|454279043|FG001|Overall Study|Physician Decision|1|||
126269295|NCT02618408|454279044|FG002|Overall Study|Physician Decision|2|||
126269296|NCT02618408|454279042|FG000|Overall Study|Protocol Violation|1|||
126269297|NCT02618408|454279043|FG001|Overall Study|Protocol Violation|1|||
126269298|NCT02618408|454279044|FG002|Overall Study|Protocol Violation|2|||
126269299|NCT02618408|454279042|FG000|Overall Study|Other, Multiple Categories|0|||
126269300|NCT02618408|454279043|FG001|Overall Study|Other, Multiple Categories|0|||
126269301|NCT02618408|454279044|FG002|Overall Study|Other, Multiple Categories|4|||
126269302|NCT02575911|454279048|FG000|Overall Study|Lost to Follow-up|1|||
126269303|NCT01249365|454279049|FG000|Overall Study|Lost to Follow-up|1|||
126269304|NCT01460901|454279050|FG000|Overall Study|Withdrawal by Subject|2|||
126269305|NCT02566993|454279051|FG000|Overall Study|Randomized but not treated|5|||
126269306|NCT02566993|454279052|FG001|Overall Study|Randomized but not treated|16|||
126269307|NCT02566993|454279051|FG000|Overall Study|Progressive disease|213|||
126269308|NCT02566993|454279052|FG001|Overall Study|Progressive disease|152|||
126269309|NCT02566993|454279051|FG000|Overall Study|Withdrawal by Subject|12|||
126269310|NCT02566993|454279052|FG001|Overall Study|Withdrawal by Subject|28|||
126269311|NCT02566993|454279051|FG000|Overall Study|Death|17|||
126269312|NCT02566993|454279052|FG001|Overall Study|Death|23|||
126269313|NCT02566993|454279051|FG000|Overall Study|Physician Decision|10|||
126269314|NCT02566993|454279052|FG001|Overall Study|Physician Decision|17|||
126269315|NCT02566993|454279051|FG000|Overall Study|Study drug-related adverse event|20|||
126269316|NCT02566993|454279052|FG001|Overall Study|Study drug-related adverse event|41|||
126269317|NCT02566993|454279051|FG000|Overall Study|Non study drug-related adverse event|9|||
126269318|NCT02566993|454279052|FG001|Overall Study|Non study drug-related adverse event|9|||
126269319|NCT02566993|454279051|FG000|Overall Study|Symptomatic deterioration|9|||
126269320|NCT02566993|454279052|FG001|Overall Study|Symptomatic deterioration|16|||
126269321|NCT02566993|454279051|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
126269322|NCT02566993|454279052|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
126453437|NCT00797966|454961416|FG003|Phase A+|Withdrawal by Subject|0|||
126453438|NCT00797966|454961417|FG004|Phase A+|Withdrawal by Subject|0|||
126705320|NCT00594399|455871729|FG001|Initial 3 Month Counseling|Moved|0|||
126705321|NCT00594399|455871730|FG002|Initial 3 Month Counseling|Moved|0|||
126269323|NCT02566993|454279051|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
126269324|NCT02566993|454279052|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
126269325|NCT02566993|454279051|FG000|Overall Study|Screening failure|2|||
126269326|NCT02566993|454279052|FG001|Overall Study|Screening failure|0|||
126269327|NCT02566993|454279051|FG000|Overall Study|Lost to Follow-up|0|||
126269328|NCT02566993|454279052|FG001|Overall Study|Lost to Follow-up|1|||
126269329|NCT02566993|454279051|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
126269330|NCT02566993|454279052|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
126269331|NCT01169532|454279058|FG000|Overall Study|Withdrawal by Subject|1|||
126269332|NCT03127644|454279066|FG000|Overall Study|Study-specific withdrawal criteria|0|||
126269333|NCT03127644|454279067|FG001|Overall Study|Study-specific withdrawal criteria|0|||
126269334|NCT03127644|454279068|FG002|Overall Study|Study-specific withdrawal criteria|2|||
126269335|NCT02032706|454279069|FG000|Overall Study|Did not qualify|5|||
126269336|NCT02032706|454279069|FG000|Overall Study|Protocol Violation|1|||
126269337|NCT01156142|454279072|FG000|Overall Study|Withdrawal by Subject|8|||
126269338|NCT01156142|454279073|FG001|Overall Study|Withdrawal by Subject|6|||
126269339|NCT01156142|454279072|FG000|Overall Study|Ineligible|0|||
126269340|NCT01156142|454279073|FG001|Overall Study|Ineligible|1|||
126269341|NCT00893737|454279074|FG000|Overall Study|Adverse Event|4|||
126269342|NCT00893737|454279074|FG000|Overall Study|Withdrawal by Subject|2|||
126269343|NCT00893737|454279074|FG000|Overall Study|Lost to Follow-up|6|||
126269344|NCT02140411|454279075|FG000|Overall Study|Adverse Event|1|||
126269345|NCT03981419|454279078|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
126269346|NCT03981419|454279079|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
126269347|NCT01330459|454279084|FG000|Overall Study|Physician Decision|0|||
126269348|NCT01330459|454279085|FG001|Overall Study|Physician Decision|2|||
126269349|NCT00895947|454279087|FG000|Overall Study|Adverse Event|3|||
126269350|NCT00895947|454279088|FG001|Overall Study|Adverse Event|4|||
126269351|NCT00895947|454279087|FG000|Overall Study|Lost to Follow-up|3|||
126269352|NCT00895947|454279088|FG001|Overall Study|Lost to Follow-up|4|||
126269353|NCT00895947|454279087|FG000|Overall Study|Protocol Violation|4|||
126269354|NCT00895947|454279088|FG001|Overall Study|Protocol Violation|2|||
126269355|NCT00895947|454279087|FG000|Overall Study|Withdrawal by Subject|2|||
126269356|NCT00895947|454279088|FG001|Overall Study|Withdrawal by Subject|0|||
126269357|NCT04620135|454279091|FG000|Study Completion|Adverse Event|2|||
126269358|NCT04620135|454279092|FG001|Study Completion|Adverse Event|3|||
126269359|NCT04620135|454279091|FG000|Study Completion|Withdrawal by Subject|2|||
126269360|NCT04620135|454279092|FG001|Study Completion|Withdrawal by Subject|0|||
126269361|NCT02005887|454279101|FG000|Overall Study|Protocol Violation|0|||
126269362|NCT02005887|454279102|FG001|Overall Study|Protocol Violation|2|||
126269363|NCT01550744|454279103|FG000|Open-Label|Lost to Follow-up|7|||
126269364|NCT01550744|454279104|FG001|Open-Label|Lost to Follow-up|0|||
126269365|NCT01550744|454279105|FG002|Open-Label|Lost to Follow-up|0|||
126269366|NCT01550744|454279103|FG000|Open-Label|Withdrawal by Subject|13|||
126269367|NCT01550744|454279104|FG001|Open-Label|Withdrawal by Subject|0|||
126269368|NCT01550744|454279105|FG002|Open-Label|Withdrawal by Subject|0|||
126269369|NCT01550744|454279103|FG000|Open-Label|Adverse Event|11|||
126269370|NCT01550744|454279104|FG001|Open-Label|Adverse Event|0|||
126269371|NCT01550744|454279105|FG002|Open-Label|Adverse Event|0|||
126269372|NCT01550744|454279103|FG000|Open-Label|Lack of Efficacy|4|||
126269373|NCT01550744|454279104|FG001|Open-Label|Lack of Efficacy|0|||
126269374|NCT01550744|454279105|FG002|Open-Label|Lack of Efficacy|0|||
126269375|NCT01550744|454279103|FG000|Open-Label|Protocol Violation|4|||
126269376|NCT01550744|454279104|FG001|Open-Label|Protocol Violation|0|||
126269377|NCT01550744|454279105|FG002|Open-Label|Protocol Violation|0|||
126269378|NCT01550744|454279103|FG000|Open-Label|Not all 3 study drug injections received|2|||
126269379|NCT01550744|454279104|FG001|Open-Label|Not all 3 study drug injections received|0|||
126269380|NCT01550744|454279105|FG002|Open-Label|Not all 3 study drug injections received|0|||
126269381|NCT01550744|454279103|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
126547359|NCT03757234|455296210|FG003|Overall Study|Other|0|||
126705322|NCT00594399|455871728|FG000|Initial 3 Month Counseling|Family illness|1|||
126269382|NCT01550744|454279104|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
126269383|NCT01550744|454279105|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
126269384|NCT01550744|454279103|FG000|Open-Label|Other|1|||
126269385|NCT01550744|454279104|FG001|Open-Label|Other|0|||
126269386|NCT01550744|454279105|FG002|Open-Label|Other|0|||
126269387|NCT01550744|454279103|FG000|Double-Blind|Lost to Follow-up|0|||
126269388|NCT01550744|454279104|FG001|Double-Blind|Lost to Follow-up|6|||
126269389|NCT01550744|454279105|FG002|Double-Blind|Lost to Follow-up|12|||
126269390|NCT01550744|454279103|FG000|Double-Blind|Withdrawal by Subject|0|||
126269391|NCT01550744|454279104|FG001|Double-Blind|Withdrawal by Subject|2|||
126269392|NCT01550744|454279105|FG002|Double-Blind|Withdrawal by Subject|15|||
126269393|NCT01550744|454279103|FG000|Double-Blind|Adverse Event|0|||
126547360|NCT03757234|455296211|FG004|Overall Study|Other|0|||
126705323|NCT00594399|455871729|FG001|Initial 3 Month Counseling|Family illness|0|||
126269394|NCT01550744|454279104|FG001|Double-Blind|Adverse Event|4|||
126269395|NCT01550744|454279105|FG002|Double-Blind|Adverse Event|15|||
126269396|NCT01550744|454279103|FG000|Double-Blind|Death|0|||
126269397|NCT01550744|454279104|FG001|Double-Blind|Death|1|||
126269398|NCT01550744|454279105|FG002|Double-Blind|Death|0|||
126269399|NCT01550744|454279103|FG000|Double-Blind|Lack of Efficacy|0|||
126269400|NCT01550744|454279104|FG001|Double-Blind|Lack of Efficacy|2|||
126269401|NCT01550744|454279105|FG002|Double-Blind|Lack of Efficacy|8|||
126269402|NCT01550744|454279103|FG000|Double-Blind|Protocol Violation|0|||
126269403|NCT01550744|454279104|FG001|Double-Blind|Protocol Violation|0|||
126269404|NCT01550744|454279105|FG002|Double-Blind|Protocol Violation|4|||
126269405|NCT01550744|454279103|FG000|Double-Blind|Pregnancy|0|||
126269406|NCT01550744|454279104|FG001|Double-Blind|Pregnancy|0|||
126269407|NCT01550744|454279105|FG002|Double-Blind|Pregnancy|3|||
126269408|NCT01550744|454279103|FG000|Double-Blind|Other|0|||
126269409|NCT01550744|454279104|FG001|Double-Blind|Other|2|||
126269410|NCT01550744|454279105|FG002|Double-Blind|Other|10|||
126269411|NCT01660334|454279106|FG000|Overall Study|Lost to Follow-up|1|||
126269412|NCT00311311|454279108|FG000|Overall Study|Adverse Event|3|||
126269413|NCT00311311|454279109|FG001|Overall Study|Adverse Event|2|||
126269414|NCT00311311|454279108|FG000|Overall Study|Withdrawal by Subject|1|||
126269415|NCT00311311|454279109|FG001|Overall Study|Withdrawal by Subject|1|||
126269416|NCT00311311|454279108|FG000|Overall Study|Noncompliance|0|||
126269417|NCT00311311|454279109|FG001|Overall Study|Noncompliance|1|||
126269418|NCT00311311|454279108|FG000|Overall Study|Study Termination by Sponsor|3|||
126269419|NCT00311311|454279109|FG001|Overall Study|Study Termination by Sponsor|4|||
126269420|NCT00311311|454279108|FG000|Overall Study|Death|1|||
126269421|NCT00311311|454279109|FG001|Overall Study|Death|0|||
126269422|NCT00311311|454279108|FG000|Overall Study|Lack of ancillary assistance|0|||
126269423|NCT00311311|454279109|FG001|Overall Study|Lack of ancillary assistance|1|||
126269424|NCT00988065|454279111|FG000|Overall Study|Adverse Event|4|||
126269425|NCT00988065|454279112|FG001|Overall Study|Adverse Event|10|||
126453439|NCT00797966|454961418|FG005|Phase A+|Withdrawal by Subject|6|||
126453440|NCT00797966|454961413|FG000|Phase A+|Adverse Event|0|||
126453441|NCT00797966|454961414|FG001|Phase A+|Adverse Event|0|||
126453442|NCT00797966|454961415|FG002|Phase A+|Adverse Event|0|||
126453443|NCT00797966|454961416|FG003|Phase A+|Adverse Event|0|||
126269426|NCT00988065|454279113|FG002|Overall Study|Adverse Event|2|||
126269427|NCT00988065|454279111|FG000|Overall Study|Lost to Follow-up|1|||
126269428|NCT00988065|454279112|FG001|Overall Study|Lost to Follow-up|2|||
126361163|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
126361164|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
126361165|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
126361166|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
126361167|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
126361168|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
126361169|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
126361170|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
126361171|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
126361172|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
126361173|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
126361174|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
126361175|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
126361176|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
126361177|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
126361178|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
126361179|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
126361180|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
126361181|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
126361182|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
126361183|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
126361184|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
126361185|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
126453444|NCT00797966|454961417|FG004|Phase A+|Adverse Event|0|||
126453445|NCT00797966|454961418|FG005|Phase A+|Adverse Event|4|||
126269429|NCT00988065|454279113|FG002|Overall Study|Lost to Follow-up|2|||
126269430|NCT00988065|454279111|FG000|Overall Study|Subject withdrew consent|3|||
126269431|NCT00988065|454279112|FG001|Overall Study|Subject withdrew consent|5|||
126269432|NCT00988065|454279113|FG002|Overall Study|Subject withdrew consent|2|||
126269433|NCT00988065|454279111|FG000|Overall Study|Noncompliance with protocol|5|||
126269434|NCT00988065|454279112|FG001|Overall Study|Noncompliance with protocol|6|||
126269435|NCT00988065|454279113|FG002|Overall Study|Noncompliance with protocol|9|||
126269436|NCT02685202|454279114|FG000|Overall Study|Lost to Follow-up|9|||
126269437|NCT01229735|454279115|FG000|Overall Study|Lack of Efficacy|8|||
126269438|NCT01229735|454279116|FG001|Overall Study|Lack of Efficacy|8|||
126269439|NCT01229735|454279115|FG000|Overall Study|Protocol Violation|13|||
126269440|NCT01229735|454279116|FG001|Overall Study|Protocol Violation|8|||
126269441|NCT01229735|454279115|FG000|Overall Study|Lost to Follow-up|0|||
126269442|NCT01229735|454279116|FG001|Overall Study|Lost to Follow-up|2|||
126269443|NCT01229735|454279115|FG000|Overall Study|Withdrawal by Subject|18|||
126269444|NCT01229735|454279116|FG001|Overall Study|Withdrawal by Subject|17|||
126269445|NCT01229735|454279115|FG000|Overall Study|Other Reason|13|||
126269446|NCT01229735|454279116|FG001|Overall Study|Other Reason|10|||
126269447|NCT01229735|454279115|FG000|Overall Study|SAE, non-fatal|0|||
126269448|NCT01229735|454279116|FG001|Overall Study|SAE, non-fatal|4|||
126269449|NCT01229735|454279115|FG000|Overall Study|AE, non-serious non-fatal|13|||
126269450|NCT01229735|454279116|FG001|Overall Study|AE, non-serious non-fatal|17|||
126269451|NCT01229735|454279115|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126269452|NCT01229735|454279116|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
126269453|NCT02787408|454279117|FG000|Overall Study|Death|16|||
126269454|NCT02787408|454279117|FG000|Overall Study|Withdrawal by Subject|1|||
126269455|NCT02787408|454279117|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
126269456|NCT00985712|454279118|FG000|Overall Study|Adverse Event|0|||
126269457|NCT00985712|454279119|FG001|Overall Study|Adverse Event|1|||
126269458|NCT00985712|454279118|FG000|Overall Study|Lost to Follow-up|2|||
126269459|NCT00985712|454279119|FG001|Overall Study|Lost to Follow-up|2|||
126269460|NCT00985712|454279118|FG000|Overall Study|Protocol Violation|0|||
126269461|NCT00985712|454279119|FG001|Overall Study|Protocol Violation|1|||
126269462|NCT00985712|454279118|FG000|Overall Study|Withdrawal by Subject|4|||
126269463|NCT00985712|454279119|FG001|Overall Study|Withdrawal by Subject|1|||
126269464|NCT00985712|454279118|FG000|Overall Study|Sponsor decision|0|||
126269465|NCT00985712|454279119|FG001|Overall Study|Sponsor decision|2|||
126269466|NCT00876018|454279122|FG000|Overall Study|Lost to Follow-up|0|||
126269467|NCT00876018|454279123|FG001|Overall Study|Lost to Follow-up|1|||
126269468|NCT00876018|454279124|FG002|Overall Study|Lost to Follow-up|1|||
126269469|NCT00876018|454279122|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
126269470|NCT00876018|454279123|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
126269471|NCT00876018|454279124|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
126269472|NCT00725621|454279125|FG000|Overall Study|Adverse Event|25|||
126269473|NCT00725621|454279125|FG000|Overall Study|Lack of Efficacy|46|||
126269474|NCT00725621|454279125|FG000|Overall Study|Withdrawal by Subject|57|||
126269475|NCT00725621|454279125|FG000|Overall Study|Physician Decision|19|||
126269476|NCT00725621|454279125|FG000|Overall Study|Lost to Follow-up|52|||
126269477|NCT00725621|454279125|FG000|Overall Study|Non-compliance|8|||
126269478|NCT00725621|454279125|FG000|Overall Study|Continued treatment by other physician|6|||
126269479|NCT00725621|454279125|FG000|Overall Study|Switched to other study|1|||
126269480|NCT00725621|454279125|FG000|Overall Study|Switched to other drug|1|||
126269481|NCT00725621|454279125|FG000|Overall Study|Prepared for elective surgery|1|||
126269482|NCT00725621|454279125|FG000|Overall Study|Reason not specified|55|||
126269483|NCT01189500|454279126|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
126269484|NCT01189500|454279126|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
126269485|NCT00062751|454279127|FG000|Overall Study|Disease progression|24|||
126269486|NCT00062751|454279128|FG001|Overall Study|Disease progression|17|||
126269487|NCT00062751|454279129|FG002|Overall Study|Disease progression|24|||
126269488|NCT00062751|454279130|FG003|Overall Study|Disease progression|2|||
126361186|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
126705324|NCT00594399|455871730|FG002|Initial 3 Month Counseling|Family illness|0|||
126705325|NCT00594399|455871728|FG000|Rerandomization Arm 1 Only|Death|2|||
126705326|NCT00594399|455871729|FG001|Rerandomization Arm 1 Only|Death|1|||
126705327|NCT00594399|455871730|FG002|Rerandomization Arm 1 Only|Death|0|||
126705328|NCT00594399|455871728|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
126269489|NCT00062751|454279131|FG004|Overall Study|Disease progression|2|||
126269490|NCT00062751|454279127|FG000|Overall Study|Adverse Event|4|||
126269491|NCT00062751|454279128|FG001|Overall Study|Adverse Event|7|||
126269492|NCT00062751|454279129|FG002|Overall Study|Adverse Event|2|||
126269493|NCT00062751|454279130|FG003|Overall Study|Adverse Event|2|||
126269494|NCT00062751|454279131|FG004|Overall Study|Adverse Event|2|||
126269495|NCT00062751|454279127|FG000|Overall Study|Other|2|||
126269496|NCT00062751|454279128|FG001|Overall Study|Other|3|||
126269497|NCT00062751|454279129|FG002|Overall Study|Other|1|||
126269498|NCT00062751|454279130|FG003|Overall Study|Other|0|||
126269499|NCT00062751|454279131|FG004|Overall Study|Other|1|||
126269500|NCT00062751|454279127|FG000|Overall Study|Withdrawal by Subject|1|||
126269501|NCT00062751|454279128|FG001|Overall Study|Withdrawal by Subject|2|||
126269502|NCT00062751|454279129|FG002|Overall Study|Withdrawal by Subject|2|||
126269503|NCT00062751|454279130|FG003|Overall Study|Withdrawal by Subject|1|||
126705329|NCT00594399|455871729|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
126705330|NCT00594399|455871730|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
126269504|NCT00062751|454279131|FG004|Overall Study|Withdrawal by Subject|0|||
126269505|NCT00062751|454279127|FG000|Overall Study|Symptomatic deterioration|1|||
126269506|NCT00062751|454279128|FG001|Overall Study|Symptomatic deterioration|1|||
126269507|NCT00062751|454279129|FG002|Overall Study|Symptomatic deterioration|0|||
126269508|NCT00062751|454279130|FG003|Overall Study|Symptomatic deterioration|0|||
126269509|NCT00062751|454279131|FG004|Overall Study|Symptomatic deterioration|1|||
126269510|NCT00062751|454279127|FG000|Overall Study|Death|1|||
126269511|NCT00062751|454279128|FG001|Overall Study|Death|0|||
126269512|NCT00062751|454279129|FG002|Overall Study|Death|1|||
126269513|NCT00062751|454279130|FG003|Overall Study|Death|0|||
126269514|NCT00062751|454279131|FG004|Overall Study|Death|0|||
126269515|NCT01346774|454279132|FG000|Overall Study|Did not take a single dose|6|||
126269516|NCT01346774|454279133|FG001|Overall Study|Did not take a single dose|4|||
126269517|NCT01346774|454279132|FG000|Overall Study|Lost to Follow-up|3|||
126269518|NCT01346774|454279133|FG001|Overall Study|Lost to Follow-up|4|||
126269519|NCT01346774|454279132|FG000|Overall Study|Withdrawal by Subject|1|||
126269520|NCT01346774|454279133|FG001|Overall Study|Withdrawal by Subject|4|||
126269521|NCT01346774|454279132|FG000|Overall Study|Protocol Violation|2|||
126269522|NCT01346774|454279133|FG001|Overall Study|Protocol Violation|3|||
126269523|NCT01346774|454279132|FG000|Overall Study|Adverse Event|1|||
126269524|NCT01346774|454279133|FG001|Overall Study|Adverse Event|2|||
126269525|NCT00502801|454279134|FG000|Treatment Period|Withdrawal by Subject|3|||
126269526|NCT00502801|454279134|FG000|Treatment Period|Adverse Event|7|||
126269527|NCT00502801|454279134|FG000|Treatment Period|Death|14|||
126269528|NCT00502801|454279134|FG000|Treatment Period|OTHER|30|||
126269529|NCT00502801|454279134|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
126269530|NCT00502801|454279134|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
126269531|NCT00502801|454279134|FG000|End of Therapy to Test of Cure|Death|3|||
126269532|NCT00502801|454279134|FG000|End of Therapy to Test of Cure|OTHER|2|||
126269533|NCT00444457|454279138|FG000|Infant Series|Other|0|||
126269534|NCT00444457|454279139|FG001|Infant Series|Other|1|||
126269535|NCT00444457|454279140|FG002|Infant Series|Other|0|||
126269536|NCT00444457|454279141|FG003|Infant Series|Other|0|||
126269537|NCT00444457|454279138|FG000|Infant Series|Parent or legal guardian request|18|||
126269538|NCT00444457|454279139|FG001|Infant Series|Parent or legal guardian request|29|||
126269539|NCT00444457|454279140|FG002|Infant Series|Parent or legal guardian request|34|||
126269540|NCT00444457|454279141|FG003|Infant Series|Parent or legal guardian request|14|||
126269541|NCT00444457|454279138|FG000|Infant Series|Lost to Follow-up|10|||
126269542|NCT00444457|454279139|FG001|Infant Series|Lost to Follow-up|11|||
126269543|NCT00444457|454279140|FG002|Infant Series|Lost to Follow-up|7|||
126269544|NCT00444457|454279141|FG003|Infant Series|Lost to Follow-up|6|||
126269545|NCT00444457|454279138|FG000|Infant Series|Protocol Violation|16|||
126269546|NCT00444457|454279139|FG001|Infant Series|Protocol Violation|8|||
126269547|NCT00444457|454279140|FG002|Infant Series|Protocol Violation|6|||
126269548|NCT00444457|454279141|FG003|Infant Series|Protocol Violation|3|||
126269549|NCT00444457|454279138|FG000|Infant Series|Failed to return|5|||
126269550|NCT00444457|454279139|FG001|Infant Series|Failed to return|4|||
126269551|NCT00444457|454279140|FG002|Infant Series|Failed to return|4|||
126269552|NCT00444457|454279141|FG003|Infant Series|Failed to return|2|||
126269553|NCT00444457|454279138|FG000|Infant Series|Investigator request|4|||
126269554|NCT00444457|454279139|FG001|Infant Series|Investigator request|3|||
126269555|NCT00444457|454279140|FG002|Infant Series|Investigator request|3|||
126269556|NCT00444457|454279141|FG003|Infant Series|Investigator request|2|||
126269557|NCT00444457|454279138|FG000|Infant Series|Other|0|||
126269558|NCT00444457|454279139|FG001|Infant Series|Other|2|||
126269559|NCT00444457|454279140|FG002|Infant Series|Other|4|||
126269560|NCT00444457|454279141|FG003|Infant Series|Other|0|||
126269561|NCT00444457|454279138|FG000|Infant Series|Adverse Event|1|||
126269562|NCT00444457|454279139|FG001|Infant Series|Adverse Event|2|||
126269563|NCT00444457|454279140|FG002|Infant Series|Adverse Event|2|||
126269564|NCT00444457|454279141|FG003|Infant Series|Adverse Event|0|||
126269565|NCT00444457|454279138|FG000|Infant Series|Death|0|||
126269566|NCT00444457|454279139|FG001|Infant Series|Death|1|||
126269567|NCT00444457|454279140|FG002|Infant Series|Death|1|||
126269568|NCT00444457|454279141|FG003|Infant Series|Death|1|||
126269569|NCT00444457|454279138|FG000|After Infant Series|Other|0|||
126269570|NCT00444457|454279139|FG001|After Infant Series|Other|1|||
126269571|NCT00444457|454279140|FG002|After Infant Series|Other|1|||
126269572|NCT00444457|454279141|FG003|After Infant Series|Other|1|||
126269573|NCT00444457|454279138|FG000|After Infant Series|Parent or legal guardian request|4|||
126269574|NCT00444457|454279139|FG001|After Infant Series|Parent or legal guardian request|11|||
126269575|NCT00444457|454279140|FG002|After Infant Series|Parent or legal guardian request|6|||
126269576|NCT00444457|454279141|FG003|After Infant Series|Parent or legal guardian request|3|||
126269577|NCT00444457|454279138|FG000|After Infant Series|Failed to return|7|||
126269578|NCT00444457|454279139|FG001|After Infant Series|Failed to return|6|||
126269579|NCT00444457|454279140|FG002|After Infant Series|Failed to return|5|||
126269580|NCT00444457|454279141|FG003|After Infant Series|Failed to return|1|||
126269581|NCT00444457|454279138|FG000|After Infant Series|Lost to Follow-up|5|||
126269582|NCT00444457|454279139|FG001|After Infant Series|Lost to Follow-up|5|||
126705331|NCT03953118|455871731|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
126705332|NCT03953118|455871732|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
126705333|NCT00424398|455871734|FG000|Overall Study|Withdrawal by Subject|2|||
126705334|NCT00424398|455871735|FG001|Overall Study|Withdrawal by Subject|1|||
126705335|NCT00424398|455871736|FG002|Overall Study|Withdrawal by Subject|0|||
126705336|NCT00424398|455871734|FG000|Overall Study|Subject met exclusion criteria|1|||
126705337|NCT00424398|455871735|FG001|Overall Study|Subject met exclusion criteria|0|||
126705338|NCT00424398|455871736|FG002|Overall Study|Subject met exclusion criteria|0|||
126705339|NCT01023789|455871737|FG000|3 - Year Visit|Death|29|||
126269583|NCT00444457|454279140|FG002|After Infant Series|Lost to Follow-up|5|||
126269584|NCT00444457|454279141|FG003|After Infant Series|Lost to Follow-up|2|||
126269585|NCT00444457|454279138|FG000|After Infant Series|Protocol Violation|2|||
126269586|NCT00444457|454279139|FG001|After Infant Series|Protocol Violation|4|||
126269587|NCT00444457|454279140|FG002|After Infant Series|Protocol Violation|2|||
126269588|NCT00444457|454279141|FG003|After Infant Series|Protocol Violation|2|||
126269589|NCT00444457|454279138|FG000|After Infant Series|Adverse Event|2|||
126269590|NCT00444457|454279139|FG001|After Infant Series|Adverse Event|2|||
126269591|NCT00444457|454279140|FG002|After Infant Series|Adverse Event|0|||
126269592|NCT00444457|454279141|FG003|After Infant Series|Adverse Event|0|||
126269593|NCT00444457|454279138|FG000|After Infant Series|Investigator request|0|||
126269594|NCT00444457|454279139|FG001|After Infant Series|Investigator request|0|||
126269595|NCT00444457|454279140|FG002|After Infant Series|Investigator request|0|||
126269596|NCT00444457|454279141|FG003|After Infant Series|Investigator request|1|||
126269597|NCT00444457|454279138|FG000|After Infant Series|Other|0|||
126269598|NCT00444457|454279139|FG001|After Infant Series|Other|1|||
126269599|NCT00444457|454279140|FG002|After Infant Series|Other|0|||
126269600|NCT00444457|454279141|FG003|After Infant Series|Other|0|||
126269601|NCT00444457|454279138|FG000|Toddler Dose|Lost to Follow-up|4|||
126269602|NCT00444457|454279139|FG001|Toddler Dose|Lost to Follow-up|1|||
126269603|NCT00444457|454279140|FG002|Toddler Dose|Lost to Follow-up|1|||
126269604|NCT00444457|454279141|FG003|Toddler Dose|Lost to Follow-up|3|||
126269605|NCT00444457|454279138|FG000|Toddler Dose|Failed to return|2|||
126269606|NCT00444457|454279139|FG001|Toddler Dose|Failed to return|2|||
126269607|NCT00444457|454279140|FG002|Toddler Dose|Failed to return|1|||
126269608|NCT00444457|454279141|FG003|Toddler Dose|Failed to return|3|||
126269609|NCT00444457|454279138|FG000|Toddler Dose|Parent or legal guardian request|0|||
126269610|NCT00444457|454279139|FG001|Toddler Dose|Parent or legal guardian request|3|||
126269611|NCT00444457|454279140|FG002|Toddler Dose|Parent or legal guardian request|2|||
126269612|NCT00444457|454279141|FG003|Toddler Dose|Parent or legal guardian request|1|||
126269613|NCT00444457|454279138|FG000|Toddler Dose|Protocol Violation|1|||
126269614|NCT00444457|454279139|FG001|Toddler Dose|Protocol Violation|0|||
126269615|NCT00444457|454279140|FG002|Toddler Dose|Protocol Violation|0|||
126269616|NCT00444457|454279141|FG003|Toddler Dose|Protocol Violation|1|||
126269617|NCT01602965|454279144|FG000|Overall Study|Lost to Follow-up|4|||
126269618|NCT01602965|454279145|FG001|Overall Study|Lost to Follow-up|2|||
126269619|NCT00321737|454279146|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
126269620|NCT00321737|454279147|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
126269621|NCT00321737|454279148|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
126269622|NCT00321737|454279146|FG000|Overall Study|Adverse Event|11|||
126361187|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
126361188|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
126361189|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
126361190|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
126361191|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
126361192|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
126361193|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
126361194|NCT01557244|454615179|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
126765572|NCT00650806|456094549|FG003|Overall Study|Noncompliance with study drug regimen|0|||
126269623|NCT00321737|454279147|FG001|Overall Study|Adverse Event|3|||
126269624|NCT00321737|454279148|FG002|Overall Study|Adverse Event|6|||
126269625|NCT00321737|454279146|FG000|Overall Study|Lost to Follow-up|5|||
126269626|NCT00321737|454279147|FG001|Overall Study|Lost to Follow-up|5|||
126269627|NCT00321737|454279148|FG002|Overall Study|Lost to Follow-up|6|||
126269628|NCT00321737|454279146|FG000|Overall Study|Withdrawal by Subject|19|||
126269629|NCT00321737|454279147|FG001|Overall Study|Withdrawal by Subject|12|||
126269630|NCT00321737|454279148|FG002|Overall Study|Withdrawal by Subject|17|||
126269631|NCT00321737|454279146|FG000|Overall Study|Protocol Violation|0|||
126361195|NCT01557244|454615180|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
126269632|NCT00321737|454279147|FG001|Overall Study|Protocol Violation|0|||
126269633|NCT00321737|454279148|FG002|Overall Study|Protocol Violation|1|||
126269634|NCT00321737|454279146|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
126269635|NCT00321737|454279147|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
126269636|NCT00321737|454279148|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
126269637|NCT00321737|454279146|FG000|Overall Study|Possible Barrett's Esophagus|2|||
126269638|NCT00321737|454279147|FG001|Overall Study|Possible Barrett's Esophagus|1|||
126269639|NCT00321737|454279148|FG002|Overall Study|Possible Barrett's Esophagus|1|||
126269640|NCT00321737|454279146|FG000|Overall Study|Therapeutic Failure|6|||
126269641|NCT00321737|454279147|FG001|Overall Study|Therapeutic Failure|0|||
126269642|NCT00321737|454279148|FG002|Overall Study|Therapeutic Failure|2|||
126269643|NCT00321737|454279146|FG000|Overall Study|Pregnancy|0|||
126269644|NCT00321737|454279147|FG001|Overall Study|Pregnancy|2|||
126269645|NCT00321737|454279148|FG002|Overall Study|Pregnancy|0|||
126269646|NCT00321737|454279146|FG000|Overall Study|Noncompliance|2|||
126269647|NCT00321737|454279147|FG001|Overall Study|Noncompliance|0|||
126269648|NCT00321737|454279148|FG002|Overall Study|Noncompliance|0|||
126269649|NCT00321737|454279146|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
126269650|NCT00321737|454279147|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
126269651|NCT00321737|454279148|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
126269652|NCT02283294|454279149|FG000|Overall Study|Lost to Follow-up|1|||
126269653|NCT02283294|454279150|FG001|Overall Study|Lost to Follow-up|1|||
126269654|NCT02283294|454279149|FG000|Overall Study|Withdrawal by Subject|1|||
126269655|NCT02283294|454279150|FG001|Overall Study|Withdrawal by Subject|6|||
126269656|NCT02283294|454279149|FG000|Overall Study|Protocol Violation|1|||
126269657|NCT02283294|454279150|FG001|Overall Study|Protocol Violation|0|||
126269658|NCT02283294|454279149|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
126269659|NCT02283294|454279150|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
126269660|NCT01769339|454279151|FG000|Overall Study|Lost to Follow-up|42|||
126269661|NCT01769339|454279151|FG000|Overall Study|Adverse Event|1|||
126269662|NCT00290251|454279152|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
126269663|NCT00290251|454279153|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
126269664|NCT00290251|454279154|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
126269665|NCT00290251|454279155|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
126269666|NCT00290251|454279156|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
126269667|NCT00290251|454279157|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
126269668|NCT00290251|454279152|FG000|Treatment 1 (Months 2-4)|headache|0|||
126269669|NCT00290251|454279153|FG001|Treatment 1 (Months 2-4)|headache|0|||
126269670|NCT00290251|454279154|FG002|Treatment 1 (Months 2-4)|headache|0|||
126269671|NCT00290251|454279155|FG003|Treatment 1 (Months 2-4)|headache|0|||
126269672|NCT00290251|454279156|FG004|Treatment 1 (Months 2-4)|headache|1|||
126269673|NCT00290251|454279157|FG005|Treatment 1 (Months 2-4)|headache|0|||
126269674|NCT00290251|454279152|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
126269675|NCT00290251|454279153|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
126269676|NCT00290251|454279154|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
126269677|NCT00290251|454279155|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
126269678|NCT00290251|454279156|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
126269679|NCT00290251|454279157|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
126269680|NCT04062448|454281647|FG000|Overall Study|Lost to Follow-up|1|||
126269681|NCT04062448|454281647|FG000|Overall Study|Withdrawal by Subject|2|||
126269682|NCT05101486|454281648|FG000|Overall Study|Death|1|||
126269683|NCT05101486|454281649|FG001|Overall Study|Death|0|||
126269684|NCT05101486|454281650|FG002|Overall Study|Death|1|||
126269685|NCT05101486|454281648|FG000|Overall Study|Lost to Follow-up|12|||
126269686|NCT05101486|454281649|FG001|Overall Study|Lost to Follow-up|8|||
126269687|NCT05101486|454281650|FG002|Overall Study|Lost to Follow-up|17|||
126269688|NCT05101486|454281648|FG000|Overall Study|Physician Decision|1|||
126269689|NCT05101486|454281649|FG001|Overall Study|Physician Decision|0|||
126269690|NCT05101486|454281650|FG002|Overall Study|Physician Decision|0|||
126269691|NCT05101486|454281648|FG000|Overall Study|Protocol Violation|0|||
126269692|NCT05101486|454281649|FG001|Overall Study|Protocol Violation|0|||
126269693|NCT05101486|454281650|FG002|Overall Study|Protocol Violation|1|||
126361196|NCT01557244|454615181|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
126361197|NCT01557244|454615182|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
126361198|NCT01557244|454615183|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
126361199|NCT01557244|454615184|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
126361200|NCT01557244|454615185|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
126361201|NCT01557244|454615179|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
126361202|NCT01557244|454615180|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
126361203|NCT01557244|454615181|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
126361204|NCT01557244|454615182|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
126269694|NCT05101486|454281648|FG000|Overall Study|Withdrawal by Subject|5|||
126269695|NCT05101486|454281649|FG001|Overall Study|Withdrawal by Subject|2|||
126269696|NCT05101486|454281650|FG002|Overall Study|Withdrawal by Subject|4|||
126269697|NCT05101486|454281648|FG000|Overall Study|Randomized but not vaccinated|1|||
126269698|NCT05101486|454281649|FG001|Overall Study|Randomized but not vaccinated|1|||
126269699|NCT05101486|454281650|FG002|Overall Study|Randomized but not vaccinated|1|||
126269700|NCT02788045|454281651|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
126269701|NCT02788045|454281652|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
126705340|NCT01023789|455871737|FG000|3 - Year Visit|Withdrawal of consent|1|||
126705341|NCT01023789|455871737|FG000|3 - Year Visit|Lost to Follow-up|13|||
126705342|NCT02034123|455871741|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126705343|NCT02034123|455871742|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126705344|NCT02034123|455871743|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126269702|NCT02788045|454281653|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
126269703|NCT02788045|454281651|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
126269704|NCT02788045|454281652|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
126269705|NCT02788045|454281653|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
126269706|NCT02788045|454281651|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
126269707|NCT02788045|454281652|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
126269708|NCT02788045|454281653|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
126269709|NCT02788045|454281651|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
126269710|NCT02788045|454281652|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
126269711|NCT02788045|454281653|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
126269712|NCT02788045|454281651|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
126269713|NCT02788045|454281652|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
126269714|NCT02788045|454281653|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
126269715|NCT02788045|454281651|FG000|Main Study (Up to Week 72)|Other|3|||
126269716|NCT02788045|454281652|FG001|Main Study (Up to Week 72)|Other|0|||
126269717|NCT02788045|454281653|FG002|Main Study (Up to Week 72)|Other|0|||
126269718|NCT02788045|454281651|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
126269719|NCT02788045|454281652|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
126269720|NCT02788045|454281653|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
126269721|NCT02788045|454281651|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
126269722|NCT02788045|454281652|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
126269723|NCT02788045|454281653|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
126269724|NCT02788045|454281651|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
126269725|NCT02788045|454281652|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
126269726|NCT02788045|454281653|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
126269727|NCT03188666|454281654|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
126269728|NCT03188666|454281655|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
126269729|NCT03188666|454281656|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
126269730|NCT03188666|454281657|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
126269731|NCT03188666|454281654|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
126269732|NCT03188666|454281655|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
126269733|NCT03188666|454281656|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
126269734|NCT03188666|454281657|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
126269735|NCT03188666|454281654|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
126269736|NCT03188666|454281655|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
126269737|NCT03188666|454281656|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
126269738|NCT03188666|454281657|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
126269739|NCT03188666|454281654|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
126269740|NCT03188666|454281655|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
126269741|NCT03188666|454281656|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
126269742|NCT03188666|454281657|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
126269743|NCT03696953|454281658|FG000|Overall Study|Withdrawal by Subject|6|||
126269744|NCT03696953|454281659|FG001|Overall Study|Withdrawal by Subject|1|||
126269745|NCT03696953|454281658|FG000|Overall Study|missed GBS swabs|2|||
126269746|NCT03696953|454281659|FG001|Overall Study|missed GBS swabs|2|||
126269747|NCT03696953|454281658|FG000|Overall Study|lost study bottle containing capsules|2|||
126269748|NCT03696953|454281659|FG001|Overall Study|lost study bottle containing capsules|0|||
126269749|NCT03696953|454281658|FG000|Overall Study|Premature birth|1|||
126269750|NCT03696953|454281659|FG001|Overall Study|Premature birth|4|||
126269751|NCT03696953|454281658|FG000|Overall Study|Gestational hypertension|1|||
126269752|NCT03696953|454281659|FG001|Overall Study|Gestational hypertension|1|||
126269753|NCT03696953|454281658|FG000|Overall Study|Gestational diabetes|2|||
126269754|NCT03696953|454281659|FG001|Overall Study|Gestational diabetes|1|||
126269755|NCT03696953|454281658|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
126269756|NCT03696953|454281659|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
126269757|NCT03696953|454281658|FG000|Overall Study|Changed prenatal provider|1|||
126269758|NCT03696953|454281659|FG001|Overall Study|Changed prenatal provider|1|||
126269759|NCT04908683|454281660|FG000|Overall Study|Failure to meet continuation criteria|34|||
126269760|NCT04908683|454281661|FG001|Overall Study|Failure to meet continuation criteria|22|||
126269761|NCT04908683|454281660|FG000|Overall Study|Initiated prohibited medication|3|||
126269762|NCT04908683|454281661|FG001|Overall Study|Initiated prohibited medication|0|||
126269763|NCT04908683|454281660|FG000|Overall Study|Randomized by mistake|1|||
126361205|NCT01557244|454615183|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
126361206|NCT01557244|454615184|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
126361207|NCT01557244|454615185|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
126705345|NCT02034123|455871744|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126269764|NCT04908683|454281661|FG001|Overall Study|Randomized by mistake|0|||
126269765|NCT04908683|454281660|FG000|Overall Study|Lost to Follow-up|679|||
126269766|NCT04908683|454281661|FG001|Overall Study|Lost to Follow-up|341|||
126269767|NCT04908683|454281660|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
126269768|NCT04908683|454281661|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
126269769|NCT04908683|454281660|FG000|Overall Study|Physician Decision|44|||
126269770|NCT04908683|454281661|FG001|Overall Study|Physician Decision|35|||
126269771|NCT04908683|454281660|FG000|Overall Study|Technical problems|12|||
126269772|NCT04908683|454281661|FG001|Overall Study|Technical problems|9|||
126269773|NCT04908683|454281660|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
126269774|NCT04908683|454281661|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
126269775|NCT04908683|454281660|FG000|Overall Study|Protocol Violation|2|||
126269776|NCT04908683|454281661|FG001|Overall Study|Protocol Violation|0|||
126269777|NCT04908683|454281660|FG000|Overall Study|Withdrawal by Subject|1188|||
126269778|NCT04908683|454281661|FG001|Overall Study|Withdrawal by Subject|570|||
126269779|NCT04908683|454281660|FG000|Overall Study|Site Closure by Sponsor|6|||
126269780|NCT04908683|454281661|FG001|Overall Study|Site Closure by Sponsor|3|||
126269781|NCT04908683|454281660|FG000|Overall Study|Adverse Event|21|||
126269782|NCT04908683|454281661|FG001|Overall Study|Adverse Event|11|||
126269783|NCT04908683|454281660|FG000|Overall Study|Death|101|||
126269784|NCT04908683|454281661|FG001|Overall Study|Death|61|||
126269785|NCT04908683|454281660|FG000|Overall Study|Sponsor's decision|14398|||
126269786|NCT04908683|454281661|FG001|Overall Study|Sponsor's decision|7205|||
126269787|NCT04908683|454281660|FG000|Overall Study|Other|92|||
126269788|NCT04908683|454281661|FG001|Overall Study|Other|50|||
126269789|NCT04908683|454281660|FG000|Overall Study|Randomized not vaccinated|108|||
126269790|NCT04908683|454281661|FG001|Overall Study|Randomized not vaccinated|52|||
126765573|NCT00650806|456094546|FG000|Overall Study|Study terminated by sponsor|2|||
126765574|NCT00650806|456094547|FG001|Overall Study|Study terminated by sponsor|3|||
126765575|NCT00650806|456094548|FG002|Overall Study|Study terminated by sponsor|5|||
126765576|NCT00650806|456094549|FG003|Overall Study|Study terminated by sponsor|4|||
126765577|NCT00650806|456094546|FG000|Overall Study|Other|1|||
126765578|NCT00650806|456094547|FG001|Overall Study|Other|1|||
126765579|NCT00650806|456094548|FG002|Overall Study|Other|2|||
126765580|NCT00650806|456094549|FG003|Overall Study|Other|0|||
126765581|NCT03707145|456094553|FG000|Overall Study|Lost to Follow-up|0|||
126269791|NCT03047473|454281663|FG000|Overall Study|Lost to Follow-up|2|||
126269792|NCT06204887|454281664|FG000|Overall Study|Lost to Follow-up|3|||
126269793|NCT06204887|454281665|FG001|Overall Study|Lost to Follow-up|4|||
126269794|NCT06204887|454281666|FG002|Overall Study|Lost to Follow-up|1|||
126269795|NCT06204887|454281667|FG003|Overall Study|Lost to Follow-up|6|||
126269796|NCT02935686|454281668|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
126269797|NCT02935686|454281669|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
126269798|NCT02935686|454281670|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
126269799|NCT02935686|454281671|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
126269800|NCT02935686|454281672|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
126269801|NCT02935686|454281668|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
126269802|NCT02935686|454281669|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
126269803|NCT02935686|454281670|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
126269804|NCT02935686|454281671|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
126269805|NCT02935686|454281672|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
126269806|NCT02935686|454281668|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
126269807|NCT02935686|454281669|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
126269808|NCT02935686|454281670|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
126269809|NCT02935686|454281671|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
126269810|NCT02935686|454281672|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
126269811|NCT02935686|454281668|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
126269812|NCT02935686|454281669|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
126269813|NCT02935686|454281670|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
126269814|NCT02935686|454281671|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
126453446|NCT00797966|454961413|FG000|Phase A+|Protocol deviation|0|||
126453447|NCT00797966|454961414|FG001|Phase A+|Protocol deviation|0|||
126269815|NCT02935686|454281672|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
126269816|NCT02935686|454281668|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
126269817|NCT02935686|454281669|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
126269818|NCT02935686|454281670|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
126269819|NCT02935686|454281671|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
126269820|NCT02935686|454281672|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
126269821|NCT02935686|454281668|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
126453448|NCT00797966|454961415|FG002|Phase A+|Protocol deviation|0|||
126453449|NCT00797966|454961416|FG003|Phase A+|Protocol deviation|0|||
126765582|NCT03707145|456094554|FG001|Overall Study|Lost to Follow-up|1|||
126765583|NCT03707145|456094555|FG002|Overall Study|Lost to Follow-up|1|||
126765584|NCT03707145|456094556|FG003|Overall Study|Lost to Follow-up|0|||
126765585|NCT00965562|456094560|FG000|Overall Study|Lost to Follow-up|1|||
126361208|NCT01557244|454615179|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
126361209|NCT01557244|454615180|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
126361210|NCT01557244|454615181|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
126361211|NCT01557244|454615182|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
126361212|NCT01557244|454615183|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
126361213|NCT01557244|454615184|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
126361214|NCT01557244|454615185|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
126361215|NCT01557244|454615179|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
126361216|NCT01557244|454615180|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
126361217|NCT01557244|454615181|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
126361218|NCT01557244|454615182|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
126361219|NCT01557244|454615183|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
126361220|NCT01557244|454615184|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
126361221|NCT01557244|454615185|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
126361222|NCT01557244|454615179|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
126361223|NCT01557244|454615180|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
126361224|NCT01557244|454615181|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
126361225|NCT01557244|454615182|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
126361226|NCT01557244|454615183|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
126361227|NCT01557244|454615184|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
126361228|NCT01557244|454615185|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
126361229|NCT02365064|454615191|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
126361230|NCT02365064|454615192|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
126361231|NCT02365064|454615191|FG000|Overall Study|Withdrawal by Subject|6|||
126361232|NCT02365064|454615192|FG001|Overall Study|Withdrawal by Subject|9|||
126361233|NCT02365064|454615191|FG000|Overall Study|Treatment intolerance|2|||
126361234|NCT02365064|454615192|FG001|Overall Study|Treatment intolerance|4|||
126361235|NCT00348374|454615195|FG000|Overall Study|Adverse Event|1|||
126361236|NCT00348374|454615196|FG001|Overall Study|Adverse Event|4|||
126361237|NCT00348374|454615195|FG000|Overall Study|Lost to Follow-up|1|||
126361238|NCT00348374|454615196|FG001|Overall Study|Lost to Follow-up|3|||
126361239|NCT00348374|454615195|FG000|Overall Study|Withdrawal by Subject|5|||
126361240|NCT00348374|454615196|FG001|Overall Study|Withdrawal by Subject|5|||
126361241|NCT00348374|454615195|FG000|Overall Study|Other|11|||
126361242|NCT00348374|454615196|FG001|Overall Study|Other|12|||
126361243|NCT00348374|454615195|FG000|Overall Study|ongoing at date of cutoff|1|||
126361244|NCT00348374|454615196|FG001|Overall Study|ongoing at date of cutoff|1|||
126361245|NCT00348374|454615195|FG000|Overall Study|randomized but did not receive treatment|0|||
126361246|NCT00348374|454615196|FG001|Overall Study|randomized but did not receive treatment|7|||
126361247|NCT02595437|454615205|FG000|Triferic Via IV|Withdrawal by Subject|1|||
126361248|NCT02070380|454615208|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
126361249|NCT02070380|454615209|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
126361250|NCT02070380|454615210|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
126361251|NCT02070380|454615211|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
126361252|NCT02070380|454615208|FG000|Second Injection|Image sets missing or technically inadeq|0|||
126361253|NCT02070380|454615209|FG001|Second Injection|Image sets missing or technically inadeq|1|||
126361254|NCT02070380|454615210|FG002|Second Injection|Image sets missing or technically inadeq|0|||
126361255|NCT02070380|454615211|FG003|Second Injection|Image sets missing or technically inadeq|0|||
126361256|NCT02070380|454615208|FG000|Second Injection|Protocol Violation|0|||
126361257|NCT02070380|454615209|FG001|Second Injection|Protocol Violation|1|||
126361258|NCT02070380|454615210|FG002|Second Injection|Protocol Violation|1|||
126361259|NCT02070380|454615211|FG003|Second Injection|Protocol Violation|5|||
126361260|NCT02105012|454615217|FG000|Overall Study|Withdrawal by Subject|11|||
126361261|NCT02105012|454615217|FG000|Overall Study|Protocol Specified Criteria|9|||
126361262|NCT02105012|454615217|FG000|Overall Study|Lost to Follow-up|4|||
126361263|NCT02105012|454615217|FG000|Overall Study|Protocol Violation|4|||
126361264|NCT02105012|454615217|FG000|Overall Study|Physician Decision|3|||
126361265|NCT02105012|454615217|FG000|Overall Study|Adverse Event|1|||
126705346|NCT02034123|455871745|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
126705347|NCT02034123|455871746|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126361266|NCT02105012|454615217|FG000|Overall Study|Lack of Efficacy|1|||
126361267|NCT00493285|454615218|FG000|Overall Study|Lost to Follow-up|0|||
126361268|NCT00493285|454615219|FG001|Overall Study|Lost to Follow-up|0|||
126361269|NCT00493285|454615220|FG002|Overall Study|Lost to Follow-up|0|||
126361270|NCT00493285|454615221|FG003|Overall Study|Lost to Follow-up|0|||
126361271|NCT00493285|454615222|FG004|Overall Study|Lost to Follow-up|1|||
126361272|NCT00493285|454615223|FG005|Overall Study|Lost to Follow-up|0|||
126361273|NCT04535362|454615224|FG000|Overall Study|Lost to Follow-up|3|||
126361274|NCT04535362|454615225|FG001|Overall Study|Lost to Follow-up|1|||
126765586|NCT00965562|456094561|FG001|Overall Study|Lost to Follow-up|2|||
126269822|NCT02935686|454281669|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
126269823|NCT02935686|454281670|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
126269824|NCT02935686|454281671|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
126269825|NCT02935686|454281672|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
126269826|NCT02935686|454281668|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
126269827|NCT02935686|454281669|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
126269828|NCT02935686|454281670|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
126269829|NCT02935686|454281671|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
126269830|NCT02935686|454281672|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
126269831|NCT02935686|454281668|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
126269832|NCT02935686|454281669|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
126269833|NCT02935686|454281670|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
126269834|NCT02935686|454281671|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
126269835|NCT02935686|454281672|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
126269836|NCT02935686|454281668|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
126269837|NCT02935686|454281669|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
126269838|NCT02935686|454281670|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
126269839|NCT02935686|454281671|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
126269840|NCT02935686|454281672|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
126269841|NCT02935686|454281668|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
126269842|NCT02935686|454281669|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
126269843|NCT02935686|454281670|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
126269844|NCT02935686|454281671|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
126269845|NCT02935686|454281672|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
126269846|NCT02935686|454281668|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
126269847|NCT02935686|454281669|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
126269848|NCT02935686|454281670|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
126269849|NCT02935686|454281671|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
126269850|NCT02935686|454281672|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
126269851|NCT00062010|454281673|FG000|Overall Study|Ineligible|3|||
126269852|NCT02856880|454281674|FG000|Overall Study|Withdrawal of consent|1|||
126269853|NCT00573157|454281675|FG000|Overall Study|Adverse Event|3|||
126269854|NCT00573157|454281676|FG001|Overall Study|Adverse Event|1|||
126269855|NCT00573157|454281675|FG000|Overall Study|Other|1|||
126269856|NCT00573157|454281676|FG001|Overall Study|Other|1|||
126269857|NCT02944383|454281677|FG000|Overall Study|Lost to Follow-up|0|||
126269858|NCT02944383|454281678|FG001|Overall Study|Lost to Follow-up|0|||
126269859|NCT02944383|454281679|FG002|Overall Study|Lost to Follow-up|1|||
126269860|NCT02944383|454281677|FG000|Overall Study|Withdrawal by Subject|1|||
126269861|NCT02944383|454281678|FG001|Overall Study|Withdrawal by Subject|0|||
126269862|NCT02944383|454281679|FG002|Overall Study|Withdrawal by Subject|0|||
126269863|NCT01183221|454281682|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
126269864|NCT01183221|454281683|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
126269865|NCT02444793|454281687|FG000|Overall Study|Lost to Follow-up|2|||
126269866|NCT02444793|454281688|FG001|Overall Study|Lost to Follow-up|2|||
126269867|NCT02444793|454281689|FG002|Overall Study|Lost to Follow-up|0|||
126269868|NCT02444793|454281690|FG003|Overall Study|Lost to Follow-up|0|||
126269869|NCT02444793|454281687|FG000|Overall Study|Death|0|||
126269870|NCT02444793|454281688|FG001|Overall Study|Death|3|||
126269871|NCT02444793|454281689|FG002|Overall Study|Death|0|||
126269872|NCT02444793|454281690|FG003|Overall Study|Death|0|||
126269873|NCT02444793|454281687|FG000|Overall Study|Other|0|||
126269874|NCT02444793|454281688|FG001|Overall Study|Other|0|||
126269875|NCT02444793|454281689|FG002|Overall Study|Other|2|||
126269876|NCT02444793|454281690|FG003|Overall Study|Other|0|||
126269877|NCT02444793|454281687|FG000|Overall Study|Objective progression or relapse|9|||
126269878|NCT02444793|454281688|FG001|Overall Study|Objective progression or relapse|1|||
126269879|NCT02444793|454281689|FG002|Overall Study|Objective progression or relapse|2|||
126269880|NCT02444793|454281690|FG003|Overall Study|Objective progression or relapse|3|||
126361275|NCT03791060|454615226|FG000|Overall Study|Withdrawal by Subject|1|||
126361276|NCT03436420|454615233|FG000|Overall Study|Lack of Efficacy|3|||
126361277|NCT02619812|454615234|FG000|Overall Study|Withdrawal by Subject|0|||
126361278|NCT02619812|454615235|FG001|Overall Study|Withdrawal by Subject|0|||
126269881|NCT02504671|454281691|FG000|Overall Study|Withdrawal by Subject|1|||
126269882|NCT02504671|454281692|FG001|Overall Study|Withdrawal by Subject|5|||
126269883|NCT02504671|454281693|FG002|Overall Study|Withdrawal by Subject|4|||
126269884|NCT02504671|454281694|FG003|Overall Study|Withdrawal by Subject|4|||
126269885|NCT02504671|454281695|FG004|Overall Study|Withdrawal by Subject|5|||
126361279|NCT02619812|454615236|FG002|Overall Study|Withdrawal by Subject|1|||
126269886|NCT02504671|454281696|FG005|Overall Study|Withdrawal by Subject|3|||
126269887|NCT02504671|454281691|FG000|Overall Study|Lack of Efficacy|1|||
126269888|NCT02504671|454281692|FG001|Overall Study|Lack of Efficacy|3|||
126361280|NCT02619812|454615237|FG003|Overall Study|Withdrawal by Subject|2|||
126361281|NCT00981175|454615238|FG000|Primary Dose Vaccination|Adverse Event|1|||
126361282|NCT00981175|454615239|FG001|Primary Dose Vaccination|Adverse Event|0|||
126361283|NCT00981175|454615238|FG000|Primary Dose Vaccination|Protocol Violation|0|||
126361284|NCT00981175|454615239|FG001|Primary Dose Vaccination|Protocol Violation|1|||
126361285|NCT00981175|454615238|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
126361286|NCT00981175|454615239|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
126361287|NCT00981175|454615238|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
126361288|NCT00981175|454615239|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
126361289|NCT01658735|454615242|FG000|Overall Study|Lack of Efficacy|1|||
126361290|NCT01658735|454615243|FG001|Overall Study|Lack of Efficacy|0|||
126361291|NCT01658735|454615244|FG002|Overall Study|Lack of Efficacy|1|||
126361292|NCT01658735|454615242|FG000|Overall Study|Lost to Follow-up|1|||
126361293|NCT01658735|454615243|FG001|Overall Study|Lost to Follow-up|1|||
126361294|NCT01658735|454615244|FG002|Overall Study|Lost to Follow-up|0|||
126361295|NCT01658735|454615242|FG000|Overall Study|Protocol Violation|0|||
126361296|NCT01658735|454615243|FG001|Overall Study|Protocol Violation|1|||
126361297|NCT01658735|454615244|FG002|Overall Study|Protocol Violation|0|||
126361298|NCT01658735|454615242|FG000|Overall Study|Withdrawal by Subject|3|||
126361299|NCT01658735|454615243|FG001|Overall Study|Withdrawal by Subject|5|||
126361300|NCT01658735|454615244|FG002|Overall Study|Withdrawal by Subject|3|||
126361301|NCT01379937|454615245|FG000|Overall Study|Protocol Violation|0|||
126361302|NCT01379937|454615246|FG001|Overall Study|Protocol Violation|0|||
126361303|NCT01379937|454615247|FG002|Overall Study|Protocol Violation|0|||
126361304|NCT01379937|454615248|FG003|Overall Study|Protocol Violation|1|||
126361305|NCT01379937|454615245|FG000|Overall Study|Consent withdrawal|0|||
126361306|NCT01379937|454615246|FG001|Overall Study|Consent withdrawal|1|||
126361307|NCT01379937|454615247|FG002|Overall Study|Consent withdrawal|0|||
126361308|NCT01379937|454615248|FG003|Overall Study|Consent withdrawal|0|||
126361309|NCT01379937|454615245|FG000|Overall Study|Lost to Follow-up|1|||
126361310|NCT01379937|454615246|FG001|Overall Study|Lost to Follow-up|2|||
126361311|NCT01379937|454615247|FG002|Overall Study|Lost to Follow-up|2|||
126361312|NCT01379937|454615248|FG003|Overall Study|Lost to Follow-up|0|||
126361313|NCT01104870|454615249|FG000|Overall Study|Adverse Event|1|||
126361314|NCT01104870|454615250|FG001|Overall Study|Adverse Event|1|||
126361315|NCT01104870|454615251|FG002|Overall Study|Adverse Event|0|||
126361316|NCT01104870|454615249|FG000|Overall Study|Death|0|||
126361317|NCT01104870|454615250|FG001|Overall Study|Death|0|||
126361318|NCT01104870|454615251|FG002|Overall Study|Death|1|||
126361319|NCT01104870|454615249|FG000|Overall Study|Withdrawal by Subject|0|||
126361320|NCT01104870|454615250|FG001|Overall Study|Withdrawal by Subject|0|||
126361321|NCT01104870|454615251|FG002|Overall Study|Withdrawal by Subject|1|||
126361322|NCT00079781|454615263|FG000|Pre-implant Period|Withdrawal by Subject|2|||
126361323|NCT00079781|454615264|FG001|Pre-implant Period|Withdrawal by Subject|0|||
126361324|NCT00079781|454615265|FG002|Pre-implant Period|Withdrawal by Subject|0|||
126361325|NCT00079781|454615263|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
126361326|NCT00079781|454615264|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
126361327|NCT00079781|454615265|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
126361328|NCT00079781|454615263|FG000|Follow-up Period|Withdrawal by Subject|3|||
126361329|NCT00079781|454615264|FG001|Follow-up Period|Withdrawal by Subject|0|||
126361330|NCT00079781|454615265|FG002|Follow-up Period|Withdrawal by Subject|1|||
126361331|NCT00079781|454615263|FG000|Follow-up Period|Lost to Follow-up|1|||
126361332|NCT00079781|454615264|FG001|Follow-up Period|Lost to Follow-up|0|||
126361333|NCT00079781|454615265|FG002|Follow-up Period|Lost to Follow-up|0|||
126361334|NCT00079781|454615263|FG000|Follow-up Period|Death|0|||
126361335|NCT00079781|454615264|FG001|Follow-up Period|Death|0|||
126361336|NCT00079781|454615265|FG002|Follow-up Period|Death|1|||
126361337|NCT04641975|454615266|FG000|Overall Study|Protocol Violation|1|||
126361338|NCT04641975|454615267|FG001|Overall Study|Protocol Violation|2|||
126705348|NCT02034123|455871747|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126705349|NCT02034123|455871748|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
126705350|NCT02034123|455871749|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
126705351|NCT02034123|455871750|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126361339|NCT04641975|454615268|FG002|Overall Study|Protocol Violation|0|||
126361340|NCT04641975|454615269|FG003|Overall Study|Protocol Violation|0|||
126361341|NCT04641975|454615266|FG000|Overall Study|Adverse Event|0|||
126361342|NCT04641975|454615267|FG001|Overall Study|Adverse Event|0|||
126705352|NCT02034123|455871751|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126361343|NCT04641975|454615268|FG002|Overall Study|Adverse Event|1|||
126361344|NCT04641975|454615269|FG003|Overall Study|Adverse Event|1|||
126361345|NCT04641975|454615266|FG000|Overall Study|Withdrawal by Subject|1|||
126361346|NCT04641975|454615267|FG001|Overall Study|Withdrawal by Subject|0|||
126361347|NCT04641975|454615268|FG002|Overall Study|Withdrawal by Subject|0|||
126361348|NCT04641975|454615269|FG003|Overall Study|Withdrawal by Subject|0|||
126361349|NCT02067156|454615273|FG000|Overall Study|Lost to Follow-up|4|||
126361350|NCT03596983|454615274|FG000|Overall Study|Withdrawal by Subject|3|||
126361351|NCT05287685|454615275|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
126361352|NCT05287685|454615276|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
126269889|NCT02504671|454281693|FG002|Overall Study|Lack of Efficacy|1|||
126269890|NCT02504671|454281694|FG003|Overall Study|Lack of Efficacy|0|||
126269891|NCT02504671|454281695|FG004|Overall Study|Lack of Efficacy|4|||
126269892|NCT02504671|454281696|FG005|Overall Study|Lack of Efficacy|4|||
126269893|NCT02504671|454281691|FG000|Overall Study|Adverse Event|1|||
126269894|NCT02504671|454281692|FG001|Overall Study|Adverse Event|1|||
126269895|NCT02504671|454281693|FG002|Overall Study|Adverse Event|0|||
126269896|NCT02504671|454281694|FG003|Overall Study|Adverse Event|1|||
126269897|NCT02504671|454281695|FG004|Overall Study|Adverse Event|0|||
126269898|NCT02504671|454281696|FG005|Overall Study|Adverse Event|2|||
126269899|NCT02504671|454281691|FG000|Overall Study|Protocol Violation|2|||
126269900|NCT02504671|454281692|FG001|Overall Study|Protocol Violation|1|||
126269901|NCT02504671|454281693|FG002|Overall Study|Protocol Violation|0|||
126269902|NCT02504671|454281694|FG003|Overall Study|Protocol Violation|0|||
126269903|NCT02504671|454281695|FG004|Overall Study|Protocol Violation|0|||
126269904|NCT02504671|454281696|FG005|Overall Study|Protocol Violation|1|||
126269905|NCT02504671|454281691|FG000|Overall Study|Lost to Follow-up|0|||
126269906|NCT02504671|454281692|FG001|Overall Study|Lost to Follow-up|0|||
126269907|NCT02504671|454281693|FG002|Overall Study|Lost to Follow-up|2|||
126269908|NCT02504671|454281694|FG003|Overall Study|Lost to Follow-up|0|||
126269909|NCT02504671|454281695|FG004|Overall Study|Lost to Follow-up|0|||
126269910|NCT02504671|454281696|FG005|Overall Study|Lost to Follow-up|1|||
126269911|NCT02504671|454281691|FG000|Overall Study|Protocol defined stopping criteria|7|||
126269912|NCT02504671|454281692|FG001|Overall Study|Protocol defined stopping criteria|4|||
126269913|NCT02504671|454281693|FG002|Overall Study|Protocol defined stopping criteria|3|||
126269914|NCT02504671|454281694|FG003|Overall Study|Protocol defined stopping criteria|5|||
126269915|NCT02504671|454281695|FG004|Overall Study|Protocol defined stopping criteria|3|||
126269916|NCT02504671|454281696|FG005|Overall Study|Protocol defined stopping criteria|3|||
126269917|NCT00210249|454281697|FG000|Overall Study|Lost to Follow-up|5|||
126269918|NCT00210249|454281697|FG000|Overall Study|Protocol Violation|11|||
126269919|NCT02518919|454281698|FG000|Overall Study|Protocol Violation|1|||
126269920|NCT02518919|454281699|FG001|Overall Study|Protocol Violation|1|||
126269921|NCT02518919|454281700|FG002|Overall Study|Protocol Violation|2|||
126269922|NCT00599521|454281701|FG000|Overall Study|Lack of Efficacy|4|||
126269923|NCT00599521|454281702|FG001|Overall Study|Lack of Efficacy|8|||
126269924|NCT00599521|454281701|FG000|Overall Study|Adverse Event|4|||
126269925|NCT00599521|454281702|FG001|Overall Study|Adverse Event|1|||
126269926|NCT00599521|454281701|FG000|Overall Study|Withdrawal by Subject|28|||
126269927|NCT00599521|454281702|FG001|Overall Study|Withdrawal by Subject|34|||
126269928|NCT00599521|454281701|FG000|Overall Study|Protocol Violation|1|||
126269929|NCT00599521|454281702|FG001|Overall Study|Protocol Violation|1|||
126269930|NCT00599521|454281701|FG000|Overall Study|Lost to Follow-up|23|||
126269931|NCT00599521|454281702|FG001|Overall Study|Lost to Follow-up|23|||
126269932|NCT00599521|454281701|FG000|Overall Study|Pregnancy|0|||
126269933|NCT00599521|454281702|FG001|Overall Study|Pregnancy|2|||
126269934|NCT04322149|454281704|FG000|Overall Study|Adverse Event|1|||
126269935|NCT04322149|454281705|FG001|Overall Study|Adverse Event|1|||
126269936|NCT04322149|454281706|FG002|Overall Study|Adverse Event|0|||
126269937|NCT04322149|454281707|FG003|Overall Study|Adverse Event|0|||
126269938|NCT04322149|454281704|FG000|Overall Study|Withdrawal by Subject|0|||
126269939|NCT04322149|454281705|FG001|Overall Study|Withdrawal by Subject|0|||
126361353|NCT05287685|454615275|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
126361354|NCT05287685|454615276|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
126361355|NCT03093870|454615277|FG000|Overall Study|Withdrawal by Subject|2|||
126361356|NCT03093870|454615278|FG001|Overall Study|Withdrawal by Subject|6|||
126361357|NCT03093870|454615279|FG002|Overall Study|Withdrawal by Subject|5|||
126361358|NCT03093870|454615277|FG000|Overall Study|Death|1|||
126361359|NCT03093870|454615278|FG001|Overall Study|Death|35|||
126361360|NCT03093870|454615279|FG002|Overall Study|Death|35|||
126361361|NCT03093870|454615277|FG000|Overall Study|Radiographic disease progression|10|||
126361362|NCT03093870|454615278|FG001|Overall Study|Radiographic disease progression|0|||
126361363|NCT03093870|454615279|FG002|Overall Study|Radiographic disease progression|0|||
126361364|NCT03093870|454615277|FG000|Overall Study|Clinical disease progression|1|||
126361365|NCT03093870|454615278|FG001|Overall Study|Clinical disease progression|0|||
126361366|NCT03093870|454615279|FG002|Overall Study|Clinical disease progression|0|||
126361367|NCT03093870|454615277|FG000|Overall Study|Physician Decision|2|||
126361368|NCT03093870|454615278|FG001|Overall Study|Physician Decision|0|||
126361369|NCT03093870|454615279|FG002|Overall Study|Physician Decision|0|||
126361370|NCT03093870|454615277|FG000|Overall Study|Adverse Event|7|||
126361371|NCT03093870|454615278|FG001|Overall Study|Adverse Event|0|||
126269940|NCT04322149|454281706|FG002|Overall Study|Withdrawal by Subject|0|||
126269941|NCT04322149|454281707|FG003|Overall Study|Withdrawal by Subject|2|||
126361372|NCT03093870|454615279|FG002|Overall Study|Adverse Event|0|||
126269942|NCT04322149|454281704|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
126269943|NCT04322149|454281705|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
126269944|NCT04322149|454281706|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
126269945|NCT04322149|454281707|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
126269946|NCT03827564|454281711|FG000|Overall Study|Discontinued due to Study Termination|1|||
126269947|NCT03827564|454281712|FG001|Overall Study|Discontinued due to Study Termination|0|||
126269948|NCT00307034|454281713|FG000|Overall Study|Adverse Event|1|||
126269949|NCT00307034|454281714|FG001|Overall Study|Adverse Event|2|||
126269950|NCT00307034|454281713|FG000|Overall Study|Withdrawal by Subject|1|||
126269951|NCT00307034|454281714|FG001|Overall Study|Withdrawal by Subject|2|||
126269952|NCT00307034|454281713|FG000|Overall Study|Lost to Follow-up|0|||
126269953|NCT00307034|454281714|FG001|Overall Study|Lost to Follow-up|3|||
126269954|NCT00667810|454281715|FG000|Overall Study|Adverse Event|13|||
126269955|NCT00667810|454281716|FG001|Overall Study|Adverse Event|14|||
126269956|NCT00667810|454281717|FG002|Overall Study|Adverse Event|19|||
126269957|NCT00667810|454281718|FG003|Overall Study|Adverse Event|1|||
126269958|NCT00667810|454281715|FG000|Overall Study|Death|1|||
126269959|NCT00667810|454281716|FG001|Overall Study|Death|1|||
126269960|NCT00667810|454281717|FG002|Overall Study|Death|3|||
126269961|NCT00667810|454281718|FG003|Overall Study|Death|0|||
126269962|NCT00667810|454281715|FG000|Overall Study|Lack of Efficacy|1|||
126269963|NCT00667810|454281716|FG001|Overall Study|Lack of Efficacy|0|||
126269964|NCT00667810|454281717|FG002|Overall Study|Lack of Efficacy|2|||
126269965|NCT00667810|454281718|FG003|Overall Study|Lack of Efficacy|0|||
126269966|NCT00667810|454281715|FG000|Overall Study|Lost to Follow-up|1|||
126269967|NCT00667810|454281716|FG001|Overall Study|Lost to Follow-up|4|||
126269968|NCT00667810|454281717|FG002|Overall Study|Lost to Follow-up|2|||
126269969|NCT00667810|454281718|FG003|Overall Study|Lost to Follow-up|0|||
126269970|NCT00667810|454281715|FG000|Overall Study|Physician Decision|1|||
126269971|NCT00667810|454281716|FG001|Overall Study|Physician Decision|1|||
126269972|NCT00667810|454281717|FG002|Overall Study|Physician Decision|2|||
126269973|NCT00667810|454281718|FG003|Overall Study|Physician Decision|0|||
126269974|NCT00667810|454281715|FG000|Overall Study|Protocol Violation|0|||
126269975|NCT00667810|454281716|FG001|Overall Study|Protocol Violation|2|||
126269976|NCT00667810|454281717|FG002|Overall Study|Protocol Violation|0|||
126269977|NCT00667810|454281718|FG003|Overall Study|Protocol Violation|0|||
126269978|NCT00667810|454281715|FG000|Overall Study|Withdrawal by Subject|14|||
126269979|NCT00667810|454281716|FG001|Overall Study|Withdrawal by Subject|20|||
126269980|NCT00667810|454281717|FG002|Overall Study|Withdrawal by Subject|29|||
126269981|NCT00667810|454281718|FG003|Overall Study|Withdrawal by Subject|1|||
126269982|NCT00667810|454281715|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
126269983|NCT00667810|454281716|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
126269984|NCT00667810|454281717|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
126269985|NCT00667810|454281718|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
126269986|NCT00667810|454281715|FG000|Overall Study|Failed to Return|0|||
126269987|NCT00667810|454281716|FG001|Overall Study|Failed to Return|0|||
126269988|NCT00667810|454281717|FG002|Overall Study|Failed to Return|2|||
126269989|NCT00667810|454281718|FG003|Overall Study|Failed to Return|0|||
126269990|NCT00667810|454281715|FG000|Overall Study|Loss of Caregiver|0|||
126269991|NCT00667810|454281716|FG001|Overall Study|Loss of Caregiver|1|||
126269992|NCT00667810|454281717|FG002|Overall Study|Loss of Caregiver|3|||
126269993|NCT00667810|454281718|FG003|Overall Study|Loss of Caregiver|0|||
126269994|NCT00667810|454281715|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
126269995|NCT00667810|454281716|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
126269996|NCT00667810|454281717|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
126269997|NCT00667810|454281718|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
126269998|NCT00667810|454281715|FG000|Overall Study|Other|6|||
126269999|NCT00667810|454281716|FG001|Overall Study|Other|6|||
126270000|NCT00667810|454281717|FG002|Overall Study|Other|5|||
126270001|NCT00667810|454281718|FG003|Overall Study|Other|0|||
126270002|NCT04442490|454281725|FG000|Overall Study|Withdrawal by Subject|18|||
126270003|NCT04442490|454281726|FG001|Overall Study|Withdrawal by Subject|10|||
126270004|NCT04442490|454281725|FG000|Overall Study|Lost to Follow-up|7|||
126270005|NCT04442490|454281726|FG001|Overall Study|Lost to Follow-up|7|||
126361373|NCT03093870|454615277|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
126361374|NCT03093870|454615278|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
126270006|NCT04442490|454281725|FG000|Overall Study|Adverse Event|2|||
126270007|NCT04442490|454281726|FG001|Overall Study|Adverse Event|6|||
126270008|NCT04442490|454281725|FG000|Overall Study|Noncompliance|3|||
126270009|NCT04442490|454281726|FG001|Overall Study|Noncompliance|1|||
126270010|NCT04442490|454281725|FG000|Overall Study|Physician Decision|2|||
126270011|NCT04442490|454281726|FG001|Overall Study|Physician Decision|1|||
126270012|NCT04442490|454281725|FG000|Overall Study|Reason not Specified|2|||
126270013|NCT04442490|454281726|FG001|Overall Study|Reason not Specified|1|||
126270014|NCT04442490|454281725|FG000|Overall Study|Randomized but not Treated|3|||
126270015|NCT04442490|454281726|FG001|Overall Study|Randomized but not Treated|3|||
126270016|NCT02227147|454281727|FG000|Controlled Treatment Period|Adverse Event|4|||
126270017|NCT02227147|454281728|FG001|Controlled Treatment Period|Adverse Event|3|||
126270018|NCT02227147|454281727|FG000|Controlled Treatment Period|Other|2|||
126270019|NCT02227147|454281728|FG001|Controlled Treatment Period|Other|0|||
126270020|NCT02227147|454281727|FG000|Follow-up Period|Other|3|||
126270021|NCT02227147|454281728|FG001|Follow-up Period|Other|5|||
126270022|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
126270023|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
126270024|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
126270025|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
126270026|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
126270027|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
126270028|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
126270029|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
126270030|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
126270031|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
126270032|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
126547361|NCT02936037|455297929|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
126270033|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
126270034|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
126270035|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
126270036|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
126547362|NCT02936037|455297930|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
126547363|NCT02936037|455297929|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
126547364|NCT02936037|455297930|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
126547365|NCT02936037|455297929|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
126547366|NCT02936037|455297930|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
126547367|NCT02936037|455297929|FG000|Double-Blind Treatment Period|Death|0|||
126547368|NCT02936037|455297930|FG001|Double-Blind Treatment Period|Death|1|||
126547369|NCT02936037|455297929|FG000|Double-Blind Treatment Period|Adverse Event|11|||
126547370|NCT02936037|455297930|FG001|Double-Blind Treatment Period|Adverse Event|11|||
126547371|NCT02936037|455297929|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
126547372|NCT02936037|455297930|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
126547373|NCT02936037|455297929|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126547374|NCT02936037|455297930|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
126547375|NCT02936037|455297929|FG000|Open Label Extension|Adverse Event|0|||
126547376|NCT02936037|455297930|FG001|Open Label Extension|Adverse Event|3|||
126547377|NCT02936037|455297929|FG000|Open Label Extension|Other|0|||
126547378|NCT02936037|455297930|FG001|Open Label Extension|Other|3|||
126547379|NCT02936037|455297929|FG000|Open Label Extension|Withdrawal by Subject|0|||
126547380|NCT02936037|455297930|FG001|Open Label Extension|Withdrawal by Subject|4|||
126547381|NCT01382940|455297931|FG000|Overall Study|Adverse Event|19|||
126547382|NCT01382940|455297931|FG000|Overall Study|Lost to Follow-up|4|||
126547383|NCT01382940|455297931|FG000|Overall Study|Physician Decision|7|||
126547384|NCT01382940|455297931|FG000|Overall Study|Withdrawal by Subject|23|||
126547385|NCT01382940|455297931|FG000|Overall Study|Protocol Violation|20|||
126547386|NCT00244374|455297932|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
126547387|NCT00244374|455297933|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
126547388|NCT00244374|455297934|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
126547389|NCT00244374|455297935|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
126547390|NCT00244374|455297936|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
126547391|NCT00244374|455297932|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
126547392|NCT00244374|455297933|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
126547393|NCT00244374|455297934|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
126270037|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
126270038|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
126270039|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
126270040|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
126270041|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
126270042|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
126270043|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
126270044|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
126270045|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
126270046|NCT03514641|454281729|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
126270047|NCT03514641|454281730|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
126270048|NCT03514641|454281731|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
126547394|NCT00244374|455297935|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
126547395|NCT00244374|455297936|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
126547396|NCT00244374|455297932|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
126270049|NCT03514641|454281732|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
126270050|NCT03514641|454281729|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
126547397|NCT00244374|455297933|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
126361375|NCT03093870|454615279|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
126361376|NCT03093870|454615277|FG000|Overall Study|Lost to Follow-up|0|||
126361377|NCT03093870|454615278|FG001|Overall Study|Lost to Follow-up|0|||
126361378|NCT03093870|454615279|FG002|Overall Study|Lost to Follow-up|1|||
126361379|NCT04008069|454615280|FG000|Open-Label Period|Adverse Event|1|||
126361380|NCT04008069|454615281|FG001|Open-Label Period|Adverse Event|0|||
126361381|NCT04008069|454615282|FG002|Open-Label Period|Adverse Event|0|||
126361382|NCT04008069|454615280|FG000|Open-Label Period|Lack of Efficacy|4|||
126361383|NCT04008069|454615281|FG001|Open-Label Period|Lack of Efficacy|0|||
126361384|NCT04008069|454615282|FG002|Open-Label Period|Lack of Efficacy|0|||
126361385|NCT04008069|454615280|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
126453450|NCT00797966|454961417|FG004|Phase A+|Protocol deviation|0|||
126453451|NCT00797966|454961418|FG005|Phase A+|Protocol deviation|4|||
126453452|NCT03859973|454961420|FG000|Overall Study|Other reason than listed|3|||
126453453|NCT03859973|454961421|FG001|Overall Study|Other reason than listed|2|||
126453454|NCT03859973|454961420|FG000|Overall Study|COVID-19 related, not due to AE|3|||
126270051|NCT03514641|454281730|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
126270052|NCT03514641|454281731|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
126270053|NCT03514641|454281732|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
126270054|NCT03514641|454281729|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
126270055|NCT03514641|454281730|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
126270056|NCT03514641|454281731|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
126270057|NCT03514641|454281732|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
126270058|NCT03514641|454281729|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
126270059|NCT03514641|454281730|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
126270060|NCT03514641|454281731|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
126270061|NCT03514641|454281732|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
126270062|NCT03514641|454281729|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
126270063|NCT03514641|454281730|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
126270064|NCT03514641|454281731|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
126270065|NCT03514641|454281732|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
126270066|NCT03514641|454281729|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
126270067|NCT03514641|454281730|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
126270068|NCT03514641|454281731|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
126270069|NCT03514641|454281732|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
126270070|NCT01449279|454281733|FG000|Overall Study|Lack of Efficacy|5|||
126270071|NCT01449279|454281733|FG000|Overall Study|Toxicity|2|||
126270072|NCT00505375|454281734|FG000|Overall Study|Death|1|||
126270073|NCT00505375|454281735|FG001|Overall Study|Death|0|||
126270074|NCT00505375|454281734|FG000|Overall Study|Withdrawal by Subject|2|||
126270075|NCT00505375|454281735|FG001|Overall Study|Withdrawal by Subject|2|||
126270076|NCT00505375|454281734|FG000|Overall Study|Lost to Follow-up|0|||
126270077|NCT00505375|454281735|FG001|Overall Study|Lost to Follow-up|2|||
126270078|NCT00505375|454281734|FG000|Overall Study|Pregnancy|1|||
126270079|NCT00505375|454281735|FG001|Overall Study|Pregnancy|0|||
126270080|NCT00505375|454281734|FG000|Overall Study|Travel issues|0|||
126270081|NCT00505375|454281735|FG001|Overall Study|Travel issues|1|||
126270082|NCT03709823|454281736|FG000|Overall Study|Adverse Event|0|||
126270083|NCT03709823|454281737|FG001|Overall Study|Adverse Event|0|||
126270084|NCT03709823|454281738|FG002|Overall Study|Adverse Event|1|||
126270085|NCT03709823|454281739|FG003|Overall Study|Adverse Event|0|||
126270086|NCT03709823|454281740|FG004|Overall Study|Adverse Event|0|||
126270087|NCT03709823|454281741|FG005|Overall Study|Adverse Event|0|||
126270088|NCT03709823|454281736|FG000|Overall Study|Lost to Follow-up|2|||
126270089|NCT03709823|454281737|FG001|Overall Study|Lost to Follow-up|2|||
126270090|NCT03709823|454281738|FG002|Overall Study|Lost to Follow-up|2|||
126270091|NCT03709823|454281739|FG003|Overall Study|Lost to Follow-up|1|||
126270092|NCT03709823|454281740|FG004|Overall Study|Lost to Follow-up|1|||
126270093|NCT03709823|454281741|FG005|Overall Study|Lost to Follow-up|0|||
126270094|NCT03709823|454281736|FG000|Overall Study|Withdrawal by Subject|1|||
126270095|NCT03709823|454281737|FG001|Overall Study|Withdrawal by Subject|3|||
126361386|NCT04008069|454615281|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
126453455|NCT03859973|454961421|FG001|Overall Study|COVID-19 related, not due to AE|4|||
126453456|NCT03859973|454961420|FG000|Overall Study|Withdrawal by Subject|8|||
126270096|NCT03709823|454281738|FG002|Overall Study|Withdrawal by Subject|0|||
126361387|NCT04008069|454615282|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
126361388|NCT04008069|454615280|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
126453457|NCT03859973|454961421|FG001|Overall Study|Withdrawal by Subject|9|||
126270097|NCT03709823|454281739|FG003|Overall Study|Withdrawal by Subject|0|||
126270098|NCT03709823|454281740|FG004|Overall Study|Withdrawal by Subject|0|||
126270099|NCT03709823|454281741|FG005|Overall Study|Withdrawal by Subject|0|||
126270100|NCT03709823|454281736|FG000|Overall Study|Other, Not Specified|0|||
126270101|NCT03709823|454281737|FG001|Overall Study|Other, Not Specified|0|||
126270102|NCT03709823|454281738|FG002|Overall Study|Other, Not Specified|0|||
126270103|NCT03709823|454281739|FG003|Overall Study|Other, Not Specified|1|||
126270104|NCT03709823|454281740|FG004|Overall Study|Other, Not Specified|0|||
126270105|NCT03709823|454281741|FG005|Overall Study|Other, Not Specified|0|||
126270106|NCT04234984|454281742|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
126270107|NCT04234984|454281742|FG000|Follow-up at the Second Time Point|Death|1|||
126270108|NCT04234984|454281742|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
126270109|NCT02038907|454281743|FG000|Overall Study|Protocol Violation|0|||
126270110|NCT02038907|454281744|FG001|Overall Study|Protocol Violation|0|||
126270111|NCT02038907|454281745|FG002|Overall Study|Protocol Violation|0|||
126270112|NCT02038907|454281746|FG003|Overall Study|Protocol Violation|0|||
126270113|NCT02038907|454281747|FG004|Overall Study|Protocol Violation|0|||
126270114|NCT02038907|454281748|FG005|Overall Study|Protocol Violation|0|||
126270115|NCT02038907|454281749|FG006|Overall Study|Protocol Violation|0|||
126270116|NCT02038907|454281750|FG007|Overall Study|Protocol Violation|0|||
126270117|NCT02038907|454281751|FG008|Overall Study|Protocol Violation|0|||
126270118|NCT02038907|454281752|FG009|Overall Study|Protocol Violation|0|||
126270119|NCT02038907|454281753|FG010|Overall Study|Protocol Violation|1|||
126270120|NCT02038907|454281754|FG011|Overall Study|Protocol Violation|0|||
126270121|NCT02038907|454281755|FG012|Overall Study|Protocol Violation|0|||
126270122|NCT02038907|454281756|FG013|Overall Study|Protocol Violation|0|||
126270123|NCT02038907|454281743|FG000|Overall Study|Withdrawal by Subject|0|||
126270124|NCT02038907|454281744|FG001|Overall Study|Withdrawal by Subject|0|||
126270125|NCT02038907|454281745|FG002|Overall Study|Withdrawal by Subject|0|||
126270126|NCT02038907|454281746|FG003|Overall Study|Withdrawal by Subject|0|||
126270127|NCT02038907|454281747|FG004|Overall Study|Withdrawal by Subject|0|||
126270128|NCT02038907|454281748|FG005|Overall Study|Withdrawal by Subject|0|||
126270129|NCT02038907|454281749|FG006|Overall Study|Withdrawal by Subject|0|||
126270130|NCT02038907|454281750|FG007|Overall Study|Withdrawal by Subject|0|||
126270131|NCT02038907|454281751|FG008|Overall Study|Withdrawal by Subject|0|||
126270132|NCT02038907|454281752|FG009|Overall Study|Withdrawal by Subject|0|||
126270133|NCT02038907|454281753|FG010|Overall Study|Withdrawal by Subject|1|||
126270134|NCT02038907|454281754|FG011|Overall Study|Withdrawal by Subject|0|||
126270135|NCT02038907|454281755|FG012|Overall Study|Withdrawal by Subject|0|||
126270136|NCT02038907|454281756|FG013|Overall Study|Withdrawal by Subject|0|||
126270137|NCT04594707|454281760|FG000|Overall Study|Adverse Event|0|||
126270138|NCT04594707|454281761|FG001|Overall Study|Adverse Event|0|||
126270139|NCT04594707|454281762|FG002|Overall Study|Adverse Event|1|||
126270140|NCT04594707|454281760|FG000|Overall Study|Death|0|||
126270141|NCT04594707|454281761|FG001|Overall Study|Death|2|||
126270142|NCT04594707|454281762|FG002|Overall Study|Death|2|||
126270143|NCT04594707|454281760|FG000|Overall Study|Lung Transplant|0|||
126270144|NCT04594707|454281761|FG001|Overall Study|Lung Transplant|0|||
126453458|NCT03859973|454961420|FG000|Overall Study|Lost to Follow-up|2|||
126453459|NCT03859973|454961421|FG001|Overall Study|Lost to Follow-up|3|||
126453460|NCT03859973|454961420|FG000|Overall Study|Protocol Violation|1|||
126453461|NCT03859973|454961421|FG001|Overall Study|Protocol Violation|3|||
126453462|NCT03859973|454961420|FG000|Overall Study|Adverse Event|3|||
126453463|NCT03859973|454961421|FG001|Overall Study|Adverse Event|5|||
126453464|NCT02855541|454961422|FG000|Overall Study|Change in health status|2|||
126453465|NCT02855541|454961422|FG000|Overall Study|Withdrawal by Subject|2|||
126453466|NCT00422513|454961423|FG000|Overall Study|Lack of Efficacy|4|||
126453467|NCT00422513|454961424|FG001|Overall Study|Lack of Efficacy|5|||
126453468|NCT00422513|454961423|FG000|Overall Study|Protocol Violation|23|||
126453469|NCT00422513|454961424|FG001|Overall Study|Protocol Violation|7|||
126453470|NCT00422513|454961423|FG000|Overall Study|Refused Treatment|4|||
126453471|NCT00422513|454961424|FG001|Overall Study|Refused Treatment|2|||
126453472|NCT00422513|454961423|FG000|Overall Study|Withdrawal by Subject|2|||
126453473|NCT00422513|454961424|FG001|Overall Study|Withdrawal by Subject|1|||
126453474|NCT00422513|454961423|FG000|Overall Study|early termination of the study|67|||
126453475|NCT00422513|454961424|FG001|Overall Study|early termination of the study|80|||
126453476|NCT00422513|454961423|FG000|Overall Study|Adverse Event|4|||
126270145|NCT04594707|454281762|FG002|Overall Study|Lung Transplant|1|||
126270146|NCT04594707|454281760|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
126270147|NCT04594707|454281761|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
126270148|NCT04594707|454281762|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
126270149|NCT04594707|454281760|FG000|Overall Study|Study Terminated By Sponsor|19|||
126270150|NCT04594707|454281761|FG001|Overall Study|Study Terminated By Sponsor|47|||
126270151|NCT04594707|454281762|FG002|Overall Study|Study Terminated By Sponsor|41|||
126270152|NCT04594707|454281760|FG000|Overall Study|Withdrawal by Subject|1|||
126453477|NCT00422513|454961424|FG001|Overall Study|Adverse Event|4|||
126453478|NCT00422513|454961423|FG000|Overall Study|Death|3|||
126270153|NCT04594707|454281761|FG001|Overall Study|Withdrawal by Subject|0|||
126270154|NCT04594707|454281762|FG002|Overall Study|Withdrawal by Subject|2|||
126270155|NCT01359644|454281765|FG000|Treatment Period|Lack of Efficacy|0|||
126270156|NCT01359644|454281766|FG001|Treatment Period|Lack of Efficacy|1|||
126453479|NCT00422513|454961424|FG001|Overall Study|Death|7|||
126453480|NCT03135119|454961425|FG000|Overall Study|Lost to Follow-up|2|||
126453481|NCT03135119|454961426|FG001|Overall Study|Lost to Follow-up|0|||
126270157|NCT01359644|454281767|FG002|Treatment Period|Lack of Efficacy|0|||
126270158|NCT01359644|454281768|FG003|Treatment Period|Lack of Efficacy|0|||
126270159|NCT01359644|454281769|FG004|Treatment Period|Lack of Efficacy|0|||
126270160|NCT01359644|454281770|FG005|Treatment Period|Lack of Efficacy|0|||
126270161|NCT01359644|454281771|FG006|Treatment Period|Lack of Efficacy|0|||
126270162|NCT01359644|454281772|FG007|Treatment Period|Lack of Efficacy|0|||
126270163|NCT01359644|454281773|FG008|Treatment Period|Lack of Efficacy|0|||
126270164|NCT01359644|454281774|FG009|Treatment Period|Lack of Efficacy|0|||
126270165|NCT01359644|454281765|FG000|Treatment Period|Adverse Event|0|||
126270166|NCT01359644|454281766|FG001|Treatment Period|Adverse Event|0|||
126270167|NCT01359644|454281767|FG002|Treatment Period|Adverse Event|1|||
126270168|NCT01359644|454281768|FG003|Treatment Period|Adverse Event|0|||
126270169|NCT01359644|454281769|FG004|Treatment Period|Adverse Event|0|||
126270170|NCT01359644|454281770|FG005|Treatment Period|Adverse Event|1|||
126270171|NCT01359644|454281771|FG006|Treatment Period|Adverse Event|0|||
126270172|NCT01359644|454281772|FG007|Treatment Period|Adverse Event|0|||
126270173|NCT01359644|454281773|FG008|Treatment Period|Adverse Event|0|||
126270174|NCT01359644|454281774|FG009|Treatment Period|Adverse Event|0|||
126270175|NCT01359644|454281765|FG000|Treatment Period|Lost to Follow-up|0|||
126270176|NCT01359644|454281766|FG001|Treatment Period|Lost to Follow-up|0|||
126270177|NCT01359644|454281767|FG002|Treatment Period|Lost to Follow-up|0|||
126270178|NCT01359644|454281768|FG003|Treatment Period|Lost to Follow-up|0|||
126270179|NCT01359644|454281769|FG004|Treatment Period|Lost to Follow-up|0|||
126270180|NCT01359644|454281770|FG005|Treatment Period|Lost to Follow-up|1|||
126270181|NCT01359644|454281771|FG006|Treatment Period|Lost to Follow-up|0|||
126270182|NCT01359644|454281772|FG007|Treatment Period|Lost to Follow-up|0|||
126270183|NCT01359644|454281773|FG008|Treatment Period|Lost to Follow-up|0|||
126270184|NCT01359644|454281774|FG009|Treatment Period|Lost to Follow-up|0|||
126270185|NCT01359644|454281765|FG000|Follow-up Period|Withdrawal by Subject|0|||
126270186|NCT01359644|454281766|FG001|Follow-up Period|Withdrawal by Subject|0|||
126270187|NCT01359644|454281767|FG002|Follow-up Period|Withdrawal by Subject|0|||
126270188|NCT01359644|454281768|FG003|Follow-up Period|Withdrawal by Subject|0|||
126270189|NCT01359644|454281769|FG004|Follow-up Period|Withdrawal by Subject|0|||
126270190|NCT01359644|454281770|FG005|Follow-up Period|Withdrawal by Subject|1|||
126270191|NCT01359644|454281771|FG006|Follow-up Period|Withdrawal by Subject|0|||
126270192|NCT01359644|454281772|FG007|Follow-up Period|Withdrawal by Subject|0|||
126270193|NCT01359644|454281773|FG008|Follow-up Period|Withdrawal by Subject|0|||
126270194|NCT01359644|454281774|FG009|Follow-up Period|Withdrawal by Subject|0|||
126270195|NCT01359644|454281765|FG000|Follow-up Period|Lost to Follow-up|0|||
126270196|NCT01359644|454281766|FG001|Follow-up Period|Lost to Follow-up|0|||
126270197|NCT01359644|454281767|FG002|Follow-up Period|Lost to Follow-up|0|||
126270198|NCT01359644|454281768|FG003|Follow-up Period|Lost to Follow-up|0|||
126270199|NCT01359644|454281769|FG004|Follow-up Period|Lost to Follow-up|0|||
126270200|NCT01359644|454281770|FG005|Follow-up Period|Lost to Follow-up|0|||
126270201|NCT01359644|454281771|FG006|Follow-up Period|Lost to Follow-up|1|||
126270202|NCT01359644|454281772|FG007|Follow-up Period|Lost to Follow-up|2|||
126270203|NCT01359644|454281773|FG008|Follow-up Period|Lost to Follow-up|0|||
126270204|NCT01359644|454281774|FG009|Follow-up Period|Lost to Follow-up|0|||
126270205|NCT02130882|454281775|FG000|Overall Study|Withdrawal by Subject|0|||
126270206|NCT02130882|454281776|FG001|Overall Study|Withdrawal by Subject|1|||
126270207|NCT01194973|454281787|FG000|Screening Period|Screen Failure|3|||
126270208|NCT01194973|454281787|FG000|26 Week Treatment Period|Adverse Event|1|||
126270209|NCT01194973|454281787|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
126270210|NCT01194973|454281787|FG000|26 Week Treatment Period|Pregnancy|1|||
126270211|NCT00359632|454281790|FG000|Overall Study|Death|2|||
126270212|NCT00359632|454281791|FG001|Overall Study|Death|0|||
126270213|NCT00359632|454281790|FG000|Overall Study|Adverse Event|1|||
126270214|NCT00359632|454281791|FG001|Overall Study|Adverse Event|0|||
126270215|NCT00359632|454281790|FG000|Overall Study|Non-compliance with visit schedule|1|||
126270216|NCT00359632|454281791|FG001|Overall Study|Non-compliance with visit schedule|0|||
126270217|NCT02615171|454281792|FG000|Overall Study|Lost to Follow-up|2|||
126270218|NCT02615171|454281793|FG001|Overall Study|Lost to Follow-up|1|||
126270219|NCT01000493|454281801|FG000|Overall Study|Adverse Event|3|||
126270220|NCT01000493|454281802|FG001|Overall Study|Adverse Event|6|||
126453482|NCT03135119|454961425|FG000|Overall Study|Physician Decision|1|||
126270221|NCT01000493|454281801|FG000|Overall Study|Lack of Efficacy|1|||
126453483|NCT03135119|454961426|FG001|Overall Study|Physician Decision|1|||
126270222|NCT01000493|454281802|FG001|Overall Study|Lack of Efficacy|1|||
126270223|NCT01000493|454281801|FG000|Overall Study|Protocol Violation|1|||
126270224|NCT01000493|454281802|FG001|Overall Study|Protocol Violation|8|||
126270225|NCT01000493|454281801|FG000|Overall Study|Study closed/terminated|25|||
126270226|NCT01000493|454281802|FG001|Overall Study|Study closed/terminated|23|||
126270227|NCT01000493|454281801|FG000|Overall Study|Lost to Follow-up|5|||
126270228|NCT01000493|454281802|FG001|Overall Study|Lost to Follow-up|9|||
126270229|NCT01000493|454281801|FG000|Overall Study|Physician Decision|1|||
126270230|NCT01000493|454281802|FG001|Overall Study|Physician Decision|1|||
126270231|NCT01000493|454281801|FG000|Overall Study|Withdrawal by Subject|3|||
126270232|NCT01000493|454281802|FG001|Overall Study|Withdrawal by Subject|7|||
126361389|NCT04008069|454615281|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
126361390|NCT04008069|454615282|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
126361391|NCT02134028|454615284|FG000|Overall Study|Lack of Efficacy|1|||
126361392|NCT02134028|454615285|FG001|Overall Study|Lack of Efficacy|0|||
126361393|NCT02134028|454615286|FG002|Overall Study|Lack of Efficacy|3|||
126361394|NCT02134028|454615287|FG003|Overall Study|Lack of Efficacy|2|||
126361395|NCT02134028|454615288|FG004|Overall Study|Lack of Efficacy|1|||
126361396|NCT02134028|454615289|FG005|Overall Study|Lack of Efficacy|2|||
126361397|NCT02134028|454615290|FG006|Overall Study|Lack of Efficacy|1|||
126361398|NCT02134028|454615291|FG007|Overall Study|Lack of Efficacy|0|||
126361399|NCT02134028|454615284|FG000|Overall Study|Poor compliance to protocol|1|||
126361400|NCT02134028|454615285|FG001|Overall Study|Poor compliance to protocol|1|||
126361401|NCT02134028|454615286|FG002|Overall Study|Poor compliance to protocol|3|||
126361402|NCT02134028|454615287|FG003|Overall Study|Poor compliance to protocol|7|||
126361403|NCT02134028|454615288|FG004|Overall Study|Poor compliance to protocol|1|||
126361404|NCT02134028|454615289|FG005|Overall Study|Poor compliance to protocol|1|||
126361405|NCT02134028|454615290|FG006|Overall Study|Poor compliance to protocol|0|||
126361406|NCT02134028|454615291|FG007|Overall Study|Poor compliance to protocol|0|||
126361407|NCT02134028|454615284|FG000|Overall Study|Other unspecified|4|||
126361408|NCT02134028|454615285|FG001|Overall Study|Other unspecified|22|||
126705353|NCT02034123|455871752|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126705354|NCT02034123|455871753|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126705355|NCT02034123|455871754|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126270233|NCT01408628|454281804|FG000|Consented|Withdrawal by Subject|12|||
126270234|NCT01408628|454281804|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
126270235|NCT01408628|454281804|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
126270236|NCT01408628|454281804|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
126270237|NCT01941940|454281805|FG000|Overall Study|Adverse Event|11|||
126270238|NCT01941940|454281805|FG000|Overall Study|Lost to Follow-up|2|||
126270239|NCT01941940|454281805|FG000|Overall Study|Physician Decision|2|||
126270240|NCT01941940|454281805|FG000|Overall Study|Withdrawal by Subject|15|||
126270241|NCT01941940|454281805|FG000|Overall Study|Death|1|||
126270242|NCT01941940|454281805|FG000|Overall Study|Other|1|||
126270243|NCT01941940|454281805|FG000|Overall Study|Other|1|||
126270244|NCT00750308|454281806|FG000|First Treatment|Adverse Event|0|||
126270245|NCT00750308|454281807|FG001|First Treatment|Adverse Event|1|||
126270246|NCT00750308|454281808|FG002|First Treatment|Adverse Event|0|||
126270247|NCT00750308|454281809|FG003|First Treatment|Adverse Event|0|||
126270248|NCT00750308|454281810|FG004|First Treatment|Adverse Event|0|||
126270249|NCT00750308|454281811|FG005|First Treatment|Adverse Event|0|||
126270250|NCT00750308|454281812|FG006|First Treatment|Adverse Event|0|||
126270251|NCT00750308|454281813|FG007|First Treatment|Adverse Event|0|||
126270252|NCT00750308|454281814|FG008|First Treatment|Adverse Event|0|||
126270253|NCT00750308|454281815|FG009|First Treatment|Adverse Event|0|||
126270254|NCT00750308|454281816|FG010|First Treatment|Adverse Event|1|||
126270255|NCT00750308|454281817|FG011|First Treatment|Adverse Event|1|||
126270256|NCT00750308|454281806|FG000|First Treatment|Withdrawal by Subject|0|||
126270257|NCT00750308|454281807|FG001|First Treatment|Withdrawal by Subject|0|||
126270258|NCT00750308|454281808|FG002|First Treatment|Withdrawal by Subject|0|||
126270259|NCT00750308|454281809|FG003|First Treatment|Withdrawal by Subject|1|||
126270260|NCT00750308|454281810|FG004|First Treatment|Withdrawal by Subject|0|||
126270261|NCT00750308|454281811|FG005|First Treatment|Withdrawal by Subject|0|||
126270262|NCT00750308|454281812|FG006|First Treatment|Withdrawal by Subject|0|||
126270263|NCT00750308|454281813|FG007|First Treatment|Withdrawal by Subject|1|||
126270264|NCT00750308|454281814|FG008|First Treatment|Withdrawal by Subject|0|||
126270265|NCT00750308|454281815|FG009|First Treatment|Withdrawal by Subject|0|||
126270266|NCT00750308|454281816|FG010|First Treatment|Withdrawal by Subject|0|||
126270267|NCT00750308|454281817|FG011|First Treatment|Withdrawal by Subject|0|||
126270268|NCT00750308|454281806|FG000|Second Treatment|Adverse Event|0|||
126270269|NCT00750308|454281807|FG001|Second Treatment|Adverse Event|0|||
126270270|NCT00750308|454281808|FG002|Second Treatment|Adverse Event|0|||
126270271|NCT00750308|454281809|FG003|Second Treatment|Adverse Event|0|||
126270272|NCT00750308|454281810|FG004|Second Treatment|Adverse Event|0|||
126270273|NCT00750308|454281811|FG005|Second Treatment|Adverse Event|1|||
126270274|NCT00750308|454281812|FG006|Second Treatment|Adverse Event|0|||
126270275|NCT00750308|454281813|FG007|Second Treatment|Adverse Event|0|||
126765587|NCT00965562|456094562|FG002|Overall Study|Lost to Follow-up|3|||
126270276|NCT00750308|454281814|FG008|Second Treatment|Adverse Event|1|||
126270277|NCT00750308|454281815|FG009|Second Treatment|Adverse Event|0|||
126270278|NCT00750308|454281816|FG010|Second Treatment|Adverse Event|0|||
126270279|NCT00750308|454281817|FG011|Second Treatment|Adverse Event|0|||
126270280|NCT00750308|454281806|FG000|Second Treatment|Withdrawal by Subject|0|||
126270281|NCT00750308|454281807|FG001|Second Treatment|Withdrawal by Subject|0|||
126270282|NCT00750308|454281808|FG002|Second Treatment|Withdrawal by Subject|0|||
126270283|NCT00750308|454281809|FG003|Second Treatment|Withdrawal by Subject|0|||
126270284|NCT00750308|454281810|FG004|Second Treatment|Withdrawal by Subject|1|||
126270285|NCT00750308|454281811|FG005|Second Treatment|Withdrawal by Subject|0|||
126270286|NCT00750308|454281812|FG006|Second Treatment|Withdrawal by Subject|0|||
126765588|NCT00965562|456094560|FG000|Overall Study|Withdrawal by Subject|2|||
126765589|NCT00965562|456094561|FG001|Overall Study|Withdrawal by Subject|2|||
126270287|NCT00750308|454281813|FG007|Second Treatment|Withdrawal by Subject|0|||
126270288|NCT00750308|454281814|FG008|Second Treatment|Withdrawal by Subject|0|||
126270289|NCT00750308|454281815|FG009|Second Treatment|Withdrawal by Subject|0|||
126270290|NCT00750308|454281816|FG010|Second Treatment|Withdrawal by Subject|0|||
126270291|NCT00750308|454281817|FG011|Second Treatment|Withdrawal by Subject|0|||
126270292|NCT00750308|454281806|FG000|Third Treatment|Withdrawal by Subject|0|||
126270293|NCT00750308|454281807|FG001|Third Treatment|Withdrawal by Subject|1|||
126270294|NCT00750308|454281808|FG002|Third Treatment|Withdrawal by Subject|0|||
126270295|NCT00750308|454281809|FG003|Third Treatment|Withdrawal by Subject|0|||
126270296|NCT00750308|454281810|FG004|Third Treatment|Withdrawal by Subject|0|||
126270297|NCT00750308|454281811|FG005|Third Treatment|Withdrawal by Subject|0|||
126270298|NCT00750308|454281812|FG006|Third Treatment|Withdrawal by Subject|0|||
126270299|NCT00750308|454281813|FG007|Third Treatment|Withdrawal by Subject|0|||
126270300|NCT00750308|454281814|FG008|Third Treatment|Withdrawal by Subject|0|||
126270301|NCT00750308|454281815|FG009|Third Treatment|Withdrawal by Subject|0|||
126270302|NCT00750308|454281816|FG010|Third Treatment|Withdrawal by Subject|0|||
126270303|NCT00750308|454281817|FG011|Third Treatment|Withdrawal by Subject|0|||
126270304|NCT00513682|454281818|FG000|Washout Phase|Adverse Event|2|||
126270305|NCT03212521|454281823|FG000|Overall Study|Adverse Event|1|||
126270306|NCT03212521|454281823|FG000|Overall Study|Lost to Follow-up|4|||
126270307|NCT03212521|454281823|FG000|Overall Study|Withdrawal by Subject|1|||
126270308|NCT03212521|454281823|FG000|Overall Study|Other|1|||
126270309|NCT01121666|454281826|FG000|Overall Study|Protocol Violation|29|||
126270310|NCT01121666|454281827|FG001|Overall Study|Protocol Violation|10|||
126270311|NCT03176459|454281828|FG000|Overall Study|Lost to Follow-up|5|||
126270312|NCT03176459|454281829|FG001|Overall Study|Lost to Follow-up|7|||
126270313|NCT00541970|454284452|FG000|Month 7|Protocol Violation|9|||
126270314|NCT00541970|454284453|FG001|Month 7|Protocol Violation|13|||
126270315|NCT00541970|454284454|FG002|Month 7|Protocol Violation|11|||
126270316|NCT00541970|454284455|FG003|Month 7|Protocol Violation|5|||
126270317|NCT00541970|454284452|FG000|Month 12|Adverse Event|0|||
126270318|NCT00541970|454284453|FG001|Month 12|Adverse Event|1|||
126270319|NCT00541970|454284454|FG002|Month 12|Adverse Event|1|||
126270320|NCT00541970|454284455|FG003|Month 12|Adverse Event|1|||
126270321|NCT00541970|454284452|FG000|Month 12|Protocol Violation|12|||
126270322|NCT00541970|454284453|FG001|Month 12|Protocol Violation|21|||
126270323|NCT00541970|454284454|FG002|Month 12|Protocol Violation|20|||
126270324|NCT00541970|454284455|FG003|Month 12|Protocol Violation|15|||
126270325|NCT00541970|454284452|FG000|Month 18|Adverse Event|0|||
126270326|NCT00541970|454284453|FG001|Month 18|Adverse Event|1|||
126270327|NCT00541970|454284454|FG002|Month 18|Adverse Event|1|||
126270328|NCT00541970|454284455|FG003|Month 18|Adverse Event|1|||
126270329|NCT00541970|454284452|FG000|Month 18|Protocol Violation|14|||
126270330|NCT00541970|454284453|FG001|Month 18|Protocol Violation|23|||
126270331|NCT00541970|454284454|FG002|Month 18|Protocol Violation|24|||
126270332|NCT00541970|454284455|FG003|Month 18|Protocol Violation|16|||
126270333|NCT00541970|454284452|FG000|Month 24|Adverse Event|0|||
126270334|NCT00541970|454284453|FG001|Month 24|Adverse Event|1|||
126270335|NCT00541970|454284454|FG002|Month 24|Adverse Event|1|||
126270336|NCT00541970|454284455|FG003|Month 24|Adverse Event|1|||
126270337|NCT00541970|454284452|FG000|Month 24|Protocol Violation|29|||
126270338|NCT00541970|454284453|FG001|Month 24|Protocol Violation|31|||
126270339|NCT00541970|454284454|FG002|Month 24|Protocol Violation|31|||
126270340|NCT00541970|454284455|FG003|Month 24|Protocol Violation|21|||
126270341|NCT00541970|454284452|FG000|Month 36|Protocol Violation|61|||
126270342|NCT00541970|454284453|FG001|Month 36|Protocol Violation|66|||
126270343|NCT00541970|454284454|FG002|Month 36|Protocol Violation|66|||
126270344|NCT00541970|454284455|FG003|Month 36|Protocol Violation|60|||
126270345|NCT00541970|454284452|FG000|Month 48|Withdrawal by Subject|2|||
126270346|NCT00541970|454284453|FG001|Month 48|Withdrawal by Subject|4|||
126270347|NCT00541970|454284454|FG002|Month 48|Withdrawal by Subject|4|||
126270348|NCT00541970|454284455|FG003|Month 48|Withdrawal by Subject|2|||
126270349|NCT00541970|454284452|FG000|Month 48|Other|3|||
126270350|NCT00541970|454284453|FG001|Month 48|Other|1|||
126270351|NCT00541970|454284454|FG002|Month 48|Other|1|||
126270352|NCT00541970|454284455|FG003|Month 48|Other|0|||
126270353|NCT00541970|454284452|FG000|Month 48|Lost to Follow-up|66|||
126270354|NCT00541970|454284453|FG001|Month 48|Lost to Follow-up|68|||
126270355|NCT00541970|454284454|FG002|Month 48|Lost to Follow-up|68|||
126765590|NCT00965562|456094562|FG002|Overall Study|Withdrawal by Subject|0|||
126270356|NCT00541970|454284455|FG003|Month 48|Lost to Follow-up|73|||
126270357|NCT00541970|454284452|FG000|Month 60|Protocol Violation|78|||
126270358|NCT00541970|454284453|FG001|Month 60|Protocol Violation|77|||
126270359|NCT00541970|454284454|FG002|Month 60|Protocol Violation|82|||
126270360|NCT00541970|454284455|FG003|Month 60|Protocol Violation|72|||
126270361|NCT00321828|454284456|FG000|Overall Study|Ineligible|3|||
126270362|NCT00321828|454284456|FG000|Overall Study|No follow up data|1|||
126270363|NCT00858143|454284461|FG000|Overall Study|Adverse Event|16|||
126270364|NCT00858143|454284461|FG000|Overall Study|Lack of Efficacy|4|||
126361409|NCT02134028|454615286|FG002|Overall Study|Other unspecified|33|||
126361410|NCT02134028|454615287|FG003|Overall Study|Other unspecified|64|||
126361411|NCT02134028|454615288|FG004|Overall Study|Other unspecified|8|||
126361412|NCT02134028|454615289|FG005|Overall Study|Other unspecified|6|||
126361413|NCT02134028|454615290|FG006|Overall Study|Other unspecified|2|||
126361414|NCT02134028|454615291|FG007|Overall Study|Other unspecified|1|||
126361415|NCT02134028|454615284|FG000|Overall Study|Adverse Event|3|||
126361416|NCT02134028|454615285|FG001|Overall Study|Adverse Event|19|||
126361417|NCT02134028|454615286|FG002|Overall Study|Adverse Event|13|||
126361418|NCT02134028|454615287|FG003|Overall Study|Adverse Event|32|||
126361419|NCT02134028|454615288|FG004|Overall Study|Adverse Event|4|||
126361420|NCT02134028|454615289|FG005|Overall Study|Adverse Event|5|||
126361421|NCT02134028|454615290|FG006|Overall Study|Adverse Event|1|||
126361422|NCT02134028|454615291|FG007|Overall Study|Adverse Event|2|||
126361423|NCT00819832|454615292|FG000|Overall Study|Sponsor Termination of Study|3|||
126361424|NCT00819832|454615293|FG001|Overall Study|Sponsor Termination of Study|0|||
126453484|NCT03135119|454961425|FG000|Overall Study|COVID-19 Shutdown|2|||
126453485|NCT03135119|454961426|FG001|Overall Study|COVID-19 Shutdown|2|||
126453486|NCT01478048|454961427|FG000|Overall Study|Disease Progression|52|||
126453487|NCT01478048|454961428|FG001|Overall Study|Disease Progression|35|||
126270365|NCT00858143|454284461|FG000|Overall Study|Death|7|||
126270366|NCT00858143|454284461|FG000|Overall Study|Other|23|||
126270367|NCT03853148|454284462|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
126270368|NCT03853148|454284463|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
126270369|NCT03853148|454284464|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
126270370|NCT03853148|454284465|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
126270371|NCT00852969|454284466|FG000|Overall Study|Adverse Event|0|||
126270372|NCT00852969|454284467|FG001|Overall Study|Adverse Event|1|||
126270373|NCT00852969|454284466|FG000|Overall Study|Lost to Follow-up|0|||
126270374|NCT00852969|454284467|FG001|Overall Study|Lost to Follow-up|1|||
126270375|NCT00658658|454284468|FG000|Overall Study|Withdrawal by Subject|0|||
126270376|NCT00658658|454284469|FG001|Overall Study|Withdrawal by Subject|1|||
126270377|NCT00658658|454284470|FG002|Overall Study|Withdrawal by Subject|0|||
126270378|NCT00658658|454284471|FG003|Overall Study|Withdrawal by Subject|0|||
126270379|NCT00658658|454284472|FG004|Overall Study|Withdrawal by Subject|0|||
126270380|NCT00658658|454284468|FG000|Overall Study|Death|4|||
126270381|NCT00658658|454284469|FG001|Overall Study|Death|0|||
126270382|NCT00658658|454284470|FG002|Overall Study|Death|0|||
126270383|NCT00658658|454284471|FG003|Overall Study|Death|1|||
126270384|NCT00658658|454284472|FG004|Overall Study|Death|1|||
126270385|NCT00658658|454284468|FG000|Overall Study|Disease Progression|0|||
126270386|NCT00658658|454284469|FG001|Overall Study|Disease Progression|1|||
126270387|NCT00658658|454284470|FG002|Overall Study|Disease Progression|0|||
126270388|NCT00658658|454284471|FG003|Overall Study|Disease Progression|1|||
126270389|NCT00658658|454284472|FG004|Overall Study|Disease Progression|3|||
126270390|NCT00658658|454284468|FG000|Overall Study|Protocol-specified Criteria|1|||
126270391|NCT00658658|454284469|FG001|Overall Study|Protocol-specified Criteria|0|||
126270392|NCT00658658|454284470|FG002|Overall Study|Protocol-specified Criteria|0|||
126270393|NCT00658658|454284471|FG003|Overall Study|Protocol-specified Criteria|0|||
126270394|NCT00658658|454284472|FG004|Overall Study|Protocol-specified Criteria|0|||
126270395|NCT00658658|454284468|FG000|Overall Study|Other|0|||
126270396|NCT00658658|454284469|FG001|Overall Study|Other|0|||
126270397|NCT00658658|454284470|FG002|Overall Study|Other|0|||
126270398|NCT00658658|454284471|FG003|Overall Study|Other|0|||
126270399|NCT00658658|454284472|FG004|Overall Study|Other|1|||
126270400|NCT00678041|454284475|FG000|Overall Study|Physician Decision|5|||
126270401|NCT00678041|454284476|FG001|Overall Study|Physician Decision|5|||
126270402|NCT02358343|454284477|FG000|Screening Intervention|Death|0|||
126270403|NCT02358343|454284478|FG001|Screening Intervention|Death|2|||
126270404|NCT02358343|454284479|FG002|Screening Intervention|Death|0|||
126270405|NCT02358343|454284480|FG003|Screening Intervention|Death|0|||
126453488|NCT01478048|454961427|FG000|Overall Study|study drug toxicity|11|||
126453489|NCT01478048|454961428|FG001|Overall Study|study drug toxicity|14|||
126361425|NCT00819832|454615294|FG002|Overall Study|Sponsor Termination of Study|0|||
126453490|NCT01478048|454961427|FG000|Overall Study|Adverse Event|2|||
126270406|NCT02358343|454284481|FG004|Screening Intervention|Death|0|||
126361426|NCT00819832|454615295|FG003|Overall Study|Sponsor Termination of Study|0|||
126361427|NCT00819832|454615296|FG004|Overall Study|Sponsor Termination of Study|0|||
126270407|NCT02358343|454284477|FG000|Screening Intervention|Withdrawal by Subject|1|||
126270408|NCT02358343|454284478|FG001|Screening Intervention|Withdrawal by Subject|0|||
126270409|NCT02358343|454284479|FG002|Screening Intervention|Withdrawal by Subject|0|||
126270410|NCT02358343|454284480|FG003|Screening Intervention|Withdrawal by Subject|0|||
126270411|NCT02358343|454284481|FG004|Screening Intervention|Withdrawal by Subject|0|||
126270412|NCT02358343|454284477|FG000|Screening Intervention|Determined Ineligible|5|||
126361428|NCT00819832|454615297|FG005|Overall Study|Sponsor Termination of Study|0|||
126361429|NCT01340170|454615303|FG000|Overall Study|Lost to Follow-up|2|||
126453491|NCT01478048|454961428|FG001|Overall Study|Adverse Event|11|||
126270413|NCT02358343|454284478|FG001|Screening Intervention|Determined Ineligible|6|||
126270414|NCT02358343|454284479|FG002|Screening Intervention|Determined Ineligible|0|||
126270415|NCT02358343|454284480|FG003|Screening Intervention|Determined Ineligible|0|||
126270416|NCT02358343|454284481|FG004|Screening Intervention|Determined Ineligible|0|||
126270417|NCT02358343|454284477|FG000|Comparative Efficacy Trial / Observation|Death|0|||
126270418|NCT02358343|454284478|FG001|Comparative Efficacy Trial / Observation|Death|0|||
126270419|NCT02358343|454284479|FG002|Comparative Efficacy Trial / Observation|Death|2|||
126270420|NCT02358343|454284480|FG003|Comparative Efficacy Trial / Observation|Death|0|||
126270421|NCT02358343|454284481|FG004|Comparative Efficacy Trial / Observation|Death|0|||
126270422|NCT02358343|454284477|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
126270423|NCT02358343|454284478|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
126270424|NCT02358343|454284479|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
126270425|NCT02358343|454284480|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
126270426|NCT02358343|454284481|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
126270427|NCT02358343|454284477|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
126270428|NCT02358343|454284478|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
126270429|NCT02358343|454284479|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
126270430|NCT02358343|454284480|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
126270431|NCT02358343|454284481|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
126270432|NCT00090610|454284484|FG000|Overall Study|Withdrawal by Subject|1|||
126270433|NCT00090610|454284485|FG001|Overall Study|Withdrawal by Subject|1|||
126270434|NCT04498403|454284489|FG000|Overall Study|Adverse Event|1|||
126270435|NCT04498403|454284490|FG001|Overall Study|Adverse Event|0|||
126270436|NCT04498403|454284489|FG000|Overall Study|Study Terminated By Sponsor|29|||
126270437|NCT04498403|454284490|FG001|Overall Study|Study Terminated By Sponsor|10|||
126270438|NCT01951885|454284491|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
126270439|NCT01951885|454284492|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
126270440|NCT01951885|454284491|FG000|Overall Study|Adverse Event|1|||
126270441|NCT01951885|454284492|FG001|Overall Study|Adverse Event|0|||
126270442|NCT01951885|454284491|FG000|Overall Study|Withdrawal by Subject|0|||
126270443|NCT01951885|454284492|FG001|Overall Study|Withdrawal by Subject|1|||
126270444|NCT01951885|454284491|FG000|Overall Study|ineligible due to a change in donor|0|||
126270445|NCT01951885|454284492|FG001|Overall Study|ineligible due to a change in donor|1|||
126270446|NCT01951885|454284491|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
126270447|NCT01951885|454284492|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
126270448|NCT01293539|454284493|FG000|Overall Study|Physician Decision|1|||
126270449|NCT00866658|454284494|FG000|Overall Study|Adverse Event|5|||
126270450|NCT00866658|454284495|FG001|Overall Study|Adverse Event|14|||
126270451|NCT00866658|454284494|FG000|Overall Study|Lack of Efficacy|2|||
126270452|NCT00866658|454284495|FG001|Overall Study|Lack of Efficacy|1|||
126270453|NCT00866658|454284494|FG000|Overall Study|Withdrawal by Subject|1|||
126270454|NCT00866658|454284495|FG001|Overall Study|Withdrawal by Subject|0|||
126270455|NCT00866658|454284494|FG000|Overall Study|Protocol Violation|1|||
126270456|NCT00866658|454284495|FG001|Overall Study|Protocol Violation|1|||
126270457|NCT00866658|454284494|FG000|Overall Study|Familial and Personal Reasons|4|||
126270458|NCT00866658|454284495|FG001|Overall Study|Familial and Personal Reasons|5|||
126270459|NCT01687478|454284498|FG000|Overall Study|Adverse Event|3|||
126270460|NCT01687478|454284499|FG001|Overall Study|Adverse Event|10|||
126270461|NCT01687478|454284498|FG000|Overall Study|Lost to Follow-up|1|||
126270462|NCT01687478|454284499|FG001|Overall Study|Lost to Follow-up|3|||
126270463|NCT01687478|454284498|FG000|Overall Study|Protocol Violation|0|||
126270464|NCT01687478|454284499|FG001|Overall Study|Protocol Violation|2|||
126270465|NCT01687478|454284498|FG000|Overall Study|Withdrawal by Subject|21|||
126270466|NCT01687478|454284499|FG001|Overall Study|Withdrawal by Subject|19|||
126270467|NCT01687478|454284498|FG000|Overall Study|Physician Decision|1|||
126270468|NCT01687478|454284499|FG001|Overall Study|Physician Decision|3|||
126270469|NCT01687478|454284498|FG000|Overall Study|Entry Criteria Not Met|6|||
126270470|NCT01687478|454284499|FG001|Overall Study|Entry Criteria Not Met|2|||
126270471|NCT01700049|454284502|FG000|Overall Study|Withdrawal by Subject|1|||
126361430|NCT01340170|454615304|FG001|Overall Study|Lost to Follow-up|4|||
126270472|NCT01206101|454284503|FG000|Overall Study|Adverse Event|1|||
126270473|NCT01206101|454284504|FG001|Overall Study|Adverse Event|0|||
126270474|NCT01206101|454284503|FG000|Overall Study|Physician Decision|0|||
126270475|NCT01206101|454284504|FG001|Overall Study|Physician Decision|1|||
126270476|NCT01206101|454284503|FG000|Overall Study|Unclassified|1|||
126270477|NCT01206101|454284504|FG001|Overall Study|Unclassified|0|||
126270478|NCT01248013|454284505|FG000|Overall Study|Withdrawal by Subject|14|||
126270479|NCT01859130|454284506|FG000|Overall Study|Death|4|||
126270480|NCT01859130|454284506|FG000|Overall Study|Lost to Follow-up|16|||
126270481|NCT01859130|454284506|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
126270482|NCT01859130|454284506|FG000|Overall Study|Physician Decision|6|||
126270483|NCT01859130|454284506|FG000|Overall Study|Withdrawal by Subject|17|||
126361431|NCT01340170|454615305|FG002|Overall Study|Lost to Follow-up|0|||
126270484|NCT01859130|454284506|FG000|Overall Study|Adverse Event|11|||
126270485|NCT01462318|454284509|FG000|Main Study / TP-DI Study|Other|2|||
126270486|NCT01462318|454284510|FG001|Main Study / TP-DI Study|Other|0|||
126270487|NCT01462318|454284511|FG002|Main Study / TP-DI Study|Other|0|||
126270488|NCT01462318|454284509|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
126270489|NCT01462318|454284510|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
126270490|NCT01462318|454284511|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
126270491|NCT01462318|454284509|FG000|Main Study / TP-DI Study|Adverse Event|4|||
126270492|NCT01462318|454284510|FG001|Main Study / TP-DI Study|Adverse Event|0|||
126270493|NCT01462318|454284511|FG002|Main Study / TP-DI Study|Adverse Event|0|||
126270494|NCT01462318|454284509|FG000|Extension Phase|Lost to Follow-up|0|||
126270495|NCT01462318|454284510|FG001|Extension Phase|Lost to Follow-up|0|||
126270496|NCT01462318|454284511|FG002|Extension Phase|Lost to Follow-up|1|||
126270497|NCT01462318|454284509|FG000|Extension Phase|Other|0|||
126270498|NCT01462318|454284510|FG001|Extension Phase|Other|0|||
126270499|NCT01462318|454284511|FG002|Extension Phase|Other|1|||
126270500|NCT01462318|454284509|FG000|Extension Phase|Disease Progression|0|||
126270501|NCT01462318|454284510|FG001|Extension Phase|Disease Progression|0|||
126270502|NCT01462318|454284511|FG002|Extension Phase|Disease Progression|1|||
126270503|NCT01462318|454284509|FG000|Extension Phase|Withdrawal by Subject|0|||
126270504|NCT01462318|454284510|FG001|Extension Phase|Withdrawal by Subject|0|||
126270505|NCT01462318|454284511|FG002|Extension Phase|Withdrawal by Subject|15|||
126270506|NCT01462318|454284509|FG000|Extension Phase|Investigator Decision|0|||
126270507|NCT01462318|454284510|FG001|Extension Phase|Investigator Decision|0|||
126270508|NCT01462318|454284511|FG002|Extension Phase|Investigator Decision|5|||
126270509|NCT01462318|454284509|FG000|Extension Phase|Adverse Event|0|||
126270510|NCT01462318|454284510|FG001|Extension Phase|Adverse Event|0|||
126270511|NCT01462318|454284511|FG002|Extension Phase|Adverse Event|22|||
126270512|NCT00891371|454284512|FG000|Pre-assignment|Inclusion/exclusion|5|||
126270513|NCT00891371|454284512|FG000|Pre-assignment|Consent withdrawal|1|||
126270514|NCT00891371|454284512|FG000|Treatment|Lack of Efficacy|5|||
126270515|NCT00891371|454284512|FG000|Treatment|Adverse Event|2|||
126270516|NCT00891371|454284512|FG000|Treatment|Death|1|||
126270517|NCT00891371|454284512|FG000|Treatment|Lost to Follow-up|1|||
126270518|NCT02238626|454284513|FG000|Overall Study|Adverse Event|3|||
126270519|NCT02238626|454284514|FG001|Overall Study|Adverse Event|5|||
126270520|NCT02238626|454284515|FG002|Overall Study|Adverse Event|0|||
126270521|NCT02238626|454284516|FG003|Overall Study|Adverse Event|3|||
126270522|NCT02238626|454284513|FG000|Overall Study|Lost to Follow-up|2|||
126270523|NCT02238626|454284514|FG001|Overall Study|Lost to Follow-up|4|||
126270524|NCT02238626|454284515|FG002|Overall Study|Lost to Follow-up|2|||
126270525|NCT02238626|454284516|FG003|Overall Study|Lost to Follow-up|2|||
126270526|NCT02238626|454284513|FG000|Overall Study|Withdrawal by Subject|0|||
126270527|NCT02238626|454284514|FG001|Overall Study|Withdrawal by Subject|3|||
126270528|NCT02238626|454284515|FG002|Overall Study|Withdrawal by Subject|0|||
126270529|NCT02238626|454284516|FG003|Overall Study|Withdrawal by Subject|1|||
126270530|NCT02238626|454284513|FG000|Overall Study|Death|0|||
126270531|NCT02238626|454284514|FG001|Overall Study|Death|0|||
126270532|NCT02238626|454284515|FG002|Overall Study|Death|1|||
126270533|NCT02238626|454284516|FG003|Overall Study|Death|1|||
126270534|NCT02238626|454284513|FG000|Overall Study|Other|0|||
126270535|NCT02238626|454284514|FG001|Overall Study|Other|2|||
126270536|NCT02238626|454284515|FG002|Overall Study|Other|0|||
126270537|NCT02238626|454284516|FG003|Overall Study|Other|0|||
126270538|NCT02622113|454284519|FG000|Overall Study|Adverse Event|4|||
126270539|NCT02622113|454284520|FG001|Overall Study|Adverse Event|4|||
126270540|NCT02622113|454284519|FG000|Overall Study|Physician Decision|0|||
126270541|NCT02622113|454284520|FG001|Overall Study|Physician Decision|1|||
126270542|NCT02622113|454284519|FG000|Overall Study|Withdrawal by Subject|0|||
126270543|NCT02622113|454284520|FG001|Overall Study|Withdrawal by Subject|2|||
126270544|NCT02622113|454284519|FG000|Overall Study|Stopping Criteria|1|||
126270545|NCT02622113|454284520|FG001|Overall Study|Stopping Criteria|3|||
126270546|NCT02746471|454284521|FG000|Overall Study|Death|43|||
126270547|NCT02746471|454284521|FG000|Overall Study|Exited before 36 months|1119|||
126270548|NCT01593696|454284522|FG000|Dose Escalation|Progressive Disease|2|||
126270549|NCT01593696|454284523|FG001|Dose Escalation|Progressive Disease|0|||
126270550|NCT01593696|454284524|FG002|Dose Escalation|Progressive Disease|0|||
126270551|NCT01593696|454284525|FG003|Dose Escalation|Progressive Disease|0|||
126270552|NCT01593696|454284522|FG000|Dose Expansion|Fungal infection|0|||
126270553|NCT01593696|454284523|FG001|Dose Expansion|Fungal infection|0|||
126270554|NCT01593696|454284524|FG002|Dose Expansion|Fungal infection|1|||
126270555|NCT01593696|454284525|FG003|Dose Expansion|Fungal infection|0|||
126270556|NCT01936623|454284526|FG000|Overall Study|Lost to Follow-up|0|||
126270557|NCT01936623|454284527|FG001|Overall Study|Lost to Follow-up|5|||
126270558|NCT03167723|454284528|FG000|Overall Study|Protocol Violation|4|||
126270559|NCT03167723|454284529|FG001|Overall Study|Protocol Violation|6|||
126270560|NCT02992418|454284532|FG000|Overall Study|Withdrawal by Subject|11|||
126270561|NCT02992418|454284533|FG001|Overall Study|Withdrawal by Subject|12|||
126270562|NCT02992418|454284532|FG000|Overall Study|Non-compliance with the protocol|308|||
126270563|NCT02992418|454284533|FG001|Overall Study|Non-compliance with the protocol|308|||
126270564|NCT02992418|454284532|FG000|Overall Study|Lost to Follow-up|27|||
126270565|NCT02992418|454284533|FG001|Overall Study|Lost to Follow-up|22|||
126270566|NCT03246126|454284538|FG000|Overall Study|Withdrawal by Subject|0|||
126270567|NCT03246126|454284539|FG001|Overall Study|Withdrawal by Subject|1|||
126270568|NCT01006135|454284542|FG000|Overall Study|Adverse Event|22|||
126270569|NCT01006135|454284542|FG000|Overall Study|Protocol Violation|14|||
126270570|NCT01006135|454284542|FG000|Overall Study|Lost to Follow-up|32|||
126270571|NCT01006135|454284542|FG000|Overall Study|Other|72|||
126270572|NCT01732484|454284548|FG000|Overall Study|Death|7|||
126270573|NCT01732484|454284548|FG000|Overall Study|Lost to Follow-up|14|||
126270574|NCT01732484|454284548|FG000|Overall Study|chronical illness|5|||
126270575|NCT00928707|454284549|FG000|Overall Study|Protocol Violation|1|||
126270576|NCT00928707|454284550|FG001|Overall Study|Protocol Violation|0|||
126270577|NCT00132028|454284551|FG000|Overall Study|Adverse Event|7|||
126270578|NCT00132028|454284551|FG000|Overall Study|Death|2|||
126270579|NCT00132028|454284551|FG000|Overall Study|Lack of Efficacy|11|||
126270580|NCT00132028|454284551|FG000|Overall Study|Withdrawal by Subject|2|||
126270581|NCT00132028|454284551|FG000|Overall Study|not eligible|2|||
126270582|NCT00132028|454284551|FG000|Overall Study|Physician Decision|3|||
126270583|NCT02731326|454284557|FG000|Overall Study|Withdrawal by Subject|4|||
126270584|NCT02731326|454284558|FG001|Overall Study|Withdrawal by Subject|1|||
126270585|NCT02731326|454284557|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
126270586|NCT02731326|454284558|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
126270587|NCT02731326|454284557|FG000|Overall Study|Discharged without AliveCor|10|||
126270588|NCT02731326|454284558|FG001|Overall Study|Discharged without AliveCor|0|||
126270589|NCT02731326|454284557|FG000|Overall Study|Duplicate Participant|1|||
126270590|NCT02731326|454284558|FG001|Overall Study|Duplicate Participant|1|||
126270591|NCT02272634|454284560|FG000|Overall Study|Adverse Event|1|||
126270592|NCT02272634|454284561|FG001|Overall Study|Adverse Event|0|||
126270593|NCT02272634|454284562|FG002|Overall Study|Adverse Event|0|||
126270594|NCT02272634|454284560|FG000|Overall Study|Protocol Violation|0|||
126270595|NCT02272634|454284561|FG001|Overall Study|Protocol Violation|0|||
126270596|NCT02272634|454284562|FG002|Overall Study|Protocol Violation|1|||
126270597|NCT02272634|454284560|FG000|Overall Study|Withdrawal by Subject|0|||
126270598|NCT02272634|454284561|FG001|Overall Study|Withdrawal by Subject|1|||
126270599|NCT02272634|454284562|FG002|Overall Study|Withdrawal by Subject|0|||
126270600|NCT04647721|454284563|FG000|Overall Study|Withdrawal by Subject|0|||
126270601|NCT04647721|454284564|FG001|Overall Study|Withdrawal by Subject|2|||
126270602|NCT04647721|454284563|FG000|Overall Study|Lost to Follow-up|2|||
126270603|NCT04647721|454284564|FG001|Overall Study|Lost to Follow-up|0|||
126270604|NCT05070546|454284565|FG000|Overall Study|Death|0|||
126270605|NCT05070546|454284566|FG001|Overall Study|Death|0|||
126270606|NCT05070546|454284567|FG002|Overall Study|Death|0|||
126270607|NCT05070546|454284568|FG003|Overall Study|Death|0|||
126270608|NCT05070546|454284569|FG004|Overall Study|Death|0|||
126270609|NCT05070546|454284570|FG005|Overall Study|Death|1|||
126270610|NCT05070546|454284565|FG000|Overall Study|Lost to Follow-up|8|||
126270611|NCT05070546|454284566|FG001|Overall Study|Lost to Follow-up|2|||
126270612|NCT05070546|454284567|FG002|Overall Study|Lost to Follow-up|7|||
126270613|NCT05070546|454284568|FG003|Overall Study|Lost to Follow-up|1|||
126270614|NCT05070546|454284569|FG004|Overall Study|Lost to Follow-up|2|||
126270615|NCT05070546|454284570|FG005|Overall Study|Lost to Follow-up|0|||
126270616|NCT05070546|454284565|FG000|Overall Study|Withdrawal by Subject|1|||
126270617|NCT05070546|454284566|FG001|Overall Study|Withdrawal by Subject|1|||
126270618|NCT05070546|454284567|FG002|Overall Study|Withdrawal by Subject|3|||
126270619|NCT05070546|454284568|FG003|Overall Study|Withdrawal by Subject|0|||
126270620|NCT05070546|454284569|FG004|Overall Study|Withdrawal by Subject|0|||
126270621|NCT05070546|454284570|FG005|Overall Study|Withdrawal by Subject|0|||
126270622|NCT05070546|454284565|FG000|Overall Study|Other|0|||
126270623|NCT05070546|454284566|FG001|Overall Study|Other|0|||
126705356|NCT02034123|455871755|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126705357|NCT02034123|455871756|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126270624|NCT05070546|454284567|FG002|Overall Study|Other|0|||
126270625|NCT05070546|454284568|FG003|Overall Study|Other|0|||
126270626|NCT05070546|454284569|FG004|Overall Study|Other|3|||
126270627|NCT05070546|454284570|FG005|Overall Study|Other|0|||
126270628|NCT05070546|454284565|FG000|Overall Study|Randomized but not vaccinated|1|||
126270629|NCT05070546|454284566|FG001|Overall Study|Randomized but not vaccinated|0|||
126270630|NCT05070546|454284567|FG002|Overall Study|Randomized but not vaccinated|1|||
126270631|NCT05070546|454284568|FG003|Overall Study|Randomized but not vaccinated|1|||
126270632|NCT05070546|454284569|FG004|Overall Study|Randomized but not vaccinated|3|||
126270633|NCT05070546|454284570|FG005|Overall Study|Randomized but not vaccinated|0|||
126270634|NCT00302081|454284571|FG000|Overall Study|Adverse Event|6|||
126270635|NCT00302081|454284572|FG001|Overall Study|Adverse Event|5|||
126270636|NCT00302081|454284573|FG002|Overall Study|Adverse Event|4|||
126270637|NCT00302081|454284571|FG000|Overall Study|Lost to Follow-up|21|||
126270638|NCT00302081|454284572|FG001|Overall Study|Lost to Follow-up|18|||
126270639|NCT00302081|454284573|FG002|Overall Study|Lost to Follow-up|28|||
126270640|NCT00302081|454284571|FG000|Overall Study|Withdrawal by Subject|8|||
126547398|NCT00244374|455297934|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
126270641|NCT00302081|454284572|FG001|Overall Study|Withdrawal by Subject|12|||
126270642|NCT00302081|454284573|FG002|Overall Study|Withdrawal by Subject|8|||
126270643|NCT00302081|454284571|FG000|Overall Study|Protocol Violation|5|||
126270644|NCT00302081|454284572|FG001|Overall Study|Protocol Violation|1|||
126270645|NCT00302081|454284573|FG002|Overall Study|Protocol Violation|2|||
126270646|NCT00302081|454284571|FG000|Overall Study|Lack of Efficacy|1|||
126270647|NCT00302081|454284572|FG001|Overall Study|Lack of Efficacy|0|||
126270648|NCT00302081|454284573|FG002|Overall Study|Lack of Efficacy|5|||
126270649|NCT00302081|454284571|FG000|Overall Study|Death|2|||
126270650|NCT00302081|454284572|FG001|Overall Study|Death|1|||
126270651|NCT00302081|454284573|FG002|Overall Study|Death|0|||
126270652|NCT00302081|454284571|FG000|Overall Study|Other|13|||
126270653|NCT00302081|454284572|FG001|Overall Study|Other|6|||
126270654|NCT00302081|454284573|FG002|Overall Study|Other|5|||
126270655|NCT04771403|454284574|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
126270656|NCT04771403|454284575|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
126270657|NCT04771403|454284574|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
126270658|NCT04771403|454284575|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
126270659|NCT04771403|454284574|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
126270660|NCT04771403|454284575|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
126270661|NCT04771403|454284574|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
126270662|NCT04771403|454284575|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
126270663|NCT04771403|454284574|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
126270664|NCT04771403|454284575|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
126270665|NCT04771403|454284574|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
126270666|NCT04771403|454284575|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
126270667|NCT04771403|454284574|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
126270668|NCT04771403|454284575|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
126270669|NCT04771403|454284574|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
126270670|NCT04771403|454284575|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
126270671|NCT05084963|454284576|FG000|Overall Study|Withdrawal by Subject|0|||
126270672|NCT05084963|454284577|FG001|Overall Study|Withdrawal by Subject|0|||
126270673|NCT05084963|454284578|FG002|Overall Study|Withdrawal by Subject|1|||
126270674|NCT05442866|454284579|FG000|Overall Study|Death|1|||
126270675|NCT05442866|454284579|FG000|Overall Study|Lost to Follow-up|9|||
126270676|NCT05442866|454284579|FG000|Overall Study|Protocol Violation|1|||
126270677|NCT03819049|454284580|FG000|Overall Study|Lost to Follow-up|1|||
126270678|NCT03819049|454284581|FG001|Overall Study|Lost to Follow-up|2|||
126270679|NCT03819049|454284582|FG002|Overall Study|Lost to Follow-up|9|||
126270680|NCT03819049|454284583|FG003|Overall Study|Lost to Follow-up|0|||
126270681|NCT03819049|454284584|FG004|Overall Study|Lost to Follow-up|3|||
126270682|NCT03819049|454284585|FG005|Overall Study|Lost to Follow-up|1|||
126270683|NCT03819049|454284586|FG006|Overall Study|Lost to Follow-up|0|||
126270684|NCT03819049|454284580|FG000|Overall Study|Withdrawal by Subject|0|||
126270685|NCT03819049|454284581|FG001|Overall Study|Withdrawal by Subject|0|||
126270686|NCT03819049|454284582|FG002|Overall Study|Withdrawal by Subject|18|||
126270687|NCT03819049|454284583|FG003|Overall Study|Withdrawal by Subject|0|||
126270688|NCT03819049|454284584|FG004|Overall Study|Withdrawal by Subject|10|||
126270689|NCT03819049|454284585|FG005|Overall Study|Withdrawal by Subject|9|||
126270690|NCT03819049|454284586|FG006|Overall Study|Withdrawal by Subject|1|||
126270691|NCT03819049|454284580|FG000|Overall Study|Ongoing|0|||
126270692|NCT03819049|454284581|FG001|Overall Study|Ongoing|0|||
126270693|NCT03819049|454284582|FG002|Overall Study|Ongoing|75|||
126270694|NCT03819049|454284583|FG003|Overall Study|Ongoing|0|||
126270695|NCT03819049|454284584|FG004|Overall Study|Ongoing|41|||
126270696|NCT03819049|454284585|FG005|Overall Study|Ongoing|0|||
126270697|NCT03819049|454284586|FG006|Overall Study|Ongoing|0|||
126270698|NCT03819049|454284580|FG000|Overall Study|Other|0|||
126270699|NCT03819049|454284581|FG001|Overall Study|Other|0|||
126547399|NCT00244374|455297935|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
126547400|NCT00244374|455297936|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
126270700|NCT03819049|454284582|FG002|Overall Study|Other|2|||
126270701|NCT03819049|454284583|FG003|Overall Study|Other|0|||
126270702|NCT03819049|454284584|FG004|Overall Study|Other|0|||
126270703|NCT03819049|454284585|FG005|Overall Study|Other|0|||
126361432|NCT01340170|454615303|FG000|Overall Study|Implant failure|1|||
126361433|NCT01340170|454615304|FG001|Overall Study|Implant failure|3|||
126361434|NCT01340170|454615305|FG002|Overall Study|Implant failure|0|||
126361435|NCT00472641|454615307|FG000|Overall Study|Lack of Efficacy|3|||
126361436|NCT00472641|454615307|FG000|Overall Study|Adverse Event|3|||
126361437|NCT00472641|454615307|FG000|Overall Study|Lost to Follow-up|1|||
126361438|NCT03721107|454615308|FG000|Overall Study|Adverse Event|1|||
126361439|NCT03721107|454615309|FG001|Overall Study|Adverse Event|1|||
126361440|NCT03721107|454615310|FG002|Overall Study|Adverse Event|6|||
126361441|NCT03721107|454615311|FG003|Overall Study|Adverse Event|5|||
126361442|NCT03721107|454615308|FG000|Overall Study|Lost to Follow-up|2|||
126361443|NCT03721107|454615309|FG001|Overall Study|Lost to Follow-up|0|||
126361444|NCT03721107|454615310|FG002|Overall Study|Lost to Follow-up|3|||
126361445|NCT03721107|454615311|FG003|Overall Study|Lost to Follow-up|0|||
126361446|NCT03721107|454615308|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
126361447|NCT03721107|454615309|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
126361448|NCT03721107|454615310|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
126361449|NCT03721107|454615311|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
126361450|NCT03721107|454615308|FG000|Overall Study|Physician Decision|0|||
126361451|NCT03721107|454615309|FG001|Overall Study|Physician Decision|1|||
126361452|NCT03721107|454615310|FG002|Overall Study|Physician Decision|0|||
126361453|NCT03721107|454615311|FG003|Overall Study|Physician Decision|0|||
126361454|NCT03721107|454615308|FG000|Overall Study|Pregnancy|0|||
126361455|NCT03721107|454615309|FG001|Overall Study|Pregnancy|0|||
126361456|NCT03721107|454615310|FG002|Overall Study|Pregnancy|1|||
126361457|NCT03721107|454615311|FG003|Overall Study|Pregnancy|0|||
126361458|NCT03721107|454615308|FG000|Overall Study|Withdrawal by Subject|1|||
126361459|NCT03721107|454615309|FG001|Overall Study|Withdrawal by Subject|1|||
126361460|NCT03721107|454615310|FG002|Overall Study|Withdrawal by Subject|5|||
126361461|NCT03721107|454615311|FG003|Overall Study|Withdrawal by Subject|5|||
126361462|NCT03721107|454615308|FG000|Overall Study|Other|1|||
126361463|NCT03721107|454615309|FG001|Overall Study|Other|0|||
126361464|NCT03721107|454615310|FG002|Overall Study|Other|0|||
126361465|NCT03721107|454615311|FG003|Overall Study|Other|1|||
126361466|NCT01189227|454615312|FG000|Overall Study|Study terminated due to low accrual|6|||
126361467|NCT01189227|454615313|FG001|Overall Study|Study terminated due to low accrual|3|||
126361468|NCT01608308|454615319|FG000|Overall Study|pretreatment medical and billing reasons|0|||
126361469|NCT01608308|454615320|FG001|Overall Study|pretreatment medical and billing reasons|2|||
126361470|NCT04648241|454615323|FG000|Overall Study|Lost to Follow-up|1|||
126361471|NCT04648241|454615324|FG001|Overall Study|Lost to Follow-up|0|||
126361472|NCT05259722|454615325|FG000|Overall Study|Adverse Event|2|||
126361473|NCT05259722|454615326|FG001|Overall Study|Adverse Event|24|||
126361474|NCT05259722|454615325|FG000|Overall Study|Lost to Follow-up|5|||
126361475|NCT05259722|454615326|FG001|Overall Study|Lost to Follow-up|1|||
126361476|NCT05259722|454615325|FG000|Overall Study|Lack of Efficacy|8|||
126361477|NCT05259722|454615326|FG001|Overall Study|Lack of Efficacy|26|||
126361478|NCT05259722|454615325|FG000|Overall Study|Withdrawal by Subject|15|||
126361479|NCT05259722|454615326|FG001|Overall Study|Withdrawal by Subject|33|||
126361480|NCT05259722|454615325|FG000|Overall Study|Various reasons|3|||
126361481|NCT05259722|454615326|FG001|Overall Study|Various reasons|9|||
126361482|NCT05259722|454615325|FG000|Overall Study|Not exposed to IMP|1|||
126705358|NCT02034123|455871757|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126705359|NCT02034123|455871758|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
126705360|NCT02034123|455871741|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126270704|NCT03819049|454284586|FG006|Overall Study|Other|0|||
126270705|NCT03819049|454284580|FG000|Overall Study|Randomized but not vaccinated|0|||
126270706|NCT03819049|454284581|FG001|Overall Study|Randomized but not vaccinated|0|||
126270707|NCT03819049|454284582|FG002|Overall Study|Randomized but not vaccinated|0|||
126270708|NCT03819049|454284583|FG003|Overall Study|Randomized but not vaccinated|1|||
126270709|NCT03819049|454284584|FG004|Overall Study|Randomized but not vaccinated|0|||
126270710|NCT03819049|454284585|FG005|Overall Study|Randomized but not vaccinated|2|||
126270711|NCT03819049|454284586|FG006|Overall Study|Randomized but not vaccinated|1|||
126361483|NCT05259722|454615326|FG001|Overall Study|Not exposed to IMP|12|||
126361484|NCT05259722|454615325|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
126361485|NCT05259722|454615326|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
126361486|NCT00962650|454615327|FG000|Overall Study|Transgastric DP was not completed|2|||
126361487|NCT02268851|454615329|FG000|Overall Study|Death|0|||
126361488|NCT02268851|454615330|FG001|Overall Study|Death|0|||
126361489|NCT02268851|454615331|FG002|Overall Study|Death|0|||
126361490|NCT02268851|454615332|FG003|Overall Study|Death|1|||
126361491|NCT02268851|454615333|FG004|Overall Study|Death|2|||
126361492|NCT02268851|454615334|FG005|Overall Study|Death|1|||
126361493|NCT02268851|454615329|FG000|Overall Study|Adverse Event|0|||
126361494|NCT02268851|454615330|FG001|Overall Study|Adverse Event|0|||
126361495|NCT02268851|454615331|FG002|Overall Study|Adverse Event|0|||
126361496|NCT02268851|454615332|FG003|Overall Study|Adverse Event|0|||
126361497|NCT02268851|454615333|FG004|Overall Study|Adverse Event|2|||
126270712|NCT03819049|454284580|FG000|Overall Study|Physician Decision|0|||
126270713|NCT03819049|454284581|FG001|Overall Study|Physician Decision|0|||
126270714|NCT03819049|454284582|FG002|Overall Study|Physician Decision|0|||
126270715|NCT03819049|454284583|FG003|Overall Study|Physician Decision|0|||
126270716|NCT03819049|454284584|FG004|Overall Study|Physician Decision|0|||
126270717|NCT03819049|454284585|FG005|Overall Study|Physician Decision|0|||
126270718|NCT03819049|454284586|FG006|Overall Study|Physician Decision|1|||
126270719|NCT01616953|454284591|FG000|Overall Study|Lost to Follow-up|1|||
126270720|NCT01616953|454284592|FG001|Overall Study|Lost to Follow-up|0|||
126270721|NCT01616953|454284591|FG000|Overall Study|lack of bone and soft tissue|1|||
126270722|NCT01616953|454284592|FG001|Overall Study|lack of bone and soft tissue|0|||
126270723|NCT01568320|454284593|FG000|Overall Study|Death|20|||
126270724|NCT01568320|454284593|FG000|Overall Study|Lost to Follow-up|9|||
126270725|NCT01568320|454284593|FG000|Overall Study|Withdrawal by Subject|10|||
126270726|NCT01568320|454284593|FG000|Overall Study|Conversion to open repair|1|||
126270727|NCT01568320|454284593|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
126270728|NCT00816361|454284594|FG000|Overall Study|Withdrawal by Subject|0|||
126270729|NCT00816361|454284595|FG001|Overall Study|Withdrawal by Subject|0|||
126270730|NCT00816361|454284596|FG002|Overall Study|Withdrawal by Subject|0|||
126270731|NCT00816361|454284597|FG003|Overall Study|Withdrawal by Subject|0|||
126270732|NCT00816361|454284598|FG004|Overall Study|Withdrawal by Subject|1|||
126270733|NCT00816361|454284599|FG005|Overall Study|Withdrawal by Subject|2|||
126270734|NCT00816361|454284600|FG006|Overall Study|Withdrawal by Subject|0|||
126270735|NCT00816361|454284601|FG007|Overall Study|Withdrawal by Subject|2|||
126270736|NCT00816361|454284602|FG008|Overall Study|Withdrawal by Subject|1|||
126270737|NCT00816361|454284594|FG000|Overall Study|Death|4|||
126270738|NCT00816361|454284595|FG001|Overall Study|Death|3|||
126270739|NCT00816361|454284596|FG002|Overall Study|Death|3|||
126270740|NCT00816361|454284597|FG003|Overall Study|Death|3|||
126270741|NCT00816361|454284598|FG004|Overall Study|Death|1|||
126270742|NCT00816361|454284599|FG005|Overall Study|Death|1|||
126270743|NCT00816361|454284600|FG006|Overall Study|Death|3|||
126270744|NCT00816361|454284601|FG007|Overall Study|Death|7|||
126270745|NCT00816361|454284602|FG008|Overall Study|Death|8|||
126270746|NCT00816361|454284594|FG000|Overall Study|Other|0|||
126270747|NCT00816361|454284595|FG001|Overall Study|Other|0|||
126270748|NCT00816361|454284596|FG002|Overall Study|Other|0|||
126270749|NCT00816361|454284597|FG003|Overall Study|Other|0|||
126270750|NCT00816361|454284598|FG004|Overall Study|Other|0|||
126270751|NCT00816361|454284599|FG005|Overall Study|Other|0|||
126270752|NCT00816361|454284600|FG006|Overall Study|Other|0|||
126270753|NCT00816361|454284601|FG007|Overall Study|Other|0|||
126270754|NCT00816361|454284602|FG008|Overall Study|Other|1|||
126270755|NCT00546572|454284604|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
126270756|NCT00546572|454284605|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
126270757|NCT00546572|454284604|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
126270758|NCT00546572|454284605|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
126270759|NCT00546572|454284604|FG000|Vax 1 / Year 0|Protocol Violation|3|||
126270760|NCT00546572|454284605|FG001|Vax 1 / Year 0|Protocol Violation|4|||
126270761|NCT00546572|454284604|FG000|Vax 1 / Year 0|Death|2|||
126270762|NCT00546572|454284605|FG001|Vax 1 / Year 0|Death|2|||
126270763|NCT00546572|454284604|FG000|Vax 1 / Year 0|Adverse Event|0|||
126270764|NCT00546572|454284605|FG001|Vax 1 / Year 0|Adverse Event|1|||
126270765|NCT00546572|454284604|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
126270766|NCT00546572|454284605|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
126270767|NCT00546572|454284604|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
126270768|NCT00546572|454284605|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
126270769|NCT00546572|454284604|FG000|Vax 2 / Year 1|Other|1|||
126270770|NCT00546572|454284605|FG001|Vax 2 / Year 1|Other|1|||
126270771|NCT00546572|454284604|FG000|Vax 2 / Year 1|Adverse Event|1|||
126270772|NCT00546572|454284605|FG001|Vax 2 / Year 1|Adverse Event|0|||
126270773|NCT00546572|454284604|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
126705361|NCT02034123|455871742|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126270774|NCT00546572|454284605|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
126270775|NCT01394952|454284606|FG000|Overall Study|Lost to Follow-up|0|||
126270776|NCT01394952|454284607|FG001|Overall Study|Lost to Follow-up|5|||
126270777|NCT01394952|454284606|FG000|Overall Study|Withdrawal by Subject|10|||
126270778|NCT01394952|454284607|FG001|Overall Study|Withdrawal by Subject|5|||
126270779|NCT01394952|454284606|FG000|Overall Study|Physician Decision|2|||
126705362|NCT02034123|455871743|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126270780|NCT01394952|454284607|FG001|Overall Study|Physician Decision|0|||
126270781|NCT01394952|454284606|FG000|Overall Study|Sponsor Decision|5|||
126270782|NCT01394952|454284607|FG001|Overall Study|Sponsor Decision|7|||
126270783|NCT02500641|454284610|FG000|Overall Study|Adverse Event|0|||
126270784|NCT02500641|454284611|FG001|Overall Study|Adverse Event|2|||
126270785|NCT02500641|454284610|FG000|Overall Study|Withdrawal by Subject|4|||
126270786|NCT02500641|454284611|FG001|Overall Study|Withdrawal by Subject|5|||
126270787|NCT02500641|454284610|FG000|Overall Study|Unable to follow study procedures|3|||
126270788|NCT02500641|454284611|FG001|Overall Study|Unable to follow study procedures|2|||
126270789|NCT02500641|454284610|FG000|Overall Study|Protocol Violation|1|||
126270790|NCT02500641|454284611|FG001|Overall Study|Protocol Violation|2|||
126270791|NCT02500641|454284610|FG000|Overall Study|Lost to Follow-up|1|||
126270792|NCT02500641|454284611|FG001|Overall Study|Lost to Follow-up|0|||
126270793|NCT02500641|454284610|FG000|Overall Study|Sponsor decision|1|||
126270794|NCT02500641|454284611|FG001|Overall Study|Sponsor decision|0|||
126270795|NCT02500641|454284610|FG000|Overall Study|Non compliance to study drug|0|||
126270796|NCT02500641|454284611|FG001|Overall Study|Non compliance to study drug|1|||
126270797|NCT00643565|454284613|FG000|Overall Study|Death|12|||
126270798|NCT00643565|454284614|FG001|Overall Study|Death|11|||
126270799|NCT00643565|454284613|FG000|Overall Study|Withdrawal by Subject|4|||
126270800|NCT00643565|454284614|FG001|Overall Study|Withdrawal by Subject|1|||
126270801|NCT00643565|454284613|FG000|Overall Study|Lost to Follow-up|0|||
126270802|NCT00643565|454284614|FG001|Overall Study|Lost to Follow-up|6|||
126270803|NCT00643565|454284613|FG000|Overall Study|Other|7|||
126270804|NCT00643565|454284614|FG001|Overall Study|Other|8|||
126270805|NCT00643565|454284613|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
126270806|NCT00643565|454284614|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
126270807|NCT00643565|454284613|FG000|Overall Study|Recurrence of Disease|2|||
126270808|NCT00643565|454284614|FG001|Overall Study|Recurrence of Disease|1|||
126270809|NCT00643565|454284613|FG000|Overall Study|Progression of Disease|18|||
126270810|NCT00643565|454284614|FG001|Overall Study|Progression of Disease|14|||
126270811|NCT00643565|454284613|FG000|Overall Study|Protocol Violation|3|||
126270812|NCT00643565|454284614|FG001|Overall Study|Protocol Violation|0|||
126270813|NCT00643565|454284613|FG000|Overall Study|Did Not Cooperate|0|||
126270814|NCT00643565|454284614|FG001|Overall Study|Did Not Cooperate|1|||
126270815|NCT00643565|454284613|FG000|Overall Study|Administrative|22|||
126270816|NCT00643565|454284614|FG001|Overall Study|Administrative|16|||
126270817|NCT00643565|454284613|FG000|Overall Study|Adverse Event|5|||
126270818|NCT00643565|454284614|FG001|Overall Study|Adverse Event|8|||
126270819|NCT02317614|454284615|FG000|Overall Study|Lost to Follow-up|1|||
126270820|NCT02317614|454284616|FG001|Overall Study|Lost to Follow-up|1|||
126270821|NCT02317614|454284615|FG000|Overall Study|Withdrawal by Subject|1|||
126270822|NCT02317614|454284616|FG001|Overall Study|Withdrawal by Subject|0|||
126270823|NCT02317614|454284615|FG000|Overall Study|Death|1|||
126270824|NCT02317614|454284616|FG001|Overall Study|Death|1|||
126270825|NCT00669071|454284617|FG000|Overall Study|Lost to Follow-up|3|||
126270826|NCT00669071|454284617|FG000|Overall Study|Final visit 40 days out of window|1|||
126270827|NCT01355159|454284618|FG000|Overall Study|Withdrew consent|39|||
126270828|NCT01355159|454284619|FG001|Overall Study|Withdrew consent|47|||
126270829|NCT01355159|454284618|FG000|Overall Study|No primary outcome data|17|||
126270830|NCT01355159|454284619|FG001|Overall Study|No primary outcome data|11|||
126270831|NCT01355159|454284618|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
126270832|NCT01355159|454284619|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
126270833|NCT01355159|454284618|FG000|Overall Study|Early intrauterine fetal death|6|||
126270834|NCT01355159|454284619|FG001|Overall Study|Early intrauterine fetal death|6|||
126270835|NCT04700280|454284620|FG000|Overall Study|Adverse Event|4|||
126270836|NCT04700280|454284621|FG001|Overall Study|Adverse Event|0|||
126270837|NCT04700280|454284620|FG000|Overall Study|Lack of Efficacy|1|||
126270838|NCT04700280|454284621|FG001|Overall Study|Lack of Efficacy|0|||
126270839|NCT04700280|454284620|FG000|Overall Study|Study terminated by sponsor|5|||
126270840|NCT04700280|454284621|FG001|Overall Study|Study terminated by sponsor|3|||
126270841|NCT04700280|454284620|FG000|Overall Study|Other than specified|1|||
126270842|NCT04700280|454284621|FG001|Overall Study|Other than specified|0|||
126270843|NCT00741936|454284625|FG000|Overall Study|Lost to Follow-up|1|||
126270844|NCT00741936|454284626|FG001|Overall Study|Lost to Follow-up|1|||
126270845|NCT00741936|454284625|FG000|Overall Study|Adverse Event|3|||
126270846|NCT00741936|454284626|FG001|Overall Study|Adverse Event|4|||
126270847|NCT00741936|454284625|FG000|Overall Study|Pregnancy|0|||
126270848|NCT00741936|454284626|FG001|Overall Study|Pregnancy|1|||
126270849|NCT00741936|454284625|FG000|Overall Study|Protocol Violation|2|||
126270850|NCT00741936|454284626|FG001|Overall Study|Protocol Violation|0|||
126270851|NCT00741936|454284625|FG000|Overall Study|Lack of Efficacy|0|||
126270852|NCT00741936|454284626|FG001|Overall Study|Lack of Efficacy|2|||
126270853|NCT00741936|454284625|FG000|Overall Study|Low compliance|3|||
126270854|NCT00741936|454284626|FG001|Overall Study|Low compliance|0|||
126270855|NCT02450526|454284627|FG000|DB Period (Cycle 1)|Adverse Event|0|||
126270856|NCT02450526|454284628|FG001|DB Period (Cycle 1)|Adverse Event|0|||
126270857|NCT02450526|454284629|FG002|DB Period (Cycle 1)|Adverse Event|2|||
126270858|NCT02450526|454284630|FG003|DB Period (Cycle 1)|Adverse Event|0|||
126270859|NCT02450526|454284631|FG004|DB Period (Cycle 1)|Adverse Event|0|||
126270860|NCT02450526|454284627|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
126270861|NCT02450526|454284628|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
126270862|NCT02450526|454284629|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
126270863|NCT02450526|454284630|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
126361498|NCT02268851|454615334|FG005|Overall Study|Adverse Event|2|||
126361499|NCT02268851|454615329|FG000|Overall Study|Withdrawal by Subject|0|||
126270864|NCT02450526|454284631|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
126270865|NCT02450526|454284627|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
126270866|NCT02450526|454284628|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
126270867|NCT02450526|454284629|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
126270868|NCT02450526|454284630|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
126270869|NCT02450526|454284631|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
126270870|NCT02450526|454284627|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
126270871|NCT02450526|454284628|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
126270872|NCT02450526|454284629|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
126270873|NCT02450526|454284630|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
126270874|NCT02450526|454284631|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
126270875|NCT02450526|454284627|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
126270876|NCT02450526|454284628|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
126270877|NCT02450526|454284629|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
126270878|NCT02450526|454284630|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
126270879|NCT02450526|454284631|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
126270880|NCT02450526|454284627|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
126270881|NCT02450526|454284628|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
126270882|NCT02450526|454284629|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
126270883|NCT02450526|454284630|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
126270884|NCT02450526|454284631|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
126270885|NCT02450526|454284627|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
126270886|NCT02450526|454284628|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
126270887|NCT02450526|454284629|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
126270888|NCT02450526|454284630|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
126270889|NCT02450526|454284631|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
126270890|NCT02450526|454284627|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
126270891|NCT02450526|454284628|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
126270892|NCT02450526|454284629|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
126270893|NCT02450526|454284630|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
126270894|NCT02450526|454284631|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
126270895|NCT01970865|454284632|FG000|Overall Study|Death|3|||
126270896|NCT01970865|454284633|FG001|Overall Study|Death|2|||
126270897|NCT01970865|454284634|FG002|Overall Study|Death|3|||
126270898|NCT01970865|454284635|FG003|Overall Study|Death|6|||
126270899|NCT01970865|454284636|FG004|Overall Study|Death|9|||
126270900|NCT01970865|454284637|FG005|Overall Study|Death|3|||
126270901|NCT01970865|454284638|FG006|Overall Study|Death|2|||
126270902|NCT01970865|454284639|FG007|Overall Study|Death|3|||
126270903|NCT01970865|454284640|FG008|Overall Study|Death|2|||
126270904|NCT01970865|454284641|FG009|Overall Study|Death|2|||
126270905|NCT01970865|454284642|FG010|Overall Study|Death|8|||
126270906|NCT01970865|454284643|FG011|Overall Study|Death|13|||
126270907|NCT01970865|454284644|FG012|Overall Study|Death|25|||
126270908|NCT01970865|454284645|FG013|Overall Study|Death|46|||
126270909|NCT01970865|454284646|FG014|Overall Study|Death|37|||
126270910|NCT01970865|454284647|FG015|Overall Study|Death|22|||
126270911|NCT01970865|454284648|FG016|Overall Study|Death|1|||
126270912|NCT01970865|454284649|FG017|Overall Study|Death|17|||
126270913|NCT01970865|454284632|FG000|Overall Study|Lost to Follow-up|0|||
126270914|NCT01970865|454284633|FG001|Overall Study|Lost to Follow-up|0|||
126270915|NCT01970865|454284634|FG002|Overall Study|Lost to Follow-up|0|||
126270916|NCT01970865|454284635|FG003|Overall Study|Lost to Follow-up|1|||
126270917|NCT01970865|454284636|FG004|Overall Study|Lost to Follow-up|1|||
126270918|NCT01970865|454284637|FG005|Overall Study|Lost to Follow-up|0|||
126270919|NCT01970865|454284638|FG006|Overall Study|Lost to Follow-up|0|||
126270920|NCT01970865|454284639|FG007|Overall Study|Lost to Follow-up|0|||
126270921|NCT01970865|454284640|FG008|Overall Study|Lost to Follow-up|0|||
126270922|NCT01970865|454284641|FG009|Overall Study|Lost to Follow-up|0|||
126270923|NCT01970865|454284642|FG010|Overall Study|Lost to Follow-up|1|||
126270924|NCT01970865|454284643|FG011|Overall Study|Lost to Follow-up|0|||
126361500|NCT02268851|454615330|FG001|Overall Study|Withdrawal by Subject|0|||
126270925|NCT01970865|454284644|FG012|Overall Study|Lost to Follow-up|2|||
126270926|NCT01970865|454284645|FG013|Overall Study|Lost to Follow-up|0|||
126270927|NCT01970865|454284646|FG014|Overall Study|Lost to Follow-up|1|||
126270928|NCT01970865|454284647|FG015|Overall Study|Lost to Follow-up|4|||
126270929|NCT01970865|454284648|FG016|Overall Study|Lost to Follow-up|0|||
126270930|NCT01970865|454284649|FG017|Overall Study|Lost to Follow-up|1|||
126270931|NCT01970865|454284632|FG000|Overall Study|Other|0|||
126270932|NCT01970865|454284633|FG001|Overall Study|Other|1|||
126270933|NCT01970865|454284634|FG002|Overall Study|Other|0|||
126270934|NCT01970865|454284635|FG003|Overall Study|Other|1|||
126270935|NCT01970865|454284636|FG004|Overall Study|Other|1|||
126270936|NCT01970865|454284637|FG005|Overall Study|Other|0|||
126270937|NCT01970865|454284638|FG006|Overall Study|Other|1|||
126361501|NCT02268851|454615331|FG002|Overall Study|Withdrawal by Subject|0|||
126270938|NCT01970865|454284639|FG007|Overall Study|Other|0|||
126270939|NCT01970865|454284640|FG008|Overall Study|Other|0|||
126270940|NCT01970865|454284641|FG009|Overall Study|Other|0|||
126270941|NCT01970865|454284642|FG010|Overall Study|Other|2|||
126361502|NCT02268851|454615332|FG003|Overall Study|Withdrawal by Subject|2|||
126361503|NCT02268851|454615333|FG004|Overall Study|Withdrawal by Subject|0|||
126361504|NCT02268851|454615334|FG005|Overall Study|Withdrawal by Subject|1|||
126361505|NCT02268851|454615329|FG000|Overall Study|Progressive Disease|1|||
126361506|NCT02268851|454615330|FG001|Overall Study|Progressive Disease|3|||
126361507|NCT02268851|454615331|FG002|Overall Study|Progressive Disease|0|||
126361508|NCT02268851|454615332|FG003|Overall Study|Progressive Disease|0|||
126361509|NCT02268851|454615333|FG004|Overall Study|Progressive Disease|1|||
126361510|NCT02268851|454615334|FG005|Overall Study|Progressive Disease|4|||
126361511|NCT02268851|454615329|FG000|Overall Study|Physician Decision|0|||
126361512|NCT02268851|454615330|FG001|Overall Study|Physician Decision|0|||
126361513|NCT02268851|454615331|FG002|Overall Study|Physician Decision|1|||
126361514|NCT02268851|454615332|FG003|Overall Study|Physician Decision|0|||
126361515|NCT02268851|454615333|FG004|Overall Study|Physician Decision|0|||
126361516|NCT02268851|454615334|FG005|Overall Study|Physician Decision|1|||
126361517|NCT02268851|454615329|FG000|Overall Study|Patient Compliance|0|||
126361518|NCT02268851|454615330|FG001|Overall Study|Patient Compliance|0|||
126361519|NCT02268851|454615331|FG002|Overall Study|Patient Compliance|0|||
126361520|NCT02268851|454615332|FG003|Overall Study|Patient Compliance|0|||
126361521|NCT02268851|454615333|FG004|Overall Study|Patient Compliance|1|||
126361522|NCT02268851|454615334|FG005|Overall Study|Patient Compliance|1|||
126361523|NCT02268851|454615329|FG000|Overall Study|Co-Morbid Condition|0|||
126361524|NCT02268851|454615330|FG001|Overall Study|Co-Morbid Condition|0|||
126361525|NCT02268851|454615331|FG002|Overall Study|Co-Morbid Condition|0|||
126361526|NCT02268851|454615332|FG003|Overall Study|Co-Morbid Condition|0|||
126361527|NCT02268851|454615333|FG004|Overall Study|Co-Morbid Condition|1|||
126361528|NCT02268851|454615334|FG005|Overall Study|Co-Morbid Condition|1|||
126361529|NCT02539394|454615335|FG000|Overall Study|Protocol Violation|1|||
126361530|NCT02539394|454615336|FG001|Overall Study|Protocol Violation|3|||
126361531|NCT02539394|454615335|FG000|Overall Study|Lost to Follow-up|1|||
126361532|NCT02539394|454615336|FG001|Overall Study|Lost to Follow-up|2|||
126361533|NCT02539394|454615335|FG000|Overall Study|Incomplete dataset|6|||
126361534|NCT02539394|454615336|FG001|Overall Study|Incomplete dataset|6|||
126270942|NCT01970865|454284643|FG011|Overall Study|Other|3|||
126270943|NCT01970865|454284644|FG012|Overall Study|Other|8|||
126270944|NCT01970865|454284645|FG013|Overall Study|Other|3|||
126270945|NCT01970865|454284646|FG014|Overall Study|Other|2|||
126270946|NCT01970865|454284647|FG015|Overall Study|Other|3|||
126270947|NCT01970865|454284648|FG016|Overall Study|Other|0|||
126270948|NCT01970865|454284649|FG017|Overall Study|Other|2|||
126270949|NCT01970865|454284632|FG000|Overall Study|Participant refused further follow-up|0|||
126270950|NCT01970865|454284633|FG001|Overall Study|Participant refused further follow-up|0|||
126270951|NCT01970865|454284634|FG002|Overall Study|Participant refused further follow-up|0|||
126270952|NCT01970865|454284635|FG003|Overall Study|Participant refused further follow-up|2|||
126270953|NCT01970865|454284636|FG004|Overall Study|Participant refused further follow-up|3|||
126270954|NCT01970865|454284637|FG005|Overall Study|Participant refused further follow-up|0|||
126270955|NCT01970865|454284638|FG006|Overall Study|Participant refused further follow-up|0|||
126361535|NCT02205359|454615337|FG000|Overall Study|Death|293|||
126361536|NCT02205359|454615338|FG001|Overall Study|Death|327|||
126361537|NCT02205359|454615337|FG000|Overall Study|Lost to Follow-up|182|||
126361538|NCT02205359|454615338|FG001|Overall Study|Lost to Follow-up|162|||
126361539|NCT02205359|454615337|FG000|Overall Study|Physician Decision|51|||
126361540|NCT02205359|454615338|FG001|Overall Study|Physician Decision|53|||
126361541|NCT02205359|454615337|FG000|Overall Study|Withdrawal by Subject|167|||
126361542|NCT02205359|454615338|FG001|Overall Study|Withdrawal by Subject|169|||
126361543|NCT00236197|454615339|FG000|Overall Study|Withdrawal by Subject|3|||
126361544|NCT00236197|454615340|FG001|Overall Study|Withdrawal by Subject|2|||
126361545|NCT00236197|454615339|FG000|Overall Study|Lost to Follow-up|1|||
126361546|NCT00236197|454615340|FG001|Overall Study|Lost to Follow-up|5|||
126361547|NCT00236197|454615339|FG000|Overall Study|Protocol Violation|0|||
126361548|NCT00236197|454615340|FG001|Overall Study|Protocol Violation|3|||
126361549|NCT00236197|454615339|FG000|Overall Study|Medication non-compliance|1|||
126361550|NCT00236197|454615340|FG001|Overall Study|Medication non-compliance|2|||
126361551|NCT00236197|454615339|FG000|Overall Study|Other|0|||
126361552|NCT00236197|454615340|FG001|Overall Study|Other|2|||
126361553|NCT00992394|454615343|FG000|Overall Study|Lack of Efficacy|6|||
126361554|NCT00992394|454615344|FG001|Overall Study|Lack of Efficacy|3|||
126361555|NCT00992394|454615343|FG000|Overall Study|Adverse Event|4|||
126270956|NCT01970865|454284639|FG007|Overall Study|Participant refused further follow-up|0|||
126270957|NCT01970865|454284640|FG008|Overall Study|Participant refused further follow-up|0|||
126270958|NCT01970865|454284641|FG009|Overall Study|Participant refused further follow-up|0|||
126361556|NCT00992394|454615344|FG001|Overall Study|Adverse Event|5|||
126270959|NCT01970865|454284642|FG010|Overall Study|Participant refused further follow-up|1|||
126361557|NCT00992394|454615343|FG000|Overall Study|Withdrawal by Subject|8|||
126361558|NCT00992394|454615344|FG001|Overall Study|Withdrawal by Subject|2|||
126361559|NCT00992394|454615343|FG000|Overall Study|Physician Decision|1|||
126361560|NCT00992394|454615344|FG001|Overall Study|Physician Decision|0|||
126361561|NCT00992394|454615343|FG000|Overall Study|Protocol Violation|2|||
126361562|NCT00992394|454615344|FG001|Overall Study|Protocol Violation|4|||
126270960|NCT01970865|454284643|FG011|Overall Study|Participant refused further follow-up|4|||
126270961|NCT01970865|454284644|FG012|Overall Study|Participant refused further follow-up|7|||
126270962|NCT01970865|454284645|FG013|Overall Study|Participant refused further follow-up|8|||
126270963|NCT01970865|454284646|FG014|Overall Study|Participant refused further follow-up|3|||
126270964|NCT01970865|454284647|FG015|Overall Study|Participant refused further follow-up|11|||
126270965|NCT01970865|454284648|FG016|Overall Study|Participant refused further follow-up|0|||
126270966|NCT01970865|454284649|FG017|Overall Study|Participant refused further follow-up|6|||
126270967|NCT01855074|454284652|FG000|Overall Study|Adverse Event|1|||
126270968|NCT01855074|454284652|FG000|Overall Study|Lost to Follow-up|4|||
126270969|NCT01855074|454284652|FG000|Overall Study|Withdrawal by Subject|8|||
126270970|NCT01855074|454284652|FG000|Overall Study|Started but not treated|1|||
126270971|NCT01150890|454284653|FG000|Overall Study|Other|0|||
126270972|NCT01150890|454284654|FG001|Overall Study|Other|1|||
126270973|NCT01150890|454284655|FG002|Overall Study|Other|0|||
126270974|NCT01150890|454284656|FG003|Overall Study|Other|2|||
126270975|NCT01150890|454284653|FG000|Overall Study|Pregnancy|0|||
126270976|NCT01150890|454284654|FG001|Overall Study|Pregnancy|0|||
126270977|NCT01150890|454284655|FG002|Overall Study|Pregnancy|0|||
126270978|NCT01150890|454284656|FG003|Overall Study|Pregnancy|1|||
126270979|NCT01150890|454284653|FG000|Overall Study|Administrative Decision|4|||
126270980|NCT01150890|454284654|FG001|Overall Study|Administrative Decision|4|||
126270981|NCT01150890|454284655|FG002|Overall Study|Administrative Decision|5|||
126270982|NCT01150890|454284656|FG003|Overall Study|Administrative Decision|6|||
126270983|NCT01150890|454284653|FG000|Overall Study|Ineligibility determined|0|||
126270984|NCT01150890|454284654|FG001|Overall Study|Ineligibility determined|1|||
126270985|NCT01150890|454284655|FG002|Overall Study|Ineligibility determined|0|||
126270986|NCT01150890|454284656|FG003|Overall Study|Ineligibility determined|0|||
126270987|NCT01150890|454284653|FG000|Overall Study|Adverse Event|0|||
126270988|NCT01150890|454284654|FG001|Overall Study|Adverse Event|0|||
126270989|NCT01150890|454284655|FG002|Overall Study|Adverse Event|2|||
126270990|NCT01150890|454284656|FG003|Overall Study|Adverse Event|0|||
126270991|NCT01150890|454284653|FG000|Overall Study|Withdrawal by Subject|0|||
126270992|NCT01150890|454284654|FG001|Overall Study|Withdrawal by Subject|0|||
126270993|NCT01150890|454284655|FG002|Overall Study|Withdrawal by Subject|2|||
126270994|NCT01150890|454284656|FG003|Overall Study|Withdrawal by Subject|1|||
126270995|NCT01150890|454284653|FG000|Overall Study|Disease progression|0|||
126270996|NCT01150890|454284654|FG001|Overall Study|Disease progression|7|||
126270997|NCT01150890|454284655|FG002|Overall Study|Disease progression|3|||
126270998|NCT01150890|454284656|FG003|Overall Study|Disease progression|7|||
126270999|NCT01079832|454284660|FG000|Overall Study|Withdrawal by Subject|1|||
126271000|NCT06077487|454286566|FG000|Overall Study|Withdrawal by Subject|0|||
126271001|NCT06077487|454286567|FG001|Overall Study|Withdrawal by Subject|1|||
126271002|NCT00759902|454286569|FG000|Overall Study|Adverse Event|0|||
126271003|NCT00759902|454286570|FG001|Overall Study|Adverse Event|1|||
126271004|NCT02128217|454286571|FG000|Overall Study|Lost to Follow-up|0|||
126271005|NCT02128217|454286572|FG001|Overall Study|Lost to Follow-up|1|||
126271006|NCT05071313|454286575|FG000|Overall Study|Lost to Follow-up|17|||
126271007|NCT05071313|454286576|FG001|Overall Study|Lost to Follow-up|10|||
126271008|NCT05071313|454286575|FG000|Overall Study|Physician Decision|1|||
126271009|NCT05071313|454286576|FG001|Overall Study|Physician Decision|6|||
126271010|NCT05071313|454286575|FG000|Overall Study|Death|1|||
126271011|NCT05071313|454286576|FG001|Overall Study|Death|0|||
126271012|NCT05071313|454286575|FG000|Overall Study|Withdrawal by Subject|10|||
126271013|NCT05071313|454286576|FG001|Overall Study|Withdrawal by Subject|15|||
126271014|NCT05071313|454286575|FG000|Overall Study|Other|1|||
126271015|NCT05071313|454286576|FG001|Overall Study|Other|0|||
126271016|NCT05071313|454286575|FG000|Overall Study|Randomized but not vaccinated|4|||
126271017|NCT05071313|454286576|FG001|Overall Study|Randomized but not vaccinated|2|||
126271018|NCT03107026|454286577|FG000|Overall Study|Adverse Event|2|||
126271019|NCT03107026|454286578|FG001|Overall Study|Adverse Event|14|||
126271020|NCT03107026|454286579|FG002|Overall Study|Adverse Event|23|||
126271021|NCT03107026|454286577|FG000|Overall Study|Lost to Follow-up|12|||
126271022|NCT03107026|454286578|FG001|Overall Study|Lost to Follow-up|12|||
126271023|NCT03107026|454286579|FG002|Overall Study|Lost to Follow-up|13|||
126271024|NCT03107026|454286577|FG000|Overall Study|Protocol Violation|1|||
126271025|NCT03107026|454286578|FG001|Overall Study|Protocol Violation|2|||
126271026|NCT03107026|454286579|FG002|Overall Study|Protocol Violation|0|||
126271027|NCT03107026|454286577|FG000|Overall Study|Pregnancy|1|||
126271028|NCT03107026|454286578|FG001|Overall Study|Pregnancy|0|||
126271029|NCT03107026|454286579|FG002|Overall Study|Pregnancy|0|||
126271030|NCT03107026|454286577|FG000|Overall Study|Withdrawal by Subject|13|||
126271031|NCT03107026|454286578|FG001|Overall Study|Withdrawal by Subject|5|||
126271032|NCT03107026|454286579|FG002|Overall Study|Withdrawal by Subject|17|||
126271033|NCT03107026|454286577|FG000|Overall Study|non compliance with study visits|1|||
126271034|NCT03107026|454286578|FG001|Overall Study|non compliance with study visits|2|||
126271035|NCT03107026|454286579|FG002|Overall Study|non compliance with study visits|0|||
126271036|NCT03107026|454286577|FG000|Overall Study|non-compliance with study drug|2|||
126271037|NCT03107026|454286578|FG001|Overall Study|non-compliance with study drug|2|||
126271038|NCT03107026|454286579|FG002|Overall Study|non-compliance with study drug|3|||
126271039|NCT03107026|454286577|FG000|Overall Study|Physician Decision|0|||
126271040|NCT03107026|454286578|FG001|Overall Study|Physician Decision|1|||
126271041|NCT03107026|454286579|FG002|Overall Study|Physician Decision|0|||
126271042|NCT02049450|454286580|FG000|Overall Study|Adverse Event|2|||
126271043|NCT02049450|454286580|FG000|Overall Study|Withdrawal by Subject|1|||
126271044|NCT02049450|454286580|FG000|Overall Study|Patients/guardian decision|1|||
126271045|NCT00577395|454286581|FG000|Overall Study|Study was terminated early by Sponsor|7|||
126271046|NCT00577395|454286582|FG001|Overall Study|Study was terminated early by Sponsor|6|||
126271047|NCT03347422|454286588|FG000|Part A (26 Weeks)|Adverse Event|3|||
126271048|NCT03347422|454286589|FG001|Part A (26 Weeks)|Adverse Event|0|||
126271049|NCT03347422|454286588|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
126271050|NCT03347422|454286589|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
126271051|NCT03347422|454286588|FG000|Part B (149 Weeks)|Adverse Event|0|||
126271052|NCT03347422|454286589|FG001|Part B (149 Weeks)|Adverse Event|1|||
126271053|NCT03347422|454286588|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
126271054|NCT03347422|454286589|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
126271055|NCT03347422|454286588|FG000|Part B (149 Weeks)|Other|1|||
126271056|NCT03347422|454286589|FG001|Part B (149 Weeks)|Other|0|||
126271057|NCT00910091|454286590|FG000|Pre-assignment|Withdrawal by Subject|0|||
126271058|NCT00910091|454286591|FG001|Pre-assignment|Withdrawal by Subject|2|||
126271059|NCT00910091|454286590|FG000|Treatment and Survival|Withdrawal by Subject|3|||
126271060|NCT00910091|454286591|FG001|Treatment and Survival|Withdrawal by Subject|4|||
126271061|NCT00910091|454286590|FG000|Treatment and Survival|Adverse Event|1|||
126271062|NCT00910091|454286591|FG001|Treatment and Survival|Adverse Event|0|||
126271063|NCT01155024|454286592|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
126271064|NCT01155024|454286593|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
126271065|NCT01155024|454286592|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
126271066|NCT01155024|454286593|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
126271067|NCT01155024|454286592|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
126271068|NCT01155024|454286593|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
126271069|NCT03201250|454286596|FG000|Overall Study|screen failures|3|||
126271070|NCT03201250|454286597|FG001|Overall Study|screen failures|0|||
126271071|NCT03201250|454286598|FG002|Overall Study|screen failures|0|||
126271072|NCT01175811|454286600|FG000|Overall Study|Adverse Event|1|||
126271073|NCT01175811|454286601|FG001|Overall Study|Adverse Event|1|||
126271074|NCT01175811|454286600|FG000|Overall Study|Entry criteria not met|3|||
126271075|NCT01175811|454286601|FG001|Overall Study|Entry criteria not met|1|||
126271076|NCT01175811|454286600|FG000|Overall Study|Lack of Efficacy|1|||
126271077|NCT01175811|454286601|FG001|Overall Study|Lack of Efficacy|0|||
126271078|NCT01175811|454286600|FG000|Overall Study|Lost to Follow-up|3|||
126271079|NCT01175811|454286601|FG001|Overall Study|Lost to Follow-up|2|||
126271080|NCT01175811|454286600|FG000|Overall Study|Physician Decision|1|||
126271081|NCT01175811|454286601|FG001|Overall Study|Physician Decision|1|||
126271082|NCT01175811|454286600|FG000|Overall Study|Protocol Violation|1|||
126271083|NCT01175811|454286601|FG001|Overall Study|Protocol Violation|2|||
126271084|NCT01175811|454286600|FG000|Overall Study|Withdrawal by Subject|6|||
126271085|NCT01175811|454286601|FG001|Overall Study|Withdrawal by Subject|7|||
126271086|NCT03579966|454286602|FG000|Overall Study|Adverse Event|6|||
126271087|NCT03579966|454286602|FG000|Overall Study|Lost to Follow-up|4|||
126271088|NCT03579966|454286602|FG000|Overall Study|Physician Decision|10|||
126271089|NCT03579966|454286602|FG000|Overall Study|Pregnancy|1|||
126271090|NCT03579966|454286602|FG000|Overall Study|Withdrawal by Subject|16|||
126271091|NCT03579966|454286602|FG000|Overall Study|Study terminated by Sponsor|22|||
126271092|NCT03579966|454286602|FG000|Overall Study|Protocol Violation|1|||
126271093|NCT01340768|454286603|FG000|Overall Study|Lost to Follow-up|10|||
126271094|NCT01340768|454286604|FG001|Overall Study|Lost to Follow-up|4|||
126271095|NCT01340768|454286603|FG000|Overall Study|Withdrawal by Subject|5|||
126271096|NCT01340768|454286604|FG001|Overall Study|Withdrawal by Subject|1|||
126271097|NCT01340768|454286603|FG000|Overall Study|Other|2|||
126271098|NCT01340768|454286604|FG001|Overall Study|Other|0|||
126271099|NCT03052959|454286605|FG000|Overall Study|Lost to Follow-up|4|||
126271100|NCT03052959|454286606|FG001|Overall Study|Lost to Follow-up|5|||
126271101|NCT01297465|454286607|FG000|Overall Study|Lack of Ovarian Response|1|||
126271102|NCT01297465|454286608|FG001|Overall Study|Lack of Ovarian Response|1|||
126271103|NCT01297465|454286607|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
126271104|NCT01297465|454286608|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
126271105|NCT01297465|454286607|FG000|Overall Study|No Oocytes Retrieved|1|||
126271106|NCT01297465|454286608|FG001|Overall Study|No Oocytes Retrieved|1|||
126271107|NCT01297465|454286607|FG000|Overall Study|Poor oocyte quality|0|||
126271108|NCT01297465|454286608|FG001|Overall Study|Poor oocyte quality|1|||
126271109|NCT01297465|454286607|FG000|Overall Study|No Fertilization|6|||
126271110|NCT01297465|454286608|FG001|Overall Study|No Fertilization|4|||
126271111|NCT01297465|454286607|FG000|Overall Study|All Embryos Discarded|0|||
126271112|NCT01297465|454286608|FG001|Overall Study|All Embryos Discarded|1|||
126453492|NCT01478048|454961427|FG000|Overall Study|subject request to discontinue treatment|3|||
126361563|NCT00992394|454615343|FG000|Overall Study|Lost to Follow-up|2|||
126361564|NCT00992394|454615344|FG001|Overall Study|Lost to Follow-up|0|||
126361565|NCT00992394|454615343|FG000|Overall Study|Other event|1|||
126361566|NCT00992394|454615344|FG001|Overall Study|Other event|0|||
126361567|NCT00537082|454615345|FG000|Overall Study|Adverse Event|6|||
126361568|NCT00537082|454615346|FG001|Overall Study|Adverse Event|6|||
126361569|NCT00537082|454615347|FG002|Overall Study|Adverse Event|3|||
126361570|NCT00537082|454615345|FG000|Overall Study|Protocol Violation|0|||
126361571|NCT00537082|454615346|FG001|Overall Study|Protocol Violation|2|||
126361572|NCT00537082|454615347|FG002|Overall Study|Protocol Violation|1|||
126361573|NCT00537082|454615345|FG000|Overall Study|Lack of Efficacy|0|||
126361574|NCT00537082|454615346|FG001|Overall Study|Lack of Efficacy|0|||
126361575|NCT00537082|454615347|FG002|Overall Study|Lack of Efficacy|2|||
126361576|NCT00537082|454615345|FG000|Overall Study|Withdrawal by Subject|0|||
126361577|NCT00537082|454615346|FG001|Overall Study|Withdrawal by Subject|1|||
126361578|NCT00537082|454615347|FG002|Overall Study|Withdrawal by Subject|0|||
126361579|NCT00537082|454615345|FG000|Overall Study|Discontinued before initiating treatment|3|||
126361580|NCT00537082|454615346|FG001|Overall Study|Discontinued before initiating treatment|0|||
126361581|NCT00537082|454615347|FG002|Overall Study|Discontinued before initiating treatment|0|||
126361582|NCT00655746|454615348|FG000|Overall Study|Withdrawal by Subject|1|||
126361583|NCT01793129|454617195|FG000|Overall Study|Lost to Follow-up|3|||
126361584|NCT01793129|454617196|FG001|Overall Study|Lost to Follow-up|7|||
126361585|NCT01793129|454617195|FG000|Overall Study|Withdrawal by Subject|0|||
126361586|NCT01793129|454617196|FG001|Overall Study|Withdrawal by Subject|2|||
126361587|NCT01926509|454617199|FG000|Overall Study|vital sign met discontinuation criteria|1|||
126361588|NCT01926509|454617200|FG001|Overall Study|vital sign met discontinuation criteria|0|||
126361589|NCT01926509|454617201|FG002|Overall Study|vital sign met discontinuation criteria|0|||
126361590|NCT01926509|454617202|FG003|Overall Study|vital sign met discontinuation criteria|0|||
126361591|NCT03004183|454617203|FG000|Overall Study|Adverse Event|7|||
126361592|NCT03004183|454617203|FG000|Overall Study|Lost to Follow-up|1|||
126361593|NCT03004183|454617203|FG000|Overall Study|Physician Decision|40|||
126361594|NCT03004183|454617203|FG000|Overall Study|Withdrawal by Subject|1|||
126361595|NCT03004183|454617203|FG000|Overall Study|COVID-19|1|||
126361596|NCT03681093|454617204|FG000|Overall Study|Subject decision|0|||
126361597|NCT03681093|454617205|FG001|Overall Study|Subject decision|2|||
126361598|NCT03681093|454617206|FG002|Overall Study|Subject decision|1|||
126361599|NCT02698787|454617207|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
126361600|NCT02698787|454617208|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
126361601|NCT01882829|454617212|FG000|Overall Study|Adverse Event|4|||
126361602|NCT01882829|454617212|FG000|Overall Study|Protocol Violation|1|||
126361603|NCT01882829|454617212|FG000|Overall Study|Withdrawal by Subject|1|||
126361604|NCT01313676|454617215|FG000|Overall Study|Adverse Event|395|||
126361605|NCT01313676|454617216|FG001|Overall Study|Adverse Event|365|||
126361606|NCT01313676|454617217|FG002|Overall Study|Adverse Event|372|||
126361607|NCT01313676|454617218|FG003|Overall Study|Adverse Event|333|||
126361608|NCT01313676|454617215|FG000|Overall Study|Lack of Efficacy|98|||
126361609|NCT01313676|454617216|FG001|Overall Study|Lack of Efficacy|90|||
126361610|NCT01313676|454617217|FG002|Overall Study|Lack of Efficacy|65|||
126361611|NCT01313676|454617218|FG003|Overall Study|Lack of Efficacy|46|||
126361612|NCT01313676|454617215|FG000|Overall Study|Protocol Violation|37|||
126361613|NCT01313676|454617216|FG001|Overall Study|Protocol Violation|44|||
126361614|NCT01313676|454617217|FG002|Overall Study|Protocol Violation|46|||
126361615|NCT01313676|454617218|FG003|Overall Study|Protocol Violation|44|||
126361616|NCT01313676|454617215|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
126361617|NCT01313676|454617216|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
126361618|NCT01313676|454617217|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
126361619|NCT01313676|454617218|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
126361620|NCT01313676|454617215|FG000|Overall Study|Study Closed/terminated|7|||
126361621|NCT01313676|454617216|FG001|Overall Study|Study Closed/terminated|6|||
126361622|NCT01313676|454617217|FG002|Overall Study|Study Closed/terminated|9|||
126361623|NCT01313676|454617218|FG003|Overall Study|Study Closed/terminated|9|||
126361624|NCT01313676|454617215|FG000|Overall Study|Lost to Follow-up|0|||
126361625|NCT01313676|454617216|FG001|Overall Study|Lost to Follow-up|0|||
126361626|NCT01313676|454617217|FG002|Overall Study|Lost to Follow-up|1|||
126361627|NCT01313676|454617218|FG003|Overall Study|Lost to Follow-up|0|||
126361628|NCT01313676|454617215|FG000|Overall Study|Physician Decision|53|||
126361629|NCT01313676|454617216|FG001|Overall Study|Physician Decision|64|||
126361630|NCT01313676|454617217|FG002|Overall Study|Physician Decision|62|||
126361631|NCT01313676|454617218|FG003|Overall Study|Physician Decision|48|||
126361632|NCT01313676|454617215|FG000|Overall Study|Decision by Participant or Proxy|643|||
126361633|NCT01313676|454617216|FG001|Overall Study|Decision by Participant or Proxy|527|||
126361634|NCT01313676|454617217|FG002|Overall Study|Decision by Participant or Proxy|515|||
126361635|NCT01313676|454617218|FG003|Overall Study|Decision by Participant or Proxy|492|||
126361636|NCT01313676|454617215|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
126361637|NCT01313676|454617216|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
126361638|NCT01313676|454617217|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
126361639|NCT01313676|454617218|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
126361640|NCT01313676|454617215|FG000|Overall Study|Investigator Site Closed|12|||
126361641|NCT01313676|454617216|FG001|Overall Study|Investigator Site Closed|11|||
126361642|NCT01313676|454617217|FG002|Overall Study|Investigator Site Closed|15|||
126361643|NCT01313676|454617218|FG003|Overall Study|Investigator Site Closed|10|||
126361644|NCT01313676|454617215|FG000|Overall Study|Missing|1|||
126361645|NCT01313676|454617216|FG001|Overall Study|Missing|1|||
126361646|NCT01313676|454617217|FG002|Overall Study|Missing|1|||
126361647|NCT01313676|454617218|FG003|Overall Study|Missing|0|||
126361648|NCT02469961|454617220|FG000|Overall Study|Physician Decision|4|||
126361649|NCT02469961|454617221|FG001|Overall Study|Physician Decision|1|||
126361650|NCT05130281|454617225|FG000|Overall Study|Withdrawal by Subject|0|||
126361651|NCT05130281|454617226|FG001|Overall Study|Withdrawal by Subject|0|||
126361652|NCT05130281|454617227|FG002|Overall Study|Withdrawal by Subject|1|||
126361653|NCT06844812|454617228|FG000|Overall Study|Lost to Follow-up|5|||
126361654|NCT06844812|454617228|FG000|Overall Study|stigmatization concerns|2|||
126361655|NCT06844812|454617228|FG000|Overall Study|medication refusal|2|||
126361656|NCT06844812|454617228|FG000|Overall Study|concerns about possible side effects|2|||
126361657|NCT06844812|454617228|FG000|Overall Study|wanting to seek another specialist opinion|2|||
126361658|NCT06844812|454617228|FG000|Overall Study|side effects (dizziness)|1|||
126361659|NCT00368849|454617231|FG000|Overall Study|Withdrawal by Subject|0|||
126361660|NCT00368849|454617232|FG001|Overall Study|Withdrawal by Subject|1|||
126361661|NCT00368849|454617231|FG000|Overall Study|Physician Decision|0|||
126361662|NCT00368849|454617232|FG001|Overall Study|Physician Decision|1|||
126361663|NCT01699685|454617236|FG000|Period 1|Adverse Event|1|||
126361664|NCT01699685|454617237|FG001|Period 1|Adverse Event|1|||
126361665|NCT01699685|454617236|FG000|Period 1|Medical or ethical, noncompliance|2|||
126361666|NCT01699685|454617237|FG001|Period 1|Medical or ethical, noncompliance|0|||
126361667|NCT01699685|454617236|FG000|Period 1|Other|0|||
126361668|NCT01699685|454617237|FG001|Period 1|Other|1|||
126361669|NCT01699685|454617236|FG000|Period 1|Patient request|0|||
126361670|NCT01699685|454617237|FG001|Period 1|Patient request|1|||
126361671|NCT01699685|454617236|FG000|Period 2|Lost to Follow-up|1|||
126361672|NCT01699685|454617237|FG001|Period 2|Lost to Follow-up|0|||
126361673|NCT03635996|454617238|FG000|Overall Study|Study terminated by Sponsor|94|||
126361674|NCT03635996|454617238|FG000|Overall Study|Withdrawal by Subject|20|||
126361675|NCT03635996|454617238|FG000|Overall Study|Ablation|26|||
126361676|NCT03635996|454617238|FG000|Overall Study|Adverse Event|7|||
126361677|NCT03635996|454617238|FG000|Overall Study|Physician Decision|3|||
126361678|NCT03635996|454617238|FG000|Overall Study|Prohibited medication|5|||
126361679|NCT03635996|454617238|FG000|Overall Study|Did not meet eligibility criteria|5|||
126361680|NCT03635996|454617238|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
126361681|NCT03635996|454617238|FG000|Overall Study|Protocol Violation|1|||
126361682|NCT03635996|454617238|FG000|Overall Study|Lost to Follow-up|1|||
126361683|NCT05058456|454617239|FG000|Overall Study|Death|1|||
126361684|NCT05058456|454617239|FG000|Overall Study|End of Study data not yet due for release|34|||
126361685|NCT02933151|454617240|FG000|Overall Study|Lost to Follow-up|19|||
126361686|NCT02933151|454617241|FG001|Overall Study|Lost to Follow-up|18|||
126361687|NCT02933151|454617240|FG000|Overall Study|Death|1732|||
126361688|NCT02933151|454617241|FG001|Overall Study|Death|1827|||
126361689|NCT02933151|454617240|FG000|Overall Study|Transplant|210|||
126361690|NCT02933151|454617241|FG001|Overall Study|Transplant|278|||
126361691|NCT02933151|454617240|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
126361692|NCT02933151|454617241|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
126361693|NCT02933151|454617240|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
126453493|NCT01478048|454961428|FG001|Overall Study|subject request to discontinue treatment|5|||
126453494|NCT01478048|454961427|FG000|Overall Study|Withdrawal by Subject|2|||
126453495|NCT01478048|454961428|FG001|Overall Study|Withdrawal by Subject|5|||
126453496|NCT01478048|454961427|FG000|Overall Study|non-specified|6|||
126361694|NCT02933151|454617241|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
126361695|NCT02933151|454617240|FG000|Overall Study|Recovered Kidney Function|47|||
126361696|NCT02933151|454617241|FG001|Overall Study|Recovered Kidney Function|29|||
126361697|NCT01428713|454617244|FG000|Overall Study|Non-compliance|2|||
126361698|NCT01428713|454617245|FG001|Overall Study|Non-compliance|2|||
126361699|NCT01428713|454617244|FG000|Overall Study|Withdrawal by Subject|1|||
126453497|NCT01478048|454961428|FG001|Overall Study|non-specified|4|||
126453498|NCT01478048|454961427|FG000|Overall Study|poor/non-compliance|0|||
126453499|NCT01478048|454961428|FG001|Overall Study|poor/non-compliance|1|||
126453500|NCT01478048|454961427|FG000|Overall Study|no longer meets study criteria|1|||
126361700|NCT01428713|454617245|FG001|Overall Study|Withdrawal by Subject|1|||
126361701|NCT01428713|454617244|FG000|Overall Study|Adverse Event|0|||
126361702|NCT01428713|454617245|FG001|Overall Study|Adverse Event|2|||
126361703|NCT00862277|454617246|FG000|Overall Study|Protocol Violation|1|||
126361704|NCT00862277|454617247|FG001|Overall Study|Protocol Violation|2|||
126361705|NCT00862277|454617248|FG002|Overall Study|Protocol Violation|5|||
126361706|NCT00871000|454617249|FG000|Overall Study|Withdrawal by Subject|1|||
126361707|NCT00871000|454617250|FG001|Overall Study|Withdrawal by Subject|0|||
126271113|NCT01297465|454286607|FG000|Overall Study|Intention to Freeze all Embryos|0|||
126271114|NCT01297465|454286608|FG001|Overall Study|Intention to Freeze all Embryos|1|||
126271115|NCT00140426|454286609|FG000|Overall Study|Withdrawal by Subject|0|||
126271116|NCT00140426|454286610|FG001|Overall Study|Withdrawal by Subject|3|||
126271117|NCT02149108|454286611|FG000|Overall Study|Not treated|1|||
126271118|NCT02149108|454286612|FG001|Overall Study|Not treated|2|||
126271119|NCT02149108|454286611|FG000|Overall Study|Progressive Disease (PD)|324|||
126271120|NCT02149108|454286612|FG001|Overall Study|Progressive Disease (PD)|318|||
126271121|NCT02149108|454286611|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
126271122|NCT02149108|454286612|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
126271123|NCT02149108|454286611|FG000|Overall Study|Other Adverse Event (AE)|8|||
126271124|NCT02149108|454286612|FG001|Overall Study|Other Adverse Event (AE)|18|||
126271125|NCT02149108|454286611|FG000|Overall Study|Other not defined above|0|||
126271126|NCT02149108|454286612|FG001|Overall Study|Other not defined above|2|||
126271127|NCT02149108|454286611|FG000|Overall Study|Refusal to continue trial medication|15|||
126271128|NCT02149108|454286612|FG001|Overall Study|Refusal to continue trial medication|11|||
126271129|NCT02149108|454286611|FG000|Overall Study|Lost to Follow-up|1|||
126271130|NCT02149108|454286612|FG001|Overall Study|Lost to Follow-up|0|||
126271131|NCT00950963|454286613|FG000|Overall Study|Lost to Follow-up|29|||
126271132|NCT00950963|454286614|FG001|Overall Study|Lost to Follow-up|24|||
126271133|NCT00848107|454286615|FG000|Overall Study|Lost to Follow-up|2|||
126271134|NCT00848107|454286615|FG000|Overall Study|Withdrawal by Subject|8|||
126271135|NCT00848107|454286615|FG000|Overall Study|Adverse Event|9|||
126271136|NCT00848107|454286615|FG000|Overall Study|Death|1|||
126271137|NCT00848107|454286615|FG000|Overall Study|Pregnancy|1|||
126271138|NCT02335983|454286616|FG000|Overall Study|Sponsor Decision|0|||
126271139|NCT02335983|454286617|FG001|Overall Study|Sponsor Decision|0|||
126271140|NCT02335983|454286618|FG002|Overall Study|Sponsor Decision|1|||
126271141|NCT02335983|454286619|FG003|Overall Study|Sponsor Decision|1|||
126271142|NCT02335983|454286620|FG004|Overall Study|Sponsor Decision|0|||
126271143|NCT02335983|454286621|FG005|Overall Study|Sponsor Decision|1|||
126271144|NCT02335983|454286616|FG000|Overall Study|Withdrawal by Subject|3|||
126271145|NCT02335983|454286617|FG001|Overall Study|Withdrawal by Subject|2|||
126271146|NCT02335983|454286618|FG002|Overall Study|Withdrawal by Subject|2|||
126271147|NCT02335983|454286619|FG003|Overall Study|Withdrawal by Subject|1|||
126271148|NCT02335983|454286620|FG004|Overall Study|Withdrawal by Subject|3|||
126271149|NCT02335983|454286621|FG005|Overall Study|Withdrawal by Subject|9|||
126271150|NCT02335983|454286616|FG000|Overall Study|Death|0|||
126271151|NCT02335983|454286617|FG001|Overall Study|Death|0|||
126271152|NCT02335983|454286618|FG002|Overall Study|Death|2|||
126271153|NCT02335983|454286619|FG003|Overall Study|Death|0|||
126271154|NCT02335983|454286620|FG004|Overall Study|Death|0|||
126271155|NCT02335983|454286621|FG005|Overall Study|Death|0|||
126271156|NCT02335983|454286616|FG000|Overall Study|Lost to Follow-up|0|||
126271157|NCT02335983|454286617|FG001|Overall Study|Lost to Follow-up|0|||
126271158|NCT02335983|454286618|FG002|Overall Study|Lost to Follow-up|0|||
126271159|NCT02335983|454286619|FG003|Overall Study|Lost to Follow-up|0|||
126271160|NCT02335983|454286620|FG004|Overall Study|Lost to Follow-up|0|||
126271161|NCT02335983|454286621|FG005|Overall Study|Lost to Follow-up|1|||
126271162|NCT02335983|454286616|FG000|Overall Study|Protocol Specified Criteria|5|||
126271163|NCT02335983|454286617|FG001|Overall Study|Protocol Specified Criteria|7|||
126271164|NCT02335983|454286618|FG002|Overall Study|Protocol Specified Criteria|27|||
126271165|NCT02335983|454286619|FG003|Overall Study|Protocol Specified Criteria|7|||
126271166|NCT02335983|454286620|FG004|Overall Study|Protocol Specified Criteria|5|||
126271167|NCT02335983|454286621|FG005|Overall Study|Protocol Specified Criteria|21|||
126271168|NCT00987389|454286622|FG000|Overall Study|Ineligible|0|||
126271169|NCT00987389|454286623|FG001|Overall Study|Ineligible|3|||
126271170|NCT00987389|454286624|FG002|Overall Study|Ineligible|0|||
126271171|NCT00987389|454286625|FG003|Overall Study|Ineligible|0|||
126271172|NCT00987389|454286622|FG000|Overall Study|Lost to Follow-up|4|||
126271173|NCT00987389|454286623|FG001|Overall Study|Lost to Follow-up|1|||
126271174|NCT00987389|454286624|FG002|Overall Study|Lost to Follow-up|3|||
126271175|NCT00987389|454286625|FG003|Overall Study|Lost to Follow-up|1|||
126271176|NCT00987389|454286622|FG000|Overall Study|Withdrawal by Subject|4|||
126361708|NCT01052428|454617251|FG000|Overall Study|Death|1|||
126271177|NCT00987389|454286623|FG001|Overall Study|Withdrawal by Subject|3|||
126271178|NCT00987389|454286624|FG002|Overall Study|Withdrawal by Subject|2|||
126271179|NCT00987389|454286625|FG003|Overall Study|Withdrawal by Subject|1|||
126271180|NCT00987389|454286622|FG000|Overall Study|Withdrawn from Treatment|0|||
126271181|NCT00987389|454286623|FG001|Overall Study|Withdrawn from Treatment|1|||
126271182|NCT00987389|454286624|FG002|Overall Study|Withdrawn from Treatment|0|||
126271183|NCT00987389|454286625|FG003|Overall Study|Withdrawn from Treatment|0|||
126271184|NCT00987389|454286622|FG000|Overall Study|Multiple different reasons|1|||
126271185|NCT00987389|454286623|FG001|Overall Study|Multiple different reasons|0|||
126271186|NCT00987389|454286624|FG002|Overall Study|Multiple different reasons|3|||
126271187|NCT00987389|454286625|FG003|Overall Study|Multiple different reasons|1|||
126271188|NCT01831765|454286626|FG000|Overall Study|Lack of Efficacy|1|||
126361709|NCT01052428|454617252|FG001|Overall Study|Death|0|||
126271189|NCT01831765|454286627|FG001|Overall Study|Lack of Efficacy|0|||
126271190|NCT01831765|454286628|FG002|Overall Study|Lack of Efficacy|0|||
126271191|NCT01831765|454286626|FG000|Overall Study|Other, sponsor withdrew subject|0|||
126271192|NCT01831765|454286627|FG001|Overall Study|Other, sponsor withdrew subject|1|||
126271193|NCT01831765|454286628|FG002|Overall Study|Other, sponsor withdrew subject|0|||
126271194|NCT01831765|454286626|FG000|Overall Study|Pregnancy|1|||
126271195|NCT01831765|454286627|FG001|Overall Study|Pregnancy|1|||
126271196|NCT01831765|454286628|FG002|Overall Study|Pregnancy|2|||
126271197|NCT01831765|454286626|FG000|Overall Study|Death|0|||
126271198|NCT01831765|454286627|FG001|Overall Study|Death|1|||
126271199|NCT01831765|454286628|FG002|Overall Study|Death|1|||
126271200|NCT01831765|454286626|FG000|Overall Study|Other, site closed|1|||
126271201|NCT01831765|454286627|FG001|Overall Study|Other, site closed|1|||
126271202|NCT01831765|454286628|FG002|Overall Study|Other, site closed|0|||
126271203|NCT01831765|454286626|FG000|Overall Study|Adverse Event|5|||
126271204|NCT01831765|454286627|FG001|Overall Study|Adverse Event|3|||
126271205|NCT01831765|454286628|FG002|Overall Study|Adverse Event|3|||
126271206|NCT01831765|454286626|FG000|Overall Study|Withdrawal by Subject|22|||
126271207|NCT01831765|454286627|FG001|Overall Study|Withdrawal by Subject|7|||
126271208|NCT01831765|454286628|FG002|Overall Study|Withdrawal by Subject|17|||
126271209|NCT01831765|454286626|FG000|Overall Study|Withdrawal criteria|12|||
126271210|NCT01831765|454286627|FG001|Overall Study|Withdrawal criteria|10|||
126271211|NCT01831765|454286628|FG002|Overall Study|Withdrawal criteria|16|||
126271212|NCT01831765|454286626|FG000|Overall Study|Lost to Follow-up|2|||
126271213|NCT01831765|454286627|FG001|Overall Study|Lost to Follow-up|3|||
126271214|NCT01831765|454286628|FG002|Overall Study|Lost to Follow-up|3|||
126271215|NCT00655876|454286629|FG000|Overall Study|Protocol Violation|9|||
126271216|NCT00655876|454286630|FG001|Overall Study|Protocol Violation|7|||
126271217|NCT00326963|454286631|FG000|Overall Study|Adverse Event|2|||
126271218|NCT00326963|454286631|FG000|Overall Study|Injection site reaction|1|||
126271219|NCT00326963|454286631|FG000|Overall Study|Death|1|||
126271220|NCT00326963|454286631|FG000|Overall Study|Failure to return|10|||
126271221|NCT00326963|454286631|FG000|Overall Study|Withdrawal by Subject|10|||
126271222|NCT00326963|454286631|FG000|Overall Study|Refused treatment / did not cooperate|5|||
126271223|NCT00326963|454286631|FG000|Overall Study|Violation of selection criteria at entry|2|||
126271224|NCT00326963|454286631|FG000|Overall Study|Other protocol violation|1|||
126271225|NCT00326963|454286631|FG000|Overall Study|Administrative / other|1|||
126271226|NCT00507130|454286632|FG000|Overall Study|Lost to Follow-up|0|||
126271227|NCT00507130|454286633|FG001|Overall Study|Lost to Follow-up|0|||
126271228|NCT00507130|454286634|FG002|Overall Study|Lost to Follow-up|1|||
126271229|NCT00507130|454286635|FG003|Overall Study|Lost to Follow-up|1|||
126271230|NCT00507130|454286632|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
126271231|NCT00507130|454286633|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
126271232|NCT00507130|454286634|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
126271233|NCT00507130|454286635|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
126271234|NCT00859586|454286636|FG000|Overall Study|Donors|4|||
126271235|NCT00080938|454286641|FG000|Overall Study|Adverse Event|3|||
126271236|NCT00080938|454286641|FG000|Overall Study|Withdrawal by Subject|6|||
126271237|NCT00080938|454286641|FG000|Overall Study|Death|2|||
126271238|NCT00080938|454286641|FG000|Overall Study|Lack of Efficacy|7|||
126271239|NCT00080938|454286641|FG000|Overall Study|other disease|1|||
126271240|NCT00080938|454286641|FG000|Overall Study|Not started protocol therapy|1|||
126271241|NCT00080938|454286641|FG000|Overall Study|Ineligible|4|||
126271242|NCT00706511|454286644|FG000|Overall Study|Withdrawal by Subject|1|||
126271243|NCT00706511|454286645|FG001|Overall Study|Withdrawal by Subject|0|||
126271244|NCT00706511|454286646|FG002|Overall Study|Withdrawal by Subject|0|||
126271245|NCT00706511|454286647|FG003|Overall Study|Withdrawal by Subject|0|||
126271246|NCT02605993|454286649|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
126271247|NCT02605993|454286650|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
126271248|NCT02605993|454286651|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
126271249|NCT02605993|454286652|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
126271250|NCT02603393|454286653|FG000|Overall Study|Patient/guardian decision|32|||
126271251|NCT02603393|454286654|FG001|Overall Study|Patient/guardian decision|18|||
126271252|NCT02603393|454286653|FG000|Overall Study|Adverse Event|17|||
126271253|NCT02603393|454286654|FG001|Overall Study|Adverse Event|15|||
126271254|NCT02603393|454286653|FG000|Overall Study|Technical problems|4|||
126271255|NCT02603393|454286654|FG001|Overall Study|Technical problems|7|||
126271256|NCT02603393|454286653|FG000|Overall Study|Lack of Efficacy|7|||
126271257|NCT02603393|454286654|FG001|Overall Study|Lack of Efficacy|2|||
126271258|NCT02603393|454286653|FG000|Overall Study|Death|3|||
126271259|NCT02603393|454286654|FG001|Overall Study|Death|4|||
126271260|NCT02603393|454286653|FG000|Overall Study|Physician Decision|3|||
126271261|NCT02603393|454286654|FG001|Overall Study|Physician Decision|3|||
126271262|NCT02603393|454286653|FG000|Overall Study|Protocol deviation|2|||
126271263|NCT02603393|454286654|FG001|Overall Study|Protocol deviation|3|||
126271264|NCT02603393|454286653|FG000|Overall Study|Lost to Follow-up|1|||
126271265|NCT02603393|454286654|FG001|Overall Study|Lost to Follow-up|2|||
126271266|NCT02603393|454286653|FG000|Overall Study|Non-compliance with study treatment|1|||
126271267|NCT02603393|454286654|FG001|Overall Study|Non-compliance with study treatment|0|||
126271268|NCT02603393|454286653|FG000|Overall Study|Sponsor decision|1|||
126271269|NCT02603393|454286654|FG001|Overall Study|Sponsor decision|0|||
126271270|NCT00338455|454286662|FG000|Overall Study|Death|2|||
126271271|NCT00338455|454286663|FG001|Overall Study|Death|1|||
126271272|NCT00338455|454286662|FG000|Overall Study|Physician Decision|1|||
126271273|NCT00338455|454286663|FG001|Overall Study|Physician Decision|0|||
126271274|NCT02266134|454286664|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
126271275|NCT02266134|454286665|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
126271276|NCT02266134|454286666|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
126271277|NCT02266134|454286667|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
126271278|NCT02266134|454286664|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
126271279|NCT02266134|454286665|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
126271280|NCT02266134|454286666|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
126271281|NCT02266134|454286667|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
126271282|NCT02266134|454286664|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
126271283|NCT02266134|454286665|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
126271284|NCT02266134|454286666|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
126271285|NCT02266134|454286667|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
126271286|NCT02266134|454286664|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
126271287|NCT02266134|454286665|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
126271288|NCT02266134|454286666|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
126271289|NCT02266134|454286667|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
126271290|NCT02266134|454286664|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
126271291|NCT02266134|454286665|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
126271292|NCT02266134|454286666|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
126271293|NCT02266134|454286667|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
126271294|NCT02266134|454286664|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
126271295|NCT02266134|454286665|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
126271296|NCT02266134|454286666|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
126271297|NCT02266134|454286667|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
126271298|NCT01437943|454286670|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
126271299|NCT01437943|454286671|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
126271300|NCT01437943|454286670|FG000|Overall Study|Subject expressed pregnancy plans|1|||
126271301|NCT01437943|454286671|FG001|Overall Study|Subject expressed pregnancy plans|0|||
126271302|NCT01437943|454286670|FG000|Overall Study|Adverse Event|2|||
126271303|NCT01437943|454286671|FG001|Overall Study|Adverse Event|0|||
126271304|NCT01986010|454286672|FG000|Overall Study|Adverse Event|0|||
126271305|NCT01986010|454286673|FG001|Overall Study|Adverse Event|1|||
126271306|NCT01986010|454286674|FG002|Overall Study|Adverse Event|0|||
126271307|NCT01986010|454286675|FG003|Overall Study|Adverse Event|0|||
126271308|NCT01986010|454286676|FG004|Overall Study|Adverse Event|0|||
126271309|NCT01986010|454286677|FG005|Overall Study|Adverse Event|0|||
126271310|NCT01986010|454286678|FG006|Overall Study|Adverse Event|0|||
126271311|NCT01986010|454286679|FG007|Overall Study|Adverse Event|0|||
126271312|NCT01986010|454286680|FG008|Overall Study|Adverse Event|0|||
126271313|NCT01986010|454286681|FG009|Overall Study|Adverse Event|0|||
126271314|NCT01986010|454286682|FG010|Overall Study|Adverse Event|0|||
126271315|NCT01986010|454286683|FG011|Overall Study|Adverse Event|0|||
126271316|NCT01986010|454286684|FG012|Overall Study|Adverse Event|0|||
126271317|NCT01986010|454286685|FG013|Overall Study|Adverse Event|0|||
126705363|NCT02034123|455871744|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
126705364|NCT02034123|455871745|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126705365|NCT02034123|455871746|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126705366|NCT02034123|455871747|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126705367|NCT02034123|455871748|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126705368|NCT02034123|455871749|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126705369|NCT02034123|455871750|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126705370|NCT02034123|455871751|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126705371|NCT02034123|455871752|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126705372|NCT02034123|455871753|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126705373|NCT02034123|455871754|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126705374|NCT02034123|455871755|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126705375|NCT02034123|455871756|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126705376|NCT02034123|455871757|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126271318|NCT01986010|454286686|FG014|Overall Study|Adverse Event|0|||
126705377|NCT02034123|455871758|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
126271319|NCT01986010|454286687|FG015|Overall Study|Adverse Event|1|||
126271320|NCT01986010|454286688|FG016|Overall Study|Adverse Event|0|||
126705378|NCT02034123|455871741|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705379|NCT02034123|455871742|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705380|NCT02034123|455871743|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126271321|NCT01986010|454286672|FG000|Overall Study|Lost to Follow-up|2|||
126271322|NCT01986010|454286673|FG001|Overall Study|Lost to Follow-up|1|||
126271323|NCT01986010|454286674|FG002|Overall Study|Lost to Follow-up|2|||
126271324|NCT01986010|454286675|FG003|Overall Study|Lost to Follow-up|2|||
126271325|NCT01986010|454286676|FG004|Overall Study|Lost to Follow-up|2|||
126271326|NCT01986010|454286677|FG005|Overall Study|Lost to Follow-up|2|||
126271327|NCT01986010|454286678|FG006|Overall Study|Lost to Follow-up|0|||
126271328|NCT01986010|454286679|FG007|Overall Study|Lost to Follow-up|0|||
126271329|NCT01986010|454286680|FG008|Overall Study|Lost to Follow-up|4|||
126271330|NCT01986010|454286681|FG009|Overall Study|Lost to Follow-up|2|||
126271331|NCT01986010|454286682|FG010|Overall Study|Lost to Follow-up|0|||
126271332|NCT01986010|454286683|FG011|Overall Study|Lost to Follow-up|1|||
126271333|NCT01986010|454286684|FG012|Overall Study|Lost to Follow-up|1|||
126271334|NCT01986010|454286685|FG013|Overall Study|Lost to Follow-up|1|||
126271335|NCT01986010|454286686|FG014|Overall Study|Lost to Follow-up|2|||
126271336|NCT01986010|454286687|FG015|Overall Study|Lost to Follow-up|0|||
126271337|NCT01986010|454286688|FG016|Overall Study|Lost to Follow-up|0|||
126271338|NCT01986010|454286672|FG000|Overall Study|Physician Decision|0|||
126271339|NCT01986010|454286673|FG001|Overall Study|Physician Decision|0|||
126271340|NCT01986010|454286674|FG002|Overall Study|Physician Decision|0|||
126271341|NCT01986010|454286675|FG003|Overall Study|Physician Decision|0|||
126271342|NCT01986010|454286676|FG004|Overall Study|Physician Decision|0|||
126271343|NCT01986010|454286677|FG005|Overall Study|Physician Decision|0|||
126271344|NCT01986010|454286678|FG006|Overall Study|Physician Decision|0|||
126271345|NCT01986010|454286679|FG007|Overall Study|Physician Decision|0|||
126271346|NCT01986010|454286680|FG008|Overall Study|Physician Decision|0|||
126271347|NCT01986010|454286681|FG009|Overall Study|Physician Decision|0|||
126271348|NCT01986010|454286682|FG010|Overall Study|Physician Decision|0|||
126271349|NCT01986010|454286683|FG011|Overall Study|Physician Decision|0|||
126271350|NCT01986010|454286684|FG012|Overall Study|Physician Decision|0|||
126271351|NCT01986010|454286685|FG013|Overall Study|Physician Decision|0|||
126271352|NCT01986010|454286686|FG014|Overall Study|Physician Decision|1|||
126271353|NCT01986010|454286687|FG015|Overall Study|Physician Decision|0|||
126271354|NCT01986010|454286688|FG016|Overall Study|Physician Decision|0|||
126271355|NCT01986010|454286672|FG000|Overall Study|Withdrawal by Subject|2|||
126271356|NCT01986010|454286673|FG001|Overall Study|Withdrawal by Subject|2|||
126271357|NCT01986010|454286674|FG002|Overall Study|Withdrawal by Subject|3|||
126271358|NCT01986010|454286675|FG003|Overall Study|Withdrawal by Subject|0|||
126271359|NCT01986010|454286676|FG004|Overall Study|Withdrawal by Subject|2|||
126271360|NCT01986010|454286677|FG005|Overall Study|Withdrawal by Subject|4|||
126271361|NCT01986010|454286678|FG006|Overall Study|Withdrawal by Subject|0|||
126271362|NCT01986010|454286679|FG007|Overall Study|Withdrawal by Subject|0|||
126271363|NCT01986010|454286680|FG008|Overall Study|Withdrawal by Subject|0|||
126271364|NCT01986010|454286681|FG009|Overall Study|Withdrawal by Subject|0|||
126271365|NCT01986010|454286682|FG010|Overall Study|Withdrawal by Subject|0|||
126271366|NCT01986010|454286683|FG011|Overall Study|Withdrawal by Subject|2|||
126271367|NCT01986010|454286684|FG012|Overall Study|Withdrawal by Subject|0|||
126271368|NCT01986010|454286685|FG013|Overall Study|Withdrawal by Subject|1|||
126271369|NCT01986010|454286686|FG014|Overall Study|Withdrawal by Subject|2|||
126271370|NCT01986010|454286687|FG015|Overall Study|Withdrawal by Subject|0|||
126271371|NCT01986010|454286688|FG016|Overall Study|Withdrawal by Subject|0|||
126271372|NCT01986010|454286672|FG000|Overall Study|Status Not Recorded|2|||
126271373|NCT01986010|454286673|FG001|Overall Study|Status Not Recorded|4|||
126271374|NCT01986010|454286674|FG002|Overall Study|Status Not Recorded|2|||
126271375|NCT01986010|454286675|FG003|Overall Study|Status Not Recorded|0|||
126271376|NCT01986010|454286676|FG004|Overall Study|Status Not Recorded|1|||
126705381|NCT02034123|455871744|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705382|NCT02034123|455871745|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705383|NCT02034123|455871746|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126271377|NCT01986010|454286677|FG005|Overall Study|Status Not Recorded|2|||
126271378|NCT01986010|454286678|FG006|Overall Study|Status Not Recorded|0|||
126271379|NCT01986010|454286679|FG007|Overall Study|Status Not Recorded|0|||
126705384|NCT02034123|455871747|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126765591|NCT04636437|456094563|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
126271380|NCT01986010|454286680|FG008|Overall Study|Status Not Recorded|2|||
126271381|NCT01986010|454286681|FG009|Overall Study|Status Not Recorded|1|||
126271382|NCT01986010|454286682|FG010|Overall Study|Status Not Recorded|7|||
126271383|NCT01986010|454286683|FG011|Overall Study|Status Not Recorded|7|||
126271384|NCT01986010|454286684|FG012|Overall Study|Status Not Recorded|9|||
126271385|NCT01986010|454286685|FG013|Overall Study|Status Not Recorded|9|||
126271386|NCT01986010|454286686|FG014|Overall Study|Status Not Recorded|5|||
126271387|NCT01986010|454286687|FG015|Overall Study|Status Not Recorded|10|||
126271388|NCT01986010|454286688|FG016|Overall Study|Status Not Recorded|4|||
126271389|NCT01335997|454286689|FG000|Period I and II|Adverse Event|63|||
126271390|NCT01335997|454286690|FG001|Period I and II|Adverse Event|43|||
126271391|NCT01335997|454286689|FG000|Period I and II|Noncompliance with Study Drug|1|||
126271392|NCT01335997|454286690|FG001|Period I and II|Noncompliance with Study Drug|1|||
126271393|NCT01335997|454286689|FG000|Period I and II|Lost to Follow-up|3|||
126271394|NCT01335997|454286690|FG001|Period I and II|Lost to Follow-up|5|||
126271395|NCT01335997|454286689|FG000|Period I and II|Withdrawal by Subject|9|||
126271396|NCT01335997|454286690|FG001|Period I and II|Withdrawal by Subject|4|||
126271397|NCT01335997|454286689|FG000|Period I and II|Study Terminated by Sponsor|406|||
126271398|NCT01335997|454286690|FG001|Period I and II|Study Terminated by Sponsor|415|||
126271399|NCT01335997|454286689|FG000|Period I and II|Protocol Violation|9|||
126271400|NCT01335997|454286690|FG001|Period I and II|Protocol Violation|10|||
126271401|NCT01335997|454286689|FG000|Period I and II|Physician Decision|2|||
126271402|NCT01335997|454286690|FG001|Period I and II|Physician Decision|1|||
126271403|NCT01335997|454286689|FG000|Period III|Adverse Event|0|||
126271404|NCT01335997|454286690|FG001|Period III|Adverse Event|2|||
126271405|NCT01335997|454286689|FG000|Period III|Study Terminated by Sponsor|77|||
126271406|NCT01335997|454286690|FG001|Period III|Study Terminated by Sponsor|76|||
126271407|NCT01335997|454286689|FG000|Period III|Protocol Violation|0|||
126271408|NCT01335997|454286690|FG001|Period III|Protocol Violation|1|||
126271409|NCT01335997|454286689|FG000|Period III|Lost to Follow-up|1|||
126271410|NCT01335997|454286690|FG001|Period III|Lost to Follow-up|0|||
126271411|NCT04740814|454286691|FG000|Overall Study|Adverse Event|3|||
126271412|NCT04740814|454286691|FG000|Overall Study|Protocol Violation|2|||
126271413|NCT04740814|454286691|FG000|Overall Study|Lost to Follow-up|2|||
126271414|NCT04740814|454286691|FG000|Overall Study|Withdrawal by Subject|3|||
126271415|NCT01763684|454286692|FG000|Overall Study|Study terminated early due to low enrollment|126|||
126271416|NCT01763684|454286693|FG001|Overall Study|Study terminated early due to low enrollment|127|||
126271417|NCT01763684|454286692|FG000|Overall Study|Study surgery not performed|7|||
126271418|NCT01763684|454286693|FG001|Overall Study|Study surgery not performed|6|||
126271419|NCT04453202|454286698|FG000|Overall Study|Adverse Event|0|||
126271420|NCT04453202|454286699|FG001|Overall Study|Adverse Event|0|||
126271421|NCT04453202|454286700|FG002|Overall Study|Adverse Event|0|||
126271422|NCT04453202|454286701|FG003|Overall Study|Adverse Event|0|||
126271423|NCT04453202|454286702|FG004|Overall Study|Adverse Event|0|||
126271424|NCT04453202|454286703|FG005|Overall Study|Adverse Event|0|||
126271425|NCT04453202|454286704|FG006|Overall Study|Adverse Event|1|||
126271426|NCT04453202|454286705|FG007|Overall Study|Adverse Event|0|||
126271427|NCT04453202|454286706|FG008|Overall Study|Adverse Event|0|||
126271428|NCT04453202|454286707|FG009|Overall Study|Adverse Event|0|||
126271429|NCT04453202|454286708|FG010|Overall Study|Adverse Event|0|||
126271430|NCT04453202|454286698|FG000|Overall Study|Death|0|||
126271431|NCT04453202|454286699|FG001|Overall Study|Death|0|||
126271432|NCT04453202|454286700|FG002|Overall Study|Death|0|||
126271433|NCT04453202|454286701|FG003|Overall Study|Death|0|||
126271434|NCT04453202|454286702|FG004|Overall Study|Death|0|||
126271435|NCT04453202|454286703|FG005|Overall Study|Death|0|||
126271436|NCT04453202|454286704|FG006|Overall Study|Death|0|||
126271437|NCT04453202|454286705|FG007|Overall Study|Death|0|||
126271438|NCT04453202|454286706|FG008|Overall Study|Death|0|||
126271439|NCT04453202|454286707|FG009|Overall Study|Death|1|||
126271440|NCT04453202|454286708|FG010|Overall Study|Death|0|||
126271441|NCT04453202|454286698|FG000|Overall Study|Lost to Follow-up|0|||
126271442|NCT04453202|454286699|FG001|Overall Study|Lost to Follow-up|1|||
126271443|NCT04453202|454286700|FG002|Overall Study|Lost to Follow-up|0|||
126271444|NCT04453202|454286701|FG003|Overall Study|Lost to Follow-up|1|||
126271445|NCT04453202|454286702|FG004|Overall Study|Lost to Follow-up|0|||
126271446|NCT04453202|454286703|FG005|Overall Study|Lost to Follow-up|0|||
126271447|NCT04453202|454286704|FG006|Overall Study|Lost to Follow-up|0|||
126271448|NCT04453202|454286705|FG007|Overall Study|Lost to Follow-up|0|||
126271449|NCT04453202|454286706|FG008|Overall Study|Lost to Follow-up|0|||
126271450|NCT04453202|454286707|FG009|Overall Study|Lost to Follow-up|1|||
126271451|NCT04453202|454286708|FG010|Overall Study|Lost to Follow-up|1|||
126271452|NCT04453202|454286698|FG000|Overall Study|Withdrawal by Subject|1|||
126271453|NCT04453202|454286699|FG001|Overall Study|Withdrawal by Subject|2|||
126271454|NCT04453202|454286700|FG002|Overall Study|Withdrawal by Subject|1|||
126271455|NCT04453202|454286701|FG003|Overall Study|Withdrawal by Subject|2|||
126705385|NCT02034123|455871748|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705386|NCT02034123|455871749|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
126271456|NCT04453202|454286702|FG004|Overall Study|Withdrawal by Subject|1|||
126271457|NCT04453202|454286703|FG005|Overall Study|Withdrawal by Subject|1|||
126271458|NCT04453202|454286704|FG006|Overall Study|Withdrawal by Subject|0|||
126271459|NCT04453202|454286705|FG007|Overall Study|Withdrawal by Subject|0|||
126271460|NCT04453202|454286706|FG008|Overall Study|Withdrawal by Subject|0|||
126271461|NCT04453202|454286707|FG009|Overall Study|Withdrawal by Subject|1|||
126271462|NCT04453202|454286708|FG010|Overall Study|Withdrawal by Subject|0|||
126271463|NCT04453202|454286698|FG000|Overall Study|Adverse Event|0|||
126271464|NCT04453202|454286699|FG001|Overall Study|Adverse Event|0|||
126271465|NCT04453202|454286700|FG002|Overall Study|Adverse Event|0|||
126271466|NCT04453202|454286701|FG003|Overall Study|Adverse Event|0|||
126271467|NCT04453202|454286702|FG004|Overall Study|Adverse Event|0|||
126271468|NCT04453202|454286703|FG005|Overall Study|Adverse Event|1|||
126271469|NCT04453202|454286704|FG006|Overall Study|Adverse Event|0|||
126271470|NCT04453202|454286705|FG007|Overall Study|Adverse Event|0|||
126271471|NCT04453202|454286706|FG008|Overall Study|Adverse Event|0|||
126271472|NCT04453202|454286707|FG009|Overall Study|Adverse Event|0|||
126271473|NCT04453202|454286708|FG010|Overall Study|Adverse Event|0|||
126271474|NCT01157897|454286709|FG000|Overall Study|Lost to Follow-up|2|||
126271475|NCT01157897|454286710|FG001|Overall Study|Lost to Follow-up|0|||
126271476|NCT01157897|454286711|FG002|Overall Study|Lost to Follow-up|0|||
126271477|NCT01157897|454286712|FG003|Overall Study|Lost to Follow-up|1|||
126271478|NCT01157897|454286709|FG000|Overall Study|Relocated|0|||
126271479|NCT01157897|454286710|FG001|Overall Study|Relocated|2|||
126271480|NCT01157897|454286711|FG002|Overall Study|Relocated|0|||
126271481|NCT01157897|454286712|FG003|Overall Study|Relocated|0|||
126271482|NCT03276221|454286713|FG000|Overall Study|Lost to Follow-up|6|||
126271483|NCT03276221|454286714|FG001|Overall Study|Lost to Follow-up|2|||
126271484|NCT03276221|454286715|FG002|Overall Study|Lost to Follow-up|0|||
126271485|NCT03276221|454286713|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
126271486|NCT03276221|454286714|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
126271487|NCT03276221|454286715|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
126271488|NCT02912650|454286716|FG000|Overall Study|Withdrawal by Subject|1|||
126271489|NCT02912650|454286717|FG001|Overall Study|Withdrawal by Subject|0|||
126271490|NCT02912650|454286718|FG002|Overall Study|Withdrawal by Subject|1|||
126271491|NCT02912650|454286719|FG003|Overall Study|Withdrawal by Subject|5|||
126271492|NCT02912650|454286716|FG000|Overall Study|Adverse Event|0|||
126271493|NCT02912650|454286717|FG001|Overall Study|Adverse Event|0|||
126271494|NCT02912650|454286718|FG002|Overall Study|Adverse Event|1|||
126271495|NCT02912650|454286719|FG003|Overall Study|Adverse Event|0|||
126271496|NCT02562482|454286721|FG000|Overall Study|Enrolled, but did not receive product|4|||
126271497|NCT02562482|454286722|FG001|Overall Study|Enrolled, but did not receive product|0|||
126271498|NCT02562482|454286721|FG000|Overall Study|Lost to Follow-up|9|||
126271499|NCT02562482|454286722|FG001|Overall Study|Lost to Follow-up|6|||
126271500|NCT02562482|454286721|FG000|Overall Study|Moved from area|2|||
126271501|NCT02562482|454286722|FG001|Overall Study|Moved from area|3|||
126271502|NCT02562482|454286721|FG000|Overall Study|Withdrawal by Subject|5|||
126271503|NCT02562482|454286722|FG001|Overall Study|Withdrawal by Subject|3|||
126271504|NCT02562482|454286721|FG000|Overall Study|Physician Decision|1|||
126271505|NCT02562482|454286722|FG001|Overall Study|Physician Decision|3|||
126271506|NCT02562482|454286721|FG000|Overall Study|Illness/Injury unrelated to product|0|||
126271507|NCT02562482|454286722|FG001|Overall Study|Illness/Injury unrelated to product|1|||
126271508|NCT02980874|454286727|FG000|Overall Study|Adverse Event|2|||
126271509|NCT02980874|454286728|FG001|Overall Study|Adverse Event|7|||
126271510|NCT02980874|454286727|FG000|Overall Study|Withdrawal by Subject|7|||
126271511|NCT02980874|454286728|FG001|Overall Study|Withdrawal by Subject|2|||
126271512|NCT02980874|454286727|FG000|Overall Study|Lost to Follow-up|5|||
126271513|NCT02980874|454286728|FG001|Overall Study|Lost to Follow-up|5|||
126271514|NCT02980874|454286727|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
126271515|NCT02980874|454286728|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
126271516|NCT02980874|454286727|FG000|Overall Study|Unknown study completion status|1|||
126271517|NCT02980874|454286728|FG001|Overall Study|Unknown study completion status|0|||
126271518|NCT02722148|454286729|FG000|Overall Study|Lost to Follow-up|2|||
126271519|NCT02722148|454286729|FG000|Overall Study|Non compliant with treatment regimen|3|||
126271520|NCT02435836|454286730|FG000|Overall Study|Lost to Follow-up|21|||
126271521|NCT02435836|454286730|FG000|Overall Study|Lack of Efficacy|1|||
126271522|NCT02435836|454286730|FG000|Overall Study|Withdrawal by Subject|236|||
126271523|NCT02435836|454286730|FG000|Overall Study|Insufficient Clinical Response|26|||
126271524|NCT02435836|454286730|FG000|Overall Study|Adverse Event|44|||
126271525|NCT02435836|454286730|FG000|Overall Study|Sponsor discontinued trial|167|||
126271526|NCT02435836|454286730|FG000|Overall Study|Noncompliance|27|||
126271527|NCT02435836|454286730|FG000|Overall Study|Protocol Violation|6|||
126271528|NCT02435836|454286730|FG000|Overall Study|Met Withdrawal Criteria|7|||
126271529|NCT02435836|454286730|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
126271530|NCT02041091|454286731|FG000|Treatment|Adverse Event|3|||
126271531|NCT02041091|454286732|FG001|Treatment|Adverse Event|3|||
126271532|NCT02041091|454286731|FG000|Treatment|Withdrawal by Subject|2|||
126271533|NCT02041091|454286732|FG001|Treatment|Withdrawal by Subject|4|||
126271534|NCT02041091|454286731|FG000|Treatment|Physician Decision|1|||
126453501|NCT01478048|454961428|FG001|Overall Study|no longer meets study criteria|0|||
126715188|NCT01052012|455908709|FG003|Overall Study|Withdrawal by Subject|0|||
126271535|NCT02041091|454286732|FG001|Treatment|Physician Decision|0|||
126271536|NCT02041091|454286731|FG000|Treatment|Sponsor Decision|15|||
126271537|NCT02041091|454286732|FG001|Treatment|Sponsor Decision|16|||
126271538|NCT02041091|454286731|FG000|Treatment|Lost to Follow-up|1|||
126271539|NCT02041091|454286732|FG001|Treatment|Lost to Follow-up|0|||
126271540|NCT02041091|454286731|FG000|Optional Safety Extension Period|Adverse Event|4|||
126271541|NCT02041091|454286732|FG001|Optional Safety Extension Period|Adverse Event|2|||
126271542|NCT02041091|454286731|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
126271543|NCT02041091|454286732|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
126271544|NCT02041091|454286731|FG000|Optional Safety Extension Period|Protocol Violation|2|||
126271545|NCT02041091|454286732|FG001|Optional Safety Extension Period|Protocol Violation|0|||
126271546|NCT02041091|454286731|FG000|Optional Safety Extension Period|Physician Decision|2|||
126271547|NCT02041091|454286732|FG001|Optional Safety Extension Period|Physician Decision|1|||
126271548|NCT02041091|454286731|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
126271549|NCT02041091|454286732|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
126271550|NCT02041091|454286731|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
126271551|NCT02041091|454286732|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
126271552|NCT00922987|454286733|FG000|Overall Study|Insufficient clinical response|1|||
126271553|NCT00922987|454286733|FG000|Overall Study|Protocol Violation|2|||
126271554|NCT00922987|454286733|FG000|Overall Study|Adverse Event|1|||
126271555|NCT00446199|454286734|FG000|Overall Study|Adverse Event|7|||
126271556|NCT00446199|454286735|FG001|Overall Study|Adverse Event|4|||
126271557|NCT00446199|454286736|FG002|Overall Study|Adverse Event|6|||
126271558|NCT00446199|454286737|FG003|Overall Study|Adverse Event|4|||
126271559|NCT00446199|454286734|FG000|Overall Study|Lost to Follow-up|4|||
126271560|NCT00446199|454286735|FG001|Overall Study|Lost to Follow-up|5|||
126271561|NCT00446199|454286736|FG002|Overall Study|Lost to Follow-up|2|||
126271562|NCT00446199|454286737|FG003|Overall Study|Lost to Follow-up|6|||
126271563|NCT00446199|454286734|FG000|Overall Study|Protocol Violation|1|||
126271564|NCT00446199|454286735|FG001|Overall Study|Protocol Violation|2|||
126271565|NCT00446199|454286736|FG002|Overall Study|Protocol Violation|1|||
126271566|NCT00446199|454286737|FG003|Overall Study|Protocol Violation|3|||
126271567|NCT00446199|454286734|FG000|Overall Study|Withdrawal by Subject|2|||
126271568|NCT00446199|454286735|FG001|Overall Study|Withdrawal by Subject|5|||
126271569|NCT00446199|454286736|FG002|Overall Study|Withdrawal by Subject|9|||
126271570|NCT00446199|454286737|FG003|Overall Study|Withdrawal by Subject|10|||
126271571|NCT00446199|454286734|FG000|Overall Study|Site termination|2|||
126271572|NCT00446199|454286735|FG001|Overall Study|Site termination|0|||
126271573|NCT00446199|454286736|FG002|Overall Study|Site termination|0|||
126271574|NCT00446199|454286737|FG003|Overall Study|Site termination|1|||
126271575|NCT00446199|454286734|FG000|Overall Study|Randomization in Error|2|||
126271576|NCT00446199|454286735|FG001|Overall Study|Randomization in Error|0|||
126271577|NCT00446199|454286736|FG002|Overall Study|Randomization in Error|1|||
126271578|NCT00446199|454286737|FG003|Overall Study|Randomization in Error|1|||
126271579|NCT00446199|454286734|FG000|Overall Study|Lack of Efficacy|1|||
126271580|NCT00446199|454286735|FG001|Overall Study|Lack of Efficacy|0|||
126271581|NCT00446199|454286736|FG002|Overall Study|Lack of Efficacy|0|||
126271582|NCT00446199|454286737|FG003|Overall Study|Lack of Efficacy|1|||
126271583|NCT00446199|454286734|FG000|Overall Study|Non-compliant with study drug|1|||
126271584|NCT00446199|454286735|FG001|Overall Study|Non-compliant with study drug|0|||
126271585|NCT00446199|454286736|FG002|Overall Study|Non-compliant with study drug|5|||
126271586|NCT00446199|454286737|FG003|Overall Study|Non-compliant with study drug|0|||
126271587|NCT00446199|454286734|FG000|Overall Study|Non-compliant with visit schedule|1|||
126271588|NCT00446199|454286735|FG001|Overall Study|Non-compliant with visit schedule|1|||
126271589|NCT00446199|454286736|FG002|Overall Study|Non-compliant with visit schedule|1|||
126271590|NCT00446199|454286737|FG003|Overall Study|Non-compliant with visit schedule|2|||
126271591|NCT00446199|454286734|FG000|Overall Study|Hormone fear|0|||
126271592|NCT00446199|454286735|FG001|Overall Study|Hormone fear|0|||
126271593|NCT00446199|454286736|FG002|Overall Study|Hormone fear|0|||
126271594|NCT00446199|454286737|FG003|Overall Study|Hormone fear|1|||
126271595|NCT00446199|454286734|FG000|Overall Study|Lost interest in study participation|0|||
126271596|NCT00446199|454286735|FG001|Overall Study|Lost interest in study participation|1|||
126271597|NCT00446199|454286736|FG002|Overall Study|Lost interest in study participation|0|||
126271598|NCT00446199|454286737|FG003|Overall Study|Lost interest in study participation|0|||
126271599|NCT00446199|454286734|FG000|Overall Study|In-/Exclusion criterion violated|2|||
126705387|NCT02034123|455871750|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705388|NCT02034123|455871751|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705389|NCT02034123|455871752|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705390|NCT02034123|455871753|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705391|NCT02034123|455871754|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126271600|NCT00446199|454286735|FG001|Overall Study|In-/Exclusion criterion violated|1|||
126271601|NCT00446199|454286736|FG002|Overall Study|In-/Exclusion criterion violated|2|||
126271602|NCT00446199|454286737|FG003|Overall Study|In-/Exclusion criterion violated|1|||
126271603|NCT00446199|454286734|FG000|Overall Study|Move|0|||
126271604|NCT00446199|454286735|FG001|Overall Study|Move|1|||
126271605|NCT00446199|454286736|FG002|Overall Study|Move|0|||
126271606|NCT00446199|454286737|FG003|Overall Study|Move|0|||
126271607|NCT03071094|454286738|FG000|Overall Study|Death|1|||
126271608|NCT03071094|454286739|FG001|Overall Study|Death|1|||
126271609|NCT03071094|454286738|FG000|Overall Study|Adverse Event|1|||
126453502|NCT03032380|454961437|FG000|Overall Study|Adverse Event|0|||
126453503|NCT03032380|454961438|FG001|Overall Study|Adverse Event|1|||
126453504|NCT03032380|454961437|FG000|Overall Study|Lack of Efficacy|1|||
126453505|NCT03032380|454961438|FG001|Overall Study|Lack of Efficacy|0|||
126453506|NCT03032380|454961437|FG000|Overall Study|Withdrawal by Subject|2|||
126453507|NCT03032380|454961438|FG001|Overall Study|Withdrawal by Subject|3|||
126453508|NCT03032380|454961437|FG000|Overall Study|Recovery|0|||
126453509|NCT03032380|454961438|FG001|Overall Study|Recovery|1|||
126453510|NCT03032380|454961437|FG000|Overall Study|Death|39|||
126453511|NCT03032380|454961438|FG001|Overall Study|Death|34|||
126453512|NCT03032380|454961437|FG000|Overall Study|Other - Miscellaneous|0|||
126453513|NCT03032380|454961438|FG001|Overall Study|Other - Miscellaneous|1|||
126453514|NCT01561898|454961439|FG000|Overall Study|Withdrawal by Subject|0|||
126453515|NCT01561898|454961440|FG001|Overall Study|Withdrawal by Subject|8|||
126453516|NCT01561898|454961441|FG002|Overall Study|Withdrawal by Subject|12|||
126453517|NCT01561898|454961442|FG003|Overall Study|Withdrawal by Subject|5|||
126271610|NCT03071094|454286739|FG001|Overall Study|Adverse Event|0|||
126271611|NCT02312063|454286740|FG000|Overall Study|Withdrawal by Subject|0|||
126271612|NCT02312063|454286741|FG001|Overall Study|Withdrawal by Subject|1|||
126271613|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
126271614|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
126271615|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271616|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271617|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271618|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271619|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271620|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271621|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271622|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271623|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271624|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271625|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271626|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
126271627|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
126271628|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
126271629|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271630|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271631|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271632|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271633|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271634|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271635|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271636|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271637|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271638|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271639|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271640|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
126271641|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
126271642|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
126271643|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271644|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271645|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271646|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271647|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271648|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271649|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271650|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271651|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271652|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271653|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271654|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
126271655|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
126271656|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
126271657|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271658|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271659|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126453518|NCT01561898|454961439|FG000|Overall Study|Lack of Efficacy|0|||
126453519|NCT01561898|454961440|FG001|Overall Study|Lack of Efficacy|8|||
126453520|NCT01561898|454961441|FG002|Overall Study|Lack of Efficacy|10|||
126453521|NCT01561898|454961442|FG003|Overall Study|Lack of Efficacy|5|||
126705392|NCT02034123|455871755|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705393|NCT02034123|455871756|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705394|NCT02034123|455871757|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705395|NCT02034123|455871758|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
126705396|NCT02034123|455871741|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705397|NCT02034123|455871742|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705398|NCT02034123|455871743|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705399|NCT02034123|455871744|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
126705400|NCT02034123|455871745|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
126705401|NCT02034123|455871746|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705402|NCT02034123|455871747|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705403|NCT02034123|455871748|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705404|NCT02034123|455871749|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705405|NCT02034123|455871750|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705406|NCT02034123|455871751|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705407|NCT02034123|455871752|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705408|NCT02034123|455871753|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705409|NCT02034123|455871754|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705410|NCT02034123|455871755|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705411|NCT02034123|455871756|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705412|NCT02034123|455871757|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705413|NCT02034123|455871758|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
126705414|NCT02698189|455871759|FG000|Overall Study|Physician Decision|3|||
126705415|NCT02698189|455871760|FG001|Overall Study|Physician Decision|0|||
126271660|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271661|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271662|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271663|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271664|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271665|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271666|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271667|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271668|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
126271669|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
126271670|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
126271671|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271672|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271673|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271674|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271675|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271676|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271677|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271678|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271679|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271680|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271681|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271682|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
126271683|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
126271684|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
126271685|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271686|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271687|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271688|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271689|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271690|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126705416|NCT02698189|455871759|FG000|Overall Study|Progressive disease|0|||
126705417|NCT02698189|455871760|FG001|Overall Study|Progressive disease|5|||
126705418|NCT02698189|455871759|FG000|Overall Study|Study terminated by sponsor|0|||
126705419|NCT02698189|455871760|FG001|Overall Study|Study terminated by sponsor|1|||
126705420|NCT02240706|455871763|FG000|Overall Study|Lack of Efficacy|2|||
126705421|NCT02240706|455871764|FG001|Overall Study|Lack of Efficacy|2|||
126705422|NCT02240706|455871765|FG002|Overall Study|Lack of Efficacy|2|||
126705423|NCT02240706|455871766|FG003|Overall Study|Lack of Efficacy|2|||
126705424|NCT02240706|455871767|FG004|Overall Study|Lack of Efficacy|5|||
126705425|NCT02240706|455871768|FG005|Overall Study|Lack of Efficacy|0|||
126705426|NCT02240706|455871769|FG006|Overall Study|Lack of Efficacy|0|||
126705427|NCT02240706|455871763|FG000|Overall Study|Adverse Event|1|||
126271691|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126705428|NCT02240706|455871764|FG001|Overall Study|Adverse Event|0|||
126705429|NCT02240706|455871765|FG002|Overall Study|Adverse Event|1|||
126705430|NCT02240706|455871766|FG003|Overall Study|Adverse Event|0|||
126705431|NCT02240706|455871767|FG004|Overall Study|Adverse Event|2|||
126705432|NCT02240706|455871768|FG005|Overall Study|Adverse Event|0|||
126705433|NCT02240706|455871769|FG006|Overall Study|Adverse Event|0|||
126705434|NCT02240706|455871763|FG000|Overall Study|Progressive disease|0|||
126271692|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271693|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271694|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271695|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271696|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
126271697|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
126271698|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
126271699|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271700|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271701|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271702|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271703|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271704|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271705|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271706|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271707|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271708|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271709|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271710|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
126271711|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
126271712|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
126271713|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271714|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271715|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271716|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271717|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271718|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271719|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271720|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271721|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271722|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271723|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271724|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
126271725|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
126271726|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
126271727|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271728|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126765592|NCT04636437|456094564|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
126765593|NCT04636437|456094565|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
126765594|NCT04636437|456094563|FG000|Overall Study|Started weight loss drug/program|2|||
126765595|NCT04636437|456094564|FG001|Overall Study|Started weight loss drug/program|1|||
126271729|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271730|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271731|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271732|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271733|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271734|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271735|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126361710|NCT01052428|454617251|FG000|Overall Study|Withdrawal by Subject|0|||
126705435|NCT02240706|455871764|FG001|Overall Study|Progressive disease|0|||
126705436|NCT02240706|455871765|FG002|Overall Study|Progressive disease|0|||
126765596|NCT04636437|456094565|FG002|Overall Study|Started weight loss drug/program|1|||
126271736|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271737|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271738|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
126271739|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
126765597|NCT04636437|456094563|FG000|Overall Study|Lost to Follow-up|3|||
126361711|NCT01052428|454617252|FG001|Overall Study|Withdrawal by Subject|1|||
126705437|NCT02240706|455871766|FG003|Overall Study|Progressive disease|0|||
126705438|NCT02240706|455871767|FG004|Overall Study|Progressive disease|1|||
126705439|NCT02240706|455871768|FG005|Overall Study|Progressive disease|0|||
126705440|NCT02240706|455871769|FG006|Overall Study|Progressive disease|0|||
126705441|NCT02240706|455871763|FG000|Overall Study|Dose limiting toxicity|0|||
126705442|NCT02240706|455871764|FG001|Overall Study|Dose limiting toxicity|0|||
126705443|NCT02240706|455871765|FG002|Overall Study|Dose limiting toxicity|0|||
126705444|NCT02240706|455871766|FG003|Overall Study|Dose limiting toxicity|0|||
126705445|NCT02240706|455871767|FG004|Overall Study|Dose limiting toxicity|1|||
126705446|NCT02240706|455871768|FG005|Overall Study|Dose limiting toxicity|0|||
126705447|NCT02240706|455871769|FG006|Overall Study|Dose limiting toxicity|0|||
126705448|NCT02240706|455871763|FG000|Overall Study|Refused to continue taking medication|0|||
126705449|NCT02240706|455871764|FG001|Overall Study|Refused to continue taking medication|1|||
126705450|NCT02240706|455871765|FG002|Overall Study|Refused to continue taking medication|3|||
126705451|NCT02240706|455871766|FG003|Overall Study|Refused to continue taking medication|1|||
126705452|NCT02240706|455871767|FG004|Overall Study|Refused to continue taking medication|2|||
126705453|NCT02240706|455871768|FG005|Overall Study|Refused to continue taking medication|0|||
126705454|NCT02240706|455871769|FG006|Overall Study|Refused to continue taking medication|0|||
126705455|NCT02240706|455871763|FG000|Overall Study|Insurance billing concerns|0|||
126705456|NCT02240706|455871764|FG001|Overall Study|Insurance billing concerns|0|||
126705457|NCT02240706|455871765|FG002|Overall Study|Insurance billing concerns|0|||
126271740|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
126271741|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271742|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271743|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271744|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271745|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271746|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271747|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271748|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271749|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271750|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271751|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271752|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
126271753|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
126271754|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
126271755|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271756|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271757|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271758|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271759|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271760|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271761|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271762|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271763|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271764|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271765|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271766|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
126271767|NCT03982199|454286742|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
126271768|NCT03982199|454286743|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
126271769|NCT03982199|454286744|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271770|NCT03982199|454286745|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271771|NCT03982199|454286746|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271772|NCT03982199|454286747|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271773|NCT03982199|454286748|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271774|NCT03982199|454286749|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271775|NCT03982199|454286750|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271776|NCT03982199|454286751|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271777|NCT03982199|454286752|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271778|NCT03982199|454286753|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271779|NCT03982199|454286754|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126271780|NCT03982199|454286755|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
126705458|NCT02240706|455871766|FG003|Overall Study|Insurance billing concerns|1|||
126705459|NCT02240706|455871767|FG004|Overall Study|Insurance billing concerns|0|||
126705460|NCT02240706|455871768|FG005|Overall Study|Insurance billing concerns|0|||
126705461|NCT02240706|455871769|FG006|Overall Study|Insurance billing concerns|0|||
126705462|NCT03301857|455871770|FG000|Overall Study|Death|0|||
126705463|NCT03301857|455871771|FG001|Overall Study|Death|2|||
126705464|NCT03301857|455871770|FG000|Overall Study|Lost to Follow-up|4|||
126705465|NCT03301857|455871771|FG001|Overall Study|Lost to Follow-up|2|||
126705466|NCT03301857|455871770|FG000|Overall Study|Decision by Sponsor|6|||
126705467|NCT03301857|455871771|FG001|Overall Study|Decision by Sponsor|0|||
126705468|NCT03301857|455871770|FG000|Overall Study|Withdrawal by Subject|12|||
126705469|NCT03301857|455871771|FG001|Overall Study|Withdrawal by Subject|4|||
126705470|NCT00855439|455871772|FG000|Overall Study|Withdrawal by Subject|2|||
126705471|NCT00855439|455871773|FG001|Overall Study|Withdrawal by Subject|0|||
126705472|NCT00855439|455871772|FG000|Overall Study|Pregnancy|1|||
126705473|NCT00855439|455871773|FG001|Overall Study|Pregnancy|0|||
126705474|NCT00613626|455871774|FG000|Overall Study|Ineligible|0|||
126705475|NCT00613626|455871775|FG001|Overall Study|Ineligible|1|||
126705476|NCT00613626|455871776|FG002|Overall Study|Ineligible|0|||
126705477|NCT05480514|455871777|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
126705478|NCT05480514|455871778|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
126705479|NCT05480514|455871777|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
126705480|NCT05480514|455871778|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
126705481|NCT05480514|455871777|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
126705482|NCT05480514|455871778|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
126705483|NCT05480514|455871777|FG000|Period 1|Covid-19 Related|1|||
126705484|NCT05480514|455871778|FG001|Period 1|Covid-19 Related|0|||
126705485|NCT05480514|455871777|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
126705486|NCT05480514|455871778|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
126705487|NCT00457639|455871779|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
126705488|NCT00457639|455871780|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
126705489|NCT00457639|455871779|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
126705490|NCT00457639|455871780|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
126705491|NCT00457639|455871779|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
126705492|NCT00457639|455871780|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
126705493|NCT00628355|455871781|FG000|Overall Study|Withdrawal by Subject|1|||
126705494|NCT00628355|455871782|FG001|Overall Study|Withdrawal by Subject|1|||
126705495|NCT03232073|455871785|FG000|Overall Study|Death|1|||
126705496|NCT03232073|455871786|FG001|Overall Study|Death|0|||
126705497|NCT03232073|455871785|FG000|Overall Study|Adverse Event|7|||
126705498|NCT03232073|455871786|FG001|Overall Study|Adverse Event|12|||
126705499|NCT03232073|455871785|FG000|Overall Study|Lost to Follow-up|6|||
126705500|NCT03232073|455871786|FG001|Overall Study|Lost to Follow-up|6|||
126705501|NCT03232073|455871785|FG000|Overall Study|Lack of Efficacy|10|||
126705502|NCT03232073|455871786|FG001|Overall Study|Lack of Efficacy|8|||
126705503|NCT03232073|455871785|FG000|Overall Study|Physician Decision|9|||
126705504|NCT03232073|455871786|FG001|Overall Study|Physician Decision|2|||
126705505|NCT03232073|455871785|FG000|Overall Study|Withdrawal by Subject|54|||
126705506|NCT03232073|455871786|FG001|Overall Study|Withdrawal by Subject|39|||
126705507|NCT01672892|455873452|FG000|Overall Study|Protocol Violation|7|||
126705508|NCT01672892|455873453|FG001|Overall Study|Protocol Violation|3|||
126705509|NCT02579603|455873459|FG000|Overall Study|Not treated|1|||
126705510|NCT02579603|455873460|FG001|Overall Study|Not treated|0|||
126705511|NCT02579603|455873459|FG000|Overall Study|Adverse Event|2|||
126705512|NCT02579603|455873460|FG001|Overall Study|Adverse Event|2|||
126705513|NCT02579603|455873459|FG000|Overall Study|Other than stated|1|||
126705514|NCT02579603|455873460|FG001|Overall Study|Other than stated|0|||
126705515|NCT01006356|455873461|FG000|Overall Study|Adverse Event|6|||
126705516|NCT01006356|455873461|FG000|Overall Study|Physician Decision|1|||
126705517|NCT01006356|455873461|FG000|Overall Study|Paticipants did not cooperate|6|||
126271781|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271782|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271783|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271784|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
126271785|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271786|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271787|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271788|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271789|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271790|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271791|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126705518|NCT01006356|455873461|FG000|Overall Study|Withdrawal by Subject|1|||
126705519|NCT01006356|455873461|FG000|Overall Study|Choice by participants|2|||
126705520|NCT01006356|455873461|FG000|Overall Study|Protocol Violation|3|||
126705521|NCT01006356|455873461|FG000|Overall Study|Other|23|||
126361712|NCT03400787|454617253|FG000|Overall Study|Lost to Follow-up|1|||
126705522|NCT01756157|455873466|FG000|First Intervention Period|Withdrawal by Subject|1|||
126705523|NCT01756157|455873467|FG001|First Intervention Period|Withdrawal by Subject|0|||
126705524|NCT01756157|455873466|FG000|First Intervention Period|Lost to Follow-up|0|||
126705525|NCT01756157|455873467|FG001|First Intervention Period|Lost to Follow-up|2|||
126705526|NCT03368859|455873468|FG000|Overall Study|Withdrew Consent|5|||
126705527|NCT03368859|455873469|FG001|Overall Study|Withdrew Consent|4|||
126705528|NCT03368859|455873468|FG000|Overall Study|Death|12|||
126705529|NCT03368859|455873469|FG001|Overall Study|Death|6|||
126705530|NCT03368859|455873468|FG000|Overall Study|Study terminated by Sponsor|18|||
126705531|NCT03368859|455873469|FG001|Overall Study|Study terminated by Sponsor|23|||
126705532|NCT03368859|455873468|FG000|Overall Study|Other|1|||
126705533|NCT03368859|455873469|FG001|Overall Study|Other|1|||
126705534|NCT02559505|455873474|FG000|Overall Study|Lost to Follow-up|23|||
126705535|NCT02559505|455873475|FG001|Overall Study|Lost to Follow-up|20|||
126705536|NCT02559505|455873474|FG000|Overall Study|Withdrawal by Subject|4|||
126705537|NCT02559505|455873475|FG001|Overall Study|Withdrawal by Subject|2|||
126705538|NCT04331899|455873482|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
126705539|NCT04331899|455873483|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
126705540|NCT02424539|455873486|FG000|Overall Study|Adverse Event|0|||
126705541|NCT02424539|455873487|FG001|Overall Study|Adverse Event|0|||
126705542|NCT02424539|455873488|FG002|Overall Study|Adverse Event|1|||
126705543|NCT02424539|455873486|FG000|Overall Study|Physician Decision|0|||
126705544|NCT02424539|455873487|FG001|Overall Study|Physician Decision|0|||
126705545|NCT02424539|455873488|FG002|Overall Study|Physician Decision|1|||
126705546|NCT02424539|455873486|FG000|Overall Study|Withdrawal by Subject|3|||
126705547|NCT02424539|455873487|FG001|Overall Study|Withdrawal by Subject|1|||
126705548|NCT02424539|455873488|FG002|Overall Study|Withdrawal by Subject|0|||
126705549|NCT02424539|455873486|FG000|Overall Study|Other: Reached stopping criteria|11|||
126705550|NCT02424539|455873487|FG001|Overall Study|Other: Reached stopping criteria|7|||
126705551|NCT02424539|455873488|FG002|Overall Study|Other: Reached stopping criteria|6|||
126705552|NCT04893265|455873491|FG000|Overall Study|Withdrawal by Subject|2|||
126705553|NCT04893265|455873492|FG001|Overall Study|Withdrawal by Subject|5|||
126705554|NCT04893265|455873491|FG000|Overall Study|Lost to Follow-up|0|||
126705555|NCT04893265|455873492|FG001|Overall Study|Lost to Follow-up|4|||
126705556|NCT00573131|455873493|FG000|Overall Study|Withdrawal by Subject|10|||
126705557|NCT00573131|455873494|FG001|Overall Study|Withdrawal by Subject|8|||
126705558|NCT02024464|455873496|FG000|Overall Study|Discontinued|5|||
126705559|NCT02024464|455873497|FG001|Overall Study|Discontinued|4|||
126705560|NCT02024464|455873496|FG000|Overall Study|Missed Visits|1|||
126705561|NCT02024464|455873497|FG001|Overall Study|Missed Visits|0|||
126705562|NCT02024464|455873496|FG000|Overall Study|Lost to Follow-up|4|||
126705563|NCT02024464|455873497|FG001|Overall Study|Lost to Follow-up|7|||
126705564|NCT02037919|455873503|FG000|Overall Study|Lost to Follow-up|30|||
126705565|NCT02037919|455873504|FG001|Overall Study|Lost to Follow-up|45|||
126705566|NCT01697215|455873519|FG000|Overall Study|Physician Decision|5|||
126705567|NCT01697215|455873519|FG000|Overall Study|Malfunction|9|||
126705568|NCT01697215|455873519|FG000|Overall Study|CXR not available|9|||
126705569|NCT01829048|455873520|FG000|Overall Study|Withdrawal by Subject|0|||
126705570|NCT01829048|455873521|FG001|Overall Study|Withdrawal by Subject|0|||
126705571|NCT01829048|455873522|FG002|Overall Study|Withdrawal by Subject|0|||
126705572|NCT01829048|455873523|FG003|Overall Study|Withdrawal by Subject|2|||
126705573|NCT01829048|455873524|FG004|Overall Study|Withdrawal by Subject|0|||
126705574|NCT00504257|455873525|FG000|Overall Study|Withdrawal by Subject|2|||
126705575|NCT00504257|455873525|FG000|Overall Study|ineligible histology|2|||
126271792|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271793|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271794|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
126271795|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271796|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271797|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
126271798|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271799|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271800|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271801|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271802|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271803|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126705576|NCT02317510|455873529|FG000|Overall Study|Adverse Event|0|||
126705577|NCT02317510|455873530|FG001|Overall Study|Adverse Event|1|||
126705578|NCT00728416|455873539|FG000|Overall Study|Adverse Event|1|||
126705579|NCT00728416|455873540|FG001|Overall Study|Adverse Event|1|||
126271804|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126361713|NCT03400787|454617254|FG001|Overall Study|Lost to Follow-up|0|||
126705580|NCT00728416|455873539|FG000|Overall Study|Treatment Failure|0|||
126705581|NCT00728416|455873540|FG001|Overall Study|Treatment Failure|1|||
126705582|NCT00728416|455873539|FG000|Overall Study|Withdrawal by Subject|1|||
126705583|NCT00728416|455873540|FG001|Overall Study|Withdrawal by Subject|0|||
126705584|NCT01244737|455873548|FG000|Overall Study|Physician Decision|2|||
126705585|NCT01244737|455873549|FG001|Overall Study|Physician Decision|18|||
126705586|NCT01244737|455873550|FG002|Overall Study|Physician Decision|5|||
126705587|NCT01244737|455873548|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
126715189|NCT01052012|455908710|FG004|Overall Study|Withdrawal by Subject|3|||
126361714|NCT03400787|454617253|FG000|Overall Study|Death|1|||
126361715|NCT03400787|454617254|FG001|Overall Study|Death|0|||
126361716|NCT03400787|454617253|FG000|Overall Study|Protocol Violation|0|||
126361717|NCT03400787|454617254|FG001|Overall Study|Protocol Violation|2|||
126361718|NCT03400787|454617253|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
126361719|NCT03400787|454617254|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
126361720|NCT04432298|454617257|FG000|Overall Study|Other than specified|1|||
126361721|NCT04432298|454617258|FG001|Overall Study|Other than specified|0|||
126361722|NCT04432298|454617257|FG000|Overall Study|Lost to Follow-up|0|||
126361723|NCT04432298|454617258|FG001|Overall Study|Lost to Follow-up|1|||
126361724|NCT04432298|454617257|FG000|Overall Study|Death|3|||
126361725|NCT04432298|454617258|FG001|Overall Study|Death|2|||
126705588|NCT01244737|455873549|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
126705589|NCT01244737|455873550|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
126705590|NCT01244737|455873548|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
126705591|NCT01244737|455873549|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
126705592|NCT01244737|455873550|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
126705593|NCT01244737|455873548|FG000|Overall Study|MIB immunopathology results not available|3|||
126705594|NCT01244737|455873549|FG001|Overall Study|MIB immunopathology results not available|2|||
126705595|NCT01244737|455873550|FG002|Overall Study|MIB immunopathology results not available|0|||
126271805|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271806|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271807|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271808|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
126271809|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271810|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271811|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
126271812|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271813|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271814|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271815|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271816|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271817|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271818|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271819|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271820|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271821|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271822|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
126271823|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271824|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271825|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
126271826|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
126271827|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271828|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271829|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271830|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271831|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271832|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271833|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271834|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271835|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271836|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
126271837|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271838|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271839|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271840|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
126271841|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271842|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271843|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271844|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271845|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126361726|NCT04432298|454617257|FG000|Overall Study|Withdrawal by Subject|2|||
126361727|NCT04432298|454617258|FG001|Overall Study|Withdrawal by Subject|0|||
126361728|NCT02451007|454617259|FG000|Overall Study|Withdrawal by Subject|4|||
126361729|NCT02451007|454617259|FG000|Overall Study|Adverse Event|1|||
126705596|NCT01244737|455873548|FG000|Overall Study|PET data failure|0|||
126705597|NCT01244737|455873549|FG001|Overall Study|PET data failure|1|||
126705598|NCT01244737|455873550|FG002|Overall Study|PET data failure|0|||
126705599|NCT01244737|455873548|FG000|Overall Study|Withdrawal by Subject|0|||
126705600|NCT01244737|455873549|FG001|Overall Study|Withdrawal by Subject|0|||
126705601|NCT01244737|455873550|FG002|Overall Study|Withdrawal by Subject|1|||
126705602|NCT00730236|455873553|FG000|Overall Study|Adverse Event|4|||
126705603|NCT00730236|455873553|FG000|Overall Study|Withdrawal by Subject|1|||
126271846|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271847|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271848|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271849|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271850|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
126271851|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271852|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271853|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
126271854|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
126271855|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271856|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271857|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271858|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271859|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271860|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271861|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271862|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271863|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271864|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
126271865|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271866|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271867|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271868|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271869|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271870|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271871|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271872|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271873|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
126271874|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271875|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271876|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271877|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271878|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
126271879|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271880|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271881|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271882|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271883|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271884|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271885|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271886|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271887|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
126271888|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271889|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271890|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271891|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271892|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
126271893|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271894|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271895|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271896|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271897|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271898|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126453522|NCT01561898|454961439|FG000|Overall Study|Worsening of complications|0|||
126705604|NCT00730236|455873553|FG000|Overall Study|Non-compliance|1|||
126705605|NCT04003610|455873556|FG000|Overall Study|Lost to Follow-up|0|||
126705606|NCT04003610|455873557|FG001|Overall Study|Lost to Follow-up|1|||
126705607|NCT04003610|455873558|FG002|Overall Study|Lost to Follow-up|0|||
126705608|NCT04003610|455873556|FG000|Overall Study|Death|0|||
126705609|NCT04003610|455873557|FG001|Overall Study|Death|0|||
126271899|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271900|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271901|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
126271902|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271903|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271904|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271905|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271906|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
126271907|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271908|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271909|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271910|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271911|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271912|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271913|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271914|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271915|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
126271916|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271917|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271918|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271919|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271920|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
126271921|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271922|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271923|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271924|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271925|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271926|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271927|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271928|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271929|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
126271930|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271931|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271932|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271933|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271934|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
126271935|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271936|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271937|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271938|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271939|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271940|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
126271941|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271942|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
126271943|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
126271944|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271945|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271946|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271947|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271948|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
126271949|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271950|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271951|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271952|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271953|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271954|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271955|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271956|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271957|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
126271958|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271959|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271960|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271961|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126705610|NCT04003610|455873558|FG002|Overall Study|Death|3|||
126705611|NCT04003610|455873556|FG000|Overall Study|Study Terminated by Sponsor|0|||
126705612|NCT04003610|455873557|FG001|Overall Study|Study Terminated by Sponsor|0|||
126705613|NCT04003610|455873558|FG002|Overall Study|Study Terminated by Sponsor|3|||
126705614|NCT00246259|455873565|FG000|Overall Study|Other|3|||
126705615|NCT00246259|455873566|FG001|Overall Study|Other|3|||
126705616|NCT00246259|455873565|FG000|Overall Study|Not stable by Week 18|2|||
126705617|NCT00246259|455873566|FG001|Overall Study|Not stable by Week 18|1|||
126705618|NCT00246259|455873565|FG000|Overall Study|Participant non-compliant|4|||
126705619|NCT00246259|455873566|FG001|Overall Study|Participant non-compliant|9|||
126705620|NCT00246259|455873565|FG000|Overall Study|Lack of Efficacy|2|||
126705621|NCT00246259|455873566|FG001|Overall Study|Lack of Efficacy|2|||
126705622|NCT00246259|455873565|FG000|Overall Study|Investigator withdrew participant|2|||
126271962|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
126271963|NCT03982199|454286742|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271964|NCT03982199|454286743|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271965|NCT03982199|454286744|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271966|NCT03982199|454286745|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271967|NCT03982199|454286746|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271968|NCT03982199|454286747|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
126271969|NCT03982199|454286748|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271970|NCT03982199|454286749|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
126271971|NCT03982199|454286750|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
126271972|NCT03982199|454286751|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271973|NCT03982199|454286752|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271974|NCT03982199|454286753|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271975|NCT03982199|454286754|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271976|NCT03982199|454286755|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
126271977|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271978|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271979|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271980|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271981|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271982|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271983|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271984|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271985|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
126271986|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
126271987|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
126271988|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
126271989|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
126271990|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
126271991|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271992|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271993|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271994|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271995|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271996|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271997|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271998|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126271999|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126272000|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
126272001|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126272002|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126272003|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126705623|NCT00246259|455873566|FG001|Overall Study|Investigator withdrew participant|0|||
126705624|NCT00246259|455873565|FG000|Overall Study|Adverse Event|5|||
126705625|NCT00246259|455873566|FG001|Overall Study|Adverse Event|0|||
126765598|NCT04636437|456094564|FG001|Overall Study|Lost to Follow-up|1|||
126765599|NCT04636437|456094565|FG002|Overall Study|Lost to Follow-up|4|||
126765600|NCT04636437|456094563|FG000|Overall Study|Participant or physician decision|3|||
126765601|NCT04636437|456094564|FG001|Overall Study|Participant or physician decision|1|||
126765602|NCT04636437|456094565|FG002|Overall Study|Participant or physician decision|1|||
126765603|NCT00352664|456094566|FG000|Overall Study|Withdrawal by Subject|7|||
126272004|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
126272005|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272006|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272007|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272008|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272009|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272010|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272011|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272012|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272013|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272014|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272015|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272016|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272017|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
126272018|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
126272019|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272020|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272021|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272022|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272023|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272024|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272025|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272026|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272027|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272028|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272029|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
126272030|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
126272031|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
126272032|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
126272033|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272034|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272035|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272036|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272037|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272038|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272039|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272040|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272041|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272042|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272043|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272044|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272045|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
126272046|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
126272047|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272048|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272049|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272050|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272051|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272052|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272053|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272054|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272055|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272056|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272057|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272058|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
126272059|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
126272060|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
126272061|NCT03982199|454286742|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272062|NCT03982199|454286743|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272063|NCT03982199|454286744|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126361730|NCT02451007|454617259|FG000|Overall Study|Disease Progression|2|||
126361731|NCT01034657|454617271|FG000|Core Phase|Withdrawal by Subject|1|||
126361732|NCT01034657|454617272|FG001|Core Phase|Withdrawal by Subject|0|||
126361733|NCT01034657|454617273|FG002|Core Phase|Withdrawal by Subject|0|||
126361734|NCT01034657|454617271|FG000|Core Phase|Lack of Efficacy|2|||
126705626|NCT00246259|455873565|FG000|Overall Study|Lost to Follow-up|3|||
126705627|NCT00246259|455873566|FG001|Overall Study|Lost to Follow-up|4|||
126705628|NCT00246259|455873565|FG000|Overall Study|Withdrawal by Subject|5|||
126705629|NCT00246259|455873566|FG001|Overall Study|Withdrawal by Subject|1|||
126272064|NCT03982199|454286745|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272065|NCT03982199|454286746|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272066|NCT03982199|454286747|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272067|NCT03982199|454286748|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272068|NCT03982199|454286749|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272069|NCT03982199|454286750|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272070|NCT03982199|454286751|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272071|NCT03982199|454286752|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272072|NCT03982199|454286753|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272073|NCT03982199|454286754|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
126272074|NCT03982199|454286755|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
126272075|NCT00594646|454286756|FG000|Overall Study|Withdrawal by Subject|1|||
126272076|NCT00594646|454286756|FG000|Overall Study|Lost to Follow-up|15|||
126272077|NCT03907462|454286759|FG000|Overall Study|Physician Decision|1|||
126272078|NCT03907462|454286760|FG001|Overall Study|Physician Decision|3|||
126272079|NCT03907462|454286761|FG002|Overall Study|Physician Decision|1|||
126272080|NCT03907462|454286759|FG000|Overall Study|Withdrawal by Subject|6|||
126272081|NCT03907462|454286760|FG001|Overall Study|Withdrawal by Subject|3|||
126272082|NCT03907462|454286761|FG002|Overall Study|Withdrawal by Subject|3|||
126272083|NCT03907462|454286759|FG000|Overall Study|Pregnancy|4|||
126272084|NCT03907462|454286760|FG001|Overall Study|Pregnancy|2|||
126272085|NCT03907462|454286761|FG002|Overall Study|Pregnancy|6|||
126272086|NCT03907462|454286759|FG000|Overall Study|Lost to Follow-up|16|||
126272087|NCT03907462|454286760|FG001|Overall Study|Lost to Follow-up|18|||
126272088|NCT03907462|454286761|FG002|Overall Study|Lost to Follow-up|22|||
126272089|NCT03303625|454288935|FG000|Overall Study|Withdrawal by Subject|2|||
126272090|NCT03303625|454288936|FG001|Overall Study|Withdrawal by Subject|0|||
126272091|NCT03303625|454288937|FG002|Overall Study|Withdrawal by Subject|0|||
126272092|NCT03303625|454288938|FG003|Overall Study|Withdrawal by Subject|0|||
126272093|NCT02492880|454288939|FG000|Overall Study|Lost to Follow-up|1|||
126272094|NCT02492880|454288939|FG000|Overall Study|Protocol Violation|1|||
126272095|NCT00554190|454288940|FG000|Overall Study|Termination forms not completed|10|||
126272096|NCT04709835|454288944|FG000|Overall Study|Withdrawal by Subject|0|||
126272097|NCT04709835|454288945|FG001|Overall Study|Withdrawal by Subject|1|||
126272098|NCT04709835|454288946|FG002|Overall Study|Withdrawal by Subject|0|||
126272099|NCT04325204|454288947|FG000|Overall Study|Death|0|||
126272100|NCT04325204|454288948|FG001|Overall Study|Death|1|||
126272101|NCT04325204|454288947|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
126272102|NCT04325204|454288948|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
126272103|NCT04325204|454288947|FG000|Overall Study|Lost to Follow-up|8|||
126272104|NCT04325204|454288948|FG001|Overall Study|Lost to Follow-up|8|||
126272105|NCT04325204|454288947|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
126272106|NCT04325204|454288948|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
126272107|NCT04711902|454288950|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
126272108|NCT04711902|454288951|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
126272109|NCT04711902|454288952|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
126272110|NCT04711902|454288953|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
126272111|NCT04711902|454288954|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
126272112|NCT04711902|454288955|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
126272113|NCT04710979|454288956|FG000|Overall Study|Lost to Follow-up|2|||
126272114|NCT04710979|454288957|FG001|Overall Study|Lost to Follow-up|4|||
126272115|NCT04710979|454288956|FG000|Overall Study|Withdrawal by Subject|1|||
126272116|NCT04710979|454288957|FG001|Overall Study|Withdrawal by Subject|0|||
126272117|NCT01561430|454288960|FG000|Overall Study|Adverse Event|0|||
126272118|NCT01561430|454288961|FG001|Overall Study|Adverse Event|0|||
126272119|NCT01561430|454288962|FG002|Overall Study|Adverse Event|3|||
126272120|NCT01561430|454288963|FG003|Overall Study|Adverse Event|1|||
126272121|NCT01561430|454288960|FG000|Overall Study|Withdrawal by Subject|0|||
126272122|NCT01561430|454288961|FG001|Overall Study|Withdrawal by Subject|0|||
126272123|NCT01561430|454288962|FG002|Overall Study|Withdrawal by Subject|1|||
126272124|NCT01561430|454288963|FG003|Overall Study|Withdrawal by Subject|0|||
126272125|NCT01561430|454288960|FG000|Overall Study|Physician Decision|0|||
126272126|NCT01561430|454288961|FG001|Overall Study|Physician Decision|1|||
126361735|NCT01034657|454617272|FG001|Core Phase|Lack of Efficacy|0|||
126361736|NCT01034657|454617273|FG002|Core Phase|Lack of Efficacy|0|||
126705630|NCT00246259|455873565|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
126705631|NCT00246259|455873566|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
126272127|NCT01561430|454288962|FG002|Overall Study|Physician Decision|0|||
126705632|NCT03133767|455873573|FG000|Overall Study|Lost to Follow-up|38|||
126272128|NCT01561430|454288963|FG003|Overall Study|Physician Decision|0|||
126272129|NCT01561430|454288960|FG000|Overall Study|Sponsor Decision|1|||
126272130|NCT01561430|454288961|FG001|Overall Study|Sponsor Decision|14|||
126272131|NCT01561430|454288962|FG002|Overall Study|Sponsor Decision|13|||
126272132|NCT01561430|454288963|FG003|Overall Study|Sponsor Decision|12|||
126272133|NCT02570113|454288966|FG000|Overall Study|Withdrawal by Subject|3|||
126272134|NCT02564211|454288967|FG000|Overall Study|Adverse Event|4|||
126272135|NCT00622466|454288968|FG000|Overall Study|Death|1|||
126272136|NCT00622466|454288968|FG000|Overall Study|Adverse Event|1|||
126272137|NCT00622466|454288968|FG000|Overall Study|Withdrawal by Subject|2|||
126272138|NCT01908816|454288969|FG000|Overall Study|Subject's no longer requires study drug|0|||
126272139|NCT01908816|454288970|FG001|Overall Study|Subject's no longer requires study drug|0|||
126272140|NCT01908816|454288971|FG002|Overall Study|Subject's no longer requires study drug|0|||
126272141|NCT01908816|454288972|FG003|Overall Study|Subject's no longer requires study drug|1|||
126272142|NCT01908816|454288969|FG000|Overall Study|Protocol deviation|1|||
126272143|NCT01908816|454288970|FG001|Overall Study|Protocol deviation|2|||
126272144|NCT01908816|454288971|FG002|Overall Study|Protocol deviation|1|||
126272145|NCT01908816|454288972|FG003|Overall Study|Protocol deviation|1|||
126272146|NCT01908816|454288969|FG000|Overall Study|Withdrawal by Subject|0|||
126272147|NCT01908816|454288970|FG001|Overall Study|Withdrawal by Subject|4|||
126272148|NCT01908816|454288971|FG002|Overall Study|Withdrawal by Subject|2|||
126272149|NCT01908816|454288972|FG003|Overall Study|Withdrawal by Subject|2|||
126272150|NCT01908816|454288969|FG000|Overall Study|Lost to Follow-up|3|||
126272151|NCT01908816|454288970|FG001|Overall Study|Lost to Follow-up|5|||
126272152|NCT01908816|454288971|FG002|Overall Study|Lost to Follow-up|4|||
126272153|NCT01908816|454288972|FG003|Overall Study|Lost to Follow-up|2|||
126272154|NCT01908816|454288969|FG000|Overall Study|Death|1|||
126272155|NCT01908816|454288970|FG001|Overall Study|Death|0|||
126272156|NCT01908816|454288971|FG002|Overall Study|Death|7|||
126272157|NCT01908816|454288972|FG003|Overall Study|Death|1|||
126272158|NCT01908816|454288969|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126272159|NCT01908816|454288970|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
126272160|NCT01908816|454288971|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
126272161|NCT01908816|454288972|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
126272162|NCT01908816|454288969|FG000|Overall Study|Early termination|87|||
126272163|NCT01908816|454288970|FG001|Overall Study|Early termination|60|||
126272164|NCT01908816|454288971|FG002|Overall Study|Early termination|43|||
126272165|NCT01908816|454288972|FG003|Overall Study|Early termination|28|||
126272166|NCT05183217|454288973|FG000|Overall Study|Withdrawal by Subject|1|||
126272167|NCT05183217|454288974|FG001|Overall Study|Withdrawal by Subject|1|||
126272168|NCT04585789|454288976|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
126272169|NCT04585789|454288977|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
126361737|NCT01034657|454617271|FG000|Core Phase|Abnormal laboratory value|1|||
126361738|NCT01034657|454617272|FG001|Core Phase|Abnormal laboratory value|0|||
126272170|NCT04585789|454288978|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
126361739|NCT01034657|454617273|FG002|Core Phase|Abnormal laboratory value|0|||
126361740|NCT01034657|454617271|FG000|Core Phase|Adverse Event|8|||
126361741|NCT01034657|454617272|FG001|Core Phase|Adverse Event|0|||
126361742|NCT01034657|454617273|FG002|Core Phase|Adverse Event|0|||
126361743|NCT01034657|454617271|FG000|Core Phase|Protocol Violation|2|||
126361744|NCT01034657|454617272|FG001|Core Phase|Protocol Violation|0|||
126361745|NCT01034657|454617273|FG002|Core Phase|Protocol Violation|0|||
126361746|NCT01034657|454617271|FG000|Randomized Phase|Withdrawal by Subject|0|||
126361747|NCT01034657|454617272|FG001|Randomized Phase|Withdrawal by Subject|2|||
126361748|NCT01034657|454617273|FG002|Randomized Phase|Withdrawal by Subject|0|||
126361749|NCT01034657|454617271|FG000|Randomized Phase|Lack of Efficacy|5|||
126361750|NCT01034657|454617272|FG001|Randomized Phase|Lack of Efficacy|1|||
126361751|NCT01034657|454617273|FG002|Randomized Phase|Lack of Efficacy|0|||
126361752|NCT01034657|454617271|FG000|Randomized Phase|Abnormal laboratory value|0|||
126361753|NCT01034657|454617272|FG001|Randomized Phase|Abnormal laboratory value|1|||
126361754|NCT01034657|454617273|FG002|Randomized Phase|Abnormal laboratory value|0|||
126361755|NCT01034657|454617271|FG000|Randomized Phase|Adverse Event|0|||
126361756|NCT01034657|454617272|FG001|Randomized Phase|Adverse Event|2|||
126272171|NCT04585789|454288976|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
126272172|NCT04585789|454288977|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
126272173|NCT04585789|454288978|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
126272174|NCT00415194|454288981|FG000|Overall Study|Adverse Event|37|||
126272175|NCT00415194|454288982|FG001|Overall Study|Adverse Event|32|||
126272176|NCT00415194|454288981|FG000|Overall Study|Entry Criteria Not Met|4|||
126272177|NCT00415194|454288982|FG001|Overall Study|Entry Criteria Not Met|8|||
126361757|NCT01034657|454617273|FG002|Randomized Phase|Adverse Event|1|||
126361758|NCT01791205|454617274|FG000|Phase II|Lack of Efficacy|6|||
126361759|NCT01791205|454617275|FG001|Phase II|Lack of Efficacy|0|||
126361760|NCT01791205|454617274|FG000|Phase II|Adverse Event|2|||
126361761|NCT01791205|454617275|FG001|Phase II|Adverse Event|0|||
126361762|NCT01791205|454617274|FG000|Phase II|Safety|1|||
126361763|NCT01791205|454617275|FG001|Phase II|Safety|0|||
126361764|NCT01791205|454617274|FG000|Phase II|Lost to Follow-up|1|||
126361765|NCT01791205|454617275|FG001|Phase II|Lost to Follow-up|0|||
126361766|NCT01791205|454617274|FG000|Phase II|Remission of disease|1|||
126361767|NCT01791205|454617275|FG001|Phase II|Remission of disease|0|||
126361768|NCT01791205|454617274|FG000|Phase II|Physician's decision|1|||
126361769|NCT01791205|454617275|FG001|Phase II|Physician's decision|0|||
126361770|NCT02242903|454617276|FG000|Overall Study|Withdrawal by Subject|1|||
126453523|NCT01561898|454961440|FG001|Overall Study|Worsening of complications|1|||
126453524|NCT01561898|454961441|FG002|Overall Study|Worsening of complications|0|||
126453525|NCT01561898|454961442|FG003|Overall Study|Worsening of complications|0|||
126453526|NCT01561898|454961439|FG000|Overall Study|Lost to Follow-up|0|||
126453527|NCT01561898|454961440|FG001|Overall Study|Lost to Follow-up|0|||
126453528|NCT01561898|454961441|FG002|Overall Study|Lost to Follow-up|1|||
126453529|NCT01561898|454961442|FG003|Overall Study|Lost to Follow-up|0|||
126453530|NCT01561898|454961439|FG000|Overall Study|Adverse Event|1|||
126453531|NCT01561898|454961440|FG001|Overall Study|Adverse Event|19|||
126453532|NCT01561898|454961441|FG002|Overall Study|Adverse Event|14|||
126453533|NCT01561898|454961442|FG003|Overall Study|Adverse Event|9|||
126453534|NCT01561898|454961439|FG000|Overall Study|Physician Decision|1|||
126453535|NCT01561898|454961440|FG001|Overall Study|Physician Decision|5|||
126453536|NCT01561898|454961441|FG002|Overall Study|Physician Decision|7|||
126453537|NCT01561898|454961442|FG003|Overall Study|Physician Decision|1|||
126453538|NCT00294762|454961443|FG000|Overall Study|Did not receive study treatment|3|||
126453539|NCT00294762|454961444|FG001|Overall Study|Did not receive study treatment|3|||
126453540|NCT02238080|454961445|FG000|Overall Study|Death|13|||
126453541|NCT02238080|454961445|FG000|Overall Study|Treatment interrupted|6|||
126453542|NCT02238080|454961445|FG000|Overall Study|Withdrawal by Subject|2|||
126453543|NCT02238080|454961445|FG000|Overall Study|Other|4|||
126453544|NCT01738646|454961446|FG000|Overall Study|Still Receiving Treatment|2|||
126453545|NCT04093024|454961449|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
126453546|NCT04093024|454961450|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
126453547|NCT04093024|454961449|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
126453548|NCT04093024|454961450|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
126453549|NCT04093024|454961449|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
126453550|NCT04093024|454961450|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
126453551|NCT04093024|454961449|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
126453552|NCT04093024|454961450|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
126453553|NCT02267317|454961453|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
126453554|NCT02267317|454961454|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
126453555|NCT02267317|454961455|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
126453556|NCT02267317|454961456|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
126453557|NCT02267317|454961457|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
126453558|NCT02267317|454961458|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
126453559|NCT02267317|454961453|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
126453560|NCT02267317|454961454|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
126453561|NCT02267317|454961455|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
126453562|NCT02267317|454961456|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
126453563|NCT02267317|454961457|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
126453564|NCT02267317|454961458|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
126453565|NCT00796445|454961461|FG000|Overall Study|Protocol Violation|5|||
126453566|NCT00796445|454961462|FG001|Overall Study|Protocol Violation|3|||
126453567|NCT00796445|454961461|FG000|Overall Study|Adverse event, serious fatal|10|||
126453568|NCT00796445|454961462|FG001|Overall Study|Adverse event, serious fatal|5|||
126453569|NCT00796445|454961461|FG000|Overall Study|Adverse event, non-fatal|4|||
126453570|NCT00796445|454961462|FG001|Overall Study|Adverse event, non-fatal|0|||
126453571|NCT00796445|454961461|FG000|Overall Study|Disease progression/recurrence|537|||
126705633|NCT03133767|455873574|FG001|Overall Study|Lost to Follow-up|24|||
126705634|NCT03133767|455873573|FG000|Overall Study|Protocol Violation|0|||
126705635|NCT03133767|455873574|FG001|Overall Study|Protocol Violation|1|||
126705636|NCT05502289|455873579|FG000|Period 1|Out Of Window|1|||
126705637|NCT05502289|455873580|FG001|Period 1|Out Of Window|0|||
126705638|NCT02333227|455873586|FG000|Overall Study|Lost to Follow-up|137|||
126361771|NCT02242903|454617277|FG001|Overall Study|Withdrawal by Subject|0|||
126453572|NCT00796445|454961462|FG001|Overall Study|Disease progression/recurrence|268|||
126453573|NCT00796445|454961461|FG000|Overall Study|Other|10|||
126453574|NCT00796445|454961462|FG001|Overall Study|Other|7|||
126453575|NCT00796445|454961461|FG000|Overall Study|Withdrawal by Subject|18|||
126453576|NCT00796445|454961462|FG001|Overall Study|Withdrawal by Subject|9|||
126453577|NCT00796445|454961461|FG000|Overall Study|Invalid Informed Consent Form|1|||
126705639|NCT02333227|455873587|FG001|Overall Study|Lost to Follow-up|106|||
126361772|NCT02242903|454617278|FG002|Overall Study|Withdrawal by Subject|0|||
126705640|NCT02333227|455873586|FG000|Overall Study|Pregnancy Interrupted|42|||
126361773|NCT02242903|454617279|FG003|Overall Study|Withdrawal by Subject|0|||
126705641|NCT02333227|455873587|FG001|Overall Study|Pregnancy Interrupted|89|||
126705642|NCT02333227|455873586|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
126705643|NCT02333227|455873587|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
126705644|NCT00816036|455873590|FG000|Overall Study|Death|47|||
126705645|NCT00816036|455873591|FG001|Overall Study|Death|28|||
126705646|NCT00816036|455873590|FG000|Overall Study|Lost to Follow-up|75|||
126705647|NCT00816036|455873591|FG001|Overall Study|Lost to Follow-up|57|||
126705648|NCT00816036|455873590|FG000|Overall Study|Withdrawal by Subject|54|||
126705649|NCT00816036|455873591|FG001|Overall Study|Withdrawal by Subject|23|||
126705650|NCT01624194|455873592|FG000|Overall Study|Lost to Follow-up|1|||
126705651|NCT01624194|455873593|FG001|Overall Study|Lost to Follow-up|0|||
126705652|NCT01624194|455873592|FG000|Overall Study|Withdrawal by Subject|1|||
126705653|NCT01624194|455873593|FG001|Overall Study|Withdrawal by Subject|0|||
126705654|NCT03212261|455873594|FG000|Overall Study|Became ineligible d/t tech|2|||
126705655|NCT03212261|455873594|FG000|Overall Study|Tech Trouble- No first study visit|1|||
126705656|NCT03212261|455873594|FG000|Overall Study|Lost to Follow-up|7|||
126705657|NCT03212261|455873594|FG000|Overall Study|Family Emergency|1|||
126705658|NCT03212261|455873594|FG000|Overall Study|Too busy/ No time|5|||
126705659|NCT01076179|455873595|FG000|Overall Study|Withdrawal by Subject|1|||
126705660|NCT00986349|455873598|FG000|Overall Study|Unsuccessful implant procedure|3|||
126705661|NCT00986349|455873598|FG000|Overall Study|Adverse Event|2|||
126705662|NCT00986349|455873598|FG000|Overall Study|Physician Decision|1|||
126705663|NCT00986349|455873598|FG000|Overall Study|device migration|1|||
126705664|NCT02299934|455873599|FG000|Overall Study|Termination of study|13|||
126705665|NCT02722044|455873600|FG000|Overall Study|Adverse Event|2|||
126705666|NCT02722044|455873600|FG000|Overall Study|Physician Decision|1|||
126705667|NCT02722044|455873600|FG000|Overall Study|Withdrawal by Subject|1|||
126705668|NCT02722044|455873600|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
126705669|NCT01901328|455873606|FG000|Overall Study|Lost to Follow-up|1|||
126705670|NCT01901328|455873607|FG001|Overall Study|Lost to Follow-up|0|||
126705671|NCT01901328|455873606|FG000|Overall Study|Physician Decision|0|||
126705672|NCT01901328|455873607|FG001|Overall Study|Physician Decision|1|||
126705673|NCT01901328|455873606|FG000|Overall Study|Protocol Violation|1|||
126705674|NCT01901328|455873607|FG001|Overall Study|Protocol Violation|1|||
126705675|NCT01901328|455873606|FG000|Overall Study|Study Terminated by Sponsor|19|||
126705676|NCT01901328|455873607|FG001|Overall Study|Study Terminated by Sponsor|16|||
126705677|NCT01901328|455873606|FG000|Overall Study|Withdrawal by Subject|1|||
126705678|NCT01901328|455873607|FG001|Overall Study|Withdrawal by Subject|2|||
126705679|NCT01901328|455873606|FG000|Overall Study|Lack of Efficacy|0|||
126705680|NCT01901328|455873607|FG001|Overall Study|Lack of Efficacy|1|||
126705681|NCT03528681|455875428|FG000|Open-Label Phase|Physician Decision|2|||
126705682|NCT03528681|455875429|FG001|Open-Label Phase|Physician Decision|0|||
126705683|NCT03528681|455875430|FG002|Open-Label Phase|Physician Decision|0|||
126705684|NCT03528681|455875431|FG003|Open-Label Phase|Physician Decision|0|||
126705685|NCT03528681|455875428|FG000|Open-Label Phase|Withdrawal by Subject|8|||
126705686|NCT03528681|455875429|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126705687|NCT03528681|455875430|FG002|Open-Label Phase|Withdrawal by Subject|0|||
126705688|NCT03528681|455875431|FG003|Open-Label Phase|Withdrawal by Subject|0|||
126705689|NCT03528681|455875428|FG000|Open-Label Phase|(Not collected)|4|||
126705690|NCT03528681|455875429|FG001|Open-Label Phase|(Not collected)|0|||
126705691|NCT03528681|455875430|FG002|Open-Label Phase|(Not collected)|0|||
126705692|NCT03528681|455875431|FG003|Open-Label Phase|(Not collected)|0|||
126705693|NCT03528681|455875428|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
126705694|NCT03528681|455875429|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
126705695|NCT03528681|455875430|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
126705696|NCT03528681|455875431|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
126453578|NCT00796445|454961462|FG001|Overall Study|Invalid Informed Consent Form|0|||
126453579|NCT03774823|454961467|FG000|Overall Study|Withdrawal by Subject|1|||
126705697|NCT03528681|455875428|FG000|Randomized Treatment Phase|Physician Decision|0|||
126705698|NCT03528681|455875429|FG001|Randomized Treatment Phase|Physician Decision|5|||
126705699|NCT03528681|455875430|FG002|Randomized Treatment Phase|Physician Decision|1|||
126453580|NCT03774823|454961468|FG001|Overall Study|Withdrawal by Subject|1|||
126705700|NCT03528681|455875431|FG003|Randomized Treatment Phase|Physician Decision|2|||
126705701|NCT03528681|455875428|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
126705702|NCT03528681|455875429|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
126705703|NCT03528681|455875430|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
126705704|NCT03528681|455875431|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
126705705|NCT03528681|455875428|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
126705706|NCT03528681|455875429|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
126705707|NCT03528681|455875430|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
126272178|NCT00415194|454288981|FG000|Overall Study|Lost to Follow-up|1|||
126705708|NCT03528681|455875431|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
126705709|NCT03528681|455875428|FG000|Randomized Treatment Phase|(Not collected)|0|||
126272179|NCT00415194|454288982|FG001|Overall Study|Lost to Follow-up|0|||
126272180|NCT00415194|454288981|FG000|Overall Study|Physician Decision|10|||
126272181|NCT00415194|454288982|FG001|Overall Study|Physician Decision|16|||
126272182|NCT00415194|454288981|FG000|Overall Study|Progressive Disease|180|||
126272183|NCT00415194|454288982|FG001|Overall Study|Progressive Disease|217|||
126272184|NCT00415194|454288981|FG000|Overall Study|Protocol Violation|4|||
126272185|NCT00415194|454288982|FG001|Overall Study|Protocol Violation|2|||
126272186|NCT00415194|454288981|FG000|Overall Study|Withdrawal by Subject|28|||
126272187|NCT00415194|454288982|FG001|Overall Study|Withdrawal by Subject|21|||
126272188|NCT00415194|454288981|FG000|Overall Study|Death Due to Study Disease|26|||
126272189|NCT00415194|454288982|FG001|Overall Study|Death Due to Study Disease|29|||
126272190|NCT00415194|454288981|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
126272191|NCT00415194|454288982|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
126272192|NCT00415194|454288981|FG000|Overall Study|Death Due to Procedural Related AE|0|||
126272193|NCT00415194|454288982|FG001|Overall Study|Death Due to Procedural Related AE|1|||
126272194|NCT00415194|454288981|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
126272195|NCT00415194|454288982|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
126272196|NCT00969540|454288983|FG000|Overall Study|Lost to Follow-up|1|||
126272197|NCT00969540|454288984|FG001|Overall Study|Lost to Follow-up|1|||
126272198|NCT02397408|454288985|FG000|Overall Study|Physician Decision|4|||
126272199|NCT02397408|454288985|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
126272200|NCT00369655|454288986|FG000|Overall Study|Refusal of further treatment|2|||
126272201|NCT01646138|454288987|FG000|Overall Study|Lost to Follow-up|0|||
126272202|NCT01646138|454288988|FG001|Overall Study|Lost to Follow-up|0|||
126272203|NCT01646138|454288989|FG002|Overall Study|Lost to Follow-up|0|||
126272204|NCT01646138|454288990|FG003|Overall Study|Lost to Follow-up|0|||
126272205|NCT01646138|454288991|FG004|Overall Study|Lost to Follow-up|2|||
126272206|NCT01683838|454288992|FG000|Overall Study|Adverse Event|12|||
126272207|NCT01683838|454288993|FG001|Overall Study|Adverse Event|2|||
126272208|NCT01683838|454288992|FG000|Overall Study|Protocol Violation|3|||
126272209|NCT01683838|454288993|FG001|Overall Study|Protocol Violation|1|||
126272210|NCT01683838|454288992|FG000|Overall Study|Withdrawal by Subject|6|||
126272211|NCT01683838|454288993|FG001|Overall Study|Withdrawal by Subject|5|||
126272212|NCT01683838|454288992|FG000|Overall Study|Lost to Follow-up|1|||
126272213|NCT01683838|454288993|FG001|Overall Study|Lost to Follow-up|1|||
126272214|NCT01683838|454288992|FG000|Overall Study|Other|4|||
126361774|NCT02242903|454617280|FG004|Overall Study|Withdrawal by Subject|0|||
126361775|NCT02242903|454617281|FG005|Overall Study|Withdrawal by Subject|0|||
126361776|NCT02242903|454617282|FG006|Overall Study|Withdrawal by Subject|0|||
126361777|NCT04985682|454617285|FG000|Overall Study|Withdrawal by Subject|1|||
126361778|NCT01546987|454617288|FG000|Overall Study|Protocol Violation|3|||
126361779|NCT01546987|454617289|FG001|Overall Study|Protocol Violation|4|||
126272215|NCT01683838|454288993|FG001|Overall Study|Other|3|||
126272216|NCT04049617|454288994|FG000|Overall Study|Adverse Event|0|||
126272217|NCT04049617|454288995|FG001|Overall Study|Adverse Event|0|||
126272218|NCT04049617|454288996|FG002|Overall Study|Adverse Event|0|||
126272219|NCT04049617|454288997|FG003|Overall Study|Adverse Event|1|||
126272220|NCT04049617|454288998|FG004|Overall Study|Adverse Event|0|||
126272221|NCT04049617|454288999|FG005|Overall Study|Adverse Event|0|||
126272222|NCT04049617|454288994|FG000|Overall Study|Death|0|||
126272223|NCT04049617|454288995|FG001|Overall Study|Death|0|||
126272224|NCT04049617|454288996|FG002|Overall Study|Death|0|||
126272225|NCT04049617|454288997|FG003|Overall Study|Death|0|||
126272226|NCT04049617|454288998|FG004|Overall Study|Death|0|||
126272227|NCT04049617|454288999|FG005|Overall Study|Death|1|||
126272228|NCT04049617|454288994|FG000|Overall Study|Lost to Follow-up|0|||
126272229|NCT04049617|454288995|FG001|Overall Study|Lost to Follow-up|0|||
126272230|NCT04049617|454288996|FG002|Overall Study|Lost to Follow-up|0|||
126272231|NCT04049617|454288997|FG003|Overall Study|Lost to Follow-up|1|||
126272232|NCT04049617|454288998|FG004|Overall Study|Lost to Follow-up|0|||
126272233|NCT04049617|454288999|FG005|Overall Study|Lost to Follow-up|0|||
126272234|NCT04049617|454288994|FG000|Overall Study|Withdrew consent|0|||
126272235|NCT04049617|454288995|FG001|Overall Study|Withdrew consent|0|||
126272236|NCT04049617|454288996|FG002|Overall Study|Withdrew consent|1|||
126272237|NCT04049617|454288997|FG003|Overall Study|Withdrew consent|0|||
126361780|NCT03878602|454617290|FG000|Overall Study|cord blood donation|7|||
126361781|NCT03878602|454617291|FG001|Overall Study|cord blood donation|1|||
126272238|NCT04049617|454288998|FG004|Overall Study|Withdrew consent|0|||
126272239|NCT04049617|454288999|FG005|Overall Study|Withdrew consent|0|||
126272240|NCT03551496|454289000|FG000|Overall Study|Death|11|||
126272241|NCT03551496|454289001|FG001|Overall Study|Death|7|||
126272242|NCT03551496|454289000|FG000|Overall Study|Withdrawal by Subject|4|||
126272243|NCT03551496|454289001|FG001|Overall Study|Withdrawal by Subject|3|||
126272244|NCT03551496|454289000|FG000|Overall Study|Other Reasons|1|||
126272245|NCT03551496|454289001|FG001|Overall Study|Other Reasons|0|||
126272246|NCT01524679|454289002|FG000|Overall Study|Lost to Follow-up|1|||
126272247|NCT01524679|454289003|FG001|Overall Study|Lost to Follow-up|4|||
126272248|NCT01524679|454289002|FG000|Overall Study|Withdrawal by Subject|4|||
126361782|NCT03878602|454617290|FG000|Overall Study|incomplete data collection|2|||
126361783|NCT03878602|454617291|FG001|Overall Study|incomplete data collection|0|||
126705710|NCT03528681|455875429|FG001|Randomized Treatment Phase|(Not collected)|4|||
126705711|NCT03528681|455875430|FG002|Randomized Treatment Phase|(Not collected)|6|||
126705712|NCT03528681|455875431|FG003|Randomized Treatment Phase|(Not collected)|5|||
126705713|NCT02981472|455875439|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
126705714|NCT02981472|455875440|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
126705715|NCT02981472|455875439|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126705716|NCT02981472|455875440|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126705717|NCT02981472|455875439|FG000|Treatment Period|Adverse Event|6|||
126705718|NCT02981472|455875440|FG001|Treatment Period|Adverse Event|1|||
126705719|NCT02981472|455875439|FG000|Treatment Period|Participant withdrew consent|1|||
126705720|NCT02981472|455875440|FG001|Treatment Period|Participant withdrew consent|0|||
126705721|NCT02981472|455875439|FG000|Treatment Period|Lost to Follow-up|0|||
126705722|NCT02981472|455875440|FG001|Treatment Period|Lost to Follow-up|1|||
126705723|NCT00621023|455875443|FG000|Overall Study|Death|5|||
126705724|NCT00621023|455875443|FG000|Overall Study|Follow up discontinued|1|||
126765604|NCT00352664|456094567|FG001|Overall Study|Withdrawal by Subject|0|||
126765605|NCT03075215|456094570|FG000|12-Month Primary Endpoint|Death|152|||
126272249|NCT01524679|454289003|FG001|Overall Study|Withdrawal by Subject|4|||
126272250|NCT01524679|454289002|FG000|Overall Study|Adverse Event|9|||
126272251|NCT01524679|454289003|FG001|Overall Study|Adverse Event|0|||
126272252|NCT01524679|454289002|FG000|Overall Study|Protocol Violation|1|||
126272253|NCT01524679|454289003|FG001|Overall Study|Protocol Violation|0|||
126272254|NCT01524679|454289002|FG000|Overall Study|Lack of Efficacy|2|||
126272255|NCT01524679|454289003|FG001|Overall Study|Lack of Efficacy|0|||
126272256|NCT01524679|454289002|FG000|Overall Study|e.g.wish for children, relocation|6|||
126272257|NCT01524679|454289003|FG001|Overall Study|e.g.wish for children, relocation|1|||
126272258|NCT01154816|454289004|FG000|Overall Study|Withdrawal by Subject|1|||
126272259|NCT01154816|454289005|FG001|Overall Study|Withdrawal by Subject|0|||
126272260|NCT01154816|454289006|FG002|Overall Study|Withdrawal by Subject|0|||
126272261|NCT01154816|454289007|FG003|Overall Study|Withdrawal by Subject|1|||
126272262|NCT01154816|454289008|FG004|Overall Study|Withdrawal by Subject|0|||
126272263|NCT01154816|454289009|FG005|Overall Study|Withdrawal by Subject|0|||
126272264|NCT01154816|454289010|FG006|Overall Study|Withdrawal by Subject|0|||
126272265|NCT01154816|454289011|FG007|Overall Study|Withdrawal by Subject|0|||
126272266|NCT01154816|454289012|FG008|Overall Study|Withdrawal by Subject|1|||
126272267|NCT01154816|454289013|FG009|Overall Study|Withdrawal by Subject|3|||
126272268|NCT01154816|454289014|FG010|Overall Study|Withdrawal by Subject|0|||
126272269|NCT01154816|454289015|FG011|Overall Study|Withdrawal by Subject|0|||
126272270|NCT01154816|454289004|FG000|Overall Study|Progressive Disease|13|||
126272271|NCT01154816|454289005|FG001|Overall Study|Progressive Disease|8|||
126272272|NCT01154816|454289006|FG002|Overall Study|Progressive Disease|9|||
126272273|NCT01154816|454289007|FG003|Overall Study|Progressive Disease|9|||
126272274|NCT01154816|454289008|FG004|Overall Study|Progressive Disease|8|||
126272275|NCT01154816|454289009|FG005|Overall Study|Progressive Disease|8|||
126272276|NCT01154816|454289010|FG006|Overall Study|Progressive Disease|5|||
126272277|NCT01154816|454289011|FG007|Overall Study|Progressive Disease|6|||
126272278|NCT01154816|454289012|FG008|Overall Study|Progressive Disease|8|||
126272279|NCT01154816|454289013|FG009|Overall Study|Progressive Disease|6|||
126272280|NCT01154816|454289014|FG010|Overall Study|Progressive Disease|10|||
126272281|NCT01154816|454289015|FG011|Overall Study|Progressive Disease|3|||
126272282|NCT01154816|454289004|FG000|Overall Study|Physician Decision|1|||
126272283|NCT01154816|454289005|FG001|Overall Study|Physician Decision|0|||
126272284|NCT01154816|454289006|FG002|Overall Study|Physician Decision|1|||
126272285|NCT01154816|454289007|FG003|Overall Study|Physician Decision|0|||
126272286|NCT01154816|454289008|FG004|Overall Study|Physician Decision|2|||
126272287|NCT01154816|454289009|FG005|Overall Study|Physician Decision|0|||
126705725|NCT04430348|455875448|FG000|Overall Study|Death|3|||
126705726|NCT04430348|455875449|FG001|Overall Study|Death|2|||
126705727|NCT04430348|455875450|FG002|Overall Study|Death|2|||
126705728|NCT04430348|455875451|FG003|Overall Study|Death|2|||
126705729|NCT04430348|455875452|FG004|Overall Study|Death|2|||
126765606|NCT03075215|456094570|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
126272288|NCT01154816|454289010|FG006|Overall Study|Physician Decision|0|||
126272289|NCT01154816|454289011|FG007|Overall Study|Physician Decision|0|||
126272290|NCT01154816|454289012|FG008|Overall Study|Physician Decision|0|||
126272291|NCT01154816|454289013|FG009|Overall Study|Physician Decision|1|||
126272292|NCT01154816|454289014|FG010|Overall Study|Physician Decision|1|||
126272293|NCT01154816|454289015|FG011|Overall Study|Physician Decision|1|||
126272294|NCT01154816|454289004|FG000|Overall Study|Adverse Event|5|||
126705730|NCT04430348|455875453|FG005|Overall Study|Death|3|||
126272295|NCT01154816|454289005|FG001|Overall Study|Adverse Event|2|||
126272296|NCT01154816|454289006|FG002|Overall Study|Adverse Event|0|||
126272297|NCT01154816|454289007|FG003|Overall Study|Adverse Event|0|||
126272298|NCT01154816|454289008|FG004|Overall Study|Adverse Event|0|||
126272299|NCT01154816|454289009|FG005|Overall Study|Adverse Event|0|||
126272300|NCT01154816|454289010|FG006|Overall Study|Adverse Event|1|||
126705731|NCT04430348|455875448|FG000|Overall Study|Lost to Follow-up|0|||
126705732|NCT04430348|455875449|FG001|Overall Study|Lost to Follow-up|0|||
126705733|NCT04430348|455875450|FG002|Overall Study|Lost to Follow-up|0|||
126705734|NCT04430348|455875451|FG003|Overall Study|Lost to Follow-up|1|||
126705735|NCT04430348|455875452|FG004|Overall Study|Lost to Follow-up|0|||
126705736|NCT04430348|455875453|FG005|Overall Study|Lost to Follow-up|0|||
126705737|NCT04430348|455875448|FG000|Overall Study|Adverse Event|0|||
126705738|NCT04430348|455875449|FG001|Overall Study|Adverse Event|0|||
126705739|NCT04430348|455875450|FG002|Overall Study|Adverse Event|0|||
126705740|NCT04430348|455875451|FG003|Overall Study|Adverse Event|0|||
126705741|NCT04430348|455875452|FG004|Overall Study|Adverse Event|0|||
126705742|NCT04430348|455875453|FG005|Overall Study|Adverse Event|1|||
126705743|NCT04430348|455875448|FG000|Overall Study|Withdrawal by Subject|0|||
126705744|NCT04430348|455875449|FG001|Overall Study|Withdrawal by Subject|1|||
126705745|NCT04430348|455875450|FG002|Overall Study|Withdrawal by Subject|0|||
126705746|NCT04430348|455875451|FG003|Overall Study|Withdrawal by Subject|0|||
126705747|NCT04430348|455875452|FG004|Overall Study|Withdrawal by Subject|0|||
126705748|NCT04430348|455875453|FG005|Overall Study|Withdrawal by Subject|1|||
126705749|NCT04430348|455875448|FG000|Overall Study|Study Terminated by Sponsor|0|||
126705750|NCT04430348|455875449|FG001|Overall Study|Study Terminated by Sponsor|0|||
126705751|NCT04430348|455875450|FG002|Overall Study|Study Terminated by Sponsor|2|||
126705752|NCT04430348|455875451|FG003|Overall Study|Study Terminated by Sponsor|0|||
126705753|NCT04430348|455875452|FG004|Overall Study|Study Terminated by Sponsor|1|||
126705754|NCT04430348|455875453|FG005|Overall Study|Study Terminated by Sponsor|1|||
126705755|NCT03715465|455875454|FG000|Overall Study|Withdrawal by Subject|1|||
126705756|NCT03715465|455875455|FG001|Overall Study|Withdrawal by Subject|2|||
126705757|NCT00756002|455875459|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
126705758|NCT00756002|455875460|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
126705759|NCT00756002|455875459|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126705760|NCT00756002|455875460|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
126705761|NCT00756002|455875459|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
126705762|NCT00756002|455875460|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
126705763|NCT00756002|455875459|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
126705764|NCT00756002|455875460|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
126705765|NCT00756002|455875459|FG000|Double-Blind Treatment Period|Other|2|||
126705766|NCT00756002|455875460|FG001|Double-Blind Treatment Period|Other|2|||
126705767|NCT04899271|455875467|FG000|Overall Study|Lost to Follow-up|1|||
126272301|NCT01154816|454289011|FG007|Overall Study|Adverse Event|1|||
126272302|NCT01154816|454289012|FG008|Overall Study|Adverse Event|0|||
126272303|NCT01154816|454289013|FG009|Overall Study|Adverse Event|0|||
126272304|NCT01154816|454289014|FG010|Overall Study|Adverse Event|0|||
126272305|NCT01154816|454289015|FG011|Overall Study|Adverse Event|0|||
126272306|NCT00801099|454289016|FG000|Overall Study|Lost to Follow-up|101|||
126272307|NCT03397771|454289019|FG000|Overall Study|2 erroneously randomized, never treated|3|||
126272308|NCT03397771|454289020|FG001|Overall Study|2 erroneously randomized, never treated|1|||
126272309|NCT03397771|454289019|FG000|Overall Study|Withdrawal by Subject|1|||
126272310|NCT03397771|454289020|FG001|Overall Study|Withdrawal by Subject|3|||
126272311|NCT03397771|454289019|FG000|Overall Study|Protocol Violation|2|||
126272312|NCT03397771|454289020|FG001|Overall Study|Protocol Violation|2|||
126272313|NCT03397771|454289019|FG000|Overall Study|Adverse Event|2|||
126272314|NCT03397771|454289020|FG001|Overall Study|Adverse Event|1|||
126272315|NCT04078126|454289023|FG000|Washout|Study put on hold due to COVID-19|0|||
126272316|NCT04078126|454289024|FG001|Washout|Study put on hold due to COVID-19|2|||
126272317|NCT04078126|454289023|FG000|Period 2|Study put on hold due to COVID-19|1|||
126272318|NCT04078126|454289024|FG001|Period 2|Study put on hold due to COVID-19|1|||
126272319|NCT02455050|454289025|FG000|Treatment Period 1|Lost to Follow-up|1|||
126272320|NCT02455050|454289026|FG001|Treatment Period 1|Lost to Follow-up|1|||
126272321|NCT02455050|454289027|FG002|Treatment Period 1|Lost to Follow-up|1|||
126272322|NCT02455050|454289028|FG003|Treatment Period 1|Lost to Follow-up|2|||
126272323|NCT02455050|454289025|FG000|Treatment Period 2|Lost to Follow-up|1|||
126361784|NCT02191397|454617292|FG000|Overall Study|Adverse Event|28|||
126705768|NCT04899271|455875468|FG001|Overall Study|Lost to Follow-up|0|||
126705769|NCT04899271|455875467|FG000|Overall Study|Subject request/consent withdrawal|2|||
126705770|NCT04899271|455875468|FG001|Overall Study|Subject request/consent withdrawal|0|||
126705771|NCT01929083|455875471|FG000|Intervention 1|Lost to Follow-up|2|||
126705772|NCT01929083|455875472|FG001|Intervention 1|Lost to Follow-up|0|||
126272324|NCT02455050|454289026|FG001|Treatment Period 2|Lost to Follow-up|0|||
126361785|NCT02191397|454617293|FG001|Overall Study|Adverse Event|17|||
126705773|NCT01929083|455875471|FG000|Intervention 1|Nonadherent to study medications|1|||
126705774|NCT01929083|455875472|FG001|Intervention 1|Nonadherent to study medications|0|||
126705775|NCT01929083|455875471|FG000|Intervention 2|Adverse Event|0|||
126705776|NCT01929083|455875472|FG001|Intervention 2|Adverse Event|1|||
126705777|NCT02586805|455875477|FG000|Overall Study|Withdrawal by Subject|3|||
126705778|NCT02586805|455875478|FG001|Overall Study|Withdrawal by Subject|1|||
126705779|NCT02586805|455875479|FG002|Overall Study|Withdrawal by Subject|1|||
126705780|NCT02586805|455875480|FG003|Overall Study|Withdrawal by Subject|2|||
126272325|NCT02455050|454289027|FG002|Treatment Period 2|Lost to Follow-up|2|||
126361786|NCT02191397|454617292|FG000|Overall Study|Lack of Efficacy|10|||
126272326|NCT02455050|454289028|FG003|Treatment Period 2|Lost to Follow-up|1|||
126272327|NCT02981303|454289029|FG000|Overall Study|Progressive Disease|17|||
126272328|NCT02981303|454289030|FG001|Overall Study|Progressive Disease|37|||
126272329|NCT02981303|454289029|FG000|Overall Study|Adverse Event|1|||
126272330|NCT02981303|454289030|FG001|Overall Study|Adverse Event|4|||
126272331|NCT02981303|454289029|FG000|Overall Study|Withdrawal by Subject|0|||
126272332|NCT02981303|454289030|FG001|Overall Study|Withdrawal by Subject|1|||
126272333|NCT02325518|454289031|FG000|Overall Study|Adverse Event|4|||
126453581|NCT00958438|454961469|FG000|Overall Study|Protocol Violation|3|||
126272334|NCT02325518|454289032|FG001|Overall Study|Adverse Event|1|||
126272335|NCT02325518|454289031|FG000|Overall Study|Physician Decision|0|||
126272336|NCT02325518|454289032|FG001|Overall Study|Physician Decision|1|||
126272337|NCT02325518|454289031|FG000|Overall Study|Withdrawal by Subject|0|||
126272338|NCT02325518|454289032|FG001|Overall Study|Withdrawal by Subject|1|||
126272339|NCT03393806|454289035|FG000|Overall Study|Physician Decision|1|||
126272340|NCT03393806|454289036|FG001|Overall Study|Physician Decision|0|||
126272341|NCT00886288|454289037|FG000|Overall Study|no respect of the 12 weeks period|657|||
126272342|NCT00886288|454289038|FG001|Overall Study|no respect of the 12 weeks period|227|||
126272343|NCT00886288|454289037|FG000|Overall Study|Lost to Follow-up|86|||
126272344|NCT00886288|454289038|FG001|Overall Study|Lost to Follow-up|0|||
126272345|NCT01259115|454289039|FG000|Period 1|Adverse Event|1|||
126272346|NCT01259115|454289040|FG001|Period 1|Adverse Event|0|||
126272347|NCT01259115|454289039|FG000|Period 1|Protocol Violation|2|||
126272348|NCT01259115|454289040|FG001|Period 1|Protocol Violation|0|||
126272349|NCT01259115|454289039|FG000|Period 1|Lost to Follow-up|0|||
126272350|NCT01259115|454289040|FG001|Period 1|Lost to Follow-up|1|||
126272351|NCT01259115|454289039|FG000|Period 2|Adverse Event|1|||
126272352|NCT01259115|454289040|FG001|Period 2|Adverse Event|0|||
126272353|NCT01675661|454289041|FG000|Overall Study|Lost to Follow-up|22|||
126272354|NCT01675661|454289042|FG001|Overall Study|Lost to Follow-up|23|||
126272355|NCT01675661|454289041|FG000|Overall Study|Practical problems|9|||
126272356|NCT01675661|454289042|FG001|Overall Study|Practical problems|5|||
126272357|NCT01675661|454289041|FG000|Overall Study|Moved away|5|||
126272358|NCT01675661|454289042|FG001|Overall Study|Moved away|6|||
126272359|NCT01675661|454289041|FG000|Overall Study|Withdrawal by Subject|3|||
126272360|NCT01675661|454289042|FG001|Overall Study|Withdrawal by Subject|7|||
126272361|NCT01675661|454289041|FG000|Overall Study|Physician Decision|0|||
126272362|NCT01675661|454289042|FG001|Overall Study|Physician Decision|2|||
126272363|NCT01675661|454289041|FG000|Overall Study|Death|0|||
126272364|NCT01675661|454289042|FG001|Overall Study|Death|1|||
126272365|NCT01675661|454289041|FG000|Overall Study|Other reason|1|||
126272366|NCT01675661|454289042|FG001|Overall Study|Other reason|2|||
126272367|NCT02393248|454289043|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272368|NCT02393248|454289044|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
126272369|NCT02393248|454289045|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272370|NCT02393248|454289046|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272371|NCT02393248|454289047|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272372|NCT02393248|454289048|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
126453582|NCT00958438|454961470|FG001|Overall Study|Protocol Violation|2|||
126453583|NCT00958438|454961471|FG002|Overall Study|Protocol Violation|2|||
126453584|NCT00958438|454961469|FG000|Overall Study|Withdrawal by Subject|4|||
126453585|NCT00958438|454961470|FG001|Overall Study|Withdrawal by Subject|2|||
126453586|NCT00958438|454961471|FG002|Overall Study|Withdrawal by Subject|1|||
126453587|NCT00958438|454961469|FG000|Overall Study|Adverse Event|0|||
126453588|NCT00958438|454961470|FG001|Overall Study|Adverse Event|3|||
126453589|NCT00958438|454961471|FG002|Overall Study|Adverse Event|0|||
126453590|NCT00958438|454961469|FG000|Overall Study|Physician Decision|1|||
126272373|NCT02393248|454289049|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
126272374|NCT02393248|454289050|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272375|NCT02393248|454289051|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272376|NCT02393248|454289052|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272377|NCT02393248|454289053|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272378|NCT02393248|454289054|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272379|NCT02393248|454289055|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272380|NCT02393248|454289056|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126453591|NCT00958438|454961470|FG001|Overall Study|Physician Decision|0|||
126453592|NCT00958438|454961471|FG002|Overall Study|Physician Decision|1|||
126453593|NCT00958438|454961469|FG000|Overall Study|Other than specified above|2|||
126453594|NCT00958438|454961470|FG001|Overall Study|Other than specified above|3|||
126453595|NCT00958438|454961471|FG002|Overall Study|Other than specified above|2|||
126453596|NCT00759564|454961472|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
126453597|NCT00759564|454961473|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
126453598|NCT00759564|454961474|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
126547401|NCT00244374|455297932|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
126272381|NCT02393248|454289057|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126453599|NCT00759564|454961475|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
126705781|NCT02586805|455875477|FG000|Overall Study|Adverse Event|2|||
126705782|NCT02586805|455875478|FG001|Overall Study|Adverse Event|0|||
126272382|NCT02393248|454289058|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272383|NCT02393248|454289059|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272384|NCT02393248|454289060|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272385|NCT02393248|454289061|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272386|NCT02393248|454289062|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272387|NCT02393248|454289063|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272388|NCT02393248|454289064|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272389|NCT02393248|454289065|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272390|NCT02393248|454289066|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272391|NCT02393248|454289067|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
126272392|NCT02393248|454289043|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272393|NCT02393248|454289044|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
126272394|NCT02393248|454289045|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272395|NCT02393248|454289046|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272396|NCT02393248|454289047|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272397|NCT02393248|454289048|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272398|NCT02393248|454289049|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272399|NCT02393248|454289050|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272400|NCT02393248|454289051|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272401|NCT02393248|454289052|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272402|NCT02393248|454289053|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272403|NCT02393248|454289054|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272404|NCT02393248|454289055|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272405|NCT02393248|454289056|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272406|NCT02393248|454289057|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272407|NCT02393248|454289058|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272408|NCT02393248|454289059|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272409|NCT02393248|454289060|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272410|NCT02393248|454289061|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272411|NCT02393248|454289062|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272412|NCT02393248|454289063|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272413|NCT02393248|454289064|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272414|NCT02393248|454289065|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272415|NCT02393248|454289066|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272416|NCT02393248|454289067|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
126272417|NCT02393248|454289043|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
126272418|NCT02393248|454289044|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
126272419|NCT02393248|454289045|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
126272420|NCT02393248|454289046|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
126272421|NCT02393248|454289047|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
126272422|NCT02393248|454289048|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
126272423|NCT02393248|454289049|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
126272424|NCT02393248|454289050|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
126272425|NCT02393248|454289051|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
126272426|NCT02393248|454289052|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
126272427|NCT02393248|454289053|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
126272428|NCT02393248|454289054|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
126272429|NCT02393248|454289055|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
126272430|NCT02393248|454289056|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
126272431|NCT02393248|454289057|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
126272432|NCT02393248|454289058|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
126272433|NCT02393248|454289059|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
126272434|NCT02393248|454289060|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
126272435|NCT02393248|454289061|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
126272436|NCT02393248|454289062|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
126272437|NCT02393248|454289063|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
126272438|NCT02393248|454289064|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
126272439|NCT02393248|454289065|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
126272440|NCT02393248|454289066|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
126272441|NCT02393248|454289067|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
126272442|NCT02393248|454289043|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
126705783|NCT02586805|455875479|FG002|Overall Study|Adverse Event|1|||
126705784|NCT02586805|455875480|FG003|Overall Study|Adverse Event|0|||
126705785|NCT02586805|455875477|FG000|Overall Study|Lost to Follow-up|0|||
126705786|NCT02586805|455875478|FG001|Overall Study|Lost to Follow-up|0|||
126361787|NCT02191397|454617293|FG001|Overall Study|Lack of Efficacy|5|||
126705787|NCT02586805|455875479|FG002|Overall Study|Lost to Follow-up|1|||
126705788|NCT02586805|455875480|FG003|Overall Study|Lost to Follow-up|0|||
126705789|NCT02586805|455875477|FG000|Overall Study|Physician Decision|1|||
126361788|NCT02191397|454617292|FG000|Overall Study|Protocol Violation|0|||
126361789|NCT02191397|454617293|FG001|Overall Study|Protocol Violation|3|||
126361790|NCT02191397|454617292|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
126361791|NCT02191397|454617293|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
126361792|NCT02191397|454617292|FG000|Overall Study|Lost to Follow-up|10|||
126361793|NCT02191397|454617293|FG001|Overall Study|Lost to Follow-up|11|||
126361794|NCT02191397|454617292|FG000|Overall Study|Physician Decision|8|||
126361795|NCT02191397|454617293|FG001|Overall Study|Physician Decision|3|||
126361796|NCT02191397|454617292|FG000|Overall Study|Withdrawal by Subject|22|||
126361797|NCT02191397|454617293|FG001|Overall Study|Withdrawal by Subject|27|||
126361798|NCT04629521|454617294|FG000|Overall Study|Death|1|||
126361799|NCT04629521|454617294|FG000|Overall Study|Lost to Follow-up|3|||
126361800|NCT04629521|454617294|FG000|Overall Study|Subject withdrew consent|3|||
126361801|NCT04629521|454617294|FG000|Overall Study|Enrolled in error|1|||
126361802|NCT01618708|454617295|FG000|Overall Study|Adverse Event|10|||
126361803|NCT01618708|454617296|FG001|Overall Study|Adverse Event|10|||
126361804|NCT01618708|454617295|FG000|Overall Study|Lost to Follow-up|3|||
126361805|NCT01618708|454617296|FG001|Overall Study|Lost to Follow-up|3|||
126361806|NCT01618708|454617295|FG000|Overall Study|Withdrawal by Subject|17|||
126361807|NCT01618708|454617296|FG001|Overall Study|Withdrawal by Subject|22|||
126361808|NCT01618708|454617295|FG000|Overall Study|Lack of Efficacy|8|||
126361809|NCT01618708|454617296|FG001|Overall Study|Lack of Efficacy|8|||
126361810|NCT01618708|454617295|FG000|Overall Study|Technical problems|2|||
126361811|NCT01618708|454617296|FG001|Overall Study|Technical problems|0|||
126361812|NCT01618708|454617295|FG000|Overall Study|Other than specified above|1|||
126361813|NCT01618708|454617296|FG001|Overall Study|Other than specified above|1|||
126361814|NCT01618708|454617295|FG000|Overall Study|Randomized but not treated|3|||
126361815|NCT01618708|454617296|FG001|Overall Study|Randomized but not treated|2|||
126361816|NCT02554474|454617299|FG000|Overall Study|Protocol Violation|1|||
126361817|NCT02554474|454617300|FG001|Overall Study|Protocol Violation|1|||
126361818|NCT02554474|454617299|FG000|Overall Study|Health issue not related to the study|1|||
126361819|NCT02554474|454617300|FG001|Overall Study|Health issue not related to the study|0|||
126361820|NCT02554474|454617299|FG000|Overall Study|Withdrawal by Subject|1|||
126361821|NCT02554474|454617300|FG001|Overall Study|Withdrawal by Subject|1|||
126361822|NCT03211832|454617301|FG000|Overall Study|No longer with agency|32|||
126361823|NCT03211832|454617302|FG001|Overall Study|No longer with agency|49|||
126361824|NCT03211832|454617303|FG002|Overall Study|No longer with agency|30|||
126361825|NCT03211832|454617301|FG000|Overall Study|Declined survey|3|||
126361826|NCT03211832|454617302|FG001|Overall Study|Declined survey|3|||
126361827|NCT03211832|454617303|FG002|Overall Study|Declined survey|2|||
126361828|NCT03211832|454617301|FG000|Overall Study|Not available during data collection|1|||
126361829|NCT03211832|454617302|FG001|Overall Study|Not available during data collection|0|||
126361830|NCT03211832|454617303|FG002|Overall Study|Not available during data collection|2|||
126361831|NCT02991859|454617307|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361832|NCT02991859|454617308|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
126361833|NCT02991859|454617309|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361834|NCT02991859|454617310|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361835|NCT02991859|454617311|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
126361836|NCT02991859|454617312|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361837|NCT02991859|454617313|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361838|NCT02991859|454617314|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361839|NCT02991859|454617315|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361840|NCT02991859|454617316|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361841|NCT02991859|454617317|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361842|NCT02991859|454617318|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361843|NCT02991859|454617319|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361844|NCT02991859|454617320|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361845|NCT02991859|454617321|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361846|NCT02991859|454617322|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361847|NCT02991859|454617323|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
126361848|NCT02991859|454617307|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361849|NCT02991859|454617308|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361850|NCT02991859|454617309|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361851|NCT02991859|454617310|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361852|NCT02991859|454617311|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361853|NCT02991859|454617312|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361854|NCT02991859|454617313|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361855|NCT02991859|454617314|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361856|NCT02991859|454617315|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361857|NCT02991859|454617316|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361858|NCT02991859|454617317|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361859|NCT02991859|454617318|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361860|NCT02991859|454617319|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
126361861|NCT02991859|454617320|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
126361862|NCT02991859|454617321|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361863|NCT02991859|454617322|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361864|NCT02991859|454617323|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
126361865|NCT02991859|454617307|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361866|NCT02991859|454617308|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361867|NCT02991859|454617309|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361868|NCT02991859|454617310|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361869|NCT02991859|454617311|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361870|NCT02991859|454617312|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
126361871|NCT02991859|454617313|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361872|NCT02991859|454617314|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361873|NCT02991859|454617315|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361874|NCT02991859|454617316|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361875|NCT02991859|454617317|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361876|NCT02991859|454617318|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361877|NCT02991859|454617319|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126272443|NCT02393248|454289044|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272444|NCT02393248|454289045|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272445|NCT02393248|454289046|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272446|NCT02393248|454289047|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272447|NCT02393248|454289048|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272448|NCT02393248|454289049|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272449|NCT02393248|454289050|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272450|NCT02393248|454289051|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272451|NCT02393248|454289052|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272452|NCT02393248|454289053|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272453|NCT02393248|454289054|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272454|NCT02393248|454289055|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272455|NCT02393248|454289056|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272456|NCT02393248|454289057|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272457|NCT02393248|454289058|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272458|NCT02393248|454289059|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272459|NCT02393248|454289060|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272460|NCT02393248|454289061|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272461|NCT02393248|454289062|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272462|NCT02393248|454289063|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272463|NCT02393248|454289064|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272464|NCT02393248|454289065|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272465|NCT02393248|454289066|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272466|NCT02393248|454289067|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
126272467|NCT02393248|454289043|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272468|NCT02393248|454289044|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272469|NCT02393248|454289045|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272470|NCT02393248|454289046|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272471|NCT02393248|454289047|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272472|NCT02393248|454289048|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
126272473|NCT02393248|454289049|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
126272474|NCT02393248|454289050|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272475|NCT02393248|454289051|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272476|NCT02393248|454289052|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
126272477|NCT02393248|454289053|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272478|NCT02393248|454289054|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126361878|NCT02991859|454617320|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361879|NCT02991859|454617321|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361880|NCT02991859|454617322|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361881|NCT02991859|454617323|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
126361882|NCT02991859|454617307|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361883|NCT02991859|454617308|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361884|NCT02991859|454617309|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126705790|NCT02586805|455875478|FG001|Overall Study|Physician Decision|0|||
126705791|NCT02586805|455875479|FG002|Overall Study|Physician Decision|0|||
126705792|NCT02586805|455875480|FG003|Overall Study|Physician Decision|0|||
126765607|NCT03075215|456094570|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
126765608|NCT03075215|456094570|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
126765609|NCT02756182|456094571|FG000|Overall Study|StudyTechnical Difficulties|4|||
126765610|NCT02146365|456094572|FG000|Overall Study|Lost to Follow-up|2|||
126765611|NCT02146365|456094573|FG001|Overall Study|Lost to Follow-up|1|||
126765612|NCT02146365|456094574|FG002|Overall Study|Lost to Follow-up|3|||
126765613|NCT02146365|456094575|FG003|Overall Study|Lost to Follow-up|3|||
126765614|NCT02146365|456094576|FG004|Overall Study|Lost to Follow-up|1|||
126272479|NCT02393248|454289055|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272480|NCT02393248|454289056|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272481|NCT02393248|454289057|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272482|NCT02393248|454289058|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272483|NCT02393248|454289059|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272484|NCT02393248|454289060|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272485|NCT02393248|454289061|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272486|NCT02393248|454289062|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272487|NCT02393248|454289063|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272488|NCT02393248|454289064|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272489|NCT02393248|454289065|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272490|NCT02393248|454289066|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272491|NCT02393248|454289067|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
126272492|NCT02393248|454289043|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272493|NCT02393248|454289044|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272494|NCT02393248|454289045|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272495|NCT02393248|454289046|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272496|NCT02393248|454289047|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272497|NCT02393248|454289048|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272498|NCT02393248|454289049|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
126272499|NCT02393248|454289050|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272500|NCT02393248|454289051|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272501|NCT02393248|454289052|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272502|NCT02393248|454289053|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272503|NCT02393248|454289054|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272504|NCT02393248|454289055|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272505|NCT02393248|454289056|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272506|NCT02393248|454289057|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272507|NCT02393248|454289058|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272508|NCT02393248|454289059|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272509|NCT02393248|454289060|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272510|NCT02393248|454289061|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272511|NCT02393248|454289062|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272512|NCT02393248|454289063|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272513|NCT02393248|454289064|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272514|NCT02393248|454289065|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272515|NCT02393248|454289066|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272516|NCT02393248|454289067|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
126272517|NCT02393248|454289043|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272518|NCT02393248|454289044|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272519|NCT02393248|454289045|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272520|NCT02393248|454289046|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272521|NCT02393248|454289047|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272522|NCT02393248|454289048|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272523|NCT02393248|454289049|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272524|NCT02393248|454289050|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272525|NCT02393248|454289051|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272526|NCT02393248|454289052|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272527|NCT02393248|454289053|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272528|NCT02393248|454289054|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
126453600|NCT00759564|454961476|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
126453601|NCT00329849|454961478|FG000|Overall Study|Withdrawal by Subject|6|||
126765615|NCT02146365|456094577|FG005|Overall Study|Lost to Follow-up|1|||
126765616|NCT02146365|456094578|FG006|Overall Study|Lost to Follow-up|0|||
126361885|NCT02991859|454617310|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361886|NCT02991859|454617311|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361887|NCT02991859|454617312|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361888|NCT02991859|454617313|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361889|NCT02991859|454617314|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361890|NCT02991859|454617315|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361891|NCT02991859|454617316|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
126361892|NCT02991859|454617317|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361893|NCT02991859|454617318|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361894|NCT02991859|454617319|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361895|NCT02991859|454617320|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361896|NCT02991859|454617321|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361897|NCT02991859|454617322|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361898|NCT02991859|454617323|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
126361899|NCT02991859|454617307|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361900|NCT02991859|454617308|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361901|NCT02991859|454617309|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361902|NCT02991859|454617310|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361903|NCT02991859|454617311|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361904|NCT02991859|454617312|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361905|NCT02991859|454617313|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361906|NCT02991859|454617314|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361907|NCT02991859|454617315|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
126361908|NCT02991859|454617316|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361909|NCT02991859|454617317|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361910|NCT02991859|454617318|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361911|NCT02991859|454617319|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361912|NCT02991859|454617320|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361913|NCT02991859|454617321|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361914|NCT02991859|454617322|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361915|NCT02991859|454617323|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
126361916|NCT01065766|454617324|FG000|Overall Study|Assessed before the contracted date|1|||
126361917|NCT01065766|454617324|FG000|Overall Study|Contraindication to administration|6|||
126361918|NCT01065766|454617324|FG000|Overall Study|Violated dosage/administration|25|||
126361919|NCT04223687|454617331|FG000|Overall Study|Missing primary outcome|1|||
126361920|NCT04223687|454617332|FG001|Overall Study|Missing primary outcome|0|||
126361921|NCT00425854|454617333|FG000|Overall Study|Progressive Disease|19|||
126361922|NCT00425854|454617334|FG001|Overall Study|Progressive Disease|12|||
126361923|NCT00425854|454617333|FG000|Overall Study|Dose reduction toxicity AE|8|||
126361924|NCT00425854|454617334|FG001|Overall Study|Dose reduction toxicity AE|7|||
126361925|NCT00425854|454617333|FG000|Overall Study|Other Adverse Event|2|||
126361926|NCT00425854|454617334|FG001|Overall Study|Other Adverse Event|2|||
126361927|NCT05652140|454617338|FG000|Overall Study|Lost to Follow-up|7|||
126361928|NCT05652140|454617339|FG001|Overall Study|Lost to Follow-up|16|||
126361929|NCT05652140|454617340|FG002|Overall Study|Lost to Follow-up|22|||
126361930|NCT05652140|454617341|FG003|Overall Study|Lost to Follow-up|31|||
126361931|NCT06048705|454617342|FG000|Overall Study|Physician Decision|1|||
126361932|NCT06048705|454617343|FG001|Overall Study|Physician Decision|0|||
126361933|NCT06048705|454617344|FG002|Overall Study|Physician Decision|0|||
126361934|NCT06048705|454617342|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
126361935|NCT06048705|454617343|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
126361936|NCT06048705|454617344|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
126361937|NCT06048705|454617342|FG000|Overall Study|Death prior to lymphodepletion|0|||
126361938|NCT06048705|454617343|FG001|Overall Study|Death prior to lymphodepletion|0|||
126361939|NCT06048705|454617344|FG002|Overall Study|Death prior to lymphodepletion|1|||
126361940|NCT01016015|454617345|FG000|Overall Study|Not Treated|3|||
126361941|NCT01016015|454617345|FG000|Overall Study|Withdrawal by Subject|1|||
126361942|NCT01016015|454617345|FG000|Overall Study|Adverse Event|15|||
126361943|NCT02057666|454617346|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
126361944|NCT02057666|454617347|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
126705793|NCT02504541|455875481|FG000|Overall Study|Adverse Event|4|||
126705794|NCT02504541|455875481|FG000|Overall Study|Withdrawal by Subject|4|||
126705795|NCT02504541|455875481|FG000|Overall Study|Lost to Follow-up|1|||
126361945|NCT02057666|454617346|FG000|Double Blind Treatment Period|Poor tolerability|7|||
126361946|NCT02057666|454617347|FG001|Double Blind Treatment Period|Poor tolerability|2|||
126361947|NCT02057666|454617346|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
126361948|NCT02057666|454617347|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
126705796|NCT02504541|455875481|FG000|Overall Study|Met Stopping Criteria|1|||
126361949|NCT02057666|454617346|FG000|Double Blind Treatment Period|Physician Decision|1|||
126361950|NCT02057666|454617347|FG001|Double Blind Treatment Period|Physician Decision|0|||
126705797|NCT02504541|455875481|FG000|Overall Study|Protocol Violation|2|||
126272529|NCT02393248|454289055|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
126272530|NCT02393248|454289056|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
126272531|NCT02393248|454289057|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
126272532|NCT02393248|454289058|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272533|NCT02393248|454289059|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272534|NCT02393248|454289060|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272535|NCT02393248|454289061|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272536|NCT02393248|454289062|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272537|NCT02393248|454289063|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272538|NCT02393248|454289064|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272539|NCT02393248|454289065|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272540|NCT02393248|454289066|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272541|NCT02393248|454289067|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
126272542|NCT02393248|454289043|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272543|NCT02393248|454289044|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272544|NCT02393248|454289045|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272545|NCT02393248|454289046|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272546|NCT02393248|454289047|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272547|NCT02393248|454289048|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272548|NCT02393248|454289049|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272549|NCT02393248|454289050|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272550|NCT02393248|454289051|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272551|NCT02393248|454289052|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272552|NCT02393248|454289053|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
126272553|NCT02393248|454289054|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
126272554|NCT02393248|454289055|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272555|NCT02393248|454289056|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272556|NCT02393248|454289057|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272557|NCT02393248|454289058|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272558|NCT02393248|454289059|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272559|NCT02393248|454289060|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272560|NCT02393248|454289061|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272561|NCT02393248|454289062|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272562|NCT02393248|454289063|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272563|NCT02393248|454289064|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272564|NCT02393248|454289065|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272565|NCT02393248|454289066|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272566|NCT02393248|454289067|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
126272567|NCT02393248|454289043|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
126272568|NCT02393248|454289044|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
126272569|NCT02393248|454289045|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
126272570|NCT02393248|454289046|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
126272571|NCT02393248|454289047|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
126272572|NCT02393248|454289048|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
126272573|NCT02393248|454289049|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
126272574|NCT02393248|454289050|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
126272575|NCT02393248|454289051|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
126272576|NCT02393248|454289052|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
126272577|NCT02393248|454289053|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
126272578|NCT02393248|454289054|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
126272579|NCT02393248|454289055|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
126272580|NCT02393248|454289056|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
126272581|NCT02393248|454289057|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
126272582|NCT02393248|454289058|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
126272583|NCT02393248|454289059|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
126272584|NCT02393248|454289060|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
126272585|NCT02393248|454289061|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
126272586|NCT02393248|454289062|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
126272587|NCT02393248|454289063|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
126272588|NCT02393248|454289064|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
126272589|NCT02393248|454289065|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
126272590|NCT02393248|454289066|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
126272591|NCT02393248|454289067|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
126272592|NCT02393248|454289043|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272593|NCT02393248|454289044|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272594|NCT02393248|454289045|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272595|NCT02393248|454289046|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272596|NCT02393248|454289047|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126705798|NCT02504541|455875481|FG000|Overall Study|Termination by Sponsor|1|||
126705799|NCT02504541|455875481|FG000|Overall Study|Other|2|||
126705800|NCT02504541|455875481|FG000|Overall Study|Multiple|5|||
126705801|NCT00500071|455875482|FG000|Screening and Washout Phase|Protocol Violation|1|||
126705802|NCT00500071|455875482|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
126272597|NCT02393248|454289048|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272598|NCT02393248|454289049|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272599|NCT02393248|454289050|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272600|NCT02393248|454289051|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272601|NCT02393248|454289052|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272602|NCT02393248|454289053|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272603|NCT02393248|454289054|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
126272604|NCT02393248|454289055|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272605|NCT02393248|454289056|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
126272606|NCT02393248|454289057|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272607|NCT02393248|454289058|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272608|NCT02393248|454289059|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272609|NCT02393248|454289060|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272610|NCT02393248|454289061|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272611|NCT02393248|454289062|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272612|NCT02393248|454289063|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272613|NCT02393248|454289064|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272614|NCT02393248|454289065|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272615|NCT02393248|454289066|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272616|NCT02393248|454289067|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
126272617|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272618|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272619|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272620|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272621|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272622|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272623|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272624|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272625|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272626|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272627|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272628|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272629|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272630|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272631|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272632|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272633|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272634|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272635|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
126272636|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272637|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
126272638|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
126272639|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272640|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
126272641|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
126272642|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Death|0|||
126272643|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Death|0|||
126272644|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Death|0|||
126272645|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Death|0|||
126272646|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Death|0|||
126272647|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Death|0|||
126272648|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Death|0|||
126272649|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Death|0|||
126272650|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Death|0|||
126705803|NCT00500071|455875482|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
126705804|NCT00500071|455875482|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
126272651|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Death|0|||
126272652|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Death|0|||
126272653|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Death|0|||
126272654|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Death|0|||
126272655|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Death|0|||
126272656|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Death|0|||
126705805|NCT00500071|455875482|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
126705806|NCT00500071|455875482|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
126272657|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Death|1|||
126272658|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Death|7|||
126272659|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Death|5|||
126272660|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Death|5|||
126272661|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Death|3|||
126272662|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Death|7|||
126272663|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Death|5|||
126272664|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Death|6|||
126272665|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Death|3|||
126272666|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Death|0|||
126272667|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272668|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272669|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272670|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272671|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272672|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272673|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272674|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272675|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272676|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272677|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272678|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272679|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272680|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272681|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272682|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272683|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272684|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
126272685|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
126272686|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
126272687|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
126272688|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
126272689|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
126272690|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
126272691|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
126272692|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Disease Progression|0|||
126272693|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Disease Progression|0|||
126272694|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Disease Progression|0|||
126272695|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Disease Progression|0|||
126272696|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Disease Progression|0|||
126272697|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Disease Progression|0|||
126272698|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Disease Progression|0|||
126272699|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Disease Progression|0|||
126272700|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Disease Progression|0|||
126272701|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Disease Progression|0|||
126272702|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Disease Progression|0|||
126272703|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Disease Progression|0|||
126272704|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Disease Progression|0|||
126272705|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Disease Progression|0|||
126272706|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Disease Progression|0|||
126272707|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Disease Progression|0|||
126272708|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Disease Progression|0|||
126272709|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Disease Progression|0|||
126272710|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Disease Progression|0|||
126272711|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Disease Progression|0|||
126272712|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Disease Progression|2|||
126272713|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Disease Progression|1|||
126272714|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Disease Progression|0|||
126272715|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Disease Progression|0|||
126272716|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Disease Progression|0|||
126272717|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272718|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
126361951|NCT02057666|454617346|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
126272719|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272720|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272721|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272722|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272723|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
126361952|NCT02057666|454617347|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
126272724|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272725|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272726|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272727|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272728|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272729|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272730|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272731|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272732|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272733|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272734|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272735|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272736|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272737|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
126272738|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
126272739|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272740|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272741|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
126272742|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272743|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272744|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272745|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272746|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272747|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272748|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272749|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272750|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272751|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272752|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272753|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272754|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272755|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272756|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272757|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272758|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272759|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272760|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272761|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272762|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
126272763|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272764|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272765|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272766|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
126272767|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Adverse Event|0|||
126272768|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Adverse Event|0|||
126272769|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Adverse Event|0|||
126272770|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Adverse Event|0|||
126272771|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Adverse Event|0|||
126272772|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Adverse Event|0|||
126272773|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Adverse Event|0|||
126272774|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Adverse Event|0|||
126453602|NCT00329849|454961479|FG001|Overall Study|Withdrawal by Subject|4|||
126453603|NCT03996369|454961480|FG000|Overall Study|Protocol deviation|1|||
126453604|NCT03996369|454961481|FG001|Overall Study|Protocol deviation|1|||
126453605|NCT03996369|454961480|FG000|Overall Study|Physician Decision|4|||
126453606|NCT03996369|454961481|FG001|Overall Study|Physician Decision|2|||
126453607|NCT03996369|454961480|FG000|Overall Study|Participant decision|0|||
126453608|NCT03996369|454961481|FG001|Overall Study|Participant decision|1|||
126453609|NCT03996369|454961480|FG000|Overall Study|Lack of Efficacy|4|||
126453610|NCT03996369|454961481|FG001|Overall Study|Lack of Efficacy|0|||
126453611|NCT03996369|454961480|FG000|Overall Study|Adverse Event|9|||
126272775|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Adverse Event|0|||
126272776|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Adverse Event|0|||
126272777|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Adverse Event|0|||
126272778|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Adverse Event|0|||
126272779|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Adverse Event|0|||
126272780|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Adverse Event|0|||
126272781|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Adverse Event|0|||
126272782|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Adverse Event|0|||
126272783|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Adverse Event|0|||
126272784|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Adverse Event|0|||
126272785|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Adverse Event|0|||
126272786|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Adverse Event|0|||
126272787|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Adverse Event|0|||
126272788|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Adverse Event|0|||
126272789|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Adverse Event|0|||
126272790|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Adverse Event|1|||
126272791|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Adverse Event|0|||
126272792|NCT02393248|454289043|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272793|NCT02393248|454289044|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272794|NCT02393248|454289045|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272795|NCT02393248|454289046|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272796|NCT02393248|454289047|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272797|NCT02393248|454289048|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272798|NCT02393248|454289049|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272799|NCT02393248|454289050|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272800|NCT02393248|454289051|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272801|NCT02393248|454289052|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272802|NCT02393248|454289053|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272803|NCT02393248|454289054|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272804|NCT02393248|454289055|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272805|NCT02393248|454289056|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272806|NCT02393248|454289057|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272807|NCT02393248|454289058|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272808|NCT02393248|454289059|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272809|NCT02393248|454289060|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272810|NCT02393248|454289061|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272811|NCT02393248|454289062|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272812|NCT02393248|454289063|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272813|NCT02393248|454289064|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272814|NCT02393248|454289065|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272815|NCT02393248|454289066|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
126272816|NCT02393248|454289067|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
126272817|NCT04765384|454289068|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
126272818|NCT04765384|454289069|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
126272819|NCT04765384|454289070|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
126272820|NCT04765384|454289071|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
126272821|NCT04765384|454289072|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
126272822|NCT04765384|454289073|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
126272823|NCT04765384|454289068|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
126272824|NCT04765384|454289069|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
126272825|NCT04765384|454289070|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
126272826|NCT04765384|454289071|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
126272827|NCT04765384|454289072|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
126272828|NCT04765384|454289073|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
126272829|NCT04765384|454289068|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
126272830|NCT04765384|454289069|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
126272831|NCT04765384|454289070|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
126272832|NCT04765384|454289071|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
126272833|NCT04765384|454289072|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
126272834|NCT04765384|454289073|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
126272835|NCT04765384|454289068|FG000|Post-natal: Neonates and Infants|Death|0|||
126361953|NCT02057666|454617346|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
126361954|NCT02057666|454617347|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
126361955|NCT02057666|454617346|FG000|Double Blind Treatment Period|Sponsor's request|70|||
126361956|NCT02057666|454617347|FG001|Double Blind Treatment Period|Sponsor's request|34|||
126361957|NCT02057666|454617346|FG000|Open-Label Treatment Period|Poor tolerability|0|||
126705807|NCT00500071|455875482|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
126272836|NCT04765384|454289069|FG001|Post-natal: Neonates and Infants|Death|0|||
126272837|NCT04765384|454289070|FG002|Post-natal: Neonates and Infants|Death|0|||
126272838|NCT04765384|454289071|FG003|Post-natal: Neonates and Infants|Death|1|||
126272839|NCT04765384|454289072|FG004|Post-natal: Neonates and Infants|Death|0|||
126272840|NCT04765384|454289073|FG005|Post-natal: Neonates and Infants|Death|0|||
126272841|NCT04765384|454289068|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
126272842|NCT04765384|454289069|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
126272843|NCT04765384|454289070|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
126272844|NCT04765384|454289071|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
126272845|NCT04765384|454289072|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
126272846|NCT04765384|454289073|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
126272847|NCT01971970|454289074|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
126272848|NCT01971970|454289075|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
126272849|NCT01971970|454289074|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
126272850|NCT01971970|454289075|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
126272851|NCT01971970|454289074|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
126272852|NCT01971970|454289075|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
126272853|NCT01971970|454289074|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
126272854|NCT01971970|454289075|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
126272855|NCT01971970|454289074|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
126272856|NCT01971970|454289075|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
126272857|NCT01971970|454289074|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
126272858|NCT01971970|454289075|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
126272859|NCT01971970|454289074|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
126272860|NCT01971970|454289075|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
126272861|NCT02524730|454289076|FG000|Overall Study|Lost to Follow-up|5|||
126272862|NCT02524730|454289076|FG000|Overall Study|Withdrawal by Subject|18|||
126272863|NCT02524730|454289076|FG000|Overall Study|Death|10|||
126272864|NCT02524730|454289076|FG000|Overall Study|Adverse Event|8|||
126272865|NCT02524730|454289076|FG000|Overall Study|Protocol Violation|1|||
126272866|NCT02524730|454289076|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
126272867|NCT00977379|454289077|FG000|Overall Study|Withdrawal by Subject|1|||
126272868|NCT00977379|454289078|FG001|Overall Study|Withdrawal by Subject|1|||
126272869|NCT00977379|454289077|FG000|Overall Study|Death|7|||
126272870|NCT00977379|454289078|FG001|Overall Study|Death|9|||
126272871|NCT00977379|454289077|FG000|Overall Study|Premature Study Termination|4|||
126272872|NCT00977379|454289078|FG001|Overall Study|Premature Study Termination|0|||
126272873|NCT00977379|454289077|FG000|Overall Study|Participant Moving House|0|||
126272874|NCT00977379|454289078|FG001|Overall Study|Participant Moving House|1|||
126272875|NCT00977379|454289077|FG000|Overall Study|Randomization Error|0|||
126272876|NCT00977379|454289078|FG001|Overall Study|Randomization Error|1|||
126272877|NCT01868893|454289085|FG000|Overall Study|Adverse Event|2|||
126272878|NCT01868893|454289085|FG000|Overall Study|Commercial availability of study drug|17|||
126272879|NCT01868893|454289085|FG000|Overall Study|Neutropenia|1|||
126272880|NCT01783548|454289086|FG000|Overall Study|Adverse Event|8|||
126272881|NCT01783548|454289087|FG001|Overall Study|Adverse Event|4|||
126272882|NCT01783548|454289086|FG000|Overall Study|Withdrawal by Subject|11|||
126272883|NCT01783548|454289087|FG001|Overall Study|Withdrawal by Subject|8|||
126272884|NCT01783548|454289086|FG000|Overall Study|Non-compliance|4|||
126272885|NCT01783548|454289087|FG001|Overall Study|Non-compliance|0|||
126272886|NCT01783548|454289086|FG000|Overall Study|Protocol Violation|2|||
126272887|NCT01783548|454289087|FG001|Overall Study|Protocol Violation|2|||
126272888|NCT01783548|454289086|FG000|Overall Study|Lost to Follow-up|8|||
126272889|NCT01783548|454289087|FG001|Overall Study|Lost to Follow-up|3|||
126272890|NCT01783548|454289086|FG000|Overall Study|Lack of Efficacy|1|||
126272891|NCT01783548|454289087|FG001|Overall Study|Lack of Efficacy|1|||
126272892|NCT00988442|454289088|FG000|Overall Study|Death|1|||
126272893|NCT00988442|454289089|FG001|Overall Study|Death|2|||
126272894|NCT00988442|454289088|FG000|Overall Study|Lost to Follow-up|0|||
126272895|NCT00988442|454289089|FG001|Overall Study|Lost to Follow-up|1|||
126272896|NCT00988442|454289088|FG000|Overall Study|Early Study Closure|29|||
126272897|NCT00988442|454289089|FG001|Overall Study|Early Study Closure|25|||
126272898|NCT05297578|454289092|FG000|Overall Study|Lost to Follow-up|1|||
126272899|NCT05297578|454289093|FG001|Overall Study|Lost to Follow-up|1|||
126272900|NCT05297578|454289094|FG002|Overall Study|Lost to Follow-up|2|||
126272901|NCT05297578|454289095|FG003|Overall Study|Lost to Follow-up|1|||
126272902|NCT05297578|454289092|FG000|Overall Study|Death|0|||
126272903|NCT05297578|454289093|FG001|Overall Study|Death|1|||
126272904|NCT05297578|454289094|FG002|Overall Study|Death|0|||
126272905|NCT05297578|454289095|FG003|Overall Study|Death|0|||
126272906|NCT05297578|454289092|FG000|Overall Study|Withdrawal by Subject|0|||
126272907|NCT05297578|454289093|FG001|Overall Study|Withdrawal by Subject|0|||
126272908|NCT05297578|454289094|FG002|Overall Study|Withdrawal by Subject|1|||
126705808|NCT00472303|455875483|FG000|Titration Phase|Adverse Event|22|||
126705809|NCT00472303|455875484|FG001|Titration Phase|Adverse Event|12|||
126705810|NCT00472303|455875485|FG002|Titration Phase|Adverse Event|0|||
126705811|NCT00472303|455875483|FG000|Titration Phase|Death|4|||
126705812|NCT00472303|455875484|FG001|Titration Phase|Death|2|||
126272909|NCT05297578|454289095|FG003|Overall Study|Withdrawal by Subject|0|||
126272910|NCT01087489|454289096|FG000|Overall Study|enrolled in another VA study|0|||
126272911|NCT01087489|454289097|FG001|Overall Study|enrolled in another VA study|1|||
126272912|NCT01087489|454289096|FG000|Overall Study|Death|0|||
126272913|NCT01087489|454289097|FG001|Overall Study|Death|1|||
126272914|NCT01087489|454289096|FG000|Overall Study|unable to survey by telephone|0|||
126272915|NCT01087489|454289097|FG001|Overall Study|unable to survey by telephone|1|||
126272916|NCT00117325|454289098|FG000|Overall Study|Adverse Event|3|||
126272917|NCT00117325|454289099|FG001|Overall Study|Adverse Event|3|||
126272918|NCT00117325|454289098|FG000|Overall Study|Lost to Follow-up|1|||
126272919|NCT00117325|454289099|FG001|Overall Study|Lost to Follow-up|1|||
126272920|NCT00117325|454289098|FG000|Overall Study|Protocol Violation|2|||
126272921|NCT00117325|454289099|FG001|Overall Study|Protocol Violation|3|||
126272922|NCT00117325|454289098|FG000|Overall Study|Withdrawal by Subject|3|||
126272923|NCT00117325|454289099|FG001|Overall Study|Withdrawal by Subject|2|||
126272924|NCT00117325|454289098|FG000|Overall Study|Lack of Efficacy|1|||
126272925|NCT00117325|454289099|FG001|Overall Study|Lack of Efficacy|0|||
126272926|NCT00117325|454289098|FG000|Overall Study|Use of prohibited medicine|1|||
126272927|NCT00117325|454289099|FG001|Overall Study|Use of prohibited medicine|2|||
126272928|NCT00117325|454289098|FG000|Overall Study|Early termination|1|||
126272929|NCT00117325|454289099|FG001|Overall Study|Early termination|1|||
126272930|NCT00117325|454289098|FG000|Overall Study|Admisnitrative|1|||
126272931|NCT00117325|454289099|FG001|Overall Study|Admisnitrative|0|||
126272932|NCT01974440|454289100|FG000|Overall Study|Lost to Follow-up|7|||
126272933|NCT01974440|454289101|FG001|Overall Study|Lost to Follow-up|7|||
126272934|NCT01974440|454289100|FG000|Overall Study|Withdrawal by Subject|24|||
126272935|NCT01974440|454289101|FG001|Overall Study|Withdrawal by Subject|20|||
126272936|NCT01974440|454289100|FG000|Overall Study|Sponsor decision|109|||
126272937|NCT01974440|454289101|FG001|Overall Study|Sponsor decision|110|||
126272938|NCT02387983|454289102|FG000|Overall Study|Adverse Event|4|||
126272939|NCT02387983|454289102|FG000|Overall Study|Protocol Violation|1|||
126272940|NCT02387983|454289102|FG000|Overall Study|Withdrawal by Subject|2|||
126272941|NCT03569228|454289103|FG000|Overall Study|Withdrawal by PI|0|||
126272942|NCT03569228|454289104|FG001|Overall Study|Withdrawal by PI|0|||
126272943|NCT03569228|454289105|FG002|Overall Study|Withdrawal by PI|2|||
126272944|NCT03569228|454289106|FG003|Overall Study|Withdrawal by PI|2|||
126272945|NCT03569228|454289107|FG004|Overall Study|Withdrawal by PI|1|||
126272946|NCT03569228|454289108|FG005|Overall Study|Withdrawal by PI|0|||
126272947|NCT03569228|454289109|FG006|Overall Study|Withdrawal by PI|0|||
126272948|NCT03569228|454289110|FG007|Overall Study|Withdrawal by PI|0|||
126272949|NCT03569228|454289111|FG008|Overall Study|Withdrawal by PI|0|||
126272950|NCT03569228|454289103|FG000|Overall Study|Lost to Follow-up|0|||
126272951|NCT03569228|454289104|FG001|Overall Study|Lost to Follow-up|0|||
126272952|NCT03569228|454289105|FG002|Overall Study|Lost to Follow-up|0|||
126272953|NCT03569228|454289106|FG003|Overall Study|Lost to Follow-up|0|||
126272954|NCT03569228|454289107|FG004|Overall Study|Lost to Follow-up|0|||
126272955|NCT03569228|454289108|FG005|Overall Study|Lost to Follow-up|0|||
126272956|NCT03569228|454289109|FG006|Overall Study|Lost to Follow-up|0|||
126272957|NCT03569228|454289110|FG007|Overall Study|Lost to Follow-up|0|||
126272958|NCT03569228|454289111|FG008|Overall Study|Lost to Follow-up|1|||
126272959|NCT03569228|454289103|FG000|Overall Study|Screen Fail|2|||
126272960|NCT03569228|454289104|FG001|Overall Study|Screen Fail|2|||
126272961|NCT03569228|454289105|FG002|Overall Study|Screen Fail|1|||
126272962|NCT03569228|454289106|FG003|Overall Study|Screen Fail|1|||
126272963|NCT03569228|454289107|FG004|Overall Study|Screen Fail|1|||
126272964|NCT03569228|454289108|FG005|Overall Study|Screen Fail|3|||
126272965|NCT03569228|454289109|FG006|Overall Study|Screen Fail|1|||
126272966|NCT03569228|454289110|FG007|Overall Study|Screen Fail|5|||
126705813|NCT00472303|455875485|FG002|Titration Phase|Death|0|||
126705814|NCT00472303|455875483|FG000|Titration Phase|Lack of Efficacy|10|||
126705815|NCT00472303|455875484|FG001|Titration Phase|Lack of Efficacy|0|||
126272967|NCT03569228|454289111|FG008|Overall Study|Screen Fail|2|||
126361958|NCT02057666|454617347|FG001|Open-Label Treatment Period|Poor tolerability|1|||
126361959|NCT02057666|454617346|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
126361960|NCT02057666|454617347|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
126705816|NCT00472303|455875485|FG002|Titration Phase|Lack of Efficacy|0|||
126765617|NCT02146365|456094579|FG007|Overall Study|Lost to Follow-up|1|||
126272968|NCT06354998|454289112|FG000|Overall Study|Withdrawal by Subject|3|||
126272969|NCT06354998|454289113|FG001|Overall Study|Withdrawal by Subject|0|||
126272970|NCT01103466|454289121|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
126272971|NCT01103466|454289122|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
126272972|NCT01103466|454289123|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
126272973|NCT01103466|454289121|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
126705817|NCT00472303|455875483|FG000|Titration Phase|Withdrawal by Subject|16|||
126361961|NCT02057666|454617346|FG000|Open-Label Treatment Period|Sponsor's request|0|||
126361962|NCT02057666|454617347|FG001|Open-Label Treatment Period|Sponsor's request|4|||
126361963|NCT00498485|454617352|FG000|Overall Study|Adverse Event|1|||
126361964|NCT00498485|454617353|FG001|Overall Study|Adverse Event|5|||
126361965|NCT01539525|454617354|FG000|Overall Study|Lost to Follow-up|19|||
126361966|NCT01539525|454617355|FG001|Overall Study|Lost to Follow-up|12|||
126361967|NCT01539525|454617356|FG002|Overall Study|Lost to Follow-up|11|||
126361968|NCT01539525|454617354|FG000|Overall Study|Withdrawal by Subject|0|||
126361969|NCT01539525|454617355|FG001|Overall Study|Withdrawal by Subject|3|||
126361970|NCT01539525|454617356|FG002|Overall Study|Withdrawal by Subject|2|||
126361971|NCT01539525|454617354|FG000|Overall Study|Protocol Violation|1|||
126361972|NCT01539525|454617355|FG001|Overall Study|Protocol Violation|1|||
126361973|NCT01539525|454617356|FG002|Overall Study|Protocol Violation|4|||
126361974|NCT01712074|454617357|FG000|Placebo Run-in Period|Adverse Event|2|||
126361975|NCT01712074|454617358|FG001|Placebo Run-in Period|Adverse Event|0|||
126361976|NCT01712074|454617359|FG002|Placebo Run-in Period|Adverse Event|0|||
126361977|NCT01712074|454617357|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
126361978|NCT01712074|454617358|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
126361979|NCT01712074|454617359|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
126361980|NCT01712074|454617357|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
126361981|NCT01712074|454617358|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
126361982|NCT01712074|454617359|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
126361983|NCT01712074|454617357|FG000|Placebo Run-in Period|Other|1|||
126361984|NCT01712074|454617358|FG001|Placebo Run-in Period|Other|0|||
126361985|NCT01712074|454617359|FG002|Placebo Run-in Period|Other|0|||
126361986|NCT01712074|454617357|FG000|Placebo Run-in Period|No longer willing to participate|1|||
126361987|NCT01712074|454617358|FG001|Placebo Run-in Period|No longer willing to participate|0|||
126361988|NCT01712074|454617359|FG002|Placebo Run-in Period|No longer willing to participate|0|||
126361989|NCT01712074|454617357|FG000|Double Blind Period|Adverse Event|0|||
126361990|NCT01712074|454617358|FG001|Double Blind Period|Adverse Event|2|||
126361991|NCT01712074|454617359|FG002|Double Blind Period|Adverse Event|1|||
126361992|NCT01712074|454617357|FG000|Double Blind Period|No longer willing to participate|0|||
126361993|NCT01712074|454617358|FG001|Double Blind Period|No longer willing to participate|2|||
126361994|NCT01712074|454617359|FG002|Double Blind Period|No longer willing to participate|4|||
126361995|NCT01712074|454617357|FG000|Double Blind Period|Death|0|||
126361996|NCT01712074|454617358|FG001|Double Blind Period|Death|1|||
126361997|NCT01712074|454617359|FG002|Double Blind Period|Death|0|||
126361998|NCT01712074|454617357|FG000|Double Blind Period|Lost to Follow-up|0|||
126361999|NCT01712074|454617358|FG001|Double Blind Period|Lost to Follow-up|2|||
126362000|NCT01712074|454617359|FG002|Double Blind Period|Lost to Follow-up|1|||
126362001|NCT01712074|454617357|FG000|Double Blind Period|Other|0|||
126362002|NCT01712074|454617358|FG001|Double Blind Period|Other|4|||
126362003|NCT01712074|454617359|FG002|Double Blind Period|Other|1|||
126362004|NCT01712074|454617357|FG000|Double Blind Period|Protocol Violation|0|||
126362005|NCT01712074|454617358|FG001|Double Blind Period|Protocol Violation|0|||
126362006|NCT01712074|454617359|FG002|Double Blind Period|Protocol Violation|1|||
126362007|NCT01712074|454617357|FG000|Double Blind Period|No longer met eligibility criteria|0|||
126362008|NCT01712074|454617358|FG001|Double Blind Period|No longer met eligibility criteria|3|||
126362009|NCT01712074|454617359|FG002|Double Blind Period|No longer met eligibility criteria|0|||
126362010|NCT01472835|454617362|FG000|Overall Study|Lost to Follow-up|2|||
126362011|NCT01472835|454617363|FG001|Overall Study|Lost to Follow-up|0|||
126362012|NCT02792257|454617387|FG000|Overall Study|Lost to Follow-up|3|||
126362013|NCT02792257|454617388|FG001|Overall Study|Lost to Follow-up|4|||
126362014|NCT02792257|454617387|FG000|Overall Study|Allergy|0|||
126362015|NCT02792257|454617388|FG001|Overall Study|Allergy|1|||
126362016|NCT02792257|454617387|FG000|Overall Study|Protocol Violation|2|||
126453612|NCT03996369|454961481|FG001|Overall Study|Adverse Event|0|||
126453613|NCT03996369|454961480|FG000|Overall Study|Withdrawal by Subject|6|||
126453614|NCT03996369|454961481|FG001|Overall Study|Withdrawal by Subject|8|||
126453615|NCT03996369|454961480|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
126453616|NCT03996369|454961481|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
126705818|NCT00472303|455875484|FG001|Titration Phase|Withdrawal by Subject|13|||
126362017|NCT02792257|454617388|FG001|Overall Study|Protocol Violation|0|||
126362018|NCT02792257|454617387|FG000|Overall Study|Excessive Agitation|0|||
126362019|NCT02792257|454617388|FG001|Overall Study|Excessive Agitation|1|||
126362020|NCT02792257|454617387|FG000|Overall Study|Not Feeling Well|0|||
126362021|NCT02792257|454617388|FG001|Overall Study|Not Feeling Well|1|||
126362022|NCT00553475|454617389|FG000|Overall Study|Adverse Event|7|||
126362023|NCT00553475|454617390|FG001|Overall Study|Adverse Event|17|||
126362024|NCT00553475|454617391|FG002|Overall Study|Adverse Event|13|||
126362025|NCT00553475|454617389|FG000|Overall Study|Lack of Efficacy|7|||
126362026|NCT00553475|454617390|FG001|Overall Study|Lack of Efficacy|1|||
126362027|NCT00553475|454617391|FG002|Overall Study|Lack of Efficacy|0|||
126362028|NCT00553475|454617389|FG000|Overall Study|Withdrawal by Subject|1|||
126362029|NCT00553475|454617390|FG001|Overall Study|Withdrawal by Subject|1|||
126362030|NCT00553475|454617391|FG002|Overall Study|Withdrawal by Subject|0|||
126705819|NCT00472303|455875485|FG002|Titration Phase|Withdrawal by Subject|0|||
126705820|NCT00472303|455875483|FG000|Titration Phase|Trial Medication non-compliant|4|||
126705821|NCT00472303|455875484|FG001|Titration Phase|Trial Medication non-compliant|1|||
126705822|NCT00472303|455875485|FG002|Titration Phase|Trial Medication non-compliant|0|||
126705823|NCT00472303|455875483|FG000|Titration Phase|Other|3|||
126705824|NCT00472303|455875484|FG001|Titration Phase|Other|1|||
126705825|NCT00472303|455875485|FG002|Titration Phase|Other|0|||
126705826|NCT00472303|455875483|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
126705827|NCT00472303|455875484|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
126705828|NCT00472303|455875485|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
126705829|NCT00472303|455875483|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
126705830|NCT00472303|455875484|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
126705831|NCT00472303|455875485|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
126705832|NCT00472303|455875483|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
126705833|NCT00472303|455875484|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
126705834|NCT00472303|455875485|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
126705835|NCT00472303|455875483|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
126705836|NCT00472303|455875484|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
126705837|NCT00472303|455875485|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
126705838|NCT00472303|455875483|FG000|Discontinuations After Titration Phase|Other|5|||
126705839|NCT00472303|455875484|FG001|Discontinuations After Titration Phase|Other|0|||
126705840|NCT00472303|455875485|FG002|Discontinuations After Titration Phase|Other|0|||
126705841|NCT00472303|455875483|FG000|Maintenance Phase|Adverse Event|5|||
126705842|NCT00472303|455875484|FG001|Maintenance Phase|Adverse Event|6|||
126705843|NCT00472303|455875485|FG002|Maintenance Phase|Adverse Event|6|||
126705844|NCT00472303|455875483|FG000|Maintenance Phase|Death|3|||
126705845|NCT00472303|455875484|FG001|Maintenance Phase|Death|0|||
126705846|NCT00472303|455875485|FG002|Maintenance Phase|Death|2|||
126705847|NCT00472303|455875483|FG000|Maintenance Phase|Lack of Efficacy|2|||
126705848|NCT00472303|455875484|FG001|Maintenance Phase|Lack of Efficacy|2|||
126705849|NCT00472303|455875485|FG002|Maintenance Phase|Lack of Efficacy|4|||
126705850|NCT00472303|455875483|FG000|Maintenance Phase|Withdrawal by Subject|6|||
126705851|NCT00472303|455875484|FG001|Maintenance Phase|Withdrawal by Subject|7|||
126705852|NCT00472303|455875485|FG002|Maintenance Phase|Withdrawal by Subject|3|||
126705853|NCT00472303|455875483|FG000|Maintenance Phase|Trial medication non-compliant|0|||
126705854|NCT00472303|455875484|FG001|Maintenance Phase|Trial medication non-compliant|0|||
126705855|NCT00472303|455875485|FG002|Maintenance Phase|Trial medication non-compliant|1|||
126705856|NCT00472303|455875483|FG000|Maintenance Phase|Resolution of pain|0|||
126705857|NCT00472303|455875484|FG001|Maintenance Phase|Resolution of pain|0|||
126705858|NCT00472303|455875485|FG002|Maintenance Phase|Resolution of pain|1|||
126705859|NCT00472303|455875483|FG000|Maintenance Phase|Other|1|||
126705860|NCT00472303|455875484|FG001|Maintenance Phase|Other|1|||
126272974|NCT01103466|454289122|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
126272975|NCT01103466|454289123|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
126272976|NCT01103466|454289121|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
126272977|NCT01103466|454289122|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
126272978|NCT01103466|454289123|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
126272979|NCT01103466|454289121|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
126272980|NCT01103466|454289122|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
126272981|NCT01103466|454289123|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
126272982|NCT01103466|454289121|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
126272983|NCT01103466|454289122|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
126272984|NCT01103466|454289123|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
126272985|NCT01103466|454289121|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
126272986|NCT01103466|454289122|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
126272987|NCT01103466|454289123|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
126705861|NCT00472303|455875485|FG002|Maintenance Phase|Other|0|||
126705862|NCT03182738|455875486|FG000|Overall Study|Lost to Follow-up|9|||
126705863|NCT03182738|455875487|FG001|Overall Study|Lost to Follow-up|3|||
126705864|NCT03182738|455875486|FG000|Overall Study|Pregnancy|0|||
126272988|NCT02331368|454289130|FG000|Overall Study|Withdrawal by Subject|3|||
126272989|NCT02302859|454289131|FG000|Overall Study|Lost Phone|1|||
126272990|NCT02302859|454289132|FG001|Overall Study|Lost Phone|1|||
126272991|NCT02302859|454289131|FG000|Overall Study|Withdrawal by Subject|0|||
126272992|NCT02302859|454289132|FG001|Overall Study|Withdrawal by Subject|1|||
126272993|NCT02283983|454289135|FG000|Overall Study|Inclusion criteria not met|0|||
126705865|NCT03182738|455875487|FG001|Overall Study|Pregnancy|1|||
126705866|NCT03182738|455875486|FG000|Overall Study|Withdrawal by Subject|0|||
126705867|NCT03182738|455875487|FG001|Overall Study|Withdrawal by Subject|1|||
126705868|NCT01486238|455875491|FG000|Overall Study|Death|0|||
126705869|NCT01486238|455875492|FG001|Overall Study|Death|2|||
126705870|NCT01486238|455875491|FG000|Overall Study|Withdrawal by Subject|2|||
126705871|NCT01486238|455875492|FG001|Overall Study|Withdrawal by Subject|1|||
126453617|NCT03996369|454961480|FG000|Overall Study|Lost to Follow-up|0|||
126453618|NCT03996369|454961481|FG001|Overall Study|Lost to Follow-up|1|||
126453619|NCT02238067|454961482|FG000|Overall Study|Not completed survey at Month 6|45|||
126453620|NCT01566214|454961484|FG000|Overall Study|Lost to Follow-up|3|||
126453621|NCT01566214|454961485|FG001|Overall Study|Lost to Follow-up|0|||
126453622|NCT04620798|454961486|FG000|Overall Study|Lost to Follow-up|126|||
126453623|NCT04620798|454961487|FG001|Overall Study|Lost to Follow-up|138|||
126453624|NCT01960907|454961493|FG000|Overall Study|Death|4|||
126453625|NCT01960907|454961494|FG001|Overall Study|Death|3|||
126453626|NCT01960907|454961493|FG000|Overall Study|Withdrawal by Subject|32|||
126453627|NCT01960907|454961494|FG001|Overall Study|Withdrawal by Subject|42|||
126453628|NCT00439738|454961497|FG000|Overall Study|Withdrawal by Subject|16|||
126453629|NCT00439738|454961498|FG001|Overall Study|Withdrawal by Subject|13|||
126453630|NCT00439738|454961497|FG000|Overall Study|Adverse Event|6|||
126453631|NCT00439738|454961498|FG001|Overall Study|Adverse Event|4|||
126453632|NCT00439738|454961497|FG000|Overall Study|Lost to Follow-up|5|||
126453633|NCT00439738|454961498|FG001|Overall Study|Lost to Follow-up|6|||
126453634|NCT00439738|454961497|FG000|Overall Study|Protocol Violation|6|||
126453635|NCT00439738|454961498|FG001|Overall Study|Protocol Violation|3|||
126453636|NCT00439738|454961497|FG000|Overall Study|Lack of Efficacy|2|||
126453637|NCT00439738|454961498|FG001|Overall Study|Lack of Efficacy|2|||
126453638|NCT00439738|454961497|FG000|Overall Study|Abnormal Lab Values|1|||
126453639|NCT00439738|454961498|FG001|Overall Study|Abnormal Lab Values|0|||
126453640|NCT00978757|454961499|FG000|Overall Study|Physician Decision|1|||
126453641|NCT00978757|454961500|FG001|Overall Study|Physician Decision|3|||
126453642|NCT00402740|454961504|FG000|Overall Study|Withdrawal by Subject|18|||
126453643|NCT00402740|454961504|FG000|Overall Study|Death|50|||
126705872|NCT01486238|455875491|FG000|Overall Study|Lost to Follow-up|0|||
126705873|NCT01486238|455875492|FG001|Overall Study|Lost to Follow-up|3|||
126272994|NCT02283983|454289136|FG001|Overall Study|Inclusion criteria not met|1|||
126272995|NCT02283983|454289135|FG000|Overall Study|Withdrawal by Subject|4|||
126272996|NCT02283983|454289136|FG001|Overall Study|Withdrawal by Subject|2|||
126272997|NCT02283983|454289135|FG000|Overall Study|Protocol Violation|0|||
126272998|NCT02283983|454289136|FG001|Overall Study|Protocol Violation|4|||
126272999|NCT02283983|454289135|FG000|Overall Study|Physician Decision|2|||
126273000|NCT02283983|454289136|FG001|Overall Study|Physician Decision|4|||
126273001|NCT02283983|454289135|FG000|Overall Study|Death|1|||
126273002|NCT02283983|454289136|FG001|Overall Study|Death|0|||
126273003|NCT02283983|454289135|FG000|Overall Study|Adverse Event|1|||
126273004|NCT02283983|454289136|FG001|Overall Study|Adverse Event|0|||
126273005|NCT02283983|454289135|FG000|Overall Study|Lost to Follow-up|9|||
126273006|NCT02283983|454289136|FG001|Overall Study|Lost to Follow-up|8|||
126273007|NCT02283983|454289135|FG000|Overall Study|Relapse|1|||
126273008|NCT02283983|454289136|FG001|Overall Study|Relapse|0|||
126273009|NCT00424775|454289141|FG000|Overall Study|Adverse Event|2|||
126273010|NCT00424775|454289142|FG001|Overall Study|Adverse Event|0|||
126273011|NCT00424775|454289141|FG000|Overall Study|Lack of Efficacy|1|||
126273012|NCT00424775|454289142|FG001|Overall Study|Lack of Efficacy|0|||
126273013|NCT01791153|454289143|FG000|Part 1: Blinded Period|Adverse Event|7|||
126273014|NCT01791153|454289144|FG001|Part 1: Blinded Period|Adverse Event|3|||
126273015|NCT01791153|454289145|FG002|Part 1: Blinded Period|Adverse Event|2|||
126273016|NCT01791153|454289146|FG003|Part 1: Blinded Period|Adverse Event|0|||
126273017|NCT01791153|454289147|FG004|Part 1: Blinded Period|Adverse Event|0|||
126273018|NCT01791153|454289148|FG005|Part 1: Blinded Period|Adverse Event|0|||
126273019|NCT01791153|454289149|FG006|Part 1: Blinded Period|Adverse Event|0|||
126273020|NCT01791153|454289150|FG007|Part 1: Blinded Period|Adverse Event|0|||
126273021|NCT01791153|454289143|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
126273022|NCT01791153|454289144|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
126273023|NCT01791153|454289145|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
126273024|NCT01791153|454289146|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
126273025|NCT01791153|454289147|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
126273026|NCT01791153|454289148|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
126273027|NCT01791153|454289149|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
126273028|NCT01791153|454289150|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
126273029|NCT01791153|454289143|FG000|Part 1: Blinded Period|Non-Compliance|1|||
126273030|NCT01791153|454289144|FG001|Part 1: Blinded Period|Non-Compliance|0|||
126273031|NCT01791153|454289145|FG002|Part 1: Blinded Period|Non-Compliance|0|||
126273032|NCT01791153|454289146|FG003|Part 1: Blinded Period|Non-Compliance|0|||
126453644|NCT00402740|454961504|FG000|Overall Study|Lost to Follow-up|6|||
126453645|NCT00402740|454961504|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
126453646|NCT00402740|454961504|FG000|Overall Study|Subject disposition unknown.|1|||
126453647|NCT01700387|454961505|FG000|Overall Study|Withdrawal by Subject|1|||
126453648|NCT01700387|454961506|FG001|Overall Study|Withdrawal by Subject|2|||
126453649|NCT01700387|454961505|FG000|Overall Study|Adverse Event|1|||
126453650|NCT01700387|454961506|FG001|Overall Study|Adverse Event|1|||
126453651|NCT01700387|454961505|FG000|Overall Study|Lost to Follow-up|2|||
126453652|NCT01700387|454961506|FG001|Overall Study|Lost to Follow-up|1|||
126453653|NCT01185353|454961508|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
126705874|NCT00356915|455875493|FG000|Overall Study|Non compliance|1|||
126273033|NCT01791153|454289147|FG004|Part 1: Blinded Period|Non-Compliance|0|||
126273034|NCT01791153|454289148|FG005|Part 1: Blinded Period|Non-Compliance|0|||
126273035|NCT01791153|454289149|FG006|Part 1: Blinded Period|Non-Compliance|0|||
126273036|NCT01791153|454289150|FG007|Part 1: Blinded Period|Non-Compliance|0|||
126273037|NCT01791153|454289143|FG000|Part 1: Blinded Period|Physician Decision|0|||
126273038|NCT01791153|454289144|FG001|Part 1: Blinded Period|Physician Decision|0|||
126273039|NCT01791153|454289145|FG002|Part 1: Blinded Period|Physician Decision|0|||
126273040|NCT01791153|454289146|FG003|Part 1: Blinded Period|Physician Decision|1|||
126273041|NCT01791153|454289147|FG004|Part 1: Blinded Period|Physician Decision|0|||
126273042|NCT01791153|454289148|FG005|Part 1: Blinded Period|Physician Decision|0|||
126273043|NCT01791153|454289149|FG006|Part 1: Blinded Period|Physician Decision|0|||
126273044|NCT01791153|454289150|FG007|Part 1: Blinded Period|Physician Decision|0|||
126273045|NCT01791153|454289143|FG000|Part 1: Blinded Period|Protocol Violation|0|||
126273046|NCT01791153|454289144|FG001|Part 1: Blinded Period|Protocol Violation|0|||
126273047|NCT01791153|454289145|FG002|Part 1: Blinded Period|Protocol Violation|0|||
126273048|NCT01791153|454289146|FG003|Part 1: Blinded Period|Protocol Violation|1|||
126273049|NCT01791153|454289147|FG004|Part 1: Blinded Period|Protocol Violation|0|||
126273050|NCT01791153|454289148|FG005|Part 1: Blinded Period|Protocol Violation|0|||
126273051|NCT01791153|454289149|FG006|Part 1: Blinded Period|Protocol Violation|0|||
126273052|NCT01791153|454289150|FG007|Part 1: Blinded Period|Protocol Violation|0|||
126273053|NCT01791153|454289143|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
126273054|NCT01791153|454289144|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
126273055|NCT01791153|454289145|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
126273056|NCT01791153|454289146|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
126273057|NCT01791153|454289147|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
126273058|NCT01791153|454289148|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
126273059|NCT01791153|454289149|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
126273060|NCT01791153|454289150|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
126273061|NCT01791153|454289143|FG000|Part 2: Open-label Period|Adverse Event|0|||
126273062|NCT01791153|454289144|FG001|Part 2: Open-label Period|Adverse Event|0|||
126273063|NCT01791153|454289145|FG002|Part 2: Open-label Period|Adverse Event|0|||
126273064|NCT01791153|454289146|FG003|Part 2: Open-label Period|Adverse Event|0|||
126273065|NCT01791153|454289147|FG004|Part 2: Open-label Period|Adverse Event|0|||
126273066|NCT01791153|454289148|FG005|Part 2: Open-label Period|Adverse Event|1|||
126273067|NCT01791153|454289149|FG006|Part 2: Open-label Period|Adverse Event|1|||
126273068|NCT01791153|454289150|FG007|Part 2: Open-label Period|Adverse Event|2|||
126273069|NCT01791153|454289143|FG000|Part 2: Open-label Period|Death|0|||
126273070|NCT01791153|454289144|FG001|Part 2: Open-label Period|Death|0|||
126273071|NCT01791153|454289145|FG002|Part 2: Open-label Period|Death|0|||
126273072|NCT01791153|454289146|FG003|Part 2: Open-label Period|Death|0|||
126273073|NCT01791153|454289147|FG004|Part 2: Open-label Period|Death|0|||
126273074|NCT01791153|454289148|FG005|Part 2: Open-label Period|Death|1|||
126273075|NCT01791153|454289149|FG006|Part 2: Open-label Period|Death|1|||
126273076|NCT01791153|454289150|FG007|Part 2: Open-label Period|Death|1|||
126273077|NCT01791153|454289143|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
126273078|NCT01791153|454289144|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
126273079|NCT01791153|454289145|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
126273080|NCT01791153|454289146|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
126273081|NCT01791153|454289147|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
126273082|NCT01791153|454289148|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
126273083|NCT01791153|454289149|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
126273084|NCT01791153|454289150|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
126273085|NCT01791153|454289143|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
126273086|NCT01791153|454289144|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
126273087|NCT01791153|454289145|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
126273088|NCT01791153|454289146|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
126273089|NCT01791153|454289147|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
126273090|NCT01791153|454289148|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
126273091|NCT01791153|454289149|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
126273092|NCT01791153|454289150|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
126273093|NCT01791153|454289143|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
126273094|NCT01791153|454289144|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
126273095|NCT01791153|454289145|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
126273096|NCT01791153|454289146|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
126273097|NCT01791153|454289147|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
126273098|NCT01791153|454289148|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
126273099|NCT01791153|454289149|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
126362031|NCT00553475|454617389|FG000|Overall Study|Physician Decision|1|||
126362032|NCT00553475|454617390|FG001|Overall Study|Physician Decision|0|||
126362033|NCT00553475|454617391|FG002|Overall Study|Physician Decision|0|||
126362034|NCT00553475|454617389|FG000|Overall Study|Due to moving|0|||
126362035|NCT00553475|454617390|FG001|Overall Study|Due to moving|1|||
126362036|NCT00553475|454617391|FG002|Overall Study|Due to moving|0|||
126362037|NCT01905683|454617394|FG000|Overall Study|Protocol Violation|1|||
126705875|NCT00356915|455875494|FG001|Overall Study|Non compliance|2|||
126273100|NCT01791153|454289150|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
126273101|NCT01791153|454289143|FG000|Part 2: Open-label Period|Physician Decision|0|||
126273102|NCT01791153|454289144|FG001|Part 2: Open-label Period|Physician Decision|0|||
126273103|NCT01791153|454289145|FG002|Part 2: Open-label Period|Physician Decision|0|||
126273104|NCT01791153|454289146|FG003|Part 2: Open-label Period|Physician Decision|0|||
126273105|NCT01791153|454289147|FG004|Part 2: Open-label Period|Physician Decision|1|||
126273106|NCT01791153|454289148|FG005|Part 2: Open-label Period|Physician Decision|1|||
126273107|NCT01791153|454289149|FG006|Part 2: Open-label Period|Physician Decision|0|||
126273108|NCT01791153|454289150|FG007|Part 2: Open-label Period|Physician Decision|0|||
126273109|NCT00975286|454289151|FG000|Overall Study|Adverse Event|9|||
126273110|NCT00975286|454289152|FG001|Overall Study|Adverse Event|19|||
126273111|NCT00975286|454289151|FG000|Overall Study|Protocol Violation|1|||
126273112|NCT00975286|454289152|FG001|Overall Study|Protocol Violation|2|||
126273113|NCT00975286|454289151|FG000|Overall Study|Withdrawal by Subject|0|||
126273114|NCT00975286|454289152|FG001|Overall Study|Withdrawal by Subject|2|||
126273115|NCT00975286|454289151|FG000|Overall Study|Familial and Personal Reasons|2|||
126273116|NCT00975286|454289152|FG001|Overall Study|Familial and Personal Reasons|2|||
126273117|NCT00975286|454289151|FG000|Overall Study|Poor Compliance to Protocol|0|||
126273118|NCT00975286|454289152|FG001|Overall Study|Poor Compliance to Protocol|2|||
126273119|NCT00975286|454289151|FG000|Overall Study|Sponsor Decision|0|||
126273120|NCT00975286|454289152|FG001|Overall Study|Sponsor Decision|2|||
126273121|NCT02357342|454289153|FG000|First 6 Months|Death|2|||
126273122|NCT02357342|454289154|FG001|First 6 Months|Death|0|||
126273123|NCT01674647|454289155|FG000|Treatment Period|Death|4|||
126273124|NCT01674647|454289156|FG001|Treatment Period|Death|1|||
126273125|NCT01674647|454289155|FG000|Treatment Period|Efficacy outcome reached|0|||
126273126|NCT01674647|454289156|FG001|Treatment Period|Efficacy outcome reached|1|||
126273127|NCT01674647|454289155|FG000|Treatment Period|Physician Decision|3|||
126273128|NCT01674647|454289156|FG001|Treatment Period|Physician Decision|1|||
126273129|NCT01674647|454289155|FG000|Treatment Period|Adverse Event|60|||
126273130|NCT01674647|454289156|FG001|Treatment Period|Adverse Event|22|||
126273131|NCT01674647|454289155|FG000|Treatment Period|Non-compliance with study drug|3|||
126273132|NCT01674647|454289156|FG001|Treatment Period|Non-compliance with study drug|0|||
126273133|NCT01674647|454289155|FG000|Treatment Period|Lost to Follow-up|1|||
126273134|NCT01674647|454289156|FG001|Treatment Period|Lost to Follow-up|1|||
126273135|NCT01674647|454289155|FG000|Treatment Period|Withdrawal by Subject|19|||
126273136|NCT01674647|454289156|FG001|Treatment Period|Withdrawal by Subject|16|||
126273137|NCT01674647|454289155|FG000|Treatment Period|Switching to other therapy|5|||
126273138|NCT01674647|454289156|FG001|Treatment Period|Switching to other therapy|2|||
126273139|NCT01674647|454289155|FG000|Treatment Period|Logistical difficulties|5|||
126273140|NCT01674647|454289156|FG001|Treatment Period|Logistical difficulties|8|||
126273141|NCT01674647|454289155|FG000|Treatment Period|Treatment failure|0|||
126273142|NCT01674647|454289156|FG001|Treatment Period|Treatment failure|14|||
126273143|NCT01674647|454289155|FG000|Treatment Period|Protocol Violation|56|||
126273144|NCT01674647|454289156|FG001|Treatment Period|Protocol Violation|36|||
126273145|NCT01674647|454289155|FG000|30-day Safety Follow-up Period|Death|3|||
126273146|NCT01674647|454289156|FG001|30-day Safety Follow-up Period|Death|2|||
126273147|NCT01674647|454289155|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
126273148|NCT01674647|454289156|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
126273149|NCT01674647|454289155|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
126273150|NCT01674647|454289156|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
126273151|NCT01674647|454289155|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
126273152|NCT01674647|454289156|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
126273153|NCT01674647|454289155|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
126273154|NCT01674647|454289156|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
126273155|NCT01674647|454289155|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
126273156|NCT01674647|454289156|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
126273157|NCT01490866|454289157|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
126453654|NCT01185353|454961509|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
126705876|NCT00356915|455875495|FG002|Overall Study|Non compliance|1|||
126705877|NCT00356915|455875493|FG000|Overall Study|Protocol Violation|2|||
126273158|NCT01490866|454289157|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
126273159|NCT01490866|454289157|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
126273160|NCT01490866|454289157|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
126273161|NCT01490866|454289157|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
126273162|NCT01490866|454289157|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
126273163|NCT01490866|454289157|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
126273164|NCT01490866|454289157|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
126273165|NCT01490866|454289157|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
126453655|NCT01185353|454961510|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
126453656|NCT01185353|454961511|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
126453657|NCT01185353|454961512|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
126362038|NCT01905683|454617394|FG000|Overall Study|Re-injection criteria not met; others|13|||
126362039|NCT01905683|454617394|FG000|Overall Study|Physician Decision|1|||
126362040|NCT01905683|454617394|FG000|Overall Study|Lack of Efficacy|8|||
126362041|NCT01905683|454617394|FG000|Overall Study|Withdrawal by Subject|20|||
126362042|NCT01905683|454617394|FG000|Overall Study|Adverse Event|4|||
126362043|NCT01905683|454617394|FG000|Overall Study|Lost to Follow-up|4|||
126362044|NCT02568254|454617396|FG000|Period 2|Adverse Event|0|||
126362045|NCT02568254|454617397|FG001|Period 2|Adverse Event|0|||
126362046|NCT02568254|454617398|FG002|Period 2|Adverse Event|1|||
126362047|NCT02568254|454617399|FG003|Period 2|Adverse Event|0|||
126362048|NCT02568254|454617400|FG004|Period 2|Adverse Event|0|||
126362049|NCT02568254|454617401|FG005|Period 2|Adverse Event|0|||
126362050|NCT02568254|454617396|FG000|Period 3|Unstatisfactory Lens fitting|0|||
126362051|NCT02568254|454617397|FG001|Period 3|Unstatisfactory Lens fitting|0|||
126362052|NCT02568254|454617398|FG002|Period 3|Unstatisfactory Lens fitting|0|||
126362053|NCT02568254|454617399|FG003|Period 3|Unstatisfactory Lens fitting|0|||
126362054|NCT02568254|454617400|FG004|Period 3|Unstatisfactory Lens fitting|1|||
126362055|NCT02568254|454617401|FG005|Period 3|Unstatisfactory Lens fitting|0|||
126362056|NCT01832038|454619012|FG000|Overall Study|Death|5|||
126362057|NCT01832038|454619012|FG000|Overall Study|Adverse Event|50|||
126362058|NCT01832038|454619012|FG000|Overall Study|Lack of Efficacy|81|||
126362059|NCT01832038|454619012|FG000|Overall Study|Protocol Violation|7|||
126362060|NCT01832038|454619012|FG000|Overall Study|Lost to Follow-up|10|||
126362061|NCT01832038|454619012|FG000|Overall Study|Withdrawal by Subject|49|||
126362062|NCT01832038|454619012|FG000|Overall Study|Visit non-compliance|2|||
126362063|NCT01832038|454619012|FG000|Overall Study|Subject refused to return visit|2|||
126362064|NCT01832038|454619012|FG000|Overall Study|Not convenient to come back to site|2|||
126362065|NCT01832038|454619012|FG000|Overall Study|Participant was asked to quit|5|||
126362066|NCT01832038|454619012|FG000|Overall Study|Back home|1|||
126362067|NCT01832038|454619012|FG000|Overall Study|Pregnancy|1|||
126362068|NCT01832038|454619012|FG000|Overall Study|Low compliance|3|||
126362069|NCT01832038|454619012|FG000|Overall Study|Prohibit procedure|2|||
126362070|NCT01832038|454619012|FG000|Overall Study|Not possible to visit the hospital|1|||
126362071|NCT01832038|454619012|FG000|Overall Study|Changes of implementation system|3|||
126362072|NCT01832038|454619012|FG000|Overall Study|Plan to pregnancy|7|||
126362073|NCT01832038|454619012|FG000|Overall Study|Bad mood and has suicidal thought|1|||
126362074|NCT01832038|454619012|FG000|Overall Study|Prohibited concomitant medication|1|||
126362075|NCT01832038|454619012|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
126362076|NCT01832038|454619012|FG000|Overall Study|Subject considered the efficacy was poor|1|||
126362077|NCT00101400|454619017|FG000|Survival Follow-Up|Alive|7|||
126362078|NCT05333965|454619038|FG000|First Intervention|Adverse Event|0|||
126362079|NCT05333965|454619039|FG001|First Intervention|Adverse Event|1|||
126362080|NCT05333965|454619038|FG000|First Intervention|Withdrawal by Subject|0|||
126362081|NCT05333965|454619039|FG001|First Intervention|Withdrawal by Subject|1|||
126362082|NCT00382863|454619040|FG000|Overall Study|Death|9|||
126362083|NCT00382863|454619041|FG001|Overall Study|Death|9|||
126362084|NCT00382863|454619040|FG000|Overall Study|Lost to Follow-up|1|||
126362085|NCT00382863|454619041|FG001|Overall Study|Lost to Follow-up|2|||
126362086|NCT00382863|454619040|FG000|Overall Study|Withdrawal by Subject|5|||
126362087|NCT00382863|454619041|FG001|Overall Study|Withdrawal by Subject|25|||
126362088|NCT02168439|454619042|FG000|Overall Study|Protocol Violation|0|||
126362089|NCT02168439|454619043|FG001|Overall Study|Protocol Violation|2|||
126362090|NCT00605657|454619045|FG000|Overall Study|Adverse Event|1|||
126362091|NCT00605657|454619045|FG000|Overall Study|Protocol Violation|1|||
126362092|NCT02180672|454619046|FG000|Overall Study|Lost to Follow-up|5|||
126362093|NCT02180672|454619047|FG001|Overall Study|Lost to Follow-up|7|||
126362094|NCT02837952|454619048|FG000|Overall Study|Adverse Event|0|||
126362095|NCT02837952|454619049|FG001|Overall Study|Adverse Event|1|||
126362096|NCT02837952|454619048|FG000|Overall Study|Withdrawal by Subject|4|||
126362097|NCT02837952|454619049|FG001|Overall Study|Withdrawal by Subject|5|||
126362098|NCT02837952|454619048|FG000|Overall Study|Medication Error|1|||
126362099|NCT02837952|454619049|FG001|Overall Study|Medication Error|0|||
126362100|NCT01362530|454619050|FG000|Base Study (Cycle 1)|Adverse Event|2|||
126362101|NCT01362530|454619051|FG001|Base Study (Cycle 1)|Adverse Event|0|||
126362102|NCT01362530|454619050|FG000|Base Study (Cycle 1)|Physician Decision|0|||
126362103|NCT01362530|454619051|FG001|Base Study (Cycle 1)|Physician Decision|1|||
126362104|NCT01362530|454619050|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
126362105|NCT01362530|454619051|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
126362106|NCT01362530|454619050|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
126362107|NCT01362530|454619051|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
126705878|NCT00356915|455875494|FG001|Overall Study|Protocol Violation|3|||
126362108|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
126362109|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
126362110|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
126362111|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
126362112|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
126362113|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
126362114|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
126362115|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
126362116|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
126362117|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
126362118|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
126362119|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
126362120|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
126362121|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
126362122|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
126362123|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
126362124|NCT01362530|454619050|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
126362125|NCT01362530|454619051|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
126362126|NCT03021005|454619063|FG000|Overall Study|Lost to Follow-up|39|||
126362127|NCT03021005|454619064|FG001|Overall Study|Lost to Follow-up|26|||
126362128|NCT00276380|454619067|FG000|Overall Study|Adverse Event|5|||
126362129|NCT00276380|454619068|FG001|Overall Study|Adverse Event|3|||
126362130|NCT00276380|454619067|FG000|Overall Study|Lost to Follow-up|1|||
126362131|NCT00276380|454619068|FG001|Overall Study|Lost to Follow-up|1|||
126362132|NCT00276380|454619067|FG000|Overall Study|Withdrawal by Subject|3|||
126362133|NCT00276380|454619068|FG001|Overall Study|Withdrawal by Subject|6|||
126362134|NCT00276380|454619067|FG000|Overall Study|Death|5|||
126362135|NCT00276380|454619068|FG001|Overall Study|Death|3|||
126362136|NCT00276380|454619067|FG000|Overall Study|Abnormal aPPT Levels|0|||
126362137|NCT00276380|454619068|FG001|Overall Study|Abnormal aPPT Levels|1|||
126362138|NCT03473301|454619069|FG000|Overall Study|Protocol Violation|4|||
126362139|NCT03473301|454619070|FG001|Overall Study|Protocol Violation|0|||
126362140|NCT03473301|454619071|FG002|Overall Study|Protocol Violation|0|||
126362141|NCT03473301|454619069|FG000|Overall Study|Withdrawal by Subject|0|||
126705879|NCT00356915|455875495|FG002|Overall Study|Protocol Violation|2|||
126705880|NCT00356915|455875493|FG000|Overall Study|Withdrawal by Subject|14|||
126705881|NCT00356915|455875494|FG001|Overall Study|Withdrawal by Subject|14|||
126705882|NCT00356915|455875495|FG002|Overall Study|Withdrawal by Subject|10|||
126705883|NCT00356915|455875493|FG000|Overall Study|Lack of Efficacy|0|||
126705884|NCT00356915|455875494|FG001|Overall Study|Lack of Efficacy|0|||
126765618|NCT02146365|456094572|FG000|Overall Study|Withdrawal by Subject|1|||
126765619|NCT02146365|456094573|FG001|Overall Study|Withdrawal by Subject|2|||
126765620|NCT02146365|456094574|FG002|Overall Study|Withdrawal by Subject|1|||
126362142|NCT03473301|454619070|FG001|Overall Study|Withdrawal by Subject|1|||
126362143|NCT03473301|454619071|FG002|Overall Study|Withdrawal by Subject|0|||
126705885|NCT00356915|455875495|FG002|Overall Study|Lack of Efficacy|3|||
126705886|NCT00356915|455875493|FG000|Overall Study|Lost to Follow-up|27|||
126705887|NCT00356915|455875494|FG001|Overall Study|Lost to Follow-up|34|||
126705888|NCT00356915|455875495|FG002|Overall Study|Lost to Follow-up|14|||
126705889|NCT00356915|455875493|FG000|Overall Study|Administrative Decision|0|||
126705890|NCT00356915|455875494|FG001|Overall Study|Administrative Decision|0|||
126705891|NCT00356915|455875495|FG002|Overall Study|Administrative Decision|1|||
126705892|NCT00356915|455875493|FG000|Overall Study|Physician Decision|0|||
126705893|NCT00356915|455875494|FG001|Overall Study|Physician Decision|2|||
126705894|NCT00356915|455875495|FG002|Overall Study|Physician Decision|0|||
126705895|NCT00356915|455875493|FG000|Overall Study|Adverse Event|21|||
126705896|NCT00356915|455875494|FG001|Overall Study|Adverse Event|31|||
126705897|NCT00356915|455875495|FG002|Overall Study|Adverse Event|8|||
126705898|NCT00356915|455875493|FG000|Overall Study|Miscellaneous reasons|11|||
126705899|NCT00356915|455875494|FG001|Overall Study|Miscellaneous reasons|8|||
126765621|NCT02146365|456094575|FG003|Overall Study|Withdrawal by Subject|5|||
126362144|NCT03473301|454619069|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
126362145|NCT03473301|454619070|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
126362146|NCT03473301|454619071|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
126362147|NCT04829214|454619072|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
126765622|NCT02146365|456094576|FG004|Overall Study|Withdrawal by Subject|1|||
126362148|NCT04829214|454619073|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
126362149|NCT04829214|454619072|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
126362150|NCT04829214|454619073|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
126362151|NCT02571244|454619075|FG000|Overall Study|Lost to Follow-up|0|||
126765623|NCT02146365|456094577|FG005|Overall Study|Withdrawal by Subject|0|||
126362152|NCT02571244|454619076|FG001|Overall Study|Lost to Follow-up|1|||
126362153|NCT02571244|454619075|FG000|Overall Study|Unable to reach out post discharge|3|||
126362154|NCT02571244|454619076|FG001|Overall Study|Unable to reach out post discharge|0|||
126362155|NCT01696214|454619078|FG000|Overall Study|Lost to Follow-up|1|||
126362156|NCT01696214|454619079|FG001|Overall Study|Lost to Follow-up|0|||
126705900|NCT00356915|455875495|FG002|Overall Study|Miscellaneous reasons|3|||
126705901|NCT00509106|455875497|FG000|Overall Study|Adverse Event|3|||
126705902|NCT00509106|455875498|FG001|Overall Study|Adverse Event|2|||
126705903|NCT00509106|455875497|FG000|Overall Study|Noncompliance|0|||
126765624|NCT02146365|456094578|FG006|Overall Study|Withdrawal by Subject|0|||
126705904|NCT00509106|455875498|FG001|Overall Study|Noncompliance|1|||
126705905|NCT00509106|455875497|FG000|Overall Study|At the request of sponsor/investigator|1|||
126705906|NCT00509106|455875498|FG001|Overall Study|At the request of sponsor/investigator|2|||
126705907|NCT00509106|455875497|FG000|Overall Study|Withdrew consent|4|||
126705908|NCT00509106|455875498|FG001|Overall Study|Withdrew consent|8|||
126705909|NCT00509106|455875497|FG000|Overall Study|Lost to Follow-up|16|||
126705910|NCT00509106|455875498|FG001|Overall Study|Lost to Follow-up|10|||
126273166|NCT01490866|454289157|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
126273167|NCT01490866|454289157|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
126273168|NCT01104779|454289158|FG000|Overall Study|Protocol Violation|1|||
126273169|NCT01104779|454289159|FG001|Overall Study|Protocol Violation|2|||
126705911|NCT00509106|455875497|FG000|Overall Study|Other|1|||
126273170|NCT01104779|454289160|FG002|Overall Study|Protocol Violation|2|||
126273171|NCT01104779|454289158|FG000|Overall Study|Lack of Efficacy|26|||
126273172|NCT01104779|454289159|FG001|Overall Study|Lack of Efficacy|12|||
126273173|NCT01104779|454289160|FG002|Overall Study|Lack of Efficacy|13|||
126273174|NCT01104779|454289158|FG000|Overall Study|Adverse Event|13|||
126273175|NCT01104779|454289159|FG001|Overall Study|Adverse Event|14|||
126273176|NCT01104779|454289160|FG002|Overall Study|Adverse Event|13|||
126273177|NCT01104779|454289158|FG000|Overall Study|Did not meet inc/exc criteria|1|||
126273178|NCT01104779|454289159|FG001|Overall Study|Did not meet inc/exc criteria|1|||
126273179|NCT01104779|454289160|FG002|Overall Study|Did not meet inc/exc criteria|1|||
126273180|NCT01104779|454289158|FG000|Overall Study|Other reasons|0|||
126273181|NCT01104779|454289159|FG001|Overall Study|Other reasons|1|||
126273182|NCT01104779|454289160|FG002|Overall Study|Other reasons|0|||
126273183|NCT01104779|454289158|FG000|Overall Study|Lost to Follow-up|2|||
126273184|NCT01104779|454289159|FG001|Overall Study|Lost to Follow-up|0|||
126273185|NCT01104779|454289160|FG002|Overall Study|Lost to Follow-up|1|||
126273186|NCT01104779|454289158|FG000|Overall Study|Withdrawal by Subject|16|||
126273187|NCT01104779|454289159|FG001|Overall Study|Withdrawal by Subject|25|||
126273188|NCT01104779|454289160|FG002|Overall Study|Withdrawal by Subject|32|||
126273189|NCT03548064|454291002|FG000|Overall Study|Withdrawal by Subject|0|||
126273190|NCT03548064|454291003|FG001|Overall Study|Withdrawal by Subject|0|||
126273191|NCT03548064|454291004|FG002|Overall Study|Withdrawal by Subject|0|||
126273192|NCT03548064|454291005|FG003|Overall Study|Withdrawal by Subject|1|||
126273193|NCT03548064|454291006|FG004|Overall Study|Withdrawal by Subject|0|||
126273194|NCT03548064|454291007|FG005|Overall Study|Withdrawal by Subject|0|||
126273195|NCT03548064|454291008|FG006|Overall Study|Withdrawal by Subject|0|||
126273196|NCT03548064|454291009|FG007|Overall Study|Withdrawal by Subject|0|||
126273197|NCT03548064|454291002|FG000|Overall Study|Lost to Follow-up|0|||
126273198|NCT03548064|454291003|FG001|Overall Study|Lost to Follow-up|0|||
126273199|NCT03548064|454291004|FG002|Overall Study|Lost to Follow-up|0|||
126273200|NCT03548064|454291005|FG003|Overall Study|Lost to Follow-up|0|||
126273201|NCT03548064|454291006|FG004|Overall Study|Lost to Follow-up|2|||
126273202|NCT03548064|454291007|FG005|Overall Study|Lost to Follow-up|0|||
126273203|NCT03548064|454291008|FG006|Overall Study|Lost to Follow-up|0|||
126273204|NCT03548064|454291009|FG007|Overall Study|Lost to Follow-up|0|||
126273205|NCT03548064|454291002|FG000|Overall Study|Covid-19 Pandemic|0|||
126273206|NCT03548064|454291003|FG001|Overall Study|Covid-19 Pandemic|0|||
126273207|NCT03548064|454291004|FG002|Overall Study|Covid-19 Pandemic|0|||
126273208|NCT03548064|454291005|FG003|Overall Study|Covid-19 Pandemic|0|||
126273209|NCT03548064|454291006|FG004|Overall Study|Covid-19 Pandemic|10|||
126273210|NCT03548064|454291007|FG005|Overall Study|Covid-19 Pandemic|3|||
126273211|NCT03548064|454291008|FG006|Overall Study|Covid-19 Pandemic|0|||
126273212|NCT03548064|454291009|FG007|Overall Study|Covid-19 Pandemic|0|||
126273213|NCT05011123|454291010|FG000|Overall Study|Withdrawal by Subject|4|||
126273214|NCT05011123|454291011|FG001|Overall Study|Withdrawal by Subject|2|||
126273215|NCT05011123|454291010|FG000|Overall Study|Lost to Follow-up|7|||
126273216|NCT05011123|454291011|FG001|Overall Study|Lost to Follow-up|6|||
126273217|NCT05011123|454291010|FG000|Overall Study|Ongoing at the time of DBL date|36|||
126273218|NCT05011123|454291011|FG001|Overall Study|Ongoing at the time of DBL date|10|||
126273219|NCT05011123|454291010|FG000|Overall Study|Randomized but did not receive vaccination|1|||
126362157|NCT01696214|454619080|FG002|Overall Study|Lost to Follow-up|0|||
126362158|NCT01696214|454619081|FG003|Overall Study|Lost to Follow-up|0|||
126362159|NCT00452530|454619085|FG000|Overall Study|Death|1|||
126362160|NCT00452530|454619086|FG001|Overall Study|Death|0|||
126362161|NCT00452530|454619085|FG000|Overall Study|Adverse Event|40|||
126705912|NCT00509106|455875498|FG001|Overall Study|Other|0|||
126273220|NCT05011123|454291011|FG001|Overall Study|Randomized but did not receive vaccination|0|||
126273221|NCT04221789|454291012|FG000|Overall Study|deviation from protoco|22|||
126273222|NCT04221789|454291013|FG001|Overall Study|deviation from protoco|8|||
126273223|NCT05091307|454291014|FG000|Overall Study|Death|0|||
126273224|NCT05091307|454291015|FG001|Overall Study|Death|0|||
126273225|NCT05091307|454291016|FG002|Overall Study|Death|1|||
126705913|NCT00509106|455875497|FG000|Overall Study|Death|6|||
126362162|NCT00452530|454619086|FG001|Overall Study|Adverse Event|44|||
126362163|NCT00452530|454619085|FG000|Overall Study|Withdrawal by Subject|68|||
126362164|NCT00452530|454619086|FG001|Overall Study|Withdrawal by Subject|57|||
126362165|NCT00452530|454619085|FG000|Overall Study|Lost to Follow-up|1|||
126362166|NCT00452530|454619086|FG001|Overall Study|Lost to Follow-up|0|||
126362167|NCT00452530|454619085|FG000|Overall Study|Poor compliance/noncompliance|1|||
126362168|NCT00452530|454619086|FG001|Overall Study|Poor compliance/noncompliance|2|||
126362169|NCT00452530|454619085|FG000|Overall Study|No longer met study criteria|18|||
126362170|NCT00452530|454619086|FG001|Overall Study|No longer met study criteria|22|||
126362171|NCT00452530|454619085|FG000|Overall Study|Other|7|||
126362172|NCT00452530|454619086|FG001|Overall Study|Other|11|||
126362173|NCT01905267|454619087|FG000|Overall Study|Physician Decision|2|||
126362174|NCT01905267|454619088|FG001|Overall Study|Physician Decision|2|||
126705914|NCT00509106|455875498|FG001|Overall Study|Death|6|||
126705915|NCT02318602|455875499|FG000|Overall Study|Adverse Event|0|||
126705916|NCT02318602|455875500|FG001|Overall Study|Adverse Event|1|||
126705917|NCT02318602|455875501|FG002|Overall Study|Adverse Event|1|||
126362175|NCT03888482|454619089|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
126362176|NCT03888482|454619090|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
126362177|NCT03888482|454619089|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
126362178|NCT03888482|454619090|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
126362179|NCT01725308|454619095|FG000|Treatment Period I|Did Not Receive Drug|1|||
126362180|NCT01725308|454619096|FG001|Treatment Period I|Did Not Receive Drug|0|||
126362181|NCT01725308|454619097|FG002|Treatment Period I|Did Not Receive Drug|0|||
126362182|NCT01725308|454619095|FG000|Treatment Period I|Adverse Event|5|||
126362183|NCT01725308|454619096|FG001|Treatment Period I|Adverse Event|4|||
126362184|NCT01725308|454619097|FG002|Treatment Period I|Adverse Event|21|||
126362185|NCT01725308|454619095|FG000|Treatment Period I|Insufficient Response|7|||
126362186|NCT01725308|454619096|FG001|Treatment Period I|Insufficient Response|0|||
126362187|NCT01725308|454619097|FG002|Treatment Period I|Insufficient Response|5|||
126362188|NCT01725308|454619095|FG000|Treatment Period I|Worsening of the Target Disease|8|||
126362189|NCT01725308|454619096|FG001|Treatment Period I|Worsening of the Target Disease|0|||
126362190|NCT01725308|454619097|FG002|Treatment Period I|Worsening of the Target Disease|2|||
126362191|NCT01725308|454619095|FG000|Treatment Period I|Changes in the Episodes|3|||
126362192|NCT01725308|454619096|FG001|Treatment Period I|Changes in the Episodes|0|||
126362193|NCT01725308|454619097|FG002|Treatment Period I|Changes in the Episodes|2|||
126362194|NCT01725308|454619095|FG000|Treatment Period I|Withdrawal of Consent|12|||
126362195|NCT01725308|454619096|FG001|Treatment Period I|Withdrawal of Consent|7|||
126362196|NCT01725308|454619097|FG002|Treatment Period I|Withdrawal of Consent|5|||
126362197|NCT01725308|454619095|FG000|Treatment Period I|Lost to Follow-up|3|||
126362198|NCT01725308|454619096|FG001|Treatment Period I|Lost to Follow-up|2|||
126362199|NCT01725308|454619097|FG002|Treatment Period I|Lost to Follow-up|2|||
126362200|NCT01725308|454619095|FG000|Treatment Period I|Protocol Deviations|3|||
126362201|NCT01725308|454619096|FG001|Treatment Period I|Protocol Deviations|1|||
126362202|NCT01725308|454619097|FG002|Treatment Period I|Protocol Deviations|1|||
126362203|NCT01725308|454619095|FG000|Treatment Period I|Miscellaneous|2|||
126705918|NCT02318602|455875499|FG000|Overall Study|Withdrawal by Subject|0|||
126273226|NCT05091307|454291017|FG003|Overall Study|Death|0|||
126273227|NCT05091307|454291014|FG000|Overall Study|Lost to Follow-up|33|||
126273228|NCT05091307|454291015|FG001|Overall Study|Lost to Follow-up|33|||
126273229|NCT05091307|454291016|FG002|Overall Study|Lost to Follow-up|2|||
126273230|NCT05091307|454291017|FG003|Overall Study|Lost to Follow-up|0|||
126273231|NCT05091307|454291014|FG000|Overall Study|Physician Decision|1|||
126273232|NCT05091307|454291015|FG001|Overall Study|Physician Decision|0|||
126273233|NCT05091307|454291016|FG002|Overall Study|Physician Decision|0|||
126273234|NCT05091307|454291017|FG003|Overall Study|Physician Decision|0|||
126273235|NCT05091307|454291014|FG000|Overall Study|Protocol Violation|1|||
126273236|NCT05091307|454291015|FG001|Overall Study|Protocol Violation|0|||
126273237|NCT05091307|454291016|FG002|Overall Study|Protocol Violation|0|||
126273238|NCT05091307|454291017|FG003|Overall Study|Protocol Violation|0|||
126273239|NCT05091307|454291014|FG000|Overall Study|Withdrawal by Subject|16|||
126362204|NCT01725308|454619096|FG001|Treatment Period I|Miscellaneous|0|||
126362205|NCT01725308|454619097|FG002|Treatment Period I|Miscellaneous|3|||
126362206|NCT01725308|454619095|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
126362207|NCT01725308|454619096|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
126362208|NCT01725308|454619097|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
126362209|NCT01725308|454619095|FG000|Treatment Period II|Did Not Receive Drug|4|||
126705919|NCT02318602|455875500|FG001|Overall Study|Withdrawal by Subject|3|||
126705920|NCT02318602|455875501|FG002|Overall Study|Withdrawal by Subject|0|||
126705921|NCT02318602|455875499|FG000|Overall Study|Death|1|||
126273240|NCT05091307|454291015|FG001|Overall Study|Withdrawal by Subject|16|||
126273241|NCT05091307|454291016|FG002|Overall Study|Withdrawal by Subject|0|||
126273242|NCT05091307|454291017|FG003|Overall Study|Withdrawal by Subject|1|||
126362210|NCT01725308|454619096|FG001|Treatment Period II|Did Not Receive Drug|0|||
126362211|NCT01725308|454619097|FG002|Treatment Period II|Did Not Receive Drug|0|||
126362212|NCT01725308|454619095|FG000|Treatment Period II|Adverse Event|13|||
126362213|NCT01725308|454619096|FG001|Treatment Period II|Adverse Event|8|||
126362214|NCT01725308|454619097|FG002|Treatment Period II|Adverse Event|20|||
126362215|NCT01725308|454619095|FG000|Treatment Period II|Insufficient Response|2|||
126362216|NCT01725308|454619096|FG001|Treatment Period II|Insufficient Response|4|||
126453658|NCT01185353|454961513|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
126453659|NCT01185353|454961514|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
126273243|NCT05091307|454291014|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
126273244|NCT05091307|454291015|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
126273245|NCT05091307|454291016|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
126273246|NCT05091307|454291017|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
126273247|NCT05091307|454291014|FG000|Overall Study|Initiated Prohibited Medication|1|||
126273248|NCT05091307|454291015|FG001|Overall Study|Initiated Prohibited Medication|0|||
126273249|NCT05091307|454291016|FG002|Overall Study|Initiated Prohibited Medication|0|||
126273250|NCT05091307|454291017|FG003|Overall Study|Initiated Prohibited Medication|0|||
126273251|NCT05091307|454291014|FG000|Overall Study|Other|4|||
126273252|NCT05091307|454291015|FG001|Overall Study|Other|4|||
126273253|NCT05091307|454291016|FG002|Overall Study|Other|0|||
126273254|NCT05091307|454291017|FG003|Overall Study|Other|0|||
126273255|NCT05091307|454291014|FG000|Overall Study|Randomized but not vaccinated|0|||
126273256|NCT05091307|454291015|FG001|Overall Study|Randomized but not vaccinated|2|||
126273257|NCT05091307|454291016|FG002|Overall Study|Randomized but not vaccinated|0|||
126273258|NCT05091307|454291017|FG003|Overall Study|Randomized but not vaccinated|0|||
126273259|NCT04732221|454291018|FG000|Base Period|Death|2|||
126273260|NCT04732221|454291019|FG001|Base Period|Death|0|||
126273261|NCT04732221|454291020|FG002|Base Period|Death|0|||
126273262|NCT04732221|454291021|FG003|Base Period|Death|0|||
126273263|NCT04732221|454291022|FG004|Base Period|Death|0|||
126273264|NCT04732221|454291023|FG005|Base Period|Death|0|||
126273265|NCT04732221|454291024|FG006|Base Period|Death|0|||
126273266|NCT04732221|454291018|FG000|Base Period|Withdrawal by Subject|0|||
126273267|NCT04732221|454291019|FG001|Base Period|Withdrawal by Subject|1|||
126273268|NCT04732221|454291020|FG002|Base Period|Withdrawal by Subject|1|||
126273269|NCT04732221|454291021|FG003|Base Period|Withdrawal by Subject|0|||
126273270|NCT04732221|454291022|FG004|Base Period|Withdrawal by Subject|0|||
126273271|NCT04732221|454291023|FG005|Base Period|Withdrawal by Subject|0|||
126273272|NCT04732221|454291024|FG006|Base Period|Withdrawal by Subject|0|||
126273273|NCT04732221|454291018|FG000|Extension Period|Adverse Event|0|||
126273274|NCT04732221|454291019|FG001|Extension Period|Adverse Event|0|||
126273275|NCT04732221|454291020|FG002|Extension Period|Adverse Event|0|||
126273276|NCT04732221|454291021|FG003|Extension Period|Adverse Event|0|||
126273277|NCT04732221|454291022|FG004|Extension Period|Adverse Event|0|||
126273278|NCT04732221|454291023|FG005|Extension Period|Adverse Event|1|||
126273279|NCT04732221|454291024|FG006|Extension Period|Adverse Event|0|||
126273280|NCT04732221|454291018|FG000|Extension Period|Death|0|||
126273281|NCT04732221|454291019|FG001|Extension Period|Death|0|||
126273282|NCT04732221|454291020|FG002|Extension Period|Death|0|||
126273283|NCT04732221|454291021|FG003|Extension Period|Death|0|||
126273284|NCT04732221|454291022|FG004|Extension Period|Death|1|||
126273285|NCT04732221|454291023|FG005|Extension Period|Death|0|||
126273286|NCT04732221|454291024|FG006|Extension Period|Death|2|||
126273287|NCT04732221|454291018|FG000|Extension Period|Pregnancy|0|||
126273288|NCT04732221|454291019|FG001|Extension Period|Pregnancy|0|||
126273289|NCT04732221|454291020|FG002|Extension Period|Pregnancy|0|||
126273290|NCT04732221|454291021|FG003|Extension Period|Pregnancy|0|||
126273291|NCT04732221|454291022|FG004|Extension Period|Pregnancy|1|||
126273292|NCT04732221|454291023|FG005|Extension Period|Pregnancy|0|||
126273293|NCT04732221|454291024|FG006|Extension Period|Pregnancy|0|||
126273294|NCT04732221|454291018|FG000|Extension Period|Sponsors Decision|0|||
126273295|NCT04732221|454291019|FG001|Extension Period|Sponsors Decision|0|||
126273296|NCT04732221|454291020|FG002|Extension Period|Sponsors Decision|0|||
126273297|NCT04732221|454291021|FG003|Extension Period|Sponsors Decision|0|||
126273298|NCT04732221|454291022|FG004|Extension Period|Sponsors Decision|41|||
126273299|NCT04732221|454291023|FG005|Extension Period|Sponsors Decision|40|||
126273300|NCT04732221|454291024|FG006|Extension Period|Sponsors Decision|40|||
126273301|NCT04732221|454291018|FG000|Extension Period|Withdrawal by Subject|0|||
126453660|NCT01185353|454961515|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
126273302|NCT04732221|454291019|FG001|Extension Period|Withdrawal by Subject|0|||
126273303|NCT04732221|454291020|FG002|Extension Period|Withdrawal by Subject|0|||
126273304|NCT04732221|454291021|FG003|Extension Period|Withdrawal by Subject|0|||
126273305|NCT04732221|454291022|FG004|Extension Period|Withdrawal by Subject|1|||
126273306|NCT04732221|454291023|FG005|Extension Period|Withdrawal by Subject|5|||
126273307|NCT04732221|454291024|FG006|Extension Period|Withdrawal by Subject|2|||
126273308|NCT03747601|454291025|FG000|Overall Study|COVID halt to visits|4|||
126453661|NCT01185353|454961516|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
126273309|NCT05327816|454291026|FG000|Overall Study|Lost to Follow-up|1|||
126453662|NCT01185353|454961517|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
126273310|NCT05327816|454291027|FG001|Overall Study|Lost to Follow-up|0|||
126273311|NCT05327816|454291028|FG002|Overall Study|Lost to Follow-up|0|||
126273312|NCT05327816|454291029|FG003|Overall Study|Lost to Follow-up|0|||
126273313|NCT05327816|454291030|FG004|Overall Study|Lost to Follow-up|0|||
126273314|NCT05327816|454291031|FG005|Overall Study|Lost to Follow-up|0|||
126273315|NCT05327816|454291032|FG006|Overall Study|Lost to Follow-up|0|||
126273316|NCT05327816|454291033|FG007|Overall Study|Lost to Follow-up|0|||
126273317|NCT05327816|454291034|FG008|Overall Study|Lost to Follow-up|0|||
126705922|NCT02318602|455875500|FG001|Overall Study|Death|0|||
126705923|NCT02318602|455875501|FG002|Overall Study|Death|0|||
126273318|NCT05327816|454291035|FG009|Overall Study|Lost to Follow-up|1|||
126273319|NCT05327816|454291036|FG010|Overall Study|Lost to Follow-up|0|||
126273320|NCT05327816|454291026|FG000|Overall Study|Withdrawal by Subject|0|||
126273321|NCT05327816|454291027|FG001|Overall Study|Withdrawal by Subject|0|||
126273322|NCT05327816|454291028|FG002|Overall Study|Withdrawal by Subject|0|||
126273323|NCT05327816|454291029|FG003|Overall Study|Withdrawal by Subject|0|||
126273324|NCT05327816|454291030|FG004|Overall Study|Withdrawal by Subject|1|||
126273325|NCT05327816|454291031|FG005|Overall Study|Withdrawal by Subject|1|||
126273326|NCT05327816|454291032|FG006|Overall Study|Withdrawal by Subject|0|||
126273327|NCT05327816|454291033|FG007|Overall Study|Withdrawal by Subject|0|||
126273328|NCT05327816|454291034|FG008|Overall Study|Withdrawal by Subject|0|||
126273329|NCT05327816|454291035|FG009|Overall Study|Withdrawal by Subject|0|||
126273330|NCT05327816|454291036|FG010|Overall Study|Withdrawal by Subject|0|||
126273331|NCT05327816|454291026|FG000|Overall Study|Study Terminated by Sponsor|11|||
126273332|NCT05327816|454291027|FG001|Overall Study|Study Terminated by Sponsor|12|||
126273333|NCT05327816|454291028|FG002|Overall Study|Study Terminated by Sponsor|12|||
126273334|NCT05327816|454291029|FG003|Overall Study|Study Terminated by Sponsor|12|||
126273335|NCT05327816|454291030|FG004|Overall Study|Study Terminated by Sponsor|11|||
126273336|NCT05327816|454291031|FG005|Overall Study|Study Terminated by Sponsor|11|||
126273337|NCT05327816|454291032|FG006|Overall Study|Study Terminated by Sponsor|11|||
126273338|NCT05327816|454291033|FG007|Overall Study|Study Terminated by Sponsor|11|||
126273339|NCT05327816|454291034|FG008|Overall Study|Study Terminated by Sponsor|11|||
126273340|NCT05327816|454291035|FG009|Overall Study|Study Terminated by Sponsor|11|||
126273341|NCT05327816|454291036|FG010|Overall Study|Study Terminated by Sponsor|12|||
126273342|NCT05327816|454291026|FG000|Overall Study|Randomized but not treated|0|||
126273343|NCT05327816|454291027|FG001|Overall Study|Randomized but not treated|0|||
126273344|NCT05327816|454291028|FG002|Overall Study|Randomized but not treated|0|||
126273345|NCT05327816|454291029|FG003|Overall Study|Randomized but not treated|0|||
126273346|NCT05327816|454291030|FG004|Overall Study|Randomized but not treated|0|||
126273347|NCT05327816|454291031|FG005|Overall Study|Randomized but not treated|0|||
126273348|NCT05327816|454291032|FG006|Overall Study|Randomized but not treated|1|||
126273349|NCT05327816|454291033|FG007|Overall Study|Randomized but not treated|1|||
126273350|NCT05327816|454291034|FG008|Overall Study|Randomized but not treated|1|||
126273351|NCT05327816|454291035|FG009|Overall Study|Randomized but not treated|0|||
126273352|NCT05327816|454291036|FG010|Overall Study|Randomized but not treated|0|||
126273353|NCT00112866|454291037|FG000|Overall Study|Protocol Violation|1|||
126273354|NCT00112866|454291038|FG001|Overall Study|Protocol Violation|0|||
126273355|NCT00112866|454291037|FG000|Overall Study|did not start treatment post-op|1|||
126273356|NCT00112866|454291038|FG001|Overall Study|did not start treatment post-op|2|||
126273357|NCT01167257|454291039|FG000|Overall Study|Lost to Follow-up|2|||
126273358|NCT01167257|454291040|FG001|Overall Study|Lost to Follow-up|2|||
126273359|NCT01167257|454291039|FG000|Overall Study|Withdrew consent|1|||
126273360|NCT01167257|454291040|FG001|Overall Study|Withdrew consent|1|||
126273361|NCT04305587|454291041|FG000|Overall Study|Withdrawal by Subject|0|||
126273362|NCT04305587|454291042|FG001|Overall Study|Withdrawal by Subject|0|||
126273363|NCT04305587|454291043|FG002|Overall Study|Withdrawal by Subject|0|||
126273364|NCT04305587|454291044|FG003|Overall Study|Withdrawal by Subject|1|||
126273365|NCT04305587|454291045|FG004|Overall Study|Withdrawal by Subject|0|||
126273366|NCT04305587|454291046|FG005|Overall Study|Withdrawal by Subject|0|||
126273367|NCT04305587|454291047|FG006|Overall Study|Withdrawal by Subject|0|||
126547402|NCT00244374|455297933|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
126705924|NCT02318602|455875499|FG000|Overall Study|Guardian decision to withdraw|0|||
126705925|NCT02318602|455875500|FG001|Overall Study|Guardian decision to withdraw|0|||
126705926|NCT02318602|455875501|FG002|Overall Study|Guardian decision to withdraw|1|||
126705927|NCT00693706|455875502|FG000|Overall Study|Protocol Violation|0|||
126705928|NCT00693706|455875503|FG001|Overall Study|Protocol Violation|1|||
126273368|NCT04305587|454291048|FG007|Overall Study|Withdrawal by Subject|0|||
126273369|NCT04305587|454291049|FG008|Overall Study|Withdrawal by Subject|0|||
126273370|NCT01367665|454291050|FG000|Overall Study|Death|102|||
126273371|NCT01367665|454291051|FG001|Overall Study|Death|19|||
126273372|NCT01367665|454291050|FG000|Overall Study|Lost to Follow-up|222|||
126273373|NCT01367665|454291051|FG001|Overall Study|Lost to Follow-up|22|||
126273374|NCT01367665|454291050|FG000|Overall Study|Not Done|118|||
126273375|NCT01367665|454291051|FG001|Overall Study|Not Done|14|||
126273376|NCT02752906|454291052|FG000|Overall Study|Protocol Violation|2|||
126705929|NCT00488631|455875504|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
126273377|NCT02752906|454291053|FG001|Overall Study|Protocol Violation|1|||
126273378|NCT02752906|454291052|FG000|Overall Study|Withdrawal by Subject|2|||
126273379|NCT02752906|454291053|FG001|Overall Study|Withdrawal by Subject|2|||
126273380|NCT02752906|454291052|FG000|Overall Study|Lost to Follow-up|3|||
126273381|NCT02752906|454291053|FG001|Overall Study|Lost to Follow-up|2|||
126273382|NCT02771795|454291054|FG000|Overall Study|Withdrawal by Subject|47|||
126273383|NCT02771795|454291055|FG001|Overall Study|Withdrawal by Subject|37|||
126273384|NCT02771795|454291054|FG000|Overall Study|Termination by premature discontinuation of study|168|||
126765625|NCT02146365|456094579|FG007|Overall Study|Withdrawal by Subject|0|||
126765626|NCT02146365|456094572|FG000|Overall Study|Unable to Comply with Protocol|0|||
126273385|NCT02771795|454291055|FG001|Overall Study|Termination by premature discontinuation of study|185|||
126273386|NCT04112173|454291056|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
126273387|NCT02906930|454291057|FG000|Overall Study|Withdrawal by Subject|0|||
126273388|NCT02906930|454291058|FG001|Overall Study|Withdrawal by Subject|5|||
126273389|NCT02906930|454291059|FG002|Overall Study|Withdrawal by Subject|5|||
126273390|NCT02906930|454291060|FG003|Overall Study|Withdrawal by Subject|4|||
126273391|NCT02906930|454291057|FG000|Overall Study|Lost to Follow-up|5|||
126273392|NCT02906930|454291058|FG001|Overall Study|Lost to Follow-up|7|||
126273393|NCT02906930|454291059|FG002|Overall Study|Lost to Follow-up|5|||
126273394|NCT02906930|454291060|FG003|Overall Study|Lost to Follow-up|2|||
126273395|NCT02906930|454291057|FG000|Overall Study|Death|0|||
126273396|NCT02906930|454291058|FG001|Overall Study|Death|0|||
126273397|NCT02906930|454291059|FG002|Overall Study|Death|1|||
126273398|NCT02906930|454291060|FG003|Overall Study|Death|0|||
126273399|NCT02906930|454291057|FG000|Overall Study|Other|1|||
126273400|NCT02906930|454291058|FG001|Overall Study|Other|2|||
126273401|NCT02906930|454291059|FG002|Overall Study|Other|1|||
126273402|NCT02906930|454291060|FG003|Overall Study|Other|2|||
126273403|NCT01383135|454291070|FG000|Overall Study|Not Scanned / Imaged|1|||
126273404|NCT01383135|454291071|FG001|Overall Study|Not Scanned / Imaged|0|||
126273405|NCT01383135|454291072|FG002|Overall Study|Not Scanned / Imaged|1|||
126273406|NCT01383135|454291073|FG003|Overall Study|Not Scanned / Imaged|0|||
126273407|NCT03321630|454291074|FG000|Overall Study|Adverse Event|1|||
126273408|NCT03321630|454291074|FG000|Overall Study|Investigator Discretion|2|||
126273409|NCT03321630|454291074|FG000|Overall Study|Withdrawal by Subject|1|||
126273410|NCT02669758|454291075|FG000|Overall Study|Withdrawal by Subject|43|||
126273411|NCT02669758|454291075|FG000|Overall Study|Lost to Follow-up|19|||
126273412|NCT02669758|454291075|FG000|Overall Study|Adverse Event|16|||
126273413|NCT02669758|454291075|FG000|Overall Study|Non-Compliance with Study Drug|8|||
126273414|NCT02669758|454291075|FG000|Overall Study|Lack of Efficacy|5|||
126273415|NCT02669758|454291075|FG000|Overall Study|Pregnancy|1|||
126273416|NCT02669758|454291075|FG000|Overall Study|Study noncompliance|1|||
126273417|NCT02669758|454291075|FG000|Overall Study|Protocol Violation|1|||
126273418|NCT01468818|454291082|FG000|Overall Study|Death during treatment|2|||
126273419|NCT01212588|454291083|FG000|Overall Study|Physician Decision|0|||
126273420|NCT01212588|454291084|FG001|Overall Study|Physician Decision|1|||
126273421|NCT01212588|454291083|FG000|Overall Study|Protocol Violation|1|||
126273422|NCT01212588|454291084|FG001|Overall Study|Protocol Violation|1|||
126273423|NCT01735955|454291085|FG000|Overall Study|Administrative problems|1|||
126273424|NCT01735955|454291085|FG000|Overall Study|Patient/guardian decision|1|||
126273425|NCT01735955|454291085|FG000|Overall Study|Patient withdrew consent|2|||
126273426|NCT01735955|454291085|FG000|Overall Study|Physician Decision|4|||
126273427|NCT01735955|454291085|FG000|Overall Study|Disease progression|24|||
126273428|NCT01735955|454291085|FG000|Overall Study|Adverse Event|5|||
126273429|NCT03317834|454291088|FG000|Overall Study|Death|2|||
126273430|NCT03317834|454291088|FG000|Overall Study|Device Revision|5|||
126273431|NCT03317834|454291088|FG000|Overall Study|Withdrawal by Subject|13|||
126273432|NCT03317834|454291088|FG000|Overall Study|Lost to Follow-up|13|||
126273433|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
126273434|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
126453663|NCT01185353|454961508|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
126453664|NCT01185353|454961509|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
126453665|NCT01185353|454961510|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
126453666|NCT01185353|454961511|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
126273435|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
126273436|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
126273437|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
126273438|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
126273439|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
126273440|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
126273441|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
126273442|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273443|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
126273444|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273445|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126453667|NCT01185353|454961512|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
126273446|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273447|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273448|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273449|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273450|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
126273451|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273452|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
126273453|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273454|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
126273455|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273456|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273457|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273458|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273459|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273460|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273461|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
126273462|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273463|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
126273464|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273465|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273466|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273467|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273468|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
126273469|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
126273470|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
126273471|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
126273472|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273473|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
126273474|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273475|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273476|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273477|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273478|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273479|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
126273480|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273481|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273482|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273483|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273484|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273485|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273486|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
126273487|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273488|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273489|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273490|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
126273491|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273492|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273493|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273494|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273495|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273496|NCT03893565|454291098|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
126273497|NCT03893565|454291099|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
126273498|NCT03893565|454291100|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
126273499|NCT03893565|454291101|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
126273500|NCT03893565|454291102|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
126273501|NCT03893565|454291103|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
126273502|NCT03893565|454291104|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
126273503|NCT03893565|454291105|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
126273504|NCT03893565|454291106|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
126273505|NCT03893565|454291098|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
126273506|NCT03893565|454291099|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
126273507|NCT03893565|454291100|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
126273508|NCT03893565|454291101|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
126273509|NCT03893565|454291102|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
126362217|NCT01725308|454619097|FG002|Treatment Period II|Insufficient Response|6|||
126362218|NCT01725308|454619095|FG000|Treatment Period II|Worsening of the Target Disease|1|||
126362219|NCT01725308|454619096|FG001|Treatment Period II|Worsening of the Target Disease|4|||
126273510|NCT03893565|454291103|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
126273511|NCT03893565|454291104|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
126273512|NCT03893565|454291105|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
126273513|NCT03893565|454291106|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
126273514|NCT03893565|454291098|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273515|NCT03893565|454291099|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273516|NCT03893565|454291100|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273517|NCT03893565|454291101|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273518|NCT03893565|454291102|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273519|NCT03893565|454291103|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273520|NCT03893565|454291104|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
126273521|NCT03893565|454291105|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273522|NCT03893565|454291106|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
126273523|NCT03893565|454291098|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273524|NCT03893565|454291099|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273525|NCT03893565|454291100|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273526|NCT03893565|454291101|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273527|NCT03893565|454291102|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273528|NCT03893565|454291103|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
126273529|NCT03893565|454291104|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
126273530|NCT03893565|454291105|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273531|NCT03893565|454291106|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
126273532|NCT03893565|454291098|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
126273533|NCT03893565|454291099|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
126273534|NCT03893565|454291100|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
126273535|NCT03893565|454291101|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
126273536|NCT03893565|454291102|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
126273537|NCT03893565|454291103|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
126273538|NCT03893565|454291104|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
126273539|NCT03893565|454291105|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
126273540|NCT03893565|454291106|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
126273541|NCT03893565|454291098|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273542|NCT03893565|454291099|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273543|NCT03893565|454291100|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273544|NCT03893565|454291101|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273545|NCT03893565|454291102|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273546|NCT03893565|454291103|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273547|NCT03893565|454291104|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273548|NCT03893565|454291105|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
126273549|NCT03893565|454291106|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
126273550|NCT03893565|454291098|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273551|NCT03893565|454291099|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273552|NCT03893565|454291100|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273553|NCT03893565|454291101|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273554|NCT03893565|454291102|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273555|NCT03893565|454291103|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273556|NCT03893565|454291104|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273557|NCT03893565|454291105|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
126273558|NCT03893565|454291106|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
126273559|NCT03893565|454291098|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273560|NCT03893565|454291099|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273561|NCT03893565|454291100|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273562|NCT03893565|454291101|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273563|NCT03893565|454291102|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273564|NCT03893565|454291103|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273565|NCT03893565|454291104|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273566|NCT03893565|454291105|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
126273567|NCT03893565|454291106|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
126273568|NCT03893565|454291098|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126273569|NCT03893565|454291099|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126306212|NCT01250873|454410239|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
126306213|NCT01250873|454410239|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
126306214|NCT02278939|454410240|FG000|Overall Study|lack of time|1|||
126306215|NCT02278939|454410241|FG001|Overall Study|lack of time|0|||
126705930|NCT00488631|455875505|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
126705931|NCT00488631|455875506|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
126705932|NCT00488631|455875507|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
126705933|NCT00488631|455875508|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
126705934|NCT00488631|455875509|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
126705935|NCT00488631|455875510|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
126705936|NCT00488631|455875511|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
126705937|NCT00488631|455875512|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
126705938|NCT00488631|455875513|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
126705939|NCT00488631|455875504|FG000|Double Blind Period (Week 0-54)|Death|0|||
126705940|NCT00488631|455875505|FG001|Double Blind Period (Week 0-54)|Death|0|||
126705941|NCT00488631|455875506|FG002|Double Blind Period (Week 0-54)|Death|0|||
126705942|NCT00488631|455875507|FG003|Double Blind Period (Week 0-54)|Death|0|||
126705943|NCT00488631|455875508|FG004|Double Blind Period (Week 0-54)|Death|0|||
126705944|NCT00488631|455875509|FG005|Double Blind Period (Week 0-54)|Death|1|||
126705945|NCT00488631|455875510|FG006|Double Blind Period (Week 0-54)|Death|0|||
126705946|NCT00488631|455875511|FG007|Double Blind Period (Week 0-54)|Death|0|||
126453668|NCT01185353|454961513|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
126453669|NCT01185353|454961514|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
126705947|NCT00488631|455875512|FG008|Double Blind Period (Week 0-54)|Death|0|||
126705948|NCT00488631|455875513|FG009|Double Blind Period (Week 0-54)|Death|0|||
126705949|NCT00488631|455875504|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
126705950|NCT00488631|455875505|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
126705951|NCT00488631|455875506|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
126273570|NCT03893565|454291100|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126453670|NCT01185353|454961515|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
126453671|NCT01185353|454961516|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
126453672|NCT01185353|454961517|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
126453673|NCT01185353|454961508|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
126453674|NCT01185353|454961509|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
126453675|NCT01185353|454961510|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
126453676|NCT01185353|454961511|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
126453677|NCT01185353|454961512|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
126453678|NCT01185353|454961513|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
126551845|NCT01004250|455315872|FG000|Induction Therapy Period|Adverse Event|10|||
126705952|NCT00488631|455875507|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
126705953|NCT00488631|455875508|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
126705954|NCT00488631|455875509|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
126705955|NCT00488631|455875510|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
126273571|NCT03893565|454291101|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126273572|NCT03893565|454291102|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126273573|NCT03893565|454291103|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126273574|NCT03893565|454291104|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126273575|NCT03893565|454291105|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
126273576|NCT03893565|454291106|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
126273577|NCT05788289|454291112|FG000|Overall Study|Death|3|||
126273578|NCT00762437|454291113|FG000|Overall Study|Lost to Follow-up|7|||
126273579|NCT00762437|454291113|FG000|Overall Study|Missed final study visit|11|||
126273580|NCT00762437|454291113|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
126273581|NCT00085423|454291118|FG000|Overall Study|Withdrawal by Subject|1|||
126273582|NCT00085423|454291118|FG000|Overall Study|screen failure|1|||
126273583|NCT02440568|454291121|FG000|Overall Study|Death|1|||
126273584|NCT02440568|454291122|FG001|Overall Study|Death|3|||
126273585|NCT02440568|454291123|FG002|Overall Study|Death|4|||
126273586|NCT02440568|454291124|FG003|Overall Study|Death|2|||
126273587|NCT02440568|454291121|FG000|Overall Study|Lack of Efficacy|2|||
126273588|NCT02440568|454291122|FG001|Overall Study|Lack of Efficacy|0|||
126273589|NCT02440568|454291123|FG002|Overall Study|Lack of Efficacy|1|||
126273590|NCT02440568|454291124|FG003|Overall Study|Lack of Efficacy|0|||
126705956|NCT00488631|455875511|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
126705957|NCT00488631|455875512|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
126273591|NCT02440568|454291121|FG000|Overall Study|Lost to Follow-up|1|||
126273592|NCT02440568|454291122|FG001|Overall Study|Lost to Follow-up|0|||
126273593|NCT02440568|454291123|FG002|Overall Study|Lost to Follow-up|0|||
126273594|NCT02440568|454291124|FG003|Overall Study|Lost to Follow-up|0|||
126273595|NCT00536263|454291125|FG000|Overall Study|Adverse Event|5|||
126273596|NCT00536263|454291126|FG001|Overall Study|Adverse Event|5|||
126273597|NCT00536263|454291127|FG002|Overall Study|Adverse Event|7|||
126273598|NCT00536263|454291125|FG000|Overall Study|Lost to Follow-up|3|||
126273599|NCT00536263|454291126|FG001|Overall Study|Lost to Follow-up|4|||
126273600|NCT00536263|454291127|FG002|Overall Study|Lost to Follow-up|4|||
126273601|NCT00536263|454291125|FG000|Overall Study|Subject withdrew - not treatment related|2|||
126273602|NCT00536263|454291126|FG001|Overall Study|Subject withdrew - not treatment related|0|||
126273603|NCT00536263|454291127|FG002|Overall Study|Subject withdrew - not treatment related|5|||
126273604|NCT00536263|454291125|FG000|Overall Study|Subject withdrew - treatment related|0|||
126273605|NCT00536263|454291126|FG001|Overall Study|Subject withdrew - treatment related|3|||
126273606|NCT00536263|454291127|FG002|Overall Study|Subject withdrew - treatment related|2|||
126273607|NCT00536263|454291125|FG000|Overall Study|Noncompliance with protocol|0|||
126273608|NCT00536263|454291126|FG001|Overall Study|Noncompliance with protocol|0|||
126273609|NCT00536263|454291127|FG002|Overall Study|Noncompliance with protocol|1|||
126273610|NCT00536263|454291125|FG000|Overall Study|Did not meet protocol eligibility|1|||
126273611|NCT00536263|454291126|FG001|Overall Study|Did not meet protocol eligibility|2|||
126273612|NCT00536263|454291127|FG002|Overall Study|Did not meet protocol eligibility|2|||
126273613|NCT03285308|454291138|FG000|Overall Study|Adverse Event|3|||
126273614|NCT03285308|454291139|FG001|Overall Study|Adverse Event|7|||
126273615|NCT03285308|454291138|FG000|Overall Study|Withdrawal by Subject|8|||
126273616|NCT03285308|454291139|FG001|Overall Study|Withdrawal by Subject|9|||
126273617|NCT03285308|454291138|FG000|Overall Study|Lost to Follow-up|3|||
126273618|NCT03285308|454291139|FG001|Overall Study|Lost to Follow-up|1|||
126273619|NCT03285308|454291138|FG000|Overall Study|Protocol Deviation|6|||
126273620|NCT03285308|454291139|FG001|Overall Study|Protocol Deviation|5|||
126273621|NCT03285308|454291138|FG000|Overall Study|Reason not Specified|0|||
126273622|NCT03285308|454291139|FG001|Overall Study|Reason not Specified|1|||
126273623|NCT03734666|454291143|FG000|Overall Study|Other|7|||
126273624|NCT03734666|454291144|FG001|Overall Study|Other|4|||
126273625|NCT03734666|454291143|FG000|Overall Study|Lost to Follow-up|12|||
126273626|NCT03734666|454291144|FG001|Overall Study|Lost to Follow-up|12|||
126273627|NCT00681590|454291145|FG000|Overall Study|Withdrawal by Subject|2|||
126273628|NCT00681590|454291146|FG001|Overall Study|Withdrawal by Subject|12|||
126273629|NCT01898650|454291148|FG000|Overall Study|the subject would not lie still for imaging|1|||
126273630|NCT01181271|454291153|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
126273631|NCT01181271|454291153|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
126273632|NCT01181271|454291153|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
126273633|NCT01181271|454291153|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
126273634|NCT04156620|454291154|FG000|Overall Study|Adverse event - TP 1|5|||
126273635|NCT04156620|454291155|FG001|Overall Study|Adverse event - TP 1|2|||
126273636|NCT04156620|454291154|FG000|Overall Study|Lost to follow-up TP 1|1|||
126273637|NCT04156620|454291155|FG001|Overall Study|Lost to follow-up TP 1|1|||
126273638|NCT04156620|454291154|FG000|Overall Study|Progressive disease - TP 1|0|||
126273639|NCT04156620|454291155|FG001|Overall Study|Progressive disease - TP 1|1|||
126273640|NCT04156620|454291154|FG000|Overall Study|Subject decision - TP 1|3|||
126273641|NCT04156620|454291155|FG001|Overall Study|Subject decision - TP 1|5|||
126273642|NCT04156620|454291154|FG000|Overall Study|Adverse event - TP 2|5|||
126273643|NCT04156620|454291155|FG001|Overall Study|Adverse event - TP 2|6|||
126273644|NCT04156620|454291154|FG000|Overall Study|Death - TP 2|1|||
126273645|NCT04156620|454291155|FG001|Overall Study|Death - TP 2|0|||
126273646|NCT04156620|454291154|FG000|Overall Study|Lost to follow-up - TP 2|5|||
126273647|NCT04156620|454291155|FG001|Overall Study|Lost to follow-up - TP 2|2|||
126273648|NCT04156620|454291154|FG000|Overall Study|Physician decision - TP 2|4|||
126273649|NCT04156620|454291155|FG001|Overall Study|Physician decision - TP 2|2|||
126273650|NCT04156620|454291154|FG000|Overall Study|Pregnancy - TP 2|1|||
126273651|NCT04156620|454291155|FG001|Overall Study|Pregnancy - TP 2|1|||
126273652|NCT04156620|454291154|FG000|Overall Study|Subject decision - TP 2|11|||
126273653|NCT04156620|454291155|FG001|Overall Study|Subject decision - TP 2|9|||
126273654|NCT04156620|454291154|FG000|Overall Study|New therapy for study indication - TP 2|1|||
126273655|NCT04156620|454291155|FG001|Overall Study|New therapy for study indication - TP 2|0|||
126273656|NCT04135196|454291156|FG000|Overall Study|Lost to Follow-up|8|||
126273657|NCT04135196|454291157|FG001|Overall Study|Lost to Follow-up|7|||
126273658|NCT04135196|454291158|FG002|Overall Study|Lost to Follow-up|8|||
126273659|NCT04135196|454291159|FG003|Overall Study|Lost to Follow-up|9|||
126273660|NCT04135196|454291160|FG004|Overall Study|Lost to Follow-up|1|||
126273661|NCT04135196|454291156|FG000|Overall Study|Pregnancy|0|||
126273662|NCT04135196|454291157|FG001|Overall Study|Pregnancy|0|||
126547403|NCT00244374|455297934|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
126273663|NCT04135196|454291158|FG002|Overall Study|Pregnancy|1|||
126273664|NCT04135196|454291159|FG003|Overall Study|Pregnancy|0|||
126273665|NCT04135196|454291160|FG004|Overall Study|Pregnancy|0|||
126273666|NCT04135196|454291156|FG000|Overall Study|Withdrawal by Subject|0|||
126273667|NCT04135196|454291157|FG001|Overall Study|Withdrawal by Subject|0|||
126273668|NCT04135196|454291158|FG002|Overall Study|Withdrawal by Subject|0|||
126273669|NCT04135196|454291159|FG003|Overall Study|Withdrawal by Subject|0|||
126705958|NCT00488631|455875513|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
126273670|NCT04135196|454291160|FG004|Overall Study|Withdrawal by Subject|1|||
126273671|NCT01753336|454291162|FG000|Overall Study|Patient decision|12|||
126273672|NCT01753336|454291162|FG000|Overall Study|Lost to Follow-up|3|||
126453679|NCT01185353|454961514|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
126705959|NCT00488631|455875504|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
126705960|NCT00488631|455875505|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
126705961|NCT00488631|455875506|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
126705962|NCT00488631|455875507|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
126705963|NCT00488631|455875508|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
126705964|NCT00488631|455875509|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
126705965|NCT00488631|455875510|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
126705966|NCT00488631|455875511|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
126273673|NCT01753336|454291162|FG000|Overall Study|Physician Decision|2|||
126273674|NCT01753336|454291162|FG000|Overall Study|Sponsor's decision|2|||
126273675|NCT01753336|454291162|FG000|Overall Study|Withdrawal by Subject|1|||
126273676|NCT00914459|454291163|FG000|Overall Study|Protocol Violation|0|||
126273677|NCT00914459|454291164|FG001|Overall Study|Protocol Violation|1|||
126273678|NCT00914459|454291163|FG000|Overall Study|Parent/Legal guardian request|1|||
126273679|NCT00914459|454291164|FG001|Overall Study|Parent/Legal guardian request|0|||
126273680|NCT01661179|454291168|FG000|Overall Study|Death|1|||
126273681|NCT01661179|454291168|FG000|Overall Study|Withdrawal by Subject|1|||
126273682|NCT01661179|454291168|FG000|Overall Study|Other Eligibility criteria|4|||
126273683|NCT01946191|454291169|FG000|Allocation|Did not complete orientation|1|||
126273684|NCT01946191|454291170|FG001|Allocation|Did not complete orientation|1|||
126273685|NCT01946191|454291169|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
126273686|NCT01946191|454291170|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
126273687|NCT01946191|454291169|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
126273688|NCT01946191|454291170|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
126273689|NCT01946191|454291169|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
126273690|NCT01946191|454291170|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
126273691|NCT01629966|454291171|FG000|Overall Study|Pregnancy|0|||
126273692|NCT01629966|454291172|FG001|Overall Study|Pregnancy|1|||
126273693|NCT01629966|454291173|FG002|Overall Study|Pregnancy|0|||
126273694|NCT01629966|454291171|FG000|Overall Study|Lost to Follow-up|10|||
126273695|NCT01629966|454291172|FG001|Overall Study|Lost to Follow-up|13|||
126273696|NCT01629966|454291173|FG002|Overall Study|Lost to Follow-up|9|||
126273697|NCT01629966|454291171|FG000|Overall Study|Withdrawal by Subject|8|||
126273698|NCT01629966|454291172|FG001|Overall Study|Withdrawal by Subject|9|||
126273699|NCT01629966|454291173|FG002|Overall Study|Withdrawal by Subject|16|||
126273700|NCT01629966|454291171|FG000|Overall Study|Protocol Violation|7|||
126273701|NCT01629966|454291172|FG001|Overall Study|Protocol Violation|9|||
126273702|NCT01629966|454291173|FG002|Overall Study|Protocol Violation|7|||
126273703|NCT01629966|454291171|FG000|Overall Study|Lack of Efficacy|5|||
126273704|NCT01629966|454291172|FG001|Overall Study|Lack of Efficacy|2|||
126273705|NCT01629966|454291173|FG002|Overall Study|Lack of Efficacy|4|||
126273706|NCT01629966|454291171|FG000|Overall Study|Adverse Event|11|||
126273707|NCT01629966|454291172|FG001|Overall Study|Adverse Event|18|||
126273708|NCT01629966|454291173|FG002|Overall Study|Adverse Event|30|||
126273709|NCT04188301|454291181|FG000|Month 3|Lost to Follow-up|0|||
126273710|NCT04188301|454291182|FG001|Month 3|Lost to Follow-up|0|||
126273711|NCT04188301|454291183|FG002|Month 3|Lost to Follow-up|1|||
126273712|NCT04188301|454291181|FG000|Month 12|Lost to Follow-up|0|||
126273713|NCT04188301|454291182|FG001|Month 12|Lost to Follow-up|0|||
126273714|NCT04188301|454291183|FG002|Month 12|Lost to Follow-up|2|||
126273715|NCT04188301|454291181|FG000|Month 12|Death|1|||
126273716|NCT04188301|454291182|FG001|Month 12|Death|1|||
126273717|NCT04188301|454291183|FG002|Month 12|Death|0|||
126273718|NCT04188301|454291181|FG000|Month 18|Lost to Follow-up|6|||
126273719|NCT04188301|454291182|FG001|Month 18|Lost to Follow-up|0|||
126273720|NCT04188301|454291183|FG002|Month 18|Lost to Follow-up|0|||
126273721|NCT00006721|454293875|FG000|Overall Study|Adverse Event|0|||
126273722|NCT00006721|454293876|FG001|Overall Study|Adverse Event|4|||
126273723|NCT00006721|454293877|FG002|Overall Study|Adverse Event|4|||
126273724|NCT00006721|454293875|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
126273725|NCT00006721|454293876|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
126273726|NCT00006721|454293877|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
126273727|NCT00006721|454293875|FG000|Overall Study|Progression/Relapse|0|||
126273728|NCT00006721|454293876|FG001|Overall Study|Progression/Relapse|1|||
126273729|NCT00006721|454293877|FG002|Overall Study|Progression/Relapse|2|||
126273730|NCT00006721|454293875|FG000|Overall Study|Death|0|||
126273731|NCT00006721|454293876|FG001|Overall Study|Death|1|||
126273732|NCT00006721|454293877|FG002|Overall Study|Death|2|||
126273733|NCT00006721|454293875|FG000|Overall Study|Other - Not Protocol Specified|0|||
126306216|NCT02278939|454410240|FG000|Overall Study|Lost to Follow-up|1|||
126306217|NCT02278939|454410241|FG001|Overall Study|Lost to Follow-up|1|||
126306218|NCT02278939|454410240|FG000|Overall Study|death in family|1|||
126306219|NCT02278939|454410241|FG001|Overall Study|death in family|0|||
126306220|NCT02278939|454410240|FG000|Overall Study|family emergency unable to commit|2|||
126306221|NCT02278939|454410241|FG001|Overall Study|family emergency unable to commit|0|||
126306222|NCT01680861|454410246|FG000|Early Post-transplant Period|Protocol Violation|1|||
126306223|NCT01680861|454410247|FG001|Early Post-transplant Period|Protocol Violation|1|||
126273734|NCT00006721|454293876|FG001|Overall Study|Other - Not Protocol Specified|7|||
126273735|NCT00006721|454293877|FG002|Overall Study|Other - Not Protocol Specified|7|||
126273736|NCT00006721|454293875|FG000|Overall Study|Ineligible|2|||
126273737|NCT00006721|454293876|FG001|Overall Study|Ineligible|12|||
126273738|NCT00006721|454293877|FG002|Overall Study|Ineligible|10|||
126273739|NCT00006721|454293875|FG000|Overall Study|Eligible but no Treatment Received|1|||
126273740|NCT00006721|454293876|FG001|Overall Study|Eligible but no Treatment Received|0|||
126273741|NCT00006721|454293877|FG002|Overall Study|Eligible but no Treatment Received|0|||
126273742|NCT01200992|454293886|FG000|Overall Study|Study terminated early|35|||
126273743|NCT01200992|454293887|FG001|Overall Study|Study terminated early|41|||
126273744|NCT01200992|454293886|FG000|Overall Study|Randomized but not treated|2|||
126273745|NCT01200992|454293887|FG001|Overall Study|Randomized but not treated|0|||
126273746|NCT02213510|454293896|FG000|Overall Study|Death|0|||
126273747|NCT02213510|454293897|FG001|Overall Study|Death|1|||
126273748|NCT02213510|454293896|FG000|Overall Study|Lost to Follow-up|1|||
126273749|NCT02213510|454293897|FG001|Overall Study|Lost to Follow-up|0|||
126273750|NCT04241315|454293910|FG000|Overall Study|Withdrawal by Subject|0|||
126273751|NCT04241315|454293911|FG001|Overall Study|Withdrawal by Subject|1|||
126273752|NCT00699283|454293912|FG000|Overall Study|Lack of Efficacy|15|||
126273753|NCT00699283|454293913|FG001|Overall Study|Lack of Efficacy|5|||
126273754|NCT00699283|454293912|FG000|Overall Study|Lost to Follow-up|2|||
126273755|NCT00699283|454293913|FG001|Overall Study|Lost to Follow-up|0|||
126273756|NCT00699283|454293912|FG000|Overall Study|Withdrawal by Subject|1|||
126273757|NCT00699283|454293913|FG001|Overall Study|Withdrawal by Subject|0|||
126273758|NCT00699283|454293912|FG000|Overall Study|Other Reason|5|||
126273759|NCT00699283|454293913|FG001|Overall Study|Other Reason|1|||
126273760|NCT00699283|454293912|FG000|Overall Study|SAE, non-fatal|1|||
126273761|NCT00699283|454293913|FG001|Overall Study|SAE, non-fatal|1|||
126273762|NCT00699283|454293912|FG000|Overall Study|AE, non-serious non-fatal|8|||
126273763|NCT00699283|454293913|FG001|Overall Study|AE, non-serious non-fatal|1|||
126273764|NCT00699283|454293912|FG000|Overall Study|AE of unknown type|1|||
126273765|NCT00699283|454293913|FG001|Overall Study|AE of unknown type|0|||
126273766|NCT00394524|454293914|FG000|Overall Study|Protocol Violation|2|||
126273767|NCT00394524|454293915|FG001|Overall Study|Protocol Violation|3|||
126273768|NCT00394524|454293914|FG000|Overall Study|Death|1|||
126273769|NCT00394524|454293915|FG001|Overall Study|Death|0|||
126273770|NCT00394524|454293914|FG000|Overall Study|Withdrawal by Subject|0|||
126273771|NCT00394524|454293915|FG001|Overall Study|Withdrawal by Subject|1|||
126273772|NCT01398514|454293916|FG000|Overall Study|Adverse Event|1|||
126273773|NCT01398514|454293917|FG001|Overall Study|Adverse Event|0|||
126273774|NCT01398514|454293916|FG000|Overall Study|Non-compliance with study procedures|2|||
126273775|NCT01398514|454293917|FG001|Overall Study|Non-compliance with study procedures|0|||
126273776|NCT01398514|454293916|FG000|Overall Study|Physiologic non-responsiveness|1|||
126273777|NCT01398514|454293917|FG001|Overall Study|Physiologic non-responsiveness|3|||
126273778|NCT01398514|454293916|FG000|Overall Study|Failure to show a conditioned response|4|||
126273779|NCT01398514|454293917|FG001|Overall Study|Failure to show a conditioned response|3|||
126273780|NCT01345175|454293919|FG000|Overall Study|Physician Decision|0|||
126273781|NCT01345175|454293920|FG001|Overall Study|Physician Decision|1|||
126273782|NCT01345175|454293919|FG000|Overall Study|Withdrawal by Subject|1|||
126273783|NCT01345175|454293920|FG001|Overall Study|Withdrawal by Subject|1|||
126273784|NCT01345175|454293919|FG000|Overall Study|Failed to complete BFI|3|||
126362220|NCT01725308|454619097|FG002|Treatment Period II|Worsening of the Target Disease|2|||
126362221|NCT01725308|454619095|FG000|Treatment Period II|Changes in the Episodes|1|||
126362222|NCT01725308|454619096|FG001|Treatment Period II|Changes in the Episodes|0|||
126362223|NCT01725308|454619097|FG002|Treatment Period II|Changes in the Episodes|5|||
126362224|NCT01725308|454619095|FG000|Treatment Period II|Withdrawal of Consent|28|||
126362225|NCT01725308|454619096|FG001|Treatment Period II|Withdrawal of Consent|2|||
126362226|NCT01725308|454619097|FG002|Treatment Period II|Withdrawal of Consent|16|||
126362227|NCT01725308|454619095|FG000|Treatment Period II|Lost to Follow-up|1|||
126362228|NCT01725308|454619096|FG001|Treatment Period II|Lost to Follow-up|5|||
126362229|NCT01725308|454619097|FG002|Treatment Period II|Lost to Follow-up|3|||
126362230|NCT01725308|454619095|FG000|Treatment Period II|Protocol Deviations|0|||
126362231|NCT01725308|454619096|FG001|Treatment Period II|Protocol Deviations|0|||
126362232|NCT01725308|454619097|FG002|Treatment Period II|Protocol Deviations|1|||
126362233|NCT01725308|454619095|FG000|Treatment Period II|Miscellaneous|5|||
126273785|NCT01345175|454293920|FG001|Overall Study|Failed to complete BFI|2|||
126273786|NCT01345175|454293919|FG000|Overall Study|Stopped taking medication|2|||
126273787|NCT01345175|454293920|FG001|Overall Study|Stopped taking medication|2|||
126273788|NCT03537599|454293924|FG000|Overall Study|Disease Progression|2|||
126273789|NCT03537599|454293925|FG001|Overall Study|Disease Progression|1|||
126273790|NCT03537599|454293924|FG000|Overall Study|Death|0|||
126273791|NCT03537599|454293925|FG001|Overall Study|Death|1|||
126273792|NCT01007942|454293926|FG000|Overall Study|Adverse Event|29|||
126273793|NCT01007942|454293927|FG001|Overall Study|Adverse Event|14|||
126362234|NCT01725308|454619096|FG001|Treatment Period II|Miscellaneous|3|||
126362235|NCT01725308|454619097|FG002|Treatment Period II|Miscellaneous|7|||
126362236|NCT04128228|454619098|FG000|Overall Study|Withdrawal by Subject|3|||
126362237|NCT04128228|454619099|FG001|Overall Study|Withdrawal by Subject|3|||
126362238|NCT04128228|454619100|FG002|Overall Study|Withdrawal by Subject|0|||
126362239|NCT04128228|454619101|FG003|Overall Study|Withdrawal by Subject|0|||
126362240|NCT04128228|454619098|FG000|Overall Study|noncompliance|2|||
126362241|NCT04128228|454619099|FG001|Overall Study|noncompliance|2|||
126362242|NCT04128228|454619100|FG002|Overall Study|noncompliance|0|||
126362243|NCT04128228|454619101|FG003|Overall Study|noncompliance|0|||
126362244|NCT03163264|454619102|FG000|Overall Study|Withdrawal by Subject|13|||
126362245|NCT03163264|454619103|FG001|Overall Study|Withdrawal by Subject|3|||
126362246|NCT03163264|454619104|FG002|Overall Study|Withdrawal by Subject|4|||
126362247|NCT03163264|454619105|FG003|Overall Study|Withdrawal by Subject|2|||
126362248|NCT03163264|454619102|FG000|Overall Study|Lost to Follow-up|17|||
126362249|NCT03163264|454619103|FG001|Overall Study|Lost to Follow-up|20|||
126362250|NCT03163264|454619104|FG002|Overall Study|Lost to Follow-up|0|||
126362251|NCT03163264|454619105|FG003|Overall Study|Lost to Follow-up|0|||
126362252|NCT03163264|454619102|FG000|Overall Study|Death|0|||
126362253|NCT03163264|454619103|FG001|Overall Study|Death|2|||
126362254|NCT03163264|454619104|FG002|Overall Study|Death|0|||
126362255|NCT03163264|454619105|FG003|Overall Study|Death|0|||
126362256|NCT00215657|454619108|FG000|Overall Study|Adverse Event|5|||
126362257|NCT00215657|454619109|FG001|Overall Study|Adverse Event|1|||
126362258|NCT00215657|454619110|FG002|Overall Study|Adverse Event|3|||
126362259|NCT00215657|454619111|FG003|Overall Study|Adverse Event|0|||
126362260|NCT00215657|454619112|FG004|Overall Study|Adverse Event|3|||
126362261|NCT00215657|454619113|FG005|Overall Study|Adverse Event|1|||
126362262|NCT00215657|454619114|FG006|Overall Study|Adverse Event|0|||
126362263|NCT00215657|454619115|FG007|Overall Study|Adverse Event|3|||
126362264|NCT00215657|454619108|FG000|Overall Study|Withdrawal by Subject|6|||
126362265|NCT00215657|454619109|FG001|Overall Study|Withdrawal by Subject|3|||
126362266|NCT00215657|454619110|FG002|Overall Study|Withdrawal by Subject|3|||
126362267|NCT00215657|454619111|FG003|Overall Study|Withdrawal by Subject|1|||
126362268|NCT00215657|454619112|FG004|Overall Study|Withdrawal by Subject|6|||
126362269|NCT00215657|454619113|FG005|Overall Study|Withdrawal by Subject|1|||
126362270|NCT00215657|454619114|FG006|Overall Study|Withdrawal by Subject|10|||
126362271|NCT00215657|454619115|FG007|Overall Study|Withdrawal by Subject|3|||
126362272|NCT00215657|454619108|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
126362273|NCT00215657|454619109|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
126362274|NCT00215657|454619110|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
126362275|NCT00215657|454619111|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
126362276|NCT00215657|454619112|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
126362277|NCT00215657|454619113|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
126362278|NCT00215657|454619114|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
126362279|NCT00215657|454619115|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
126362280|NCT00215657|454619108|FG000|Overall Study|Insufficient testosterone response|5|||
126362281|NCT00215657|454619109|FG001|Overall Study|Insufficient testosterone response|4|||
126362282|NCT00215657|454619110|FG002|Overall Study|Insufficient testosterone response|1|||
126362283|NCT00215657|454619111|FG003|Overall Study|Insufficient testosterone response|12|||
126362284|NCT00215657|454619112|FG004|Overall Study|Insufficient testosterone response|8|||
126362285|NCT00215657|454619113|FG005|Overall Study|Insufficient testosterone response|12|||
126362286|NCT00215657|454619114|FG006|Overall Study|Insufficient testosterone response|4|||
126362287|NCT00215657|454619115|FG007|Overall Study|Insufficient testosterone response|7|||
126362288|NCT00215657|454619108|FG000|Overall Study|Other|3|||
126362289|NCT00215657|454619109|FG001|Overall Study|Other|1|||
126362290|NCT00215657|454619110|FG002|Overall Study|Other|2|||
126362291|NCT00215657|454619111|FG003|Overall Study|Other|3|||
126362292|NCT00215657|454619112|FG004|Overall Study|Other|5|||
126362293|NCT00215657|454619113|FG005|Overall Study|Other|4|||
126362294|NCT00215657|454619114|FG006|Overall Study|Other|6|||
126362295|NCT00215657|454619115|FG007|Overall Study|Other|1|||
126362296|NCT03769467|454619116|FG000|Overall Study|Adverse Event|1|||
126453680|NCT01185353|454961515|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
126705967|NCT00488631|455875512|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
126705968|NCT00488631|455875513|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
126705969|NCT00488631|455875504|FG000|Double Blind Period (Week 0-54)|Other|6|||
126453681|NCT01185353|454961516|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
126453682|NCT01185353|454961517|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
126705970|NCT00488631|455875505|FG001|Double Blind Period (Week 0-54)|Other|12|||
126705971|NCT00488631|455875506|FG002|Double Blind Period (Week 0-54)|Other|10|||
126362297|NCT03769467|454619117|FG001|Overall Study|Adverse Event|1|||
126362298|NCT03769467|454619118|FG002|Overall Study|Adverse Event|0|||
126453683|NCT01185353|454961508|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
126362299|NCT03769467|454619116|FG000|Overall Study|Death|3|||
126362300|NCT03769467|454619117|FG001|Overall Study|Death|3|||
126362301|NCT03769467|454619118|FG002|Overall Study|Death|0|||
126362302|NCT03769467|454619116|FG000|Overall Study|Study Terminated By Sponsor|2|||
126362303|NCT03769467|454619117|FG001|Overall Study|Study Terminated By Sponsor|1|||
126362304|NCT03769467|454619118|FG002|Overall Study|Study Terminated By Sponsor|0|||
126362305|NCT03769467|454619116|FG000|Overall Study|Withdrawal by Subject|0|||
126362306|NCT03769467|454619117|FG001|Overall Study|Withdrawal by Subject|1|||
126362307|NCT03769467|454619118|FG002|Overall Study|Withdrawal by Subject|0|||
126362308|NCT02614066|454619119|FG000|Overall Study|Death|6|||
126362309|NCT02614066|454619120|FG001|Overall Study|Death|14|||
126362310|NCT02614066|454619121|FG002|Overall Study|Death|11|||
126362311|NCT02614066|454619122|FG003|Overall Study|Death|29|||
126362312|NCT02614066|454619119|FG000|Overall Study|Full consent withdrawn|0|||
126362313|NCT02614066|454619120|FG001|Overall Study|Full consent withdrawn|1|||
126362314|NCT02614066|454619121|FG002|Overall Study|Full consent withdrawn|0|||
126362315|NCT02614066|454619122|FG003|Overall Study|Full consent withdrawn|8|||
126362316|NCT02614066|454619119|FG000|Overall Study|Lost to Follow-up|0|||
126362317|NCT02614066|454619120|FG001|Overall Study|Lost to Follow-up|2|||
126362318|NCT02614066|454619121|FG002|Overall Study|Lost to Follow-up|2|||
126362319|NCT02614066|454619122|FG003|Overall Study|Lost to Follow-up|2|||
126362320|NCT02614066|454619119|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
126362321|NCT02614066|454619120|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
126362322|NCT02614066|454619121|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
126362323|NCT02614066|454619122|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
126362324|NCT02614066|454619119|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
126362325|NCT02614066|454619120|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
126362326|NCT02614066|454619121|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
126362327|NCT02614066|454619122|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
126362328|NCT02614066|454619119|FG000|Overall Study|Reason not specified|0|||
126362329|NCT02614066|454619120|FG001|Overall Study|Reason not specified|2|||
126362330|NCT02614066|454619121|FG002|Overall Study|Reason not specified|1|||
126362331|NCT02614066|454619122|FG003|Overall Study|Reason not specified|1|||
126362332|NCT04565756|454619123|FG000|Overall Study|Withdrawal by Subject|0|||
126362333|NCT04565756|454619124|FG001|Overall Study|Withdrawal by Subject|0|||
126362334|NCT04565756|454619125|FG002|Overall Study|Withdrawal by Subject|0|||
126362335|NCT04565756|454619126|FG003|Overall Study|Withdrawal by Subject|0|||
126362336|NCT04565756|454619127|FG004|Overall Study|Withdrawal by Subject|1|||
126362337|NCT04565756|454619128|FG005|Overall Study|Withdrawal by Subject|0|||
126362338|NCT04565756|454619123|FG000|Overall Study|Protocol Violation|0|||
126362339|NCT04565756|454619124|FG001|Overall Study|Protocol Violation|0|||
126362340|NCT04565756|454619125|FG002|Overall Study|Protocol Violation|0|||
126273794|NCT01007942|454293926|FG000|Overall Study|Abnormal test procedure|0|||
126273795|NCT01007942|454293927|FG001|Overall Study|Abnormal test procedure|1|||
126273796|NCT01007942|454293926|FG000|Overall Study|Disease progression|217|||
126273797|NCT01007942|454293927|FG001|Overall Study|Disease progression|242|||
126273798|NCT01007942|454293926|FG000|Overall Study|New cancer therapy|5|||
126273799|NCT01007942|454293927|FG001|Overall Study|New cancer therapy|1|||
126273800|NCT01007942|454293926|FG000|Overall Study|Protocol Violation|1|||
126273801|NCT01007942|454293927|FG001|Overall Study|Protocol Violation|1|||
126273802|NCT01007942|454293926|FG000|Overall Study|Withdrawal by Subject|19|||
126273803|NCT01007942|454293927|FG001|Overall Study|Withdrawal by Subject|14|||
126273804|NCT01007942|454293926|FG000|Overall Study|Lost to Follow-up|1|||
126273805|NCT01007942|454293927|FG001|Overall Study|Lost to Follow-up|0|||
126273806|NCT01007942|454293926|FG000|Overall Study|Administrative problems|2|||
126273807|NCT01007942|454293927|FG001|Overall Study|Administrative problems|0|||
126273808|NCT01007942|454293926|FG000|Overall Study|Death|3|||
126273809|NCT01007942|454293927|FG001|Overall Study|Death|2|||
126273810|NCT01007942|454293926|FG000|Overall Study|Patients untreated|4|||
126273811|NCT01007942|454293927|FG001|Overall Study|Patients untreated|3|||
126273812|NCT05083585|454293932|FG000|Overall Study|Death|1|||
126273813|NCT05083585|454293933|FG001|Overall Study|Death|1|||
126273814|NCT05083585|454293932|FG000|Overall Study|Lost to Follow-up|1|||
126273815|NCT05083585|454293933|FG001|Overall Study|Lost to Follow-up|1|||
126273816|NCT05083585|454293932|FG000|Overall Study|Withdrawal by Subject|2|||
126273817|NCT05083585|454293933|FG001|Overall Study|Withdrawal by Subject|0|||
126273818|NCT05083585|454293932|FG000|Overall Study|Randomized but not vaccinated|2|||
126273819|NCT05083585|454293933|FG001|Overall Study|Randomized but not vaccinated|0|||
126362341|NCT04565756|454619126|FG003|Overall Study|Protocol Violation|0|||
126362342|NCT04565756|454619127|FG004|Overall Study|Protocol Violation|0|||
126362343|NCT04565756|454619128|FG005|Overall Study|Protocol Violation|1|||
126453684|NCT01185353|454961509|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
126453685|NCT01185353|454961510|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
126273820|NCT03929757|454293934|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
126273821|NCT03929757|454293935|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
126273822|NCT03929757|454293936|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
126273823|NCT03929757|454293934|FG000|Main Study: Up to Day 365|Other|1|||
126362344|NCT03069937|454619137|FG000|Overall Study|Second primary malignancy noted|1|||
126362345|NCT00968968|454619138|FG000|Overall Study|Study closed/terminated|10|||
126362346|NCT00968968|454619139|FG001|Overall Study|Study closed/terminated|10|||
126362347|NCT00968968|454619138|FG000|Overall Study|Protocol defined stopping criteria|3|||
126273824|NCT03929757|454293935|FG001|Main Study: Up to Day 365|Other|0|||
126273825|NCT03929757|454293936|FG002|Main Study: Up to Day 365|Other|0|||
126273826|NCT03929757|454293934|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
126273827|NCT03929757|454293935|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
126273828|NCT03929757|454293936|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
126273829|NCT00114166|454293938|FG000|Overall Study|Wrong primary|0|||
126273830|NCT00114166|454293939|FG001|Overall Study|Wrong primary|1|||
126273831|NCT00806286|454293945|FG000|Overall Study|Adverse Event|5|||
126273832|NCT00806286|454293946|FG001|Overall Study|Adverse Event|2|||
126273833|NCT00806286|454293947|FG002|Overall Study|Adverse Event|0|||
126273834|NCT00806286|454293945|FG000|Overall Study|Disease progression|31|||
126273835|NCT00806286|454293946|FG001|Overall Study|Disease progression|38|||
126273836|NCT00806286|454293947|FG002|Overall Study|Disease progression|1|||
126273837|NCT00806286|454293945|FG000|Overall Study|Death|1|||
126273838|NCT00806286|454293946|FG001|Overall Study|Death|6|||
126273839|NCT00806286|454293947|FG002|Overall Study|Death|0|||
126273840|NCT00806286|454293945|FG000|Overall Study|Lost to Follow-up|0|||
126273841|NCT00806286|454293946|FG001|Overall Study|Lost to Follow-up|1|||
126273842|NCT00806286|454293947|FG002|Overall Study|Lost to Follow-up|0|||
126273843|NCT00806286|454293945|FG000|Overall Study|Withdrawal by Subject|8|||
126273844|NCT00806286|454293946|FG001|Overall Study|Withdrawal by Subject|3|||
126273845|NCT00806286|454293947|FG002|Overall Study|Withdrawal by Subject|1|||
126273846|NCT00806286|454293945|FG000|Overall Study|Physician Decision|2|||
126273847|NCT00806286|454293946|FG001|Overall Study|Physician Decision|2|||
126273848|NCT00806286|454293947|FG002|Overall Study|Physician Decision|0|||
126273849|NCT00806286|454293945|FG000|Overall Study|Due to a variety of reasons|7|||
126273850|NCT00806286|454293946|FG001|Overall Study|Due to a variety of reasons|2|||
126273851|NCT00806286|454293947|FG002|Overall Study|Due to a variety of reasons|1|||
126273852|NCT03402750|454293948|FG000|Overall Study|Lost to Follow-up|2|||
126273853|NCT03402750|454293949|FG001|Overall Study|Lost to Follow-up|1|||
126273854|NCT03469336|454293950|FG000|Overall Study|Adverse Event|1|||
126273855|NCT02628743|454293952|FG000|Overall Study|Other|3|||
126273856|NCT02628743|454293952|FG000|Overall Study|Withdrawal by Subject|50|||
126273857|NCT02628743|454293952|FG000|Overall Study|Study Terminated by Sponsor|76|||
126273858|NCT02628743|454293952|FG000|Overall Study|Physician Decision|2|||
126273859|NCT02534844|454293953|FG000|Part B|Withdrawal by Subject|0|||
126273860|NCT02534844|454293954|FG001|Part B|Withdrawal by Subject|0|||
126273861|NCT02534844|454293955|FG002|Part B|Withdrawal by Subject|0|||
126273862|NCT02534844|454293956|FG003|Part B|Withdrawal by Subject|0|||
126273863|NCT02534844|454293957|FG004|Part B|Withdrawal by Subject|2|||
126273864|NCT02534844|454293958|FG005|Part B|Withdrawal by Subject|1|||
126273865|NCT03560986|454293959|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
126273866|NCT03560986|454293960|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
126273867|NCT03560986|454293959|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
126273868|NCT03560986|454293960|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
126273869|NCT03560986|454293959|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
126273870|NCT03560986|454293960|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
126273871|NCT03560986|454293959|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
126273872|NCT03560986|454293960|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
126273873|NCT03560986|454293959|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
126273874|NCT03560986|454293960|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
126273875|NCT03560986|454293959|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
126273876|NCT03560986|454293960|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
126273877|NCT03560986|454293959|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
126273878|NCT03560986|454293960|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
126273879|NCT00593736|454293972|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
126273880|NCT00593736|454293973|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
126273881|NCT00593736|454293974|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
126273882|NCT00593736|454293975|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
126273883|NCT00593736|454293972|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
126273884|NCT00593736|454293973|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
126273885|NCT00593736|454293974|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
126273886|NCT00593736|454293975|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
126273887|NCT00593736|454293972|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
126273888|NCT00593736|454293973|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
126273889|NCT00593736|454293974|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
126273890|NCT00593736|454293975|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
126273891|NCT00593736|454293972|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
126273892|NCT00593736|454293973|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
126273893|NCT00593736|454293974|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
126273894|NCT00593736|454293975|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
126273895|NCT00593736|454293972|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
126273896|NCT00593736|454293973|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
126273897|NCT00593736|454293974|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
126273898|NCT00593736|454293975|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
126273899|NCT00593736|454293972|FG000|Screening Period and Placebo Run-in|Various|0|||
126273900|NCT00593736|454293973|FG001|Screening Period and Placebo Run-in|Various|0|||
126273901|NCT00593736|454293974|FG002|Screening Period and Placebo Run-in|Various|0|||
126273902|NCT00593736|454293975|FG003|Screening Period and Placebo Run-in|Various|25|||
126273903|NCT00593736|454293972|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
126273904|NCT00593736|454293973|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
126273905|NCT00593736|454293974|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
126273906|NCT00593736|454293975|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
126273907|NCT00593736|454293972|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
126273908|NCT00593736|454293973|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
126273909|NCT00593736|454293974|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
126273910|NCT00593736|454293975|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
126273911|NCT00593736|454293972|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
126273912|NCT00593736|454293973|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
126273913|NCT00593736|454293974|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
126273914|NCT00593736|454293975|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
126273915|NCT00593736|454293972|FG000|Treatment Period and Placebo Run-out|Various|1|||
126273916|NCT00593736|454293973|FG001|Treatment Period and Placebo Run-out|Various|1|||
126273917|NCT00593736|454293974|FG002|Treatment Period and Placebo Run-out|Various|1|||
126273918|NCT00593736|454293975|FG003|Treatment Period and Placebo Run-out|Various|0|||
126273919|NCT01857271|454293976|FG000|Overall Study|Lost to Follow-up|1|||
126273920|NCT03493386|454293977|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126273921|NCT03493386|454293978|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
126453686|NCT01185353|454961511|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
126453687|NCT01185353|454961512|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
126453688|NCT01185353|454961513|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
126453689|NCT01185353|454961514|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
126453690|NCT01185353|454961515|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
126453691|NCT01185353|454961516|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
126453692|NCT01185353|454961517|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
126453693|NCT01185353|454961508|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
126453694|NCT01185353|454961509|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
126453695|NCT01185353|454961510|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
126453696|NCT01185353|454961511|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
126453697|NCT01185353|454961512|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
126453698|NCT01185353|454961513|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
126453699|NCT01185353|454961514|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
126453700|NCT01185353|454961515|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
126453701|NCT01185353|454961516|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
126453702|NCT01185353|454961517|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
126453703|NCT01185353|454961508|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
126453704|NCT01185353|454961509|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
126453705|NCT01185353|454961510|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
126453706|NCT01185353|454961511|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
126453707|NCT01185353|454961512|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
126705972|NCT00488631|455875507|FG003|Double Blind Period (Week 0-54)|Other|11|||
126705973|NCT00488631|455875508|FG004|Double Blind Period (Week 0-54)|Other|14|||
126705974|NCT00488631|455875509|FG005|Double Blind Period (Week 0-54)|Other|34|||
126705975|NCT00488631|455875510|FG006|Double Blind Period (Week 0-54)|Other|0|||
126273922|NCT03493386|454293979|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126273923|NCT03493386|454293980|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126273924|NCT03825341|454293981|FG000|Overall Study|Withdrawal by Subject|0|||
126453708|NCT01185353|454961513|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
126453709|NCT01185353|454961514|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
126453710|NCT01185353|454961515|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
126453711|NCT01185353|454961516|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
126453712|NCT01185353|454961517|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
126453713|NCT01185353|454961508|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
126453714|NCT01185353|454961509|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
126273925|NCT03825341|454293982|FG001|Overall Study|Withdrawal by Subject|1|||
126273926|NCT00289536|454293984|FG000|Period 3|Lost to Follow-up|0|||
126453715|NCT01185353|454961510|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
126453716|NCT01185353|454961511|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
126453717|NCT01185353|454961512|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
126453718|NCT01185353|454961513|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
126705976|NCT00488631|455875511|FG007|Double Blind Period (Week 0-54)|Other|0|||
126273927|NCT00289536|454293985|FG001|Period 3|Lost to Follow-up|0|||
126273928|NCT00289536|454293986|FG002|Period 3|Lost to Follow-up|1|||
126273929|NCT02116608|454293988|FG000|Overall Study|Lost to Follow-up|0|||
126273930|NCT02116608|454293989|FG001|Overall Study|Lost to Follow-up|0|||
126273931|NCT02116608|454293990|FG002|Overall Study|Lost to Follow-up|1|||
126273932|NCT02116608|454293988|FG000|Overall Study|Physician Decision|0|||
126273933|NCT02116608|454293989|FG001|Overall Study|Physician Decision|1|||
126273934|NCT02116608|454293990|FG002|Overall Study|Physician Decision|0|||
126273935|NCT02116608|454293988|FG000|Overall Study|Death|0|||
126273936|NCT02116608|454293989|FG001|Overall Study|Death|1|||
126273937|NCT02116608|454293990|FG002|Overall Study|Death|0|||
126273938|NCT04053465|454293994|FG000|Overall Study|Withdrawal by Subject|4|||
126273939|NCT04053465|454293995|FG001|Overall Study|Withdrawal by Subject|4|||
126273940|NCT02338193|454293997|FG000|Overall Study|Withdrawal by Subject|0|||
126273941|NCT02338193|454293998|FG001|Overall Study|Withdrawal by Subject|0|||
126273942|NCT02338193|454293999|FG002|Overall Study|Withdrawal by Subject|2|||
126273943|NCT02338193|454293997|FG000|Overall Study|Pregnancy|0|||
126273944|NCT02338193|454293998|FG001|Overall Study|Pregnancy|1|||
126273945|NCT02338193|454293999|FG002|Overall Study|Pregnancy|1|||
126273946|NCT02338193|454293997|FG000|Overall Study|Noncompliant with visits|2|||
126273947|NCT02338193|454293998|FG001|Overall Study|Noncompliant with visits|2|||
126273948|NCT02338193|454293999|FG002|Overall Study|Noncompliant with visits|7|||
126273949|NCT02338193|454293997|FG000|Overall Study|moved out of state|0|||
126273950|NCT02338193|454293998|FG001|Overall Study|moved out of state|1|||
126273951|NCT02338193|454293999|FG002|Overall Study|moved out of state|0|||
126273952|NCT02338193|454293997|FG000|Overall Study|intolerant of side effects|1|||
126273953|NCT02338193|454293998|FG001|Overall Study|intolerant of side effects|0|||
126273954|NCT02338193|454293999|FG002|Overall Study|intolerant of side effects|0|||
126273955|NCT01140503|454294001|FG000|Overall Study|Withdrawal by Subject|1|||
126273956|NCT03201211|454294002|FG000|Overall Study|Adverse Event|1|||
126273957|NCT03201211|454294003|FG001|Overall Study|Adverse Event|0|||
126273958|NCT03201211|454294004|FG002|Overall Study|Adverse Event|0|||
126273959|NCT03201211|454294002|FG000|Overall Study|Protocol Violation|1|||
126273960|NCT03201211|454294003|FG001|Overall Study|Protocol Violation|0|||
126273961|NCT03201211|454294004|FG002|Overall Study|Protocol Violation|0|||
126273962|NCT03201211|454294002|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126273963|NCT03201211|454294003|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126273964|NCT03201211|454294004|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
126273965|NCT03201211|454294002|FG000|Overall Study|OTHER unknown reasons|0|||
126273966|NCT03201211|454294003|FG001|Overall Study|OTHER unknown reasons|1|||
126273967|NCT03201211|454294004|FG002|Overall Study|OTHER unknown reasons|0|||
126273968|NCT01083810|454294005|FG000|Overall Study|Lost to Follow-up|23|||
126273969|NCT01083810|454294006|FG001|Overall Study|Lost to Follow-up|11|||
126273970|NCT01083810|454294007|FG002|Overall Study|Lost to Follow-up|4|||
126273971|NCT01083810|454294005|FG000|Overall Study|Adverse Event|15|||
126273972|NCT01083810|454294006|FG001|Overall Study|Adverse Event|11|||
126273973|NCT01083810|454294007|FG002|Overall Study|Adverse Event|4|||
126273974|NCT01083810|454294005|FG000|Overall Study|Withdrawal by Subject|7|||
126273975|NCT01083810|454294006|FG001|Overall Study|Withdrawal by Subject|2|||
126273976|NCT01083810|454294007|FG002|Overall Study|Withdrawal by Subject|4|||
126273977|NCT01083810|454294005|FG000|Overall Study|Reason not reported|6|||
126273978|NCT01083810|454294006|FG001|Overall Study|Reason not reported|1|||
126273979|NCT01083810|454294007|FG002|Overall Study|Reason not reported|1|||
126273980|NCT01083810|454294005|FG000|Overall Study|Non-compliance|4|||
126273981|NCT01083810|454294006|FG001|Overall Study|Non-compliance|7|||
126273982|NCT01083810|454294007|FG002|Overall Study|Non-compliance|2|||
126273983|NCT01083810|454294005|FG000|Overall Study|Simplification|4|||
126273984|NCT01083810|454294006|FG001|Overall Study|Simplification|1|||
126273985|NCT01083810|454294007|FG002|Overall Study|Simplification|0|||
126273986|NCT01083810|454294005|FG000|Overall Study|Death|2|||
126273987|NCT01083810|454294006|FG001|Overall Study|Death|2|||
126273988|NCT01083810|454294007|FG002|Overall Study|Death|3|||
126273989|NCT01083810|454294005|FG000|Overall Study|Co-morbidities|1|||
126273990|NCT01083810|454294006|FG001|Overall Study|Co-morbidities|0|||
126273991|NCT01083810|454294007|FG002|Overall Study|Co-morbidities|0|||
126273992|NCT01083810|454294005|FG000|Overall Study|Participation in study|1|||
126273993|NCT01083810|454294006|FG001|Overall Study|Participation in study|0|||
126273994|NCT01083810|454294007|FG002|Overall Study|Participation in study|0|||
126273995|NCT01083810|454294005|FG000|Overall Study|Therapy break|1|||
126273996|NCT01083810|454294006|FG001|Overall Study|Therapy break|2|||
126273997|NCT01083810|454294007|FG002|Overall Study|Therapy break|2|||
126273998|NCT01083810|454294005|FG000|Overall Study|Virologic failure|1|||
126273999|NCT01083810|454294006|FG001|Overall Study|Virologic failure|8|||
126274000|NCT01083810|454294007|FG002|Overall Study|Virologic failure|0|||
126274001|NCT02991430|454294010|FG000|Treatment Period 1|Adverse Event|1|||
126274002|NCT02991430|454294011|FG001|Treatment Period 1|Adverse Event|0|||
126274003|NCT02991430|454294012|FG002|Treatment Period 1|Adverse Event|2|||
126274004|NCT02991430|454294010|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126274005|NCT02991430|454294011|FG001|Treatment Period 1|Withdrawal by Subject|4|||
126274006|NCT02991430|454294012|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126274007|NCT02991430|454294010|FG000|Treatment Period 2|Study Termination|6|||
126274008|NCT02991430|454294011|FG001|Treatment Period 2|Study Termination|3|||
126274009|NCT02991430|454294012|FG002|Treatment Period 2|Study Termination|3|||
126274010|NCT02991430|454294010|FG000|Treatment Period 2|Lost to Follow-up|0|||
126274011|NCT02991430|454294011|FG001|Treatment Period 2|Lost to Follow-up|0|||
126274012|NCT02991430|454294012|FG002|Treatment Period 2|Lost to Follow-up|1|||
126274013|NCT02991430|454294010|FG000|Post-treatment Observation Period|Study Termination|3|||
126274014|NCT02991430|454294011|FG001|Post-treatment Observation Period|Study Termination|6|||
126274015|NCT02991430|454294012|FG002|Post-treatment Observation Period|Study Termination|5|||
126274016|NCT03118570|454294013|FG000|Overall Study|Adverse Event|2|||
126274017|NCT03118570|454294014|FG001|Overall Study|Adverse Event|0|||
126274018|NCT03118570|454294015|FG002|Overall Study|Adverse Event|0|||
126274019|NCT03118570|454294016|FG003|Overall Study|Adverse Event|0|||
126274020|NCT03118570|454294017|FG004|Overall Study|Adverse Event|3|||
126274021|NCT03118570|454294013|FG000|Overall Study|Withdrawal by Subject|0|||
126274022|NCT03118570|454294014|FG001|Overall Study|Withdrawal by Subject|1|||
126274023|NCT03118570|454294015|FG002|Overall Study|Withdrawal by Subject|4|||
126274024|NCT03118570|454294016|FG003|Overall Study|Withdrawal by Subject|0|||
126274025|NCT03118570|454294017|FG004|Overall Study|Withdrawal by Subject|1|||
126274026|NCT03118570|454294013|FG000|Overall Study|Lost to Follow-up|2|||
126274027|NCT03118570|454294014|FG001|Overall Study|Lost to Follow-up|3|||
126274028|NCT03118570|454294015|FG002|Overall Study|Lost to Follow-up|1|||
126274029|NCT03118570|454294016|FG003|Overall Study|Lost to Follow-up|0|||
126274030|NCT03118570|454294017|FG004|Overall Study|Lost to Follow-up|1|||
126274031|NCT03118570|454294013|FG000|Overall Study|Other, Not Specified|1|||
126274032|NCT03118570|454294014|FG001|Overall Study|Other, Not Specified|3|||
126274033|NCT03118570|454294015|FG002|Overall Study|Other, Not Specified|0|||
126274034|NCT03118570|454294016|FG003|Overall Study|Other, Not Specified|0|||
126274035|NCT03118570|454294017|FG004|Overall Study|Other, Not Specified|0|||
126274036|NCT03970837|454294018|FG000|Overall Study|Adverse Event|23|||
126274037|NCT03970837|454294019|FG001|Overall Study|Adverse Event|20|||
126274038|NCT03970837|454294020|FG002|Overall Study|Adverse Event|16|||
126274039|NCT03970837|454294021|FG003|Overall Study|Adverse Event|6|||
126274040|NCT03970837|454294022|FG004|Overall Study|Adverse Event|4|||
126274041|NCT03970837|454294023|FG005|Overall Study|Adverse Event|5|||
126274042|NCT03970837|454294024|FG006|Overall Study|Adverse Event|1|||
126274043|NCT03970837|454294025|FG007|Overall Study|Adverse Event|5|||
126274044|NCT03970837|454294026|FG008|Overall Study|Adverse Event|0|||
126274045|NCT03970837|454294027|FG009|Overall Study|Adverse Event|0|||
126274046|NCT03970837|454294028|FG010|Overall Study|Adverse Event|1|||
126274047|NCT03970837|454294029|FG011|Overall Study|Adverse Event|1|||
126274048|NCT03970837|454294018|FG000|Overall Study|Lack of Efficacy|14|||
126274049|NCT03970837|454294019|FG001|Overall Study|Lack of Efficacy|12|||
126274050|NCT03970837|454294020|FG002|Overall Study|Lack of Efficacy|1|||
126274051|NCT03970837|454294021|FG003|Overall Study|Lack of Efficacy|2|||
126274052|NCT03970837|454294022|FG004|Overall Study|Lack of Efficacy|3|||
126274053|NCT03970837|454294023|FG005|Overall Study|Lack of Efficacy|4|||
126274054|NCT03970837|454294024|FG006|Overall Study|Lack of Efficacy|6|||
126274055|NCT03970837|454294025|FG007|Overall Study|Lack of Efficacy|1|||
126274056|NCT03970837|454294026|FG008|Overall Study|Lack of Efficacy|1|||
126274057|NCT03970837|454294027|FG009|Overall Study|Lack of Efficacy|0|||
126274058|NCT03970837|454294028|FG010|Overall Study|Lack of Efficacy|0|||
126274059|NCT03970837|454294029|FG011|Overall Study|Lack of Efficacy|0|||
126274060|NCT03970837|454294018|FG000|Overall Study|Lost to Follow-up|6|||
126274061|NCT03970837|454294019|FG001|Overall Study|Lost to Follow-up|5|||
126274062|NCT03970837|454294020|FG002|Overall Study|Lost to Follow-up|5|||
126274063|NCT03970837|454294021|FG003|Overall Study|Lost to Follow-up|1|||
126274064|NCT03970837|454294022|FG004|Overall Study|Lost to Follow-up|0|||
126362348|NCT00968968|454619139|FG001|Overall Study|Protocol defined stopping criteria|1|||
126362349|NCT00968968|454619138|FG000|Overall Study|Withdrawal by Subject|2|||
126274065|NCT03970837|454294023|FG005|Overall Study|Lost to Follow-up|2|||
126274066|NCT03970837|454294024|FG006|Overall Study|Lost to Follow-up|0|||
126274067|NCT03970837|454294025|FG007|Overall Study|Lost to Follow-up|0|||
126274068|NCT03970837|454294026|FG008|Overall Study|Lost to Follow-up|0|||
126705977|NCT00488631|455875512|FG008|Double Blind Period (Week 0-54)|Other|0|||
126705978|NCT00488631|455875513|FG009|Double Blind Period (Week 0-54)|Other|0|||
126274069|NCT03970837|454294027|FG009|Overall Study|Lost to Follow-up|0|||
126274070|NCT03970837|454294028|FG010|Overall Study|Lost to Follow-up|0|||
126274071|NCT03970837|454294029|FG011|Overall Study|Lost to Follow-up|0|||
126274072|NCT03970837|454294018|FG000|Overall Study|Protocol Violation|1|||
126274073|NCT03970837|454294019|FG001|Overall Study|Protocol Violation|0|||
126274074|NCT03970837|454294020|FG002|Overall Study|Protocol Violation|0|||
126274075|NCT03970837|454294021|FG003|Overall Study|Protocol Violation|0|||
126274076|NCT03970837|454294022|FG004|Overall Study|Protocol Violation|0|||
126274077|NCT03970837|454294023|FG005|Overall Study|Protocol Violation|0|||
126274078|NCT03970837|454294024|FG006|Overall Study|Protocol Violation|0|||
126274079|NCT03970837|454294025|FG007|Overall Study|Protocol Violation|0|||
126362350|NCT00968968|454619139|FG001|Overall Study|Withdrawal by Subject|0|||
126362351|NCT00968968|454619138|FG000|Overall Study|Physician Decision|1|||
126362352|NCT00968968|454619139|FG001|Overall Study|Physician Decision|2|||
126362353|NCT00968968|454619138|FG000|Overall Study|Lost to Follow-up|0|||
126362354|NCT00968968|454619139|FG001|Overall Study|Lost to Follow-up|1|||
126362355|NCT03624036|454619140|FG000|Overall Study|Death|2|||
126362356|NCT03624036|454619141|FG001|Overall Study|Death|3|||
126362357|NCT03624036|454619142|FG002|Overall Study|Death|0|||
126362358|NCT03624036|454619143|FG003|Overall Study|Death|1|||
126362359|NCT03624036|454619140|FG000|Overall Study|Withdrawal by Subject|1|||
126362360|NCT03624036|454619141|FG001|Overall Study|Withdrawal by Subject|0|||
126362361|NCT03624036|454619142|FG002|Overall Study|Withdrawal by Subject|1|||
126362362|NCT03624036|454619143|FG003|Overall Study|Withdrawal by Subject|0|||
126362363|NCT03624036|454619140|FG000|Overall Study|Enrolled but Never Treated|1|||
126362364|NCT03624036|454619141|FG001|Overall Study|Enrolled but Never Treated|0|||
126362365|NCT03624036|454619142|FG002|Overall Study|Enrolled but Never Treated|0|||
126362366|NCT03624036|454619143|FG003|Overall Study|Enrolled but Never Treated|0|||
126362367|NCT03624036|454619140|FG000|Overall Study|Reason not Specified|3|||
126362368|NCT03624036|454619141|FG001|Overall Study|Reason not Specified|0|||
126362369|NCT03624036|454619142|FG002|Overall Study|Reason not Specified|2|||
126362370|NCT03624036|454619143|FG003|Overall Study|Reason not Specified|2|||
126362371|NCT01185366|454619144|FG000|First Line Therapy|Insurance Coverage Denied|1|||
126362372|NCT01185366|454619145|FG001|First Line Therapy|Insurance Coverage Denied|1|||
126362373|NCT01185366|454619144|FG000|First Line Therapy|Withdrawal by Subject|1|||
126362374|NCT01185366|454619145|FG001|First Line Therapy|Withdrawal by Subject|0|||
126362375|NCT01185366|454619144|FG000|First Line Therapy|Lack of Metastatic Site|1|||
126362376|NCT01185366|454619145|FG001|First Line Therapy|Lack of Metastatic Site|0|||
126362377|NCT01185366|454619144|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
126362378|NCT01185366|454619145|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
126362379|NCT01185366|454619144|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
126362380|NCT01185366|454619145|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
126362381|NCT01185366|454619144|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
126362382|NCT01185366|454619145|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
126362383|NCT01185366|454619144|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
126362384|NCT01185366|454619145|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
126362385|NCT02774278|454619146|FG000|Overall Study|Lack of Efficacy|199|||
126362386|NCT02774278|454619146|FG000|Overall Study|Death|29|||
126362387|NCT02774278|454619146|FG000|Overall Study|Adverse event/intercurrent illness|16|||
126362388|NCT02774278|454619146|FG000|Overall Study|Refused treatment/did not cooperate|9|||
126362389|NCT02774278|454619146|FG000|Overall Study|Administrative reasons|6|||
126362390|NCT02774278|454619146|FG000|Overall Study|Withdrawal by Subject|3|||
126362391|NCT02774278|454619146|FG000|Overall Study|Protocol Violation|2|||
126362392|NCT00127933|454619153|FG000|Overall Study|Randomized but not dosed|1|||
126362393|NCT00127933|454619154|FG001|Overall Study|Randomized but not dosed|0|||
126362394|NCT01783938|454619156|FG000|Overall Study|Disease Progression|18|||
126362395|NCT01783938|454619157|FG001|Overall Study|Disease Progression|41|||
126362396|NCT01783938|454619156|FG000|Overall Study|Study Drug Toxicity|27|||
126362397|NCT01783938|454619157|FG001|Overall Study|Study Drug Toxicity|14|||
126362398|NCT01783938|454619156|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
126362399|NCT01783938|454619157|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
126362400|NCT01783938|454619156|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
126362401|NCT01783938|454619157|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
126362402|NCT01783938|454619156|FG000|Overall Study|Participant Withdrew Consent|2|||
126362403|NCT01783938|454619157|FG001|Overall Study|Participant Withdrew Consent|0|||
126362404|NCT01783938|454619156|FG000|Overall Study|Maximum Clinical Benefit|1|||
126362405|NCT01783938|454619157|FG001|Overall Study|Maximum Clinical Benefit|0|||
126362406|NCT01783938|454619156|FG000|Overall Study|Other Reasons|3|||
126362407|NCT01783938|454619157|FG001|Overall Study|Other Reasons|1|||
126362408|NCT03072875|454619162|FG000|Overall Study|Lost to Follow-up|1|||
126362409|NCT03478787|454619163|FG000|Overall Study|Adverse Event|5|||
126362410|NCT03478787|454619164|FG001|Overall Study|Adverse Event|1|||
126362411|NCT03478787|454619163|FG000|Overall Study|Protocol Violation|3|||
126362412|NCT03478787|454619164|FG001|Overall Study|Protocol Violation|0|||
126362413|NCT03478787|454619163|FG000|Overall Study|Lack of Efficacy|7|||
126362414|NCT03478787|454619164|FG001|Overall Study|Lack of Efficacy|1|||
126362415|NCT03478787|454619163|FG000|Overall Study|Lost to Follow-up|9|||
126362416|NCT03478787|454619164|FG001|Overall Study|Lost to Follow-up|5|||
126362417|NCT03478787|454619163|FG000|Overall Study|Withdrawal by Subject|2|||
126362418|NCT03478787|454619164|FG001|Overall Study|Withdrawal by Subject|6|||
126362419|NCT03478787|454619163|FG000|Overall Study|Other, Not Specified|3|||
126362420|NCT03478787|454619164|FG001|Overall Study|Other, Not Specified|0|||
126362421|NCT02413346|454619167|FG000|Overall Study|Adverse Event|6|||
126362422|NCT02413346|454619168|FG001|Overall Study|Adverse Event|6|||
126362423|NCT02413346|454619167|FG000|Overall Study|Withdrawal by Subject|30|||
126362424|NCT02413346|454619168|FG001|Overall Study|Withdrawal by Subject|40|||
126274080|NCT03970837|454294026|FG008|Overall Study|Protocol Violation|0|||
126274081|NCT03970837|454294027|FG009|Overall Study|Protocol Violation|0|||
126274082|NCT03970837|454294028|FG010|Overall Study|Protocol Violation|0|||
126274083|NCT03970837|454294029|FG011|Overall Study|Protocol Violation|0|||
126274084|NCT03970837|454294018|FG000|Overall Study|Physician Decision|5|||
126274085|NCT03970837|454294019|FG001|Overall Study|Physician Decision|8|||
126274086|NCT03970837|454294020|FG002|Overall Study|Physician Decision|4|||
126274087|NCT03970837|454294021|FG003|Overall Study|Physician Decision|1|||
126274088|NCT03970837|454294022|FG004|Overall Study|Physician Decision|5|||
126274089|NCT03970837|454294023|FG005|Overall Study|Physician Decision|2|||
126274090|NCT03970837|454294024|FG006|Overall Study|Physician Decision|4|||
126274091|NCT03970837|454294025|FG007|Overall Study|Physician Decision|5|||
126274092|NCT03970837|454294026|FG008|Overall Study|Physician Decision|0|||
126274093|NCT03970837|454294027|FG009|Overall Study|Physician Decision|1|||
126274094|NCT03970837|454294028|FG010|Overall Study|Physician Decision|0|||
126274095|NCT03970837|454294029|FG011|Overall Study|Physician Decision|0|||
126274096|NCT03970837|454294018|FG000|Overall Study|Withdrawal by Subject|32|||
126274097|NCT03970837|454294019|FG001|Overall Study|Withdrawal by Subject|35|||
126274098|NCT03970837|454294020|FG002|Overall Study|Withdrawal by Subject|12|||
126274099|NCT03970837|454294021|FG003|Overall Study|Withdrawal by Subject|8|||
126274100|NCT03970837|454294022|FG004|Overall Study|Withdrawal by Subject|6|||
126274101|NCT03970837|454294023|FG005|Overall Study|Withdrawal by Subject|8|||
126274102|NCT03970837|454294024|FG006|Overall Study|Withdrawal by Subject|2|||
126274103|NCT03970837|454294025|FG007|Overall Study|Withdrawal by Subject|3|||
126274104|NCT03970837|454294026|FG008|Overall Study|Withdrawal by Subject|0|||
126274105|NCT03970837|454294027|FG009|Overall Study|Withdrawal by Subject|0|||
126274106|NCT03970837|454294028|FG010|Overall Study|Withdrawal by Subject|0|||
126274107|NCT03970837|454294029|FG011|Overall Study|Withdrawal by Subject|1|||
126274108|NCT03970837|454294018|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
126274109|NCT03970837|454294019|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
126274110|NCT03970837|454294020|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
126274111|NCT03970837|454294021|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
126274112|NCT03970837|454294022|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
126274113|NCT03970837|454294023|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126274114|NCT03970837|454294024|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126274115|NCT03970837|454294025|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126274116|NCT03970837|454294026|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126274117|NCT03970837|454294027|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
126274118|NCT03970837|454294028|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
126274119|NCT03970837|454294029|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
126274120|NCT03970837|454294018|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126274121|NCT03970837|454294019|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126274122|NCT03970837|454294020|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126274123|NCT03970837|454294021|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126274124|NCT03970837|454294022|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126274125|NCT03970837|454294023|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126274126|NCT03970837|454294024|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
126274127|NCT03970837|454294025|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
126274128|NCT03970837|454294026|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
126274129|NCT03970837|454294027|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
126274130|NCT03970837|454294028|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
126274131|NCT03970837|454294029|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
126274132|NCT00477295|454294032|FG000|Overall Study|Adverse Event|31|||
126274133|NCT00477295|454294033|FG001|Overall Study|Adverse Event|35|||
126274134|NCT00477295|454294032|FG000|Overall Study|Withdrawal by Subject|35|||
126274135|NCT00477295|454294033|FG001|Overall Study|Withdrawal by Subject|24|||
126453719|NCT01185353|454961514|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
126453720|NCT01185353|454961515|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
126274136|NCT00477295|454294032|FG000|Overall Study|Lack of Efficacy|23|||
126274137|NCT00477295|454294033|FG001|Overall Study|Lack of Efficacy|23|||
126453721|NCT01185353|454961516|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
126453722|NCT01185353|454961517|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
126274138|NCT00477295|454294032|FG000|Overall Study|Protocol Violation|3|||
126274139|NCT00477295|454294033|FG001|Overall Study|Protocol Violation|8|||
126274140|NCT00477295|454294032|FG000|Overall Study|Physician Decision|4|||
126274141|NCT00477295|454294033|FG001|Overall Study|Physician Decision|5|||
126274142|NCT00477295|454294032|FG000|Overall Study|Lost to Follow-up|21|||
126274143|NCT00477295|454294033|FG001|Overall Study|Lost to Follow-up|11|||
126274144|NCT00477295|454294032|FG000|Overall Study|Other|4|||
126274145|NCT00477295|454294033|FG001|Overall Study|Other|3|||
126274146|NCT04568031|454294034|FG000|Overall Study|Lost to Follow-up|1|||
126274147|NCT04568031|454294035|FG001|Overall Study|Lost to Follow-up|0|||
126274148|NCT04568031|454294036|FG002|Overall Study|Lost to Follow-up|0|||
126274149|NCT04568031|454294037|FG003|Overall Study|Lost to Follow-up|0|||
126274150|NCT04568031|454294034|FG000|Overall Study|Physician Decision|1|||
126274151|NCT04568031|454294035|FG001|Overall Study|Physician Decision|0|||
126705979|NCT00488631|455875504|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126274152|NCT04568031|454294036|FG002|Overall Study|Physician Decision|1|||
126274153|NCT04568031|454294037|FG003|Overall Study|Physician Decision|0|||
126274154|NCT04568031|454294034|FG000|Overall Study|Withdrawal by Subject|1|||
126274155|NCT04568031|454294035|FG001|Overall Study|Withdrawal by Subject|0|||
126274156|NCT04568031|454294036|FG002|Overall Study|Withdrawal by Subject|4|||
126274157|NCT04568031|454294037|FG003|Overall Study|Withdrawal by Subject|1|||
126274158|NCT04430855|454294038|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
126274159|NCT04430855|454294039|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
126274160|NCT04430855|454294038|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
126274161|NCT04430855|454294039|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
126274162|NCT04430855|454294038|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
126274163|NCT04430855|454294039|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
126274164|NCT04430855|454294038|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
126274165|NCT04430855|454294039|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
126274166|NCT04430855|454294038|FG000|Period 1 (Weeks 1-12)|Other|0|||
126274167|NCT04430855|454294039|FG001|Period 1 (Weeks 1-12)|Other|1|||
126274168|NCT04430855|454294038|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
126274169|NCT04430855|454294039|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
126274170|NCT04430855|454294038|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
126274171|NCT04430855|454294039|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
126274172|NCT04430855|454294038|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
126274173|NCT04430855|454294039|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
126274174|NCT01425723|454294040|FG000|Overall Study|Lack of Efficacy|0|||
126274175|NCT01425723|454294041|FG001|Overall Study|Lack of Efficacy|1|||
126274176|NCT01425723|454294040|FG000|Overall Study|Withdrawal by Subject|1|||
126274177|NCT01425723|454294041|FG001|Overall Study|Withdrawal by Subject|4|||
126274178|NCT01425723|454294040|FG000|Overall Study|Lost to Follow-up|0|||
126274179|NCT01425723|454294041|FG001|Overall Study|Lost to Follow-up|3|||
126274180|NCT01425723|454294040|FG000|Overall Study|Physician Decision|2|||
126274181|NCT01425723|454294041|FG001|Overall Study|Physician Decision|0|||
126274182|NCT01425723|454294040|FG000|Overall Study|Other|1|||
126274183|NCT01425723|454294041|FG001|Overall Study|Other|10|||
126274184|NCT00186043|454294042|FG000|Overall Study|Lack of Efficacy|1|||
126274185|NCT00186043|454294043|FG001|Overall Study|Lack of Efficacy|3|||
126274186|NCT00186043|454294042|FG000|Overall Study|Lost to Follow-up|4|||
126274187|NCT00186043|454294043|FG001|Overall Study|Lost to Follow-up|6|||
126274188|NCT00186043|454294042|FG000|Overall Study|Withdrawal by Subject|1|||
126274189|NCT00186043|454294043|FG001|Overall Study|Withdrawal by Subject|0|||
126274190|NCT00186043|454294042|FG000|Overall Study|Adverse Event|7|||
126274191|NCT00186043|454294043|FG001|Overall Study|Adverse Event|3|||
126274192|NCT00186043|454294042|FG000|Overall Study|Protocol Violation|2|||
126274193|NCT00186043|454294043|FG001|Overall Study|Protocol Violation|1|||
126274194|NCT04874636|454294044|FG000|Overall Study|Adverse Event|17|||
126274195|NCT04874636|454294045|FG001|Overall Study|Adverse Event|7|||
126274196|NCT04874636|454294044|FG000|Overall Study|Lost to Follow-up|1|||
126274197|NCT04874636|454294045|FG001|Overall Study|Lost to Follow-up|0|||
126274198|NCT04874636|454294044|FG000|Overall Study|Non-Compliance with Study Drug|2|||
126274199|NCT04874636|454294045|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126274200|NCT04874636|454294044|FG000|Overall Study|Physician Decision|1|||
126274201|NCT04874636|454294045|FG001|Overall Study|Physician Decision|0|||
126274202|NCT04874636|454294044|FG000|Overall Study|Withdrawal by Subject|6|||
126274203|NCT04874636|454294045|FG001|Overall Study|Withdrawal by Subject|5|||
126274204|NCT00228423|454294048|FG000|Overall Study|Adverse Event|2|||
126274205|NCT00228423|454294049|FG001|Overall Study|Adverse Event|5|||
126274206|NCT00228423|454294048|FG000|Overall Study|Withdrawal by Subject|7|||
126274207|NCT00228423|454294049|FG001|Overall Study|Withdrawal by Subject|3|||
126274208|NCT00228423|454294048|FG000|Overall Study|Protocol Violation|1|||
126274209|NCT00228423|454294049|FG001|Overall Study|Protocol Violation|3|||
126274210|NCT00228423|454294048|FG000|Overall Study|Physician Decision|0|||
126274211|NCT00228423|454294049|FG001|Overall Study|Physician Decision|1|||
126274212|NCT03258853|454294063|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
126274213|NCT03258853|454294064|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
126705980|NCT00488631|455875505|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126274214|NCT03870477|454294065|FG000|Overall Study|Early Study Termination|1|||
126274215|NCT01709838|454294068|FG000|Overall Study|Withdrawal by Subject|21|||
126274216|NCT01709838|454294068|FG000|Overall Study|Lost to Follow-up|16|||
126274217|NCT01709838|454294068|FG000|Overall Study|Pregnancy|10|||
126274218|NCT01709838|454294068|FG000|Overall Study|Subject/guardian decision|8|||
126274219|NCT01709838|454294068|FG000|Overall Study|Adverse Event|4|||
126453723|NCT01185353|454961508|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
126453724|NCT01185353|454961509|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
126453725|NCT01185353|454961510|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
126274220|NCT01709838|454294068|FG000|Overall Study|Physician Decision|4|||
126274221|NCT01709838|454294068|FG000|Overall Study|Death|3|||
126274222|NCT01709838|454294068|FG000|Overall Study|Protocol Violation|1|||
126274223|NCT03753763|454294076|FG000|Overall Study|Adverse Event|2|||
126274224|NCT03753763|454294077|FG001|Overall Study|Adverse Event|0|||
126274225|NCT03753763|454294076|FG000|Overall Study|Withdrawal by Subject|3|||
126274226|NCT03753763|454294077|FG001|Overall Study|Withdrawal by Subject|1|||
126274227|NCT03753763|454294076|FG000|Overall Study|clinical deterioration|1|||
126274228|NCT03753763|454294077|FG001|Overall Study|clinical deterioration|0|||
126274229|NCT00389831|454294078|FG000|Overall Study|Lack of Efficacy|0|||
126274230|NCT00389831|454294079|FG001|Overall Study|Lack of Efficacy|2|||
126274231|NCT00389831|454294078|FG000|Overall Study|Did not receive treatment.|0|||
126274232|NCT00389831|454294079|FG001|Overall Study|Did not receive treatment.|2|||
126274233|NCT00389831|454294078|FG000|Overall Study|Other reasons|0|||
126274234|NCT00389831|454294079|FG001|Overall Study|Other reasons|2|||
126274235|NCT00389831|454294078|FG000|Overall Study|Lost to Follow-up|0|||
126274236|NCT00389831|454294079|FG001|Overall Study|Lost to Follow-up|1|||
126274237|NCT03433755|454294080|FG000|Overall Study|Lost to Follow-up|1|||
126274238|NCT03433755|454294081|FG001|Overall Study|Lost to Follow-up|0|||
126274239|NCT03433755|454294082|FG002|Overall Study|Lost to Follow-up|0|||
126274240|NCT03433755|454294083|FG003|Overall Study|Lost to Follow-up|0|||
126274241|NCT03433755|454294080|FG000|Overall Study|Decision by Sponsor|1|||
126274242|NCT03433755|454294081|FG001|Overall Study|Decision by Sponsor|0|||
126274243|NCT03433755|454294082|FG002|Overall Study|Decision by Sponsor|0|||
126274244|NCT03433755|454294083|FG003|Overall Study|Decision by Sponsor|0|||
126274245|NCT04941729|454296407|FG000|Overall Study|Death|0|||
126274246|NCT04941729|454296408|FG001|Overall Study|Death|1|||
126274247|NCT04941729|454296407|FG000|Overall Study|Study terminated by sponsor|11|||
126274248|NCT04941729|454296408|FG001|Overall Study|Study terminated by sponsor|10|||
126274249|NCT03190330|454296410|FG000|Overall Study|Adverse Event|2|||
126274250|NCT03190330|454296410|FG000|Overall Study|Death|10|||
126274251|NCT03190330|454296410|FG000|Overall Study|Lost to Follow-up|1|||
126274252|NCT03190330|454296410|FG000|Overall Study|Withdrawal by Subject|6|||
126274253|NCT03190330|454296410|FG000|Overall Study|Progressive Disease|1|||
126274254|NCT03845296|454296419|FG000|Overall Study|On Treatment|2|||
126274255|NCT03845296|454296420|FG001|Overall Study|On Treatment|1|||
126274256|NCT03845296|454296419|FG000|Overall Study|Adverse Event|4|||
126274257|NCT03845296|454296420|FG001|Overall Study|Adverse Event|11|||
126274258|NCT03845296|454296419|FG000|Overall Study|Refusal unrelated to adverse event|0|||
126274259|NCT03845296|454296420|FG001|Overall Study|Refusal unrelated to adverse event|1|||
126274260|NCT03845296|454296419|FG000|Overall Study|Progression/relapse|14|||
126274261|NCT03845296|454296420|FG001|Overall Study|Progression/relapse|18|||
126274262|NCT03845296|454296419|FG000|Overall Study|Death|4|||
126274263|NCT03845296|454296420|FG001|Overall Study|Death|0|||
126274264|NCT03845296|454296419|FG000|Overall Study|Other - not protocol specified|1|||
126274265|NCT03845296|454296420|FG001|Overall Study|Other - not protocol specified|3|||
126274266|NCT02081209|454296423|FG000|Overall Study|Withdrawal by Subject|1|||
126274267|NCT04395001|454296430|FG000|Overall Study|Lost to Follow-up|8|||
126274268|NCT04395001|454296431|FG001|Overall Study|Lost to Follow-up|9|||
126274269|NCT04395001|454296432|FG002|Overall Study|Lost to Follow-up|5|||
126274270|NCT04395001|454296430|FG000|Overall Study|Withdrawal by Subject|3|||
126274271|NCT04395001|454296431|FG001|Overall Study|Withdrawal by Subject|1|||
126274272|NCT04395001|454296432|FG002|Overall Study|Withdrawal by Subject|3|||
126274273|NCT04395001|454296430|FG000|Overall Study|missed appointment|7|||
126274274|NCT04395001|454296431|FG001|Overall Study|missed appointment|4|||
126274275|NCT04395001|454296432|FG002|Overall Study|missed appointment|1|||
126274276|NCT04347122|454296433|FG000|Overall Study|Physician Decision|0|||
126274277|NCT04347122|454296434|FG001|Overall Study|Physician Decision|3|||
126274278|NCT04347122|454296435|FG002|Overall Study|Physician Decision|3|||
126274279|NCT04347122|454296436|FG003|Overall Study|Physician Decision|6|||
126274280|NCT04994483|454296437|FG000|Overall Study|Adverse Event|26|||
126274281|NCT04994483|454296438|FG001|Overall Study|Adverse Event|17|||
126274282|NCT04994483|454296437|FG000|Overall Study|Lost to Follow-up|6|||
126274283|NCT04994483|454296438|FG001|Overall Study|Lost to Follow-up|10|||
126274284|NCT04994483|454296437|FG000|Overall Study|Noncompliance with study drug|8|||
126274285|NCT04994483|454296438|FG001|Overall Study|Noncompliance with study drug|5|||
126274286|NCT04994483|454296437|FG000|Overall Study|Physician Decision|5|||
126274287|NCT04994483|454296438|FG001|Overall Study|Physician Decision|0|||
126705981|NCT00488631|455875506|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126274288|NCT04994483|454296437|FG000|Overall Study|Withdrawal by Subject|41|||
126274289|NCT04994483|454296438|FG001|Overall Study|Withdrawal by Subject|38|||
126274290|NCT04994483|454296437|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
126274291|NCT04994483|454296438|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
126274292|NCT04994483|454296437|FG000|Overall Study|Met stopping criteria|1|||
126274293|NCT04994483|454296438|FG001|Overall Study|Met stopping criteria|0|||
126274294|NCT04994483|454296437|FG000|Overall Study|Randomized in error, not treated|4|||
126274295|NCT04994483|454296438|FG001|Overall Study|Randomized in error, not treated|3|||
126274296|NCT04994483|454296437|FG000|Overall Study|Lack of a reliable study partner|0|||
126274297|NCT04994483|454296438|FG001|Overall Study|Lack of a reliable study partner|1|||
126274298|NCT04994483|454296437|FG000|Overall Study|Met MRI exclusion criteria|0|||
126274299|NCT04994483|454296438|FG001|Overall Study|Met MRI exclusion criteria|1|||
126765627|NCT02146365|456094573|FG001|Overall Study|Unable to Comply with Protocol|1|||
126765628|NCT02146365|456094574|FG002|Overall Study|Unable to Comply with Protocol|1|||
126765629|NCT02146365|456094575|FG003|Overall Study|Unable to Comply with Protocol|0|||
126274300|NCT03589768|454296443|FG000|Overall Study|Death|1|||
126274301|NCT03589768|454296444|FG001|Overall Study|Death|0|||
126274302|NCT03589768|454296445|FG002|Overall Study|Death|8|||
126274303|NCT03589768|454296446|FG003|Overall Study|Death|3|||
126274304|NCT03589768|454296443|FG000|Overall Study|Withdrawal by Subject|2|||
126274305|NCT03589768|454296444|FG001|Overall Study|Withdrawal by Subject|0|||
126274306|NCT03589768|454296445|FG002|Overall Study|Withdrawal by Subject|0|||
126274307|NCT03589768|454296446|FG003|Overall Study|Withdrawal by Subject|0|||
126274308|NCT03589768|454296443|FG000|Overall Study|Protocol Violation|1|||
126274309|NCT03589768|454296444|FG001|Overall Study|Protocol Violation|0|||
126274310|NCT03589768|454296445|FG002|Overall Study|Protocol Violation|0|||
126274311|NCT03589768|454296446|FG003|Overall Study|Protocol Violation|0|||
126274312|NCT00191113|454296447|FG000|Core Study|Withdrawal by Subject|25|||
126274313|NCT00191113|454296448|FG001|Core Study|Withdrawal by Subject|9|||
126274314|NCT00191113|454296447|FG000|Core Study|Protocol Violation|6|||
126274315|NCT00191113|454296448|FG001|Core Study|Protocol Violation|2|||
126274316|NCT00191113|454296447|FG000|Core Study|Lost to Follow-up|3|||
126274317|NCT00191113|454296448|FG001|Core Study|Lost to Follow-up|0|||
126274318|NCT00191113|454296447|FG000|Core Study|Adverse Event|0|||
126274319|NCT00191113|454296448|FG001|Core Study|Adverse Event|2|||
126274320|NCT00191113|454296447|FG000|Core Study|Lack of Efficacy|0|||
126274321|NCT00191113|454296448|FG001|Core Study|Lack of Efficacy|2|||
126274322|NCT00191113|454296447|FG000|Core Study|Death|1|||
126274323|NCT00191113|454296448|FG001|Core Study|Death|0|||
126274324|NCT03786718|454296451|FG000|Overall Study|Lost to Follow-up|3|||
126274325|NCT03786718|454296451|FG000|Overall Study|Withdrawal by Subject|1|||
126274326|NCT03786718|454296451|FG000|Overall Study|Did not use the intervention|2|||
126274327|NCT03786718|454296451|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
126274328|NCT00368979|454296452|FG000|Overall Study|Adverse Event|9|||
126274329|NCT00368979|454296453|FG001|Overall Study|Adverse Event|16|||
126274330|NCT00368979|454296452|FG000|Overall Study|Lack of Efficacy|5|||
126274331|NCT00368979|454296453|FG001|Overall Study|Lack of Efficacy|3|||
126274332|NCT00368979|454296452|FG000|Overall Study|Other|3|||
126274333|NCT00368979|454296453|FG001|Overall Study|Other|1|||
126274334|NCT00368979|454296452|FG000|Overall Study|Lost to Follow-up|1|||
126274335|NCT00368979|454296453|FG001|Overall Study|Lost to Follow-up|0|||
126274336|NCT00368979|454296452|FG000|Overall Study|Protocol Violation|2|||
126274337|NCT00368979|454296453|FG001|Overall Study|Protocol Violation|1|||
126274338|NCT00368979|454296452|FG000|Overall Study|Withdrawal by Subject|5|||
126274339|NCT00368979|454296453|FG001|Overall Study|Withdrawal by Subject|9|||
126274340|NCT04645966|454296456|FG000|Vaccination Phase|Adverse Event|1|||
126274341|NCT04645966|454296457|FG001|Vaccination Phase|Adverse Event|0|||
126274342|NCT04645966|454296458|FG002|Vaccination Phase|Adverse Event|0|||
126274343|NCT04645966|454296459|FG003|Vaccination Phase|Adverse Event|0|||
126274344|NCT04645966|454296460|FG004|Vaccination Phase|Adverse Event|0|||
126274345|NCT04645966|454296461|FG005|Vaccination Phase|Adverse Event|0|||
126274346|NCT04645966|454296462|FG006|Vaccination Phase|Adverse Event|1|||
126765630|NCT02146365|456094576|FG004|Overall Study|Unable to Comply with Protocol|0|||
126765631|NCT02146365|456094577|FG005|Overall Study|Unable to Comply with Protocol|0|||
126765632|NCT02146365|456094578|FG006|Overall Study|Unable to Comply with Protocol|0|||
126765633|NCT02146365|456094579|FG007|Overall Study|Unable to Comply with Protocol|0|||
126765634|NCT02146365|456094572|FG000|Overall Study|Other|1|||
126765635|NCT02146365|456094573|FG001|Overall Study|Other|0|||
126765636|NCT02146365|456094574|FG002|Overall Study|Other|2|||
126765637|NCT02146365|456094575|FG003|Overall Study|Other|1|||
126765638|NCT02146365|456094576|FG004|Overall Study|Other|0|||
126274347|NCT04645966|454296463|FG007|Vaccination Phase|Adverse Event|0|||
126765639|NCT02146365|456094577|FG005|Overall Study|Other|0|||
126765640|NCT02146365|456094578|FG006|Overall Study|Other|0|||
126765641|NCT02146365|456094579|FG007|Overall Study|Other|0|||
126274348|NCT04645966|454296464|FG008|Vaccination Phase|Adverse Event|0|||
126274349|NCT04645966|454296456|FG000|Vaccination Phase|Death|0|||
126274350|NCT04645966|454296457|FG001|Vaccination Phase|Death|0|||
126274351|NCT04645966|454296458|FG002|Vaccination Phase|Death|0|||
126274352|NCT04645966|454296459|FG003|Vaccination Phase|Death|0|||
126274353|NCT04645966|454296460|FG004|Vaccination Phase|Death|0|||
126274354|NCT04645966|454296461|FG005|Vaccination Phase|Death|1|||
126274355|NCT04645966|454296462|FG006|Vaccination Phase|Death|0|||
126274356|NCT04645966|454296463|FG007|Vaccination Phase|Death|0|||
126274357|NCT04645966|454296464|FG008|Vaccination Phase|Death|0|||
126274358|NCT04645966|454296456|FG000|Vaccination Phase|Protocol Violation|0|||
126274359|NCT04645966|454296457|FG001|Vaccination Phase|Protocol Violation|0|||
126274360|NCT04645966|454296458|FG002|Vaccination Phase|Protocol Violation|0|||
126274361|NCT04645966|454296459|FG003|Vaccination Phase|Protocol Violation|0|||
126274362|NCT04645966|454296460|FG004|Vaccination Phase|Protocol Violation|1|||
126274363|NCT04645966|454296461|FG005|Vaccination Phase|Protocol Violation|0|||
126274364|NCT04645966|454296462|FG006|Vaccination Phase|Protocol Violation|0|||
126765642|NCT01843660|456094580|FG000|Overall Study|Other|30|||
126274365|NCT04645966|454296463|FG007|Vaccination Phase|Protocol Violation|0|||
126274366|NCT04645966|454296464|FG008|Vaccination Phase|Protocol Violation|0|||
126274367|NCT04645966|454296456|FG000|Vaccination Phase|Study terminated by sponsor|0|||
126274368|NCT04645966|454296457|FG001|Vaccination Phase|Study terminated by sponsor|0|||
126274369|NCT04645966|454296458|FG002|Vaccination Phase|Study terminated by sponsor|14|||
126274370|NCT04645966|454296459|FG003|Vaccination Phase|Study terminated by sponsor|15|||
126274371|NCT04645966|454296460|FG004|Vaccination Phase|Study terminated by sponsor|47|||
126274372|NCT04645966|454296461|FG005|Vaccination Phase|Study terminated by sponsor|43|||
126274373|NCT04645966|454296462|FG006|Vaccination Phase|Study terminated by sponsor|29|||
126274374|NCT04645966|454296463|FG007|Vaccination Phase|Study terminated by sponsor|29|||
126274375|NCT04645966|454296464|FG008|Vaccination Phase|Study terminated by sponsor|12|||
126274376|NCT04645966|454296456|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
126274377|NCT04645966|454296457|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
126274378|NCT04645966|454296458|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
126274379|NCT04645966|454296459|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
126274380|NCT04645966|454296460|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
126274381|NCT04645966|454296461|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
126274382|NCT04645966|454296462|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
126274383|NCT04645966|454296463|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
126274384|NCT04645966|454296464|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
126274385|NCT04645966|454296456|FG000|Vaccination Phase|Other|0|||
126274386|NCT04645966|454296457|FG001|Vaccination Phase|Other|0|||
126274387|NCT04645966|454296458|FG002|Vaccination Phase|Other|0|||
126274388|NCT04645966|454296459|FG003|Vaccination Phase|Other|0|||
126274389|NCT04645966|454296460|FG004|Vaccination Phase|Other|0|||
126274390|NCT04645966|454296461|FG005|Vaccination Phase|Other|2|||
126274391|NCT04645966|454296462|FG006|Vaccination Phase|Other|0|||
126274392|NCT04645966|454296463|FG007|Vaccination Phase|Other|0|||
126274393|NCT04645966|454296464|FG008|Vaccination Phase|Other|0|||
126274394|NCT04645966|454296456|FG000|Vaccination Phase|Lost to Follow-up|0|||
126274395|NCT04645966|454296457|FG001|Vaccination Phase|Lost to Follow-up|0|||
126274396|NCT04645966|454296458|FG002|Vaccination Phase|Lost to Follow-up|0|||
126274397|NCT04645966|454296459|FG003|Vaccination Phase|Lost to Follow-up|0|||
126274398|NCT04645966|454296460|FG004|Vaccination Phase|Lost to Follow-up|0|||
126274399|NCT04645966|454296461|FG005|Vaccination Phase|Lost to Follow-up|0|||
126274400|NCT04645966|454296462|FG006|Vaccination Phase|Lost to Follow-up|0|||
126274401|NCT04645966|454296463|FG007|Vaccination Phase|Lost to Follow-up|1|||
126274402|NCT04645966|454296464|FG008|Vaccination Phase|Lost to Follow-up|0|||
126274403|NCT04645966|454296456|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
126274404|NCT04645966|454296457|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
126274405|NCT04645966|454296458|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
126274406|NCT04645966|454296459|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
126274407|NCT04645966|454296460|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
126274408|NCT04645966|454296461|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
126274409|NCT04645966|454296462|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
126274410|NCT04645966|454296463|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
126274411|NCT04645966|454296464|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
126274412|NCT04645966|454296456|FG000|Follow-up Phase|Lost to Follow-up|0|||
126274413|NCT04645966|454296457|FG001|Follow-up Phase|Lost to Follow-up|0|||
126274414|NCT04645966|454296458|FG002|Follow-up Phase|Lost to Follow-up|0|||
126274415|NCT04645966|454296459|FG003|Follow-up Phase|Lost to Follow-up|0|||
126274416|NCT04645966|454296460|FG004|Follow-up Phase|Lost to Follow-up|0|||
126274417|NCT04645966|454296461|FG005|Follow-up Phase|Lost to Follow-up|0|||
126274418|NCT04645966|454296462|FG006|Follow-up Phase|Lost to Follow-up|0|||
126274419|NCT04645966|454296463|FG007|Follow-up Phase|Lost to Follow-up|1|||
126274420|NCT04645966|454296464|FG008|Follow-up Phase|Lost to Follow-up|0|||
126274421|NCT04283500|454296468|FG000|Overall Study|Lost to Follow-up|8|||
126274422|NCT04283500|454296468|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
126274423|NCT02006693|454296471|FG000|Overall Study|No Reason Specified|6|||
126274424|NCT02006693|454296472|FG001|Overall Study|No Reason Specified|8|||
126274425|NCT02006693|454296471|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
126274426|NCT02006693|454296472|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
126274427|NCT02006693|454296471|FG000|Overall Study|XEN Implant Explantation|0|||
126274428|NCT02006693|454296472|FG001|Overall Study|XEN Implant Explantation|1|||
126274429|NCT02006693|454296471|FG000|Overall Study|Death|2|||
126274430|NCT02006693|454296472|FG001|Overall Study|Death|2|||
126274431|NCT02006693|454296471|FG000|Overall Study|Lost to Follow-up|4|||
126274432|NCT02006693|454296472|FG001|Overall Study|Lost to Follow-up|1|||
126274433|NCT02006693|454296471|FG000|Overall Study|Patient Decision|4|||
126274434|NCT02006693|454296472|FG001|Overall Study|Patient Decision|0|||
126274435|NCT01119508|454296475|FG000|Overall Study|Adverse Event|56|||
126274436|NCT01119508|454296475|FG000|Overall Study|Withdrawal by Subject|2|||
126274437|NCT01119508|454296475|FG000|Overall Study|Died before tumor response evaluation|1|||
126274438|NCT00265395|454296476|FG000|Overall Study|Adverse Event|3|||
126274439|NCT00265395|454296477|FG001|Overall Study|Adverse Event|6|||
126274440|NCT00265395|454296476|FG000|Overall Study|Lost to Follow-up|2|||
126274441|NCT00265395|454296477|FG001|Overall Study|Lost to Follow-up|1|||
126274442|NCT00265395|454296476|FG000|Overall Study|Withdrawal by Subject|1|||
126274443|NCT00265395|454296477|FG001|Overall Study|Withdrawal by Subject|6|||
126274444|NCT00265395|454296476|FG000|Overall Study|Protocol Violation|2|||
126274445|NCT00265395|454296477|FG001|Overall Study|Protocol Violation|2|||
126274446|NCT00265395|454296476|FG000|Overall Study|Lack of Efficacy|0|||
126274447|NCT00265395|454296477|FG001|Overall Study|Lack of Efficacy|1|||
126274448|NCT00265395|454296476|FG000|Overall Study|Administrative|0|||
126274449|NCT00265395|454296477|FG001|Overall Study|Administrative|1|||
126274450|NCT00123474|454296478|FG000|Randomized to Treatment|Randomized, never treated|1|||
126274451|NCT00123474|454296479|FG001|Randomized to Treatment|Randomized, never treated|4|||
126274452|NCT00123474|454296480|FG002|Randomized to Treatment|Randomized, never treated|2|||
126274453|NCT00123474|454296481|FG003|Randomized to Treatment|Randomized, never treated|1|||
126274454|NCT00123474|454296478|FG000|As Treated at Study Closure|not reported when site closed|1|||
126274455|NCT00123474|454296479|FG001|As Treated at Study Closure|not reported when site closed|0|||
126274456|NCT00123474|454296480|FG002|As Treated at Study Closure|not reported when site closed|1|||
126274457|NCT00123474|454296481|FG003|As Treated at Study Closure|not reported when site closed|0|||
126274458|NCT00123474|454296478|FG000|As Treated at Study Closure|Adverse Event|10|||
126274459|NCT00123474|454296479|FG001|As Treated at Study Closure|Adverse Event|4|||
126274460|NCT00123474|454296480|FG002|As Treated at Study Closure|Adverse Event|10|||
126274461|NCT00123474|454296481|FG003|As Treated at Study Closure|Adverse Event|8|||
126274462|NCT00123474|454296478|FG000|As Treated at Study Closure|Disease Progression|35|||
126274463|NCT00123474|454296479|FG001|As Treated at Study Closure|Disease Progression|42|||
126274464|NCT00123474|454296480|FG002|As Treated at Study Closure|Disease Progression|29|||
126274465|NCT00123474|454296481|FG003|As Treated at Study Closure|Disease Progression|27|||
126274466|NCT00123474|454296478|FG000|As Treated at Study Closure|Investigator Request|12|||
126274467|NCT00123474|454296479|FG001|As Treated at Study Closure|Investigator Request|6|||
126274468|NCT00123474|454296480|FG002|As Treated at Study Closure|Investigator Request|7|||
126274469|NCT00123474|454296481|FG003|As Treated at Study Closure|Investigator Request|5|||
126274470|NCT00123474|454296478|FG000|As Treated at Study Closure|non-specified|54|||
126274471|NCT00123474|454296479|FG001|As Treated at Study Closure|non-specified|47|||
126274472|NCT00123474|454296480|FG002|As Treated at Study Closure|non-specified|57|||
126274473|NCT00123474|454296481|FG003|As Treated at Study Closure|non-specified|60|||
126274474|NCT00123474|454296478|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
126705982|NCT00488631|455875507|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126705983|NCT00488631|455875508|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126705984|NCT00488631|455875509|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126705985|NCT00488631|455875510|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
126705986|NCT00488631|455875511|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
126705987|NCT00488631|455875512|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
126705988|NCT00488631|455875513|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
126274475|NCT00123474|454296479|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
126274476|NCT00123474|454296480|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
126274477|NCT00123474|454296481|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
126274478|NCT00123474|454296478|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
126274479|NCT00123474|454296479|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
126274480|NCT00123474|454296480|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
126274481|NCT00123474|454296481|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
126274482|NCT01059344|454296482|FG000|Overall Study|Adverse Event|12|||
126274483|NCT01059344|454296483|FG001|Overall Study|Adverse Event|30|||
126274484|NCT01059344|454296482|FG000|Overall Study|Withdrawal by Subject|6|||
126274485|NCT01059344|454296483|FG001|Overall Study|Withdrawal by Subject|9|||
126274486|NCT01059344|454296482|FG000|Overall Study|Lost to Follow-up|1|||
126274487|NCT01059344|454296483|FG001|Overall Study|Lost to Follow-up|1|||
126274488|NCT01059344|454296482|FG000|Overall Study|Other|3|||
126274489|NCT01059344|454296483|FG001|Overall Study|Other|6|||
126274490|NCT01739348|454296484|FG000|Part I (Base Study)|Adverse Event|41|||
126274491|NCT01739348|454296485|FG001|Part I (Base Study)|Adverse Event|52|||
126274492|NCT01739348|454296486|FG002|Part I (Base Study)|Adverse Event|8|||
126274493|NCT01739348|454296487|FG003|Part I (Base Study)|Adverse Event|33|||
126274494|NCT01739348|454296484|FG000|Part I (Base Study)|Death|10|||
126274495|NCT01739348|454296485|FG001|Part I (Base Study)|Death|7|||
126274496|NCT01739348|454296486|FG002|Part I (Base Study)|Death|2|||
126274497|NCT01739348|454296487|FG003|Part I (Base Study)|Death|8|||
126274498|NCT01739348|454296484|FG000|Part I (Base Study)|Lack of Efficacy|3|||
126274499|NCT01739348|454296485|FG001|Part I (Base Study)|Lack of Efficacy|8|||
126274500|NCT01739348|454296486|FG002|Part I (Base Study)|Lack of Efficacy|0|||
126274501|NCT01739348|454296487|FG003|Part I (Base Study)|Lack of Efficacy|7|||
126274502|NCT01739348|454296484|FG000|Part I (Base Study)|Lost to Follow-up|4|||
126274503|NCT01739348|454296485|FG001|Part I (Base Study)|Lost to Follow-up|2|||
126274504|NCT01739348|454296486|FG002|Part I (Base Study)|Lost to Follow-up|4|||
126274505|NCT01739348|454296487|FG003|Part I (Base Study)|Lost to Follow-up|4|||
126705989|NCT00488631|455875504|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
126705990|NCT00488631|455875505|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
126705991|NCT00488631|455875506|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
126705992|NCT00488631|455875507|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
126705993|NCT00488631|455875508|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
126705994|NCT00488631|455875509|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
126705995|NCT00488631|455875510|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
126705996|NCT00488631|455875511|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
126705997|NCT00488631|455875512|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
126705998|NCT00488631|455875513|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
126705999|NCT00488631|455875504|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
126706000|NCT00488631|455875505|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
126706001|NCT00488631|455875506|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
126706002|NCT00488631|455875507|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
126706003|NCT00488631|455875508|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
126706004|NCT00488631|455875509|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
126274506|NCT01739348|454296484|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
126274507|NCT01739348|454296485|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
126274508|NCT01739348|454296486|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
126274509|NCT01739348|454296487|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
126274510|NCT01739348|454296484|FG000|Part I (Base Study)|Physician Decision|10|||
126274511|NCT01739348|454296485|FG001|Part I (Base Study)|Physician Decision|7|||
126274512|NCT01739348|454296486|FG002|Part I (Base Study)|Physician Decision|1|||
126274513|NCT01739348|454296487|FG003|Part I (Base Study)|Physician Decision|4|||
126274514|NCT01739348|454296484|FG000|Part I (Base Study)|Protocol Violation|2|||
126274515|NCT01739348|454296485|FG001|Part I (Base Study)|Protocol Violation|0|||
126274516|NCT01739348|454296486|FG002|Part I (Base Study)|Protocol Violation|1|||
126274517|NCT01739348|454296487|FG003|Part I (Base Study)|Protocol Violation|2|||
126274518|NCT01739348|454296484|FG000|Part I (Base Study)|Screen Failure|2|||
126274519|NCT01739348|454296485|FG001|Part I (Base Study)|Screen Failure|0|||
126274520|NCT01739348|454296486|FG002|Part I (Base Study)|Screen Failure|0|||
126274521|NCT01739348|454296487|FG003|Part I (Base Study)|Screen Failure|0|||
126274522|NCT01739348|454296484|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
126274523|NCT01739348|454296485|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
126274524|NCT01739348|454296486|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
126274525|NCT01739348|454296487|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
126274526|NCT01739348|454296484|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
126274527|NCT01739348|454296485|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
126274528|NCT01739348|454296486|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
126274529|NCT01739348|454296487|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
126274530|NCT01739348|454296484|FG000|Part I (Base Study)|Participant Moved|4|||
126274531|NCT01739348|454296485|FG001|Part I (Base Study)|Participant Moved|3|||
126274532|NCT01739348|454296486|FG002|Part I (Base Study)|Participant Moved|1|||
126274533|NCT01739348|454296487|FG003|Part I (Base Study)|Participant Moved|7|||
126274534|NCT01739348|454296484|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
126274535|NCT01739348|454296485|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
126274536|NCT01739348|454296486|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
126274537|NCT01739348|454296487|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
126274538|NCT01739348|454296484|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
126274539|NCT01739348|454296485|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
126274540|NCT01739348|454296486|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
126274541|NCT01739348|454296487|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
126274542|NCT01739348|454296484|FG000|Part II (Extension Study)|Adverse Event|10|||
126274543|NCT01739348|454296485|FG001|Part II (Extension Study)|Adverse Event|11|||
126274544|NCT01739348|454296486|FG002|Part II (Extension Study)|Adverse Event|7|||
126274545|NCT01739348|454296487|FG003|Part II (Extension Study)|Adverse Event|26|||
126274546|NCT01739348|454296484|FG000|Part II (Extension Study)|Death|3|||
126274547|NCT01739348|454296485|FG001|Part II (Extension Study)|Death|3|||
126274548|NCT01739348|454296486|FG002|Part II (Extension Study)|Death|2|||
126274549|NCT01739348|454296487|FG003|Part II (Extension Study)|Death|6|||
126274550|NCT01739348|454296484|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
126274551|NCT01739348|454296485|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
126274552|NCT01739348|454296486|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
126274553|NCT01739348|454296487|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
126274554|NCT01739348|454296484|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
126274555|NCT01739348|454296485|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
126274556|NCT01739348|454296486|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
126274557|NCT01739348|454296487|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
126274558|NCT01739348|454296484|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
126274559|NCT01739348|454296485|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
126706005|NCT00488631|455875510|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
126706006|NCT00488631|455875511|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
126706007|NCT00488631|455875512|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
126706008|NCT00488631|455875513|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
126706009|NCT00488631|455875504|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126706010|NCT00488631|455875505|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126706011|NCT00488631|455875506|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126706012|NCT00488631|455875507|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126706013|NCT00488631|455875508|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126706014|NCT00488631|455875509|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126706015|NCT00488631|455875510|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
126706016|NCT00488631|455875511|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126706017|NCT00488631|455875512|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
126706018|NCT00488631|455875513|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
126706019|NCT00488631|455875504|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126765643|NCT01977482|456094581|FG000|Overall Study|Adverse Event|0|||
126274560|NCT01739348|454296486|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
126274561|NCT01739348|454296487|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
126274562|NCT01739348|454296484|FG000|Part II (Extension Study)|Physician Decision|7|||
126274563|NCT01739348|454296485|FG001|Part II (Extension Study)|Physician Decision|11|||
126274564|NCT01739348|454296486|FG002|Part II (Extension Study)|Physician Decision|6|||
126274565|NCT01739348|454296487|FG003|Part II (Extension Study)|Physician Decision|12|||
126274566|NCT01739348|454296484|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
126274567|NCT01739348|454296485|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
126274568|NCT01739348|454296486|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
126274569|NCT01739348|454296487|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
126274570|NCT01739348|454296484|FG000|Part II (Extension Study)|Participant Moved|3|||
126274571|NCT01739348|454296485|FG001|Part II (Extension Study)|Participant Moved|3|||
126274572|NCT01739348|454296486|FG002|Part II (Extension Study)|Participant Moved|0|||
126274573|NCT01739348|454296487|FG003|Part II (Extension Study)|Participant Moved|3|||
126274574|NCT01739348|454296484|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
126274575|NCT01739348|454296485|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
126274576|NCT01739348|454296486|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
126274577|NCT01739348|454296487|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
126274578|NCT01739348|454296484|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
126274579|NCT01739348|454296485|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
126274580|NCT01739348|454296486|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
126274581|NCT01739348|454296487|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
126274582|NCT00742924|454296491|FG000|Overall Study|Adverse Event|0|||
126274583|NCT00742924|454296492|FG001|Overall Study|Adverse Event|0|||
126274584|NCT00742924|454296493|FG002|Overall Study|Adverse Event|1|||
126274585|NCT00742924|454296494|FG003|Overall Study|Adverse Event|1|||
126274586|NCT00742924|454296491|FG000|Overall Study|Lack of Efficacy|5|||
126274587|NCT00742924|454296492|FG001|Overall Study|Lack of Efficacy|1|||
126274588|NCT00742924|454296493|FG002|Overall Study|Lack of Efficacy|2|||
126274589|NCT00742924|454296494|FG003|Overall Study|Lack of Efficacy|4|||
126274590|NCT00742924|454296491|FG000|Overall Study|Physician Decision|0|||
126274591|NCT00742924|454296492|FG001|Overall Study|Physician Decision|0|||
126274592|NCT00742924|454296493|FG002|Overall Study|Physician Decision|0|||
126274593|NCT00742924|454296494|FG003|Overall Study|Physician Decision|1|||
126274594|NCT00742924|454296491|FG000|Overall Study|Withdrawal by Subject|0|||
126274595|NCT00742924|454296492|FG001|Overall Study|Withdrawal by Subject|1|||
126274596|NCT00742924|454296493|FG002|Overall Study|Withdrawal by Subject|1|||
126274597|NCT00742924|454296494|FG003|Overall Study|Withdrawal by Subject|0|||
126274598|NCT00660400|454296495|FG000|Overall Study|Lack of insurance approval|1|||
126274599|NCT00660400|454296495|FG000|Overall Study|Suboptimal organ function|1|||
126274600|NCT00660400|454296495|FG000|Overall Study|Intracranial hemorrhage|1|||
126274601|NCT00660400|454296495|FG000|Overall Study|Withdrawal by Subject|1|||
126274602|NCT01447420|454296496|FG000|Overall Study|Adverse Event|2|||
126274603|NCT01447420|454296497|FG001|Overall Study|Adverse Event|4|||
126274604|NCT01447420|454296498|FG002|Overall Study|Adverse Event|2|||
126274605|NCT01447420|454296496|FG000|Overall Study|Protocol Violation|3|||
126274606|NCT01447420|454296497|FG001|Overall Study|Protocol Violation|3|||
126274607|NCT01447420|454296498|FG002|Overall Study|Protocol Violation|0|||
126274608|NCT01447420|454296496|FG000|Overall Study|Withdrawal by Subject|4|||
126274609|NCT01447420|454296497|FG001|Overall Study|Withdrawal by Subject|1|||
126274610|NCT01447420|454296498|FG002|Overall Study|Withdrawal by Subject|0|||
126274611|NCT01447420|454296496|FG000|Overall Study|Lack of Efficacy|1|||
126274612|NCT01447420|454296497|FG001|Overall Study|Lack of Efficacy|19|||
126274613|NCT01447420|454296498|FG002|Overall Study|Lack of Efficacy|8|||
126274614|NCT02643355|454296499|FG000|Overall Study|Withdrawal by Subject|1|||
126274615|NCT02643355|454296500|FG001|Overall Study|Withdrawal by Subject|3|||
126274616|NCT02643355|454296499|FG000|Overall Study|Protocol Violation|0|||
126274617|NCT02643355|454296500|FG001|Overall Study|Protocol Violation|2|||
126274618|NCT04524364|454296505|FG000|Overall Study|Physician Decision|3|||
126274619|NCT04524364|454296506|FG001|Overall Study|Physician Decision|6|||
126274620|NCT04524364|454296505|FG000|Overall Study|Adverse Event|0|||
126274621|NCT04524364|454296506|FG001|Overall Study|Adverse Event|1|||
126274622|NCT04524364|454296505|FG000|Overall Study|Investigational device deficiency|0|||
126274623|NCT04524364|454296506|FG001|Overall Study|Investigational device deficiency|1|||
126274624|NCT04524364|454296505|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
126274625|NCT04524364|454296506|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
126274626|NCT04524364|454296505|FG000|Overall Study|Device unavailability|0|||
126274627|NCT04524364|454296506|FG001|Overall Study|Device unavailability|2|||
126274628|NCT04524364|454296505|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
126274629|NCT04524364|454296506|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
126274630|NCT04524364|454296505|FG000|Overall Study|Low International normalized ratio (INR)|1|||
126274631|NCT04524364|454296506|FG001|Overall Study|Low International normalized ratio (INR)|0|||
126274632|NCT00826449|454296507|FG000|Overall Study|Disease Progression|4|||
126274633|NCT00826449|454296507|FG000|Overall Study|Withdrawal by Subject|1|||
126274634|NCT02994940|454296508|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
126274635|NCT02994940|454296509|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
126274636|NCT02994940|454296508|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
126274637|NCT02994940|454296509|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
126274638|NCT02994940|454296508|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
126274639|NCT02994940|454296509|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
126274640|NCT03233230|454296510|FG000|Overall Study|Adverse Event|6|||
126274641|NCT03233230|454296511|FG001|Overall Study|Adverse Event|3|||
126274642|NCT03233230|454296512|FG002|Overall Study|Adverse Event|6|||
126274643|NCT03233230|454296513|FG003|Overall Study|Adverse Event|3|||
126274644|NCT03233230|454296510|FG000|Overall Study|Protocol Violation|1|||
126274645|NCT03233230|454296511|FG001|Overall Study|Protocol Violation|2|||
126274646|NCT03233230|454296512|FG002|Overall Study|Protocol Violation|1|||
126274647|NCT03233230|454296513|FG003|Overall Study|Protocol Violation|1|||
126274648|NCT03233230|454296510|FG000|Overall Study|Lack of Efficacy|1|||
126274649|NCT03233230|454296511|FG001|Overall Study|Lack of Efficacy|0|||
126274650|NCT03233230|454296512|FG002|Overall Study|Lack of Efficacy|0|||
126274651|NCT03233230|454296513|FG003|Overall Study|Lack of Efficacy|0|||
126274652|NCT03233230|454296510|FG000|Overall Study|Other|5|||
126274653|NCT03233230|454296511|FG001|Overall Study|Other|5|||
126274654|NCT03233230|454296512|FG002|Overall Study|Other|5|||
126274655|NCT03233230|454296513|FG003|Overall Study|Other|3|||
126274656|NCT03233230|454296510|FG000|Overall Study|Withdrawal by Subject|2|||
126274657|NCT03233230|454296511|FG001|Overall Study|Withdrawal by Subject|2|||
126274658|NCT03233230|454296512|FG002|Overall Study|Withdrawal by Subject|0|||
126274659|NCT03233230|454296513|FG003|Overall Study|Withdrawal by Subject|1|||
126274660|NCT03233230|454296510|FG000|Overall Study|Lost to Follow-up|0|||
126274661|NCT03233230|454296511|FG001|Overall Study|Lost to Follow-up|3|||
126274662|NCT03233230|454296512|FG002|Overall Study|Lost to Follow-up|0|||
126706020|NCT00488631|455875505|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126706021|NCT00488631|455875506|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126706022|NCT00488631|455875507|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126706023|NCT00488631|455875508|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126706024|NCT00488631|455875509|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126706025|NCT00488631|455875510|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
126706026|NCT00488631|455875511|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
126706027|NCT00488631|455875512|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
126706028|NCT00488631|455875513|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
126706029|NCT01873950|455875514|FG000|Period 5|Withdrawal by Subject|0|||
126706030|NCT01873950|455875515|FG001|Period 5|Withdrawal by Subject|0|||
126706031|NCT01873950|455875516|FG002|Period 5|Withdrawal by Subject|0|||
126765644|NCT01977482|456094582|FG001|Overall Study|Adverse Event|1|||
126274663|NCT03233230|454296513|FG003|Overall Study|Lost to Follow-up|0|||
126274664|NCT02987959|454296518|FG000|Overall Study|Grantor stopped supply of drugs|6|||
126274665|NCT04126213|454296519|FG000|Overall Study|Lost to Follow-up|9|||
126274666|NCT04126213|454296520|FG001|Overall Study|Lost to Follow-up|1|||
126274667|NCT04126213|454296521|FG002|Overall Study|Lost to Follow-up|5|||
126274668|NCT04126213|454296522|FG003|Overall Study|Lost to Follow-up|10|||
126274669|NCT04126213|454296523|FG004|Overall Study|Lost to Follow-up|4|||
126362425|NCT02413346|454619167|FG000|Overall Study|Lost to Follow-up|17|||
126274670|NCT04126213|454296524|FG005|Overall Study|Lost to Follow-up|7|||
126362426|NCT02413346|454619168|FG001|Overall Study|Lost to Follow-up|21|||
126274671|NCT04126213|454296519|FG000|Overall Study|Withdrawal by Subject|3|||
126274672|NCT04126213|454296520|FG001|Overall Study|Withdrawal by Subject|2|||
126274673|NCT04126213|454296521|FG002|Overall Study|Withdrawal by Subject|1|||
126274674|NCT04126213|454296522|FG003|Overall Study|Withdrawal by Subject|1|||
126274675|NCT04126213|454296523|FG004|Overall Study|Withdrawal by Subject|1|||
126274676|NCT04126213|454296524|FG005|Overall Study|Withdrawal by Subject|1|||
126274677|NCT04126213|454296519|FG000|Overall Study|Other|0|||
126274678|NCT04126213|454296520|FG001|Overall Study|Other|0|||
126274679|NCT04126213|454296521|FG002|Overall Study|Other|2|||
126274680|NCT04126213|454296522|FG003|Overall Study|Other|2|||
126274681|NCT04126213|454296523|FG004|Overall Study|Other|0|||
126274682|NCT04126213|454296524|FG005|Overall Study|Other|1|||
126274683|NCT04126213|454296519|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126274684|NCT04126213|454296520|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
126274685|NCT04126213|454296521|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126274686|NCT04126213|454296522|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126274687|NCT04126213|454296523|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126274688|NCT04126213|454296524|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
126274689|NCT02853370|454296527|FG000|Overall Study|Physician Decision|1|||
126274690|NCT02853370|454296527|FG000|Overall Study|Lack of Efficacy|2|||
126274691|NCT02853370|454296527|FG000|Overall Study|Death|1|||
126274692|NCT02853370|454296527|FG000|Overall Study|Adverse Event|4|||
126274693|NCT02853370|454296527|FG000|Overall Study|Withdrawal by Subject|3|||
126274694|NCT02196701|454296528|FG000|Overall Study|Adverse Event|1|||
126274695|NCT02196701|454296528|FG000|Overall Study|Lost to Follow-up|1|||
126274696|NCT02196701|454296528|FG000|Overall Study|Non-adherence to Protocol|1|||
126274697|NCT03275064|454296533|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
126274698|NCT03275064|454296534|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
126274699|NCT03275064|454296535|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
126274700|NCT03275064|454296536|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
126274701|NCT03275064|454296537|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
126274702|NCT03275064|454296533|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
126274703|NCT03275064|454296534|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
126274704|NCT03275064|454296535|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
126274705|NCT03275064|454296536|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
126274706|NCT03275064|454296537|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
126274707|NCT03275064|454296533|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
126274708|NCT03275064|454296534|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
126274709|NCT03275064|454296535|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
126274710|NCT03275064|454296536|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
126274711|NCT03275064|454296537|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
126274712|NCT03275064|454296533|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
126274713|NCT03275064|454296534|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
126274714|NCT03275064|454296535|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
126274715|NCT03275064|454296536|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
126274716|NCT03275064|454296537|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
126274717|NCT03275064|454296533|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
126274718|NCT03275064|454296534|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
126274719|NCT03275064|454296535|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
126274720|NCT03275064|454296536|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
126274721|NCT03275064|454296537|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
126274722|NCT04159935|454296538|FG000|Overall Study|Study terminated due to COVID-19|1|||
126274723|NCT04159935|454296539|FG001|Overall Study|Study terminated due to COVID-19|3|||
126274724|NCT01341782|454296540|FG000|Overall Study|Adverse Event|1|||
126274725|NCT01341782|454296541|FG001|Overall Study|Adverse Event|1|||
126274726|NCT01341782|454296540|FG000|Overall Study|Withdrawal by Subject|6|||
126274727|NCT01341782|454296541|FG001|Overall Study|Withdrawal by Subject|5|||
126274728|NCT01341782|454296540|FG000|Overall Study|Missed 3 consecutive doses|0|||
126706032|NCT01873950|455875517|FG003|Period 5|Withdrawal by Subject|1|||
126706033|NCT01873950|455875518|FG004|Period 5|Withdrawal by Subject|0|||
126706034|NCT01772134|455875523|FG000|Overall Study|Adverse Event|6|||
126706035|NCT01772134|455875524|FG001|Overall Study|Adverse Event|5|||
126706036|NCT01772134|455875525|FG002|Overall Study|Adverse Event|10|||
126706037|NCT01772134|455875523|FG000|Overall Study|Withdrew Consent|3|||
126706038|NCT01772134|455875524|FG001|Overall Study|Withdrew Consent|1|||
126706039|NCT01772134|455875525|FG002|Overall Study|Withdrew Consent|5|||
126706040|NCT01772134|455875523|FG000|Overall Study|Lost to Follow-up|2|||
126765645|NCT01977482|456094583|FG002|Overall Study|Adverse Event|1|||
126765646|NCT01977482|456094584|FG003|Overall Study|Adverse Event|0|||
126274729|NCT01341782|454296541|FG001|Overall Study|Missed 3 consecutive doses|4|||
126274730|NCT01341782|454296540|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
126274731|NCT01341782|454296541|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
126274732|NCT01341782|454296540|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
126274733|NCT01341782|454296541|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
126274734|NCT01341782|454296540|FG000|Overall Study|Other|5|||
126274735|NCT01341782|454296541|FG001|Overall Study|Other|0|||
126453726|NCT01185353|454961511|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
126453727|NCT01185353|454961512|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
126453728|NCT01185353|454961513|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
126453729|NCT01185353|454961514|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
126453730|NCT01185353|454961515|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
126453731|NCT01185353|454961516|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
126453732|NCT01185353|454961517|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
126453733|NCT01185353|454961508|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
126453734|NCT01185353|454961509|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
126453735|NCT01185353|454961510|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
126453736|NCT01185353|454961511|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
126453737|NCT01185353|454961512|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
126453738|NCT01185353|454961513|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
126453739|NCT01185353|454961514|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
126453740|NCT01185353|454961515|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
126453741|NCT01185353|454961516|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
126453742|NCT01185353|454961517|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
126453743|NCT01185353|454961508|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
126453744|NCT01185353|454961509|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
126453745|NCT01185353|454961510|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
126453746|NCT01185353|454961511|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
126453747|NCT01185353|454961512|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
126453748|NCT01185353|454961513|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
126453749|NCT01185353|454961514|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
126453750|NCT01185353|454961515|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
126453751|NCT01185353|454961516|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
126453752|NCT01185353|454961517|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
126453753|NCT01185353|454961508|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
126453754|NCT01185353|454961509|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
126453755|NCT01185353|454961510|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
126453756|NCT01185353|454961511|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
126453757|NCT01185353|454961512|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
126453758|NCT01185353|454961513|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
126453759|NCT01185353|454961514|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
126453760|NCT01185353|454961515|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
126453761|NCT01185353|454961516|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
126453762|NCT01185353|454961517|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
126453763|NCT01185353|454961508|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
126453764|NCT01185353|454961509|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
126453765|NCT01185353|454961510|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
126453766|NCT01185353|454961511|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
126453767|NCT01185353|454961512|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
126453768|NCT01185353|454961513|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
126453769|NCT01185353|454961514|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
126453770|NCT01185353|454961515|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
126453771|NCT01185353|454961516|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
126453772|NCT01185353|454961517|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
126453773|NCT01185353|454961508|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
126453774|NCT01185353|454961509|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
126453775|NCT01185353|454961510|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
126453776|NCT01185353|454961511|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
126453777|NCT01185353|454961512|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
126453778|NCT01185353|454961513|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
126453779|NCT01185353|454961514|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
126453780|NCT01185353|454961515|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
126453781|NCT01185353|454961516|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
126274736|NCT00620555|454296542|FG000|Overall Study|Adverse Event|4|||
126274737|NCT00620555|454296542|FG000|Overall Study|Protocol Violation|2|||
126453782|NCT01185353|454961517|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
126453783|NCT01185353|454961508|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
126453784|NCT01185353|454961509|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
126765647|NCT01977482|456094585|FG004|Overall Study|Adverse Event|2|||
126765648|NCT01977482|456094586|FG005|Overall Study|Adverse Event|0|||
126765649|NCT01977482|456094581|FG000|Overall Study|Lost to Follow-up|1|||
126765650|NCT01977482|456094582|FG001|Overall Study|Lost to Follow-up|0|||
126765651|NCT01977482|456094583|FG002|Overall Study|Lost to Follow-up|0|||
126765652|NCT01977482|456094584|FG003|Overall Study|Lost to Follow-up|0|||
126765653|NCT01977482|456094585|FG004|Overall Study|Lost to Follow-up|0|||
126765654|NCT01977482|456094586|FG005|Overall Study|Lost to Follow-up|0|||
126765655|NCT01977482|456094581|FG000|Overall Study|Physician Decision|0|||
126765656|NCT01977482|456094582|FG001|Overall Study|Physician Decision|1|||
126765657|NCT01977482|456094583|FG002|Overall Study|Physician Decision|0|||
126765658|NCT01977482|456094584|FG003|Overall Study|Physician Decision|0|||
126765659|NCT01977482|456094585|FG004|Overall Study|Physician Decision|0|||
126765660|NCT01977482|456094586|FG005|Overall Study|Physician Decision|0|||
126765661|NCT01977482|456094581|FG000|Overall Study|Protocol Violation|0|||
126765662|NCT01977482|456094582|FG001|Overall Study|Protocol Violation|0|||
126765663|NCT01977482|456094583|FG002|Overall Study|Protocol Violation|1|||
126274738|NCT00620555|454296542|FG000|Overall Study|Lack of Efficacy|12|||
126274739|NCT00620555|454296542|FG000|Overall Study|Withdrawal by Subject|1|||
126274740|NCT00620555|454296542|FG000|Overall Study|Choice of other treatment|1|||
126274741|NCT00620555|454296542|FG000|Overall Study|Visit failure against planned|1|||
126274742|NCT00724048|454296543|FG000|Overall Study|Adverse Event|1|||
126274743|NCT00724048|454296544|FG001|Overall Study|Adverse Event|1|||
126274744|NCT00724048|454296545|FG002|Overall Study|Adverse Event|1|||
126274745|NCT00724048|454296546|FG003|Overall Study|Adverse Event|0|||
126274746|NCT00724048|454296543|FG000|Overall Study|Lost to Follow-up|0|||
126274747|NCT00724048|454296544|FG001|Overall Study|Lost to Follow-up|1|||
126274748|NCT00724048|454296545|FG002|Overall Study|Lost to Follow-up|0|||
126274749|NCT00724048|454296546|FG003|Overall Study|Lost to Follow-up|0|||
126274750|NCT00724048|454296543|FG000|Overall Study|Withdrawal by Subject|1|||
126274751|NCT00724048|454296544|FG001|Overall Study|Withdrawal by Subject|2|||
126274752|NCT00724048|454296545|FG002|Overall Study|Withdrawal by Subject|1|||
126274753|NCT00724048|454296546|FG003|Overall Study|Withdrawal by Subject|2|||
126274754|NCT00724048|454296543|FG000|Overall Study|Investigator decision|0|||
126274755|NCT00724048|454296544|FG001|Overall Study|Investigator decision|0|||
126274756|NCT00724048|454296545|FG002|Overall Study|Investigator decision|1|||
126274757|NCT00724048|454296546|FG003|Overall Study|Investigator decision|0|||
126274758|NCT00724048|454296543|FG000|Overall Study|Did not tolerate study drug|0|||
126274759|NCT00724048|454296544|FG001|Overall Study|Did not tolerate study drug|0|||
126274760|NCT00724048|454296545|FG002|Overall Study|Did not tolerate study drug|0|||
126274761|NCT00724048|454296546|FG003|Overall Study|Did not tolerate study drug|1|||
126274762|NCT00724048|454296543|FG000|Overall Study|Other than specified|1|||
126274763|NCT00724048|454296544|FG001|Overall Study|Other than specified|1|||
126274764|NCT00724048|454296545|FG002|Overall Study|Other than specified|0|||
126274765|NCT00724048|454296546|FG003|Overall Study|Other than specified|0|||
126274766|NCT03923530|454296547|FG000|Overall Study|Withdrawal by Subject|1|||
126274767|NCT03923530|454296547|FG000|Overall Study|screen failure|3|||
126274768|NCT00911807|454296550|FG000|Overall Study|Adverse Event|2|||
126274769|NCT00911807|454296551|FG001|Overall Study|Adverse Event|1|||
126274770|NCT00911807|454296552|FG002|Overall Study|Adverse Event|5|||
126274771|NCT00911807|454296550|FG000|Overall Study|Death|0|||
126274772|NCT00911807|454296551|FG001|Overall Study|Death|0|||
126274773|NCT00911807|454296552|FG002|Overall Study|Death|1|||
126274774|NCT00911807|454296550|FG000|Overall Study|Protocol Violation|6|||
126274775|NCT00911807|454296551|FG001|Overall Study|Protocol Violation|4|||
126274776|NCT00911807|454296552|FG002|Overall Study|Protocol Violation|9|||
126274777|NCT00911807|454296550|FG000|Overall Study|Withdrawal by Subject|8|||
126274778|NCT00911807|454296551|FG001|Overall Study|Withdrawal by Subject|10|||
126274779|NCT00911807|454296552|FG002|Overall Study|Withdrawal by Subject|7|||
126274780|NCT00911807|454296550|FG000|Overall Study|Organizational reasons|1|||
126274781|NCT00911807|454296551|FG001|Overall Study|Organizational reasons|3|||
126274782|NCT00911807|454296552|FG002|Overall Study|Organizational reasons|1|||
126274783|NCT00809159|454296553|FG000|Part 1|Adverse Event|1|||
126274784|NCT00809159|454296554|FG001|Part 1|Adverse Event|1|||
126274785|NCT00809159|454296555|FG002|Part 1|Adverse Event|0|||
126274786|NCT00809159|454296556|FG003|Part 1|Adverse Event|0|||
126274787|NCT00809159|454296557|FG004|Part 1|Adverse Event|0|||
126274788|NCT00809159|454296558|FG005|Part 1|Adverse Event|0|||
126274789|NCT00809159|454296553|FG000|Part 1|Lost to Follow-up|1|||
126274790|NCT00809159|454296554|FG001|Part 1|Lost to Follow-up|0|||
126274791|NCT00809159|454296555|FG002|Part 1|Lost to Follow-up|0|||
126274792|NCT00809159|454296556|FG003|Part 1|Lost to Follow-up|0|||
126274793|NCT00809159|454296557|FG004|Part 1|Lost to Follow-up|0|||
126274794|NCT00809159|454296558|FG005|Part 1|Lost to Follow-up|0|||
126274795|NCT00809159|454296553|FG000|Part 1|Withdrawal by Subject|3|||
126274796|NCT00809159|454296554|FG001|Part 1|Withdrawal by Subject|1|||
126274797|NCT00809159|454296555|FG002|Part 1|Withdrawal by Subject|0|||
126274798|NCT00809159|454296556|FG003|Part 1|Withdrawal by Subject|0|||
126274799|NCT00809159|454296557|FG004|Part 1|Withdrawal by Subject|0|||
126274800|NCT00809159|454296558|FG005|Part 1|Withdrawal by Subject|0|||
126274801|NCT00809159|454296553|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
126274802|NCT00809159|454296554|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
126274803|NCT00809159|454296555|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
126274804|NCT00809159|454296556|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
126274805|NCT00809159|454296557|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
126274806|NCT00809159|454296558|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
126274807|NCT00809159|454296553|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
126274808|NCT00809159|454296554|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
126274809|NCT00809159|454296555|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
126274810|NCT00809159|454296556|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
126274811|NCT00809159|454296557|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
126274812|NCT00809159|454296558|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
126274813|NCT00809159|454296553|FG000|Part 1 and 2|Administrative problems|0|||
126274814|NCT00809159|454296554|FG001|Part 1 and 2|Administrative problems|0|||
126274815|NCT00809159|454296555|FG002|Part 1 and 2|Administrative problems|0|||
126274816|NCT00809159|454296556|FG003|Part 1 and 2|Administrative problems|1|||
126274817|NCT00809159|454296557|FG004|Part 1 and 2|Administrative problems|0|||
126274818|NCT00809159|454296558|FG005|Part 1 and 2|Administrative problems|0|||
126274819|NCT00809159|454296553|FG000|Part 1 and 2|Adverse Event|0|||
126274820|NCT00809159|454296554|FG001|Part 1 and 2|Adverse Event|0|||
126274821|NCT00809159|454296555|FG002|Part 1 and 2|Adverse Event|1|||
126274822|NCT00809159|454296556|FG003|Part 1 and 2|Adverse Event|0|||
126274823|NCT00809159|454296557|FG004|Part 1 and 2|Adverse Event|1|||
126274824|NCT00809159|454296558|FG005|Part 1 and 2|Adverse Event|1|||
126274825|NCT00809159|454296553|FG000|Part 1 and 2|Lost to Follow-up|0|||
126274826|NCT00809159|454296554|FG001|Part 1 and 2|Lost to Follow-up|0|||
126274827|NCT00809159|454296555|FG002|Part 1 and 2|Lost to Follow-up|1|||
126274828|NCT00809159|454296556|FG003|Part 1 and 2|Lost to Follow-up|1|||
126274829|NCT00809159|454296557|FG004|Part 1 and 2|Lost to Follow-up|0|||
126274830|NCT00809159|454296558|FG005|Part 1 and 2|Lost to Follow-up|0|||
126274831|NCT00809159|454296553|FG000|Part 1 and 2|Withdrawal by Subject|0|||
126274832|NCT00809159|454296554|FG001|Part 1 and 2|Withdrawal by Subject|0|||
126274833|NCT00809159|454296555|FG002|Part 1 and 2|Withdrawal by Subject|4|||
126274834|NCT00809159|454296556|FG003|Part 1 and 2|Withdrawal by Subject|0|||
126274835|NCT00809159|454296557|FG004|Part 1 and 2|Withdrawal by Subject|0|||
126274836|NCT00809159|454296558|FG005|Part 1 and 2|Withdrawal by Subject|1|||
126274837|NCT01672970|454296561|FG000|Overall Study|Lack of Efficacy|12|||
126274838|NCT01672970|454296561|FG000|Overall Study|Adverse Event|18|||
126274839|NCT01672970|454296561|FG000|Overall Study|Withdrawal by Subject|2|||
126274840|NCT01672970|454296561|FG000|Overall Study|Lost to Follow-up|5|||
126274841|NCT01672970|454296561|FG000|Overall Study|Other|9|||
126274842|NCT01672970|454296561|FG000|Overall Study|Enrolled but not treated|1|||
126274843|NCT03835221|454296566|FG000|Methafilcon A|Withdrawal by Subject|1|||
126274844|NCT01770392|454296568|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
126274845|NCT04639713|454296571|FG000|Overall Study|Protocol Noncompliance|2|||
126274846|NCT04639713|454296571|FG000|Overall Study|Withdrawal by Subject|1|||
126274847|NCT00390221|454296572|FG000|Overall Study|Lost to Follow-up|0|||
126274848|NCT00390221|454296573|FG001|Overall Study|Lost to Follow-up|3|||
126274849|NCT00390221|454296574|FG002|Overall Study|Lost to Follow-up|0|||
126274850|NCT00390221|454296572|FG000|Overall Study|Adverse Event|1|||
126274851|NCT00390221|454296573|FG001|Overall Study|Adverse Event|4|||
126274852|NCT00390221|454296574|FG002|Overall Study|Adverse Event|3|||
126274853|NCT00390221|454296572|FG000|Overall Study|Investigator Decision|0|||
126362427|NCT02413346|454619167|FG000|Overall Study|Protocol Violation|2|||
126362428|NCT02413346|454619168|FG001|Overall Study|Protocol Violation|0|||
126274854|NCT00390221|454296573|FG001|Overall Study|Investigator Decision|0|||
126274855|NCT00390221|454296574|FG002|Overall Study|Investigator Decision|1|||
126274856|NCT00390221|454296572|FG000|Overall Study|Withdrawal by Subject|13|||
126274857|NCT00390221|454296573|FG001|Overall Study|Withdrawal by Subject|9|||
126274858|NCT00390221|454296574|FG002|Overall Study|Withdrawal by Subject|7|||
126274859|NCT00390221|454296572|FG000|Overall Study|Subject Non-compliance|1|||
126274860|NCT00390221|454296573|FG001|Overall Study|Subject Non-compliance|0|||
126274861|NCT00390221|454296574|FG002|Overall Study|Subject Non-compliance|2|||
126274862|NCT00390221|454296572|FG000|Overall Study|Other|3|||
126274863|NCT00390221|454296573|FG001|Overall Study|Other|4|||
126274864|NCT00390221|454296574|FG002|Overall Study|Other|2|||
126274865|NCT02533375|454296577|FG000|Overall Study|Lack of Efficacy|3|||
126274866|NCT02533375|454296577|FG000|Overall Study|Adverse Event|2|||
126362429|NCT02413346|454619167|FG000|Overall Study|Other Miscellaneous Reasons|4|||
126706041|NCT01772134|455875524|FG001|Overall Study|Lost to Follow-up|0|||
126706042|NCT01772134|455875525|FG002|Overall Study|Lost to Follow-up|0|||
126706043|NCT01772134|455875523|FG000|Overall Study|Protocol Deviation|4|||
126706044|NCT01772134|455875524|FG001|Overall Study|Protocol Deviation|3|||
126706045|NCT01772134|455875525|FG002|Overall Study|Protocol Deviation|3|||
126706046|NCT01772134|455875523|FG000|Overall Study|Lack of Efficacy|11|||
126706047|NCT01772134|455875524|FG001|Overall Study|Lack of Efficacy|5|||
126274867|NCT02582866|454296584|FG000|Overall Study|Death|1|||
126274868|NCT02582866|454296584|FG000|Overall Study|Lack of Efficacy|2|||
126274869|NCT02582866|454296584|FG000|Overall Study|Lost to Follow-up|2|||
126274870|NCT02582866|454296584|FG000|Overall Study|Withdrawal by Subject|7|||
126274871|NCT02582866|454296584|FG000|Overall Study|Investigator decision|5|||
126274872|NCT02582866|454296584|FG000|Overall Study|Participant wants to get pregnant|1|||
126274873|NCT02582866|454296584|FG000|Overall Study|Pregnancy|2|||
126274874|NCT02582866|454296584|FG000|Overall Study|Sponsor decision|1|||
126274875|NCT02582866|454296584|FG000|Overall Study|Withdrawal due to personal reasons|1|||
126274876|NCT01193127|454296591|FG000|Randomized|Surgery Cancelled|0|||
126274877|NCT01193127|454296592|FG001|Randomized|Surgery Cancelled|0|||
126274878|NCT01193127|454296593|FG002|Randomized|Surgery Cancelled|0|||
126274879|NCT01193127|454296594|FG003|Randomized|Surgery Cancelled|1|||
126274880|NCT01193127|454296591|FG000|Treated|Withdrawal by Subject|0|||
126274881|NCT01193127|454296592|FG001|Treated|Withdrawal by Subject|0|||
126274882|NCT01193127|454296593|FG002|Treated|Withdrawal by Subject|0|||
126274883|NCT01193127|454296594|FG003|Treated|Withdrawal by Subject|1|||
126274884|NCT03246646|454296597|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
126274885|NCT03246646|454296598|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
126274886|NCT03246646|454296597|FG000|Overall Study|Withdrawal by Subject|3|||
126274887|NCT03246646|454296598|FG001|Overall Study|Withdrawal by Subject|0|||
126274888|NCT03246646|454296597|FG000|Overall Study|Lost to Follow-up|7|||
126274889|NCT03246646|454296598|FG001|Overall Study|Lost to Follow-up|0|||
126274890|NCT02352779|454296601|FG000|Overall Study|Personal Issues|1|||
126274891|NCT02352779|454296602|FG001|Overall Study|Personal Issues|1|||
126274892|NCT02352779|454296603|FG002|Overall Study|Personal Issues|0|||
126274893|NCT02352779|454296601|FG000|Overall Study|Too Many Forms|2|||
126274894|NCT02352779|454296602|FG001|Overall Study|Too Many Forms|0|||
126274895|NCT02352779|454296603|FG002|Overall Study|Too Many Forms|0|||
126274896|NCT02352779|454296601|FG000|Overall Study|Feeling Overwhelmed|1|||
126274897|NCT02352779|454296602|FG001|Overall Study|Feeling Overwhelmed|0|||
126274898|NCT02352779|454296603|FG002|Overall Study|Feeling Overwhelmed|0|||
126274899|NCT02352779|454296601|FG000|Overall Study|Disliked Intervention|1|||
126274900|NCT02352779|454296602|FG001|Overall Study|Disliked Intervention|0|||
126274901|NCT02352779|454296603|FG002|Overall Study|Disliked Intervention|0|||
126274902|NCT02352779|454296601|FG000|Overall Study|Changed Mind|1|||
126274903|NCT02352779|454296602|FG001|Overall Study|Changed Mind|0|||
126274904|NCT02352779|454296603|FG002|Overall Study|Changed Mind|0|||
126274905|NCT02352779|454296601|FG000|Overall Study|Study Related Symptoms|1|||
126274906|NCT02352779|454296602|FG001|Overall Study|Study Related Symptoms|0|||
126274907|NCT02352779|454296603|FG002|Overall Study|Study Related Symptoms|0|||
126274908|NCT02352779|454296601|FG000|Overall Study|Absence of Symptoms|1|||
126274909|NCT02352779|454296602|FG001|Overall Study|Absence of Symptoms|0|||
126274910|NCT02352779|454296603|FG002|Overall Study|Absence of Symptoms|0|||
126274911|NCT02352779|454296601|FG000|Overall Study|Other Medical Reason|0|||
126274912|NCT02352779|454296602|FG001|Overall Study|Other Medical Reason|0|||
126274913|NCT02352779|454296603|FG002|Overall Study|Other Medical Reason|1|||
126274914|NCT02352779|454296601|FG000|Overall Study|No Reason|0|||
126274915|NCT02352779|454296602|FG001|Overall Study|No Reason|0|||
126274916|NCT02352779|454296603|FG002|Overall Study|No Reason|1|||
126274917|NCT00871741|454296604|FG000|Overall Study|Premature study termination|9|||
126274918|NCT00871741|454296605|FG001|Overall Study|Premature study termination|7|||
126274919|NCT01565850|454296610|FG000|Overall Study|Adverse Event|0|||
126274920|NCT01565850|454296611|FG001|Overall Study|Adverse Event|1|||
126274921|NCT01565850|454296610|FG000|Overall Study|Lost to Follow-up|12|||
126274922|NCT01565850|454296611|FG001|Overall Study|Lost to Follow-up|4|||
126274923|NCT01565850|454296610|FG000|Overall Study|Investigator's Discretion|2|||
126274924|NCT01565850|454296611|FG001|Overall Study|Investigator's Discretion|1|||
126706048|NCT01772134|455875525|FG002|Overall Study|Lack of Efficacy|3|||
126706049|NCT01772134|455875523|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
126706050|NCT01772134|455875524|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
126706051|NCT01772134|455875525|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
126706052|NCT01772134|455875523|FG000|Overall Study|Randomized Study Medication Not Received|2|||
126706053|NCT01772134|455875524|FG001|Overall Study|Randomized Study Medication Not Received|0|||
126274925|NCT01565850|454296610|FG000|Overall Study|Participant noncompliance|2|||
126765664|NCT01977482|456094584|FG003|Overall Study|Protocol Violation|0|||
126274926|NCT01565850|454296611|FG001|Overall Study|Participant noncompliance|0|||
126274927|NCT01565850|454296610|FG000|Overall Study|Withdrew Consent|4|||
126274928|NCT01565850|454296611|FG001|Overall Study|Withdrew Consent|2|||
126453785|NCT01185353|454961510|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
126453786|NCT01185353|454961511|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
126274929|NCT03611543|454299844|FG000|Overall Study|Withdrawal by Subject|4|||
126274930|NCT03611543|454299845|FG001|Overall Study|Withdrawal by Subject|4|||
126274931|NCT03611543|454299844|FG000|Overall Study|Physician Decision|1|||
126274932|NCT03611543|454299845|FG001|Overall Study|Physician Decision|1|||
126274933|NCT03611543|454299844|FG000|Overall Study|Protocol Violation|2|||
126274934|NCT03611543|454299845|FG001|Overall Study|Protocol Violation|2|||
126274935|NCT03611543|454299844|FG000|Overall Study|Device failure|2|||
126274936|NCT03611543|454299845|FG001|Overall Study|Device failure|2|||
126274937|NCT03611543|454299844|FG000|Overall Study|Missing information|5|||
126274938|NCT03611543|454299845|FG001|Overall Study|Missing information|5|||
126274939|NCT02799095|454299846|FG000|Part A|Adverse Event|1|||
126274940|NCT02799095|454299847|FG001|Part A|Adverse Event|0|||
126274941|NCT02799095|454299848|FG002|Part A|Adverse Event|1|||
126274942|NCT02799095|454299849|FG003|Part A|Adverse Event|4|||
126274943|NCT02799095|454299850|FG004|Part A|Adverse Event|1|||
126274944|NCT02799095|454299851|FG005|Part A|Adverse Event|0|||
126274945|NCT02799095|454299852|FG006|Part A|Adverse Event|0|||
126274946|NCT02799095|454299853|FG007|Part A|Adverse Event|0|||
126274947|NCT02799095|454299854|FG008|Part A|Adverse Event|0|||
126274948|NCT02799095|454299855|FG009|Part A|Adverse Event|0|||
126274949|NCT02799095|454299856|FG010|Part A|Adverse Event|0|||
126274950|NCT02799095|454299857|FG011|Part A|Adverse Event|0|||
126274951|NCT02799095|454299858|FG012|Part A|Adverse Event|0|||
126274952|NCT02799095|454299859|FG013|Part A|Adverse Event|0|||
126274953|NCT02799095|454299860|FG014|Part A|Adverse Event|0|||
126274954|NCT02799095|454299861|FG015|Part A|Adverse Event|0|||
126274955|NCT02799095|454299862|FG016|Part A|Adverse Event|0|||
126274956|NCT02799095|454299846|FG000|Part A|Death|0|||
126274957|NCT02799095|454299847|FG001|Part A|Death|0|||
126274958|NCT02799095|454299848|FG002|Part A|Death|0|||
126274959|NCT02799095|454299849|FG003|Part A|Death|0|||
126274960|NCT02799095|454299850|FG004|Part A|Death|0|||
126274961|NCT02799095|454299851|FG005|Part A|Death|0|||
126274962|NCT02799095|454299852|FG006|Part A|Death|3|||
126274963|NCT02799095|454299853|FG007|Part A|Death|0|||
126274964|NCT02799095|454299854|FG008|Part A|Death|0|||
126274965|NCT02799095|454299855|FG009|Part A|Death|0|||
126274966|NCT02799095|454299856|FG010|Part A|Death|0|||
126274967|NCT02799095|454299857|FG011|Part A|Death|0|||
126274968|NCT02799095|454299858|FG012|Part A|Death|0|||
126274969|NCT02799095|454299859|FG013|Part A|Death|0|||
126274970|NCT02799095|454299860|FG014|Part A|Death|0|||
126274971|NCT02799095|454299861|FG015|Part A|Death|0|||
126274972|NCT02799095|454299862|FG016|Part A|Death|0|||
126274973|NCT02799095|454299846|FG000|Part A|Lost to Follow-up|0|||
126274974|NCT02799095|454299847|FG001|Part A|Lost to Follow-up|1|||
126274975|NCT02799095|454299848|FG002|Part A|Lost to Follow-up|0|||
126274976|NCT02799095|454299849|FG003|Part A|Lost to Follow-up|0|||
126274977|NCT02799095|454299850|FG004|Part A|Lost to Follow-up|0|||
126274978|NCT02799095|454299851|FG005|Part A|Lost to Follow-up|0|||
126274979|NCT02799095|454299852|FG006|Part A|Lost to Follow-up|1|||
126274980|NCT02799095|454299853|FG007|Part A|Lost to Follow-up|0|||
126274981|NCT02799095|454299854|FG008|Part A|Lost to Follow-up|0|||
126274982|NCT02799095|454299855|FG009|Part A|Lost to Follow-up|0|||
126274983|NCT02799095|454299856|FG010|Part A|Lost to Follow-up|0|||
126274984|NCT02799095|454299857|FG011|Part A|Lost to Follow-up|0|||
126274985|NCT02799095|454299858|FG012|Part A|Lost to Follow-up|0|||
126274986|NCT02799095|454299859|FG013|Part A|Lost to Follow-up|0|||
126274987|NCT02799095|454299860|FG014|Part A|Lost to Follow-up|0|||
126274988|NCT02799095|454299861|FG015|Part A|Lost to Follow-up|0|||
126274989|NCT02799095|454299862|FG016|Part A|Lost to Follow-up|0|||
126274990|NCT02799095|454299846|FG000|Part A|Progressive Disease|3|||
126274991|NCT02799095|454299847|FG001|Part A|Progressive Disease|3|||
126274992|NCT02799095|454299848|FG002|Part A|Progressive Disease|3|||
126274993|NCT02799095|454299849|FG003|Part A|Progressive Disease|2|||
126274994|NCT02799095|454299850|FG004|Part A|Progressive Disease|2|||
126274995|NCT02799095|454299851|FG005|Part A|Progressive Disease|0|||
126274996|NCT02799095|454299852|FG006|Part A|Progressive Disease|0|||
126274997|NCT02799095|454299853|FG007|Part A|Progressive Disease|0|||
126274998|NCT02799095|454299854|FG008|Part A|Progressive Disease|0|||
126274999|NCT02799095|454299855|FG009|Part A|Progressive Disease|0|||
126275000|NCT02799095|454299856|FG010|Part A|Progressive Disease|0|||
126275001|NCT02799095|454299857|FG011|Part A|Progressive Disease|0|||
126275002|NCT02799095|454299858|FG012|Part A|Progressive Disease|0|||
126275003|NCT02799095|454299859|FG013|Part A|Progressive Disease|0|||
126275004|NCT02799095|454299860|FG014|Part A|Progressive Disease|0|||
126275005|NCT02799095|454299861|FG015|Part A|Progressive Disease|0|||
126275006|NCT02799095|454299862|FG016|Part A|Progressive Disease|0|||
126275007|NCT02799095|454299846|FG000|Part A|Clinical Progression|1|||
126275008|NCT02799095|454299847|FG001|Part A|Clinical Progression|0|||
126275009|NCT02799095|454299848|FG002|Part A|Clinical Progression|2|||
126275010|NCT02799095|454299849|FG003|Part A|Clinical Progression|1|||
126275011|NCT02799095|454299850|FG004|Part A|Clinical Progression|5|||
126275012|NCT02799095|454299851|FG005|Part A|Clinical Progression|0|||
126275013|NCT02799095|454299852|FG006|Part A|Clinical Progression|0|||
126275014|NCT02799095|454299853|FG007|Part A|Clinical Progression|0|||
126275015|NCT02799095|454299854|FG008|Part A|Clinical Progression|0|||
126275016|NCT02799095|454299855|FG009|Part A|Clinical Progression|0|||
126275017|NCT02799095|454299856|FG010|Part A|Clinical Progression|0|||
126275018|NCT02799095|454299857|FG011|Part A|Clinical Progression|0|||
126275019|NCT02799095|454299858|FG012|Part A|Clinical Progression|0|||
126275020|NCT02799095|454299859|FG013|Part A|Clinical Progression|0|||
126275021|NCT02799095|454299860|FG014|Part A|Clinical Progression|0|||
126275022|NCT02799095|454299861|FG015|Part A|Clinical Progression|0|||
126706054|NCT01772134|455875525|FG002|Overall Study|Randomized Study Medication Not Received|1|||
126706055|NCT03486314|455875530|FG000|Part A|Adverse Event|1|||
126275023|NCT02799095|454299862|FG016|Part A|Clinical Progression|0|||
126275024|NCT02799095|454299846|FG000|Part A|Protocol Deviation|0|||
126275025|NCT02799095|454299847|FG001|Part A|Protocol Deviation|0|||
126275026|NCT02799095|454299848|FG002|Part A|Protocol Deviation|1|||
126275027|NCT02799095|454299849|FG003|Part A|Protocol Deviation|0|||
126275028|NCT02799095|454299850|FG004|Part A|Protocol Deviation|0|||
126275029|NCT02799095|454299851|FG005|Part A|Protocol Deviation|0|||
126275030|NCT02799095|454299852|FG006|Part A|Protocol Deviation|0|||
126275031|NCT02799095|454299853|FG007|Part A|Protocol Deviation|0|||
126275032|NCT02799095|454299854|FG008|Part A|Protocol Deviation|0|||
126275033|NCT02799095|454299855|FG009|Part A|Protocol Deviation|0|||
126275034|NCT02799095|454299856|FG010|Part A|Protocol Deviation|0|||
126275035|NCT02799095|454299857|FG011|Part A|Protocol Deviation|0|||
126275036|NCT02799095|454299858|FG012|Part A|Protocol Deviation|0|||
126275037|NCT02799095|454299859|FG013|Part A|Protocol Deviation|0|||
126275038|NCT02799095|454299860|FG014|Part A|Protocol Deviation|0|||
126275039|NCT02799095|454299861|FG015|Part A|Protocol Deviation|0|||
126547404|NCT00244374|455297935|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
126275040|NCT02799095|454299862|FG016|Part A|Protocol Deviation|0|||
126275041|NCT02799095|454299846|FG000|Part A|Withdrawal by Subject|0|||
126275042|NCT02799095|454299847|FG001|Part A|Withdrawal by Subject|0|||
126547405|NCT00244374|455297936|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
126706056|NCT03486314|455875531|FG001|Part A|Adverse Event|0|||
126706057|NCT03486314|455875532|FG002|Part A|Adverse Event|0|||
126706058|NCT03486314|455875530|FG000|Part A|Symptomatic Deterioration|2|||
126706059|NCT03486314|455875531|FG001|Part A|Symptomatic Deterioration|0|||
126706060|NCT03486314|455875532|FG002|Part A|Symptomatic Deterioration|0|||
126706061|NCT00659438|455875533|FG000|Overall Study|Withdrawal by Subject|2|||
126706062|NCT00659438|455875534|FG001|Overall Study|Withdrawal by Subject|2|||
126706063|NCT00659438|455875533|FG000|Overall Study|Death|11|||
126706064|NCT00659438|455875534|FG001|Overall Study|Death|6|||
126706065|NCT00659438|455875533|FG000|Overall Study|Lost to Follow-up|1|||
126706066|NCT00659438|455875534|FG001|Overall Study|Lost to Follow-up|0|||
126706067|NCT02388776|455875535|FG000|Overall Study|Death|1|||
126275043|NCT02799095|454299848|FG002|Part A|Withdrawal by Subject|0|||
126275044|NCT02799095|454299849|FG003|Part A|Withdrawal by Subject|1|||
126275045|NCT02799095|454299850|FG004|Part A|Withdrawal by Subject|3|||
126275046|NCT02799095|454299851|FG005|Part A|Withdrawal by Subject|1|||
126275047|NCT02799095|454299852|FG006|Part A|Withdrawal by Subject|1|||
126275048|NCT02799095|454299853|FG007|Part A|Withdrawal by Subject|0|||
126362430|NCT02413346|454619168|FG001|Overall Study|Other Miscellaneous Reasons|3|||
126362431|NCT01316900|454619171|FG000|Overall Study|Adverse Event|10|||
126362432|NCT01316900|454619172|FG001|Overall Study|Adverse Event|10|||
126362433|NCT01316900|454619173|FG002|Overall Study|Adverse Event|15|||
126362434|NCT01316900|454619174|FG003|Overall Study|Adverse Event|9|||
126362435|NCT01316900|454619171|FG000|Overall Study|Lack of Efficacy|17|||
126362436|NCT01316900|454619172|FG001|Overall Study|Lack of Efficacy|9|||
126362437|NCT01316900|454619173|FG002|Overall Study|Lack of Efficacy|5|||
126362438|NCT01316900|454619174|FG003|Overall Study|Lack of Efficacy|7|||
126362439|NCT01316900|454619171|FG000|Overall Study|Protocol Violation|7|||
126362440|NCT01316900|454619172|FG001|Overall Study|Protocol Violation|1|||
126362441|NCT01316900|454619173|FG002|Overall Study|Protocol Violation|4|||
126362442|NCT01316900|454619174|FG003|Overall Study|Protocol Violation|0|||
126362443|NCT01316900|454619171|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
126362444|NCT01316900|454619172|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
126362445|NCT01316900|454619173|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
126362446|NCT01316900|454619174|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
126362447|NCT01316900|454619171|FG000|Overall Study|Lost to Follow-up|1|||
126362448|NCT01316900|454619172|FG001|Overall Study|Lost to Follow-up|0|||
126362449|NCT01316900|454619173|FG002|Overall Study|Lost to Follow-up|1|||
126362450|NCT01316900|454619174|FG003|Overall Study|Lost to Follow-up|1|||
126362451|NCT01316900|454619171|FG000|Overall Study|Withdrawal by Subject|7|||
126362452|NCT01316900|454619172|FG001|Overall Study|Withdrawal by Subject|8|||
126362453|NCT01316900|454619173|FG002|Overall Study|Withdrawal by Subject|6|||
126362454|NCT01316900|454619174|FG003|Overall Study|Withdrawal by Subject|9|||
126362455|NCT01684033|454619175|FG000|Period 1, First 30 Days|Adverse Event|1|||
126362456|NCT01684033|454619176|FG001|Period 1, First 30 Days|Adverse Event|1|||
126362457|NCT01684033|454619175|FG000|Period 1, First 30 Days|Noncompliance|1|||
126706068|NCT02388776|455875535|FG000|Overall Study|Lost to Follow-up|1|||
126706069|NCT00542828|455875537|FG000|Overall Study|Physician Decision|1|||
126706070|NCT00542828|455875537|FG000|Overall Study|Need for Prohibited Treatment|3|||
126706071|NCT00542828|455875537|FG000|Overall Study|Study Prematurely Discontinued|7|||
126275049|NCT02799095|454299854|FG008|Part A|Withdrawal by Subject|0|||
126275050|NCT02799095|454299855|FG009|Part A|Withdrawal by Subject|0|||
126275051|NCT02799095|454299856|FG010|Part A|Withdrawal by Subject|0|||
126275052|NCT02799095|454299857|FG011|Part A|Withdrawal by Subject|0|||
126362458|NCT01684033|454619176|FG001|Period 1, First 30 Days|Noncompliance|0|||
126362459|NCT01684033|454619175|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
126275053|NCT02799095|454299858|FG012|Part A|Withdrawal by Subject|0|||
126275054|NCT02799095|454299859|FG013|Part A|Withdrawal by Subject|0|||
126275055|NCT02799095|454299860|FG014|Part A|Withdrawal by Subject|0|||
126275056|NCT02799095|454299861|FG015|Part A|Withdrawal by Subject|0|||
126275057|NCT02799095|454299862|FG016|Part A|Withdrawal by Subject|0|||
126706072|NCT00542828|455875537|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
126706073|NCT03228186|455875540|FG000|Overall Study|Patient never started treatment|1|||
126706074|NCT04246047|455875543|FG000|Overall Study|Death|50|||
126706075|NCT04246047|455875544|FG001|Overall Study|Death|77|||
126275058|NCT02799095|454299846|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
126275059|NCT02799095|454299847|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
126275060|NCT02799095|454299848|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
126275061|NCT02799095|454299849|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
126275062|NCT02799095|454299850|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
126275063|NCT02799095|454299851|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
126275064|NCT02799095|454299852|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
126275065|NCT02799095|454299853|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
126275066|NCT02799095|454299854|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
126275067|NCT02799095|454299855|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
126275068|NCT02799095|454299856|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
126275069|NCT02799095|454299857|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
126275070|NCT02799095|454299858|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
126275071|NCT02799095|454299859|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
126275072|NCT02799095|454299860|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
126275073|NCT02799095|454299861|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
126275074|NCT02799095|454299862|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
126275075|NCT02799095|454299846|FG000|Part B|Death|0|||
126275076|NCT02799095|454299847|FG001|Part B|Death|0|||
126275077|NCT02799095|454299848|FG002|Part B|Death|0|||
126275078|NCT02799095|454299849|FG003|Part B|Death|0|||
126275079|NCT02799095|454299850|FG004|Part B|Death|0|||
126275080|NCT02799095|454299851|FG005|Part B|Death|0|||
126275081|NCT02799095|454299852|FG006|Part B|Death|0|||
126275082|NCT02799095|454299853|FG007|Part B|Death|7|||
126275083|NCT02799095|454299854|FG008|Part B|Death|7|||
126275084|NCT02799095|454299855|FG009|Part B|Death|0|||
126275085|NCT02799095|454299856|FG010|Part B|Death|0|||
126275086|NCT02799095|454299857|FG011|Part B|Death|0|||
126275087|NCT02799095|454299858|FG012|Part B|Death|0|||
126275088|NCT02799095|454299859|FG013|Part B|Death|0|||
126275089|NCT02799095|454299860|FG014|Part B|Death|0|||
126275090|NCT02799095|454299861|FG015|Part B|Death|0|||
126275091|NCT02799095|454299862|FG016|Part B|Death|0|||
126275092|NCT02799095|454299846|FG000|Part B|Progressive Disease|0|||
126275093|NCT02799095|454299847|FG001|Part B|Progressive Disease|0|||
126275094|NCT02799095|454299848|FG002|Part B|Progressive Disease|0|||
126275095|NCT02799095|454299849|FG003|Part B|Progressive Disease|0|||
126275096|NCT02799095|454299850|FG004|Part B|Progressive Disease|0|||
126275097|NCT02799095|454299851|FG005|Part B|Progressive Disease|0|||
126275098|NCT02799095|454299852|FG006|Part B|Progressive Disease|0|||
126275099|NCT02799095|454299853|FG007|Part B|Progressive Disease|1|||
126275100|NCT02799095|454299854|FG008|Part B|Progressive Disease|0|||
126275101|NCT02799095|454299855|FG009|Part B|Progressive Disease|0|||
126275102|NCT02799095|454299856|FG010|Part B|Progressive Disease|0|||
126275103|NCT02799095|454299857|FG011|Part B|Progressive Disease|0|||
126275104|NCT02799095|454299858|FG012|Part B|Progressive Disease|0|||
126275105|NCT02799095|454299859|FG013|Part B|Progressive Disease|0|||
126275106|NCT02799095|454299860|FG014|Part B|Progressive Disease|0|||
126275107|NCT02799095|454299861|FG015|Part B|Progressive Disease|0|||
126275108|NCT02799095|454299862|FG016|Part B|Progressive Disease|0|||
126275109|NCT02799095|454299846|FG000|Part B|Withdrawal by Subject|0|||
126275110|NCT02799095|454299847|FG001|Part B|Withdrawal by Subject|0|||
126275111|NCT02799095|454299848|FG002|Part B|Withdrawal by Subject|0|||
126275112|NCT02799095|454299849|FG003|Part B|Withdrawal by Subject|0|||
126275113|NCT02799095|454299850|FG004|Part B|Withdrawal by Subject|0|||
126275114|NCT02799095|454299851|FG005|Part B|Withdrawal by Subject|0|||
126275115|NCT02799095|454299852|FG006|Part B|Withdrawal by Subject|0|||
126275116|NCT02799095|454299853|FG007|Part B|Withdrawal by Subject|10|||
126275117|NCT02799095|454299854|FG008|Part B|Withdrawal by Subject|7|||
126275118|NCT02799095|454299855|FG009|Part B|Withdrawal by Subject|0|||
126275119|NCT02799095|454299856|FG010|Part B|Withdrawal by Subject|0|||
126275120|NCT02799095|454299857|FG011|Part B|Withdrawal by Subject|0|||
126706076|NCT04246047|455875543|FG000|Overall Study|Lost to Follow-up|1|||
126706077|NCT04246047|455875544|FG001|Overall Study|Lost to Follow-up|3|||
126275121|NCT02799095|454299858|FG012|Part B|Withdrawal by Subject|0|||
126275122|NCT02799095|454299859|FG013|Part B|Withdrawal by Subject|0|||
126275123|NCT02799095|454299860|FG014|Part B|Withdrawal by Subject|0|||
126275124|NCT02799095|454299861|FG015|Part B|Withdrawal by Subject|0|||
126706078|NCT04246047|455875543|FG000|Overall Study|Physician Decision|4|||
126706079|NCT04246047|455875544|FG001|Overall Study|Physician Decision|10|||
126275125|NCT02799095|454299862|FG016|Part B|Withdrawal by Subject|0|||
126275126|NCT02799095|454299846|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
126275127|NCT02799095|454299847|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
126275128|NCT02799095|454299848|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
126275129|NCT02799095|454299849|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
126275130|NCT02799095|454299850|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
126275131|NCT02799095|454299851|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
126275132|NCT02799095|454299852|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
126275133|NCT02799095|454299853|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
126275134|NCT02799095|454299854|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
126275135|NCT02799095|454299855|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
126275136|NCT02799095|454299856|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
126275137|NCT02799095|454299857|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
126275138|NCT02799095|454299858|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
126275139|NCT02799095|454299859|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
126275140|NCT02799095|454299860|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
126275141|NCT02799095|454299861|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
126275142|NCT02799095|454299862|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
126275143|NCT02799095|454299846|FG000|Part C|Adverse Event|0|||
126275144|NCT02799095|454299847|FG001|Part C|Adverse Event|0|||
126275145|NCT02799095|454299848|FG002|Part C|Adverse Event|0|||
126275146|NCT02799095|454299849|FG003|Part C|Adverse Event|0|||
126275147|NCT02799095|454299850|FG004|Part C|Adverse Event|0|||
126275148|NCT02799095|454299851|FG005|Part C|Adverse Event|0|||
126275149|NCT02799095|454299852|FG006|Part C|Adverse Event|0|||
126275150|NCT02799095|454299853|FG007|Part C|Adverse Event|0|||
126275151|NCT02799095|454299854|FG008|Part C|Adverse Event|0|||
126275152|NCT02799095|454299855|FG009|Part C|Adverse Event|0|||
126275153|NCT02799095|454299856|FG010|Part C|Adverse Event|3|||
126275154|NCT02799095|454299857|FG011|Part C|Adverse Event|1|||
126275155|NCT02799095|454299858|FG012|Part C|Adverse Event|0|||
126275156|NCT02799095|454299859|FG013|Part C|Adverse Event|1|||
126275157|NCT02799095|454299860|FG014|Part C|Adverse Event|0|||
126275158|NCT02799095|454299861|FG015|Part C|Adverse Event|0|||
126275159|NCT02799095|454299862|FG016|Part C|Adverse Event|0|||
126275160|NCT02799095|454299846|FG000|Part C|Death|0|||
126275161|NCT02799095|454299847|FG001|Part C|Death|0|||
126275162|NCT02799095|454299848|FG002|Part C|Death|0|||
126275163|NCT02799095|454299849|FG003|Part C|Death|0|||
126275164|NCT02799095|454299850|FG004|Part C|Death|0|||
126275165|NCT02799095|454299851|FG005|Part C|Death|0|||
126275166|NCT02799095|454299852|FG006|Part C|Death|0|||
126275167|NCT02799095|454299853|FG007|Part C|Death|0|||
126275168|NCT02799095|454299854|FG008|Part C|Death|0|||
126275169|NCT02799095|454299855|FG009|Part C|Death|0|||
126275170|NCT02799095|454299856|FG010|Part C|Death|7|||
126275171|NCT02799095|454299857|FG011|Part C|Death|5|||
126275172|NCT02799095|454299858|FG012|Part C|Death|6|||
126275173|NCT02799095|454299859|FG013|Part C|Death|8|||
126275174|NCT02799095|454299860|FG014|Part C|Death|1|||
126275175|NCT02799095|454299861|FG015|Part C|Death|8|||
126275176|NCT02799095|454299862|FG016|Part C|Death|1|||
126275177|NCT02799095|454299846|FG000|Part C|Lost to Follow-up|0|||
126275178|NCT02799095|454299847|FG001|Part C|Lost to Follow-up|0|||
126275179|NCT02799095|454299848|FG002|Part C|Lost to Follow-up|0|||
126275180|NCT02799095|454299849|FG003|Part C|Lost to Follow-up|0|||
126275181|NCT02799095|454299850|FG004|Part C|Lost to Follow-up|0|||
126275182|NCT02799095|454299851|FG005|Part C|Lost to Follow-up|0|||
126275183|NCT02799095|454299852|FG006|Part C|Lost to Follow-up|0|||
126275184|NCT02799095|454299853|FG007|Part C|Lost to Follow-up|0|||
126275185|NCT02799095|454299854|FG008|Part C|Lost to Follow-up|0|||
126275186|NCT02799095|454299855|FG009|Part C|Lost to Follow-up|0|||
126706080|NCT04246047|455875543|FG000|Overall Study|Withdrawal by Subject|19|||
126706081|NCT04246047|455875544|FG001|Overall Study|Withdrawal by Subject|26|||
126275187|NCT02799095|454299856|FG010|Part C|Lost to Follow-up|1|||
126275188|NCT02799095|454299857|FG011|Part C|Lost to Follow-up|1|||
126275189|NCT02799095|454299858|FG012|Part C|Lost to Follow-up|1|||
126275190|NCT02799095|454299859|FG013|Part C|Lost to Follow-up|3|||
126275191|NCT02799095|454299860|FG014|Part C|Lost to Follow-up|0|||
126275192|NCT02799095|454299861|FG015|Part C|Lost to Follow-up|0|||
126275193|NCT02799095|454299862|FG016|Part C|Lost to Follow-up|0|||
126275194|NCT02799095|454299846|FG000|Part C|Progressive Disease|0|||
126275195|NCT02799095|454299847|FG001|Part C|Progressive Disease|0|||
126275196|NCT02799095|454299848|FG002|Part C|Progressive Disease|0|||
126706082|NCT04246047|455875543|FG000|Overall Study|Ongoing|169|||
126706083|NCT04246047|455875544|FG001|Overall Study|Ongoing|135|||
126275197|NCT02799095|454299849|FG003|Part C|Progressive Disease|0|||
126275198|NCT02799095|454299850|FG004|Part C|Progressive Disease|0|||
126275199|NCT02799095|454299851|FG005|Part C|Progressive Disease|0|||
126275200|NCT02799095|454299852|FG006|Part C|Progressive Disease|0|||
126275201|NCT02799095|454299853|FG007|Part C|Progressive Disease|0|||
126275202|NCT02799095|454299854|FG008|Part C|Progressive Disease|0|||
126275203|NCT02799095|454299855|FG009|Part C|Progressive Disease|2|||
126275204|NCT02799095|454299856|FG010|Part C|Progressive Disease|13|||
126275205|NCT02799095|454299857|FG011|Part C|Progressive Disease|2|||
126275206|NCT02799095|454299858|FG012|Part C|Progressive Disease|0|||
126275207|NCT02799095|454299859|FG013|Part C|Progressive Disease|1|||
126362460|NCT01684033|454619176|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
126362461|NCT01684033|454619175|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
126362462|NCT01684033|454619176|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
126362463|NCT01684033|454619175|FG000|Period 2, Second 30 Days|Adverse Event|1|||
126362464|NCT01684033|454619176|FG001|Period 2, Second 30 Days|Adverse Event|0|||
126362465|NCT00089583|454619179|FG000|Overall Study|Adverse Event|0|||
126362466|NCT00089583|454619180|FG001|Overall Study|Adverse Event|3|||
126362467|NCT00089583|454619179|FG000|Overall Study|Insufficient Viral Load Response|5|||
126362468|NCT00089583|454619180|FG001|Overall Study|Insufficient Viral Load Response|5|||
126362469|NCT00089583|454619179|FG000|Overall Study|Withdrawal by Subject|0|||
126362470|NCT00089583|454619180|FG001|Overall Study|Withdrawal by Subject|4|||
126362471|NCT00089583|454619179|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
126362472|NCT00089583|454619180|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
126362473|NCT00089583|454619179|FG000|Overall Study|Participant Refused Study Medication|0|||
126362474|NCT00089583|454619180|FG001|Overall Study|Participant Refused Study Medication|2|||
126362475|NCT00089583|454619179|FG000|Overall Study|Non-Compliance|0|||
126362476|NCT00089583|454619180|FG001|Overall Study|Non-Compliance|4|||
126362477|NCT00089583|454619179|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
126362478|NCT00089583|454619180|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
126362479|NCT00089583|454619179|FG000|Overall Study|Participant Management Criteria Met|0|||
126362480|NCT00089583|454619180|FG001|Overall Study|Participant Management Criteria Met|1|||
126362481|NCT00089583|454619179|FG000|Overall Study|Reason Not Provided|0|||
126362482|NCT00089583|454619180|FG001|Overall Study|Reason Not Provided|1|||
126362483|NCT00089583|454619179|FG000|Overall Study|Protocol Violation|0|||
126362484|NCT00089583|454619180|FG001|Overall Study|Protocol Violation|3|||
126362485|NCT00089583|454619179|FG000|Overall Study|Principal Investigator Decision|0|||
126362486|NCT00089583|454619180|FG001|Overall Study|Principal Investigator Decision|10|||
126362487|NCT00089583|454619179|FG000|Overall Study|Start of Disallowed Medication|0|||
126362488|NCT00089583|454619180|FG001|Overall Study|Start of Disallowed Medication|1|||
126362489|NCT00089583|454619179|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
126362490|NCT00089583|454619180|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
126362491|NCT00089583|454619179|FG000|Overall Study|Participant Incarcerated|0|||
126362492|NCT00089583|454619180|FG001|Overall Study|Participant Incarcerated|1|||
126362493|NCT00507507|454619181|FG000|Treatment Period|Lost to Follow-up|0|||
126362494|NCT00507507|454619182|FG001|Treatment Period|Lost to Follow-up|2|||
126362495|NCT00507507|454619181|FG000|Treatment Period|Physician Decision|4|||
126362496|NCT00507507|454619182|FG001|Treatment Period|Physician Decision|1|||
126362497|NCT00507507|454619181|FG000|Treatment Period|Protocol Violation|1|||
126547406|NCT00244374|455297932|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
126547407|NCT00244374|455297933|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
126547408|NCT00244374|455297934|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
126547409|NCT00244374|455297935|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
126547410|NCT00244374|455297936|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
126547411|NCT00244374|455297932|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
126547412|NCT00244374|455297933|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
126362498|NCT00507507|454619182|FG001|Treatment Period|Protocol Violation|2|||
126362499|NCT00507507|454619181|FG000|Treatment Period|Adverse Event|1|||
126362500|NCT00507507|454619182|FG001|Treatment Period|Adverse Event|1|||
126362501|NCT00507507|454619181|FG000|Treatment Period|Withdrawal by Subject|46|||
126362502|NCT00507507|454619182|FG001|Treatment Period|Withdrawal by Subject|47|||
126362503|NCT00507507|454619181|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
126362504|NCT00507507|454619182|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
126362505|NCT00507507|454619181|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
126362506|NCT00507507|454619182|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
126362507|NCT00507507|454619181|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
126362508|NCT00507507|454619182|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
126362509|NCT02916433|454619183|FG000|Overall Study|Withdrawal by Subject|1|||
126362510|NCT02916433|454619184|FG001|Overall Study|Withdrawal by Subject|0|||
126362511|NCT02916433|454619183|FG000|Overall Study|Physician Decision|1|||
126362512|NCT02916433|454619184|FG001|Overall Study|Physician Decision|0|||
126362513|NCT01412983|454619185|FG000|1st Period|Ineligible|0|||
126362514|NCT01412983|454619186|FG001|1st Period|Ineligible|1|||
126362515|NCT01412983|454619185|FG000|1st Period|Positive slit lamp finding|0|||
126362516|NCT01412983|454619186|FG001|1st Period|Positive slit lamp finding|1|||
126362517|NCT01412983|454619185|FG000|1st Period|Unacceptable lens movement|0|||
126362518|NCT01412983|454619186|FG001|1st Period|Unacceptable lens movement|1|||
126362519|NCT01412983|454619185|FG000|1st Period|Inability to maintain wear|0|||
126362520|NCT01412983|454619186|FG001|1st Period|Inability to maintain wear|1|||
126362521|NCT01623154|454619187|FG000|Overall Study|Did not drink Pranactin Citric|4|||
126362522|NCT00890097|454619188|FG000|Overall Study|Adverse Event|21|||
126362523|NCT00890097|454619189|FG001|Overall Study|Adverse Event|32|||
126275208|NCT02799095|454299860|FG014|Part C|Progressive Disease|0|||
126275209|NCT02799095|454299861|FG015|Part C|Progressive Disease|0|||
126275210|NCT02799095|454299862|FG016|Part C|Progressive Disease|0|||
126275211|NCT02799095|454299846|FG000|Part C|Clinical Progression|0|||
126275212|NCT02799095|454299847|FG001|Part C|Clinical Progression|0|||
126275213|NCT02799095|454299848|FG002|Part C|Clinical Progression|0|||
126275214|NCT02799095|454299849|FG003|Part C|Clinical Progression|0|||
126275215|NCT02799095|454299850|FG004|Part C|Clinical Progression|0|||
126275216|NCT02799095|454299851|FG005|Part C|Clinical Progression|0|||
126547413|NCT00244374|455297934|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
126547414|NCT00244374|455297935|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
126547415|NCT00244374|455297936|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
126547416|NCT00244374|455297932|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
126275217|NCT02799095|454299852|FG006|Part C|Clinical Progression|0|||
126275218|NCT02799095|454299853|FG007|Part C|Clinical Progression|0|||
126547417|NCT00244374|455297933|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
126547418|NCT00244374|455297934|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
126547419|NCT00244374|455297935|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
126547420|NCT00244374|455297936|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
126547421|NCT00244374|455297932|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
126547422|NCT00244374|455297933|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
126547423|NCT00244374|455297934|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
126547424|NCT00244374|455297935|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
126547425|NCT00244374|455297936|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
126547426|NCT00244374|455297932|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
126547427|NCT00244374|455297933|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
126547428|NCT00244374|455297934|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
126275219|NCT02799095|454299854|FG008|Part C|Clinical Progression|0|||
126275220|NCT02799095|454299855|FG009|Part C|Clinical Progression|1|||
126275221|NCT02799095|454299856|FG010|Part C|Clinical Progression|3|||
126275222|NCT02799095|454299857|FG011|Part C|Clinical Progression|0|||
126275223|NCT02799095|454299858|FG012|Part C|Clinical Progression|0|||
126275224|NCT02799095|454299859|FG013|Part C|Clinical Progression|1|||
126275225|NCT02799095|454299860|FG014|Part C|Clinical Progression|0|||
126275226|NCT02799095|454299861|FG015|Part C|Clinical Progression|0|||
126275227|NCT02799095|454299862|FG016|Part C|Clinical Progression|0|||
126275228|NCT02799095|454299846|FG000|Part C|Withdrawal by Subject|0|||
126275229|NCT02799095|454299847|FG001|Part C|Withdrawal by Subject|0|||
126275230|NCT02799095|454299848|FG002|Part C|Withdrawal by Subject|0|||
126275231|NCT02799095|454299849|FG003|Part C|Withdrawal by Subject|0|||
126275232|NCT02799095|454299850|FG004|Part C|Withdrawal by Subject|0|||
126275233|NCT02799095|454299851|FG005|Part C|Withdrawal by Subject|0|||
126275234|NCT02799095|454299852|FG006|Part C|Withdrawal by Subject|0|||
126275235|NCT02799095|454299853|FG007|Part C|Withdrawal by Subject|0|||
126275236|NCT02799095|454299854|FG008|Part C|Withdrawal by Subject|0|||
126275237|NCT02799095|454299855|FG009|Part C|Withdrawal by Subject|0|||
126275238|NCT02799095|454299856|FG010|Part C|Withdrawal by Subject|13|||
126275239|NCT02799095|454299857|FG011|Part C|Withdrawal by Subject|15|||
126275240|NCT02799095|454299858|FG012|Part C|Withdrawal by Subject|13|||
126275241|NCT02799095|454299859|FG013|Part C|Withdrawal by Subject|21|||
126275242|NCT02799095|454299860|FG014|Part C|Withdrawal by Subject|0|||
126275243|NCT02799095|454299861|FG015|Part C|Withdrawal by Subject|12|||
126275244|NCT02799095|454299862|FG016|Part C|Withdrawal by Subject|1|||
126275245|NCT02799095|454299846|FG000|Part C|Physician Decision|0|||
126275246|NCT02799095|454299847|FG001|Part C|Physician Decision|0|||
126275247|NCT02799095|454299848|FG002|Part C|Physician Decision|0|||
126275248|NCT02799095|454299849|FG003|Part C|Physician Decision|0|||
126275249|NCT02799095|454299850|FG004|Part C|Physician Decision|0|||
126275250|NCT02799095|454299851|FG005|Part C|Physician Decision|0|||
126275251|NCT02799095|454299852|FG006|Part C|Physician Decision|0|||
126275252|NCT02799095|454299853|FG007|Part C|Physician Decision|0|||
126275253|NCT02799095|454299854|FG008|Part C|Physician Decision|0|||
126275254|NCT02799095|454299855|FG009|Part C|Physician Decision|0|||
126275255|NCT02799095|454299856|FG010|Part C|Physician Decision|1|||
126362524|NCT00890097|454619190|FG002|Overall Study|Adverse Event|28|||
126362525|NCT00890097|454619188|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
126275256|NCT02799095|454299857|FG011|Part C|Physician Decision|0|||
126275257|NCT02799095|454299858|FG012|Part C|Physician Decision|0|||
126275258|NCT02799095|454299859|FG013|Part C|Physician Decision|0|||
126275259|NCT02799095|454299860|FG014|Part C|Physician Decision|0|||
126275260|NCT02799095|454299861|FG015|Part C|Physician Decision|0|||
126275261|NCT02799095|454299862|FG016|Part C|Physician Decision|0|||
126275262|NCT02799095|454299846|FG000|Part C|Other|0|||
126275263|NCT02799095|454299847|FG001|Part C|Other|0|||
126275264|NCT02799095|454299848|FG002|Part C|Other|0|||
126275265|NCT02799095|454299849|FG003|Part C|Other|0|||
126275266|NCT02799095|454299850|FG004|Part C|Other|0|||
126275267|NCT02799095|454299851|FG005|Part C|Other|0|||
126275268|NCT02799095|454299852|FG006|Part C|Other|0|||
126275269|NCT02799095|454299853|FG007|Part C|Other|0|||
126275270|NCT02799095|454299854|FG008|Part C|Other|0|||
126275271|NCT02799095|454299855|FG009|Part C|Other|0|||
126275272|NCT02799095|454299856|FG010|Part C|Other|0|||
126275273|NCT02799095|454299857|FG011|Part C|Other|2|||
126275274|NCT02799095|454299858|FG012|Part C|Other|2|||
126275275|NCT02799095|454299859|FG013|Part C|Other|0|||
126275276|NCT02799095|454299860|FG014|Part C|Other|0|||
126275277|NCT02799095|454299861|FG015|Part C|Other|0|||
126275278|NCT02799095|454299862|FG016|Part C|Other|0|||
126275279|NCT03283319|454299863|FG000|Overall Study|Lost to Follow-up|5|||
126275280|NCT03283319|454299864|FG001|Overall Study|Lost to Follow-up|4|||
126275281|NCT03283319|454299865|FG002|Overall Study|Lost to Follow-up|5|||
126275282|NCT03283319|454299866|FG003|Overall Study|Lost to Follow-up|5|||
126275283|NCT03283319|454299867|FG004|Overall Study|Lost to Follow-up|4|||
126275284|NCT03283319|454299868|FG005|Overall Study|Lost to Follow-up|3|||
126275285|NCT03283319|454299863|FG000|Overall Study|Withdrawal by Subject|2|||
126275286|NCT03283319|454299864|FG001|Overall Study|Withdrawal by Subject|2|||
126275287|NCT03283319|454299865|FG002|Overall Study|Withdrawal by Subject|2|||
126275288|NCT03283319|454299866|FG003|Overall Study|Withdrawal by Subject|1|||
126275289|NCT03283319|454299867|FG004|Overall Study|Withdrawal by Subject|0|||
126275290|NCT03283319|454299868|FG005|Overall Study|Withdrawal by Subject|1|||
126275291|NCT03283319|454299863|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
126275292|NCT03283319|454299864|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
126275293|NCT03283319|454299865|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
126275294|NCT03283319|454299866|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
126275295|NCT03283319|454299867|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
126275296|NCT03283319|454299868|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
126453787|NCT01185353|454961512|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
126453788|NCT01185353|454961513|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
126453789|NCT01185353|454961514|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
126453790|NCT01185353|454961515|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
126453791|NCT01185353|454961516|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
126453792|NCT01185353|454961517|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
126453793|NCT01185353|454961508|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
126453794|NCT01185353|454961509|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
126453795|NCT01185353|454961510|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
126453796|NCT01185353|454961511|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
126453797|NCT01185353|454961512|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
126453798|NCT01185353|454961513|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
126453799|NCT01185353|454961514|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
126453800|NCT01185353|454961515|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
126453801|NCT01185353|454961516|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
126453802|NCT01185353|454961517|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
126453803|NCT01185353|454961508|FG000|Part C (Weeks 24 Through 76)|Death|0|||
126453804|NCT01185353|454961509|FG001|Part C (Weeks 24 Through 76)|Death|0|||
126453805|NCT01185353|454961510|FG002|Part C (Weeks 24 Through 76)|Death|0|||
126453806|NCT01185353|454961511|FG003|Part C (Weeks 24 Through 76)|Death|0|||
126453807|NCT01185353|454961512|FG004|Part C (Weeks 24 Through 76)|Death|0|||
126453808|NCT01185353|454961513|FG005|Part C (Weeks 24 Through 76)|Death|0|||
126453809|NCT01185353|454961514|FG006|Part C (Weeks 24 Through 76)|Death|0|||
126453810|NCT01185353|454961515|FG007|Part C (Weeks 24 Through 76)|Death|0|||
126453811|NCT01185353|454961516|FG008|Part C (Weeks 24 Through 76)|Death|0|||
126453812|NCT01185353|454961517|FG009|Part C (Weeks 24 Through 76)|Death|1|||
126453813|NCT01185353|454961508|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
126453814|NCT01185353|454961509|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
126765665|NCT01977482|456094585|FG004|Overall Study|Protocol Violation|0|||
126275297|NCT00721630|454299869|FG000|Overall Study|Participant found to be ineligible|1|||
126275298|NCT03186781|454299870|FG000|Overall Study|Lost to Follow-up|0|||
126275299|NCT03186781|454299871|FG001|Overall Study|Lost to Follow-up|0|||
126275300|NCT03186781|454299872|FG002|Overall Study|Lost to Follow-up|1|||
126275301|NCT03186781|454299873|FG003|Overall Study|Lost to Follow-up|0|||
126275302|NCT03186781|454299874|FG004|Overall Study|Lost to Follow-up|1|||
126275303|NCT03186781|454299875|FG005|Overall Study|Lost to Follow-up|0|||
126275304|NCT03186781|454299870|FG000|Overall Study|Moved from Area|0|||
126275305|NCT03186781|454299871|FG001|Overall Study|Moved from Area|0|||
126275306|NCT03186781|454299872|FG002|Overall Study|Moved from Area|0|||
126453815|NCT01185353|454961510|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
126453816|NCT01185353|454961511|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
126275307|NCT03186781|454299873|FG003|Overall Study|Moved from Area|0|||
126275308|NCT03186781|454299874|FG004|Overall Study|Moved from Area|1|||
126275309|NCT03186781|454299875|FG005|Overall Study|Moved from Area|0|||
126275310|NCT03186781|454299870|FG000|Overall Study|Withdrawal by Subject|0|||
126453817|NCT01185353|454961512|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
126275311|NCT03186781|454299871|FG001|Overall Study|Withdrawal by Subject|0|||
126275312|NCT03186781|454299872|FG002|Overall Study|Withdrawal by Subject|0|||
126275313|NCT03186781|454299873|FG003|Overall Study|Withdrawal by Subject|0|||
126275314|NCT03186781|454299874|FG004|Overall Study|Withdrawal by Subject|1|||
126275315|NCT03186781|454299875|FG005|Overall Study|Withdrawal by Subject|0|||
126275316|NCT00792935|454299876|FG000|Overall Study|Adverse Event|2|||
126275317|NCT00792935|454299877|FG001|Overall Study|Adverse Event|1|||
126275318|NCT00792935|454299876|FG000|Overall Study|Lost to Follow-up|0|||
126275319|NCT00792935|454299877|FG001|Overall Study|Lost to Follow-up|1|||
126275320|NCT00792935|454299876|FG000|Overall Study|Protocol Violation|2|||
126275321|NCT00792935|454299877|FG001|Overall Study|Protocol Violation|0|||
126275322|NCT00792935|454299876|FG000|Overall Study|Withdrawal by Subject|0|||
126275323|NCT00792935|454299877|FG001|Overall Study|Withdrawal by Subject|1|||
126275324|NCT04663295|454299878|FG000|Run-in Period|Withdrawal by Subject|3|||
126275325|NCT04663295|454299878|FG000|Overall Study Period|Pregnancy|1|||
126275326|NCT04663295|454299878|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
126275327|NCT03954834|454299879|FG000|Overall Study|Adverse Event|1|||
126275328|NCT03954834|454299880|FG001|Overall Study|Adverse Event|3|||
126275329|NCT03954834|454299881|FG002|Overall Study|Adverse Event|1|||
126275330|NCT03954834|454299882|FG003|Overall Study|Adverse Event|1|||
126275331|NCT03954834|454299879|FG000|Overall Study|Death|0|||
126275332|NCT03954834|454299880|FG001|Overall Study|Death|0|||
126275333|NCT03954834|454299881|FG002|Overall Study|Death|0|||
126275334|NCT03954834|454299882|FG003|Overall Study|Death|1|||
126275335|NCT03954834|454299879|FG000|Overall Study|Physician Decision|0|||
126275336|NCT03954834|454299880|FG001|Overall Study|Physician Decision|1|||
126275337|NCT03954834|454299881|FG002|Overall Study|Physician Decision|0|||
126275338|NCT03954834|454299882|FG003|Overall Study|Physician Decision|2|||
126275339|NCT03954834|454299879|FG000|Overall Study|Protocol Violation|1|||
126275340|NCT03954834|454299880|FG001|Overall Study|Protocol Violation|0|||
126275341|NCT03954834|454299881|FG002|Overall Study|Protocol Violation|0|||
126275342|NCT03954834|454299882|FG003|Overall Study|Protocol Violation|1|||
126453818|NCT01185353|454961513|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
126453819|NCT01185353|454961514|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
126453820|NCT01185353|454961515|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
126453821|NCT01185353|454961516|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
126453822|NCT01185353|454961517|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
126453823|NCT01185353|454961508|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
126453824|NCT01185353|454961509|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
126453825|NCT01185353|454961510|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
126453826|NCT01185353|454961511|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
126453827|NCT01185353|454961512|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
126453828|NCT01185353|454961513|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
126453829|NCT01185353|454961514|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
126453830|NCT01185353|454961515|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
126453831|NCT01185353|454961516|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
126453832|NCT01185353|454961517|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
126453833|NCT01185353|454961508|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
126453834|NCT01185353|454961509|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
126453835|NCT01185353|454961510|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
126453836|NCT01185353|454961511|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
126453837|NCT01185353|454961512|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
126453838|NCT01185353|454961513|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
126453839|NCT01185353|454961514|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
126453840|NCT01185353|454961515|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
126453841|NCT01185353|454961516|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
126453842|NCT01185353|454961517|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
126453843|NCT01185353|454961508|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
126453844|NCT01185353|454961509|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
126453845|NCT01185353|454961510|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
126453846|NCT01185353|454961511|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
126275343|NCT03954834|454299879|FG000|Overall Study|Withdrawal by Subject|2|||
126275344|NCT03954834|454299880|FG001|Overall Study|Withdrawal by Subject|3|||
126275345|NCT03954834|454299881|FG002|Overall Study|Withdrawal by Subject|13|||
126275346|NCT03954834|454299882|FG003|Overall Study|Withdrawal by Subject|6|||
126275347|NCT03954834|454299879|FG000|Overall Study|Participant left the country|0|||
126275348|NCT03954834|454299880|FG001|Overall Study|Participant left the country|0|||
126453847|NCT01185353|454961512|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
126453848|NCT01185353|454961513|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
126547429|NCT00244374|455297935|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
126547430|NCT00244374|455297936|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
126275349|NCT03954834|454299881|FG002|Overall Study|Participant left the country|1|||
126547431|NCT01486758|455297939|FG000|Overall Study|Lost to Follow-up|0|||
126275350|NCT03954834|454299882|FG003|Overall Study|Participant left the country|0|||
126275351|NCT03954834|454299879|FG000|Overall Study|Lost to Follow-up|3|||
126275352|NCT03954834|454299880|FG001|Overall Study|Lost to Follow-up|2|||
126275353|NCT03954834|454299881|FG002|Overall Study|Lost to Follow-up|3|||
126275354|NCT03954834|454299882|FG003|Overall Study|Lost to Follow-up|5|||
126275355|NCT01502410|454299885|FG000|Overall Study|Adverse Event|1|||
126275356|NCT01502410|454299886|FG001|Overall Study|Adverse Event|2|||
126275357|NCT01502410|454299887|FG002|Overall Study|Adverse Event|0|||
126275358|NCT01502410|454299888|FG003|Overall Study|Adverse Event|0|||
126275359|NCT01502410|454299885|FG000|Overall Study|Lack of Efficacy|7|||
126453849|NCT01185353|454961514|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
126453850|NCT01185353|454961515|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
126453851|NCT01185353|454961516|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
126453852|NCT01185353|454961517|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
126453853|NCT01185353|454961508|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
126453854|NCT01185353|454961509|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
126453855|NCT01185353|454961510|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
126453856|NCT01185353|454961511|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
126453857|NCT01185353|454961512|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
126453858|NCT01185353|454961513|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
126453859|NCT01185353|454961514|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
126453860|NCT01185353|454961515|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
126453861|NCT01185353|454961516|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
126453862|NCT01185353|454961517|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
126453863|NCT01185353|454961508|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
126453864|NCT01185353|454961509|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
126453865|NCT01185353|454961510|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
126453866|NCT01185353|454961511|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
126453867|NCT01185353|454961512|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
126453868|NCT01185353|454961513|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
126453869|NCT01185353|454961514|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
126453870|NCT01185353|454961515|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
126453871|NCT01185353|454961516|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
126453872|NCT01185353|454961517|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
126453873|NCT02270944|454961518|FG000|Overall Study|Lost to Follow-up|9|||
126453874|NCT02270944|454961519|FG001|Overall Study|Lost to Follow-up|4|||
126453875|NCT02270944|454961518|FG000|Overall Study|Withdrawal by Subject|2|||
126453876|NCT02270944|454961519|FG001|Overall Study|Withdrawal by Subject|1|||
126453877|NCT00095147|454961520|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
126453878|NCT00095147|454961521|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
126453879|NCT00095147|454961522|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
126453880|NCT00095147|454961523|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
126453881|NCT00095147|454961524|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
126453882|NCT00095147|454961520|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
126453883|NCT00095147|454961521|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
126453884|NCT00095147|454961522|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
126453885|NCT00095147|454961523|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
126453886|NCT00095147|454961524|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
126453887|NCT00095147|454961520|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
126453888|NCT00095147|454961521|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
126453889|NCT00095147|454961522|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
126453890|NCT00095147|454961523|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
126453891|NCT00095147|454961524|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
126453892|NCT00095147|454961520|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
126453893|NCT00095147|454961521|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
126453894|NCT00095147|454961522|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
126453895|NCT00095147|454961523|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
126453896|NCT00095147|454961524|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
126453897|NCT00095147|454961520|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
126453898|NCT00095147|454961521|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
126453899|NCT00095147|454961522|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
126547432|NCT01486758|455297940|FG001|Overall Study|Lost to Follow-up|1|||
126275360|NCT01502410|454299886|FG001|Overall Study|Lack of Efficacy|7|||
126275361|NCT01502410|454299887|FG002|Overall Study|Lack of Efficacy|0|||
126275362|NCT01502410|454299888|FG003|Overall Study|Lack of Efficacy|0|||
126275363|NCT01502410|454299885|FG000|Overall Study|Physician Decision|0|||
126275364|NCT01502410|454299886|FG001|Overall Study|Physician Decision|1|||
126275365|NCT01502410|454299887|FG002|Overall Study|Physician Decision|0|||
126275366|NCT01502410|454299888|FG003|Overall Study|Physician Decision|0|||
126453900|NCT00095147|454961523|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
126275367|NCT01502410|454299885|FG000|Overall Study|Withdrawal by Subject|2|||
126547433|NCT01642602|455297952|FG000|Overall Study|Adverse Event|2|||
126547434|NCT02291432|455297953|FG000|Overall Study|Withdrawal by Subject|2|||
126547435|NCT00422799|455297959|FG000|Overall Study|Withdrawal by Subject|6|||
126547436|NCT00422799|455297959|FG000|Overall Study|Adverse Event|7|||
126547437|NCT01619787|455297963|FG000|Overall Study|Lost to Follow-up|5|||
126547438|NCT01130883|455297964|FG000|Overall Study|Patient Noncompliance|6|||
126547439|NCT01130883|455297964|FG000|Overall Study|Reason Unknown|1|||
126547440|NCT01130883|455297964|FG000|Overall Study|Adverse Event|3|||
126547441|NCT03560258|455297965|FG000|Overall Study|Lost to Follow-up|3|||
126547442|NCT03560258|455297966|FG001|Overall Study|Lost to Follow-up|0|||
126547443|NCT03560258|455297967|FG002|Overall Study|Lost to Follow-up|0|||
126547444|NCT03560258|455297965|FG000|Overall Study|Protocol Violation|0|||
126547445|NCT03560258|455297966|FG001|Overall Study|Protocol Violation|1|||
126547446|NCT03560258|455297967|FG002|Overall Study|Protocol Violation|0|||
126547447|NCT03560258|455297965|FG000|Overall Study|Withdrawal by Subject|0|||
126547448|NCT03560258|455297966|FG001|Overall Study|Withdrawal by Subject|0|||
126275368|NCT01502410|454299886|FG001|Overall Study|Withdrawal by Subject|0|||
126547449|NCT03560258|455297967|FG002|Overall Study|Withdrawal by Subject|1|||
126547450|NCT02091739|455297975|FG000|MP: 16 Weeks|Adverse Event|1|||
126547451|NCT02091739|455297976|FG001|MP: 16 Weeks|Adverse Event|1|||
126547452|NCT02091739|455297977|FG002|MP: 16 Weeks|Adverse Event|1|||
126547453|NCT02091739|455297978|FG003|MP: 16 Weeks|Adverse Event|0|||
126547454|NCT02091739|455297979|FG004|MP: 16 Weeks|Adverse Event|0|||
126275369|NCT01502410|454299887|FG002|Overall Study|Withdrawal by Subject|0|||
126275370|NCT01502410|454299888|FG003|Overall Study|Withdrawal by Subject|0|||
126275371|NCT02903030|454299889|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
126275372|NCT02903030|454299890|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
126275373|NCT01284361|454299904|FG000|Overall Study|Withdrawal by Subject|1|||
126275374|NCT01284361|454299904|FG000|Overall Study|Protocol Violation|5|||
126275375|NCT01284361|454299904|FG000|Overall Study|Adverse Event|1|||
126275376|NCT01284361|454299904|FG000|Overall Study|Lost to Follow-up|2|||
126275377|NCT00663026|454299905|FG000|Overall Study|Lost to Follow-up|1|||
126275378|NCT00663026|454299906|FG001|Overall Study|Lost to Follow-up|0|||
126275379|NCT00663026|454299907|FG002|Overall Study|Lost to Follow-up|0|||
126275380|NCT00663026|454299905|FG000|Overall Study|Other|1|||
126275381|NCT00663026|454299906|FG001|Overall Study|Other|2|||
126275382|NCT00663026|454299907|FG002|Overall Study|Other|0|||
126275383|NCT00663026|454299905|FG000|Overall Study|Adverse Event|0|||
126275384|NCT00663026|454299906|FG001|Overall Study|Adverse Event|2|||
126275385|NCT00663026|454299907|FG002|Overall Study|Adverse Event|3|||
126275386|NCT00663026|454299905|FG000|Overall Study|Caregiver Request|0|||
126275387|NCT00663026|454299906|FG001|Overall Study|Caregiver Request|2|||
126275388|NCT00663026|454299907|FG002|Overall Study|Caregiver Request|0|||
126275389|NCT00663026|454299905|FG000|Overall Study|Withdrawal by Subject|0|||
126275390|NCT00663026|454299906|FG001|Overall Study|Withdrawal by Subject|0|||
126275391|NCT00663026|454299907|FG002|Overall Study|Withdrawal by Subject|1|||
126275392|NCT01570686|454299908|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126275393|NCT01570686|454299909|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126453901|NCT00095147|454961524|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
126453902|NCT00095147|454961520|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
126453903|NCT00095147|454961521|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
126453904|NCT00095147|454961522|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
126453905|NCT00095147|454961523|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
126453906|NCT00095147|454961524|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
126453907|NCT00095147|454961520|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
126453908|NCT00095147|454961521|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
126453909|NCT00095147|454961522|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
126453910|NCT00095147|454961523|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
126453911|NCT00095147|454961524|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
126453912|NCT00095147|454961520|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
126453913|NCT00095147|454961521|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
126453914|NCT00095147|454961522|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
126453915|NCT00095147|454961523|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
126547455|NCT02091739|455297975|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
126547456|NCT02091739|455297976|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
126547457|NCT02091739|455297977|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
126275394|NCT01570686|454299908|FG000|Overall Study|Administrative problems|0|||
126275395|NCT01570686|454299909|FG001|Overall Study|Administrative problems|1|||
126275396|NCT01570686|454299908|FG000|Overall Study|Adverse Event|8|||
126275397|NCT01570686|454299909|FG001|Overall Study|Adverse Event|6|||
126275398|NCT01570686|454299908|FG000|Overall Study|Lost to Follow-up|4|||
126275399|NCT01570686|454299909|FG001|Overall Study|Lost to Follow-up|3|||
126453916|NCT00095147|454961524|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
126453917|NCT00095147|454961520|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
126547458|NCT02091739|455297978|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
126547459|NCT02091739|455297979|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
126453918|NCT00095147|454961521|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
126453919|NCT00095147|454961522|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
126453920|NCT00095147|454961523|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
126453921|NCT00095147|454961524|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
126453922|NCT00095147|454961520|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
126453923|NCT00095147|454961521|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
126453924|NCT00095147|454961522|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
126706084|NCT05139030|455875548|FG000|Overall Study|Withdrawal by Subject|1|||
126706085|NCT05139030|455875549|FG001|Overall Study|Withdrawal by Subject|3|||
126706086|NCT05139030|455875548|FG000|Overall Study|Adverse Event|0|||
126706087|NCT05139030|455875549|FG001|Overall Study|Adverse Event|1|||
126706088|NCT05139030|455875548|FG000|Overall Study|Failure to meet continuation criteria|0|||
126706089|NCT05139030|455875549|FG001|Overall Study|Failure to meet continuation criteria|1|||
126706090|NCT02502864|455875550|FG000|Overall Study|Withdrawal by Subject|1|||
126706091|NCT03772327|455875551|FG000|Overall Study|Lost to Follow-up|3|||
126706092|NCT03772327|455875552|FG001|Overall Study|Lost to Follow-up|4|||
126706093|NCT03772327|455875551|FG000|Overall Study|Withdrawal by Subject|2|||
126706094|NCT03772327|455875552|FG001|Overall Study|Withdrawal by Subject|3|||
126706095|NCT04233424|455875553|FG000|Overall Study|Death|15|||
126706096|NCT04233424|455875554|FG001|Overall Study|Death|16|||
126706097|NCT04233424|455875553|FG000|Overall Study|Withdrawal by Subject|2|||
126706098|NCT04233424|455875554|FG001|Overall Study|Withdrawal by Subject|8|||
126706099|NCT04233424|455875553|FG000|Overall Study|Physician Decision|1|||
126706100|NCT04233424|455875554|FG001|Overall Study|Physician Decision|3|||
126706101|NCT04233424|455875553|FG000|Overall Study|Protocol Violation|3|||
126706102|NCT04233424|455875554|FG001|Overall Study|Protocol Violation|1|||
126706103|NCT04233424|455875553|FG000|Overall Study|Lost to Follow-up|1|||
126706104|NCT04233424|455875554|FG001|Overall Study|Lost to Follow-up|3|||
126706105|NCT04233424|455875553|FG000|Overall Study|subject refuse to visit site|2|||
126706106|NCT04233424|455875554|FG001|Overall Study|subject refuse to visit site|0|||
126706107|NCT03517436|455875555|FG000|Overall Study|Death|3|||
126706108|NCT03517436|455875555|FG000|Overall Study|Withdrawal by Subject|4|||
126706109|NCT03517436|455875555|FG000|Overall Study|Did not receive study valve.|1|||
126706110|NCT01254344|455875558|FG000|Overall Study|Adverse Event|2|||
126706111|NCT01254344|455875559|FG001|Overall Study|Adverse Event|5|||
126706112|NCT01254344|455875558|FG000|Overall Study|Physician Decision|7|||
126706113|NCT01254344|455875559|FG001|Overall Study|Physician Decision|4|||
126706114|NCT01254344|455875558|FG000|Overall Study|Protocol Violation|1|||
126706115|NCT01254344|455875559|FG001|Overall Study|Protocol Violation|4|||
126706116|NCT01254344|455875558|FG000|Overall Study|Withdrawal by Subject|3|||
126706117|NCT01254344|455875559|FG001|Overall Study|Withdrawal by Subject|6|||
126706118|NCT03022461|455875560|FG000|Overall Study|Death|3|||
126706119|NCT01982630|455875561|FG000|Overall Study|Adverse Event|2|||
126706120|NCT01982630|455875562|FG001|Overall Study|Adverse Event|0|||
126275400|NCT01570686|454299908|FG000|Overall Study|Protocol Deviation|3|||
126275401|NCT01570686|454299909|FG001|Overall Study|Protocol Deviation|0|||
126275402|NCT01570686|454299908|FG000|Overall Study|Withdrawal by Subject|4|||
126275403|NCT01570686|454299909|FG001|Overall Study|Withdrawal by Subject|4|||
126453925|NCT00095147|454961523|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
126453926|NCT00095147|454961524|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
126453927|NCT00095147|454961520|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
126453928|NCT00095147|454961521|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
126453929|NCT00095147|454961522|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
126453930|NCT00095147|454961523|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
126453931|NCT00095147|454961524|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
126453932|NCT00095147|454961520|FG000|Long-term Extension Period|Death|0|||
126453933|NCT00095147|454961521|FG001|Long-term Extension Period|Death|0|||
126453934|NCT00095147|454961522|FG002|Long-term Extension Period|Death|0|||
126453935|NCT00095147|454961523|FG003|Long-term Extension Period|Death|0|||
126453936|NCT00095147|454961524|FG004|Long-term Extension Period|Death|3|||
126453937|NCT00095147|454961520|FG000|Long-term Extension Period|Adverse Event|0|||
126453938|NCT00095147|454961521|FG001|Long-term Extension Period|Adverse Event|0|||
126453939|NCT00095147|454961522|FG002|Long-term Extension Period|Adverse Event|0|||
126453940|NCT00095147|454961523|FG003|Long-term Extension Period|Adverse Event|0|||
126275404|NCT01570686|454299908|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126275405|NCT01570686|454299909|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126275406|NCT00754650|454299910|FG000|Overall Study|Disease Progression|2|||
126706121|NCT01982630|455875563|FG002|Overall Study|Adverse Event|1|||
126706122|NCT01982630|455875564|FG003|Overall Study|Adverse Event|0|||
126706123|NCT01982630|455875565|FG004|Overall Study|Adverse Event|1|||
126706124|NCT01982630|455875566|FG005|Overall Study|Adverse Event|2|||
126706125|NCT01982630|455875567|FG006|Overall Study|Adverse Event|1|||
126706126|NCT01982630|455875568|FG007|Overall Study|Adverse Event|0|||
126275407|NCT00805675|454299911|FG000|Overall Study|Adverse Event|0|||
126706127|NCT01982630|455875561|FG000|Overall Study|Physician Decision|1|||
126706128|NCT01982630|455875562|FG001|Overall Study|Physician Decision|0|||
126275408|NCT00805675|454299912|FG001|Overall Study|Adverse Event|0|||
126275409|NCT00805675|454299913|FG002|Overall Study|Adverse Event|1|||
126275410|NCT00325195|454299917|FG000|Randomized|Not dosed|5|||
126275411|NCT00325195|454299918|FG001|Randomized|Not dosed|5|||
126275412|NCT00325195|454299919|FG002|Randomized|Not dosed|3|||
126275413|NCT00325195|454299917|FG000|Received Intervention: ITT Population|Adverse Event|15|||
126275414|NCT00325195|454299918|FG001|Received Intervention: ITT Population|Adverse Event|17|||
126275415|NCT00325195|454299919|FG002|Received Intervention: ITT Population|Adverse Event|1|||
126275416|NCT00325195|454299917|FG000|Received Intervention: ITT Population|Death|3|||
126275417|NCT00325195|454299918|FG001|Received Intervention: ITT Population|Death|1|||
126275418|NCT00325195|454299919|FG002|Received Intervention: ITT Population|Death|0|||
126275419|NCT00325195|454299917|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
126275420|NCT00325195|454299918|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
126275421|NCT00325195|454299919|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
126275422|NCT00325195|454299917|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
126275423|NCT00325195|454299918|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
126275424|NCT00325195|454299919|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
126275425|NCT00325195|454299917|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
126275426|NCT00325195|454299918|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
126275427|NCT00325195|454299919|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
126275428|NCT00686075|454299921|FG000|Overall Study|Withdrawal by Subject|4|||
126275429|NCT00686075|454299922|FG001|Overall Study|Withdrawal by Subject|3|||
126275430|NCT00686075|454299923|FG002|Overall Study|Withdrawal by Subject|3|||
126275431|NCT00686075|454299924|FG003|Overall Study|Withdrawal by Subject|7|||
126275432|NCT00686075|454299925|FG004|Overall Study|Withdrawal by Subject|1|||
126275433|NCT00686075|454299926|FG005|Overall Study|Withdrawal by Subject|0|||
126275434|NCT00686075|454299927|FG006|Overall Study|Withdrawal by Subject|0|||
126275435|NCT00686075|454299928|FG007|Overall Study|Withdrawal by Subject|2|||
126275436|NCT00686075|454299929|FG008|Overall Study|Withdrawal by Subject|4|||
126275437|NCT00686075|454299930|FG009|Overall Study|Withdrawal by Subject|6|||
126275438|NCT00686075|454299921|FG000|Overall Study|Lost to Follow-up|3|||
126275439|NCT00686075|454299922|FG001|Overall Study|Lost to Follow-up|6|||
126275440|NCT00686075|454299923|FG002|Overall Study|Lost to Follow-up|3|||
126275441|NCT00686075|454299924|FG003|Overall Study|Lost to Follow-up|2|||
126275442|NCT00686075|454299925|FG004|Overall Study|Lost to Follow-up|3|||
126275443|NCT00686075|454299926|FG005|Overall Study|Lost to Follow-up|3|||
126275444|NCT00686075|454299927|FG006|Overall Study|Lost to Follow-up|0|||
126275445|NCT00686075|454299928|FG007|Overall Study|Lost to Follow-up|0|||
126275446|NCT00686075|454299929|FG008|Overall Study|Lost to Follow-up|2|||
126275447|NCT00686075|454299930|FG009|Overall Study|Lost to Follow-up|3|||
126275448|NCT00686075|454299921|FG000|Overall Study|Other|1|||
126275449|NCT00686075|454299922|FG001|Overall Study|Other|1|||
126275450|NCT00686075|454299923|FG002|Overall Study|Other|0|||
126275451|NCT00686075|454299924|FG003|Overall Study|Other|0|||
126275452|NCT00686075|454299925|FG004|Overall Study|Other|0|||
126275453|NCT00686075|454299926|FG005|Overall Study|Other|0|||
126275454|NCT00686075|454299927|FG006|Overall Study|Other|0|||
126275455|NCT00686075|454299928|FG007|Overall Study|Other|0|||
126275456|NCT00686075|454299929|FG008|Overall Study|Other|0|||
126275457|NCT00686075|454299930|FG009|Overall Study|Other|1|||
126275458|NCT04715932|454299931|FG000|Overall Study|Lost to Follow-up|1|||
126275459|NCT04715932|454299932|FG001|Overall Study|Lost to Follow-up|0|||
126275460|NCT02740699|454299944|FG000|Overall Study|Lost to Follow-up|5|||
126275461|NCT02740699|454299944|FG000|Overall Study|Withdrawal by Subject|14|||
126275462|NCT02740699|454299944|FG000|Overall Study|Physician Decision|5|||
126275463|NCT03783039|454299946|FG000|Overall Study|Death|2|||
126275464|NCT03783039|454299947|FG001|Overall Study|Death|1|||
126275465|NCT01682863|454299948|FG000|Overall Study|Subject/guardian decision|19|||
126275466|NCT01682863|454299949|FG001|Overall Study|Subject/guardian decision|12|||
126275467|NCT01682863|454299950|FG002|Overall Study|Subject/guardian decision|10|||
126275468|NCT01682863|454299948|FG000|Overall Study|Lost to Follow-up|5|||
126275469|NCT01682863|454299949|FG001|Overall Study|Lost to Follow-up|1|||
126275470|NCT01682863|454299950|FG002|Overall Study|Lost to Follow-up|6|||
126275471|NCT01682863|454299948|FG000|Overall Study|Death|1|||
126275472|NCT01682863|454299949|FG001|Overall Study|Death|3|||
126275473|NCT01682863|454299950|FG002|Overall Study|Death|4|||
126362526|NCT00890097|454619189|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
126362527|NCT00890097|454619190|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
126362528|NCT00890097|454619188|FG000|Overall Study|Withdrew Consent|9|||
126362529|NCT00890097|454619189|FG001|Overall Study|Withdrew Consent|6|||
126362530|NCT00890097|454619190|FG002|Overall Study|Withdrew Consent|9|||
126362531|NCT00890097|454619188|FG000|Overall Study|Lost to Follow-up|5|||
126362532|NCT00890097|454619189|FG001|Overall Study|Lost to Follow-up|5|||
126275474|NCT01682863|454299948|FG000|Overall Study|Protocol deviation|1|||
126362533|NCT00890097|454619190|FG002|Overall Study|Lost to Follow-up|5|||
126362534|NCT00890097|454619188|FG000|Overall Study|Noncompliance|0|||
126706129|NCT01982630|455875563|FG002|Overall Study|Physician Decision|2|||
126706130|NCT01982630|455875564|FG003|Overall Study|Physician Decision|1|||
126706131|NCT01982630|455875565|FG004|Overall Study|Physician Decision|2|||
126706132|NCT01982630|455875566|FG005|Overall Study|Physician Decision|0|||
126706133|NCT01982630|455875567|FG006|Overall Study|Physician Decision|0|||
126706134|NCT01982630|455875568|FG007|Overall Study|Physician Decision|0|||
126706135|NCT01982630|455875561|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126706136|NCT01982630|455875562|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126706137|NCT01982630|455875563|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
126706138|NCT01982630|455875564|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126706139|NCT01982630|455875565|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126706140|NCT01982630|455875566|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126706141|NCT01982630|455875567|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126706142|NCT01982630|455875568|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
126706143|NCT01982630|455875561|FG000|Overall Study|Withdrawal by Subject|0|||
126706144|NCT01982630|455875562|FG001|Overall Study|Withdrawal by Subject|0|||
126706145|NCT01982630|455875563|FG002|Overall Study|Withdrawal by Subject|0|||
126706146|NCT01982630|455875564|FG003|Overall Study|Withdrawal by Subject|0|||
126706147|NCT01982630|455875565|FG004|Overall Study|Withdrawal by Subject|0|||
126706148|NCT01982630|455875566|FG005|Overall Study|Withdrawal by Subject|1|||
126706149|NCT01982630|455875567|FG006|Overall Study|Withdrawal by Subject|0|||
126706150|NCT01982630|455875568|FG007|Overall Study|Withdrawal by Subject|0|||
126706151|NCT03459040|455875569|FG000|Overall Study|Death|8|||
126706152|NCT03459040|455875569|FG000|Overall Study|Withdrawal by Subject|1|||
126706153|NCT00561353|455875570|FG000|Overall Study|Subject reached a virologic endpoint|2|||
126706154|NCT00561353|455875571|FG001|Overall Study|Subject reached a virologic endpoint|1|||
126547460|NCT02091739|455297975|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
126547461|NCT02091739|455297976|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
126547462|NCT02091739|455297977|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
126547463|NCT02091739|455297978|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
126706155|NCT00561353|455875572|FG002|Overall Study|Subject reached a virologic endpoint|1|||
126706156|NCT00561353|455875573|FG003|Overall Study|Subject reached a virologic endpoint|4|||
126706157|NCT00561353|455875574|FG004|Overall Study|Subject reached a virologic endpoint|1|||
126706158|NCT00561353|455875575|FG005|Overall Study|Subject reached a virologic endpoint|3|||
126706159|NCT00561353|455875576|FG006|Overall Study|Subject reached a virologic endpoint|4|||
126765666|NCT01977482|456094586|FG005|Overall Study|Protocol Violation|0|||
126765667|NCT01977482|456094581|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
126765668|NCT01977482|456094582|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
126765669|NCT01977482|456094583|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
126765670|NCT01977482|456094584|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
126765671|NCT01977482|456094585|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
126765672|NCT01977482|456094586|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
126765673|NCT01977482|456094581|FG000|Overall Study|Withdrawal by Subject|2|||
126765674|NCT01977482|456094582|FG001|Overall Study|Withdrawal by Subject|4|||
126765675|NCT01977482|456094583|FG002|Overall Study|Withdrawal by Subject|1|||
126765676|NCT01977482|456094584|FG003|Overall Study|Withdrawal by Subject|3|||
126765677|NCT01977482|456094585|FG004|Overall Study|Withdrawal by Subject|1|||
126275475|NCT01682863|454299949|FG001|Overall Study|Protocol deviation|0|||
126275476|NCT01682863|454299950|FG002|Overall Study|Protocol deviation|1|||
126275477|NCT01682863|454299948|FG000|Overall Study|Technical problems|1|||
126275478|NCT01682863|454299949|FG001|Overall Study|Technical problems|0|||
126275479|NCT01682863|454299950|FG002|Overall Study|Technical problems|0|||
126275480|NCT01682863|454299948|FG000|Overall Study|Adverse Event|0|||
126453941|NCT00095147|454961524|FG004|Long-term Extension Period|Adverse Event|11|||
126453942|NCT00095147|454961520|FG000|Long-term Extension Period|Lack of Efficacy|0|||
126453943|NCT00095147|454961521|FG001|Long-term Extension Period|Lack of Efficacy|0|||
126453944|NCT00095147|454961522|FG002|Long-term Extension Period|Lack of Efficacy|0|||
126453945|NCT00095147|454961523|FG003|Long-term Extension Period|Lack of Efficacy|0|||
126453946|NCT00095147|454961524|FG004|Long-term Extension Period|Lack of Efficacy|9|||
126453947|NCT00095147|454961520|FG000|Long-term Extension Period|Lost to Follow-up|0|||
126453948|NCT00095147|454961521|FG001|Long-term Extension Period|Lost to Follow-up|0|||
126453949|NCT00095147|454961522|FG002|Long-term Extension Period|Lost to Follow-up|0|||
126453950|NCT00095147|454961523|FG003|Long-term Extension Period|Lost to Follow-up|0|||
126453951|NCT00095147|454961524|FG004|Long-term Extension Period|Lost to Follow-up|6|||
126453952|NCT00095147|454961520|FG000|Long-term Extension Period|Withdrawal of consent|0|||
126453953|NCT00095147|454961521|FG001|Long-term Extension Period|Withdrawal of consent|0|||
126453954|NCT00095147|454961522|FG002|Long-term Extension Period|Withdrawal of consent|0|||
126765678|NCT01977482|456094586|FG005|Overall Study|Withdrawal by Subject|5|||
126765679|NCT00209560|456094587|FG000|Overall Study|Lack of Efficacy|1|||
126765680|NCT00209560|456094588|FG001|Overall Study|Lack of Efficacy|0|||
126275481|NCT01682863|454299949|FG001|Overall Study|Adverse Event|1|||
126547464|NCT02091739|455297979|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
126547465|NCT02091739|455297975|FG000|EP: 48 Weeks|Other|0|||
126362535|NCT00890097|454619189|FG001|Overall Study|Noncompliance|4|||
126362536|NCT00890097|454619190|FG002|Overall Study|Noncompliance|4|||
126362537|NCT00890097|454619188|FG000|Overall Study|Sponsor Decision|7|||
126362538|NCT00890097|454619189|FG001|Overall Study|Sponsor Decision|11|||
126362539|NCT00890097|454619190|FG002|Overall Study|Sponsor Decision|7|||
126362540|NCT00890097|454619188|FG000|Overall Study|Did not attend final visit|2|||
126362541|NCT00890097|454619189|FG001|Overall Study|Did not attend final visit|3|||
126362542|NCT00890097|454619190|FG002|Overall Study|Did not attend final visit|0|||
126362543|NCT00890097|454619188|FG000|Overall Study|Subject Decision|3|||
126362544|NCT00890097|454619189|FG001|Overall Study|Subject Decision|2|||
126362545|NCT00890097|454619190|FG002|Overall Study|Subject Decision|6|||
126362546|NCT00890097|454619188|FG000|Overall Study|Randomization Error|2|||
126362547|NCT00890097|454619189|FG001|Overall Study|Randomization Error|0|||
126362548|NCT00890097|454619190|FG002|Overall Study|Randomization Error|0|||
126362549|NCT00890097|454619188|FG000|Overall Study|Failed inclusion criteria|3|||
126362550|NCT00890097|454619189|FG001|Overall Study|Failed inclusion criteria|4|||
126362551|NCT00890097|454619190|FG002|Overall Study|Failed inclusion criteria|0|||
126547466|NCT02091739|455297976|FG001|EP: 48 Weeks|Other|0|||
126547467|NCT02091739|455297977|FG002|EP: 48 Weeks|Other|0|||
126547468|NCT02091739|455297978|FG003|EP: 48 Weeks|Other|1|||
126547469|NCT02091739|455297979|FG004|EP: 48 Weeks|Other|0|||
126547470|NCT02091739|455297975|FG000|EP: 48 Weeks|Death|0|||
126547471|NCT02091739|455297976|FG001|EP: 48 Weeks|Death|0|||
126547472|NCT02091739|455297977|FG002|EP: 48 Weeks|Death|0|||
126547473|NCT02091739|455297978|FG003|EP: 48 Weeks|Death|3|||
126547474|NCT02091739|455297979|FG004|EP: 48 Weeks|Death|2|||
126547475|NCT02091739|455297975|FG000|EP: 48 Weeks|Adverse Event|0|||
126547476|NCT02091739|455297976|FG001|EP: 48 Weeks|Adverse Event|0|||
126547477|NCT02091739|455297977|FG002|EP: 48 Weeks|Adverse Event|0|||
126547478|NCT02091739|455297978|FG003|EP: 48 Weeks|Adverse Event|2|||
126547479|NCT02091739|455297979|FG004|EP: 48 Weeks|Adverse Event|6|||
126547480|NCT02091739|455297975|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
126547481|NCT02091739|455297976|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
126547482|NCT02091739|455297977|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
126547483|NCT02091739|455297978|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
126547484|NCT02091739|455297979|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
126547485|NCT00192023|455297980|FG000|Period III - Double-Blind|Adverse Event|3|||
126547486|NCT00192023|455297981|FG001|Period III - Double-Blind|Adverse Event|0|||
126547487|NCT00192023|455297980|FG000|Period III - Double-Blind|Physician Decision|2|||
126547488|NCT00192023|455297981|FG001|Period III - Double-Blind|Physician Decision|0|||
126547489|NCT00192023|455297980|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
126547490|NCT00192023|455297981|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
126275482|NCT01682863|454299950|FG002|Overall Study|Adverse Event|2|||
126275483|NCT01682863|454299948|FG000|Overall Study|Physician Decision|0|||
126275484|NCT01682863|454299949|FG001|Overall Study|Physician Decision|0|||
126275485|NCT01682863|454299950|FG002|Overall Study|Physician Decision|1|||
126275486|NCT00918138|454299951|FG000|Overall Study|Subject withdrew consent|1|||
126275487|NCT00918138|454299952|FG001|Overall Study|Subject withdrew consent|1|||
126275488|NCT00918138|454299951|FG000|Overall Study|Death|1|||
126275489|NCT00918138|454299952|FG001|Overall Study|Death|0|||
126275490|NCT00552578|454299956|FG000|Overall Study|Lost to Follow-up|1|||
126275491|NCT00552578|454299957|FG001|Overall Study|Lost to Follow-up|1|||
126275492|NCT01136967|454299958|FG000|Overall Study|Adverse Event|9|||
126275493|NCT01136967|454299959|FG001|Overall Study|Adverse Event|12|||
126275494|NCT01136967|454299958|FG000|Overall Study|Participant Choice|8|||
126275495|NCT01136967|454299959|FG001|Overall Study|Participant Choice|3|||
126275496|NCT01136967|454299958|FG000|Overall Study|Lost to Follow-up|0|||
126275497|NCT01136967|454299959|FG001|Overall Study|Lost to Follow-up|1|||
126275498|NCT01136967|454299958|FG000|Overall Study|Withdrawal by Subject|1|||
126275499|NCT01136967|454299959|FG001|Overall Study|Withdrawal by Subject|2|||
126275500|NCT01136967|454299958|FG000|Overall Study|Clinical Progression|3|||
126275501|NCT01136967|454299959|FG001|Overall Study|Clinical Progression|5|||
126275502|NCT01136967|454299958|FG000|Overall Study|Radiation|1|||
126275503|NCT01136967|454299959|FG001|Overall Study|Radiation|0|||
126362552|NCT00890097|454619188|FG000|Overall Study|Transportation|0|||
126362553|NCT00890097|454619189|FG001|Overall Study|Transportation|2|||
126547491|NCT00192023|455297980|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
126547492|NCT00192023|455297981|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
126547493|NCT00192023|455297980|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
126547494|NCT00192023|455297981|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
126275504|NCT01136967|454299958|FG000|Overall Study|Non-compliance|1|||
126275505|NCT01136967|454299959|FG001|Overall Study|Non-compliance|0|||
126275506|NCT01136967|454299958|FG000|Overall Study|Investigator's Choice|1|||
126275507|NCT01136967|454299959|FG001|Overall Study|Investigator's Choice|1|||
126362554|NCT00890097|454619190|FG002|Overall Study|Transportation|0|||
126362555|NCT00890097|454619188|FG000|Overall Study|Subject Moved|0|||
126362556|NCT00890097|454619189|FG001|Overall Study|Subject Moved|4|||
126362557|NCT00890097|454619190|FG002|Overall Study|Subject Moved|0|||
126362558|NCT00890097|454619188|FG000|Overall Study|Protocol Deviation|1|||
126547495|NCT00192023|455297980|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
126547496|NCT00192023|455297981|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
126547497|NCT00192023|455297980|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
126547498|NCT00192023|455297981|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
126547499|NCT00192023|455297980|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
126547500|NCT00192023|455297981|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
126547501|NCT00192023|455297980|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
126547502|NCT00192023|455297981|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
126547503|NCT00192023|455297980|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
126547504|NCT00192023|455297981|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
126547505|NCT02086162|455297982|FG000|Overall Study|Withdrawal by Subject|4|||
126547506|NCT02086162|455297983|FG001|Overall Study|Withdrawal by Subject|4|||
126547507|NCT02086162|455297982|FG000|Overall Study|moved|1|||
126547508|NCT02086162|455297983|FG001|Overall Study|moved|1|||
126547509|NCT02086162|455297982|FG000|Overall Study|Lost to Follow-up|4|||
126547510|NCT02086162|455297983|FG001|Overall Study|Lost to Follow-up|2|||
126547511|NCT02086162|455297982|FG000|Overall Study|Death|1|||
126547512|NCT02086162|455297983|FG001|Overall Study|Death|0|||
126547513|NCT00245856|455297984|FG000|Period Two|Withdrawal by Subject|0|||
126547514|NCT00245856|455297985|FG001|Period Two|Withdrawal by Subject|1|||
126547515|NCT01003184|455297986|FG000|Overall Study|Adverse Event|12|||
126547516|NCT01003184|455297987|FG001|Overall Study|Adverse Event|5|||
126547517|NCT01003184|455297986|FG000|Overall Study|Lost to Follow-up|1|||
126547518|NCT01003184|455297987|FG001|Overall Study|Lost to Follow-up|0|||
126547519|NCT01003184|455297986|FG000|Overall Study|Loss of glucose control|1|||
126547520|NCT01003184|455297987|FG001|Overall Study|Loss of glucose control|1|||
126547521|NCT01003184|455297986|FG000|Overall Study|Protocol Violation|3|||
126547522|NCT01003184|455297987|FG001|Overall Study|Protocol Violation|0|||
126547523|NCT01003184|455297986|FG000|Overall Study|Withdrawal by Subject|1|||
126765681|NCT00795886|456094589|FG000|Overall Study|Death|10|||
126765682|NCT05554471|456094599|FG000|Overall Study|Physician Decision|2|||
126765683|NCT05554471|456094600|FG001|Overall Study|Physician Decision|1|||
126275508|NCT01136967|454299958|FG000|Overall Study|Increase in Lesion Size|0|||
126275509|NCT01136967|454299959|FG001|Overall Study|Increase in Lesion Size|2|||
126275510|NCT01136967|454299958|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
126275511|NCT01136967|454299959|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
126275512|NCT02885181|454299960|FG000|Overall Study|Investigator's Discretion|0|||
126275513|NCT02885181|454299961|FG001|Overall Study|Investigator's Discretion|1|||
126275514|NCT02885181|454299962|FG002|Overall Study|Investigator's Discretion|0|||
126275515|NCT02885181|454299963|FG003|Overall Study|Investigator's Discretion|1|||
126275516|NCT02885181|454299960|FG000|Overall Study|Adverse Event|0|||
126275517|NCT02885181|454299961|FG001|Overall Study|Adverse Event|0|||
126275518|NCT02885181|454299962|FG002|Overall Study|Adverse Event|0|||
126275519|NCT02885181|454299963|FG003|Overall Study|Adverse Event|1|||
126275520|NCT02885181|454299960|FG000|Overall Study|Withdrawal by Subject|0|||
126275521|NCT02885181|454299961|FG001|Overall Study|Withdrawal by Subject|0|||
126275522|NCT02885181|454299962|FG002|Overall Study|Withdrawal by Subject|0|||
126275523|NCT02885181|454299963|FG003|Overall Study|Withdrawal by Subject|1|||
126275524|NCT01716715|454299964|FG000|Overall Study|Never Treated|2|||
126275525|NCT01716715|454299965|FG001|Overall Study|Never Treated|4|||
126275526|NCT04228783|454299966|FG000|Overall Study|Adverse Event|1|||
126275527|NCT04228783|454299967|FG001|Overall Study|Adverse Event|0|||
126275528|NCT04228783|454299968|FG002|Overall Study|Adverse Event|2|||
126275529|NCT04228783|454299969|FG003|Overall Study|Adverse Event|0|||
126362559|NCT00890097|454619189|FG001|Overall Study|Protocol Deviation|1|||
126362560|NCT00890097|454619190|FG002|Overall Study|Protocol Deviation|1|||
126362561|NCT00954538|454619191|FG000|Part III|Withdrawal by Subject|0|||
126362562|NCT00954538|454619192|FG001|Part III|Withdrawal by Subject|0|||
126362563|NCT00954538|454619193|FG002|Part III|Withdrawal by Subject|0|||
126362564|NCT00954538|454619194|FG003|Part III|Withdrawal by Subject|0|||
126362565|NCT00954538|454619195|FG004|Part III|Withdrawal by Subject|1|||
126362566|NCT00954538|454619196|FG005|Part III|Withdrawal by Subject|0|||
126362567|NCT03178942|454619200|FG000|Overall Study|Withdrawal by Subject|2|||
126362568|NCT03178942|454619201|FG001|Overall Study|Withdrawal by Subject|0|||
126362569|NCT03178942|454619200|FG000|Overall Study|Lost to Follow-up|1|||
126362570|NCT03178942|454619201|FG001|Overall Study|Lost to Follow-up|2|||
126547524|NCT01003184|455297987|FG001|Overall Study|Withdrawal by Subject|6|||
126547525|NCT01003184|455297986|FG000|Overall Study|Physician Decision|1|||
126275530|NCT04228783|454299970|FG004|Overall Study|Adverse Event|0|||
126547526|NCT01003184|455297987|FG001|Overall Study|Physician Decision|0|||
126547527|NCT03662997|455297988|FG000|Overall Study|Adverse Event|0|||
126547528|NCT03662997|455297989|FG001|Overall Study|Adverse Event|2|||
126275531|NCT04228783|454299971|FG005|Overall Study|Adverse Event|1|||
126275532|NCT04228783|454299966|FG000|Overall Study|Death|0|||
126275533|NCT04228783|454299967|FG001|Overall Study|Death|0|||
126362571|NCT00107614|454621548|FG000|Overall Study|Physician Decision|10|||
126362572|NCT00107614|454621548|FG000|Overall Study|Death|2|||
126362573|NCT02715856|454621552|FG000|Overall Study|Software Issues|12|||
126362574|NCT02715856|454621553|FG001|Overall Study|Software Issues|7|||
126362575|NCT02715856|454621552|FG000|Overall Study|Death|6|||
126362576|NCT02715856|454621553|FG001|Overall Study|Death|5|||
126362577|NCT02715856|454621552|FG000|Overall Study|Non- Compliant|0|||
126362578|NCT02715856|454621553|FG001|Overall Study|Non- Compliant|40|||
126362579|NCT01772693|454621554|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
126362580|NCT01772693|454621555|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
126362581|NCT01772693|454621554|FG000|Overall Study|Withdrawal by Subject|2|||
126362582|NCT01772693|454621555|FG001|Overall Study|Withdrawal by Subject|0|||
126362583|NCT01772693|454621554|FG000|Overall Study|Alternative Treatment|2|||
126362584|NCT01772693|454621555|FG001|Overall Study|Alternative Treatment|0|||
126362585|NCT02094885|454621558|FG000|Overall Study|Death|1|||
126362586|NCT02094885|454621559|FG001|Overall Study|Death|5|||
126362587|NCT02094885|454621558|FG000|Overall Study|Withdrawn due to age|1|||
126362588|NCT02094885|454621559|FG001|Overall Study|Withdrawn due to age|0|||
126362589|NCT00215553|454621568|FG000|Overall Study|Adverse Event|0|||
126362590|NCT00215553|454621569|FG001|Overall Study|Adverse Event|1|||
126362591|NCT00215553|454621570|FG002|Overall Study|Adverse Event|2|||
126362592|NCT00215553|454621571|FG003|Overall Study|Adverse Event|1|||
126362593|NCT00215553|454621572|FG004|Overall Study|Adverse Event|2|||
126362594|NCT00215553|454621573|FG005|Overall Study|Adverse Event|6|||
126362595|NCT00215553|454621574|FG006|Overall Study|Adverse Event|0|||
126362596|NCT00756314|454621575|FG000|Overall Study|Lost to Follow-up|2|||
126362597|NCT00756314|454621576|FG001|Overall Study|Lost to Follow-up|59|||
126362598|NCT02605967|454621578|FG000|Overall Study|subject / guardian decision|1|||
126362599|NCT02605967|454621579|FG001|Overall Study|subject / guardian decision|2|||
126362600|NCT02605967|454621578|FG000|Overall Study|Physician Decision|10|||
126362601|NCT02605967|454621579|FG001|Overall Study|Physician Decision|1|||
126362602|NCT02605967|454621578|FG000|Overall Study|Death|4|||
126362603|NCT02605967|454621579|FG001|Overall Study|Death|2|||
126362604|NCT02605967|454621578|FG000|Overall Study|Adverse Event|1|||
126362605|NCT02605967|454621579|FG001|Overall Study|Adverse Event|0|||
126362606|NCT02605967|454621578|FG000|Overall Study|progressive disease|66|||
126453955|NCT00095147|454961523|FG003|Long-term Extension Period|Withdrawal of consent|0|||
126453956|NCT00095147|454961524|FG004|Long-term Extension Period|Withdrawal of consent|12|||
126362607|NCT02605967|454621579|FG001|Overall Study|progressive disease|35|||
126362608|NCT00159874|454621584|FG000|Overall Study|Adverse Event|2|||
126362609|NCT00159874|454621585|FG001|Overall Study|Adverse Event|2|||
126362610|NCT00159874|454621586|FG002|Overall Study|Adverse Event|5|||
126362611|NCT00159874|454621587|FG003|Overall Study|Adverse Event|1|||
126362612|NCT00159874|454621588|FG004|Overall Study|Adverse Event|1|||
126453957|NCT00095147|454961520|FG000|Long-term Extension Period|Pregnancy|0|||
126453958|NCT00095147|454961521|FG001|Long-term Extension Period|Pregnancy|0|||
126453959|NCT00095147|454961522|FG002|Long-term Extension Period|Pregnancy|0|||
126453960|NCT00095147|454961523|FG003|Long-term Extension Period|Pregnancy|0|||
126453961|NCT00095147|454961524|FG004|Long-term Extension Period|Pregnancy|1|||
126453962|NCT00095147|454961520|FG000|Long-term Extension Period|No longer meets study criteria|0|||
126453963|NCT00095147|454961521|FG001|Long-term Extension Period|No longer meets study criteria|0|||
126453964|NCT00095147|454961522|FG002|Long-term Extension Period|No longer meets study criteria|0|||
126453965|NCT00095147|454961523|FG003|Long-term Extension Period|No longer meets study criteria|0|||
126453966|NCT00095147|454961524|FG004|Long-term Extension Period|No longer meets study criteria|1|||
126453967|NCT00095147|454961520|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
126453968|NCT00095147|454961521|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
126453969|NCT00095147|454961522|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
126453970|NCT00095147|454961523|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
126453971|NCT00095147|454961524|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
126453972|NCT00095147|454961520|FG000|Long-term Extension Period|Leaving country|0|||
126453973|NCT00095147|454961521|FG001|Long-term Extension Period|Leaving country|0|||
126453974|NCT00095147|454961522|FG002|Long-term Extension Period|Leaving country|0|||
126453975|NCT00095147|454961523|FG003|Long-term Extension Period|Leaving country|0|||
126453976|NCT00095147|454961524|FG004|Long-term Extension Period|Leaving country|1|||
126453977|NCT01375075|454961527|FG000|Overall Study|Adverse Event|0|||
126453978|NCT01375075|454961528|FG001|Overall Study|Adverse Event|0|||
126453979|NCT01375075|454961529|FG002|Overall Study|Adverse Event|3|||
126453980|NCT01375075|454961530|FG003|Overall Study|Adverse Event|1|||
126453981|NCT01375075|454961531|FG004|Overall Study|Adverse Event|0|||
126453982|NCT01375075|454961532|FG005|Overall Study|Adverse Event|1|||
126453983|NCT01375075|454961527|FG000|Overall Study|Entry Criterion Not Met|1|||
126362613|NCT00159874|454621589|FG005|Overall Study|Adverse Event|2|||
126362614|NCT00159874|454621590|FG006|Overall Study|Adverse Event|0|||
126362615|NCT00159874|454621584|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
126362616|NCT00159874|454621585|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
126362617|NCT00159874|454621586|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
126362618|NCT00159874|454621587|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
126362619|NCT00159874|454621588|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
126275534|NCT04228783|454299968|FG002|Overall Study|Death|0|||
126275535|NCT04228783|454299969|FG003|Overall Study|Death|0|||
126275536|NCT04228783|454299970|FG004|Overall Study|Death|1|||
126275537|NCT04228783|454299971|FG005|Overall Study|Death|0|||
126275538|NCT04228783|454299966|FG000|Overall Study|Lost to Follow-up|36|||
126275539|NCT04228783|454299967|FG001|Overall Study|Lost to Follow-up|36|||
126275540|NCT04228783|454299968|FG002|Overall Study|Lost to Follow-up|28|||
126275541|NCT04228783|454299969|FG003|Overall Study|Lost to Follow-up|6|||
126275542|NCT04228783|454299970|FG004|Overall Study|Lost to Follow-up|14|||
126275543|NCT04228783|454299971|FG005|Overall Study|Lost to Follow-up|3|||
126275544|NCT04228783|454299966|FG000|Overall Study|Physician Decision|1|||
126275545|NCT04228783|454299967|FG001|Overall Study|Physician Decision|2|||
126275546|NCT04228783|454299968|FG002|Overall Study|Physician Decision|0|||
126275547|NCT04228783|454299969|FG003|Overall Study|Physician Decision|0|||
126275548|NCT04228783|454299970|FG004|Overall Study|Physician Decision|0|||
126275549|NCT04228783|454299971|FG005|Overall Study|Physician Decision|0|||
126275550|NCT04228783|454299966|FG000|Overall Study|Protocol Violation|0|||
126275551|NCT04228783|454299967|FG001|Overall Study|Protocol Violation|0|||
126275552|NCT04228783|454299968|FG002|Overall Study|Protocol Violation|0|||
126275553|NCT04228783|454299969|FG003|Overall Study|Protocol Violation|1|||
126275554|NCT04228783|454299970|FG004|Overall Study|Protocol Violation|0|||
126275555|NCT04228783|454299971|FG005|Overall Study|Protocol Violation|0|||
126275556|NCT04228783|454299966|FG000|Overall Study|Withdrawal by Subject|6|||
126275557|NCT04228783|454299967|FG001|Overall Study|Withdrawal by Subject|10|||
126275558|NCT04228783|454299968|FG002|Overall Study|Withdrawal by Subject|19|||
126275559|NCT04228783|454299969|FG003|Overall Study|Withdrawal by Subject|1|||
126275560|NCT04228783|454299970|FG004|Overall Study|Withdrawal by Subject|2|||
126275561|NCT04228783|454299971|FG005|Overall Study|Withdrawal by Subject|0|||
126275562|NCT04228783|454299966|FG000|Overall Study|Other|4|||
126275563|NCT04228783|454299967|FG001|Overall Study|Other|3|||
126275564|NCT04228783|454299968|FG002|Overall Study|Other|2|||
126275565|NCT04228783|454299969|FG003|Overall Study|Other|1|||
126275566|NCT04228783|454299970|FG004|Overall Study|Other|0|||
126275567|NCT04228783|454299971|FG005|Overall Study|Other|0|||
126275568|NCT00626392|454299972|FG000|Run-in Period|Adverse Event|0|||
126275569|NCT00626392|454299973|FG001|Run-in Period|Adverse Event|0|||
126275570|NCT00626392|454299974|FG002|Run-in Period|Adverse Event|1|||
126275571|NCT00626392|454299975|FG003|Run-in Period|Adverse Event|0|||
126275572|NCT00626392|454299976|FG004|Run-in Period|Adverse Event|1|||
126275573|NCT00626392|454299977|FG005|Run-in Period|Adverse Event|0|||
126275574|NCT00626392|454299972|FG000|Run-in Period|Withdrawal by Subject|0|||
126275575|NCT00626392|454299973|FG001|Run-in Period|Withdrawal by Subject|1|||
126275576|NCT00626392|454299974|FG002|Run-in Period|Withdrawal by Subject|1|||
126275577|NCT00626392|454299975|FG003|Run-in Period|Withdrawal by Subject|1|||
126275578|NCT00626392|454299976|FG004|Run-in Period|Withdrawal by Subject|3|||
126275579|NCT00626392|454299977|FG005|Run-in Period|Withdrawal by Subject|1|||
126275580|NCT00626392|454299972|FG000|Run-in Period|Noncompliance|1|||
126275581|NCT00626392|454299973|FG001|Run-in Period|Noncompliance|0|||
126275582|NCT00626392|454299974|FG002|Run-in Period|Noncompliance|1|||
126275583|NCT00626392|454299975|FG003|Run-in Period|Noncompliance|0|||
126275584|NCT00626392|454299976|FG004|Run-in Period|Noncompliance|0|||
126275585|NCT00626392|454299977|FG005|Run-in Period|Noncompliance|0|||
126275586|NCT00626392|454299972|FG000|Coadministration Period|Adverse Event|3|||
126275587|NCT00626392|454299973|FG001|Coadministration Period|Adverse Event|1|||
126275588|NCT00626392|454299974|FG002|Coadministration Period|Adverse Event|7|||
126275589|NCT00626392|454299975|FG003|Coadministration Period|Adverse Event|4|||
126275590|NCT00626392|454299976|FG004|Coadministration Period|Adverse Event|3|||
126275591|NCT00626392|454299977|FG005|Coadministration Period|Adverse Event|4|||
126275592|NCT00626392|454299972|FG000|Coadministration Period|Withdrawal by Subject|1|||
126275593|NCT00626392|454299973|FG001|Coadministration Period|Withdrawal by Subject|1|||
126275594|NCT00626392|454299974|FG002|Coadministration Period|Withdrawal by Subject|0|||
126275595|NCT00626392|454299975|FG003|Coadministration Period|Withdrawal by Subject|1|||
126275596|NCT00626392|454299976|FG004|Coadministration Period|Withdrawal by Subject|0|||
126275597|NCT00626392|454299977|FG005|Coadministration Period|Withdrawal by Subject|1|||
126275598|NCT00626392|454299972|FG000|Coadministration Period|Protocol Violation|0|||
126275599|NCT00626392|454299973|FG001|Coadministration Period|Protocol Violation|1|||
126275600|NCT00626392|454299974|FG002|Coadministration Period|Protocol Violation|0|||
126275601|NCT00626392|454299975|FG003|Coadministration Period|Protocol Violation|1|||
126275602|NCT00626392|454299976|FG004|Coadministration Period|Protocol Violation|1|||
126275603|NCT00626392|454299977|FG005|Coadministration Period|Protocol Violation|0|||
126275604|NCT00626392|454299972|FG000|Coadministration Period|Other|0|||
126275605|NCT00626392|454299973|FG001|Coadministration Period|Other|2|||
126275606|NCT00626392|454299974|FG002|Coadministration Period|Other|3|||
126275607|NCT00626392|454299975|FG003|Coadministration Period|Other|1|||
126275608|NCT00626392|454299976|FG004|Coadministration Period|Other|1|||
126275609|NCT00626392|454299977|FG005|Coadministration Period|Other|1|||
126275610|NCT03327792|454299978|FG000|Overall Study|Adverse Event|4|||
126275611|NCT03327792|454299979|FG001|Overall Study|Adverse Event|0|||
126275612|NCT03327792|454299978|FG000|Overall Study|Family/Personal issues|3|||
126547529|NCT03662997|455297990|FG002|Overall Study|Adverse Event|0|||
126547530|NCT03662997|455297991|FG003|Overall Study|Adverse Event|0|||
126547531|NCT01719224|455297992|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
126547532|NCT01719224|455297993|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
126547533|NCT02563522|455297994|FG000|Overall Study|Adverse Event|2|||
126547534|NCT02563522|455297995|FG001|Overall Study|Adverse Event|3|||
126547535|NCT02563522|455297994|FG000|Overall Study|Lost to Follow-up|1|||
126547536|NCT02563522|455297995|FG001|Overall Study|Lost to Follow-up|0|||
126547537|NCT02563522|455297994|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
126547538|NCT02563522|455297995|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
126547539|NCT00675506|455298000|FG000|Overall Study|Lost to Follow-up|1|||
126547540|NCT00675506|455298001|FG001|Overall Study|Lost to Follow-up|5|||
126547541|NCT00675506|455298000|FG000|Overall Study|Lost interest|3|||
126547542|NCT00675506|455298001|FG001|Overall Study|Lost interest|5|||
126547543|NCT00675506|455298000|FG000|Overall Study|Elevated fasting glucose|2|||
126547544|NCT00675506|455298001|FG001|Overall Study|Elevated fasting glucose|1|||
126547545|NCT00675506|455298000|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
126547546|NCT00675506|455298001|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
126547547|NCT00675506|455298000|FG000|Overall Study|Elevated IGF-1|2|||
126547548|NCT00675506|455298001|FG001|Overall Study|Elevated IGF-1|0|||
126547549|NCT00675506|455298000|FG000|Overall Study|Hypersensitivity Reaction|1|||
126547550|NCT00675506|455298001|FG001|Overall Study|Hypersensitivity Reaction|0|||
126547551|NCT00675506|455298000|FG000|Overall Study|Disclosed history of cancer|1|||
126547552|NCT00675506|455298001|FG001|Overall Study|Disclosed history of cancer|0|||
126547553|NCT00675506|455298000|FG000|Overall Study|Declined participation|1|||
126547554|NCT00675506|455298001|FG001|Overall Study|Declined participation|0|||
126547555|NCT00675506|455298000|FG000|Overall Study|Schedule conflict|0|||
126275613|NCT03327792|454299979|FG001|Overall Study|Family/Personal issues|2|||
126275614|NCT03327792|454299978|FG000|Overall Study|Lost to Follow-up|0|||
126275615|NCT03327792|454299979|FG001|Overall Study|Lost to Follow-up|1|||
126275616|NCT03151811|454299984|FG000|Overall Study|Randomized But Not Treated|18|||
126275617|NCT03151811|454299985|FG001|Overall Study|Randomized But Not Treated|3|||
126275618|NCT03151811|454299984|FG000|Overall Study|Progressive Disease|130|||
126275619|NCT03151811|454299985|FG001|Overall Study|Progressive Disease|170|||
126275620|NCT03151811|454299984|FG000|Overall Study|Adverse Event|49|||
126275621|NCT03151811|454299985|FG001|Overall Study|Adverse Event|40|||
126275622|NCT03151811|454299984|FG000|Overall Study|Lack of Efficacy|6|||
126275623|NCT03151811|454299985|FG001|Overall Study|Lack of Efficacy|8|||
126275624|NCT03151811|454299984|FG000|Overall Study|Physician Decision|21|||
126275625|NCT03151811|454299985|FG001|Overall Study|Physician Decision|9|||
126275626|NCT03151811|454299984|FG000|Overall Study|Withdrawal by Subject|17|||
126275627|NCT03151811|454299985|FG001|Overall Study|Withdrawal by Subject|7|||
126275628|NCT03151811|454299984|FG000|Overall Study|Lost to Follow-up|0|||
126275629|NCT03151811|454299985|FG001|Overall Study|Lost to Follow-up|1|||
126275630|NCT03151811|454299984|FG000|Overall Study|Study Terminated by Sponsor|5|||
126275631|NCT03151811|454299985|FG001|Overall Study|Study Terminated by Sponsor|11|||
126275632|NCT01085734|454299993|FG000|Overall Study|Adverse Event|0|||
126275633|NCT01085734|454299994|FG001|Overall Study|Adverse Event|2|||
126275634|NCT01085734|454299993|FG000|Overall Study|Death|1|||
126275635|NCT01085734|454299994|FG001|Overall Study|Death|0|||
126275636|NCT01085734|454299993|FG000|Overall Study|Lost to Follow-up|0|||
126275637|NCT01085734|454299994|FG001|Overall Study|Lost to Follow-up|1|||
126275638|NCT01085734|454299993|FG000|Overall Study|Withdrawal by Subject|0|||
126275639|NCT01085734|454299994|FG001|Overall Study|Withdrawal by Subject|1|||
126275640|NCT00528411|454299996|FG000|Overall Study|Adverse Event|4|||
126275641|NCT00528411|454299997|FG001|Overall Study|Adverse Event|0|||
126275642|NCT00528411|454299998|FG002|Overall Study|Adverse Event|1|||
126275643|NCT00528411|454299996|FG000|Overall Study|Incorrect Enrolment|1|||
126547556|NCT00675506|455298001|FG001|Overall Study|Schedule conflict|1|||
126547557|NCT02912468|455298003|FG000|Overall Study|Adverse Event|3|||
126547558|NCT02912468|455298004|FG001|Overall Study|Adverse Event|2|||
126547559|NCT02912468|455298003|FG000|Overall Study|Withdrawal by Subject|6|||
126547560|NCT02912468|455298004|FG001|Overall Study|Withdrawal by Subject|2|||
126547561|NCT02912468|455298003|FG000|Overall Study|Randomized and not treated|0|||
126275644|NCT00528411|454299997|FG001|Overall Study|Incorrect Enrolment|1|||
126547562|NCT02912468|455298004|FG001|Overall Study|Randomized and not treated|1|||
126765684|NCT05554471|456094599|FG000|Overall Study|Lost to Follow-up|2|||
126275645|NCT00528411|454299998|FG002|Overall Study|Incorrect Enrolment|0|||
126275646|NCT00528411|454299996|FG000|Overall Study|Severe non-compliance to protocol|0|||
126275647|NCT00528411|454299997|FG001|Overall Study|Severe non-compliance to protocol|1|||
126275648|NCT00528411|454299998|FG002|Overall Study|Severe non-compliance to protocol|0|||
126275649|NCT00528411|454299996|FG000|Overall Study|Prior commitment medication|0|||
126547563|NCT03853317|455298005|FG000|Overall Study|Progressive Disease|5|||
126547564|NCT03853317|455298005|FG000|Overall Study|Adverse Event|1|||
126547565|NCT03853317|455298005|FG000|Overall Study|Death|1|||
126547566|NCT03853317|455298005|FG000|Overall Study|other event|2|||
126547567|NCT01320735|455298006|FG000|Overall Study|Adverse Event|3|||
126453984|NCT01375075|454961528|FG001|Overall Study|Entry Criterion Not Met|0|||
126453985|NCT01375075|454961529|FG002|Overall Study|Entry Criterion Not Met|0|||
126453986|NCT01375075|454961530|FG003|Overall Study|Entry Criterion Not Met|0|||
126453987|NCT01375075|454961531|FG004|Overall Study|Entry Criterion Not Met|0|||
126453988|NCT01375075|454961532|FG005|Overall Study|Entry Criterion Not Met|1|||
126453989|NCT01375075|454961527|FG000|Overall Study|Withdrawal by Subject|0|||
126453990|NCT01375075|454961528|FG001|Overall Study|Withdrawal by Subject|1|||
126453991|NCT01375075|454961529|FG002|Overall Study|Withdrawal by Subject|0|||
126765685|NCT05554471|456094600|FG001|Overall Study|Lost to Follow-up|1|||
126275650|NCT00528411|454299997|FG001|Overall Study|Prior commitment medication|1|||
126706160|NCT00561353|455875577|FG007|Overall Study|Subject reached a virologic endpoint|4|||
126706161|NCT00561353|455875578|FG008|Overall Study|Subject reached a virologic endpoint|5|||
126275651|NCT00528411|454299998|FG002|Overall Study|Prior commitment medication|0|||
126275652|NCT01715571|454299999|FG000|Overall Study|Lost to Follow-up|8|||
126275653|NCT00407758|454300000|FG000|Overall Study|ineligible -improper prior treatment|1|||
126275654|NCT01822275|454300006|FG000|Overall Study|Withdrawal by Subject|3|||
126275655|NCT01822275|454300006|FG000|Overall Study|Adverse Event|3|||
126275656|NCT01822275|454300006|FG000|Overall Study|Progression|14|||
126275657|NCT01822275|454300006|FG000|Overall Study|Physician Decision|2|||
126275658|NCT01458106|454300008|FG000|Overall Study|Withdrawal by Subject|2|||
126275659|NCT01458106|454300009|FG001|Overall Study|Withdrawal by Subject|0|||
126275660|NCT01458106|454300008|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
126275661|NCT01458106|454300009|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
126275662|NCT01458106|454300008|FG000|Overall Study|Withdrawn Per Protocol|0|||
126275663|NCT01458106|454300009|FG001|Overall Study|Withdrawn Per Protocol|1|||
126275664|NCT00073021|454300010|FG000|Overall Study|Protocol Violation|2|||
126275665|NCT00073021|454300011|FG001|Overall Study|Protocol Violation|1|||
126275666|NCT00073021|454300010|FG000|Overall Study|Adverse Event|4|||
126275667|NCT00073021|454300011|FG001|Overall Study|Adverse Event|4|||
126275668|NCT00073021|454300010|FG000|Overall Study|Withdrawal by Subject|6|||
126275669|NCT00073021|454300011|FG001|Overall Study|Withdrawal by Subject|5|||
126275670|NCT00073021|454300010|FG000|Overall Study|Physician Decision|3|||
126275671|NCT00073021|454300011|FG001|Overall Study|Physician Decision|1|||
126275672|NCT00073021|454300010|FG000|Overall Study|Lack of Efficacy|11|||
126275673|NCT00073021|454300011|FG001|Overall Study|Lack of Efficacy|5|||
126275674|NCT00855803|454300012|FG000|Overall Study|Death|2|||
126275675|NCT00855803|454300012|FG000|Overall Study|Lost to Follow-up|2|||
126275676|NCT00855803|454300012|FG000|Overall Study|Technical inability to undergo procedure|2|||
126275677|NCT00855803|454300012|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
126275678|NCT00855803|454300012|FG000|Overall Study|Withdrawal by Subject|3|||
126275679|NCT00855803|454300012|FG000|Overall Study|Physician Decision|3|||
126275680|NCT02132754|454300014|FG000|Overall Study|Adverse Event|0|||
126275681|NCT02132754|454300015|FG001|Overall Study|Adverse Event|0|||
126275682|NCT02132754|454300016|FG002|Overall Study|Adverse Event|0|||
126275683|NCT02132754|454300017|FG003|Overall Study|Adverse Event|0|||
126275684|NCT02132754|454300018|FG004|Overall Study|Adverse Event|0|||
126275685|NCT02132754|454300019|FG005|Overall Study|Adverse Event|0|||
126275686|NCT02132754|454300020|FG006|Overall Study|Adverse Event|0|||
126275687|NCT02132754|454300021|FG007|Overall Study|Adverse Event|0|||
126275688|NCT02132754|454300022|FG008|Overall Study|Adverse Event|0|||
126275689|NCT02132754|454300023|FG009|Overall Study|Adverse Event|0|||
126275690|NCT02132754|454300024|FG010|Overall Study|Adverse Event|0|||
126275691|NCT02132754|454300025|FG011|Overall Study|Adverse Event|0|||
126275692|NCT02132754|454300026|FG012|Overall Study|Adverse Event|0|||
126453992|NCT01375075|454961530|FG003|Overall Study|Withdrawal by Subject|0|||
126453993|NCT01375075|454961531|FG004|Overall Study|Withdrawal by Subject|0|||
126453994|NCT01375075|454961532|FG005|Overall Study|Withdrawal by Subject|1|||
126453995|NCT01011309|454961533|FG000|Overall Study|Adverse Event|2|||
126453996|NCT01011309|454961534|FG001|Overall Study|Adverse Event|1|||
126706162|NCT00561353|455875579|FG009|Overall Study|Subject reached a virologic endpoint|0|||
126706163|NCT00561353|455875570|FG000|Overall Study|Subject ineligible to continue the trial|0|||
126706164|NCT00561353|455875571|FG001|Overall Study|Subject ineligible to continue the trial|0|||
126706165|NCT00561353|455875572|FG002|Overall Study|Subject ineligible to continue the trial|0|||
126275693|NCT02132754|454300027|FG013|Overall Study|Adverse Event|0|||
126275694|NCT02132754|454300028|FG014|Overall Study|Adverse Event|0|||
126275695|NCT02132754|454300029|FG015|Overall Study|Adverse Event|0|||
126275696|NCT02132754|454300030|FG016|Overall Study|Adverse Event|0|||
126275697|NCT02132754|454300031|FG017|Overall Study|Adverse Event|1|||
126275698|NCT02132754|454300032|FG018|Overall Study|Adverse Event|0|||
126275699|NCT02132754|454300033|FG019|Overall Study|Adverse Event|0|||
126706166|NCT00561353|455875573|FG003|Overall Study|Subject ineligible to continue the trial|0|||
126706167|NCT00561353|455875574|FG004|Overall Study|Subject ineligible to continue the trial|0|||
126706168|NCT00561353|455875575|FG005|Overall Study|Subject ineligible to continue the trial|1|||
126706169|NCT00561353|455875576|FG006|Overall Study|Subject ineligible to continue the trial|1|||
126706170|NCT00561353|455875577|FG007|Overall Study|Subject ineligible to continue the trial|0|||
126706171|NCT00561353|455875578|FG008|Overall Study|Subject ineligible to continue the trial|2|||
126275700|NCT02132754|454300034|FG020|Overall Study|Adverse Event|0|||
126275701|NCT02132754|454300035|FG021|Overall Study|Adverse Event|0|||
126275702|NCT02132754|454300036|FG022|Overall Study|Adverse Event|0|||
126275703|NCT02132754|454300037|FG023|Overall Study|Adverse Event|0|||
126275704|NCT02132754|454300038|FG024|Overall Study|Adverse Event|0|||
126275705|NCT02132754|454300039|FG025|Overall Study|Adverse Event|1|||
126275706|NCT02132754|454300040|FG026|Overall Study|Adverse Event|1|||
126275707|NCT02132754|454300041|FG027|Overall Study|Adverse Event|0|||
126275708|NCT02132754|454300042|FG028|Overall Study|Adverse Event|0|||
126275709|NCT02132754|454300043|FG029|Overall Study|Adverse Event|0|||
126275710|NCT02132754|454300044|FG030|Overall Study|Adverse Event|1|||
126275711|NCT02132754|454300045|FG031|Overall Study|Adverse Event|0|||
126275712|NCT02132754|454300046|FG032|Overall Study|Adverse Event|1|||
126275713|NCT02132754|454300047|FG033|Overall Study|Adverse Event|1|||
126275714|NCT02132754|454300014|FG000|Overall Study|Clinical Progression|0|||
126275715|NCT02132754|454300015|FG001|Overall Study|Clinical Progression|0|||
126275716|NCT02132754|454300016|FG002|Overall Study|Clinical Progression|0|||
126275717|NCT02132754|454300017|FG003|Overall Study|Clinical Progression|0|||
126275718|NCT02132754|454300018|FG004|Overall Study|Clinical Progression|0|||
126275719|NCT02132754|454300019|FG005|Overall Study|Clinical Progression|0|||
126275720|NCT02132754|454300020|FG006|Overall Study|Clinical Progression|0|||
126275721|NCT02132754|454300021|FG007|Overall Study|Clinical Progression|0|||
126275722|NCT02132754|454300022|FG008|Overall Study|Clinical Progression|0|||
126275723|NCT02132754|454300023|FG009|Overall Study|Clinical Progression|1|||
126275724|NCT02132754|454300024|FG010|Overall Study|Clinical Progression|0|||
126275725|NCT02132754|454300025|FG011|Overall Study|Clinical Progression|0|||
126275726|NCT02132754|454300026|FG012|Overall Study|Clinical Progression|0|||
126275727|NCT02132754|454300027|FG013|Overall Study|Clinical Progression|0|||
126275728|NCT02132754|454300028|FG014|Overall Study|Clinical Progression|0|||
126275729|NCT02132754|454300029|FG015|Overall Study|Clinical Progression|0|||
126275730|NCT02132754|454300030|FG016|Overall Study|Clinical Progression|1|||
126453997|NCT01011309|454961535|FG002|Overall Study|Adverse Event|2|||
126453998|NCT01011309|454961533|FG000|Overall Study|Lack of Efficacy|0|||
126453999|NCT01011309|454961534|FG001|Overall Study|Lack of Efficacy|1|||
126454000|NCT01011309|454961535|FG002|Overall Study|Lack of Efficacy|0|||
126454001|NCT01011309|454961533|FG000|Overall Study|Protocol Violation|0|||
126454002|NCT01011309|454961534|FG001|Overall Study|Protocol Violation|1|||
126454003|NCT01011309|454961535|FG002|Overall Study|Protocol Violation|3|||
126454004|NCT01031836|454963090|FG000|Stage I|Adverse Event|1|||
126454005|NCT01031836|454963091|FG001|Stage I|Adverse Event|1|||
126454006|NCT01031836|454963092|FG002|Stage I|Adverse Event|0|||
126454007|NCT01031836|454963093|FG003|Stage I|Adverse Event|0|||
126454008|NCT01031836|454963094|FG004|Stage I|Adverse Event|0|||
126454009|NCT01031836|454963095|FG005|Stage I|Adverse Event|0|||
126454010|NCT01031836|454963090|FG000|Stage I|Other|0|||
126454011|NCT01031836|454963091|FG001|Stage I|Other|1|||
126454012|NCT01031836|454963092|FG002|Stage I|Other|0|||
126454013|NCT01031836|454963093|FG003|Stage I|Other|0|||
126454014|NCT01031836|454963094|FG004|Stage I|Other|0|||
126454015|NCT01031836|454963095|FG005|Stage I|Other|1|||
126454016|NCT01031836|454963090|FG000|Stage II|Adverse Event|0|||
126454017|NCT01031836|454963091|FG001|Stage II|Adverse Event|0|||
126454018|NCT01031836|454963092|FG002|Stage II|Adverse Event|2|||
126454019|NCT01031836|454963093|FG003|Stage II|Adverse Event|2|||
126454020|NCT01031836|454963094|FG004|Stage II|Adverse Event|1|||
126454021|NCT01031836|454963095|FG005|Stage II|Adverse Event|1|||
126454022|NCT01031836|454963090|FG000|Stage II|Other|2|||
126454023|NCT01031836|454963091|FG001|Stage II|Other|0|||
126454024|NCT01031836|454963092|FG002|Stage II|Other|0|||
126454025|NCT01031836|454963093|FG003|Stage II|Other|1|||
126454026|NCT01031836|454963094|FG004|Stage II|Other|1|||
126454027|NCT01031836|454963095|FG005|Stage II|Other|0|||
126454028|NCT03137069|454963097|FG000|Overall Study|Withdrawal by Subject|1|||
126454029|NCT03137069|454963098|FG001|Overall Study|Withdrawal by Subject|2|||
126275731|NCT02132754|454300031|FG017|Overall Study|Clinical Progression|1|||
126275732|NCT02132754|454300032|FG018|Overall Study|Clinical Progression|0|||
126275733|NCT02132754|454300033|FG019|Overall Study|Clinical Progression|1|||
126275734|NCT02132754|454300034|FG020|Overall Study|Clinical Progression|0|||
126275735|NCT02132754|454300035|FG021|Overall Study|Clinical Progression|0|||
126454030|NCT03137069|454963099|FG002|Overall Study|Withdrawal by Subject|2|||
126275736|NCT02132754|454300036|FG022|Overall Study|Clinical Progression|1|||
126454031|NCT03137069|454963100|FG003|Overall Study|Withdrawal by Subject|2|||
126275737|NCT02132754|454300037|FG023|Overall Study|Clinical Progression|0|||
126275738|NCT02132754|454300038|FG024|Overall Study|Clinical Progression|1|||
126275739|NCT02132754|454300039|FG025|Overall Study|Clinical Progression|1|||
126454032|NCT03137069|454963101|FG004|Overall Study|Withdrawal by Subject|0|||
126454033|NCT03137069|454963102|FG005|Overall Study|Withdrawal by Subject|0|||
126454034|NCT03137069|454963097|FG000|Overall Study|Adverse Event|0|||
126454035|NCT03137069|454963098|FG001|Overall Study|Adverse Event|3|||
126454036|NCT03137069|454963099|FG002|Overall Study|Adverse Event|1|||
126454037|NCT03137069|454963100|FG003|Overall Study|Adverse Event|1|||
126454038|NCT03137069|454963101|FG004|Overall Study|Adverse Event|0|||
126547568|NCT01320735|455298006|FG000|Overall Study|Withdrawal by Subject|3|||
126547569|NCT01320735|455298006|FG000|Overall Study|Lost to Follow-up|13|||
126547570|NCT01320735|455298006|FG000|Overall Study|Administrative Reason|6|||
126547571|NCT01320735|455298006|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
126547572|NCT01320735|455298006|FG000|Overall Study|Protocol Violation|1|||
126547573|NCT01320735|455298006|FG000|Overall Study|Other|1|||
126547574|NCT01320735|455298006|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
126547575|NCT01320735|455298006|FG000|Overall Study|Investigator Unable to be Contacted|17|||
126547576|NCT00406419|455298009|FG000|Overall Study|Death|3|||
126547577|NCT00406419|455298010|FG001|Overall Study|Death|1|||
126547578|NCT00406419|455298011|FG002|Overall Study|Death|4|||
126547579|NCT00406419|455298009|FG000|Overall Study|Protocol Violation|6|||
126547580|NCT00406419|455298010|FG001|Overall Study|Protocol Violation|2|||
126547581|NCT00406419|455298011|FG002|Overall Study|Protocol Violation|5|||
126547582|NCT00406419|455298009|FG000|Overall Study|Study Terminated by Sponsor|260|||
126547583|NCT00406419|455298010|FG001|Overall Study|Study Terminated by Sponsor|288|||
126547584|NCT00406419|455298011|FG002|Overall Study|Study Terminated by Sponsor|282|||
126547585|NCT00406419|455298009|FG000|Overall Study|Withdrawal by Subject|17|||
126547586|NCT00406419|455298010|FG001|Overall Study|Withdrawal by Subject|24|||
126547587|NCT00406419|455298011|FG002|Overall Study|Withdrawal by Subject|26|||
126547588|NCT00406419|455298009|FG000|Overall Study|Lack of Efficacy|12|||
126547589|NCT00406419|455298010|FG001|Overall Study|Lack of Efficacy|1|||
126547590|NCT00406419|455298011|FG002|Overall Study|Lack of Efficacy|6|||
126547591|NCT00406419|455298009|FG000|Overall Study|Non-Compliance with Study Drug|5|||
126547592|NCT00406419|455298010|FG001|Overall Study|Non-Compliance with Study Drug|6|||
126547593|NCT00406419|455298011|FG002|Overall Study|Non-Compliance with Study Drug|3|||
126547594|NCT00406419|455298009|FG000|Overall Study|Adverse Event|10|||
126547595|NCT00406419|455298010|FG001|Overall Study|Adverse Event|12|||
126547596|NCT00406419|455298011|FG002|Overall Study|Adverse Event|16|||
126547597|NCT00406419|455298009|FG000|Overall Study|Lost to Follow-up|11|||
126547598|NCT00406419|455298010|FG001|Overall Study|Lost to Follow-up|10|||
126547599|NCT00406419|455298011|FG002|Overall Study|Lost to Follow-up|5|||
126547600|NCT01290822|455298012|FG000|Overall Study|Withdrawal by Subject|1|||
126275740|NCT02132754|454300040|FG026|Overall Study|Clinical Progression|0|||
126275741|NCT02132754|454300041|FG027|Overall Study|Clinical Progression|1|||
126275742|NCT02132754|454300042|FG028|Overall Study|Clinical Progression|1|||
126275743|NCT02132754|454300043|FG029|Overall Study|Clinical Progression|0|||
126275744|NCT02132754|454300044|FG030|Overall Study|Clinical Progression|1|||
126275745|NCT02132754|454300045|FG031|Overall Study|Clinical Progression|0|||
126275746|NCT02132754|454300046|FG032|Overall Study|Clinical Progression|0|||
126275747|NCT02132754|454300047|FG033|Overall Study|Clinical Progression|2|||
126275748|NCT02132754|454300014|FG000|Overall Study|Death|0|||
126275749|NCT02132754|454300015|FG001|Overall Study|Death|0|||
126275750|NCT02132754|454300016|FG002|Overall Study|Death|0|||
126275751|NCT02132754|454300017|FG003|Overall Study|Death|0|||
126275752|NCT02132754|454300018|FG004|Overall Study|Death|0|||
126275753|NCT02132754|454300019|FG005|Overall Study|Death|0|||
126275754|NCT02132754|454300020|FG006|Overall Study|Death|0|||
126547601|NCT01290822|455298012|FG000|Overall Study|Physician Decision|10|||
126547602|NCT00089895|455298015|FG000|Overall Study|Consent Withdrawn|11|||
126547603|NCT00089895|455298016|FG001|Overall Study|Consent Withdrawn|14|||
126547604|NCT00089895|455298015|FG000|Overall Study|Technical reason|7|||
126547605|NCT00089895|455298016|FG001|Overall Study|Technical reason|2|||
126547606|NCT00089895|455298015|FG000|Overall Study|Surgery|0|||
126275755|NCT02132754|454300021|FG007|Overall Study|Death|0|||
126275756|NCT02132754|454300022|FG008|Overall Study|Death|0|||
126275757|NCT02132754|454300023|FG009|Overall Study|Death|0|||
126275758|NCT02132754|454300024|FG010|Overall Study|Death|0|||
126275759|NCT02132754|454300025|FG011|Overall Study|Death|0|||
126275760|NCT02132754|454300026|FG012|Overall Study|Death|0|||
126275761|NCT02132754|454300027|FG013|Overall Study|Death|0|||
126275762|NCT02132754|454300028|FG014|Overall Study|Death|0|||
126275763|NCT02132754|454300029|FG015|Overall Study|Death|1|||
126275764|NCT02132754|454300030|FG016|Overall Study|Death|0|||
126275765|NCT02132754|454300031|FG017|Overall Study|Death|0|||
126275766|NCT02132754|454300032|FG018|Overall Study|Death|0|||
126275767|NCT02132754|454300033|FG019|Overall Study|Death|1|||
126275768|NCT02132754|454300034|FG020|Overall Study|Death|0|||
126275769|NCT02132754|454300035|FG021|Overall Study|Death|1|||
126275770|NCT02132754|454300036|FG022|Overall Study|Death|0|||
126275771|NCT02132754|454300037|FG023|Overall Study|Death|0|||
126275772|NCT02132754|454300038|FG024|Overall Study|Death|0|||
126275773|NCT02132754|454300039|FG025|Overall Study|Death|0|||
126275774|NCT02132754|454300040|FG026|Overall Study|Death|1|||
126275775|NCT02132754|454300041|FG027|Overall Study|Death|0|||
126547607|NCT00089895|455298016|FG001|Overall Study|Surgery|1|||
126275776|NCT02132754|454300042|FG028|Overall Study|Death|0|||
126275777|NCT02132754|454300043|FG029|Overall Study|Death|0|||
126275778|NCT02132754|454300044|FG030|Overall Study|Death|0|||
126275779|NCT02132754|454300045|FG031|Overall Study|Death|0|||
126275780|NCT02132754|454300046|FG032|Overall Study|Death|0|||
126547608|NCT00089895|455298015|FG000|Overall Study|Bleeding|0|||
126547609|NCT00089895|455298016|FG001|Overall Study|Bleeding|2|||
126547610|NCT00089895|455298015|FG000|Overall Study|Physician Decision|3|||
126547611|NCT00089895|455298016|FG001|Overall Study|Physician Decision|7|||
126547612|NCT00089895|455298015|FG000|Overall Study|Exclusion criteria met|6|||
126547613|NCT00089895|455298016|FG001|Overall Study|Exclusion criteria met|6|||
126547614|NCT00089895|455298015|FG000|Overall Study|Not otherwise specified|4|||
126547615|NCT00089895|455298016|FG001|Overall Study|Not otherwise specified|8|||
126547616|NCT00089895|455298015|FG000|Overall Study|Missing|4|||
126547617|NCT00089895|455298016|FG001|Overall Study|Missing|2|||
126547618|NCT01535274|455298017|FG000|Overall Study|Determined to be ineligible|0|||
126706172|NCT00561353|455875579|FG009|Overall Study|Subject ineligible to continue the trial|1|||
126706173|NCT00561353|455875570|FG000|Overall Study|Other|1|||
126706174|NCT00561353|455875571|FG001|Overall Study|Other|0|||
126706175|NCT00561353|455875572|FG002|Overall Study|Other|1|||
126275781|NCT02132754|454300047|FG033|Overall Study|Death|2|||
126275782|NCT02132754|454300014|FG000|Overall Study|Excluded Medication|0|||
126275783|NCT02132754|454300015|FG001|Overall Study|Excluded Medication|0|||
126275784|NCT02132754|454300016|FG002|Overall Study|Excluded Medication|0|||
126275785|NCT02132754|454300017|FG003|Overall Study|Excluded Medication|0|||
126275786|NCT02132754|454300018|FG004|Overall Study|Excluded Medication|0|||
126275787|NCT02132754|454300019|FG005|Overall Study|Excluded Medication|0|||
126275788|NCT02132754|454300020|FG006|Overall Study|Excluded Medication|0|||
126275789|NCT02132754|454300021|FG007|Overall Study|Excluded Medication|0|||
126275790|NCT02132754|454300022|FG008|Overall Study|Excluded Medication|0|||
126275791|NCT02132754|454300023|FG009|Overall Study|Excluded Medication|0|||
126275792|NCT02132754|454300024|FG010|Overall Study|Excluded Medication|0|||
126275793|NCT02132754|454300025|FG011|Overall Study|Excluded Medication|0|||
126275794|NCT02132754|454300026|FG012|Overall Study|Excluded Medication|0|||
126275795|NCT02132754|454300027|FG013|Overall Study|Excluded Medication|0|||
126275796|NCT02132754|454300028|FG014|Overall Study|Excluded Medication|0|||
126275797|NCT02132754|454300029|FG015|Overall Study|Excluded Medication|0|||
126275798|NCT02132754|454300030|FG016|Overall Study|Excluded Medication|0|||
126275799|NCT02132754|454300031|FG017|Overall Study|Excluded Medication|0|||
126275800|NCT02132754|454300032|FG018|Overall Study|Excluded Medication|0|||
126275801|NCT02132754|454300033|FG019|Overall Study|Excluded Medication|0|||
126275802|NCT02132754|454300034|FG020|Overall Study|Excluded Medication|1|||
126275803|NCT02132754|454300035|FG021|Overall Study|Excluded Medication|0|||
126275804|NCT02132754|454300036|FG022|Overall Study|Excluded Medication|0|||
126275805|NCT02132754|454300037|FG023|Overall Study|Excluded Medication|0|||
126275806|NCT02132754|454300038|FG024|Overall Study|Excluded Medication|0|||
126275807|NCT02132754|454300039|FG025|Overall Study|Excluded Medication|0|||
126275808|NCT02132754|454300040|FG026|Overall Study|Excluded Medication|0|||
126275809|NCT02132754|454300041|FG027|Overall Study|Excluded Medication|0|||
126275810|NCT02132754|454300042|FG028|Overall Study|Excluded Medication|0|||
126275811|NCT02132754|454300043|FG029|Overall Study|Excluded Medication|0|||
126275812|NCT02132754|454300044|FG030|Overall Study|Excluded Medication|0|||
126275813|NCT02132754|454300045|FG031|Overall Study|Excluded Medication|0|||
126275814|NCT02132754|454300046|FG032|Overall Study|Excluded Medication|0|||
126275815|NCT02132754|454300047|FG033|Overall Study|Excluded Medication|1|||
126275816|NCT02132754|454300014|FG000|Overall Study|Physician Decision|0|||
126275817|NCT02132754|454300015|FG001|Overall Study|Physician Decision|0|||
126275818|NCT02132754|454300016|FG002|Overall Study|Physician Decision|0|||
126275819|NCT02132754|454300017|FG003|Overall Study|Physician Decision|0|||
126275820|NCT02132754|454300018|FG004|Overall Study|Physician Decision|0|||
126275821|NCT02132754|454300019|FG005|Overall Study|Physician Decision|0|||
126275822|NCT02132754|454300020|FG006|Overall Study|Physician Decision|0|||
126275823|NCT02132754|454300021|FG007|Overall Study|Physician Decision|0|||
126275824|NCT02132754|454300022|FG008|Overall Study|Physician Decision|0|||
126275825|NCT02132754|454300023|FG009|Overall Study|Physician Decision|1|||
126275826|NCT02132754|454300024|FG010|Overall Study|Physician Decision|0|||
126275827|NCT02132754|454300025|FG011|Overall Study|Physician Decision|1|||
126275828|NCT02132754|454300026|FG012|Overall Study|Physician Decision|1|||
126275829|NCT02132754|454300027|FG013|Overall Study|Physician Decision|0|||
126547619|NCT01535274|455298018|FG001|Overall Study|Determined to be ineligible|1|||
126547620|NCT01535274|455298017|FG000|Overall Study|Misallocated to propofol intervention|0|||
126706176|NCT00561353|455875573|FG003|Overall Study|Other|0|||
126706177|NCT00561353|455875574|FG004|Overall Study|Other|0|||
126706178|NCT00561353|455875575|FG005|Overall Study|Other|2|||
126275830|NCT02132754|454300028|FG014|Overall Study|Physician Decision|0|||
126275831|NCT02132754|454300029|FG015|Overall Study|Physician Decision|1|||
126275832|NCT02132754|454300030|FG016|Overall Study|Physician Decision|0|||
126275833|NCT02132754|454300031|FG017|Overall Study|Physician Decision|0|||
126275834|NCT02132754|454300032|FG018|Overall Study|Physician Decision|0|||
126275835|NCT02132754|454300033|FG019|Overall Study|Physician Decision|0|||
126275836|NCT02132754|454300034|FG020|Overall Study|Physician Decision|0|||
126275837|NCT02132754|454300035|FG021|Overall Study|Physician Decision|0|||
126275838|NCT02132754|454300036|FG022|Overall Study|Physician Decision|0|||
126275839|NCT02132754|454300037|FG023|Overall Study|Physician Decision|0|||
126275840|NCT02132754|454300038|FG024|Overall Study|Physician Decision|1|||
126275841|NCT02132754|454300039|FG025|Overall Study|Physician Decision|0|||
126706179|NCT00561353|455875576|FG006|Overall Study|Other|0|||
126362620|NCT00159874|454621589|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
126362621|NCT00159874|454621590|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
126547621|NCT01535274|455298018|FG001|Overall Study|Misallocated to propofol intervention|1|||
126362622|NCT00159874|454621584|FG000|Overall Study|Lack of Efficacy|2|||
126362623|NCT00159874|454621585|FG001|Overall Study|Lack of Efficacy|0|||
126362624|NCT00159874|454621586|FG002|Overall Study|Lack of Efficacy|1|||
126362625|NCT00159874|454621587|FG003|Overall Study|Lack of Efficacy|1|||
126362626|NCT00159874|454621588|FG004|Overall Study|Lack of Efficacy|0|||
126362627|NCT00159874|454621589|FG005|Overall Study|Lack of Efficacy|3|||
126362628|NCT00159874|454621590|FG006|Overall Study|Lack of Efficacy|0|||
126765686|NCT05554471|456094599|FG000|Overall Study|Death|0|||
126765687|NCT05554471|456094600|FG001|Overall Study|Death|1|||
126765688|NCT00526227|456094603|FG000|Overall Study|Device not implanted|1|||
126765689|NCT00526227|456094603|FG000|Overall Study|Death|1|||
126765690|NCT03222856|456094606|FG000|Overall Study|Adverse Event|6|||
126765691|NCT03222856|456094606|FG000|Overall Study|Death|1|||
126765692|NCT01319994|456095772|FG000|Overall Study|Protocol Violation|7|||
126765693|NCT01319994|456095773|FG001|Overall Study|Protocol Violation|6|||
126765694|NCT01340794|456095774|FG000|Overall Study|Withdrawal by Subject|0|||
126362629|NCT00159874|454621584|FG000|Overall Study|Lost to Follow-up|1|||
126362630|NCT00159874|454621585|FG001|Overall Study|Lost to Follow-up|0|||
126362631|NCT00159874|454621586|FG002|Overall Study|Lost to Follow-up|3|||
126362632|NCT00159874|454621587|FG003|Overall Study|Lost to Follow-up|0|||
126362633|NCT00159874|454621588|FG004|Overall Study|Lost to Follow-up|1|||
126362634|NCT00159874|454621589|FG005|Overall Study|Lost to Follow-up|2|||
126362635|NCT00159874|454621590|FG006|Overall Study|Lost to Follow-up|1|||
126362636|NCT00159874|454621584|FG000|Overall Study|Other|8|||
126362637|NCT00159874|454621585|FG001|Overall Study|Other|8|||
126362638|NCT00159874|454621586|FG002|Overall Study|Other|8|||
126362639|NCT00159874|454621587|FG003|Overall Study|Other|0|||
126362640|NCT00159874|454621588|FG004|Overall Study|Other|2|||
126362641|NCT00159874|454621589|FG005|Overall Study|Other|1|||
126362642|NCT00159874|454621590|FG006|Overall Study|Other|3|||
126362643|NCT00159874|454621584|FG000|Overall Study|Protocol Violation|0|||
126362644|NCT00159874|454621585|FG001|Overall Study|Protocol Violation|5|||
126362645|NCT00159874|454621586|FG002|Overall Study|Protocol Violation|2|||
126362646|NCT00159874|454621587|FG003|Overall Study|Protocol Violation|0|||
126362647|NCT00159874|454621588|FG004|Overall Study|Protocol Violation|0|||
126362648|NCT00159874|454621589|FG005|Overall Study|Protocol Violation|0|||
126362649|NCT00159874|454621590|FG006|Overall Study|Protocol Violation|0|||
126362650|NCT00159874|454621584|FG000|Overall Study|Death|3|||
126547622|NCT03679767|455298019|FG000|Overall Study|Death|16|||
126547623|NCT03679767|455298020|FG001|Overall Study|Death|11|||
126547624|NCT03679767|455298021|FG002|Overall Study|Death|17|||
126547625|NCT03679767|455298022|FG003|Overall Study|Death|10|||
126547626|NCT03679767|455298019|FG000|Overall Study|Lost to Follow-up|1|||
126547627|NCT03679767|455298020|FG001|Overall Study|Lost to Follow-up|1|||
126547628|NCT03679767|455298021|FG002|Overall Study|Lost to Follow-up|1|||
126547629|NCT03679767|455298022|FG003|Overall Study|Lost to Follow-up|1|||
126547630|NCT03679767|455298019|FG000|Overall Study|Withdrawal by Subject|0|||
126547631|NCT03679767|455298020|FG001|Overall Study|Withdrawal by Subject|0|||
126547632|NCT03679767|455298021|FG002|Overall Study|Withdrawal by Subject|0|||
126547633|NCT03679767|455298022|FG003|Overall Study|Withdrawal by Subject|1|||
126547634|NCT03679767|455298019|FG000|Overall Study|Follow-up Completed|18|||
126547635|NCT03679767|455298020|FG001|Overall Study|Follow-up Completed|11|||
126547636|NCT03679767|455298021|FG002|Overall Study|Follow-up Completed|11|||
126547637|NCT03679767|455298022|FG003|Overall Study|Follow-up Completed|20|||
126362651|NCT00159874|454621585|FG001|Overall Study|Death|8|||
126362652|NCT00159874|454621586|FG002|Overall Study|Death|15|||
126362653|NCT00159874|454621587|FG003|Overall Study|Death|0|||
126362654|NCT00159874|454621588|FG004|Overall Study|Death|1|||
126547638|NCT03679767|455298019|FG000|Overall Study|Entered Hospice Care|0|||
126547639|NCT03679767|455298020|FG001|Overall Study|Entered Hospice Care|0|||
126547640|NCT03679767|455298021|FG002|Overall Study|Entered Hospice Care|0|||
126547641|NCT03679767|455298022|FG003|Overall Study|Entered Hospice Care|1|||
126547642|NCT03679767|455298019|FG000|Overall Study|Progressive Disease|0|||
126547643|NCT03679767|455298020|FG001|Overall Study|Progressive Disease|0|||
126547644|NCT03679767|455298021|FG002|Overall Study|Progressive Disease|0|||
126765695|NCT01340794|456095775|FG001|Overall Study|Withdrawal by Subject|1|||
126362655|NCT00159874|454621589|FG005|Overall Study|Death|2|||
126362656|NCT00159874|454621590|FG006|Overall Study|Death|0|||
126547645|NCT03679767|455298022|FG003|Overall Study|Progressive Disease|1|||
126547646|NCT02954458|455298023|FG000|Overall Study|Adverse Event|0|||
126547647|NCT02954458|455298024|FG001|Overall Study|Adverse Event|0|||
126547648|NCT02954458|455298025|FG002|Overall Study|Adverse Event|0|||
126362657|NCT00159874|454621584|FG000|Overall Study|Withdrawal by Subject|2|||
126362658|NCT00159874|454621585|FG001|Overall Study|Withdrawal by Subject|6|||
126362659|NCT00159874|454621586|FG002|Overall Study|Withdrawal by Subject|8|||
126362660|NCT00159874|454621587|FG003|Overall Study|Withdrawal by Subject|4|||
126362661|NCT00159874|454621588|FG004|Overall Study|Withdrawal by Subject|3|||
126765696|NCT01118949|456095778|FG000|Overall Study|Adverse Event|5|||
126275842|NCT02132754|454300040|FG026|Overall Study|Physician Decision|0|||
126275843|NCT02132754|454300041|FG027|Overall Study|Physician Decision|0|||
126275844|NCT02132754|454300042|FG028|Overall Study|Physician Decision|0|||
126275845|NCT02132754|454300043|FG029|Overall Study|Physician Decision|0|||
126275846|NCT02132754|454300044|FG030|Overall Study|Physician Decision|0|||
126275847|NCT02132754|454300045|FG031|Overall Study|Physician Decision|1|||
126275848|NCT02132754|454300046|FG032|Overall Study|Physician Decision|0|||
126275849|NCT02132754|454300047|FG033|Overall Study|Physician Decision|3|||
126275850|NCT02132754|454300014|FG000|Overall Study|Progressive Disease|1|||
126275851|NCT02132754|454300015|FG001|Overall Study|Progressive Disease|1|||
126275852|NCT02132754|454300016|FG002|Overall Study|Progressive Disease|1|||
126275853|NCT02132754|454300017|FG003|Overall Study|Progressive Disease|1|||
126275854|NCT02132754|454300018|FG004|Overall Study|Progressive Disease|1|||
126275855|NCT02132754|454300019|FG005|Overall Study|Progressive Disease|1|||
126275856|NCT02132754|454300020|FG006|Overall Study|Progressive Disease|1|||
126275857|NCT02132754|454300021|FG007|Overall Study|Progressive Disease|1|||
126275858|NCT02132754|454300022|FG008|Overall Study|Progressive Disease|1|||
126275859|NCT02132754|454300023|FG009|Overall Study|Progressive Disease|3|||
126275860|NCT02132754|454300024|FG010|Overall Study|Progressive Disease|3|||
126362662|NCT00159874|454621589|FG005|Overall Study|Withdrawal by Subject|2|||
126362663|NCT00159874|454621590|FG006|Overall Study|Withdrawal by Subject|1|||
126362664|NCT00159874|454621584|FG000|Overall Study|Pregnancy|1|||
126362665|NCT00159874|454621585|FG001|Overall Study|Pregnancy|1|||
126362666|NCT00159874|454621586|FG002|Overall Study|Pregnancy|0|||
126362667|NCT00159874|454621587|FG003|Overall Study|Pregnancy|0|||
126362668|NCT00159874|454621588|FG004|Overall Study|Pregnancy|0|||
126362669|NCT00159874|454621589|FG005|Overall Study|Pregnancy|0|||
126362670|NCT00159874|454621590|FG006|Overall Study|Pregnancy|0|||
126362671|NCT01475825|454621594|FG000|Overall Study|Adverse Event|41|||
126362672|NCT01475825|454621595|FG001|Overall Study|Adverse Event|15|||
126362673|NCT01475825|454621596|FG002|Overall Study|Adverse Event|27|||
126362674|NCT01475825|454621597|FG003|Overall Study|Adverse Event|11|||
126362675|NCT01475825|454621594|FG000|Overall Study|Death|1|||
126362676|NCT01475825|454621595|FG001|Overall Study|Death|0|||
126362677|NCT01475825|454621596|FG002|Overall Study|Death|1|||
126362678|NCT01475825|454621597|FG003|Overall Study|Death|0|||
126362679|NCT01475825|454621594|FG000|Overall Study|Lack of Efficacy|0|||
126362680|NCT01475825|454621595|FG001|Overall Study|Lack of Efficacy|0|||
126362681|NCT01475825|454621596|FG002|Overall Study|Lack of Efficacy|1|||
126362682|NCT01475825|454621597|FG003|Overall Study|Lack of Efficacy|0|||
126362683|NCT01475825|454621594|FG000|Overall Study|Lost to Follow-up|0|||
126362684|NCT01475825|454621595|FG001|Overall Study|Lost to Follow-up|0|||
126362685|NCT01475825|454621596|FG002|Overall Study|Lost to Follow-up|3|||
126362686|NCT01475825|454621597|FG003|Overall Study|Lost to Follow-up|1|||
126362687|NCT01475825|454621594|FG000|Overall Study|Non-compliance with Study Drug|1|||
126362688|NCT01475825|454621595|FG001|Overall Study|Non-compliance with Study Drug|2|||
126362689|NCT01475825|454621596|FG002|Overall Study|Non-compliance with Study Drug|4|||
126362690|NCT01475825|454621597|FG003|Overall Study|Non-compliance with Study Drug|0|||
126362691|NCT01475825|454621594|FG000|Overall Study|Other: Not available|0|||
126362692|NCT01475825|454621595|FG001|Overall Study|Other: Not available|0|||
126362693|NCT01475825|454621596|FG002|Overall Study|Other: Not available|2|||
126362694|NCT01475825|454621597|FG003|Overall Study|Other: Not available|0|||
126362695|NCT01475825|454621594|FG000|Overall Study|Protocol Violation|1|||
126362696|NCT01475825|454621595|FG001|Overall Study|Protocol Violation|0|||
126362697|NCT01475825|454621596|FG002|Overall Study|Protocol Violation|0|||
126362698|NCT01475825|454621597|FG003|Overall Study|Protocol Violation|0|||
126362699|NCT01475825|454621594|FG000|Overall Study|Physician Decision|0|||
126362700|NCT01475825|454621595|FG001|Overall Study|Physician Decision|1|||
126362701|NCT01475825|454621596|FG002|Overall Study|Physician Decision|0|||
126362702|NCT01475825|454621597|FG003|Overall Study|Physician Decision|0|||
126362703|NCT01475825|454621594|FG000|Overall Study|Withdrawal by Subject|8|||
126362704|NCT01475825|454621595|FG001|Overall Study|Withdrawal by Subject|3|||
126362705|NCT01475825|454621596|FG002|Overall Study|Withdrawal by Subject|11|||
126362706|NCT01475825|454621597|FG003|Overall Study|Withdrawal by Subject|7|||
126362707|NCT01475825|454621594|FG000|Overall Study|Did not enter OLC|15|||
126362708|NCT01475825|454621595|FG001|Overall Study|Did not enter OLC|11|||
126362709|NCT01475825|454621596|FG002|Overall Study|Did not enter OLC|15|||
126362710|NCT01475825|454621597|FG003|Overall Study|Did not enter OLC|11|||
126362711|NCT00309946|454621600|FG000|Overall Study|Withdrawal by Subject|1|||
126275861|NCT02132754|454300025|FG011|Overall Study|Progressive Disease|2|||
126275862|NCT02132754|454300026|FG012|Overall Study|Progressive Disease|2|||
126275863|NCT02132754|454300027|FG013|Overall Study|Progressive Disease|3|||
126275864|NCT02132754|454300028|FG014|Overall Study|Progressive Disease|2|||
126275865|NCT02132754|454300029|FG015|Overall Study|Progressive Disease|1|||
126275866|NCT02132754|454300030|FG016|Overall Study|Progressive Disease|2|||
126275867|NCT02132754|454300031|FG017|Overall Study|Progressive Disease|1|||
126362712|NCT02662582|454621601|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
126362713|NCT02662582|454621602|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
126362714|NCT02662582|454621601|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
126362715|NCT02662582|454621602|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
126275868|NCT02132754|454300032|FG018|Overall Study|Progressive Disease|3|||
126275869|NCT02132754|454300033|FG019|Overall Study|Progressive Disease|1|||
126275870|NCT02132754|454300034|FG020|Overall Study|Progressive Disease|1|||
126275871|NCT02132754|454300035|FG021|Overall Study|Progressive Disease|3|||
126275872|NCT02132754|454300036|FG022|Overall Study|Progressive Disease|2|||
126275873|NCT02132754|454300037|FG023|Overall Study|Progressive Disease|3|||
126275874|NCT02132754|454300038|FG024|Overall Study|Progressive Disease|0|||
126275875|NCT02132754|454300039|FG025|Overall Study|Progressive Disease|1|||
126275876|NCT02132754|454300040|FG026|Overall Study|Progressive Disease|2|||
126275877|NCT02132754|454300041|FG027|Overall Study|Progressive Disease|1|||
126275878|NCT02132754|454300042|FG028|Overall Study|Progressive Disease|2|||
126275879|NCT02132754|454300043|FG029|Overall Study|Progressive Disease|3|||
126275880|NCT02132754|454300044|FG030|Overall Study|Progressive Disease|1|||
126275881|NCT02132754|454300045|FG031|Overall Study|Progressive Disease|1|||
126275882|NCT02132754|454300046|FG032|Overall Study|Progressive Disease|3|||
126275883|NCT02132754|454300047|FG033|Overall Study|Progressive Disease|6|||
126275884|NCT02132754|454300014|FG000|Overall Study|Screen Failure|0|||
126275885|NCT02132754|454300015|FG001|Overall Study|Screen Failure|0|||
126275886|NCT02132754|454300016|FG002|Overall Study|Screen Failure|0|||
126275887|NCT02132754|454300017|FG003|Overall Study|Screen Failure|0|||
126275888|NCT02132754|454300018|FG004|Overall Study|Screen Failure|0|||
126275889|NCT02132754|454300019|FG005|Overall Study|Screen Failure|0|||
126275890|NCT02132754|454300020|FG006|Overall Study|Screen Failure|0|||
126275891|NCT02132754|454300021|FG007|Overall Study|Screen Failure|0|||
126275892|NCT02132754|454300022|FG008|Overall Study|Screen Failure|0|||
126275893|NCT02132754|454300023|FG009|Overall Study|Screen Failure|0|||
126275894|NCT02132754|454300024|FG010|Overall Study|Screen Failure|0|||
126275895|NCT02132754|454300025|FG011|Overall Study|Screen Failure|0|||
126275896|NCT02132754|454300026|FG012|Overall Study|Screen Failure|0|||
126275897|NCT02132754|454300027|FG013|Overall Study|Screen Failure|0|||
126275898|NCT02132754|454300028|FG014|Overall Study|Screen Failure|0|||
126275899|NCT02132754|454300029|FG015|Overall Study|Screen Failure|0|||
126275900|NCT02132754|454300030|FG016|Overall Study|Screen Failure|0|||
126275901|NCT02132754|454300031|FG017|Overall Study|Screen Failure|0|||
126275902|NCT02132754|454300032|FG018|Overall Study|Screen Failure|0|||
126275903|NCT02132754|454300033|FG019|Overall Study|Screen Failure|1|||
126275904|NCT02132754|454300034|FG020|Overall Study|Screen Failure|0|||
126275905|NCT02132754|454300035|FG021|Overall Study|Screen Failure|1|||
126275906|NCT02132754|454300036|FG022|Overall Study|Screen Failure|0|||
126275907|NCT02132754|454300037|FG023|Overall Study|Screen Failure|0|||
126275908|NCT02132754|454300038|FG024|Overall Study|Screen Failure|0|||
126275909|NCT02132754|454300039|FG025|Overall Study|Screen Failure|0|||
126275910|NCT02132754|454300040|FG026|Overall Study|Screen Failure|0|||
126362716|NCT02662582|454621601|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
126454039|NCT03137069|454963102|FG005|Overall Study|Adverse Event|1|||
126454040|NCT03137069|454963097|FG000|Overall Study|Protocol Violation|0|||
126454041|NCT03137069|454963098|FG001|Overall Study|Protocol Violation|1|||
126454042|NCT03137069|454963099|FG002|Overall Study|Protocol Violation|0|||
126454043|NCT03137069|454963100|FG003|Overall Study|Protocol Violation|1|||
126454044|NCT03137069|454963101|FG004|Overall Study|Protocol Violation|1|||
126454045|NCT03137069|454963102|FG005|Overall Study|Protocol Violation|1|||
126454046|NCT03137069|454963097|FG000|Overall Study|Physician Decision|0|||
126454047|NCT03137069|454963098|FG001|Overall Study|Physician Decision|0|||
126547649|NCT02954458|455298026|FG003|Overall Study|Adverse Event|1|||
126547650|NCT02954458|455298023|FG000|Overall Study|Withdrawal by Subject|0|||
126706180|NCT00561353|455875577|FG007|Overall Study|Other|0|||
126706181|NCT00561353|455875578|FG008|Overall Study|Other|0|||
126362717|NCT02662582|454621602|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
126362718|NCT02662582|454621601|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126362719|NCT02662582|454621602|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126362720|NCT04135352|454621603|FG000|Overall Study|Not treated-randomization error|0|||
126362721|NCT04135352|454621604|FG001|Overall Study|Not treated-randomization error|0|||
126362722|NCT04135352|454621605|FG002|Overall Study|Not treated-randomization error|1|||
126362723|NCT04135352|454621606|FG003|Overall Study|Not treated-randomization error|0|||
126362724|NCT04135352|454621607|FG004|Overall Study|Not treated-randomization error|0|||
126275911|NCT02132754|454300041|FG027|Overall Study|Screen Failure|0|||
126275912|NCT02132754|454300042|FG028|Overall Study|Screen Failure|0|||
126275913|NCT02132754|454300043|FG029|Overall Study|Screen Failure|0|||
126275914|NCT02132754|454300044|FG030|Overall Study|Screen Failure|0|||
126275915|NCT02132754|454300045|FG031|Overall Study|Screen Failure|0|||
126275916|NCT02132754|454300046|FG032|Overall Study|Screen Failure|0|||
126275917|NCT02132754|454300047|FG033|Overall Study|Screen Failure|0|||
126275918|NCT02132754|454300014|FG000|Overall Study|Transferred to Extension Study|0|||
126275919|NCT02132754|454300015|FG001|Overall Study|Transferred to Extension Study|0|||
126275920|NCT02132754|454300016|FG002|Overall Study|Transferred to Extension Study|0|||
126275921|NCT02132754|454300017|FG003|Overall Study|Transferred to Extension Study|0|||
126275922|NCT02132754|454300018|FG004|Overall Study|Transferred to Extension Study|0|||
126454048|NCT03137069|454963099|FG002|Overall Study|Physician Decision|0|||
126706182|NCT00561353|455875579|FG009|Overall Study|Other|0|||
126362725|NCT04135352|454621608|FG005|Overall Study|Not treated-randomization error|0|||
126362726|NCT04135352|454621609|FG006|Overall Study|Not treated-randomization error|0|||
126362727|NCT04135352|454621610|FG007|Overall Study|Not treated-randomization error|0|||
126362728|NCT04135352|454621603|FG000|Overall Study|Withdrawal by Subject|0|||
126362729|NCT04135352|454621604|FG001|Overall Study|Withdrawal by Subject|0|||
126362730|NCT04135352|454621605|FG002|Overall Study|Withdrawal by Subject|2|||
126706183|NCT00561353|455875570|FG000|Overall Study|Adverse Event|0|||
126706184|NCT00561353|455875571|FG001|Overall Study|Adverse Event|0|||
126706185|NCT00561353|455875572|FG002|Overall Study|Adverse Event|0|||
126706186|NCT00561353|455875573|FG003|Overall Study|Adverse Event|2|||
126706187|NCT00561353|455875574|FG004|Overall Study|Adverse Event|0|||
126706188|NCT00561353|455875575|FG005|Overall Study|Adverse Event|0|||
126706189|NCT00561353|455875576|FG006|Overall Study|Adverse Event|1|||
126706190|NCT00561353|455875577|FG007|Overall Study|Adverse Event|0|||
126706191|NCT00561353|455875578|FG008|Overall Study|Adverse Event|0|||
126706192|NCT00561353|455875579|FG009|Overall Study|Adverse Event|1|||
126706193|NCT00561353|455875570|FG000|Overall Study|Lost to Follow-up|2|||
126706194|NCT00561353|455875571|FG001|Overall Study|Lost to Follow-up|0|||
126362731|NCT04135352|454621606|FG003|Overall Study|Withdrawal by Subject|0|||
126362732|NCT04135352|454621607|FG004|Overall Study|Withdrawal by Subject|0|||
126362733|NCT04135352|454621608|FG005|Overall Study|Withdrawal by Subject|0|||
126362734|NCT04135352|454621609|FG006|Overall Study|Withdrawal by Subject|0|||
126362735|NCT04135352|454621610|FG007|Overall Study|Withdrawal by Subject|0|||
126362736|NCT04135352|454621603|FG000|Overall Study|Sponsor Decision|0|||
126362737|NCT04135352|454621604|FG001|Overall Study|Sponsor Decision|0|||
126362738|NCT04135352|454621605|FG002|Overall Study|Sponsor Decision|2|||
126362739|NCT04135352|454621606|FG003|Overall Study|Sponsor Decision|5|||
126362740|NCT04135352|454621607|FG004|Overall Study|Sponsor Decision|1|||
126706195|NCT00561353|455875572|FG002|Overall Study|Lost to Follow-up|1|||
126706196|NCT00561353|455875573|FG003|Overall Study|Lost to Follow-up|0|||
126362741|NCT04135352|454621608|FG005|Overall Study|Sponsor Decision|4|||
126362742|NCT04135352|454621609|FG006|Overall Study|Sponsor Decision|0|||
126362743|NCT04135352|454621610|FG007|Overall Study|Sponsor Decision|0|||
126362744|NCT04135352|454621603|FG000|Overall Study|Physician Decision|0|||
126362745|NCT04135352|454621604|FG001|Overall Study|Physician Decision|0|||
126362746|NCT04135352|454621605|FG002|Overall Study|Physician Decision|1|||
126362747|NCT04135352|454621606|FG003|Overall Study|Physician Decision|0|||
126362748|NCT04135352|454621607|FG004|Overall Study|Physician Decision|1|||
126362749|NCT04135352|454621608|FG005|Overall Study|Physician Decision|0|||
126362750|NCT04135352|454621609|FG006|Overall Study|Physician Decision|0|||
126362751|NCT04135352|454621610|FG007|Overall Study|Physician Decision|0|||
126362752|NCT04135352|454621603|FG000|Overall Study|Death|3|||
126362753|NCT04135352|454621604|FG001|Overall Study|Death|4|||
126362754|NCT04135352|454621605|FG002|Overall Study|Death|7|||
126362755|NCT04135352|454621606|FG003|Overall Study|Death|0|||
126362756|NCT04135352|454621607|FG004|Overall Study|Death|3|||
126362757|NCT04135352|454621608|FG005|Overall Study|Death|1|||
126362758|NCT04135352|454621609|FG006|Overall Study|Death|0|||
126362759|NCT04135352|454621610|FG007|Overall Study|Death|0|||
126362760|NCT00511199|454621611|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
126362761|NCT00511199|454621612|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
126454049|NCT03137069|454963100|FG003|Overall Study|Physician Decision|1|||
126454050|NCT03137069|454963101|FG004|Overall Study|Physician Decision|0|||
126454051|NCT03137069|454963102|FG005|Overall Study|Physician Decision|0|||
126454052|NCT03137069|454963097|FG000|Overall Study|Study Terminated by Sponsor|0|||
126454053|NCT03137069|454963098|FG001|Overall Study|Study Terminated by Sponsor|0|||
126454054|NCT03137069|454963099|FG002|Overall Study|Study Terminated by Sponsor|0|||
126454055|NCT03137069|454963100|FG003|Overall Study|Study Terminated by Sponsor|0|||
126454056|NCT03137069|454963101|FG004|Overall Study|Study Terminated by Sponsor|1|||
126454057|NCT03137069|454963102|FG005|Overall Study|Study Terminated by Sponsor|0|||
126454058|NCT03137069|454963097|FG000|Overall Study|Data Entry Error|0|||
126454059|NCT03137069|454963098|FG001|Overall Study|Data Entry Error|0|||
126454060|NCT03137069|454963099|FG002|Overall Study|Data Entry Error|0|||
126547651|NCT02954458|455298024|FG001|Overall Study|Withdrawal by Subject|0|||
126547652|NCT02954458|455298025|FG002|Overall Study|Withdrawal by Subject|0|||
126547653|NCT02954458|455298026|FG003|Overall Study|Withdrawal by Subject|1|||
126547654|NCT02954458|455298023|FG000|Overall Study|Physician Decision|0|||
126362762|NCT00511199|454621611|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
126362763|NCT00511199|454621612|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
126362764|NCT00511199|454621611|FG000|Overall Study|Withdrawal of Informed Consent|19|||
126362765|NCT00511199|454621612|FG001|Overall Study|Withdrawal of Informed Consent|4|||
126362766|NCT00511199|454621611|FG000|Overall Study|Pregnancy|6|||
126362767|NCT00511199|454621612|FG001|Overall Study|Pregnancy|3|||
126362768|NCT00511199|454621611|FG000|Overall Study|Pregnancy Wish|16|||
126362769|NCT00511199|454621612|FG001|Overall Study|Pregnancy Wish|8|||
126362770|NCT00511199|454621611|FG000|Overall Study|Lost to Follow-up|40|||
126454061|NCT03137069|454963100|FG003|Overall Study|Data Entry Error|1|||
126706197|NCT00561353|455875574|FG004|Overall Study|Lost to Follow-up|0|||
126706198|NCT00561353|455875575|FG005|Overall Study|Lost to Follow-up|0|||
126706199|NCT00561353|455875576|FG006|Overall Study|Lost to Follow-up|0|||
126706200|NCT00561353|455875577|FG007|Overall Study|Lost to Follow-up|0|||
126706201|NCT00561353|455875578|FG008|Overall Study|Lost to Follow-up|0|||
126706202|NCT00561353|455875579|FG009|Overall Study|Lost to Follow-up|0|||
126706203|NCT00561353|455875570|FG000|Overall Study|Withdrawal by Subject|0|||
126706204|NCT00561353|455875571|FG001|Overall Study|Withdrawal by Subject|2|||
126706205|NCT00561353|455875572|FG002|Overall Study|Withdrawal by Subject|0|||
126706206|NCT00561353|455875573|FG003|Overall Study|Withdrawal by Subject|0|||
126706207|NCT00561353|455875574|FG004|Overall Study|Withdrawal by Subject|0|||
126706208|NCT00561353|455875575|FG005|Overall Study|Withdrawal by Subject|0|||
126706209|NCT00561353|455875576|FG006|Overall Study|Withdrawal by Subject|0|||
126706210|NCT00561353|455875577|FG007|Overall Study|Withdrawal by Subject|0|||
126706211|NCT00561353|455875578|FG008|Overall Study|Withdrawal by Subject|0|||
126706212|NCT00561353|455875579|FG009|Overall Study|Withdrawal by Subject|0|||
126706213|NCT01273818|455875580|FG000|Overall Study|Physician Decision|13|||
126706214|NCT01273818|455875581|FG001|Overall Study|Physician Decision|2|||
126706215|NCT01273818|455875582|FG002|Overall Study|Physician Decision|9|||
126706216|NCT03815175|455875583|FG000|Overall Study|Subject Lost to Follow-up|6|||
126706217|NCT03815175|455875583|FG000|Overall Study|Subject Withdrew Consent|48|||
126706218|NCT03815175|455875583|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
126706219|NCT03815175|455875583|FG000|Overall Study|Death|86|||
126275923|NCT02132754|454300019|FG005|Overall Study|Transferred to Extension Study|0|||
126275924|NCT02132754|454300020|FG006|Overall Study|Transferred to Extension Study|0|||
126275925|NCT02132754|454300021|FG007|Overall Study|Transferred to Extension Study|0|||
126275926|NCT02132754|454300022|FG008|Overall Study|Transferred to Extension Study|0|||
126275927|NCT02132754|454300023|FG009|Overall Study|Transferred to Extension Study|0|||
126275928|NCT02132754|454300024|FG010|Overall Study|Transferred to Extension Study|0|||
126275929|NCT02132754|454300025|FG011|Overall Study|Transferred to Extension Study|0|||
126275930|NCT02132754|454300026|FG012|Overall Study|Transferred to Extension Study|0|||
126275931|NCT02132754|454300027|FG013|Overall Study|Transferred to Extension Study|0|||
126275932|NCT02132754|454300028|FG014|Overall Study|Transferred to Extension Study|0|||
126275933|NCT02132754|454300029|FG015|Overall Study|Transferred to Extension Study|0|||
126275934|NCT02132754|454300030|FG016|Overall Study|Transferred to Extension Study|0|||
126275935|NCT02132754|454300031|FG017|Overall Study|Transferred to Extension Study|0|||
126275936|NCT02132754|454300032|FG018|Overall Study|Transferred to Extension Study|0|||
126275937|NCT02132754|454300033|FG019|Overall Study|Transferred to Extension Study|0|||
126275938|NCT02132754|454300034|FG020|Overall Study|Transferred to Extension Study|0|||
126275939|NCT02132754|454300035|FG021|Overall Study|Transferred to Extension Study|0|||
126275940|NCT02132754|454300036|FG022|Overall Study|Transferred to Extension Study|0|||
126275941|NCT02132754|454300037|FG023|Overall Study|Transferred to Extension Study|0|||
126275942|NCT02132754|454300038|FG024|Overall Study|Transferred to Extension Study|0|||
126275943|NCT02132754|454300039|FG025|Overall Study|Transferred to Extension Study|0|||
126275944|NCT02132754|454300040|FG026|Overall Study|Transferred to Extension Study|0|||
126275945|NCT02132754|454300041|FG027|Overall Study|Transferred to Extension Study|0|||
126275946|NCT02132754|454300042|FG028|Overall Study|Transferred to Extension Study|0|||
126275947|NCT02132754|454300043|FG029|Overall Study|Transferred to Extension Study|0|||
126275948|NCT02132754|454300044|FG030|Overall Study|Transferred to Extension Study|0|||
126275949|NCT02132754|454300045|FG031|Overall Study|Transferred to Extension Study|0|||
126275950|NCT02132754|454300046|FG032|Overall Study|Transferred to Extension Study|0|||
126275951|NCT02132754|454300047|FG033|Overall Study|Transferred to Extension Study|6|||
126275952|NCT02132754|454300014|FG000|Overall Study|Withdrawal by Subject|0|||
126275953|NCT02132754|454300015|FG001|Overall Study|Withdrawal by Subject|0|||
126275954|NCT02132754|454300016|FG002|Overall Study|Withdrawal by Subject|0|||
126275955|NCT02132754|454300017|FG003|Overall Study|Withdrawal by Subject|0|||
126275956|NCT02132754|454300018|FG004|Overall Study|Withdrawal by Subject|0|||
126275957|NCT02132754|454300019|FG005|Overall Study|Withdrawal by Subject|0|||
126275958|NCT02132754|454300020|FG006|Overall Study|Withdrawal by Subject|0|||
126706220|NCT03815175|455875583|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
126706221|NCT03815175|455875583|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
126706222|NCT03815175|455875583|FG000|Overall Study|Other Status Change Reason|1|||
126706223|NCT03815175|455875583|FG000|Overall Study|Missed Visit|12|||
126706224|NCT00820040|455875584|FG000|Overall Study|Death|1|||
126275959|NCT02132754|454300021|FG007|Overall Study|Withdrawal by Subject|0|||
126275960|NCT02132754|454300022|FG008|Overall Study|Withdrawal by Subject|0|||
126275961|NCT02132754|454300023|FG009|Overall Study|Withdrawal by Subject|1|||
126362771|NCT00511199|454621612|FG001|Overall Study|Lost to Follow-up|17|||
126706225|NCT00820040|455875584|FG000|Overall Study|Sponsor terminated study|1|||
126275962|NCT02132754|454300024|FG010|Overall Study|Withdrawal by Subject|0|||
126275963|NCT02132754|454300025|FG011|Overall Study|Withdrawal by Subject|0|||
126275964|NCT02132754|454300026|FG012|Overall Study|Withdrawal by Subject|1|||
126275965|NCT02132754|454300027|FG013|Overall Study|Withdrawal by Subject|0|||
126706226|NCT00820040|455875584|FG000|Overall Study|Screen failure|1|||
126706227|NCT02493751|455875585|FG000|Overall Study|Withdrawal by Subject|2|||
126706228|NCT02493751|455875586|FG001|Overall Study|Withdrawal by Subject|8|||
126275966|NCT02132754|454300028|FG014|Overall Study|Withdrawal by Subject|1|||
126275967|NCT02132754|454300029|FG015|Overall Study|Withdrawal by Subject|2|||
126275968|NCT02132754|454300030|FG016|Overall Study|Withdrawal by Subject|1|||
126275969|NCT02132754|454300031|FG017|Overall Study|Withdrawal by Subject|0|||
126275970|NCT02132754|454300032|FG018|Overall Study|Withdrawal by Subject|0|||
126275971|NCT02132754|454300033|FG019|Overall Study|Withdrawal by Subject|0|||
126275972|NCT02132754|454300034|FG020|Overall Study|Withdrawal by Subject|1|||
126275973|NCT02132754|454300035|FG021|Overall Study|Withdrawal by Subject|0|||
126275974|NCT02132754|454300036|FG022|Overall Study|Withdrawal by Subject|0|||
126275975|NCT02132754|454300037|FG023|Overall Study|Withdrawal by Subject|0|||
126275976|NCT02132754|454300038|FG024|Overall Study|Withdrawal by Subject|1|||
126275977|NCT02132754|454300039|FG025|Overall Study|Withdrawal by Subject|0|||
126275978|NCT02132754|454300040|FG026|Overall Study|Withdrawal by Subject|0|||
126275979|NCT02132754|454300041|FG027|Overall Study|Withdrawal by Subject|1|||
126275980|NCT02132754|454300042|FG028|Overall Study|Withdrawal by Subject|0|||
126275981|NCT02132754|454300043|FG029|Overall Study|Withdrawal by Subject|0|||
126275982|NCT02132754|454300044|FG030|Overall Study|Withdrawal by Subject|0|||
126275983|NCT02132754|454300045|FG031|Overall Study|Withdrawal by Subject|1|||
126275984|NCT02132754|454300046|FG032|Overall Study|Withdrawal by Subject|0|||
126362772|NCT00511199|454621611|FG000|Overall Study|Other Reason|78|||
126362773|NCT00511199|454621612|FG001|Overall Study|Other Reason|37|||
126362774|NCT02739828|454621618|FG000|Overall Study|Adverse Event|1|||
126362775|NCT02739828|454621618|FG000|Overall Study|Lost to Follow-up|4|||
126454062|NCT03137069|454963101|FG004|Overall Study|Data Entry Error|0|||
126454063|NCT03137069|454963102|FG005|Overall Study|Data Entry Error|0|||
126454064|NCT02043899|454963104|FG000|Overall Study|Adverse Event|3|||
126454065|NCT02043899|454963104|FG000|Overall Study|Physician Decision|1|||
126454066|NCT02043899|454963104|FG000|Overall Study|Withdrawal by Subject|2|||
126454067|NCT02043899|454963104|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
126454068|NCT02043899|454963104|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
126454069|NCT02043899|454963104|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
126454070|NCT02043899|454963104|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
126454071|NCT02043899|454963104|FG000|Overall Study|Treatment delayed|1|||
126454072|NCT01325337|454963106|FG000|Overall Study|Adverse Event|0|||
126454073|NCT01325337|454963107|FG001|Overall Study|Adverse Event|2|||
126454074|NCT01325337|454963108|FG002|Overall Study|Adverse Event|2|||
126454075|NCT01325337|454963109|FG003|Overall Study|Adverse Event|1|||
126454076|NCT01325337|454963110|FG004|Overall Study|Adverse Event|2|||
126454077|NCT01325337|454963106|FG000|Overall Study|Lost to Follow-up|2|||
126454078|NCT01325337|454963107|FG001|Overall Study|Lost to Follow-up|2|||
126454079|NCT01325337|454963108|FG002|Overall Study|Lost to Follow-up|2|||
126454080|NCT01325337|454963109|FG003|Overall Study|Lost to Follow-up|1|||
126454081|NCT01325337|454963110|FG004|Overall Study|Lost to Follow-up|2|||
126454082|NCT01325337|454963106|FG000|Overall Study|Personal Reasons|2|||
126454083|NCT01325337|454963107|FG001|Overall Study|Personal Reasons|5|||
126454084|NCT01325337|454963108|FG002|Overall Study|Personal Reasons|4|||
126454085|NCT01325337|454963109|FG003|Overall Study|Personal Reasons|8|||
126454086|NCT01325337|454963110|FG004|Overall Study|Personal Reasons|3|||
126454087|NCT01325337|454963106|FG000|Overall Study|Withdrawal by Subject|1|||
126454088|NCT01325337|454963107|FG001|Overall Study|Withdrawal by Subject|0|||
126454089|NCT01325337|454963108|FG002|Overall Study|Withdrawal by Subject|1|||
126454090|NCT01325337|454963109|FG003|Overall Study|Withdrawal by Subject|0|||
126454091|NCT01325337|454963110|FG004|Overall Study|Withdrawal by Subject|1|||
126454092|NCT04140227|454963112|FG000|Overall Study|Withdrawal by Subject|26|||
126454093|NCT04140227|454963112|FG000|Overall Study|Lost to Follow-up|8|||
126454094|NCT04140227|454963112|FG000|Overall Study|Adverse Event|8|||
126362776|NCT01953354|454621619|FG000|Overall Study|Withdrawal by Subject|0|||
126362777|NCT01953354|454621620|FG001|Overall Study|Withdrawal by Subject|1|||
126362778|NCT01953354|454621619|FG000|Overall Study|Decision of Sponsor|0|||
126362779|NCT01953354|454621620|FG001|Overall Study|Decision of Sponsor|1|||
126362780|NCT01953354|454621619|FG000|Overall Study|Disease Exacerbation|1|||
126362781|NCT01953354|454621620|FG001|Overall Study|Disease Exacerbation|0|||
126362782|NCT01392495|454621621|FG000|Overall Study|Death|3|||
126362783|NCT01392495|454621621|FG000|Overall Study|Administrative problems|8|||
126362784|NCT01392495|454621621|FG000|Overall Study|Withdrawal by Subject|2|||
126362785|NCT01392495|454621621|FG000|Overall Study|Adverse Event|3|||
126362786|NCT01570192|454621622|FG000|Overall Study|no qualifying organism|6|||
126454095|NCT04140227|454963112|FG000|Overall Study|Death|1|||
126275985|NCT02132754|454300047|FG033|Overall Study|Withdrawal by Subject|2|||
126275986|NCT03050060|454300050|FG000|Overall Study|Adverse Event|7|||
126275987|NCT03050060|454300050|FG000|Overall Study|Withdrawal by Subject|1|||
126275988|NCT03050060|454300050|FG000|Overall Study|Progression|7|||
126362787|NCT01570192|454621623|FG001|Overall Study|no qualifying organism|12|||
126362788|NCT01570192|454621622|FG000|Overall Study|changed to palliative care|1|||
126454096|NCT04140227|454963112|FG000|Overall Study|Other|3|||
126362789|NCT01570192|454621623|FG001|Overall Study|changed to palliative care|0|||
126454097|NCT04140227|454963112|FG000|Overall Study|Protocol Violation|2|||
126275989|NCT03276780|454300051|FG000|Overall Study|Withdrawal by Subject|5|||
126275990|NCT03276780|454300052|FG001|Overall Study|Withdrawal by Subject|3|||
126275991|NCT03276780|454300051|FG000|Overall Study|Lost to Follow-up|3|||
126275992|NCT03276780|454300052|FG001|Overall Study|Lost to Follow-up|5|||
126275993|NCT03276780|454300051|FG000|Overall Study|Moved out of state|1|||
126275994|NCT03276780|454300052|FG001|Overall Study|Moved out of state|1|||
126275995|NCT03276780|454300051|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
126275996|NCT03276780|454300052|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
126275997|NCT03276780|454300051|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
126275998|NCT03276780|454300052|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
126275999|NCT03665441|454301727|FG000|Overall Study|survival follow up ongoing|23|||
126276000|NCT03665441|454301728|FG001|Overall Study|survival follow up ongoing|0|||
126276001|NCT03665441|454301727|FG000|Overall Study|Patients ongoing on treatment|9|||
126276002|NCT03665441|454301728|FG001|Overall Study|Patients ongoing on treatment|6|||
126276003|NCT03665441|454301727|FG000|Overall Study|Randomized but not treated|7|||
126276004|NCT03665441|454301728|FG001|Overall Study|Randomized but not treated|11|||
126276005|NCT00372411|454301729|FG000|Overall Study|Withdrawal by Subject|3|||
126276006|NCT00372411|454301730|FG001|Overall Study|Withdrawal by Subject|4|||
126276007|NCT00372411|454301731|FG002|Overall Study|Withdrawal by Subject|1|||
126276008|NCT00372411|454301729|FG000|Overall Study|Death|0|||
126276009|NCT00372411|454301730|FG001|Overall Study|Death|2|||
126276010|NCT00372411|454301731|FG002|Overall Study|Death|1|||
126276011|NCT00372411|454301729|FG000|Overall Study|Lost to Follow-up|1|||
126276012|NCT00372411|454301730|FG001|Overall Study|Lost to Follow-up|1|||
126276013|NCT00372411|454301731|FG002|Overall Study|Lost to Follow-up|1|||
126276014|NCT00372411|454301729|FG000|Overall Study|Adverse Event|1|||
126276015|NCT00372411|454301730|FG001|Overall Study|Adverse Event|1|||
126276016|NCT00372411|454301731|FG002|Overall Study|Adverse Event|0|||
126276017|NCT00631657|454301732|FG000|6-Month Treatment Period|Adverse Event|47|||
126276018|NCT00631657|454301733|FG001|6-Month Treatment Period|Adverse Event|0|||
126276019|NCT00631657|454301734|FG002|6-Month Treatment Period|Adverse Event|7|||
126276020|NCT00631657|454301732|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
126276021|NCT00631657|454301733|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
126276022|NCT00631657|454301734|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
126276023|NCT00631657|454301732|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
126276024|NCT00631657|454301733|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
126276025|NCT00631657|454301734|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
126276026|NCT00631657|454301732|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
126276027|NCT00631657|454301733|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
126276028|NCT00631657|454301734|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
126276029|NCT00631657|454301732|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
126276030|NCT00631657|454301733|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
126276031|NCT00631657|454301734|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
126276032|NCT00631657|454301732|FG000|6-Month Treatment Period|Other|16|||
126276033|NCT00631657|454301733|FG001|6-Month Treatment Period|Other|0|||
126276034|NCT00631657|454301734|FG002|6-Month Treatment Period|Other|4|||
126276035|NCT00631657|454301732|FG000|6-Month Treatment Period|Not Treated|2|||
126276036|NCT00631657|454301733|FG001|6-Month Treatment Period|Not Treated|0|||
126454098|NCT05315908|454963119|FG000|Overall Study|Lost to Follow-up|4477|||
126454099|NCT05315908|454963120|FG001|Overall Study|Lost to Follow-up|4606|||
126454100|NCT04493892|454963125|FG000|Overall Study|Withdrawal by Subject|15|||
126454101|NCT01541397|454963126|FG000|Overall Study|Study ended prior to data collection|4|||
126454102|NCT01541397|454963127|FG001|Overall Study|Study ended prior to data collection|2|||
126454103|NCT01128621|454963128|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
126454104|NCT01128621|454963129|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
126454105|NCT01689532|454963132|FG000|Overall Study|Adverse Event|9|||
126454106|NCT01689532|454963133|FG001|Overall Study|Adverse Event|5|||
126454107|NCT01689532|454963132|FG000|Overall Study|Lack of Efficacy|2|||
126454108|NCT01689532|454963133|FG001|Overall Study|Lack of Efficacy|2|||
126454109|NCT01689532|454963132|FG000|Overall Study|Withdrawal by Subject|1|||
126454110|NCT01689532|454963133|FG001|Overall Study|Withdrawal by Subject|2|||
126454111|NCT01689532|454963132|FG000|Overall Study|Physician Decision|2|||
126454112|NCT01689532|454963133|FG001|Overall Study|Physician Decision|0|||
126454113|NCT01363349|454963134|FG000|Overall Study|Adverse Event|6|||
126454114|NCT01363349|454963135|FG001|Overall Study|Adverse Event|7|||
126454115|NCT01363349|454963134|FG000|Overall Study|Lack of Efficacy|3|||
126454116|NCT01363349|454963135|FG001|Overall Study|Lack of Efficacy|10|||
126454117|NCT01363349|454963134|FG000|Overall Study|Non compliance/Protocol deviations|2|||
126454118|NCT01363349|454963135|FG001|Overall Study|Non compliance/Protocol deviations|2|||
126547655|NCT02954458|455298024|FG001|Overall Study|Physician Decision|0|||
126547656|NCT02954458|455298025|FG002|Overall Study|Physician Decision|1|||
126276037|NCT00631657|454301734|FG002|6-Month Treatment Period|Not Treated|1|||
126276038|NCT00631657|454301732|FG000|7-Day Discontinuation Period|Not Treated|1|||
126454119|NCT01363349|454963134|FG000|Overall Study|Withdrawal by Subject|14|||
126706229|NCT02493751|455875585|FG000|Overall Study|Death|6|||
126706230|NCT02493751|455875586|FG001|Overall Study|Death|13|||
126706231|NCT02493751|455875585|FG000|Overall Study|Lost to Follow-up|2|||
126706232|NCT02493751|455875586|FG001|Overall Study|Lost to Follow-up|3|||
126706233|NCT02493751|455875585|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
126706234|NCT02493751|455875586|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
126706235|NCT01824602|455875589|FG000|Overall Study|Withdrawal by Subject|0|||
126706236|NCT01824602|455875590|FG001|Overall Study|Withdrawal by Subject|0|||
126706237|NCT01824602|455875591|FG002|Overall Study|Withdrawal by Subject|1|||
126706238|NCT01824602|455875592|FG003|Overall Study|Withdrawal by Subject|2|||
126706239|NCT01824602|455875589|FG000|Overall Study|Patient non-compliance|0|||
126706240|NCT01824602|455875590|FG001|Overall Study|Patient non-compliance|0|||
126706241|NCT01824602|455875591|FG002|Overall Study|Patient non-compliance|1|||
126706242|NCT01824602|455875592|FG003|Overall Study|Patient non-compliance|0|||
126706243|NCT01824602|455875589|FG000|Overall Study|Adverse Event|1|||
126706244|NCT01824602|455875590|FG001|Overall Study|Adverse Event|0|||
126706245|NCT01824602|455875591|FG002|Overall Study|Adverse Event|2|||
126706246|NCT01824602|455875592|FG003|Overall Study|Adverse Event|2|||
126706247|NCT01824602|455875589|FG000|Overall Study|Treatment failure|0|||
126706248|NCT01824602|455875590|FG001|Overall Study|Treatment failure|0|||
126706249|NCT01824602|455875591|FG002|Overall Study|Treatment failure|0|||
126706250|NCT01824602|455875592|FG003|Overall Study|Treatment failure|1|||
126706251|NCT02485717|455875595|FG000|Overall Study|Lost to Follow-up|6|||
126706252|NCT02485717|455875596|FG001|Overall Study|Lost to Follow-up|0|||
126706253|NCT02485717|455875597|FG002|Overall Study|Lost to Follow-up|0|||
126706254|NCT02485717|455875595|FG000|Overall Study|Withdrawal by Subject|0|||
126706255|NCT02485717|455875596|FG001|Overall Study|Withdrawal by Subject|0|||
126706256|NCT02485717|455875597|FG002|Overall Study|Withdrawal by Subject|1|||
126706257|NCT02485717|455875595|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
126706258|NCT02485717|455875596|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
126276039|NCT00631657|454301733|FG001|7-Day Discontinuation Period|Not Treated|1|||
126276040|NCT00631657|454301734|FG002|7-Day Discontinuation Period|Not Treated|1|||
126276041|NCT00631657|454301732|FG000|7-Day Discontinuation Period|Other|1|||
126276042|NCT00631657|454301733|FG001|7-Day Discontinuation Period|Other|0|||
126276043|NCT00631657|454301734|FG002|7-Day Discontinuation Period|Other|0|||
126276044|NCT00699374|454301736|FG000|Overall Study|Death|93|||
126276045|NCT00699374|454301737|FG001|Overall Study|Death|83|||
126276046|NCT00699374|454301736|FG000|Overall Study|Adverse Event|70|||
126276047|NCT00699374|454301737|FG001|Overall Study|Adverse Event|67|||
126276048|NCT00699374|454301736|FG000|Overall Study|Global deterioration of health status|7|||
126276049|NCT00699374|454301737|FG001|Overall Study|Global deterioration of health status|8|||
126276050|NCT00699374|454301736|FG000|Overall Study|Lost to Follow-up|3|||
126276051|NCT00699374|454301737|FG001|Overall Study|Lost to Follow-up|5|||
126276052|NCT00699374|454301736|FG000|Overall Study|Withdrawal by Subject|34|||
126276053|NCT00699374|454301737|FG001|Overall Study|Withdrawal by Subject|44|||
126276054|NCT00699374|454301736|FG000|Overall Study|Objective progression or relapse|281|||
126276055|NCT00699374|454301737|FG001|Overall Study|Objective progression or relapse|277|||
126276056|NCT00699374|454301736|FG000|Overall Study|Other|18|||
126276057|NCT00699374|454301737|FG001|Overall Study|Other|15|||
126276058|NCT00699374|454301736|FG000|Overall Study|Protocol Violation|2|||
126276059|NCT00699374|454301737|FG001|Overall Study|Protocol Violation|6|||
126276060|NCT00699374|454301736|FG000|Overall Study|Study terminated by sponsor|13|||
126276061|NCT00699374|454301737|FG001|Overall Study|Study terminated by sponsor|28|||
126276062|NCT00699374|454301736|FG000|Overall Study|Randomized but not treated|4|||
126276063|NCT00699374|454301737|FG001|Overall Study|Randomized but not treated|2|||
126276064|NCT00699374|454301736|FG000|Overall Study|Died 28 days after last dose|5|||
126276065|NCT00699374|454301737|FG001|Overall Study|Died 28 days after last dose|9|||
126276066|NCT03839823|454301740|FG000|Overall Study|Adverse Event|8|||
126276067|NCT03839823|454301741|FG001|Overall Study|Adverse Event|4|||
126276068|NCT03839823|454301740|FG000|Overall Study|Death|1|||
126276069|NCT03839823|454301741|FG001|Overall Study|Death|0|||
126276070|NCT03839823|454301740|FG000|Overall Study|Physician Decision|1|||
126706259|NCT02485717|455875597|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
126706260|NCT02485717|455875595|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
126454120|NCT01363349|454963135|FG001|Overall Study|Withdrawal by Subject|6|||
126454121|NCT01363349|454963134|FG000|Overall Study|Lost to Follow-up|5|||
126706261|NCT02485717|455875596|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
126706262|NCT02485717|455875597|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
126706263|NCT03822468|455875598|FG000|Treatment Period|Progressive disease|98|||
126276071|NCT03839823|454301741|FG001|Overall Study|Physician Decision|5|||
126276072|NCT03839823|454301740|FG000|Overall Study|Progressive Disease (PD)|65|||
126276073|NCT03839823|454301741|FG001|Overall Study|Progressive Disease (PD)|65|||
126276074|NCT03839823|454301740|FG000|Overall Study|Subject Decision|2|||
126276075|NCT03839823|454301741|FG001|Overall Study|Subject Decision|9|||
126706264|NCT03822468|455875599|FG001|Treatment Period|Progressive disease|94|||
126706265|NCT03822468|455875598|FG000|Treatment Period|Adverse Event|21|||
126362790|NCT01570192|454621622|FG000|Overall Study|Physician Decision|0|||
126362791|NCT01570192|454621623|FG001|Overall Study|Physician Decision|1|||
126362792|NCT02965976|454621624|FG000|Overall Study|Withdrawal by Subject|2|||
126362793|NCT02965976|454621625|FG001|Overall Study|Withdrawal by Subject|0|||
126362794|NCT00806026|454621626|FG000|Overall Study|Death|0|||
126362795|NCT00806026|454621627|FG001|Overall Study|Death|0|||
126362796|NCT00806026|454621628|FG002|Overall Study|Death|0|||
126362797|NCT00806026|454621629|FG003|Overall Study|Death|1|||
126362798|NCT00806026|454621630|FG004|Overall Study|Death|0|||
126362799|NCT00806026|454621631|FG005|Overall Study|Death|0|||
126362800|NCT00806026|454621626|FG000|Overall Study|Did not meet entrance criteria|4|||
126362801|NCT00806026|454621627|FG001|Overall Study|Did not meet entrance criteria|1|||
126362802|NCT00806026|454621628|FG002|Overall Study|Did not meet entrance criteria|2|||
126362803|NCT00806026|454621629|FG003|Overall Study|Did not meet entrance criteria|1|||
126276076|NCT03839823|454301740|FG000|Overall Study|Not Treated|0|||
126276077|NCT03839823|454301741|FG001|Overall Study|Not Treated|10|||
126276078|NCT01517373|454301742|FG000|Run-in Period|Death|1|||
126276079|NCT01517373|454301743|FG001|Run-in Period|Death|0|||
126276080|NCT01517373|454301744|FG002|Run-in Period|Death|0|||
126276081|NCT01517373|454301745|FG003|Run-in Period|Death|0|||
126276082|NCT01517373|454301746|FG004|Run-in Period|Death|0|||
126276083|NCT01517373|454301747|FG005|Run-in Period|Death|0|||
126276084|NCT01517373|454301742|FG000|Run-in Period|Adverse Event|5|||
126276085|NCT01517373|454301743|FG001|Run-in Period|Adverse Event|0|||
126276086|NCT01517373|454301744|FG002|Run-in Period|Adverse Event|0|||
126276087|NCT01517373|454301745|FG003|Run-in Period|Adverse Event|0|||
126276088|NCT01517373|454301746|FG004|Run-in Period|Adverse Event|0|||
126276089|NCT01517373|454301747|FG005|Run-in Period|Adverse Event|0|||
126276090|NCT01517373|454301742|FG000|Run-in Period|Did not meet eligibility criteria|34|||
126276091|NCT01517373|454301743|FG001|Run-in Period|Did not meet eligibility criteria|0|||
126276092|NCT01517373|454301744|FG002|Run-in Period|Did not meet eligibility criteria|0|||
126276093|NCT01517373|454301745|FG003|Run-in Period|Did not meet eligibility criteria|0|||
126276094|NCT01517373|454301746|FG004|Run-in Period|Did not meet eligibility criteria|0|||
126276095|NCT01517373|454301747|FG005|Run-in Period|Did not meet eligibility criteria|0|||
126276096|NCT01517373|454301742|FG000|Run-in Period|Lost to Follow-up|1|||
126276097|NCT01517373|454301743|FG001|Run-in Period|Lost to Follow-up|0|||
126276098|NCT01517373|454301744|FG002|Run-in Period|Lost to Follow-up|0|||
126276099|NCT01517373|454301745|FG003|Run-in Period|Lost to Follow-up|0|||
126276100|NCT01517373|454301746|FG004|Run-in Period|Lost to Follow-up|0|||
126276101|NCT01517373|454301747|FG005|Run-in Period|Lost to Follow-up|0|||
126276102|NCT01517373|454301742|FG000|Run-in Period|Withdrawal by Subject|12|||
126276103|NCT01517373|454301743|FG001|Run-in Period|Withdrawal by Subject|0|||
126276104|NCT01517373|454301744|FG002|Run-in Period|Withdrawal by Subject|0|||
126276105|NCT01517373|454301745|FG003|Run-in Period|Withdrawal by Subject|0|||
126276106|NCT01517373|454301746|FG004|Run-in Period|Withdrawal by Subject|0|||
126276107|NCT01517373|454301747|FG005|Run-in Period|Withdrawal by Subject|0|||
126276108|NCT01517373|454301742|FG000|Run-in Period|Sponsor Decision|3|||
126276109|NCT01517373|454301743|FG001|Run-in Period|Sponsor Decision|0|||
126276110|NCT01517373|454301744|FG002|Run-in Period|Sponsor Decision|0|||
126276111|NCT01517373|454301745|FG003|Run-in Period|Sponsor Decision|0|||
126276112|NCT01517373|454301746|FG004|Run-in Period|Sponsor Decision|0|||
126362804|NCT00806026|454621630|FG004|Overall Study|Did not meet entrance criteria|0|||
126362805|NCT00806026|454621631|FG005|Overall Study|Did not meet entrance criteria|0|||
126362806|NCT00806026|454621626|FG000|Overall Study|Lack of Efficacy|5|||
126362807|NCT00806026|454621627|FG001|Overall Study|Lack of Efficacy|18|||
126362808|NCT00806026|454621628|FG002|Overall Study|Lack of Efficacy|13|||
126362809|NCT00806026|454621629|FG003|Overall Study|Lack of Efficacy|4|||
126362810|NCT00806026|454621630|FG004|Overall Study|Lack of Efficacy|8|||
126362811|NCT00806026|454621631|FG005|Overall Study|Lack of Efficacy|7|||
126362812|NCT00806026|454621626|FG000|Overall Study|Lost to Follow-up|8|||
126362813|NCT00806026|454621627|FG001|Overall Study|Lost to Follow-up|15|||
126362814|NCT00806026|454621628|FG002|Overall Study|Lost to Follow-up|8|||
126362815|NCT00806026|454621629|FG003|Overall Study|Lost to Follow-up|2|||
126362816|NCT00806026|454621630|FG004|Overall Study|Lost to Follow-up|6|||
126362817|NCT00806026|454621631|FG005|Overall Study|Lost to Follow-up|6|||
126362818|NCT00806026|454621626|FG000|Overall Study|Withdrawal by Subject|14|||
126362819|NCT00806026|454621627|FG001|Overall Study|Withdrawal by Subject|17|||
126362820|NCT00806026|454621628|FG002|Overall Study|Withdrawal by Subject|9|||
126362821|NCT00806026|454621629|FG003|Overall Study|Withdrawal by Subject|2|||
126362822|NCT00806026|454621630|FG004|Overall Study|Withdrawal by Subject|5|||
126362823|NCT00806026|454621631|FG005|Overall Study|Withdrawal by Subject|3|||
126276113|NCT01517373|454301747|FG005|Run-in Period|Sponsor Decision|0|||
126276114|NCT01517373|454301742|FG000|Run-in Period|Other|1|||
126276115|NCT01517373|454301743|FG001|Run-in Period|Other|0|||
126362824|NCT00806026|454621626|FG000|Overall Study|Other|3|||
126362825|NCT00806026|454621627|FG001|Overall Study|Other|6|||
126362826|NCT00806026|454621628|FG002|Overall Study|Other|8|||
126362827|NCT00806026|454621629|FG003|Overall Study|Other|2|||
126362828|NCT00806026|454621630|FG004|Overall Study|Other|0|||
126362829|NCT00806026|454621631|FG005|Overall Study|Other|4|||
126454122|NCT01363349|454963135|FG001|Overall Study|Lost to Follow-up|6|||
126454123|NCT01363349|454963134|FG000|Overall Study|Not reported|36|||
126454124|NCT01363349|454963135|FG001|Overall Study|Not reported|37|||
126454125|NCT01363349|454963134|FG000|Overall Study|missing|1|||
126454126|NCT01363349|454963135|FG001|Overall Study|missing|2|||
126454127|NCT02208063|454963136|FG000|Overall Study|Death|3|||
126454128|NCT02208063|454963137|FG001|Overall Study|Death|5|||
126454129|NCT02208063|454963136|FG000|Overall Study|Not Specified in report|3|||
126454130|NCT02208063|454963137|FG001|Overall Study|Not Specified in report|4|||
126454131|NCT02208063|454963136|FG000|Overall Study|Withdrawal by Subject|5|||
126765697|NCT01118949|456095778|FG000|Overall Study|Withdrawal by Subject|4|||
126765698|NCT00685763|456095783|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
126765699|NCT00685763|456095783|FG000|Overall Study|Protocol Violation|1|||
126276116|NCT01517373|454301744|FG002|Run-in Period|Other|0|||
126276117|NCT01517373|454301745|FG003|Run-in Period|Other|0|||
126276118|NCT01517373|454301746|FG004|Run-in Period|Other|0|||
126276119|NCT01517373|454301747|FG005|Run-in Period|Other|0|||
126276120|NCT01517373|454301742|FG000|Treatment Period|Adverse Event|0|||
126276121|NCT01517373|454301743|FG001|Treatment Period|Adverse Event|0|||
126276122|NCT01517373|454301744|FG002|Treatment Period|Adverse Event|0|||
126276123|NCT01517373|454301745|FG003|Treatment Period|Adverse Event|0|||
126276124|NCT01517373|454301746|FG004|Treatment Period|Adverse Event|0|||
126276125|NCT01517373|454301747|FG005|Treatment Period|Adverse Event|2|||
126276126|NCT01517373|454301742|FG000|Treatment Period|Lost to Follow-up|0|||
126276127|NCT01517373|454301743|FG001|Treatment Period|Lost to Follow-up|0|||
126276128|NCT01517373|454301744|FG002|Treatment Period|Lost to Follow-up|1|||
126276129|NCT01517373|454301745|FG003|Treatment Period|Lost to Follow-up|1|||
126276130|NCT01517373|454301746|FG004|Treatment Period|Lost to Follow-up|0|||
126276131|NCT01517373|454301747|FG005|Treatment Period|Lost to Follow-up|0|||
126276132|NCT01517373|454301742|FG000|Treatment Period|Withdrawal by Subject|0|||
126276133|NCT01517373|454301743|FG001|Treatment Period|Withdrawal by Subject|3|||
126276134|NCT01517373|454301744|FG002|Treatment Period|Withdrawal by Subject|2|||
126276135|NCT01517373|454301745|FG003|Treatment Period|Withdrawal by Subject|2|||
126276136|NCT01517373|454301746|FG004|Treatment Period|Withdrawal by Subject|2|||
126276137|NCT01517373|454301747|FG005|Treatment Period|Withdrawal by Subject|3|||
126276138|NCT01517373|454301742|FG000|Treatment Period|Other|0|||
126276139|NCT01517373|454301743|FG001|Treatment Period|Other|0|||
126276140|NCT01517373|454301744|FG002|Treatment Period|Other|0|||
126276141|NCT01517373|454301745|FG003|Treatment Period|Other|0|||
126276142|NCT01517373|454301746|FG004|Treatment Period|Other|1|||
126276143|NCT01517373|454301747|FG005|Treatment Period|Other|0|||
126276144|NCT01517373|454301742|FG000|Treatment Period|Protocol Violation|0|||
126276145|NCT01517373|454301743|FG001|Treatment Period|Protocol Violation|0|||
126276146|NCT01517373|454301744|FG002|Treatment Period|Protocol Violation|0|||
126276147|NCT01517373|454301745|FG003|Treatment Period|Protocol Violation|0|||
126276148|NCT01517373|454301746|FG004|Treatment Period|Protocol Violation|1|||
126276149|NCT01517373|454301747|FG005|Treatment Period|Protocol Violation|0|||
126276150|NCT01517373|454301742|FG000|Treatment Period|Lack of Efficacy|0|||
126276151|NCT01517373|454301743|FG001|Treatment Period|Lack of Efficacy|1|||
126276152|NCT01517373|454301744|FG002|Treatment Period|Lack of Efficacy|1|||
126276153|NCT01517373|454301745|FG003|Treatment Period|Lack of Efficacy|3|||
126276154|NCT01517373|454301746|FG004|Treatment Period|Lack of Efficacy|2|||
126276155|NCT01517373|454301747|FG005|Treatment Period|Lack of Efficacy|0|||
126276156|NCT01517373|454301742|FG000|Treatment Period|Medication error without AEs|0|||
126276157|NCT01517373|454301743|FG001|Treatment Period|Medication error without AEs|0|||
126276158|NCT01517373|454301744|FG002|Treatment Period|Medication error without AEs|2|||
126276159|NCT01517373|454301745|FG003|Treatment Period|Medication error without AEs|1|||
126276160|NCT01517373|454301746|FG004|Treatment Period|Medication error without AEs|0|||
126276161|NCT01517373|454301747|FG005|Treatment Period|Medication error without AEs|2|||
126276162|NCT04562155|454301749|FG000|Overall Study|COVID-19 pandemic|0|||
126276163|NCT04562155|454301750|FG001|Overall Study|COVID-19 pandemic|0|||
126276164|NCT04562155|454301751|FG002|Overall Study|COVID-19 pandemic|0|||
126276165|NCT04562155|454301752|FG003|Overall Study|COVID-19 pandemic|1|||
126276166|NCT04562155|454301749|FG000|Overall Study|Adverse Event|7|||
126276167|NCT04562155|454301750|FG001|Overall Study|Adverse Event|3|||
126276168|NCT04562155|454301751|FG002|Overall Study|Adverse Event|8|||
126276169|NCT04562155|454301752|FG003|Overall Study|Adverse Event|1|||
126276170|NCT04562155|454301749|FG000|Overall Study|Withdrawal by Subject|3|||
126276171|NCT04562155|454301750|FG001|Overall Study|Withdrawal by Subject|6|||
126276172|NCT04562155|454301751|FG002|Overall Study|Withdrawal by Subject|3|||
126276173|NCT04562155|454301752|FG003|Overall Study|Withdrawal by Subject|3|||
126276174|NCT04562155|454301749|FG000|Overall Study|Participant personal reason|1|||
126454132|NCT02208063|454963137|FG001|Overall Study|Withdrawal by Subject|2|||
126454133|NCT02208063|454963136|FG000|Overall Study|Lost to Follow-up|1|||
126454134|NCT02208063|454963137|FG001|Overall Study|Lost to Follow-up|0|||
126454135|NCT00913458|454963138|FG000|Phase 1|Non-Responder|54|||
126276175|NCT04562155|454301750|FG001|Overall Study|Participant personal reason|0|||
126276176|NCT04562155|454301751|FG002|Overall Study|Participant personal reason|2|||
126454136|NCT00913458|454963139|FG001|Phase 1|Non-Responder|0|||
126276177|NCT04562155|454301752|FG003|Overall Study|Participant personal reason|1|||
126276178|NCT01085201|454301755|FG000|Overall Study|Scheduling conflict|1|||
126276179|NCT01085201|454301756|FG001|Overall Study|Scheduling conflict|0|||
126276180|NCT01085201|454301757|FG002|Overall Study|Scheduling conflict|1|||
126276181|NCT01085201|454301758|FG003|Overall Study|Scheduling conflict|0|||
126276182|NCT01085201|454301759|FG004|Overall Study|Scheduling conflict|0|||
126276183|NCT01085201|454301755|FG000|Overall Study|Unknown- no study drug|2|||
126276184|NCT01085201|454301756|FG001|Overall Study|Unknown- no study drug|0|||
126276185|NCT01085201|454301757|FG002|Overall Study|Unknown- no study drug|0|||
126276186|NCT01085201|454301758|FG003|Overall Study|Unknown- no study drug|0|||
126276187|NCT01085201|454301759|FG004|Overall Study|Unknown- no study drug|0|||
126276188|NCT01085201|454301755|FG000|Overall Study|Fond ineligible after consent|0|||
126276189|NCT01085201|454301756|FG001|Overall Study|Fond ineligible after consent|1|||
126276190|NCT01085201|454301757|FG002|Overall Study|Fond ineligible after consent|1|||
126276191|NCT01085201|454301758|FG003|Overall Study|Fond ineligible after consent|0|||
126276192|NCT01085201|454301759|FG004|Overall Study|Fond ineligible after consent|0|||
126276193|NCT04516759|454301761|FG000|Overall Study|Withdrawal by Subject|1|||
126276194|NCT04516759|454301762|FG001|Overall Study|Withdrawal by Subject|1|||
126276195|NCT04516759|454301761|FG000|Overall Study|Other|0|||
126276196|NCT04516759|454301762|FG001|Overall Study|Other|1|||
126276197|NCT00867503|454301766|FG000|Overall Study|Withdrawal by Subject|1|||
126276198|NCT01001988|454301767|FG000|Overall Study|Protocol Violation|84|||
126276199|NCT01001988|454301767|FG000|Overall Study|Withdrawal by Subject|18|||
126276200|NCT01001988|454301767|FG000|Overall Study|Lost to Follow-up|15|||
126276201|NCT00927394|454301770|FG000|Overall Study|Adverse Event|14|||
126276202|NCT00927394|454301771|FG001|Overall Study|Adverse Event|9|||
126276203|NCT00927394|454301770|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
126276204|NCT00927394|454301771|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
126276205|NCT00927394|454301770|FG000|Overall Study|Withdrawal by Subject|20|||
126276206|NCT00927394|454301771|FG001|Overall Study|Withdrawal by Subject|24|||
126276207|NCT00927394|454301770|FG000|Overall Study|Lost to Follow-up|8|||
126276208|NCT00927394|454301771|FG001|Overall Study|Lost to Follow-up|14|||
126276209|NCT00927394|454301770|FG000|Overall Study|Administrative Problem|1|||
126276210|NCT00927394|454301771|FG001|Overall Study|Administrative Problem|0|||
126276211|NCT00927394|454301770|FG000|Overall Study|Death|1|||
126276212|NCT00927394|454301771|FG001|Overall Study|Death|1|||
126276213|NCT00927394|454301770|FG000|Overall Study|Protocol deviation|16|||
126276214|NCT00927394|454301771|FG001|Overall Study|Protocol deviation|13|||
126276215|NCT00927394|454301770|FG000|Overall Study|Randomized in error|0|||
126276216|NCT00927394|454301771|FG001|Overall Study|Randomized in error|1|||
126276217|NCT01221363|454301772|FG000|Overall Study|Pregnancy|1|||
126276218|NCT01221363|454301773|FG001|Overall Study|Pregnancy|0|||
126276219|NCT01221363|454301772|FG000|Overall Study|Withdrawal by Subject|11|||
126276220|NCT01221363|454301773|FG001|Overall Study|Withdrawal by Subject|5|||
126276221|NCT02695537|454301783|FG000|Overall Study|Adverse Event|3|||
126276222|NCT02695537|454301783|FG000|Overall Study|Lack of Efficacy|28|||
126276223|NCT02695537|454301783|FG000|Overall Study|Withdrawal by Subject|4|||
126276224|NCT02695537|454301783|FG000|Overall Study|Protocol Violation|3|||
126276225|NCT03597529|454301784|FG000|Overall Study|Lost to Follow-up|10|||
126276226|NCT03597529|454301785|FG001|Overall Study|Lost to Follow-up|12|||
126276227|NCT03597529|454301784|FG000|Overall Study|Physician Decision|3|||
126276228|NCT03597529|454301785|FG001|Overall Study|Physician Decision|1|||
126276229|NCT03597529|454301784|FG000|Overall Study|Withdrawal by Subject|6|||
126276230|NCT03597529|454301785|FG001|Overall Study|Withdrawal by Subject|3|||
126276231|NCT03597529|454301784|FG000|Overall Study|Non-compliant with study activities|1|||
126276232|NCT03597529|454301785|FG001|Overall Study|Non-compliant with study activities|2|||
126276233|NCT02238795|454301788|FG000|Overall Study|Patient without purpura fulminans|1|||
126276234|NCT04480710|454301791|FG000|Overall Study|Adverse Event|0|||
126706266|NCT03822468|455875599|FG001|Treatment Period|Adverse Event|24|||
126276235|NCT04480710|454301792|FG001|Overall Study|Adverse Event|2|||
126276236|NCT04480710|454301793|FG002|Overall Study|Adverse Event|0|||
126276237|NCT04480710|454301794|FG003|Overall Study|Adverse Event|0|||
126706267|NCT03822468|455875598|FG000|Treatment Period|Withdrawal by Subject|9|||
126706268|NCT03822468|455875599|FG001|Treatment Period|Withdrawal by Subject|5|||
126706269|NCT03822468|455875598|FG000|Treatment Period|Physician Decision|9|||
126706270|NCT03822468|455875599|FG001|Treatment Period|Physician Decision|7|||
126706271|NCT03822468|455875598|FG000|Treatment Period|Protocol Violation|2|||
126706272|NCT03822468|455875599|FG001|Treatment Period|Protocol Violation|1|||
126706273|NCT03822468|455875598|FG000|Treatment Period|Death|2|||
126706274|NCT03822468|455875599|FG001|Treatment Period|Death|3|||
126276238|NCT04480710|454301791|FG000|Overall Study|Withdrawal by Subject|0|||
126276239|NCT04480710|454301792|FG001|Overall Study|Withdrawal by Subject|1|||
126276240|NCT04480710|454301793|FG002|Overall Study|Withdrawal by Subject|0|||
126276241|NCT04480710|454301794|FG003|Overall Study|Withdrawal by Subject|0|||
126276242|NCT04480710|454301791|FG000|Overall Study|Physician Decision|0|||
126276243|NCT04480710|454301792|FG001|Overall Study|Physician Decision|0|||
126454137|NCT00913458|454963140|FG002|Phase 1|Non-Responder|0|||
126276244|NCT04480710|454301793|FG002|Overall Study|Physician Decision|1|||
126276245|NCT04480710|454301794|FG003|Overall Study|Physician Decision|0|||
126276246|NCT04480021|454301795|FG000|Overall Study|Lost to Follow-up|3|||
126276247|NCT04480021|454301796|FG001|Overall Study|Lost to Follow-up|4|||
126276248|NCT03384654|454301800|FG000|Overall Study|Withdrawal by Subject|0|||
126276249|NCT03384654|454301801|FG001|Overall Study|Withdrawal by Subject|0|||
126276250|NCT03384654|454301802|FG002|Overall Study|Withdrawal by Subject|1|||
126276251|NCT03384654|454301803|FG003|Overall Study|Withdrawal by Subject|0|||
126276252|NCT00423319|454301804|FG000|Overall Study|Death|2|||
126276253|NCT00423319|454301805|FG001|Overall Study|Death|0|||
126276254|NCT00423319|454301804|FG000|Overall Study|Adverse Event|93|||
126276255|NCT00423319|454301805|FG001|Overall Study|Adverse Event|112|||
126276256|NCT00423319|454301804|FG000|Overall Study|Withdrawal by Subject|86|||
126276257|NCT00423319|454301805|FG001|Overall Study|Withdrawal by Subject|99|||
126276258|NCT00423319|454301804|FG000|Overall Study|Lost to Follow-up|4|||
126276259|NCT00423319|454301805|FG001|Overall Study|Lost to Follow-up|3|||
126276260|NCT00423319|454301804|FG000|Overall Study|Poor compliance or noncompliance|1|||
126276261|NCT00423319|454301805|FG001|Overall Study|Poor compliance or noncompliance|1|||
126276262|NCT00423319|454301804|FG000|Overall Study|No longer meets study criteria|15|||
126276263|NCT00423319|454301805|FG001|Overall Study|No longer meets study criteria|15|||
126276264|NCT00423319|454301804|FG000|Overall Study|Other|23|||
126276265|NCT00423319|454301805|FG001|Overall Study|Other|22|||
126276266|NCT01584843|454301806|FG000|First Treatment Period|Adverse Event|0|||
126276267|NCT01584843|454301807|FG001|First Treatment Period|Adverse Event|0|||
126276268|NCT01584843|454301808|FG002|First Treatment Period|Adverse Event|1|||
126276269|NCT01584843|454301809|FG003|First Treatment Period|Adverse Event|0|||
126276270|NCT01584843|454301810|FG004|First Treatment Period|Adverse Event|0|||
126276271|NCT01584843|454301811|FG005|First Treatment Period|Adverse Event|0|||
126276272|NCT01584843|454301806|FG000|First Treatment Period|Protocol Violation|0|||
126276273|NCT01584843|454301807|FG001|First Treatment Period|Protocol Violation|0|||
126276274|NCT01584843|454301808|FG002|First Treatment Period|Protocol Violation|0|||
126276275|NCT01584843|454301809|FG003|First Treatment Period|Protocol Violation|0|||
126276276|NCT01584843|454301810|FG004|First Treatment Period|Protocol Violation|0|||
126276277|NCT01584843|454301811|FG005|First Treatment Period|Protocol Violation|1|||
126276278|NCT01584843|454301806|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
126276279|NCT01584843|454301807|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
126276280|NCT01584843|454301808|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
126276281|NCT01584843|454301809|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
126276282|NCT01584843|454301810|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
126276283|NCT01584843|454301811|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
126276284|NCT01584843|454301806|FG000|Second Treatment Period|Withdrawal by Subject|0|||
126276285|NCT01584843|454301807|FG001|Second Treatment Period|Withdrawal by Subject|0|||
126276286|NCT01584843|454301808|FG002|Second Treatment Period|Withdrawal by Subject|0|||
126276287|NCT01584843|454301809|FG003|Second Treatment Period|Withdrawal by Subject|0|||
126276288|NCT01584843|454301810|FG004|Second Treatment Period|Withdrawal by Subject|0|||
126276289|NCT01584843|454301811|FG005|Second Treatment Period|Withdrawal by Subject|1|||
126276290|NCT00311402|454301812|FG000|Overall Study|Adverse Event|118|||
126276291|NCT00311402|454301813|FG001|Overall Study|Adverse Event|105|||
126276292|NCT00311402|454301812|FG000|Overall Study|Lost to Follow-up|0|||
126276293|NCT00311402|454301813|FG001|Overall Study|Lost to Follow-up|3|||
126276294|NCT00311402|454301812|FG000|Overall Study|Withdrawal by Subject|17|||
126276295|NCT00311402|454301813|FG001|Overall Study|Withdrawal by Subject|18|||
126276296|NCT00311402|454301812|FG000|Overall Study|Lack of Efficacy|58|||
126276297|NCT00311402|454301813|FG001|Overall Study|Lack of Efficacy|42|||
126276298|NCT00311402|454301812|FG000|Overall Study|Protocol Violation|7|||
126706275|NCT03822468|455875598|FG000|Treatment Period|Lost to Follow-up|1|||
126706276|NCT03822468|455875599|FG001|Treatment Period|Lost to Follow-up|1|||
126706277|NCT03822468|455875598|FG000|Treatment Period|Sponsor decision|46|||
126706278|NCT03822468|455875599|FG001|Treatment Period|Sponsor decision|53|||
126706279|NCT03822468|455875598|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
126706280|NCT03822468|455875599|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
126706281|NCT03822468|455875598|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
126706282|NCT03822468|455875599|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
126706283|NCT03822468|455875598|FG000|Post-treatment Efficacy Follow-up|Death|1|||
126706284|NCT03822468|455875599|FG001|Post-treatment Efficacy Follow-up|Death|0|||
126706285|NCT03822468|455875598|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126276299|NCT00311402|454301813|FG001|Overall Study|Protocol Violation|6|||
126276300|NCT00311402|454301812|FG000|Overall Study|IRB's rejection etc.|10|||
126276301|NCT00311402|454301813|FG001|Overall Study|IRB's rejection etc.|3|||
126276302|NCT02640053|454301814|FG000|Overall Study|Withdrawal by Subject|2|||
126276303|NCT02640053|454301815|FG001|Overall Study|Withdrawal by Subject|1|||
126276304|NCT02640053|454301814|FG000|Overall Study|Adverse Event|1|||
126276305|NCT02640053|454301815|FG001|Overall Study|Adverse Event|1|||
126276306|NCT02640053|454301814|FG000|Overall Study|Alternative Therapy|1|||
126276307|NCT02640053|454301815|FG001|Overall Study|Alternative Therapy|1|||
126276308|NCT02640053|454301814|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
126276309|NCT02640053|454301815|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
126276310|NCT03283761|454301816|FG000|Study Treatment|Patient Non-Compliance|1|||
126276311|NCT03283761|454301816|FG000|Study Treatment|Alternative Cancer Therapy|7|||
126276312|NCT03283761|454301816|FG000|Study Treatment|Disease progression|21|||
126276313|NCT03283761|454301816|FG000|Study Treatment|Adverse Event|3|||
126276314|NCT03283761|454301816|FG000|Study Treatment|Withdrawal by Subject|4|||
126276315|NCT03283761|454301816|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
126276316|NCT03283761|454301816|FG000|Study Treatment|Symptomatic Deterioration|1|||
126454138|NCT00913458|454963141|FG003|Phase 1|Non-Responder|0|||
126454139|NCT00913458|454963142|FG004|Phase 1|Non-Responder|0|||
126454140|NCT00913458|454963143|FG005|Phase 1|Non-Responder|0|||
126454141|NCT00913458|454963144|FG006|Phase 1|Non-Responder|0|||
126454142|NCT00913458|454963138|FG000|Phase 1|Subject Request|17|||
126454143|NCT00913458|454963139|FG001|Phase 1|Subject Request|0|||
126454144|NCT00913458|454963140|FG002|Phase 1|Subject Request|0|||
126454145|NCT00913458|454963141|FG003|Phase 1|Subject Request|0|||
126454146|NCT00913458|454963142|FG004|Phase 1|Subject Request|0|||
126454147|NCT00913458|454963143|FG005|Phase 1|Subject Request|0|||
126454148|NCT00913458|454963144|FG006|Phase 1|Subject Request|0|||
126454149|NCT00913458|454963138|FG000|Phase 1|Adverse Event|20|||
126454150|NCT00913458|454963139|FG001|Phase 1|Adverse Event|0|||
126454151|NCT00913458|454963140|FG002|Phase 1|Adverse Event|0|||
126454152|NCT00913458|454963141|FG003|Phase 1|Adverse Event|0|||
126454153|NCT00913458|454963142|FG004|Phase 1|Adverse Event|0|||
126454154|NCT00913458|454963143|FG005|Phase 1|Adverse Event|0|||
126454155|NCT00913458|454963144|FG006|Phase 1|Adverse Event|0|||
126454156|NCT00913458|454963138|FG000|Phase 1|Lost to Follow-up|2|||
126454157|NCT00913458|454963139|FG001|Phase 1|Lost to Follow-up|0|||
126454158|NCT00913458|454963140|FG002|Phase 1|Lost to Follow-up|0|||
126454159|NCT00913458|454963141|FG003|Phase 1|Lost to Follow-up|0|||
126454160|NCT00913458|454963142|FG004|Phase 1|Lost to Follow-up|0|||
126454161|NCT00913458|454963143|FG005|Phase 1|Lost to Follow-up|0|||
126454162|NCT00913458|454963144|FG006|Phase 1|Lost to Follow-up|0|||
126454163|NCT00913458|454963138|FG000|Phase 1|Protocol Violation|10|||
126454164|NCT00913458|454963139|FG001|Phase 1|Protocol Violation|0|||
126454165|NCT00913458|454963140|FG002|Phase 1|Protocol Violation|0|||
126454166|NCT00913458|454963141|FG003|Phase 1|Protocol Violation|0|||
126454167|NCT00913458|454963142|FG004|Phase 1|Protocol Violation|0|||
126454168|NCT00913458|454963143|FG005|Phase 1|Protocol Violation|0|||
126454169|NCT00913458|454963144|FG006|Phase 1|Protocol Violation|0|||
126454170|NCT00913458|454963138|FG000|Phase 1|Sponsor|2|||
126454171|NCT00913458|454963139|FG001|Phase 1|Sponsor|0|||
126454172|NCT00913458|454963140|FG002|Phase 1|Sponsor|0|||
126454173|NCT00913458|454963141|FG003|Phase 1|Sponsor|0|||
126454174|NCT00913458|454963142|FG004|Phase 1|Sponsor|0|||
126454175|NCT00913458|454963143|FG005|Phase 1|Sponsor|0|||
126454176|NCT00913458|454963144|FG006|Phase 1|Sponsor|0|||
126454177|NCT00913458|454963138|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
126276317|NCT03283761|454301816|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
126276318|NCT03283761|454301816|FG000|Follow up|Lost to Follow-up|1|||
126276319|NCT03283761|454301816|FG000|Follow up|Symptomatic Deterioration|1|||
126276320|NCT03283761|454301816|FG000|Follow up|Death|29|||
126276321|NCT03283761|454301816|FG000|Follow up|study terminated|4|||
126276322|NCT03283761|454301816|FG000|Follow up|Primary Investigator Withdrawal|1|||
126276323|NCT03283761|454301816|FG000|Follow up|Switched to alternative therapy|1|||
126276324|NCT03283761|454301816|FG000|Follow up|Subject is now in Hospice|1|||
126276325|NCT02036775|454301817|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
126276326|NCT02036775|454301818|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
126276327|NCT02036775|454301819|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
126276328|NCT02036775|454301820|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
126276329|NCT02036775|454301821|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
126276330|NCT02036775|454301822|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
126276331|NCT01268501|454301823|FG000|Overall Study|Lost to Follow-up|1|||
126276332|NCT01268501|454301823|FG000|Overall Study|Withdrawal by Subject|3|||
126454178|NCT00913458|454963139|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
126454179|NCT00913458|454963140|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
126454180|NCT00913458|454963141|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
126454181|NCT00913458|454963142|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
126454182|NCT00913458|454963143|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
126454183|NCT00913458|454963144|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
126454184|NCT00913458|454963138|FG000|Phase 2|Non-Responder|0|||
126454185|NCT00913458|454963139|FG001|Phase 2|Non-Responder|5|||
126276333|NCT01268501|454301823|FG000|Overall Study|Unacceptable Subjective Vision|3|||
126454186|NCT00913458|454963140|FG002|Phase 2|Non-Responder|7|||
126454187|NCT00913458|454963141|FG003|Phase 2|Non-Responder|12|||
126454188|NCT00913458|454963142|FG004|Phase 2|Non-Responder|0|||
126454189|NCT00913458|454963143|FG005|Phase 2|Non-Responder|0|||
126454190|NCT00913458|454963144|FG006|Phase 2|Non-Responder|0|||
126454191|NCT00913458|454963138|FG000|Phase 2|Subject Request|0|||
126454192|NCT00913458|454963139|FG001|Phase 2|Subject Request|0|||
126706286|NCT03822468|455875599|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
126706287|NCT03822468|455875598|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
126706288|NCT03822468|455875599|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126706289|NCT03822468|455875598|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
126276334|NCT01268501|454301823|FG000|Overall Study|Handling Difficulties|2|||
126276335|NCT00678886|454301824|FG000|Overall Study|Withdrawal by Subject|0|||
126276336|NCT00678886|454301825|FG001|Overall Study|Withdrawal by Subject|0|||
126276337|NCT00678886|454301826|FG002|Overall Study|Withdrawal by Subject|4|||
126276338|NCT00678886|454301827|FG003|Overall Study|Withdrawal by Subject|6|||
126276339|NCT00678886|454301824|FG000|Overall Study|Physician Decision|0|||
126276340|NCT00678886|454301825|FG001|Overall Study|Physician Decision|0|||
126276341|NCT00678886|454301826|FG002|Overall Study|Physician Decision|1|||
126276342|NCT00678886|454301827|FG003|Overall Study|Physician Decision|1|||
126276343|NCT00678886|454301824|FG000|Overall Study|Lost to Follow-up|0|||
126276344|NCT00678886|454301825|FG001|Overall Study|Lost to Follow-up|0|||
126276345|NCT00678886|454301826|FG002|Overall Study|Lost to Follow-up|3|||
126276346|NCT00678886|454301827|FG003|Overall Study|Lost to Follow-up|2|||
126276347|NCT00678886|454301824|FG000|Overall Study|Other|0|||
126276348|NCT00678886|454301825|FG001|Overall Study|Other|0|||
126276349|NCT00678886|454301826|FG002|Overall Study|Other|1|||
126276350|NCT00678886|454301827|FG003|Overall Study|Other|0|||
126276351|NCT00206323|454301828|FG000|Overall Study|Lack of Efficacy|4|||
126276352|NCT00206323|454301829|FG001|Overall Study|Lack of Efficacy|1|||
126276353|NCT00206323|454301828|FG000|Overall Study|Adverse Event|1|||
126276354|NCT00206323|454301829|FG001|Overall Study|Adverse Event|1|||
126276355|NCT00206323|454301828|FG000|Overall Study|Lost to Follow-up|1|||
126276356|NCT00206323|454301829|FG001|Overall Study|Lost to Follow-up|1|||
126276357|NCT02329847|454301830|FG000|Overall Study|Death|4|||
126276358|NCT02329847|454301831|FG001|Overall Study|Death|4|||
126276359|NCT02329847|454301832|FG002|Overall Study|Death|22|||
126276360|NCT02329847|454301833|FG003|Overall Study|Death|12|||
126276361|NCT02329847|454301834|FG004|Overall Study|Death|20|||
126276362|NCT02329847|454301835|FG005|Overall Study|Death|13|||
126276363|NCT02329847|454301830|FG000|Overall Study|Lost to Follow-up|0|||
126276364|NCT02329847|454301831|FG001|Overall Study|Lost to Follow-up|0|||
126276365|NCT02329847|454301832|FG002|Overall Study|Lost to Follow-up|2|||
126276366|NCT02329847|454301833|FG003|Overall Study|Lost to Follow-up|3|||
126276367|NCT02329847|454301834|FG004|Overall Study|Lost to Follow-up|0|||
126276368|NCT02329847|454301835|FG005|Overall Study|Lost to Follow-up|1|||
126276369|NCT02329847|454301830|FG000|Overall Study|Physician Decision|0|||
126276370|NCT02329847|454301831|FG001|Overall Study|Physician Decision|0|||
126276371|NCT02329847|454301832|FG002|Overall Study|Physician Decision|0|||
126276372|NCT02329847|454301833|FG003|Overall Study|Physician Decision|0|||
126276373|NCT02329847|454301834|FG004|Overall Study|Physician Decision|1|||
126276374|NCT02329847|454301835|FG005|Overall Study|Physician Decision|0|||
126276375|NCT02329847|454301830|FG000|Overall Study|Withdrawal by Subject|2|||
126276376|NCT02329847|454301831|FG001|Overall Study|Withdrawal by Subject|1|||
126276377|NCT02329847|454301832|FG002|Overall Study|Withdrawal by Subject|5|||
126276378|NCT02329847|454301833|FG003|Overall Study|Withdrawal by Subject|7|||
126276379|NCT02329847|454301834|FG004|Overall Study|Withdrawal by Subject|8|||
126276380|NCT02329847|454301835|FG005|Overall Study|Withdrawal by Subject|3|||
126276381|NCT02329847|454301830|FG000|Overall Study|Other|1|||
126276382|NCT02329847|454301831|FG001|Overall Study|Other|2|||
126276383|NCT02329847|454301832|FG002|Overall Study|Other|6|||
126276384|NCT02329847|454301833|FG003|Overall Study|Other|13|||
126276385|NCT02329847|454301834|FG004|Overall Study|Other|10|||
126276386|NCT02329847|454301835|FG005|Overall Study|Other|3|||
126276387|NCT05293639|454301836|FG000|Overall Study|Withdrawal by Subject|1|||
126276388|NCT05293639|454301837|FG001|Overall Study|Withdrawal by Subject|1|||
126276389|NCT05293639|454301838|FG002|Overall Study|Withdrawal by Subject|2|||
126276390|NCT05293639|454301836|FG000|Overall Study|Death|0|||
126276391|NCT05293639|454301837|FG001|Overall Study|Death|1|||
126276392|NCT05293639|454301838|FG002|Overall Study|Death|0|||
126276393|NCT05293639|454301836|FG000|Overall Study|Lost to Follow-up|0|||
126276394|NCT05293639|454301837|FG001|Overall Study|Lost to Follow-up|0|||
126276395|NCT05293639|454301838|FG002|Overall Study|Lost to Follow-up|5|||
126276396|NCT05293639|454301836|FG000|Overall Study|Other|0|||
126276397|NCT05293639|454301837|FG001|Overall Study|Other|0|||
126362830|NCT00806026|454621626|FG000|Overall Study|Protocol Violation|6|||
126362831|NCT00806026|454621627|FG001|Overall Study|Protocol Violation|9|||
126706290|NCT03822468|455875599|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126276398|NCT05293639|454301838|FG002|Overall Study|Other|1|||
126276399|NCT00827632|454301842|FG000|Overall Study|Lost to Follow-up|8|||
126276400|NCT00827632|454301843|FG001|Overall Study|Lost to Follow-up|12|||
126276401|NCT00827632|454301842|FG000|Overall Study|Early withdrawal|14|||
126276402|NCT00827632|454301843|FG001|Overall Study|Early withdrawal|11|||
126276403|NCT01910389|454301845|FG000|Overall Study|Withdrawal by Subject|2|||
126276404|NCT01910389|454301846|FG001|Overall Study|Withdrawal by Subject|0|||
126276405|NCT01910389|454301845|FG000|Overall Study|Study Closed|13|||
126276406|NCT01910389|454301846|FG001|Overall Study|Study Closed|8|||
126454193|NCT00913458|454963140|FG002|Phase 2|Subject Request|1|||
126454194|NCT00913458|454963141|FG003|Phase 2|Subject Request|2|||
126454195|NCT00913458|454963142|FG004|Phase 2|Subject Request|0|||
126276407|NCT04669691|454301851|FG000|Overall Study|Death|0|||
126276408|NCT04669691|454301852|FG001|Overall Study|Death|1|||
126276409|NCT04669691|454301853|FG002|Overall Study|Death|0|||
126276410|NCT04669691|454301854|FG003|Overall Study|Death|0|||
126276411|NCT04669691|454301855|FG004|Overall Study|Death|0|||
126276412|NCT04669691|454301856|FG005|Overall Study|Death|0|||
126276413|NCT02304458|454301857|FG000|Overall Study|Adverse Event|0|||
126276414|NCT02304458|454301858|FG001|Overall Study|Adverse Event|0|||
126276415|NCT02304458|454301859|FG002|Overall Study|Adverse Event|7|||
126276416|NCT02304458|454301860|FG003|Overall Study|Adverse Event|0|||
126276417|NCT02304458|454301861|FG004|Overall Study|Adverse Event|0|||
126454196|NCT00913458|454963143|FG005|Phase 2|Subject Request|0|||
126454197|NCT00913458|454963144|FG006|Phase 2|Subject Request|0|||
126454198|NCT00913458|454963138|FG000|Phase 2|Adverse Event|0|||
126454199|NCT00913458|454963139|FG001|Phase 2|Adverse Event|3|||
126454200|NCT00913458|454963140|FG002|Phase 2|Adverse Event|0|||
126454201|NCT00913458|454963141|FG003|Phase 2|Adverse Event|1|||
126454202|NCT00913458|454963142|FG004|Phase 2|Adverse Event|0|||
126454203|NCT00913458|454963143|FG005|Phase 2|Adverse Event|0|||
126454204|NCT00913458|454963144|FG006|Phase 2|Adverse Event|0|||
126454205|NCT00913458|454963138|FG000|Phase 2|Lost to Follow-up|0|||
126454206|NCT00913458|454963139|FG001|Phase 2|Lost to Follow-up|0|||
126454207|NCT00913458|454963140|FG002|Phase 2|Lost to Follow-up|0|||
126454208|NCT00913458|454963141|FG003|Phase 2|Lost to Follow-up|1|||
126454209|NCT00913458|454963142|FG004|Phase 2|Lost to Follow-up|0|||
126454210|NCT00913458|454963143|FG005|Phase 2|Lost to Follow-up|0|||
126454211|NCT00913458|454963144|FG006|Phase 2|Lost to Follow-up|0|||
126454212|NCT00913458|454963138|FG000|Phase 2|Protocol Violation|0|||
126454213|NCT00913458|454963139|FG001|Phase 2|Protocol Violation|2|||
126454214|NCT00913458|454963140|FG002|Phase 2|Protocol Violation|0|||
126454215|NCT00913458|454963141|FG003|Phase 2|Protocol Violation|0|||
126454216|NCT00913458|454963142|FG004|Phase 2|Protocol Violation|0|||
126454217|NCT00913458|454963143|FG005|Phase 2|Protocol Violation|0|||
126454218|NCT00913458|454963144|FG006|Phase 2|Protocol Violation|0|||
126454219|NCT00913458|454963138|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
126454220|NCT00913458|454963139|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
126454221|NCT00913458|454963140|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
126454222|NCT00913458|454963141|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
126454223|NCT00913458|454963142|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
126454224|NCT00913458|454963143|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
126454225|NCT00913458|454963144|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
126454226|NCT00913458|454963138|FG000|Phase 3|Adverse Event|0|||
126454227|NCT00913458|454963139|FG001|Phase 3|Adverse Event|0|||
126454228|NCT00913458|454963140|FG002|Phase 3|Adverse Event|0|||
126454229|NCT00913458|454963141|FG003|Phase 3|Adverse Event|0|||
126454230|NCT00913458|454963142|FG004|Phase 3|Adverse Event|5|||
126454231|NCT00913458|454963143|FG005|Phase 3|Adverse Event|4|||
126454232|NCT00913458|454963144|FG006|Phase 3|Adverse Event|1|||
126454233|NCT00913458|454963138|FG000|Phase 3|Lost to Follow-up|0|||
126454234|NCT00913458|454963139|FG001|Phase 3|Lost to Follow-up|0|||
126454235|NCT00913458|454963140|FG002|Phase 3|Lost to Follow-up|0|||
126454236|NCT00913458|454963141|FG003|Phase 3|Lost to Follow-up|0|||
126454237|NCT00913458|454963142|FG004|Phase 3|Lost to Follow-up|2|||
126454238|NCT00913458|454963143|FG005|Phase 3|Lost to Follow-up|0|||
126454239|NCT00913458|454963144|FG006|Phase 3|Lost to Follow-up|0|||
126454240|NCT00913458|454963138|FG000|Phase 3|Non-Responder|0|||
126454241|NCT00913458|454963139|FG001|Phase 3|Non-Responder|0|||
126276418|NCT02304458|454301862|FG005|Overall Study|Adverse Event|0|||
126276419|NCT02304458|454301863|FG006|Overall Study|Adverse Event|3|||
126276420|NCT02304458|454301864|FG007|Overall Study|Adverse Event|4|||
126276421|NCT02304458|454301857|FG000|Overall Study|Death|0|||
126276422|NCT02304458|454301858|FG001|Overall Study|Death|0|||
126454242|NCT00913458|454963140|FG002|Phase 3|Non-Responder|0|||
126454243|NCT00913458|454963141|FG003|Phase 3|Non-Responder|0|||
126454244|NCT00913458|454963142|FG004|Phase 3|Non-Responder|0|||
126276423|NCT02304458|454301859|FG002|Overall Study|Death|2|||
126454245|NCT00913458|454963143|FG005|Phase 3|Non-Responder|1|||
126454246|NCT00913458|454963144|FG006|Phase 3|Non-Responder|3|||
126454247|NCT00913458|454963138|FG000|Phase 3|Withdrawal by Subject|0|||
126454248|NCT00913458|454963139|FG001|Phase 3|Withdrawal by Subject|0|||
126454249|NCT00913458|454963140|FG002|Phase 3|Withdrawal by Subject|0|||
126454250|NCT00913458|454963141|FG003|Phase 3|Withdrawal by Subject|0|||
126276424|NCT02304458|454301860|FG003|Overall Study|Death|0|||
126276425|NCT02304458|454301861|FG004|Overall Study|Death|0|||
126276426|NCT02304458|454301862|FG005|Overall Study|Death|0|||
126276427|NCT02304458|454301863|FG006|Overall Study|Death|1|||
126454251|NCT00913458|454963142|FG004|Phase 3|Withdrawal by Subject|1|||
126454252|NCT00913458|454963143|FG005|Phase 3|Withdrawal by Subject|2|||
126454253|NCT00913458|454963144|FG006|Phase 3|Withdrawal by Subject|0|||
126454254|NCT00913458|454963138|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
126454255|NCT00913458|454963139|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
126706291|NCT03822468|455875598|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
126706292|NCT03822468|455875599|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
126706293|NCT02117687|455875600|FG000|Overall Study|Lost to Follow-up|0|||
126706294|NCT02117687|455875601|FG001|Overall Study|Lost to Follow-up|1|||
126706295|NCT02117687|455875600|FG000|Overall Study|Adverse Event|0|||
126706296|NCT02117687|455875601|FG001|Overall Study|Adverse Event|2|||
126706297|NCT02117687|455875600|FG000|Overall Study|Other Reasons|1|||
126706298|NCT02117687|455875601|FG001|Overall Study|Other Reasons|1|||
126706299|NCT01084252|455877254|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706300|NCT01084252|455877255|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706301|NCT01084252|455877256|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706302|NCT01084252|455877257|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706303|NCT01084252|455877258|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706304|NCT01084252|455877259|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706305|NCT01084252|455877260|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706306|NCT01084252|455877261|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706307|NCT01084252|455877262|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706308|NCT01084252|455877263|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706309|NCT01084252|455877264|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706310|NCT01084252|455877265|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706311|NCT01084252|455877266|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
126706312|NCT01084252|455877267|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
126706313|NCT04909463|455877268|FG000|Overall Study|Withdrawal by Subject|0|||
126706314|NCT04909463|455877269|FG001|Overall Study|Withdrawal by Subject|1|||
126706315|NCT04909463|455877270|FG002|Overall Study|Withdrawal by Subject|0|||
126706316|NCT04909463|455877271|FG003|Overall Study|Withdrawal by Subject|0|||
126765700|NCT00698009|456095784|FG000|Overall Study|Withdrawal by Subject|1|||
126276428|NCT02304458|454301864|FG007|Overall Study|Death|0|||
126276429|NCT02304458|454301857|FG000|Overall Study|Lack of Efficacy|4|||
126276430|NCT02304458|454301858|FG001|Overall Study|Lack of Efficacy|6|||
126276431|NCT02304458|454301859|FG002|Overall Study|Lack of Efficacy|38|||
126276432|NCT02304458|454301860|FG003|Overall Study|Lack of Efficacy|5|||
126276433|NCT02304458|454301861|FG004|Overall Study|Lack of Efficacy|6|||
126276434|NCT02304458|454301862|FG005|Overall Study|Lack of Efficacy|6|||
126276435|NCT02304458|454301863|FG006|Overall Study|Lack of Efficacy|21|||
126276436|NCT02304458|454301864|FG007|Overall Study|Lack of Efficacy|4|||
126276437|NCT02304458|454301857|FG000|Overall Study|Physician Decision|2|||
126276438|NCT02304458|454301858|FG001|Overall Study|Physician Decision|0|||
126454256|NCT00913458|454963140|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
126454257|NCT00913458|454963141|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
126454258|NCT00913458|454963142|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
126454259|NCT00913458|454963143|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
126454260|NCT00913458|454963144|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
126454261|NCT03595618|454963145|FG000|Overall Study|Adverse Event|16|||
126454262|NCT03595618|454963146|FG001|Overall Study|Adverse Event|17|||
126454263|NCT03595618|454963147|FG002|Overall Study|Adverse Event|20|||
126454264|NCT03595618|454963148|FG003|Overall Study|Adverse Event|8|||
126454265|NCT03595618|454963145|FG000|Overall Study|Withdrawal by Subject|12|||
126454266|NCT03595618|454963146|FG001|Overall Study|Withdrawal by Subject|14|||
126454267|NCT03595618|454963147|FG002|Overall Study|Withdrawal by Subject|14|||
126454268|NCT03595618|454963148|FG003|Overall Study|Withdrawal by Subject|10|||
126454269|NCT03595618|454963145|FG000|Overall Study|Lost to Follow-up|6|||
126454270|NCT03595618|454963146|FG001|Overall Study|Lost to Follow-up|4|||
126454271|NCT03595618|454963147|FG002|Overall Study|Lost to Follow-up|5|||
126454272|NCT03595618|454963148|FG003|Overall Study|Lost to Follow-up|6|||
126454273|NCT03595618|454963145|FG000|Overall Study|Protocol Violation|2|||
126454274|NCT03595618|454963146|FG001|Overall Study|Protocol Violation|0|||
126454275|NCT03595618|454963147|FG002|Overall Study|Protocol Violation|6|||
126454276|NCT03595618|454963148|FG003|Overall Study|Protocol Violation|2|||
126454277|NCT03595618|454963145|FG000|Overall Study|Physician Decision|0|||
126454278|NCT03595618|454963146|FG001|Overall Study|Physician Decision|0|||
126706317|NCT04909463|455877268|FG000|Overall Study|Lost to Follow-up|2|||
126706318|NCT04909463|455877269|FG001|Overall Study|Lost to Follow-up|1|||
126706319|NCT04909463|455877270|FG002|Overall Study|Lost to Follow-up|1|||
126765701|NCT02856282|456095785|FG000|Overall Study|Withdrawal by Subject|1|||
126454279|NCT03595618|454963147|FG002|Overall Study|Physician Decision|1|||
126454280|NCT03595618|454963148|FG003|Overall Study|Physician Decision|2|||
126706320|NCT04909463|455877271|FG003|Overall Study|Lost to Follow-up|0|||
126765702|NCT02074982|456095786|FG000|Overall Study|Adverse Event|15|||
126765703|NCT02074982|456095787|FG001|Overall Study|Adverse Event|7|||
126454281|NCT03595618|454963145|FG000|Overall Study|Miscellaneous|7|||
126454282|NCT03595618|454963146|FG001|Overall Study|Miscellaneous|5|||
126454283|NCT03595618|454963147|FG002|Overall Study|Miscellaneous|10|||
126276439|NCT02304458|454301859|FG002|Overall Study|Physician Decision|16|||
126276440|NCT02304458|454301860|FG003|Overall Study|Physician Decision|1|||
126276441|NCT02304458|454301861|FG004|Overall Study|Physician Decision|0|||
126547657|NCT02954458|455298026|FG003|Overall Study|Physician Decision|1|||
126547658|NCT02954458|455298023|FG000|Overall Study|Lost to Follow-up|1|||
126547659|NCT02954458|455298024|FG001|Overall Study|Lost to Follow-up|0|||
126547660|NCT02954458|455298025|FG002|Overall Study|Lost to Follow-up|0|||
126547661|NCT02954458|455298026|FG003|Overall Study|Lost to Follow-up|1|||
126547662|NCT02954458|455298023|FG000|Overall Study|Death|0|||
126547663|NCT02954458|455298024|FG001|Overall Study|Death|0|||
126547664|NCT02954458|455298025|FG002|Overall Study|Death|0|||
126547665|NCT02954458|455298026|FG003|Overall Study|Death|1|||
126547666|NCT02954458|455298023|FG000|Overall Study|Other|0|||
126547667|NCT02954458|455298024|FG001|Overall Study|Other|0|||
126547668|NCT02954458|455298025|FG002|Overall Study|Other|0|||
126547669|NCT02954458|455298026|FG003|Overall Study|Other|7|||
126547670|NCT00882921|455298029|FG000|Overall Study|Death|2|||
126547671|NCT00882921|455298029|FG000|Overall Study|Other|3|||
126547672|NCT00882921|455298029|FG000|Overall Study|Lost to Follow-up|2|||
126547673|NCT00882921|455298029|FG000|Overall Study|Termination By Investigator|3|||
126547674|NCT00882921|455298029|FG000|Overall Study|Withdrawal Of Consent|1|||
126547675|NCT02120664|455298031|FG000|Overall Study|Withdrawal by Subject|0|||
126547676|NCT02120664|455298032|FG001|Overall Study|Withdrawal by Subject|0|||
126547677|NCT02120664|455298033|FG002|Overall Study|Withdrawal by Subject|0|||
126547678|NCT02120664|455298034|FG003|Overall Study|Withdrawal by Subject|1|||
126547679|NCT02120664|455298035|FG004|Overall Study|Withdrawal by Subject|0|||
126547680|NCT02460263|455298036|FG000|Transition Period|Withdrawal by Subject|1|||
126547681|NCT02460263|455298036|FG000|Transition Period|Death|1|||
126547682|NCT03176238|455298039|FG000|Overall Study|Unacceptable AEs|15|||
126547683|NCT03176238|455298040|FG001|Overall Study|Unacceptable AEs|8|||
126547684|NCT03176238|455298039|FG000|Overall Study|Abnormal lab value(s)|2|||
126547685|NCT03176238|455298040|FG001|Overall Study|Abnormal lab value(s)|0|||
126547686|NCT03176238|455298039|FG000|Overall Study|Inter-current illness|0|||
126547687|NCT03176238|455298040|FG001|Overall Study|Inter-current illness|1|||
126547688|NCT03176238|455298039|FG000|Overall Study|Consent withdrawal|14|||
126547689|NCT03176238|455298040|FG001|Overall Study|Consent withdrawal|2|||
126547690|NCT03176238|455298039|FG000|Overall Study|Lost to Follow-up|3|||
126547691|NCT03176238|455298040|FG001|Overall Study|Lost to Follow-up|0|||
126547692|NCT03176238|455298039|FG000|Overall Study|Administrative problems|1|||
126547693|NCT03176238|455298040|FG001|Overall Study|Administrative problems|0|||
126547694|NCT03176238|455298039|FG000|Overall Study|Death|3|||
126547695|NCT03176238|455298040|FG001|Overall Study|Death|0|||
126547696|NCT03176238|455298039|FG000|Overall Study|Disease Progression|133|||
126547697|NCT03176238|455298040|FG001|Overall Study|Disease Progression|22|||
126547698|NCT03176238|455298039|FG000|Overall Study|Tx duration completed per EAP|0|||
126547699|NCT03176238|455298040|FG001|Overall Study|Tx duration completed per EAP|1|||
126547700|NCT03176238|455298039|FG000|Overall Study|Patient is switched to commercial drug|16|||
126547701|NCT03176238|455298040|FG001|Overall Study|Patient is switched to commercial drug|1|||
126547702|NCT03176238|455298039|FG000|Overall Study|Protocol Violation|1|||
126547703|NCT03176238|455298040|FG001|Overall Study|Protocol Violation|0|||
126547704|NCT03176238|455298039|FG000|Overall Study|Changes in the patient's condition|2|||
126547705|NCT03176238|455298040|FG001|Overall Study|Changes in the patient's condition|1|||
126547706|NCT03176238|455298039|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
126547707|NCT03176238|455298040|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
126547708|NCT04524598|455298041|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
126454284|NCT03595618|454963148|FG003|Overall Study|Miscellaneous|6|||
126454285|NCT00917644|454963149|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
126454286|NCT00917644|454963150|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
126454287|NCT00917644|454963149|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
126454288|NCT00917644|454963150|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
126454289|NCT00917644|454963149|FG000|Period 2: Second Intervention|family emergency|1|||
126454290|NCT00917644|454963150|FG001|Period 2: Second Intervention|family emergency|0|||
126454291|NCT02338232|454963151|FG000|Overall Study|Screen Failure|3|||
126454292|NCT02338232|454963151|FG000|Overall Study|Withdrawal by Subject|6|||
126454293|NCT02338232|454963151|FG000|Overall Study|Adverse Event|2|||
126547709|NCT04524598|455298042|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
126547710|NCT04524598|455298043|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
126547711|NCT04524598|455298044|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
126547712|NCT04524598|455298045|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
126706321|NCT00955110|455877272|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
126547713|NCT04524598|455298041|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
126547714|NCT04524598|455298042|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
126547715|NCT04524598|455298043|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
126547716|NCT04524598|455298044|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
126547717|NCT04524598|455298045|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
126706322|NCT00955110|455877272|FG000|Treatment Phase|Adverse Event|2|||
126454294|NCT02279407|454963152|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
126765704|NCT02074982|456095786|FG000|Overall Study|Lack of Efficacy|6|||
126276442|NCT02304458|454301862|FG005|Overall Study|Physician Decision|0|||
126276443|NCT02304458|454301863|FG006|Overall Study|Physician Decision|3|||
126276444|NCT02304458|454301864|FG007|Overall Study|Physician Decision|0|||
126276445|NCT02304458|454301857|FG000|Overall Study|Protocol Violation|0|||
126276446|NCT02304458|454301858|FG001|Overall Study|Protocol Violation|0|||
126276447|NCT02304458|454301859|FG002|Overall Study|Protocol Violation|1|||
126276448|NCT02304458|454301860|FG003|Overall Study|Protocol Violation|0|||
126276449|NCT02304458|454301861|FG004|Overall Study|Protocol Violation|0|||
126547718|NCT04524598|455298041|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
126547719|NCT04524598|455298042|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
126547720|NCT04524598|455298043|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
126547721|NCT04524598|455298044|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
126547722|NCT04524598|455298045|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
126547723|NCT04524598|455298041|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
126547724|NCT04524598|455298042|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
126547725|NCT04524598|455298043|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
126547726|NCT04524598|455298044|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
126547727|NCT04524598|455298045|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
126547728|NCT04524598|455298041|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
126547729|NCT04524598|455298042|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
126547730|NCT04524598|455298043|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
126547731|NCT04524598|455298044|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
126547732|NCT04524598|455298045|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
126547733|NCT04524598|455298041|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
126547734|NCT04524598|455298042|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
126547735|NCT04524598|455298043|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
126547736|NCT04524598|455298044|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
126547737|NCT04524598|455298045|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
126547738|NCT04524598|455298041|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
126547739|NCT04524598|455298042|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
126547740|NCT04524598|455298043|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
126547741|NCT04524598|455298044|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
126547742|NCT04524598|455298045|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
126547743|NCT04395183|455298046|FG000|Overall Study|Withdrawal by Subject|1|||
126547744|NCT04395183|455298047|FG001|Overall Study|Withdrawal by Subject|0|||
126547745|NCT04395183|455298048|FG002|Overall Study|Withdrawal by Subject|2|||
126547746|NCT04395183|455298049|FG003|Overall Study|Withdrawal by Subject|2|||
126276450|NCT02304458|454301862|FG005|Overall Study|Protocol Violation|0|||
126276451|NCT02304458|454301863|FG006|Overall Study|Protocol Violation|0|||
126276452|NCT02304458|454301864|FG007|Overall Study|Protocol Violation|0|||
126276453|NCT02304458|454301857|FG000|Overall Study|Withdrawal by Subject|1|||
126276454|NCT02304458|454301858|FG001|Overall Study|Withdrawal by Subject|0|||
126276455|NCT02304458|454301859|FG002|Overall Study|Withdrawal by Subject|7|||
126276456|NCT02304458|454301860|FG003|Overall Study|Withdrawal by Subject|0|||
126276457|NCT02304458|454301861|FG004|Overall Study|Withdrawal by Subject|0|||
126276458|NCT02304458|454301862|FG005|Overall Study|Withdrawal by Subject|0|||
126276459|NCT02304458|454301863|FG006|Overall Study|Withdrawal by Subject|1|||
126276460|NCT02304458|454301864|FG007|Overall Study|Withdrawal by Subject|0|||
126276461|NCT03401450|454301865|FG000|Overall Study|Lost to Follow-up|4|||
126276462|NCT03401450|454301866|FG001|Overall Study|Lost to Follow-up|6|||
126276463|NCT03401450|454301865|FG000|Overall Study|Anesthesia plan changed|2|||
126276464|NCT03401450|454301866|FG001|Overall Study|Anesthesia plan changed|2|||
126276465|NCT03401450|454301865|FG000|Overall Study|Did not complete medication diary|4|||
126276466|NCT03401450|454301866|FG001|Overall Study|Did not complete medication diary|2|||
126276467|NCT03401450|454301865|FG000|Overall Study|post surgery medication change|2|||
126276468|NCT03401450|454301866|FG001|Overall Study|post surgery medication change|1|||
126454295|NCT02279407|454963153|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
126454296|NCT02279407|454963154|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
126454297|NCT02279407|454963155|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
126454298|NCT02279407|454963152|FG000|Overall Study|Withdrawal by Subject|1|||
126454299|NCT02279407|454963153|FG001|Overall Study|Withdrawal by Subject|0|||
126454300|NCT02279407|454963154|FG002|Overall Study|Withdrawal by Subject|1|||
126454301|NCT02279407|454963155|FG003|Overall Study|Withdrawal by Subject|1|||
126454302|NCT02279407|454963152|FG000|Overall Study|Adverse Event|1|||
126276469|NCT03401450|454301865|FG000|Overall Study|Cancelled surgery|0|||
126276470|NCT03401450|454301866|FG001|Overall Study|Cancelled surgery|2|||
126276471|NCT02288182|454301867|FG000|Overall Study|Adverse Event|0|||
126276472|NCT02288182|454301868|FG001|Overall Study|Adverse Event|1|||
126276473|NCT02288182|454301867|FG000|Overall Study|Lost to Follow-up|0|||
126276474|NCT02288182|454301868|FG001|Overall Study|Lost to Follow-up|1|||
126276475|NCT02823652|454301870|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
126706323|NCT00955110|455877272|FG000|Treatment Phase|Administrative reasons|2|||
126706324|NCT00955110|455877272|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
126706325|NCT00955110|455877272|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
126706326|NCT01416181|455877275|FG000|Part 1|Other|10|||
126276476|NCT02823652|454301871|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
126276477|NCT02823652|454301872|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
126276478|NCT02823652|454301870|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
126276479|NCT02823652|454301871|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
126276480|NCT02823652|454301872|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
126706327|NCT01416181|455877276|FG001|Part 1|Other|24|||
126706328|NCT01416181|455877275|FG000|Part 1|Death|0|||
126706329|NCT01416181|455877276|FG001|Part 1|Death|1|||
126706330|NCT01416181|455877275|FG000|Part 1|Investigator Decision|7|||
126706331|NCT01416181|455877276|FG001|Part 1|Investigator Decision|6|||
126706332|NCT01416181|455877275|FG000|Part 1|Withdrawal by Subject|74|||
126706333|NCT01416181|455877276|FG001|Part 1|Withdrawal by Subject|48|||
126706334|NCT01416181|455877275|FG000|Part 1|Lack of Efficacy|16|||
126706335|NCT01416181|455877276|FG001|Part 1|Lack of Efficacy|8|||
126706336|NCT01416181|455877275|FG000|Part 1|Lost to Follow-up|1|||
126706337|NCT01416181|455877276|FG001|Part 1|Lost to Follow-up|1|||
126706338|NCT01416181|455877275|FG000|Part 1|Adverse Event|15|||
126706339|NCT01416181|455877276|FG001|Part 1|Adverse Event|18|||
126706340|NCT01416181|455877275|FG000|Part 1|Ongoing in Follow-Up|14|||
126276481|NCT02823652|454301870|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
126276482|NCT02823652|454301871|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
126276483|NCT02823652|454301872|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
126276484|NCT02823652|454301870|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
126276485|NCT02823652|454301871|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
126276486|NCT02823652|454301872|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
126276487|NCT03567382|454301873|FG000|Overall Study|Lost to Follow-up|1|||
126276488|NCT03567382|454301874|FG001|Overall Study|Lost to Follow-up|21|||
126276489|NCT03567382|454301875|FG002|Overall Study|Lost to Follow-up|1|||
126276490|NCT03567382|454301876|FG003|Overall Study|Lost to Follow-up|21|||
126276491|NCT03567382|454301873|FG000|Overall Study|Withdrawal by Subject|2|||
126276492|NCT03567382|454301874|FG001|Overall Study|Withdrawal by Subject|14|||
126276493|NCT03567382|454301875|FG002|Overall Study|Withdrawal by Subject|1|||
126276494|NCT03567382|454301876|FG003|Overall Study|Withdrawal by Subject|12|||
126276495|NCT00620659|454301879|FG000|Treatment Period 1|Adverse Event|1|||
126276496|NCT00620659|454301880|FG001|Treatment Period 1|Adverse Event|0|||
126276497|NCT00620659|454301881|FG002|Treatment Period 1|Adverse Event|0|||
126276498|NCT00620659|454301882|FG003|Treatment Period 1|Adverse Event|3|||
126276499|NCT00620659|454301883|FG004|Treatment Period 1|Adverse Event|0|||
126276500|NCT00620659|454301884|FG005|Treatment Period 1|Adverse Event|0|||
126276501|NCT00620659|454301879|FG000|Treatment Period 1|Protocol Violation|1|||
126276502|NCT00620659|454301880|FG001|Treatment Period 1|Protocol Violation|0|||
126276503|NCT00620659|454301881|FG002|Treatment Period 1|Protocol Violation|0|||
126276504|NCT00620659|454301882|FG003|Treatment Period 1|Protocol Violation|0|||
126276505|NCT00620659|454301883|FG004|Treatment Period 1|Protocol Violation|0|||
126276506|NCT00620659|454301884|FG005|Treatment Period 1|Protocol Violation|0|||
126276507|NCT00620659|454301879|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126276508|NCT00620659|454301880|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126276509|NCT00620659|454301881|FG002|Treatment Period 1|Withdrawal by Subject|1|||
126276510|NCT00620659|454301882|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126276511|NCT00620659|454301883|FG004|Treatment Period 1|Withdrawal by Subject|1|||
126276512|NCT00620659|454301884|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126276513|NCT00620659|454301879|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
126276514|NCT00620659|454301880|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
126276515|NCT00620659|454301881|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
126276516|NCT00620659|454301882|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
126276517|NCT00620659|454301883|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
126276518|NCT00620659|454301884|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
126276519|NCT00620659|454301879|FG000|Treatment Period 2|Adverse Event|0|||
126276520|NCT00620659|454301880|FG001|Treatment Period 2|Adverse Event|3|||
126276521|NCT00620659|454301881|FG002|Treatment Period 2|Adverse Event|0|||
126276522|NCT00620659|454301882|FG003|Treatment Period 2|Adverse Event|0|||
126276523|NCT00620659|454301883|FG004|Treatment Period 2|Adverse Event|2|||
126276524|NCT00620659|454301884|FG005|Treatment Period 2|Adverse Event|0|||
126276525|NCT00620659|454301879|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126276526|NCT00620659|454301880|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126276527|NCT00620659|454301881|FG002|Treatment Period 2|Withdrawal by Subject|1|||
126276528|NCT00620659|454301882|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126547747|NCT02569710|455298051|FG000|Overall Study|Adverse Event|1|||
126706341|NCT01416181|455877276|FG001|Part 1|Ongoing in Follow-Up|8|||
126706342|NCT01416181|455877275|FG000|Part 2|Adverse Event|11|||
126706343|NCT01416181|455877276|FG001|Part 2|Adverse Event|4|||
126706344|NCT01416181|455877275|FG000|Part 2|Other|234|||
126706345|NCT01416181|455877276|FG001|Part 2|Other|267|||
126706346|NCT01416181|455877275|FG000|Part 2|Investigator Decision|6|||
126706347|NCT01416181|455877276|FG001|Part 2|Investigator Decision|7|||
126706348|NCT01416181|455877275|FG000|Part 2|Withdrawal by Subject|14|||
126706349|NCT01416181|455877276|FG001|Part 2|Withdrawal by Subject|5|||
126706350|NCT01416181|455877275|FG000|Part 2|Lack of Efficacy|4|||
126706351|NCT01416181|455877276|FG001|Part 2|Lack of Efficacy|1|||
126706352|NCT01416181|455877275|FG000|Part 2|Lost to Follow-up|2|||
126706353|NCT01416181|455877276|FG001|Part 2|Lost to Follow-up|2|||
126706354|NCT00698516|455877279|FG000|Overall Study|Study Termination|2|||
126706355|NCT00698516|455877279|FG000|Overall Study|Withdrawal by Subject|3|||
126706356|NCT02586207|455877283|FG000|Overall Study|Physician Decision|1|||
126706357|NCT02586207|455877283|FG000|Overall Study|Withdrawal by Subject|1|||
126706358|NCT02158533|455877291|FG000|Stage 1|Adverse Event|6|||
126706359|NCT02158533|455877292|FG001|Stage 1|Adverse Event|4|||
126706360|NCT02158533|455877293|FG002|Stage 1|Adverse Event|7|||
126706361|NCT02158533|455877294|FG003|Stage 1|Adverse Event|0|||
126706362|NCT02158533|455877295|FG004|Stage 1|Adverse Event|0|||
126706363|NCT02158533|455877296|FG005|Stage 1|Adverse Event|0|||
126706364|NCT02158533|455877291|FG000|Stage 1|Withdrawal by Subject|3|||
126706365|NCT02158533|455877292|FG001|Stage 1|Withdrawal by Subject|2|||
126706366|NCT02158533|455877293|FG002|Stage 1|Withdrawal by Subject|1|||
126706367|NCT02158533|455877294|FG003|Stage 1|Withdrawal by Subject|0|||
126706368|NCT02158533|455877295|FG004|Stage 1|Withdrawal by Subject|0|||
126706369|NCT02158533|455877296|FG005|Stage 1|Withdrawal by Subject|0|||
126706370|NCT02158533|455877291|FG000|Stage 1|Lack of Efficacy|1|||
126276529|NCT00620659|454301883|FG004|Treatment Period 2|Withdrawal by Subject|3|||
126276530|NCT00620659|454301884|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126276531|NCT00620659|454301879|FG000|Placebo Washout Period 2|Adverse Event|2|||
126276532|NCT00620659|454301880|FG001|Placebo Washout Period 2|Adverse Event|0|||
126276533|NCT00620659|454301881|FG002|Placebo Washout Period 2|Adverse Event|0|||
126276534|NCT00620659|454301882|FG003|Placebo Washout Period 2|Adverse Event|0|||
126276535|NCT00620659|454301883|FG004|Placebo Washout Period 2|Adverse Event|0|||
126276536|NCT00620659|454301884|FG005|Placebo Washout Period 2|Adverse Event|0|||
126276537|NCT00620659|454301879|FG000|Treatment Period 3|Adverse Event|0|||
126276538|NCT00620659|454301880|FG001|Treatment Period 3|Adverse Event|2|||
126276539|NCT00620659|454301881|FG002|Treatment Period 3|Adverse Event|0|||
126276540|NCT00620659|454301882|FG003|Treatment Period 3|Adverse Event|0|||
126276541|NCT00620659|454301883|FG004|Treatment Period 3|Adverse Event|0|||
126276542|NCT00620659|454301884|FG005|Treatment Period 3|Adverse Event|0|||
126276543|NCT00620659|454301879|FG000|Treatment Period 3|Withdrawal by Subject|0|||
126276544|NCT00620659|454301880|FG001|Treatment Period 3|Withdrawal by Subject|0|||
126276545|NCT00620659|454301881|FG002|Treatment Period 3|Withdrawal by Subject|0|||
126276546|NCT00620659|454301882|FG003|Treatment Period 3|Withdrawal by Subject|1|||
126276547|NCT00620659|454301883|FG004|Treatment Period 3|Withdrawal by Subject|0|||
126276548|NCT00620659|454301884|FG005|Treatment Period 3|Withdrawal by Subject|0|||
126276549|NCT01214915|454301886|FG000|Overall Study|Adverse Event|8|||
126276550|NCT01214915|454301886|FG000|Overall Study|Lack of Efficacy|3|||
126276551|NCT02056392|454301887|FG000|Overall Study|Lost to Follow-up|0|||
126276552|NCT02056392|454301888|FG001|Overall Study|Lost to Follow-up|1|||
126276553|NCT02056392|454301889|FG002|Overall Study|Lost to Follow-up|2|||
126276554|NCT02056392|454301890|FG003|Overall Study|Lost to Follow-up|0|||
126276555|NCT02056392|454301891|FG004|Overall Study|Lost to Follow-up|0|||
126706371|NCT02158533|455877292|FG001|Stage 1|Lack of Efficacy|0|||
126706372|NCT02158533|455877293|FG002|Stage 1|Lack of Efficacy|0|||
126706373|NCT02158533|455877294|FG003|Stage 1|Lack of Efficacy|0|||
126276556|NCT02056392|454301892|FG005|Overall Study|Lost to Follow-up|0|||
126276557|NCT02056392|454301887|FG000|Overall Study|Protocol Violation|1|||
126276558|NCT02056392|454301888|FG001|Overall Study|Protocol Violation|0|||
126276559|NCT02056392|454301889|FG002|Overall Study|Protocol Violation|1|||
126454303|NCT02279407|454963153|FG001|Overall Study|Adverse Event|1|||
126276560|NCT02056392|454301890|FG003|Overall Study|Protocol Violation|0|||
126276561|NCT02056392|454301891|FG004|Overall Study|Protocol Violation|0|||
126276562|NCT02056392|454301892|FG005|Overall Study|Protocol Violation|0|||
126454304|NCT02279407|454963154|FG002|Overall Study|Adverse Event|2|||
126454305|NCT02279407|454963155|FG003|Overall Study|Adverse Event|0|||
126454306|NCT00864916|454963156|FG000|Overall Study|Lost to Follow-up|4|||
126454307|NCT00864916|454963157|FG001|Overall Study|Lost to Follow-up|4|||
126454308|NCT00864916|454963156|FG000|Overall Study|Protocol Violation|1|||
126454309|NCT00864916|454963157|FG001|Overall Study|Protocol Violation|0|||
126706374|NCT02158533|455877295|FG004|Stage 1|Lack of Efficacy|0|||
126706375|NCT02158533|455877296|FG005|Stage 1|Lack of Efficacy|0|||
126706376|NCT02158533|455877291|FG000|Stage 1|Lost to Follow-up|3|||
126706377|NCT02158533|455877292|FG001|Stage 1|Lost to Follow-up|1|||
126706378|NCT02158533|455877293|FG002|Stage 1|Lost to Follow-up|0|||
126706379|NCT02158533|455877294|FG003|Stage 1|Lost to Follow-up|0|||
126276563|NCT02056392|454301887|FG000|Overall Study|Withdrawal by Subject|1|||
126276564|NCT02056392|454301888|FG001|Overall Study|Withdrawal by Subject|0|||
126276565|NCT02056392|454301889|FG002|Overall Study|Withdrawal by Subject|0|||
126276566|NCT02056392|454301890|FG003|Overall Study|Withdrawal by Subject|0|||
126547748|NCT02569710|455298052|FG001|Overall Study|Adverse Event|0|||
126706380|NCT02158533|455877295|FG004|Stage 1|Lost to Follow-up|0|||
126706381|NCT02158533|455877296|FG005|Stage 1|Lost to Follow-up|0|||
126276567|NCT02056392|454301891|FG004|Overall Study|Withdrawal by Subject|1|||
126706382|NCT02158533|455877291|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
126706383|NCT02158533|455877292|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
126706384|NCT02158533|455877293|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
126706385|NCT02158533|455877294|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
126706386|NCT02158533|455877295|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
126706387|NCT02158533|455877296|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
126706388|NCT02158533|455877291|FG000|Stage 1|Non-compliance with study visits|1|||
126706389|NCT02158533|455877292|FG001|Stage 1|Non-compliance with study visits|0|||
126706390|NCT02158533|455877293|FG002|Stage 1|Non-compliance with study visits|0|||
126706391|NCT02158533|455877294|FG003|Stage 1|Non-compliance with study visits|0|||
126706392|NCT02158533|455877295|FG004|Stage 1|Non-compliance with study visits|0|||
126276568|NCT02056392|454301892|FG005|Overall Study|Withdrawal by Subject|0|||
126276569|NCT04555720|454301895|FG000|Overall Study|Lost to Follow-up|2|||
126276570|NCT04555720|454301896|FG001|Overall Study|Lost to Follow-up|0|||
126276571|NCT04555720|454301897|FG002|Overall Study|Lost to Follow-up|0|||
126276572|NCT04555720|454301898|FG003|Overall Study|Lost to Follow-up|0|||
126276573|NCT04555720|454301895|FG000|Overall Study|Withdrawal by Subject|4|||
126276574|NCT04555720|454301896|FG001|Overall Study|Withdrawal by Subject|6|||
126276575|NCT04555720|454301897|FG002|Overall Study|Withdrawal by Subject|0|||
126276576|NCT04555720|454301898|FG003|Overall Study|Withdrawal by Subject|0|||
126276577|NCT00968799|454301899|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
126276578|NCT00719849|454301900|FG000|Overall Study|Death|0|||
126276579|NCT00719849|454301901|FG001|Overall Study|Death|1|||
126276580|NCT01372774|454301904|FG000|Overall Study|Withdrawal prior to treatment|4|||
126276581|NCT01372774|454301905|FG001|Overall Study|Withdrawal prior to treatment|5|||
126276582|NCT02201290|454301906|FG000|Overall Study|Withdrawal by Subject|2|||
126276583|NCT02201290|454301906|FG000|Overall Study|Lack of Efficacy|2|||
126276584|NCT02201290|454301906|FG000|Overall Study|Adverse Event|1|||
126276585|NCT02022748|454303679|FG000|Overall Study|Adverse Event|1|||
126276586|NCT02022748|454303680|FG001|Overall Study|Adverse Event|1|||
126276587|NCT02022748|454303681|FG002|Overall Study|Adverse Event|0|||
126276588|NCT02022748|454303679|FG000|Overall Study|Withdrawal by Subject|0|||
126276589|NCT02022748|454303680|FG001|Overall Study|Withdrawal by Subject|1|||
126276590|NCT02022748|454303681|FG002|Overall Study|Withdrawal by Subject|0|||
126276591|NCT00633243|454303682|FG000|Overall Study|Withdrawal by Subject|0|||
126276592|NCT00633243|454303683|FG001|Overall Study|Withdrawal by Subject|1|||
126276593|NCT00633243|454303682|FG000|Overall Study|incarceration|0|||
126276594|NCT00633243|454303683|FG001|Overall Study|incarceration|2|||
126276595|NCT00633243|454303682|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
126276596|NCT00633243|454303683|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
126276597|NCT00633243|454303682|FG000|Overall Study|Not comfortable with self-injecting|0|||
126454310|NCT00864916|454963156|FG000|Overall Study|Withdrawal by Subject|1|||
126454311|NCT00864916|454963157|FG001|Overall Study|Withdrawal by Subject|0|||
126454312|NCT00422084|454963160|FG000|Overall Study|Adverse Event|21|||
126454313|NCT00422084|454963161|FG001|Overall Study|Adverse Event|7|||
126454314|NCT00422084|454963160|FG000|Overall Study|Withdrawal by Subject|12|||
126454315|NCT00422084|454963161|FG001|Overall Study|Withdrawal by Subject|9|||
126454316|NCT00422084|454963160|FG000|Overall Study|Lost to Follow-up|14|||
126454317|NCT00422084|454963161|FG001|Overall Study|Lost to Follow-up|9|||
126454318|NCT00422084|454963160|FG000|Overall Study|Protocol Violation|4|||
126454319|NCT00422084|454963161|FG001|Overall Study|Protocol Violation|1|||
126454320|NCT00422084|454963160|FG000|Overall Study|Lack of Efficacy|40|||
126454321|NCT00422084|454963161|FG001|Overall Study|Lack of Efficacy|42|||
126454322|NCT00422084|454963160|FG000|Overall Study|P. vivax infection|3|||
126454323|NCT00422084|454963161|FG001|Overall Study|P. vivax infection|6|||
126454324|NCT00422084|454963160|FG000|Overall Study|Cyesis|1|||
126454325|NCT00422084|454963161|FG001|Overall Study|Cyesis|0|||
126454326|NCT00422084|454963160|FG000|Overall Study|Withdrawn from study accidentally|1|||
126454327|NCT00422084|454963161|FG001|Overall Study|Withdrawn from study accidentally|0|||
126454328|NCT00422084|454963160|FG000|Overall Study|Non-compliance|1|||
126454329|NCT00422084|454963161|FG001|Overall Study|Non-compliance|0|||
126454330|NCT00422084|454963160|FG000|Overall Study|Re-location|0|||
126454331|NCT00422084|454963161|FG001|Overall Study|Re-location|1|||
126454332|NCT00422084|454963160|FG000|Overall Study|Not defined|1|||
126454333|NCT00422084|454963161|FG001|Overall Study|Not defined|1|||
126454334|NCT02788279|454963162|FG000|Overall Study|Death|62|||
126454335|NCT02788279|454963163|FG001|Overall Study|Death|136|||
126547749|NCT02569710|455298053|FG002|Overall Study|Adverse Event|0|||
126706393|NCT02158533|455877296|FG005|Stage 1|Non-compliance with study visits|0|||
126276598|NCT00633243|454303683|FG001|Overall Study|Not comfortable with self-injecting|1|||
126276599|NCT00633243|454303682|FG000|Overall Study|Mental Health--Depression|0|||
126276600|NCT00633243|454303683|FG001|Overall Study|Mental Health--Depression|1|||
126276601|NCT00633243|454303682|FG000|Overall Study|Couldn't tolerate side-effects|1|||
126276602|NCT00633243|454303683|FG001|Overall Study|Couldn't tolerate side-effects|1|||
126454336|NCT02788279|454963164|FG002|Overall Study|Death|72|||
126454337|NCT02788279|454963162|FG000|Overall Study|Withdrawal by Subject|10|||
126276603|NCT04345601|454303684|FG000|Overall Study|Death|0|||
126276604|NCT04345601|454303685|FG001|Overall Study|Death|3|||
126276605|NCT04345601|454303686|FG002|Overall Study|Death|2|||
126276606|NCT04345601|454303684|FG000|Overall Study|Lost to Follow-up|0|||
126276607|NCT04345601|454303685|FG001|Overall Study|Lost to Follow-up|0|||
126276608|NCT04345601|454303686|FG002|Overall Study|Lost to Follow-up|2|||
126276609|NCT03700385|454303687|FG000|Overall Study|Lost to Follow-up|1|||
126276610|NCT01555671|454303690|FG000|Overall Study|Physician Decision|20|||
126276611|NCT01555671|454303691|FG001|Overall Study|Physician Decision|25|||
126276612|NCT04590040|454303695|FG000|Treatment Period|Lost to Follow-up|2|||
126276613|NCT04590040|454303696|FG001|Treatment Period|Lost to Follow-up|5|||
126276614|NCT04590040|454303697|FG002|Treatment Period|Lost to Follow-up|0|||
126276615|NCT04590040|454303695|FG000|Treatment Period|Physician Decision|0|||
126276616|NCT04590040|454303696|FG001|Treatment Period|Physician Decision|0|||
126276617|NCT04590040|454303697|FG002|Treatment Period|Physician Decision|2|||
126276618|NCT00000378|454303698|FG000|Overall Study|Lack of Efficacy|16|||
126276619|NCT00000378|454303699|FG001|Overall Study|Lack of Efficacy|14|||
126276620|NCT04003896|454303700|FG000|Overall Study|Withdrawal by Subject|3|||
126276621|NCT04003896|454303700|FG000|Overall Study|Physician Decision|1|||
126276622|NCT01957397|454303703|FG000|Test Period 1|sudden leakage/small bag|1|||
126276623|NCT01957397|454303704|FG001|Test Period 1|sudden leakage/small bag|1|||
126276624|NCT01957397|454303703|FG000|Test Period 1|Withdrawal by Subject|1|||
126276625|NCT01957397|454303704|FG001|Test Period 1|Withdrawal by Subject|0|||
126276626|NCT01957397|454303703|FG000|Test Period 2|Adverse Event|0|||
126276627|NCT01957397|454303704|FG001|Test Period 2|Adverse Event|1|||
126276628|NCT01957397|454303703|FG000|Test Period 3|Adverse Event|1|||
126276629|NCT01957397|454303704|FG001|Test Period 3|Adverse Event|2|||
126276630|NCT01957397|454303703|FG000|Test Period 3|the adhesive did not work|1|||
126276631|NCT01957397|454303704|FG001|Test Period 3|the adhesive did not work|0|||
126276632|NCT00324649|454303705|FG000|Overall Study|Adverse Event|1|||
126276633|NCT00324649|454303706|FG001|Overall Study|Adverse Event|4|||
126276634|NCT00324649|454303705|FG000|Overall Study|Withdrawal by Subject|0|||
126276635|NCT00324649|454303706|FG001|Overall Study|Withdrawal by Subject|1|||
126276636|NCT00324649|454303705|FG000|Overall Study|Noncompliance|1|||
126276637|NCT00324649|454303706|FG001|Overall Study|Noncompliance|0|||
126276638|NCT04713553|454303709|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
126276639|NCT04713553|454303710|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
126454338|NCT02788279|454963163|FG001|Overall Study|Withdrawal by Subject|15|||
126454339|NCT02788279|454963164|FG002|Overall Study|Withdrawal by Subject|5|||
126454340|NCT02788279|454963162|FG000|Overall Study|Lost to Follow-up|0|||
126454341|NCT02788279|454963163|FG001|Overall Study|Lost to Follow-up|3|||
126454342|NCT02788279|454963164|FG002|Overall Study|Lost to Follow-up|2|||
126454343|NCT02788279|454963162|FG000|Overall Study|Sponsor decision|18|||
126454344|NCT02788279|454963163|FG001|Overall Study|Sponsor decision|29|||
126454345|NCT02788279|454963164|FG002|Overall Study|Sponsor decision|11|||
126454346|NCT01782469|454963165|FG000|Overall Study|Lost to Follow-up|1|||
126454347|NCT00357760|454963172|FG000|Overall Study|Disease progression|44|||
126454348|NCT00357760|454963173|FG001|Overall Study|Disease progression|17|||
126454349|NCT00357760|454963172|FG000|Overall Study|Adverse Event|10|||
126454350|NCT00357760|454963173|FG001|Overall Study|Adverse Event|7|||
126454351|NCT00357760|454963172|FG000|Overall Study|Death|0|||
126454352|NCT00357760|454963173|FG001|Overall Study|Death|3|||
126454353|NCT00357760|454963172|FG000|Overall Study|Alternative therapy|1|||
126454354|NCT00357760|454963173|FG001|Overall Study|Alternative therapy|0|||
126454355|NCT00357760|454963172|FG000|Overall Study|Withdrawal by Subject|0|||
126454356|NCT00357760|454963173|FG001|Overall Study|Withdrawal by Subject|2|||
126454357|NCT00357760|454963172|FG000|Overall Study|Never started treatment|2|||
126454358|NCT00357760|454963173|FG001|Overall Study|Never started treatment|1|||
126454359|NCT00357760|454963172|FG000|Overall Study|Ineligible|0|||
126454360|NCT00357760|454963173|FG001|Overall Study|Ineligible|2|||
126454361|NCT00357760|454963172|FG000|Overall Study|Physician Decision|2|||
126454362|NCT00357760|454963173|FG001|Overall Study|Physician Decision|1|||
126276640|NCT04713553|454303711|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
126276641|NCT04713553|454303712|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
126454363|NCT00357760|454963172|FG000|Overall Study|Protocol Violation|0|||
126454364|NCT00357760|454963173|FG001|Overall Study|Protocol Violation|1|||
126454365|NCT00357760|454963172|FG000|Overall Study|To receive hospice care|0|||
126454366|NCT00357760|454963173|FG001|Overall Study|To receive hospice care|1|||
126454367|NCT04136444|454963174|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
126454368|NCT04136444|454963175|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
126454369|NCT02184572|454963181|FG000|Overall Study|Lost to Follow-up|29|||
126454370|NCT02184572|454963182|FG001|Overall Study|Lost to Follow-up|21|||
126547750|NCT02569710|455298054|FG003|Overall Study|Adverse Event|0|||
126276642|NCT04713553|454303713|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
126276643|NCT04713553|454303714|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
126276644|NCT04713553|454303715|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
126276645|NCT04713553|454303709|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
126306224|NCT01940887|454410250|FG000|Year 1|Protocol Violation|0|||
126276646|NCT04713553|454303710|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
126276647|NCT04713553|454303711|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
126276648|NCT04713553|454303712|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
126276649|NCT04713553|454303713|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
126276650|NCT04713553|454303714|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
126276651|NCT04713553|454303715|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
126276652|NCT04713553|454303709|FG000|Primary Study (2 Months)|Other|1|||
126276653|NCT04713553|454303710|FG001|Primary Study (2 Months)|Other|2|||
126276654|NCT04713553|454303711|FG002|Primary Study (2 Months)|Other|0|||
126276655|NCT04713553|454303712|FG003|Primary Study (2 Months)|Other|0|||
126276656|NCT04713553|454303713|FG004|Primary Study (2 Months)|Other|1|||
126454371|NCT02184572|454963181|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
126454372|NCT02184572|454963182|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
126706394|NCT02158533|455877291|FG000|Stage 2|Adverse Event|0|||
126706395|NCT02158533|455877292|FG001|Stage 2|Adverse Event|0|||
126706396|NCT02158533|455877293|FG002|Stage 2|Adverse Event|0|||
126706397|NCT02158533|455877294|FG003|Stage 2|Adverse Event|0|||
126706398|NCT02158533|455877295|FG004|Stage 2|Adverse Event|0|||
126706399|NCT02158533|455877296|FG005|Stage 2|Adverse Event|1|||
126706400|NCT02158533|455877291|FG000|Stage 2|Lack of Efficacy|0|||
126706401|NCT02158533|455877292|FG001|Stage 2|Lack of Efficacy|0|||
126706402|NCT02158533|455877293|FG002|Stage 2|Lack of Efficacy|0|||
126706403|NCT02158533|455877294|FG003|Stage 2|Lack of Efficacy|0|||
126454373|NCT02184572|454963181|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
126706404|NCT02158533|455877295|FG004|Stage 2|Lack of Efficacy|1|||
126706405|NCT02158533|455877296|FG005|Stage 2|Lack of Efficacy|0|||
126706406|NCT02158533|455877291|FG000|Stage 2|Lost to Follow-up|0|||
126454374|NCT02184572|454963182|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
126454375|NCT02184572|454963181|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
126454376|NCT02184572|454963182|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
126454377|NCT02184572|454963181|FG000|Overall Study|Traveling Outside The Country|1|||
126454378|NCT02184572|454963182|FG001|Overall Study|Traveling Outside The Country|0|||
126454379|NCT02184572|454963181|FG000|Overall Study|Withdrawal by Subject|14|||
126454380|NCT02184572|454963182|FG001|Overall Study|Withdrawal by Subject|9|||
126454381|NCT03726996|454963183|FG000|Overall Study|Parent's decision|2|||
126454382|NCT03726996|454963183|FG000|Overall Study|Study early termination|2|||
126454383|NCT01328444|454963184|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
126454384|NCT01328444|454963185|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
126454385|NCT01328444|454963186|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
126454386|NCT01328444|454963187|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
126454387|NCT01328444|454963188|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
126454388|NCT01328444|454963189|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
126454389|NCT01328444|454963184|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
126454390|NCT01328444|454963185|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
126454391|NCT01328444|454963186|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
126454392|NCT01328444|454963187|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
126454393|NCT01328444|454963188|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
126454394|NCT01328444|454963189|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
126454395|NCT01328444|454963184|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
126454396|NCT01328444|454963185|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
126454397|NCT01328444|454963186|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
126454398|NCT01328444|454963187|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
126454399|NCT01328444|454963188|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
126454400|NCT01328444|454963189|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
126454401|NCT01328444|454963184|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
126706407|NCT02158533|455877292|FG001|Stage 2|Lost to Follow-up|0|||
126706408|NCT02158533|455877293|FG002|Stage 2|Lost to Follow-up|0|||
126706409|NCT02158533|455877294|FG003|Stage 2|Lost to Follow-up|1|||
126706410|NCT02158533|455877295|FG004|Stage 2|Lost to Follow-up|1|||
126706411|NCT02158533|455877296|FG005|Stage 2|Lost to Follow-up|2|||
126454402|NCT01328444|454963185|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
126454403|NCT01328444|454963186|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
126454404|NCT01328444|454963187|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
126454405|NCT01328444|454963188|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
126454406|NCT01328444|454963189|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
126706412|NCT02158533|455877291|FG000|Stage 2|Withdrawal by Subject|0|||
126706413|NCT02158533|455877292|FG001|Stage 2|Withdrawal by Subject|0|||
126706414|NCT02158533|455877293|FG002|Stage 2|Withdrawal by Subject|0|||
126706415|NCT02158533|455877294|FG003|Stage 2|Withdrawal by Subject|0|||
126706416|NCT02158533|455877295|FG004|Stage 2|Withdrawal by Subject|1|||
126454407|NCT01328444|454963184|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
126547751|NCT02569710|455298055|FG004|Overall Study|Adverse Event|0|||
126706417|NCT02158533|455877296|FG005|Stage 2|Withdrawal by Subject|2|||
126706418|NCT02158533|455877291|FG000|Stage 2|Physician Decision|0|||
126454408|NCT01328444|454963185|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126454409|NCT01328444|454963186|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126547752|NCT02569710|455298056|FG005|Overall Study|Adverse Event|0|||
126547753|NCT02569710|455298057|FG006|Overall Study|Adverse Event|0|||
126547754|NCT02569710|455298058|FG007|Overall Study|Adverse Event|0|||
126706419|NCT02158533|455877292|FG001|Stage 2|Physician Decision|0|||
126706420|NCT02158533|455877293|FG002|Stage 2|Physician Decision|0|||
126706421|NCT02158533|455877294|FG003|Stage 2|Physician Decision|0|||
126706422|NCT02158533|455877295|FG004|Stage 2|Physician Decision|1|||
126706423|NCT02158533|455877296|FG005|Stage 2|Physician Decision|0|||
126706424|NCT02158533|455877291|FG000|Stage 2|Pregnancy|0|||
126706425|NCT02158533|455877292|FG001|Stage 2|Pregnancy|0|||
126706426|NCT02158533|455877293|FG002|Stage 2|Pregnancy|0|||
126454410|NCT01328444|454963187|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
126454411|NCT01328444|454963188|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126454412|NCT01328444|454963189|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
126454413|NCT01328444|454963184|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126454414|NCT01328444|454963185|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
126454415|NCT01328444|454963186|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
126454416|NCT01328444|454963187|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
126454417|NCT01328444|454963188|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
126454418|NCT01328444|454963189|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126454419|NCT01328444|454963184|FG000|Washout Period (14 Days)|Adverse Event|1|||
126454420|NCT01328444|454963185|FG001|Washout Period (14 Days)|Adverse Event|1|||
126454421|NCT01328444|454963186|FG002|Washout Period (14 Days)|Adverse Event|0|||
126454422|NCT01328444|454963187|FG003|Washout Period (14 Days)|Adverse Event|1|||
126454423|NCT01328444|454963188|FG004|Washout Period (14 Days)|Adverse Event|1|||
126454424|NCT01328444|454963189|FG005|Washout Period (14 Days)|Adverse Event|2|||
126454425|NCT01328444|454963184|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
126454426|NCT01328444|454963185|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
126454427|NCT01328444|454963186|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
126454428|NCT01328444|454963187|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
126454429|NCT01328444|454963188|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
126454430|NCT01328444|454963189|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
126454431|NCT01328444|454963184|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
126454432|NCT01328444|454963185|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
126706427|NCT02158533|455877294|FG003|Stage 2|Pregnancy|1|||
126706428|NCT02158533|455877295|FG004|Stage 2|Pregnancy|0|||
126706429|NCT02158533|455877296|FG005|Stage 2|Pregnancy|0|||
126706430|NCT02158533|455877291|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
126706431|NCT02158533|455877292|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
126706432|NCT02158533|455877293|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
126706433|NCT02158533|455877294|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
126706434|NCT02158533|455877295|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
126706435|NCT02158533|455877296|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
126706436|NCT02158533|455877291|FG000|Stage 2|Non-adherence with study visits|0|||
126706437|NCT02158533|455877292|FG001|Stage 2|Non-adherence with study visits|0|||
126706438|NCT02158533|455877293|FG002|Stage 2|Non-adherence with study visits|0|||
126706439|NCT02158533|455877294|FG003|Stage 2|Non-adherence with study visits|0|||
126706440|NCT02158533|455877295|FG004|Stage 2|Non-adherence with study visits|0|||
126706441|NCT02158533|455877296|FG005|Stage 2|Non-adherence with study visits|1|||
126706442|NCT00384956|455877303|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
126706443|NCT00917384|455877304|FG000|Overall Study|Lost to Follow-up|4|||
126706444|NCT00917384|455877305|FG001|Overall Study|Lost to Follow-up|2|||
126706445|NCT00917384|455877304|FG000|Overall Study|Withdrawal by Subject|10|||
126276657|NCT04713553|454303714|FG005|Primary Study (2 Months)|Other|0|||
126454433|NCT01328444|454963186|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
126454434|NCT01328444|454963187|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
126454435|NCT01328444|454963188|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
126454436|NCT01328444|454963189|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
126454437|NCT01328444|454963184|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
126454438|NCT01328444|454963185|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
126454439|NCT01328444|454963186|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
126454440|NCT01328444|454963187|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
126547755|NCT02569710|455298059|FG008|Overall Study|Adverse Event|0|||
126706446|NCT00917384|455877305|FG001|Overall Study|Withdrawal by Subject|2|||
126706447|NCT03126227|455877308|FG000|Overall Study|Adverse Event|43|||
126706448|NCT03126227|455877309|FG001|Overall Study|Adverse Event|4|||
126706449|NCT03126227|455877308|FG000|Overall Study|Death|0|||
126706450|NCT03126227|455877309|FG001|Overall Study|Death|1|||
126706451|NCT03126227|455877308|FG000|Overall Study|Lost to Follow-up|0|||
126706452|NCT03126227|455877309|FG001|Overall Study|Lost to Follow-up|1|||
126706453|NCT03126227|455877308|FG000|Overall Study|Physician Decision|2|||
126276658|NCT04713553|454303715|FG006|Primary Study (2 Months)|Other|0|||
126454441|NCT01328444|454963188|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
126706454|NCT03126227|455877309|FG001|Overall Study|Physician Decision|0|||
126706455|NCT03126227|455877308|FG000|Overall Study|Protocol Violation|1|||
126706456|NCT03126227|455877309|FG001|Overall Study|Protocol Violation|0|||
126276659|NCT04713553|454303709|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
126276660|NCT04713553|454303710|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
126276661|NCT04713553|454303711|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
126276662|NCT04713553|454303712|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
126276663|NCT04713553|454303713|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
126276664|NCT04713553|454303714|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
126276665|NCT04713553|454303715|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
126276666|NCT04713553|454303709|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
126276667|NCT04713553|454303710|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
126276668|NCT04713553|454303711|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
126276669|NCT04713553|454303712|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
126276670|NCT04713553|454303713|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
126276671|NCT04713553|454303714|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
126276672|NCT04713553|454303715|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
126276673|NCT01359969|454303716|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
126276674|NCT02315196|454303722|FG000|Overall Study|Withdrew consent|9|||
126276675|NCT00470067|454303723|FG000|Overall Study|Death|1|||
126276676|NCT00470067|454303723|FG000|Overall Study|Disease Progression|6|||
126276677|NCT04091659|454303724|FG000|Overall Study|Protocol Violation|3|||
126276678|NCT04091659|454303725|FG001|Overall Study|Protocol Violation|0|||
126276679|NCT04091659|454303724|FG000|Overall Study|Lost to Follow-up|0|||
126276680|NCT04091659|454303725|FG001|Overall Study|Lost to Follow-up|1|||
126276681|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
126276682|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
126276683|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
126276684|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
126276685|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
126276686|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
126276687|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
126276688|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
126276689|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
126276690|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
126276691|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Death|1|||
126276692|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Death|0|||
126276693|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Death|0|||
126276694|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Death|0|||
126276695|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Death|0|||
126276696|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
126276697|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
126276698|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
126276699|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
126276700|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
126276701|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
126276702|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
126276703|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
126276704|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
126276705|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
126276706|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
126276707|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
126276708|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
126276709|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
126276710|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
126306225|NCT01940887|454410251|FG001|Year 1|Protocol Violation|1|||
126454442|NCT01328444|454963189|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
126454443|NCT01328444|454963184|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
126454444|NCT01328444|454963185|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
126454445|NCT01328444|454963186|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
126454446|NCT01328444|454963187|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
126454447|NCT01328444|454963188|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
126454448|NCT01328444|454963189|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
126454449|NCT01328444|454963184|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
126706457|NCT03126227|455877308|FG000|Overall Study|Withdrawal by Subject|19|||
126706458|NCT03126227|455877309|FG001|Overall Study|Withdrawal by Subject|3|||
126706459|NCT03126227|455877308|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
126454450|NCT01328444|454963185|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
126454451|NCT01328444|454963186|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
126454452|NCT01328444|454963187|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
126765705|NCT02074982|456095787|FG001|Overall Study|Lack of Efficacy|1|||
126706460|NCT03126227|455877309|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
126706461|NCT03126227|455877308|FG000|Overall Study|Lack of dosing compliance|2|||
126706462|NCT03126227|455877309|FG001|Overall Study|Lack of dosing compliance|0|||
126706463|NCT03126227|455877308|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
126276711|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
126276712|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
126276713|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
126276714|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
126276715|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126276716|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
126276717|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126276718|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126276719|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126276720|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126276721|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Other|4|||
126276722|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Other|4|||
126276723|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Other|3|||
126276724|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Other|1|||
126276725|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Other|0|||
126276726|NCT01081834|454303729|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
126276727|NCT01081834|454303730|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
126276728|NCT01081834|454303731|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
126276729|NCT01081834|454303732|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
126276730|NCT01081834|454303733|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
126276731|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
126276732|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
126276733|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
126276734|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
126276735|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
126276736|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Death|1|||
126276737|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Death|0|||
126454453|NCT01328444|454963188|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
126454454|NCT01328444|454963189|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
126454455|NCT01328444|454963184|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
126454456|NCT01328444|454963185|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
126454457|NCT01328444|454963186|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
126454458|NCT01328444|454963187|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
126454459|NCT01328444|454963188|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
126454460|NCT01328444|454963189|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
126454461|NCT01328444|454963184|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
126454462|NCT01328444|454963185|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
126454463|NCT01328444|454963186|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
126454464|NCT01328444|454963187|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
126454465|NCT01328444|454963188|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
126454466|NCT01328444|454963189|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
126454467|NCT01328444|454963184|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126454468|NCT01328444|454963185|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126454469|NCT01328444|454963186|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126454470|NCT01328444|454963187|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126454471|NCT01328444|454963188|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126454472|NCT01328444|454963189|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126454473|NCT02743611|454963190|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
126454474|NCT02743611|454963191|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
126454475|NCT02743611|454963192|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
126454476|NCT02743611|454963193|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
126454477|NCT00561977|454963194|FG000|Overall Study|Withdrawal by Subject|0|||
126454478|NCT00561977|454963195|FG001|Overall Study|Withdrawal by Subject|2|||
126454479|NCT00561977|454963196|FG002|Overall Study|Withdrawal by Subject|1|||
126454480|NCT00561977|454963194|FG000|Overall Study|Pregnancy|0|||
126454481|NCT00561977|454963195|FG001|Overall Study|Pregnancy|1|||
126454482|NCT00561977|454963196|FG002|Overall Study|Pregnancy|1|||
126454483|NCT00946985|454963197|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
126454484|NCT00946985|454963197|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
126454485|NCT00946985|454963197|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
126706464|NCT03126227|455877309|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
126454486|NCT00946985|454963197|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
126454487|NCT00946985|454963197|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
126454488|NCT00946985|454963197|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
126454489|NCT00946985|454963197|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
126454490|NCT00946985|454963197|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
126454491|NCT00946985|454963197|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
126454492|NCT04345367|454963198|FG000|Overall Study|Other|3|||
126454493|NCT04345367|454963199|FG001|Overall Study|Other|4|||
126454494|NCT04345367|454963198|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
126454495|NCT04345367|454963199|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
126454496|NCT04345367|454963198|FG000|Overall Study|Withdrawal by Subject|11|||
126454497|NCT04345367|454963199|FG001|Overall Study|Withdrawal by Subject|11|||
126454498|NCT04345367|454963198|FG000|Overall Study|Protocol Violation|4|||
126454499|NCT04345367|454963199|FG001|Overall Study|Protocol Violation|3|||
126454500|NCT04345367|454963198|FG000|Overall Study|Lost to Follow-up|2|||
126454501|NCT04345367|454963199|FG001|Overall Study|Lost to Follow-up|4|||
126454502|NCT04345367|454963198|FG000|Overall Study|Lack of Efficacy|2|||
126454503|NCT04345367|454963199|FG001|Overall Study|Lack of Efficacy|0|||
126454504|NCT04345367|454963198|FG000|Overall Study|Death|2|||
126454505|NCT04345367|454963199|FG001|Overall Study|Death|0|||
126454506|NCT04345367|454963198|FG000|Overall Study|Adverse Event|10|||
126276738|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Death|0|||
126276739|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Death|0|||
126276740|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Death|0|||
126276741|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
126276742|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
126276743|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126276744|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126276745|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126276746|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126276747|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
126276748|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126276749|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126276750|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126276751|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126276752|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
126276753|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
126276754|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
126276755|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
126276756|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
126276757|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126276758|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
126276759|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126276760|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126276761|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
126276762|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
126276763|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
126276764|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
126276765|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
126276766|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Other|4|||
126276767|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Other|5|||
126276768|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Other|4|||
126276769|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Other|0|||
126276770|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Other|0|||
126276771|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
126276772|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
126276773|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
126276774|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
126454507|NCT04345367|454963199|FG001|Overall Study|Adverse Event|9|||
126454508|NCT00852371|454963200|FG000|Overall Study|Lost to Follow-up|2|||
126454509|NCT00852371|454963201|FG001|Overall Study|Lost to Follow-up|3|||
126454510|NCT00852371|454963202|FG002|Overall Study|Lost to Follow-up|4|||
126454511|NCT00852371|454963203|FG003|Overall Study|Lost to Follow-up|2|||
126454512|NCT00796523|454963204|FG000|Overall Study|Lost to Follow-up|9|||
126454513|NCT00796523|454963205|FG001|Overall Study|Lost to Follow-up|7|||
126454514|NCT04525885|454963207|FG000|Overall Study|Screen Failure|1|||
126454515|NCT04525885|454963208|FG001|Overall Study|Screen Failure|0|||
126454516|NCT04525885|454963209|FG002|Overall Study|Screen Failure|0|||
126276775|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
126276776|NCT01081834|454303729|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126276777|NCT01081834|454303730|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
126276778|NCT01081834|454303731|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126276779|NCT01081834|454303732|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126276780|NCT01081834|454303733|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126276781|NCT03678285|454303736|FG000|Overall Study|Adverse Event|2|||
126276782|NCT03678285|454303736|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
126276783|NCT03678285|454303736|FG000|Overall Study|Dehydrated prior to start of workout|1|||
126276784|NCT00616629|454303737|FG000|Overall Study|Protocol Violation|1|||
126276785|NCT00616629|454303738|FG001|Overall Study|Protocol Violation|2|||
126276786|NCT00616629|454303739|FG002|Overall Study|Protocol Violation|1|||
126276787|NCT00616629|454303740|FG003|Overall Study|Protocol Violation|0|||
126276788|NCT00616629|454303741|FG004|Overall Study|Protocol Violation|0|||
126276789|NCT00616629|454303737|FG000|Overall Study|AV-block|1|||
126276790|NCT00616629|454303738|FG001|Overall Study|AV-block|0|||
126276791|NCT00616629|454303739|FG002|Overall Study|AV-block|0|||
126276792|NCT00616629|454303740|FG003|Overall Study|AV-block|0|||
126276793|NCT00616629|454303741|FG004|Overall Study|AV-block|0|||
126276794|NCT01475097|454303748|FG000|Overall Study|Protocol Violation|1|||
126276795|NCT01475097|454303749|FG001|Overall Study|Protocol Violation|1|||
126276796|NCT04058067|454303763|FG000|Overall Study|Adverse Event|2|||
126276797|NCT04058067|454303764|FG001|Overall Study|Adverse Event|0|||
126276798|NCT04058067|454303763|FG000|Overall Study|Death|0|||
126276799|NCT04058067|454303764|FG001|Overall Study|Death|1|||
126276800|NCT04058067|454303763|FG000|Overall Study|Physician Decision|3|||
126276801|NCT04058067|454303764|FG001|Overall Study|Physician Decision|1|||
126276802|NCT04058067|454303763|FG000|Overall Study|Protocol Violation|0|||
126276803|NCT04058067|454303764|FG001|Overall Study|Protocol Violation|1|||
126276804|NCT04058067|454303763|FG000|Overall Study|Withdrawal by Subject|7|||
126276805|NCT04058067|454303764|FG001|Overall Study|Withdrawal by Subject|8|||
126276806|NCT05005312|454303765|FG000|Overall Study|Enrolled, but not treated|0|||
126276807|NCT05005312|454303766|FG001|Overall Study|Enrolled, but not treated|1|||
126276808|NCT01283035|454303768|FG000|Overall Study|Subject later found ineligible|1|||
126276809|NCT02704403|454303769|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
126276810|NCT02704403|454303770|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
126276811|NCT02704403|454303769|FG000|Overall Study|Administrative reasons by sponsor|1251|||
126362832|NCT00806026|454621628|FG002|Overall Study|Protocol Violation|9|||
126362833|NCT00806026|454621629|FG003|Overall Study|Protocol Violation|0|||
126362834|NCT00806026|454621630|FG004|Overall Study|Protocol Violation|2|||
126362835|NCT00806026|454621631|FG005|Overall Study|Protocol Violation|3|||
126362836|NCT00806026|454621626|FG000|Overall Study|Adverse Event|52|||
126362837|NCT00806026|454621627|FG001|Overall Study|Adverse Event|35|||
126362838|NCT00806026|454621628|FG002|Overall Study|Adverse Event|44|||
126362839|NCT00806026|454621629|FG003|Overall Study|Adverse Event|17|||
126362840|NCT00806026|454621630|FG004|Overall Study|Adverse Event|9|||
126362841|NCT00806026|454621631|FG005|Overall Study|Adverse Event|9|||
126362842|NCT01687595|454621632|FG000|Overall Study|Withdrawal by Subject|8|||
126362843|NCT01687595|454621633|FG001|Overall Study|Withdrawal by Subject|0|||
126362844|NCT01687595|454621632|FG000|Overall Study|Lost to Follow-up|3|||
126362845|NCT01687595|454621633|FG001|Overall Study|Lost to Follow-up|1|||
126362846|NCT01687595|454621632|FG000|Overall Study|Investigator's decision|1|||
126362847|NCT01687595|454621633|FG001|Overall Study|Investigator's decision|0|||
126362848|NCT01687595|454621632|FG000|Overall Study|Sponsor's decision|1|||
126362849|NCT01687595|454621633|FG001|Overall Study|Sponsor's decision|0|||
126362850|NCT01687595|454621632|FG000|Overall Study|Noncompliance|1|||
126362851|NCT01687595|454621633|FG001|Overall Study|Noncompliance|2|||
126362852|NCT01687595|454621632|FG000|Overall Study|Other than specified|56|||
126362853|NCT01687595|454621633|FG001|Overall Study|Other than specified|7|||
126362854|NCT00489359|454621636|FG000|Overall Study|Death|0|||
126362855|NCT00489359|454621637|FG001|Overall Study|Death|2|||
126362856|NCT00489359|454621636|FG000|Overall Study|Progressive Disease|5|||
126706465|NCT03126227|455877308|FG000|Overall Study|Scheduling conflict|1|||
126276812|NCT02704403|454303770|FG001|Overall Study|Administrative reasons by sponsor|616|||
126276813|NCT02704403|454303769|FG000|Overall Study|Death|4|||
126276814|NCT02704403|454303770|FG001|Overall Study|Death|3|||
126276815|NCT02704403|454303769|FG000|Overall Study|Endpoint event|52|||
126276816|NCT02704403|454303770|FG001|Overall Study|Endpoint event|24|||
126276817|NCT02704403|454303769|FG000|Overall Study|Lost to Follow-up|22|||
126276818|NCT02704403|454303770|FG001|Overall Study|Lost to Follow-up|11|||
126276819|NCT02704403|454303769|FG000|Overall Study|Protocol Violation|15|||
126276820|NCT02704403|454303770|FG001|Overall Study|Protocol Violation|15|||
126276821|NCT02704403|454303769|FG000|Overall Study|Adverse Event|2|||
126362857|NCT00489359|454621637|FG001|Overall Study|Progressive Disease|6|||
126362858|NCT00489359|454621636|FG000|Overall Study|Lost to Follow-up|1|||
126362859|NCT00489359|454621637|FG001|Overall Study|Lost to Follow-up|0|||
126362860|NCT00489359|454621636|FG000|Overall Study|Withdrawal by Subject|1|||
126706466|NCT03126227|455877309|FG001|Overall Study|Scheduling conflict|0|||
126706467|NCT00900796|455877314|FG000|Phase 1|Lacked sufficient information|4|||
126706468|NCT00900796|455877314|FG000|Phase 1|Missing information at Week 16|7|||
126706469|NCT00900796|455877314|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
126706470|NCT00900796|455877314|FG000|Phase 2|Lost to Follow-up|5|||
126706471|NCT01859403|455877315|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
126706472|NCT01859403|455877316|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
126276822|NCT02704403|454303770|FG001|Overall Study|Adverse Event|0|||
126276823|NCT02704403|454303769|FG000|Overall Study|Withdrawal by Subject|85|||
126276824|NCT02704403|454303770|FG001|Overall Study|Withdrawal by Subject|45|||
126276825|NCT02704403|454303769|FG000|Overall Study|Investigator decision|1|||
126276826|NCT02704403|454303770|FG001|Overall Study|Investigator decision|1|||
126276827|NCT02704403|454303769|FG000|Overall Study|Follow-up not possible|1|||
126276828|NCT02704403|454303770|FG001|Overall Study|Follow-up not possible|2|||
126276829|NCT00851318|454303771|FG000|Overall Study|Withdrawal by Subject|7|||
126276830|NCT00851318|454303772|FG001|Overall Study|Withdrawal by Subject|1|||
126276831|NCT00851318|454303773|FG002|Overall Study|Withdrawal by Subject|5|||
126276832|NCT00851318|454303774|FG003|Overall Study|Withdrawal by Subject|3|||
126276833|NCT00851318|454303771|FG000|Overall Study|Adverse Event|13|||
126276834|NCT00851318|454303772|FG001|Overall Study|Adverse Event|2|||
126276835|NCT00851318|454303773|FG002|Overall Study|Adverse Event|9|||
126276836|NCT00851318|454303774|FG003|Overall Study|Adverse Event|12|||
126276837|NCT00851318|454303771|FG000|Overall Study|Pregnancy|0|||
126276838|NCT00851318|454303772|FG001|Overall Study|Pregnancy|0|||
126276839|NCT00851318|454303773|FG002|Overall Study|Pregnancy|1|||
126276840|NCT00851318|454303774|FG003|Overall Study|Pregnancy|1|||
126276841|NCT00851318|454303771|FG000|Overall Study|Lack of Efficacy|8|||
126276842|NCT00851318|454303772|FG001|Overall Study|Lack of Efficacy|2|||
126276843|NCT00851318|454303773|FG002|Overall Study|Lack of Efficacy|4|||
126276844|NCT00851318|454303774|FG003|Overall Study|Lack of Efficacy|2|||
126276845|NCT00851318|454303771|FG000|Overall Study|Non-compliance with Study Procedures|2|||
126276846|NCT00851318|454303772|FG001|Overall Study|Non-compliance with Study Procedures|0|||
126276847|NCT00851318|454303773|FG002|Overall Study|Non-compliance with Study Procedures|1|||
126276848|NCT00851318|454303774|FG003|Overall Study|Non-compliance with Study Procedures|0|||
126276849|NCT00851318|454303771|FG000|Overall Study|Physician Decision|0|||
126276850|NCT00851318|454303772|FG001|Overall Study|Physician Decision|0|||
126276851|NCT00851318|454303773|FG002|Overall Study|Physician Decision|1|||
126276852|NCT00851318|454303774|FG003|Overall Study|Physician Decision|1|||
126276853|NCT01844856|454303781|FG000|Overall Study|Lost to Follow-up|15|||
126276854|NCT01844856|454303782|FG001|Overall Study|Lost to Follow-up|3|||
126276855|NCT01844856|454303781|FG000|Overall Study|Adverse Event|3|||
126276856|NCT01844856|454303782|FG001|Overall Study|Adverse Event|6|||
126276857|NCT01844856|454303781|FG000|Overall Study|Withdrawal by Subject|3|||
126276858|NCT01844856|454303782|FG001|Overall Study|Withdrawal by Subject|2|||
126276859|NCT01844856|454303781|FG000|Overall Study|Noncompliance|2|||
126276860|NCT01844856|454303782|FG001|Overall Study|Noncompliance|3|||
126276861|NCT01844856|454303781|FG000|Overall Study|Enterococcus Resistant|0|||
126276862|NCT01844856|454303782|FG001|Overall Study|Enterococcus Resistant|1|||
126276863|NCT01844856|454303781|FG000|Overall Study|Inadvertently Not Scheduled|1|||
126276864|NCT01844856|454303782|FG001|Overall Study|Inadvertently Not Scheduled|0|||
126276865|NCT01844856|454303781|FG000|Overall Study|Randomized but was a Screen Failure|0|||
126276866|NCT01844856|454303782|FG001|Overall Study|Randomized but was a Screen Failure|1|||
126454517|NCT04525885|454963207|FG000|Overall Study|Withdrawal by Subject|14|||
126454518|NCT04525885|454963208|FG001|Overall Study|Withdrawal by Subject|6|||
126454519|NCT04525885|454963209|FG002|Overall Study|Withdrawal by Subject|20|||
126454520|NCT04525885|454963207|FG000|Overall Study|Physician Decision|1|||
126454521|NCT04525885|454963208|FG001|Overall Study|Physician Decision|0|||
126454522|NCT04525885|454963209|FG002|Overall Study|Physician Decision|1|||
126454523|NCT00781885|454963217|FG000|Overall Study|Physician Decision|1|||
126454524|NCT01755026|454963218|FG000|Overall Study|Adverse Event|1|||
126454525|NCT01755026|454963219|FG001|Overall Study|Adverse Event|0|||
126454526|NCT01755026|454963218|FG000|Overall Study|Withdrawal by Subject|1|||
126276867|NCT01442688|454303783|FG000|First Intervention|Withdrawal by Subject|1|||
126276868|NCT01442688|454303784|FG001|First Intervention|Withdrawal by Subject|0|||
126454527|NCT01755026|454963219|FG001|Overall Study|Withdrawal by Subject|1|||
126454528|NCT03678870|454963220|FG000|Overall Study|prescribed non- protocol medications|10|||
126454529|NCT03678870|454963221|FG001|Overall Study|prescribed non- protocol medications|6|||
126276869|NCT01442688|454303783|FG000|First Intervention|subject incarcerated|1|||
126276870|NCT01442688|454303784|FG001|First Intervention|subject incarcerated|0|||
126454530|NCT03678870|454963220|FG000|Overall Study|Lost to Follow-up|3|||
126454531|NCT03678870|454963221|FG001|Overall Study|Lost to Follow-up|2|||
126276871|NCT01442688|454303783|FG000|Second Intervention|Adverse Event|1|||
126276872|NCT01442688|454303784|FG001|Second Intervention|Adverse Event|0|||
126276873|NCT01329549|454303791|FG000|Overall Study|Withdrawal by Subject|1|||
126276874|NCT01329549|454303791|FG000|Overall Study|Adverse Event|1|||
126276875|NCT01755767|454303792|FG000|Overall Study|Progressive Disease|8|||
126276876|NCT01755767|454303793|FG001|Overall Study|Progressive Disease|7|||
126706473|NCT01859403|455877315|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
126276877|NCT01755767|454303794|FG002|Overall Study|Progressive Disease|91|||
126276878|NCT01755767|454303795|FG003|Overall Study|Progressive Disease|43|||
126276879|NCT01755767|454303792|FG000|Overall Study|Clinical Disease Progression|4|||
126276880|NCT01755767|454303793|FG001|Overall Study|Clinical Disease Progression|2|||
126276881|NCT01755767|454303794|FG002|Overall Study|Clinical Disease Progression|29|||
126276882|NCT01755767|454303795|FG003|Overall Study|Clinical Disease Progression|20|||
126276883|NCT01755767|454303792|FG000|Overall Study|Radiographic Disease Progression|9|||
126276884|NCT01755767|454303793|FG001|Overall Study|Radiographic Disease Progression|4|||
126276885|NCT01755767|454303794|FG002|Overall Study|Radiographic Disease Progression|44|||
126276886|NCT01755767|454303795|FG003|Overall Study|Radiographic Disease Progression|27|||
126276887|NCT01755767|454303792|FG000|Overall Study|Adverse Event|6|||
126276888|NCT01755767|454303793|FG001|Overall Study|Adverse Event|0|||
126276889|NCT01755767|454303794|FG002|Overall Study|Adverse Event|28|||
126276890|NCT01755767|454303795|FG003|Overall Study|Adverse Event|11|||
126276891|NCT01755767|454303792|FG000|Overall Study|Death|1|||
126276892|NCT01755767|454303793|FG001|Overall Study|Death|2|||
126276893|NCT01755767|454303794|FG002|Overall Study|Death|15|||
126276894|NCT01755767|454303795|FG003|Overall Study|Death|4|||
126276895|NCT01755767|454303792|FG000|Overall Study|Subject Decision|0|||
126276896|NCT01755767|454303793|FG001|Overall Study|Subject Decision|0|||
126276897|NCT01755767|454303794|FG002|Overall Study|Subject Decision|10|||
126276898|NCT01755767|454303795|FG003|Overall Study|Subject Decision|3|||
126276899|NCT01755767|454303792|FG000|Overall Study|Withdrawal by Subject|0|||
126276900|NCT01755767|454303793|FG001|Overall Study|Withdrawal by Subject|0|||
126276901|NCT01755767|454303794|FG002|Overall Study|Withdrawal by Subject|2|||
126276902|NCT01755767|454303795|FG003|Overall Study|Withdrawal by Subject|1|||
126276903|NCT01755767|454303792|FG000|Overall Study|Other|0|||
126276904|NCT01755767|454303793|FG001|Overall Study|Other|0|||
126276905|NCT01755767|454303794|FG002|Overall Study|Other|2|||
126362861|NCT00489359|454621637|FG001|Overall Study|Withdrawal by Subject|5|||
126547756|NCT02569710|455298060|FG009|Overall Study|Adverse Event|0|||
126547757|NCT02569710|455298051|FG000|Overall Study|Lost to Follow-up|0|||
126547758|NCT02569710|455298052|FG001|Overall Study|Lost to Follow-up|0|||
126547759|NCT02569710|455298053|FG002|Overall Study|Lost to Follow-up|0|||
126547760|NCT02569710|455298054|FG003|Overall Study|Lost to Follow-up|0|||
126547761|NCT02569710|455298055|FG004|Overall Study|Lost to Follow-up|0|||
126547762|NCT02569710|455298056|FG005|Overall Study|Lost to Follow-up|0|||
126547763|NCT02569710|455298057|FG006|Overall Study|Lost to Follow-up|1|||
126547764|NCT02569710|455298058|FG007|Overall Study|Lost to Follow-up|0|||
126547765|NCT02569710|455298059|FG008|Overall Study|Lost to Follow-up|1|||
126547766|NCT02569710|455298060|FG009|Overall Study|Lost to Follow-up|0|||
126547767|NCT02569710|455298051|FG000|Overall Study|Virologic failure|0|||
126547768|NCT02569710|455298052|FG001|Overall Study|Virologic failure|0|||
126547769|NCT02569710|455298053|FG002|Overall Study|Virologic failure|0|||
126547770|NCT02569710|455298054|FG003|Overall Study|Virologic failure|0|||
126547771|NCT02569710|455298055|FG004|Overall Study|Virologic failure|1|||
126547772|NCT02569710|455298056|FG005|Overall Study|Virologic failure|0|||
126547773|NCT02569710|455298057|FG006|Overall Study|Virologic failure|1|||
126547774|NCT02569710|455298058|FG007|Overall Study|Virologic failure|0|||
126547775|NCT02569710|455298059|FG008|Overall Study|Virologic failure|0|||
126547776|NCT02569710|455298060|FG009|Overall Study|Virologic failure|0|||
126547777|NCT02569710|455298051|FG000|Overall Study|Withdrawal by Subject|0|||
126547778|NCT02569710|455298052|FG001|Overall Study|Withdrawal by Subject|0|||
126547779|NCT02569710|455298053|FG002|Overall Study|Withdrawal by Subject|0|||
126547780|NCT02569710|455298054|FG003|Overall Study|Withdrawal by Subject|0|||
126547781|NCT02569710|455298055|FG004|Overall Study|Withdrawal by Subject|0|||
126547782|NCT02569710|455298056|FG005|Overall Study|Withdrawal by Subject|1|||
126547783|NCT02569710|455298057|FG006|Overall Study|Withdrawal by Subject|0|||
126547784|NCT02569710|455298058|FG007|Overall Study|Withdrawal by Subject|0|||
126706474|NCT01859403|455877316|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
126706475|NCT01859403|455877315|FG000|Primary Endpoint Measure|Physician Decision|0|||
126706476|NCT01859403|455877316|FG001|Primary Endpoint Measure|Physician Decision|1|||
126276906|NCT01755767|454303795|FG003|Overall Study|Other|3|||
126276907|NCT01755767|454303792|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
126276908|NCT01755767|454303793|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
126276909|NCT01755767|454303794|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
126362862|NCT00489359|454621636|FG000|Overall Study|Adverse Event|0|||
126547785|NCT02569710|455298059|FG008|Overall Study|Withdrawal by Subject|0|||
126547786|NCT02569710|455298060|FG009|Overall Study|Withdrawal by Subject|0|||
126547787|NCT04152343|455298061|FG000|Overall Study|Transplanted|5|||
126547788|NCT04152343|455298061|FG000|Overall Study|Death|20|||
126276910|NCT01755767|454303795|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
126276911|NCT00191165|454303796|FG000|Overall Study|Adverse Event|2|||
126276912|NCT00191165|454303797|FG001|Overall Study|Adverse Event|0|||
126547789|NCT04152343|455298061|FG000|Overall Study|Lost to Follow-up|3|||
126547790|NCT00550550|455298062|FG000|Overall Study|Adverse Event|13|||
126547791|NCT00550550|455298063|FG001|Overall Study|Adverse Event|5|||
126547792|NCT00550550|455298062|FG000|Overall Study|Treatment Failure|0|||
126706477|NCT01859403|455877315|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
126706478|NCT01859403|455877316|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
126706479|NCT00892437|455877322|FG000|Randomized Phase|Randomized but not treated|6|||
126706480|NCT00892437|455877323|FG001|Randomized Phase|Randomized but not treated|0|||
126706481|NCT00892437|455877322|FG000|Randomized Phase|Adverse Event|2|||
126706482|NCT00892437|455877323|FG001|Randomized Phase|Adverse Event|2|||
126706483|NCT00892437|455877322|FG000|Randomized Phase|Lost to Follow-up|1|||
126706484|NCT00892437|455877323|FG001|Randomized Phase|Lost to Follow-up|3|||
126706485|NCT00892437|455877322|FG000|Randomized Phase|Investigator's Discretion|1|||
126706486|NCT00892437|455877323|FG001|Randomized Phase|Investigator's Discretion|0|||
126276913|NCT00191165|454303796|FG000|Overall Study|Protocol Violation|0|||
126276914|NCT00191165|454303797|FG001|Overall Study|Protocol Violation|1|||
126276915|NCT00191165|454303796|FG000|Overall Study|Participant Moved Away|0|||
126276916|NCT00191165|454303797|FG001|Overall Study|Participant Moved Away|1|||
126276917|NCT00998309|454303802|FG000|Overall Study|Protocol Violation|4|||
126276918|NCT02865460|454303803|FG000|Overall Study|Adverse Event|1|||
126276919|NCT02865460|454303804|FG001|Overall Study|Adverse Event|0|||
126276920|NCT02865460|454303803|FG000|Overall Study|Withdrawal by Subject|1|||
126276921|NCT02865460|454303804|FG001|Overall Study|Withdrawal by Subject|1|||
126276922|NCT02865460|454303803|FG000|Overall Study|Lost to Follow-up|7|||
126276923|NCT02865460|454303804|FG001|Overall Study|Lost to Follow-up|4|||
126276924|NCT02865460|454303803|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
126276925|NCT02865460|454303804|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
126276926|NCT01292226|454303820|FG000|Overall Study|Adverse Event|5|||
126276927|NCT01292226|454303820|FG000|Overall Study|Death|1|||
126276928|NCT01292226|454303820|FG000|Overall Study|Graft loss|1|||
126276929|NCT01292226|454303820|FG000|Overall Study|Protocol Violation|3|||
126276930|NCT01292226|454303820|FG000|Overall Study|Withdrawal by Subject|1|||
126276931|NCT01292226|454303820|FG000|Overall Study|Other|2|||
126276932|NCT01844505|454303821|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
126276933|NCT01844505|454303822|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
126276934|NCT01844505|454303823|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
126276935|NCT01844505|454303821|FG000|Treatment Period|Other Reasons|120|||
126276936|NCT01844505|454303822|FG001|Treatment Period|Other Reasons|136|||
126276937|NCT01844505|454303823|FG002|Treatment Period|Other Reasons|58|||
126276938|NCT01844505|454303821|FG000|Treatment Period|Lost to Follow-up|9|||
126276939|NCT01844505|454303822|FG001|Treatment Period|Lost to Follow-up|11|||
126276940|NCT01844505|454303823|FG002|Treatment Period|Lost to Follow-up|6|||
126276941|NCT01844505|454303821|FG000|Treatment Period|Death|175|||
126276942|NCT01844505|454303822|FG001|Treatment Period|Death|154|||
126276943|NCT01844505|454303823|FG002|Treatment Period|Death|228|||
126276944|NCT03918109|454303832|FG000|Overall Study|Withdrawal by Subject|0|||
126276945|NCT03918109|454303833|FG001|Overall Study|Withdrawal by Subject|0|||
126276946|NCT03918109|454303834|FG002|Overall Study|Withdrawal by Subject|2|||
126276947|NCT03918109|454303835|FG003|Overall Study|Withdrawal by Subject|1|||
126276948|NCT03918109|454303832|FG000|Overall Study|Lost to Follow-up|0|||
126276949|NCT03918109|454303833|FG001|Overall Study|Lost to Follow-up|0|||
126276950|NCT03918109|454303834|FG002|Overall Study|Lost to Follow-up|0|||
126276951|NCT03918109|454303835|FG003|Overall Study|Lost to Follow-up|1|||
126276952|NCT00861198|454303836|FG000|Overall Study|SpyGlass Failed|5|||
126276953|NCT00499174|454303839|FG000|Overall Study|Physician Decision|78|||
126276954|NCT00499174|454303840|FG001|Overall Study|Physician Decision|9|||
126276955|NCT02269163|454303841|FG000|Overall Study|Lost to Follow-up|1|||
126276956|NCT02269163|454303842|FG001|Overall Study|Lost to Follow-up|0|||
126276957|NCT02269163|454303841|FG000|Overall Study|Major protocol violation|0|||
126276958|NCT02269163|454303842|FG001|Overall Study|Major protocol violation|1|||
126276959|NCT02269163|454303841|FG000|Overall Study|Other|2|||
126276960|NCT02269163|454303842|FG001|Overall Study|Other|2|||
126276961|NCT02269163|454303841|FG000|Overall Study|Withdrawal by Subject|0|||
126276962|NCT02269163|454303842|FG001|Overall Study|Withdrawal by Subject|3|||
126276963|NCT02269163|454303841|FG000|Overall Study|Physician Decision|0|||
126276964|NCT02269163|454303842|FG001|Overall Study|Physician Decision|1|||
126276965|NCT01177059|454303848|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
126276966|NCT01177059|454303848|FG000|Overall Study|Withdrew consent|2|||
126276967|NCT01177059|454303848|FG000|Overall Study|Lost to Follow-up|18|||
126276968|NCT03395405|454305531|FG000|Overall Study|Death|0|||
126276969|NCT03395405|454305532|FG001|Overall Study|Death|2|||
126276970|NCT03395405|454305531|FG000|Overall Study|Lost to Follow-up|0|||
126276971|NCT03395405|454305532|FG001|Overall Study|Lost to Follow-up|1|||
126276972|NCT03395405|454305531|FG000|Overall Study|Protocol Violation|0|||
126276973|NCT03395405|454305532|FG001|Overall Study|Protocol Violation|1|||
126276974|NCT03395405|454305531|FG000|Overall Study|Withdrawal by Subject|3|||
126454532|NCT03104816|454963223|FG000|Overall Study|Lack of Efficacy|0|||
126276975|NCT03395405|454305532|FG001|Overall Study|Withdrawal by Subject|1|||
126276976|NCT03395405|454305531|FG000|Overall Study|COVID-19 Pandemic|1|||
126276977|NCT03395405|454305532|FG001|Overall Study|COVID-19 Pandemic|0|||
126276978|NCT00461253|454305533|FG000|Overall Study|Death|985|||
126706487|NCT00892437|455877322|FG000|Randomized Phase|Withdrew Consent|1|||
126276979|NCT00461253|454305534|FG001|Overall Study|Death|0|||
126276980|NCT00461253|454305533|FG000|Overall Study|Protocol Violation|613|||
126276981|NCT00461253|454305534|FG001|Overall Study|Protocol Violation|236|||
126276982|NCT00461253|454305533|FG000|Overall Study|no response|2609|||
126276983|NCT00461253|454305534|FG001|Overall Study|no response|11789|||
126276984|NCT00461253|454305533|FG000|Overall Study|administrative|773|||
126276985|NCT00461253|454305534|FG001|Overall Study|administrative|7773|||
126276986|NCT04240392|454305535|FG000|Overall Study|Withdrawal by Subject|13|||
126276987|NCT04240392|454305536|FG001|Overall Study|Withdrawal by Subject|4|||
126276988|NCT04240392|454305535|FG000|Overall Study|Lost to Follow-up|11|||
126276989|NCT04240392|454305536|FG001|Overall Study|Lost to Follow-up|12|||
126276990|NCT01523457|454305537|FG000|Overall Study|Withdrawal by Subject|7|||
126276991|NCT01523457|454305538|FG001|Overall Study|Withdrawal by Subject|2|||
126276992|NCT03047330|454305541|FG000|Sleep Block 1|Withdrawal by Subject|3|||
126276993|NCT02886624|454305543|FG000|12-week Post Treatment Follow-up|Death|1|||
126276994|NCT02886624|454305543|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
126276995|NCT00540293|454305548|FG000|Overall Study|Adverse event related to study drug|10|||
126276996|NCT00540293|454305548|FG000|Overall Study|Adverse event not related to study drug|7|||
126276997|NCT00540293|454305548|FG000|Overall Study|Withdrawal by Subject|6|||
126276998|NCT00540293|454305548|FG000|Overall Study|Protocol violation, & subject schedule|12|||
126276999|NCT02585934|454305551|FG000|Overall Study|Lost to Follow-up|2|||
126277000|NCT02585934|454305552|FG001|Overall Study|Lost to Follow-up|2|||
126277001|NCT02585934|454305551|FG000|Overall Study|Protocol Violation|14|||
126277002|NCT02585934|454305552|FG001|Overall Study|Protocol Violation|11|||
126277003|NCT02585934|454305551|FG000|Overall Study|Adverse Event|21|||
126277004|NCT02585934|454305552|FG001|Overall Study|Adverse Event|22|||
126277005|NCT02585934|454305551|FG000|Overall Study|Physician Decision|3|||
126277006|NCT02585934|454305552|FG001|Overall Study|Physician Decision|2|||
126277007|NCT02585934|454305551|FG000|Overall Study|Withdrawal by Subject|7|||
126277008|NCT02585934|454305552|FG001|Overall Study|Withdrawal by Subject|21|||
126277009|NCT02585934|454305551|FG000|Overall Study|Lack of Efficacy|2|||
126277010|NCT02585934|454305552|FG001|Overall Study|Lack of Efficacy|1|||
126277011|NCT02585934|454305551|FG000|Overall Study|Death|2|||
126277012|NCT02585934|454305552|FG001|Overall Study|Death|0|||
126277013|NCT02585934|454305551|FG000|Overall Study|Caregiver Withdrew Consent|7|||
126277014|NCT02585934|454305552|FG001|Overall Study|Caregiver Withdrew Consent|7|||
126277015|NCT02585934|454305551|FG000|Overall Study|Sponsor Termination|1|||
126277016|NCT02585934|454305552|FG001|Overall Study|Sponsor Termination|2|||
126277017|NCT02585934|454305551|FG000|Overall Study|Another Reason|10|||
126277018|NCT02585934|454305552|FG001|Overall Study|Another Reason|5|||
126277019|NCT02448706|454305553|FG000|Overall Study|Withdrawal by Subject|4|||
126277020|NCT02448706|454305554|FG001|Overall Study|Withdrawal by Subject|3|||
126277021|NCT02448706|454305553|FG000|Overall Study|Protocol Violation|1|||
126277022|NCT02448706|454305554|FG001|Overall Study|Protocol Violation|1|||
126277023|NCT03972163|454305561|FG000|Overall Study|Death|0|||
126277024|NCT03972163|454305562|FG001|Overall Study|Death|1|||
126277025|NCT03400943|454305565|FG000|Treatment Period 1|Adverse Event|0|||
126277026|NCT03400943|454305566|FG001|Treatment Period 1|Adverse Event|0|||
126277027|NCT03400943|454305567|FG002|Treatment Period 1|Adverse Event|0|||
126454533|NCT03104816|454963224|FG001|Overall Study|Lack of Efficacy|2|||
126454534|NCT03104816|454963225|FG002|Overall Study|Lack of Efficacy|0|||
126454535|NCT03104816|454963223|FG000|Overall Study|Protocol Violation|2|||
126454536|NCT03104816|454963224|FG001|Overall Study|Protocol Violation|0|||
126454537|NCT03104816|454963225|FG002|Overall Study|Protocol Violation|2|||
126454538|NCT01159431|454963227|FG000|Overall Study|Adverse Event|1|||
126454539|NCT01159431|454963228|FG001|Overall Study|Adverse Event|2|||
126454540|NCT01159431|454963227|FG000|Overall Study|non-compliance|1|||
126454541|NCT01159431|454963228|FG001|Overall Study|non-compliance|1|||
126454542|NCT01159431|454963227|FG000|Overall Study|Lack of Efficacy|0|||
126454543|NCT01159431|454963228|FG001|Overall Study|Lack of Efficacy|3|||
126454544|NCT01227629|454963229|FG000|Overall Study|Adverse Event|2|||
126454545|NCT01227629|454963230|FG001|Overall Study|Adverse Event|2|||
126454546|NCT01227629|454963231|FG002|Overall Study|Adverse Event|1|||
126547793|NCT00550550|455298063|FG001|Overall Study|Treatment Failure|1|||
126277028|NCT03400943|454305568|FG003|Treatment Period 1|Adverse Event|1|||
126547794|NCT00550550|455298062|FG000|Overall Study|Lost to Follow-up|4|||
126277029|NCT03400943|454305565|FG000|Treatment Period 1|Lost to Follow-up|1|||
126454547|NCT01227629|454963232|FG003|Overall Study|Adverse Event|6|||
126454548|NCT01227629|454963233|FG004|Overall Study|Adverse Event|1|||
126454549|NCT01227629|454963234|FG005|Overall Study|Adverse Event|1|||
126765706|NCT02074982|456095786|FG000|Overall Study|Lost to Follow-up|9|||
126277030|NCT03400943|454305566|FG001|Treatment Period 1|Lost to Follow-up|0|||
126277031|NCT03400943|454305567|FG002|Treatment Period 1|Lost to Follow-up|0|||
126277032|NCT03400943|454305568|FG003|Treatment Period 1|Lost to Follow-up|0|||
126277033|NCT03400943|454305565|FG000|Treatment Period 1|Protocol Violation|0|||
126277034|NCT03400943|454305566|FG001|Treatment Period 1|Protocol Violation|1|||
126277035|NCT03400943|454305567|FG002|Treatment Period 1|Protocol Violation|1|||
126454550|NCT01227629|454963235|FG006|Overall Study|Adverse Event|6|||
126454551|NCT01227629|454963236|FG007|Overall Study|Adverse Event|6|||
126706488|NCT00892437|455877323|FG001|Randomized Phase|Withdrew Consent|0|||
126277036|NCT03400943|454305568|FG003|Treatment Period 1|Protocol Violation|0|||
126277037|NCT03400943|454305565|FG000|Treatment Period 1|Study terminated by sponsor|2|||
126277038|NCT03400943|454305566|FG001|Treatment Period 1|Study terminated by sponsor|0|||
126277039|NCT03400943|454305567|FG002|Treatment Period 1|Study terminated by sponsor|0|||
126277040|NCT03400943|454305568|FG003|Treatment Period 1|Study terminated by sponsor|1|||
126277041|NCT03400943|454305565|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126277042|NCT03400943|454305566|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126277043|NCT03400943|454305567|FG002|Treatment Period 1|Withdrawal by Subject|3|||
126277044|NCT03400943|454305568|FG003|Treatment Period 1|Withdrawal by Subject|1|||
126277045|NCT03400943|454305565|FG000|Treatment Period 1|Other|2|||
126277046|NCT03400943|454305566|FG001|Treatment Period 1|Other|1|||
126277047|NCT03400943|454305567|FG002|Treatment Period 1|Other|2|||
126277048|NCT03400943|454305568|FG003|Treatment Period 1|Other|2|||
126277049|NCT03400943|454305565|FG000|Post-treatment Period 1|Adverse Event|2|||
126277050|NCT03400943|454305566|FG001|Post-treatment Period 1|Adverse Event|0|||
126277051|NCT03400943|454305567|FG002|Post-treatment Period 1|Adverse Event|0|||
126277052|NCT03400943|454305568|FG003|Post-treatment Period 1|Adverse Event|0|||
126277053|NCT03400943|454305565|FG000|Post-treatment Period 1|Protocol Violation|1|||
126277054|NCT03400943|454305566|FG001|Post-treatment Period 1|Protocol Violation|0|||
126277055|NCT03400943|454305567|FG002|Post-treatment Period 1|Protocol Violation|0|||
126277056|NCT03400943|454305568|FG003|Post-treatment Period 1|Protocol Violation|0|||
126277057|NCT03400943|454305565|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
126277058|NCT03400943|454305566|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
126277059|NCT03400943|454305567|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
126277060|NCT03400943|454305568|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
126277061|NCT03400943|454305565|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
126277062|NCT03400943|454305566|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
126277063|NCT03400943|454305567|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
126277064|NCT03400943|454305568|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
126277065|NCT03400943|454305565|FG000|Post-treatment Period 1|Other|2|||
126277066|NCT03400943|454305566|FG001|Post-treatment Period 1|Other|0|||
126277067|NCT03400943|454305567|FG002|Post-treatment Period 1|Other|4|||
126277068|NCT03400943|454305568|FG003|Post-treatment Period 1|Other|5|||
126277069|NCT03400943|454305565|FG000|Treatment Period 2|Study terminated by sponsor|0|||
126277070|NCT03400943|454305566|FG001|Treatment Period 2|Study terminated by sponsor|1|||
126277071|NCT03400943|454305567|FG002|Treatment Period 2|Study terminated by sponsor|0|||
126277072|NCT03400943|454305568|FG003|Treatment Period 2|Study terminated by sponsor|0|||
126277073|NCT03400943|454305565|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126277074|NCT03400943|454305566|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126277075|NCT03400943|454305567|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126277076|NCT03400943|454305568|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126277077|NCT03400943|454305565|FG000|Treatment Period 2|Other|1|||
126277078|NCT03400943|454305566|FG001|Treatment Period 2|Other|6|||
126277079|NCT03400943|454305567|FG002|Treatment Period 2|Other|0|||
126277080|NCT03400943|454305568|FG003|Treatment Period 2|Other|0|||
126277081|NCT03400943|454305565|FG000|Follow-up Period|Withdrawal by Subject|1|||
126277082|NCT03400943|454305566|FG001|Follow-up Period|Withdrawal by Subject|0|||
126277083|NCT03400943|454305567|FG002|Follow-up Period|Withdrawal by Subject|0|||
126277084|NCT03400943|454305568|FG003|Follow-up Period|Withdrawal by Subject|0|||
126277085|NCT02563106|454305569|FG000|Overall Study|Withdrawal by Subject|7|||
126454552|NCT01227629|454963237|FG008|Overall Study|Adverse Event|4|||
126454553|NCT01227629|454963238|FG009|Overall Study|Adverse Event|0|||
126454554|NCT01227629|454963229|FG000|Overall Study|Protocol Violation|0|||
126454555|NCT01227629|454963230|FG001|Overall Study|Protocol Violation|0|||
126454556|NCT01227629|454963231|FG002|Overall Study|Protocol Violation|0|||
126454557|NCT01227629|454963232|FG003|Overall Study|Protocol Violation|1|||
126706489|NCT00892437|455877322|FG000|Open-Label Extension Phase|Adverse Event|4|||
126706490|NCT00892437|455877323|FG001|Open-Label Extension Phase|Adverse Event|2|||
126277086|NCT02563106|454305570|FG001|Overall Study|Withdrawal by Subject|8|||
126277087|NCT02563106|454305569|FG000|Overall Study|Adverse Event|17|||
126277088|NCT02563106|454305570|FG001|Overall Study|Adverse Event|15|||
126454558|NCT01227629|454963233|FG004|Overall Study|Protocol Violation|0|||
126277089|NCT02563106|454305569|FG000|Overall Study|Protocol Violation|1|||
126277090|NCT02563106|454305570|FG001|Overall Study|Protocol Violation|0|||
126454559|NCT01227629|454963234|FG005|Overall Study|Protocol Violation|0|||
126454560|NCT01227629|454963235|FG006|Overall Study|Protocol Violation|0|||
126454561|NCT01227629|454963236|FG007|Overall Study|Protocol Violation|0|||
126547795|NCT00550550|455298063|FG001|Overall Study|Lost to Follow-up|0|||
126706491|NCT00892437|455877322|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
126277091|NCT02563106|454305569|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
126277092|NCT02563106|454305570|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
126277093|NCT02563106|454305569|FG000|Overall Study|Lost to Follow-up|3|||
126277094|NCT02563106|454305570|FG001|Overall Study|Lost to Follow-up|2|||
126454562|NCT01227629|454963237|FG008|Overall Study|Protocol Violation|0|||
126454563|NCT01227629|454963238|FG009|Overall Study|Protocol Violation|0|||
126706492|NCT00892437|455877323|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
126706493|NCT00892437|455877322|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
126706494|NCT00892437|455877323|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
126706495|NCT00892437|455877322|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
126706496|NCT00892437|455877323|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
126706497|NCT00892437|455877322|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
126706498|NCT00892437|455877323|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
126706499|NCT02750410|455877324|FG000|Double-Blind Treatment Period|Adverse Event|2|||
126277095|NCT02563106|454305569|FG000|Overall Study|Physician Decision|3|||
126277096|NCT02563106|454305570|FG001|Overall Study|Physician Decision|1|||
126277097|NCT02563106|454305569|FG000|Overall Study|Other reason - not specified|2|||
126277098|NCT02563106|454305570|FG001|Overall Study|Other reason - not specified|1|||
126277099|NCT04729309|454305571|FG000|Period 1|Subject unable to return for Period 2|3|||
126277100|NCT04729309|454305572|FG001|Period 1|Subject unable to return for Period 2|0|||
126277101|NCT04729309|454305571|FG000|Period 1|Lost to Follow-up|1|||
126277102|NCT04729309|454305572|FG001|Period 1|Lost to Follow-up|0|||
126277103|NCT01059539|454305573|FG000|Overall Study|Adverse Event|66|||
126277104|NCT01059539|454305573|FG000|Overall Study|Insufficient Therapeutic Response|26|||
126277105|NCT01059539|454305573|FG000|Overall Study|Protocol Violation|55|||
126277106|NCT01059539|454305573|FG000|Overall Study|Withdrawal of Consent|80|||
126277107|NCT01059539|454305573|FG000|Overall Study|Lost to Follow-up|42|||
126277108|NCT01059539|454305573|FG000|Overall Study|Reason Not Specified|2|||
126277109|NCT00537303|454305574|FG000|Overall Study|Adverse Event|1|||
126277110|NCT00537303|454305575|FG001|Overall Study|Adverse Event|4|||
126277111|NCT00537303|454305574|FG000|Overall Study|Lack of Efficacy|6|||
126277112|NCT00537303|454305575|FG001|Overall Study|Lack of Efficacy|7|||
126277113|NCT00537303|454305574|FG000|Overall Study|Protocol Violation|8|||
126277114|NCT00537303|454305575|FG001|Overall Study|Protocol Violation|4|||
126277115|NCT00537303|454305574|FG000|Overall Study|Withdrawal criteria|3|||
126277116|NCT00537303|454305575|FG001|Overall Study|Withdrawal criteria|3|||
126277117|NCT00537303|454305574|FG000|Overall Study|Unclassified|8|||
126277118|NCT00537303|454305575|FG001|Overall Study|Unclassified|7|||
126277119|NCT02085135|454305577|FG000|Overall Study|Adverse Event|4|||
126277120|NCT02085135|454305578|FG001|Overall Study|Adverse Event|7|||
126277121|NCT02085135|454305577|FG000|Overall Study|Lost to Follow-up|2|||
126277122|NCT02085135|454305578|FG001|Overall Study|Lost to Follow-up|2|||
126277123|NCT02085135|454305577|FG000|Overall Study|Withdrawal by Subject|3|||
126277124|NCT02085135|454305578|FG001|Overall Study|Withdrawal by Subject|0|||
126277125|NCT02085135|454305577|FG000|Overall Study|Lack of Efficacy|2|||
126277126|NCT02085135|454305578|FG001|Overall Study|Lack of Efficacy|0|||
126277127|NCT01777620|454305584|FG000|Overall Study|Subject Withdrawal|1|||
126277128|NCT01777620|454305585|FG001|Overall Study|Subject Withdrawal|0|||
126277129|NCT04005352|454305586|FG000|Overall Study|Adverse Event|4|||
126277130|NCT04005352|454305587|FG001|Overall Study|Adverse Event|5|||
126454564|NCT01227629|454963229|FG000|Overall Study|Lost to Follow-up|0|||
126454565|NCT01227629|454963230|FG001|Overall Study|Lost to Follow-up|0|||
126454566|NCT01227629|454963231|FG002|Overall Study|Lost to Follow-up|0|||
126454567|NCT01227629|454963232|FG003|Overall Study|Lost to Follow-up|0|||
126454568|NCT01227629|454963233|FG004|Overall Study|Lost to Follow-up|1|||
126454569|NCT01227629|454963234|FG005|Overall Study|Lost to Follow-up|0|||
126454570|NCT01227629|454963235|FG006|Overall Study|Lost to Follow-up|0|||
126454571|NCT01227629|454963236|FG007|Overall Study|Lost to Follow-up|0|||
126454572|NCT01227629|454963237|FG008|Overall Study|Lost to Follow-up|0|||
126454573|NCT01227629|454963238|FG009|Overall Study|Lost to Follow-up|0|||
126454574|NCT01227629|454963229|FG000|Overall Study|Withdrawal by Subject|0|||
126454575|NCT01227629|454963230|FG001|Overall Study|Withdrawal by Subject|0|||
126454576|NCT01227629|454963231|FG002|Overall Study|Withdrawal by Subject|0|||
126454577|NCT01227629|454963232|FG003|Overall Study|Withdrawal by Subject|0|||
126454578|NCT01227629|454963233|FG004|Overall Study|Withdrawal by Subject|0|||
126454579|NCT01227629|454963234|FG005|Overall Study|Withdrawal by Subject|0|||
126454580|NCT01227629|454963235|FG006|Overall Study|Withdrawal by Subject|2|||
126454581|NCT01227629|454963236|FG007|Overall Study|Withdrawal by Subject|0|||
126454582|NCT01227629|454963237|FG008|Overall Study|Withdrawal by Subject|0|||
126454583|NCT01227629|454963238|FG009|Overall Study|Withdrawal by Subject|1|||
126454584|NCT01227629|454963229|FG000|Overall Study|Other|0|||
126454585|NCT01227629|454963230|FG001|Overall Study|Other|0|||
126706500|NCT02750410|455877325|FG001|Double-Blind Treatment Period|Adverse Event|2|||
126277131|NCT04005352|454305586|FG000|Overall Study|Death|4|||
126277132|NCT04005352|454305587|FG001|Overall Study|Death|2|||
126454586|NCT01227629|454963231|FG002|Overall Study|Other|0|||
126277133|NCT04005352|454305586|FG000|Overall Study|Lost to Follow-up|6|||
126277134|NCT04005352|454305587|FG001|Overall Study|Lost to Follow-up|2|||
126277135|NCT04005352|454305586|FG000|Overall Study|Physician Decision|7|||
126277136|NCT04005352|454305587|FG001|Overall Study|Physician Decision|13|||
126277137|NCT04005352|454305586|FG000|Overall Study|Protocol Violation|0|||
126277138|NCT04005352|454305587|FG001|Overall Study|Protocol Violation|1|||
126454587|NCT01227629|454963232|FG003|Overall Study|Other|1|||
126454588|NCT01227629|454963233|FG004|Overall Study|Other|0|||
126706501|NCT02750410|455877324|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126706502|NCT02750410|455877325|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126706503|NCT02750410|455877324|FG000|Open-Label Extension Period|Adverse Event|5|||
126706504|NCT02750410|455877325|FG001|Open-Label Extension Period|Adverse Event|3|||
126706505|NCT02750410|455877324|FG000|Open-Label Extension Period|Protocol Violation|0|||
126706506|NCT02750410|455877325|FG001|Open-Label Extension Period|Protocol Violation|1|||
126706507|NCT02750410|455877324|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
126706508|NCT02750410|455877325|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
126706509|NCT01531725|455877329|FG000|Overall Study|Protocol Violation|5|||
126706510|NCT03596164|455877331|FG000|Overall Study|Adverse Event|0|||
126706511|NCT03596164|455877332|FG001|Overall Study|Adverse Event|1|||
126706512|NCT03596164|455877331|FG000|Overall Study|Death|1|||
126706513|NCT03596164|455877332|FG001|Overall Study|Death|0|||
126706514|NCT04112914|455877333|FG000|Overall Study|Lost to Follow-up|13|||
126706515|NCT04112914|455877334|FG001|Overall Study|Lost to Follow-up|9|||
126706516|NCT04112914|455877333|FG000|Overall Study|Withdrawal by Subject|1|||
126706517|NCT04112914|455877334|FG001|Overall Study|Withdrawal by Subject|0|||
126706518|NCT03427073|455877335|FG000|Overall Study|Disease Progression|1|||
126706519|NCT03427073|455877336|FG001|Overall Study|Disease Progression|1|||
126706520|NCT03427073|455877337|FG002|Overall Study|Disease Progression|1|||
126706521|NCT03427073|455877338|FG003|Overall Study|Disease Progression|3|||
126706522|NCT03427073|455877339|FG004|Overall Study|Disease Progression|3|||
126706523|NCT03427073|455877340|FG005|Overall Study|Disease Progression|4|||
126706524|NCT03427073|455877341|FG006|Overall Study|Disease Progression|2|||
126706525|NCT03427073|455877342|FG007|Overall Study|Disease Progression|3|||
126706526|NCT03427073|455877335|FG000|Overall Study|Physician Decision|0|||
126706527|NCT03427073|455877336|FG001|Overall Study|Physician Decision|0|||
126706528|NCT03427073|455877337|FG002|Overall Study|Physician Decision|0|||
126706529|NCT03427073|455877338|FG003|Overall Study|Physician Decision|0|||
126706530|NCT03427073|455877339|FG004|Overall Study|Physician Decision|0|||
126706531|NCT03427073|455877340|FG005|Overall Study|Physician Decision|0|||
126706532|NCT03427073|455877341|FG006|Overall Study|Physician Decision|1|||
126706533|NCT03427073|455877342|FG007|Overall Study|Physician Decision|1|||
126706534|NCT02835495|455877347|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
126706535|NCT02835495|455877348|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
126706536|NCT02835495|455877347|FG000|Overall Study|Declined in-person follow-up visit|4|||
126706537|NCT02835495|455877348|FG001|Overall Study|Declined in-person follow-up visit|2|||
126706538|NCT05421754|455877349|FG000|Overall Study|Technical issue with sensor|1|||
126706539|NCT02580058|455877352|FG000|Overall Study|Adverse Event|16|||
126706540|NCT02580058|455877353|FG001|Overall Study|Adverse Event|30|||
126706541|NCT02580058|455877354|FG002|Overall Study|Adverse Event|20|||
126706542|NCT02580058|455877352|FG000|Overall Study|Death|4|||
126706543|NCT02580058|455877353|FG001|Overall Study|Death|4|||
126706544|NCT02580058|455877354|FG002|Overall Study|Death|5|||
126706545|NCT02580058|455877352|FG000|Overall Study|Physician Decision|1|||
126706546|NCT02580058|455877353|FG001|Overall Study|Physician Decision|3|||
126706547|NCT02580058|455877354|FG002|Overall Study|Physician Decision|11|||
126706548|NCT02580058|455877352|FG000|Overall Study|Other|5|||
126706549|NCT02580058|455877353|FG001|Overall Study|Other|1|||
126277139|NCT04005352|454305586|FG000|Overall Study|Withdrawal by Subject|28|||
126277140|NCT04005352|454305587|FG001|Overall Study|Withdrawal by Subject|38|||
126277141|NCT00936897|454305588|FG000|Overall Study|Withdrawal by Subject|9|||
126277142|NCT00936897|454305589|FG001|Overall Study|Withdrawal by Subject|19|||
126277143|NCT00936897|454305588|FG000|Overall Study|Adverse Event|4|||
126277144|NCT00936897|454305589|FG001|Overall Study|Adverse Event|13|||
126277145|NCT00936897|454305588|FG000|Overall Study|Other|3|||
126277146|NCT00936897|454305589|FG001|Overall Study|Other|9|||
126277147|NCT00936897|454305588|FG000|Overall Study|Lost to Follow-up|1|||
126277148|NCT00936897|454305589|FG001|Overall Study|Lost to Follow-up|10|||
126277149|NCT00936897|454305588|FG000|Overall Study|Administrative Decision|1|||
126277150|NCT00936897|454305589|FG001|Overall Study|Administrative Decision|2|||
126706550|NCT02580058|455877354|FG002|Overall Study|Other|3|||
126706551|NCT02580058|455877352|FG000|Overall Study|Withdrawal by Subject|4|||
126706552|NCT02580058|455877353|FG001|Overall Study|Withdrawal by Subject|7|||
126277151|NCT00936897|454305588|FG000|Overall Study|Protocol Violation|1|||
126706553|NCT02580058|455877354|FG002|Overall Study|Withdrawal by Subject|31|||
126706554|NCT02580058|455877352|FG000|Overall Study|Global Deterioration of Health Status|19|||
126706555|NCT02580058|455877353|FG001|Overall Study|Global Deterioration of Health Status|18|||
126277152|NCT00936897|454305589|FG001|Overall Study|Protocol Violation|1|||
126277153|NCT00936897|454305588|FG000|Overall Study|Ineligibility Determined|0|||
126706556|NCT02580058|455877354|FG002|Overall Study|Global Deterioration of Health Status|24|||
126706557|NCT02580058|455877352|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
126706558|NCT02580058|455877353|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126706559|NCT02580058|455877354|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
126706560|NCT02580058|455877352|FG000|Overall Study|Progressive Disease|137|||
126706561|NCT02580058|455877353|FG001|Overall Study|Progressive Disease|125|||
126706562|NCT02580058|455877354|FG002|Overall Study|Progressive Disease|94|||
126765707|NCT02074982|456095787|FG001|Overall Study|Lost to Follow-up|10|||
126706563|NCT02580058|455877352|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126706564|NCT02580058|455877353|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126277154|NCT00936897|454305589|FG001|Overall Study|Ineligibility Determined|3|||
126706565|NCT02580058|455877354|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126706566|NCT01193335|455877355|FG000|After Infant Series|Lost to Follow-up|1|||
126706567|NCT01193335|455877356|FG001|After Infant Series|Lost to Follow-up|2|||
126706568|NCT01193335|455877355|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
126706569|NCT01193335|455877356|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
126706570|NCT01193335|455877355|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
126706571|NCT01193335|455877356|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
126706572|NCT01193335|455877355|FG000|1-Year Follow-up|Lost to Follow-up|4|||
126706573|NCT01193335|455877356|FG001|1-Year Follow-up|Lost to Follow-up|0|||
126706574|NCT01193335|455877355|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
126706575|NCT01193335|455877356|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
126706576|NCT01193335|455877355|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
126706577|NCT01193335|455877356|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
126706578|NCT01733329|455877358|FG000|Overall Study|Protocol Violation|1|||
126706579|NCT01733329|455877359|FG001|Overall Study|Protocol Violation|1|||
126706580|NCT01733329|455877358|FG000|Overall Study|Uterine artery injury|1|||
126706581|NCT01733329|455877359|FG001|Overall Study|Uterine artery injury|0|||
126706582|NCT02500550|455877366|FG000|Overall Study|Death|7|||
126706583|NCT03826914|455877367|FG000|Overall Study|Withdrawal by Subject|1|||
126706584|NCT03826914|455877368|FG001|Overall Study|Withdrawal by Subject|1|||
126706585|NCT04334148|455877371|FG000|Overall Study|positive nasal swab at baseline|0|||
126706586|NCT04334148|455877372|FG001|Overall Study|positive nasal swab at baseline|1|||
126277155|NCT00936897|454305588|FG000|Overall Study|Noncompliance|0|||
126277156|NCT00936897|454305589|FG001|Overall Study|Noncompliance|2|||
126277157|NCT00936897|454305588|FG000|Overall Study|Death|0|||
126277158|NCT00936897|454305589|FG001|Overall Study|Death|1|||
126277159|NCT00417170|454305590|FG000|Overall Study|Adverse Event|1|||
126277160|NCT00417170|454305591|FG001|Overall Study|Adverse Event|1|||
126277161|NCT00417170|454305590|FG000|Overall Study|Withdrawal by Subject|1|||
126277162|NCT00417170|454305591|FG001|Overall Study|Withdrawal by Subject|1|||
126277163|NCT00417170|454305590|FG000|Overall Study|Lost to Follow-up|0|||
126277164|NCT00417170|454305591|FG001|Overall Study|Lost to Follow-up|1|||
126277165|NCT02792699|454305592|FG000|Overall Study|Adverse Event|1|||
126277166|NCT02792699|454305593|FG001|Overall Study|Adverse Event|2|||
126277167|NCT02792699|454305594|FG002|Overall Study|Adverse Event|4|||
126277168|NCT02792699|454305592|FG000|Overall Study|Withdrawal by Subject|4|||
126277169|NCT02792699|454305593|FG001|Overall Study|Withdrawal by Subject|4|||
126277170|NCT02792699|454305594|FG002|Overall Study|Withdrawal by Subject|3|||
126277171|NCT02792699|454305592|FG000|Overall Study|Lost to Follow-up|0|||
126277172|NCT02792699|454305593|FG001|Overall Study|Lost to Follow-up|1|||
126277173|NCT02792699|454305594|FG002|Overall Study|Lost to Follow-up|2|||
126277174|NCT02792699|454305592|FG000|Overall Study|Physician Decision|2|||
126277175|NCT02792699|454305593|FG001|Overall Study|Physician Decision|0|||
126277176|NCT02792699|454305594|FG002|Overall Study|Physician Decision|0|||
126277177|NCT02792699|454305592|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
126277178|NCT02792699|454305593|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
126277179|NCT02792699|454305594|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
126277180|NCT02792699|454305592|FG000|Overall Study|Other|1|||
126277181|NCT02792699|454305593|FG001|Overall Study|Other|0|||
126277182|NCT02792699|454305594|FG002|Overall Study|Other|0|||
126277183|NCT03464630|454305595|FG000|Overall Study|Lost to Follow-up|62|||
126277184|NCT03464630|454305596|FG001|Overall Study|Lost to Follow-up|52|||
126277185|NCT03464630|454305595|FG000|Overall Study|Withdrawal by Subject|16|||
126277186|NCT03464630|454305596|FG001|Overall Study|Withdrawal by Subject|10|||
126277187|NCT03464630|454305595|FG000|Overall Study|Passive Disengagement|8|||
126277188|NCT03464630|454305596|FG001|Overall Study|Passive Disengagement|4|||
126277189|NCT03196635|454305597|FG000|Overall Study|Withdrawal by Subject|1|||
126277190|NCT00380744|454305602|FG000|Overall Study|Death|0|||
126277191|NCT00380744|454305603|FG001|Overall Study|Death|0|||
126454589|NCT01227629|454963234|FG005|Overall Study|Other|0|||
126706587|NCT05300087|455877375|FG000|Overall Study|Withdrawal by Subject|0|||
126706588|NCT05300087|455877376|FG001|Overall Study|Withdrawal by Subject|1|||
126706589|NCT03248128|455877377|FG000|Overall Study|Lost to Follow-up|1|||
126706590|NCT03248128|455877378|FG001|Overall Study|Lost to Follow-up|0|||
126277192|NCT00380744|454305604|FG002|Overall Study|Death|0|||
126277193|NCT00380744|454305605|FG003|Overall Study|Death|0|||
126277194|NCT00380744|454305606|FG004|Overall Study|Death|0|||
126277195|NCT00380744|454305607|FG005|Overall Study|Death|0|||
126277196|NCT00380744|454305608|FG006|Overall Study|Death|1|||
126454590|NCT01227629|454963235|FG006|Overall Study|Other|0|||
126277197|NCT00380744|454305602|FG000|Overall Study|Withdrawal by Subject|1|||
126277198|NCT00380744|454305603|FG001|Overall Study|Withdrawal by Subject|0|||
126277199|NCT00380744|454305604|FG002|Overall Study|Withdrawal by Subject|0|||
126454591|NCT01227629|454963236|FG007|Overall Study|Other|0|||
126277200|NCT00380744|454305605|FG003|Overall Study|Withdrawal by Subject|0|||
126277201|NCT00380744|454305606|FG004|Overall Study|Withdrawal by Subject|0|||
126277202|NCT00380744|454305607|FG005|Overall Study|Withdrawal by Subject|0|||
126277203|NCT00380744|454305608|FG006|Overall Study|Withdrawal by Subject|0|||
126277204|NCT01338870|454305609|FG000|Overall Study|Lost to Follow-up|0|||
126277205|NCT01338870|454305610|FG001|Overall Study|Lost to Follow-up|0|||
126277206|NCT01338870|454305611|FG002|Overall Study|Lost to Follow-up|1|||
126277207|NCT01338870|454305612|FG003|Overall Study|Lost to Follow-up|0|||
126277208|NCT01338870|454305613|FG004|Overall Study|Lost to Follow-up|1|||
126277209|NCT01338870|454305614|FG005|Overall Study|Lost to Follow-up|0|||
126277210|NCT01338870|454305609|FG000|Overall Study|Withdrawal by Subject|2|||
126277211|NCT01338870|454305610|FG001|Overall Study|Withdrawal by Subject|3|||
126277212|NCT01338870|454305611|FG002|Overall Study|Withdrawal by Subject|4|||
126277213|NCT01338870|454305612|FG003|Overall Study|Withdrawal by Subject|0|||
126277214|NCT01338870|454305613|FG004|Overall Study|Withdrawal by Subject|0|||
126277215|NCT01338870|454305614|FG005|Overall Study|Withdrawal by Subject|2|||
126277216|NCT01338870|454305609|FG000|Overall Study|Other|3|||
126277217|NCT01338870|454305610|FG001|Overall Study|Other|3|||
126277218|NCT01338870|454305611|FG002|Overall Study|Other|3|||
126277219|NCT01338870|454305612|FG003|Overall Study|Other|2|||
126277220|NCT01338870|454305613|FG004|Overall Study|Other|0|||
126277221|NCT01338870|454305614|FG005|Overall Study|Other|2|||
126277222|NCT01338870|454305609|FG000|Overall Study|Protocol Violation|0|||
126277223|NCT01338870|454305610|FG001|Overall Study|Protocol Violation|2|||
126277224|NCT01338870|454305611|FG002|Overall Study|Protocol Violation|2|||
126277225|NCT01338870|454305612|FG003|Overall Study|Protocol Violation|2|||
126277226|NCT01338870|454305613|FG004|Overall Study|Protocol Violation|1|||
126277227|NCT01338870|454305614|FG005|Overall Study|Protocol Violation|1|||
126277228|NCT01338870|454305609|FG000|Overall Study|Adverse Event|4|||
126277229|NCT01338870|454305610|FG001|Overall Study|Adverse Event|4|||
126277230|NCT01338870|454305611|FG002|Overall Study|Adverse Event|1|||
126277231|NCT01338870|454305612|FG003|Overall Study|Adverse Event|5|||
126277232|NCT01338870|454305613|FG004|Overall Study|Adverse Event|4|||
126277233|NCT01338870|454305614|FG005|Overall Study|Adverse Event|1|||
126277234|NCT02871492|454305617|FG000|Overall Study|Lost to Follow-up|6|||
126277235|NCT02871492|454305618|FG001|Overall Study|Lost to Follow-up|3|||
126277236|NCT02871492|454305619|FG002|Overall Study|Lost to Follow-up|5|||
126277237|NCT02871492|454305617|FG000|Overall Study|Withdrawal by Subject|0|||
126277238|NCT02871492|454305618|FG001|Overall Study|Withdrawal by Subject|0|||
126277239|NCT02871492|454305619|FG002|Overall Study|Withdrawal by Subject|1|||
126277240|NCT04546724|454305620|FG000|Overall Study|Withdrawal by Subject|145|||
126277241|NCT04546724|454305621|FG001|Overall Study|Withdrawal by Subject|41|||
126277242|NCT04546724|454305620|FG000|Overall Study|Adverse Event|1|||
126277243|NCT04546724|454305621|FG001|Overall Study|Adverse Event|1|||
126277244|NCT04546724|454305620|FG000|Overall Study|Lost to Follow-up|186|||
126277245|NCT04546724|454305621|FG001|Overall Study|Lost to Follow-up|63|||
126277246|NCT04546724|454305620|FG000|Overall Study|Physician Decision|8|||
126277247|NCT04546724|454305621|FG001|Overall Study|Physician Decision|2|||
126277248|NCT04546724|454305620|FG000|Overall Study|Death|2|||
126277249|NCT04546724|454305621|FG001|Overall Study|Death|1|||
126277250|NCT04546724|454305620|FG000|Overall Study|subject has been out of town|1|||
126277251|NCT04546724|454305621|FG001|Overall Study|subject has been out of town|0|||
126277252|NCT04546724|454305620|FG000|Overall Study|subject is incarcerated|2|||
126277253|NCT04546724|454305621|FG001|Overall Study|subject is incarcerated|0|||
126277254|NCT04546724|454305620|FG000|Overall Study|subject is relocating|12|||
126277255|NCT04546724|454305621|FG001|Overall Study|subject is relocating|4|||
126277256|NCT04546724|454305620|FG000|Overall Study|Subject in another study|1|||
126277257|NCT04546724|454305621|FG001|Overall Study|Subject in another study|1|||
126277258|NCT02256436|454305622|FG000|Overall Study|Adverse Event|9|||
126277259|NCT02256436|454305623|FG001|Overall Study|Adverse Event|14|||
126277260|NCT02256436|454305622|FG000|Overall Study|Death|216|||
126277261|NCT02256436|454305623|FG001|Overall Study|Death|208|||
126277262|NCT02256436|454305622|FG000|Overall Study|Lost to Follow-up|1|||
126277263|NCT02256436|454305623|FG001|Overall Study|Lost to Follow-up|2|||
126277264|NCT02256436|454305622|FG000|Overall Study|Physician Decision|1|||
126277265|NCT02256436|454305623|FG001|Overall Study|Physician Decision|0|||
126277266|NCT02256436|454305622|FG000|Overall Study|Protocol Violation|0|||
126277267|NCT02256436|454305623|FG001|Overall Study|Protocol Violation|1|||
126277268|NCT02256436|454305622|FG000|Overall Study|Withdrawal by Subject|26|||
126277269|NCT02256436|454305623|FG001|Overall Study|Withdrawal by Subject|10|||
126277270|NCT02256436|454305622|FG000|Overall Study|Transferred to Extension Study|11|||
126277271|NCT02256436|454305623|FG001|Overall Study|Transferred to Extension Study|23|||
126277272|NCT02256436|454305622|FG000|Overall Study|Did Not Continue on Extension Study|8|||
126277273|NCT02256436|454305623|FG001|Overall Study|Did Not Continue on Extension Study|12|||
126362863|NCT00489359|454621637|FG001|Overall Study|Adverse Event|16|||
126277274|NCT01441947|454305624|FG000|Overall Study|Withdrawal by Subject|3|||
126277275|NCT01441947|454305625|FG001|Overall Study|Withdrawal by Subject|0|||
126277276|NCT00077857|454305626|FG000|Overall Study|Adverse Event|30|||
126277277|NCT00077857|454305627|FG001|Overall Study|Adverse Event|32|||
126277278|NCT00077857|454305626|FG000|Overall Study|Death|7|||
126277279|NCT00077857|454305627|FG001|Overall Study|Death|3|||
126277280|NCT00077857|454305626|FG000|Overall Study|Insufficient therapeutic response|112|||
126277281|NCT00077857|454305627|FG001|Overall Study|Insufficient therapeutic response|128|||
126277282|NCT00077857|454305626|FG000|Overall Study|Violation of selection criteria at entry|3|||
126277283|NCT00077857|454305627|FG001|Overall Study|Violation of selection criteria at entry|1|||
126277284|NCT00077857|454305626|FG000|Overall Study|Other protocol violation|0|||
126277285|NCT00077857|454305627|FG001|Overall Study|Other protocol violation|1|||
126277286|NCT00077857|454305626|FG000|Overall Study|Refused treatment|29|||
126277287|NCT00077857|454305627|FG001|Overall Study|Refused treatment|21|||
126277288|NCT00077857|454305626|FG000|Overall Study|Failure to return|5|||
126277289|NCT00077857|454305627|FG001|Overall Study|Failure to return|5|||
126277290|NCT00077857|454305626|FG000|Overall Study|Other|15|||
126277291|NCT00077857|454305627|FG001|Overall Study|Other|13|||
126277292|NCT00468650|454305628|FG000|Overall Study|Lost to Follow-up|4|||
126277293|NCT00468650|454305628|FG000|Overall Study|Withdrawal by Subject|2|||
126277294|NCT00468650|454305628|FG000|Overall Study|Protocol Violation|1|||
126277295|NCT02348723|454305631|FG000|Overall Study|No ablation|21|||
126277296|NCT02348723|454305632|FG001|Overall Study|No ablation|20|||
126277297|NCT02348723|454305631|FG000|Overall Study|Non-compliant with Protocol|1|||
126277298|NCT02348723|454305632|FG001|Overall Study|Non-compliant with Protocol|0|||
126277299|NCT02348723|454305631|FG000|Overall Study|Lost to Follow-up|1|||
126277300|NCT02348723|454305632|FG001|Overall Study|Lost to Follow-up|1|||
126277301|NCT02348723|454305631|FG000|Overall Study|Consent withdrawn|1|||
126277302|NCT02348723|454305632|FG001|Overall Study|Consent withdrawn|3|||
126277303|NCT02348723|454305631|FG000|Overall Study|Reason other than specified|1|||
126277304|NCT02348723|454305632|FG001|Overall Study|Reason other than specified|1|||
126277305|NCT02348723|454305631|FG000|Overall Study|Adverse Event|3|||
126277306|NCT02348723|454305632|FG001|Overall Study|Adverse Event|1|||
126277307|NCT04874155|454305633|FG000|Overall Study|Lost to Follow-up|1|||
126277308|NCT04874155|454305634|FG001|Overall Study|Lost to Follow-up|1|||
126277309|NCT04874155|454305633|FG000|Overall Study|Withdrawal by Subject|2|||
126277310|NCT04874155|454305634|FG001|Overall Study|Withdrawal by Subject|2|||
126277311|NCT03477903|454305639|FG000|Overall Study|Study Terminated by Sponsor|1|||
126454592|NCT01227629|454963237|FG008|Overall Study|Other|2|||
126454593|NCT01227629|454963238|FG009|Overall Study|Other|1|||
126454594|NCT00362180|454964736|FG000|Treated Period|Withdrawal by Subject|1|||
126454595|NCT00362180|454964737|FG001|Treated Period|Withdrawal by Subject|0|||
126454596|NCT00362180|454964738|FG002|Treated Period|Withdrawal by Subject|0|||
126454597|NCT00362180|454964739|FG003|Treated Period|Withdrawal by Subject|0|||
126454598|NCT00362180|454964740|FG004|Treated Period|Withdrawal by Subject|0|||
126454599|NCT00362180|454964741|FG005|Treated Period|Withdrawal by Subject|0|||
126454600|NCT00362180|454964742|FG006|Treated Period|Withdrawal by Subject|0|||
126454601|NCT00362180|454964743|FG007|Treated Period|Withdrawal by Subject|0|||
126454602|NCT00362180|454964744|FG008|Treated Period|Withdrawal by Subject|0|||
126454603|NCT00362180|454964736|FG000|Treated Period|Adverse Event|0|||
126454604|NCT00362180|454964737|FG001|Treated Period|Adverse Event|0|||
126454605|NCT00362180|454964738|FG002|Treated Period|Adverse Event|0|||
126454606|NCT00362180|454964739|FG003|Treated Period|Adverse Event|0|||
126454607|NCT00362180|454964740|FG004|Treated Period|Adverse Event|0|||
126454608|NCT00362180|454964741|FG005|Treated Period|Adverse Event|1|||
126454609|NCT00362180|454964742|FG006|Treated Period|Adverse Event|0|||
126454610|NCT00362180|454964743|FG007|Treated Period|Adverse Event|1|||
126277312|NCT03201965|454305640|FG000|Overall Study|Death|5|||
126277313|NCT03201965|454305641|FG001|Overall Study|Death|27|||
126277314|NCT03201965|454305642|FG002|Overall Study|Death|27|||
126277315|NCT03201965|454305640|FG000|Overall Study|Lost to Follow-up|0|||
126277316|NCT03201965|454305641|FG001|Overall Study|Lost to Follow-up|1|||
126277317|NCT03201965|454305642|FG002|Overall Study|Lost to Follow-up|0|||
126277318|NCT03201965|454305640|FG000|Overall Study|Withdrawal by Subject|3|||
126277319|NCT03201965|454305641|FG001|Overall Study|Withdrawal by Subject|13|||
126454611|NCT00362180|454964744|FG008|Treated Period|Adverse Event|0|||
126277320|NCT03201965|454305642|FG002|Overall Study|Withdrawal by Subject|4|||
126277321|NCT03201965|454305640|FG000|Overall Study|Ongoing|20|||
126454612|NCT02434471|454964754|FG000|Overall Study|Physician Decision|9|||
126454613|NCT00369629|454964755|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
126454614|NCT00369629|454964756|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
126454615|NCT00369629|454964757|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
126454616|NCT00369629|454964758|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
126277322|NCT03201965|454305641|FG001|Overall Study|Ongoing|152|||
126277323|NCT03201965|454305642|FG002|Overall Study|Ongoing|164|||
126277324|NCT00369317|454305643|FG000|Overall Study|Adverse Event|3|||
126454617|NCT00369629|454964755|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
126454618|NCT00369629|454964756|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
126454619|NCT00369629|454964757|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
126454620|NCT00369629|454964758|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
126277325|NCT00369317|454305643|FG000|Overall Study|Death|1|||
126277326|NCT00369317|454305643|FG000|Overall Study|Lack of Efficacy|5|||
126706591|NCT03248128|455877377|FG000|Overall Study|Withdrawal by Subject|16|||
126706592|NCT03248128|455877378|FG001|Overall Study|Withdrawal by Subject|14|||
126706593|NCT03248128|455877377|FG000|Overall Study|Site Closed|4|||
126277327|NCT00369317|454305643|FG000|Overall Study|Physician Decision|2|||
126277328|NCT00369317|454305643|FG000|Overall Study|Withdrawal by Subject|8|||
126277329|NCT00369317|454305643|FG000|Overall Study|Ineligible|1|||
126454621|NCT00369629|454964755|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
126454622|NCT00369629|454964756|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
126454623|NCT00369629|454964757|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
126454624|NCT00369629|454964758|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
126454625|NCT00369629|454964755|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
126454626|NCT00369629|454964756|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
126454627|NCT00369629|454964757|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
126454628|NCT00369629|454964758|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
126454629|NCT00369629|454964755|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
126277330|NCT02365558|454305644|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
126277331|NCT02365558|454305645|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
126277332|NCT02365558|454305644|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
126277333|NCT02365558|454305645|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
126277334|NCT02828241|454305654|FG000|Overall Study|Adverse Event|7|||
126277335|NCT02828241|454305655|FG001|Overall Study|Adverse Event|2|||
126277336|NCT02828241|454305654|FG000|Overall Study|Protocol Violation|1|||
126277337|NCT02828241|454305655|FG001|Overall Study|Protocol Violation|0|||
126277338|NCT01197755|454305656|FG000|Overall Study|Adverse Event|8|||
126277339|NCT01197755|454305657|FG001|Overall Study|Adverse Event|10|||
126277340|NCT01197755|454305658|FG002|Overall Study|Adverse Event|10|||
126277341|NCT01197755|454305656|FG000|Overall Study|Study-specific discontinuation criteria|2|||
126277342|NCT01197755|454305657|FG001|Overall Study|Study-specific discontinuation criteria|1|||
126277343|NCT01197755|454305658|FG002|Overall Study|Study-specific discontinuation criteria|0|||
126277344|NCT01197755|454305656|FG000|Overall Study|Entered the long-term extension study|18|||
126277345|NCT01197755|454305657|FG001|Overall Study|Entered the long-term extension study|21|||
126277346|NCT01197755|454305658|FG002|Overall Study|Entered the long-term extension study|35|||
126277347|NCT01197755|454305656|FG000|Overall Study|Lack of therapeutic response|0|||
126277348|NCT01197755|454305657|FG001|Overall Study|Lack of therapeutic response|7|||
126277349|NCT01197755|454305658|FG002|Overall Study|Lack of therapeutic response|4|||
126277350|NCT01197755|454305656|FG000|Overall Study|Severe non-compliance to the protocol|2|||
126277351|NCT01197755|454305657|FG001|Overall Study|Severe non-compliance to the protocol|1|||
126277352|NCT01197755|454305658|FG002|Overall Study|Severe non-compliance to the protocol|2|||
126277353|NCT01197755|454305656|FG000|Overall Study|Withdrawal by Subject|1|||
126277354|NCT01197755|454305657|FG001|Overall Study|Withdrawal by Subject|0|||
126277355|NCT01197755|454305658|FG002|Overall Study|Withdrawal by Subject|0|||
126277356|NCT01197755|454305656|FG000|Overall Study|Lost to Follow-up|0|||
126277357|NCT01197755|454305657|FG001|Overall Study|Lost to Follow-up|0|||
126277358|NCT01197755|454305658|FG002|Overall Study|Lost to Follow-up|1|||
126277359|NCT01197755|454305656|FG000|Overall Study|eg, change in circumstances|7|||
126277360|NCT01197755|454305657|FG001|Overall Study|eg, change in circumstances|3|||
126277361|NCT01197755|454305658|FG002|Overall Study|eg, change in circumstances|2|||
126454630|NCT00369629|454964756|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
126454631|NCT00369629|454964757|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
126454632|NCT00369629|454964758|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
126706594|NCT03248128|455877378|FG001|Overall Study|Site Closed|3|||
126706595|NCT03248128|455877377|FG000|Overall Study|Randomized, but did not receive treatment|1|||
126706596|NCT03248128|455877378|FG001|Overall Study|Randomized, but did not receive treatment|3|||
126277362|NCT00758680|454305659|FG000|Overall Study|Adverse Event|0|||
126277363|NCT00758680|454305660|FG001|Overall Study|Adverse Event|0|||
126454633|NCT00369629|454964755|FG000|Completed 4 More Cycles|Progressive disease|2|||
126454634|NCT00369629|454964756|FG001|Completed 4 More Cycles|Progressive disease|1|||
126454635|NCT00369629|454964757|FG002|Completed 4 More Cycles|Progressive disease|2|||
126706597|NCT01914679|455877379|FG000|Overall Study|Lack of Efficacy|1|||
126706598|NCT01914679|455877379|FG000|Overall Study|Sponsor terminated study|4|||
126277364|NCT00758680|454305661|FG002|Overall Study|Adverse Event|0|||
126277365|NCT00758680|454305662|FG003|Overall Study|Adverse Event|0|||
126277366|NCT00758680|454305663|FG004|Overall Study|Adverse Event|0|||
126277367|NCT00758680|454305664|FG005|Overall Study|Adverse Event|0|||
126706599|NCT00002850|455877381|FG000|Overall Study|Death|4|||
126706600|NCT00002850|455877382|FG001|Overall Study|Death|1|||
126277368|NCT00758680|454305665|FG006|Overall Study|Adverse Event|0|||
126277369|NCT00758680|454305666|FG007|Overall Study|Adverse Event|1|||
126277370|NCT00758680|454305667|FG008|Overall Study|Adverse Event|0|||
126277371|NCT00758680|454305668|FG009|Overall Study|Adverse Event|1|||
126277372|NCT00758680|454305659|FG000|Overall Study|Laboratory Adverse Event|0|||
126277373|NCT00758680|454305660|FG001|Overall Study|Laboratory Adverse Event|0|||
126277374|NCT00758680|454305661|FG002|Overall Study|Laboratory Adverse Event|0|||
126306226|NCT01940887|454410250|FG000|Year 1|Physician Decision|7|||
126454636|NCT00369629|454964758|FG003|Completed 4 More Cycles|Progressive disease|0|||
126454637|NCT00369629|454964755|FG000|Follow up for 1 Year|Death|2|||
126454638|NCT00369629|454964756|FG001|Follow up for 1 Year|Death|1|||
126454639|NCT00369629|454964757|FG002|Follow up for 1 Year|Death|1|||
126454640|NCT00369629|454964758|FG003|Follow up for 1 Year|Death|0|||
126277375|NCT00758680|454305662|FG003|Overall Study|Laboratory Adverse Event|0|||
126277376|NCT00758680|454305663|FG004|Overall Study|Laboratory Adverse Event|0|||
126277377|NCT00758680|454305664|FG005|Overall Study|Laboratory Adverse Event|0|||
126277378|NCT00758680|454305665|FG006|Overall Study|Laboratory Adverse Event|0|||
126277379|NCT00758680|454305666|FG007|Overall Study|Laboratory Adverse Event|0|||
126277380|NCT00758680|454305667|FG008|Overall Study|Laboratory Adverse Event|1|||
126277381|NCT00758680|454305668|FG009|Overall Study|Laboratory Adverse Event|0|||
126277382|NCT00758680|454305659|FG000|Overall Study|Withdrawal by Subject|0|||
126277383|NCT00758680|454305660|FG001|Overall Study|Withdrawal by Subject|0|||
126277384|NCT00758680|454305661|FG002|Overall Study|Withdrawal by Subject|0|||
126277385|NCT00758680|454305662|FG003|Overall Study|Withdrawal by Subject|0|||
126277386|NCT00758680|454305663|FG004|Overall Study|Withdrawal by Subject|0|||
126277387|NCT00758680|454305664|FG005|Overall Study|Withdrawal by Subject|0|||
126277388|NCT00758680|454305665|FG006|Overall Study|Withdrawal by Subject|1|||
126277389|NCT00758680|454305666|FG007|Overall Study|Withdrawal by Subject|0|||
126277390|NCT00758680|454305667|FG008|Overall Study|Withdrawal by Subject|1|||
126277391|NCT00758680|454305668|FG009|Overall Study|Withdrawal by Subject|0|||
126277392|NCT00761865|454305669|FG000|Overall Study|Lost to Follow-up|8|||
126277393|NCT00761865|454305670|FG001|Overall Study|Lost to Follow-up|7|||
126277394|NCT03866902|454305672|FG000|Overall Study|Lost to Follow-up|98|||
126277395|NCT03866902|454305673|FG001|Overall Study|Lost to Follow-up|82|||
126277396|NCT03866902|454305672|FG000|Overall Study|Pregnancy|18|||
126277397|NCT03866902|454305673|FG001|Overall Study|Pregnancy|24|||
126277398|NCT00638027|454305674|FG000|Overall Study|Adverse Event|0|||
126277399|NCT00638027|454305675|FG001|Overall Study|Adverse Event|2|||
126277400|NCT00371397|454305676|FG000|Session 1|Withdrawal by Subject|1|||
126277401|NCT00371397|454305677|FG001|Session 1|Withdrawal by Subject|0|||
126277402|NCT00371397|454305678|FG002|Session 1|Withdrawal by Subject|0|||
126277403|NCT00371397|454305679|FG003|Session 1|Withdrawal by Subject|0|||
126277404|NCT00371397|454305680|FG004|Session 1|Withdrawal by Subject|0|||
126277405|NCT00371397|454305681|FG005|Session 1|Withdrawal by Subject|0|||
126277406|NCT00371397|454305682|FG006|Session 1|Withdrawal by Subject|0|||
126277407|NCT00371397|454305683|FG007|Session 1|Withdrawal by Subject|1|||
126277408|NCT00371397|454305684|FG008|Session 1|Withdrawal by Subject|0|||
126277409|NCT00371397|454305685|FG009|Session 1|Withdrawal by Subject|0|||
126277410|NCT00371397|454305686|FG010|Session 1|Withdrawal by Subject|0|||
126277411|NCT00371397|454305687|FG011|Session 1|Withdrawal by Subject|0|||
126277412|NCT03014180|454305688|FG000|Overall Study|Protocol Violation|2|||
126277413|NCT01284621|454305689|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
126277414|NCT01284621|454305690|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
126277415|NCT01284621|454305691|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
126277416|NCT01284621|454305692|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
126277417|NCT01284621|454305693|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
126277418|NCT01284621|454305694|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
126277419|NCT02802631|454305697|FG000|Overall Study|Withdrawal by Subject|1|||
126277420|NCT02802631|454305698|FG001|Overall Study|Withdrawal by Subject|0|||
126277421|NCT02802631|454305699|FG002|Overall Study|Withdrawal by Subject|0|||
126277422|NCT02802631|454305700|FG003|Overall Study|Withdrawal by Subject|0|||
126277423|NCT02802631|454305701|FG004|Overall Study|Withdrawal by Subject|0|||
126277424|NCT02802631|454305702|FG005|Overall Study|Withdrawal by Subject|0|||
126277425|NCT02802631|454305703|FG006|Overall Study|Withdrawal by Subject|0|||
126277426|NCT02802631|454305704|FG007|Overall Study|Withdrawal by Subject|0|||
126277427|NCT02802631|454305697|FG000|Overall Study|Physician Decision|1|||
126277428|NCT02802631|454305698|FG001|Overall Study|Physician Decision|0|||
126277429|NCT02802631|454305699|FG002|Overall Study|Physician Decision|0|||
126277430|NCT02802631|454305700|FG003|Overall Study|Physician Decision|0|||
126277431|NCT02802631|454305701|FG004|Overall Study|Physician Decision|0|||
126277432|NCT02802631|454305702|FG005|Overall Study|Physician Decision|0|||
126454641|NCT00369629|454964755|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
126454642|NCT00369629|454964756|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
126454643|NCT00369629|454964757|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
126454644|NCT00369629|454964758|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
126454645|NCT00369629|454964755|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
126277433|NCT02802631|454305703|FG006|Overall Study|Physician Decision|1|||
126277434|NCT02802631|454305704|FG007|Overall Study|Physician Decision|0|||
126277435|NCT02802631|454305697|FG000|Overall Study|Adverse Event|0|||
126277436|NCT02802631|454305698|FG001|Overall Study|Adverse Event|2|||
126277437|NCT02802631|454305699|FG002|Overall Study|Adverse Event|0|||
126277438|NCT02802631|454305700|FG003|Overall Study|Adverse Event|1|||
126277439|NCT02802631|454305701|FG004|Overall Study|Adverse Event|6|||
126454646|NCT00369629|454964756|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
126277440|NCT02802631|454305702|FG005|Overall Study|Adverse Event|1|||
126277441|NCT02802631|454305703|FG006|Overall Study|Adverse Event|4|||
126277442|NCT02802631|454305704|FG007|Overall Study|Adverse Event|0|||
126277443|NCT02802631|454305697|FG000|Overall Study|Sponsor Decision|0|||
126277444|NCT02802631|454305698|FG001|Overall Study|Sponsor Decision|0|||
126277445|NCT02802631|454305699|FG002|Overall Study|Sponsor Decision|6|||
126277446|NCT02802631|454305700|FG003|Overall Study|Sponsor Decision|0|||
126277447|NCT02802631|454305701|FG004|Overall Study|Sponsor Decision|2|||
126277448|NCT02802631|454305702|FG005|Overall Study|Sponsor Decision|0|||
126277449|NCT02802631|454305703|FG006|Overall Study|Sponsor Decision|0|||
126277450|NCT02802631|454305704|FG007|Overall Study|Sponsor Decision|4|||
126277451|NCT02968849|454305705|FG000|Overall Study|Death|8|||
126277452|NCT02968849|454305706|FG001|Overall Study|Death|10|||
126277453|NCT02968849|454305705|FG000|Overall Study|Lost to Follow-up|31|||
126277454|NCT02968849|454305706|FG001|Overall Study|Lost to Follow-up|29|||
126277455|NCT02968849|454305705|FG000|Overall Study|Withdrawal by Subject|73|||
126277456|NCT02968849|454305706|FG001|Overall Study|Withdrawal by Subject|64|||
126277457|NCT02968849|454305705|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
126277458|NCT02968849|454305706|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
126277459|NCT02968849|454305705|FG000|Overall Study|Physician Decision|6|||
126277460|NCT02968849|454305706|FG001|Overall Study|Physician Decision|9|||
126277461|NCT02968849|454305705|FG000|Overall Study|Other|16|||
126277462|NCT02968849|454305706|FG001|Overall Study|Other|10|||
126277463|NCT00704730|454305708|FG000|Overall Study|Adverse Event|35|||
126277464|NCT00704730|454305709|FG001|Overall Study|Adverse Event|9|||
126277465|NCT00704730|454305708|FG000|Overall Study|Death|11|||
126277466|NCT00704730|454305709|FG001|Overall Study|Death|5|||
126277467|NCT00704730|454305708|FG000|Overall Study|Physician Decision|2|||
126277468|NCT00704730|454305709|FG001|Overall Study|Physician Decision|0|||
126277469|NCT00704730|454305708|FG000|Overall Study|Did not receive drug|5|||
126277470|NCT00704730|454305709|FG001|Overall Study|Did not receive drug|2|||
126277471|NCT00704730|454305708|FG000|Overall Study|Disease progression per PI|58|||
126277472|NCT00704730|454305709|FG001|Overall Study|Disease progression per PI|67|||
126277473|NCT00704730|454305708|FG000|Overall Study|data unavailable|1|||
126277474|NCT00704730|454305709|FG001|Overall Study|data unavailable|0|||
126277475|NCT00704730|454305708|FG000|Overall Study|Withdrawal by Subject|9|||
126277476|NCT00704730|454305709|FG001|Overall Study|Withdrawal by Subject|13|||
126277477|NCT02551666|454305711|FG000|Overall Study|Withdrawal by Subject|1|||
126277478|NCT02551666|454305712|FG001|Overall Study|Withdrawal by Subject|3|||
126277479|NCT03510598|454307255|FG000|Overall Study|Withdrawal by Subject|1|||
126277480|NCT05307510|454307257|FG000|Overall Study|Lost to Follow-up|3|||
126277481|NCT05307510|454307258|FG001|Overall Study|Lost to Follow-up|6|||
126277482|NCT05307510|454307257|FG000|Overall Study|Withdrawal by Subject|0|||
126277483|NCT05307510|454307258|FG001|Overall Study|Withdrawal by Subject|1|||
126277484|NCT00554606|454307265|FG000|Overall Study|Adverse Event|3|||
126277485|NCT00554606|454307265|FG000|Overall Study|Abnormal laboratory values|1|||
126277486|NCT00554606|454307265|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
126277487|NCT00554606|454307265|FG000|Overall Study|Subject withdrew consent|2|||
126277488|NCT00554606|454307265|FG000|Overall Study|Lost to Follow-up|2|||
126277489|NCT00554606|454307265|FG000|Overall Study|Administrative problems|60|||
126277490|NCT00554606|454307265|FG000|Overall Study|Death|1|||
126277491|NCT00554606|454307265|FG000|Overall Study|Protocol deviation|2|||
126362864|NCT03180138|454621638|FG000|Overall Study|Mobile-phone could not be verified|2|||
126362865|NCT03180138|454621639|FG001|Overall Study|Mobile-phone could not be verified|13|||
126362866|NCT03180138|454621640|FG002|Overall Study|Mobile-phone could not be verified|15|||
126277492|NCT00849186|454307274|FG000|Overall Study|Adverse Event|2|||
126277493|NCT00849186|454307274|FG000|Overall Study|Withdrawal by Subject|1|||
126277494|NCT00849186|454307274|FG000|Overall Study|not treated|6|||
126277495|NCT00849186|454307274|FG000|Overall Study|Other|1|||
126362867|NCT03180138|454621638|FG000|Overall Study|No prior immunization records|17|||
126362868|NCT03180138|454621639|FG001|Overall Study|No prior immunization records|0|||
126362869|NCT03180138|454621640|FG002|Overall Study|No prior immunization records|6|||
126362870|NCT03180138|454621638|FG000|Overall Study|Found to be >24 mon after randomization|3|||
126362871|NCT03180138|454621639|FG001|Overall Study|Found to be >24 mon after randomization|0|||
126362872|NCT03180138|454621640|FG002|Overall Study|Found to be >24 mon after randomization|3|||
126362873|NCT02100644|454621642|FG000|LTG Escalation Phase|Adverse Event|9|||
126362874|NCT02100644|454621643|FG001|LTG Escalation Phase|Adverse Event|0|||
126362875|NCT02100644|454621644|FG002|LTG Escalation Phase|Adverse Event|0|||
126454647|NCT00369629|454964757|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
126277496|NCT00492024|454307275|FG000|Treatment|Adverse Event|3|||
126277497|NCT00492024|454307276|FG001|Treatment|Adverse Event|1|||
126277498|NCT00492024|454307275|FG000|Treatment|Lack of Efficacy|21|||
126277499|NCT00492024|454307276|FG001|Treatment|Lack of Efficacy|20|||
126277500|NCT00492024|454307275|FG000|Treatment|Lost to Follow-up|3|||
126277501|NCT00492024|454307276|FG001|Treatment|Lost to Follow-up|1|||
126362876|NCT02100644|454621642|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
126277502|NCT00492024|454307275|FG000|Treatment|Withdrawal by Subject|2|||
126362877|NCT02100644|454621643|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
126765708|NCT02074982|456095786|FG000|Overall Study|Non-compliance with study treatment|0|||
126277503|NCT00492024|454307276|FG001|Treatment|Withdrawal by Subject|0|||
126277504|NCT00492024|454307275|FG000|Follow up|Lack of Efficacy|0|||
126277505|NCT00492024|454307276|FG001|Follow up|Lack of Efficacy|1|||
126277506|NCT00492024|454307275|FG000|Follow up|Lost to Follow-up|1|||
126277507|NCT00492024|454307276|FG001|Follow up|Lost to Follow-up|1|||
126277508|NCT03247816|454307277|FG000|Overall Study|Adverse Event|12|||
126277509|NCT03247816|454307277|FG000|Overall Study|Physician Decision|3|||
126277510|NCT03247816|454307277|FG000|Overall Study|Lack of Efficacy|1|||
126277511|NCT03247816|454307277|FG000|Overall Study|Lost to Follow-up|10|||
126277512|NCT03247816|454307277|FG000|Overall Study|Missing Feraccru stop date|3|||
126277513|NCT03257865|454307284|FG000|Overall Study|Adverse Event|4|||
126277514|NCT03257865|454307285|FG001|Overall Study|Adverse Event|8|||
126277515|NCT03257865|454307284|FG000|Overall Study|Lack of Efficacy|1|||
126277516|NCT03257865|454307285|FG001|Overall Study|Lack of Efficacy|2|||
126277517|NCT03257865|454307284|FG000|Overall Study|Non-compliance with Study Drug|0|||
126277518|NCT03257865|454307285|FG001|Overall Study|Non-compliance with Study Drug|2|||
126277519|NCT03257865|454307284|FG000|Overall Study|Withdrawal by Subject|23|||
126277520|NCT03257865|454307285|FG001|Overall Study|Withdrawal by Subject|17|||
126277521|NCT03257865|454307284|FG000|Overall Study|Physician Decision|3|||
126277522|NCT03257865|454307285|FG001|Overall Study|Physician Decision|1|||
126277523|NCT03257865|454307284|FG000|Overall Study|Other|0|||
126277524|NCT03257865|454307285|FG001|Overall Study|Other|1|||
126277525|NCT03257865|454307284|FG000|Overall Study|Lost to Follow-up|4|||
126277526|NCT03257865|454307285|FG001|Overall Study|Lost to Follow-up|4|||
126277527|NCT02677714|454307286|FG000|Overall Study|Withdrawal by Subject|2|||
126277528|NCT02677714|454307287|FG001|Overall Study|Withdrawal by Subject|0|||
126277529|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
126277530|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
126277531|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
126277532|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
126277533|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
126277534|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
126277535|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
126277536|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
126277537|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
126277538|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
126277539|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
126277540|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
126277541|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
126277542|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
126277543|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
126277544|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
126362878|NCT02100644|454621644|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
126362879|NCT02100644|454621642|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
126362880|NCT02100644|454621643|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
126362881|NCT02100644|454621644|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
126362882|NCT00728182|454621645|FG000|Overall Study|Adverse Event|1|||
126362883|NCT00728182|454621646|FG001|Overall Study|Adverse Event|0|||
126362884|NCT00728182|454621645|FG000|Overall Study|Lost to Follow-up|2|||
126362885|NCT00728182|454621646|FG001|Overall Study|Lost to Follow-up|0|||
126362886|NCT00728182|454621645|FG000|Overall Study|Death|0|||
126362887|NCT00728182|454621646|FG001|Overall Study|Death|2|||
126362888|NCT00728182|454621645|FG000|Overall Study|Protocol Noncompliance|0|||
126362889|NCT00728182|454621646|FG001|Overall Study|Protocol Noncompliance|1|||
126362890|NCT01898091|454621648|FG000|Overall Study|Lost to Follow-up|1|||
126454648|NCT00369629|454964758|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
126454649|NCT02184455|454964759|FG000|Overall Study|Lost to Follow-up|1|||
126454650|NCT01347580|454964763|FG000|Overall Study|Withdrawal by Subject|13|||
126454651|NCT01347580|454964764|FG001|Overall Study|Withdrawal by Subject|23|||
126454652|NCT01347580|454964763|FG000|Overall Study|Death|30|||
126454653|NCT01347580|454964764|FG001|Overall Study|Death|19|||
126454654|NCT01347580|454964763|FG000|Overall Study|Protocol Violation|10|||
126454655|NCT01347580|454964764|FG001|Overall Study|Protocol Violation|7|||
126454656|NCT01347580|454964763|FG000|Overall Study|Lost to Follow-up|3|||
126454657|NCT01347580|454964764|FG001|Overall Study|Lost to Follow-up|1|||
126454658|NCT01347580|454964763|FG000|Overall Study|Had other reason|9|||
126454659|NCT01347580|454964764|FG001|Overall Study|Had other reason|6|||
126454660|NCT00874939|454964765|FG000|Overall Study|Study terminated|4|||
126454661|NCT02870933|454964766|FG000|Overall Study|Death|2|||
126454662|NCT02870933|454964767|FG001|Overall Study|Death|1|||
126454663|NCT02870933|454964766|FG000|Overall Study|Withdrawal by Subject|0|||
126454664|NCT02870933|454964767|FG001|Overall Study|Withdrawal by Subject|1|||
126277545|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
126277546|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
126277547|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
126277548|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
126277549|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
126277550|NCT04040192|454307289|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
126277551|NCT04040192|454307290|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
126277552|NCT04040192|454307291|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
126277553|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
126277554|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
126277555|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
126277556|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
126277557|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
126277558|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
126277559|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
126277560|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
126277561|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
126277562|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
126277563|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
126277564|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
126277565|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
126277566|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
126277567|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
126277568|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
126277569|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
126277570|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
126277571|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
126277572|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
126706601|NCT00002850|455877383|FG002|Overall Study|Death|3|||
126277573|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
126277574|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
126277575|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
126277576|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
126277577|NCT04040192|454307289|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
126277578|NCT04040192|454307290|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
126277579|NCT04040192|454307291|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
126277580|NCT02538965|454307292|FG000|Treatment Period|Other = Death due to disease progression|1|||
126277581|NCT02538965|454307292|FG000|Treatment Period|Adverse Event|2|||
126277582|NCT02538965|454307292|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
126277583|NCT02538965|454307292|FG000|Treatment Period|Treatment Failure|9|||
126277584|NCT02538965|454307292|FG000|Treatment Period|Disease Progression|1|||
126277585|NCT02538965|454307292|FG000|Treatment Period|Physician Decision|2|||
126277586|NCT02538965|454307292|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
126277587|NCT02538965|454307292|FG000|Follow-Up Period|Withdrawal by Parent|4|||
126277588|NCT00875797|454307293|FG000|Overall Study|Protocol Violation|6|||
126277589|NCT00875797|454307294|FG001|Overall Study|Protocol Violation|3|||
126277590|NCT01955083|454307297|FG000|Overall Study|Lost to Follow-up|1|||
126277591|NCT01955083|454307298|FG001|Overall Study|Lost to Follow-up|1|||
126277592|NCT03583086|454307301|FG000|Overall Study|Death|2|||
126277593|NCT03583086|454307302|FG001|Overall Study|Death|6|||
126277594|NCT03583086|454307303|FG002|Overall Study|Death|12|||
126277595|NCT03583086|454307304|FG003|Overall Study|Death|10|||
126706602|NCT00002850|455877381|FG000|Overall Study|Protocol Violation|1|||
126706603|NCT00002850|455877382|FG001|Overall Study|Protocol Violation|0|||
126706604|NCT00002850|455877383|FG002|Overall Study|Protocol Violation|1|||
126277596|NCT03583086|454307305|FG004|Overall Study|Death|14|||
126277597|NCT03583086|454307306|FG005|Overall Study|Death|14|||
126277598|NCT03583086|454307307|FG006|Overall Study|Death|4|||
126277599|NCT03583086|454307301|FG000|Overall Study|Withdrawal by Subject|0|||
126277600|NCT03583086|454307302|FG001|Overall Study|Withdrawal by Subject|0|||
126277601|NCT03583086|454307303|FG002|Overall Study|Withdrawal by Subject|1|||
126454665|NCT01250496|454964770|FG000|Overall Study|Study terminated|124|||
126454666|NCT01250496|454964771|FG001|Overall Study|Study terminated|124|||
126454667|NCT00003590|454964772|FG000|Overall Study|Ineligible Patient|1|||
126454668|NCT00003590|454964772|FG000|Overall Study|Adverse Event|7|||
126454669|NCT00003590|454964772|FG000|Overall Study|Withdrawal by Subject|1|||
126454670|NCT00003590|454964772|FG000|Overall Study|Lack of Efficacy|11|||
126454671|NCT00003590|454964772|FG000|Overall Study|Death|1|||
126454672|NCT00003590|454964772|FG000|Overall Study|Physician Decision|1|||
126454673|NCT01425463|454964773|FG000|Overall Study|Adverse Event|5|||
126454674|NCT01425463|454964774|FG001|Overall Study|Adverse Event|7|||
126277602|NCT03583086|454307304|FG003|Overall Study|Withdrawal by Subject|0|||
126277603|NCT03583086|454307305|FG004|Overall Study|Withdrawal by Subject|0|||
126277604|NCT03583086|454307306|FG005|Overall Study|Withdrawal by Subject|0|||
126277605|NCT03583086|454307307|FG006|Overall Study|Withdrawal by Subject|1|||
126277606|NCT03583086|454307301|FG000|Overall Study|Refused follow-up|0|||
126277607|NCT03583086|454307302|FG001|Overall Study|Refused follow-up|0|||
126277608|NCT03583086|454307303|FG002|Overall Study|Refused follow-up|1|||
126277609|NCT03583086|454307304|FG003|Overall Study|Refused follow-up|0|||
126277610|NCT03583086|454307305|FG004|Overall Study|Refused follow-up|1|||
126277611|NCT03583086|454307306|FG005|Overall Study|Refused follow-up|0|||
126277612|NCT03583086|454307307|FG006|Overall Study|Refused follow-up|0|||
126277613|NCT03583086|454307301|FG000|Overall Study|Declining Performance Status|0|||
126277614|NCT03583086|454307302|FG001|Overall Study|Declining Performance Status|0|||
126277615|NCT03583086|454307303|FG002|Overall Study|Declining Performance Status|1|||
126277616|NCT03583086|454307304|FG003|Overall Study|Declining Performance Status|0|||
126277617|NCT03583086|454307305|FG004|Overall Study|Declining Performance Status|0|||
126277618|NCT03583086|454307306|FG005|Overall Study|Declining Performance Status|0|||
126277619|NCT03583086|454307307|FG006|Overall Study|Declining Performance Status|0|||
126277620|NCT03583086|454307301|FG000|Overall Study|Still on study|0|||
126277621|NCT03583086|454307302|FG001|Overall Study|Still on study|0|||
126277622|NCT03583086|454307303|FG002|Overall Study|Still on study|0|||
126277623|NCT03583086|454307304|FG003|Overall Study|Still on study|1|||
126277624|NCT03583086|454307305|FG004|Overall Study|Still on study|0|||
126277625|NCT03583086|454307306|FG005|Overall Study|Still on study|0|||
126277626|NCT03583086|454307307|FG006|Overall Study|Still on study|1|||
126277627|NCT03583086|454307301|FG000|Overall Study|Disease progression|0|||
126277628|NCT03583086|454307302|FG001|Overall Study|Disease progression|0|||
126277629|NCT03583086|454307303|FG002|Overall Study|Disease progression|0|||
126277630|NCT03583086|454307304|FG003|Overall Study|Disease progression|0|||
126277631|NCT03583086|454307305|FG004|Overall Study|Disease progression|0|||
126277632|NCT03583086|454307306|FG005|Overall Study|Disease progression|0|||
126277633|NCT03583086|454307307|FG006|Overall Study|Disease progression|1|||
126277634|NCT03583086|454307301|FG000|Overall Study|Undergoing radiation therapy|0|||
126277635|NCT03583086|454307302|FG001|Overall Study|Undergoing radiation therapy|0|||
126277636|NCT03583086|454307303|FG002|Overall Study|Undergoing radiation therapy|0|||
126277637|NCT03583086|454307304|FG003|Overall Study|Undergoing radiation therapy|0|||
126277638|NCT03583086|454307305|FG004|Overall Study|Undergoing radiation therapy|0|||
126277639|NCT03583086|454307306|FG005|Overall Study|Undergoing radiation therapy|0|||
126277640|NCT03583086|454307307|FG006|Overall Study|Undergoing radiation therapy|1|||
126277641|NCT03583086|454307301|FG000|Overall Study|Lost to Follow-up|0|||
126277642|NCT03583086|454307302|FG001|Overall Study|Lost to Follow-up|0|||
126547796|NCT00550550|455298062|FG000|Overall Study|Withdrawal by Subject|10|||
126547797|NCT00550550|455298063|FG001|Overall Study|Withdrawal by Subject|8|||
126706605|NCT00002850|455877381|FG000|Overall Study|Withdrawal by Subject|0|||
126706606|NCT00002850|455877382|FG001|Overall Study|Withdrawal by Subject|1|||
126277643|NCT03583086|454307303|FG002|Overall Study|Lost to Follow-up|0|||
126277644|NCT03583086|454307304|FG003|Overall Study|Lost to Follow-up|0|||
126277645|NCT03583086|454307305|FG004|Overall Study|Lost to Follow-up|0|||
126362891|NCT01898091|454621649|FG001|Overall Study|Lost to Follow-up|1|||
126362892|NCT01898091|454621648|FG000|Overall Study|Withdrawal by Subject|1|||
126362893|NCT01898091|454621649|FG001|Overall Study|Withdrawal by Subject|5|||
126362894|NCT01630811|454621651|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
126362895|NCT01630811|454621652|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
126362896|NCT04818086|454621653|FG000|Overall Study|Physician Decision|1|||
126362897|NCT04818086|454621654|FG001|Overall Study|Physician Decision|0|||
126362898|NCT04818086|454621653|FG000|Overall Study|Withdrawal by Subject|0|||
126362899|NCT04818086|454621654|FG001|Overall Study|Withdrawal by Subject|1|||
126362900|NCT03511209|454621658|FG000|Overall Study|Withdrawal by Subject|2|||
126362901|NCT03511209|454621659|FG001|Overall Study|Withdrawal by Subject|4|||
126362902|NCT03511209|454621658|FG000|Overall Study|Death|1|||
126362903|NCT03511209|454621659|FG001|Overall Study|Death|0|||
126362904|NCT03511209|454621658|FG000|Overall Study|Lost to Follow-up|0|||
126362905|NCT03511209|454621659|FG001|Overall Study|Lost to Follow-up|2|||
126362906|NCT01602666|454621660|FG000|Induction Chemotherapy|Death|2|||
126362907|NCT01602666|454621661|FG001|Induction Chemotherapy|Death|1|||
126362908|NCT01602666|454621660|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
126362909|NCT01602666|454621661|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
126362910|NCT01602666|454621660|FG000|Induction Chemotherapy|Physician Decision|12|||
126362911|NCT01602666|454621661|FG001|Induction Chemotherapy|Physician Decision|5|||
126362912|NCT01602666|454621660|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
126277646|NCT03583086|454307306|FG005|Overall Study|Lost to Follow-up|1|||
126277647|NCT03583086|454307307|FG006|Overall Study|Lost to Follow-up|0|||
126277648|NCT03583086|454307301|FG000|Overall Study|Adverse Event|0|||
126277649|NCT03583086|454307302|FG001|Overall Study|Adverse Event|0|||
126277650|NCT03583086|454307303|FG002|Overall Study|Adverse Event|0|||
126277651|NCT03583086|454307304|FG003|Overall Study|Adverse Event|0|||
126277652|NCT03583086|454307305|FG004|Overall Study|Adverse Event|0|||
126362913|NCT01602666|454621661|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
126362914|NCT01602666|454621660|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
126362915|NCT01602666|454621661|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
126362916|NCT01602666|454621660|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
126362917|NCT01602666|454621661|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
126362918|NCT01602666|454621660|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
126362919|NCT01602666|454621661|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
126362920|NCT01602666|454621660|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
126362921|NCT01602666|454621661|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
126362922|NCT01602666|454621660|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
126362923|NCT01602666|454621661|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
126362924|NCT01602666|454621660|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
126362925|NCT01602666|454621661|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
126454675|NCT01425463|454964773|FG000|Overall Study|Lack of Efficacy|1|||
126454676|NCT01425463|454964774|FG001|Overall Study|Lack of Efficacy|1|||
126454677|NCT01425463|454964773|FG000|Overall Study|Protocol Violation|2|||
126454678|NCT01425463|454964774|FG001|Overall Study|Protocol Violation|2|||
126454679|NCT01425463|454964773|FG000|Overall Study|Lost to Follow-up|5|||
126454680|NCT01425463|454964774|FG001|Overall Study|Lost to Follow-up|2|||
126454681|NCT01425463|454964773|FG000|Overall Study|Withdrawal by Subject|7|||
126454682|NCT01425463|454964774|FG001|Overall Study|Withdrawal by Subject|5|||
126454683|NCT01425463|454964773|FG000|Overall Study|Unknown Reason|4|||
126454684|NCT01425463|454964774|FG001|Overall Study|Unknown Reason|7|||
126454685|NCT00883688|454964777|FG000|Overall Study|Ineligible|2|||
126454686|NCT01009840|454964778|FG000|Overall Study|Lost to Follow-up|1|||
126454687|NCT01009840|454964778|FG000|Overall Study|Adverse Event|4|||
126454688|NCT01009840|454964778|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
126454689|NCT01009840|454964778|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
126454690|NCT01009840|454964778|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
126454691|NCT01104376|454964781|FG000|Overall Study|Withdrawal by Subject|15|||
126454692|NCT01104376|454964781|FG000|Overall Study|Consented but excluded after labs|13|||
126454693|NCT03085914|454964793|FG000|Overall Study|Death|6|||
126454694|NCT03085914|454964794|FG001|Overall Study|Death|6|||
126454695|NCT03085914|454964795|FG002|Overall Study|Death|4|||
126454696|NCT03085914|454964796|FG003|Overall Study|Death|1|||
126454697|NCT03085914|454964797|FG004|Overall Study|Death|5|||
126454698|NCT03085914|454964798|FG005|Overall Study|Death|2|||
126454699|NCT03085914|454964799|FG006|Overall Study|Death|2|||
126454700|NCT03085914|454964793|FG000|Overall Study|Withdrawal by Subject|1|||
126454701|NCT03085914|454964794|FG001|Overall Study|Withdrawal by Subject|1|||
126454702|NCT03085914|454964795|FG002|Overall Study|Withdrawal by Subject|2|||
126454703|NCT03085914|454964796|FG003|Overall Study|Withdrawal by Subject|2|||
126454704|NCT03085914|454964797|FG004|Overall Study|Withdrawal by Subject|2|||
126454705|NCT03085914|454964798|FG005|Overall Study|Withdrawal by Subject|0|||
126454706|NCT03085914|454964799|FG006|Overall Study|Withdrawal by Subject|1|||
126454707|NCT03085914|454964793|FG000|Overall Study|Lost to Follow-up|0|||
126454708|NCT03085914|454964794|FG001|Overall Study|Lost to Follow-up|0|||
126454709|NCT03085914|454964795|FG002|Overall Study|Lost to Follow-up|1|||
126454710|NCT03085914|454964796|FG003|Overall Study|Lost to Follow-up|0|||
126454711|NCT03085914|454964797|FG004|Overall Study|Lost to Follow-up|0|||
126454712|NCT03085914|454964798|FG005|Overall Study|Lost to Follow-up|1|||
126454713|NCT03085914|454964799|FG006|Overall Study|Lost to Follow-up|1|||
126454714|NCT03085914|454964793|FG000|Overall Study|Reason was not specified,|2|||
126454715|NCT03085914|454964794|FG001|Overall Study|Reason was not specified,|2|||
126454716|NCT03085914|454964795|FG002|Overall Study|Reason was not specified,|2|||
126454717|NCT03085914|454964796|FG003|Overall Study|Reason was not specified,|3|||
126454718|NCT03085914|454964797|FG004|Overall Study|Reason was not specified,|3|||
126454719|NCT03085914|454964798|FG005|Overall Study|Reason was not specified,|3|||
126454720|NCT03085914|454964799|FG006|Overall Study|Reason was not specified,|6|||
126454721|NCT03085914|454964793|FG000|Overall Study|Progressive Disease|0|||
126362926|NCT01602666|454621660|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
126362927|NCT01602666|454621661|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
126362928|NCT04754399|454621664|FG000|Overall Study|Adverse Event|5|||
126454722|NCT03085914|454964794|FG001|Overall Study|Progressive Disease|0|||
126454723|NCT03085914|454964795|FG002|Overall Study|Progressive Disease|2|||
126454724|NCT03085914|454964796|FG003|Overall Study|Progressive Disease|2|||
126454725|NCT03085914|454964797|FG004|Overall Study|Progressive Disease|1|||
126454726|NCT03085914|454964798|FG005|Overall Study|Progressive Disease|1|||
126454727|NCT03085914|454964799|FG006|Overall Study|Progressive Disease|1|||
126454728|NCT03085914|454964793|FG000|Overall Study|Study Terminated by the Sponsor|0|||
126454729|NCT03085914|454964794|FG001|Overall Study|Study Terminated by the Sponsor|0|||
126454730|NCT03085914|454964795|FG002|Overall Study|Study Terminated by the Sponsor|0|||
126454731|NCT03085914|454964796|FG003|Overall Study|Study Terminated by the Sponsor|1|||
126454732|NCT03085914|454964797|FG004|Overall Study|Study Terminated by the Sponsor|2|||
126277653|NCT03583086|454307306|FG005|Overall Study|Adverse Event|1|||
126277654|NCT03583086|454307307|FG006|Overall Study|Adverse Event|0|||
126277655|NCT00128830|454307309|FG000|Overall Study|Adverse Event|10|||
126277656|NCT00128830|454307309|FG000|Overall Study|Withdrawal by Subject|14|||
126277657|NCT00128830|454307309|FG000|Overall Study|Lost to Follow-up|4|||
126277658|NCT00128830|454307309|FG000|Overall Study|Reached a virologic endpoint|29|||
126277659|NCT00128830|454307309|FG000|Overall Study|Non-compliant|4|||
126277660|NCT00128830|454307309|FG000|Overall Study|Discontinued or ineligible for study|2|||
126277661|NCT00128830|454307309|FG000|Overall Study|Other|9|||
126277662|NCT03185013|454307322|FG000|Overall Study|Withdrawal by Subject|5|||
126277663|NCT03185013|454307323|FG001|Overall Study|Withdrawal by Subject|3|||
126277664|NCT03185013|454307322|FG000|Overall Study|Adverse Event|1|||
126277665|NCT03185013|454307323|FG001|Overall Study|Adverse Event|0|||
126277666|NCT03185013|454307322|FG000|Overall Study|Progressive Disease|1|||
126277667|NCT03185013|454307323|FG001|Overall Study|Progressive Disease|0|||
126277668|NCT03185013|454307322|FG000|Overall Study|Lost to Follow-up|8|||
126277669|NCT03185013|454307323|FG001|Overall Study|Lost to Follow-up|2|||
126277670|NCT03185013|454307322|FG000|Overall Study|Physician Decision|1|||
126277671|NCT03185013|454307323|FG001|Overall Study|Physician Decision|0|||
126277672|NCT03185013|454307322|FG000|Overall Study|Protocol Deviation|2|||
126277673|NCT03185013|454307323|FG001|Overall Study|Protocol Deviation|0|||
126277674|NCT03185013|454307322|FG000|Overall Study|Reason not Specified|3|||
126277675|NCT03185013|454307323|FG001|Overall Study|Reason not Specified|2|||
126277676|NCT03185013|454307322|FG000|Overall Study|Death|1|||
126277677|NCT03185013|454307323|FG001|Overall Study|Death|0|||
126277678|NCT00510289|454307327|FG000|Overall Study|Withdrawal by Subject|7|||
126277679|NCT00510289|454307327|FG000|Overall Study|Refused bone marrow biopsy|2|||
126277680|NCT00510289|454307327|FG000|Overall Study|Lost to Follow-up|1|||
126277681|NCT00510289|454307327|FG000|Overall Study|Progressed prior to starting drug|2|||
126277682|NCT00673387|454307330|FG000|Overall Study|Withdrawal by Subject|15|||
126277683|NCT00673387|454307331|FG001|Overall Study|Withdrawal by Subject|16|||
126277684|NCT00673387|454307332|FG002|Overall Study|Withdrawal by Subject|20|||
126277685|NCT00673387|454307333|FG003|Overall Study|Withdrawal by Subject|16|||
126277686|NCT00673387|454307334|FG004|Overall Study|Withdrawal by Subject|18|||
126277687|NCT00673387|454307335|FG005|Overall Study|Withdrawal by Subject|21|||
126277688|NCT00673387|454307336|FG006|Overall Study|Withdrawal by Subject|15|||
126277689|NCT00673387|454307337|FG007|Overall Study|Withdrawal by Subject|21|||
126277690|NCT00673387|454307330|FG000|Overall Study|Adverse Event|3|||
126277691|NCT00673387|454307331|FG001|Overall Study|Adverse Event|1|||
126277692|NCT00673387|454307332|FG002|Overall Study|Adverse Event|5|||
126277693|NCT00673387|454307333|FG003|Overall Study|Adverse Event|2|||
126277694|NCT00673387|454307334|FG004|Overall Study|Adverse Event|6|||
126277695|NCT00673387|454307335|FG005|Overall Study|Adverse Event|2|||
126277696|NCT00673387|454307336|FG006|Overall Study|Adverse Event|5|||
126277697|NCT00673387|454307337|FG007|Overall Study|Adverse Event|5|||
126277698|NCT00673387|454307330|FG000|Overall Study|Physician Decision|0|||
126277699|NCT00673387|454307331|FG001|Overall Study|Physician Decision|0|||
126277700|NCT00673387|454307332|FG002|Overall Study|Physician Decision|0|||
126277701|NCT00673387|454307333|FG003|Overall Study|Physician Decision|0|||
126277702|NCT00673387|454307334|FG004|Overall Study|Physician Decision|0|||
126277703|NCT00673387|454307335|FG005|Overall Study|Physician Decision|5|||
126277704|NCT00673387|454307336|FG006|Overall Study|Physician Decision|1|||
126277705|NCT00673387|454307337|FG007|Overall Study|Physician Decision|1|||
126277706|NCT00673387|454307330|FG000|Overall Study|Protocol Violation|3|||
126277707|NCT00673387|454307331|FG001|Overall Study|Protocol Violation|0|||
126454733|NCT03085914|454964798|FG005|Overall Study|Study Terminated by the Sponsor|1|||
126454734|NCT03085914|454964799|FG006|Overall Study|Study Terminated by the Sponsor|0|||
126454735|NCT04644315|454964800|FG000|Overall Study|Subject withdrawal of consent|1|||
126454736|NCT01445548|454964801|FG000|Overall Study|Adverse Event|1|||
126277708|NCT00673387|454307332|FG002|Overall Study|Protocol Violation|1|||
126277709|NCT00673387|454307333|FG003|Overall Study|Protocol Violation|2|||
126277710|NCT00673387|454307334|FG004|Overall Study|Protocol Violation|0|||
126277711|NCT00673387|454307335|FG005|Overall Study|Protocol Violation|1|||
126277712|NCT00673387|454307336|FG006|Overall Study|Protocol Violation|1|||
126277713|NCT00673387|454307337|FG007|Overall Study|Protocol Violation|3|||
126277714|NCT00673387|454307330|FG000|Overall Study|Lost to Follow-up|8|||
126277715|NCT00673387|454307331|FG001|Overall Study|Lost to Follow-up|6|||
126277716|NCT00673387|454307332|FG002|Overall Study|Lost to Follow-up|5|||
126277717|NCT00673387|454307333|FG003|Overall Study|Lost to Follow-up|6|||
126277718|NCT00673387|454307334|FG004|Overall Study|Lost to Follow-up|6|||
126277719|NCT00673387|454307335|FG005|Overall Study|Lost to Follow-up|5|||
126277720|NCT00673387|454307336|FG006|Overall Study|Lost to Follow-up|8|||
126454737|NCT03642132|454964803|FG000|Chemotherapy Period|Adverse Event|1|||
126454738|NCT03642132|454964804|FG001|Chemotherapy Period|Adverse Event|1|||
126277721|NCT00673387|454307337|FG007|Overall Study|Lost to Follow-up|5|||
126277722|NCT00960115|454307338|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
126277723|NCT00960115|454307339|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
126277724|NCT01094886|454307340|FG000|Overall Study|Adverse Event|2|||
126454739|NCT03642132|454964805|FG002|Chemotherapy Period|Adverse Event|0|||
126454740|NCT03642132|454964803|FG000|Chemotherapy Period|Physician's decision|4|||
126454741|NCT03642132|454964804|FG001|Chemotherapy Period|Physician's decision|1|||
126454742|NCT03642132|454964805|FG002|Chemotherapy Period|Physician's decision|0|||
126454743|NCT03642132|454964803|FG000|Chemotherapy Period|Progressive disease|0|||
126454744|NCT03642132|454964804|FG001|Chemotherapy Period|Progressive disease|0|||
126706607|NCT00002850|455877383|FG002|Overall Study|Withdrawal by Subject|0|||
126706608|NCT02452359|455877389|FG000|Overall Study|Adverse Event|1|||
126706609|NCT02452359|455877389|FG000|Overall Study|Lost to Follow-up|15|||
126706610|NCT02452359|455877389|FG000|Overall Study|Pregnancy|1|||
126706611|NCT02452359|455877389|FG000|Overall Study|Withdrawal by Subject|4|||
126706612|NCT01877655|455877392|FG000|Overall Study|Death|57|||
126706613|NCT01877655|455877393|FG001|Overall Study|Death|52|||
126706614|NCT01877655|455877392|FG000|Overall Study|Withdrawal by Subject|18|||
126706615|NCT01877655|455877393|FG001|Overall Study|Withdrawal by Subject|26|||
126706616|NCT01877655|455877392|FG000|Overall Study|Physician Decision|11|||
126706617|NCT01877655|455877393|FG001|Overall Study|Physician Decision|10|||
126706618|NCT01877655|455877392|FG000|Overall Study|Miscellaneous|4|||
126706619|NCT01877655|455877393|FG001|Overall Study|Miscellaneous|4|||
126706620|NCT01877655|455877392|FG000|Overall Study|Randomized but Never Received Drug|8|||
126706621|NCT01877655|455877393|FG001|Overall Study|Randomized but Never Received Drug|5|||
126706622|NCT05635838|455878832|FG000|16-Week DBVC Period|Adverse Event|2|||
126706623|NCT05635838|455878833|FG001|16-Week DBVC Period|Adverse Event|0|||
126706624|NCT05635838|455878834|FG002|16-Week DBVC Period|Adverse Event|0|||
126706625|NCT05635838|455878835|FG003|16-Week DBVC Period|Adverse Event|0|||
126706626|NCT05635838|455878832|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
126706627|NCT05635838|455878833|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
126706628|NCT05635838|455878834|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
126706629|NCT05635838|455878835|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
126706630|NCT05635838|455878832|FG000|16-Week DBVC Period|Physician Decision|0|||
126706631|NCT05635838|455878833|FG001|16-Week DBVC Period|Physician Decision|1|||
126706632|NCT05635838|455878834|FG002|16-Week DBVC Period|Physician Decision|0|||
126706633|NCT05635838|455878835|FG003|16-Week DBVC Period|Physician Decision|0|||
126706634|NCT05635838|455878832|FG000|16-Week DBVC Period|Protocol Violation|1|||
126706635|NCT05635838|455878833|FG001|16-Week DBVC Period|Protocol Violation|0|||
126706636|NCT05635838|455878834|FG002|16-Week DBVC Period|Protocol Violation|0|||
126277725|NCT01094886|454307340|FG000|Overall Study|Withdrawal by Subject|5|||
126277726|NCT00574912|454307341|FG000|Overall Study|Could not place IV lines.|3|||
126277727|NCT00574912|454307341|FG000|Overall Study|scheduling conflicts|3|||
126277728|NCT00574912|454307341|FG000|Overall Study|Physician Decision|2|||
126277729|NCT04730349|454307343|FG000|Overall Study|Participant withdrew consent|1|||
126277730|NCT04730349|454307344|FG001|Overall Study|Participant withdrew consent|0|||
126277731|NCT04730349|454307343|FG000|Overall Study|Disease progression|6|||
126277732|NCT04730349|454307344|FG001|Overall Study|Disease progression|4|||
126277733|NCT04730349|454307343|FG000|Overall Study|Study drug toxicity|0|||
126277734|NCT04730349|454307344|FG001|Overall Study|Study drug toxicity|1|||
126277735|NCT02377427|454307348|FG000|Part A (Up to Week 20)|Physician Decision|1|||
126277736|NCT02377427|454307349|FG001|Part A (Up to Week 20)|Physician Decision|0|||
126277737|NCT02377427|454307350|FG002|Part A (Up to Week 20)|Physician Decision|0|||
126277738|NCT02377427|454307351|FG003|Part A (Up to Week 20)|Physician Decision|0|||
126277739|NCT02377427|454307352|FG004|Part A (Up to Week 20)|Physician Decision|0|||
126277740|NCT02377427|454307348|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
126277741|NCT02377427|454307349|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
126277742|NCT02377427|454307350|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
126454745|NCT03642132|454964805|FG002|Chemotherapy Period|Progressive disease|1|||
126454746|NCT03642132|454964803|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
126454747|NCT03642132|454964804|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
126454748|NCT03642132|454964805|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
126454749|NCT03642132|454964803|FG000|Chemotherapy Period|Other|1|||
126277743|NCT02377427|454307351|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
126277744|NCT02377427|454307352|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
126454750|NCT03642132|454964804|FG001|Chemotherapy Period|Other|0|||
126547798|NCT00550550|455298062|FG000|Overall Study|Protocol Violation|5|||
126706637|NCT05635838|455878835|FG003|16-Week DBVC Period|Protocol Violation|0|||
126706638|NCT05635838|455878832|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
126706639|NCT05635838|455878833|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
126706640|NCT05635838|455878834|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
126706641|NCT05635838|455878835|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
126706642|NCT05635838|455878832|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
126706643|NCT05635838|455878833|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
126706644|NCT05635838|455878834|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
126706645|NCT05635838|455878835|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
126706646|NCT05635838|455878832|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
126706647|NCT05635838|455878833|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
126277745|NCT02377427|454307348|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
126454751|NCT03642132|454964805|FG002|Chemotherapy Period|Other|2|||
126277746|NCT02377427|454307349|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
126277747|NCT02377427|454307350|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
126277748|NCT02377427|454307351|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
126277749|NCT02377427|454307352|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
126277750|NCT02377427|454307348|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
126277751|NCT02377427|454307349|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
126277752|NCT02377427|454307350|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
126277753|NCT02377427|454307351|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
126277754|NCT02377427|454307352|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
126277755|NCT02342639|454307353|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
126277756|NCT02342639|454307354|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
126277757|NCT02342639|454307353|FG000|Overall Study|Protocol Violation|0|||
126277758|NCT02342639|454307354|FG001|Overall Study|Protocol Violation|2|||
126277759|NCT02212379|454307355|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
126277760|NCT02212379|454307355|FG000|From Baseline to Week 48|Adverse Event|7|||
126277761|NCT02212379|454307355|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
126306227|NCT01940887|454410251|FG001|Year 1|Physician Decision|3|||
126306228|NCT01940887|454410250|FG000|Year 1|Death|5|||
126306229|NCT01940887|454410251|FG001|Year 1|Death|3|||
126306230|NCT01940887|454410250|FG000|Year 1|Adverse Event|7|||
126306231|NCT01940887|454410251|FG001|Year 1|Adverse Event|6|||
126306232|NCT01940887|454410250|FG000|Year 1|Withdrawal by Subject|18|||
126306233|NCT01940887|454410251|FG001|Year 1|Withdrawal by Subject|9|||
126306234|NCT01940887|454410250|FG000|Year 1|Lost to Follow-up|2|||
126306235|NCT01940887|454410251|FG001|Year 1|Lost to Follow-up|1|||
126306236|NCT01940887|454410250|FG000|Year 2|Physician Decision|8|||
126306237|NCT01940887|454410251|FG001|Year 2|Physician Decision|1|||
126306238|NCT01940887|454410250|FG000|Year 2|Death|0|||
126306239|NCT01940887|454410251|FG001|Year 2|Death|2|||
126306240|NCT01940887|454410250|FG000|Year 2|Sponsor Decision, early termination|192|||
126306241|NCT01940887|454410251|FG001|Year 2|Sponsor Decision, early termination|203|||
126306242|NCT01940887|454410250|FG000|Year 2|Adverse Event|8|||
126306243|NCT01940887|454410251|FG001|Year 2|Adverse Event|2|||
126306244|NCT01940887|454410250|FG000|Year 2|Withdrawal by Subject|8|||
126306245|NCT01940887|454410251|FG001|Year 2|Withdrawal by Subject|8|||
126306246|NCT01940887|454410250|FG000|Year 2|Lost to Follow-up|1|||
126306247|NCT01940887|454410251|FG001|Year 2|Lost to Follow-up|6|||
126306248|NCT02475265|454410254|FG000|Overall Study|Physician Decision|1|||
126306249|NCT02475265|454410254|FG000|Overall Study|Withdrawal by Subject|2|||
126306250|NCT04590586|454410257|FG000|Overall Study|Death|7|||
126306251|NCT04590586|454410258|FG001|Overall Study|Death|1|||
126306252|NCT04590586|454410259|FG002|Overall Study|Death|37|||
126306253|NCT04590586|454410260|FG003|Overall Study|Death|34|||
126306254|NCT04590586|454410261|FG004|Overall Study|Death|19|||
126306255|NCT04590586|454410262|FG005|Overall Study|Death|3|||
126306256|NCT04590586|454410257|FG000|Overall Study|Lost to Follow-up|3|||
126306257|NCT04590586|454410258|FG001|Overall Study|Lost to Follow-up|0|||
126306258|NCT04590586|454410259|FG002|Overall Study|Lost to Follow-up|11|||
126306259|NCT04590586|454410260|FG003|Overall Study|Lost to Follow-up|11|||
126306260|NCT04590586|454410261|FG004|Overall Study|Lost to Follow-up|6|||
126306261|NCT04590586|454410262|FG005|Overall Study|Lost to Follow-up|0|||
126306262|NCT04590586|454410257|FG000|Overall Study|Withdrawal by Subject|0|||
126306263|NCT04590586|454410258|FG001|Overall Study|Withdrawal by Subject|0|||
126306264|NCT04590586|454410259|FG002|Overall Study|Withdrawal by Subject|6|||
126306265|NCT04590586|454410260|FG003|Overall Study|Withdrawal by Subject|0|||
126306266|NCT04590586|454410261|FG004|Overall Study|Withdrawal by Subject|3|||
126306267|NCT04590586|454410262|FG005|Overall Study|Withdrawal by Subject|0|||
126306268|NCT04590586|454410257|FG000|Overall Study|Other|3|||
126306269|NCT04590586|454410258|FG001|Overall Study|Other|0|||
126306270|NCT04590586|454410259|FG002|Overall Study|Other|1|||
126306271|NCT04590586|454410260|FG003|Overall Study|Other|1|||
126306272|NCT04590586|454410261|FG004|Overall Study|Other|2|||
126306273|NCT04590586|454410262|FG005|Overall Study|Other|1|||
126306274|NCT03063086|454410264|FG000|Overall Study|technical problems|1|||
126306275|NCT03063086|454410265|FG001|Overall Study|technical problems|0|||
126306276|NCT03063086|454410266|FG002|Overall Study|technical problems|0|||
126306277|NCT03063086|454410267|FG003|Overall Study|technical problems|0|||
126306278|NCT03063086|454410268|FG004|Overall Study|technical problems|0|||
126306279|NCT03063086|454410269|FG005|Overall Study|technical problems|0|||
126306280|NCT03063086|454410264|FG000|Overall Study|Adverse Event|1|||
126306281|NCT03063086|454410265|FG001|Overall Study|Adverse Event|1|||
126306282|NCT03063086|454410266|FG002|Overall Study|Adverse Event|1|||
126306283|NCT03063086|454410267|FG003|Overall Study|Adverse Event|1|||
126306284|NCT03063086|454410268|FG004|Overall Study|Adverse Event|0|||
126306285|NCT03063086|454410269|FG005|Overall Study|Adverse Event|0|||
126306286|NCT03063086|454410264|FG000|Overall Study|subject/guardian decision|1|||
126306287|NCT03063086|454410265|FG001|Overall Study|subject/guardian decision|0|||
126277762|NCT02212379|454307355|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
126277763|NCT02212379|454307355|FG000|From Week 48 to Week 96|Adverse Event|1|||
126277764|NCT02212379|454307355|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
126277765|NCT02105974|454307356|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
126277766|NCT02105974|454307357|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
126277767|NCT02105974|454307358|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
126277768|NCT02105974|454307356|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
126277769|NCT02105974|454307357|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
126277770|NCT02105974|454307358|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
126277771|NCT02105974|454307356|FG000|2 Week Run-in Period|Adverse Event|6|||
126277772|NCT02105974|454307357|FG001|2 Week Run-in Period|Adverse Event|0|||
126277773|NCT02105974|454307358|FG002|2 Week Run-in Period|Adverse Event|0|||
126277774|NCT02105974|454307356|FG000|2 Week Run-in Period|Study closed/terminated|1|||
126277775|NCT02105974|454307357|FG001|2 Week Run-in Period|Study closed/terminated|0|||
126277776|NCT02105974|454307358|FG002|2 Week Run-in Period|Study closed/terminated|0|||
126277777|NCT02105974|454307356|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
126277778|NCT02105974|454307357|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
126277779|NCT02105974|454307358|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
126277780|NCT02105974|454307356|FG000|2 Week Run-in Period|Withdrew consent|23|||
126277781|NCT02105974|454307357|FG001|2 Week Run-in Period|Withdrew consent|0|||
126277782|NCT02105974|454307358|FG002|2 Week Run-in Period|Withdrew consent|0|||
126277783|NCT02105974|454307356|FG000|2 Week Run-in Period|Investigator discretion|8|||
126277784|NCT02105974|454307357|FG001|2 Week Run-in Period|Investigator discretion|0|||
126277785|NCT02105974|454307358|FG002|2 Week Run-in Period|Investigator discretion|0|||
126277786|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
126277787|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
126277788|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
126277789|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
126277790|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
126277791|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
126277792|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
126277793|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
126277794|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
126277795|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
126277796|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
126277797|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
126277798|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
126277799|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
126277800|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
126277801|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
126277802|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
126277803|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
126277804|NCT02105974|454307356|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
126277805|NCT02105974|454307357|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
126277806|NCT02105974|454307358|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
126277807|NCT03155945|454307359|FG000|Overall Study|Lost to Follow-up|0|||
126454752|NCT03642132|454964803|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
126454753|NCT03642132|454964804|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
126454754|NCT03642132|454964805|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
126454755|NCT03642132|454964803|FG000|Maintenance Period|Adverse Event|1|||
126454756|NCT03642132|454964804|FG001|Maintenance Period|Adverse Event|2|||
126454757|NCT03642132|454964805|FG002|Maintenance Period|Adverse Event|0|||
126454758|NCT03642132|454964803|FG000|Maintenance Period|Non-compliance with study drug|0|||
126454759|NCT03642132|454964804|FG001|Maintenance Period|Non-compliance with study drug|0|||
126454760|NCT03642132|454964805|FG002|Maintenance Period|Non-compliance with study drug|1|||
126454761|NCT03642132|454964803|FG000|Maintenance Period|Physician's decision|2|||
126454762|NCT03642132|454964804|FG001|Maintenance Period|Physician's decision|2|||
126454763|NCT03642132|454964805|FG002|Maintenance Period|Physician's decision|2|||
126454764|NCT03642132|454964803|FG000|Maintenance Period|Progressive disease|9|||
126547799|NCT00550550|455298063|FG001|Overall Study|Protocol Violation|14|||
126547800|NCT00550550|455298062|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
126547801|NCT00550550|455298063|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
126547802|NCT00550550|455298062|FG000|Overall Study|Randomized But Not Treated|1|||
126277808|NCT03155945|454307360|FG001|Overall Study|Lost to Follow-up|1|||
126277809|NCT03155945|454307359|FG000|Overall Study|Withdrawal by Subject|0|||
126277810|NCT03155945|454307360|FG001|Overall Study|Withdrawal by Subject|1|||
126277811|NCT03155945|454307359|FG000|Overall Study|Other Reason|0|||
126277812|NCT03155945|454307360|FG001|Overall Study|Other Reason|1|||
126454765|NCT03642132|454964804|FG001|Maintenance Period|Progressive disease|3|||
126454766|NCT03642132|454964805|FG002|Maintenance Period|Progressive disease|6|||
126277813|NCT02013674|454307363|FG000|Overall Study|Death|0|||
126277814|NCT02013674|454307364|FG001|Overall Study|Death|1|||
126277815|NCT02013674|454307363|FG000|Overall Study|Lost to Follow-up|1|||
126277816|NCT02013674|454307364|FG001|Overall Study|Lost to Follow-up|0|||
126277817|NCT00416884|454307366|FG000|Overall Study|Study terminated due to low accrual|1|||
126277818|NCT02203331|454307367|FG000|Overall Study|Pregnancy|1|||
126277819|NCT02203331|454307368|FG001|Overall Study|Pregnancy|0|||
126277820|NCT02203331|454307369|FG002|Overall Study|Pregnancy|0|||
126277821|NCT02203331|454307370|FG003|Overall Study|Pregnancy|0|||
126277822|NCT02203331|454307371|FG004|Overall Study|Pregnancy|2|||
126277823|NCT02203331|454307372|FG005|Overall Study|Pregnancy|0|||
126277824|NCT02203331|454307367|FG000|Overall Study|Withdrawal by Subject|1|||
126277825|NCT02203331|454307368|FG001|Overall Study|Withdrawal by Subject|0|||
126277826|NCT02203331|454307369|FG002|Overall Study|Withdrawal by Subject|1|||
126277827|NCT02203331|454307370|FG003|Overall Study|Withdrawal by Subject|0|||
126277828|NCT02203331|454307371|FG004|Overall Study|Withdrawal by Subject|0|||
126277829|NCT02203331|454307372|FG005|Overall Study|Withdrawal by Subject|3|||
126277830|NCT02203331|454307367|FG000|Overall Study|Adverse Event|4|||
126277831|NCT02203331|454307368|FG001|Overall Study|Adverse Event|8|||
126277832|NCT02203331|454307369|FG002|Overall Study|Adverse Event|3|||
126277833|NCT02203331|454307370|FG003|Overall Study|Adverse Event|4|||
126277834|NCT02203331|454307371|FG004|Overall Study|Adverse Event|3|||
126277835|NCT02203331|454307372|FG005|Overall Study|Adverse Event|3|||
126277836|NCT02203331|454307367|FG000|Overall Study|Other Reasons|1|||
126277837|NCT02203331|454307368|FG001|Overall Study|Other Reasons|2|||
126277838|NCT02203331|454307369|FG002|Overall Study|Other Reasons|0|||
126277839|NCT02203331|454307370|FG003|Overall Study|Other Reasons|2|||
126277840|NCT02203331|454307371|FG004|Overall Study|Other Reasons|0|||
126277841|NCT02203331|454307372|FG005|Overall Study|Other Reasons|0|||
126277842|NCT02203331|454307367|FG000|Overall Study|Lack of Efficacy|0|||
126277843|NCT02203331|454307368|FG001|Overall Study|Lack of Efficacy|2|||
126277844|NCT02203331|454307369|FG002|Overall Study|Lack of Efficacy|1|||
126277845|NCT02203331|454307370|FG003|Overall Study|Lack of Efficacy|0|||
126277846|NCT02203331|454307371|FG004|Overall Study|Lack of Efficacy|0|||
126277847|NCT02203331|454307372|FG005|Overall Study|Lack of Efficacy|1|||
126277848|NCT02203331|454307367|FG000|Overall Study|Protocol Violation|0|||
126277849|NCT02203331|454307368|FG001|Overall Study|Protocol Violation|2|||
126277850|NCT02203331|454307369|FG002|Overall Study|Protocol Violation|0|||
126277851|NCT02203331|454307370|FG003|Overall Study|Protocol Violation|1|||
126277852|NCT02203331|454307371|FG004|Overall Study|Protocol Violation|1|||
126277853|NCT02203331|454307372|FG005|Overall Study|Protocol Violation|0|||
126362929|NCT04754399|454621664|FG000|Overall Study|Withdrawal by Subject|6|||
126362930|NCT00231465|454621665|FG000|Overall Study|Completed only one cycle|1|||
126362931|NCT00231465|454621665|FG000|Overall Study|Did not have follow up CT scans|1|||
126362932|NCT00025233|454621666|FG000|Overall Study|Ineligible: wrong cell type|1|||
126362933|NCT00025233|454621666|FG000|Overall Study|Ineligible: wrong primary|1|||
126362934|NCT00025233|454621666|FG000|Overall Study|Ineligible: improper prior treatment|1|||
126362935|NCT00025233|454621666|FG000|Overall Study|Never treated|1|||
126362936|NCT00930176|454621668|FG000|Overall Study|Death|1|||
126362937|NCT00401830|454621672|FG000|Overall Study|Adverse Event|10|||
126362938|NCT00401830|454621673|FG001|Overall Study|Adverse Event|18|||
126362939|NCT00401830|454621672|FG000|Overall Study|Lack of Efficacy|11|||
126362940|NCT00401830|454621673|FG001|Overall Study|Lack of Efficacy|5|||
126362941|NCT00401830|454621672|FG000|Overall Study|Withdrawal by Subject|4|||
126362942|NCT00401830|454621673|FG001|Overall Study|Withdrawal by Subject|3|||
126362943|NCT00401830|454621672|FG000|Overall Study|Protocol Violation|3|||
126362944|NCT00401830|454621673|FG001|Overall Study|Protocol Violation|3|||
126362945|NCT00401830|454621672|FG000|Overall Study|Non-compliance with drug study|1|||
126362946|NCT00401830|454621673|FG001|Overall Study|Non-compliance with drug study|0|||
126362947|NCT00401830|454621672|FG000|Overall Study|Lost to Follow-up|1|||
126362948|NCT00401830|454621673|FG001|Overall Study|Lost to Follow-up|3|||
126362949|NCT00401830|454621672|FG000|Overall Study|Other: Personal / Family problems|1|||
126362950|NCT00401830|454621673|FG001|Overall Study|Other: Personal / Family problems|0|||
126362951|NCT00452400|454621674|FG000|Overall Study|Adverse Event|1|||
126454767|NCT03642132|454964803|FG000|Maintenance Period|Other|0|||
126454768|NCT03642132|454964804|FG001|Maintenance Period|Other|0|||
126362952|NCT00452400|454621675|FG001|Overall Study|Adverse Event|1|||
126362953|NCT00452400|454621676|FG002|Overall Study|Adverse Event|5|||
126454769|NCT03642132|454964805|FG002|Maintenance Period|Other|3|||
126277854|NCT02203331|454307367|FG000|Overall Study|Lost to Follow-up|0|||
126362954|NCT00452400|454621677|FG003|Overall Study|Adverse Event|0|||
126362955|NCT00452400|454621678|FG004|Overall Study|Adverse Event|2|||
126362956|NCT00452400|454621674|FG000|Overall Study|Protocol Violation|0|||
126277855|NCT02203331|454307368|FG001|Overall Study|Lost to Follow-up|0|||
126277856|NCT02203331|454307369|FG002|Overall Study|Lost to Follow-up|0|||
126277857|NCT02203331|454307370|FG003|Overall Study|Lost to Follow-up|0|||
126277858|NCT02203331|454307371|FG004|Overall Study|Lost to Follow-up|1|||
126277859|NCT02203331|454307372|FG005|Overall Study|Lost to Follow-up|0|||
126362957|NCT00452400|454621675|FG001|Overall Study|Protocol Violation|0|||
126454770|NCT03642132|454964803|FG000|Maintenance Period|Withdrawal by Subject|1|||
126706648|NCT05635838|455878834|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
126706649|NCT05635838|455878835|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
126706650|NCT05635838|455878832|FG000|16-Week OLE Period|Adverse Event|0|||
126706651|NCT05635838|455878833|FG001|16-Week OLE Period|Adverse Event|0|||
126706652|NCT05635838|455878834|FG002|16-Week OLE Period|Adverse Event|0|||
126706653|NCT05635838|455878835|FG003|16-Week OLE Period|Adverse Event|2|||
126706654|NCT05635838|455878832|FG000|16-Week OLE Period|Lost to Follow-up|0|||
126706655|NCT05635838|455878833|FG001|16-Week OLE Period|Lost to Follow-up|0|||
126706656|NCT05635838|455878834|FG002|16-Week OLE Period|Lost to Follow-up|1|||
126706657|NCT05635838|455878835|FG003|16-Week OLE Period|Lost to Follow-up|3|||
126706658|NCT05635838|455878832|FG000|16-Week OLE Period|Physician Decision|0|||
126706659|NCT05635838|455878833|FG001|16-Week OLE Period|Physician Decision|0|||
126706660|NCT05635838|455878834|FG002|16-Week OLE Period|Physician Decision|0|||
126706661|NCT05635838|455878835|FG003|16-Week OLE Period|Physician Decision|1|||
126706662|NCT05635838|455878832|FG000|16-Week OLE Period|Protocol Violation|0|||
126706663|NCT05635838|455878833|FG001|16-Week OLE Period|Protocol Violation|0|||
126706664|NCT05635838|455878834|FG002|16-Week OLE Period|Protocol Violation|1|||
126706665|NCT05635838|455878835|FG003|16-Week OLE Period|Protocol Violation|1|||
126706666|NCT05635838|455878832|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
126706667|NCT05635838|455878833|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
126706668|NCT05635838|455878834|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
126706669|NCT05635838|455878835|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
126706670|NCT05635838|455878832|FG000|16-Week OLE Period|Pregnancy|0|||
126706671|NCT05635838|455878833|FG001|16-Week OLE Period|Pregnancy|0|||
126706672|NCT05635838|455878834|FG002|16-Week OLE Period|Pregnancy|1|||
126706673|NCT05635838|455878835|FG003|16-Week OLE Period|Pregnancy|0|||
126706674|NCT04493619|455878837|FG000|Overall Study|Death|4|||
126706675|NCT04493619|455878838|FG001|Overall Study|Death|3|||
126706676|NCT04493619|455878839|FG002|Overall Study|Death|3|||
126706677|NCT04493619|455878840|FG003|Overall Study|Death|4|||
126706678|NCT04493619|455878837|FG000|Overall Study|Study discontinued early|10|||
126706679|NCT04493619|455878838|FG001|Overall Study|Study discontinued early|0|||
126706680|NCT04493619|455878839|FG002|Overall Study|Study discontinued early|4|||
126706681|NCT04493619|455878840|FG003|Overall Study|Study discontinued early|8|||
126706682|NCT04493619|455878837|FG000|Overall Study|Lost to Follow-up|0|||
126706683|NCT04493619|455878838|FG001|Overall Study|Lost to Follow-up|0|||
126706684|NCT04493619|455878839|FG002|Overall Study|Lost to Follow-up|0|||
126706685|NCT04493619|455878840|FG003|Overall Study|Lost to Follow-up|1|||
126706686|NCT02128490|455878843|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
126706687|NCT02128490|455878844|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
126706688|NCT02128490|455878845|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
126706689|NCT02128490|455878846|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
126706690|NCT02128490|455878847|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
126706691|NCT02128490|455878843|FG000|Overall Study|Major Protocol Deviation|1|||
126706692|NCT02128490|455878844|FG001|Overall Study|Major Protocol Deviation|2|||
126706693|NCT02128490|455878845|FG002|Overall Study|Major Protocol Deviation|0|||
126706694|NCT02128490|455878846|FG003|Overall Study|Major Protocol Deviation|2|||
126706695|NCT02128490|455878847|FG004|Overall Study|Major Protocol Deviation|2|||
126706696|NCT02128490|455878843|FG000|Overall Study|Lost to Follow-up|0|||
126765709|NCT02074982|456095787|FG001|Overall Study|Non-compliance with study treatment|2|||
126277860|NCT04051619|454307379|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
126277861|NCT04051619|454307380|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
126277862|NCT04051619|454307379|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
126277863|NCT04051619|454307380|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
126277864|NCT03610516|454309050|FG000|Treatment Epoch|Adverse Event|3|||
126277865|NCT03610516|454309051|FG001|Treatment Epoch|Adverse Event|1|||
126277866|NCT03610516|454309050|FG000|Treatment Epoch|Death|1|||
126277867|NCT03610516|454309051|FG001|Treatment Epoch|Death|0|||
126277868|NCT03610516|454309050|FG000|Treatment Epoch|Lack of Efficacy|0|||
126277869|NCT03610516|454309051|FG001|Treatment Epoch|Lack of Efficacy|1|||
126277870|NCT03610516|454309050|FG000|Treatment Epoch|No longer requires treatment|1|||
126765710|NCT02074982|456095786|FG000|Overall Study|Physician Decision|1|||
126277871|NCT03610516|454309051|FG001|Treatment Epoch|No longer requires treatment|0|||
126277872|NCT03610516|454309050|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
126706697|NCT02128490|455878844|FG001|Overall Study|Lost to Follow-up|0|||
126706698|NCT02128490|455878845|FG002|Overall Study|Lost to Follow-up|1|||
126706699|NCT02128490|455878846|FG003|Overall Study|Lost to Follow-up|1|||
126706700|NCT02128490|455878847|FG004|Overall Study|Lost to Follow-up|1|||
126706701|NCT02128490|455878843|FG000|Overall Study|Voluntary Withdrawal|3|||
126706702|NCT02128490|455878844|FG001|Overall Study|Voluntary Withdrawal|3|||
126706703|NCT02128490|455878845|FG002|Overall Study|Voluntary Withdrawal|1|||
126706704|NCT02128490|455878846|FG003|Overall Study|Voluntary Withdrawal|1|||
126706705|NCT02128490|455878847|FG004|Overall Study|Voluntary Withdrawal|2|||
126706706|NCT02128490|455878843|FG000|Overall Study|Lack of Efficacy|0|||
126706707|NCT02128490|455878844|FG001|Overall Study|Lack of Efficacy|1|||
126765711|NCT02074982|456095787|FG001|Overall Study|Physician Decision|1|||
126706708|NCT02128490|455878845|FG002|Overall Study|Lack of Efficacy|0|||
126706709|NCT02128490|455878846|FG003|Overall Study|Lack of Efficacy|0|||
126706710|NCT02128490|455878847|FG004|Overall Study|Lack of Efficacy|0|||
126706711|NCT02128490|455878843|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
126706712|NCT02128490|455878844|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
126706713|NCT02128490|455878845|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
126706714|NCT02128490|455878846|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
126277873|NCT03610516|454309051|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
126277874|NCT03610516|454309050|FG000|Treatment Epoch|Physician Decision|8|||
126277875|NCT03610516|454309051|FG001|Treatment Epoch|Physician Decision|5|||
126277876|NCT03610516|454309050|FG000|Treatment Epoch|Protocol Deviation|1|||
126277877|NCT03610516|454309051|FG001|Treatment Epoch|Protocol Deviation|0|||
126277878|NCT03610516|454309050|FG000|Treatment Epoch|Withdrawal by Subject|3|||
126277879|NCT03610516|454309051|FG001|Treatment Epoch|Withdrawal by Subject|1|||
126277880|NCT03610516|454309050|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
126277881|NCT03610516|454309051|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
126277882|NCT03610516|454309050|FG000|Post-Treatment Follow-up|Death|1|||
126277883|NCT03610516|454309051|FG001|Post-Treatment Follow-up|Death|0|||
126277884|NCT00660907|454309055|FG000|Overall Study|Incorrect Enrollment|1|||
126277885|NCT00660907|454309056|FG001|Overall Study|Incorrect Enrollment|1|||
126277886|NCT00660907|454309055|FG000|Overall Study|Adverse Event|33|||
126277887|NCT00660907|454309056|FG001|Overall Study|Adverse Event|19|||
126362958|NCT00452400|454621676|FG002|Overall Study|Protocol Violation|1|||
126706715|NCT02128490|455878847|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
126706716|NCT02128490|455878843|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126706717|NCT02128490|455878844|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126277888|NCT00660907|454309055|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
126277889|NCT00660907|454309056|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
126277890|NCT00660907|454309055|FG000|Overall Study|Withdrawal by Subject|23|||
126362959|NCT00452400|454621677|FG003|Overall Study|Protocol Violation|0|||
126362960|NCT00452400|454621678|FG004|Overall Study|Protocol Violation|0|||
126362961|NCT00452400|454621674|FG000|Overall Study|Lost to Follow-up|1|||
126362962|NCT00452400|454621675|FG001|Overall Study|Lost to Follow-up|0|||
126362963|NCT00452400|454621676|FG002|Overall Study|Lost to Follow-up|0|||
126362964|NCT00452400|454621677|FG003|Overall Study|Lost to Follow-up|0|||
126362965|NCT00452400|454621678|FG004|Overall Study|Lost to Follow-up|0|||
126362966|NCT00452400|454621674|FG000|Overall Study|Withdrawal by Subject|1|||
126362967|NCT00452400|454621675|FG001|Overall Study|Withdrawal by Subject|0|||
126362968|NCT00452400|454621676|FG002|Overall Study|Withdrawal by Subject|1|||
126362969|NCT00452400|454621677|FG003|Overall Study|Withdrawal by Subject|0|||
126362970|NCT00452400|454621678|FG004|Overall Study|Withdrawal by Subject|0|||
126362971|NCT00452400|454621674|FG000|Overall Study|Lack of Efficacy|2|||
126362972|NCT00452400|454621675|FG001|Overall Study|Lack of Efficacy|0|||
126362973|NCT00452400|454621676|FG002|Overall Study|Lack of Efficacy|0|||
126362974|NCT00452400|454621677|FG003|Overall Study|Lack of Efficacy|0|||
126362975|NCT00452400|454621678|FG004|Overall Study|Lack of Efficacy|0|||
126362976|NCT00452400|454621674|FG000|Overall Study|Other reasons not listed above|0|||
126362977|NCT00452400|454621675|FG001|Overall Study|Other reasons not listed above|0|||
126362978|NCT00452400|454621676|FG002|Overall Study|Other reasons not listed above|0|||
126362979|NCT00452400|454621677|FG003|Overall Study|Other reasons not listed above|1|||
126362980|NCT00452400|454621678|FG004|Overall Study|Other reasons not listed above|1|||
126362981|NCT01943825|454621679|FG000|Overall Study|Lost to Follow-up|9|||
126362982|NCT01943825|454621680|FG001|Overall Study|Lost to Follow-up|3|||
126362983|NCT01943825|454621681|FG002|Overall Study|Lost to Follow-up|12|||
126362984|NCT01943825|454621682|FG003|Overall Study|Lost to Follow-up|8|||
126362985|NCT01943825|454621679|FG000|Overall Study|Withdrawal by Subject|1|||
126362986|NCT01943825|454621680|FG001|Overall Study|Withdrawal by Subject|0|||
126362987|NCT01943825|454621681|FG002|Overall Study|Withdrawal by Subject|3|||
126362988|NCT01943825|454621682|FG003|Overall Study|Withdrawal by Subject|2|||
126362989|NCT01943825|454621679|FG000|Overall Study|Other than specified above|0|||
126362990|NCT01943825|454621680|FG001|Overall Study|Other than specified above|1|||
126362991|NCT01943825|454621681|FG002|Overall Study|Other than specified above|0|||
126362992|NCT01943825|454621682|FG003|Overall Study|Other than specified above|1|||
126362993|NCT01720602|454621683|FG000|Overall Study|Adverse Event|3|||
126362994|NCT01720602|454621683|FG000|Overall Study|Progressive disease on therapy|2|||
126362995|NCT03378635|454621685|FG000|Overall Study|Adverse Event|1|||
126362996|NCT03378635|454621686|FG001|Overall Study|Adverse Event|0|||
126362997|NCT03378635|454621687|FG002|Overall Study|Adverse Event|0|||
126706718|NCT02128490|455878845|FG002|Overall Study|Other Miscellaneous Reasons|2|||
126277891|NCT00660907|454309056|FG001|Overall Study|Withdrawal by Subject|32|||
126362998|NCT03378635|454621685|FG000|Overall Study|Withdrawal by Subject|1|||
126362999|NCT03378635|454621686|FG001|Overall Study|Withdrawal by Subject|0|||
126363000|NCT03378635|454621687|FG002|Overall Study|Withdrawal by Subject|0|||
126363001|NCT03425188|454621689|FG000|Overall Study|Withdrawal by Subject|1|||
126363002|NCT00562861|454621692|FG000|Overall Study|Adverse Event|1|||
126277892|NCT00660907|454309055|FG000|Overall Study|Lost to Follow-up|3|||
126277893|NCT00660907|454309056|FG001|Overall Study|Lost to Follow-up|3|||
126277894|NCT00660907|454309055|FG000|Overall Study|Poor/Non-Compliance|5|||
126277895|NCT00660907|454309056|FG001|Overall Study|Poor/Non-Compliance|1|||
126277896|NCT00660907|454309055|FG000|Overall Study|Safety|1|||
126277897|NCT00660907|454309056|FG001|Overall Study|Safety|0|||
126454771|NCT03642132|454964804|FG001|Maintenance Period|Withdrawal by Subject|1|||
126454772|NCT03642132|454964805|FG002|Maintenance Period|Withdrawal by Subject|2|||
126454773|NCT03642132|454964803|FG000|Follow-up Period|Other|0|||
126454774|NCT03642132|454964804|FG001|Follow-up Period|Other|0|||
126454775|NCT03642132|454964805|FG002|Follow-up Period|Other|1|||
126454776|NCT03642132|454964803|FG000|Follow-up Period|Withdrawal by Subject|1|||
126454777|NCT03642132|454964804|FG001|Follow-up Period|Withdrawal by Subject|2|||
126454778|NCT03642132|454964805|FG002|Follow-up Period|Withdrawal by Subject|0|||
126454779|NCT03642132|454964803|FG000|Follow-up Period|Study terminated by sponsor|1|||
126454780|NCT03642132|454964804|FG001|Follow-up Period|Study terminated by sponsor|0|||
126454781|NCT03642132|454964805|FG002|Follow-up Period|Study terminated by sponsor|1|||
126454782|NCT03642132|454964803|FG000|Follow-up Period|Lack of Efficacy|1|||
126454783|NCT03642132|454964804|FG001|Follow-up Period|Lack of Efficacy|0|||
126454784|NCT03642132|454964805|FG002|Follow-up Period|Lack of Efficacy|0|||
126454785|NCT03642132|454964803|FG000|Follow-up Period|Death|1|||
126454786|NCT03642132|454964804|FG001|Follow-up Period|Death|0|||
126454787|NCT03642132|454964805|FG002|Follow-up Period|Death|2|||
126454788|NCT03642132|454964803|FG000|Follow-up Period|Adverse Event|1|||
126454789|NCT03642132|454964804|FG001|Follow-up Period|Adverse Event|0|||
126454790|NCT03642132|454964805|FG002|Follow-up Period|Adverse Event|0|||
126454791|NCT01958489|454964812|FG000|Period 2|Adverse Event|0|||
126454792|NCT01958489|454964813|FG001|Period 2|Adverse Event|1|||
126454793|NCT02500056|454964814|FG000|Overall Study|Lost to Follow-up|3|||
126454794|NCT02500056|454964815|FG001|Overall Study|Lost to Follow-up|7|||
126454795|NCT02500056|454964814|FG000|Overall Study|Recurrence|1|||
126454796|NCT02500056|454964815|FG001|Overall Study|Recurrence|0|||
126454797|NCT02500056|454964814|FG000|Overall Study|Death|3|||
126454798|NCT02500056|454964815|FG001|Overall Study|Death|1|||
126454799|NCT01253811|454964818|FG000|Overall Study|Withdrawal criteria|1|||
126454800|NCT01087736|454964819|FG000|Overall Study|Lost to Follow-up|1|||
126454801|NCT01087736|454964820|FG001|Overall Study|Lost to Follow-up|0|||
126454802|NCT01087736|454964819|FG000|Overall Study|Death|0|||
126454803|NCT01087736|454964820|FG001|Overall Study|Death|1|||
126454804|NCT01087736|454964819|FG000|Overall Study|Withdrawal by Subject|0|||
126454805|NCT01087736|454964820|FG001|Overall Study|Withdrawal by Subject|1|||
126454806|NCT01101308|454964827|FG000|Period 1|Adverse Event|2|||
126454807|NCT01101308|454964828|FG001|Period 1|Adverse Event|1|||
126454808|NCT01101308|454964827|FG000|Period 1|Positive for cotinine|1|||
126454809|NCT01101308|454964828|FG001|Period 1|Positive for cotinine|0|||
126454810|NCT00869778|454964833|FG000|Overall Study|Adverse Event|2|||
126454811|NCT00869778|454964834|FG001|Overall Study|Adverse Event|0|||
126454812|NCT00869778|454964835|FG002|Overall Study|Adverse Event|0|||
126454813|NCT00869778|454964833|FG000|Overall Study|Withdrawal by Subject|3|||
126454814|NCT00869778|454964834|FG001|Overall Study|Withdrawal by Subject|4|||
126454815|NCT00869778|454964835|FG002|Overall Study|Withdrawal by Subject|5|||
126454816|NCT00869778|454964833|FG000|Overall Study|Pregnancy|1|||
126454817|NCT00869778|454964834|FG001|Overall Study|Pregnancy|0|||
126454818|NCT00869778|454964835|FG002|Overall Study|Pregnancy|0|||
126454819|NCT00869778|454964833|FG000|Overall Study|Protocol Violation|5|||
126454820|NCT00869778|454964834|FG001|Overall Study|Protocol Violation|3|||
126454821|NCT00869778|454964835|FG002|Overall Study|Protocol Violation|5|||
126454822|NCT00869778|454964833|FG000|Overall Study|Unblinding|1|||
126454823|NCT00869778|454964834|FG001|Overall Study|Unblinding|0|||
126454824|NCT00869778|454964835|FG002|Overall Study|Unblinding|0|||
126454825|NCT03180619|454964836|FG000|Overall Study|Withdrew Consent|5|||
126454826|NCT03180619|454964837|FG001|Overall Study|Withdrew Consent|0|||
126454827|NCT03180619|454964838|FG002|Overall Study|Withdrew Consent|2|||
126454828|NCT03180619|454964836|FG000|Overall Study|Death|2|||
126454829|NCT03180619|454964837|FG001|Overall Study|Death|1|||
126454830|NCT03180619|454964838|FG002|Overall Study|Death|2|||
126277898|NCT00660907|454309055|FG000|Overall Study|Death|1|||
126277899|NCT00660907|454309056|FG001|Overall Study|Death|3|||
126277900|NCT00660907|454309055|FG000|Overall Study|Various|11|||
126277901|NCT00660907|454309056|FG001|Overall Study|Various|8|||
126454831|NCT03180619|454964836|FG000|Overall Study|Adverse Event|2|||
126454832|NCT03180619|454964837|FG001|Overall Study|Adverse Event|0|||
126454833|NCT03180619|454964838|FG002|Overall Study|Adverse Event|1|||
126454834|NCT03180619|454964836|FG000|Overall Study|Investigator's discretion|2|||
126454835|NCT03180619|454964837|FG001|Overall Study|Investigator's discretion|0|||
126454836|NCT03180619|454964838|FG002|Overall Study|Investigator's discretion|1|||
126454837|NCT02112045|454964841|FG000|Overall Study|Withdrawal by Subject|1|||
126454838|NCT02112045|454964842|FG001|Overall Study|Withdrawal by Subject|0|||
126454839|NCT00977080|454964843|FG000|Overall Study|Adverse Event|2|||
126454840|NCT00977080|454964844|FG001|Overall Study|Adverse Event|7|||
126454841|NCT00977080|454964845|FG002|Overall Study|Adverse Event|7|||
126454842|NCT00977080|454964846|FG003|Overall Study|Adverse Event|7|||
126547803|NCT00550550|455298063|FG001|Overall Study|Randomized But Not Treated|0|||
126547804|NCT02714205|455298077|FG000|Overall Study|Cannot tolerate medication|1|||
126547805|NCT02714205|455298078|FG001|Overall Study|Cannot tolerate medication|0|||
126547806|NCT02714205|455298077|FG000|Overall Study|Adverse Event|2|||
126547807|NCT02714205|455298078|FG001|Overall Study|Adverse Event|0|||
126547808|NCT02714205|455298077|FG000|Overall Study|Too busy|1|||
126547809|NCT02714205|455298078|FG001|Overall Study|Too busy|0|||
126547810|NCT02714205|455298077|FG000|Overall Study|Incomplete outcome data|0|||
126547811|NCT02714205|455298078|FG001|Overall Study|Incomplete outcome data|1|||
126547812|NCT00381641|455298079|FG000|Overall Study|Withdrawal by Subject|0|||
126547813|NCT00381641|455298080|FG001|Overall Study|Withdrawal by Subject|2|||
126547814|NCT01598298|455298081|FG000|Overall Study|Not eligible|5|||
126547815|NCT01598298|455298082|FG001|Overall Study|Not eligible|5|||
126547816|NCT01598298|455298081|FG000|Overall Study|Adverse Event|21|||
126547817|NCT01598298|455298082|FG001|Overall Study|Adverse Event|19|||
126547818|NCT01598298|455298081|FG000|Overall Study|Progression/relapse|0|||
126547819|NCT01598298|455298082|FG001|Overall Study|Progression/relapse|2|||
126547820|NCT01598298|455298081|FG000|Overall Study|Withdrawal by Subject|10|||
126547821|NCT01598298|455298082|FG001|Overall Study|Withdrawal by Subject|15|||
126547822|NCT01598298|455298081|FG000|Overall Study|Other reason (not protocol specified)|4|||
126547823|NCT01598298|455298082|FG001|Overall Study|Other reason (not protocol specified)|0|||
126547824|NCT04287868|455298083|FG000|Overall Study|Screening fail|1|||
126547825|NCT04287868|455298084|FG001|Overall Study|Screening fail|0|||
126547826|NCT03813147|455298085|FG000|Overall Study|Lack of Efficacy|4|||
126547827|NCT03813147|455298086|FG001|Overall Study|Lack of Efficacy|4|||
126547828|NCT03813147|455298085|FG000|Overall Study|Physician Decision|2|||
126547829|NCT03813147|455298086|FG001|Overall Study|Physician Decision|1|||
126547830|NCT04567693|455299747|FG000|Overall Study|Death|0|||
126547831|NCT04567693|455299748|FG001|Overall Study|Death|0|||
126547832|NCT04567693|455299749|FG002|Overall Study|Death|2|||
126547833|NCT04567693|455299747|FG000|Overall Study|Lost to Follow-up|1|||
126547834|NCT04567693|455299748|FG001|Overall Study|Lost to Follow-up|0|||
126547835|NCT04567693|455299749|FG002|Overall Study|Lost to Follow-up|2|||
126547836|NCT04567693|455299747|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
126547837|NCT04567693|455299748|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
126547838|NCT04567693|455299749|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
126547839|NCT03462706|455299750|FG000|Overall Study|Polyp was pedunculated|1|||
126547840|NCT03462706|455299751|FG001|Overall Study|Polyp was pedunculated|0|||
126547841|NCT03462706|455299752|FG002|Overall Study|Polyp was pedunculated|1|||
126547842|NCT03462706|455299753|FG003|Overall Study|Polyp was pedunculated|0|||
126547843|NCT03462706|455299750|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
126547844|NCT03462706|455299751|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
126547845|NCT03462706|455299752|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
126547846|NCT03462706|455299753|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
126547847|NCT04105972|455299758|FG000|Overall Study|Adverse Event|2|||
126547848|NCT04105972|455299759|FG001|Overall Study|Adverse Event|1|||
126547849|NCT00553202|455299764|FG000|Overall Study|Death|16|||
126547850|NCT00553202|455299764|FG000|Overall Study|Lost to Follow-up|1|||
126547851|NCT00553202|455299764|FG000|Overall Study|Physician Decision|28|||
126547852|NCT00553202|455299764|FG000|Overall Study|Withdrawal by Subject|1|||
126547853|NCT00553202|455299764|FG000|Overall Study|No donor identified|16|||
126547854|NCT00553202|455299764|FG000|Overall Study|Fails to meet organ function|6|||
126547855|NCT04651114|455299765|FG000|Overall Study|Withdrawal by Subject|8|||
126547856|NCT00474929|455299770|FG000|Overall Study|Withdrawal by Subject|0|||
126547857|NCT00474929|455299771|FG001|Overall Study|Withdrawal by Subject|1|||
126547858|NCT00474929|455299772|FG002|Overall Study|Withdrawal by Subject|0|||
126547859|NCT00474929|455299773|FG003|Overall Study|Withdrawal by Subject|0|||
126547860|NCT00474929|455299774|FG004|Overall Study|Withdrawal by Subject|0|||
126547861|NCT00474929|455299770|FG000|Overall Study|Unrelated medical condition|0|||
126547862|NCT00474929|455299771|FG001|Overall Study|Unrelated medical condition|0|||
126547863|NCT00474929|455299772|FG002|Overall Study|Unrelated medical condition|1|||
126547864|NCT00474929|455299773|FG003|Overall Study|Unrelated medical condition|0|||
126277902|NCT02932306|454309069|FG000|Overall Study|Withdrawal by Subject|16|||
126277903|NCT02932306|454309070|FG001|Overall Study|Withdrawal by Subject|25|||
126547865|NCT00474929|455299774|FG004|Overall Study|Unrelated medical condition|0|||
126547866|NCT00474929|455299770|FG000|Overall Study|Physician Decision|0|||
126547867|NCT00474929|455299771|FG001|Overall Study|Physician Decision|0|||
126277904|NCT02932306|454309069|FG000|Overall Study|Adverse Event|3|||
126547868|NCT00474929|455299772|FG002|Overall Study|Physician Decision|1|||
126547869|NCT00474929|455299773|FG003|Overall Study|Physician Decision|2|||
126547870|NCT00474929|455299774|FG004|Overall Study|Physician Decision|0|||
126547871|NCT02593305|455299775|FG000|Post 1|Comparison only group. No intervention.|0|||
126547872|NCT02593305|455299776|FG001|Post 1|Comparison only group. No intervention.|0|||
126547873|NCT02593305|455299777|FG002|Post 1|Comparison only group. No intervention.|10|||
126277905|NCT02932306|454309070|FG001|Overall Study|Adverse Event|0|||
126765712|NCT02074982|456095786|FG000|Overall Study|Pregnancy|1|||
126706719|NCT02128490|455878846|FG003|Overall Study|Other Miscellaneous Reasons|1|||
126547874|NCT01161472|455299778|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
126547875|NCT01161472|455299779|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
126547876|NCT01161472|455299780|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
126547877|NCT01161472|455299781|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
126547878|NCT00768430|455299804|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
126547879|NCT00768430|455299805|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
126547880|NCT00041756|455299807|FG000|Overall Study|Adverse Event|4|||
126547881|NCT00041756|455299808|FG001|Overall Study|Adverse Event|10|||
126547882|NCT00041756|455299809|FG002|Overall Study|Adverse Event|6|||
126706720|NCT02128490|455878847|FG004|Overall Study|Other Miscellaneous Reasons|1|||
126706721|NCT02243176|455878848|FG000|Overall Study|Other reason|1|||
126706722|NCT02243176|455878849|FG001|Overall Study|Other reason|2|||
126706723|NCT02243176|455878848|FG000|Overall Study|protocol specified withdrawal critera|1|||
126706724|NCT02243176|455878849|FG001|Overall Study|protocol specified withdrawal critera|3|||
126706725|NCT02243176|455878848|FG000|Overall Study|Protocol Violation|2|||
126706726|NCT02243176|455878849|FG001|Overall Study|Protocol Violation|1|||
126706727|NCT02243176|455878848|FG000|Overall Study|Withdrawal by Subject|8|||
126706728|NCT02243176|455878849|FG001|Overall Study|Withdrawal by Subject|7|||
126706729|NCT02243176|455878848|FG000|Overall Study|Adverse Event|2|||
126706730|NCT02243176|455878849|FG001|Overall Study|Adverse Event|2|||
126706731|NCT03518840|455878853|FG000|Overall Study|Lost to Follow-up|6|||
126706732|NCT00875420|455878855|FG000|Overall Study|Adverse Event|0|||
126706733|NCT00875420|455878856|FG001|Overall Study|Adverse Event|1|||
126706734|NCT00875420|455878857|FG002|Overall Study|Adverse Event|1|||
126706735|NCT00875420|455878858|FG003|Overall Study|Adverse Event|0|||
126706736|NCT00875420|455878859|FG004|Overall Study|Adverse Event|0|||
126706737|NCT00875420|455878855|FG000|Overall Study|Inability to complete study procedures|1|||
126706738|NCT00875420|455878856|FG001|Overall Study|Inability to complete study procedures|0|||
126706739|NCT00875420|455878857|FG002|Overall Study|Inability to complete study procedures|1|||
126706740|NCT00875420|455878858|FG003|Overall Study|Inability to complete study procedures|1|||
126706741|NCT00875420|455878859|FG004|Overall Study|Inability to complete study procedures|1|||
126706742|NCT00875420|455878855|FG000|Overall Study|Lost to Follow-up|1|||
126706743|NCT00875420|455878856|FG001|Overall Study|Lost to Follow-up|0|||
126706744|NCT00875420|455878857|FG002|Overall Study|Lost to Follow-up|0|||
126706745|NCT00875420|455878858|FG003|Overall Study|Lost to Follow-up|0|||
126706746|NCT00875420|455878859|FG004|Overall Study|Lost to Follow-up|0|||
126706747|NCT00875420|455878855|FG000|Overall Study|Personal reason|0|||
126706748|NCT00875420|455878856|FG001|Overall Study|Personal reason|0|||
126706749|NCT00875420|455878857|FG002|Overall Study|Personal reason|0|||
126706750|NCT00875420|455878858|FG003|Overall Study|Personal reason|0|||
126706751|NCT00875420|455878859|FG004|Overall Study|Personal reason|1|||
126706752|NCT00875420|455878855|FG000|Overall Study|Prohibited medication|0|||
126706753|NCT00875420|455878856|FG001|Overall Study|Prohibited medication|0|||
126706754|NCT00875420|455878857|FG002|Overall Study|Prohibited medication|0|||
126706755|NCT00875420|455878858|FG003|Overall Study|Prohibited medication|1|||
126706756|NCT00875420|455878859|FG004|Overall Study|Prohibited medication|0|||
126706757|NCT00875420|455878855|FG000|Overall Study|Sponsor decision|0|||
126706758|NCT00875420|455878856|FG001|Overall Study|Sponsor decision|1|||
126706759|NCT00875420|455878857|FG002|Overall Study|Sponsor decision|0|||
126706760|NCT00875420|455878858|FG003|Overall Study|Sponsor decision|0|||
126706761|NCT00875420|455878859|FG004|Overall Study|Sponsor decision|0|||
126706762|NCT00875420|455878855|FG000|Overall Study|Withdrawal by Subject|0|||
126706763|NCT00875420|455878856|FG001|Overall Study|Withdrawal by Subject|0|||
126706764|NCT00875420|455878857|FG002|Overall Study|Withdrawal by Subject|1|||
126706765|NCT00875420|455878858|FG003|Overall Study|Withdrawal by Subject|0|||
126706766|NCT00875420|455878859|FG004|Overall Study|Withdrawal by Subject|0|||
126706767|NCT00001259|455878860|FG000|Study 2|Adverse Event|0|||
126277906|NCT02932306|454309069|FG000|Overall Study|Pregnancy|2|||
126277907|NCT02932306|454309070|FG001|Overall Study|Pregnancy|0|||
126277908|NCT02932306|454309069|FG000|Overall Study|Protocol Violation|1|||
126277909|NCT02932306|454309070|FG001|Overall Study|Protocol Violation|1|||
126277910|NCT02932306|454309069|FG000|Overall Study|Noncompliance with Study Drug|1|||
126277911|NCT02932306|454309070|FG001|Overall Study|Noncompliance with Study Drug|1|||
126547883|NCT00041756|455299810|FG003|Overall Study|Adverse Event|11|||
126706768|NCT00001259|455878861|FG001|Study 2|Adverse Event|0|||
126706769|NCT00001259|455878862|FG002|Study 2|Adverse Event|0|||
126706770|NCT00001259|455878863|FG003|Study 2|Adverse Event|0|||
126706771|NCT00001259|455878864|FG004|Study 2|Adverse Event|2|||
126706772|NCT00001259|455878865|FG005|Study 2|Adverse Event|0|||
126706773|NCT00001259|455878866|FG006|Study 2|Adverse Event|0|||
126706774|NCT03704051|455878867|FG000|Overall Study|Withdrawal by Subject|4|||
126706775|NCT03704051|455878868|FG001|Overall Study|Withdrawal by Subject|0|||
126706776|NCT02629393|455878869|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
126706777|NCT02629393|455878869|FG000|Overall Study|Physician Decision|1|||
126706778|NCT03716726|455878870|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
126765713|NCT02074982|456095787|FG001|Overall Study|Pregnancy|2|||
126277912|NCT02932306|454309069|FG000|Overall Study|Lost to Follow-up|36|||
126277913|NCT02932306|454309070|FG001|Overall Study|Lost to Follow-up|40|||
126277914|NCT02932306|454309069|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
126277915|NCT02932306|454309070|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
126277916|NCT02932306|454309069|FG000|Overall Study|Lack of Efficacy|0|||
126277917|NCT02932306|454309070|FG001|Overall Study|Lack of Efficacy|2|||
126277918|NCT02932306|454309069|FG000|Overall Study|Worsening condition|2|||
126277919|NCT02932306|454309070|FG001|Overall Study|Worsening condition|0|||
126277920|NCT02932306|454309069|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
126277921|NCT02932306|454309070|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
126277922|NCT05776862|454309071|FG000|Overall Study|Adverse Event|0|||
126277923|NCT05776862|454309072|FG001|Overall Study|Adverse Event|1|||
126277924|NCT05776862|454309071|FG000|Overall Study|non-compliance|1|||
126277925|NCT05776862|454309072|FG001|Overall Study|non-compliance|0|||
126277926|NCT01199471|454309073|FG000|Overall Study|Protocol Violation|4|||
126277927|NCT01199471|454309073|FG000|Overall Study|Withdrawal by Subject|1|||
126277928|NCT01199471|454309073|FG000|Overall Study|Physician Decision|1|||
126277929|NCT02065700|454309074|FG000|Overall Study|Adverse Event|165|||
126277930|NCT02065700|454309075|FG001|Overall Study|Adverse Event|101|||
126277931|NCT02065700|454309074|FG000|Overall Study|Withdrawal by Subject|90|||
126454843|NCT00977080|454964843|FG000|Overall Study|Withdrawal by Subject|1|||
126454844|NCT00977080|454964844|FG001|Overall Study|Withdrawal by Subject|5|||
126454845|NCT00977080|454964845|FG002|Overall Study|Withdrawal by Subject|1|||
126454846|NCT00977080|454964846|FG003|Overall Study|Withdrawal by Subject|5|||
126454847|NCT00977080|454964843|FG000|Overall Study|Protocol Violation|7|||
126454848|NCT00977080|454964844|FG001|Overall Study|Protocol Violation|3|||
126454849|NCT00977080|454964845|FG002|Overall Study|Protocol Violation|4|||
126454850|NCT00977080|454964846|FG003|Overall Study|Protocol Violation|3|||
126454851|NCT00977080|454964843|FG000|Overall Study|Noncompliance|0|||
126454852|NCT00977080|454964844|FG001|Overall Study|Noncompliance|2|||
126454853|NCT00977080|454964845|FG002|Overall Study|Noncompliance|1|||
126454854|NCT00977080|454964846|FG003|Overall Study|Noncompliance|0|||
126454855|NCT00977080|454964843|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
126454856|NCT00977080|454964844|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
126454857|NCT00977080|454964845|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
126454858|NCT00977080|454964846|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
126454859|NCT00977080|454964843|FG000|Overall Study|Required kidney transplantation|1|||
126454860|NCT00977080|454964844|FG001|Overall Study|Required kidney transplantation|3|||
126454861|NCT00977080|454964845|FG002|Overall Study|Required kidney transplantation|3|||
126454862|NCT00977080|454964846|FG003|Overall Study|Required kidney transplantation|1|||
126454863|NCT00977080|454964843|FG000|Overall Study|Travel for family reasons|1|||
126454864|NCT00977080|454964844|FG001|Overall Study|Travel for family reasons|0|||
126454865|NCT00977080|454964845|FG002|Overall Study|Travel for family reasons|0|||
126454866|NCT00977080|454964846|FG003|Overall Study|Travel for family reasons|0|||
126454867|NCT00441116|454964847|FG000|Overall Study|Adverse Event|1|||
126454868|NCT00441116|454964848|FG001|Overall Study|Adverse Event|1|||
126454869|NCT00441116|454964847|FG000|Overall Study|Withdrawal by Subject|1|||
126454870|NCT00441116|454964848|FG001|Overall Study|Withdrawal by Subject|0|||
126454871|NCT00441116|454964847|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
126454872|NCT00441116|454964848|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
126454873|NCT01765218|454964857|FG000|Overall Study|Protocol Violation|1|||
126454874|NCT01765218|454964858|FG001|Overall Study|Protocol Violation|2|||
126454875|NCT00171834|454964859|FG000|Overall Study|Adverse Event|2|||
126454876|NCT00171834|454964860|FG001|Overall Study|Adverse Event|1|||
126454877|NCT00171834|454964861|FG002|Overall Study|Adverse Event|3|||
126454878|NCT00171834|454964862|FG003|Overall Study|Adverse Event|2|||
126454879|NCT00171834|454964863|FG004|Overall Study|Adverse Event|2|||
126454880|NCT00171834|454964864|FG005|Overall Study|Adverse Event|15|||
126454881|NCT00171834|454964865|FG006|Overall Study|Adverse Event|1|||
126454882|NCT00171834|454964859|FG000|Overall Study|Withdrawal by Subject|0|||
126454883|NCT00171834|454964860|FG001|Overall Study|Withdrawal by Subject|2|||
126454884|NCT00171834|454964861|FG002|Overall Study|Withdrawal by Subject|0|||
126454885|NCT00171834|454964862|FG003|Overall Study|Withdrawal by Subject|1|||
126277932|NCT02065700|454309075|FG001|Overall Study|Withdrawal by Subject|29|||
126277933|NCT02065700|454309074|FG000|Overall Study|Lost to Follow-up|12|||
126277934|NCT02065700|454309075|FG001|Overall Study|Lost to Follow-up|9|||
126277935|NCT02065700|454309074|FG000|Overall Study|Physician Decision|2|||
126277936|NCT02065700|454309075|FG001|Overall Study|Physician Decision|0|||
126277937|NCT02065700|454309074|FG000|Overall Study|Sponsor Request|38|||
126454886|NCT00171834|454964863|FG004|Overall Study|Withdrawal by Subject|1|||
126454887|NCT00171834|454964864|FG005|Overall Study|Withdrawal by Subject|1|||
126454888|NCT00171834|454964865|FG006|Overall Study|Withdrawal by Subject|0|||
126454889|NCT00171834|454964859|FG000|Overall Study|Death from study indication|0|||
126454890|NCT00171834|454964860|FG001|Overall Study|Death from study indication|1|||
126454891|NCT00171834|454964861|FG002|Overall Study|Death from study indication|0|||
126454892|NCT00171834|454964862|FG003|Overall Study|Death from study indication|0|||
126454893|NCT00171834|454964863|FG004|Overall Study|Death from study indication|1|||
126363003|NCT00562861|454621693|FG001|Overall Study|Adverse Event|1|||
126363004|NCT00562861|454621692|FG000|Overall Study|Lack of Efficacy|5|||
126363005|NCT00562861|454621693|FG001|Overall Study|Lack of Efficacy|5|||
126363006|NCT00562861|454621692|FG000|Overall Study|noncompliance, moved|7|||
126363007|NCT00562861|454621693|FG001|Overall Study|noncompliance, moved|2|||
126363008|NCT00562861|454621692|FG000|Overall Study|Lost to Follow-up|7|||
126363009|NCT00562861|454621693|FG001|Overall Study|Lost to Follow-up|3|||
126363010|NCT01694771|454621694|FG000|Overall Study|Adverse Event|18|||
126363011|NCT01694771|454621695|FG001|Overall Study|Adverse Event|16|||
126363012|NCT01694771|454621694|FG000|Overall Study|Lack of Efficacy|1|||
126363013|NCT01694771|454621695|FG001|Overall Study|Lack of Efficacy|0|||
126363014|NCT01694771|454621694|FG000|Overall Study|Non compliance protocol|7|||
126363015|NCT01694771|454621695|FG001|Overall Study|Non compliance protocol|6|||
126363016|NCT01694771|454621694|FG000|Overall Study|Lost to Follow-up|2|||
126363017|NCT01694771|454621695|FG001|Overall Study|Lost to Follow-up|3|||
126363018|NCT01694771|454621694|FG000|Overall Study|Consent withdrawn|7|||
126363019|NCT01694771|454621695|FG001|Overall Study|Consent withdrawn|9|||
126363020|NCT01694771|454621694|FG000|Overall Study|Other reasons|5|||
126363021|NCT01694771|454621695|FG001|Overall Study|Other reasons|6|||
126363022|NCT00289900|454621699|FG000|Overall Study|Adverse Event|28|||
126363023|NCT00289900|454621700|FG001|Overall Study|Adverse Event|40|||
126363024|NCT00289900|454621701|FG002|Overall Study|Adverse Event|13|||
126363025|NCT00289900|454621702|FG003|Overall Study|Adverse Event|19|||
126363026|NCT00289900|454621703|FG004|Overall Study|Adverse Event|20|||
126363027|NCT00289900|454621704|FG005|Overall Study|Adverse Event|33|||
126363028|NCT00289900|454621699|FG000|Overall Study|Lost to Follow-up|7|||
126363029|NCT00289900|454621700|FG001|Overall Study|Lost to Follow-up|7|||
126363030|NCT00289900|454621701|FG002|Overall Study|Lost to Follow-up|8|||
126363031|NCT00289900|454621702|FG003|Overall Study|Lost to Follow-up|8|||
126363032|NCT00289900|454621703|FG004|Overall Study|Lost to Follow-up|4|||
126363033|NCT00289900|454621704|FG005|Overall Study|Lost to Follow-up|8|||
126363034|NCT00289900|454621699|FG000|Overall Study|Participant had flushing|18|||
126363035|NCT00289900|454621700|FG001|Overall Study|Participant had flushing|42|||
126363036|NCT00289900|454621701|FG002|Overall Study|Participant had flushing|1|||
126363037|NCT00289900|454621702|FG003|Overall Study|Participant had flushing|2|||
126363038|NCT00289900|454621703|FG004|Overall Study|Participant had flushing|0|||
126363039|NCT00289900|454621704|FG005|Overall Study|Participant had flushing|4|||
126363040|NCT00289900|454621699|FG000|Overall Study|Other|0|||
126363041|NCT00289900|454621700|FG001|Overall Study|Other|0|||
126363042|NCT00289900|454621701|FG002|Overall Study|Other|0|||
126363043|NCT00289900|454621702|FG003|Overall Study|Other|5|||
126363044|NCT00289900|454621703|FG004|Overall Study|Other|1|||
126363045|NCT00289900|454621704|FG005|Overall Study|Other|0|||
126363046|NCT00289900|454621699|FG000|Overall Study|Participant moved|1|||
126363047|NCT00289900|454621700|FG001|Overall Study|Participant moved|0|||
126363048|NCT00289900|454621701|FG002|Overall Study|Participant moved|0|||
126363049|NCT00289900|454621702|FG003|Overall Study|Participant moved|1|||
126363050|NCT00289900|454621703|FG004|Overall Study|Participant moved|1|||
126363051|NCT00289900|454621704|FG005|Overall Study|Participant moved|1|||
126363052|NCT00289900|454621699|FG000|Overall Study|Withdrawal by Subject|10|||
126363053|NCT00289900|454621700|FG001|Overall Study|Withdrawal by Subject|21|||
126363054|NCT00289900|454621701|FG002|Overall Study|Withdrawal by Subject|8|||
126363055|NCT00289900|454621702|FG003|Overall Study|Withdrawal by Subject|18|||
126363056|NCT00289900|454621703|FG004|Overall Study|Withdrawal by Subject|12|||
126363057|NCT00289900|454621704|FG005|Overall Study|Withdrawal by Subject|11|||
126363058|NCT00289900|454621699|FG000|Overall Study|Protocol Violation|3|||
126363059|NCT00289900|454621700|FG001|Overall Study|Protocol Violation|9|||
126363060|NCT00289900|454621701|FG002|Overall Study|Protocol Violation|2|||
126363061|NCT00289900|454621702|FG003|Overall Study|Protocol Violation|6|||
126363062|NCT00289900|454621703|FG004|Overall Study|Protocol Violation|7|||
126363063|NCT00289900|454621704|FG005|Overall Study|Protocol Violation|4|||
126363064|NCT00289900|454621699|FG000|Overall Study|site terminated|1|||
126363065|NCT00289900|454621700|FG001|Overall Study|site terminated|0|||
126363066|NCT00289900|454621701|FG002|Overall Study|site terminated|1|||
126363067|NCT00289900|454621702|FG003|Overall Study|site terminated|0|||
126363068|NCT00289900|454621703|FG004|Overall Study|site terminated|0|||
126363069|NCT00289900|454621704|FG005|Overall Study|site terminated|0|||
126363070|NCT00289900|454621699|FG000|Overall Study|Not treated|0|||
126363071|NCT00289900|454621700|FG001|Overall Study|Not treated|1|||
126363072|NCT00289900|454621701|FG002|Overall Study|Not treated|0|||
126363073|NCT00289900|454621702|FG003|Overall Study|Not treated|0|||
126363074|NCT00289900|454621703|FG004|Overall Study|Not treated|0|||
126363075|NCT00289900|454621704|FG005|Overall Study|Not treated|0|||
126363076|NCT01152385|454621705|FG000|Overall Study|Withdrawal by Subject|3|||
126363077|NCT01152385|454621706|FG001|Overall Study|Withdrawal by Subject|1|||
126363078|NCT01152385|454621707|FG002|Overall Study|Withdrawal by Subject|1|||
126363079|NCT01152385|454621708|FG003|Overall Study|Withdrawal by Subject|1|||
126363080|NCT01152385|454621705|FG000|Overall Study|Protocol Violation|0|||
126363081|NCT01152385|454621706|FG001|Overall Study|Protocol Violation|0|||
126363082|NCT01152385|454621707|FG002|Overall Study|Protocol Violation|0|||
126363083|NCT01152385|454621708|FG003|Overall Study|Protocol Violation|1|||
126363084|NCT01152385|454621705|FG000|Overall Study|Adverse Event|1|||
126547884|NCT00041756|455299811|FG004|Overall Study|Adverse Event|34|||
126547885|NCT00041756|455299807|FG000|Overall Study|Protocol Violation|1|||
126547886|NCT00041756|455299808|FG001|Overall Study|Protocol Violation|1|||
126547887|NCT00041756|455299809|FG002|Overall Study|Protocol Violation|2|||
126547888|NCT00041756|455299810|FG003|Overall Study|Protocol Violation|2|||
126547889|NCT00041756|455299811|FG004|Overall Study|Protocol Violation|1|||
126547890|NCT00041756|455299807|FG000|Overall Study|Withdrawal by Subject|3|||
126547891|NCT00041756|455299808|FG001|Overall Study|Withdrawal by Subject|3|||
126547892|NCT00041756|455299809|FG002|Overall Study|Withdrawal by Subject|4|||
126547893|NCT00041756|455299810|FG003|Overall Study|Withdrawal by Subject|2|||
126547894|NCT00041756|455299811|FG004|Overall Study|Withdrawal by Subject|3|||
126547895|NCT00041756|455299807|FG000|Overall Study|Lost to Follow-up|0|||
126547896|NCT00041756|455299808|FG001|Overall Study|Lost to Follow-up|1|||
126547897|NCT00041756|455299809|FG002|Overall Study|Lost to Follow-up|0|||
126547898|NCT00041756|455299810|FG003|Overall Study|Lost to Follow-up|1|||
126547899|NCT00041756|455299811|FG004|Overall Study|Lost to Follow-up|0|||
126547900|NCT00041756|455299807|FG000|Overall Study|Unable to meet protocol criteria|0|||
126547901|NCT00041756|455299808|FG001|Overall Study|Unable to meet protocol criteria|0|||
126547902|NCT00041756|455299809|FG002|Overall Study|Unable to meet protocol criteria|1|||
126547903|NCT00041756|455299810|FG003|Overall Study|Unable to meet protocol criteria|0|||
126547904|NCT00041756|455299811|FG004|Overall Study|Unable to meet protocol criteria|1|||
126547905|NCT00041756|455299807|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
126547906|NCT00041756|455299808|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
126547907|NCT00041756|455299809|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
126547908|NCT00041756|455299810|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
126547909|NCT00041756|455299811|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
126547910|NCT00603265|455299812|FG000|Overall Study|Adverse Event|2|||
126547911|NCT00603265|455299813|FG001|Overall Study|Adverse Event|11|||
126547912|NCT00603265|455299814|FG002|Overall Study|Adverse Event|1|||
126547913|NCT00603265|455299812|FG000|Overall Study|Withdrawal by Subject|1|||
126547914|NCT00603265|455299813|FG001|Overall Study|Withdrawal by Subject|2|||
126547915|NCT00603265|455299814|FG002|Overall Study|Withdrawal by Subject|1|||
126547916|NCT00603265|455299812|FG000|Overall Study|Lack of Efficacy|3|||
126547917|NCT00603265|455299813|FG001|Overall Study|Lack of Efficacy|0|||
126547918|NCT00603265|455299814|FG002|Overall Study|Lack of Efficacy|3|||
126547919|NCT00603265|455299812|FG000|Overall Study|Lost to Follow-up|0|||
126547920|NCT00603265|455299813|FG001|Overall Study|Lost to Follow-up|1|||
126547921|NCT00603265|455299814|FG002|Overall Study|Lost to Follow-up|0|||
126547922|NCT00603265|455299812|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
126547923|NCT00603265|455299813|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
126547924|NCT00603265|455299814|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
126547925|NCT00603265|455299812|FG000|Overall Study|Participant Left Country, No Responses|0|||
126706779|NCT03716726|455878871|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
126706780|NCT03716726|455878870|FG000|12 Months Followup|Lost to Follow-up|10|||
126706781|NCT03716726|455878871|FG001|12 Months Followup|Lost to Follow-up|17|||
126706782|NCT01943539|455878872|FG000|Overall Study|Non-compliance with at-home intervention|4|||
126547926|NCT00603265|455299813|FG001|Overall Study|Participant Left Country, No Responses|1|||
126706783|NCT01943539|455878873|FG001|Overall Study|Non-compliance with at-home intervention|0|||
126706784|NCT03199911|455878874|FG000|Overall Study|Lost to Follow-up|5|||
126706785|NCT03199911|455878875|FG001|Overall Study|Lost to Follow-up|5|||
126363085|NCT01152385|454621706|FG001|Overall Study|Adverse Event|1|||
126363086|NCT01152385|454621707|FG002|Overall Study|Adverse Event|0|||
126363087|NCT01152385|454621708|FG003|Overall Study|Adverse Event|0|||
126363088|NCT01152385|454621705|FG000|Overall Study|Study-specific withdrawal criteria|1|||
126363089|NCT01152385|454621706|FG001|Overall Study|Study-specific withdrawal criteria|1|||
126363090|NCT01152385|454621707|FG002|Overall Study|Study-specific withdrawal criteria|2|||
126363091|NCT01152385|454621708|FG003|Overall Study|Study-specific withdrawal criteria|0|||
126363092|NCT01152385|454621705|FG000|Overall Study|Other|4|||
126363093|NCT01152385|454621706|FG001|Overall Study|Other|3|||
126363094|NCT01152385|454621707|FG002|Overall Study|Other|2|||
126363095|NCT01152385|454621708|FG003|Overall Study|Other|3|||
126363096|NCT02656173|454621709|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
126363097|NCT02656173|454621710|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
126363098|NCT02656173|454621709|FG000|Overall Study|Adverse Event|7|||
126363099|NCT02656173|454621710|FG001|Overall Study|Adverse Event|5|||
126363100|NCT02656173|454621709|FG000|Overall Study|Withdrawal by Subject|1|||
126547927|NCT00603265|455299814|FG002|Overall Study|Participant Left Country, No Responses|0|||
126547928|NCT00603265|455299812|FG000|Overall Study|Protocol Violation|1|||
126547929|NCT00603265|455299813|FG001|Overall Study|Protocol Violation|0|||
126547930|NCT00603265|455299814|FG002|Overall Study|Protocol Violation|0|||
126547931|NCT02002884|455299815|FG000|Main Period (MP)|Other|0|||
126547932|NCT02002884|455299816|FG001|Main Period (MP)|Other|3|||
126547933|NCT02002884|455299817|FG002|Main Period (MP)|Other|3|||
126547934|NCT02002884|455299818|FG003|Main Period (MP)|Other|0|||
126547935|NCT02002884|455299815|FG000|Main Period (MP)|Adverse Event|0|||
126706786|NCT03199911|455878874|FG000|Overall Study|Did not proceed with surgery|2|||
126706787|NCT03199911|455878875|FG001|Overall Study|Did not proceed with surgery|1|||
126706788|NCT00345605|455878881|FG000|Arm 1|Adverse Event|0|||
126706789|NCT00345605|455878882|FG001|Arm 1|Adverse Event|1|||
126706790|NCT00345605|455878881|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
126706791|NCT00345605|455878882|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
126706792|NCT01335971|455878883|FG000|Overall Study|Withdrawal by Subject|1|||
126706793|NCT01335971|455878884|FG001|Overall Study|Withdrawal by Subject|0|||
126706794|NCT01335971|455878885|FG002|Overall Study|Withdrawal by Subject|0|||
126706795|NCT01335971|455878883|FG000|Overall Study|Did not complete bronchoscopy|1|||
126706796|NCT01335971|455878884|FG001|Overall Study|Did not complete bronchoscopy|1|||
126706797|NCT01335971|455878885|FG002|Overall Study|Did not complete bronchoscopy|1|||
126706798|NCT00149214|455878890|FG000|Overall Study|Adverse Event|12|||
126706799|NCT00149214|455878891|FG001|Overall Study|Adverse Event|9|||
126706800|NCT00149214|455878890|FG000|Overall Study|Withdrawal by Subject|4|||
126706801|NCT00149214|455878891|FG001|Overall Study|Withdrawal by Subject|1|||
126706802|NCT00149214|455878890|FG000|Overall Study|Physician Decision|3|||
126706803|NCT00149214|455878891|FG001|Overall Study|Physician Decision|3|||
126706804|NCT00149214|455878890|FG000|Overall Study|Sponsor Decision|0|||
126706805|NCT00149214|455878891|FG001|Overall Study|Sponsor Decision|1|||
126706806|NCT00149214|455878890|FG000|Overall Study|Progressive Disease|7|||
126706807|NCT00149214|455878891|FG001|Overall Study|Progressive Disease|3|||
126706808|NCT00174941|455878892|FG000|Overall Study|Adverse Event|1|||
126706809|NCT00174941|455878893|FG001|Overall Study|Adverse Event|10|||
126706810|NCT00174941|455878894|FG002|Overall Study|Adverse Event|2|||
126706811|NCT00174941|455878895|FG003|Overall Study|Adverse Event|13|||
126706812|NCT00174941|455878892|FG000|Overall Study|Protocol Violation|0|||
126706813|NCT00174941|455878893|FG001|Overall Study|Protocol Violation|1|||
126706814|NCT00174941|455878894|FG002|Overall Study|Protocol Violation|0|||
126706815|NCT00174941|455878895|FG003|Overall Study|Protocol Violation|1|||
126706816|NCT00174941|455878892|FG000|Overall Study|Lost to Follow-up|0|||
126706817|NCT00174941|455878893|FG001|Overall Study|Lost to Follow-up|3|||
126706818|NCT00174941|455878894|FG002|Overall Study|Lost to Follow-up|2|||
126706819|NCT00174941|455878895|FG003|Overall Study|Lost to Follow-up|5|||
126706820|NCT00174941|455878892|FG000|Overall Study|Personal Reason(s)|0|||
126706821|NCT00174941|455878893|FG001|Overall Study|Personal Reason(s)|14|||
126706822|NCT00174941|455878894|FG002|Overall Study|Personal Reason(s)|8|||
126706823|NCT00174941|455878895|FG003|Overall Study|Personal Reason(s)|22|||
126706824|NCT00174941|455878892|FG000|Overall Study|Gout Flare|0|||
126706825|NCT00174941|455878893|FG001|Overall Study|Gout Flare|4|||
126706826|NCT00174941|455878894|FG002|Overall Study|Gout Flare|4|||
126706827|NCT00174941|455878895|FG003|Overall Study|Gout Flare|8|||
126706828|NCT00174941|455878892|FG000|Overall Study|Reason Not Specified|1|||
126706829|NCT00174941|455878893|FG001|Overall Study|Reason Not Specified|6|||
126706830|NCT00174941|455878894|FG002|Overall Study|Reason Not Specified|2|||
126706831|NCT00174941|455878895|FG003|Overall Study|Reason Not Specified|9|||
126706832|NCT03230097|455878899|FG000|Overall Study|Adverse Event|2|||
126706833|NCT03230097|455878900|FG001|Overall Study|Adverse Event|1|||
126706834|NCT03230097|455878899|FG000|Overall Study|non-compliance|0|||
126706835|NCT03230097|455878900|FG001|Overall Study|non-compliance|1|||
126706836|NCT03230097|455878899|FG000|Overall Study|Lost to Follow-up|2|||
126706837|NCT03230097|455878900|FG001|Overall Study|Lost to Follow-up|4|||
126706838|NCT03230097|455878899|FG000|Overall Study|Withdrawal by Subject|7|||
126706839|NCT03230097|455878900|FG001|Overall Study|Withdrawal by Subject|3|||
126706840|NCT03230097|455878899|FG000|Overall Study|Trial termination|4|||
126706841|NCT03230097|455878900|FG001|Overall Study|Trial termination|5|||
126277938|NCT02065700|454309075|FG001|Overall Study|Sponsor Request|15|||
126277939|NCT02065700|454309074|FG000|Overall Study|Treatment Failure|3|||
126277940|NCT02065700|454309075|FG001|Overall Study|Treatment Failure|2|||
126277941|NCT02065700|454309074|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
126277942|NCT02065700|454309075|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
126277943|NCT02065700|454309074|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
126277944|NCT02065700|454309075|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
126277945|NCT02065700|454309074|FG000|Overall Study|Non-compliance with Study Procedures|2|||
126706842|NCT03230097|455878899|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
126706843|NCT03230097|455878900|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
126706844|NCT03230097|455878899|FG000|Overall Study|outcome event|0|||
126547936|NCT02002884|455299816|FG001|Main Period (MP)|Adverse Event|1|||
126706845|NCT03230097|455878900|FG001|Overall Study|outcome event|1|||
126706846|NCT01121406|455878905|FG000|Overall Study|Progressive disease RECIST|44|||
126706847|NCT01121406|455878906|FG001|Overall Study|Progressive disease RECIST|28|||
126706848|NCT01121406|455878905|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
126706849|NCT01121406|455878906|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
126277946|NCT02065700|454309075|FG001|Overall Study|Non-compliance with Study Procedures|0|||
126706850|NCT01121406|455878905|FG000|Overall Study|Other AE|3|||
126706851|NCT01121406|455878906|FG001|Overall Study|Other AE|10|||
126706852|NCT01121406|455878905|FG000|Overall Study|Non-compliant with protocol|0|||
126706853|NCT01121406|455878906|FG001|Overall Study|Non-compliant with protocol|2|||
126277947|NCT02065700|454309074|FG000|Overall Study|Not Defined|21|||
126277948|NCT02065700|454309075|FG001|Overall Study|Not Defined|3|||
126277949|NCT01664130|454309076|FG000|Overall Study|competing secondary disease|2|||
126277950|NCT01161407|454309078|FG000|Overall Study|Protocol Violation|3|||
126277951|NCT01161407|454309079|FG001|Overall Study|Protocol Violation|1|||
126277952|NCT04746794|454309082|FG000|Overall Study|Did not complete any study assessment|50303|||
126277953|NCT04746794|454309083|FG001|Overall Study|Did not complete any study assessment|44997|||
126277954|NCT03207243|454309084|FG000|Overall Study|Adverse Event|2|||
126277955|NCT03207243|454309085|FG001|Overall Study|Adverse Event|2|||
126277956|NCT03207243|454309084|FG000|Overall Study|Loss of Asthma Control|47|||
126277957|NCT03207243|454309085|FG001|Overall Study|Loss of Asthma Control|31|||
126277958|NCT03207243|454309084|FG000|Overall Study|Withdrawal by Subject|2|||
126277959|NCT03207243|454309085|FG001|Overall Study|Withdrawal by Subject|4|||
126277960|NCT03207243|454309084|FG000|Overall Study|Physician Decision|1|||
126277961|NCT03207243|454309085|FG001|Overall Study|Physician Decision|1|||
126363101|NCT02656173|454621710|FG001|Overall Study|Withdrawal by Subject|3|||
126277962|NCT03207243|454309084|FG000|Overall Study|Lost to Follow-up|0|||
126277963|NCT03207243|454309085|FG001|Overall Study|Lost to Follow-up|1|||
126277964|NCT03207243|454309084|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
126277965|NCT03207243|454309085|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
126277966|NCT03207243|454309084|FG000|Overall Study|Protocol Violation|0|||
126363102|NCT02656173|454621709|FG000|Overall Study|Protocol Violation|0|||
126363103|NCT02656173|454621710|FG001|Overall Study|Protocol Violation|1|||
126363104|NCT02656173|454621709|FG000|Overall Study|Miscellaneous|2|||
126363105|NCT02656173|454621710|FG001|Overall Study|Miscellaneous|0|||
126363106|NCT01064622|454621711|FG000|Randomized Phase II|Withdrawal by Subject|2|||
126363107|NCT01064622|454621712|FG001|Randomized Phase II|Withdrawal by Subject|2|||
126363108|NCT01064622|454621711|FG000|Randomized Phase II|Protocol Violation|0|||
126363109|NCT01064622|454621712|FG001|Randomized Phase II|Protocol Violation|1|||
126363110|NCT03289741|454621717|FG000|Overall Study|Adverse Event|1|||
126363111|NCT03289741|454621718|FG001|Overall Study|Adverse Event|1|||
126363112|NCT03289741|454621717|FG000|Overall Study|Physician Decision|2|||
126363113|NCT03289741|454621718|FG001|Overall Study|Physician Decision|2|||
126363114|NCT03289741|454621717|FG000|Overall Study|Withdrawal by Subject|1|||
126363115|NCT03289741|454621718|FG001|Overall Study|Withdrawal by Subject|0|||
126363116|NCT02037984|454621723|FG000|Overall Study|Lack of Efficacy|0|||
126363117|NCT02037984|454621724|FG001|Overall Study|Lack of Efficacy|0|||
126363118|NCT02037984|454621725|FG002|Overall Study|Lack of Efficacy|3|||
126363119|NCT02037984|454621726|FG003|Overall Study|Lack of Efficacy|10|||
126363120|NCT02037984|454621727|FG004|Overall Study|Lack of Efficacy|2|||
126363121|NCT02037984|454621728|FG005|Overall Study|Lack of Efficacy|2|||
126363122|NCT02037984|454621729|FG006|Overall Study|Lack of Efficacy|4|||
126363123|NCT02037984|454621730|FG007|Overall Study|Lack of Efficacy|3|||
126363124|NCT02037984|454621723|FG000|Overall Study|Lost to Follow-up|1|||
126363125|NCT02037984|454621724|FG001|Overall Study|Lost to Follow-up|0|||
126363126|NCT02037984|454621725|FG002|Overall Study|Lost to Follow-up|3|||
126363127|NCT02037984|454621726|FG003|Overall Study|Lost to Follow-up|5|||
126363128|NCT02037984|454621727|FG004|Overall Study|Lost to Follow-up|2|||
126363129|NCT02037984|454621728|FG005|Overall Study|Lost to Follow-up|2|||
126363130|NCT02037984|454621729|FG006|Overall Study|Lost to Follow-up|2|||
126363131|NCT02037984|454621730|FG007|Overall Study|Lost to Follow-up|4|||
126363132|NCT02037984|454621723|FG000|Overall Study|Physician Decision|0|||
126363133|NCT02037984|454621724|FG001|Overall Study|Physician Decision|0|||
126363134|NCT02037984|454621725|FG002|Overall Study|Physician Decision|0|||
126363135|NCT02037984|454621726|FG003|Overall Study|Physician Decision|0|||
126363136|NCT02037984|454621727|FG004|Overall Study|Physician Decision|0|||
126363137|NCT02037984|454621728|FG005|Overall Study|Physician Decision|0|||
126363138|NCT02037984|454621729|FG006|Overall Study|Physician Decision|1|||
126363139|NCT02037984|454621730|FG007|Overall Study|Physician Decision|0|||
126363140|NCT02037984|454621723|FG000|Overall Study|Protocol Violation|0|||
126363141|NCT02037984|454621724|FG001|Overall Study|Protocol Violation|0|||
126363142|NCT02037984|454621725|FG002|Overall Study|Protocol Violation|0|||
126363143|NCT02037984|454621726|FG003|Overall Study|Protocol Violation|0|||
126363144|NCT02037984|454621727|FG004|Overall Study|Protocol Violation|0|||
126363145|NCT02037984|454621728|FG005|Overall Study|Protocol Violation|1|||
126363146|NCT02037984|454621729|FG006|Overall Study|Protocol Violation|2|||
126363147|NCT02037984|454621730|FG007|Overall Study|Protocol Violation|0|||
126363148|NCT02037984|454621723|FG000|Overall Study|Technical Problems|0|||
126363149|NCT02037984|454621724|FG001|Overall Study|Technical Problems|0|||
126363150|NCT02037984|454621725|FG002|Overall Study|Technical Problems|3|||
126363151|NCT02037984|454621726|FG003|Overall Study|Technical Problems|3|||
126277967|NCT03207243|454309085|FG001|Overall Study|Protocol Violation|3|||
126363152|NCT02037984|454621727|FG004|Overall Study|Technical Problems|2|||
126363153|NCT02037984|454621728|FG005|Overall Study|Technical Problems|3|||
126363154|NCT02037984|454621729|FG006|Overall Study|Technical Problems|4|||
126363155|NCT02037984|454621730|FG007|Overall Study|Technical Problems|2|||
126363156|NCT02037984|454621723|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126363157|NCT02037984|454621724|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126363158|NCT02037984|454621725|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
126277968|NCT01422187|454309086|FG000|Overall Study|Personal reason|1|||
126277969|NCT01422187|454309087|FG001|Overall Study|Personal reason|0|||
126277970|NCT01422187|454309088|FG002|Overall Study|Personal reason|0|||
126277971|NCT01422187|454309086|FG000|Overall Study|Lost to Follow-up|0|||
126277972|NCT01422187|454309087|FG001|Overall Study|Lost to Follow-up|1|||
126277973|NCT01422187|454309088|FG002|Overall Study|Lost to Follow-up|0|||
126277974|NCT04015908|454309089|FG000|Overall Study|Lost to Follow-up|0|||
126277975|NCT04015908|454309090|FG001|Overall Study|Lost to Follow-up|1|||
126277976|NCT02227446|454309091|FG000|Overall Study|not eligible post randomization|18|||
126277977|NCT02227446|454309092|FG001|Overall Study|not eligible post randomization|29|||
126277978|NCT02227446|454309091|FG000|Overall Study|Withdrawal by Subject|4|||
126277979|NCT02227446|454309092|FG001|Overall Study|Withdrawal by Subject|5|||
126277980|NCT04623086|454309093|FG000|Overall Study|Withdrawal by Subject|0|||
126277981|NCT04623086|454309094|FG001|Overall Study|Withdrawal by Subject|0|||
126277982|NCT04623086|454309095|FG002|Overall Study|Withdrawal by Subject|10|||
126277983|NCT00715624|454309096|FG000|Overall Study|Adverse Event|12|||
126277984|NCT00715624|454309097|FG001|Overall Study|Adverse Event|37|||
126277985|NCT00715624|454309096|FG000|Overall Study|Lack of Efficacy|11|||
126277986|NCT00715624|454309097|FG001|Overall Study|Lack of Efficacy|11|||
126277987|NCT00715624|454309096|FG000|Overall Study|Lost to Follow-up|1|||
126277988|NCT00715624|454309097|FG001|Overall Study|Lost to Follow-up|2|||
126277989|NCT00715624|454309096|FG000|Overall Study|Protocol Violation|1|||
126277990|NCT00715624|454309097|FG001|Overall Study|Protocol Violation|0|||
126277991|NCT00715624|454309096|FG000|Overall Study|Withdrawal by Subject|11|||
126454894|NCT00171834|454964864|FG005|Overall Study|Death from study indication|0|||
126454895|NCT00171834|454964865|FG006|Overall Study|Death from study indication|0|||
126454896|NCT00171834|454964859|FG000|Overall Study|Disease Progression|4|||
126454897|NCT00171834|454964860|FG001|Overall Study|Disease Progression|8|||
126454898|NCT00171834|454964861|FG002|Overall Study|Disease Progression|8|||
126454899|NCT00171834|454964862|FG003|Overall Study|Disease Progression|9|||
126454900|NCT00171834|454964863|FG004|Overall Study|Disease Progression|2|||
126454901|NCT00171834|454964864|FG005|Overall Study|Disease Progression|18|||
126454902|NCT00171834|454964865|FG006|Overall Study|Disease Progression|3|||
126454903|NCT00171834|454964859|FG000|Overall Study|Treatment Duration Completed|0|||
126454904|NCT00171834|454964860|FG001|Overall Study|Treatment Duration Completed|0|||
126454905|NCT00171834|454964861|FG002|Overall Study|Treatment Duration Completed|1|||
126454906|NCT00171834|454964862|FG003|Overall Study|Treatment Duration Completed|0|||
126454907|NCT00171834|454964863|FG004|Overall Study|Treatment Duration Completed|2|||
126454908|NCT00171834|454964864|FG005|Overall Study|Treatment Duration Completed|1|||
126454909|NCT00171834|454964865|FG006|Overall Study|Treatment Duration Completed|0|||
126454910|NCT00392379|454964866|FG000|Overall Study|Withdrawal by Subject|17|||
126454911|NCT00392379|454964867|FG001|Overall Study|Withdrawal by Subject|28|||
126454912|NCT00392379|454964866|FG000|Overall Study|Lost to Follow-up|4|||
126454913|NCT00392379|454964867|FG001|Overall Study|Lost to Follow-up|9|||
126454914|NCT00392379|454964866|FG000|Overall Study|Adverse Event|1|||
126454915|NCT00392379|454964867|FG001|Overall Study|Adverse Event|1|||
126454916|NCT02342418|454964868|FG000|Overall Study|Adverse Event|0|||
126454917|NCT02342418|454964869|FG001|Overall Study|Adverse Event|1|||
126454918|NCT04255394|454964870|FG000|Overall Study|Death|35|||
126454919|NCT04255394|454964871|FG001|Overall Study|Death|25|||
126454920|NCT04255394|454964870|FG000|Overall Study|Device removed|2|||
126454921|NCT04255394|454964871|FG001|Overall Study|Device removed|10|||
126454922|NCT04255394|454964870|FG000|Overall Study|Withdrawal by Subject|9|||
126454923|NCT04255394|454964871|FG001|Overall Study|Withdrawal by Subject|8|||
126454924|NCT04255394|454964870|FG000|Overall Study|Screen Failure/Not treated|12|||
126454925|NCT04255394|454964871|FG001|Overall Study|Screen Failure/Not treated|8|||
126454926|NCT04255394|454964870|FG000|Overall Study|Lost to Follow-up|123|||
126454927|NCT04255394|454964871|FG001|Overall Study|Lost to Follow-up|265|||
126454928|NCT04255394|454964870|FG000|Overall Study|Adverse Event|1|||
126454929|NCT04255394|454964871|FG001|Overall Study|Adverse Event|3|||
126454930|NCT02285062|454964877|FG000|Pre-Treatment Period|Protocol Violation|0|||
126454931|NCT02285062|454964878|FG001|Pre-Treatment Period|Protocol Violation|2|||
126454932|NCT02285062|454964877|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
126454933|NCT02285062|454964878|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
126277992|NCT00715624|454309097|FG001|Overall Study|Withdrawal by Subject|25|||
126277993|NCT00715624|454309096|FG000|Overall Study|Familial and personal reasons|10|||
126277994|NCT00715624|454309097|FG001|Overall Study|Familial and personal reasons|22|||
126277995|NCT00715624|454309096|FG000|Overall Study|Poor compliance|6|||
126277996|NCT00715624|454309097|FG001|Overall Study|Poor compliance|13|||
126277997|NCT00715624|454309096|FG000|Overall Study|Sponsor decision|0|||
126454934|NCT03041129|454964879|FG000|Overall Study|Withdrawal by Subject|2|||
126454935|NCT03041129|454964880|FG001|Overall Study|Withdrawal by Subject|0|||
126454936|NCT03041129|454964881|FG002|Overall Study|Withdrawal by Subject|0|||
126454937|NCT03041129|454964882|FG003|Overall Study|Withdrawal by Subject|0|||
126454938|NCT00821509|454964883|FG000|Overall Study|Withdrawal by Subject|12|||
126454939|NCT00821509|454964884|FG001|Overall Study|Withdrawal by Subject|11|||
126454940|NCT00821509|454964885|FG002|Overall Study|Withdrawal by Subject|34|||
126547937|NCT02002884|455299817|FG002|Main Period (MP)|Adverse Event|1|||
126277998|NCT00715624|454309097|FG001|Overall Study|Sponsor decision|4|||
126277999|NCT00715624|454309096|FG000|Overall Study|Incorrect randomization (not treated)|0|||
126278000|NCT00715624|454309097|FG001|Overall Study|Incorrect randomization (not treated)|1|||
126278001|NCT00715624|454309096|FG000|Overall Study|Other|0|||
126278002|NCT00715624|454309097|FG001|Overall Study|Other|1|||
126278003|NCT03200912|454309098|FG000|Overall Study|Adverse Event|3|||
126278004|NCT03200912|454309099|FG001|Overall Study|Adverse Event|0|||
126278005|NCT03200912|454309100|FG002|Overall Study|Adverse Event|0|||
126278006|NCT03200912|454309098|FG000|Overall Study|Withdrawal by Subject|1|||
126278007|NCT03200912|454309099|FG001|Overall Study|Withdrawal by Subject|2|||
126278008|NCT03200912|454309100|FG002|Overall Study|Withdrawal by Subject|4|||
126278009|NCT03200912|454309098|FG000|Overall Study|Non-compliance with study drug|0|||
126278010|NCT03200912|454309099|FG001|Overall Study|Non-compliance with study drug|1|||
126278011|NCT03200912|454309100|FG002|Overall Study|Non-compliance with study drug|0|||
126278012|NCT00229723|454309101|FG000|Concomitant Phase|Adverse Event|4|||
126278013|NCT00229723|454309102|FG001|Concomitant Phase|Adverse Event|2|||
126278014|NCT00229723|454309103|FG002|Concomitant Phase|Adverse Event|5|||
126278015|NCT00229723|454309104|FG003|Concomitant Phase|Adverse Event|2|||
126278016|NCT00229723|454309105|FG004|Concomitant Phase|Adverse Event|0|||
126278017|NCT00229723|454309106|FG005|Concomitant Phase|Adverse Event|1|||
126278018|NCT00229723|454309107|FG006|Concomitant Phase|Adverse Event|2|||
126278019|NCT00229723|454309101|FG000|Concomitant Phase|Objective disease progression|0|||
126278020|NCT00229723|454309102|FG001|Concomitant Phase|Objective disease progression|0|||
126278021|NCT00229723|454309103|FG002|Concomitant Phase|Objective disease progression|0|||
126278022|NCT00229723|454309104|FG003|Concomitant Phase|Objective disease progression|0|||
126278023|NCT00229723|454309105|FG004|Concomitant Phase|Objective disease progression|0|||
126278024|NCT00229723|454309106|FG005|Concomitant Phase|Objective disease progression|0|||
126278025|NCT00229723|454309107|FG006|Concomitant Phase|Objective disease progression|0|||
126278026|NCT00229723|454309101|FG000|Concomitant Phase|Clinical progression|0|||
126278027|NCT00229723|454309102|FG001|Concomitant Phase|Clinical progression|0|||
126278028|NCT00229723|454309103|FG002|Concomitant Phase|Clinical progression|0|||
126547938|NCT02002884|455299818|FG003|Main Period (MP)|Adverse Event|0|||
126547939|NCT02002884|455299815|FG000|Main Period (MP)|Withdrawal by Subject|6|||
126547940|NCT02002884|455299816|FG001|Main Period (MP)|Withdrawal by Subject|2|||
126547941|NCT02002884|455299817|FG002|Main Period (MP)|Withdrawal by Subject|2|||
126547942|NCT02002884|455299818|FG003|Main Period (MP)|Withdrawal by Subject|0|||
126547943|NCT02002884|455299815|FG000|Main Period (MP)|Lost to Follow-up|0|||
126278029|NCT00229723|454309104|FG003|Concomitant Phase|Clinical progression|0|||
126278030|NCT00229723|454309105|FG004|Concomitant Phase|Clinical progression|0|||
126278031|NCT00229723|454309106|FG005|Concomitant Phase|Clinical progression|0|||
126278032|NCT00229723|454309107|FG006|Concomitant Phase|Clinical progression|1|||
126278033|NCT00229723|454309101|FG000|Concomitant Phase|Lost to Follow-up|0|||
126547944|NCT02002884|455299816|FG001|Main Period (MP)|Lost to Follow-up|0|||
126547945|NCT02002884|455299817|FG002|Main Period (MP)|Lost to Follow-up|2|||
126547946|NCT02002884|455299818|FG003|Main Period (MP)|Lost to Follow-up|0|||
126547947|NCT02002884|455299815|FG000|Open-Label Extension Period (OLEX)|Other|0|||
126547948|NCT02002884|455299816|FG001|Open-Label Extension Period (OLEX)|Other|0|||
126547949|NCT02002884|455299817|FG002|Open-Label Extension Period (OLEX)|Other|0|||
126547950|NCT02002884|455299818|FG003|Open-Label Extension Period (OLEX)|Other|24|||
126547951|NCT02002884|455299815|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
126278034|NCT00229723|454309102|FG001|Concomitant Phase|Lost to Follow-up|0|||
126278035|NCT00229723|454309103|FG002|Concomitant Phase|Lost to Follow-up|0|||
126278036|NCT00229723|454309104|FG003|Concomitant Phase|Lost to Follow-up|0|||
126278037|NCT00229723|454309105|FG004|Concomitant Phase|Lost to Follow-up|1|||
126278038|NCT00229723|454309106|FG005|Concomitant Phase|Lost to Follow-up|0|||
126278039|NCT00229723|454309107|FG006|Concomitant Phase|Lost to Follow-up|0|||
126278040|NCT00229723|454309101|FG000|Concomitant Phase|Informed consent withdrawn|3|||
126278041|NCT00229723|454309102|FG001|Concomitant Phase|Informed consent withdrawn|2|||
126278042|NCT00229723|454309103|FG002|Concomitant Phase|Informed consent withdrawn|0|||
126278043|NCT00229723|454309104|FG003|Concomitant Phase|Informed consent withdrawn|2|||
126706854|NCT01121406|455878905|FG000|Overall Study|Lost to Follow-up|0|||
126278044|NCT00229723|454309105|FG004|Concomitant Phase|Informed consent withdrawn|0|||
126278045|NCT00229723|454309106|FG005|Concomitant Phase|Informed consent withdrawn|0|||
126278046|NCT00229723|454309107|FG006|Concomitant Phase|Informed consent withdrawn|0|||
126278047|NCT00229723|454309101|FG000|Concomitant Phase|Severe non-compliance|0|||
126278048|NCT00229723|454309102|FG001|Concomitant Phase|Severe non-compliance|1|||
126278049|NCT00229723|454309103|FG002|Concomitant Phase|Severe non-compliance|0|||
126278050|NCT00229723|454309104|FG003|Concomitant Phase|Severe non-compliance|0|||
126278051|NCT00229723|454309105|FG004|Concomitant Phase|Severe non-compliance|1|||
126278052|NCT00229723|454309106|FG005|Concomitant Phase|Severe non-compliance|0|||
126547952|NCT02002884|455299816|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
126547953|NCT02002884|455299817|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
126547954|NCT02002884|455299818|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
126547955|NCT02002884|455299815|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
126547956|NCT02002884|455299816|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
126547957|NCT02002884|455299817|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
126547958|NCT02002884|455299818|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
126547959|NCT02002884|455299815|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
126547960|NCT02002884|455299816|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
126547961|NCT02002884|455299817|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
126547962|NCT02002884|455299818|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
126547963|NCT02002884|455299815|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
126547964|NCT02002884|455299816|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
126547965|NCT02002884|455299817|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
126547966|NCT02002884|455299818|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
126547967|NCT02966002|455299819|FG000|Overall Study|Withdrawal by Subject|2|||
126547968|NCT02966002|455299819|FG000|Overall Study|Adverse Event|1|||
126547969|NCT02966002|455299819|FG000|Overall Study|Lost to Follow-up|1|||
126547970|NCT00067990|455299823|FG000|Overall Study|Death|5|||
126547971|NCT00067990|455299824|FG001|Overall Study|Death|7|||
126547972|NCT00067990|455299823|FG000|Overall Study|ESRD, Non IF/TA|1|||
126547973|NCT00067990|455299824|FG001|Overall Study|ESRD, Non IF/TA|3|||
126547974|NCT00067990|455299823|FG000|Overall Study|Withdrawal by Subject|4|||
126547975|NCT00067990|455299824|FG001|Overall Study|Withdrawal by Subject|12|||
126547976|NCT03377790|455299832|FG000|Overall Study|Withdrawal by Subject|1|||
126547977|NCT03377790|455299833|FG001|Overall Study|Withdrawal by Subject|0|||
126547978|NCT03377790|455299832|FG000|Overall Study|Adverse Event|1|||
126547979|NCT03377790|455299833|FG001|Overall Study|Adverse Event|0|||
126547980|NCT03377790|455299832|FG000|Overall Study|Lost to Follow-up|0|||
126547981|NCT03377790|455299833|FG001|Overall Study|Lost to Follow-up|2|||
126547982|NCT03377790|455299832|FG000|Overall Study|Randomized but not treated|1|||
126547983|NCT03377790|455299833|FG001|Overall Study|Randomized but not treated|0|||
126547984|NCT03377790|455299832|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
126547985|NCT03377790|455299833|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
126547986|NCT02632786|455299834|FG000|Overall Study|Adverse Event|2|||
126547987|NCT02632786|455299835|FG001|Overall Study|Adverse Event|1|||
126547988|NCT02632786|455299834|FG000|Overall Study|Death|3|||
126547989|NCT02632786|455299835|FG001|Overall Study|Death|2|||
126547990|NCT02632786|455299834|FG000|Overall Study|Physician Decision|5|||
126547991|NCT02632786|455299835|FG001|Overall Study|Physician Decision|4|||
126547992|NCT02632786|455299834|FG000|Overall Study|Withdrawal by Subject|1|||
126547993|NCT02632786|455299835|FG001|Overall Study|Withdrawal by Subject|0|||
126547994|NCT01454830|455299839|FG000|Overall Study|Withdrawal by Subject|4|||
126547995|NCT01454830|455299840|FG001|Overall Study|Withdrawal by Subject|4|||
126547996|NCT01454830|455299839|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
126547997|NCT01454830|455299840|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
126547998|NCT01454830|455299839|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
126547999|NCT01454830|455299840|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
126548000|NCT01454830|455299839|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
126548001|NCT01454830|455299840|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
126548002|NCT01454830|455299839|FG000|Overall Study|Withdrawal - no polysomnography|3|||
126548003|NCT01454830|455299840|FG001|Overall Study|Withdrawal - no polysomnography|2|||
126548004|NCT00152763|455299841|FG000|Overall Study|Death|4|||
126548005|NCT00152763|455299842|FG001|Overall Study|Death|1|||
126548006|NCT00152763|455299843|FG002|Overall Study|Death|2|||
126548007|NCT00152763|455299844|FG003|Overall Study|Death|1|||
126548008|NCT00152763|455299841|FG000|Overall Study|Lost to Follow-up|6|||
126548009|NCT00152763|455299842|FG001|Overall Study|Lost to Follow-up|4|||
126548010|NCT00152763|455299843|FG002|Overall Study|Lost to Follow-up|2|||
126548011|NCT00152763|455299844|FG003|Overall Study|Lost to Follow-up|13|||
126548012|NCT00569803|455299845|FG000|Overall Study|Lost to Follow-up|1|||
126548013|NCT00569803|455299846|FG001|Overall Study|Lost to Follow-up|0|||
126548014|NCT00569803|455299847|FG002|Overall Study|Lost to Follow-up|0|||
126548015|NCT00569803|455299848|FG003|Overall Study|Lost to Follow-up|0|||
126548016|NCT00569803|455299849|FG004|Overall Study|Lost to Follow-up|0|||
126548017|NCT00569803|455299850|FG005|Overall Study|Lost to Follow-up|0|||
126548018|NCT00569803|455299851|FG006|Overall Study|Lost to Follow-up|0|||
126548019|NCT00569803|455299852|FG007|Overall Study|Lost to Follow-up|0|||
126548020|NCT00569803|455299845|FG000|Overall Study|injection syringe leaked during dosing|0|||
126548021|NCT00569803|455299846|FG001|Overall Study|injection syringe leaked during dosing|0|||
126548022|NCT00569803|455299847|FG002|Overall Study|injection syringe leaked during dosing|0|||
126548023|NCT00569803|455299848|FG003|Overall Study|injection syringe leaked during dosing|1|||
126548024|NCT00569803|455299849|FG004|Overall Study|injection syringe leaked during dosing|0|||
126548025|NCT00569803|455299850|FG005|Overall Study|injection syringe leaked during dosing|0|||
126548026|NCT00569803|455299851|FG006|Overall Study|injection syringe leaked during dosing|0|||
126548027|NCT00569803|455299852|FG007|Overall Study|injection syringe leaked during dosing|0|||
126548028|NCT00569803|455299845|FG000|Overall Study|Withdrawal by Subject|0|||
126548029|NCT00569803|455299846|FG001|Overall Study|Withdrawal by Subject|0|||
126278053|NCT00229723|454309107|FG006|Concomitant Phase|Severe non-compliance|0|||
126278054|NCT00229723|454309101|FG000|Concomitant Phase|Other|3|||
126278055|NCT00229723|454309102|FG001|Concomitant Phase|Other|0|||
126278056|NCT00229723|454309103|FG002|Concomitant Phase|Other|1|||
126278057|NCT00229723|454309104|FG003|Concomitant Phase|Other|1|||
126278058|NCT00229723|454309105|FG004|Concomitant Phase|Other|0|||
126278059|NCT00229723|454309106|FG005|Concomitant Phase|Other|2|||
126278060|NCT00229723|454309107|FG006|Concomitant Phase|Other|0|||
126278061|NCT00229723|454309101|FG000|Maintenance Phase|Adverse Event|7|||
126278062|NCT00229723|454309102|FG001|Maintenance Phase|Adverse Event|2|||
126278063|NCT00229723|454309103|FG002|Maintenance Phase|Adverse Event|1|||
126548030|NCT00569803|455299847|FG002|Overall Study|Withdrawal by Subject|0|||
126548031|NCT00569803|455299848|FG003|Overall Study|Withdrawal by Subject|0|||
126548032|NCT00569803|455299849|FG004|Overall Study|Withdrawal by Subject|0|||
126548033|NCT00569803|455299850|FG005|Overall Study|Withdrawal by Subject|0|||
126548034|NCT00569803|455299851|FG006|Overall Study|Withdrawal by Subject|0|||
126548035|NCT00569803|455299852|FG007|Overall Study|Withdrawal by Subject|1|||
126548036|NCT01235975|455299855|FG000|Overall Study|Serious Adverse Event|0|||
126548037|NCT01235975|455299856|FG001|Overall Study|Serious Adverse Event|1|||
126548038|NCT01235975|455299855|FG000|Overall Study|Withdrawal by Subject|8|||
126548039|NCT01235975|455299856|FG001|Overall Study|Withdrawal by Subject|2|||
126548040|NCT01235975|455299855|FG000|Overall Study|Migrated/moved from study area|2|||
126548041|NCT01235975|455299856|FG001|Overall Study|Migrated/moved from study area|1|||
126548042|NCT01235975|455299855|FG000|Overall Study|Lost to Follow-up|7|||
126548043|NCT01235975|455299856|FG001|Overall Study|Lost to Follow-up|3|||
126548044|NCT00791921|455299857|FG000|Overall Study|Protocol planed|24|||
126548045|NCT00791921|455299858|FG001|Overall Study|Protocol planed|88|||
126548046|NCT00791921|455299857|FG000|Overall Study|Withdrawal by Subject|1|||
126548047|NCT00791921|455299858|FG001|Overall Study|Withdrawal by Subject|2|||
126548048|NCT00791921|455299857|FG000|Overall Study|Adverse Event|8|||
126548049|NCT00791921|455299858|FG001|Overall Study|Adverse Event|2|||
126548050|NCT00791921|455299857|FG000|Overall Study|Lack of Efficacy|0|||
126548051|NCT00791921|455299858|FG001|Overall Study|Lack of Efficacy|2|||
126548052|NCT00791921|455299857|FG000|Overall Study|Lack of study drug administration|1|||
126548053|NCT00791921|455299858|FG001|Overall Study|Lack of study drug administration|1|||
126548054|NCT00791921|455299857|FG000|Overall Study|Reason other than those above|0|||
126548055|NCT00791921|455299858|FG001|Overall Study|Reason other than those above|1|||
126548056|NCT01965158|455299860|FG000|Overall Study|Adverse Event|14|||
126548057|NCT01965158|455299861|FG001|Overall Study|Adverse Event|5|||
126548058|NCT01965158|455299860|FG000|Overall Study|Withdrawal by Subject|16|||
126548059|NCT01965158|455299861|FG001|Overall Study|Withdrawal by Subject|24|||
126548060|NCT01965158|455299860|FG000|Overall Study|Lost to Follow-up|7|||
126548061|NCT01965158|455299861|FG001|Overall Study|Lost to Follow-up|5|||
126548062|NCT01965158|455299860|FG000|Overall Study|Protocol Violation|1|||
126548063|NCT01965158|455299861|FG001|Overall Study|Protocol Violation|1|||
126548064|NCT01965158|455299860|FG000|Overall Study|Other - Miscellaneous|3|||
126548065|NCT01965158|455299861|FG001|Overall Study|Other - Miscellaneous|0|||
126548066|NCT00474175|455299862|FG000|Overall Study|Lack of Efficacy|0|||
126548067|NCT00474175|455299863|FG001|Overall Study|Lack of Efficacy|0|||
126548068|NCT00474175|455299864|FG002|Overall Study|Lack of Efficacy|1|||
126548069|NCT00474175|455299862|FG000|Overall Study|Withdrawal by Subject|0|||
126548070|NCT00474175|455299863|FG001|Overall Study|Withdrawal by Subject|1|||
126548071|NCT00474175|455299864|FG002|Overall Study|Withdrawal by Subject|1|||
126548072|NCT00474175|455299862|FG000|Overall Study|Ineligible|1|||
126548073|NCT00474175|455299863|FG001|Overall Study|Ineligible|3|||
126548074|NCT00474175|455299864|FG002|Overall Study|Ineligible|1|||
126548075|NCT00474175|455299862|FG000|Overall Study|Protocol Violation|0|||
126548076|NCT00474175|455299863|FG001|Overall Study|Protocol Violation|2|||
126548077|NCT00474175|455299864|FG002|Overall Study|Protocol Violation|1|||
126548078|NCT00474175|455299862|FG000|Overall Study|Administrative|0|||
126548079|NCT00474175|455299863|FG001|Overall Study|Administrative|1|||
126548080|NCT00474175|455299864|FG002|Overall Study|Administrative|0|||
126548081|NCT01027364|455299869|FG000|Overall Study|Adverse Event|1|||
126548082|NCT01027364|455299870|FG001|Overall Study|Adverse Event|0|||
126548083|NCT01027364|455299871|FG002|Overall Study|Adverse Event|1|||
126278064|NCT00229723|454309104|FG003|Maintenance Phase|Adverse Event|4|||
126278065|NCT00229723|454309105|FG004|Maintenance Phase|Adverse Event|7|||
126278066|NCT00229723|454309106|FG005|Maintenance Phase|Adverse Event|5|||
126363159|NCT02037984|454621726|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
126548084|NCT01027364|455299872|FG003|Overall Study|Adverse Event|0|||
126548085|NCT01027364|455299869|FG000|Overall Study|Lost to Follow-up|1|||
126548086|NCT01027364|455299870|FG001|Overall Study|Lost to Follow-up|0|||
126548087|NCT01027364|455299871|FG002|Overall Study|Lost to Follow-up|0|||
126548088|NCT01027364|455299872|FG003|Overall Study|Lost to Follow-up|0|||
126548089|NCT01027364|455299869|FG000|Overall Study|Protocol Violation|1|||
126548090|NCT01027364|455299870|FG001|Overall Study|Protocol Violation|0|||
126548091|NCT01027364|455299871|FG002|Overall Study|Protocol Violation|0|||
126363160|NCT02037984|454621727|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
126548092|NCT01027364|455299872|FG003|Overall Study|Protocol Violation|1|||
126363161|NCT02037984|454621728|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
126363162|NCT02037984|454621729|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
126363163|NCT02037984|454621730|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
126363164|NCT02037984|454621723|FG000|Overall Study|Withdrawal by Subject|0|||
126363165|NCT02037984|454621724|FG001|Overall Study|Withdrawal by Subject|0|||
126363166|NCT02037984|454621725|FG002|Overall Study|Withdrawal by Subject|0|||
126454941|NCT00534599|454964891|FG000|Overall Study|Adverse Event|25|||
126454942|NCT00534599|454964892|FG001|Overall Study|Adverse Event|4|||
126454943|NCT00534599|454964891|FG000|Overall Study|Incorrect enrollment|2|||
126454944|NCT00534599|454964892|FG001|Overall Study|Incorrect enrollment|1|||
126454945|NCT00534599|454964891|FG000|Overall Study|Mis-randomization|2|||
126454946|NCT00534599|454964892|FG001|Overall Study|Mis-randomization|2|||
126454947|NCT00534599|454964891|FG000|Overall Study|Developed study-specific d/c criteria|5|||
126454948|NCT00534599|454964892|FG001|Overall Study|Developed study-specific d/c criteria|0|||
126454949|NCT00534599|454964891|FG000|Overall Study|Lack of Efficacy|0|||
126454950|NCT00534599|454964892|FG001|Overall Study|Lack of Efficacy|1|||
126454951|NCT00534599|454964891|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
126454952|NCT00534599|454964892|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
126454953|NCT00534599|454964891|FG000|Overall Study|Protocol Violation|1|||
126454954|NCT00534599|454964892|FG001|Overall Study|Protocol Violation|3|||
126454955|NCT00534599|454964891|FG000|Overall Study|Lost to Follow-up|11|||
126454956|NCT00534599|454964892|FG001|Overall Study|Lost to Follow-up|14|||
126454957|NCT00534599|454964891|FG000|Overall Study|Withdrawal by Subject|4|||
126454958|NCT00534599|454964892|FG001|Overall Study|Withdrawal by Subject|6|||
126454959|NCT00534599|454964891|FG000|Overall Study|Other|7|||
126454960|NCT00534599|454964892|FG001|Overall Study|Other|0|||
126454961|NCT03645434|454964896|FG000|Period 1|Adverse Event|0|||
126454962|NCT03645434|454964897|FG001|Period 1|Adverse Event|0|||
126454963|NCT03645434|454964898|FG002|Period 1|Adverse Event|0|||
126454964|NCT03645434|454964899|FG003|Period 1|Adverse Event|1|||
126454965|NCT03645434|454964900|FG004|Period 1|Adverse Event|0|||
126454966|NCT03645434|454964901|FG005|Period 1|Adverse Event|0|||
126454967|NCT03645434|454964896|FG000|Period 1|COPD exacerbation|0|||
126454968|NCT03645434|454964897|FG001|Period 1|COPD exacerbation|0|||
126454969|NCT03645434|454964898|FG002|Period 1|COPD exacerbation|0|||
126454970|NCT03645434|454964899|FG003|Period 1|COPD exacerbation|0|||
126454971|NCT03645434|454964900|FG004|Period 1|COPD exacerbation|1|||
126454972|NCT03645434|454964901|FG005|Period 1|COPD exacerbation|0|||
126454973|NCT03865316|454966474|FG000|Overall Study|Procedure Cancelled|4|||
126454974|NCT03865316|454966474|FG000|Overall Study|Equipment failure|4|||
126454975|NCT03658876|454966476|FG000|Overall Study|Protocol Violation|3|||
126454976|NCT03658876|454966477|FG001|Overall Study|Protocol Violation|2|||
126454977|NCT03658876|454966476|FG000|Overall Study|Withdrawal by Subject|2|||
126454978|NCT03658876|454966477|FG001|Overall Study|Withdrawal by Subject|0|||
126454979|NCT03658876|454966476|FG000|Overall Study|Death|0|||
126454980|NCT03658876|454966477|FG001|Overall Study|Death|1|||
126765714|NCT02074982|456095786|FG000|Overall Study|Protocol deviation|4|||
126765715|NCT02074982|456095787|FG001|Overall Study|Protocol deviation|3|||
126765716|NCT02074982|456095786|FG000|Overall Study|Technical problems|0|||
126765717|NCT02074982|456095787|FG001|Overall Study|Technical problems|2|||
126765718|NCT02074982|456095786|FG000|Overall Study|Subject/guardian decision|15|||
126765719|NCT02074982|456095787|FG001|Overall Study|Subject/guardian decision|24|||
126363167|NCT02037984|454621726|FG003|Overall Study|Withdrawal by Subject|1|||
126363168|NCT02037984|454621727|FG004|Overall Study|Withdrawal by Subject|1|||
126363169|NCT02037984|454621728|FG005|Overall Study|Withdrawal by Subject|3|||
126363170|NCT02037984|454621729|FG006|Overall Study|Withdrawal by Subject|0|||
126363171|NCT02037984|454621730|FG007|Overall Study|Withdrawal by Subject|1|||
126363172|NCT00974233|454621731|FG000|Induction Chemoimmunotherapy|Death|2|||
126363173|NCT00974233|454621731|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
126363174|NCT00974233|454621731|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
126363175|NCT00974233|454621731|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
126363176|NCT00974233|454621731|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
126363177|NCT00974233|454621731|FG000|Maintenance Lenalidomide|Adverse Event|8|||
126363178|NCT01691092|454621732|FG000|Overall Study|Lost to Follow-up|10|||
126363179|NCT01691092|454621732|FG000|Overall Study|Physician Decision|4|||
126363180|NCT01691092|454621732|FG000|Overall Study|Withdrawal by Subject|3|||
126363181|NCT01691092|454621732|FG000|Overall Study|non-compliance|3|||
126363182|NCT01691092|454621732|FG000|Overall Study|used for different study|2|||
126454981|NCT03658876|454966476|FG000|Overall Study|Intercurrent illness|6|||
126454982|NCT03658876|454966477|FG001|Overall Study|Intercurrent illness|4|||
126454983|NCT03658876|454966476|FG000|Overall Study|Transplantation/other operation|1|||
126454984|NCT03658876|454966477|FG001|Overall Study|Transplantation/other operation|5|||
126454985|NCT01330017|454966478|FG000|Overall Study|Adverse Event|0|||
126454986|NCT01330017|454966479|FG001|Overall Study|Adverse Event|1|||
126454987|NCT01330017|454966480|FG002|Overall Study|Adverse Event|1|||
126454988|NCT01330017|454966481|FG003|Overall Study|Adverse Event|4|||
126454989|NCT01330017|454966482|FG004|Overall Study|Adverse Event|0|||
126454990|NCT01330017|454966478|FG000|Overall Study|Withdrawal by Subject|0|||
126363183|NCT01691092|454621732|FG000|Overall Study|screen fail|19|||
126363184|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
126363185|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
126363186|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
126363187|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Adverse Event|5|||
126363188|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Adverse Event|1|||
126363189|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Adverse Event|0|||
126363190|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
126363191|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
126363192|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
126363193|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Death|8|||
126363194|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Death|24|||
126363195|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Death|0|||
126363196|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
126363197|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
126363198|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
126363199|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
126363200|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
126363201|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
126363202|NCT02931539|454621733|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
126363203|NCT02931539|454621734|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
126363204|NCT02931539|454621735|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
126363205|NCT02931539|454621733|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
126363206|NCT02931539|454621734|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
126363207|NCT02931539|454621735|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
126363208|NCT01657942|454621738|FG000|Overall Study|Alternative Treatment|7|||
126363209|NCT01657942|454621738|FG000|Overall Study|Lost to Follow-up|1|||
126363210|NCT03061214|454621739|FG000|Overall Study|Withdrawal by Subject|21|||
126363211|NCT03061214|454621740|FG001|Overall Study|Withdrawal by Subject|26|||
126363212|NCT03061214|454621741|FG002|Overall Study|Withdrawal by Subject|9|||
126363213|NCT03061214|454621739|FG000|Overall Study|Lost to Follow-up|3|||
126363214|NCT03061214|454621740|FG001|Overall Study|Lost to Follow-up|1|||
126363215|NCT03061214|454621741|FG002|Overall Study|Lost to Follow-up|1|||
126363216|NCT03061214|454621739|FG000|Overall Study|Death|1|||
126363217|NCT03061214|454621740|FG001|Overall Study|Death|1|||
126363218|NCT03061214|454621741|FG002|Overall Study|Death|0|||
126363219|NCT01569763|454623401|FG000|Overall Study|Lack of Efficacy|2|||
126363220|NCT01569763|454623402|FG001|Overall Study|Lack of Efficacy|7|||
126363221|NCT01569763|454623401|FG000|Overall Study|Adverse Event|1|||
126363222|NCT01569763|454623402|FG001|Overall Study|Adverse Event|0|||
126363223|NCT03211858|454623404|FG000|Overall Study|Adverse Event|8|||
126363224|NCT03211858|454623405|FG001|Overall Study|Adverse Event|6|||
126363225|NCT03211858|454623404|FG000|Overall Study|Lack of Efficacy|0|||
126363226|NCT03211858|454623405|FG001|Overall Study|Lack of Efficacy|4|||
126363227|NCT03211858|454623404|FG000|Overall Study|Poor compliance to protocol|6|||
126363228|NCT03211858|454623405|FG001|Overall Study|Poor compliance to protocol|2|||
126363229|NCT03211858|454623404|FG000|Overall Study|Non-serious Hypoglycemia|1|||
126363230|NCT03211858|454623405|FG001|Overall Study|Non-serious Hypoglycemia|0|||
126363231|NCT03211858|454623404|FG000|Overall Study|Other than specified above|22|||
126363232|NCT03211858|454623405|FG001|Overall Study|Other than specified above|21|||
126363233|NCT03810365|454623407|FG000|Overall Study|Lost to Follow-up|2|||
126363234|NCT03810365|454623408|FG001|Overall Study|Lost to Follow-up|2|||
126363235|NCT03810365|454623407|FG000|Overall Study|Withdrawal by Subject|4|||
126363236|NCT03810365|454623408|FG001|Overall Study|Withdrawal by Subject|5|||
126363237|NCT00185614|454623413|FG000|Inter-treatment Period|Physician Decision|1|||
126363238|NCT00185614|454623413|FG000|Inter-treatment Period|Relapse|2|||
126363239|NCT00185614|454623413|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
126363240|NCT03160573|454623414|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
126363241|NCT03160573|454623415|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
126363242|NCT03160573|454623416|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
126363243|NCT03160573|454623417|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
126363244|NCT02402907|454623421|FG000|Overall Study|Delivered vaginally|9|||
126363245|NCT02402907|454623422|FG001|Overall Study|Delivered vaginally|3|||
126363246|NCT02402907|454623421|FG000|Overall Study|Delivered outside of Sinai|1|||
126363247|NCT02402907|454623422|FG001|Overall Study|Delivered outside of Sinai|1|||
126363248|NCT02402907|454623421|FG000|Overall Study|Lost to follow up after C-Section|10|||
126363249|NCT02402907|454623422|FG001|Overall Study|Lost to follow up after C-Section|23|||
126363250|NCT01423084|454623423|FG000|Overall Study|Adverse Event|0|||
126363251|NCT01423084|454623424|FG001|Overall Study|Adverse Event|1|||
126363252|NCT01423084|454623423|FG000|Overall Study|Withdrawal by Subject|2|||
126363253|NCT01423084|454623424|FG001|Overall Study|Withdrawal by Subject|3|||
126706855|NCT01121406|455878906|FG001|Overall Study|Lost to Follow-up|1|||
126706856|NCT01121406|455878905|FG000|Overall Study|Refused continuation of study med.|1|||
126706857|NCT01121406|455878906|FG001|Overall Study|Refused continuation of study med.|2|||
126706858|NCT01121406|455878905|FG000|Overall Study|Reason other than specified above|2|||
126706859|NCT01121406|455878906|FG001|Overall Study|Reason other than specified above|6|||
126278067|NCT00229723|454309107|FG006|Maintenance Phase|Adverse Event|2|||
126278068|NCT00229723|454309101|FG000|Maintenance Phase|Objective disease progression|5|||
126278069|NCT00229723|454309102|FG001|Maintenance Phase|Objective disease progression|5|||
126278070|NCT00229723|454309103|FG002|Maintenance Phase|Objective disease progression|3|||
126278071|NCT00229723|454309104|FG003|Maintenance Phase|Objective disease progression|6|||
126278072|NCT00229723|454309105|FG004|Maintenance Phase|Objective disease progression|2|||
126278073|NCT00229723|454309106|FG005|Maintenance Phase|Objective disease progression|9|||
126278074|NCT00229723|454309107|FG006|Maintenance Phase|Objective disease progression|5|||
126278075|NCT00229723|454309101|FG000|Maintenance Phase|Clinical progression|4|||
126278076|NCT00229723|454309102|FG001|Maintenance Phase|Clinical progression|1|||
126278077|NCT00229723|454309103|FG002|Maintenance Phase|Clinical progression|2|||
126706860|NCT01121406|455878905|FG000|Overall Study|Not treated|1|||
126706861|NCT01121406|455878906|FG001|Overall Study|Not treated|0|||
126278078|NCT00229723|454309104|FG003|Maintenance Phase|Clinical progression|2|||
126278079|NCT00229723|454309105|FG004|Maintenance Phase|Clinical progression|1|||
126278080|NCT00229723|454309106|FG005|Maintenance Phase|Clinical progression|1|||
126278081|NCT00229723|454309107|FG006|Maintenance Phase|Clinical progression|1|||
126363254|NCT00661687|454623425|FG000|Overall Study|Study related symptoms and complaints|5|||
126363255|NCT00661687|454623425|FG000|Overall Study|Positive slit lamp findings|4|||
126706862|NCT03185130|455878908|FG000|Overall Study|Withdrawal by Subject|0|||
126706863|NCT03185130|455878909|FG001|Overall Study|Withdrawal by Subject|2|||
126706864|NCT01925703|455878910|FG000|Overall Study|Physician Decision|1|||
126706865|NCT01925703|455878910|FG000|Overall Study|Lost to Follow-up|2|||
126706866|NCT01925703|455878910|FG000|Overall Study|Discharge prior to full iron repletion|1|||
126706867|NCT03215277|455878912|FG000|Overall Study|Adverse Event|2|||
126706868|NCT03215277|455878913|FG001|Overall Study|Adverse Event|3|||
126706869|NCT03215277|455878912|FG000|Overall Study|Death|1|||
126706870|NCT03215277|455878913|FG001|Overall Study|Death|0|||
126706871|NCT03215277|455878912|FG000|Overall Study|Lost to Follow-up|0|||
126706872|NCT03215277|455878913|FG001|Overall Study|Lost to Follow-up|1|||
126706873|NCT03215277|455878912|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
126706874|NCT03215277|455878913|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
126706875|NCT03794986|455878914|FG000|Overall Study|0 Sessions Attended|34|||
126706876|NCT03794986|455878915|FG001|Overall Study|0 Sessions Attended|37|||
126706877|NCT03794986|455878914|FG000|Overall Study|Withdrawal by Subject|4|||
126706878|NCT03794986|455878915|FG001|Overall Study|Withdrawal by Subject|6|||
126706879|NCT03794986|455878914|FG000|Overall Study|Protocol Violation|1|||
126706880|NCT03794986|455878915|FG001|Overall Study|Protocol Violation|0|||
126706881|NCT01238120|455878918|FG000|Overall Study|Withdrawal by Subject|4|||
126706882|NCT01238120|455878919|FG001|Overall Study|Withdrawal by Subject|1|||
126363256|NCT00661687|454623425|FG000|Overall Study|Inability to maintain wearing schedule|3|||
126363257|NCT00661687|454623425|FG000|Overall Study|Physician Decision|1|||
126363258|NCT00661687|454623425|FG000|Overall Study|Adverse Event|2|||
126363259|NCT02462057|454623426|FG000|Overall Study|Left Vitality|32|||
126363260|NCT02462057|454623427|FG001|Overall Study|Left Vitality|27|||
126363261|NCT02462057|454623428|FG002|Overall Study|Left Vitality|23|||
126363262|NCT02462057|454623429|FG003|Overall Study|Left Vitality|35|||
126363263|NCT02462057|454623430|FG004|Overall Study|Left Vitality|33|||
126363264|NCT02462057|454623426|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
126363265|NCT02462057|454623427|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
126363266|NCT02462057|454623428|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
126363267|NCT02462057|454623429|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
126363268|NCT02462057|454623430|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
126363269|NCT02336555|454623431|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126363270|NCT02336555|454623432|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
126363271|NCT02336555|454623431|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
126363272|NCT02336555|454623432|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
126363273|NCT02336555|454623431|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
126363274|NCT02336555|454623432|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
126363275|NCT01633112|454623433|FG000|Overall Study|Lack of Efficacy|1|||
126363276|NCT01633112|454623434|FG001|Overall Study|Lack of Efficacy|6|||
126363277|NCT01633112|454623435|FG002|Overall Study|Lack of Efficacy|13|||
126363278|NCT01633112|454623433|FG000|Overall Study|Abnormal laboratory value(s)|3|||
126363279|NCT01633112|454623434|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126363280|NCT01633112|454623435|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126363281|NCT01633112|454623433|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126363282|NCT01633112|454623434|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126363283|NCT01633112|454623435|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126454991|NCT01330017|454966479|FG001|Overall Study|Withdrawal by Subject|0|||
126706883|NCT01238120|455878920|FG002|Overall Study|Withdrawal by Subject|2|||
126706884|NCT01238120|455878921|FG003|Overall Study|Withdrawal by Subject|5|||
126706885|NCT01238120|455878918|FG000|Overall Study|Lost to Follow-up|2|||
126706886|NCT01238120|455878919|FG001|Overall Study|Lost to Follow-up|0|||
126706887|NCT01238120|455878920|FG002|Overall Study|Lost to Follow-up|1|||
126706888|NCT01238120|455878921|FG003|Overall Study|Lost to Follow-up|1|||
126706889|NCT01238120|455878918|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
126706890|NCT01238120|455878919|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
126706891|NCT01238120|455878920|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
126706892|NCT01238120|455878921|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
126454992|NCT01330017|454966480|FG002|Overall Study|Withdrawal by Subject|1|||
126454993|NCT01330017|454966481|FG003|Overall Study|Withdrawal by Subject|0|||
126454994|NCT01330017|454966482|FG004|Overall Study|Withdrawal by Subject|1|||
126454995|NCT01330017|454966478|FG000|Overall Study|Lost to Follow-up|0|||
126454996|NCT01330017|454966479|FG001|Overall Study|Lost to Follow-up|0|||
126454997|NCT01330017|454966480|FG002|Overall Study|Lost to Follow-up|1|||
126454998|NCT01330017|454966481|FG003|Overall Study|Lost to Follow-up|0|||
126454999|NCT01330017|454966482|FG004|Overall Study|Lost to Follow-up|0|||
126455000|NCT01330017|454966478|FG000|Overall Study|Protocol Violation|0|||
126455001|NCT01330017|454966479|FG001|Overall Study|Protocol Violation|0|||
126455002|NCT01330017|454966480|FG002|Overall Study|Protocol Violation|0|||
126455003|NCT01330017|454966481|FG003|Overall Study|Protocol Violation|1|||
126455004|NCT01330017|454966482|FG004|Overall Study|Protocol Violation|0|||
126455005|NCT01330017|454966478|FG000|Overall Study|Unknown Reason|5|||
126455006|NCT01330017|454966479|FG001|Overall Study|Unknown Reason|3|||
126455007|NCT01330017|454966480|FG002|Overall Study|Unknown Reason|5|||
126455008|NCT01330017|454966481|FG003|Overall Study|Unknown Reason|7|||
126455009|NCT01330017|454966482|FG004|Overall Study|Unknown Reason|2|||
126455010|NCT02616146|454966483|FG000|Overall Study|Adverse Event|64|||
126455011|NCT02616146|454966484|FG001|Overall Study|Adverse Event|24|||
126455012|NCT02616146|454966483|FG000|Overall Study|Lost to Follow-up|23|||
126455013|NCT02616146|454966484|FG001|Overall Study|Lost to Follow-up|13|||
126455014|NCT02616146|454966483|FG000|Overall Study|Non-compliance with study protocol|2|||
126455015|NCT02616146|454966484|FG001|Overall Study|Non-compliance with study protocol|0|||
126455016|NCT02616146|454966483|FG000|Overall Study|Non-compliance with study drug|4|||
126455017|NCT02616146|454966484|FG001|Overall Study|Non-compliance with study drug|2|||
126455018|NCT02616146|454966483|FG000|Overall Study|Pregnancy|2|||
126455019|NCT02616146|454966484|FG001|Overall Study|Pregnancy|2|||
126455020|NCT02616146|454966483|FG000|Overall Study|Pregnancy wish|3|||
126455021|NCT02616146|454966484|FG001|Overall Study|Pregnancy wish|0|||
126455022|NCT02616146|454966483|FG000|Overall Study|Protocol Violation|6|||
126455023|NCT02616146|454966484|FG001|Overall Study|Protocol Violation|3|||
126455024|NCT02616146|454966483|FG000|Overall Study|Study terminated by sponsor|1372|||
126455025|NCT02616146|454966484|FG001|Overall Study|Study terminated by sponsor|432|||
126455026|NCT02616146|454966483|FG000|Overall Study|Participant moved|4|||
126455027|NCT02616146|454966484|FG001|Overall Study|Participant moved|3|||
126455028|NCT02616146|454966483|FG000|Overall Study|Withdrawal by Subject|30|||
126455029|NCT02616146|454966484|FG001|Overall Study|Withdrawal by Subject|24|||
126455030|NCT02616146|454966483|FG000|Overall Study|Physician Decision|2|||
126706893|NCT02498652|455878924|FG000|Overall Study|Protocol Violation|0|||
126706894|NCT02498652|455878925|FG001|Overall Study|Protocol Violation|1|||
126455031|NCT02616146|454966484|FG001|Overall Study|Physician Decision|1|||
126455032|NCT00336856|454966485|FG000|Overall Study|Withdrawal by Subject|3|||
126455033|NCT00336856|454966485|FG000|Overall Study|Found ineligible at time of analysis|1|||
126455034|NCT01106092|454966486|FG000|Overall Study|Withdrawal by Subject|0|||
126455035|NCT01106092|454966487|FG001|Overall Study|Withdrawal by Subject|0|||
126455036|NCT01106092|454966488|FG002|Overall Study|Withdrawal by Subject|0|||
126455037|NCT01106092|454966489|FG003|Overall Study|Withdrawal by Subject|1|||
126455038|NCT00843778|454966490|FG000|Overall Study|Adverse Event|15|||
126455039|NCT00843778|454966490|FG000|Overall Study|Lack of Efficacy|14|||
126455040|NCT00843778|454966490|FG000|Overall Study|Loss of efficacy|2|||
126455041|NCT00843778|454966490|FG000|Overall Study|Withdrawal by Subject|4|||
126455042|NCT03338959|454966495|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
126455043|NCT03338959|454966495|FG000|Overall Study|Physician Decision|1|||
126455044|NCT01604278|454966496|FG000|Overall Study|Lack of Efficacy|0|||
126455045|NCT01604278|454966497|FG001|Overall Study|Lack of Efficacy|1|||
126455046|NCT01604278|454966496|FG000|Overall Study|Lost to Follow-up|1|||
126455047|NCT01604278|454966497|FG001|Overall Study|Lost to Follow-up|0|||
126548093|NCT01027364|455299869|FG000|Overall Study|Withdrawal by Subject|1|||
126706895|NCT00465569|455878927|FG000|Overall Study|persistent eczema during dose escalation|1|||
126455048|NCT01604278|454966496|FG000|Overall Study|Administrative problems|2|||
126455049|NCT01604278|454966497|FG001|Overall Study|Administrative problems|1|||
126706896|NCT00465569|455878928|FG001|Overall Study|persistent eczema during dose escalation|0|||
126455050|NCT01604278|454966496|FG000|Overall Study|Withdrawal by Subject|3|||
126455051|NCT01604278|454966497|FG001|Overall Study|Withdrawal by Subject|3|||
126548094|NCT01027364|455299870|FG001|Overall Study|Withdrawal by Subject|2|||
126706897|NCT00922935|455878929|FG000|Overall Study|Protocol Violation|0|||
126706898|NCT00922935|455878930|FG001|Overall Study|Protocol Violation|3|||
126455052|NCT01604278|454966496|FG000|Overall Study|Adverse Event|3|||
126548095|NCT01027364|455299871|FG002|Overall Study|Withdrawal by Subject|0|||
126706899|NCT00922935|455878931|FG002|Overall Study|Protocol Violation|0|||
126706900|NCT00922935|455878929|FG000|Overall Study|Physician Decision|1|||
126706901|NCT00922935|455878930|FG001|Overall Study|Physician Decision|1|||
126706902|NCT00922935|455878931|FG002|Overall Study|Physician Decision|0|||
126706903|NCT00922935|455878929|FG000|Overall Study|Lost to Follow-up|0|||
126706904|NCT00922935|455878930|FG001|Overall Study|Lost to Follow-up|1|||
126706905|NCT00922935|455878931|FG002|Overall Study|Lost to Follow-up|0|||
126706906|NCT00849212|455878932|FG000|Overall Study|Lack of Efficacy|1|||
126706907|NCT00849212|455878932|FG000|Overall Study|Withdrawal by Subject|3|||
126706908|NCT00849212|455878932|FG000|Overall Study|Adverse Event|2|||
126706909|NCT00849212|455878932|FG000|Overall Study|Miscellaneous|1|||
126706910|NCT00095303|455878933|FG000|Main Study|Lost to Follow-up|91|||
126706911|NCT00095303|455878934|FG001|Main Study|Lost to Follow-up|87|||
126706912|NCT00095303|455878933|FG000|Follow Up Study|Lost to Follow-up|59|||
126706913|NCT00095303|455878934|FG001|Follow Up Study|Lost to Follow-up|58|||
126706914|NCT01499576|455878935|FG000|Overall Study|Physician Decision|12|||
126706915|NCT01499576|455878935|FG000|Overall Study|Withdrawal by Subject|9|||
126706916|NCT04283461|455878936|FG000|Overall Study|Enrolled in separate trial|0|||
126706917|NCT04283461|455878937|FG001|Overall Study|Enrolled in separate trial|0|||
126706918|NCT04283461|455878938|FG002|Overall Study|Enrolled in separate trial|8|||
126706919|NCT04283461|455878939|FG003|Overall Study|Enrolled in separate trial|13|||
126706920|NCT04283461|455878940|FG004|Overall Study|Enrolled in separate trial|12|||
126706921|NCT04283461|455878941|FG005|Overall Study|Enrolled in separate trial|0|||
126706922|NCT04283461|455878942|FG006|Overall Study|Enrolled in separate trial|0|||
126706923|NCT04283461|455878943|FG007|Overall Study|Enrolled in separate trial|8|||
126706924|NCT04283461|455878944|FG008|Overall Study|Enrolled in separate trial|0|||
126706925|NCT04283461|455878945|FG009|Overall Study|Enrolled in separate trial|0|||
126706926|NCT04283461|455878946|FG010|Overall Study|Enrolled in separate trial|0|||
126706927|NCT04283461|455878947|FG011|Overall Study|Enrolled in separate trial|7|||
126548096|NCT01027364|455299872|FG003|Overall Study|Withdrawal by Subject|0|||
126548097|NCT03000673|455299877|FG000|Overall Study|Withdrawal by Subject|1|||
126548098|NCT03000673|455299878|FG001|Overall Study|Withdrawal by Subject|0|||
126765720|NCT02074982|456095786|FG000|Overall Study|Death|0|||
126706928|NCT04283461|455878948|FG012|Overall Study|Enrolled in separate trial|0|||
126706929|NCT04375878|455878955|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
126548099|NCT03000673|455299879|FG002|Overall Study|Withdrawal by Subject|0|||
126548100|NCT03000673|455299880|FG003|Overall Study|Withdrawal by Subject|0|||
126548101|NCT01121484|455299881|FG000|Overall Study|Adverse Event|12|||
126548102|NCT01121484|455299882|FG001|Overall Study|Adverse Event|5|||
126548103|NCT01121484|455299881|FG000|Overall Study|Lack of Efficacy|3|||
126548104|NCT01121484|455299882|FG001|Overall Study|Lack of Efficacy|11|||
126548105|NCT01121484|455299881|FG000|Overall Study|Lost to Follow-up|5|||
126548106|NCT01121484|455299882|FG001|Overall Study|Lost to Follow-up|9|||
126548107|NCT01121484|455299881|FG000|Overall Study|Physician Decision|0|||
126548108|NCT01121484|455299882|FG001|Overall Study|Physician Decision|3|||
126548109|NCT01121484|455299881|FG000|Overall Study|Protocol Violation|1|||
126548110|NCT01121484|455299882|FG001|Overall Study|Protocol Violation|0|||
126548111|NCT01121484|455299881|FG000|Overall Study|Withdrawal by Subject|8|||
126548112|NCT01121484|455299882|FG001|Overall Study|Withdrawal by Subject|7|||
126548113|NCT01121484|455299881|FG000|Overall Study|Discontinuation of study by sponsor|0|||
126548114|NCT01121484|455299882|FG001|Overall Study|Discontinuation of study by sponsor|1|||
126548115|NCT01121484|455299881|FG000|Overall Study|Other|3|||
126548116|NCT01121484|455299882|FG001|Overall Study|Other|3|||
126548117|NCT01121484|455299881|FG000|Overall Study|Randomized, not treated|1|||
126548118|NCT01121484|455299882|FG001|Overall Study|Randomized, not treated|4|||
126548119|NCT00562978|455299883|FG000|Overall Study|Patient had imaging dose only|1|||
126548120|NCT00562978|455299884|FG001|Overall Study|Patient had imaging dose only|11|||
126548121|NCT01913639|455299894|FG000|Overall Study|Not Eligible|3|||
126548122|NCT01396395|455299898|FG000|Overall Study|Withdrawal by Subject|10|||
126548123|NCT01396395|455299899|FG001|Overall Study|Withdrawal by Subject|12|||
126548124|NCT01396395|455299898|FG000|Overall Study|Protocol Violation|3|||
126765721|NCT02074982|456095787|FG001|Overall Study|Death|2|||
126706930|NCT04375878|455878956|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
126548125|NCT01396395|455299899|FG001|Overall Study|Protocol Violation|1|||
126548126|NCT01396395|455299898|FG000|Overall Study|Adverse Event|10|||
126706931|NCT04375878|455878957|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
126765722|NCT02094573|456095790|FG000|Overall Study|Adverse Event|4|||
126548127|NCT01396395|455299899|FG001|Overall Study|Adverse Event|2|||
126548128|NCT01396395|455299898|FG000|Overall Study|Lost to Follow-up|17|||
126548129|NCT01396395|455299899|FG001|Overall Study|Lost to Follow-up|11|||
126548130|NCT01396395|455299898|FG000|Overall Study|Other|0|||
126548131|NCT01396395|455299899|FG001|Overall Study|Other|1|||
126706932|NCT04375878|455878958|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
126706933|NCT04375878|455878959|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
126706934|NCT04375878|455878960|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
126765723|NCT02094573|456095791|FG001|Overall Study|Adverse Event|14|||
126548132|NCT02009696|455299904|FG000|Overall Study|Withdrawal by Subject|2|||
126548133|NCT05490329|455299905|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
126706935|NCT04375878|455878955|FG000|Crossover First and Second Interventions|Adverse Event|0|||
126706936|NCT04375878|455878956|FG001|Crossover First and Second Interventions|Adverse Event|0|||
126706937|NCT04375878|455878957|FG002|Crossover First and Second Interventions|Adverse Event|1|||
126706938|NCT04375878|455878958|FG003|Crossover First and Second Interventions|Adverse Event|0|||
126706939|NCT04375878|455878959|FG004|Crossover First and Second Interventions|Adverse Event|0|||
126706940|NCT04375878|455878960|FG005|Crossover First and Second Interventions|Adverse Event|0|||
126706941|NCT04375878|455878955|FG000|Extension Phase|Withdrawal by Subject|0|||
126706942|NCT04375878|455878956|FG001|Extension Phase|Withdrawal by Subject|0|||
126706943|NCT04375878|455878957|FG002|Extension Phase|Withdrawal by Subject|0|||
126706944|NCT04375878|455878958|FG003|Extension Phase|Withdrawal by Subject|0|||
126706945|NCT04375878|455878959|FG004|Extension Phase|Withdrawal by Subject|1|||
126706946|NCT04375878|455878960|FG005|Extension Phase|Withdrawal by Subject|0|||
126706947|NCT00195351|455878961|FG000|Overall Study|Lost to Follow-up|9|||
126706948|NCT00195351|455878962|FG001|Overall Study|Lost to Follow-up|9|||
126706949|NCT00195351|455878961|FG000|Overall Study|Withdrawal by Subject|6|||
126706950|NCT00195351|455878962|FG001|Overall Study|Withdrawal by Subject|3|||
126706951|NCT00195351|455878961|FG000|Overall Study|Protocol Deviation|3|||
126706952|NCT00195351|455878962|FG001|Overall Study|Protocol Deviation|2|||
126706953|NCT00195351|455878961|FG000|Overall Study|Death|3|||
126706954|NCT00195351|455878962|FG001|Overall Study|Death|1|||
126706955|NCT00195351|455878961|FG000|Overall Study|Lack of Efficacy|0|||
126706956|NCT00195351|455878962|FG001|Overall Study|Lack of Efficacy|1|||
126706957|NCT02111369|455878963|FG000|Overall Study|Lost to Follow-up|2|||
126706958|NCT02111369|455878963|FG000|Overall Study|Withdrawal by Subject|1|||
126706959|NCT01259466|455878964|FG000|Overall Study|Withdrawal by Subject|1|||
126706960|NCT01259466|455878965|FG001|Overall Study|Withdrawal by Subject|9|||
126706961|NCT00519623|455878968|FG000|Overall Study|Adverse Event|1|||
126706962|NCT00104871|455878970|FG000|Overall Study|Not evaluable|1|||
126706963|NCT03875235|455878983|FG000|Overall Study|Ongoing study treatment|63|||
126706964|NCT03875235|455878984|FG001|Overall Study|Ongoing study treatment|20|||
126706965|NCT03875235|455878983|FG000|Overall Study|Off treatment|77|||
126706966|NCT03875235|455878984|FG001|Overall Study|Off treatment|91|||
126706967|NCT03875235|455878983|FG000|Overall Study|Withdrawal by Subject|3|||
126706968|NCT03875235|455878984|FG001|Overall Study|Withdrawal by Subject|10|||
126455053|NCT01604278|454966497|FG001|Overall Study|Adverse Event|5|||
126455054|NCT01604278|454966496|FG000|Overall Study|Protocol Deviation|5|||
126455055|NCT01604278|454966497|FG001|Overall Study|Protocol Deviation|3|||
126455056|NCT03328182|454966502|FG000|Overall Study|Withdrawal by Subject|1|||
126455057|NCT03328182|454966502|FG000|Overall Study|Protocol Violation|2|||
126455058|NCT03328182|454966502|FG000|Overall Study|No Product Evaluated|1|||
126455059|NCT01444092|454966505|FG000|Overall Study|Adverse Event|8|||
126455060|NCT01444092|454966505|FG000|Overall Study|Protocol Violation|1|||
126455061|NCT01444092|454966505|FG000|Overall Study|Withdrawal by Subject|1|||
126455062|NCT01444092|454966505|FG000|Overall Study|Other Eligibility criteria|7|||
126455063|NCT01328366|454966506|FG000|Overall Study|Death|1|||
126455064|NCT01328366|454966506|FG000|Overall Study|Withdrawal by Subject|2|||
126455065|NCT01328366|454966506|FG000|Overall Study|Lost to Follow-up|7|||
126455066|NCT01122264|454966510|FG000|Overall Study|Adverse Event|6|||
126455067|NCT01122264|454966511|FG001|Overall Study|Adverse Event|5|||
126455068|NCT01122264|454966512|FG002|Overall Study|Adverse Event|7|||
126455069|NCT01122264|454966510|FG000|Overall Study|Death|1|||
126455070|NCT01122264|454966511|FG001|Overall Study|Death|0|||
126455071|NCT01122264|454966512|FG002|Overall Study|Death|0|||
126455072|NCT01122264|454966510|FG000|Overall Study|Lost to Follow-up|5|||
126455073|NCT01122264|454966511|FG001|Overall Study|Lost to Follow-up|9|||
126455074|NCT01122264|454966512|FG002|Overall Study|Lost to Follow-up|13|||
126455075|NCT01122264|454966510|FG000|Overall Study|Entry Criteria Not Met|1|||
126455076|NCT01122264|454966511|FG001|Overall Study|Entry Criteria Not Met|0|||
126455077|NCT01122264|454966512|FG002|Overall Study|Entry Criteria Not Met|0|||
126455078|NCT01122264|454966510|FG000|Overall Study|Protocol Violation|7|||
126455079|NCT01122264|454966511|FG001|Overall Study|Protocol Violation|7|||
126455080|NCT01122264|454966512|FG002|Overall Study|Protocol Violation|9|||
126455081|NCT01122264|454966510|FG000|Overall Study|Withdrawal by Subject|6|||
126455082|NCT01122264|454966511|FG001|Overall Study|Withdrawal by Subject|6|||
126455083|NCT01122264|454966512|FG002|Overall Study|Withdrawal by Subject|16|||
126455084|NCT01122264|454966510|FG000|Overall Study|Physician Decision|3|||
126455085|NCT01122264|454966511|FG001|Overall Study|Physician Decision|1|||
126455086|NCT01122264|454966512|FG002|Overall Study|Physician Decision|1|||
126455087|NCT01122264|454966510|FG000|Overall Study|Lack of Efficacy|3|||
126455088|NCT01122264|454966511|FG001|Overall Study|Lack of Efficacy|1|||
126455089|NCT01122264|454966512|FG002|Overall Study|Lack of Efficacy|1|||
126455090|NCT03005873|454966513|FG000|Overall Study|Prohibited medication use post radnomization|1|||
126455091|NCT03005873|454966514|FG001|Overall Study|Prohibited medication use post radnomization|1|||
126706969|NCT03875235|455878983|FG000|Overall Study|Death|198|||
126706970|NCT03875235|455878984|FG001|Overall Study|Death|223|||
126706971|NCT01687673|455878985|FG000|Overall Study|Physician Decision|1|||
126706972|NCT02234622|455878986|FG000|Overall Study|Withdrawal by Subject|16|||
126706973|NCT02234622|455878987|FG001|Overall Study|Withdrawal by Subject|22|||
126706974|NCT02234622|455878986|FG000|Overall Study|Lost to Follow-up|27|||
126278082|NCT00229723|454309101|FG000|Maintenance Phase|Lost to Follow-up|0|||
126278083|NCT00229723|454309102|FG001|Maintenance Phase|Lost to Follow-up|1|||
126278084|NCT00229723|454309103|FG002|Maintenance Phase|Lost to Follow-up|2|||
126278085|NCT00229723|454309104|FG003|Maintenance Phase|Lost to Follow-up|2|||
126278086|NCT00229723|454309105|FG004|Maintenance Phase|Lost to Follow-up|0|||
126278087|NCT00229723|454309106|FG005|Maintenance Phase|Lost to Follow-up|0|||
126278088|NCT00229723|454309107|FG006|Maintenance Phase|Lost to Follow-up|1|||
126278089|NCT00229723|454309101|FG000|Maintenance Phase|Informed consent withdrawn|1|||
126278090|NCT00229723|454309102|FG001|Maintenance Phase|Informed consent withdrawn|0|||
126278091|NCT00229723|454309103|FG002|Maintenance Phase|Informed consent withdrawn|0|||
126278092|NCT00229723|454309104|FG003|Maintenance Phase|Informed consent withdrawn|1|||
126278093|NCT00229723|454309105|FG004|Maintenance Phase|Informed consent withdrawn|1|||
126278094|NCT00229723|454309106|FG005|Maintenance Phase|Informed consent withdrawn|1|||
126278095|NCT00229723|454309107|FG006|Maintenance Phase|Informed consent withdrawn|0|||
126278096|NCT00229723|454309101|FG000|Maintenance Phase|Severe non-compliance|3|||
126278097|NCT00229723|454309102|FG001|Maintenance Phase|Severe non-compliance|1|||
126278098|NCT00229723|454309103|FG002|Maintenance Phase|Severe non-compliance|0|||
126706975|NCT02234622|455878987|FG001|Overall Study|Lost to Follow-up|14|||
126706976|NCT00618956|455878988|FG000|Overall Study|Adverse Event|10|||
126706977|NCT00618956|455878989|FG001|Overall Study|Adverse Event|34|||
126706978|NCT00618956|455878988|FG000|Overall Study|Lack of Efficacy|2|||
126706979|NCT00618956|455878989|FG001|Overall Study|Lack of Efficacy|1|||
126706980|NCT00618956|455878988|FG000|Overall Study|Withdrawal by Subject|5|||
126706981|NCT00618956|455878989|FG001|Overall Study|Withdrawal by Subject|7|||
126706982|NCT00618956|455878988|FG000|Overall Study|Lost to Follow-up|4|||
126706983|NCT00618956|455878989|FG001|Overall Study|Lost to Follow-up|5|||
126706984|NCT00618956|455878988|FG000|Overall Study|Protocol Violation|2|||
126706985|NCT00618956|455878989|FG001|Overall Study|Protocol Violation|2|||
126706986|NCT00618956|455878988|FG000|Overall Study|did not meet criteria, non-compliance|2|||
126706987|NCT00618956|455878989|FG001|Overall Study|did not meet criteria, non-compliance|1|||
126706988|NCT02006576|455878990|FG000|Overall Study|Withdrawal by Subject|4|||
126706989|NCT02006576|455878991|FG001|Overall Study|Withdrawal by Subject|6|||
126706990|NCT02006576|455878992|FG002|Overall Study|Withdrawal by Subject|2|||
126706991|NCT02006576|455878990|FG000|Overall Study|Death|0|||
126706992|NCT02006576|455878991|FG001|Overall Study|Death|0|||
126706993|NCT02006576|455878992|FG002|Overall Study|Death|1|||
126706994|NCT02006576|455878990|FG000|Overall Study|Lost to Follow-up|1|||
126706995|NCT02006576|455878991|FG001|Overall Study|Lost to Follow-up|0|||
126455092|NCT03005873|454966515|FG002|Overall Study|Prohibited medication use post radnomization|1|||
126455093|NCT03005873|454966513|FG000|Overall Study|Withdrew consent|0|||
126455094|NCT03005873|454966514|FG001|Overall Study|Withdrew consent|1|||
126455095|NCT03005873|454966515|FG002|Overall Study|Withdrew consent|2|||
126455096|NCT03005873|454966513|FG000|Overall Study|Lost to Follow-up|0|||
126455097|NCT03005873|454966514|FG001|Overall Study|Lost to Follow-up|1|||
126455098|NCT03005873|454966515|FG002|Overall Study|Lost to Follow-up|0|||
126455099|NCT03005873|454966513|FG000|Overall Study|Ineligible post randomization|0|||
126455100|NCT03005873|454966514|FG001|Overall Study|Ineligible post randomization|0|||
126455101|NCT03005873|454966515|FG002|Overall Study|Ineligible post randomization|1|||
126455102|NCT04585009|454966524|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
126455103|NCT04585009|454966525|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
126455104|NCT04585009|454966526|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
126455105|NCT04585009|454966527|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
126455106|NCT04585009|454966528|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
126455107|NCT04585009|454966529|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
126455108|NCT04585009|454966530|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
126455109|NCT04585009|454966531|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
126455110|NCT04585009|454966532|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
126455111|NCT04585009|454966533|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
126455112|NCT04585009|454966534|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
126455113|NCT04585009|454966535|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
126455114|NCT04585009|454966524|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
126455115|NCT04585009|454966525|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
126706996|NCT02006576|455878992|FG002|Overall Study|Lost to Follow-up|1|||
126706997|NCT02006576|455878990|FG000|Overall Study|Screen Failure, too sick, other|13|||
126706998|NCT02006576|455878991|FG001|Overall Study|Screen Failure, too sick, other|1|||
126706999|NCT02006576|455878992|FG002|Overall Study|Screen Failure, too sick, other|13|||
126707000|NCT03478683|455878993|FG000|Overall Study|Adverse Event|5|||
126707001|NCT03478683|455878994|FG001|Overall Study|Adverse Event|3|||
126707002|NCT03478683|455878993|FG000|Overall Study|Lost to Follow-up|0|||
126707003|NCT03478683|455878994|FG001|Overall Study|Lost to Follow-up|5|||
126707004|NCT03478683|455878993|FG000|Overall Study|Physician Decision|1|||
126707005|NCT03478683|455878994|FG001|Overall Study|Physician Decision|3|||
126707006|NCT03478683|455878993|FG000|Overall Study|Withdrawal by Subject|7|||
126707007|NCT03478683|455878994|FG001|Overall Study|Withdrawal by Subject|7|||
126707008|NCT04090164|455878997|FG000|Overall Study|incomplete data on file|245|||
126707009|NCT04090164|455878998|FG001|Overall Study|incomplete data on file|0|||
126707010|NCT01650805|455878999|FG000|Overall Study|Withdrawal by Subject|1|||
126707011|NCT01650805|455879000|FG001|Overall Study|Withdrawal by Subject|0|||
126707012|NCT01887210|455879001|FG000|Overall Study|Withdrawal by Subject|1|||
126707013|NCT01887210|455879002|FG001|Overall Study|Withdrawal by Subject|3|||
126707014|NCT01887210|455879001|FG000|Overall Study|Lost to Follow-up|0|||
126707015|NCT01887210|455879002|FG001|Overall Study|Lost to Follow-up|1|||
126707016|NCT00630032|455879005|FG000|Overall Study|Death|55|||
126707017|NCT00630032|455879006|FG001|Overall Study|Death|49|||
126707018|NCT00630032|455879005|FG000|Overall Study|Withdrawal by Subject|3|||
126707019|NCT00630032|455879006|FG001|Overall Study|Withdrawal by Subject|2|||
126707020|NCT00630032|455879005|FG000|Overall Study|Lost to Follow-up|18|||
126707021|NCT00630032|455879006|FG001|Overall Study|Lost to Follow-up|31|||
126707022|NCT00630032|455879005|FG000|Overall Study|Protocol Violation|1|||
126707023|NCT00630032|455879006|FG001|Overall Study|Protocol Violation|0|||
126707024|NCT00630032|455879005|FG000|Overall Study|Patient has moved|1|||
126707025|NCT00630032|455879006|FG001|Overall Study|Patient has moved|1|||
126707026|NCT00630032|455879005|FG000|Overall Study|Disease progression|1|||
126707027|NCT00630032|455879006|FG001|Overall Study|Disease progression|1|||
126707028|NCT00630032|455879005|FG000|Overall Study|End of monitoring in US centers|11|||
126707029|NCT00630032|455879006|FG001|Overall Study|End of monitoring in US centers|11|||
126707030|NCT02332915|455879007|FG000|Overall Study|Moved out of region|3|||
126707031|NCT02332915|455879008|FG001|Overall Study|Moved out of region|0|||
126707032|NCT02332915|455879007|FG000|Overall Study|Unrelated illness|1|||
126707033|NCT02332915|455879008|FG001|Overall Study|Unrelated illness|1|||
126707034|NCT02332915|455879007|FG000|Overall Study|Travel distance prohibitive|0|||
126707035|NCT02332915|455879008|FG001|Overall Study|Travel distance prohibitive|1|||
126707036|NCT02332915|455879007|FG000|Overall Study|did not meet inclusion criteria|2|||
126707037|NCT02332915|455879008|FG001|Overall Study|did not meet inclusion criteria|4|||
126707038|NCT05847881|455879009|FG000|Overall Study|Principal Investigator Decision|8|||
126278099|NCT00229723|454309104|FG003|Maintenance Phase|Severe non-compliance|0|||
126278100|NCT00229723|454309105|FG004|Maintenance Phase|Severe non-compliance|1|||
126278101|NCT00229723|454309106|FG005|Maintenance Phase|Severe non-compliance|0|||
126278102|NCT00229723|454309107|FG006|Maintenance Phase|Severe non-compliance|0|||
126278103|NCT00229723|454309101|FG000|Maintenance Phase|Other|5|||
126278104|NCT00229723|454309102|FG001|Maintenance Phase|Other|4|||
126278105|NCT00229723|454309103|FG002|Maintenance Phase|Other|1|||
126278106|NCT00229723|454309104|FG003|Maintenance Phase|Other|2|||
126278107|NCT00229723|454309105|FG004|Maintenance Phase|Other|3|||
126278108|NCT00229723|454309106|FG005|Maintenance Phase|Other|3|||
126363284|NCT01633112|454623433|FG000|Overall Study|Administrative problems|1|||
126363285|NCT01633112|454623434|FG001|Overall Study|Administrative problems|2|||
126363286|NCT01633112|454623435|FG002|Overall Study|Administrative problems|5|||
126363287|NCT01633112|454623433|FG000|Overall Study|Adverse Event|16|||
126363288|NCT01633112|454623434|FG001|Overall Study|Adverse Event|18|||
126363289|NCT01633112|454623435|FG002|Overall Study|Adverse Event|20|||
126363290|NCT01633112|454623433|FG000|Overall Study|Lost to Follow-up|7|||
126363291|NCT01633112|454623434|FG001|Overall Study|Lost to Follow-up|19|||
126363292|NCT01633112|454623435|FG002|Overall Study|Lost to Follow-up|6|||
126363293|NCT01633112|454623433|FG000|Overall Study|Protocol Violation|4|||
126363294|NCT01633112|454623434|FG001|Overall Study|Protocol Violation|0|||
126363295|NCT01633112|454623435|FG002|Overall Study|Protocol Violation|2|||
126363296|NCT01633112|454623433|FG000|Overall Study|Subject no longer requires study drug|0|||
126363297|NCT01633112|454623434|FG001|Overall Study|Subject no longer requires study drug|0|||
126363298|NCT01633112|454623435|FG002|Overall Study|Subject no longer requires study drug|1|||
126363299|NCT01633112|454623433|FG000|Overall Study|Withdrawal by Subject|20|||
126363300|NCT01633112|454623434|FG001|Overall Study|Withdrawal by Subject|12|||
126363301|NCT01633112|454623435|FG002|Overall Study|Withdrawal by Subject|41|||
126363302|NCT01633112|454623433|FG000|Overall Study|missing Study Completion CRF|1|||
126707039|NCT05847881|455879009|FG000|Overall Study|Withdrawal by Subject|2|||
126707040|NCT04513158|455879012|FG000|Overall Study|Screen Failure|1|||
126707041|NCT02342171|455880849|FG000|Overall Study|Death|4|||
126278109|NCT00229723|454309107|FG006|Maintenance Phase|Other|1|||
126278110|NCT03421730|454309116|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278111|NCT03421730|454309117|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
126363303|NCT01633112|454623434|FG001|Overall Study|missing Study Completion CRF|1|||
126363304|NCT01633112|454623435|FG002|Overall Study|missing Study Completion CRF|4|||
126707042|NCT02342171|455880850|FG001|Overall Study|Death|87|||
126363305|NCT01959919|454623436|FG000|Overall Study|Did not meet the eligibility criteria|2|||
126707043|NCT02342171|455880849|FG000|Overall Study|Received favipiravir|10|||
126707044|NCT02342171|455880850|FG001|Overall Study|Received favipiravir|0|||
126707045|NCT02342171|455880849|FG000|Overall Study|Missing cycle treshold value|1|||
126363306|NCT01908699|454623437|FG000|Overall Study|Adverse Event|8|||
126363307|NCT01908699|454623438|FG001|Overall Study|Adverse Event|12|||
126363308|NCT01908699|454623437|FG000|Overall Study|Lack of Efficacy|2|||
126363309|NCT01908699|454623438|FG001|Overall Study|Lack of Efficacy|2|||
126363310|NCT01908699|454623437|FG000|Overall Study|Lost to Follow-up|2|||
126363311|NCT01908699|454623438|FG001|Overall Study|Lost to Follow-up|4|||
126363312|NCT01908699|454623437|FG000|Overall Study|Physician Decision|8|||
126363313|NCT01908699|454623438|FG001|Overall Study|Physician Decision|8|||
126363314|NCT01908699|454623437|FG000|Overall Study|Withdrawal by Subject|15|||
126363315|NCT01908699|454623438|FG001|Overall Study|Withdrawal by Subject|10|||
126363316|NCT01908699|454623437|FG000|Overall Study|Pregnancy|0|||
126363317|NCT01908699|454623438|FG001|Overall Study|Pregnancy|1|||
126363318|NCT01908699|454623437|FG000|Overall Study|Randomized in Error|1|||
126363319|NCT01908699|454623438|FG001|Overall Study|Randomized in Error|0|||
126363320|NCT01908699|454623437|FG000|Overall Study|Death|9|||
126363321|NCT01908699|454623438|FG001|Overall Study|Death|12|||
126363322|NCT01908699|454623437|FG000|Overall Study|Progressive Disease|30|||
126363323|NCT01908699|454623438|FG001|Overall Study|Progressive Disease|29|||
126363324|NCT01697501|454623439|FG000|Overall Study|Protocol Violation|2|||
126363325|NCT00889005|454623442|FG000|Overall Study|Lost to Follow-up|4|||
126363326|NCT00889005|454623443|FG001|Overall Study|Lost to Follow-up|2|||
126363327|NCT00889005|454623442|FG000|Overall Study|Withdrawal by Subject|4|||
126363328|NCT00889005|454623443|FG001|Overall Study|Withdrawal by Subject|0|||
126363329|NCT00128492|454623444|FG000|Overall Study|AE unrelated to study|2|||
126363330|NCT00128492|454623445|FG001|Overall Study|AE unrelated to study|9|||
126363331|NCT00128492|454623444|FG000|Overall Study|Study drug intolerance (AE)|2|||
126363332|NCT00128492|454623445|FG001|Overall Study|Study drug intolerance (AE)|8|||
126363333|NCT00128492|454623444|FG000|Overall Study|AE related to study|1|||
126363334|NCT00128492|454623445|FG001|Overall Study|AE related to study|4|||
126363335|NCT00128492|454623444|FG000|Overall Study|Death|1|||
126363336|NCT00128492|454623445|FG001|Overall Study|Death|0|||
126363337|NCT00128492|454623444|FG000|Overall Study|Lost to Follow-up|1|||
126363338|NCT00128492|454623445|FG001|Overall Study|Lost to Follow-up|5|||
126363339|NCT00128492|454623444|FG000|Overall Study|Noncompliance|0|||
126363340|NCT00128492|454623445|FG001|Overall Study|Noncompliance|5|||
126363341|NCT00128492|454623444|FG000|Overall Study|Personal or administrative|10|||
126363342|NCT00128492|454623445|FG001|Overall Study|Personal or administrative|22|||
126363343|NCT00128492|454623444|FG000|Overall Study|Withdrawal by Subject|3|||
126363344|NCT00128492|454623445|FG001|Overall Study|Withdrawal by Subject|5|||
126363345|NCT00128492|454623444|FG000|Overall Study|Pregnancy|0|||
126363346|NCT00128492|454623445|FG001|Overall Study|Pregnancy|1|||
126363347|NCT00692237|454623449|FG000|Overall Study|Withdrawal by Subject|1|||
126363348|NCT00692237|454623450|FG001|Overall Study|Withdrawal by Subject|3|||
126363349|NCT00692237|454623449|FG000|Overall Study|Adverse Event|0|||
126363350|NCT00692237|454623450|FG001|Overall Study|Adverse Event|1|||
126363351|NCT01347086|454623454|FG000|Overall Study|failed screening visit|0|||
126363352|NCT01347086|454623455|FG001|Overall Study|failed screening visit|0|||
126363353|NCT01347086|454623456|FG002|Overall Study|failed screening visit|1|||
126363354|NCT01347086|454623457|FG003|Overall Study|failed screening visit|0|||
126363355|NCT01347086|454623458|FG004|Overall Study|failed screening visit|0|||
126363356|NCT01347086|454623459|FG005|Overall Study|failed screening visit|0|||
126363357|NCT01347086|454623460|FG006|Overall Study|failed screening visit|1|||
126363358|NCT01347086|454623461|FG007|Overall Study|failed screening visit|1|||
126363359|NCT01347086|454623462|FG008|Overall Study|failed screening visit|0|||
126363360|NCT01347086|454623463|FG009|Overall Study|failed screening visit|1|||
126363361|NCT00395447|454623465|FG000|Overall Study|Death|37|||
126363362|NCT00395447|454623466|FG001|Overall Study|Death|32|||
126363363|NCT00395447|454623465|FG000|Overall Study|Lost to Follow-up|52|||
126363364|NCT00395447|454623466|FG001|Overall Study|Lost to Follow-up|43|||
126363365|NCT00395447|454623465|FG000|Overall Study|Withdrawal by Subject|24|||
126363366|NCT00395447|454623466|FG001|Overall Study|Withdrawal by Subject|19|||
126363367|NCT00395447|454623465|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
126363368|NCT00395447|454623466|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
126363369|NCT03111108|454623468|FG000|Overall Study|Death|0|||
126363370|NCT03111108|454623469|FG001|Overall Study|Death|1|||
126363371|NCT03111108|454623468|FG000|Overall Study|Withdrawal by Subject|1|||
126363372|NCT03111108|454623469|FG001|Overall Study|Withdrawal by Subject|0|||
126363373|NCT02771145|454623470|FG000|Overall Study|Adverse Event|3|||
126363374|NCT02771145|454623470|FG000|Overall Study|Lost to Follow-up|1|||
126765724|NCT02094573|456095790|FG000|Overall Study|Clinical Progressive Disease|9|||
126363375|NCT02264821|454623471|FG000|Overall Study|Protocol Violation|1|||
126363376|NCT02264821|454623472|FG001|Overall Study|Protocol Violation|3|||
126363377|NCT02264821|454623473|FG002|Overall Study|Protocol Violation|6|||
126363378|NCT05071027|454623474|FG000|Overall Study|Lost to Follow-up|1|||
126363379|NCT05071027|454623475|FG001|Overall Study|Lost to Follow-up|4|||
126363380|NCT02314247|454623476|FG000|Overall Study|Adverse Event|2|||
126363381|NCT02314247|454623477|FG001|Overall Study|Adverse Event|1|||
126363382|NCT02314247|454623478|FG002|Overall Study|Adverse Event|0|||
126363383|NCT02314247|454623476|FG000|Overall Study|Withdrawal by Subject|1|||
126455116|NCT04585009|454966526|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
126455117|NCT04585009|454966527|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
126707046|NCT02342171|455880850|FG001|Overall Study|Missing cycle treshold value|0|||
126707047|NCT02342171|455880849|FG000|Overall Study|Unknown outcome|0|||
126455118|NCT04585009|454966528|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
126455119|NCT04585009|454966529|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
126455120|NCT04585009|454966530|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
126455121|NCT04585009|454966531|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
126455122|NCT04585009|454966532|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
126455123|NCT04585009|454966533|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
126707048|NCT02342171|455880850|FG001|Overall Study|Unknown outcome|1|||
126707049|NCT02342171|455880849|FG000|Overall Study|Missing age data|0|||
126707050|NCT02342171|455880850|FG001|Overall Study|Missing age data|1|||
126707051|NCT03705494|455880853|FG000|Overall Study|Lost to Follow-up|2|||
126707052|NCT03705494|455880854|FG001|Overall Study|Lost to Follow-up|1|||
126707053|NCT03705494|455880853|FG000|Overall Study|Withdrawal by Subject|5|||
126707054|NCT03705494|455880854|FG001|Overall Study|Withdrawal by Subject|2|||
126707055|NCT01981187|455880860|FG000|Overall Study|Participant/guardian decision|2|||
126707056|NCT01981187|455880860|FG000|Overall Study|Physician Decision|1|||
126707057|NCT01981187|455880860|FG000|Overall Study|Disease progression|2|||
126707058|NCT01981187|455880860|FG000|Overall Study|Adverse Event|7|||
126707059|NCT02413255|455880864|FG000|Overall Study|Voluntary Withdrawal|0|||
126707060|NCT02413255|455880865|FG001|Overall Study|Voluntary Withdrawal|0|||
126707061|NCT02413255|455880866|FG002|Overall Study|Voluntary Withdrawal|0|||
126707062|NCT02413255|455880867|FG003|Overall Study|Voluntary Withdrawal|0|||
126707063|NCT02413255|455880868|FG004|Overall Study|Voluntary Withdrawal|0|||
126707064|NCT02413255|455880869|FG005|Overall Study|Voluntary Withdrawal|0|||
126707065|NCT02413255|455880870|FG006|Overall Study|Voluntary Withdrawal|0|||
126707066|NCT02413255|455880871|FG007|Overall Study|Voluntary Withdrawal|0|||
126707067|NCT02413255|455880872|FG008|Overall Study|Voluntary Withdrawal|0|||
126707068|NCT02413255|455880873|FG009|Overall Study|Voluntary Withdrawal|0|||
126707069|NCT02413255|455880874|FG010|Overall Study|Voluntary Withdrawal|0|||
126707070|NCT02413255|455880875|FG011|Overall Study|Voluntary Withdrawal|0|||
126707071|NCT02413255|455880876|FG012|Overall Study|Voluntary Withdrawal|0|||
126707072|NCT02413255|455880877|FG013|Overall Study|Voluntary Withdrawal|0|||
126707073|NCT02413255|455880878|FG014|Overall Study|Voluntary Withdrawal|1|||
126707074|NCT02413255|455880879|FG015|Overall Study|Voluntary Withdrawal|0|||
126707075|NCT02413255|455880880|FG016|Overall Study|Voluntary Withdrawal|0|||
126707076|NCT02333331|455880881|FG000|Overall Study|Adverse Event|1|||
126707077|NCT02333331|455880882|FG001|Overall Study|Adverse Event|0|||
126707078|NCT02333331|455880883|FG002|Overall Study|Adverse Event|4|||
126707079|NCT02333331|455880884|FG003|Overall Study|Adverse Event|1|||
126707080|NCT02333331|455880881|FG000|Overall Study|Death|0|||
126707081|NCT02333331|455880882|FG001|Overall Study|Death|0|||
126707082|NCT02333331|455880883|FG002|Overall Study|Death|2|||
126707083|NCT02333331|455880884|FG003|Overall Study|Death|0|||
126707084|NCT02333331|455880881|FG000|Overall Study|Lost to Follow-up|0|||
126707085|NCT02333331|455880882|FG001|Overall Study|Lost to Follow-up|0|||
126707086|NCT02333331|455880883|FG002|Overall Study|Lost to Follow-up|1|||
126707087|NCT02333331|455880884|FG003|Overall Study|Lost to Follow-up|0|||
126278112|NCT03421730|454309118|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278113|NCT03421730|454309119|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278114|NCT03421730|454309120|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278115|NCT03421730|454309121|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278116|NCT03421730|454309122|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278117|NCT03421730|454309123|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278118|NCT03421730|454309124|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278119|NCT03421730|454309125|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126455124|NCT04585009|454966534|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
126707088|NCT02333331|455880881|FG000|Overall Study|Physician Decision|0|||
126707089|NCT02333331|455880882|FG001|Overall Study|Physician Decision|1|||
126707090|NCT02333331|455880883|FG002|Overall Study|Physician Decision|0|||
126707091|NCT02333331|455880884|FG003|Overall Study|Physician Decision|0|||
126707092|NCT02333331|455880881|FG000|Overall Study|Protocol Deviation|0|||
126707093|NCT02333331|455880882|FG001|Overall Study|Protocol Deviation|3|||
126707094|NCT02333331|455880883|FG002|Overall Study|Protocol Deviation|2|||
126707095|NCT02333331|455880884|FG003|Overall Study|Protocol Deviation|1|||
126707096|NCT02333331|455880881|FG000|Overall Study|Patient/Guardian Decision|1|||
126707097|NCT02333331|455880882|FG001|Overall Study|Patient/Guardian Decision|2|||
126765725|NCT02094573|456095791|FG001|Overall Study|Clinical Progressive Disease|13|||
126707098|NCT02333331|455880883|FG002|Overall Study|Patient/Guardian Decision|9|||
126707099|NCT02333331|455880884|FG003|Overall Study|Patient/Guardian Decision|1|||
126765726|NCT02094573|456095790|FG000|Overall Study|Death|11|||
126455125|NCT04585009|454966535|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
126707100|NCT05309668|455880885|FG000|Overall Study|Ongoing at data cut-off|14|||
126707101|NCT05309668|455880886|FG001|Overall Study|Ongoing at data cut-off|17|||
126707102|NCT05309668|455880887|FG002|Overall Study|Ongoing at data cut-off|4|||
126455126|NCT04585009|454966524|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
126455127|NCT04585009|454966525|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
126455128|NCT04585009|454966526|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
126455129|NCT04585009|454966527|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
126765727|NCT02094573|456095791|FG001|Overall Study|Death|3|||
126765728|NCT02094573|456095790|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
126765729|NCT02094573|456095791|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
126765730|NCT02094573|456095790|FG000|Overall Study|Non-compliance with Study Drug|1|||
126765731|NCT02094573|456095791|FG001|Overall Study|Non-compliance with Study Drug|1|||
126765732|NCT02094573|456095790|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
126765733|NCT02094573|456095791|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
126765734|NCT02094573|456095790|FG000|Overall Study|Physician Decision|4|||
126765735|NCT02094573|456095791|FG001|Overall Study|Physician Decision|4|||
126765736|NCT02094573|456095790|FG000|Overall Study|Site Terminated by Sponsor|10|||
126765737|NCT02094573|456095791|FG001|Overall Study|Site Terminated by Sponsor|17|||
126765738|NCT02094573|456095790|FG000|Overall Study|Withdrawal by Subject|6|||
126765739|NCT02094573|456095791|FG001|Overall Study|Withdrawal by Subject|8|||
126765740|NCT02094573|456095790|FG000|Overall Study|Randomized but not Treated|3|||
126765741|NCT02094573|456095791|FG001|Overall Study|Randomized but not Treated|0|||
126765742|NCT00471237|456095796|FG000|Overall Study|Adverse Event|6|||
126765743|NCT00471237|456095797|FG001|Overall Study|Adverse Event|5|||
126765744|NCT00471237|456095798|FG002|Overall Study|Adverse Event|4|||
126765745|NCT00471237|456095799|FG003|Overall Study|Adverse Event|8|||
126765746|NCT00471237|456095800|FG004|Overall Study|Adverse Event|7|||
126765747|NCT00471237|456095801|FG005|Overall Study|Adverse Event|5|||
126765748|NCT00471237|456095802|FG006|Overall Study|Adverse Event|0|||
126765749|NCT00471237|456095796|FG000|Overall Study|Lost to Follow-up|1|||
126765750|NCT00471237|456095797|FG001|Overall Study|Lost to Follow-up|1|||
126765751|NCT00471237|456095798|FG002|Overall Study|Lost to Follow-up|0|||
126765752|NCT00471237|456095799|FG003|Overall Study|Lost to Follow-up|2|||
126765753|NCT00471237|456095800|FG004|Overall Study|Lost to Follow-up|3|||
126765754|NCT00471237|456095801|FG005|Overall Study|Lost to Follow-up|0|||
126765755|NCT00471237|456095802|FG006|Overall Study|Lost to Follow-up|0|||
126765756|NCT00471237|456095796|FG000|Overall Study|Protocol Violation|3|||
126765757|NCT00471237|456095797|FG001|Overall Study|Protocol Violation|6|||
126765758|NCT00471237|456095798|FG002|Overall Study|Protocol Violation|3|||
126765759|NCT00471237|456095799|FG003|Overall Study|Protocol Violation|2|||
126765760|NCT00471237|456095800|FG004|Overall Study|Protocol Violation|2|||
126765761|NCT00471237|456095801|FG005|Overall Study|Protocol Violation|4|||
126765762|NCT00471237|456095802|FG006|Overall Study|Protocol Violation|1|||
126765763|NCT00471237|456095796|FG000|Overall Study|Withdrawal by Subject|8|||
126765764|NCT00471237|456095797|FG001|Overall Study|Withdrawal by Subject|6|||
126765765|NCT00471237|456095798|FG002|Overall Study|Withdrawal by Subject|5|||
126765766|NCT00471237|456095799|FG003|Overall Study|Withdrawal by Subject|8|||
126765767|NCT00471237|456095800|FG004|Overall Study|Withdrawal by Subject|7|||
126765768|NCT00471237|456095801|FG005|Overall Study|Withdrawal by Subject|4|||
126765769|NCT00471237|456095802|FG006|Overall Study|Withdrawal by Subject|2|||
126765770|NCT00471237|456095796|FG000|Overall Study|Sponsor terminated study|20|||
126765771|NCT00471237|456095797|FG001|Overall Study|Sponsor terminated study|23|||
126765772|NCT00471237|456095798|FG002|Overall Study|Sponsor terminated study|19|||
126765773|NCT00471237|456095799|FG003|Overall Study|Sponsor terminated study|22|||
126765774|NCT00471237|456095800|FG004|Overall Study|Sponsor terminated study|18|||
126765775|NCT00471237|456095801|FG005|Overall Study|Sponsor terminated study|24|||
126765776|NCT00471237|456095802|FG006|Overall Study|Sponsor terminated study|0|||
126765777|NCT00471237|456095796|FG000|Overall Study|Non-compliance|0|||
126765778|NCT00471237|456095797|FG001|Overall Study|Non-compliance|1|||
126765779|NCT00471237|456095798|FG002|Overall Study|Non-compliance|0|||
126707103|NCT04329949|455880891|FG000|Overall Study|Death|36|||
126707104|NCT04329949|455880891|FG000|Overall Study|Withdrawal by Subject|4|||
126707105|NCT04329949|455880891|FG000|Overall Study|Termination of study by sponsor|3|||
126707106|NCT01451515|455880892|FG000|Overall Study|Death|0|||
126707107|NCT01451515|455880893|FG001|Overall Study|Death|1|||
126765780|NCT00471237|456095799|FG003|Overall Study|Non-compliance|1|||
126765781|NCT00471237|456095800|FG004|Overall Study|Non-compliance|0|||
126707108|NCT01451515|455880894|FG002|Overall Study|Death|0|||
126765782|NCT00471237|456095801|FG005|Overall Study|Non-compliance|0|||
126765783|NCT00471237|456095802|FG006|Overall Study|Non-compliance|0|||
126765784|NCT00471237|456095796|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
126765785|NCT00471237|456095797|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
126765786|NCT00471237|456095798|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
126278120|NCT03421730|454309126|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126707109|NCT01451515|455880892|FG000|Overall Study|Withdrawal by Subject|0|||
126707110|NCT01451515|455880893|FG001|Overall Study|Withdrawal by Subject|1|||
126707111|NCT01451515|455880894|FG002|Overall Study|Withdrawal by Subject|0|||
126707112|NCT01451515|455880892|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
126707113|NCT01451515|455880893|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
126707114|NCT01451515|455880894|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
126707115|NCT01451515|455880892|FG000|Overall Study|Relapse (except CNS)|1|||
126707116|NCT01451515|455880893|FG001|Overall Study|Relapse (except CNS)|1|||
126707117|NCT01451515|455880894|FG002|Overall Study|Relapse (except CNS)|0|||
126707118|NCT01458340|455880895|FG000|Overall Study|Adverse Event|5|||
126707119|NCT01458340|455880896|FG001|Overall Study|Adverse Event|4|||
126707120|NCT01458340|455880897|FG002|Overall Study|Adverse Event|2|||
126707121|NCT01458340|455880895|FG000|Overall Study|Lost to Follow-up|3|||
126707122|NCT01458340|455880896|FG001|Overall Study|Lost to Follow-up|3|||
126707123|NCT01458340|455880897|FG002|Overall Study|Lost to Follow-up|10|||
126707124|NCT01458340|455880895|FG000|Overall Study|Miscellaneous|0|||
126707125|NCT01458340|455880896|FG001|Overall Study|Miscellaneous|1|||
126707126|NCT01458340|455880897|FG002|Overall Study|Miscellaneous|0|||
126707127|NCT01458340|455880895|FG000|Overall Study|Physician Decision|1|||
126707128|NCT01458340|455880896|FG001|Overall Study|Physician Decision|1|||
126707129|NCT01458340|455880897|FG002|Overall Study|Physician Decision|2|||
126707130|NCT01458340|455880895|FG000|Overall Study|Protocol Violation|6|||
126707131|NCT01458340|455880896|FG001|Overall Study|Protocol Violation|6|||
126707132|NCT01458340|455880897|FG002|Overall Study|Protocol Violation|5|||
126707133|NCT01458340|455880895|FG000|Overall Study|Withdrawal by Subject|12|||
126707134|NCT01458340|455880896|FG001|Overall Study|Withdrawal by Subject|6|||
126707135|NCT01458340|455880897|FG002|Overall Study|Withdrawal by Subject|4|||
126707136|NCT01126619|455880900|FG000|Overall Study|Not eligible for the study|2|||
126707137|NCT01126619|455880900|FG000|Overall Study|Investigator decision|4|||
126707138|NCT01126619|455880900|FG000|Overall Study|Serious adverse event|1|||
126707139|NCT01126619|455880900|FG000|Overall Study|Withdrawal by Subject|9|||
126707140|NCT01126619|455880900|FG000|Overall Study|Non-compliance|1|||
126707141|NCT03351244|455880901|FG000|Overall Study|Adverse Event|7|||
126707142|NCT03351244|455880902|FG001|Overall Study|Adverse Event|11|||
126707143|NCT03351244|455880903|FG002|Overall Study|Adverse Event|12|||
126707144|NCT03351244|455880901|FG000|Overall Study|Investigator's decision|0|||
126707145|NCT03351244|455880902|FG001|Overall Study|Investigator's decision|0|||
126707146|NCT03351244|455880903|FG002|Overall Study|Investigator's decision|2|||
126707147|NCT03351244|455880901|FG000|Overall Study|System error|0|||
126707148|NCT03351244|455880902|FG001|Overall Study|System error|0|||
126707149|NCT03351244|455880903|FG002|Overall Study|System error|2|||
126707150|NCT03351244|455880901|FG000|Overall Study|COVID-19 restrictions|3|||
126707151|NCT03351244|455880902|FG001|Overall Study|COVID-19 restrictions|0|||
126707152|NCT03351244|455880903|FG002|Overall Study|COVID-19 restrictions|1|||
126707153|NCT03351244|455880901|FG000|Overall Study|Non-compliance|2|||
126707154|NCT03351244|455880902|FG001|Overall Study|Non-compliance|5|||
126707155|NCT03351244|455880903|FG002|Overall Study|Non-compliance|0|||
126278121|NCT03421730|454309127|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
126278122|NCT03421730|454309116|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278123|NCT03421730|454309117|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278124|NCT03421730|454309118|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278125|NCT03421730|454309119|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126707156|NCT03351244|455880901|FG000|Overall Study|Withdrawal by Subject|11|||
126707157|NCT03351244|455880902|FG001|Overall Study|Withdrawal by Subject|16|||
126707158|NCT03351244|455880903|FG002|Overall Study|Withdrawal by Subject|13|||
126707159|NCT03351244|455880901|FG000|Overall Study|Lost to Follow-up|2|||
126707160|NCT03351244|455880902|FG001|Overall Study|Lost to Follow-up|6|||
126707161|NCT03351244|455880903|FG002|Overall Study|Lost to Follow-up|4|||
126707162|NCT03351244|455880901|FG000|Overall Study|Protocol Violation|2|||
126707163|NCT03351244|455880902|FG001|Overall Study|Protocol Violation|2|||
126707164|NCT03351244|455880903|FG002|Overall Study|Protocol Violation|0|||
126707165|NCT00091793|455880905|FG000|Overall Study|Adverse Event|1|||
126707166|NCT00091793|455880906|FG001|Overall Study|Adverse Event|2|||
126707167|NCT00091793|455880905|FG000|Overall Study|Withdrawal by Subject|10|||
126707168|NCT00091793|455880906|FG001|Overall Study|Withdrawal by Subject|15|||
126707169|NCT00091793|455880905|FG000|Overall Study|Ineligibility determined|2|||
126707170|NCT00091793|455880906|FG001|Overall Study|Ineligibility determined|0|||
126707171|NCT00091793|455880905|FG000|Overall Study|Lost to Follow-up|7|||
126707172|NCT00091793|455880906|FG001|Overall Study|Lost to Follow-up|5|||
126707173|NCT00091793|455880905|FG000|Overall Study|Noncompliance|2|||
126707174|NCT00091793|455880906|FG001|Overall Study|Noncompliance|0|||
126707175|NCT00091793|455880905|FG000|Overall Study|Other|2|||
126707176|NCT00091793|455880906|FG001|Overall Study|Other|0|||
126707177|NCT05309083|455880908|FG000|Overall Study|Withdrawal by Subject|2|||
126707178|NCT01165229|455880909|FG000|Overall Study|Serious Adverse Event|456|||
126707179|NCT01165229|455880910|FG001|Overall Study|Serious Adverse Event|487|||
126707180|NCT01165229|455880909|FG000|Overall Study|Non-Serious Adverse Event|47|||
126707181|NCT01165229|455880910|FG001|Overall Study|Non-Serious Adverse Event|15|||
126707182|NCT01165229|455880909|FG000|Overall Study|Protocol Violation|6|||
126707183|NCT01165229|455880910|FG001|Overall Study|Protocol Violation|8|||
126707184|NCT01165229|455880909|FG000|Overall Study|Withdrawal by Subject|387|||
126707185|NCT01165229|455880910|FG001|Overall Study|Withdrawal by Subject|396|||
126707186|NCT01165229|455880909|FG000|Overall Study|Migrated/moved from study area|51|||
126707187|NCT01165229|455880910|FG001|Overall Study|Migrated/moved from study area|46|||
126707188|NCT01165229|455880909|FG000|Overall Study|Lost to Follow-up|123|||
126707189|NCT01165229|455880910|FG001|Overall Study|Lost to Follow-up|133|||
126707190|NCT01165229|455880909|FG000|Overall Study|Suspected HZ Episode|2|||
126278126|NCT03421730|454309120|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
126278127|NCT03421730|454309121|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278128|NCT03421730|454309122|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278129|NCT03421730|454309123|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278130|NCT03421730|454309124|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278131|NCT03421730|454309125|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278132|NCT03421730|454309126|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278133|NCT03421730|454309127|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
126278134|NCT02901548|454309130|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
126278135|NCT01559389|454309139|FG000|Overall Study|Withdrawal by Subject|20|||
126278136|NCT01559389|454309140|FG001|Overall Study|Withdrawal by Subject|20|||
126278137|NCT01696279|454309141|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
126278138|NCT01696279|454309142|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
126278139|NCT01696279|454309143|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
126278140|NCT01696279|454309144|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
126278141|NCT01696279|454309141|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
126278142|NCT01696279|454309142|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
126363384|NCT02314247|454623477|FG001|Overall Study|Withdrawal by Subject|3|||
126363385|NCT02314247|454623478|FG002|Overall Study|Withdrawal by Subject|1|||
126363386|NCT02314247|454623476|FG000|Overall Study|Progression of Disease|6|||
126363387|NCT02314247|454623477|FG001|Overall Study|Progression of Disease|2|||
126363388|NCT02314247|454623478|FG002|Overall Study|Progression of Disease|0|||
126363389|NCT01903733|454623479|FG000|Overall Study|Death|23|||
126363390|NCT01903733|454623480|FG001|Overall Study|Death|54|||
126363391|NCT01903733|454623481|FG002|Overall Study|Death|30|||
126363392|NCT01903733|454623482|FG003|Overall Study|Death|98|||
126363393|NCT01903733|454623479|FG000|Overall Study|Participant refused further follow-up|35|||
126363394|NCT01903733|454623480|FG001|Overall Study|Participant refused further follow-up|38|||
126363395|NCT01903733|454623481|FG002|Overall Study|Participant refused further follow-up|13|||
126363396|NCT01903733|454623482|FG003|Overall Study|Participant refused further follow-up|9|||
126363397|NCT01903733|454623479|FG000|Overall Study|Lost to Follow-up|18|||
126363398|NCT01903733|454623480|FG001|Overall Study|Lost to Follow-up|19|||
126363399|NCT01903733|454623481|FG002|Overall Study|Lost to Follow-up|6|||
126363400|NCT01903733|454623482|FG003|Overall Study|Lost to Follow-up|9|||
126363401|NCT01903733|454623479|FG000|Overall Study|Other|10|||
126363402|NCT01903733|454623480|FG001|Overall Study|Other|15|||
126363403|NCT01903733|454623481|FG002|Overall Study|Other|12|||
126363404|NCT01903733|454623482|FG003|Overall Study|Other|3|||
126363405|NCT01903733|454623479|FG000|Overall Study|Missing|2|||
126363406|NCT01903733|454623480|FG001|Overall Study|Missing|0|||
126363407|NCT01903733|454623481|FG002|Overall Study|Missing|0|||
126363408|NCT01903733|454623482|FG003|Overall Study|Missing|0|||
126363409|NCT01903733|454623479|FG000|Overall Study|Investigator request|18|||
126363410|NCT01903733|454623480|FG001|Overall Study|Investigator request|0|||
126363411|NCT01903733|454623481|FG002|Overall Study|Investigator request|0|||
126363412|NCT01903733|454623482|FG003|Overall Study|Investigator request|0|||
126363413|NCT02395627|454623483|FG000|Overall Study|Withdrawal by Subject|0|||
126363414|NCT02395627|454623484|FG001|Overall Study|Withdrawal by Subject|2|||
126363415|NCT02395627|454623485|FG002|Overall Study|Withdrawal by Subject|0|||
126363416|NCT02395627|454623483|FG000|Overall Study|Did not receive pembrolizumab|3|||
126363417|NCT02395627|454623484|FG001|Overall Study|Did not receive pembrolizumab|1|||
126363418|NCT02395627|454623485|FG002|Overall Study|Did not receive pembrolizumab|0|||
126363419|NCT02852005|454623487|FG000|Overall Study|Lost to Follow-up|0|||
126363420|NCT02852005|454623488|FG001|Overall Study|Lost to Follow-up|0|||
126363421|NCT02852005|454623489|FG002|Overall Study|Lost to Follow-up|0|||
126278143|NCT01696279|454309143|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
126278144|NCT01696279|454309144|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
126278145|NCT01696279|454309141|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
126363422|NCT02852005|454623490|FG003|Overall Study|Lost to Follow-up|0|||
126363423|NCT02852005|454623491|FG004|Overall Study|Lost to Follow-up|1|||
126363424|NCT02852005|454623487|FG000|Overall Study|Withdrawal by Subject|1|||
126707191|NCT01165229|455880910|FG001|Overall Study|Suspected HZ Episode|2|||
126707192|NCT01165229|455880909|FG000|Overall Study|No reason from the subject|108|||
126707193|NCT01165229|455880910|FG001|Overall Study|No reason from the subject|102|||
126707194|NCT01165229|455880909|FG000|Overall Study|Unknown completion status|0|||
126707195|NCT01165229|455880910|FG001|Overall Study|Unknown completion status|1|||
126707196|NCT00779038|455880914|FG000|Overall Study|Study Prematurely Terminated|13|||
126707197|NCT00537745|455880915|FG000|Overall Study|Did not meet eligibility criteria|2|||
126707198|NCT00537745|455880915|FG000|Overall Study|Withdrawal by Subject|2|||
126707199|NCT00537745|455880915|FG000|Overall Study|Subject unable to provide Interlock info|1|||
126278146|NCT01696279|454309142|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
126278147|NCT01696279|454309143|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
126278148|NCT01696279|454309144|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
126278149|NCT01696279|454309141|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
126278150|NCT01696279|454309142|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
126278151|NCT01696279|454309143|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
126278152|NCT01696279|454309144|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
126278153|NCT01696279|454309141|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
126278154|NCT01696279|454309142|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
126548134|NCT05490329|455299906|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
126548135|NCT05490329|455299905|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
126548136|NCT05490329|455299906|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
126548137|NCT05490329|455299905|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
126548138|NCT05490329|455299906|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
126548139|NCT00447954|455299907|FG000|Overall Study|Adverse Event|0|||
126548140|NCT00447954|455299908|FG001|Overall Study|Adverse Event|2|||
126548141|NCT00447954|455299909|FG002|Overall Study|Adverse Event|0|||
126548142|NCT00447954|455299907|FG000|Overall Study|Withdrawal by Subject|0|||
126548143|NCT00447954|455299908|FG001|Overall Study|Withdrawal by Subject|1|||
126548144|NCT00447954|455299909|FG002|Overall Study|Withdrawal by Subject|1|||
126548145|NCT00447954|455299907|FG000|Overall Study|Lost to Follow-up|0|||
126548146|NCT00447954|455299908|FG001|Overall Study|Lost to Follow-up|1|||
126548147|NCT00447954|455299909|FG002|Overall Study|Lost to Follow-up|0|||
126548148|NCT00447954|455299907|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
126548149|NCT00447954|455299908|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
126548150|NCT00447954|455299909|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
126548151|NCT00856661|455299910|FG000|Overall Study|Death|15|||
126548152|NCT00856661|455299911|FG001|Overall Study|Death|18|||
126548153|NCT00856661|455299910|FG000|Overall Study|Protocol Violation|2|||
126548154|NCT00856661|455299911|FG001|Overall Study|Protocol Violation|1|||
126548155|NCT00856661|455299910|FG000|Overall Study|Withdrawal by Subject|1|||
126548156|NCT00856661|455299911|FG001|Overall Study|Withdrawal by Subject|2|||
126548157|NCT00856661|455299910|FG000|Overall Study|Lost to Follow-up|1|||
126548158|NCT00856661|455299911|FG001|Overall Study|Lost to Follow-up|3|||
126548159|NCT00856661|455299910|FG000|Overall Study|Physician Judgement|8|||
126548160|NCT00856661|455299911|FG001|Overall Study|Physician Judgement|5|||
126548161|NCT01164228|455299912|FG000|Overall Study|Progression|24|||
126548162|NCT01164228|455299913|FG001|Overall Study|Progression|25|||
126548163|NCT01164228|455299912|FG000|Overall Study|Adverse Event|13|||
126548164|NCT01164228|455299913|FG001|Overall Study|Adverse Event|7|||
126548165|NCT01164228|455299912|FG000|Overall Study|Death|1|||
126548166|NCT01164228|455299913|FG001|Overall Study|Death|1|||
126548167|NCT01164228|455299912|FG000|Overall Study|Withdrawal by Subject|2|||
126548168|NCT01164228|455299913|FG001|Overall Study|Withdrawal by Subject|0|||
126548169|NCT01164228|455299912|FG000|Overall Study|Physician Decision|1|||
126548170|NCT01164228|455299913|FG001|Overall Study|Physician Decision|2|||
126278155|NCT01696279|454309143|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
126278156|NCT01696279|454309144|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
126278157|NCT01696279|454309141|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
126278158|NCT01696279|454309142|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
126278159|NCT01696279|454309143|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
126363425|NCT02852005|454623488|FG001|Overall Study|Withdrawal by Subject|0|||
126707200|NCT04786210|455880916|FG000|Overall Study|Lost to Follow-up|2|||
126707201|NCT04786210|455880916|FG000|Overall Study|Withdrawal by Subject|4|||
126707202|NCT05370157|455880917|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
126765787|NCT00471237|456095799|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
126765788|NCT00471237|456095800|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
126765789|NCT00471237|456095801|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
126363426|NCT02852005|454623489|FG002|Overall Study|Withdrawal by Subject|0|||
126548171|NCT01164228|455299912|FG000|Overall Study|Symptomatic deterioration|1|||
126548172|NCT01164228|455299913|FG001|Overall Study|Symptomatic deterioration|0|||
126548173|NCT01164228|455299912|FG000|Overall Study|Never started treatment|1|||
126548174|NCT01164228|455299913|FG001|Overall Study|Never started treatment|3|||
126548175|NCT01164228|455299912|FG000|Overall Study|Ineligible|1|||
126548176|NCT01164228|455299913|FG001|Overall Study|Ineligible|0|||
126548177|NCT02090634|455299914|FG000|Overall Study|Lost to Follow-up|0|||
126548178|NCT02090634|455299915|FG001|Overall Study|Lost to Follow-up|1|||
126548179|NCT02090634|455299914|FG000|Overall Study|Death|0|||
126765790|NCT00471237|456095802|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
126765791|NCT00471237|456095796|FG000|Overall Study|Early stopping due to non-efficacy|1|||
126765792|NCT00471237|456095797|FG001|Overall Study|Early stopping due to non-efficacy|0|||
126765793|NCT00471237|456095798|FG002|Overall Study|Early stopping due to non-efficacy|0|||
126278160|NCT01696279|454309144|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
126278161|NCT01696279|454309141|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
126278162|NCT01696279|454309142|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
126707203|NCT05370157|455880918|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
126707204|NCT05370157|455880917|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
126707205|NCT05370157|455880918|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
126707206|NCT03700892|455880919|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
126707207|NCT03700892|455880920|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
126707208|NCT03700892|455880921|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
126707209|NCT01364467|455880931|FG000|Overall Study|Lost to Follow-up|1|||
126707210|NCT01364467|455880932|FG001|Overall Study|Lost to Follow-up|2|||
126707211|NCT01634243|455880933|FG000|Overall Study|Adverse Event|5|||
126707212|NCT01634243|455880934|FG001|Overall Study|Adverse Event|5|||
126707213|NCT01634243|455880933|FG000|Overall Study|Lack of Efficacy|1|||
126707214|NCT01634243|455880934|FG001|Overall Study|Lack of Efficacy|0|||
126707215|NCT00587223|455880944|FG000|Overall Study|Adverse Event|1|||
126278163|NCT01696279|454309143|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
126278164|NCT01696279|454309144|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
126278165|NCT01696279|454309141|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
126278166|NCT01696279|454309142|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
126278167|NCT01696279|454309143|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
126278168|NCT01696279|454309144|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
126278169|NCT01696279|454309141|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
126278170|NCT01696279|454309142|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
126278171|NCT01696279|454309143|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
126278172|NCT01696279|454309144|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
126278173|NCT01696279|454309141|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
126278174|NCT01696279|454309142|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
126278175|NCT01696279|454309143|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
126278176|NCT01696279|454309144|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
126278177|NCT01696279|454309141|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
126278178|NCT01696279|454309142|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
126278179|NCT01696279|454309143|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
126278180|NCT01696279|454309144|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
126278181|NCT01346293|454309146|FG000|Overall Study|Protocol Violation|30|||
126278182|NCT01346293|454309147|FG001|Overall Study|Protocol Violation|9|||
126278183|NCT01346293|454309146|FG000|Overall Study|Lost to Follow-up|21|||
126278184|NCT01346293|454309147|FG001|Overall Study|Lost to Follow-up|8|||
126278185|NCT01346293|454309146|FG000|Overall Study|Withdrawal by Subject|15|||
126278186|NCT01346293|454309147|FG001|Overall Study|Withdrawal by Subject|4|||
126278187|NCT01346293|454309146|FG000|Overall Study|Other|1|||
126278188|NCT01346293|454309147|FG001|Overall Study|Other|0|||
126278189|NCT03503864|454309152|FG000|Overall Study|Protocol Violation|6|||
126278190|NCT03503864|454309152|FG000|Overall Study|Withdrawal by Subject|7|||
126278191|NCT02639052|454309154|FG000|Overall Study|Lost to Follow-up|1|||
126278192|NCT02730351|454309155|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
126278193|NCT02730351|454309156|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
126278194|NCT02730351|454309155|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
126278195|NCT02730351|454309156|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
126278196|NCT02730351|454309155|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
126278197|NCT02730351|454309156|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
126278198|NCT02730351|454309155|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
126278199|NCT02730351|454309156|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
126278200|NCT02730351|454309155|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
126278201|NCT02730351|454309156|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
126278202|NCT00838435|454309157|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
126278203|NCT00838435|454309157|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
126278204|NCT00838435|454309157|FG000|Part 2 (7 Years)|Adverse Event|2|||
126278205|NCT00838435|454309157|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
126278206|NCT00838435|454309157|FG000|Part 2 (7 Years)|Physician Decision|1|||
126278207|NCT00838435|454309157|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
126278208|NCT00838435|454309157|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
126548180|NCT02090634|455299915|FG001|Overall Study|Death|1|||
126707216|NCT00883753|455880945|FG000|Overall Study|Adverse Event|37|||
126707217|NCT00883753|455880945|FG000|Overall Study|Death|2|||
126707218|NCT00883753|455880945|FG000|Overall Study|Insufficient therapeutic response|16|||
126707219|NCT00883753|455880945|FG000|Overall Study|Lost to Follow-up|4|||
126707220|NCT00883753|455880945|FG000|Overall Study|Violation of selection criteria at entry|7|||
126707221|NCT00883753|455880945|FG000|Overall Study|Protocol Violation|2|||
126707222|NCT00883753|455880945|FG000|Overall Study|Refused treatment|4|||
126707223|NCT00883753|455880945|FG000|Overall Study|Withdrew consent|10|||
126707224|NCT00883753|455880945|FG000|Overall Study|Investigator's decision|17|||
126707225|NCT00883753|455880945|FG000|Overall Study|Administrative/Other|8|||
126707226|NCT00971321|455880950|FG000|Up to Month 7|Withdrawal by Subject|1|||
126707227|NCT00971321|455880951|FG001|Up to Month 7|Withdrawal by Subject|0|||
126707228|NCT00971321|455880950|FG000|Up to Month 7|Migrated/moved from study area|3|||
126707229|NCT00971321|455880951|FG001|Up to Month 7|Migrated/moved from study area|2|||
126707230|NCT00971321|455880950|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
126707231|NCT00971321|455880951|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
126707232|NCT00971321|455880950|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
126707233|NCT00971321|455880951|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
126707234|NCT00971321|455880950|FG000|Up to Month 11-12|Lost to Follow-up|1|||
126707235|NCT00971321|455880951|FG001|Up to Month 11-12|Lost to Follow-up|0|||
126707236|NCT02296840|455880954|FG000|Overall Study|Adverse Event|1|||
126707237|NCT02296840|455880955|FG001|Overall Study|Adverse Event|1|||
126707238|NCT02296840|455880954|FG000|Overall Study|Protocol Violation|2|||
126707239|NCT02296840|455880955|FG001|Overall Study|Protocol Violation|1|||
126707240|NCT02296840|455880954|FG000|Overall Study|Lost to Follow-up|6|||
126707241|NCT02296840|455880955|FG001|Overall Study|Lost to Follow-up|17|||
126707242|NCT00761215|455880956|FG000|Overall Study|Randomized but didn't receive drug|1|||
126707243|NCT00761215|455880957|FG001|Overall Study|Randomized but didn't receive drug|1|||
126707244|NCT00761215|455880958|FG002|Overall Study|Randomized but didn't receive drug|2|||
126707245|NCT00761215|455880956|FG000|Overall Study|Lost to Follow-up|6|||
126707246|NCT00761215|455880957|FG001|Overall Study|Lost to Follow-up|3|||
126707247|NCT00761215|455880958|FG002|Overall Study|Lost to Follow-up|6|||
126707248|NCT00761215|455880956|FG000|Overall Study|Withdrawal by Subject|1|||
126707249|NCT00761215|455880957|FG001|Overall Study|Withdrawal by Subject|0|||
126707250|NCT00761215|455880958|FG002|Overall Study|Withdrawal by Subject|0|||
126707251|NCT00761215|455880956|FG000|Overall Study|Bacteremia|1|||
126455130|NCT04585009|454966528|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
126455131|NCT04585009|454966529|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
126707252|NCT00761215|455880957|FG001|Overall Study|Bacteremia|0|||
126707253|NCT00761215|455880958|FG002|Overall Study|Bacteremia|0|||
126707254|NCT05121103|455880959|FG000|Overall Study|Progressive disease|2|||
126707255|NCT05121103|455880960|FG001|Overall Study|Progressive disease|1|||
126707256|NCT05121103|455880961|FG002|Overall Study|Progressive disease|6|||
126707257|NCT05121103|455880959|FG000|Overall Study|Physician Decision|2|||
126707258|NCT05121103|455880960|FG001|Overall Study|Physician Decision|1|||
126707259|NCT05121103|455880961|FG002|Overall Study|Physician Decision|0|||
126707260|NCT05121103|455880959|FG000|Overall Study|Withdrawal by Subject|0|||
126707261|NCT05121103|455880960|FG001|Overall Study|Withdrawal by Subject|1|||
126707262|NCT05121103|455880961|FG002|Overall Study|Withdrawal by Subject|0|||
126707263|NCT03885284|455880962|FG000|Overall Study|Disease Progression|1|||
126707264|NCT03885284|455880963|FG001|Overall Study|Disease Progression|3|||
126707265|NCT03885284|455880962|FG000|Overall Study|Physician Decision|0|||
126707266|NCT03885284|455880963|FG001|Overall Study|Physician Decision|1|||
126707267|NCT01476787|455880968|FG000|Treatment|Progression|64|||
126707268|NCT01476787|455880969|FG001|Treatment|Progression|71|||
126707269|NCT01476787|455880968|FG000|Treatment|Toxicity|44|||
126455132|NCT04585009|454966530|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
126455133|NCT04585009|454966531|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
126455134|NCT04585009|454966532|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
126455135|NCT04585009|454966533|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
126455136|NCT04585009|454966534|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
126455137|NCT04585009|454966535|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
126455138|NCT04585009|454966524|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
126548181|NCT02090634|455299914|FG000|Overall Study|Protocol Violation|3|||
126707270|NCT01476787|455880969|FG001|Treatment|Toxicity|16|||
126707271|NCT01476787|455880968|FG000|Treatment|Death|0|||
126707272|NCT01476787|455880969|FG001|Treatment|Death|1|||
126707273|NCT01476787|455880968|FG000|Treatment|Withdrawal by Subject|3|||
126707274|NCT01476787|455880969|FG001|Treatment|Withdrawal by Subject|14|||
126707275|NCT01476787|455880968|FG000|Treatment|Major protocol violation|1|||
126707276|NCT01476787|455880969|FG001|Treatment|Major protocol violation|6|||
126707277|NCT01476787|455880968|FG000|Treatment|Other reasons|10|||
126707278|NCT01476787|455880969|FG001|Treatment|Other reasons|22|||
126707279|NCT01476787|455880968|FG000|Treatment|Concurrent illness|12|||
126707280|NCT01476787|455880969|FG001|Treatment|Concurrent illness|9|||
126707281|NCT01476787|455880968|FG000|Treatment|Insufficient response|15|||
126707282|NCT01476787|455880969|FG001|Treatment|Insufficient response|3|||
126548182|NCT02090634|455299915|FG001|Overall Study|Protocol Violation|1|||
126548183|NCT02090634|455299914|FG000|Overall Study|Adverse Event|2|||
126548184|NCT02090634|455299915|FG001|Overall Study|Adverse Event|0|||
126548185|NCT01965938|455299916|FG000|Overall Study|Withdrawal by Subject|1|||
126548186|NCT01965938|455299917|FG001|Overall Study|Withdrawal by Subject|0|||
126548187|NCT01518946|455299918|FG000|Open-label Phase|Other|4|||
126548188|NCT01518946|455299919|FG001|Open-label Phase|Other|0|||
126548189|NCT01518946|455299920|FG002|Open-label Phase|Other|0|||
126548190|NCT01518946|455299918|FG000|Randomized Phase (First Intervention)|Other|0|||
126548191|NCT01518946|455299919|FG001|Randomized Phase (First Intervention)|Other|1|||
126548192|NCT01518946|455299920|FG002|Randomized Phase (First Intervention)|Other|0|||
126548193|NCT00384059|455299921|FG000|Infant Series|Not consented|2|||
126548194|NCT00384059|455299922|FG001|Infant Series|Not consented|6|||
126548195|NCT00384059|455299921|FG000|Infant Series|Withdrawal by Subject|2|||
126548196|NCT00384059|455299922|FG001|Infant Series|Withdrawal by Subject|2|||
126548197|NCT00384059|455299921|FG000|Infant Series|Adverse Event|1|||
126548198|NCT00384059|455299922|FG001|Infant Series|Adverse Event|2|||
126548199|NCT00384059|455299921|FG000|Infant Series|Protocol Violation|1|||
126548200|NCT00384059|455299922|FG001|Infant Series|Protocol Violation|2|||
126548201|NCT00384059|455299921|FG000|Infant Series|Lost to Follow-up|0|||
126548202|NCT00384059|455299922|FG001|Infant Series|Lost to Follow-up|1|||
126548203|NCT00384059|455299921|FG000|After Infant Series|Protocol Violation|2|||
126548204|NCT00384059|455299922|FG001|After Infant Series|Protocol Violation|3|||
126548205|NCT00384059|455299921|FG000|After Infant Series|Withdrawal by Subject|2|||
126548206|NCT00384059|455299922|FG001|After Infant Series|Withdrawal by Subject|2|||
126548207|NCT00384059|455299921|FG000|After Infant Series|Failed to Return|0|||
126548208|NCT00384059|455299922|FG001|After Infant Series|Failed to Return|2|||
126548209|NCT00384059|455299921|FG000|After Infant Series|Adverse Event|0|||
126548210|NCT00384059|455299922|FG001|After Infant Series|Adverse Event|1|||
126548211|NCT00384059|455299921|FG000|After Infant Series|Physician Decision|0|||
126548212|NCT00384059|455299922|FG001|After Infant Series|Physician Decision|1|||
126548213|NCT00384059|455299921|FG000|After Infant Series|Lost to Follow-up|0|||
126548214|NCT00384059|455299922|FG001|After Infant Series|Lost to Follow-up|1|||
126548215|NCT00384059|455299921|FG000|Toddler Dose|Lost to Follow-up|1|||
126548216|NCT00384059|455299922|FG001|Toddler Dose|Lost to Follow-up|1|||
126548217|NCT00384059|455299921|FG000|Toddler Dose|Failed to return|0|||
126548218|NCT00384059|455299922|FG001|Toddler Dose|Failed to return|1|||
126548219|NCT04666922|455302054|FG000|Overall Study|Withdrawal by Subject|1|||
126548220|NCT04666922|455302055|FG001|Overall Study|Withdrawal by Subject|0|||
126548221|NCT04666922|455302056|FG002|Overall Study|Withdrawal by Subject|0|||
126548222|NCT04666922|455302057|FG003|Overall Study|Withdrawal by Subject|0|||
126363427|NCT02852005|454623490|FG003|Overall Study|Withdrawal by Subject|0|||
126548223|NCT04666922|455302058|FG004|Overall Study|Withdrawal by Subject|0|||
126548224|NCT04666922|455302059|FG005|Overall Study|Withdrawal by Subject|0|||
126548225|NCT04666922|455302060|FG006|Overall Study|Withdrawal by Subject|0|||
126548226|NCT03722264|455302061|FG000|Overall Study|Physician Decision|3|||
126548227|NCT02959671|455302062|FG000|Overall Study|Adverse Event|2|||
126548228|NCT02959671|455302062|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
126548229|NCT01923896|455302065|FG000|Overall Study|Adverse Event|1|||
126548230|NCT01923896|455302066|FG001|Overall Study|Adverse Event|0|||
126548231|NCT00592319|455302069|FG000|Overall Study|Lost to Follow-up|0|||
126548232|NCT00592319|455302070|FG001|Overall Study|Lost to Follow-up|3|||
126548233|NCT00235443|455302073|FG000|Overall Study|Adverse Event|4|||
126548234|NCT00235443|455302074|FG001|Overall Study|Adverse Event|12|||
126363428|NCT02852005|454623491|FG004|Overall Study|Withdrawal by Subject|0|||
126363429|NCT02294019|454623493|FG000|Overall Study|Adverse Event|2|||
126363430|NCT02294019|454623493|FG000|Overall Study|Protocol Violation|68|||
126363431|NCT02294019|454623493|FG000|Overall Study|Lost to Follow-up|31|||
126363432|NCT02294019|454623493|FG000|Overall Study|Other|1|||
126363433|NCT02294019|454623493|FG000|Overall Study|Withdrawal by Subject|1|||
126363434|NCT02369159|454623494|FG000|Overall Study|Adverse Event|0|||
126363435|NCT02369159|454623495|FG001|Overall Study|Adverse Event|1|||
126363436|NCT02369159|454623494|FG000|Overall Study|Lost to Follow-up|1|||
126363437|NCT02369159|454623495|FG001|Overall Study|Lost to Follow-up|1|||
126363438|NCT02369159|454623494|FG000|Overall Study|Withdrawal by Subject|7|||
126363439|NCT02369159|454623495|FG001|Overall Study|Withdrawal by Subject|0|||
126363440|NCT03769116|454623496|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
126548235|NCT00235443|455302075|FG002|Overall Study|Adverse Event|17|||
126548236|NCT00235443|455302076|FG003|Overall Study|Adverse Event|44|||
126548237|NCT00235443|455302077|FG004|Overall Study|Adverse Event|10|||
126548238|NCT00235443|455302078|FG005|Overall Study|Adverse Event|15|||
126548239|NCT00235443|455302073|FG000|Overall Study|Lack of Efficacy|0|||
126548240|NCT00235443|455302074|FG001|Overall Study|Lack of Efficacy|1|||
126548241|NCT00235443|455302075|FG002|Overall Study|Lack of Efficacy|5|||
126548242|NCT00235443|455302076|FG003|Overall Study|Lack of Efficacy|12|||
126363441|NCT03769116|454623497|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
126363442|NCT03769116|454623496|FG000|Part 3 - Open Label|Physician Decision|1|||
126548243|NCT00235443|455302077|FG004|Overall Study|Lack of Efficacy|2|||
126707283|NCT01476787|455880968|FG000|Treatment|Voluntary treatment discontinuation|8|||
126707284|NCT01476787|455880969|FG001|Treatment|Voluntary treatment discontinuation|4|||
126707285|NCT01926886|455880970|FG000|Overall Study|Administrative/other|1|||
126707286|NCT01926886|455880971|FG001|Overall Study|Administrative/other|0|||
126707287|NCT01926886|455880970|FG000|Overall Study|Adverse event/intercurrent illness|4|||
126707288|NCT01926886|455880971|FG001|Overall Study|Adverse event/intercurrent illness|0|||
126707289|NCT01926886|455880970|FG000|Overall Study|Disease progression/recurrence|4|||
126707290|NCT01926886|455880971|FG001|Overall Study|Disease progression/recurrence|0|||
126707291|NCT01926886|455880970|FG000|Overall Study|Withdrawal by Subject|15|||
126707292|NCT01926886|455880971|FG001|Overall Study|Withdrawal by Subject|0|||
126278209|NCT03796039|454309159|FG000|Overall Study|Death|2|||
126278210|NCT03796039|454309160|FG001|Overall Study|Death|1|||
126278211|NCT03796039|454309159|FG000|Overall Study|Withdrawal by Subject|7|||
126278212|NCT03796039|454309160|FG001|Overall Study|Withdrawal by Subject|4|||
126278213|NCT02927366|454309161|FG000|Overall Study|Adverse Event|1|||
126278214|NCT02927366|454309162|FG001|Overall Study|Adverse Event|0|||
126278215|NCT02927366|454309161|FG000|Overall Study|Patient schedule|1|||
126707293|NCT01926886|455880970|FG000|Overall Study|Failure to return|3|||
126707294|NCT01926886|455880971|FG001|Overall Study|Failure to return|0|||
126707295|NCT01926886|455880970|FG000|Overall Study|Recurrence of disease|1|||
126707296|NCT01926886|455880971|FG001|Overall Study|Recurrence of disease|0|||
126707297|NCT01926886|455880970|FG000|Overall Study|Progression of disease|2|||
126707298|NCT01926886|455880971|FG001|Overall Study|Progression of disease|0|||
126707299|NCT01926886|455880970|FG000|Overall Study|Death|1|||
126707300|NCT01926886|455880971|FG001|Overall Study|Death|0|||
126707301|NCT01926886|455880970|FG000|Overall Study|Did not cooperate|1|||
126707302|NCT01926886|455880971|FG001|Overall Study|Did not cooperate|0|||
126278216|NCT02927366|454309162|FG001|Overall Study|Patient schedule|0|||
126278217|NCT00587990|454309163|FG000|Overall Study|Death|0|||
126363443|NCT03769116|454623497|FG001|Part 3 - Open Label|Physician Decision|0|||
126363444|NCT03769116|454623496|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
126707303|NCT01450540|455880972|FG000|Overall Study|Withdrawal by Subject|19|||
126707304|NCT01450540|455880973|FG001|Overall Study|Withdrawal by Subject|13|||
126707305|NCT01450540|455880972|FG000|Overall Study|protocol deviation|3|||
126707306|NCT01450540|455880973|FG001|Overall Study|protocol deviation|23|||
126707307|NCT01662999|455880982|FG000|Period 3|Withdrawal by Subject|0|||
126707308|NCT01662999|455880983|FG001|Period 3|Withdrawal by Subject|1|||
126707309|NCT01662999|455880984|FG002|Period 3|Withdrawal by Subject|0|||
126707310|NCT01662999|455880985|FG003|Period 3|Withdrawal by Subject|0|||
126707311|NCT01662999|455880986|FG004|Period 3|Withdrawal by Subject|0|||
126707312|NCT01662999|455880987|FG005|Period 3|Withdrawal by Subject|0|||
126707313|NCT02932267|455880990|FG000|Overall Study|Withdrawal by Subject|3|||
126707314|NCT02932267|455880990|FG000|Overall Study|Lost to Follow-up|4|||
126707315|NCT02932267|455880990|FG000|Overall Study|Pregnancy|1|||
126707316|NCT02453841|455880991|FG000|Overall Study|Protocol Violation|1|||
126707317|NCT02453841|455880991|FG000|Overall Study|Unable to obtain blood samples|2|||
126707318|NCT03851510|455880992|FG000|Overall Study|Screen Fail|1|||
126707319|NCT03851510|455880992|FG000|Overall Study|Adverse Event|1|||
126707320|NCT03851510|455880992|FG000|Overall Study|Withdrawal by Subject|1|||
126707321|NCT01151137|455880993|FG000|Overall Study|Death|15|||
126707322|NCT01151137|455880994|FG001|Overall Study|Death|27|||
126707323|NCT01151137|455880993|FG000|Overall Study|Lost to Follow-up|1|||
126707324|NCT01151137|455880994|FG001|Overall Study|Lost to Follow-up|1|||
126278218|NCT00587990|454309164|FG001|Overall Study|Death|0|||
126363445|NCT03769116|454623497|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
126363446|NCT01887600|454623505|FG000|Overall Study|Death|39|||
126363447|NCT01887600|454623506|FG001|Overall Study|Death|16|||
126363448|NCT01887600|454623505|FG000|Overall Study|Lack of Efficacy|3|||
126363449|NCT01887600|454623506|FG001|Overall Study|Lack of Efficacy|26|||
126363450|NCT01887600|454623505|FG000|Overall Study|Lost to Follow-up|5|||
126363451|NCT01887600|454623506|FG001|Overall Study|Lost to Follow-up|1|||
126363452|NCT01887600|454623505|FG000|Overall Study|Physician Decision|7|||
126363453|NCT01887600|454623506|FG001|Overall Study|Physician Decision|8|||
126363454|NCT01887600|454623505|FG000|Overall Study|Protocol Deviation|3|||
126363455|NCT01887600|454623506|FG001|Overall Study|Protocol Deviation|0|||
126363456|NCT01887600|454623505|FG000|Overall Study|Withdrawal by Subject|58|||
126363457|NCT01887600|454623506|FG001|Overall Study|Withdrawal by Subject|52|||
126363458|NCT01887600|454623505|FG000|Overall Study|Adverse Event|21|||
126363459|NCT01887600|454623506|FG001|Overall Study|Adverse Event|9|||
126363460|NCT01887600|454623505|FG000|Overall Study|Non-compliance with study drug|3|||
126278219|NCT00587990|454309165|FG002|Overall Study|Death|1|||
126278220|NCT02754856|454309166|FG000|Overall Study|Withdrawal by Subject|1|||
126363461|NCT01887600|454623506|FG001|Overall Study|Non-compliance with study drug|0|||
126363462|NCT01887600|454623505|FG000|Overall Study|Miscellaneous|6|||
126707325|NCT03497689|455881002|FG000|Overall Study|Adverse Event|2|||
126707326|NCT03497689|455881002|FG000|Overall Study|Death|1|||
126707327|NCT03497689|455881002|FG000|Overall Study|Physician Decision|1|||
126707328|NCT03497689|455881002|FG000|Overall Study|Withdrawal by Subject|1|||
126707329|NCT03497689|455881002|FG000|Overall Study|Protocol Violation|2|||
126548244|NCT00235443|455302078|FG005|Overall Study|Lack of Efficacy|9|||
126548245|NCT00235443|455302073|FG000|Overall Study|Withdrawal by Subject|3|||
126548246|NCT00235443|455302074|FG001|Overall Study|Withdrawal by Subject|9|||
126548247|NCT00235443|455302075|FG002|Overall Study|Withdrawal by Subject|25|||
126548248|NCT00235443|455302076|FG003|Overall Study|Withdrawal by Subject|24|||
126548249|NCT00235443|455302077|FG004|Overall Study|Withdrawal by Subject|10|||
126548250|NCT00235443|455302078|FG005|Overall Study|Withdrawal by Subject|12|||
126548251|NCT00235443|455302073|FG000|Overall Study|Lost to Follow-up|0|||
126548252|NCT00235443|455302074|FG001|Overall Study|Lost to Follow-up|8|||
126548253|NCT00235443|455302075|FG002|Overall Study|Lost to Follow-up|6|||
126548254|NCT00235443|455302076|FG003|Overall Study|Lost to Follow-up|6|||
126548255|NCT00235443|455302077|FG004|Overall Study|Lost to Follow-up|4|||
126548256|NCT00235443|455302078|FG005|Overall Study|Lost to Follow-up|3|||
126548257|NCT00235443|455302073|FG000|Overall Study|Unsatisfactory compliance|0|||
126548258|NCT00235443|455302074|FG001|Overall Study|Unsatisfactory compliance|2|||
126548259|NCT00235443|455302075|FG002|Overall Study|Unsatisfactory compliance|3|||
126548260|NCT00235443|455302076|FG003|Overall Study|Unsatisfactory compliance|4|||
126548261|NCT00235443|455302077|FG004|Overall Study|Unsatisfactory compliance|1|||
126548262|NCT00235443|455302078|FG005|Overall Study|Unsatisfactory compliance|0|||
126707330|NCT03191786|455881003|FG000|Overall Study|Death|236|||
126707331|NCT03191786|455881004|FG001|Overall Study|Death|127|||
126707332|NCT03191786|455881003|FG000|Overall Study|Lost to Follow-up|9|||
126278221|NCT01147107|454309167|FG000|Overall Study|Lack of Efficacy|5|||
126278222|NCT01147107|454309168|FG001|Overall Study|Lack of Efficacy|0|||
126278223|NCT01147107|454309167|FG000|Overall Study|Withdrawal by Subject|1|||
126278224|NCT01147107|454309168|FG001|Overall Study|Withdrawal by Subject|1|||
126278225|NCT04693416|454309169|FG000|Overall Study|Lost to Follow-up|13|||
126707333|NCT03191786|455881004|FG001|Overall Study|Lost to Follow-up|3|||
126707334|NCT03191786|455881003|FG000|Overall Study|Physician Decision|1|||
126278226|NCT04693416|454309170|FG001|Overall Study|Lost to Follow-up|0|||
126278227|NCT00474266|454309171|FG000|Overall Study|Withdrawal by Subject|7|||
126278228|NCT00474266|454309172|FG001|Overall Study|Withdrawal by Subject|20|||
126278229|NCT00474266|454309173|FG002|Overall Study|Withdrawal by Subject|4|||
126278230|NCT00474266|454309174|FG003|Overall Study|Withdrawal by Subject|7|||
126278231|NCT02774642|454309175|FG000|Overall Study|Lost to Follow-up|9|||
126278232|NCT02774642|454309176|FG001|Overall Study|Lost to Follow-up|7|||
126363463|NCT01887600|454623506|FG001|Overall Study|Miscellaneous|2|||
126707335|NCT03191786|455881004|FG001|Overall Study|Physician Decision|0|||
126707336|NCT03191786|455881003|FG000|Overall Study|Moved to Post Trial Access Program|30|||
126707337|NCT03191786|455881004|FG001|Overall Study|Moved to Post Trial Access Program|5|||
126707338|NCT03191786|455881003|FG000|Overall Study|Withdrawal by Subject|26|||
126707339|NCT03191786|455881004|FG001|Overall Study|Withdrawal by Subject|16|||
126707340|NCT03439345|455882708|FG000|Overall Study|Lost to Follow-up|0|||
126707341|NCT03439345|455882709|FG001|Overall Study|Lost to Follow-up|1|||
126707342|NCT03439345|455882708|FG000|Overall Study|Consent withdrawn|0|||
126707343|NCT03439345|455882709|FG001|Overall Study|Consent withdrawn|1|||
126707344|NCT05165394|455882713|FG000|Overall Study|Withdrawal by Subject|5|||
126707345|NCT05165394|455882714|FG001|Overall Study|Withdrawal by Subject|1|||
126707346|NCT05165394|455882713|FG000|Overall Study|Lost to Follow-up|1|||
126707347|NCT05165394|455882714|FG001|Overall Study|Lost to Follow-up|2|||
126707348|NCT05165394|455882713|FG000|Overall Study|Other Than Specified|0|||
126707349|NCT05165394|455882714|FG001|Overall Study|Other Than Specified|1|||
126707350|NCT02517515|455882720|FG000|Overall Study|Adverse Event|0|||
126707351|NCT02517515|455882721|FG001|Overall Study|Adverse Event|1|||
126707352|NCT02517515|455882720|FG000|Overall Study|Withdrew Consent|0|||
126707353|NCT02517515|455882721|FG001|Overall Study|Withdrew Consent|1|||
126707354|NCT02517515|455882720|FG000|Overall Study|Lost to Follow-up|1|||
126707355|NCT02517515|455882721|FG001|Overall Study|Lost to Follow-up|0|||
126707356|NCT02517515|455882720|FG000|Overall Study|Other|1|||
126707357|NCT02517515|455882721|FG001|Overall Study|Other|0|||
126707358|NCT02786537|455882722|FG000|As Randomized|Adverse Event|0|||
126363464|NCT01887600|454623505|FG000|Overall Study|Progressive Disease|1|||
126363465|NCT01887600|454623506|FG001|Overall Study|Progressive Disease|0|||
126707359|NCT02786537|455882723|FG001|As Randomized|Adverse Event|11|||
126707360|NCT02786537|455882724|FG002|As Randomized|Adverse Event|0|||
126707361|NCT02786537|455882725|FG003|As Randomized|Adverse Event|4|||
126707362|NCT02786537|455882726|FG004|As Randomized|Adverse Event|6|||
126278233|NCT00426361|454309177|FG000|Overall Study|Lost to Follow-up|3|||
126363466|NCT03688139|454623507|FG000|Overall Study|Lost to Follow-up|2|||
126548263|NCT00235443|455302073|FG000|Overall Study|Other reasons for premature termination|1|||
126548264|NCT00235443|455302074|FG001|Overall Study|Other reasons for premature termination|6|||
126548265|NCT00235443|455302075|FG002|Overall Study|Other reasons for premature termination|6|||
126548266|NCT00235443|455302076|FG003|Overall Study|Other reasons for premature termination|7|||
126707363|NCT02786537|455882727|FG005|As Randomized|Adverse Event|2|||
126707364|NCT02786537|455882722|FG000|As Randomized|Lack of Efficacy|0|||
126707365|NCT02786537|455882723|FG001|As Randomized|Lack of Efficacy|0|||
126707366|NCT02786537|455882724|FG002|As Randomized|Lack of Efficacy|0|||
126707367|NCT02786537|455882725|FG003|As Randomized|Lack of Efficacy|1|||
126707368|NCT02786537|455882726|FG004|As Randomized|Lack of Efficacy|0|||
126707369|NCT02786537|455882727|FG005|As Randomized|Lack of Efficacy|0|||
126707370|NCT02786537|455882722|FG000|As Randomized|Withdrawal by Subject|1|||
126707371|NCT02786537|455882723|FG001|As Randomized|Withdrawal by Subject|2|||
126707372|NCT02786537|455882724|FG002|As Randomized|Withdrawal by Subject|0|||
126707373|NCT02786537|455882725|FG003|As Randomized|Withdrawal by Subject|1|||
126707374|NCT02786537|455882726|FG004|As Randomized|Withdrawal by Subject|1|||
126707375|NCT02786537|455882727|FG005|As Randomized|Withdrawal by Subject|0|||
126707376|NCT02786537|455882722|FG000|As Randomized|Death|0|||
126707377|NCT02786537|455882723|FG001|As Randomized|Death|2|||
126707378|NCT02786537|455882724|FG002|As Randomized|Death|0|||
126707379|NCT02786537|455882725|FG003|As Randomized|Death|3|||
126707380|NCT02786537|455882726|FG004|As Randomized|Death|1|||
126707381|NCT02786537|455882727|FG005|As Randomized|Death|0|||
126707382|NCT02786537|455882722|FG000|As Randomized|Non-compliance with study drug|1|||
126707383|NCT02786537|455882723|FG001|As Randomized|Non-compliance with study drug|11|||
126707384|NCT02786537|455882724|FG002|As Randomized|Non-compliance with study drug|0|||
126707385|NCT02786537|455882725|FG003|As Randomized|Non-compliance with study drug|1|||
126707386|NCT02786537|455882726|FG004|As Randomized|Non-compliance with study drug|0|||
126707387|NCT02786537|455882727|FG005|As Randomized|Non-compliance with study drug|1|||
126707388|NCT02786537|455882722|FG000|As Randomized|Lost to treatment follow-up|4|||
126707389|NCT02786537|455882723|FG001|As Randomized|Lost to treatment follow-up|32|||
126363467|NCT03688139|454623508|FG001|Overall Study|Lost to Follow-up|0|||
126363468|NCT03688139|454623507|FG000|Overall Study|Physician Decision|0|||
126363469|NCT03688139|454623508|FG001|Overall Study|Physician Decision|1|||
126363470|NCT03688139|454623507|FG000|Overall Study|Withdrawal by Subject|2|||
126363471|NCT03688139|454623508|FG001|Overall Study|Withdrawal by Subject|3|||
126363472|NCT01390584|454623515|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
126363473|NCT01390584|454623516|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
126363474|NCT01390584|454623517|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
126363475|NCT01835431|454623518|FG000|Overall Study|Adverse Event|1|||
126363476|NCT01835431|454623519|FG001|Overall Study|Adverse Event|0|||
126363477|NCT01835431|454623518|FG000|Overall Study|other|0|||
126363478|NCT01835431|454623519|FG001|Overall Study|other|2|||
126363479|NCT01835431|454623518|FG000|Overall Study|Withdrawal by Subject|6|||
126363480|NCT01835431|454623519|FG001|Overall Study|Withdrawal by Subject|10|||
126363481|NCT01835431|454623518|FG000|Overall Study|Protocol Violation|1|||
126363482|NCT01835431|454623519|FG001|Overall Study|Protocol Violation|0|||
126363483|NCT00655356|454623520|FG000|Overall Study|Withdrawal by Subject|3|||
126363484|NCT00655356|454623521|FG001|Overall Study|Withdrawal by Subject|4|||
126363485|NCT00655356|454623520|FG000|Overall Study|Sponsor Request|10|||
126363486|NCT00655356|454623521|FG001|Overall Study|Sponsor Request|4|||
126363487|NCT00655356|454623520|FG000|Overall Study|Adverse Event|1|||
126363488|NCT00655356|454623521|FG001|Overall Study|Adverse Event|1|||
126363489|NCT00655356|454623520|FG000|Overall Study|Protocol Violation|2|||
126363490|NCT00655356|454623521|FG001|Overall Study|Protocol Violation|1|||
126363491|NCT00655356|454623520|FG000|Overall Study|Other Reason|1|||
126363492|NCT00655356|454623521|FG001|Overall Study|Other Reason|0|||
126363493|NCT02496156|454623522|FG000|Overall Study|Lost to Follow-up|5|||
126363494|NCT02496156|454623523|FG001|Overall Study|Lost to Follow-up|0|||
126363495|NCT02496156|454623522|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
126363496|NCT02496156|454623523|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
126363497|NCT03760666|454623524|FG000|Overall Study|Adverse Event|2|||
126363498|NCT03760666|454623525|FG001|Overall Study|Adverse Event|4|||
126363499|NCT03760666|454623526|FG002|Overall Study|Adverse Event|1|||
126363500|NCT03760666|454623524|FG000|Overall Study|AML Disease Progression|3|||
126363501|NCT03760666|454623525|FG001|Overall Study|AML Disease Progression|3|||
126363502|NCT03760666|454623526|FG002|Overall Study|AML Disease Progression|0|||
126363503|NCT03760666|454623524|FG000|Overall Study|Physician Decision|0|||
126363504|NCT03760666|454623525|FG001|Overall Study|Physician Decision|3|||
126363505|NCT03760666|454623526|FG002|Overall Study|Physician Decision|0|||
126363506|NCT03760666|454623524|FG000|Overall Study|Withdrawal by Subject|0|||
126363507|NCT03760666|454623525|FG001|Overall Study|Withdrawal by Subject|1|||
126363508|NCT03760666|454623526|FG002|Overall Study|Withdrawal by Subject|0|||
126363509|NCT04349098|454623527|FG000|Overall Study|Death|16|||
126363510|NCT04349098|454623528|FG001|Overall Study|Death|8|||
126363511|NCT04349098|454623527|FG000|Overall Study|Lost to Follow-up|11|||
126363512|NCT04349098|454623528|FG001|Overall Study|Lost to Follow-up|8|||
126363513|NCT04349098|454623527|FG000|Overall Study|Withdrawal by Subject|8|||
126363514|NCT04349098|454623528|FG001|Overall Study|Withdrawal by Subject|5|||
126363515|NCT04349098|454623527|FG000|Overall Study|Other|3|||
126363516|NCT04349098|454623528|FG001|Overall Study|Other|5|||
126363517|NCT01703221|454623529|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
126707390|NCT02786537|455882724|FG002|As Randomized|Lost to treatment follow-up|0|||
126707391|NCT02786537|455882725|FG003|As Randomized|Lost to treatment follow-up|24|||
126707392|NCT02786537|455882726|FG004|As Randomized|Lost to treatment follow-up|4|||
126707393|NCT02786537|455882727|FG005|As Randomized|Lost to treatment follow-up|4|||
126707394|NCT02786537|455882722|FG000|As Randomized|Incarceration|0|||
126455139|NCT04585009|454966525|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
126455140|NCT04585009|454966526|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
126455141|NCT04585009|454966527|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
126455142|NCT04585009|454966528|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
126455143|NCT04585009|454966529|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
126455144|NCT04585009|454966530|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
126455145|NCT04585009|454966531|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
126455146|NCT04585009|454966532|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
126455147|NCT04585009|454966533|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
126455148|NCT04585009|454966534|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
126455149|NCT04585009|454966535|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
126455150|NCT04585009|454966524|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
126455151|NCT04585009|454966525|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
126707395|NCT02786537|455882723|FG001|As Randomized|Incarceration|1|||
126455152|NCT04585009|454966526|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
126455153|NCT04585009|454966527|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
126455154|NCT04585009|454966528|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
126455155|NCT04585009|454966529|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
126455156|NCT04585009|454966530|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
126455157|NCT04585009|454966531|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
126455158|NCT04585009|454966532|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
126455159|NCT04585009|454966533|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
126455160|NCT04585009|454966534|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
126455161|NCT04585009|454966535|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
126455162|NCT04585009|454966524|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
126455163|NCT04585009|454966525|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
126455164|NCT04585009|454966526|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
126455165|NCT04585009|454966527|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
126455166|NCT04585009|454966528|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
126455167|NCT04585009|454966529|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
126455168|NCT04585009|454966530|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
126455169|NCT04585009|454966531|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
126455170|NCT04585009|454966532|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
126455171|NCT04585009|454966533|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
126455172|NCT04585009|454966534|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
126455173|NCT04585009|454966535|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
126455174|NCT00097981|454966536|FG000|Overall Study|Adverse Event|31|||
126455175|NCT00097981|454966537|FG001|Overall Study|Adverse Event|44|||
126455176|NCT00097981|454966536|FG000|Overall Study|Withdrawal by Subject|10|||
126455177|NCT00097981|454966537|FG001|Overall Study|Withdrawal by Subject|8|||
126455178|NCT00097981|454966536|FG000|Overall Study|Protocol Violation|1|||
126455179|NCT00097981|454966537|FG001|Overall Study|Protocol Violation|1|||
126548267|NCT00235443|455302077|FG004|Overall Study|Other reasons for premature termination|3|||
126707396|NCT02786537|455882724|FG002|As Randomized|Incarceration|0|||
126707397|NCT02786537|455882725|FG003|As Randomized|Incarceration|0|||
126707398|NCT02786537|455882726|FG004|As Randomized|Incarceration|0|||
126707399|NCT02786537|455882727|FG005|As Randomized|Incarceration|0|||
126707400|NCT02786537|455882722|FG000|As Randomized|Opiate Dependency Relapse|0|||
126707401|NCT02786537|455882723|FG001|As Randomized|Opiate Dependency Relapse|1|||
126707402|NCT02786537|455882724|FG002|As Randomized|Opiate Dependency Relapse|0|||
126707403|NCT02786537|455882725|FG003|As Randomized|Opiate Dependency Relapse|0|||
126707404|NCT02786537|455882726|FG004|As Randomized|Opiate Dependency Relapse|0|||
126707405|NCT02786537|455882727|FG005|As Randomized|Opiate Dependency Relapse|0|||
126707406|NCT02786537|455882722|FG000|As Randomized|HCV drugs stolen from pt|0|||
126707407|NCT02786537|455882723|FG001|As Randomized|HCV drugs stolen from pt|1|||
126707408|NCT02786537|455882724|FG002|As Randomized|HCV drugs stolen from pt|0|||
126707409|NCT02786537|455882725|FG003|As Randomized|HCV drugs stolen from pt|0|||
126455180|NCT00097981|454966536|FG000|Overall Study|Death|2|||
126455181|NCT00097981|454966537|FG001|Overall Study|Death|4|||
126455182|NCT00097981|454966536|FG000|Overall Study|Physician Decision|7|||
126455183|NCT00097981|454966537|FG001|Overall Study|Physician Decision|1|||
126455184|NCT00097981|454966536|FG000|Overall Study|Disease Progression|8|||
126455185|NCT00097981|454966537|FG001|Overall Study|Disease Progression|2|||
126455186|NCT00097981|454966536|FG000|Overall Study|Transplant planned|28|||
126455187|NCT00097981|454966537|FG001|Overall Study|Transplant planned|27|||
126455188|NCT00097981|454966536|FG000|Overall Study|Other|19|||
126707410|NCT02786537|455882726|FG004|As Randomized|HCV drugs stolen from pt|0|||
126707411|NCT02786537|455882727|FG005|As Randomized|HCV drugs stolen from pt|0|||
126707412|NCT02786537|455882722|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
126707413|NCT02786537|455882723|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
126455189|NCT00097981|454966537|FG001|Overall Study|Other|13|||
126707414|NCT02786537|455882724|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
126707415|NCT02786537|455882725|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
126707416|NCT02786537|455882726|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
126707417|NCT02786537|455882727|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
126707418|NCT02786537|455882722|FG000|As Randomized|Subject lost insurance|0|||
126707419|NCT02786537|455882723|FG001|As Randomized|Subject lost insurance|0|||
126707420|NCT02786537|455882724|FG002|As Randomized|Subject lost insurance|0|||
126707421|NCT02786537|455882725|FG003|As Randomized|Subject lost insurance|1|||
126707422|NCT02786537|455882726|FG004|As Randomized|Subject lost insurance|0|||
126707423|NCT02786537|455882727|FG005|As Randomized|Subject lost insurance|0|||
126707424|NCT02786537|455882722|FG000|As Treated|Adverse Event|0|||
126707425|NCT02786537|455882723|FG001|As Treated|Adverse Event|11|||
126707426|NCT02786537|455882724|FG002|As Treated|Adverse Event|0|||
126707427|NCT02786537|455882725|FG003|As Treated|Adverse Event|4|||
126707428|NCT02786537|455882726|FG004|As Treated|Adverse Event|6|||
126707429|NCT02786537|455882727|FG005|As Treated|Adverse Event|2|||
126707430|NCT02786537|455882722|FG000|As Treated|Death|0|||
126707431|NCT02786537|455882723|FG001|As Treated|Death|2|||
126707432|NCT02786537|455882724|FG002|As Treated|Death|0|||
126707433|NCT02786537|455882725|FG003|As Treated|Death|3|||
126707434|NCT02786537|455882726|FG004|As Treated|Death|1|||
126707435|NCT02786537|455882727|FG005|As Treated|Death|0|||
126707436|NCT02786537|455882722|FG000|As Treated|Lack of Efficacy|0|||
126707437|NCT02786537|455882723|FG001|As Treated|Lack of Efficacy|0|||
126707438|NCT02786537|455882724|FG002|As Treated|Lack of Efficacy|0|||
126707439|NCT02786537|455882725|FG003|As Treated|Lack of Efficacy|1|||
126707440|NCT02786537|455882726|FG004|As Treated|Lack of Efficacy|0|||
126707441|NCT02786537|455882727|FG005|As Treated|Lack of Efficacy|0|||
126707442|NCT02786537|455882722|FG000|As Treated|Lost to Follow-up|4|||
126707443|NCT02786537|455882723|FG001|As Treated|Lost to Follow-up|32|||
126707444|NCT02786537|455882724|FG002|As Treated|Lost to Follow-up|0|||
126707445|NCT02786537|455882725|FG003|As Treated|Lost to Follow-up|25|||
126707446|NCT02786537|455882726|FG004|As Treated|Lost to Follow-up|4|||
126707447|NCT02786537|455882727|FG005|As Treated|Lost to Follow-up|4|||
126707448|NCT02786537|455882722|FG000|As Treated|Non-compliance with study drug|1|||
126707449|NCT02786537|455882723|FG001|As Treated|Non-compliance with study drug|11|||
126707450|NCT02786537|455882724|FG002|As Treated|Non-compliance with study drug|0|||
126707451|NCT02786537|455882725|FG003|As Treated|Non-compliance with study drug|1|||
126707452|NCT02786537|455882726|FG004|As Treated|Non-compliance with study drug|0|||
126707453|NCT02786537|455882727|FG005|As Treated|Non-compliance with study drug|1|||
126707454|NCT02786537|455882722|FG000|As Treated|Lost insurance|0|||
126707455|NCT02786537|455882723|FG001|As Treated|Lost insurance|0|||
126707456|NCT02786537|455882724|FG002|As Treated|Lost insurance|0|||
126707457|NCT02786537|455882725|FG003|As Treated|Lost insurance|1|||
126707458|NCT02786537|455882726|FG004|As Treated|Lost insurance|0|||
126707459|NCT02786537|455882727|FG005|As Treated|Lost insurance|0|||
126707460|NCT02786537|455882722|FG000|As Treated|Withdrawal by Subject|1|||
126707461|NCT02786537|455882723|FG001|As Treated|Withdrawal by Subject|2|||
126707462|NCT02786537|455882724|FG002|As Treated|Withdrawal by Subject|0|||
126707463|NCT02786537|455882725|FG003|As Treated|Withdrawal by Subject|0|||
126707464|NCT02786537|455882726|FG004|As Treated|Withdrawal by Subject|1|||
126707465|NCT02786537|455882727|FG005|As Treated|Withdrawal by Subject|0|||
126707466|NCT02786537|455882722|FG000|As Treated|Incarceration|0|||
126707467|NCT02786537|455882723|FG001|As Treated|Incarceration|1|||
126707468|NCT02786537|455882724|FG002|As Treated|Incarceration|0|||
126707469|NCT02786537|455882725|FG003|As Treated|Incarceration|0|||
126707470|NCT02786537|455882726|FG004|As Treated|Incarceration|0|||
126707471|NCT02786537|455882727|FG005|As Treated|Incarceration|0|||
126707472|NCT02786537|455882722|FG000|As Treated|Opiate dependency relapse|0|||
126707473|NCT02786537|455882723|FG001|As Treated|Opiate dependency relapse|1|||
126278234|NCT00426361|454309178|FG001|Overall Study|Lost to Follow-up|2|||
126278235|NCT00426361|454309179|FG002|Overall Study|Lost to Follow-up|5|||
126278236|NCT00426361|454309177|FG000|Overall Study|Withdrawal by Subject|1|||
126278237|NCT00426361|454309178|FG001|Overall Study|Withdrawal by Subject|3|||
126278238|NCT00426361|454309179|FG002|Overall Study|Withdrawal by Subject|0|||
126278239|NCT04642365|454309182|FG000|Overall Study|Death|3|||
126278240|NCT04642365|454309183|FG001|Overall Study|Death|2|||
126278241|NCT04642365|454309184|FG002|Overall Study|Death|4|||
126707474|NCT02786537|455882724|FG002|As Treated|Opiate dependency relapse|0|||
126707475|NCT02786537|455882725|FG003|As Treated|Opiate dependency relapse|0|||
126707476|NCT02786537|455882726|FG004|As Treated|Opiate dependency relapse|0|||
126707477|NCT02786537|455882727|FG005|As Treated|Opiate dependency relapse|0|||
126707478|NCT02786537|455882722|FG000|As Treated|Drugs stolen from patient|0|||
126707479|NCT02786537|455882723|FG001|As Treated|Drugs stolen from patient|1|||
126707480|NCT02786537|455882724|FG002|As Treated|Drugs stolen from patient|0|||
126278242|NCT04642365|454309185|FG003|Overall Study|Death|5|||
126707481|NCT02786537|455882725|FG003|As Treated|Drugs stolen from patient|0|||
126707482|NCT02786537|455882726|FG004|As Treated|Drugs stolen from patient|0|||
126707483|NCT02786537|455882727|FG005|As Treated|Drugs stolen from patient|0|||
126707484|NCT02786537|455882722|FG000|As Treated|Advised to stop tx after loss of meds|0|||
126548268|NCT00235443|455302078|FG005|Overall Study|Other reasons for premature termination|6|||
126548269|NCT03661996|455302084|FG000|Overall Study|Adverse Event|0|||
126548270|NCT03661996|455302085|FG001|Overall Study|Adverse Event|0|||
126548271|NCT03661996|455302086|FG002|Overall Study|Adverse Event|1|||
126548272|NCT03661996|455302087|FG003|Overall Study|Adverse Event|1|||
126548273|NCT03661996|455302088|FG004|Overall Study|Adverse Event|0|||
126548274|NCT03661996|455302084|FG000|Overall Study|Lost to Follow-up|5|||
126548275|NCT03661996|455302085|FG001|Overall Study|Lost to Follow-up|1|||
126548276|NCT03661996|455302086|FG002|Overall Study|Lost to Follow-up|2|||
126548277|NCT03661996|455302087|FG003|Overall Study|Lost to Follow-up|2|||
126548278|NCT03661996|455302088|FG004|Overall Study|Lost to Follow-up|6|||
126548279|NCT03661996|455302084|FG000|Overall Study|Physician Decision|1|||
126548280|NCT03661996|455302085|FG001|Overall Study|Physician Decision|1|||
126548281|NCT03661996|455302086|FG002|Overall Study|Physician Decision|1|||
126548282|NCT03661996|455302087|FG003|Overall Study|Physician Decision|2|||
126548283|NCT03661996|455302088|FG004|Overall Study|Physician Decision|0|||
126548284|NCT03661996|455302084|FG000|Overall Study|Protocol Violation|0|||
126548285|NCT03661996|455302085|FG001|Overall Study|Protocol Violation|0|||
126548286|NCT03661996|455302086|FG002|Overall Study|Protocol Violation|0|||
126548287|NCT03661996|455302087|FG003|Overall Study|Protocol Violation|0|||
126548288|NCT03661996|455302088|FG004|Overall Study|Protocol Violation|1|||
126548289|NCT03661996|455302084|FG000|Overall Study|Withdrawal by Subject|3|||
126548290|NCT03661996|455302085|FG001|Overall Study|Withdrawal by Subject|5|||
126548291|NCT03661996|455302086|FG002|Overall Study|Withdrawal by Subject|1|||
126548292|NCT03661996|455302087|FG003|Overall Study|Withdrawal by Subject|7|||
126548293|NCT03661996|455302088|FG004|Overall Study|Withdrawal by Subject|7|||
126548294|NCT03661996|455302084|FG000|Overall Study|Sponsors Decision|2|||
126548295|NCT03661996|455302085|FG001|Overall Study|Sponsors Decision|0|||
126548296|NCT03661996|455302086|FG002|Overall Study|Sponsors Decision|0|||
126548297|NCT03661996|455302087|FG003|Overall Study|Sponsors Decision|0|||
126548298|NCT03661996|455302088|FG004|Overall Study|Sponsors Decision|0|||
126548299|NCT03661996|455302084|FG000|Overall Study|Other|1|||
126548300|NCT03661996|455302085|FG001|Overall Study|Other|1|||
126548301|NCT03661996|455302086|FG002|Overall Study|Other|1|||
126548302|NCT03661996|455302087|FG003|Overall Study|Other|1|||
126548303|NCT03661996|455302088|FG004|Overall Study|Other|0|||
126548304|NCT03321513|455302089|FG000|Overall Study|Death|11|||
126548305|NCT03321513|455302090|FG001|Overall Study|Death|5|||
126548306|NCT03321513|455302089|FG000|Overall Study|Withdrawal by Subject|5|||
126548307|NCT03321513|455302090|FG001|Overall Study|Withdrawal by Subject|10|||
126548308|NCT03321513|455302089|FG000|Overall Study|Lost to Follow-up|10|||
126548309|NCT03321513|455302090|FG001|Overall Study|Lost to Follow-up|11|||
126548310|NCT03029247|455302091|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
126548311|NCT03029247|455302092|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
126548312|NCT03029247|455302091|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
126548313|NCT03029247|455302092|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
126548314|NCT03029247|455302091|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
126548315|NCT03029247|455302092|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
126548316|NCT03029247|455302091|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
126548317|NCT03029247|455302092|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
126548318|NCT00068380|455302095|FG000|Overall Study|Withdrawal by Subject|3|||
126548319|NCT00068380|455302095|FG000|Overall Study|Adverse Event|2|||
126548320|NCT02757521|455302096|FG000|Overall Study|Adverse Event|1|||
126548321|NCT02757521|455302097|FG001|Overall Study|Adverse Event|0|||
126548322|NCT01190215|455302098|FG000|Up to Month 6|Lost to Follow-up|2|||
126548323|NCT01190215|455302099|FG001|Up to Month 6|Lost to Follow-up|0|||
126548324|NCT02961881|455302113|FG000|Overall Study|Adverse Event|1|||
126548325|NCT02961881|455302114|FG001|Overall Study|Adverse Event|2|||
126548326|NCT02961881|455302115|FG002|Overall Study|Adverse Event|2|||
126548327|NCT02961881|455302116|FG003|Overall Study|Adverse Event|0|||
126707485|NCT02786537|455882723|FG001|As Treated|Advised to stop tx after loss of meds|1|||
126707486|NCT02786537|455882724|FG002|As Treated|Advised to stop tx after loss of meds|0|||
126707487|NCT02786537|455882725|FG003|As Treated|Advised to stop tx after loss of meds|0|||
126548328|NCT02961881|455302117|FG004|Overall Study|Adverse Event|1|||
126548329|NCT02961881|455302113|FG000|Overall Study|Participant request|0|||
126548330|NCT02961881|455302114|FG001|Overall Study|Participant request|2|||
126548331|NCT02961881|455302115|FG002|Overall Study|Participant request|0|||
126548332|NCT02961881|455302116|FG003|Overall Study|Participant request|0|||
126548333|NCT02961881|455302117|FG004|Overall Study|Participant request|0|||
126548334|NCT02961881|455302113|FG000|Overall Study|Disease progression|1|||
126548335|NCT02961881|455302114|FG001|Overall Study|Disease progression|0|||
126548336|NCT02961881|455302115|FG002|Overall Study|Disease progression|1|||
126548337|NCT02961881|455302116|FG003|Overall Study|Disease progression|0|||
126548338|NCT02961881|455302117|FG004|Overall Study|Disease progression|0|||
126548339|NCT01973491|455302118|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
126548340|NCT01973491|455302118|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
126548341|NCT01973491|455302118|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
126548342|NCT01928225|455302121|FG000|Overall Study|Pregnancy|1|||
126455190|NCT00538785|454966538|FG000|Overall Study|Death|9|||
126455191|NCT00538785|454966539|FG001|Overall Study|Death|10|||
126455192|NCT00538785|454966538|FG000|Overall Study|Withdrawal of consent|9|||
126455193|NCT00538785|454966539|FG001|Overall Study|Withdrawal of consent|7|||
126455194|NCT00538785|454966538|FG000|Overall Study|Lost to Follow-up|1|||
126455195|NCT00538785|454966539|FG001|Overall Study|Lost to Follow-up|0|||
126455196|NCT01002820|454966540|FG000|Overall Study|Adverse Event|1|||
126455197|NCT01002820|454966540|FG000|Overall Study|Withdrawal by Subject|2|||
126455198|NCT01002820|454966540|FG000|Overall Study|Lack of Efficacy|1|||
126455199|NCT02577887|454966543|FG000|Overall Study|Death|93|||
126455200|NCT02577887|454966543|FG000|Overall Study|Protocol Violation|125|||
126455201|NCT02577887|454966543|FG000|Overall Study|Withdrawal by Subject|80|||
126455202|NCT03560518|454966544|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
126455203|NCT03560518|454966545|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
126455204|NCT03560518|454966546|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
126455205|NCT03560518|454966544|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
126455206|NCT03560518|454966545|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
126455207|NCT03560518|454966546|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
126455208|NCT03560518|454966544|FG000|Double Blind Treatment Period|Protocol Violation|1|||
126455209|NCT03560518|454966545|FG001|Double Blind Treatment Period|Protocol Violation|2|||
126455210|NCT03560518|454966546|FG002|Double Blind Treatment Period|Protocol Violation|0|||
126455211|NCT03560518|454966544|FG000|Double Blind Treatment Period|Pregnancy|0|||
126455212|NCT03560518|454966545|FG001|Double Blind Treatment Period|Pregnancy|2|||
126455213|NCT03560518|454966546|FG002|Double Blind Treatment Period|Pregnancy|0|||
126455214|NCT03560518|454966544|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
126455215|NCT03560518|454966545|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
126455216|NCT03560518|454966546|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
126455217|NCT03560518|454966544|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
126455218|NCT03560518|454966545|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
126455219|NCT03560518|454966546|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
126455220|NCT03560518|454966544|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
126455221|NCT03560518|454966545|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
126455222|NCT03560518|454966546|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
126455223|NCT03560518|454966544|FG000|Double Blind Treatment Period|Adverse Event|0|||
126455224|NCT03560518|454966545|FG001|Double Blind Treatment Period|Adverse Event|3|||
126455225|NCT03560518|454966546|FG002|Double Blind Treatment Period|Adverse Event|1|||
126455226|NCT02122783|454966552|FG000|Overall Study|Adverse Event|0|||
126455227|NCT02122783|454966553|FG001|Overall Study|Adverse Event|1|||
126455228|NCT01579812|454966555|FG000|Overall Study|Ineligible after treatment start|40|||
126455229|NCT01579812|454966555|FG000|Overall Study|Patient choice|3|||
126455230|NCT01579812|454966555|FG000|Overall Study|Noncompliance|3|||
126455231|NCT01579812|454966555|FG000|Overall Study|Withdrawal by Subject|6|||
126455232|NCT05277337|454966557|FG000|Overall Study|Lost to Follow-up|2|||
126455233|NCT05277337|454966558|FG001|Overall Study|Lost to Follow-up|0|||
126455234|NCT05277337|454966557|FG000|Overall Study|Withdrawal by Subject|1|||
126455235|NCT05277337|454966558|FG001|Overall Study|Withdrawal by Subject|0|||
126455236|NCT02282345|454966559|FG000|Overall Study|Progression|0|||
126455237|NCT02282345|454966560|FG001|Overall Study|Progression|1|||
126455238|NCT01185301|454966561|FG000|Overall Study|Adverse Event|3|||
126455239|NCT01185301|454966562|FG001|Overall Study|Adverse Event|0|||
126455240|NCT01185301|454966563|FG002|Overall Study|Adverse Event|2|||
126455241|NCT01185301|454966564|FG003|Overall Study|Adverse Event|3|||
126455242|NCT01185301|454966561|FG000|Overall Study|Withdrawal by Subject|7|||
126455243|NCT01185301|454966562|FG001|Overall Study|Withdrawal by Subject|5|||
126455244|NCT01185301|454966563|FG002|Overall Study|Withdrawal by Subject|2|||
126455245|NCT01185301|454966564|FG003|Overall Study|Withdrawal by Subject|3|||
126455246|NCT01185301|454966561|FG000|Overall Study|Lost to Follow-up|2|||
126455247|NCT01185301|454966562|FG001|Overall Study|Lost to Follow-up|0|||
126455248|NCT01185301|454966563|FG002|Overall Study|Lost to Follow-up|0|||
126455249|NCT01185301|454966564|FG003|Overall Study|Lost to Follow-up|1|||
126455250|NCT01185301|454966561|FG000|Overall Study|Other Reason|3|||
126455251|NCT01185301|454966562|FG001|Overall Study|Other Reason|2|||
126455252|NCT01185301|454966563|FG002|Overall Study|Other Reason|2|||
126455253|NCT01185301|454966564|FG003|Overall Study|Other Reason|2|||
126455254|NCT02683746|454966565|FG000|Overall Study|Adverse Event|3|||
126455255|NCT02683746|454966566|FG001|Overall Study|Adverse Event|2|||
126455256|NCT02683746|454966565|FG000|Overall Study|Lost to Follow-up|5|||
126455257|NCT02683746|454966566|FG001|Overall Study|Lost to Follow-up|6|||
126455258|NCT02683746|454966565|FG000|Overall Study|Withdrawal by Subject|6|||
126455259|NCT02683746|454966566|FG001|Overall Study|Withdrawal by Subject|5|||
126455260|NCT02683746|454966565|FG000|Overall Study|Physician Decision|2|||
126455261|NCT02683746|454966566|FG001|Overall Study|Physician Decision|1|||
126455262|NCT04987944|454966567|FG000|Overall Study|Adverse Event|0|||
126455263|NCT04987944|454966568|FG001|Overall Study|Adverse Event|1|||
126455264|NCT04987944|454966567|FG000|Overall Study|Withdrawal by Subject|0|||
126455265|NCT04987944|454966568|FG001|Overall Study|Withdrawal by Subject|1|||
126363518|NCT01703221|454623530|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
126363519|NCT01703221|454623531|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
126363520|NCT01703221|454623529|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
126363521|NCT01703221|454623530|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
126363522|NCT01703221|454623531|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
126363523|NCT01703221|454623529|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
126363524|NCT01703221|454623530|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126363525|NCT01703221|454623531|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126363526|NCT01703221|454623529|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
126363527|NCT01703221|454623530|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126363528|NCT01703221|454623531|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
126363529|NCT01703221|454623529|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126363530|NCT01703221|454623530|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126363531|NCT01703221|454623531|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
126363532|NCT01703221|454623529|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
126363533|NCT01703221|454623530|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
126363534|NCT01703221|454623531|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
126363535|NCT01703221|454623529|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
126363536|NCT01703221|454623530|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
126363537|NCT01703221|454623531|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
126363538|NCT01703221|454623529|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
126363539|NCT01703221|454623530|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
126363540|NCT01703221|454623531|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
126363541|NCT05486065|454623532|FG000|Overall Study|Withdrawal by Subject|1|||
126363542|NCT05486065|454623533|FG001|Overall Study|Withdrawal by Subject|5|||
126363543|NCT05486065|454623534|FG002|Overall Study|Withdrawal by Subject|4|||
126363544|NCT05486065|454623535|FG003|Overall Study|Withdrawal by Subject|3|||
126363545|NCT05486065|454623532|FG000|Overall Study|Lost to Follow-up|4|||
126363546|NCT05486065|454623533|FG001|Overall Study|Lost to Follow-up|2|||
126455266|NCT02353143|454966573|FG000|Overall Study|Withdrawal by Subject|1|||
126455267|NCT02353143|454966574|FG001|Overall Study|Withdrawal by Subject|0|||
126455268|NCT02353143|454966575|FG002|Overall Study|Withdrawal by Subject|0|||
126455269|NCT02353143|454966576|FG003|Overall Study|Withdrawal by Subject|0|||
126455270|NCT02353143|454966577|FG004|Overall Study|Withdrawal by Subject|1|||
126455271|NCT02353143|454966578|FG005|Overall Study|Withdrawal by Subject|0|||
126455272|NCT02353143|454966579|FG006|Overall Study|Withdrawal by Subject|0|||
126455273|NCT02353143|454966580|FG007|Overall Study|Withdrawal by Subject|1|||
126455274|NCT02353143|454966581|FG008|Overall Study|Withdrawal by Subject|1|||
126455275|NCT02353143|454966573|FG000|Overall Study|Lack of Efficacy|2|||
126455276|NCT02353143|454966574|FG001|Overall Study|Lack of Efficacy|1|||
126455277|NCT02353143|454966575|FG002|Overall Study|Lack of Efficacy|2|||
126455278|NCT02353143|454966576|FG003|Overall Study|Lack of Efficacy|4|||
126455279|NCT02353143|454966577|FG004|Overall Study|Lack of Efficacy|13|||
126455280|NCT02353143|454966578|FG005|Overall Study|Lack of Efficacy|2|||
126455281|NCT02353143|454966579|FG006|Overall Study|Lack of Efficacy|2|||
126455282|NCT02353143|454966580|FG007|Overall Study|Lack of Efficacy|2|||
126455283|NCT02353143|454966581|FG008|Overall Study|Lack of Efficacy|1|||
126455284|NCT02353143|454966573|FG000|Overall Study|reason not specified|1|||
126455285|NCT02353143|454966574|FG001|Overall Study|reason not specified|2|||
126455286|NCT02353143|454966575|FG002|Overall Study|reason not specified|0|||
126455287|NCT02353143|454966576|FG003|Overall Study|reason not specified|0|||
126455288|NCT02353143|454966577|FG004|Overall Study|reason not specified|6|||
126455289|NCT02353143|454966578|FG005|Overall Study|reason not specified|1|||
126455290|NCT02353143|454966579|FG006|Overall Study|reason not specified|0|||
126455291|NCT02353143|454966580|FG007|Overall Study|reason not specified|3|||
126455292|NCT02353143|454966581|FG008|Overall Study|reason not specified|1|||
126455293|NCT02353143|454966573|FG000|Overall Study|Physician Decision|0|||
126455294|NCT02353143|454966574|FG001|Overall Study|Physician Decision|4|||
126455295|NCT02353143|454966575|FG002|Overall Study|Physician Decision|2|||
126455296|NCT02353143|454966576|FG003|Overall Study|Physician Decision|3|||
126455297|NCT02353143|454966577|FG004|Overall Study|Physician Decision|4|||
126455298|NCT02353143|454966578|FG005|Overall Study|Physician Decision|0|||
126455299|NCT02353143|454966579|FG006|Overall Study|Physician Decision|1|||
126455300|NCT02353143|454966580|FG007|Overall Study|Physician Decision|2|||
126455301|NCT02353143|454966581|FG008|Overall Study|Physician Decision|0|||
126455302|NCT02353143|454966573|FG000|Overall Study|Adverse Event|0|||
126455303|NCT02353143|454966574|FG001|Overall Study|Adverse Event|0|||
126363547|NCT05486065|454623534|FG002|Overall Study|Lost to Follow-up|2|||
126363548|NCT05486065|454623535|FG003|Overall Study|Lost to Follow-up|2|||
126363549|NCT05486065|454623532|FG000|Overall Study|Physician Decision|0|||
126363550|NCT05486065|454623533|FG001|Overall Study|Physician Decision|1|||
126455304|NCT02353143|454966575|FG002|Overall Study|Adverse Event|1|||
126455305|NCT02353143|454966576|FG003|Overall Study|Adverse Event|0|||
126455306|NCT02353143|454966577|FG004|Overall Study|Adverse Event|1|||
126455307|NCT02353143|454966578|FG005|Overall Study|Adverse Event|1|||
126455308|NCT02353143|454966579|FG006|Overall Study|Adverse Event|0|||
126363551|NCT05486065|454623534|FG002|Overall Study|Physician Decision|1|||
126363552|NCT05486065|454623535|FG003|Overall Study|Physician Decision|0|||
126363553|NCT05486065|454623532|FG000|Overall Study|Failure to meet randomization criteria|0|||
126363554|NCT05486065|454623533|FG001|Overall Study|Failure to meet randomization criteria|0|||
126363555|NCT05486065|454623534|FG002|Overall Study|Failure to meet randomization criteria|0|||
126363556|NCT05486065|454623535|FG003|Overall Study|Failure to meet randomization criteria|1|||
126363557|NCT03927846|454623537|FG000|Overall Study|Lost to Follow-up|10|||
126363558|NCT03927846|454623538|FG001|Overall Study|Lost to Follow-up|11|||
126363559|NCT03878069|454623539|FG000|Overall Study|Death|0|||
126363560|NCT03878069|454623540|FG001|Overall Study|Death|1|||
126363561|NCT03878069|454623541|FG002|Overall Study|Death|0|||
126363562|NCT00834587|454623542|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
126363563|NCT00834587|454623543|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
126363564|NCT03810495|454623544|FG000|Overall Study|Lost to Follow-up|2|||
126363565|NCT03810495|454623544|FG000|Overall Study|Withdrawal by Subject|1|||
126363566|NCT02536339|454623546|FG000|Overall Study|Death|20|||
126363567|NCT02536339|454623546|FG000|Overall Study|Withdrawal by Subject|3|||
126363568|NCT02536339|454623546|FG000|Overall Study|Lost to Follow-up|2|||
126363569|NCT02536339|454623546|FG000|Overall Study|Treatment discontinued|2|||
126363570|NCT02536339|454623546|FG000|Overall Study|Physician Decision|1|||
126455309|NCT02353143|454966580|FG007|Overall Study|Adverse Event|0|||
126455310|NCT02353143|454966581|FG008|Overall Study|Adverse Event|0|||
126455311|NCT02353143|454966573|FG000|Overall Study|patient receiving other treatment for AML|0|||
126455312|NCT02353143|454966574|FG001|Overall Study|patient receiving other treatment for AML|0|||
126455313|NCT02353143|454966575|FG002|Overall Study|patient receiving other treatment for AML|1|||
126455314|NCT02353143|454966576|FG003|Overall Study|patient receiving other treatment for AML|0|||
126455315|NCT02353143|454966577|FG004|Overall Study|patient receiving other treatment for AML|0|||
126455316|NCT02353143|454966578|FG005|Overall Study|patient receiving other treatment for AML|0|||
126455317|NCT02353143|454966579|FG006|Overall Study|patient receiving other treatment for AML|0|||
126455318|NCT02353143|454966580|FG007|Overall Study|patient receiving other treatment for AML|0|||
126455319|NCT02353143|454966581|FG008|Overall Study|patient receiving other treatment for AML|0|||
126455320|NCT02353143|454966573|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
126455321|NCT02353143|454966574|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
126455322|NCT02353143|454966575|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
126455323|NCT02353143|454966576|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
126455324|NCT02353143|454966577|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
126455325|NCT02353143|454966578|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
126455326|NCT02353143|454966579|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
126455327|NCT02353143|454966580|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
126455328|NCT02353143|454966581|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
126455329|NCT04905498|454966584|FG000|Overall Study|Lost to Follow-up|0|||
126455330|NCT04905498|454966585|FG001|Overall Study|Lost to Follow-up|2|||
126455331|NCT04905498|454966584|FG000|Overall Study|COVID lockdown|1|||
126455332|NCT04905498|454966585|FG001|Overall Study|COVID lockdown|0|||
126455333|NCT02946931|454966588|FG000|Overall Study|Did not require collection of CRFs|588|||
126455334|NCT02946931|454966588|FG000|Overall Study|Other than listed|37|||
126455335|NCT02946931|454966588|FG000|Overall Study|Discharge from hospital|118|||
126455336|NCT02946931|454966588|FG000|Overall Study|Adverse Event|81|||
126455337|NCT02946931|454966588|FG000|Overall Study|CRFs not valid|1|||
126455338|NCT02946931|454966588|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
126455339|NCT03339297|454966589|FG000|Overall Study|Relapse of Hematologic Disease|1|||
126455340|NCT03339297|454966590|FG001|Overall Study|Relapse of Hematologic Disease|0|||
126455341|NCT03339297|454966589|FG000|Overall Study|Death|10|||
126455342|NCT03339297|454966590|FG001|Overall Study|Death|7|||
126455343|NCT03339297|454966589|FG000|Overall Study|Hepatic Candidosis|1|||
126455344|NCT03339297|454966590|FG001|Overall Study|Hepatic Candidosis|0|||
126455345|NCT03339297|454966589|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
126455346|NCT03339297|454966590|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
126455347|NCT03339297|454966589|FG000|Overall Study|Consent Withdrawn by Participant|3|||
126455348|NCT03339297|454966590|FG001|Overall Study|Consent Withdrawn by Participant|3|||
126455349|NCT03339297|454966589|FG000|Overall Study|Disease Relapse|2|||
126455350|NCT03339297|454966590|FG001|Overall Study|Disease Relapse|0|||
126455351|NCT03339297|454966589|FG000|Overall Study|Physician Decision|1|||
126707488|NCT02786537|455882726|FG004|As Treated|Advised to stop tx after loss of meds|0|||
126363571|NCT03449147|454623547|FG000|52-week Treatment Period|Death|0|||
126363572|NCT03449147|454623548|FG001|52-week Treatment Period|Death|1|||
126363573|NCT03449147|454623549|FG002|52-week Treatment Period|Death|0|||
126363574|NCT03449147|454623547|FG000|52-week Treatment Period|Lost to Follow-up|6|||
126455352|NCT03339297|454966590|FG001|Overall Study|Physician Decision|1|||
126455353|NCT03339297|454966589|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
126363575|NCT03449147|454623548|FG001|52-week Treatment Period|Lost to Follow-up|2|||
126363576|NCT03449147|454623549|FG002|52-week Treatment Period|Lost to Follow-up|5|||
126363577|NCT03449147|454623547|FG000|52-week Treatment Period|Other|0|||
126363578|NCT03449147|454623548|FG001|52-week Treatment Period|Other|1|||
126548343|NCT01928225|455302122|FG001|Overall Study|Pregnancy|0|||
126548344|NCT01928225|455302121|FG000|Overall Study|basaloid cervical cancer|1|||
126548345|NCT01928225|455302122|FG001|Overall Study|basaloid cervical cancer|0|||
126548346|NCT01928225|455302121|FG000|Overall Study|Lost to Follow-up|1|||
126548347|NCT01928225|455302122|FG001|Overall Study|Lost to Follow-up|3|||
126548348|NCT04250337|455302123|FG000|Overall Study|Adverse Event|0|||
126548349|NCT04250337|455302124|FG001|Overall Study|Adverse Event|3|||
126548350|NCT04250337|455302123|FG000|Overall Study|Lack of Efficacy|1|||
126548351|NCT04250337|455302124|FG001|Overall Study|Lack of Efficacy|3|||
126548352|NCT04250337|455302123|FG000|Overall Study|Physician Decision|1|||
126548353|NCT04250337|455302124|FG001|Overall Study|Physician Decision|0|||
126548354|NCT04250337|455302123|FG000|Overall Study|Protocol Deviation|2|||
126548355|NCT04250337|455302124|FG001|Overall Study|Protocol Deviation|2|||
126548356|NCT04250337|455302123|FG000|Overall Study|Withdrawal by Subject|4|||
126548357|NCT04250337|455302124|FG001|Overall Study|Withdrawal by Subject|3|||
126548358|NCT03321006|455302127|FG000|Overall Study|Death|1|||
126548359|NCT03321006|455302128|FG001|Overall Study|Death|0|||
126548360|NCT03321006|455302127|FG000|Overall Study|Lack of Efficacy|1|||
126548361|NCT03321006|455302128|FG001|Overall Study|Lack of Efficacy|0|||
126548362|NCT00365378|455302129|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
126548363|NCT00365378|455302130|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
126548364|NCT00365378|455302131|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
126548365|NCT00365378|455302129|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
126548366|NCT00365378|455302130|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
126548367|NCT00365378|455302131|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
126548368|NCT00365378|455302129|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
126548369|NCT00365378|455302130|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
126548370|NCT00365378|455302131|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
126548371|NCT00365378|455302129|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
126548372|NCT00365378|455302130|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
126548373|NCT00365378|455302131|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
126548374|NCT00365378|455302129|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
126548375|NCT00365378|455302130|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
126548376|NCT00365378|455302131|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
126548377|NCT00365378|455302129|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
126548378|NCT00365378|455302130|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
126548379|NCT00365378|455302131|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
126548380|NCT00365378|455302129|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
126548381|NCT00365378|455302130|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
126548382|NCT00365378|455302131|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
126548383|NCT00365378|455302129|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
126548384|NCT00365378|455302130|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
126548385|NCT00365378|455302131|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
126548386|NCT00365378|455302129|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
126548387|NCT00365378|455302130|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
126548388|NCT00365378|455302131|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
126548389|NCT00365378|455302129|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
126548390|NCT00365378|455302130|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
126548391|NCT00365378|455302131|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
126548392|NCT00365378|455302129|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
126548393|NCT00365378|455302130|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
126548394|NCT00365378|455302131|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
126548395|NCT00365378|455302129|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
126548396|NCT00365378|455302130|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
126548397|NCT00365378|455302131|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
126548398|NCT00365378|455302129|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
126548399|NCT00365378|455302130|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
126707489|NCT02786537|455882727|FG005|As Treated|Advised to stop tx after loss of meds|0|||
126707490|NCT02638012|455882728|FG000|Overall Study|Lost to Follow-up|1|||
126707491|NCT00443560|455882729|FG000|Overall Study|No intrathecal dose|58|||
126707492|NCT00443560|455882730|FG001|Overall Study|No intrathecal dose|26|||
126278243|NCT04642365|454309186|FG004|Overall Study|Death|5|||
126278244|NCT04642365|454309187|FG005|Overall Study|Death|3|||
126278245|NCT04642365|454309188|FG006|Overall Study|Death|2|||
126278246|NCT04642365|454309189|FG007|Overall Study|Death|1|||
126278247|NCT04642365|454309182|FG000|Overall Study|Physician Decision|1|||
126278248|NCT04642365|454309183|FG001|Overall Study|Physician Decision|0|||
126278249|NCT04642365|454309184|FG002|Overall Study|Physician Decision|0|||
126278250|NCT04642365|454309185|FG003|Overall Study|Physician Decision|0|||
126278251|NCT04642365|454309186|FG004|Overall Study|Physician Decision|0|||
126548400|NCT00365378|455302131|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
126548401|NCT00365378|455302129|FG000|Extension|Adverse Event|0|||
126548402|NCT00365378|455302130|FG001|Extension|Adverse Event|0|||
126707493|NCT00443560|455882729|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
126548403|NCT00365378|455302131|FG002|Extension|Adverse Event|1|||
126707494|NCT00443560|455882730|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
126707495|NCT01009463|455882731|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
126707496|NCT01009463|455882732|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126707497|NCT01009463|455882733|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126707498|NCT01009463|455882734|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126707499|NCT01009463|455882735|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
126707500|NCT01009463|455882731|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
126707501|NCT01009463|455882732|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
126707502|NCT01009463|455882733|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
126707503|NCT01009463|455882734|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
126707504|NCT01009463|455882735|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
126707505|NCT01009463|455882731|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
126707506|NCT01009463|455882732|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126707507|NCT01009463|455882733|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126707508|NCT01009463|455882734|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126707509|NCT01009463|455882735|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
126707510|NCT01009463|455882731|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
126707511|NCT01009463|455882732|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
126707512|NCT01009463|455882733|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
126707513|NCT01009463|455882734|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
126707514|NCT01009463|455882735|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
126707515|NCT01009463|455882731|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
126707516|NCT01009463|455882732|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126707517|NCT01009463|455882733|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126707518|NCT01009463|455882734|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126707519|NCT01009463|455882735|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
126707520|NCT01009463|455882731|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
126707521|NCT01009463|455882732|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
126707522|NCT01009463|455882733|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
126707523|NCT01009463|455882734|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
126707524|NCT01009463|455882735|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
126707525|NCT01009463|455882731|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126707526|NCT01009463|455882732|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
126707527|NCT01009463|455882733|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
126707528|NCT01009463|455882734|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
126707529|NCT01009463|455882735|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
126707530|NCT01009463|455882731|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
126707531|NCT01009463|455882732|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
126707532|NCT01009463|455882733|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
126707533|NCT01009463|455882734|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
126707534|NCT01009463|455882735|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
126707535|NCT01009463|455882731|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
126278252|NCT04642365|454309187|FG005|Overall Study|Physician Decision|0|||
126278253|NCT04642365|454309188|FG006|Overall Study|Physician Decision|0|||
126278254|NCT04642365|454309189|FG007|Overall Study|Physician Decision|0|||
126278255|NCT04642365|454309182|FG000|Overall Study|Progressive Disease|1|||
126278256|NCT04642365|454309183|FG001|Overall Study|Progressive Disease|1|||
126278257|NCT04642365|454309184|FG002|Overall Study|Progressive Disease|1|||
126278258|NCT04642365|454309185|FG003|Overall Study|Progressive Disease|0|||
126363579|NCT03449147|454623549|FG002|52-week Treatment Period|Other|2|||
126363580|NCT03449147|454623547|FG000|52-week Treatment Period|Physician Decision|1|||
126363581|NCT03449147|454623548|FG001|52-week Treatment Period|Physician Decision|0|||
126363582|NCT03449147|454623549|FG002|52-week Treatment Period|Physician Decision|3|||
126363583|NCT03449147|454623547|FG000|52-week Treatment Period|Screen Failure|1|||
126363584|NCT03449147|454623548|FG001|52-week Treatment Period|Screen Failure|2|||
126363585|NCT03449147|454623549|FG002|52-week Treatment Period|Screen Failure|0|||
126363586|NCT03449147|454623547|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
126363587|NCT03449147|454623548|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
126363588|NCT03449147|454623549|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
126363589|NCT03449147|454623547|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
126363590|NCT03449147|454623548|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
126363591|NCT03449147|454623549|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
126363592|NCT03449147|454623547|FG000|12-Week Off-Treatment Durability Period|Other|0|||
126363593|NCT03449147|454623548|FG001|12-Week Off-Treatment Durability Period|Other|1|||
126278259|NCT04642365|454309186|FG004|Overall Study|Progressive Disease|0|||
126278260|NCT04642365|454309187|FG005|Overall Study|Progressive Disease|0|||
126278261|NCT04642365|454309188|FG006|Overall Study|Progressive Disease|1|||
126707536|NCT01009463|455882732|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
126707537|NCT01009463|455882733|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
126707538|NCT01009463|455882734|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
126707539|NCT01009463|455882735|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
126278262|NCT04642365|454309189|FG007|Overall Study|Progressive Disease|0|||
126278263|NCT04642365|454309182|FG000|Overall Study|Study Terminated By Sponsor|0|||
126278264|NCT04642365|454309183|FG001|Overall Study|Study Terminated By Sponsor|2|||
126278265|NCT04642365|454309184|FG002|Overall Study|Study Terminated By Sponsor|1|||
126278266|NCT04642365|454309185|FG003|Overall Study|Study Terminated By Sponsor|1|||
126278267|NCT04642365|454309186|FG004|Overall Study|Study Terminated By Sponsor|1|||
126278268|NCT04642365|454309187|FG005|Overall Study|Study Terminated By Sponsor|2|||
126278269|NCT04642365|454309188|FG006|Overall Study|Study Terminated By Sponsor|2|||
126278270|NCT04642365|454309189|FG007|Overall Study|Study Terminated By Sponsor|1|||
126278271|NCT04642365|454309182|FG000|Overall Study|Symptomatic Deterioration|1|||
126278272|NCT04642365|454309183|FG001|Overall Study|Symptomatic Deterioration|1|||
126278273|NCT04642365|454309184|FG002|Overall Study|Symptomatic Deterioration|0|||
126278274|NCT04642365|454309185|FG003|Overall Study|Symptomatic Deterioration|0|||
126278275|NCT04642365|454309186|FG004|Overall Study|Symptomatic Deterioration|0|||
126278276|NCT04642365|454309187|FG005|Overall Study|Symptomatic Deterioration|1|||
126278277|NCT04642365|454309188|FG006|Overall Study|Symptomatic Deterioration|0|||
126278278|NCT04642365|454309189|FG007|Overall Study|Symptomatic Deterioration|0|||
126278279|NCT04642365|454309182|FG000|Overall Study|Withdrawal by Subject|0|||
126278280|NCT04642365|454309183|FG001|Overall Study|Withdrawal by Subject|0|||
126278281|NCT04642365|454309184|FG002|Overall Study|Withdrawal by Subject|1|||
126707540|NCT01009463|455882731|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
126707541|NCT01009463|455882732|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
126707542|NCT01009463|455882733|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
126707543|NCT01009463|455882734|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
126455354|NCT03339297|454966590|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
126707544|NCT01009463|455882735|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
126455355|NCT03339297|454966589|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
126455356|NCT03339297|454966590|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
126455357|NCT03339297|454966589|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
126455358|NCT03339297|454966590|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
126455359|NCT03339297|454966589|FG000|Overall Study|Adverse Event, Non-fatal|1|||
126455360|NCT03339297|454966590|FG001|Overall Study|Adverse Event, Non-fatal|0|||
126455361|NCT03339297|454966589|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
126455362|NCT03339297|454966590|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
126455363|NCT03339297|454966589|FG000|Overall Study|Patient Was Not Eligible|1|||
126455364|NCT03339297|454966590|FG001|Overall Study|Patient Was Not Eligible|0|||
126455365|NCT03051620|454966591|FG000|Overall Study|Lost to Follow-up|6|||
126455366|NCT03051620|454966591|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
126455367|NCT00393510|454966592|FG000|Overall Study|Physician Decision|3|||
126455368|NCT00393510|454966593|FG001|Overall Study|Physician Decision|9|||
126455369|NCT03077087|454966596|FG000|Overall Study|Physician Decision|2|||
126455370|NCT00796991|454966608|FG000|Overall Study|Adverse Event|0|||
126455371|NCT00796991|454966609|FG001|Overall Study|Adverse Event|0|||
126455372|NCT00796991|454966610|FG002|Overall Study|Adverse Event|1|||
126455373|NCT00796991|454966608|FG000|Overall Study|Death|2|||
126455374|NCT00796991|454966609|FG001|Overall Study|Death|0|||
126455375|NCT00796991|454966610|FG002|Overall Study|Death|0|||
126455376|NCT00796991|454966608|FG000|Overall Study|Disease Progression|10|||
126455377|NCT00796991|454966609|FG001|Overall Study|Disease Progression|9|||
126455378|NCT00796991|454966610|FG002|Overall Study|Disease Progression|7|||
126455379|NCT00796991|454966608|FG000|Overall Study|Study Drug Toxicity|3|||
126455380|NCT00796991|454966609|FG001|Overall Study|Study Drug Toxicity|3|||
126455381|NCT00796991|454966610|FG002|Overall Study|Study Drug Toxicity|5|||
126455382|NCT00796991|454966608|FG000|Overall Study|Withdrawal by Subject|0|||
126455383|NCT00796991|454966609|FG001|Overall Study|Withdrawal by Subject|0|||
126455384|NCT00796991|454966610|FG002|Overall Study|Withdrawal by Subject|1|||
126455385|NCT03148691|454966611|FG000|Overall Study|Protocol Violation|1|||
126707545|NCT01009463|455882731|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
126707546|NCT01009463|455882732|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
126707547|NCT01009463|455882733|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
126455386|NCT03148691|454966612|FG001|Overall Study|Protocol Violation|2|||
126455387|NCT03148691|454966613|FG002|Overall Study|Protocol Violation|7|||
126455388|NCT03148691|454966611|FG000|Overall Study|Lost to Follow-up|0|||
126548404|NCT00365378|455302129|FG000|Extension|Moved|0|||
126278282|NCT04642365|454309185|FG003|Overall Study|Withdrawal by Subject|1|||
126278283|NCT04642365|454309186|FG004|Overall Study|Withdrawal by Subject|0|||
126278284|NCT04642365|454309187|FG005|Overall Study|Withdrawal by Subject|0|||
126548405|NCT00365378|455302130|FG001|Extension|Moved|0|||
126707548|NCT01009463|455882734|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
126707549|NCT01009463|455882735|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
126707550|NCT01009463|455882731|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126707551|NCT01009463|455882732|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
126707552|NCT01009463|455882733|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
126707553|NCT01009463|455882734|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
126455389|NCT03148691|454966612|FG001|Overall Study|Lost to Follow-up|0|||
126278285|NCT04642365|454309188|FG006|Overall Study|Withdrawal by Subject|2|||
126278286|NCT04642365|454309189|FG007|Overall Study|Withdrawal by Subject|0|||
126278287|NCT04642365|454309182|FG000|Overall Study|Adverse Event|0|||
126278288|NCT04642365|454309183|FG001|Overall Study|Adverse Event|0|||
126278289|NCT04642365|454309184|FG002|Overall Study|Adverse Event|0|||
126278290|NCT04642365|454309185|FG003|Overall Study|Adverse Event|0|||
126278291|NCT04642365|454309186|FG004|Overall Study|Adverse Event|0|||
126278292|NCT04642365|454309187|FG005|Overall Study|Adverse Event|0|||
126278293|NCT04642365|454309188|FG006|Overall Study|Adverse Event|0|||
126278294|NCT04642365|454309189|FG007|Overall Study|Adverse Event|1|||
126278295|NCT02478320|454309190|FG000|Overall Study|Adverse Event|2|||
126278296|NCT02478320|454309191|FG001|Overall Study|Adverse Event|0|||
126278297|NCT02478320|454309190|FG000|Overall Study|Death|1|||
126278298|NCT02478320|454309191|FG001|Overall Study|Death|0|||
126278299|NCT02478320|454309190|FG000|Overall Study|Lack of Efficacy|4|||
126278300|NCT02478320|454309191|FG001|Overall Study|Lack of Efficacy|0|||
126278301|NCT02478320|454309190|FG000|Overall Study|Withdrawal by Subject|2|||
126278302|NCT02478320|454309191|FG001|Overall Study|Withdrawal by Subject|0|||
126278303|NCT02478320|454309190|FG000|Overall Study|Screen Failure|3|||
126278304|NCT02478320|454309191|FG001|Overall Study|Screen Failure|0|||
126278305|NCT02011386|454309194|FG000|Overall Study|Non-compliance|2|||
126278306|NCT02011386|454309194|FG000|Overall Study|Lack of Efficacy|3|||
126278307|NCT03255655|454309195|FG000|Overall Study|Lost to Follow-up|7|||
126278308|NCT03255655|454309196|FG001|Overall Study|Lost to Follow-up|4|||
126278309|NCT04428333|454309197|FG000|Overall Study|Physician Decision|5|||
126278310|NCT04428333|454309198|FG001|Overall Study|Physician Decision|6|||
126278311|NCT04428333|454309197|FG000|Overall Study|Withdrawal by Subject|1|||
126278312|NCT04428333|454309198|FG001|Overall Study|Withdrawal by Subject|3|||
126278313|NCT04428333|454309197|FG000|Overall Study|Study Terminated By Sponsor|14|||
126278314|NCT04428333|454309198|FG001|Overall Study|Study Terminated By Sponsor|16|||
126278315|NCT03365011|454309199|FG000|Overall Study|Withdrawal by Subject|1|||
126278316|NCT03365011|454309200|FG001|Overall Study|Withdrawal by Subject|2|||
126278317|NCT04853992|454309201|FG000|Treatment Period A|Adverse Event|0|||
126278318|NCT04853992|454309202|FG001|Treatment Period A|Adverse Event|1|||
126278319|NCT04853992|454309201|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
126278320|NCT04853992|454309202|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
126278321|NCT03582826|454309203|FG000|Overall Study|Lost to Follow-up|39|||
126278322|NCT03582826|454309204|FG001|Overall Study|Lost to Follow-up|0|||
126278323|NCT03582826|454309203|FG000|Overall Study|Withdrawal by Subject|2|||
126278324|NCT03582826|454309204|FG001|Overall Study|Withdrawal by Subject|0|||
126278325|NCT00319982|454309205|FG000|Overall Study|Withdrawal by Subject|1|||
126278326|NCT00319982|454309206|FG001|Overall Study|Withdrawal by Subject|0|||
126278327|NCT02351960|454309207|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
126278328|NCT02351960|454309208|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
126278329|NCT02351960|454309207|FG000|Overall Study|Voluntary Withdrawal|5|||
126278330|NCT02351960|454309208|FG001|Overall Study|Voluntary Withdrawal|4|||
126278331|NCT02351960|454309207|FG000|Overall Study|Significant Protocol Deviation|0|||
126278332|NCT02351960|454309208|FG001|Overall Study|Significant Protocol Deviation|5|||
126278333|NCT03480386|454309209|FG000|Overall Study|Did not complete measures at 3-months|17|||
126278334|NCT03480386|454309210|FG001|Overall Study|Did not complete measures at 3-months|14|||
126278335|NCT03480386|454309209|FG000|Overall Study|No baseline measures|11|||
126278336|NCT03480386|454309210|FG001|Overall Study|No baseline measures|14|||
126278337|NCT03480386|454309209|FG000|Overall Study|Death|0|||
126278338|NCT03480386|454309210|FG001|Overall Study|Death|5|||
126278339|NCT03480386|454309209|FG000|Overall Study|Withdrawal by Subject|12|||
126278340|NCT03480386|454309210|FG001|Overall Study|Withdrawal by Subject|8|||
126278341|NCT03480386|454309209|FG000|Overall Study|Lost to Follow-up|2|||
126278342|NCT03480386|454309210|FG001|Overall Study|Lost to Follow-up|1|||
126278343|NCT03480386|454309209|FG000|Overall Study|Complicating disease|0|||
126278344|NCT03480386|454309210|FG001|Overall Study|Complicating disease|1|||
126278345|NCT03480386|454309209|FG000|Overall Study|Disease progression|3|||
126278346|NCT03480386|454309210|FG001|Overall Study|Disease progression|0|||
126278347|NCT03480386|454309209|FG000|Overall Study|Became ineligible|0|||
126278348|NCT03480386|454309210|FG001|Overall Study|Became ineligible|2|||
126278349|NCT02099682|454309211|FG000|Overall Study|Data Not Available|51|||
126278350|NCT02099682|454309211|FG000|Overall Study|Lost to Follow-up|31|||
126278351|NCT02099682|454309211|FG000|Overall Study|Other|29|||
126278352|NCT05065567|454309212|FG000|Overall Study|Lost to Follow-up|10|||
126278353|NCT05065567|454309213|FG001|Overall Study|Lost to Follow-up|9|||
126363594|NCT03449147|454623549|FG002|12-Week Off-Treatment Durability Period|Other|0|||
126363595|NCT02730169|454624859|FG000|Overall Study|Protocol Violation|1|||
126363596|NCT02730169|454624860|FG001|Overall Study|Protocol Violation|0|||
126363597|NCT02730169|454624861|FG002|Overall Study|Protocol Violation|0|||
126363598|NCT02730169|454624862|FG003|Overall Study|Protocol Violation|1|||
126363599|NCT02730169|454624859|FG000|Overall Study|Adverse Event|2|||
126363600|NCT02730169|454624860|FG001|Overall Study|Adverse Event|3|||
126363601|NCT02730169|454624861|FG002|Overall Study|Adverse Event|3|||
126363602|NCT02730169|454624862|FG003|Overall Study|Adverse Event|0|||
126363603|NCT02730169|454624859|FG000|Overall Study|Adverse Event of Special Interest|0|||
126363604|NCT02730169|454624860|FG001|Overall Study|Adverse Event of Special Interest|1|||
126363605|NCT02730169|454624861|FG002|Overall Study|Adverse Event of Special Interest|2|||
126363606|NCT02730169|454624862|FG003|Overall Study|Adverse Event of Special Interest|0|||
126363607|NCT02730169|454624859|FG000|Overall Study|Withdrawal by Subject|6|||
126363608|NCT02730169|454624860|FG001|Overall Study|Withdrawal by Subject|11|||
126363609|NCT02730169|454624861|FG002|Overall Study|Withdrawal by Subject|6|||
126363610|NCT02730169|454624862|FG003|Overall Study|Withdrawal by Subject|8|||
126363611|NCT02730169|454624859|FG000|Overall Study|Lost to Follow-up|5|||
126363612|NCT02730169|454624860|FG001|Overall Study|Lost to Follow-up|6|||
126363613|NCT02730169|454624861|FG002|Overall Study|Lost to Follow-up|5|||
126363614|NCT02730169|454624862|FG003|Overall Study|Lost to Follow-up|6|||
126363615|NCT02730169|454624859|FG000|Overall Study|Other|0|||
126363616|NCT02730169|454624860|FG001|Overall Study|Other|0|||
126363617|NCT02730169|454624861|FG002|Overall Study|Other|1|||
126363618|NCT02730169|454624862|FG003|Overall Study|Other|1|||
126363619|NCT02144337|454624869|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
126363620|NCT02144337|454624870|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
126363621|NCT02144337|454624869|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
126363622|NCT02144337|454624870|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
126363623|NCT02144337|454624869|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
126363624|NCT02144337|454624870|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
126363625|NCT02144337|454624869|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
126363626|NCT02144337|454624870|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
126363627|NCT02144337|454624869|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
126363628|NCT02144337|454624870|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
126363629|NCT01730729|454624871|FG000|Overall Study|Adverse Event|1|||
126278354|NCT05065567|454309214|FG002|Overall Study|Lost to Follow-up|6|||
126278355|NCT04975191|454310848|FG000|Overall Study|Protocol Violation|1|||
126278356|NCT04975191|454310849|FG001|Overall Study|Protocol Violation|2|||
126278357|NCT04975191|454310850|FG002|Overall Study|Protocol Violation|2|||
126278358|NCT04975191|454310851|FG003|Overall Study|Protocol Violation|2|||
126278359|NCT04975191|454310848|FG000|Overall Study|Lost to Follow-up|13|||
126707554|NCT01009463|455882735|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
126707555|NCT01009463|455882731|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
126707556|NCT01009463|455882732|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
126707557|NCT01009463|455882733|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
126707558|NCT01009463|455882734|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
126707559|NCT01009463|455882735|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
126707560|NCT01494038|455882736|FG000|Overall Study|Protocol Violation|1|||
126707561|NCT01494038|455882737|FG001|Overall Study|Protocol Violation|1|||
126707562|NCT01494038|455882736|FG000|Overall Study|Lost to Follow-up|18|||
126707563|NCT01494038|455882737|FG001|Overall Study|Lost to Follow-up|20|||
126707564|NCT01494038|455882736|FG000|Overall Study|Withdrawal by Subject|44|||
126278360|NCT04975191|454310849|FG001|Overall Study|Lost to Follow-up|3|||
126278361|NCT04975191|454310850|FG002|Overall Study|Lost to Follow-up|8|||
126278362|NCT04975191|454310851|FG003|Overall Study|Lost to Follow-up|8|||
126278363|NCT01056289|454310859|FG000|Open-label Phase|Adverse Event|29|||
126278364|NCT01056289|454310860|FG001|Open-label Phase|Adverse Event|0|||
126278365|NCT01056289|454310861|FG002|Open-label Phase|Adverse Event|0|||
126278366|NCT01056289|454310862|FG003|Open-label Phase|Adverse Event|0|||
126278367|NCT01056289|454310859|FG000|Open-label Phase|Lost to Follow-up|30|||
126278368|NCT01056289|454310860|FG001|Open-label Phase|Lost to Follow-up|0|||
126278369|NCT01056289|454310861|FG002|Open-label Phase|Lost to Follow-up|0|||
126278370|NCT01056289|454310862|FG003|Open-label Phase|Lost to Follow-up|0|||
126278371|NCT01056289|454310859|FG000|Open-label Phase|Other|9|||
126278372|NCT01056289|454310860|FG001|Open-label Phase|Other|0|||
126278373|NCT01056289|454310861|FG002|Open-label Phase|Other|0|||
126363630|NCT01730729|454624871|FG000|Overall Study|Death|1|||
126363631|NCT01730729|454624871|FG000|Overall Study|Progressive Disease|12|||
126363632|NCT00449787|454624872|FG000|Overall Study|Lost to Follow-up|10|||
126363633|NCT00449787|454624873|FG001|Overall Study|Lost to Follow-up|8|||
126363634|NCT00449787|454624872|FG000|Overall Study|Did not require medication|95|||
126363635|NCT00449787|454624873|FG001|Overall Study|Did not require medication|92|||
126363636|NCT03701074|454624874|FG000|Overall Study|Physician Decision|1|||
126278374|NCT01056289|454310862|FG003|Open-label Phase|Other|0|||
126363637|NCT03701074|454624875|FG001|Overall Study|Physician Decision|0|||
126278375|NCT01056289|454310859|FG000|Open-label Phase|Protocol Violation|6|||
126278376|NCT01056289|454310860|FG001|Open-label Phase|Protocol Violation|0|||
126278377|NCT01056289|454310861|FG002|Open-label Phase|Protocol Violation|0|||
126278378|NCT01056289|454310862|FG003|Open-label Phase|Protocol Violation|0|||
126278379|NCT01056289|454310859|FG000|Open-label Phase|Withdrawal by Subject|26|||
126278380|NCT01056289|454310860|FG001|Open-label Phase|Withdrawal by Subject|0|||
126278381|NCT01056289|454310861|FG002|Open-label Phase|Withdrawal by Subject|0|||
126278382|NCT01056289|454310862|FG003|Open-label Phase|Withdrawal by Subject|0|||
126278383|NCT01056289|454310859|FG000|Open-label Phase|Lack of Efficacy|18|||
126278384|NCT01056289|454310860|FG001|Open-label Phase|Lack of Efficacy|0|||
126278385|NCT01056289|454310861|FG002|Open-label Phase|Lack of Efficacy|0|||
126278386|NCT01056289|454310862|FG003|Open-label Phase|Lack of Efficacy|0|||
126278387|NCT01056289|454310859|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
126278388|NCT01056289|454310860|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
126278389|NCT01056289|454310861|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
126278390|NCT01056289|454310862|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
126278391|NCT01056289|454310859|FG000|Double-blind Phase|Adverse Event|0|||
126278392|NCT01056289|454310860|FG001|Double-blind Phase|Adverse Event|1|||
126278393|NCT01056289|454310861|FG002|Double-blind Phase|Adverse Event|2|||
126278394|NCT01056289|454310862|FG003|Double-blind Phase|Adverse Event|1|||
126278395|NCT01056289|454310859|FG000|Double-blind Phase|Lost to Follow-up|0|||
126278396|NCT01056289|454310860|FG001|Double-blind Phase|Lost to Follow-up|2|||
126278397|NCT01056289|454310861|FG002|Double-blind Phase|Lost to Follow-up|2|||
126278398|NCT01056289|454310862|FG003|Double-blind Phase|Lost to Follow-up|2|||
126278399|NCT01056289|454310859|FG000|Double-blind Phase|Other|0|||
126278400|NCT01056289|454310860|FG001|Double-blind Phase|Other|0|||
126278401|NCT01056289|454310861|FG002|Double-blind Phase|Other|1|||
126278402|NCT01056289|454310862|FG003|Double-blind Phase|Other|2|||
126278403|NCT01056289|454310859|FG000|Double-blind Phase|Protocol Violation|0|||
126278404|NCT01056289|454310860|FG001|Double-blind Phase|Protocol Violation|0|||
126278405|NCT01056289|454310861|FG002|Double-blind Phase|Protocol Violation|1|||
126278406|NCT01056289|454310862|FG003|Double-blind Phase|Protocol Violation|1|||
126278407|NCT01056289|454310859|FG000|Double-blind Phase|Withdrawal by Subject|0|||
126278408|NCT01056289|454310860|FG001|Double-blind Phase|Withdrawal by Subject|0|||
126278409|NCT01056289|454310861|FG002|Double-blind Phase|Withdrawal by Subject|4|||
126278410|NCT01056289|454310862|FG003|Double-blind Phase|Withdrawal by Subject|2|||
126278411|NCT01056289|454310859|FG000|Double-blind Phase|Discontinuation symptom|0|||
126278412|NCT01056289|454310860|FG001|Double-blind Phase|Discontinuation symptom|1|||
126278413|NCT01056289|454310861|FG002|Double-blind Phase|Discontinuation symptom|2|||
126278414|NCT01056289|454310862|FG003|Double-blind Phase|Discontinuation symptom|2|||
126278415|NCT01056289|454310859|FG000|Double-blind Phase|Physician Decision|0|||
126278416|NCT01056289|454310860|FG001|Double-blind Phase|Physician Decision|0|||
126278417|NCT01056289|454310861|FG002|Double-blind Phase|Physician Decision|1|||
126278418|NCT01056289|454310862|FG003|Double-blind Phase|Physician Decision|0|||
126278419|NCT03333941|454310868|FG000|Overall Study|Lost to Follow-up|10|||
126278420|NCT03333941|454310868|FG000|Overall Study|Death|2|||
126278421|NCT03333941|454310868|FG000|Overall Study|Adverse Event|1|||
126278422|NCT03323437|454310873|FG000|Overall Study|Withdrawal by Subject|0|||
126278423|NCT03323437|454310874|FG001|Overall Study|Withdrawal by Subject|4|||
126707565|NCT01494038|455882737|FG001|Overall Study|Withdrawal by Subject|34|||
126707566|NCT01494038|455882736|FG000|Overall Study|Not able to get to clinic|21|||
126707567|NCT01494038|455882737|FG001|Overall Study|Not able to get to clinic|15|||
126707568|NCT01494038|455882736|FG000|Overall Study|Not willing to adhere to reqs|2|||
126707569|NCT01494038|455882737|FG001|Overall Study|Not willing to adhere to reqs|9|||
126707570|NCT01494038|455882736|FG000|Overall Study|Death|2|||
126707571|NCT01494038|455882737|FG001|Overall Study|Death|4|||
126707572|NCT02401256|455882738|FG000|Overall Study|Adverse Event|5|||
126707573|NCT02401256|455882738|FG000|Overall Study|Withdrawal by Subject|12|||
126707574|NCT00430781|455882739|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
126707575|NCT00430781|455882740|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
126707576|NCT00430781|455882741|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
126707577|NCT00430781|455882739|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
126707578|NCT00430781|455882740|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
126707579|NCT00430781|455882741|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
126707580|NCT00430781|455882739|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
126707581|NCT00430781|455882740|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
126707582|NCT00430781|455882741|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
126707583|NCT00430781|455882739|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
126707584|NCT00430781|455882740|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
126707585|NCT00430781|455882741|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
126707586|NCT00430781|455882739|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
126707587|NCT00430781|455882740|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
126707588|NCT00430781|455882741|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
126707589|NCT00430781|455882739|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
126707590|NCT00430781|455882740|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
126707591|NCT00430781|455882741|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
126707592|NCT00430781|455882739|FG000|Interim Analysis; 11 February 2008|Death|0|||
126707593|NCT00430781|455882740|FG001|Interim Analysis; 11 February 2008|Death|1|||
126707594|NCT00430781|455882741|FG002|Interim Analysis; 11 February 2008|Death|0|||
126707595|NCT00430781|455882739|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
126707596|NCT00430781|455882740|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
126278424|NCT00049530|454310880|FG000|Overall Study|Lack of Efficacy|25|||
126278425|NCT00049530|454310880|FG000|Overall Study|Adverse Event|2|||
126278426|NCT00049530|454310880|FG000|Overall Study|Death|1|||
126278427|NCT00049530|454310880|FG000|Overall Study|symptomatic deterioration|1|||
126278428|NCT00049530|454310880|FG000|Overall Study|ineligible|3|||
126278429|NCT02383810|454310881|FG000|Overall Study|Physician Decision|1|||
126278430|NCT02383810|454310882|FG001|Overall Study|Physician Decision|1|||
126278431|NCT02383810|454310883|FG002|Overall Study|Physician Decision|0|||
126278432|NCT02383810|454310884|FG003|Overall Study|Physician Decision|0|||
126278433|NCT02383810|454310885|FG004|Overall Study|Physician Decision|0|||
126278434|NCT02383810|454310886|FG005|Overall Study|Physician Decision|0|||
126548406|NCT00365378|455302131|FG002|Extension|Moved|8|||
126548407|NCT00365378|455302129|FG000|Extension|Lost to Follow-up|0|||
126548408|NCT00365378|455302130|FG001|Extension|Lost to Follow-up|0|||
126548409|NCT00365378|455302131|FG002|Extension|Lost to Follow-up|57|||
126548410|NCT00365378|455302129|FG000|Extension|Protocol Violation|0|||
126548411|NCT00365378|455302130|FG001|Extension|Protocol Violation|0|||
126548412|NCT00365378|455302131|FG002|Extension|Protocol Violation|2|||
126707597|NCT00430781|455882741|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
126278435|NCT02383810|454310887|FG006|Overall Study|Physician Decision|0|||
126278436|NCT02383810|454310888|FG007|Overall Study|Physician Decision|0|||
126278437|NCT02383810|454310881|FG000|Overall Study|Withdrawal by Subject|2|||
126278438|NCT02383810|454310882|FG001|Overall Study|Withdrawal by Subject|3|||
126278439|NCT02383810|454310883|FG002|Overall Study|Withdrawal by Subject|3|||
126278440|NCT02383810|454310884|FG003|Overall Study|Withdrawal by Subject|3|||
126278441|NCT02383810|454310885|FG004|Overall Study|Withdrawal by Subject|0|||
126707598|NCT00430781|455882739|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
126707599|NCT00430781|455882740|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
126707600|NCT00430781|455882741|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
126707601|NCT00430781|455882739|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
126707602|NCT00430781|455882740|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
126707603|NCT00430781|455882741|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
126707604|NCT00430781|455882739|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
126707605|NCT00430781|455882740|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
126707606|NCT00430781|455882741|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
126707607|NCT00430781|455882739|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
126707608|NCT00430781|455882740|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
126707609|NCT00430781|455882741|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
126707610|NCT00430781|455882739|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
126707611|NCT00430781|455882740|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
126707612|NCT00430781|455882741|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
126707613|NCT00430781|455882739|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
126707614|NCT00430781|455882740|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
126707615|NCT00430781|455882741|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
126707616|NCT00430781|455882739|FG000|Final Analysis; 31 July 2008|Other|0|||
126707617|NCT00430781|455882740|FG001|Final Analysis; 31 July 2008|Other|1|||
126707618|NCT00430781|455882741|FG002|Final Analysis; 31 July 2008|Other|0|||
126707619|NCT00430781|455882739|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
126363638|NCT03574389|454624879|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
126363639|NCT03574389|454624880|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
126363640|NCT03574389|454624881|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
126363641|NCT03574389|454624882|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
126363642|NCT03574389|454624883|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
126363643|NCT03574389|454624884|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
126363644|NCT03574389|454624885|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
126363645|NCT03574389|454624879|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
126278442|NCT02383810|454310886|FG005|Overall Study|Withdrawal by Subject|0|||
126278443|NCT02383810|454310887|FG006|Overall Study|Withdrawal by Subject|0|||
126278444|NCT02383810|454310888|FG007|Overall Study|Withdrawal by Subject|0|||
126278445|NCT02383810|454310881|FG000|Overall Study|Adverse Event|0|||
126278446|NCT02383810|454310882|FG001|Overall Study|Adverse Event|2|||
126363646|NCT03574389|454624880|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
126363647|NCT03574389|454624881|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
126363648|NCT03574389|454624882|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
126548413|NCT00365378|455302129|FG000|Extension|Withdrawal by Subject|0|||
126278447|NCT02383810|454310883|FG002|Overall Study|Adverse Event|4|||
126278448|NCT02383810|454310884|FG003|Overall Study|Adverse Event|5|||
126278449|NCT02383810|454310885|FG004|Overall Study|Adverse Event|0|||
126278450|NCT02383810|454310886|FG005|Overall Study|Adverse Event|1|||
126278451|NCT02383810|454310887|FG006|Overall Study|Adverse Event|1|||
126278452|NCT02383810|454310888|FG007|Overall Study|Adverse Event|0|||
126278453|NCT02383810|454310881|FG000|Overall Study|Lost to Follow-up|0|||
126278454|NCT02383810|454310882|FG001|Overall Study|Lost to Follow-up|1|||
126278455|NCT02383810|454310883|FG002|Overall Study|Lost to Follow-up|0|||
126278456|NCT02383810|454310884|FG003|Overall Study|Lost to Follow-up|1|||
126278457|NCT02383810|454310885|FG004|Overall Study|Lost to Follow-up|0|||
126278458|NCT02383810|454310886|FG005|Overall Study|Lost to Follow-up|0|||
126278459|NCT02383810|454310887|FG006|Overall Study|Lost to Follow-up|0|||
126278460|NCT02383810|454310888|FG007|Overall Study|Lost to Follow-up|0|||
126278461|NCT02383810|454310881|FG000|Overall Study|other|0|||
126278462|NCT02383810|454310882|FG001|Overall Study|other|0|||
126278463|NCT02383810|454310883|FG002|Overall Study|other|0|||
126278464|NCT02383810|454310884|FG003|Overall Study|other|2|||
126278465|NCT02383810|454310885|FG004|Overall Study|other|0|||
126278466|NCT02383810|454310886|FG005|Overall Study|other|0|||
126278467|NCT02383810|454310887|FG006|Overall Study|other|0|||
126455390|NCT03148691|454966613|FG002|Overall Study|Lost to Follow-up|1|||
126455391|NCT03148691|454966611|FG000|Overall Study|Other|1|||
126455392|NCT03148691|454966612|FG001|Overall Study|Other|0|||
126455393|NCT03148691|454966613|FG002|Overall Study|Other|0|||
126455394|NCT03148691|454966611|FG000|Overall Study|Withdrawal by Subject|1|||
126455395|NCT03148691|454966612|FG001|Overall Study|Withdrawal by Subject|0|||
126455396|NCT03148691|454966613|FG002|Overall Study|Withdrawal by Subject|0|||
126455397|NCT02365233|454966623|FG000|Overall Study|IRB withheld the data|1|||
126455398|NCT02365233|454966624|FG001|Overall Study|IRB withheld the data|2|||
126455399|NCT02365233|454966625|FG002|Overall Study|IRB withheld the data|2|||
126455400|NCT01978938|454966626|FG000|Overall Study|Lost to Follow-up|12|||
126765794|NCT00471237|456095799|FG003|Overall Study|Early stopping due to non-efficacy|0|||
126765795|NCT00471237|456095800|FG004|Overall Study|Early stopping due to non-efficacy|1|||
126765796|NCT00471237|456095801|FG005|Overall Study|Early stopping due to non-efficacy|0|||
126765797|NCT00471237|456095802|FG006|Overall Study|Early stopping due to non-efficacy|0|||
126278468|NCT02383810|454310888|FG007|Overall Study|other|0|||
126278469|NCT02383810|454310881|FG000|Overall Study|subject did not receive study treatment|0|||
126278470|NCT02383810|454310882|FG001|Overall Study|subject did not receive study treatment|1|||
126278471|NCT02383810|454310883|FG002|Overall Study|subject did not receive study treatment|0|||
126278472|NCT02383810|454310884|FG003|Overall Study|subject did not receive study treatment|0|||
126278473|NCT02383810|454310885|FG004|Overall Study|subject did not receive study treatment|0|||
126278474|NCT02383810|454310886|FG005|Overall Study|subject did not receive study treatment|0|||
126278475|NCT02383810|454310887|FG006|Overall Study|subject did not receive study treatment|0|||
126278476|NCT02383810|454310888|FG007|Overall Study|subject did not receive study treatment|0|||
126278477|NCT01635283|454310891|FG000|Overall Study|Tumor Progression|3|||
126278478|NCT01635283|454310891|FG000|Overall Study|Lost to Follow-up|1|||
126278479|NCT01433549|454310892|FG000|Phase 2: Second Study Product|Adverse Event|0|||
126278480|NCT01433549|454310893|FG001|Phase 2: Second Study Product|Adverse Event|1|||
126278481|NCT03511326|454310896|FG000|Overall Study|Withdrawal by Subject|1|||
126278482|NCT01305044|454310897|FG000|Overall Study|Withdrawal by Subject|3|||
126278483|NCT01305044|454310898|FG001|Overall Study|Withdrawal by Subject|6|||
126278484|NCT04628793|454310899|FG000|Overall Study|Study terminated by sponsor|0|||
126278485|NCT04628793|454310900|FG001|Overall Study|Study terminated by sponsor|0|||
126278486|NCT04628793|454310901|FG002|Overall Study|Study terminated by sponsor|8|||
126278487|NCT04628793|454310899|FG000|Overall Study|Withdrawal by Subject|2|||
126278488|NCT04628793|454310900|FG001|Overall Study|Withdrawal by Subject|3|||
126278489|NCT04628793|454310901|FG002|Overall Study|Withdrawal by Subject|0|||
126278490|NCT04628793|454310899|FG000|Overall Study|Lost to Follow-up|0|||
126278491|NCT04628793|454310900|FG001|Overall Study|Lost to Follow-up|1|||
126455401|NCT01978938|454966627|FG001|Overall Study|Lost to Follow-up|6|||
126455402|NCT01978938|454966626|FG000|Overall Study|Withdrawal by Subject|8|||
126455403|NCT01978938|454966627|FG001|Overall Study|Withdrawal by Subject|4|||
126278492|NCT04628793|454310901|FG002|Overall Study|Lost to Follow-up|0|||
126278493|NCT01696058|454310903|FG000|Overall Study|Adverse Event|21|||
126278494|NCT01696058|454310904|FG001|Overall Study|Adverse Event|11|||
126278495|NCT01696058|454310903|FG000|Overall Study|Lack of Efficacy|2|||
126278496|NCT01696058|454310904|FG001|Overall Study|Lack of Efficacy|3|||
126278497|NCT01696058|454310903|FG000|Overall Study|Protocol Violation|9|||
126278498|NCT01696058|454310904|FG001|Overall Study|Protocol Violation|3|||
126278499|NCT01696058|454310903|FG000|Overall Study|Lost to Follow-up|2|||
126278500|NCT01696058|454310904|FG001|Overall Study|Lost to Follow-up|5|||
126278501|NCT01696058|454310903|FG000|Overall Study|Withdrawal by Subject|4|||
126455404|NCT01978938|454966626|FG000|Overall Study|Adverse Event, non-fatal|2|||
126455405|NCT01978938|454966627|FG001|Overall Study|Adverse Event, non-fatal|1|||
126278502|NCT01696058|454310904|FG001|Overall Study|Withdrawal by Subject|6|||
126278503|NCT01696058|454310903|FG000|Overall Study|Other reason prematurely discontinued|5|||
126278504|NCT01696058|454310904|FG001|Overall Study|Other reason prematurely discontinued|3|||
126278505|NCT02278055|454310905|FG000|Overall Study|Adverse Event|1|||
126278506|NCT02278055|454310905|FG000|Overall Study|Lost to Follow-up|1|||
126278507|NCT02278055|454310905|FG000|Overall Study|Withdrawal by Subject|2|||
126278508|NCT02278055|454310905|FG000|Overall Study|Progressive Disease|4|||
126278509|NCT01934335|454310906|FG000|Overall Study|Withdrawal by Subject|1|||
126548414|NCT00365378|455302130|FG001|Extension|Withdrawal by Subject|0|||
126707620|NCT00430781|455882740|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
126707621|NCT00430781|455882741|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
126707622|NCT00430781|455882739|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
126707623|NCT00430781|455882740|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
126707624|NCT00430781|455882741|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
126765798|NCT00471237|456095796|FG000|Overall Study|Participant planned to travel to abraod|1|||
126765799|NCT00471237|456095797|FG001|Overall Study|Participant planned to travel to abraod|0|||
126765800|NCT00471237|456095798|FG002|Overall Study|Participant planned to travel to abraod|0|||
126765801|NCT00471237|456095799|FG003|Overall Study|Participant planned to travel to abraod|0|||
126765802|NCT00471237|456095800|FG004|Overall Study|Participant planned to travel to abraod|0|||
126765803|NCT00471237|456095801|FG005|Overall Study|Participant planned to travel to abraod|1|||
126707625|NCT00430781|455882739|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
126707626|NCT00430781|455882740|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
126707627|NCT00430781|455882741|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
126707628|NCT00430781|455882739|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
126707629|NCT00430781|455882740|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
126707630|NCT00430781|455882741|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
126707631|NCT00430781|455882739|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
126765804|NCT00471237|456095802|FG006|Overall Study|Participant planned to travel to abraod|0|||
126765805|NCT00471237|456095796|FG000|Overall Study|High parathyroid hormone|0|||
126765806|NCT00471237|456095797|FG001|Overall Study|High parathyroid hormone|0|||
126707632|NCT00430781|455882740|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
126707633|NCT00430781|455882741|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
126707634|NCT00430781|455882739|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
126707635|NCT00430781|455882740|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
126707636|NCT00430781|455882741|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
126707637|NCT00430781|455882739|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
126707638|NCT00430781|455882740|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
126707639|NCT00430781|455882741|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
126765807|NCT00471237|456095798|FG002|Overall Study|High parathyroid hormone|1|||
126765808|NCT00471237|456095799|FG003|Overall Study|High parathyroid hormone|0|||
126765809|NCT00471237|456095800|FG004|Overall Study|High parathyroid hormone|0|||
126765810|NCT00471237|456095801|FG005|Overall Study|High parathyroid hormone|0|||
126765811|NCT00471237|456095802|FG006|Overall Study|High parathyroid hormone|0|||
126765812|NCT00471237|456095796|FG000|Overall Study|Participant lost medication|0|||
126765813|NCT00471237|456095797|FG001|Overall Study|Participant lost medication|0|||
126765814|NCT00471237|456095798|FG002|Overall Study|Participant lost medication|0|||
126707640|NCT01389128|455882744|FG000|Overall Study|Fetal distress|1|||
126707641|NCT01389128|455882745|FG001|Overall Study|Fetal distress|0|||
126707642|NCT01389128|455882744|FG000|Overall Study|Cervix dilation stop|1|||
126707643|NCT01389128|455882745|FG001|Overall Study|Cervix dilation stop|2|||
126707644|NCT01389128|455882744|FG000|Overall Study|Rapid labor evolution|3|||
126707645|NCT01389128|455882745|FG001|Overall Study|Rapid labor evolution|2|||
126707646|NCT01389128|455882744|FG000|Overall Study|Intolerance to procedure|0|||
126707647|NCT01389128|455882745|FG001|Overall Study|Intolerance to procedure|2|||
126707648|NCT01059812|455882746|FG000|Overall Study|Adverse Event|9|||
126707649|NCT01059812|455882747|FG001|Overall Study|Adverse Event|5|||
126707650|NCT01059812|455882746|FG000|Overall Study|Lack of Efficacy|2|||
126707651|NCT01059812|455882747|FG001|Overall Study|Lack of Efficacy|2|||
126707652|NCT01059812|455882746|FG000|Overall Study|Protocol Violation|3|||
126707653|NCT01059812|455882747|FG001|Overall Study|Protocol Violation|1|||
126707654|NCT01059812|455882746|FG000|Overall Study|Withdrawal Criteria|9|||
126707655|NCT01059812|455882747|FG001|Overall Study|Withdrawal Criteria|4|||
126707656|NCT01059812|455882746|FG000|Overall Study|Unclassified|14|||
126707657|NCT01059812|455882747|FG001|Overall Study|Unclassified|4|||
126765815|NCT00471237|456095799|FG003|Overall Study|Participant lost medication|0|||
126765816|NCT00471237|456095800|FG004|Overall Study|Participant lost medication|1|||
126765817|NCT00471237|456095801|FG005|Overall Study|Participant lost medication|0|||
126707658|NCT03180736|455882748|FG000|Overall Study|Adverse Event|3|||
126707659|NCT03180736|455882749|FG001|Overall Study|Adverse Event|4|||
126707660|NCT03180736|455882748|FG000|Overall Study|Death|10|||
126707661|NCT03180736|455882749|FG001|Overall Study|Death|7|||
126707662|NCT03180736|455882748|FG000|Overall Study|Withdrawal by Subject|5|||
126707663|NCT03180736|455882749|FG001|Overall Study|Withdrawal by Subject|12|||
126707664|NCT03180736|455882748|FG000|Overall Study|Lost to Follow-up|1|||
126278510|NCT01934335|454310907|FG001|Overall Study|Withdrawal by Subject|1|||
126707665|NCT03180736|455882749|FG001|Overall Study|Lost to Follow-up|0|||
126707666|NCT03180736|455882748|FG000|Overall Study|Lack of Efficacy|66|||
126707667|NCT03180736|455882749|FG001|Overall Study|Lack of Efficacy|87|||
126707668|NCT03180736|455882748|FG000|Overall Study|Physician Decision|4|||
126707669|NCT03180736|455882749|FG001|Overall Study|Physician Decision|7|||
126707670|NCT03180736|455882748|FG000|Overall Study|randomized but not treated|2|||
126707671|NCT03180736|455882749|FG001|Overall Study|randomized but not treated|3|||
126707672|NCT03056287|455882754|FG000|Overall Study|Withdrawal by Subject|0|||
126707673|NCT03056287|455882755|FG001|Overall Study|Withdrawal by Subject|1|||
126707674|NCT03056287|455882756|FG002|Overall Study|Withdrawal by Subject|0|||
126707675|NCT03056287|455882757|FG003|Overall Study|Withdrawal by Subject|0|||
126707676|NCT03056287|455882754|FG000|Overall Study|move out of area|0|||
126707677|NCT03056287|455882755|FG001|Overall Study|move out of area|0|||
126707678|NCT03056287|455882756|FG002|Overall Study|move out of area|1|||
126707679|NCT03056287|455882757|FG003|Overall Study|move out of area|1|||
126707680|NCT00881205|455882758|FG000|Overall Study|Adverse Event|8|||
126707681|NCT00881205|455882759|FG001|Overall Study|Adverse Event|3|||
126707682|NCT00881205|455882758|FG000|Overall Study|Withdrawal by Subject|1|||
126707683|NCT00881205|455882759|FG001|Overall Study|Withdrawal by Subject|2|||
126707684|NCT00881205|455882758|FG000|Overall Study|Lost to Follow-up|0|||
126707685|NCT00881205|455882759|FG001|Overall Study|Lost to Follow-up|1|||
126707686|NCT00881205|455882758|FG000|Overall Study|Administrative problems|1|||
126707687|NCT00881205|455882759|FG001|Overall Study|Administrative problems|1|||
126707688|NCT00881205|455882758|FG000|Overall Study|Condition no longer requires drug|1|||
126707689|NCT00881205|455882759|FG001|Overall Study|Condition no longer requires drug|0|||
126765818|NCT00471237|456095802|FG006|Overall Study|Participant lost medication|0|||
126278511|NCT05384171|454310908|FG000|Overall Study|Lost to Follow-up|9|||
126278512|NCT05384171|454310909|FG001|Overall Study|Lost to Follow-up|9|||
126455406|NCT01978938|454966626|FG000|Overall Study|Participant noncompliance|1|||
126455407|NCT01978938|454966627|FG001|Overall Study|Participant noncompliance|1|||
126765819|NCT00471237|456095796|FG000|Overall Study|Administration of prohibited medicine|0|||
126765820|NCT00471237|456095797|FG001|Overall Study|Administration of prohibited medicine|0|||
126765821|NCT00471237|456095798|FG002|Overall Study|Administration of prohibited medicine|0|||
126765822|NCT00471237|456095799|FG003|Overall Study|Administration of prohibited medicine|0|||
126765823|NCT00471237|456095800|FG004|Overall Study|Administration of prohibited medicine|1|||
126765824|NCT00471237|456095801|FG005|Overall Study|Administration of prohibited medicine|0|||
126765825|NCT00471237|456095802|FG006|Overall Study|Administration of prohibited medicine|0|||
126765826|NCT00471237|456095796|FG000|Overall Study|Participant shifted residence|0|||
126765827|NCT00471237|456095797|FG001|Overall Study|Participant shifted residence|0|||
126765828|NCT00471237|456095798|FG002|Overall Study|Participant shifted residence|0|||
126765829|NCT00471237|456095799|FG003|Overall Study|Participant shifted residence|0|||
126765830|NCT00471237|456095800|FG004|Overall Study|Participant shifted residence|1|||
126765831|NCT00471237|456095801|FG005|Overall Study|Participant shifted residence|0|||
126765832|NCT00471237|456095802|FG006|Overall Study|Participant shifted residence|0|||
126765833|NCT00471237|456095796|FG000|Overall Study|Participant's decision|0|||
126765834|NCT00471237|456095797|FG001|Overall Study|Participant's decision|0|||
126765835|NCT00471237|456095798|FG002|Overall Study|Participant's decision|0|||
126765836|NCT00471237|456095799|FG003|Overall Study|Participant's decision|0|||
126765837|NCT00471237|456095800|FG004|Overall Study|Participant's decision|0|||
126765838|NCT00471237|456095801|FG005|Overall Study|Participant's decision|1|||
126765839|NCT00471237|456095802|FG006|Overall Study|Participant's decision|0|||
126765840|NCT02684370|456095806|FG000|Part A|Adverse Event|2|||
126765841|NCT02684370|456095807|FG001|Part A|Adverse Event|0|||
126765842|NCT02684370|456095808|FG002|Part A|Adverse Event|1|||
126765843|NCT02684370|456095809|FG003|Part A|Adverse Event|0|||
126765844|NCT02684370|456095810|FG004|Part A|Adverse Event|0|||
126765845|NCT02684370|456095811|FG005|Part A|Adverse Event|0|||
126765846|NCT02684370|456095806|FG000|Part A|Lost to Follow-up|1|||
126765847|NCT02684370|456095807|FG001|Part A|Lost to Follow-up|1|||
126765848|NCT02684370|456095808|FG002|Part A|Lost to Follow-up|0|||
126765849|NCT02684370|456095809|FG003|Part A|Lost to Follow-up|0|||
126765850|NCT02684370|456095810|FG004|Part A|Lost to Follow-up|0|||
126765851|NCT02684370|456095811|FG005|Part A|Lost to Follow-up|0|||
126765852|NCT02684370|456095806|FG000|Part A|Subject Withdrawal|1|||
126765853|NCT02684370|456095807|FG001|Part A|Subject Withdrawal|0|||
126765854|NCT02684370|456095808|FG002|Part A|Subject Withdrawal|3|||
126765855|NCT02684370|456095809|FG003|Part A|Subject Withdrawal|0|||
126278513|NCT05384171|454310908|FG000|Overall Study|Withdrawal by Subject|3|||
126278514|NCT05384171|454310909|FG001|Overall Study|Withdrawal by Subject|0|||
126278515|NCT00106964|454310910|FG000|Overall Study|Lost to Follow-up|8|||
126278516|NCT00106964|454310911|FG001|Overall Study|Lost to Follow-up|6|||
126278517|NCT00106964|454310912|FG002|Overall Study|Lost to Follow-up|2|||
126278518|NCT00106964|454310910|FG000|Overall Study|Pregnancy|2|||
126707690|NCT00550238|455882760|FG000|Overall Study|Adverse Event|88|||
126707691|NCT00550238|455882760|FG000|Overall Study|Death|34|||
126707692|NCT00550238|455882760|FG000|Overall Study|Disease progression|46|||
126765856|NCT02684370|456095810|FG004|Part A|Subject Withdrawal|0|||
126278519|NCT00106964|454310911|FG001|Overall Study|Pregnancy|3|||
126278520|NCT00106964|454310912|FG002|Overall Study|Pregnancy|2|||
126278521|NCT00106964|454310910|FG000|Overall Study|Death|1|||
126278522|NCT00106964|454310911|FG001|Overall Study|Death|1|||
126278523|NCT00106964|454310912|FG002|Overall Study|Death|0|||
126278524|NCT00106964|454310910|FG000|Overall Study|Incarceration|0|||
126278525|NCT00106964|454310911|FG001|Overall Study|Incarceration|1|||
126278526|NCT00106964|454310912|FG002|Overall Study|Incarceration|0|||
126278527|NCT00106964|454310910|FG000|Overall Study|Site Funding Terminated|0|||
126278528|NCT00106964|454310911|FG001|Overall Study|Site Funding Terminated|1|||
126278529|NCT00106964|454310912|FG002|Overall Study|Site Funding Terminated|1|||
126278530|NCT00106964|454310910|FG000|Overall Study|Failure to adhere|2|||
126278531|NCT00106964|454310911|FG001|Overall Study|Failure to adhere|0|||
126278532|NCT00106964|454310912|FG002|Overall Study|Failure to adhere|0|||
126278533|NCT00106964|454310910|FG000|Overall Study|Did not meet eligibility criteria|0|||
126278534|NCT00106964|454310911|FG001|Overall Study|Did not meet eligibility criteria|2|||
126278535|NCT00106964|454310912|FG002|Overall Study|Did not meet eligibility criteria|2|||
126278536|NCT00106964|454310910|FG000|Overall Study|Required disallowed medication|0|||
126278537|NCT00106964|454310911|FG001|Overall Study|Required disallowed medication|1|||
126278538|NCT00106964|454310912|FG002|Overall Study|Required disallowed medication|0|||
126278539|NCT00168818|454310917|FG000|Overall Study|Adverse Event|23|||
126278540|NCT00168818|454310918|FG001|Overall Study|Adverse Event|29|||
126278541|NCT00168818|454310919|FG002|Overall Study|Adverse Event|31|||
126278542|NCT00168818|454310917|FG000|Overall Study|Protocol Violation|16|||
126278543|NCT00168818|454310918|FG001|Overall Study|Protocol Violation|11|||
126278544|NCT00168818|454310919|FG002|Overall Study|Protocol Violation|11|||
126278545|NCT00168818|454310917|FG000|Overall Study|Lost to Follow-up|13|||
126278546|NCT00168818|454310918|FG001|Overall Study|Lost to Follow-up|4|||
126278547|NCT00168818|454310919|FG002|Overall Study|Lost to Follow-up|15|||
126278548|NCT00168818|454310917|FG000|Overall Study|Withdrawal by Subject|43|||
126278549|NCT00168818|454310918|FG001|Overall Study|Withdrawal by Subject|41|||
126278550|NCT00168818|454310919|FG002|Overall Study|Withdrawal by Subject|37|||
126278551|NCT00168818|454310917|FG000|Overall Study|Other|22|||
126278552|NCT00168818|454310918|FG001|Overall Study|Other|24|||
126455408|NCT01978938|454966626|FG000|Overall Study|Did not meet inclusion criteria|0|||
126455409|NCT01978938|454966627|FG001|Overall Study|Did not meet inclusion criteria|1|||
126455410|NCT01978938|454966626|FG000|Overall Study|Previously scheduled procedure|0|||
126455411|NCT01978938|454966627|FG001|Overall Study|Previously scheduled procedure|1|||
126455412|NCT01947855|454966628|FG000|Overall Study|Withdrawal by Subject|1|||
126455413|NCT01947855|454966629|FG001|Overall Study|Withdrawal by Subject|0|||
126455414|NCT01947855|454966630|FG002|Overall Study|Withdrawal by Subject|0|||
126455415|NCT00436501|454966631|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
126455416|NCT00436501|454966632|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
126455417|NCT00436501|454966631|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
126455418|NCT00436501|454966632|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
126455419|NCT01246466|454968924|FG000|Overall Study|Death|1|||
126455420|NCT01246466|454968924|FG000|Overall Study|Withdrawal by Subject|1|||
126455421|NCT01012219|454968925|FG000|Period 1|Withdrawal by Subject|1|||
126455422|NCT01012219|454968925|FG000|Period 2|Withdrawal by Subject|1|||
126455423|NCT01350544|454968934|FG000|Overall Study|Administrative Withdrawal|0|||
126455424|NCT01350544|454968935|FG001|Overall Study|Administrative Withdrawal|1|||
126455425|NCT01350544|454968934|FG000|Overall Study|Death|1|||
126455426|NCT01350544|454968935|FG001|Overall Study|Death|2|||
126455427|NCT01350544|454968934|FG000|Overall Study|Moved out of LA County|2|||
126455428|NCT01350544|454968935|FG001|Overall Study|Moved out of LA County|2|||
126455429|NCT01350544|454968934|FG000|Overall Study|Medical Issues|1|||
126455430|NCT01350544|454968935|FG001|Overall Study|Medical Issues|1|||
126455431|NCT01350544|454968934|FG000|Overall Study|Withdrawal by Subject|0|||
126455432|NCT01350544|454968935|FG001|Overall Study|Withdrawal by Subject|1|||
126455433|NCT01350544|454968934|FG000|Overall Study|Incarceration|1|||
126455434|NCT01350544|454968935|FG001|Overall Study|Incarceration|0|||
126455435|NCT01350544|454968934|FG000|Overall Study|Lost to Follow-up|18|||
126455436|NCT01350544|454968935|FG001|Overall Study|Lost to Follow-up|15|||
126455437|NCT00895011|454968937|FG000|Overall Study|Withdrawal by Subject|14|||
126455438|NCT00895011|454968938|FG001|Overall Study|Withdrawal by Subject|7|||
126278553|NCT00168818|454310919|FG002|Overall Study|Other|30|||
126278554|NCT00168818|454310917|FG000|Treatment|Adverse Event|77|||
126455439|NCT00895011|454968939|FG002|Overall Study|Withdrawal by Subject|2|||
126455440|NCT00895011|454968937|FG000|Overall Study|Lost to Follow-up|5|||
126455441|NCT00895011|454968938|FG001|Overall Study|Lost to Follow-up|4|||
126455442|NCT00895011|454968939|FG002|Overall Study|Lost to Follow-up|1|||
126455443|NCT00895011|454968937|FG000|Overall Study|Protocol Violation|3|||
126455444|NCT00895011|454968938|FG001|Overall Study|Protocol Violation|1|||
126455445|NCT00895011|454968939|FG002|Overall Study|Protocol Violation|3|||
126278555|NCT00168818|454310918|FG001|Treatment|Adverse Event|89|||
126278556|NCT00168818|454310919|FG002|Treatment|Adverse Event|68|||
126278557|NCT00168818|454310917|FG000|Treatment|Protocol Violation|8|||
126278558|NCT00168818|454310918|FG001|Treatment|Protocol Violation|11|||
126278559|NCT00168818|454310919|FG002|Treatment|Protocol Violation|11|||
126278560|NCT00168818|454310917|FG000|Treatment|Lost to Follow-up|0|||
126278561|NCT00168818|454310918|FG001|Treatment|Lost to Follow-up|2|||
126278562|NCT00168818|454310919|FG002|Treatment|Lost to Follow-up|1|||
126278563|NCT00168818|454310917|FG000|Treatment|Withdrawal by Subject|25|||
126278564|NCT00168818|454310918|FG001|Treatment|Withdrawal by Subject|20|||
126278565|NCT00168818|454310919|FG002|Treatment|Withdrawal by Subject|22|||
126278566|NCT00168818|454310917|FG000|Treatment|Other|23|||
126278567|NCT00168818|454310918|FG001|Treatment|Other|29|||
126765857|NCT02684370|456095811|FG005|Part A|Subject Withdrawal|0|||
126765858|NCT02684370|456095806|FG000|Part A|Other|0|||
126765859|NCT02684370|456095807|FG001|Part A|Other|0|||
126765860|NCT02684370|456095808|FG002|Part A|Other|1|||
126765861|NCT02684370|456095809|FG003|Part A|Other|0|||
126765862|NCT02684370|456095810|FG004|Part A|Other|0|||
126765863|NCT02684370|456095811|FG005|Part A|Other|0|||
126765864|NCT02684370|456095806|FG000|Part B|Adverse Event|0|||
126765865|NCT02684370|456095807|FG001|Part B|Adverse Event|0|||
126765866|NCT02684370|456095808|FG002|Part B|Adverse Event|0|||
126765867|NCT02684370|456095809|FG003|Part B|Adverse Event|0|||
126765868|NCT02684370|456095810|FG004|Part B|Adverse Event|2|||
126765869|NCT02684370|456095811|FG005|Part B|Adverse Event|1|||
126765870|NCT02684370|456095806|FG000|Part B|Lost to Follow-up|0|||
126765871|NCT02684370|456095807|FG001|Part B|Lost to Follow-up|0|||
126765872|NCT02684370|456095808|FG002|Part B|Lost to Follow-up|0|||
126765873|NCT02684370|456095809|FG003|Part B|Lost to Follow-up|1|||
126765874|NCT02684370|456095810|FG004|Part B|Lost to Follow-up|2|||
126765875|NCT02684370|456095811|FG005|Part B|Lost to Follow-up|5|||
126765876|NCT02684370|456095806|FG000|Part B|Subject Withdrawal|0|||
126765877|NCT02684370|456095807|FG001|Part B|Subject Withdrawal|0|||
126765878|NCT02684370|456095808|FG002|Part B|Subject Withdrawal|0|||
126765879|NCT02684370|456095809|FG003|Part B|Subject Withdrawal|1|||
126278568|NCT00168818|454310919|FG002|Treatment|Other|31|||
126278569|NCT01994291|454310920|FG000|Overall Study|Adverse Event|4|||
126278570|NCT01994291|454310921|FG001|Overall Study|Adverse Event|1|||
126278571|NCT01994291|454310922|FG002|Overall Study|Adverse Event|3|||
126278572|NCT01994291|454310920|FG000|Overall Study|Lost to Follow-up|1|||
126278573|NCT01994291|454310921|FG001|Overall Study|Lost to Follow-up|1|||
126278574|NCT01994291|454310922|FG002|Overall Study|Lost to Follow-up|0|||
126278575|NCT01994291|454310920|FG000|Overall Study|Does not meet entrance criteria|1|||
126278576|NCT01994291|454310921|FG001|Overall Study|Does not meet entrance criteria|0|||
126278577|NCT01994291|454310922|FG002|Overall Study|Does not meet entrance criteria|0|||
126278578|NCT01994291|454310920|FG000|Overall Study|Medication error without associated AE|1|||
126278579|NCT01994291|454310921|FG001|Overall Study|Medication error without associated AE|0|||
126278580|NCT01994291|454310922|FG002|Overall Study|Medication error without associated AE|1|||
126278581|NCT01994291|454310920|FG000|Overall Study|Protocol Violation|1|||
126278582|NCT01994291|454310921|FG001|Overall Study|Protocol Violation|0|||
126278583|NCT01994291|454310922|FG002|Overall Study|Protocol Violation|0|||
126278584|NCT01994291|454310920|FG000|Overall Study|Withdrawal by Subject|6|||
126278585|NCT01994291|454310921|FG001|Overall Study|Withdrawal by Subject|3|||
126278586|NCT01994291|454310922|FG002|Overall Study|Withdrawal by Subject|5|||
126278587|NCT01994291|454310920|FG000|Overall Study|Other|1|||
126278588|NCT01994291|454310921|FG001|Overall Study|Other|2|||
126278589|NCT01994291|454310922|FG002|Overall Study|Other|0|||
126278590|NCT02309138|454310925|FG000|Overall Study|Withdrawal by Subject|44|||
126278591|NCT02309138|454310926|FG001|Overall Study|Withdrawal by Subject|15|||
126278592|NCT02309138|454310925|FG000|Overall Study|Protocol Violation|4|||
126278593|NCT02309138|454310926|FG001|Overall Study|Protocol Violation|2|||
126278594|NCT02309138|454310925|FG000|Overall Study|delivered before visit 2|0|||
126278595|NCT02309138|454310926|FG001|Overall Study|delivered before visit 2|1|||
126278596|NCT00735397|454310929|FG000|Overall Study|Adverse Event|194|||
126278597|NCT00735397|454310929|FG000|Overall Study|Lost to Follow-up|33|||
126278598|NCT00735397|454310929|FG000|Overall Study|Participant choice|252|||
126278599|NCT00735397|454310929|FG000|Overall Study|Inadequate therapeutic effect|202|||
126278600|NCT00735397|454310929|FG000|Overall Study|Administrative/Other|502|||
126278601|NCT03016975|454310934|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
126278602|NCT03016975|454310935|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
126278603|NCT03016975|454310936|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
126765880|NCT02684370|456095810|FG004|Part B|Subject Withdrawal|1|||
126765881|NCT02684370|456095811|FG005|Part B|Subject Withdrawal|2|||
126765882|NCT04221373|456095812|FG000|Overall Study|Physician Decision|4|||
126765883|NCT04221373|456095813|FG001|Overall Study|Physician Decision|0|||
126278604|NCT03016975|454310934|FG000|At 6 Months Follow-up|Death|2|||
126278605|NCT03016975|454310935|FG001|At 6 Months Follow-up|Death|0|||
126765884|NCT00627094|456095819|FG000|Overall Study|Adverse Event|8|||
126278606|NCT03016975|454310936|FG002|At 6 Months Follow-up|Death|0|||
126278607|NCT03016975|454310934|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
126278608|NCT03016975|454310935|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
126455446|NCT00895011|454968937|FG000|Overall Study|Adverse Event|1|||
126765885|NCT00627094|456095820|FG001|Overall Study|Adverse Event|7|||
126765886|NCT00627094|456095819|FG000|Overall Study|Lost to Follow-up|1|||
126765887|NCT00627094|456095820|FG001|Overall Study|Lost to Follow-up|0|||
126363649|NCT03574389|454624883|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
126363650|NCT03574389|454624884|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
126363651|NCT03574389|454624885|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
126363652|NCT03574389|454624879|FG000|Vaccination Period|Other|6|||
126363653|NCT03574389|454624880|FG001|Vaccination Period|Other|0|||
126548415|NCT00365378|455302131|FG002|Extension|Withdrawal by Subject|98|||
126548416|NCT00365378|455302129|FG000|Extension|Other|0|||
126548417|NCT00365378|455302130|FG001|Extension|Other|0|||
126548418|NCT00365378|455302131|FG002|Extension|Other|31|||
126548419|NCT04161807|455302137|FG000|Overall Study|Withdrawal by Subject|2|||
126548420|NCT04161807|455302137|FG000|Overall Study|Performed only 1 treatment|2|||
126548421|NCT02006121|455302138|FG000|Double Blind Phase|Adverse Event|6|||
126548422|NCT02006121|455302139|FG001|Double Blind Phase|Adverse Event|0|||
126548423|NCT02006121|455302138|FG000|Double Blind Phase|Lack of Efficacy|1|||
126548424|NCT02006121|455302139|FG001|Double Blind Phase|Lack of Efficacy|16|||
126548425|NCT02006121|455302138|FG000|Double Blind Phase|Withdrawal by Subject|3|||
126548426|NCT02006121|455302139|FG001|Double Blind Phase|Withdrawal by Subject|4|||
126548427|NCT02006121|455302138|FG000|Double Blind Phase|Non-compliance with study drug|1|||
126548428|NCT02006121|455302139|FG001|Double Blind Phase|Non-compliance with study drug|3|||
126548429|NCT02006121|455302138|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
126548430|NCT02006121|455302139|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
126548431|NCT02006121|455302138|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
126548432|NCT02006121|455302139|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
126548433|NCT02006121|455302138|FG000|Open Label Phase|Adverse Event|15|||
126548434|NCT02006121|455302139|FG001|Open Label Phase|Adverse Event|0|||
126548435|NCT02006121|455302138|FG000|Open Label Phase|Lack of Efficacy|2|||
126548436|NCT02006121|455302139|FG001|Open Label Phase|Lack of Efficacy|0|||
126548437|NCT02006121|455302138|FG000|Open Label Phase|Protocol Violation|2|||
126548438|NCT02006121|455302139|FG001|Open Label Phase|Protocol Violation|0|||
126548439|NCT02006121|455302138|FG000|Open Label Phase|Withdrawal by Subject|3|||
126548440|NCT02006121|455302139|FG001|Open Label Phase|Withdrawal by Subject|0|||
126548441|NCT02006121|455302138|FG000|Open Label Phase|Non-compliance with study drug|3|||
126363654|NCT03574389|454624881|FG002|Vaccination Period|Other|0|||
126363655|NCT03574389|454624882|FG003|Vaccination Period|Other|0|||
126548442|NCT02006121|455302139|FG001|Open Label Phase|Non-compliance with study drug|0|||
126278609|NCT03016975|454310936|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
126278610|NCT03016975|454310934|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
126278611|NCT03016975|454310935|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
126278612|NCT03016975|454310936|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
126278613|NCT03016975|454310934|FG000|At 6 Months Follow-up|Aborted implant|1|||
126278614|NCT03016975|454310935|FG001|At 6 Months Follow-up|Aborted implant|0|||
126278615|NCT03016975|454310936|FG002|At 6 Months Follow-up|Aborted implant|0|||
126278616|NCT03016975|454310934|FG000|At 2 Year Follow-up|Death|1|||
126278617|NCT03016975|454310935|FG001|At 2 Year Follow-up|Death|0|||
126278618|NCT03016975|454310936|FG002|At 2 Year Follow-up|Death|0|||
126278619|NCT03016975|454310934|FG000|At 3 Year Follow-up|Death|1|||
126278620|NCT03016975|454310935|FG001|At 3 Year Follow-up|Death|0|||
126278621|NCT03016975|454310936|FG002|At 3 Year Follow-up|Death|0|||
126278622|NCT03016975|454310934|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
126278623|NCT03016975|454310935|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
126278624|NCT03016975|454310936|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
126278625|NCT03016975|454310934|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
126278626|NCT03016975|454310935|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
126278627|NCT03016975|454310936|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
126278628|NCT01590797|454310939|FG000|Overall Study|Adverse Event|4|||
126278629|NCT01590797|454310940|FG001|Overall Study|Adverse Event|3|||
126278630|NCT01590797|454310939|FG000|Overall Study|Lack of Efficacy|0|||
126278631|NCT01590797|454310940|FG001|Overall Study|Lack of Efficacy|2|||
126278632|NCT01590797|454310939|FG000|Overall Study|Lost to Follow-up|0|||
126278633|NCT01590797|454310940|FG001|Overall Study|Lost to Follow-up|1|||
126278634|NCT01590797|454310939|FG000|Overall Study|Protocol Violation|4|||
126278635|NCT01590797|454310940|FG001|Overall Study|Protocol Violation|1|||
126548443|NCT04789577|455302140|FG000|Overall Study|Withdrawal by Subject|1|||
126548444|NCT04789577|455302141|FG001|Overall Study|Withdrawal by Subject|1|||
126548445|NCT04789577|455302142|FG002|Overall Study|Withdrawal by Subject|1|||
126548446|NCT04789577|455302143|FG003|Overall Study|Withdrawal by Subject|3|||
126548447|NCT04789577|455302144|FG004|Overall Study|Withdrawal by Subject|1|||
126363656|NCT03574389|454624883|FG004|Vaccination Period|Other|0|||
126363657|NCT03574389|454624884|FG005|Vaccination Period|Other|0|||
126548448|NCT04789577|455302145|FG005|Overall Study|Withdrawal by Subject|7|||
126548449|NCT04789577|455302146|FG006|Overall Study|Withdrawal by Subject|1|||
126278636|NCT01590797|454310939|FG000|Overall Study|Withdrawal by Subject|7|||
126278637|NCT01590797|454310940|FG001|Overall Study|Withdrawal by Subject|5|||
126278638|NCT01590797|454310939|FG000|Overall Study|Other Protocol Specified Criteria|2|||
126278639|NCT01590797|454310940|FG001|Overall Study|Other Protocol Specified Criteria|4|||
126278640|NCT00901576|454310944|FG000|Second Intervention|Withdrawal by Subject|0|||
126363658|NCT03574389|454624885|FG006|Vaccination Period|Other|0|||
126707693|NCT00550238|455882760|FG000|Overall Study|Withdrawal by Subject|167|||
126707694|NCT00550238|455882760|FG000|Overall Study|Physician Decision|31|||
126707695|NCT00550238|455882760|FG000|Overall Study|Patient noncompliance|25|||
126707696|NCT00550238|455882760|FG000|Overall Study|Lost to Follow-up|13|||
126707697|NCT00550238|455882760|FG000|Overall Study|Sponsor decision|55|||
126707698|NCT00845429|455882761|FG000|Overall Study|Protocol Violation|5|||
126707699|NCT00845429|455882762|FG001|Overall Study|Protocol Violation|4|||
126707700|NCT00845429|455882763|FG002|Overall Study|Protocol Violation|7|||
126707701|NCT00845429|455882761|FG000|Overall Study|Lost to Follow-up|7|||
126707702|NCT00845429|455882762|FG001|Overall Study|Lost to Follow-up|9|||
126707703|NCT00845429|455882763|FG002|Overall Study|Lost to Follow-up|10|||
126707704|NCT00845429|455882761|FG000|Overall Study|Withdrawal by Subject|2|||
126707705|NCT00845429|455882762|FG001|Overall Study|Withdrawal by Subject|2|||
126707706|NCT00845429|455882763|FG002|Overall Study|Withdrawal by Subject|2|||
126707707|NCT00845429|455882761|FG000|Overall Study|Serious adverse event|0|||
126707708|NCT00845429|455882762|FG001|Overall Study|Serious adverse event|0|||
126707709|NCT00845429|455882763|FG002|Overall Study|Serious adverse event|1|||
126707710|NCT03240081|455882770|FG000|Overall Study|Withdrawal by Subject|0|||
126707711|NCT03240081|455882771|FG001|Overall Study|Withdrawal by Subject|2|||
126707712|NCT03240081|455882770|FG000|Overall Study|Lost to Follow-up|0|||
126707713|NCT03240081|455882771|FG001|Overall Study|Lost to Follow-up|1|||
126707714|NCT01480180|455882772|FG000|Main Phase|Withdrawal criteria|12|||
126707715|NCT01480180|455882773|FG001|Main Phase|Withdrawal criteria|1|||
126707716|NCT01480180|455882774|FG002|Main Phase|Withdrawal criteria|0|||
126707717|NCT01480180|455882775|FG003|Main Phase|Withdrawal criteria|0|||
126707718|NCT01480180|455882776|FG004|Main Phase|Withdrawal criteria|0|||
126765888|NCT00627094|456095819|FG000|Overall Study|Withdrawal by Subject|1|||
126278641|NCT00901576|454310945|FG001|Second Intervention|Withdrawal by Subject|0|||
126278642|NCT00901576|454310946|FG002|Second Intervention|Withdrawal by Subject|0|||
126278643|NCT00901576|454310947|FG003|Second Intervention|Withdrawal by Subject|1|||
126278644|NCT00901576|454310948|FG004|Second Intervention|Withdrawal by Subject|0|||
126278645|NCT00901576|454310949|FG005|Second Intervention|Withdrawal by Subject|1|||
126278646|NCT00901576|454310944|FG000|Second Intervention|Physician Decision|1|||
126278647|NCT00901576|454310945|FG001|Second Intervention|Physician Decision|0|||
126278648|NCT00901576|454310946|FG002|Second Intervention|Physician Decision|0|||
126278649|NCT00901576|454310947|FG003|Second Intervention|Physician Decision|0|||
126278650|NCT00901576|454310948|FG004|Second Intervention|Physician Decision|0|||
126278651|NCT00901576|454310949|FG005|Second Intervention|Physician Decision|0|||
126278652|NCT01228019|454310950|FG000|Overall Study|Dose Violation|70|||
126278653|NCT01228019|454310950|FG000|Overall Study|Duplicate enrollment|1|||
126278654|NCT01228019|454310950|FG000|Overall Study|Missing pre-treatment data|72|||
126278655|NCT01228019|454310950|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
126278656|NCT01228019|454310950|FG000|Overall Study|Violation of Entry Criterion|9|||
126278657|NCT04106661|454310953|FG000|Overall Study|Protocol Violation|3|||
126278658|NCT04106661|454310954|FG001|Overall Study|Protocol Violation|0|||
126278659|NCT04106661|454310953|FG000|Overall Study|Scheduling difficulties|1|||
126278660|NCT04106661|454310954|FG001|Overall Study|Scheduling difficulties|1|||
126278661|NCT00530218|454310957|FG000|Overall Study|CMV Not Detected|13|||
126278662|NCT00530218|454310957|FG000|Overall Study|Death|12|||
126278663|NCT02910063|454310965|FG000|Phase 2|Withdrawal by Subject|3|||
126278664|NCT02910063|454310966|FG001|Phase 2|Withdrawal by Subject|0|||
126278665|NCT02910063|454310967|FG002|Phase 2|Withdrawal by Subject|0|||
126363659|NCT03574389|454624879|FG000|Vaccination Period|Adverse Event|0|||
126707719|NCT01480180|455882777|FG005|Main Phase|Withdrawal criteria|0|||
126707720|NCT01480180|455882772|FG000|Main Phase|Lack of Efficacy|1|||
126707721|NCT01480180|455882773|FG001|Main Phase|Lack of Efficacy|0|||
126707722|NCT01480180|455882774|FG002|Main Phase|Lack of Efficacy|0|||
126707723|NCT01480180|455882775|FG003|Main Phase|Lack of Efficacy|0|||
126707724|NCT01480180|455882776|FG004|Main Phase|Lack of Efficacy|0|||
126707725|NCT01480180|455882777|FG005|Main Phase|Lack of Efficacy|0|||
126707726|NCT01480180|455882772|FG000|Main Phase|Non-compliance|3|||
126707727|NCT01480180|455882773|FG001|Main Phase|Non-compliance|0|||
126707728|NCT01480180|455882774|FG002|Main Phase|Non-compliance|0|||
126278666|NCT02910063|454310965|FG000|Phase 2|Lost to Follow-up|1|||
126278667|NCT02910063|454310966|FG001|Phase 2|Lost to Follow-up|0|||
126278668|NCT02910063|454310967|FG002|Phase 2|Lost to Follow-up|0|||
126278669|NCT02910063|454310965|FG000|Phase 2|Death|24|||
126278670|NCT02910063|454310966|FG001|Phase 2|Death|0|||
126278671|NCT02910063|454310967|FG002|Phase 2|Death|0|||
126707729|NCT01480180|455882775|FG003|Main Phase|Non-compliance|0|||
126707730|NCT01480180|455882776|FG004|Main Phase|Non-compliance|0|||
126707731|NCT01480180|455882777|FG005|Main Phase|Non-compliance|0|||
126707732|NCT01480180|455882772|FG000|Main Phase|Unclassified|3|||
126707733|NCT01480180|455882773|FG001|Main Phase|Unclassified|0|||
126707734|NCT01480180|455882774|FG002|Main Phase|Unclassified|0|||
126707735|NCT01480180|455882775|FG003|Main Phase|Unclassified|0|||
126707736|NCT01480180|455882776|FG004|Main Phase|Unclassified|0|||
126707737|NCT01480180|455882777|FG005|Main Phase|Unclassified|0|||
126765889|NCT00627094|456095820|FG001|Overall Study|Withdrawal by Subject|1|||
126278672|NCT00813800|454310970|FG000|Overall Study|Screen Failure after Consent|2|||
126548450|NCT04789577|455302140|FG000|Overall Study|Lost to Follow-up|7|||
126548451|NCT04789577|455302141|FG001|Overall Study|Lost to Follow-up|12|||
126548452|NCT04789577|455302142|FG002|Overall Study|Lost to Follow-up|7|||
126548453|NCT04789577|455302143|FG003|Overall Study|Lost to Follow-up|10|||
126548454|NCT04789577|455302144|FG004|Overall Study|Lost to Follow-up|8|||
126548455|NCT04789577|455302145|FG005|Overall Study|Lost to Follow-up|6|||
126548456|NCT04789577|455302146|FG006|Overall Study|Lost to Follow-up|10|||
126548457|NCT04789577|455302140|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
126548458|NCT04789577|455302141|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
126548459|NCT04789577|455302142|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
126548460|NCT04789577|455302143|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
126548461|NCT04789577|455302144|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
126548462|NCT04789577|455302145|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
126548463|NCT04789577|455302146|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
126548464|NCT04789577|455302140|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
126548465|NCT04789577|455302141|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
126548466|NCT04789577|455302142|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
126548467|NCT04789577|455302143|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
126548468|NCT04789577|455302144|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
126548469|NCT04789577|455302145|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
126548470|NCT04789577|455302146|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
126548471|NCT02693834|455302157|FG000|Baseline Measurement|Withdrawal by Subject|1|||
126548472|NCT02693834|455302158|FG001|Baseline Measurement|Withdrawal by Subject|0|||
126548473|NCT02693834|455302157|FG000|Baseline Measurement|Adverse Event|1|||
126548474|NCT02693834|455302158|FG001|Baseline Measurement|Adverse Event|0|||
126548475|NCT02693834|455302157|FG000|Week 2 Practice|Adverse Event|0|||
126548476|NCT02693834|455302158|FG001|Week 2 Practice|Adverse Event|1|||
126548477|NCT04848662|455302161|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
126548478|NCT04848662|455302162|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
126548479|NCT00152971|455302166|FG000|Overall Study|Adverse Event|12|||
126548480|NCT00152971|455302167|FG001|Overall Study|Adverse Event|10|||
126548481|NCT00152971|455302168|FG002|Overall Study|Adverse Event|9|||
126548482|NCT00152971|455302166|FG000|Overall Study|Protocol Violation|10|||
126548483|NCT00152971|455302167|FG001|Overall Study|Protocol Violation|11|||
126548484|NCT00152971|455302168|FG002|Overall Study|Protocol Violation|8|||
126548485|NCT00152971|455302166|FG000|Overall Study|Lost to Follow-up|17|||
126548486|NCT00152971|455302167|FG001|Overall Study|Lost to Follow-up|14|||
126548487|NCT00152971|455302168|FG002|Overall Study|Lost to Follow-up|13|||
126548488|NCT00152971|455302166|FG000|Overall Study|Withdrawal by Subject|9|||
126548489|NCT00152971|455302167|FG001|Overall Study|Withdrawal by Subject|8|||
126548490|NCT00152971|455302168|FG002|Overall Study|Withdrawal by Subject|14|||
126548491|NCT00152971|455302166|FG000|Overall Study|Other|3|||
126548492|NCT00152971|455302167|FG001|Overall Study|Other|5|||
126548493|NCT00152971|455302168|FG002|Overall Study|Other|5|||
126548494|NCT00152971|455302166|FG000|Treatment|Adverse Event|49|||
126548495|NCT00152971|455302167|FG001|Treatment|Adverse Event|40|||
126548496|NCT00152971|455302168|FG002|Treatment|Adverse Event|54|||
126548497|NCT00152971|455302166|FG000|Treatment|Protocol Violation|8|||
126548498|NCT00152971|455302167|FG001|Treatment|Protocol Violation|6|||
126548499|NCT00152971|455302168|FG002|Treatment|Protocol Violation|10|||
126548500|NCT00152971|455302166|FG000|Treatment|Lost to Follow-up|1|||
126548501|NCT00152971|455302167|FG001|Treatment|Lost to Follow-up|2|||
126548502|NCT00152971|455302168|FG002|Treatment|Lost to Follow-up|1|||
126548503|NCT00152971|455302166|FG000|Treatment|Withdrawal by Subject|4|||
126548504|NCT00152971|455302167|FG001|Treatment|Withdrawal by Subject|4|||
126548505|NCT00152971|455302168|FG002|Treatment|Withdrawal by Subject|5|||
126548506|NCT00152971|455302166|FG000|Treatment|Other|9|||
126548507|NCT00152971|455302167|FG001|Treatment|Other|11|||
126548508|NCT00152971|455302168|FG002|Treatment|Other|10|||
126548509|NCT01348776|455302169|FG000|Overall Study|Lost to Follow-up|3|||
126548510|NCT01463293|455302170|FG000|Overall Study|Lost to Follow-up|1|||
126548511|NCT01463293|455302171|FG001|Overall Study|Lost to Follow-up|4|||
126548512|NCT01463293|455302172|FG002|Overall Study|Lost to Follow-up|5|||
126548513|NCT01463293|455302170|FG000|Overall Study|Adverse Event|1|||
126548514|NCT01463293|455302171|FG001|Overall Study|Adverse Event|2|||
126548515|NCT01463293|455302172|FG002|Overall Study|Adverse Event|0|||
126278673|NCT00813800|454310970|FG000|Overall Study|Adverse Event|1|||
126548516|NCT01463293|455302170|FG000|Overall Study|Withdrawal by Subject|4|||
126548517|NCT01463293|455302171|FG001|Overall Study|Withdrawal by Subject|10|||
126548518|NCT01463293|455302172|FG002|Overall Study|Withdrawal by Subject|5|||
126548519|NCT01463293|455302170|FG000|Overall Study|Other|0|||
126548520|NCT01463293|455302171|FG001|Overall Study|Other|0|||
126548521|NCT01463293|455302172|FG002|Overall Study|Other|2|||
126548522|NCT00779584|455302179|FG000|Overall Study|Protocol Violation|0|||
126548523|NCT00779584|455302180|FG001|Overall Study|Protocol Violation|0|||
126548524|NCT00779584|455302181|FG002|Overall Study|Protocol Violation|0|||
126548525|NCT00779584|455302182|FG003|Overall Study|Protocol Violation|0|||
126548526|NCT00779584|455302183|FG004|Overall Study|Protocol Violation|0|||
126278674|NCT00813800|454310970|FG000|Overall Study|Worsening of depression|2|||
126278675|NCT00813800|454310970|FG000|Overall Study|Physician Decision|1|||
126278676|NCT03456453|454310971|FG000|Overall Study|Withdrawal by Subject|2|||
126278677|NCT03456453|454310972|FG001|Overall Study|Withdrawal by Subject|0|||
126278678|NCT03456453|454310971|FG000|Overall Study|Not released to community|1|||
126278679|NCT03456453|454310972|FG001|Overall Study|Not released to community|5|||
126278680|NCT03456453|454310971|FG000|Overall Study|Lost to Follow-up|0|||
126278681|NCT03456453|454310972|FG001|Overall Study|Lost to Follow-up|2|||
126278682|NCT01144715|454310973|FG000|Overall Study|Lost to Follow-up|2|||
126278683|NCT01144715|454310974|FG001|Overall Study|Lost to Follow-up|1|||
126278684|NCT01144715|454310973|FG000|Overall Study|Withdrawal by Subject|2|||
126278685|NCT01144715|454310974|FG001|Overall Study|Withdrawal by Subject|1|||
126278686|NCT01144715|454310973|FG000|Overall Study|Adverse Event|0|||
126278687|NCT01144715|454310974|FG001|Overall Study|Adverse Event|1|||
126278688|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
126278689|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
126278690|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
126278691|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
126278692|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
126278693|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
126278694|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
126278695|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
126278696|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
126278697|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
126548527|NCT00779584|455302184|FG005|Overall Study|Protocol Violation|1|||
126548528|NCT00779584|455302185|FG006|Overall Study|Protocol Violation|0|||
126548529|NCT00779584|455302186|FG007|Overall Study|Protocol Violation|0|||
126548530|NCT00779584|455302187|FG008|Overall Study|Protocol Violation|0|||
126548531|NCT00779584|455302179|FG000|Overall Study|Withdrawal by Subject|1|||
126548532|NCT00779584|455302180|FG001|Overall Study|Withdrawal by Subject|1|||
126548533|NCT00779584|455302181|FG002|Overall Study|Withdrawal by Subject|2|||
126548534|NCT00779584|455302182|FG003|Overall Study|Withdrawal by Subject|0|||
126548535|NCT00779584|455302183|FG004|Overall Study|Withdrawal by Subject|0|||
126548536|NCT00779584|455302184|FG005|Overall Study|Withdrawal by Subject|2|||
126548537|NCT00779584|455302185|FG006|Overall Study|Withdrawal by Subject|1|||
126548538|NCT00779584|455302186|FG007|Overall Study|Withdrawal by Subject|0|||
126548539|NCT00779584|455302187|FG008|Overall Study|Withdrawal by Subject|0|||
126548540|NCT00779584|455302179|FG000|Overall Study|Lost to Follow-up|0|||
126548541|NCT00779584|455302180|FG001|Overall Study|Lost to Follow-up|0|||
126278698|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
126548542|NCT00779584|455302181|FG002|Overall Study|Lost to Follow-up|0|||
126278699|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
126278700|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
126278701|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
126278702|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
126278703|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
126278704|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
126278705|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
126278706|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
126278707|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
126278708|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
126278709|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
126278710|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
126278711|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
126278712|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
126278713|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
126278714|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
126278715|NCT02552212|454310975|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
126278716|NCT02552212|454310976|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
126278717|NCT02552212|454310977|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
126548543|NCT00779584|455302182|FG003|Overall Study|Lost to Follow-up|0|||
126548544|NCT00779584|455302183|FG004|Overall Study|Lost to Follow-up|1|||
126548545|NCT00779584|455302184|FG005|Overall Study|Lost to Follow-up|0|||
126548546|NCT00779584|455302185|FG006|Overall Study|Lost to Follow-up|0|||
126548547|NCT00779584|455302186|FG007|Overall Study|Lost to Follow-up|0|||
126278718|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
126278719|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
126278720|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
126278721|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
126278722|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
126278723|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
126548548|NCT00779584|455302187|FG008|Overall Study|Lost to Follow-up|0|||
126278724|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
126278725|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
126278726|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
126278727|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
126278728|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
126278729|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
126278730|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
126278731|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
126278732|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
126278733|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
126278734|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
126278735|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
126278736|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
126278737|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
126278738|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
126278739|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
126278740|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
126278741|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
126278742|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
126278743|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
126278744|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
126278745|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
126278746|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
126278747|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
126278748|NCT02552212|454310975|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
126278749|NCT02552212|454310976|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
126278750|NCT02552212|454310977|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
126278751|NCT02369458|454310978|FG000|Overall Study|Determined to be not eligible|1|||
126278752|NCT02369458|454310979|FG001|Overall Study|Determined to be not eligible|0|||
126278753|NCT04572893|454310980|FG000|Part A|Adverse Event|1|||
126278754|NCT04572893|454310981|FG001|Part A|Adverse Event|0|||
126278755|NCT04572893|454310982|FG002|Part A|Adverse Event|0|||
126278756|NCT04572893|454310983|FG003|Part A|Adverse Event|0|||
126278757|NCT04572893|454310984|FG004|Part A|Adverse Event|0|||
126278758|NCT04572893|454310985|FG005|Part A|Adverse Event|0|||
126278759|NCT04572893|454310986|FG006|Part A|Adverse Event|0|||
126278760|NCT04572893|454310980|FG000|Part B|Withdrawal by Subject|0|||
126278761|NCT04572893|454310981|FG001|Part B|Withdrawal by Subject|0|||
126278762|NCT04572893|454310982|FG002|Part B|Withdrawal by Subject|0|||
126278763|NCT04572893|454310983|FG003|Part B|Withdrawal by Subject|0|||
126278764|NCT04572893|454310984|FG004|Part B|Withdrawal by Subject|0|||
126278765|NCT04572893|454310985|FG005|Part B|Withdrawal by Subject|1|||
126278766|NCT04572893|454310986|FG006|Part B|Withdrawal by Subject|0|||
126278767|NCT04572893|454310980|FG000|Part B|Study terminated by sponsor|0|||
126278768|NCT04572893|454310981|FG001|Part B|Study terminated by sponsor|0|||
126278769|NCT04572893|454310982|FG002|Part B|Study terminated by sponsor|0|||
126278770|NCT04572893|454310983|FG003|Part B|Study terminated by sponsor|0|||
126278771|NCT04572893|454310984|FG004|Part B|Study terminated by sponsor|7|||
126278772|NCT04572893|454310985|FG005|Part B|Study terminated by sponsor|5|||
126278773|NCT04572893|454310986|FG006|Part B|Study terminated by sponsor|3|||
126278774|NCT04572893|454310980|FG000|Part B|Lost to Follow-up|0|||
126278775|NCT04572893|454310981|FG001|Part B|Lost to Follow-up|0|||
126278776|NCT04572893|454310982|FG002|Part B|Lost to Follow-up|0|||
126278777|NCT04572893|454310983|FG003|Part B|Lost to Follow-up|0|||
126278778|NCT04572893|454310984|FG004|Part B|Lost to Follow-up|0|||
126278779|NCT04572893|454310985|FG005|Part B|Lost to Follow-up|0|||
126278780|NCT04572893|454310986|FG006|Part B|Lost to Follow-up|1|||
126278781|NCT04572893|454310980|FG000|Part B|Adverse Event|0|||
126278782|NCT04572893|454310981|FG001|Part B|Adverse Event|0|||
126278783|NCT04572893|454310982|FG002|Part B|Adverse Event|0|||
126278784|NCT04572893|454310983|FG003|Part B|Adverse Event|0|||
126278785|NCT04572893|454310984|FG004|Part B|Adverse Event|1|||
126278786|NCT04572893|454310985|FG005|Part B|Adverse Event|1|||
126278787|NCT04572893|454310986|FG006|Part B|Adverse Event|0|||
126278788|NCT00121134|454310987|FG000|Overall Study|Progression of Disease|5|||
126278789|NCT00121134|454310988|FG001|Overall Study|Progression of Disease|3|||
126363660|NCT03574389|454624880|FG001|Vaccination Period|Adverse Event|1|||
126363661|NCT03574389|454624881|FG002|Vaccination Period|Adverse Event|0|||
126278790|NCT00121134|454310989|FG002|Overall Study|Progression of Disease|4|||
126278791|NCT00121134|454310990|FG003|Overall Study|Progression of Disease|2|||
126278792|NCT00121134|454310987|FG000|Overall Study|Toxicity|4|||
126278793|NCT00121134|454310988|FG001|Overall Study|Toxicity|7|||
126278794|NCT00121134|454310989|FG002|Overall Study|Toxicity|13|||
126278795|NCT00121134|454310990|FG003|Overall Study|Toxicity|5|||
126278796|NCT00121134|454310987|FG000|Overall Study|Physician Decision|6|||
126707738|NCT01480180|455882772|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
126707739|NCT01480180|455882773|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
126707740|NCT01480180|455882774|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
126707741|NCT01480180|455882775|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
126707742|NCT01480180|455882776|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
126707743|NCT01480180|455882777|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
126707744|NCT01480180|455882772|FG000|Extension Phase, Part 1|Unclassified|0|||
126707745|NCT01480180|455882773|FG001|Extension Phase, Part 1|Unclassified|0|||
126707746|NCT01480180|455882774|FG002|Extension Phase, Part 1|Unclassified|1|||
126707747|NCT01480180|455882775|FG003|Extension Phase, Part 1|Unclassified|0|||
126707748|NCT01480180|455882776|FG004|Extension Phase, Part 1|Unclassified|0|||
126707749|NCT01480180|455882777|FG005|Extension Phase, Part 1|Unclassified|0|||
126707750|NCT01480180|455882772|FG000|Extension Phase, Part 1|Adverse Event|0|||
126707751|NCT01480180|455882773|FG001|Extension Phase, Part 1|Adverse Event|0|||
126278797|NCT00121134|454310988|FG001|Overall Study|Physician Decision|4|||
126278798|NCT00121134|454310989|FG002|Overall Study|Physician Decision|4|||
126278799|NCT00121134|454310990|FG003|Overall Study|Physician Decision|1|||
126278800|NCT00121134|454310987|FG000|Overall Study|Treatment Delay|1|||
126278801|NCT00121134|454310988|FG001|Overall Study|Treatment Delay|0|||
126278802|NCT00121134|454310989|FG002|Overall Study|Treatment Delay|0|||
126278803|NCT00121134|454310990|FG003|Overall Study|Treatment Delay|0|||
126278804|NCT00121134|454310987|FG000|Overall Study|Intercurrent Illness|0|||
126278805|NCT00121134|454310988|FG001|Overall Study|Intercurrent Illness|0|||
126278806|NCT00121134|454310989|FG002|Overall Study|Intercurrent Illness|0|||
126278807|NCT00121134|454310990|FG003|Overall Study|Intercurrent Illness|1|||
126278808|NCT00121134|454310987|FG000|Overall Study|Patient Personal Reasons|0|||
126278809|NCT00121134|454310988|FG001|Overall Study|Patient Personal Reasons|1|||
126278810|NCT00121134|454310989|FG002|Overall Study|Patient Personal Reasons|0|||
126278811|NCT00121134|454310990|FG003|Overall Study|Patient Personal Reasons|0|||
126278812|NCT00197496|454310997|FG000|Baseline to Discharge|not interested|1|||
126278813|NCT00197496|454310998|FG001|Baseline to Discharge|not interested|0|||
126278814|NCT00197496|454310997|FG000|Baseline to Discharge|MRSA|1|||
126278815|NCT00197496|454310998|FG001|Baseline to Discharge|MRSA|0|||
126278816|NCT00197496|454310997|FG000|Baseline to Discharge|Physician Decision|0|||
126278817|NCT00197496|454310998|FG001|Baseline to Discharge|Physician Decision|1|||
126278818|NCT00197496|454310997|FG000|Baseline to Discharge|Protocol Violation|0|||
126278819|NCT00197496|454310998|FG001|Baseline to Discharge|Protocol Violation|1|||
126278820|NCT00197496|454310997|FG000|Follow-up|Lost to Follow-up|2|||
126278821|NCT00197496|454310998|FG001|Follow-up|Lost to Follow-up|1|||
126278822|NCT00857584|454311004|FG000|Overall Study|Lack of Efficacy|1|||
126278823|NCT00857584|454311005|FG001|Overall Study|Lack of Efficacy|2|||
126278824|NCT00857584|454311004|FG000|Overall Study|Adverse Event|2|||
126278825|NCT00857584|454311005|FG001|Overall Study|Adverse Event|2|||
126278826|NCT00857584|454311004|FG000|Overall Study|Physician Decision|1|||
126278827|NCT00857584|454311005|FG001|Overall Study|Physician Decision|1|||
126278828|NCT00418821|454311006|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
126278829|NCT00259272|454311007|FG000|Overall Study|Adverse Event|2|||
126278830|NCT00259272|454311008|FG001|Overall Study|Adverse Event|1|||
126278831|NCT00259272|454311009|FG002|Overall Study|Adverse Event|0|||
126278832|NCT00259272|454311010|FG003|Overall Study|Adverse Event|3|||
126278833|NCT00259272|454311007|FG000|Overall Study|Lack of Efficacy|5|||
126278834|NCT00259272|454311008|FG001|Overall Study|Lack of Efficacy|1|||
126278835|NCT00259272|454311009|FG002|Overall Study|Lack of Efficacy|2|||
126278836|NCT00259272|454311010|FG003|Overall Study|Lack of Efficacy|6|||
126278837|NCT00259272|454311007|FG000|Overall Study|Physician Decision|1|||
126278838|NCT00259272|454311008|FG001|Overall Study|Physician Decision|2|||
126707752|NCT01480180|455882774|FG002|Extension Phase, Part 1|Adverse Event|4|||
126707753|NCT01480180|455882775|FG003|Extension Phase, Part 1|Adverse Event|1|||
126707754|NCT01480180|455882776|FG004|Extension Phase, Part 1|Adverse Event|0|||
126278839|NCT00259272|454311009|FG002|Overall Study|Physician Decision|1|||
126278840|NCT00259272|454311010|FG003|Overall Study|Physician Decision|3|||
126278841|NCT00259272|454311007|FG000|Overall Study|Protocol Violation|2|||
126278842|NCT00259272|454311008|FG001|Overall Study|Protocol Violation|0|||
126278843|NCT00259272|454311009|FG002|Overall Study|Protocol Violation|0|||
126278844|NCT00259272|454311010|FG003|Overall Study|Protocol Violation|1|||
126278845|NCT00259272|454311007|FG000|Overall Study|Sponsor Decision|0|||
126278846|NCT00259272|454311008|FG001|Overall Study|Sponsor Decision|1|||
126278847|NCT00259272|454311009|FG002|Overall Study|Sponsor Decision|0|||
126278848|NCT00259272|454311010|FG003|Overall Study|Sponsor Decision|0|||
126278849|NCT00259272|454311007|FG000|Overall Study|Withdrawal by Subject|4|||
126278850|NCT00259272|454311008|FG001|Overall Study|Withdrawal by Subject|2|||
126278851|NCT00259272|454311009|FG002|Overall Study|Withdrawal by Subject|2|||
126707755|NCT01480180|455882777|FG005|Extension Phase, Part 1|Adverse Event|0|||
126707756|NCT01480180|455882772|FG000|Extension Phase, Part 1|Change of treatment|0|||
126765890|NCT00627094|456095819|FG000|Overall Study|ulcer healed|1|||
126278852|NCT00259272|454311010|FG003|Overall Study|Withdrawal by Subject|7|||
126278853|NCT00259272|454311007|FG000|Overall Study|Lost to Follow-up|1|||
126707757|NCT01480180|455882773|FG001|Extension Phase, Part 1|Change of treatment|0|||
126707758|NCT01480180|455882774|FG002|Extension Phase, Part 1|Change of treatment|0|||
126707759|NCT01480180|455882775|FG003|Extension Phase, Part 1|Change of treatment|9|||
126707760|NCT01480180|455882776|FG004|Extension Phase, Part 1|Change of treatment|0|||
126707761|NCT01480180|455882777|FG005|Extension Phase, Part 1|Change of treatment|0|||
126707762|NCT01480180|455882772|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
126707763|NCT01480180|455882773|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
126707764|NCT01480180|455882774|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
126707765|NCT01480180|455882775|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
126707766|NCT01480180|455882776|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
126707767|NCT01480180|455882777|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
126707768|NCT01480180|455882772|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
126707769|NCT01480180|455882773|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
126707770|NCT01480180|455882774|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
126765891|NCT00627094|456095820|FG001|Overall Study|ulcer healed|7|||
126278854|NCT00259272|454311008|FG001|Overall Study|Lost to Follow-up|0|||
126278855|NCT00259272|454311009|FG002|Overall Study|Lost to Follow-up|0|||
126278856|NCT00259272|454311010|FG003|Overall Study|Lost to Follow-up|1|||
126278857|NCT00805467|454312524|FG000|Overall Study|Lack of Efficacy|0|||
126278858|NCT00805467|454312525|FG001|Overall Study|Lack of Efficacy|8|||
126278859|NCT00805467|454312526|FG002|Overall Study|Lack of Efficacy|13|||
126278860|NCT00805467|454312527|FG003|Overall Study|Lack of Efficacy|86|||
126278861|NCT00805467|454312524|FG000|Overall Study|Lost to Follow-up|0|||
126278862|NCT00805467|454312525|FG001|Overall Study|Lost to Follow-up|1|||
126765892|NCT00627094|456095819|FG000|Overall Study|Other reason|1|||
126765893|NCT00627094|456095820|FG001|Overall Study|Other reason|0|||
126278863|NCT00805467|454312526|FG002|Overall Study|Lost to Follow-up|7|||
126278864|NCT00805467|454312527|FG003|Overall Study|Lost to Follow-up|21|||
126278865|NCT00805467|454312524|FG000|Overall Study|Withdrawal by Subject|0|||
126278866|NCT00805467|454312525|FG001|Overall Study|Withdrawal by Subject|6|||
126278867|NCT00805467|454312526|FG002|Overall Study|Withdrawal by Subject|45|||
126278868|NCT00805467|454312527|FG003|Overall Study|Withdrawal by Subject|50|||
126765894|NCT00183170|456095822|FG000|First Intervention|Did not complete study|1|||
126765895|NCT00183170|456095823|FG001|First Intervention|Did not complete study|0|||
126765896|NCT00183170|456095822|FG000|First Intervention|Did not meet targeted BrAC|1|||
126278869|NCT00805467|454312524|FG000|Overall Study|Protocol Violation|0|||
126278870|NCT00805467|454312525|FG001|Overall Study|Protocol Violation|3|||
126278871|NCT00805467|454312526|FG002|Overall Study|Protocol Violation|0|||
126278872|NCT00805467|454312527|FG003|Overall Study|Protocol Violation|5|||
126278873|NCT00805467|454312524|FG000|Overall Study|Adverse Event|0|||
126765897|NCT00183170|456095823|FG001|First Intervention|Did not meet targeted BrAC|0|||
126765898|NCT00183170|456095822|FG000|Washout 1 Week|Did not complete study|6|||
126765899|NCT00183170|456095823|FG001|Washout 1 Week|Did not complete study|8|||
126765900|NCT00183170|456095822|FG000|Second Intervention|Did not complete study|1|||
126765901|NCT00183170|456095823|FG001|Second Intervention|Did not complete study|0|||
126765902|NCT00183170|456095822|FG000|Second Intervention|Did not meet targeted BrAC|0|||
126765903|NCT00183170|456095823|FG001|Second Intervention|Did not meet targeted BrAC|2|||
126765904|NCT00924820|456095824|FG000|Overall Study|Death|2|||
126765905|NCT00924820|456095824|FG000|Overall Study|Ineligible, Screen Failure|5|||
126765906|NCT04983589|456095825|FG000|Overall Study|Withdrawal by Subject|0|||
126765907|NCT04983589|456095826|FG001|Overall Study|Withdrawal by Subject|3|||
126765908|NCT04983589|456095825|FG000|Overall Study|COVID-19 Infection|1|||
126765909|NCT04983589|456095826|FG001|Overall Study|COVID-19 Infection|0|||
126765910|NCT04983589|456095825|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
126765911|NCT04983589|456095826|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
126765912|NCT00761969|456095827|FG000|Overall Study|Death|112|||
126278874|NCT00805467|454312525|FG001|Overall Study|Adverse Event|13|||
126455447|NCT00895011|454968938|FG001|Overall Study|Adverse Event|2|||
126707771|NCT01480180|455882775|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
126707772|NCT01480180|455882776|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
126765913|NCT00761969|456095828|FG001|Overall Study|Death|47|||
126765914|NCT00761969|456095827|FG000|Overall Study|Lost to Follow-up|88|||
126765915|NCT00761969|456095828|FG001|Overall Study|Lost to Follow-up|93|||
126455448|NCT00895011|454968939|FG002|Overall Study|Adverse Event|2|||
126707773|NCT01480180|455882777|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
126707774|NCT01480180|455882772|FG000|Extension Phase, Part 2|Unclassified|0|||
126765916|NCT01353586|456095831|FG000|Overall Study|Procedure terminated prior to ablation|3|||
126765917|NCT01353586|456095832|FG001|Overall Study|Procedure terminated prior to ablation|0|||
126765918|NCT01353586|456095831|FG000|Overall Study|Never had insertion of study catheter|4|||
126765919|NCT01353586|456095832|FG001|Overall Study|Never had insertion of study catheter|1|||
126278875|NCT00805467|454312526|FG002|Overall Study|Adverse Event|26|||
126278876|NCT00805467|454312527|FG003|Overall Study|Adverse Event|57|||
126278877|NCT00805467|454312524|FG000|Overall Study|Death|0|||
126278878|NCT00805467|454312525|FG001|Overall Study|Death|2|||
126278879|NCT00805467|454312526|FG002|Overall Study|Death|7|||
126278880|NCT00805467|454312527|FG003|Overall Study|Death|5|||
126278881|NCT00805467|454312524|FG000|Overall Study|Physician Decision|0|||
126278882|NCT00805467|454312525|FG001|Overall Study|Physician Decision|1|||
126278883|NCT00805467|454312526|FG002|Overall Study|Physician Decision|2|||
126278884|NCT00805467|454312527|FG003|Overall Study|Physician Decision|6|||
126278885|NCT00805467|454312524|FG000|Overall Study|Not reported|0|||
126278886|NCT00805467|454312525|FG001|Overall Study|Not reported|0|||
126278887|NCT00805467|454312526|FG002|Overall Study|Not reported|3|||
126278888|NCT00805467|454312527|FG003|Overall Study|Not reported|7|||
126278889|NCT00213135|454312528|FG000|Overall Study|Adverse Event|9|||
126278890|NCT00213135|454312529|FG001|Overall Study|Adverse Event|5|||
126278891|NCT00213135|454312530|FG002|Overall Study|Adverse Event|5|||
126278892|NCT00213135|454312528|FG000|Overall Study|Lost to Follow-up|11|||
126278893|NCT00213135|454312529|FG001|Overall Study|Lost to Follow-up|8|||
126278894|NCT00213135|454312530|FG002|Overall Study|Lost to Follow-up|4|||
126278895|NCT00213135|454312528|FG000|Overall Study|Protocol Violation|4|||
126278896|NCT00213135|454312529|FG001|Overall Study|Protocol Violation|4|||
126278897|NCT00213135|454312530|FG002|Overall Study|Protocol Violation|10|||
126278898|NCT00213135|454312528|FG000|Overall Study|Death|1|||
126278899|NCT00213135|454312529|FG001|Overall Study|Death|1|||
126278900|NCT00213135|454312530|FG002|Overall Study|Death|2|||
126278901|NCT00213135|454312528|FG000|Overall Study|Disease progression|4|||
126278902|NCT00213135|454312529|FG001|Overall Study|Disease progression|5|||
126278903|NCT00213135|454312530|FG002|Overall Study|Disease progression|21|||
126278904|NCT00213135|454312528|FG000|Overall Study|Other|21|||
126278905|NCT00213135|454312529|FG001|Overall Study|Other|12|||
126278906|NCT00213135|454312530|FG002|Overall Study|Other|15|||
126278907|NCT02618759|454312539|FG000|Overall Study|Lost to Follow-up|0|||
126278908|NCT02618759|454312540|FG001|Overall Study|Lost to Follow-up|1|||
126278909|NCT02618759|454312539|FG000|Overall Study|Withdrawal by Subject|1|||
126278910|NCT02618759|454312540|FG001|Overall Study|Withdrawal by Subject|0|||
126278911|NCT02618759|454312539|FG000|Overall Study|Other Reasons|1|||
126278912|NCT02618759|454312540|FG001|Overall Study|Other Reasons|4|||
126278913|NCT02856555|454312543|FG000|Overall Study|Adverse Event|1|||
126278914|NCT02856555|454312544|FG001|Overall Study|Adverse Event|0|||
126278915|NCT02856555|454312545|FG002|Overall Study|Adverse Event|0|||
126278916|NCT02856555|454312543|FG000|Overall Study|Lost to Follow-up|1|||
126278917|NCT02856555|454312544|FG001|Overall Study|Lost to Follow-up|3|||
126278918|NCT02856555|454312545|FG002|Overall Study|Lost to Follow-up|0|||
126278919|NCT02856555|454312543|FG000|Overall Study|Withdrawal by Subject|3|||
126278920|NCT02856555|454312544|FG001|Overall Study|Withdrawal by Subject|0|||
126278921|NCT02856555|454312545|FG002|Overall Study|Withdrawal by Subject|0|||
126278922|NCT02856555|454312543|FG000|Overall Study|Randomized but Never Treated|0|||
126278923|NCT02856555|454312544|FG001|Overall Study|Randomized but Never Treated|1|||
126278924|NCT02856555|454312545|FG002|Overall Study|Randomized but Never Treated|0|||
126278925|NCT01724489|454312546|FG000|Overall Study|Adverse Event|8|||
126278926|NCT01724489|454312547|FG001|Overall Study|Adverse Event|3|||
126278927|NCT01724489|454312546|FG000|Overall Study|Surgery, medication|1|||
126278928|NCT01724489|454312547|FG001|Overall Study|Surgery, medication|1|||
126278929|NCT01724489|454312546|FG000|Overall Study|Lost to Follow-up|1|||
126278930|NCT01724489|454312547|FG001|Overall Study|Lost to Follow-up|2|||
126278931|NCT01724489|454312546|FG000|Overall Study|Withdrawal by Subject|6|||
126278932|NCT01724489|454312547|FG001|Overall Study|Withdrawal by Subject|6|||
126278933|NCT04576923|454312548|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
126278934|NCT00923273|454312551|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
126278935|NCT00923273|454312552|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
126278936|NCT00923273|454312553|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
126278937|NCT00923273|454312554|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
126278938|NCT00923273|454312555|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
126363662|NCT03574389|454624882|FG003|Vaccination Period|Adverse Event|0|||
126363663|NCT03574389|454624883|FG004|Vaccination Period|Adverse Event|0|||
126363664|NCT03574389|454624884|FG005|Vaccination Period|Adverse Event|0|||
126765920|NCT01353586|456095831|FG000|Overall Study|Neurological exam not done|0|||
126278939|NCT00923273|454312551|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
126278940|NCT00923273|454312552|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
126278941|NCT00923273|454312553|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
126278942|NCT00923273|454312554|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
126363665|NCT03574389|454624885|FG006|Vaccination Period|Adverse Event|0|||
126278943|NCT00923273|454312555|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
126278944|NCT00605540|454312556|FG000|Overall Study|Death|15|||
126363666|NCT03574389|454624879|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
126363667|NCT03574389|454624880|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
126278945|NCT00605540|454312556|FG000|Overall Study|Lost to Follow-up|23|||
126278946|NCT01473524|454312559|FG000|DB Phase|Adverse Event|4|||
126278947|NCT01473524|454312560|FG001|DB Phase|Adverse Event|8|||
126278948|NCT01473524|454312561|FG002|DB Phase|Adverse Event|2|||
126278949|NCT01473524|454312562|FG003|DB Phase|Adverse Event|0|||
126278950|NCT01473524|454312563|FG004|DB Phase|Adverse Event|0|||
126548549|NCT00779584|455302179|FG000|Overall Study|Progression of Disease|0|||
126548550|NCT00779584|455302180|FG001|Overall Study|Progression of Disease|1|||
126548551|NCT00779584|455302181|FG002|Overall Study|Progression of Disease|2|||
126548552|NCT00779584|455302182|FG003|Overall Study|Progression of Disease|6|||
126548553|NCT00779584|455302183|FG004|Overall Study|Progression of Disease|5|||
126548554|NCT00779584|455302184|FG005|Overall Study|Progression of Disease|1|||
126548555|NCT00779584|455302185|FG006|Overall Study|Progression of Disease|4|||
126548556|NCT00779584|455302186|FG007|Overall Study|Progression of Disease|2|||
126548557|NCT00779584|455302187|FG008|Overall Study|Progression of Disease|1|||
126548558|NCT00779584|455302179|FG000|Overall Study|Adverse Event|1|||
126548559|NCT00779584|455302180|FG001|Overall Study|Adverse Event|0|||
126548560|NCT00779584|455302181|FG002|Overall Study|Adverse Event|2|||
126548561|NCT00779584|455302182|FG003|Overall Study|Adverse Event|0|||
126548562|NCT00779584|455302183|FG004|Overall Study|Adverse Event|0|||
126548563|NCT00779584|455302184|FG005|Overall Study|Adverse Event|0|||
126548564|NCT00779584|455302185|FG006|Overall Study|Adverse Event|2|||
126278951|NCT01473524|454312564|FG005|DB Phase|Adverse Event|0|||
126278952|NCT01473524|454312559|FG000|DB Phase|Death|1|||
126278953|NCT01473524|454312560|FG001|DB Phase|Death|0|||
126278954|NCT01473524|454312561|FG002|DB Phase|Death|0|||
126278955|NCT01473524|454312562|FG003|DB Phase|Death|0|||
126278956|NCT01473524|454312563|FG004|DB Phase|Death|0|||
126278957|NCT01473524|454312564|FG005|DB Phase|Death|0|||
126278958|NCT01473524|454312559|FG000|DB Phase|Withdrawal by Subject|2|||
126278959|NCT01473524|454312560|FG001|DB Phase|Withdrawal by Subject|1|||
126278960|NCT01473524|454312561|FG002|DB Phase|Withdrawal by Subject|1|||
126278961|NCT01473524|454312562|FG003|DB Phase|Withdrawal by Subject|0|||
126278962|NCT01473524|454312563|FG004|DB Phase|Withdrawal by Subject|0|||
126278963|NCT01473524|454312564|FG005|DB Phase|Withdrawal by Subject|0|||
126707775|NCT01480180|455882773|FG001|Extension Phase, Part 2|Unclassified|0|||
126707776|NCT01480180|455882774|FG002|Extension Phase, Part 2|Unclassified|3|||
126707777|NCT01480180|455882775|FG003|Extension Phase, Part 2|Unclassified|1|||
126707778|NCT01480180|455882776|FG004|Extension Phase, Part 2|Unclassified|1|||
126707779|NCT01480180|455882777|FG005|Extension Phase, Part 2|Unclassified|0|||
126707780|NCT00184054|455882779|FG000|Overall Study|Adverse Event|1|||
126707781|NCT04925570|455882780|FG000|Overall Study|Protocol Violation|24|||
126707782|NCT04925570|455882781|FG001|Overall Study|Protocol Violation|30|||
126707783|NCT04925570|455882780|FG000|Overall Study|Withdrawal by Subject|0|||
126707784|NCT04925570|455882781|FG001|Overall Study|Withdrawal by Subject|2|||
126707785|NCT00828451|455882782|FG000|Overall Study|Death|2|||
126707786|NCT00828451|455882782|FG000|Overall Study|Lack of intravenous line|7|||
126707787|NCT00828451|455882782|FG000|Overall Study|Withdrawal by Subject|1|||
126707788|NCT00828451|455882782|FG000|Overall Study|Deterioration in clinical status|1|||
126707789|NCT00519532|455882786|FG000|Overall Study|Adverse Event|11|||
126707790|NCT00519532|455882786|FG000|Overall Study|Withdrawal by Subject|5|||
126707791|NCT00519532|455882786|FG000|Overall Study|Lost to Follow-up|2|||
126707792|NCT00667277|455882787|FG000|Overall Study|Withdrawal by Subject|2|||
126707793|NCT03138564|455882790|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
126707794|NCT03138564|455882791|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
126707795|NCT03138564|455882790|FG000|Overall Study|Lost to Follow-up|16|||
126707796|NCT03138564|455882791|FG001|Overall Study|Lost to Follow-up|2|||
126707797|NCT03138564|455882790|FG000|Overall Study|Withdrawal by Subject|48|||
126707798|NCT03138564|455882791|FG001|Overall Study|Withdrawal by Subject|4|||
126707799|NCT03138564|455882790|FG000|Overall Study|No longer met eligibility criteria|2|||
126707800|NCT03138564|455882791|FG001|Overall Study|No longer met eligibility criteria|0|||
126707801|NCT03138564|455882790|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
126707802|NCT03138564|455882791|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
126707803|NCT03138564|455882790|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
126707804|NCT03138564|455882791|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
126707805|NCT03138564|455882790|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
126707806|NCT03138564|455882791|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
126278964|NCT01473524|454312559|FG000|LTSE Phase|Withdrawal by Subject|0|||
126278965|NCT01473524|454312560|FG001|LTSE Phase|Withdrawal by Subject|0|||
126278966|NCT01473524|454312561|FG002|LTSE Phase|Withdrawal by Subject|0|||
126548565|NCT00779584|455302186|FG007|Overall Study|Adverse Event|1|||
126548566|NCT00779584|455302187|FG008|Overall Study|Adverse Event|1|||
126548567|NCT00779584|455302179|FG000|Overall Study|Symptomatic Deterioration|1|||
126707807|NCT03138564|455882790|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
126278967|NCT01473524|454312562|FG003|LTSE Phase|Withdrawal by Subject|3|||
126278968|NCT01473524|454312563|FG004|LTSE Phase|Withdrawal by Subject|3|||
126278969|NCT01473524|454312564|FG005|LTSE Phase|Withdrawal by Subject|6|||
126278970|NCT01473524|454312559|FG000|LTSE Phase|Death|0|||
126278971|NCT01473524|454312560|FG001|LTSE Phase|Death|0|||
126278972|NCT01473524|454312561|FG002|LTSE Phase|Death|0|||
126707808|NCT03138564|455882791|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
126707809|NCT00814710|455882792|FG000|Overall Study|Adverse Event|1|||
126707810|NCT00814710|455882793|FG001|Overall Study|Adverse Event|0|||
126707811|NCT00814710|455882792|FG000|Overall Study|Lost to Follow-up|7|||
126707812|NCT00814710|455882793|FG001|Overall Study|Lost to Follow-up|3|||
126707813|NCT00624338|455882801|FG000|Overall Study|Adverse Event|14|||
126707814|NCT00624338|455882802|FG001|Overall Study|Adverse Event|14|||
126707815|NCT00624338|455882803|FG002|Overall Study|Adverse Event|18|||
126707816|NCT00624338|455882801|FG000|Overall Study|Lost to Follow-up|1|||
126707817|NCT00624338|455882802|FG001|Overall Study|Lost to Follow-up|0|||
126707818|NCT00624338|455882803|FG002|Overall Study|Lost to Follow-up|0|||
126707819|NCT00624338|455882801|FG000|Overall Study|Lack of Efficacy|11|||
126707820|NCT00624338|455882802|FG001|Overall Study|Lack of Efficacy|3|||
126707821|NCT00624338|455882803|FG002|Overall Study|Lack of Efficacy|14|||
126707822|NCT00624338|455882801|FG000|Overall Study|Protocol Violation|3|||
126707823|NCT00624338|455882802|FG001|Overall Study|Protocol Violation|3|||
126707824|NCT00624338|455882803|FG002|Overall Study|Protocol Violation|2|||
126707825|NCT00624338|455882801|FG000|Overall Study|Death|0|||
126707826|NCT00624338|455882802|FG001|Overall Study|Death|2|||
126707827|NCT00624338|455882803|FG002|Overall Study|Death|0|||
126707828|NCT00624338|455882801|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
126707829|NCT00624338|455882802|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
126707830|NCT00624338|455882803|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
126707831|NCT00624338|455882801|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
126707832|NCT00624338|455882802|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
126707833|NCT00624338|455882803|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
126707834|NCT00624338|455882801|FG000|Overall Study|Other|15|||
126707835|NCT00624338|455882802|FG001|Overall Study|Other|5|||
126707836|NCT00624338|455882803|FG002|Overall Study|Other|9|||
126707837|NCT00624338|455882801|FG000|Overall Study|Randomized but not treated|2|||
126707838|NCT00624338|455882802|FG001|Overall Study|Randomized but not treated|1|||
126707839|NCT00624338|455882803|FG002|Overall Study|Randomized but not treated|3|||
126707840|NCT01548638|455882804|FG000|Overall Study|Protocol Violation|3|||
126707841|NCT01548638|455882804|FG000|Overall Study|Withdrawal by Subject|1|||
126707842|NCT05593432|455882805|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
126707843|NCT05593432|455882806|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
126707844|NCT05593432|455882807|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
126707845|NCT05593432|455882808|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
126707846|NCT05593432|455882805|FG000|16-Week OLE Period|Lack of Efficacy|0|||
126707847|NCT05593432|455882806|FG001|16-Week OLE Period|Lack of Efficacy|0|||
126707848|NCT05593432|455882807|FG002|16-Week OLE Period|Lack of Efficacy|0|||
126707849|NCT05593432|455882808|FG003|16-Week OLE Period|Lack of Efficacy|1|||
126707850|NCT05593432|455882805|FG000|16-Week OLE Period|Lost to Follow-up|0|||
126707851|NCT05593432|455882806|FG001|16-Week OLE Period|Lost to Follow-up|0|||
126707852|NCT05593432|455882807|FG002|16-Week OLE Period|Lost to Follow-up|1|||
126363668|NCT03574389|454624881|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
126707853|NCT05593432|455882808|FG003|16-Week OLE Period|Lost to Follow-up|2|||
126707854|NCT05593432|455882805|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
126707855|NCT05593432|455882806|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
126707856|NCT05593432|455882807|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
126707857|NCT05593432|455882808|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
126707858|NCT01591330|455882811|FG000|Period 1|Adverse Event|1|||
126707859|NCT01591330|455882812|FG001|Period 1|Adverse Event|0|||
126707860|NCT01591330|455882813|FG002|Period 1|Adverse Event|0|||
126707861|NCT01591330|455882814|FG003|Period 1|Adverse Event|0|||
126707862|NCT01591330|455882811|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
126707863|NCT01591330|455882812|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
126707864|NCT01591330|455882813|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
126707865|NCT01591330|455882814|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
126707866|NCT01591330|455882811|FG000|Period 2|Adverse Event|1|||
126707867|NCT01591330|455882812|FG001|Period 2|Adverse Event|0|||
126455449|NCT00895011|454968937|FG000|Overall Study|schedule conflict|1|||
126707868|NCT01591330|455882813|FG002|Period 2|Adverse Event|0|||
126707869|NCT01591330|455882814|FG003|Period 2|Adverse Event|0|||
126707870|NCT01450137|455882818|FG000|Up to Week 12|Adverse Event|2|||
126707871|NCT01450137|455882819|FG001|Up to Week 12|Adverse Event|1|||
126707872|NCT01450137|455882818|FG000|Up to Week 12|Withdrawal by Subject|0|||
126707873|NCT01450137|455882819|FG001|Up to Week 12|Withdrawal by Subject|2|||
126707874|NCT01450137|455882818|FG000|Week 12 to Study End|Death|0|||
126707875|NCT01450137|455882819|FG001|Week 12 to Study End|Death|1|||
126707876|NCT01450137|455882818|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
126707877|NCT01450137|455882819|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
126707878|NCT02609399|455882821|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
126707879|NCT02609399|455882822|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
126707880|NCT02609399|455882821|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
126707881|NCT02609399|455882822|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
126707882|NCT02609399|455882821|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
126278973|NCT01473524|454312562|FG003|LTSE Phase|Death|0|||
126278974|NCT01473524|454312563|FG004|LTSE Phase|Death|1|||
126278975|NCT01473524|454312564|FG005|LTSE Phase|Death|0|||
126278976|NCT01473524|454312559|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
126278977|NCT01473524|454312560|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
126278978|NCT01473524|454312561|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
126278979|NCT01473524|454312562|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
126278980|NCT01473524|454312563|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
126278981|NCT01473524|454312564|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
126278982|NCT01473524|454312559|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
126278983|NCT01473524|454312560|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
126278984|NCT01473524|454312561|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
126278985|NCT01473524|454312562|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
126278986|NCT01473524|454312563|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
126278987|NCT01473524|454312564|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
126278988|NCT01473524|454312559|FG000|LTSE Phase|Lost to Follow-up|0|||
126278989|NCT01473524|454312560|FG001|LTSE Phase|Lost to Follow-up|0|||
126278990|NCT01473524|454312561|FG002|LTSE Phase|Lost to Follow-up|0|||
126278991|NCT01473524|454312562|FG003|LTSE Phase|Lost to Follow-up|1|||
126278992|NCT01473524|454312563|FG004|LTSE Phase|Lost to Follow-up|3|||
126278993|NCT01473524|454312564|FG005|LTSE Phase|Lost to Follow-up|2|||
126278994|NCT01473524|454312559|FG000|LTSE Phase|Principal Investigator Decision|0|||
126278995|NCT01473524|454312560|FG001|LTSE Phase|Principal Investigator Decision|0|||
126278996|NCT01473524|454312561|FG002|LTSE Phase|Principal Investigator Decision|0|||
126278997|NCT01473524|454312562|FG003|LTSE Phase|Principal Investigator Decision|1|||
126278998|NCT01473524|454312563|FG004|LTSE Phase|Principal Investigator Decision|1|||
126278999|NCT01473524|454312564|FG005|LTSE Phase|Principal Investigator Decision|3|||
126279000|NCT01473524|454312559|FG000|LTSE Phase|Liver Transplantation|0|||
126279001|NCT01473524|454312560|FG001|LTSE Phase|Liver Transplantation|0|||
126279002|NCT01473524|454312561|FG002|LTSE Phase|Liver Transplantation|0|||
126279003|NCT01473524|454312562|FG003|LTSE Phase|Liver Transplantation|0|||
126279004|NCT01473524|454312563|FG004|LTSE Phase|Liver Transplantation|0|||
126279005|NCT01473524|454312564|FG005|LTSE Phase|Liver Transplantation|1|||
126279006|NCT01473524|454312559|FG000|LTSE Phase|Pregnancy|0|||
126279007|NCT01473524|454312560|FG001|LTSE Phase|Pregnancy|0|||
126279008|NCT01473524|454312561|FG002|LTSE Phase|Pregnancy|0|||
126279009|NCT01473524|454312562|FG003|LTSE Phase|Pregnancy|1|||
126279010|NCT01473524|454312563|FG004|LTSE Phase|Pregnancy|0|||
126279011|NCT01473524|454312564|FG005|LTSE Phase|Pregnancy|0|||
126279012|NCT01473524|454312559|FG000|LTSE Phase|Protocol Violation|0|||
126279013|NCT01473524|454312560|FG001|LTSE Phase|Protocol Violation|0|||
126279014|NCT01473524|454312561|FG002|LTSE Phase|Protocol Violation|0|||
126279015|NCT01473524|454312562|FG003|LTSE Phase|Protocol Violation|0|||
126279016|NCT01473524|454312563|FG004|LTSE Phase|Protocol Violation|0|||
126279017|NCT01473524|454312564|FG005|LTSE Phase|Protocol Violation|1|||
126279018|NCT01544179|454312565|FG000|Overall Study|Death|50|||
126279019|NCT01544179|454312566|FG001|Overall Study|Death|37|||
126279020|NCT01544179|454312565|FG000|Overall Study|Lost to Follow-up|0|||
126279021|NCT01544179|454312566|FG001|Overall Study|Lost to Follow-up|1|||
126279022|NCT01544179|454312565|FG000|Overall Study|Adverse Event|0|||
126279023|NCT01544179|454312566|FG001|Overall Study|Adverse Event|1|||
126279024|NCT01544179|454312565|FG000|Overall Study|Withdrawal by Subject|12|||
126279025|NCT01544179|454312566|FG001|Overall Study|Withdrawal by Subject|7|||
126279026|NCT01544179|454312565|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
126279027|NCT01544179|454312566|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126279028|NCT00282919|454312567|FG000|Overall Study|Lack of Efficacy|4|||
126279029|NCT00282919|454312567|FG000|Overall Study|Withdrawal by Subject|1|||
126279030|NCT00282919|454312567|FG000|Overall Study|Asymptomatic Parasitemia|2|||
126279031|NCT01438996|454312570|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
126279032|NCT01438996|454312571|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
126548568|NCT00779584|455302180|FG001|Overall Study|Symptomatic Deterioration|1|||
126548569|NCT00779584|455302181|FG002|Overall Study|Symptomatic Deterioration|1|||
126279033|NCT01438996|454312572|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
126279034|NCT02540850|454312573|FG000|Overall Study|Lost to Follow-up|69|||
126279035|NCT02540850|454312574|FG001|Overall Study|Lost to Follow-up|66|||
126363669|NCT03574389|454624882|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
126548570|NCT00779584|455302182|FG003|Overall Study|Symptomatic Deterioration|0|||
126548571|NCT00779584|455302183|FG004|Overall Study|Symptomatic Deterioration|0|||
126279036|NCT02540850|454312575|FG002|Overall Study|Lost to Follow-up|34|||
126279037|NCT02861014|454312576|FG000|Primary Analysis|Adverse Event|7|||
126279038|NCT02861014|454312576|FG000|Primary Analysis|Death|1|||
126279039|NCT02861014|454312576|FG000|Primary Analysis|Lack of Efficacy|3|||
126279040|NCT02861014|454312576|FG000|Primary Analysis|Physician Decision|2|||
126279041|NCT02861014|454312576|FG000|Primary Analysis|Pregnancy|4|||
126279042|NCT02861014|454312576|FG000|Primary Analysis|Protocol Violation|2|||
126363670|NCT03574389|454624883|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
126279043|NCT02861014|454312576|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
126707883|NCT02609399|455882822|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
126707884|NCT04800315|455882826|FG000|Randomization|Did not receive study treatment|1|||
126707885|NCT04800315|455882827|FG001|Randomization|Did not receive study treatment|0|||
126707886|NCT04800315|455882828|FG002|Randomization|Did not receive study treatment|0|||
126279044|NCT02861014|454312576|FG000|Primary Analysis|Withdrawal by Subject|14|||
126279045|NCT02861014|454312576|FG000|Primary Analysis|Commercial ocrelizumab|3|||
126279046|NCT02861014|454312576|FG000|Safety Follow-up|Adverse Event|1|||
126279047|NCT02861014|454312576|FG000|Safety Follow-up|Pregnancy|1|||
126279048|NCT02861014|454312576|FG000|Safety Follow-up|Withdrawal by Subject|9|||
126279049|NCT02861014|454312576|FG000|Safety Follow-up|Study terminated by sponsor|1|||
126279050|NCT02861014|454312576|FG000|Safety Follow-up|Physician Decision|1|||
126279051|NCT02861014|454312576|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
126279052|NCT02861014|454312576|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
126279053|NCT01756079|454312582|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
126279054|NCT01756079|454312582|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
126279055|NCT01756079|454312582|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
126279056|NCT01756079|454312582|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
126279057|NCT01756079|454312582|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
126279058|NCT03201445|454312583|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
126279059|NCT03201445|454312584|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
126279060|NCT03201445|454312583|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
126279061|NCT03201445|454312584|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
126279062|NCT03201445|454312583|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
126279063|NCT03201445|454312584|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
126279064|NCT03201445|454312583|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
126279065|NCT03201445|454312584|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
126279066|NCT03201445|454312583|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
126279067|NCT03201445|454312584|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
126279068|NCT03201445|454312583|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
126279069|NCT03201445|454312584|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
126279070|NCT03201445|454312583|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
126279071|NCT03201445|454312584|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
126279072|NCT03201445|454312583|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
126279073|NCT03201445|454312584|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
126279074|NCT03201445|454312583|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
126279075|NCT03201445|454312584|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
126279076|NCT03201445|454312583|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
126279077|NCT03201445|454312584|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
126279078|NCT03201445|454312583|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
126279079|NCT03201445|454312584|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
126279080|NCT03201445|454312583|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
126279081|NCT03201445|454312584|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
126279082|NCT03201445|454312583|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
126279083|NCT03201445|454312584|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
126279084|NCT03201445|454312583|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
126279085|NCT03201445|454312584|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
126279086|NCT03201445|454312583|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
126279087|NCT03201445|454312584|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
126279088|NCT03201445|454312583|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
126279089|NCT03201445|454312584|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
126279090|NCT03201445|454312583|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
126279091|NCT03201445|454312584|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
126279092|NCT03201445|454312583|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
126279093|NCT03201445|454312584|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
126279094|NCT03201445|454312583|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
126279095|NCT03201445|454312584|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
126279096|NCT03201445|454312583|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
126279097|NCT03201445|454312584|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
126279098|NCT03201445|454312583|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
126707887|NCT04800315|455882829|FG003|Randomization|Did not receive study treatment|0|||
126707888|NCT04800315|455882826|FG000|Treatment Period|Adverse Event|4|||
126707889|NCT04800315|455882827|FG001|Treatment Period|Adverse Event|2|||
126279099|NCT03201445|454312584|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
126279100|NCT02087189|454312585|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
126279101|NCT01189487|454312590|FG000|Overall Study|Lack of Efficacy|2|||
126363671|NCT03574389|454624884|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
126279102|NCT01189487|454312590|FG000|Overall Study|Adverse Event|1|||
126279103|NCT04630158|454312591|FG000|Overall Study|Adverse Event|1|||
126279104|NCT04630158|454312592|FG001|Overall Study|Adverse Event|1|||
126279105|NCT04630158|454312593|FG002|Overall Study|Adverse Event|1|||
126279106|NCT04630158|454312591|FG000|Overall Study|Physician Decision|0|||
126279107|NCT04630158|454312592|FG001|Overall Study|Physician Decision|2|||
126279108|NCT04630158|454312593|FG002|Overall Study|Physician Decision|0|||
126279109|NCT04630158|454312591|FG000|Overall Study|Protocol Violation|1|||
126279110|NCT04630158|454312592|FG001|Overall Study|Protocol Violation|0|||
126279111|NCT04630158|454312593|FG002|Overall Study|Protocol Violation|1|||
126279112|NCT04630158|454312591|FG000|Overall Study|Withdrawal by Subject|2|||
126279113|NCT04630158|454312592|FG001|Overall Study|Withdrawal by Subject|1|||
126279114|NCT04630158|454312593|FG002|Overall Study|Withdrawal by Subject|2|||
126279115|NCT03136965|454312596|FG000|Overall Study|Lost to Follow-up|0|||
126548572|NCT00779584|455302184|FG005|Overall Study|Symptomatic Deterioration|1|||
126548573|NCT00779584|455302185|FG006|Overall Study|Symptomatic Deterioration|1|||
126548574|NCT00779584|455302186|FG007|Overall Study|Symptomatic Deterioration|0|||
126548575|NCT00779584|455302187|FG008|Overall Study|Symptomatic Deterioration|0|||
126548576|NCT00779584|455302179|FG000|Overall Study|Ongoing in Study|0|||
126548577|NCT00779584|455302180|FG001|Overall Study|Ongoing in Study|0|||
126548578|NCT00779584|455302181|FG002|Overall Study|Ongoing in Study|0|||
126548579|NCT00779584|455302182|FG003|Overall Study|Ongoing in Study|0|||
126548580|NCT00779584|455302183|FG004|Overall Study|Ongoing in Study|1|||
126548581|NCT00779584|455302184|FG005|Overall Study|Ongoing in Study|1|||
126548582|NCT00779584|455302185|FG006|Overall Study|Ongoing in Study|0|||
126548583|NCT00779584|455302186|FG007|Overall Study|Ongoing in Study|0|||
126548584|NCT00779584|455302187|FG008|Overall Study|Ongoing in Study|0|||
126548585|NCT02878213|455302188|FG000|Overall Study|Withdrawal by Subject|2|||
126548586|NCT02878213|455302188|FG000|Overall Study|Adverse Event|1|||
126548587|NCT02302066|455302204|FG000|Overall Study|Adverse Event|1|||
126548588|NCT02302066|455302205|FG001|Overall Study|Adverse Event|1|||
126548589|NCT02302066|455302206|FG002|Overall Study|Adverse Event|3|||
126548590|NCT02302066|455302207|FG003|Overall Study|Adverse Event|0|||
126548591|NCT02302066|455302204|FG000|Overall Study|Lost to Follow-up|4|||
126548592|NCT02302066|455302205|FG001|Overall Study|Lost to Follow-up|5|||
126548593|NCT02302066|455302206|FG002|Overall Study|Lost to Follow-up|24|||
126548594|NCT02302066|455302207|FG003|Overall Study|Lost to Follow-up|7|||
126548595|NCT02302066|455302204|FG000|Overall Study|Withdrawal by Subject|25|||
126548596|NCT02302066|455302205|FG001|Overall Study|Withdrawal by Subject|58|||
126548597|NCT02302066|455302206|FG002|Overall Study|Withdrawal by Subject|124|||
126548598|NCT02302066|455302207|FG003|Overall Study|Withdrawal by Subject|33|||
126548599|NCT02302066|455302204|FG000|Overall Study|Pregnancy|2|||
126548600|NCT02302066|455302205|FG001|Overall Study|Pregnancy|10|||
126548601|NCT02302066|455302206|FG002|Overall Study|Pregnancy|12|||
126548602|NCT02302066|455302207|FG003|Overall Study|Pregnancy|0|||
126548603|NCT02302066|455302204|FG000|Overall Study|Reason Not Specified|1|||
126548604|NCT02302066|455302205|FG001|Overall Study|Reason Not Specified|1|||
126548605|NCT02302066|455302206|FG002|Overall Study|Reason Not Specified|9|||
126548606|NCT02302066|455302207|FG003|Overall Study|Reason Not Specified|1|||
126548607|NCT02301156|455302208|FG000|Overall Study|Adverse Event|13|||
126548608|NCT02301156|455302209|FG001|Overall Study|Adverse Event|14|||
126548609|NCT02301156|455302208|FG000|Overall Study|Death|1|||
126548610|NCT02301156|455302209|FG001|Overall Study|Death|5|||
126548611|NCT02301156|455302208|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
126548612|NCT02301156|455302209|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
126548613|NCT02301156|455302208|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
126548614|NCT02301156|455302209|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
126548615|NCT02301156|455302208|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
126548616|NCT02301156|455302209|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
126548617|NCT02301156|455302208|FG000|Overall Study|Reason not Specified|6|||
126548618|NCT02301156|455302209|FG001|Overall Study|Reason not Specified|3|||
126548619|NCT00105586|455302210|FG000|Overall Study|Adverse Event|4|||
126548620|NCT00105586|455302211|FG001|Overall Study|Adverse Event|3|||
126548621|NCT00105586|455302210|FG000|Overall Study|Physician Decision|13|||
126548622|NCT00105586|455302211|FG001|Overall Study|Physician Decision|13|||
126548623|NCT02306122|455302212|FG000|Initial Physician Randomization|Physician Decision|0|||
126548624|NCT02306122|455302213|FG001|Initial Physician Randomization|Physician Decision|0|||
126279116|NCT03136965|454312597|FG001|Overall Study|Lost to Follow-up|1|||
126279117|NCT03136965|454312598|FG002|Overall Study|Lost to Follow-up|0|||
126279118|NCT03496610|454312599|FG000|Overall Study|Lost to Follow-up|3|||
126279119|NCT03496610|454312600|FG001|Overall Study|Lost to Follow-up|2|||
126279120|NCT03496610|454312599|FG000|Overall Study|Physician Decision|1|||
126279121|NCT03496610|454312600|FG001|Overall Study|Physician Decision|0|||
126279122|NCT03496610|454312599|FG000|Overall Study|Withdrawal by Subject|1|||
126279123|NCT03496610|454312600|FG001|Overall Study|Withdrawal by Subject|0|||
126548625|NCT02306122|455302214|FG002|Initial Physician Randomization|Physician Decision|0|||
126707890|NCT04800315|455882828|FG002|Treatment Period|Adverse Event|1|||
126707891|NCT04800315|455882829|FG003|Treatment Period|Adverse Event|2|||
126707892|NCT04800315|455882826|FG000|Treatment Period|Lack of Efficacy|1|||
126279124|NCT04435184|454312601|FG000|Overall Study|follow-up blood draws missing|3|||
126279125|NCT04435184|454312602|FG001|Overall Study|follow-up blood draws missing|5|||
126279126|NCT02714426|454312603|FG000|Overall Study|Withdrawal by Subject|2|||
126279127|NCT02714426|454312604|FG001|Overall Study|Withdrawal by Subject|2|||
126279128|NCT01860677|454312608|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
126279129|NCT01860677|454312609|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
126279130|NCT04762277|454312610|FG000|Overall Study|Withdrawal by Subject|0|||
126279131|NCT04762277|454312611|FG001|Overall Study|Withdrawal by Subject|2|||
126279132|NCT04762277|454312610|FG000|Overall Study|Protocol Violation|0|||
126279133|NCT04762277|454312611|FG001|Overall Study|Protocol Violation|1|||
126279134|NCT04762277|454312610|FG000|Overall Study|Adverse Event|1|||
126279135|NCT04762277|454312611|FG001|Overall Study|Adverse Event|0|||
126279136|NCT00642278|454312612|FG000|Overall Study|Adverse Event|2|||
126279137|NCT00642278|454312613|FG001|Overall Study|Adverse Event|1|||
126279138|NCT00642278|454312614|FG002|Overall Study|Adverse Event|3|||
126279139|NCT00642278|454312615|FG003|Overall Study|Adverse Event|1|||
126279140|NCT00642278|454312616|FG004|Overall Study|Adverse Event|2|||
126279141|NCT00642278|454312617|FG005|Overall Study|Adverse Event|2|||
126279142|NCT00642278|454312618|FG006|Overall Study|Adverse Event|0|||
126279143|NCT00642278|454312612|FG000|Overall Study|Lack of Efficacy|0|||
126279144|NCT00642278|454312613|FG001|Overall Study|Lack of Efficacy|1|||
126279145|NCT00642278|454312614|FG002|Overall Study|Lack of Efficacy|0|||
126279146|NCT00642278|454312615|FG003|Overall Study|Lack of Efficacy|0|||
126279147|NCT00642278|454312616|FG004|Overall Study|Lack of Efficacy|0|||
126279148|NCT00642278|454312617|FG005|Overall Study|Lack of Efficacy|0|||
126279149|NCT00642278|454312618|FG006|Overall Study|Lack of Efficacy|0|||
126279150|NCT00642278|454312612|FG000|Overall Study|Lost to Follow-up|5|||
126279151|NCT00642278|454312613|FG001|Overall Study|Lost to Follow-up|1|||
126279152|NCT00642278|454312614|FG002|Overall Study|Lost to Follow-up|0|||
126279153|NCT00642278|454312615|FG003|Overall Study|Lost to Follow-up|1|||
126279154|NCT00642278|454312616|FG004|Overall Study|Lost to Follow-up|0|||
126279155|NCT00642278|454312617|FG005|Overall Study|Lost to Follow-up|1|||
126279156|NCT00642278|454312618|FG006|Overall Study|Lost to Follow-up|1|||
126279157|NCT00642278|454312612|FG000|Overall Study|Physician Decision|0|||
126279158|NCT00642278|454312613|FG001|Overall Study|Physician Decision|0|||
126279159|NCT00642278|454312614|FG002|Overall Study|Physician Decision|0|||
126279160|NCT00642278|454312615|FG003|Overall Study|Physician Decision|1|||
126279161|NCT00642278|454312616|FG004|Overall Study|Physician Decision|0|||
126279162|NCT00642278|454312617|FG005|Overall Study|Physician Decision|0|||
126279163|NCT00642278|454312618|FG006|Overall Study|Physician Decision|0|||
126279164|NCT00642278|454312612|FG000|Overall Study|Protocol Violation|0|||
126279165|NCT00642278|454312613|FG001|Overall Study|Protocol Violation|0|||
126279166|NCT00642278|454312614|FG002|Overall Study|Protocol Violation|1|||
126279167|NCT00642278|454312615|FG003|Overall Study|Protocol Violation|1|||
126279168|NCT00642278|454312616|FG004|Overall Study|Protocol Violation|0|||
126279169|NCT00642278|454312617|FG005|Overall Study|Protocol Violation|1|||
126279170|NCT00642278|454312618|FG006|Overall Study|Protocol Violation|2|||
126279171|NCT00642278|454312612|FG000|Overall Study|Withdrawal by Subject|1|||
126707893|NCT04800315|455882827|FG001|Treatment Period|Lack of Efficacy|0|||
126707894|NCT04800315|455882828|FG002|Treatment Period|Lack of Efficacy|0|||
126707895|NCT04800315|455882829|FG003|Treatment Period|Lack of Efficacy|3|||
126707896|NCT04800315|455882826|FG000|Treatment Period|Lost to Follow-up|0|||
126707897|NCT04800315|455882827|FG001|Treatment Period|Lost to Follow-up|1|||
126707898|NCT04800315|455882828|FG002|Treatment Period|Lost to Follow-up|2|||
126707899|NCT04800315|455882829|FG003|Treatment Period|Lost to Follow-up|2|||
126707900|NCT04800315|455882826|FG000|Treatment Period|Withdrawal by participant|0|||
126707901|NCT04800315|455882827|FG001|Treatment Period|Withdrawal by participant|0|||
126765921|NCT01353586|456095832|FG001|Overall Study|Neurological exam not done|1|||
126765922|NCT00978120|456095833|FG000|Overall Study|Death|0|||
126279172|NCT00642278|454312613|FG001|Overall Study|Withdrawal by Subject|1|||
126279173|NCT00642278|454312614|FG002|Overall Study|Withdrawal by Subject|1|||
126279174|NCT00642278|454312615|FG003|Overall Study|Withdrawal by Subject|3|||
126455450|NCT00895011|454968938|FG001|Overall Study|schedule conflict|0|||
126279175|NCT00642278|454312616|FG004|Overall Study|Withdrawal by Subject|6|||
126279176|NCT00642278|454312617|FG005|Overall Study|Withdrawal by Subject|2|||
126279177|NCT00642278|454312618|FG006|Overall Study|Withdrawal by Subject|2|||
126279178|NCT00642278|454312612|FG000|Overall Study|Noncompliance with study drug regimen|0|||
126279179|NCT00642278|454312613|FG001|Overall Study|Noncompliance with study drug regimen|0|||
126279180|NCT00642278|454312614|FG002|Overall Study|Noncompliance with study drug regimen|0|||
126455451|NCT00895011|454968939|FG002|Overall Study|schedule conflict|0|||
126455452|NCT02230527|454968941|FG000|Overall Study|Withdrawal by Subject|1|||
126707902|NCT04800315|455882828|FG002|Treatment Period|Withdrawal by participant|0|||
126765923|NCT00978120|456095834|FG001|Overall Study|Death|0|||
126765924|NCT00978120|456095835|FG002|Overall Study|Death|0|||
126279181|NCT00642278|454312615|FG003|Overall Study|Noncompliance with study drug regimen|1|||
126279182|NCT00642278|454312616|FG004|Overall Study|Noncompliance with study drug regimen|0|||
126765925|NCT00978120|456095836|FG003|Overall Study|Death|1|||
126279183|NCT00642278|454312617|FG005|Overall Study|Noncompliance with study drug regimen|0|||
126279184|NCT00642278|454312618|FG006|Overall Study|Noncompliance with study drug regimen|0|||
126279185|NCT00642278|454312612|FG000|Overall Study|Other|2|||
126279186|NCT00642278|454312613|FG001|Overall Study|Other|1|||
126279187|NCT00642278|454312614|FG002|Overall Study|Other|0|||
126279188|NCT00642278|454312615|FG003|Overall Study|Other|1|||
126279189|NCT00642278|454312616|FG004|Overall Study|Other|0|||
126279190|NCT00642278|454312617|FG005|Overall Study|Other|1|||
126279191|NCT00642278|454312618|FG006|Overall Study|Other|0|||
126279192|NCT00090363|454312619|FG000|Overall Study|Lost to Follow-up|1|||
126279193|NCT00090363|454312620|FG001|Overall Study|Lost to Follow-up|2|||
126279194|NCT00090363|454312621|FG002|Overall Study|Lost to Follow-up|1|||
126279195|NCT00090363|454312619|FG000|Overall Study|Withdrawal by Subject|7|||
126279196|NCT00090363|454312620|FG001|Overall Study|Withdrawal by Subject|7|||
126279197|NCT00090363|454312621|FG002|Overall Study|Withdrawal by Subject|6|||
126279198|NCT00090363|454312619|FG000|Overall Study|Study-specific discontinuation criteria|75|||
126279199|NCT00090363|454312620|FG001|Overall Study|Study-specific discontinuation criteria|74|||
126279200|NCT00090363|454312621|FG002|Overall Study|Study-specific discontinuation criteria|62|||
126279201|NCT00090363|454312619|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126279202|NCT00090363|454312620|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126279203|NCT00090363|454312621|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
126279204|NCT00090363|454312619|FG000|Overall Study|Consent expired|7|||
126279205|NCT00090363|454312620|FG001|Overall Study|Consent expired|10|||
126279206|NCT00090363|454312621|FG002|Overall Study|Consent expired|9|||
126279207|NCT00090363|454312619|FG000|Overall Study|Reasons not specified|2|||
126279208|NCT00090363|454312620|FG001|Overall Study|Reasons not specified|1|||
126279209|NCT00090363|454312621|FG002|Overall Study|Reasons not specified|1|||
126279210|NCT00090363|454312619|FG000|Overall Study|Continuing on study off treatment|14|||
126279211|NCT00090363|454312620|FG001|Overall Study|Continuing on study off treatment|13|||
126279212|NCT00090363|454312621|FG002|Overall Study|Continuing on study off treatment|16|||
126279213|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
126279214|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
126279215|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
126279216|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
126363672|NCT03574389|454624885|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
126363673|NCT01682603|454624886|FG000|Overall Study|Lost to Follow-up|3|||
126363674|NCT00993473|454624887|FG000|Overall Study|Adverse Event|0|||
126765926|NCT00978120|456095833|FG000|Overall Study|Lost to Follow-up|0|||
126765927|NCT00978120|456095834|FG001|Overall Study|Lost to Follow-up|0|||
126765928|NCT00978120|456095835|FG002|Overall Study|Lost to Follow-up|3|||
126765929|NCT00978120|456095836|FG003|Overall Study|Lost to Follow-up|0|||
126765930|NCT00978120|456095833|FG000|Overall Study|Withdrawal by Subject|2|||
126279217|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
126279218|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
126279219|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
126279220|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
126279221|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
126279222|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
126279223|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
126279224|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
126279225|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
126279226|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
126279227|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
126279228|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
126279229|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126279230|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126279231|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126279232|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126279233|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
126279234|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
126279235|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
126279236|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
126279237|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
126279238|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
126548626|NCT02306122|455302215|FG003|Initial Physician Randomization|Physician Decision|0|||
126548627|NCT02306122|455302216|FG004|Initial Physician Randomization|Physician Decision|0|||
126279239|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
126279240|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
126279241|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
126548628|NCT02306122|455302217|FG005|Initial Physician Randomization|Physician Decision|0|||
126765931|NCT00978120|456095834|FG001|Overall Study|Withdrawal by Subject|0|||
126548629|NCT02306122|455302218|FG006|Initial Physician Randomization|Physician Decision|0|||
126548630|NCT02306122|455302219|FG007|Initial Physician Randomization|Physician Decision|0|||
126548631|NCT02306122|455302220|FG008|Initial Physician Randomization|Physician Decision|1|||
126548632|NCT02306122|455302221|FG009|Initial Physician Randomization|Physician Decision|0|||
126548633|NCT02306122|455302222|FG010|Initial Physician Randomization|Physician Decision|0|||
126548634|NCT03734991|455302225|FG000|Overall Study|Adverse Event|4|||
126548635|NCT03734991|455302226|FG001|Overall Study|Adverse Event|0|||
126548636|NCT03734991|455302225|FG000|Overall Study|Lost to Follow-up|4|||
126548637|NCT03734991|455302226|FG001|Overall Study|Lost to Follow-up|0|||
126548638|NCT03734991|455302225|FG000|Overall Study|Physician Decision|0|||
126548639|NCT03734991|455302226|FG001|Overall Study|Physician Decision|1|||
126548640|NCT03734991|455302225|FG000|Overall Study|Pregnancy|1|||
126548641|NCT03734991|455302226|FG001|Overall Study|Pregnancy|0|||
126548642|NCT03734991|455302225|FG000|Overall Study|Withdrawal by Subject|6|||
126548643|NCT03734991|455302226|FG001|Overall Study|Withdrawal by Subject|3|||
126548644|NCT03734991|455302225|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
126548645|NCT03734991|455302226|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
126765932|NCT00978120|456095835|FG002|Overall Study|Withdrawal by Subject|0|||
126765933|NCT00978120|456095836|FG003|Overall Study|Withdrawal by Subject|0|||
126279242|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
126279243|NCT03713619|454312622|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
126279244|NCT03713619|454312623|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
126279245|NCT03713619|454312624|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
126279246|NCT03713619|454312625|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
126279247|NCT03713619|454312626|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
126279248|NCT03713619|454312622|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
126279249|NCT03713619|454312623|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
126279250|NCT03713619|454312624|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
126279251|NCT03713619|454312625|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
126279252|NCT03713619|454312626|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
126279253|NCT03713619|454312622|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
126279254|NCT03713619|454312623|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126279255|NCT03713619|454312624|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126279256|NCT03713619|454312625|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
126279257|NCT03713619|454312626|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126279258|NCT03713619|454312622|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
126279259|NCT03713619|454312623|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
126279260|NCT03713619|454312624|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
126279261|NCT03713619|454312625|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
126279262|NCT03713619|454312626|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
126279263|NCT03713619|454312622|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
126279264|NCT03713619|454312623|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
126279265|NCT03713619|454312624|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
126279266|NCT03713619|454312625|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
126279267|NCT03713619|454312626|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
126279268|NCT03713619|454312622|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
126279269|NCT03713619|454312623|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
126279270|NCT03713619|454312624|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
126279271|NCT03713619|454312625|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
126279272|NCT03713619|454312626|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
126279273|NCT03713619|454312622|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
126279274|NCT03713619|454312623|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
126548646|NCT03734991|455302225|FG000|Overall Study|Other|2|||
126765934|NCT00978120|456095833|FG000|Overall Study|Moved out of state|0|||
126765935|NCT00978120|456095834|FG001|Overall Study|Moved out of state|0|||
126765936|NCT00978120|456095835|FG002|Overall Study|Moved out of state|0|||
126765937|NCT00978120|456095836|FG003|Overall Study|Moved out of state|1|||
126279275|NCT03713619|454312624|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
126548647|NCT03734991|455302226|FG001|Overall Study|Other|2|||
126548648|NCT02638623|455302227|FG000|Overall Study|Surgery timing|5|||
126548649|NCT02638623|455302228|FG001|Overall Study|Surgery timing|6|||
126548650|NCT02638623|455302227|FG000|Overall Study|Not given intervention|2|||
126548651|NCT02638623|455302228|FG001|Overall Study|Not given intervention|0|||
126548652|NCT00886639|455302229|FG000|Overall Study|acute exacerbation|14|||
126548653|NCT00886639|455302229|FG000|Overall Study|non-compliance|2|||
126765938|NCT01068418|456095839|FG000|Overall Study|Physician Decision|12|||
126279276|NCT03713619|454312625|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
126279277|NCT03713619|454312626|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
126279278|NCT06281171|454312635|FG000|Timepoint 2|Lost to Follow-up|6|||
126279279|NCT06281171|454312636|FG001|Timepoint 2|Lost to Follow-up|4|||
126765939|NCT03155269|456095846|FG000|Overall Study|Withdrawal by Subject|4|||
126765940|NCT03155269|456095847|FG001|Overall Study|Withdrawal by Subject|5|||
126707903|NCT04800315|455882829|FG003|Treatment Period|Withdrawal by participant|4|||
126707904|NCT04800315|455882826|FG000|Treatment Period|Other Reasons|0|||
126707905|NCT04800315|455882827|FG001|Treatment Period|Other Reasons|2|||
126707906|NCT04800315|455882828|FG002|Treatment Period|Other Reasons|0|||
126707907|NCT04800315|455882829|FG003|Treatment Period|Other Reasons|1|||
126707908|NCT00753922|455882830|FG000|Overall Study|Lost to Follow-up|155|||
126707909|NCT00753922|455882831|FG001|Overall Study|Lost to Follow-up|24|||
126707910|NCT00753922|455882832|FG002|Overall Study|Lost to Follow-up|28|||
126707911|NCT00753922|455882833|FG003|Overall Study|Lost to Follow-up|5|||
126707912|NCT00753922|455882830|FG000|Overall Study|Withdrawal by Subject|9|||
126707913|NCT00753922|455882831|FG001|Overall Study|Withdrawal by Subject|11|||
126707914|NCT00753922|455882832|FG002|Overall Study|Withdrawal by Subject|4|||
126707915|NCT00753922|455882833|FG003|Overall Study|Withdrawal by Subject|2|||
126707916|NCT00753922|455882830|FG000|Overall Study|Patient Non-compliance|55|||
126707917|NCT00753922|455882831|FG001|Overall Study|Patient Non-compliance|22|||
126707918|NCT00753922|455882832|FG002|Overall Study|Patient Non-compliance|14|||
126707919|NCT00753922|455882833|FG003|Overall Study|Patient Non-compliance|11|||
126707920|NCT00753922|455882830|FG000|Overall Study|Patients Not Completing Visit|11|||
126707921|NCT00753922|455882831|FG001|Overall Study|Patients Not Completing Visit|0|||
126707922|NCT00753922|455882832|FG002|Overall Study|Patients Not Completing Visit|1|||
126707923|NCT00753922|455882833|FG003|Overall Study|Patients Not Completing Visit|0|||
126707924|NCT00753922|455882830|FG000|Overall Study|Death|2|||
126707925|NCT00753922|455882831|FG001|Overall Study|Death|23|||
126279280|NCT06281171|454312635|FG000|Timepoint 3|Lost to Follow-up|0|||
126279281|NCT06281171|454312636|FG001|Timepoint 3|Lost to Follow-up|5|||
126279282|NCT00205803|454312640|FG000|Infant Series|Lost to Follow-up|10|||
126279283|NCT00205803|454312641|FG001|Infant Series|Lost to Follow-up|4|||
126279284|NCT00205803|454312640|FG000|Infant Series|Withdrawal by Subject|2|||
126279285|NCT00205803|454312641|FG001|Infant Series|Withdrawal by Subject|5|||
126279286|NCT00205803|454312640|FG000|Infant Series|Physician Decision|3|||
126279287|NCT00205803|454312641|FG001|Infant Series|Physician Decision|1|||
126279288|NCT00205803|454312640|FG000|Infant Series|Protocol Violation|1|||
126279289|NCT00205803|454312641|FG001|Infant Series|Protocol Violation|0|||
126279290|NCT00205803|454312640|FG000|Infant Series|Lost Kaiser coverage|0|||
126279291|NCT00205803|454312641|FG001|Infant Series|Lost Kaiser coverage|1|||
126279292|NCT00205803|454312640|FG000|Infant Series|Non-compliant|1|||
126279293|NCT00205803|454312641|FG001|Infant Series|Non-compliant|0|||
126279294|NCT00205803|454312640|FG000|Infant Series|Sponsor request|1|||
126279295|NCT00205803|454312641|FG001|Infant Series|Sponsor request|0|||
126279296|NCT00205803|454312640|FG000|After Infant Series|Adverse Event|1|||
126279297|NCT00205803|454312641|FG001|After Infant Series|Adverse Event|1|||
126279298|NCT00205803|454312640|FG000|After Infant Series|Protocol Violation|1|||
126279299|NCT00205803|454312641|FG001|After Infant Series|Protocol Violation|1|||
126279300|NCT00205803|454312640|FG000|After Infant Series|Lost to Follow-up|2|||
126279301|NCT00205803|454312641|FG001|After Infant Series|Lost to Follow-up|1|||
126279302|NCT00205803|454312640|FG000|After Infant Series|Physician Decision|3|||
126279303|NCT00205803|454312641|FG001|After Infant Series|Physician Decision|2|||
126279304|NCT00205803|454312640|FG000|After Infant Series|Withdrawal by Subject|1|||
126279305|NCT00205803|454312641|FG001|After Infant Series|Withdrawal by Subject|4|||
126279306|NCT00205803|454312640|FG000|After Infant Series|Other|10|||
126279307|NCT00205803|454312641|FG001|After Infant Series|Other|4|||
126279308|NCT00205803|454312640|FG000|Toddler Dose|Lost to Follow-up|2|||
126279309|NCT00205803|454312641|FG001|Toddler Dose|Lost to Follow-up|3|||
126707926|NCT00753922|455882832|FG002|Overall Study|Death|2|||
126707927|NCT00753922|455882833|FG003|Overall Study|Death|1|||
126707928|NCT00753922|455882830|FG000|Overall Study|Discontinuation Due to Explantation|14|||
126279310|NCT01102374|454312650|FG000|Overall Study|Death|9|||
126279311|NCT01102374|454312651|FG001|Overall Study|Death|13|||
126707929|NCT00753922|455882831|FG001|Overall Study|Discontinuation Due to Explantation|14|||
126707930|NCT00753922|455882832|FG002|Overall Study|Discontinuation Due to Explantation|14|||
126765941|NCT03155269|456095846|FG000|Overall Study|Lost to Follow-up|1|||
126279312|NCT01102374|454312650|FG000|Overall Study|Lost to Follow-up|7|||
126279313|NCT01102374|454312651|FG001|Overall Study|Lost to Follow-up|6|||
126279314|NCT02071849|454312652|FG000|6-month Primary Endpoint|Did not receive device|4|||
126765942|NCT03155269|456095847|FG001|Overall Study|Lost to Follow-up|2|||
126279315|NCT02071849|454312652|FG000|6-month Primary Endpoint|Adverse Event|1|||
126279316|NCT02071849|454312652|FG000|2-year Extended Follow-up|Adverse Event|1|||
126363675|NCT00993473|454624888|FG001|Overall Study|Adverse Event|2|||
126279317|NCT04619992|454312653|FG000|Overall Study|Withdrawal by Subject|1|||
126279318|NCT04619992|454312654|FG001|Overall Study|Withdrawal by Subject|0|||
126279319|NCT00658021|454312655|FG000|28-Week Treatment Period|Adverse Event|3|||
126707931|NCT00753922|455882833|FG003|Overall Study|Discontinuation Due to Explantation|4|||
126707932|NCT01287117|455882842|FG000|Overall Study|Adverse Event|2|||
126707933|NCT01287117|455882843|FG001|Overall Study|Adverse Event|1|||
126707934|NCT01287117|455882844|FG002|Overall Study|Adverse Event|1|||
126707935|NCT01287117|455882845|FG003|Overall Study|Adverse Event|1|||
126707936|NCT01287117|455882842|FG000|Overall Study|Lost to Follow-up|1|||
126279320|NCT00658021|454312656|FG001|28-Week Treatment Period|Adverse Event|1|||
126279321|NCT00658021|454312657|FG002|28-Week Treatment Period|Adverse Event|0|||
126279322|NCT00658021|454312655|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
126279323|NCT00658021|454312656|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
126279324|NCT00658021|454312657|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
126279325|NCT00658021|454312655|FG000|28-Week Treatment Period|Protocol Violation|0|||
126279326|NCT00658021|454312656|FG001|28-Week Treatment Period|Protocol Violation|2|||
126279327|NCT00658021|454312657|FG002|28-Week Treatment Period|Protocol Violation|1|||
126279328|NCT00658021|454312655|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
126279329|NCT00658021|454312656|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
126279330|NCT00658021|454312657|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
126279331|NCT00658021|454312655|FG000|28-Week Treatment Period|Physician Decision|1|||
126279332|NCT00658021|454312656|FG001|28-Week Treatment Period|Physician Decision|2|||
126279333|NCT00658021|454312657|FG002|28-Week Treatment Period|Physician Decision|1|||
126279334|NCT00658021|454312655|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
126279335|NCT00658021|454312656|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
126279336|NCT00658021|454312657|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
126279337|NCT00658021|454312655|FG000|28-Week Treatment Period|Loss of glucose control|1|||
126363676|NCT00993473|454624887|FG000|Overall Study|Protocol Violation|1|||
126363677|NCT00993473|454624888|FG001|Overall Study|Protocol Violation|2|||
126363678|NCT00993473|454624887|FG000|Overall Study|Lost to Follow-up|1|||
126363679|NCT00993473|454624888|FG001|Overall Study|Lost to Follow-up|0|||
126279338|NCT00658021|454312656|FG001|28-Week Treatment Period|Loss of glucose control|1|||
126279339|NCT00658021|454312657|FG002|28-Week Treatment Period|Loss of glucose control|10|||
126279340|NCT00658021|454312655|FG000|28-Week Treatment Period|Other|2|||
126707937|NCT01287117|455882843|FG001|Overall Study|Lost to Follow-up|1|||
126707938|NCT01287117|455882844|FG002|Overall Study|Lost to Follow-up|0|||
126707939|NCT01287117|455882845|FG003|Overall Study|Lost to Follow-up|0|||
126707940|NCT01287117|455882842|FG000|Overall Study|Physician Decision|0|||
126707941|NCT01287117|455882843|FG001|Overall Study|Physician Decision|1|||
126707942|NCT01287117|455882844|FG002|Overall Study|Physician Decision|1|||
126707943|NCT01287117|455882845|FG003|Overall Study|Physician Decision|1|||
126707944|NCT01287117|455882842|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
126707945|NCT01287117|455882843|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
126707946|NCT01287117|455882844|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
126707947|NCT01287117|455882845|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
126707948|NCT01287117|455882842|FG000|Overall Study|Disease Progression|10|||
126707949|NCT01287117|455882843|FG001|Overall Study|Disease Progression|5|||
126707950|NCT01287117|455882844|FG002|Overall Study|Disease Progression|6|||
126363680|NCT00993473|454624887|FG000|Overall Study|Withdrawal by Subject|1|||
126363681|NCT00993473|454624888|FG001|Overall Study|Withdrawal by Subject|5|||
126707951|NCT01287117|455882845|FG003|Overall Study|Disease Progression|5|||
126707952|NCT02975349|455882850|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126707953|NCT02975349|455882851|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126707954|NCT02975349|455882852|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126707955|NCT02975349|455882853|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
126707956|NCT02975349|455882854|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
126707957|NCT02975349|455882855|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126707958|NCT02975349|455882856|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126707959|NCT02975349|455882850|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126707960|NCT02975349|455882851|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126765943|NCT03733301|456095852|FG000|Overall Study|Screen Fail|1|||
126765944|NCT03733301|456095853|FG001|Overall Study|Screen Fail|0|||
126279341|NCT00658021|454312656|FG001|28-Week Treatment Period|Other|3|||
126363682|NCT00993473|454624887|FG000|Overall Study|Technical problem with CGM device|0|||
126363683|NCT00993473|454624888|FG001|Overall Study|Technical problem with CGM device|1|||
126363684|NCT00993473|454624887|FG000|Overall Study|Family event|1|||
126363685|NCT00993473|454624888|FG001|Overall Study|Family event|0|||
126363686|NCT03439072|454624889|FG000|Overall Study|Withdrawal by Subject|2|||
126363687|NCT03439072|454624890|FG001|Overall Study|Withdrawal by Subject|3|||
126363688|NCT03439072|454624889|FG000|Overall Study|Physician Decision|0|||
126363689|NCT03439072|454624890|FG001|Overall Study|Physician Decision|1|||
126363690|NCT01537432|454624891|FG000|Overall Study|Lost to Follow-up|3|||
126363691|NCT01537432|454624892|FG001|Overall Study|Lost to Follow-up|1|||
126363692|NCT01537432|454624891|FG000|Overall Study|Withdrawal by Subject|0|||
126363693|NCT01537432|454624892|FG001|Overall Study|Withdrawal by Subject|1|||
126363694|NCT01537432|454624891|FG000|Overall Study|Administrative problems|1|||
126455453|NCT02230527|454968942|FG001|Overall Study|Withdrawal by Subject|1|||
126707961|NCT02975349|455882852|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126707962|NCT02975349|455882853|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126707963|NCT02975349|455882854|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126707964|NCT02975349|455882855|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126363695|NCT01537432|454624892|FG001|Overall Study|Administrative problems|0|||
126363696|NCT01537432|454624891|FG000|Overall Study|Adverse Event|1|||
126279342|NCT00658021|454312657|FG002|28-Week Treatment Period|Other|1|||
126279343|NCT00658021|454312655|FG000|28-Week Treatment Period|Did not receive treatment|2|||
126279344|NCT00658021|454312656|FG001|28-Week Treatment Period|Did not receive treatment|0|||
126707965|NCT02975349|455882856|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126707966|NCT02975349|455882850|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
126707967|NCT02975349|455882851|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
126279345|NCT00658021|454312657|FG002|28-Week Treatment Period|Did not receive treatment|0|||
126279346|NCT00658021|454312655|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
126279347|NCT00658021|454312656|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
126279348|NCT00658021|454312657|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
126279349|NCT00658021|454312655|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
126279350|NCT00658021|454312656|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
126279351|NCT00658021|454312657|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
126279352|NCT02092467|454312658|FG000|Overall Study|Death|49|||
126279353|NCT02092467|454312659|FG001|Overall Study|Death|66|||
126279354|NCT02092467|454312660|FG002|Overall Study|Death|38|||
126455454|NCT02230527|454968941|FG000|Overall Study|Death|1|||
126455455|NCT02230527|454968942|FG001|Overall Study|Death|0|||
126455456|NCT02230527|454968941|FG000|Overall Study|Lost to Follow-up|2|||
126455457|NCT02230527|454968942|FG001|Overall Study|Lost to Follow-up|1|||
126455458|NCT02230527|454968941|FG000|Overall Study|Other|1|||
126455459|NCT02230527|454968942|FG001|Overall Study|Other|0|||
126455460|NCT02661178|454968943|FG000|Part 1|Protocol Violation|1|||
126455461|NCT02661178|454968944|FG001|Part 1|Protocol Violation|0|||
126455462|NCT02661178|454968945|FG002|Part 1|Protocol Violation|0|||
126455463|NCT02661178|454968946|FG003|Part 1|Protocol Violation|0|||
126455464|NCT02661178|454968947|FG004|Part 1|Protocol Violation|0|||
126455465|NCT02661178|454968948|FG005|Part 1|Protocol Violation|0|||
126455466|NCT02661178|454968949|FG006|Part 1|Protocol Violation|0|||
126455467|NCT02661178|454968950|FG007|Part 1|Protocol Violation|0|||
126455468|NCT02661178|454968951|FG008|Part 1|Protocol Violation|0|||
126455469|NCT02661178|454968952|FG009|Part 1|Protocol Violation|0|||
126455470|NCT02661178|454968953|FG010|Part 1|Protocol Violation|0|||
126455471|NCT02661178|454968954|FG011|Part 1|Protocol Violation|0|||
126455472|NCT02661178|454968955|FG012|Part 1|Protocol Violation|0|||
126455473|NCT02661178|454968956|FG013|Part 1|Protocol Violation|0|||
126455474|NCT02661178|454968957|FG014|Part 1|Protocol Violation|0|||
126455475|NCT04461600|454968959|FG000|Overall Study|Death|6|||
126455476|NCT04461600|454968960|FG001|Overall Study|Death|5|||
126455477|NCT04461600|454968959|FG000|Overall Study|Withdrawal by Subject|0|||
126455478|NCT04461600|454968960|FG001|Overall Study|Withdrawal by Subject|1|||
126455479|NCT01242813|454968961|FG000|Overall Study|Lost to Follow-up|2|||
126455480|NCT01369329|454968964|FG000|Overall Study|Withdrawal by Subject|8|||
126455481|NCT01369329|454968965|FG001|Overall Study|Withdrawal by Subject|6|||
126455482|NCT01369329|454968966|FG002|Overall Study|Withdrawal by Subject|10|||
126455483|NCT01369329|454968964|FG000|Overall Study|Lost to Follow-up|2|||
126455484|NCT01369329|454968965|FG001|Overall Study|Lost to Follow-up|2|||
126455485|NCT01369329|454968966|FG002|Overall Study|Lost to Follow-up|2|||
126455486|NCT01369329|454968964|FG000|Overall Study|Other|2|||
126455487|NCT01369329|454968965|FG001|Overall Study|Other|3|||
126455488|NCT01369329|454968966|FG002|Overall Study|Other|2|||
126455489|NCT01252667|454968967|FG000|Overall Study|Transplant aborted post-conditioning|0|||
126455490|NCT01252667|454968968|FG001|Overall Study|Transplant aborted post-conditioning|0|||
126455491|NCT01252667|454968969|FG002|Overall Study|Transplant aborted post-conditioning|0|||
126455492|NCT01252667|454968970|FG003|Overall Study|Transplant aborted post-conditioning|0|||
126455493|NCT01252667|454968971|FG004|Overall Study|Transplant aborted post-conditioning|0|||
126455494|NCT01252667|454968972|FG005|Overall Study|Transplant aborted post-conditioning|1|||
126455495|NCT01836276|454968973|FG000|Overall Study|Lost to Follow-up|28|||
126455496|NCT01836276|454968974|FG001|Overall Study|Lost to Follow-up|51|||
126455497|NCT00331552|454968977|FG000|Period 3: Phase II|Neurological Symptoms|1|||
126455498|NCT00331552|454968978|FG001|Period 3: Phase II|Neurological Symptoms|0|||
126455499|NCT00331552|454968977|FG000|Period 3: Phase II|Severe Nausea|1|||
126455500|NCT00331552|454968978|FG001|Period 3: Phase II|Severe Nausea|0|||
126455501|NCT02984943|454968979|FG000|Overall Study|Withdrawal by Subject|3|||
126455502|NCT02984943|454968979|FG000|Overall Study|Physician Decision|1|||
126455503|NCT01133990|454968980|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
126455504|NCT01133990|454968981|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
126455505|NCT01133990|454968982|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
126455506|NCT01133990|454968983|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
126455507|NCT01133990|454968984|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
126455508|NCT01133990|454968985|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
126707968|NCT02975349|455882852|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
126279355|NCT02092467|454312658|FG000|Overall Study|Lost to Follow-up|38|||
126455509|NCT01133990|454968980|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
126455510|NCT01133990|454968981|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
126455511|NCT01133990|454968982|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
126707969|NCT02975349|455882853|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
126455512|NCT01133990|454968983|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
126765945|NCT03733301|456095854|FG002|Overall Study|Screen Fail|0|||
126765946|NCT03733301|456095852|FG000|Overall Study|Non-compliance|1|||
126279356|NCT02092467|454312659|FG001|Overall Study|Lost to Follow-up|35|||
126279357|NCT02092467|454312660|FG002|Overall Study|Lost to Follow-up|40|||
126279358|NCT02092467|454312658|FG000|Overall Study|Global Deterioration of Health Status|1|||
126279359|NCT02092467|454312659|FG001|Overall Study|Global Deterioration of Health Status|0|||
126279360|NCT02092467|454312660|FG002|Overall Study|Global Deterioration of Health Status|0|||
126279361|NCT02092467|454312658|FG000|Overall Study|Other|32|||
126279362|NCT02092467|454312659|FG001|Overall Study|Other|30|||
126279363|NCT02092467|454312660|FG002|Overall Study|Other|24|||
126279364|NCT02092467|454312658|FG000|Overall Study|Withdrawal by Subject|282|||
126279365|NCT02092467|454312659|FG001|Overall Study|Withdrawal by Subject|327|||
126279366|NCT02092467|454312660|FG002|Overall Study|Withdrawal by Subject|289|||
126279367|NCT02092467|454312658|FG000|Overall Study|Randomized but not treated|2|||
126279368|NCT02092467|454312659|FG001|Overall Study|Randomized but not treated|1|||
126279369|NCT02092467|454312660|FG002|Overall Study|Randomized but not treated|7|||
126279370|NCT02952898|454312662|FG000|Overall Study|Withdrawal by Subject|10|||
126279371|NCT02952898|454312663|FG001|Overall Study|Withdrawal by Subject|8|||
126279372|NCT02952898|454312664|FG002|Overall Study|Withdrawal by Subject|8|||
126279373|NCT02952898|454312662|FG000|Overall Study|Adverse Event|8|||
126279374|NCT02952898|454312663|FG001|Overall Study|Adverse Event|8|||
126279375|NCT02952898|454312664|FG002|Overall Study|Adverse Event|3|||
126279376|NCT02952898|454312662|FG000|Overall Study|Lost to Follow-up|3|||
126279377|NCT02952898|454312663|FG001|Overall Study|Lost to Follow-up|2|||
126279378|NCT02952898|454312664|FG002|Overall Study|Lost to Follow-up|2|||
126279379|NCT02952898|454312662|FG000|Overall Study|Non-compliance with study drug|1|||
126279380|NCT02952898|454312663|FG001|Overall Study|Non-compliance with study drug|1|||
126279381|NCT02952898|454312664|FG002|Overall Study|Non-compliance with study drug|2|||
126279382|NCT01908907|454314402|FG000|Overall Study|Physician Decision|1|||
126279383|NCT01908907|454314403|FG001|Overall Study|Physician Decision|0|||
126279384|NCT01908907|454314402|FG000|Overall Study|Protocol Violation|1|||
126279385|NCT01908907|454314403|FG001|Overall Study|Protocol Violation|0|||
126279386|NCT00761657|454314404|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
126279387|NCT00761657|454314405|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
126279388|NCT00761657|454314406|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
126279389|NCT00761657|454314407|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
126279390|NCT00761657|454314408|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
126279391|NCT00761657|454314409|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
126279392|NCT00761657|454314410|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
126279393|NCT00761657|454314411|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
126279394|NCT00761657|454314412|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
126279395|NCT00761657|454314404|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279396|NCT00761657|454314405|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279397|NCT00761657|454314406|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
126279398|NCT00761657|454314407|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
126279399|NCT00761657|454314408|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279400|NCT00761657|454314409|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279401|NCT00761657|454314410|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279402|NCT00761657|454314411|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279403|NCT00761657|454314412|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
126279404|NCT00761657|454314404|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
126279405|NCT00761657|454314405|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
126279406|NCT00761657|454314406|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
126279407|NCT00761657|454314407|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
126279408|NCT00761657|454314408|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
126279409|NCT00761657|454314409|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
126279410|NCT00761657|454314410|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
126279411|NCT00761657|454314411|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
126279412|NCT00761657|454314412|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
126279413|NCT00761657|454314404|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
126279414|NCT00761657|454314405|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
126279415|NCT00761657|454314406|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
126279416|NCT00761657|454314407|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
126279417|NCT00761657|454314408|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
126279418|NCT00761657|454314409|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
126279419|NCT00761657|454314410|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
126279420|NCT00761657|454314411|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
126279421|NCT00761657|454314412|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
126279422|NCT00359801|454314413|FG000|Overall Study|Lost to Follow-up|72|||
126279423|NCT00359801|454314414|FG001|Overall Study|Lost to Follow-up|58|||
126279424|NCT00359801|454314413|FG000|Overall Study|Withdrawal by Subject|143|||
126279425|NCT00359801|454314414|FG001|Overall Study|Withdrawal by Subject|96|||
126279426|NCT00359801|454314413|FG000|Overall Study|Other|66|||
126707970|NCT02975349|455882854|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
126707971|NCT02975349|455882855|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
126707972|NCT02975349|455882856|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
126707973|NCT02975349|455882850|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
126707974|NCT02975349|455882851|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
126707975|NCT02975349|455882852|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
126707976|NCT02975349|455882853|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
126707977|NCT02975349|455882854|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
126707978|NCT02975349|455882855|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
126707979|NCT02975349|455882856|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
126707980|NCT02975349|455882850|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
126707981|NCT02975349|455882851|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
126707982|NCT02975349|455882852|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
126707983|NCT02975349|455882853|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
126707984|NCT02975349|455882854|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
126707985|NCT02975349|455882855|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
126707986|NCT02975349|455882856|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
126707987|NCT02975349|455882850|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
126707988|NCT02975349|455882851|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
126707989|NCT02975349|455882852|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
126707990|NCT02975349|455882853|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
126707991|NCT02975349|455882854|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
126707992|NCT02975349|455882855|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
126707993|NCT02975349|455882856|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
126707994|NCT02975349|455882850|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
126707995|NCT02975349|455882851|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
126707996|NCT02975349|455882852|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
126707997|NCT02975349|455882853|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
126707998|NCT02975349|455882854|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
126707999|NCT02975349|455882855|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
126708000|NCT02975349|455882856|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
126708001|NCT02975349|455882850|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
126708002|NCT02975349|455882851|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
126708003|NCT02975349|455882852|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
126708004|NCT02975349|455882853|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
126708005|NCT02975349|455882854|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
126708006|NCT02975349|455882855|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
126708007|NCT02975349|455882856|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
126708008|NCT02975349|455882850|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
126708009|NCT02975349|455882851|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
126708010|NCT02975349|455882852|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
126708011|NCT02975349|455882853|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
126708012|NCT02975349|455882854|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
126708013|NCT02975349|455882855|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
126708014|NCT02975349|455882856|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
126708015|NCT02975349|455882850|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
126708016|NCT02975349|455882851|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
126708017|NCT02975349|455882852|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
126708018|NCT02975349|455882853|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
126708019|NCT02975349|455882854|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
126708020|NCT02975349|455882855|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
126708021|NCT02975349|455882856|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
126708022|NCT02975349|455882850|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
126708023|NCT02975349|455882851|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
126708024|NCT02975349|455882852|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
126708025|NCT02975349|455882853|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
126708026|NCT02975349|455882854|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
126708027|NCT02975349|455882855|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
126708028|NCT02975349|455882856|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
126708029|NCT02975349|455882850|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
126708030|NCT02975349|455882851|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
126708031|NCT02975349|455882852|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
126708032|NCT02975349|455882853|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
126548654|NCT03203694|455302230|FG000|Overall Study|Withdrawal by Subject|2|||
126708033|NCT02975349|455882854|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
126708034|NCT02975349|455882855|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
126279427|NCT00359801|454314414|FG001|Overall Study|Other|46|||
126279428|NCT00359801|454314413|FG000|Overall Study|Final Status Unknown: missing data|7|||
126279429|NCT00359801|454314414|FG001|Overall Study|Final Status Unknown: missing data|4|||
126279430|NCT00359801|454314413|FG000|Overall Study|Sponsor Decision|17|||
126279431|NCT00359801|454314414|FG001|Overall Study|Sponsor Decision|16|||
126279432|NCT00270855|454314419|FG000|Overall Study|Withdrawal by Subject|8|||
126279433|NCT00270855|454314420|FG001|Overall Study|Withdrawal by Subject|8|||
126279434|NCT02152605|454314423|FG000|Overall Study|Adverse Event|6|||
126279435|NCT02152605|454314424|FG001|Overall Study|Adverse Event|8|||
126279436|NCT02152605|454314423|FG000|Overall Study|Lack of Efficacy|7|||
126279437|NCT02152605|454314424|FG001|Overall Study|Lack of Efficacy|4|||
126279438|NCT02152605|454314423|FG000|Overall Study|Protocol deviation|1|||
126279439|NCT02152605|454314424|FG001|Overall Study|Protocol deviation|4|||
126279440|NCT02152605|454314423|FG000|Overall Study|Lost to Follow-up|1|||
126279441|NCT02152605|454314424|FG001|Overall Study|Lost to Follow-up|0|||
126279442|NCT02152605|454314423|FG000|Overall Study|Withdrew consent|4|||
126279443|NCT02152605|454314424|FG001|Overall Study|Withdrew consent|2|||
126279444|NCT02500043|454314425|FG000|Overall Study|Randomized, but not Treated|2|||
126279445|NCT02500043|454314426|FG001|Overall Study|Randomized, but not Treated|2|||
126279446|NCT02500043|454314425|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
126279447|NCT02500043|454314426|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
126279448|NCT02500043|454314425|FG000|Overall Study|Adverse Event|33|||
126279449|NCT02500043|454314426|FG001|Overall Study|Adverse Event|11|||
126279450|NCT02500043|454314425|FG000|Overall Study|Clinical Progression|54|||
126279451|NCT02500043|454314426|FG001|Overall Study|Clinical Progression|35|||
126279452|NCT02500043|454314425|FG000|Overall Study|Radiological Progression|192|||
126279453|NCT02500043|454314426|FG001|Overall Study|Radiological Progression|110|||
126279454|NCT02500043|454314425|FG000|Overall Study|Physician's Decision|11|||
126279455|NCT02500043|454314426|FG001|Overall Study|Physician's Decision|3|||
126279456|NCT02500043|454314425|FG000|Overall Study|Withdrawal by Subject|14|||
126279457|NCT02500043|454314426|FG001|Overall Study|Withdrawal by Subject|4|||
126279458|NCT02500043|454314425|FG000|Overall Study|Death|11|||
126279459|NCT02500043|454314426|FG001|Overall Study|Death|2|||
126279460|NCT02500043|454314425|FG000|Overall Study|Protocol Deviation|1|||
126279461|NCT02500043|454314426|FG001|Overall Study|Protocol Deviation|0|||
126279462|NCT03151408|454314427|FG000|Overall Study|Adverse Event|24|||
126279463|NCT03151408|454314428|FG001|Overall Study|Adverse Event|23|||
126455513|NCT01133990|454968984|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
126455514|NCT01133990|454968985|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
126455515|NCT01133990|454968980|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
126455516|NCT01133990|454968981|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
126455517|NCT01133990|454968982|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
126455518|NCT01133990|454968983|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
126455519|NCT01133990|454968984|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
126455520|NCT01133990|454968985|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
126455521|NCT01133990|454968980|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
126455522|NCT01133990|454968981|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
126455523|NCT01133990|454968982|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
126455524|NCT01133990|454968983|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
126455525|NCT01133990|454968984|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
126455526|NCT01133990|454968985|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
126455527|NCT02213133|454968988|FG000|Overall Study|Participant discontinued study therapy|2|||
126455528|NCT02213133|454968989|FG001|Overall Study|Participant discontinued study therapy|0|||
126455529|NCT02213133|454968990|FG002|Overall Study|Participant discontinued study therapy|0|||
126455530|NCT02213133|454968988|FG000|Overall Study|Participant withdrew informed consent|2|||
126455531|NCT02213133|454968989|FG001|Overall Study|Participant withdrew informed consent|1|||
126455532|NCT02213133|454968990|FG002|Overall Study|Participant withdrew informed consent|2|||
126455533|NCT02213133|454968988|FG000|Overall Study|Disease progression|11|||
126455534|NCT02213133|454968989|FG001|Overall Study|Disease progression|2|||
126455535|NCT02213133|454968990|FG002|Overall Study|Disease progression|0|||
126455536|NCT02213133|454968988|FG000|Overall Study|Adverse Event (AE)|1|||
126455537|NCT02213133|454968989|FG001|Overall Study|Adverse Event (AE)|0|||
126455538|NCT02213133|454968990|FG002|Overall Study|Adverse Event (AE)|0|||
126455539|NCT02213133|454968988|FG000|Overall Study|Death|16|||
126455540|NCT02213133|454968989|FG001|Overall Study|Death|2|||
126455541|NCT02213133|454968990|FG002|Overall Study|Death|1|||
126455542|NCT02213133|454968988|FG000|Overall Study|Other|5|||
126455543|NCT02213133|454968989|FG001|Overall Study|Other|0|||
126455544|NCT02213133|454968990|FG002|Overall Study|Other|0|||
126279464|NCT03151408|454314427|FG000|Overall Study|Death|46|||
126279465|NCT03151408|454314428|FG001|Overall Study|Death|26|||
126455545|NCT04740905|454968997|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
126455546|NCT04740905|454968998|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
126279466|NCT03151408|454314427|FG000|Overall Study|Physician Decision|13|||
126279467|NCT03151408|454314428|FG001|Overall Study|Physician Decision|19|||
126455547|NCT04740905|454968997|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
126455548|NCT04740905|454968998|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
126455549|NCT04740905|454968997|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
126455550|NCT04740905|454968998|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
126455551|NCT04740905|454968997|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
126279468|NCT03151408|454314427|FG000|Overall Study|Withdrawal by Subject|16|||
126279469|NCT03151408|454314428|FG001|Overall Study|Withdrawal by Subject|20|||
126279470|NCT03151408|454314427|FG000|Overall Study|Progressive disease|45|||
126279471|NCT03151408|454314428|FG001|Overall Study|Progressive disease|61|||
126279472|NCT03151408|454314427|FG000|Overall Study|non-compliance by patient|1|||
126279473|NCT03151408|454314428|FG001|Overall Study|non-compliance by patient|0|||
126279474|NCT03151408|454314427|FG000|Overall Study|other reasons|56|||
126279475|NCT03151408|454314428|FG001|Overall Study|other reasons|52|||
126279476|NCT03151408|454314427|FG000|Overall Study|randomized and not treated|2|||
126279477|NCT03151408|454314428|FG001|Overall Study|randomized and not treated|2|||
126279478|NCT00837473|454314429|FG000|Overall Study|Lost to Follow-up|1|||
126279479|NCT00837473|454314429|FG000|Overall Study|Withdrawal by Subject|2|||
126279480|NCT00926783|454314430|FG000|Overall Study|Incomplete CFAE Procedures|3|||
126279481|NCT00926783|454314431|FG001|Overall Study|Incomplete CFAE Procedures|3|||
126279482|NCT02549027|454314433|FG000|Washout After Period 4|Withdrawal by Subject|0|||
126279483|NCT02549027|454314434|FG001|Washout After Period 4|Withdrawal by Subject|1|||
126279484|NCT02549027|454314435|FG002|Washout After Period 4|Withdrawal by Subject|1|||
126279485|NCT02549027|454314436|FG003|Washout After Period 4|Withdrawal by Subject|1|||
126279486|NCT02549027|454314437|FG004|Washout After Period 4|Withdrawal by Subject|0|||
126279487|NCT02549027|454314438|FG005|Washout After Period 4|Withdrawal by Subject|0|||
126279488|NCT02549027|454314433|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
126279489|NCT02549027|454314434|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
126279490|NCT02549027|454314435|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
126279491|NCT02549027|454314436|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
126279492|NCT02549027|454314437|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
126279493|NCT02549027|454314438|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
126279494|NCT02186834|454314439|FG000|Dose Escalation|Death|0|||
126279495|NCT02186834|454314440|FG001|Dose Escalation|Death|0|||
126279496|NCT02186834|454314441|FG002|Dose Escalation|Death|0|||
126279497|NCT02186834|454314442|FG003|Dose Escalation|Death|1|||
126279498|NCT02186834|454314443|FG004|Dose Escalation|Death|0|||
126279499|NCT02186834|454314444|FG005|Dose Escalation|Death|0|||
126279500|NCT02186834|454314439|FG000|Treatment at RP2D|Died prior to treatment|0|||
126279501|NCT02186834|454314440|FG001|Treatment at RP2D|Died prior to treatment|0|||
126279502|NCT02186834|454314441|FG002|Treatment at RP2D|Died prior to treatment|0|||
126279503|NCT02186834|454314442|FG003|Treatment at RP2D|Died prior to treatment|0|||
126279504|NCT02186834|454314443|FG004|Treatment at RP2D|Died prior to treatment|0|||
126279505|NCT02186834|454314444|FG005|Treatment at RP2D|Died prior to treatment|1|||
126279506|NCT01421511|454314450|FG000|Overall Study|Lost to Follow-up|11|||
126279507|NCT01421511|454314451|FG001|Overall Study|Lost to Follow-up|14|||
126279508|NCT01421511|454314450|FG000|Overall Study|Randomized but didn't receive study drug|1|||
126279509|NCT01421511|454314451|FG001|Overall Study|Randomized but didn't receive study drug|7|||
126279510|NCT01421511|454314450|FG000|Overall Study|Physician Decision|0|||
126279511|NCT01421511|454314451|FG001|Overall Study|Physician Decision|1|||
126279512|NCT01421511|454314450|FG000|Overall Study|Withdrawal by Subject|6|||
126279513|NCT01421511|454314451|FG001|Overall Study|Withdrawal by Subject|5|||
126279514|NCT01421511|454314450|FG000|Overall Study|Death|1|||
126279515|NCT01421511|454314451|FG001|Overall Study|Death|1|||
126279516|NCT00749892|454314452|FG000|Overall Study|Withdrawal by Subject|3|||
126279517|NCT04581369|454314453|FG000|Overall Study|Death|7|||
126279518|NCT04581369|454314454|FG001|Overall Study|Death|6|||
126279519|NCT04581369|454314455|FG002|Overall Study|Death|0|||
126279520|NCT04581369|454314453|FG000|Overall Study|Lost to Follow-up|7|||
126279521|NCT04581369|454314454|FG001|Overall Study|Lost to Follow-up|3|||
126279522|NCT04581369|454314455|FG002|Overall Study|Lost to Follow-up|0|||
126279523|NCT04581369|454314453|FG000|Overall Study|liver transplant|2|||
126279524|NCT04581369|454314454|FG001|Overall Study|liver transplant|2|||
126279525|NCT04581369|454314455|FG002|Overall Study|liver transplant|0|||
126279526|NCT04581369|454314453|FG000|Overall Study|transitioned to hospice care|0|||
126279527|NCT04581369|454314454|FG001|Overall Study|transitioned to hospice care|5|||
126279528|NCT04581369|454314455|FG002|Overall Study|transitioned to hospice care|0|||
126279529|NCT00780910|454314456|FG000|Overall Study|Adverse Event|2|||
126279530|NCT01111825|454314459|FG000|Overall Study|Withdrawal by Subject|0|||
126279531|NCT01111825|454314460|FG001|Overall Study|Withdrawal by Subject|0|||
126279532|NCT01111825|454314461|FG002|Overall Study|Withdrawal by Subject|1|||
126279533|NCT01111825|454314462|FG003|Overall Study|Withdrawal by Subject|0|||
126279534|NCT01111825|454314459|FG000|Overall Study|Lost to Follow-up|0|||
126279535|NCT01111825|454314460|FG001|Overall Study|Lost to Follow-up|0|||
126279536|NCT01111825|454314461|FG002|Overall Study|Lost to Follow-up|3|||
126279537|NCT01111825|454314462|FG003|Overall Study|Lost to Follow-up|1|||
126279538|NCT01111825|454314459|FG000|Overall Study|Adverse Event|2|||
126279539|NCT01111825|454314460|FG001|Overall Study|Adverse Event|1|||
126708035|NCT02975349|455882856|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
126708036|NCT02975349|455882850|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
126708037|NCT02975349|455882851|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
126708038|NCT02975349|455882852|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
126708039|NCT02975349|455882853|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
126708040|NCT02975349|455882854|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
126708041|NCT02975349|455882855|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
126708042|NCT02975349|455882856|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
126708043|NCT02975349|455882850|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
126708044|NCT02975349|455882851|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
126708045|NCT02975349|455882852|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
126708046|NCT02975349|455882853|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
126708047|NCT02975349|455882854|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
126708048|NCT02975349|455882855|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
126708049|NCT02975349|455882856|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
126708050|NCT02975349|455882850|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
126708051|NCT02975349|455882851|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
126708052|NCT02975349|455882852|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
126708053|NCT02975349|455882853|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
126708054|NCT02975349|455882854|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
126708055|NCT02975349|455882855|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
126708056|NCT02975349|455882856|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
126708057|NCT02082184|455884843|FG000|Overall Study|Adverse Event|1|||
126708058|NCT02082184|455884844|FG001|Overall Study|Adverse Event|0|||
126708059|NCT02082184|455884843|FG000|Overall Study|Medical diagnosis|1|||
126708060|NCT02082184|455884844|FG001|Overall Study|Medical diagnosis|2|||
126708061|NCT02082184|455884843|FG000|Overall Study|Device associated symptoms|5|||
126708062|NCT02082184|455884844|FG001|Overall Study|Device associated symptoms|0|||
126708063|NCT02082184|455884843|FG000|Overall Study|Withdrawal by Subject|3|||
126708064|NCT02082184|455884844|FG001|Overall Study|Withdrawal by Subject|2|||
126708065|NCT02082184|455884843|FG000|Overall Study|Protocol Violation|0|||
126708066|NCT02082184|455884844|FG001|Overall Study|Protocol Violation|6|||
126708067|NCT02082184|455884843|FG000|Overall Study|Lost to Follow-up|0|||
126708068|NCT02082184|455884844|FG001|Overall Study|Lost to Follow-up|2|||
126708069|NCT02082184|455884843|FG000|Overall Study|Subject non-compliance|0|||
126708070|NCT02082184|455884844|FG001|Overall Study|Subject non-compliance|1|||
126708071|NCT00537940|455884851|FG000|Overall Study|Adverse Event|20|||
126279540|NCT01111825|454314461|FG002|Overall Study|Adverse Event|4|||
126279541|NCT01111825|454314462|FG003|Overall Study|Adverse Event|0|||
126279542|NCT01111825|454314459|FG000|Overall Study|Disease Progression|1|||
126279543|NCT01111825|454314460|FG001|Overall Study|Disease Progression|0|||
126279544|NCT01111825|454314461|FG002|Overall Study|Disease Progression|0|||
126279545|NCT01111825|454314462|FG003|Overall Study|Disease Progression|0|||
126279546|NCT01111825|454314459|FG000|Overall Study|Discontinuation by Sponsor|0|||
126279547|NCT01111825|454314460|FG001|Overall Study|Discontinuation by Sponsor|0|||
126279548|NCT01111825|454314461|FG002|Overall Study|Discontinuation by Sponsor|0|||
126279549|NCT01111825|454314462|FG003|Overall Study|Discontinuation by Sponsor|20|||
126279550|NCT02552303|454314472|FG000|Allocation|Withdrawal by Subject|2|||
126279551|NCT02552303|454314473|FG001|Allocation|Withdrawal by Subject|1|||
126279552|NCT02552303|454314474|FG002|Allocation|Withdrawal by Subject|1|||
126279553|NCT02552303|454314475|FG003|Allocation|Withdrawal by Subject|1|||
126279554|NCT02552303|454314472|FG000|Allocation|ineligible|1|||
126279555|NCT02552303|454314473|FG001|Allocation|ineligible|1|||
126279556|NCT02552303|454314474|FG002|Allocation|ineligible|0|||
126279557|NCT02552303|454314475|FG003|Allocation|ineligible|0|||
126279558|NCT02552303|454314472|FG000|Follow-Up|Lost to Follow-up|0|||
126279559|NCT02552303|454314473|FG001|Follow-Up|Lost to Follow-up|0|||
126708072|NCT00537940|455884852|FG001|Overall Study|Adverse Event|19|||
126708073|NCT00537940|455884851|FG000|Overall Study|Lack of Efficacy|8|||
126279560|NCT02552303|454314474|FG002|Follow-Up|Lost to Follow-up|1|||
126279561|NCT02552303|454314475|FG003|Follow-Up|Lost to Follow-up|0|||
126279562|NCT02552303|454314472|FG000|Follow-Up|ineligible|0|||
126279563|NCT02552303|454314473|FG001|Follow-Up|ineligible|2|||
126279564|NCT02552303|454314474|FG002|Follow-Up|ineligible|0|||
126363697|NCT01537432|454624892|FG001|Overall Study|Adverse Event|0|||
126708074|NCT00537940|455884852|FG001|Overall Study|Lack of Efficacy|16|||
126708075|NCT00537940|455884851|FG000|Overall Study|Lost to Follow-up|23|||
126708076|NCT00537940|455884852|FG001|Overall Study|Lost to Follow-up|29|||
126708077|NCT00537940|455884851|FG000|Overall Study|Withdrawal by Subject|113|||
126279565|NCT02552303|454314475|FG003|Follow-Up|ineligible|0|||
126279566|NCT01377987|454314476|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
126279567|NCT01377987|454314477|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
126279568|NCT00469144|454314480|FG000|Overall Study|Death|0|||
126708078|NCT00537940|455884852|FG001|Overall Study|Withdrawal by Subject|95|||
126708079|NCT00537940|455884851|FG000|Overall Study|Protocol Violation|6|||
126708080|NCT00537940|455884852|FG001|Overall Study|Protocol Violation|4|||
126455552|NCT04740905|454968998|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
126455553|NCT04740905|454968997|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
126455554|NCT04740905|454968998|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
126455555|NCT04740905|454968997|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
126765947|NCT03733301|456095853|FG001|Overall Study|Non-compliance|0|||
126455556|NCT04740905|454968998|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
126279569|NCT00469144|454314481|FG001|Overall Study|Death|1|||
126279570|NCT00469144|454314480|FG000|Overall Study|No Response|5|||
126279571|NCT00469144|454314481|FG001|Overall Study|No Response|5|||
126279572|NCT00469144|454314480|FG000|Overall Study|Progressive Disease|1|||
126279573|NCT00469144|454314481|FG001|Overall Study|Progressive Disease|0|||
126279574|NCT02794246|454314482|FG000|Overall Study|Withdrawal by Subject|2|||
126279575|NCT02794246|454314482|FG000|Overall Study|Physician Decision|4|||
126279576|NCT04602546|454314483|FG000|Overall Study|Training|2|||
126279577|NCT04602546|454314484|FG001|Overall Study|Training|2|||
126279578|NCT04602546|454314485|FG002|Overall Study|Training|1|||
126279579|NCT04602546|454314486|FG003|Overall Study|Training|2|||
126279580|NCT04602546|454314487|FG004|Overall Study|Training|0|||
126279581|NCT04602546|454314483|FG000|Overall Study|Randomized with disqualified data|2|||
126279582|NCT04602546|454314484|FG001|Overall Study|Randomized with disqualified data|0|||
126279583|NCT04602546|454314485|FG002|Overall Study|Randomized with disqualified data|2|||
126279584|NCT04602546|454314486|FG003|Overall Study|Randomized with disqualified data|5|||
126279585|NCT04602546|454314487|FG004|Overall Study|Randomized with disqualified data|3|||
126279586|NCT01775189|454314488|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126279587|NCT01775189|454314489|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
126279588|NCT01775189|454314490|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126279589|NCT01775189|454314491|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126279590|NCT01775189|454314492|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126279591|NCT01775189|454314493|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126279592|NCT01775189|454314494|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
126279593|NCT01775189|454314488|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126279594|NCT01775189|454314489|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
126279595|NCT01775189|454314490|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126279596|NCT01775189|454314491|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126279597|NCT01775189|454314492|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126279598|NCT01775189|454314493|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126279599|NCT01775189|454314494|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
126279600|NCT01775189|454314488|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
126455557|NCT04740905|454968997|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
126455558|NCT04740905|454968998|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
126455559|NCT04740905|454968997|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
126455560|NCT04740905|454968998|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
126455561|NCT04740905|454968997|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
126455562|NCT04740905|454968998|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
126455563|NCT04740905|454968997|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
126455564|NCT04740905|454968998|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
126455565|NCT04740905|454968997|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
126455566|NCT04740905|454968998|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
126455567|NCT04740905|454968997|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
126455568|NCT04740905|454968998|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
126455569|NCT04740905|454968997|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
126455570|NCT04740905|454968998|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
126455571|NCT04740905|454968997|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
126455572|NCT04740905|454968998|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
126455573|NCT02412488|454969001|FG000|Overall Study|Lost to Follow-up|10|||
126455574|NCT02412488|454969001|FG000|Overall Study|Withdrawal by Subject|5|||
126455575|NCT02412488|454969001|FG000|Overall Study|Physician Decision|1|||
126455576|NCT02412488|454969001|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
126455577|NCT02412488|454969001|FG000|Overall Study|Reveal LINQ explant|1|||
126455578|NCT01989468|454969002|FG000|Overall Study|Adverse Event|10|||
126455579|NCT01989468|454969003|FG001|Overall Study|Adverse Event|15|||
126455580|NCT01989468|454969004|FG002|Overall Study|Adverse Event|4|||
126279601|NCT01775189|454314489|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
126455581|NCT01989468|454969005|FG003|Overall Study|Adverse Event|5|||
126455582|NCT01989468|454969006|FG004|Overall Study|Adverse Event|4|||
126455583|NCT01989468|454969002|FG000|Overall Study|Lack of Efficacy|11|||
126279602|NCT01775189|454314490|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
126279603|NCT01775189|454314491|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
126279604|NCT01775189|454314492|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
126455584|NCT01989468|454969003|FG001|Overall Study|Lack of Efficacy|11|||
126455585|NCT01989468|454969004|FG002|Overall Study|Lack of Efficacy|7|||
126765948|NCT03733301|456095854|FG002|Overall Study|Non-compliance|0|||
126363698|NCT01537432|454624891|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126363699|NCT01537432|454624892|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126363700|NCT03707821|454624893|FG000|Overall Study|Protocol Violation|0|||
126363701|NCT03707821|454624894|FG001|Overall Study|Protocol Violation|1|||
126363702|NCT03707821|454624893|FG000|Overall Study|Unsatisfactory Visual Response|1|||
126363703|NCT03707821|454624894|FG001|Overall Study|Unsatisfactory Visual Response|0|||
126363704|NCT03707821|454624893|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
126363705|NCT03707821|454624894|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
126363706|NCT05122143|454624897|FG000|Overall Study|Adverse Event|1|||
126363707|NCT05122143|454624898|FG001|Overall Study|Adverse Event|0|||
126363708|NCT05122143|454624899|FG002|Overall Study|Adverse Event|0|||
126363709|NCT05122143|454624900|FG003|Overall Study|Adverse Event|0|||
126363710|NCT05122143|454624901|FG004|Overall Study|Adverse Event|1|||
126363711|NCT05122143|454624902|FG005|Overall Study|Adverse Event|0|||
126363712|NCT05122143|454624897|FG000|Overall Study|Protocol non-compliance|0|||
126363713|NCT05122143|454624898|FG001|Overall Study|Protocol non-compliance|0|||
126363714|NCT05122143|454624899|FG002|Overall Study|Protocol non-compliance|1|||
126363715|NCT05122143|454624900|FG003|Overall Study|Protocol non-compliance|0|||
126363716|NCT05122143|454624901|FG004|Overall Study|Protocol non-compliance|0|||
126363717|NCT05122143|454624902|FG005|Overall Study|Protocol non-compliance|0|||
126363718|NCT05122143|454624897|FG000|Overall Study|Covid contact|0|||
126363719|NCT05122143|454624898|FG001|Overall Study|Covid contact|0|||
126363720|NCT05122143|454624899|FG002|Overall Study|Covid contact|0|||
126363721|NCT05122143|454624900|FG003|Overall Study|Covid contact|0|||
126363722|NCT05122143|454624901|FG004|Overall Study|Covid contact|1|||
126363723|NCT05122143|454624902|FG005|Overall Study|Covid contact|0|||
126363724|NCT03766906|454624903|FG000|Overall Study|Withdrawal by Subject|6|||
126363725|NCT02624687|454624904|FG000|Overall Study|Withdrawal by Subject|1|||
126363726|NCT02624687|454624905|FG001|Overall Study|Withdrawal by Subject|1|||
126363727|NCT02624687|454624904|FG000|Overall Study|medical leave from work|0|||
126279605|NCT01775189|454314493|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
126279606|NCT01775189|454314494|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
126279607|NCT01775189|454314488|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
126279608|NCT01775189|454314489|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
126279609|NCT01775189|454314490|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
126279610|NCT01775189|454314491|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
126279611|NCT01775189|454314492|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
126279612|NCT01775189|454314493|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
126279613|NCT01775189|454314494|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
126279614|NCT01775189|454314488|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
126279615|NCT01775189|454314489|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
126279616|NCT01775189|454314490|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
126279617|NCT01775189|454314491|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
126279618|NCT01775189|454314492|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
126279619|NCT01775189|454314493|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
126279620|NCT01775189|454314494|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
126279621|NCT01775189|454314488|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
126279622|NCT01775189|454314489|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
126279623|NCT01775189|454314490|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
126279624|NCT01775189|454314491|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
126279625|NCT01775189|454314492|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
126279626|NCT01775189|454314493|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
126279627|NCT01775189|454314494|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
126279628|NCT00856375|454314497|FG000|Overall Study|Other|0|||
126279629|NCT00856375|454314498|FG001|Overall Study|Other|1|||
126279630|NCT00856375|454314497|FG000|Overall Study|Death|32|||
126279631|NCT00856375|454314498|FG001|Overall Study|Death|30|||
126279632|NCT00856375|454314497|FG000|Overall Study|Sponsor Terminated Study|7|||
126279633|NCT00856375|454314498|FG001|Overall Study|Sponsor Terminated Study|7|||
126279634|NCT00856375|454314497|FG000|Overall Study|Withdrawal by Subject|2|||
126279635|NCT00856375|454314498|FG001|Overall Study|Withdrawal by Subject|1|||
126279636|NCT00856375|454314497|FG000|Overall Study|Lost to Follow-up|1|||
126279637|NCT00856375|454314498|FG001|Overall Study|Lost to Follow-up|2|||
126279638|NCT02121392|454314500|FG000|Prior to Intervention|Protocol Violation|40|||
126279639|NCT02121392|454314501|FG001|Prior to Intervention|Protocol Violation|35|||
126279640|NCT02121392|454314500|FG000|Prior to Intervention|Withdrawal by Subject|8|||
126279641|NCT02121392|454314501|FG001|Prior to Intervention|Withdrawal by Subject|6|||
126363728|NCT02624687|454624905|FG001|Overall Study|medical leave from work|1|||
126363729|NCT00552279|454624906|FG000|Overall Study|Adverse Event|0|||
126363730|NCT00552279|454624907|FG001|Overall Study|Adverse Event|1|||
126363731|NCT00552279|454624906|FG000|Overall Study|Withdrawal by Subject|12|||
126363732|NCT00552279|454624907|FG001|Overall Study|Withdrawal by Subject|1|||
126363733|NCT00552279|454624906|FG000|Overall Study|Lost to Follow-up|1|||
126363734|NCT00552279|454624907|FG001|Overall Study|Lost to Follow-up|0|||
126363735|NCT00552279|454624906|FG000|Overall Study|Other|1|||
126363736|NCT00552279|454624907|FG001|Overall Study|Other|1|||
126363737|NCT01651208|454624909|FG000|Overall Study|Lost to Follow-up|14|||
126363738|NCT01651208|454624910|FG001|Overall Study|Lost to Follow-up|16|||
126363739|NCT00836901|454624911|FG000|First Intervention|Withdrawal by Subject|1|||
126363740|NCT00836901|454624912|FG001|First Intervention|Withdrawal by Subject|0|||
126363741|NCT05463952|454624916|FG000|Treatment|Progressive disease|4|||
126363742|NCT05463952|454624916|FG000|Treatment|Ongoing|2|||
126363743|NCT05261490|454624917|FG000|Overall Study|Other|1|||
126363744|NCT05261490|454624918|FG001|Overall Study|Other|0|||
126363745|NCT05261490|454624919|FG002|Overall Study|Other|0|||
126363746|NCT05261490|454624917|FG000|Overall Study|Study Terminated by Sponsor|1|||
126363747|NCT05261490|454624918|FG001|Overall Study|Study Terminated by Sponsor|1|||
126363748|NCT05261490|454624919|FG002|Overall Study|Study Terminated by Sponsor|4|||
126363749|NCT05261490|454624917|FG000|Overall Study|Death|1|||
126363750|NCT05261490|454624918|FG001|Overall Study|Death|2|||
126708081|NCT00537940|455884851|FG000|Overall Study|Pregnancy|1|||
126708082|NCT00537940|455884852|FG001|Overall Study|Pregnancy|1|||
126708083|NCT00537940|455884851|FG000|Overall Study|Study terminated by sponsor|2|||
126708084|NCT00537940|455884852|FG001|Overall Study|Study terminated by sponsor|3|||
126363751|NCT05261490|454624919|FG002|Overall Study|Death|0|||
126363752|NCT04191733|454624932|FG000|Overall Study|Withdrawn due to study closure|13|||
126363753|NCT04191733|454624933|FG001|Overall Study|Withdrawn due to study closure|14|||
126455586|NCT01989468|454969005|FG003|Overall Study|Lack of Efficacy|4|||
126455587|NCT01989468|454969006|FG004|Overall Study|Lack of Efficacy|2|||
126279642|NCT02121392|454314500|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
126279643|NCT02121392|454314501|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
126279644|NCT02121392|454314500|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
126279645|NCT02121392|454314501|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
126279646|NCT00741286|454314502|FG000|Overall Study|Lost to Follow-up|15|||
126279647|NCT00741286|454314503|FG001|Overall Study|Lost to Follow-up|10|||
126279648|NCT00741286|454314502|FG000|Overall Study|Adverse Event|1|||
126279649|NCT00741286|454314503|FG001|Overall Study|Adverse Event|6|||
126279650|NCT00741286|454314502|FG000|Overall Study|Protocol Violation|3|||
126279651|NCT00741286|454314503|FG001|Overall Study|Protocol Violation|2|||
126279652|NCT00741286|454314502|FG000|Overall Study|Primary Outcome|1|||
126279653|NCT00741286|454314503|FG001|Overall Study|Primary Outcome|1|||
126279654|NCT01352416|454314504|FG000|Overall Study|Physician Decision|1|||
126279655|NCT01352416|454314505|FG001|Overall Study|Physician Decision|2|||
126363754|NCT04191733|454624932|FG000|Overall Study|Withdrawal by Subject|2|||
126363755|NCT04191733|454624933|FG001|Overall Study|Withdrawal by Subject|4|||
126363756|NCT04191733|454624932|FG000|Overall Study|Physician Decision|1|||
126363757|NCT04191733|454624933|FG001|Overall Study|Physician Decision|1|||
126455588|NCT01989468|454969002|FG000|Overall Study|Lost to Follow-up|5|||
126455589|NCT01989468|454969003|FG001|Overall Study|Lost to Follow-up|2|||
126455590|NCT01989468|454969004|FG002|Overall Study|Lost to Follow-up|0|||
126455591|NCT01989468|454969005|FG003|Overall Study|Lost to Follow-up|1|||
126455592|NCT01989468|454969006|FG004|Overall Study|Lost to Follow-up|1|||
126455593|NCT01989468|454969002|FG000|Overall Study|Physician Decision|4|||
126455594|NCT01989468|454969003|FG001|Overall Study|Physician Decision|1|||
126455595|NCT01989468|454969004|FG002|Overall Study|Physician Decision|0|||
126455596|NCT01989468|454969005|FG003|Overall Study|Physician Decision|1|||
126455597|NCT01989468|454969006|FG004|Overall Study|Physician Decision|0|||
126455598|NCT01989468|454969002|FG000|Overall Study|Pregnancy|0|||
126455599|NCT01989468|454969003|FG001|Overall Study|Pregnancy|1|||
126455600|NCT01989468|454969004|FG002|Overall Study|Pregnancy|0|||
126455601|NCT01989468|454969005|FG003|Overall Study|Pregnancy|0|||
126455602|NCT01989468|454969006|FG004|Overall Study|Pregnancy|0|||
126455603|NCT01989468|454969002|FG000|Overall Study|Technical Problems|3|||
126455604|NCT01989468|454969003|FG001|Overall Study|Technical Problems|1|||
126363758|NCT04191733|454624932|FG000|Overall Study|Lost to Follow-up|5|||
126279656|NCT01352416|454314506|FG002|Overall Study|Physician Decision|2|||
126279657|NCT01352416|454314507|FG003|Overall Study|Physician Decision|1|||
126279658|NCT01831258|454314508|FG000|Overall Study|Withdrawal by Subject|2|||
126279659|NCT01831258|454314509|FG001|Overall Study|Withdrawal by Subject|1|||
126363759|NCT04191733|454624933|FG001|Overall Study|Lost to Follow-up|6|||
126363760|NCT04191733|454624932|FG000|Overall Study|Death|0|||
126363761|NCT04191733|454624933|FG001|Overall Study|Death|1|||
126455605|NCT01989468|454969004|FG002|Overall Study|Technical Problems|3|||
126455606|NCT01989468|454969005|FG003|Overall Study|Technical Problems|1|||
126455607|NCT01989468|454969006|FG004|Overall Study|Technical Problems|0|||
126455608|NCT01989468|454969002|FG000|Overall Study|Subject Guardian Decision|11|||
126363762|NCT01714063|454624939|FG000|Overall Study|Equipment malfunction|2|||
126363763|NCT01646216|454624940|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
126455609|NCT01989468|454969003|FG001|Overall Study|Subject Guardian Decision|6|||
126455610|NCT01989468|454969004|FG002|Overall Study|Subject Guardian Decision|4|||
126455611|NCT01989468|454969005|FG003|Overall Study|Subject Guardian Decision|4|||
126708085|NCT00537940|455884851|FG000|Overall Study|Other|10|||
126708086|NCT00537940|455884852|FG001|Overall Study|Other|12|||
126708087|NCT00634543|455884854|FG000|Overall Study|Other|1|||
126708088|NCT00634543|455884855|FG001|Overall Study|Other|2|||
126708089|NCT00634543|455884854|FG000|Overall Study|Protocol Violation|3|||
126279660|NCT01831258|454314508|FG000|Overall Study|Lost to Follow-up|3|||
126279661|NCT01831258|454314509|FG001|Overall Study|Lost to Follow-up|2|||
126279662|NCT00811928|454314522|FG000|Overall Study|AEs and SAEs Including Death|7|||
126279663|NCT00811928|454314523|FG001|Overall Study|AEs and SAEs Including Death|11|||
126279664|NCT00811928|454314522|FG000|Overall Study|Withdrawal by Subject|18|||
126279665|NCT00811928|454314523|FG001|Overall Study|Withdrawal by Subject|12|||
126708090|NCT00634543|455884855|FG001|Overall Study|Protocol Violation|3|||
126708091|NCT00634543|455884854|FG000|Overall Study|Adverse Event|11|||
126708092|NCT00634543|455884855|FG001|Overall Study|Adverse Event|11|||
126708093|NCT00634543|455884854|FG000|Overall Study|Withdrawal by Subject|4|||
126708094|NCT00634543|455884855|FG001|Overall Study|Withdrawal by Subject|4|||
126708095|NCT00634543|455884854|FG000|Overall Study|Lost to Follow-up|0|||
126708096|NCT00634543|455884855|FG001|Overall Study|Lost to Follow-up|1|||
126708097|NCT02465034|455884856|FG000|Overall Study|Withdrawal by Subject|1|||
126708098|NCT02465034|455884857|FG001|Overall Study|Withdrawal by Subject|1|||
126708099|NCT02465034|455884856|FG000|Overall Study|Screen fail|2|||
126708100|NCT02465034|455884857|FG001|Overall Study|Screen fail|0|||
126708101|NCT02465034|455884856|FG000|Overall Study|Could not be scheduled for study visit|0|||
126708102|NCT02465034|455884857|FG001|Overall Study|Could not be scheduled for study visit|5|||
126708103|NCT05299892|455884859|FG000|Overall Study|Withdrawal by Subject|2|||
126708104|NCT02397655|455884860|FG000|Overall Study|data not completed|1301|||
126708105|NCT01736683|455884861|FG000|Overall Study|Disease Relapse|0|||
126708106|NCT01736683|455884862|FG001|Overall Study|Disease Relapse|0|||
126708107|NCT01736683|455884863|FG002|Overall Study|Disease Relapse|2|||
126708108|NCT01736683|455884864|FG003|Overall Study|Disease Relapse|1|||
126708109|NCT01736683|455884865|FG004|Overall Study|Disease Relapse|0|||
126708110|NCT01736683|455884861|FG000|Overall Study|Adverse Event|0|||
126708111|NCT01736683|455884862|FG001|Overall Study|Adverse Event|2|||
126708112|NCT01736683|455884863|FG002|Overall Study|Adverse Event|2|||
126708113|NCT01736683|455884864|FG003|Overall Study|Adverse Event|3|||
126708114|NCT01736683|455884865|FG004|Overall Study|Adverse Event|2|||
126708115|NCT01736683|455884861|FG000|Overall Study|Withdrawal by Subject|0|||
126708116|NCT01736683|455884862|FG001|Overall Study|Withdrawal by Subject|0|||
126708117|NCT01736683|455884863|FG002|Overall Study|Withdrawal by Subject|3|||
126708118|NCT01736683|455884864|FG003|Overall Study|Withdrawal by Subject|1|||
126708119|NCT01736683|455884865|FG004|Overall Study|Withdrawal by Subject|1|||
126708120|NCT01736683|455884861|FG000|Overall Study|Lack of Therapeutic Effect|7|||
126708121|NCT01736683|455884862|FG001|Overall Study|Lack of Therapeutic Effect|4|||
126708122|NCT01736683|455884863|FG002|Overall Study|Lack of Therapeutic Effect|13|||
126708123|NCT01736683|455884864|FG003|Overall Study|Lack of Therapeutic Effect|20|||
126708124|NCT01736683|455884865|FG004|Overall Study|Lack of Therapeutic Effect|1|||
126708125|NCT01736683|455884861|FG000|Overall Study|Progressive Disease|0|||
126708126|NCT01736683|455884862|FG001|Overall Study|Progressive Disease|0|||
126708127|NCT01736683|455884863|FG002|Overall Study|Progressive Disease|0|||
126708128|NCT01736683|455884864|FG003|Overall Study|Progressive Disease|1|||
126708129|NCT01736683|455884865|FG004|Overall Study|Progressive Disease|0|||
126708130|NCT01736683|455884861|FG000|Overall Study|Other|0|||
126708131|NCT01736683|455884862|FG001|Overall Study|Other|0|||
126708132|NCT01736683|455884863|FG002|Overall Study|Other|1|||
126708133|NCT01736683|455884864|FG003|Overall Study|Other|9|||
126708134|NCT01736683|455884865|FG004|Overall Study|Other|1|||
126708135|NCT00947154|455884869|FG000|Overall Study|Lost to Follow-up|1|||
126708136|NCT01588197|455884872|FG000|Overall Study|Lack of Efficacy|0|||
126708137|NCT01588197|455884873|FG001|Overall Study|Lack of Efficacy|1|||
126708138|NCT01588197|455884872|FG000|Overall Study|No MRI|1|||
126708139|NCT01588197|455884873|FG001|Overall Study|No MRI|0|||
126708140|NCT01844076|455884876|FG000|Overall Study|Adverse Event|1|||
126279666|NCT00811928|454314522|FG000|Overall Study|Did Not Take Study Drug|3|||
126279667|NCT00811928|454314523|FG001|Overall Study|Did Not Take Study Drug|0|||
126279668|NCT00811928|454314522|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
126279669|NCT00811928|454314523|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
126708141|NCT01844076|455884877|FG001|Overall Study|Adverse Event|0|||
126708142|NCT01844076|455884878|FG002|Overall Study|Adverse Event|0|||
126708143|NCT01844076|455884879|FG003|Overall Study|Adverse Event|0|||
126708144|NCT01844076|455884876|FG000|Overall Study|Withdrawal by Subject|1|||
126279670|NCT00811928|454314522|FG000|Overall Study|Investigator Decision|2|||
126363764|NCT01646216|454624941|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
126708145|NCT01844076|455884877|FG001|Overall Study|Withdrawal by Subject|0|||
126708146|NCT01844076|455884878|FG002|Overall Study|Withdrawal by Subject|0|||
126708147|NCT01844076|455884879|FG003|Overall Study|Withdrawal by Subject|0|||
126708148|NCT00440401|455884888|FG000|Overall Study|Adverse Event|2|||
126708149|NCT00440401|455884889|FG001|Overall Study|Adverse Event|1|||
126708150|NCT00440401|455884888|FG000|Overall Study|Other|2|||
126708151|NCT00440401|455884889|FG001|Overall Study|Other|5|||
126708152|NCT02286960|455884890|FG000|Overall Study|Lost to Follow-up|3|||
126708153|NCT02286960|455884891|FG001|Overall Study|Lost to Follow-up|3|||
126279671|NCT00811928|454314523|FG001|Overall Study|Investigator Decision|1|||
126279672|NCT00811928|454314522|FG000|Overall Study|Poor Compliance|2|||
126279673|NCT00811928|454314523|FG001|Overall Study|Poor Compliance|5|||
126279674|NCT00171951|454314524|FG000|Overall Study|Adverse Event|1|||
126708154|NCT01937312|455884892|FG000|Overall Study|Adverse Event|10|||
126708155|NCT01937312|455884893|FG001|Overall Study|Adverse Event|1|||
126708156|NCT01937312|455884892|FG000|Overall Study|Lack of Efficacy|0|||
126708157|NCT01937312|455884893|FG001|Overall Study|Lack of Efficacy|1|||
126708158|NCT01937312|455884892|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
126708159|NCT01937312|455884893|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
126708160|NCT00474253|455884894|FG000|Overall Study|Withdrew consent|2|||
126708161|NCT00474253|455884895|FG001|Overall Study|Withdrew consent|0|||
126708162|NCT00474253|455884894|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
126708163|NCT00474253|455884895|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
126708164|NCT00474253|455884894|FG000|Overall Study|Lost to Follow-up|1|||
126708165|NCT00474253|455884895|FG001|Overall Study|Lost to Follow-up|0|||
126708166|NCT00474253|455884894|FG000|Overall Study|Discharged prior to study completion|0|||
126708167|NCT00474253|455884895|FG001|Overall Study|Discharged prior to study completion|1|||
126708168|NCT00593112|455884903|FG000|Overall Study|Scan Anxiety|3|||
126708169|NCT00593112|455884904|FG001|Overall Study|Scan Anxiety|0|||
126708170|NCT00593112|455884903|FG000|Overall Study|Abnormal Scan|1|||
126708171|NCT00593112|455884904|FG001|Overall Study|Abnormal Scan|0|||
126708172|NCT00593112|455884903|FG000|Overall Study|Unreadable Scan|1|||
126708173|NCT00593112|455884904|FG001|Overall Study|Unreadable Scan|0|||
126708174|NCT00593112|455884903|FG000|Overall Study|Withdrawal by Subject|5|||
126708175|NCT00593112|455884904|FG001|Overall Study|Withdrawal by Subject|0|||
126708176|NCT00482001|455884905|FG000|Overall Study|Protocol Violation|1|||
126708177|NCT00482001|455884906|FG001|Overall Study|Protocol Violation|1|||
126708178|NCT00258154|455884907|FG000|Overall Study|Adverse Event|1|||
126708179|NCT00258154|455884908|FG001|Overall Study|Adverse Event|0|||
126708180|NCT00258154|455884907|FG000|Overall Study|Lost to Follow-up|0|||
126708181|NCT00258154|455884908|FG001|Overall Study|Lost to Follow-up|1|||
126708182|NCT00258154|455884907|FG000|Overall Study|Protocol Violation|2|||
126708183|NCT00258154|455884908|FG001|Overall Study|Protocol Violation|1|||
126708184|NCT00258154|455884907|FG000|Overall Study|Withdrawal by Subject|3|||
126708185|NCT00258154|455884908|FG001|Overall Study|Withdrawal by Subject|4|||
126708186|NCT00258154|455884907|FG000|Overall Study|Patient Moved|3|||
126708187|NCT00258154|455884908|FG001|Overall Study|Patient Moved|1|||
126708188|NCT00847613|455884913|FG000|Overall Study|Ongoing at cut-off date|250|||
126708189|NCT00847613|455884914|FG001|Overall Study|Ongoing at cut-off date|265|||
126708190|NCT00847613|455884915|FG002|Overall Study|Ongoing at cut-off date|64|||
126708191|NCT00847613|455884916|FG003|Overall Study|Ongoing at cut-off date|64|||
126708192|NCT00847613|455884913|FG000|Overall Study|Death|1|||
126708193|NCT00847613|455884914|FG001|Overall Study|Death|1|||
126708194|NCT00847613|455884915|FG002|Overall Study|Death|0|||
126708195|NCT00847613|455884916|FG003|Overall Study|Death|0|||
126708196|NCT00847613|455884913|FG000|Overall Study|Adverse Event|36|||
126708197|NCT00847613|455884914|FG001|Overall Study|Adverse Event|26|||
126708198|NCT00847613|455884915|FG002|Overall Study|Adverse Event|5|||
126708199|NCT00847613|455884916|FG003|Overall Study|Adverse Event|6|||
126708200|NCT00847613|455884913|FG000|Overall Study|Lack of Efficacy|7|||
126708201|NCT00847613|455884914|FG001|Overall Study|Lack of Efficacy|3|||
126708202|NCT00847613|455884915|FG002|Overall Study|Lack of Efficacy|3|||
126708203|NCT00847613|455884916|FG003|Overall Study|Lack of Efficacy|1|||
126708204|NCT00847613|455884913|FG000|Overall Study|Study terminated by Sponsor|1|||
126708205|NCT00847613|455884914|FG001|Overall Study|Study terminated by Sponsor|0|||
126708206|NCT00847613|455884915|FG002|Overall Study|Study terminated by Sponsor|2|||
126708207|NCT00847613|455884916|FG003|Overall Study|Study terminated by Sponsor|1|||
126708208|NCT00847613|455884913|FG000|Overall Study|Lost to Follow-up|5|||
126708209|NCT00847613|455884914|FG001|Overall Study|Lost to Follow-up|0|||
126708210|NCT00847613|455884915|FG002|Overall Study|Lost to Follow-up|0|||
126279675|NCT00171951|454314524|FG000|Overall Study|Abnormal Laboratory Values|2|||
126279676|NCT00171951|454314524|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126708211|NCT00847613|455884916|FG003|Overall Study|Lost to Follow-up|3|||
126708212|NCT00847613|455884913|FG000|Overall Study|Protocol Violation|6|||
126708213|NCT00847613|455884914|FG001|Overall Study|Protocol Violation|6|||
126765949|NCT03733301|456095852|FG000|Overall Study|Lack of Efficacy|2|||
126765950|NCT03733301|456095853|FG001|Overall Study|Lack of Efficacy|3|||
126279677|NCT00171951|454314524|FG000|Overall Study|Participants Withdrew Consent|3|||
126708214|NCT00847613|455884915|FG002|Overall Study|Protocol Violation|3|||
126708215|NCT00847613|455884916|FG003|Overall Study|Protocol Violation|1|||
126708216|NCT00847613|455884913|FG000|Overall Study|Pregnancy|1|||
126708217|NCT00847613|455884914|FG001|Overall Study|Pregnancy|1|||
126708218|NCT00847613|455884915|FG002|Overall Study|Pregnancy|0|||
126708219|NCT00847613|455884916|FG003|Overall Study|Pregnancy|0|||
126708220|NCT00847613|455884913|FG000|Overall Study|Site closure|1|||
126708221|NCT00847613|455884914|FG001|Overall Study|Site closure|0|||
126708222|NCT00847613|455884915|FG002|Overall Study|Site closure|0|||
126708223|NCT00847613|455884916|FG003|Overall Study|Site closure|1|||
126279678|NCT00171951|454314524|FG000|Overall Study|New Cancer Therapy|5|||
126279679|NCT00171951|454314524|FG000|Overall Study|Reason not Specified|2|||
126279680|NCT00396812|454314525|FG000|Overall Study|Physician Decision|1|||
126279681|NCT00233402|454314526|FG000|Overall Study|No pathology data|12|||
126279682|NCT00233402|454314527|FG001|Overall Study|No pathology data|9|||
126279683|NCT00233402|454314526|FG000|Overall Study|No Ta/T1|89|||
126279684|NCT00233402|454314527|FG001|Overall Study|No Ta/T1|94|||
126279685|NCT00233402|454314526|FG000|Overall Study|Lost to follow up etc|3|||
126279686|NCT00233402|454314527|FG001|Overall Study|Lost to follow up etc|21|||
126279687|NCT03485365|454314532|FG000|Overall Study|Protocol Violation|0|||
126279688|NCT03485365|454314533|FG001|Overall Study|Protocol Violation|0|||
126279689|NCT03485365|454314534|FG002|Overall Study|Protocol Violation|0|||
126279690|NCT03485365|454314535|FG003|Overall Study|Protocol Violation|1|||
126279691|NCT03485365|454314536|FG004|Overall Study|Protocol Violation|0|||
126279692|NCT03485365|454314537|FG005|Overall Study|Protocol Violation|0|||
126279693|NCT03485365|454314538|FG006|Overall Study|Protocol Violation|1|||
126279694|NCT03485365|454314539|FG007|Overall Study|Protocol Violation|0|||
126279695|NCT03485365|454314540|FG008|Overall Study|Protocol Violation|0|||
126279696|NCT04868968|454314543|FG000|Overall Study|Lost to Follow-up|1|||
126279697|NCT02752087|454314546|FG000|Washout|Physician Decision|1|||
126279698|NCT02752087|454314547|FG001|Washout|Physician Decision|0|||
126708224|NCT00847613|455884913|FG000|Overall Study|Withdrawal by Subject|8|||
126708225|NCT00847613|455884914|FG001|Overall Study|Withdrawal by Subject|11|||
126708226|NCT00847613|455884915|FG002|Overall Study|Withdrawal by Subject|2|||
126708227|NCT00847613|455884916|FG003|Overall Study|Withdrawal by Subject|2|||
126708228|NCT00847613|455884913|FG000|Overall Study|Participant moved|4|||
126708229|NCT00847613|455884914|FG001|Overall Study|Participant moved|1|||
126708230|NCT00847613|455884915|FG002|Overall Study|Participant moved|0|||
126708231|NCT00847613|455884916|FG003|Overall Study|Participant moved|0|||
126708232|NCT00847613|455884913|FG000|Overall Study|Sponsor request|0|||
126708233|NCT00847613|455884914|FG001|Overall Study|Sponsor request|1|||
126708234|NCT00847613|455884915|FG002|Overall Study|Sponsor request|0|||
126708235|NCT00847613|455884916|FG003|Overall Study|Sponsor request|0|||
126708236|NCT00847613|455884913|FG000|Overall Study|Randomized, but not treated|0|||
126708237|NCT00847613|455884914|FG001|Overall Study|Randomized, but not treated|3|||
126708238|NCT00847613|455884915|FG002|Overall Study|Randomized, but not treated|0|||
126708239|NCT00847613|455884916|FG003|Overall Study|Randomized, but not treated|0|||
126708240|NCT00847613|455884913|FG000|Overall Study|Other|1|||
126708241|NCT00847613|455884914|FG001|Overall Study|Other|1|||
126708242|NCT00847613|455884915|FG002|Overall Study|Other|2|||
126708243|NCT00847613|455884916|FG003|Overall Study|Other|0|||
126708244|NCT00754390|455884917|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
126708245|NCT00754390|455884917|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
126708246|NCT00754390|455884917|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
126708247|NCT00754390|455884917|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
126708248|NCT01009294|455884918|FG000|Overall Study|Study discontinued by Sponsor|6|||
126708249|NCT01856673|455884919|FG000|Overall Study|Withdrawal by Subject|44|||
126708250|NCT01856673|455884920|FG001|Overall Study|Withdrawal by Subject|50|||
126708251|NCT01856673|455884921|FG002|Overall Study|Withdrawal by Subject|33|||
126708252|NCT01856673|455884919|FG000|Overall Study|Lost to Follow-up|31|||
126708253|NCT01856673|455884920|FG001|Overall Study|Lost to Follow-up|34|||
126708254|NCT01856673|455884921|FG002|Overall Study|Lost to Follow-up|0|||
126708255|NCT01856673|455884919|FG000|Overall Study|Unknown reasons|9|||
126708256|NCT01856673|455884920|FG001|Overall Study|Unknown reasons|0|||
126708257|NCT01856673|455884921|FG002|Overall Study|Unknown reasons|0|||
126279699|NCT01547130|454314548|FG000|Overall Study|Lost to Follow-up|9|||
126279700|NCT01547130|454314549|FG001|Overall Study|Lost to Follow-up|5|||
126279701|NCT00843635|454314550|FG000|Overall Study|Adverse Event|2|||
126279702|NCT00843635|454314551|FG001|Overall Study|Adverse Event|2|||
126279703|NCT00843635|454314552|FG002|Overall Study|Adverse Event|0|||
126279704|NCT00896480|454314554|FG000|Overall Study|Disease progression/recurrence|21|||
126279705|NCT03553576|454314558|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
126279706|NCT03553576|454314559|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
126455612|NCT01989468|454969006|FG004|Overall Study|Subject Guardian Decision|1|||
126455613|NCT01989468|454969002|FG000|Overall Study|Death|3|||
126708258|NCT01856673|455884919|FG000|Overall Study|Psychologist decision|1|||
126708259|NCT01856673|455884920|FG001|Overall Study|Psychologist decision|0|||
126708260|NCT01856673|455884921|FG002|Overall Study|Psychologist decision|0|||
126708261|NCT01856673|455884919|FG000|Overall Study|Paperwork errors|8|||
126708262|NCT01856673|455884920|FG001|Overall Study|Paperwork errors|0|||
126279707|NCT03553576|454314558|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
126279708|NCT03553576|454314559|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
126279709|NCT03553576|454314558|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
126279710|NCT03553576|454314559|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
126455614|NCT01989468|454969003|FG001|Overall Study|Death|0|||
126708263|NCT01856673|455884921|FG002|Overall Study|Paperwork errors|0|||
126279711|NCT03553576|454314558|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
126279712|NCT03553576|454314559|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
126279713|NCT03553576|454314558|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
126279714|NCT03553576|454314559|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
126708264|NCT01856673|455884919|FG000|Overall Study|Death|1|||
126708265|NCT01856673|455884920|FG001|Overall Study|Death|1|||
126708266|NCT01856673|455884921|FG002|Overall Study|Death|0|||
126708267|NCT01856673|455884919|FG000|Overall Study|Protocol Violation|1|||
126708268|NCT01856673|455884920|FG001|Overall Study|Protocol Violation|0|||
126708269|NCT01856673|455884921|FG002|Overall Study|Protocol Violation|1|||
126708270|NCT04332419|455884922|FG000|Overall Study|Withdrawal by Subject|1|||
126708271|NCT02436239|455884923|FG000|Open-Lable Treatment Period|Adverse Event|12|||
126708272|NCT02436239|455884924|FG001|Open-Lable Treatment Period|Adverse Event|3|||
126708273|NCT02436239|455884925|FG002|Open-Lable Treatment Period|Adverse Event|4|||
126708274|NCT02436239|455884926|FG003|Open-Lable Treatment Period|Adverse Event|2|||
126708275|NCT02436239|455884923|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
126708276|NCT02436239|455884924|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
126708277|NCT02436239|455884925|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
126708278|NCT02436239|455884926|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
126708279|NCT02436239|455884923|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
126708280|NCT02436239|455884924|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
126708281|NCT02436239|455884925|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
126708282|NCT02436239|455884926|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
126708283|NCT02436239|455884923|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
126708284|NCT02436239|455884924|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
126708285|NCT02436239|455884925|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
126708286|NCT02436239|455884926|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
126708287|NCT02436239|455884923|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
126708288|NCT02436239|455884924|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
126708289|NCT02436239|455884925|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
126708290|NCT02436239|455884926|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
126708291|NCT02436239|455884923|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
126708292|NCT02436239|455884924|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
126708293|NCT02436239|455884925|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
126708294|NCT02436239|455884926|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
126708295|NCT02436239|455884923|FG000|Open-Lable Treatment Period|Other Reason|1|||
126708296|NCT02436239|455884924|FG001|Open-Lable Treatment Period|Other Reason|1|||
126708297|NCT02436239|455884925|FG002|Open-Lable Treatment Period|Other Reason|0|||
126708298|NCT02436239|455884926|FG003|Open-Lable Treatment Period|Other Reason|0|||
126708299|NCT02436239|455884923|FG000|Down-Taper Period|Withdrawal by Subject|4|||
126708300|NCT02436239|455884924|FG001|Down-Taper Period|Withdrawal by Subject|4|||
126708301|NCT02436239|455884925|FG002|Down-Taper Period|Withdrawal by Subject|1|||
126708302|NCT02436239|455884926|FG003|Down-Taper Period|Withdrawal by Subject|2|||
126708303|NCT00658333|455884927|FG000|Overall Study|Adverse Event|2|||
126708304|NCT00658333|455884928|FG001|Overall Study|Adverse Event|1|||
126708305|NCT03443024|455884933|FG000|Overall Study|Adverse Event|2|||
126708306|NCT03443024|455884934|FG001|Overall Study|Adverse Event|4|||
126708307|NCT03443024|455884935|FG002|Overall Study|Adverse Event|3|||
126708308|NCT03443024|455884936|FG003|Overall Study|Adverse Event|1|||
126708309|NCT03443024|455884933|FG000|Overall Study|Lost to Follow-up|9|||
126708310|NCT03443024|455884934|FG001|Overall Study|Lost to Follow-up|9|||
126708311|NCT03443024|455884935|FG002|Overall Study|Lost to Follow-up|7|||
126708312|NCT03443024|455884936|FG003|Overall Study|Lost to Follow-up|5|||
126708313|NCT03443024|455884933|FG000|Overall Study|Withdrawal by Subject|8|||
126708314|NCT03443024|455884934|FG001|Overall Study|Withdrawal by Subject|15|||
126708315|NCT03443024|455884935|FG002|Overall Study|Withdrawal by Subject|9|||
126708316|NCT03443024|455884936|FG003|Overall Study|Withdrawal by Subject|23|||
126708317|NCT03443024|455884933|FG000|Overall Study|Physician Decision|1|||
126708318|NCT03443024|455884934|FG001|Overall Study|Physician Decision|2|||
126708319|NCT03443024|455884935|FG002|Overall Study|Physician Decision|0|||
126708320|NCT03443024|455884936|FG003|Overall Study|Physician Decision|1|||
126279715|NCT03553576|454314558|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
126708321|NCT03443024|455884933|FG000|Overall Study|Sponsor Decision|1|||
126708322|NCT03443024|455884934|FG001|Overall Study|Sponsor Decision|1|||
126708323|NCT03443024|455884935|FG002|Overall Study|Sponsor Decision|0|||
126708324|NCT03443024|455884936|FG003|Overall Study|Sponsor Decision|0|||
126708325|NCT03443024|455884933|FG000|Overall Study|Protocol Deviation|0|||
126708326|NCT03443024|455884934|FG001|Overall Study|Protocol Deviation|0|||
126708327|NCT03443024|455884935|FG002|Overall Study|Protocol Deviation|0|||
126708328|NCT03443024|455884936|FG003|Overall Study|Protocol Deviation|2|||
126708329|NCT03598777|455884937|FG000|Overall Study|Study Terminated by Sponsor|3|||
126708330|NCT03598777|455884938|FG001|Overall Study|Study Terminated by Sponsor|0|||
126708331|NCT03598777|455884939|FG002|Overall Study|Study Terminated by Sponsor|0|||
126708332|NCT03598777|455884940|FG003|Overall Study|Study Terminated by Sponsor|0|||
126708333|NCT03598777|455884941|FG004|Overall Study|Study Terminated by Sponsor|15|||
126708334|NCT03598777|455884937|FG000|Overall Study|Withdrawal by Subject|1|||
126708335|NCT03598777|455884938|FG001|Overall Study|Withdrawal by Subject|1|||
126708336|NCT03598777|455884939|FG002|Overall Study|Withdrawal by Subject|0|||
126708337|NCT03598777|455884940|FG003|Overall Study|Withdrawal by Subject|0|||
126708338|NCT03598777|455884941|FG004|Overall Study|Withdrawal by Subject|0|||
126708339|NCT03598777|455884937|FG000|Overall Study|Adverse Event|1|||
126708340|NCT03598777|455884938|FG001|Overall Study|Adverse Event|0|||
126708341|NCT03598777|455884939|FG002|Overall Study|Adverse Event|0|||
126708342|NCT03598777|455884940|FG003|Overall Study|Adverse Event|0|||
126708343|NCT03598777|455884941|FG004|Overall Study|Adverse Event|0|||
126708344|NCT03598777|455884937|FG000|Overall Study|Lost to Follow-up|1|||
126708345|NCT03598777|455884938|FG001|Overall Study|Lost to Follow-up|0|||
126708346|NCT03598777|455884939|FG002|Overall Study|Lost to Follow-up|0|||
126708347|NCT03598777|455884940|FG003|Overall Study|Lost to Follow-up|0|||
126708348|NCT03598777|455884941|FG004|Overall Study|Lost to Follow-up|0|||
126708349|NCT01919411|455884942|FG000|Overall Study|Lost to Follow-up|2|||
126708350|NCT01919411|455884943|FG001|Overall Study|Lost to Follow-up|4|||
126708351|NCT01919411|455884942|FG000|Overall Study|Physician Decision|1|||
126708352|NCT01919411|455884943|FG001|Overall Study|Physician Decision|0|||
126708353|NCT01919411|455884942|FG000|Overall Study|Protocol Violation|2|||
126708354|NCT01919411|455884943|FG001|Overall Study|Protocol Violation|1|||
126708355|NCT00072189|455884944|FG000|Overall Study|Withdrawal by Subject|1|||
126708356|NCT01933672|455884945|FG000|Metformin Run-in Period|Adverse Event|1|||
126708357|NCT01933672|455884946|FG001|Metformin Run-in Period|Adverse Event|0|||
126708358|NCT01933672|455884947|FG002|Metformin Run-in Period|Adverse Event|0|||
126708359|NCT01933672|455884948|FG003|Metformin Run-in Period|Adverse Event|0|||
126279716|NCT03553576|454314559|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
126279717|NCT03553576|454314558|FG000|Overall Study|Physician Decision|2|||
126279718|NCT03553576|454314559|FG001|Overall Study|Physician Decision|5|||
126279719|NCT05038800|454314561|FG000|Overall Study|Death|1|||
126279720|NCT05038800|454314562|FG001|Overall Study|Death|1|||
126279721|NCT05038800|454314563|FG002|Overall Study|Death|5|||
126279722|NCT05038800|454314564|FG003|Overall Study|Death|3|||
126279723|NCT05038800|454314565|FG004|Overall Study|Death|1|||
126279724|NCT05038800|454314561|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126279725|NCT05038800|454314562|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126279726|NCT05038800|454314563|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126279727|NCT05038800|454314564|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126279728|NCT05038800|454314565|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126279729|NCT05038800|454314561|FG000|Overall Study|Lack of Efficacy|0|||
126279730|NCT05038800|454314562|FG001|Overall Study|Lack of Efficacy|0|||
126279731|NCT05038800|454314563|FG002|Overall Study|Lack of Efficacy|0|||
126279732|NCT05038800|454314564|FG003|Overall Study|Lack of Efficacy|0|||
126279733|NCT05038800|454314565|FG004|Overall Study|Lack of Efficacy|1|||
126279734|NCT01104792|454314566|FG000|Overall Study|Adverse Event|77|||
126279735|NCT01104792|454314566|FG000|Overall Study|Insufficient Therapeutic Response|22|||
126279736|NCT01104792|454314566|FG000|Overall Study|Protocol Violation|45|||
126279737|NCT01104792|454314566|FG000|Overall Study|Withdrawal of Consent|179|||
126279738|NCT01104792|454314566|FG000|Overall Study|Lost to Follow-up|43|||
126279739|NCT01104792|454314566|FG000|Overall Study|Reasons Not Specified|27|||
126279740|NCT01104792|454314566|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
126279741|NCT00103610|454314570|FG000|Overall Study|Entered Rescue Procedure|10|||
126279742|NCT00103610|454314571|FG001|Overall Study|Entered Rescue Procedure|52|||
126279743|NCT00103610|454314570|FG000|Overall Study|Death|16|||
126279744|NCT00103610|454314571|FG001|Overall Study|Death|12|||
126279745|NCT00103610|454314570|FG000|Overall Study|Elective Withdrawal|4|||
126279746|NCT00103610|454314571|FG001|Overall Study|Elective Withdrawal|0|||
126279747|NCT00103610|454314570|FG000|Overall Study|Lost to Follow-up|3|||
126279748|NCT00103610|454314571|FG001|Overall Study|Lost to Follow-up|1|||
126708360|NCT01933672|455884949|FG004|Metformin Run-in Period|Adverse Event|0|||
126279749|NCT00103610|454314570|FG000|Overall Study|Adverse Event|2|||
126279750|NCT00103610|454314571|FG001|Overall Study|Adverse Event|2|||
126708361|NCT01933672|455884950|FG005|Metformin Run-in Period|Adverse Event|0|||
126279751|NCT00103610|454314570|FG000|Overall Study|Other|2|||
126279752|NCT00103610|454314571|FG001|Overall Study|Other|7|||
126279753|NCT00103610|454314570|FG000|Overall Study|Failed mobilization|1|||
126279754|NCT00103610|454314571|FG001|Overall Study|Failed mobilization|5|||
126279755|NCT00103610|454314570|FG000|Overall Study|Noncompliance|0|||
126279756|NCT00103610|454314571|FG001|Overall Study|Noncompliance|1|||
126279757|NCT03301623|454314572|FG000|Overall Study|Death|3|||
126279758|NCT03301623|454314573|FG001|Overall Study|Death|1|||
126279759|NCT03301623|454314572|FG000|Overall Study|Withdrawal by Subject|11|||
126708362|NCT01933672|455884951|FG006|Metformin Run-in Period|Adverse Event|0|||
126708363|NCT01933672|455884945|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
126279760|NCT03301623|454314573|FG001|Overall Study|Withdrawal by Subject|13|||
126279761|NCT03301623|454314572|FG000|Overall Study|Lost to Follow-up|3|||
126279762|NCT03301623|454314573|FG001|Overall Study|Lost to Follow-up|1|||
126279763|NCT04400682|454314582|FG000|Period 1|Withdrawal by Subject|1|||
126279764|NCT04400682|454314583|FG001|Period 1|Withdrawal by Subject|4|||
126279765|NCT02293863|454314584|FG000|Overall Study|Death|4|||
126279766|NCT02293863|454314585|FG001|Overall Study|Death|6|||
126279767|NCT02293863|454314586|FG002|Overall Study|Death|4|||
126279768|NCT02293863|454314584|FG000|Overall Study|Lost to Follow-up|2|||
126279769|NCT02293863|454314585|FG001|Overall Study|Lost to Follow-up|2|||
126279770|NCT02293863|454314586|FG002|Overall Study|Lost to Follow-up|2|||
126279771|NCT02293863|454314584|FG000|Overall Study|Withdrawal by Subject|3|||
126279772|NCT02293863|454314585|FG001|Overall Study|Withdrawal by Subject|3|||
126279773|NCT02293863|454314586|FG002|Overall Study|Withdrawal by Subject|1|||
126279774|NCT02293863|454314584|FG000|Overall Study|Reason Not Specified|0|||
126279775|NCT02293863|454314585|FG001|Overall Study|Reason Not Specified|2|||
126455615|NCT01989468|454969004|FG002|Overall Study|Death|1|||
126455616|NCT01989468|454969005|FG003|Overall Study|Death|0|||
126455617|NCT01989468|454969006|FG004|Overall Study|Death|0|||
126455618|NCT03222492|454969009|FG000|Overall Study|Withdrawal by Subject|0|||
126455619|NCT03222492|454969010|FG001|Overall Study|Withdrawal by Subject|0|||
126455620|NCT03222492|454969011|FG002|Overall Study|Withdrawal by Subject|1|||
126455621|NCT03222492|454969012|FG003|Overall Study|Withdrawal by Subject|0|||
126455622|NCT03222492|454969009|FG000|Overall Study|COVID-19 related|0|||
126455623|NCT03222492|454969010|FG001|Overall Study|COVID-19 related|0|||
126279776|NCT02293863|454314586|FG002|Overall Study|Reason Not Specified|2|||
126279777|NCT03462459|454314592|FG000|Overall Study|Death|1|||
126279778|NCT03462459|454314593|FG001|Overall Study|Death|0|||
126279779|NCT03462459|454314592|FG000|Overall Study|Lack of Efficacy|2|||
126279780|NCT03462459|454314593|FG001|Overall Study|Lack of Efficacy|4|||
126279781|NCT03462459|454314592|FG000|Overall Study|Lost to Follow-up|1|||
126279782|NCT03462459|454314593|FG001|Overall Study|Lost to Follow-up|3|||
126279783|NCT03462459|454314592|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
126279784|NCT03462459|454314593|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
126279785|NCT03462459|454314592|FG000|Overall Study|Withdrawal by Subject|3|||
126279786|NCT03462459|454314593|FG001|Overall Study|Withdrawal by Subject|2|||
126279787|NCT03462459|454314592|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
126279788|NCT03462459|454314593|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
126279789|NCT04042376|454314595|FG000|Overall Study|Withdrawal by Subject|1|||
126279790|NCT04042376|454314595|FG000|Overall Study|Death|3|||
126279791|NCT00478244|454316108|FG000|Overall Study|Did not receive transplant|1|||
126279792|NCT02929056|454316109|FG000|Overall Study|Lost to Follow-up|0|||
126279793|NCT02929056|454316110|FG001|Overall Study|Lost to Follow-up|1|||
126279794|NCT03132155|454316111|FG000|Overall Study|Lack of Efficacy|6|||
126279795|NCT03132155|454316111|FG000|Overall Study|Lost to Follow-up|1|||
126279796|NCT03132155|454316111|FG000|Overall Study|Withdrawal by Subject|1|||
126279797|NCT02925403|454316115|FG000|Overall Study|Lost to Follow-up|0|||
126279798|NCT02925403|454316116|FG001|Overall Study|Lost to Follow-up|1|||
126279799|NCT00459043|454316117|FG000|Overall Study|Withdrawal by Subject|1|||
126279800|NCT00459043|454316118|FG001|Overall Study|Withdrawal by Subject|0|||
126279801|NCT02899195|454316121|FG000|Concurrent Durvalumab|Adverse Event|4|||
126279802|NCT02899195|454316121|FG000|Concurrent Durvalumab|Physician Decision|1|||
126279803|NCT02899195|454316121|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
126279804|NCT02899195|454316121|FG000|Concurrent Durvalumab|Progressive Disease|5|||
126279805|NCT02899195|454316121|FG000|Maintenance Durvalumab|Adverse Event|1|||
126279806|NCT02899195|454316121|FG000|Maintenance Durvalumab|Physician Decision|1|||
126279807|NCT02899195|454316121|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
126279808|NCT02899195|454316121|FG000|Maintenance Durvalumab|Progressive Disease|31|||
126279809|NCT03156504|454316123|FG000|Overall Study|Withdrawal by Subject|1|||
126279810|NCT00450801|454316124|FG000|Overall Study|Death|1|||
126279811|NCT03452137|454316125|FG000|Overall Study|Death|67|||
126279812|NCT03452137|454316126|FG001|Overall Study|Death|70|||
126279813|NCT03452137|454316125|FG000|Overall Study|Lost to Follow-up|4|||
126279814|NCT03452137|454316126|FG001|Overall Study|Lost to Follow-up|2|||
126279815|NCT03452137|454316125|FG000|Overall Study|Physician Decision|0|||
126279816|NCT03452137|454316126|FG001|Overall Study|Physician Decision|1|||
126279817|NCT03452137|454316125|FG000|Overall Study|Study Terminated by Sponsor|120|||
126279818|NCT03452137|454316126|FG001|Overall Study|Study Terminated by Sponsor|121|||
126279819|NCT03452137|454316125|FG000|Overall Study|Withdrawal by Subject|12|||
126279820|NCT03452137|454316126|FG001|Overall Study|Withdrawal by Subject|9|||
126455624|NCT03222492|454969011|FG002|Overall Study|COVID-19 related|1|||
126455625|NCT03222492|454969012|FG003|Overall Study|COVID-19 related|0|||
126765951|NCT03733301|456095854|FG002|Overall Study|Lack of Efficacy|0|||
126279821|NCT01396512|454316127|FG000|Overall Study|Withdrawal by Subject|0|||
126279822|NCT01396512|454316128|FG001|Overall Study|Withdrawal by Subject|1|||
126279823|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
126279824|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
126455626|NCT01224782|454969015|FG000|Overall Study|Lost to Follow-up|177|||
126455627|NCT01224782|454969015|FG000|Overall Study|Withdrawal by Subject|16|||
126708364|NCT01933672|455884946|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
126708365|NCT01933672|455884947|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
126279825|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
126279826|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
126279827|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
126279828|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
126279829|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
126279830|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
126279831|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
126279832|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
126279833|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
126279834|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
126279835|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
126279836|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
126279837|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
126279838|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
126279839|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
126279840|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
126279841|NCT00261443|454316129|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
126279842|NCT00261443|454316130|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
126279843|NCT00261443|454316131|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
126279844|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
126279845|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
126279846|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
126455628|NCT01224782|454969015|FG000|Overall Study|Death|14|||
126455629|NCT01224782|454969015|FG000|Overall Study|Improvement|13|||
126455630|NCT01224782|454969015|FG000|Overall Study|Adverse Event|12|||
126455631|NCT01224782|454969015|FG000|Overall Study|Adverse Reaction|11|||
126455632|NCT01224782|454969015|FG000|Overall Study|Noncompliance|10|||
126455633|NCT01224782|454969015|FG000|Overall Study|Other|4|||
126455634|NCT01224782|454969015|FG000|Overall Study|Start of Dialysis|3|||
126455635|NCT01224782|454969015|FG000|Overall Study|Change of Treatment|1|||
126455636|NCT01224782|454969015|FG000|Overall Study|Financial Reasons|1|||
126455637|NCT01224782|454969015|FG000|Overall Study|Deterioration|1|||
126455638|NCT01224782|454969015|FG000|Overall Study|Transplantation|1|||
126455639|NCT00065429|454969018|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
126455640|NCT00065429|454969019|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
126455641|NCT00065429|454969020|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
126455642|NCT00065429|454969021|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
126455643|NCT00065429|454969022|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
126455644|NCT00065429|454969023|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
126455645|NCT00065429|454969024|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
126455646|NCT00065429|454969018|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
126455647|NCT00065429|454969019|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
126455648|NCT00065429|454969020|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
126455649|NCT00065429|454969021|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
126708366|NCT01933672|455884948|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
126279847|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
126279848|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
126279849|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
126279850|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
126279851|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
126279852|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
126279853|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
126279854|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
126279855|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
126279856|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
126279857|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
126279858|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
126279859|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
126279860|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
126279861|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
126279862|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
126279863|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
126279864|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
126455650|NCT00065429|454969022|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
126708367|NCT01933672|455884949|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
126455651|NCT00065429|454969023|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
126455652|NCT00065429|454969024|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
126455653|NCT00065429|454969018|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
126455654|NCT00065429|454969019|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
126455655|NCT00065429|454969020|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
126455656|NCT00065429|454969021|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
126455657|NCT00065429|454969022|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
126455658|NCT00065429|454969023|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
126455659|NCT00065429|454969024|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
126455660|NCT00065429|454969018|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
126455661|NCT00065429|454969019|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
126455662|NCT00065429|454969020|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
126455663|NCT00065429|454969021|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
126455664|NCT00065429|454969022|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
126455665|NCT00065429|454969023|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
126455666|NCT00065429|454969024|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
126455667|NCT00065429|454969018|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
126455668|NCT00065429|454969019|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
126455669|NCT00065429|454969020|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
126455670|NCT00065429|454969021|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
126455671|NCT00065429|454969022|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
126455672|NCT00065429|454969023|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
126455673|NCT00065429|454969024|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
126455674|NCT00065429|454969018|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
126455675|NCT00065429|454969019|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
126455676|NCT00065429|454969020|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
126455677|NCT00065429|454969021|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
126455678|NCT00065429|454969022|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
126455679|NCT00065429|454969023|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
126455680|NCT00065429|454969024|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
126455681|NCT00065429|454969018|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
126455682|NCT00065429|454969019|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
126455683|NCT00065429|454969020|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
126455684|NCT00065429|454969021|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
126455685|NCT00065429|454969022|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
126455686|NCT00065429|454969023|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
126455687|NCT00065429|454969024|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
126455688|NCT02509117|454969025|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
126455689|NCT02509117|454969026|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
126455690|NCT02509117|454969027|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
126455691|NCT02509117|454969028|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
126455692|NCT02509117|454969029|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
126455693|NCT02509117|454969030|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
126455694|NCT02509117|454969031|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
126455695|NCT02509117|454969032|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
126455696|NCT02509117|454969033|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
126455697|NCT02509117|454969034|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
126455698|NCT02509117|454969025|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
126455699|NCT02509117|454969026|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
126455700|NCT02509117|454969027|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
126455701|NCT02509117|454969028|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
126455702|NCT02509117|454969029|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
126455703|NCT02509117|454969030|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
126455704|NCT02509117|454969031|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
126455705|NCT02509117|454969032|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
126455706|NCT02509117|454969033|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
126455707|NCT02509117|454969034|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
126455708|NCT02509117|454969025|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
126455709|NCT02509117|454969026|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
126455710|NCT02509117|454969027|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
126455711|NCT02509117|454969028|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
126455712|NCT02509117|454969029|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
126455713|NCT02509117|454969030|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
126455714|NCT02509117|454969031|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
126455715|NCT02509117|454969032|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
126548655|NCT03203694|455302231|FG001|Overall Study|Withdrawal by Subject|0|||
126279865|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
126548656|NCT03203694|455302232|FG002|Overall Study|Withdrawal by Subject|0|||
126548657|NCT03203694|455302233|FG003|Overall Study|Withdrawal by Subject|0|||
126548658|NCT03203694|455302234|FG004|Overall Study|Withdrawal by Subject|0|||
126548659|NCT03203694|455302235|FG005|Overall Study|Withdrawal by Subject|0|||
126279866|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
126279867|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
126279868|NCT00261443|454316129|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
126279869|NCT00261443|454316130|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
126548660|NCT01103960|455302236|FG000|Overall Study|Adverse Event|2|||
126548661|NCT01103960|455302237|FG001|Overall Study|Adverse Event|1|||
126548662|NCT01103960|455302236|FG000|Overall Study|Withdrawal by Subject|2|||
126548663|NCT01103960|455302237|FG001|Overall Study|Withdrawal by Subject|1|||
126548664|NCT01103960|455302236|FG000|Overall Study|Other|1|||
126548665|NCT01103960|455302237|FG001|Overall Study|Other|0|||
126548666|NCT02875834|455302240|FG000|Open-label Phase|Withdrawal by Subject|3|||
126548667|NCT02875834|455302241|FG001|Open-label Phase|Withdrawal by Subject|0|||
126548668|NCT02875834|455302242|FG002|Open-label Phase|Withdrawal by Subject|0|||
126548669|NCT02875834|455302243|FG003|Open-label Phase|Withdrawal by Subject|0|||
126548670|NCT02875834|455302240|FG000|Open-label Phase|(Not collected)|4|||
126548671|NCT02875834|455302241|FG001|Open-label Phase|(Not collected)|0|||
126708368|NCT01933672|455884950|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
126708369|NCT01933672|455884951|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
126708370|NCT01933672|455884945|FG000|Metformin Run-in Period|Other|5|||
126708371|NCT01933672|455884946|FG001|Metformin Run-in Period|Other|0|||
126708372|NCT01933672|455884947|FG002|Metformin Run-in Period|Other|0|||
126708373|NCT01933672|455884948|FG003|Metformin Run-in Period|Other|0|||
126708374|NCT01933672|455884949|FG004|Metformin Run-in Period|Other|0|||
126708375|NCT01933672|455884950|FG005|Metformin Run-in Period|Other|0|||
126708376|NCT01933672|455884951|FG006|Metformin Run-in Period|Other|0|||
126708377|NCT01933672|455884945|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126708378|NCT01933672|455884946|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126708379|NCT01933672|455884947|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126708380|NCT01933672|455884948|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126708381|NCT01933672|455884949|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
126708382|NCT01933672|455884950|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126708383|NCT01933672|455884951|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126708384|NCT01933672|455884945|FG000|First Intervention Period (12-16 Days)|Other|0|||
126708385|NCT01933672|455884946|FG001|First Intervention Period (12-16 Days)|Other|0|||
126708386|NCT01933672|455884947|FG002|First Intervention Period (12-16 Days)|Other|1|||
126708387|NCT01933672|455884948|FG003|First Intervention Period (12-16 Days)|Other|0|||
126708388|NCT01933672|455884949|FG004|First Intervention Period (12-16 Days)|Other|0|||
126708389|NCT01933672|455884950|FG005|First Intervention Period (12-16 Days)|Other|1|||
126708390|NCT01933672|455884951|FG006|First Intervention Period (12-16 Days)|Other|0|||
126708391|NCT01933672|455884945|FG000|Second Intervention Period (12-16 Days)|Other|0|||
126708392|NCT01933672|455884946|FG001|Second Intervention Period (12-16 Days)|Other|1|||
126708393|NCT01933672|455884947|FG002|Second Intervention Period (12-16 Days)|Other|1|||
126708394|NCT01933672|455884948|FG003|Second Intervention Period (12-16 Days)|Other|0|||
126708395|NCT01933672|455884949|FG004|Second Intervention Period (12-16 Days)|Other|0|||
126708396|NCT01933672|455884950|FG005|Second Intervention Period (12-16 Days)|Other|0|||
126708397|NCT01933672|455884951|FG006|Second Intervention Period (12-16 Days)|Other|0|||
126708398|NCT01933672|455884945|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126708399|NCT01933672|455884946|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126708400|NCT01933672|455884947|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126708401|NCT01933672|455884948|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
126708402|NCT01933672|455884949|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126708403|NCT01933672|455884950|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126708404|NCT01933672|455884951|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
126708405|NCT01933672|455884945|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
126708406|NCT01933672|455884946|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
126708407|NCT01933672|455884947|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
126708408|NCT01933672|455884948|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
126708409|NCT01933672|455884949|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
126708410|NCT01933672|455884950|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
126708411|NCT01933672|455884951|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
126708412|NCT02426086|455884952|FG000|Overall Study|Death|33|||
126708413|NCT02426086|455884953|FG001|Overall Study|Death|36|||
126708414|NCT02426086|455884952|FG000|Overall Study|Lost to Follow-up|2|||
126708415|NCT02426086|455884953|FG001|Overall Study|Lost to Follow-up|0|||
126548672|NCT02875834|455302242|FG002|Open-label Phase|(Not collected)|0|||
126708416|NCT02426086|455884952|FG000|Overall Study|Study Terminated by Sponsor|5|||
126708417|NCT02426086|455884953|FG001|Overall Study|Study Terminated by Sponsor|14|||
126708418|NCT02426086|455884952|FG000|Overall Study|Withdrawal by Subject|8|||
126708419|NCT02426086|455884953|FG001|Overall Study|Withdrawal by Subject|9|||
126708420|NCT00524303|455884954|FG000|Overall Study|Lost to Follow-up|6|||
126708421|NCT00524303|455884955|FG001|Overall Study|Lost to Follow-up|0|||
126708422|NCT00524303|455884956|FG002|Overall Study|Lost to Follow-up|3|||
126708423|NCT00524303|455884954|FG000|Overall Study|Protocol Violation|0|||
126708424|NCT00524303|455884955|FG001|Overall Study|Protocol Violation|1|||
126708425|NCT00524303|455884956|FG002|Overall Study|Protocol Violation|1|||
126708426|NCT00524303|455884954|FG000|Overall Study|Withdrawal by Subject|3|||
126708427|NCT00524303|455884955|FG001|Overall Study|Withdrawal by Subject|0|||
126708428|NCT00524303|455884956|FG002|Overall Study|Withdrawal by Subject|4|||
126708429|NCT00524303|455884954|FG000|Overall Study|Death|0|||
126708430|NCT00524303|455884955|FG001|Overall Study|Death|2|||
126708431|NCT00524303|455884956|FG002|Overall Study|Death|3|||
126708432|NCT00524303|455884954|FG000|Overall Study|Adverse Event|1|||
126708433|NCT00524303|455884955|FG001|Overall Study|Adverse Event|2|||
126708434|NCT00524303|455884956|FG002|Overall Study|Adverse Event|3|||
126708435|NCT00524303|455884954|FG000|Overall Study|Did not Complete Study Dosing|1|||
126708436|NCT00524303|455884955|FG001|Overall Study|Did not Complete Study Dosing|0|||
126708437|NCT00524303|455884956|FG002|Overall Study|Did not Complete Study Dosing|0|||
126708438|NCT00524303|455884954|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
126708439|NCT00524303|455884955|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
126708440|NCT00524303|455884956|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
126708441|NCT00524303|455884954|FG000|Overall Study|Disease Progression|0|||
126708442|NCT00524303|455884955|FG001|Overall Study|Disease Progression|4|||
126708443|NCT00524303|455884956|FG002|Overall Study|Disease Progression|1|||
126708444|NCT00524303|455884954|FG000|Overall Study|Disease Recurrence|0|||
126708445|NCT00524303|455884955|FG001|Overall Study|Disease Recurrence|1|||
126708446|NCT00524303|455884956|FG002|Overall Study|Disease Recurrence|0|||
126708447|NCT00524303|455884954|FG000|Overall Study|Sponsor Request|0|||
126708448|NCT00524303|455884955|FG001|Overall Study|Sponsor Request|0|||
126708449|NCT00524303|455884956|FG002|Overall Study|Sponsor Request|1|||
126708450|NCT00524303|455884954|FG000|Overall Study|Physician Decision|0|||
126708451|NCT00524303|455884955|FG001|Overall Study|Physician Decision|0|||
126708452|NCT00524303|455884956|FG002|Overall Study|Physician Decision|1|||
126708453|NCT00524303|455884954|FG000|Overall Study|Completed 5 years|0|||
126708454|NCT00524303|455884955|FG001|Overall Study|Completed 5 years|0|||
126708455|NCT00524303|455884956|FG002|Overall Study|Completed 5 years|1|||
126708456|NCT00840463|455884957|FG000|Overall Study|Adverse Event|1|||
126708457|NCT00840463|455884958|FG001|Overall Study|Adverse Event|0|||
126708458|NCT02515669|455884962|FG000|228 Week Open-Label Phase|Other|0|||
126708459|NCT02515669|455884963|FG001|228 Week Open-Label Phase|Other|0|||
126708460|NCT02515669|455884964|FG002|228 Week Open-Label Phase|Other|1|||
126708461|NCT02515669|455884965|FG003|228 Week Open-Label Phase|Other|4|||
126708462|NCT02515669|455884962|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
126708463|NCT02515669|455884963|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
126708464|NCT02515669|455884964|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
126279870|NCT00261443|454316131|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
126279871|NCT00261443|454316129|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
126279872|NCT00261443|454316130|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
126279873|NCT00261443|454316131|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
126279874|NCT00261443|454316129|FG000|3: Assessment of Relapse|Adverse Event|0|||
126279875|NCT00261443|454316130|FG001|3: Assessment of Relapse|Adverse Event|15|||
126279876|NCT00261443|454316131|FG002|3: Assessment of Relapse|Adverse Event|19|||
126708465|NCT02515669|455884965|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
126708466|NCT02515669|455884962|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
126708467|NCT02515669|455884963|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
126708468|NCT02515669|455884964|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
126279877|NCT00261443|454316129|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
126279878|NCT00261443|454316130|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
126279879|NCT00261443|454316131|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
126279880|NCT00261443|454316129|FG000|3: Assessment of Relapse|Death|0|||
126279881|NCT00261443|454316130|FG001|3: Assessment of Relapse|Death|0|||
126279882|NCT00261443|454316131|FG002|3: Assessment of Relapse|Death|1|||
126279883|NCT00261443|454316129|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
126708469|NCT02515669|455884965|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
126765952|NCT03733301|456095852|FG000|Overall Study|Adverse Event|0|||
126279884|NCT00261443|454316130|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
126279885|NCT00261443|454316131|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
126708470|NCT02515669|455884962|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
126708471|NCT02515669|455884963|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
126708472|NCT02515669|455884964|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
126708473|NCT02515669|455884965|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
126279886|NCT00261443|454316129|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
126279887|NCT00261443|454316130|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
126279888|NCT00261443|454316131|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
126279889|NCT00261443|454316129|FG000|3: Assessment of Relapse|Pregnancy|0|||
126279890|NCT00261443|454316130|FG001|3: Assessment of Relapse|Pregnancy|2|||
126279891|NCT00261443|454316131|FG002|3: Assessment of Relapse|Pregnancy|1|||
126279892|NCT00261443|454316129|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
126279893|NCT00261443|454316130|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
126279894|NCT00261443|454316131|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
126279895|NCT00261443|454316129|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
126279896|NCT00261443|454316130|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
126279897|NCT00261443|454316131|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
126279898|NCT00261443|454316129|FG000|3: Assessment of Relapse|Other Reasons|0|||
126279899|NCT00261443|454316130|FG001|3: Assessment of Relapse|Other Reasons|4|||
126279900|NCT00261443|454316131|FG002|3: Assessment of Relapse|Other Reasons|3|||
126279901|NCT00261443|454316129|FG000|4: Extension Phase|Adverse Event|0|||
126279902|NCT00261443|454316130|FG001|4: Extension Phase|Adverse Event|1|||
126279903|NCT00261443|454316131|FG002|4: Extension Phase|Adverse Event|0|||
126279904|NCT00261443|454316129|FG000|4: Extension Phase|Withdrawal by Subject|0|||
126279905|NCT00261443|454316130|FG001|4: Extension Phase|Withdrawal by Subject|1|||
126279906|NCT00261443|454316131|FG002|4: Extension Phase|Withdrawal by Subject|2|||
126279907|NCT00261443|454316129|FG000|4: Extension Phase|Lost to Follow-up|0|||
126279908|NCT00261443|454316130|FG001|4: Extension Phase|Lost to Follow-up|1|||
126279909|NCT00261443|454316131|FG002|4: Extension Phase|Lost to Follow-up|0|||
126279910|NCT02755649|454316132|FG000|Overall Study|Transitioned into OLE study|99|||
126279911|NCT02755649|454316133|FG001|Overall Study|Transitioned into OLE study|98|||
126279912|NCT02755649|454316134|FG002|Overall Study|Transitioned into OLE study|100|||
126279913|NCT02755649|454316132|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
126279914|NCT02755649|454316133|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
126279915|NCT02755649|454316134|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
126279916|NCT02755649|454316132|FG000|Overall Study|Physician Decision|0|||
126279917|NCT02755649|454316133|FG001|Overall Study|Physician Decision|0|||
126279918|NCT02755649|454316134|FG002|Overall Study|Physician Decision|2|||
126279919|NCT02755649|454316132|FG000|Overall Study|Withdrawal by Subject|0|||
126279920|NCT02755649|454316133|FG001|Overall Study|Withdrawal by Subject|1|||
126279921|NCT02755649|454316134|FG002|Overall Study|Withdrawal by Subject|0|||
126279922|NCT02755649|454316132|FG000|Overall Study|Undecided|1|||
126279923|NCT02755649|454316133|FG001|Overall Study|Undecided|0|||
126279924|NCT02755649|454316134|FG002|Overall Study|Undecided|0|||
126279925|NCT01286753|454316135|FG000|Overall Study|Adverse Event|7|||
126279926|NCT01286753|454316136|FG001|Overall Study|Adverse Event|6|||
126279927|NCT01286753|454316135|FG000|Overall Study|Progression|11|||
126279928|NCT01286753|454316136|FG001|Overall Study|Progression|13|||
126279929|NCT01286753|454316135|FG000|Overall Study|Refused Treatment|1|||
126279930|NCT01286753|454316136|FG001|Overall Study|Refused Treatment|0|||
126279931|NCT01286753|454316135|FG000|Overall Study|Withdrawal of Consent|0|||
126279932|NCT01286753|454316136|FG001|Overall Study|Withdrawal of Consent|2|||
126279933|NCT01286753|454316135|FG000|Overall Study|Discontinued to Join Extension Study|6|||
126279934|NCT01286753|454316136|FG001|Overall Study|Discontinued to Join Extension Study|4|||
126279935|NCT01286753|454316135|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
126279936|NCT01286753|454316136|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
126279937|NCT02094417|454316144|FG000|Overall Study|Adverse Event|0|||
126279938|NCT02094417|454316145|FG001|Overall Study|Adverse Event|0|||
126279939|NCT02094417|454316146|FG002|Overall Study|Adverse Event|0|||
126279940|NCT02094417|454316147|FG003|Overall Study|Adverse Event|1|||
126279941|NCT02094417|454316144|FG000|Overall Study|Eligibility criteria|0|||
126279942|NCT02094417|454316145|FG001|Overall Study|Eligibility criteria|1|||
126279943|NCT02094417|454316146|FG002|Overall Study|Eligibility criteria|0|||
126279944|NCT02094417|454316147|FG003|Overall Study|Eligibility criteria|0|||
126279945|NCT02094417|454316144|FG000|Overall Study|No responder|4|||
126279946|NCT02094417|454316145|FG001|Overall Study|No responder|4|||
126279947|NCT02094417|454316146|FG002|Overall Study|No responder|4|||
126279948|NCT02094417|454316147|FG003|Overall Study|No responder|3|||
126279949|NCT02094417|454316144|FG000|Overall Study|Unable to conduct observations or assess|0|||
126279950|NCT02094417|454316145|FG001|Overall Study|Unable to conduct observations or assess|1|||
126279951|NCT02094417|454316146|FG002|Overall Study|Unable to conduct observations or assess|0|||
126708474|NCT02515669|455884962|FG000|228 Week Open-Label Phase|Missing|0|||
126708475|NCT02515669|455884963|FG001|228 Week Open-Label Phase|Missing|2|||
126279952|NCT02094417|454316147|FG003|Overall Study|Unable to conduct observations or assess|0|||
126279953|NCT02094417|454316144|FG000|Overall Study|Withdrawal by Subject|1|||
126279954|NCT02094417|454316145|FG001|Overall Study|Withdrawal by Subject|2|||
126279955|NCT02094417|454316146|FG002|Overall Study|Withdrawal by Subject|1|||
126279956|NCT02094417|454316147|FG003|Overall Study|Withdrawal by Subject|3|||
126548673|NCT02875834|455302243|FG003|Open-label Phase|(Not collected)|0|||
126708476|NCT02515669|455884964|FG002|228 Week Open-Label Phase|Missing|2|||
126279957|NCT03301649|454316150|FG000|Overall Study|Need alternate therapy due to live lice|17|||
126279958|NCT03301649|454316151|FG001|Overall Study|Need alternate therapy due to live lice|25|||
126279959|NCT03301649|454316152|FG002|Overall Study|Need alternate therapy due to live lice|81|||
126279960|NCT03301649|454316150|FG000|Overall Study|Lost to Follow-up|11|||
126279961|NCT03301649|454316151|FG001|Overall Study|Lost to Follow-up|11|||
126279962|NCT03301649|454316152|FG002|Overall Study|Lost to Follow-up|3|||
126279963|NCT03301649|454316150|FG000|Overall Study|Protocol Violation|0|||
126279964|NCT03301649|454316151|FG001|Overall Study|Protocol Violation|1|||
126279965|NCT03301649|454316152|FG002|Overall Study|Protocol Violation|1|||
126279966|NCT03301649|454316150|FG000|Overall Study|Withdrawal by Subject|10|||
126279967|NCT03301649|454316151|FG001|Overall Study|Withdrawal by Subject|4|||
126279968|NCT03301649|454316152|FG002|Overall Study|Withdrawal by Subject|0|||
126279969|NCT03301649|454316150|FG000|Overall Study|Other than specified|5|||
126279970|NCT03301649|454316151|FG001|Overall Study|Other than specified|3|||
126279971|NCT03301649|454316152|FG002|Overall Study|Other than specified|0|||
126279972|NCT01564537|454316153|FG000|Overall Study|Site Terminated by Sponsor|1|||
126279973|NCT01564537|454316154|FG001|Overall Study|Site Terminated by Sponsor|0|||
126279974|NCT01564537|454316153|FG000|Overall Study|Withdrawal by Subject|12|||
126279975|NCT01564537|454316154|FG001|Overall Study|Withdrawal by Subject|14|||
126279976|NCT01564537|454316153|FG000|Overall Study|Lost to Follow-up|7|||
126279977|NCT01564537|454316154|FG001|Overall Study|Lost to Follow-up|3|||
126279978|NCT01564537|454316153|FG000|Overall Study|Reason not specified|81|||
126279979|NCT01564537|454316154|FG001|Overall Study|Reason not specified|82|||
126279980|NCT01635218|454316155|FG000|Overall Study|Lost to Follow-up|3|||
126279981|NCT01635218|454316156|FG001|Overall Study|Lost to Follow-up|7|||
126279982|NCT01635218|454316157|FG002|Overall Study|Lost to Follow-up|6|||
126279983|NCT03559400|454316158|FG000|Overall Study|Lost to Follow-up|9|||
126279984|NCT03559400|454316159|FG001|Overall Study|Lost to Follow-up|7|||
126279985|NCT03559400|454316158|FG000|Overall Study|Death|0|||
126279986|NCT03559400|454316159|FG001|Overall Study|Death|2|||
126279987|NCT03262038|454316160|FG000|Overall Study|Withdrawal by Subject|0|||
126279988|NCT03262038|454316161|FG001|Overall Study|Withdrawal by Subject|1|||
126279989|NCT02679235|454316162|FG000|Overall Study|Withdrawal by Subject|3|||
126279990|NCT02679235|454316162|FG000|Overall Study|Adverse Event|1|||
126279991|NCT00094861|454316163|FG000|Overall Study|Adverse Event|5|||
126279992|NCT00094861|454316164|FG001|Overall Study|Adverse Event|2|||
126279993|NCT00094861|454316163|FG000|Overall Study|Withdrawal by Subject|5|||
126279994|NCT00094861|454316164|FG001|Overall Study|Withdrawal by Subject|3|||
126279995|NCT00094861|454316163|FG000|Overall Study|Physician Decision|1|||
126279996|NCT00094861|454316164|FG001|Overall Study|Physician Decision|1|||
126455716|NCT02509117|454969033|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
126455717|NCT02509117|454969034|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
126455718|NCT00548184|454969037|FG000|Overall Study|Adverse Event|3|||
126455719|NCT00548184|454969037|FG000|Overall Study|took other drug|1|||
126455720|NCT00548184|454969037|FG000|Overall Study|Found Her2 negative|1|||
126455721|NCT00313781|454969038|FG000|Before Crossover|Death|22|||
126455722|NCT00313781|454969039|FG001|Before Crossover|Death|8|||
126765953|NCT03733301|456095853|FG001|Overall Study|Adverse Event|1|||
126765954|NCT03733301|456095854|FG002|Overall Study|Adverse Event|3|||
126765955|NCT03733301|456095852|FG000|Overall Study|Withdrawal by Subject|3|||
126765956|NCT03733301|456095853|FG001|Overall Study|Withdrawal by Subject|5|||
126765957|NCT03733301|456095854|FG002|Overall Study|Withdrawal by Subject|1|||
126765958|NCT00807040|456095858|FG000|Overall Study|Death|24|||
126765959|NCT00807040|456095859|FG001|Overall Study|Death|29|||
126765960|NCT00807040|456095858|FG000|Overall Study|Withdrawal by Subject|8|||
126765961|NCT00807040|456095859|FG001|Overall Study|Withdrawal by Subject|6|||
126279997|NCT00094861|454316163|FG000|Overall Study|Lost to Follow-up|0|||
126279998|NCT00094861|454316164|FG001|Overall Study|Lost to Follow-up|1|||
126279999|NCT00094861|454316163|FG000|Overall Study|Death|4|||
126765962|NCT00807040|456095858|FG000|Overall Study|Lost to Follow-up|4|||
126280000|NCT00094861|454316164|FG001|Overall Study|Death|2|||
126280001|NCT00094861|454316163|FG000|Overall Study|Other|3|||
126280002|NCT00094861|454316164|FG001|Overall Study|Other|0|||
126280003|NCT00253448|454316170|FG000|Overall Study|Withdrawal by Subject|1|||
126455723|NCT00313781|454969040|FG002|Before Crossover|Death|0|||
126455724|NCT00313781|454969038|FG000|Before Crossover|Lost to Follow-up|0|||
126455725|NCT00313781|454969039|FG001|Before Crossover|Lost to Follow-up|3|||
126455726|NCT00313781|454969040|FG002|Before Crossover|Lost to Follow-up|0|||
126765963|NCT00807040|456095859|FG001|Overall Study|Lost to Follow-up|6|||
126280004|NCT02564887|454316171|FG000|Overall Study|Lost to Follow-up|6|||
126280005|NCT02564887|454316172|FG001|Overall Study|Lost to Follow-up|0|||
126280006|NCT00000620|454316173|FG000|Overall Study|Death|86|||
126280007|NCT00000620|454316174|FG001|Overall Study|Death|67|||
126455727|NCT00313781|454969038|FG000|Before Crossover|Withdrawal by Subject|3|||
126455728|NCT00313781|454969039|FG001|Before Crossover|Withdrawal by Subject|1|||
126280008|NCT00000620|454316175|FG002|Overall Study|Death|112|||
126280009|NCT00000620|454316176|FG003|Overall Study|Death|126|||
126280010|NCT00000620|454316177|FG004|Overall Study|Death|64|||
126280011|NCT00000620|454316178|FG005|Overall Study|Death|77|||
126708477|NCT02515669|455884965|FG003|228 Week Open-Label Phase|Missing|2|||
126708478|NCT01739595|455884966|FG000|Overall Study|Adverse Event|3|||
126708479|NCT01739595|455884967|FG001|Overall Study|Adverse Event|0|||
126708480|NCT01739595|455884968|FG002|Overall Study|Adverse Event|0|||
126708481|NCT01739595|455884966|FG000|Overall Study|Lost to Follow-up|2|||
126708482|NCT01739595|455884967|FG001|Overall Study|Lost to Follow-up|0|||
126708483|NCT01739595|455884968|FG002|Overall Study|Lost to Follow-up|0|||
126708484|NCT01739595|455884966|FG000|Overall Study|Withdrawal by Subject|2|||
126708485|NCT01739595|455884967|FG001|Overall Study|Withdrawal by Subject|1|||
126708486|NCT01739595|455884968|FG002|Overall Study|Withdrawal by Subject|2|||
126708487|NCT01739595|455884966|FG000|Overall Study|Eligibility issue|3|||
126708488|NCT01739595|455884967|FG001|Overall Study|Eligibility issue|0|||
126708489|NCT01739595|455884968|FG002|Overall Study|Eligibility issue|0|||
126280012|NCT00000620|454316179|FG006|Overall Study|Death|91|||
126280013|NCT00000620|454316180|FG007|Overall Study|Death|95|||
126708490|NCT01739595|455884966|FG000|Overall Study|Protocol Violation|1|||
126708491|NCT01739595|455884967|FG001|Overall Study|Protocol Violation|0|||
126708492|NCT01739595|455884968|FG002|Overall Study|Protocol Violation|0|||
126708493|NCT01739595|455884966|FG000|Overall Study|Lab assessment|1|||
126708494|NCT01739595|455884967|FG001|Overall Study|Lab assessment|0|||
126708495|NCT01739595|455884968|FG002|Overall Study|Lab assessment|0|||
126708496|NCT01739595|455884966|FG000|Overall Study|Drug discrepancy|1|||
126708497|NCT01739595|455884967|FG001|Overall Study|Drug discrepancy|0|||
126708498|NCT01739595|455884968|FG002|Overall Study|Drug discrepancy|0|||
126708499|NCT03750838|455884971|FG000|Overall Study|Lost to Follow-up|10|||
126708500|NCT03750838|455884972|FG001|Overall Study|Lost to Follow-up|6|||
126708501|NCT01676116|455884974|FG000|Overall Study|Withdrawal criteria|2|||
126708502|NCT01676116|455884975|FG001|Overall Study|Withdrawal criteria|14|||
126708503|NCT01676116|455884974|FG000|Overall Study|Adverse Event|1|||
126708504|NCT01676116|455884975|FG001|Overall Study|Adverse Event|2|||
126708505|NCT01676116|455884974|FG000|Overall Study|Unclassified|4|||
126708506|NCT01676116|455884975|FG001|Overall Study|Unclassified|10|||
126708507|NCT01676116|455884974|FG000|Overall Study|Protocol Violation|9|||
126708508|NCT01676116|455884975|FG001|Overall Study|Protocol Violation|3|||
126708509|NCT01769404|455884980|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
126280014|NCT00000620|454316173|FG000|Overall Study|Lost to Follow-up|14|||
126280015|NCT00000620|454316174|FG001|Overall Study|Lost to Follow-up|14|||
126280016|NCT00000620|454316175|FG002|Overall Study|Lost to Follow-up|14|||
126280017|NCT00000620|454316176|FG003|Overall Study|Lost to Follow-up|14|||
126280018|NCT00000620|454316177|FG004|Overall Study|Lost to Follow-up|15|||
126280019|NCT00000620|454316178|FG005|Overall Study|Lost to Follow-up|15|||
126280020|NCT00000620|454316179|FG006|Overall Study|Lost to Follow-up|13|||
126455729|NCT00313781|454969040|FG002|Before Crossover|Withdrawal by Subject|0|||
126455730|NCT00313781|454969038|FG000|Before Crossover|Other|45|||
126455731|NCT00313781|454969039|FG001|Before Crossover|Other|30|||
126455732|NCT00313781|454969040|FG002|Before Crossover|Other|0|||
126455733|NCT00313781|454969038|FG000|Before Crossover|Crossover|0|||
126455734|NCT00313781|454969039|FG001|Before Crossover|Crossover|37|||
126455735|NCT00313781|454969040|FG002|Before Crossover|Crossover|0|||
126708510|NCT01769404|455884981|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
126280021|NCT00000620|454316180|FG007|Overall Study|Lost to Follow-up|14|||
126280022|NCT00000620|454316173|FG000|Overall Study|Withdrawal by Subject|40|||
126280023|NCT00000620|454316174|FG001|Overall Study|Withdrawal by Subject|27|||
126280024|NCT00000620|454316175|FG002|Overall Study|Withdrawal by Subject|28|||
126280025|NCT00000620|454316176|FG003|Overall Study|Withdrawal by Subject|27|||
126280026|NCT00000620|454316177|FG004|Overall Study|Withdrawal by Subject|30|||
126280027|NCT00000620|454316178|FG005|Overall Study|Withdrawal by Subject|32|||
126280028|NCT00000620|454316179|FG006|Overall Study|Withdrawal by Subject|32|||
126280029|NCT00000620|454316180|FG007|Overall Study|Withdrawal by Subject|21|||
126280030|NCT00000620|454316173|FG000|Overall Study|missed closeout visit|22|||
126280031|NCT00000620|454316174|FG001|Overall Study|missed closeout visit|28|||
126280032|NCT00000620|454316175|FG002|Overall Study|missed closeout visit|16|||
126280033|NCT00000620|454316176|FG003|Overall Study|missed closeout visit|11|||
126280034|NCT00000620|454316177|FG004|Overall Study|missed closeout visit|26|||
126455736|NCT00313781|454969038|FG000|Before Crossover|Randomized, not treated|5|||
126708511|NCT01769404|455884980|FG000|Treatment Period 1|Withdrawal by Subject|3|||
126708512|NCT01769404|455884981|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126708513|NCT01769404|455884980|FG000|Treatment Period 1|Sponsor decision|1|||
126708514|NCT01769404|455884981|FG001|Treatment Period 1|Sponsor decision|0|||
126708515|NCT01769404|455884980|FG000|Treatment Period 2|Sponsor decision|7|||
126765964|NCT00625846|456095860|FG000|Overall Study|Withdrawal by Subject|2|||
126280035|NCT00000620|454316178|FG005|Overall Study|missed closeout visit|28|||
126280036|NCT00000620|454316179|FG006|Overall Study|missed closeout visit|13|||
126280037|NCT00000620|454316180|FG007|Overall Study|missed closeout visit|16|||
126455737|NCT00313781|454969039|FG001|Before Crossover|Randomized, not treated|0|||
126455738|NCT00313781|454969040|FG002|Before Crossover|Randomized, not treated|0|||
126708516|NCT01769404|455884981|FG001|Treatment Period 2|Sponsor decision|0|||
126708517|NCT00538733|455884982|FG000|Overall Study|Adverse Event|8|||
126708518|NCT00538733|455884982|FG000|Overall Study|Death|1|||
126280038|NCT01199016|454316181|FG000|Overall Study|No longer meets eligibility criteria|4|||
126280039|NCT01199016|454316181|FG000|Overall Study|Entrance criteria|5|||
126280040|NCT01199016|454316181|FG000|Overall Study|Protocol Violation|9|||
126280041|NCT01199016|454316181|FG000|Overall Study|Other|13|||
126280042|NCT01199016|454316181|FG000|Overall Study|Withdrawal by Subject|21|||
126280043|NCT01199016|454316181|FG000|Overall Study|Lost to Follow-up|25|||
126280044|NCT00314951|454316190|FG000|Treatment|Didn't meet criteria for mITT population|16|||
126280045|NCT00314951|454316191|FG001|Treatment|Didn't meet criteria for mITT population|11|||
126280046|NCT00314951|454316190|FG000|Follow-up|mITT failure|44|||
126280047|NCT00314951|454316191|FG001|Follow-up|mITT failure|34|||
126280048|NCT05320887|454316194|FG000|Overall Study|Lost to Follow-up|0|||
126280049|NCT05320887|454316195|FG001|Overall Study|Lost to Follow-up|3|||
126280050|NCT05320887|454316196|FG002|Overall Study|Lost to Follow-up|0|||
126280051|NCT05320887|454316197|FG003|Overall Study|Lost to Follow-up|0|||
126280052|NCT02015065|454316202|FG000|Overall Study|Death on study|1|||
126280053|NCT02015065|454316203|FG001|Overall Study|Death on study|2|||
126280054|NCT02015065|454316204|FG002|Overall Study|Death on study|1|||
126280055|NCT01671332|454316237|FG000|Overall Study|Withdrawal by Subject|1|||
126280056|NCT01671332|454316238|FG001|Overall Study|Withdrawal by Subject|1|||
126280057|NCT02728843|454316239|FG000|Overall Study|Adverse Event|0|||
126280058|NCT02728843|454316240|FG001|Overall Study|Adverse Event|2|||
126280059|NCT02728843|454316241|FG002|Overall Study|Adverse Event|3|||
126280060|NCT02728843|454316242|FG003|Overall Study|Adverse Event|1|||
126280061|NCT02728843|454316243|FG004|Overall Study|Adverse Event|2|||
126280062|NCT02728843|454316239|FG000|Overall Study|Lack of Efficacy|0|||
126280063|NCT02728843|454316240|FG001|Overall Study|Lack of Efficacy|1|||
126280064|NCT02728843|454316241|FG002|Overall Study|Lack of Efficacy|1|||
126280065|NCT02728843|454316242|FG003|Overall Study|Lack of Efficacy|0|||
126280066|NCT02728843|454316243|FG004|Overall Study|Lack of Efficacy|0|||
126280067|NCT02728843|454316239|FG000|Overall Study|Protocol Violation|2|||
126280068|NCT02728843|454316240|FG001|Overall Study|Protocol Violation|0|||
126280069|NCT02728843|454316241|FG002|Overall Study|Protocol Violation|4|||
126280070|NCT02728843|454316242|FG003|Overall Study|Protocol Violation|2|||
126280071|NCT02728843|454316243|FG004|Overall Study|Protocol Violation|2|||
126280072|NCT02728843|454316239|FG000|Overall Study|Withdrawal by Subject|1|||
126280073|NCT02728843|454316240|FG001|Overall Study|Withdrawal by Subject|0|||
126280074|NCT02728843|454316241|FG002|Overall Study|Withdrawal by Subject|0|||
126280075|NCT02728843|454316242|FG003|Overall Study|Withdrawal by Subject|1|||
126280076|NCT02728843|454316243|FG004|Overall Study|Withdrawal by Subject|0|||
126280077|NCT02728843|454316239|FG000|Overall Study|Use of rescue medication|0|||
126280078|NCT02728843|454316240|FG001|Overall Study|Use of rescue medication|2|||
126280079|NCT02728843|454316241|FG002|Overall Study|Use of rescue medication|0|||
126280080|NCT02728843|454316242|FG003|Overall Study|Use of rescue medication|2|||
126280081|NCT02728843|454316243|FG004|Overall Study|Use of rescue medication|1|||
126280082|NCT01806506|454316245|FG000|Overall Study|Lost to Follow-up|2|||
126280083|NCT01806506|454316246|FG001|Overall Study|Lost to Follow-up|1|||
126280084|NCT04844762|454316251|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280085|NCT04844762|454316252|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280086|NCT04844762|454316253|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
126280087|NCT04844762|454316254|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280088|NCT04844762|454316255|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280089|NCT04844762|454316256|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280090|NCT04844762|454316251|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
126455739|NCT00313781|454969038|FG000|After Crossover|Death|0|||
126455740|NCT00313781|454969039|FG001|After Crossover|Death|0|||
126455741|NCT00313781|454969040|FG002|After Crossover|Death|6|||
126455742|NCT00313781|454969038|FG000|After Crossover|Withdrawal by Subject|0|||
126455743|NCT00313781|454969039|FG001|After Crossover|Withdrawal by Subject|0|||
126455744|NCT00313781|454969040|FG002|After Crossover|Withdrawal by Subject|3|||
126455745|NCT00313781|454969038|FG000|After Crossover|Other|0|||
126280091|NCT04844762|454316252|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
126280092|NCT04844762|454316253|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
126280093|NCT04844762|454316254|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
126280094|NCT04844762|454316255|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
126280095|NCT04844762|454316256|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
126280096|NCT04844762|454316251|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280097|NCT04844762|454316252|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280098|NCT04844762|454316253|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
126455746|NCT00313781|454969039|FG001|After Crossover|Other|0|||
126280099|NCT04844762|454316254|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
126280100|NCT04844762|454316255|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280101|NCT04844762|454316256|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
126280102|NCT04844762|454316251|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126455747|NCT00313781|454969040|FG002|After Crossover|Other|18|||
126765965|NCT00625846|456095861|FG001|Overall Study|Withdrawal by Subject|0|||
126280103|NCT04844762|454316252|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280104|NCT04844762|454316253|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
126280105|NCT04844762|454316254|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
126280106|NCT04844762|454316255|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
126280107|NCT04844762|454316256|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280108|NCT04844762|454316251|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
126280109|NCT04844762|454316252|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
126280110|NCT04844762|454316253|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280111|NCT04844762|454316254|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280112|NCT04844762|454316255|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126455748|NCT03567343|454969042|FG000|Overall Study|Lost to Follow-up|2|||
126280113|NCT04844762|454316256|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280114|NCT04844762|454316251|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
126280115|NCT04844762|454316252|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280116|NCT04844762|454316253|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280117|NCT04844762|454316254|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280118|NCT04844762|454316255|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280119|NCT04844762|454316256|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280120|NCT04844762|454316251|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280121|NCT04844762|454316252|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280122|NCT04844762|454316253|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280123|NCT04844762|454316254|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280124|NCT04844762|454316255|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
126280125|NCT04844762|454316256|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
126280126|NCT04844762|454316251|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
126280127|NCT04844762|454316252|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280128|NCT04844762|454316253|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280129|NCT04844762|454316254|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280130|NCT04844762|454316255|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280131|NCT04844762|454316256|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
126280132|NCT04844762|454316251|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
126280133|NCT04844762|454316252|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280134|NCT04844762|454316253|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280135|NCT04844762|454316254|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280136|NCT04844762|454316255|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
126280137|NCT04844762|454316256|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
126280138|NCT04844762|454316251|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
126280139|NCT04844762|454316252|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
126280140|NCT04844762|454316253|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
126280141|NCT04844762|454316254|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
126280142|NCT04844762|454316255|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
126280143|NCT04844762|454316256|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
126280144|NCT04844762|454316251|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
126280145|NCT04844762|454316252|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
126280146|NCT04844762|454316253|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
126280147|NCT04844762|454316254|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
126280148|NCT04844762|454316255|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
126280149|NCT04844762|454316256|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
126280150|NCT00477633|454316257|FG000|Overall Study|Did not receive treatment|23|||
126280151|NCT00477633|454316257|FG000|Overall Study|Adverse Event|143|||
126280152|NCT00477633|454316257|FG000|Overall Study|Pregnancy|23|||
126280153|NCT00477633|454316257|FG000|Overall Study|Lost to Follow-up|271|||
126280154|NCT00477633|454316257|FG000|Overall Study|Withdrawal by Subject|149|||
126280155|NCT00477633|454316257|FG000|Overall Study|Protocol Violation|25|||
126280156|NCT00477633|454316257|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
126280157|NCT04123561|454316263|FG000|Overall Study|Lost to Follow-up|20|||
126280158|NCT04123561|454316264|FG001|Overall Study|Lost to Follow-up|12|||
126280159|NCT04123561|454316265|FG002|Overall Study|Lost to Follow-up|5|||
126280160|NCT04123561|454316263|FG000|Overall Study|Withdrawal by Subject|9|||
126280161|NCT04123561|454316264|FG001|Overall Study|Withdrawal by Subject|7|||
126280162|NCT04123561|454316265|FG002|Overall Study|Withdrawal by Subject|9|||
126280163|NCT04123561|454316263|FG000|Overall Study|Lack of Efficacy|7|||
126280164|NCT04123561|454316264|FG001|Overall Study|Lack of Efficacy|8|||
126280165|NCT04123561|454316265|FG002|Overall Study|Lack of Efficacy|6|||
126280166|NCT04123561|454316263|FG000|Overall Study|Adverse Event|5|||
126280167|NCT04123561|454316264|FG001|Overall Study|Adverse Event|2|||
126455749|NCT03567343|454969043|FG001|Overall Study|Lost to Follow-up|1|||
126455750|NCT03567343|454969042|FG000|Overall Study|No longer eligible|2|||
126280168|NCT04123561|454316265|FG002|Overall Study|Adverse Event|3|||
126280169|NCT04123561|454316263|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
126280170|NCT04123561|454316264|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
126280171|NCT04123561|454316265|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
126280172|NCT04123561|454316263|FG000|Overall Study|Death|0|||
126280173|NCT04123561|454316264|FG001|Overall Study|Death|0|||
126280174|NCT04123561|454316265|FG002|Overall Study|Death|1|||
126280175|NCT04123561|454316263|FG000|Overall Study|Protocol Violation|0|||
126280176|NCT04123561|454316264|FG001|Overall Study|Protocol Violation|1|||
126280177|NCT04123561|454316265|FG002|Overall Study|Protocol Violation|0|||
126280178|NCT01374269|454316273|FG000|Overall Study|Withdrawal by Subject|4|||
126280179|NCT01374269|454316274|FG001|Overall Study|Withdrawal by Subject|0|||
126280180|NCT01374269|454316273|FG000|Overall Study|Lost to Follow-up|1|||
126280181|NCT01374269|454316274|FG001|Overall Study|Lost to Follow-up|3|||
126280182|NCT01374269|454316273|FG000|Overall Study|closed research|1|||
126280183|NCT01374269|454316274|FG001|Overall Study|closed research|2|||
126280184|NCT01987479|454316275|FG000|Overall Study|Protocol Violation|1|||
126280185|NCT01987479|454316275|FG000|Overall Study|Physician Decision|2|||
126280186|NCT01987479|454316275|FG000|Overall Study|Participant/legal guardian decision|1|||
126280187|NCT01987479|454316275|FG000|Overall Study|Other|5|||
126280188|NCT01987479|454316275|FG000|Overall Study|Lost to Follow-up|1|||
126280189|NCT01987479|454316275|FG000|Overall Study|Adverse Event|7|||
126280190|NCT00278889|454316276|FG000|Overall Study|Withdrawal by Subject|0|||
126280191|NCT00278889|454316277|FG001|Overall Study|Withdrawal by Subject|5|||
126280192|NCT00278889|454316278|FG002|Overall Study|Withdrawal by Subject|3|||
126280193|NCT00278889|454316276|FG000|Overall Study|Lost to Follow-up|1|||
126280194|NCT00278889|454316277|FG001|Overall Study|Lost to Follow-up|1|||
126280195|NCT00278889|454316278|FG002|Overall Study|Lost to Follow-up|0|||
126280196|NCT00278889|454316276|FG000|Overall Study|Death|24|||
126280197|NCT00278889|454316277|FG001|Overall Study|Death|21|||
126280198|NCT00278889|454316278|FG002|Overall Study|Death|17|||
126280199|NCT04998851|454318248|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
126548674|NCT02875834|455302240|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
126548675|NCT02875834|455302241|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
126548676|NCT02875834|455302242|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
126548677|NCT02875834|455302243|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
126548678|NCT02875834|455302240|FG000|Randomized Treatment Phase|Protocol Violation|0|||
126548679|NCT02875834|455302241|FG001|Randomized Treatment Phase|Protocol Violation|2|||
126548680|NCT02875834|455302242|FG002|Randomized Treatment Phase|Protocol Violation|0|||
126548681|NCT02875834|455302243|FG003|Randomized Treatment Phase|Protocol Violation|0|||
126548682|NCT02875834|455302240|FG000|Randomized Treatment Phase|(Not collected)|0|||
126548683|NCT02875834|455302241|FG001|Randomized Treatment Phase|(Not collected)|9|||
126548684|NCT02875834|455302242|FG002|Randomized Treatment Phase|(Not collected)|10|||
126548685|NCT02875834|455302243|FG003|Randomized Treatment Phase|(Not collected)|9|||
126548686|NCT01032044|455302244|FG000|Overall Study|Protocol Violation|14|||
126548687|NCT01032044|455302245|FG001|Overall Study|Protocol Violation|8|||
126548688|NCT01032044|455302244|FG000|Overall Study|Adverse Event|0|||
126548689|NCT01032044|455302245|FG001|Overall Study|Adverse Event|1|||
126548690|NCT01032044|455302244|FG000|Overall Study|Lost to Follow-up|11|||
126548691|NCT01032044|455302245|FG001|Overall Study|Lost to Follow-up|11|||
126548692|NCT03311230|455302248|FG000|Overall Study|Withdrawal by Subject|1|||
126548693|NCT03311230|455302249|FG001|Overall Study|Withdrawal by Subject|4|||
126548694|NCT03311230|455302250|FG002|Overall Study|Withdrawal by Subject|2|||
126548695|NCT03311230|455302251|FG003|Overall Study|Withdrawal by Subject|7|||
126548696|NCT03311230|455302248|FG000|Overall Study|Unrelated injury|0|||
126548697|NCT03311230|455302249|FG001|Overall Study|Unrelated injury|1|||
126548698|NCT03311230|455302250|FG002|Overall Study|Unrelated injury|0|||
126548699|NCT03311230|455302251|FG003|Overall Study|Unrelated injury|0|||
126548700|NCT01302938|455302252|FG000|Overall Study|Withdrawal by Subject|1|||
126708519|NCT00538733|455884982|FG000|Overall Study|declined to participate|2|||
126708520|NCT00538733|455884982|FG000|Overall Study|still on therapy|1|||
126280200|NCT04998851|454318249|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
126280201|NCT04998851|454318248|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
126548701|NCT01302938|455302253|FG001|Overall Study|Withdrawal by Subject|0|||
126548702|NCT01302938|455302252|FG000|Overall Study|Adverse Event|1|||
126548703|NCT01302938|455302253|FG001|Overall Study|Adverse Event|0|||
126548704|NCT03342053|455302254|FG000|Overall Study|Adverse Event|2|||
126548705|NCT03342053|455302255|FG001|Overall Study|Adverse Event|0|||
126708521|NCT00095121|455884987|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
126708522|NCT00095121|455884988|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
126280202|NCT04998851|454318249|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
126280203|NCT04933968|454318253|FG000|Overall Study|Adverse Event|0|||
126280204|NCT04933968|454318254|FG001|Overall Study|Adverse Event|0|||
126280205|NCT04933968|454318255|FG002|Overall Study|Adverse Event|1|||
126280206|NCT04933968|454318256|FG003|Overall Study|Adverse Event|1|||
126280207|NCT04933968|454318257|FG004|Overall Study|Adverse Event|0|||
126548706|NCT03342053|455302254|FG000|Overall Study|Withdrawal by Subject|0|||
126548707|NCT03342053|455302255|FG001|Overall Study|Withdrawal by Subject|1|||
126548708|NCT01233609|455302256|FG000|Overall Study|Death|1|||
126548709|NCT01233609|455302257|FG001|Overall Study|Death|0|||
126548710|NCT01233609|455302256|FG000|Overall Study|Lost to Follow-up|3|||
126548711|NCT01233609|455302257|FG001|Overall Study|Lost to Follow-up|1|||
126548712|NCT01233609|455302256|FG000|Overall Study|Adverse Event|2|||
126548713|NCT01233609|455302257|FG001|Overall Study|Adverse Event|1|||
126548714|NCT01233609|455302256|FG000|Overall Study|Withdrawal by Subject|3|||
126548715|NCT01233609|455302257|FG001|Overall Study|Withdrawal by Subject|0|||
126548716|NCT02961374|455302258|FG000|Overall Study|Adverse Event|4|||
126548717|NCT00735644|455302259|FG000|Overall Study|Did not receive study vaccine|0|||
126548718|NCT00735644|455302260|FG001|Overall Study|Did not receive study vaccine|1|||
126548719|NCT00735644|455302261|FG002|Overall Study|Did not receive study vaccine|0|||
126548720|NCT00735644|455302262|FG003|Overall Study|Did not receive study vaccine|0|||
126548721|NCT00735644|455302263|FG004|Overall Study|Did not receive study vaccine|0|||
126548722|NCT00735644|455302259|FG000|Overall Study|Withdrawal by Subject|0|||
126548723|NCT00735644|455302260|FG001|Overall Study|Withdrawal by Subject|1|||
126548724|NCT00735644|455302261|FG002|Overall Study|Withdrawal by Subject|1|||
126548725|NCT00735644|455302262|FG003|Overall Study|Withdrawal by Subject|1|||
126548726|NCT00735644|455302263|FG004|Overall Study|Withdrawal by Subject|0|||
126548727|NCT00649389|455303843|FG000|Overall Study|Adverse Event|22|||
126548728|NCT00649389|455303844|FG001|Overall Study|Adverse Event|46|||
126548729|NCT00649389|455303845|FG002|Overall Study|Adverse Event|38|||
126548730|NCT00649389|455303846|FG003|Overall Study|Adverse Event|48|||
126548731|NCT00649389|455303843|FG000|Overall Study|Lost to Follow-up|15|||
126548732|NCT00649389|455303844|FG001|Overall Study|Lost to Follow-up|17|||
126548733|NCT00649389|455303845|FG002|Overall Study|Lost to Follow-up|21|||
126548734|NCT00649389|455303846|FG003|Overall Study|Lost to Follow-up|26|||
126548735|NCT00649389|455303843|FG000|Overall Study|Protocol Violation|11|||
126548736|NCT00649389|455303844|FG001|Overall Study|Protocol Violation|13|||
126548737|NCT00649389|455303845|FG002|Overall Study|Protocol Violation|9|||
126548738|NCT00649389|455303846|FG003|Overall Study|Protocol Violation|8|||
126548739|NCT00649389|455303843|FG000|Overall Study|Withdrawal by Subject|20|||
126548740|NCT00649389|455303844|FG001|Overall Study|Withdrawal by Subject|21|||
126708523|NCT00095121|455884987|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
126708524|NCT00095121|455884988|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
126455751|NCT03567343|454969043|FG001|Overall Study|No longer eligible|1|||
126455752|NCT03567343|454969042|FG000|Overall Study|Adverse Event|1|||
126455753|NCT03567343|454969043|FG001|Overall Study|Adverse Event|0|||
126455754|NCT03567343|454969042|FG000|Overall Study|Protocol Violation|1|||
126455755|NCT03567343|454969043|FG001|Overall Study|Protocol Violation|1|||
126455756|NCT01433250|454969044|FG000|Overall Study|Protocol Violation|0|||
126455757|NCT01433250|454969045|FG001|Overall Study|Protocol Violation|1|||
126455758|NCT01433250|454969044|FG000|Overall Study|Withdrawal by Subject|3|||
126455759|NCT01433250|454969045|FG001|Overall Study|Withdrawal by Subject|2|||
126455760|NCT00834080|454969046|FG000|Overall Study|Adverse Event|7|||
126455761|NCT00834080|454969046|FG000|Overall Study|Lost to Follow-up|7|||
126455762|NCT00834080|454969046|FG000|Overall Study|Withdrawal by Subject|5|||
126455763|NCT00834080|454969046|FG000|Overall Study|Other - Pregnancy|1|||
126455764|NCT00834080|454969046|FG000|Overall Study|Other - False positive tests of the UDS|1|||
126455765|NCT00834080|454969046|FG000|Overall Study|Physician Decision|1|||
126455766|NCT00834080|454969046|FG000|Overall Study|Subject Relocated|1|||
126455767|NCT02431260|454969047|FG000|Overall Study|Subject Decision|0|||
126455768|NCT02431260|454969048|FG001|Overall Study|Subject Decision|1|||
126455769|NCT02431260|454969049|FG002|Overall Study|Subject Decision|1|||
126455770|NCT02431260|454969050|FG003|Overall Study|Subject Decision|0|||
126455771|NCT02431260|454969051|FG004|Overall Study|Subject Decision|0|||
126455772|NCT02431260|454969052|FG005|Overall Study|Subject Decision|0|||
126455773|NCT02431260|454969053|FG006|Overall Study|Subject Decision|0|||
126455774|NCT02431260|454969054|FG007|Overall Study|Subject Decision|0|||
126455775|NCT02431260|454969055|FG008|Overall Study|Subject Decision|1|||
126455776|NCT02431260|454969056|FG009|Overall Study|Subject Decision|1|||
126455777|NCT02431260|454969057|FG010|Overall Study|Subject Decision|0|||
126455778|NCT02431260|454969058|FG011|Overall Study|Subject Decision|1|||
126455779|NCT02431260|454969059|FG012|Overall Study|Subject Decision|0|||
126548741|NCT00649389|455303845|FG002|Overall Study|Withdrawal by Subject|19|||
126455780|NCT02431260|454969060|FG013|Overall Study|Subject Decision|0|||
126455781|NCT02431260|454969047|FG000|Overall Study|Death|4|||
126455782|NCT02431260|454969048|FG001|Overall Study|Death|4|||
126455783|NCT02431260|454969049|FG002|Overall Study|Death|3|||
126455784|NCT02431260|454969050|FG003|Overall Study|Death|4|||
126455785|NCT02431260|454969051|FG004|Overall Study|Death|2|||
126548742|NCT00649389|455303846|FG003|Overall Study|Withdrawal by Subject|23|||
126548743|NCT00649389|455303843|FG000|Overall Study|Other|3|||
126455786|NCT02431260|454969052|FG005|Overall Study|Death|2|||
126548744|NCT00649389|455303844|FG001|Overall Study|Other|9|||
126548745|NCT00649389|455303845|FG002|Overall Study|Other|1|||
126548746|NCT00649389|455303846|FG003|Overall Study|Other|6|||
126280208|NCT04933968|454318258|FG005|Overall Study|Adverse Event|0|||
126280209|NCT04933968|454318253|FG000|Overall Study|Lost to Follow-up|1|||
126280210|NCT04933968|454318254|FG001|Overall Study|Lost to Follow-up|0|||
126280211|NCT04933968|454318255|FG002|Overall Study|Lost to Follow-up|1|||
126280212|NCT04933968|454318256|FG003|Overall Study|Lost to Follow-up|0|||
126280213|NCT04933968|454318257|FG004|Overall Study|Lost to Follow-up|0|||
126280214|NCT04933968|454318258|FG005|Overall Study|Lost to Follow-up|0|||
126280215|NCT04933968|454318253|FG000|Overall Study|Randomized not treated|1|||
126280216|NCT04933968|454318254|FG001|Overall Study|Randomized not treated|0|||
126280217|NCT04933968|454318255|FG002|Overall Study|Randomized not treated|0|||
126280218|NCT04933968|454318256|FG003|Overall Study|Randomized not treated|0|||
126280219|NCT04933968|454318257|FG004|Overall Study|Randomized not treated|0|||
126280220|NCT04933968|454318258|FG005|Overall Study|Randomized not treated|0|||
126280221|NCT04933968|454318253|FG000|Overall Study|Sponsor terminated study|0|||
126280222|NCT04933968|454318254|FG001|Overall Study|Sponsor terminated study|0|||
126280223|NCT04933968|454318255|FG002|Overall Study|Sponsor terminated study|0|||
126280224|NCT04933968|454318256|FG003|Overall Study|Sponsor terminated study|1|||
126280225|NCT04933968|454318257|FG004|Overall Study|Sponsor terminated study|2|||
126280226|NCT04933968|454318258|FG005|Overall Study|Sponsor terminated study|0|||
126280227|NCT04933968|454318253|FG000|Overall Study|Other|0|||
126280228|NCT04933968|454318254|FG001|Overall Study|Other|0|||
126280229|NCT04933968|454318255|FG002|Overall Study|Other|0|||
126280230|NCT04933968|454318256|FG003|Overall Study|Other|1|||
126280231|NCT04933968|454318257|FG004|Overall Study|Other|0|||
126280232|NCT04933968|454318258|FG005|Overall Study|Other|0|||
126280233|NCT04933968|454318253|FG000|Overall Study|Missing|1|||
126280234|NCT04933968|454318254|FG001|Overall Study|Missing|3|||
126280235|NCT04933968|454318255|FG002|Overall Study|Missing|2|||
126280236|NCT04933968|454318256|FG003|Overall Study|Missing|1|||
126280237|NCT04933968|454318257|FG004|Overall Study|Missing|1|||
126280238|NCT04933968|454318258|FG005|Overall Study|Missing|0|||
126455787|NCT02431260|454969053|FG006|Overall Study|Death|3|||
126455788|NCT02431260|454969054|FG007|Overall Study|Death|1|||
126280239|NCT00509366|454318259|FG000|Overall Study|Not Treated (Screen Failure)|1|||
126280240|NCT00509366|454318260|FG001|Overall Study|Not Treated (Screen Failure)|1|||
126280241|NCT00509366|454318261|FG002|Overall Study|Not Treated (Screen Failure)|1|||
126280242|NCT00509366|454318262|FG003|Overall Study|Not Treated (Screen Failure)|0|||
126280243|NCT00509366|454318263|FG004|Overall Study|Not Treated (Screen Failure)|0|||
126280244|NCT02119819|454318264|FG000|Overall Study|Adverse Event|3|||
126280245|NCT02119819|454318265|FG001|Overall Study|Adverse Event|1|||
126280246|NCT02119819|454318266|FG002|Overall Study|Adverse Event|2|||
126280247|NCT02119819|454318267|FG003|Overall Study|Adverse Event|3|||
126280248|NCT02119819|454318268|FG004|Overall Study|Adverse Event|0|||
126280249|NCT02119819|454318269|FG005|Overall Study|Adverse Event|1|||
126280250|NCT02119819|454318264|FG000|Overall Study|Lack of Efficacy|0|||
126280251|NCT02119819|454318265|FG001|Overall Study|Lack of Efficacy|0|||
126280252|NCT02119819|454318266|FG002|Overall Study|Lack of Efficacy|0|||
126280253|NCT02119819|454318267|FG003|Overall Study|Lack of Efficacy|0|||
126280254|NCT02119819|454318268|FG004|Overall Study|Lack of Efficacy|0|||
126280255|NCT02119819|454318269|FG005|Overall Study|Lack of Efficacy|1|||
126280256|NCT02119819|454318264|FG000|Overall Study|Lost to Follow-up|0|||
126280257|NCT02119819|454318265|FG001|Overall Study|Lost to Follow-up|0|||
126280258|NCT02119819|454318266|FG002|Overall Study|Lost to Follow-up|1|||
126280259|NCT02119819|454318267|FG003|Overall Study|Lost to Follow-up|2|||
126280260|NCT02119819|454318268|FG004|Overall Study|Lost to Follow-up|1|||
126280261|NCT02119819|454318269|FG005|Overall Study|Lost to Follow-up|2|||
126280262|NCT02119819|454318264|FG000|Overall Study|Physician Decision|1|||
126280263|NCT02119819|454318265|FG001|Overall Study|Physician Decision|1|||
126280264|NCT02119819|454318266|FG002|Overall Study|Physician Decision|0|||
126280265|NCT02119819|454318267|FG003|Overall Study|Physician Decision|0|||
126455789|NCT02431260|454969055|FG008|Overall Study|Death|6|||
126455790|NCT02431260|454969056|FG009|Overall Study|Death|6|||
126455791|NCT02431260|454969057|FG010|Overall Study|Death|3|||
126280266|NCT02119819|454318268|FG004|Overall Study|Physician Decision|0|||
126280267|NCT02119819|454318269|FG005|Overall Study|Physician Decision|1|||
126280268|NCT02119819|454318264|FG000|Overall Study|Withdrawal by Subject|5|||
126280269|NCT02119819|454318265|FG001|Overall Study|Withdrawal by Subject|3|||
126280270|NCT02119819|454318266|FG002|Overall Study|Withdrawal by Subject|0|||
126280271|NCT02119819|454318267|FG003|Overall Study|Withdrawal by Subject|0|||
126280272|NCT02119819|454318268|FG004|Overall Study|Withdrawal by Subject|6|||
126280273|NCT02119819|454318269|FG005|Overall Study|Withdrawal by Subject|10|||
126280274|NCT02119819|454318264|FG000|Overall Study|Jury Duty|0|||
126280275|NCT02119819|454318265|FG001|Overall Study|Jury Duty|0|||
126280276|NCT02119819|454318266|FG002|Overall Study|Jury Duty|1|||
126280277|NCT02119819|454318267|FG003|Overall Study|Jury Duty|0|||
126280278|NCT02119819|454318268|FG004|Overall Study|Jury Duty|0|||
126455792|NCT02431260|454969058|FG011|Overall Study|Death|2|||
126455793|NCT02431260|454969059|FG012|Overall Study|Death|5|||
126280279|NCT02119819|454318269|FG005|Overall Study|Jury Duty|0|||
126280280|NCT02119819|454318264|FG000|Overall Study|Protocol Violation|0|||
126455794|NCT02431260|454969060|FG013|Overall Study|Death|1|||
126708525|NCT00778999|455884995|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
126708526|NCT00778999|455884996|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
126708527|NCT00778999|455884995|FG000|Overall Study|Did not receive recFSH|14|||
126708528|NCT00778999|455884996|FG001|Overall Study|Did not receive recFSH|20|||
126708529|NCT02032524|455884997|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
126708530|NCT02032524|455884998|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
126708531|NCT02032524|455884999|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
126708532|NCT02032524|455885000|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
126708533|NCT02032524|455885001|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
126280281|NCT02119819|454318265|FG001|Overall Study|Protocol Violation|0|||
126280282|NCT02119819|454318266|FG002|Overall Study|Protocol Violation|0|||
126280283|NCT02119819|454318267|FG003|Overall Study|Protocol Violation|1|||
126280284|NCT02119819|454318268|FG004|Overall Study|Protocol Violation|0|||
126708534|NCT02032524|455885002|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
126708535|NCT02032524|455884997|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
126708536|NCT02032524|455884998|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
126708537|NCT02032524|455884999|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
126708538|NCT02032524|455885000|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
126708539|NCT02032524|455885001|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
126708540|NCT02032524|455885002|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
126708541|NCT02032524|455884997|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
126708542|NCT02032524|455884998|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
126708543|NCT02032524|455884999|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
126708544|NCT02032524|455885000|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
126708545|NCT02032524|455885001|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
126708546|NCT02032524|455885002|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
126708547|NCT02032524|455884997|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
126708548|NCT02032524|455884998|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
126708549|NCT02032524|455884999|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
126708550|NCT02032524|455885000|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
126708551|NCT02032524|455885001|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
126708552|NCT02032524|455885002|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
126548747|NCT01806740|455303847|FG000|Overall Study|Withdrawal by Subject|4|||
126548748|NCT01806740|455303847|FG000|Overall Study|Physician Decision|1|||
126548749|NCT01806740|455303847|FG000|Overall Study|Patient's refusal of treatment|1|||
126548750|NCT01976364|455303848|FG000|Main Study (36 Months)|Adverse Event|63|||
126548751|NCT01976364|455303849|FG001|Main Study (36 Months)|Adverse Event|0|||
126548752|NCT01976364|455303850|FG002|Main Study (36 Months)|Adverse Event|0|||
126548753|NCT01976364|455303848|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
126548754|NCT01976364|455303849|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
126548755|NCT01976364|455303850|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
126548756|NCT01976364|455303848|FG000|Main Study (36 Months)|Other|13|||
126548757|NCT01976364|455303849|FG001|Main Study (36 Months)|Other|0|||
126548758|NCT01976364|455303850|FG002|Main Study (36 Months)|Other|0|||
126548759|NCT01976364|455303848|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
126708553|NCT02032524|455884997|FG000|Period 2: LTS13769 Study|Other|0|||
126708554|NCT02032524|455884998|FG001|Period 2: LTS13769 Study|Other|0|||
126280285|NCT02119819|454318269|FG005|Overall Study|Protocol Violation|0|||
126280286|NCT02119819|454318264|FG000|Overall Study|Left the city to get a job|0|||
126280287|NCT02119819|454318265|FG001|Overall Study|Left the city to get a job|0|||
126280288|NCT02119819|454318266|FG002|Overall Study|Left the city to get a job|0|||
126280289|NCT02119819|454318267|FG003|Overall Study|Left the city to get a job|1|||
126280290|NCT02119819|454318268|FG004|Overall Study|Left the city to get a job|0|||
126280291|NCT02119819|454318269|FG005|Overall Study|Left the city to get a job|0|||
126280292|NCT02699684|454318270|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
126280293|NCT02699684|454318271|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
126280294|NCT01145508|454318272|FG000|Overall Study|Adverse Event|1|||
126548760|NCT01976364|455303849|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
126548761|NCT01976364|455303850|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
126548762|NCT01976364|455303848|FG000|Main Study (36 Months)|Medication error|1|||
126708555|NCT02032524|455884999|FG002|Period 2: LTS13769 Study|Other|0|||
126280295|NCT01145508|454318273|FG001|Overall Study|Adverse Event|0|||
126280296|NCT01145508|454318272|FG000|Overall Study|Death|1|||
126280297|NCT01145508|454318273|FG001|Overall Study|Death|0|||
126548763|NCT01976364|455303849|FG001|Main Study (36 Months)|Medication error|0|||
126548764|NCT01976364|455303850|FG002|Main Study (36 Months)|Medication error|0|||
126708556|NCT02032524|455885000|FG003|Period 2: LTS13769 Study|Other|0|||
126708557|NCT02032524|455885001|FG004|Period 2: LTS13769 Study|Other|0|||
126708558|NCT02032524|455885002|FG005|Period 2: LTS13769 Study|Other|1|||
126708559|NCT03567187|455885003|FG000|Overall Study|Lost to Follow-up|18|||
126708560|NCT02032875|455885006|FG000|Treatment Period|Adverse Event|1|||
126280298|NCT01145508|454318272|FG000|Overall Study|Physician Decision|2|||
126280299|NCT01145508|454318273|FG001|Overall Study|Physician Decision|1|||
126548765|NCT01976364|455303848|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
126280300|NCT01145508|454318272|FG000|Overall Study|Never started treatment|1|||
126280301|NCT01145508|454318273|FG001|Overall Study|Never started treatment|1|||
126280302|NCT04839692|454318274|FG000|Overall Study|Withdrawal by Subject|0|||
126280303|NCT04839692|454318275|FG001|Overall Study|Withdrawal by Subject|3|||
126280304|NCT04839692|454318274|FG000|Overall Study|Physician Decision|1|||
126280305|NCT04839692|454318275|FG001|Overall Study|Physician Decision|0|||
126280306|NCT03146962|454318276|FG000|Overall Study|Lost to Follow-up|1|||
126280307|NCT03146962|454318277|FG001|Overall Study|Lost to Follow-up|1|||
126280308|NCT03146962|454318278|FG002|Overall Study|Lost to Follow-up|0|||
126280309|NCT03146962|454318279|FG003|Overall Study|Lost to Follow-up|0|||
126280310|NCT03146962|454318280|FG004|Overall Study|Lost to Follow-up|0|||
126280311|NCT03146962|454318281|FG005|Overall Study|Lost to Follow-up|0|||
126280312|NCT03146962|454318282|FG006|Overall Study|Lost to Follow-up|0|||
126280313|NCT03146962|454318283|FG007|Overall Study|Lost to Follow-up|0|||
126280314|NCT03146962|454318284|FG008|Overall Study|Lost to Follow-up|0|||
126280315|NCT03146962|454318285|FG009|Overall Study|Lost to Follow-up|0|||
126280316|NCT03146962|454318276|FG000|Overall Study|Adverse Event|0|||
126280317|NCT03146962|454318277|FG001|Overall Study|Adverse Event|3|||
126280318|NCT03146962|454318278|FG002|Overall Study|Adverse Event|0|||
126280319|NCT03146962|454318279|FG003|Overall Study|Adverse Event|0|||
126280320|NCT03146962|454318280|FG004|Overall Study|Adverse Event|0|||
126455795|NCT02431260|454969047|FG000|Overall Study|Lost to Follow-up|0|||
126455796|NCT02431260|454969048|FG001|Overall Study|Lost to Follow-up|0|||
126455797|NCT02431260|454969049|FG002|Overall Study|Lost to Follow-up|0|||
126455798|NCT02431260|454969050|FG003|Overall Study|Lost to Follow-up|0|||
126455799|NCT02431260|454969051|FG004|Overall Study|Lost to Follow-up|0|||
126455800|NCT02431260|454969052|FG005|Overall Study|Lost to Follow-up|1|||
126455801|NCT02431260|454969053|FG006|Overall Study|Lost to Follow-up|0|||
126455802|NCT02431260|454969054|FG007|Overall Study|Lost to Follow-up|0|||
126455803|NCT02431260|454969055|FG008|Overall Study|Lost to Follow-up|0|||
126455804|NCT02431260|454969056|FG009|Overall Study|Lost to Follow-up|0|||
126455805|NCT02431260|454969057|FG010|Overall Study|Lost to Follow-up|0|||
126455806|NCT02431260|454969058|FG011|Overall Study|Lost to Follow-up|0|||
126455807|NCT02431260|454969059|FG012|Overall Study|Lost to Follow-up|0|||
126455808|NCT02431260|454969060|FG013|Overall Study|Lost to Follow-up|0|||
126455809|NCT02431260|454969047|FG000|Overall Study|Study Terminated by the Sponsor|0|||
126455810|NCT02431260|454969048|FG001|Overall Study|Study Terminated by the Sponsor|0|||
126455811|NCT02431260|454969049|FG002|Overall Study|Study Terminated by the Sponsor|2|||
126455812|NCT02431260|454969050|FG003|Overall Study|Study Terminated by the Sponsor|1|||
126455813|NCT02431260|454969051|FG004|Overall Study|Study Terminated by the Sponsor|1|||
126455814|NCT02431260|454969052|FG005|Overall Study|Study Terminated by the Sponsor|0|||
126455815|NCT02431260|454969053|FG006|Overall Study|Study Terminated by the Sponsor|1|||
126455816|NCT02431260|454969054|FG007|Overall Study|Study Terminated by the Sponsor|2|||
126455817|NCT02431260|454969055|FG008|Overall Study|Study Terminated by the Sponsor|1|||
126455818|NCT02431260|454969056|FG009|Overall Study|Study Terminated by the Sponsor|1|||
126455819|NCT02431260|454969057|FG010|Overall Study|Study Terminated by the Sponsor|1|||
126455820|NCT02431260|454969058|FG011|Overall Study|Study Terminated by the Sponsor|0|||
126455821|NCT02431260|454969059|FG012|Overall Study|Study Terminated by the Sponsor|4|||
126455822|NCT02431260|454969060|FG013|Overall Study|Study Terminated by the Sponsor|0|||
126455823|NCT02431260|454969047|FG000|Overall Study|Physician Decision|0|||
126455824|NCT02431260|454969048|FG001|Overall Study|Physician Decision|0|||
126455825|NCT02431260|454969049|FG002|Overall Study|Physician Decision|0|||
126455826|NCT02431260|454969050|FG003|Overall Study|Physician Decision|0|||
126455827|NCT02431260|454969051|FG004|Overall Study|Physician Decision|0|||
126455828|NCT02431260|454969052|FG005|Overall Study|Physician Decision|1|||
126455829|NCT02431260|454969053|FG006|Overall Study|Physician Decision|0|||
126455830|NCT02431260|454969054|FG007|Overall Study|Physician Decision|0|||
126455831|NCT02431260|454969055|FG008|Overall Study|Physician Decision|0|||
126455832|NCT02431260|454969056|FG009|Overall Study|Physician Decision|0|||
126455833|NCT02431260|454969057|FG010|Overall Study|Physician Decision|0|||
126455834|NCT02431260|454969058|FG011|Overall Study|Physician Decision|0|||
126455835|NCT02431260|454969059|FG012|Overall Study|Physician Decision|0|||
126455836|NCT02431260|454969060|FG013|Overall Study|Physician Decision|0|||
126455837|NCT02431260|454969047|FG000|Overall Study|Other Unspecified|0|||
126455838|NCT02431260|454969048|FG001|Overall Study|Other Unspecified|0|||
126455839|NCT02431260|454969049|FG002|Overall Study|Other Unspecified|0|||
126455840|NCT02431260|454969050|FG003|Overall Study|Other Unspecified|0|||
126455841|NCT02431260|454969051|FG004|Overall Study|Other Unspecified|0|||
126455842|NCT02431260|454969052|FG005|Overall Study|Other Unspecified|0|||
126280321|NCT03146962|454318281|FG005|Overall Study|Adverse Event|0|||
126280322|NCT03146962|454318282|FG006|Overall Study|Adverse Event|0|||
126280323|NCT03146962|454318283|FG007|Overall Study|Adverse Event|1|||
126280324|NCT03146962|454318284|FG008|Overall Study|Adverse Event|0|||
126280325|NCT03146962|454318285|FG009|Overall Study|Adverse Event|0|||
126280326|NCT03146962|454318276|FG000|Overall Study|Withdrawal by Subject|0|||
126455843|NCT02431260|454969053|FG006|Overall Study|Other Unspecified|0|||
126455844|NCT02431260|454969054|FG007|Overall Study|Other Unspecified|0|||
126455845|NCT02431260|454969055|FG008|Overall Study|Other Unspecified|0|||
126455846|NCT02431260|454969056|FG009|Overall Study|Other Unspecified|0|||
126455847|NCT02431260|454969057|FG010|Overall Study|Other Unspecified|0|||
126708561|NCT02032875|455885007|FG001|Treatment Period|Adverse Event|0|||
126708562|NCT02032875|455885006|FG000|Treatment Period|Liver transplant, No extension needed|0|||
126708563|NCT02032875|455885007|FG001|Treatment Period|Liver transplant, No extension needed|1|||
126708564|NCT02032875|455885006|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
126708565|NCT02032875|455885007|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
126708566|NCT02032875|455885006|FG000|Follow-up Period|Death|0|||
126708567|NCT02032875|455885007|FG001|Follow-up Period|Death|1|||
126708568|NCT02032875|455885006|FG000|Follow-up Period|Virologic Relapse|3|||
126708569|NCT02032875|455885007|FG001|Follow-up Period|Virologic Relapse|10|||
126708570|NCT04358458|455885008|FG000|Overall Study|Death|1|||
126708571|NCT04358458|455885009|FG001|Overall Study|Death|1|||
126708572|NCT04358458|455885010|FG002|Overall Study|Death|3|||
126708573|NCT04358458|455885011|FG003|Overall Study|Death|8|||
126708574|NCT04358458|455885012|FG004|Overall Study|Death|1|||
126708575|NCT04358458|455885013|FG005|Overall Study|Death|6|||
126708576|NCT04358458|455885014|FG006|Overall Study|Death|2|||
126708577|NCT04358458|455885015|FG007|Overall Study|Death|3|||
126708578|NCT04358458|455885008|FG000|Overall Study|Lost to Follow-up|0|||
126708579|NCT04358458|455885009|FG001|Overall Study|Lost to Follow-up|0|||
126708580|NCT04358458|455885010|FG002|Overall Study|Lost to Follow-up|0|||
126708581|NCT04358458|455885011|FG003|Overall Study|Lost to Follow-up|0|||
126708582|NCT04358458|455885012|FG004|Overall Study|Lost to Follow-up|0|||
126708583|NCT04358458|455885013|FG005|Overall Study|Lost to Follow-up|0|||
126708584|NCT04358458|455885014|FG006|Overall Study|Lost to Follow-up|0|||
126708585|NCT04358458|455885015|FG007|Overall Study|Lost to Follow-up|1|||
126708586|NCT04358458|455885008|FG000|Overall Study|Site is closing study participation|0|||
126708587|NCT04358458|455885009|FG001|Overall Study|Site is closing study participation|0|||
126708588|NCT04358458|455885010|FG002|Overall Study|Site is closing study participation|0|||
126708589|NCT04358458|455885011|FG003|Overall Study|Site is closing study participation|1|||
126708590|NCT04358458|455885012|FG004|Overall Study|Site is closing study participation|0|||
126708591|NCT04358458|455885013|FG005|Overall Study|Site is closing study participation|0|||
126708592|NCT04358458|455885014|FG006|Overall Study|Site is closing study participation|0|||
126708593|NCT04358458|455885015|FG007|Overall Study|Site is closing study participation|0|||
126708594|NCT04358458|455885008|FG000|Overall Study|Sponsor request|2|||
126708595|NCT04358458|455885009|FG001|Overall Study|Sponsor request|3|||
126708596|NCT04358458|455885010|FG002|Overall Study|Sponsor request|3|||
126708597|NCT04358458|455885011|FG003|Overall Study|Sponsor request|0|||
126708598|NCT04358458|455885012|FG004|Overall Study|Sponsor request|2|||
126708599|NCT04358458|455885013|FG005|Overall Study|Sponsor request|3|||
126708600|NCT04358458|455885014|FG006|Overall Study|Sponsor request|1|||
126708601|NCT04358458|455885015|FG007|Overall Study|Sponsor request|1|||
126708602|NCT04358458|455885008|FG000|Overall Study|Withdrawal by Subject|0|||
126708603|NCT04358458|455885009|FG001|Overall Study|Withdrawal by Subject|0|||
126708604|NCT04358458|455885010|FG002|Overall Study|Withdrawal by Subject|1|||
126708605|NCT04358458|455885011|FG003|Overall Study|Withdrawal by Subject|1|||
126708606|NCT04358458|455885012|FG004|Overall Study|Withdrawal by Subject|0|||
126708607|NCT04358458|455885013|FG005|Overall Study|Withdrawal by Subject|1|||
126280327|NCT03146962|454318277|FG001|Overall Study|Withdrawal by Subject|0|||
126280328|NCT03146962|454318278|FG002|Overall Study|Withdrawal by Subject|0|||
126280329|NCT03146962|454318279|FG003|Overall Study|Withdrawal by Subject|0|||
126280330|NCT03146962|454318280|FG004|Overall Study|Withdrawal by Subject|1|||
126280331|NCT03146962|454318281|FG005|Overall Study|Withdrawal by Subject|0|||
126280332|NCT03146962|454318282|FG006|Overall Study|Withdrawal by Subject|0|||
126280333|NCT03146962|454318283|FG007|Overall Study|Withdrawal by Subject|0|||
126280334|NCT03146962|454318284|FG008|Overall Study|Withdrawal by Subject|0|||
126280335|NCT03146962|454318285|FG009|Overall Study|Withdrawal by Subject|0|||
126280336|NCT03146962|454318276|FG000|Overall Study|Death|0|||
126280337|NCT03146962|454318277|FG001|Overall Study|Death|1|||
126280338|NCT03146962|454318278|FG002|Overall Study|Death|0|||
126280339|NCT03146962|454318279|FG003|Overall Study|Death|0|||
126280340|NCT03146962|454318280|FG004|Overall Study|Death|0|||
126363765|NCT01646216|454624940|FG000|Overall Study|Did not complete training|0|||
126708608|NCT04358458|455885014|FG006|Overall Study|Withdrawal by Subject|0|||
126708609|NCT04358458|455885015|FG007|Overall Study|Withdrawal by Subject|1|||
126363766|NCT01646216|454624941|FG001|Overall Study|Did not complete training|2|||
126708610|NCT02031146|455886177|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
126708611|NCT02031146|455886178|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
126708612|NCT02031146|455886179|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
126708613|NCT02031146|455886180|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
126708614|NCT02031146|455886181|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
126708615|NCT02031146|455886182|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
126280341|NCT03146962|454318281|FG005|Overall Study|Death|0|||
126280342|NCT03146962|454318282|FG006|Overall Study|Death|0|||
126280343|NCT03146962|454318283|FG007|Overall Study|Death|0|||
126280344|NCT03146962|454318284|FG008|Overall Study|Death|0|||
126280345|NCT03146962|454318285|FG009|Overall Study|Death|0|||
126548766|NCT01976364|455303849|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
126548767|NCT01976364|455303850|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
126548768|NCT01976364|455303848|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
126548769|NCT01976364|455303849|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
126548770|NCT01976364|455303850|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
126548771|NCT01976364|455303848|FG000|Main Study (36 Months)|Protocol Violation|13|||
126548772|NCT01976364|455303849|FG001|Main Study (36 Months)|Protocol Violation|0|||
126548773|NCT01976364|455303850|FG002|Main Study (36 Months)|Protocol Violation|0|||
126548774|NCT01976364|455303848|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
126548775|NCT01976364|455303849|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
126548776|NCT01976364|455303850|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
126548777|NCT01976364|455303848|FG000|Main Study (36 Months)|Death|5|||
126548778|NCT01976364|455303849|FG001|Main Study (36 Months)|Death|0|||
126548779|NCT01976364|455303850|FG002|Main Study (36 Months)|Death|0|||
126548780|NCT01976364|455303848|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
126548781|NCT01976364|455303849|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
126548782|NCT01976364|455303850|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
126548783|NCT01976364|455303848|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
126548784|NCT01976364|455303849|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
126548785|NCT01976364|455303850|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
126548786|NCT01976364|455303848|FG000|Sub-study (12 Months)|Protocol Violation|0|||
126548787|NCT01976364|455303849|FG001|Sub-study (12 Months)|Protocol Violation|1|||
126548788|NCT01976364|455303850|FG002|Sub-study (12 Months)|Protocol Violation|1|||
126548789|NCT01976364|455303848|FG000|Sub-study (12 Months)|Adverse Event|0|||
126548790|NCT01976364|455303849|FG001|Sub-study (12 Months)|Adverse Event|4|||
126548791|NCT01976364|455303850|FG002|Sub-study (12 Months)|Adverse Event|3|||
126548792|NCT00003511|455303851|FG000|Overall Study|Not evaluable|4|||
126548793|NCT02318719|455303859|FG000|Double-blind Phase|Adverse Event|7|||
126548794|NCT02318719|455303860|FG001|Double-blind Phase|Adverse Event|6|||
126548795|NCT02318719|455303861|FG002|Double-blind Phase|Adverse Event|12|||
126548796|NCT02318719|455303862|FG003|Double-blind Phase|Adverse Event|4|||
126548797|NCT02318719|455303863|FG004|Double-blind Phase|Adverse Event|0|||
126548798|NCT02318719|455303859|FG000|Double-blind Phase|Lack of Efficacy|5|||
126548799|NCT02318719|455303860|FG001|Double-blind Phase|Lack of Efficacy|0|||
126548800|NCT02318719|455303861|FG002|Double-blind Phase|Lack of Efficacy|1|||
126548801|NCT02318719|455303862|FG003|Double-blind Phase|Lack of Efficacy|1|||
126548802|NCT02318719|455303863|FG004|Double-blind Phase|Lack of Efficacy|0|||
126548803|NCT02318719|455303859|FG000|Double-blind Phase|Protocol Violation|0|||
126548804|NCT02318719|455303860|FG001|Double-blind Phase|Protocol Violation|1|||
126548805|NCT02318719|455303861|FG002|Double-blind Phase|Protocol Violation|3|||
126708616|NCT02031146|455886183|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
126708617|NCT01266148|455886188|FG000|Overall Study|Adverse Event|2|||
126708618|NCT01266148|455886189|FG001|Overall Study|Adverse Event|0|||
126708619|NCT01266148|455886188|FG000|Overall Study|Ongoing rejection|1|||
126280346|NCT03146962|454318276|FG000|Overall Study|COVID Precautions|1|||
126280347|NCT03146962|454318277|FG001|Overall Study|COVID Precautions|0|||
126280348|NCT03146962|454318278|FG002|Overall Study|COVID Precautions|0|||
126280349|NCT03146962|454318279|FG003|Overall Study|COVID Precautions|0|||
126280350|NCT03146962|454318280|FG004|Overall Study|COVID Precautions|0|||
126280351|NCT03146962|454318281|FG005|Overall Study|COVID Precautions|0|||
126280352|NCT03146962|454318282|FG006|Overall Study|COVID Precautions|0|||
126280353|NCT03146962|454318283|FG007|Overall Study|COVID Precautions|0|||
126280354|NCT03146962|454318284|FG008|Overall Study|COVID Precautions|0|||
126280355|NCT03146962|454318285|FG009|Overall Study|COVID Precautions|0|||
126280356|NCT03146962|454318276|FG000|Overall Study|Physician Decision|0|||
126280357|NCT03146962|454318277|FG001|Overall Study|Physician Decision|0|||
126280358|NCT03146962|454318278|FG002|Overall Study|Physician Decision|0|||
126280359|NCT03146962|454318279|FG003|Overall Study|Physician Decision|0|||
126280360|NCT03146962|454318280|FG004|Overall Study|Physician Decision|0|||
126280361|NCT03146962|454318281|FG005|Overall Study|Physician Decision|0|||
126280362|NCT03146962|454318282|FG006|Overall Study|Physician Decision|0|||
126280363|NCT03146962|454318283|FG007|Overall Study|Physician Decision|0|||
126280364|NCT03146962|454318284|FG008|Overall Study|Physician Decision|0|||
126280365|NCT03146962|454318285|FG009|Overall Study|Physician Decision|1|||
126280366|NCT03146962|454318276|FG000|Overall Study|Started New Treatment|0|||
126280367|NCT03146962|454318277|FG001|Overall Study|Started New Treatment|1|||
126280368|NCT03146962|454318278|FG002|Overall Study|Started New Treatment|0|||
126280369|NCT03146962|454318279|FG003|Overall Study|Started New Treatment|0|||
126548806|NCT02318719|455303862|FG003|Double-blind Phase|Protocol Violation|0|||
126548807|NCT02318719|455303863|FG004|Double-blind Phase|Protocol Violation|0|||
126548808|NCT02318719|455303859|FG000|Double-blind Phase|Withdrawal by Subject|25|||
126708620|NCT01266148|455886189|FG001|Overall Study|Ongoing rejection|0|||
126280370|NCT03146962|454318280|FG004|Overall Study|Started New Treatment|0|||
126280371|NCT03146962|454318281|FG005|Overall Study|Started New Treatment|0|||
126280372|NCT03146962|454318282|FG006|Overall Study|Started New Treatment|0|||
126280373|NCT03146962|454318283|FG007|Overall Study|Started New Treatment|0|||
126548809|NCT02318719|455303860|FG001|Double-blind Phase|Withdrawal by Subject|7|||
126280374|NCT03146962|454318284|FG008|Overall Study|Started New Treatment|0|||
126280375|NCT03146962|454318285|FG009|Overall Study|Started New Treatment|0|||
126280376|NCT00264550|454318286|FG000|Overall Study|Death|0|||
126280377|NCT00264550|454318287|FG001|Overall Study|Death|3|||
126280378|NCT00264550|454318288|FG002|Overall Study|Death|0|||
126280379|NCT00264550|454318289|FG003|Overall Study|Death|0|||
126280380|NCT00264550|454318286|FG000|Overall Study|Lost to Follow-up|3|||
126280381|NCT00264550|454318287|FG001|Overall Study|Lost to Follow-up|1|||
126280382|NCT00264550|454318288|FG002|Overall Study|Lost to Follow-up|1|||
126280383|NCT00264550|454318289|FG003|Overall Study|Lost to Follow-up|1|||
126363767|NCT01646216|454624940|FG000|Overall Study|Investigator decision|1|||
126363768|NCT01646216|454624941|FG001|Overall Study|Investigator decision|1|||
126363769|NCT02633527|454624942|FG000|Overall Study|Failed to meet eligibility|0|||
126363770|NCT02633527|454624943|FG001|Overall Study|Failed to meet eligibility|1|||
126363771|NCT02633527|454624944|FG002|Overall Study|Failed to meet eligibility|1|||
126363772|NCT02633527|454624945|FG003|Overall Study|Failed to meet eligibility|0|||
126363773|NCT02633527|454624946|FG004|Overall Study|Failed to meet eligibility|1|||
126363774|NCT02633527|454624942|FG000|Overall Study|Adverse Event|0|||
126363775|NCT02633527|454624943|FG001|Overall Study|Adverse Event|4|||
126363776|NCT02633527|454624944|FG002|Overall Study|Adverse Event|3|||
126363777|NCT02633527|454624945|FG003|Overall Study|Adverse Event|1|||
126363778|NCT02633527|454624946|FG004|Overall Study|Adverse Event|5|||
126363779|NCT02633527|454624942|FG000|Overall Study|Lost to Follow-up|1|||
126363780|NCT02633527|454624943|FG001|Overall Study|Lost to Follow-up|2|||
126363781|NCT02633527|454624944|FG002|Overall Study|Lost to Follow-up|5|||
126363782|NCT02633527|454624945|FG003|Overall Study|Lost to Follow-up|5|||
126363783|NCT02633527|454624946|FG004|Overall Study|Lost to Follow-up|4|||
126363784|NCT02633527|454624942|FG000|Overall Study|Withdrawal by Subject|0|||
126363785|NCT02633527|454624943|FG001|Overall Study|Withdrawal by Subject|3|||
126363786|NCT02633527|454624944|FG002|Overall Study|Withdrawal by Subject|5|||
126363787|NCT02633527|454624945|FG003|Overall Study|Withdrawal by Subject|4|||
126363788|NCT02633527|454624946|FG004|Overall Study|Withdrawal by Subject|4|||
126363789|NCT02633527|454624942|FG000|Overall Study|Protocol Violation|0|||
126363790|NCT02633527|454624943|FG001|Overall Study|Protocol Violation|1|||
126363791|NCT02633527|454624944|FG002|Overall Study|Protocol Violation|1|||
126363792|NCT02633527|454624945|FG003|Overall Study|Protocol Violation|1|||
126363793|NCT02633527|454624946|FG004|Overall Study|Protocol Violation|1|||
126363794|NCT02633527|454624942|FG000|Overall Study|Physician Decision|0|||
126363795|NCT02633527|454624943|FG001|Overall Study|Physician Decision|0|||
126363796|NCT02633527|454624944|FG002|Overall Study|Physician Decision|0|||
126363797|NCT02633527|454624945|FG003|Overall Study|Physician Decision|0|||
126363798|NCT02633527|454624946|FG004|Overall Study|Physician Decision|1|||
126363799|NCT02633527|454624942|FG000|Overall Study|Administrative reason|1|||
126363800|NCT02633527|454624943|FG001|Overall Study|Administrative reason|0|||
126363801|NCT02633527|454624944|FG002|Overall Study|Administrative reason|0|||
126363802|NCT02633527|454624945|FG003|Overall Study|Administrative reason|1|||
126363803|NCT02633527|454624946|FG004|Overall Study|Administrative reason|0|||
126363804|NCT02633527|454624942|FG000|Overall Study|Multiple reasons|1|||
126363805|NCT02633527|454624943|FG001|Overall Study|Multiple reasons|0|||
126363806|NCT02633527|454624944|FG002|Overall Study|Multiple reasons|2|||
126363807|NCT02633527|454624945|FG003|Overall Study|Multiple reasons|2|||
126363808|NCT02633527|454624946|FG004|Overall Study|Multiple reasons|1|||
126363809|NCT01681849|454624949|FG000|Overall Study|Protocol Violation|2|||
126363810|NCT01681849|454624950|FG001|Overall Study|Protocol Violation|0|||
126363811|NCT01681849|454624951|FG002|Overall Study|Protocol Violation|0|||
126363812|NCT01681849|454624949|FG000|Overall Study|Withdrawal by Subject|3|||
126363813|NCT01681849|454624950|FG001|Overall Study|Withdrawal by Subject|5|||
126363814|NCT01681849|454624951|FG002|Overall Study|Withdrawal by Subject|33|||
126363815|NCT01681849|454624949|FG000|Overall Study|Lost to Follow-up|3|||
126363816|NCT01681849|454624950|FG001|Overall Study|Lost to Follow-up|2|||
126363817|NCT01681849|454624951|FG002|Overall Study|Lost to Follow-up|6|||
126363818|NCT02420314|454624954|FG000|Overall Study|Withdrawal by Subject|1|||
126280384|NCT00264550|454318286|FG000|Overall Study|Adverse Event|23|||
126363819|NCT02420314|454624954|FG000|Overall Study|Protocol Violation|1|||
126363820|NCT03760068|454624955|FG000|Overall Study|Withdrawal by Subject|7|||
126363821|NCT03760068|454624956|FG001|Overall Study|Withdrawal by Subject|8|||
126363822|NCT03760068|454624955|FG000|Overall Study|Adverse Event|1|||
126363823|NCT03760068|454624956|FG001|Overall Study|Adverse Event|2|||
126363824|NCT03760068|454624955|FG000|Overall Study|Administrative Decision by Sponsor|0|||
126363825|NCT03760068|454624956|FG001|Overall Study|Administrative Decision by Sponsor|2|||
126363826|NCT03760068|454624955|FG000|Overall Study|Physician Decision|1|||
126363827|NCT03760068|454624956|FG001|Overall Study|Physician Decision|2|||
126280385|NCT00264550|454318287|FG001|Overall Study|Adverse Event|18|||
126280386|NCT00264550|454318288|FG002|Overall Study|Adverse Event|9|||
126280387|NCT00264550|454318289|FG003|Overall Study|Adverse Event|14|||
126363828|NCT03760068|454624955|FG000|Overall Study|Lost to Follow-up|4|||
126363829|NCT03760068|454624956|FG001|Overall Study|Lost to Follow-up|9|||
126363830|NCT03760068|454624955|FG000|Overall Study|Subject Moved Out of State|1|||
126363831|NCT03760068|454624956|FG001|Overall Study|Subject Moved Out of State|0|||
126708621|NCT01266148|455886188|FG000|Overall Study|2 2R rejections|1|||
126708622|NCT01266148|455886189|FG001|Overall Study|2 2R rejections|0|||
126708623|NCT01266148|455886188|FG000|Overall Study|Death|2|||
126708624|NCT01266148|455886189|FG001|Overall Study|Death|3|||
126765966|NCT00625846|456095862|FG002|Overall Study|Withdrawal by Subject|1|||
126765967|NCT00625846|456095863|FG003|Overall Study|Withdrawal by Subject|2|||
126765968|NCT00890409|456095868|FG000|Overall Study|Lost to Follow-up|20|||
126765969|NCT00890409|456095869|FG001|Overall Study|Lost to Follow-up|21|||
126708625|NCT01266148|455886188|FG000|Overall Study|missing mGFR value + AE|1|||
126708626|NCT01266148|455886189|FG001|Overall Study|missing mGFR value + AE|0|||
126708627|NCT01853228|455886192|FG000|Phase 1|Lack of Efficacy|8|||
126708628|NCT01853228|455886193|FG001|Phase 1|Lack of Efficacy|0|||
126708629|NCT01853228|455886192|FG000|Phase 1|Other|1|||
126708630|NCT01853228|455886193|FG001|Phase 1|Other|0|||
126708631|NCT01853228|455886192|FG000|Phase 2|Physician Decision|0|||
126708632|NCT01853228|455886193|FG001|Phase 2|Physician Decision|1|||
126708633|NCT01853228|455886192|FG000|Phase 2|Proceed To Transplant|0|||
126708634|NCT01853228|455886193|FG001|Phase 2|Proceed To Transplant|3|||
126708635|NCT01853228|455886192|FG000|Phase 2|Lack of Efficacy|0|||
126708636|NCT01853228|455886193|FG001|Phase 2|Lack of Efficacy|4|||
126708637|NCT03167619|455886194|FG000|Overall Study|Death|11|||
126708638|NCT03167619|455886195|FG001|Overall Study|Death|8|||
126708639|NCT03167619|455886194|FG000|Overall Study|Withdrawal by Subject|1|||
126708640|NCT03167619|455886195|FG001|Overall Study|Withdrawal by Subject|2|||
126708641|NCT03167619|455886194|FG000|Overall Study|Physician Decision|0|||
126708642|NCT03167619|455886195|FG001|Overall Study|Physician Decision|1|||
126708643|NCT01348919|455886199|FG000|Overall Study|Adverse Event|3|||
126708644|NCT01348919|455886200|FG001|Overall Study|Adverse Event|1|||
126708645|NCT01348919|455886201|FG002|Overall Study|Adverse Event|0|||
126708646|NCT01348919|455886199|FG000|Overall Study|Withdrawal by Subject|0|||
126708647|NCT01348919|455886200|FG001|Overall Study|Withdrawal by Subject|1|||
126708648|NCT01348919|455886201|FG002|Overall Study|Withdrawal by Subject|0|||
126708649|NCT01348919|455886199|FG000|Overall Study|Disease progression|0|||
126708650|NCT01348919|455886200|FG001|Overall Study|Disease progression|1|||
126708651|NCT01348919|455886201|FG002|Overall Study|Disease progression|1|||
126708652|NCT02089737|455886202|FG000|Overall Study|Survey form not completed|5|||
126708653|NCT02089737|455886202|FG000|Overall Study|Not treated|1|||
126708654|NCT02767570|455886203|FG000|Overall Study|Lost to Follow-up|3|||
126708655|NCT02767570|455886204|FG001|Overall Study|Lost to Follow-up|0|||
126708656|NCT02767570|455886203|FG000|Overall Study|COVID shutdown|2|||
126708657|NCT02767570|455886204|FG001|Overall Study|COVID shutdown|5|||
126708658|NCT02767570|455886203|FG000|Overall Study|Increased pain|2|||
126708659|NCT02767570|455886204|FG001|Overall Study|Increased pain|0|||
126708660|NCT02767570|455886203|FG000|Overall Study|Withdrawal by Subject|1|||
126708661|NCT02767570|455886204|FG001|Overall Study|Withdrawal by Subject|3|||
126708662|NCT02767570|455886203|FG000|Overall Study|Unrelated medical issue|1|||
126708663|NCT02767570|455886204|FG001|Overall Study|Unrelated medical issue|1|||
126708664|NCT02767570|455886203|FG000|Overall Study|Received intra-articular injection|0|||
126708665|NCT02767570|455886204|FG001|Overall Study|Received intra-articular injection|1|||
126708666|NCT00151411|455886205|FG000|Overall Study|Lost to Follow-up|15|||
126708667|NCT00151411|455886206|FG001|Overall Study|Lost to Follow-up|19|||
126708668|NCT00151411|455886205|FG000|Overall Study|Withdrawal by Subject|12|||
126708669|NCT00151411|455886206|FG001|Overall Study|Withdrawal by Subject|20|||
126708670|NCT00151411|455886205|FG000|Overall Study|Adverse Event|6|||
126708671|NCT00151411|455886206|FG001|Overall Study|Adverse Event|0|||
126708672|NCT00151411|455886205|FG000|Overall Study|Pregnancy|0|||
126708673|NCT00151411|455886206|FG001|Overall Study|Pregnancy|4|||
126708674|NCT01712438|455886207|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
126765970|NCT00769132|456095870|FG000|Period 1|Adverse Event|1|||
126765971|NCT00769132|456095871|FG001|Period 1|Adverse Event|0|||
126765972|NCT00769132|456095872|FG002|Period 1|Adverse Event|0|||
126765973|NCT00769132|456095873|FG003|Period 1|Adverse Event|1|||
126765974|NCT00769132|456095870|FG000|Period 2|Withdrawal by Subject|0|||
126765975|NCT00769132|456095871|FG001|Period 2|Withdrawal by Subject|0|||
126280388|NCT00264550|454318286|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126280389|NCT00264550|454318287|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
126280390|NCT00264550|454318288|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
126708675|NCT01712438|455886207|FG000|Overall Study|Ongoing ITI treatment|6|||
126708676|NCT01712438|455886207|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
126708677|NCT01712438|455886207|FG000|Overall Study|Prematurely Discontinued|25|||
126708678|NCT04426630|455886208|FG000|Overall Study|Death|4|||
126708679|NCT04426630|455886208|FG000|Overall Study|Lost to Follow-up|2|||
126765976|NCT00769132|456095872|FG002|Period 2|Withdrawal by Subject|0|||
126765977|NCT00769132|456095873|FG003|Period 2|Withdrawal by Subject|1|||
126708680|NCT01157169|455886211|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
126708681|NCT01157169|455886212|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
126708682|NCT01157169|455886211|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
126280391|NCT00264550|454318289|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
126708683|NCT01157169|455886212|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
126363832|NCT03460704|454624960|FG000|Overall Study|Withdrawal by Subject|11|||
126363833|NCT03460704|454624961|FG001|Overall Study|Withdrawal by Subject|14|||
126363834|NCT03460704|454624960|FG000|Overall Study|Study terminated by the Sponsor|29|||
126363835|NCT03460704|454624961|FG001|Overall Study|Study terminated by the Sponsor|19|||
126363836|NCT03460704|454624960|FG000|Overall Study|Adverse Event|10|||
126363837|NCT03460704|454624961|FG001|Overall Study|Adverse Event|5|||
126363838|NCT03460704|454624960|FG000|Overall Study|Death|3|||
126363839|NCT03460704|454624961|FG001|Overall Study|Death|2|||
126363840|NCT03460704|454624960|FG000|Overall Study|Non-Compliance with Study Drug|3|||
126363841|NCT03460704|454624961|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126363842|NCT03460704|454624960|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126363843|NCT03460704|454624961|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
126363844|NCT03460704|454624960|FG000|Overall Study|Other|2|||
126363845|NCT03460704|454624961|FG001|Overall Study|Other|1|||
126363846|NCT02913326|454624966|FG000|Overall Study|Reason not listed|0|||
126363847|NCT02913326|454624967|FG001|Overall Study|Reason not listed|1|||
126363848|NCT02913326|454624966|FG000|Overall Study|Lost to Follow-up|0|||
126363849|NCT02913326|454624967|FG001|Overall Study|Lost to Follow-up|1|||
126363850|NCT02913326|454624966|FG000|Overall Study|Adverse Event|1|||
126363851|NCT02913326|454624967|FG001|Overall Study|Adverse Event|0|||
126363852|NCT01767857|454624968|FG000|Overall Study|Adverse Event|27|||
126363853|NCT01767857|454624969|FG001|Overall Study|Adverse Event|7|||
126363854|NCT01767857|454624968|FG000|Overall Study|Death|28|||
126363855|NCT01767857|454624969|FG001|Overall Study|Death|13|||
126363856|NCT01767857|454624968|FG000|Overall Study|Lack of Efficacy|299|||
126548810|NCT02318719|455303861|FG002|Double-blind Phase|Withdrawal by Subject|9|||
126548811|NCT02318719|455303862|FG003|Double-blind Phase|Withdrawal by Subject|10|||
126548812|NCT02318719|455303863|FG004|Double-blind Phase|Withdrawal by Subject|0|||
126548813|NCT02318719|455303859|FG000|Double-blind Phase|Other|1|||
126363857|NCT01767857|454624969|FG001|Overall Study|Lack of Efficacy|151|||
126363858|NCT01767857|454624968|FG000|Overall Study|Lost to Follow-up|1|||
126548814|NCT02318719|455303860|FG001|Double-blind Phase|Other|2|||
126548815|NCT02318719|455303861|FG002|Double-blind Phase|Other|0|||
126548816|NCT02318719|455303862|FG003|Double-blind Phase|Other|0|||
126548817|NCT02318719|455303863|FG004|Double-blind Phase|Other|0|||
126363859|NCT01767857|454624969|FG001|Overall Study|Lost to Follow-up|1|||
126363860|NCT01767857|454624968|FG000|Overall Study|Withdrawal by Subject|38|||
126363861|NCT01767857|454624969|FG001|Overall Study|Withdrawal by Subject|18|||
126363862|NCT01767857|454624968|FG000|Overall Study|Physician Decision|17|||
126363863|NCT01767857|454624969|FG001|Overall Study|Physician Decision|10|||
126363864|NCT01767857|454624968|FG000|Overall Study|Protocol Terminated|1|||
126363865|NCT01767857|454624969|FG001|Overall Study|Protocol Terminated|0|||
126363866|NCT01767857|454624968|FG000|Overall Study|Randomized But Never Treated|19|||
126548818|NCT02318719|455303859|FG000|Open-label Extension Phase|Adverse Event|0|||
126548819|NCT02318719|455303860|FG001|Open-label Extension Phase|Adverse Event|0|||
126548820|NCT02318719|455303861|FG002|Open-label Extension Phase|Adverse Event|0|||
126708684|NCT01123889|455886213|FG000|Overall Study|Lost to Follow-up|3|||
126708685|NCT01123889|455886214|FG001|Overall Study|Lost to Follow-up|1|||
126708686|NCT03846947|455886219|FG000|Overall Study|technical issues with imaging sequence|2|||
126708687|NCT01362322|455886222|FG000|Overall Study|Withdrawal by Subject|3|||
126708688|NCT01362322|455886223|FG001|Overall Study|Withdrawal by Subject|1|||
126708689|NCT01362322|455886222|FG000|Overall Study|Lost to Follow-up|2|||
126708690|NCT01362322|455886223|FG001|Overall Study|Lost to Follow-up|6|||
126708691|NCT02413398|455886226|FG000|Overall Study|Lost to Follow-up|2|||
126708692|NCT02413398|455886227|FG001|Overall Study|Lost to Follow-up|4|||
126708693|NCT02413398|455886226|FG000|Overall Study|Withdrawal by Subject|1|||
126708694|NCT02413398|455886227|FG001|Overall Study|Withdrawal by Subject|1|||
126708695|NCT02413398|455886226|FG000|Overall Study|Other Eligibility criteria|1|||
126708696|NCT02413398|455886227|FG001|Overall Study|Other Eligibility criteria|2|||
126708697|NCT02874794|455886232|FG000|Overall Study|Physician Decision|3|||
126708698|NCT02874794|455886233|FG001|Overall Study|Physician Decision|2|||
126708699|NCT02874794|455886232|FG000|Overall Study|Withdrawal by Subject|2|||
126708700|NCT02874794|455886233|FG001|Overall Study|Withdrawal by Subject|8|||
126363867|NCT01767857|454624969|FG001|Overall Study|Randomized But Never Treated|13|||
126363868|NCT01514422|454624970|FG000|Overall Study|Lost to Follow-up|1|||
126708701|NCT02874794|455886232|FG000|Overall Study|Death|2|||
126708702|NCT02874794|455886233|FG001|Overall Study|Death|1|||
126363869|NCT04126174|454624971|FG000|Overall Study|Lost to Follow-up|3|||
126363870|NCT04126174|454624972|FG001|Overall Study|Lost to Follow-up|3|||
126363871|NCT00420056|454624987|FG000|Overall Study|Objective progression or relapse|17|||
126363872|NCT01044459|454624996|FG000|Overall Study|Withdrawal by Subject|21|||
126363873|NCT01044459|454624997|FG001|Overall Study|Withdrawal by Subject|28|||
126363874|NCT01044459|454624996|FG000|Overall Study|Terminated by Sponsor|22|||
126708703|NCT01062399|455886235|FG000|Overall Study|Protocol Violation|0|||
126363875|NCT01044459|454624997|FG001|Overall Study|Terminated by Sponsor|21|||
126363876|NCT01044459|454624996|FG000|Overall Study|Adverse Event|22|||
126548821|NCT02318719|455303862|FG003|Open-label Extension Phase|Adverse Event|0|||
126708704|NCT01062399|455886236|FG001|Overall Study|Protocol Violation|1|||
126708705|NCT01062399|455886237|FG002|Overall Study|Protocol Violation|0|||
126280392|NCT00264550|454318286|FG000|Overall Study|Discontinued oral study agent|0|||
126280393|NCT00264550|454318287|FG001|Overall Study|Discontinued oral study agent|1|||
126280394|NCT00264550|454318288|FG002|Overall Study|Discontinued oral study agent|0|||
126280395|NCT00264550|454318289|FG003|Overall Study|Discontinued oral study agent|0|||
126280396|NCT00264550|454318286|FG000|Overall Study|Other|13|||
126280397|NCT00264550|454318287|FG001|Overall Study|Other|7|||
126280398|NCT00264550|454318288|FG002|Overall Study|Other|3|||
126280399|NCT00264550|454318289|FG003|Overall Study|Other|9|||
126280400|NCT02246114|454318290|FG000|Overall Study|miscarriage|1|||
126280401|NCT02246114|454318291|FG001|Overall Study|miscarriage|0|||
126708706|NCT01062399|455886238|FG003|Overall Study|Protocol Violation|6|||
126708707|NCT01062399|455886239|FG004|Overall Study|Protocol Violation|4|||
126280402|NCT01439009|454318297|FG000|Overall Study|Physician Decision|5|||
126280403|NCT01439009|454318298|FG001|Overall Study|Physician Decision|3|||
126280404|NCT01439009|454318297|FG000|Overall Study|Protocol Violation|2|||
126280405|NCT01439009|454318298|FG001|Overall Study|Protocol Violation|0|||
126280406|NCT01439009|454318297|FG000|Overall Study|Deviation of exclusion criteria|1|||
126280407|NCT01439009|454318298|FG001|Overall Study|Deviation of exclusion criteria|0|||
126280408|NCT00696787|454318300|FG000|Overall Study|Adverse Event|1|||
126280409|NCT00696787|454318301|FG001|Overall Study|Adverse Event|0|||
126455848|NCT02431260|454969058|FG011|Overall Study|Other Unspecified|1|||
126455849|NCT02431260|454969059|FG012|Overall Study|Other Unspecified|1|||
126455850|NCT02431260|454969060|FG013|Overall Study|Other Unspecified|0|||
126455851|NCT03007888|454969061|FG000|First Intervention (14 Days)|Adverse Event|1|||
126455852|NCT03007888|454969062|FG001|First Intervention (14 Days)|Adverse Event|0|||
126455853|NCT01806662|454969063|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
126455854|NCT01806662|454969064|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
126455855|NCT01806662|454969063|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
126455856|NCT01806662|454969064|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
126455857|NCT01806662|454969063|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
126280410|NCT00696787|454318302|FG002|Overall Study|Adverse Event|6|||
126280411|NCT00696787|454318300|FG000|Overall Study|Discontinuation by Sponsor|9|||
126280412|NCT00696787|454318301|FG001|Overall Study|Discontinuation by Sponsor|13|||
126280413|NCT00696787|454318302|FG002|Overall Study|Discontinuation by Sponsor|14|||
126280414|NCT00696787|454318300|FG000|Overall Study|Lack of Efficacy|0|||
126280415|NCT00696787|454318301|FG001|Overall Study|Lack of Efficacy|1|||
126280416|NCT00696787|454318302|FG002|Overall Study|Lack of Efficacy|0|||
126280417|NCT00696787|454318300|FG000|Overall Study|Lost to Follow-up|4|||
126280418|NCT00696787|454318301|FG001|Overall Study|Lost to Follow-up|0|||
126280419|NCT00696787|454318302|FG002|Overall Study|Lost to Follow-up|3|||
126280420|NCT00696787|454318300|FG000|Overall Study|Withdrawal by Subject|0|||
126280421|NCT00696787|454318301|FG001|Overall Study|Withdrawal by Subject|3|||
126280422|NCT00696787|454318302|FG002|Overall Study|Withdrawal by Subject|2|||
126280423|NCT00696787|454318300|FG000|Overall Study|Failed to return|1|||
126455858|NCT01806662|454969064|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
126455859|NCT01806662|454969063|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
126455860|NCT01806662|454969064|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
126455861|NCT00827931|454969071|FG000|Overall Study|Death|3|||
126455862|NCT00827931|454969072|FG001|Overall Study|Death|5|||
126455863|NCT00827931|454969071|FG000|Overall Study|Adverse Event|1|||
126455864|NCT00827931|454969072|FG001|Overall Study|Adverse Event|0|||
126455865|NCT00827931|454969071|FG000|Overall Study|Lost to Follow-up|1|||
126455866|NCT00827931|454969072|FG001|Overall Study|Lost to Follow-up|0|||
126455867|NCT00827931|454969071|FG000|Overall Study|Withdrawal by Subject|0|||
126708708|NCT03334214|455886249|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
126280424|NCT00696787|454318301|FG001|Overall Study|Failed to return|3|||
126280425|NCT00696787|454318302|FG002|Overall Study|Failed to return|1|||
126280426|NCT00129389|454318305|FG000|Overall Study|Adverse Event|19|||
126280427|NCT00129389|454318306|FG001|Overall Study|Adverse Event|87|||
126280428|NCT00129389|454318305|FG000|Overall Study|Death|0|||
126280429|NCT00129389|454318306|FG001|Overall Study|Death|1|||
126280430|NCT00129389|454318305|FG000|Overall Study|Lost to Follow-up|2|||
126280431|NCT00129389|454318306|FG001|Overall Study|Lost to Follow-up|1|||
126280432|NCT00129389|454318305|FG000|Overall Study|Physician Decision|0|||
126280433|NCT00129389|454318306|FG001|Overall Study|Physician Decision|4|||
126280434|NCT00129389|454318305|FG000|Overall Study|Protocol Violation|0|||
126455868|NCT00827931|454969072|FG001|Overall Study|Withdrawal by Subject|1|||
126455869|NCT00827931|454969071|FG000|Overall Study|Other|1|||
126455870|NCT00827931|454969072|FG001|Overall Study|Other|0|||
126708709|NCT03334214|455886250|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
126280435|NCT00129389|454318306|FG001|Overall Study|Protocol Violation|6|||
126280436|NCT00129389|454318305|FG000|Overall Study|Withdrawal by Subject|9|||
126280437|NCT00129389|454318306|FG001|Overall Study|Withdrawal by Subject|23|||
126280438|NCT00129389|454318305|FG000|Overall Study|Relapse|1|||
126280439|NCT00129389|454318306|FG001|Overall Study|Relapse|0|||
126280440|NCT00129389|454318305|FG000|Overall Study|Not eligible|1|||
126280441|NCT00129389|454318306|FG001|Overall Study|Not eligible|2|||
126280442|NCT00129389|454318305|FG000|Overall Study|Crossed to the other arm|1|||
126280443|NCT00129389|454318306|FG001|Overall Study|Crossed to the other arm|16|||
126280444|NCT01191944|454318309|FG000|Overall Study|Adverse Event|11|||
126280445|NCT01191944|454318310|FG001|Overall Study|Adverse Event|12|||
126280446|NCT01191944|454318309|FG000|Overall Study|Protocol Violation|1|||
126280447|NCT01191944|454318310|FG001|Overall Study|Protocol Violation|2|||
126280448|NCT01191944|454318309|FG000|Overall Study|Withdrawal by Subject|4|||
126280449|NCT01191944|454318310|FG001|Overall Study|Withdrawal by Subject|2|||
126280450|NCT01191944|454318309|FG000|Overall Study|Other|1|||
126280451|NCT01191944|454318310|FG001|Overall Study|Other|3|||
126280452|NCT00603837|454318313|FG000|Overall Study|Physician Decision|3|||
126280453|NCT00603837|454318314|FG001|Overall Study|Physician Decision|0|||
126280454|NCT04611529|454318315|FG000|2-day Follow up|Lost to Follow-up|5|||
126280455|NCT04611529|454318316|FG001|2-day Follow up|Lost to Follow-up|6|||
126280456|NCT04611529|454318317|FG002|2-day Follow up|Lost to Follow-up|3|||
126280457|NCT00425373|454318384|FG000|Overall Study|Adverse Event|2|||
126280458|NCT00425373|454318385|FG001|Overall Study|Adverse Event|2|||
126280459|NCT00425373|454318386|FG002|Overall Study|Adverse Event|0|||
126280460|NCT00425373|454318387|FG003|Overall Study|Adverse Event|1|||
126280461|NCT00425373|454318388|FG004|Overall Study|Adverse Event|4|||
126280462|NCT00425373|454318389|FG005|Overall Study|Adverse Event|6|||
126280463|NCT00425373|454318390|FG006|Overall Study|Adverse Event|2|||
126280464|NCT00425373|454318391|FG007|Overall Study|Adverse Event|3|||
126280465|NCT00425373|454318392|FG008|Overall Study|Adverse Event|8|||
126280466|NCT00425373|454318384|FG000|Overall Study|Lost to Follow-up|0|||
126280467|NCT00425373|454318385|FG001|Overall Study|Lost to Follow-up|1|||
126280468|NCT00425373|454318386|FG002|Overall Study|Lost to Follow-up|0|||
126280469|NCT00425373|454318387|FG003|Overall Study|Lost to Follow-up|0|||
126280470|NCT00425373|454318388|FG004|Overall Study|Lost to Follow-up|1|||
126280471|NCT00425373|454318389|FG005|Overall Study|Lost to Follow-up|0|||
126708710|NCT03334214|455886249|FG000|Overall Study|Withdrawal by Subject|0|||
126708711|NCT03334214|455886250|FG001|Overall Study|Withdrawal by Subject|1|||
126708712|NCT03334214|455886249|FG000|Overall Study|Other|1|||
126708713|NCT03334214|455886250|FG001|Overall Study|Other|0|||
126708714|NCT01260181|455886253|FG000|Overall Study|Decision of Investigator|1|||
126708715|NCT00592683|455886259|FG000|Overall Study|Found ineligible|0|||
126708716|NCT00592683|455886260|FG001|Overall Study|Found ineligible|1|||
126708717|NCT00592683|455886259|FG000|Overall Study|Withdrawal by Subject|1|||
126708718|NCT00592683|455886260|FG001|Overall Study|Withdrawal by Subject|0|||
126765978|NCT00769132|456095870|FG000|Period 3|Withdrawal by Subject|1|||
126280472|NCT00425373|454318390|FG006|Overall Study|Lost to Follow-up|0|||
126280473|NCT00425373|454318391|FG007|Overall Study|Lost to Follow-up|0|||
126280474|NCT00425373|454318392|FG008|Overall Study|Lost to Follow-up|0|||
126280475|NCT00425373|454318384|FG000|Overall Study|Protocol Violation|1|||
126280476|NCT00425373|454318385|FG001|Overall Study|Protocol Violation|0|||
126280477|NCT00425373|454318386|FG002|Overall Study|Protocol Violation|1|||
126280478|NCT00425373|454318387|FG003|Overall Study|Protocol Violation|0|||
126280479|NCT00425373|454318388|FG004|Overall Study|Protocol Violation|0|||
126280480|NCT00425373|454318389|FG005|Overall Study|Protocol Violation|0|||
126280481|NCT00425373|454318390|FG006|Overall Study|Protocol Violation|0|||
126280482|NCT00425373|454318391|FG007|Overall Study|Protocol Violation|5|||
126280483|NCT00425373|454318392|FG008|Overall Study|Protocol Violation|3|||
126280484|NCT00425373|454318384|FG000|Overall Study|Withdrawal by Subject|2|||
126280485|NCT00425373|454318385|FG001|Overall Study|Withdrawal by Subject|0|||
126280486|NCT00425373|454318386|FG002|Overall Study|Withdrawal by Subject|2|||
126280487|NCT00425373|454318387|FG003|Overall Study|Withdrawal by Subject|1|||
126280488|NCT00425373|454318388|FG004|Overall Study|Withdrawal by Subject|4|||
126280489|NCT00425373|454318389|FG005|Overall Study|Withdrawal by Subject|0|||
126280490|NCT00425373|454318390|FG006|Overall Study|Withdrawal by Subject|2|||
126280491|NCT00425373|454318391|FG007|Overall Study|Withdrawal by Subject|2|||
126280492|NCT00425373|454318392|FG008|Overall Study|Withdrawal by Subject|2|||
126280493|NCT00425373|454318384|FG000|Overall Study|Lack of Efficacy|0|||
126280494|NCT00425373|454318385|FG001|Overall Study|Lack of Efficacy|0|||
126280495|NCT00425373|454318386|FG002|Overall Study|Lack of Efficacy|0|||
126280496|NCT00425373|454318387|FG003|Overall Study|Lack of Efficacy|0|||
126280497|NCT00425373|454318388|FG004|Overall Study|Lack of Efficacy|1|||
126280498|NCT00425373|454318389|FG005|Overall Study|Lack of Efficacy|3|||
126280499|NCT00425373|454318390|FG006|Overall Study|Lack of Efficacy|3|||
126280500|NCT00425373|454318391|FG007|Overall Study|Lack of Efficacy|0|||
126548822|NCT02318719|455303863|FG004|Open-label Extension Phase|Adverse Event|15|||
126280501|NCT00425373|454318392|FG008|Overall Study|Lack of Efficacy|5|||
126708719|NCT00592683|455886259|FG000|Overall Study|Adverse Event|0|||
126280502|NCT01851330|454318393|FG000|Overall Study|Lack of Efficacy|10|||
126280503|NCT01851330|454318394|FG001|Overall Study|Lack of Efficacy|9|||
126280504|NCT01851330|454318395|FG002|Overall Study|Lack of Efficacy|2|||
126280505|NCT01851330|454318393|FG000|Overall Study|Lost to Follow-up|1|||
126280506|NCT01851330|454318394|FG001|Overall Study|Lost to Follow-up|6|||
126280507|NCT01851330|454318395|FG002|Overall Study|Lost to Follow-up|9|||
126280508|NCT01851330|454318393|FG000|Overall Study|Withdrew Consent|2|||
126708720|NCT00592683|455886260|FG001|Overall Study|Adverse Event|2|||
126708721|NCT00592683|455886259|FG000|Overall Study|Protocol Violation|1|||
126280509|NCT01851330|454318394|FG001|Overall Study|Withdrew Consent|1|||
126280510|NCT01851330|454318395|FG002|Overall Study|Withdrew Consent|0|||
126280511|NCT01851330|454318393|FG000|Overall Study|Investigator's Discretion|0|||
126280512|NCT01851330|454318394|FG001|Overall Study|Investigator's Discretion|0|||
126280513|NCT01851330|454318395|FG002|Overall Study|Investigator's Discretion|1|||
126280514|NCT02368314|454318399|FG000|Overall Study|Withdrawal by Subject|2|||
126280515|NCT02368314|454318400|FG001|Overall Study|Withdrawal by Subject|1|||
126280516|NCT02368314|454318399|FG000|Overall Study|Adverse Event|1|||
126280517|NCT02368314|454318400|FG001|Overall Study|Adverse Event|2|||
126280518|NCT01307111|454318403|FG000|IUD Insertion|Lost to Follow-up|2|||
126280519|NCT01307111|454318404|FG001|IUD Insertion|Lost to Follow-up|0|||
126280520|NCT01307111|454318403|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
126280521|NCT01307111|454318404|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
126280522|NCT02842073|454318412|FG000|Overall Study|Withdrawal by Subject|1|||
126280523|NCT00195338|454318413|FG000|Overall Study|Lost to Follow-up|2|||
126280524|NCT00195338|454318413|FG000|Overall Study|Adverse Event|5|||
126280525|NCT00195338|454318413|FG000|Overall Study|Lack of Efficacy|1|||
126280526|NCT00195338|454318413|FG000|Overall Study|Early closure of the site|4|||
126280527|NCT01333397|454318414|FG000|Overall Study|Lost to Follow-up|1|||
126280528|NCT01333397|454318415|FG001|Overall Study|Lost to Follow-up|0|||
126280529|NCT01333397|454318416|FG002|Overall Study|Lost to Follow-up|0|||
126280530|NCT01333397|454318417|FG003|Overall Study|Lost to Follow-up|1|||
126280531|NCT01333397|454318418|FG004|Overall Study|Lost to Follow-up|0|||
126280532|NCT01085357|454318419|FG000|Overall Study|Adverse Event|1|||
126280533|NCT01085357|454318420|FG001|Overall Study|Adverse Event|1|||
126280534|NCT01085357|454318419|FG000|Overall Study|Subject Decision|4|||
126280535|NCT01085357|454318420|FG001|Overall Study|Subject Decision|3|||
126280536|NCT01085357|454318419|FG000|Overall Study|Investigator Decision|1|||
126280537|NCT01085357|454318420|FG001|Overall Study|Investigator Decision|1|||
126280538|NCT01085357|454318419|FG000|Overall Study|Death|11|||
126280539|NCT01085357|454318420|FG001|Overall Study|Death|1|||
126280540|NCT01085357|454318419|FG000|Overall Study|Lost to Follow-up|2|||
126280541|NCT01085357|454318420|FG001|Overall Study|Lost to Follow-up|0|||
126280542|NCT02289456|454318430|FG000|Induction Period|Death|2|||
126280543|NCT02289456|454318430|FG000|Induction Period|Adverse Event|11|||
126280544|NCT02289456|454318430|FG000|Induction Period|Progressive Disease (PD)|4|||
126280545|NCT02289456|454318430|FG000|Induction Period|Symptomatic Deterioration|4|||
126280546|NCT02289456|454318430|FG000|Induction Period|Withdrawal by Subject|2|||
126280547|NCT02289456|454318430|FG000|Induction Period|Miscellaneous|1|||
126280548|NCT02289456|454318430|FG000|Monotherapy Period|Death|1|||
126280549|NCT02289456|454318430|FG000|Monotherapy Period|Adverse Event|1|||
126280550|NCT02289456|454318430|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
126280551|NCT02289456|454318430|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
126280552|NCT02289456|454318430|FG000|Monotherapy Period|Withdrawal by Subject|2|||
126280553|NCT02289456|454318430|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
126280554|NCT02289456|454318430|FG000|Monotherapy Period|Miscellaneous|1|||
126280555|NCT00920790|454318431|FG000|Overall Study|aggravation of general condition|14|||
126280556|NCT01661062|454318434|FG000|Overall Study|Completed Treatment Off Study|3|||
126280557|NCT01661062|454318434|FG000|Overall Study|Withdrawal by Subject|2|||
126280558|NCT04411914|454318435|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
126280559|NCT04411914|454318436|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
126280560|NCT00895414|454318442|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
126280561|NCT00895414|454318443|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
126280562|NCT00895414|454318442|FG000|First Intervention (14 Days)|Physician Decision|0|||
126280563|NCT00895414|454318443|FG001|First Intervention (14 Days)|Physician Decision|1|||
126280564|NCT00252239|454318444|FG000|Overall Study|Withdrawal by Subject|1|||
126280565|NCT00252239|454318445|FG001|Overall Study|Withdrawal by Subject|0|||
126280566|NCT00252239|454318446|FG002|Overall Study|Withdrawal by Subject|0|||
126280567|NCT00252239|454318447|FG003|Overall Study|Withdrawal by Subject|1|||
126280568|NCT00252239|454318444|FG000|Overall Study|Lost to Follow-up|0|||
126280569|NCT00252239|454318445|FG001|Overall Study|Lost to Follow-up|0|||
126455871|NCT02015221|454969073|FG000|Overall Study|Withdrawal by Subject|8|||
126455872|NCT02015221|454969074|FG001|Overall Study|Withdrawal by Subject|6|||
126455873|NCT02015221|454969073|FG000|Overall Study|Lost to Follow-up|1|||
126455874|NCT02015221|454969074|FG001|Overall Study|Lost to Follow-up|0|||
126455875|NCT00995566|454969075|FG000|Overall Study|Adverse Event|2|||
126455876|NCT00995566|454969075|FG000|Overall Study|Early study termination|52|||
126765979|NCT00769132|456095871|FG001|Period 3|Withdrawal by Subject|0|||
126280570|NCT00252239|454318446|FG002|Overall Study|Lost to Follow-up|2|||
126280571|NCT00252239|454318447|FG003|Overall Study|Lost to Follow-up|0|||
126280572|NCT00478426|454318448|FG000|Overall Study|Withdrawal by Subject|1|||
126280573|NCT03489109|454318455|FG000|Overall Study|Lost to Follow-up|1|||
126280574|NCT03489109|454318456|FG001|Overall Study|Lost to Follow-up|2|||
126280575|NCT02181790|454318457|FG000|Overall Study|study terminated|2|||
126455877|NCT00510653|454969076|FG000|Overall Study|Withdrawal by Subject|8|||
126280576|NCT02181790|454318458|FG001|Overall Study|study terminated|0|||
126455878|NCT00510653|454969076|FG000|Overall Study|Monetary|3|||
126765980|NCT00769132|456095872|FG002|Period 3|Withdrawal by Subject|0|||
126280577|NCT00908310|454318459|FG000|Overall Study|Death|37|||
126280578|NCT00908310|454318459|FG000|Overall Study|Withdrawal by Subject|7|||
126280579|NCT00908310|454318459|FG000|Overall Study|Lost to Follow-up|7|||
126280580|NCT00908310|454318459|FG000|Overall Study|Screening failure|5|||
126280581|NCT00908310|454318459|FG000|Overall Study|Other reasons|4|||
126280582|NCT02785952|454318460|FG000|Overall Study|Adverse Event|31|||
126280583|NCT02785952|454318461|FG001|Overall Study|Adverse Event|19|||
126548823|NCT02318719|455303859|FG000|Open-label Extension Phase|Death|0|||
126548824|NCT02318719|455303860|FG001|Open-label Extension Phase|Death|0|||
126548825|NCT02318719|455303861|FG002|Open-label Extension Phase|Death|0|||
126548826|NCT02318719|455303862|FG003|Open-label Extension Phase|Death|0|||
126548827|NCT02318719|455303863|FG004|Open-label Extension Phase|Death|1|||
126548828|NCT02318719|455303859|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
126280584|NCT02785952|454318460|FG000|Overall Study|Refusal unrelated to adverse events|10|||
126280585|NCT02785952|454318461|FG001|Overall Study|Refusal unrelated to adverse events|5|||
126280586|NCT02785952|454318460|FG000|Overall Study|Disease progression/relapse|61|||
126280587|NCT02785952|454318461|FG001|Overall Study|Disease progression/relapse|89|||
126280588|NCT02785952|454318460|FG000|Overall Study|Death|11|||
126548829|NCT02318719|455303860|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
126548830|NCT02318719|455303861|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
126548831|NCT02318719|455303862|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
126548832|NCT02318719|455303863|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
126280589|NCT02785952|454318461|FG001|Overall Study|Death|7|||
126280590|NCT02785952|454318460|FG000|Overall Study|Other- not protocol specified|6|||
126280591|NCT02785952|454318461|FG001|Overall Study|Other- not protocol specified|4|||
126280592|NCT02785952|454318460|FG000|Overall Study|On protocol treatment|6|||
126548833|NCT02318719|455303859|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
126280593|NCT02785952|454318461|FG001|Overall Study|On protocol treatment|3|||
126280594|NCT00351533|454318462|FG000|Overall Study|Extubated before first BAL|1|||
126280595|NCT00351533|454318463|FG001|Overall Study|Extubated before first BAL|0|||
126280596|NCT00351533|454318462|FG000|Overall Study|Lost to Follow-up|1|||
126280597|NCT00351533|454318463|FG001|Overall Study|Lost to Follow-up|3|||
126280598|NCT00351533|454318462|FG000|Overall Study|Physician Decision|0|||
126280599|NCT00351533|454318463|FG001|Overall Study|Physician Decision|1|||
126280600|NCT00351533|454318462|FG000|Overall Study|Withdrawal by Subject|0|||
126280601|NCT00351533|454318463|FG001|Overall Study|Withdrawal by Subject|1|||
126280602|NCT00996892|454318465|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
126280603|NCT00996892|454318466|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
126280604|NCT00996892|454318467|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
126280605|NCT00996892|454318468|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
126280606|NCT00996892|454318469|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
126280607|NCT00996892|454318470|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
126280608|NCT00996892|454318471|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
126280609|NCT00996892|454318472|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
126363877|NCT01044459|454624997|FG001|Overall Study|Adverse Event|20|||
126363878|NCT01044459|454624996|FG000|Overall Study|Lack of Efficacy|23|||
126363879|NCT01044459|454624997|FG001|Overall Study|Lack of Efficacy|12|||
126363880|NCT01044459|454624996|FG000|Overall Study|Protocol Violation|11|||
126363881|NCT01044459|454624997|FG001|Overall Study|Protocol Violation|16|||
126363882|NCT01044459|454624996|FG000|Overall Study|Other Reason|7|||
126363883|NCT01044459|454624997|FG001|Overall Study|Other Reason|14|||
126363884|NCT01044459|454624996|FG000|Overall Study|COPD exacerbation|9|||
126363885|NCT01044459|454624997|FG001|Overall Study|COPD exacerbation|8|||
126363886|NCT01044459|454624996|FG000|Overall Study|Lost to Follow-up|18|||
126363887|NCT01044459|454624997|FG001|Overall Study|Lost to Follow-up|12|||
126363888|NCT04105725|454624998|FG000|Primary Intervention|Lost to Follow-up|0|||
126363889|NCT04105725|454624999|FG001|Primary Intervention|Lost to Follow-up|2|||
126363890|NCT04105725|454624998|FG000|Primary Intervention|Withdrawal by Subject|0|||
126363891|NCT04105725|454624999|FG001|Primary Intervention|Withdrawal by Subject|1|||
126363892|NCT04634331|454625000|FG000|Overall Study|Withdrawal by Subject|2|||
126363893|NCT04634331|454625001|FG001|Overall Study|Withdrawal by Subject|2|||
126363894|NCT00176254|454625002|FG000|Overall Study|Lost to Follow-up|1|||
126363895|NCT02457546|454626659|FG000|Overall Study|Other reasons|4|||
126363896|NCT02457546|454626660|FG001|Overall Study|Other reasons|1|||
126363897|NCT02457546|454626659|FG000|Overall Study|Refused to complete study/procedures|1|||
126363898|NCT02457546|454626660|FG001|Overall Study|Refused to complete study/procedures|1|||
126363899|NCT02457546|454626659|FG000|Overall Study|Lost to Follow-up|4|||
126363900|NCT02457546|454626660|FG001|Overall Study|Lost to Follow-up|1|||
126363901|NCT02457546|454626659|FG000|Overall Study|Adverse Event|0|||
126363902|NCT02457546|454626660|FG001|Overall Study|Adverse Event|1|||
126363903|NCT05069415|454626661|FG000|Overall Study|Withdrawal by Subject|2|||
126280610|NCT00996892|454318473|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
126280611|NCT00996892|454318474|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
126280612|NCT00996892|454318475|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
126280613|NCT00996892|454318476|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
126363904|NCT05069415|454626662|FG001|Overall Study|Withdrawal by Subject|0|||
126548834|NCT02318719|455303860|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
126280614|NCT00996892|454318477|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
126280615|NCT00996892|454318478|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
126280616|NCT00996892|454318479|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
126280617|NCT00996892|454318480|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
126280618|NCT00996892|454318481|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
126280619|NCT00996892|454318482|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
126280620|NCT00996892|454318483|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
126280621|NCT00996892|454318484|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
126280622|NCT00996892|454318465|FG000|Dose-Escalation Stage 1|Death|1|||
126280623|NCT00996892|454318466|FG001|Dose-Escalation Stage 1|Death|0|||
126280624|NCT00996892|454318467|FG002|Dose-Escalation Stage 1|Death|0|||
126280625|NCT00996892|454318468|FG003|Dose-Escalation Stage 1|Death|0|||
126280626|NCT00996892|454318469|FG004|Dose-Escalation Stage 1|Death|0|||
126280627|NCT00996892|454318470|FG005|Dose-Escalation Stage 1|Death|1|||
126280628|NCT00996892|454318471|FG006|Dose-Escalation Stage 1|Death|0|||
126280629|NCT00996892|454318472|FG007|Dose-Escalation Stage 1|Death|0|||
126280630|NCT00996892|454318473|FG008|Dose-Escalation Stage 1|Death|0|||
126280631|NCT00996892|454318474|FG009|Dose-Escalation Stage 1|Death|0|||
126280632|NCT00996892|454318475|FG010|Dose-Escalation Stage 1|Death|0|||
126280633|NCT00996892|454318476|FG011|Dose-Escalation Stage 1|Death|0|||
126280634|NCT00996892|454318477|FG012|Dose-Escalation Stage 1|Death|0|||
126280635|NCT00996892|454318478|FG013|Dose-Escalation Stage 1|Death|0|||
126280636|NCT00996892|454318479|FG014|Dose-Escalation Stage 1|Death|0|||
126280637|NCT00996892|454318480|FG015|Dose-Escalation Stage 1|Death|0|||
126280638|NCT00996892|454318481|FG016|Dose-Escalation Stage 1|Death|0|||
126280639|NCT00996892|454318482|FG017|Dose-Escalation Stage 1|Death|0|||
126280640|NCT00996892|454318483|FG018|Dose-Escalation Stage 1|Death|0|||
126280641|NCT00996892|454318484|FG019|Dose-Escalation Stage 1|Death|0|||
126280642|NCT00996892|454318465|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
126280643|NCT00996892|454318466|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
126280644|NCT00996892|454318467|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
126280645|NCT00996892|454318468|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
126280646|NCT00996892|454318469|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
126280647|NCT00996892|454318470|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
126280648|NCT00996892|454318471|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
126280649|NCT00996892|454318472|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
126280650|NCT00996892|454318473|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
126280651|NCT00996892|454318474|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
126280652|NCT00996892|454318475|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
126280653|NCT00996892|454318476|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
126280654|NCT00996892|454318477|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
126280655|NCT00996892|454318478|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
126280656|NCT00996892|454318479|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
126280657|NCT00996892|454318480|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
126280658|NCT00996892|454318481|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
126280659|NCT00996892|454318482|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
126280660|NCT00996892|454318483|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
126280661|NCT00996892|454318484|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
126280662|NCT00996892|454318465|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280663|NCT00996892|454318466|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
126280664|NCT00996892|454318467|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280665|NCT00996892|454318468|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
126280666|NCT00996892|454318469|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
126280667|NCT00996892|454318470|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
126280668|NCT00996892|454318471|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
126280669|NCT00996892|454318472|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280670|NCT00996892|454318473|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280671|NCT00996892|454318474|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280672|NCT00996892|454318475|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280673|NCT00996892|454318476|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280674|NCT00996892|454318477|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280675|NCT00996892|454318478|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280676|NCT00996892|454318479|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280677|NCT00996892|454318480|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280678|NCT00996892|454318481|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280679|NCT00996892|454318482|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280680|NCT00996892|454318483|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280681|NCT00996892|454318484|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
126280682|NCT00996892|454318465|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
126280683|NCT00996892|454318466|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
126280684|NCT00996892|454318467|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
126280685|NCT00996892|454318468|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
126280686|NCT00996892|454318469|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
126708722|NCT00592683|455886260|FG001|Overall Study|Protocol Violation|0|||
126363905|NCT05069415|454626661|FG000|Overall Study|Adverse Event|2|||
126363906|NCT05069415|454626662|FG001|Overall Study|Adverse Event|0|||
126363907|NCT00203242|454626665|FG000|Overall Study|Lost to Follow-up|1|||
126765981|NCT00769132|456095873|FG003|Period 3|Withdrawal by Subject|0|||
126765982|NCT00769132|456095870|FG000|Period 4|Withdrawal by Subject|0|||
126765983|NCT00769132|456095871|FG001|Period 4|Withdrawal by Subject|1|||
126765984|NCT00769132|456095872|FG002|Period 4|Withdrawal by Subject|0|||
126765985|NCT00769132|456095873|FG003|Period 4|Withdrawal by Subject|0|||
126765986|NCT00669110|456095874|FG000|Overall Study|Adverse Event|4|||
126765987|NCT00669110|456095875|FG001|Overall Study|Adverse Event|3|||
126765988|NCT00669110|456095874|FG000|Overall Study|Caregiver request|3|||
126765989|NCT00669110|456095875|FG001|Overall Study|Caregiver request|2|||
126765990|NCT00669110|456095874|FG000|Overall Study|Physician Decision|0|||
126765991|NCT00669110|456095875|FG001|Overall Study|Physician Decision|1|||
126280687|NCT00996892|454318470|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
126708723|NCT00592683|455886259|FG000|Overall Study|Study drug expired|1|||
126708724|NCT00592683|455886260|FG001|Overall Study|Study drug expired|0|||
126708725|NCT00592683|455886259|FG000|Overall Study|Other|1|||
126708726|NCT00592683|455886260|FG001|Overall Study|Other|0|||
126708727|NCT00592683|455886259|FG000|Overall Study|Lost to Follow-up|0|||
126708728|NCT00592683|455886260|FG001|Overall Study|Lost to Follow-up|1|||
126708729|NCT02723630|455886264|FG000|Intervention Period 1|Adverse Event|1|||
126708730|NCT02723630|455886265|FG001|Intervention Period 1|Adverse Event|0|||
126708731|NCT02723630|455886266|FG002|Intervention Period 1|Adverse Event|0|||
126708732|NCT02723630|455886267|FG003|Intervention Period 1|Adverse Event|0|||
126708733|NCT02723630|455886268|FG004|Intervention Period 1|Adverse Event|0|||
126708734|NCT02723630|455886269|FG005|Intervention Period 1|Adverse Event|0|||
126708735|NCT02723630|455886264|FG000|Intervention Period 3|consumption of restricted item|0|||
126708736|NCT02723630|455886265|FG001|Intervention Period 3|consumption of restricted item|1|||
126708737|NCT02723630|455886266|FG002|Intervention Period 3|consumption of restricted item|0|||
126708738|NCT02723630|455886267|FG003|Intervention Period 3|consumption of restricted item|0|||
126708739|NCT02723630|455886268|FG004|Intervention Period 3|consumption of restricted item|0|||
126708740|NCT02723630|455886269|FG005|Intervention Period 3|consumption of restricted item|0|||
126708741|NCT03633331|455886272|FG000|Overall Study|Withdrawal by Subject|1|||
126708742|NCT02986373|455886273|FG000|Overall Study|Adverse Event|4|||
126708743|NCT02986373|455886273|FG000|Overall Study|Lost to Follow-up|1|||
126708744|NCT02986373|455886273|FG000|Overall Study|Withdrawal by Subject|10|||
126708745|NCT02986373|455886273|FG000|Overall Study|Other|24|||
126708746|NCT00995371|455886279|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
126708747|NCT00995371|455886280|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
126708748|NCT04725682|455886281|FG000|Overall Study|Withdrawal by Subject|7|||
126708749|NCT04725682|455886282|FG001|Overall Study|Withdrawal by Subject|5|||
126708750|NCT04725682|455886281|FG000|Overall Study|Failed to comply with the requirements|2|||
126708751|NCT04725682|455886282|FG001|Overall Study|Failed to comply with the requirements|1|||
126708752|NCT04725682|455886281|FG000|Overall Study|Adverse Event|1|||
126708753|NCT04725682|455886282|FG001|Overall Study|Adverse Event|1|||
126708754|NCT04725682|455886281|FG000|Overall Study|Death|0|||
126708755|NCT04725682|455886282|FG001|Overall Study|Death|1|||
126708756|NCT02190591|455886283|FG000|Overall Study|Withdrawal by Subject|1|||
126708757|NCT02190591|455886284|FG001|Overall Study|Withdrawal by Subject|8|||
126708758|NCT02190591|455886283|FG000|Overall Study|Protocol Violation|1|||
126708759|NCT02190591|455886284|FG001|Overall Study|Protocol Violation|0|||
126708760|NCT02190591|455886283|FG000|Overall Study|did not use peanut ball as instructed|0|||
126280688|NCT00996892|454318471|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
126280689|NCT00996892|454318472|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
126280690|NCT00996892|454318473|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
126280691|NCT00996892|454318474|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
126280692|NCT00996892|454318475|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
126363908|NCT00866775|454626666|FG000|Overall Study|Adverse Event|5|||
126708761|NCT02190591|455886284|FG001|Overall Study|did not use peanut ball as instructed|2|||
126765992|NCT00669110|456095874|FG000|Overall Study|Lost to Follow-up|1|||
126708762|NCT02190591|455886283|FG000|Overall Study|face presentation so she was ineligible|0|||
126708763|NCT02190591|455886284|FG001|Overall Study|face presentation so she was ineligible|1|||
126708764|NCT00144300|455886285|FG000|Overall Study|Adverse Event|18|||
126708765|NCT00144300|455886286|FG001|Overall Study|Adverse Event|16|||
126708766|NCT00144300|455886285|FG000|Overall Study|Protocol Violation|1|||
126708767|NCT00144300|455886286|FG001|Overall Study|Protocol Violation|3|||
126280693|NCT00996892|454318476|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
126708768|NCT00144300|455886285|FG000|Overall Study|Lost to Follow-up|3|||
126708769|NCT00144300|455886286|FG001|Overall Study|Lost to Follow-up|0|||
126708770|NCT00144300|455886285|FG000|Overall Study|Withdrawal by Subject|6|||
126765993|NCT00669110|456095875|FG001|Overall Study|Lost to Follow-up|0|||
126765994|NCT00669110|456095874|FG000|Overall Study|Protocol Violation|0|||
126765995|NCT00669110|456095875|FG001|Overall Study|Protocol Violation|5|||
126765996|NCT00669110|456095874|FG000|Overall Study|Withdrawal by Subject|0|||
126708771|NCT00144300|455886286|FG001|Overall Study|Withdrawal by Subject|6|||
126708772|NCT00144300|455886285|FG000|Overall Study|Other reason (not specified)|1|||
126708773|NCT00144300|455886286|FG001|Overall Study|Other reason (not specified)|3|||
126708774|NCT01607892|455886287|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
126280694|NCT00996892|454318477|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
126280695|NCT00996892|454318478|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
126280696|NCT00996892|454318479|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
126280697|NCT00996892|454318480|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
126280698|NCT00996892|454318481|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
126280699|NCT00996892|454318482|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
126280700|NCT00996892|454318483|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
126280701|NCT00996892|454318484|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
126280702|NCT00996892|454318465|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
126280703|NCT00996892|454318466|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
126280704|NCT00996892|454318467|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
126280705|NCT00996892|454318468|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
126280706|NCT00996892|454318469|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
126280707|NCT00996892|454318470|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
126280708|NCT00996892|454318471|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
126280709|NCT00996892|454318472|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
126280710|NCT00996892|454318473|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
126280711|NCT00996892|454318474|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
126280712|NCT00996892|454318475|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
126280713|NCT00996892|454318476|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
126280714|NCT00996892|454318477|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
126280715|NCT00996892|454318478|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
126280716|NCT00996892|454318479|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
126280717|NCT00996892|454318480|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
126280718|NCT00996892|454318481|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
126280719|NCT00996892|454318482|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
126280720|NCT00996892|454318483|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
126280721|NCT00996892|454318484|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
126280722|NCT00996892|454318465|FG000|Dose-Escalation Stage 1A|Death|0|||
126280723|NCT00996892|454318466|FG001|Dose-Escalation Stage 1A|Death|0|||
126280724|NCT00996892|454318467|FG002|Dose-Escalation Stage 1A|Death|0|||
126280725|NCT00996892|454318468|FG003|Dose-Escalation Stage 1A|Death|0|||
126280726|NCT00996892|454318469|FG004|Dose-Escalation Stage 1A|Death|0|||
126280727|NCT00996892|454318470|FG005|Dose-Escalation Stage 1A|Death|0|||
126280728|NCT00996892|454318471|FG006|Dose-Escalation Stage 1A|Death|0|||
126280729|NCT00996892|454318472|FG007|Dose-Escalation Stage 1A|Death|0|||
126363909|NCT00866775|454626667|FG001|Overall Study|Adverse Event|19|||
126363910|NCT00866775|454626666|FG000|Overall Study|Death|1|||
126363911|NCT00866775|454626667|FG001|Overall Study|Death|0|||
126363912|NCT00866775|454626666|FG000|Overall Study|Lost to Follow-up|0|||
126363913|NCT00866775|454626667|FG001|Overall Study|Lost to Follow-up|4|||
126363914|NCT00866775|454626666|FG000|Overall Study|Physician Decision|0|||
126363915|NCT00866775|454626667|FG001|Overall Study|Physician Decision|3|||
126363916|NCT00866775|454626666|FG000|Overall Study|Protocol Violation|3|||
126363917|NCT00866775|454626667|FG001|Overall Study|Protocol Violation|4|||
126363918|NCT00866775|454626666|FG000|Overall Study|Withdrawal by Subject|4|||
126363919|NCT00866775|454626667|FG001|Overall Study|Withdrawal by Subject|4|||
126363920|NCT00866775|454626666|FG000|Overall Study|met exit criteria|23|||
126363921|NCT00866775|454626667|FG001|Overall Study|met exit criteria|17|||
126363922|NCT00866775|454626666|FG000|Overall Study|discontinued due to communication error|0|||
126363923|NCT00866775|454626667|FG001|Overall Study|discontinued due to communication error|1|||
126363924|NCT01661595|454626668|FG000|Phase 1: Week 0-4|Adverse Event|1|||
126363925|NCT01661595|454626669|FG001|Phase 1: Week 0-4|Adverse Event|0|||
126363926|NCT01661595|454626670|FG002|Phase 1: Week 0-4|Adverse Event|0|||
126363927|NCT01661595|454626671|FG003|Phase 1: Week 0-4|Adverse Event|0|||
126363928|NCT01661595|454626668|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
126363929|NCT01661595|454626669|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
126363930|NCT01661595|454626670|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
126363931|NCT01661595|454626671|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
126363932|NCT01500135|454626672|FG000|Overall Study|Withdrawal of Consent|4|||
126363933|NCT01500135|454626673|FG001|Overall Study|Withdrawal of Consent|0|||
126363934|NCT01500135|454626672|FG000|Overall Study|Lost to Follow-up|6|||
126363935|NCT01500135|454626673|FG001|Overall Study|Lost to Follow-up|4|||
126363936|NCT01500135|454626672|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
126363937|NCT01500135|454626673|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
126363938|NCT01500135|454626672|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
126363939|NCT01500135|454626673|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
126708775|NCT01607892|455886288|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
126280730|NCT00996892|454318473|FG008|Dose-Escalation Stage 1A|Death|0|||
126280731|NCT00996892|454318474|FG009|Dose-Escalation Stage 1A|Death|2|||
126280732|NCT00996892|454318475|FG010|Dose-Escalation Stage 1A|Death|0|||
126280733|NCT00996892|454318476|FG011|Dose-Escalation Stage 1A|Death|1|||
126708776|NCT01607892|455886289|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
126708777|NCT01607892|455886290|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
126708778|NCT01607892|455886291|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
126708779|NCT01607892|455886287|FG000|Overall Study|Death|4|||
126708780|NCT01607892|455886288|FG001|Overall Study|Death|2|||
126708781|NCT01607892|455886289|FG002|Overall Study|Death|8|||
126708782|NCT01607892|455886290|FG003|Overall Study|Death|10|||
126708783|NCT01607892|455886291|FG004|Overall Study|Death|3|||
126708784|NCT01607892|455886287|FG000|Overall Study|Investigator discretion|2|||
126708785|NCT01607892|455886288|FG001|Overall Study|Investigator discretion|4|||
126708786|NCT01607892|455886289|FG002|Overall Study|Investigator discretion|4|||
126708787|NCT01607892|455886290|FG003|Overall Study|Investigator discretion|8|||
126708788|NCT01607892|455886291|FG004|Overall Study|Investigator discretion|0|||
126708789|NCT01607892|455886287|FG000|Overall Study|Other treatments became available|1|||
126708790|NCT01607892|455886288|FG001|Overall Study|Other treatments became available|1|||
126708791|NCT01607892|455886289|FG002|Overall Study|Other treatments became available|0|||
126708792|NCT01607892|455886290|FG003|Overall Study|Other treatments became available|0|||
126765997|NCT00669110|456095875|FG001|Overall Study|Withdrawal by Subject|2|||
126765998|NCT01870921|456095876|FG000|Overall Study|Subject decision|80|||
126280734|NCT00996892|454318477|FG012|Dose-Escalation Stage 1A|Death|1|||
126280735|NCT00996892|454318478|FG013|Dose-Escalation Stage 1A|Death|0|||
126280736|NCT00996892|454318479|FG014|Dose-Escalation Stage 1A|Death|0|||
126280737|NCT00996892|454318480|FG015|Dose-Escalation Stage 1A|Death|0|||
126280738|NCT00996892|454318481|FG016|Dose-Escalation Stage 1A|Death|0|||
126280739|NCT00996892|454318482|FG017|Dose-Escalation Stage 1A|Death|0|||
126280740|NCT00996892|454318483|FG018|Dose-Escalation Stage 1A|Death|0|||
126280741|NCT00996892|454318484|FG019|Dose-Escalation Stage 1A|Death|0|||
126280742|NCT00996892|454318465|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
126280743|NCT00996892|454318466|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
126280744|NCT00996892|454318467|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
126280745|NCT00996892|454318468|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
126280746|NCT00996892|454318469|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
126280747|NCT00996892|454318470|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
126280748|NCT00996892|454318471|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
126280749|NCT00996892|454318472|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
126280750|NCT00996892|454318473|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
126280751|NCT00996892|454318474|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
126280752|NCT00996892|454318475|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
126280753|NCT00996892|454318476|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
126280754|NCT00996892|454318477|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
126280755|NCT00996892|454318478|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
126280756|NCT00996892|454318479|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
126280757|NCT00996892|454318480|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
126280758|NCT00996892|454318481|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
126280759|NCT00996892|454318482|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
126280760|NCT00996892|454318483|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
126280761|NCT00996892|454318484|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
126280762|NCT00996892|454318465|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280763|NCT00996892|454318466|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280764|NCT00996892|454318467|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126363940|NCT01500135|454626672|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
126363941|NCT01500135|454626673|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
126363942|NCT01500135|454626672|FG000|Overall Study|Participant was a Safety Concern|1|||
126363943|NCT01500135|454626673|FG001|Overall Study|Participant was a Safety Concern|0|||
126363944|NCT01500135|454626672|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
126363945|NCT01500135|454626673|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
126363946|NCT00912509|454626674|FG000|Overall Study|Lost to Follow-up|1|||
126363947|NCT00912509|454626675|FG001|Overall Study|Lost to Follow-up|0|||
126363948|NCT00912509|454626674|FG000|Overall Study|Lack of Efficacy|4|||
126363949|NCT00912509|454626675|FG001|Overall Study|Lack of Efficacy|3|||
126363950|NCT05166902|454626677|FG000|First Intervention|Lost to Follow-up|0|||
126363951|NCT05166902|454626678|FG001|First Intervention|Lost to Follow-up|1|||
126708793|NCT01607892|455886291|FG004|Overall Study|Other treatments became available|2|||
126708794|NCT01607892|455886287|FG000|Overall Study|Intercurrent illness|1|||
126708795|NCT01607892|455886288|FG001|Overall Study|Intercurrent illness|0|||
126280765|NCT00996892|454318468|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280766|NCT00996892|454318469|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280767|NCT00996892|454318470|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280768|NCT00996892|454318471|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280769|NCT00996892|454318472|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280770|NCT00996892|454318473|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280771|NCT00996892|454318474|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
126708796|NCT01607892|455886289|FG002|Overall Study|Intercurrent illness|0|||
126280772|NCT00996892|454318475|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
126280773|NCT00996892|454318476|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
126280774|NCT00996892|454318477|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
126280775|NCT00996892|454318478|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280776|NCT00996892|454318479|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280777|NCT00996892|454318480|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280778|NCT00996892|454318481|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280779|NCT00996892|454318482|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280780|NCT00996892|454318483|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280781|NCT00996892|454318484|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
126280782|NCT00996892|454318465|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
126280783|NCT00996892|454318466|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
126280784|NCT00996892|454318467|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
126280785|NCT00996892|454318468|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
126548835|NCT02318719|455303861|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
126548836|NCT02318719|455303862|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
126548837|NCT02318719|455303863|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
126548838|NCT02318719|455303859|FG000|Open-label Extension Phase|Other|0|||
126548839|NCT02318719|455303860|FG001|Open-label Extension Phase|Other|0|||
126548840|NCT02318719|455303861|FG002|Open-label Extension Phase|Other|0|||
126548841|NCT02318719|455303862|FG003|Open-label Extension Phase|Other|0|||
126548842|NCT02318719|455303863|FG004|Open-label Extension Phase|Other|7|||
126548843|NCT01868035|455303864|FG000|Overall Study|Lost to Follow-up|3|||
126548844|NCT01868035|455303864|FG000|Overall Study|Withdrawal by Subject|1|||
126548845|NCT01868035|455303864|FG000|Overall Study|Progressive Disease|2|||
126548846|NCT01868035|455303864|FG000|Overall Study|Non-compliance|1|||
126548847|NCT00432835|455303865|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
126280786|NCT00996892|454318469|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
126280787|NCT00996892|454318470|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
126280788|NCT00996892|454318471|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
126280789|NCT00996892|454318472|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
126280790|NCT00996892|454318473|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
126280791|NCT00996892|454318474|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
126280792|NCT00996892|454318475|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
126280793|NCT00996892|454318476|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
126280794|NCT00996892|454318477|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
126280795|NCT00996892|454318478|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
126280796|NCT00996892|454318479|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
126280797|NCT00996892|454318480|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
126280798|NCT00996892|454318481|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
126280799|NCT00996892|454318482|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
126280800|NCT00996892|454318483|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
126280801|NCT00996892|454318484|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
126280802|NCT00996892|454318465|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
126280803|NCT00996892|454318466|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
126280804|NCT00996892|454318467|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
126280805|NCT00996892|454318468|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
126280806|NCT00996892|454318469|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
126280807|NCT00996892|454318470|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
126280808|NCT00996892|454318471|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
126280809|NCT00996892|454318472|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
126280810|NCT00996892|454318473|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
126280811|NCT00996892|454318474|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
126280812|NCT00996892|454318475|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
126280813|NCT00996892|454318476|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
126280814|NCT00996892|454318477|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
126280815|NCT00996892|454318478|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
126280816|NCT00996892|454318479|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
126280817|NCT00996892|454318480|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
126280818|NCT00996892|454318481|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
126280819|NCT00996892|454318482|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
126548848|NCT00432835|455303866|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
126280820|NCT00996892|454318483|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
126280821|NCT00996892|454318484|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
126280822|NCT00996892|454318465|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
126280823|NCT00996892|454318466|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
126280824|NCT00996892|454318467|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
126280825|NCT00996892|454318468|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
126280826|NCT00996892|454318469|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
126548849|NCT00802659|455303867|FG000|Overall Study|Physician Decision|0|||
126548850|NCT00802659|455303868|FG001|Overall Study|Physician Decision|1|||
126363952|NCT01998477|454626679|FG000|Overall Study|Lost to Follow-up|4|||
126363953|NCT01998477|454626680|FG001|Overall Study|Lost to Follow-up|5|||
126280827|NCT00996892|454318470|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
126280828|NCT00996892|454318471|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
126280829|NCT00996892|454318472|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
126280830|NCT00996892|454318473|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
126280831|NCT00996892|454318474|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
126280832|NCT00996892|454318475|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
126280833|NCT00996892|454318476|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
126280834|NCT00996892|454318477|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
126280835|NCT00996892|454318478|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
126280836|NCT00996892|454318479|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
126280837|NCT00996892|454318480|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
126280838|NCT00996892|454318481|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
126280839|NCT00996892|454318482|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
126280840|NCT00996892|454318483|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
126280841|NCT00996892|454318484|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
126280842|NCT00996892|454318465|FG000|Expansion Stage 2|Adverse Event|0|||
126280843|NCT00996892|454318466|FG001|Expansion Stage 2|Adverse Event|0|||
126280844|NCT00996892|454318467|FG002|Expansion Stage 2|Adverse Event|0|||
126280845|NCT00996892|454318468|FG003|Expansion Stage 2|Adverse Event|0|||
126280846|NCT00996892|454318469|FG004|Expansion Stage 2|Adverse Event|0|||
126280847|NCT00996892|454318470|FG005|Expansion Stage 2|Adverse Event|0|||
126280848|NCT00996892|454318471|FG006|Expansion Stage 2|Adverse Event|0|||
126280849|NCT00996892|454318472|FG007|Expansion Stage 2|Adverse Event|0|||
126280850|NCT00996892|454318473|FG008|Expansion Stage 2|Adverse Event|0|||
126280851|NCT00996892|454318474|FG009|Expansion Stage 2|Adverse Event|0|||
126363954|NCT01998477|454626679|FG000|Overall Study|Withdrawal by Subject|6|||
126363955|NCT01998477|454626680|FG001|Overall Study|Withdrawal by Subject|0|||
126363956|NCT00779909|454626681|FG000|Overall Study|Lost to Follow-up|1|||
126363957|NCT00779909|454626682|FG001|Overall Study|Lost to Follow-up|0|||
126363958|NCT00779909|454626683|FG002|Overall Study|Lost to Follow-up|0|||
126363959|NCT00779909|454626684|FG003|Overall Study|Lost to Follow-up|1|||
126455879|NCT03011892|454969078|FG000|Double Blind (DB) Period|Adverse Event|0|||
126455880|NCT03011892|454969079|FG001|Double Blind (DB) Period|Adverse Event|1|||
126455881|NCT03011892|454969080|FG002|Double Blind (DB) Period|Adverse Event|1|||
126455882|NCT03011892|454969081|FG003|Double Blind (DB) Period|Adverse Event|0|||
126455883|NCT03011892|454969082|FG004|Double Blind (DB) Period|Adverse Event|0|||
126455884|NCT03011892|454969083|FG005|Double Blind (DB) Period|Adverse Event|0|||
126455885|NCT03011892|454969084|FG006|Double Blind (DB) Period|Adverse Event|0|||
126455886|NCT03011892|454969085|FG007|Double Blind (DB) Period|Adverse Event|0|||
126455887|NCT03011892|454969086|FG008|Double Blind (DB) Period|Adverse Event|0|||
126455888|NCT03011892|454969087|FG009|Double Blind (DB) Period|Adverse Event|0|||
126455889|NCT03011892|454969088|FG010|Double Blind (DB) Period|Adverse Event|0|||
126455890|NCT03011892|454969089|FG011|Double Blind (DB) Period|Adverse Event|0|||
126455891|NCT03011892|454969078|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
126455892|NCT03011892|454969079|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
126455893|NCT03011892|454969080|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
126455894|NCT03011892|454969081|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
126455895|NCT03011892|454969082|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
126455896|NCT03011892|454969083|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
126455897|NCT03011892|454969084|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
126455898|NCT03011892|454969085|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
126455899|NCT03011892|454969086|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
126455900|NCT03011892|454969087|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
126455901|NCT03011892|454969088|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
126455902|NCT03011892|454969089|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
126455903|NCT03011892|454969078|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
126455904|NCT03011892|454969079|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
126455905|NCT03011892|454969080|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
126455906|NCT03011892|454969081|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
126708797|NCT01607892|455886290|FG003|Overall Study|Intercurrent illness|3|||
126708798|NCT01607892|455886291|FG004|Overall Study|Intercurrent illness|0|||
126280852|NCT00996892|454318475|FG010|Expansion Stage 2|Adverse Event|0|||
126455907|NCT03011892|454969082|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
126280853|NCT00996892|454318476|FG011|Expansion Stage 2|Adverse Event|0|||
126455908|NCT03011892|454969083|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
126455909|NCT03011892|454969084|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
126455910|NCT03011892|454969085|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
126455911|NCT03011892|454969086|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
126280854|NCT00996892|454318477|FG012|Expansion Stage 2|Adverse Event|0|||
126280855|NCT00996892|454318478|FG013|Expansion Stage 2|Adverse Event|0|||
126280856|NCT00996892|454318479|FG014|Expansion Stage 2|Adverse Event|0|||
126280857|NCT00996892|454318480|FG015|Expansion Stage 2|Adverse Event|0|||
126363960|NCT00779909|454626681|FG000|Overall Study|Withdrawal by Subject|0|||
126363961|NCT00779909|454626682|FG001|Overall Study|Withdrawal by Subject|1|||
126363962|NCT00779909|454626683|FG002|Overall Study|Withdrawal by Subject|0|||
126363963|NCT00779909|454626684|FG003|Overall Study|Withdrawal by Subject|0|||
126363964|NCT03523585|454626685|FG000|Overall Study|Progressive Disease|174|||
126363965|NCT03523585|454626686|FG001|Overall Study|Progressive Disease|64|||
126363966|NCT03523585|454626687|FG002|Overall Study|Progressive Disease|77|||
126363967|NCT03523585|454626685|FG000|Overall Study|Adverse Event|74|||
126363968|NCT03523585|454626686|FG001|Overall Study|Adverse Event|5|||
126363969|NCT03523585|454626687|FG002|Overall Study|Adverse Event|9|||
126363970|NCT03523585|454626685|FG000|Overall Study|Withdrawal by Subject|30|||
126363971|NCT03523585|454626686|FG001|Overall Study|Withdrawal by Subject|11|||
126363972|NCT03523585|454626687|FG002|Overall Study|Withdrawal by Subject|6|||
126363973|NCT03523585|454626685|FG000|Overall Study|Clinical Progression|23|||
126363974|NCT03523585|454626686|FG001|Overall Study|Clinical Progression|5|||
126363975|NCT03523585|454626687|FG002|Overall Study|Clinical Progression|10|||
126363976|NCT03523585|454626685|FG000|Overall Study|Death|4|||
126363977|NCT03523585|454626686|FG001|Overall Study|Death|0|||
126363978|NCT03523585|454626687|FG002|Overall Study|Death|1|||
126363979|NCT03523585|454626685|FG000|Overall Study|Physician Decision|2|||
126363980|NCT03523585|454626686|FG001|Overall Study|Physician Decision|1|||
126363981|NCT03523585|454626687|FG002|Overall Study|Physician Decision|0|||
126363982|NCT03523585|454626685|FG000|Overall Study|Lost to Follow-up|1|||
126363983|NCT03523585|454626686|FG001|Overall Study|Lost to Follow-up|0|||
126363984|NCT03523585|454626687|FG002|Overall Study|Lost to Follow-up|0|||
126363985|NCT03523585|454626685|FG000|Overall Study|Miscellaneous|1|||
126363986|NCT03523585|454626686|FG001|Overall Study|Miscellaneous|0|||
126363987|NCT03523585|454626687|FG002|Overall Study|Miscellaneous|0|||
126363988|NCT03523585|454626685|FG000|Overall Study|Protocol Deviation|1|||
126363989|NCT03523585|454626686|FG001|Overall Study|Protocol Deviation|0|||
126363990|NCT03523585|454626687|FG002|Overall Study|Protocol Deviation|1|||
126363991|NCT03523585|454626685|FG000|Overall Study|Randomized But Not Treated|2|||
126363992|NCT03523585|454626686|FG001|Overall Study|Randomized But Not Treated|4|||
126708799|NCT01607892|455886287|FG000|Overall Study|Non-Compliance with study procedures|0|||
126708800|NCT01607892|455886288|FG001|Overall Study|Non-Compliance with study procedures|0|||
126708801|NCT01607892|455886289|FG002|Overall Study|Non-Compliance with study procedures|1|||
126363993|NCT03523585|454626687|FG002|Overall Study|Randomized But Not Treated|3|||
126363994|NCT05345405|454626688|FG000|Overall Study|Withdrawal by Subject|2|||
126363995|NCT05345405|454626689|FG001|Overall Study|Withdrawal by Subject|0|||
126363996|NCT05345405|454626690|FG002|Overall Study|Withdrawal by Subject|0|||
126363997|NCT05345405|454626688|FG000|Overall Study|Did not meet eligibility criteria|0|||
126363998|NCT05345405|454626689|FG001|Overall Study|Did not meet eligibility criteria|2|||
126363999|NCT05345405|454626690|FG002|Overall Study|Did not meet eligibility criteria|0|||
126364000|NCT05345405|454626688|FG000|Overall Study|Lost to Follow-up|0|||
126364001|NCT05345405|454626689|FG001|Overall Study|Lost to Follow-up|0|||
126364002|NCT05345405|454626690|FG002|Overall Study|Lost to Follow-up|1|||
126364003|NCT02872142|454626698|FG000|Overall Study|Adverse Event|2|||
126364004|NCT02872142|454626698|FG000|Overall Study|Death|1|||
126364005|NCT02872142|454626698|FG000|Overall Study|Participant Decision|3|||
126364006|NCT01903720|454626699|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
126364007|NCT01903720|454626699|FG000|Overall Study|Adverse Event|1|||
126364008|NCT01903720|454626699|FG000|Overall Study|Rescinding of informed consent|2|||
126364009|NCT01903720|454626699|FG000|Overall Study|Lost to Follow-up|2|||
126364010|NCT01903720|454626699|FG000|Overall Study|Treatment with alternative drug|1|||
126364011|NCT02244957|454626700|FG000|Overall Study|Lack of Efficacy|1|||
126364012|NCT02244957|454626701|FG001|Overall Study|Lack of Efficacy|0|||
126364013|NCT02150863|454626702|FG000|Overall Study|Lost to Follow-up|0|||
126364014|NCT02150863|454626703|FG001|Overall Study|Lost to Follow-up|1|||
126364015|NCT02150863|454626704|FG002|Overall Study|Lost to Follow-up|0|||
126455912|NCT03011892|454969087|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
126455913|NCT03011892|454969088|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
126455914|NCT03011892|454969089|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
126455915|NCT03011892|454969078|FG000|Double Blind (DB) Period|Other|1|||
126455916|NCT03011892|454969079|FG001|Double Blind (DB) Period|Other|1|||
126455917|NCT03011892|454969080|FG002|Double Blind (DB) Period|Other|1|||
126364016|NCT00830336|454626705|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
126364017|NCT00830336|454626706|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
126364018|NCT01853280|454626713|FG000|Overall Study|Lack of Efficacy|2|||
126364019|NCT01853280|454626714|FG001|Overall Study|Lack of Efficacy|2|||
126364020|NCT01853280|454626713|FG000|Overall Study|Lost to Follow-up|0|||
126455918|NCT03011892|454969081|FG003|Double Blind (DB) Period|Other|0|||
126364021|NCT01853280|454626714|FG001|Overall Study|Lost to Follow-up|1|||
126364022|NCT01853280|454626713|FG000|Overall Study|Physician Decision|0|||
126364023|NCT01853280|454626714|FG001|Overall Study|Physician Decision|1|||
126364024|NCT01853280|454626713|FG000|Overall Study|Withdrawal by Subject|0|||
126364025|NCT01853280|454626714|FG001|Overall Study|Withdrawal by Subject|1|||
126364026|NCT01853280|454626713|FG000|Overall Study|Ineligible|0|||
126364027|NCT01853280|454626714|FG001|Overall Study|Ineligible|1|||
126455919|NCT03011892|454969082|FG004|Double Blind (DB) Period|Other|1|||
126280858|NCT00996892|454318481|FG016|Expansion Stage 2|Adverse Event|0|||
126280859|NCT00996892|454318482|FG017|Expansion Stage 2|Adverse Event|0|||
126280860|NCT00996892|454318483|FG018|Expansion Stage 2|Adverse Event|3|||
126280861|NCT00996892|454318484|FG019|Expansion Stage 2|Adverse Event|0|||
126280862|NCT00996892|454318465|FG000|Expansion Stage 2|Death|0|||
126280863|NCT00996892|454318466|FG001|Expansion Stage 2|Death|0|||
126280864|NCT00996892|454318467|FG002|Expansion Stage 2|Death|0|||
126280865|NCT00996892|454318468|FG003|Expansion Stage 2|Death|0|||
126280866|NCT00996892|454318469|FG004|Expansion Stage 2|Death|0|||
126280867|NCT00996892|454318470|FG005|Expansion Stage 2|Death|0|||
126280868|NCT00996892|454318471|FG006|Expansion Stage 2|Death|0|||
126280869|NCT00996892|454318472|FG007|Expansion Stage 2|Death|0|||
126280870|NCT00996892|454318473|FG008|Expansion Stage 2|Death|0|||
126280871|NCT00996892|454318474|FG009|Expansion Stage 2|Death|0|||
126280872|NCT00996892|454318475|FG010|Expansion Stage 2|Death|0|||
126280873|NCT00996892|454318476|FG011|Expansion Stage 2|Death|0|||
126280874|NCT00996892|454318477|FG012|Expansion Stage 2|Death|0|||
126280875|NCT00996892|454318478|FG013|Expansion Stage 2|Death|0|||
126280876|NCT00996892|454318479|FG014|Expansion Stage 2|Death|0|||
126280877|NCT00996892|454318480|FG015|Expansion Stage 2|Death|0|||
126280878|NCT00996892|454318481|FG016|Expansion Stage 2|Death|0|||
126280879|NCT00996892|454318482|FG017|Expansion Stage 2|Death|0|||
126280880|NCT00996892|454318483|FG018|Expansion Stage 2|Death|2|||
126280881|NCT00996892|454318484|FG019|Expansion Stage 2|Death|0|||
126280882|NCT00996892|454318465|FG000|Expansion Stage 2|Physician Decision|0|||
126280883|NCT00996892|454318466|FG001|Expansion Stage 2|Physician Decision|0|||
126280884|NCT00996892|454318467|FG002|Expansion Stage 2|Physician Decision|0|||
126280885|NCT00996892|454318468|FG003|Expansion Stage 2|Physician Decision|0|||
126280886|NCT00996892|454318469|FG004|Expansion Stage 2|Physician Decision|0|||
126280887|NCT00996892|454318470|FG005|Expansion Stage 2|Physician Decision|0|||
126280888|NCT00996892|454318471|FG006|Expansion Stage 2|Physician Decision|0|||
126280889|NCT00996892|454318472|FG007|Expansion Stage 2|Physician Decision|0|||
126280890|NCT00996892|454318473|FG008|Expansion Stage 2|Physician Decision|0|||
126280891|NCT00996892|454318474|FG009|Expansion Stage 2|Physician Decision|0|||
126280892|NCT00996892|454318475|FG010|Expansion Stage 2|Physician Decision|0|||
126280893|NCT00996892|454318476|FG011|Expansion Stage 2|Physician Decision|0|||
126280894|NCT00996892|454318477|FG012|Expansion Stage 2|Physician Decision|0|||
126280895|NCT00996892|454318478|FG013|Expansion Stage 2|Physician Decision|0|||
126280896|NCT00996892|454318479|FG014|Expansion Stage 2|Physician Decision|0|||
126280897|NCT00996892|454318480|FG015|Expansion Stage 2|Physician Decision|0|||
126280898|NCT00996892|454318481|FG016|Expansion Stage 2|Physician Decision|0|||
126280899|NCT00996892|454318482|FG017|Expansion Stage 2|Physician Decision|0|||
126280900|NCT00996892|454318483|FG018|Expansion Stage 2|Physician Decision|1|||
126280901|NCT00996892|454318484|FG019|Expansion Stage 2|Physician Decision|0|||
126455920|NCT03011892|454969083|FG005|Double Blind (DB) Period|Other|0|||
126455921|NCT03011892|454969084|FG006|Double Blind (DB) Period|Other|0|||
126455922|NCT03011892|454969085|FG007|Double Blind (DB) Period|Other|0|||
126455923|NCT03011892|454969086|FG008|Double Blind (DB) Period|Other|0|||
126455924|NCT03011892|454969087|FG009|Double Blind (DB) Period|Other|0|||
126455925|NCT03011892|454969088|FG010|Double Blind (DB) Period|Other|0|||
126455926|NCT03011892|454969089|FG011|Double Blind (DB) Period|Other|0|||
126455927|NCT03011892|454969078|FG000|Double Blind (DB) Period|Physician Decision|1|||
126455928|NCT03011892|454969079|FG001|Double Blind (DB) Period|Physician Decision|0|||
126455929|NCT03011892|454969080|FG002|Double Blind (DB) Period|Physician Decision|1|||
126455930|NCT03011892|454969081|FG003|Double Blind (DB) Period|Physician Decision|0|||
126455931|NCT03011892|454969082|FG004|Double Blind (DB) Period|Physician Decision|0|||
126455932|NCT03011892|454969083|FG005|Double Blind (DB) Period|Physician Decision|0|||
126455933|NCT03011892|454969084|FG006|Double Blind (DB) Period|Physician Decision|0|||
126455934|NCT03011892|454969085|FG007|Double Blind (DB) Period|Physician Decision|0|||
126455935|NCT03011892|454969086|FG008|Double Blind (DB) Period|Physician Decision|0|||
126455936|NCT03011892|454969087|FG009|Double Blind (DB) Period|Physician Decision|0|||
126455937|NCT03011892|454969088|FG010|Double Blind (DB) Period|Physician Decision|0|||
126455938|NCT03011892|454969089|FG011|Double Blind (DB) Period|Physician Decision|0|||
126455939|NCT03011892|454969078|FG000|Double Blind (DB) Period|Pregnancy|0|||
126280902|NCT00996892|454318465|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
126280903|NCT00996892|454318466|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
126280904|NCT00996892|454318467|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
126280905|NCT00996892|454318468|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
126280906|NCT00996892|454318469|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
126280907|NCT00996892|454318470|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
126280908|NCT00996892|454318471|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
126280909|NCT00996892|454318472|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
126280910|NCT00996892|454318473|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
126280911|NCT00996892|454318474|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
126280912|NCT00996892|454318475|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
126280913|NCT00996892|454318476|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
126280914|NCT00996892|454318477|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
126455940|NCT03011892|454969079|FG001|Double Blind (DB) Period|Pregnancy|0|||
126364028|NCT00104884|454626715|FG000|Overall Study|Disease progression|4|||
126364029|NCT03032484|454626716|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
126548851|NCT00802659|455303869|FG002|Overall Study|Physician Decision|0|||
126548852|NCT00802659|455303870|FG003|Overall Study|Physician Decision|0|||
126548853|NCT00423293|455303871|FG000|Overall Study|Ineligible / No protocol treatment|11|||
126548854|NCT01912222|455303874|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
126364030|NCT03032484|454626717|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
126364031|NCT03032484|454626716|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
126364032|NCT03032484|454626717|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
126364033|NCT01229111|454626718|FG000|Overall Study|Death|1|||
126364034|NCT01689649|454626721|FG000|Overall Study|Lack of Efficacy|3|||
126364035|NCT01689649|454626721|FG000|Overall Study|Non-compliance|11|||
126364036|NCT01689649|454626721|FG000|Overall Study|Protocol Violation|3|||
126364037|NCT01689649|454626721|FG000|Overall Study|Lost to Follow-up|5|||
126548855|NCT01912222|455303875|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
126280915|NCT00996892|454318478|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
126280916|NCT00996892|454318479|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
126280917|NCT00996892|454318480|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
126364038|NCT04893811|454626722|FG000|Vaccination Phase|Death|1|||
126364039|NCT04893811|454626723|FG001|Vaccination Phase|Death|0|||
126364040|NCT04893811|454626722|FG000|Vaccination Phase|Lost to Follow-up|1|||
126364041|NCT04893811|454626723|FG001|Vaccination Phase|Lost to Follow-up|1|||
126364042|NCT04893811|454626722|FG000|Vaccination Phase|Protocol Violation|2|||
126364043|NCT04893811|454626723|FG001|Vaccination Phase|Protocol Violation|0|||
126364044|NCT04893811|454626722|FG000|Vaccination Phase|Withdrawal by Subject|2|||
126364045|NCT04893811|454626723|FG001|Vaccination Phase|Withdrawal by Subject|1|||
126364046|NCT04893811|454626722|FG000|Vaccination Phase|Other|0|||
126364047|NCT04893811|454626723|FG001|Vaccination Phase|Other|1|||
126364048|NCT04893811|454626722|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
126364049|NCT04893811|454626723|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
126364050|NCT04893811|454626722|FG000|Follow-up Phase|Lost to Follow-up|0|||
126364051|NCT04893811|454626723|FG001|Follow-up Phase|Lost to Follow-up|1|||
126364052|NCT03268499|454626724|FG000|Overall Study|Withdrawal by Subject|2|||
126364053|NCT03268499|454626725|FG001|Overall Study|Withdrawal by Subject|1|||
126364054|NCT03760081|454626729|FG000|Overall Study|Miscellaneous|0|||
126364055|NCT03760081|454626730|FG001|Overall Study|Miscellaneous|1|||
126364056|NCT03760081|454626729|FG000|Overall Study|Progressive Disease|5|||
126364057|NCT03760081|454626730|FG001|Overall Study|Progressive Disease|10|||
126364058|NCT03760081|454626729|FG000|Overall Study|Death|1|||
126364059|NCT03760081|454626730|FG001|Overall Study|Death|1|||
126364060|NCT03533491|454626731|FG000|Overall Study|Lost to Follow-up|2|||
126364061|NCT01725282|454626734|FG000|Overall Study|Adverse Event|1|||
126364062|NCT01725282|454626735|FG001|Overall Study|Adverse Event|3|||
126364063|NCT01725282|454626736|FG002|Overall Study|Adverse Event|6|||
126364064|NCT01725282|454626737|FG003|Overall Study|Adverse Event|4|||
126364065|NCT01725282|454626734|FG000|Overall Study|Exacerbation of Target Disease|1|||
126364066|NCT01725282|454626735|FG001|Overall Study|Exacerbation of Target Disease|0|||
126364067|NCT01725282|454626736|FG002|Overall Study|Exacerbation of Target Disease|0|||
126364068|NCT01725282|454626737|FG003|Overall Study|Exacerbation of Target Disease|1|||
126364069|NCT01725282|454626734|FG000|Overall Study|Met Exclusion Criteria|0|||
126364070|NCT01725282|454626735|FG001|Overall Study|Met Exclusion Criteria|0|||
126364071|NCT01725282|454626736|FG002|Overall Study|Met Exclusion Criteria|1|||
126364072|NCT01725282|454626737|FG003|Overall Study|Met Exclusion Criteria|0|||
126280918|NCT00996892|454318481|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
126280919|NCT00996892|454318482|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
126280920|NCT00996892|454318483|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
126280921|NCT00996892|454318484|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
126280922|NCT00996892|454318465|FG000|Expansion Stage 2|Disease Progression|0|||
126280923|NCT00996892|454318466|FG001|Expansion Stage 2|Disease Progression|0|||
126280924|NCT00996892|454318467|FG002|Expansion Stage 2|Disease Progression|0|||
126280925|NCT00996892|454318468|FG003|Expansion Stage 2|Disease Progression|0|||
126280926|NCT00996892|454318469|FG004|Expansion Stage 2|Disease Progression|0|||
126280927|NCT00996892|454318470|FG005|Expansion Stage 2|Disease Progression|0|||
126280928|NCT00996892|454318471|FG006|Expansion Stage 2|Disease Progression|0|||
126364073|NCT01725282|454626734|FG000|Overall Study|Study Site Withdrawal|0|||
126280929|NCT00996892|454318472|FG007|Expansion Stage 2|Disease Progression|0|||
126364074|NCT01725282|454626735|FG001|Overall Study|Study Site Withdrawal|1|||
126364075|NCT01725282|454626736|FG002|Overall Study|Study Site Withdrawal|0|||
126364076|NCT01725282|454626737|FG003|Overall Study|Study Site Withdrawal|0|||
126364077|NCT01725282|454626734|FG000|Overall Study|Withdrawal by Subject|0|||
126364078|NCT01725282|454626735|FG001|Overall Study|Withdrawal by Subject|0|||
126364079|NCT01725282|454626736|FG002|Overall Study|Withdrawal by Subject|1|||
126364080|NCT01725282|454626737|FG003|Overall Study|Withdrawal by Subject|1|||
126364081|NCT01725282|454626734|FG000|Overall Study|Lack of Efficacy|0|||
126364082|NCT01725282|454626735|FG001|Overall Study|Lack of Efficacy|1|||
126280930|NCT00996892|454318473|FG008|Expansion Stage 2|Disease Progression|0|||
126364083|NCT01725282|454626736|FG002|Overall Study|Lack of Efficacy|0|||
126280931|NCT00996892|454318474|FG009|Expansion Stage 2|Disease Progression|0|||
126280932|NCT00996892|454318475|FG010|Expansion Stage 2|Disease Progression|0|||
126280933|NCT00996892|454318476|FG011|Expansion Stage 2|Disease Progression|0|||
126280934|NCT00996892|454318477|FG012|Expansion Stage 2|Disease Progression|0|||
126280935|NCT00996892|454318478|FG013|Expansion Stage 2|Disease Progression|0|||
126280936|NCT00996892|454318479|FG014|Expansion Stage 2|Disease Progression|0|||
126280937|NCT00996892|454318480|FG015|Expansion Stage 2|Disease Progression|0|||
126280938|NCT00996892|454318481|FG016|Expansion Stage 2|Disease Progression|0|||
126280939|NCT00996892|454318482|FG017|Expansion Stage 2|Disease Progression|0|||
126280940|NCT00996892|454318483|FG018|Expansion Stage 2|Disease Progression|28|||
126280941|NCT00996892|454318484|FG019|Expansion Stage 2|Disease Progression|0|||
126280942|NCT00996892|454318465|FG000|Expansion Stage 2A|Adverse Event|0|||
126280943|NCT00996892|454318466|FG001|Expansion Stage 2A|Adverse Event|0|||
126280944|NCT00996892|454318467|FG002|Expansion Stage 2A|Adverse Event|0|||
126280945|NCT00996892|454318468|FG003|Expansion Stage 2A|Adverse Event|0|||
126280946|NCT00996892|454318469|FG004|Expansion Stage 2A|Adverse Event|0|||
126280947|NCT00996892|454318470|FG005|Expansion Stage 2A|Adverse Event|0|||
126280948|NCT00996892|454318471|FG006|Expansion Stage 2A|Adverse Event|0|||
126280949|NCT00996892|454318472|FG007|Expansion Stage 2A|Adverse Event|0|||
126280950|NCT00996892|454318473|FG008|Expansion Stage 2A|Adverse Event|0|||
126280951|NCT00996892|454318474|FG009|Expansion Stage 2A|Adverse Event|0|||
126280952|NCT00996892|454318475|FG010|Expansion Stage 2A|Adverse Event|0|||
126280953|NCT00996892|454318476|FG011|Expansion Stage 2A|Adverse Event|0|||
126280954|NCT00996892|454318477|FG012|Expansion Stage 2A|Adverse Event|0|||
126364084|NCT01725282|454626737|FG003|Overall Study|Lack of Efficacy|1|||
126364085|NCT04064567|454626738|FG000|Overall Study|Lost to Follow-up|23|||
126364086|NCT04064567|454626739|FG001|Overall Study|Lost to Follow-up|22|||
126364087|NCT04064567|454626738|FG000|Overall Study|Withdrawal by Subject|0|||
126364088|NCT04064567|454626739|FG001|Overall Study|Withdrawal by Subject|1|||
126364089|NCT04064567|454626738|FG000|Overall Study|Reincarcerated|7|||
126364090|NCT04064567|454626739|FG001|Overall Study|Reincarcerated|10|||
126364091|NCT04064567|454626738|FG000|Overall Study|Moved out of U.S.|0|||
126364092|NCT04064567|454626739|FG001|Overall Study|Moved out of U.S.|1|||
126364093|NCT04576481|454626741|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
126364094|NCT04576481|454626742|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
126364095|NCT04576481|454626743|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
126364096|NCT04576481|454626744|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
126364097|NCT01946880|454626745|FG000|Overall Study|Lost to Follow-up|1|||
126364098|NCT01946880|454626746|FG001|Overall Study|Lost to Follow-up|0|||
126364099|NCT01946880|454626745|FG000|Overall Study|Physician Decision|1|||
126364100|NCT01946880|454626746|FG001|Overall Study|Physician Decision|1|||
126364101|NCT01946880|454626745|FG000|Overall Study|Withdrawal by Subject|3|||
126364102|NCT01946880|454626746|FG001|Overall Study|Withdrawal by Subject|2|||
126364103|NCT01946880|454626745|FG000|Overall Study|Met Primary Endpoint|1|||
126364104|NCT01946880|454626746|FG001|Overall Study|Met Primary Endpoint|0|||
126364105|NCT01946880|454626745|FG000|Overall Study|Personal and Family Issues|1|||
126364106|NCT01946880|454626746|FG001|Overall Study|Personal and Family Issues|0|||
126364107|NCT01682720|454626749|FG000|Overall Study|Randomized but Not Treated|0|||
126364108|NCT01682720|454626750|FG001|Overall Study|Randomized but Not Treated|1|||
126364109|NCT01682720|454626751|FG002|Overall Study|Randomized but Not Treated|1|||
126364110|NCT01682720|454626752|FG003|Overall Study|Randomized but Not Treated|0|||
126364111|NCT01682720|454626749|FG000|Overall Study|Terminated by Sponsor|83|||
126364112|NCT01682720|454626750|FG001|Overall Study|Terminated by Sponsor|0|||
126280955|NCT00996892|454318478|FG013|Expansion Stage 2A|Adverse Event|0|||
126280956|NCT00996892|454318479|FG014|Expansion Stage 2A|Adverse Event|0|||
126364113|NCT01682720|454626751|FG002|Overall Study|Terminated by Sponsor|0|||
126364114|NCT01682720|454626752|FG003|Overall Study|Terminated by Sponsor|0|||
126364115|NCT01682720|454626749|FG000|Overall Study|Efficacy Failure|0|||
126364116|NCT01682720|454626750|FG001|Overall Study|Efficacy Failure|3|||
126364117|NCT01682720|454626751|FG002|Overall Study|Efficacy Failure|3|||
126364118|NCT01682720|454626752|FG003|Overall Study|Efficacy Failure|30|||
126364119|NCT01682720|454626749|FG000|Overall Study|Lost to Follow-up|1|||
126364120|NCT01682720|454626750|FG001|Overall Study|Lost to Follow-up|1|||
126364121|NCT01682720|454626751|FG002|Overall Study|Lost to Follow-up|0|||
126364122|NCT01682720|454626752|FG003|Overall Study|Lost to Follow-up|6|||
126364123|NCT01682720|454626749|FG000|Overall Study|Subject Withdrew Consent|0|||
126364124|NCT01682720|454626750|FG001|Overall Study|Subject Withdrew Consent|0|||
126364125|NCT01682720|454626751|FG002|Overall Study|Subject Withdrew Consent|2|||
126364126|NCT01682720|454626752|FG003|Overall Study|Subject Withdrew Consent|2|||
126364127|NCT01682720|454626749|FG000|Overall Study|Adverse Event|1|||
126364128|NCT01682720|454626750|FG001|Overall Study|Adverse Event|0|||
126364129|NCT01682720|454626751|FG002|Overall Study|Adverse Event|1|||
126280957|NCT00996892|454318480|FG015|Expansion Stage 2A|Adverse Event|0|||
126280958|NCT00996892|454318481|FG016|Expansion Stage 2A|Adverse Event|0|||
126280959|NCT00996892|454318482|FG017|Expansion Stage 2A|Adverse Event|0|||
126280960|NCT00996892|454318483|FG018|Expansion Stage 2A|Adverse Event|0|||
126708802|NCT01607892|455886290|FG003|Overall Study|Non-Compliance with study procedures|0|||
126708803|NCT01607892|455886291|FG004|Overall Study|Non-Compliance with study procedures|0|||
126708804|NCT01607892|455886287|FG000|Overall Study|Consent withdrawn by participant|9|||
126708805|NCT01607892|455886288|FG001|Overall Study|Consent withdrawn by participant|4|||
126708806|NCT01607892|455886289|FG002|Overall Study|Consent withdrawn by participant|24|||
126280961|NCT00996892|454318484|FG019|Expansion Stage 2A|Adverse Event|8|||
126280962|NCT00996892|454318465|FG000|Expansion Stage 2A|Physician Decision|0|||
126280963|NCT00996892|454318466|FG001|Expansion Stage 2A|Physician Decision|0|||
126280964|NCT00996892|454318467|FG002|Expansion Stage 2A|Physician Decision|0|||
126280965|NCT00996892|454318468|FG003|Expansion Stage 2A|Physician Decision|0|||
126280966|NCT00996892|454318469|FG004|Expansion Stage 2A|Physician Decision|0|||
126280967|NCT00996892|454318470|FG005|Expansion Stage 2A|Physician Decision|0|||
126280968|NCT00996892|454318471|FG006|Expansion Stage 2A|Physician Decision|0|||
126280969|NCT00996892|454318472|FG007|Expansion Stage 2A|Physician Decision|0|||
126280970|NCT00996892|454318473|FG008|Expansion Stage 2A|Physician Decision|0|||
126280971|NCT00996892|454318474|FG009|Expansion Stage 2A|Physician Decision|0|||
126280972|NCT00996892|454318475|FG010|Expansion Stage 2A|Physician Decision|0|||
126280973|NCT00996892|454318476|FG011|Expansion Stage 2A|Physician Decision|0|||
126280974|NCT00996892|454318477|FG012|Expansion Stage 2A|Physician Decision|0|||
126280975|NCT00996892|454318478|FG013|Expansion Stage 2A|Physician Decision|0|||
126280976|NCT00996892|454318479|FG014|Expansion Stage 2A|Physician Decision|0|||
126280977|NCT00996892|454318480|FG015|Expansion Stage 2A|Physician Decision|0|||
126280978|NCT00996892|454318481|FG016|Expansion Stage 2A|Physician Decision|0|||
126280979|NCT00996892|454318482|FG017|Expansion Stage 2A|Physician Decision|0|||
126280980|NCT00996892|454318483|FG018|Expansion Stage 2A|Physician Decision|0|||
126280981|NCT00996892|454318484|FG019|Expansion Stage 2A|Physician Decision|2|||
126280982|NCT00996892|454318465|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
126280983|NCT00996892|454318466|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
126280984|NCT00996892|454318467|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
126280985|NCT00996892|454318468|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
126280986|NCT00996892|454318469|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
126280987|NCT00996892|454318470|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
126280988|NCT00996892|454318471|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
126280989|NCT00996892|454318472|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
126280990|NCT00996892|454318473|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
126280991|NCT00996892|454318474|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
126280992|NCT00996892|454318475|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
126280993|NCT00996892|454318476|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
126280994|NCT00996892|454318477|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
126280995|NCT00996892|454318478|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
126280996|NCT00996892|454318479|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
126280997|NCT00996892|454318480|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
126280998|NCT00996892|454318481|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
126280999|NCT00996892|454318482|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
126281000|NCT00996892|454318483|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
126281001|NCT00996892|454318484|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
126281002|NCT00996892|454318465|FG000|Expansion Stage 2A|Disease Progression|0|||
126281003|NCT00996892|454318466|FG001|Expansion Stage 2A|Disease Progression|0|||
126281004|NCT00996892|454318467|FG002|Expansion Stage 2A|Disease Progression|0|||
126281005|NCT00996892|454318468|FG003|Expansion Stage 2A|Disease Progression|0|||
126281006|NCT00996892|454318469|FG004|Expansion Stage 2A|Disease Progression|0|||
126281007|NCT00996892|454318470|FG005|Expansion Stage 2A|Disease Progression|0|||
126281008|NCT00996892|454318471|FG006|Expansion Stage 2A|Disease Progression|0|||
126281009|NCT00996892|454318472|FG007|Expansion Stage 2A|Disease Progression|0|||
126281010|NCT00996892|454318473|FG008|Expansion Stage 2A|Disease Progression|0|||
126281011|NCT00996892|454318474|FG009|Expansion Stage 2A|Disease Progression|0|||
126281012|NCT00996892|454318475|FG010|Expansion Stage 2A|Disease Progression|0|||
126281013|NCT00996892|454318476|FG011|Expansion Stage 2A|Disease Progression|0|||
126281014|NCT00996892|454318477|FG012|Expansion Stage 2A|Disease Progression|0|||
126281015|NCT00996892|454318478|FG013|Expansion Stage 2A|Disease Progression|0|||
126281016|NCT00996892|454318479|FG014|Expansion Stage 2A|Disease Progression|0|||
126281017|NCT00996892|454318480|FG015|Expansion Stage 2A|Disease Progression|0|||
126281018|NCT00996892|454318481|FG016|Expansion Stage 2A|Disease Progression|0|||
126281019|NCT00996892|454318482|FG017|Expansion Stage 2A|Disease Progression|0|||
126281020|NCT00996892|454318483|FG018|Expansion Stage 2A|Disease Progression|0|||
126281021|NCT00996892|454318484|FG019|Expansion Stage 2A|Disease Progression|31|||
126708807|NCT01607892|455886290|FG003|Overall Study|Consent withdrawn by participant|14|||
126281022|NCT01653912|454318485|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
126281023|NCT01653912|454318486|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
126281024|NCT01653912|454318487|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
126281025|NCT01653912|454318488|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
126281026|NCT01653912|454318489|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
126281027|NCT01653912|454318490|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
126281028|NCT01653912|454318485|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
126281029|NCT01653912|454318486|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
126281030|NCT01653912|454318487|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
126281031|NCT01653912|454318488|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
126281032|NCT01653912|454318489|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
126281033|NCT01653912|454318490|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
126281034|NCT01653912|454318485|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
126281035|NCT01653912|454318486|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
126281036|NCT01653912|454318487|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
126281037|NCT01653912|454318488|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
126281038|NCT01653912|454318489|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
126281039|NCT01653912|454318490|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
126281040|NCT01653912|454318485|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281041|NCT01653912|454318486|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281042|NCT01653912|454318487|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281043|NCT01653912|454318488|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
126281044|NCT01653912|454318489|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281045|NCT01653912|454318490|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281046|NCT01653912|454318485|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
126281047|NCT01653912|454318486|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
126281048|NCT01653912|454318487|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
126281049|NCT01653912|454318488|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
126281050|NCT01653912|454318489|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
126281051|NCT01653912|454318490|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
126281052|NCT01653912|454318485|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
126281053|NCT01653912|454318486|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
126281054|NCT01653912|454318487|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
126281055|NCT01653912|454318488|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
126281056|NCT01653912|454318489|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
126281057|NCT01653912|454318490|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
126281058|NCT01653912|454318485|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281059|NCT01653912|454318486|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281060|NCT01653912|454318487|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281061|NCT01653912|454318488|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281062|NCT01653912|454318489|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
126281063|NCT01653912|454318490|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
126281064|NCT00602641|454320698|FG000|Overall Study|Never started protocol therapy|6|||
126281065|NCT00602641|454320699|FG001|Overall Study|Never started protocol therapy|2|||
126281066|NCT00602641|454320698|FG000|Overall Study|Still on treatment at time of analysis|8|||
126281067|NCT00602641|454320699|FG001|Overall Study|Still on treatment at time of analysis|15|||
126281068|NCT00602641|454320698|FG000|Overall Study|Adverse Event|62|||
126281069|NCT00602641|454320699|FG001|Overall Study|Adverse Event|53|||
126281070|NCT00602641|454320698|FG000|Overall Study|Disease progression|38|||
126281071|NCT00602641|454320699|FG001|Overall Study|Disease progression|55|||
126281072|NCT00602641|454320698|FG000|Overall Study|Death|6|||
126281073|NCT00602641|454320699|FG001|Overall Study|Death|5|||
126281074|NCT00602641|454320698|FG000|Overall Study|Withdrawal by Subject|15|||
126281075|NCT00602641|454320699|FG001|Overall Study|Withdrawal by Subject|12|||
126281076|NCT00602641|454320698|FG000|Overall Study|Alternative therapy|5|||
126281077|NCT00602641|454320699|FG001|Overall Study|Alternative therapy|2|||
126281078|NCT00602641|454320698|FG000|Overall Study|Other Complicating Disease|5|||
126281079|NCT00602641|454320699|FG001|Overall Study|Other Complicating Disease|2|||
126281080|NCT00602641|454320698|FG000|Overall Study|Physician Decision|5|||
126281081|NCT00602641|454320699|FG001|Overall Study|Physician Decision|4|||
126281082|NCT00602641|454320698|FG000|Overall Study|Administrative Closure|1|||
126281083|NCT00602641|454320699|FG001|Overall Study|Administrative Closure|1|||
126281084|NCT00602641|454320698|FG000|Overall Study|Other|3|||
126281085|NCT00602641|454320699|FG001|Overall Study|Other|1|||
126281086|NCT03408639|454320705|FG000|Overall Study|Death|5|||
126281087|NCT03408639|454320706|FG001|Overall Study|Death|5|||
126281088|NCT03408639|454320705|FG000|Overall Study|Lost to Follow-up|1|||
126281089|NCT03408639|454320706|FG001|Overall Study|Lost to Follow-up|4|||
126765999|NCT01870921|456095876|FG000|Overall Study|Severe non-compliance to protocol|7|||
126364130|NCT01682720|454626752|FG003|Overall Study|Adverse Event|1|||
126281090|NCT03408639|454320705|FG000|Overall Study|Withdrawal by Subject|2|||
126281091|NCT03408639|454320706|FG001|Overall Study|Withdrawal by Subject|7|||
126281092|NCT03408639|454320705|FG000|Overall Study|Physician Decision|3|||
126281093|NCT03408639|454320706|FG001|Overall Study|Physician Decision|6|||
126281094|NCT00070499|454320707|FG000|Overall Study|Adverse Event|6|||
126281095|NCT00070499|454320708|FG001|Overall Study|Adverse Event|6|||
126281096|NCT00070499|454320709|FG002|Overall Study|Adverse Event|19|||
126281097|NCT00070499|454320710|FG003|Overall Study|Adverse Event|15|||
126281098|NCT00070499|454320707|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
126281099|NCT00070499|454320708|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
126281100|NCT00070499|454320709|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
126281101|NCT00070499|454320710|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
126281102|NCT00070499|454320707|FG000|Overall Study|Progression/relapse|4|||
126281103|NCT00070499|454320708|FG001|Overall Study|Progression/relapse|2|||
126281104|NCT00070499|454320709|FG002|Overall Study|Progression/relapse|1|||
126281105|NCT00070499|454320710|FG003|Overall Study|Progression/relapse|4|||
126281106|NCT00070499|454320707|FG000|Overall Study|Death|1|||
126281107|NCT00070499|454320708|FG001|Overall Study|Death|1|||
126281108|NCT00070499|454320709|FG002|Overall Study|Death|1|||
126281109|NCT00070499|454320710|FG003|Overall Study|Death|2|||
126281110|NCT00070499|454320707|FG000|Overall Study|Other - not protocol specified|7|||
126281111|NCT00070499|454320708|FG001|Overall Study|Other - not protocol specified|3|||
126281112|NCT00070499|454320709|FG002|Overall Study|Other - not protocol specified|12|||
126281113|NCT00070499|454320710|FG003|Overall Study|Other - not protocol specified|20|||
126281114|NCT00070499|454320707|FG000|Overall Study|Still on protocol treatment|10|||
126281115|NCT00070499|454320708|FG001|Overall Study|Still on protocol treatment|4|||
126281116|NCT00070499|454320709|FG002|Overall Study|Still on protocol treatment|79|||
126281117|NCT00070499|454320710|FG003|Overall Study|Still on protocol treatment|57|||
126281118|NCT00070499|454320707|FG000|Overall Study|Did not start treatment|1|||
126281119|NCT00070499|454320708|FG001|Overall Study|Did not start treatment|0|||
126281120|NCT00070499|454320709|FG002|Overall Study|Did not start treatment|0|||
126281121|NCT00070499|454320710|FG003|Overall Study|Did not start treatment|2|||
126281122|NCT00070499|454320707|FG000|Overall Study|Not eligible|2|||
126281123|NCT00070499|454320708|FG001|Overall Study|Not eligible|5|||
126281124|NCT00070499|454320709|FG002|Overall Study|Not eligible|3|||
126281125|NCT00070499|454320710|FG003|Overall Study|Not eligible|2|||
126281126|NCT00587860|454320718|FG000|Overall Study|Lost to Follow-up|2|||
126281127|NCT00587860|454320719|FG001|Overall Study|Lost to Follow-up|2|||
126281128|NCT00587860|454320718|FG000|Overall Study|Withdrawal by Subject|3|||
126281129|NCT00587860|454320719|FG001|Overall Study|Withdrawal by Subject|3|||
126281130|NCT01371747|454320722|FG000|Overall Study|Adverse Event|4|||
126281131|NCT01371747|454320723|FG001|Overall Study|Adverse Event|2|||
126281132|NCT01371747|454320724|FG002|Overall Study|Adverse Event|7|||
126281133|NCT01371747|454320725|FG003|Overall Study|Adverse Event|2|||
126281134|NCT01371747|454320726|FG004|Overall Study|Adverse Event|2|||
126281135|NCT01371747|454320727|FG005|Overall Study|Adverse Event|2|||
126281136|NCT01371747|454320722|FG000|Overall Study|Death|1|||
126281137|NCT01371747|454320723|FG001|Overall Study|Death|0|||
126281138|NCT01371747|454320724|FG002|Overall Study|Death|4|||
126281139|NCT01371747|454320725|FG003|Overall Study|Death|1|||
126281140|NCT01371747|454320726|FG004|Overall Study|Death|2|||
126281141|NCT01371747|454320727|FG005|Overall Study|Death|0|||
126281142|NCT01371747|454320722|FG000|Overall Study|Abnormal Renal Function|0|||
126281143|NCT01371747|454320723|FG001|Overall Study|Abnormal Renal Function|2|||
126281144|NCT01371747|454320724|FG002|Overall Study|Abnormal Renal Function|0|||
126364131|NCT04204902|454626753|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
126364132|NCT04204902|454626754|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
126281145|NCT01371747|454320725|FG003|Overall Study|Abnormal Renal Function|1|||
126281146|NCT01371747|454320726|FG004|Overall Study|Abnormal Renal Function|0|||
126281147|NCT01371747|454320727|FG005|Overall Study|Abnormal Renal Function|1|||
126281148|NCT01371747|454320722|FG000|Overall Study|High Serum Potassium Results|1|||
126281149|NCT01371747|454320723|FG001|Overall Study|High Serum Potassium Results|1|||
126281150|NCT01371747|454320724|FG002|Overall Study|High Serum Potassium Results|1|||
126281151|NCT01371747|454320725|FG003|Overall Study|High Serum Potassium Results|2|||
126281152|NCT01371747|454320726|FG004|Overall Study|High Serum Potassium Results|0|||
126281153|NCT01371747|454320727|FG005|Overall Study|High Serum Potassium Results|2|||
126281154|NCT01371747|454320722|FG000|Overall Study|Low Serum Potassium Results|1|||
126281155|NCT01371747|454320723|FG001|Overall Study|Low Serum Potassium Results|1|||
126281156|NCT01371747|454320724|FG002|Overall Study|Low Serum Potassium Results|1|||
126281157|NCT01371747|454320725|FG003|Overall Study|Low Serum Potassium Results|1|||
126281158|NCT01371747|454320726|FG004|Overall Study|Low Serum Potassium Results|0|||
126281159|NCT01371747|454320727|FG005|Overall Study|Low Serum Potassium Results|3|||
126281160|NCT01371747|454320722|FG000|Overall Study|Protocol Violation|0|||
126281161|NCT01371747|454320723|FG001|Overall Study|Protocol Violation|0|||
126281162|NCT01371747|454320724|FG002|Overall Study|Protocol Violation|1|||
126281163|NCT01371747|454320725|FG003|Overall Study|Protocol Violation|0|||
126281164|NCT01371747|454320726|FG004|Overall Study|Protocol Violation|0|||
126281165|NCT01371747|454320727|FG005|Overall Study|Protocol Violation|0|||
126281166|NCT01371747|454320722|FG000|Overall Study|Non-Compliance|3|||
126281167|NCT01371747|454320723|FG001|Overall Study|Non-Compliance|4|||
126281168|NCT01371747|454320724|FG002|Overall Study|Non-Compliance|3|||
126281169|NCT01371747|454320725|FG003|Overall Study|Non-Compliance|0|||
126281170|NCT01371747|454320726|FG004|Overall Study|Non-Compliance|0|||
126281171|NCT01371747|454320727|FG005|Overall Study|Non-Compliance|1|||
126281172|NCT01371747|454320722|FG000|Overall Study|Physician Decision|0|||
126281173|NCT01371747|454320723|FG001|Overall Study|Physician Decision|0|||
126281174|NCT01371747|454320724|FG002|Overall Study|Physician Decision|0|||
126281175|NCT01371747|454320725|FG003|Overall Study|Physician Decision|0|||
126364133|NCT04525183|454626757|FG000|Overall Study|Withdrawal by Subject|0|||
126364134|NCT04525183|454626758|FG001|Overall Study|Withdrawal by Subject|0|||
126364135|NCT04525183|454626759|FG002|Overall Study|Withdrawal by Subject|3|||
126364136|NCT04525183|454626757|FG000|Overall Study|Study non-compliance|0|||
126364137|NCT04525183|454626758|FG001|Overall Study|Study non-compliance|0|||
126364138|NCT04525183|454626759|FG002|Overall Study|Study non-compliance|1|||
126364139|NCT04525183|454626757|FG000|Overall Study|Recurrent disease before starting on study|0|||
126364140|NCT04525183|454626758|FG001|Overall Study|Recurrent disease before starting on study|0|||
126364141|NCT04525183|454626759|FG002|Overall Study|Recurrent disease before starting on study|1|||
126548856|NCT01912222|455303876|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
126548857|NCT01912222|455303874|FG000|Part B: Treatment Period|Progressive disease|10|||
126548858|NCT01912222|455303875|FG001|Part B: Treatment Period|Progressive disease|12|||
126548859|NCT01912222|455303876|FG002|Part B: Treatment Period|Progressive disease|15|||
126548860|NCT01912222|455303874|FG000|Part B: Treatment Period|Adverse Event|1|||
126548861|NCT01912222|455303875|FG001|Part B: Treatment Period|Adverse Event|2|||
126548862|NCT01912222|455303876|FG002|Part B: Treatment Period|Adverse Event|3|||
126708808|NCT01607892|455886291|FG004|Overall Study|Consent withdrawn by participant|4|||
126708809|NCT01607892|455886287|FG000|Overall Study|Disease progression|38|||
126708810|NCT01607892|455886288|FG001|Overall Study|Disease progression|13|||
126708811|NCT01607892|455886289|FG002|Overall Study|Disease progression|37|||
126708812|NCT01607892|455886290|FG003|Overall Study|Disease progression|57|||
126708813|NCT01607892|455886291|FG004|Overall Study|Disease progression|9|||
126708814|NCT01607892|455886287|FG000|Overall Study|Incidence or severity of Adverse events|3|||
126708815|NCT01607892|455886288|FG001|Overall Study|Incidence or severity of Adverse events|3|||
126708816|NCT01607892|455886289|FG002|Overall Study|Incidence or severity of Adverse events|7|||
126708817|NCT01607892|455886290|FG003|Overall Study|Incidence or severity of Adverse events|2|||
126708818|NCT01607892|455886291|FG004|Overall Study|Incidence or severity of Adverse events|6|||
126708819|NCT02273973|455886295|FG000|Overall Study|Adverse Event|4|||
126708820|NCT02273973|455886296|FG001|Overall Study|Adverse Event|0|||
126281176|NCT01371747|454320726|FG004|Overall Study|Physician Decision|1|||
126281177|NCT01371747|454320727|FG005|Overall Study|Physician Decision|0|||
126281178|NCT01371747|454320722|FG000|Overall Study|Withdrawal by Subject|6|||
126281179|NCT01371747|454320723|FG001|Overall Study|Withdrawal by Subject|12|||
126281180|NCT01371747|454320724|FG002|Overall Study|Withdrawal by Subject|5|||
126281181|NCT01371747|454320725|FG003|Overall Study|Withdrawal by Subject|2|||
126281182|NCT01371747|454320726|FG004|Overall Study|Withdrawal by Subject|2|||
126281183|NCT01371747|454320727|FG005|Overall Study|Withdrawal by Subject|4|||
126281184|NCT01371747|454320722|FG000|Overall Study|Other Reasons|2|||
126281185|NCT01371747|454320723|FG001|Overall Study|Other Reasons|1|||
126281186|NCT01371747|454320724|FG002|Overall Study|Other Reasons|2|||
126281187|NCT01371747|454320725|FG003|Overall Study|Other Reasons|0|||
126281188|NCT01371747|454320726|FG004|Overall Study|Other Reasons|0|||
126281189|NCT01371747|454320727|FG005|Overall Study|Other Reasons|1|||
126281190|NCT03092219|454320728|FG000|Overall Study|Protocol Violation|7|||
126281191|NCT03092219|454320729|FG001|Overall Study|Protocol Violation|4|||
126281192|NCT00580788|454320732|FG000|Overall Study|Adverse Event|0|||
126281193|NCT00580788|454320733|FG001|Overall Study|Adverse Event|0|||
126281194|NCT00580788|454320734|FG002|Overall Study|Adverse Event|0|||
126281195|NCT00580788|454320735|FG003|Overall Study|Adverse Event|1|||
126281196|NCT04971187|454320736|FG000|Overall Study|Screen failures|2|||
126281197|NCT01443728|454320737|FG000|Overall Study|Lost to Follow-up|2|||
126281198|NCT01443728|454320738|FG001|Overall Study|Lost to Follow-up|0|||
126281199|NCT01443728|454320737|FG000|Overall Study|Withdrawal by Subject|1|||
126281200|NCT01443728|454320738|FG001|Overall Study|Withdrawal by Subject|1|||
126281201|NCT01443728|454320737|FG000|Overall Study|Adverse Event|0|||
126281202|NCT01443728|454320738|FG001|Overall Study|Adverse Event|2|||
126281203|NCT02906358|454320739|FG000|Overall Study|Withdrawal by Subject|10|||
126281204|NCT02906358|454320740|FG001|Overall Study|Withdrawal by Subject|7|||
126281205|NCT02906358|454320739|FG000|Overall Study|Lost to Follow-up|12|||
126281206|NCT02906358|454320740|FG001|Overall Study|Lost to Follow-up|15|||
126281207|NCT02045147|454320742|FG000|Overall Study|Withdrawal by Subject|2|||
126281208|NCT02045147|454320743|FG001|Overall Study|Withdrawal by Subject|0|||
126281209|NCT02045147|454320744|FG002|Overall Study|Withdrawal by Subject|0|||
126281210|NCT02045147|454320745|FG003|Overall Study|Withdrawal by Subject|0|||
126281211|NCT02045147|454320746|FG004|Overall Study|Withdrawal by Subject|0|||
126281212|NCT02045147|454320747|FG005|Overall Study|Withdrawal by Subject|0|||
126364142|NCT00979407|454626760|FG000|Overall Study|Withdrawal by Subject|3|||
126364143|NCT00979407|454626761|FG001|Overall Study|Withdrawal by Subject|4|||
126364144|NCT00979407|454626760|FG000|Overall Study|Lost to Follow-up|3|||
126708821|NCT02273973|455886295|FG000|Overall Study|Withdrawal by Subject|2|||
126708822|NCT02273973|455886296|FG001|Overall Study|Withdrawal by Subject|3|||
126281213|NCT02045147|454320748|FG006|Overall Study|Withdrawal by Subject|0|||
126281214|NCT02045147|454320749|FG007|Overall Study|Withdrawal by Subject|1|||
126281215|NCT02045147|454320742|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
126708823|NCT02273973|455886295|FG000|Overall Study|Death|1|||
126708824|NCT02273973|455886296|FG001|Overall Study|Death|0|||
126281216|NCT02045147|454320743|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
126281217|NCT02045147|454320744|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
126281218|NCT02045147|454320745|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
126281219|NCT02045147|454320746|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
126281220|NCT02045147|454320747|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
126281221|NCT02045147|454320748|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
126281222|NCT02045147|454320749|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
126281223|NCT04497948|454320752|FG000|Overall Study|Death|2|||
126364145|NCT00979407|454626761|FG001|Overall Study|Lost to Follow-up|3|||
126364146|NCT01166646|454626762|FG000|Overall Study|Protocol Violation|0|||
126364147|NCT01166646|454626763|FG001|Overall Study|Protocol Violation|1|||
126364148|NCT01166646|454626762|FG000|Overall Study|Adverse Event|1|||
126364149|NCT01166646|454626763|FG001|Overall Study|Adverse Event|0|||
126364150|NCT01335685|454626765|FG000|Overall Study|Study Terminated by Sponsor|2|||
126281224|NCT03760185|454320753|FG000|Overall Study|Lost to Follow-up|1|||
126281225|NCT03760185|454320754|FG001|Overall Study|Lost to Follow-up|1|||
126281226|NCT02954991|454320755|FG000|Overall Study|Death|92|||
126281227|NCT02954991|454320756|FG001|Overall Study|Death|11|||
126281228|NCT02954991|454320757|FG002|Overall Study|Death|2|||
126281229|NCT02954991|454320755|FG000|Overall Study|Lost to Follow-up|3|||
126281230|NCT02954991|454320756|FG001|Overall Study|Lost to Follow-up|2|||
126281231|NCT02954991|454320757|FG002|Overall Study|Lost to Follow-up|0|||
126281232|NCT02954991|454320755|FG000|Overall Study|Withdrawal by Subject|9|||
126281233|NCT02954991|454320756|FG001|Overall Study|Withdrawal by Subject|8|||
126364151|NCT01335685|454626766|FG001|Overall Study|Study Terminated by Sponsor|1|||
126364152|NCT01335685|454626767|FG002|Overall Study|Study Terminated by Sponsor|1|||
126364153|NCT01335685|454626768|FG003|Overall Study|Study Terminated by Sponsor|10|||
126364154|NCT01335685|454626769|FG004|Overall Study|Study Terminated by Sponsor|0|||
126455941|NCT03011892|454969080|FG002|Double Blind (DB) Period|Pregnancy|0|||
126455942|NCT03011892|454969081|FG003|Double Blind (DB) Period|Pregnancy|0|||
126455943|NCT03011892|454969082|FG004|Double Blind (DB) Period|Pregnancy|1|||
126455944|NCT03011892|454969083|FG005|Double Blind (DB) Period|Pregnancy|0|||
126455945|NCT03011892|454969084|FG006|Double Blind (DB) Period|Pregnancy|0|||
126455946|NCT03011892|454969085|FG007|Double Blind (DB) Period|Pregnancy|0|||
126455947|NCT03011892|454969086|FG008|Double Blind (DB) Period|Pregnancy|0|||
126455948|NCT03011892|454969087|FG009|Double Blind (DB) Period|Pregnancy|0|||
126455949|NCT03011892|454969088|FG010|Double Blind (DB) Period|Pregnancy|0|||
126455950|NCT03011892|454969089|FG011|Double Blind (DB) Period|Pregnancy|0|||
126455951|NCT03011892|454969078|FG000|Double Blind (DB) Period|Protocol Violation|1|||
126455952|NCT03011892|454969079|FG001|Double Blind (DB) Period|Protocol Violation|0|||
126455953|NCT03011892|454969080|FG002|Double Blind (DB) Period|Protocol Violation|0|||
126455954|NCT03011892|454969081|FG003|Double Blind (DB) Period|Protocol Violation|0|||
126455955|NCT03011892|454969082|FG004|Double Blind (DB) Period|Protocol Violation|0|||
126455956|NCT03011892|454969083|FG005|Double Blind (DB) Period|Protocol Violation|0|||
126455957|NCT03011892|454969084|FG006|Double Blind (DB) Period|Protocol Violation|0|||
126455958|NCT03011892|454969085|FG007|Double Blind (DB) Period|Protocol Violation|0|||
126455959|NCT03011892|454969086|FG008|Double Blind (DB) Period|Protocol Violation|0|||
126455960|NCT03011892|454969087|FG009|Double Blind (DB) Period|Protocol Violation|0|||
126455961|NCT03011892|454969088|FG010|Double Blind (DB) Period|Protocol Violation|0|||
126455962|NCT03011892|454969089|FG011|Double Blind (DB) Period|Protocol Violation|0|||
126455963|NCT03011892|454969078|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
126455964|NCT03011892|454969079|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
126455965|NCT03011892|454969080|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
126455966|NCT03011892|454969081|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
126455967|NCT03011892|454969082|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
126455968|NCT03011892|454969083|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
126455969|NCT03011892|454969084|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
126455970|NCT03011892|454969085|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
126455971|NCT03011892|454969086|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
126455972|NCT03011892|454969087|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
126455973|NCT03011892|454969088|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
126455974|NCT03011892|454969089|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
126455975|NCT03011892|454969078|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
126455976|NCT03011892|454969079|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
126455977|NCT03011892|454969080|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
126455978|NCT03011892|454969081|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
126455979|NCT03011892|454969082|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
126455980|NCT03011892|454969083|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
126455981|NCT03011892|454969084|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
126455982|NCT03011892|454969085|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
126455983|NCT03011892|454969086|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
126708825|NCT02273973|455886295|FG000|Overall Study|Non-compliance|1|||
126708826|NCT02273973|455886296|FG001|Overall Study|Non-compliance|0|||
126708827|NCT02273973|455886295|FG000|Overall Study|Protocol Violation|1|||
126708828|NCT02273973|455886296|FG001|Overall Study|Protocol Violation|0|||
126708829|NCT02273973|455886295|FG000|Overall Study|Progression of disease|0|||
126281234|NCT02954991|454320757|FG002|Overall Study|Withdrawal by Subject|1|||
126281235|NCT02954991|454320755|FG000|Overall Study|Study Terminated by Sponsor|18|||
126281236|NCT02954991|454320756|FG001|Overall Study|Study Terminated by Sponsor|10|||
126281237|NCT02954991|454320757|FG002|Overall Study|Study Terminated by Sponsor|1|||
126281238|NCT02954991|454320755|FG000|Overall Study|Miscellaneous|2|||
126281239|NCT02954991|454320756|FG001|Overall Study|Miscellaneous|1|||
126281240|NCT02954991|454320757|FG002|Overall Study|Miscellaneous|1|||
126281241|NCT02052011|454320758|FG000|Overall Study|Lost to Follow-up|3|||
126281242|NCT02052011|454320759|FG001|Overall Study|Lost to Follow-up|0|||
126281243|NCT02052011|454320758|FG000|Overall Study|Withdrawal by Subject|1|||
126281244|NCT02052011|454320759|FG001|Overall Study|Withdrawal by Subject|2|||
126281245|NCT02648932|454320760|FG000|Overall Study|No transplant|3|||
126281246|NCT02648932|454320761|FG001|Overall Study|No transplant|1|||
126281247|NCT02960490|454320762|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
126281248|NCT02960490|454320763|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
126281249|NCT02960490|454320764|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281250|NCT02960490|454320765|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281251|NCT02960490|454320766|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281252|NCT02960490|454320767|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281253|NCT02960490|454320768|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281254|NCT02960490|454320769|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281255|NCT02960490|454320770|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281256|NCT02960490|454320771|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
126281257|NCT02960490|454320762|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281258|NCT02960490|454320763|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
126281259|NCT02960490|454320764|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281260|NCT02960490|454320765|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281261|NCT02960490|454320766|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281262|NCT02960490|454320767|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281263|NCT02960490|454320768|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281264|NCT02960490|454320769|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281265|NCT02960490|454320770|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281266|NCT02960490|454320771|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
126281267|NCT02960490|454320762|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
126281268|NCT02960490|454320763|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
126281269|NCT02960490|454320764|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281270|NCT02960490|454320765|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281271|NCT02960490|454320766|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281272|NCT02960490|454320767|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281273|NCT02960490|454320768|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281274|NCT02960490|454320769|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281275|NCT02960490|454320770|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281276|NCT02960490|454320771|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
126281277|NCT02960490|454320762|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
126281278|NCT02960490|454320763|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
126281279|NCT02960490|454320764|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281280|NCT02960490|454320765|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281281|NCT02960490|454320766|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281282|NCT02960490|454320767|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281283|NCT02960490|454320768|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281284|NCT02960490|454320769|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281285|NCT02960490|454320770|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281286|NCT02960490|454320771|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
126281287|NCT02960490|454320762|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126281288|NCT02960490|454320763|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126281289|NCT02960490|454320764|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
126281290|NCT02960490|454320765|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
126281291|NCT02960490|454320766|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126281292|NCT02960490|454320767|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
126281293|NCT02960490|454320768|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126364155|NCT01335685|454626770|FG005|Overall Study|Study Terminated by Sponsor|4|||
126708830|NCT02273973|455886296|FG001|Overall Study|Progression of disease|2|||
126708831|NCT02273973|455886295|FG000|Overall Study|Lost to Follow-up|0|||
126364156|NCT01335685|454626771|FG006|Overall Study|Study Terminated by Sponsor|2|||
126364157|NCT01335685|454626772|FG007|Overall Study|Study Terminated by Sponsor|3|||
126364158|NCT01335685|454626765|FG000|Overall Study|Withdrawal by Subject|1|||
126281294|NCT02960490|454320769|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126281295|NCT02960490|454320770|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126281296|NCT02960490|454320771|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
126281297|NCT02960490|454320762|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126281298|NCT02960490|454320763|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126281299|NCT02960490|454320764|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
126281300|NCT02960490|454320765|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126281301|NCT02960490|454320766|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
126281302|NCT02960490|454320767|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126281303|NCT02960490|454320768|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126281304|NCT02960490|454320769|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126364159|NCT01335685|454626766|FG001|Overall Study|Withdrawal by Subject|0|||
126364160|NCT01335685|454626767|FG002|Overall Study|Withdrawal by Subject|0|||
126548863|NCT01912222|455303874|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
126548864|NCT01912222|455303875|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
126364161|NCT01335685|454626768|FG003|Overall Study|Withdrawal by Subject|1|||
126364162|NCT01335685|454626769|FG004|Overall Study|Withdrawal by Subject|0|||
126364163|NCT01335685|454626770|FG005|Overall Study|Withdrawal by Subject|0|||
126364164|NCT01335685|454626771|FG006|Overall Study|Withdrawal by Subject|0|||
126364165|NCT01335685|454626772|FG007|Overall Study|Withdrawal by Subject|0|||
126364166|NCT01335685|454626765|FG000|Overall Study|Reason not Specified|0|||
126364167|NCT01335685|454626766|FG001|Overall Study|Reason not Specified|0|||
126364168|NCT01335685|454626767|FG002|Overall Study|Reason not Specified|1|||
126364169|NCT01335685|454626768|FG003|Overall Study|Reason not Specified|0|||
126364170|NCT01335685|454626769|FG004|Overall Study|Reason not Specified|0|||
126364171|NCT01335685|454626770|FG005|Overall Study|Reason not Specified|1|||
126364172|NCT01335685|454626771|FG006|Overall Study|Reason not Specified|0|||
126364173|NCT01335685|454626772|FG007|Overall Study|Reason not Specified|0|||
126364174|NCT03777020|454626775|FG000|Overall Study|Withdrawal by Subject|4|||
126364175|NCT03777020|454626776|FG001|Overall Study|Withdrawal by Subject|4|||
126364176|NCT03777020|454626775|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
126364177|NCT03777020|454626776|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
126364178|NCT00489476|454626777|FG000|Overall Study|Lost to Follow-up|0|||
126364179|NCT00489476|454626778|FG001|Overall Study|Lost to Follow-up|1|||
126364180|NCT00489476|454626779|FG002|Overall Study|Lost to Follow-up|0|||
126364181|NCT00489476|454626780|FG003|Overall Study|Lost to Follow-up|0|||
126548865|NCT01912222|455303876|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
126548866|NCT05340751|455303877|FG000|Overall Study|Physician Decision|3|||
126281305|NCT02960490|454320770|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126364182|NCT00480025|454626781|FG000|Overall Study|Protocol Violation|12|||
126281306|NCT02960490|454320771|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
126281307|NCT02960490|454320762|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
126281308|NCT02960490|454320763|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
126281309|NCT02960490|454320764|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
126281310|NCT02960490|454320765|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
126281311|NCT02960490|454320766|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
126281312|NCT02960490|454320767|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
126281313|NCT02960490|454320768|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
126281314|NCT02960490|454320769|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
126281315|NCT02960490|454320770|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
126281316|NCT02960490|454320771|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
126281317|NCT02960490|454320762|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281318|NCT02960490|454320763|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281319|NCT02960490|454320764|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281320|NCT02960490|454320765|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281321|NCT02960490|454320766|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281322|NCT02960490|454320767|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281323|NCT02960490|454320768|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
126281324|NCT02960490|454320769|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
126548867|NCT04399551|455303878|FG000|Overall Study|Adverse Event|15|||
126281325|NCT02960490|454320770|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
126281326|NCT02960490|454320771|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
126281327|NCT02960490|454320762|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126364183|NCT00480025|454626782|FG001|Overall Study|Protocol Violation|7|||
126364184|NCT00480025|454626781|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
126364185|NCT00480025|454626782|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
126364186|NCT00480025|454626781|FG000|Overall Study|Disease Progression / Recurrence|449|||
126281328|NCT02960490|454320763|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126708832|NCT02273973|455886296|FG001|Overall Study|Lost to Follow-up|1|||
126708833|NCT02273973|455886295|FG000|Overall Study|Physician Decision|0|||
126708834|NCT02273973|455886296|FG001|Overall Study|Physician Decision|1|||
126708835|NCT02273973|455886295|FG000|Overall Study|Reason not specified|0|||
126708836|NCT02273973|455886296|FG001|Overall Study|Reason not specified|1|||
126708837|NCT02403206|455886297|FG000|Overall Study|Lost to Follow-up|4|||
126708838|NCT02403206|455886298|FG001|Overall Study|Lost to Follow-up|3|||
126708839|NCT02403206|455886297|FG000|Overall Study|Physician Decision|2|||
126708840|NCT02403206|455886298|FG001|Overall Study|Physician Decision|0|||
126708841|NCT02403206|455886297|FG000|Overall Study|Withdrawal by Subject|3|||
126708842|NCT02403206|455886298|FG001|Overall Study|Withdrawal by Subject|3|||
126708843|NCT02403206|455886297|FG000|Overall Study|Reason not given|2|||
126708844|NCT02403206|455886298|FG001|Overall Study|Reason not given|4|||
126708845|NCT02209597|455886299|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
126708846|NCT02209597|455886299|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
126708847|NCT02209597|455886299|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
126708848|NCT02209597|455886299|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
126708849|NCT03937986|455887872|FG000|Overall Study|COVID-19 Pandemic|1|||
126708850|NCT02114203|455887873|FG000|Overall Study|Adverse Event|0|||
126708851|NCT02114203|455887874|FG001|Overall Study|Adverse Event|1|||
126708852|NCT02114203|455887875|FG002|Overall Study|Adverse Event|0|||
126708853|NCT02114203|455887873|FG000|Overall Study|Withdrawal by Subject|0|||
126708854|NCT02114203|455887874|FG001|Overall Study|Withdrawal by Subject|1|||
126708855|NCT02114203|455887875|FG002|Overall Study|Withdrawal by Subject|0|||
126708856|NCT01518699|455887876|FG000|Period 2|Protocol Violation|1|||
126708857|NCT01518699|455887877|FG001|Period 2|Protocol Violation|1|||
126708858|NCT01518699|455887878|FG002|Period 2|Protocol Violation|0|||
126708859|NCT01518699|455887879|FG003|Period 2|Protocol Violation|0|||
126708860|NCT01518699|455887880|FG004|Period 2|Protocol Violation|0|||
126708861|NCT01518699|455887881|FG005|Period 2|Protocol Violation|0|||
126708862|NCT01518699|455887876|FG000|Period 2|Lost to Follow-up|0|||
126708863|NCT01518699|455887877|FG001|Period 2|Lost to Follow-up|1|||
126281329|NCT02960490|454320764|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281330|NCT02960490|454320765|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281331|NCT02960490|454320766|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281332|NCT02960490|454320767|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281333|NCT02960490|454320768|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281334|NCT02960490|454320769|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
126281335|NCT02960490|454320770|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281336|NCT02960490|454320771|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
126281337|NCT02960490|454320762|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
126281338|NCT02960490|454320763|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
126281339|NCT02960490|454320764|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
126281340|NCT02960490|454320765|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
126281341|NCT02960490|454320766|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
126281342|NCT02960490|454320767|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
126281343|NCT02960490|454320768|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
126281344|NCT02960490|454320769|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
126281345|NCT02960490|454320770|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
126281346|NCT02960490|454320771|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
126281347|NCT02960490|454320762|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281348|NCT02960490|454320763|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281349|NCT02960490|454320764|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281350|NCT02960490|454320765|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281351|NCT02960490|454320766|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281352|NCT02960490|454320767|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281353|NCT02960490|454320768|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
126708864|NCT01518699|455887878|FG002|Period 2|Lost to Follow-up|0|||
126281354|NCT02960490|454320769|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281355|NCT02960490|454320770|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126281356|NCT02960490|454320771|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
126708865|NCT01518699|455887879|FG003|Period 2|Lost to Follow-up|0|||
126708866|NCT01518699|455887880|FG004|Period 2|Lost to Follow-up|0|||
126708867|NCT01518699|455887881|FG005|Period 2|Lost to Follow-up|0|||
126708868|NCT01518699|455887876|FG000|Period 2|Adverse Event|1|||
126708869|NCT01518699|455887877|FG001|Period 2|Adverse Event|0|||
126708870|NCT01518699|455887878|FG002|Period 2|Adverse Event|0|||
126708871|NCT01518699|455887879|FG003|Period 2|Adverse Event|0|||
126708872|NCT01518699|455887880|FG004|Period 2|Adverse Event|0|||
126708873|NCT01518699|455887881|FG005|Period 2|Adverse Event|0|||
126708874|NCT02839746|455887883|FG000|Overall Study|Not met selection criteria|12|||
126281357|NCT02960490|454320762|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281358|NCT02960490|454320763|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281359|NCT02960490|454320764|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281360|NCT02960490|454320765|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281361|NCT02960490|454320766|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281362|NCT02960490|454320767|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281363|NCT02960490|454320768|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281364|NCT02960490|454320769|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
126281365|NCT02960490|454320770|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281366|NCT02960490|454320771|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
126281367|NCT01266031|454320772|FG000|Overall Study|Not treated|0|||
126281368|NCT01266031|454320773|FG001|Overall Study|Not treated|3|||
126281369|NCT01266031|454320774|FG002|Overall Study|Not treated|2|||
126281370|NCT01434810|454320777|FG000|Overall Study|Did not receive treatment|11|||
126281371|NCT01434810|454320778|FG001|Overall Study|Did not receive treatment|3|||
126281372|NCT01434810|454320777|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
126281373|NCT01434810|454320778|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
126281374|NCT02252406|454320780|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
126281375|NCT02252406|454320781|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
126281376|NCT02252406|454320780|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
126281377|NCT02252406|454320781|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
126281378|NCT02252406|454320780|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
126281379|NCT02252406|454320781|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
126281380|NCT02252406|454320780|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
126281381|NCT02252406|454320781|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
126281382|NCT02252406|454320780|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
126281383|NCT02252406|454320781|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
126281384|NCT02533180|454320784|FG000|Overall Study|Death|0|||
126281385|NCT02533180|454320785|FG001|Overall Study|Death|2|||
126281386|NCT02533180|454320784|FG000|Overall Study|Lost to Follow-up|0|||
126281387|NCT02533180|454320785|FG001|Overall Study|Lost to Follow-up|1|||
126281388|NCT02533180|454320784|FG000|Overall Study|Physician Decision|0|||
126281389|NCT02533180|454320785|FG001|Overall Study|Physician Decision|1|||
126281390|NCT02533180|454320784|FG000|Overall Study|Withdrawal by Subject|2|||
126281391|NCT02533180|454320785|FG001|Overall Study|Withdrawal by Subject|5|||
126281392|NCT02533180|454320784|FG000|Overall Study|Screen Failure|37|||
126281393|NCT02533180|454320785|FG001|Overall Study|Screen Failure|0|||
126281394|NCT02533180|454320784|FG000|Overall Study|Protocol Deviation|0|||
126281395|NCT02533180|454320785|FG001|Overall Study|Protocol Deviation|1|||
126281396|NCT02533180|454320784|FG000|Overall Study|Non-compliance|0|||
126281397|NCT02533180|454320785|FG001|Overall Study|Non-compliance|1|||
126281398|NCT00447876|454320786|FG000|Overall Study|Withdrawal by Subject|1|||
126281399|NCT00447876|454320787|FG001|Overall Study|Withdrawal by Subject|4|||
126281400|NCT00447876|454320786|FG000|Overall Study|Lost to Follow-up|1|||
126281401|NCT00447876|454320787|FG001|Overall Study|Lost to Follow-up|0|||
126281402|NCT00447876|454320786|FG000|Overall Study|Deterioration of symptomology|1|||
126281403|NCT00447876|454320787|FG001|Overall Study|Deterioration of symptomology|0|||
126281404|NCT01609023|454320790|FG000|Overall Study|Lack of Efficacy|3|||
126281405|NCT01609023|454320790|FG000|Overall Study|Withdrawal by Subject|4|||
126281406|NCT01609023|454320790|FG000|Overall Study|Lost to Follow-up|8|||
126281407|NCT01609023|454320790|FG000|Overall Study|Toxicity|3|||
126281408|NCT01609023|454320790|FG000|Overall Study|Disease progression|10|||
126281409|NCT01609023|454320790|FG000|Overall Study|Physician Decision|2|||
126281410|NCT01609023|454320790|FG000|Overall Study|Death|2|||
126281411|NCT01609023|454320790|FG000|Overall Study|Personal reasons|1|||
126281412|NCT02047734|454320791|FG000|Overall Study|Adverse Event|18|||
126281413|NCT02047734|454320792|FG001|Overall Study|Adverse Event|13|||
126281414|NCT02047734|454320793|FG002|Overall Study|Adverse Event|13|||
126281415|NCT02047734|454320791|FG000|Overall Study|Lack of Efficacy|4|||
126281416|NCT02047734|454320792|FG001|Overall Study|Lack of Efficacy|5|||
126281417|NCT02047734|454320793|FG002|Overall Study|Lack of Efficacy|1|||
126281418|NCT02047734|454320791|FG000|Overall Study|Protocol Violation|3|||
126281419|NCT02047734|454320792|FG001|Overall Study|Protocol Violation|1|||
126281420|NCT02047734|454320793|FG002|Overall Study|Protocol Violation|1|||
126281421|NCT02047734|454320791|FG000|Overall Study|Lost to Follow-up|1|||
126455984|NCT03011892|454969087|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
126281422|NCT02047734|454320792|FG001|Overall Study|Lost to Follow-up|4|||
126281423|NCT02047734|454320793|FG002|Overall Study|Lost to Follow-up|0|||
126281424|NCT02047734|454320791|FG000|Overall Study|Death|0|||
126281425|NCT02047734|454320792|FG001|Overall Study|Death|1|||
126455985|NCT03011892|454969088|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
126281426|NCT02047734|454320793|FG002|Overall Study|Death|0|||
126281427|NCT02047734|454320791|FG000|Overall Study|Withdrawal by Subject|30|||
126281428|NCT02047734|454320792|FG001|Overall Study|Withdrawal by Subject|31|||
126455986|NCT03011892|454969089|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
126281429|NCT02047734|454320793|FG002|Overall Study|Withdrawal by Subject|19|||
126281430|NCT02047734|454320791|FG000|Overall Study|Physician Decision|7|||
126281431|NCT02047734|454320792|FG001|Overall Study|Physician Decision|6|||
126281432|NCT02047734|454320793|FG002|Overall Study|Physician Decision|5|||
126281433|NCT02047734|454320791|FG000|Overall Study|Miscellaneous|2|||
126281434|NCT02047734|454320792|FG001|Overall Study|Miscellaneous|4|||
126281435|NCT02047734|454320793|FG002|Overall Study|Miscellaneous|6|||
126281436|NCT02047734|454320791|FG000|Overall Study|Did Not Receive Study Drug|2|||
126281437|NCT02047734|454320792|FG001|Overall Study|Did Not Receive Study Drug|4|||
126281438|NCT02047734|454320793|FG002|Overall Study|Did Not Receive Study Drug|1|||
126281439|NCT02952586|454320800|FG000|Lead-In Phase (7 Days)|Death|0|||
126281440|NCT02952586|454320801|FG001|Lead-In Phase (7 Days)|Death|1|||
126281441|NCT02952586|454320800|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
126281442|NCT02952586|454320801|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
126281443|NCT02952586|454320800|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
126281444|NCT02952586|454320801|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
126281445|NCT02952586|454320800|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
126281446|NCT02952586|454320801|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
126281447|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
126281448|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
126281449|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
126281450|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
126281451|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
126281452|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
126281453|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
126281454|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
126281455|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
126281456|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
126281457|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
126281458|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
126281459|NCT02952586|454320800|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
126281460|NCT02952586|454320801|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
126281461|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Death|3|||
126281462|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Death|8|||
126281463|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
126281464|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
126281465|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
126281466|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
126281467|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
126281468|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
126281469|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
126281470|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
126281471|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
126281472|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
126281473|NCT02952586|454320800|FG000|CRT for Cisplatin (63 Days)|Other|1|||
126281474|NCT02952586|454320801|FG001|CRT for Cisplatin (63 Days)|Other|1|||
126281475|NCT02952586|454320800|FG000|CRT for IMRT (63 Days)|Death|5|||
126281476|NCT02952586|454320801|FG001|CRT for IMRT (63 Days)|Death|8|||
126281477|NCT02952586|454320800|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
126281478|NCT02952586|454320801|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
126281479|NCT02952586|454320800|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
126281480|NCT02952586|454320801|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
126281481|NCT02952586|454320800|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
126281482|NCT02952586|454320801|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
126281483|NCT02952586|454320800|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
126281484|NCT02952586|454320801|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
126281485|NCT02952586|454320800|FG000|CRT for IMRT (63 Days)|Other|1|||
126281486|NCT02952586|454320801|FG001|CRT for IMRT (63 Days)|Other|0|||
126364187|NCT00480025|454626782|FG001|Overall Study|Disease Progression / Recurrence|224|||
126364188|NCT00480025|454626781|FG000|Overall Study|Adverse Event|44|||
126364189|NCT00480025|454626782|FG001|Overall Study|Adverse Event|12|||
126364190|NCT00480025|454626781|FG000|Overall Study|Other|70|||
126364191|NCT00480025|454626782|FG001|Overall Study|Other|29|||
126364192|NCT00480025|454626781|FG000|Overall Study|SAE including intercurrent illness|76|||
126364193|NCT00480025|454626782|FG001|Overall Study|SAE including intercurrent illness|42|||
126364194|NCT03726879|454626787|FG000|Overall Study|Death|11|||
126364195|NCT03726879|454626788|FG001|Overall Study|Death|13|||
126708875|NCT00744055|455887884|FG000|Overall Study|Withdrawal by Subject|6|||
126364196|NCT03726879|454626787|FG000|Overall Study|Physician Decision|0|||
126364197|NCT03726879|454626788|FG001|Overall Study|Physician Decision|2|||
126364198|NCT03726879|454626787|FG000|Overall Study|Protocol Violation|0|||
126708876|NCT00744055|455887885|FG001|Overall Study|Withdrawal by Subject|9|||
126364199|NCT03726879|454626788|FG001|Overall Study|Protocol Violation|1|||
126364200|NCT03726879|454626787|FG000|Overall Study|Withdrawal by Subject|5|||
126364201|NCT03726879|454626788|FG001|Overall Study|Withdrawal by Subject|6|||
126364202|NCT03726879|454626787|FG000|Overall Study|TSH result is unstable|0|||
126364203|NCT03726879|454626788|FG001|Overall Study|TSH result is unstable|1|||
126364204|NCT03726879|454626787|FG000|Overall Study|Disease relapse|1|||
126364205|NCT03726879|454626788|FG001|Overall Study|Disease relapse|0|||
126364206|NCT03726879|454626787|FG000|Overall Study|Lost to Follow-up|3|||
126364207|NCT03726879|454626788|FG001|Overall Study|Lost to Follow-up|0|||
126364208|NCT02766478|454626789|FG000|Overall Study|Withdrawal by Subject|1|||
126364209|NCT02766478|454626790|FG001|Overall Study|Withdrawal by Subject|1|||
126364210|NCT05626686|454626791|FG000|Overall Study|Protocol Violation|3|||
126364211|NCT05626686|454626791|FG000|Overall Study|Withdrawal by Subject|3|||
126364212|NCT01093573|454626792|FG000|Overall Study|Physician Decision|0|||
126364213|NCT01093573|454626793|FG001|Overall Study|Physician Decision|0|||
126364214|NCT01093573|454626794|FG002|Overall Study|Physician Decision|1|||
126364215|NCT01093573|454626792|FG000|Overall Study|Insurance Denied|0|||
126364216|NCT01093573|454626793|FG001|Overall Study|Insurance Denied|0|||
126364217|NCT01093573|454626794|FG002|Overall Study|Insurance Denied|1|||
126364218|NCT00581100|454628246|FG000|Overall Study|Death|1|||
126364219|NCT00581100|454628247|FG001|Overall Study|Death|0|||
126364220|NCT00581100|454628246|FG000|Overall Study|Adverse Event|2|||
126364221|NCT00581100|454628247|FG001|Overall Study|Adverse Event|1|||
126364222|NCT00581100|454628246|FG000|Overall Study|Withdrawal by Subject|1|||
126364223|NCT00581100|454628247|FG001|Overall Study|Withdrawal by Subject|4|||
126364224|NCT00581100|454628246|FG000|Overall Study|Other|3|||
126364225|NCT00581100|454628247|FG001|Overall Study|Other|0|||
126364226|NCT04744831|454628248|FG000|Overall Study|Progressive Disease|31|||
126281487|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Death|17|||
126281488|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Death|11|||
126281489|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
126281490|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
126281491|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
126281492|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
126281493|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
126281494|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
126281495|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
126281496|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
126281497|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
126281498|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
126281499|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
126281500|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
126281501|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
126281502|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
126281503|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Other|2|||
126281504|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Other|1|||
126281505|NCT02952586|454320800|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
126281506|NCT02952586|454320801|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
126281507|NCT02952586|454320800|FG000|Follow-Up Phase (90 Days)|Death|12|||
126281508|NCT02952586|454320801|FG001|Follow-Up Phase (90 Days)|Death|10|||
126281509|NCT02952586|454320800|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
126281510|NCT02952586|454320801|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
126364227|NCT04744831|454628249|FG001|Overall Study|Progressive Disease|27|||
126364228|NCT04744831|454628250|FG002|Overall Study|Progressive Disease|25|||
126364229|NCT04744831|454628248|FG000|Overall Study|Adverse Event|3|||
126281511|NCT02952586|454320800|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
126281512|NCT02952586|454320801|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
126281513|NCT02952586|454320800|FG000|Follow-Up Phase (90 Days)|Other|7|||
126281514|NCT02952586|454320801|FG001|Follow-Up Phase (90 Days)|Other|5|||
126281515|NCT02952586|454320800|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
126281516|NCT02952586|454320801|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
126364230|NCT04744831|454628249|FG001|Overall Study|Adverse Event|3|||
126364231|NCT04744831|454628250|FG002|Overall Study|Adverse Event|3|||
126364232|NCT04744831|454628248|FG000|Overall Study|Clinical Progression|3|||
126364233|NCT04744831|454628249|FG001|Overall Study|Clinical Progression|2|||
126364234|NCT04744831|454628250|FG002|Overall Study|Clinical Progression|5|||
126281517|NCT02952586|454320800|FG000|LT Follow-up (up to 45 Months)|Death|51|||
126281518|NCT02952586|454320801|FG001|LT Follow-up (up to 45 Months)|Death|31|||
126364235|NCT04744831|454628248|FG000|Overall Study|Other|0|||
126364236|NCT04744831|454628249|FG001|Overall Study|Other|2|||
126364237|NCT04744831|454628250|FG002|Overall Study|Other|1|||
126364238|NCT04744831|454628248|FG000|Overall Study|Death|0|||
126364239|NCT04744831|454628249|FG001|Overall Study|Death|2|||
126364240|NCT04744831|454628250|FG002|Overall Study|Death|1|||
126364241|NCT04616196|454628260|FG000|Overall Study|Progressive Disease|3|||
126364242|NCT04616196|454628261|FG001|Overall Study|Progressive Disease|0|||
126364243|NCT04616196|454628262|FG002|Overall Study|Progressive Disease|4|||
126364244|NCT04616196|454628263|FG003|Overall Study|Progressive Disease|1|||
126708877|NCT00744055|455887884|FG000|Overall Study|Lack of Efficacy|0|||
126281519|NCT02952586|454320800|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
126281520|NCT02952586|454320801|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
126281521|NCT02952586|454320800|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
126281522|NCT02952586|454320801|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
126281523|NCT02952586|454320800|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
126281524|NCT02952586|454320801|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
126281525|NCT00492778|454320802|FG000|Overall Study|Ineligible by Pathology Review|8|||
126281526|NCT00492778|454320803|FG001|Overall Study|Ineligible by Pathology Review|1|||
126281527|NCT00789035|454320804|FG000|Overall Study|Adverse Event|0|||
126281528|NCT00789035|454320805|FG001|Overall Study|Adverse Event|2|||
126281529|NCT00789035|454320806|FG002|Overall Study|Adverse Event|0|||
126281530|NCT00789035|454320807|FG003|Overall Study|Adverse Event|1|||
126281531|NCT00789035|454320808|FG004|Overall Study|Adverse Event|3|||
126281532|NCT00789035|454320804|FG000|Overall Study|Lack of Efficacy|3|||
126281533|NCT00789035|454320805|FG001|Overall Study|Lack of Efficacy|0|||
126281534|NCT00789035|454320806|FG002|Overall Study|Lack of Efficacy|0|||
126281535|NCT00789035|454320807|FG003|Overall Study|Lack of Efficacy|0|||
126281536|NCT00789035|454320808|FG004|Overall Study|Lack of Efficacy|2|||
126281537|NCT00789035|454320804|FG000|Overall Study|Protocol Violation|1|||
126281538|NCT00789035|454320805|FG001|Overall Study|Protocol Violation|0|||
126281539|NCT00789035|454320806|FG002|Overall Study|Protocol Violation|0|||
126281540|NCT00789035|454320807|FG003|Overall Study|Protocol Violation|0|||
126281541|NCT00789035|454320808|FG004|Overall Study|Protocol Violation|0|||
126281542|NCT00789035|454320804|FG000|Overall Study|Withdrawal by Subject|0|||
126281543|NCT00789035|454320805|FG001|Overall Study|Withdrawal by Subject|2|||
126281544|NCT00789035|454320806|FG002|Overall Study|Withdrawal by Subject|0|||
126281545|NCT00789035|454320807|FG003|Overall Study|Withdrawal by Subject|0|||
126281546|NCT00789035|454320808|FG004|Overall Study|Withdrawal by Subject|0|||
126281547|NCT00789035|454320804|FG000|Overall Study|Other reason not defined above|2|||
126281548|NCT00789035|454320805|FG001|Overall Study|Other reason not defined above|3|||
126281549|NCT00789035|454320806|FG002|Overall Study|Other reason not defined above|1|||
126281550|NCT00789035|454320807|FG003|Overall Study|Other reason not defined above|0|||
126281551|NCT00789035|454320808|FG004|Overall Study|Other reason not defined above|1|||
126281552|NCT01118975|454320809|FG000|Overall Study|Adverse Event|0|||
126281553|NCT01118975|454320810|FG001|Overall Study|Adverse Event|1|||
126281554|NCT00789737|454320821|FG000|Overall Study|Withdrawal by Subject|13|||
126281555|NCT00789737|454320822|FG001|Overall Study|Withdrawal by Subject|22|||
126281556|NCT00789737|454320821|FG000|Overall Study|Lost to Follow-up|10|||
126281557|NCT00789737|454320822|FG001|Overall Study|Lost to Follow-up|14|||
126281558|NCT00789737|454320821|FG000|Overall Study|Adverse Event|8|||
126281559|NCT00789737|454320822|FG001|Overall Study|Adverse Event|8|||
126281560|NCT00789737|454320821|FG000|Overall Study|Protocol Violation|3|||
126281561|NCT00789737|454320822|FG001|Overall Study|Protocol Violation|0|||
126281562|NCT00789737|454320821|FG000|Overall Study|Lack of Efficacy|3|||
126281563|NCT00789737|454320822|FG001|Overall Study|Lack of Efficacy|0|||
126281564|NCT00789737|454320821|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
126281565|NCT00789737|454320822|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
126281566|NCT00789737|454320821|FG000|Overall Study|Other|11|||
126281567|NCT00789737|454320822|FG001|Overall Study|Other|7|||
126281568|NCT00384930|454320823|FG000|Overall Study|Adverse Event|5|||
126281569|NCT00384930|454320824|FG001|Overall Study|Adverse Event|4|||
126281570|NCT00384930|454320825|FG002|Overall Study|Adverse Event|12|||
126281571|NCT00384930|454320826|FG003|Overall Study|Adverse Event|11|||
126281572|NCT00384930|454320827|FG004|Overall Study|Adverse Event|14|||
126708878|NCT00744055|455887885|FG001|Overall Study|Lack of Efficacy|1|||
126281573|NCT00384930|454320823|FG000|Overall Study|Entry Criteria Not Met|2|||
126281574|NCT00384930|454320824|FG001|Overall Study|Entry Criteria Not Met|6|||
126281575|NCT00384930|454320825|FG002|Overall Study|Entry Criteria Not Met|7|||
126281576|NCT00384930|454320826|FG003|Overall Study|Entry Criteria Not Met|8|||
126708879|NCT00744055|455887884|FG000|Overall Study|Physician Decision|0|||
126281577|NCT00384930|454320827|FG004|Overall Study|Entry Criteria Not Met|4|||
126281578|NCT00384930|454320823|FG000|Overall Study|Lack of Efficacy|1|||
126281579|NCT00384930|454320824|FG001|Overall Study|Lack of Efficacy|1|||
126281580|NCT00384930|454320825|FG002|Overall Study|Lack of Efficacy|2|||
126281581|NCT00384930|454320826|FG003|Overall Study|Lack of Efficacy|1|||
126281582|NCT00384930|454320827|FG004|Overall Study|Lack of Efficacy|2|||
126281583|NCT00384930|454320823|FG000|Overall Study|Lost to Follow-up|5|||
126281584|NCT00384930|454320824|FG001|Overall Study|Lost to Follow-up|3|||
126281585|NCT00384930|454320825|FG002|Overall Study|Lost to Follow-up|0|||
126281586|NCT00384930|454320826|FG003|Overall Study|Lost to Follow-up|4|||
126281587|NCT00384930|454320827|FG004|Overall Study|Lost to Follow-up|6|||
126281588|NCT00384930|454320823|FG000|Overall Study|Physician Decision|0|||
126281589|NCT00384930|454320824|FG001|Overall Study|Physician Decision|1|||
126281590|NCT00384930|454320825|FG002|Overall Study|Physician Decision|1|||
126281591|NCT00384930|454320826|FG003|Overall Study|Physician Decision|0|||
126281592|NCT00384930|454320827|FG004|Overall Study|Physician Decision|1|||
126281593|NCT00384930|454320823|FG000|Overall Study|Protocol Violation|1|||
126281594|NCT00384930|454320824|FG001|Overall Study|Protocol Violation|0|||
126281595|NCT00384930|454320825|FG002|Overall Study|Protocol Violation|1|||
126281596|NCT00384930|454320826|FG003|Overall Study|Protocol Violation|6|||
126281597|NCT00384930|454320827|FG004|Overall Study|Protocol Violation|4|||
126281598|NCT00384930|454320823|FG000|Overall Study|Sponsor Decision|3|||
126281599|NCT00384930|454320824|FG001|Overall Study|Sponsor Decision|4|||
126281600|NCT00384930|454320825|FG002|Overall Study|Sponsor Decision|0|||
126281601|NCT00384930|454320826|FG003|Overall Study|Sponsor Decision|5|||
126281602|NCT00384930|454320827|FG004|Overall Study|Sponsor Decision|0|||
126281603|NCT00384930|454320823|FG000|Overall Study|Withdrawal by Subject|9|||
126281604|NCT00384930|454320824|FG001|Overall Study|Withdrawal by Subject|7|||
126281605|NCT00384930|454320825|FG002|Overall Study|Withdrawal by Subject|7|||
126281606|NCT00384930|454320826|FG003|Overall Study|Withdrawal by Subject|6|||
126281607|NCT00384930|454320827|FG004|Overall Study|Withdrawal by Subject|16|||
126281608|NCT00384930|454320823|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
126281609|NCT00384930|454320824|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
126281610|NCT00384930|454320825|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
126281611|NCT00384930|454320826|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
126281612|NCT00384930|454320827|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
126281613|NCT02613182|454320828|FG000|Overall Study|Death|6|||
126281614|NCT02613182|454320828|FG000|Overall Study|Physician Decision|1|||
126281615|NCT02613182|454320828|FG000|Overall Study|Study Terminated by Sponsor|21|||
126281616|NCT02613182|454320828|FG000|Overall Study|Withdrawal by Subject|6|||
126281617|NCT03968978|454320829|FG000|Overall Study|Adverse Event|1|||
126281618|NCT03968978|454320830|FG001|Overall Study|Adverse Event|0|||
126281619|NCT00025259|454320832|FG000|Overall Study|Death|1|||
126281620|NCT00025259|454320833|FG001|Overall Study|Death|3|||
126281621|NCT00025259|454320834|FG002|Overall Study|Death|0|||
126281622|NCT00025259|454320835|FG003|Overall Study|Death|3|||
126281623|NCT00025259|454320836|FG004|Overall Study|Death|0|||
126281624|NCT00025259|454320837|FG005|Overall Study|Death|1|||
126281625|NCT00025259|454320838|FG006|Overall Study|Death|2|||
126281626|NCT00025259|454320832|FG000|Overall Study|Lack of Efficacy|2|||
126281627|NCT00025259|454320833|FG001|Overall Study|Lack of Efficacy|46|||
126281628|NCT00025259|454320834|FG002|Overall Study|Lack of Efficacy|60|||
126281629|NCT00025259|454320835|FG003|Overall Study|Lack of Efficacy|78|||
126281630|NCT00025259|454320836|FG004|Overall Study|Lack of Efficacy|11|||
126281631|NCT00025259|454320837|FG005|Overall Study|Lack of Efficacy|30|||
126281632|NCT00025259|454320838|FG006|Overall Study|Lack of Efficacy|38|||
126281633|NCT00025259|454320832|FG000|Overall Study|Lost to Follow-up|2|||
126281634|NCT00025259|454320833|FG001|Overall Study|Lost to Follow-up|9|||
126281635|NCT00025259|454320834|FG002|Overall Study|Lost to Follow-up|13|||
126281636|NCT00025259|454320835|FG003|Overall Study|Lost to Follow-up|13|||
126281637|NCT00025259|454320836|FG004|Overall Study|Lost to Follow-up|1|||
126281638|NCT00025259|454320837|FG005|Overall Study|Lost to Follow-up|3|||
126281639|NCT00025259|454320838|FG006|Overall Study|Lost to Follow-up|1|||
126281640|NCT00025259|454320832|FG000|Overall Study|Physician Decision|12|||
126281641|NCT00025259|454320833|FG001|Overall Study|Physician Decision|1|||
126281642|NCT00025259|454320834|FG002|Overall Study|Physician Decision|0|||
126281643|NCT00025259|454320835|FG003|Overall Study|Physician Decision|5|||
126281644|NCT00025259|454320836|FG004|Overall Study|Physician Decision|4|||
126281645|NCT00025259|454320837|FG005|Overall Study|Physician Decision|2|||
126281646|NCT00025259|454320838|FG006|Overall Study|Physician Decision|1|||
126281647|NCT00025259|454320832|FG000|Overall Study|Protocol Violation|3|||
126281648|NCT00025259|454320833|FG001|Overall Study|Protocol Violation|2|||
126281649|NCT00025259|454320834|FG002|Overall Study|Protocol Violation|2|||
126281650|NCT00025259|454320835|FG003|Overall Study|Protocol Violation|1|||
126281651|NCT00025259|454320836|FG004|Overall Study|Protocol Violation|2|||
126281652|NCT00025259|454320837|FG005|Overall Study|Protocol Violation|1|||
126281653|NCT00025259|454320838|FG006|Overall Study|Protocol Violation|3|||
126281654|NCT00025259|454320832|FG000|Overall Study|Withdrawal by Subject|9|||
126281655|NCT00025259|454320833|FG001|Overall Study|Withdrawal by Subject|27|||
126281656|NCT00025259|454320834|FG002|Overall Study|Withdrawal by Subject|6|||
126281657|NCT00025259|454320835|FG003|Overall Study|Withdrawal by Subject|14|||
126281658|NCT00025259|454320836|FG004|Overall Study|Withdrawal by Subject|11|||
126281659|NCT00025259|454320837|FG005|Overall Study|Withdrawal by Subject|8|||
126281660|NCT00025259|454320838|FG006|Overall Study|Withdrawal by Subject|3|||
126281661|NCT00025259|454320832|FG000|Overall Study|Ineligible|14|||
126281662|NCT00025259|454320833|FG001|Overall Study|Ineligible|1|||
126708880|NCT00744055|455887885|FG001|Overall Study|Physician Decision|2|||
126281663|NCT00025259|454320834|FG002|Overall Study|Ineligible|0|||
126281664|NCT00025259|454320835|FG003|Overall Study|Ineligible|0|||
126281665|NCT00025259|454320836|FG004|Overall Study|Ineligible|6|||
126281666|NCT00025259|454320837|FG005|Overall Study|Ineligible|0|||
126281667|NCT00025259|454320838|FG006|Overall Study|Ineligible|1|||
126281668|NCT00025259|454320832|FG000|Overall Study|Randomization error|1|||
126281669|NCT00025259|454320833|FG001|Overall Study|Randomization error|0|||
126281670|NCT00025259|454320834|FG002|Overall Study|Randomization error|0|||
126281671|NCT00025259|454320835|FG003|Overall Study|Randomization error|0|||
126708881|NCT00744055|455887884|FG000|Overall Study|Protocol Violation|1|||
126708882|NCT00744055|455887885|FG001|Overall Study|Protocol Violation|1|||
126708883|NCT00744055|455887884|FG000|Overall Study|Lost to Follow-up|0|||
126708884|NCT00744055|455887885|FG001|Overall Study|Lost to Follow-up|1|||
126708885|NCT00849693|455887888|FG000|Acute Treatment Phase|Adverse Event|12|||
126708886|NCT00849693|455887889|FG001|Acute Treatment Phase|Adverse Event|7|||
126281672|NCT00025259|454320836|FG004|Overall Study|Randomization error|1|||
126281673|NCT00025259|454320837|FG005|Overall Study|Randomization error|7|||
126281674|NCT00025259|454320838|FG006|Overall Study|Randomization error|2|||
126281675|NCT00025259|454320832|FG000|Overall Study|Adverse Event|1|||
126281676|NCT00025259|454320833|FG001|Overall Study|Adverse Event|0|||
126281677|NCT00025259|454320834|FG002|Overall Study|Adverse Event|0|||
126281678|NCT00025259|454320835|FG003|Overall Study|Adverse Event|0|||
126455987|NCT03011892|454969078|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
126455988|NCT03011892|454969079|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
126455989|NCT03011892|454969080|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
126455990|NCT03011892|454969081|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
126455991|NCT03011892|454969082|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
126455992|NCT03011892|454969083|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
126455993|NCT03011892|454969084|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
126455994|NCT03011892|454969085|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
126455995|NCT03011892|454969086|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
126455996|NCT03011892|454969087|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
126455997|NCT03011892|454969088|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
126455998|NCT03011892|454969089|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
126455999|NCT03011892|454969078|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
126456000|NCT03011892|454969079|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
126456001|NCT03011892|454969080|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
126456002|NCT03011892|454969081|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
126456003|NCT03011892|454969082|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
126456004|NCT03011892|454969083|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
126456005|NCT03011892|454969084|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
126456006|NCT03011892|454969085|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
126456007|NCT03011892|454969086|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
126456008|NCT03011892|454969087|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
126456009|NCT03011892|454969088|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
126456010|NCT03011892|454969089|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
126456011|NCT03011892|454969078|FG000|Open Label (OL) Period|Reason not specified|0|||
126456012|NCT03011892|454969079|FG001|Open Label (OL) Period|Reason not specified|0|||
126456013|NCT03011892|454969080|FG002|Open Label (OL) Period|Reason not specified|0|||
126456014|NCT03011892|454969081|FG003|Open Label (OL) Period|Reason not specified|0|||
126456015|NCT03011892|454969082|FG004|Open Label (OL) Period|Reason not specified|0|||
126456016|NCT03011892|454969083|FG005|Open Label (OL) Period|Reason not specified|0|||
126456017|NCT03011892|454969084|FG006|Open Label (OL) Period|Reason not specified|0|||
126456018|NCT03011892|454969085|FG007|Open Label (OL) Period|Reason not specified|1|||
126456019|NCT03011892|454969086|FG008|Open Label (OL) Period|Reason not specified|0|||
126456020|NCT03011892|454969087|FG009|Open Label (OL) Period|Reason not specified|0|||
126456021|NCT03011892|454969088|FG010|Open Label (OL) Period|Reason not specified|0|||
126456022|NCT03011892|454969089|FG011|Open Label (OL) Period|Reason not specified|0|||
126456023|NCT02312687|454969090|FG000|Overall Study|Other, Not Specified|1|||
126456024|NCT00217464|454969093|FG000|Overall Study|Progression|15|||
126456025|NCT00217464|454969093|FG000|Overall Study|Other|2|||
126456026|NCT01576159|454969094|FG000|Overall Study|Withdrawal by Subject|0|||
126456027|NCT01576159|454969095|FG001|Overall Study|Withdrawal by Subject|1|||
126456028|NCT01576159|454969096|FG002|Overall Study|Withdrawal by Subject|0|||
126456029|NCT01576159|454969097|FG003|Overall Study|Withdrawal by Subject|0|||
126456030|NCT01576159|454969094|FG000|Overall Study|Physician Decision|0|||
126456031|NCT01576159|454969095|FG001|Overall Study|Physician Decision|0|||
126456032|NCT01576159|454969096|FG002|Overall Study|Physician Decision|1|||
126456033|NCT01576159|454969097|FG003|Overall Study|Physician Decision|0|||
126456034|NCT01576159|454969094|FG000|Overall Study|Lost to Follow-up|0|||
126456035|NCT01576159|454969095|FG001|Overall Study|Lost to Follow-up|0|||
126456036|NCT01576159|454969096|FG002|Overall Study|Lost to Follow-up|0|||
126456037|NCT01576159|454969097|FG003|Overall Study|Lost to Follow-up|1|||
126456038|NCT01576159|454969094|FG000|Overall Study|Protocol Violation|1|||
126456039|NCT01576159|454969095|FG001|Overall Study|Protocol Violation|0|||
126456040|NCT01576159|454969096|FG002|Overall Study|Protocol Violation|0|||
126456041|NCT01576159|454969097|FG003|Overall Study|Protocol Violation|0|||
126456042|NCT00169442|454969098|FG000|Overall Study|Withdrawal by Subject|0|||
126281679|NCT00025259|454320836|FG004|Overall Study|Adverse Event|0|||
126281680|NCT00025259|454320837|FG005|Overall Study|Adverse Event|0|||
126456043|NCT00169442|454969099|FG001|Overall Study|Withdrawal by Subject|0|||
126456044|NCT00169442|454969100|FG002|Overall Study|Withdrawal by Subject|1|||
126456045|NCT00169442|454969101|FG003|Overall Study|Withdrawal by Subject|0|||
126708887|NCT00849693|455887890|FG002|Acute Treatment Phase|Adverse Event|6|||
126708888|NCT00849693|455887891|FG003|Acute Treatment Phase|Adverse Event|4|||
126281681|NCT00025259|454320838|FG006|Overall Study|Adverse Event|0|||
126281682|NCT01449370|454320839|FG000|Overall Study|Disease Progression|5|||
126281683|NCT01449370|454320840|FG001|Overall Study|Disease Progression|4|||
126281684|NCT01449370|454320841|FG002|Overall Study|Disease Progression|8|||
126281685|NCT01449370|454320842|FG003|Overall Study|Disease Progression|3|||
126281686|NCT01449370|454320843|FG004|Overall Study|Disease Progression|3|||
126281687|NCT01449370|454320844|FG005|Overall Study|Disease Progression|3|||
126281688|NCT01449370|454320845|FG006|Overall Study|Disease Progression|3|||
126281689|NCT01449370|454320846|FG007|Overall Study|Disease Progression|2|||
126281690|NCT01449370|454320847|FG008|Overall Study|Disease Progression|9|||
126281691|NCT01449370|454320848|FG009|Overall Study|Disease Progression|1|||
126281692|NCT01449370|454320849|FG010|Overall Study|Disease Progression|3|||
126281693|NCT01449370|454320850|FG011|Overall Study|Disease Progression|3|||
126281694|NCT01449370|454320851|FG012|Overall Study|Disease Progression|2|||
126281695|NCT01449370|454320852|FG013|Overall Study|Disease Progression|8|||
126281696|NCT01449370|454320853|FG014|Overall Study|Disease Progression|3|||
126281697|NCT01449370|454320854|FG015|Overall Study|Disease Progression|1|||
126281698|NCT01449370|454320855|FG016|Overall Study|Disease Progression|4|||
126281699|NCT01449370|454320856|FG017|Overall Study|Disease Progression|3|||
126281700|NCT01449370|454320857|FG018|Overall Study|Disease Progression|1|||
126281701|NCT01449370|454320858|FG019|Overall Study|Disease Progression|2|||
126281702|NCT01449370|454320859|FG020|Overall Study|Disease Progression|5|||
126456046|NCT00169442|454969102|FG004|Overall Study|Withdrawal by Subject|0|||
126456047|NCT00169442|454969103|FG005|Overall Study|Withdrawal by Subject|0|||
126456048|NCT00169442|454969098|FG000|Overall Study|Migrated/moved from study area|0|||
126456049|NCT00169442|454969099|FG001|Overall Study|Migrated/moved from study area|0|||
126456050|NCT00169442|454969100|FG002|Overall Study|Migrated/moved from study area|0|||
126456051|NCT00169442|454969101|FG003|Overall Study|Migrated/moved from study area|0|||
126456052|NCT00169442|454969102|FG004|Overall Study|Migrated/moved from study area|0|||
126456053|NCT00169442|454969103|FG005|Overall Study|Migrated/moved from study area|2|||
126456054|NCT00169442|454969098|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
126456055|NCT00169442|454969099|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
126456056|NCT00169442|454969100|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
126456057|NCT00169442|454969101|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
126456058|NCT00169442|454969102|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
126456059|NCT00169442|454969103|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
126456060|NCT00169442|454969098|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
126456061|NCT00169442|454969099|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
126281703|NCT01449370|454320860|FG021|Overall Study|Disease Progression|2|||
126281704|NCT01449370|454320861|FG022|Overall Study|Disease Progression|3|||
126281705|NCT01449370|454320862|FG023|Overall Study|Disease Progression|7|||
126281706|NCT01449370|454320863|FG024|Overall Study|Disease Progression|3|||
126281707|NCT01449370|454320839|FG000|Overall Study|Adverse Event|1|||
126281708|NCT01449370|454320840|FG001|Overall Study|Adverse Event|2|||
126281709|NCT01449370|454320841|FG002|Overall Study|Adverse Event|0|||
126281710|NCT01449370|454320842|FG003|Overall Study|Adverse Event|1|||
126281711|NCT01449370|454320843|FG004|Overall Study|Adverse Event|0|||
126281712|NCT01449370|454320844|FG005|Overall Study|Adverse Event|0|||
126281713|NCT01449370|454320845|FG006|Overall Study|Adverse Event|0|||
126281714|NCT01449370|454320846|FG007|Overall Study|Adverse Event|0|||
126281715|NCT01449370|454320847|FG008|Overall Study|Adverse Event|1|||
126281716|NCT01449370|454320848|FG009|Overall Study|Adverse Event|1|||
126281717|NCT01449370|454320849|FG010|Overall Study|Adverse Event|0|||
126281718|NCT01449370|454320850|FG011|Overall Study|Adverse Event|0|||
126281719|NCT01449370|454320851|FG012|Overall Study|Adverse Event|0|||
126281720|NCT01449370|454320852|FG013|Overall Study|Adverse Event|2|||
126281721|NCT01449370|454320853|FG014|Overall Study|Adverse Event|0|||
126281722|NCT01449370|454320854|FG015|Overall Study|Adverse Event|1|||
126281723|NCT01449370|454320855|FG016|Overall Study|Adverse Event|0|||
126281724|NCT01449370|454320856|FG017|Overall Study|Adverse Event|0|||
126281725|NCT01449370|454320857|FG018|Overall Study|Adverse Event|1|||
126281726|NCT01449370|454320858|FG019|Overall Study|Adverse Event|1|||
126281727|NCT01449370|454320859|FG020|Overall Study|Adverse Event|0|||
126281728|NCT01449370|454320860|FG021|Overall Study|Adverse Event|1|||
126281729|NCT01449370|454320861|FG022|Overall Study|Adverse Event|0|||
126281730|NCT01449370|454320862|FG023|Overall Study|Adverse Event|1|||
126281731|NCT01449370|454320863|FG024|Overall Study|Adverse Event|3|||
126281732|NCT01449370|454320839|FG000|Overall Study|Participant Decision|0|||
126456062|NCT00169442|454969100|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
126456063|NCT00169442|454969101|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
126281733|NCT01449370|454320840|FG001|Overall Study|Participant Decision|0|||
126281734|NCT01449370|454320841|FG002|Overall Study|Participant Decision|0|||
126281735|NCT01449370|454320842|FG003|Overall Study|Participant Decision|0|||
126281736|NCT01449370|454320843|FG004|Overall Study|Participant Decision|0|||
126281737|NCT01449370|454320844|FG005|Overall Study|Participant Decision|0|||
126281738|NCT01449370|454320845|FG006|Overall Study|Participant Decision|0|||
126281739|NCT01449370|454320846|FG007|Overall Study|Participant Decision|1|||
126548868|NCT04399551|455303878|FG000|Overall Study|Withdrawal by Subject|6|||
126548869|NCT04399551|455303878|FG000|Overall Study|Physician Decision|3|||
126548870|NCT04399551|455303878|FG000|Overall Study|Lost to Follow-up|2|||
126548871|NCT04399551|455303878|FG000|Overall Study|Protocol Deviation|2|||
126708889|NCT00849693|455887888|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
126708890|NCT00849693|455887889|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
126708891|NCT00849693|455887890|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
126281740|NCT01449370|454320847|FG008|Overall Study|Participant Decision|1|||
126548872|NCT01014975|455303879|FG000|Overall Study|Withdrawal by Subject|1|||
126548873|NCT01014975|455303880|FG001|Overall Study|Withdrawal by Subject|0|||
126548874|NCT01014975|455303881|FG002|Overall Study|Withdrawal by Subject|1|||
126548875|NCT01014975|455303879|FG000|Overall Study|Death|3|||
126548876|NCT01014975|455303880|FG001|Overall Study|Death|3|||
126548877|NCT01014975|455303881|FG002|Overall Study|Death|4|||
126548878|NCT01014975|455303879|FG000|Overall Study|Lost to Follow-up|0|||
126548879|NCT01014975|455303880|FG001|Overall Study|Lost to Follow-up|0|||
126548880|NCT01014975|455303881|FG002|Overall Study|Lost to Follow-up|1|||
126548881|NCT01336634|455303884|FG000|Overall Study|Study closed/terminated|5|||
126548882|NCT01336634|455303885|FG001|Overall Study|Study closed/terminated|6|||
126548883|NCT01336634|455303886|FG002|Overall Study|Study closed/terminated|6|||
126548884|NCT01336634|455303884|FG000|Overall Study|Lost to Follow-up|2|||
126548885|NCT01336634|455303885|FG001|Overall Study|Lost to Follow-up|1|||
126548886|NCT01336634|455303886|FG002|Overall Study|Lost to Follow-up|1|||
126548887|NCT01336634|455303884|FG000|Overall Study|Physician Decision|1|||
126548888|NCT01336634|455303885|FG001|Overall Study|Physician Decision|1|||
126548889|NCT01336634|455303886|FG002|Overall Study|Physician Decision|0|||
126548890|NCT01336634|455303884|FG000|Overall Study|Withdrawal by Subject|6|||
126548891|NCT01336634|455303885|FG001|Overall Study|Withdrawal by Subject|0|||
126548892|NCT01336634|455303886|FG002|Overall Study|Withdrawal by Subject|2|||
126548893|NCT01863043|455303887|FG000|Overall Study|Death|6|||
126548894|NCT01863043|455303888|FG001|Overall Study|Death|1|||
126548895|NCT01863043|455303887|FG000|Overall Study|Withdrawal by Subject|0|||
126708892|NCT00849693|455887891|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
126708893|NCT00849693|455887888|FG000|Acute Treatment Phase|Protocol Violation|1|||
126708894|NCT00849693|455887889|FG001|Acute Treatment Phase|Protocol Violation|5|||
126708895|NCT00849693|455887890|FG002|Acute Treatment Phase|Protocol Violation|2|||
126708896|NCT00849693|455887891|FG003|Acute Treatment Phase|Protocol Violation|6|||
126281741|NCT01449370|454320848|FG009|Overall Study|Participant Decision|0|||
126281742|NCT01449370|454320849|FG010|Overall Study|Participant Decision|0|||
126281743|NCT01449370|454320850|FG011|Overall Study|Participant Decision|0|||
126281744|NCT01449370|454320851|FG012|Overall Study|Participant Decision|1|||
126281745|NCT01449370|454320852|FG013|Overall Study|Participant Decision|1|||
126281746|NCT01449370|454320853|FG014|Overall Study|Participant Decision|0|||
126281747|NCT01449370|454320854|FG015|Overall Study|Participant Decision|1|||
126281748|NCT01449370|454320855|FG016|Overall Study|Participant Decision|3|||
126281749|NCT01449370|454320856|FG017|Overall Study|Participant Decision|0|||
126281750|NCT01449370|454320857|FG018|Overall Study|Participant Decision|1|||
126281751|NCT01449370|454320858|FG019|Overall Study|Participant Decision|0|||
126281752|NCT01449370|454320859|FG020|Overall Study|Participant Decision|0|||
126281753|NCT01449370|454320860|FG021|Overall Study|Participant Decision|1|||
126281754|NCT01449370|454320861|FG022|Overall Study|Participant Decision|0|||
126281755|NCT01449370|454320862|FG023|Overall Study|Participant Decision|0|||
126281756|NCT01449370|454320863|FG024|Overall Study|Participant Decision|1|||
126281757|NCT01449370|454320839|FG000|Overall Study|Lost to Follow-up|0|||
126708897|NCT00849693|455887888|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
126708898|NCT00849693|455887889|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
126281758|NCT01449370|454320840|FG001|Overall Study|Lost to Follow-up|0|||
126281759|NCT01449370|454320841|FG002|Overall Study|Lost to Follow-up|0|||
126281760|NCT01449370|454320842|FG003|Overall Study|Lost to Follow-up|0|||
126281761|NCT01449370|454320843|FG004|Overall Study|Lost to Follow-up|0|||
126281762|NCT01449370|454320844|FG005|Overall Study|Lost to Follow-up|0|||
126281763|NCT01449370|454320845|FG006|Overall Study|Lost to Follow-up|0|||
126281764|NCT01449370|454320846|FG007|Overall Study|Lost to Follow-up|0|||
126281765|NCT01449370|454320847|FG008|Overall Study|Lost to Follow-up|0|||
126281766|NCT01449370|454320848|FG009|Overall Study|Lost to Follow-up|0|||
126281767|NCT01449370|454320849|FG010|Overall Study|Lost to Follow-up|0|||
126364245|NCT04616196|454628260|FG000|Overall Study|Death|2|||
126364246|NCT04616196|454628261|FG001|Overall Study|Death|4|||
126364247|NCT04616196|454628262|FG002|Overall Study|Death|1|||
126364248|NCT04616196|454628263|FG003|Overall Study|Death|0|||
126548896|NCT01863043|455303888|FG001|Overall Study|Withdrawal by Subject|2|||
126548897|NCT01863043|455303887|FG000|Overall Study|Adverse Event|7|||
126548898|NCT01863043|455303888|FG001|Overall Study|Adverse Event|8|||
126548899|NCT01863043|455303887|FG000|Overall Study|exclusion criteria found after enrollment|0|||
126548900|NCT01863043|455303888|FG001|Overall Study|exclusion criteria found after enrollment|1|||
126548901|NCT01912781|455303889|FG000|Overall Study|Withdrawal by Subject|2|||
126708899|NCT00849693|455887890|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
126708900|NCT00849693|455887891|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
126281768|NCT01449370|454320850|FG011|Overall Study|Lost to Follow-up|0|||
126281769|NCT01449370|454320851|FG012|Overall Study|Lost to Follow-up|0|||
126281770|NCT01449370|454320852|FG013|Overall Study|Lost to Follow-up|0|||
126281771|NCT01449370|454320853|FG014|Overall Study|Lost to Follow-up|0|||
126281772|NCT01449370|454320854|FG015|Overall Study|Lost to Follow-up|0|||
126281773|NCT01449370|454320855|FG016|Overall Study|Lost to Follow-up|0|||
126281774|NCT01449370|454320856|FG017|Overall Study|Lost to Follow-up|0|||
126281775|NCT01449370|454320857|FG018|Overall Study|Lost to Follow-up|0|||
126281776|NCT01449370|454320858|FG019|Overall Study|Lost to Follow-up|0|||
126364249|NCT04616196|454628260|FG000|Overall Study|Withdrawal by Subject|0|||
126548902|NCT01912781|455303890|FG001|Overall Study|Withdrawal by Subject|0|||
126548903|NCT00854295|455303891|FG000|Overall Study|Death|7|||
126548904|NCT00854295|455303892|FG001|Overall Study|Death|0|||
126548905|NCT00854295|455303893|FG002|Overall Study|Death|1|||
126548906|NCT00854295|455303894|FG003|Overall Study|Death|1|||
126548907|NCT00854295|455303891|FG000|Overall Study|Adverse Event|6|||
126548908|NCT00854295|455303892|FG001|Overall Study|Adverse Event|1|||
126548909|NCT00854295|455303893|FG002|Overall Study|Adverse Event|1|||
126548910|NCT00854295|455303894|FG003|Overall Study|Adverse Event|3|||
126548911|NCT00854295|455303891|FG000|Overall Study|Lost to Follow-up|18|||
126548912|NCT00854295|455303892|FG001|Overall Study|Lost to Follow-up|5|||
126548913|NCT00854295|455303893|FG002|Overall Study|Lost to Follow-up|21|||
126548914|NCT00854295|455303894|FG003|Overall Study|Lost to Follow-up|21|||
126548915|NCT00854295|455303891|FG000|Overall Study|Physician Decision|10|||
126548916|NCT00854295|455303892|FG001|Overall Study|Physician Decision|0|||
126548917|NCT00854295|455303893|FG002|Overall Study|Physician Decision|0|||
126548918|NCT00854295|455303894|FG003|Overall Study|Physician Decision|0|||
126548919|NCT03154359|455303895|FG000|Overall Study|Adverse Event|1|||
126548920|NCT03154359|455303895|FG000|Overall Study|Lack of Efficacy|2|||
126548921|NCT03154359|455303895|FG000|Overall Study|Lost to Follow-up|3|||
126548922|NCT03154359|455303895|FG000|Overall Study|Physician Decision|3|||
126548923|NCT03154359|455303895|FG000|Overall Study|Protocol Violation|4|||
126548924|NCT03154359|455303895|FG000|Overall Study|Withdrawal by Subject|5|||
126548925|NCT03154359|455303895|FG000|Overall Study|Disruption of study due to COVID-19|4|||
126548926|NCT05033743|455303901|FG000|Overall Study|Lost to Follow-up|1|||
126548927|NCT05033743|455303901|FG000|Overall Study|Protocol Violation|2|||
126548928|NCT05033743|455303901|FG000|Overall Study|Withdrawal by Subject|1|||
126548929|NCT04537897|455303902|FG000|Overall Study|Other than listed|0|||
126548930|NCT04537897|455303903|FG001|Overall Study|Other than listed|0|||
126548931|NCT04537897|455303904|FG002|Overall Study|Other than listed|0|||
126364250|NCT04616196|454628261|FG001|Overall Study|Withdrawal by Subject|2|||
126364251|NCT04616196|454628262|FG002|Overall Study|Withdrawal by Subject|0|||
126364252|NCT04616196|454628263|FG003|Overall Study|Withdrawal by Subject|0|||
126364253|NCT04616196|454628260|FG000|Overall Study|Lost to Follow-up|1|||
126364254|NCT04616196|454628261|FG001|Overall Study|Lost to Follow-up|0|||
126364255|NCT04616196|454628262|FG002|Overall Study|Lost to Follow-up|0|||
126364256|NCT04616196|454628263|FG003|Overall Study|Lost to Follow-up|0|||
126364257|NCT04616196|454628260|FG000|Overall Study|Sponsor request|2|||
126364258|NCT04616196|454628261|FG001|Overall Study|Sponsor request|1|||
126364259|NCT04616196|454628262|FG002|Overall Study|Sponsor request|1|||
126364260|NCT04616196|454628263|FG003|Overall Study|Sponsor request|2|||
126548932|NCT04537897|455303905|FG003|Overall Study|Other than listed|0|||
126548933|NCT04537897|455303906|FG004|Overall Study|Other than listed|0|||
126708901|NCT00849693|455887888|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
126708902|NCT00849693|455887889|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
126708903|NCT00849693|455887890|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
126708904|NCT00849693|455887891|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
126708905|NCT00849693|455887888|FG000|Acute Treatment Phase|Physician Decision|2|||
126708906|NCT00849693|455887889|FG001|Acute Treatment Phase|Physician Decision|1|||
126708907|NCT00849693|455887890|FG002|Acute Treatment Phase|Physician Decision|2|||
126708908|NCT00849693|455887891|FG003|Acute Treatment Phase|Physician Decision|1|||
126708909|NCT00849693|455887888|FG000|Acute Treatment Phase|Sponsor decision|0|||
126708910|NCT00849693|455887889|FG001|Acute Treatment Phase|Sponsor decision|0|||
126708911|NCT00849693|455887890|FG002|Acute Treatment Phase|Sponsor decision|1|||
126281777|NCT01449370|454320859|FG020|Overall Study|Lost to Follow-up|1|||
126281778|NCT01449370|454320860|FG021|Overall Study|Lost to Follow-up|0|||
126364261|NCT05401409|454628264|FG000|Overall Study|Lost to Follow-up|1|||
126364262|NCT05401409|454628265|FG001|Overall Study|Lost to Follow-up|0|||
126548934|NCT04537897|455303907|FG005|Overall Study|Other than listed|0|||
126548935|NCT04537897|455303908|FG006|Overall Study|Other than listed|1|||
126548936|NCT04537897|455303909|FG007|Overall Study|Other than listed|0|||
126548937|NCT04537897|455303910|FG008|Overall Study|Other than listed|0|||
126364263|NCT02371889|454628266|FG000|Overall Study|Adverse medication effect|11|||
126364264|NCT02371889|454628267|FG001|Overall Study|Adverse medication effect|2|||
126548938|NCT04537897|455303902|FG000|Overall Study|Adverse Event|0|||
126548939|NCT04537897|455303903|FG001|Overall Study|Adverse Event|0|||
126548940|NCT04537897|455303904|FG002|Overall Study|Adverse Event|0|||
126708912|NCT00849693|455887891|FG003|Acute Treatment Phase|Sponsor decision|0|||
126708913|NCT00849693|455887888|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
126281779|NCT01449370|454320861|FG022|Overall Study|Lost to Follow-up|0|||
126281780|NCT01449370|454320862|FG023|Overall Study|Lost to Follow-up|0|||
126281781|NCT01449370|454320863|FG024|Overall Study|Lost to Follow-up|0|||
126281782|NCT01449370|454320839|FG000|Overall Study|Other|0|||
126281783|NCT01449370|454320840|FG001|Overall Study|Other|0|||
126281784|NCT01449370|454320841|FG002|Overall Study|Other|0|||
126281785|NCT01449370|454320842|FG003|Overall Study|Other|0|||
126281786|NCT01449370|454320843|FG004|Overall Study|Other|0|||
126281787|NCT01449370|454320844|FG005|Overall Study|Other|0|||
126281788|NCT01449370|454320845|FG006|Overall Study|Other|0|||
126281789|NCT01449370|454320846|FG007|Overall Study|Other|0|||
126281790|NCT01449370|454320847|FG008|Overall Study|Other|1|||
126281791|NCT01449370|454320848|FG009|Overall Study|Other|1|||
126281792|NCT01449370|454320849|FG010|Overall Study|Other|0|||
126281793|NCT01449370|454320850|FG011|Overall Study|Other|0|||
126281794|NCT01449370|454320851|FG012|Overall Study|Other|0|||
126281795|NCT01449370|454320852|FG013|Overall Study|Other|0|||
126281796|NCT01449370|454320853|FG014|Overall Study|Other|0|||
126281797|NCT01449370|454320854|FG015|Overall Study|Other|0|||
126281798|NCT01449370|454320855|FG016|Overall Study|Other|0|||
126281799|NCT01449370|454320856|FG017|Overall Study|Other|0|||
126281800|NCT01449370|454320857|FG018|Overall Study|Other|0|||
126281801|NCT01449370|454320858|FG019|Overall Study|Other|0|||
126281802|NCT01449370|454320859|FG020|Overall Study|Other|0|||
126281803|NCT01449370|454320860|FG021|Overall Study|Other|0|||
126281804|NCT01449370|454320861|FG022|Overall Study|Other|1|||
126281805|NCT01449370|454320862|FG023|Overall Study|Other|1|||
126281806|NCT01449370|454320863|FG024|Overall Study|Other|0|||
126281807|NCT01449370|454320839|FG000|Overall Study|Medication Prohibited by Protocol|0|||
126281808|NCT01449370|454320840|FG001|Overall Study|Medication Prohibited by Protocol|0|||
126281809|NCT01449370|454320841|FG002|Overall Study|Medication Prohibited by Protocol|0|||
126281810|NCT01449370|454320842|FG003|Overall Study|Medication Prohibited by Protocol|0|||
126281811|NCT01449370|454320843|FG004|Overall Study|Medication Prohibited by Protocol|0|||
126281812|NCT01449370|454320844|FG005|Overall Study|Medication Prohibited by Protocol|0|||
126281813|NCT01449370|454320845|FG006|Overall Study|Medication Prohibited by Protocol|0|||
126281814|NCT01449370|454320846|FG007|Overall Study|Medication Prohibited by Protocol|0|||
126281815|NCT01449370|454320847|FG008|Overall Study|Medication Prohibited by Protocol|0|||
126708914|NCT00849693|455887889|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
126708915|NCT00849693|455887890|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
126708916|NCT00849693|455887891|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
126281816|NCT01449370|454320848|FG009|Overall Study|Medication Prohibited by Protocol|0|||
126281817|NCT01449370|454320849|FG010|Overall Study|Medication Prohibited by Protocol|0|||
126281818|NCT01449370|454320850|FG011|Overall Study|Medication Prohibited by Protocol|0|||
126281819|NCT01449370|454320851|FG012|Overall Study|Medication Prohibited by Protocol|0|||
126281820|NCT01449370|454320852|FG013|Overall Study|Medication Prohibited by Protocol|0|||
126281821|NCT01449370|454320853|FG014|Overall Study|Medication Prohibited by Protocol|0|||
126281822|NCT01449370|454320854|FG015|Overall Study|Medication Prohibited by Protocol|0|||
126364265|NCT02371889|454628266|FG000|Overall Study|Lost to Follow-up|6|||
126364266|NCT02371889|454628267|FG001|Overall Study|Lost to Follow-up|5|||
126364267|NCT02371889|454628266|FG000|Overall Study|Personal time constraints|2|||
126364268|NCT02371889|454628267|FG001|Overall Study|Personal time constraints|4|||
126364269|NCT02371889|454628266|FG000|Overall Study|Lack of Efficacy|0|||
126364270|NCT02371889|454628267|FG001|Overall Study|Lack of Efficacy|2|||
126364271|NCT02371889|454628266|FG000|Overall Study|Relapse|0|||
126364272|NCT02371889|454628267|FG001|Overall Study|Relapse|1|||
126364273|NCT05520333|454628268|FG000|Overall Study|Lost to Follow-up|3|||
126364274|NCT05520333|454628269|FG001|Overall Study|Lost to Follow-up|6|||
126364275|NCT02579759|454628270|FG000|Overall Study|Protocol Violation|2|||
126364276|NCT02579759|454628271|FG001|Overall Study|Protocol Violation|0|||
126364277|NCT02579759|454628272|FG002|Overall Study|Protocol Violation|0|||
126364278|NCT02579759|454628270|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
126364279|NCT02579759|454628271|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
126364280|NCT02579759|454628272|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
126364281|NCT02579759|454628270|FG000|Overall Study|BfArM hold|13|||
126364282|NCT02579759|454628271|FG001|Overall Study|BfArM hold|12|||
126364283|NCT02579759|454628272|FG002|Overall Study|BfArM hold|12|||
126364284|NCT02579759|454628270|FG000|Overall Study|Sponsor stopped Dose 2|0|||
126364285|NCT02579759|454628271|FG001|Overall Study|Sponsor stopped Dose 2|41|||
126364286|NCT02579759|454628272|FG002|Overall Study|Sponsor stopped Dose 2|0|||
126548941|NCT04537897|455303905|FG003|Overall Study|Adverse Event|1|||
126281823|NCT01449370|454320855|FG016|Overall Study|Medication Prohibited by Protocol|0|||
126364287|NCT02579759|454628270|FG000|Overall Study|Non compliance|0|||
126364288|NCT02579759|454628271|FG001|Overall Study|Non compliance|1|||
126281824|NCT01449370|454320856|FG017|Overall Study|Medication Prohibited by Protocol|0|||
126281825|NCT01449370|454320857|FG018|Overall Study|Medication Prohibited by Protocol|0|||
126364289|NCT02579759|454628272|FG002|Overall Study|Non compliance|0|||
126364290|NCT02579759|454628270|FG000|Overall Study|Pregnancy|0|||
126364291|NCT02579759|454628271|FG001|Overall Study|Pregnancy|1|||
126364292|NCT02579759|454628272|FG002|Overall Study|Pregnancy|0|||
126708917|NCT00849693|455887888|FG000|Extension Phase|Adverse Event|4|||
126281826|NCT01449370|454320858|FG019|Overall Study|Medication Prohibited by Protocol|0|||
126281827|NCT01449370|454320859|FG020|Overall Study|Medication Prohibited by Protocol|0|||
126281828|NCT01449370|454320860|FG021|Overall Study|Medication Prohibited by Protocol|0|||
126281829|NCT01449370|454320861|FG022|Overall Study|Medication Prohibited by Protocol|0|||
126281830|NCT01449370|454320862|FG023|Overall Study|Medication Prohibited by Protocol|1|||
126281831|NCT01449370|454320863|FG024|Overall Study|Medication Prohibited by Protocol|0|||
126281832|NCT01449370|454320839|FG000|Overall Study|Death|0|||
126281833|NCT01449370|454320840|FG001|Overall Study|Death|0|||
126281834|NCT01449370|454320841|FG002|Overall Study|Death|0|||
126281835|NCT01449370|454320842|FG003|Overall Study|Death|0|||
126281836|NCT01449370|454320843|FG004|Overall Study|Death|0|||
126281837|NCT01449370|454320844|FG005|Overall Study|Death|0|||
126281838|NCT01449370|454320845|FG006|Overall Study|Death|0|||
126281839|NCT01449370|454320846|FG007|Overall Study|Death|0|||
126281840|NCT01449370|454320847|FG008|Overall Study|Death|0|||
126281841|NCT01449370|454320848|FG009|Overall Study|Death|0|||
126281842|NCT01449370|454320849|FG010|Overall Study|Death|0|||
126281843|NCT01449370|454320850|FG011|Overall Study|Death|0|||
126281844|NCT01449370|454320851|FG012|Overall Study|Death|0|||
126281845|NCT01449370|454320852|FG013|Overall Study|Death|0|||
126281846|NCT01449370|454320853|FG014|Overall Study|Death|0|||
126281847|NCT01449370|454320854|FG015|Overall Study|Death|0|||
126281848|NCT01449370|454320855|FG016|Overall Study|Death|0|||
126281849|NCT01449370|454320856|FG017|Overall Study|Death|0|||
126281850|NCT01449370|454320857|FG018|Overall Study|Death|0|||
126281851|NCT01449370|454320858|FG019|Overall Study|Death|0|||
126281852|NCT01449370|454320859|FG020|Overall Study|Death|0|||
126281853|NCT01449370|454320860|FG021|Overall Study|Death|0|||
126281854|NCT01449370|454320861|FG022|Overall Study|Death|0|||
126281855|NCT01449370|454320862|FG023|Overall Study|Death|0|||
126281856|NCT01449370|454320863|FG024|Overall Study|Death|1|||
126281857|NCT00863772|454320864|FG000|Overall Study|Adverse Event|1|||
126281858|NCT00863772|454320865|FG001|Overall Study|Adverse Event|4|||
126281859|NCT00863772|454320866|FG002|Overall Study|Adverse Event|0|||
126281860|NCT00863772|454320864|FG000|Overall Study|Lack of Efficacy|4|||
126281861|NCT00863772|454320865|FG001|Overall Study|Lack of Efficacy|2|||
126281862|NCT00863772|454320866|FG002|Overall Study|Lack of Efficacy|4|||
126281863|NCT00863772|454320864|FG000|Overall Study|Lost to Follow-up|5|||
126281864|NCT00863772|454320865|FG001|Overall Study|Lost to Follow-up|1|||
126281865|NCT00863772|454320866|FG002|Overall Study|Lost to Follow-up|1|||
126281866|NCT00863772|454320864|FG000|Overall Study|Protocol Violation|2|||
126281867|NCT00863772|454320865|FG001|Overall Study|Protocol Violation|0|||
126281868|NCT00863772|454320866|FG002|Overall Study|Protocol Violation|2|||
126281869|NCT00863772|454320864|FG000|Overall Study|Withdrawal by Subject|4|||
126281870|NCT00863772|454320865|FG001|Overall Study|Withdrawal by Subject|7|||
126281871|NCT00863772|454320866|FG002|Overall Study|Withdrawal by Subject|5|||
126281872|NCT00863772|454320864|FG000|Overall Study|Study terminated by sponsor|44|||
126281873|NCT00863772|454320865|FG001|Overall Study|Study terminated by sponsor|45|||
126281874|NCT00863772|454320866|FG002|Overall Study|Study terminated by sponsor|36|||
126281875|NCT00863772|454320864|FG000|Overall Study|Entered extension study|6|||
126364293|NCT02579759|454628270|FG000|Overall Study|Inclusion/exclusion criteria|0|||
126364294|NCT02579759|454628271|FG001|Overall Study|Inclusion/exclusion criteria|0|||
126364295|NCT02579759|454628272|FG002|Overall Study|Inclusion/exclusion criteria|1|||
126364296|NCT02579759|454628270|FG000|Overall Study|Adverse Event|4|||
126364297|NCT02579759|454628271|FG001|Overall Study|Adverse Event|3|||
126364298|NCT02579759|454628272|FG002|Overall Study|Adverse Event|1|||
126364299|NCT02579759|454628270|FG000|Overall Study|Withdrawal by Subject|3|||
126364300|NCT02579759|454628271|FG001|Overall Study|Withdrawal by Subject|3|||
126364301|NCT02579759|454628272|FG002|Overall Study|Withdrawal by Subject|5|||
126364302|NCT02579759|454628270|FG000|Overall Study|Lost to Follow-up|2|||
126364303|NCT02579759|454628271|FG001|Overall Study|Lost to Follow-up|2|||
126364304|NCT02579759|454628272|FG002|Overall Study|Lost to Follow-up|2|||
126364305|NCT03412591|454628275|FG000|Overall Study|Withdrawal by Subject|1|||
126364306|NCT03412591|454628276|FG001|Overall Study|Withdrawal by Subject|8|||
126364307|NCT03412591|454628275|FG000|Overall Study|Adverse Event|0|||
126364308|NCT03412591|454628276|FG001|Overall Study|Adverse Event|1|||
126364309|NCT00160563|454628277|FG000|Overall Study|Adverse Event|1|||
126364310|NCT00160563|454628278|FG001|Overall Study|Adverse Event|1|||
126364311|NCT00160563|454628279|FG002|Overall Study|Adverse Event|1|||
126364312|NCT00160563|454628277|FG000|Overall Study|Lost to Follow-up|1|||
126364313|NCT00160563|454628278|FG001|Overall Study|Lost to Follow-up|1|||
126364314|NCT00160563|454628279|FG002|Overall Study|Lost to Follow-up|2|||
126364315|NCT00160563|454628277|FG000|Overall Study|Protocol Violation|0|||
126364316|NCT00160563|454628278|FG001|Overall Study|Protocol Violation|0|||
126364317|NCT00160563|454628279|FG002|Overall Study|Protocol Violation|3|||
126364318|NCT00160563|454628277|FG000|Overall Study|Withdrawal by Subject|1|||
126364319|NCT00160563|454628278|FG001|Overall Study|Withdrawal by Subject|2|||
126548942|NCT04537897|455303906|FG004|Overall Study|Adverse Event|0|||
126281876|NCT00863772|454320865|FG001|Overall Study|Entered extension study|4|||
126281877|NCT00863772|454320866|FG002|Overall Study|Entered extension study|9|||
126281878|NCT00863772|454320864|FG000|Overall Study|Other|1|||
126281879|NCT00863772|454320865|FG001|Overall Study|Other|2|||
126281880|NCT00863772|454320866|FG002|Overall Study|Other|4|||
126281881|NCT00863772|454320864|FG000|Overall Study|Randomized but not Treated|1|||
126281882|NCT00863772|454320865|FG001|Overall Study|Randomized but not Treated|0|||
126281883|NCT00863772|454320866|FG002|Overall Study|Randomized but not Treated|0|||
126281884|NCT00534404|454320869|FG000|Overall Study|Death|0|||
126281885|NCT00534404|454320870|FG001|Overall Study|Death|0|||
126281886|NCT00534404|454320871|FG002|Overall Study|Death|2|||
126281887|NCT00534404|454320869|FG000|Overall Study|Withdrawal by Subject|8|||
126281888|NCT00534404|454320870|FG001|Overall Study|Withdrawal by Subject|2|||
126281889|NCT00534404|454320871|FG002|Overall Study|Withdrawal by Subject|38|||
126281890|NCT00534404|454320869|FG000|Overall Study|Removed by study staff|2|||
126281891|NCT00534404|454320870|FG001|Overall Study|Removed by study staff|3|||
126281892|NCT00534404|454320871|FG002|Overall Study|Removed by study staff|1|||
126281893|NCT00534404|454320869|FG000|Overall Study|Lost to Follow-up|170|||
126281894|NCT00534404|454320870|FG001|Overall Study|Lost to Follow-up|138|||
126281895|NCT00534404|454320871|FG002|Overall Study|Lost to Follow-up|201|||
126281896|NCT00315731|454320876|FG000|Overall Study|Lost to Follow-up|1|||
126281897|NCT00315731|454320876|FG000|Overall Study|Death|5|||
126281898|NCT04614246|454320877|FG000|Overall Study|Adverse Event|0|||
126281899|NCT04614246|454320878|FG001|Overall Study|Adverse Event|1|||
126281900|NCT04614246|454320879|FG002|Overall Study|Adverse Event|1|||
126281901|NCT04614246|454320880|FG003|Overall Study|Adverse Event|2|||
126281902|NCT04614246|454320881|FG004|Overall Study|Adverse Event|1|||
126281903|NCT04614246|454320877|FG000|Overall Study|Lost to Follow-up|0|||
126281904|NCT04614246|454320878|FG001|Overall Study|Lost to Follow-up|1|||
126456064|NCT00169442|454969102|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
126456065|NCT00169442|454969103|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
126456066|NCT01426789|454969104|FG000|Part 1|Protocol deviation|0|||
126456067|NCT01426789|454969105|FG001|Part 1|Protocol deviation|1|||
126456068|NCT01426789|454969106|FG002|Part 1|Protocol deviation|0|||
126456069|NCT01426789|454969107|FG003|Part 1|Protocol deviation|0|||
126456070|NCT01426789|454969108|FG004|Part 1|Protocol deviation|0|||
126456071|NCT01426789|454969109|FG005|Part 1|Protocol deviation|0|||
126456072|NCT01426789|454969104|FG000|Part 1|Lost to Follow-up|1|||
126456073|NCT01426789|454969105|FG001|Part 1|Lost to Follow-up|2|||
126456074|NCT01426789|454969106|FG002|Part 1|Lost to Follow-up|0|||
126456075|NCT01426789|454969107|FG003|Part 1|Lost to Follow-up|0|||
126456076|NCT01426789|454969108|FG004|Part 1|Lost to Follow-up|0|||
126456077|NCT01426789|454969109|FG005|Part 1|Lost to Follow-up|0|||
126456078|NCT01426789|454969104|FG000|Part 1|Lack of Efficacy|2|||
126281905|NCT04614246|454320879|FG002|Overall Study|Lost to Follow-up|0|||
126281906|NCT04614246|454320880|FG003|Overall Study|Lost to Follow-up|1|||
126281907|NCT04614246|454320881|FG004|Overall Study|Lost to Follow-up|3|||
126281908|NCT04614246|454320877|FG000|Overall Study|Other reason|0|||
126281909|NCT04614246|454320878|FG001|Overall Study|Other reason|1|||
126281910|NCT04614246|454320879|FG002|Overall Study|Other reason|2|||
126456079|NCT01426789|454969105|FG001|Part 1|Lack of Efficacy|1|||
126456080|NCT01426789|454969106|FG002|Part 1|Lack of Efficacy|0|||
126456081|NCT01426789|454969107|FG003|Part 1|Lack of Efficacy|0|||
126456082|NCT01426789|454969108|FG004|Part 1|Lack of Efficacy|0|||
126456083|NCT01426789|454969109|FG005|Part 1|Lack of Efficacy|0|||
126456084|NCT01426789|454969104|FG000|Part 1|Adverse Event|3|||
126281911|NCT04614246|454320880|FG003|Overall Study|Other reason|0|||
126281912|NCT04614246|454320881|FG004|Overall Study|Other reason|0|||
126281913|NCT04614246|454320877|FG000|Overall Study|Withdrawal by Subject|4|||
126281914|NCT04614246|454320878|FG001|Overall Study|Withdrawal by Subject|2|||
126281915|NCT04614246|454320879|FG002|Overall Study|Withdrawal by Subject|4|||
126281916|NCT04614246|454320880|FG003|Overall Study|Withdrawal by Subject|3|||
126281917|NCT04614246|454320881|FG004|Overall Study|Withdrawal by Subject|4|||
126281918|NCT04614246|454320877|FG000|Overall Study|Physician Decision|0|||
126281919|NCT04614246|454320878|FG001|Overall Study|Physician Decision|2|||
126281920|NCT04614246|454320879|FG002|Overall Study|Physician Decision|1|||
126281921|NCT04614246|454320880|FG003|Overall Study|Physician Decision|0|||
126281922|NCT04614246|454320881|FG004|Overall Study|Physician Decision|0|||
126281923|NCT04614246|454320877|FG000|Overall Study|Study terminated by sponsor|10|||
126281924|NCT04614246|454320878|FG001|Overall Study|Study terminated by sponsor|15|||
126281925|NCT04614246|454320879|FG002|Overall Study|Study terminated by sponsor|12|||
126281926|NCT04614246|454320880|FG003|Overall Study|Study terminated by sponsor|13|||
126281927|NCT04614246|454320881|FG004|Overall Study|Study terminated by sponsor|9|||
126281928|NCT04614246|454320877|FG000|Overall Study|Pregnancy|2|||
126281929|NCT04614246|454320878|FG001|Overall Study|Pregnancy|0|||
126281930|NCT04614246|454320879|FG002|Overall Study|Pregnancy|1|||
126281931|NCT04614246|454320880|FG003|Overall Study|Pregnancy|0|||
126456085|NCT01426789|454969105|FG001|Part 1|Adverse Event|0|||
126456086|NCT01426789|454969106|FG002|Part 1|Adverse Event|0|||
126456087|NCT01426789|454969107|FG003|Part 1|Adverse Event|0|||
126456088|NCT01426789|454969108|FG004|Part 1|Adverse Event|0|||
126456089|NCT01426789|454969109|FG005|Part 1|Adverse Event|0|||
126281932|NCT04614246|454320881|FG004|Overall Study|Pregnancy|0|||
126456090|NCT01426789|454969104|FG000|Part 2|Protocol deviation|0|||
126456091|NCT01426789|454969105|FG001|Part 2|Protocol deviation|0|||
126364320|NCT00160563|454628279|FG002|Overall Study|Withdrawal by Subject|3|||
126364321|NCT00160563|454628277|FG000|Overall Study|Other (listed in the study report)|48|||
126364322|NCT00160563|454628278|FG001|Overall Study|Other (listed in the study report)|40|||
126364323|NCT00160563|454628279|FG002|Overall Study|Other (listed in the study report)|81|||
126364324|NCT00160563|454628277|FG000|Overall Study|Missing reason|0|||
126364325|NCT00160563|454628278|FG001|Overall Study|Missing reason|1|||
126364326|NCT00160563|454628279|FG002|Overall Study|Missing reason|0|||
126364327|NCT04157738|454628280|FG000|Overall Study|Moved out of state|0|||
126364328|NCT04157738|454628281|FG001|Overall Study|Moved out of state|2|||
126364329|NCT04157738|454628280|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
126281933|NCT00725205|454320882|FG000|Overall Study|Adverse Event|22|||
126364330|NCT04157738|454628281|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
126364331|NCT00347269|454628287|FG000|Overall Study|Lost to Follow-up|74|||
126364332|NCT00347269|454628288|FG001|Overall Study|Lost to Follow-up|65|||
126364333|NCT00347269|454628287|FG000|Overall Study|Withdrawal by Subject|18|||
126364334|NCT00347269|454628288|FG001|Overall Study|Withdrawal by Subject|38|||
126364335|NCT00347269|454628287|FG000|Overall Study|Death|2|||
126364336|NCT00347269|454628288|FG001|Overall Study|Death|3|||
126364337|NCT04102514|454628289|FG000|Overall Study|Death|3|||
126364338|NCT04102514|454628290|FG001|Overall Study|Death|0|||
126364339|NCT04102514|454628291|FG002|Overall Study|Death|0|||
126364340|NCT04102514|454628292|FG003|Overall Study|Death|0|||
126364341|NCT04102514|454628289|FG000|Overall Study|Lost to Follow-up|0|||
126364342|NCT04102514|454628290|FG001|Overall Study|Lost to Follow-up|0|||
126364343|NCT04102514|454628291|FG002|Overall Study|Lost to Follow-up|3|||
126364344|NCT04102514|454628292|FG003|Overall Study|Lost to Follow-up|0|||
126281934|NCT00725205|454320882|FG000|Overall Study|Investigator Discontinued|1|||
126281935|NCT00725205|454320882|FG000|Overall Study|Non-compliance With Protocol|14|||
126281936|NCT00725205|454320882|FG000|Overall Study|Other|8|||
126281937|NCT00725205|454320882|FG000|Overall Study|Protocol Defined Clinical Event|1|||
126281938|NCT00725205|454320882|FG000|Overall Study|Treatment Failure|41|||
126281939|NCT01680497|454320883|FG000|Overall Study|Lost to Follow-up|2|||
126281940|NCT01200069|454322873|FG000|Overall Study|Withdrawal by Subject|0|||
126281941|NCT01200069|454322874|FG001|Overall Study|Withdrawal by Subject|1|||
126281942|NCT02883049|454322875|FG000|Induction|Adverse Event|52|||
126281943|NCT02883049|454322876|FG001|Induction|Adverse Event|2|||
126281944|NCT02883049|454322877|FG002|Induction|Adverse Event|0|||
126281945|NCT02883049|454322878|FG003|Induction|Adverse Event|0|||
126364345|NCT04102514|454628289|FG000|Overall Study|Physician Decision|0|||
126364346|NCT04102514|454628290|FG001|Overall Study|Physician Decision|0|||
126364347|NCT04102514|454628291|FG002|Overall Study|Physician Decision|1|||
126364348|NCT04102514|454628292|FG003|Overall Study|Physician Decision|0|||
126364349|NCT04102514|454628289|FG000|Overall Study|Withdrawal by Subject|7|||
126364350|NCT04102514|454628290|FG001|Overall Study|Withdrawal by Subject|13|||
126364351|NCT04102514|454628291|FG002|Overall Study|Withdrawal by Subject|7|||
126364352|NCT04102514|454628292|FG003|Overall Study|Withdrawal by Subject|14|||
126364353|NCT04102514|454628289|FG000|Overall Study|Moved to longterm care facility|6|||
126364354|NCT04102514|454628290|FG001|Overall Study|Moved to longterm care facility|0|||
126364355|NCT04102514|454628291|FG002|Overall Study|Moved to longterm care facility|4|||
126364356|NCT04102514|454628292|FG003|Overall Study|Moved to longterm care facility|0|||
126364357|NCT00595075|454628314|FG000|Overall Study|Withdrawal by Subject|1|||
126364358|NCT00595075|454628315|FG001|Overall Study|Withdrawal by Subject|0|||
126364359|NCT00456365|454628316|FG000|Overall Study|Lost to Follow-up|1|||
126364360|NCT00456365|454628317|FG001|Overall Study|Lost to Follow-up|3|||
126364361|NCT00456365|454628316|FG000|Overall Study|Withdrawal by Subject|4|||
126364362|NCT00456365|454628317|FG001|Overall Study|Withdrawal by Subject|7|||
126364363|NCT00456365|454628316|FG000|Overall Study|Pregnancy|1|||
126364364|NCT00456365|454628317|FG001|Overall Study|Pregnancy|1|||
126364365|NCT00456365|454628316|FG000|Overall Study|oncologic diagnosis|1|||
126364366|NCT00456365|454628317|FG001|Overall Study|oncologic diagnosis|1|||
126364367|NCT05451329|454628318|FG000|Overall Study|Adverse Event|1|||
126364368|NCT05451329|454628319|FG001|Overall Study|Adverse Event|1|||
126364369|NCT05451329|454628320|FG002|Overall Study|Adverse Event|0|||
126364370|NCT05451329|454628318|FG000|Overall Study|Withdrawal by Subject|1|||
126364371|NCT05451329|454628319|FG001|Overall Study|Withdrawal by Subject|0|||
126364372|NCT05451329|454628320|FG002|Overall Study|Withdrawal by Subject|0|||
126364373|NCT05451329|454628318|FG000|Overall Study|Investigational Product Lot exchange|1|||
126364374|NCT05451329|454628319|FG001|Overall Study|Investigational Product Lot exchange|1|||
126364375|NCT05451329|454628320|FG002|Overall Study|Investigational Product Lot exchange|0|||
126364376|NCT02202577|454628321|FG000|Overall Study|Lost to Follow-up|6|||
126364377|NCT02202577|454628322|FG001|Overall Study|Lost to Follow-up|16|||
126364378|NCT02202577|454628321|FG000|Overall Study|Protocol Violation|7|||
126364379|NCT02202577|454628322|FG001|Overall Study|Protocol Violation|3|||
126281946|NCT02883049|454322879|FG004|Induction|Adverse Event|0|||
126281947|NCT02883049|454322880|FG005|Induction|Adverse Event|0|||
126364380|NCT00069953|454628323|FG000|Overall Study|Protocol Violation|2|||
126364381|NCT02034565|454628324|FG000|Overall Study|Adverse Event|1|||
126281948|NCT02883049|454322881|FG006|Induction|Adverse Event|0|||
126281949|NCT02883049|454322882|FG007|Induction|Adverse Event|0|||
126281950|NCT02883049|454322883|FG008|Induction|Adverse Event|0|||
126281951|NCT02883049|454322884|FG009|Induction|Adverse Event|0|||
126281952|NCT02883049|454322885|FG010|Induction|Adverse Event|0|||
126281953|NCT02883049|454322886|FG011|Induction|Adverse Event|0|||
126281954|NCT02883049|454322887|FG012|Induction|Adverse Event|0|||
126281955|NCT02883049|454322888|FG013|Induction|Adverse Event|0|||
126281956|NCT02883049|454322889|FG014|Induction|Adverse Event|0|||
126281957|NCT02883049|454322890|FG015|Induction|Adverse Event|0|||
126281958|NCT02883049|454322875|FG000|Induction|Death|76|||
126281959|NCT02883049|454322876|FG001|Induction|Death|8|||
126281960|NCT02883049|454322877|FG002|Induction|Death|0|||
126281961|NCT02883049|454322878|FG003|Induction|Death|0|||
126281962|NCT02883049|454322879|FG004|Induction|Death|0|||
126281963|NCT02883049|454322880|FG005|Induction|Death|0|||
126281964|NCT02883049|454322881|FG006|Induction|Death|0|||
126281965|NCT02883049|454322882|FG007|Induction|Death|0|||
126281966|NCT02883049|454322883|FG008|Induction|Death|0|||
126281967|NCT02883049|454322884|FG009|Induction|Death|0|||
126281968|NCT02883049|454322885|FG010|Induction|Death|0|||
126281969|NCT02883049|454322886|FG011|Induction|Death|0|||
126281970|NCT02883049|454322887|FG012|Induction|Death|0|||
126281971|NCT02883049|454322888|FG013|Induction|Death|0|||
126281972|NCT02883049|454322889|FG014|Induction|Death|0|||
126281973|NCT02883049|454322890|FG015|Induction|Death|0|||
126281974|NCT02883049|454322875|FG000|Induction|Lost to Follow-up|2|||
126281975|NCT02883049|454322876|FG001|Induction|Lost to Follow-up|0|||
126281976|NCT02883049|454322877|FG002|Induction|Lost to Follow-up|0|||
126281977|NCT02883049|454322878|FG003|Induction|Lost to Follow-up|0|||
126281978|NCT02883049|454322879|FG004|Induction|Lost to Follow-up|0|||
126281979|NCT02883049|454322880|FG005|Induction|Lost to Follow-up|0|||
126281980|NCT02883049|454322881|FG006|Induction|Lost to Follow-up|0|||
126281981|NCT02883049|454322882|FG007|Induction|Lost to Follow-up|0|||
126281982|NCT02883049|454322883|FG008|Induction|Lost to Follow-up|0|||
126281983|NCT02883049|454322884|FG009|Induction|Lost to Follow-up|0|||
126281984|NCT02883049|454322885|FG010|Induction|Lost to Follow-up|0|||
126281985|NCT02883049|454322886|FG011|Induction|Lost to Follow-up|0|||
126281986|NCT02883049|454322887|FG012|Induction|Lost to Follow-up|0|||
126281987|NCT02883049|454322888|FG013|Induction|Lost to Follow-up|0|||
126281988|NCT02883049|454322889|FG014|Induction|Lost to Follow-up|0|||
126281989|NCT02883049|454322890|FG015|Induction|Lost to Follow-up|0|||
126281990|NCT02883049|454322875|FG000|Induction|Physician Decision|1407|||
126281991|NCT02883049|454322876|FG001|Induction|Physician Decision|8|||
126281992|NCT02883049|454322877|FG002|Induction|Physician Decision|0|||
126281993|NCT02883049|454322878|FG003|Induction|Physician Decision|0|||
126281994|NCT02883049|454322879|FG004|Induction|Physician Decision|0|||
126281995|NCT02883049|454322880|FG005|Induction|Physician Decision|0|||
126281996|NCT02883049|454322881|FG006|Induction|Physician Decision|0|||
126281997|NCT02883049|454322882|FG007|Induction|Physician Decision|0|||
126281998|NCT02883049|454322883|FG008|Induction|Physician Decision|0|||
126281999|NCT02883049|454322884|FG009|Induction|Physician Decision|0|||
126282000|NCT02883049|454322885|FG010|Induction|Physician Decision|0|||
126282001|NCT02883049|454322886|FG011|Induction|Physician Decision|0|||
126282002|NCT02883049|454322887|FG012|Induction|Physician Decision|0|||
126282003|NCT02883049|454322888|FG013|Induction|Physician Decision|0|||
126282004|NCT02883049|454322889|FG014|Induction|Physician Decision|0|||
126282005|NCT02883049|454322890|FG015|Induction|Physician Decision|0|||
126282006|NCT02883049|454322875|FG000|Induction|Protocol Violation|6|||
126282007|NCT02883049|454322876|FG001|Induction|Protocol Violation|0|||
126282008|NCT02883049|454322877|FG002|Induction|Protocol Violation|0|||
126282009|NCT02883049|454322878|FG003|Induction|Protocol Violation|0|||
126282010|NCT02883049|454322879|FG004|Induction|Protocol Violation|0|||
126282011|NCT02883049|454322880|FG005|Induction|Protocol Violation|0|||
126282012|NCT02883049|454322881|FG006|Induction|Protocol Violation|0|||
126282013|NCT02883049|454322882|FG007|Induction|Protocol Violation|0|||
126282014|NCT02883049|454322883|FG008|Induction|Protocol Violation|0|||
126282015|NCT02883049|454322884|FG009|Induction|Protocol Violation|0|||
126282016|NCT02883049|454322885|FG010|Induction|Protocol Violation|0|||
126282017|NCT02883049|454322886|FG011|Induction|Protocol Violation|0|||
126282018|NCT02883049|454322887|FG012|Induction|Protocol Violation|0|||
126282019|NCT02883049|454322888|FG013|Induction|Protocol Violation|0|||
126282020|NCT02883049|454322889|FG014|Induction|Protocol Violation|0|||
126282021|NCT02883049|454322890|FG015|Induction|Protocol Violation|0|||
126282022|NCT02883049|454322875|FG000|Induction|Withdrawal by Subject|6|||
126282023|NCT02883049|454322876|FG001|Induction|Withdrawal by Subject|0|||
126282024|NCT02883049|454322877|FG002|Induction|Withdrawal by Subject|0|||
126282025|NCT02883049|454322878|FG003|Induction|Withdrawal by Subject|0|||
126282026|NCT02883049|454322879|FG004|Induction|Withdrawal by Subject|0|||
126282027|NCT02883049|454322880|FG005|Induction|Withdrawal by Subject|0|||
126282028|NCT02883049|454322881|FG006|Induction|Withdrawal by Subject|0|||
126282029|NCT02883049|454322882|FG007|Induction|Withdrawal by Subject|0|||
126282030|NCT02883049|454322883|FG008|Induction|Withdrawal by Subject|0|||
126282031|NCT02883049|454322884|FG009|Induction|Withdrawal by Subject|0|||
126282032|NCT02883049|454322885|FG010|Induction|Withdrawal by Subject|0|||
126282033|NCT02883049|454322886|FG011|Induction|Withdrawal by Subject|0|||
126282034|NCT02883049|454322887|FG012|Induction|Withdrawal by Subject|0|||
126282035|NCT02883049|454322888|FG013|Induction|Withdrawal by Subject|0|||
126282036|NCT02883049|454322889|FG014|Induction|Withdrawal by Subject|0|||
126282037|NCT02883049|454322890|FG015|Induction|Withdrawal by Subject|0|||
126282038|NCT02883049|454322875|FG000|Induction|Ineligible|35|||
126282039|NCT02883049|454322876|FG001|Induction|Ineligible|1|||
126282040|NCT02883049|454322877|FG002|Induction|Ineligible|0|||
126282041|NCT02883049|454322878|FG003|Induction|Ineligible|0|||
126282042|NCT02883049|454322879|FG004|Induction|Ineligible|0|||
126282043|NCT02883049|454322880|FG005|Induction|Ineligible|0|||
126282044|NCT02883049|454322881|FG006|Induction|Ineligible|0|||
126282045|NCT02883049|454322882|FG007|Induction|Ineligible|0|||
126282046|NCT02883049|454322883|FG008|Induction|Ineligible|0|||
126282047|NCT02883049|454322884|FG009|Induction|Ineligible|0|||
126282048|NCT02883049|454322885|FG010|Induction|Ineligible|0|||
126282049|NCT02883049|454322886|FG011|Induction|Ineligible|0|||
126282050|NCT02883049|454322887|FG012|Induction|Ineligible|0|||
126282051|NCT02883049|454322888|FG013|Induction|Ineligible|0|||
126282052|NCT02883049|454322889|FG014|Induction|Ineligible|0|||
126282053|NCT02883049|454322890|FG015|Induction|Ineligible|0|||
126282054|NCT02883049|454322875|FG000|Induction|Refusal of further protocol therapy|466|||
126282055|NCT02883049|454322876|FG001|Induction|Refusal of further protocol therapy|2|||
126282056|NCT02883049|454322877|FG002|Induction|Refusal of further protocol therapy|0|||
126282057|NCT02883049|454322878|FG003|Induction|Refusal of further protocol therapy|0|||
126282058|NCT02883049|454322879|FG004|Induction|Refusal of further protocol therapy|0|||
126282059|NCT02883049|454322880|FG005|Induction|Refusal of further protocol therapy|0|||
126282060|NCT02883049|454322881|FG006|Induction|Refusal of further protocol therapy|0|||
126282061|NCT02883049|454322882|FG007|Induction|Refusal of further protocol therapy|0|||
126282062|NCT02883049|454322883|FG008|Induction|Refusal of further protocol therapy|0|||
126282063|NCT02883049|454322884|FG009|Induction|Refusal of further protocol therapy|0|||
126282064|NCT02883049|454322885|FG010|Induction|Refusal of further protocol therapy|0|||
126282065|NCT02883049|454322886|FG011|Induction|Refusal of further protocol therapy|0|||
126282066|NCT02883049|454322887|FG012|Induction|Refusal of further protocol therapy|0|||
126282067|NCT02883049|454322888|FG013|Induction|Refusal of further protocol therapy|0|||
126282068|NCT02883049|454322889|FG014|Induction|Refusal of further protocol therapy|0|||
126282069|NCT02883049|454322890|FG015|Induction|Refusal of further protocol therapy|0|||
126282070|NCT02883049|454322875|FG000|Induction|Identified as Ph+ patients|279|||
126282071|NCT02883049|454322876|FG001|Induction|Identified as Ph+ patients|1|||
126282072|NCT02883049|454322877|FG002|Induction|Identified as Ph+ patients|0|||
126282073|NCT02883049|454322878|FG003|Induction|Identified as Ph+ patients|0|||
126282074|NCT02883049|454322879|FG004|Induction|Identified as Ph+ patients|0|||
126282075|NCT02883049|454322880|FG005|Induction|Identified as Ph+ patients|0|||
126282076|NCT02883049|454322881|FG006|Induction|Identified as Ph+ patients|0|||
126282077|NCT02883049|454322882|FG007|Induction|Identified as Ph+ patients|0|||
126282078|NCT02883049|454322883|FG008|Induction|Identified as Ph+ patients|0|||
126282079|NCT02883049|454322884|FG009|Induction|Identified as Ph+ patients|0|||
126282080|NCT02883049|454322885|FG010|Induction|Identified as Ph+ patients|0|||
126282081|NCT02883049|454322886|FG011|Induction|Identified as Ph+ patients|0|||
126282082|NCT02883049|454322887|FG012|Induction|Identified as Ph+ patients|0|||
126282083|NCT02883049|454322888|FG013|Induction|Identified as Ph+ patients|0|||
126282084|NCT02883049|454322889|FG014|Induction|Identified as Ph+ patients|0|||
126282085|NCT02883049|454322890|FG015|Induction|Identified as Ph+ patients|0|||
126282086|NCT02883049|454322875|FG000|Induction|M3 Marrow at Day29|8|||
126282087|NCT02883049|454322876|FG001|Induction|M3 Marrow at Day29|1|||
126282088|NCT02883049|454322877|FG002|Induction|M3 Marrow at Day29|0|||
126282089|NCT02883049|454322878|FG003|Induction|M3 Marrow at Day29|0|||
126282090|NCT02883049|454322879|FG004|Induction|M3 Marrow at Day29|0|||
126282091|NCT02883049|454322880|FG005|Induction|M3 Marrow at Day29|0|||
126282092|NCT02883049|454322881|FG006|Induction|M3 Marrow at Day29|0|||
126282093|NCT02883049|454322882|FG007|Induction|M3 Marrow at Day29|0|||
126282094|NCT02883049|454322883|FG008|Induction|M3 Marrow at Day29|0|||
126282095|NCT02883049|454322884|FG009|Induction|M3 Marrow at Day29|0|||
126282096|NCT02883049|454322885|FG010|Induction|M3 Marrow at Day29|0|||
126282097|NCT02883049|454322886|FG011|Induction|M3 Marrow at Day29|0|||
126282098|NCT02883049|454322887|FG012|Induction|M3 Marrow at Day29|0|||
126282099|NCT02883049|454322888|FG013|Induction|M3 Marrow at Day29|0|||
126282100|NCT02883049|454322889|FG014|Induction|M3 Marrow at Day29|0|||
126282101|NCT02883049|454322890|FG015|Induction|M3 Marrow at Day29|0|||
126282102|NCT02883049|454322875|FG000|Induction|Inevaluable|33|||
126364382|NCT02034565|454628325|FG001|Overall Study|Adverse Event|0|||
126282103|NCT02883049|454322876|FG001|Induction|Inevaluable|1|||
126282104|NCT02883049|454322877|FG002|Induction|Inevaluable|0|||
126282105|NCT02883049|454322878|FG003|Induction|Inevaluable|0|||
126282106|NCT02883049|454322879|FG004|Induction|Inevaluable|0|||
126364383|NCT00113373|454628326|FG000|Overall Study|Ineligible: wrong primary|1|||
126282107|NCT02883049|454322880|FG005|Induction|Inevaluable|0|||
126282108|NCT02883049|454322881|FG006|Induction|Inevaluable|0|||
126282109|NCT02883049|454322882|FG007|Induction|Inevaluable|0|||
126364384|NCT00113373|454628326|FG000|Overall Study|Ineligible: second primary|1|||
126364385|NCT00113373|454628326|FG000|Overall Study|Never Treated|1|||
126364386|NCT00829868|454628327|FG000|Washout|Physician Decision|1|||
126364387|NCT00829868|454628328|FG001|Washout|Physician Decision|0|||
126364388|NCT02799043|454628330|FG000|Overall Study|Adverse Event|0|||
126364389|NCT02799043|454628331|FG001|Overall Study|Adverse Event|1|||
126364390|NCT02799043|454628330|FG000|Overall Study|Death|1|||
126364391|NCT02799043|454628331|FG001|Overall Study|Death|1|||
126364392|NCT02799043|454628330|FG000|Overall Study|Lost to Follow-up|3|||
126364393|NCT02799043|454628331|FG001|Overall Study|Lost to Follow-up|6|||
126364394|NCT02799043|454628330|FG000|Overall Study|Withdrawal by Subject|4|||
126364395|NCT02799043|454628331|FG001|Overall Study|Withdrawal by Subject|4|||
126364396|NCT02799043|454628330|FG000|Overall Study|Moved to different country|0|||
126548943|NCT04537897|455303907|FG005|Overall Study|Adverse Event|0|||
126548944|NCT04537897|455303908|FG006|Overall Study|Adverse Event|0|||
126364397|NCT02799043|454628331|FG001|Overall Study|Moved to different country|1|||
126364398|NCT02799043|454628330|FG000|Overall Study|Trial Screen Failure|1|||
126364399|NCT02799043|454628331|FG001|Overall Study|Trial Screen Failure|0|||
126364400|NCT02799043|454628330|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
126364401|NCT02799043|454628331|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
126364402|NCT06091956|454628332|FG000|Overall Study|Withdrawal by Subject|1|||
126364403|NCT06091956|454628332|FG000|Overall Study|Complicating Disease|1|||
126364404|NCT00803049|454628347|FG000|Overall Study|Adverse Event|21|||
126282110|NCT02883049|454322883|FG008|Induction|Inevaluable|0|||
126282111|NCT02883049|454322884|FG009|Induction|Inevaluable|0|||
126282112|NCT02883049|454322885|FG010|Induction|Inevaluable|0|||
126282113|NCT02883049|454322886|FG011|Induction|Inevaluable|0|||
126282114|NCT02883049|454322887|FG012|Induction|Inevaluable|0|||
126282115|NCT02883049|454322888|FG013|Induction|Inevaluable|0|||
126282116|NCT02883049|454322889|FG014|Induction|Inevaluable|0|||
126282117|NCT02883049|454322890|FG015|Induction|Inevaluable|0|||
126282118|NCT02883049|454322875|FG000|Induction|Identified as VHR at end of Induction|244|||
126282119|NCT02883049|454322876|FG001|Induction|Identified as VHR at end of Induction|0|||
126282120|NCT02883049|454322877|FG002|Induction|Identified as VHR at end of Induction|0|||
126282121|NCT02883049|454322878|FG003|Induction|Identified as VHR at end of Induction|0|||
126282122|NCT02883049|454322879|FG004|Induction|Identified as VHR at end of Induction|0|||
126282123|NCT02883049|454322880|FG005|Induction|Identified as VHR at end of Induction|0|||
126282124|NCT02883049|454322881|FG006|Induction|Identified as VHR at end of Induction|0|||
126282125|NCT02883049|454322882|FG007|Induction|Identified as VHR at end of Induction|0|||
126282126|NCT02883049|454322883|FG008|Induction|Identified as VHR at end of Induction|0|||
126364405|NCT00803049|454628348|FG001|Overall Study|Adverse Event|33|||
126282127|NCT02883049|454322884|FG009|Induction|Identified as VHR at end of Induction|0|||
126282128|NCT02883049|454322885|FG010|Induction|Identified as VHR at end of Induction|0|||
126364406|NCT00803049|454628349|FG002|Overall Study|Adverse Event|13|||
126364407|NCT00803049|454628350|FG003|Overall Study|Adverse Event|27|||
126364408|NCT00803049|454628347|FG000|Overall Study|Lack of Efficacy|10|||
126364409|NCT00803049|454628348|FG001|Overall Study|Lack of Efficacy|19|||
126364410|NCT00803049|454628349|FG002|Overall Study|Lack of Efficacy|6|||
126364411|NCT00803049|454628350|FG003|Overall Study|Lack of Efficacy|13|||
126364412|NCT00803049|454628347|FG000|Overall Study|Lost to Follow-up|0|||
126364413|NCT00803049|454628348|FG001|Overall Study|Lost to Follow-up|2|||
126364414|NCT00803049|454628349|FG002|Overall Study|Lost to Follow-up|0|||
126364415|NCT00803049|454628350|FG003|Overall Study|Lost to Follow-up|3|||
126364416|NCT00803049|454628347|FG000|Overall Study|Death|2|||
126364417|NCT00803049|454628348|FG001|Overall Study|Death|1|||
126364418|NCT00803049|454628349|FG002|Overall Study|Death|0|||
126364419|NCT00803049|454628350|FG003|Overall Study|Death|2|||
126364420|NCT00803049|454628347|FG000|Overall Study|Progressive Disease|6|||
126364421|NCT00803049|454628348|FG001|Overall Study|Progressive Disease|10|||
126364422|NCT00803049|454628349|FG002|Overall Study|Progressive Disease|6|||
126364423|NCT00803049|454628350|FG003|Overall Study|Progressive Disease|6|||
126364424|NCT00803049|454628347|FG000|Overall Study|Withdrawal by Subject|19|||
126364425|NCT00803049|454628348|FG001|Overall Study|Withdrawal by Subject|43|||
126548945|NCT04537897|455303909|FG007|Overall Study|Adverse Event|0|||
126548946|NCT04537897|455303910|FG008|Overall Study|Adverse Event|0|||
126282129|NCT02883049|454322886|FG011|Induction|Identified as VHR at end of Induction|0|||
126282130|NCT02883049|454322887|FG012|Induction|Identified as VHR at end of Induction|0|||
126364426|NCT00803049|454628349|FG002|Overall Study|Withdrawal by Subject|16|||
126364427|NCT00803049|454628350|FG003|Overall Study|Withdrawal by Subject|44|||
126364428|NCT00803049|454628347|FG000|Overall Study|Protocol Violation|0|||
126364429|NCT00803049|454628348|FG001|Overall Study|Protocol Violation|1|||
126364430|NCT00803049|454628349|FG002|Overall Study|Protocol Violation|1|||
126364431|NCT00803049|454628350|FG003|Overall Study|Protocol Violation|0|||
126364432|NCT00803049|454628347|FG000|Overall Study|Randomized and Not Treated|0|||
126364433|NCT00803049|454628348|FG001|Overall Study|Randomized and Not Treated|0|||
126364434|NCT00803049|454628349|FG002|Overall Study|Randomized and Not Treated|0|||
126364435|NCT00803049|454628350|FG003|Overall Study|Randomized and Not Treated|2|||
126364436|NCT00803049|454628347|FG000|Overall Study|Other than Specified Above|3|||
126548947|NCT04537897|455303902|FG000|Overall Study|Withdrawal by Subject|0|||
126282131|NCT02883049|454322888|FG013|Induction|Identified as VHR at end of Induction|0|||
126282132|NCT02883049|454322889|FG014|Induction|Identified as VHR at end of Induction|0|||
126282133|NCT02883049|454322890|FG015|Induction|Identified as VHR at end of Induction|0|||
126282134|NCT02883049|454322875|FG000|Induction|Moved to another non-COG institution|3|||
126282135|NCT02883049|454322876|FG001|Induction|Moved to another non-COG institution|0|||
126282136|NCT02883049|454322877|FG002|Induction|Moved to another non-COG institution|0|||
126282137|NCT02883049|454322878|FG003|Induction|Moved to another non-COG institution|0|||
126282138|NCT02883049|454322879|FG004|Induction|Moved to another non-COG institution|0|||
126282139|NCT02883049|454322880|FG005|Induction|Moved to another non-COG institution|0|||
126282140|NCT02883049|454322881|FG006|Induction|Moved to another non-COG institution|0|||
126282141|NCT02883049|454322882|FG007|Induction|Moved to another non-COG institution|0|||
126282142|NCT02883049|454322883|FG008|Induction|Moved to another non-COG institution|0|||
126282143|NCT02883049|454322884|FG009|Induction|Moved to another non-COG institution|0|||
126282144|NCT02883049|454322885|FG010|Induction|Moved to another non-COG institution|0|||
126282145|NCT02883049|454322886|FG011|Induction|Moved to another non-COG institution|0|||
126282146|NCT02883049|454322887|FG012|Induction|Moved to another non-COG institution|0|||
126282147|NCT02883049|454322888|FG013|Induction|Moved to another non-COG institution|0|||
126282148|NCT02883049|454322889|FG014|Induction|Moved to another non-COG institution|0|||
126282149|NCT02883049|454322890|FG015|Induction|Moved to another non-COG institution|0|||
126282150|NCT02883049|454322875|FG000|Induction|Randomization closed|41|||
126282151|NCT02883049|454322876|FG001|Induction|Randomization closed|0|||
126282152|NCT02883049|454322877|FG002|Induction|Randomization closed|0|||
126282153|NCT02883049|454322878|FG003|Induction|Randomization closed|0|||
126282154|NCT02883049|454322879|FG004|Induction|Randomization closed|0|||
126282155|NCT02883049|454322880|FG005|Induction|Randomization closed|0|||
126282156|NCT02883049|454322881|FG006|Induction|Randomization closed|0|||
126282157|NCT02883049|454322882|FG007|Induction|Randomization closed|0|||
126282158|NCT02883049|454322883|FG008|Induction|Randomization closed|0|||
126282159|NCT02883049|454322884|FG009|Induction|Randomization closed|0|||
126282160|NCT02883049|454322885|FG010|Induction|Randomization closed|0|||
126282161|NCT02883049|454322886|FG011|Induction|Randomization closed|0|||
126548948|NCT04537897|455303903|FG001|Overall Study|Withdrawal by Subject|1|||
126548949|NCT04537897|455303904|FG002|Overall Study|Withdrawal by Subject|0|||
126548950|NCT04537897|455303905|FG003|Overall Study|Withdrawal by Subject|0|||
126548951|NCT04537897|455303906|FG004|Overall Study|Withdrawal by Subject|0|||
126548952|NCT04537897|455303907|FG005|Overall Study|Withdrawal by Subject|0|||
126548953|NCT04537897|455303908|FG006|Overall Study|Withdrawal by Subject|0|||
126548954|NCT04537897|455303909|FG007|Overall Study|Withdrawal by Subject|0|||
126548955|NCT04537897|455303910|FG008|Overall Study|Withdrawal by Subject|0|||
126548956|NCT00197028|455303914|FG000|Overall Study|Adverse Event|2|||
126548957|NCT00197028|455303915|FG001|Overall Study|Adverse Event|2|||
126548958|NCT00197028|455303914|FG000|Overall Study|Protocol Violation|2|||
126548959|NCT00197028|455303915|FG001|Overall Study|Protocol Violation|1|||
126548960|NCT00197028|455303914|FG000|Overall Study|Withdrawal by Subject|8|||
126548961|NCT00197028|455303915|FG001|Overall Study|Withdrawal by Subject|12|||
126548962|NCT00197028|455303914|FG000|Overall Study|Lost to Follow-up|1|||
126282162|NCT02883049|454322887|FG012|Induction|Randomization closed|0|||
126282163|NCT02883049|454322888|FG013|Induction|Randomization closed|0|||
126282164|NCT02883049|454322889|FG014|Induction|Randomization closed|0|||
126282165|NCT02883049|454322890|FG015|Induction|Randomization closed|0|||
126282166|NCT02883049|454322875|FG000|Induction|MRD negative|36|||
126282167|NCT02883049|454322876|FG001|Induction|MRD negative|0|||
126282168|NCT02883049|454322877|FG002|Induction|MRD negative|0|||
126282169|NCT02883049|454322878|FG003|Induction|MRD negative|0|||
126282170|NCT02883049|454322879|FG004|Induction|MRD negative|0|||
126282171|NCT02883049|454322880|FG005|Induction|MRD negative|0|||
126282172|NCT02883049|454322881|FG006|Induction|MRD negative|0|||
126282173|NCT02883049|454322882|FG007|Induction|MRD negative|0|||
126282174|NCT02883049|454322883|FG008|Induction|MRD negative|0|||
126282175|NCT02883049|454322884|FG009|Induction|MRD negative|0|||
126282176|NCT02883049|454322885|FG010|Induction|MRD negative|0|||
126282177|NCT02883049|454322886|FG011|Induction|MRD negative|0|||
126282178|NCT02883049|454322887|FG012|Induction|MRD negative|0|||
126282179|NCT02883049|454322888|FG013|Induction|MRD negative|0|||
126282180|NCT02883049|454322889|FG014|Induction|MRD negative|0|||
126282181|NCT02883049|454322890|FG015|Induction|MRD negative|0|||
126282182|NCT02883049|454322875|FG000|Induction|Identified as HR patients|165|||
126282183|NCT02883049|454322876|FG001|Induction|Identified as HR patients|0|||
126282184|NCT02883049|454322877|FG002|Induction|Identified as HR patients|0|||
126282185|NCT02883049|454322878|FG003|Induction|Identified as HR patients|0|||
126282186|NCT02883049|454322879|FG004|Induction|Identified as HR patients|0|||
126282187|NCT02883049|454322880|FG005|Induction|Identified as HR patients|0|||
126282188|NCT02883049|454322881|FG006|Induction|Identified as HR patients|0|||
126282189|NCT02883049|454322882|FG007|Induction|Identified as HR patients|0|||
126282190|NCT02883049|454322883|FG008|Induction|Identified as HR patients|0|||
126548963|NCT00197028|455303915|FG001|Overall Study|Lost to Follow-up|0|||
126548964|NCT00197028|455303914|FG000|Overall Study|Other|3|||
126282191|NCT02883049|454322884|FG009|Induction|Identified as HR patients|0|||
126282192|NCT02883049|454322885|FG010|Induction|Identified as HR patients|0|||
126282193|NCT02883049|454322886|FG011|Induction|Identified as HR patients|0|||
126282194|NCT02883049|454322887|FG012|Induction|Identified as HR patients|0|||
126282195|NCT02883049|454322888|FG013|Induction|Identified as HR patients|0|||
126282196|NCT02883049|454322889|FG014|Induction|Identified as HR patients|0|||
126282197|NCT02883049|454322890|FG015|Induction|Identified as HR patients|0|||
126282198|NCT02883049|454322875|FG000|Induction|Developed SMN|0|||
126282199|NCT02883049|454322876|FG001|Induction|Developed SMN|1|||
126282200|NCT02883049|454322877|FG002|Induction|Developed SMN|0|||
126282201|NCT02883049|454322878|FG003|Induction|Developed SMN|0|||
126282202|NCT02883049|454322879|FG004|Induction|Developed SMN|0|||
126282203|NCT02883049|454322880|FG005|Induction|Developed SMN|0|||
126282204|NCT02883049|454322881|FG006|Induction|Developed SMN|0|||
126282205|NCT02883049|454322882|FG007|Induction|Developed SMN|0|||
126282206|NCT02883049|454322883|FG008|Induction|Developed SMN|0|||
126282207|NCT02883049|454322884|FG009|Induction|Developed SMN|0|||
126282208|NCT02883049|454322885|FG010|Induction|Developed SMN|0|||
126282209|NCT02883049|454322886|FG011|Induction|Developed SMN|0|||
126282210|NCT02883049|454322887|FG012|Induction|Developed SMN|0|||
126282211|NCT02883049|454322888|FG013|Induction|Developed SMN|0|||
126282212|NCT02883049|454322889|FG014|Induction|Developed SMN|0|||
126282213|NCT02883049|454322890|FG015|Induction|Developed SMN|0|||
126282214|NCT02883049|454322875|FG000|Induction|Enrolled onto another COG study|72|||
126282215|NCT02883049|454322876|FG001|Induction|Enrolled onto another COG study|0|||
126282216|NCT02883049|454322877|FG002|Induction|Enrolled onto another COG study|0|||
126282217|NCT02883049|454322878|FG003|Induction|Enrolled onto another COG study|0|||
126282218|NCT02883049|454322879|FG004|Induction|Enrolled onto another COG study|0|||
126282219|NCT02883049|454322880|FG005|Induction|Enrolled onto another COG study|0|||
126282220|NCT02883049|454322881|FG006|Induction|Enrolled onto another COG study|0|||
126282221|NCT02883049|454322882|FG007|Induction|Enrolled onto another COG study|0|||
126282222|NCT02883049|454322883|FG008|Induction|Enrolled onto another COG study|0|||
126282223|NCT02883049|454322884|FG009|Induction|Enrolled onto another COG study|0|||
126282224|NCT02883049|454322885|FG010|Induction|Enrolled onto another COG study|0|||
126282225|NCT02883049|454322886|FG011|Induction|Enrolled onto another COG study|0|||
126282226|NCT02883049|454322887|FG012|Induction|Enrolled onto another COG study|0|||
126282227|NCT02883049|454322888|FG013|Induction|Enrolled onto another COG study|0|||
126282228|NCT02883049|454322889|FG014|Induction|Enrolled onto another COG study|0|||
126282229|NCT02883049|454322890|FG015|Induction|Enrolled onto another COG study|0|||
126282230|NCT02883049|454322875|FG000|Induction|Incomplete induction data|17|||
126282231|NCT02883049|454322876|FG001|Induction|Incomplete induction data|0|||
126282232|NCT02883049|454322877|FG002|Induction|Incomplete induction data|0|||
126282233|NCT02883049|454322878|FG003|Induction|Incomplete induction data|0|||
126282234|NCT02883049|454322879|FG004|Induction|Incomplete induction data|0|||
126282235|NCT02883049|454322880|FG005|Induction|Incomplete induction data|0|||
126282236|NCT02883049|454322881|FG006|Induction|Incomplete induction data|0|||
126282237|NCT02883049|454322882|FG007|Induction|Incomplete induction data|0|||
126282238|NCT02883049|454322883|FG008|Induction|Incomplete induction data|0|||
126282239|NCT02883049|454322884|FG009|Induction|Incomplete induction data|0|||
126282240|NCT02883049|454322885|FG010|Induction|Incomplete induction data|0|||
126282241|NCT02883049|454322886|FG011|Induction|Incomplete induction data|0|||
126282242|NCT02883049|454322887|FG012|Induction|Incomplete induction data|0|||
126282243|NCT02883049|454322888|FG013|Induction|Incomplete induction data|0|||
126282244|NCT02883049|454322889|FG014|Induction|Incomplete induction data|0|||
126282245|NCT02883049|454322890|FG015|Induction|Incomplete induction data|0|||
126282246|NCT02883049|454322875|FG000|Post Induction|Adverse Event|0|||
126282247|NCT02883049|454322876|FG001|Post Induction|Adverse Event|0|||
126282248|NCT02883049|454322877|FG002|Post Induction|Adverse Event|0|||
126282249|NCT02883049|454322878|FG003|Post Induction|Adverse Event|7|||
126282250|NCT02883049|454322879|FG004|Post Induction|Adverse Event|8|||
126282251|NCT02883049|454322880|FG005|Post Induction|Adverse Event|3|||
126282252|NCT02883049|454322881|FG006|Post Induction|Adverse Event|4|||
126282253|NCT02883049|454322882|FG007|Post Induction|Adverse Event|5|||
126282254|NCT02883049|454322883|FG008|Post Induction|Adverse Event|6|||
126282255|NCT02883049|454322884|FG009|Post Induction|Adverse Event|7|||
126456092|NCT01426789|454969106|FG002|Part 2|Protocol deviation|1|||
126282256|NCT02883049|454322885|FG010|Post Induction|Adverse Event|2|||
126282257|NCT02883049|454322886|FG011|Post Induction|Adverse Event|2|||
126282258|NCT02883049|454322887|FG012|Post Induction|Adverse Event|0|||
126282259|NCT02883049|454322888|FG013|Post Induction|Adverse Event|0|||
126282260|NCT02883049|454322889|FG014|Post Induction|Adverse Event|5|||
126282261|NCT02883049|454322890|FG015|Post Induction|Adverse Event|2|||
126282262|NCT02883049|454322875|FG000|Post Induction|Death|0|||
126282263|NCT02883049|454322876|FG001|Post Induction|Death|0|||
126282264|NCT02883049|454322877|FG002|Post Induction|Death|0|||
126282265|NCT02883049|454322878|FG003|Post Induction|Death|9|||
126282266|NCT02883049|454322879|FG004|Post Induction|Death|9|||
126282267|NCT02883049|454322880|FG005|Post Induction|Death|0|||
126282268|NCT02883049|454322881|FG006|Post Induction|Death|1|||
126456093|NCT01426789|454969107|FG003|Part 2|Protocol deviation|0|||
126282269|NCT02883049|454322882|FG007|Post Induction|Death|6|||
126282270|NCT02883049|454322883|FG008|Post Induction|Death|5|||
126282271|NCT02883049|454322884|FG009|Post Induction|Death|3|||
126282272|NCT02883049|454322885|FG010|Post Induction|Death|1|||
126282273|NCT02883049|454322886|FG011|Post Induction|Death|0|||
126282274|NCT02883049|454322887|FG012|Post Induction|Death|1|||
126282275|NCT02883049|454322888|FG013|Post Induction|Death|1|||
126282276|NCT02883049|454322889|FG014|Post Induction|Death|10|||
126282277|NCT02883049|454322890|FG015|Post Induction|Death|2|||
126282278|NCT02883049|454322875|FG000|Post Induction|Lost to Follow-up|0|||
126282279|NCT02883049|454322876|FG001|Post Induction|Lost to Follow-up|0|||
126282280|NCT02883049|454322877|FG002|Post Induction|Lost to Follow-up|0|||
126282281|NCT02883049|454322878|FG003|Post Induction|Lost to Follow-up|0|||
126282282|NCT02883049|454322879|FG004|Post Induction|Lost to Follow-up|1|||
126456094|NCT01426789|454969108|FG004|Part 2|Protocol deviation|0|||
126282283|NCT02883049|454322880|FG005|Post Induction|Lost to Follow-up|1|||
126282284|NCT02883049|454322881|FG006|Post Induction|Lost to Follow-up|0|||
126282285|NCT02883049|454322882|FG007|Post Induction|Lost to Follow-up|0|||
126282286|NCT02883049|454322883|FG008|Post Induction|Lost to Follow-up|3|||
126282287|NCT02883049|454322884|FG009|Post Induction|Lost to Follow-up|0|||
126282288|NCT02883049|454322885|FG010|Post Induction|Lost to Follow-up|1|||
126282289|NCT02883049|454322886|FG011|Post Induction|Lost to Follow-up|0|||
126282290|NCT02883049|454322887|FG012|Post Induction|Lost to Follow-up|0|||
126282291|NCT02883049|454322888|FG013|Post Induction|Lost to Follow-up|0|||
126282292|NCT02883049|454322889|FG014|Post Induction|Lost to Follow-up|0|||
126282293|NCT02883049|454322890|FG015|Post Induction|Lost to Follow-up|0|||
126282294|NCT02883049|454322875|FG000|Post Induction|Physician Decision|0|||
126282295|NCT02883049|454322876|FG001|Post Induction|Physician Decision|0|||
126282296|NCT02883049|454322877|FG002|Post Induction|Physician Decision|0|||
126282297|NCT02883049|454322878|FG003|Post Induction|Physician Decision|27|||
126282298|NCT02883049|454322879|FG004|Post Induction|Physician Decision|27|||
126282299|NCT02883049|454322880|FG005|Post Induction|Physician Decision|23|||
126282300|NCT02883049|454322881|FG006|Post Induction|Physician Decision|30|||
126282301|NCT02883049|454322882|FG007|Post Induction|Physician Decision|56|||
126282302|NCT02883049|454322883|FG008|Post Induction|Physician Decision|85|||
126282303|NCT02883049|454322884|FG009|Post Induction|Physician Decision|12|||
126282304|NCT02883049|454322885|FG010|Post Induction|Physician Decision|5|||
126282305|NCT02883049|454322886|FG011|Post Induction|Physician Decision|14|||
126282306|NCT02883049|454322887|FG012|Post Induction|Physician Decision|1|||
126282307|NCT02883049|454322888|FG013|Post Induction|Physician Decision|11|||
126282308|NCT02883049|454322889|FG014|Post Induction|Physician Decision|19|||
126282309|NCT02883049|454322890|FG015|Post Induction|Physician Decision|5|||
126456095|NCT01426789|454969109|FG005|Part 2|Protocol deviation|0|||
126456096|NCT01426789|454969104|FG000|Part 2|Death|0|||
126456097|NCT01426789|454969105|FG001|Part 2|Death|0|||
126456098|NCT01426789|454969106|FG002|Part 2|Death|1|||
126456099|NCT01426789|454969107|FG003|Part 2|Death|0|||
126456100|NCT01426789|454969108|FG004|Part 2|Death|1|||
126456101|NCT01426789|454969109|FG005|Part 2|Death|0|||
126456102|NCT01426789|454969104|FG000|Part 2|Administrative problems|0|||
126456103|NCT01426789|454969105|FG001|Part 2|Administrative problems|0|||
126456104|NCT01426789|454969106|FG002|Part 2|Administrative problems|2|||
126456105|NCT01426789|454969107|FG003|Part 2|Administrative problems|0|||
126456106|NCT01426789|454969108|FG004|Part 2|Administrative problems|1|||
126456107|NCT01426789|454969109|FG005|Part 2|Administrative problems|0|||
126456108|NCT01426789|454969104|FG000|Part 2|Lost to Follow-up|0|||
126456109|NCT01426789|454969105|FG001|Part 2|Lost to Follow-up|0|||
126456110|NCT01426789|454969106|FG002|Part 2|Lost to Follow-up|4|||
126708918|NCT00849693|455887889|FG001|Extension Phase|Adverse Event|6|||
126282310|NCT02883049|454322875|FG000|Post Induction|Protocol Violation|0|||
126282311|NCT02883049|454322876|FG001|Post Induction|Protocol Violation|0|||
126282312|NCT02883049|454322877|FG002|Post Induction|Protocol Violation|0|||
126282313|NCT02883049|454322878|FG003|Post Induction|Protocol Violation|0|||
126282314|NCT02883049|454322879|FG004|Post Induction|Protocol Violation|0|||
126282315|NCT02883049|454322880|FG005|Post Induction|Protocol Violation|0|||
126282316|NCT02883049|454322881|FG006|Post Induction|Protocol Violation|0|||
126282317|NCT02883049|454322882|FG007|Post Induction|Protocol Violation|1|||
126282318|NCT02883049|454322883|FG008|Post Induction|Protocol Violation|0|||
126282319|NCT02883049|454322884|FG009|Post Induction|Protocol Violation|0|||
126456111|NCT01426789|454969107|FG003|Part 2|Lost to Follow-up|0|||
126456112|NCT01426789|454969108|FG004|Part 2|Lost to Follow-up|1|||
126282320|NCT02883049|454322885|FG010|Post Induction|Protocol Violation|0|||
126456113|NCT01426789|454969109|FG005|Part 2|Lost to Follow-up|0|||
126456114|NCT01426789|454969104|FG000|Part 2|Withdrawal by Subject|0|||
126282321|NCT02883049|454322886|FG011|Post Induction|Protocol Violation|0|||
126282322|NCT02883049|454322887|FG012|Post Induction|Protocol Violation|0|||
126282323|NCT02883049|454322888|FG013|Post Induction|Protocol Violation|0|||
126282324|NCT02883049|454322889|FG014|Post Induction|Protocol Violation|0|||
126282325|NCT02883049|454322890|FG015|Post Induction|Protocol Violation|0|||
126282326|NCT02883049|454322875|FG000|Post Induction|Withdrawal by Subject|0|||
126282327|NCT02883049|454322876|FG001|Post Induction|Withdrawal by Subject|0|||
126282328|NCT02883049|454322877|FG002|Post Induction|Withdrawal by Subject|0|||
126456115|NCT01426789|454969105|FG001|Part 2|Withdrawal by Subject|0|||
126708919|NCT00849693|455887890|FG002|Extension Phase|Adverse Event|3|||
126708920|NCT00849693|455887891|FG003|Extension Phase|Adverse Event|7|||
126708921|NCT00849693|455887888|FG000|Extension Phase|Lost to Follow-up|7|||
126708922|NCT00849693|455887889|FG001|Extension Phase|Lost to Follow-up|5|||
126282329|NCT02883049|454322878|FG003|Post Induction|Withdrawal by Subject|5|||
126282330|NCT02883049|454322879|FG004|Post Induction|Withdrawal by Subject|2|||
126282331|NCT02883049|454322880|FG005|Post Induction|Withdrawal by Subject|1|||
126282332|NCT02883049|454322881|FG006|Post Induction|Withdrawal by Subject|0|||
126282333|NCT02883049|454322882|FG007|Post Induction|Withdrawal by Subject|0|||
126282334|NCT02883049|454322883|FG008|Post Induction|Withdrawal by Subject|2|||
126282335|NCT02883049|454322884|FG009|Post Induction|Withdrawal by Subject|0|||
126282336|NCT02883049|454322885|FG010|Post Induction|Withdrawal by Subject|1|||
126282337|NCT02883049|454322886|FG011|Post Induction|Withdrawal by Subject|1|||
126282338|NCT02883049|454322887|FG012|Post Induction|Withdrawal by Subject|0|||
126282339|NCT02883049|454322888|FG013|Post Induction|Withdrawal by Subject|0|||
126282340|NCT02883049|454322889|FG014|Post Induction|Withdrawal by Subject|1|||
126282341|NCT02883049|454322890|FG015|Post Induction|Withdrawal by Subject|0|||
126282342|NCT02883049|454322875|FG000|Post Induction|Ineligible|0|||
126282343|NCT02883049|454322876|FG001|Post Induction|Ineligible|0|||
126282344|NCT02883049|454322877|FG002|Post Induction|Ineligible|2|||
126282345|NCT02883049|454322878|FG003|Post Induction|Ineligible|0|||
126282346|NCT02883049|454322879|FG004|Post Induction|Ineligible|0|||
126282347|NCT02883049|454322880|FG005|Post Induction|Ineligible|0|||
126282348|NCT02883049|454322881|FG006|Post Induction|Ineligible|1|||
126282349|NCT02883049|454322882|FG007|Post Induction|Ineligible|0|||
126282350|NCT02883049|454322883|FG008|Post Induction|Ineligible|0|||
126282351|NCT02883049|454322884|FG009|Post Induction|Ineligible|0|||
126282352|NCT02883049|454322885|FG010|Post Induction|Ineligible|1|||
126282353|NCT02883049|454322886|FG011|Post Induction|Ineligible|0|||
126282354|NCT02883049|454322887|FG012|Post Induction|Ineligible|0|||
126282355|NCT02883049|454322888|FG013|Post Induction|Ineligible|0|||
126282356|NCT02883049|454322889|FG014|Post Induction|Ineligible|0|||
126282357|NCT02883049|454322890|FG015|Post Induction|Ineligible|1|||
126282358|NCT02883049|454322875|FG000|Post Induction|Refusal of further protocol therapy|0|||
126364437|NCT00803049|454628348|FG001|Overall Study|Other than Specified Above|9|||
126708923|NCT00849693|455887890|FG002|Extension Phase|Lost to Follow-up|6|||
126282359|NCT02883049|454322876|FG001|Post Induction|Refusal of further protocol therapy|0|||
126364438|NCT00803049|454628349|FG002|Overall Study|Other than Specified Above|2|||
126282360|NCT02883049|454322877|FG002|Post Induction|Refusal of further protocol therapy|0|||
126364439|NCT00803049|454628350|FG003|Overall Study|Other than Specified Above|5|||
126364440|NCT01421459|454628351|FG000|Overall Study|Adverse Event|6|||
126364441|NCT01421459|454628352|FG001|Overall Study|Adverse Event|10|||
126364442|NCT01421459|454628351|FG000|Overall Study|Death|1|||
126364443|NCT01421459|454628352|FG001|Overall Study|Death|1|||
126364444|NCT01421459|454628351|FG000|Overall Study|Lack of Efficacy|1|||
126364445|NCT01421459|454628352|FG001|Overall Study|Lack of Efficacy|2|||
126364446|NCT01421459|454628351|FG000|Overall Study|Lost to Follow-up|8|||
126364447|NCT01421459|454628352|FG001|Overall Study|Lost to Follow-up|9|||
126364448|NCT01421459|454628351|FG000|Overall Study|Physician Decision|9|||
126364449|NCT01421459|454628352|FG001|Overall Study|Physician Decision|9|||
126364450|NCT01421459|454628351|FG000|Overall Study|Protocol Violation|8|||
126364451|NCT01421459|454628352|FG001|Overall Study|Protocol Violation|5|||
126364452|NCT01421459|454628351|FG000|Overall Study|Withdrawal by Subject|12|||
126364453|NCT01421459|454628352|FG001|Overall Study|Withdrawal by Subject|16|||
126364454|NCT04439903|454628363|FG000|Overall Study|Withdrawal by Subject|2|||
126364455|NCT04439903|454628363|FG000|Overall Study|Screen Failure|1|||
126364456|NCT04003142|454628368|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
126364457|NCT04003142|454628369|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
126364458|NCT04003142|454628370|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
126364459|NCT04003142|454628371|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
126364460|NCT04003142|454628372|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
126364461|NCT04003142|454628368|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
126364462|NCT04003142|454628369|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
126364463|NCT04003142|454628370|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
126364464|NCT04003142|454628371|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
126364465|NCT04003142|454628372|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
126364466|NCT04003142|454628368|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
126364467|NCT04003142|454628369|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
126282361|NCT02883049|454322878|FG003|Post Induction|Refusal of further protocol therapy|11|||
126282362|NCT02883049|454322879|FG004|Post Induction|Refusal of further protocol therapy|15|||
126364468|NCT04003142|454628370|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
126364469|NCT04003142|454628371|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
126282363|NCT02883049|454322880|FG005|Post Induction|Refusal of further protocol therapy|9|||
126282364|NCT02883049|454322881|FG006|Post Induction|Refusal of further protocol therapy|13|||
126364470|NCT04003142|454628372|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
126708924|NCT00849693|455887891|FG003|Extension Phase|Lost to Follow-up|6|||
126708925|NCT00849693|455887888|FG000|Extension Phase|Protocol Violation|0|||
126708926|NCT00849693|455887889|FG001|Extension Phase|Protocol Violation|3|||
126708927|NCT00849693|455887890|FG002|Extension Phase|Protocol Violation|2|||
126708928|NCT00849693|455887891|FG003|Extension Phase|Protocol Violation|3|||
126708929|NCT00849693|455887888|FG000|Extension Phase|Withdrawal by Subject|6|||
126708930|NCT00849693|455887889|FG001|Extension Phase|Withdrawal by Subject|9|||
126708931|NCT00849693|455887890|FG002|Extension Phase|Withdrawal by Subject|10|||
126708932|NCT00849693|455887891|FG003|Extension Phase|Withdrawal by Subject|15|||
126708933|NCT00849693|455887888|FG000|Extension Phase|Parent or caregiver decision|9|||
126708934|NCT00849693|455887889|FG001|Extension Phase|Parent or caregiver decision|4|||
126708935|NCT00849693|455887890|FG002|Extension Phase|Parent or caregiver decision|10|||
126708936|NCT00849693|455887891|FG003|Extension Phase|Parent or caregiver decision|5|||
126708937|NCT00849693|455887888|FG000|Extension Phase|Physician Decision|1|||
126708938|NCT00849693|455887889|FG001|Extension Phase|Physician Decision|1|||
126708939|NCT00849693|455887890|FG002|Extension Phase|Physician Decision|2|||
126708940|NCT00849693|455887891|FG003|Extension Phase|Physician Decision|0|||
126708941|NCT00849693|455887888|FG000|Extension Phase|Sponsor decision|1|||
126708942|NCT00849693|455887889|FG001|Extension Phase|Sponsor decision|0|||
126708943|NCT00849693|455887890|FG002|Extension Phase|Sponsor decision|0|||
126708944|NCT00849693|455887891|FG003|Extension Phase|Sponsor decision|1|||
126708945|NCT00849693|455887888|FG000|Extension Phase|Lack of Efficacy|2|||
126708946|NCT00849693|455887889|FG001|Extension Phase|Lack of Efficacy|2|||
126708947|NCT00849693|455887890|FG002|Extension Phase|Lack of Efficacy|2|||
126708948|NCT00849693|455887891|FG003|Extension Phase|Lack of Efficacy|1|||
126708949|NCT00984659|455887894|FG000|2-week Run-in Period|Adverse Event|8|||
126708950|NCT00984659|455887895|FG001|2-week Run-in Period|Adverse Event|0|||
126708951|NCT00984659|455887896|FG002|2-week Run-in Period|Adverse Event|0|||
126708952|NCT00984659|455887897|FG003|2-week Run-in Period|Adverse Event|0|||
126708953|NCT00984659|455887894|FG000|2-week Run-in Period|Protocol Violation|5|||
126708954|NCT00984659|455887895|FG001|2-week Run-in Period|Protocol Violation|0|||
126708955|NCT00984659|455887896|FG002|2-week Run-in Period|Protocol Violation|0|||
126708956|NCT00984659|455887897|FG003|2-week Run-in Period|Protocol Violation|0|||
126708957|NCT00984659|455887894|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
126708958|NCT00984659|455887895|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
126708959|NCT00984659|455887896|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
126708960|NCT00984659|455887897|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
126708961|NCT00984659|455887894|FG000|2-week Run-in Period|Lost to Follow-up|3|||
126708962|NCT00984659|455887895|FG001|2-week Run-in Period|Lost to Follow-up|0|||
126708963|NCT00984659|455887896|FG002|2-week Run-in Period|Lost to Follow-up|0|||
126708964|NCT00984659|455887897|FG003|2-week Run-in Period|Lost to Follow-up|0|||
126708965|NCT00984659|455887894|FG000|2-week Run-in Period|Physician Decision|10|||
126708966|NCT00984659|455887895|FG001|2-week Run-in Period|Physician Decision|0|||
126708967|NCT00984659|455887896|FG002|2-week Run-in Period|Physician Decision|0|||
126708968|NCT00984659|455887897|FG003|2-week Run-in Period|Physician Decision|0|||
126708969|NCT00984659|455887894|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
126708970|NCT00984659|455887895|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126708971|NCT00984659|455887896|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126708972|NCT00984659|455887897|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
126708973|NCT00984659|455887894|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
126708974|NCT00984659|455887895|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
126708975|NCT00984659|455887896|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
126708976|NCT00984659|455887897|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
126708977|NCT00984659|455887894|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
126708978|NCT00984659|455887895|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
126282365|NCT02883049|454322882|FG007|Post Induction|Refusal of further protocol therapy|5|||
126282366|NCT02883049|454322883|FG008|Post Induction|Refusal of further protocol therapy|21|||
126282367|NCT02883049|454322884|FG009|Post Induction|Refusal of further protocol therapy|7|||
126282368|NCT02883049|454322885|FG010|Post Induction|Refusal of further protocol therapy|0|||
126282369|NCT02883049|454322886|FG011|Post Induction|Refusal of further protocol therapy|7|||
126282370|NCT02883049|454322887|FG012|Post Induction|Refusal of further protocol therapy|3|||
126282371|NCT02883049|454322888|FG013|Post Induction|Refusal of further protocol therapy|0|||
126708979|NCT00984659|455887896|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
126282372|NCT02883049|454322889|FG014|Post Induction|Refusal of further protocol therapy|4|||
126708980|NCT00984659|455887897|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
126708981|NCT00984659|455887894|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
126708982|NCT00984659|455887895|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
126708983|NCT00984659|455887896|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
126708984|NCT00984659|455887897|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
126708985|NCT00984659|455887894|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
126708986|NCT00984659|455887895|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
126708987|NCT00984659|455887896|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
126708988|NCT00984659|455887897|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
126708989|NCT00984659|455887894|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
126708990|NCT00984659|455887895|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
126708991|NCT00984659|455887896|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
126708992|NCT00984659|455887897|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
126708993|NCT00984659|455887894|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126708994|NCT00984659|455887895|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
126708995|NCT00984659|455887896|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
126708996|NCT00984659|455887897|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
126708997|NCT00635102|455887900|FG000|Overall Study|Withdrawal by Subject|7|||
126708998|NCT00635102|455887901|FG001|Overall Study|Withdrawal by Subject|8|||
126708999|NCT01938625|455887902|FG000|Overall Study|Withdrawal by Subject|0|||
126709000|NCT01938625|455887903|FG001|Overall Study|Withdrawal by Subject|1|||
126709001|NCT01938625|455887902|FG000|Overall Study|Adverse Event|0|||
126709002|NCT01938625|455887903|FG001|Overall Study|Adverse Event|1|||
126709003|NCT02088034|455887904|FG000|Overall Study|Lost to Follow-up|1|||
126709004|NCT02088034|455887905|FG001|Overall Study|Lost to Follow-up|1|||
126709005|NCT02088034|455887906|FG002|Overall Study|Lost to Follow-up|0|||
126709006|NCT02088034|455887904|FG000|Overall Study|Pregnancy|2|||
126709007|NCT02088034|455887905|FG001|Overall Study|Pregnancy|1|||
126282373|NCT02883049|454322890|FG015|Post Induction|Refusal of further protocol therapy|1|||
126282374|NCT02883049|454322875|FG000|Post Induction|Inevaluable|0|||
126282375|NCT02883049|454322876|FG001|Post Induction|Inevaluable|0|||
126282376|NCT02883049|454322877|FG002|Post Induction|Inevaluable|0|||
126282377|NCT02883049|454322878|FG003|Post Induction|Inevaluable|1|||
126282378|NCT02883049|454322879|FG004|Post Induction|Inevaluable|1|||
126282379|NCT02883049|454322880|FG005|Post Induction|Inevaluable|2|||
126282380|NCT02883049|454322881|FG006|Post Induction|Inevaluable|7|||
126282381|NCT02883049|454322882|FG007|Post Induction|Inevaluable|6|||
126282382|NCT02883049|454322883|FG008|Post Induction|Inevaluable|4|||
126282383|NCT02883049|454322884|FG009|Post Induction|Inevaluable|4|||
126282384|NCT02883049|454322885|FG010|Post Induction|Inevaluable|1|||
126282385|NCT02883049|454322886|FG011|Post Induction|Inevaluable|1|||
126282386|NCT02883049|454322887|FG012|Post Induction|Inevaluable|2|||
126282387|NCT02883049|454322888|FG013|Post Induction|Inevaluable|0|||
126282388|NCT02883049|454322889|FG014|Post Induction|Inevaluable|0|||
126282389|NCT02883049|454322890|FG015|Post Induction|Inevaluable|1|||
126282390|NCT02883049|454322875|FG000|Post Induction|Moved to another non-COG institution|0|||
126282391|NCT02883049|454322876|FG001|Post Induction|Moved to another non-COG institution|0|||
126282392|NCT02883049|454322877|FG002|Post Induction|Moved to another non-COG institution|0|||
126282393|NCT02883049|454322878|FG003|Post Induction|Moved to another non-COG institution|0|||
126282394|NCT02883049|454322879|FG004|Post Induction|Moved to another non-COG institution|0|||
126282395|NCT02883049|454322880|FG005|Post Induction|Moved to another non-COG institution|0|||
126282396|NCT02883049|454322881|FG006|Post Induction|Moved to another non-COG institution|0|||
126282397|NCT02883049|454322882|FG007|Post Induction|Moved to another non-COG institution|2|||
126282398|NCT02883049|454322883|FG008|Post Induction|Moved to another non-COG institution|2|||
126282399|NCT02883049|454322884|FG009|Post Induction|Moved to another non-COG institution|0|||
126282400|NCT02883049|454322885|FG010|Post Induction|Moved to another non-COG institution|0|||
126282401|NCT02883049|454322886|FG011|Post Induction|Moved to another non-COG institution|1|||
126282402|NCT02883049|454322887|FG012|Post Induction|Moved to another non-COG institution|0|||
126282403|NCT02883049|454322888|FG013|Post Induction|Moved to another non-COG institution|0|||
126282404|NCT02883049|454322889|FG014|Post Induction|Moved to another non-COG institution|0|||
126282405|NCT02883049|454322890|FG015|Post Induction|Moved to another non-COG institution|0|||
126282406|NCT02883049|454322875|FG000|Post Induction|Randomization closed|0|||
126282407|NCT02883049|454322876|FG001|Post Induction|Randomization closed|0|||
126282408|NCT02883049|454322877|FG002|Post Induction|Randomization closed|0|||
126282409|NCT02883049|454322878|FG003|Post Induction|Randomization closed|0|||
126282410|NCT02883049|454322879|FG004|Post Induction|Randomization closed|0|||
126282411|NCT02883049|454322880|FG005|Post Induction|Randomization closed|0|||
126709008|NCT02088034|455887906|FG002|Overall Study|Pregnancy|2|||
126709009|NCT00308620|455887907|FG000|Overall Study|Death|1|||
126709010|NCT00308620|455887908|FG001|Overall Study|Death|1|||
126282412|NCT02883049|454322881|FG006|Post Induction|Randomization closed|0|||
126282413|NCT02883049|454322882|FG007|Post Induction|Randomization closed|20|||
126282414|NCT02883049|454322883|FG008|Post Induction|Randomization closed|0|||
126282415|NCT02883049|454322884|FG009|Post Induction|Randomization closed|0|||
126282416|NCT02883049|454322885|FG010|Post Induction|Randomization closed|0|||
126282417|NCT02883049|454322886|FG011|Post Induction|Randomization closed|0|||
126282418|NCT02883049|454322887|FG012|Post Induction|Randomization closed|0|||
126282419|NCT02883049|454322888|FG013|Post Induction|Randomization closed|0|||
126364471|NCT04003142|454628368|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
126364472|NCT04003142|454628369|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
126709011|NCT00308620|455887909|FG002|Overall Study|Death|0|||
126709012|NCT00308620|455887907|FG000|Overall Study|Lost to Follow-up|0|||
126709013|NCT00308620|455887908|FG001|Overall Study|Lost to Follow-up|0|||
126282420|NCT02883049|454322889|FG014|Post Induction|Randomization closed|0|||
126282421|NCT02883049|454322890|FG015|Post Induction|Randomization closed|0|||
126282422|NCT02883049|454322875|FG000|Post Induction|MRD negative|0|||
126282423|NCT02883049|454322876|FG001|Post Induction|MRD negative|0|||
126282424|NCT02883049|454322877|FG002|Post Induction|MRD negative|0|||
126282425|NCT02883049|454322878|FG003|Post Induction|MRD negative|0|||
126282426|NCT02883049|454322879|FG004|Post Induction|MRD negative|0|||
126282427|NCT02883049|454322880|FG005|Post Induction|MRD negative|0|||
126282428|NCT02883049|454322881|FG006|Post Induction|MRD negative|0|||
126282429|NCT02883049|454322882|FG007|Post Induction|MRD negative|11|||
126282430|NCT02883049|454322883|FG008|Post Induction|MRD negative|0|||
126282431|NCT02883049|454322884|FG009|Post Induction|MRD negative|0|||
126282432|NCT02883049|454322885|FG010|Post Induction|MRD negative|0|||
126282433|NCT02883049|454322886|FG011|Post Induction|MRD negative|0|||
126282434|NCT02883049|454322887|FG012|Post Induction|MRD negative|0|||
126282435|NCT02883049|454322888|FG013|Post Induction|MRD negative|0|||
126282436|NCT02883049|454322889|FG014|Post Induction|MRD negative|0|||
126282437|NCT02883049|454322890|FG015|Post Induction|MRD negative|0|||
126282438|NCT02883049|454322875|FG000|Post Induction|Developed SMN|0|||
126282439|NCT02883049|454322876|FG001|Post Induction|Developed SMN|0|||
126282440|NCT02883049|454322877|FG002|Post Induction|Developed SMN|0|||
126282441|NCT02883049|454322878|FG003|Post Induction|Developed SMN|0|||
126282442|NCT02883049|454322879|FG004|Post Induction|Developed SMN|1|||
126282443|NCT02883049|454322880|FG005|Post Induction|Developed SMN|0|||
126282444|NCT02883049|454322881|FG006|Post Induction|Developed SMN|1|||
126282445|NCT02883049|454322882|FG007|Post Induction|Developed SMN|0|||
126282446|NCT02883049|454322883|FG008|Post Induction|Developed SMN|0|||
126282447|NCT02883049|454322884|FG009|Post Induction|Developed SMN|0|||
126282448|NCT02883049|454322885|FG010|Post Induction|Developed SMN|1|||
126282449|NCT02883049|454322886|FG011|Post Induction|Developed SMN|1|||
126282450|NCT02883049|454322887|FG012|Post Induction|Developed SMN|0|||
126282451|NCT02883049|454322888|FG013|Post Induction|Developed SMN|0|||
126282452|NCT02883049|454322889|FG014|Post Induction|Developed SMN|1|||
126282453|NCT02883049|454322890|FG015|Post Induction|Developed SMN|0|||
126282454|NCT02883049|454322875|FG000|Post Induction|Enrolled onto another COG study|0|||
126282455|NCT02883049|454322876|FG001|Post Induction|Enrolled onto another COG study|0|||
126282456|NCT02883049|454322877|FG002|Post Induction|Enrolled onto another COG study|0|||
126282457|NCT02883049|454322878|FG003|Post Induction|Enrolled onto another COG study|1|||
126282458|NCT02883049|454322879|FG004|Post Induction|Enrolled onto another COG study|1|||
126282459|NCT02883049|454322880|FG005|Post Induction|Enrolled onto another COG study|0|||
126282460|NCT02883049|454322881|FG006|Post Induction|Enrolled onto another COG study|0|||
126282461|NCT02883049|454322882|FG007|Post Induction|Enrolled onto another COG study|4|||
126282462|NCT02883049|454322883|FG008|Post Induction|Enrolled onto another COG study|0|||
126456116|NCT01426789|454969106|FG002|Part 2|Withdrawal by Subject|0|||
126282463|NCT02883049|454322884|FG009|Post Induction|Enrolled onto another COG study|0|||
126282464|NCT02883049|454322885|FG010|Post Induction|Enrolled onto another COG study|0|||
126282465|NCT02883049|454322886|FG011|Post Induction|Enrolled onto another COG study|2|||
126282466|NCT02883049|454322887|FG012|Post Induction|Enrolled onto another COG study|0|||
126282467|NCT02883049|454322888|FG013|Post Induction|Enrolled onto another COG study|1|||
126282468|NCT02883049|454322889|FG014|Post Induction|Enrolled onto another COG study|0|||
126282469|NCT02883049|454322890|FG015|Post Induction|Enrolled onto another COG study|0|||
126282470|NCT02883049|454322875|FG000|Post Induction|Recurrent leukemia|0|||
126282471|NCT02883049|454322876|FG001|Post Induction|Recurrent leukemia|0|||
126282472|NCT02883049|454322877|FG002|Post Induction|Recurrent leukemia|0|||
126282473|NCT02883049|454322878|FG003|Post Induction|Recurrent leukemia|17|||
126282474|NCT02883049|454322879|FG004|Post Induction|Recurrent leukemia|12|||
126282475|NCT02883049|454322880|FG005|Post Induction|Recurrent leukemia|4|||
126282476|NCT02883049|454322881|FG006|Post Induction|Recurrent leukemia|1|||
126282477|NCT02883049|454322882|FG007|Post Induction|Recurrent leukemia|13|||
126282478|NCT02883049|454322883|FG008|Post Induction|Recurrent leukemia|27|||
126282479|NCT02883049|454322884|FG009|Post Induction|Recurrent leukemia|5|||
126282480|NCT02883049|454322885|FG010|Post Induction|Recurrent leukemia|3|||
126282481|NCT02883049|454322886|FG011|Post Induction|Recurrent leukemia|12|||
126282482|NCT02883049|454322887|FG012|Post Induction|Recurrent leukemia|1|||
126282483|NCT02883049|454322888|FG013|Post Induction|Recurrent leukemia|1|||
126282484|NCT02883049|454322889|FG014|Post Induction|Recurrent leukemia|9|||
126282485|NCT02883049|454322890|FG015|Post Induction|Recurrent leukemia|3|||
126282486|NCT02883049|454322875|FG000|Post Induction|Induction Failure|0|||
126282487|NCT02883049|454322876|FG001|Post Induction|Induction Failure|0|||
126282488|NCT02883049|454322877|FG002|Post Induction|Induction Failure|0|||
126282489|NCT02883049|454322878|FG003|Post Induction|Induction Failure|0|||
126282490|NCT02883049|454322879|FG004|Post Induction|Induction Failure|0|||
126282491|NCT02883049|454322880|FG005|Post Induction|Induction Failure|0|||
126282492|NCT02883049|454322881|FG006|Post Induction|Induction Failure|0|||
126282493|NCT02883049|454322882|FG007|Post Induction|Induction Failure|2|||
126282494|NCT02883049|454322883|FG008|Post Induction|Induction Failure|2|||
126282495|NCT02883049|454322884|FG009|Post Induction|Induction Failure|0|||
126364473|NCT04003142|454628370|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
126364474|NCT04003142|454628371|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
126364475|NCT04003142|454628372|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
126364476|NCT04003142|454628368|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
126364477|NCT04003142|454628369|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
126364478|NCT04003142|454628370|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
126364479|NCT04003142|454628371|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
126364480|NCT04003142|454628372|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
126364481|NCT04003142|454628368|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
126364482|NCT04003142|454628369|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
126364483|NCT04003142|454628370|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
126364484|NCT04003142|454628371|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
126364485|NCT04003142|454628372|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
126364486|NCT04003142|454628368|FG000|Extension Period (40 Weeks)|Death|0|||
126364487|NCT04003142|454628369|FG001|Extension Period (40 Weeks)|Death|0|||
126364488|NCT04003142|454628370|FG002|Extension Period (40 Weeks)|Death|0|||
126364489|NCT04003142|454628371|FG003|Extension Period (40 Weeks)|Death|0|||
126364490|NCT04003142|454628372|FG004|Extension Period (40 Weeks)|Death|1|||
126364491|NCT04003142|454628368|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
126364492|NCT04003142|454628369|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
126364493|NCT04003142|454628370|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
126364494|NCT04003142|454628371|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
126364495|NCT04003142|454628372|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
126364496|NCT04003142|454628368|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
126364497|NCT04003142|454628369|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
126364498|NCT04003142|454628370|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
126364499|NCT04003142|454628371|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
126364500|NCT04003142|454628372|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
126364501|NCT04003142|454628368|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
126364502|NCT04003142|454628369|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
126364503|NCT04003142|454628370|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
126364504|NCT04003142|454628371|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
126364505|NCT04003142|454628372|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
126364506|NCT04003142|454628368|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
126364507|NCT04003142|454628369|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
126364508|NCT04003142|454628370|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
126364509|NCT04003142|454628371|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
126364510|NCT04003142|454628372|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
126364511|NCT04042311|454628373|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
126364512|NCT04042311|454628373|FG000|Overall Study|Unable to tolerate|4|||
126364513|NCT04042311|454628373|FG000|Overall Study|Concurrent illness|2|||
126364514|NCT04042311|454628373|FG000|Overall Study|Adverse Event|2|||
126364515|NCT04042311|454628373|FG000|Overall Study|No longer meeting inclusion criteria|2|||
126364516|NCT04042311|454628373|FG000|Overall Study|No reason given|1|||
126364517|NCT04042311|454628373|FG000|Overall Study|Withdrawal by Subject|4|||
126364518|NCT03382873|454628374|FG000|Overall Study|Lost to Follow-up|9|||
126364519|NCT03382873|454628375|FG001|Overall Study|Lost to Follow-up|10|||
126364520|NCT03382873|454628374|FG000|Overall Study|Withdrawal by Subject|6|||
126364521|NCT03382873|454628375|FG001|Overall Study|Withdrawal by Subject|11|||
126364522|NCT03382873|454628374|FG000|Overall Study|Visit not completed due to pandemic|16|||
126364523|NCT03382873|454628375|FG001|Overall Study|Visit not completed due to pandemic|41|||
126364524|NCT03996395|454628378|FG000|Overall Study|Lost to Follow-up|4|||
126364525|NCT03996395|454628378|FG000|Overall Study|Withdrawal by Subject|1|||
126364526|NCT03996395|454628378|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
126364527|NCT02061085|454628381|FG000|Overall Study|Adverse Event|8|||
126364528|NCT03247673|454628382|FG000|Overall Study|Withdrawal by Subject|1|||
126364529|NCT03247673|454628383|FG001|Overall Study|Withdrawal by Subject|0|||
126364530|NCT03247673|454628384|FG002|Overall Study|Withdrawal by Subject|3|||
126364531|NCT03247673|454628382|FG000|Overall Study|Lost to Follow-up|0|||
126364532|NCT03247673|454628383|FG001|Overall Study|Lost to Follow-up|0|||
126364533|NCT03247673|454628384|FG002|Overall Study|Lost to Follow-up|1|||
126364534|NCT02097225|454628385|FG000|Dose Level 4|Adverse Event|0|||
126364535|NCT02097225|454628386|FG001|Dose Level 4|Adverse Event|0|||
126364536|NCT02097225|454628387|FG002|Dose Level 4|Adverse Event|0|||
126364537|NCT02097225|454628388|FG003|Dose Level 4|Adverse Event|0|||
126364538|NCT02097225|454628389|FG004|Dose Level 4|Adverse Event|1|||
126364539|NCT01027351|454628391|FG000|Overall Study|Withdrawal by Subject|1|||
126364540|NCT01027351|454628392|FG001|Overall Study|Withdrawal by Subject|0|||
126364541|NCT01027351|454628393|FG002|Overall Study|Withdrawal by Subject|1|||
126364542|NCT01027351|454628394|FG003|Overall Study|Withdrawal by Subject|0|||
126364543|NCT01027351|454628395|FG004|Overall Study|Withdrawal by Subject|3|||
126364544|NCT01027351|454628396|FG005|Overall Study|Withdrawal by Subject|5|||
126364545|NCT01027351|454628391|FG000|Overall Study|Lost to Follow-up|1|||
126364546|NCT01027351|454628392|FG001|Overall Study|Lost to Follow-up|1|||
126282496|NCT02883049|454322885|FG010|Post Induction|Induction Failure|0|||
126282497|NCT02883049|454322886|FG011|Post Induction|Induction Failure|0|||
126282498|NCT02883049|454322887|FG012|Post Induction|Induction Failure|0|||
126456117|NCT01426789|454969107|FG003|Part 2|Withdrawal by Subject|1|||
126456118|NCT01426789|454969108|FG004|Part 2|Withdrawal by Subject|2|||
126456119|NCT01426789|454969109|FG005|Part 2|Withdrawal by Subject|0|||
126709014|NCT00308620|455887909|FG002|Overall Study|Lost to Follow-up|1|||
126709015|NCT00546351|455887910|FG000|Overall Study|Adverse Event|76|||
126709016|NCT00546351|455887910|FG000|Overall Study|Lack of Efficacy|15|||
126709017|NCT00546351|455887910|FG000|Overall Study|Withdrawal by Subject|109|||
126709018|NCT00546351|455887910|FG000|Overall Study|Lost to Follow-up|9|||
126709019|NCT00546351|455887910|FG000|Overall Study|Protocol Deviation|1|||
126709020|NCT00546351|455887910|FG000|Overall Study|Unsatisfactory compliance|9|||
126709021|NCT00546351|455887910|FG000|Overall Study|Other reasons for premature termination|17|||
126282499|NCT02883049|454322888|FG013|Post Induction|Induction Failure|2|||
126282500|NCT02883049|454322889|FG014|Post Induction|Induction Failure|0|||
126282501|NCT02883049|454322890|FG015|Post Induction|Induction Failure|0|||
126282502|NCT01924754|454322894|FG000|Overall Study|Lost to Follow-up|1|||
126282503|NCT01924754|454322895|FG001|Overall Study|Lost to Follow-up|2|||
126282504|NCT01924754|454322896|FG002|Overall Study|Lost to Follow-up|1|||
126282505|NCT01924754|454322894|FG000|Overall Study|Pregnancy|0|||
126282506|NCT01924754|454322895|FG001|Overall Study|Pregnancy|1|||
126282507|NCT01924754|454322896|FG002|Overall Study|Pregnancy|2|||
126282508|NCT02245412|454322899|FG000|Treatment Period|Death|1|||
126282509|NCT02245412|454322900|FG001|Treatment Period|Death|1|||
126282510|NCT02245412|454322901|FG002|Treatment Period|Death|0|||
126282511|NCT02245412|454322899|FG000|Treatment Period|Physician Decision|1|||
126282512|NCT02245412|454322900|FG001|Treatment Period|Physician Decision|1|||
126282513|NCT02245412|454322901|FG002|Treatment Period|Physician Decision|0|||
126282514|NCT02245412|454322899|FG000|Treatment Period|Withdrawal by Subject|2|||
126282515|NCT02245412|454322900|FG001|Treatment Period|Withdrawal by Subject|1|||
126282516|NCT02245412|454322901|FG002|Treatment Period|Withdrawal by Subject|0|||
126282517|NCT02245412|454322899|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
126282518|NCT02245412|454322900|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
126282519|NCT02245412|454322901|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
126282520|NCT02245412|454322899|FG000|Follow-Up Period|Death|4|||
126282521|NCT02245412|454322900|FG001|Follow-Up Period|Death|2|||
126282522|NCT02245412|454322901|FG002|Follow-Up Period|Death|1|||
126282523|NCT02245412|454322899|FG000|Follow-Up Period|Physician Decision|1|||
126282524|NCT02245412|454322900|FG001|Follow-Up Period|Physician Decision|0|||
126282525|NCT02245412|454322901|FG002|Follow-Up Period|Physician Decision|0|||
126282526|NCT02245412|454322899|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
126282527|NCT02245412|454322900|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
126282528|NCT02245412|454322901|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
126282529|NCT00369486|454322902|FG000|4-Week Visit|Missed visit|2|||
126282530|NCT00369486|454322903|FG001|4-Week Visit|Missed visit|2|||
126282531|NCT00369486|454322904|FG002|4-Week Visit|Missed visit|0|||
126282532|NCT00369486|454322905|FG003|4-Week Visit|Missed visit|2|||
126282533|NCT00369486|454322906|FG004|4-Week Visit|Missed visit|1|||
126282534|NCT00369486|454322902|FG000|4-Week Visit|Dropped|0|||
126282535|NCT00369486|454322903|FG001|4-Week Visit|Dropped|0|||
126282536|NCT00369486|454322904|FG002|4-Week Visit|Dropped|1|||
126282537|NCT00369486|454322905|FG003|4-Week Visit|Dropped|0|||
126282538|NCT00369486|454322906|FG004|4-Week Visit|Dropped|0|||
126282539|NCT00369486|454322902|FG000|8-Week Visit|Missed visit|0|||
126282540|NCT00369486|454322903|FG001|8-Week Visit|Missed visit|1|||
126282541|NCT00369486|454322904|FG002|8-Week Visit|Missed visit|0|||
126282542|NCT00369486|454322905|FG003|8-Week Visit|Missed visit|0|||
126282543|NCT00369486|454322906|FG004|8-Week Visit|Missed visit|1|||
126282544|NCT00369486|454322902|FG000|8-Week Visit|Dropped|0|||
126282545|NCT00369486|454322903|FG001|8-Week Visit|Dropped|0|||
126282546|NCT00369486|454322904|FG002|8-Week Visit|Dropped|0|||
126456120|NCT01426789|454969104|FG000|Part 2|Lack of Efficacy|0|||
126456121|NCT01426789|454969105|FG001|Part 2|Lack of Efficacy|0|||
126456122|NCT01426789|454969106|FG002|Part 2|Lack of Efficacy|5|||
126282547|NCT00369486|454322905|FG003|8-Week Visit|Dropped|1|||
126282548|NCT00369486|454322906|FG004|8-Week Visit|Dropped|0|||
126282549|NCT00369486|454322902|FG000|17-Week Visit|Missed visit|0|||
126282550|NCT00369486|454322903|FG001|17-Week Visit|Missed visit|0|||
126282551|NCT00369486|454322904|FG002|17-Week Visit|Missed visit|1|||
126282552|NCT00369486|454322905|FG003|17-Week Visit|Missed visit|1|||
126456123|NCT01426789|454969107|FG003|Part 2|Lack of Efficacy|0|||
126456124|NCT01426789|454969108|FG004|Part 2|Lack of Efficacy|2|||
126282553|NCT00369486|454322906|FG004|17-Week Visit|Missed visit|1|||
126282554|NCT00369486|454322902|FG000|34-Week Visit|Dropped|0|||
126282555|NCT00369486|454322903|FG001|34-Week Visit|Dropped|1|||
126282556|NCT00369486|454322904|FG002|34-Week Visit|Dropped|1|||
126282557|NCT00369486|454322905|FG003|34-Week Visit|Dropped|3|||
126282558|NCT00369486|454322906|FG004|34-Week Visit|Dropped|3|||
126282559|NCT01392963|454322907|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
126456125|NCT01426789|454969109|FG005|Part 2|Lack of Efficacy|0|||
126709022|NCT03952650|455887911|FG000|Overall Study|TRAVEL|0|||
126282560|NCT01392963|454322908|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
126282561|NCT01392963|454322907|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
126282562|NCT01392963|454322908|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
126282563|NCT01392963|454322907|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
126282564|NCT01392963|454322908|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
126282565|NCT00402116|454322909|FG000|Overall Study|Jaw infection after surgery-other|1|||
126282566|NCT00402116|454322910|FG001|Overall Study|Jaw infection after surgery-other|0|||
126282567|NCT00402116|454322911|FG002|Overall Study|Jaw infection after surgery-other|0|||
126282568|NCT00402116|454322909|FG000|Overall Study|Withdrawal by Subject|1|||
126282569|NCT00402116|454322910|FG001|Overall Study|Withdrawal by Subject|0|||
126282570|NCT00402116|454322911|FG002|Overall Study|Withdrawal by Subject|5|||
126282571|NCT00402116|454322909|FG000|Overall Study|Treatment completed per protocol|1|||
126282572|NCT00402116|454322910|FG001|Overall Study|Treatment completed per protocol|1|||
126282573|NCT00402116|454322911|FG002|Overall Study|Treatment completed per protocol|2|||
126282574|NCT00402116|454322909|FG000|Overall Study|other complicating disease|0|||
126282575|NCT00402116|454322910|FG001|Overall Study|other complicating disease|0|||
126282576|NCT00402116|454322911|FG002|Overall Study|other complicating disease|2|||
126282577|NCT00402116|454322909|FG000|Overall Study|Disease Progression|0|||
126282578|NCT00402116|454322910|FG001|Overall Study|Disease Progression|4|||
126282579|NCT00402116|454322911|FG002|Overall Study|Disease Progression|38|||
126282580|NCT00402116|454322909|FG000|Overall Study|mistaken thrombocytopenia|0|||
126282581|NCT00402116|454322910|FG001|Overall Study|mistaken thrombocytopenia|0|||
126282582|NCT00402116|454322911|FG002|Overall Study|mistaken thrombocytopenia|1|||
126282583|NCT00402116|454322909|FG000|Overall Study|decline related hyponatremia/tumor|0|||
126282584|NCT00402116|454322910|FG001|Overall Study|decline related hyponatremia/tumor|0|||
126282585|NCT00402116|454322911|FG002|Overall Study|decline related hyponatremia/tumor|1|||
126282586|NCT00402116|454322909|FG000|Overall Study|Adverse Event|0|||
126282587|NCT00402116|454322910|FG001|Overall Study|Adverse Event|1|||
126282588|NCT00402116|454322911|FG002|Overall Study|Adverse Event|6|||
126282589|NCT04778904|454322912|FG000|Overall Study|Protocol Violation|1|||
126282590|NCT04778904|454322913|FG001|Overall Study|Protocol Violation|0|||
126282591|NCT04778904|454322914|FG002|Overall Study|Protocol Violation|0|||
126282592|NCT04778904|454322915|FG003|Overall Study|Protocol Violation|0|||
126282593|NCT04778904|454322912|FG000|Overall Study|Withdrawal by Subject|0|||
126282594|NCT04778904|454322913|FG001|Overall Study|Withdrawal by Subject|0|||
126282595|NCT04778904|454322914|FG002|Overall Study|Withdrawal by Subject|1|||
126282596|NCT04778904|454322915|FG003|Overall Study|Withdrawal by Subject|0|||
126282597|NCT05048329|454322922|FG000|Overall Study|Withdrawal by Subject|1|||
126282598|NCT05048329|454322922|FG000|Overall Study|Screenfail|1|||
126282599|NCT03772717|454322923|FG000|Overall Study|Withdrawal by Subject|2|||
126282600|NCT02856802|454322924|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
126282601|NCT02856802|454322925|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
126282602|NCT02856802|454322924|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
126282603|NCT02856802|454322925|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
126282604|NCT02856802|454322924|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
126282605|NCT02856802|454322925|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
126282606|NCT02856802|454322924|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
126282607|NCT02856802|454322925|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
126282608|NCT02856802|454322924|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
126282609|NCT02856802|454322925|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
126282610|NCT02856802|454322924|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
126282611|NCT02856802|454322925|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
126282612|NCT04138043|454322926|FG000|Overall Study|Withdrawal by Subject|0|||
126282613|NCT04138043|454322927|FG001|Overall Study|Withdrawal by Subject|1|||
126282614|NCT01403051|454322928|FG000|Overall Study|Protocol Violation|2|||
126282615|NCT01403051|454322929|FG001|Overall Study|Protocol Violation|0|||
126282616|NCT01403051|454322928|FG000|Overall Study|Death|1|||
126282617|NCT01403051|454322929|FG001|Overall Study|Death|0|||
126456126|NCT01426789|454969104|FG000|Part 2|Adverse Event|0|||
126456127|NCT01426789|454969105|FG001|Part 2|Adverse Event|0|||
126456128|NCT01426789|454969106|FG002|Part 2|Adverse Event|2|||
126456129|NCT01426789|454969107|FG003|Part 2|Adverse Event|0|||
126456130|NCT01426789|454969108|FG004|Part 2|Adverse Event|1|||
126456131|NCT01426789|454969109|FG005|Part 2|Adverse Event|0|||
126456132|NCT01181986|454969112|FG000|Phase 1|Lost to Follow-up|0|||
126282618|NCT01403051|454322928|FG000|Overall Study|Withdrawal by Subject|2|||
126282619|NCT01403051|454322929|FG001|Overall Study|Withdrawal by Subject|1|||
126282620|NCT01403051|454322928|FG000|Overall Study|Lost to Follow-up|5|||
126282621|NCT01403051|454322929|FG001|Overall Study|Lost to Follow-up|5|||
126282622|NCT00287586|454322939|FG000|Overall Study|Withdrew Consent|19|||
126282623|NCT00287586|454322940|FG001|Overall Study|Withdrew Consent|30|||
126282624|NCT00287586|454322939|FG000|Overall Study|Lost to Follow-up|5|||
126282625|NCT00287586|454322940|FG001|Overall Study|Lost to Follow-up|4|||
126282626|NCT00287586|454322939|FG000|Overall Study|Death|2|||
126456133|NCT01181986|454969113|FG001|Phase 1|Lost to Follow-up|1|||
126456134|NCT01181986|454969114|FG002|Phase 1|Lost to Follow-up|1|||
126282627|NCT00287586|454322940|FG001|Overall Study|Death|3|||
126282628|NCT00287586|454322939|FG000|Overall Study|Elevated Hematocrit|3|||
126282629|NCT00287586|454322940|FG001|Overall Study|Elevated Hematocrit|0|||
126282630|NCT00287586|454322939|FG000|Overall Study|Rash|3|||
126282631|NCT00287586|454322940|FG001|Overall Study|Rash|0|||
126282632|NCT00287586|454322939|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
126282633|NCT00287586|454322940|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
126282634|NCT00287586|454322939|FG000|Overall Study|Stroke|2|||
126282635|NCT00287586|454322940|FG001|Overall Study|Stroke|0|||
126282636|NCT00287586|454322939|FG000|Overall Study|Myocardial Infarction|1|||
126282637|NCT00287586|454322940|FG001|Overall Study|Myocardial Infarction|0|||
126282638|NCT00287586|454322939|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
126282639|NCT00287586|454322940|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
126282640|NCT00287586|454322939|FG000|Overall Study|Cognitive Impairment|1|||
126282641|NCT00287586|454322940|FG001|Overall Study|Cognitive Impairment|0|||
126282642|NCT00287586|454322939|FG000|Overall Study|Pancreatic Cancer|1|||
126282643|NCT00287586|454322940|FG001|Overall Study|Pancreatic Cancer|3|||
126282644|NCT00287586|454322939|FG000|Overall Study|Sleep Apnea|1|||
126282645|NCT00287586|454322940|FG001|Overall Study|Sleep Apnea|0|||
126282646|NCT00287586|454322939|FG000|Overall Study|Shoulder Pain|1|||
126282647|NCT00287586|454322940|FG001|Overall Study|Shoulder Pain|0|||
126282648|NCT00287586|454322939|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
126282649|NCT00287586|454322940|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
126282650|NCT00287586|454322939|FG000|Overall Study|Nonadherence|1|||
126282651|NCT00287586|454322940|FG001|Overall Study|Nonadherence|1|||
126282652|NCT00287586|454322939|FG000|Overall Study|Enrolled in Another Study|1|||
126282653|NCT00287586|454322940|FG001|Overall Study|Enrolled in Another Study|0|||
126282654|NCT00287586|454322939|FG000|Overall Study|Major Depression|0|||
126282655|NCT00287586|454322940|FG001|Overall Study|Major Depression|2|||
126282656|NCT00287586|454322939|FG000|Overall Study|Lung Cancer|0|||
126282657|NCT00287586|454322940|FG001|Overall Study|Lung Cancer|2|||
126282658|NCT00287586|454322939|FG000|Overall Study|Elevated IPSS Score|0|||
126282659|NCT00287586|454322940|FG001|Overall Study|Elevated IPSS Score|1|||
126282660|NCT00287586|454322939|FG000|Overall Study|Retroperitoneal Cancer|0|||
126282661|NCT00287586|454322940|FG001|Overall Study|Retroperitoneal Cancer|1|||
126282662|NCT00287586|454322939|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
126282663|NCT00287586|454322940|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
126282664|NCT00287586|454322939|FG000|Overall Study|Mood Swings and Irritability|0|||
126282665|NCT00287586|454322940|FG001|Overall Study|Mood Swings and Irritability|1|||
126282666|NCT00287586|454322939|FG000|Overall Study|Bradycardia|0|||
126282667|NCT00287586|454322940|FG001|Overall Study|Bradycardia|1|||
126282668|NCT00287586|454322939|FG000|Overall Study|Itchy Swollen Eyes|0|||
126282669|NCT00287586|454322940|FG001|Overall Study|Itchy Swollen Eyes|1|||
126282670|NCT00287586|454322939|FG000|Overall Study|Recurrent Melanoma|0|||
126282671|NCT00287586|454322940|FG001|Overall Study|Recurrent Melanoma|1|||
126282672|NCT03743415|454322942|FG000|Overall Study|Death|5|||
126282673|NCT03743415|454322943|FG001|Overall Study|Death|3|||
126282674|NCT03743415|454322944|FG002|Overall Study|Death|1|||
126282675|NCT03743415|454322945|FG003|Overall Study|Death|4|||
126282676|NCT03743415|454322946|FG004|Overall Study|Death|0|||
126282677|NCT03743415|454322947|FG005|Overall Study|Death|0|||
126282678|NCT03743415|454322948|FG006|Overall Study|Death|0|||
126282679|NCT03743415|454322949|FG007|Overall Study|Death|0|||
126282680|NCT03743415|454322950|FG008|Overall Study|Death|1|||
126282681|NCT03743415|454322951|FG009|Overall Study|Death|0|||
126282682|NCT03743415|454322942|FG000|Overall Study|Withdrawal by Subject|1|||
126282683|NCT03743415|454322943|FG001|Overall Study|Withdrawal by Subject|0|||
126282684|NCT03743415|454322944|FG002|Overall Study|Withdrawal by Subject|4|||
126282685|NCT03743415|454322945|FG003|Overall Study|Withdrawal by Subject|5|||
126282686|NCT03743415|454322946|FG004|Overall Study|Withdrawal by Subject|5|||
126766000|NCT01870921|456095876|FG000|Overall Study|Subject Lost to Follow up|2|||
126766001|NCT01870921|456095876|FG000|Overall Study|Other|1|||
126766002|NCT04409509|456095877|FG000|Overall Study|Failure to meet randomization requirement|1|||
126766003|NCT04409509|456095878|FG001|Overall Study|Failure to meet randomization requirement|0|||
126282687|NCT03743415|454322947|FG005|Overall Study|Withdrawal by Subject|2|||
126282688|NCT03743415|454322948|FG006|Overall Study|Withdrawal by Subject|2|||
126282689|NCT03743415|454322949|FG007|Overall Study|Withdrawal by Subject|5|||
126282690|NCT03743415|454322950|FG008|Overall Study|Withdrawal by Subject|9|||
126282691|NCT03743415|454322951|FG009|Overall Study|Withdrawal by Subject|10|||
126282692|NCT03743415|454322942|FG000|Overall Study|Lost to Follow-up|2|||
126282693|NCT03743415|454322943|FG001|Overall Study|Lost to Follow-up|0|||
126766004|NCT04409509|456095877|FG000|Overall Study|Adverse Event|0|||
126282694|NCT03743415|454322944|FG002|Overall Study|Lost to Follow-up|2|||
126282695|NCT03743415|454322945|FG003|Overall Study|Lost to Follow-up|1|||
126282696|NCT03743415|454322946|FG004|Overall Study|Lost to Follow-up|1|||
126282697|NCT03743415|454322947|FG005|Overall Study|Lost to Follow-up|0|||
126282698|NCT03743415|454322948|FG006|Overall Study|Lost to Follow-up|1|||
126282699|NCT03743415|454322949|FG007|Overall Study|Lost to Follow-up|4|||
126282700|NCT03743415|454322950|FG008|Overall Study|Lost to Follow-up|13|||
126766005|NCT04409509|456095878|FG001|Overall Study|Adverse Event|1|||
126282701|NCT03743415|454322951|FG009|Overall Study|Lost to Follow-up|13|||
126282702|NCT02242045|454322955|FG000|Overall Study|Investigator's Discretion|1|||
126282703|NCT02242045|454322955|FG000|Overall Study|Progressive Disease|2|||
126282704|NCT02242045|454322955|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
126282705|NCT02242045|454322955|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
126282706|NCT02473523|454322956|FG000|Overall Study|Death|1|||
126282707|NCT02473523|454322956|FG000|Overall Study|Lost to Follow-up|1|||
126282708|NCT00976911|454322959|FG000|Overall Study|Withdrawal by Subject|4|||
126282709|NCT00976911|454322960|FG001|Overall Study|Withdrawal by Subject|6|||
126282710|NCT00976911|454322959|FG000|Overall Study|Death|138|||
126282711|NCT00976911|454322960|FG001|Overall Study|Death|126|||
126282712|NCT00976911|454322959|FG000|Overall Study|Adverse Event|0|||
126282713|NCT00976911|454322960|FG001|Overall Study|Adverse Event|1|||
126282714|NCT00976911|454322959|FG000|Overall Study|Protocol Violation|2|||
126282715|NCT00976911|454322960|FG001|Overall Study|Protocol Violation|0|||
126282716|NCT00976911|454322959|FG000|Overall Study|Other|8|||
126282717|NCT00976911|454322960|FG001|Overall Study|Other|9|||
126282718|NCT00976911|454322959|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
126282719|NCT00976911|454322960|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
126282720|NCT00576316|454322961|FG000|Overall Study|Adverse Event|9|||
126282721|NCT00576316|454322961|FG000|Overall Study|Withdrawal by Subject|2|||
126282722|NCT00576316|454322961|FG000|Overall Study|Protocol Violation|9|||
126282723|NCT04893018|454322964|FG000|Overall Study|Lost to Follow-up|1|||
126282724|NCT04893018|454322965|FG001|Overall Study|Lost to Follow-up|0|||
126282725|NCT04893018|454322964|FG000|Overall Study|Withdrawal by Subject|2|||
126282726|NCT04893018|454322965|FG001|Overall Study|Withdrawal by Subject|0|||
126282727|NCT04893018|454322964|FG000|Overall Study|Study Terminated|1|||
126282728|NCT04893018|454322965|FG001|Overall Study|Study Terminated|2|||
126282729|NCT00005957|454322967|FG000|Overall Study|No treated|3|||
126282730|NCT00005957|454322968|FG001|Overall Study|No treated|9|||
126282731|NCT00005957|454322967|FG000|Overall Study|Crossover to the other arm|5|||
126282732|NCT00005957|454322968|FG001|Overall Study|Crossover to the other arm|19|||
126282733|NCT00799825|454322969|FG000|Overall Study|Adverse Event|1|||
126282734|NCT00799825|454322969|FG000|Overall Study|Withdrawal by Subject|6|||
126282735|NCT00799825|454322969|FG000|Overall Study|Lost to Follow-up|38|||
126282736|NCT00799825|454322969|FG000|Overall Study|Pregnancy|3|||
126282737|NCT02439970|454322970|FG000|Overall Study|Study Terminated|2|||
126282738|NCT02439970|454322971|FG001|Overall Study|Study Terminated|3|||
126282739|NCT03717012|454322972|FG000|Overall Study|Due to trial termination|1|||
126282740|NCT03717012|454322973|FG001|Overall Study|Due to trial termination|2|||
126282741|NCT03717012|454322972|FG000|Overall Study|Protocol Violation|0|||
126282742|NCT03717012|454322973|FG001|Overall Study|Protocol Violation|2|||
126282743|NCT03717012|454322972|FG000|Overall Study|Adverse Event|0|||
126282744|NCT03717012|454322973|FG001|Overall Study|Adverse Event|1|||
126282745|NCT03717012|454322972|FG000|Overall Study|Lung transplant|0|||
126282746|NCT03717012|454322973|FG001|Overall Study|Lung transplant|1|||
126282747|NCT02640690|454322974|FG000|Overall Study|Lost to Follow-up|7|||
126282748|NCT02640690|454322975|FG001|Overall Study|Lost to Follow-up|7|||
126282749|NCT02640690|454322974|FG000|Overall Study|Withdrawal by Subject|16|||
126282750|NCT02640690|454322975|FG001|Overall Study|Withdrawal by Subject|20|||
126282751|NCT02640690|454322974|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
126282752|NCT02640690|454322975|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
126282753|NCT01520870|454322976|FG000|Overall Study|Withdrawal by Subject|2|||
126282754|NCT02910011|454322979|FG000|Overall Study|Physician Decision|2|||
126282755|NCT02463357|454322980|FG000|Overall Study|Withdrawal by Subject|1|||
126282756|NCT02463357|454322981|FG001|Overall Study|Withdrawal by Subject|0|||
126282757|NCT02463357|454322982|FG002|Overall Study|Withdrawal by Subject|0|||
126282758|NCT02463357|454322983|FG003|Overall Study|Withdrawal by Subject|0|||
126282759|NCT02463357|454322984|FG004|Overall Study|Withdrawal by Subject|0|||
126282760|NCT02463357|454322980|FG000|Overall Study|Withdrawal by Subject|0|||
126282761|NCT02463357|454322981|FG001|Overall Study|Withdrawal by Subject|0|||
126282762|NCT02463357|454322982|FG002|Overall Study|Withdrawal by Subject|0|||
126282763|NCT02463357|454322983|FG003|Overall Study|Withdrawal by Subject|0|||
126282764|NCT02463357|454322984|FG004|Overall Study|Withdrawal by Subject|1|||
126282765|NCT01399658|454322987|FG000|Overall Study|Ineligible|1|||
126282766|NCT01399658|454322987|FG000|Overall Study|Machine Technical Issue|3|||
126282767|NCT01399658|454322987|FG000|Overall Study|Alternative therapy|1|||
126282768|NCT01399658|454322987|FG000|Overall Study|No reason given|1|||
126282769|NCT02460679|454322988|FG000|Overall Study|Investigator Decision|1|||
126282770|NCT02460679|454322988|FG000|Overall Study|Withdrawal by Subject|4|||
126282771|NCT02620579|454322989|FG000|Overall Study|Physician Decision|0|||
126282772|NCT02620579|454322990|FG001|Overall Study|Physician Decision|0|||
126282773|NCT02620579|454322991|FG002|Overall Study|Physician Decision|0|||
126282774|NCT02620579|454322992|FG003|Overall Study|Physician Decision|1|||
126282775|NCT02620579|454322989|FG000|Overall Study|Withdrawal by Subject|0|||
126282776|NCT02620579|454322990|FG001|Overall Study|Withdrawal by Subject|1|||
126282777|NCT02620579|454322991|FG002|Overall Study|Withdrawal by Subject|1|||
126282778|NCT02620579|454322992|FG003|Overall Study|Withdrawal by Subject|0|||
126282779|NCT00796107|454322998|FG000|Overall Study|Lack of Efficacy|1|||
126282780|NCT00796107|454322998|FG000|Overall Study|Progressive Disease|5|||
126282781|NCT01721317|454323000|FG000|Overall Study|Study Closed / Terminated|2|||
126282782|NCT01721317|454323001|FG001|Overall Study|Study Closed / Terminated|2|||
126282783|NCT01721317|454323000|FG000|Overall Study|Physician Decision|0|||
126282784|NCT01721317|454323001|FG001|Overall Study|Physician Decision|1|||
126282785|NCT01721317|454323000|FG000|Overall Study|Withdrawal by Subject|0|||
126282786|NCT01721317|454323001|FG001|Overall Study|Withdrawal by Subject|1|||
126282787|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
126282788|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
126282789|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
126282790|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
126282791|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
126282792|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
126282793|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
126282794|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
126282795|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
126282796|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
126282797|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
126282798|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
126282799|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
126282800|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
126282801|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
126282802|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
126282803|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
126282804|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
126282805|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
126282806|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
126282807|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
126282808|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126282809|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
126282810|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126282811|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
126282812|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
126282813|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
126282814|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
126282815|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
126282816|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
126282817|NCT03713632|454323011|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
126282818|NCT03713632|454323012|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
126282819|NCT03713632|454323013|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
126282820|NCT03713632|454323014|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
126282821|NCT03713632|454323015|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
126282822|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
126282823|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
126282824|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
126282825|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
126282826|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
126282827|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
126282828|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
126282829|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
126282830|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
126282831|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
126282832|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
126282833|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
126282834|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
126282835|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
126282836|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
126282837|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
126282838|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
126282839|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
126282840|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
126456135|NCT01181986|454969112|FG000|Phase 1|Adverse Event|0|||
126282841|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
126282842|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
126282843|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
126282844|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
126456136|NCT01181986|454969113|FG001|Phase 1|Adverse Event|0|||
126282845|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
126282846|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
126282847|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
126282848|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
126282849|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
126282850|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
126282851|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
126282852|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Death|0|||
126282853|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Death|1|||
126282854|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Death|0|||
126282855|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Death|0|||
126282856|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Death|0|||
126282857|NCT03713632|454323011|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126282858|NCT03713632|454323012|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
126282859|NCT03713632|454323013|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126282860|NCT03713632|454323014|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126282861|NCT03713632|454323015|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
126282862|NCT02806024|454323016|FG000|Overall Study|Night Delivery|1|||
126282863|NCT02806024|454323017|FG001|Overall Study|Night Delivery|1|||
126282864|NCT02806024|454323016|FG000|Overall Study|DVT during antepartum admission|0|||
126282865|NCT02806024|454323017|FG001|Overall Study|DVT during antepartum admission|1|||
126282866|NCT02892149|454323018|FG000|Overall Study|Death|262|||
126282867|NCT02892149|454323019|FG001|Overall Study|Death|278|||
126282868|NCT02892149|454323018|FG000|Overall Study|Withdrawal by Subject|53|||
126282869|NCT02892149|454323019|FG001|Overall Study|Withdrawal by Subject|47|||
126282870|NCT02892149|454323018|FG000|Overall Study|Lost to Follow-up|37|||
126282871|NCT02892149|454323019|FG001|Overall Study|Lost to Follow-up|31|||
126282872|NCT01994850|454323020|FG000|Overall Study|Physician Decision|1|||
126282873|NCT01994850|454323020|FG000|Overall Study|Withdrawal by Subject|1|||
126282874|NCT00339144|454323023|FG000|Overall Study|Disease progression|5|||
126282875|NCT00339144|454323024|FG001|Overall Study|Disease progression|2|||
126282876|NCT00339144|454323025|FG002|Overall Study|Disease progression|2|||
126282877|NCT00339144|454323023|FG000|Overall Study|Study drug toxicity|3|||
126282878|NCT00339144|454323024|FG001|Overall Study|Study drug toxicity|1|||
126282879|NCT00339144|454323025|FG002|Overall Study|Study drug toxicity|1|||
126282880|NCT00339144|454323023|FG000|Overall Study|Participant's request to discontinuation|1|||
126282881|NCT00339144|454323024|FG001|Overall Study|Participant's request to discontinuation|0|||
126282882|NCT00339144|454323025|FG002|Overall Study|Participant's request to discontinuation|1|||
126282883|NCT02257385|454323026|FG000|Overall Study|Adverse Event|12|||
126282884|NCT02257385|454323027|FG001|Overall Study|Adverse Event|8|||
126282885|NCT02257385|454323026|FG000|Overall Study|Lack of Efficacy|1|||
126282886|NCT02257385|454323027|FG001|Overall Study|Lack of Efficacy|2|||
126282887|NCT02257385|454323026|FG000|Overall Study|Protocol Violation|5|||
126282888|NCT02257385|454323027|FG001|Overall Study|Protocol Violation|7|||
126282889|NCT02257385|454323026|FG000|Overall Study|Lost to Follow-up|0|||
126282890|NCT02257385|454323027|FG001|Overall Study|Lost to Follow-up|1|||
126282891|NCT02257385|454323026|FG000|Overall Study|Withdrawal by Subject|4|||
126282892|NCT02257385|454323027|FG001|Overall Study|Withdrawal by Subject|4|||
126282893|NCT04988087|454323031|FG000|Overall Study|Adverse Event|4|||
126282894|NCT04988087|454323032|FG001|Overall Study|Adverse Event|0|||
126282895|NCT04988087|454323033|FG002|Overall Study|Adverse Event|0|||
126282896|NCT04988087|454323034|FG003|Overall Study|Adverse Event|0|||
126282897|NCT04988087|454323031|FG000|Overall Study|Withdrawal by Subject|1|||
126282898|NCT04988087|454323032|FG001|Overall Study|Withdrawal by Subject|1|||
126282899|NCT04988087|454323033|FG002|Overall Study|Withdrawal by Subject|0|||
126282900|NCT04988087|454323034|FG003|Overall Study|Withdrawal by Subject|0|||
126282901|NCT04988087|454323031|FG000|Overall Study|Technical problems|7|||
126282902|NCT04988087|454323032|FG001|Overall Study|Technical problems|9|||
126282903|NCT04988087|454323033|FG002|Overall Study|Technical problems|1|||
126282904|NCT04988087|454323034|FG003|Overall Study|Technical problems|2|||
126282905|NCT02458287|454323035|FG000|Overall Study|Adverse Event|0|||
126282906|NCT02458287|454323036|FG001|Overall Study|Adverse Event|0|||
126282907|NCT02458287|454323037|FG002|Overall Study|Adverse Event|0|||
126282908|NCT02458287|454323038|FG003|Overall Study|Adverse Event|1|||
126282909|NCT02458287|454323035|FG000|Overall Study|Lost to Follow-up|0|||
126282910|NCT02458287|454323036|FG001|Overall Study|Lost to Follow-up|1|||
126282911|NCT02458287|454323037|FG002|Overall Study|Lost to Follow-up|1|||
126282912|NCT02458287|454323038|FG003|Overall Study|Lost to Follow-up|0|||
126282913|NCT02458287|454323035|FG000|Overall Study|Protocol Violation|0|||
126282914|NCT02458287|454323036|FG001|Overall Study|Protocol Violation|1|||
126282915|NCT02458287|454323037|FG002|Overall Study|Protocol Violation|0|||
126282916|NCT02458287|454323038|FG003|Overall Study|Protocol Violation|0|||
126282917|NCT02458287|454323035|FG000|Overall Study|Withdrawal by Subject|0|||
126282918|NCT02458287|454323036|FG001|Overall Study|Withdrawal by Subject|2|||
126364547|NCT01027351|454628393|FG002|Overall Study|Lost to Follow-up|0|||
126282919|NCT02458287|454323037|FG002|Overall Study|Withdrawal by Subject|2|||
126364548|NCT01027351|454628394|FG003|Overall Study|Lost to Follow-up|1|||
126364549|NCT01027351|454628395|FG004|Overall Study|Lost to Follow-up|6|||
126364550|NCT01027351|454628396|FG005|Overall Study|Lost to Follow-up|0|||
126364551|NCT01027351|454628391|FG000|Overall Study|Inappropriate enrollment|0|||
126364552|NCT01027351|454628392|FG001|Overall Study|Inappropriate enrollment|0|||
126364553|NCT01027351|454628393|FG002|Overall Study|Inappropriate enrollment|0|||
126364554|NCT01027351|454628394|FG003|Overall Study|Inappropriate enrollment|0|||
126364555|NCT01027351|454628395|FG004|Overall Study|Inappropriate enrollment|1|||
126364556|NCT01027351|454628396|FG005|Overall Study|Inappropriate enrollment|0|||
126364557|NCT01027351|454628391|FG000|Overall Study|Protocol Violation|1|||
126364558|NCT01027351|454628392|FG001|Overall Study|Protocol Violation|0|||
126364559|NCT01027351|454628393|FG002|Overall Study|Protocol Violation|0|||
126364560|NCT01027351|454628394|FG003|Overall Study|Protocol Violation|1|||
126364561|NCT01027351|454628395|FG004|Overall Study|Protocol Violation|1|||
126364562|NCT01027351|454628396|FG005|Overall Study|Protocol Violation|0|||
126364563|NCT02971137|454628397|FG000|Overall Study|Lost to Follow-up|44|||
126364564|NCT02971137|454628398|FG001|Overall Study|Lost to Follow-up|56|||
126364565|NCT02757963|454628399|FG000|Overall Study|Adverse Event|3|||
126364566|NCT02757963|454628399|FG000|Overall Study|Reached Stopping Criteria|1054|||
126364567|NCT02757963|454628399|FG000|Overall Study|Lost to Follow-up|5|||
126364568|NCT02757963|454628399|FG000|Overall Study|Physician Decision|1|||
126364569|NCT02757963|454628399|FG000|Overall Study|Withdrawal by Subject|34|||
126364570|NCT00911157|454628400|FG000|Overall Study|Adverse Event|4|||
126364571|NCT00911157|454628401|FG001|Overall Study|Adverse Event|1|||
126364572|NCT00911157|454628400|FG000|Overall Study|Withdrawal by Subject|1|||
126364573|NCT00911157|454628401|FG001|Overall Study|Withdrawal by Subject|1|||
126364574|NCT00911157|454628400|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
126364575|NCT00911157|454628401|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
126364576|NCT00911157|454628400|FG000|Overall Study|Need to treat for lung cancer|1|||
126364577|NCT00911157|454628401|FG001|Overall Study|Need to treat for lung cancer|0|||
126364578|NCT04650893|454628402|FG000|Overall Study|Lost to Follow-up|11|||
126364579|NCT04650893|454628403|FG001|Overall Study|Lost to Follow-up|10|||
126364580|NCT04650893|454628404|FG002|Overall Study|Lost to Follow-up|11|||
126364581|NCT05346640|454628410|FG000|Overall Study|Lack of Efficacy|2|||
126364582|NCT05346640|454628410|FG000|Overall Study|Lost to Follow-up|14|||
126364583|NCT05346640|454628410|FG000|Overall Study|Protocol Violation|4|||
126364584|NCT05346640|454628410|FG000|Overall Study|Withdrawal by Subject|2|||
126364585|NCT05346640|454628410|FG000|Overall Study|Physiological Complications|3|||
126364586|NCT05346640|454628410|FG000|Overall Study|Other Reason|3|||
126364587|NCT01197300|454630246|FG000|Overall Study|Lost to Follow-up|0|||
126364588|NCT01197300|454630247|FG001|Overall Study|Lost to Follow-up|1|||
126364589|NCT01197300|454630246|FG000|Overall Study|Protocol Violation|0|||
126364590|NCT01197300|454630247|FG001|Overall Study|Protocol Violation|1|||
126364591|NCT02113878|454630248|FG000|Overall Study|Adverse Event|1|||
126364592|NCT02113878|454630249|FG001|Overall Study|Adverse Event|0|||
126364593|NCT02113878|454630248|FG000|Overall Study|Withdrawal by Subject|1|||
126364594|NCT02113878|454630249|FG001|Overall Study|Withdrawal by Subject|0|||
126364595|NCT02113878|454630248|FG000|Overall Study|patient non-compliance|1|||
126364596|NCT02113878|454630249|FG001|Overall Study|patient non-compliance|0|||
126456137|NCT01181986|454969114|FG002|Phase 1|Adverse Event|1|||
126456138|NCT01181986|454969112|FG000|Phase 1|Protocol Violation|1|||
126364597|NCT04129398|454630252|FG000|Overall Study|Physician Decision|2|||
126364598|NCT03058952|454630253|FG000|Overall Study|Adverse Event|1|||
126364599|NCT03058952|454630254|FG001|Overall Study|Adverse Event|0|||
126364600|NCT03058952|454630253|FG000|Overall Study|Lost to Follow-up|15|||
126364601|NCT03058952|454630254|FG001|Overall Study|Lost to Follow-up|15|||
126364602|NCT03058952|454630253|FG000|Overall Study|Withdrawal by Subject|7|||
126364603|NCT03058952|454630254|FG001|Overall Study|Withdrawal by Subject|11|||
126364604|NCT03837509|454630257|FG000|Phase 1|Death|5|||
126364605|NCT03837509|454630258|FG001|Phase 1|Death|2|||
126364606|NCT03837509|454630259|FG002|Phase 1|Death|0|||
126364607|NCT03837509|454630260|FG003|Phase 1|Death|0|||
126364608|NCT03837509|454630261|FG004|Phase 1|Death|0|||
126364609|NCT03837509|454630257|FG000|Phase 2|Death|0|||
126364610|NCT03837509|454630258|FG001|Phase 2|Death|0|||
126364611|NCT03837509|454630259|FG002|Phase 2|Death|0|||
126364612|NCT03837509|454630260|FG003|Phase 2|Death|1|||
126364613|NCT03837509|454630261|FG004|Phase 2|Death|1|||
126364614|NCT01251965|454630262|FG000|Overall Study|Participant/physician decision|1|||
126364615|NCT01251965|454630263|FG001|Overall Study|Participant/physician decision|2|||
126364616|NCT01251965|454630264|FG002|Overall Study|Participant/physician decision|0|||
126364617|NCT01251965|454630262|FG000|Overall Study|Death|0|||
126364618|NCT01251965|454630263|FG001|Overall Study|Death|0|||
126364619|NCT01251965|454630264|FG002|Overall Study|Death|11|||
126364620|NCT02363283|454630265|FG000|Overall Study|Withdrawal by Subject|1|||
126364621|NCT02363283|454630265|FG000|Overall Study|Not eligible due to transaminitis|1|||
126364622|NCT00530257|454630271|FG000|Overall Study|Lost to Follow-up|1|||
126364623|NCT02410200|454630272|FG000|Overall Study|Adverse Event|2|||
126364624|NCT01897896|454630273|FG000|Overall Study|Death|1|||
126364625|NCT01897896|454630274|FG001|Overall Study|Death|0|||
126548965|NCT00197028|455303915|FG001|Overall Study|Other|6|||
126548966|NCT00885352|455303920|FG000|Overall Study|Adverse Event|2|||
126548967|NCT00885352|455303921|FG001|Overall Study|Adverse Event|3|||
126548968|NCT00885352|455303920|FG000|Overall Study|Lost to Follow-up|2|||
126548969|NCT00885352|455303921|FG001|Overall Study|Lost to Follow-up|2|||
126548970|NCT00885352|455303920|FG000|Overall Study|Physician Decision|0|||
126548971|NCT00885352|455303921|FG001|Overall Study|Physician Decision|3|||
126548972|NCT00885352|455303920|FG000|Overall Study|Protocol Violation|0|||
126548973|NCT00885352|455303921|FG001|Overall Study|Protocol Violation|2|||
126548974|NCT00885352|455303920|FG000|Overall Study|Withdrawal by Subject|1|||
126548975|NCT00885352|455303921|FG001|Overall Study|Withdrawal by Subject|5|||
126548976|NCT00885352|455303920|FG000|Overall Study|Contradiction to study medication|0|||
126548977|NCT00885352|455303921|FG001|Overall Study|Contradiction to study medication|2|||
126548978|NCT00885352|455303920|FG000|Overall Study|Excluded medication|2|||
126548979|NCT00885352|455303921|FG001|Overall Study|Excluded medication|2|||
126548980|NCT00885352|455303920|FG000|Overall Study|Lab abnormalities|1|||
126548981|NCT00885352|455303921|FG001|Overall Study|Lab abnormalities|1|||
126548982|NCT00669903|455303924|FG000|Overall Study|Adverse Event|0|||
126548983|NCT00669903|455303925|FG001|Overall Study|Adverse Event|1|||
126548984|NCT00669903|455303926|FG002|Overall Study|Adverse Event|3|||
126548985|NCT00669903|455303927|FG003|Overall Study|Adverse Event|1|||
126548986|NCT00669903|455303924|FG000|Overall Study|Withdrawal by Subject|0|||
126548987|NCT00669903|455303925|FG001|Overall Study|Withdrawal by Subject|2|||
126548988|NCT00669903|455303926|FG002|Overall Study|Withdrawal by Subject|2|||
126548989|NCT00669903|455303927|FG003|Overall Study|Withdrawal by Subject|2|||
126548990|NCT00669903|455303924|FG000|Overall Study|Lost to Follow-up|1|||
126709023|NCT03952650|455887912|FG001|Overall Study|TRAVEL|4|||
126709024|NCT03952650|455887913|FG002|Overall Study|TRAVEL|0|||
126709025|NCT03952650|455887914|FG003|Overall Study|TRAVEL|4|||
126709026|NCT03952650|455887915|FG004|Overall Study|TRAVEL|0|||
126709027|NCT03952650|455887916|FG005|Overall Study|TRAVEL|3|||
126282920|NCT02458287|454323038|FG003|Overall Study|Withdrawal by Subject|1|||
126282921|NCT02458287|454323035|FG000|Overall Study|Relocated Out of State|0|||
126282922|NCT02458287|454323036|FG001|Overall Study|Relocated Out of State|0|||
126282923|NCT02458287|454323037|FG002|Overall Study|Relocated Out of State|0|||
126282924|NCT02458287|454323038|FG003|Overall Study|Relocated Out of State|1|||
126282925|NCT02800642|454323041|FG000|Overall Study|Death|3|||
126282926|NCT02800642|454323041|FG000|Overall Study|Other|10|||
126282927|NCT02800642|454323041|FG000|Overall Study|Physician Decision|2|||
126282928|NCT02800642|454323041|FG000|Overall Study|Adverse Event|6|||
126282929|NCT02800642|454323041|FG000|Overall Study|Withdrawal by Subject|3|||
126282930|NCT02800642|454323041|FG000|Overall Study|Lost to Follow-up|1|||
126282931|NCT03371459|454323048|FG000|Washout|Lost to Follow-up|0|||
126282932|NCT03371459|454323049|FG001|Washout|Lost to Follow-up|1|||
126282933|NCT01589497|454323050|FG000|Overall Study|Withdrawal by Subject|0|||
126282934|NCT01589497|454323051|FG001|Overall Study|Withdrawal by Subject|1|||
126282935|NCT01589497|454323052|FG002|Overall Study|Withdrawal by Subject|0|||
126282936|NCT01589497|454323053|FG003|Overall Study|Withdrawal by Subject|1|||
126282937|NCT01589497|454323050|FG000|Overall Study|Death|1|||
126282938|NCT01589497|454323051|FG001|Overall Study|Death|0|||
126282939|NCT01589497|454323052|FG002|Overall Study|Death|0|||
126282940|NCT01589497|454323053|FG003|Overall Study|Death|0|||
126282941|NCT01589497|454323050|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
126282942|NCT01589497|454323051|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
126282943|NCT01589497|454323052|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
126282944|NCT01589497|454323053|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
126282945|NCT02521376|454323056|FG000|Overall Study|Enrolled, But Not Treated|1|||
126282946|NCT02521376|454323057|FG001|Overall Study|Enrolled, But Not Treated|0|||
126282947|NCT02521376|454323058|FG002|Overall Study|Enrolled, But Not Treated|0|||
126282948|NCT02521376|454323059|FG003|Overall Study|Enrolled, But Not Treated|0|||
126282949|NCT03597464|454323064|FG000|Overall Study|Withdrawal by Subject|4|||
126282950|NCT03597464|454323065|FG001|Overall Study|Withdrawal by Subject|5|||
126282951|NCT03597464|454323064|FG000|Overall Study|Lost to Follow-up|3|||
126282952|NCT03597464|454323065|FG001|Overall Study|Lost to Follow-up|1|||
126282953|NCT03597464|454323064|FG000|Overall Study|Pregnancy|3|||
126282954|NCT03597464|454323065|FG001|Overall Study|Pregnancy|1|||
126282955|NCT03597464|454323064|FG000|Overall Study|Lack of Efficacy|2|||
126282956|NCT03597464|454323065|FG001|Overall Study|Lack of Efficacy|0|||
126282957|NCT03597464|454323064|FG000|Overall Study|Physician Decision|2|||
126282958|NCT03597464|454323065|FG001|Overall Study|Physician Decision|2|||
126282959|NCT03597464|454323064|FG000|Overall Study|Protocol Violation|1|||
126282960|NCT03597464|454323065|FG001|Overall Study|Protocol Violation|1|||
126282961|NCT03597464|454323064|FG000|Overall Study|Adverse Event|0|||
126282962|NCT03597464|454323065|FG001|Overall Study|Adverse Event|2|||
126282963|NCT03597464|454323064|FG000|Overall Study|Death|0|||
126282964|NCT03597464|454323065|FG001|Overall Study|Death|3|||
126548991|NCT00669903|455303925|FG001|Overall Study|Lost to Follow-up|1|||
126548992|NCT00669903|455303926|FG002|Overall Study|Lost to Follow-up|0|||
126709028|NCT03952650|455887917|FG006|Overall Study|TRAVEL|2|||
126709029|NCT03952650|455887911|FG000|Overall Study|Withdrawal by Subject|0|||
126709030|NCT03952650|455887912|FG001|Overall Study|Withdrawal by Subject|2|||
126709031|NCT03952650|455887913|FG002|Overall Study|Withdrawal by Subject|0|||
126709032|NCT03952650|455887914|FG003|Overall Study|Withdrawal by Subject|3|||
126709033|NCT03952650|455887915|FG004|Overall Study|Withdrawal by Subject|0|||
126709034|NCT03952650|455887916|FG005|Overall Study|Withdrawal by Subject|1|||
126709035|NCT03952650|455887917|FG006|Overall Study|Withdrawal by Subject|1|||
126709036|NCT03952650|455887911|FG000|Overall Study|Lost to Follow-up|0|||
126709037|NCT03952650|455887912|FG001|Overall Study|Lost to Follow-up|1|||
126709038|NCT03952650|455887913|FG002|Overall Study|Lost to Follow-up|0|||
126709039|NCT03952650|455887914|FG003|Overall Study|Lost to Follow-up|0|||
126709040|NCT03952650|455887915|FG004|Overall Study|Lost to Follow-up|0|||
126709041|NCT03952650|455887916|FG005|Overall Study|Lost to Follow-up|1|||
126709042|NCT03952650|455887917|FG006|Overall Study|Lost to Follow-up|1|||
126709043|NCT03952650|455887911|FG000|Overall Study|Received wrong vaccine and travelled|0|||
126709044|NCT03952650|455887912|FG001|Overall Study|Received wrong vaccine and travelled|0|||
126709045|NCT03952650|455887913|FG002|Overall Study|Received wrong vaccine and travelled|0|||
126709046|NCT03952650|455887914|FG003|Overall Study|Received wrong vaccine and travelled|0|||
126709047|NCT03952650|455887915|FG004|Overall Study|Received wrong vaccine and travelled|0|||
126709048|NCT03952650|455887916|FG005|Overall Study|Received wrong vaccine and travelled|1|||
126709049|NCT03952650|455887917|FG006|Overall Study|Received wrong vaccine and travelled|0|||
126709050|NCT03952650|455887911|FG000|Overall Study|Unable to make study visit|0|||
126709051|NCT03952650|455887912|FG001|Overall Study|Unable to make study visit|0|||
126709052|NCT03952650|455887913|FG002|Overall Study|Unable to make study visit|0|||
126709053|NCT03952650|455887914|FG003|Overall Study|Unable to make study visit|0|||
126709054|NCT03952650|455887915|FG004|Overall Study|Unable to make study visit|0|||
126709055|NCT03952650|455887916|FG005|Overall Study|Unable to make study visit|1|||
126709056|NCT03952650|455887917|FG006|Overall Study|Unable to make study visit|0|||
126709057|NCT02424149|455887919|FG000|Overall Study|surgery cancelled|2|||
126709058|NCT02424149|455887920|FG001|Overall Study|surgery cancelled|0|||
126709059|NCT02424149|455887919|FG000|Overall Study|Withdrawal by Subject|0|||
126709060|NCT02424149|455887920|FG001|Overall Study|Withdrawal by Subject|1|||
126709061|NCT01025336|455887921|FG000|Overall Study|Protocol Violation|0|||
126709062|NCT01025336|455887922|FG001|Overall Study|Protocol Violation|0|||
126709063|NCT01025336|455887923|FG002|Overall Study|Protocol Violation|0|||
126709064|NCT01025336|455887924|FG003|Overall Study|Protocol Violation|2|||
126709065|NCT01025336|455887925|FG004|Overall Study|Protocol Violation|0|||
126709066|NCT03133481|455887928|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
126709067|NCT03133481|455887929|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
126709068|NCT00545818|455887930|FG000|Overall Study|Protocol Violation|1|||
126709069|NCT00545818|455887931|FG001|Overall Study|Protocol Violation|0|||
126709070|NCT00545818|455887930|FG000|Overall Study|Adverse Event|1|||
126709071|NCT00545818|455887931|FG001|Overall Study|Adverse Event|1|||
126709072|NCT00545818|455887930|FG000|Overall Study|Lost to Follow-up|1|||
126709073|NCT00545818|455887931|FG001|Overall Study|Lost to Follow-up|6|||
126709074|NCT00637728|455887932|FG000|Double-blind Phase|Adverse Event|1|||
126709075|NCT00637728|455887933|FG001|Double-blind Phase|Adverse Event|0|||
126282965|NCT02542605|454323068|FG000|Part B: Challenge Phase|Sponsor decision|1|||
126282966|NCT02542605|454323069|FG001|Part B: Challenge Phase|Sponsor decision|0|||
126709076|NCT00637728|455887934|FG002|Double-blind Phase|Adverse Event|0|||
126709077|NCT00637728|455887932|FG000|Double-blind Phase|Non-compliance|2|||
126709078|NCT00637728|455887933|FG001|Double-blind Phase|Non-compliance|0|||
126709079|NCT00637728|455887934|FG002|Double-blind Phase|Non-compliance|0|||
126709080|NCT00637728|455887932|FG000|Double-blind Phase|Study Discontinued|1|||
126709081|NCT00637728|455887933|FG001|Double-blind Phase|Study Discontinued|1|||
126709082|NCT00637728|455887934|FG002|Double-blind Phase|Study Discontinued|0|||
126709083|NCT01184989|455887937|FG000|Overall Study|Adverse Event|11|||
126709084|NCT01184989|455887937|FG000|Overall Study|Withdrawal by Subject|1|||
126282967|NCT02542605|454323070|FG002|Part B: Challenge Phase|Sponsor decision|0|||
126282968|NCT02542605|454323068|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
126282969|NCT02542605|454323069|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
126282970|NCT02542605|454323070|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
126282971|NCT02682927|454323072|FG000|Overall Study|Adverse Event|0|||
126282972|NCT02682927|454323073|FG001|Overall Study|Adverse Event|0|||
126282973|NCT02682927|454323074|FG002|Overall Study|Adverse Event|5|||
126282974|NCT02682927|454323075|FG003|Overall Study|Adverse Event|1|||
126282975|NCT02682927|454323076|FG004|Overall Study|Adverse Event|0|||
126282976|NCT02682927|454323077|FG005|Overall Study|Adverse Event|2|||
126282977|NCT02682927|454323072|FG000|Overall Study|Death|0|||
126282978|NCT02682927|454323073|FG001|Overall Study|Death|0|||
126282979|NCT02682927|454323074|FG002|Overall Study|Death|0|||
126282980|NCT02682927|454323075|FG003|Overall Study|Death|1|||
126282981|NCT02682927|454323076|FG004|Overall Study|Death|0|||
126282982|NCT02682927|454323077|FG005|Overall Study|Death|0|||
126282983|NCT02682927|454323072|FG000|Overall Study|Lack of Efficacy|1|||
126282984|NCT02682927|454323073|FG001|Overall Study|Lack of Efficacy|0|||
126709085|NCT01570491|455887938|FG000|Overall Study|Lost to Follow-up|3|||
126709086|NCT01570491|455887939|FG001|Overall Study|Lost to Follow-up|1|||
126282985|NCT02682927|454323074|FG002|Overall Study|Lack of Efficacy|0|||
126282986|NCT02682927|454323075|FG003|Overall Study|Lack of Efficacy|1|||
126282987|NCT02682927|454323076|FG004|Overall Study|Lack of Efficacy|0|||
126282988|NCT02682927|454323077|FG005|Overall Study|Lack of Efficacy|0|||
126282989|NCT02682927|454323072|FG000|Overall Study|Other|0|||
126282990|NCT02682927|454323073|FG001|Overall Study|Other|0|||
126282991|NCT02682927|454323074|FG002|Overall Study|Other|0|||
126282992|NCT02682927|454323075|FG003|Overall Study|Other|2|||
126282993|NCT02682927|454323076|FG004|Overall Study|Other|0|||
126282994|NCT02682927|454323077|FG005|Overall Study|Other|0|||
126282995|NCT02682927|454323072|FG000|Overall Study|Withdrawal by Subject|2|||
126282996|NCT02682927|454323073|FG001|Overall Study|Withdrawal by Subject|0|||
126282997|NCT02682927|454323074|FG002|Overall Study|Withdrawal by Subject|1|||
126282998|NCT02682927|454323075|FG003|Overall Study|Withdrawal by Subject|0|||
126456139|NCT01181986|454969113|FG001|Phase 1|Protocol Violation|0|||
126456140|NCT01181986|454969114|FG002|Phase 1|Protocol Violation|0|||
126456141|NCT01181986|454969112|FG000|Phase 2|Adverse Event|0|||
126456142|NCT01181986|454969113|FG001|Phase 2|Adverse Event|3|||
126456143|NCT01181986|454969114|FG002|Phase 2|Adverse Event|0|||
126456144|NCT01181986|454969112|FG000|Phase 2|Medical condition|0|||
126456145|NCT01181986|454969113|FG001|Phase 2|Medical condition|1|||
126456146|NCT01181986|454969114|FG002|Phase 2|Medical condition|0|||
126456147|NCT00311584|454969117|FG000|Overall Study|Death|1|||
126456148|NCT00311584|454969118|FG001|Overall Study|Death|0|||
126456149|NCT00311584|454969117|FG000|Overall Study|Lack of Efficacy|12|||
126456150|NCT00311584|454969118|FG001|Overall Study|Lack of Efficacy|15|||
126456151|NCT00311584|454969117|FG000|Overall Study|Physician Decision|4|||
126456152|NCT00311584|454969118|FG001|Overall Study|Physician Decision|5|||
126456153|NCT00311584|454969117|FG000|Overall Study|Withdrawal by Subject|1|||
126456154|NCT00311584|454969118|FG001|Overall Study|Withdrawal by Subject|1|||
126456155|NCT00311584|454969117|FG000|Overall Study|ineligible|2|||
126456156|NCT00311584|454969118|FG001|Overall Study|ineligible|2|||
126456157|NCT03720652|454969119|FG000|Overall Study|Withdrawal by Subject|2|||
126456158|NCT03720652|454969120|FG001|Overall Study|Withdrawal by Subject|7|||
126456159|NCT03720652|454969119|FG000|Overall Study|Lost to Follow-up|0|||
126456160|NCT03720652|454969120|FG001|Overall Study|Lost to Follow-up|4|||
126456161|NCT03073733|454969121|FG000|Overall Study|Lost to Follow-up|1|||
126282999|NCT02682927|454323076|FG004|Overall Study|Withdrawal by Subject|1|||
126283000|NCT02682927|454323077|FG005|Overall Study|Withdrawal by Subject|1|||
126283001|NCT00340678|454323086|FG000|Overall Study|Lost to Follow-up|1|||
126283002|NCT00340678|454323087|FG001|Overall Study|Lost to Follow-up|0|||
126283003|NCT00340678|454323088|FG002|Overall Study|Lost to Follow-up|0|||
126283004|NCT00340678|454323089|FG003|Overall Study|Lost to Follow-up|0|||
126283005|NCT02766283|454323090|FG000|Overall Study|Lost to Follow-up|27|||
126283006|NCT04007991|454323091|FG000|Overall Study|Withdrawal by Subject|1|||
126283007|NCT04007991|454323092|FG001|Overall Study|Withdrawal by Subject|1|||
126283008|NCT04007991|454323091|FG000|Overall Study|Physician Decision|1|||
126283009|NCT04007991|454323092|FG001|Overall Study|Physician Decision|1|||
126283010|NCT04007991|454323091|FG000|Overall Study|Non-compliance with Study Drug|0|||
126283011|NCT04007991|454323092|FG001|Overall Study|Non-compliance with Study Drug|1|||
126283012|NCT04007991|454323091|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
126283013|NCT04007991|454323092|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
126283014|NCT04007991|454323091|FG000|Overall Study|Adverse event, non-fatal|5|||
126283015|NCT04007991|454323092|FG001|Overall Study|Adverse event, non-fatal|0|||
126283016|NCT04007991|454323091|FG000|Overall Study|Lost to Follow-up|2|||
126283017|NCT04007991|454323092|FG001|Overall Study|Lost to Follow-up|1|||
126283018|NCT05314816|454323093|FG000|Overall Study|Lost to Follow-up|5|||
126283019|NCT05314816|454323094|FG001|Overall Study|Lost to Follow-up|0|||
126283020|NCT05314816|454323095|FG002|Overall Study|Lost to Follow-up|1|||
126283021|NCT05314816|454323093|FG000|Overall Study|Protocol Violation|13|||
126283022|NCT05314816|454323094|FG001|Overall Study|Protocol Violation|8|||
126283023|NCT05314816|454323095|FG002|Overall Study|Protocol Violation|0|||
126283024|NCT01810302|454324640|FG000|Overall Study|Death|1|||
126283025|NCT01810302|454324641|FG001|Overall Study|Death|0|||
126283026|NCT01810302|454324640|FG000|Overall Study|Physician Decision|0|||
126283027|NCT01810302|454324641|FG001|Overall Study|Physician Decision|1|||
126283028|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #1|24|||
126283029|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #1|0|||
126283030|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
126283031|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
126283032|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283033|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283034|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
126283035|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
126283036|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
126283037|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
126306288|NCT03063086|454410266|FG002|Overall Study|subject/guardian decision|0|||
126456162|NCT03073733|454969122|FG001|Overall Study|Lost to Follow-up|0|||
126283038|NCT03888066|454324645|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283039|NCT03888066|454324646|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283040|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283041|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283042|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
126283043|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
126283044|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283045|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283046|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
126283047|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283048|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #2|5|||
126283049|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #2|0|||
126283050|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
126283051|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
126283052|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
126283053|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
126283054|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
126283055|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
126283056|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #3|11|||
126283057|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #3|0|||
126283058|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
126283059|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
126283060|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
126283061|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
126283062|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283063|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126456163|NCT03073733|454969123|FG002|Overall Study|Lost to Follow-up|0|||
126456164|NCT03073733|454969121|FG000|Overall Study|Physician Decision|0|||
126456165|NCT03073733|454969122|FG001|Overall Study|Physician Decision|1|||
126456166|NCT03073733|454969123|FG002|Overall Study|Physician Decision|0|||
126456167|NCT03073733|454969121|FG000|Overall Study|Withdrawal by Subject|0|||
126456168|NCT03073733|454969122|FG001|Overall Study|Withdrawal by Subject|0|||
126456169|NCT03073733|454969123|FG002|Overall Study|Withdrawal by Subject|1|||
126456170|NCT01454778|454969128|FG000|Overall Study|Lost to Follow-up|2|||
126456171|NCT01454778|454969128|FG000|Overall Study|Death|1|||
126456172|NCT00835731|454969129|FG000|Overall Study|Withdrawal by Subject|1|||
126456173|NCT00835731|454969130|FG001|Overall Study|Withdrawal by Subject|0|||
126456174|NCT00835731|454969129|FG000|Overall Study|Physician Decision|1|||
126456175|NCT00835731|454969130|FG001|Overall Study|Physician Decision|1|||
126456176|NCT00348881|454969131|FG000|Overall Study|Lost to Follow-up|12|||
126456177|NCT00348881|454969132|FG001|Overall Study|Lost to Follow-up|6|||
126456178|NCT00348881|454969131|FG000|Overall Study|Withdrawal by Subject|3|||
126456179|NCT00348881|454969132|FG001|Overall Study|Withdrawal by Subject|4|||
126283064|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #4|3|||
126283065|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #4|0|||
126283066|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
126456180|NCT00348881|454969131|FG000|Overall Study|Adverse Event|2|||
126456181|NCT00348881|454969132|FG001|Overall Study|Adverse Event|0|||
126456182|NCT00348881|454969131|FG000|Overall Study|Serious Adverse Event|0|||
126456183|NCT00348881|454969132|FG001|Overall Study|Serious Adverse Event|2|||
126456184|NCT00167778|454969133|FG000|Overall Study|Withdrawal by Subject|1|||
126456185|NCT02654717|454969134|FG000|Overall Study|Adverse Event|2|||
126456186|NCT02654717|454969135|FG001|Overall Study|Adverse Event|2|||
126456187|NCT02654717|454969134|FG000|Overall Study|Protocol Violation|1|||
126456188|NCT02654717|454969135|FG001|Overall Study|Protocol Violation|2|||
126364626|NCT01897896|454630273|FG000|Overall Study|Adverse Event|11|||
126364627|NCT01897896|454630274|FG001|Overall Study|Adverse Event|1|||
126364628|NCT01897896|454630273|FG000|Overall Study|Lost to Follow-up|1|||
126364629|NCT01897896|454630274|FG001|Overall Study|Lost to Follow-up|0|||
126364630|NCT01897896|454630273|FG000|Overall Study|Non-compliance with study drug dosing|1|||
126364631|NCT01897896|454630274|FG001|Overall Study|Non-compliance with study drug dosing|1|||
126364632|NCT01897896|454630273|FG000|Overall Study|Withdrawal by Subject|7|||
126364633|NCT01897896|454630274|FG001|Overall Study|Withdrawal by Subject|1|||
126364634|NCT01897896|454630273|FG000|Overall Study|Require drug that interfere with study|1|||
126364635|NCT01897896|454630274|FG001|Overall Study|Require drug that interfere with study|4|||
126364636|NCT01897896|454630273|FG000|Overall Study|Protocol Violation|1|||
126364637|NCT01897896|454630274|FG001|Overall Study|Protocol Violation|1|||
126364638|NCT01897896|454630273|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
126548993|NCT00669903|455303927|FG003|Overall Study|Lost to Follow-up|1|||
126364639|NCT01897896|454630274|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
126364640|NCT01897896|454630273|FG000|Overall Study|Caregiver can no longer participate|0|||
126364641|NCT01897896|454630274|FG001|Overall Study|Caregiver can no longer participate|2|||
126283067|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
126283068|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
126283069|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
126283070|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
126283071|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
126283072|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
126364642|NCT01897896|454630273|FG000|Overall Study|Other than specified|2|||
126364643|NCT01897896|454630274|FG001|Overall Study|Other than specified|1|||
126364644|NCT02801578|454630291|FG000|Overall Study|Adverse Event|2|||
126364645|NCT00668642|454630292|FG000|First Off-cycle|Cancer progression|1|||
126364646|NCT00668642|454630293|FG001|First Off-cycle|Cancer progression|0|||
126364647|NCT00668642|454630292|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
126364648|NCT00668642|454630293|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
126364649|NCT02003898|454630294|FG000|Overall Study|Death|3|||
126364650|NCT02003898|454630294|FG000|Overall Study|Lost to Follow-up|12|||
126364651|NCT02003898|454630294|FG000|Overall Study|Withdrawal by Subject|52|||
126364652|NCT03682367|454630297|FG000|Overall Study|Protocol Violation|2|||
126364653|NCT03682367|454630298|FG001|Overall Study|Protocol Violation|1|||
126364654|NCT03682367|454630297|FG000|Overall Study|Closed Study Early|0|||
126364655|NCT03682367|454630298|FG001|Overall Study|Closed Study Early|3|||
126364656|NCT00770679|454630299|FG000|Overall Study|Lost to Follow-up|3|||
126364657|NCT00770679|454630299|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
126364658|NCT00129974|454630300|FG000|Overall Study|Other|1|||
126364659|NCT00414609|454630301|FG000|Core Study|Adverse Event|9|||
126364660|NCT00414609|454630302|FG001|Core Study|Adverse Event|11|||
126364661|NCT00414609|454630303|FG002|Core Study|Adverse Event|0|||
126364662|NCT00414609|454630301|FG000|Core Study|Abnormal laboratory values|0|||
126364663|NCT00414609|454630302|FG001|Core Study|Abnormal laboratory values|1|||
126364664|NCT00414609|454630303|FG002|Core Study|Abnormal laboratory values|0|||
126364665|NCT00414609|454630301|FG000|Core Study|Abnormal test procedure results|1|||
126364666|NCT00414609|454630302|FG001|Core Study|Abnormal test procedure results|1|||
126364667|NCT00414609|454630303|FG002|Core Study|Abnormal test procedure results|0|||
126283073|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
126456189|NCT02654717|454969134|FG000|Overall Study|Withdrawal by Subject|0|||
126456190|NCT02654717|454969135|FG001|Overall Study|Withdrawal by Subject|1|||
126456191|NCT02654717|454969134|FG000|Overall Study|Non-permitted medication|3|||
126456192|NCT02654717|454969135|FG001|Overall Study|Non-permitted medication|0|||
126456193|NCT01221272|454970805|FG000|Period 1|Adverse Event|2|||
126456194|NCT01221272|454970806|FG001|Period 1|Adverse Event|0|||
126456195|NCT01221272|454970805|FG000|Period 1|Consent Withdrawal|0|||
126456196|NCT01221272|454970806|FG001|Period 1|Consent Withdrawal|1|||
126283074|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
126283075|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283076|NCT03888066|454324645|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
126283077|NCT03888066|454324646|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
126283078|NCT03888066|454324645|FG000|Run-in Phase|AE (Adverse Event)|17|||
126283079|NCT03888066|454324646|FG001|Run-in Phase|AE (Adverse Event)|0|||
126283080|NCT03888066|454324645|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
126283081|NCT03888066|454324646|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
126283082|NCT03888066|454324645|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283083|NCT03888066|454324646|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283084|NCT03888066|454324645|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
126283085|NCT03888066|454324646|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283086|NCT03888066|454324645|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
126283087|NCT03888066|454324646|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
126283088|NCT03888066|454324645|FG000|Run-in Phase|Withdrawal by Subject|43|||
126283089|NCT03888066|454324646|FG001|Run-in Phase|Withdrawal by Subject|0|||
126283090|NCT03888066|454324645|FG000|Run-in Phase|AE; Physician Decision|1|||
126283091|NCT03888066|454324646|FG001|Run-in Phase|AE; Physician Decision|0|||
126364668|NCT00414609|454630301|FG000|Core Study|Protocol deviation|0|||
126364669|NCT00414609|454630302|FG001|Core Study|Protocol deviation|1|||
126364670|NCT00414609|454630303|FG002|Core Study|Protocol deviation|0|||
126364671|NCT00414609|454630301|FG000|Core Study|Patient withdrew consent|10|||
126364672|NCT00414609|454630302|FG001|Core Study|Patient withdrew consent|11|||
126364673|NCT00414609|454630303|FG002|Core Study|Patient withdrew consent|0|||
126364674|NCT00414609|454630301|FG000|Core Study|Lost to Follow-up|7|||
126456197|NCT01221272|454970805|FG000|Period 1|Significant Dosing Noncompliance|0|||
126283092|NCT03888066|454324645|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
126283093|NCT03888066|454324646|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
126283094|NCT03888066|454324645|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
126283095|NCT03888066|454324646|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
126283096|NCT03888066|454324645|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
126283097|NCT03888066|454324646|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
126283098|NCT03888066|454324645|FG000|Run-in Phase|Death|1|||
126283099|NCT03888066|454324646|FG001|Run-in Phase|Death|0|||
126283100|NCT03888066|454324645|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
126283101|NCT03888066|454324646|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
126283102|NCT03888066|454324645|FG000|Run-in Phase|Physician Decision|1|||
126283103|NCT03888066|454324646|FG001|Run-in Phase|Physician Decision|0|||
126364675|NCT00414609|454630302|FG001|Core Study|Lost to Follow-up|4|||
126364676|NCT00414609|454630303|FG002|Core Study|Lost to Follow-up|0|||
126364677|NCT00414609|454630301|FG000|Core Study|Administrative problems|0|||
126364678|NCT00414609|454630302|FG001|Core Study|Administrative problems|2|||
126364679|NCT00414609|454630303|FG002|Core Study|Administrative problems|0|||
126364680|NCT00414609|454630301|FG000|Core Study|Death|7|||
126364681|NCT00414609|454630302|FG001|Core Study|Death|14|||
126364682|NCT00414609|454630303|FG002|Core Study|Death|0|||
126364683|NCT00414609|454630301|FG000|Extension Study|Adverse Event|0|||
126364684|NCT00414609|454630302|FG001|Extension Study|Adverse Event|0|||
126364685|NCT00414609|454630303|FG002|Extension Study|Adverse Event|14|||
126364686|NCT00414609|454630301|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
126364687|NCT00414609|454630302|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
126364688|NCT00414609|454630303|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
126364689|NCT00414609|454630301|FG000|Extension Study|Withdrawal by Subject|0|||
126364690|NCT00414609|454630302|FG001|Extension Study|Withdrawal by Subject|0|||
126364691|NCT00414609|454630303|FG002|Extension Study|Withdrawal by Subject|13|||
126364692|NCT00414609|454630301|FG000|Extension Study|Lost to Follow-up|0|||
126364693|NCT00414609|454630302|FG001|Extension Study|Lost to Follow-up|0|||
126364694|NCT00414609|454630303|FG002|Extension Study|Lost to Follow-up|10|||
126364695|NCT00414609|454630301|FG000|Extension Study|Administrative problems|0|||
126364696|NCT00414609|454630302|FG001|Extension Study|Administrative problems|0|||
126364697|NCT00414609|454630303|FG002|Extension Study|Administrative problems|1|||
126364698|NCT00414609|454630301|FG000|Extension Study|Death|0|||
126364699|NCT00414609|454630302|FG001|Extension Study|Death|0|||
126364700|NCT00414609|454630303|FG002|Extension Study|Death|17|||
126364701|NCT00814983|454630308|FG000|Overall Study|Screen failure|1|||
126364702|NCT00814983|454630309|FG001|Overall Study|Screen failure|0|||
126364703|NCT00814983|454630308|FG000|Overall Study|Withdrawal by Subject|1|||
126364704|NCT00814983|454630309|FG001|Overall Study|Withdrawal by Subject|0|||
126364705|NCT00814983|454630308|FG000|Overall Study|Graft failure|1|||
126364706|NCT00814983|454630309|FG001|Overall Study|Graft failure|0|||
126364707|NCT03627468|454630310|FG000|Overall Study|Adverse Event|5|||
126364708|NCT03627468|454630311|FG001|Overall Study|Adverse Event|33|||
126364709|NCT03627468|454630310|FG000|Overall Study|Withdrawal by Subject|13|||
126364710|NCT03627468|454630311|FG001|Overall Study|Withdrawal by Subject|23|||
126364711|NCT03627468|454630310|FG000|Overall Study|Physician Decision|1|||
126364712|NCT03627468|454630311|FG001|Overall Study|Physician Decision|0|||
126364713|NCT03627468|454630310|FG000|Overall Study|Protocol Violation|0|||
126364714|NCT03627468|454630311|FG001|Overall Study|Protocol Violation|2|||
126364715|NCT03627468|454630310|FG000|Overall Study|Lost to Follow-up|10|||
126364716|NCT03627468|454630311|FG001|Overall Study|Lost to Follow-up|16|||
126364717|NCT03627468|454630310|FG000|Overall Study|Death|1|||
126364718|NCT03627468|454630311|FG001|Overall Study|Death|0|||
126364719|NCT03627468|454630310|FG000|Overall Study|Pregnancy|1|||
126364720|NCT03627468|454630311|FG001|Overall Study|Pregnancy|1|||
126364721|NCT03627468|454630310|FG000|Overall Study|Lack of Efficacy|0|||
126364722|NCT03627468|454630311|FG001|Overall Study|Lack of Efficacy|2|||
126364723|NCT03627468|454630310|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
126364724|NCT03627468|454630311|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
126364725|NCT01047540|454630312|FG000|Overall Study|Protocol Violation|1|||
126364726|NCT01047540|454630313|FG001|Overall Study|Protocol Violation|0|||
126364727|NCT01047540|454630314|FG002|Overall Study|Protocol Violation|0|||
126364728|NCT01047540|454630315|FG003|Overall Study|Protocol Violation|0|||
126364729|NCT01047540|454630316|FG004|Overall Study|Protocol Violation|0|||
126364730|NCT01047540|454630312|FG000|Overall Study|Lost to Follow-up|1|||
126364731|NCT01047540|454630313|FG001|Overall Study|Lost to Follow-up|0|||
126364732|NCT01047540|454630314|FG002|Overall Study|Lost to Follow-up|0|||
126364733|NCT01047540|454630315|FG003|Overall Study|Lost to Follow-up|0|||
126364734|NCT01047540|454630316|FG004|Overall Study|Lost to Follow-up|0|||
126364735|NCT01047540|454630312|FG000|Overall Study|Withdrawal by Subject|1|||
126364736|NCT01047540|454630313|FG001|Overall Study|Withdrawal by Subject|0|||
126364737|NCT01047540|454630314|FG002|Overall Study|Withdrawal by Subject|3|||
126364738|NCT01047540|454630315|FG003|Overall Study|Withdrawal by Subject|0|||
126364739|NCT01047540|454630316|FG004|Overall Study|Withdrawal by Subject|1|||
126364740|NCT01047540|454630312|FG000|Overall Study|Pregnancy|1|||
126283104|NCT03888066|454324645|FG000|Run-in Phase|Protocol Violation|13|||
126283105|NCT03888066|454324646|FG001|Run-in Phase|Protocol Violation|0|||
126283106|NCT03888066|454324645|FG000|Run-in Phase|Sponsor Request|34|||
126283107|NCT03888066|454324646|FG001|Run-in Phase|Sponsor Request|0|||
126283108|NCT03888066|454324645|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
126283109|NCT03888066|454324646|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
126283110|NCT03888066|454324645|FG000|Run-in Phase|Withdrawal Of Consent|1|||
126283111|NCT03888066|454324646|FG001|Run-in Phase|Withdrawal Of Consent|0|||
126283112|NCT03888066|454324645|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
126283113|NCT03888066|454324646|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
126283114|NCT03888066|454324645|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
126283115|NCT03888066|454324646|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
126283116|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
126283117|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
126283118|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
126283119|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
126283120|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
126283121|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
126283122|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
126283123|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
126283124|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
126283125|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
126283126|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
126283127|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
126283128|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
126283129|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
126283130|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
126283131|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
126283132|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
126283133|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
126283134|NCT03888066|454324645|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
126283135|NCT03888066|454324646|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
126283136|NCT03278626|454324647|FG000|Overall Study|Death|2|||
126283137|NCT03278626|454324647|FG000|Overall Study|Toxicity|1|||
126283138|NCT03278626|454324647|FG000|Overall Study|Disease Progression|2|||
126283139|NCT05013008|454324649|FG000|Overall Study|Exclusion from mBFAS|5|||
126283140|NCT05013008|454324650|FG001|Overall Study|Exclusion from mBFAS|25|||
126283141|NCT04981717|454324651|FG000|Overall Study|Protocol Violation|0|||
126283142|NCT04981717|454324652|FG001|Overall Study|Protocol Violation|3|||
126283143|NCT04981717|454324651|FG000|Overall Study|Adverse Event|1|||
126283144|NCT04981717|454324652|FG001|Overall Study|Adverse Event|3|||
126283145|NCT04981717|454324651|FG000|Overall Study|Pregnancy|1|||
126283146|NCT04981717|454324652|FG001|Overall Study|Pregnancy|0|||
126283147|NCT04981717|454324651|FG000|Overall Study|Physician Decision|1|||
126283148|NCT04981717|454324652|FG001|Overall Study|Physician Decision|0|||
126283149|NCT04981717|454324651|FG000|Overall Study|Sponsor Request|157|||
126283150|NCT04981717|454324652|FG001|Overall Study|Sponsor Request|172|||
126283151|NCT04981717|454324651|FG000|Overall Study|Lost to Follow-up|4|||
126283152|NCT04981717|454324652|FG001|Overall Study|Lost to Follow-up|5|||
126283153|NCT04981717|454324651|FG000|Overall Study|Withdrawal by Subject|50|||
126283154|NCT04981717|454324652|FG001|Overall Study|Withdrawal by Subject|37|||
126283155|NCT02207634|454324653|FG000|Overall Study|Withdrawal by Subject|21|||
126283156|NCT02207634|454324654|FG001|Overall Study|Withdrawal by Subject|31|||
126283157|NCT02207634|454324653|FG000|Overall Study|Lost to Follow-up|1|||
126283158|NCT02207634|454324654|FG001|Overall Study|Lost to Follow-up|0|||
126283159|NCT00887289|454324655|FG000|Overall Study|Lack of Efficacy|14|||
126283160|NCT00887289|454324655|FG000|Overall Study|Adverse Event|27|||
126283161|NCT00887289|454324655|FG000|Overall Study|Withdrawal by Subject|26|||
126283162|NCT00887289|454324655|FG000|Overall Study|Lost to Follow-up|8|||
126364741|NCT01047540|454630313|FG001|Overall Study|Pregnancy|0|||
126364742|NCT01047540|454630314|FG002|Overall Study|Pregnancy|0|||
126364743|NCT01047540|454630315|FG003|Overall Study|Pregnancy|0|||
126364744|NCT01047540|454630316|FG004|Overall Study|Pregnancy|0|||
126364745|NCT01047540|454630312|FG000|Overall Study|Adverse Event|1|||
126364746|NCT01047540|454630313|FG001|Overall Study|Adverse Event|0|||
126364747|NCT01047540|454630314|FG002|Overall Study|Adverse Event|0|||
126364748|NCT01047540|454630315|FG003|Overall Study|Adverse Event|0|||
126364749|NCT01047540|454630316|FG004|Overall Study|Adverse Event|0|||
126364750|NCT01437189|454630320|FG000|Overall Study|Adverse Event|3|||
126364751|NCT01437189|454630320|FG000|Overall Study|Lack of Efficacy|4|||
126364752|NCT01437189|454630320|FG000|Overall Study|Withdrawal by Subject|8|||
126364753|NCT03654326|454630321|FG000|Overall Study|Withdrawal by Subject|5|||
126364754|NCT03654326|454630322|FG001|Overall Study|Withdrawal by Subject|3|||
126364755|NCT03654326|454630321|FG000|Overall Study|Physician Decision|0|||
126364756|NCT03654326|454630322|FG001|Overall Study|Physician Decision|1|||
126709087|NCT01570491|455887938|FG000|Overall Study|treatment: not given or discontinued|2|||
126709088|NCT01570491|455887939|FG001|Overall Study|treatment: not given or discontinued|0|||
126709089|NCT03047213|455887940|FG000|Overall Study|Withdrawal by Subject|2|||
126709090|NCT03047213|455887941|FG001|Overall Study|Withdrawal by Subject|0|||
126709091|NCT03047213|455887940|FG000|Overall Study|Adverse Event|2|||
126709092|NCT03047213|455887941|FG001|Overall Study|Adverse Event|0|||
126709093|NCT00650585|455887946|FG000|Overall Study|Lost to Follow-up|505|||
126709094|NCT00650585|455887947|FG001|Overall Study|Lost to Follow-up|482|||
126709095|NCT00650585|455887946|FG000|Overall Study|No parental consent|935|||
126709096|NCT00650585|455887947|FG001|Overall Study|No parental consent|866|||
126709097|NCT00650585|455887946|FG000|Overall Study|Excluded/ruled ineligible|357|||
126709098|NCT00650585|455887947|FG001|Overall Study|Excluded/ruled ineligible|129|||
126709099|NCT04407507|455887949|FG000|Overall Study|Withdrawal by Subject|0|||
126709100|NCT04407507|455887950|FG001|Overall Study|Withdrawal by Subject|1|||
126709101|NCT00923091|455887951|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
126709102|NCT00923091|455887952|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
126709103|NCT00923091|455887953|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
126709104|NCT00923091|455887954|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
126709105|NCT00923091|455887955|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
126709106|NCT00923091|455887956|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
126709107|NCT00923091|455887957|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
126709108|NCT00923091|455887958|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
126709109|NCT00923091|455887959|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
126709110|NCT00923091|455887960|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
126709111|NCT00923091|455887961|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
126709112|NCT00923091|455887962|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
126709113|NCT00923091|455887963|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
126709114|NCT00923091|455887951|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
126709115|NCT00923091|455887952|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
126709116|NCT00923091|455887953|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
126709117|NCT00923091|455887954|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
126709118|NCT00923091|455887955|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
126709119|NCT00923091|455887956|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
126709120|NCT00923091|455887957|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
126709121|NCT00923091|455887958|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
126709122|NCT00923091|455887959|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
126709123|NCT00923091|455887960|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
126709124|NCT00923091|455887961|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
126709125|NCT00923091|455887962|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
126709126|NCT00923091|455887963|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
126709127|NCT00923091|455887951|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
126283163|NCT00887289|454324655|FG000|Overall Study|Other|20|||
126283164|NCT00591773|454324658|FG000|Overall Study|Adverse Event|9|||
126283165|NCT00591773|454324659|FG001|Overall Study|Adverse Event|9|||
126283166|NCT00591773|454324660|FG002|Overall Study|Adverse Event|6|||
126283167|NCT00591773|454324658|FG000|Overall Study|Protocol Violation|2|||
126283168|NCT00591773|454324659|FG001|Overall Study|Protocol Violation|3|||
126283169|NCT00591773|454324660|FG002|Overall Study|Protocol Violation|0|||
126283170|NCT00591773|454324658|FG000|Overall Study|Lost to Follow-up|1|||
126283171|NCT00591773|454324659|FG001|Overall Study|Lost to Follow-up|4|||
126283172|NCT00591773|454324660|FG002|Overall Study|Lost to Follow-up|1|||
126283173|NCT00591773|454324658|FG000|Overall Study|Withdrawal by Subject|2|||
126283174|NCT00591773|454324659|FG001|Overall Study|Withdrawal by Subject|5|||
126283175|NCT00591773|454324660|FG002|Overall Study|Withdrawal by Subject|3|||
126456198|NCT01221272|454970806|FG001|Period 1|Significant Dosing Noncompliance|1|||
126456199|NCT01221272|454970805|FG000|Period 2|Adverse Event|0|||
126456200|NCT01221272|454970806|FG001|Period 2|Adverse Event|2|||
126456201|NCT04839562|454970811|FG000|Overall Study|Withdrawal by Subject|0|||
126456202|NCT04839562|454970812|FG001|Overall Study|Withdrawal by Subject|1|||
126456203|NCT04839562|454970811|FG000|Overall Study|Physician Decision|0|||
126709128|NCT00923091|455887952|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
126283176|NCT00591773|454324658|FG000|Overall Study|Lack of Efficacy|1|||
126283177|NCT00591773|454324659|FG001|Overall Study|Lack of Efficacy|2|||
126283178|NCT00591773|454324660|FG002|Overall Study|Lack of Efficacy|2|||
126283179|NCT00591773|454324658|FG000|Overall Study|Other|1|||
126283180|NCT00591773|454324659|FG001|Overall Study|Other|1|||
126456204|NCT04839562|454970812|FG001|Overall Study|Physician Decision|1|||
126283181|NCT00591773|454324660|FG002|Overall Study|Other|4|||
126283182|NCT00459355|454324661|FG000|Overall Study|Subject no longer met inc criteria|20|||
126283183|NCT00459355|454324662|FG001|Overall Study|Subject no longer met inc criteria|18|||
126283184|NCT02135614|454324663|FG000|Overall Study|Randomized but Not Treated|2|||
126456205|NCT00877773|454970813|FG000|Overall Study|Disease Progression|44|||
126364757|NCT03654326|454630321|FG000|Overall Study|Unable to adhere to study schedule|0|||
126364758|NCT03654326|454630322|FG001|Overall Study|Unable to adhere to study schedule|1|||
126364759|NCT03654326|454630321|FG000|Overall Study|Lost to Follow-up|1|||
126364760|NCT03654326|454630322|FG001|Overall Study|Lost to Follow-up|1|||
126364761|NCT00835549|454630323|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
126364762|NCT00835549|454630324|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
126364763|NCT00619918|454630325|FG000|Overall Study|Withdrawal by Subject|4|||
126364764|NCT00619918|454630326|FG001|Overall Study|Withdrawal by Subject|3|||
126364765|NCT00619918|454630325|FG000|Overall Study|Physician Decision|2|||
126364766|NCT00619918|454630326|FG001|Overall Study|Physician Decision|4|||
126364767|NCT00619918|454630325|FG000|Overall Study|Transfer to outside facility|3|||
126364768|NCT00619918|454630326|FG001|Overall Study|Transfer to outside facility|3|||
126364769|NCT00619918|454630325|FG000|Overall Study|Left before receiving first dose|7|||
126364770|NCT00619918|454630326|FG001|Overall Study|Left before receiving first dose|6|||
126364771|NCT00619918|454630325|FG000|Overall Study|ICU admission|4|||
126364772|NCT00619918|454630326|FG001|Overall Study|ICU admission|6|||
126364773|NCT05524948|454630338|FG000|Overall Study|Withdrawal by Subject|1|||
126364774|NCT05524948|454630339|FG001|Overall Study|Withdrawal by Subject|0|||
126364775|NCT05524948|454630338|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
126364776|NCT05524948|454630339|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
126364777|NCT04661839|454630344|FG000|Overall Study|Not Treated|0|||
126364778|NCT04661839|454630345|FG001|Overall Study|Not Treated|0|||
126364779|NCT04661839|454630346|FG002|Overall Study|Not Treated|1|||
126364780|NCT04661839|454630347|FG003|Overall Study|Not Treated|0|||
126364781|NCT04661839|454630344|FG000|Overall Study|Lost to Follow-up|1|||
126364782|NCT04661839|454630345|FG001|Overall Study|Lost to Follow-up|0|||
126364783|NCT04661839|454630346|FG002|Overall Study|Lost to Follow-up|0|||
126364784|NCT04661839|454630347|FG003|Overall Study|Lost to Follow-up|1|||
126364785|NCT02758626|454630349|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
126364786|NCT02758626|454630350|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
126364787|NCT02758626|454630349|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
126364788|NCT02758626|454630350|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
126364789|NCT02758626|454630349|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
126364790|NCT02758626|454630350|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
126364791|NCT02758626|454630349|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
126364792|NCT02758626|454630350|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
126364793|NCT00855166|454630351|FG000|Overall Study|Adverse Event|0|||
126364794|NCT00855166|454630352|FG001|Overall Study|Adverse Event|2|||
126364795|NCT00855166|454630351|FG000|Overall Study|Death|0|||
126364796|NCT00855166|454630352|FG001|Overall Study|Death|1|||
126364797|NCT00855166|454630351|FG000|Overall Study|Withdrawal by Subject|1|||
126364798|NCT00855166|454630352|FG001|Overall Study|Withdrawal by Subject|4|||
126364799|NCT00855166|454630351|FG000|Overall Study|Poor/non-compliance|2|||
126364800|NCT00855166|454630352|FG001|Overall Study|Poor/non-compliance|0|||
126364801|NCT00855166|454630351|FG000|Overall Study|Administrative reasons by sponsor|1|||
126364802|NCT00855166|454630352|FG001|Overall Study|Administrative reasons by sponsor|0|||
126364803|NCT00855166|454630351|FG000|Overall Study|Subject no longer meets study criteria|1|||
126456206|NCT00003472|454970816|FG000|Overall Study|Not evaluable|3|||
126456207|NCT00528970|454970817|FG000|Overall Study|Adverse Event|6|||
126456208|NCT00528970|454970818|FG001|Overall Study|Adverse Event|8|||
126456209|NCT00528970|454970819|FG002|Overall Study|Adverse Event|5|||
126456210|NCT00528970|454970817|FG000|Overall Study|Lost to Follow-up|0|||
126456211|NCT00528970|454970818|FG001|Overall Study|Lost to Follow-up|0|||
126456212|NCT00528970|454970819|FG002|Overall Study|Lost to Follow-up|1|||
126456213|NCT00528970|454970817|FG000|Overall Study|Other than specified|2|||
126456214|NCT00528970|454970818|FG001|Overall Study|Other than specified|3|||
126456215|NCT00528970|454970819|FG002|Overall Study|Other than specified|3|||
126456216|NCT00528970|454970817|FG000|Overall Study|Protocol Violation|2|||
126456217|NCT00528970|454970818|FG001|Overall Study|Protocol Violation|1|||
126456218|NCT00528970|454970819|FG002|Overall Study|Protocol Violation|4|||
126456219|NCT00528970|454970817|FG000|Overall Study|Lack of Efficacy|0|||
126456220|NCT00528970|454970818|FG001|Overall Study|Lack of Efficacy|0|||
126456221|NCT00528970|454970819|FG002|Overall Study|Lack of Efficacy|1|||
126456222|NCT00528970|454970817|FG000|Overall Study|Withdrawal by Subject|4|||
126456223|NCT00528970|454970818|FG001|Overall Study|Withdrawal by Subject|3|||
126456224|NCT00528970|454970819|FG002|Overall Study|Withdrawal by Subject|5|||
126456225|NCT00528970|454970817|FG000|Overall Study|Randomized but not treated|0|||
126456226|NCT00528970|454970818|FG001|Overall Study|Randomized but not treated|0|||
126456227|NCT00528970|454970819|FG002|Overall Study|Randomized but not treated|1|||
126456228|NCT01673347|454970820|FG000|Overall Study|failure of allograft|7|||
126456229|NCT03086967|454970821|FG000|Overall Study|Screen Failure|2|||
126456230|NCT03086967|454970822|FG001|Overall Study|Screen Failure|2|||
126364804|NCT00855166|454630352|FG001|Overall Study|Subject no longer meets study criteria|1|||
126364805|NCT01848457|454630355|FG000|Overall Study|Death|1|||
126364806|NCT01848457|454630356|FG001|Overall Study|Death|0|||
126283185|NCT02135614|454324664|FG001|Overall Study|Randomized but Not Treated|1|||
126283186|NCT02135614|454324663|FG000|Overall Study|Adverse Event|0|||
126283187|NCT02135614|454324664|FG001|Overall Study|Adverse Event|1|||
126283188|NCT02135614|454324663|FG000|Overall Study|Death|1|||
126709129|NCT00923091|455887953|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
126709130|NCT00923091|455887954|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
126283189|NCT02135614|454324664|FG001|Overall Study|Death|0|||
126283190|NCT02135614|454324663|FG000|Overall Study|Investigator's Discretion|0|||
126283191|NCT02135614|454324664|FG001|Overall Study|Investigator's Discretion|1|||
126283192|NCT02135614|454324663|FG000|Overall Study|Withdrew Consent|2|||
126283193|NCT02135614|454324664|FG001|Overall Study|Withdrew Consent|2|||
126283194|NCT02135614|454324663|FG000|Overall Study|Lost to Follow-up|3|||
126364807|NCT01848457|454630357|FG002|Overall Study|Death|0|||
126364808|NCT01848457|454630358|FG003|Overall Study|Death|0|||
126364809|NCT01272219|454630359|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
126364810|NCT01272219|454630360|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
126364811|NCT01272219|454630361|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
126364812|NCT01272219|454630362|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
126364813|NCT01272219|454630363|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
126364814|NCT01272219|454630364|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
126364815|NCT01272219|454630359|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
126364816|NCT01272219|454630360|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
126364817|NCT01272219|454630361|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
126364818|NCT01272219|454630362|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
126364819|NCT01272219|454630363|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
126364820|NCT01272219|454630364|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
126364821|NCT01272219|454630359|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
126364822|NCT01272219|454630360|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
126364823|NCT01272219|454630361|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
126364824|NCT01272219|454630362|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
126364825|NCT01272219|454630363|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
126364826|NCT01272219|454630364|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
126364827|NCT01272219|454630359|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
126364828|NCT01272219|454630360|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
126364829|NCT01272219|454630361|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
126364830|NCT01272219|454630362|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
126364831|NCT01272219|454630363|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
126364832|NCT01272219|454630364|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
126364833|NCT01272219|454630359|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
126364834|NCT01272219|454630360|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
126364835|NCT01272219|454630361|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
126364836|NCT01272219|454630362|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
126364837|NCT01272219|454630363|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
126364838|NCT01272219|454630364|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
126364839|NCT01272219|454630359|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
126364840|NCT01272219|454630360|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
126364841|NCT01272219|454630361|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
126364842|NCT01272219|454630362|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
126364843|NCT01272219|454630363|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
126364844|NCT01272219|454630364|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
126364845|NCT01272219|454630359|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
126364846|NCT01272219|454630360|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
126364847|NCT01272219|454630361|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
126364848|NCT01272219|454630362|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
126364849|NCT01272219|454630363|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
126364850|NCT01272219|454630364|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
126364851|NCT01272219|454630359|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
126364852|NCT01272219|454630360|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
126364853|NCT01272219|454630361|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
126364854|NCT01272219|454630362|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
126364855|NCT01272219|454630363|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
126364856|NCT01272219|454630364|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
126364857|NCT01272219|454630359|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
126364858|NCT01272219|454630360|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
126364859|NCT01272219|454630361|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
126364860|NCT01272219|454630362|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
126364861|NCT01272219|454630363|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
126364862|NCT01272219|454630364|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
126364863|NCT01272219|454630359|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
126283195|NCT02135614|454324664|FG001|Overall Study|Lost to Follow-up|0|||
126283196|NCT01275729|454324673|FG000|Overall Study|Death|3|||
126283197|NCT01275729|454324673|FG000|Overall Study|Withdrawal by Subject|1|||
126283198|NCT00582010|454324676|FG000|Overall Study|Death|0|||
126283199|NCT00582010|454324677|FG001|Overall Study|Death|1|||
126283200|NCT02681510|454324678|FG000|Overall Study|Withdrawal by Subject|1|||
126283201|NCT02681510|454324678|FG000|Overall Study|Lost to Follow-up|9|||
126283202|NCT04315506|454324679|FG000|Overall Study|Lost to Follow-up|74|||
126283203|NCT04315506|454324680|FG001|Overall Study|Lost to Follow-up|82|||
126283204|NCT04315506|454324679|FG000|Overall Study|Withdrawal by Subject|8|||
126283205|NCT04315506|454324680|FG001|Overall Study|Withdrawal by Subject|8|||
126283206|NCT04315506|454324679|FG000|Overall Study|Physician Decision|0|||
126283207|NCT04315506|454324680|FG001|Overall Study|Physician Decision|1|||
126283208|NCT00958893|454324681|FG000|Overall Study|Study prematurely terminated|4|||
126283209|NCT03593395|454324682|FG000|Overall Study|Lost to Follow-up|48|||
126283210|NCT03593395|454324683|FG001|Overall Study|Lost to Follow-up|3|||
126283211|NCT03593395|454324682|FG000|Overall Study|Withdrawal by Subject|5|||
126283212|NCT03593395|454324683|FG001|Overall Study|Withdrawal by Subject|24|||
126456231|NCT00704522|454970828|FG000|Overall Study|Lack of Efficacy|65|||
126283213|NCT03593395|454324682|FG000|Overall Study|Death|2|||
126456232|NCT00704522|454970829|FG001|Overall Study|Lack of Efficacy|17|||
126456233|NCT00704522|454970828|FG000|Overall Study|Failure to appear again at hospital|56|||
126456234|NCT00704522|454970829|FG001|Overall Study|Failure to appear again at hospital|10|||
126456235|NCT00704522|454970828|FG000|Overall Study|Withdrawal by Subject|17|||
126456236|NCT00704522|454970829|FG001|Overall Study|Withdrawal by Subject|8|||
126456237|NCT00704522|454970828|FG000|Overall Study|Adverse Event|9|||
126283214|NCT03593395|454324683|FG001|Overall Study|Death|3|||
126283215|NCT03593395|454324682|FG000|Overall Study|Physician Decision|0|||
126283216|NCT03593395|454324683|FG001|Overall Study|Physician Decision|6|||
126283217|NCT03593395|454324682|FG000|Overall Study|Participant Relocated|19|||
126283218|NCT03593395|454324683|FG001|Overall Study|Participant Relocated|3|||
126283219|NCT03593395|454324682|FG000|Overall Study|No Information|1|||
126283220|NCT03593395|454324683|FG001|Overall Study|No Information|7|||
126283221|NCT00741338|454324684|FG000|Overall Study|Adverse Event|0|||
126283222|NCT00741338|454324685|FG001|Overall Study|Adverse Event|1|||
126283223|NCT01098474|454324688|FG000|Active Phase|Other|0|||
126283224|NCT01098474|454324689|FG001|Active Phase|Other|0|||
126283225|NCT01098474|454324690|FG002|Active Phase|Other|3|||
126283226|NCT01098474|454324691|FG003|Active Phase|Other|0|||
126283227|NCT01098474|454324692|FG004|Active Phase|Other|0|||
126283228|NCT01098474|454324693|FG005|Active Phase|Other|0|||
126283229|NCT01098474|454324688|FG000|Active Phase|Withdrawal by Subject|1|||
126283230|NCT01098474|454324689|FG001|Active Phase|Withdrawal by Subject|1|||
126283231|NCT01098474|454324690|FG002|Active Phase|Withdrawal by Subject|2|||
126283232|NCT01098474|454324691|FG003|Active Phase|Withdrawal by Subject|0|||
126283233|NCT01098474|454324692|FG004|Active Phase|Withdrawal by Subject|0|||
126283234|NCT01098474|454324693|FG005|Active Phase|Withdrawal by Subject|0|||
126283235|NCT01098474|454324688|FG000|Active Phase|Lost to Follow-up|1|||
126283236|NCT01098474|454324689|FG001|Active Phase|Lost to Follow-up|0|||
126283237|NCT01098474|454324690|FG002|Active Phase|Lost to Follow-up|0|||
126283238|NCT01098474|454324691|FG003|Active Phase|Lost to Follow-up|0|||
126283239|NCT01098474|454324692|FG004|Active Phase|Lost to Follow-up|0|||
126283240|NCT01098474|454324693|FG005|Active Phase|Lost to Follow-up|0|||
126283241|NCT01098474|454324688|FG000|Follow Up Phase|Travelled out of study area|0|||
126283242|NCT01098474|454324689|FG001|Follow Up Phase|Travelled out of study area|0|||
126283243|NCT01098474|454324690|FG002|Follow Up Phase|Travelled out of study area|0|||
126283244|NCT01098474|454324691|FG003|Follow Up Phase|Travelled out of study area|0|||
126283245|NCT01098474|454324692|FG004|Follow Up Phase|Travelled out of study area|1|||
126283246|NCT01098474|454324693|FG005|Follow Up Phase|Travelled out of study area|0|||
126283247|NCT01098474|454324688|FG000|Follow Up Phase|Other|0|||
126283248|NCT01098474|454324689|FG001|Follow Up Phase|Other|0|||
126283249|NCT01098474|454324690|FG002|Follow Up Phase|Other|0|||
126456238|NCT00704522|454970829|FG001|Overall Study|Adverse Event|1|||
126456239|NCT00704522|454970828|FG000|Overall Study|Undefined causes|9|||
126283250|NCT01098474|454324691|FG003|Follow Up Phase|Other|0|||
126283251|NCT01098474|454324692|FG004|Follow Up Phase|Other|0|||
126283252|NCT01098474|454324693|FG005|Follow Up Phase|Other|4|||
126283253|NCT01098474|454324688|FG000|Follow Up Phase|Withdrawal by Subject|0|||
126283254|NCT01098474|454324689|FG001|Follow Up Phase|Withdrawal by Subject|0|||
126283255|NCT01098474|454324690|FG002|Follow Up Phase|Withdrawal by Subject|0|||
126456240|NCT00704522|454970829|FG001|Overall Study|Undefined causes|7|||
126283256|NCT01098474|454324691|FG003|Follow Up Phase|Withdrawal by Subject|2|||
126283257|NCT01098474|454324692|FG004|Follow Up Phase|Withdrawal by Subject|0|||
126283258|NCT01098474|454324693|FG005|Follow Up Phase|Withdrawal by Subject|1|||
126283259|NCT01098474|454324688|FG000|Follow Up Phase|Lost to Follow-up|0|||
126283260|NCT01098474|454324689|FG001|Follow Up Phase|Lost to Follow-up|0|||
126283261|NCT01098474|454324690|FG002|Follow Up Phase|Lost to Follow-up|0|||
126283262|NCT01098474|454324691|FG003|Follow Up Phase|Lost to Follow-up|0|||
126283263|NCT01098474|454324692|FG004|Follow Up Phase|Lost to Follow-up|1|||
126709131|NCT00923091|455887955|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
126709132|NCT00923091|455887956|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
126709133|NCT00923091|455887957|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
126709134|NCT00923091|455887958|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
126709135|NCT00923091|455887959|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
126709136|NCT00923091|455887960|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
126709137|NCT00923091|455887961|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
126709138|NCT00923091|455887962|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
126709139|NCT00923091|455887963|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
126709140|NCT00923091|455887951|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126709141|NCT00923091|455887952|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126709142|NCT00923091|455887953|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126709143|NCT00923091|455887954|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126709144|NCT00923091|455887955|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126364864|NCT01272219|454630360|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
126709145|NCT00923091|455887956|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
126709146|NCT00923091|455887957|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126709147|NCT00923091|455887958|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126709148|NCT00923091|455887959|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126709149|NCT00923091|455887960|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126709150|NCT00923091|455887961|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126709151|NCT00923091|455887962|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126709152|NCT00923091|455887963|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
126709153|NCT00923091|455887951|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126709154|NCT00923091|455887952|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
126709155|NCT00923091|455887953|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126709156|NCT00923091|455887954|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
126709157|NCT00923091|455887955|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126709158|NCT00923091|455887956|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
126709159|NCT00923091|455887957|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126364865|NCT01272219|454630361|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
126364866|NCT01272219|454630362|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
126364867|NCT01272219|454630363|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
126364868|NCT01272219|454630364|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
126548994|NCT00669903|455303924|FG000|Overall Study|Protocol Violation|0|||
126548995|NCT00669903|455303925|FG001|Overall Study|Protocol Violation|1|||
126548996|NCT00669903|455303926|FG002|Overall Study|Protocol Violation|0|||
126548997|NCT00669903|455303927|FG003|Overall Study|Protocol Violation|0|||
126548998|NCT01827254|455303932|FG000|Overall Study|Death|10|||
126548999|NCT01827254|455303932|FG000|Overall Study|Case report form not completed|4|||
126549000|NCT01827254|455303932|FG000|Overall Study|Invalidated centre|3|||
126549001|NCT01827254|455303932|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
126549002|NCT01827254|455303932|FG000|Overall Study|Did not complete re-challenge|1|||
126549003|NCT01827254|455303932|FG000|Overall Study|Disease progression|36|||
126549004|NCT01827254|455303932|FG000|Overall Study|Intolerance to treatment|4|||
126549005|NCT01923389|455303933|FG000|Overall Study|Protocol Violation|1|||
126549006|NCT01923389|455303934|FG001|Overall Study|Protocol Violation|0|||
126549007|NCT03292146|455303935|FG000|Baseline to 12 Months|Relocation|1|||
126549008|NCT03292146|455303936|FG001|Baseline to 12 Months|Relocation|0|||
126549009|NCT03292146|455303935|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
126549010|NCT03292146|455303936|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
126709160|NCT00923091|455887958|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126709161|NCT00923091|455887959|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126709162|NCT00923091|455887960|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126709163|NCT00923091|455887961|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126709164|NCT00923091|455887962|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126709165|NCT00923091|455887963|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
126709166|NCT00923091|455887951|FG000|Period III (Single-Blind)|Adverse Event|5|||
126709167|NCT00923091|455887952|FG001|Period III (Single-Blind)|Adverse Event|0|||
126709168|NCT00923091|455887953|FG002|Period III (Single-Blind)|Adverse Event|0|||
126709169|NCT00923091|455887954|FG003|Period III (Single-Blind)|Adverse Event|0|||
126709170|NCT00923091|455887955|FG004|Period III (Single-Blind)|Adverse Event|0|||
126709171|NCT00923091|455887956|FG005|Period III (Single-Blind)|Adverse Event|0|||
126709172|NCT00923091|455887957|FG006|Period III (Single-Blind)|Adverse Event|0|||
126364869|NCT01272219|454630359|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
126549011|NCT03292146|455303935|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
126549012|NCT03292146|455303936|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
126549013|NCT03292146|455303935|FG000|12 Months to 24 Months|Planning pregnancy|2|||
126283264|NCT01098474|454324693|FG005|Follow Up Phase|Lost to Follow-up|0|||
126283265|NCT00101283|454324696|FG000|Overall Study|Withdrawal by Subject|0|||
126283266|NCT00101283|454324697|FG001|Overall Study|Withdrawal by Subject|1|||
126283267|NCT00101283|454324696|FG000|Overall Study|Insurance Refusal|0|||
126283268|NCT00101283|454324697|FG001|Overall Study|Insurance Refusal|1|||
126283269|NCT00101283|454324696|FG000|Overall Study|Prostate Cancer Recurrence|0|||
126283270|NCT00101283|454324697|FG001|Overall Study|Prostate Cancer Recurrence|1|||
126283271|NCT00595309|454324698|FG000|Overall Study|Lost to Follow-up|1|||
126283272|NCT00595309|454324698|FG000|Overall Study|planned vaccination against yellow fever|1|||
126283273|NCT00595309|454324698|FG000|Overall Study|acute infection after V0|1|||
126283274|NCT00595309|454324698|FG000|Overall Study|personal reason|1|||
126283275|NCT00626561|454324699|FG000|Overall Study|Withdrawal by Subject|2|||
126283276|NCT00626561|454324699|FG000|Overall Study|Disease Progression|2|||
126283277|NCT00398866|454324706|FG000|Overall Study|Adverse Event|1|||
126283278|NCT00398866|454324707|FG001|Overall Study|Adverse Event|0|||
126283279|NCT00398866|454324708|FG002|Overall Study|Adverse Event|0|||
126283280|NCT00398866|454324706|FG000|Overall Study|Lack of Efficacy|0|||
126283281|NCT00398866|454324707|FG001|Overall Study|Lack of Efficacy|0|||
126283282|NCT00398866|454324708|FG002|Overall Study|Lack of Efficacy|1|||
126283283|NCT00398866|454324706|FG000|Overall Study|Lost to Follow-up|7|||
126283284|NCT00398866|454324707|FG001|Overall Study|Lost to Follow-up|6|||
126283285|NCT00398866|454324708|FG002|Overall Study|Lost to Follow-up|4|||
126283286|NCT00398866|454324706|FG000|Overall Study|Withdrawal by Subject|5|||
126283287|NCT00398866|454324707|FG001|Overall Study|Withdrawal by Subject|1|||
126283288|NCT00398866|454324708|FG002|Overall Study|Withdrawal by Subject|2|||
126283289|NCT00398866|454324706|FG000|Overall Study|Unable to complete requirements of study|1|||
126283290|NCT00398866|454324707|FG001|Overall Study|Unable to complete requirements of study|1|||
126283291|NCT00398866|454324708|FG002|Overall Study|Unable to complete requirements of study|1|||
126283292|NCT00606632|454324709|FG000|Overall Study|Withdrawal by Subject|13|||
126283293|NCT00606632|454324709|FG000|Overall Study|Miscellaneous reasons|9|||
126283294|NCT00704132|454324713|FG000|Overall Study|Clinical Adverse Experience|1|||
126283295|NCT00704132|454324714|FG001|Overall Study|Clinical Adverse Experience|0|||
126283296|NCT00704132|454324713|FG000|Overall Study|Lack of Efficacy|0|||
126283297|NCT00704132|454324714|FG001|Overall Study|Lack of Efficacy|1|||
126283298|NCT00704132|454324713|FG000|Overall Study|Withdrawal by Subject|0|||
126283299|NCT00704132|454324714|FG001|Overall Study|Withdrawal by Subject|1|||
126283300|NCT00442962|454324715|FG000|Overall Study|Pregnancy|1|||
126283301|NCT00442962|454324715|FG000|Overall Study|Lost to Follow-up|7|||
126283302|NCT03633825|454324716|FG000|Enrollment|Did not post on network|5066|||
126283303|NCT03633825|454324717|FG001|Enrollment|Did not post on network|5080|||
126283304|NCT03633825|454324716|FG000|Enrollment|Post not classified as crisis|13967|||
126283305|NCT03633825|454324717|FG001|Enrollment|Post not classified as crisis|13757|||
126283306|NCT03633825|454324716|FG000|Follow up|Lost to Follow-up|478|||
126283307|NCT03633825|454324717|FG001|Follow up|Lost to Follow-up|450|||
126283308|NCT02756208|454324721|FG000|Overall Study|Withdrawal by Subject|1|||
126283309|NCT02756208|454324722|FG001|Overall Study|Withdrawal by Subject|0|||
126283310|NCT02756208|454324723|FG002|Overall Study|Withdrawal by Subject|1|||
126283311|NCT02756208|454324724|FG003|Overall Study|Withdrawal by Subject|3|||
126283312|NCT02756208|454324721|FG000|Overall Study|Lost to Follow-up|3|||
126283313|NCT02756208|454324722|FG001|Overall Study|Lost to Follow-up|1|||
126283314|NCT02756208|454324723|FG002|Overall Study|Lost to Follow-up|1|||
126283315|NCT02756208|454324724|FG003|Overall Study|Lost to Follow-up|1|||
126283316|NCT02756208|454324721|FG000|Overall Study|Physician Decision|1|||
126283317|NCT02756208|454324722|FG001|Overall Study|Physician Decision|0|||
126283318|NCT02756208|454324723|FG002|Overall Study|Physician Decision|0|||
126283319|NCT02756208|454324724|FG003|Overall Study|Physician Decision|0|||
126283320|NCT02756208|454324721|FG000|Overall Study|Protocol Violation|0|||
126283321|NCT02756208|454324722|FG001|Overall Study|Protocol Violation|1|||
126283322|NCT02756208|454324723|FG002|Overall Study|Protocol Violation|0|||
126283323|NCT02756208|454324724|FG003|Overall Study|Protocol Violation|0|||
126283324|NCT04841577|454324726|FG000|Overall Study|Adverse Event|5|||
126283325|NCT04841577|454324727|FG001|Overall Study|Adverse Event|10|||
126283326|NCT04841577|454324726|FG000|Overall Study|Lost to Follow-up|8|||
126283327|NCT04841577|454324727|FG001|Overall Study|Lost to Follow-up|7|||
126283328|NCT04841577|454324726|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
126283329|NCT04841577|454324727|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
126283330|NCT04841577|454324726|FG000|Overall Study|Other|0|||
126283331|NCT04841577|454324727|FG001|Overall Study|Other|1|||
126283332|NCT00182325|454324728|FG000|Overall Study|Lost to Follow-up|7|||
126283333|NCT00182325|454324729|FG001|Overall Study|Lost to Follow-up|7|||
126283334|NCT00182325|454324728|FG000|Overall Study|Miscarriage|5|||
126283335|NCT00182325|454324729|FG001|Overall Study|Miscarriage|3|||
126283336|NCT00182325|454324728|FG000|Overall Study|Did not complete survey|22|||
126283337|NCT00182325|454324729|FG001|Overall Study|Did not complete survey|43|||
126364870|NCT01272219|454630360|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
126283338|NCT01420965|454324732|FG000|Overall Study|Withdrawal by Subject|1|||
126283339|NCT01420965|454324733|FG001|Overall Study|Withdrawal by Subject|0|||
126283340|NCT01420965|454324734|FG002|Overall Study|Withdrawal by Subject|0|||
126549014|NCT03292146|455303936|FG001|12 Months to 24 Months|Planning pregnancy|2|||
126549015|NCT03292146|455303935|FG000|12 Months to 24 Months|Personal reasons|1|||
126549016|NCT03292146|455303936|FG001|12 Months to 24 Months|Personal reasons|0|||
126549017|NCT03292146|455303935|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
126549018|NCT03292146|455303936|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
126549019|NCT00545363|455303939|FG000|Overall Study|Adverse Event|6|||
126549020|NCT00545363|455303940|FG001|Overall Study|Adverse Event|7|||
126283341|NCT01420965|454324732|FG000|Overall Study|Adverse Event|0|||
126283342|NCT01420965|454324733|FG001|Overall Study|Adverse Event|1|||
126283343|NCT01420965|454324734|FG002|Overall Study|Adverse Event|0|||
126283344|NCT01890434|454324739|FG000|Overall Study|Adverse Event|8|||
126283345|NCT01890434|454324739|FG000|Overall Study|PCI at external hospital|1|||
126283346|NCT01890434|454324739|FG000|Overall Study|Assessment discrepancy|1|||
126283347|NCT01890434|454324739|FG000|Overall Study|CRC didn't contact participant for FU|1|||
126283348|NCT01890434|454324739|FG000|Overall Study|Could not get whole set of images|1|||
126283349|NCT01890434|454324739|FG000|Overall Study|Decline to return for GSPECT|1|||
126283350|NCT01890434|454324739|FG000|Overall Study|GSPECT at rest was not done|1|||
126283351|NCT01890434|454324739|FG000|Overall Study|Participant didn't complete MRI|1|||
126283352|NCT01890434|454324739|FG000|Overall Study|Uncontactable by phone|1|||
126283353|NCT01890434|454324739|FG000|Overall Study|Moved out of position|1|||
126283354|NCT01890434|454324739|FG000|Overall Study|Unable to contact|1|||
126283355|NCT01890434|454324739|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
126283356|NCT03280381|454324740|FG000|Overall Study|Physician Decision|0|||
126283357|NCT03280381|454324741|FG001|Overall Study|Physician Decision|2|||
126283358|NCT01141205|454324742|FG000|Overall Study|Physician Decision|1|||
126283359|NCT01141205|454324743|FG001|Overall Study|Physician Decision|1|||
126283360|NCT01141205|454324742|FG000|Overall Study|Lost to Follow-up|1|||
126283361|NCT01141205|454324743|FG001|Overall Study|Lost to Follow-up|0|||
126283362|NCT01141205|454324742|FG000|Overall Study|Withdrawal by Subject|1|||
126283363|NCT01141205|454324743|FG001|Overall Study|Withdrawal by Subject|1|||
126283364|NCT01822366|454324745|FG000|Overall Study|Lost to Follow-up|5|||
126283365|NCT01822366|454324746|FG001|Overall Study|Lost to Follow-up|1|||
126283366|NCT01822366|454324747|FG002|Overall Study|Lost to Follow-up|5|||
126283367|NCT01822366|454324748|FG003|Overall Study|Lost to Follow-up|1|||
126283368|NCT01822366|454324745|FG000|Overall Study|Withdrawal by Subject|0|||
126283369|NCT01822366|454324746|FG001|Overall Study|Withdrawal by Subject|6|||
126283370|NCT01822366|454324747|FG002|Overall Study|Withdrawal by Subject|0|||
126283371|NCT01822366|454324748|FG003|Overall Study|Withdrawal by Subject|6|||
126283372|NCT01822366|454324745|FG000|Overall Study|Partial Intervention Completion|0|||
126283373|NCT01822366|454324746|FG001|Overall Study|Partial Intervention Completion|15|||
126283374|NCT01822366|454324747|FG002|Overall Study|Partial Intervention Completion|0|||
126283375|NCT01822366|454324748|FG003|Overall Study|Partial Intervention Completion|15|||
126283376|NCT03276078|454324749|FG000|Overall Study|Adverse Event|1|||
126283377|NCT02552732|454324750|FG000|Overall Study|Lost to Follow-up|2|||
126283378|NCT02552732|454324750|FG000|Overall Study|Physician Decision|1|||
126283379|NCT02552732|454324750|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
126283380|NCT02552732|454324750|FG000|Overall Study|Withdrawal by Subject|6|||
126283381|NCT02290223|454324751|FG000|6 Months|Lost to Follow-up|9|||
126283382|NCT02290223|454324752|FG001|6 Months|Lost to Follow-up|6|||
126283383|NCT02290223|454324751|FG000|6 Months|Withdrawal by Subject|5|||
126283384|NCT02290223|454324752|FG001|6 Months|Withdrawal by Subject|0|||
126283385|NCT02290223|454324751|FG000|6 Months|deceased (not related to study)|2|||
126283386|NCT02290223|454324752|FG001|6 Months|deceased (not related to study)|0|||
126283387|NCT02290223|454324751|FG000|12 Months|Lost to Follow-up|16|||
126283388|NCT02290223|454324752|FG001|12 Months|Lost to Follow-up|10|||
126283389|NCT02290223|454324751|FG000|12 Months|Refusal|0|||
126283390|NCT02290223|454324752|FG001|12 Months|Refusal|1|||
126283391|NCT02027428|454324756|FG000|Induction|Never treated|7|||
126283392|NCT02027428|454324757|FG001|Induction|Never treated|0|||
126709173|NCT00923091|455887958|FG007|Period III (Single-Blind)|Adverse Event|0|||
126283393|NCT02027428|454324758|FG002|Induction|Never treated|0|||
126283394|NCT02027428|454324756|FG000|Induction|Progressive disease|77|||
126283395|NCT02027428|454324757|FG001|Induction|Progressive disease|0|||
126283396|NCT02027428|454324758|FG002|Induction|Progressive disease|0|||
126283397|NCT02027428|454324756|FG000|Induction|Adverse Event|51|||
126283398|NCT02027428|454324757|FG001|Induction|Adverse Event|0|||
126283399|NCT02027428|454324758|FG002|Induction|Adverse Event|0|||
126283400|NCT02027428|454324756|FG000|Induction|Withdrawal by Subject|22|||
126283401|NCT02027428|454324757|FG001|Induction|Withdrawal by Subject|0|||
126283402|NCT02027428|454324758|FG002|Induction|Withdrawal by Subject|0|||
126709174|NCT00923091|455887959|FG008|Period III (Single-Blind)|Adverse Event|0|||
126283403|NCT02027428|454324756|FG000|Induction|Death|21|||
126283404|NCT02027428|454324757|FG001|Induction|Death|0|||
126283405|NCT02027428|454324758|FG002|Induction|Death|0|||
126283406|NCT02027428|454324756|FG000|Induction|Symptomatic deterioration|16|||
126549021|NCT00545363|455303939|FG000|Overall Study|Withdrawal by Subject|6|||
126283407|NCT02027428|454324757|FG001|Induction|Symptomatic deterioration|0|||
126283408|NCT02027428|454324758|FG002|Induction|Symptomatic deterioration|0|||
126549022|NCT00545363|455303940|FG001|Overall Study|Withdrawal by Subject|5|||
126283409|NCT02027428|454324756|FG000|Induction|Study terminated by sponsor|12|||
126283410|NCT02027428|454324757|FG001|Induction|Study terminated by sponsor|0|||
126283411|NCT02027428|454324758|FG002|Induction|Study terminated by sponsor|0|||
126283412|NCT02027428|454324756|FG000|Induction|Protocol Violation|1|||
126283413|NCT02027428|454324757|FG001|Induction|Protocol Violation|0|||
126283414|NCT02027428|454324758|FG002|Induction|Protocol Violation|0|||
126283415|NCT02027428|454324756|FG000|Induction|Miscellaneous|14|||
126283416|NCT02027428|454324757|FG001|Induction|Miscellaneous|0|||
126283417|NCT02027428|454324758|FG002|Induction|Miscellaneous|0|||
126283418|NCT02027428|454324756|FG000|Induction|Induction Treatment Ongoing|4|||
126283419|NCT02027428|454324757|FG001|Induction|Induction Treatment Ongoing|0|||
126283420|NCT02027428|454324758|FG002|Induction|Induction Treatment Ongoing|0|||
126283421|NCT02027428|454324756|FG000|Maintenance|Death|0|||
126283422|NCT02027428|454324757|FG001|Maintenance|Death|3|||
126283423|NCT02027428|454324758|FG002|Maintenance|Death|2|||
126283424|NCT02027428|454324756|FG000|Maintenance|Adverse Event|0|||
126283425|NCT02027428|454324757|FG001|Maintenance|Adverse Event|21|||
126283426|NCT02027428|454324758|FG002|Maintenance|Adverse Event|1|||
126283427|NCT02027428|454324756|FG000|Maintenance|Progressive disease|0|||
126283428|NCT02027428|454324757|FG001|Maintenance|Progressive disease|84|||
126283429|NCT02027428|454324758|FG002|Maintenance|Progressive disease|47|||
126283430|NCT02027428|454324756|FG000|Maintenance|Symptomatic deterioration|0|||
126283431|NCT02027428|454324757|FG001|Maintenance|Symptomatic deterioration|4|||
126283432|NCT02027428|454324758|FG002|Maintenance|Symptomatic deterioration|1|||
126283433|NCT02027428|454324756|FG000|Maintenance|Withdrawal by Subject|0|||
126283434|NCT02027428|454324757|FG001|Maintenance|Withdrawal by Subject|6|||
126283435|NCT02027428|454324758|FG002|Maintenance|Withdrawal by Subject|5|||
126283436|NCT02027428|454324756|FG000|Maintenance|Protocol Violation|0|||
126283437|NCT02027428|454324757|FG001|Maintenance|Protocol Violation|0|||
126283438|NCT02027428|454324758|FG002|Maintenance|Protocol Violation|1|||
126283439|NCT02027428|454324756|FG000|Maintenance|Other|0|||
126283440|NCT02027428|454324757|FG001|Maintenance|Other|6|||
126283441|NCT02027428|454324758|FG002|Maintenance|Other|3|||
126283442|NCT02027428|454324756|FG000|Survival Follow-up|Death|0|||
126549023|NCT00545363|455303939|FG000|Overall Study|Non-compliance|3|||
126283443|NCT02027428|454324757|FG001|Survival Follow-up|Death|78|||
126283444|NCT02027428|454324758|FG002|Survival Follow-up|Death|45|||
126283445|NCT02027428|454324756|FG000|Survival Follow-up|Lost to Follow-up|0|||
126283446|NCT02027428|454324757|FG001|Survival Follow-up|Lost to Follow-up|1|||
126283447|NCT02027428|454324758|FG002|Survival Follow-up|Lost to Follow-up|1|||
126283448|NCT01004003|454324759|FG000|Overall Study|Progressive disease|2|||
126283449|NCT01004003|454324760|FG001|Overall Study|Progressive disease|1|||
126283450|NCT01004003|454324761|FG002|Overall Study|Progressive disease|1|||
126283451|NCT01004003|454324762|FG003|Overall Study|Progressive disease|0|||
126283452|NCT01004003|454324763|FG004|Overall Study|Progressive disease|2|||
126283453|NCT01004003|454324764|FG005|Overall Study|Progressive disease|1|||
126283454|NCT01004003|454324765|FG006|Overall Study|Progressive disease|1|||
126283455|NCT01004003|454324766|FG007|Overall Study|Progressive disease|39|||
126283456|NCT01004003|454324767|FG008|Overall Study|Progressive disease|22|||
126283457|NCT01004003|454324759|FG000|Overall Study|Adverse Event|4|||
126283458|NCT01004003|454324760|FG001|Overall Study|Adverse Event|2|||
126283459|NCT01004003|454324761|FG002|Overall Study|Adverse Event|3|||
126283460|NCT01004003|454324762|FG003|Overall Study|Adverse Event|3|||
126283461|NCT01004003|454324763|FG004|Overall Study|Adverse Event|2|||
126283462|NCT01004003|454324764|FG005|Overall Study|Adverse Event|2|||
126283463|NCT01004003|454324765|FG006|Overall Study|Adverse Event|7|||
126283464|NCT01004003|454324766|FG007|Overall Study|Adverse Event|21|||
126283465|NCT01004003|454324767|FG008|Overall Study|Adverse Event|6|||
126283466|NCT01004003|454324759|FG000|Overall Study|Refused to continue taking trial med.|0|||
126283467|NCT01004003|454324760|FG001|Overall Study|Refused to continue taking trial med.|0|||
126283468|NCT01004003|454324761|FG002|Overall Study|Refused to continue taking trial med.|0|||
126283469|NCT01004003|454324762|FG003|Overall Study|Refused to continue taking trial med.|0|||
126283470|NCT01004003|454324763|FG004|Overall Study|Refused to continue taking trial med.|0|||
126283471|NCT01004003|454324764|FG005|Overall Study|Refused to continue taking trial med.|0|||
126283472|NCT01004003|454324765|FG006|Overall Study|Refused to continue taking trial med.|0|||
126283473|NCT01004003|454324766|FG007|Overall Study|Refused to continue taking trial med.|0|||
126283474|NCT01004003|454324767|FG008|Overall Study|Refused to continue taking trial med.|2|||
126283475|NCT01004003|454324759|FG000|Overall Study|Other|0|||
126283476|NCT01004003|454324760|FG001|Overall Study|Other|0|||
126283477|NCT01004003|454324761|FG002|Overall Study|Other|0|||
126283478|NCT01004003|454324762|FG003|Overall Study|Other|0|||
126364871|NCT01272219|454630361|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
126364872|NCT01272219|454630362|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
126364873|NCT01272219|454630363|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
126364874|NCT01272219|454630364|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
126364875|NCT01272219|454630359|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
126364876|NCT01272219|454630360|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
126364877|NCT01272219|454630361|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
126549024|NCT00545363|455303940|FG001|Overall Study|Non-compliance|1|||
126364878|NCT01272219|454630362|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
126364879|NCT01272219|454630363|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
126364880|NCT01272219|454630364|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
126364881|NCT01272219|454630359|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
126364882|NCT01272219|454630360|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
126364883|NCT01272219|454630361|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
126364884|NCT01272219|454630362|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
126364885|NCT01272219|454630363|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
126364886|NCT01272219|454630364|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
126364887|NCT01272219|454630359|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
126364888|NCT01272219|454630360|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
126364889|NCT01272219|454630361|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
126364890|NCT01272219|454630362|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
126364891|NCT01272219|454630363|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
126364892|NCT01272219|454630364|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
126364893|NCT01272219|454630359|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
126364894|NCT01272219|454630360|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
126364895|NCT01272219|454630361|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
126364896|NCT01272219|454630362|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
126364897|NCT01272219|454630363|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
126364898|NCT01272219|454630364|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
126364899|NCT01272219|454630359|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
126364900|NCT01272219|454630360|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
126364901|NCT01272219|454630361|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
126364902|NCT01272219|454630362|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
126364903|NCT01272219|454630363|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
126364904|NCT01272219|454630364|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
126364905|NCT03131479|454630365|FG000|Overall Study|Adverse Event|0|||
126364906|NCT03131479|454630366|FG001|Overall Study|Adverse Event|0|||
126364907|NCT03131479|454630367|FG002|Overall Study|Adverse Event|1|||
126456241|NCT00704522|454970828|FG000|Overall Study|No information on therapy end|27|||
126456242|NCT00704522|454970829|FG001|Overall Study|No information on therapy end|2|||
126456243|NCT00775203|454970830|FG000|Overall Study|Adverse Event|25|||
126456244|NCT00775203|454970831|FG001|Overall Study|Adverse Event|6|||
126456245|NCT00775203|454970830|FG000|Overall Study|Lack of Efficacy|8|||
126456246|NCT00775203|454970831|FG001|Overall Study|Lack of Efficacy|9|||
126456247|NCT00775203|454970830|FG000|Overall Study|Withdrawal by Subject|11|||
126709175|NCT00923091|455887960|FG009|Period III (Single-Blind)|Adverse Event|0|||
126709176|NCT00923091|455887961|FG010|Period III (Single-Blind)|Adverse Event|0|||
126709177|NCT00923091|455887962|FG011|Period III (Single-Blind)|Adverse Event|0|||
126709178|NCT00923091|455887963|FG012|Period III (Single-Blind)|Adverse Event|0|||
126709179|NCT00923091|455887951|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
126709180|NCT00923091|455887952|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
126364908|NCT03131479|454630368|FG003|Overall Study|Adverse Event|1|||
126456248|NCT00775203|454970831|FG001|Overall Study|Withdrawal by Subject|9|||
126456249|NCT00775203|454970830|FG000|Overall Study|Lost to Follow-up|11|||
126456250|NCT00775203|454970831|FG001|Overall Study|Lost to Follow-up|15|||
126456251|NCT00775203|454970830|FG000|Overall Study|Administrative reason|2|||
126456252|NCT00775203|454970831|FG001|Overall Study|Administrative reason|0|||
126456253|NCT00775203|454970830|FG000|Overall Study|Noncompliance|4|||
126456254|NCT00775203|454970831|FG001|Overall Study|Noncompliance|2|||
126456255|NCT00775203|454970830|FG000|Overall Study|Protocol Violation|0|||
126456256|NCT00775203|454970831|FG001|Overall Study|Protocol Violation|1|||
126456257|NCT00775203|454970830|FG000|Overall Study|Entered other study|1|||
126456258|NCT00775203|454970831|FG001|Overall Study|Entered other study|0|||
126456259|NCT00775203|454970830|FG000|Overall Study|Physician Decision|0|||
126456260|NCT00775203|454970831|FG001|Overall Study|Physician Decision|1|||
126456261|NCT04575597|454970837|FG000|Overall Study|Death|0|||
126456262|NCT04575597|454970838|FG001|Overall Study|Death|0|||
126456263|NCT04575597|454970839|FG002|Overall Study|Death|0|||
126456264|NCT04575597|454970840|FG003|Overall Study|Death|1|||
126456265|NCT04575597|454970841|FG004|Overall Study|Death|3|||
126456266|NCT04575597|454970842|FG005|Overall Study|Death|14|||
126456267|NCT04575597|454970837|FG000|Overall Study|Lost to Follow-up|2|||
126456268|NCT04575597|454970838|FG001|Overall Study|Lost to Follow-up|1|||
126456269|NCT04575597|454970839|FG002|Overall Study|Lost to Follow-up|1|||
126456270|NCT04575597|454970840|FG003|Overall Study|Lost to Follow-up|2|||
126456271|NCT04575597|454970841|FG004|Overall Study|Lost to Follow-up|10|||
126456272|NCT04575597|454970842|FG005|Overall Study|Lost to Follow-up|8|||
126456273|NCT04575597|454970837|FG000|Overall Study|Withdrawal by Subject|2|||
126456274|NCT04575597|454970838|FG001|Overall Study|Withdrawal by Subject|2|||
126456275|NCT04575597|454970839|FG002|Overall Study|Withdrawal by Subject|4|||
126456276|NCT04575597|454970840|FG003|Overall Study|Withdrawal by Subject|2|||
126456277|NCT04575597|454970841|FG004|Overall Study|Withdrawal by Subject|25|||
126283479|NCT01004003|454324763|FG004|Overall Study|Other|0|||
126283480|NCT01004003|454324764|FG005|Overall Study|Other|1|||
126283481|NCT01004003|454324765|FG006|Overall Study|Other|0|||
126283482|NCT01004003|454324766|FG007|Overall Study|Other|0|||
126283483|NCT01004003|454324767|FG008|Overall Study|Other|0|||
126283484|NCT01130597|454324768|FG000|Overall Study|Protocol-specified (High K+)|1|||
126283485|NCT01130597|454324768|FG000|Overall Study|Adverse Event|4|||
126283486|NCT01130597|454324768|FG000|Overall Study|Death|1|||
126283487|NCT01130597|454324768|FG000|Overall Study|Protocol Violation|1|||
126283488|NCT05819203|454324776|FG000|Overall Study|Protocol Violation|1|||
126283489|NCT05819203|454324777|FG001|Overall Study|Protocol Violation|2|||
126283490|NCT05819203|454324776|FG000|Overall Study|Withdrawal by Subject|1|||
126283491|NCT05819203|454324777|FG001|Overall Study|Withdrawal by Subject|0|||
126283492|NCT02185053|454324778|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
126283493|NCT02185053|454324779|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
126283494|NCT02185053|454324780|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
126283495|NCT02185053|454324778|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
126283496|NCT02185053|454324779|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
126283497|NCT02185053|454324780|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
126283498|NCT02185053|454324778|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
126283499|NCT02185053|454324779|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
126283500|NCT02185053|454324780|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
126283501|NCT02185053|454324778|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
126283502|NCT02185053|454324779|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
126283503|NCT02185053|454324780|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
126283504|NCT02185053|454324778|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
126283505|NCT02185053|454324779|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
126283506|NCT02185053|454324780|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
126283507|NCT02185053|454324778|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
126283508|NCT02185053|454324779|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
126283509|NCT02185053|454324780|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
126283510|NCT02185053|454324778|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
126283511|NCT02185053|454324779|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
126283512|NCT02185053|454324780|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
126283513|NCT02185053|454324778|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
126283514|NCT02185053|454324779|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
126283515|NCT02185053|454324780|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
126283516|NCT00143247|454324782|FG000|Overall Study|Death|8|||
126283517|NCT00143247|454324782|FG000|Overall Study|Adverse Event|19|||
126283518|NCT00143247|454324782|FG000|Overall Study|Lack of Efficacy|3|||
126283519|NCT00143247|454324782|FG000|Overall Study|Withdrawal by Subject|55|||
126283520|NCT00143247|454324782|FG000|Overall Study|Study terminated by sponsor|31|||
126283521|NCT00143247|454324782|FG000|Overall Study|Protocol Violation|15|||
126283522|NCT00143247|454324782|FG000|Overall Study|Lost to Follow-up|12|||
126364909|NCT03131479|454630369|FG004|Overall Study|Adverse Event|0|||
126283523|NCT00143247|454324782|FG000|Overall Study|following inaccurate lab adverse event|1|||
126283524|NCT00143247|454324782|FG000|Overall Study|Other|12|||
126283525|NCT02126826|454326412|FG000|Overall Study|Withdrawal by Subject|0|||
126283526|NCT02126826|454326413|FG001|Overall Study|Withdrawal by Subject|0|||
126283527|NCT02126826|454326414|FG002|Overall Study|Withdrawal by Subject|0|||
126283528|NCT02126826|454326415|FG003|Overall Study|Withdrawal by Subject|1|||
126283529|NCT02126826|454326416|FG004|Overall Study|Withdrawal by Subject|0|||
126283530|NCT02126826|454326417|FG005|Overall Study|Withdrawal by Subject|0|||
126283531|NCT02126826|454326418|FG006|Overall Study|Withdrawal by Subject|0|||
126283532|NCT01762800|454326425|FG000|Overall Study|Adverse Event|8|||
126283533|NCT01762800|454326426|FG001|Overall Study|Adverse Event|13|||
126283534|NCT01762800|454326425|FG000|Overall Study|Lack of Efficacy|3|||
126283535|NCT01762800|454326426|FG001|Overall Study|Lack of Efficacy|2|||
126283536|NCT01762800|454326425|FG000|Overall Study|Study Closed/Terminated|0|||
126283537|NCT01762800|454326426|FG001|Overall Study|Study Closed/Terminated|1|||
126283538|NCT01762800|454326425|FG000|Overall Study|Physician Decision|1|||
126283539|NCT01762800|454326426|FG001|Overall Study|Physician Decision|1|||
126283540|NCT01762800|454326425|FG000|Overall Study|Withdrawal by Subject|7|||
126283541|NCT01762800|454326426|FG001|Overall Study|Withdrawal by Subject|4|||
126283542|NCT02111603|454326430|FG000|Overall Study|Withdrawal by Subject|1|||
126283543|NCT03106987|454326431|FG000|Overall Study|Death|37|||
126283544|NCT03106987|454326432|FG001|Overall Study|Death|22|||
126283545|NCT03106987|454326433|FG002|Overall Study|Death|12|||
126283546|NCT03106987|454326434|FG003|Overall Study|Death|8|||
126283547|NCT03106987|454326431|FG000|Overall Study|Lost to Follow-up|2|||
126283548|NCT03106987|454326432|FG001|Overall Study|Lost to Follow-up|0|||
126283549|NCT03106987|454326433|FG002|Overall Study|Lost to Follow-up|2|||
126283550|NCT03106987|454326434|FG003|Overall Study|Lost to Follow-up|2|||
126283551|NCT03106987|454326431|FG000|Overall Study|Withdrawal by Subject|5|||
126283552|NCT03106987|454326432|FG001|Overall Study|Withdrawal by Subject|1|||
126283553|NCT03106987|454326433|FG002|Overall Study|Withdrawal by Subject|4|||
126283554|NCT03106987|454326434|FG003|Overall Study|Withdrawal by Subject|1|||
126283555|NCT02114385|454326436|FG000|Overall Study|Withdrawal by Subject|3|||
126283556|NCT02114385|454326437|FG001|Overall Study|Withdrawal by Subject|2|||
126283557|NCT02114385|454326436|FG000|Overall Study|Lost to Follow-up|0|||
126283558|NCT02114385|454326437|FG001|Overall Study|Lost to Follow-up|6|||
126283559|NCT01753297|454326439|FG000|Overall Study|Lost to Follow-up|7|||
126283560|NCT01753297|454326440|FG001|Overall Study|Lost to Follow-up|2|||
126283561|NCT01753297|454326439|FG000|Overall Study|Withdrawal by Subject|26|||
126283562|NCT01753297|454326440|FG001|Overall Study|Withdrawal by Subject|23|||
126283563|NCT01753297|454326439|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
126549025|NCT00545363|455303939|FG000|Overall Study|Did not meet entry criteria|1|||
126549026|NCT00545363|455303940|FG001|Overall Study|Did not meet entry criteria|1|||
126549027|NCT00545363|455303939|FG000|Overall Study|Lost to Follow-up|2|||
126549028|NCT00545363|455303940|FG001|Overall Study|Lost to Follow-up|0|||
126549029|NCT00545363|455303939|FG000|Overall Study|Other|1|||
126549030|NCT00545363|455303940|FG001|Overall Study|Other|1|||
126549031|NCT00366301|455303941|FG000|Overall Study|Lost to Follow-up|4|||
126549032|NCT00366301|455303942|FG001|Overall Study|Lost to Follow-up|4|||
126549033|NCT00366301|455303943|FG002|Overall Study|Lost to Follow-up|3|||
126549034|NCT00366301|455303944|FG003|Overall Study|Lost to Follow-up|7|||
126549035|NCT00366301|455303941|FG000|Overall Study|Withdrawal by Subject|4|||
126549036|NCT00366301|455303942|FG001|Overall Study|Withdrawal by Subject|2|||
126549037|NCT00366301|455303943|FG002|Overall Study|Withdrawal by Subject|1|||
126549038|NCT00366301|455303944|FG003|Overall Study|Withdrawal by Subject|1|||
126549039|NCT03125941|455303949|FG000|Overall Study|did not receive intervention|1|||
126549040|NCT03125941|455303950|FG001|Overall Study|did not receive intervention|2|||
126549041|NCT02494206|455303955|FG000|Overall Study|Adverse Event|1|||
126549042|NCT02494206|455303955|FG000|Overall Study|Disease Progression|1|||
126549043|NCT04276090|455303956|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
126549044|NCT04276090|455303957|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
126549045|NCT01799720|455303958|FG000|Overall Study|Withdrawal by Subject|3|||
126549046|NCT01799720|455303959|FG001|Overall Study|Withdrawal by Subject|0|||
126549047|NCT01799720|455303960|FG002|Overall Study|Withdrawal by Subject|0|||
126549048|NCT01799720|455303958|FG000|Overall Study|Protocol Violation|0|||
126549049|NCT01799720|455303959|FG001|Overall Study|Protocol Violation|1|||
126549050|NCT01799720|455303960|FG002|Overall Study|Protocol Violation|0|||
126549051|NCT01799720|455303958|FG000|Overall Study|Pregnancy|0|||
126549052|NCT01799720|455303959|FG001|Overall Study|Pregnancy|0|||
126549053|NCT01799720|455303960|FG002|Overall Study|Pregnancy|1|||
126549054|NCT04986982|455303961|FG000|Overall Study|Withdrawal by Subject|3|||
126549055|NCT04986982|455303962|FG001|Overall Study|Withdrawal by Subject|1|||
126549056|NCT04986982|455303961|FG000|Overall Study|Lack of Efficacy|0|||
126549057|NCT04986982|455303962|FG001|Overall Study|Lack of Efficacy|2|||
126549058|NCT04986982|455303961|FG000|Overall Study|Ineligibility|3|||
126549059|NCT04986982|455303962|FG001|Overall Study|Ineligibility|0|||
126549060|NCT04986982|455303961|FG000|Overall Study|Adverse Event|4|||
126549061|NCT04986982|455303962|FG001|Overall Study|Adverse Event|4|||
126549062|NCT04986982|455303961|FG000|Overall Study|Lost to Follow-up|0|||
126549063|NCT04986982|455303962|FG001|Overall Study|Lost to Follow-up|1|||
126549064|NCT04986982|455303961|FG000|Overall Study|Sponsor's discretion|1|||
126549065|NCT04986982|455303962|FG001|Overall Study|Sponsor's discretion|0|||
126549066|NCT01155661|455303963|FG000|Overall Study|Adverse Event|101|||
126549067|NCT01155661|455303963|FG000|Overall Study|Death|1|||
126709181|NCT00923091|455887953|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
126283564|NCT01753297|454326440|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
126283565|NCT01753297|454326439|FG000|Overall Study|Death|0|||
126283566|NCT01753297|454326440|FG001|Overall Study|Death|2|||
126283567|NCT01753297|454326439|FG000|Overall Study|Did not attend end of study visit|7|||
126283568|NCT01753297|454326440|FG001|Overall Study|Did not attend end of study visit|8|||
126283569|NCT01174043|454326443|FG000|Overall Study|Disease progression|5|||
126283570|NCT01174043|454326443|FG000|Overall Study|Adverse Event|3|||
126283571|NCT01174043|454326443|FG000|Overall Study|Death|1|||
126283572|NCT01174043|454326443|FG000|Overall Study|Withdrawal by Subject|2|||
126283573|NCT01645787|454326449|FG000|Washout (2 Weeks)|Adverse Event|1|||
126283574|NCT01645787|454326450|FG001|Washout (2 Weeks)|Adverse Event|0|||
126283575|NCT01371539|454326451|FG000|Period One: One Week|Lost to Follow-up|0|||
126283576|NCT01371539|454326452|FG001|Period One: One Week|Lost to Follow-up|1|||
126283577|NCT01371539|454326451|FG000|Period Two: One Week|Lost to Follow-up|0|||
126283578|NCT01371539|454326452|FG001|Period Two: One Week|Lost to Follow-up|1|||
126549068|NCT01155661|455303963|FG000|Overall Study|Lack of Efficacy|32|||
126549069|NCT01155661|455303963|FG000|Overall Study|Lost to Follow-up|22|||
126549070|NCT01155661|455303963|FG000|Overall Study|Physician Decision|3|||
126549071|NCT01155661|455303963|FG000|Overall Study|Protocol Violation|35|||
126549072|NCT01155661|455303963|FG000|Overall Study|Withdrawal by Subject|73|||
126549073|NCT01155661|455303963|FG000|Overall Study|Sponsor Decision|13|||
126283579|NCT01371539|454326451|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
126283580|NCT01371539|454326452|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
126283581|NCT01371539|454326451|FG000|Period Two: One Week|Time/job conflict|0|||
126283582|NCT01371539|454326452|FG001|Period Two: One Week|Time/job conflict|1|||
126283583|NCT01524978|454326469|FG000|Overall Study|Other|16|||
126283584|NCT01524978|454326470|FG001|Overall Study|Other|2|||
126283585|NCT01524978|454326471|FG002|Overall Study|Other|1|||
126283586|NCT01524978|454326472|FG003|Overall Study|Other|2|||
126283587|NCT01524978|454326473|FG004|Overall Study|Other|1|||
126283588|NCT01524978|454326474|FG005|Overall Study|Other|3|||
126283589|NCT01524978|454326475|FG006|Overall Study|Other|17|||
126283590|NCT01524978|454326476|FG007|Overall Study|Other|1|||
126283591|NCT01524978|454326477|FG008|Overall Study|Other|2|||
126283592|NCT01524978|454326478|FG009|Overall Study|Other|2|||
126283593|NCT01524978|454326479|FG010|Overall Study|Other|5|||
126283594|NCT01524978|454326469|FG000|Overall Study|Withdrawal by Subject|12|||
126283595|NCT01524978|454326470|FG001|Overall Study|Withdrawal by Subject|0|||
126283596|NCT01524978|454326471|FG002|Overall Study|Withdrawal by Subject|1|||
126283597|NCT01524978|454326472|FG003|Overall Study|Withdrawal by Subject|1|||
126283598|NCT01524978|454326473|FG004|Overall Study|Withdrawal by Subject|3|||
126283599|NCT01524978|454326474|FG005|Overall Study|Withdrawal by Subject|1|||
126283600|NCT01524978|454326475|FG006|Overall Study|Withdrawal by Subject|6|||
126283601|NCT01524978|454326476|FG007|Overall Study|Withdrawal by Subject|2|||
126283602|NCT01524978|454326477|FG008|Overall Study|Withdrawal by Subject|4|||
126283603|NCT01524978|454326478|FG009|Overall Study|Withdrawal by Subject|0|||
126283604|NCT01524978|454326479|FG010|Overall Study|Withdrawal by Subject|5|||
126283605|NCT01524978|454326469|FG000|Overall Study|Lost to Follow-up|0|||
126283606|NCT01524978|454326470|FG001|Overall Study|Lost to Follow-up|0|||
126283607|NCT01524978|454326471|FG002|Overall Study|Lost to Follow-up|3|||
126283608|NCT01524978|454326472|FG003|Overall Study|Lost to Follow-up|0|||
126283609|NCT01524978|454326473|FG004|Overall Study|Lost to Follow-up|1|||
126283610|NCT01524978|454326474|FG005|Overall Study|Lost to Follow-up|1|||
126283611|NCT01524978|454326475|FG006|Overall Study|Lost to Follow-up|2|||
126283612|NCT01524978|454326476|FG007|Overall Study|Lost to Follow-up|0|||
126283613|NCT01524978|454326477|FG008|Overall Study|Lost to Follow-up|1|||
126283614|NCT01524978|454326478|FG009|Overall Study|Lost to Follow-up|1|||
126283615|NCT01524978|454326479|FG010|Overall Study|Lost to Follow-up|1|||
126283616|NCT01524978|454326469|FG000|Overall Study|Death|34|||
126283617|NCT01524978|454326470|FG001|Overall Study|Death|2|||
126283618|NCT01524978|454326471|FG002|Overall Study|Death|5|||
126283619|NCT01524978|454326472|FG003|Overall Study|Death|24|||
126283620|NCT01524978|454326473|FG004|Overall Study|Death|4|||
126283621|NCT01524978|454326474|FG005|Overall Study|Death|4|||
126283622|NCT01524978|454326475|FG006|Overall Study|Death|1|||
126283623|NCT01524978|454326476|FG007|Overall Study|Death|9|||
126283624|NCT01524978|454326477|FG008|Overall Study|Death|5|||
126283625|NCT01524978|454326478|FG009|Overall Study|Death|6|||
126709182|NCT00923091|455887954|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
126283626|NCT01524978|454326479|FG010|Overall Study|Death|17|||
126283627|NCT02165735|454326482|FG000|Overall Study|Lost to Follow-up|12|||
126283628|NCT02165735|454326483|FG001|Overall Study|Lost to Follow-up|10|||
126283629|NCT02165735|454326482|FG000|Overall Study|Withdrawal by Subject|3|||
126283630|NCT02165735|454326483|FG001|Overall Study|Withdrawal by Subject|0|||
126283631|NCT02165735|454326482|FG000|Overall Study|Participant indicated lack of time|1|||
126283632|NCT02165735|454326483|FG001|Overall Study|Participant indicated lack of time|3|||
126283633|NCT02165735|454326482|FG000|Overall Study|Protocol Violation|0|||
126283634|NCT02165735|454326483|FG001|Overall Study|Protocol Violation|1|||
126283635|NCT03066258|454326484|FG000|Overall Study|Death|1|||
126283636|NCT03066258|454326485|FG001|Overall Study|Death|0|||
126283637|NCT03066258|454326486|FG002|Overall Study|Death|0|||
126283638|NCT03066258|454326487|FG003|Overall Study|Death|0|||
126283639|NCT03066258|454326488|FG004|Overall Study|Death|1|||
126283640|NCT02784795|454326489|FG000|Overall Study|Progressive Disease|2|||
126283641|NCT02784795|454326490|FG001|Overall Study|Progressive Disease|1|||
126283642|NCT02784795|454326491|FG002|Overall Study|Progressive Disease|1|||
126283643|NCT02784795|454326492|FG003|Overall Study|Progressive Disease|0|||
126283644|NCT02784795|454326493|FG004|Overall Study|Progressive Disease|2|||
126283645|NCT02784795|454326494|FG005|Overall Study|Progressive Disease|0|||
126283646|NCT02784795|454326495|FG006|Overall Study|Progressive Disease|2|||
126283647|NCT02784795|454326496|FG007|Overall Study|Progressive Disease|0|||
126283648|NCT02784795|454326497|FG008|Overall Study|Progressive Disease|0|||
126283649|NCT02784795|454326498|FG009|Overall Study|Progressive Disease|0|||
126283650|NCT02784795|454326499|FG010|Overall Study|Progressive Disease|1|||
126283651|NCT02784795|454326500|FG011|Overall Study|Progressive Disease|0|||
126283652|NCT02784795|454326489|FG000|Overall Study|Adverse Event|1|||
126283653|NCT02784795|454326490|FG001|Overall Study|Adverse Event|0|||
126283654|NCT02784795|454326491|FG002|Overall Study|Adverse Event|0|||
126283655|NCT02784795|454326492|FG003|Overall Study|Adverse Event|1|||
126283656|NCT02784795|454326493|FG004|Overall Study|Adverse Event|0|||
126283657|NCT02784795|454326494|FG005|Overall Study|Adverse Event|0|||
126283658|NCT02784795|454326495|FG006|Overall Study|Adverse Event|1|||
126283659|NCT02784795|454326496|FG007|Overall Study|Adverse Event|0|||
126283660|NCT02784795|454326497|FG008|Overall Study|Adverse Event|0|||
126283661|NCT02784795|454326498|FG009|Overall Study|Adverse Event|0|||
126283662|NCT02784795|454326499|FG010|Overall Study|Adverse Event|0|||
126283663|NCT02784795|454326500|FG011|Overall Study|Adverse Event|2|||
126283664|NCT02784795|454326489|FG000|Overall Study|Withdrawal by Subject|1|||
126283665|NCT02784795|454326490|FG001|Overall Study|Withdrawal by Subject|0|||
126283666|NCT02784795|454326491|FG002|Overall Study|Withdrawal by Subject|2|||
126283667|NCT02784795|454326492|FG003|Overall Study|Withdrawal by Subject|1|||
126456278|NCT04575597|454970842|FG005|Overall Study|Withdrawal by Subject|28|||
126456279|NCT04575597|454970837|FG000|Overall Study|Not Recorded|0|||
126456280|NCT04575597|454970838|FG001|Overall Study|Not Recorded|0|||
126456281|NCT04575597|454970839|FG002|Overall Study|Not Recorded|0|||
126456282|NCT04575597|454970840|FG003|Overall Study|Not Recorded|0|||
126456283|NCT04575597|454970841|FG004|Overall Study|Not Recorded|0|||
126456284|NCT04575597|454970842|FG005|Overall Study|Not Recorded|2|||
126456285|NCT04575597|454970837|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126456286|NCT04575597|454970838|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126456287|NCT04575597|454970839|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126456288|NCT04575597|454970840|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126456289|NCT04575597|454970841|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
126456290|NCT04575597|454970842|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
126456291|NCT03316911|454970856|FG000|Overall Study|Lost to Follow-up|33|||
126456292|NCT03316911|454970857|FG001|Overall Study|Lost to Follow-up|29|||
126456293|NCT01119937|454970858|FG000|Overall Study|Adverse Event|11|||
126456294|NCT01119937|454970859|FG001|Overall Study|Adverse Event|5|||
126456295|NCT01119937|454970858|FG000|Overall Study|Protocol deviation|3|||
126456296|NCT01119937|454970859|FG001|Overall Study|Protocol deviation|1|||
126456297|NCT01119937|454970858|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
126456298|NCT01119937|454970859|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126456299|NCT01119937|454970858|FG000|Overall Study|Withdrawal by Subject|2|||
126283668|NCT02784795|454326493|FG004|Overall Study|Withdrawal by Subject|3|||
126283669|NCT02784795|454326494|FG005|Overall Study|Withdrawal by Subject|0|||
126283670|NCT02784795|454326495|FG006|Overall Study|Withdrawal by Subject|0|||
126283671|NCT02784795|454326496|FG007|Overall Study|Withdrawal by Subject|1|||
126283672|NCT02784795|454326497|FG008|Overall Study|Withdrawal by Subject|0|||
126283673|NCT02784795|454326498|FG009|Overall Study|Withdrawal by Subject|0|||
126283674|NCT02784795|454326499|FG010|Overall Study|Withdrawal by Subject|0|||
126283675|NCT02784795|454326500|FG011|Overall Study|Withdrawal by Subject|2|||
126283676|NCT02784795|454326489|FG000|Overall Study|Death|0|||
126283677|NCT02784795|454326490|FG001|Overall Study|Death|0|||
126283678|NCT02784795|454326491|FG002|Overall Study|Death|0|||
126283679|NCT02784795|454326492|FG003|Overall Study|Death|0|||
126283680|NCT02784795|454326493|FG004|Overall Study|Death|1|||
126283681|NCT02784795|454326494|FG005|Overall Study|Death|0|||
126283682|NCT02784795|454326495|FG006|Overall Study|Death|0|||
126283683|NCT02784795|454326496|FG007|Overall Study|Death|0|||
126283684|NCT02784795|454326497|FG008|Overall Study|Death|0|||
126283685|NCT02784795|454326498|FG009|Overall Study|Death|0|||
126283686|NCT02784795|454326499|FG010|Overall Study|Death|0|||
126283687|NCT02784795|454326500|FG011|Overall Study|Death|0|||
126283688|NCT02784795|454326489|FG000|Overall Study|Physician Decision|0|||
126283689|NCT02784795|454326490|FG001|Overall Study|Physician Decision|0|||
126283690|NCT02784795|454326491|FG002|Overall Study|Physician Decision|0|||
126283691|NCT02784795|454326492|FG003|Overall Study|Physician Decision|0|||
126283692|NCT02784795|454326493|FG004|Overall Study|Physician Decision|0|||
126283693|NCT02784795|454326494|FG005|Overall Study|Physician Decision|0|||
126283694|NCT02784795|454326495|FG006|Overall Study|Physician Decision|1|||
126283695|NCT02784795|454326496|FG007|Overall Study|Physician Decision|0|||
126283696|NCT02784795|454326497|FG008|Overall Study|Physician Decision|0|||
126283697|NCT02784795|454326498|FG009|Overall Study|Physician Decision|0|||
126283698|NCT02784795|454326499|FG010|Overall Study|Physician Decision|0|||
126283699|NCT02784795|454326500|FG011|Overall Study|Physician Decision|0|||
126283700|NCT00185588|454326503|FG000|Overall Study|Adverse Event|3|||
126283701|NCT00185588|454326504|FG001|Overall Study|Adverse Event|1|||
126456300|NCT01119937|454970859|FG001|Overall Study|Withdrawal by Subject|1|||
126456301|NCT00770146|454970862|FG000|Treatment Period|Withdrawal by Subject|6|||
126456302|NCT00770146|454970863|FG001|Treatment Period|Withdrawal by Subject|13|||
126456303|NCT00770146|454970862|FG000|Treatment Period|Adverse Event|2|||
126456304|NCT00770146|454970863|FG001|Treatment Period|Adverse Event|26|||
126456305|NCT00770146|454970862|FG000|Treatment Period|Other|1|||
126456306|NCT00770146|454970863|FG001|Treatment Period|Other|5|||
126283702|NCT00185588|454326505|FG002|Overall Study|Adverse Event|4|||
126283703|NCT00185588|454326506|FG003|Overall Study|Adverse Event|2|||
126283704|NCT00185588|454326503|FG000|Overall Study|Lost to Follow-up|0|||
126283705|NCT00185588|454326504|FG001|Overall Study|Lost to Follow-up|0|||
126283706|NCT00185588|454326505|FG002|Overall Study|Lost to Follow-up|1|||
126283707|NCT00185588|454326506|FG003|Overall Study|Lost to Follow-up|2|||
126283708|NCT00185588|454326503|FG000|Overall Study|Withdrawal by Subject|0|||
126283709|NCT00185588|454326504|FG001|Overall Study|Withdrawal by Subject|1|||
126283710|NCT00185588|454326505|FG002|Overall Study|Withdrawal by Subject|0|||
126283711|NCT00185588|454326506|FG003|Overall Study|Withdrawal by Subject|0|||
126283712|NCT00185588|454326503|FG000|Overall Study|Physician Decision|0|||
126283713|NCT00185588|454326504|FG001|Overall Study|Physician Decision|0|||
126549074|NCT01370005|455303964|FG000|Overall Study|Not treated|1|||
126549075|NCT01370005|455303965|FG001|Overall Study|Not treated|0|||
126549076|NCT01370005|455303966|FG002|Overall Study|Not treated|0|||
126549077|NCT01370005|455303964|FG000|Overall Study|Adverse Event|5|||
126549078|NCT01370005|455303965|FG001|Overall Study|Adverse Event|5|||
126549079|NCT01370005|455303966|FG002|Overall Study|Adverse Event|6|||
126549080|NCT01370005|455303964|FG000|Overall Study|Lack of Efficacy|1|||
126549081|NCT01370005|455303965|FG001|Overall Study|Lack of Efficacy|0|||
126549082|NCT01370005|455303966|FG002|Overall Study|Lack of Efficacy|0|||
126549083|NCT01370005|455303964|FG000|Overall Study|Non compliant with protocol|0|||
126549084|NCT01370005|455303965|FG001|Overall Study|Non compliant with protocol|1|||
126549085|NCT01370005|455303966|FG002|Overall Study|Non compliant with protocol|2|||
126549086|NCT01370005|455303964|FG000|Overall Study|Lost to Follow-up|1|||
126549087|NCT01370005|455303965|FG001|Overall Study|Lost to Follow-up|1|||
126549088|NCT01370005|455303966|FG002|Overall Study|Lost to Follow-up|1|||
126549089|NCT01370005|455303964|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
126549090|NCT01370005|455303965|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
126549091|NCT01370005|455303966|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
126549092|NCT01370005|455303964|FG000|Overall Study|Other reason not defined above|3|||
126283714|NCT00185588|454326505|FG002|Overall Study|Physician Decision|1|||
126283715|NCT00185588|454326506|FG003|Overall Study|Physician Decision|0|||
126549093|NCT01370005|455303965|FG001|Overall Study|Other reason not defined above|0|||
126549094|NCT01370005|455303966|FG002|Overall Study|Other reason not defined above|2|||
126549095|NCT01871558|455303976|FG000|Overall Study|Other reason|0|||
126549096|NCT01871558|455303977|FG001|Overall Study|Other reason|1|||
126549097|NCT01871558|455303976|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
126549098|NCT01871558|455303977|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
126549099|NCT01871558|455303976|FG000|Overall Study|Withdrawal by Subject|2|||
126549100|NCT01871558|455303977|FG001|Overall Study|Withdrawal by Subject|0|||
126549101|NCT02401308|455303978|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
126549102|NCT02401308|455303979|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
126549103|NCT02736968|455303980|FG000|Overall Study|Lost to Follow-up|0|||
126549104|NCT02736968|455303981|FG001|Overall Study|Lost to Follow-up|0|||
126549105|NCT02736968|455303982|FG002|Overall Study|Lost to Follow-up|0|||
126549106|NCT02736968|455303983|FG003|Overall Study|Lost to Follow-up|0|||
126549107|NCT02736968|455303984|FG004|Overall Study|Lost to Follow-up|0|||
126549108|NCT02736968|455303985|FG005|Overall Study|Lost to Follow-up|0|||
126549109|NCT02736968|455303986|FG006|Overall Study|Lost to Follow-up|5|||
126549110|NCT02736968|455303987|FG007|Overall Study|Lost to Follow-up|2|||
126549111|NCT02736968|455303980|FG000|Overall Study|COVID-19 Pandemic|0|||
126549112|NCT02736968|455303981|FG001|Overall Study|COVID-19 Pandemic|0|||
126549113|NCT02736968|455303982|FG002|Overall Study|COVID-19 Pandemic|0|||
126549114|NCT02736968|455303983|FG003|Overall Study|COVID-19 Pandemic|0|||
126549115|NCT02736968|455303984|FG004|Overall Study|COVID-19 Pandemic|0|||
126549116|NCT02736968|455303985|FG005|Overall Study|COVID-19 Pandemic|0|||
126549117|NCT02736968|455303986|FG006|Overall Study|COVID-19 Pandemic|2|||
126549118|NCT02736968|455303987|FG007|Overall Study|COVID-19 Pandemic|0|||
126549119|NCT02736968|455303980|FG000|Overall Study|Withdrawal by Subject|0|||
126549120|NCT02736968|455303981|FG001|Overall Study|Withdrawal by Subject|0|||
126549121|NCT02736968|455303982|FG002|Overall Study|Withdrawal by Subject|0|||
126549122|NCT02736968|455303983|FG003|Overall Study|Withdrawal by Subject|0|||
126549123|NCT02736968|455303984|FG004|Overall Study|Withdrawal by Subject|0|||
126549124|NCT02736968|455303985|FG005|Overall Study|Withdrawal by Subject|0|||
126549125|NCT02736968|455303986|FG006|Overall Study|Withdrawal by Subject|1|||
126549126|NCT02736968|455303987|FG007|Overall Study|Withdrawal by Subject|0|||
126549127|NCT00147225|455303988|FG000|Overall Study|Withdrawal by Subject|1|||
126283716|NCT02604407|454326507|FG000|Overall Study|Adverse Event|0|||
126283717|NCT02604407|454326508|FG001|Overall Study|Adverse Event|7|||
126283718|NCT02604407|454326509|FG002|Overall Study|Adverse Event|5|||
126283719|NCT02604407|454326507|FG000|Overall Study|Protocol Violation|2|||
126549128|NCT00147225|455303989|FG001|Overall Study|Withdrawal by Subject|0|||
126549129|NCT00147225|455303990|FG002|Overall Study|Withdrawal by Subject|1|||
126549130|NCT00147225|455303991|FG003|Overall Study|Withdrawal by Subject|0|||
126549131|NCT00147225|455303992|FG004|Overall Study|Withdrawal by Subject|0|||
126549132|NCT00147225|455303993|FG005|Overall Study|Withdrawal by Subject|1|||
126283720|NCT02604407|454326508|FG001|Overall Study|Protocol Violation|0|||
126283721|NCT02604407|454326509|FG002|Overall Study|Protocol Violation|0|||
126283722|NCT02604407|454326507|FG000|Overall Study|Withdrawal by Subject|3|||
126549133|NCT00147225|455303988|FG000|Overall Study|Adverse Event|0|||
126549134|NCT00147225|455303989|FG001|Overall Study|Adverse Event|0|||
126549135|NCT00147225|455303990|FG002|Overall Study|Adverse Event|1|||
126549136|NCT00147225|455303991|FG003|Overall Study|Adverse Event|1|||
126283723|NCT02604407|454326508|FG001|Overall Study|Withdrawal by Subject|3|||
126283724|NCT02604407|454326509|FG002|Overall Study|Withdrawal by Subject|5|||
126283725|NCT02604407|454326507|FG000|Overall Study|Lost to Follow-up|2|||
126283726|NCT02604407|454326508|FG001|Overall Study|Lost to Follow-up|1|||
126283727|NCT02604407|454326509|FG002|Overall Study|Lost to Follow-up|2|||
126283728|NCT02604407|454326507|FG000|Overall Study|Lack of Efficacy|1|||
126283729|NCT02604407|454326508|FG001|Overall Study|Lack of Efficacy|0|||
126283730|NCT02604407|454326509|FG002|Overall Study|Lack of Efficacy|0|||
126283731|NCT02604407|454326507|FG000|Overall Study|Other|3|||
126283732|NCT02604407|454326508|FG001|Overall Study|Other|1|||
126283733|NCT02604407|454326509|FG002|Overall Study|Other|4|||
126283734|NCT00652340|454326512|FG000|Overall Study|Had not progressed.|4|||
126283735|NCT00652340|454326513|FG001|Overall Study|Had not progressed.|3|||
126283736|NCT03682107|454326514|FG000|Overall Study|Withdrawal by Subject|0|||
126283737|NCT03682107|454326515|FG001|Overall Study|Withdrawal by Subject|1|||
126283738|NCT03682107|454326516|FG002|Overall Study|Withdrawal by Subject|0|||
126283739|NCT03682107|454326517|FG003|Overall Study|Withdrawal by Subject|0|||
126283740|NCT03682107|454326518|FG004|Overall Study|Withdrawal by Subject|0|||
126283741|NCT00214383|454326519|FG000|Overall Study|Lost to Follow-up|16|||
126283742|NCT00214383|454326520|FG001|Overall Study|Lost to Follow-up|26|||
126283743|NCT03607487|454326521|FG000|Overall Study|Withdrawal by Subject|2|||
126283744|NCT03607487|454326522|FG001|Overall Study|Withdrawal by Subject|0|||
126283745|NCT03607487|454326523|FG002|Overall Study|Withdrawal by Subject|0|||
126283746|NCT03607487|454326524|FG003|Overall Study|Withdrawal by Subject|1|||
126283747|NCT02125877|454326527|FG000|Overall Study|Physician Decision|1|||
126283748|NCT02125877|454326528|FG001|Overall Study|Physician Decision|0|||
126283749|NCT02125877|454326527|FG000|Overall Study|Death|0|||
126283750|NCT02125877|454326528|FG001|Overall Study|Death|1|||
126283751|NCT02125877|454326527|FG000|Overall Study|Administrative problems|0|||
126283752|NCT02125877|454326528|FG001|Overall Study|Administrative problems|1|||
126283753|NCT02125877|454326527|FG000|Overall Study|Participant/guardian decision|0|||
126283754|NCT02125877|454326528|FG001|Overall Study|Participant/guardian decision|2|||
126283755|NCT02125877|454326527|FG000|Overall Study|Withdrawal by Subject|2|||
126283756|NCT02125877|454326528|FG001|Overall Study|Withdrawal by Subject|1|||
126283757|NCT02125877|454326527|FG000|Overall Study|Protocol deviation|4|||
126283758|NCT02125877|454326528|FG001|Overall Study|Protocol deviation|1|||
126283759|NCT02125877|454326527|FG000|Overall Study|Adverse Event|6|||
126283760|NCT02125877|454326528|FG001|Overall Study|Adverse Event|4|||
126283761|NCT02655666|454326532|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
126283762|NCT01267994|454326533|FG000|Overall Study|Adverse Event|2|||
126283763|NCT05199090|454326537|FG000|Overall Study|Adverse Event|1|||
126283764|NCT05199090|454326538|FG001|Overall Study|Adverse Event|4|||
126456307|NCT00770146|454970862|FG000|Treatment Period|Protocol non-compliance|0|||
126456308|NCT00770146|454970863|FG001|Treatment Period|Protocol non-compliance|1|||
126456309|NCT00770146|454970862|FG000|Follow-up Period|Withdrawal by Subject|7|||
126456310|NCT00770146|454970863|FG001|Follow-up Period|Withdrawal by Subject|13|||
126456311|NCT00770146|454970862|FG000|Follow-up Period|Adverse Event|0|||
126456312|NCT00770146|454970863|FG001|Follow-up Period|Adverse Event|2|||
126456313|NCT00770146|454970862|FG000|Follow-up Period|Other|4|||
126456314|NCT00770146|454970863|FG001|Follow-up Period|Other|5|||
126456315|NCT00816023|454970865|FG000|Overall Study|Lost to Follow-up|1|||
126456316|NCT00816023|454970866|FG001|Overall Study|Lost to Follow-up|1|||
126456317|NCT00816023|454970867|FG002|Overall Study|Lost to Follow-up|0|||
126456318|NCT00816023|454970868|FG003|Overall Study|Lost to Follow-up|0|||
126456319|NCT00816023|454970865|FG000|Overall Study|Withdrawal by Subject|1|||
126456320|NCT00816023|454970866|FG001|Overall Study|Withdrawal by Subject|0|||
126456321|NCT00816023|454970867|FG002|Overall Study|Withdrawal by Subject|0|||
126456322|NCT00816023|454970868|FG003|Overall Study|Withdrawal by Subject|0|||
126456323|NCT00816023|454970865|FG000|Overall Study|Physician Decision|0|||
126456324|NCT00816023|454970866|FG001|Overall Study|Physician Decision|0|||
126456325|NCT00816023|454970867|FG002|Overall Study|Physician Decision|1|||
126456326|NCT00816023|454970868|FG003|Overall Study|Physician Decision|0|||
126283765|NCT05199090|454326539|FG002|Overall Study|Adverse Event|0|||
126283766|NCT05199090|454326540|FG003|Overall Study|Adverse Event|0|||
126283767|NCT05199090|454326541|FG004|Overall Study|Adverse Event|0|||
126283768|NCT05199090|454326542|FG005|Overall Study|Adverse Event|0|||
126283769|NCT05199090|454326537|FG000|Overall Study|Lost to Follow-up|1|||
126283770|NCT05199090|454326538|FG001|Overall Study|Lost to Follow-up|0|||
126283771|NCT05199090|454326539|FG002|Overall Study|Lost to Follow-up|1|||
126283772|NCT05199090|454326540|FG003|Overall Study|Lost to Follow-up|4|||
126456327|NCT00816023|454970865|FG000|Overall Study|assessments complete prior to window|1|||
126283773|NCT05199090|454326541|FG004|Overall Study|Lost to Follow-up|0|||
126283774|NCT05199090|454326542|FG005|Overall Study|Lost to Follow-up|5|||
126283775|NCT05199090|454326537|FG000|Overall Study|Physician Decision|0|||
126283776|NCT05199090|454326538|FG001|Overall Study|Physician Decision|0|||
126283777|NCT05199090|454326539|FG002|Overall Study|Physician Decision|0|||
126283778|NCT05199090|454326540|FG003|Overall Study|Physician Decision|0|||
126283779|NCT05199090|454326541|FG004|Overall Study|Physician Decision|0|||
126456328|NCT00816023|454970866|FG001|Overall Study|assessments complete prior to window|1|||
126709183|NCT00923091|455887955|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
126709184|NCT00923091|455887956|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
126709185|NCT00923091|455887957|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
126709186|NCT00923091|455887958|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
126709187|NCT00923091|455887959|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
126709188|NCT00923091|455887960|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
126709189|NCT00923091|455887961|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
126709190|NCT00923091|455887962|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
126709191|NCT00923091|455887963|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
126709192|NCT00923091|455887951|FG000|Period III (Single-Blind)|Protocol Violation|3|||
126709193|NCT00923091|455887952|FG001|Period III (Single-Blind)|Protocol Violation|0|||
126709194|NCT00923091|455887953|FG002|Period III (Single-Blind)|Protocol Violation|0|||
126709195|NCT00923091|455887954|FG003|Period III (Single-Blind)|Protocol Violation|0|||
126709196|NCT00923091|455887955|FG004|Period III (Single-Blind)|Protocol Violation|0|||
126709197|NCT00923091|455887956|FG005|Period III (Single-Blind)|Protocol Violation|0|||
126709198|NCT00923091|455887957|FG006|Period III (Single-Blind)|Protocol Violation|0|||
126709199|NCT00923091|455887958|FG007|Period III (Single-Blind)|Protocol Violation|0|||
126709200|NCT00923091|455887959|FG008|Period III (Single-Blind)|Protocol Violation|0|||
126549137|NCT00147225|455303992|FG004|Overall Study|Adverse Event|0|||
126549138|NCT00147225|455303993|FG005|Overall Study|Adverse Event|0|||
126549139|NCT00147225|455303988|FG000|Overall Study|Screen Failure|0|||
126549140|NCT00147225|455303989|FG001|Overall Study|Screen Failure|0|||
126549141|NCT00147225|455303990|FG002|Overall Study|Screen Failure|0|||
126549142|NCT00147225|455303991|FG003|Overall Study|Screen Failure|0|||
126549143|NCT00147225|455303992|FG004|Overall Study|Screen Failure|1|||
126549144|NCT00147225|455303993|FG005|Overall Study|Screen Failure|0|||
126549145|NCT00147225|455303988|FG000|Overall Study|Chemotherapy Changed|0|||
126549146|NCT00147225|455303989|FG001|Overall Study|Chemotherapy Changed|0|||
126549147|NCT00147225|455303990|FG002|Overall Study|Chemotherapy Changed|0|||
126549148|NCT00147225|455303991|FG003|Overall Study|Chemotherapy Changed|0|||
126549149|NCT00147225|455303992|FG004|Overall Study|Chemotherapy Changed|0|||
126549150|NCT00147225|455303993|FG005|Overall Study|Chemotherapy Changed|1|||
126549151|NCT02998021|455303994|FG000|Overall Study|Withdrawal by Subject|3|||
126549152|NCT02998021|455303995|FG001|Overall Study|Withdrawal by Subject|1|||
126549153|NCT02998021|455303994|FG000|Overall Study|unsafe home|0|||
126549154|NCT02998021|455303995|FG001|Overall Study|unsafe home|1|||
126549155|NCT02041923|455303998|FG000|Overall Study|Lost to Follow-up|26|||
126549156|NCT02041923|455303999|FG001|Overall Study|Lost to Follow-up|30|||
126709201|NCT00923091|455887960|FG009|Period III (Single-Blind)|Protocol Violation|0|||
126709202|NCT00923091|455887961|FG010|Period III (Single-Blind)|Protocol Violation|0|||
126709203|NCT00923091|455887962|FG011|Period III (Single-Blind)|Protocol Violation|0|||
126709204|NCT00923091|455887963|FG012|Period III (Single-Blind)|Protocol Violation|0|||
126709205|NCT00923091|455887951|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
126283780|NCT05199090|454326542|FG005|Overall Study|Physician Decision|1|||
126456329|NCT00816023|454970867|FG002|Overall Study|assessments complete prior to window|2|||
126456330|NCT00816023|454970868|FG003|Overall Study|assessments complete prior to window|1|||
126456331|NCT00816023|454970865|FG000|Overall Study|Randomized Not Treated|6|||
126456332|NCT00816023|454970866|FG001|Overall Study|Randomized Not Treated|4|||
126456333|NCT00816023|454970867|FG002|Overall Study|Randomized Not Treated|6|||
126456334|NCT00816023|454970868|FG003|Overall Study|Randomized Not Treated|11|||
126456335|NCT01525901|454970869|FG000|Period 2: 12 Weeks|Adverse Event|0|||
126456336|NCT01525901|454970870|FG001|Period 2: 12 Weeks|Adverse Event|1|||
126456337|NCT01525901|454970871|FG002|Period 2: 12 Weeks|Adverse Event|0|||
126456338|NCT01525901|454970872|FG003|Period 2: 12 Weeks|Adverse Event|0|||
126456339|NCT05027971|454970877|FG000|Overall Study|Physician Decision|7|||
126456340|NCT05027971|454970878|FG001|Overall Study|Physician Decision|3|||
126456341|NCT05027971|454970877|FG000|Overall Study|Lost to Follow-up|1|||
126456342|NCT05027971|454970878|FG001|Overall Study|Lost to Follow-up|1|||
126456343|NCT05027971|454970877|FG000|Overall Study|Withdrawal by Subject|0|||
126456344|NCT05027971|454970878|FG001|Overall Study|Withdrawal by Subject|2|||
126456345|NCT05027971|454970877|FG000|Overall Study|Non-study fiber used.|0|||
126456346|NCT05027971|454970878|FG001|Overall Study|Non-study fiber used.|1|||
126456347|NCT05027971|454970877|FG000|Overall Study|Protocol Violation|0|||
126456348|NCT05027971|454970878|FG001|Overall Study|Protocol Violation|2|||
126456349|NCT02486627|454970879|FG000|Overall Study|Death|1|||
126456350|NCT02486627|454970880|FG001|Overall Study|Death|0|||
126456351|NCT02486627|454970879|FG000|Overall Study|Other Unspecified|0|||
126456352|NCT02486627|454970880|FG001|Overall Study|Other Unspecified|2|||
126456353|NCT02486627|454970879|FG000|Overall Study|Consent Withdrawn by Participant|4|||
126456354|NCT02486627|454970880|FG001|Overall Study|Consent Withdrawn by Participant|3|||
126456355|NCT02486627|454970879|FG000|Overall Study|Significant Participant Noncompliance|1|||
126456356|NCT02486627|454970880|FG001|Overall Study|Significant Participant Noncompliance|1|||
126456357|NCT02486627|454970879|FG000|Overall Study|Lost to Follow-up|1|||
126456358|NCT02486627|454970880|FG001|Overall Study|Lost to Follow-up|3|||
126456359|NCT01073462|454970881|FG000|Overall Study|Death|14|||
126283781|NCT05199090|454326537|FG000|Overall Study|Study terminated by sponsor|0|||
126283782|NCT05199090|454326538|FG001|Overall Study|Study terminated by sponsor|6|||
126283783|NCT05199090|454326539|FG002|Overall Study|Study terminated by sponsor|0|||
126283784|NCT05199090|454326540|FG003|Overall Study|Study terminated by sponsor|0|||
126283785|NCT05199090|454326541|FG004|Overall Study|Study terminated by sponsor|0|||
126283786|NCT05199090|454326542|FG005|Overall Study|Study terminated by sponsor|5|||
126283787|NCT05199090|454326537|FG000|Overall Study|Subject decision|0|||
126283788|NCT05199090|454326538|FG001|Overall Study|Subject decision|4|||
126283789|NCT05199090|454326539|FG002|Overall Study|Subject decision|0|||
126456360|NCT01073462|454970881|FG000|Overall Study|Kidney transplant|10|||
126456361|NCT01073462|454970881|FG000|Overall Study|Low parathyroid hormone levels|8|||
126456362|NCT01073462|454970881|FG000|Overall Study|Serious adverse event|2|||
126456363|NCT01073462|454970881|FG000|Overall Study|Lost to Follow-up|7|||
126456364|NCT05395091|454970884|FG000|Baseline to Month 12|Adverse Event|7|||
126456365|NCT05395091|454970885|FG001|Baseline to Month 12|Adverse Event|2|||
126456366|NCT05395091|454970886|FG002|Baseline to Month 12|Adverse Event|0|||
126456367|NCT05395091|454970884|FG000|Baseline to Month 12|Death|3|||
126456368|NCT05395091|454970885|FG001|Baseline to Month 12|Death|1|||
126456369|NCT05395091|454970886|FG002|Baseline to Month 12|Death|0|||
126456370|NCT05395091|454970884|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
126456371|NCT05395091|454970885|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
126456372|NCT05395091|454970886|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
126456373|NCT05395091|454970884|FG000|Baseline to Month 12|Protocol Violation|2|||
126456374|NCT05395091|454970885|FG001|Baseline to Month 12|Protocol Violation|3|||
126456375|NCT05395091|454970886|FG002|Baseline to Month 12|Protocol Violation|0|||
126283790|NCT05199090|454326540|FG003|Overall Study|Subject decision|2|||
126283791|NCT05199090|454326541|FG004|Overall Study|Subject decision|5|||
126283792|NCT05199090|454326542|FG005|Overall Study|Subject decision|2|||
126283793|NCT04759768|454326543|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
126283794|NCT04759768|454326544|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
126283795|NCT04759768|454326543|FG000|Washout (7 Days)|Physician Decision|0|||
126283796|NCT04759768|454326544|FG001|Washout (7 Days)|Physician Decision|1|||
126283797|NCT04873934|454326547|FG000|Overall Study|Adverse Event|0|||
126283798|NCT04873934|454326548|FG001|Overall Study|Adverse Event|1|||
126283799|NCT04873934|454326547|FG000|Overall Study|Death|0|||
126283800|NCT04873934|454326548|FG001|Overall Study|Death|2|||
126283801|NCT04873934|454326547|FG000|Overall Study|Lost to Follow-up|13|||
126283802|NCT04873934|454326548|FG001|Overall Study|Lost to Follow-up|9|||
126283803|NCT04873934|454326547|FG000|Overall Study|Physician Decision|1|||
126283804|NCT04873934|454326548|FG001|Overall Study|Physician Decision|1|||
126364910|NCT03131479|454630365|FG000|Overall Study|Subject/Guardian Decision|0|||
126364911|NCT03131479|454630366|FG001|Overall Study|Subject/Guardian Decision|0|||
126364912|NCT03131479|454630367|FG002|Overall Study|Subject/Guardian Decision|0|||
126456376|NCT05395091|454970884|FG000|Baseline to Month 12|Physician Decision|1|||
126456377|NCT05395091|454970885|FG001|Baseline to Month 12|Physician Decision|0|||
126456378|NCT05395091|454970886|FG002|Baseline to Month 12|Physician Decision|0|||
126456379|NCT05395091|454970884|FG000|Month 12 to Month 18|Death|1|||
126456380|NCT05395091|454970885|FG001|Month 12 to Month 18|Death|0|||
126456381|NCT05395091|454970886|FG002|Month 12 to Month 18|Death|0|||
126456382|NCT05395091|454970884|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
126456383|NCT05395091|454970885|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
126456384|NCT05395091|454970886|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
126456385|NCT05395091|454970884|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
126456386|NCT05395091|454970885|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
126456387|NCT05395091|454970886|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
126456388|NCT05395091|454970884|FG000|Month 12 to Month 18|Other reasons|0|||
126456389|NCT05395091|454970885|FG001|Month 12 to Month 18|Other reasons|0|||
126549157|NCT01734434|455304000|FG000|Overall Study|Death Infant|3|||
126766006|NCT04409509|456095877|FG000|Overall Study|Death|11|||
126766007|NCT04409509|456095878|FG001|Overall Study|Death|10|||
126766008|NCT04409509|456095877|FG000|Overall Study|Non-compliance with study drug|0|||
126283805|NCT04873934|454326547|FG000|Overall Study|Protocol deviation|2|||
126283806|NCT04873934|454326548|FG001|Overall Study|Protocol deviation|1|||
126364913|NCT03131479|454630368|FG003|Overall Study|Subject/Guardian Decision|1|||
126364914|NCT03131479|454630369|FG004|Overall Study|Subject/Guardian Decision|0|||
126364915|NCT02899754|454630372|FG000|Overall Study|Lost to Follow-up|7|||
126364916|NCT02899754|454630373|FG001|Overall Study|Lost to Follow-up|9|||
126364917|NCT04818229|454630374|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
126364918|NCT04818229|454630375|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
126364919|NCT04818229|454630376|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
126283807|NCT04873934|454326547|FG000|Overall Study|Subject decision|1|||
126283808|NCT04873934|454326548|FG001|Overall Study|Subject decision|8|||
126283809|NCT04873934|454326547|FG000|Overall Study|Withdrew consent|0|||
126283810|NCT04873934|454326548|FG001|Overall Study|Withdrew consent|4|||
126283811|NCT04873934|454326547|FG000|Overall Study|Missing|1|||
126456390|NCT05395091|454970886|FG002|Month 12 to Month 18|Other reasons|1|||
126766009|NCT04409509|456095878|FG001|Overall Study|Non-compliance with study drug|1|||
126709206|NCT00923091|455887952|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
126709207|NCT00923091|455887953|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
126709208|NCT00923091|455887954|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
126709209|NCT00923091|455887955|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
126709210|NCT00923091|455887956|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
126709211|NCT00923091|455887957|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
126709212|NCT00923091|455887958|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
126283812|NCT04873934|454326548|FG001|Overall Study|Missing|0|||
126283813|NCT05794503|454326549|FG000|Overall Study|Operation Cancelled|2|||
126283814|NCT05794503|454326550|FG001|Overall Study|Operation Cancelled|0|||
126283815|NCT05794503|454326549|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
126283816|NCT05794503|454326550|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
126283817|NCT05794503|454326549|FG000|Overall Study|Protocol Violation|1|||
126709213|NCT00923091|455887959|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
126709214|NCT00923091|455887960|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
126709215|NCT00923091|455887961|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
126709216|NCT00923091|455887962|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
126709217|NCT00923091|455887963|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
126709218|NCT00923091|455887951|FG000|Period IV (Double-Blind)|Adverse Event|2|||
126709219|NCT00923091|455887952|FG001|Period IV (Double-Blind)|Adverse Event|0|||
126709220|NCT00923091|455887953|FG002|Period IV (Double-Blind)|Adverse Event|0|||
126709221|NCT00923091|455887954|FG003|Period IV (Double-Blind)|Adverse Event|0|||
126709222|NCT00923091|455887955|FG004|Period IV (Double-Blind)|Adverse Event|0|||
126709223|NCT00923091|455887956|FG005|Period IV (Double-Blind)|Adverse Event|0|||
126709224|NCT00923091|455887957|FG006|Period IV (Double-Blind)|Adverse Event|0|||
126283818|NCT05794503|454326550|FG001|Overall Study|Protocol Violation|0|||
126283819|NCT03052127|454326551|FG000|Overall Study|Withdrawal by Subject|0|||
126283820|NCT03052127|454326552|FG001|Overall Study|Withdrawal by Subject|0|||
126283821|NCT03052127|454326553|FG002|Overall Study|Withdrawal by Subject|0|||
126283822|NCT03052127|454326554|FG003|Overall Study|Withdrawal by Subject|0|||
126283823|NCT03052127|454326555|FG004|Overall Study|Withdrawal by Subject|0|||
126283824|NCT03052127|454326556|FG005|Overall Study|Withdrawal by Subject|0|||
126283825|NCT03052127|454326557|FG006|Overall Study|Withdrawal by Subject|0|||
126283826|NCT03052127|454326558|FG007|Overall Study|Withdrawal by Subject|1|||
126456391|NCT03554486|454970888|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
126456392|NCT03554486|454970889|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
126456393|NCT03554486|454970890|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
126456394|NCT03554486|454970888|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
126456395|NCT03554486|454970889|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
126456396|NCT03554486|454970890|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
126456397|NCT03554486|454970888|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
126456398|NCT03554486|454970889|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
126456399|NCT03554486|454970890|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
126456400|NCT01509053|454970891|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
126456401|NCT01509053|454970891|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
126456402|NCT01509053|454970891|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
126709225|NCT00923091|455887958|FG007|Period IV (Double-Blind)|Adverse Event|0|||
126709226|NCT00923091|455887959|FG008|Period IV (Double-Blind)|Adverse Event|0|||
126709227|NCT00923091|455887960|FG009|Period IV (Double-Blind)|Adverse Event|0|||
126283827|NCT03052127|454326559|FG008|Overall Study|Withdrawal by Subject|1|||
126283828|NCT03052127|454326560|FG009|Overall Study|Withdrawal by Subject|1|||
126283829|NCT03052127|454326561|FG010|Overall Study|Withdrawal by Subject|0|||
126283830|NCT03052127|454326562|FG011|Overall Study|Withdrawal by Subject|0|||
126283831|NCT03052127|454326551|FG000|Overall Study|Discontinuation by Sponsor|0|||
126283832|NCT03052127|454326552|FG001|Overall Study|Discontinuation by Sponsor|0|||
126283833|NCT03052127|454326553|FG002|Overall Study|Discontinuation by Sponsor|0|||
126283834|NCT03052127|454326554|FG003|Overall Study|Discontinuation by Sponsor|0|||
126709228|NCT00923091|455887961|FG010|Period IV (Double-Blind)|Adverse Event|0|||
126709229|NCT00923091|455887962|FG011|Period IV (Double-Blind)|Adverse Event|0|||
126709230|NCT00923091|455887963|FG012|Period IV (Double-Blind)|Adverse Event|0|||
126709231|NCT00923091|455887951|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126709232|NCT00923091|455887952|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
126283835|NCT03052127|454326555|FG004|Overall Study|Discontinuation by Sponsor|0|||
126283836|NCT03052127|454326556|FG005|Overall Study|Discontinuation by Sponsor|0|||
126283837|NCT03052127|454326557|FG006|Overall Study|Discontinuation by Sponsor|0|||
126283838|NCT03052127|454326558|FG007|Overall Study|Discontinuation by Sponsor|0|||
126283839|NCT03052127|454326559|FG008|Overall Study|Discontinuation by Sponsor|4|||
126283840|NCT03052127|454326560|FG009|Overall Study|Discontinuation by Sponsor|2|||
126549158|NCT01734434|455304001|FG001|Overall Study|Death Infant|1|||
126283841|NCT03052127|454326561|FG010|Overall Study|Discontinuation by Sponsor|5|||
126283842|NCT03052127|454326562|FG011|Overall Study|Discontinuation by Sponsor|13|||
126283843|NCT03052127|454326551|FG000|Overall Study|Inability to comply with trial requirements|0|||
126283844|NCT03052127|454326552|FG001|Overall Study|Inability to comply with trial requirements|0|||
126283845|NCT03052127|454326553|FG002|Overall Study|Inability to comply with trial requirements|1|||
126283846|NCT03052127|454326554|FG003|Overall Study|Inability to comply with trial requirements|0|||
126283847|NCT03052127|454326555|FG004|Overall Study|Inability to comply with trial requirements|0|||
126283848|NCT03052127|454326556|FG005|Overall Study|Inability to comply with trial requirements|0|||
126283849|NCT03052127|454326557|FG006|Overall Study|Inability to comply with trial requirements|0|||
126283850|NCT03052127|454326558|FG007|Overall Study|Inability to comply with trial requirements|0|||
126283851|NCT03052127|454326559|FG008|Overall Study|Inability to comply with trial requirements|0|||
126283852|NCT03052127|454326560|FG009|Overall Study|Inability to comply with trial requirements|0|||
126283853|NCT03052127|454326561|FG010|Overall Study|Inability to comply with trial requirements|0|||
126283854|NCT03052127|454326562|FG011|Overall Study|Inability to comply with trial requirements|0|||
126283855|NCT03052127|454326551|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
126283856|NCT03052127|454326552|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283857|NCT03052127|454326553|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283858|NCT03052127|454326554|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283859|NCT03052127|454326555|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
126283860|NCT03052127|454326556|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
126283861|NCT03052127|454326557|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
126283862|NCT03052127|454326558|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283863|NCT03052127|454326559|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283864|NCT03052127|454326560|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283865|NCT03052127|454326561|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283866|NCT03052127|454326562|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
126283867|NCT03694327|454326565|FG000|Overall Study|Lost to Follow-up|13|||
126283868|NCT03694327|454326566|FG001|Overall Study|Lost to Follow-up|23|||
126283869|NCT01464931|454326569|FG000|Overall Study|Withdrawal by Subject|1|||
126283870|NCT01464931|454326570|FG001|Overall Study|Withdrawal by Subject|0|||
126283871|NCT01982812|454326571|FG000|Overall Study|Death|1|||
126283872|NCT01982812|454326572|FG001|Overall Study|Death|5|||
126283873|NCT01982812|454326571|FG000|Overall Study|Adverse Event|0|||
126283874|NCT01982812|454326572|FG001|Overall Study|Adverse Event|5|||
126283875|NCT04784533|454326573|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
126283876|NCT04784533|454326574|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
126283877|NCT04784533|454326575|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283878|NCT04784533|454326576|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283879|NCT04784533|454326577|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283880|NCT04784533|454326578|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283881|NCT04784533|454326579|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283882|NCT04784533|454326580|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283883|NCT04784533|454326581|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283884|NCT04784533|454326582|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
126283885|NCT04784533|454326573|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
126364920|NCT04818229|454630374|FG000|Overall Study|Adverse Event|3|||
126766010|NCT04409509|456095877|FG000|Overall Study|Lost to Follow-up|0|||
126364921|NCT04818229|454630375|FG001|Overall Study|Adverse Event|1|||
126364922|NCT04818229|454630376|FG002|Overall Study|Adverse Event|1|||
126364923|NCT04818229|454630374|FG000|Overall Study|Withdrawal by Subject|0|||
126364924|NCT04818229|454630375|FG001|Overall Study|Withdrawal by Subject|0|||
126364925|NCT04818229|454630376|FG002|Overall Study|Withdrawal by Subject|2|||
126364926|NCT04818229|454630374|FG000|Overall Study|Lost to Follow-up|0|||
126364927|NCT04818229|454630375|FG001|Overall Study|Lost to Follow-up|0|||
126364928|NCT04818229|454630376|FG002|Overall Study|Lost to Follow-up|1|||
126364929|NCT04082364|454630377|FG000|Overall Study|Death|23|||
126364930|NCT04082364|454630378|FG001|Overall Study|Death|1|||
126364931|NCT04082364|454630379|FG002|Overall Study|Death|1|||
126364932|NCT04082364|454630380|FG003|Overall Study|Death|2|||
126364933|NCT04082364|454630381|FG004|Overall Study|Death|1|||
126364934|NCT04082364|454630377|FG000|Overall Study|Lost to Follow-up|1|||
126364935|NCT04082364|454630378|FG001|Overall Study|Lost to Follow-up|0|||
126364936|NCT04082364|454630379|FG002|Overall Study|Lost to Follow-up|0|||
126364937|NCT04082364|454630380|FG003|Overall Study|Lost to Follow-up|0|||
126364938|NCT04082364|454630381|FG004|Overall Study|Lost to Follow-up|1|||
126364939|NCT04082364|454630377|FG000|Overall Study|Physician Decision|1|||
126364940|NCT04082364|454630378|FG001|Overall Study|Physician Decision|1|||
126364941|NCT04082364|454630379|FG002|Overall Study|Physician Decision|0|||
126364942|NCT04082364|454630380|FG003|Overall Study|Physician Decision|2|||
126364943|NCT04082364|454630381|FG004|Overall Study|Physician Decision|1|||
126364944|NCT04082364|454630377|FG000|Overall Study|Withdrawal by Subject|1|||
126364945|NCT04082364|454630378|FG001|Overall Study|Withdrawal by Subject|1|||
126364946|NCT04082364|454630379|FG002|Overall Study|Withdrawal by Subject|0|||
126364947|NCT04082364|454630380|FG003|Overall Study|Withdrawal by Subject|0|||
126283886|NCT04784533|454326574|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
126283887|NCT04784533|454326575|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283888|NCT04784533|454326576|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283889|NCT04784533|454326577|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283890|NCT04784533|454326578|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283891|NCT04784533|454326579|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283892|NCT04784533|454326580|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283893|NCT04784533|454326581|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283894|NCT04784533|454326582|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
126283895|NCT04784533|454326573|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283896|NCT04784533|454326574|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
126283897|NCT04784533|454326575|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283898|NCT04784533|454326576|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283899|NCT04784533|454326577|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283900|NCT04784533|454326578|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283901|NCT04784533|454326579|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283902|NCT04784533|454326580|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283903|NCT04784533|454326581|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283904|NCT04784533|454326582|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
126283905|NCT04784533|454326573|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
126283906|NCT04784533|454326574|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283907|NCT04784533|454326575|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283908|NCT04784533|454326576|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283909|NCT04784533|454326577|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283910|NCT04784533|454326578|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283911|NCT04784533|454326579|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283912|NCT04784533|454326580|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283913|NCT04784533|454326581|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283914|NCT04784533|454326582|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
126283915|NCT04784533|454326573|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
126456403|NCT01509053|454970891|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
126456404|NCT01509053|454970891|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
126456405|NCT01509053|454970891|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
126456406|NCT01738477|454970893|FG000|Overall Study|Lost to Follow-up|1|||
126456407|NCT01738477|454970894|FG001|Overall Study|Lost to Follow-up|4|||
126456408|NCT01915303|454970895|FG000|Core Phase|Adverse Event|7|||
126456409|NCT01915303|454970895|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
126456410|NCT01915303|454970895|FG000|Core Phase|Death|2|||
126456411|NCT01915303|454970895|FG000|Core Phase|Protocol Violation|2|||
126456412|NCT01915303|454970895|FG000|Core Phase|Abnormal lab value|1|||
126456413|NCT01915303|454970895|FG000|Core Phase|Withdrawal by Subject|1|||
126456414|NCT01915303|454970895|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
126456415|NCT01915303|454970895|FG000|Extension Phase|Withdrawal by Subject|4|||
126456416|NCT01915303|454970895|FG000|Extension Phase|Adverse Event|3|||
126456417|NCT01915303|454970895|FG000|Extension Phase|Death|1|||
126456418|NCT01915303|454970895|FG000|Extension Phase|Protocol Violation|1|||
126456419|NCT02925338|454970896|FG000|Overall Study|Death|0|||
126456420|NCT02925338|454970897|FG001|Overall Study|Death|2|||
126549159|NCT01734434|455304002|FG002|Overall Study|Death Infant|17|||
126283916|NCT04784533|454326574|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
126283917|NCT04784533|454326575|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283918|NCT04784533|454326576|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283919|NCT04784533|454326577|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283920|NCT04784533|454326578|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283921|NCT04784533|454326579|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283922|NCT04784533|454326580|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283923|NCT04784533|454326581|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283924|NCT04784533|454326582|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
126283925|NCT04784533|454326573|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
126283926|NCT04784533|454326574|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
126283927|NCT04784533|454326575|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283928|NCT04784533|454326576|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283929|NCT04784533|454326577|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126456421|NCT02925338|454970898|FG002|Overall Study|Death|1|||
126456422|NCT02925338|454970899|FG003|Overall Study|Death|0|||
126456423|NCT02925338|454970900|FG004|Overall Study|Death|0|||
126456424|NCT02925338|454970896|FG000|Overall Study|Lost to Follow-up|30|||
126549160|NCT01734434|455304003|FG003|Overall Study|Death Infant|5|||
126709233|NCT00923091|455887953|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126283930|NCT04784533|454326578|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283931|NCT04784533|454326579|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283932|NCT04784533|454326580|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283933|NCT04784533|454326581|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283934|NCT04784533|454326582|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
126283935|NCT04784533|454326573|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283936|NCT04784533|454326574|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283937|NCT04784533|454326575|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
126283938|NCT04784533|454326576|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283939|NCT04784533|454326577|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283940|NCT04784533|454326578|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283941|NCT04784533|454326579|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283942|NCT04784533|454326580|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283943|NCT04784533|454326581|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283944|NCT04784533|454326582|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
126283945|NCT04784533|454326573|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283946|NCT04784533|454326574|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283947|NCT04784533|454326575|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283948|NCT04784533|454326576|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283949|NCT04784533|454326577|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283950|NCT04784533|454326578|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283951|NCT04784533|454326579|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283952|NCT04784533|454326580|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283953|NCT04784533|454326581|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
126283954|NCT04784533|454326582|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
126283955|NCT04784533|454326573|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283956|NCT04784533|454326574|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283957|NCT04784533|454326575|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283958|NCT04784533|454326576|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283959|NCT04784533|454326577|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283960|NCT04784533|454326578|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283961|NCT04784533|454326579|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283962|NCT04784533|454326580|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
126283963|NCT04784533|454326581|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
126283964|NCT04784533|454326582|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
126283965|NCT00307437|454326583|FG000|Controlled Period|Adverse Event|7|||
126283966|NCT00307437|454326584|FG001|Controlled Period|Adverse Event|2|||
126283967|NCT00307437|454326585|FG002|Controlled Period|Adverse Event|5|||
126283968|NCT00307437|454326586|FG003|Controlled Period|Adverse Event|0|||
126283969|NCT00307437|454326587|FG004|Controlled Period|Adverse Event|0|||
126283970|NCT00307437|454326588|FG005|Controlled Period|Adverse Event|0|||
126283971|NCT00307437|454326589|FG006|Controlled Period|Adverse Event|0|||
126283972|NCT00307437|454326583|FG000|Controlled Period|Death|0|||
126283973|NCT00307437|454326584|FG001|Controlled Period|Death|0|||
126283974|NCT00307437|454326585|FG002|Controlled Period|Death|1|||
126283975|NCT00307437|454326586|FG003|Controlled Period|Death|0|||
126283976|NCT00307437|454326587|FG004|Controlled Period|Death|0|||
126283977|NCT00307437|454326588|FG005|Controlled Period|Death|0|||
126283978|NCT00307437|454326589|FG006|Controlled Period|Death|0|||
126283979|NCT00307437|454326583|FG000|Controlled Period|Lack of Efficacy|2|||
126283980|NCT00307437|454326584|FG001|Controlled Period|Lack of Efficacy|0|||
126283981|NCT00307437|454326585|FG002|Controlled Period|Lack of Efficacy|0|||
126283982|NCT00307437|454326586|FG003|Controlled Period|Lack of Efficacy|0|||
126283983|NCT00307437|454326587|FG004|Controlled Period|Lack of Efficacy|0|||
126283984|NCT00307437|454326588|FG005|Controlled Period|Lack of Efficacy|0|||
126283985|NCT00307437|454326589|FG006|Controlled Period|Lack of Efficacy|0|||
126283986|NCT00307437|454326583|FG000|Controlled Period|Lost to Follow-up|2|||
126283987|NCT00307437|454326584|FG001|Controlled Period|Lost to Follow-up|3|||
126283988|NCT00307437|454326585|FG002|Controlled Period|Lost to Follow-up|0|||
126283989|NCT00307437|454326586|FG003|Controlled Period|Lost to Follow-up|0|||
126709234|NCT00923091|455887954|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126283990|NCT00307437|454326587|FG004|Controlled Period|Lost to Follow-up|0|||
126283991|NCT00307437|454326588|FG005|Controlled Period|Lost to Follow-up|0|||
126283992|NCT00307437|454326589|FG006|Controlled Period|Lost to Follow-up|0|||
126283993|NCT00307437|454326583|FG000|Controlled Period|Other|5|||
126709235|NCT00923091|455887955|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126283994|NCT00307437|454326584|FG001|Controlled Period|Other|1|||
126283995|NCT00307437|454326585|FG002|Controlled Period|Other|3|||
126283996|NCT00307437|454326586|FG003|Controlled Period|Other|0|||
126283997|NCT00307437|454326587|FG004|Controlled Period|Other|0|||
126709236|NCT00923091|455887956|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126283998|NCT00307437|454326588|FG005|Controlled Period|Other|0|||
126283999|NCT00307437|454326589|FG006|Controlled Period|Other|0|||
126549161|NCT01734434|455304000|FG000|Overall Study|Lost to Follow-up|2|||
126549162|NCT01734434|455304001|FG001|Overall Study|Lost to Follow-up|9|||
126549163|NCT01734434|455304002|FG002|Overall Study|Lost to Follow-up|67|||
126549164|NCT01734434|455304003|FG003|Overall Study|Lost to Follow-up|11|||
126549165|NCT01734434|455304000|FG000|Overall Study|No Live Birth|1|||
126549166|NCT01734434|455304001|FG001|Overall Study|No Live Birth|2|||
126549167|NCT01734434|455304002|FG002|Overall Study|No Live Birth|32|||
126549168|NCT01734434|455304003|FG003|Overall Study|No Live Birth|6|||
126709237|NCT00923091|455887957|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126709238|NCT00923091|455887958|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126549169|NCT01734434|455304000|FG000|Overall Study|Withdrawal by Subject|4|||
126549170|NCT01734434|455304001|FG001|Overall Study|Withdrawal by Subject|0|||
126709239|NCT00923091|455887959|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126709240|NCT00923091|455887960|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126709241|NCT00923091|455887961|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126709242|NCT00923091|455887962|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126709243|NCT00923091|455887963|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
126709244|NCT00923091|455887951|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
126709245|NCT00923091|455887952|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
126709246|NCT00923091|455887953|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
126709247|NCT00923091|455887954|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
126709248|NCT00923091|455887955|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
126709249|NCT00923091|455887956|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
126709250|NCT00923091|455887957|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
126709251|NCT00923091|455887958|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
126709252|NCT00923091|455887959|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
126709253|NCT00923091|455887960|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
126284000|NCT00307437|454326583|FG000|After Controlled Period|Adverse Event|0|||
126284001|NCT00307437|454326584|FG001|After Controlled Period|Adverse Event|0|||
126284002|NCT00307437|454326585|FG002|After Controlled Period|Adverse Event|0|||
126284003|NCT00307437|454326586|FG003|After Controlled Period|Adverse Event|18|||
126284004|NCT00307437|454326587|FG004|After Controlled Period|Adverse Event|16|||
126284005|NCT00307437|454326588|FG005|After Controlled Period|Adverse Event|31|||
126284006|NCT00307437|454326589|FG006|After Controlled Period|Adverse Event|40|||
126284007|NCT00307437|454326583|FG000|After Controlled Period|Death|0|||
126284008|NCT00307437|454326584|FG001|After Controlled Period|Death|0|||
126284009|NCT00307437|454326585|FG002|After Controlled Period|Death|0|||
126284010|NCT00307437|454326586|FG003|After Controlled Period|Death|3|||
126284011|NCT00307437|454326587|FG004|After Controlled Period|Death|1|||
126284012|NCT00307437|454326588|FG005|After Controlled Period|Death|1|||
126284013|NCT00307437|454326589|FG006|After Controlled Period|Death|3|||
126284014|NCT00307437|454326583|FG000|After Controlled Period|Lack of Efficacy|0|||
126284015|NCT00307437|454326584|FG001|After Controlled Period|Lack of Efficacy|0|||
126284016|NCT00307437|454326585|FG002|After Controlled Period|Lack of Efficacy|0|||
126284017|NCT00307437|454326586|FG003|After Controlled Period|Lack of Efficacy|15|||
126284018|NCT00307437|454326587|FG004|After Controlled Period|Lack of Efficacy|17|||
126284019|NCT00307437|454326588|FG005|After Controlled Period|Lack of Efficacy|37|||
126284020|NCT00307437|454326589|FG006|After Controlled Period|Lack of Efficacy|24|||
126284021|NCT00307437|454326583|FG000|After Controlled Period|Lost to Follow-up|0|||
126284022|NCT00307437|454326584|FG001|After Controlled Period|Lost to Follow-up|0|||
126284023|NCT00307437|454326585|FG002|After Controlled Period|Lost to Follow-up|0|||
126284024|NCT00307437|454326586|FG003|After Controlled Period|Lost to Follow-up|7|||
126284025|NCT00307437|454326587|FG004|After Controlled Period|Lost to Follow-up|12|||
126284026|NCT00307437|454326588|FG005|After Controlled Period|Lost to Follow-up|13|||
126284027|NCT00307437|454326589|FG006|After Controlled Period|Lost to Follow-up|18|||
126284028|NCT00307437|454326583|FG000|After Controlled Period|Other|0|||
126284029|NCT00307437|454326584|FG001|After Controlled Period|Other|0|||
126284030|NCT00307437|454326585|FG002|After Controlled Period|Other|0|||
126284031|NCT00307437|454326586|FG003|After Controlled Period|Other|15|||
126709254|NCT00923091|455887961|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
126709255|NCT00923091|455887962|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
126709256|NCT00923091|455887963|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
126709257|NCT00923091|455887951|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
126284032|NCT00307437|454326587|FG004|After Controlled Period|Other|9|||
126284033|NCT00307437|454326588|FG005|After Controlled Period|Other|40|||
126284034|NCT00307437|454326589|FG006|After Controlled Period|Other|28|||
126549171|NCT01734434|455304002|FG002|Overall Study|Withdrawal by Subject|8|||
126549172|NCT01734434|455304003|FG003|Overall Study|Withdrawal by Subject|1|||
126549173|NCT01734434|455304000|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
126549174|NCT01734434|455304001|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
126709258|NCT00923091|455887952|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
126709259|NCT00923091|455887953|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
126284035|NCT00338728|454326595|FG000|Overall Study|Screen Failure|14|||
126709260|NCT00923091|455887954|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
126284036|NCT00708227|454326602|FG000|Overall Study|Physician Decision|0|||
126709261|NCT00923091|455887955|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
126709262|NCT00923091|455887956|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
126709263|NCT00923091|455887957|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
126709264|NCT00923091|455887958|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
126709265|NCT00923091|455887959|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
126284037|NCT00708227|454326603|FG001|Overall Study|Physician Decision|3|||
126284038|NCT00708227|454326604|FG002|Overall Study|Physician Decision|1|||
126284039|NCT00708227|454326605|FG003|Overall Study|Physician Decision|2|||
126284040|NCT00708227|454326602|FG000|Overall Study|Withdrawal by Subject|1|||
126284041|NCT00708227|454326603|FG001|Overall Study|Withdrawal by Subject|2|||
126284042|NCT00708227|454326604|FG002|Overall Study|Withdrawal by Subject|0|||
126284043|NCT00708227|454326605|FG003|Overall Study|Withdrawal by Subject|1|||
126284044|NCT03654599|454326607|FG000|Overall Study|Lost to Follow-up|14|||
126284045|NCT03654599|454326608|FG001|Overall Study|Lost to Follow-up|12|||
126284046|NCT03654599|454326607|FG000|Overall Study|Death|8|||
126284047|NCT03654599|454326608|FG001|Overall Study|Death|6|||
126284048|NCT03654599|454326607|FG000|Overall Study|Withdrawal by Subject|6|||
126284049|NCT03654599|454326608|FG001|Overall Study|Withdrawal by Subject|4|||
126284050|NCT03765788|454328805|FG000|Overall Study|Subject decision|2|||
126284051|NCT03765788|454328806|FG001|Overall Study|Subject decision|3|||
126284052|NCT03765788|454328805|FG000|Overall Study|Physician Decision|2|||
126284053|NCT03765788|454328806|FG001|Overall Study|Physician Decision|4|||
126284054|NCT03765788|454328805|FG000|Overall Study|Death|0|||
126284055|NCT03765788|454328806|FG001|Overall Study|Death|1|||
126284056|NCT03765788|454328805|FG000|Overall Study|Lost to Follow-up|1|||
126284057|NCT03765788|454328806|FG001|Overall Study|Lost to Follow-up|0|||
126284058|NCT01659125|454328807|FG000|Overall Study|Withdrawal by Subject|2|||
126284059|NCT01659125|454328807|FG000|Overall Study|Lost to Follow-up|7|||
126284060|NCT01659125|454328807|FG000|Overall Study|Technical Problem|1|||
126284061|NCT01659125|454328807|FG000|Overall Study|Time Constraints|2|||
126284062|NCT01659125|454328807|FG000|Overall Study|Failed to Start Treatment|2|||
126284063|NCT02640482|454328808|FG000|Overall Study|Lost to Follow-up|3|||
126284064|NCT02640482|454328809|FG001|Overall Study|Lost to Follow-up|0|||
126284065|NCT02013817|454328812|FG000|Overall Study|Adverse Event|12|||
126284066|NCT02013817|454328812|FG000|Overall Study|Withdrawal by Subject|4|||
126284067|NCT02013817|454328812|FG000|Overall Study|Death|2|||
126284068|NCT02013817|454328812|FG000|Overall Study|Other|9|||
126284069|NCT03055624|454328819|FG000|Overall Study|Study closed|9|||
126284070|NCT02794870|454328823|FG000|Overall Study|Withdrawal by Subject|2|||
126284071|NCT02794870|454328824|FG001|Overall Study|Withdrawal by Subject|0|||
126284072|NCT03336528|454328825|FG000|Overall Study|Protocol Violation|1|||
126284073|NCT03336528|454328826|FG001|Overall Study|Protocol Violation|1|||
126284074|NCT03336528|454328825|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
126284075|NCT03336528|454328826|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
126284076|NCT03336528|454328825|FG000|Overall Study|Did not receive study medication|1|||
126284077|NCT03336528|454328826|FG001|Overall Study|Did not receive study medication|2|||
126284078|NCT00230178|454328831|FG000|Overall Study|Adverse Event|1|||
126284079|NCT00230178|454328832|FG001|Overall Study|Adverse Event|5|||
126284080|NCT00230178|454328833|FG002|Overall Study|Adverse Event|2|||
126284081|NCT00230178|454328831|FG000|Overall Study|Withdrawal by Subject|0|||
126284082|NCT00230178|454328832|FG001|Overall Study|Withdrawal by Subject|0|||
126284083|NCT00230178|454328833|FG002|Overall Study|Withdrawal by Subject|1|||
126284084|NCT00230178|454328831|FG000|Overall Study|Various other reasons|3|||
126284085|NCT00230178|454328832|FG001|Overall Study|Various other reasons|2|||
126284086|NCT00230178|454328833|FG002|Overall Study|Various other reasons|4|||
126284087|NCT04974749|454328850|FG000|Overall Study|Withdrawal by Subject|2|||
126284088|NCT04974749|454328850|FG000|Overall Study|Gestation|1|||
126284089|NCT04414618|454328851|FG000|Overall Study|Death|3|||
126284090|NCT04414618|454328852|FG001|Overall Study|Death|3|||
126284091|NCT04414618|454328851|FG000|Overall Study|Withdrawal by Subject|2|||
126284092|NCT04414618|454328852|FG001|Overall Study|Withdrawal by Subject|1|||
126709266|NCT00923091|455887960|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
126284093|NCT04414618|454328851|FG000|Overall Study|Lost to Follow-up|2|||
126284094|NCT04414618|454328852|FG001|Overall Study|Lost to Follow-up|3|||
126284095|NCT04414618|454328851|FG000|Overall Study|Physician Decision|1|||
126284096|NCT04414618|454328852|FG001|Overall Study|Physician Decision|0|||
126364948|NCT04082364|454630381|FG004|Overall Study|Withdrawal by Subject|1|||
126709267|NCT00923091|455887961|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
126709268|NCT00923091|455887962|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
126284097|NCT00362336|454328853|FG000|Overall Study|Serious Adverse Event|1|||
126284098|NCT00362336|454328854|FG001|Overall Study|Serious Adverse Event|0|||
126284099|NCT00362336|454328855|FG002|Overall Study|Serious Adverse Event|1|||
126284100|NCT00362336|454328853|FG000|Overall Study|Protocol Violation|0|||
126284101|NCT00362336|454328854|FG001|Overall Study|Protocol Violation|0|||
126284102|NCT00362336|454328855|FG002|Overall Study|Protocol Violation|1|||
126284103|NCT00362336|454328853|FG000|Overall Study|Lost to Follow-up|6|||
126284104|NCT00362336|454328854|FG001|Overall Study|Lost to Follow-up|4|||
126284105|NCT00362336|454328855|FG002|Overall Study|Lost to Follow-up|0|||
126284106|NCT00362336|454328853|FG000|Overall Study|Withdrawal by Subject|3|||
126284107|NCT00362336|454328854|FG001|Overall Study|Withdrawal by Subject|3|||
126284108|NCT00362336|454328855|FG002|Overall Study|Withdrawal by Subject|1|||
126284109|NCT00658879|454328856|FG000|Overall Study|Protocol Violation|1|||
126284110|NCT00616421|454328859|FG000|Overall Study|Withdrawal by Subject|9|||
126549175|NCT01734434|455304002|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
126549176|NCT01734434|455304003|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
126549177|NCT01734434|455304000|FG000|Overall Study|Subject Not Reachable|0|||
126549178|NCT01734434|455304001|FG001|Overall Study|Subject Not Reachable|0|||
126549179|NCT01734434|455304002|FG002|Overall Study|Subject Not Reachable|1|||
126549180|NCT01734434|455304003|FG003|Overall Study|Subject Not Reachable|0|||
126549181|NCT01734434|455304000|FG000|Overall Study|Treatment Defaulter|0|||
126549182|NCT01734434|455304001|FG001|Overall Study|Treatment Defaulter|0|||
126549183|NCT01734434|455304002|FG002|Overall Study|Treatment Defaulter|1|||
126549184|NCT01734434|455304003|FG003|Overall Study|Treatment Defaulter|0|||
126284111|NCT00616421|454328860|FG001|Overall Study|Withdrawal by Subject|11|||
126284112|NCT00616421|454328861|FG002|Overall Study|Withdrawal by Subject|8|||
126549185|NCT01734434|455304000|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
126284113|NCT00616421|454328859|FG000|Overall Study|Lost to Follow-up|12|||
126284114|NCT00616421|454328860|FG001|Overall Study|Lost to Follow-up|26|||
126284115|NCT00616421|454328861|FG002|Overall Study|Lost to Follow-up|30|||
126284116|NCT00616421|454328859|FG000|Overall Study|Inappropriate enrollment|3|||
126284117|NCT00616421|454328860|FG001|Overall Study|Inappropriate enrollment|0|||
126284118|NCT00616421|454328861|FG002|Overall Study|Inappropriate enrollment|1|||
126284119|NCT00616421|454328859|FG000|Overall Study|Administrative reason|1|||
126284120|NCT00616421|454328860|FG001|Overall Study|Administrative reason|0|||
126284121|NCT00616421|454328861|FG002|Overall Study|Administrative reason|0|||
126284122|NCT00616421|454328859|FG000|Overall Study|Protocol Violation|0|||
126284123|NCT00616421|454328860|FG001|Overall Study|Protocol Violation|1|||
126284124|NCT00616421|454328861|FG002|Overall Study|Protocol Violation|2|||
126284125|NCT00616421|454328859|FG000|Overall Study|Unable to classify|1|||
126284126|NCT00616421|454328860|FG001|Overall Study|Unable to classify|0|||
126284127|NCT00616421|454328861|FG002|Overall Study|Unable to classify|0|||
126284128|NCT02661217|454328862|FG000|Overall Study|Physician Decision|12|||
126284129|NCT02661217|454328863|FG001|Overall Study|Physician Decision|15|||
126284130|NCT02661217|454328862|FG000|Overall Study|Lost to Follow-up|1|||
126284131|NCT02661217|454328863|FG001|Overall Study|Lost to Follow-up|4|||
126284132|NCT02661217|454328862|FG000|Overall Study|Protocol Deviation|0|||
126549186|NCT01734434|455304001|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
126549187|NCT01734434|455304002|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
126549188|NCT01734434|455304003|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
126549189|NCT01734434|455304000|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
126709269|NCT00923091|455887963|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
126709270|NCT00923091|455887951|FG000|Period V (Double -Blind)|Protocol Violation|0|||
126709271|NCT00923091|455887952|FG001|Period V (Double -Blind)|Protocol Violation|0|||
126284133|NCT02661217|454328863|FG001|Overall Study|Protocol Deviation|4|||
126284134|NCT02661217|454328862|FG000|Overall Study|Non-compliance with study treatment|5|||
126284135|NCT02661217|454328863|FG001|Overall Study|Non-compliance with study treatment|5|||
126284136|NCT02661217|454328862|FG000|Overall Study|Death|21|||
126284137|NCT02661217|454328863|FG001|Overall Study|Death|15|||
126284138|NCT02661217|454328862|FG000|Overall Study|Adverse Event|10|||
126284139|NCT02661217|454328863|FG001|Overall Study|Adverse Event|8|||
126284140|NCT02661217|454328862|FG000|Overall Study|Withdrawal by Subject|15|||
126284141|NCT02661217|454328863|FG001|Overall Study|Withdrawal by Subject|19|||
126284142|NCT02661217|454328862|FG000|Overall Study|Did not enter follow-up epoch|7|||
126284143|NCT02661217|454328863|FG001|Overall Study|Did not enter follow-up epoch|10|||
126284144|NCT02661217|454328862|FG000|Overall Study|Death - no study drug received|1|||
126284145|NCT02661217|454328863|FG001|Overall Study|Death - no study drug received|2|||
126549190|NCT01734434|455304001|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
126549191|NCT01734434|455304002|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
126284146|NCT02661217|454328862|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
126549192|NCT01734434|455304003|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
126549193|NCT02049710|455304004|FG000|Overall Study|Lost to Follow-up|319|||
126549194|NCT02049710|455304005|FG001|Overall Study|Lost to Follow-up|324|||
126284147|NCT02661217|454328863|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
126284148|NCT00196326|454328864|FG000|Overall Study|Did not meet protocol requirements|64|||
126284149|NCT00196326|454328864|FG000|Overall Study|Non-compliance with the protocol|81|||
126284150|NCT00196326|454328864|FG000|Overall Study|Physician Decision|3|||
126284151|NCT00196326|454328864|FG000|Overall Study|Withdrawal by Subject|225|||
126284152|NCT00196326|454328864|FG000|Overall Study|Adverse Event|253|||
126284153|NCT00196326|454328864|FG000|Overall Study|Pregnancy|34|||
126284154|NCT00196326|454328864|FG000|Overall Study|Lost to Follow-up|304|||
126549195|NCT00874432|455304009|FG000|Overall Study|Withdrawal by Subject|1|||
126284155|NCT00196326|454328864|FG000|Overall Study|Other|22|||
126284156|NCT02481869|454328873|FG000|Overall Study|Lost to Follow-up|3|||
126284157|NCT02481869|454328874|FG001|Overall Study|Lost to Follow-up|4|||
126284158|NCT02481869|454328873|FG000|Overall Study|Withdrawal by Subject|2|||
126284159|NCT02481869|454328874|FG001|Overall Study|Withdrawal by Subject|0|||
126284160|NCT00711880|454328875|FG000|Overall Study|Adverse Event|11|||
126284161|NCT00711880|454328876|FG001|Overall Study|Adverse Event|2|||
126284162|NCT00711880|454328875|FG000|Overall Study|Patient non-compliance|1|||
126284163|NCT00711880|454328876|FG001|Overall Study|Patient non-compliance|0|||
126284164|NCT00711880|454328875|FG000|Overall Study|Lack of Efficacy|1|||
126284165|NCT00711880|454328876|FG001|Overall Study|Lack of Efficacy|5|||
126284166|NCT03908437|454328879|FG000|Overall Study|Death|0|||
126284167|NCT03908437|454328880|FG001|Overall Study|Death|1|||
126284168|NCT03908437|454328879|FG000|Overall Study|Lost to Follow-up|31|||
126284169|NCT03908437|454328880|FG001|Overall Study|Lost to Follow-up|24|||
126284170|NCT05445492|454328881|FG000|Overall Study|Physician Decision|1|||
126284171|NCT00191191|454328882|FG000|Overall Study|Entry Criteria Exclusion|2|||
126284172|NCT00191191|454328883|FG001|Overall Study|Entry Criteria Exclusion|0|||
126284173|NCT00191191|454328882|FG000|Overall Study|Treated with Another Systemic Agent|1|||
126284174|NCT00191191|454328883|FG001|Overall Study|Treated with Another Systemic Agent|1|||
126284175|NCT00191191|454328882|FG000|Overall Study|Adverse Event|11|||
126284176|NCT00191191|454328883|FG001|Overall Study|Adverse Event|21|||
126284177|NCT00191191|454328882|FG000|Overall Study|Progressive Disease|84|||
126284178|NCT00191191|454328883|FG001|Overall Study|Progressive Disease|72|||
126284179|NCT00191191|454328882|FG000|Overall Study|Toxicity After Dose Reduction|7|||
126284180|NCT00191191|454328883|FG001|Overall Study|Toxicity After Dose Reduction|8|||
126284181|NCT00191191|454328882|FG000|Overall Study|Family/Caregiver Decision|5|||
126284182|NCT00191191|454328883|FG001|Overall Study|Family/Caregiver Decision|7|||
126284183|NCT00191191|454328882|FG000|Overall Study|Lost to Follow-up|1|||
126284184|NCT00191191|454328883|FG001|Overall Study|Lost to Follow-up|0|||
126284185|NCT00191191|454328882|FG000|Overall Study|Physician Decision|3|||
126284186|NCT00191191|454328883|FG001|Overall Study|Physician Decision|2|||
126284187|NCT00191191|454328882|FG000|Overall Study|Good Clinical Practice Violation|0|||
126284188|NCT00191191|454328883|FG001|Overall Study|Good Clinical Practice Violation|1|||
126284189|NCT04238650|454328884|FG000|Overall Study|Withdrawal by Subject|0|||
126284190|NCT04238650|454328885|FG001|Overall Study|Withdrawal by Subject|1|||
126284191|NCT03348163|454328886|FG000|Overall Study|Withdrawal by Subject|2|||
126284192|NCT03348163|454328887|FG001|Overall Study|Withdrawal by Subject|0|||
126284193|NCT02370238|454328888|FG000|Overall Study|Death|42|||
126284194|NCT02370238|454328889|FG001|Overall Study|Death|35|||
126284195|NCT02370238|454328888|FG000|Overall Study|Lost to Follow-up|1|||
126284196|NCT02370238|454328889|FG001|Overall Study|Lost to Follow-up|3|||
126284197|NCT02370238|454328888|FG000|Overall Study|Withdrawal by Subject|2|||
126284198|NCT02370238|454328889|FG001|Overall Study|Withdrawal by Subject|6|||
126284199|NCT02370238|454328888|FG000|Overall Study|Other|2|||
126284200|NCT02370238|454328889|FG001|Overall Study|Other|1|||
126284201|NCT01295320|454328892|FG000|Overall Study|Adverse Event|2|||
126284202|NCT01295320|454328892|FG000|Overall Study|Lost to Follow-up|4|||
126284203|NCT01295320|454328892|FG000|Overall Study|Withdrawal by Subject|2|||
126284204|NCT01295320|454328892|FG000|Overall Study|Subject was bedridden|1|||
126284205|NCT01295320|454328892|FG000|Overall Study|Unable to travel|1|||
126284206|NCT04342819|454328893|FG000|Overall Study|Declined|4|||
126284207|NCT04342819|454328893|FG000|Overall Study|Not meeeting selection criteria|1|||
126284208|NCT01569295|454328894|FG000|Overall Study|Progressive Disease|75|||
126284209|NCT01569295|454328895|FG001|Overall Study|Progressive Disease|139|||
126284210|NCT01569295|454328894|FG000|Overall Study|Adverse Event|39|||
126284211|NCT01569295|454328895|FG001|Overall Study|Adverse Event|14|||
126284212|NCT01569295|454328894|FG000|Overall Study|Withdrawal by Subject|25|||
126284213|NCT01569295|454328895|FG001|Overall Study|Withdrawal by Subject|12|||
126284214|NCT01569295|454328894|FG000|Overall Study|Death|19|||
126284215|NCT01569295|454328895|FG001|Overall Study|Death|15|||
126284216|NCT01569295|454328894|FG000|Overall Study|Physician Decision|13|||
126284217|NCT01569295|454328895|FG001|Overall Study|Physician Decision|18|||
126284218|NCT01569295|454328894|FG000|Overall Study|Study Terminated by Sponsor|24|||
126364949|NCT04082364|454630377|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
126364950|NCT04082364|454630378|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
126284219|NCT01569295|454328895|FG001|Overall Study|Study Terminated by Sponsor|2|||
126284220|NCT01569295|454328894|FG000|Overall Study|Other Reason not Specified|3|||
126284221|NCT01569295|454328895|FG001|Overall Study|Other Reason not Specified|5|||
126284222|NCT01569295|454328894|FG000|Overall Study|Non-Compliance with Study Drug|6|||
126284223|NCT01569295|454328895|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126284224|NCT01569295|454328894|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
126284225|NCT01569295|454328895|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
126284226|NCT01569295|454328894|FG000|Overall Study|Lost to Follow-up|1|||
126284227|NCT01569295|454328895|FG001|Overall Study|Lost to Follow-up|1|||
126284228|NCT03597295|454328896|FG000|Overall Study|Death|70|||
126284229|NCT03597295|454328896|FG000|Overall Study|Lost to Follow-up|7|||
126284230|NCT00879411|454328897|FG000|Overall Study|lost to follow-up (non-AE)|162|||
126284231|NCT01884337|454328898|FG000|Treatment|Adverse Event|2|||
126284232|NCT01884337|454328899|FG001|Treatment|Adverse Event|2|||
126284233|NCT01884337|454328898|FG000|Treatment|Subj. request to discont. treatment|2|||
126284234|NCT01884337|454328899|FG001|Treatment|Subj. request to discont. treatment|0|||
126284235|NCT01884337|454328898|FG000|Follow-up Period|Lost to Follow-up|1|||
126284236|NCT01884337|454328899|FG001|Follow-up Period|Lost to Follow-up|1|||
126284237|NCT00428116|454328900|FG000|Overall Study|Death|1|||
126284238|NCT00428116|454328901|FG001|Overall Study|Death|0|||
126284239|NCT00428116|454328900|FG000|Overall Study|Withdrawal by Subject|1|||
126284240|NCT00428116|454328901|FG001|Overall Study|Withdrawal by Subject|0|||
126284241|NCT00428116|454328900|FG000|Overall Study|Lost to Follow-up|1|||
126284242|NCT00428116|454328901|FG001|Overall Study|Lost to Follow-up|0|||
126284243|NCT02455518|454328902|FG000|Overall Study|Protocol Violation|0|||
126284244|NCT02455518|454328903|FG001|Overall Study|Protocol Violation|1|||
126284245|NCT02455518|454328904|FG002|Overall Study|Protocol Violation|1|||
126284246|NCT02455518|454328905|FG003|Overall Study|Protocol Violation|3|||
126284247|NCT01038297|454328906|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
126284248|NCT01038297|454328907|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
126284249|NCT01038297|454328908|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
126284250|NCT01973595|454328912|FG000|Washout|Withdrawal by Subject|1|||
126284251|NCT01973595|454328913|FG001|Washout|Withdrawal by Subject|0|||
126284252|NCT01973595|454328914|FG002|Washout|Withdrawal by Subject|1|||
126284253|NCT01973595|454328915|FG003|Washout|Withdrawal by Subject|0|||
126284254|NCT02508935|454328916|FG000|Overall Study|Withdrawal by Subject|1|||
126284255|NCT02508935|454328916|FG000|Overall Study|Withdrawal by Caregiver|8|||
126284256|NCT02508935|454328916|FG000|Overall Study|Pain Score <4|1|||
126284257|NCT02508935|454328916|FG000|Overall Study|Emesis|3|||
126284258|NCT02508935|454328916|FG000|Overall Study|Adverse Event|3|||
126284259|NCT02508935|454328916|FG000|Overall Study|Protocol Violation|1|||
126284260|NCT02508935|454328916|FG000|Overall Study|Physician Decision|1|||
126284261|NCT02508935|454328916|FG000|Overall Study|Trial terminated by sponsor|5|||
126284262|NCT03837743|454328921|FG000|Overall Study|Adverse Event|1|||
126284263|NCT03837743|454328921|FG000|Overall Study|Withdrawal by Subject|2|||
126284264|NCT01210612|454328923|FG000|Overall Study|Withdrawal by Subject|0|||
126284265|NCT01210612|454328924|FG001|Overall Study|Withdrawal by Subject|2|||
126284266|NCT01275430|454328925|FG000|Overall Study|Adverse Event|1|||
126284267|NCT01275430|454328925|FG000|Overall Study|No Contrast Injection|6|||
126284268|NCT01275430|454328925|FG000|Overall Study|Device Malfunction|1|||
126284269|NCT01275430|454328925|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
126284270|NCT00710866|454328928|FG000|Overall Study|Protocol Violation|5|||
126284271|NCT00710866|454328929|FG001|Overall Study|Protocol Violation|4|||
126284272|NCT00710866|454328928|FG000|Overall Study|Withdrawal by Subject|2|||
126284273|NCT00710866|454328929|FG001|Overall Study|Withdrawal by Subject|1|||
126284274|NCT00710866|454328928|FG000|Overall Study|Lost to Follow-up|1|||
126284275|NCT00710866|454328929|FG001|Overall Study|Lost to Follow-up|0|||
126284276|NCT00710866|454328928|FG000|Overall Study|Failed to meet eligibility|1|||
126284277|NCT00710866|454328929|FG001|Overall Study|Failed to meet eligibility|1|||
126284278|NCT00086281|454328930|FG000|Phase 1|Adverse Event|0|||
126284279|NCT00086281|454328931|FG001|Phase 1|Adverse Event|0|||
126284280|NCT00086281|454328932|FG002|Phase 1|Adverse Event|0|||
126284281|NCT00086281|454328933|FG003|Phase 1|Adverse Event|0|||
126284282|NCT00086281|454328934|FG004|Phase 1|Adverse Event|0|||
126284283|NCT00086281|454328935|FG005|Phase 1|Adverse Event|0|||
126284284|NCT00086281|454328936|FG006|Phase 1|Adverse Event|0|||
126284285|NCT00086281|454328937|FG007|Phase 1|Adverse Event|0|||
126284286|NCT00086281|454328938|FG008|Phase 1|Adverse Event|0|||
126284287|NCT00086281|454328939|FG009|Phase 1|Adverse Event|1|||
126284288|NCT00086281|454328940|FG010|Phase 1|Adverse Event|2|||
126284289|NCT00086281|454328941|FG011|Phase 1|Adverse Event|1|||
126284290|NCT00086281|454328942|FG012|Phase 1|Adverse Event|1|||
126284291|NCT00086281|454328943|FG013|Phase 1|Adverse Event|1|||
126284292|NCT00086281|454328944|FG014|Phase 1|Adverse Event|2|||
126284293|NCT00086281|454328930|FG000|Phase 1|Protocol Violation|0|||
126284294|NCT00086281|454328931|FG001|Phase 1|Protocol Violation|0|||
126284295|NCT00086281|454328932|FG002|Phase 1|Protocol Violation|0|||
126284296|NCT00086281|454328933|FG003|Phase 1|Protocol Violation|0|||
126284297|NCT00086281|454328934|FG004|Phase 1|Protocol Violation|0|||
126284298|NCT00086281|454328935|FG005|Phase 1|Protocol Violation|0|||
126284299|NCT00086281|454328936|FG006|Phase 1|Protocol Violation|0|||
126284300|NCT00086281|454328937|FG007|Phase 1|Protocol Violation|0|||
126284301|NCT00086281|454328938|FG008|Phase 1|Protocol Violation|0|||
126284302|NCT00086281|454328939|FG009|Phase 1|Protocol Violation|0|||
126284303|NCT00086281|454328940|FG010|Phase 1|Protocol Violation|1|||
126284304|NCT00086281|454328941|FG011|Phase 1|Protocol Violation|0|||
126284305|NCT00086281|454328942|FG012|Phase 1|Protocol Violation|0|||
126284306|NCT00086281|454328943|FG013|Phase 1|Protocol Violation|0|||
126284307|NCT00086281|454328944|FG014|Phase 1|Protocol Violation|0|||
126284308|NCT00086281|454328930|FG000|Phase 1|Serious Adverse Event|0|||
126284309|NCT00086281|454328931|FG001|Phase 1|Serious Adverse Event|0|||
126284310|NCT00086281|454328932|FG002|Phase 1|Serious Adverse Event|0|||
126284311|NCT00086281|454328933|FG003|Phase 1|Serious Adverse Event|0|||
126284312|NCT00086281|454328934|FG004|Phase 1|Serious Adverse Event|0|||
126709272|NCT00923091|455887953|FG002|Period V (Double -Blind)|Protocol Violation|0|||
126284313|NCT00086281|454328935|FG005|Phase 1|Serious Adverse Event|0|||
126284314|NCT00086281|454328936|FG006|Phase 1|Serious Adverse Event|0|||
126284315|NCT00086281|454328937|FG007|Phase 1|Serious Adverse Event|0|||
126284316|NCT00086281|454328938|FG008|Phase 1|Serious Adverse Event|0|||
126284317|NCT00086281|454328939|FG009|Phase 1|Serious Adverse Event|0|||
126284318|NCT00086281|454328940|FG010|Phase 1|Serious Adverse Event|0|||
126284319|NCT00086281|454328941|FG011|Phase 1|Serious Adverse Event|0|||
126284320|NCT00086281|454328942|FG012|Phase 1|Serious Adverse Event|0|||
126284321|NCT00086281|454328943|FG013|Phase 1|Serious Adverse Event|0|||
126284322|NCT00086281|454328944|FG014|Phase 1|Serious Adverse Event|1|||
126284323|NCT00086281|454328930|FG000|Phase 2|Adverse Event|0|||
126284324|NCT00086281|454328931|FG001|Phase 2|Adverse Event|0|||
126284325|NCT00086281|454328932|FG002|Phase 2|Adverse Event|0|||
126284326|NCT00086281|454328933|FG003|Phase 2|Adverse Event|0|||
126284327|NCT00086281|454328934|FG004|Phase 2|Adverse Event|0|||
126284328|NCT00086281|454328935|FG005|Phase 2|Adverse Event|0|||
126284329|NCT00086281|454328936|FG006|Phase 2|Adverse Event|0|||
126284330|NCT00086281|454328937|FG007|Phase 2|Adverse Event|0|||
126284331|NCT00086281|454328938|FG008|Phase 2|Adverse Event|0|||
126284332|NCT00086281|454328939|FG009|Phase 2|Adverse Event|0|||
126284333|NCT00086281|454328940|FG010|Phase 2|Adverse Event|0|||
126284334|NCT00086281|454328941|FG011|Phase 2|Adverse Event|0|||
126284335|NCT00086281|454328942|FG012|Phase 2|Adverse Event|1|||
126284336|NCT00086281|454328943|FG013|Phase 2|Adverse Event|1|||
126284337|NCT00086281|454328944|FG014|Phase 2|Adverse Event|0|||
126284338|NCT02996487|454328945|FG000|Overall Study|Lost to Follow-up|1|||
126284339|NCT02996487|454328946|FG001|Overall Study|Lost to Follow-up|1|||
126284340|NCT02996487|454328947|FG002|Overall Study|Lost to Follow-up|0|||
126284341|NCT02996487|454328945|FG000|Overall Study|Death|0|||
126284342|NCT02996487|454328946|FG001|Overall Study|Death|1|||
126284343|NCT02996487|454328947|FG002|Overall Study|Death|0|||
126284344|NCT02996487|454328945|FG000|Overall Study|Withdrawal by Subject|2|||
126284345|NCT02996487|454328946|FG001|Overall Study|Withdrawal by Subject|3|||
126284346|NCT02996487|454328947|FG002|Overall Study|Withdrawal by Subject|0|||
126284347|NCT01301729|454328949|FG000|Overall Study|Withdrawal by Subject|2|||
126284348|NCT01301729|454328949|FG000|Overall Study|Participant did not Return for Treatment|1|||
126284349|NCT01301729|454328949|FG000|Overall Study|Violated Selection Criteria|1|||
126284350|NCT03071276|454328950|FG000|Overall Study|Adverse Event|1|||
126284351|NCT03071276|454328950|FG000|Overall Study|Lack of Efficacy|14|||
126284352|NCT03390426|454328951|FG000|Overall Study|Protocol Violation|0|||
126284353|NCT03390426|454328952|FG001|Overall Study|Protocol Violation|1|||
126284354|NCT02516553|454328957|FG000|Overall Study|Progressive disease|2|||
126284355|NCT02516553|454328958|FG001|Overall Study|Progressive disease|2|||
126284356|NCT02516553|454328959|FG002|Overall Study|Progressive disease|3|||
126284357|NCT02516553|454328960|FG003|Overall Study|Progressive disease|5|||
126284358|NCT02516553|454328961|FG004|Overall Study|Progressive disease|3|||
126284359|NCT02516553|454328962|FG005|Overall Study|Progressive disease|0|||
126456425|NCT02925338|454970897|FG001|Overall Study|Lost to Follow-up|10|||
126456426|NCT02925338|454970898|FG002|Overall Study|Lost to Follow-up|1|||
126456427|NCT02925338|454970899|FG003|Overall Study|Lost to Follow-up|16|||
126456428|NCT02925338|454970900|FG004|Overall Study|Lost to Follow-up|3|||
126456429|NCT02925338|454970896|FG000|Overall Study|Withdrawal by Subject|3|||
126456430|NCT02925338|454970897|FG001|Overall Study|Withdrawal by Subject|0|||
126456431|NCT02925338|454970898|FG002|Overall Study|Withdrawal by Subject|3|||
126456432|NCT02925338|454970899|FG003|Overall Study|Withdrawal by Subject|2|||
126456433|NCT02925338|454970900|FG004|Overall Study|Withdrawal by Subject|2|||
126456434|NCT02925338|454970896|FG000|Overall Study|Missing|38|||
126456435|NCT02925338|454970897|FG001|Overall Study|Missing|27|||
126456436|NCT02925338|454970898|FG002|Overall Study|Missing|0|||
126456437|NCT02925338|454970899|FG003|Overall Study|Missing|3|||
126456438|NCT02925338|454970900|FG004|Overall Study|Missing|2|||
126456439|NCT02925338|454970896|FG000|Overall Study|Participant's Decision|11|||
126456440|NCT02925338|454970897|FG001|Overall Study|Participant's Decision|7|||
126549196|NCT00874432|455304010|FG001|Overall Study|Withdrawal by Subject|0|||
126284360|NCT02516553|454328963|FG006|Overall Study|Progressive disease|5|||
126284361|NCT02516553|454328964|FG007|Overall Study|Progressive disease|5|||
126456441|NCT02925338|454970898|FG002|Overall Study|Participant's Decision|3|||
126456442|NCT02925338|454970899|FG003|Overall Study|Participant's Decision|8|||
126284362|NCT02516553|454328965|FG008|Overall Study|Progressive disease|11|||
126284363|NCT02516553|454328966|FG009|Overall Study|Progressive disease|3|||
126284364|NCT02516553|454328967|FG010|Overall Study|Progressive disease|10|||
126284365|NCT02516553|454328968|FG011|Overall Study|Progressive disease|8|||
126284366|NCT02516553|454328969|FG012|Overall Study|Progressive disease|8|||
126284367|NCT02516553|454328970|FG013|Overall Study|Progressive disease|2|||
126284368|NCT02516553|454328971|FG014|Overall Study|Progressive disease|2|||
126284369|NCT02516553|454328972|FG015|Overall Study|Progressive disease|2|||
126284370|NCT02516553|454328973|FG016|Overall Study|Progressive disease|1|||
126284371|NCT02516553|454328974|FG017|Overall Study|Progressive disease|9|||
126284372|NCT02516553|454328975|FG018|Overall Study|Progressive disease|12|||
126456443|NCT02925338|454970900|FG004|Overall Study|Participant's Decision|1|||
126284373|NCT02516553|454328976|FG019|Overall Study|Progressive disease|7|||
126284374|NCT02516553|454328977|FG020|Overall Study|Progressive disease|16|||
126284375|NCT02516553|454328978|FG021|Overall Study|Progressive disease|18|||
126284376|NCT02516553|454328957|FG000|Overall Study|Dose limiting toxicity|0|||
126284377|NCT02516553|454328958|FG001|Overall Study|Dose limiting toxicity|0|||
126284378|NCT02516553|454328959|FG002|Overall Study|Dose limiting toxicity|0|||
126284379|NCT02516553|454328960|FG003|Overall Study|Dose limiting toxicity|0|||
126284380|NCT02516553|454328961|FG004|Overall Study|Dose limiting toxicity|3|||
126284381|NCT02516553|454328962|FG005|Overall Study|Dose limiting toxicity|1|||
126284382|NCT02516553|454328963|FG006|Overall Study|Dose limiting toxicity|1|||
126284383|NCT02516553|454328964|FG007|Overall Study|Dose limiting toxicity|0|||
126284384|NCT02516553|454328965|FG008|Overall Study|Dose limiting toxicity|1|||
126284385|NCT02516553|454328966|FG009|Overall Study|Dose limiting toxicity|0|||
126284386|NCT02516553|454328967|FG010|Overall Study|Dose limiting toxicity|0|||
126284387|NCT02516553|454328968|FG011|Overall Study|Dose limiting toxicity|1|||
126284388|NCT02516553|454328969|FG012|Overall Study|Dose limiting toxicity|0|||
126284389|NCT02516553|454328970|FG013|Overall Study|Dose limiting toxicity|1|||
126284390|NCT02516553|454328971|FG014|Overall Study|Dose limiting toxicity|0|||
126284391|NCT02516553|454328972|FG015|Overall Study|Dose limiting toxicity|0|||
126284392|NCT02516553|454328973|FG016|Overall Study|Dose limiting toxicity|1|||
126284393|NCT02516553|454328974|FG017|Overall Study|Dose limiting toxicity|1|||
126284394|NCT02516553|454328975|FG018|Overall Study|Dose limiting toxicity|0|||
126284395|NCT02516553|454328976|FG019|Overall Study|Dose limiting toxicity|2|||
126284396|NCT02516553|454328977|FG020|Overall Study|Dose limiting toxicity|0|||
126284397|NCT02516553|454328978|FG021|Overall Study|Dose limiting toxicity|0|||
126284398|NCT02516553|454328957|FG000|Overall Study|Other Adverse Events|0|||
126284399|NCT02516553|454328958|FG001|Overall Study|Other Adverse Events|0|||
126284400|NCT02516553|454328959|FG002|Overall Study|Other Adverse Events|0|||
126284401|NCT02516553|454328960|FG003|Overall Study|Other Adverse Events|1|||
126284402|NCT02516553|454328961|FG004|Overall Study|Other Adverse Events|0|||
126284403|NCT02516553|454328962|FG005|Overall Study|Other Adverse Events|1|||
126284404|NCT02516553|454328963|FG006|Overall Study|Other Adverse Events|0|||
126284405|NCT02516553|454328964|FG007|Overall Study|Other Adverse Events|0|||
126284406|NCT02516553|454328965|FG008|Overall Study|Other Adverse Events|0|||
126284407|NCT02516553|454328966|FG009|Overall Study|Other Adverse Events|1|||
126284408|NCT02516553|454328967|FG010|Overall Study|Other Adverse Events|3|||
126284409|NCT02516553|454328968|FG011|Overall Study|Other Adverse Events|2|||
126284410|NCT02516553|454328969|FG012|Overall Study|Other Adverse Events|0|||
126284411|NCT02516553|454328970|FG013|Overall Study|Other Adverse Events|1|||
126284412|NCT02516553|454328971|FG014|Overall Study|Other Adverse Events|0|||
126284413|NCT02516553|454328972|FG015|Overall Study|Other Adverse Events|0|||
126284414|NCT02516553|454328973|FG016|Overall Study|Other Adverse Events|0|||
126284415|NCT02516553|454328974|FG017|Overall Study|Other Adverse Events|2|||
126284416|NCT02516553|454328975|FG018|Overall Study|Other Adverse Events|1|||
126284417|NCT02516553|454328976|FG019|Overall Study|Other Adverse Events|2|||
126284418|NCT02516553|454328977|FG020|Overall Study|Other Adverse Events|2|||
126284419|NCT02516553|454328978|FG021|Overall Study|Other Adverse Events|1|||
126284420|NCT02516553|454328957|FG000|Overall Study|Refused to continue trial medication|0|||
126284421|NCT02516553|454328958|FG001|Overall Study|Refused to continue trial medication|0|||
126284422|NCT02516553|454328959|FG002|Overall Study|Refused to continue trial medication|0|||
126284423|NCT02516553|454328960|FG003|Overall Study|Refused to continue trial medication|0|||
126284424|NCT02516553|454328961|FG004|Overall Study|Refused to continue trial medication|0|||
126284425|NCT02516553|454328962|FG005|Overall Study|Refused to continue trial medication|0|||
126284426|NCT02516553|454328963|FG006|Overall Study|Refused to continue trial medication|0|||
126284427|NCT02516553|454328964|FG007|Overall Study|Refused to continue trial medication|0|||
126284428|NCT02516553|454328965|FG008|Overall Study|Refused to continue trial medication|0|||
126284429|NCT02516553|454328966|FG009|Overall Study|Refused to continue trial medication|0|||
126284430|NCT02516553|454328967|FG010|Overall Study|Refused to continue trial medication|1|||
126284431|NCT02516553|454328968|FG011|Overall Study|Refused to continue trial medication|0|||
126284432|NCT02516553|454328969|FG012|Overall Study|Refused to continue trial medication|0|||
126284433|NCT02516553|454328970|FG013|Overall Study|Refused to continue trial medication|0|||
126284434|NCT02516553|454328971|FG014|Overall Study|Refused to continue trial medication|0|||
126284435|NCT02516553|454328972|FG015|Overall Study|Refused to continue trial medication|0|||
126284436|NCT02516553|454328973|FG016|Overall Study|Refused to continue trial medication|0|||
126284437|NCT02516553|454328974|FG017|Overall Study|Refused to continue trial medication|0|||
126456444|NCT02925338|454970896|FG000|Overall Study|Treatment Discontinuation|144|||
126284438|NCT02516553|454328975|FG018|Overall Study|Refused to continue trial medication|1|||
126284439|NCT02516553|454328976|FG019|Overall Study|Refused to continue trial medication|0|||
126284440|NCT02516553|454328977|FG020|Overall Study|Refused to continue trial medication|0|||
126284441|NCT02516553|454328978|FG021|Overall Study|Refused to continue trial medication|1|||
126284442|NCT02516553|454328957|FG000|Overall Study|other reasons than listed|0|||
126284443|NCT02516553|454328958|FG001|Overall Study|other reasons than listed|0|||
126284444|NCT02516553|454328959|FG002|Overall Study|other reasons than listed|0|||
126284445|NCT02516553|454328960|FG003|Overall Study|other reasons than listed|0|||
126284446|NCT02516553|454328961|FG004|Overall Study|other reasons than listed|0|||
126284447|NCT02516553|454328962|FG005|Overall Study|other reasons than listed|0|||
126284448|NCT02516553|454328963|FG006|Overall Study|other reasons than listed|0|||
126284449|NCT02516553|454328964|FG007|Overall Study|other reasons than listed|1|||
126284450|NCT02516553|454328965|FG008|Overall Study|other reasons than listed|1|||
126284451|NCT02516553|454328966|FG009|Overall Study|other reasons than listed|0|||
126284452|NCT02516553|454328967|FG010|Overall Study|other reasons than listed|1|||
126284453|NCT02516553|454328968|FG011|Overall Study|other reasons than listed|1|||
126284454|NCT02516553|454328969|FG012|Overall Study|other reasons than listed|0|||
126284455|NCT02516553|454328970|FG013|Overall Study|other reasons than listed|0|||
126284456|NCT02516553|454328971|FG014|Overall Study|other reasons than listed|0|||
126284457|NCT02516553|454328972|FG015|Overall Study|other reasons than listed|0|||
126284458|NCT02516553|454328973|FG016|Overall Study|other reasons than listed|0|||
126284459|NCT02516553|454328974|FG017|Overall Study|other reasons than listed|0|||
126284460|NCT02516553|454328975|FG018|Overall Study|other reasons than listed|0|||
126284461|NCT02516553|454328976|FG019|Overall Study|other reasons than listed|0|||
126284462|NCT02516553|454328977|FG020|Overall Study|other reasons than listed|2|||
126284463|NCT02516553|454328978|FG021|Overall Study|other reasons than listed|2|||
126284464|NCT02924727|454328981|FG000|Overall Study|Withdrawal by Subject|2|||
126284465|NCT02924727|454328982|FG001|Overall Study|Withdrawal by Subject|4|||
126284466|NCT02924727|454328981|FG000|Overall Study|Lost to Follow-up|2|||
126284467|NCT02924727|454328982|FG001|Overall Study|Lost to Follow-up|5|||
126284468|NCT02924727|454328981|FG000|Overall Study|Death|221|||
126284469|NCT02924727|454328982|FG001|Overall Study|Death|247|||
126284470|NCT02924727|454328981|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
126284471|NCT02924727|454328982|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
126284472|NCT04102189|454328985|FG000|Overall Study|Withdrawal by Subject|1|||
126284473|NCT04102189|454328986|FG001|Overall Study|Withdrawal by Subject|2|||
126284474|NCT04102189|454328985|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126284475|NCT04102189|454328986|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126284476|NCT04102189|454328985|FG000|Overall Study|Lost to Follow-up|1|||
126284477|NCT04102189|454328986|FG001|Overall Study|Lost to Follow-up|0|||
126284478|NCT02933255|454328991|FG000|Overall Study|Discontinued due to study closure.|1|||
126284479|NCT02933255|454328992|FG001|Overall Study|Discontinued due to study closure.|0|||
126284480|NCT04803305|454328993|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
126284481|NCT04803305|454328994|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
126284482|NCT04803305|454328993|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
126284483|NCT04803305|454328994|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
126284484|NCT04803305|454328993|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
126284485|NCT04803305|454328994|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
126284486|NCT04803305|454328993|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
126284487|NCT04803305|454328994|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
126284488|NCT04803305|454328993|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
126284489|NCT04803305|454328994|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
126284490|NCT04803305|454328993|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
126284491|NCT04803305|454328994|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
126284492|NCT04803305|454328993|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
126284493|NCT04803305|454328994|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
126284494|NCT04803305|454328993|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
126284495|NCT04803305|454328994|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
126284496|NCT03316547|454328996|FG000|Overall Study|Death|3|||
126284497|NCT03316547|454328997|FG001|Overall Study|Death|1|||
126284498|NCT03316547|454328996|FG000|Overall Study|Lost to Follow-up|6|||
126284499|NCT03316547|454328997|FG001|Overall Study|Lost to Follow-up|6|||
126284500|NCT03316547|454328996|FG000|Overall Study|Withdrawal by Subject|3|||
126364951|NCT04082364|454630379|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
126364952|NCT04082364|454630380|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
126364953|NCT04082364|454630381|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
126364954|NCT04082364|454630377|FG000|Overall Study|Disease progression|0|||
126364955|NCT04082364|454630378|FG001|Overall Study|Disease progression|0|||
126364956|NCT04082364|454630379|FG002|Overall Study|Disease progression|0|||
126364957|NCT04082364|454630380|FG003|Overall Study|Disease progression|1|||
126364958|NCT04082364|454630381|FG004|Overall Study|Disease progression|0|||
126364959|NCT03186378|454630382|FG000|Overall Study|Lost to Follow-up|1|||
126549197|NCT00874432|455304011|FG002|Overall Study|Withdrawal by Subject|0|||
126284501|NCT03316547|454328997|FG001|Overall Study|Withdrawal by Subject|2|||
126284502|NCT03316547|454328996|FG000|Overall Study|Transfer to another hospital|6|||
126284503|NCT03316547|454328997|FG001|Overall Study|Transfer to another hospital|4|||
126284504|NCT00721227|454328998|FG000|Overall Study|Lost to Follow-up|3|||
126284505|NCT00721227|454328999|FG001|Overall Study|Lost to Follow-up|0|||
126549198|NCT00874432|455304012|FG003|Overall Study|Withdrawal by Subject|0|||
126364960|NCT03186378|454630383|FG001|Overall Study|Lost to Follow-up|0|||
126284506|NCT00721227|454328998|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
126284507|NCT00721227|454328999|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
126284508|NCT02759692|454329000|FG000|Period 1|Test article no longer available|1|||
126284509|NCT02759692|454329001|FG001|Period 1|Test article no longer available|1|||
126284510|NCT02759692|454329000|FG000|Period 1|No longer meets eligibility criteria.|1|||
126284511|NCT02759692|454329001|FG001|Period 1|No longer meets eligibility criteria.|0|||
126284512|NCT02759692|454329000|FG000|Period 1|Miss-Randomized|1|||
126284513|NCT02759692|454329001|FG001|Period 1|Miss-Randomized|1|||
126284514|NCT02759692|454329000|FG000|Period 2|Lost to Follow-up|1|||
126284515|NCT02759692|454329001|FG001|Period 2|Lost to Follow-up|0|||
126284516|NCT02759692|454329000|FG000|Period 2|Test article no longer available|0|||
126284517|NCT02759692|454329001|FG001|Period 2|Test article no longer available|1|||
126284518|NCT00451178|454329002|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
126284519|NCT00451178|454329003|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
126284520|NCT00451178|454329002|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
126284521|NCT00451178|454329003|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
126284522|NCT00451178|454329002|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
126284523|NCT00451178|454329003|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
126284524|NCT00451178|454329002|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
126284525|NCT00451178|454329003|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
126284526|NCT00451178|454329002|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
126284527|NCT00451178|454329003|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
126284528|NCT00451178|454329002|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
126284529|NCT00451178|454329003|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
126284530|NCT00451178|454329002|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
126284531|NCT00451178|454329003|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
126284532|NCT00451178|454329002|FG000|Prior to Maintenance Therapy|PD|2|||
126284533|NCT00451178|454329003|FG001|Prior to Maintenance Therapy|PD|0|||
126284534|NCT00451178|454329002|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
126284535|NCT00451178|454329003|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
126284536|NCT00451178|454329002|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
126284537|NCT00451178|454329003|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
126284538|NCT00451178|454329002|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
126284539|NCT00451178|454329003|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
126284540|NCT00451178|454329002|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
126284541|NCT00451178|454329003|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
126284542|NCT00451178|454329002|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
126284543|NCT00451178|454329003|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
126284544|NCT00451178|454329002|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
126284545|NCT00451178|454329003|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
126284546|NCT00451178|454329002|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
126284547|NCT00451178|454329003|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
126284548|NCT01243775|454329004|FG000|Overall Study|Withdrawal by Subject|2|||
126284549|NCT03207867|454329005|FG000|Overall Study|Adverse Event|1|||
126284550|NCT03207867|454329006|FG001|Overall Study|Adverse Event|0|||
126284551|NCT03207867|454329007|FG002|Overall Study|Adverse Event|1|||
126284552|NCT03207867|454329008|FG003|Overall Study|Adverse Event|0|||
126284553|NCT03207867|454329009|FG004|Overall Study|Adverse Event|0|||
126284554|NCT03207867|454329010|FG005|Overall Study|Adverse Event|2|||
126284555|NCT03207867|454329011|FG006|Overall Study|Adverse Event|1|||
126456445|NCT02925338|454970897|FG001|Overall Study|Treatment Discontinuation|65|||
126284556|NCT03207867|454329012|FG007|Overall Study|Adverse Event|1|||
126284557|NCT03207867|454329013|FG008|Overall Study|Adverse Event|2|||
126284558|NCT03207867|454329014|FG009|Overall Study|Adverse Event|2|||
126284559|NCT03207867|454329015|FG010|Overall Study|Adverse Event|0|||
126284560|NCT03207867|454329016|FG011|Overall Study|Adverse Event|0|||
126284561|NCT03207867|454329017|FG012|Overall Study|Adverse Event|0|||
126284562|NCT03207867|454329018|FG013|Overall Study|Adverse Event|0|||
126284563|NCT03207867|454329019|FG014|Overall Study|Adverse Event|0|||
126456446|NCT02925338|454970898|FG002|Overall Study|Treatment Discontinuation|56|||
126284564|NCT03207867|454329020|FG015|Overall Study|Adverse Event|0|||
126284565|NCT03207867|454329021|FG016|Overall Study|Adverse Event|3|||
126284566|NCT03207867|454329022|FG017|Overall Study|Adverse Event|1|||
126284567|NCT03207867|454329023|FG018|Overall Study|Adverse Event|2|||
126284568|NCT03207867|454329024|FG019|Overall Study|Adverse Event|1|||
126284569|NCT03207867|454329025|FG020|Overall Study|Adverse Event|0|||
126284570|NCT03207867|454329026|FG021|Overall Study|Adverse Event|0|||
126284571|NCT03207867|454329027|FG022|Overall Study|Adverse Event|0|||
126284572|NCT03207867|454329028|FG023|Overall Study|Adverse Event|0|||
126284573|NCT03207867|454329005|FG000|Overall Study|Death|0|||
126284574|NCT03207867|454329006|FG001|Overall Study|Death|0|||
126284575|NCT03207867|454329007|FG002|Overall Study|Death|0|||
126284576|NCT03207867|454329008|FG003|Overall Study|Death|0|||
126456447|NCT02925338|454970899|FG003|Overall Study|Treatment Discontinuation|131|||
126709273|NCT00923091|455887954|FG003|Period V (Double -Blind)|Protocol Violation|0|||
126709274|NCT00923091|455887955|FG004|Period V (Double -Blind)|Protocol Violation|0|||
126284577|NCT03207867|454329009|FG004|Overall Study|Death|0|||
126284578|NCT03207867|454329010|FG005|Overall Study|Death|1|||
126284579|NCT03207867|454329011|FG006|Overall Study|Death|0|||
126284580|NCT03207867|454329012|FG007|Overall Study|Death|3|||
126284581|NCT03207867|454329013|FG008|Overall Study|Death|1|||
126284582|NCT03207867|454329014|FG009|Overall Study|Death|2|||
126284583|NCT03207867|454329015|FG010|Overall Study|Death|0|||
126284584|NCT03207867|454329016|FG011|Overall Study|Death|1|||
126284585|NCT03207867|454329017|FG012|Overall Study|Death|0|||
126284586|NCT03207867|454329018|FG013|Overall Study|Death|1|||
126284587|NCT03207867|454329019|FG014|Overall Study|Death|0|||
126284588|NCT03207867|454329020|FG015|Overall Study|Death|0|||
126284589|NCT03207867|454329021|FG016|Overall Study|Death|0|||
126284590|NCT03207867|454329022|FG017|Overall Study|Death|2|||
126284591|NCT03207867|454329023|FG018|Overall Study|Death|0|||
126284592|NCT03207867|454329024|FG019|Overall Study|Death|1|||
126284593|NCT03207867|454329025|FG020|Overall Study|Death|0|||
126284594|NCT03207867|454329026|FG021|Overall Study|Death|0|||
126284595|NCT03207867|454329027|FG022|Overall Study|Death|0|||
126284596|NCT03207867|454329028|FG023|Overall Study|Death|0|||
126284597|NCT03207867|454329005|FG000|Overall Study|Physician Decision|3|||
126284598|NCT03207867|454329006|FG001|Overall Study|Physician Decision|5|||
126284599|NCT03207867|454329007|FG002|Overall Study|Physician Decision|0|||
126284600|NCT03207867|454329008|FG003|Overall Study|Physician Decision|3|||
126284601|NCT03207867|454329009|FG004|Overall Study|Physician Decision|2|||
126284602|NCT03207867|454329010|FG005|Overall Study|Physician Decision|0|||
126284603|NCT03207867|454329011|FG006|Overall Study|Physician Decision|0|||
126284604|NCT03207867|454329012|FG007|Overall Study|Physician Decision|0|||
126284605|NCT03207867|454329013|FG008|Overall Study|Physician Decision|4|||
126284606|NCT03207867|454329014|FG009|Overall Study|Physician Decision|2|||
126284607|NCT03207867|454329015|FG010|Overall Study|Physician Decision|0|||
126284608|NCT03207867|454329016|FG011|Overall Study|Physician Decision|4|||
126284609|NCT03207867|454329017|FG012|Overall Study|Physician Decision|0|||
126284610|NCT03207867|454329018|FG013|Overall Study|Physician Decision|0|||
126284611|NCT03207867|454329019|FG014|Overall Study|Physician Decision|2|||
126284612|NCT03207867|454329020|FG015|Overall Study|Physician Decision|1|||
126284613|NCT03207867|454329021|FG016|Overall Study|Physician Decision|1|||
126284614|NCT03207867|454329022|FG017|Overall Study|Physician Decision|2|||
126284615|NCT03207867|454329023|FG018|Overall Study|Physician Decision|1|||
126284616|NCT03207867|454329024|FG019|Overall Study|Physician Decision|3|||
126284617|NCT03207867|454329025|FG020|Overall Study|Physician Decision|0|||
126284618|NCT03207867|454329026|FG021|Overall Study|Physician Decision|0|||
126284619|NCT03207867|454329027|FG022|Overall Study|Physician Decision|0|||
126284620|NCT03207867|454329028|FG023|Overall Study|Physician Decision|0|||
126284621|NCT03207867|454329005|FG000|Overall Study|Progressive Disease|7|||
126284622|NCT03207867|454329006|FG001|Overall Study|Progressive Disease|7|||
126284623|NCT03207867|454329007|FG002|Overall Study|Progressive Disease|9|||
126284624|NCT03207867|454329008|FG003|Overall Study|Progressive Disease|10|||
126284625|NCT03207867|454329009|FG004|Overall Study|Progressive Disease|11|||
126284626|NCT03207867|454329010|FG005|Overall Study|Progressive Disease|10|||
126284627|NCT03207867|454329011|FG006|Overall Study|Progressive Disease|9|||
126284628|NCT03207867|454329012|FG007|Overall Study|Progressive Disease|8|||
126284629|NCT03207867|454329013|FG008|Overall Study|Progressive Disease|19|||
126284630|NCT03207867|454329014|FG009|Overall Study|Progressive Disease|23|||
126284631|NCT03207867|454329015|FG010|Overall Study|Progressive Disease|2|||
126284632|NCT03207867|454329016|FG011|Overall Study|Progressive Disease|24|||
126284633|NCT03207867|454329017|FG012|Overall Study|Progressive Disease|3|||
126284634|NCT03207867|454329018|FG013|Overall Study|Progressive Disease|11|||
126284635|NCT03207867|454329019|FG014|Overall Study|Progressive Disease|9|||
126284636|NCT03207867|454329020|FG015|Overall Study|Progressive Disease|5|||
126364961|NCT02514746|454630384|FG000|Overall Study|Chronically Ill|1|||
126364962|NCT02514746|454630385|FG001|Overall Study|Chronically Ill|2|||
126549199|NCT00874432|455304009|FG000|Overall Study|Physician Decision|1|||
126284637|NCT03207867|454329021|FG016|Overall Study|Progressive Disease|10|||
126284638|NCT03207867|454329022|FG017|Overall Study|Progressive Disease|14|||
126709275|NCT00923091|455887956|FG005|Period V (Double -Blind)|Protocol Violation|0|||
126709276|NCT00923091|455887957|FG006|Period V (Double -Blind)|Protocol Violation|0|||
126284639|NCT03207867|454329023|FG018|Overall Study|Progressive Disease|13|||
126284640|NCT03207867|454329024|FG019|Overall Study|Progressive Disease|14|||
126284641|NCT03207867|454329025|FG020|Overall Study|Progressive Disease|6|||
126284642|NCT03207867|454329026|FG021|Overall Study|Progressive Disease|3|||
126284643|NCT03207867|454329027|FG022|Overall Study|Progressive Disease|3|||
126284644|NCT03207867|454329028|FG023|Overall Study|Progressive Disease|3|||
126284645|NCT03207867|454329005|FG000|Overall Study|Patient/guardian Decision|0|||
126284646|NCT03207867|454329006|FG001|Overall Study|Patient/guardian Decision|0|||
126284647|NCT03207867|454329007|FG002|Overall Study|Patient/guardian Decision|1|||
126284648|NCT03207867|454329008|FG003|Overall Study|Patient/guardian Decision|1|||
126284649|NCT03207867|454329009|FG004|Overall Study|Patient/guardian Decision|1|||
126284650|NCT03207867|454329010|FG005|Overall Study|Patient/guardian Decision|2|||
126284651|NCT03207867|454329011|FG006|Overall Study|Patient/guardian Decision|1|||
126284652|NCT03207867|454329012|FG007|Overall Study|Patient/guardian Decision|0|||
126284653|NCT03207867|454329013|FG008|Overall Study|Patient/guardian Decision|1|||
126284654|NCT03207867|454329014|FG009|Overall Study|Patient/guardian Decision|0|||
126284655|NCT03207867|454329015|FG010|Overall Study|Patient/guardian Decision|0|||
126284656|NCT03207867|454329016|FG011|Overall Study|Patient/guardian Decision|1|||
126284657|NCT03207867|454329017|FG012|Overall Study|Patient/guardian Decision|0|||
126284658|NCT03207867|454329018|FG013|Overall Study|Patient/guardian Decision|1|||
126284659|NCT03207867|454329019|FG014|Overall Study|Patient/guardian Decision|2|||
126284660|NCT03207867|454329020|FG015|Overall Study|Patient/guardian Decision|0|||
126284661|NCT03207867|454329021|FG016|Overall Study|Patient/guardian Decision|1|||
126284662|NCT03207867|454329022|FG017|Overall Study|Patient/guardian Decision|3|||
126284663|NCT03207867|454329023|FG018|Overall Study|Patient/guardian Decision|4|||
126284664|NCT03207867|454329024|FG019|Overall Study|Patient/guardian Decision|1|||
126284665|NCT03207867|454329025|FG020|Overall Study|Patient/guardian Decision|0|||
126284666|NCT03207867|454329026|FG021|Overall Study|Patient/guardian Decision|0|||
126284667|NCT03207867|454329027|FG022|Overall Study|Patient/guardian Decision|0|||
126284668|NCT03207867|454329028|FG023|Overall Study|Patient/guardian Decision|0|||
126284669|NCT02447744|454329029|FG000|Overall Study|Withdrawal by Subject|3|||
126284670|NCT02447744|454329030|FG001|Overall Study|Withdrawal by Subject|1|||
126284671|NCT02447744|454329029|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
126284672|NCT02447744|454329030|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
126284673|NCT05422625|454329031|FG000|Overall Study|Withdrawal by Subject|1|||
126284674|NCT05422625|454329032|FG001|Overall Study|Withdrawal by Subject|0|||
126306289|NCT03063086|454410267|FG003|Overall Study|subject/guardian decision|0|||
126306290|NCT03063086|454410268|FG004|Overall Study|subject/guardian decision|0|||
126306291|NCT03063086|454410269|FG005|Overall Study|subject/guardian decision|0|||
126306292|NCT03063086|454410264|FG000|Overall Study|Non-compliance with study treatment|0|||
126306293|NCT03063086|454410265|FG001|Overall Study|Non-compliance with study treatment|0|||
126306294|NCT03063086|454410266|FG002|Overall Study|Non-compliance with study treatment|0|||
126306295|NCT03063086|454410267|FG003|Overall Study|Non-compliance with study treatment|1|||
126306296|NCT03063086|454410268|FG004|Overall Study|Non-compliance with study treatment|0|||
126306297|NCT03063086|454410269|FG005|Overall Study|Non-compliance with study treatment|1|||
126306298|NCT03063086|454410264|FG000|Overall Study|Physician Decision|0|||
126306299|NCT03063086|454410265|FG001|Overall Study|Physician Decision|0|||
126306300|NCT03063086|454410266|FG002|Overall Study|Physician Decision|0|||
126306301|NCT03063086|454410267|FG003|Overall Study|Physician Decision|1|||
126306302|NCT03063086|454410268|FG004|Overall Study|Physician Decision|0|||
126306303|NCT03063086|454410269|FG005|Overall Study|Physician Decision|0|||
126306304|NCT02218736|454410270|FG000|Overall Study|Withdrawal by Subject|10|||
126306305|NCT02218736|454410271|FG001|Overall Study|Withdrawal by Subject|9|||
126306306|NCT02218736|454410270|FG000|Overall Study|Protocol Violation|2|||
126306307|NCT02218736|454410271|FG001|Overall Study|Protocol Violation|0|||
126306308|NCT02244463|454410274|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
126306309|NCT02244463|454410275|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
126306310|NCT02244463|454410276|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
126306311|NCT02244463|454410277|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
126306312|NCT02244463|454410278|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
126306313|NCT02244463|454410279|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
126306314|NCT02244463|454410274|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
126306315|NCT02244463|454410275|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
126306316|NCT02244463|454410276|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
126306317|NCT02244463|454410277|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
126306318|NCT02244463|454410278|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
126306319|NCT02244463|454410279|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
126306320|NCT02244463|454410274|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
126306321|NCT02244463|454410275|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
126306322|NCT02244463|454410276|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
126306323|NCT02244463|454410277|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
126306324|NCT02244463|454410278|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
126306325|NCT02244463|454410279|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
126306326|NCT02244463|454410274|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
126306327|NCT02244463|454410275|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
126456448|NCT02925338|454970900|FG004|Overall Study|Treatment Discontinuation|22|||
126456449|NCT00636363|454970903|FG000|Overall Study|Conjunctivitis|0|||
126456450|NCT00636363|454970904|FG001|Overall Study|Conjunctivitis|0|||
126456451|NCT00636363|454970905|FG002|Overall Study|Conjunctivitis|1|||
126456452|NCT00636363|454970903|FG000|Overall Study|Adverse Event|0|||
126456453|NCT00636363|454970904|FG001|Overall Study|Adverse Event|0|||
126306328|NCT02244463|454410276|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
126306329|NCT02244463|454410277|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
126306330|NCT02244463|454410278|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
126306331|NCT02244463|454410279|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
126456454|NCT00636363|454970905|FG002|Overall Study|Adverse Event|1|||
126284675|NCT03922529|454331015|FG000|Overall Study|Withdrawal by Subject|13|||
126284676|NCT03922529|454331016|FG001|Overall Study|Withdrawal by Subject|12|||
126284677|NCT03922529|454331015|FG000|Overall Study|Death|7|||
126284678|NCT03922529|454331016|FG001|Overall Study|Death|12|||
126284679|NCT03922529|454331015|FG000|Overall Study|Lost to Follow-up|12|||
126284680|NCT03922529|454331016|FG001|Overall Study|Lost to Follow-up|19|||
126284681|NCT03922529|454331015|FG000|Overall Study|Adverse Event|1|||
126284682|NCT03922529|454331016|FG001|Overall Study|Adverse Event|0|||
126284683|NCT03922529|454331015|FG000|Overall Study|Death after withdrawal|1|||
126284684|NCT03922529|454331016|FG001|Overall Study|Death after withdrawal|0|||
126284685|NCT03922529|454331015|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
126284686|NCT03922529|454331016|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
126284687|NCT03922529|454331015|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
126284688|NCT03922529|454331016|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
126284689|NCT02017015|454331017|FG000|Overall Study|Adverse Event|9|||
126284690|NCT02017015|454331017|FG000|Overall Study|Withdrawal by Subject|21|||
126284691|NCT02017015|454331017|FG000|Overall Study|Death|4|||
126284692|NCT02017015|454331017|FG000|Overall Study|Progressive Disease|31|||
126284693|NCT02017015|454331017|FG000|Overall Study|Non-compliance with study drug|2|||
126284694|NCT02017015|454331017|FG000|Overall Study|Physician Decision|2|||
126284695|NCT01277601|454331020|FG000|Overall Study|Adverse Event|5|||
126284696|NCT01277601|454331021|FG001|Overall Study|Adverse Event|3|||
126284697|NCT01277601|454331022|FG002|Overall Study|Adverse Event|0|||
126284698|NCT01277601|454331023|FG003|Overall Study|Adverse Event|7|||
126284699|NCT01277601|454331020|FG000|Overall Study|Withdrawal by Subject|18|||
126284700|NCT01277601|454331021|FG001|Overall Study|Withdrawal by Subject|21|||
126284701|NCT01277601|454331022|FG002|Overall Study|Withdrawal by Subject|8|||
126284702|NCT01277601|454331023|FG003|Overall Study|Withdrawal by Subject|17|||
126284703|NCT01277601|454331020|FG000|Overall Study|Lost to Follow-up|7|||
126284704|NCT01277601|454331021|FG001|Overall Study|Lost to Follow-up|9|||
126284705|NCT01277601|454331022|FG002|Overall Study|Lost to Follow-up|4|||
126284706|NCT01277601|454331023|FG003|Overall Study|Lost to Follow-up|2|||
126284707|NCT01277601|454331020|FG000|Overall Study|Physician Decision|3|||
126284708|NCT01277601|454331021|FG001|Overall Study|Physician Decision|5|||
126284709|NCT01277601|454331022|FG002|Overall Study|Physician Decision|1|||
126284710|NCT01277601|454331023|FG003|Overall Study|Physician Decision|6|||
126284711|NCT01277601|454331020|FG000|Overall Study|Pregnancy|2|||
126284712|NCT01277601|454331021|FG001|Overall Study|Pregnancy|2|||
126284713|NCT01277601|454331022|FG002|Overall Study|Pregnancy|4|||
126284714|NCT01277601|454331023|FG003|Overall Study|Pregnancy|1|||
126284715|NCT01277601|454331020|FG000|Overall Study|Noncompliance with Study Drug|1|||
126284716|NCT01277601|454331021|FG001|Overall Study|Noncompliance with Study Drug|3|||
126284717|NCT01277601|454331022|FG002|Overall Study|Noncompliance with Study Drug|2|||
126284718|NCT01277601|454331023|FG003|Overall Study|Noncompliance with Study Drug|0|||
126284719|NCT01277601|454331020|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
126284720|NCT01277601|454331021|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
126284721|NCT01277601|454331022|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
126284722|NCT01277601|454331023|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
126284723|NCT01277601|454331020|FG000|Overall Study|Protocol Violation|0|||
126284724|NCT01277601|454331021|FG001|Overall Study|Protocol Violation|2|||
126284725|NCT01277601|454331022|FG002|Overall Study|Protocol Violation|5|||
126284726|NCT01277601|454331023|FG003|Overall Study|Protocol Violation|0|||
126284727|NCT01277601|454331020|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
126284728|NCT01277601|454331021|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
126284729|NCT01277601|454331022|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
126284730|NCT01277601|454331023|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
126284731|NCT02291510|454331024|FG000|Overall Study|Adverse Event|0|||
126284732|NCT02291510|454331025|FG001|Overall Study|Adverse Event|0|||
126284733|NCT02291510|454331026|FG002|Overall Study|Adverse Event|0|||
126284734|NCT02291510|454331027|FG003|Overall Study|Adverse Event|1|||
126284735|NCT06390839|454331028|FG000|Overall Study|Ineligible|2|||
126284736|NCT06390839|454331028|FG000|Overall Study|Never start protocol therapy|3|||
126284737|NCT06390839|454331028|FG000|Overall Study|Adverse Event|1|||
126284738|NCT06390839|454331028|FG000|Overall Study|Alternative therapy|2|||
126284739|NCT06390839|454331028|FG000|Overall Study|Death|3|||
126284740|NCT06390839|454331028|FG000|Overall Study|Disease progression|28|||
126364963|NCT02514746|454630384|FG000|Overall Study|Physician Decision|4|||
126284741|NCT06390839|454331028|FG000|Overall Study|Withdrawal by Subject|2|||
126284742|NCT06390839|454331028|FG000|Overall Study|Complicating disease|1|||
126284743|NCT06390839|454331028|FG000|Overall Study|Noncompliance|1|||
126284744|NCT03203850|454331029|FG000|Overall Study|Subject/guardian decision|4|||
126284745|NCT03203850|454331030|FG001|Overall Study|Subject/guardian decision|3|||
126284746|NCT03203850|454331029|FG000|Overall Study|Adverse Event|3|||
126284747|NCT03203850|454331030|FG001|Overall Study|Adverse Event|0|||
126284748|NCT03203850|454331029|FG000|Overall Study|Death|1|||
126284749|NCT03203850|454331030|FG001|Overall Study|Death|0|||
126284750|NCT01272037|454331031|FG000|Overall Study|Death|25|||
126284751|NCT01272037|454331032|FG001|Overall Study|Death|28|||
126284752|NCT01272037|454331031|FG000|Overall Study|Adverse Event|12|||
126284753|NCT01272037|454331032|FG001|Overall Study|Adverse Event|7|||
126284754|NCT01272037|454331031|FG000|Overall Study|Withdrawal by Subject|175|||
126284755|NCT01272037|454331032|FG001|Overall Study|Withdrawal by Subject|93|||
126284756|NCT01272037|454331031|FG000|Overall Study|Disease progression|70|||
126284757|NCT01272037|454331032|FG001|Overall Study|Disease progression|111|||
126284758|NCT01272037|454331031|FG000|Overall Study|Other reason|42|||
126284759|NCT01272037|454331032|FG001|Overall Study|Other reason|41|||
126284760|NCT01272037|454331031|FG000|Overall Study|Delinquent data|24|||
126284761|NCT01272037|454331032|FG001|Overall Study|Delinquent data|19|||
126284762|NCT01272037|454331031|FG000|Overall Study|Reason under review|33|||
126284763|NCT01272037|454331032|FG001|Overall Study|Reason under review|29|||
126284764|NCT01272037|454331031|FG000|Overall Study|On treatment|626|||
126284765|NCT01272037|454331032|FG001|Overall Study|On treatment|632|||
126284766|NCT00678210|454331034|FG000|Overall Study|Adverse Event|1|||
126284767|NCT00678210|454331035|FG001|Overall Study|Adverse Event|2|||
126284768|NCT00678210|454331036|FG002|Overall Study|Adverse Event|3|||
126284769|NCT00678210|454331037|FG003|Overall Study|Adverse Event|3|||
126284770|NCT00678210|454331034|FG000|Overall Study|Lack of Efficacy|2|||
126284771|NCT00678210|454331035|FG001|Overall Study|Lack of Efficacy|3|||
126284772|NCT00678210|454331036|FG002|Overall Study|Lack of Efficacy|1|||
126284773|NCT00678210|454331037|FG003|Overall Study|Lack of Efficacy|9|||
126284774|NCT00678210|454331034|FG000|Overall Study|Lost to Follow-up|4|||
126284775|NCT00678210|454331035|FG001|Overall Study|Lost to Follow-up|2|||
126284776|NCT00678210|454331036|FG002|Overall Study|Lost to Follow-up|0|||
126284777|NCT00678210|454331037|FG003|Overall Study|Lost to Follow-up|1|||
126284778|NCT00678210|454331034|FG000|Overall Study|Withdrawal by Subject|3|||
126284779|NCT00678210|454331035|FG001|Overall Study|Withdrawal by Subject|4|||
126284780|NCT00678210|454331036|FG002|Overall Study|Withdrawal by Subject|1|||
126284781|NCT00678210|454331037|FG003|Overall Study|Withdrawal by Subject|7|||
126284782|NCT00678210|454331034|FG000|Overall Study|Other|1|||
126284783|NCT00678210|454331035|FG001|Overall Study|Other|0|||
126284784|NCT00678210|454331036|FG002|Overall Study|Other|1|||
126284785|NCT00678210|454331037|FG003|Overall Study|Other|0|||
126284786|NCT04825912|454331038|FG000|Overall Study|Death|3|||
126284787|NCT04825912|454331038|FG000|Overall Study|Withdrawal by Subject|1|||
126284788|NCT02077140|454331039|FG000|Overall Study|Lost to Follow-up|4|||
126284789|NCT02077140|454331040|FG001|Overall Study|Lost to Follow-up|1|||
126284790|NCT02077140|454331041|FG002|Overall Study|Lost to Follow-up|2|||
126284791|NCT02077140|454331042|FG003|Overall Study|Lost to Follow-up|2|||
126284792|NCT02077140|454331043|FG004|Overall Study|Lost to Follow-up|3|||
126284793|NCT02077140|454331039|FG000|Overall Study|Withdrawal by Subject|0|||
126284794|NCT02077140|454331040|FG001|Overall Study|Withdrawal by Subject|1|||
126284795|NCT02077140|454331041|FG002|Overall Study|Withdrawal by Subject|0|||
126284796|NCT02077140|454331042|FG003|Overall Study|Withdrawal by Subject|2|||
126284797|NCT02077140|454331043|FG004|Overall Study|Withdrawal by Subject|2|||
126284798|NCT00974922|454331044|FG000|Overall Study|study terminated|24|||
126284799|NCT01173120|454331047|FG000|Overall Study|Lack of Efficacy|2|||
126284800|NCT01173120|454331047|FG000|Overall Study|Lost to Follow-up|1|||
126284801|NCT01173120|454331047|FG000|Overall Study|Participant Decision|2|||
126284802|NCT01173120|454331047|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
126284803|NCT01173120|454331047|FG000|Overall Study|Switch-Participant Decision|12|||
126284804|NCT01173120|454331047|FG000|Overall Study|Switch-Difficulty With Device|12|||
126456455|NCT00636363|454970903|FG000|Overall Study|Positive slit lamp finding|0|||
126456456|NCT00636363|454970904|FG001|Overall Study|Positive slit lamp finding|2|||
126456457|NCT00636363|454970905|FG002|Overall Study|Positive slit lamp finding|1|||
126456458|NCT00636363|454970903|FG000|Overall Study|Study related symptoms/complaints|8|||
126456459|NCT00636363|454970904|FG001|Overall Study|Study related symptoms/complaints|7|||
126456460|NCT00636363|454970905|FG002|Overall Study|Study related symptoms/complaints|4|||
126456461|NCT00636363|454970903|FG000|Overall Study|Met ineligibility criteria|0|||
126456462|NCT00636363|454970904|FG001|Overall Study|Met ineligibility criteria|0|||
126549200|NCT00874432|455304010|FG001|Overall Study|Physician Decision|0|||
126284805|NCT00517881|454331048|FG000|Overall Study|Protocol Violation|2|||
126284806|NCT00517881|454331048|FG000|Overall Study|Adverse Event|1|||
126284807|NCT00517881|454331048|FG000|Overall Study|Renal transplantation|2|||
126284808|NCT00113763|454331049|FG000|Overall Study|Adverse Event|5|||
126284809|NCT00113763|454331050|FG001|Overall Study|Adverse Event|2|||
126284810|NCT00113763|454331049|FG000|Overall Study|Disease Progression|28|||
126284811|NCT00113763|454331050|FG001|Overall Study|Disease Progression|14|||
126284812|NCT00113763|454331049|FG000|Overall Study|Lost to Follow-up|10|||
126284813|NCT00113763|454331050|FG001|Overall Study|Lost to Follow-up|0|||
126284814|NCT00113763|454331049|FG000|Overall Study|Withdrawal by Subject|1|||
126284815|NCT00113763|454331050|FG001|Overall Study|Withdrawal by Subject|4|||
126284816|NCT00113763|454331049|FG000|Overall Study|Other|27|||
126284817|NCT00113763|454331050|FG001|Overall Study|Other|6|||
126284818|NCT00113763|454331049|FG000|Overall Study|Non-compliance|1|||
126284819|NCT00113763|454331050|FG001|Overall Study|Non-compliance|0|||
126456463|NCT00636363|454970905|FG002|Overall Study|Met ineligibility criteria|3|||
126456464|NCT00636363|454970903|FG000|Overall Study|Missed > 1 visit|0|||
126456465|NCT00636363|454970904|FG001|Overall Study|Missed > 1 visit|1|||
126456466|NCT00636363|454970905|FG002|Overall Study|Missed > 1 visit|3|||
126456467|NCT00636363|454970903|FG000|Overall Study|Lack of motivation|1|||
126456468|NCT00636363|454970904|FG001|Overall Study|Lack of motivation|0|||
126456469|NCT00636363|454970905|FG002|Overall Study|Lack of motivation|1|||
126456470|NCT00636363|454970903|FG000|Overall Study|Protocol Violation|0|||
126456471|NCT00636363|454970904|FG001|Overall Study|Protocol Violation|3|||
126456472|NCT00636363|454970905|FG002|Overall Study|Protocol Violation|0|||
126456473|NCT00636363|454970903|FG000|Overall Study|Lost to Follow-up|3|||
126456474|NCT00636363|454970904|FG001|Overall Study|Lost to Follow-up|4|||
126456475|NCT00636363|454970905|FG002|Overall Study|Lost to Follow-up|2|||
126456476|NCT00636363|454970903|FG000|Overall Study|Withdrawal by Subject|1|||
126456477|NCT00636363|454970904|FG001|Overall Study|Withdrawal by Subject|3|||
126456478|NCT00636363|454970905|FG002|Overall Study|Withdrawal by Subject|2|||
126456479|NCT00280748|454970907|FG000|Overall Study|Decline in performance|3|||
126456480|NCT00280748|454970907|FG000|Overall Study|Extra-cranial disease progression|1|||
126456481|NCT00029146|454970908|FG000|Overall Study|Lost to Follow-up|2|||
126456482|NCT00029146|454970909|FG001|Overall Study|Lost to Follow-up|1|||
126456483|NCT00043550|454970916|FG000|Overall Study|Withdrawal by Subject|22|||
126549201|NCT00874432|455304011|FG002|Overall Study|Physician Decision|0|||
126549202|NCT00874432|455304012|FG003|Overall Study|Physician Decision|0|||
126549203|NCT00874432|455304009|FG000|Overall Study|Other|1|||
126284820|NCT00113763|454331049|FG000|Overall Study|Ongoing|1|||
126284821|NCT00113763|454331050|FG001|Overall Study|Ongoing|0|||
126284822|NCT01207583|454331051|FG000|Overall Study|Withdrawal by Subject|0|||
126284823|NCT01207583|454331052|FG001|Overall Study|Withdrawal by Subject|3|||
126284824|NCT01207583|454331053|FG002|Overall Study|Withdrawal by Subject|1|||
126284825|NCT01207583|454331051|FG000|Overall Study|Participant failed to return|1|||
126284826|NCT01207583|454331052|FG001|Overall Study|Participant failed to return|0|||
126284827|NCT01207583|454331053|FG002|Overall Study|Participant failed to return|0|||
126284828|NCT01207583|454331051|FG000|Overall Study|Lost to Follow-up|0|||
126284829|NCT01207583|454331052|FG001|Overall Study|Lost to Follow-up|2|||
126284830|NCT01207583|454331053|FG002|Overall Study|Lost to Follow-up|0|||
126284831|NCT01383707|454331058|FG000|Overall Study|Consent withdrawal|6|||
126284832|NCT01383707|454331058|FG000|Overall Study|Death|19|||
126284833|NCT01383707|454331058|FG000|Overall Study|Other|8|||
126284834|NCT01383707|454331058|FG000|Overall Study|Sponsor's decision|2|||
126284835|NCT01383707|454331058|FG000|Overall Study|Adverse Event|14|||
126284836|NCT01383707|454331058|FG000|Overall Study|Progressive disease|23|||
126284837|NCT02129608|454331059|FG000|Overall Study|Lost to Follow-up|0|||
126364964|NCT02514746|454630385|FG001|Overall Study|Physician Decision|2|||
126364965|NCT02514746|454630384|FG000|Overall Study|Withdrawal by Subject|12|||
126364966|NCT02514746|454630385|FG001|Overall Study|Withdrawal by Subject|10|||
126364967|NCT02514746|454630384|FG000|Overall Study|Other|5|||
126364968|NCT02514746|454630385|FG001|Overall Study|Other|1|||
126364969|NCT02181413|454630386|FG000|Overall Study|Withdrawal by Subject|45|||
126364970|NCT02181413|454630387|FG001|Overall Study|Withdrawal by Subject|61|||
126364971|NCT02181413|454630386|FG000|Overall Study|Reason Not Specified|2|||
126364972|NCT02181413|454630387|FG001|Overall Study|Reason Not Specified|5|||
126364973|NCT02181413|454630386|FG000|Overall Study|Lost to Follow-up|8|||
126364974|NCT02181413|454630387|FG001|Overall Study|Lost to Follow-up|7|||
126364975|NCT00050011|454630389|FG000|Overall Study|Adverse Event|41|||
126364976|NCT00050011|454630390|FG001|Overall Study|Adverse Event|46|||
126364977|NCT00050011|454630389|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126364978|NCT00050011|454630390|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126364979|NCT00050011|454630389|FG000|Overall Study|Abnormal test procedure results|0|||
126364980|NCT00050011|454630390|FG001|Overall Study|Abnormal test procedure results|1|||
126284838|NCT02129608|454331060|FG001|Overall Study|Lost to Follow-up|1|||
126284839|NCT02129608|454331061|FG002|Overall Study|Lost to Follow-up|1|||
126364981|NCT00050011|454630389|FG000|Overall Study|Lack of Efficacy|16|||
126284840|NCT02129608|454331059|FG000|Overall Study|Withdrawal by Subject|0|||
126284841|NCT02129608|454331060|FG001|Overall Study|Withdrawal by Subject|0|||
126364982|NCT00050011|454630390|FG001|Overall Study|Lack of Efficacy|21|||
126364983|NCT00050011|454630389|FG000|Overall Study|Participant condition no longer required|1|||
126364984|NCT00050011|454630390|FG001|Overall Study|Participant condition no longer required|0|||
126456484|NCT00043550|454970917|FG001|Overall Study|Withdrawal by Subject|12|||
126549204|NCT00874432|455304010|FG001|Overall Study|Other|2|||
126549205|NCT00874432|455304011|FG002|Overall Study|Other|8|||
126549206|NCT00874432|455304012|FG003|Overall Study|Other|3|||
126284842|NCT02129608|454331061|FG002|Overall Study|Withdrawal by Subject|2|||
126284843|NCT00451204|454331062|FG000|Overall Study|Adverse Event|4|||
126284844|NCT00451204|454331063|FG001|Overall Study|Adverse Event|6|||
126284845|NCT00451204|454331062|FG000|Overall Study|Lack of Efficacy|4|||
126364985|NCT00050011|454630389|FG000|Overall Study|Protocol Violation|4|||
126456485|NCT00043550|454970918|FG002|Overall Study|Withdrawal by Subject|20|||
126456486|NCT01917656|454970922|FG000|Overall Study|Adverse Event|11|||
126456487|NCT01917656|454970923|FG001|Overall Study|Adverse Event|0|||
126709277|NCT00923091|455887958|FG007|Period V (Double -Blind)|Protocol Violation|0|||
126709278|NCT00923091|455887959|FG008|Period V (Double -Blind)|Protocol Violation|0|||
126709279|NCT00923091|455887960|FG009|Period V (Double -Blind)|Protocol Violation|0|||
126709280|NCT00923091|455887961|FG010|Period V (Double -Blind)|Protocol Violation|0|||
126709281|NCT00923091|455887962|FG011|Period V (Double -Blind)|Protocol Violation|0|||
126709282|NCT00923091|455887963|FG012|Period V (Double -Blind)|Protocol Violation|1|||
126709283|NCT00923091|455887951|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
126709284|NCT00923091|455887952|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
126709285|NCT00923091|455887953|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
126709286|NCT00923091|455887954|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
126709287|NCT00923091|455887955|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
126709288|NCT00923091|455887956|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
126709289|NCT00923091|455887957|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
126709290|NCT00923091|455887958|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
126709291|NCT00923091|455887959|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
126709292|NCT00923091|455887960|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
126709293|NCT00923091|455887961|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
126709294|NCT00923091|455887962|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
126709295|NCT00923091|455887963|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
126709296|NCT00923091|455887951|FG000|Period VI (Open-Label)|Adverse Event|17|||
126284846|NCT00451204|454331063|FG001|Overall Study|Lack of Efficacy|4|||
126284847|NCT00451204|454331062|FG000|Overall Study|Lost to Follow-up|4|||
126709297|NCT00923091|455887952|FG001|Period VI (Open-Label)|Adverse Event|0|||
126284848|NCT00451204|454331063|FG001|Overall Study|Lost to Follow-up|4|||
126284849|NCT00451204|454331062|FG000|Overall Study|Protocol Violation|1|||
126284850|NCT00451204|454331063|FG001|Overall Study|Protocol Violation|0|||
126284851|NCT00451204|454331062|FG000|Overall Study|Patient refusal|8|||
126284852|NCT00451204|454331063|FG001|Overall Study|Patient refusal|4|||
126284853|NCT00451204|454331062|FG000|Overall Study|Other|1|||
126284854|NCT00451204|454331063|FG001|Overall Study|Other|2|||
126284855|NCT01582152|454331064|FG000|Overall Study|Disease Progression|4|||
126284856|NCT01582152|454331065|FG001|Overall Study|Disease Progression|5|||
126284857|NCT01582152|454331064|FG000|Overall Study|Adverse Event|2|||
126284858|NCT01582152|454331065|FG001|Overall Study|Adverse Event|1|||
126284859|NCT02437903|454331068|FG000|Overall Study|Adverse Event|1|||
126709298|NCT00923091|455887953|FG002|Period VI (Open-Label)|Adverse Event|4|||
126284860|NCT02437903|454331068|FG000|Overall Study|Withdrawal by Subject|1|||
126284861|NCT02437903|454331068|FG000|Overall Study|Lost to Follow-up|3|||
126284862|NCT04172597|454331072|FG000|Overall Study|Disease Progression|0|||
126284863|NCT04172597|454331073|FG001|Overall Study|Disease Progression|0|||
126284864|NCT04172597|454331074|FG002|Overall Study|Disease Progression|0|||
126284865|NCT04172597|454331075|FG003|Overall Study|Disease Progression|0|||
126284866|NCT04172597|454331076|FG004|Overall Study|Disease Progression|1|||
126284867|NCT00794339|454331077|FG000|Overall Study|Withdrawal by Subject|3|||
126284868|NCT00794339|454331077|FG000|Overall Study|Ineligible|4|||
126284869|NCT00794339|454331077|FG000|Overall Study|Tx prior to ATSM|3|||
126284870|NCT00794339|454331077|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
126284871|NCT00794339|454331077|FG000|Overall Study|Tx not per protocol|1|||
126284872|NCT01611857|454331078|FG000|Overall Study|Withdrawal by Subject|0|||
126284873|NCT01611857|454331079|FG001|Overall Study|Withdrawal by Subject|2|||
126709299|NCT00923091|455887954|FG003|Period VI (Open-Label)|Adverse Event|1|||
126709300|NCT00923091|455887955|FG004|Period VI (Open-Label)|Adverse Event|1|||
126709301|NCT00923091|455887956|FG005|Period VI (Open-Label)|Adverse Event|0|||
126709302|NCT00923091|455887957|FG006|Period VI (Open-Label)|Adverse Event|0|||
126709303|NCT00923091|455887958|FG007|Period VI (Open-Label)|Adverse Event|0|||
126709304|NCT00923091|455887959|FG008|Period VI (Open-Label)|Adverse Event|0|||
126709305|NCT00923091|455887960|FG009|Period VI (Open-Label)|Adverse Event|0|||
126709306|NCT00923091|455887961|FG010|Period VI (Open-Label)|Adverse Event|0|||
126709307|NCT00923091|455887962|FG011|Period VI (Open-Label)|Adverse Event|0|||
126709308|NCT00923091|455887963|FG012|Period VI (Open-Label)|Adverse Event|0|||
126709309|NCT00923091|455887951|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
126709310|NCT00923091|455887952|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
126709311|NCT00923091|455887953|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
126709312|NCT00923091|455887954|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
126284874|NCT02540083|454331084|FG000|Overall Study|Withdrawal by Subject|16|||
126284875|NCT01372748|454331085|FG000|Overall Study|Lost to Follow-up|16|||
126709313|NCT00923091|455887955|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
126709314|NCT00923091|455887956|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
126709315|NCT00923091|455887957|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
126709316|NCT00923091|455887958|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
126709317|NCT00923091|455887959|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
126709318|NCT00923091|455887960|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
126709319|NCT00923091|455887961|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
126709320|NCT00923091|455887962|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
126709321|NCT00923091|455887963|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
126549207|NCT03713021|455304013|FG000|Overall Study|Did not have CT sim scan available|6|||
126549208|NCT03713021|455304013|FG000|Overall Study|Not eligible|4|||
126284876|NCT01372748|454331086|FG001|Overall Study|Lost to Follow-up|34|||
126284877|NCT01372748|454331085|FG000|Overall Study|Withdrawal by Subject|7|||
126284878|NCT01372748|454331086|FG001|Overall Study|Withdrawal by Subject|5|||
126284879|NCT00134901|454331087|FG000|Overall Study|Lost to Follow-up|5|||
126284880|NCT00134901|454331088|FG001|Overall Study|Lost to Follow-up|5|||
126284881|NCT00134901|454331087|FG000|Overall Study|discontinued intervention|12|||
126284882|NCT00134901|454331088|FG001|Overall Study|discontinued intervention|10|||
126284883|NCT04289363|454331089|FG000|Overall Study|Lost to Follow-up|14|||
126284884|NCT04289363|454331090|FG001|Overall Study|Lost to Follow-up|0|||
126284885|NCT01807065|454331091|FG000|Overall Study|Receive no sip-T due to IV access|1|||
126284886|NCT01807065|454331092|FG001|Overall Study|Receive no sip-T due to IV access|1|||
126284887|NCT00445432|454331093|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
126284888|NCT00445432|454331094|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
126284889|NCT00445432|454331095|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
126284890|NCT00445432|454331096|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
126284891|NCT00445432|454331093|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
126284892|NCT00445432|454331094|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
126284893|NCT00445432|454331095|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
126284894|NCT00445432|454331096|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
126284895|NCT00445432|454331093|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
126284896|NCT00445432|454331094|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
126284897|NCT00445432|454331095|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
126284898|NCT00445432|454331096|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
126284899|NCT00445432|454331093|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
126284900|NCT00445432|454331094|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
126284901|NCT00445432|454331095|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
126284902|NCT00445432|454331096|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
126284903|NCT00445432|454331093|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
126284904|NCT00445432|454331094|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
126284905|NCT00445432|454331095|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
126284906|NCT00445432|454331096|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
126284907|NCT00445432|454331093|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
126284908|NCT00445432|454331094|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
126284909|NCT00445432|454331095|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
126284910|NCT00445432|454331096|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
126284911|NCT00445432|454331093|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
126284912|NCT00445432|454331094|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
126284913|NCT00445432|454331095|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
126284914|NCT00445432|454331096|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
126284915|NCT00356525|454331100|FG000|Overall Study|Progressive Disease|8|||
126284916|NCT00356525|454331101|FG001|Overall Study|Progressive Disease|5|||
126284917|NCT00356525|454331102|FG002|Overall Study|Progressive Disease|4|||
126549209|NCT03713021|455304013|FG000|Overall Study|Issues with TraceIT markers|5|||
126549210|NCT03391960|455304019|FG000|Overall Study|Protocol Violation|0|||
126549211|NCT03391960|455304020|FG001|Overall Study|Protocol Violation|0|||
126549212|NCT01167179|455305551|FG000|Overall Study|disease recurrence|4|||
126549213|NCT01167179|455305552|FG001|Overall Study|disease recurrence|4|||
126284918|NCT00356525|454331103|FG003|Overall Study|Progressive Disease|2|||
126284919|NCT00356525|454331100|FG000|Overall Study|Adverse Event|1|||
126284920|NCT00356525|454331101|FG001|Overall Study|Adverse Event|3|||
126284921|NCT00356525|454331102|FG002|Overall Study|Adverse Event|1|||
126284922|NCT00356525|454331103|FG003|Overall Study|Adverse Event|1|||
126284923|NCT00356525|454331100|FG000|Overall Study|Lost to Follow-up|1|||
126284924|NCT00356525|454331101|FG001|Overall Study|Lost to Follow-up|0|||
126284925|NCT00356525|454331102|FG002|Overall Study|Lost to Follow-up|0|||
126284926|NCT00356525|454331103|FG003|Overall Study|Lost to Follow-up|0|||
126284927|NCT00356525|454331100|FG000|Overall Study|Physician Decision|2|||
126284928|NCT00356525|454331101|FG001|Overall Study|Physician Decision|2|||
126284929|NCT00356525|454331102|FG002|Overall Study|Physician Decision|2|||
126284930|NCT00356525|454331103|FG003|Overall Study|Physician Decision|1|||
126284931|NCT00356525|454331100|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
126284932|NCT00356525|454331101|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
126364986|NCT00050011|454630390|FG001|Overall Study|Protocol Violation|10|||
126364987|NCT00050011|454630389|FG000|Overall Study|Withdrawal by Subject|34|||
126364988|NCT00050011|454630390|FG001|Overall Study|Withdrawal by Subject|26|||
126364989|NCT00050011|454630389|FG000|Overall Study|Lost to Follow-up|7|||
126364990|NCT00050011|454630390|FG001|Overall Study|Lost to Follow-up|9|||
126364991|NCT00050011|454630389|FG000|Overall Study|Administrative problems|10|||
126364992|NCT00050011|454630390|FG001|Overall Study|Administrative problems|6|||
126364993|NCT00050011|454630389|FG000|Overall Study|Death|7|||
126364994|NCT00050011|454630390|FG001|Overall Study|Death|4|||
126549214|NCT01167179|455305551|FG000|Overall Study|Death|4|||
126549215|NCT01167179|455305552|FG001|Overall Study|Death|10|||
126549216|NCT01167179|455305551|FG000|Overall Study|Withdrawal by Subject|1|||
126549217|NCT01167179|455305552|FG001|Overall Study|Withdrawal by Subject|2|||
126549218|NCT01167179|455305551|FG000|Overall Study|diverse|6|||
126549219|NCT01167179|455305552|FG001|Overall Study|diverse|5|||
126549220|NCT02781506|455305553|FG000|Overall Study|Adverse Event|5|||
126549221|NCT01158378|455305554|FG000|Overall Study|Death|4|||
126549222|NCT01158378|455305555|FG001|Overall Study|Death|5|||
126549223|NCT01158378|455305554|FG000|Overall Study|Lost to Follow-up|2|||
126549224|NCT01158378|455305555|FG001|Overall Study|Lost to Follow-up|4|||
126549225|NCT01158378|455305554|FG000|Overall Study|Withdrawal by Subject|4|||
126549226|NCT01158378|455305555|FG001|Overall Study|Withdrawal by Subject|0|||
126549227|NCT03017235|455305556|FG000|Overall Study|Withdrawal by Subject|4|||
126549228|NCT03017235|455305557|FG001|Overall Study|Withdrawal by Subject|3|||
126549229|NCT03017235|455305556|FG000|Overall Study|Lost to Follow-up|2|||
126549230|NCT03017235|455305557|FG001|Overall Study|Lost to Follow-up|7|||
126549231|NCT03017235|455305556|FG000|Overall Study|Adverse Event|0|||
126549232|NCT03017235|455305557|FG001|Overall Study|Adverse Event|1|||
126549233|NCT03017235|455305556|FG000|Overall Study|Protocol Violation|2|||
126549234|NCT03017235|455305557|FG001|Overall Study|Protocol Violation|1|||
126549235|NCT03017235|455305556|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
126549236|NCT03017235|455305557|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
126549237|NCT02593539|455305561|FG000|Overall Study|Adverse Event|1|||
126284933|NCT00356525|454331102|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
126284934|NCT00356525|454331103|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
126284935|NCT00356525|454331100|FG000|Overall Study|Withdrawal by Subject|1|||
126549238|NCT01282476|455305562|FG000|Overall Study|Death|11|||
126549239|NCT00437125|455305563|FG000|Overall Study|Adverse Event|12|||
126549240|NCT00437125|455305563|FG000|Overall Study|Death|1|||
126549241|NCT00437125|455305563|FG000|Overall Study|Clinical Relapse|1|||
126284936|NCT00356525|454331101|FG001|Overall Study|Withdrawal by Subject|1|||
126284937|NCT00356525|454331102|FG002|Overall Study|Withdrawal by Subject|0|||
126284938|NCT00356525|454331103|FG003|Overall Study|Withdrawal by Subject|3|||
126284939|NCT00356525|454331100|FG000|Overall Study|Death|0|||
126284940|NCT00356525|454331101|FG001|Overall Study|Death|0|||
126284941|NCT00356525|454331102|FG002|Overall Study|Death|0|||
126284942|NCT00356525|454331103|FG003|Overall Study|Death|1|||
126284943|NCT00356525|454331100|FG000|Overall Study|Sponsor Decision|0|||
126284944|NCT00356525|454331101|FG001|Overall Study|Sponsor Decision|0|||
126284945|NCT00356525|454331102|FG002|Overall Study|Sponsor Decision|0|||
126284946|NCT00356525|454331103|FG003|Overall Study|Sponsor Decision|1|||
126284947|NCT00462904|454331104|FG000|Overall Study|Lost to Follow-up|1|||
126284948|NCT04036110|454331107|FG000|Overall Study|Lost to Follow-up|3|||
126284949|NCT04036110|454331108|FG001|Overall Study|Lost to Follow-up|2|||
126284950|NCT04036110|454331109|FG002|Overall Study|Lost to Follow-up|1|||
126284951|NCT04036110|454331107|FG000|Overall Study|Study Suspended|4|||
126284952|NCT04036110|454331108|FG001|Overall Study|Study Suspended|5|||
126284953|NCT04036110|454331109|FG002|Overall Study|Study Suspended|1|||
126284954|NCT00396565|454331112|FG000|Overall Study|Physician Decision|3|||
126284955|NCT00396565|454331113|FG001|Overall Study|Physician Decision|1|||
126284956|NCT00396565|454331114|FG002|Overall Study|Physician Decision|2|||
126284957|NCT00396565|454331112|FG000|Overall Study|Adverse Event|5|||
126284958|NCT00396565|454331113|FG001|Overall Study|Adverse Event|13|||
126284959|NCT00396565|454331114|FG002|Overall Study|Adverse Event|3|||
126284960|NCT00396565|454331112|FG000|Overall Study|Withdrawal by Subject|8|||
126284961|NCT00396565|454331113|FG001|Overall Study|Withdrawal by Subject|13|||
126284962|NCT00396565|454331114|FG002|Overall Study|Withdrawal by Subject|1|||
126284963|NCT00396565|454331112|FG000|Overall Study|Lack of Efficacy|32|||
126284964|NCT00396565|454331113|FG001|Overall Study|Lack of Efficacy|64|||
126549242|NCT00437125|455305563|FG000|Overall Study|Lack of Efficacy|1|||
126549243|NCT00437125|455305563|FG000|Overall Study|Lost to Follow-up|1|||
126549244|NCT00437125|455305563|FG000|Overall Study|Withdrawal by Subject|13|||
126549245|NCT00437125|455305563|FG000|Overall Study|Withdrawal by Caregiver|2|||
126549246|NCT00437125|455305563|FG000|Overall Study|Physician Decision|1|||
126284965|NCT00396565|454331114|FG002|Overall Study|Lack of Efficacy|11|||
126284966|NCT04324021|454331117|FG000|Overall Study|Adverse Event|1|||
126549247|NCT02248961|455305566|FG000|Overall Study|Adverse Event|1|||
126549248|NCT02248961|455305567|FG001|Overall Study|Adverse Event|0|||
126549249|NCT02248961|455305566|FG000|Overall Study|Withdrawal by Subject|1|||
126549250|NCT02248961|455305567|FG001|Overall Study|Withdrawal by Subject|2|||
126549251|NCT02248961|455305566|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
126549252|NCT02248961|455305567|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
126549253|NCT03518658|455305570|FG000|Overall Study|Other|51|||
126549254|NCT03518658|455305571|FG001|Overall Study|Other|0|||
126549255|NCT00453310|455305576|FG000|Overall Study|Progression of Disease|10|||
126284967|NCT04324021|454331118|FG001|Overall Study|Adverse Event|0|||
126284968|NCT04324021|454331119|FG002|Overall Study|Adverse Event|0|||
126284969|NCT04324021|454331117|FG000|Overall Study|Lack of Efficacy|0|||
126284970|NCT04324021|454331118|FG001|Overall Study|Lack of Efficacy|0|||
126364995|NCT00050011|454630389|FG000|Overall Study|Unknown - Reason is missing|0|||
126364996|NCT00050011|454630390|FG001|Overall Study|Unknown - Reason is missing|2|||
126364997|NCT04903093|454630397|FG000|Overall Study|Withdrawal by Subject|0|||
126364998|NCT04903093|454630398|FG001|Overall Study|Withdrawal by Subject|0|||
126364999|NCT04903093|454630399|FG002|Overall Study|Withdrawal by Subject|0|||
126365000|NCT04903093|454630400|FG003|Overall Study|Withdrawal by Subject|1|||
126365001|NCT04903093|454630401|FG004|Overall Study|Withdrawal by Subject|0|||
126365002|NCT04903093|454630402|FG005|Overall Study|Withdrawal by Subject|0|||
126365003|NCT03973489|454630408|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
126365004|NCT03973489|454630409|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
126365005|NCT03973489|454630410|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
126365006|NCT03973489|454630411|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
126365007|NCT03973489|454630412|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
126365008|NCT03973489|454630413|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
126365009|NCT03973489|454630414|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
126365010|NCT03973489|454630415|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
126365011|NCT03973489|454630408|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
126365012|NCT03973489|454630409|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
126365013|NCT03973489|454630410|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
126365014|NCT03973489|454630411|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
126365015|NCT03973489|454630412|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
126365016|NCT03973489|454630413|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
126365017|NCT03973489|454630414|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
126365018|NCT03973489|454630415|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
126365019|NCT03973489|454630408|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
126365020|NCT03973489|454630409|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
126365021|NCT03973489|454630410|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
126365022|NCT03973489|454630411|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
126365023|NCT03973489|454630412|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
126365024|NCT03973489|454630413|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
126365025|NCT03973489|454630414|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
126365026|NCT03973489|454630415|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
126365027|NCT03973489|454630408|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
126365028|NCT03973489|454630409|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
126365029|NCT03973489|454630410|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
126365030|NCT03973489|454630411|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
126365031|NCT03973489|454630412|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
126365032|NCT03973489|454630413|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
126365033|NCT03973489|454630414|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
126365034|NCT03973489|454630415|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
126365035|NCT03973489|454630408|FG000|Second Intervention (1 Day)|Adverse Event|0|||
126365036|NCT03973489|454630409|FG001|Second Intervention (1 Day)|Adverse Event|0|||
126365037|NCT03973489|454630410|FG002|Second Intervention (1 Day)|Adverse Event|0|||
126549256|NCT01267825|455305577|FG000|Overall Study|study terminated. no data collected.|1|||
126549257|NCT01267825|455305578|FG001|Overall Study|study terminated. no data collected.|0|||
126365038|NCT03973489|454630411|FG003|Second Intervention (1 Day)|Adverse Event|1|||
126365039|NCT03973489|454630412|FG004|Second Intervention (1 Day)|Adverse Event|0|||
126365040|NCT03973489|454630413|FG005|Second Intervention (1 Day)|Adverse Event|0|||
126365041|NCT03973489|454630414|FG006|Second Intervention (1 Day)|Adverse Event|0|||
126365042|NCT03973489|454630415|FG007|Second Intervention (1 Day)|Adverse Event|0|||
126549258|NCT02105636|455305587|FG000|Pre-Treatment|Disease Progression|1|||
126549259|NCT02105636|455305588|FG001|Pre-Treatment|Disease Progression|0|||
126549260|NCT02105636|455305587|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
126549261|NCT02105636|455305588|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
126549262|NCT02105636|455305587|FG000|Pre-Treatment|Participant withdrew consent|0|||
126709322|NCT00923091|455887951|FG000|Period VI (Open-Label)|Protocol Violation|6|||
126709323|NCT00923091|455887952|FG001|Period VI (Open-Label)|Protocol Violation|1|||
126709324|NCT00923091|455887953|FG002|Period VI (Open-Label)|Protocol Violation|3|||
126709325|NCT00923091|455887954|FG003|Period VI (Open-Label)|Protocol Violation|1|||
126365043|NCT00392288|454630416|FG000|Overall Study|Adverse Event|17|||
126365044|NCT00392288|454630417|FG001|Overall Study|Adverse Event|7|||
126365045|NCT00392288|454630418|FG002|Overall Study|Adverse Event|8|||
126365046|NCT00392288|454630416|FG000|Overall Study|Lack of Efficacy|8|||
126365047|NCT00392288|454630417|FG001|Overall Study|Lack of Efficacy|5|||
126365048|NCT00392288|454630418|FG002|Overall Study|Lack of Efficacy|3|||
126709326|NCT00923091|455887955|FG004|Period VI (Open-Label)|Protocol Violation|4|||
126365049|NCT00392288|454630416|FG000|Overall Study|Protocol Violation|1|||
126549263|NCT02105636|455305588|FG001|Pre-Treatment|Participant withdrew consent|6|||
126709327|NCT00923091|455887956|FG005|Period VI (Open-Label)|Protocol Violation|0|||
126709328|NCT00923091|455887957|FG006|Period VI (Open-Label)|Protocol Violation|0|||
126284971|NCT04324021|454331119|FG002|Overall Study|Lack of Efficacy|1|||
126284972|NCT04324021|454331117|FG000|Overall Study|Death|1|||
126284973|NCT04324021|454331118|FG001|Overall Study|Death|1|||
126284974|NCT04324021|454331119|FG002|Overall Study|Death|0|||
126284975|NCT03097991|454331120|FG000|Overall Study|Didn't meet study criteria|8|||
126284976|NCT03097991|454331121|FG001|Overall Study|Didn't meet study criteria|0|||
126284977|NCT03097991|454331120|FG000|Overall Study|Withdrawal by Subject|12|||
126284978|NCT03097991|454331121|FG001|Overall Study|Withdrawal by Subject|6|||
126284979|NCT03097991|454331120|FG000|Overall Study|Death of Baby|3|||
126284980|NCT03097991|454331121|FG001|Overall Study|Death of Baby|1|||
126284981|NCT03097991|454331120|FG000|Overall Study|Lost to Follow-up|24|||
126284982|NCT03097991|454331121|FG001|Overall Study|Lost to Follow-up|38|||
126284983|NCT03097991|454331120|FG000|Overall Study|Adverse Event|3|||
126284984|NCT03097991|454331121|FG001|Overall Study|Adverse Event|5|||
126284985|NCT00246324|454331122|FG000|Overall Study|Withdrawal by Subject|1|||
126284986|NCT02006732|454331123|FG000|Overall Study|Adverse Event|10|||
126284987|NCT02006732|454331124|FG001|Overall Study|Adverse Event|7|||
126284988|NCT02006732|454331125|FG002|Overall Study|Adverse Event|4|||
126284989|NCT02006732|454331126|FG003|Overall Study|Adverse Event|2|||
126284990|NCT02006732|454331123|FG000|Overall Study|Lack of Efficacy|6|||
126284991|NCT02006732|454331124|FG001|Overall Study|Lack of Efficacy|3|||
126284992|NCT02006732|454331125|FG002|Overall Study|Lack of Efficacy|1|||
126284993|NCT02006732|454331126|FG003|Overall Study|Lack of Efficacy|1|||
126284994|NCT02006732|454331123|FG000|Overall Study|Protocol Violation|1|||
126284995|NCT02006732|454331124|FG001|Overall Study|Protocol Violation|1|||
126284996|NCT02006732|454331125|FG002|Overall Study|Protocol Violation|0|||
126284997|NCT02006732|454331126|FG003|Overall Study|Protocol Violation|0|||
126284998|NCT02006732|454331123|FG000|Overall Study|Lost to Follow-up|0|||
126284999|NCT02006732|454331124|FG001|Overall Study|Lost to Follow-up|1|||
126285000|NCT02006732|454331125|FG002|Overall Study|Lost to Follow-up|0|||
126285001|NCT02006732|454331126|FG003|Overall Study|Lost to Follow-up|0|||
126285002|NCT02006732|454331123|FG000|Overall Study|Withdrawal by Subject|3|||
126285003|NCT02006732|454331124|FG001|Overall Study|Withdrawal by Subject|0|||
126285004|NCT02006732|454331125|FG002|Overall Study|Withdrawal by Subject|4|||
126285005|NCT02006732|454331126|FG003|Overall Study|Withdrawal by Subject|1|||
126285006|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
126285007|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
126285008|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
126285009|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Death|1|||
126285010|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Death|3|||
126285011|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Death|1|||
126285012|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
126285013|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
126285014|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
126285015|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
126285016|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
126285017|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
126285018|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
126285019|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
126285020|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
126285021|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
126285022|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
126285023|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
126285024|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
126285025|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
126285026|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
126285027|NCT00299130|454331127|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
126285028|NCT00299130|454331128|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
126285029|NCT00299130|454331129|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
126285030|NCT00299130|454331127|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
126285031|NCT00299130|454331128|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
126285032|NCT00299130|454331129|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
126285033|NCT00299130|454331127|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
126285034|NCT00299130|454331128|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
126285035|NCT00299130|454331129|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
126285036|NCT00299130|454331127|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
126285037|NCT00299130|454331128|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
126285038|NCT00299130|454331129|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
126285039|NCT00299130|454331127|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
126285040|NCT00299130|454331128|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
126285041|NCT00299130|454331129|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
126285042|NCT00299130|454331127|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
126285043|NCT00299130|454331128|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
126285044|NCT00299130|454331129|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
126285045|NCT00299130|454331127|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
126285046|NCT00299130|454331128|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
126285047|NCT00299130|454331129|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
126285048|NCT00299130|454331127|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
126285049|NCT00299130|454331128|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
126285050|NCT00299130|454331129|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
126285051|NCT00299130|454331127|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
126285052|NCT00299130|454331128|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
126285053|NCT00299130|454331129|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
126285054|NCT00299130|454331127|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
126285055|NCT00299130|454331128|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
126285056|NCT00299130|454331129|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
126285057|NCT01198132|454331130|FG000|Overall Study|Withdrawal by Subject|4|||
126285058|NCT01198132|454331131|FG001|Overall Study|Withdrawal by Subject|5|||
126285059|NCT01198132|454331130|FG000|Overall Study|Physician Decision|5|||
126285060|NCT01198132|454331131|FG001|Overall Study|Physician Decision|4|||
126285061|NCT01198132|454331130|FG000|Overall Study|Other Unspecified|3|||
126285062|NCT01198132|454331131|FG001|Overall Study|Other Unspecified|6|||
126285063|NCT01198132|454331130|FG000|Overall Study|Lack of Efficacy|2|||
126285064|NCT01198132|454331131|FG001|Overall Study|Lack of Efficacy|3|||
126285065|NCT01198132|454331130|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
126285066|NCT01198132|454331131|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
126285067|NCT01198132|454331130|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
126285068|NCT01198132|454331131|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
126285069|NCT01198132|454331130|FG000|Overall Study|Adverse Event|0|||
126285070|NCT01198132|454331131|FG001|Overall Study|Adverse Event|1|||
126285071|NCT01198132|454331130|FG000|Overall Study|Protocol Violation|1|||
126285072|NCT01198132|454331131|FG001|Overall Study|Protocol Violation|0|||
126285073|NCT03516513|454331132|FG000|Overall Study|Withdrawal by Subject|2|||
126285074|NCT03516513|454331133|FG001|Overall Study|Withdrawal by Subject|2|||
126285075|NCT03516513|454331134|FG002|Overall Study|Withdrawal by Subject|0|||
126285076|NCT03516513|454331135|FG003|Overall Study|Withdrawal by Subject|0|||
126285077|NCT01098487|454331136|FG000|Overall Study|Adverse Event|22|||
126285078|NCT01098487|454331136|FG000|Overall Study|Lack of Efficacy|11|||
126285079|NCT01098487|454331136|FG000|Overall Study|Withdrawal by Subject|7|||
126285080|NCT01098487|454331136|FG000|Overall Study|Lost to Follow-up|3|||
126365050|NCT00392288|454630417|FG001|Overall Study|Protocol Violation|3|||
126365051|NCT00392288|454630418|FG002|Overall Study|Protocol Violation|1|||
126365052|NCT00392288|454630416|FG000|Overall Study|Lost to Follow-up|1|||
126365053|NCT00392288|454630417|FG001|Overall Study|Lost to Follow-up|1|||
126365054|NCT00392288|454630418|FG002|Overall Study|Lost to Follow-up|1|||
126365055|NCT00392288|454630416|FG000|Overall Study|Withdrawal by Subject|1|||
126365056|NCT00392288|454630417|FG001|Overall Study|Withdrawal by Subject|0|||
126365057|NCT00392288|454630418|FG002|Overall Study|Withdrawal by Subject|2|||
126365058|NCT00392288|454630416|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
126365059|NCT00392288|454630417|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
126365060|NCT00392288|454630418|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
126365061|NCT00392288|454630416|FG000|Overall Study|Other|3|||
126365062|NCT00392288|454630417|FG001|Overall Study|Other|4|||
126365063|NCT00392288|454630418|FG002|Overall Study|Other|1|||
126365064|NCT02544763|454630419|FG000|Overall Study|Adverse Event|8|||
126365065|NCT02544763|454630420|FG001|Overall Study|Adverse Event|8|||
126365066|NCT02544763|454630421|FG002|Overall Study|Adverse Event|0|||
126365067|NCT02544763|454630419|FG000|Overall Study|Withdrawn by parent/guardian|1|||
126365068|NCT02544763|454630420|FG001|Overall Study|Withdrawn by parent/guardian|1|||
126365069|NCT02544763|454630421|FG002|Overall Study|Withdrawn by parent/guardian|1|||
126365070|NCT02544763|454630419|FG000|Overall Study|Met withdrawal criteria|0|||
126365071|NCT02544763|454630420|FG001|Overall Study|Met withdrawal criteria|2|||
126365072|NCT02544763|454630421|FG002|Overall Study|Met withdrawal criteria|0|||
126365073|NCT02544763|454630419|FG000|Overall Study|Physician Decision|0|||
126365074|NCT02544763|454630420|FG001|Overall Study|Physician Decision|1|||
126365075|NCT02544763|454630421|FG002|Overall Study|Physician Decision|0|||
126365076|NCT02544763|454630419|FG000|Overall Study|Difficulties taking IMP|1|||
126365077|NCT02544763|454630420|FG001|Overall Study|Difficulties taking IMP|0|||
126365078|NCT02544763|454630421|FG002|Overall Study|Difficulties taking IMP|0|||
126365079|NCT04755231|454630422|FG000|Overall Study|Lost to Follow-up|5|||
126365080|NCT04755231|454630422|FG000|Overall Study|Withdrawal by Subject|5|||
126365081|NCT02613507|454630431|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
126365082|NCT02613507|454630432|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
126365083|NCT02613507|454630431|FG000|Pre-Treamtent|Participant withdrew consent|0|||
126365084|NCT02613507|454630432|FG001|Pre-Treamtent|Participant withdrew consent|4|||
126285081|NCT01098487|454331136|FG000|Overall Study|Physician Decision|1|||
126549264|NCT02105636|455305587|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
126549265|NCT02105636|455305588|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
126549266|NCT02105636|455305587|FG000|Treatment|Study Drug Toxicity|14|||
126549267|NCT02105636|455305588|FG001|Treatment|Study Drug Toxicity|10|||
126549268|NCT02105636|455305587|FG000|Treatment|Adverse event unrelated to study drug|19|||
126549269|NCT02105636|455305588|FG001|Treatment|Adverse event unrelated to study drug|3|||
126549270|NCT02105636|455305587|FG000|Treatment|Participant request to discontinue study treatment|8|||
126549271|NCT02105636|455305588|FG001|Treatment|Participant request to discontinue study treatment|6|||
126549272|NCT02105636|455305587|FG000|Treatment|Participant withdrew consent|5|||
126549273|NCT02105636|455305588|FG001|Treatment|Participant withdrew consent|1|||
126549274|NCT02105636|455305587|FG000|Treatment|Lost to Follow-up|1|||
126549275|NCT02105636|455305588|FG001|Treatment|Lost to Follow-up|0|||
126549276|NCT02105636|455305587|FG000|Treatment|Maximum Clinical Benefit|1|||
126549277|NCT02105636|455305588|FG001|Treatment|Maximum Clinical Benefit|3|||
126549278|NCT02105636|455305587|FG000|Treatment|Poor/Non-compliance|0|||
126549279|NCT02105636|455305588|FG001|Treatment|Poor/Non-compliance|1|||
126285082|NCT00345631|454331137|FG000|Overall Study|Withdrawal by Subject|1|||
126285083|NCT00345631|454331138|FG001|Overall Study|Withdrawal by Subject|0|||
126285084|NCT00345631|454331139|FG002|Overall Study|Withdrawal by Subject|1|||
126285085|NCT00345631|454331137|FG000|Overall Study|Adverse Event|0|||
126285086|NCT00345631|454331138|FG001|Overall Study|Adverse Event|1|||
126285087|NCT00345631|454331139|FG002|Overall Study|Adverse Event|0|||
126285088|NCT00345631|454331137|FG000|Overall Study|Lost to Follow-up|3|||
126285089|NCT00345631|454331138|FG001|Overall Study|Lost to Follow-up|7|||
126285090|NCT00345631|454331139|FG002|Overall Study|Lost to Follow-up|4|||
126285091|NCT00345631|454331137|FG000|Overall Study|Other reasons|0|||
126285092|NCT00345631|454331138|FG001|Overall Study|Other reasons|0|||
126285093|NCT00345631|454331139|FG002|Overall Study|Other reasons|1|||
126285094|NCT01885195|454331140|FG000|Overall Study|Adverse Event|29|||
126285095|NCT01885195|454331140|FG000|Overall Study|Death|1|||
126285096|NCT01885195|454331140|FG000|Overall Study|Disease Progression|67|||
126285097|NCT01885195|454331140|FG000|Overall Study|Protocol Deviation|2|||
126285098|NCT01885195|454331140|FG000|Overall Study|Physician Decision|3|||
126285099|NCT01885195|454331140|FG000|Overall Study|Patient/guardian decision|8|||
126285100|NCT00509795|454331143|FG000|Overall Study|Adverse Event|4|||
126285101|NCT00509795|454331144|FG001|Overall Study|Adverse Event|3|||
126285102|NCT00509795|454331145|FG002|Overall Study|Adverse Event|5|||
126285103|NCT00509795|454331146|FG003|Overall Study|Adverse Event|4|||
126285104|NCT00509795|454331143|FG000|Overall Study|Death|3|||
126285105|NCT00509795|454331144|FG001|Overall Study|Death|1|||
126285106|NCT00509795|454331145|FG002|Overall Study|Death|2|||
126285107|NCT00509795|454331146|FG003|Overall Study|Death|7|||
126285108|NCT00509795|454331143|FG000|Overall Study|Lack of Efficacy|0|||
126285109|NCT00509795|454331144|FG001|Overall Study|Lack of Efficacy|0|||
126285110|NCT00509795|454331145|FG002|Overall Study|Lack of Efficacy|2|||
126285111|NCT00509795|454331146|FG003|Overall Study|Lack of Efficacy|2|||
126285112|NCT00509795|454331143|FG000|Overall Study|Lost to Follow-up|1|||
126285113|NCT00509795|454331144|FG001|Overall Study|Lost to Follow-up|2|||
126285114|NCT00509795|454331145|FG002|Overall Study|Lost to Follow-up|4|||
126285115|NCT00509795|454331146|FG003|Overall Study|Lost to Follow-up|4|||
126285116|NCT00509795|454331143|FG000|Overall Study|OTHER|1|||
126285117|NCT00509795|454331144|FG001|Overall Study|OTHER|0|||
126285118|NCT00509795|454331145|FG002|Overall Study|OTHER|4|||
126285119|NCT00509795|454331146|FG003|Overall Study|OTHER|1|||
126285120|NCT00509795|454331143|FG000|Overall Study|Protocol Violation|3|||
126285121|NCT00509795|454331144|FG001|Overall Study|Protocol Violation|0|||
126285122|NCT00509795|454331145|FG002|Overall Study|Protocol Violation|3|||
126285123|NCT00509795|454331146|FG003|Overall Study|Protocol Violation|1|||
126285124|NCT00509795|454331143|FG000|Overall Study|Withdrawal by Subject|10|||
126285125|NCT00509795|454331144|FG001|Overall Study|Withdrawal by Subject|5|||
126285126|NCT00509795|454331145|FG002|Overall Study|Withdrawal by Subject|7|||
126285127|NCT00509795|454331146|FG003|Overall Study|Withdrawal by Subject|8|||
126285128|NCT00912912|454331150|FG000|Overall Study|Withdrawal by Subject|1|||
126285129|NCT00912912|454331150|FG000|Overall Study|Disease Progression|3|||
126285130|NCT00306995|454331151|FG000|Study Part I|Withdrawal by Subject|0|||
126709329|NCT00923091|455887958|FG007|Period VI (Open-Label)|Protocol Violation|0|||
126285131|NCT00306995|454331152|FG001|Study Part I|Withdrawal by Subject|0|||
126285132|NCT00306995|454331153|FG002|Study Part I|Withdrawal by Subject|0|||
126709330|NCT00923091|455887959|FG008|Period VI (Open-Label)|Protocol Violation|0|||
126285133|NCT00306995|454331154|FG003|Study Part I|Withdrawal by Subject|0|||
126285134|NCT00306995|454331155|FG004|Study Part I|Withdrawal by Subject|0|||
126285135|NCT00306995|454331156|FG005|Study Part I|Withdrawal by Subject|0|||
126285136|NCT00306995|454331157|FG006|Study Part I|Withdrawal by Subject|1|||
126285137|NCT00306995|454331151|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
126285138|NCT00306995|454331152|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
126549280|NCT02105636|455305587|FG000|Treatment|Participant no longer meets study criteria|1|||
126549281|NCT02105636|455305588|FG001|Treatment|Participant no longer meets study criteria|0|||
126549282|NCT02105636|455305587|FG000|Treatment|Other reasons|1|||
126285139|NCT00306995|454331153|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
126285140|NCT00306995|454331154|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
126285141|NCT00306995|454331155|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
126285142|NCT00306995|454331156|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
126285143|NCT00306995|454331157|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
126285144|NCT04324073|454332903|FG000|Overall Study|withdrew consent|0|||
126285145|NCT04324073|454332904|FG001|Overall Study|withdrew consent|4|||
126285146|NCT04324073|454332905|FG002|Overall Study|withdrew consent|2|||
126285147|NCT04324073|454332906|FG003|Overall Study|withdrew consent|8|||
126285148|NCT05833139|454332907|FG000|Study Period 2|Adverse Event|1|||
126285149|NCT00371033|454332908|FG000|Overall Study|Lost to Follow-up|3|||
126285150|NCT00371033|454332909|FG001|Overall Study|Lost to Follow-up|2|||
126285151|NCT00371033|454332908|FG000|Overall Study|No longer interested|2|||
126285152|NCT00371033|454332909|FG001|Overall Study|No longer interested|0|||
126285153|NCT00371033|454332908|FG000|Overall Study|Uknown|3|||
126285154|NCT00371033|454332909|FG001|Overall Study|Uknown|1|||
126285155|NCT04158245|454332910|FG000|Overall Study|Lost to Follow-up|1|||
126285156|NCT03842228|454332913|FG000|Overall Study|Adverse Event|1|||
126285157|NCT03842228|454332914|FG001|Overall Study|Adverse Event|1|||
126285158|NCT03842228|454332915|FG002|Overall Study|Adverse Event|1|||
126285159|NCT03842228|454332916|FG003|Overall Study|Adverse Event|0|||
126285160|NCT03842228|454332917|FG004|Overall Study|Adverse Event|0|||
126285161|NCT03842228|454332918|FG005|Overall Study|Adverse Event|0|||
126285162|NCT03842228|454332919|FG006|Overall Study|Adverse Event|0|||
126285163|NCT03842228|454332913|FG000|Overall Study|Death|0|||
126285164|NCT03842228|454332914|FG001|Overall Study|Death|1|||
126285165|NCT03842228|454332915|FG002|Overall Study|Death|0|||
126285166|NCT03842228|454332916|FG003|Overall Study|Death|0|||
126285167|NCT03842228|454332917|FG004|Overall Study|Death|0|||
126285168|NCT03842228|454332918|FG005|Overall Study|Death|0|||
126285169|NCT03842228|454332919|FG006|Overall Study|Death|0|||
126285170|NCT03842228|454332913|FG000|Overall Study|Withdrawal by Subject|0|||
126285171|NCT03842228|454332914|FG001|Overall Study|Withdrawal by Subject|0|||
126285172|NCT03842228|454332915|FG002|Overall Study|Withdrawal by Subject|2|||
126285173|NCT03842228|454332916|FG003|Overall Study|Withdrawal by Subject|1|||
126285174|NCT03842228|454332917|FG004|Overall Study|Withdrawal by Subject|0|||
126285175|NCT03842228|454332918|FG005|Overall Study|Withdrawal by Subject|0|||
126285176|NCT03842228|454332919|FG006|Overall Study|Withdrawal by Subject|2|||
126285177|NCT03842228|454332913|FG000|Overall Study|Progression|8|||
126285178|NCT03842228|454332914|FG001|Overall Study|Progression|1|||
126285179|NCT03842228|454332915|FG002|Overall Study|Progression|7|||
126285180|NCT03842228|454332916|FG003|Overall Study|Progression|5|||
126285181|NCT03842228|454332917|FG004|Overall Study|Progression|4|||
126285182|NCT03842228|454332918|FG005|Overall Study|Progression|2|||
126285183|NCT03842228|454332919|FG006|Overall Study|Progression|3|||
126285184|NCT02567435|454332920|FG000|Overall Study|Death|1|||
126456488|NCT01917656|454970922|FG000|Overall Study|Withdrawal criteria|8|||
126285185|NCT02567435|454332921|FG001|Overall Study|Death|1|||
126285186|NCT02567435|454332922|FG002|Overall Study|Death|0|||
126285187|NCT02567435|454332923|FG003|Overall Study|Death|0|||
126285188|NCT02567435|454332920|FG000|Overall Study|Ineligible|1|||
126285189|NCT02567435|454332921|FG001|Overall Study|Ineligible|3|||
126285190|NCT02567435|454332922|FG002|Overall Study|Ineligible|0|||
126285191|NCT02567435|454332923|FG003|Overall Study|Ineligible|0|||
126285192|NCT02567435|454332920|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
126285193|NCT02567435|454332921|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
126285194|NCT02567435|454332922|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
126456489|NCT01917656|454970923|FG001|Overall Study|Withdrawal criteria|14|||
126456490|NCT01917656|454970922|FG000|Overall Study|Unclassified|0|||
126456491|NCT01917656|454970923|FG001|Overall Study|Unclassified|3|||
126456492|NCT01917656|454970922|FG000|Overall Study|Withdrawal by Subject|4|||
126456493|NCT01917656|454970923|FG001|Overall Study|Withdrawal by Subject|3|||
126456494|NCT01917656|454970922|FG000|Overall Study|Lost to Follow-up|3|||
126456495|NCT01917656|454970923|FG001|Overall Study|Lost to Follow-up|4|||
126456496|NCT02081859|454970924|FG000|Overall Study|No fertilization|2|||
126456497|NCT02081859|454970925|FG001|Overall Study|No fertilization|2|||
126456498|NCT02081859|454970924|FG000|Overall Study|No sperm|1|||
126456499|NCT02081859|454970925|FG001|Overall Study|No sperm|0|||
126456500|NCT02081859|454970924|FG000|Overall Study|Unanticipated freeze all cycle|2|||
126456501|NCT02081859|454970925|FG001|Overall Study|Unanticipated freeze all cycle|6|||
126456502|NCT02081859|454970924|FG000|Overall Study|< 4 embryos|27|||
126456503|NCT02081859|454970925|FG001|Overall Study|< 4 embryos|23|||
126456504|NCT02081859|454970924|FG000|Overall Study|Other reasons|2|||
126456505|NCT02081859|454970925|FG001|Overall Study|Other reasons|0|||
126456506|NCT00492063|454970932|FG000|Overall Study|Death|0|||
126456507|NCT00492063|454970933|FG001|Overall Study|Death|0|||
126456508|NCT00492063|454970934|FG002|Overall Study|Death|1|||
126456509|NCT00492063|454970935|FG003|Overall Study|Death|2|||
126456510|NCT00492063|454970932|FG000|Overall Study|Withdrawal by Subject|4|||
126456511|NCT00492063|454970933|FG001|Overall Study|Withdrawal by Subject|3|||
126709331|NCT00923091|455887960|FG009|Period VI (Open-Label)|Protocol Violation|0|||
126709332|NCT00923091|455887961|FG010|Period VI (Open-Label)|Protocol Violation|0|||
126709333|NCT00923091|455887962|FG011|Period VI (Open-Label)|Protocol Violation|0|||
126709334|NCT00923091|455887963|FG012|Period VI (Open-Label)|Protocol Violation|0|||
126709335|NCT00923091|455887951|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
126709336|NCT00923091|455887952|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
126709337|NCT00923091|455887953|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
126709338|NCT00923091|455887954|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
126709339|NCT00923091|455887955|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
126709340|NCT00923091|455887956|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
126709341|NCT00923091|455887957|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
126709342|NCT00923091|455887958|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
126709343|NCT00923091|455887959|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
126709344|NCT00923091|455887960|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
126709345|NCT00923091|455887961|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
126709346|NCT00923091|455887962|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
126709347|NCT00923091|455887963|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
126709348|NCT00923091|455887951|FG000|Period VI (Open-Label)|Other Reason|0|||
126709349|NCT00923091|455887952|FG001|Period VI (Open-Label)|Other Reason|0|||
126709350|NCT00923091|455887953|FG002|Period VI (Open-Label)|Other Reason|0|||
126709351|NCT00923091|455887954|FG003|Period VI (Open-Label)|Other Reason|1|||
126709352|NCT00923091|455887955|FG004|Period VI (Open-Label)|Other Reason|1|||
126709353|NCT00923091|455887956|FG005|Period VI (Open-Label)|Other Reason|0|||
126709354|NCT00923091|455887957|FG006|Period VI (Open-Label)|Other Reason|0|||
126709355|NCT00923091|455887958|FG007|Period VI (Open-Label)|Other Reason|0|||
126709356|NCT00923091|455887959|FG008|Period VI (Open-Label)|Other Reason|0|||
126709357|NCT00923091|455887960|FG009|Period VI (Open-Label)|Other Reason|0|||
126709358|NCT00923091|455887961|FG010|Period VI (Open-Label)|Other Reason|0|||
126709359|NCT00923091|455887962|FG011|Period VI (Open-Label)|Other Reason|0|||
126709360|NCT00923091|455887963|FG012|Period VI (Open-Label)|Other Reason|0|||
126709361|NCT00467649|455887964|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
126709362|NCT00467649|455887965|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
126709363|NCT00467649|455887966|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
126709364|NCT00467649|455887967|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
126709365|NCT00467649|455887968|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
126709366|NCT00467649|455887969|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
126709367|NCT00467649|455887964|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
126709368|NCT00467649|455887965|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
126709369|NCT00467649|455887966|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
126285195|NCT02567435|454332923|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
126285196|NCT06390826|454332924|FG000|Overall Study|Never Start Protocol Therapy|1|||
126285197|NCT06390826|454332924|FG000|Overall Study|Adverse Event|1|||
126285198|NCT06390826|454332924|FG000|Overall Study|Disease Progression|8|||
126285199|NCT04458922|454332926|FG000|Overall Study|Withdrawal by Subject|1|||
126285200|NCT04458922|454332927|FG001|Overall Study|Withdrawal by Subject|0|||
126285201|NCT04458922|454332928|FG002|Overall Study|Withdrawal by Subject|2|||
126285202|NCT04458922|454332926|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
126285203|NCT04458922|454332927|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
126285204|NCT04458922|454332928|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
126285205|NCT04458922|454332926|FG000|Overall Study|Adverse Event|1|||
126285206|NCT04458922|454332927|FG001|Overall Study|Adverse Event|0|||
126285207|NCT04458922|454332928|FG002|Overall Study|Adverse Event|0|||
126285208|NCT04458922|454332926|FG000|Overall Study|Started new study|0|||
126285209|NCT04458922|454332927|FG001|Overall Study|Started new study|0|||
126285210|NCT04458922|454332928|FG002|Overall Study|Started new study|1|||
126285211|NCT04458922|454332926|FG000|Overall Study|Progressive disease|6|||
126285212|NCT04458922|454332927|FG001|Overall Study|Progressive disease|8|||
126285213|NCT04458922|454332928|FG002|Overall Study|Progressive disease|2|||
126285214|NCT04458922|454332926|FG000|Overall Study|Death|1|||
126285215|NCT04458922|454332927|FG001|Overall Study|Death|0|||
126285216|NCT04458922|454332928|FG002|Overall Study|Death|2|||
126285217|NCT04458922|454332926|FG000|Overall Study|Participant started chemotherapy|0|||
126285218|NCT04458922|454332927|FG001|Overall Study|Participant started chemotherapy|1|||
126285219|NCT04458922|454332928|FG002|Overall Study|Participant started chemotherapy|0|||
126285220|NCT06351371|454332929|FG000|Overall Study|Mutation Status Not Confirmed|9|||
126285221|NCT06351371|454332929|FG000|Overall Study|Ineligible|1|||
126285222|NCT06351371|454332929|FG000|Overall Study|Adverse Event|4|||
126285223|NCT06351371|454332929|FG000|Overall Study|Death|1|||
126709370|NCT00467649|455887967|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
126709371|NCT00467649|455887968|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
126709372|NCT00467649|455887969|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
126709373|NCT00467649|455887964|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
126709374|NCT00467649|455887965|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
126709375|NCT00467649|455887966|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
126285224|NCT06351371|454332929|FG000|Overall Study|Disease progression|14|||
126285225|NCT06351371|454332929|FG000|Overall Study|Withdrawal by Subject|3|||
126285226|NCT06351371|454332929|FG000|Overall Study|Physician Decision|3|||
126285227|NCT04856930|454332931|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
126285228|NCT04856930|454332932|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
126285229|NCT04856930|454332933|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
126285230|NCT04856930|454332931|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
126285231|NCT04856930|454332932|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
126285232|NCT04856930|454332933|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
126285233|NCT04856930|454332931|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
126285234|NCT04856930|454332932|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
126285235|NCT04856930|454332933|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
126285236|NCT04856930|454332931|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
126285237|NCT04856930|454332932|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
126285238|NCT04856930|454332933|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
126285239|NCT04856930|454332931|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
126285240|NCT04856930|454332932|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
126285241|NCT04856930|454332933|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
126285242|NCT04856930|454332931|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
126285243|NCT04856930|454332932|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
126285244|NCT04856930|454332933|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
126285245|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
126285246|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
126285247|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
126285248|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
126285249|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
126285250|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
126285251|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
126285252|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
126285253|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
126285254|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
126285255|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
126285256|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
126285257|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
126285258|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
126285259|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
126285260|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
126285261|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
126285262|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
126285263|NCT04856930|454332931|FG000|Extension Period (16 Weeks)|Other than specified|0|||
126285264|NCT04856930|454332932|FG001|Extension Period (16 Weeks)|Other than specified|0|||
126285265|NCT04856930|454332933|FG002|Extension Period (16 Weeks)|Other than specified|1|||
126285266|NCT04856930|454332931|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
126285267|NCT04856930|454332932|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
126285268|NCT04856930|454332933|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
126285269|NCT04856930|454332931|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
126285270|NCT04856930|454332932|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
126285271|NCT04856930|454332933|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
126285272|NCT04856930|454332931|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
126285273|NCT04856930|454332932|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
126285274|NCT04856930|454332933|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
126285275|NCT04856930|454332931|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
126285276|NCT04856930|454332932|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
126285277|NCT04856930|454332933|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
126285278|NCT01009814|454332934|FG000|Overall Study|No longer met study criteria|1|||
126285279|NCT01009814|454332935|FG001|Overall Study|No longer met study criteria|1|||
126285280|NCT01009814|454332936|FG002|Overall Study|No longer met study criteria|0|||
126709376|NCT00467649|455887967|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
126709377|NCT00467649|455887968|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
126285281|NCT01009814|454332937|FG003|Overall Study|No longer met study criteria|0|||
126285282|NCT01009814|454332938|FG004|Overall Study|No longer met study criteria|0|||
126285283|NCT00618371|454332939|FG000|Overall Study|Withdrawal by Subject|2|||
126285284|NCT03965689|454332942|FG000|Overall Study|Too sick to get study intervention|2|||
126285285|NCT03022084|454332943|FG000|Overall Study|Lost to Follow-up|2|||
126285286|NCT03022084|454332944|FG001|Overall Study|Lost to Follow-up|3|||
126549283|NCT02105636|455305588|FG001|Treatment|Other reasons|0|||
126285287|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
126285288|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
126285289|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
126285290|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
126285291|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
126285292|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
126285293|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
126285294|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
126285295|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
126285296|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
126285297|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
126285298|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
126285299|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
126285300|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
126285301|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
126285302|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
126285303|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
126285304|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
126285305|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
126285306|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
126285307|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
126285308|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
126285309|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
126285310|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
126285311|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
126285312|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
126285313|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
126285314|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
126285315|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
126285316|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
126285317|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
126285318|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
126285319|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
126285320|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
126285321|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
126285322|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
126285323|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
126285324|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
126285325|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
126285326|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
126285327|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285328|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285329|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285330|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
126285331|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285332|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285333|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285334|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285335|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285336|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
126285337|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
126285338|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
126285339|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
126285340|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
126285341|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
126285342|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
126285343|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
126285344|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
126285345|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
126285346|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
126285347|NCT03104400|454332945|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285348|NCT03104400|454332946|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285349|NCT03104400|454332947|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285350|NCT03104400|454332948|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
126285351|NCT03104400|454332949|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285352|NCT03104400|454332950|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285353|NCT03104400|454332951|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285354|NCT03104400|454332952|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285355|NCT03104400|454332953|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285356|NCT03104400|454332954|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
126285357|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
126285358|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
126285359|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
126285360|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
126285361|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
126285362|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
126285363|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
126285364|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
126285365|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
126285366|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
126285367|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
126285368|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
126285369|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
126285370|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
126285371|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
126285372|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
126285373|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
126285374|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
126285375|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
126285376|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
126285377|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
126285378|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
126285379|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
126285380|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
126285381|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
126285382|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
126285383|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
126285384|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
126285385|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
126285386|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
126285387|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
126285388|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
126285389|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
126285390|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
126285391|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
126285392|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
126285393|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
126285394|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
126285395|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
126285396|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
126285397|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285398|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285399|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285400|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285401|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285402|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285403|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
126285404|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
126285405|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
126285406|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
126285407|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285408|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285409|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285410|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285411|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285412|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285413|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285414|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
126285415|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
126365085|NCT02613507|454630431|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
126285416|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
126285417|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
126285418|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
126365086|NCT02613507|454630432|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
126365087|NCT02613507|454630431|FG000|Treatment|Not reported|3|||
126365088|NCT02613507|454630432|FG001|Treatment|Not reported|0|||
126365089|NCT02613507|454630431|FG000|Treatment|Other reasons|8|||
126365090|NCT02613507|454630432|FG001|Treatment|Other reasons|0|||
126365091|NCT02613507|454630431|FG000|Treatment|Participant no longer meets criteria|3|||
126365092|NCT02613507|454630432|FG001|Treatment|Participant no longer meets criteria|0|||
126365093|NCT02613507|454630431|FG000|Treatment|Maximum clinical benefit|5|||
126365094|NCT02613507|454630432|FG001|Treatment|Maximum clinical benefit|10|||
126365095|NCT02613507|454630431|FG000|Treatment|Lost to Follow-up|1|||
126365096|NCT02613507|454630432|FG001|Treatment|Lost to Follow-up|0|||
126365097|NCT02613507|454630431|FG000|Treatment|Participant withdrew consent|0|||
126285419|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
126285420|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
126285421|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
126285422|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
126285423|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
126285424|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
126285425|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
126285426|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
126285427|NCT03104400|454332945|FG000|Period 2 Week 56 - 260)|Other|0|||
126285428|NCT03104400|454332946|FG001|Period 2 Week 56 - 260)|Other|0|||
126285429|NCT03104400|454332947|FG002|Period 2 Week 56 - 260)|Other|0|||
126285430|NCT03104400|454332948|FG003|Period 2 Week 56 - 260)|Other|0|||
126285431|NCT03104400|454332949|FG004|Period 2 Week 56 - 260)|Other|0|||
126285432|NCT03104400|454332950|FG005|Period 2 Week 56 - 260)|Other|0|||
126285433|NCT03104400|454332951|FG006|Period 2 Week 56 - 260)|Other|0|||
126285434|NCT03104400|454332952|FG007|Period 2 Week 56 - 260)|Other|0|||
126285435|NCT03104400|454332953|FG008|Period 2 Week 56 - 260)|Other|1|||
126285436|NCT03104400|454332954|FG009|Period 2 Week 56 - 260)|Other|1|||
126285437|NCT04948333|454332955|FG000|Overall Study|Adverse Event|6|||
126285438|NCT04948333|454332956|FG001|Overall Study|Adverse Event|4|||
126285439|NCT04948333|454332957|FG002|Overall Study|Adverse Event|0|||
126285440|NCT04948333|454332958|FG003|Overall Study|Adverse Event|2|||
126285441|NCT04948333|454332955|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
126285442|NCT04948333|454332956|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126285443|NCT04948333|454332957|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126285444|NCT04948333|454332958|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126285445|NCT04948333|454332955|FG000|Overall Study|Progressive Disease|1|||
126285446|NCT04948333|454332956|FG001|Overall Study|Progressive Disease|5|||
126285447|NCT04948333|454332957|FG002|Overall Study|Progressive Disease|0|||
126285448|NCT04948333|454332958|FG003|Overall Study|Progressive Disease|0|||
126285449|NCT04948333|454332955|FG000|Overall Study|Physician Decision|2|||
126285450|NCT04948333|454332956|FG001|Overall Study|Physician Decision|2|||
126285451|NCT04948333|454332957|FG002|Overall Study|Physician Decision|0|||
126285452|NCT04948333|454332958|FG003|Overall Study|Physician Decision|0|||
126285453|NCT04948333|454332955|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
126285454|NCT04948333|454332956|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
126285455|NCT04948333|454332957|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
126285456|NCT04948333|454332958|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
126285457|NCT04948333|454332955|FG000|Overall Study|Withdrawal by Subject|2|||
126285458|NCT04948333|454332956|FG001|Overall Study|Withdrawal by Subject|0|||
126285459|NCT04948333|454332957|FG002|Overall Study|Withdrawal by Subject|0|||
126285460|NCT04948333|454332958|FG003|Overall Study|Withdrawal by Subject|1|||
126285461|NCT04948333|454332955|FG000|Overall Study|Protocol Violation|0|||
126285462|NCT04948333|454332956|FG001|Overall Study|Protocol Violation|1|||
126285463|NCT04948333|454332957|FG002|Overall Study|Protocol Violation|0|||
126285464|NCT04948333|454332958|FG003|Overall Study|Protocol Violation|0|||
126285465|NCT04948333|454332955|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
126285466|NCT04948333|454332956|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
126285467|NCT04948333|454332957|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
126285468|NCT04948333|454332958|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
126285469|NCT01625988|454332959|FG000|Overall Study|Lost to Follow-up|5|||
126285470|NCT01625988|454332960|FG001|Overall Study|Lost to Follow-up|6|||
126285471|NCT01625988|454332959|FG000|Overall Study|Withdrawal by Subject|8|||
126456512|NCT00492063|454970934|FG002|Overall Study|Withdrawal by Subject|5|||
126456513|NCT00492063|454970935|FG003|Overall Study|Withdrawal by Subject|4|||
126456514|NCT00492063|454970932|FG000|Overall Study|Lost to Follow-up|6|||
126456515|NCT00492063|454970933|FG001|Overall Study|Lost to Follow-up|11|||
126456516|NCT00492063|454970934|FG002|Overall Study|Lost to Follow-up|5|||
126456517|NCT00492063|454970935|FG003|Overall Study|Lost to Follow-up|3|||
126456518|NCT00492063|454970932|FG000|Overall Study|Protocol Violation|0|||
126456519|NCT00492063|454970933|FG001|Overall Study|Protocol Violation|0|||
126456520|NCT00492063|454970934|FG002|Overall Study|Protocol Violation|0|||
126456521|NCT00492063|454970935|FG003|Overall Study|Protocol Violation|1|||
126285472|NCT01625988|454332960|FG001|Overall Study|Withdrawal by Subject|3|||
126456522|NCT01870076|454970936|FG000|Overall Study|Withdrawal by Subject|1|||
126549284|NCT02105636|455305587|FG000|Treatment|Disease Progression|185|||
126285473|NCT01625988|454332959|FG000|Overall Study|Adverse Event|0|||
126285474|NCT01625988|454332960|FG001|Overall Study|Adverse Event|1|||
126285475|NCT01625988|454332959|FG000|Overall Study|Lack of Efficacy|0|||
126285476|NCT01625988|454332960|FG001|Overall Study|Lack of Efficacy|1|||
126285477|NCT01625988|454332959|FG000|Overall Study|Randomized Inappropriately|1|||
126285478|NCT01625988|454332960|FG001|Overall Study|Randomized Inappropriately|0|||
126456523|NCT01870076|454970937|FG001|Overall Study|Withdrawal by Subject|0|||
126456524|NCT01870076|454970938|FG002|Overall Study|Withdrawal by Subject|1|||
126456525|NCT01870076|454970939|FG003|Overall Study|Withdrawal by Subject|0|||
126549285|NCT02105636|455305588|FG001|Treatment|Disease Progression|87|||
126549286|NCT00871351|455305589|FG000|Overall Study|Withdrawal by Subject|1|||
126549287|NCT00871351|455305590|FG001|Overall Study|Withdrawal by Subject|0|||
126549288|NCT00871351|455305591|FG002|Overall Study|Withdrawal by Subject|0|||
126549289|NCT00871351|455305589|FG000|Overall Study|Adverse Event|3|||
126549290|NCT00871351|455305590|FG001|Overall Study|Adverse Event|1|||
126549291|NCT00871351|455305591|FG002|Overall Study|Adverse Event|0|||
126549292|NCT02791490|455305593|FG000|Overall Study|Lost to Follow-up|1|||
126549293|NCT02791490|455305594|FG001|Overall Study|Lost to Follow-up|2|||
126549294|NCT02791490|455305593|FG000|Overall Study|Withdrawal by Subject|2|||
126549295|NCT02791490|455305594|FG001|Overall Study|Withdrawal by Subject|6|||
126549296|NCT01984424|455305595|FG000|Overall Study|Withdrawal by Subject|3|||
126549297|NCT01984424|455305596|FG001|Overall Study|Withdrawal by Subject|5|||
126549298|NCT01984424|455305595|FG000|Overall Study|Sponsor Decision|0|||
126549299|NCT01984424|455305596|FG001|Overall Study|Sponsor Decision|1|||
126549300|NCT01984424|455305595|FG000|Overall Study|Lost to Follow-up|0|||
126549301|NCT01984424|455305596|FG001|Overall Study|Lost to Follow-up|1|||
126549302|NCT00077636|455305598|FG000|Overall Study|Refused Treatment|9|||
126549303|NCT00077636|455305599|FG001|Overall Study|Refused Treatment|31|||
126549304|NCT00077636|455305598|FG000|Overall Study|Admin|3|||
126549305|NCT00077636|455305599|FG001|Overall Study|Admin|3|||
126549306|NCT00077636|455305598|FG000|Overall Study|Withdrawal by Subject|2|||
126549307|NCT00077636|455305599|FG001|Overall Study|Withdrawal by Subject|2|||
126549308|NCT00077636|455305598|FG000|Overall Study|Adverse Event|17|||
126549309|NCT00077636|455305599|FG001|Overall Study|Adverse Event|34|||
126549310|NCT00077636|455305598|FG000|Overall Study|Protocol Violation|0|||
126549311|NCT00077636|455305599|FG001|Overall Study|Protocol Violation|2|||
126549312|NCT00077636|455305598|FG000|Overall Study|Lost to Follow-up|10|||
126549313|NCT00077636|455305599|FG001|Overall Study|Lost to Follow-up|18|||
126549314|NCT00077636|455305598|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
126549315|NCT00077636|455305599|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
126549316|NCT02032173|455305600|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
126549317|NCT01993017|455305603|FG000|Overall Study|Death|23|||
126549318|NCT01993017|455305604|FG001|Overall Study|Death|26|||
126549319|NCT01993017|455305605|FG002|Overall Study|Death|18|||
126549320|NCT01993017|455305603|FG000|Overall Study|Could not be contacted|43|||
126549321|NCT01993017|455305604|FG001|Overall Study|Could not be contacted|42|||
126549322|NCT01993017|455305605|FG002|Overall Study|Could not be contacted|38|||
126549323|NCT01993017|455305603|FG000|Overall Study|Dropped out|19|||
126549324|NCT01993017|455305604|FG001|Overall Study|Dropped out|6|||
126549325|NCT01993017|455305605|FG002|Overall Study|Dropped out|11|||
126549326|NCT01993017|455305603|FG000|Overall Study|Other reasons|17|||
126549327|NCT01993017|455305604|FG001|Overall Study|Other reasons|11|||
126285479|NCT01625988|454332959|FG000|Overall Study|Protocol Violation|0|||
126285480|NCT01625988|454332960|FG001|Overall Study|Protocol Violation|2|||
126285481|NCT01121562|454332961|FG000|Overall Study|Objective progression or relapse|8|||
126285482|NCT01121562|454332961|FG000|Overall Study|Withdrawal by Subject|1|||
126285483|NCT01121562|454332961|FG000|Overall Study|Adverse Event|1|||
126285484|NCT01121562|454332961|FG000|Overall Study|Sponsor Decision|1|||
126285485|NCT01121562|454332961|FG000|Overall Study|Met study discontinuation criteria|1|||
126285486|NCT01495702|454332962|FG000|Randomized Phase|Randomized But Not Treated|1|||
126285487|NCT01495702|454332963|FG001|Randomized Phase|Randomized But Not Treated|4|||
126285488|NCT01495702|454332962|FG000|Randomized Phase|Adverse Event|2|||
126285489|NCT01495702|454332963|FG001|Randomized Phase|Adverse Event|2|||
126285490|NCT01495702|454332962|FG000|Randomized Phase|Death|1|||
126285491|NCT01495702|454332963|FG001|Randomized Phase|Death|0|||
126285492|NCT01495702|454332962|FG000|Randomized Phase|Lack of Efficacy|2|||
126285493|NCT01495702|454332963|FG001|Randomized Phase|Lack of Efficacy|0|||
126285494|NCT01495702|454332962|FG000|Randomized Phase|Investigators Discretion|2|||
126285495|NCT01495702|454332963|FG001|Randomized Phase|Investigators Discretion|0|||
126285496|NCT01495702|454332962|FG000|Randomized Phase|Withdrew Consent|10|||
126285497|NCT01495702|454332963|FG001|Randomized Phase|Withdrew Consent|18|||
126285498|NCT01495702|454332962|FG000|Randomized Phase|Lost to Follow-up|4|||
126285499|NCT01495702|454332963|FG001|Randomized Phase|Lost to Follow-up|3|||
126285500|NCT01495702|454332962|FG000|Randomized Phase|Participant Noncompliance|1|||
126285501|NCT01495702|454332963|FG001|Randomized Phase|Participant Noncompliance|0|||
126285502|NCT01495702|454332962|FG000|Randomized Phase|Protocol Violation|3|||
126549328|NCT01993017|455305605|FG002|Overall Study|Other reasons|7|||
126549329|NCT01993017|455305603|FG000|Overall Study|Ineligible after randomization|4|||
126549330|NCT01993017|455305604|FG001|Overall Study|Ineligible after randomization|5|||
126549331|NCT01993017|455305605|FG002|Overall Study|Ineligible after randomization|5|||
126549332|NCT00917267|455305607|FG000|Overall Study|Adverse Event|15|||
126549333|NCT00917267|455305608|FG001|Overall Study|Adverse Event|36|||
126549334|NCT00917267|455305607|FG000|Overall Study|Physician Decision|2|||
126549335|NCT00917267|455305608|FG001|Overall Study|Physician Decision|4|||
126549336|NCT00917267|455305607|FG000|Overall Study|Protocol Violation|9|||
126549337|NCT00917267|455305608|FG001|Overall Study|Protocol Violation|18|||
126549338|NCT00917267|455305607|FG000|Overall Study|Withdrawal by Subject|5|||
126709378|NCT00467649|455887969|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
126709379|NCT00467649|455887964|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
126285503|NCT01495702|454332963|FG001|Randomized Phase|Protocol Violation|1|||
126285504|NCT04152863|454332964|FG000|Overall Study|Death|13|||
126285505|NCT04152863|454332965|FG001|Overall Study|Death|12|||
126285506|NCT04152863|454332966|FG002|Overall Study|Death|7|||
126285507|NCT04152863|454332964|FG000|Overall Study|Physician Decision|1|||
126285508|NCT04152863|454332965|FG001|Overall Study|Physician Decision|1|||
126285509|NCT04152863|454332966|FG002|Overall Study|Physician Decision|1|||
126285510|NCT04152863|454332964|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
126285511|NCT04152863|454332965|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
126285512|NCT04152863|454332966|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
126285513|NCT04152863|454332964|FG000|Overall Study|Withdrawal by Subject|2|||
126285514|NCT04152863|454332965|FG001|Overall Study|Withdrawal by Subject|1|||
126285515|NCT04152863|454332966|FG002|Overall Study|Withdrawal by Subject|3|||
126285516|NCT01644617|454332967|FG000|Overall Study|Withdrawal by Subject|3|||
126285517|NCT01644617|454332968|FG001|Overall Study|Withdrawal by Subject|4|||
126285518|NCT01644617|454332969|FG002|Overall Study|Withdrawal by Subject|1|||
126285519|NCT01644617|454332967|FG000|Overall Study|Lost to Follow-up|0|||
126285520|NCT01644617|454332968|FG001|Overall Study|Lost to Follow-up|1|||
126285521|NCT01644617|454332969|FG002|Overall Study|Lost to Follow-up|0|||
126285522|NCT01644617|454332967|FG000|Overall Study|Adverse Event|3|||
126285523|NCT01644617|454332968|FG001|Overall Study|Adverse Event|0|||
126285524|NCT01644617|454332969|FG002|Overall Study|Adverse Event|6|||
126285525|NCT02075515|454332970|FG000|Overall Study|Serious Adverse Event|1|||
126285526|NCT02075515|454332971|FG001|Overall Study|Serious Adverse Event|1|||
126285527|NCT02075515|454332972|FG002|Overall Study|Serious Adverse Event|1|||
126285528|NCT02075515|454332970|FG000|Overall Study|Non-Serious Adverse Event|0|||
126285529|NCT02075515|454332971|FG001|Overall Study|Non-Serious Adverse Event|1|||
126285530|NCT02075515|454332972|FG002|Overall Study|Non-Serious Adverse Event|0|||
126285531|NCT02075515|454332970|FG000|Overall Study|Withdrawal by Subject|2|||
126285532|NCT02075515|454332971|FG001|Overall Study|Withdrawal by Subject|0|||
126285533|NCT02075515|454332972|FG002|Overall Study|Withdrawal by Subject|1|||
126285534|NCT02075515|454332970|FG000|Overall Study|Lost to Follow-up|1|||
126285535|NCT02075515|454332971|FG001|Overall Study|Lost to Follow-up|3|||
126285536|NCT02075515|454332972|FG002|Overall Study|Lost to Follow-up|6|||
126285537|NCT00378573|454332975|FG000|Treatment Period|Adverse Event|9|||
126285538|NCT00378573|454332975|FG000|Treatment Period|Physician Decision|1|||
126285539|NCT00378573|454332975|FG000|Treatment Period|Withdrawal by Subject|2|||
126285540|NCT00378573|454332975|FG000|Treatment Period|Disease Progression|4|||
126285541|NCT00378573|454332975|FG000|Treatment Period|Sponsor decision to close study|1|||
126285542|NCT00378573|454332975|FG000|Follow-up|Death|12|||
126285543|NCT00378573|454332975|FG000|Follow-up|Lost to Follow-up|1|||
126285544|NCT00378573|454332975|FG000|Follow-up|Withdrawal by Subject|1|||
126285545|NCT02797171|454332979|FG000|Overall Study|Lost to Follow-up|2|||
126285546|NCT02797171|454332980|FG001|Overall Study|Lost to Follow-up|0|||
126285547|NCT02797171|454332981|FG002|Overall Study|Lost to Follow-up|2|||
126285548|NCT02797171|454332982|FG003|Overall Study|Lost to Follow-up|1|||
126285549|NCT02797171|454332983|FG004|Overall Study|Lost to Follow-up|2|||
126285550|NCT02797171|454332984|FG005|Overall Study|Lost to Follow-up|0|||
126285551|NCT02797171|454332979|FG000|Overall Study|Withdrawal by Subject|1|||
126285552|NCT02797171|454332980|FG001|Overall Study|Withdrawal by Subject|1|||
126285553|NCT02797171|454332981|FG002|Overall Study|Withdrawal by Subject|0|||
126285554|NCT02797171|454332982|FG003|Overall Study|Withdrawal by Subject|0|||
126285555|NCT02797171|454332983|FG004|Overall Study|Withdrawal by Subject|0|||
126285556|NCT02797171|454332984|FG005|Overall Study|Withdrawal by Subject|0|||
126285557|NCT02797171|454332979|FG000|Overall Study|Protocol Violation|1|||
126285558|NCT02797171|454332980|FG001|Overall Study|Protocol Violation|0|||
126285559|NCT02797171|454332981|FG002|Overall Study|Protocol Violation|0|||
126285560|NCT02797171|454332982|FG003|Overall Study|Protocol Violation|0|||
126285561|NCT02797171|454332983|FG004|Overall Study|Protocol Violation|0|||
126285562|NCT02797171|454332984|FG005|Overall Study|Protocol Violation|0|||
126285563|NCT02797171|454332979|FG000|Overall Study|Participant unable to adhere|0|||
126285564|NCT02797171|454332980|FG001|Overall Study|Participant unable to adhere|1|||
126285565|NCT02797171|454332981|FG002|Overall Study|Participant unable to adhere|0|||
126285566|NCT02797171|454332982|FG003|Overall Study|Participant unable to adhere|0|||
126285567|NCT02797171|454332983|FG004|Overall Study|Participant unable to adhere|0|||
126285568|NCT02797171|454332984|FG005|Overall Study|Participant unable to adhere|0|||
126285569|NCT02797171|454332979|FG000|Overall Study|Not Randomized|0|||
126285570|NCT02797171|454332980|FG001|Overall Study|Not Randomized|0|||
126285571|NCT02797171|454332981|FG002|Overall Study|Not Randomized|0|||
126285572|NCT02797171|454332982|FG003|Overall Study|Not Randomized|0|||
126285573|NCT02797171|454332983|FG004|Overall Study|Not Randomized|0|||
126285574|NCT02797171|454332984|FG005|Overall Study|Not Randomized|1|||
126285575|NCT01427608|454332985|FG000|Overall Study|Death|1|||
126285576|NCT01427608|454332986|FG001|Overall Study|Death|0|||
126285577|NCT01427608|454332985|FG000|Overall Study|Withdrawal by Subject|7|||
126285578|NCT01427608|454332986|FG001|Overall Study|Withdrawal by Subject|3|||
126549339|NCT00917267|455305608|FG001|Overall Study|Withdrawal by Subject|12|||
126549340|NCT00917267|455305607|FG000|Overall Study|Lost to follow up|0|||
126549341|NCT00917267|455305608|FG001|Overall Study|Lost to follow up|2|||
126549342|NCT00917267|455305607|FG000|Overall Study|Entry Criteria Not Met|1|||
126549343|NCT00917267|455305608|FG001|Overall Study|Entry Criteria Not Met|0|||
126549344|NCT00917267|455305607|FG000|Overall Study|Sponsor Decision|5|||
126549345|NCT00917267|455305608|FG001|Overall Study|Sponsor Decision|5|||
126549346|NCT00917267|455305607|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
126549347|NCT00917267|455305608|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
126549348|NCT02960763|455305609|FG000|Step 1|Withdrawal by Subject|10|||
126549349|NCT02960763|455305610|FG001|Step 1|Withdrawal by Subject|8|||
126549350|NCT02960763|455305611|FG002|Step 1|Withdrawal by Subject|13|||
126549351|NCT02960763|455305612|FG003|Step 1|Withdrawal by Subject|0|||
126549352|NCT02960763|455305613|FG004|Step 1|Withdrawal by Subject|0|||
126285579|NCT01427608|454332985|FG000|Overall Study|Relapsed-all cause|13|||
126285580|NCT01427608|454332986|FG001|Overall Study|Relapsed-all cause|34|||
126285581|NCT01427608|454332985|FG000|Overall Study|Events not attributed to study meds|0|||
126285582|NCT01427608|454332986|FG001|Overall Study|Events not attributed to study meds|1|||
126285583|NCT03993379|454332987|FG000|Overall Study|The study was terminated early due to business decision.|0|||
126285584|NCT03993379|454332988|FG001|Overall Study|The study was terminated early due to business decision.|2|||
126285585|NCT03993379|454332989|FG002|Overall Study|The study was terminated early due to business decision.|0|||
126285586|NCT03993379|454332990|FG003|Overall Study|The study was terminated early due to business decision.|0|||
126285587|NCT03993379|454332987|FG000|Overall Study|Withdrawal by Subject|0|||
126285588|NCT03993379|454332988|FG001|Overall Study|Withdrawal by Subject|1|||
126285589|NCT03993379|454332989|FG002|Overall Study|Withdrawal by Subject|0|||
126285590|NCT03993379|454332990|FG003|Overall Study|Withdrawal by Subject|0|||
126285591|NCT02585778|454332995|FG000|Overall Study|Adverse Event|17|||
126285592|NCT02585778|454332996|FG001|Overall Study|Adverse Event|4|||
126285593|NCT02585778|454332995|FG000|Overall Study|Participant did not wish to continue|9|||
126285594|NCT02585778|454332996|FG001|Overall Study|Participant did not wish to continue|4|||
126549353|NCT02960763|455305609|FG000|Step 1|Lost to Follow-up|7|||
126549354|NCT02960763|455305610|FG001|Step 1|Lost to Follow-up|9|||
126549355|NCT02960763|455305611|FG002|Step 1|Lost to Follow-up|12|||
126709380|NCT00467649|455887965|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
126709381|NCT00467649|455887966|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
126709382|NCT00467649|455887967|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
126709383|NCT00467649|455887968|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
126709384|NCT00467649|455887969|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
126709385|NCT00467649|455887964|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
126709386|NCT00467649|455887965|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
126709387|NCT00467649|455887966|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
126709388|NCT00467649|455887967|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
126709389|NCT00467649|455887968|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
126709390|NCT00467649|455887969|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
126709391|NCT00467649|455887964|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
126709392|NCT00467649|455887965|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
126709393|NCT00467649|455887966|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
126709394|NCT00467649|455887967|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
126709395|NCT00467649|455887968|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
126709396|NCT00467649|455887969|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
126709397|NCT00467649|455887964|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
126709398|NCT00467649|455887965|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
126709399|NCT00467649|455887966|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
126709400|NCT00467649|455887967|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
126709401|NCT00467649|455887968|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
126709402|NCT00467649|455887969|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
126709403|NCT03233048|455887972|FG000|Overall Study|Withdrawal by Subject|1|||
126709404|NCT04222725|455887977|FG000|Overall Study|Adverse Event|0|||
126709405|NCT04222725|455887978|FG001|Overall Study|Adverse Event|1|||
126709406|NCT04222725|455887979|FG002|Overall Study|Adverse Event|0|||
126709407|NCT04222725|455887980|FG003|Overall Study|Adverse Event|0|||
126709408|NCT01743027|455887985|FG000|Overall Study|Adverse Event|2|||
126709409|NCT01743027|455887986|FG001|Overall Study|Adverse Event|0|||
126709410|NCT01743027|455887987|FG002|Overall Study|Adverse Event|0|||
126709411|NCT01743027|455887988|FG003|Overall Study|Adverse Event|0|||
126549356|NCT02960763|455305612|FG003|Step 1|Lost to Follow-up|0|||
126549357|NCT02960763|455305613|FG004|Step 1|Lost to Follow-up|0|||
126549358|NCT02960763|455305609|FG000|Step 1|Death|1|||
126549359|NCT02960763|455305610|FG001|Step 1|Death|1|||
126549360|NCT02960763|455305611|FG002|Step 1|Death|1|||
126709412|NCT01743027|455887985|FG000|Overall Study|Lost to Follow-up|0|||
126549361|NCT02960763|455305612|FG003|Step 1|Death|0|||
126549362|NCT02960763|455305613|FG004|Step 1|Death|0|||
126549363|NCT02960763|455305609|FG000|Step 1|Investigator discretion|1|||
126549364|NCT02960763|455305610|FG001|Step 1|Investigator discretion|0|||
126549365|NCT02960763|455305611|FG002|Step 1|Investigator discretion|1|||
126549366|NCT02960763|455305612|FG003|Step 1|Investigator discretion|0|||
126709413|NCT01743027|455887986|FG001|Overall Study|Lost to Follow-up|0|||
126709414|NCT01743027|455887987|FG002|Overall Study|Lost to Follow-up|2|||
126285595|NCT02585778|454332995|FG000|Overall Study|Poor compliance to study protocol|0|||
126285596|NCT02585778|454332996|FG001|Overall Study|Poor compliance to study protocol|2|||
126285597|NCT02585778|454332995|FG000|Overall Study|Death|0|||
126285598|NCT02585778|454332996|FG001|Overall Study|Death|1|||
126285599|NCT02585778|454332995|FG000|Overall Study|Randomized but not treated|1|||
126285600|NCT02585778|454332996|FG001|Overall Study|Randomized but not treated|2|||
126285601|NCT02585778|454332995|FG000|Overall Study|Other than specified above|6|||
126285602|NCT02585778|454332996|FG001|Overall Study|Other than specified above|2|||
126285603|NCT02789137|454332998|FG000|Overall Study|Dropped out/Died|58|||
126285604|NCT01482312|454332999|FG000|Period 1, 90 Minutes of Wear|Other|1|||
126285605|NCT01482312|454333000|FG001|Period 1, 90 Minutes of Wear|Other|0|||
126285606|NCT01482312|454333001|FG002|Period 1, 90 Minutes of Wear|Other|0|||
126285607|NCT01482312|454332999|FG000|Period 2, 90 Minutes of Wear|Other|1|||
126285608|NCT01482312|454333000|FG001|Period 2, 90 Minutes of Wear|Other|0|||
126285609|NCT01482312|454333001|FG002|Period 2, 90 Minutes of Wear|Other|0|||
126285610|NCT01699815|454333002|FG000|Overall Study|Protocol Violation|4|||
126285611|NCT01699815|454333003|FG001|Overall Study|Protocol Violation|7|||
126285612|NCT01699815|454333002|FG000|Overall Study|record could not be located|1|||
126285613|NCT01699815|454333003|FG001|Overall Study|record could not be located|0|||
126285614|NCT01699815|454333002|FG000|Overall Study|Adverse Event|0|||
126285615|NCT01699815|454333003|FG001|Overall Study|Adverse Event|1|||
126285616|NCT05246670|454333008|FG000|Overall Study|Withdrawal by Subject|2|||
126285617|NCT05246670|454333009|FG001|Overall Study|Withdrawal by Subject|3|||
126285618|NCT05246670|454333010|FG002|Overall Study|Withdrawal by Subject|0|||
126285619|NCT05246670|454333011|FG003|Overall Study|Withdrawal by Subject|1|||
126285620|NCT05246670|454333008|FG000|Overall Study|Adverse Event|0|||
126285621|NCT05246670|454333009|FG001|Overall Study|Adverse Event|0|||
126285622|NCT05246670|454333010|FG002|Overall Study|Adverse Event|1|||
126285623|NCT05246670|454333011|FG003|Overall Study|Adverse Event|0|||
126285624|NCT05246670|454333008|FG000|Overall Study|Physician Decision|1|||
126285625|NCT05246670|454333009|FG001|Overall Study|Physician Decision|0|||
126285626|NCT05246670|454333010|FG002|Overall Study|Physician Decision|0|||
126285627|NCT05246670|454333011|FG003|Overall Study|Physician Decision|0|||
126285628|NCT05246670|454333008|FG000|Overall Study|Protocol Violation|1|||
126285629|NCT05246670|454333009|FG001|Overall Study|Protocol Violation|0|||
126285630|NCT05246670|454333010|FG002|Overall Study|Protocol Violation|0|||
126285631|NCT05246670|454333011|FG003|Overall Study|Protocol Violation|0|||
126285632|NCT00799058|454333017|FG000|Overall Study|Withdrawal by Subject|2|||
126456526|NCT00384111|454970944|FG000|Overall Study|Disease Progression|3|||
126456527|NCT00384111|454970944|FG000|Overall Study|Adverse Event|1|||
126456528|NCT00384111|454970944|FG000|Overall Study|Investigator Decision|3|||
126456529|NCT00384111|454970944|FG000|Overall Study|Study Terminated by the Sponsor|19|||
126456530|NCT01089361|454970945|FG000|Overall Study|Death|1|||
126456531|NCT01089361|454970946|FG001|Overall Study|Death|0|||
126456532|NCT03612856|454970947|FG000|Pre-dose Period|Physician Decision|0|||
126456533|NCT03612856|454970948|FG001|Pre-dose Period|Physician Decision|1|||
126456534|NCT03612856|454970949|FG002|Pre-dose Period|Physician Decision|1|||
126709415|NCT01743027|455887988|FG003|Overall Study|Lost to Follow-up|0|||
126709416|NCT01743027|455887985|FG000|Overall Study|Progressive Disease|1|||
126709417|NCT01743027|455887986|FG001|Overall Study|Progressive Disease|4|||
126709418|NCT01743027|455887987|FG002|Overall Study|Progressive Disease|3|||
126709419|NCT01743027|455887988|FG003|Overall Study|Progressive Disease|0|||
126709420|NCT01743027|455887985|FG000|Overall Study|Protocol Violation|1|||
126709421|NCT01743027|455887986|FG001|Overall Study|Protocol Violation|1|||
126709422|NCT01743027|455887987|FG002|Overall Study|Protocol Violation|1|||
126709423|NCT01743027|455887988|FG003|Overall Study|Protocol Violation|0|||
126709424|NCT01743027|455887985|FG000|Overall Study|Withdrawal by Subject|1|||
126709425|NCT01743027|455887986|FG001|Overall Study|Withdrawal by Subject|0|||
126709426|NCT01743027|455887987|FG002|Overall Study|Withdrawal by Subject|3|||
126285633|NCT00799058|454333018|FG001|Overall Study|Withdrawal by Subject|2|||
126285634|NCT00799058|454333019|FG002|Overall Study|Withdrawal by Subject|2|||
126285635|NCT00799058|454333017|FG000|Overall Study|Lost to Follow-up|1|||
126456535|NCT03612856|454970947|FG000|Pre-dose Period|Withdrawal by Subject|0|||
126456536|NCT03612856|454970948|FG001|Pre-dose Period|Withdrawal by Subject|1|||
126549367|NCT02960763|455305613|FG004|Step 1|Investigator discretion|0|||
126285636|NCT00799058|454333018|FG001|Overall Study|Lost to Follow-up|2|||
126456537|NCT03612856|454970949|FG002|Pre-dose Period|Withdrawal by Subject|0|||
126549368|NCT02960763|455305609|FG000|Step 1|Other|0|||
126549369|NCT02960763|455305610|FG001|Step 1|Other|0|||
126709427|NCT01743027|455887988|FG003|Overall Study|Withdrawal by Subject|1|||
126709428|NCT05897853|455887995|FG000|Overall Study|Lost to Follow-up|2|||
126709429|NCT05897853|455887996|FG001|Overall Study|Lost to Follow-up|0|||
126285637|NCT00799058|454333019|FG002|Overall Study|Lost to Follow-up|1|||
126285638|NCT00799058|454333017|FG000|Overall Study|Adverse Event|0|||
126285639|NCT00799058|454333018|FG001|Overall Study|Adverse Event|2|||
126285640|NCT00799058|454333019|FG002|Overall Study|Adverse Event|0|||
126285641|NCT00799058|454333017|FG000|Overall Study|Pregnancy|1|||
126285642|NCT00799058|454333018|FG001|Overall Study|Pregnancy|0|||
126285643|NCT00799058|454333019|FG002|Overall Study|Pregnancy|0|||
126766011|NCT04409509|456095878|FG001|Overall Study|Lost to Follow-up|3|||
126766012|NCT04409509|456095877|FG000|Overall Study|Withdrawal by Subject|0|||
126766013|NCT04409509|456095878|FG001|Overall Study|Withdrawal by Subject|3|||
126766014|NCT04409509|456095877|FG000|Overall Study|Randomized by mistake|0|||
126766015|NCT04409509|456095878|FG001|Overall Study|Randomized by mistake|1|||
126766016|NCT04409509|456095877|FG000|Overall Study|Other|1|||
126766017|NCT04409509|456095878|FG001|Overall Study|Other|1|||
126766018|NCT04455620|456095881|FG000|Overall Study|Withdrawal by Subject|0|||
126766019|NCT04455620|456095882|FG001|Overall Study|Withdrawal by Subject|0|||
126766020|NCT04455620|456095883|FG002|Overall Study|Withdrawal by Subject|2|||
126766021|NCT04455620|456095884|FG003|Overall Study|Withdrawal by Subject|0|||
126766022|NCT04455620|456095885|FG004|Overall Study|Withdrawal by Subject|1|||
126766023|NCT04455620|456095881|FG000|Overall Study|Lost to Follow-up|0|||
126766024|NCT04455620|456095882|FG001|Overall Study|Lost to Follow-up|0|||
126766025|NCT04455620|456095883|FG002|Overall Study|Lost to Follow-up|1|||
126766026|NCT04455620|456095884|FG003|Overall Study|Lost to Follow-up|1|||
126766027|NCT04455620|456095885|FG004|Overall Study|Lost to Follow-up|0|||
126766028|NCT04455620|456095881|FG000|Overall Study|Death|1|||
126766029|NCT04455620|456095882|FG001|Overall Study|Death|6|||
126766030|NCT04455620|456095883|FG002|Overall Study|Death|20|||
126766031|NCT04455620|456095884|FG003|Overall Study|Death|1|||
126766032|NCT04455620|456095885|FG004|Overall Study|Death|7|||
126766033|NCT04455620|456095881|FG000|Overall Study|Study Termination|0|||
126766034|NCT04455620|456095882|FG001|Overall Study|Study Termination|2|||
126766035|NCT04455620|456095883|FG002|Overall Study|Study Termination|1|||
126766036|NCT04455620|456095884|FG003|Overall Study|Study Termination|0|||
126766037|NCT04455620|456095885|FG004|Overall Study|Study Termination|6|||
126766038|NCT02851069|456095887|FG000|Overall Study|Failure to Return|3|||
126766039|NCT02851069|456095887|FG000|Overall Study|Other|3|||
126766040|NCT03539952|456095894|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
126766041|NCT03539952|456095895|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
126766042|NCT03539952|456095894|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
126766043|NCT03539952|456095895|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
126766044|NCT03539952|456095894|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
126766045|NCT03539952|456095895|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
126766046|NCT03539952|456095894|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
126766047|NCT03539952|456095895|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
126766048|NCT03539952|456095894|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
126766049|NCT03539952|456095895|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
126766050|NCT03539952|456095894|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
126766051|NCT03539952|456095895|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
126766052|NCT03539952|456095894|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
126766053|NCT03539952|456095895|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
126766054|NCT03188991|456095896|FG000|Overall Study|Withdrawal by Subject|0|||
126766055|NCT03188991|456095897|FG001|Overall Study|Withdrawal by Subject|0|||
126766056|NCT03188991|456095898|FG002|Overall Study|Withdrawal by Subject|0|||
126766057|NCT03188991|456095899|FG003|Overall Study|Withdrawal by Subject|1|||
126709430|NCT05897853|455887995|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
126709431|NCT05897853|455887996|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
126709432|NCT02782715|455888001|FG000|Overall Study|Withdrawal by Subject|1|||
126709433|NCT04458857|455888002|FG000|Overall Study|Adverse Event|0|||
126709434|NCT04458857|455888003|FG001|Overall Study|Adverse Event|1|||
126709435|NCT04458857|455888004|FG002|Overall Study|Adverse Event|0|||
126766058|NCT00798707|456097230|FG000|Overall Study|Adverse Event|6|||
126285644|NCT00799058|454333017|FG000|Overall Study|Not adherent|3|||
126456538|NCT04463069|454970950|FG000|Overall Study|Withdrawal by Subject|2|||
126456539|NCT04463069|454970951|FG001|Overall Study|Withdrawal by Subject|10|||
126766059|NCT00798707|456097231|FG001|Overall Study|Adverse Event|8|||
126766060|NCT00798707|456097232|FG002|Overall Study|Adverse Event|8|||
126766061|NCT00798707|456097230|FG000|Overall Study|Failed to return|2|||
126456540|NCT04463069|454970950|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
126456541|NCT04463069|454970951|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
126709436|NCT04458857|455888002|FG000|Overall Study|Withdrawal by Subject|2|||
126766062|NCT00798707|456097231|FG001|Overall Study|Failed to return|2|||
126766063|NCT00798707|456097232|FG002|Overall Study|Failed to return|0|||
126766064|NCT00798707|456097230|FG000|Overall Study|Investigator|0|||
126766065|NCT00798707|456097231|FG001|Overall Study|Investigator|1|||
126285645|NCT00799058|454333018|FG001|Overall Study|Not adherent|2|||
126285646|NCT00799058|454333019|FG002|Overall Study|Not adherent|1|||
126285647|NCT00799058|454333017|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
126285648|NCT00799058|454333018|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
126285649|NCT00799058|454333019|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
126285650|NCT00799058|454333017|FG000|Overall Study|IP dispensing error|1|||
126285651|NCT00799058|454333018|FG001|Overall Study|IP dispensing error|0|||
126285652|NCT00799058|454333019|FG002|Overall Study|IP dispensing error|0|||
126285653|NCT00799058|454333017|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
126285654|NCT00799058|454333018|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
126549370|NCT02960763|455305611|FG002|Step 1|Other|1|||
126549371|NCT02960763|455305612|FG003|Step 1|Other|0|||
126549372|NCT02960763|455305613|FG004|Step 1|Other|0|||
126549373|NCT02960763|455305609|FG000|Step 2|Withdrawal by Subject|0|||
126549374|NCT02960763|455305610|FG001|Step 2|Withdrawal by Subject|0|||
126549375|NCT02960763|455305611|FG002|Step 2|Withdrawal by Subject|0|||
126549376|NCT02960763|455305612|FG003|Step 2|Withdrawal by Subject|7|||
126549377|NCT02960763|455305613|FG004|Step 2|Withdrawal by Subject|3|||
126549378|NCT02960763|455305609|FG000|Step 2|Lost to Follow-up|0|||
126549379|NCT02960763|455305610|FG001|Step 2|Lost to Follow-up|0|||
126549380|NCT02960763|455305611|FG002|Step 2|Lost to Follow-up|0|||
126549381|NCT02960763|455305612|FG003|Step 2|Lost to Follow-up|4|||
126549382|NCT02960763|455305613|FG004|Step 2|Lost to Follow-up|1|||
126549383|NCT02960763|455305609|FG000|Step 2|Investigator discretion|0|||
126549384|NCT02960763|455305610|FG001|Step 2|Investigator discretion|0|||
126549385|NCT02960763|455305611|FG002|Step 2|Investigator discretion|0|||
126549386|NCT02960763|455305612|FG003|Step 2|Investigator discretion|0|||
126549387|NCT02960763|455305613|FG004|Step 2|Investigator discretion|1|||
126549388|NCT00312858|455305617|FG000|Overall Study|Adverse Event|0|||
126549389|NCT00312858|455305618|FG001|Overall Study|Adverse Event|1|||
126549390|NCT00312858|455305617|FG000|Overall Study|Lost to Follow-up|25|||
126549391|NCT00312858|455305618|FG001|Overall Study|Lost to Follow-up|42|||
126549392|NCT00312858|455305617|FG000|Overall Study|Protocol Violation|3|||
126549393|NCT00312858|455305618|FG001|Overall Study|Protocol Violation|8|||
126549394|NCT00312858|455305617|FG000|Overall Study|Withdraw by Participant|20|||
126549395|NCT00312858|455305618|FG001|Overall Study|Withdraw by Participant|20|||
126549396|NCT00312858|455305617|FG000|Overall Study|Participant Moved|11|||
126549397|NCT00312858|455305618|FG001|Overall Study|Participant Moved|10|||
126549398|NCT00312858|455305617|FG000|Overall Study|Other|9|||
126549399|NCT00312858|455305618|FG001|Overall Study|Other|12|||
126549400|NCT01372605|455305619|FG000|Overall Study|Death|1|||
126549401|NCT01372605|455305620|FG001|Overall Study|Death|2|||
126549402|NCT01372605|455305619|FG000|Overall Study|Lost to Follow-up|2|||
126549403|NCT01372605|455305620|FG001|Overall Study|Lost to Follow-up|1|||
126549404|NCT01372605|455305619|FG000|Overall Study|Withdrawal by Subject|4|||
126549405|NCT01372605|455305620|FG001|Overall Study|Withdrawal by Subject|7|||
126549406|NCT01372605|455305619|FG000|Overall Study|Moved|3|||
126549407|NCT01372605|455305620|FG001|Overall Study|Moved|0|||
126549408|NCT01372605|455305619|FG000|Overall Study|Changed medical home|2|||
126709437|NCT04458857|455888003|FG001|Overall Study|Withdrawal by Subject|0|||
126709438|NCT04458857|455888004|FG002|Overall Study|Withdrawal by Subject|0|||
126709439|NCT04458857|455888002|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126709440|NCT04458857|455888003|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126709441|NCT04458857|455888004|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126709442|NCT04458857|455888002|FG000|Overall Study|Non-compliance with study drug|0|||
126709443|NCT04458857|455888003|FG001|Overall Study|Non-compliance with study drug|1|||
126709444|NCT04458857|455888004|FG002|Overall Study|Non-compliance with study drug|0|||
126709445|NCT04458857|455888002|FG000|Overall Study|Lost to Follow-up|4|||
126709446|NCT04458857|455888003|FG001|Overall Study|Lost to Follow-up|1|||
126709447|NCT04458857|455888004|FG002|Overall Study|Lost to Follow-up|0|||
126709448|NCT00069121|455888005|FG000|Overall Study|Death|286|||
126709449|NCT00069121|455888006|FG001|Overall Study|Death|242|||
126709450|NCT00069121|455888005|FG000|Overall Study|Withdrawal by Subject|18|||
126709451|NCT00069121|455888006|FG001|Overall Study|Withdrawal by Subject|20|||
126709452|NCT00069121|455888005|FG000|Overall Study|Lost to Follow-up|63|||
126709453|NCT00069121|455888006|FG001|Overall Study|Lost to Follow-up|63|||
126709454|NCT03368404|455888009|FG000|Overall Study|Adverse Event|2|||
126709455|NCT03368404|455888010|FG001|Overall Study|Adverse Event|1|||
126709456|NCT03368404|455888009|FG000|Overall Study|Withdrawal by Subject|1|||
126709457|NCT03368404|455888010|FG001|Overall Study|Withdrawal by Subject|1|||
126709458|NCT02983292|455888011|FG000|Overall Study|Participant unwell & cannot travel|2|||
126709459|NCT02983292|455888011|FG000|Overall Study|Lost to Follow-up|3|||
126766066|NCT00798707|456097232|FG002|Overall Study|Investigator|2|||
126549409|NCT01372605|455305620|FG001|Overall Study|Changed medical home|0|||
126549410|NCT01108510|455305621|FG000|Overall Study|Randomized but Not Treated|5|||
126709460|NCT02983292|455888011|FG000|Overall Study|Participant withdrew consent|2|||
126709461|NCT02983292|455888011|FG000|Overall Study|Revision|7|||
126709462|NCT02983292|455888011|FG000|Overall Study|Death|1|||
126766067|NCT00798707|456097230|FG000|Overall Study|Lack of Efficacy|2|||
126549411|NCT01108510|455305622|FG001|Overall Study|Randomized but Not Treated|1|||
126549412|NCT01108510|455305621|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
126549413|NCT01108510|455305622|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
126549414|NCT01108510|455305621|FG000|Overall Study|Adverse Event|26|||
126285655|NCT00799058|454333019|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
126285656|NCT00799058|454333017|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
126285657|NCT00799058|454333018|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
126285658|NCT00799058|454333019|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
126285659|NCT00799058|454333017|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
126285660|NCT00799058|454333018|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
126285661|NCT00799058|454333019|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
126285662|NCT00799058|454333017|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
126285663|NCT00799058|454333018|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
126285664|NCT00799058|454333019|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
126285665|NCT03639779|454333020|FG000|Overall Study|Lost to Follow-up|1|||
126285666|NCT00810511|454333021|FG000|Overall Study|Protocol Violation|0|||
126285667|NCT00810511|454333022|FG001|Overall Study|Protocol Violation|1|||
126285668|NCT00810511|454333021|FG000|Overall Study|Lack of Efficacy|9|||
126285669|NCT00810511|454333022|FG001|Overall Study|Lack of Efficacy|1|||
126285670|NCT00810511|454333021|FG000|Overall Study|death in the family|0|||
126285671|NCT00810511|454333022|FG001|Overall Study|death in the family|1|||
126285672|NCT00810511|454333021|FG000|Overall Study|Lost to Follow-up|1|||
126285673|NCT00810511|454333022|FG001|Overall Study|Lost to Follow-up|0|||
126285674|NCT00810511|454333021|FG000|Overall Study|deposits on contact lens|0|||
126285675|NCT00810511|454333022|FG001|Overall Study|deposits on contact lens|1|||
126285676|NCT02088697|454333023|FG000|Period I|Physician Decision|1|||
126285677|NCT02088697|454333024|FG001|Period I|Physician Decision|4|||
126285678|NCT02088697|454333023|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
126285679|NCT02088697|454333024|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
126285680|NCT00911300|454333028|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
126285681|NCT00911300|454333029|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
126285682|NCT00911300|454333028|FG000|Overall Study|Death|1|||
126285683|NCT00911300|454333029|FG001|Overall Study|Death|0|||
126285684|NCT00911300|454333028|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
126285685|NCT00911300|454333029|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
126285686|NCT00911300|454333028|FG000|Overall Study|Adverse Event|14|||
126285687|NCT00911300|454333029|FG001|Overall Study|Adverse Event|6|||
126285688|NCT00911300|454333028|FG000|Overall Study|Protocol Violation|3|||
126285689|NCT00911300|454333029|FG001|Overall Study|Protocol Violation|2|||
126285690|NCT00911300|454333028|FG000|Overall Study|Consent Withdrawn|4|||
126285691|NCT00911300|454333029|FG001|Overall Study|Consent Withdrawn|12|||
126285692|NCT00911300|454333028|FG000|Overall Study|Coronary Angiography Performed|1|||
126285693|NCT00911300|454333029|FG001|Overall Study|Coronary Angiography Performed|0|||
126285694|NCT00911300|454333028|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
126285695|NCT00911300|454333029|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
126285696|NCT00911300|454333028|FG000|Overall Study|Received Commercial Treatment|1|||
126285697|NCT00911300|454333029|FG001|Overall Study|Received Commercial Treatment|0|||
126285698|NCT00911300|454333028|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
126285699|NCT00911300|454333029|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
126285700|NCT00911300|454333028|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
126285701|NCT00911300|454333029|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
126285702|NCT00911300|454333028|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
126285703|NCT00911300|454333029|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
126285704|NCT00911300|454333028|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
126285705|NCT00911300|454333029|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
126285706|NCT00911300|454333028|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
126285707|NCT00911300|454333029|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
126285708|NCT00911300|454333028|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
126285709|NCT00911300|454333029|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
126549415|NCT01108510|455305622|FG001|Overall Study|Adverse Event|19|||
126549416|NCT01108510|455305621|FG000|Overall Study|Lost to Follow-up|20|||
126549417|NCT01108510|455305622|FG001|Overall Study|Lost to Follow-up|17|||
126285710|NCT00911300|454333028|FG000|Overall Study|International Normalized Ratio Too High|0|||
126285711|NCT00911300|454333029|FG001|Overall Study|International Normalized Ratio Too High|1|||
126285712|NCT00911300|454333028|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
126285713|NCT00911300|454333029|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
126285714|NCT00911300|454333028|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
126365098|NCT02613507|454630432|FG001|Treatment|Participant withdrew consent|2|||
126549418|NCT01108510|455305621|FG000|Overall Study|Withdrew Consent|21|||
126549419|NCT01108510|455305622|FG001|Overall Study|Withdrew Consent|15|||
126549420|NCT01108510|455305621|FG000|Overall Study|Investigator's Discretion|12|||
126285715|NCT00911300|454333029|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
126285716|NCT00911300|454333028|FG000|Overall Study|Physician Decision|0|||
126285717|NCT00911300|454333029|FG001|Overall Study|Physician Decision|1|||
126285718|NCT00911300|454333028|FG000|Overall Study|Treatment Stopped by Mistake|0|||
126285719|NCT00911300|454333029|FG001|Overall Study|Treatment Stopped by Mistake|1|||
126285720|NCT00911300|454333028|FG000|Overall Study|Randomized; No Study Medication Received|0|||
126285721|NCT00911300|454333029|FG001|Overall Study|Randomized; No Study Medication Received|2|||
126285722|NCT04152291|454333032|FG000|Overall Study|Covid-19 restrictions|27|||
126285723|NCT04152291|454333032|FG000|Overall Study|Withdrawal by Subject|3|||
126285724|NCT01685840|454333033|FG000|Overall Study|Death|77|||
126285725|NCT01685840|454333034|FG001|Overall Study|Death|66|||
126285726|NCT01685840|454333033|FG000|Overall Study|Lost to Follow-up|27|||
126285727|NCT01685840|454333034|FG001|Overall Study|Lost to Follow-up|25|||
126285728|NCT01685840|454333033|FG000|Overall Study|Physician Decision|3|||
126285729|NCT01685840|454333034|FG001|Overall Study|Physician Decision|7|||
126285730|NCT01685840|454333033|FG000|Overall Study|Withdrawal by Subject|14|||
126285731|NCT01685840|454333034|FG001|Overall Study|Withdrawal by Subject|17|||
126285732|NCT01685840|454333033|FG000|Overall Study|Futility|197|||
126285733|NCT01685840|454333034|FG001|Overall Study|Futility|200|||
126285734|NCT01685840|454333033|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
126285735|NCT01685840|454333034|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
126285736|NCT02211417|454333039|FG000|Overall Study|Withdrawal by Subject|11|||
126285737|NCT02211417|454333040|FG001|Overall Study|Withdrawal by Subject|8|||
126285738|NCT02211417|454333039|FG000|Overall Study|Protocol Violation|1|||
126285739|NCT02211417|454333040|FG001|Overall Study|Protocol Violation|0|||
126285740|NCT02211417|454333039|FG000|Overall Study|Pregnancy|0|||
126285741|NCT02211417|454333040|FG001|Overall Study|Pregnancy|1|||
126456542|NCT01155167|454970952|FG000|Overall Study|Insufficient ultrasound data|2|||
126456543|NCT01155167|454970953|FG001|Overall Study|Insufficient ultrasound data|0|||
126456544|NCT01155167|454970952|FG000|Overall Study|Access site changed to femoral artery|1|||
126709463|NCT02983292|455888011|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
126285742|NCT02211417|454333039|FG000|Overall Study|Lost to Follow-up|2|||
126285743|NCT02211417|454333040|FG001|Overall Study|Lost to Follow-up|3|||
126285744|NCT02211417|454333039|FG000|Overall Study|Adverse Event|1|||
126285745|NCT02211417|454333040|FG001|Overall Study|Adverse Event|4|||
126285746|NCT00447993|454333041|FG000|Overall Study|Lost to Follow-up|0|||
126285747|NCT00447993|454333042|FG001|Overall Study|Lost to Follow-up|0|||
126285748|NCT00447993|454333043|FG002|Overall Study|Lost to Follow-up|2|||
126285749|NCT00447993|454333044|FG003|Overall Study|Lost to Follow-up|2|||
126285750|NCT00447993|454333041|FG000|Overall Study|Withdrawal by Subject|0|||
126285751|NCT00447993|454333042|FG001|Overall Study|Withdrawal by Subject|0|||
126285752|NCT00447993|454333043|FG002|Overall Study|Withdrawal by Subject|2|||
126285753|NCT00447993|454333044|FG003|Overall Study|Withdrawal by Subject|2|||
126285754|NCT04700137|454333049|FG000|Overall Study|Lost to Follow-up|1|||
126285755|NCT04700137|454333050|FG001|Overall Study|Lost to Follow-up|6|||
126285756|NCT04700137|454333051|FG002|Overall Study|Lost to Follow-up|1|||
126285757|NCT04700137|454333052|FG003|Overall Study|Lost to Follow-up|1|||
126285758|NCT04700137|454333049|FG000|Overall Study|Withdrawal by Subject|0|||
126285759|NCT04700137|454333050|FG001|Overall Study|Withdrawal by Subject|0|||
126285760|NCT04700137|454333051|FG002|Overall Study|Withdrawal by Subject|1|||
126285761|NCT04700137|454333052|FG003|Overall Study|Withdrawal by Subject|0|||
126285762|NCT04700137|454333049|FG000|Overall Study|Death|0|||
126285763|NCT04700137|454333050|FG001|Overall Study|Death|0|||
126285764|NCT04700137|454333051|FG002|Overall Study|Death|1|||
126285765|NCT04700137|454333052|FG003|Overall Study|Death|0|||
126285766|NCT00548093|454333053|FG000|Overall Study|Death|33|||
126285767|NCT00548093|454333054|FG001|Overall Study|Death|13|||
126285768|NCT00548093|454333053|FG000|Overall Study|Lost to Follow-up|3|||
126285769|NCT00548093|454333054|FG001|Overall Study|Lost to Follow-up|1|||
126285770|NCT00548093|454333053|FG000|Overall Study|Objective progression or relapse|1|||
126285771|NCT00548093|454333054|FG001|Overall Study|Objective progression or relapse|1|||
126285772|NCT00548093|454333053|FG000|Overall Study|Other|11|||
126456545|NCT01155167|454970953|FG001|Overall Study|Access site changed to femoral artery|0|||
126285773|NCT00548093|454333054|FG001|Overall Study|Other|1|||
126285774|NCT00548093|454333053|FG000|Overall Study|Withdrawal by Subject|1|||
126285775|NCT00548093|454333054|FG001|Overall Study|Withdrawal by Subject|0|||
126285776|NCT00548093|454333053|FG000|Overall Study|Completed post-treatment follow-up|1|||
126285777|NCT00548093|454333054|FG001|Overall Study|Completed post-treatment follow-up|0|||
126285778|NCT02296931|454333060|FG000|Overall Study|Protocol Violation|0|||
126285779|NCT02296931|454333061|FG001|Overall Study|Protocol Violation|2|||
126285780|NCT01590277|454333062|FG000|Overall Study|Withdrawal by Subject|3|||
126285781|NCT01590277|454333062|FG000|Overall Study|Withdrawal by Subject|2|||
126285782|NCT01590277|454333062|FG000|Overall Study|Withdrawal by Subject|1|||
126285783|NCT01590277|454333062|FG000|Overall Study|Withdrawal by Subject|1|||
126285784|NCT04386616|454333063|FG000|Overall Study|Death|22|||
126285785|NCT04386616|454333064|FG001|Overall Study|Death|22|||
126285786|NCT04386616|454333065|FG002|Overall Study|Death|21|||
126456546|NCT00576420|454972806|FG000|Overall Study|Death|0|||
126285787|NCT04386616|454333063|FG000|Overall Study|Lost to Follow-up|5|||
126285788|NCT04386616|454333064|FG001|Overall Study|Lost to Follow-up|8|||
126285789|NCT04386616|454333065|FG002|Overall Study|Lost to Follow-up|6|||
126285790|NCT04386616|454333063|FG000|Overall Study|Withdrawal by Subject|2|||
126285791|NCT04386616|454333064|FG001|Overall Study|Withdrawal by Subject|4|||
126285792|NCT04386616|454333065|FG002|Overall Study|Withdrawal by Subject|1|||
126709464|NCT02983292|455888011|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
126709465|NCT02983292|455888011|FG000|Overall Study|Participant relocation|1|||
126709466|NCT00964795|455888012|FG000|Overall Study|Withdrawal by Subject|79|||
126709467|NCT00964795|455888012|FG000|Overall Study|Adverse Event|12|||
126709468|NCT00964795|455888012|FG000|Overall Study|Death|14|||
126285793|NCT04386616|454333063|FG000|Overall Study|Adverse Event|1|||
126285794|NCT04386616|454333064|FG001|Overall Study|Adverse Event|1|||
126285795|NCT04386616|454333065|FG002|Overall Study|Adverse Event|0|||
126285796|NCT00805961|454333068|FG000|Modality Therapy|Withdrawal by Subject|1|||
126709469|NCT00964795|455888012|FG000|Overall Study|Lost to Follow-up|7|||
126285797|NCT00805961|454333068|FG000|Modality Therapy|Adverse Event|1|||
126285798|NCT00805961|454333068|FG000|Modality Therapy|Disease Progression|2|||
126285799|NCT00805961|454333068|FG000|Treatment-Free Interval|Adverse Event|3|||
126365099|NCT02613507|454630431|FG000|Treatment|Participant request to discontinue study treatment|13|||
126365100|NCT02613507|454630432|FG001|Treatment|Participant request to discontinue study treatment|17|||
126365101|NCT02613507|454630431|FG000|Treatment|Adverse event unrelated to study drug|20|||
126365102|NCT02613507|454630432|FG001|Treatment|Adverse event unrelated to study drug|3|||
126365103|NCT02613507|454630431|FG000|Treatment|Death|2|||
126365104|NCT02613507|454630432|FG001|Treatment|Death|0|||
126365105|NCT02613507|454630431|FG000|Treatment|Study drug toxicity|19|||
126365106|NCT02613507|454630432|FG001|Treatment|Study drug toxicity|14|||
126365107|NCT02613507|454630431|FG000|Treatment|Disease progression|263|||
126365108|NCT02613507|454630432|FG001|Treatment|Disease progression|110|||
126365109|NCT03941093|454630433|FG000|Overall Study|Protocol Violation|0|||
126365110|NCT03941093|454630434|FG001|Overall Study|Protocol Violation|1|||
126365111|NCT03941093|454630433|FG000|Overall Study|Withdrawal by Subject|9|||
126365112|NCT03941093|454630434|FG001|Overall Study|Withdrawal by Subject|6|||
126365113|NCT00590317|454631681|FG000|Overall Study|Lack of Efficacy|1|||
126365114|NCT00590317|454631682|FG001|Overall Study|Lack of Efficacy|5|||
126365115|NCT00003907|454631689|FG000|Overall Study|Adverse Event|2|||
126365116|NCT00003907|454631690|FG001|Overall Study|Adverse Event|11|||
126365117|NCT00003907|454631689|FG000|Overall Study|Death|2|||
126365118|NCT00003907|454631690|FG001|Overall Study|Death|0|||
126365119|NCT00003907|454631689|FG000|Overall Study|Withdrawal by Subject|1|||
126365120|NCT00003907|454631690|FG001|Overall Study|Withdrawal by Subject|3|||
126365121|NCT00003907|454631689|FG000|Overall Study|Progressive disease|4|||
126365122|NCT00003907|454631690|FG001|Overall Study|Progressive disease|4|||
126365123|NCT00003907|454631689|FG000|Overall Study|Complicating disease|1|||
126365124|NCT00003907|454631690|FG001|Overall Study|Complicating disease|0|||
126365125|NCT00003907|454631689|FG000|Overall Study|Other|1|||
126365126|NCT00003907|454631690|FG001|Overall Study|Other|3|||
126365127|NCT00003907|454631689|FG000|Overall Study|ineligible or not treated|2|||
126365128|NCT00003907|454631690|FG001|Overall Study|ineligible or not treated|2|||
126365129|NCT01517178|454631691|FG000|Period 1|Adverse Event|1|||
126365130|NCT01517178|454631692|FG001|Period 1|Adverse Event|2|||
126365131|NCT01517178|454631691|FG000|Period 1|Lack of Efficacy|0|||
126365132|NCT01517178|454631692|FG001|Period 1|Lack of Efficacy|1|||
126365133|NCT01517178|454631691|FG000|Period 1|E.g. study termination|3|||
126365134|NCT01517178|454631692|FG001|Period 1|E.g. study termination|1|||
126365135|NCT01517178|454631691|FG000|Period 1|Withdrawal by Subject|0|||
126365136|NCT01517178|454631692|FG001|Period 1|Withdrawal by Subject|1|||
126365137|NCT01517178|454631691|FG000|Period 2|Adverse Event|1|||
126365138|NCT01517178|454631692|FG001|Period 2|Adverse Event|0|||
126365139|NCT01517178|454631691|FG000|Period 2|Withdrawal by Subject|3|||
126365140|NCT01517178|454631692|FG001|Period 2|Withdrawal by Subject|0|||
126365141|NCT01517178|454631691|FG000|Period 2|E.g. study termination|2|||
126365142|NCT01517178|454631692|FG001|Period 2|E.g. study termination|2|||
126365143|NCT01050218|454631699|FG000|Overall Study|Adverse Event|37|||
126365144|NCT01050218|454631699|FG000|Overall Study|Lack of Efficacy|8|||
126365145|NCT01050218|454631699|FG000|Overall Study|Protocol Violation|3|||
126365146|NCT01050218|454631699|FG000|Overall Study|Withdrawal by Subject|18|||
126365147|NCT01050218|454631699|FG000|Overall Study|Discontinued by sponsor|18|||
126365148|NCT01050218|454631699|FG000|Overall Study|Compliance|2|||
126365149|NCT01050218|454631699|FG000|Overall Study|Failed to return|7|||
126365150|NCT01050218|454631699|FG000|Overall Study|Serious Adverse Event|1|||
126365151|NCT01050218|454631699|FG000|Overall Study|Family emergency|1|||
126365152|NCT01149460|454631700|FG000|Overall Study|Withdrawal by Subject|0|||
126365153|NCT01149460|454631701|FG001|Overall Study|Withdrawal by Subject|2|||
126365154|NCT02272985|454631704|FG000|Overall Study|Withdrawal by Subject|1|||
126365155|NCT02272985|454631704|FG000|Overall Study|hip fracture|1|||
126365156|NCT02272985|454631704|FG000|Overall Study|kidney transplantation|1|||
126365157|NCT00266032|454631705|FG000|Treatment|Adverse Event|42|||
126365158|NCT00266032|454631706|FG001|Treatment|Adverse Event|26|||
126766068|NCT00798707|456097231|FG001|Overall Study|Lack of Efficacy|2|||
126365159|NCT00266032|454631707|FG002|Treatment|Adverse Event|10|||
126365160|NCT00266032|454631705|FG000|Treatment|Lost to Follow-up|19|||
126365161|NCT00266032|454631706|FG001|Treatment|Lost to Follow-up|4|||
126365162|NCT00266032|454631707|FG002|Treatment|Lost to Follow-up|2|||
126365163|NCT00266032|454631705|FG000|Treatment|Pregnancy|3|||
126365164|NCT00266032|454631706|FG001|Treatment|Pregnancy|2|||
126365165|NCT00266032|454631707|FG002|Treatment|Pregnancy|2|||
126365166|NCT00266032|454631705|FG000|Treatment|Protocol Violation|6|||
126365167|NCT00266032|454631706|FG001|Treatment|Protocol Violation|14|||
126365168|NCT00266032|454631707|FG002|Treatment|Protocol Violation|13|||
126365169|NCT00266032|454631705|FG000|Treatment|Withdrawal by Subject|28|||
126365170|NCT00266032|454631706|FG001|Treatment|Withdrawal by Subject|13|||
126365171|NCT00266032|454631707|FG002|Treatment|Withdrawal by Subject|12|||
126456547|NCT00576420|454972807|FG001|Overall Study|Death|0|||
126456548|NCT00576420|454972808|FG002|Overall Study|Death|1|||
126456549|NCT01340872|454972810|FG000|Double-blind Phase|Adverse Event|6|||
126456550|NCT01340872|454972811|FG001|Double-blind Phase|Adverse Event|4|||
126456551|NCT01340872|454972812|FG002|Double-blind Phase|Adverse Event|0|||
126456552|NCT01340872|454972813|FG003|Double-blind Phase|Adverse Event|0|||
126456553|NCT01340872|454972810|FG000|Double-blind Phase|Withdrawal by Subject|3|||
126456554|NCT01340872|454972811|FG001|Double-blind Phase|Withdrawal by Subject|5|||
126456555|NCT01340872|454972812|FG002|Double-blind Phase|Withdrawal by Subject|0|||
126456556|NCT01340872|454972813|FG003|Double-blind Phase|Withdrawal by Subject|0|||
126456557|NCT01340872|454972810|FG000|Double-blind Phase|Lost to Follow-up|0|||
126456558|NCT01340872|454972811|FG001|Double-blind Phase|Lost to Follow-up|1|||
126456559|NCT01340872|454972812|FG002|Double-blind Phase|Lost to Follow-up|0|||
126456560|NCT01340872|454972813|FG003|Double-blind Phase|Lost to Follow-up|0|||
126456561|NCT01340872|454972810|FG000|Double-blind Phase|Protocol Violation|0|||
126456562|NCT01340872|454972811|FG001|Double-blind Phase|Protocol Violation|1|||
126456563|NCT01340872|454972812|FG002|Double-blind Phase|Protocol Violation|0|||
126456564|NCT01340872|454972813|FG003|Double-blind Phase|Protocol Violation|0|||
126456565|NCT01340872|454972810|FG000|Open-label Phase|Physician Decision|0|||
126456566|NCT01340872|454972811|FG001|Open-label Phase|Physician Decision|0|||
126456567|NCT01340872|454972812|FG002|Open-label Phase|Physician Decision|2|||
126456568|NCT01340872|454972813|FG003|Open-label Phase|Physician Decision|1|||
126456569|NCT01340872|454972810|FG000|Open-label Phase|Pregnancy|0|||
126456570|NCT01340872|454972811|FG001|Open-label Phase|Pregnancy|0|||
126456571|NCT01340872|454972812|FG002|Open-label Phase|Pregnancy|1|||
126456572|NCT01340872|454972813|FG003|Open-label Phase|Pregnancy|0|||
126456573|NCT01340872|454972810|FG000|Open-label Phase|Adverse Event|0|||
126456574|NCT01340872|454972811|FG001|Open-label Phase|Adverse Event|0|||
126456575|NCT01340872|454972812|FG002|Open-label Phase|Adverse Event|8|||
126456576|NCT01340872|454972813|FG003|Open-label Phase|Adverse Event|4|||
126456577|NCT01340872|454972810|FG000|Open-label Phase|Withdrawal by Subject|0|||
126456578|NCT01340872|454972811|FG001|Open-label Phase|Withdrawal by Subject|0|||
126456579|NCT01340872|454972812|FG002|Open-label Phase|Withdrawal by Subject|1|||
126456580|NCT01340872|454972813|FG003|Open-label Phase|Withdrawal by Subject|6|||
126456581|NCT01340872|454972810|FG000|Open-label Phase|Worsening of IBD|0|||
126456582|NCT01340872|454972811|FG001|Open-label Phase|Worsening of IBD|0|||
126456583|NCT01340872|454972812|FG002|Open-label Phase|Worsening of IBD|1|||
126456584|NCT01340872|454972813|FG003|Open-label Phase|Worsening of IBD|0|||
126456585|NCT01771809|454972817|FG000|Overall Study|Adverse Event|4|||
126456586|NCT01771809|454972818|FG001|Overall Study|Adverse Event|12|||
126456587|NCT01771809|454972817|FG000|Overall Study|Protocol Violation|0|||
126456588|NCT01771809|454972818|FG001|Overall Study|Protocol Violation|1|||
126456589|NCT01771809|454972817|FG000|Overall Study|Withdrawal by Subject|34|||
126456590|NCT01771809|454972818|FG001|Overall Study|Withdrawal by Subject|42|||
126456591|NCT01771809|454972817|FG000|Overall Study|Lost to Follow-up|1|||
126456592|NCT01771809|454972818|FG001|Overall Study|Lost to Follow-up|3|||
126456593|NCT01771809|454972817|FG000|Overall Study|Other (Insufficient clinical response)|22|||
126456594|NCT01771809|454972818|FG001|Overall Study|Other (Insufficient clinical response)|20|||
126456595|NCT01771809|454972817|FG000|Overall Study|Death|1|||
126456596|NCT01771809|454972818|FG001|Overall Study|Death|0|||
126456597|NCT01771809|454972817|FG000|Overall Study|Other (other)|9|||
126456598|NCT01771809|454972818|FG001|Overall Study|Other (other)|5|||
126456599|NCT03603509|454972819|FG000|Overall Study|Lost to Follow-up|3|||
126456600|NCT03603509|454972820|FG001|Overall Study|Lost to Follow-up|4|||
126456601|NCT02656680|454972823|FG000|Overall Study|Lost to Follow-up|0|||
126456602|NCT02656680|454972824|FG001|Overall Study|Lost to Follow-up|1|||
126456603|NCT02656680|454972825|FG002|Overall Study|Lost to Follow-up|7|||
126456604|NCT04966910|454972826|FG000|Baseline|Participant did not complete measure|0|||
126365172|NCT00266032|454631705|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
126365173|NCT00266032|454631706|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
126456605|NCT04966910|454972827|FG001|Baseline|Participant did not complete measure|0|||
126365174|NCT00266032|454631707|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
126456606|NCT04966910|454972828|FG002|Baseline|Participant did not complete measure|1|||
126456607|NCT04966910|454972829|FG003|Baseline|Participant did not complete measure|0|||
126456608|NCT04966910|454972826|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
126709470|NCT00964795|455888012|FG000|Overall Study|Termination of Study by Sponsor|169|||
126709471|NCT00964795|455888012|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
126709472|NCT00964795|455888012|FG000|Overall Study|Other|23|||
126709473|NCT00586690|455888017|FG000|Overall Study|Death|2|||
126709474|NCT00586690|455888018|FG001|Overall Study|Death|0|||
126709475|NCT00586690|455888017|FG000|Overall Study|Disease Progression|10|||
126709476|NCT00586690|455888018|FG001|Overall Study|Disease Progression|0|||
126285800|NCT00805961|454333068|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
126285801|NCT00805961|454333068|FG000|Treatment-Free Interval|Physician Decision|1|||
126285802|NCT00805961|454333068|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
126285803|NCT00805961|454333068|FG000|Maintenance Treatment|Lack of Efficacy|13|||
126285804|NCT00805961|454333068|FG000|Maintenance Treatment|Intercurrent Illness|7|||
126285805|NCT00805961|454333068|FG000|Maintenance Treatment|Adverse Event|6|||
126285806|NCT00805961|454333068|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
126285807|NCT00805961|454333068|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
126285808|NCT00805961|454333068|FG000|Maintenance Treatment|Withdrawn Consent|1|||
126285809|NCT01862484|454333069|FG000|Overall Study|Lack of Efficacy|1|||
126285810|NCT01862484|454333070|FG001|Overall Study|Lack of Efficacy|1|||
126285811|NCT01862484|454333069|FG000|Overall Study|Lost to Follow-up|1|||
126285812|NCT01862484|454333070|FG001|Overall Study|Lost to Follow-up|2|||
126285813|NCT01862484|454333069|FG000|Overall Study|Protocol Violation|0|||
126285814|NCT01862484|454333070|FG001|Overall Study|Protocol Violation|2|||
126285815|NCT01862484|454333069|FG000|Overall Study|Withdrawal by Subject|0|||
126285816|NCT01862484|454333070|FG001|Overall Study|Withdrawal by Subject|3|||
126285817|NCT01632280|454333071|FG000|Overall Study|Withdrawal by Subject|1|||
126285818|NCT01632280|454333072|FG001|Overall Study|Withdrawal by Subject|0|||
126285819|NCT00993421|454333073|FG000|Overall Study|Adverse Event|2|||
126285820|NCT00993421|454333074|FG001|Overall Study|Adverse Event|7|||
126285821|NCT00993421|454333075|FG002|Overall Study|Adverse Event|6|||
126285822|NCT00993421|454333076|FG003|Overall Study|Adverse Event|9|||
126285823|NCT00993421|454333077|FG004|Overall Study|Adverse Event|5|||
126285824|NCT00993421|454333078|FG005|Overall Study|Adverse Event|7|||
126285825|NCT00993421|454333079|FG006|Overall Study|Adverse Event|1|||
126285826|NCT00993421|454333073|FG000|Overall Study|Sponsor Decision|36|||
126285827|NCT00993421|454333074|FG001|Overall Study|Sponsor Decision|31|||
126285828|NCT00993421|454333075|FG002|Overall Study|Sponsor Decision|28|||
126285829|NCT00993421|454333076|FG003|Overall Study|Sponsor Decision|30|||
126285830|NCT00993421|454333077|FG004|Overall Study|Sponsor Decision|38|||
126285831|NCT00993421|454333078|FG005|Overall Study|Sponsor Decision|30|||
126285832|NCT00993421|454333079|FG006|Overall Study|Sponsor Decision|29|||
126285833|NCT00993421|454333073|FG000|Overall Study|Lost to Follow-up|3|||
126285834|NCT00993421|454333074|FG001|Overall Study|Lost to Follow-up|5|||
126285835|NCT00993421|454333075|FG002|Overall Study|Lost to Follow-up|5|||
126285836|NCT00993421|454333076|FG003|Overall Study|Lost to Follow-up|0|||
126285837|NCT00993421|454333077|FG004|Overall Study|Lost to Follow-up|0|||
126709477|NCT00586690|455888017|FG000|Overall Study|Adverse Event|1|||
126709478|NCT00586690|455888018|FG001|Overall Study|Adverse Event|0|||
126709479|NCT00586690|455888017|FG000|Overall Study|Lack of Efficacy|2|||
126709480|NCT00586690|455888018|FG001|Overall Study|Lack of Efficacy|0|||
126709481|NCT00586690|455888017|FG000|Overall Study|Lab can't accommodate|1|||
126709482|NCT00586690|455888018|FG001|Overall Study|Lab can't accommodate|0|||
126709483|NCT00857246|455888019|FG000|Induction Regimen|Adverse Event|1|||
126709484|NCT00857246|455888019|FG000|Induction Regimen|disease-related complications|1|||
126709485|NCT00857246|455888019|FG000|Induction Regimen|Withdrawal by Subject|1|||
126709486|NCT00857246|455888019|FG000|Surgery (Curative)|disease progression|6|||
126709487|NCT00857246|455888019|FG000|ChemoRT|Withdrawal by Subject|1|||
126709488|NCT00857246|455888019|FG000|ChemoRT|Adverse Event|2|||
126709489|NCT03414359|455888025|FG000|Overall Study|Lack of Efficacy|1|||
126709490|NCT03414359|455888026|FG001|Overall Study|Lack of Efficacy|1|||
126709491|NCT03414359|455888025|FG000|Overall Study|Protocol Violation|0|||
126709492|NCT03414359|455888026|FG001|Overall Study|Protocol Violation|1|||
126709493|NCT03022422|455888028|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
126709494|NCT03022422|455888029|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
126709495|NCT03022422|455888030|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
126709496|NCT03022422|455888031|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
126709497|NCT03022422|455888032|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
126709498|NCT03022422|455888033|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
126709499|NCT01282814|455888034|FG000|First Intervention|Emesis During Dosing Interval|0|||
126709500|NCT01282814|455888035|FG001|First Intervention|Emesis During Dosing Interval|3|||
126709501|NCT01282814|455888034|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
126709502|NCT01282814|455888035|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
126709503|NCT00957372|455888036|FG000|PART I|Lost to Follow-up|0|||
126709504|NCT00957372|455888037|FG001|PART I|Lost to Follow-up|0|||
126709505|NCT00957372|455888038|FG002|PART I|Lost to Follow-up|1|||
126709506|NCT00957372|455888039|FG003|PART I|Lost to Follow-up|0|||
126709507|NCT00957372|455888036|FG000|PART II|Withdrawal by Subject|0|||
126709508|NCT00957372|455888037|FG001|PART II|Withdrawal by Subject|0|||
126709509|NCT00957372|455888038|FG002|PART II|Withdrawal by Subject|0|||
126766069|NCT00798707|456097232|FG002|Overall Study|Lack of Efficacy|1|||
126766070|NCT00798707|456097230|FG000|Overall Study|Lost to Follow-up|5|||
126766071|NCT00798707|456097231|FG001|Overall Study|Lost to Follow-up|6|||
126766072|NCT00798707|456097232|FG002|Overall Study|Lost to Follow-up|6|||
126766073|NCT00798707|456097230|FG000|Overall Study|Other|0|||
126766074|NCT00798707|456097231|FG001|Overall Study|Other|1|||
126766075|NCT00798707|456097232|FG002|Overall Study|Other|0|||
126766076|NCT00798707|456097230|FG000|Overall Study|Protocol Violation|4|||
126766077|NCT00798707|456097231|FG001|Overall Study|Protocol Violation|0|||
126766078|NCT00798707|456097232|FG002|Overall Study|Protocol Violation|2|||
126766079|NCT00798707|456097230|FG000|Overall Study|Withdrawal by Subject|3|||
126766080|NCT00798707|456097231|FG001|Overall Study|Withdrawal by Subject|8|||
126766081|NCT00798707|456097232|FG002|Overall Study|Withdrawal by Subject|2|||
126766082|NCT00798707|456097230|FG000|Overall Study|Randomized not treated|4|||
126766083|NCT00798707|456097231|FG001|Overall Study|Randomized not treated|5|||
126766084|NCT00798707|456097232|FG002|Overall Study|Randomized not treated|1|||
126766085|NCT01160770|456097235|FG000|Overall Study|Adverse Event|10|||
126766086|NCT01160770|456097235|FG000|Overall Study|Protocol Violation|2|||
126766087|NCT01160770|456097235|FG000|Overall Study|Subject/parent/caregiver request|33|||
126766088|NCT01160770|456097235|FG000|Overall Study|Physician Decision|1|||
126766089|NCT01160770|456097235|FG000|Overall Study|Lost to Follow-up|7|||
126766090|NCT01160770|456097235|FG000|Overall Study|Study termination or sponsor request|1|||
126766091|NCT01160770|456097235|FG000|Overall Study|Death|9|||
126766092|NCT01160770|456097235|FG000|Overall Study|Lack of Efficacy|15|||
126766093|NCT01160770|456097235|FG000|Overall Study|Other Reasons|1|||
126766094|NCT05553600|456097236|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
126766095|NCT05553600|456097237|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
126766096|NCT05553600|456097238|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
126766097|NCT05553600|456097239|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
126766098|NCT05553600|456097236|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
126766099|NCT05553600|456097237|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
126766100|NCT05553600|456097238|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
126766101|NCT05553600|456097239|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
126766102|NCT05553600|456097236|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
126766103|NCT05553600|456097237|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
126766104|NCT05553600|456097238|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
126766105|NCT05553600|456097239|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
126766106|NCT05553600|456097236|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
126766107|NCT05553600|456097237|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
126766108|NCT05553600|456097238|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
126766109|NCT05553600|456097239|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
126766110|NCT05553600|456097236|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
126766111|NCT05553600|456097237|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
126766112|NCT05553600|456097238|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
126766113|NCT05553600|456097239|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
126766114|NCT05553600|456097236|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
126766115|NCT05553600|456097237|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
126766116|NCT05553600|456097238|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
126766117|NCT05553600|456097239|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
126766118|NCT05553600|456097236|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
126766119|NCT05553600|456097237|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
126766120|NCT05553600|456097238|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
126766121|NCT05553600|456097239|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
126766122|NCT05553600|456097236|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
126766123|NCT05553600|456097237|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
126766124|NCT05553600|456097238|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
126456609|NCT04966910|454972827|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
126456610|NCT04966910|454972828|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
126456611|NCT04966910|454972829|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
126456612|NCT04966910|454972826|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
126766125|NCT05553600|456097239|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
126456613|NCT04966910|454972827|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
126456614|NCT04966910|454972828|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
126766126|NCT05553600|456097236|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
126766127|NCT05553600|456097237|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
126285838|NCT00993421|454333078|FG005|Overall Study|Lost to Follow-up|0|||
126285839|NCT00993421|454333079|FG006|Overall Study|Lost to Follow-up|6|||
126285840|NCT00993421|454333073|FG000|Overall Study|Withdrawal by Subject|3|||
126549421|NCT01108510|455305622|FG001|Overall Study|Investigator's Discretion|10|||
126766128|NCT05553600|456097238|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
126766129|NCT05553600|456097239|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
126766130|NCT05553600|456097236|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
126766131|NCT05553600|456097237|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
126285841|NCT00993421|454333074|FG001|Overall Study|Withdrawal by Subject|2|||
126285842|NCT00993421|454333075|FG002|Overall Study|Withdrawal by Subject|3|||
126285843|NCT00993421|454333076|FG003|Overall Study|Withdrawal by Subject|3|||
126285844|NCT00993421|454333077|FG004|Overall Study|Withdrawal by Subject|3|||
126285845|NCT00993421|454333078|FG005|Overall Study|Withdrawal by Subject|5|||
126285846|NCT00993421|454333079|FG006|Overall Study|Withdrawal by Subject|3|||
126285847|NCT00993421|454333073|FG000|Overall Study|Death|0|||
126766132|NCT05553600|456097238|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
126766133|NCT05553600|456097239|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
126766134|NCT05553600|456097236|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
126766135|NCT05553600|456097237|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
126766136|NCT05553600|456097238|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
126766137|NCT05553600|456097239|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
126766138|NCT05553600|456097236|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
126766139|NCT05553600|456097237|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
126766140|NCT05553600|456097238|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
126766141|NCT05553600|456097239|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
126766142|NCT02116309|456097243|FG000|Overall Study|Lost to Follow-up|0|||
126766143|NCT02116309|456097244|FG001|Overall Study|Lost to Follow-up|1|||
126766144|NCT00848965|456097245|FG000|Overall Study|Adverse Event|1|||
126766145|NCT00848965|456097245|FG000|Overall Study|Withdrawal by Subject|1|||
126766146|NCT03710824|456097246|FG000|Overall Study|Withdrawal by Subject|1|||
126766147|NCT03710824|456097246|FG000|Overall Study|Lost to Follow-up|3|||
126766148|NCT03710824|456097246|FG000|Overall Study|Adverse Event|25|||
126766149|NCT03710824|456097246|FG000|Overall Study|Treatment discontinuation|2|||
126766150|NCT02329834|456097247|FG000|Overall Study|Physician Decision|1|||
126766151|NCT02329834|456097248|FG001|Overall Study|Physician Decision|0|||
126766152|NCT00578448|456097249|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
126766153|NCT00578448|456097249|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
126766154|NCT00578448|456097249|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
126766155|NCT00578448|456097249|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
126766156|NCT01976104|456097250|FG000|Overall Study|Adverse Event|0|||
126766157|NCT01976104|456097251|FG001|Overall Study|Adverse Event|0|||
126766158|NCT01976104|456097252|FG002|Overall Study|Adverse Event|1|||
126766159|NCT01976104|456097253|FG003|Overall Study|Adverse Event|0|||
126766160|NCT01976104|456097250|FG000|Overall Study|Lost to Follow-up|3|||
126766161|NCT01976104|456097251|FG001|Overall Study|Lost to Follow-up|0|||
126766162|NCT01976104|456097252|FG002|Overall Study|Lost to Follow-up|1|||
126766163|NCT01976104|456097253|FG003|Overall Study|Lost to Follow-up|1|||
126766164|NCT01976104|456097250|FG000|Overall Study|Subject Choice|0|||
126766165|NCT01976104|456097251|FG001|Overall Study|Subject Choice|1|||
126766166|NCT01976104|456097252|FG002|Overall Study|Subject Choice|0|||
126766167|NCT01976104|456097253|FG003|Overall Study|Subject Choice|1|||
126766168|NCT01976104|456097250|FG000|Overall Study|Withdrawal by Subject|3|||
126766169|NCT01976104|456097251|FG001|Overall Study|Withdrawal by Subject|0|||
126766170|NCT01976104|456097252|FG002|Overall Study|Withdrawal by Subject|0|||
126766171|NCT01976104|456097253|FG003|Overall Study|Withdrawal by Subject|1|||
126766172|NCT01976104|456097250|FG000|Overall Study|Other|0|||
126766173|NCT01976104|456097251|FG001|Overall Study|Other|1|||
126766174|NCT01976104|456097252|FG002|Overall Study|Other|0|||
126766175|NCT01976104|456097253|FG003|Overall Study|Other|0|||
126766176|NCT01317199|456097254|FG000|Dose-escalation Phase 1|Physician Decision|5|||
126766177|NCT01317199|456097255|FG001|Dose-escalation Phase 1|Physician Decision|0|||
126766178|NCT01317199|456097256|FG002|Dose-escalation Phase 1|Physician Decision|0|||
126285848|NCT00993421|454333074|FG001|Overall Study|Death|0|||
126365175|NCT00266032|454631705|FG000|Open-label Safety Extension|Adverse Event|5|||
126365176|NCT00266032|454631706|FG001|Open-label Safety Extension|Adverse Event|0|||
126365177|NCT00266032|454631707|FG002|Open-label Safety Extension|Adverse Event|4|||
126365178|NCT00266032|454631705|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
126365179|NCT00266032|454631706|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
126365180|NCT00266032|454631707|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
126365181|NCT00266032|454631705|FG000|Open-label Safety Extension|Pregnancy|4|||
126365182|NCT00266032|454631706|FG001|Open-label Safety Extension|Pregnancy|1|||
126365183|NCT00266032|454631707|FG002|Open-label Safety Extension|Pregnancy|2|||
126365184|NCT00266032|454631705|FG000|Open-label Safety Extension|Protocol Violation|1|||
126365185|NCT00266032|454631706|FG001|Open-label Safety Extension|Protocol Violation|3|||
126365186|NCT00266032|454631707|FG002|Open-label Safety Extension|Protocol Violation|2|||
126285849|NCT00993421|454333075|FG002|Overall Study|Death|0|||
126766179|NCT01317199|456097257|FG003|Dose-escalation Phase 1|Physician Decision|0|||
126766180|NCT01317199|456097254|FG000|Dose-escalation Phase 1|Disease progression|1|||
126766181|NCT01317199|456097255|FG001|Dose-escalation Phase 1|Disease progression|0|||
126766182|NCT01317199|456097256|FG002|Dose-escalation Phase 1|Disease progression|0|||
126766183|NCT01317199|456097257|FG003|Dose-escalation Phase 1|Disease progression|0|||
126766184|NCT01317199|456097254|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
126766185|NCT01317199|456097255|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
126766186|NCT01317199|456097256|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
126766187|NCT01317199|456097257|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
126766188|NCT01317199|456097254|FG000|Randomized Phase 2|Disease progression|0|||
126766189|NCT01317199|456097255|FG001|Randomized Phase 2|Disease progression|3|||
126766190|NCT01317199|456097256|FG002|Randomized Phase 2|Disease progression|7|||
126766191|NCT01317199|456097257|FG003|Randomized Phase 2|Disease progression|5|||
126766192|NCT01317199|456097254|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
126766193|NCT01317199|456097255|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
126766194|NCT01317199|456097256|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
126766195|NCT01317199|456097257|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
126766196|NCT01317199|456097254|FG000|Randomized Phase 2|Adverse Event|0|||
126766197|NCT01317199|456097255|FG001|Randomized Phase 2|Adverse Event|0|||
126766198|NCT01317199|456097256|FG002|Randomized Phase 2|Adverse Event|0|||
126766199|NCT01317199|456097257|FG003|Randomized Phase 2|Adverse Event|1|||
126766200|NCT01317199|456097254|FG000|Randomized Phase 2|Comorbidities|0|||
126766201|NCT01317199|456097255|FG001|Randomized Phase 2|Comorbidities|2|||
126766202|NCT01317199|456097256|FG002|Randomized Phase 2|Comorbidities|2|||
126766203|NCT01317199|456097257|FG003|Randomized Phase 2|Comorbidities|2|||
126766204|NCT01317199|456097254|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
126766205|NCT01317199|456097255|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
126766206|NCT01317199|456097256|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
126766207|NCT01317199|456097257|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
126766208|NCT01317199|456097254|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
126766209|NCT01317199|456097255|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
126766210|NCT01317199|456097256|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
126766211|NCT01317199|456097257|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
126766212|NCT01317199|456097254|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
126766213|NCT01317199|456097255|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
126766214|NCT01317199|456097256|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
126766215|NCT01317199|456097257|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
126766216|NCT01317199|456097254|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
126766217|NCT01317199|456097255|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
126766218|NCT01317199|456097256|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
126766219|NCT01317199|456097257|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
126766220|NCT01353209|456097258|FG000|Overall Study|Adverse Event|1|||
126766221|NCT01353209|456097259|FG001|Overall Study|Adverse Event|1|||
126766222|NCT01301625|456097271|FG000|Overall Study|Death|5|||
126766223|NCT01301625|456097271|FG000|Overall Study|Not Due|21|||
126766224|NCT01301625|456097271|FG000|Overall Study|Expected|8|||
126766225|NCT01301625|456097271|FG000|Overall Study|Lost to Follow-up|1|||
126549422|NCT01108510|455305621|FG000|Overall Study|Participant Noncompliance|5|||
126549423|NCT01108510|455305622|FG001|Overall Study|Participant Noncompliance|7|||
126766226|NCT03237325|456097274|FG000|Overall Study|Lost to Follow-up|3|||
126766227|NCT03237325|456097275|FG001|Overall Study|Lost to Follow-up|5|||
126766228|NCT03237325|456097274|FG000|Overall Study|Physician Decision|2|||
126766229|NCT03237325|456097275|FG001|Overall Study|Physician Decision|4|||
126766230|NCT03237325|456097274|FG000|Overall Study|Withdrawal by Subject|9|||
126365187|NCT00266032|454631705|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
126365188|NCT00266032|454631706|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
126365189|NCT00266032|454631707|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
126365190|NCT00266032|454631705|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
126365191|NCT00266032|454631706|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
126365192|NCT00266032|454631707|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
126365193|NCT01514357|454631711|FG000|Overall Study|Screen failure|2|||
126365194|NCT01514357|454631712|FG001|Overall Study|Screen failure|0|||
126365195|NCT01514357|454631711|FG000|Overall Study|Withdrawal by Subject|2|||
126365196|NCT01514357|454631712|FG001|Overall Study|Withdrawal by Subject|0|||
126365197|NCT00752219|454631713|FG000|Overall Study|Clinical failure|0|||
126365198|NCT00752219|454631714|FG001|Overall Study|Clinical failure|1|||
126365199|NCT00752219|454631713|FG000|Overall Study|Adverse Event|5|||
126365200|NCT00752219|454631714|FG001|Overall Study|Adverse Event|3|||
126365201|NCT00752219|454631713|FG000|Overall Study|Protocol deviation|1|||
126365202|NCT00752219|454631714|FG001|Overall Study|Protocol deviation|0|||
126365203|NCT00752219|454631713|FG000|Overall Study|Lost to Follow-up|1|||
126365204|NCT00752219|454631714|FG001|Overall Study|Lost to Follow-up|2|||
126365205|NCT00752219|454631713|FG000|Overall Study|Randomized but not treated|1|||
126365206|NCT00752219|454631714|FG001|Overall Study|Randomized but not treated|0|||
126365207|NCT00752219|454631713|FG000|Overall Study|Other|3|||
126365208|NCT00752219|454631714|FG001|Overall Study|Other|0|||
126365209|NCT04691115|454631717|FG000|Overall Study|Withdrawal by Subject|0|||
126365210|NCT04691115|454631718|FG001|Overall Study|Withdrawal by Subject|0|||
126365211|NCT04691115|454631719|FG002|Overall Study|Withdrawal by Subject|0|||
126365212|NCT04691115|454631720|FG003|Overall Study|Withdrawal by Subject|0|||
126365213|NCT04691115|454631721|FG004|Overall Study|Withdrawal by Subject|0|||
126365214|NCT04691115|454631722|FG005|Overall Study|Withdrawal by Subject|1|||
126365215|NCT04691115|454631723|FG006|Overall Study|Withdrawal by Subject|0|||
126365216|NCT04691115|454631724|FG007|Overall Study|Withdrawal by Subject|0|||
126365217|NCT04691115|454631725|FG008|Overall Study|Withdrawal by Subject|0|||
126365218|NCT04691115|454631726|FG009|Overall Study|Withdrawal by Subject|0|||
126365219|NCT04691115|454631727|FG010|Overall Study|Withdrawal by Subject|0|||
126365220|NCT04691115|454631728|FG011|Overall Study|Withdrawal by Subject|0|||
126365221|NCT04691115|454631729|FG012|Overall Study|Withdrawal by Subject|0|||
126365222|NCT04691115|454631730|FG013|Overall Study|Withdrawal by Subject|0|||
126709510|NCT00957372|455888039|FG003|PART II|Withdrawal by Subject|8|||
126709511|NCT00957372|455888036|FG000|PART II|Physician Decision|0|||
126709512|NCT00957372|455888037|FG001|PART II|Physician Decision|0|||
126709513|NCT00957372|455888038|FG002|PART II|Physician Decision|0|||
126709514|NCT00957372|455888039|FG003|PART II|Physician Decision|1|||
126709515|NCT00957372|455888036|FG000|PART II|Pregnancy|0|||
126709516|NCT00957372|455888037|FG001|PART II|Pregnancy|0|||
126709517|NCT00957372|455888038|FG002|PART II|Pregnancy|0|||
126709518|NCT00957372|455888039|FG003|PART II|Pregnancy|1|||
126709519|NCT00957372|455888036|FG000|PART II|Not Know|0|||
126709520|NCT00957372|455888037|FG001|PART II|Not Know|0|||
126709521|NCT00957372|455888038|FG002|PART II|Not Know|0|||
126766231|NCT03237325|456097275|FG001|Overall Study|Withdrawal by Subject|12|||
126766232|NCT03237325|456097274|FG000|Overall Study|Noncompliance with Study Procedures|1|||
126766233|NCT03237325|456097275|FG001|Overall Study|Noncompliance with Study Procedures|1|||
126766234|NCT03237325|456097274|FG000|Overall Study|Termination by Sponsor|0|||
126766235|NCT03237325|456097275|FG001|Overall Study|Termination by Sponsor|1|||
126766236|NCT03237325|456097274|FG000|Overall Study|Reason other than described|0|||
126766237|NCT03237325|456097275|FG001|Overall Study|Reason other than described|2|||
126766238|NCT05102162|456097278|FG000|Overall Study|Withdrawal by Subject|3|||
126766239|NCT05102162|456097279|FG001|Overall Study|Withdrawal by Subject|0|||
126766240|NCT05102162|456097278|FG000|Overall Study|Baseline cultures negative|4|||
126766241|NCT05102162|456097279|FG001|Overall Study|Baseline cultures negative|2|||
126766242|NCT05102162|456097278|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
126766243|NCT05102162|456097279|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
126766244|NCT05102162|456097278|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
126766245|NCT05102162|456097279|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
126766246|NCT01165424|456097280|FG000|Overall Study|Clinical adverse experiences|1|||
126766247|NCT01165424|456097280|FG000|Overall Study|Laboratory adverse experiences|1|||
126766248|NCT01165424|456097280|FG000|Overall Study|Did not meet entry criteria|1|||
126766249|NCT01165424|456097280|FG000|Overall Study|Participant moved (relocated)|1|||
126766250|NCT02181673|456097281|FG000|Up to Week 24|Adverse Event|2|||
126766251|NCT02181673|456097282|FG001|Up to Week 24|Adverse Event|0|||
126766252|NCT02181673|456097283|FG002|Up to Week 24|Adverse Event|3|||
126766253|NCT02181673|456097281|FG000|Up to Week 24|Death|1|||
126766254|NCT02181673|456097282|FG001|Up to Week 24|Death|0|||
126766255|NCT02181673|456097283|FG002|Up to Week 24|Death|0|||
126766256|NCT02181673|456097281|FG000|Up to Week 24|Lack of Efficacy|1|||
126766257|NCT02181673|456097282|FG001|Up to Week 24|Lack of Efficacy|0|||
126766258|NCT02181673|456097283|FG002|Up to Week 24|Lack of Efficacy|0|||
126766259|NCT02181673|456097281|FG000|Up to Week 24|Lost to Follow-up|1|||
126766260|NCT02181673|456097282|FG001|Up to Week 24|Lost to Follow-up|0|||
126766261|NCT02181673|456097283|FG002|Up to Week 24|Lost to Follow-up|0|||
126766262|NCT02181673|456097281|FG000|Up to Week 24|Physician Decision|0|||
126766263|NCT02181673|456097282|FG001|Up to Week 24|Physician Decision|0|||
126766264|NCT02181673|456097283|FG002|Up to Week 24|Physician Decision|3|||
126766265|NCT02181673|456097281|FG000|Up to Week 24|Withdrawal by Subject|10|||
126766266|NCT02181673|456097282|FG001|Up to Week 24|Withdrawal by Subject|0|||
126766267|NCT02181673|456097283|FG002|Up to Week 24|Withdrawal by Subject|1|||
126766268|NCT02181673|456097281|FG000|Up to Week 24|Other|2|||
126766269|NCT02181673|456097282|FG001|Up to Week 24|Other|0|||
126365223|NCT00835042|454631735|FG000|First Intervention|Withdrawal by Subject|3|||
126365224|NCT00835042|454631736|FG001|First Intervention|Withdrawal by Subject|0|||
126709522|NCT00957372|455888039|FG003|PART II|Not Know|20|||
126709523|NCT00957372|455888036|FG000|PART II|Adverse Event|0|||
126709524|NCT00957372|455888037|FG001|PART II|Adverse Event|0|||
126709525|NCT00957372|455888038|FG002|PART II|Adverse Event|0|||
126709526|NCT00957372|455888039|FG003|PART II|Adverse Event|10|||
126766270|NCT02181673|456097283|FG002|Up to Week 24|Other|3|||
126766271|NCT02181673|456097281|FG000|Up to Week 24|Randomized not Treated|0|||
126766272|NCT02181673|456097282|FG001|Up to Week 24|Randomized not Treated|0|||
126766273|NCT02181673|456097283|FG002|Up to Week 24|Randomized not Treated|1|||
126456615|NCT04966910|454972829|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
126766274|NCT02181673|456097281|FG000|Week 24-Week 60|Adverse Event|0|||
126766275|NCT02181673|456097282|FG001|Week 24-Week 60|Adverse Event|4|||
126766276|NCT02181673|456097283|FG002|Week 24-Week 60|Adverse Event|10|||
126766277|NCT02181673|456097281|FG000|Week 24-Week 60|Other|0|||
126766278|NCT02181673|456097282|FG001|Week 24-Week 60|Other|2|||
126766279|NCT02181673|456097283|FG002|Week 24-Week 60|Other|1|||
126766280|NCT02181673|456097281|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
126766281|NCT02181673|456097282|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
126766282|NCT02181673|456097283|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
126766283|NCT02181673|456097281|FG000|Week 24-Week 60|Pregnancy|0|||
126766284|NCT02181673|456097282|FG001|Week 24-Week 60|Pregnancy|0|||
126766285|NCT02181673|456097283|FG002|Week 24-Week 60|Pregnancy|1|||
126766286|NCT02181673|456097281|FG000|Week 24-Week 60|Lack of Efficacy|0|||
126766287|NCT02181673|456097282|FG001|Week 24-Week 60|Lack of Efficacy|0|||
126766288|NCT02181673|456097283|FG002|Week 24-Week 60|Lack of Efficacy|1|||
126766289|NCT02181673|456097281|FG000|Week 24-Week 60|Lost to Follow-up|0|||
126766290|NCT02181673|456097282|FG001|Week 24-Week 60|Lost to Follow-up|0|||
126766291|NCT02181673|456097283|FG002|Week 24-Week 60|Lost to Follow-up|1|||
126766292|NCT02181673|456097281|FG000|Week 24-Week 60|Physician Decision|0|||
126766293|NCT02181673|456097282|FG001|Week 24-Week 60|Physician Decision|0|||
126766294|NCT02181673|456097283|FG002|Week 24-Week 60|Physician Decision|1|||
126766295|NCT00138658|456097284|FG000|Overall Study|Adverse Event|23|||
126766296|NCT00138658|456097284|FG000|Overall Study|Death|1|||
126766297|NCT00138658|456097284|FG000|Overall Study|Disease Progression|21|||
126766298|NCT00138658|456097284|FG000|Overall Study|Physician Decision|11|||
126766299|NCT00138658|456097284|FG000|Overall Study|Withdrawal by Subject|5|||
126766300|NCT04637815|456097287|FG000|Overall Study|Death|1|||
126766301|NCT04637815|456097288|FG001|Overall Study|Death|0|||
126766302|NCT04637815|456097287|FG000|Overall Study|Lost to Follow-up|5|||
126766303|NCT04637815|456097288|FG001|Overall Study|Lost to Follow-up|2|||
126766304|NCT00337727|456097289|FG000|Overall Study|Adverse Event|5|||
126766305|NCT00337727|456097290|FG001|Overall Study|Adverse Event|3|||
126285850|NCT00993421|454333076|FG003|Overall Study|Death|0|||
126456616|NCT04966910|454972826|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
126766306|NCT00337727|456097289|FG000|Overall Study|Lost to Follow-up|5|||
126766307|NCT00337727|456097290|FG001|Overall Study|Lost to Follow-up|4|||
126766308|NCT00337727|456097289|FG000|Overall Study|Physician Decision|1|||
126766309|NCT00337727|456097290|FG001|Overall Study|Physician Decision|0|||
126766310|NCT00337727|456097289|FG000|Overall Study|Protocol Violation|4|||
126766311|NCT00337727|456097290|FG001|Overall Study|Protocol Violation|0|||
126766312|NCT00337727|456097289|FG000|Overall Study|Withdrawal by Subject|3|||
126766313|NCT00337727|456097290|FG001|Overall Study|Withdrawal by Subject|5|||
126766314|NCT00320801|456097291|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
126766315|NCT00320801|456097292|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
126766316|NCT00320801|456097293|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
126766317|NCT00320801|456097294|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
126766318|NCT00320801|456097291|FG000|Open-label Run-in Period|Adverse Event|33|||
126766319|NCT00320801|456097292|FG001|Open-label Run-in Period|Adverse Event|0|||
126766320|NCT00320801|456097293|FG002|Open-label Run-in Period|Adverse Event|0|||
126766321|NCT00320801|456097294|FG003|Open-label Run-in Period|Adverse Event|0|||
126766322|NCT00320801|456097291|FG000|Open-label Run-in Period|Administrative|10|||
126766323|NCT00320801|456097292|FG001|Open-label Run-in Period|Administrative|0|||
126766324|NCT00320801|456097293|FG002|Open-label Run-in Period|Administrative|0|||
126456617|NCT04966910|454972827|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
126456618|NCT04966910|454972828|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
126456619|NCT04966910|454972829|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
126456620|NCT01142089|454972836|FG000|Overall Study|Physician Decision|1|||
126456621|NCT01142089|454972837|FG001|Overall Study|Physician Decision|0|||
126456622|NCT01142089|454972836|FG000|Overall Study|Withdrawal by Subject|1|||
126456623|NCT01142089|454972837|FG001|Overall Study|Withdrawal by Subject|2|||
126456624|NCT01142089|454972836|FG000|Overall Study|Use of prohibited medications|0|||
126456625|NCT01142089|454972837|FG001|Overall Study|Use of prohibited medications|1|||
126456626|NCT01142089|454972836|FG000|Overall Study|Noncompliance with study procedures|2|||
126766325|NCT00320801|456097294|FG003|Open-label Run-in Period|Administrative|0|||
126766326|NCT00320801|456097291|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
126766327|NCT00320801|456097292|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
126456627|NCT01142089|454972837|FG001|Overall Study|Noncompliance with study procedures|1|||
126766328|NCT00320801|456097293|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
126766329|NCT00320801|456097294|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
126456628|NCT01142089|454972836|FG000|Overall Study|Patient required rescue medication|8|||
126766330|NCT00320801|456097291|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
126766331|NCT00320801|456097292|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
126766332|NCT00320801|456097293|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
126285851|NCT00993421|454333077|FG004|Overall Study|Death|0|||
126766333|NCT00320801|456097294|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
126766334|NCT00320801|456097291|FG000|Open-label Run-in Period|Did not qualify|1|||
126766335|NCT00320801|456097292|FG001|Open-label Run-in Period|Did not qualify|0|||
126766336|NCT00320801|456097293|FG002|Open-label Run-in Period|Did not qualify|0|||
126766337|NCT00320801|456097294|FG003|Open-label Run-in Period|Did not qualify|0|||
126766338|NCT00320801|456097291|FG000|Double-blind Phase|Withdrawal by Subject|0|||
126766339|NCT00320801|456097292|FG001|Double-blind Phase|Withdrawal by Subject|0|||
126766340|NCT00320801|456097293|FG002|Double-blind Phase|Withdrawal by Subject|1|||
126766341|NCT00320801|456097294|FG003|Double-blind Phase|Withdrawal by Subject|0|||
126766342|NCT00320801|456097291|FG000|Double-blind Phase|Adverse Event|0|||
126766343|NCT00320801|456097292|FG001|Double-blind Phase|Adverse Event|2|||
126766344|NCT00320801|456097293|FG002|Double-blind Phase|Adverse Event|8|||
126456629|NCT01142089|454972837|FG001|Overall Study|Patient required rescue medication|17|||
126456630|NCT02907892|454972840|FG000|Overall Study|Lost to Follow-up|27|||
126456631|NCT02907892|454972841|FG001|Overall Study|Lost to Follow-up|40|||
126456632|NCT01974765|454972842|FG000|Overall Study|Withdrawal by Subject|1|||
126456633|NCT01974765|454972842|FG000|Overall Study|Death|1|||
126456634|NCT01974765|454972842|FG000|Overall Study|Adverse Event|2|||
126456635|NCT00730028|454972846|FG000|Overall Study|Adverse Event|23|||
126456636|NCT00730028|454972847|FG001|Overall Study|Adverse Event|26|||
126456637|NCT00730028|454972848|FG002|Overall Study|Adverse Event|16|||
126456638|NCT00730028|454972849|FG003|Overall Study|Adverse Event|20|||
126456639|NCT00730028|454972850|FG004|Overall Study|Adverse Event|43|||
126456640|NCT00730028|454972846|FG000|Overall Study|Lost to Follow-up|13|||
126456641|NCT00730028|454972847|FG001|Overall Study|Lost to Follow-up|26|||
126456642|NCT00730028|454972848|FG002|Overall Study|Lost to Follow-up|22|||
126456643|NCT00730028|454972849|FG003|Overall Study|Lost to Follow-up|26|||
126456644|NCT00730028|454972850|FG004|Overall Study|Lost to Follow-up|25|||
126456645|NCT00730028|454972846|FG000|Overall Study|Protocol Violation|6|||
126456646|NCT00730028|454972847|FG001|Overall Study|Protocol Violation|1|||
126456647|NCT00730028|454972848|FG002|Overall Study|Protocol Violation|1|||
126456648|NCT00730028|454972849|FG003|Overall Study|Protocol Violation|2|||
126456649|NCT00730028|454972850|FG004|Overall Study|Protocol Violation|0|||
126456650|NCT00730028|454972846|FG000|Overall Study|Withdrawal by Subject|9|||
126456651|NCT00730028|454972847|FG001|Overall Study|Withdrawal by Subject|5|||
126456652|NCT00730028|454972848|FG002|Overall Study|Withdrawal by Subject|4|||
126456653|NCT00730028|454972849|FG003|Overall Study|Withdrawal by Subject|5|||
126456654|NCT00730028|454972850|FG004|Overall Study|Withdrawal by Subject|9|||
126456655|NCT00730028|454972846|FG000|Overall Study|Physician Decision|3|||
126456656|NCT00730028|454972847|FG001|Overall Study|Physician Decision|3|||
126456657|NCT00730028|454972848|FG002|Overall Study|Physician Decision|2|||
126456658|NCT00730028|454972849|FG003|Overall Study|Physician Decision|3|||
126456659|NCT00730028|454972850|FG004|Overall Study|Physician Decision|2|||
126456660|NCT00730028|454972846|FG000|Overall Study|Treatment Failure|5|||
126456661|NCT00730028|454972847|FG001|Overall Study|Treatment Failure|5|||
126456662|NCT00730028|454972848|FG002|Overall Study|Treatment Failure|0|||
126456663|NCT00730028|454972849|FG003|Overall Study|Treatment Failure|0|||
126456664|NCT00730028|454972850|FG004|Overall Study|Treatment Failure|1|||
126456665|NCT00730028|454972846|FG000|Overall Study|Randomization Error|1|||
126456666|NCT00730028|454972847|FG001|Overall Study|Randomization Error|0|||
126456667|NCT00730028|454972848|FG002|Overall Study|Randomization Error|0|||
126456668|NCT00730028|454972849|FG003|Overall Study|Randomization Error|0|||
126456669|NCT00730028|454972850|FG004|Overall Study|Randomization Error|2|||
126456670|NCT03860935|454972851|FG000|Overall Study|Withdrawal of Consent|15|||
126456671|NCT03860935|454972852|FG001|Overall Study|Withdrawal of Consent|6|||
126456672|NCT03860935|454972851|FG000|Overall Study|Death|75|||
126456673|NCT03860935|454972852|FG001|Overall Study|Death|51|||
126456674|NCT01430754|454972853|FG000|Run-In Phase|Circadian Period Ineligible|24|||
126766345|NCT00320801|456097294|FG003|Double-blind Phase|Adverse Event|0|||
126766346|NCT00320801|456097291|FG000|Double-blind Phase|Administrative|0|||
126456675|NCT01430754|454972854|FG001|Run-In Phase|Circadian Period Ineligible|0|||
126456676|NCT01430754|454972853|FG000|Run-In Phase|Protocol Violation|6|||
126456677|NCT01430754|454972854|FG001|Run-In Phase|Protocol Violation|0|||
126456678|NCT01430754|454972853|FG000|Run-In Phase|Adverse Event|2|||
126456679|NCT01430754|454972854|FG001|Run-In Phase|Adverse Event|0|||
126456680|NCT01430754|454972853|FG000|Run-In Phase|Other|2|||
126456681|NCT01430754|454972854|FG001|Run-In Phase|Other|0|||
126456682|NCT01430754|454972853|FG000|Run-In Phase|Withdrawal by Subject|2|||
126456683|NCT01430754|454972854|FG001|Run-In Phase|Withdrawal by Subject|0|||
126456684|NCT01430754|454972853|FG000|Run-In Phase|Lost to Follow-up|1|||
126456685|NCT01430754|454972854|FG001|Run-In Phase|Lost to Follow-up|0|||
126456686|NCT00701662|454972858|FG000|Overall Study|Lack of Efficacy|1|||
126456687|NCT00635024|454972859|FG000|Overall Study|Adverse Event|1|||
126456688|NCT01105065|454972860|FG000|Overall Study|Adverse Event|5|||
126456689|NCT01105065|454972860|FG000|Overall Study|Technical Problems|1|||
126456690|NCT01038869|454972862|FG000|Overall Study|Withdrawal by Subject|1|||
126549424|NCT01108510|455305621|FG000|Overall Study|Lack of Efficacy|3|||
126456691|NCT01038869|454972862|FG000|Overall Study|Lost to Follow-up|6|||
126456692|NCT02536404|454972865|FG000|Overall Study|Adverse Event|5|||
126766347|NCT00320801|456097292|FG001|Double-blind Phase|Administrative|0|||
126766348|NCT00320801|456097293|FG002|Double-blind Phase|Administrative|4|||
126766349|NCT00320801|456097294|FG003|Double-blind Phase|Administrative|0|||
126456693|NCT02536404|454972866|FG001|Overall Study|Adverse Event|0|||
126456694|NCT02536404|454972865|FG000|Overall Study|Withdrawal by Subject|4|||
126456695|NCT02536404|454972866|FG001|Overall Study|Withdrawal by Subject|1|||
126456696|NCT02536404|454972865|FG000|Overall Study|Physician Decision|10|||
126456697|NCT02536404|454972866|FG001|Overall Study|Physician Decision|0|||
126456698|NCT02536404|454972865|FG000|Overall Study|Sponsor decision|1|||
126456699|NCT02536404|454972866|FG001|Overall Study|Sponsor decision|0|||
126456700|NCT01238588|454972868|FG000|Overall Study|Withdrawal by Subject|1|||
126456701|NCT01238588|454972868|FG000|Overall Study|Physician Decision|2|||
126456702|NCT00321646|454972869|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
126456703|NCT00321646|454972869|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
126456704|NCT00321646|454972869|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
126456705|NCT02576145|454972870|FG000|Overall Study|Adverse Event|1|||
126456706|NCT02576145|454972871|FG001|Overall Study|Adverse Event|0|||
126456707|NCT02576145|454972870|FG000|Overall Study|Withdrawal by Subject|1|||
126456708|NCT02576145|454972871|FG001|Overall Study|Withdrawal by Subject|0|||
126456709|NCT02576145|454972870|FG000|Overall Study|Acute rejection|1|||
126456710|NCT02576145|454972871|FG001|Overall Study|Acute rejection|0|||
126456711|NCT02576145|454972870|FG000|Overall Study|Tetanus Titers Decreased|0|||
126456712|NCT02576145|454972871|FG001|Overall Study|Tetanus Titers Decreased|1|||
126456713|NCT02660138|454972873|FG000|Overall Study|Adverse Event|0|||
126456714|NCT02660138|454972874|FG001|Overall Study|Adverse Event|3|||
126456715|NCT02660138|454972875|FG002|Overall Study|Adverse Event|2|||
126549425|NCT01108510|455305622|FG001|Overall Study|Lack of Efficacy|0|||
126549426|NCT01108510|455305621|FG000|Overall Study|Pregnancy|0|||
126709527|NCT00957372|455888036|FG000|PART II|Patient non-compliance|0|||
126709528|NCT00957372|455888037|FG001|PART II|Patient non-compliance|0|||
126709529|NCT00957372|455888038|FG002|PART II|Patient non-compliance|0|||
126709530|NCT00957372|455888039|FG003|PART II|Patient non-compliance|4|||
126709531|NCT02104180|455888040|FG000|Overall Study|Protocol Violation|1|||
126709532|NCT02104180|455888041|FG001|Overall Study|Protocol Violation|0|||
126709533|NCT01524289|455888042|FG000|Overall Study|Lost to Follow-up|0|||
126709534|NCT01524289|455888043|FG001|Overall Study|Lost to Follow-up|1|||
126709535|NCT01524289|455888042|FG000|Overall Study|Physician Decision|1|||
126709536|NCT01524289|455888043|FG001|Overall Study|Physician Decision|0|||
126709537|NCT01524289|455888042|FG000|Overall Study|Protocol Violation|5|||
126709538|NCT01524289|455888043|FG001|Overall Study|Protocol Violation|1|||
126709539|NCT01524289|455888042|FG000|Overall Study|Withdrawal by Subject|11|||
126709540|NCT01524289|455888043|FG001|Overall Study|Withdrawal by Subject|7|||
126709541|NCT01524289|455888042|FG000|Overall Study|Adverse Event|12|||
126709542|NCT01524289|455888043|FG001|Overall Study|Adverse Event|5|||
126709543|NCT01524289|455888042|FG000|Overall Study|Did not take study medication|1|||
126709544|NCT01524289|455888043|FG001|Overall Study|Did not take study medication|0|||
126709545|NCT01444391|455888044|FG000|Overall Study|Death|1|||
126709546|NCT01855789|455888046|FG000|1) Baseline up to Week 24|Adverse Event|37|||
126709547|NCT01855789|455888047|FG001|1) Baseline up to Week 24|Adverse Event|0|||
126709548|NCT01855789|455888048|FG002|1) Baseline up to Week 24|Adverse Event|0|||
126709549|NCT01855789|455888049|FG003|1) Baseline up to Week 24|Adverse Event|0|||
126709550|NCT01855789|455888046|FG000|1) Baseline up to Week 24|Death|2|||
126709551|NCT01855789|455888047|FG001|1) Baseline up to Week 24|Death|0|||
126709552|NCT01855789|455888048|FG002|1) Baseline up to Week 24|Death|0|||
126709553|NCT01855789|455888049|FG003|1) Baseline up to Week 24|Death|0|||
126709554|NCT01855789|455888046|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
126709555|NCT01855789|455888047|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
126709556|NCT01855789|455888048|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
126709557|NCT01855789|455888049|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
126709558|NCT01855789|455888046|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
126709559|NCT01855789|455888047|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
126709560|NCT01855789|455888048|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
126709561|NCT01855789|455888049|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
126709562|NCT01855789|455888046|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
126709563|NCT01855789|455888047|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
126709564|NCT01855789|455888048|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
126766350|NCT00320801|456097291|FG000|Double-blind Phase|Lack of Efficacy|0|||
126456716|NCT02660138|454972873|FG000|Overall Study|Lack of Efficacy|1|||
126456717|NCT02660138|454972874|FG001|Overall Study|Lack of Efficacy|2|||
126456718|NCT02660138|454972875|FG002|Overall Study|Lack of Efficacy|1|||
126456719|NCT02660138|454972873|FG000|Overall Study|Withdrawal by Subject|7|||
126549427|NCT01108510|455305622|FG001|Overall Study|Pregnancy|3|||
126709565|NCT01855789|455888049|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
126709566|NCT01855789|455888046|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
126709567|NCT01855789|455888047|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
126709568|NCT01855789|455888048|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
126709569|NCT01855789|455888049|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
126766351|NCT00320801|456097292|FG001|Double-blind Phase|Lack of Efficacy|9|||
126456720|NCT02660138|454972874|FG001|Overall Study|Withdrawal by Subject|6|||
126456721|NCT02660138|454972875|FG002|Overall Study|Withdrawal by Subject|6|||
126456722|NCT02660138|454972873|FG000|Overall Study|Lost to Follow-up|4|||
126456723|NCT02660138|454972874|FG001|Overall Study|Lost to Follow-up|4|||
126456724|NCT02660138|454972875|FG002|Overall Study|Lost to Follow-up|1|||
126456725|NCT02660138|454972873|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
126456726|NCT02660138|454972874|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
126456727|NCT02660138|454972875|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
126456728|NCT02660138|454972873|FG000|Overall Study|Other|1|||
126456729|NCT02660138|454972874|FG001|Overall Study|Other|1|||
126456730|NCT02660138|454972875|FG002|Overall Study|Other|0|||
126456731|NCT02660138|454972873|FG000|Overall Study|Not treated|0|||
126456732|NCT02660138|454972874|FG001|Overall Study|Not treated|1|||
126456733|NCT02660138|454972875|FG002|Overall Study|Not treated|0|||
126456734|NCT00308581|454972876|FG000|Induction Phase|Adverse Event|0|||
126456735|NCT00308581|454972877|FG001|Induction Phase|Adverse Event|0|||
126456736|NCT00308581|454972878|FG002|Induction Phase|Adverse Event|37|||
126456737|NCT00308581|454972876|FG000|Induction Phase|Lack of Efficacy|0|||
126456738|NCT00308581|454972877|FG001|Induction Phase|Lack of Efficacy|0|||
126456739|NCT00308581|454972878|FG002|Induction Phase|Lack of Efficacy|121|||
126456740|NCT00308581|454972876|FG000|Induction Phase|Withdrawal by Subject|0|||
126456741|NCT00308581|454972877|FG001|Induction Phase|Withdrawal by Subject|0|||
126456742|NCT00308581|454972878|FG002|Induction Phase|Withdrawal by Subject|5|||
126456743|NCT00308581|454972876|FG000|Induction Phase|Unknown reason|0|||
126456744|NCT00308581|454972877|FG001|Induction Phase|Unknown reason|0|||
126456745|NCT00308581|454972878|FG002|Induction Phase|Unknown reason|3|||
126709570|NCT01855789|455888046|FG000|1) Baseline up to Week 24|Physician Decision|4|||
126709571|NCT01855789|455888047|FG001|1) Baseline up to Week 24|Physician Decision|0|||
126709572|NCT01855789|455888048|FG002|1) Baseline up to Week 24|Physician Decision|0|||
126709573|NCT01855789|455888049|FG003|1) Baseline up to Week 24|Physician Decision|0|||
126709574|NCT01855789|455888046|FG000|1) Baseline up to Week 24|Pregnancy|1|||
126709575|NCT01855789|455888047|FG001|1) Baseline up to Week 24|Pregnancy|0|||
126709576|NCT01855789|455888048|FG002|1) Baseline up to Week 24|Pregnancy|0|||
126709577|NCT01855789|455888049|FG003|1) Baseline up to Week 24|Pregnancy|0|||
126709578|NCT01855789|455888046|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
126709579|NCT01855789|455888047|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
126709580|NCT01855789|455888048|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
126709581|NCT01855789|455888049|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
126709582|NCT01855789|455888046|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
126709583|NCT01855789|455888047|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
126709584|NCT01855789|455888048|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
126709585|NCT01855789|455888049|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
126709586|NCT01855789|455888046|FG000|1) Baseline up to Week 24|Other|4|||
126709587|NCT01855789|455888047|FG001|1) Baseline up to Week 24|Other|0|||
126709588|NCT01855789|455888048|FG002|1) Baseline up to Week 24|Other|0|||
126709589|NCT01855789|455888049|FG003|1) Baseline up to Week 24|Other|0|||
126709590|NCT01855789|455888046|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
126709591|NCT01855789|455888047|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
126709592|NCT01855789|455888048|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
126709593|NCT01855789|455888049|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
126709594|NCT01855789|455888046|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
126709595|NCT01855789|455888047|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
126709596|NCT01855789|455888048|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
126709597|NCT01855789|455888049|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
126709598|NCT01855789|455888046|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
126709599|NCT01855789|455888047|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
126709600|NCT01855789|455888048|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
126709601|NCT01855789|455888049|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
126709602|NCT01855789|455888046|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
126709603|NCT01855789|455888047|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
126709604|NCT01855789|455888048|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
126709605|NCT01855789|455888049|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
126709606|NCT01855789|455888046|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
126709607|NCT01855789|455888047|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
126709608|NCT01855789|455888048|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
126709609|NCT01855789|455888049|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
126456746|NCT00308581|454972876|FG000|Randomized Maintenance Phase|Adverse Event|10|||
126456747|NCT00308581|454972877|FG001|Randomized Maintenance Phase|Adverse Event|17|||
126456748|NCT00308581|454972878|FG002|Randomized Maintenance Phase|Adverse Event|0|||
126456749|NCT00308581|454972876|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
126456750|NCT00308581|454972877|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
126456751|NCT00308581|454972878|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
126456752|NCT00308581|454972876|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
126709610|NCT01855789|455888046|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
126285852|NCT00993421|454333078|FG005|Overall Study|Death|0|||
126456753|NCT00308581|454972877|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
126456754|NCT00308581|454972878|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
126456755|NCT00308581|454972876|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
126456756|NCT00308581|454972877|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
126456757|NCT00308581|454972878|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
126456758|NCT00308581|454972876|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
126456759|NCT00308581|454972877|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
126456760|NCT00308581|454972878|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
126456761|NCT00308581|454972876|FG000|Randomized Maintenance Phase|Unknown reason|3|||
126456762|NCT00308581|454972877|FG001|Randomized Maintenance Phase|Unknown reason|0|||
126766352|NCT00320801|456097293|FG002|Double-blind Phase|Lack of Efficacy|1|||
126766353|NCT00320801|456097294|FG003|Double-blind Phase|Lack of Efficacy|0|||
126766354|NCT00320801|456097291|FG000|Extension Phase|Withdrawal by Subject|0|||
126766355|NCT00320801|456097292|FG001|Extension Phase|Withdrawal by Subject|0|||
126766356|NCT00320801|456097293|FG002|Extension Phase|Withdrawal by Subject|0|||
126766357|NCT00320801|456097294|FG003|Extension Phase|Withdrawal by Subject|6|||
126456763|NCT00308581|454972878|FG002|Randomized Maintenance Phase|Unknown reason|0|||
126456764|NCT02730793|454972880|FG000|Overall Study|Physician Decision|0|||
126456765|NCT02730793|454972881|FG001|Overall Study|Physician Decision|1|||
126456766|NCT02730793|454972880|FG000|Overall Study|Withdrawal by Subject|0|||
126456767|NCT02730793|454972881|FG001|Overall Study|Withdrawal by Subject|1|||
126456768|NCT01087788|454972882|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
126456769|NCT01087788|454972883|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
126456770|NCT01087788|454972884|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
126456771|NCT01087788|454972882|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
126456772|NCT01087788|454972883|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
126456773|NCT01087788|454972884|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
126456774|NCT01087788|454972882|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
126456775|NCT01087788|454972883|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
126456776|NCT01087788|454972884|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
126456777|NCT01087788|454972882|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
126456778|NCT01087788|454972883|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
126456779|NCT01087788|454972884|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
126456780|NCT01087788|454972882|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
126456781|NCT01087788|454972883|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
126456782|NCT01087788|454972884|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
126456783|NCT01087788|454972882|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
126456784|NCT01087788|454972883|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
126456785|NCT01087788|454972884|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
126456786|NCT01087788|454972882|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
126456787|NCT01087788|454972883|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
126456788|NCT01087788|454972884|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
126456789|NCT01087788|454972882|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
126456790|NCT01087788|454972883|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
126456791|NCT01087788|454972884|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
126456792|NCT01087788|454972882|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
126456793|NCT01087788|454972883|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
126456794|NCT01087788|454972884|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
126456795|NCT01087788|454972882|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
126456796|NCT01087788|454972883|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
126456797|NCT01087788|454972884|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
126456798|NCT01087788|454972882|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
126766358|NCT00320801|456097291|FG000|Extension Phase|Adverse Event|0|||
126766359|NCT00320801|456097292|FG001|Extension Phase|Adverse Event|0|||
126766360|NCT00320801|456097293|FG002|Extension Phase|Adverse Event|0|||
126766361|NCT00320801|456097294|FG003|Extension Phase|Adverse Event|8|||
126766362|NCT00320801|456097291|FG000|Extension Phase|Administrative|0|||
126766363|NCT00320801|456097292|FG001|Extension Phase|Administrative|0|||
126285853|NCT00993421|454333079|FG006|Overall Study|Death|1|||
126285854|NCT00993421|454333073|FG000|Overall Study|Entry Criteria Exclusion|0|||
126456799|NCT01087788|454972883|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
126456800|NCT01087788|454972884|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
126456801|NCT01087788|454972882|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
126456802|NCT01087788|454972883|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
126456803|NCT01087788|454972884|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
126456804|NCT01087788|454972882|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
126766364|NCT00320801|456097293|FG002|Extension Phase|Administrative|0|||
126766365|NCT00320801|456097294|FG003|Extension Phase|Administrative|29|||
126766366|NCT00320801|456097291|FG000|Extension Phase|Lack of Efficacy|0|||
126709611|NCT01855789|455888047|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
126709612|NCT01855789|455888048|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
126709613|NCT01855789|455888049|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
126709614|NCT01855789|455888046|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
126709615|NCT01855789|455888047|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
126709616|NCT01855789|455888048|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
126709617|NCT01855789|455888049|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
126709618|NCT01855789|455888046|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
126709619|NCT01855789|455888047|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
126709620|NCT01855789|455888048|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
126709621|NCT01855789|455888049|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
126709622|NCT01855789|455888046|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
126709623|NCT01855789|455888047|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
126709624|NCT01855789|455888048|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
126709625|NCT01855789|455888049|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
126709626|NCT01855789|455888046|FG000|2) Week 24 up to End of Study|Other|0|||
126709627|NCT01855789|455888047|FG001|2) Week 24 up to End of Study|Other|0|||
126709628|NCT01855789|455888048|FG002|2) Week 24 up to End of Study|Other|0|||
126709629|NCT01855789|455888049|FG003|2) Week 24 up to End of Study|Other|1|||
126709630|NCT03067311|455888050|FG000|Overall Study|Lost to Follow-up|1|||
126709631|NCT03067311|455888051|FG001|Overall Study|Lost to Follow-up|1|||
126709632|NCT03067311|455888050|FG000|Overall Study|Moved away|1|||
126709633|NCT03067311|455888051|FG001|Overall Study|Moved away|1|||
126709634|NCT00907738|455888052|FG000|Overall Study|Adverse Event|2|||
126709635|NCT00907738|455888053|FG001|Overall Study|Adverse Event|0|||
126709636|NCT00907738|455888054|FG002|Overall Study|Adverse Event|1|||
126709637|NCT00907738|455888055|FG003|Overall Study|Adverse Event|0|||
126709638|NCT00907738|455888056|FG004|Overall Study|Adverse Event|0|||
126709639|NCT00907738|455888052|FG000|Overall Study|not specified or withdrew consent|3|||
126709640|NCT00907738|455888053|FG001|Overall Study|not specified or withdrew consent|0|||
126709641|NCT00907738|455888054|FG002|Overall Study|not specified or withdrew consent|0|||
126709642|NCT00907738|455888055|FG003|Overall Study|not specified or withdrew consent|0|||
126709643|NCT00907738|455888056|FG004|Overall Study|not specified or withdrew consent|0|||
126709644|NCT00907738|455888052|FG000|Overall Study|Disease progression|8|||
126709645|NCT00907738|455888053|FG001|Overall Study|Disease progression|1|||
126709646|NCT00907738|455888054|FG002|Overall Study|Disease progression|6|||
126709647|NCT00907738|455888055|FG003|Overall Study|Disease progression|4|||
126709648|NCT00907738|455888056|FG004|Overall Study|Disease progression|2|||
126709649|NCT01089725|455888057|FG000|Overall Study|Adverse Event|1|||
126709650|NCT01089725|455888058|FG001|Overall Study|Adverse Event|1|||
126709651|NCT01089725|455888059|FG002|Overall Study|Adverse Event|0|||
126766367|NCT00320801|456097292|FG001|Extension Phase|Lack of Efficacy|0|||
126766368|NCT00320801|456097293|FG002|Extension Phase|Lack of Efficacy|0|||
126766369|NCT00320801|456097294|FG003|Extension Phase|Lack of Efficacy|2|||
126766370|NCT00320801|456097291|FG000|Extension Phase|Lost to Follow-up|0|||
126766371|NCT00320801|456097292|FG001|Extension Phase|Lost to Follow-up|0|||
126766372|NCT00320801|456097293|FG002|Extension Phase|Lost to Follow-up|0|||
126766373|NCT00320801|456097294|FG003|Extension Phase|Lost to Follow-up|3|||
126766374|NCT00577031|456097295|FG000|Overall Study|Adverse Event|52|||
126766375|NCT00577031|456097295|FG000|Overall Study|Progression of disease|93|||
126766376|NCT00577031|456097295|FG000|Overall Study|Protocol Violation|5|||
126766377|NCT00577031|456097295|FG000|Overall Study|Participant withdrew consent|13|||
126766378|NCT00577031|456097295|FG000|Overall Study|Participant non-compliance|5|||
126766379|NCT00577031|456097295|FG000|Overall Study|Need for surgery|17|||
126766380|NCT00577031|456097295|FG000|Overall Study|Medical decision|14|||
126766381|NCT00577031|456097295|FG000|Overall Study|Death|6|||
126766382|NCT06067191|456097296|FG000|Overall Study|Withdrawal by Subject|0|||
126766383|NCT06067191|456097297|FG001|Overall Study|Withdrawal by Subject|1|||
126766384|NCT04764669|456097299|FG000|Overall Study|Adverse Event|1|||
126766385|NCT04764669|456097300|FG001|Overall Study|Adverse Event|0|||
126766386|NCT04764669|456097301|FG002|Overall Study|Adverse Event|1|||
126709652|NCT01089725|455888060|FG003|Overall Study|Adverse Event|0|||
126709653|NCT01089725|455888061|FG004|Overall Study|Adverse Event|2|||
126709654|NCT01089725|455888057|FG000|Overall Study|Lack of Efficacy|4|||
126709655|NCT01089725|455888058|FG001|Overall Study|Lack of Efficacy|3|||
126766387|NCT04764669|456097302|FG003|Overall Study|Adverse Event|0|||
126766388|NCT04764669|456097299|FG000|Overall Study|Subject Choice|0|||
126549428|NCT01108510|455305621|FG000|Overall Study|Death|1|||
126709656|NCT01089725|455888059|FG002|Overall Study|Lack of Efficacy|1|||
126709657|NCT01089725|455888060|FG003|Overall Study|Lack of Efficacy|0|||
126709658|NCT01089725|455888061|FG004|Overall Study|Lack of Efficacy|4|||
126709659|NCT01089725|455888057|FG000|Overall Study|Lost to Follow-up|2|||
126709660|NCT01089725|455888058|FG001|Overall Study|Lost to Follow-up|2|||
126766389|NCT04764669|456097300|FG001|Overall Study|Subject Choice|0|||
126766390|NCT04764669|456097301|FG002|Overall Study|Subject Choice|1|||
126766391|NCT04764669|456097302|FG003|Overall Study|Subject Choice|0|||
126766392|NCT04764669|456097299|FG000|Overall Study|Withdrawal by Subject|2|||
126766393|NCT04764669|456097300|FG001|Overall Study|Withdrawal by Subject|0|||
126766394|NCT04764669|456097301|FG002|Overall Study|Withdrawal by Subject|0|||
126766395|NCT04764669|456097302|FG003|Overall Study|Withdrawal by Subject|0|||
126766396|NCT01067339|456097303|FG000|Overall Study|Withdrawal by Subject|6|||
126766397|NCT01067339|456097304|FG001|Overall Study|Withdrawal by Subject|5|||
126766398|NCT00877799|456097308|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
126766399|NCT00877799|456097309|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
126766400|NCT00877799|456097310|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
126766401|NCT00877799|456097311|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
126766402|NCT00877799|456097312|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
126766403|NCT00877799|456097308|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
126766404|NCT00877799|456097309|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
126766405|NCT00877799|456097310|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
126766406|NCT00877799|456097311|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
126766407|NCT00877799|456097312|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
126766408|NCT00877799|456097308|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
126766409|NCT00877799|456097309|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
126766410|NCT00877799|456097310|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
126766411|NCT00877799|456097311|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
126766412|NCT00877799|456097312|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
126766413|NCT00877799|456097308|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
126766414|NCT00877799|456097309|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
126766415|NCT00877799|456097310|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
126766416|NCT00877799|456097311|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
126766417|NCT00877799|456097312|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
126766418|NCT00877799|456097308|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
126766419|NCT00877799|456097309|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
126766420|NCT00877799|456097310|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
126766421|NCT00877799|456097311|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
126766422|NCT00877799|456097312|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
126766423|NCT04054011|456097313|FG000|Overall Study|COVID|3|||
126766424|NCT00557830|456097317|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
126365225|NCT00835042|454631735|FG000|First Intervention|Adverse Event|1|||
126365226|NCT00835042|454631736|FG001|First Intervention|Adverse Event|2|||
126709661|NCT01089725|455888059|FG002|Overall Study|Lost to Follow-up|0|||
126709662|NCT01089725|455888060|FG003|Overall Study|Lost to Follow-up|3|||
126709663|NCT01089725|455888061|FG004|Overall Study|Lost to Follow-up|0|||
126709664|NCT01089725|455888057|FG000|Overall Study|Protocol Violation|0|||
126709665|NCT01089725|455888058|FG001|Overall Study|Protocol Violation|0|||
126709666|NCT01089725|455888059|FG002|Overall Study|Protocol Violation|1|||
126709667|NCT01089725|455888060|FG003|Overall Study|Protocol Violation|1|||
126709668|NCT01089725|455888061|FG004|Overall Study|Protocol Violation|0|||
126709669|NCT01089725|455888057|FG000|Overall Study|Withdrawal by Subject|5|||
126709670|NCT01089725|455888058|FG001|Overall Study|Withdrawal by Subject|5|||
126709671|NCT01089725|455888059|FG002|Overall Study|Withdrawal by Subject|4|||
126365227|NCT00835042|454631735|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
126365228|NCT00835042|454631736|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
126365229|NCT02096354|454631737|FG000|Overall Study|Physician Decision|4|||
126365230|NCT02096354|454631738|FG001|Overall Study|Physician Decision|5|||
126365231|NCT02096354|454631739|FG002|Overall Study|Physician Decision|0|||
126365232|NCT02096354|454631737|FG000|Overall Study|Withdrawal by Subject|3|||
126365233|NCT02096354|454631738|FG001|Overall Study|Withdrawal by Subject|1|||
126365234|NCT02096354|454631739|FG002|Overall Study|Withdrawal by Subject|0|||
126365235|NCT02096354|454631737|FG000|Overall Study|Adverse Event|7|||
126365236|NCT02096354|454631738|FG001|Overall Study|Adverse Event|4|||
126365237|NCT02096354|454631739|FG002|Overall Study|Adverse Event|0|||
126365238|NCT02096354|454631737|FG000|Overall Study|Ineligible|0|||
126365239|NCT02096354|454631738|FG001|Overall Study|Ineligible|0|||
126365240|NCT02096354|454631739|FG002|Overall Study|Ineligible|11|||
126365241|NCT03715829|454631740|FG000|Dose Ranging Period|Adverse Event|2|||
126365242|NCT03715829|454631741|FG001|Dose Ranging Period|Adverse Event|4|||
126365243|NCT03715829|454631742|FG002|Dose Ranging Period|Adverse Event|5|||
126365244|NCT03715829|454631743|FG003|Dose Ranging Period|Adverse Event|2|||
126365245|NCT03715829|454631744|FG004|Dose Ranging Period|Adverse Event|3|||
126365246|NCT03715829|454631745|FG005|Dose Ranging Period|Adverse Event|3|||
126365247|NCT03715829|454631746|FG006|Dose Ranging Period|Adverse Event|0|||
126365248|NCT03715829|454631747|FG007|Dose Ranging Period|Adverse Event|0|||
126365249|NCT03715829|454631748|FG008|Dose Ranging Period|Adverse Event|0|||
126365250|NCT03715829|454631749|FG009|Dose Ranging Period|Adverse Event|0|||
126365251|NCT03715829|454631750|FG010|Dose Ranging Period|Adverse Event|0|||
126709672|NCT01089725|455888060|FG003|Overall Study|Withdrawal by Subject|5|||
126766425|NCT00557830|456097318|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
126766426|NCT00557830|456097319|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
126365252|NCT03715829|454631740|FG000|Dose Ranging Period|Lack of Efficacy|0|||
126709673|NCT01089725|455888061|FG004|Overall Study|Withdrawal by Subject|4|||
126709674|NCT01089725|455888057|FG000|Overall Study|Study Terminated by Sponsor|51|||
126709675|NCT01089725|455888058|FG001|Overall Study|Study Terminated by Sponsor|56|||
126709676|NCT01089725|455888059|FG002|Overall Study|Study Terminated by Sponsor|53|||
126709677|NCT01089725|455888060|FG003|Overall Study|Study Terminated by Sponsor|68|||
126709678|NCT01089725|455888061|FG004|Overall Study|Study Terminated by Sponsor|68|||
126709679|NCT01089725|455888057|FG000|Overall Study|Randomized, but not treated|0|||
126709680|NCT01089725|455888058|FG001|Overall Study|Randomized, but not treated|1|||
126709681|NCT01089725|455888059|FG002|Overall Study|Randomized, but not treated|2|||
126709682|NCT01089725|455888060|FG003|Overall Study|Randomized, but not treated|1|||
126709683|NCT01089725|455888061|FG004|Overall Study|Randomized, but not treated|2|||
126709684|NCT01089725|455888057|FG000|Overall Study|Other|3|||
126709685|NCT01089725|455888058|FG001|Overall Study|Other|0|||
126709686|NCT01089725|455888059|FG002|Overall Study|Other|0|||
126709687|NCT01089725|455888060|FG003|Overall Study|Other|1|||
126709688|NCT01089725|455888061|FG004|Overall Study|Other|0|||
126709689|NCT01582282|455889876|FG000|Overall Study|Adverse Event|1|||
126709690|NCT01582282|455889877|FG001|Overall Study|Adverse Event|1|||
126709691|NCT01582282|455889878|FG002|Overall Study|Adverse Event|0|||
126709692|NCT01582282|455889876|FG000|Overall Study|Lost to Follow-up|1|||
126709693|NCT01582282|455889877|FG001|Overall Study|Lost to Follow-up|0|||
126709694|NCT01582282|455889878|FG002|Overall Study|Lost to Follow-up|0|||
126709695|NCT01582282|455889876|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
126709696|NCT01582282|455889877|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
126709697|NCT01582282|455889878|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
126709698|NCT01486316|455889879|FG000|Overall Study|Device explanted with/without re-implant|3|||
126709699|NCT01486316|455889880|FG001|Overall Study|Device explanted with/without re-implant|2|||
126709700|NCT01486316|455889881|FG002|Overall Study|Device explanted with/without re-implant|0|||
126709701|NCT01486316|455889882|FG003|Overall Study|Device explanted with/without re-implant|2|||
126709702|NCT01486316|455889879|FG000|Overall Study|Not meeting eligibility criteria|0|||
126709703|NCT01486316|455889880|FG001|Overall Study|Not meeting eligibility criteria|0|||
126709704|NCT01486316|455889881|FG002|Overall Study|Not meeting eligibility criteria|1|||
126709705|NCT01486316|455889882|FG003|Overall Study|Not meeting eligibility criteria|0|||
126709706|NCT01486316|455889879|FG000|Overall Study|Withdrawal by Subject|1|||
126709707|NCT01486316|455889880|FG001|Overall Study|Withdrawal by Subject|0|||
126709708|NCT01486316|455889881|FG002|Overall Study|Withdrawal by Subject|3|||
126709709|NCT01486316|455889882|FG003|Overall Study|Withdrawal by Subject|0|||
126709710|NCT01486316|455889879|FG000|Overall Study|Physician Decision|0|||
126709711|NCT01486316|455889880|FG001|Overall Study|Physician Decision|0|||
126709712|NCT01486316|455889881|FG002|Overall Study|Physician Decision|1|||
126709713|NCT01486316|455889882|FG003|Overall Study|Physician Decision|0|||
126709714|NCT01486316|455889879|FG000|Overall Study|Death|0|||
126709715|NCT01486316|455889880|FG001|Overall Study|Death|1|||
126709716|NCT01486316|455889881|FG002|Overall Study|Death|0|||
126709717|NCT01486316|455889882|FG003|Overall Study|Death|0|||
126709718|NCT02495077|455889891|FG000|Overall Study|Adverse Event|0|||
126709719|NCT02495077|455889892|FG001|Overall Study|Adverse Event|1|||
126709720|NCT02495077|455889893|FG002|Overall Study|Adverse Event|1|||
126709721|NCT02495077|455889894|FG003|Overall Study|Adverse Event|0|||
126709722|NCT02495077|455889891|FG000|Overall Study|Death|3|||
126709723|NCT02495077|455889892|FG001|Overall Study|Death|5|||
126709724|NCT02495077|455889893|FG002|Overall Study|Death|0|||
126365253|NCT03715829|454631741|FG001|Dose Ranging Period|Lack of Efficacy|1|||
126365254|NCT03715829|454631742|FG002|Dose Ranging Period|Lack of Efficacy|0|||
126365255|NCT03715829|454631743|FG003|Dose Ranging Period|Lack of Efficacy|1|||
126365256|NCT03715829|454631744|FG004|Dose Ranging Period|Lack of Efficacy|0|||
126365257|NCT03715829|454631745|FG005|Dose Ranging Period|Lack of Efficacy|0|||
126365258|NCT03715829|454631746|FG006|Dose Ranging Period|Lack of Efficacy|0|||
126365259|NCT03715829|454631747|FG007|Dose Ranging Period|Lack of Efficacy|0|||
126365260|NCT03715829|454631748|FG008|Dose Ranging Period|Lack of Efficacy|0|||
126365261|NCT03715829|454631749|FG009|Dose Ranging Period|Lack of Efficacy|0|||
126365262|NCT03715829|454631750|FG010|Dose Ranging Period|Lack of Efficacy|0|||
126365263|NCT03715829|454631740|FG000|Dose Ranging Period|Lost to Follow-up|2|||
126365264|NCT03715829|454631741|FG001|Dose Ranging Period|Lost to Follow-up|0|||
126365265|NCT03715829|454631742|FG002|Dose Ranging Period|Lost to Follow-up|1|||
126365266|NCT03715829|454631743|FG003|Dose Ranging Period|Lost to Follow-up|1|||
126709725|NCT02495077|455889894|FG003|Overall Study|Death|0|||
126709726|NCT02495077|455889891|FG000|Overall Study|Lost to Follow-up|6|||
126365267|NCT03715829|454631744|FG004|Dose Ranging Period|Lost to Follow-up|1|||
126365268|NCT03715829|454631745|FG005|Dose Ranging Period|Lost to Follow-up|2|||
126365269|NCT03715829|454631746|FG006|Dose Ranging Period|Lost to Follow-up|0|||
126709727|NCT02495077|455889892|FG001|Overall Study|Lost to Follow-up|4|||
126709728|NCT02495077|455889893|FG002|Overall Study|Lost to Follow-up|0|||
126709729|NCT02495077|455889894|FG003|Overall Study|Lost to Follow-up|0|||
126709730|NCT02495077|455889891|FG000|Overall Study|Physician Decision|2|||
126709731|NCT02495077|455889892|FG001|Overall Study|Physician Decision|1|||
126709732|NCT02495077|455889893|FG002|Overall Study|Physician Decision|4|||
126709733|NCT02495077|455889894|FG003|Overall Study|Physician Decision|0|||
126709734|NCT02495077|455889891|FG000|Overall Study|Protocol Violation|0|||
126709735|NCT02495077|455889892|FG001|Overall Study|Protocol Violation|1|||
126709736|NCT02495077|455889893|FG002|Overall Study|Protocol Violation|0|||
126709737|NCT02495077|455889894|FG003|Overall Study|Protocol Violation|0|||
126709738|NCT02495077|455889891|FG000|Overall Study|Screen Failure|0|||
126709739|NCT02495077|455889892|FG001|Overall Study|Screen Failure|0|||
126709740|NCT02495077|455889893|FG002|Overall Study|Screen Failure|0|||
126709741|NCT02495077|455889894|FG003|Overall Study|Screen Failure|48|||
126709742|NCT02495077|455889891|FG000|Overall Study|Withdrawal by Subject|7|||
126709743|NCT02495077|455889892|FG001|Overall Study|Withdrawal by Subject|7|||
126709744|NCT02495077|455889893|FG002|Overall Study|Withdrawal by Subject|7|||
126709745|NCT02495077|455889894|FG003|Overall Study|Withdrawal by Subject|0|||
126709746|NCT02495077|455889891|FG000|Overall Study|Covid-19 research restrictions|1|||
126709747|NCT02495077|455889892|FG001|Overall Study|Covid-19 research restrictions|0|||
126709748|NCT02495077|455889893|FG002|Overall Study|Covid-19 research restrictions|0|||
126709749|NCT02495077|455889894|FG003|Overall Study|Covid-19 research restrictions|0|||
126709750|NCT02495077|455889891|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
126709751|NCT02495077|455889892|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
126709752|NCT02495077|455889893|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
126709753|NCT02495077|455889894|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
126709754|NCT02495077|455889891|FG000|Overall Study|Incarcerated|0|||
126709755|NCT02495077|455889892|FG001|Overall Study|Incarcerated|1|||
126709756|NCT02495077|455889893|FG002|Overall Study|Incarcerated|0|||
126709757|NCT02495077|455889894|FG003|Overall Study|Incarcerated|0|||
126709758|NCT02495077|455889891|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
126709759|NCT02495077|455889892|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
126709760|NCT02495077|455889893|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
126709761|NCT02495077|455889894|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
126709762|NCT02495077|455889891|FG000|Overall Study|Timing of transplant and randomization|0|||
126709763|NCT02495077|455889892|FG001|Overall Study|Timing of transplant and randomization|0|||
126709764|NCT02495077|455889893|FG002|Overall Study|Timing of transplant and randomization|5|||
126709765|NCT02495077|455889894|FG003|Overall Study|Timing of transplant and randomization|0|||
126709766|NCT02742649|455889895|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
126709767|NCT02742649|455889896|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
126709768|NCT02742649|455889897|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
126709769|NCT02742649|455889898|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
126709770|NCT02742649|455889899|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
126709771|NCT02742649|455889895|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126709772|NCT02742649|455889896|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126709773|NCT02742649|455889897|FG002|Double-Blind Treatment Period|Adverse Event|0|||
126709774|NCT02742649|455889898|FG003|Double-Blind Treatment Period|Adverse Event|0|||
126709775|NCT02742649|455889899|FG004|Double-Blind Treatment Period|Adverse Event|0|||
126709776|NCT02742649|455889895|FG000|Open-Label Period|Lost to Follow-up|0|||
126709777|NCT02742649|455889896|FG001|Open-Label Period|Lost to Follow-up|0|||
126709778|NCT02742649|455889897|FG002|Open-Label Period|Lost to Follow-up|0|||
126709779|NCT02742649|455889898|FG003|Open-Label Period|Lost to Follow-up|0|||
126709780|NCT02742649|455889899|FG004|Open-Label Period|Lost to Follow-up|1|||
126709781|NCT03635190|455889909|FG000|Overall Study|Lost to Follow-up|4|||
126709782|NCT03635190|455889909|FG000|Overall Study|Death|3|||
126709783|NCT03635190|455889909|FG000|Overall Study|Withdrawal by Subject|1|||
126709784|NCT03635190|455889909|FG000|Overall Study|Patient moved and did not return for follow up|1|||
126709785|NCT04328623|455889912|FG000|Overall Study|Protocol Violation|0|||
126709786|NCT04328623|455889913|FG001|Overall Study|Protocol Violation|1|||
126709787|NCT01408537|455889917|FG000|Overall Study|Withdrawal by Subject|2|||
126709788|NCT01408537|455889917|FG000|Overall Study|Protocol Violation|3|||
126709789|NCT01408537|455889917|FG000|Overall Study|Lost to Follow-up|3|||
126709790|NCT02760602|455889920|FG000|Overall Study|Withdrawal by Subject|1|||
126709791|NCT02760602|455889921|FG001|Overall Study|Withdrawal by Subject|0|||
126709792|NCT02760602|455889920|FG000|Overall Study|Terminated by sponsor|12|||
126709793|NCT02760602|455889921|FG001|Overall Study|Terminated by sponsor|13|||
126709794|NCT02046564|455889927|FG000|Overall Study|Adverse Event|6|||
126285855|NCT00993421|454333074|FG001|Overall Study|Entry Criteria Exclusion|0|||
126709795|NCT02046564|455889928|FG001|Overall Study|Adverse Event|3|||
126709796|NCT02046564|455889927|FG000|Overall Study|Physician Decision|0|||
126709797|NCT02046564|455889928|FG001|Overall Study|Physician Decision|1|||
126709798|NCT02046564|455889927|FG000|Overall Study|Protocol Violation|3|||
126709799|NCT02046564|455889928|FG001|Overall Study|Protocol Violation|1|||
126709800|NCT02046564|455889927|FG000|Overall Study|Withdrawal by Subject|4|||
126709801|NCT02046564|455889928|FG001|Overall Study|Withdrawal by Subject|10|||
126709802|NCT02046564|455889927|FG000|Overall Study|Subject met withdrawal criteria|2|||
126709803|NCT02046564|455889928|FG001|Overall Study|Subject met withdrawal criteria|5|||
126709804|NCT01295905|455889931|FG000|Overall Study|Did not meet inclusion criteria|1|||
126709805|NCT01295905|455889932|FG001|Overall Study|Did not meet inclusion criteria|0|||
126709806|NCT01295905|455889931|FG000|Overall Study|Met exclusion criteria|1|||
126709807|NCT01295905|455889932|FG001|Overall Study|Met exclusion criteria|0|||
126456805|NCT01087788|454972883|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
126456806|NCT01087788|454972884|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
126456807|NCT01087788|454972882|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
126456808|NCT01087788|454972883|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
126456809|NCT01087788|454972884|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
126456810|NCT01087788|454972882|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
126456811|NCT01087788|454972883|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
126456812|NCT01087788|454972884|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
126456813|NCT01087788|454972882|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
126456814|NCT01087788|454972883|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
126456815|NCT01087788|454972884|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
126456816|NCT01087788|454972882|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
126456817|NCT01087788|454972883|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
126456818|NCT01087788|454972884|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
126456819|NCT01087788|454972882|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
126456820|NCT01087788|454972883|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
126456821|NCT01087788|454972884|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
126456822|NCT01087788|454972882|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
126456823|NCT01087788|454972883|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
126456824|NCT01087788|454972884|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
126456825|NCT01087788|454972882|FG000|24-weeks Dose-blind Period|Patient moved|0|||
126456826|NCT01087788|454972883|FG001|24-weeks Dose-blind Period|Patient moved|0|||
126456827|NCT01087788|454972884|FG002|24-weeks Dose-blind Period|Patient moved|1|||
126456828|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
126456829|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
126456830|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
126456831|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
126456832|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
126456833|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
126456834|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
126456835|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
126456836|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
126456837|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
126456838|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
126456839|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
126456840|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
126456841|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
126456842|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
126456843|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
126456844|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
126456845|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
126456846|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
126456847|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
126456848|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
126456849|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
126709808|NCT00791128|455889934|FG000|Overall Study|Adverse Event|4|||
126709809|NCT00791128|455889934|FG000|Overall Study|Device migration|2|||
126709810|NCT00791128|455889934|FG000|Overall Study|non-compliance by subject|2|||
126709811|NCT00791128|455889934|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
126709812|NCT01357239|455889937|FG000|Stratum: All Patients|Adverse Event|0|||
126709813|NCT01357239|455889938|FG001|Stratum: All Patients|Adverse Event|0|||
126709814|NCT01357239|455889939|FG002|Stratum: All Patients|Adverse Event|1|||
126709815|NCT01357239|455889940|FG003|Stratum: All Patients|Adverse Event|1|||
126709816|NCT01357239|455889937|FG000|Stratum: All Patients|Subject withdrew consent|0|||
126709817|NCT01357239|455889938|FG001|Stratum: All Patients|Subject withdrew consent|0|||
126709818|NCT01357239|455889939|FG002|Stratum: All Patients|Subject withdrew consent|1|||
126709819|NCT01357239|455889940|FG003|Stratum: All Patients|Subject withdrew consent|1|||
126709820|NCT01357239|455889937|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
126709821|NCT01357239|455889938|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
126709822|NCT01357239|455889939|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
126709823|NCT01357239|455889940|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
126709824|NCT01357239|455889937|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
126709825|NCT01357239|455889938|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
126709826|NCT01357239|455889939|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
126709827|NCT01357239|455889940|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
126549429|NCT01108510|455305622|FG001|Overall Study|Death|1|||
126766427|NCT00557830|456097317|FG000|Screening Treatment Phase|Adverse Event|2|||
126766428|NCT00557830|456097318|FG001|Screening Treatment Phase|Adverse Event|0|||
126766429|NCT00557830|456097319|FG002|Screening Treatment Phase|Adverse Event|0|||
126766430|NCT00557830|456097317|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
126766431|NCT00557830|456097318|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
126766432|NCT00557830|456097319|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
126766433|NCT00538473|456097320|FG000|Overall Study|Adverse Event|1|||
126766434|NCT00538473|456097321|FG001|Overall Study|Adverse Event|0|||
126766435|NCT01833897|456097322|FG000|Overall Study|Lack of Efficacy|1|||
126766436|NCT00127192|456097323|FG000|Overall Study|Adverse Event|0|||
126766437|NCT00127192|456097324|FG001|Overall Study|Adverse Event|1|||
126766438|NCT00127192|456097325|FG002|Overall Study|Adverse Event|1|||
126766439|NCT00127192|456097326|FG003|Overall Study|Adverse Event|1|||
126766440|NCT00127192|456097327|FG004|Overall Study|Adverse Event|0|||
126766441|NCT00127192|456097323|FG000|Overall Study|Lack of Efficacy|2|||
126766442|NCT00127192|456097324|FG001|Overall Study|Lack of Efficacy|0|||
126766443|NCT00127192|456097325|FG002|Overall Study|Lack of Efficacy|0|||
126766444|NCT00127192|456097326|FG003|Overall Study|Lack of Efficacy|0|||
126766445|NCT00127192|456097327|FG004|Overall Study|Lack of Efficacy|2|||
126766446|NCT00127192|456097323|FG000|Overall Study|Withdrawal by Subject|0|||
126766447|NCT00127192|456097324|FG001|Overall Study|Withdrawal by Subject|0|||
126766448|NCT00127192|456097325|FG002|Overall Study|Withdrawal by Subject|1|||
126766449|NCT00127192|456097326|FG003|Overall Study|Withdrawal by Subject|0|||
126766450|NCT00127192|456097327|FG004|Overall Study|Withdrawal by Subject|3|||
126766451|NCT00127192|456097323|FG000|Overall Study|Adverse event in pre-treatment period|1|||
126766452|NCT00127192|456097324|FG001|Overall Study|Adverse event in pre-treatment period|0|||
126766453|NCT00127192|456097325|FG002|Overall Study|Adverse event in pre-treatment period|0|||
126766454|NCT00127192|456097326|FG003|Overall Study|Adverse event in pre-treatment period|0|||
126766455|NCT00127192|456097327|FG004|Overall Study|Adverse event in pre-treatment period|0|||
126766456|NCT00227591|456097330|FG000|Overall Study|Withdrawal by Subject|1|||
126766457|NCT00077766|456097331|FG000|Overall Study|Adverse Event|1|||
126766458|NCT00077766|456097332|FG001|Overall Study|Adverse Event|1|||
126766459|NCT00077766|456097331|FG000|Overall Study|Withdrawal by Subject|4|||
126766460|NCT00077766|456097332|FG001|Overall Study|Withdrawal by Subject|3|||
126766461|NCT00077766|456097331|FG000|Overall Study|Death|12|||
126766462|NCT00077766|456097332|FG001|Overall Study|Death|10|||
126766463|NCT00077766|456097331|FG000|Overall Study|Lost to Follow-up|2|||
126766464|NCT00077766|456097332|FG001|Overall Study|Lost to Follow-up|0|||
126766465|NCT00077766|456097331|FG000|Overall Study|Protocol Violation|1|||
126456850|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
126456851|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
126766466|NCT00077766|456097332|FG001|Overall Study|Protocol Violation|0|||
126766467|NCT00077766|456097331|FG000|Overall Study|Kidney Transplantation|9|||
126766468|NCT00077766|456097332|FG001|Overall Study|Kidney Transplantation|5|||
126766469|NCT00077766|456097331|FG000|Overall Study|Transplantation|5|||
126766470|NCT00077766|456097332|FG001|Overall Study|Transplantation|1|||
126766471|NCT00077766|456097331|FG000|Overall Study|Investigators Discretion|1|||
126285856|NCT00993421|454333075|FG002|Overall Study|Entry Criteria Exclusion|1|||
126285857|NCT00993421|454333076|FG003|Overall Study|Entry Criteria Exclusion|3|||
126285858|NCT00993421|454333077|FG004|Overall Study|Entry Criteria Exclusion|0|||
126285859|NCT00993421|454333078|FG005|Overall Study|Entry Criteria Exclusion|1|||
126285860|NCT00993421|454333079|FG006|Overall Study|Entry Criteria Exclusion|0|||
126285861|NCT00993421|454333073|FG000|Overall Study|Physician Decision|0|||
126285862|NCT00993421|454333074|FG001|Overall Study|Physician Decision|0|||
126285863|NCT00993421|454333075|FG002|Overall Study|Physician Decision|0|||
126285864|NCT00993421|454333076|FG003|Overall Study|Physician Decision|0|||
126285865|NCT00993421|454333077|FG004|Overall Study|Physician Decision|0|||
126285866|NCT00993421|454333078|FG005|Overall Study|Physician Decision|1|||
126285867|NCT00993421|454333079|FG006|Overall Study|Physician Decision|1|||
126285868|NCT00993421|454333073|FG000|Overall Study|Protocol Violation|0|||
126285869|NCT00993421|454333074|FG001|Overall Study|Protocol Violation|0|||
126285870|NCT00993421|454333075|FG002|Overall Study|Protocol Violation|0|||
126285871|NCT00993421|454333076|FG003|Overall Study|Protocol Violation|0|||
126285872|NCT00993421|454333077|FG004|Overall Study|Protocol Violation|0|||
126285873|NCT00993421|454333078|FG005|Overall Study|Protocol Violation|2|||
126285874|NCT00993421|454333079|FG006|Overall Study|Protocol Violation|1|||
126285875|NCT02215967|454333080|FG000|Overall Study|Patient became ineligible for treatment|0|||
126285876|NCT02215967|454333081|FG001|Overall Study|Patient became ineligible for treatment|0|||
126285877|NCT02215967|454333082|FG002|Overall Study|Patient became ineligible for treatment|0|||
126285878|NCT02215967|454333083|FG003|Overall Study|Patient became ineligible for treatment|3|||
126285879|NCT02215967|454333080|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
126285880|NCT02215967|454333081|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
126285881|NCT02215967|454333082|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
126285882|NCT02215967|454333083|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
126456852|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
126766472|NCT00077766|456097332|FG001|Overall Study|Investigators Discretion|0|||
126766473|NCT00077766|456097331|FG000|Overall Study|Participant's decision|1|||
126766474|NCT00077766|456097332|FG001|Overall Study|Participant's decision|0|||
126766475|NCT00077766|456097331|FG000|Overall Study|Dialysis Discontinued|1|||
126766476|NCT00077766|456097332|FG001|Overall Study|Dialysis Discontinued|0|||
126766477|NCT00077766|456097331|FG000|Overall Study|Dialysis|0|||
126766478|NCT00077766|456097332|FG001|Overall Study|Dialysis|1|||
126766479|NCT00077766|456097331|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
126766480|NCT00077766|456097332|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
126766481|NCT00077766|456097331|FG000|Overall Study|Started Nocturnal Dialysis|0|||
126766482|NCT00077766|456097332|FG001|Overall Study|Started Nocturnal Dialysis|1|||
126285883|NCT01954745|454333087|FG000|Overall Study|Radiological Progression|11|||
126285884|NCT01954745|454333087|FG000|Overall Study|Clinical Progression|5|||
126285885|NCT01954745|454333087|FG000|Overall Study|Adverse Event|2|||
126285886|NCT01954745|454333087|FG000|Overall Study|Death|1|||
126285887|NCT00352417|454333088|FG000|Overall Study|Adverse Event|1|||
126285888|NCT00352417|454333089|FG001|Overall Study|Adverse Event|0|||
126285889|NCT00352417|454333088|FG000|Overall Study|Protocol Violation|0|||
126285890|NCT00352417|454333089|FG001|Overall Study|Protocol Violation|2|||
126285891|NCT00352417|454333088|FG000|Overall Study|Withdrawal by Subject|1|||
126285892|NCT00352417|454333089|FG001|Overall Study|Withdrawal by Subject|2|||
126285893|NCT00352417|454333088|FG000|Overall Study|Lost to Follow-up|1|||
126285894|NCT00352417|454333089|FG001|Overall Study|Lost to Follow-up|0|||
126285895|NCT00352417|454333088|FG000|Overall Study|Schedule Change|2|||
126285896|NCT00352417|454333089|FG001|Overall Study|Schedule Change|1|||
126285897|NCT01496976|454334916|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
126285898|NCT05938621|454334917|FG000|Overall Study|Lost to Follow-up|1|||
126285899|NCT05938621|454334918|FG001|Overall Study|Lost to Follow-up|5|||
126285900|NCT05938621|454334919|FG002|Overall Study|Lost to Follow-up|2|||
126285901|NCT05938621|454334920|FG003|Overall Study|Lost to Follow-up|2|||
126285902|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
126285903|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
126285904|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
126285905|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
126285906|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
126285907|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
126285908|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
126285909|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
126285910|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
126285911|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
126285912|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
126285913|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
126285914|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
126285915|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
126285916|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
126285917|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
126285918|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
126285919|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
126285920|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
126285921|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
126285922|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
126285923|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
126285924|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
126285925|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
126285926|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
126285927|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
126766483|NCT00077766|456097331|FG000|Overall Study|Stop Dialysis|0|||
126766484|NCT00077766|456097332|FG001|Overall Study|Stop Dialysis|1|||
126766485|NCT00077766|456097331|FG000|Overall Study|Participants Vacation|2|||
126766486|NCT00077766|456097332|FG001|Overall Study|Participants Vacation|1|||
126766487|NCT01886105|456097333|FG000|Overall Study|Lack of Efficacy|3|||
126766488|NCT03843775|456097336|FG000|Overall Study|Adverse Event|1|||
126766489|NCT03843775|456097337|FG001|Overall Study|Adverse Event|1|||
126766490|NCT03843775|456097336|FG000|Overall Study|Lack of Efficacy|2|||
126766491|NCT03843775|456097337|FG001|Overall Study|Lack of Efficacy|6|||
126766492|NCT03843775|456097336|FG000|Overall Study|Withdrawal by Subject|0|||
126766493|NCT03843775|456097337|FG001|Overall Study|Withdrawal by Subject|1|||
126766494|NCT04150107|456097338|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
126766495|NCT04150107|456097339|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
126766496|NCT04150107|456097338|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
126766497|NCT04150107|456097339|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
126766498|NCT02184988|456097347|FG000|Overall Study|Pregnancy|2|||
126766499|NCT02184988|456097347|FG000|Overall Study|Adverse Event|2|||
126766500|NCT02184988|456097347|FG000|Overall Study|moving away/travelling/unable to complet|6|||
126285928|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
126285929|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
126285930|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
126285931|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
126285932|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
126285933|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
126456853|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
126456854|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
126456855|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
126456856|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
126456857|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
126456858|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
126456859|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
126456860|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
126456861|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
126456862|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
126456863|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
126456864|NCT01087788|454972882|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
126456865|NCT01087788|454972883|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
126456866|NCT01087788|454972884|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
126456867|NCT00160667|454972885|FG000|Overall Study|Adverse Event|3|||
126709828|NCT01357239|455889937|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
126709829|NCT01357239|455889938|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
126709830|NCT01357239|455889939|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
126709831|NCT01357239|455889940|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
126709832|NCT01050062|455889947|FG000|Overall Study|Adverse Event|75|||
126709833|NCT01050062|455889948|FG001|Overall Study|Adverse Event|22|||
126709834|NCT01050062|455889947|FG000|Overall Study|Lost to Follow-up|83|||
126709835|NCT01050062|455889948|FG001|Overall Study|Lost to Follow-up|35|||
126709836|NCT01050062|455889947|FG000|Overall Study|Lack of Efficacy|22|||
126709837|NCT01050062|455889948|FG001|Overall Study|Lack of Efficacy|35|||
126709838|NCT01050062|455889947|FG000|Overall Study|Physician Decision|74|||
126709839|NCT01050062|455889948|FG001|Overall Study|Physician Decision|9|||
126709840|NCT01050062|455889947|FG000|Overall Study|Others|17|||
126709841|NCT01050062|455889948|FG001|Overall Study|Others|11|||
126709842|NCT00670111|455889951|FG000|Enrollment to One Month|Testing Failure|0|||
126709843|NCT00670111|455889952|FG001|Enrollment to One Month|Testing Failure|0|||
126709844|NCT00670111|455889953|FG002|Enrollment to One Month|Testing Failure|13|||
126709845|NCT00670111|455889951|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
126709846|NCT00670111|455889952|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
126709847|NCT00670111|455889953|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
126709848|NCT00670111|455889951|FG000|Enrollment to One Month|Physician Decision|1|||
126709849|NCT00670111|455889952|FG001|Enrollment to One Month|Physician Decision|0|||
126709850|NCT00670111|455889953|FG002|Enrollment to One Month|Physician Decision|0|||
126709851|NCT03988751|455889954|FG000|Overall Study|Withdrawal by Subject|1|||
126709852|NCT03988751|455889955|FG001|Overall Study|Withdrawal by Subject|0|||
126709853|NCT03988751|455889954|FG000|Overall Study|Protocol Violation|0|||
126709854|NCT03988751|455889955|FG001|Overall Study|Protocol Violation|1|||
126709855|NCT02623361|455889956|FG000|Overall Study|Protocol Violation|0|||
126709856|NCT02623361|455889957|FG001|Overall Study|Protocol Violation|1|||
126709857|NCT02623361|455889956|FG000|Overall Study|Withdrawal by Subject|0|||
126709858|NCT02623361|455889957|FG001|Overall Study|Withdrawal by Subject|1|||
126709859|NCT00844883|455889958|FG000|Overall Study|Bridged to liver transplant|3|||
126709860|NCT00844883|455889958|FG000|Overall Study|Bridged to resection|1|||
126709861|NCT03894540|455889961|FG000|Overall Study|Adverse Event|0|||
126709862|NCT03894540|455889962|FG001|Overall Study|Adverse Event|0|||
126709863|NCT03894540|455889963|FG002|Overall Study|Adverse Event|0|||
126709864|NCT03894540|455889964|FG003|Overall Study|Adverse Event|0|||
126709865|NCT03894540|455889965|FG004|Overall Study|Adverse Event|1|||
126709866|NCT03894540|455889966|FG005|Overall Study|Adverse Event|0|||
126709867|NCT03894540|455889961|FG000|Overall Study|Withdrawal by Subject|0|||
126709868|NCT03894540|455889962|FG001|Overall Study|Withdrawal by Subject|0|||
126709869|NCT03894540|455889963|FG002|Overall Study|Withdrawal by Subject|0|||
126709870|NCT03894540|455889964|FG003|Overall Study|Withdrawal by Subject|0|||
126709871|NCT03894540|455889965|FG004|Overall Study|Withdrawal by Subject|1|||
126709872|NCT03894540|455889966|FG005|Overall Study|Withdrawal by Subject|0|||
126549430|NCT02796963|455305623|FG000|Overall Study|Lost to Follow-up|89|||
126709873|NCT03894540|455889961|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
126709874|NCT03894540|455889962|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
126709875|NCT03894540|455889963|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
126709876|NCT03894540|455889964|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
126709877|NCT03894540|455889965|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
126709878|NCT03894540|455889966|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
126285934|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
126285935|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
126285936|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
126285937|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
126285938|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
126285939|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
126285940|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
126285941|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
126285942|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
126285943|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
126285944|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
126365270|NCT03715829|454631747|FG007|Dose Ranging Period|Lost to Follow-up|0|||
126365271|NCT03715829|454631748|FG008|Dose Ranging Period|Lost to Follow-up|0|||
126285945|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
126365272|NCT03715829|454631749|FG009|Dose Ranging Period|Lost to Follow-up|0|||
126365273|NCT03715829|454631750|FG010|Dose Ranging Period|Lost to Follow-up|0|||
126365274|NCT03715829|454631740|FG000|Dose Ranging Period|Protocol Violation|0|||
126365275|NCT03715829|454631741|FG001|Dose Ranging Period|Protocol Violation|0|||
126365276|NCT03715829|454631742|FG002|Dose Ranging Period|Protocol Violation|0|||
126365277|NCT03715829|454631743|FG003|Dose Ranging Period|Protocol Violation|1|||
126365278|NCT03715829|454631744|FG004|Dose Ranging Period|Protocol Violation|0|||
126365279|NCT03715829|454631745|FG005|Dose Ranging Period|Protocol Violation|0|||
126365280|NCT03715829|454631746|FG006|Dose Ranging Period|Protocol Violation|0|||
126365281|NCT03715829|454631747|FG007|Dose Ranging Period|Protocol Violation|0|||
126365282|NCT03715829|454631748|FG008|Dose Ranging Period|Protocol Violation|0|||
126365283|NCT03715829|454631749|FG009|Dose Ranging Period|Protocol Violation|0|||
126365284|NCT03715829|454631750|FG010|Dose Ranging Period|Protocol Violation|0|||
126365285|NCT03715829|454631740|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
126365286|NCT03715829|454631741|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
126365287|NCT03715829|454631742|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
126709879|NCT03894540|455889961|FG000|Overall Study|Progressive Disease Clinical|1|||
126709880|NCT03894540|455889962|FG001|Overall Study|Progressive Disease Clinical|1|||
126709881|NCT03894540|455889963|FG002|Overall Study|Progressive Disease Clinical|0|||
126709882|NCT03894540|455889964|FG003|Overall Study|Progressive Disease Clinical|1|||
126709883|NCT03894540|455889965|FG004|Overall Study|Progressive Disease Clinical|5|||
126709884|NCT03894540|455889966|FG005|Overall Study|Progressive Disease Clinical|1|||
126365288|NCT03715829|454631743|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
126365289|NCT03715829|454631744|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
126365290|NCT03715829|454631745|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
126365291|NCT03715829|454631746|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
126365292|NCT03715829|454631747|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
126365293|NCT03715829|454631748|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
126365294|NCT03715829|454631749|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
126365295|NCT03715829|454631750|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
126365296|NCT03715829|454631740|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365297|NCT03715829|454631741|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126709885|NCT03894540|455889961|FG000|Overall Study|Study termination by sponsor|0|||
126709886|NCT03894540|455889962|FG001|Overall Study|Study termination by sponsor|0|||
126709887|NCT03894540|455889963|FG002|Overall Study|Study termination by sponsor|0|||
126709888|NCT03894540|455889964|FG003|Overall Study|Study termination by sponsor|0|||
126709889|NCT03894540|455889965|FG004|Overall Study|Study termination by sponsor|2|||
126709890|NCT03894540|455889966|FG005|Overall Study|Study termination by sponsor|0|||
126709891|NCT03000452|455889969|FG000|Treatment Period|Death|1|||
126709892|NCT03000452|455889969|FG000|Treatment Period|Progressive Disease (PD)|14|||
126709893|NCT03000452|455889969|FG000|Treatment Period|Physician Decision|1|||
126709894|NCT03000452|455889969|FG000|Treatment Period|Miscellaneous|2|||
126709895|NCT03000452|455889969|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
126709896|NCT03000452|455889969|FG000|Follow-Up Period|Death|3|||
126709897|NCT03000452|455889969|FG000|Follow-Up Period|Withdrawal by Subject|3|||
126709898|NCT03043365|455889970|FG000|Weeks 0 to Week 8|Adverse Event|1|||
126709899|NCT03043365|455889971|FG001|Weeks 0 to Week 8|Adverse Event|3|||
126709900|NCT03043365|455889970|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
126709901|NCT03043365|455889971|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
126709902|NCT03043365|455889970|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
126709903|NCT03043365|455889971|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
126365298|NCT03715829|454631742|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
126709904|NCT03455543|455889972|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
126709905|NCT03455543|455889973|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
126766501|NCT02184988|456097347|FG000|Overall Study|work scheduling issues|4|||
126766502|NCT02184988|456097347|FG000|Overall Study|various other reasons|9|||
126766503|NCT02184988|456097347|FG000|Overall Study|Lost to Follow-up|32|||
126766504|NCT00690573|456097356|FG000|Overall Study|Lack of Efficacy|8|||
126766505|NCT00690573|456097356|FG000|Overall Study|Withdrawal by Subject|1|||
126766506|NCT04502862|456097357|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
126766507|NCT04502862|456097358|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
126285946|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
126285947|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
126285948|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285949|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285950|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285951|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285952|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285953|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285954|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285955|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
126285956|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126285957|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
126285958|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126709906|NCT03455543|455889974|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
126709907|NCT03455543|455889972|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
126709908|NCT03455543|455889973|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
126709909|NCT03455543|455889974|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
126709910|NCT03455543|455889972|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
126709911|NCT03455543|455889973|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
126709912|NCT03455543|455889974|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
126709913|NCT03455543|455889972|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
126285959|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126285960|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126285961|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126285962|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126285963|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126285964|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126365299|NCT03715829|454631743|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365300|NCT03715829|454631744|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365301|NCT03715829|454631745|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365302|NCT03715829|454631746|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365303|NCT03715829|454631747|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365304|NCT03715829|454631748|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365305|NCT03715829|454631749|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365306|NCT03715829|454631750|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
126365307|NCT03715829|454631740|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365308|NCT03715829|454631741|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365309|NCT03715829|454631742|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
126365310|NCT03715829|454631743|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365311|NCT03715829|454631744|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
126365312|NCT03715829|454631745|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365313|NCT03715829|454631746|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365314|NCT03715829|454631747|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365315|NCT03715829|454631748|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365316|NCT03715829|454631749|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365317|NCT03715829|454631750|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
126365318|NCT03715829|454631740|FG000|Dose Ranging Period|Other|0|||
126365319|NCT03715829|454631741|FG001|Dose Ranging Period|Other|0|||
126365320|NCT03715829|454631742|FG002|Dose Ranging Period|Other|2|||
126365321|NCT03715829|454631743|FG003|Dose Ranging Period|Other|0|||
126365322|NCT03715829|454631744|FG004|Dose Ranging Period|Other|0|||
126365323|NCT03715829|454631745|FG005|Dose Ranging Period|Other|3|||
126365324|NCT03715829|454631746|FG006|Dose Ranging Period|Other|0|||
126365325|NCT03715829|454631747|FG007|Dose Ranging Period|Other|0|||
126365326|NCT03715829|454631748|FG008|Dose Ranging Period|Other|0|||
126365327|NCT03715829|454631749|FG009|Dose Ranging Period|Other|0|||
126365328|NCT03715829|454631750|FG010|Dose Ranging Period|Other|0|||
126365329|NCT03715829|454631740|FG000|Extension Period|Adverse Event|0|||
126365330|NCT03715829|454631741|FG001|Extension Period|Adverse Event|0|||
126365331|NCT03715829|454631742|FG002|Extension Period|Adverse Event|0|||
126365332|NCT03715829|454631743|FG003|Extension Period|Adverse Event|0|||
126766508|NCT04502862|456097357|FG000|Overall Study|Withdrawal by Subject|1|||
126766509|NCT04502862|456097358|FG001|Overall Study|Withdrawal by Subject|0|||
126766510|NCT04502862|456097357|FG000|Overall Study|Adverse Event|1|||
126766511|NCT04502862|456097358|FG001|Overall Study|Adverse Event|1|||
126766512|NCT02087865|456098772|FG000|Overall Study|Withdrawal by Subject|6|||
126766513|NCT02087865|456098773|FG001|Overall Study|Withdrawal by Subject|0|||
126766514|NCT02087865|456098774|FG002|Overall Study|Withdrawal by Subject|1|||
126766515|NCT02087865|456098772|FG000|Overall Study|Lost to Follow-up|0|||
126766516|NCT02087865|456098773|FG001|Overall Study|Lost to Follow-up|0|||
126766517|NCT02087865|456098774|FG002|Overall Study|Lost to Follow-up|1|||
126766518|NCT02087865|456098772|FG000|Overall Study|Drug Non-compliance|0|||
126766519|NCT02087865|456098773|FG001|Overall Study|Drug Non-compliance|2|||
126766520|NCT02087865|456098774|FG002|Overall Study|Drug Non-compliance|0|||
126766521|NCT02087865|456098772|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
126766522|NCT02087865|456098773|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
126766523|NCT02087865|456098774|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
126766524|NCT01392469|456098777|FG000|Overall Study|Adverse Event|2|||
126766525|NCT01392469|456098777|FG000|Overall Study|Withdrawal by Subject|1|||
126766526|NCT01392469|456098777|FG000|Overall Study|Protocol Violation|1|||
126766527|NCT03255226|456098778|FG000|Overall Study|Adverse Event|2|||
126766528|NCT03255226|456098778|FG000|Overall Study|Physician Decision|3|||
126766529|NCT03255226|456098778|FG000|Overall Study|Withdrawal by Subject|1|||
126766530|NCT03255226|456098778|FG000|Overall Study|Serum or blood sodium increased|4|||
126766531|NCT03255226|456098778|FG000|Overall Study|Serum or blood potassium increased|4|||
126766532|NCT01035229|456098779|FG000|Overall Study|Adverse Event|61|||
126766533|NCT01035229|456098780|FG001|Overall Study|Adverse Event|14|||
126766534|NCT01035229|456098779|FG000|Overall Study|Withdrawal by Subject|20|||
126285965|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285966|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285967|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
126285968|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126766535|NCT01035229|456098780|FG001|Overall Study|Withdrawal by Subject|7|||
126766536|NCT01035229|456098779|FG000|Overall Study|Lost to Follow-up|1|||
126766537|NCT01035229|456098780|FG001|Overall Study|Lost to Follow-up|0|||
126766538|NCT01035229|456098779|FG000|Overall Study|Administrative problems|1|||
126766539|NCT01035229|456098780|FG001|Overall Study|Administrative problems|1|||
126766540|NCT01035229|456098779|FG000|Overall Study|Death|13|||
126285969|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285970|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285971|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285972|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285973|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
126285974|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
126285975|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285976|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285977|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285978|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285979|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285980|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285981|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285982|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
126285983|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
126285984|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126285985|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126365333|NCT03715829|454631744|FG004|Extension Period|Adverse Event|0|||
126549431|NCT02796963|455305624|FG001|Overall Study|Lost to Follow-up|76|||
126549432|NCT02796963|455305625|FG002|Overall Study|Lost to Follow-up|69|||
126549433|NCT02796963|455305626|FG003|Overall Study|Lost to Follow-up|72|||
126766541|NCT01035229|456098780|FG001|Overall Study|Death|5|||
126766542|NCT01035229|456098779|FG000|Overall Study|New cancer therapy|2|||
126766543|NCT01035229|456098780|FG001|Overall Study|New cancer therapy|0|||
126766544|NCT01035229|456098779|FG000|Overall Study|Protocol Violation|0|||
126766545|NCT01035229|456098780|FG001|Overall Study|Protocol Violation|2|||
126766546|NCT01035229|456098779|FG000|Overall Study|Sponsor's decision to end study|3|||
126766547|NCT01035229|456098780|FG001|Overall Study|Sponsor's decision to end study|3|||
126766548|NCT01035229|456098779|FG000|Overall Study|Disease Progression|261|||
126365334|NCT03715829|454631745|FG005|Extension Period|Adverse Event|0|||
126365335|NCT03715829|454631746|FG006|Extension Period|Adverse Event|3|||
126766549|NCT01035229|456098780|FG001|Overall Study|Disease Progression|152|||
126766550|NCT00564486|456098782|FG000|Overall Study|Adverse Event|0|||
126766551|NCT00564486|456098783|FG001|Overall Study|Adverse Event|1|||
126766552|NCT00564486|456098784|FG002|Overall Study|Adverse Event|0|||
126549434|NCT00951509|455305627|FG000|Overall Study|Withdrawal by Subject|2|||
126549435|NCT00582491|455305628|FG000|Overall Study|Withdrawal by Subject|1|||
126549436|NCT00582491|455305629|FG001|Overall Study|Withdrawal by Subject|0|||
126549437|NCT04192630|455305630|FG000|Overall Study|Discontinued before surgery|2|||
126549438|NCT04192630|455305631|FG001|Overall Study|Discontinued before surgery|0|||
126549439|NCT04192630|455305630|FG000|Overall Study|Discontinued after surgery|5|||
126549440|NCT04192630|455305631|FG001|Overall Study|Discontinued after surgery|3|||
126549441|NCT01425632|455305632|FG000|Overall Study|Adverse Event|0|||
126549442|NCT01425632|455305633|FG001|Overall Study|Adverse Event|1|||
126549443|NCT01425632|455305634|FG002|Overall Study|Adverse Event|1|||
126549444|NCT01425632|455305632|FG000|Overall Study|Physician Decision|1|||
126549445|NCT01425632|455305633|FG001|Overall Study|Physician Decision|0|||
126549446|NCT01425632|455305634|FG002|Overall Study|Physician Decision|0|||
126549447|NCT01425632|455305632|FG000|Overall Study|Protocol Violation|0|||
126549448|NCT01425632|455305633|FG001|Overall Study|Protocol Violation|0|||
126549449|NCT01425632|455305634|FG002|Overall Study|Protocol Violation|2|||
126549450|NCT01425632|455305632|FG000|Overall Study|Withdrawal by Subject|0|||
126549451|NCT01425632|455305633|FG001|Overall Study|Withdrawal by Subject|0|||
126549452|NCT01425632|455305634|FG002|Overall Study|Withdrawal by Subject|1|||
126549453|NCT01208415|455305637|FG000|Overall Study|Death|1|||
126549454|NCT01208415|455305637|FG000|Overall Study|Lost to Follow-up|2|||
126549455|NCT01208415|455305637|FG000|Overall Study|Withdrawal by Subject|3|||
126549456|NCT01208415|455305637|FG000|Overall Study|Device not placed|1|||
126549457|NCT01208415|455305637|FG000|Overall Study|Still be eligible for follow-up|33|||
126549458|NCT01115491|455305638|FG000|Overall Study|Death|22|||
126549459|NCT01115491|455305638|FG000|Overall Study|Adverse Event|3|||
126549460|NCT01115491|455305638|FG000|Overall Study|Lost to Follow-up|3|||
126549461|NCT01115491|455305638|FG000|Overall Study|Withdrawal by Subject|1|||
126549462|NCT01115491|455305638|FG000|Overall Study|Physician Decision|1|||
126549463|NCT04297241|455305639|FG000|Overall Study|Withdrawal by Subject|1|||
126549464|NCT04297241|455305639|FG000|Overall Study|Adverse Event|1|||
126549465|NCT04297241|455305639|FG000|Overall Study|Physician Decision|3|||
126549466|NCT01003639|455305640|FG000|Overall Study|Lost to Follow-up|6|||
126549467|NCT01003639|455305641|FG001|Overall Study|Lost to Follow-up|9|||
126549468|NCT01003639|455305640|FG000|Overall Study|Withdrawal by Subject|9|||
126549469|NCT01003639|455305641|FG001|Overall Study|Withdrawal by Subject|5|||
126549470|NCT01003639|455305640|FG000|Overall Study|Lack of Efficacy|1|||
126549471|NCT01003639|455305641|FG001|Overall Study|Lack of Efficacy|6|||
126549472|NCT01003639|455305640|FG000|Overall Study|Adverse Event|0|||
126549473|NCT01003639|455305641|FG001|Overall Study|Adverse Event|1|||
126549474|NCT01003639|455305640|FG000|Overall Study|Protocol Violation|0|||
126549475|NCT01003639|455305641|FG001|Overall Study|Protocol Violation|1|||
126709914|NCT03455543|455889973|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
126709915|NCT03455543|455889974|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
126709916|NCT03455543|455889972|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
126709917|NCT03455543|455889973|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
126709918|NCT03455543|455889974|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
126709919|NCT03455543|455889972|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
126709920|NCT03455543|455889973|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
126709921|NCT03455543|455889974|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
126709922|NCT03455543|455889972|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
126709923|NCT03455543|455889973|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
126709924|NCT03455543|455889974|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
126709925|NCT03455543|455889972|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
126709926|NCT03455543|455889973|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
126709927|NCT03455543|455889974|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
126709928|NCT03455543|455889972|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
126709929|NCT03455543|455889973|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
126709930|NCT03455543|455889974|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
126709931|NCT02873221|455889975|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
126709932|NCT02873221|455889976|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
126709933|NCT02873221|455889977|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
126709934|NCT02873221|455889975|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
126709935|NCT02873221|455889976|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
126709936|NCT02873221|455889977|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
126285986|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126549476|NCT01003639|455305640|FG000|Overall Study|Physician Decision|1|||
126549477|NCT01003639|455305641|FG001|Overall Study|Physician Decision|0|||
126549478|NCT04362137|455305645|FG000|Overall Study|Death|9|||
126549479|NCT04362137|455305646|FG001|Overall Study|Death|3|||
126549480|NCT04362137|455305645|FG000|Overall Study|Patient decision|6|||
126549481|NCT04362137|455305646|FG001|Overall Study|Patient decision|3|||
126549482|NCT04362137|455305645|FG000|Overall Study|Adverse Event|1|||
126709937|NCT02873221|455889975|FG000|Treatment Period|Protocol Violation|2|||
126709938|NCT02873221|455889976|FG001|Treatment Period|Protocol Violation|5|||
126766553|NCT00564486|456098785|FG003|Overall Study|Adverse Event|0|||
126766554|NCT00564486|456098782|FG000|Overall Study|Withdrawal by Subject|4|||
126766555|NCT00564486|456098783|FG001|Overall Study|Withdrawal by Subject|0|||
126766556|NCT00564486|456098784|FG002|Overall Study|Withdrawal by Subject|0|||
126766557|NCT00564486|456098785|FG003|Overall Study|Withdrawal by Subject|5|||
126766558|NCT00564486|456098782|FG000|Overall Study|Subject refused to have blood drawn|0|||
126766559|NCT00564486|456098783|FG001|Overall Study|Subject refused to have blood drawn|0|||
126766560|NCT00564486|456098784|FG002|Overall Study|Subject refused to have blood drawn|1|||
126766561|NCT00564486|456098785|FG003|Overall Study|Subject refused to have blood drawn|0|||
126766562|NCT00564486|456098782|FG000|Overall Study|Lost to Follow-up|3|||
126766563|NCT00564486|456098783|FG001|Overall Study|Lost to Follow-up|0|||
126766564|NCT00564486|456098784|FG002|Overall Study|Lost to Follow-up|2|||
126766565|NCT00564486|456098785|FG003|Overall Study|Lost to Follow-up|2|||
126285987|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126285988|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126285989|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126285990|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126285991|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
126285992|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
126549483|NCT04362137|455305646|FG001|Overall Study|Adverse Event|0|||
126709939|NCT02873221|455889977|FG002|Treatment Period|Protocol Violation|8|||
126709940|NCT02873221|455889975|FG000|Treatment Period|Pregnancy|4|||
126709941|NCT02873221|455889976|FG001|Treatment Period|Pregnancy|6|||
126709942|NCT02873221|455889977|FG002|Treatment Period|Pregnancy|3|||
126709943|NCT02873221|455889975|FG000|Treatment Period|Lack of Qualifying Event|0|||
126709944|NCT02873221|455889976|FG001|Treatment Period|Lack of Qualifying Event|3|||
126709945|NCT02873221|455889977|FG002|Treatment Period|Lack of Qualifying Event|1|||
126709946|NCT02873221|455889975|FG000|Treatment Period|Withdrawal of Consent|52|||
126709947|NCT02873221|455889976|FG001|Treatment Period|Withdrawal of Consent|51|||
126709948|NCT02873221|455889977|FG002|Treatment Period|Withdrawal of Consent|41|||
126709949|NCT02873221|455889975|FG000|Treatment Period|Lack of Efficacy|0|||
126709950|NCT02873221|455889976|FG001|Treatment Period|Lack of Efficacy|17|||
126709951|NCT02873221|455889977|FG002|Treatment Period|Lack of Efficacy|12|||
126709952|NCT02873221|455889975|FG000|Treatment Period|Adverse Event|4|||
126709953|NCT02873221|455889976|FG001|Treatment Period|Adverse Event|9|||
126709954|NCT02873221|455889977|FG002|Treatment Period|Adverse Event|11|||
126709955|NCT02873221|455889975|FG000|Treatment Period|Lost to Follow-up|26|||
126709956|NCT02873221|455889976|FG001|Treatment Period|Lost to Follow-up|30|||
126709957|NCT02873221|455889977|FG002|Treatment Period|Lost to Follow-up|26|||
126709958|NCT02873221|455889975|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
126709959|NCT02873221|455889976|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
126709960|NCT02873221|455889977|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
126709961|NCT02873221|455889975|FG000|Safety Follow-up Period|Protocol Violation|0|||
126709962|NCT02873221|455889976|FG001|Safety Follow-up Period|Protocol Violation|0|||
126709963|NCT02873221|455889977|FG002|Safety Follow-up Period|Protocol Violation|1|||
126709964|NCT02873221|455889975|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
126709965|NCT02873221|455889976|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
126709966|NCT02873221|455889977|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
126709967|NCT02873221|455889975|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
126709968|NCT02873221|455889976|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
126709969|NCT02873221|455889977|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
126709970|NCT00479466|455889978|FG000|Overall Study|Adverse Event|5|||
126709971|NCT00479466|455889979|FG001|Overall Study|Adverse Event|1|||
126709972|NCT00479466|455889980|FG002|Overall Study|Adverse Event|0|||
126709973|NCT00479466|455889981|FG003|Overall Study|Adverse Event|1|||
126709974|NCT00479466|455889982|FG004|Overall Study|Adverse Event|2|||
126709975|NCT00479466|455889983|FG005|Overall Study|Adverse Event|0|||
126709976|NCT00479466|455889978|FG000|Overall Study|Hyperglycemia|0|||
126709977|NCT00479466|455889979|FG001|Overall Study|Hyperglycemia|0|||
126709978|NCT00479466|455889980|FG002|Overall Study|Hyperglycemia|0|||
126709979|NCT00479466|455889981|FG003|Overall Study|Hyperglycemia|0|||
126709980|NCT00479466|455889982|FG004|Overall Study|Hyperglycemia|0|||
126709981|NCT00479466|455889983|FG005|Overall Study|Hyperglycemia|1|||
126709982|NCT00479466|455889978|FG000|Overall Study|Lack of Efficacy|2|||
126766566|NCT03862807|456098790|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
126365336|NCT03715829|454631747|FG007|Extension Period|Adverse Event|1|||
126709983|NCT00479466|455889979|FG001|Overall Study|Lack of Efficacy|0|||
126709984|NCT00479466|455889980|FG002|Overall Study|Lack of Efficacy|1|||
126709985|NCT00479466|455889981|FG003|Overall Study|Lack of Efficacy|0|||
126709986|NCT00479466|455889982|FG004|Overall Study|Lack of Efficacy|0|||
126709987|NCT00479466|455889983|FG005|Overall Study|Lack of Efficacy|0|||
126709988|NCT00479466|455889978|FG000|Overall Study|Lost to Follow-up|0|||
126709989|NCT00479466|455889979|FG001|Overall Study|Lost to Follow-up|1|||
126709990|NCT00479466|455889980|FG002|Overall Study|Lost to Follow-up|1|||
126766567|NCT04362761|456098791|FG000|Part A (48 Weeks)|Adverse Event|2|||
126766568|NCT04362761|456098791|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
126766569|NCT04362761|456098791|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
126285993|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126285994|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126766570|NCT04362761|456098791|FG000|Part A (48 Weeks)|Other|5|||
126766571|NCT04362761|456098791|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
126285995|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126285996|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126285997|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126285998|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126285999|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126286000|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
126766572|NCT04362761|456098791|FG000|Part B (86 Weeks)|Other|4|||
126766573|NCT00684645|456098792|FG000|Overall Study|Death|2|||
126766574|NCT00684645|456098792|FG000|Overall Study|Progressive disease|67|||
126766575|NCT00684645|456098792|FG000|Overall Study|Adverse Event|27|||
126766576|NCT00684645|456098792|FG000|Overall Study|Lost to Follow-up|3|||
126766577|NCT00684645|456098792|FG000|Overall Study|Other|15|||
126766578|NCT02525627|456098806|FG000|Overall Study|Revision|1|||
126766579|NCT02525627|456098807|FG001|Overall Study|Revision|1|||
126766580|NCT02525627|456098806|FG000|Overall Study|Withdrawal by Subject|1|||
126766581|NCT02525627|456098807|FG001|Overall Study|Withdrawal by Subject|2|||
126766582|NCT02525627|456098806|FG000|Overall Study|Death|1|||
126286001|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286002|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
126766583|NCT02525627|456098807|FG001|Overall Study|Death|0|||
126766584|NCT02525627|456098806|FG000|Overall Study|Site terminated|11|||
126766585|NCT02525627|456098807|FG001|Overall Study|Site terminated|10|||
126766586|NCT03746080|456098808|FG000|Overall Study|In follow up|2|||
126766587|NCT03746080|456098808|FG000|Overall Study|Death|15|||
126766588|NCT01473589|456098809|FG000|Overall Study|Adverse Event|1|||
126766589|NCT01473589|456098810|FG001|Overall Study|Adverse Event|1|||
126766590|NCT01473589|456098809|FG000|Overall Study|Death|2|||
126766591|NCT01473589|456098810|FG001|Overall Study|Death|0|||
126766592|NCT01473589|456098809|FG000|Overall Study|Lost to Follow-up|2|||
126766593|NCT01473589|456098810|FG001|Overall Study|Lost to Follow-up|2|||
126766594|NCT01473589|456098809|FG000|Overall Study|Protocol Violation|1|||
126766595|NCT01473589|456098810|FG001|Overall Study|Protocol Violation|0|||
126766596|NCT01473589|456098809|FG000|Overall Study|Withdrawal by Subject|5|||
126286003|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
126286004|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286005|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286006|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286007|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286008|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286009|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
126286010|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
126286011|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
126286012|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286013|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286014|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286015|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286016|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286017|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286018|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
126286019|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126286020|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
126286021|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126549484|NCT04362137|455305645|FG000|Overall Study|Lost to Follow-up|1|||
126549485|NCT04362137|455305646|FG001|Overall Study|Lost to Follow-up|0|||
126286022|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126286023|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126286024|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126286025|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126549486|NCT04362137|455305645|FG000|Overall Study|Protocol deviation|1|||
126766597|NCT01473589|456098810|FG001|Overall Study|Withdrawal by Subject|11|||
126766598|NCT01473589|456098809|FG000|Overall Study|Physician Decision|0|||
126766599|NCT01473589|456098810|FG001|Overall Study|Physician Decision|1|||
126766600|NCT01473589|456098809|FG000|Overall Study|Entry criteria not met|0|||
126709991|NCT00479466|455889981|FG003|Overall Study|Lost to Follow-up|0|||
126709992|NCT00479466|455889982|FG004|Overall Study|Lost to Follow-up|2|||
126709993|NCT00479466|455889983|FG005|Overall Study|Lost to Follow-up|2|||
126286026|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126286027|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
126286028|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286029|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
126286030|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286031|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286032|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286033|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286034|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286035|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286036|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
126286037|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286038|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286039|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
126286040|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286041|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286042|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286043|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286044|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286045|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
126286046|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286047|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286048|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
126286049|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286050|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286051|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286052|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286053|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286054|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
126286055|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126286056|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126286057|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
126286058|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126286059|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126286060|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126456868|NCT00160667|454972886|FG001|Overall Study|Adverse Event|1|||
126456869|NCT00160667|454972887|FG002|Overall Study|Adverse Event|4|||
126456870|NCT00160667|454972885|FG000|Overall Study|Withdrawal by Subject|2|||
126456871|NCT00160667|454972886|FG001|Overall Study|Withdrawal by Subject|0|||
126456872|NCT00160667|454972887|FG002|Overall Study|Withdrawal by Subject|1|||
126456873|NCT00160667|454972885|FG000|Overall Study|Lack of Efficacy|0|||
126456874|NCT00160667|454972886|FG001|Overall Study|Lack of Efficacy|1|||
126456875|NCT00160667|454972887|FG002|Overall Study|Lack of Efficacy|0|||
126456876|NCT00160667|454972885|FG000|Overall Study|Protocol Violation|0|||
126456877|NCT00160667|454972886|FG001|Overall Study|Protocol Violation|1|||
126456878|NCT00160667|454972887|FG002|Overall Study|Protocol Violation|0|||
126456879|NCT00160667|454972885|FG000|Overall Study|Patient decision|0|||
126456880|NCT00160667|454972886|FG001|Overall Study|Patient decision|0|||
126456881|NCT00160667|454972887|FG002|Overall Study|Patient decision|1|||
126456882|NCT00534313|454972891|FG000|Short-term Period|Adverse Event|1|||
126456883|NCT00534313|454972892|FG001|Short-term Period|Adverse Event|2|||
126456884|NCT00534313|454972893|FG002|Short-term Period|Adverse Event|1|||
126456885|NCT00534313|454972894|FG003|Short-term Period|Adverse Event|3|||
126456886|NCT00534313|454972891|FG000|Short-term Period|Lack of Efficacy|3|||
126456887|NCT00534313|454972892|FG001|Short-term Period|Lack of Efficacy|4|||
126456888|NCT00534313|454972893|FG002|Short-term Period|Lack of Efficacy|0|||
126456889|NCT00534313|454972894|FG003|Short-term Period|Lack of Efficacy|3|||
126709994|NCT00479466|455889978|FG000|Overall Study|Physician Decision|2|||
126286061|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126456890|NCT00534313|454972891|FG000|Short-term Period|Participant not meeting study criteria|0|||
126456891|NCT00534313|454972892|FG001|Short-term Period|Participant not meeting study criteria|0|||
126456892|NCT00534313|454972893|FG002|Short-term Period|Participant not meeting study criteria|0|||
126709995|NCT00479466|455889979|FG001|Overall Study|Physician Decision|1|||
126549487|NCT04362137|455305646|FG001|Overall Study|Protocol deviation|0|||
126549488|NCT03306043|455305650|FG000|Overall Study|Adverse Event|1|||
126549489|NCT03306043|455305650|FG000|Overall Study|Lost to Follow-up|1|||
126286062|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126286063|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
126286064|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286065|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286066|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286067|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286068|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286069|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286070|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
126286071|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286072|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
126286073|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
126286074|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
126286075|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286076|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286077|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286078|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286079|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286080|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286081|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
126286082|NCT03598790|454334921|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286083|NCT03598790|454334922|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286084|NCT03598790|454334923|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
126286085|NCT03598790|454334924|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286086|NCT03598790|454334925|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286087|NCT03598790|454334926|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286088|NCT03598790|454334927|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286089|NCT03598790|454334928|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286090|NCT03598790|454334929|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
126286091|NCT03598790|454334921|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126286092|NCT03598790|454334922|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126286093|NCT03598790|454334923|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126286094|NCT03598790|454334924|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
126286095|NCT03598790|454334925|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
126286096|NCT03598790|454334926|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
126286097|NCT03598790|454334927|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126286098|NCT03598790|454334928|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126286099|NCT03598790|454334929|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126286100|NCT03598790|454334921|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286101|NCT03598790|454334922|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286102|NCT03598790|454334923|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286103|NCT03598790|454334924|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
126286104|NCT03598790|454334925|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286105|NCT03598790|454334926|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286106|NCT03598790|454334927|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286107|NCT03598790|454334928|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286108|NCT03598790|454334929|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
126286109|NCT03598790|454334921|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126286110|NCT03598790|454334922|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126286111|NCT03598790|454334923|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126549490|NCT03306043|455305650|FG000|Overall Study|Withdrawal by Subject|2|||
126549491|NCT00785538|455305651|FG000|Treatment Period|Adverse Event|1|||
126549492|NCT00785538|455305652|FG001|Treatment Period|Adverse Event|2|||
126549493|NCT00785538|455305653|FG002|Treatment Period|Adverse Event|2|||
126549494|NCT00785538|455305654|FG003|Treatment Period|Adverse Event|0|||
126549495|NCT00785538|455305651|FG000|Treatment Period|Withdrawal by Subject|0|||
126549496|NCT00785538|455305652|FG001|Treatment Period|Withdrawal by Subject|0|||
126766601|NCT01473589|456098810|FG001|Overall Study|Entry criteria not met|1|||
126549497|NCT00785538|455305653|FG002|Treatment Period|Withdrawal by Subject|0|||
126286112|NCT03598790|454334924|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
126286113|NCT03598790|454334925|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126286114|NCT03598790|454334926|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126286115|NCT03598790|454334927|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126766602|NCT01819467|456098811|FG000|Overall Study|Physician Decision|20|||
126766603|NCT01819467|456098812|FG001|Overall Study|Physician Decision|9|||
126766604|NCT03256526|456098814|FG000|Overall Study|Adverse Event|1|||
126766605|NCT03256526|456098815|FG001|Overall Study|Adverse Event|0|||
126766606|NCT03256526|456098816|FG002|Overall Study|Adverse Event|1|||
126766607|NCT03256526|456098814|FG000|Overall Study|Lost to Follow-up|1|||
126766608|NCT03256526|456098815|FG001|Overall Study|Lost to Follow-up|0|||
126766609|NCT03256526|456098816|FG002|Overall Study|Lost to Follow-up|2|||
126766610|NCT02875340|456098817|FG000|Overall Study|Death|2|||
126766611|NCT02875340|456098817|FG000|Overall Study|Withdrawal by Subject|2|||
126766612|NCT02875340|456098817|FG000|Overall Study|Physician Decision|3|||
126766613|NCT02875340|456098817|FG000|Overall Study|Adverse Event|1|||
126766614|NCT01607398|456098820|FG000|Overall Study|Adverse Event|0|||
126766615|NCT01607398|456098821|FG001|Overall Study|Adverse Event|2|||
126766616|NCT01607398|456098820|FG000|Overall Study|Severe COPD|2|||
126766617|NCT01607398|456098821|FG001|Overall Study|Severe COPD|0|||
126766618|NCT03457727|456098822|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
126766619|NCT03457727|456098823|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
126766620|NCT03457727|456098824|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
126766621|NCT03457727|456098825|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
126766622|NCT00929201|456098826|FG000|Period 1|Withdrawal by Subject|0|||
126766623|NCT00929201|456098827|FG001|Period 1|Withdrawal by Subject|1|||
126766624|NCT01299272|456098830|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
126766625|NCT01299272|456098831|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
126766626|NCT01299272|456098832|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
126766627|NCT01299272|456098833|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
126766628|NCT01299272|456098830|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
126766629|NCT01299272|456098831|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
126766630|NCT01299272|456098832|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
126766631|NCT01299272|456098833|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
126766632|NCT01299272|456098830|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
126766633|NCT01299272|456098831|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
126766634|NCT01299272|456098832|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
126766635|NCT01299272|456098833|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
126766636|NCT01299272|456098830|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
126766637|NCT01299272|456098831|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
126766638|NCT01299272|456098832|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
126766639|NCT01299272|456098833|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
126766640|NCT01299272|456098830|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
126766641|NCT01299272|456098831|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
126766642|NCT01299272|456098832|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
126766643|NCT01299272|456098833|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
126766644|NCT01299272|456098830|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
126766645|NCT01299272|456098831|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
126766646|NCT01299272|456098832|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
126766647|NCT01299272|456098833|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
126549498|NCT00785538|455305654|FG003|Treatment Period|Withdrawal by Subject|1|||
126766648|NCT01299272|456098830|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
126766649|NCT01299272|456098831|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
126766650|NCT01299272|456098832|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
126766651|NCT01299272|456098833|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
126766652|NCT01299272|456098830|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
126766653|NCT01299272|456098831|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
126286116|NCT03598790|454334928|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126286117|NCT03598790|454334929|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126286118|NCT03598790|454334921|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286119|NCT03598790|454334922|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286120|NCT03598790|454334923|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286121|NCT03598790|454334924|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
126286122|NCT03598790|454334925|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
126286123|NCT03598790|454334926|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286124|NCT03598790|454334927|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286125|NCT03598790|454334928|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286126|NCT03598790|454334929|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
126286127|NCT03598790|454334921|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286128|NCT03598790|454334922|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126766654|NCT01299272|456098832|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
126766655|NCT01299272|456098833|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
126766656|NCT01299272|456098830|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
126766657|NCT01299272|456098831|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
126766658|NCT01299272|456098832|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
126766659|NCT01299272|456098833|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
126766660|NCT01299272|456098830|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
126766661|NCT01299272|456098831|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
126766662|NCT01299272|456098832|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
126766663|NCT01299272|456098833|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
126766664|NCT01299272|456098830|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
126766665|NCT01299272|456098831|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
126766666|NCT01299272|456098832|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
126766667|NCT01299272|456098833|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
126766668|NCT01299272|456098830|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
126766669|NCT01299272|456098831|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
126766670|NCT01299272|456098832|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
126766671|NCT01299272|456098833|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
126766672|NCT01299272|456098830|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
126766673|NCT01299272|456098831|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
126766674|NCT01299272|456098832|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
126766675|NCT01299272|456098833|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
126766676|NCT01299272|456098830|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
126766677|NCT01299272|456098831|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
126766678|NCT01299272|456098832|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
126766679|NCT01299272|456098833|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
126766680|NCT01299272|456098830|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
126766681|NCT01299272|456098831|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
126766682|NCT01299272|456098832|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
126766683|NCT01299272|456098833|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
126766684|NCT01299272|456098830|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
126766685|NCT01299272|456098831|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
126766686|NCT01299272|456098832|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
126766687|NCT01299272|456098833|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
126766688|NCT01299272|456098830|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
126766689|NCT01299272|456098831|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
126766690|NCT01299272|456098832|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
126766691|NCT01299272|456098833|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
126456893|NCT00534313|454972894|FG003|Short-term Period|Participant not meeting study criteria|1|||
126456894|NCT00534313|454972891|FG000|Short-term Period|Participant withdrew consent|2|||
126456895|NCT00534313|454972892|FG001|Short-term Period|Participant withdrew consent|0|||
126456896|NCT00534313|454972893|FG002|Short-term Period|Participant withdrew consent|0|||
126456897|NCT00534313|454972894|FG003|Short-term Period|Participant withdrew consent|2|||
126456898|NCT00534313|454972891|FG000|Short-term Period|Pregnancy|0|||
126456899|NCT00534313|454972892|FG001|Short-term Period|Pregnancy|0|||
126456900|NCT00534313|454972893|FG002|Short-term Period|Pregnancy|1|||
126456901|NCT00534313|454972894|FG003|Short-term Period|Pregnancy|0|||
126456902|NCT00534313|454972891|FG000|Long-term Period|Adverse Event|2|||
126456903|NCT00534313|454972892|FG001|Long-term Period|Adverse Event|1|||
126456904|NCT00534313|454972893|FG002|Long-term Period|Adverse Event|0|||
126456905|NCT00534313|454972894|FG003|Long-term Period|Adverse Event|1|||
126456906|NCT00534313|454972891|FG000|Long-term Period|Lack of Efficacy|14|||
126456907|NCT00534313|454972892|FG001|Long-term Period|Lack of Efficacy|10|||
126456908|NCT00534313|454972893|FG002|Long-term Period|Lack of Efficacy|14|||
126456909|NCT00534313|454972894|FG003|Long-term Period|Lack of Efficacy|12|||
126456910|NCT00534313|454972891|FG000|Long-term Period|Lost to Follow-up|1|||
126456911|NCT00534313|454972892|FG001|Long-term Period|Lost to Follow-up|2|||
126456912|NCT00534313|454972893|FG002|Long-term Period|Lost to Follow-up|0|||
126456913|NCT00534313|454972894|FG003|Long-term Period|Lost to Follow-up|0|||
126456914|NCT00534313|454972891|FG000|Long-term Period|Withdrawal by Subject|2|||
126456915|NCT00534313|454972892|FG001|Long-term Period|Withdrawal by Subject|2|||
126456916|NCT00534313|454972893|FG002|Long-term Period|Withdrawal by Subject|0|||
126456917|NCT00534313|454972894|FG003|Long-term Period|Withdrawal by Subject|0|||
126456918|NCT00534313|454972891|FG000|Long-term Period|No longer meets study criteria|0|||
126456919|NCT00534313|454972892|FG001|Long-term Period|No longer meets study criteria|1|||
126456920|NCT00534313|454972893|FG002|Long-term Period|No longer meets study criteria|0|||
126456921|NCT00534313|454972894|FG003|Long-term Period|No longer meets study criteria|0|||
126456922|NCT00534313|454972891|FG000|Long-term Period|Poor compliance/noncompliance|0|||
126709996|NCT00479466|455889980|FG002|Overall Study|Physician Decision|1|||
126709997|NCT00479466|455889981|FG003|Overall Study|Physician Decision|0|||
126709998|NCT00479466|455889982|FG004|Overall Study|Physician Decision|0|||
126709999|NCT00479466|455889983|FG005|Overall Study|Physician Decision|0|||
126710000|NCT00479466|455889978|FG000|Overall Study|Pregnancy|0|||
126710001|NCT00479466|455889979|FG001|Overall Study|Pregnancy|0|||
126710002|NCT00479466|455889980|FG002|Overall Study|Pregnancy|0|||
126710003|NCT00479466|455889981|FG003|Overall Study|Pregnancy|0|||
126766692|NCT01299272|456098830|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
126766693|NCT01299272|456098831|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
126766694|NCT01299272|456098832|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
126766695|NCT01299272|456098833|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
126766696|NCT01299272|456098830|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
126766697|NCT01299272|456098831|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
126766698|NCT01299272|456098832|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
126766699|NCT01299272|456098833|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
126766700|NCT01299272|456098830|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
126766701|NCT01299272|456098831|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
126766702|NCT01299272|456098832|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
126766703|NCT01299272|456098833|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
126766704|NCT01299272|456098830|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
126766705|NCT01299272|456098831|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
126766706|NCT01299272|456098832|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
126766707|NCT01299272|456098833|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
126766708|NCT01299272|456098830|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
126766709|NCT01299272|456098831|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
126766710|NCT01299272|456098832|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
126766711|NCT01299272|456098833|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
126766712|NCT01299272|456098830|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
126766713|NCT01299272|456098831|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
126766714|NCT01299272|456098832|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
126766715|NCT01299272|456098833|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
126766716|NCT01299272|456098830|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
126766717|NCT01299272|456098831|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
126766718|NCT01299272|456098832|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
126766719|NCT01299272|456098833|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
126766720|NCT01299272|456098830|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
126766721|NCT01299272|456098831|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
126766722|NCT01299272|456098832|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
126766723|NCT01299272|456098833|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
126766724|NCT00464308|456098834|FG000|Overall Study|Adverse Event|22|||
126766725|NCT00464308|456098835|FG001|Overall Study|Adverse Event|27|||
126766726|NCT00464308|456098836|FG002|Overall Study|Adverse Event|16|||
126766727|NCT00464308|456098834|FG000|Overall Study|Lost to Follow-up|29|||
126766728|NCT00464308|456098835|FG001|Overall Study|Lost to Follow-up|19|||
126766729|NCT00464308|456098836|FG002|Overall Study|Lost to Follow-up|20|||
126766730|NCT00464308|456098834|FG000|Overall Study|Patient discontinued and other reasons|17|||
126766731|NCT00464308|456098835|FG001|Overall Study|Patient discontinued and other reasons|17|||
126766732|NCT00464308|456098836|FG002|Overall Study|Patient discontinued and other reasons|23|||
126766733|NCT00464308|456098834|FG000|Overall Study|Physician Decision|1|||
126766734|NCT00464308|456098835|FG001|Overall Study|Physician Decision|0|||
126766735|NCT00464308|456098836|FG002|Overall Study|Physician Decision|0|||
126766736|NCT01513759|456098837|FG000|Overall Study|Protocol Violation|4|||
126286129|NCT03598790|454334923|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286130|NCT03598790|454334924|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
126286131|NCT03598790|454334925|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286132|NCT03598790|454334926|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286133|NCT03598790|454334927|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286134|NCT03598790|454334928|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286135|NCT03598790|454334929|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
126286136|NCT05292183|454334942|FG000|Overall Study|Adverse Event|1|||
126710004|NCT00479466|455889982|FG004|Overall Study|Pregnancy|1|||
126710005|NCT00479466|455889983|FG005|Overall Study|Pregnancy|0|||
126766737|NCT01513759|456098837|FG000|Overall Study|Death during catheter placement|1|||
126766738|NCT03606109|456098838|FG000|Overall Study|Lost to Follow-up|2|||
126766739|NCT03606109|456098839|FG001|Overall Study|Lost to Follow-up|1|||
126766740|NCT00630994|456098840|FG000|Overall Study|Adverse Event|1|||
126766741|NCT00630994|456098840|FG000|Overall Study|Disease Progression|1|||
126710006|NCT00479466|455889978|FG000|Overall Study|Protocol Violation|1|||
126365337|NCT03715829|454631748|FG008|Extension Period|Adverse Event|6|||
126286137|NCT02506153|454334945|FG000|Overall Study|Adverse Event|359|||
126286138|NCT02506153|454334946|FG001|Overall Study|Adverse Event|114|||
126286139|NCT02506153|454334945|FG000|Overall Study|Refused unrelated to adverse event|127|||
126286140|NCT02506153|454334946|FG001|Overall Study|Refused unrelated to adverse event|18|||
126286141|NCT02506153|454334945|FG000|Overall Study|Progression/relapse|91|||
126286142|NCT02506153|454334946|FG001|Overall Study|Progression/relapse|136|||
126286143|NCT02506153|454334945|FG000|Overall Study|Death|2|||
126286144|NCT02506153|454334946|FG001|Overall Study|Death|1|||
126286145|NCT02506153|454334945|FG000|Overall Study|Other - not protocol specified|23|||
126286146|NCT02506153|454334946|FG001|Overall Study|Other - not protocol specified|12|||
126286147|NCT06400238|454334951|FG000|Overall Study|Started Protocol Therapy|2|||
126286148|NCT06400238|454334951|FG000|Overall Study|Adverse Event|1|||
126286149|NCT06400238|454334951|FG000|Overall Study|Death|1|||
126286150|NCT06400238|454334951|FG000|Overall Study|Disease Progression|27|||
126286151|NCT06400238|454334951|FG000|Overall Study|Withdrawal by Subject|2|||
126286152|NCT06400238|454334951|FG000|Overall Study|Physician Decision|2|||
126286153|NCT04034927|454334952|FG000|Overall Study|Adverse Event|4|||
126286154|NCT04034927|454334953|FG001|Overall Study|Adverse Event|9|||
126286155|NCT04034927|454334952|FG000|Overall Study|Death|0|||
126286156|NCT04034927|454334953|FG001|Overall Study|Death|1|||
126286157|NCT04034927|454334952|FG000|Overall Study|Withdrawal by Subject|0|||
126286158|NCT04034927|454334953|FG001|Overall Study|Withdrawal by Subject|3|||
126286159|NCT04034927|454334952|FG000|Overall Study|Still on Treatment|2|||
126766742|NCT00630994|456098840|FG000|Overall Study|Lack of Efficacy|1|||
126286160|NCT04034927|454334953|FG001|Overall Study|Still on Treatment|1|||
126286161|NCT04034927|454334952|FG000|Overall Study|Other|1|||
126286162|NCT04034927|454334953|FG001|Overall Study|Other|1|||
126286163|NCT03996447|454334956|FG000|First MRI Examination|Adverse Event|2|||
126286164|NCT03996447|454334957|FG001|First MRI Examination|Adverse Event|0|||
126286165|NCT03996447|454334956|FG000|First MRI Examination|Withdrawal by Subject|1|||
126286166|NCT03996447|454334957|FG001|First MRI Examination|Withdrawal by Subject|2|||
126286167|NCT03996447|454334956|FG000|First MRI Examination|Protocol Violation|0|||
126286168|NCT03996447|454334957|FG001|First MRI Examination|Protocol Violation|1|||
126365338|NCT03715829|454631749|FG009|Extension Period|Adverse Event|0|||
126365339|NCT03715829|454631750|FG010|Extension Period|Adverse Event|0|||
126365340|NCT03715829|454631740|FG000|Extension Period|Lack of Efficacy|0|||
126365341|NCT03715829|454631741|FG001|Extension Period|Lack of Efficacy|0|||
126365342|NCT03715829|454631742|FG002|Extension Period|Lack of Efficacy|0|||
126365343|NCT03715829|454631743|FG003|Extension Period|Lack of Efficacy|0|||
126710007|NCT00479466|455889979|FG001|Overall Study|Protocol Violation|0|||
126710008|NCT00479466|455889980|FG002|Overall Study|Protocol Violation|0|||
126710009|NCT00479466|455889981|FG003|Overall Study|Protocol Violation|0|||
126710010|NCT00479466|455889982|FG004|Overall Study|Protocol Violation|0|||
126710011|NCT00479466|455889983|FG005|Overall Study|Protocol Violation|0|||
126710012|NCT00479466|455889978|FG000|Overall Study|Withdrawal by Subject|3|||
126710013|NCT00479466|455889979|FG001|Overall Study|Withdrawal by Subject|5|||
126710014|NCT00479466|455889980|FG002|Overall Study|Withdrawal by Subject|0|||
126710015|NCT00479466|455889981|FG003|Overall Study|Withdrawal by Subject|2|||
126710016|NCT00479466|455889982|FG004|Overall Study|Withdrawal by Subject|3|||
126710017|NCT00479466|455889983|FG005|Overall Study|Withdrawal by Subject|1|||
126710018|NCT01325493|455889984|FG000|Overall Study|Protocol Violation|0|||
126710019|NCT01325493|455889985|FG001|Overall Study|Protocol Violation|1|||
126710020|NCT01325493|455889984|FG000|Overall Study|loss of neuromonitoring signals|0|||
126710021|NCT01325493|455889985|FG001|Overall Study|loss of neuromonitoring signals|2|||
126710022|NCT01325493|455889984|FG000|Overall Study|Allergy|1|||
126710023|NCT01325493|455889985|FG001|Overall Study|Allergy|0|||
126710024|NCT05372315|455889988|FG000|Overall Study|Withdrawal by Subject|1|||
126710025|NCT05372315|455889989|FG001|Overall Study|Withdrawal by Subject|0|||
126710026|NCT01508676|455889990|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
126710027|NCT01508676|455889991|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
126710028|NCT01508676|455889990|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
126710029|NCT01508676|455889991|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
126710030|NCT01508676|455889990|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
126710031|NCT01508676|455889991|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
126710032|NCT01508676|455889990|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
126286169|NCT03996447|454334956|FG000|Washout|Adverse Event|2|||
126286170|NCT03996447|454334957|FG001|Washout|Adverse Event|0|||
126286171|NCT03996447|454334956|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
126286172|NCT03996447|454334957|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
126286173|NCT03996447|454334956|FG000|Washout|Withdrawal by Subject|0|||
126286174|NCT03996447|454334957|FG001|Washout|Withdrawal by Subject|1|||
126365344|NCT03715829|454631744|FG004|Extension Period|Lack of Efficacy|0|||
126710033|NCT01508676|455889991|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
126710034|NCT01508676|455889990|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
126710035|NCT01508676|455889991|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
126710036|NCT02532543|455889992|FG000|Overall Study|Lost to Follow-up|0|||
126766743|NCT00630994|456098840|FG000|Overall Study|Other|1|||
126766744|NCT03669640|456098841|FG000|Overall Study|Study Terminated by Sponsor|0|||
126766745|NCT03669640|456098842|FG001|Overall Study|Study Terminated by Sponsor|0|||
126766746|NCT03669640|456098843|FG002|Overall Study|Study Terminated by Sponsor|0|||
126766747|NCT03669640|456098844|FG003|Overall Study|Study Terminated by Sponsor|0|||
126766748|NCT03669640|456098845|FG004|Overall Study|Study Terminated by Sponsor|1|||
126766749|NCT03669640|456098846|FG005|Overall Study|Study Terminated by Sponsor|0|||
126766750|NCT03669640|456098841|FG000|Overall Study|Lost to Follow-up|0|||
126766751|NCT03669640|456098842|FG001|Overall Study|Lost to Follow-up|0|||
126766752|NCT03669640|456098843|FG002|Overall Study|Lost to Follow-up|2|||
126766753|NCT03669640|456098844|FG003|Overall Study|Lost to Follow-up|0|||
126766754|NCT03669640|456098845|FG004|Overall Study|Lost to Follow-up|0|||
126766755|NCT03669640|456098846|FG005|Overall Study|Lost to Follow-up|0|||
126766756|NCT03669640|456098841|FG000|Overall Study|Death|0|||
126766757|NCT03669640|456098842|FG001|Overall Study|Death|0|||
126766758|NCT03669640|456098843|FG002|Overall Study|Death|1|||
126766759|NCT03669640|456098844|FG003|Overall Study|Death|0|||
126766760|NCT03669640|456098845|FG004|Overall Study|Death|0|||
126766761|NCT03669640|456098846|FG005|Overall Study|Death|0|||
126766762|NCT03669640|456098841|FG000|Overall Study|Withdrawal by Subject|1|||
126766763|NCT03669640|456098842|FG001|Overall Study|Withdrawal by Subject|2|||
126766764|NCT03669640|456098843|FG002|Overall Study|Withdrawal by Subject|1|||
126766765|NCT03669640|456098844|FG003|Overall Study|Withdrawal by Subject|0|||
126766766|NCT03669640|456098845|FG004|Overall Study|Withdrawal by Subject|1|||
126766767|NCT03669640|456098846|FG005|Overall Study|Withdrawal by Subject|3|||
126286175|NCT03996447|454334956|FG000|Washout|Other reason|1|||
126286176|NCT03996447|454334957|FG001|Washout|Other reason|1|||
126286177|NCT03355469|454334958|FG000|Overall Study|COVID-19|3|||
126286178|NCT03355469|454334959|FG001|Overall Study|COVID-19|2|||
126286179|NCT03355469|454334960|FG002|Overall Study|COVID-19|3|||
126286180|NCT03355469|454334961|FG003|Overall Study|COVID-19|3|||
126286181|NCT03355469|454334958|FG000|Overall Study|Lost to Follow-up|1|||
126286182|NCT03355469|454334959|FG001|Overall Study|Lost to Follow-up|0|||
126286183|NCT03355469|454334960|FG002|Overall Study|Lost to Follow-up|1|||
126286184|NCT03355469|454334961|FG003|Overall Study|Lost to Follow-up|0|||
126286185|NCT03355469|454334958|FG000|Overall Study|Withdrawal by Subject|2|||
126286186|NCT03355469|454334959|FG001|Overall Study|Withdrawal by Subject|1|||
126286187|NCT03355469|454334960|FG002|Overall Study|Withdrawal by Subject|0|||
126286188|NCT03355469|454334961|FG003|Overall Study|Withdrawal by Subject|3|||
126766768|NCT03669640|456098841|FG000|Overall Study|Protocol Violation|1|||
126766769|NCT03669640|456098842|FG001|Overall Study|Protocol Violation|0|||
126766770|NCT03669640|456098843|FG002|Overall Study|Protocol Violation|0|||
126766771|NCT03669640|456098844|FG003|Overall Study|Protocol Violation|0|||
126766772|NCT03669640|456098845|FG004|Overall Study|Protocol Violation|0|||
126766773|NCT03669640|456098846|FG005|Overall Study|Protocol Violation|0|||
126766774|NCT03669640|456098841|FG000|Overall Study|Physician Decision|0|||
126766775|NCT03669640|456098842|FG001|Overall Study|Physician Decision|2|||
126766776|NCT03669640|456098843|FG002|Overall Study|Physician Decision|0|||
126766777|NCT03669640|456098844|FG003|Overall Study|Physician Decision|0|||
126766778|NCT03669640|456098845|FG004|Overall Study|Physician Decision|0|||
126766779|NCT03669640|456098846|FG005|Overall Study|Physician Decision|0|||
126766780|NCT03669640|456098841|FG000|Overall Study|Disease Relapse|1|||
126766781|NCT03669640|456098842|FG001|Overall Study|Disease Relapse|0|||
126766782|NCT03669640|456098843|FG002|Overall Study|Disease Relapse|0|||
126766783|NCT03669640|456098844|FG003|Overall Study|Disease Relapse|0|||
126766784|NCT03669640|456098845|FG004|Overall Study|Disease Relapse|0|||
126766785|NCT03669640|456098846|FG005|Overall Study|Disease Relapse|0|||
126766786|NCT03669640|456098841|FG000|Overall Study|Adverse Event|2|||
126286189|NCT01708941|454334962|FG000|Overall Study|Adverse Event|4|||
126286190|NCT01708941|454334963|FG001|Overall Study|Adverse Event|6|||
126286191|NCT01708941|454334964|FG002|Overall Study|Adverse Event|1|||
126286192|NCT01708941|454334965|FG003|Overall Study|Adverse Event|0|||
126286193|NCT01708941|454334962|FG000|Overall Study|Death|1|||
126456923|NCT00534313|454972892|FG001|Long-term Period|Poor compliance/noncompliance|1|||
126456924|NCT00534313|454972893|FG002|Long-term Period|Poor compliance/noncompliance|1|||
126456925|NCT00534313|454972894|FG003|Long-term Period|Poor compliance/noncompliance|0|||
126456926|NCT00534313|454972891|FG000|Long-term Period|Administrative reason by sponsor|17|||
126766787|NCT03669640|456098842|FG001|Overall Study|Adverse Event|1|||
126766788|NCT03669640|456098843|FG002|Overall Study|Adverse Event|0|||
126766789|NCT03669640|456098844|FG003|Overall Study|Adverse Event|0|||
126286194|NCT01708941|454334963|FG001|Overall Study|Death|1|||
126286195|NCT01708941|454334964|FG002|Overall Study|Death|2|||
126286196|NCT01708941|454334965|FG003|Overall Study|Death|14|||
126456927|NCT00534313|454972892|FG001|Long-term Period|Administrative reason by sponsor|15|||
126766790|NCT03669640|456098845|FG004|Overall Study|Adverse Event|1|||
126766791|NCT03669640|456098846|FG005|Overall Study|Adverse Event|0|||
126766792|NCT03533608|456098847|FG000|Overall Study|Withdrawal by Subject|3|||
126766793|NCT03533608|456098847|FG000|Overall Study|Physician Decision|2|||
126286197|NCT01708941|454334962|FG000|Overall Study|Withdrawal by Subject|1|||
126286198|NCT01708941|454334963|FG001|Overall Study|Withdrawal by Subject|0|||
126766794|NCT03286426|456098848|FG000|Overall Study|Physician Decision|3|||
126766795|NCT03514121|456098849|FG000|Overall Study|Withdrawal by Subject|0|||
126766796|NCT03514121|456098850|FG001|Overall Study|Withdrawal by Subject|0|||
126766797|NCT03514121|456098851|FG002|Overall Study|Withdrawal by Subject|0|||
126766798|NCT03514121|456098852|FG003|Overall Study|Withdrawal by Subject|0|||
126766799|NCT03514121|456098853|FG004|Overall Study|Withdrawal by Subject|1|||
126456928|NCT00534313|454972893|FG002|Long-term Period|Administrative reason by sponsor|26|||
126456929|NCT00534313|454972894|FG003|Long-term Period|Administrative reason by sponsor|18|||
126456930|NCT00534313|454972891|FG000|Long-term Period|Other|1|||
126456931|NCT00534313|454972892|FG001|Long-term Period|Other|2|||
126456932|NCT00534313|454972893|FG002|Long-term Period|Other|2|||
126456933|NCT00534313|454972894|FG003|Long-term Period|Other|2|||
126456934|NCT00927940|454972895|FG000|Overall Study|Death|1|||
126456935|NCT03709576|454972901|FG000|Overall Study|progression prior to enrollment|1|||
126766800|NCT03514121|456098854|FG005|Overall Study|Withdrawal by Subject|2|||
126766801|NCT03514121|456098855|FG006|Overall Study|Withdrawal by Subject|1|||
126766802|NCT03514121|456098856|FG007|Overall Study|Withdrawal by Subject|1|||
126766803|NCT03514121|456098857|FG008|Overall Study|Withdrawal by Subject|7|||
126766804|NCT03514121|456098858|FG009|Overall Study|Withdrawal by Subject|2|||
126766805|NCT03514121|456098849|FG000|Overall Study|Death|0|||
126766806|NCT03514121|456098850|FG001|Overall Study|Death|0|||
126766807|NCT03514121|456098851|FG002|Overall Study|Death|0|||
126766808|NCT03514121|456098852|FG003|Overall Study|Death|0|||
126766809|NCT03514121|456098853|FG004|Overall Study|Death|0|||
126766810|NCT03514121|456098854|FG005|Overall Study|Death|3|||
126766811|NCT03514121|456098855|FG006|Overall Study|Death|2|||
126766812|NCT03514121|456098856|FG007|Overall Study|Death|1|||
126710037|NCT02532543|455889993|FG001|Overall Study|Lost to Follow-up|0|||
126710038|NCT02532543|455889994|FG002|Overall Study|Lost to Follow-up|1|||
126710039|NCT02532543|455889995|FG003|Overall Study|Lost to Follow-up|0|||
126710040|NCT02614794|455889998|FG000|Overall Study|Death|258|||
126710041|NCT02614794|455889999|FG001|Overall Study|Death|151|||
126710042|NCT02614794|455889998|FG000|Overall Study|Study closure by Sponsor|119|||
126710043|NCT02614794|455889999|FG001|Overall Study|Study closure by Sponsor|45|||
126710044|NCT02614794|455889998|FG000|Overall Study|Withdrawal by Subject|24|||
126710045|NCT02614794|455889999|FG001|Overall Study|Withdrawal by Subject|5|||
126710046|NCT02614794|455889998|FG000|Overall Study|Lost to Follow-up|7|||
126766813|NCT03514121|456098857|FG008|Overall Study|Death|26|||
126766814|NCT03514121|456098858|FG009|Overall Study|Death|3|||
126766815|NCT03514121|456098849|FG000|Overall Study|Lost to Follow-up|0|||
126766816|NCT03514121|456098850|FG001|Overall Study|Lost to Follow-up|0|||
126766817|NCT03514121|456098851|FG002|Overall Study|Lost to Follow-up|1|||
126766818|NCT03514121|456098852|FG003|Overall Study|Lost to Follow-up|0|||
126766819|NCT03514121|456098853|FG004|Overall Study|Lost to Follow-up|0|||
126766820|NCT03514121|456098854|FG005|Overall Study|Lost to Follow-up|0|||
126766821|NCT03514121|456098855|FG006|Overall Study|Lost to Follow-up|0|||
126766822|NCT03514121|456098856|FG007|Overall Study|Lost to Follow-up|0|||
126286199|NCT01708941|454334964|FG002|Overall Study|Withdrawal by Subject|3|||
126286200|NCT01708941|454334965|FG003|Overall Study|Withdrawal by Subject|4|||
126286201|NCT01708941|454334962|FG000|Overall Study|Disease progression|9|||
126286202|NCT01708941|454334963|FG001|Overall Study|Disease progression|10|||
126286203|NCT01708941|454334964|FG002|Overall Study|Disease progression|8|||
126286204|NCT01708941|454334965|FG003|Overall Study|Disease progression|0|||
126286205|NCT01708941|454334962|FG000|Overall Study|Alternative therapy|0|||
126286206|NCT01708941|454334963|FG001|Overall Study|Alternative therapy|0|||
126286207|NCT01708941|454334964|FG002|Overall Study|Alternative therapy|2|||
126286208|NCT01708941|454334965|FG003|Overall Study|Alternative therapy|0|||
126286209|NCT01708941|454334962|FG000|Overall Study|Ineligible and never started treatment|1|||
126286210|NCT01708941|454334963|FG001|Overall Study|Ineligible and never started treatment|0|||
126286211|NCT01708941|454334964|FG002|Overall Study|Ineligible and never started treatment|1|||
126286212|NCT01708941|454334965|FG003|Overall Study|Ineligible and never started treatment|0|||
126286213|NCT01708941|454334962|FG000|Overall Study|Never started treatment|2|||
126286214|NCT01708941|454334963|FG001|Overall Study|Never started treatment|1|||
126365345|NCT03715829|454631745|FG005|Extension Period|Lack of Efficacy|0|||
126365346|NCT03715829|454631746|FG006|Extension Period|Lack of Efficacy|1|||
126365347|NCT03715829|454631747|FG007|Extension Period|Lack of Efficacy|9|||
126365348|NCT03715829|454631748|FG008|Extension Period|Lack of Efficacy|2|||
126365349|NCT03715829|454631749|FG009|Extension Period|Lack of Efficacy|0|||
126365350|NCT03715829|454631750|FG010|Extension Period|Lack of Efficacy|0|||
126365351|NCT03715829|454631740|FG000|Extension Period|Lost to Follow-up|0|||
126365352|NCT03715829|454631741|FG001|Extension Period|Lost to Follow-up|0|||
126365353|NCT03715829|454631742|FG002|Extension Period|Lost to Follow-up|0|||
126456936|NCT00890045|454972902|FG000|Overall Study|Death|0|||
126710047|NCT02614794|455889999|FG001|Overall Study|Lost to Follow-up|0|||
126365354|NCT03715829|454631743|FG003|Extension Period|Lost to Follow-up|0|||
126456937|NCT00890045|454972903|FG001|Overall Study|Death|1|||
126710048|NCT02614794|455889998|FG000|Overall Study|Physician Decision|1|||
126710049|NCT02614794|455889999|FG001|Overall Study|Physician Decision|1|||
126710050|NCT02614794|455889998|FG000|Overall Study|Hospital closure|1|||
126766823|NCT03514121|456098857|FG008|Overall Study|Lost to Follow-up|1|||
126766824|NCT03514121|456098858|FG009|Overall Study|Lost to Follow-up|0|||
126456938|NCT00890045|454972902|FG000|Overall Study|Did not receive HeRO Graft|0|||
126456939|NCT00890045|454972903|FG001|Overall Study|Did not receive HeRO Graft|2|||
126456940|NCT00890045|454972902|FG000|Overall Study|Lost to Follow-up|5|||
126456941|NCT00890045|454972903|FG001|Overall Study|Lost to Follow-up|7|||
126456942|NCT00483756|454972904|FG000|Overall Study|Death|2|||
126456943|NCT00483756|454972905|FG001|Overall Study|Death|0|||
126766825|NCT03514121|456098849|FG000|Overall Study|Adverse Event|0|||
126766826|NCT03514121|456098850|FG001|Overall Study|Adverse Event|0|||
126456944|NCT00483756|454972906|FG002|Overall Study|Death|1|||
126456945|NCT00483756|454972904|FG000|Overall Study|Adverse Event|19|||
126456946|NCT00483756|454972905|FG001|Overall Study|Adverse Event|38|||
126456947|NCT00483756|454972906|FG002|Overall Study|Adverse Event|40|||
126456948|NCT00483756|454972904|FG000|Overall Study|Lack of Efficacy|1|||
126456949|NCT00483756|454972905|FG001|Overall Study|Lack of Efficacy|0|||
126766827|NCT03514121|456098851|FG002|Overall Study|Adverse Event|0|||
126766828|NCT03514121|456098852|FG003|Overall Study|Adverse Event|0|||
126766829|NCT03514121|456098853|FG004|Overall Study|Adverse Event|0|||
126766830|NCT03514121|456098854|FG005|Overall Study|Adverse Event|0|||
126286215|NCT01708941|454334964|FG002|Overall Study|Never started treatment|0|||
126286216|NCT01708941|454334965|FG003|Overall Study|Never started treatment|0|||
126456950|NCT00483756|454972906|FG002|Overall Study|Lack of Efficacy|0|||
126456951|NCT00483756|454972904|FG000|Overall Study|Lost to Follow-up|3|||
126456952|NCT00483756|454972905|FG001|Overall Study|Lost to Follow-up|1|||
126456953|NCT00483756|454972906|FG002|Overall Study|Lost to Follow-up|0|||
126456954|NCT00483756|454972904|FG000|Overall Study|Withdrawal by Subject|5|||
126456955|NCT00483756|454972905|FG001|Overall Study|Withdrawal by Subject|3|||
126286217|NCT01708941|454334962|FG000|Overall Study|Ineligible|0|||
126286218|NCT01708941|454334963|FG001|Overall Study|Ineligible|0|||
126456956|NCT00483756|454972906|FG002|Overall Study|Withdrawal by Subject|4|||
126456957|NCT00483756|454972904|FG000|Overall Study|Other|2|||
126456958|NCT00483756|454972905|FG001|Overall Study|Other|4|||
126549499|NCT01234649|455305655|FG000|Overall Study|Withdrawal by Subject|32|||
126549500|NCT01234649|455305656|FG001|Overall Study|Withdrawal by Subject|26|||
126286219|NCT01708941|454334964|FG002|Overall Study|Ineligible|2|||
126286220|NCT01708941|454334965|FG003|Overall Study|Ineligible|0|||
126286221|NCT01575548|454334966|FG000|Overall Study|Adverse Event|15|||
126286222|NCT01575548|454334967|FG001|Overall Study|Adverse Event|2|||
126286223|NCT01575548|454334966|FG000|Overall Study|Disease progression|12|||
126286224|NCT01575548|454334967|FG001|Overall Study|Disease progression|25|||
126286225|NCT01575548|454334966|FG000|Overall Study|Death|1|||
126286226|NCT01575548|454334967|FG001|Overall Study|Death|0|||
126286227|NCT01575548|454334966|FG000|Overall Study|Other complicating disease|1|||
126286228|NCT01575548|454334967|FG001|Overall Study|Other complicating disease|0|||
126286229|NCT01575548|454334966|FG000|Overall Study|Withdrawal by Subject|7|||
126286230|NCT01575548|454334967|FG001|Overall Study|Withdrawal by Subject|3|||
126286231|NCT01575548|454334966|FG000|Overall Study|Noncompliance|1|||
126286232|NCT01575548|454334967|FG001|Overall Study|Noncompliance|0|||
126286233|NCT01575548|454334966|FG000|Overall Study|Anticipated surgery|0|||
126286234|NCT01575548|454334967|FG001|Overall Study|Anticipated surgery|1|||
126286235|NCT01575548|454334966|FG000|Overall Study|Never started protocol therapy|3|||
126286236|NCT01575548|454334967|FG001|Overall Study|Never started protocol therapy|2|||
126286237|NCT04175912|454334968|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
126286238|NCT04175912|454334969|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
126286239|NCT04175912|454334968|FG000|Overall Study|Adverse Event|0|||
126286240|NCT04175912|454334969|FG001|Overall Study|Adverse Event|3|||
126549501|NCT01234649|455305655|FG000|Overall Study|Pregnancy|6|||
126286241|NCT04175912|454334968|FG000|Overall Study|Never started treatment|3|||
126286242|NCT04175912|454334969|FG001|Overall Study|Never started treatment|3|||
126286243|NCT04175912|454334968|FG000|Overall Study|Death|0|||
126286244|NCT04175912|454334969|FG001|Overall Study|Death|1|||
126286245|NCT02048813|454334973|FG000|Overall Study|Still on treatment|279|||
126286246|NCT02048813|454334974|FG001|Overall Study|Still on treatment|0|||
126286247|NCT02048813|454334973|FG000|Overall Study|Adverse Event|40|||
126456959|NCT00483756|454972906|FG002|Overall Study|Other|3|||
126456960|NCT00483756|454972904|FG000|Overall Study|Randomized, Not Treated|1|||
126549502|NCT01234649|455305656|FG001|Overall Study|Pregnancy|6|||
126456961|NCT00483756|454972905|FG001|Overall Study|Randomized, Not Treated|4|||
126456962|NCT00483756|454972906|FG002|Overall Study|Randomized, Not Treated|4|||
126456963|NCT00495040|454972908|FG000|Overall Study|Withdrawal by Subject|3|||
126710051|NCT02614794|455889999|FG001|Overall Study|Hospital closure|0|||
126710052|NCT01633060|455890009|FG000|Randomization Phase|Protocol deviation|1|||
126710053|NCT01633060|455890010|FG001|Randomization Phase|Protocol deviation|2|||
126710054|NCT01633060|455890009|FG000|Randomization Phase|Technical problem|0|||
126710055|NCT01633060|455890010|FG001|Randomization Phase|Technical problem|1|||
126710056|NCT01633060|455890009|FG000|Treatment Phase|Adverse Event|24|||
126710057|NCT01633060|455890010|FG001|Treatment Phase|Adverse Event|3|||
126710058|NCT01633060|455890009|FG000|Treatment Phase|Lost to Follow-up|1|||
126710059|NCT01633060|455890010|FG001|Treatment Phase|Lost to Follow-up|0|||
126710060|NCT01633060|455890009|FG000|Treatment Phase|Physician Decision|16|||
126710061|NCT01633060|455890010|FG001|Treatment Phase|Physician Decision|7|||
126710062|NCT01633060|455890009|FG000|Treatment Phase|Progressive Disease|210|||
126710063|NCT01633060|455890010|FG001|Treatment Phase|Progressive Disease|120|||
126710064|NCT01633060|455890009|FG000|Treatment Phase|Protocol Deviation|1|||
126710065|NCT01633060|455890010|FG001|Treatment Phase|Protocol Deviation|0|||
126710066|NCT01633060|455890009|FG000|Treatment Phase|Study Terminated by sponsor|7|||
126710067|NCT01633060|455890010|FG001|Treatment Phase|Study Terminated by sponsor|3|||
126710068|NCT01633060|455890009|FG000|Treatment Phase|Subject/guardian decision|25|||
126710069|NCT01633060|455890010|FG001|Treatment Phase|Subject/guardian decision|4|||
126766831|NCT03514121|456098855|FG006|Overall Study|Adverse Event|1|||
126766832|NCT03514121|456098856|FG007|Overall Study|Adverse Event|0|||
126766833|NCT03514121|456098857|FG008|Overall Study|Adverse Event|0|||
126766834|NCT03514121|456098858|FG009|Overall Study|Adverse Event|0|||
126766835|NCT03514121|456098849|FG000|Overall Study|Other|0|||
126766836|NCT03514121|456098850|FG001|Overall Study|Other|1|||
126766837|NCT03514121|456098851|FG002|Overall Study|Other|1|||
126766838|NCT03514121|456098852|FG003|Overall Study|Other|0|||
126766839|NCT03514121|456098853|FG004|Overall Study|Other|1|||
126766840|NCT03514121|456098854|FG005|Overall Study|Other|2|||
126766841|NCT03514121|456098855|FG006|Overall Study|Other|3|||
126766842|NCT03514121|456098856|FG007|Overall Study|Other|2|||
126766843|NCT03514121|456098857|FG008|Overall Study|Other|7|||
126766844|NCT03514121|456098858|FG009|Overall Study|Other|3|||
126286248|NCT02048813|454334974|FG001|Overall Study|Adverse Event|38|||
126286249|NCT02048813|454334973|FG000|Overall Study|Disease progression|13|||
126286250|NCT02048813|454334974|FG001|Overall Study|Disease progression|3|||
126286251|NCT02048813|454334973|FG000|Overall Study|Withdrawal by Subject|7|||
126286252|NCT02048813|454334974|FG001|Overall Study|Withdrawal by Subject|8|||
126456964|NCT00592774|454972909|FG000|Overall Study|Adverse Event|5|||
126456965|NCT00592774|454972910|FG001|Overall Study|Adverse Event|19|||
126456966|NCT00592774|454972911|FG002|Overall Study|Adverse Event|2|||
126456967|NCT00592774|454972912|FG003|Overall Study|Adverse Event|14|||
126456968|NCT00592774|454972913|FG004|Overall Study|Adverse Event|8|||
126456969|NCT00592774|454972909|FG000|Overall Study|Protocol Violation|0|||
126456970|NCT00592774|454972910|FG001|Overall Study|Protocol Violation|1|||
126456971|NCT00592774|454972911|FG002|Overall Study|Protocol Violation|0|||
126456972|NCT00592774|454972912|FG003|Overall Study|Protocol Violation|0|||
126456973|NCT00592774|454972913|FG004|Overall Study|Protocol Violation|1|||
126456974|NCT00592774|454972909|FG000|Overall Study|Withdrawal by Subject|3|||
126456975|NCT00592774|454972910|FG001|Overall Study|Withdrawal by Subject|7|||
126456976|NCT00592774|454972911|FG002|Overall Study|Withdrawal by Subject|0|||
126456977|NCT00592774|454972912|FG003|Overall Study|Withdrawal by Subject|0|||
126456978|NCT00592774|454972913|FG004|Overall Study|Withdrawal by Subject|0|||
126456979|NCT00592774|454972909|FG000|Overall Study|Lack of Efficacy|3|||
126456980|NCT00592774|454972910|FG001|Overall Study|Lack of Efficacy|3|||
126456981|NCT00592774|454972911|FG002|Overall Study|Lack of Efficacy|0|||
126456982|NCT00592774|454972912|FG003|Overall Study|Lack of Efficacy|0|||
126456983|NCT00592774|454972913|FG004|Overall Study|Lack of Efficacy|2|||
126456984|NCT00592774|454972909|FG000|Overall Study|Physician Decision|0|||
126456985|NCT00592774|454972910|FG001|Overall Study|Physician Decision|1|||
126456986|NCT00592774|454972911|FG002|Overall Study|Physician Decision|1|||
126456987|NCT00592774|454972912|FG003|Overall Study|Physician Decision|0|||
126456988|NCT00592774|454972913|FG004|Overall Study|Physician Decision|1|||
126456989|NCT00592774|454972909|FG000|Overall Study|Other|0|||
126286253|NCT02048813|454334973|FG000|Overall Study|Death|2|||
126286254|NCT02048813|454334974|FG001|Overall Study|Death|1|||
126286255|NCT02048813|454334973|FG000|Overall Study|Complication|2|||
126286256|NCT02048813|454334974|FG001|Overall Study|Complication|2|||
126286257|NCT02048813|454334973|FG000|Overall Study|Non-protocol therapy|0|||
126286258|NCT02048813|454334974|FG001|Overall Study|Non-protocol therapy|1|||
126286259|NCT02048813|454334973|FG000|Overall Study|Second primary cancer|2|||
126286260|NCT02048813|454334974|FG001|Overall Study|Second primary cancer|0|||
126286261|NCT02048813|454334973|FG000|Overall Study|Insurance|2|||
126286262|NCT02048813|454334974|FG001|Overall Study|Insurance|0|||
126286263|NCT02048813|454334973|FG000|Overall Study|Wound infection/healing|2|||
126286264|NCT02048813|454334974|FG001|Overall Study|Wound infection/healing|0|||
126456990|NCT00592774|454972910|FG001|Overall Study|Other|1|||
126286265|NCT02048813|454334973|FG000|Overall Study|Missed appointment|3|||
126286266|NCT02048813|454334974|FG001|Overall Study|Missed appointment|0|||
126456991|NCT00592774|454972911|FG002|Overall Study|Other|1|||
126456992|NCT00592774|454972912|FG003|Overall Study|Other|0|||
126456993|NCT00592774|454972913|FG004|Overall Study|Other|2|||
126456994|NCT00621621|454972920|FG000|Overall Study|Subjects were exited at EP study|30|||
126456995|NCT00621621|454972921|FG001|Overall Study|Subjects were exited at EP study|0|||
126710070|NCT01633060|455890009|FG000|Treatment Phase|Death|4|||
126710071|NCT01633060|455890010|FG001|Treatment Phase|Death|3|||
126766845|NCT03514121|456098849|FG000|Overall Study|Study termination by Sponsor|0|||
126766846|NCT03514121|456098850|FG001|Overall Study|Study termination by Sponsor|0|||
126766847|NCT03514121|456098851|FG002|Overall Study|Study termination by Sponsor|0|||
126766848|NCT03514121|456098852|FG003|Overall Study|Study termination by Sponsor|0|||
126365355|NCT03715829|454631744|FG004|Extension Period|Lost to Follow-up|0|||
126365356|NCT03715829|454631745|FG005|Extension Period|Lost to Follow-up|0|||
126365357|NCT03715829|454631746|FG006|Extension Period|Lost to Follow-up|0|||
126365358|NCT03715829|454631747|FG007|Extension Period|Lost to Follow-up|0|||
126365359|NCT03715829|454631748|FG008|Extension Period|Lost to Follow-up|2|||
126365360|NCT03715829|454631749|FG009|Extension Period|Lost to Follow-up|0|||
126365361|NCT03715829|454631750|FG010|Extension Period|Lost to Follow-up|0|||
126365362|NCT03715829|454631740|FG000|Extension Period|Protocol Violation|0|||
126365363|NCT03715829|454631741|FG001|Extension Period|Protocol Violation|0|||
126365364|NCT03715829|454631742|FG002|Extension Period|Protocol Violation|0|||
126365365|NCT03715829|454631743|FG003|Extension Period|Protocol Violation|0|||
126365366|NCT03715829|454631744|FG004|Extension Period|Protocol Violation|0|||
126365367|NCT03715829|454631745|FG005|Extension Period|Protocol Violation|0|||
126365368|NCT03715829|454631746|FG006|Extension Period|Protocol Violation|0|||
126365369|NCT03715829|454631747|FG007|Extension Period|Protocol Violation|0|||
126365370|NCT03715829|454631748|FG008|Extension Period|Protocol Violation|1|||
126365371|NCT03715829|454631749|FG009|Extension Period|Protocol Violation|0|||
126365372|NCT03715829|454631750|FG010|Extension Period|Protocol Violation|0|||
126365373|NCT03715829|454631740|FG000|Extension Period|Withdrawal by Subject|0|||
126365374|NCT03715829|454631741|FG001|Extension Period|Withdrawal by Subject|0|||
126365375|NCT03715829|454631742|FG002|Extension Period|Withdrawal by Subject|0|||
126365376|NCT03715829|454631743|FG003|Extension Period|Withdrawal by Subject|0|||
126365377|NCT03715829|454631744|FG004|Extension Period|Withdrawal by Subject|0|||
126365378|NCT03715829|454631745|FG005|Extension Period|Withdrawal by Subject|0|||
126365379|NCT03715829|454631746|FG006|Extension Period|Withdrawal by Subject|3|||
126365380|NCT03715829|454631747|FG007|Extension Period|Withdrawal by Subject|3|||
126365381|NCT03715829|454631748|FG008|Extension Period|Withdrawal by Subject|12|||
126365382|NCT03715829|454631749|FG009|Extension Period|Withdrawal by Subject|3|||
126365383|NCT03715829|454631750|FG010|Extension Period|Withdrawal by Subject|0|||
126365384|NCT03715829|454631740|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365385|NCT03715829|454631741|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365386|NCT03715829|454631742|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365387|NCT03715829|454631743|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365388|NCT03715829|454631744|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365389|NCT03715829|454631745|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365390|NCT03715829|454631746|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365391|NCT03715829|454631747|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
126365392|NCT03715829|454631748|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
126365393|NCT03715829|454631749|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365394|NCT03715829|454631750|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
126365395|NCT03715829|454631740|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365396|NCT03715829|454631741|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365397|NCT03715829|454631742|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365398|NCT03715829|454631743|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365399|NCT03715829|454631744|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365400|NCT03715829|454631745|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365401|NCT03715829|454631746|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365402|NCT03715829|454631747|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
126456996|NCT02282293|454972922|FG000|Overall Study|Lost to Follow-up|2|||
126456997|NCT02282293|454972923|FG001|Overall Study|Lost to Follow-up|2|||
126456998|NCT02282293|454972922|FG000|Overall Study|Unable to comply with study procedures|1|||
126456999|NCT02282293|454972923|FG001|Overall Study|Unable to comply with study procedures|0|||
126457000|NCT02282293|454972922|FG000|Overall Study|Moved out of study area|0|||
126457001|NCT02282293|454972923|FG001|Overall Study|Moved out of study area|1|||
126457002|NCT01924429|454972936|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
126457003|NCT01924429|454972937|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
126457004|NCT00906971|454972938|FG000|Overall Study|Withdrawal by Subject|8|||
126457005|NCT00906971|454972939|FG001|Overall Study|Withdrawal by Subject|2|||
126457006|NCT00906971|454972938|FG000|Overall Study|Lost to Follow-up|0|||
126457007|NCT00906971|454972939|FG001|Overall Study|Lost to Follow-up|1|||
126457008|NCT00807573|454972940|FG000|Overall Study|Withdrawal by Subject|1|||
126549503|NCT01234649|455305655|FG000|Overall Study|intolerant to side effects|4|||
126710072|NCT01633060|455890009|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
126710073|NCT01633060|455890010|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126457009|NCT00807573|454972940|FG000|Overall Study|Adverse Event|1|||
126365403|NCT03715829|454631748|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
126365404|NCT03715829|454631749|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365405|NCT03715829|454631750|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
126365406|NCT03715829|454631740|FG000|Extension Period|Other|0|||
126365407|NCT03715829|454631741|FG001|Extension Period|Other|0|||
126710074|NCT01633060|455890009|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
126710075|NCT01633060|455890010|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
126710076|NCT01633060|455890009|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
126710077|NCT01633060|455890010|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
126710078|NCT01633060|455890009|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
126710079|NCT01633060|455890010|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
126710080|NCT01633060|455890009|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
126710081|NCT01633060|455890010|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
126710082|NCT01633060|455890009|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
126710083|NCT01633060|455890010|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
126710084|NCT01396525|455890013|FG000|Overall Study|Withdrawal by Subject|8|||
126710085|NCT01396525|455890013|FG000|Overall Study|Death|14|||
126710086|NCT01396525|455890013|FG000|Overall Study|Lost to Follow-up|4|||
126710087|NCT03114969|455890014|FG000|Overall Study|Lost to Follow-up|0|||
126710088|NCT03114969|455890015|FG001|Overall Study|Lost to Follow-up|0|||
126457010|NCT04054947|454972941|FG000|Overall Study|Withdrawal by Subject|1|||
126457011|NCT04054947|454972942|FG001|Overall Study|Withdrawal by Subject|0|||
126457012|NCT04054947|454972941|FG000|Overall Study|Lost to Follow-up|2|||
126457013|NCT04054947|454972942|FG001|Overall Study|Lost to Follow-up|5|||
126457014|NCT01606878|454972943|FG000|Overall Study|Adverse Event|1|||
126457015|NCT01606878|454972944|FG001|Overall Study|Adverse Event|1|||
126457016|NCT01606878|454972945|FG002|Overall Study|Adverse Event|0|||
126457017|NCT01606878|454972946|FG003|Overall Study|Adverse Event|0|||
126457018|NCT01606878|454972947|FG004|Overall Study|Adverse Event|0|||
126457019|NCT01606878|454972948|FG005|Overall Study|Adverse Event|0|||
126457020|NCT01606878|454972949|FG006|Overall Study|Adverse Event|1|||
126457021|NCT01606878|454972950|FG007|Overall Study|Adverse Event|0|||
126457022|NCT01606878|454972951|FG008|Overall Study|Adverse Event|1|||
126457023|NCT01606878|454972952|FG009|Overall Study|Adverse Event|3|||
126457024|NCT01606878|454972953|FG010|Overall Study|Adverse Event|0|||
126457025|NCT01606878|454972943|FG000|Overall Study|Lack of Efficacy|1|||
126457026|NCT01606878|454972944|FG001|Overall Study|Lack of Efficacy|1|||
126457027|NCT01606878|454972945|FG002|Overall Study|Lack of Efficacy|1|||
126457028|NCT01606878|454972946|FG003|Overall Study|Lack of Efficacy|2|||
126457029|NCT01606878|454972947|FG004|Overall Study|Lack of Efficacy|1|||
126457030|NCT01606878|454972948|FG005|Overall Study|Lack of Efficacy|2|||
126710089|NCT03114969|455890016|FG002|Overall Study|Lost to Follow-up|3|||
126710090|NCT03114969|455890017|FG003|Overall Study|Lost to Follow-up|2|||
126710091|NCT03114969|455890018|FG004|Overall Study|Lost to Follow-up|0|||
126457031|NCT01606878|454972949|FG006|Overall Study|Lack of Efficacy|1|||
126457032|NCT01606878|454972950|FG007|Overall Study|Lack of Efficacy|2|||
126457033|NCT01606878|454972951|FG008|Overall Study|Lack of Efficacy|2|||
126457034|NCT01606878|454972952|FG009|Overall Study|Lack of Efficacy|0|||
126710092|NCT03114969|455890019|FG005|Overall Study|Lost to Follow-up|0|||
126710093|NCT03114969|455890020|FG006|Overall Study|Lost to Follow-up|0|||
126710094|NCT03114969|455890021|FG007|Overall Study|Lost to Follow-up|0|||
126710095|NCT03114969|455890022|FG008|Overall Study|Lost to Follow-up|0|||
126710096|NCT03114969|455890014|FG000|Overall Study|Adverse Event|0|||
126710097|NCT03114969|455890015|FG001|Overall Study|Adverse Event|0|||
126710098|NCT03114969|455890016|FG002|Overall Study|Adverse Event|1|||
126710099|NCT03114969|455890017|FG003|Overall Study|Adverse Event|0|||
126710100|NCT03114969|455890018|FG004|Overall Study|Adverse Event|0|||
126710101|NCT03114969|455890019|FG005|Overall Study|Adverse Event|1|||
126710102|NCT03114969|455890020|FG006|Overall Study|Adverse Event|1|||
126710103|NCT03114969|455890021|FG007|Overall Study|Adverse Event|0|||
126710104|NCT03114969|455890022|FG008|Overall Study|Adverse Event|2|||
126710105|NCT00949650|455890023|FG000|Overall Study|Progressive disease|188|||
126710106|NCT00949650|455890024|FG001|Overall Study|Progressive disease|19|||
126710107|NCT00949650|455890023|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
126710108|NCT00949650|455890024|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
126710109|NCT00949650|455890023|FG000|Overall Study|Other Adverse Event (AE)|28|||
126710110|NCT00949650|455890024|FG001|Overall Study|Other Adverse Event (AE)|17|||
126710111|NCT00949650|455890023|FG000|Overall Study|Protocol Violation|1|||
126710112|NCT00949650|455890024|FG001|Overall Study|Protocol Violation|4|||
126710113|NCT00949650|455890023|FG000|Overall Study|Refusal to continue medication|7|||
126710114|NCT00949650|455890024|FG001|Overall Study|Refusal to continue medication|11|||
126710115|NCT00949650|455890023|FG000|Overall Study|Not treated|1|||
126457035|NCT01606878|454972953|FG010|Overall Study|Lack of Efficacy|1|||
126457036|NCT01606878|454972943|FG000|Overall Study|Physician Decision|1|||
126457037|NCT01606878|454972944|FG001|Overall Study|Physician Decision|0|||
126457038|NCT01606878|454972945|FG002|Overall Study|Physician Decision|2|||
126549504|NCT01234649|455305656|FG001|Overall Study|intolerant to side effects|3|||
126710116|NCT00949650|455890024|FG001|Overall Study|Not treated|4|||
126710117|NCT00949650|455890023|FG000|Overall Study|Other not specified above|5|||
126710118|NCT00949650|455890024|FG001|Overall Study|Other not specified above|0|||
126710119|NCT04601272|455890025|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
126710120|NCT04601272|455890026|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
126710121|NCT04601272|455890027|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
126710122|NCT00414440|455890028|FG000|Core Period|Withdrawal by Subject|70|||
126710123|NCT00414440|455890029|FG001|Core Period|Withdrawal by Subject|32|||
126710124|NCT00414440|455890028|FG000|Extension Period|Lost to Follow-up|44|||
126710125|NCT00414440|455890029|FG001|Extension Period|Lost to Follow-up|52|||
126710126|NCT00414440|455890028|FG000|Extension Period|Did not consent to continue follow up|61|||
126710127|NCT00414440|455890029|FG001|Extension Period|Did not consent to continue follow up|54|||
126710128|NCT00414440|455890028|FG000|Extension Period|Other|1|||
126710129|NCT00414440|455890029|FG001|Extension Period|Other|1|||
126710130|NCT00414440|455890028|FG000|Extension Period|Administrative|16|||
126710131|NCT00414440|455890029|FG001|Extension Period|Administrative|16|||
126710132|NCT00414440|455890028|FG000|Extension Period|Death|1|||
126710133|NCT00414440|455890029|FG001|Extension Period|Death|2|||
126766849|NCT03514121|456098853|FG004|Overall Study|Study termination by Sponsor|0|||
126766850|NCT03514121|456098854|FG005|Overall Study|Study termination by Sponsor|0|||
126766851|NCT03514121|456098855|FG006|Overall Study|Study termination by Sponsor|0|||
126766852|NCT03514121|456098856|FG007|Overall Study|Study termination by Sponsor|0|||
126766853|NCT03514121|456098857|FG008|Overall Study|Study termination by Sponsor|11|||
126766854|NCT03514121|456098858|FG009|Overall Study|Study termination by Sponsor|3|||
126766855|NCT03514121|456098849|FG000|Overall Study|Investigator decision|0|||
126766856|NCT03514121|456098850|FG001|Overall Study|Investigator decision|0|||
126766857|NCT03514121|456098851|FG002|Overall Study|Investigator decision|0|||
126766858|NCT03514121|456098852|FG003|Overall Study|Investigator decision|0|||
126766859|NCT03514121|456098853|FG004|Overall Study|Investigator decision|0|||
126766860|NCT03514121|456098854|FG005|Overall Study|Investigator decision|0|||
126766861|NCT03514121|456098855|FG006|Overall Study|Investigator decision|0|||
126766862|NCT03514121|456098856|FG007|Overall Study|Investigator decision|0|||
126766863|NCT03514121|456098857|FG008|Overall Study|Investigator decision|1|||
126766864|NCT03514121|456098858|FG009|Overall Study|Investigator decision|0|||
126766865|NCT03286400|456098862|FG000|Overall Study|Death|10|||
126766866|NCT03286400|456098862|FG000|Overall Study|Lost to Follow-up|10|||
126766867|NCT03286400|456098862|FG000|Overall Study|Physician Decision|1|||
126286267|NCT02048813|454334973|FG000|Overall Study|Never started treatment|2|||
126286268|NCT02048813|454334974|FG001|Overall Study|Never started treatment|17|||
126286269|NCT01708954|454334975|FG000|Step 1|Disease progression|26|||
126286270|NCT01708954|454334976|FG001|Step 1|Disease progression|17|||
126286271|NCT01708954|454334977|FG002|Step 1|Disease progression|14|||
126286272|NCT01708954|454334975|FG000|Step 1|Adverse Event|3|||
126286273|NCT01708954|454334976|FG001|Step 1|Adverse Event|11|||
126286274|NCT01708954|454334977|FG002|Step 1|Adverse Event|13|||
126286275|NCT01708954|454334975|FG000|Step 1|Death|3|||
126286276|NCT01708954|454334976|FG001|Step 1|Death|2|||
126286277|NCT01708954|454334977|FG002|Step 1|Death|3|||
126286278|NCT01708954|454334975|FG000|Step 1|Withdrawal by Subject|2|||
126286279|NCT01708954|454334976|FG001|Step 1|Withdrawal by Subject|5|||
126286280|NCT01708954|454334977|FG002|Step 1|Withdrawal by Subject|3|||
126286281|NCT01708954|454334975|FG000|Step 1|Other complicating disease|0|||
126286282|NCT01708954|454334976|FG001|Step 1|Other complicating disease|2|||
126710134|NCT00414440|455890028|FG000|Extension Period|Withdrawal by Subject|9|||
126766868|NCT03286400|456098862|FG000|Overall Study|Scheduling difficulty|4|||
126766869|NCT00826176|456098865|FG000|Overall Study|Lost to Follow-up|1|||
126766870|NCT00826176|456098866|FG001|Overall Study|Lost to Follow-up|0|||
126766871|NCT00826176|456098865|FG000|Overall Study|Subject Withdrew Consent|3|||
126766872|NCT00826176|456098866|FG001|Overall Study|Subject Withdrew Consent|0|||
126766873|NCT00826176|456098865|FG000|Overall Study|Administrative|9|||
126766874|NCT00826176|456098866|FG001|Overall Study|Administrative|0|||
126710135|NCT00414440|455890029|FG001|Extension Period|Withdrawal by Subject|7|||
126710136|NCT00414440|455890028|FG000|Extension Period|Not included in follow up period|18|||
126710137|NCT00414440|455890029|FG001|Extension Period|Not included in follow up period|8|||
126710138|NCT02168946|455890030|FG000|Overall Study|Adverse Event|8|||
126710139|NCT02168946|455890031|FG001|Overall Study|Adverse Event|5|||
126766875|NCT00297882|456098872|FG000|Day 14|Lack of Efficacy|12|||
126766876|NCT00297882|456098873|FG001|Day 14|Lack of Efficacy|49|||
126766877|NCT00297882|456098872|FG000|Day 28|Lost to Follow-up|13|||
126766878|NCT00297882|456098873|FG001|Day 28|Lost to Follow-up|23|||
126766879|NCT00297882|456098872|FG000|Day 28|Lack of Efficacy|3|||
126766880|NCT00297882|456098873|FG001|Day 28|Lack of Efficacy|0|||
126286283|NCT01708954|454334977|FG002|Step 1|Other complicating disease|0|||
126286284|NCT01708954|454334975|FG000|Step 1|Crossed over to Step 2|2|||
126286285|NCT01708954|454334976|FG001|Step 1|Crossed over to Step 2|0|||
126766881|NCT04484805|456098874|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
126766882|NCT04484805|456098875|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
126766883|NCT04484805|456098874|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
126286286|NCT01708954|454334977|FG002|Step 1|Crossed over to Step 2|0|||
126286287|NCT01708954|454334975|FG000|Step 1|Symptomatic deterioration|1|||
126457039|NCT01606878|454972946|FG003|Overall Study|Physician Decision|1|||
126457040|NCT01606878|454972947|FG004|Overall Study|Physician Decision|1|||
126457041|NCT01606878|454972948|FG005|Overall Study|Physician Decision|1|||
126457042|NCT01606878|454972949|FG006|Overall Study|Physician Decision|2|||
126457043|NCT01606878|454972950|FG007|Overall Study|Physician Decision|0|||
126457044|NCT01606878|454972951|FG008|Overall Study|Physician Decision|1|||
126457045|NCT01606878|454972952|FG009|Overall Study|Physician Decision|0|||
126457046|NCT01606878|454972953|FG010|Overall Study|Physician Decision|0|||
126457047|NCT01606878|454972943|FG000|Overall Study|Withdrawal by Subject|3|||
126457048|NCT01606878|454972944|FG001|Overall Study|Withdrawal by Subject|2|||
126457049|NCT01606878|454972945|FG002|Overall Study|Withdrawal by Subject|2|||
126457050|NCT01606878|454972946|FG003|Overall Study|Withdrawal by Subject|0|||
126766884|NCT04484805|456098875|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
126766885|NCT04242264|456098876|FG000|Overall Study|Lost to Follow-up|2|||
126766886|NCT04242264|456098877|FG001|Overall Study|Lost to Follow-up|2|||
126766887|NCT04242264|456098878|FG002|Overall Study|Lost to Follow-up|1|||
126766888|NCT04242264|456098879|FG003|Overall Study|Lost to Follow-up|1|||
126766889|NCT04242264|456098876|FG000|Overall Study|Withdrawal by Subject|1|||
126766890|NCT04242264|456098877|FG001|Overall Study|Withdrawal by Subject|0|||
126766891|NCT04242264|456098878|FG002|Overall Study|Withdrawal by Subject|0|||
126766892|NCT04242264|456098879|FG003|Overall Study|Withdrawal by Subject|0|||
126766893|NCT02230332|456098888|FG000|Overall Study|Adverse Event|2|||
126766894|NCT02230332|456098889|FG001|Overall Study|Adverse Event|1|||
126766895|NCT02230332|456098888|FG000|Overall Study|Lost to Follow-up|1|||
126766896|NCT02230332|456098889|FG001|Overall Study|Lost to Follow-up|0|||
126766897|NCT02230332|456098888|FG000|Overall Study|Protocol Violation|1|||
126766898|NCT02230332|456098889|FG001|Overall Study|Protocol Violation|0|||
126766899|NCT01283282|456098893|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
126766900|NCT01283282|456098894|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
126766901|NCT01283282|456098893|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
126286288|NCT01708954|454334976|FG001|Step 1|Symptomatic deterioration|0|||
126457051|NCT01606878|454972947|FG004|Overall Study|Withdrawal by Subject|1|||
126766902|NCT01283282|456098894|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
126766903|NCT01283282|456098893|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
126766904|NCT01283282|456098894|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
126457052|NCT01606878|454972948|FG005|Overall Study|Withdrawal by Subject|1|||
126457053|NCT01606878|454972949|FG006|Overall Study|Withdrawal by Subject|2|||
126457054|NCT01606878|454972950|FG007|Overall Study|Withdrawal by Subject|1|||
126457055|NCT01606878|454972951|FG008|Overall Study|Withdrawal by Subject|2|||
126457056|NCT01606878|454972952|FG009|Overall Study|Withdrawal by Subject|0|||
126457057|NCT01606878|454972953|FG010|Overall Study|Withdrawal by Subject|2|||
126457058|NCT02880956|454972961|FG000|Overall Study|Adverse Event|3|||
126457059|NCT02880956|454972962|FG001|Overall Study|Adverse Event|6|||
126457060|NCT02880956|454972963|FG002|Overall Study|Adverse Event|5|||
126457061|NCT02880956|454972964|FG003|Overall Study|Adverse Event|4|||
126457062|NCT02880956|454972961|FG000|Overall Study|Withdrawal by Subject|9|||
126457063|NCT02880956|454972962|FG001|Overall Study|Withdrawal by Subject|4|||
126457064|NCT02880956|454972963|FG002|Overall Study|Withdrawal by Subject|6|||
126457065|NCT02880956|454972964|FG003|Overall Study|Withdrawal by Subject|11|||
126549505|NCT01234649|455305655|FG000|Overall Study|Allergic reaction|1|||
126766905|NCT00777920|456098895|FG000|Overall Study|Adverse Event|39|||
126766906|NCT00777920|456098895|FG000|Overall Study|Withdrawal of Consent|4|||
126766907|NCT00777920|456098895|FG000|Overall Study|Lost to Follow-up|1|||
126766908|NCT00777920|456098895|FG000|Overall Study|Investigator's discretion|1|||
126766909|NCT00777920|456098895|FG000|Overall Study|Clinical status did not improve|1|||
126766910|NCT00777920|456098895|FG000|Overall Study|Other, not specified|4|||
126766911|NCT00483717|456098896|FG000|Overall Study|Protocol Violation|5|||
126766912|NCT00483717|456098897|FG001|Overall Study|Protocol Violation|7|||
126766913|NCT00483717|456098896|FG000|Overall Study|Time of dosing missing|1|||
126766914|NCT00483717|456098897|FG001|Overall Study|Time of dosing missing|1|||
126766915|NCT00483717|456098896|FG000|Overall Study|No treatment for migraine|16|||
126766916|NCT00483717|456098897|FG001|Overall Study|No treatment for migraine|13|||
126766917|NCT00483717|456098896|FG000|Overall Study|Lost to Follow-up|1|||
126766918|NCT00483717|456098897|FG001|Overall Study|Lost to Follow-up|0|||
126766919|NCT00483717|456098896|FG000|Overall Study|Withdrawal by Subject|1|||
126766920|NCT00483717|456098897|FG001|Overall Study|Withdrawal by Subject|0|||
126766921|NCT01525407|456098898|FG000|Overall Study|Change in recipient treatment plan|2|||
126286289|NCT01708954|454334977|FG002|Step 1|Symptomatic deterioration|1|||
126286290|NCT01708954|454334975|FG000|Step 1|Off-treatment reason not submitted|1|||
126286291|NCT01708954|454334976|FG001|Step 1|Off-treatment reason not submitted|1|||
126457066|NCT02880956|454972961|FG000|Overall Study|Lost to Follow-up|0|||
126457067|NCT02880956|454972962|FG001|Overall Study|Lost to Follow-up|1|||
126457068|NCT02880956|454972963|FG002|Overall Study|Lost to Follow-up|0|||
126457069|NCT02880956|454972964|FG003|Overall Study|Lost to Follow-up|0|||
126457070|NCT02880956|454972961|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
126457071|NCT02880956|454972962|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
126365408|NCT03715829|454631742|FG002|Extension Period|Other|0|||
126710140|NCT02168946|455890030|FG000|Overall Study|Lost to Follow-up|3|||
126710141|NCT02168946|455890031|FG001|Overall Study|Lost to Follow-up|0|||
126710142|NCT02168946|455890030|FG000|Overall Study|Subject unable to come back for visits|1|||
126710143|NCT02168946|455890031|FG001|Overall Study|Subject unable to come back for visits|0|||
126710144|NCT00231478|455890044|FG000|Overall Study|Protocol Violation|3|||
126710145|NCT00231478|455890045|FG001|Overall Study|Protocol Violation|2|||
126710146|NCT00231478|455890044|FG000|Overall Study|Refused Treatment|1|||
126710147|NCT00231478|455890045|FG001|Overall Study|Refused Treatment|1|||
126710148|NCT00231478|455890044|FG000|Overall Study|Withdrawal by Subject|1|||
126710149|NCT00231478|455890045|FG001|Overall Study|Withdrawal by Subject|0|||
126710150|NCT00231478|455890044|FG000|Overall Study|Adverse Event|0|||
126710151|NCT00231478|455890045|FG001|Overall Study|Adverse Event|1|||
126710152|NCT00231478|455890044|FG000|Overall Study|Administrative|3|||
126710153|NCT00231478|455890045|FG001|Overall Study|Administrative|2|||
126710154|NCT00393458|455890052|FG000|Overall Study|Adverse Event|35|||
126710155|NCT00393458|455890053|FG001|Overall Study|Adverse Event|24|||
126710156|NCT00393458|455890054|FG002|Overall Study|Adverse Event|40|||
126710157|NCT00393458|455890055|FG003|Overall Study|Adverse Event|35|||
126710158|NCT00393458|455890052|FG000|Overall Study|Subject withdrew consent|27|||
126710159|NCT00393458|455890053|FG001|Overall Study|Subject withdrew consent|40|||
126710160|NCT00393458|455890054|FG002|Overall Study|Subject withdrew consent|33|||
126710161|NCT00393458|455890055|FG003|Overall Study|Subject withdrew consent|50|||
126710162|NCT00393458|455890052|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
126710163|NCT00393458|455890053|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
126710164|NCT00393458|455890054|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
126710165|NCT00393458|455890055|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
126710166|NCT00393458|455890052|FG000|Overall Study|Protocol deviation|11|||
126710167|NCT00393458|455890053|FG001|Overall Study|Protocol deviation|11|||
126710168|NCT00393458|455890054|FG002|Overall Study|Protocol deviation|11|||
126710169|NCT00393458|455890055|FG003|Overall Study|Protocol deviation|10|||
126710170|NCT00393458|455890052|FG000|Overall Study|Administrative problems|7|||
126710171|NCT00393458|455890053|FG001|Overall Study|Administrative problems|8|||
126710172|NCT00393458|455890054|FG002|Overall Study|Administrative problems|5|||
126710173|NCT00393458|455890055|FG003|Overall Study|Administrative problems|2|||
126710174|NCT00393458|455890052|FG000|Overall Study|Lost to Follow-up|5|||
126710175|NCT00393458|455890053|FG001|Overall Study|Lost to Follow-up|6|||
126710176|NCT00393458|455890054|FG002|Overall Study|Lost to Follow-up|5|||
126710177|NCT00393458|455890055|FG003|Overall Study|Lost to Follow-up|3|||
126710178|NCT00393458|455890052|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126710179|NCT00393458|455890053|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126710180|NCT00393458|455890054|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126710181|NCT00393458|455890055|FG003|Overall Study|Abnormal laboratory value(s)|0|||
126710182|NCT00393458|455890052|FG000|Overall Study|Death|1|||
126710183|NCT00393458|455890053|FG001|Overall Study|Death|1|||
126710184|NCT00393458|455890054|FG002|Overall Study|Death|5|||
126710185|NCT00393458|455890055|FG003|Overall Study|Death|5|||
126710186|NCT00393458|455890052|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126710187|NCT00393458|455890053|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126710188|NCT00393458|455890054|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126710189|NCT00393458|455890055|FG003|Overall Study|Abnormal test procedure result(s)|2|||
126710190|NCT00393458|455890052|FG000|Overall Study|Subject no longer requires study drug|0|||
126710191|NCT00393458|455890053|FG001|Overall Study|Subject no longer requires study drug|1|||
126710192|NCT00393458|455890054|FG002|Overall Study|Subject no longer requires study drug|0|||
126710193|NCT00393458|455890055|FG003|Overall Study|Subject no longer requires study drug|0|||
126710194|NCT02704429|455890064|FG000|Part A: 24 Weeks|Adverse Event|3|||
126710195|NCT02704429|455890065|FG001|Part A: 24 Weeks|Adverse Event|0|||
126710196|NCT02704429|455890064|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
126710197|NCT02704429|455890065|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
126710198|NCT00104104|455890066|FG000|Overall Study|Adverse Event|8|||
126710199|NCT00104104|455890067|FG001|Overall Study|Adverse Event|8|||
126710200|NCT00104104|455890066|FG000|Overall Study|Abnormal laboratory value(s)|20|||
126710201|NCT00104104|455890067|FG001|Overall Study|Abnormal laboratory value(s)|14|||
126710202|NCT00104104|455890066|FG000|Overall Study|Lack of Efficacy|0|||
126365409|NCT03715829|454631743|FG003|Extension Period|Other|0|||
126365410|NCT03715829|454631744|FG004|Extension Period|Other|0|||
126365411|NCT03715829|454631745|FG005|Extension Period|Other|0|||
126710203|NCT00104104|455890067|FG001|Overall Study|Lack of Efficacy|3|||
126710204|NCT00104104|455890066|FG000|Overall Study|Condition no longer requires study drug|7|||
126710205|NCT00104104|455890067|FG001|Overall Study|Condition no longer requires study drug|4|||
126710206|NCT00104104|455890066|FG000|Overall Study|Protocol Violation|5|||
126710207|NCT00104104|455890067|FG001|Overall Study|Protocol Violation|2|||
126365412|NCT03715829|454631746|FG006|Extension Period|Other|1|||
126365413|NCT03715829|454631747|FG007|Extension Period|Other|2|||
126710208|NCT00104104|455890066|FG000|Overall Study|Withdrawal by Subject|11|||
126710209|NCT00104104|455890067|FG001|Overall Study|Withdrawal by Subject|15|||
126710210|NCT00104104|455890066|FG000|Overall Study|Lost to Follow-up|3|||
126766922|NCT01525407|456098899|FG001|Overall Study|Change in recipient treatment plan|2|||
126766923|NCT01525407|456098898|FG000|Overall Study|Withdrawal by Subject|0|||
126766924|NCT01525407|456098899|FG001|Overall Study|Withdrawal by Subject|1|||
126766925|NCT01525407|456098898|FG000|Overall Study|Transplant was delayed|0|||
126766926|NCT01525407|456098899|FG001|Overall Study|Transplant was delayed|1|||
126766927|NCT01525407|456098898|FG000|Overall Study|Delay in Transplant|1|||
126766928|NCT01525407|456098899|FG001|Overall Study|Delay in Transplant|0|||
126766929|NCT03505606|456100167|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
126766930|NCT03505606|456100168|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
126766931|NCT03505606|456100169|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
126766932|NCT03505606|456100167|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
126766933|NCT03505606|456100168|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
126766934|NCT03505606|456100169|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
126286292|NCT01708954|454334977|FG002|Step 1|Off-treatment reason not submitted|1|||
126286293|NCT01708954|454334975|FG000|Step 1|Ineligible or never received treatment|4|||
126286294|NCT01708954|454334976|FG001|Step 1|Ineligible or never received treatment|2|||
126286295|NCT01708954|454334977|FG002|Step 1|Ineligible or never received treatment|8|||
126286296|NCT01708954|454334975|FG000|Step 2|Disease progression|9|||
126286297|NCT01708954|454334976|FG001|Step 2|Disease progression|4|||
126286298|NCT01708954|454334977|FG002|Step 2|Disease progression|0|||
126286299|NCT01708954|454334975|FG000|Step 2|Adverse Event|3|||
126286300|NCT01708954|454334976|FG001|Step 2|Adverse Event|2|||
126286301|NCT01708954|454334977|FG002|Step 2|Adverse Event|0|||
126286302|NCT01708954|454334975|FG000|Step 2|Withdrawal by Subject|1|||
126286303|NCT01708954|454334976|FG001|Step 2|Withdrawal by Subject|1|||
126286304|NCT01708954|454334977|FG002|Step 2|Withdrawal by Subject|0|||
126286305|NCT06400251|454334978|FG000|Overall Study|Never Start Protocol Therapy|1|||
126286306|NCT06400251|454334978|FG000|Overall Study|Ineligible|2|||
126286307|NCT06400251|454334978|FG000|Overall Study|Mutation Status Not Confirmed|3|||
126286308|NCT06400251|454334978|FG000|Overall Study|Disease Progression|25|||
126286309|NCT06400251|454334978|FG000|Overall Study|Adverse Event|1|||
126286310|NCT06400251|454334978|FG000|Overall Study|Complicating Disease|1|||
126286311|NCT06400251|454334978|FG000|Overall Study|Physician Decision|2|||
126286312|NCT03631199|454334979|FG000|Overall Study|Progressive disease|9|||
126286313|NCT03631199|454334980|FG001|Overall Study|Progressive disease|5|||
126286314|NCT03631199|454334981|FG002|Overall Study|Progressive disease|5|||
126286315|NCT03631199|454334982|FG003|Overall Study|Progressive disease|149|||
126766935|NCT03505606|456100167|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
126766936|NCT03505606|456100168|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
126766937|NCT03505606|456100169|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
126766938|NCT03505606|456100167|FG000|Overall Study|Poor compliance with refractive correction|0|||
126766939|NCT03505606|456100168|FG001|Overall Study|Poor compliance with refractive correction|0|||
126766940|NCT03505606|456100169|FG002|Overall Study|Poor compliance with refractive correction|1|||
126766941|NCT03505606|456100167|FG000|Overall Study|Insufficient anisometropia|0|||
126766942|NCT03505606|456100168|FG001|Overall Study|Insufficient anisometropia|0|||
126766943|NCT03505606|456100169|FG002|Overall Study|Insufficient anisometropia|2|||
126365414|NCT03715829|454631748|FG008|Extension Period|Other|4|||
126365415|NCT03715829|454631749|FG009|Extension Period|Other|0|||
126365416|NCT03715829|454631750|FG010|Extension Period|Other|0|||
126365417|NCT03579719|454631751|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
126365418|NCT03253627|454631754|FG000|Overall Study|Lost to Follow-up|1|||
126365419|NCT03253627|454631755|FG001|Overall Study|Lost to Follow-up|2|||
126365420|NCT03253627|454631754|FG000|Overall Study|Withdrawal by Subject|0|||
126365421|NCT03253627|454631755|FG001|Overall Study|Withdrawal by Subject|2|||
126365422|NCT03253627|454631754|FG000|Overall Study|Inability to complete MRI|1|||
126365423|NCT03253627|454631755|FG001|Overall Study|Inability to complete MRI|0|||
126365424|NCT02940223|454631759|FG000|Overall Study|Failed Requirement|2|||
126365425|NCT02940223|454631760|FG001|Overall Study|Failed Requirement|0|||
126286316|NCT03631199|454334983|FG004|Overall Study|Progressive disease|148|||
126365426|NCT01813357|454631761|FG000|Overall Study|Lost to Follow-up|5|||
126365427|NCT01813357|454631762|FG001|Overall Study|Lost to Follow-up|6|||
126286317|NCT03631199|454334979|FG000|Overall Study|Physician Decision|0|||
126286318|NCT03631199|454334980|FG001|Overall Study|Physician Decision|2|||
126286319|NCT03631199|454334981|FG002|Overall Study|Physician Decision|3|||
126286320|NCT03631199|454334982|FG003|Overall Study|Physician Decision|19|||
126286321|NCT03631199|454334983|FG004|Overall Study|Physician Decision|13|||
126286322|NCT03631199|454334979|FG000|Overall Study|Adverse Event|1|||
126365428|NCT03773562|454631763|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
126365429|NCT03773562|454631763|FG000|Overall Study|Lost to Follow-up|10|||
126365430|NCT03773562|454631763|FG000|Overall Study|Withdrawal by Subject|1|||
126365431|NCT04806373|454631767|FG000|Overall Study|Withdrawal by Subject|1|||
126365432|NCT04806373|454631768|FG001|Overall Study|Withdrawal by Subject|1|||
126365433|NCT03301415|454631771|FG000|Overall Study|Lost to Follow-up|2|||
126365434|NCT03301415|454631771|FG000|Overall Study|Unable to comply with visit schedule|2|||
126766944|NCT03505606|456100167|FG000|Overall Study|Ectopia Lentis|0|||
126766945|NCT03505606|456100168|FG001|Overall Study|Ectopia Lentis|0|||
126766946|NCT03505606|456100169|FG002|Overall Study|Ectopia Lentis|1|||
126766947|NCT03505606|456100167|FG000|Overall Study|alternation of amblyopic eye|0|||
126766948|NCT03505606|456100168|FG001|Overall Study|alternation of amblyopic eye|1|||
126766949|NCT03505606|456100169|FG002|Overall Study|alternation of amblyopic eye|0|||
126766950|NCT00648739|456100181|FG000|Overall Study|Adverse Event|1|||
126766951|NCT00648739|456100182|FG001|Overall Study|Adverse Event|0|||
126766952|NCT00648739|456100183|FG002|Overall Study|Adverse Event|1|||
126766953|NCT00648739|456100184|FG003|Overall Study|Adverse Event|2|||
126766954|NCT00648739|456100185|FG004|Overall Study|Adverse Event|1|||
126766955|NCT00648739|456100186|FG005|Overall Study|Adverse Event|0|||
126766956|NCT00648739|456100187|FG006|Overall Study|Adverse Event|0|||
126766957|NCT00648739|456100181|FG000|Overall Study|Withdrawal by Subject|1|||
126766958|NCT00648739|456100182|FG001|Overall Study|Withdrawal by Subject|0|||
126766959|NCT00648739|456100183|FG002|Overall Study|Withdrawal by Subject|1|||
126766960|NCT00648739|456100184|FG003|Overall Study|Withdrawal by Subject|0|||
126766961|NCT00648739|456100185|FG004|Overall Study|Withdrawal by Subject|0|||
126766962|NCT00648739|456100186|FG005|Overall Study|Withdrawal by Subject|2|||
126766963|NCT00648739|456100187|FG006|Overall Study|Withdrawal by Subject|0|||
126766964|NCT00648739|456100181|FG000|Overall Study|Lack of Efficacy|0|||
126766965|NCT00648739|456100182|FG001|Overall Study|Lack of Efficacy|0|||
126766966|NCT00648739|456100183|FG002|Overall Study|Lack of Efficacy|0|||
126766967|NCT00648739|456100184|FG003|Overall Study|Lack of Efficacy|0|||
126766968|NCT00648739|456100185|FG004|Overall Study|Lack of Efficacy|1|||
126766969|NCT00648739|456100186|FG005|Overall Study|Lack of Efficacy|2|||
126766970|NCT00648739|456100187|FG006|Overall Study|Lack of Efficacy|0|||
126766971|NCT00648739|456100181|FG000|Overall Study|Investigator Considered it Advisable|0|||
126286323|NCT03631199|454334980|FG001|Overall Study|Adverse Event|1|||
126286324|NCT03631199|454334981|FG002|Overall Study|Adverse Event|0|||
126286325|NCT03631199|454334982|FG003|Overall Study|Adverse Event|28|||
126286326|NCT03631199|454334983|FG004|Overall Study|Adverse Event|29|||
126286327|NCT03631199|454334979|FG000|Overall Study|Death|0|||
126286328|NCT03631199|454334980|FG001|Overall Study|Death|1|||
126286329|NCT03631199|454334981|FG002|Overall Study|Death|0|||
126286330|NCT03631199|454334982|FG003|Overall Study|Death|35|||
126286331|NCT03631199|454334983|FG004|Overall Study|Death|48|||
126286332|NCT03631199|454334979|FG000|Overall Study|Subject decision|0|||
126286333|NCT03631199|454334980|FG001|Overall Study|Subject decision|1|||
126286334|NCT03631199|454334981|FG002|Overall Study|Subject decision|0|||
126286335|NCT03631199|454334982|FG003|Overall Study|Subject decision|12|||
126286336|NCT03631199|454334983|FG004|Overall Study|Subject decision|12|||
126286337|NCT03631199|454334979|FG000|Overall Study|No treated|0|||
126286338|NCT03631199|454334980|FG001|Overall Study|No treated|0|||
126286339|NCT03631199|454334981|FG002|Overall Study|No treated|0|||
126286340|NCT03631199|454334982|FG003|Overall Study|No treated|0|||
126286341|NCT03631199|454334983|FG004|Overall Study|No treated|1|||
126286342|NCT03631199|454334979|FG000|Overall Study|Treatment ongoing|0|||
126286343|NCT03631199|454334980|FG001|Overall Study|Treatment ongoing|1|||
126286344|NCT03631199|454334981|FG002|Overall Study|Treatment ongoing|1|||
126286345|NCT03631199|454334982|FG003|Overall Study|Treatment ongoing|76|||
126286346|NCT03631199|454334983|FG004|Overall Study|Treatment ongoing|71|||
126286347|NCT03631199|454334979|FG000|Overall Study|Guardian decision|0|||
126286348|NCT03631199|454334980|FG001|Overall Study|Guardian decision|0|||
126286349|NCT03631199|454334981|FG002|Overall Study|Guardian decision|0|||
126286350|NCT03631199|454334982|FG003|Overall Study|Guardian decision|1|||
126286351|NCT03631199|454334983|FG004|Overall Study|Guardian decision|1|||
126286352|NCT03651700|454334985|FG000|Overall Study|Withdrawal by Subject|1|||
126286353|NCT03651700|454334986|FG001|Overall Study|Withdrawal by Subject|0|||
126286354|NCT05124691|454334987|FG000|Phase II|Eligibility criteria|0|||
126286355|NCT05124691|454334988|FG001|Phase II|Eligibility criteria|1|||
126286356|NCT05124691|454334989|FG002|Phase II|Eligibility criteria|0|||
126286357|NCT05124691|454334987|FG000|Phase II|Withdrawal by Subject|6|||
126457072|NCT02880956|454972963|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
126457073|NCT02880956|454972964|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
126457074|NCT02880956|454972961|FG000|Overall Study|Other, Not Specified|4|||
126766972|NCT00648739|456100182|FG001|Overall Study|Investigator Considered it Advisable|0|||
126286358|NCT05124691|454334988|FG001|Phase II|Withdrawal by Subject|2|||
126286359|NCT05124691|454334989|FG002|Phase II|Withdrawal by Subject|3|||
126286360|NCT05124691|454334987|FG000|Phase III|Withdrawal by Subject|6|||
126286361|NCT05124691|454334988|FG001|Phase III|Withdrawal by Subject|4|||
126286362|NCT05124691|454334989|FG002|Phase III|Withdrawal by Subject|4|||
126286363|NCT05124691|454334987|FG000|Phase III|Lost to Follow-up|1|||
126286364|NCT05124691|454334988|FG001|Phase III|Lost to Follow-up|0|||
126286365|NCT05124691|454334989|FG002|Phase III|Lost to Follow-up|0|||
126457075|NCT02880956|454972962|FG001|Overall Study|Other, Not Specified|2|||
126766973|NCT00648739|456100183|FG002|Overall Study|Investigator Considered it Advisable|0|||
126766974|NCT00648739|456100184|FG003|Overall Study|Investigator Considered it Advisable|0|||
126286366|NCT03509467|454334990|FG000|Overall Study|Withdrawal by Subject|5|||
126286367|NCT03509467|454334991|FG001|Overall Study|Withdrawal by Subject|1|||
126286368|NCT03509467|454334992|FG002|Overall Study|Withdrawal by Subject|6|||
126286369|NCT03509467|454334993|FG003|Overall Study|Withdrawal by Subject|7|||
126286370|NCT03509467|454334994|FG004|Overall Study|Withdrawal by Subject|10|||
126286371|NCT03509467|454334995|FG005|Overall Study|Withdrawal by Subject|10|||
126286372|NCT03509467|454334996|FG006|Overall Study|Withdrawal by Subject|10|||
126286373|NCT03509467|454334997|FG007|Overall Study|Withdrawal by Subject|10|||
126286374|NCT03509467|454334990|FG000|Overall Study|Death|0|||
126286375|NCT03509467|454334991|FG001|Overall Study|Death|0|||
126286376|NCT03509467|454334992|FG002|Overall Study|Death|2|||
126286377|NCT03509467|454334993|FG003|Overall Study|Death|2|||
126286378|NCT03509467|454334994|FG004|Overall Study|Death|1|||
126286379|NCT03509467|454334995|FG005|Overall Study|Death|0|||
126286380|NCT03509467|454334996|FG006|Overall Study|Death|1|||
126286381|NCT03509467|454334997|FG007|Overall Study|Death|0|||
126286382|NCT03509467|454334990|FG000|Overall Study|Proxy Withdrawal|0|||
126286383|NCT03509467|454334991|FG001|Overall Study|Proxy Withdrawal|0|||
126286384|NCT03509467|454334992|FG002|Overall Study|Proxy Withdrawal|0|||
126286385|NCT03509467|454334993|FG003|Overall Study|Proxy Withdrawal|0|||
126286386|NCT03509467|454334994|FG004|Overall Study|Proxy Withdrawal|0|||
126549506|NCT01234649|455305656|FG001|Overall Study|Allergic reaction|0|||
126549507|NCT01234649|455305655|FG000|Overall Study|Lack of Efficacy|0|||
126549508|NCT01234649|455305656|FG001|Overall Study|Lack of Efficacy|3|||
126549509|NCT00318149|455305659|FG000|Overall Study|Adverse Event|0|||
126549510|NCT00318149|455305660|FG001|Overall Study|Adverse Event|0|||
126549511|NCT00318149|455305661|FG002|Overall Study|Adverse Event|0|||
126549512|NCT00318149|455305662|FG003|Overall Study|Adverse Event|0|||
126549513|NCT00318149|455305663|FG004|Overall Study|Adverse Event|0|||
126549514|NCT00318149|455305664|FG005|Overall Study|Adverse Event|2|||
126286387|NCT03509467|454334995|FG005|Overall Study|Proxy Withdrawal|0|||
126286388|NCT03509467|454334996|FG006|Overall Study|Proxy Withdrawal|0|||
126549515|NCT00785707|455305670|FG000|Overall Study|Lost to Follow-up|7|||
126710211|NCT00104104|455890067|FG001|Overall Study|Lost to Follow-up|7|||
126710212|NCT00104104|455890066|FG000|Overall Study|Administrative problems|12|||
126710213|NCT00104104|455890067|FG001|Overall Study|Administrative problems|13|||
126710214|NCT00104104|455890066|FG000|Overall Study|Death|9|||
126710215|NCT00104104|455890067|FG001|Overall Study|Death|6|||
126710216|NCT01821677|455890070|FG000|Overall Study|Adverse Event|4|||
126710217|NCT01821677|455890071|FG001|Overall Study|Adverse Event|6|||
126710218|NCT01821677|455890072|FG002|Overall Study|Adverse Event|5|||
126710219|NCT01821677|455890070|FG000|Overall Study|Physician Decision|1|||
126710220|NCT01821677|455890071|FG001|Overall Study|Physician Decision|4|||
126710221|NCT01821677|455890072|FG002|Overall Study|Physician Decision|1|||
126710222|NCT01821677|455890070|FG000|Overall Study|Non-compliance|0|||
126710223|NCT01821677|455890071|FG001|Overall Study|Non-compliance|1|||
126710224|NCT01821677|455890072|FG002|Overall Study|Non-compliance|2|||
126710225|NCT01821677|455890070|FG000|Overall Study|Lost to Follow-up|2|||
126710226|NCT01821677|455890071|FG001|Overall Study|Lost to Follow-up|1|||
126710227|NCT01821677|455890072|FG002|Overall Study|Lost to Follow-up|3|||
126710228|NCT01821677|455890070|FG000|Overall Study|Protocol Violation|0|||
126710229|NCT01821677|455890071|FG001|Overall Study|Protocol Violation|0|||
126710230|NCT01821677|455890072|FG002|Overall Study|Protocol Violation|2|||
126710231|NCT01821677|455890070|FG000|Overall Study|Withdrawal by Subject|7|||
126710232|NCT01821677|455890071|FG001|Overall Study|Withdrawal by Subject|3|||
126710233|NCT01821677|455890072|FG002|Overall Study|Withdrawal by Subject|2|||
126710234|NCT01821677|455890070|FG000|Overall Study|Other|9|||
126710235|NCT01821677|455890071|FG001|Overall Study|Other|0|||
126710236|NCT01821677|455890072|FG002|Overall Study|Other|0|||
126710237|NCT01894516|455891576|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
126710238|NCT01894516|455891577|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
126710239|NCT01894516|455891578|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
126710240|NCT01894516|455891579|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
126710241|NCT01894516|455891576|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
126710242|NCT01894516|455891577|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126710243|NCT01894516|455891578|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126286389|NCT03509467|454334997|FG007|Overall Study|Proxy Withdrawal|1|||
126286390|NCT02829918|454334998|FG000|Overall Study|Death|2|||
126286391|NCT02829918|454334998|FG000|Overall Study|Withdrawal by Subject|4|||
126286392|NCT02829918|454334998|FG000|Overall Study|Adverse Event|1|||
126286393|NCT02829918|454334998|FG000|Overall Study|Progression|1|||
126549516|NCT02262260|455305671|FG000|Overall Study|Adverse Event|4|||
126549517|NCT02262260|455305672|FG001|Overall Study|Adverse Event|1|||
126549518|NCT02262260|455305671|FG000|Overall Study|Withdrawal of consent|4|||
126286394|NCT04223752|454335004|FG000|Overall Study|Participant enrolled in error|0|||
126710244|NCT01894516|455891579|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126710245|NCT01894516|455891576|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
126710246|NCT01894516|455891577|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
126710247|NCT01894516|455891578|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
126710248|NCT01894516|455891579|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
126710249|NCT01894516|455891576|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
126286395|NCT04223752|454335005|FG001|Overall Study|Participant enrolled in error|0|||
126286396|NCT04223752|454335006|FG002|Overall Study|Participant enrolled in error|0|||
126286397|NCT04223752|454335007|FG003|Overall Study|Participant enrolled in error|0|||
126286398|NCT04223752|454335008|FG004|Overall Study|Participant enrolled in error|1|||
126286399|NCT04223752|454335004|FG000|Overall Study|Death|0|||
126286400|NCT04223752|454335005|FG001|Overall Study|Death|0|||
126286401|NCT04223752|454335006|FG002|Overall Study|Death|0|||
126286402|NCT04223752|454335007|FG003|Overall Study|Death|2|||
126457076|NCT02880956|454972963|FG002|Overall Study|Other, Not Specified|0|||
126457077|NCT02880956|454972964|FG003|Overall Study|Other, Not Specified|3|||
126457078|NCT00853970|454972965|FG000|Overall Study|Withdrawal by Subject|2|||
126457079|NCT00853970|454972966|FG001|Overall Study|Withdrawal by Subject|1|||
126457080|NCT00853970|454972965|FG000|Overall Study|Cancelled surgery|4|||
126457081|NCT00853970|454972966|FG001|Overall Study|Cancelled surgery|2|||
126457082|NCT01258998|454974787|FG000|Overall Study|Ineligible|1|||
126457083|NCT01143389|454974788|FG000|Overall Study|Lost to Follow-up|26|||
126457084|NCT01143389|454974789|FG001|Overall Study|Lost to Follow-up|25|||
126457085|NCT02276027|454974792|FG000|Overall Study|Death|1|||
126457086|NCT02276027|454974793|FG001|Overall Study|Death|0|||
126457087|NCT02276027|454974794|FG002|Overall Study|Death|0|||
126457088|NCT02276027|454974795|FG003|Overall Study|Death|2|||
126457089|NCT02276027|454974792|FG000|Overall Study|Physician Decision|0|||
126457090|NCT02276027|454974793|FG001|Overall Study|Physician Decision|0|||
126457091|NCT02276027|454974794|FG002|Overall Study|Physician Decision|0|||
126710250|NCT01894516|455891577|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
126710251|NCT01894516|455891578|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
126710252|NCT01894516|455891579|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
126710253|NCT01894516|455891576|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
126710254|NCT01894516|455891577|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
126710255|NCT01894516|455891578|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
126710256|NCT01894516|455891579|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
126710257|NCT01894516|455891576|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
126710258|NCT01894516|455891577|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
126710259|NCT01894516|455891578|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
126710260|NCT01894516|455891579|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
126710261|NCT01894516|455891576|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
126710262|NCT01894516|455891577|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
126710263|NCT01894516|455891578|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
126710264|NCT01894516|455891579|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
126710265|NCT01894516|455891576|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
126710266|NCT01894516|455891577|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
126710267|NCT01894516|455891578|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
126710268|NCT01894516|455891579|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
126710269|NCT03191396|455891581|FG000|Overall Study|Lost to Follow-up|0|||
126710270|NCT03191396|455891582|FG001|Overall Study|Lost to Follow-up|3|||
126710271|NCT03191396|455891581|FG000|Overall Study|Withdrawal by Subject|3|||
126710272|NCT03191396|455891582|FG001|Overall Study|Withdrawal by Subject|2|||
126710273|NCT01300286|455891583|FG000|Overall Study|did not get dosed|1|||
126710274|NCT03692910|455891586|FG000|Overall Study|Lost to Follow-up|4|||
126710275|NCT03692910|455891587|FG001|Overall Study|Lost to Follow-up|0|||
126710276|NCT03692910|455891588|FG002|Overall Study|Lost to Follow-up|0|||
126710277|NCT03692910|455891586|FG000|Overall Study|Withdrawal by Subject|2|||
126710278|NCT03692910|455891587|FG001|Overall Study|Withdrawal by Subject|0|||
126710279|NCT03692910|455891588|FG002|Overall Study|Withdrawal by Subject|0|||
126710280|NCT00417612|455891591|FG000|Overall Study|Errant diagnosis|0|||
126710281|NCT00417612|455891592|FG001|Overall Study|Errant diagnosis|1|||
126710282|NCT00417612|455891591|FG000|Overall Study|Adverse Event|2|||
126710283|NCT00417612|455891592|FG001|Overall Study|Adverse Event|0|||
126710284|NCT00417612|455891591|FG000|Overall Study|Protocol Violation|0|||
126710285|NCT00417612|455891592|FG001|Overall Study|Protocol Violation|2|||
126710286|NCT00417612|455891591|FG000|Overall Study|Lost to Follow-up|1|||
126710287|NCT00417612|455891592|FG001|Overall Study|Lost to Follow-up|0|||
126710288|NCT01981122|455891593|FG000|Overall Study|Withdrawal by Subject|0|||
126710289|NCT01981122|455891594|FG001|Overall Study|Withdrawal by Subject|2|||
126710290|NCT01981122|455891593|FG000|Overall Study|Protocol Violation|0|||
126710291|NCT01981122|455891594|FG001|Overall Study|Protocol Violation|1|||
126286403|NCT04223752|454335008|FG004|Overall Study|Death|1|||
126457092|NCT02276027|454974795|FG003|Overall Study|Physician Decision|1|||
126457093|NCT02276027|454974792|FG000|Overall Study|Progressive disease|1|||
126457094|NCT02276027|454974793|FG001|Overall Study|Progressive disease|13|||
126457095|NCT02276027|454974794|FG002|Overall Study|Progressive disease|12|||
126286404|NCT04759703|454335009|FG000|Overall Study|Withdrawal by Subject|4|||
126286405|NCT04759703|454335010|FG001|Overall Study|Withdrawal by Subject|9|||
126286406|NCT04759703|454335009|FG000|Overall Study|Adverse Event|1|||
126286407|NCT04759703|454335010|FG001|Overall Study|Adverse Event|0|||
126286408|NCT04759703|454335009|FG000|Overall Study|Lost to Follow-up|2|||
126286409|NCT04759703|454335010|FG001|Overall Study|Lost to Follow-up|0|||
126286410|NCT01128543|454335023|FG000|Overall Study|Withdrawal by Subject|3|||
126286411|NCT01128543|454335023|FG000|Overall Study|Protocol Violation|1|||
126286412|NCT01941498|454335027|FG000|Overall Study|Relocated out of state|1|||
126286413|NCT04487067|454335028|FG000|Overall Study|Adverse Event|3|||
126457096|NCT02276027|454974795|FG003|Overall Study|Progressive disease|14|||
126457097|NCT02276027|454974792|FG000|Overall Study|Subject/guardian decision|0|||
126457098|NCT02276027|454974793|FG001|Overall Study|Subject/guardian decision|1|||
126457099|NCT02276027|454974794|FG002|Overall Study|Subject/guardian decision|0|||
126457100|NCT02276027|454974795|FG003|Overall Study|Subject/guardian decision|3|||
126457101|NCT02276027|454974792|FG000|Overall Study|Adverse Event|0|||
126457102|NCT02276027|454974793|FG001|Overall Study|Adverse Event|2|||
126457103|NCT02276027|454974794|FG002|Overall Study|Adverse Event|8|||
126457104|NCT02276027|454974795|FG003|Overall Study|Adverse Event|2|||
126457105|NCT03224598|454974796|FG000|Overall Study|Lost to Follow-up|0|||
126457106|NCT03224598|454974797|FG001|Overall Study|Lost to Follow-up|2|||
126457107|NCT03224598|454974798|FG002|Overall Study|Lost to Follow-up|0|||
126457108|NCT03224598|454974796|FG000|Overall Study|Other|0|||
126457109|NCT03224598|454974797|FG001|Overall Study|Other|1|||
126457110|NCT03224598|454974798|FG002|Overall Study|Other|0|||
126457111|NCT01527357|454974808|FG000|Overall Study|Death|8|||
126710292|NCT01981122|455891593|FG000|Overall Study|Lost to Follow-up|0|||
126710293|NCT01981122|455891594|FG001|Overall Study|Lost to Follow-up|1|||
126710294|NCT01981122|455891593|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
126710295|NCT01981122|455891594|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
126710296|NCT01981122|455891593|FG000|Overall Study|Death|14|||
126710297|NCT01981122|455891594|FG001|Overall Study|Death|15|||
126710298|NCT01330381|455891595|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
126710299|NCT01330381|455891596|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
126710300|NCT01330381|455891597|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
126710301|NCT01330381|455891595|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
126710302|NCT01330381|455891596|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
126710303|NCT01330381|455891597|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
126710304|NCT01330381|455891595|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
126710305|NCT01330381|455891596|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
126710306|NCT01330381|455891597|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
126710307|NCT01330381|455891595|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
126710308|NCT01330381|455891596|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
126710309|NCT01330381|455891597|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
126710310|NCT01330381|455891595|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
126710311|NCT01330381|455891596|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
126710312|NCT01330381|455891597|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
126710313|NCT01330381|455891595|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
126710314|NCT01330381|455891596|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
126710315|NCT01330381|455891597|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
126710316|NCT01330381|455891595|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
126710317|NCT01330381|455891596|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
126710318|NCT01330381|455891597|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
126710319|NCT01330381|455891595|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
126710320|NCT01330381|455891596|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
126710321|NCT01330381|455891597|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
126710322|NCT01330381|455891595|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
126710323|NCT01330381|455891596|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
126710324|NCT01330381|455891597|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
126710325|NCT01330381|455891595|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
126710326|NCT01330381|455891596|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
126710327|NCT01330381|455891597|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
126710328|NCT03060577|455891598|FG000|Overall Study|Withdrawal by Subject|25|||
126710329|NCT03060577|455891599|FG001|Overall Study|Withdrawal by Subject|5|||
126710330|NCT03060577|455891598|FG000|Overall Study|Physician Decision|4|||
126710331|NCT03060577|455891599|FG001|Overall Study|Physician Decision|3|||
126457112|NCT01527357|454974809|FG001|Overall Study|Death|2|||
126457113|NCT01527357|454974808|FG000|Overall Study|Lost to Follow-up|6|||
126457114|NCT01527357|454974809|FG001|Overall Study|Lost to Follow-up|4|||
126457115|NCT01527357|454974808|FG000|Overall Study|Withdrew Consent|1|||
126457116|NCT01527357|454974809|FG001|Overall Study|Withdrew Consent|1|||
126286414|NCT04487067|454335028|FG000|Overall Study|Death Other Than Progressive Disease|60|||
126457117|NCT01527357|454974808|FG000|Overall Study|Non-compliance|0|||
126457118|NCT01527357|454974809|FG001|Overall Study|Non-compliance|1|||
126286415|NCT04487067|454335028|FG000|Overall Study|Death Due To Progressive Disease|40|||
126286416|NCT04487067|454335028|FG000|Overall Study|Lost to Follow-up|3|||
126286417|NCT04487067|454335028|FG000|Overall Study|Progressive Disease|1|||
126286418|NCT04487067|454335028|FG000|Overall Study|Protocol Violation|3|||
126286419|NCT04487067|454335028|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
126286420|NCT04487067|454335028|FG000|Overall Study|Withdrawal by Subject|15|||
126286421|NCT01755091|454335029|FG000|Overall Study|Withdrawal by Subject|6|||
126286422|NCT01755091|454335030|FG001|Overall Study|Withdrawal by Subject|1|||
126286423|NCT01755091|454335031|FG002|Overall Study|Withdrawal by Subject|3|||
126286424|NCT01755091|454335029|FG000|Overall Study|Adverse Event|1|||
126286425|NCT01755091|454335030|FG001|Overall Study|Adverse Event|1|||
126286426|NCT01755091|454335031|FG002|Overall Study|Adverse Event|1|||
126286427|NCT01755091|454335029|FG000|Overall Study|Lost to Follow-up|1|||
126286428|NCT01755091|454335030|FG001|Overall Study|Lost to Follow-up|0|||
126286429|NCT01755091|454335031|FG002|Overall Study|Lost to Follow-up|1|||
126286430|NCT01755091|454335029|FG000|Overall Study|Physician Decision|1|||
126286431|NCT01755091|454335030|FG001|Overall Study|Physician Decision|1|||
126286432|NCT01755091|454335031|FG002|Overall Study|Physician Decision|2|||
126286433|NCT00490841|454335032|FG000|Overall Study|Death|5|||
126286434|NCT00490841|454335032|FG000|Overall Study|Withdrawal by Subject|4|||
126286435|NCT00490841|454335032|FG000|Overall Study|Lost to Follow-up|1|||
126286436|NCT00490841|454335032|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
126286437|NCT06385483|454335035|FG000|Overall Study|Withdrawal by Subject|2|||
126286438|NCT06385483|454335035|FG000|Overall Study|Never start protocol therapy|2|||
126286439|NCT06385483|454335035|FG000|Overall Study|Disease progression|15|||
126286440|NCT02503787|454335036|FG000|Enrollment|Withdrawal by Subject|6|||
126286441|NCT02503787|454335036|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
126286442|NCT02503787|454335036|FG000|Enrollment|Physician Decision|2|||
126286443|NCT02503787|454335036|FG000|Enrollment|Insurance issue|2|||
126286444|NCT02503787|454335036|FG000|Enrollment|Lost to Follow-up|1|||
126286445|NCT02503787|454335036|FG000|Enrollment|Study closure|1|||
126286446|NCT02503787|454335036|FG000|Enrollment|Adverse Event|1|||
126286447|NCT02503787|454335036|FG000|Enrollment|Protocol Violation|1|||
126286448|NCT02503787|454335036|FG000|Enrollment|Inability to implant system|1|||
126286449|NCT02503787|454335036|FG000|Enrollment|Unable to be programmed|1|||
126286450|NCT02503787|454335036|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
126286451|NCT02503787|454335036|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
126286452|NCT02503787|454335036|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
126286453|NCT02503787|454335036|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
126286454|NCT02503787|454335036|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
126286455|NCT02503787|454335036|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
126286456|NCT04787627|454335037|FG000|Overall Study|Withdrawal by Subject|3|||
126286457|NCT04787627|454335038|FG001|Overall Study|Withdrawal by Subject|0|||
126286458|NCT04787627|454335037|FG000|Overall Study|Physician Decision|2|||
126286459|NCT04787627|454335038|FG001|Overall Study|Physician Decision|0|||
126286460|NCT04787627|454335037|FG000|Overall Study|Excluded|0|||
126286461|NCT04787627|454335038|FG001|Overall Study|Excluded|1|||
126286462|NCT00174954|454335039|FG000|Overall Study|Adverse Event|2|||
126286463|NCT00174954|454335039|FG000|Overall Study|No tophi found in MRI|1|||
126286464|NCT00174954|454335039|FG000|Overall Study|Physician Decision|1|||
126365435|NCT04091438|454631775|FG000|Treatment Period 1 (1 Day)|Other|1|||
126365436|NCT04091438|454631776|FG001|Treatment Period 1 (1 Day)|Other|0|||
126365437|NCT04091438|454631775|FG000|Washout Period (1 Day)|Protocol deviation|0|||
126365438|NCT04091438|454631776|FG001|Washout Period (1 Day)|Protocol deviation|1|||
126365439|NCT04091438|454631775|FG000|Washout Period (1 Day)|Other|0|||
126365440|NCT04091438|454631776|FG001|Washout Period (1 Day)|Other|1|||
126457119|NCT01527357|454974808|FG000|Overall Study|No Day 29 Visit|0|||
126457120|NCT01527357|454974809|FG001|Overall Study|No Day 29 Visit|1|||
126457121|NCT01527357|454974808|FG000|Overall Study|Did Not Receive Treatment|2|||
126286465|NCT00839254|454335040|FG000|Overall Study|Protocol Violation|0|||
126365441|NCT00421408|454631777|FG000|Overall Study|Lost to Follow-up|30|||
126365442|NCT00421408|454631778|FG001|Overall Study|Lost to Follow-up|20|||
126365443|NCT00421408|454631777|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
126365444|NCT00421408|454631778|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
126365445|NCT00787800|454631782|FG000|Overall Study|Withdrawal by Subject|3|||
126365446|NCT00787800|454631783|FG001|Overall Study|Withdrawal by Subject|5|||
126286466|NCT00839254|454335041|FG001|Overall Study|Protocol Violation|1|||
126286467|NCT00839254|454335042|FG002|Overall Study|Protocol Violation|1|||
126286468|NCT00839254|454335043|FG003|Overall Study|Protocol Violation|1|||
126365447|NCT00787800|454631782|FG000|Overall Study|Death|0|||
126286469|NCT00839254|454335044|FG004|Overall Study|Protocol Violation|0|||
126286470|NCT00839254|454335045|FG005|Overall Study|Protocol Violation|0|||
126286471|NCT00839254|454335046|FG006|Overall Study|Protocol Violation|1|||
126286472|NCT00839254|454335047|FG007|Overall Study|Protocol Violation|2|||
126286473|NCT00839254|454335040|FG000|Overall Study|Physician Decision|0|||
126286474|NCT00839254|454335041|FG001|Overall Study|Physician Decision|1|||
126286475|NCT00839254|454335042|FG002|Overall Study|Physician Decision|0|||
126365448|NCT00787800|454631783|FG001|Overall Study|Death|2|||
126286476|NCT00839254|454335043|FG003|Overall Study|Physician Decision|0|||
126286477|NCT00839254|454335044|FG004|Overall Study|Physician Decision|0|||
126286478|NCT00839254|454335045|FG005|Overall Study|Physician Decision|0|||
126286479|NCT00839254|454335046|FG006|Overall Study|Physician Decision|0|||
126286480|NCT00839254|454335047|FG007|Overall Study|Physician Decision|1|||
126286481|NCT00839254|454335040|FG000|Overall Study|Wrong treatment number allocation|0|||
126286482|NCT00839254|454335041|FG001|Overall Study|Wrong treatment number allocation|1|||
126286483|NCT00839254|454335042|FG002|Overall Study|Wrong treatment number allocation|0|||
126286484|NCT00839254|454335043|FG003|Overall Study|Wrong treatment number allocation|0|||
126286485|NCT00839254|454335044|FG004|Overall Study|Wrong treatment number allocation|0|||
126286486|NCT00839254|454335045|FG005|Overall Study|Wrong treatment number allocation|1|||
126286487|NCT00839254|454335046|FG006|Overall Study|Wrong treatment number allocation|0|||
126286488|NCT00839254|454335047|FG007|Overall Study|Wrong treatment number allocation|0|||
126286489|NCT00839254|454335040|FG000|Overall Study|Adverse Event|12|||
126286490|NCT00839254|454335041|FG001|Overall Study|Adverse Event|6|||
126286491|NCT00839254|454335042|FG002|Overall Study|Adverse Event|3|||
126286492|NCT00839254|454335043|FG003|Overall Study|Adverse Event|5|||
126286493|NCT00839254|454335044|FG004|Overall Study|Adverse Event|2|||
126286494|NCT00839254|454335045|FG005|Overall Study|Adverse Event|1|||
126286495|NCT00839254|454335046|FG006|Overall Study|Adverse Event|0|||
126286496|NCT00839254|454335047|FG007|Overall Study|Adverse Event|1|||
126286497|NCT00839254|454335040|FG000|Overall Study|Withdrawal by Subject|87|||
126286498|NCT00839254|454335041|FG001|Overall Study|Withdrawal by Subject|53|||
126286499|NCT00839254|454335042|FG002|Overall Study|Withdrawal by Subject|54|||
126286500|NCT00839254|454335043|FG003|Overall Study|Withdrawal by Subject|32|||
126286501|NCT00839254|454335044|FG004|Overall Study|Withdrawal by Subject|27|||
126286502|NCT00839254|454335045|FG005|Overall Study|Withdrawal by Subject|15|||
126286503|NCT00839254|454335046|FG006|Overall Study|Withdrawal by Subject|22|||
126286504|NCT00839254|454335047|FG007|Overall Study|Withdrawal by Subject|9|||
126286505|NCT00839254|454335040|FG000|Overall Study|Wrong group allocation|0|||
126286506|NCT00839254|454335041|FG001|Overall Study|Wrong group allocation|0|||
126286507|NCT00839254|454335042|FG002|Overall Study|Wrong group allocation|0|||
126286508|NCT00839254|454335043|FG003|Overall Study|Wrong group allocation|0|||
126286509|NCT00839254|454335044|FG004|Overall Study|Wrong group allocation|0|||
126286510|NCT00839254|454335045|FG005|Overall Study|Wrong group allocation|0|||
126286511|NCT00839254|454335046|FG006|Overall Study|Wrong group allocation|1|||
126286512|NCT00839254|454335047|FG007|Overall Study|Wrong group allocation|0|||
126286513|NCT00839254|454335040|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
126286514|NCT00839254|454335041|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
126286515|NCT00839254|454335042|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
126286516|NCT00839254|454335043|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
126286517|NCT00839254|454335044|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
126286518|NCT00839254|454335045|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
126286519|NCT00839254|454335046|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
126286520|NCT00839254|454335047|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
126286521|NCT00839254|454335040|FG000|Overall Study|Withdrawn due to non-compliance|2|||
126286522|NCT00839254|454335041|FG001|Overall Study|Withdrawn due to non-compliance|0|||
126286523|NCT00839254|454335042|FG002|Overall Study|Withdrawn due to non-compliance|0|||
126286524|NCT00839254|454335043|FG003|Overall Study|Withdrawn due to non-compliance|0|||
126286525|NCT00839254|454335044|FG004|Overall Study|Withdrawn due to non-compliance|0|||
126286526|NCT00839254|454335045|FG005|Overall Study|Withdrawn due to non-compliance|0|||
126286527|NCT00839254|454335046|FG006|Overall Study|Withdrawn due to non-compliance|0|||
126286528|NCT00839254|454335047|FG007|Overall Study|Withdrawn due to non-compliance|0|||
126286529|NCT00839254|454335040|FG000|Overall Study|Lost to Follow-up|51|||
126286530|NCT00839254|454335041|FG001|Overall Study|Lost to Follow-up|30|||
126286531|NCT00839254|454335042|FG002|Overall Study|Lost to Follow-up|32|||
126286532|NCT00839254|454335043|FG003|Overall Study|Lost to Follow-up|24|||
126457122|NCT01527357|454974809|FG001|Overall Study|Did Not Receive Treatment|0|||
126457123|NCT02446171|454974810|FG000|Overall Study|Withdrawal by Subject|0|||
126457124|NCT02446171|454974811|FG001|Overall Study|Withdrawal by Subject|0|||
126457125|NCT02446171|454974812|FG002|Overall Study|Withdrawal by Subject|2|||
126457126|NCT02446171|454974813|FG003|Overall Study|Withdrawal by Subject|0|||
126286533|NCT00839254|454335044|FG004|Overall Study|Lost to Follow-up|8|||
126286534|NCT00839254|454335045|FG005|Overall Study|Lost to Follow-up|8|||
126286535|NCT00839254|454335046|FG006|Overall Study|Lost to Follow-up|4|||
126286536|NCT00839254|454335047|FG007|Overall Study|Lost to Follow-up|2|||
126286537|NCT01320150|454335049|FG000|Overall Study|Protocol Violation|15|||
126286538|NCT01320150|454335049|FG000|Overall Study|Withdrawal by Subject|5|||
126286539|NCT01320150|454335049|FG000|Overall Study|Death|2|||
126286540|NCT01320150|454335049|FG000|Overall Study|Lost to Follow-up|44|||
126286541|NCT00919854|454335052|FG000|Overall Study|Adverse Event|1|||
126286542|NCT00985491|454335053|FG000|Overall Study|Adverse Event|8|||
126286543|NCT00985491|454335053|FG000|Overall Study|device migration|7|||
126286544|NCT00985491|454335053|FG000|Overall Study|Withdrawal by Subject|1|||
126457127|NCT04531462|454974814|FG000|Overall Study|Withdrawal by Subject|3|||
126710332|NCT03060577|455891598|FG000|Overall Study|Lost to Follow-up|3|||
126286545|NCT00985491|454335053|FG000|Overall Study|implant failure|3|||
126286546|NCT00489827|454335058|FG000|Overall Study|Intraoperative exclusion criteria|1|||
126286547|NCT00489827|454335059|FG001|Overall Study|Intraoperative exclusion criteria|1|||
126286548|NCT00489827|454335058|FG000|Overall Study|Intraoperative exclusion criteria|1|||
126286549|NCT00489827|454335059|FG001|Overall Study|Intraoperative exclusion criteria|1|||
126286550|NCT01377012|454335060|FG000|Core Study|Study terminated by Sponsor|47|||
126286551|NCT01377012|454335061|FG001|Core Study|Study terminated by Sponsor|54|||
126286552|NCT01377012|454335062|FG002|Core Study|Study terminated by Sponsor|46|||
126286553|NCT01377012|454335060|FG000|Core Study|Technical problems|1|||
126286554|NCT01377012|454335061|FG001|Core Study|Technical problems|0|||
126286555|NCT01377012|454335062|FG002|Core Study|Technical problems|0|||
126286556|NCT01377012|454335060|FG000|Core Study|Withdrawal by Subject|15|||
126286557|NCT01377012|454335061|FG001|Core Study|Withdrawal by Subject|23|||
126286558|NCT01377012|454335062|FG002|Core Study|Withdrawal by Subject|18|||
126286559|NCT01377012|454335060|FG000|Core Study|Protocol Violation|7|||
126286560|NCT01377012|454335061|FG001|Core Study|Protocol Violation|3|||
126286561|NCT01377012|454335062|FG002|Core Study|Protocol Violation|2|||
126286562|NCT01377012|454335060|FG000|Core Study|Pregnancy|0|||
126286563|NCT01377012|454335061|FG001|Core Study|Pregnancy|0|||
126286564|NCT01377012|454335062|FG002|Core Study|Pregnancy|1|||
126286565|NCT01377012|454335060|FG000|Core Study|Physician Decision|5|||
126286566|NCT01377012|454335061|FG001|Core Study|Physician Decision|4|||
126286567|NCT01377012|454335062|FG002|Core Study|Physician Decision|10|||
126286568|NCT01377012|454335060|FG000|Core Study|Non-Compliant with study treatment|0|||
126286569|NCT01377012|454335061|FG001|Core Study|Non-Compliant with study treatment|0|||
126286570|NCT01377012|454335062|FG002|Core Study|Non-Compliant with study treatment|1|||
126286571|NCT01377012|454335060|FG000|Core Study|No Longer require treatment|0|||
126286572|NCT01377012|454335061|FG001|Core Study|No Longer require treatment|0|||
126286573|NCT01377012|454335062|FG002|Core Study|No Longer require treatment|1|||
126286574|NCT01377012|454335060|FG000|Core Study|Lost to Follow-up|7|||
126286575|NCT01377012|454335061|FG001|Core Study|Lost to Follow-up|5|||
126286576|NCT01377012|454335062|FG002|Core Study|Lost to Follow-up|4|||
126286577|NCT01377012|454335060|FG000|Core Study|Lack of Efficacy|41|||
126286578|NCT01377012|454335061|FG001|Core Study|Lack of Efficacy|28|||
126286579|NCT01377012|454335062|FG002|Core Study|Lack of Efficacy|37|||
126286580|NCT01377012|454335060|FG000|Core Study|Death|1|||
126286581|NCT01377012|454335061|FG001|Core Study|Death|1|||
126286582|NCT01377012|454335062|FG002|Core Study|Death|1|||
126286583|NCT01377012|454335060|FG000|Core Study|Adverse Event|10|||
126286584|NCT01377012|454335061|FG001|Core Study|Adverse Event|14|||
126286585|NCT01377012|454335062|FG002|Core Study|Adverse Event|13|||
126286586|NCT01377012|454335060|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
126286587|NCT01377012|454335061|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
126286588|NCT01377012|454335062|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
126286589|NCT01377012|454335060|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
126286590|NCT01377012|454335061|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
126286591|NCT01377012|454335062|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
126286592|NCT01377012|454335060|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
126286593|NCT01377012|454335061|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
126286594|NCT01377012|454335062|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
126286595|NCT01377012|454335060|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
126286596|NCT01377012|454335061|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
126286597|NCT01377012|454335062|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
126286598|NCT01377012|454335060|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
126286599|NCT01377012|454335061|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
126286600|NCT01377012|454335062|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
126286601|NCT01377012|454335060|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
126365449|NCT04309500|454631786|FG000|Overall Study|Lost to Follow-up|1|||
126365450|NCT04309500|454631787|FG001|Overall Study|Lost to Follow-up|0|||
126365451|NCT04309500|454631788|FG002|Overall Study|Lost to Follow-up|0|||
126365452|NCT04309500|454631789|FG003|Overall Study|Lost to Follow-up|0|||
126365453|NCT00913835|454631790|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
126365454|NCT00913835|454631791|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
126365455|NCT00913835|454631790|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
126365456|NCT00913835|454631791|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
126365457|NCT00913835|454631790|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
126365458|NCT00913835|454631791|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
126286602|NCT01377012|454335061|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
126286603|NCT01377012|454335062|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
126286604|NCT04380961|454335063|FG000|Overall Study|Lost to Follow-up|17|||
126286605|NCT04380961|454335064|FG001|Overall Study|Lost to Follow-up|11|||
126286606|NCT04380961|454335063|FG000|Overall Study|Withdrawal by Subject|3|||
126286607|NCT04380961|454335064|FG001|Overall Study|Withdrawal by Subject|0|||
126286608|NCT04380961|454335063|FG000|Overall Study|Death|22|||
126286609|NCT04380961|454335064|FG001|Overall Study|Death|16|||
126710333|NCT03060577|455891599|FG001|Overall Study|Lost to Follow-up|0|||
126286610|NCT04380961|454335063|FG000|Overall Study|Other|1|||
126286611|NCT04380961|454335064|FG001|Overall Study|Other|0|||
126286612|NCT04380961|454335063|FG000|Overall Study|Randomized but Not Treated|1|||
126286613|NCT04380961|454335064|FG001|Overall Study|Randomized but Not Treated|2|||
126549519|NCT02262260|455305672|FG001|Overall Study|Withdrawal of consent|2|||
126549520|NCT02262260|455305671|FG000|Overall Study|Lost to Follow-up|1|||
126549521|NCT02262260|455305672|FG001|Overall Study|Lost to Follow-up|2|||
126286614|NCT03736031|454335066|FG000|Overall Study|Death|2|||
126286615|NCT03736031|454335067|FG001|Overall Study|Death|4|||
126286616|NCT03736031|454335066|FG000|Overall Study|Lost to Follow-up|21|||
126286617|NCT03736031|454335067|FG001|Overall Study|Lost to Follow-up|2|||
126286618|NCT03736031|454335066|FG000|Overall Study|Withdrawal by Subject|9|||
126286619|NCT03736031|454335067|FG001|Overall Study|Withdrawal by Subject|0|||
126286620|NCT06419907|454336122|FG000|Overall Study|Protocol Violation|0|||
126286621|NCT06419907|454336123|FG001|Overall Study|Protocol Violation|3|||
126286622|NCT06419907|454336124|FG002|Overall Study|Protocol Violation|0|||
126286623|NCT06419907|454336125|FG003|Overall Study|Protocol Violation|1|||
126286624|NCT06419907|454336122|FG000|Overall Study|Lost to Follow-up|0|||
126286625|NCT06419907|454336123|FG001|Overall Study|Lost to Follow-up|0|||
126286626|NCT06419907|454336124|FG002|Overall Study|Lost to Follow-up|2|||
126286627|NCT06419907|454336125|FG003|Overall Study|Lost to Follow-up|1|||
126286628|NCT05929651|454336128|FG000|Overall Study|Protocol Deviation|1|||
126286629|NCT05929651|454336128|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
126286630|NCT02260570|454336129|FG000|Overall Study|Withdrawal by Subject|2|||
126286631|NCT02260570|454336130|FG001|Overall Study|Withdrawal by Subject|1|||
126286632|NCT02260570|454336129|FG000|Overall Study|Physician Decision|1|||
126286633|NCT02260570|454336130|FG001|Overall Study|Physician Decision|1|||
126286634|NCT05026177|454336131|FG000|Overall Study|Adverse Event|33|||
126286635|NCT05026177|454336132|FG001|Overall Study|Adverse Event|33|||
126286636|NCT05026177|454336133|FG002|Overall Study|Adverse Event|17|||
126286637|NCT05026177|454336131|FG000|Overall Study|Lost to Follow-up|7|||
126286638|NCT05026177|454336132|FG001|Overall Study|Lost to Follow-up|6|||
126286639|NCT05026177|454336133|FG002|Overall Study|Lost to Follow-up|8|||
126286640|NCT05026177|454336131|FG000|Overall Study|Noncompliance with study drug|6|||
126286641|NCT05026177|454336132|FG001|Overall Study|Noncompliance with study drug|2|||
126286642|NCT05026177|454336133|FG002|Overall Study|Noncompliance with study drug|1|||
126286643|NCT05026177|454336131|FG000|Overall Study|Physician Decision|4|||
126286644|NCT05026177|454336132|FG001|Overall Study|Physician Decision|1|||
126286645|NCT05026177|454336133|FG002|Overall Study|Physician Decision|0|||
126286646|NCT05026177|454336131|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
126286647|NCT05026177|454336132|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
126286648|NCT05026177|454336133|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
126286649|NCT05026177|454336131|FG000|Overall Study|Withdrawal by Subject|53|||
126286650|NCT05026177|454336132|FG001|Overall Study|Withdrawal by Subject|51|||
126286651|NCT05026177|454336133|FG002|Overall Study|Withdrawal by Subject|55|||
126286652|NCT05026177|454336131|FG000|Overall Study|Protocol Violation|0|||
126286653|NCT05026177|454336132|FG001|Overall Study|Protocol Violation|1|||
126286654|NCT05026177|454336133|FG002|Overall Study|Protocol Violation|0|||
126286655|NCT05026177|454336131|FG000|Overall Study|Study terminated by sponsor|70|||
126549522|NCT02262260|455305671|FG000|Overall Study|Protocol deviation|2|||
126549523|NCT02262260|455305672|FG001|Overall Study|Protocol deviation|5|||
126549524|NCT01794117|455305674|FG000|Overall Study|Adverse Event|1|||
126549525|NCT01794117|455305675|FG001|Overall Study|Adverse Event|0|||
126549526|NCT01794117|455305676|FG002|Overall Study|Adverse Event|0|||
126549527|NCT01794117|455305677|FG003|Overall Study|Adverse Event|0|||
126549528|NCT01794117|455305674|FG000|Overall Study|Participant noncompliance|0|||
126549529|NCT01794117|455305675|FG001|Overall Study|Participant noncompliance|1|||
126549530|NCT01794117|455305676|FG002|Overall Study|Participant noncompliance|0|||
126549531|NCT01794117|455305677|FG003|Overall Study|Participant noncompliance|0|||
126286656|NCT05026177|454336132|FG001|Overall Study|Study terminated by sponsor|74|||
126286657|NCT05026177|454336133|FG002|Overall Study|Study terminated by sponsor|67|||
126365459|NCT00913835|454631790|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
126365460|NCT00913835|454631791|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
126286658|NCT05026177|454336131|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
126286659|NCT05026177|454336132|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
126286660|NCT05026177|454336133|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
126286661|NCT05026177|454336131|FG000|Overall Study|Starting alternative treatment|0|||
126549532|NCT01794117|455305674|FG000|Overall Study|Refused further treatment|0|||
126286662|NCT05026177|454336132|FG001|Overall Study|Starting alternative treatment|1|||
126286663|NCT05026177|454336133|FG002|Overall Study|Starting alternative treatment|1|||
126286664|NCT05026177|454336131|FG000|Overall Study|Noncompliance with study procedures|0|||
126286665|NCT05026177|454336132|FG001|Overall Study|Noncompliance with study procedures|1|||
126286666|NCT05026177|454336133|FG002|Overall Study|Noncompliance with study procedures|1|||
126286667|NCT05026177|454336131|FG000|Overall Study|Met stopping criteria|0|||
126549533|NCT01794117|455305675|FG001|Overall Study|Refused further treatment|2|||
126549534|NCT01794117|455305676|FG002|Overall Study|Refused further treatment|0|||
126365461|NCT00913835|454631790|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
126365462|NCT00913835|454631791|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
126365463|NCT01308788|454631792|FG000|2-year Treatment|medication change by treating physician|4|||
126365464|NCT01308788|454631793|FG001|2-year Treatment|medication change by treating physician|11|||
126365465|NCT02414841|454631794|FG000|Overall Study|Withdrawal by Subject|7|||
126365466|NCT02414841|454631795|FG001|Overall Study|Withdrawal by Subject|5|||
126365467|NCT02414841|454631794|FG000|Overall Study|Lost to Follow-up|13|||
126365468|NCT02414841|454631795|FG001|Overall Study|Lost to Follow-up|6|||
126365469|NCT02414841|454631794|FG000|Overall Study|Death|17|||
126365470|NCT02414841|454631795|FG001|Overall Study|Death|14|||
126365471|NCT02414841|454631794|FG000|Overall Study|Received a Kidney Transplant|13|||
126365472|NCT02414841|454631795|FG001|Overall Study|Received a Kidney Transplant|4|||
126365473|NCT02414841|454631794|FG000|Overall Study|Randomized But Not Treated|6|||
126365474|NCT02414841|454631795|FG001|Overall Study|Randomized But Not Treated|4|||
126365475|NCT03249558|454631798|FG000|Overall Study|Lost to Follow-up|2|||
126365476|NCT03249558|454631799|FG001|Overall Study|Lost to Follow-up|1|||
126365477|NCT03249558|454631800|FG002|Overall Study|Lost to Follow-up|4|||
126365478|NCT03249558|454631798|FG000|Overall Study|Physician Decision|1|||
126365479|NCT03249558|454631799|FG001|Overall Study|Physician Decision|0|||
126365480|NCT03249558|454631800|FG002|Overall Study|Physician Decision|0|||
126365481|NCT03249558|454631798|FG000|Overall Study|Withdrawal by Subject|6|||
126365482|NCT03249558|454631799|FG001|Overall Study|Withdrawal by Subject|5|||
126365483|NCT03249558|454631800|FG002|Overall Study|Withdrawal by Subject|7|||
126365484|NCT03249558|454631798|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
126365485|NCT03249558|454631799|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
126365486|NCT03249558|454631800|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
126365487|NCT03249558|454631798|FG000|Overall Study|Protocol Violation|1|||
126365488|NCT03249558|454631799|FG001|Overall Study|Protocol Violation|1|||
126365489|NCT03249558|454631800|FG002|Overall Study|Protocol Violation|2|||
126365490|NCT05943990|454631802|FG000|Overall Study|Study Terminated by Sponsor|0|||
126365491|NCT05943990|454631803|FG001|Overall Study|Study Terminated by Sponsor|0|||
126710334|NCT03060577|455891598|FG000|Overall Study|Death|7|||
126365492|NCT05943990|454631804|FG002|Overall Study|Study Terminated by Sponsor|1|||
126365493|NCT02657356|454632786|FG000|Overall Study|Death|1|||
126365494|NCT02657356|454632787|FG001|Overall Study|Death|0|||
126365495|NCT02657356|454632786|FG000|Overall Study|Withdrawal by Subject|5|||
126710335|NCT03060577|455891599|FG001|Overall Study|Death|1|||
126710336|NCT03060577|455891598|FG000|Overall Study|Adverse Event|9|||
126365496|NCT02657356|454632787|FG001|Overall Study|Withdrawal by Subject|6|||
126365497|NCT02657356|454632786|FG000|Overall Study|Terminated by Sponsor|8|||
126365498|NCT02657356|454632787|FG001|Overall Study|Terminated by Sponsor|5|||
126365499|NCT02657356|454632786|FG000|Overall Study|Rolled over to EAP study|6|||
126365500|NCT02657356|454632787|FG001|Overall Study|Rolled over to EAP study|4|||
126365501|NCT03379870|454632788|FG000|Overall Study|Lost to Follow-up|1|||
126365502|NCT03379870|454632789|FG001|Overall Study|Lost to Follow-up|0|||
126365503|NCT03379870|454632788|FG000|Overall Study|Protocol Violation|1|||
126365504|NCT03379870|454632789|FG001|Overall Study|Protocol Violation|1|||
126365505|NCT01394185|454632790|FG000|Overall Study|Withdrawal by Subject|2|||
126365506|NCT01394185|454632791|FG001|Overall Study|Withdrawal by Subject|0|||
126365507|NCT01394185|454632792|FG002|Overall Study|Withdrawal by Subject|0|||
126365508|NCT01394185|454632793|FG003|Overall Study|Withdrawal by Subject|0|||
126365509|NCT01394185|454632794|FG004|Overall Study|Withdrawal by Subject|1|||
126365510|NCT01394185|454632795|FG005|Overall Study|Withdrawal by Subject|0|||
126365511|NCT01394185|454632790|FG000|Overall Study|Change in protocol|3|||
126365512|NCT01394185|454632791|FG001|Overall Study|Change in protocol|0|||
126365513|NCT01394185|454632792|FG002|Overall Study|Change in protocol|0|||
126365514|NCT01394185|454632793|FG003|Overall Study|Change in protocol|0|||
126365515|NCT01394185|454632794|FG004|Overall Study|Change in protocol|3|||
126365516|NCT01394185|454632795|FG005|Overall Study|Change in protocol|0|||
126365517|NCT01394185|454632790|FG000|Overall Study|Protocol Violation|1|||
126365518|NCT01394185|454632791|FG001|Overall Study|Protocol Violation|0|||
126365519|NCT01394185|454632792|FG002|Overall Study|Protocol Violation|0|||
126365520|NCT01394185|454632793|FG003|Overall Study|Protocol Violation|1|||
126365521|NCT01394185|454632794|FG004|Overall Study|Protocol Violation|0|||
126365522|NCT01394185|454632795|FG005|Overall Study|Protocol Violation|1|||
126365523|NCT01817777|454632801|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
126365524|NCT01817777|454632802|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
126365525|NCT01817777|454632803|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
126365526|NCT01817777|454632801|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
126365527|NCT01817777|454632802|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
126365528|NCT01817777|454632803|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
126365529|NCT01817777|454632801|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
126365530|NCT01817777|454632802|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
126365531|NCT01817777|454632803|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
126365532|NCT01817777|454632801|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
126286668|NCT05026177|454336132|FG001|Overall Study|Met stopping criteria|0|||
126286669|NCT05026177|454336133|FG002|Overall Study|Met stopping criteria|1|||
126286670|NCT05026177|454336131|FG000|Overall Study|Health issues preventing continuation|0|||
126286671|NCT05026177|454336132|FG001|Overall Study|Health issues preventing continuation|0|||
126286672|NCT05026177|454336133|FG002|Overall Study|Health issues preventing continuation|1|||
126286673|NCT05026177|454336131|FG000|Overall Study|Randomized in error, not treated|0|||
126286674|NCT05026177|454336132|FG001|Overall Study|Randomized in error, not treated|0|||
126286675|NCT05026177|454336133|FG002|Overall Study|Randomized in error, not treated|2|||
126286676|NCT04856917|454336134|FG000|Overall Study|Withdrawal by Subject|4|||
126286677|NCT04856917|454336135|FG001|Overall Study|Withdrawal by Subject|3|||
126286678|NCT04856917|454336136|FG002|Overall Study|Withdrawal by Subject|1|||
126286679|NCT04856917|454336134|FG000|Overall Study|Lost to Follow-up|3|||
126286680|NCT04856917|454336135|FG001|Overall Study|Lost to Follow-up|1|||
126286681|NCT04856917|454336136|FG002|Overall Study|Lost to Follow-up|1|||
126286682|NCT04856917|454336134|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
126286683|NCT04856917|454336135|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
126286684|NCT04856917|454336136|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
126286685|NCT04856917|454336134|FG000|Overall Study|Other|1|||
126286686|NCT04856917|454336135|FG001|Overall Study|Other|1|||
126286687|NCT04856917|454336136|FG002|Overall Study|Other|0|||
126286688|NCT01169337|454336137|FG000|Overall Study|Lack of Efficacy|5|||
126286689|NCT01169337|454336138|FG001|Overall Study|Lack of Efficacy|7|||
126286690|NCT01169337|454336139|FG002|Overall Study|Lack of Efficacy|0|||
126286691|NCT01169337|454336137|FG000|Overall Study|Adverse Event|12|||
126286692|NCT01169337|454336138|FG001|Overall Study|Adverse Event|18|||
126286693|NCT01169337|454336139|FG002|Overall Study|Adverse Event|0|||
126286694|NCT01169337|454336137|FG000|Overall Study|Death|2|||
126286695|NCT01169337|454336138|FG001|Overall Study|Death|0|||
126286696|NCT01169337|454336139|FG002|Overall Study|Death|0|||
126286697|NCT01169337|454336137|FG000|Overall Study|Withdrawal by Subject|11|||
126286698|NCT01169337|454336138|FG001|Overall Study|Withdrawal by Subject|11|||
126286699|NCT01169337|454336139|FG002|Overall Study|Withdrawal by Subject|6|||
126286700|NCT01169337|454336137|FG000|Overall Study|Noncompliance|2|||
126286701|NCT01169337|454336138|FG001|Overall Study|Noncompliance|0|||
126286702|NCT01169337|454336139|FG002|Overall Study|Noncompliance|0|||
126286703|NCT01169337|454336137|FG000|Overall Study|Other complicating disease|1|||
126286704|NCT01169337|454336138|FG001|Overall Study|Other complicating disease|1|||
126286705|NCT01169337|454336139|FG002|Overall Study|Other complicating disease|0|||
126286706|NCT01169337|454336137|FG000|Overall Study|Physician Decision|1|||
126286707|NCT01169337|454336138|FG001|Overall Study|Physician Decision|5|||
126286708|NCT01169337|454336139|FG002|Overall Study|Physician Decision|0|||
126286709|NCT01169337|454336137|FG000|Overall Study|Alternative therapy|0|||
126286710|NCT01169337|454336138|FG001|Overall Study|Alternative therapy|2|||
126286711|NCT01169337|454336139|FG002|Overall Study|Alternative therapy|0|||
126286712|NCT01169337|454336137|FG000|Overall Study|Changed hospital|0|||
126286713|NCT01169337|454336138|FG001|Overall Study|Changed hospital|1|||
126286714|NCT01169337|454336139|FG002|Overall Study|Changed hospital|0|||
126286715|NCT01169337|454336137|FG000|Overall Study|Never started treatment|0|||
126286716|NCT01169337|454336138|FG001|Overall Study|Never started treatment|2|||
126286717|NCT01169337|454336139|FG002|Overall Study|Never started treatment|0|||
126286718|NCT01169337|454336137|FG000|Overall Study|Reason not reported|1|||
126286719|NCT01169337|454336138|FG001|Overall Study|Reason not reported|0|||
126286720|NCT01169337|454336139|FG002|Overall Study|Reason not reported|0|||
126286721|NCT01169337|454336137|FG000|Overall Study|Continuing lenalidomide|9|||
126286722|NCT01169337|454336138|FG001|Overall Study|Continuing lenalidomide|43|||
126286723|NCT01169337|454336139|FG002|Overall Study|Continuing lenalidomide|0|||
126286724|NCT03560037|454336140|FG000|Overall Study|Protocol Violation|1|||
126286725|NCT03560037|454336141|FG001|Overall Study|Protocol Violation|0|||
126286726|NCT03560037|454336140|FG000|Overall Study|Physician Decision|0|||
126286727|NCT03560037|454336141|FG001|Overall Study|Physician Decision|1|||
126286728|NCT03816878|454336142|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
126286729|NCT03816878|454336143|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
126286730|NCT03816878|454336142|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
126286731|NCT03816878|454336143|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
126549535|NCT01794117|455305677|FG003|Overall Study|Refused further treatment|0|||
126286732|NCT00588770|454336144|FG000|Overall Study|Disease progression|85|||
126286733|NCT00588770|454336145|FG001|Overall Study|Disease progression|68|||
126286734|NCT00588770|454336144|FG000|Overall Study|Adverse Event|29|||
126286735|NCT00588770|454336145|FG001|Overall Study|Adverse Event|58|||
126286736|NCT00588770|454336144|FG000|Overall Study|Death|13|||
126286737|NCT00588770|454336145|FG001|Overall Study|Death|22|||
126286738|NCT00588770|454336144|FG000|Overall Study|Withdrawal by Subject|15|||
126286739|NCT00588770|454336145|FG001|Overall Study|Withdrawal by Subject|25|||
126286740|NCT00588770|454336144|FG000|Overall Study|Alternative therapy|2|||
126286741|NCT00588770|454336145|FG001|Overall Study|Alternative therapy|4|||
126286742|NCT00588770|454336144|FG000|Overall Study|Other complicating disease|3|||
126286743|NCT00588770|454336145|FG001|Overall Study|Other complicating disease|2|||
126286744|NCT00588770|454336144|FG000|Overall Study|Not start protocol therapy|0|||
126286745|NCT00588770|454336145|FG001|Overall Study|Not start protocol therapy|9|||
126286746|NCT00588770|454336144|FG000|Overall Study|Lack of Efficacy|8|||
126286747|NCT00588770|454336145|FG001|Overall Study|Lack of Efficacy|10|||
126286748|NCT00588770|454336144|FG000|Overall Study|Physician discretion|2|||
126286749|NCT00588770|454336145|FG001|Overall Study|Physician discretion|0|||
126286750|NCT00588770|454336144|FG000|Overall Study|Patient non-compliance|2|||
126286751|NCT00588770|454336145|FG001|Overall Study|Patient non-compliance|2|||
126286752|NCT03698019|454336146|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
126286753|NCT03698019|454336147|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
126286754|NCT03698019|454336146|FG000|Step 1: Registration|Withdrawal by Subject|7|||
126286755|NCT03698019|454336147|FG001|Step 1: Registration|Withdrawal by Subject|2|||
126286756|NCT03698019|454336146|FG000|Step 1: Registration|Toxicity|0|||
126286757|NCT03698019|454336147|FG001|Step 1: Registration|Toxicity|1|||
126286758|NCT03698019|454336146|FG000|Step 1: Registration|Disease Progression|0|||
126286759|NCT03698019|454336147|FG001|Step 1: Registration|Disease Progression|12|||
126286760|NCT03698019|454336146|FG000|Step 1: Registration|Co-morbidities|0|||
126286761|NCT03698019|454336147|FG001|Step 1: Registration|Co-morbidities|1|||
126286762|NCT03698019|454336146|FG000|Step 1: Registration|Scheduling Issues|1|||
126286763|NCT03698019|454336147|FG001|Step 1: Registration|Scheduling Issues|0|||
126286764|NCT03698019|454336146|FG000|Step 1: Registration|Participant Refusal|0|||
126286765|NCT03698019|454336147|FG001|Step 1: Registration|Participant Refusal|1|||
126286766|NCT03698019|454336146|FG000|Step 2: Surgery|Participant Refusal|2|||
126286767|NCT03698019|454336147|FG001|Step 2: Surgery|Participant Refusal|1|||
126286768|NCT03698019|454336146|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
126286769|NCT03698019|454336147|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
126286770|NCT03698019|454336146|FG000|Step 2: Surgery|Metastatic Disease|16|||
126286771|NCT03698019|454336147|FG001|Step 2: Surgery|Metastatic Disease|9|||
126286772|NCT03698019|454336146|FG000|Step 2: Surgery|Residual Disease|2|||
126286773|NCT03698019|454336147|FG001|Step 2: Surgery|Residual Disease|1|||
126286774|NCT03698019|454336146|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
126286775|NCT03698019|454336147|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
126286776|NCT03698019|454336146|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
126286777|NCT03698019|454336147|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
126286778|NCT03698019|454336146|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
126286779|NCT03698019|454336147|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
126286780|NCT03698019|454336146|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
126286781|NCT03698019|454336147|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
126286782|NCT03698019|454336146|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
126286783|NCT03698019|454336147|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
126286784|NCT03698019|454336146|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
126286785|NCT03698019|454336147|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
126286786|NCT03698019|454336146|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
126286787|NCT03698019|454336147|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
126286788|NCT03698019|454336146|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
126286789|NCT03698019|454336147|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
126286790|NCT01856192|454336148|FG000|Overall Study|Adverse Event|12|||
126286791|NCT01856192|454336149|FG001|Overall Study|Adverse Event|4|||
126286792|NCT01856192|454336148|FG000|Overall Study|Alternative therapy|0|||
126286793|NCT01856192|454336149|FG001|Overall Study|Alternative therapy|3|||
126286794|NCT01856192|454336148|FG000|Overall Study|Death|3|||
126286795|NCT01856192|454336149|FG001|Overall Study|Death|5|||
126286796|NCT01856192|454336148|FG000|Overall Study|Lack of Efficacy|0|||
126286797|NCT01856192|454336149|FG001|Overall Study|Lack of Efficacy|5|||
126286798|NCT01856192|454336148|FG000|Overall Study|Withdrawal by Subject|1|||
126286799|NCT01856192|454336149|FG001|Overall Study|Withdrawal by Subject|1|||
126286800|NCT01856192|454336148|FG000|Overall Study|Other diseases|1|||
126286801|NCT01856192|454336149|FG001|Overall Study|Other diseases|0|||
126286802|NCT01856192|454336148|FG000|Overall Study|Never started treatment|7|||
126286803|NCT01856192|454336149|FG001|Overall Study|Never started treatment|5|||
126286804|NCT01856192|454336148|FG000|Overall Study|Path ineligible|20|||
126286805|NCT01856192|454336149|FG001|Overall Study|Path ineligible|34|||
126286806|NCT01856192|454336148|FG000|Overall Study|Non-path ineligible|2|||
126286807|NCT01856192|454336149|FG001|Overall Study|Non-path ineligible|2|||
126286808|NCT01856192|454336148|FG000|Overall Study|Physician Decision|1|||
126286809|NCT01856192|454336149|FG001|Overall Study|Physician Decision|1|||
126286810|NCT01856192|454336148|FG000|Overall Study|Suspicion of progressive disease|1|||
126286811|NCT01856192|454336149|FG001|Overall Study|Suspicion of progressive disease|0|||
126286812|NCT01856192|454336148|FG000|Overall Study|Non-compliance|1|||
126286813|NCT01856192|454336149|FG001|Overall Study|Non-compliance|0|||
126286814|NCT02642042|454336150|FG000|Overall Study|Adverse Event|22|||
126286815|NCT02642042|454336150|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
126286816|NCT02642042|454336150|FG000|Overall Study|Progression/Relapse|28|||
126286817|NCT02642042|454336150|FG000|Overall Study|Death|1|||
126286818|NCT02642042|454336150|FG000|Overall Study|Not Protocol Specified|2|||
126286819|NCT04976621|454336151|FG000|Overall Study|Lost to Follow-up|2|||
126286820|NCT04976621|454336152|FG001|Overall Study|Lost to Follow-up|1|||
126286821|NCT04976621|454336151|FG000|Overall Study|Withdrawal by Subject|1|||
126286822|NCT04976621|454336152|FG001|Overall Study|Withdrawal by Subject|0|||
126286823|NCT03348631|454336155|FG000|Overall Study|Not Eligible, No treatment|0|||
126286824|NCT03348631|454336156|FG001|Overall Study|Not Eligible, No treatment|1|||
126286825|NCT03348631|454336155|FG000|Overall Study|Not Eligible, Treated|2|||
126286826|NCT03348631|454336156|FG001|Overall Study|Not Eligible, Treated|0|||
126286827|NCT03348631|454336155|FG000|Overall Study|Eligible, No Treatment|1|||
126286828|NCT03348631|454336156|FG001|Overall Study|Eligible, No Treatment|0|||
126286829|NCT05223920|454336164|FG000|Overall Study|Adverse Event|6|||
126286830|NCT05223920|454336165|FG001|Overall Study|Adverse Event|3|||
126286831|NCT05223920|454336164|FG000|Overall Study|Death|2|||
126286832|NCT05223920|454336165|FG001|Overall Study|Death|0|||
126286833|NCT05223920|454336164|FG000|Overall Study|Disease Progression|1|||
126286834|NCT05223920|454336165|FG001|Overall Study|Disease Progression|2|||
126286835|NCT05223920|454336164|FG000|Overall Study|Physician Decision|1|||
126286836|NCT05223920|454336165|FG001|Overall Study|Physician Decision|2|||
126286837|NCT05223920|454336164|FG000|Overall Study|Sponsor decision|11|||
126286838|NCT05223920|454336165|FG001|Overall Study|Sponsor decision|9|||
126286839|NCT05223920|454336164|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
126286840|NCT05223920|454336165|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
126286841|NCT05223920|454336164|FG000|Overall Study|Subject decision|1|||
126286842|NCT05223920|454336165|FG001|Overall Study|Subject decision|0|||
126286843|NCT05223920|454336164|FG000|Overall Study|Withdrawal by Subject|1|||
126286844|NCT05223920|454336165|FG001|Overall Study|Withdrawal by Subject|6|||
126286845|NCT03790657|454336166|FG000|Overall Study|Adverse Event|1|||
126286846|NCT03790657|454336167|FG001|Overall Study|Adverse Event|1|||
126286847|NCT03790657|454336166|FG000|Overall Study|Withdrawal by Subject|1|||
126286848|NCT03790657|454336167|FG001|Overall Study|Withdrawal by Subject|1|||
126286849|NCT03154125|454336168|FG000|Overall Study|Lost to Follow-up|11|||
126286850|NCT03154125|454336169|FG001|Overall Study|Lost to Follow-up|11|||
126286851|NCT03154125|454336170|FG002|Overall Study|Lost to Follow-up|0|||
126286852|NCT03154125|454336168|FG000|Overall Study|Withdrawal by Subject|49|||
126286853|NCT03154125|454336169|FG001|Overall Study|Withdrawal by Subject|55|||
126286854|NCT03154125|454336170|FG002|Overall Study|Withdrawal by Subject|8|||
126286855|NCT03154125|454336168|FG000|Overall Study|Physician Decision|13|||
126286856|NCT03154125|454336169|FG001|Overall Study|Physician Decision|6|||
126286857|NCT03154125|454336170|FG002|Overall Study|Physician Decision|0|||
126286858|NCT03154125|454336168|FG000|Overall Study|Protocol Violation|3|||
126286859|NCT03154125|454336169|FG001|Overall Study|Protocol Violation|5|||
126286860|NCT03154125|454336170|FG002|Overall Study|Protocol Violation|0|||
126286861|NCT05219448|454336171|FG000|Overall Study|Lost to Follow-up|9|||
126286862|NCT05219448|454336172|FG001|Overall Study|Lost to Follow-up|0|||
126286863|NCT02287922|454336173|FG000|Overall Study|Adverse Event|1|||
126286864|NCT02287922|454336174|FG001|Overall Study|Adverse Event|1|||
126286865|NCT02287922|454336175|FG002|Overall Study|Adverse Event|3|||
126286866|NCT02287922|454336176|FG003|Overall Study|Adverse Event|4|||
126286867|NCT02287922|454336173|FG000|Overall Study|Withdrawal by Subject|1|||
126286868|NCT02287922|454336174|FG001|Overall Study|Withdrawal by Subject|1|||
126286869|NCT02287922|454336175|FG002|Overall Study|Withdrawal by Subject|1|||
126457128|NCT04531462|454974815|FG001|Overall Study|Withdrawal by Subject|1|||
126457129|NCT04531462|454974814|FG000|Overall Study|Adverse Event|3|||
126457130|NCT04531462|454974815|FG001|Overall Study|Adverse Event|3|||
126457131|NCT00504582|454974816|FG000|Overall Study|Lost to Follow-up|1|||
126457132|NCT00504582|454974817|FG001|Overall Study|Lost to Follow-up|0|||
126457133|NCT00504582|454974818|FG002|Overall Study|Lost to Follow-up|0|||
126457134|NCT02292784|454974821|FG000|Overall Study|Lost to Follow-up|1|||
126457135|NCT02292784|454974822|FG001|Overall Study|Lost to Follow-up|17|||
126457136|NCT02292784|454974823|FG002|Overall Study|Lost to Follow-up|18|||
126457137|NCT02292784|454974821|FG000|Overall Study|Withdrawal by Subject|0|||
126457138|NCT02292784|454974822|FG001|Overall Study|Withdrawal by Subject|3|||
126457139|NCT02292784|454974823|FG002|Overall Study|Withdrawal by Subject|3|||
126457140|NCT00348933|454974824|FG000|Overall Study|Withdrawal by Subject|10|||
126457141|NCT00348933|454974824|FG000|Overall Study|Lost to Follow-up|6|||
126457142|NCT00348933|454974824|FG000|Overall Study|Protocol Violation|2|||
126549536|NCT02322814|455305678|FG000|Overall Study|Death|7|||
126549537|NCT02322814|455305679|FG001|Overall Study|Death|29|||
126286870|NCT02287922|454336176|FG003|Overall Study|Withdrawal by Subject|2|||
126286871|NCT02287922|454336173|FG000|Overall Study|Lost to Follow-up|0|||
126286872|NCT02287922|454336174|FG001|Overall Study|Lost to Follow-up|0|||
126286873|NCT02287922|454336175|FG002|Overall Study|Lost to Follow-up|1|||
126286874|NCT02287922|454336176|FG003|Overall Study|Lost to Follow-up|0|||
126286875|NCT02287922|454336173|FG000|Overall Study|Sponsor's decision|0|||
126286876|NCT02287922|454336174|FG001|Overall Study|Sponsor's decision|0|||
126286877|NCT02287922|454336175|FG002|Overall Study|Sponsor's decision|0|||
126286878|NCT02287922|454336176|FG003|Overall Study|Sponsor's decision|1|||
126457143|NCT00348933|454974824|FG000|Overall Study|Adverse Event|7|||
126286879|NCT02287922|454336173|FG000|Overall Study|Other|1|||
126286880|NCT02287922|454336174|FG001|Overall Study|Other|0|||
126286881|NCT02287922|454336175|FG002|Overall Study|Other|2|||
126286882|NCT02287922|454336176|FG003|Overall Study|Other|0|||
126286883|NCT00668317|454336177|FG000|Overall Study|Adverse Event|2|||
126286884|NCT04186845|454336196|FG000|Overall Study|Death|2|||
126286885|NCT04186845|454336196|FG000|Overall Study|Lost to Follow-up|1|||
126286886|NCT04186845|454336196|FG000|Overall Study|Physician Decision|1|||
126286887|NCT04186845|454336196|FG000|Overall Study|Protocol Violation|1|||
126286888|NCT04186845|454336196|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
126286889|NCT04186845|454336196|FG000|Overall Study|Biopsy ordered but not done|1|||
126286890|NCT04186845|454336196|FG000|Overall Study|It was previously confirmed|1|||
126286891|NCT04186845|454336196|FG000|Overall Study|Patient cancelled scheduled scans|2|||
126286892|NCT04186845|454336196|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
126286893|NCT04186845|454336196|FG000|Overall Study|Subject refused confirmatory imaging|1|||
126286894|NCT04186845|454336196|FG000|Overall Study|Too small to biopsy|1|||
126286895|NCT05061420|454336199|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
126286896|NCT05061420|454336200|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
126286897|NCT05061420|454336201|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
126286898|NCT05061420|454336199|FG000|Overall Study|Progressive disease|11|||
126286899|NCT05061420|454336200|FG001|Overall Study|Progressive disease|15|||
126286900|NCT05061420|454336201|FG002|Overall Study|Progressive disease|14|||
126286901|NCT05061420|454336199|FG000|Overall Study|Withdrawal by Subject|2|||
126286902|NCT05061420|454336200|FG001|Overall Study|Withdrawal by Subject|0|||
126286903|NCT05061420|454336201|FG002|Overall Study|Withdrawal by Subject|1|||
126286904|NCT05061420|454336199|FG000|Overall Study|Not related to COVID-19|2|||
126286905|NCT05061420|454336200|FG001|Overall Study|Not related to COVID-19|0|||
126286906|NCT05061420|454336201|FG002|Overall Study|Not related to COVID-19|0|||
126286907|NCT01814553|454336202|FG000|Overall Study|PD per clinical progression|6|||
126286908|NCT01814553|454336203|FG001|Overall Study|PD per clinical progression|8|||
126286909|NCT01814553|454336202|FG000|Overall Study|Other Adverse Event|4|||
126286910|NCT01814553|454336203|FG001|Overall Study|Other Adverse Event|5|||
126286911|NCT01814553|454336202|FG000|Overall Study|Withdrawal by Subject|1|||
126286912|NCT01814553|454336203|FG001|Overall Study|Withdrawal by Subject|1|||
126286913|NCT01814553|454336202|FG000|Overall Study|Other than stated|7|||
126286914|NCT01814553|454336203|FG001|Overall Study|Other than stated|8|||
126286915|NCT04138823|454336204|FG000|Overall Study|Clinical disease progression|0|||
126286916|NCT04138823|454336205|FG001|Overall Study|Clinical disease progression|0|||
126286917|NCT04138823|454336206|FG002|Overall Study|Clinical disease progression|1|||
126286918|NCT04138823|454336204|FG000|Overall Study|Objective disease progression|3|||
126286919|NCT04138823|454336205|FG001|Overall Study|Objective disease progression|2|||
126286920|NCT04138823|454336206|FG002|Overall Study|Objective disease progression|5|||
126457144|NCT01264081|454974825|FG000|Participants Screened|Screening failures|30|||
126457145|NCT01264081|454974825|FG000|Started Treatment|Withdrawal by Subject|1|||
126457146|NCT01264081|454974825|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
126457147|NCT01489111|454974826|FG000|Overall Study|Withdrawal criterion|1|||
126457148|NCT00134784|454974827|FG000|Overall Study|Withdrawal by Subject|2|||
126457149|NCT00134784|454974828|FG001|Overall Study|Withdrawal by Subject|2|||
126457150|NCT00134784|454974829|FG002|Overall Study|Withdrawal by Subject|2|||
126457151|NCT00134784|454974830|FG003|Overall Study|Withdrawal by Subject|1|||
126457152|NCT03811093|454974832|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
126457153|NCT03811093|454974833|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
126457154|NCT03811093|454974832|FG000|Overall Study|Unable to measure body fat percentage|2|||
126457155|NCT03811093|454974833|FG001|Overall Study|Unable to measure body fat percentage|0|||
126457156|NCT00464490|454974834|FG000|Overall Study|Physician Decision|11|||
126457157|NCT00464490|454974835|FG001|Overall Study|Physician Decision|11|||
126457158|NCT03188042|454974836|FG000|Overall Study|Withdrawal by Subject|1|||
126457159|NCT03188042|454974837|FG001|Overall Study|Withdrawal by Subject|1|||
126457160|NCT01534182|454974843|FG000|Overall Study|Administrative problems|1|||
126457161|NCT01534182|454974844|FG001|Overall Study|Administrative problems|0|||
126457162|NCT01534182|454974843|FG000|Overall Study|Withdrawal by Subject|4|||
126457163|NCT01534182|454974844|FG001|Overall Study|Withdrawal by Subject|7|||
126286921|NCT02859142|454336207|FG000|Overall Study|Adverse Event|1|||
126457164|NCT01534182|454974843|FG000|Overall Study|Adverse Event|7|||
126286922|NCT02859142|454336208|FG001|Overall Study|Adverse Event|2|||
126286923|NCT02859142|454336207|FG000|Overall Study|Lost to Follow-up|1|||
126286924|NCT02859142|454336208|FG001|Overall Study|Lost to Follow-up|4|||
126286925|NCT02859142|454336207|FG000|Overall Study|Withdrawal by Subject|2|||
126286926|NCT02859142|454336208|FG001|Overall Study|Withdrawal by Subject|0|||
126457165|NCT01534182|454974844|FG001|Overall Study|Adverse Event|3|||
126457166|NCT04098224|454974846|FG000|Overall Study|Adverse Event|1|||
126457167|NCT04098224|454974847|FG001|Overall Study|Adverse Event|0|||
126457168|NCT04098224|454974846|FG000|Overall Study|Physician Decision|1|||
126286927|NCT02859142|454336207|FG000|Overall Study|Scheduling difficulties|0|||
126286928|NCT02859142|454336208|FG001|Overall Study|Scheduling difficulties|3|||
126286929|NCT03290079|454336209|FG000|Overall Study|Death|2|||
126286930|NCT02466685|454336210|FG000|Overall Study|Adverse Event|5|||
126286931|NCT02466685|454336211|FG001|Overall Study|Adverse Event|2|||
126286932|NCT02466685|454336210|FG000|Overall Study|Lost to Follow-up|1|||
126286933|NCT02466685|454336211|FG001|Overall Study|Lost to Follow-up|1|||
126286934|NCT02466685|454336210|FG000|Overall Study|Withdrawal by Subject|1|||
126286935|NCT02466685|454336211|FG001|Overall Study|Withdrawal by Subject|0|||
126286936|NCT02466685|454336210|FG000|Overall Study|Physician Decision|1|||
126286937|NCT02466685|454336211|FG001|Overall Study|Physician Decision|1|||
126286938|NCT03340974|454336212|FG000|Completion of Study -Long Term Follow up|Death|8|||
126286939|NCT03340974|454336213|FG001|Completion of Study -Long Term Follow up|Death|5|||
126286940|NCT03340974|454336214|FG002|Completion of Study -Long Term Follow up|Death|5|||
126286941|NCT03340974|454336215|FG003|Completion of Study -Long Term Follow up|Death|7|||
126286942|NCT03340974|454336212|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
126286943|NCT03340974|454336213|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
126286944|NCT03340974|454336214|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
126286945|NCT03340974|454336215|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
126286946|NCT03340974|454336212|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
126286947|NCT03340974|454336213|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
126286948|NCT03340974|454336214|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
126286949|NCT03340974|454336215|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
126286950|NCT03340974|454336212|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
126286951|NCT03340974|454336213|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
126286952|NCT03340974|454336214|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
126286953|NCT03340974|454336215|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
126286954|NCT04877457|454336220|FG000|Overall Study|Early termination of study due to low enrollment|2|||
126286955|NCT04877457|454336221|FG001|Overall Study|Early termination of study due to low enrollment|1|||
126286956|NCT04697069|454336222|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
126286957|NCT04697069|454336223|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
126286958|NCT04697069|454336222|FG000|Overall Study|Study termination|2|||
126286959|NCT04697069|454336223|FG001|Overall Study|Study termination|1|||
126286960|NCT05180227|454336224|FG000|Overall Study|Hypertension at screening|1|||
126286961|NCT05180227|454336224|FG000|Overall Study|Lost to Follow-up|1|||
126286962|NCT04739800|454336225|FG000|Overall Study|Adverse Event|2|||
126286963|NCT04739800|454336226|FG001|Overall Study|Adverse Event|1|||
126286964|NCT04739800|454336227|FG002|Overall Study|Adverse Event|4|||
126286965|NCT04739800|454336228|FG003|Overall Study|Adverse Event|5|||
126286966|NCT04739800|454336225|FG000|Overall Study|Never Treated|2|||
126286967|NCT04739800|454336226|FG001|Overall Study|Never Treated|0|||
126286968|NCT04739800|454336227|FG002|Overall Study|Never Treated|1|||
126286969|NCT04739800|454336228|FG003|Overall Study|Never Treated|1|||
126286970|NCT04739800|454336225|FG000|Overall Study|On Treatment|5|||
126286971|NCT04739800|454336226|FG001|Overall Study|On Treatment|9|||
126286972|NCT04739800|454336227|FG002|Overall Study|On Treatment|9|||
126286973|NCT04739800|454336228|FG003|Overall Study|On Treatment|9|||
126286974|NCT04739800|454336225|FG000|Overall Study|Symptomatic Deterioration|1|||
126286975|NCT04739800|454336226|FG001|Overall Study|Symptomatic Deterioration|1|||
126286976|NCT04739800|454336227|FG002|Overall Study|Symptomatic Deterioration|3|||
126286977|NCT04739800|454336228|FG003|Overall Study|Symptomatic Deterioration|0|||
126286978|NCT04739800|454336225|FG000|Overall Study|Withdrawal by Subject|1|||
126286979|NCT04739800|454336226|FG001|Overall Study|Withdrawal by Subject|2|||
126286980|NCT04739800|454336227|FG002|Overall Study|Withdrawal by Subject|1|||
126286981|NCT04739800|454336228|FG003|Overall Study|Withdrawal by Subject|3|||
126286982|NCT04739800|454336225|FG000|Overall Study|Other Reason|1|||
126286983|NCT04739800|454336226|FG001|Overall Study|Other Reason|3|||
126286984|NCT04739800|454336227|FG002|Overall Study|Other Reason|5|||
126286985|NCT04739800|454336228|FG003|Overall Study|Other Reason|4|||
126286986|NCT02779855|454336229|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
126286987|NCT02779855|454336230|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
126286988|NCT02779855|454336231|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
126286989|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
126286990|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Off-label use|283|||
126286991|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
126286992|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
126286993|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
126365533|NCT01817777|454632802|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
126365534|NCT01817777|454632803|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
126365535|NCT01817777|454632801|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
126365536|NCT01817777|454632802|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
126365537|NCT01817777|454632803|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
126286994|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
126549538|NCT02322814|455305680|FG002|Overall Study|Death|32|||
126710337|NCT03060577|455891599|FG001|Overall Study|Adverse Event|1|||
126710338|NCT03060577|455891598|FG000|Overall Study|Inclusion/Exclusion|1|||
126710339|NCT03060577|455891599|FG001|Overall Study|Inclusion/Exclusion|0|||
126710340|NCT03060577|455891598|FG000|Overall Study|Other|8|||
126286995|NCT01070953|454336234|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
126286996|NCT01070953|454336234|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
126286997|NCT01070953|454336234|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
126286998|NCT01070953|454336234|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
126286999|NCT03514017|454336236|FG000|Overall Study|Death|1|||
126287000|NCT03514017|454336236|FG000|Overall Study|Adverse Event|1|||
126287001|NCT01290302|454337609|FG000|Overall Study|Adverse Event|2|||
126287002|NCT01290302|454337610|FG001|Overall Study|Adverse Event|0|||
126287003|NCT01290302|454337609|FG000|Overall Study|Withdrawal by Subject|1|||
126287004|NCT01290302|454337610|FG001|Overall Study|Withdrawal by Subject|0|||
126287005|NCT01290302|454337609|FG000|Overall Study|Physician Decision|0|||
126287006|NCT01290302|454337610|FG001|Overall Study|Physician Decision|2|||
126287007|NCT01290302|454337609|FG000|Overall Study|Expiration of time for screening window|1|||
126287008|NCT01290302|454337610|FG001|Overall Study|Expiration of time for screening window|0|||
126287009|NCT01059786|454337611|FG000|Overall Study|Did not receive 6 cycles.|0|||
126287010|NCT01059786|454337612|FG001|Overall Study|Did not receive 6 cycles.|0|||
126287011|NCT01059786|454337613|FG002|Overall Study|Did not receive 6 cycles.|4|||
126287012|NCT01059786|454337614|FG003|Overall Study|Did not receive 6 cycles.|1|||
126287013|NCT01059786|454337615|FG004|Overall Study|Did not receive 6 cycles.|0|||
126287014|NCT02586688|454337618|FG000|Overall Study|Lost to Follow-up|2|||
126287015|NCT02586688|454337619|FG001|Overall Study|Lost to Follow-up|1|||
126287016|NCT02586688|454337618|FG000|Overall Study|Withdrawal by Subject|1|||
126287017|NCT02586688|454337619|FG001|Overall Study|Withdrawal by Subject|1|||
126287018|NCT02586688|454337618|FG000|Overall Study|Adverse Event|3|||
126457169|NCT04098224|454974847|FG001|Overall Study|Physician Decision|0|||
126457170|NCT04098224|454974846|FG000|Overall Study|Patient not required enteral feeding|1|||
126457171|NCT04098224|454974847|FG001|Overall Study|Patient not required enteral feeding|0|||
126457172|NCT04098224|454974846|FG000|Overall Study|Patient failure nasogastric tube|1|||
126457173|NCT04098224|454974847|FG001|Overall Study|Patient failure nasogastric tube|0|||
126457174|NCT04098224|454974846|FG000|Overall Study|Patient early extubation|1|||
126457175|NCT04098224|454974847|FG001|Overall Study|Patient early extubation|3|||
126457176|NCT01587898|454974855|FG000|Overall Study|Adverse Event|1|||
126457177|NCT01587898|454974856|FG001|Overall Study|Adverse Event|1|||
126457178|NCT01587898|454974857|FG002|Overall Study|Adverse Event|0|||
126457179|NCT01587898|454974858|FG003|Overall Study|Adverse Event|0|||
126457180|NCT01587898|454974855|FG000|Overall Study|Protocol Violation|0|||
126457181|NCT01587898|454974856|FG001|Overall Study|Protocol Violation|2|||
126457182|NCT01587898|454974857|FG002|Overall Study|Protocol Violation|1|||
126457183|NCT01587898|454974858|FG003|Overall Study|Protocol Violation|1|||
126457184|NCT01587898|454974855|FG000|Overall Study|Lost to Follow-up|0|||
126457185|NCT01587898|454974856|FG001|Overall Study|Lost to Follow-up|0|||
126457186|NCT01587898|454974857|FG002|Overall Study|Lost to Follow-up|0|||
126457187|NCT01587898|454974858|FG003|Overall Study|Lost to Follow-up|1|||
126457188|NCT01587898|454974855|FG000|Overall Study|Withdrawal by Subject|2|||
126457189|NCT01587898|454974856|FG001|Overall Study|Withdrawal by Subject|1|||
126457190|NCT01587898|454974857|FG002|Overall Study|Withdrawal by Subject|0|||
126457191|NCT01587898|454974858|FG003|Overall Study|Withdrawal by Subject|0|||
126457192|NCT01587898|454974855|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
126457193|NCT01587898|454974856|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
126457194|NCT01587898|454974857|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
126457195|NCT01587898|454974858|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
126457196|NCT00502203|454974859|FG000|Overall Study|Inevaluable|1|||
126457197|NCT01903252|454974862|FG000|Double-Blind Induction|Adverse Event|20|||
126457198|NCT01903252|454974863|FG001|Double-Blind Induction|Adverse Event|18|||
126457199|NCT01903252|454974864|FG002|Double-Blind Induction|Adverse Event|0|||
126457200|NCT01903252|454974865|FG003|Double-Blind Induction|Adverse Event|0|||
126457201|NCT01903252|454974866|FG004|Double-Blind Induction|Adverse Event|0|||
126457202|NCT01903252|454974867|FG005|Double-Blind Induction|Adverse Event|0|||
126457203|NCT01903252|454974862|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
126457204|NCT01903252|454974863|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
126457205|NCT01903252|454974864|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
126457206|NCT01903252|454974865|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
126457207|NCT01903252|454974866|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
126457208|NCT01903252|454974867|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
126457209|NCT01903252|454974862|FG000|Double-Blind Induction|Physician Decision|2|||
126457210|NCT01903252|454974863|FG001|Double-Blind Induction|Physician Decision|3|||
126549539|NCT02322814|455305681|FG003|Overall Study|Death|23|||
126710341|NCT03060577|455891599|FG001|Overall Study|Other|2|||
126287019|NCT02586688|454337619|FG001|Overall Study|Adverse Event|1|||
126287020|NCT02454608|454337620|FG000|Double-Blind Period|Lack of Efficacy|0|||
126287021|NCT02454608|454337621|FG001|Double-Blind Period|Lack of Efficacy|2|||
126287022|NCT02454608|454337622|FG002|Double-Blind Period|Lack of Efficacy|0|||
126287023|NCT02454608|454337620|FG000|Open Label Period|Lost to Follow-up|0|||
126287024|NCT02454608|454337621|FG001|Open Label Period|Lost to Follow-up|0|||
126287025|NCT02454608|454337622|FG002|Open Label Period|Lost to Follow-up|11|||
126287026|NCT02454608|454337620|FG000|Open Label Period|Withdrawal by Subject|0|||
126287027|NCT02454608|454337621|FG001|Open Label Period|Withdrawal by Subject|0|||
126287028|NCT02454608|454337622|FG002|Open Label Period|Withdrawal by Subject|8|||
126287029|NCT01433055|454337623|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
126287030|NCT01433055|454337624|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
126287031|NCT01433055|454337623|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
126287032|NCT01433055|454337624|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
126287033|NCT03573830|454337628|FG000|Overall Study|Dropped without completing treatment|0|||
126287034|NCT03573830|454337629|FG001|Overall Study|Dropped without completing treatment|7|||
126287035|NCT03573830|454337628|FG000|Overall Study|Lost to Follow-up|4|||
126287036|NCT03573830|454337629|FG001|Overall Study|Lost to Follow-up|0|||
126287037|NCT01769456|454337630|FG000|Overall Study|Lost to Follow-up|19|||
126287038|NCT01769456|454337630|FG000|Overall Study|Withdrawal by Subject|3|||
126287039|NCT01769456|454337630|FG000|Overall Study|Did not receive PCC intervention|6|||
126287040|NCT01769456|454337630|FG000|Overall Study|Moved out of the area|3|||
126287041|NCT01769456|454337630|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
126287042|NCT01769456|454337630|FG000|Overall Study|Parental request to youth to withdraw|1|||
126287043|NCT02847260|454337637|FG000|Overall Study|Adverse Event|3|||
126287044|NCT02847260|454337637|FG000|Overall Study|Withdrawal by Subject|2|||
126287045|NCT02847260|454337637|FG000|Overall Study|Clinical Deterioration|1|||
126287046|NCT02847260|454337637|FG000|Overall Study|Physician Decision|1|||
126287047|NCT01692626|454337639|FG000|Overall Study|Death|0|||
126287048|NCT01692626|454337640|FG001|Overall Study|Death|1|||
126287049|NCT01692626|454337639|FG000|Overall Study|Adverse Event|2|||
126287050|NCT01692626|454337640|FG001|Overall Study|Adverse Event|3|||
126287051|NCT01692626|454337639|FG000|Overall Study|Protocol Violation|1|||
126287052|NCT01692626|454337640|FG001|Overall Study|Protocol Violation|2|||
126287053|NCT01692626|454337639|FG000|Overall Study|Withdrawal by Subject|1|||
126287054|NCT01692626|454337640|FG001|Overall Study|Withdrawal by Subject|0|||
126287055|NCT05490771|454337641|FG000|Overall Study|Disease progression|18|||
126287056|NCT05490771|454337641|FG000|Overall Study|Adverse Event|3|||
126287057|NCT05490771|454337641|FG000|Overall Study|Other complicating disease|1|||
126287058|NCT05490771|454337641|FG000|Overall Study|Withdrawal by Subject|3|||
126287059|NCT05490771|454337641|FG000|Overall Study|Physician Decision|1|||
126287060|NCT05490771|454337641|FG000|Overall Study|Still on treatment|2|||
126287061|NCT05490771|454337641|FG000|Overall Study|Never start protocol therapy|5|||
126287062|NCT05490771|454337641|FG000|Overall Study|Ineligible|2|||
126365538|NCT00557440|454632804|FG000|Treatment Period 1|Adverse Event|0|||
126365539|NCT00557440|454632805|FG001|Treatment Period 1|Adverse Event|0|||
126365540|NCT00557440|454632806|FG002|Treatment Period 1|Adverse Event|1|||
126365541|NCT03524157|454632807|FG000|Overall Study|cytology not readable|0|||
126365542|NCT03524157|454632808|FG001|Overall Study|cytology not readable|0|||
126365543|NCT03524157|454632809|FG002|Overall Study|cytology not readable|1|||
126365544|NCT01592747|454632810|FG000|Overall Study|Loss of Therapeutic Response|107|||
126365545|NCT01592747|454632811|FG001|Overall Study|Loss of Therapeutic Response|108|||
126365546|NCT01592747|454632812|FG002|Overall Study|Loss of Therapeutic Response|100|||
126365547|NCT01592747|454632810|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
126365548|NCT01592747|454632811|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
126365549|NCT01592747|454632812|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
126365550|NCT01592747|454632810|FG000|Overall Study|Adverse Event|1|||
126365551|NCT01592747|454632811|FG001|Overall Study|Adverse Event|0|||
126365552|NCT01592747|454632812|FG002|Overall Study|Adverse Event|0|||
126365553|NCT01592747|454632810|FG000|Overall Study|Protocol Violation|4|||
126365554|NCT01592747|454632811|FG001|Overall Study|Protocol Violation|0|||
126365555|NCT01592747|454632812|FG002|Overall Study|Protocol Violation|4|||
126365556|NCT01592747|454632810|FG000|Overall Study|Lack of Efficacy|0|||
126365557|NCT01592747|454632811|FG001|Overall Study|Lack of Efficacy|1|||
126287063|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
126365558|NCT01592747|454632812|FG002|Overall Study|Lack of Efficacy|0|||
126365559|NCT01592747|454632810|FG000|Overall Study|Withdrawal by Subject|2|||
126365560|NCT01592747|454632811|FG001|Overall Study|Withdrawal by Subject|0|||
126365561|NCT01592747|454632812|FG002|Overall Study|Withdrawal by Subject|2|||
126365562|NCT01592747|454632810|FG000|Overall Study|Lost to Follow-up|1|||
126365563|NCT01592747|454632811|FG001|Overall Study|Lost to Follow-up|0|||
126365564|NCT01592747|454632812|FG002|Overall Study|Lost to Follow-up|1|||
126287064|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
126365565|NCT01592747|454632810|FG000|Overall Study|Other Reasons|1|||
126365566|NCT01592747|454632811|FG001|Overall Study|Other Reasons|1|||
126365567|NCT01592747|454632812|FG002|Overall Study|Other Reasons|0|||
126287065|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
126365568|NCT02853136|454632813|FG000|Wash-out|Adverse Event|0|||
126365569|NCT02853136|454632814|FG001|Wash-out|Adverse Event|0|||
126365570|NCT02853136|454632815|FG002|Wash-out|Adverse Event|0|||
126365571|NCT02853136|454632816|FG003|Wash-out|Adverse Event|1|||
126365572|NCT00867334|454632817|FG000|Overall Study|Withdrawal by Subject|0|||
126287066|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
126365573|NCT00867334|454632818|FG001|Overall Study|Withdrawal by Subject|1|||
126365574|NCT00867334|454632817|FG000|Overall Study|Withdrawal by Subject|1|||
126365575|NCT00867334|454632818|FG001|Overall Study|Withdrawal by Subject|0|||
126365576|NCT00867334|454632817|FG000|Overall Study|Withdrawal by Subject|1|||
126365577|NCT00867334|454632818|FG001|Overall Study|Withdrawal by Subject|0|||
126365578|NCT05418426|454632820|FG000|Overall Study|Adverse Event|0|||
126365579|NCT05418426|454632821|FG001|Overall Study|Adverse Event|1|||
126365580|NCT05418426|454632822|FG002|Overall Study|Adverse Event|0|||
126365581|NCT05418426|454632820|FG000|Overall Study|Withdrawal by Subject|0|||
126365582|NCT05418426|454632821|FG001|Overall Study|Withdrawal by Subject|1|||
126365583|NCT05418426|454632822|FG002|Overall Study|Withdrawal by Subject|0|||
126365584|NCT05418426|454632820|FG000|Overall Study|Protocol Violation|0|||
126365585|NCT05418426|454632821|FG001|Overall Study|Protocol Violation|0|||
126365586|NCT05418426|454632822|FG002|Overall Study|Protocol Violation|1|||
126365587|NCT04620668|454632823|FG000|Overall Study|Withdrawal by Subject|2|||
126365588|NCT04620668|454632824|FG001|Overall Study|Withdrawal by Subject|0|||
126365589|NCT04620668|454632823|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
126365590|NCT04620668|454632824|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
126365591|NCT04620668|454632823|FG000|Overall Study|Removed before analysis: missing data|2|||
126365592|NCT04620668|454632824|FG001|Overall Study|Removed before analysis: missing data|0|||
126365593|NCT04620668|454632823|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
126365594|NCT04620668|454632824|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
126365595|NCT04620668|454632823|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
126365596|NCT04620668|454632824|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
126365597|NCT02951819|454632829|FG000|Overall Study|Death|9|||
126365598|NCT02951819|454632830|FG001|Overall Study|Death|7|||
126365599|NCT02951819|454632829|FG000|Overall Study|Withdrawal by Subject|3|||
126365600|NCT02951819|454632830|FG001|Overall Study|Withdrawal by Subject|0|||
126365601|NCT02951819|454632829|FG000|Overall Study|Adverse Event|1|||
126365602|NCT02951819|454632830|FG001|Overall Study|Adverse Event|0|||
126365603|NCT02951819|454632829|FG000|Overall Study|Lack of Efficacy|4|||
126365604|NCT02951819|454632830|FG001|Overall Study|Lack of Efficacy|0|||
126365605|NCT02951819|454632829|FG000|Overall Study|Lost to Follow-up|1|||
126365606|NCT02951819|454632830|FG001|Overall Study|Lost to Follow-up|0|||
126365607|NCT02951819|454632829|FG000|Overall Study|Progressive Disease|1|||
126365608|NCT02951819|454632830|FG001|Overall Study|Progressive Disease|0|||
126365609|NCT02951819|454632829|FG000|Overall Study|Other|9|||
126365610|NCT02951819|454632830|FG001|Overall Study|Other|0|||
126365611|NCT01922895|454632835|FG000|Overall Study|Death|0|||
126287067|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
126287068|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
126365612|NCT01922895|454632836|FG001|Overall Study|Death|1|||
126365613|NCT01922895|454632835|FG000|Overall Study|Withdrawal by Subject|1|||
126365614|NCT01922895|454632836|FG001|Overall Study|Withdrawal by Subject|2|||
126365615|NCT01922895|454632835|FG000|Overall Study|Lost to Follow-up|5|||
126287069|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
126287070|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
126287071|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
126287072|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
126287073|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
126287074|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
126287075|NCT02422797|454337642|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
126287076|NCT02422797|454337643|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
126549540|NCT02322814|455305682|FG004|Overall Study|Death|14|||
126549541|NCT02322814|455305678|FG000|Overall Study|Lost to Follow-up|1|||
126287077|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
126287078|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
126287079|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
126287080|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
126365616|NCT01922895|454632836|FG001|Overall Study|Lost to Follow-up|11|||
126365617|NCT01916226|454632837|FG000|Overall Study|Adverse Event|1|||
126365618|NCT01916226|454632838|FG001|Overall Study|Adverse Event|0|||
126365619|NCT01916226|454632839|FG002|Overall Study|Adverse Event|1|||
126365620|NCT01916226|454632840|FG003|Overall Study|Adverse Event|1|||
126365621|NCT01916226|454632837|FG000|Overall Study|Lack of Efficacy|0|||
126365622|NCT01916226|454632838|FG001|Overall Study|Lack of Efficacy|0|||
126365623|NCT01916226|454632839|FG002|Overall Study|Lack of Efficacy|2|||
126365624|NCT01916226|454632840|FG003|Overall Study|Lack of Efficacy|1|||
126549542|NCT02322814|455305679|FG001|Overall Study|Lost to Follow-up|3|||
126549543|NCT02322814|455305680|FG002|Overall Study|Lost to Follow-up|3|||
126549544|NCT02322814|455305681|FG003|Overall Study|Lost to Follow-up|1|||
126549545|NCT02322814|455305682|FG004|Overall Study|Lost to Follow-up|0|||
126549546|NCT02322814|455305678|FG000|Overall Study|Various Reasons|2|||
126549547|NCT02322814|455305679|FG001|Overall Study|Various Reasons|0|||
126549548|NCT02322814|455305680|FG002|Overall Study|Various Reasons|1|||
126549549|NCT02322814|455305681|FG003|Overall Study|Various Reasons|1|||
126549550|NCT02322814|455305682|FG004|Overall Study|Various Reasons|0|||
126549551|NCT02322814|455305678|FG000|Overall Study|Progressive Disease|0|||
126549552|NCT02322814|455305679|FG001|Overall Study|Progressive Disease|0|||
126549553|NCT02322814|455305680|FG002|Overall Study|Progressive Disease|0|||
126549554|NCT02322814|455305681|FG003|Overall Study|Progressive Disease|1|||
126549555|NCT02322814|455305682|FG004|Overall Study|Progressive Disease|1|||
126549556|NCT02322814|455305678|FG000|Overall Study|Protocol Violation|1|||
126549557|NCT02322814|455305679|FG001|Overall Study|Protocol Violation|0|||
126549558|NCT02322814|455305680|FG002|Overall Study|Protocol Violation|0|||
126549559|NCT02322814|455305681|FG003|Overall Study|Protocol Violation|0|||
126549560|NCT02322814|455305682|FG004|Overall Study|Protocol Violation|0|||
126549561|NCT02322814|455305678|FG000|Overall Study|Study Terminated by Sponsor|0|||
126549562|NCT02322814|455305679|FG001|Overall Study|Study Terminated by Sponsor|7|||
126549563|NCT02322814|455305680|FG002|Overall Study|Study Terminated by Sponsor|9|||
126549564|NCT02322814|455305681|FG003|Overall Study|Study Terminated by Sponsor|5|||
126549565|NCT02322814|455305682|FG004|Overall Study|Study Terminated by Sponsor|13|||
126549566|NCT02322814|455305678|FG000|Overall Study|Withdrawal by Subject|5|||
126549567|NCT02322814|455305679|FG001|Overall Study|Withdrawal by Subject|4|||
126549568|NCT02322814|455305680|FG002|Overall Study|Withdrawal by Subject|2|||
126549569|NCT02322814|455305681|FG003|Overall Study|Withdrawal by Subject|1|||
126549570|NCT02322814|455305682|FG004|Overall Study|Withdrawal by Subject|3|||
126287081|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
126287082|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
126287083|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
126287084|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
126287085|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
126287086|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
126287087|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
126287088|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
126287089|NCT02422797|454337642|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
126287090|NCT02422797|454337643|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
126287091|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
126287092|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
126287093|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
126287094|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
126287095|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
126287096|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
126287097|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
126287098|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
126287099|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
126287100|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
126287101|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
126287102|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
126287103|NCT02422797|454337642|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
126287104|NCT02422797|454337643|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
126287105|NCT03126435|454337644|FG000|Overall Study|Death|90|||
126287106|NCT03126435|454337645|FG001|Overall Study|Death|84|||
126287107|NCT03126435|454337644|FG000|Overall Study|Lost to Follow-up|4|||
126287108|NCT03126435|454337645|FG001|Overall Study|Lost to Follow-up|3|||
126287109|NCT03126435|454337644|FG000|Overall Study|Physician Decision|0|||
126287110|NCT03126435|454337645|FG001|Overall Study|Physician Decision|1|||
126287111|NCT03126435|454337644|FG000|Overall Study|Withdrawal by Subject|6|||
126287112|NCT03126435|454337645|FG001|Overall Study|Withdrawal by Subject|12|||
126549571|NCT00118092|455305683|FG000|Overall Study|Withdrawal by Subject|1|||
126710342|NCT03216265|455891603|FG000|Overall Study|Adverse Event|2|||
126710343|NCT03216265|455891604|FG001|Overall Study|Adverse Event|0|||
126365625|NCT01916226|454632837|FG000|Overall Study|Protocol Violation|0|||
126549572|NCT00118092|455305683|FG000|Overall Study|Protocol Violation|1|||
126549573|NCT00591864|455305684|FG000|Overall Study|Incomplete Imaging|5|||
126549574|NCT02459093|455305685|FG000|Overall Study|Protocol Violation|6|||
126549575|NCT02459093|455305686|FG001|Overall Study|Protocol Violation|11|||
126549576|NCT02459093|455305685|FG000|Overall Study|Lost to Follow-up|6|||
126549577|NCT02459093|455305686|FG001|Overall Study|Lost to Follow-up|7|||
126549578|NCT01567865|455305692|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
126549579|NCT01567865|455305693|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
126549580|NCT01567865|455305694|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
126549581|NCT01567865|455305695|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
126549582|NCT01567865|455305692|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
126549583|NCT01567865|455305693|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
126549584|NCT01567865|455305694|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
126549585|NCT01567865|455305695|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
126549586|NCT00309608|455305704|FG000|Overall Study|Adverse Event|1|||
126287113|NCT03126435|454337644|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
126287114|NCT03126435|454337645|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
126287115|NCT02276807|454337648|FG000|Overall Study|Withdrawal by Subject|8|||
126287116|NCT02276807|454337649|FG001|Overall Study|Withdrawal by Subject|7|||
126287117|NCT02276807|454337648|FG000|Overall Study|Lost to Follow-up|10|||
126287118|NCT02276807|454337649|FG001|Overall Study|Lost to Follow-up|10|||
126287119|NCT03971474|454337650|FG000|Overall Study|Adverse Event|11|||
126287120|NCT03971474|454337651|FG001|Overall Study|Adverse Event|7|||
126287121|NCT03971474|454337650|FG000|Overall Study|Refusal unrelated to adverse event|5|||
126287122|NCT03971474|454337651|FG001|Overall Study|Refusal unrelated to adverse event|1|||
126287123|NCT03971474|454337650|FG000|Overall Study|Progression/relapse|40|||
126287124|NCT03971474|454337651|FG001|Overall Study|Progression/relapse|47|||
126287125|NCT03971474|454337650|FG000|Overall Study|Death|6|||
126287126|NCT03971474|454337651|FG001|Overall Study|Death|3|||
126287127|NCT03971474|454337650|FG000|Overall Study|Other - not protocol specified|5|||
126287128|NCT03971474|454337651|FG001|Overall Study|Other - not protocol specified|4|||
126287129|NCT03971474|454337650|FG000|Overall Study|On treatment|0|||
126287130|NCT03971474|454337651|FG001|Overall Study|On treatment|7|||
126287131|NCT00261950|454337652|FG000|Overall Study|Lost to Follow-up|2|||
126287132|NCT00261950|454337652|FG000|Overall Study|Death|6|||
126287133|NCT00261950|454337652|FG000|Overall Study|Withdrawal by Subject|5|||
126287134|NCT00261950|454337652|FG000|Overall Study|Other|1|||
126287135|NCT00261950|454337652|FG000|Overall Study|Physician Decision|1|||
126287136|NCT00261950|454337652|FG000|Overall Study|Protocol specified Criteria|11|||
126287137|NCT01937871|454337659|FG000|Overall Study|Adverse Event|6|||
126287138|NCT01937871|454337660|FG001|Overall Study|Adverse Event|6|||
126287139|NCT01937871|454337661|FG002|Overall Study|Adverse Event|2|||
126287140|NCT01937871|454337659|FG000|Overall Study|Lost to Follow-up|8|||
126287141|NCT01937871|454337660|FG001|Overall Study|Lost to Follow-up|2|||
126287142|NCT01937871|454337661|FG002|Overall Study|Lost to Follow-up|4|||
126287143|NCT01937871|454337659|FG000|Overall Study|Withdrawal by Subject|9|||
126549587|NCT00309608|455305705|FG001|Overall Study|Adverse Event|5|||
126710344|NCT03216265|455891605|FG002|Overall Study|Adverse Event|2|||
126710345|NCT03216265|455891603|FG000|Overall Study|Lost to Follow-up|0|||
126710346|NCT03216265|455891604|FG001|Overall Study|Lost to Follow-up|1|||
126710347|NCT03216265|455891605|FG002|Overall Study|Lost to Follow-up|0|||
126710348|NCT03216265|455891603|FG000|Overall Study|Withdrawal by Subject|0|||
126710349|NCT03216265|455891604|FG001|Overall Study|Withdrawal by Subject|0|||
126710350|NCT03216265|455891605|FG002|Overall Study|Withdrawal by Subject|1|||
126710351|NCT01277289|455891607|FG000|Overall Study|fragile vein|1|||
126710352|NCT01277289|455891608|FG001|Overall Study|fragile vein|0|||
126710353|NCT01277289|455891607|FG000|Overall Study|Physician Decision|1|||
126710354|NCT01277289|455891608|FG001|Overall Study|Physician Decision|0|||
126710355|NCT01277289|455891607|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
126710356|NCT01277289|455891608|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
126710357|NCT01277289|455891607|FG000|Overall Study|Protocol Violation|1|||
126710358|NCT01277289|455891608|FG001|Overall Study|Protocol Violation|1|||
126710359|NCT01277289|455891607|FG000|Overall Study|Adverse Event|2|||
126287144|NCT01937871|454337660|FG001|Overall Study|Withdrawal by Subject|6|||
126287145|NCT01937871|454337661|FG002|Overall Study|Withdrawal by Subject|4|||
126287146|NCT01937871|454337659|FG000|Overall Study|Physician Decision|0|||
126287147|NCT01937871|454337660|FG001|Overall Study|Physician Decision|1|||
126287148|NCT01937871|454337661|FG002|Overall Study|Physician Decision|0|||
126287149|NCT01937871|454337659|FG000|Overall Study|Entry Criteria Not Met|1|||
126287150|NCT01937871|454337660|FG001|Overall Study|Entry Criteria Not Met|2|||
126710360|NCT01277289|455891608|FG001|Overall Study|Adverse Event|1|||
126710361|NCT01277289|455891607|FG000|Overall Study|consent withdrawn|1|||
126287151|NCT01937871|454337661|FG002|Overall Study|Entry Criteria Not Met|1|||
126287152|NCT00577863|454337668|FG000|Overall Study|Adverse Event|4|||
126287153|NCT00577863|454337669|FG001|Overall Study|Adverse Event|2|||
126287154|NCT00577863|454337668|FG000|Overall Study|Death|1|||
126287155|NCT00577863|454337669|FG001|Overall Study|Death|0|||
126287156|NCT00577863|454337668|FG000|Overall Study|Lost to Follow-up|2|||
126287157|NCT00577863|454337669|FG001|Overall Study|Lost to Follow-up|2|||
126287158|NCT00577863|454337668|FG000|Overall Study|Entry Criteria Exclusion|1|||
126287159|NCT00577863|454337669|FG001|Overall Study|Entry Criteria Exclusion|0|||
126549588|NCT00309608|455305706|FG002|Overall Study|Adverse Event|3|||
126549589|NCT00309608|455305707|FG003|Overall Study|Adverse Event|2|||
126710362|NCT01277289|455891608|FG001|Overall Study|consent withdrawn|1|||
126287160|NCT00577863|454337668|FG000|Overall Study|Withdrawal by Subject|0|||
126287161|NCT00577863|454337669|FG001|Overall Study|Withdrawal by Subject|2|||
126287162|NCT00577863|454337668|FG000|Overall Study|Sponsor Decision|2|||
126287163|NCT00577863|454337669|FG001|Overall Study|Sponsor Decision|7|||
126287164|NCT00577863|454337668|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
126287165|NCT00577863|454337669|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
126287166|NCT04868500|454337670|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
126287167|NCT04868500|454337671|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
126287168|NCT04868500|454337670|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
126287169|NCT04868500|454337671|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
126287170|NCT02676765|454337672|FG000|Overall Study|Lost to Follow-up|0|||
126287171|NCT02676765|454337673|FG001|Overall Study|Lost to Follow-up|1|||
126287172|NCT05299528|454337678|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
126287173|NCT05299528|454337679|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
126287174|NCT05299528|454337680|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
126287175|NCT05299528|454337681|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
126287176|NCT05299528|454337682|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
126287177|NCT05299528|454337683|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
126287178|NCT05299528|454337684|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
126287179|NCT05299528|454337678|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
126287180|NCT05299528|454337679|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
126287181|NCT05299528|454337680|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
126287182|NCT05299528|454337681|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
126287183|NCT05299528|454337682|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
126287184|NCT05299528|454337683|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
126287185|NCT05299528|454337684|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
126287186|NCT05299528|454337678|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
126287187|NCT05299528|454337679|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
126287188|NCT05299528|454337680|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
126287189|NCT05299528|454337681|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
126287190|NCT05299528|454337682|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
126287191|NCT05299528|454337683|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
126365626|NCT01916226|454632838|FG001|Overall Study|Protocol Violation|1|||
126365627|NCT01916226|454632839|FG002|Overall Study|Protocol Violation|0|||
126365628|NCT01916226|454632840|FG003|Overall Study|Protocol Violation|1|||
126365629|NCT01916226|454632837|FG000|Overall Study|Physician Decision|0|||
126365630|NCT01916226|454632838|FG001|Overall Study|Physician Decision|0|||
126365631|NCT01916226|454632839|FG002|Overall Study|Physician Decision|0|||
126365632|NCT01916226|454632840|FG003|Overall Study|Physician Decision|1|||
126365633|NCT03163667|454632841|FG000|Overall Study|Death|15|||
126365634|NCT03163667|454632842|FG001|Overall Study|Death|27|||
126365635|NCT03163667|454632841|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
126365636|NCT03163667|454632842|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
126365637|NCT01422382|454632847|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
126365638|NCT05810597|454632850|FG000|Period 1|Adverse Event|2|||
126365639|NCT05810597|454632851|FG001|Period 1|Adverse Event|0|||
126365640|NCT05810597|454632850|FG000|Period 1|Physician Decision|1|||
126365641|NCT05810597|454632851|FG001|Period 1|Physician Decision|0|||
126365642|NCT05021224|454632852|FG000|Overall Study|Did not complete all survey items|4|||
126365643|NCT05021224|454632853|FG001|Overall Study|Did not complete all survey items|1|||
126365644|NCT05021224|454632854|FG002|Overall Study|Did not complete all survey items|0|||
126365645|NCT05021224|454632855|FG003|Overall Study|Did not complete all survey items|2|||
126365646|NCT02412436|454632856|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
126365647|NCT02412436|454632856|FG000|Overall Study|Lost to Follow-up|6|||
126365648|NCT02412436|454632856|FG000|Overall Study|Unable to get to clinic|3|||
126365649|NCT02412436|454632856|FG000|Overall Study|Death|1|||
126365650|NCT02412436|454632856|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
126365651|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
126365652|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126365653|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126365654|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126365655|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126365656|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
126365657|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126365658|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126365659|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126549590|NCT00309608|455305708|FG004|Overall Study|Adverse Event|3|||
126287192|NCT05299528|454337684|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
126287193|NCT02445963|454337690|FG000|Overall Study|Lost to Follow-up|1|||
126287194|NCT02445963|454337691|FG001|Overall Study|Lost to Follow-up|0|||
126287195|NCT02445963|454337692|FG002|Overall Study|Lost to Follow-up|0|||
126287196|NCT02445963|454337693|FG003|Overall Study|Lost to Follow-up|0|||
126287197|NCT02445963|454337690|FG000|Overall Study|Change in employment|1|||
126287198|NCT02445963|454337691|FG001|Overall Study|Change in employment|0|||
126287199|NCT02445963|454337692|FG002|Overall Study|Change in employment|0|||
126287200|NCT02445963|454337693|FG003|Overall Study|Change in employment|0|||
126287201|NCT02445963|454337690|FG000|Overall Study|Symptoms post-vaccination|0|||
126287202|NCT02445963|454337691|FG001|Overall Study|Symptoms post-vaccination|0|||
126287203|NCT02445963|454337692|FG002|Overall Study|Symptoms post-vaccination|1|||
126287204|NCT02445963|454337693|FG003|Overall Study|Symptoms post-vaccination|0|||
126287205|NCT01957176|454337694|FG000|Overall Study|Adverse Event|2|||
126287206|NCT01957176|454337695|FG001|Overall Study|Adverse Event|0|||
126287207|NCT01957176|454337694|FG000|Overall Study|Physician Decision|2|||
126287208|NCT01957176|454337695|FG001|Overall Study|Physician Decision|1|||
126287209|NCT01957176|454337694|FG000|Overall Study|Withdrawal by Subject|1|||
126287210|NCT01957176|454337695|FG001|Overall Study|Withdrawal by Subject|0|||
126287211|NCT02359994|454337698|FG000|Overall Population Study|Adverse Event|1|||
126287212|NCT02359994|454337699|FG001|Overall Population Study|Adverse Event|1|||
126287213|NCT02359994|454337698|FG000|Overall Population Study|Death|1|||
126287214|NCT02359994|454337699|FG001|Overall Population Study|Death|5|||
126287215|NCT02359994|454337698|FG000|Overall Population Study|Lost to Follow-up|1|||
126287216|NCT02359994|454337699|FG001|Overall Population Study|Lost to Follow-up|1|||
126287217|NCT02359994|454337698|FG000|Overall Population Study|Withdrawal by Subject|1|||
126287218|NCT02359994|454337699|FG001|Overall Population Study|Withdrawal by Subject|0|||
126287219|NCT02359994|454337698|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
126287220|NCT02359994|454337699|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
126287221|NCT02359994|454337698|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
126287222|NCT02359994|454337699|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
126287223|NCT02359994|454337698|FG000|Extended Oncology 24-Month Survival|Death|19|||
126287224|NCT02359994|454337699|FG001|Extended Oncology 24-Month Survival|Death|21|||
126287225|NCT02359994|454337698|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
126287226|NCT02359994|454337699|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
126287227|NCT04597632|454337700|FG000|Overall Study|Withdrawal by Subject|10|||
126287228|NCT04597632|454337700|FG000|Overall Study|Lost to Follow-up|1|||
126287229|NCT04597632|454337700|FG000|Overall Study|Death|1|||
126287230|NCT04597632|454337700|FG000|Overall Study|Adverse Event|5|||
126287231|NCT01823835|454337701|FG000|Overall Study|Adverse Event|0|||
126287232|NCT01823835|454337702|FG001|Overall Study|Adverse Event|0|||
126287233|NCT01823835|454337703|FG002|Overall Study|Adverse Event|0|||
126287234|NCT01823835|454337704|FG003|Overall Study|Adverse Event|0|||
126287235|NCT01823835|454337705|FG004|Overall Study|Adverse Event|1|||
126287236|NCT01823835|454337706|FG005|Overall Study|Adverse Event|0|||
126287237|NCT01823835|454337707|FG006|Overall Study|Adverse Event|1|||
126287238|NCT01823835|454337708|FG007|Overall Study|Adverse Event|0|||
126287239|NCT01823835|454337709|FG008|Overall Study|Adverse Event|0|||
126287240|NCT01823835|454337710|FG009|Overall Study|Adverse Event|0|||
126287241|NCT01823835|454337711|FG010|Overall Study|Adverse Event|1|||
126457211|NCT01903252|454974864|FG002|Double-Blind Induction|Physician Decision|0|||
126457212|NCT01903252|454974865|FG003|Double-Blind Induction|Physician Decision|0|||
126457213|NCT01903252|454974866|FG004|Double-Blind Induction|Physician Decision|0|||
126457214|NCT01903252|454974867|FG005|Double-Blind Induction|Physician Decision|0|||
126457215|NCT01903252|454974862|FG000|Double-Blind Induction|non-compliance,|7|||
126457216|NCT01903252|454974863|FG001|Double-Blind Induction|non-compliance,|7|||
126457217|NCT01903252|454974864|FG002|Double-Blind Induction|non-compliance,|0|||
126457218|NCT01903252|454974865|FG003|Double-Blind Induction|non-compliance,|0|||
126766975|NCT00648739|456100185|FG004|Overall Study|Investigator Considered it Advisable|0|||
126766976|NCT00648739|456100186|FG005|Overall Study|Investigator Considered it Advisable|1|||
126766977|NCT00648739|456100187|FG006|Overall Study|Investigator Considered it Advisable|1|||
126287242|NCT01823835|454337712|FG011|Overall Study|Adverse Event|2|||
126287243|NCT01823835|454337713|FG012|Overall Study|Adverse Event|0|||
126287244|NCT01823835|454337714|FG013|Overall Study|Adverse Event|0|||
126287245|NCT01823835|454337715|FG014|Overall Study|Adverse Event|0|||
126287246|NCT01823835|454337701|FG000|Overall Study|Physician Decision|0|||
126287247|NCT01823835|454337702|FG001|Overall Study|Physician Decision|0|||
126287248|NCT01823835|454337703|FG002|Overall Study|Physician Decision|0|||
126287249|NCT01823835|454337704|FG003|Overall Study|Physician Decision|0|||
126287250|NCT01823835|454337705|FG004|Overall Study|Physician Decision|0|||
126287251|NCT01823835|454337706|FG005|Overall Study|Physician Decision|0|||
126287252|NCT01823835|454337707|FG006|Overall Study|Physician Decision|0|||
126287253|NCT01823835|454337708|FG007|Overall Study|Physician Decision|0|||
126287254|NCT01823835|454337709|FG008|Overall Study|Physician Decision|0|||
126287255|NCT01823835|454337710|FG009|Overall Study|Physician Decision|0|||
126287256|NCT01823835|454337711|FG010|Overall Study|Physician Decision|0|||
126287257|NCT01823835|454337712|FG011|Overall Study|Physician Decision|2|||
126287258|NCT01823835|454337713|FG012|Overall Study|Physician Decision|0|||
126287259|NCT01823835|454337714|FG013|Overall Study|Physician Decision|0|||
126287260|NCT01823835|454337715|FG014|Overall Study|Physician Decision|0|||
126287261|NCT01823835|454337701|FG000|Overall Study|Progressive Disease|3|||
126287262|NCT01823835|454337702|FG001|Overall Study|Progressive Disease|4|||
126287263|NCT01823835|454337703|FG002|Overall Study|Progressive Disease|3|||
126287264|NCT01823835|454337704|FG003|Overall Study|Progressive Disease|6|||
126287265|NCT01823835|454337705|FG004|Overall Study|Progressive Disease|4|||
126287266|NCT01823835|454337706|FG005|Overall Study|Progressive Disease|6|||
126710363|NCT01277289|455891607|FG000|Overall Study|premature closure of the study|4|||
126710364|NCT01277289|455891608|FG001|Overall Study|premature closure of the study|2|||
126287267|NCT01823835|454337707|FG006|Overall Study|Progressive Disease|5|||
126287268|NCT01823835|454337708|FG007|Overall Study|Progressive Disease|3|||
126287269|NCT01823835|454337709|FG008|Overall Study|Progressive Disease|3|||
126287270|NCT01823835|454337710|FG009|Overall Study|Progressive Disease|18|||
126287271|NCT01823835|454337711|FG010|Overall Study|Progressive Disease|8|||
126287272|NCT01823835|454337712|FG011|Overall Study|Progressive Disease|46|||
126287273|NCT01823835|454337713|FG012|Overall Study|Progressive Disease|18|||
126287274|NCT01823835|454337714|FG013|Overall Study|Progressive Disease|4|||
126287275|NCT01823835|454337715|FG014|Overall Study|Progressive Disease|6|||
126287276|NCT01823835|454337701|FG000|Overall Study|Study Termination|0|||
126287277|NCT01823835|454337702|FG001|Overall Study|Study Termination|0|||
126287278|NCT01823835|454337703|FG002|Overall Study|Study Termination|0|||
126287279|NCT01823835|454337704|FG003|Overall Study|Study Termination|0|||
126287280|NCT01823835|454337705|FG004|Overall Study|Study Termination|1|||
126287281|NCT01823835|454337706|FG005|Overall Study|Study Termination|0|||
126287282|NCT01823835|454337707|FG006|Overall Study|Study Termination|0|||
126287283|NCT01823835|454337708|FG007|Overall Study|Study Termination|0|||
126287284|NCT01823835|454337709|FG008|Overall Study|Study Termination|0|||
126287285|NCT01823835|454337710|FG009|Overall Study|Study Termination|0|||
126287286|NCT01823835|454337711|FG010|Overall Study|Study Termination|0|||
126287287|NCT01823835|454337712|FG011|Overall Study|Study Termination|1|||
126287288|NCT01823835|454337713|FG012|Overall Study|Study Termination|0|||
126287289|NCT01823835|454337714|FG013|Overall Study|Study Termination|0|||
126287290|NCT01823835|454337715|FG014|Overall Study|Study Termination|0|||
126287291|NCT01823835|454337701|FG000|Overall Study|Withdrawal by Subject|0|||
126287292|NCT01823835|454337702|FG001|Overall Study|Withdrawal by Subject|0|||
126287293|NCT01823835|454337703|FG002|Overall Study|Withdrawal by Subject|1|||
126287294|NCT01823835|454337704|FG003|Overall Study|Withdrawal by Subject|0|||
126287295|NCT01823835|454337705|FG004|Overall Study|Withdrawal by Subject|0|||
126287296|NCT01823835|454337706|FG005|Overall Study|Withdrawal by Subject|0|||
126287297|NCT01823835|454337707|FG006|Overall Study|Withdrawal by Subject|0|||
126287298|NCT01823835|454337708|FG007|Overall Study|Withdrawal by Subject|0|||
126287299|NCT01823835|454337709|FG008|Overall Study|Withdrawal by Subject|0|||
126287300|NCT01823835|454337710|FG009|Overall Study|Withdrawal by Subject|1|||
126287301|NCT01823835|454337711|FG010|Overall Study|Withdrawal by Subject|1|||
126287302|NCT01823835|454337712|FG011|Overall Study|Withdrawal by Subject|2|||
126457219|NCT01903252|454974866|FG004|Double-Blind Induction|non-compliance,|0|||
126457220|NCT01903252|454974867|FG005|Double-Blind Induction|non-compliance,|0|||
126457221|NCT01903252|454974862|FG000|Extended Induction, Open-Label|Adverse Event|0|||
126457222|NCT01903252|454974863|FG001|Extended Induction, Open-Label|Adverse Event|0|||
126457223|NCT01903252|454974864|FG002|Extended Induction, Open-Label|Adverse Event|17|||
126457224|NCT01903252|454974865|FG003|Extended Induction, Open-Label|Adverse Event|0|||
126457225|NCT01903252|454974866|FG004|Extended Induction, Open-Label|Adverse Event|0|||
126457226|NCT01903252|454974867|FG005|Extended Induction, Open-Label|Adverse Event|0|||
126457227|NCT01903252|454974862|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
126457228|NCT01903252|454974863|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
126457229|NCT01903252|454974864|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
126457230|NCT01903252|454974865|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
126457231|NCT01903252|454974866|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
126549591|NCT00309608|455305704|FG000|Overall Study|Protocol Violation|2|||
126710365|NCT00092547|455891609|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
126710366|NCT00092547|455891610|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
126287303|NCT01823835|454337713|FG012|Overall Study|Withdrawal by Subject|1|||
126287304|NCT01823835|454337714|FG013|Overall Study|Withdrawal by Subject|0|||
126287305|NCT01823835|454337715|FG014|Overall Study|Withdrawal by Subject|0|||
126287306|NCT03017612|454337716|FG000|Overall Study|Adverse Event|2|||
126287307|NCT04895982|454337717|FG000|Overall Study|Withdrawal by Subject|0|||
126549592|NCT00309608|455305705|FG001|Overall Study|Protocol Violation|0|||
126287308|NCT04895982|454337718|FG001|Overall Study|Withdrawal by Subject|0|||
126287309|NCT04895982|454337719|FG002|Overall Study|Withdrawal by Subject|0|||
126287310|NCT04895982|454337720|FG003|Overall Study|Withdrawal by Subject|0|||
126287311|NCT04895982|454337721|FG004|Overall Study|Withdrawal by Subject|0|||
126287312|NCT04895982|454337722|FG005|Overall Study|Withdrawal by Subject|1|||
126549593|NCT00309608|455305706|FG002|Overall Study|Protocol Violation|0|||
126549594|NCT00309608|455305707|FG003|Overall Study|Protocol Violation|0|||
126549595|NCT00309608|455305708|FG004|Overall Study|Protocol Violation|0|||
126549596|NCT00309608|455305704|FG000|Overall Study|Lost to Follow-up|0|||
126549597|NCT00309608|455305705|FG001|Overall Study|Lost to Follow-up|0|||
126549598|NCT00309608|455305706|FG002|Overall Study|Lost to Follow-up|2|||
126549599|NCT00309608|455305707|FG003|Overall Study|Lost to Follow-up|0|||
126549600|NCT00309608|455305708|FG004|Overall Study|Lost to Follow-up|1|||
126549601|NCT00309608|455305704|FG000|Overall Study|Withdrawal by Subject|1|||
126287313|NCT04895982|454337723|FG006|Overall Study|Withdrawal by Subject|1|||
126287314|NCT04895982|454337724|FG007|Overall Study|Withdrawal by Subject|0|||
126287315|NCT04895982|454337725|FG008|Overall Study|Withdrawal by Subject|0|||
126287316|NCT04895982|454337726|FG009|Overall Study|Withdrawal by Subject|1|||
126287317|NCT04895982|454337727|FG010|Overall Study|Withdrawal by Subject|0|||
126287318|NCT04895982|454337728|FG011|Overall Study|Withdrawal by Subject|1|||
126287319|NCT04895982|454337717|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126287320|NCT04895982|454337718|FG001|Overall Study|Withdrawal by parent/guardian|3|||
126287321|NCT04895982|454337719|FG002|Overall Study|Withdrawal by parent/guardian|3|||
126287322|NCT04895982|454337720|FG003|Overall Study|Withdrawal by parent/guardian|1|||
126287323|NCT04895982|454337721|FG004|Overall Study|Withdrawal by parent/guardian|3|||
126287324|NCT04895982|454337722|FG005|Overall Study|Withdrawal by parent/guardian|2|||
126287325|NCT04895982|454337723|FG006|Overall Study|Withdrawal by parent/guardian|1|||
126287326|NCT04895982|454337724|FG007|Overall Study|Withdrawal by parent/guardian|0|||
126287327|NCT04895982|454337725|FG008|Overall Study|Withdrawal by parent/guardian|3|||
126287328|NCT04895982|454337726|FG009|Overall Study|Withdrawal by parent/guardian|0|||
126287329|NCT04895982|454337727|FG010|Overall Study|Withdrawal by parent/guardian|0|||
126287330|NCT04895982|454337728|FG011|Overall Study|Withdrawal by parent/guardian|0|||
126287331|NCT04895982|454337717|FG000|Overall Study|Other|0|||
126287332|NCT04895982|454337718|FG001|Overall Study|Other|0|||
126287333|NCT04895982|454337719|FG002|Overall Study|Other|1|||
126287334|NCT04895982|454337720|FG003|Overall Study|Other|1|||
126287335|NCT04895982|454337721|FG004|Overall Study|Other|0|||
126287336|NCT04895982|454337722|FG005|Overall Study|Other|0|||
126287337|NCT04895982|454337723|FG006|Overall Study|Other|0|||
126287338|NCT04895982|454337724|FG007|Overall Study|Other|0|||
126287339|NCT04895982|454337725|FG008|Overall Study|Other|0|||
126287340|NCT04895982|454337726|FG009|Overall Study|Other|1|||
126287341|NCT04895982|454337727|FG010|Overall Study|Other|0|||
126287342|NCT04895982|454337728|FG011|Overall Study|Other|0|||
126287343|NCT04895982|454337717|FG000|Overall Study|Protocol Violation|0|||
126287344|NCT04895982|454337718|FG001|Overall Study|Protocol Violation|0|||
126287345|NCT04895982|454337719|FG002|Overall Study|Protocol Violation|1|||
126287346|NCT04895982|454337720|FG003|Overall Study|Protocol Violation|1|||
126287347|NCT04895982|454337721|FG004|Overall Study|Protocol Violation|1|||
126287348|NCT04895982|454337722|FG005|Overall Study|Protocol Violation|0|||
126287349|NCT04895982|454337723|FG006|Overall Study|Protocol Violation|0|||
126287350|NCT04895982|454337724|FG007|Overall Study|Protocol Violation|1|||
126287351|NCT04895982|454337725|FG008|Overall Study|Protocol Violation|0|||
126287352|NCT04895982|454337726|FG009|Overall Study|Protocol Violation|0|||
126287353|NCT04895982|454337727|FG010|Overall Study|Protocol Violation|0|||
126287354|NCT04895982|454337728|FG011|Overall Study|Protocol Violation|0|||
126287355|NCT04895982|454337717|FG000|Overall Study|Lost to Follow-up|0|||
126549602|NCT00309608|455305705|FG001|Overall Study|Withdrawal by Subject|4|||
126549603|NCT00309608|455305706|FG002|Overall Study|Withdrawal by Subject|2|||
126766978|NCT00648739|456100181|FG000|Overall Study|Death|0|||
126766979|NCT00648739|456100182|FG001|Overall Study|Death|1|||
126287356|NCT04895982|454337718|FG001|Overall Study|Lost to Follow-up|0|||
126287357|NCT04895982|454337719|FG002|Overall Study|Lost to Follow-up|1|||
126287358|NCT04895982|454337720|FG003|Overall Study|Lost to Follow-up|0|||
126287359|NCT04895982|454337721|FG004|Overall Study|Lost to Follow-up|0|||
126287360|NCT04895982|454337722|FG005|Overall Study|Lost to Follow-up|1|||
126287361|NCT04895982|454337723|FG006|Overall Study|Lost to Follow-up|0|||
126287362|NCT04895982|454337724|FG007|Overall Study|Lost to Follow-up|0|||
126287363|NCT04895982|454337725|FG008|Overall Study|Lost to Follow-up|1|||
126287364|NCT04895982|454337726|FG009|Overall Study|Lost to Follow-up|0|||
126287365|NCT04895982|454337727|FG010|Overall Study|Lost to Follow-up|0|||
126287366|NCT04895982|454337728|FG011|Overall Study|Lost to Follow-up|0|||
126287367|NCT04895982|454337717|FG000|Overall Study|Refused further study procedures|0|||
126287368|NCT04895982|454337718|FG001|Overall Study|Refused further study procedures|0|||
126287369|NCT04895982|454337719|FG002|Overall Study|Refused further study procedures|1|||
126287370|NCT04895982|454337720|FG003|Overall Study|Refused further study procedures|0|||
126287371|NCT04895982|454337721|FG004|Overall Study|Refused further study procedures|0|||
126287372|NCT04895982|454337722|FG005|Overall Study|Refused further study procedures|0|||
126287373|NCT04895982|454337723|FG006|Overall Study|Refused further study procedures|0|||
126549604|NCT00309608|455305707|FG003|Overall Study|Withdrawal by Subject|0|||
126287374|NCT04895982|454337724|FG007|Overall Study|Refused further study procedures|0|||
126549605|NCT00309608|455305708|FG004|Overall Study|Withdrawal by Subject|0|||
126549606|NCT00309608|455305704|FG000|Overall Study|Other incl. Lack of efficacy|10|||
126710367|NCT00092547|455891611|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
126710368|NCT00092547|455891609|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
126710369|NCT00092547|455891610|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
126710370|NCT00092547|455891611|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
126287375|NCT04895982|454337725|FG008|Overall Study|Refused further study procedures|0|||
126287376|NCT04895982|454337726|FG009|Overall Study|Refused further study procedures|0|||
126287377|NCT04895982|454337727|FG010|Overall Study|Refused further study procedures|0|||
126287378|NCT04895982|454337728|FG011|Overall Study|Refused further study procedures|0|||
126287379|NCT01893346|454337729|FG000|Overall Study|Lost to Follow-up|0|||
126287380|NCT01893346|454337730|FG001|Overall Study|Lost to Follow-up|1|||
126287381|NCT01893346|454337731|FG002|Overall Study|Lost to Follow-up|0|||
126287382|NCT01893346|454337732|FG003|Overall Study|Lost to Follow-up|0|||
126287383|NCT01893346|454337729|FG000|Overall Study|Protocol Violation|1|||
126287384|NCT01893346|454337730|FG001|Overall Study|Protocol Violation|0|||
126287385|NCT01893346|454337731|FG002|Overall Study|Protocol Violation|0|||
126287386|NCT01893346|454337732|FG003|Overall Study|Protocol Violation|0|||
126457232|NCT01903252|454974867|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
126457233|NCT01903252|454974862|FG000|Extended Induction, Open-Label|Physician Decision|0|||
126457234|NCT01903252|454974863|FG001|Extended Induction, Open-Label|Physician Decision|0|||
126457235|NCT01903252|454974864|FG002|Extended Induction, Open-Label|Physician Decision|1|||
126457236|NCT01903252|454974865|FG003|Extended Induction, Open-Label|Physician Decision|0|||
126457237|NCT01903252|454974866|FG004|Extended Induction, Open-Label|Physician Decision|0|||
126457238|NCT01903252|454974867|FG005|Extended Induction, Open-Label|Physician Decision|0|||
126457239|NCT01903252|454974862|FG000|Maintenance, Open-Label|Adverse Event|0|||
126457240|NCT01903252|454974863|FG001|Maintenance, Open-Label|Adverse Event|0|||
126457241|NCT01903252|454974864|FG002|Maintenance, Open-Label|Adverse Event|0|||
126457242|NCT01903252|454974865|FG003|Maintenance, Open-Label|Adverse Event|3|||
126457243|NCT01903252|454974866|FG004|Maintenance, Open-Label|Adverse Event|9|||
126457244|NCT01903252|454974867|FG005|Maintenance, Open-Label|Adverse Event|14|||
126457245|NCT01903252|454974862|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
126457246|NCT01903252|454974863|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
126457247|NCT01903252|454974864|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
126457248|NCT01903252|454974865|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
126457249|NCT01903252|454974866|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
126457250|NCT01903252|454974867|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
126457251|NCT01903252|454974862|FG000|Maintenance, Open-Label|Other|0|||
126457252|NCT01903252|454974863|FG001|Maintenance, Open-Label|Other|0|||
126457253|NCT01903252|454974864|FG002|Maintenance, Open-Label|Other|0|||
126457254|NCT01903252|454974865|FG003|Maintenance, Open-Label|Other|2|||
126457255|NCT01903252|454974866|FG004|Maintenance, Open-Label|Other|6|||
126457256|NCT01903252|454974867|FG005|Maintenance, Open-Label|Other|2|||
126457257|NCT02437110|454974868|FG000|Screening|Lost to Follow-up|3|||
126457258|NCT02437110|454974868|FG000|Screening|Physician Decision|1|||
126457259|NCT02437110|454974868|FG000|ART|Adverse Event|3|||
126457260|NCT02437110|454974868|FG000|ART|Protocol Violation|3|||
126457261|NCT02437110|454974868|FG000|ART|Withdrawal by Subject|4|||
126457262|NCT02437110|454974868|FG000|ART|Lost to follow-up prior to start of intervention|1|||
126457263|NCT02437110|454974868|FG000|ART|Physician decision prior to start of intervention|2|||
126457264|NCT02437110|454974868|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
126457265|NCT02437110|454974868|FG000|Post-ART|Lost to Follow-up|3|||
126457266|NCT02437110|454974868|FG000|Post-ART|Protocol Violation|4|||
126457267|NCT02437110|454974868|FG000|Post-ART|Withdrawal by Subject|3|||
126457268|NCT01227824|454974872|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
126457269|NCT01227824|454974873|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
126457270|NCT01227824|454974874|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
126457271|NCT01227824|454974872|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
126457272|NCT01227824|454974873|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
126457273|NCT01227824|454974874|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
126457274|NCT01227824|454974872|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
126457275|NCT01227824|454974873|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
126457276|NCT01227824|454974874|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
126457277|NCT01227824|454974872|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
126457278|NCT01227824|454974873|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
126457279|NCT01227824|454974874|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
126457280|NCT01227824|454974872|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
126710371|NCT00092547|455891609|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
126710372|NCT00092547|455891610|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
126710373|NCT00092547|455891611|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
126710374|NCT00092547|455891609|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
126287387|NCT01893346|454337729|FG000|Overall Study|Withdrawal by Subject|2|||
126287388|NCT01893346|454337730|FG001|Overall Study|Withdrawal by Subject|0|||
126287389|NCT01893346|454337731|FG002|Overall Study|Withdrawal by Subject|0|||
126287390|NCT01893346|454337732|FG003|Overall Study|Withdrawal by Subject|0|||
126287391|NCT01449812|454337733|FG000|Overall Study|Migrated/moved from study area|1|||
126287392|NCT01449812|454337734|FG001|Overall Study|Migrated/moved from study area|0|||
126287393|NCT01449812|454337735|FG002|Overall Study|Migrated/moved from study area|0|||
126287394|NCT01449812|454337733|FG000|Overall Study|Withdrawal by Subject|0|||
126287395|NCT01449812|454337734|FG001|Overall Study|Withdrawal by Subject|0|||
126287396|NCT01449812|454337735|FG002|Overall Study|Withdrawal by Subject|1|||
126287397|NCT01449812|454337733|FG000|Overall Study|Lost to Follow-up|1|||
126287398|NCT01449812|454337734|FG001|Overall Study|Lost to Follow-up|0|||
126287399|NCT01449812|454337735|FG002|Overall Study|Lost to Follow-up|0|||
126287400|NCT04239027|454337738|FG000|Overall Study|Adverse Event|4|||
126287401|NCT04239027|454337738|FG000|Overall Study|Withdrawal by Subject|9|||
126287402|NCT04239027|454337738|FG000|Overall Study|Death|1|||
126287403|NCT04239027|454337738|FG000|Overall Study|Physician Decision|9|||
126287404|NCT04239027|454337738|FG000|Overall Study|Lost to Follow-up|2|||
126287405|NCT04239027|454337738|FG000|Overall Study|Lack of Efficacy|1|||
126287406|NCT02839707|454337745|FG000|Phase I|Not eligible for analysis|9|||
126287407|NCT02839707|454337746|FG001|Phase I|Not eligible for analysis|0|||
126287408|NCT02839707|454337747|FG002|Phase I|Not eligible for analysis|0|||
126287409|NCT02839707|454337745|FG000|Phase II|Not treated according to protocol|4|||
126287410|NCT02839707|454337746|FG001|Phase II|Not treated according to protocol|0|||
126287411|NCT02839707|454337747|FG002|Phase II|Not treated according to protocol|2|||
126287412|NCT02839707|454337745|FG000|Phase III|Not treated according to protocol|0|||
126287413|NCT02839707|454337746|FG001|Phase III|Not treated according to protocol|0|||
126287414|NCT02839707|454337747|FG002|Phase III|Not treated according to protocol|4|||
126457281|NCT01227824|454974873|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
126457282|NCT01227824|454974874|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
126457283|NCT01227824|454974872|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
126457284|NCT01227824|454974873|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
126457285|NCT01227824|454974874|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
126457286|NCT01227824|454974872|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
126457287|NCT01227824|454974873|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
126457288|NCT01227824|454974874|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
126457289|NCT01227824|454974872|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
126457290|NCT01227824|454974873|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
126457291|NCT01227824|454974874|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
126457292|NCT01227824|454974872|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
126457293|NCT01227824|454974873|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
126457294|NCT01227824|454974874|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
126457295|NCT01227824|454974872|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
126457296|NCT01227824|454974873|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
126457297|NCT01227824|454974874|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
126457298|NCT01227824|454974872|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
126457299|NCT01227824|454974873|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
126549607|NCT00309608|455305705|FG001|Overall Study|Other incl. Lack of efficacy|4|||
126549608|NCT00309608|455305706|FG002|Overall Study|Other incl. Lack of efficacy|3|||
126549609|NCT00309608|455305707|FG003|Overall Study|Other incl. Lack of efficacy|4|||
126287415|NCT01950390|454337748|FG000|Overall Study|Never started treatment|3|||
126287416|NCT01950390|454337749|FG001|Overall Study|Never started treatment|2|||
126287417|NCT01950390|454337748|FG000|Overall Study|Disease progression|45|||
126287418|NCT01950390|454337749|FG001|Overall Study|Disease progression|52|||
126287419|NCT01950390|454337748|FG000|Overall Study|Adverse Event|22|||
126287420|NCT01950390|454337749|FG001|Overall Study|Adverse Event|16|||
126287421|NCT01950390|454337748|FG000|Overall Study|Death|5|||
126365660|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126365661|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
126365662|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126365663|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126365664|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126365665|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126365666|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
126365667|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
126365668|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
126365669|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
126365670|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
126365671|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
126365672|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
126365673|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
126287422|NCT01950390|454337749|FG001|Overall Study|Death|3|||
126287423|NCT01950390|454337748|FG000|Overall Study|Withdrawal by Subject|5|||
126287424|NCT01950390|454337749|FG001|Overall Study|Withdrawal by Subject|1|||
126287425|NCT01950390|454337748|FG000|Overall Study|Alternative therapy|0|||
126287426|NCT01950390|454337749|FG001|Overall Study|Alternative therapy|3|||
126287427|NCT01950390|454337748|FG000|Overall Study|Complicating disease|1|||
126287428|NCT01950390|454337749|FG001|Overall Study|Complicating disease|0|||
126287429|NCT01950390|454337748|FG000|Overall Study|On treatment|1|||
126287430|NCT01950390|454337749|FG001|Overall Study|On treatment|0|||
126287431|NCT01950390|454337748|FG000|Overall Study|Symptomatic deterioration|2|||
126287432|NCT01950390|454337749|FG001|Overall Study|Symptomatic deterioration|1|||
126287433|NCT01950390|454337748|FG000|Overall Study|Physician Decision|0|||
126287434|NCT01950390|454337749|FG001|Overall Study|Physician Decision|4|||
126287435|NCT01950390|454337748|FG000|Overall Study|Lack of clinical benefit|0|||
126287436|NCT01950390|454337749|FG001|Overall Study|Lack of clinical benefit|1|||
126287437|NCT01950390|454337748|FG000|Overall Study|Maintained PR and moved to observation only|0|||
126287438|NCT01950390|454337749|FG001|Overall Study|Maintained PR and moved to observation only|1|||
126287439|NCT05192889|454337751|FG000|Block 1: All Eligible Patients|Death|2|||
126287440|NCT05192889|454337752|FG001|Block 1: All Eligible Patients|Death|0|||
126287441|NCT05192889|454337753|FG002|Block 1: All Eligible Patients|Death|0|||
126287442|NCT05192889|454337751|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
126287443|NCT05192889|454337752|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
126287444|NCT05192889|454337753|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
126287445|NCT05192889|454337751|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
126287446|NCT05192889|454337752|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
126287447|NCT05192889|454337753|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
126287448|NCT02717455|454339790|FG000|Overall Study|Adverse Event|1|||
126287449|NCT02717455|454339791|FG001|Overall Study|Adverse Event|0|||
126287450|NCT02717455|454339792|FG002|Overall Study|Adverse Event|0|||
126287451|NCT02717455|454339793|FG003|Overall Study|Adverse Event|2|||
126287452|NCT02717455|454339794|FG004|Overall Study|Adverse Event|2|||
126287453|NCT02717455|454339795|FG005|Overall Study|Adverse Event|2|||
126287454|NCT02717455|454339790|FG000|Overall Study|Withdrawal by Subject|1|||
126287455|NCT02717455|454339791|FG001|Overall Study|Withdrawal by Subject|1|||
126287456|NCT02717455|454339792|FG002|Overall Study|Withdrawal by Subject|0|||
126287457|NCT02717455|454339793|FG003|Overall Study|Withdrawal by Subject|2|||
126287458|NCT02717455|454339794|FG004|Overall Study|Withdrawal by Subject|2|||
126287459|NCT02717455|454339795|FG005|Overall Study|Withdrawal by Subject|1|||
126287460|NCT02717455|454339790|FG000|Overall Study|Death|1|||
126287461|NCT02717455|454339791|FG001|Overall Study|Death|0|||
126287462|NCT02717455|454339792|FG002|Overall Study|Death|0|||
126287463|NCT02717455|454339793|FG003|Overall Study|Death|0|||
126287464|NCT02717455|454339794|FG004|Overall Study|Death|1|||
126287465|NCT02717455|454339795|FG005|Overall Study|Death|0|||
126287466|NCT02717455|454339790|FG000|Overall Study|Did not receive study drug|0|||
126287467|NCT02717455|454339791|FG001|Overall Study|Did not receive study drug|0|||
126287468|NCT02717455|454339792|FG002|Overall Study|Did not receive study drug|0|||
126287469|NCT02717455|454339793|FG003|Overall Study|Did not receive study drug|1|||
126287470|NCT02717455|454339794|FG004|Overall Study|Did not receive study drug|0|||
126287471|NCT02717455|454339795|FG005|Overall Study|Did not receive study drug|1|||
126287472|NCT02717455|454339790|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
126287473|NCT02717455|454339791|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
126287474|NCT02717455|454339792|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
126287475|NCT02717455|454339793|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
126287476|NCT02717455|454339794|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
126287477|NCT02717455|454339795|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
126287478|NCT02717455|454339790|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
126287479|NCT02717455|454339791|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
126287480|NCT02717455|454339792|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
126287481|NCT02717455|454339793|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
126287482|NCT02717455|454339794|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
126287483|NCT02717455|454339795|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
126766980|NCT00648739|456100183|FG002|Overall Study|Death|0|||
126287484|NCT00233948|454339798|FG000|Overall Study|Adverse Event|1|||
126287485|NCT00233948|454339799|FG001|Overall Study|Adverse Event|0|||
126287486|NCT00233948|454339800|FG002|Overall Study|Adverse Event|0|||
126287487|NCT00233948|454339801|FG003|Overall Study|Adverse Event|0|||
126287488|NCT00233948|454339802|FG004|Overall Study|Adverse Event|0|||
126287489|NCT00233948|454339803|FG005|Overall Study|Adverse Event|0|||
126287490|NCT02465398|454339808|FG000|Overall Study|Death|7|||
126287491|NCT02465398|454339808|FG000|Overall Study|Revision|7|||
126287492|NCT02465398|454339808|FG000|Overall Study|did not receive study device|1|||
126287493|NCT02465398|454339808|FG000|Overall Study|Withdrawal by Subject|1|||
126766981|NCT00648739|456100184|FG003|Overall Study|Death|0|||
126287494|NCT02465398|454339808|FG000|Overall Study|Lost to Follow-up|14|||
126287495|NCT05244122|454339813|FG000|Overall Study|Withdrawal by Subject|318|||
126287496|NCT02969382|454339818|FG000|Overall Study|Adverse Event|8|||
126287497|NCT02969382|454339819|FG001|Overall Study|Adverse Event|10|||
126287498|NCT02969382|454339818|FG000|Overall Study|Lack of Efficacy|4|||
126287499|NCT02969382|454339819|FG001|Overall Study|Lack of Efficacy|5|||
126287500|NCT02969382|454339818|FG000|Overall Study|Death|0|||
126287501|NCT02969382|454339819|FG001|Overall Study|Death|1|||
126287502|NCT02969382|454339818|FG000|Overall Study|PROTOCOL DEVIATION|0|||
126287503|NCT02969382|454339819|FG001|Overall Study|PROTOCOL DEVIATION|1|||
126287504|NCT02969382|454339818|FG000|Overall Study|Withdrawal by Subject|14|||
126287505|NCT02969382|454339819|FG001|Overall Study|Withdrawal by Subject|9|||
126287506|NCT00886015|454339822|FG000|Overall Study|Death|0|||
126287507|NCT00886015|454339823|FG001|Overall Study|Death|2|||
126287508|NCT00855894|454339824|FG000|Overall Study|Death|31|||
126287509|NCT00855894|454339824|FG000|Overall Study|Patient's decision|1|||
126287510|NCT00855894|454339824|FG000|Overall Study|Disease progression|1|||
126287511|NCT01473407|454339836|FG000|Overall Study|Physician Decision|1|||
126287512|NCT01473407|454339837|FG001|Overall Study|Physician Decision|4|||
126287513|NCT01473407|454339836|FG000|Overall Study|Lost to Follow-up|10|||
126287514|NCT01473407|454339837|FG001|Overall Study|Lost to Follow-up|4|||
126287515|NCT01473407|454339836|FG000|Overall Study|Adverse Event|8|||
126287516|NCT01473407|454339837|FG001|Overall Study|Adverse Event|8|||
126287517|NCT01473407|454339836|FG000|Overall Study|Randomization Error|3|||
126287518|NCT01473407|454339837|FG001|Overall Study|Randomization Error|1|||
126287519|NCT01473407|454339836|FG000|Overall Study|Withdrawal by Subject|4|||
126287520|NCT01473407|454339837|FG001|Overall Study|Withdrawal by Subject|7|||
126287521|NCT01473407|454339836|FG000|Overall Study|Kidney Transplant|7|||
126287522|NCT01473407|454339837|FG001|Overall Study|Kidney Transplant|6|||
126287523|NCT01473407|454339836|FG000|Overall Study|Vacation/Travel|1|||
126287524|NCT01473407|454339837|FG001|Overall Study|Vacation/Travel|1|||
126287525|NCT01473407|454339836|FG000|Overall Study|Elevated Hemoglobin|1|||
126287526|NCT01473407|454339837|FG001|Overall Study|Elevated Hemoglobin|0|||
126710375|NCT00092547|455891610|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
126710376|NCT00092547|455891611|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
126710377|NCT00092547|455891609|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
126710378|NCT00092547|455891610|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
126710379|NCT00092547|455891611|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
126710380|NCT00092547|455891609|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
126710381|NCT00092547|455891610|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
126710382|NCT00092547|455891611|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
126710383|NCT00092547|455891609|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
126710384|NCT00092547|455891610|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
126710385|NCT00092547|455891611|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
126710386|NCT00092547|455891609|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
126710387|NCT00092547|455891610|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
126710388|NCT00092547|455891611|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
126710389|NCT00092547|455891609|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
126710390|NCT00092547|455891610|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
126710391|NCT00092547|455891611|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
126710392|NCT00092547|455891609|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
126710393|NCT00092547|455891610|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
126710394|NCT00092547|455891611|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
126710395|NCT00092547|455891609|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
126710396|NCT00092547|455891610|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
126710397|NCT00092547|455891611|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
126287527|NCT01473407|454339836|FG000|Overall Study|Patient Received Aranesp|1|||
126287528|NCT01473407|454339837|FG001|Overall Study|Patient Received Aranesp|0|||
126457300|NCT01227824|454974874|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
126457301|NCT01227824|454974872|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
126457302|NCT01227824|454974873|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
126457303|NCT01227824|454974874|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
126457304|NCT01227824|454974872|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
126457305|NCT01227824|454974873|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
126457306|NCT01227824|454974874|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
126710398|NCT00092547|455891609|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
126287529|NCT01473407|454339836|FG000|Overall Study|Patient Lost Green Card Status|1|||
126287530|NCT01473407|454339837|FG001|Overall Study|Patient Lost Green Card Status|0|||
126287531|NCT01473407|454339836|FG000|Overall Study|Temperature Excursion|2|||
126287532|NCT01473407|454339837|FG001|Overall Study|Temperature Excursion|3|||
126287533|NCT01473407|454339836|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
126287534|NCT01473407|454339837|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
126287535|NCT01473407|454339836|FG000|Overall Study|Sponsor's Decision|10|||
126287536|NCT01473407|454339837|FG001|Overall Study|Sponsor's Decision|10|||
126287537|NCT01473407|454339836|FG000|Overall Study|Site Closure|1|||
126287538|NCT01473407|454339837|FG001|Overall Study|Site Closure|0|||
126287539|NCT04071405|454339838|FG000|Overall Study|Protocol Violation|3|||
126287540|NCT00369941|454339839|FG000|Overall Study|Never Treated|1|||
126287541|NCT00369941|454339840|FG001|Overall Study|Never Treated|2|||
126287542|NCT00369941|454339839|FG000|Overall Study|Adverse Event|14|||
126287543|NCT00369941|454339840|FG001|Overall Study|Adverse Event|28|||
126287544|NCT00369941|454339839|FG000|Overall Study|Lack of Efficacy|6|||
126287545|NCT00369941|454339840|FG001|Overall Study|Lack of Efficacy|10|||
126287546|NCT00369941|454339839|FG000|Overall Study|Lost to Follow-up|12|||
126287547|NCT00369941|454339840|FG001|Overall Study|Lost to Follow-up|22|||
126287548|NCT00369941|454339839|FG000|Overall Study|Protocol Violation|5|||
126287549|NCT00369941|454339840|FG001|Overall Study|Protocol Violation|3|||
126287550|NCT00369941|454339839|FG000|Overall Study|Withdrawal by Subject|5|||
126287551|NCT00369941|454339840|FG001|Overall Study|Withdrawal by Subject|18|||
126287552|NCT00369941|454339839|FG000|Overall Study|Pregnancy|4|||
126287553|NCT00369941|454339840|FG001|Overall Study|Pregnancy|2|||
126287554|NCT00369941|454339839|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
126287555|NCT00369941|454339840|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
126287556|NCT00369941|454339839|FG000|Overall Study|Moved|11|||
126287557|NCT00369941|454339840|FG001|Overall Study|Moved|5|||
126287558|NCT00369941|454339839|FG000|Overall Study|Treatment with Prohibited Medication|3|||
126287559|NCT00369941|454339840|FG001|Overall Study|Treatment with Prohibited Medication|1|||
126287560|NCT00369941|454339839|FG000|Overall Study|Employment Interfered with Study Visits|1|||
126287561|NCT00369941|454339840|FG001|Overall Study|Employment Interfered with Study Visits|0|||
126287562|NCT00369941|454339839|FG000|Overall Study|Study Site Terminated|2|||
126287563|NCT00369941|454339840|FG001|Overall Study|Study Site Terminated|0|||
126287564|NCT00369941|454339839|FG000|Overall Study|Miscellaneous|3|||
126287565|NCT00369941|454339840|FG001|Overall Study|Miscellaneous|3|||
126287566|NCT01027702|454339841|FG000|Overall Study|Received subsequent therapy|1|||
126287567|NCT01027702|454339842|FG001|Overall Study|Received subsequent therapy|2|||
126287568|NCT01027702|454339843|FG002|Overall Study|Received subsequent therapy|0|||
126287569|NCT01027702|454339844|FG003|Overall Study|Received subsequent therapy|4|||
126287570|NCT01027702|454339845|FG004|Overall Study|Received subsequent therapy|1|||
126287571|NCT01027702|454339846|FG005|Overall Study|Received subsequent therapy|0|||
126287572|NCT01027702|454339847|FG006|Overall Study|Received subsequent therapy|1|||
126287573|NCT01027702|454339841|FG000|Overall Study|Death|0|||
126287574|NCT01027702|454339842|FG001|Overall Study|Death|0|||
126287575|NCT01027702|454339843|FG002|Overall Study|Death|1|||
126287576|NCT01027702|454339844|FG003|Overall Study|Death|0|||
126287577|NCT01027702|454339845|FG004|Overall Study|Death|0|||
126287578|NCT01027702|454339846|FG005|Overall Study|Death|0|||
126287579|NCT01027702|454339847|FG006|Overall Study|Death|0|||
126287580|NCT00403585|454339851|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
126287581|NCT00403585|454339851|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
126287582|NCT00403585|454339851|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
126287583|NCT00661193|454339852|FG000|Overall Study|Adverse Event|2|||
126287584|NCT00661193|454339853|FG001|Overall Study|Adverse Event|1|||
126287585|NCT00661193|454339852|FG000|Overall Study|Withdrawal by Subject|3|||
126287586|NCT00661193|454339853|FG001|Overall Study|Withdrawal by Subject|1|||
126287587|NCT00661193|454339852|FG000|Overall Study|Progression|27|||
126287588|NCT00661193|454339853|FG001|Overall Study|Progression|24|||
126287589|NCT00661193|454339852|FG000|Overall Study|Not protocol specified|1|||
126287590|NCT00661193|454339853|FG001|Overall Study|Not protocol specified|0|||
126287591|NCT02964312|454339860|FG000|Overall Study|Lost to Follow-up|28|||
126287592|NCT02964312|454339860|FG000|Overall Study|Withdrawal by Subject|11|||
126287593|NCT02964312|454339860|FG000|Overall Study|Lack of Efficacy|10|||
126287594|NCT02964312|454339860|FG000|Overall Study|Did not consent to long-term FU|14|||
126287595|NCT02964312|454339860|FG000|Overall Study|Death|1|||
126287596|NCT02862730|454339865|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
126287597|NCT02862730|454339866|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
126287598|NCT02862730|454339867|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
126766982|NCT00648739|456100185|FG004|Overall Study|Death|0|||
126365674|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
126365675|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
126287599|NCT02862730|454339868|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
126287600|NCT02862730|454339869|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
126766983|NCT00648739|456100186|FG005|Overall Study|Death|0|||
126287601|NCT02862730|454339870|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
126287602|NCT02862730|454339871|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
126287603|NCT02862730|454339865|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
126287604|NCT02862730|454339866|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
126287605|NCT02862730|454339867|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
126287606|NCT02862730|454339868|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
126287607|NCT02862730|454339869|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
126287608|NCT02862730|454339870|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
126287609|NCT02862730|454339871|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
126287610|NCT02862730|454339865|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
126287611|NCT02862730|454339866|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
126287612|NCT02862730|454339867|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
126287613|NCT02862730|454339868|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
126287614|NCT02862730|454339869|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
126287615|NCT02862730|454339870|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
126287616|NCT02862730|454339871|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
126287617|NCT02862730|454339865|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
126287618|NCT02862730|454339866|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
126287619|NCT02862730|454339867|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
126287620|NCT02862730|454339868|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
126287621|NCT02862730|454339869|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
126287622|NCT02862730|454339870|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
126287623|NCT02862730|454339871|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
126287624|NCT03685344|454339872|FG000|Overall Study|Withdrawal by Subject|1|||
126287625|NCT03685344|454339873|FG001|Overall Study|Withdrawal by Subject|1|||
126287626|NCT03685344|454339874|FG002|Overall Study|Withdrawal by Subject|2|||
126287627|NCT03685344|454339875|FG003|Overall Study|Withdrawal by Subject|0|||
126287628|NCT03685344|454339872|FG000|Overall Study|Physician Decision|1|||
126287629|NCT03685344|454339873|FG001|Overall Study|Physician Decision|1|||
126287630|NCT03685344|454339874|FG002|Overall Study|Physician Decision|5|||
126287631|NCT03685344|454339875|FG003|Overall Study|Physician Decision|0|||
126287632|NCT03685344|454339872|FG000|Overall Study|Death|1|||
126287633|NCT03685344|454339873|FG001|Overall Study|Death|1|||
126287634|NCT03685344|454339874|FG002|Overall Study|Death|0|||
126287635|NCT03685344|454339875|FG003|Overall Study|Death|0|||
126287636|NCT01023035|454339878|FG000|Treatment Period|Adverse Event|27|||
126287637|NCT01023035|454339879|FG001|Treatment Period|Adverse Event|32|||
126287638|NCT01023035|454339880|FG002|Treatment Period|Adverse Event|50|||
126287639|NCT01023035|454339878|FG000|Treatment Period|Non-Medical Reasons|19|||
126287640|NCT01023035|454339879|FG001|Treatment Period|Non-Medical Reasons|22|||
126287641|NCT01023035|454339880|FG002|Treatment Period|Non-Medical Reasons|44|||
126287642|NCT01023035|454339878|FG000|Treatment Period|Treatment Failure|26|||
126287643|NCT01023035|454339879|FG001|Treatment Period|Treatment Failure|31|||
126287644|NCT01023035|454339880|FG002|Treatment Period|Treatment Failure|24|||
126287645|NCT01023035|454339878|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
126287646|NCT01023035|454339879|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
126287647|NCT01023035|454339880|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
126287648|NCT01023035|454339878|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
126287649|NCT01023035|454339879|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
126287650|NCT01023035|454339880|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
126287651|NCT00524420|454339881|FG000|Overall Study|Lack of Efficacy|1|||
126287652|NCT00524420|454339882|FG001|Overall Study|Lack of Efficacy|0|||
126287653|NCT01090414|454339883|FG000|Study 101-99|Progressive Disease|28|||
126287654|NCT01090414|454339884|FG001|Study 101-99|Progressive Disease|48|||
126287655|NCT01090414|454339885|FG002|Study 101-99|Progressive Disease|10|||
126287656|NCT01090414|454339886|FG003|Study 101-99|Progressive Disease|4|||
126287657|NCT01090414|454339883|FG000|Study 101-99|Adverse Event|10|||
126287658|NCT01090414|454339884|FG001|Study 101-99|Adverse Event|28|||
126287659|NCT01090414|454339885|FG002|Study 101-99|Adverse Event|18|||
126287660|NCT01090414|454339886|FG003|Study 101-99|Adverse Event|0|||
126287661|NCT01090414|454339883|FG000|Study 101-99|Investigator Request|1|||
126549610|NCT00309608|455305708|FG004|Overall Study|Other incl. Lack of efficacy|0|||
126549611|NCT00621296|455305709|FG000|Overall Study|Adverse Event|2|||
126549612|NCT00621296|455305709|FG000|Overall Study|Lack of Efficacy|1|||
126549613|NCT00621296|455305709|FG000|Overall Study|Physician Decision|7|||
126549614|NCT00621296|455305709|FG000|Overall Study|Unmatch Criteria|1|||
126549615|NCT00621296|455305709|FG000|Overall Study|Stopping Criteria|3|||
126287662|NCT01090414|454339884|FG001|Study 101-99|Investigator Request|11|||
126549616|NCT00386308|455307534|FG000|Overall Study|Adverse Event|3|||
126287663|NCT01090414|454339885|FG002|Study 101-99|Investigator Request|4|||
126287664|NCT01090414|454339886|FG003|Study 101-99|Investigator Request|0|||
126287665|NCT01090414|454339883|FG000|Study 101-99|Death|3|||
126365676|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
126365677|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
126766984|NCT00648739|456100187|FG006|Overall Study|Death|0|||
126287666|NCT01090414|454339884|FG001|Study 101-99|Death|8|||
126287667|NCT01090414|454339885|FG002|Study 101-99|Death|1|||
126287668|NCT01090414|454339886|FG003|Study 101-99|Death|0|||
126287669|NCT01090414|454339883|FG000|Study 101-99|Sponsor Discontinued Study|0|||
126549617|NCT00386308|455307535|FG001|Overall Study|Adverse Event|3|||
126287670|NCT01090414|454339884|FG001|Study 101-99|Sponsor Discontinued Study|7|||
126287671|NCT01090414|454339885|FG002|Study 101-99|Sponsor Discontinued Study|5|||
126287672|NCT01090414|454339886|FG003|Study 101-99|Sponsor Discontinued Study|0|||
126287673|NCT01090414|454339883|FG000|Study 101-99|Other (Unknown Reasons)|3|||
126287674|NCT01090414|454339884|FG001|Study 101-99|Other (Unknown Reasons)|3|||
126287675|NCT01090414|454339885|FG002|Study 101-99|Other (Unknown Reasons)|0|||
126287676|NCT01090414|454339886|FG003|Study 101-99|Other (Unknown Reasons)|0|||
126287677|NCT01090414|454339883|FG000|Study 101-99|Withdrew Consent|0|||
126710399|NCT00092547|455891610|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
126710400|NCT00092547|455891611|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
126710401|NCT00092547|455891609|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
126710402|NCT00092547|455891610|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
126710403|NCT00092547|455891611|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
126710404|NCT00092547|455891609|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
126710405|NCT00092547|455891610|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
126710406|NCT00092547|455891611|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
126710407|NCT00092547|455891609|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
126710408|NCT00092547|455891610|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
126710409|NCT00092547|455891611|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
126710410|NCT00092547|455891609|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
126710411|NCT00092547|455891610|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
126710412|NCT00092547|455891611|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
126710413|NCT00092547|455891609|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
126710414|NCT00092547|455891610|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
126710415|NCT00092547|455891611|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
126710416|NCT00092547|455891609|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
126710417|NCT00092547|455891610|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
126710418|NCT00092547|455891611|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
126457307|NCT01227824|454974872|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
126457308|NCT01227824|454974873|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
126457309|NCT01227824|454974874|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
126457310|NCT01227824|454974872|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
126457311|NCT01227824|454974873|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
126457312|NCT01227824|454974874|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
126457313|NCT03836001|454974875|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
126457314|NCT03836001|454974876|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
126457315|NCT03836001|454974877|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
126457316|NCT03836001|454974875|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
126457317|NCT03836001|454974876|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
126457318|NCT03836001|454974877|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
126457319|NCT03836001|454974875|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
126457320|NCT03836001|454974876|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
126457321|NCT03836001|454974877|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
126710419|NCT00092547|455891609|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
126710420|NCT00092547|455891610|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
126710421|NCT00092547|455891611|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
126710422|NCT00092547|455891609|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
126287678|NCT01090414|454339884|FG001|Study 101-99|Withdrew Consent|2|||
126287679|NCT01090414|454339885|FG002|Study 101-99|Withdrew Consent|3|||
126287680|NCT01090414|454339886|FG003|Study 101-99|Withdrew Consent|1|||
126287681|NCT01090414|454339883|FG000|Study 101-99|Participant Request|3|||
126287682|NCT01090414|454339884|FG001|Study 101-99|Participant Request|1|||
126457322|NCT03836001|454974875|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
126457323|NCT03836001|454974876|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
126457324|NCT03836001|454974877|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
126457325|NCT01381562|454974878|FG000|Overall Study|Adverse Event|0|||
126457326|NCT01381562|454974879|FG001|Overall Study|Adverse Event|1|||
126457327|NCT01381562|454974880|FG002|Overall Study|Adverse Event|0|||
126457328|NCT01642732|454974884|FG000|Overall Study|Withdrawal by Subject|1|||
126457329|NCT00899353|454974887|FG000|Overall Study|Adverse Event|2|||
126457330|NCT00899353|454974887|FG000|Overall Study|Lost to Follow-up|1|||
126457331|NCT00899353|454974887|FG000|Overall Study|Withdrawal by Subject|2|||
126457332|NCT01284491|454974893|FG000|Overall Study|Study termination|13|||
126710423|NCT00092547|455891610|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
126710424|NCT00092547|455891611|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
126710425|NCT00092547|455891609|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
126287683|NCT01090414|454339885|FG002|Study 101-99|Participant Request|0|||
126287684|NCT01090414|454339886|FG003|Study 101-99|Participant Request|0|||
126287685|NCT02413229|454339893|FG000|Overall Study|Adverse Event|0|||
126287686|NCT02413229|454339894|FG001|Overall Study|Adverse Event|0|||
126287687|NCT02413229|454339895|FG002|Overall Study|Adverse Event|0|||
126287688|NCT02413229|454339896|FG003|Overall Study|Adverse Event|1|||
126287689|NCT02413229|454339897|FG004|Overall Study|Adverse Event|0|||
126287690|NCT02413229|454339898|FG005|Overall Study|Adverse Event|0|||
126287691|NCT02413229|454339899|FG006|Overall Study|Adverse Event|0|||
126287692|NCT02413229|454339900|FG007|Overall Study|Adverse Event|1|||
126287693|NCT02413229|454339893|FG000|Overall Study|Lost to Follow-up|0|||
126287694|NCT02413229|454339894|FG001|Overall Study|Lost to Follow-up|0|||
126287695|NCT02413229|454339895|FG002|Overall Study|Lost to Follow-up|1|||
126287696|NCT02413229|454339896|FG003|Overall Study|Lost to Follow-up|0|||
126287697|NCT02413229|454339897|FG004|Overall Study|Lost to Follow-up|2|||
126287698|NCT02413229|454339898|FG005|Overall Study|Lost to Follow-up|0|||
126287699|NCT02413229|454339899|FG006|Overall Study|Lost to Follow-up|0|||
126287700|NCT02413229|454339900|FG007|Overall Study|Lost to Follow-up|0|||
126287701|NCT02413229|454339893|FG000|Overall Study|Withdrawal by Subject|1|||
126287702|NCT02413229|454339894|FG001|Overall Study|Withdrawal by Subject|1|||
126287703|NCT02413229|454339895|FG002|Overall Study|Withdrawal by Subject|0|||
126287704|NCT02413229|454339896|FG003|Overall Study|Withdrawal by Subject|0|||
126287705|NCT02413229|454339897|FG004|Overall Study|Withdrawal by Subject|1|||
126287706|NCT02413229|454339898|FG005|Overall Study|Withdrawal by Subject|0|||
126287707|NCT02413229|454339899|FG006|Overall Study|Withdrawal by Subject|0|||
126287708|NCT02413229|454339900|FG007|Overall Study|Withdrawal by Subject|2|||
126287709|NCT02413229|454339893|FG000|Overall Study|Progressive Disease|0|||
126287710|NCT02413229|454339894|FG001|Overall Study|Progressive Disease|0|||
126287711|NCT02413229|454339895|FG002|Overall Study|Progressive Disease|0|||
126287712|NCT02413229|454339896|FG003|Overall Study|Progressive Disease|0|||
126287713|NCT02413229|454339897|FG004|Overall Study|Progressive Disease|0|||
126287714|NCT02413229|454339898|FG005|Overall Study|Progressive Disease|0|||
126287715|NCT02413229|454339899|FG006|Overall Study|Progressive Disease|0|||
126287716|NCT02413229|454339900|FG007|Overall Study|Progressive Disease|1|||
126287717|NCT02932462|454339901|FG000|Overall Study|Adverse Event|1|||
126287718|NCT02932462|454339902|FG001|Overall Study|Adverse Event|2|||
126287719|NCT02932462|454339901|FG000|Overall Study|Lost to Follow-up|4|||
126287720|NCT02932462|454339902|FG001|Overall Study|Lost to Follow-up|1|||
126287721|NCT02932462|454339901|FG000|Overall Study|Protocol Violation|0|||
126287722|NCT02932462|454339902|FG001|Overall Study|Protocol Violation|5|||
126287723|NCT02932462|454339901|FG000|Overall Study|Withdrawal by Subject|1|||
126287724|NCT02932462|454339902|FG001|Overall Study|Withdrawal by Subject|4|||
126287725|NCT02932462|454339901|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126287726|NCT02932462|454339902|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126287727|NCT02932462|454339901|FG000|Overall Study|Progressive Disease|1|||
126287728|NCT02932462|454339902|FG001|Overall Study|Progressive Disease|0|||
126287729|NCT02652949|454339903|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
126287730|NCT02652949|454339903|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
126287731|NCT02652949|454339903|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
126287732|NCT02652949|454339903|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
126287733|NCT02652949|454339903|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
126287734|NCT02652949|454339903|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
126287735|NCT02652949|454339903|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
126287736|NCT02652949|454339903|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
126287737|NCT02652949|454339903|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
126287738|NCT02652949|454339903|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
126287739|NCT02652949|454339903|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
126287740|NCT02652949|454339903|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
126287741|NCT02652949|454339903|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
126287742|NCT02652949|454339903|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
126287743|NCT02652949|454339903|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
126287744|NCT02652949|454339903|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
126287745|NCT02652949|454339903|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
126710426|NCT00092547|455891610|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
126365678|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
126365679|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
126365680|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
126365681|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
126365682|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126287746|NCT03022370|454339904|FG000|Overall Study|Death|6|||
126287747|NCT03022370|454339905|FG001|Overall Study|Death|12|||
126287748|NCT03022370|454339904|FG000|Overall Study|Lost to Follow-up|174|||
126287749|NCT03022370|454339905|FG001|Overall Study|Lost to Follow-up|109|||
126287750|NCT00699816|454339906|FG000|Overall Study|Protocol Violation|1|||
126287751|NCT00699816|454339907|FG001|Overall Study|Protocol Violation|3|||
126287752|NCT02454933|454339912|FG000|Overall Study|Progressive disease|10|||
126287753|NCT02454933|454339913|FG001|Overall Study|Progressive disease|7|||
126287754|NCT02454933|454339912|FG000|Overall Study|Adverse Event|1|||
126287755|NCT02454933|454339913|FG001|Overall Study|Adverse Event|1|||
126287756|NCT02454933|454339912|FG000|Overall Study|Withdrawal by Subject|0|||
126287757|NCT02454933|454339913|FG001|Overall Study|Withdrawal by Subject|3|||
126287758|NCT02454933|454339912|FG000|Overall Study|Lost to Follow-up|1|||
126287759|NCT02454933|454339913|FG001|Overall Study|Lost to Follow-up|0|||
126287760|NCT01526655|454339914|FG000|Overall Study|Withdrawal by Subject|0|||
126287761|NCT01526655|454339915|FG001|Overall Study|Withdrawal by Subject|1|||
126287762|NCT04753216|454339916|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
126287763|NCT04753216|454339916|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
126287764|NCT04753216|454339916|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
126287765|NCT05211726|454339925|FG000|Overall Study|Withdrawal by Subject|2|||
126287766|NCT05211726|454339926|FG001|Overall Study|Withdrawal by Subject|3|||
126287767|NCT05211726|454339925|FG000|Overall Study|Protocol Violation|0|||
126287768|NCT05211726|454339926|FG001|Overall Study|Protocol Violation|1|||
126287769|NCT02374346|454339932|FG000|Overall Study|operated or discharged during weekend|48|||
126287770|NCT04807400|454339933|FG000|Overall Study|Adverse Event|2|||
126287771|NCT04807400|454339934|FG001|Overall Study|Adverse Event|3|||
126287772|NCT04807400|454339935|FG002|Overall Study|Adverse Event|3|||
126287773|NCT04807400|454339933|FG000|Overall Study|Death|2|||
126287774|NCT04807400|454339934|FG001|Overall Study|Death|0|||
126287775|NCT04807400|454339935|FG002|Overall Study|Death|0|||
126287776|NCT04807400|454339933|FG000|Overall Study|Lost to Follow-up|8|||
126287777|NCT04807400|454339934|FG001|Overall Study|Lost to Follow-up|6|||
126287778|NCT04807400|454339935|FG002|Overall Study|Lost to Follow-up|6|||
126287779|NCT04807400|454339933|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126287780|NCT04807400|454339934|FG001|Overall Study|Non-Compliance With Study Drug|4|||
126287781|NCT04807400|454339935|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126287782|NCT04807400|454339933|FG000|Overall Study|Participant Decision|20|||
126287783|NCT04807400|454339934|FG001|Overall Study|Participant Decision|19|||
126287784|NCT04807400|454339935|FG002|Overall Study|Participant Decision|26|||
126287785|NCT04807400|454339933|FG000|Overall Study|Physician Decision|0|||
126287786|NCT04807400|454339934|FG001|Overall Study|Physician Decision|1|||
126287787|NCT04807400|454339935|FG002|Overall Study|Physician Decision|0|||
126287788|NCT04807400|454339933|FG000|Overall Study|Protocol Violation|4|||
126287789|NCT04807400|454339934|FG001|Overall Study|Protocol Violation|3|||
126287790|NCT04807400|454339935|FG002|Overall Study|Protocol Violation|7|||
126287791|NCT04807400|454339933|FG000|Overall Study|Withdrawal by Subject|13|||
126287792|NCT04807400|454339934|FG001|Overall Study|Withdrawal by Subject|9|||
126287793|NCT04807400|454339935|FG002|Overall Study|Withdrawal by Subject|20|||
126287794|NCT04807400|454339933|FG000|Overall Study|Mis-randomized|1|||
126287795|NCT04807400|454339934|FG001|Overall Study|Mis-randomized|0|||
126287796|NCT04807400|454339935|FG002|Overall Study|Mis-randomized|0|||
126287797|NCT03656744|454339938|FG000|Overall Study|Adverse Event|1|||
126287798|NCT03656744|454339939|FG001|Overall Study|Adverse Event|4|||
126287799|NCT03656744|454339940|FG002|Overall Study|Adverse Event|1|||
126287800|NCT03656744|454339938|FG000|Overall Study|Protocol Violation|1|||
126287801|NCT03656744|454339939|FG001|Overall Study|Protocol Violation|0|||
126287802|NCT03656744|454339940|FG002|Overall Study|Protocol Violation|0|||
126287803|NCT03656744|454339938|FG000|Overall Study|Lost to Follow-up|2|||
126287804|NCT03656744|454339939|FG001|Overall Study|Lost to Follow-up|2|||
126287805|NCT03656744|454339940|FG002|Overall Study|Lost to Follow-up|0|||
126287806|NCT03656744|454339938|FG000|Overall Study|Withdrawal by Subject|0|||
126287807|NCT03656744|454339939|FG001|Overall Study|Withdrawal by Subject|1|||
126287808|NCT03656744|454339940|FG002|Overall Study|Withdrawal by Subject|0|||
126287809|NCT03656744|454339938|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
126287810|NCT03656744|454339939|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
126287811|NCT03656744|454339940|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
126287812|NCT01332292|454339943|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
126287813|NCT01332292|454339944|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
126287814|NCT01332292|454339943|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
126287815|NCT01332292|454339944|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
126287816|NCT01332292|454339943|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
126287817|NCT01332292|454339944|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
126287818|NCT03910673|454339946|FG000|Overall Study|Adverse Event|0|||
126287819|NCT03910673|454339947|FG001|Overall Study|Adverse Event|0|||
126287820|NCT03910673|454339948|FG002|Overall Study|Adverse Event|0|||
126287821|NCT03910673|454339949|FG003|Overall Study|Adverse Event|2|||
126287822|NCT03910673|454339950|FG004|Overall Study|Adverse Event|0|||
126287823|NCT01487525|454339951|FG000|Overall Study|Withdrawal by Subject|0|||
126287824|NCT01487525|454339952|FG001|Overall Study|Withdrawal by Subject|1|||
126287825|NCT04650204|454339953|FG000|Overall Study|Study was Terminated|2|||
126287826|NCT04650204|454339954|FG001|Overall Study|Study was Terminated|1|||
126287827|NCT01330303|454339955|FG000|Period 1|Adverse Event|1|||
126287828|NCT01330303|454339956|FG001|Period 1|Adverse Event|0|||
126287829|NCT01330303|454339955|FG000|Period 1|Protocol Violation|0|||
126287830|NCT01330303|454339956|FG001|Period 1|Protocol Violation|1|||
126287831|NCT01330303|454339955|FG000|Period 1|Withdrawal by Subject|0|||
126287832|NCT01330303|454339956|FG001|Period 1|Withdrawal by Subject|1|||
126287833|NCT01107197|454339957|FG000|Overall Study|Death|12|||
126287834|NCT01107197|454339958|FG001|Overall Study|Death|10|||
126287835|NCT01107197|454339957|FG000|Overall Study|Lost to Follow-up|5|||
126287836|NCT01107197|454339958|FG001|Overall Study|Lost to Follow-up|8|||
126287837|NCT01107197|454339957|FG000|Overall Study|Withdrawal by Subject|3|||
126287838|NCT01107197|454339958|FG001|Overall Study|Withdrawal by Subject|5|||
126287839|NCT03548337|454339959|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
126287840|NCT03548337|454339960|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
126287841|NCT03548337|454339959|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
126287842|NCT03548337|454339960|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
126287843|NCT03548337|454339959|FG000|Infant Series|Lost to Follow-up|2|||
126287844|NCT03548337|454339960|FG001|Infant Series|Lost to Follow-up|1|||
126287845|NCT03548337|454339959|FG000|Infant Series|Adverse Event|0|||
126287846|NCT03548337|454339960|FG001|Infant Series|Adverse Event|2|||
126287847|NCT03548337|454339959|FG000|Infant Series|Randomized but Not Vaccinated|1|||
126287848|NCT03548337|454339960|FG001|Infant Series|Randomized but Not Vaccinated|0|||
126287849|NCT03548337|454339959|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
126287850|NCT03548337|454339960|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
126287851|NCT01911273|454339962|FG000|Overall Study|Progression of Disease|1|||
126287852|NCT01911273|454339963|FG001|Overall Study|Progression of Disease|0|||
126287853|NCT01911273|454339962|FG000|Overall Study|Withdrawal by Subject|0|||
126287854|NCT01911273|454339963|FG001|Overall Study|Withdrawal by Subject|2|||
126287855|NCT01855828|454339967|FG000|Overall Study|Adverse Event|1|||
126287856|NCT01855828|454339967|FG000|Overall Study|Withdrawal by Subject|1|||
126287857|NCT01866098|454339972|FG000|Overall Study|Lost to Follow-up|11|||
126287858|NCT01866098|454339973|FG001|Overall Study|Lost to Follow-up|18|||
126287859|NCT01866098|454339974|FG002|Overall Study|Lost to Follow-up|13|||
126287860|NCT01866098|454339972|FG000|Overall Study|Physician Decision|0|||
126287861|NCT01866098|454339973|FG001|Overall Study|Physician Decision|1|||
126287862|NCT01866098|454339974|FG002|Overall Study|Physician Decision|2|||
126287863|NCT01866098|454339972|FG000|Overall Study|Adverse Event|1|||
126287864|NCT01866098|454339973|FG001|Overall Study|Adverse Event|5|||
126287865|NCT01866098|454339974|FG002|Overall Study|Adverse Event|4|||
126287866|NCT01866098|454339972|FG000|Overall Study|Protocol Violation|1|||
126287867|NCT01866098|454339973|FG001|Overall Study|Protocol Violation|0|||
126287868|NCT01866098|454339974|FG002|Overall Study|Protocol Violation|0|||
126287869|NCT01866098|454339972|FG000|Overall Study|Withdrawal by Subject|1|||
126287870|NCT01866098|454339973|FG001|Overall Study|Withdrawal by Subject|2|||
126287871|NCT01866098|454339974|FG002|Overall Study|Withdrawal by Subject|0|||
126287872|NCT01866098|454339972|FG000|Overall Study|Unrelated Hospitalization|2|||
126287873|NCT01866098|454339973|FG001|Overall Study|Unrelated Hospitalization|0|||
126287874|NCT01866098|454339974|FG002|Overall Study|Unrelated Hospitalization|1|||
126287875|NCT01866098|454339972|FG000|Overall Study|Non-compliance|1|||
126287876|NCT01866098|454339973|FG001|Overall Study|Non-compliance|0|||
126287877|NCT01866098|454339974|FG002|Overall Study|Non-compliance|1|||
126287878|NCT01866098|454339972|FG000|Overall Study|Pregnancy|2|||
126287879|NCT01866098|454339973|FG001|Overall Study|Pregnancy|0|||
126287880|NCT01866098|454339974|FG002|Overall Study|Pregnancy|0|||
126287881|NCT01866098|454339972|FG000|Overall Study|Death|0|||
126287882|NCT01866098|454339973|FG001|Overall Study|Death|1|||
126287883|NCT01866098|454339974|FG002|Overall Study|Death|0|||
126287884|NCT02517463|454339982|FG000|Overall Study|Lost to Follow-up|5|||
126287885|NCT02517463|454339983|FG001|Overall Study|Lost to Follow-up|2|||
126287886|NCT03449446|454339984|FG000|Overall Study|Randomized but Never Treated|0|||
126287887|NCT03449446|454339985|FG001|Overall Study|Randomized but Never Treated|0|||
126287888|NCT03449446|454339986|FG002|Overall Study|Randomized but Never Treated|1|||
126287889|NCT03449446|454339987|FG003|Overall Study|Randomized but Never Treated|1|||
126766985|NCT00648739|456100181|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
126766986|NCT00648739|456100182|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
126766987|NCT00648739|456100183|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
126766988|NCT00648739|456100184|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
126287890|NCT03449446|454339988|FG004|Overall Study|Randomized but Never Treated|1|||
126287891|NCT03449446|454339989|FG005|Overall Study|Randomized but Never Treated|0|||
126287892|NCT03449446|454339990|FG006|Overall Study|Randomized but Never Treated|0|||
126365683|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126365684|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126287893|NCT03449446|454339984|FG000|Overall Study|Unknown Reason|33|||
126287894|NCT03449446|454339985|FG001|Overall Study|Unknown Reason|1|||
126287895|NCT03449446|454339986|FG002|Overall Study|Unknown Reason|1|||
126287896|NCT03449446|454339987|FG003|Overall Study|Unknown Reason|1|||
126287897|NCT03449446|454339988|FG004|Overall Study|Unknown Reason|2|||
126287898|NCT03449446|454339989|FG005|Overall Study|Unknown Reason|2|||
126287899|NCT03449446|454339990|FG006|Overall Study|Unknown Reason|0|||
126287900|NCT03449446|454339984|FG000|Overall Study|Withdrew Consent|1|||
126287901|NCT03449446|454339985|FG001|Overall Study|Withdrew Consent|3|||
126766989|NCT00648739|456100185|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
126766990|NCT00648739|456100186|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
126766991|NCT00648739|456100187|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
126766992|NCT00648739|456100181|FG000|Overall Study|Follow-up Visits Not Completed|0|||
126766993|NCT00648739|456100182|FG001|Overall Study|Follow-up Visits Not Completed|1|||
126766994|NCT00648739|456100183|FG002|Overall Study|Follow-up Visits Not Completed|0|||
126766995|NCT00648739|456100184|FG003|Overall Study|Follow-up Visits Not Completed|0|||
126766996|NCT00648739|456100185|FG004|Overall Study|Follow-up Visits Not Completed|0|||
126766997|NCT00648739|456100186|FG005|Overall Study|Follow-up Visits Not Completed|0|||
126766998|NCT00648739|456100187|FG006|Overall Study|Follow-up Visits Not Completed|0|||
126766999|NCT04930536|456100194|FG000|Overall Study|Adverse Event|1|||
126767000|NCT04930536|456100195|FG001|Overall Study|Adverse Event|0|||
126767001|NCT04930536|456100194|FG000|Overall Study|Disease Progression|2|||
126767002|NCT04930536|456100195|FG001|Overall Study|Disease Progression|0|||
126767003|NCT04930536|456100194|FG000|Overall Study|Patient Decision|4|||
126767004|NCT04930536|456100195|FG001|Overall Study|Patient Decision|2|||
126767005|NCT04930536|456100194|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
126767006|NCT04930536|456100195|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
126767007|NCT01432600|456100196|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
126767008|NCT01432600|456100197|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
126767009|NCT01432600|456100198|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
126287902|NCT03449446|454339986|FG002|Overall Study|Withdrew Consent|1|||
126287903|NCT03449446|454339987|FG003|Overall Study|Withdrew Consent|4|||
126287904|NCT03449446|454339988|FG004|Overall Study|Withdrew Consent|4|||
126287905|NCT03449446|454339989|FG005|Overall Study|Withdrew Consent|4|||
126287906|NCT03449446|454339990|FG006|Overall Study|Withdrew Consent|1|||
126287907|NCT03449446|454339984|FG000|Overall Study|Adverse Event|1|||
126287908|NCT03449446|454339985|FG001|Overall Study|Adverse Event|2|||
126287909|NCT03449446|454339986|FG002|Overall Study|Adverse Event|1|||
126287910|NCT03449446|454339987|FG003|Overall Study|Adverse Event|0|||
126287911|NCT03449446|454339988|FG004|Overall Study|Adverse Event|0|||
126287912|NCT03449446|454339989|FG005|Overall Study|Adverse Event|2|||
126287913|NCT03449446|454339990|FG006|Overall Study|Adverse Event|0|||
126287914|NCT03449446|454339984|FG000|Overall Study|Lost to Follow-up|0|||
126287915|NCT03449446|454339985|FG001|Overall Study|Lost to Follow-up|0|||
126287916|NCT03449446|454339986|FG002|Overall Study|Lost to Follow-up|2|||
126287917|NCT03449446|454339987|FG003|Overall Study|Lost to Follow-up|1|||
126287918|NCT03449446|454339988|FG004|Overall Study|Lost to Follow-up|3|||
126287919|NCT03449446|454339989|FG005|Overall Study|Lost to Follow-up|0|||
126287920|NCT03449446|454339990|FG006|Overall Study|Lost to Follow-up|0|||
126287921|NCT03449446|454339984|FG000|Overall Study|Investigator's Discretion|0|||
126287922|NCT03449446|454339985|FG001|Overall Study|Investigator's Discretion|1|||
126287923|NCT03449446|454339986|FG002|Overall Study|Investigator's Discretion|1|||
126287924|NCT03449446|454339987|FG003|Overall Study|Investigator's Discretion|2|||
126287925|NCT03449446|454339988|FG004|Overall Study|Investigator's Discretion|0|||
126287926|NCT03449446|454339989|FG005|Overall Study|Investigator's Discretion|0|||
126287927|NCT03449446|454339990|FG006|Overall Study|Investigator's Discretion|0|||
126287928|NCT03449446|454339984|FG000|Overall Study|Non Compliance with Study Drug|1|||
126287929|NCT03449446|454339985|FG001|Overall Study|Non Compliance with Study Drug|0|||
126287930|NCT03449446|454339986|FG002|Overall Study|Non Compliance with Study Drug|0|||
126287931|NCT03449446|454339987|FG003|Overall Study|Non Compliance with Study Drug|0|||
126287932|NCT03449446|454339988|FG004|Overall Study|Non Compliance with Study Drug|0|||
126287933|NCT03449446|454339989|FG005|Overall Study|Non Compliance with Study Drug|0|||
126287934|NCT03449446|454339990|FG006|Overall Study|Non Compliance with Study Drug|0|||
126287935|NCT03449446|454339984|FG000|Overall Study|Protocol Violation|0|||
126287936|NCT03449446|454339985|FG001|Overall Study|Protocol Violation|0|||
126287937|NCT03449446|454339986|FG002|Overall Study|Protocol Violation|0|||
126287938|NCT03449446|454339987|FG003|Overall Study|Protocol Violation|0|||
126287939|NCT03449446|454339988|FG004|Overall Study|Protocol Violation|1|||
126287940|NCT03449446|454339989|FG005|Overall Study|Protocol Violation|1|||
126287941|NCT03449446|454339990|FG006|Overall Study|Protocol Violation|0|||
126287942|NCT03449446|454339984|FG000|Overall Study|Death|0|||
126457333|NCT02694757|454974896|FG000|Overall Study|Lack of Efficacy|3|||
126457334|NCT02650921|454974899|FG000|Overall Study|Withdrawal by Subject|4|||
126767010|NCT04139642|456100199|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
126457335|NCT02650921|454974899|FG000|Overall Study|Lost to Follow-up|2|||
126287943|NCT03449446|454339985|FG001|Overall Study|Death|0|||
126287944|NCT03449446|454339986|FG002|Overall Study|Death|0|||
126287945|NCT03449446|454339987|FG003|Overall Study|Death|0|||
126287946|NCT03449446|454339988|FG004|Overall Study|Death|1|||
126287947|NCT03449446|454339989|FG005|Overall Study|Death|0|||
126287948|NCT03449446|454339990|FG006|Overall Study|Death|0|||
126287949|NCT04460885|454342097|FG000|Overall Study|Withdrawal by Subject|6|||
126287950|NCT04460885|454342098|FG001|Overall Study|Withdrawal by Subject|8|||
126287951|NCT04460885|454342097|FG000|Overall Study|Site closure|1|||
126457336|NCT02650921|454974899|FG000|Overall Study|Adverse Event|1|||
126287952|NCT04460885|454342098|FG001|Overall Study|Site closure|0|||
126287953|NCT04460885|454342097|FG000|Overall Study|Death|5|||
126287954|NCT04460885|454342098|FG001|Overall Study|Death|4|||
126287955|NCT04460885|454342097|FG000|Overall Study|Physician Decision|2|||
126287956|NCT04460885|454342098|FG001|Overall Study|Physician Decision|1|||
126287957|NCT04460885|454342097|FG000|Overall Study|Lost to Follow-up|4|||
126287958|NCT04460885|454342098|FG001|Overall Study|Lost to Follow-up|4|||
126287959|NCT04559347|454342099|FG000|Overall Study|Death|1|||
126287960|NCT04559347|454342100|FG001|Overall Study|Death|0|||
126287961|NCT04559347|454342099|FG000|Overall Study|Thoracotomy conversion|1|||
126287962|NCT04559347|454342100|FG001|Overall Study|Thoracotomy conversion|1|||
126287963|NCT04559347|454342099|FG000|Overall Study|Provider unavailable|2|||
126287964|NCT04559347|454342100|FG001|Overall Study|Provider unavailable|1|||
126287965|NCT04559347|454342099|FG000|Overall Study|Other|2|||
126287966|NCT04559347|454342100|FG001|Overall Study|Other|1|||
126287967|NCT03999996|454342105|FG000|Prior to Booster|Adverse Event|2|||
126287968|NCT03999996|454342106|FG001|Prior to Booster|Adverse Event|0|||
126287969|NCT03999996|454342107|FG002|Prior to Booster|Adverse Event|0|||
126287970|NCT03999996|454342108|FG003|Prior to Booster|Adverse Event|0|||
126287971|NCT03999996|454342105|FG000|Prior to Booster|Lost to Follow-up|17|||
126287972|NCT03999996|454342106|FG001|Prior to Booster|Lost to Follow-up|22|||
126287973|NCT03999996|454342107|FG002|Prior to Booster|Lost to Follow-up|0|||
126287974|NCT03999996|454342108|FG003|Prior to Booster|Lost to Follow-up|0|||
126287975|NCT03999996|454342105|FG000|Prior to Booster|Withdrawal of Consent|51|||
126287976|NCT03999996|454342106|FG001|Prior to Booster|Withdrawal of Consent|8|||
126287977|NCT03999996|454342107|FG002|Prior to Booster|Withdrawal of Consent|0|||
126287978|NCT03999996|454342108|FG003|Prior to Booster|Withdrawal of Consent|0|||
126287979|NCT03999996|454342105|FG000|Prior to Booster|Death|0|||
126287980|NCT03999996|454342106|FG001|Prior to Booster|Death|1|||
126287981|NCT03999996|454342107|FG002|Prior to Booster|Death|0|||
126287982|NCT03999996|454342108|FG003|Prior to Booster|Death|0|||
126287983|NCT03999996|454342105|FG000|Prior to Booster|Reason Not Specified|27|||
126287984|NCT03999996|454342106|FG001|Prior to Booster|Reason Not Specified|4|||
126287985|NCT03999996|454342107|FG002|Prior to Booster|Reason Not Specified|0|||
126287986|NCT03999996|454342108|FG003|Prior to Booster|Reason Not Specified|0|||
126287987|NCT03999996|454342105|FG000|Booster Phase|Lost to Follow-up|0|||
126287988|NCT03999996|454342106|FG001|Booster Phase|Lost to Follow-up|0|||
126287989|NCT03999996|454342107|FG002|Booster Phase|Lost to Follow-up|3|||
126287990|NCT03999996|454342108|FG003|Booster Phase|Lost to Follow-up|3|||
126287991|NCT03999996|454342105|FG000|Booster Phase|Withdrawal of Consent|0|||
126287992|NCT03999996|454342106|FG001|Booster Phase|Withdrawal of Consent|0|||
126287993|NCT03999996|454342107|FG002|Booster Phase|Withdrawal of Consent|0|||
126287994|NCT03999996|454342108|FG003|Booster Phase|Withdrawal of Consent|1|||
126287995|NCT03999996|454342105|FG000|Booster Phase|Reason Not Specified|0|||
126287996|NCT03999996|454342106|FG001|Booster Phase|Reason Not Specified|0|||
126287997|NCT03999996|454342107|FG002|Booster Phase|Reason Not Specified|0|||
126287998|NCT03999996|454342108|FG003|Booster Phase|Reason Not Specified|1|||
126287999|NCT00733005|454342109|FG000|Overall Study|Adverse Event|0|||
126288000|NCT00733005|454342110|FG001|Overall Study|Adverse Event|1|||
126288001|NCT00733005|454342109|FG000|Overall Study|Treatment Failure|0|||
126288002|NCT00733005|454342110|FG001|Overall Study|Treatment Failure|1|||
126288003|NCT00733005|454342109|FG000|Overall Study|Withdrawal by Subject|0|||
126288004|NCT00733005|454342110|FG001|Overall Study|Withdrawal by Subject|1|||
126288005|NCT00733005|454342109|FG000|Overall Study|Protocol Violation|2|||
126365685|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126365686|NCT01111552|454632857|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
126365687|NCT01111552|454632858|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
126365688|NCT01111552|454632859|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
126365689|NCT01111552|454632860|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
126365690|NCT01111552|454632861|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
126365691|NCT01111552|454632857|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126365692|NCT01111552|454632858|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126365693|NCT01111552|454632859|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126365694|NCT01111552|454632860|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
126365695|NCT01111552|454632861|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126365696|NCT01111552|454632857|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
126365697|NCT01111552|454632858|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
126365698|NCT01111552|454632859|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
126288006|NCT00733005|454342110|FG001|Overall Study|Protocol Violation|0|||
126288007|NCT00266630|454342111|FG000|Overall Study|Adverse Event|8|||
126288008|NCT00266630|454342112|FG001|Overall Study|Adverse Event|6|||
126288009|NCT00266630|454342111|FG000|Overall Study|Lack of Efficacy|1|||
126288010|NCT00266630|454342112|FG001|Overall Study|Lack of Efficacy|4|||
126288011|NCT00266630|454342111|FG000|Overall Study|Entry Criteria not met|1|||
126288012|NCT00266630|454342112|FG001|Overall Study|Entry Criteria not met|0|||
126288013|NCT00266630|454342111|FG000|Overall Study|Protocol Violation|1|||
126288014|NCT00266630|454342112|FG001|Overall Study|Protocol Violation|3|||
126288015|NCT00266630|454342111|FG000|Overall Study|Physician Decision|1|||
126288016|NCT00266630|454342112|FG001|Overall Study|Physician Decision|2|||
126288017|NCT00266630|454342111|FG000|Overall Study|Withdrawal by Subject|10|||
126549618|NCT00386308|455307534|FG000|Overall Study|Protocol Violation|2|||
126549619|NCT00386308|455307535|FG001|Overall Study|Protocol Violation|5|||
126549620|NCT00386308|455307534|FG000|Overall Study|Lack of Efficacy|0|||
126549621|NCT00386308|455307535|FG001|Overall Study|Lack of Efficacy|2|||
126549622|NCT00386308|455307534|FG000|Overall Study|Lost to Follow-up|10|||
126549623|NCT00386308|455307535|FG001|Overall Study|Lost to Follow-up|6|||
126549624|NCT00386308|455307534|FG000|Overall Study|Withdrawal by Subject|6|||
126549625|NCT00386308|455307535|FG001|Overall Study|Withdrawal by Subject|2|||
126710427|NCT00092547|455891611|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
126710428|NCT01539837|455891612|FG000|Overall Study|reduce neutrophil level|0|||
126710429|NCT01539837|455891613|FG001|Overall Study|reduce neutrophil level|1|||
126288018|NCT00266630|454342112|FG001|Overall Study|Withdrawal by Subject|2|||
126288019|NCT00266630|454342111|FG000|Overall Study|Lost to Follow-up|1|||
126288020|NCT00266630|454342112|FG001|Overall Study|Lost to Follow-up|0|||
126288021|NCT00266630|454342111|FG000|Overall Study|Other|19|||
126288022|NCT00266630|454342112|FG001|Overall Study|Other|11|||
126288023|NCT03410056|454342113|FG000|Overall Study|Decision by Sponsor|0|||
126288024|NCT03410056|454342114|FG001|Overall Study|Decision by Sponsor|0|||
126288025|NCT03410056|454342115|FG002|Overall Study|Decision by Sponsor|3|||
126288026|NCT03410056|454342116|FG003|Overall Study|Decision by Sponsor|0|||
126288027|NCT03410056|454342117|FG004|Overall Study|Decision by Sponsor|0|||
126288028|NCT03410056|454342118|FG005|Overall Study|Decision by Sponsor|0|||
126288029|NCT03410056|454342119|FG006|Overall Study|Decision by Sponsor|0|||
126288030|NCT03410056|454342113|FG000|Overall Study|Withdrawal by Subject|0|||
126288031|NCT03410056|454342114|FG001|Overall Study|Withdrawal by Subject|2|||
126288032|NCT03410056|454342115|FG002|Overall Study|Withdrawal by Subject|5|||
126288033|NCT03410056|454342116|FG003|Overall Study|Withdrawal by Subject|5|||
126288034|NCT03410056|454342117|FG004|Overall Study|Withdrawal by Subject|0|||
126288035|NCT03410056|454342118|FG005|Overall Study|Withdrawal by Subject|0|||
126288036|NCT03410056|454342119|FG006|Overall Study|Withdrawal by Subject|0|||
126288037|NCT03284723|454342120|FG000|Overall Study|Death|0|||
126288038|NCT03284723|454342121|FG001|Overall Study|Death|0|||
126288039|NCT03284723|454342122|FG002|Overall Study|Death|0|||
126288040|NCT03284723|454342123|FG003|Overall Study|Death|1|||
126288041|NCT03284723|454342124|FG004|Overall Study|Death|0|||
126288042|NCT03284723|454342125|FG005|Overall Study|Death|0|||
126288043|NCT03284723|454342126|FG006|Overall Study|Death|1|||
126457337|NCT02650921|454974899|FG000|Overall Study|Due to Medical Condition|1|||
126710430|NCT01539837|455891614|FG002|Overall Study|reduce neutrophil level|1|||
126710431|NCT01539837|455891612|FG000|Overall Study|bad compliance|0|||
126710432|NCT01539837|455891613|FG001|Overall Study|bad compliance|0|||
126710433|NCT01539837|455891614|FG002|Overall Study|bad compliance|1|||
126710434|NCT01978912|455891616|FG000|Overall Study|Adverse Event|0|||
126767011|NCT04139642|456100200|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
126767012|NCT00433771|456100202|FG000|Overall Study|screen fail|14|||
126288044|NCT03284723|454342127|FG007|Overall Study|Death|0|||
126288045|NCT03284723|454342128|FG008|Overall Study|Death|0|||
126288046|NCT03284723|454342129|FG009|Overall Study|Death|2|||
126457338|NCT00783302|454974900|FG000|Overall Study|Lost to Follow-up|17|||
126457339|NCT00783302|454974900|FG000|Overall Study|Technical Problems|11|||
126457340|NCT00783302|454974900|FG000|Overall Study|Protocol Violation|3|||
126767013|NCT00433771|456100202|FG000|Overall Study|Treated and later found to be ineligible|2|||
126767014|NCT00433771|456100202|FG000|Overall Study|Death|2|||
126288047|NCT03284723|454342130|FG010|Overall Study|Death|1|||
126288048|NCT03284723|454342131|FG011|Overall Study|Death|0|||
126457341|NCT00783302|454974900|FG000|Overall Study|Physician Decision|1|||
126457342|NCT00783302|454974900|FG000|Overall Study|Withdrawal by Subject|3|||
126457343|NCT04604132|454974901|FG000|Overall Study|Adverse Event|2|||
126457344|NCT04604132|454974902|FG001|Overall Study|Adverse Event|0|||
126457345|NCT04604132|454974903|FG002|Overall Study|Adverse Event|0|||
126457346|NCT04604132|454974904|FG003|Overall Study|Adverse Event|1|||
126457347|NCT04604132|454974905|FG004|Overall Study|Adverse Event|2|||
126457348|NCT04604132|454974901|FG000|Overall Study|Study terminated by sponsor|0|||
126457349|NCT04604132|454974902|FG001|Overall Study|Study terminated by sponsor|0|||
126288049|NCT03284723|454342120|FG000|Overall Study|Lost to Follow-up|0|||
126288050|NCT03284723|454342121|FG001|Overall Study|Lost to Follow-up|0|||
126288051|NCT03284723|454342122|FG002|Overall Study|Lost to Follow-up|0|||
126288052|NCT03284723|454342123|FG003|Overall Study|Lost to Follow-up|0|||
126288053|NCT03284723|454342124|FG004|Overall Study|Lost to Follow-up|0|||
126457350|NCT04604132|454974903|FG002|Overall Study|Study terminated by sponsor|0|||
126457351|NCT04604132|454974904|FG003|Overall Study|Study terminated by sponsor|0|||
126549626|NCT00386308|455307534|FG000|Overall Study|Other Event|8|||
126549627|NCT00386308|455307535|FG001|Overall Study|Other Event|1|||
126710435|NCT01978912|455891617|FG001|Overall Study|Adverse Event|1|||
126710436|NCT01978912|455891618|FG002|Overall Study|Adverse Event|0|||
126288054|NCT03284723|454342125|FG005|Overall Study|Lost to Follow-up|2|||
126288055|NCT03284723|454342126|FG006|Overall Study|Lost to Follow-up|1|||
126288056|NCT03284723|454342127|FG007|Overall Study|Lost to Follow-up|0|||
126288057|NCT03284723|454342128|FG008|Overall Study|Lost to Follow-up|0|||
126288058|NCT03284723|454342129|FG009|Overall Study|Lost to Follow-up|2|||
126288059|NCT03284723|454342130|FG010|Overall Study|Lost to Follow-up|0|||
126288060|NCT03284723|454342131|FG011|Overall Study|Lost to Follow-up|0|||
126288061|NCT03284723|454342120|FG000|Overall Study|Study Terminated By Sponsor|0|||
126288062|NCT03284723|454342121|FG001|Overall Study|Study Terminated By Sponsor|0|||
126288063|NCT03284723|454342122|FG002|Overall Study|Study Terminated By Sponsor|0|||
126288064|NCT03284723|454342123|FG003|Overall Study|Study Terminated By Sponsor|0|||
126288065|NCT03284723|454342124|FG004|Overall Study|Study Terminated By Sponsor|1|||
126288066|NCT03284723|454342125|FG005|Overall Study|Study Terminated By Sponsor|0|||
126288067|NCT03284723|454342126|FG006|Overall Study|Study Terminated By Sponsor|0|||
126288068|NCT03284723|454342127|FG007|Overall Study|Study Terminated By Sponsor|0|||
126288069|NCT03284723|454342128|FG008|Overall Study|Study Terminated By Sponsor|1|||
126288070|NCT03284723|454342129|FG009|Overall Study|Study Terminated By Sponsor|1|||
126288071|NCT03284723|454342130|FG010|Overall Study|Study Terminated By Sponsor|1|||
126288072|NCT03284723|454342131|FG011|Overall Study|Study Terminated By Sponsor|1|||
126288073|NCT03284723|454342120|FG000|Overall Study|Withdrawal by Subject|0|||
126457352|NCT04604132|454974905|FG004|Overall Study|Study terminated by sponsor|1|||
126288074|NCT03284723|454342121|FG001|Overall Study|Withdrawal by Subject|0|||
126288075|NCT03284723|454342122|FG002|Overall Study|Withdrawal by Subject|0|||
126457353|NCT04604132|454974901|FG000|Overall Study|Progressive disease: Clinical progression|0|||
126457354|NCT04604132|454974902|FG001|Overall Study|Progressive disease: Clinical progression|0|||
126457355|NCT04604132|454974903|FG002|Overall Study|Progressive disease: Clinical progression|1|||
126457356|NCT04604132|454974904|FG003|Overall Study|Progressive disease: Clinical progression|0|||
126457357|NCT04604132|454974905|FG004|Overall Study|Progressive disease: Clinical progression|0|||
126457358|NCT04604132|454974901|FG000|Overall Study|Progressive disease: Radiological progression|8|||
126457359|NCT04604132|454974902|FG001|Overall Study|Progressive disease: Radiological progression|7|||
126457360|NCT04604132|454974903|FG002|Overall Study|Progressive disease: Radiological progression|10|||
126457361|NCT04604132|454974904|FG003|Overall Study|Progressive disease: Radiological progression|4|||
126457362|NCT04604132|454974905|FG004|Overall Study|Progressive disease: Radiological progression|3|||
126457363|NCT04604132|454974901|FG000|Overall Study|Death|3|||
126457364|NCT04604132|454974902|FG001|Overall Study|Death|1|||
126457365|NCT04604132|454974903|FG002|Overall Study|Death|2|||
126457366|NCT04604132|454974904|FG003|Overall Study|Death|1|||
126457367|NCT04604132|454974905|FG004|Overall Study|Death|0|||
126457368|NCT00952380|454974906|FG000|Overall Study|Other|0|||
126457369|NCT00952380|454974907|FG001|Overall Study|Other|0|||
126457370|NCT00952380|454974908|FG002|Overall Study|Other|0|||
126457371|NCT00952380|454974909|FG003|Overall Study|Other|0|||
126457372|NCT00952380|454974910|FG004|Overall Study|Other|1|||
126457373|NCT00952380|454974906|FG000|Overall Study|Withdrawal by Subject|0|||
126457374|NCT00952380|454974907|FG001|Overall Study|Withdrawal by Subject|0|||
126457375|NCT00952380|454974908|FG002|Overall Study|Withdrawal by Subject|1|||
126457376|NCT00952380|454974909|FG003|Overall Study|Withdrawal by Subject|0|||
126457377|NCT00952380|454974910|FG004|Overall Study|Withdrawal by Subject|2|||
126457378|NCT00952380|454974906|FG000|Overall Study|Adverse Event|0|||
126457379|NCT00952380|454974907|FG001|Overall Study|Adverse Event|1|||
126457380|NCT00952380|454974908|FG002|Overall Study|Adverse Event|0|||
126457381|NCT00952380|454974909|FG003|Overall Study|Adverse Event|0|||
126457382|NCT00952380|454974910|FG004|Overall Study|Adverse Event|3|||
126457383|NCT00952380|454974906|FG000|Overall Study|Physician Decision|0|||
126457384|NCT00952380|454974907|FG001|Overall Study|Physician Decision|0|||
126457385|NCT00952380|454974908|FG002|Overall Study|Physician Decision|1|||
126710437|NCT01978912|455891619|FG003|Overall Study|Adverse Event|0|||
126288076|NCT03284723|454342123|FG003|Overall Study|Withdrawal by Subject|0|||
126288077|NCT03284723|454342124|FG004|Overall Study|Withdrawal by Subject|5|||
126288078|NCT03284723|454342125|FG005|Overall Study|Withdrawal by Subject|3|||
126288079|NCT03284723|454342126|FG006|Overall Study|Withdrawal by Subject|1|||
126288080|NCT03284723|454342127|FG007|Overall Study|Withdrawal by Subject|0|||
126288081|NCT03284723|454342128|FG008|Overall Study|Withdrawal by Subject|6|||
126288082|NCT03284723|454342129|FG009|Overall Study|Withdrawal by Subject|0|||
126288083|NCT03284723|454342130|FG010|Overall Study|Withdrawal by Subject|3|||
126288084|NCT03284723|454342131|FG011|Overall Study|Withdrawal by Subject|1|||
126288085|NCT03284723|454342120|FG000|Overall Study|Other|1|||
126457386|NCT00952380|454974909|FG003|Overall Study|Physician Decision|2|||
126457387|NCT00952380|454974910|FG004|Overall Study|Physician Decision|0|||
126457388|NCT00952380|454974906|FG000|Overall Study|Non-compliant to protocol|0|||
126457389|NCT00952380|454974907|FG001|Overall Study|Non-compliant to protocol|0|||
126457390|NCT00952380|454974908|FG002|Overall Study|Non-compliant to protocol|0|||
126457391|NCT00952380|454974909|FG003|Overall Study|Non-compliant to protocol|1|||
126457392|NCT00952380|454974910|FG004|Overall Study|Non-compliant to protocol|0|||
126457393|NCT03400956|454974911|FG000|Treatment Period 1|Adverse Event|0|||
126457394|NCT03400956|454974912|FG001|Treatment Period 1|Adverse Event|1|||
126549628|NCT02906683|455307536|FG000|Overall Study|Adverse Event|0|||
126549629|NCT02906683|455307537|FG001|Overall Study|Adverse Event|1|||
126549630|NCT02906683|455307538|FG002|Overall Study|Adverse Event|0|||
126549631|NCT02906683|455307536|FG000|Overall Study|Physician Decision|0|||
126549632|NCT02906683|455307537|FG001|Overall Study|Physician Decision|1|||
126549633|NCT02906683|455307538|FG002|Overall Study|Physician Decision|1|||
126549634|NCT02906683|455307536|FG000|Overall Study|Withdrawal by Subject|0|||
126549635|NCT02906683|455307537|FG001|Overall Study|Withdrawal by Subject|2|||
126549636|NCT02906683|455307538|FG002|Overall Study|Withdrawal by Subject|1|||
126549637|NCT02906683|455307536|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
126549638|NCT02906683|455307537|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
126549639|NCT02906683|455307538|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
126457395|NCT03400956|454974913|FG002|Treatment Period 1|Adverse Event|0|||
126457396|NCT03400956|454974911|FG000|Treatment Period 1|Lost to Follow-up|0|||
126457397|NCT03400956|454974912|FG001|Treatment Period 1|Lost to Follow-up|0|||
126457398|NCT03400956|454974913|FG002|Treatment Period 1|Lost to Follow-up|1|||
126457399|NCT03400956|454974911|FG000|Treatment Period 1|Protocol Violation|0|||
126457400|NCT03400956|454974912|FG001|Treatment Period 1|Protocol Violation|2|||
126457401|NCT03400956|454974913|FG002|Treatment Period 1|Protocol Violation|0|||
126457402|NCT03400956|454974911|FG000|Treatment Period 1|Study terminated by sponsor|3|||
126457403|NCT03400956|454974912|FG001|Treatment Period 1|Study terminated by sponsor|1|||
126457404|NCT03400956|454974913|FG002|Treatment Period 1|Study terminated by sponsor|1|||
126457405|NCT03400956|454974911|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126457406|NCT03400956|454974912|FG001|Treatment Period 1|Withdrawal by Subject|2|||
126549640|NCT02906683|455307536|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
126549641|NCT02906683|455307537|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
126767015|NCT00433771|456100202|FG000|Overall Study|Failure to deploy stent|1|||
126288086|NCT03284723|454342121|FG001|Overall Study|Other|0|||
126288087|NCT03284723|454342122|FG002|Overall Study|Other|1|||
126288088|NCT03284723|454342123|FG003|Overall Study|Other|0|||
126288089|NCT03284723|454342124|FG004|Overall Study|Other|1|||
126288090|NCT03284723|454342125|FG005|Overall Study|Other|0|||
126288091|NCT03284723|454342126|FG006|Overall Study|Other|0|||
126288092|NCT03284723|454342127|FG007|Overall Study|Other|0|||
126288093|NCT03284723|454342128|FG008|Overall Study|Other|0|||
126288094|NCT03284723|454342129|FG009|Overall Study|Other|0|||
126288095|NCT03284723|454342130|FG010|Overall Study|Other|1|||
126288096|NCT03284723|454342131|FG011|Overall Study|Other|0|||
126288097|NCT03284723|454342120|FG000|Overall Study|Adverse Event|0|||
126288098|NCT03284723|454342121|FG001|Overall Study|Adverse Event|0|||
126288099|NCT03284723|454342122|FG002|Overall Study|Adverse Event|0|||
126288100|NCT03284723|454342123|FG003|Overall Study|Adverse Event|0|||
126288101|NCT03284723|454342124|FG004|Overall Study|Adverse Event|0|||
126288102|NCT03284723|454342125|FG005|Overall Study|Adverse Event|0|||
126288103|NCT03284723|454342126|FG006|Overall Study|Adverse Event|0|||
126288104|NCT03284723|454342127|FG007|Overall Study|Adverse Event|0|||
126288105|NCT03284723|454342128|FG008|Overall Study|Adverse Event|1|||
126288106|NCT03284723|454342129|FG009|Overall Study|Adverse Event|0|||
126288107|NCT03284723|454342130|FG010|Overall Study|Adverse Event|0|||
126288108|NCT03284723|454342131|FG011|Overall Study|Adverse Event|0|||
126288109|NCT00615199|454342132|FG000|Overall Study|Adverse Event|3|||
126288110|NCT00615199|454342133|FG001|Overall Study|Adverse Event|1|||
126288111|NCT00615199|454342134|FG002|Overall Study|Adverse Event|1|||
126288112|NCT00615199|454342135|FG003|Overall Study|Adverse Event|0|||
126288113|NCT00615199|454342132|FG000|Overall Study|Lack of Efficacy|2|||
126288114|NCT00615199|454342133|FG001|Overall Study|Lack of Efficacy|0|||
126288115|NCT00615199|454342134|FG002|Overall Study|Lack of Efficacy|0|||
126288116|NCT00615199|454342135|FG003|Overall Study|Lack of Efficacy|1|||
126288117|NCT00615199|454342132|FG000|Overall Study|Lost to Follow-up|1|||
126288118|NCT00615199|454342133|FG001|Overall Study|Lost to Follow-up|0|||
126288119|NCT00615199|454342134|FG002|Overall Study|Lost to Follow-up|0|||
126288120|NCT00615199|454342135|FG003|Overall Study|Lost to Follow-up|0|||
126288121|NCT00615199|454342132|FG000|Overall Study|Other|0|||
126288122|NCT00615199|454342133|FG001|Overall Study|Other|0|||
126288123|NCT00615199|454342134|FG002|Overall Study|Other|0|||
126288124|NCT00615199|454342135|FG003|Overall Study|Other|1|||
126288125|NCT00615199|454342132|FG000|Overall Study|Withdrawal by Subject|2|||
126288126|NCT00615199|454342133|FG001|Overall Study|Withdrawal by Subject|1|||
126288127|NCT00615199|454342134|FG002|Overall Study|Withdrawal by Subject|0|||
126288128|NCT00615199|454342135|FG003|Overall Study|Withdrawal by Subject|0|||
126288129|NCT00064987|454342140|FG000|Overall Study|Physician Decision|3|||
126288130|NCT00064987|454342141|FG001|Overall Study|Physician Decision|0|||
126288131|NCT00764881|454342142|FG000|Overall Study|Adverse Event|5|||
126288132|NCT00764881|454342143|FG001|Overall Study|Adverse Event|1|||
126288133|NCT00764881|454342142|FG000|Overall Study|Withdrawal by Subject|1|||
126288134|NCT00764881|454342143|FG001|Overall Study|Withdrawal by Subject|3|||
126549642|NCT02906683|455307538|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
126549643|NCT01340482|455307539|FG000|Overall Study|Adverse Event|2|||
126549644|NCT01340482|455307540|FG001|Overall Study|Adverse Event|0|||
126549645|NCT01340482|455307541|FG002|Overall Study|Adverse Event|0|||
126549646|NCT00744237|455307542|FG000|Overall Study|Lack of Efficacy|1|||
126549647|NCT00744237|455307543|FG001|Overall Study|Lack of Efficacy|1|||
126549648|NCT00744237|455307544|FG002|Overall Study|Lack of Efficacy|0|||
126549649|NCT00744237|455307542|FG000|Overall Study|Withdrawal by Subject|9|||
126549650|NCT00744237|455307543|FG001|Overall Study|Withdrawal by Subject|5|||
126549651|NCT00744237|455307544|FG002|Overall Study|Withdrawal by Subject|3|||
126549652|NCT00744237|455307542|FG000|Overall Study|Lost to Follow-up|1|||
126549653|NCT00744237|455307543|FG001|Overall Study|Lost to Follow-up|1|||
126549654|NCT00744237|455307544|FG002|Overall Study|Lost to Follow-up|1|||
126549655|NCT00744237|455307542|FG000|Overall Study|Protocol Violation|3|||
126549656|NCT00744237|455307543|FG001|Overall Study|Protocol Violation|4|||
126549657|NCT00744237|455307544|FG002|Overall Study|Protocol Violation|3|||
126549658|NCT00744237|455307542|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
126549659|NCT00744237|455307543|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
126549660|NCT00744237|455307544|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
126549661|NCT00744237|455307542|FG000|Overall Study|Dosing Error|1|||
126549662|NCT00744237|455307543|FG001|Overall Study|Dosing Error|0|||
126549663|NCT00744237|455307544|FG002|Overall Study|Dosing Error|1|||
126549664|NCT00744237|455307542|FG000|Overall Study|Study Drug Error|1|||
126549665|NCT00744237|455307543|FG001|Overall Study|Study Drug Error|0|||
126549666|NCT00744237|455307544|FG002|Overall Study|Study Drug Error|0|||
126549667|NCT00744237|455307542|FG000|Overall Study|Prohibited Concomitant Medication|0|||
126549668|NCT00744237|455307543|FG001|Overall Study|Prohibited Concomitant Medication|0|||
126549669|NCT00744237|455307544|FG002|Overall Study|Prohibited Concomitant Medication|1|||
126549670|NCT00744237|455307542|FG000|Overall Study|Poor Compliance|0|||
126288135|NCT00764881|454342142|FG000|Overall Study|Protocol Violation|2|||
126288136|NCT00764881|454342143|FG001|Overall Study|Protocol Violation|2|||
126288137|NCT00764881|454342142|FG000|Overall Study|Lost to Follow-up|2|||
126288138|NCT00764881|454342143|FG001|Overall Study|Lost to Follow-up|0|||
126288139|NCT00764881|454342142|FG000|Overall Study|Noncompliant|1|||
126288140|NCT00764881|454342143|FG001|Overall Study|Noncompliant|0|||
126288141|NCT00764881|454342142|FG000|Overall Study|Accidentally discontinued study drug|1|||
126288142|NCT00764881|454342143|FG001|Overall Study|Accidentally discontinued study drug|0|||
126288143|NCT00764881|454342142|FG000|Overall Study|Wished to become pregnant|1|||
126288144|NCT00764881|454342143|FG001|Overall Study|Wished to become pregnant|0|||
126288145|NCT00764881|454342142|FG000|Overall Study|Carcinoma detected|1|||
126288146|NCT00764881|454342143|FG001|Overall Study|Carcinoma detected|0|||
126288147|NCT00764881|454342142|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
126288148|NCT00764881|454342143|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
126288149|NCT00764881|454342142|FG000|Overall Study|no treatment or no observation|2|||
126288150|NCT00764881|454342143|FG001|Overall Study|no treatment or no observation|2|||
126288151|NCT01214655|454342147|FG000|Part A|Progressive Disease|7|||
126288152|NCT01214655|454342148|FG001|Part A|Progressive Disease|0|||
126288153|NCT01214655|454342149|FG002|Part A|Progressive Disease|0|||
126288154|NCT01214655|454342147|FG000|Part A|Physician Decision|1|||
126288155|NCT01214655|454342148|FG001|Part A|Physician Decision|0|||
126288156|NCT01214655|454342149|FG002|Part A|Physician Decision|0|||
126288157|NCT01214655|454342147|FG000|Part B|Progressive disease|0|||
126288158|NCT01214655|454342148|FG001|Part B|Progressive disease|10|||
126288159|NCT01214655|454342149|FG002|Part B|Progressive disease|0|||
126288160|NCT01214655|454342147|FG000|Part B|Death|0|||
126288161|NCT01214655|454342148|FG001|Part B|Death|1|||
126288162|NCT01214655|454342149|FG002|Part B|Death|0|||
126288163|NCT01214655|454342147|FG000|Part B|Withdrawal by Subject|0|||
126288164|NCT01214655|454342148|FG001|Part B|Withdrawal by Subject|2|||
126288165|NCT01214655|454342149|FG002|Part B|Withdrawal by Subject|0|||
126288166|NCT01214655|454342147|FG000|Part C|Progressive Disease|0|||
126288167|NCT01214655|454342148|FG001|Part C|Progressive Disease|0|||
126288168|NCT01214655|454342149|FG002|Part C|Progressive Disease|5|||
126288169|NCT01214655|454342147|FG000|Part C|Death|0|||
126549671|NCT00744237|455307543|FG001|Overall Study|Poor Compliance|2|||
126549672|NCT00744237|455307544|FG002|Overall Study|Poor Compliance|0|||
126549673|NCT00744237|455307542|FG000|Overall Study|Administrative. Site Closed|1|||
126549674|NCT00744237|455307543|FG001|Overall Study|Administrative. Site Closed|1|||
126549675|NCT00744237|455307544|FG002|Overall Study|Administrative. Site Closed|1|||
126549676|NCT00744237|455307542|FG000|Overall Study|Adverse Event|9|||
126549677|NCT00744237|455307543|FG001|Overall Study|Adverse Event|13|||
126288170|NCT01214655|454342148|FG001|Part C|Death|0|||
126288171|NCT01214655|454342149|FG002|Part C|Death|1|||
126288172|NCT01214655|454342147|FG000|Part C|Physician Decision|0|||
126288173|NCT01214655|454342148|FG001|Part C|Physician Decision|0|||
126288174|NCT01214655|454342149|FG002|Part C|Physician Decision|1|||
126288175|NCT05256134|454342150|FG000|Overall Study|Study Terminated by Sponsor|11|||
126288176|NCT05256134|454342151|FG001|Overall Study|Study Terminated by Sponsor|10|||
126288177|NCT05256134|454342150|FG000|Overall Study|Withdrawal by Subject|1|||
126288178|NCT05256134|454342151|FG001|Overall Study|Withdrawal by Subject|3|||
126288179|NCT01567462|454342152|FG000|Overall Study|Withdrawal by Subject|4|||
126288180|NCT01567462|454342153|FG001|Overall Study|Withdrawal by Subject|7|||
126288181|NCT01977417|454342160|FG000|Overall Study|Adverse Event|1|||
126288182|NCT01977417|454342161|FG001|Overall Study|Adverse Event|0|||
126288183|NCT01977417|454342160|FG000|Overall Study|Withdrawal by Subject|2|||
126288184|NCT01977417|454342161|FG001|Overall Study|Withdrawal by Subject|4|||
126288185|NCT01977417|454342160|FG000|Overall Study|Female enrollment goal met|0|||
126288186|NCT01977417|454342161|FG001|Overall Study|Female enrollment goal met|2|||
126288187|NCT02548156|454342167|FG000|Washout Period 1|Lost to Follow-up|0|||
126288188|NCT02548156|454342168|FG001|Washout Period 1|Lost to Follow-up|0|||
126288189|NCT02548156|454342169|FG002|Washout Period 1|Lost to Follow-up|0|||
126288190|NCT02548156|454342170|FG003|Washout Period 1|Lost to Follow-up|0|||
126288191|NCT02548156|454342171|FG004|Washout Period 1|Lost to Follow-up|1|||
126288192|NCT02548156|454342172|FG005|Washout Period 1|Lost to Follow-up|0|||
126288193|NCT01068262|454342173|FG000|Overall Study|Adverse Event|2|||
126288194|NCT01068262|454342174|FG001|Overall Study|Adverse Event|0|||
126288195|NCT01068262|454342175|FG002|Overall Study|Adverse Event|1|||
126288196|NCT01068262|454342176|FG003|Overall Study|Adverse Event|0|||
126288197|NCT01068262|454342173|FG000|Overall Study|Protocol Violation|1|||
126288198|NCT01068262|454342174|FG001|Overall Study|Protocol Violation|0|||
126288199|NCT01068262|454342175|FG002|Overall Study|Protocol Violation|0|||
126288200|NCT01068262|454342176|FG003|Overall Study|Protocol Violation|0|||
126288201|NCT01068262|454342173|FG000|Overall Study|Withdrawal by Subject|0|||
126288202|NCT01068262|454342174|FG001|Overall Study|Withdrawal by Subject|1|||
126288203|NCT01068262|454342175|FG002|Overall Study|Withdrawal by Subject|0|||
126288204|NCT01068262|454342176|FG003|Overall Study|Withdrawal by Subject|0|||
126288205|NCT00444587|454342177|FG000|Overall Study|Death|2|||
126288206|NCT00444587|454342178|FG001|Overall Study|Death|1|||
126288207|NCT00444587|454342177|FG000|Overall Study|Progression of the disease|73|||
126288208|NCT00444587|454342178|FG001|Overall Study|Progression of the disease|8|||
126288209|NCT00444587|454342177|FG000|Overall Study|Refused treatment/did not cooperate|4|||
126288210|NCT00444587|454342178|FG001|Overall Study|Refused treatment/did not cooperate|1|||
126288211|NCT00444587|454342177|FG000|Overall Study|Investigator decision|3|||
126365699|NCT01111552|454632860|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
126365700|NCT01111552|454632861|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
126767016|NCT00539006|456100206|FG000|Pre-treatment|Other|0|||
126767017|NCT00539006|456100207|FG001|Pre-treatment|Other|1|||
126288212|NCT00444587|454342178|FG001|Overall Study|Investigator decision|0|||
126288213|NCT00444587|454342177|FG000|Overall Study|Protocol Violation|1|||
126288214|NCT00444587|454342178|FG001|Overall Study|Protocol Violation|0|||
126288215|NCT00444587|454342177|FG000|Overall Study|Missing|0|||
126288216|NCT00444587|454342178|FG001|Overall Study|Missing|5|||
126288217|NCT01720225|454342185|FG000|Overall Study|Withdrawal by Subject|0|||
126288218|NCT01720225|454342186|FG001|Overall Study|Withdrawal by Subject|1|||
126288219|NCT01720225|454342185|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
126288220|NCT01720225|454342186|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
126288221|NCT02301390|454342187|FG000|Overall Study|Withdrawal by Subject|3|||
126288222|NCT02301390|454342188|FG001|Overall Study|Withdrawal by Subject|5|||
126288223|NCT02301390|454342187|FG000|Overall Study|Protocol Violation|1|||
126288224|NCT02301390|454342188|FG001|Overall Study|Protocol Violation|0|||
126288225|NCT02301390|454342187|FG000|Overall Study|Physician Decision|1|||
126288226|NCT02301390|454342188|FG001|Overall Study|Physician Decision|0|||
126288227|NCT02301390|454342187|FG000|Overall Study|Lost to Follow-up|0|||
126288228|NCT02301390|454342188|FG001|Overall Study|Lost to Follow-up|1|||
126288229|NCT02301390|454342187|FG000|Overall Study|Death|2|||
126288230|NCT02301390|454342188|FG001|Overall Study|Death|2|||
126288231|NCT02301390|454342187|FG000|Overall Study|Procedure not completed|0|||
126288232|NCT02301390|454342188|FG001|Overall Study|Procedure not completed|4|||
126288233|NCT02301390|454342187|FG000|Overall Study|Missed multiple visits|1|||
126288234|NCT02301390|454342188|FG001|Overall Study|Missed multiple visits|1|||
126288235|NCT02301390|454342187|FG000|Overall Study|study terminated|2|||
126288236|NCT02301390|454342188|FG001|Overall Study|study terminated|0|||
126288237|NCT01153425|454342190|FG000|Overall Study|Withdrawal by Subject|3|||
126288238|NCT01153425|454342191|FG001|Overall Study|Withdrawal by Subject|3|||
126288239|NCT01232452|454342197|FG000|Overall Study|Adverse Event|17|||
126288240|NCT01232452|454342198|FG001|Overall Study|Adverse Event|15|||
126288241|NCT01232452|454342197|FG000|Overall Study|Withdrawal by Subject|11|||
126288242|NCT01232452|454342198|FG001|Overall Study|Withdrawal by Subject|8|||
126288243|NCT01232452|454342197|FG000|Overall Study|Physician Decision|8|||
126288244|NCT01232452|454342198|FG001|Overall Study|Physician Decision|12|||
126288245|NCT01232452|454342197|FG000|Overall Study|Protocol entry criterion not met|0|||
126288246|NCT01232452|454342198|FG001|Overall Study|Protocol entry criterion not met|2|||
126288247|NCT01232452|454342197|FG000|Overall Study|Sponsor Decision|3|||
126549678|NCT00744237|455307544|FG002|Overall Study|Adverse Event|5|||
126288248|NCT01232452|454342198|FG001|Overall Study|Sponsor Decision|1|||
126288249|NCT01232452|454342197|FG000|Overall Study|Protocol Violation|0|||
126767018|NCT00539006|456100208|FG002|Pre-treatment|Other|0|||
126288250|NCT01232452|454342198|FG001|Overall Study|Protocol Violation|1|||
126288251|NCT05024747|454342199|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
126288252|NCT05024747|454342200|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
126288253|NCT05024747|454342199|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
126288254|NCT05024747|454342200|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
126288255|NCT05024747|454342199|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
126288256|NCT05024747|454342200|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
126288257|NCT00662649|454342201|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
126288258|NCT00662649|454342202|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
126288259|NCT00662649|454342203|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
126288260|NCT00662649|454342204|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
126288261|NCT00662649|454342205|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
126288262|NCT00662649|454342201|FG000|Core Study (24 Months)|Adverse Event|22|||
126288263|NCT00662649|454342202|FG001|Core Study (24 Months)|Adverse Event|13|||
126288264|NCT00662649|454342203|FG002|Core Study (24 Months)|Adverse Event|18|||
126288265|NCT00662649|454342204|FG003|Core Study (24 Months)|Adverse Event|0|||
126288266|NCT00662649|454342205|FG004|Core Study (24 Months)|Adverse Event|0|||
126288267|NCT00662649|454342201|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
126288268|NCT00662649|454342202|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
126288269|NCT00662649|454342203|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
126288270|NCT00662649|454342204|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
126288271|NCT00662649|454342205|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
126288272|NCT00662649|454342201|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
126288273|NCT00662649|454342202|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
126288274|NCT00662649|454342203|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
126288275|NCT00662649|454342204|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
126288276|NCT00662649|454342205|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
126288277|NCT00662649|454342201|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
126288278|NCT00662649|454342202|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
126288279|NCT00662649|454342203|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
126288280|NCT00662649|454342204|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
126288281|NCT00662649|454342205|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
126288282|NCT00662649|454342201|FG000|Core Study (24 Months)|Protocol Violation|5|||
126288283|NCT00662649|454342202|FG001|Core Study (24 Months)|Protocol Violation|5|||
126288284|NCT00662649|454342203|FG002|Core Study (24 Months)|Protocol Violation|4|||
126288285|NCT00662649|454342204|FG003|Core Study (24 Months)|Protocol Violation|0|||
126457407|NCT03400956|454974913|FG002|Treatment Period 1|Withdrawal by Subject|4|||
126457408|NCT03400956|454974911|FG000|Treatment Period 1|Other|1|||
126457409|NCT03400956|454974912|FG001|Treatment Period 1|Other|2|||
126457410|NCT03400956|454974913|FG002|Treatment Period 1|Other|3|||
126457411|NCT03400956|454974911|FG000|Post-treatment Period 1|Adverse Event|0|||
126457412|NCT03400956|454974912|FG001|Post-treatment Period 1|Adverse Event|0|||
126457413|NCT03400956|454974913|FG002|Post-treatment Period 1|Adverse Event|1|||
126457414|NCT03400956|454974911|FG000|Post-treatment Period 1|Physician Decision|2|||
126457415|NCT03400956|454974912|FG001|Post-treatment Period 1|Physician Decision|3|||
126457416|NCT03400956|454974913|FG002|Post-treatment Period 1|Physician Decision|0|||
126457417|NCT03400956|454974911|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
126457418|NCT03400956|454974912|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
126457419|NCT03400956|454974913|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
126457420|NCT03400956|454974911|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
126457421|NCT03400956|454974912|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
126457422|NCT03400956|454974913|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
126457423|NCT03400956|454974911|FG000|Post-treatment Period 1|Other|4|||
126457424|NCT03400956|454974912|FG001|Post-treatment Period 1|Other|3|||
126457425|NCT03400956|454974913|FG002|Post-treatment Period 1|Other|4|||
126457426|NCT03400956|454974911|FG000|Treatment Period 2|Adverse Event|2|||
126457427|NCT03400956|454974912|FG001|Treatment Period 2|Adverse Event|1|||
126457428|NCT03400956|454974913|FG002|Treatment Period 2|Adverse Event|1|||
126457429|NCT03400956|454974911|FG000|Treatment Period 2|Lost to Follow-up|1|||
126457430|NCT03400956|454974912|FG001|Treatment Period 2|Lost to Follow-up|1|||
126457431|NCT03400956|454974913|FG002|Treatment Period 2|Lost to Follow-up|0|||
126457432|NCT03400956|454974911|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126288286|NCT00662649|454342205|FG004|Core Study (24 Months)|Protocol Violation|0|||
126457433|NCT03400956|454974912|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126767019|NCT00539006|456100209|FG003|Pre-treatment|Other|0|||
126288287|NCT00662649|454342201|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
126288288|NCT00662649|454342202|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
126457434|NCT03400956|454974913|FG002|Treatment Period 2|Withdrawal by Subject|3|||
126457435|NCT03400956|454974911|FG000|Treatment Period 2|Other|1|||
126457436|NCT03400956|454974912|FG001|Treatment Period 2|Other|1|||
126457437|NCT03400956|454974913|FG002|Treatment Period 2|Other|0|||
126457438|NCT03400956|454974911|FG000|Follow-up Period|Withdrawal by Subject|0|||
126457439|NCT03400956|454974912|FG001|Follow-up Period|Withdrawal by Subject|0|||
126710438|NCT01978912|455891616|FG000|Overall Study|Lost to Follow-up|1|||
126710439|NCT01978912|455891617|FG001|Overall Study|Lost to Follow-up|1|||
126710440|NCT01978912|455891618|FG002|Overall Study|Lost to Follow-up|0|||
126710441|NCT01978912|455891619|FG003|Overall Study|Lost to Follow-up|1|||
126288289|NCT00662649|454342203|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
126288290|NCT00662649|454342204|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
126288291|NCT00662649|454342205|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
126288292|NCT00662649|454342201|FG000|Core Study (24 Months)|Death|1|||
126288293|NCT00662649|454342202|FG001|Core Study (24 Months)|Death|0|||
126288294|NCT00662649|454342203|FG002|Core Study (24 Months)|Death|2|||
126288295|NCT00662649|454342204|FG003|Core Study (24 Months)|Death|0|||
126288296|NCT00662649|454342205|FG004|Core Study (24 Months)|Death|0|||
126288297|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
126288298|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
126288299|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
126288300|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
126288301|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
126288302|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
126288303|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
126288304|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
126288305|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
126288306|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
126288307|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
126288308|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
126288309|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
126288310|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
126288311|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
126288312|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
126288313|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
126288314|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
126288315|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
126288316|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
126365701|NCT01111552|454632857|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
126365702|NCT01111552|454632858|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
126710442|NCT01978912|455891616|FG000|Overall Study|Withdrawal by Subject|1|||
126710443|NCT01978912|455891617|FG001|Overall Study|Withdrawal by Subject|0|||
126288317|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
126365703|NCT01111552|454632859|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
126365704|NCT01111552|454632860|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
126365705|NCT01111552|454632861|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
126365706|NCT01111552|454632857|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
126365707|NCT01111552|454632858|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
126365708|NCT01111552|454632859|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
126365709|NCT01111552|454632860|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
126365710|NCT01111552|454632861|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
126365711|NCT01111552|454632857|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
126365712|NCT01111552|454632858|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
126365713|NCT01111552|454632859|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
126365714|NCT01111552|454632860|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
126365715|NCT01111552|454632861|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
126365716|NCT01111552|454632857|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126365717|NCT01111552|454632858|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126365718|NCT01111552|454632859|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
126365719|NCT01111552|454632860|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126365720|NCT01111552|454632861|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126365721|NCT04090749|454632862|FG000|Open Label Pilot|Lost to Follow-up|1|||
126365722|NCT04090749|454632863|FG001|Open Label Pilot|Lost to Follow-up|0|||
126365723|NCT04090749|454632864|FG002|Open Label Pilot|Lost to Follow-up|0|||
126365724|NCT04090749|454632862|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
126365725|NCT04090749|454632863|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
126710444|NCT01978912|455891618|FG002|Overall Study|Withdrawal by Subject|2|||
126710445|NCT01978912|455891619|FG003|Overall Study|Withdrawal by Subject|2|||
126365726|NCT04090749|454632864|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
126365727|NCT04090749|454632862|FG000|Pilot Trial|Lost to Follow-up|0|||
126365728|NCT04090749|454632863|FG001|Pilot Trial|Lost to Follow-up|1|||
126365729|NCT04090749|454632864|FG002|Pilot Trial|Lost to Follow-up|1|||
126710446|NCT01978912|455891616|FG000|Overall Study|Lumbar Surgery|1|||
126457440|NCT03400956|454974913|FG002|Follow-up Period|Withdrawal by Subject|1|||
126457441|NCT03400956|454974911|FG000|Follow-up Period|Other|0|||
126457442|NCT03400956|454974912|FG001|Follow-up Period|Other|0|||
126457443|NCT03400956|454974913|FG002|Follow-up Period|Other|1|||
126457444|NCT03044574|454974917|FG000|Overall Study|Lost to Follow-up|37|||
126457445|NCT03044574|454974918|FG001|Overall Study|Lost to Follow-up|45|||
126457446|NCT00710762|454974923|FG000|Overall Study|Progressive disease|27|||
126457447|NCT00710762|454974924|FG001|Overall Study|Progressive disease|30|||
126457448|NCT00710762|454974923|FG000|Overall Study|Adverse Event other disease worsening|2|||
126710447|NCT01978912|455891617|FG001|Overall Study|Lumbar Surgery|0|||
126710448|NCT01978912|455891618|FG002|Overall Study|Lumbar Surgery|1|||
126288318|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
126288319|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
126288320|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
126288321|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
126288322|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
126288323|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
126288324|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
126288325|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
126288326|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
126288327|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
126288328|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
126288329|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
126288330|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
126288331|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
126288332|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
126288333|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
126288334|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
126288335|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
126288336|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
126288337|NCT00662649|454342201|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
126288338|NCT00662649|454342202|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
126288339|NCT00662649|454342203|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
126288340|NCT00662649|454342204|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
126288341|NCT00662649|454342205|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
126288342|NCT03594071|454342206|FG000|Overall Study|Re-operation|3|||
126288343|NCT03594071|454342206|FG000|Overall Study|Missed visit|2|||
126288344|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
126288345|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Death|1|||
126288346|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
126288347|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
126288348|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
126288349|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
126288350|NCT02001987|454342210|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
126288351|NCT02001987|454342210|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
126288352|NCT02001987|454342210|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
126288353|NCT02001987|454342210|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
126288354|NCT02001987|454342210|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
126288355|NCT02001987|454342210|FG000|LTE Period (52 Weeks)|Other|3|||
126288356|NCT01965860|454342211|FG000|Overall Study|Pregnancy|1|||
126288357|NCT01965860|454342212|FG001|Overall Study|Pregnancy|0|||
126288358|NCT01965860|454342213|FG002|Overall Study|Pregnancy|1|||
126288359|NCT01965860|454342211|FG000|Overall Study|Logistics|1|||
126288360|NCT01965860|454342212|FG001|Overall Study|Logistics|0|||
126288361|NCT01965860|454342213|FG002|Overall Study|Logistics|0|||
126288362|NCT02288325|454342220|FG000|Run-in Period|Adverse Event|48|||
126288363|NCT02288325|454342221|FG001|Run-in Period|Adverse Event|0|||
126288364|NCT02288325|454342222|FG002|Run-in Period|Adverse Event|0|||
126288365|NCT02288325|454342220|FG000|Run-in Period|Lack of Efficacy|16|||
126288366|NCT02288325|454342221|FG001|Run-in Period|Lack of Efficacy|0|||
126288367|NCT02288325|454342222|FG002|Run-in Period|Lack of Efficacy|0|||
126288368|NCT02288325|454342220|FG000|Run-in Period|Withdrawal of Consent|28|||
126288369|NCT02288325|454342221|FG001|Run-in Period|Withdrawal of Consent|0|||
126288370|NCT02288325|454342222|FG002|Run-in Period|Withdrawal of Consent|0|||
126549679|NCT02802319|455307545|FG000|Overall Study|Physician Decision|2|||
126288371|NCT02288325|454342220|FG000|Run-in Period|Lost to Follow-up|25|||
126288372|NCT02288325|454342221|FG001|Run-in Period|Lost to Follow-up|0|||
126288373|NCT02288325|454342222|FG002|Run-in Period|Lost to Follow-up|0|||
126288374|NCT02288325|454342220|FG000|Run-in Period|Protocol Violation|17|||
126457449|NCT00710762|454974924|FG001|Overall Study|Adverse Event other disease worsening|1|||
126457450|NCT00710762|454974923|FG000|Overall Study|Other Adverse Event|7|||
126549680|NCT02802319|455307546|FG001|Overall Study|Physician Decision|1|||
126457451|NCT00710762|454974924|FG001|Overall Study|Other Adverse Event|7|||
126457452|NCT00710762|454974923|FG000|Overall Study|Lost to Follow-up|1|||
126457453|NCT00710762|454974924|FG001|Overall Study|Lost to Follow-up|0|||
126288375|NCT02288325|454342221|FG001|Run-in Period|Protocol Violation|0|||
126288376|NCT02288325|454342222|FG002|Run-in Period|Protocol Violation|0|||
126288377|NCT02288325|454342220|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
126288378|NCT02288325|454342221|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
126288379|NCT02288325|454342222|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
126288380|NCT02288325|454342220|FG000|Run-in Period|Reason not Specified|8|||
126288381|NCT02288325|454342221|FG001|Run-in Period|Reason not Specified|0|||
126288382|NCT02288325|454342222|FG002|Run-in Period|Reason not Specified|0|||
126288383|NCT02288325|454342220|FG000|Stabilization Period|Adverse Event|13|||
126288384|NCT02288325|454342221|FG001|Stabilization Period|Adverse Event|0|||
126288385|NCT02288325|454342222|FG002|Stabilization Period|Adverse Event|0|||
126288386|NCT02288325|454342220|FG000|Stabilization Period|Lack of Efficacy|22|||
126288387|NCT02288325|454342221|FG001|Stabilization Period|Lack of Efficacy|0|||
126288388|NCT02288325|454342222|FG002|Stabilization Period|Lack of Efficacy|0|||
126288389|NCT02288325|454342220|FG000|Stabilization Period|Withdrawal of Consent|23|||
126288390|NCT02288325|454342221|FG001|Stabilization Period|Withdrawal of Consent|0|||
126288391|NCT02288325|454342222|FG002|Stabilization Period|Withdrawal of Consent|0|||
126288392|NCT02288325|454342220|FG000|Stabilization Period|Lost to Follow-up|12|||
126288393|NCT02288325|454342221|FG001|Stabilization Period|Lost to Follow-up|0|||
126288394|NCT02288325|454342222|FG002|Stabilization Period|Lost to Follow-up|0|||
126288395|NCT02288325|454342220|FG000|Stabilization Period|Protocol Violation|8|||
126288396|NCT02288325|454342221|FG001|Stabilization Period|Protocol Violation|0|||
126288397|NCT02288325|454342222|FG002|Stabilization Period|Protocol Violation|0|||
126288398|NCT02288325|454342220|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
126288399|NCT02288325|454342221|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
126288400|NCT02288325|454342222|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
126288401|NCT02288325|454342220|FG000|Stabilization Period|Reason not Specified|15|||
126288402|NCT02288325|454342221|FG001|Stabilization Period|Reason not Specified|0|||
126288403|NCT02288325|454342222|FG002|Stabilization Period|Reason not Specified|0|||
126288404|NCT02288325|454342220|FG000|Double-blind Treatment Period|Adverse Event|0|||
126288405|NCT02288325|454342221|FG001|Double-blind Treatment Period|Adverse Event|2|||
126288406|NCT02288325|454342222|FG002|Double-blind Treatment Period|Adverse Event|5|||
126288407|NCT02288325|454342220|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
126288408|NCT02288325|454342221|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
126288409|NCT02288325|454342222|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
126288410|NCT02288325|454342220|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126288411|NCT02288325|454342221|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
126288412|NCT02288325|454342222|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
126288413|NCT02288325|454342220|FG000|Double-blind Treatment Period|Protocol Violation|0|||
126288414|NCT02288325|454342221|FG001|Double-blind Treatment Period|Protocol Violation|1|||
126457454|NCT00710762|454974923|FG000|Overall Study|Reason other than listed above|2|||
126457455|NCT00710762|454974924|FG001|Overall Study|Reason other than listed above|2|||
126457456|NCT01892384|454974925|FG000|Overall Study|Withdrawal by Subject|1|||
126457457|NCT01892384|454974926|FG001|Overall Study|Withdrawal by Subject|1|||
126457458|NCT01892384|454974927|FG002|Overall Study|Withdrawal by Subject|0|||
126457459|NCT01892384|454974928|FG003|Overall Study|Withdrawal by Subject|0|||
126457460|NCT01700439|454974929|FG000|Overall Study|Lost to Follow-up|47|||
126457461|NCT01700439|454974929|FG000|Overall Study|Withdrawal by Subject|183|||
126457462|NCT01700439|454974929|FG000|Overall Study|Death|186|||
126457463|NCT00608569|454974930|FG000|Overall Study|Death|4|||
126457464|NCT00608569|454974931|FG001|Overall Study|Death|3|||
126457465|NCT00608569|454974930|FG000|Overall Study|Lost to Follow-up|4|||
126457466|NCT00608569|454974931|FG001|Overall Study|Lost to Follow-up|5|||
126457467|NCT00608569|454974930|FG000|Overall Study|Withdrawal by Subject|1|||
126457468|NCT00608569|454974931|FG001|Overall Study|Withdrawal by Subject|0|||
126288415|NCT02288325|454342222|FG002|Double-blind Treatment Period|Protocol Violation|2|||
126288416|NCT02288325|454342220|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
126457469|NCT00608569|454974930|FG000|Overall Study|Adverse Event|1|||
126457470|NCT00608569|454974931|FG001|Overall Study|Adverse Event|0|||
126457471|NCT00608569|454974930|FG000|Overall Study|Unable to adhere with study requirements|0|||
126288417|NCT02288325|454342221|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
126288418|NCT02288325|454342222|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
126288419|NCT02288325|454342220|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
126288420|NCT02288325|454342221|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
126288421|NCT02288325|454342222|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
126288422|NCT03735121|454342225|FG000|Overall Study|Death|3|||
126457472|NCT00608569|454974931|FG001|Overall Study|Unable to adhere with study requirements|1|||
126457473|NCT00053898|454974937|FG000|Overall Study|No follow-up data from any source|9|||
126457474|NCT00053898|454974938|FG001|Overall Study|No follow-up data from any source|12|||
126457475|NCT00053898|454974937|FG000|Overall Study|Follow-up from telephone contact only|5|||
126288423|NCT03735121|454342226|FG001|Overall Study|Death|6|||
126288424|NCT03735121|454342227|FG002|Overall Study|Death|8|||
126288425|NCT03735121|454342228|FG003|Overall Study|Death|37|||
126288426|NCT03735121|454342229|FG004|Overall Study|Death|86|||
126288427|NCT03735121|454342225|FG000|Overall Study|Withdrawal by Subject|1|||
126288428|NCT03735121|454342226|FG001|Overall Study|Withdrawal by Subject|1|||
126288429|NCT03735121|454342227|FG002|Overall Study|Withdrawal by Subject|3|||
126288430|NCT03735121|454342228|FG003|Overall Study|Withdrawal by Subject|4|||
126288431|NCT03735121|454342229|FG004|Overall Study|Withdrawal by Subject|2|||
126288432|NCT03735121|454342225|FG000|Overall Study|Progressive Disease|0|||
126288433|NCT03735121|454342226|FG001|Overall Study|Progressive Disease|0|||
126288434|NCT03735121|454342227|FG002|Overall Study|Progressive Disease|1|||
126549681|NCT02802319|455307545|FG000|Overall Study|Lost to Follow-up|0|||
126549682|NCT02802319|455307546|FG001|Overall Study|Lost to Follow-up|4|||
126549683|NCT03545113|455307547|FG000|Overall Study|Surgery Cancelled|1|||
126549684|NCT03545113|455307548|FG001|Overall Study|Surgery Cancelled|0|||
126549685|NCT03545113|455307547|FG000|Overall Study|Death|1|||
126549686|NCT03545113|455307548|FG001|Overall Study|Death|0|||
126549687|NCT03545113|455307547|FG000|Overall Study|Adverse Event|2|||
126549688|NCT03545113|455307548|FG001|Overall Study|Adverse Event|0|||
126549689|NCT03545113|455307547|FG000|Overall Study|Received different surgery|1|||
126549690|NCT03545113|455307548|FG001|Overall Study|Received different surgery|0|||
126549691|NCT01683994|455307551|FG000|Overall Study|Withdrawal by Subject|1|||
126288435|NCT03735121|454342228|FG003|Overall Study|Progressive Disease|0|||
126288436|NCT03735121|454342229|FG004|Overall Study|Progressive Disease|0|||
126288437|NCT03735121|454342225|FG000|Overall Study|Lost to Follow-up|0|||
126288438|NCT03735121|454342226|FG001|Overall Study|Lost to Follow-up|0|||
126288439|NCT03735121|454342227|FG002|Overall Study|Lost to Follow-up|0|||
126288440|NCT03735121|454342228|FG003|Overall Study|Lost to Follow-up|0|||
126288441|NCT03735121|454342229|FG004|Overall Study|Lost to Follow-up|1|||
126288442|NCT03735121|454342225|FG000|Overall Study|Ongoing|3|||
126288443|NCT03735121|454342226|FG001|Overall Study|Ongoing|3|||
126288444|NCT03735121|454342227|FG002|Overall Study|Ongoing|26|||
126288445|NCT03735121|454342228|FG003|Overall Study|Ongoing|83|||
126288446|NCT03735121|454342229|FG004|Overall Study|Ongoing|158|||
126288447|NCT00344448|454342233|FG000|Screening|Withdrawal by Subject|0|||
126288448|NCT00344448|454342234|FG001|Screening|Withdrawal by Subject|1|||
126288449|NCT00344448|454342233|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
126288450|NCT00344448|454342234|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
126549692|NCT01683994|455307552|FG001|Overall Study|Withdrawal by Subject|0|||
126549693|NCT01683994|455307553|FG002|Overall Study|Withdrawal by Subject|0|||
126549694|NCT01683994|455307554|FG003|Overall Study|Withdrawal by Subject|1|||
126549695|NCT01683994|455307555|FG004|Overall Study|Withdrawal by Subject|0|||
126549696|NCT01683994|455307551|FG000|Overall Study|Intercurrent illness|0|||
126549697|NCT01683994|455307552|FG001|Overall Study|Intercurrent illness|0|||
126549698|NCT01683994|455307553|FG002|Overall Study|Intercurrent illness|0|||
126549699|NCT01683994|455307554|FG003|Overall Study|Intercurrent illness|2|||
126549700|NCT01683994|455307555|FG004|Overall Study|Intercurrent illness|1|||
126549701|NCT00999661|455307556|FG000|Overall Study|Lost to Follow-up|59|||
126549702|NCT00999661|455307556|FG000|Overall Study|Adverse Event|1|||
126549703|NCT00999661|455307556|FG000|Overall Study|Withdrawal by Subject|1|||
126549704|NCT00999661|455307556|FG000|Overall Study|Not meeting eligibility criteria|9|||
126549705|NCT03638635|455307558|FG000|Initial Hospitalization|Study terminated prematurely|0|||
126549706|NCT03638635|455307559|FG001|Initial Hospitalization|Study terminated prematurely|1|||
126710449|NCT01978912|455891619|FG003|Overall Study|Lumbar Surgery|0|||
126710450|NCT01978912|455891616|FG000|Overall Study|Intradiscal Steroid Injection|0|||
126710451|NCT01978912|455891617|FG001|Overall Study|Intradiscal Steroid Injection|1|||
126710452|NCT01978912|455891618|FG002|Overall Study|Intradiscal Steroid Injection|0|||
126710453|NCT01978912|455891619|FG003|Overall Study|Intradiscal Steroid Injection|0|||
126710454|NCT00224107|455891620|FG000|Overall Study|Adverse Event|20|||
126710455|NCT00224107|455891621|FG001|Overall Study|Adverse Event|6|||
126710456|NCT00224107|455891620|FG000|Overall Study|Protocol Violation|2|||
126710457|NCT00224107|455891621|FG001|Overall Study|Protocol Violation|3|||
126288451|NCT00344448|454342233|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
126549707|NCT03638635|455307558|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
126549708|NCT03638635|455307559|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
126549709|NCT03638635|455307558|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
126710458|NCT00224107|455891620|FG000|Overall Study|Withdrawal by Subject|1|||
126710459|NCT00224107|455891621|FG001|Overall Study|Withdrawal by Subject|4|||
126710460|NCT00224107|455891620|FG000|Overall Study|Lack of Efficacy|2|||
126288452|NCT00344448|454342234|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
126288453|NCT00344448|454342233|FG000|Open Label|Withdrawal by Subject|1|||
126288454|NCT00344448|454342234|FG001|Open Label|Withdrawal by Subject|1|||
126288455|NCT00344448|454342233|FG000|Open Label|Study terminated|1|||
126288456|NCT00344448|454342234|FG001|Open Label|Study terminated|0|||
126288457|NCT03138655|454342236|FG000|Overall Study|Adverse Event|2|||
126288458|NCT03138655|454342237|FG001|Overall Study|Adverse Event|1|||
126288459|NCT03138655|454342238|FG002|Overall Study|Adverse Event|2|||
126710461|NCT00224107|455891621|FG001|Overall Study|Lack of Efficacy|0|||
126710462|NCT00224107|455891620|FG000|Overall Study|Lost to Follow-up|4|||
126710463|NCT00224107|455891621|FG001|Overall Study|Lost to Follow-up|0|||
126288460|NCT03138655|454342239|FG003|Overall Study|Adverse Event|1|||
126288461|NCT03138655|454342240|FG004|Overall Study|Adverse Event|1|||
126288462|NCT03138655|454342241|FG005|Overall Study|Adverse Event|4|||
126288463|NCT03138655|454342242|FG006|Overall Study|Adverse Event|2|||
126288464|NCT03138655|454342243|FG007|Overall Study|Adverse Event|2|||
126288465|NCT03138655|454342236|FG000|Overall Study|Withdrawal by Subject|0|||
126288466|NCT03138655|454342237|FG001|Overall Study|Withdrawal by Subject|1|||
126288467|NCT03138655|454342238|FG002|Overall Study|Withdrawal by Subject|0|||
126288468|NCT03138655|454342239|FG003|Overall Study|Withdrawal by Subject|0|||
126288469|NCT03138655|454342240|FG004|Overall Study|Withdrawal by Subject|0|||
126288470|NCT03138655|454342241|FG005|Overall Study|Withdrawal by Subject|0|||
126288471|NCT03138655|454342242|FG006|Overall Study|Withdrawal by Subject|1|||
126288472|NCT03138655|454342243|FG007|Overall Study|Withdrawal by Subject|0|||
126288473|NCT03138655|454342236|FG000|Overall Study|Reason not Specified|1|||
126288474|NCT03138655|454342237|FG001|Overall Study|Reason not Specified|0|||
126288475|NCT03138655|454342238|FG002|Overall Study|Reason not Specified|0|||
126288476|NCT03138655|454342239|FG003|Overall Study|Reason not Specified|2|||
126288477|NCT03138655|454342240|FG004|Overall Study|Reason not Specified|1|||
126288478|NCT03138655|454342241|FG005|Overall Study|Reason not Specified|1|||
126288479|NCT03138655|454342242|FG006|Overall Study|Reason not Specified|0|||
126288480|NCT03138655|454342243|FG007|Overall Study|Reason not Specified|0|||
126288481|NCT02565511|454342244|FG000|Overall Study|Study terminated by Sponsor|35|||
126288482|NCT02565511|454342245|FG001|Overall Study|Study terminated by Sponsor|22|||
126288483|NCT02565511|454342246|FG002|Overall Study|Study terminated by Sponsor|235|||
126288484|NCT02565511|454342247|FG003|Overall Study|Study terminated by Sponsor|156|||
126288485|NCT02565511|454342244|FG000|Overall Study|Withdrawal by Subject|3|||
126288486|NCT02565511|454342245|FG001|Overall Study|Withdrawal by Subject|0|||
126288487|NCT02565511|454342246|FG002|Overall Study|Withdrawal by Subject|12|||
126288488|NCT02565511|454342247|FG003|Overall Study|Withdrawal by Subject|5|||
126288489|NCT02565511|454342244|FG000|Overall Study|Adverse Event|0|||
126288490|NCT02565511|454342245|FG001|Overall Study|Adverse Event|0|||
126288491|NCT02565511|454342246|FG002|Overall Study|Adverse Event|1|||
126288492|NCT02565511|454342247|FG003|Overall Study|Adverse Event|1|||
126288493|NCT02565511|454342244|FG000|Overall Study|Lost to Follow-up|4|||
126288494|NCT02565511|454342245|FG001|Overall Study|Lost to Follow-up|1|||
126288495|NCT02565511|454342246|FG002|Overall Study|Lost to Follow-up|0|||
126288496|NCT02565511|454342247|FG003|Overall Study|Lost to Follow-up|1|||
126288497|NCT02565511|454342244|FG000|Overall Study|Physician Decision|0|||
126288498|NCT02565511|454342245|FG001|Overall Study|Physician Decision|0|||
126288499|NCT02565511|454342246|FG002|Overall Study|Physician Decision|0|||
126288500|NCT02565511|454342247|FG003|Overall Study|Physician Decision|1|||
126288501|NCT02565511|454342244|FG000|Overall Study|Protocol deviation|0|||
126288502|NCT02565511|454342245|FG001|Overall Study|Protocol deviation|0|||
126457476|NCT00053898|454974938|FG001|Overall Study|Follow-up from telephone contact only|1|||
126457477|NCT03473548|454974939|FG000|Overall Study|Did not attempt HST testing|3|||
126457478|NCT03473548|454974940|FG001|Overall Study|Did not attempt HST testing|0|||
126457479|NCT00129311|454974941|FG000|Overall Study|Withdrawal by Subject|12|||
126457480|NCT00129311|454974942|FG001|Overall Study|Withdrawal by Subject|19|||
126457481|NCT02055365|454976501|FG000|Overall Study|Prematurely Withdrawn|1|||
126457482|NCT03565367|454976502|FG000|Overall Study|No scan due to technical issues|4|||
126457483|NCT03565367|454976503|FG001|Overall Study|No scan due to technical issues|0|||
126457484|NCT04352127|454976504|FG000|Overall Study|Unable to obtain readings|4|||
126457485|NCT04352127|454976505|FG001|Overall Study|Unable to obtain readings|1|||
126457486|NCT05338671|454976506|FG000|Overall Study|Lost to Follow-up|2|||
126457487|NCT05338671|454976507|FG001|Overall Study|Lost to Follow-up|2|||
126457488|NCT05338671|454976506|FG000|Overall Study|Root canal completed in a single visit|1|||
126457489|NCT05338671|454976507|FG001|Overall Study|Root canal completed in a single visit|0|||
126457490|NCT03874429|454976508|FG000|Overall Study|Adverse Event|2|||
126288503|NCT02565511|454342246|FG002|Overall Study|Protocol deviation|3|||
126288504|NCT02565511|454342247|FG003|Overall Study|Protocol deviation|0|||
126288505|NCT03076775|454342250|FG000|Overall Study|Lost to Follow-up|1|||
126288506|NCT03076775|454342251|FG001|Overall Study|Lost to Follow-up|0|||
126457491|NCT03874429|454976509|FG001|Overall Study|Adverse Event|2|||
126710464|NCT00224107|455891620|FG000|Overall Study|Physician Decision|1|||
126710465|NCT00224107|455891621|FG001|Overall Study|Physician Decision|0|||
126288507|NCT00098774|454342255|FG000|Overall Study|Adverse Event|2|||
126288508|NCT00098774|454342255|FG000|Overall Study|Disease Progression|9|||
126288509|NCT00098774|454342255|FG000|Overall Study|Withdrawal by Subject|1|||
126288510|NCT00098774|454342255|FG000|Overall Study|Failed (to respond) during induction|4|||
126288511|NCT00098774|454342255|FG000|Overall Study|Physician Decision|2|||
126288512|NCT00796757|454342256|FG000|Overall Study|Withdrawal by Subject|14|||
126457492|NCT03874429|454976508|FG000|Overall Study|Lack of Efficacy|0|||
126457493|NCT03874429|454976509|FG001|Overall Study|Lack of Efficacy|1|||
126457494|NCT03874429|454976508|FG000|Overall Study|Covid-19 pandemic|4|||
126365730|NCT02528305|454632865|FG000|Overall Study|Withdrawal by Subject|1|||
126365731|NCT02528305|454632865|FG000|Overall Study|Adverse Event|1|||
126365732|NCT02528305|454632865|FG000|Overall Study|Physician Decision|1|||
126365733|NCT02184442|454632866|FG000|Overall Study|Death|61|||
126365734|NCT02184442|454632867|FG001|Overall Study|Death|65|||
126365735|NCT02184442|454632866|FG000|Overall Study|Withdrawal by Subject|3|||
126365736|NCT02184442|454632867|FG001|Overall Study|Withdrawal by Subject|11|||
126365737|NCT01852214|454632868|FG000|Period 1|Adverse Event|1|||
126365738|NCT01852214|454632869|FG001|Period 1|Adverse Event|2|||
126365739|NCT01852214|454632868|FG000|Period 1|Withdrawal by Subject|0|||
126365740|NCT01852214|454632869|FG001|Period 1|Withdrawal by Subject|1|||
126365741|NCT01852214|454632868|FG000|Washout Period|Withdrawal by Subject|0|||
126365742|NCT01852214|454632869|FG001|Washout Period|Withdrawal by Subject|1|||
126365743|NCT02691494|454632872|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
126365744|NCT02691494|454632873|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
126365745|NCT02691494|454632874|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
126365746|NCT02691494|454632872|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
126365747|NCT02691494|454632873|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
126365748|NCT02691494|454632874|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
126365749|NCT02691494|454632872|FG000|Post-Treatment Follow-Up Period|Other|2|||
126365750|NCT02691494|454632873|FG001|Post-Treatment Follow-Up Period|Other|1|||
126365751|NCT02691494|454632874|FG002|Post-Treatment Follow-Up Period|Other|1|||
126365752|NCT02691494|454632872|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
126365753|NCT02691494|454632873|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
126365754|NCT02691494|454632874|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
126365755|NCT02691494|454632872|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
126365756|NCT02691494|454632873|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
126365757|NCT02691494|454632874|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
126365758|NCT00637156|454632875|FG000|Overall Study|Withdrawal by Subject|0|||
126365759|NCT00637156|454632876|FG001|Overall Study|Withdrawal by Subject|7|||
126365760|NCT00637156|454632875|FG000|Overall Study|Death|0|||
126365761|NCT00637156|454632876|FG001|Overall Study|Death|1|||
126365762|NCT00637156|454632875|FG000|Overall Study|Lost to Follow-up|10|||
126365763|NCT00637156|454632876|FG001|Overall Study|Lost to Follow-up|16|||
126365764|NCT00461812|454632877|FG000|Overall Study|study terminated|10|||
126365765|NCT03193437|454632878|FG000|Overall Study|Adverse Event|4|||
126365766|NCT03193437|454632878|FG000|Overall Study|Withdrawal by Subject|2|||
126365767|NCT03193437|454632878|FG000|Overall Study|Disease Progression|2|||
126365768|NCT05487378|454632879|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
126365769|NCT05487378|454632880|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
126365770|NCT05487378|454632879|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
126365771|NCT05487378|454632880|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
126365772|NCT03359395|454632896|FG000|First Intervention A / B|Withdrawal by Subject|1|||
126365773|NCT03359395|454632897|FG001|First Intervention A / B|Withdrawal by Subject|0|||
126365774|NCT03359395|454632896|FG000|First Intervention A / B|Lost to Follow-up|2|||
126365775|NCT03359395|454632897|FG001|First Intervention A / B|Lost to Follow-up|3|||
126365776|NCT03359395|454632896|FG000|Second Intervention B/A|Exclusion criteria|0|||
126365777|NCT03359395|454632897|FG001|Second Intervention B/A|Exclusion criteria|1|||
126365778|NCT03359395|454632896|FG000|Second Intervention B/A|Lost to Follow-up|3|||
126365779|NCT03359395|454632897|FG001|Second Intervention B/A|Lost to Follow-up|2|||
126365780|NCT03164356|454632898|FG000|Overall Study|Lost to Follow-up|1|||
126365781|NCT03164356|454632899|FG001|Overall Study|Lost to Follow-up|1|||
126365782|NCT03164356|454632900|FG002|Overall Study|Lost to Follow-up|2|||
126365783|NCT03164356|454632901|FG003|Overall Study|Lost to Follow-up|1|||
126365784|NCT03164356|454632898|FG000|Overall Study|Physician Decision|0|||
126549710|NCT03638635|455307559|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
126549711|NCT00313911|455307566|FG000|Overall Study|Serious adverse event|6|||
126549712|NCT00313911|455307567|FG001|Overall Study|Serious adverse event|1|||
126549713|NCT00313911|455307566|FG000|Overall Study|Adverse Event|2|||
126549714|NCT00313911|455307567|FG001|Overall Study|Adverse Event|3|||
126549715|NCT00313911|455307566|FG000|Overall Study|Protocol Violation|19|||
126549716|NCT00313911|455307567|FG001|Overall Study|Protocol Violation|10|||
126365785|NCT03164356|454632899|FG001|Overall Study|Physician Decision|0|||
126710466|NCT00224107|455891620|FG000|Overall Study|Other|1|||
126365786|NCT03164356|454632900|FG002|Overall Study|Physician Decision|3|||
126365787|NCT03164356|454632901|FG003|Overall Study|Physician Decision|0|||
126365788|NCT03164356|454632898|FG000|Overall Study|Protocol Violation|2|||
126365789|NCT03164356|454632899|FG001|Overall Study|Protocol Violation|1|||
126365790|NCT03164356|454632900|FG002|Overall Study|Protocol Violation|0|||
126365791|NCT03164356|454632901|FG003|Overall Study|Protocol Violation|0|||
126365792|NCT03164356|454632898|FG000|Overall Study|Withdrawal by Subject|1|||
126365793|NCT03164356|454632899|FG001|Overall Study|Withdrawal by Subject|0|||
126365794|NCT03164356|454632900|FG002|Overall Study|Withdrawal by Subject|0|||
126365795|NCT03164356|454632901|FG003|Overall Study|Withdrawal by Subject|0|||
126710467|NCT00224107|455891621|FG001|Overall Study|Other|1|||
126710468|NCT00685178|455891622|FG000|Overall Study|Adverse Event|1|||
126457495|NCT03874429|454976509|FG001|Overall Study|Covid-19 pandemic|2|||
126457496|NCT00779259|454976510|FG000|Quinine Alone|Adverse Event|2|||
126457497|NCT02047318|454976514|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
126457498|NCT02047318|454976514|FG000|Core Study Period|Adverse Event|1|||
126457499|NCT02047318|454976514|FG000|Core Study Period|Withdrawal by caregiver|3|||
126457500|NCT02047318|454976514|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
126457501|NCT02296138|454976515|FG000|Overall Study|Adverse Event|348|||
126457502|NCT02296138|454976516|FG001|Overall Study|Adverse Event|259|||
126288513|NCT00796757|454342256|FG000|Overall Study|Death|61|||
126288514|NCT00796757|454342256|FG000|Overall Study|Protocol Violation|1|||
126288515|NCT00796757|454342256|FG000|Overall Study|Participant noncompliance|1|||
126288516|NCT00796757|454342256|FG000|Overall Study|Investigator's decision|2|||
126288517|NCT00796757|454342256|FG000|Overall Study|Other|7|||
126288518|NCT02324582|454342257|FG000|Overall Study|Screen Failures|0|||
126288519|NCT02324582|454342258|FG001|Overall Study|Screen Failures|5|||
126288520|NCT02890355|454342261|FG000|Overall Study|Adverse Event|5|||
126288521|NCT02890355|454342262|FG001|Overall Study|Adverse Event|5|||
126288522|NCT02890355|454342261|FG000|Overall Study|Refusal unrelated to adverse event|5|||
126288523|NCT02890355|454342262|FG001|Overall Study|Refusal unrelated to adverse event|10|||
126288524|NCT02890355|454342261|FG000|Overall Study|Progression/relapse|46|||
126288525|NCT02890355|454342262|FG001|Overall Study|Progression/relapse|39|||
126288526|NCT02890355|454342261|FG000|Overall Study|Not protocol specified|3|||
126288527|NCT02890355|454342262|FG001|Overall Study|Not protocol specified|4|||
126288528|NCT01128179|454342263|FG000|Overall Study|Death|1|||
126288529|NCT01128179|454342264|FG001|Overall Study|Death|0|||
126288530|NCT01128179|454342263|FG000|Overall Study|Protocol Violation|1|||
126288531|NCT01128179|454342264|FG001|Overall Study|Protocol Violation|0|||
126288532|NCT00720382|454342265|FG000|Overall Study|Adverse Event|54|||
126288533|NCT00720382|454342266|FG001|Overall Study|Adverse Event|17|||
126288534|NCT00720382|454342265|FG000|Overall Study|Lack of Efficacy|18|||
126288535|NCT00720382|454342266|FG001|Overall Study|Lack of Efficacy|7|||
126288536|NCT00720382|454342265|FG000|Overall Study|Non-Compliance|15|||
126457503|NCT02296138|454976515|FG000|Overall Study|Lack of Efficacy|59|||
126457504|NCT02296138|454976516|FG001|Overall Study|Lack of Efficacy|37|||
126457505|NCT02296138|454976515|FG000|Overall Study|Protocol Violation|35|||
126457506|NCT02296138|454976516|FG001|Overall Study|Protocol Violation|36|||
126457507|NCT02296138|454976515|FG000|Overall Study|Lost to Follow-up|9|||
126457508|NCT02296138|454976516|FG001|Overall Study|Lost to Follow-up|12|||
126457509|NCT02296138|454976515|FG000|Overall Study|Withdrawal by Subject|184|||
126457510|NCT02296138|454976516|FG001|Overall Study|Withdrawal by Subject|131|||
126457511|NCT02296138|454976515|FG000|Overall Study|Not Treated|1|||
126457512|NCT02296138|454976516|FG001|Overall Study|Not Treated|1|||
126457513|NCT02296138|454976515|FG000|Overall Study|Patients with data irregularities|10|||
126457514|NCT02296138|454976516|FG001|Overall Study|Patients with data irregularities|11|||
126457515|NCT02296138|454976515|FG000|Overall Study|Other than specified|15|||
126457516|NCT02296138|454976516|FG001|Overall Study|Other than specified|13|||
126457517|NCT00711516|454976517|FG000|Overall Study|Adverse Event|1|||
126457518|NCT00711516|454976518|FG001|Overall Study|Adverse Event|1|||
126457519|NCT00711516|454976517|FG000|Overall Study|Withdrawal by Subject|0|||
126457520|NCT00711516|454976518|FG001|Overall Study|Withdrawal by Subject|1|||
126457521|NCT00711516|454976517|FG000|Overall Study|Protocol Violation|0|||
126457522|NCT00711516|454976518|FG001|Overall Study|Protocol Violation|1|||
126457523|NCT00868517|454976521|FG000|Overall Study|Withdrawal by Subject|3|||
126457524|NCT00868517|454976522|FG001|Overall Study|Withdrawal by Subject|3|||
126710469|NCT00685178|455891623|FG001|Overall Study|Adverse Event|5|||
126288537|NCT00720382|454342266|FG001|Overall Study|Non-Compliance|5|||
126288538|NCT00720382|454342265|FG000|Overall Study|Withdrawal by Subject|47|||
126288539|NCT00720382|454342266|FG001|Overall Study|Withdrawal by Subject|11|||
126288540|NCT00720382|454342265|FG000|Overall Study|Lost to Follow-up|28|||
126288541|NCT00720382|454342266|FG001|Overall Study|Lost to Follow-up|14|||
126288542|NCT00720382|454342265|FG000|Overall Study|administrative|14|||
126288543|NCT00720382|454342266|FG001|Overall Study|administrative|5|||
126288544|NCT05377749|454343976|FG000|3 Weeks|Lost to Follow-up|2|||
126288545|NCT05377749|454343977|FG001|3 Weeks|Lost to Follow-up|4|||
126288546|NCT05377749|454343976|FG000|3 Weeks|Withdrawal by Subject|1|||
126288547|NCT05377749|454343977|FG001|3 Weeks|Withdrawal by Subject|1|||
126288548|NCT02121652|454343980|FG000|Overall Study|Lost to Follow-up|2|||
126288549|NCT02121652|454343981|FG001|Overall Study|Lost to Follow-up|1|||
126288550|NCT02121652|454343980|FG000|Overall Study|Death|1|||
126288551|NCT02121652|454343981|FG001|Overall Study|Death|0|||
126288552|NCT02121652|454343980|FG000|Overall Study|Withdrawal by Subject|3|||
126288553|NCT02121652|454343981|FG001|Overall Study|Withdrawal by Subject|3|||
126288554|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Other|34|||
126457525|NCT00868517|454976523|FG002|Overall Study|Withdrawal by Subject|2|||
126457526|NCT00868517|454976521|FG000|Overall Study|Protocol Violation|1|||
126457527|NCT00868517|454976522|FG001|Overall Study|Protocol Violation|1|||
126457528|NCT00868517|454976523|FG002|Overall Study|Protocol Violation|0|||
126457529|NCT00420641|454976526|FG000|Overall Study|Adverse Event|3|||
126457530|NCT00420641|454976527|FG001|Overall Study|Adverse Event|25|||
126457531|NCT00420641|454976528|FG002|Overall Study|Adverse Event|10|||
126457532|NCT00420641|454976526|FG000|Overall Study|Lost to Follow-up|2|||
126457533|NCT00420641|454976527|FG001|Overall Study|Lost to Follow-up|4|||
126457534|NCT00420641|454976528|FG002|Overall Study|Lost to Follow-up|2|||
126457535|NCT00420641|454976526|FG000|Overall Study|Protocol Violation|8|||
126710470|NCT00685178|455891624|FG002|Overall Study|Adverse Event|2|||
126288555|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Other|0|||
126288556|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Other|0|||
126288557|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Other|0|||
126288558|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Death|14|||
126288559|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Death|0|||
126288560|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Death|0|||
126288561|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Death|0|||
126288562|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
126288563|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
126288564|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
126288565|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
126288566|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
126288567|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
126288568|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
126288569|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
126288570|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
126288571|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
126288572|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
126288573|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
126288574|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
126288575|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
126288576|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
126288577|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
126288578|NCT01995513|454343982|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
126288579|NCT01995513|454343983|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
126288580|NCT01995513|454343984|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
126288581|NCT01995513|454343985|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
126288582|NCT01995513|454343982|FG000|Period 1: Second Open Label Treatment|Other|0|||
126288583|NCT01995513|454343983|FG001|Period 1: Second Open Label Treatment|Other|2|||
126288584|NCT01995513|454343984|FG002|Period 1: Second Open Label Treatment|Other|0|||
126288585|NCT01995513|454343985|FG003|Period 1: Second Open Label Treatment|Other|0|||
126288586|NCT01995513|454343982|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
126288587|NCT01995513|454343983|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
126288588|NCT01995513|454343984|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
126288589|NCT01995513|454343985|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
126288590|NCT01995513|454343982|FG000|Period 2: Double Blind Treatment|Death|0|||
126288591|NCT01995513|454343983|FG001|Period 2: Double Blind Treatment|Death|0|||
126288592|NCT01995513|454343984|FG002|Period 2: Double Blind Treatment|Death|0|||
126288593|NCT01995513|454343985|FG003|Period 2: Double Blind Treatment|Death|1|||
126288594|NCT01995513|454343982|FG000|Period 2: Double Blind Treatment|Other|0|||
126288595|NCT01995513|454343983|FG001|Period 2: Double Blind Treatment|Other|0|||
126288596|NCT01995513|454343984|FG002|Period 2: Double Blind Treatment|Other|3|||
126288597|NCT01995513|454343985|FG003|Period 2: Double Blind Treatment|Other|3|||
126288598|NCT01995513|454343982|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
126288599|NCT01995513|454343983|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
126288600|NCT01995513|454343984|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
126288601|NCT01995513|454343985|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
126288602|NCT01995513|454343982|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
126288603|NCT01995513|454343983|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
126288604|NCT01995513|454343984|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
126288605|NCT01995513|454343985|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
126288606|NCT01995513|454343982|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
126288607|NCT01995513|454343983|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
126288608|NCT01995513|454343984|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
126288609|NCT01995513|454343985|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
126288610|NCT01995513|454343982|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
126288611|NCT01995513|454343983|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
126288612|NCT01995513|454343984|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
126288613|NCT01995513|454343985|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
126288614|NCT04108299|454343990|FG000|Overall Study|Not interested in participating|2|||
126288615|NCT04108299|454343991|FG001|Overall Study|Not interested in participating|1|||
126457536|NCT00420641|454976527|FG001|Overall Study|Protocol Violation|8|||
126549717|NCT00313911|455307566|FG000|Overall Study|Lost to Follow-up|27|||
126549718|NCT00313911|455307567|FG001|Overall Study|Lost to Follow-up|14|||
126549719|NCT00313911|455307566|FG000|Overall Study|Withdrawal by Subject|39|||
126549720|NCT00313911|455307567|FG001|Overall Study|Withdrawal by Subject|12|||
126549721|NCT00313911|455307566|FG000|Overall Study|Did not meet age criteria|1|||
126288616|NCT04108299|454343992|FG002|Overall Study|Not interested in participating|2|||
126288617|NCT04108299|454343993|FG003|Overall Study|Not interested in participating|1|||
126288618|NCT04123405|454343994|FG000|Overall Study|Adverse Event|1|||
126288619|NCT04123405|454343995|FG001|Overall Study|Adverse Event|2|||
126288620|NCT04123405|454343996|FG002|Overall Study|Adverse Event|3|||
126288621|NCT04123405|454343997|FG003|Overall Study|Adverse Event|3|||
126288622|NCT04123405|454343994|FG000|Overall Study|Exclusion criteria met|1|||
126288623|NCT04123405|454343995|FG001|Overall Study|Exclusion criteria met|2|||
126288624|NCT04123405|454343996|FG002|Overall Study|Exclusion criteria met|0|||
126288625|NCT04123405|454343997|FG003|Overall Study|Exclusion criteria met|2|||
126288626|NCT04123405|454343994|FG000|Overall Study|Withdrawal by Subject|1|||
126288627|NCT04123405|454343995|FG001|Overall Study|Withdrawal by Subject|3|||
126288628|NCT04123405|454343996|FG002|Overall Study|Withdrawal by Subject|0|||
126288629|NCT04123405|454343997|FG003|Overall Study|Withdrawal by Subject|2|||
126288630|NCT04123405|454343994|FG000|Overall Study|Contact to subject lost|0|||
126288631|NCT04123405|454343995|FG001|Overall Study|Contact to subject lost|0|||
126288632|NCT04123405|454343996|FG002|Overall Study|Contact to subject lost|0|||
126288633|NCT04123405|454343997|FG003|Overall Study|Contact to subject lost|1|||
126288634|NCT04123405|454343994|FG000|Overall Study|screening failure|1|||
126288635|NCT04123405|454343995|FG001|Overall Study|screening failure|0|||
126288636|NCT04123405|454343996|FG002|Overall Study|screening failure|0|||
126288637|NCT04123405|454343997|FG003|Overall Study|screening failure|0|||
126288638|NCT00247676|454343998|FG000|Overall Study|Death|5|||
126288639|NCT00247676|454343998|FG000|Overall Study|Adverse Event|11|||
126288640|NCT00247676|454343998|FG000|Overall Study|Lack of Efficacy|15|||
126288641|NCT00247676|454343998|FG000|Overall Study|Other|3|||
126288642|NCT00247676|454343998|FG000|Overall Study|Withdrawal by Subject|2|||
126288643|NCT01026194|454343999|FG000|Period 1：Double Blind Period|Adverse Event|2|||
126288644|NCT01026194|454344000|FG001|Period 1：Double Blind Period|Adverse Event|1|||
126288645|NCT01026194|454343999|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
126288646|NCT01026194|454344000|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
126288647|NCT01026194|454343999|FG000|Period 1：Double Blind Period|Physician Decision|0|||
126288648|NCT01026194|454344000|FG001|Period 1：Double Blind Period|Physician Decision|4|||
126288649|NCT01026194|454343999|FG000|Period 2：Open-label Period|Adverse Event|4|||
126288650|NCT01026194|454344000|FG001|Period 2：Open-label Period|Adverse Event|5|||
126288651|NCT01026194|454343999|FG000|Period 2：Open-label Period|Physician Decision|3|||
126288652|NCT01026194|454344000|FG001|Period 2：Open-label Period|Physician Decision|1|||
126457537|NCT00420641|454976528|FG002|Overall Study|Protocol Violation|7|||
126457538|NCT00420641|454976526|FG000|Overall Study|Withdrawal by Subject|15|||
126457539|NCT00420641|454976527|FG001|Overall Study|Withdrawal by Subject|21|||
126457540|NCT00420641|454976528|FG002|Overall Study|Withdrawal by Subject|14|||
126457541|NCT00420641|454976526|FG000|Overall Study|Lack of Efficacy|6|||
126457542|NCT00420641|454976527|FG001|Overall Study|Lack of Efficacy|5|||
126457543|NCT00420641|454976528|FG002|Overall Study|Lack of Efficacy|4|||
126457544|NCT00420641|454976526|FG000|Overall Study|Non-compliance|7|||
126457545|NCT00420641|454976527|FG001|Overall Study|Non-compliance|5|||
126457546|NCT00420641|454976528|FG002|Overall Study|Non-compliance|4|||
126457547|NCT00420641|454976526|FG000|Overall Study|Other|4|||
126457548|NCT00420641|454976527|FG001|Overall Study|Other|4|||
126457549|NCT00420641|454976528|FG002|Overall Study|Other|3|||
126457550|NCT03459690|454976529|FG000|Overall Study|Lost to Follow-up|0|||
126457551|NCT03459690|454976530|FG001|Overall Study|Lost to Follow-up|1|||
126457552|NCT03459690|454976529|FG000|Overall Study|Withdrawal by Subject|1|||
126457553|NCT03459690|454976530|FG001|Overall Study|Withdrawal by Subject|1|||
126457554|NCT02586506|454976531|FG000|Overall Study|Protocol Violation|6|||
126457555|NCT02586506|454976531|FG000|Overall Study|Lost to Follow-up|1|||
126457556|NCT02586506|454976531|FG000|Overall Study|Other Reason|2|||
126457557|NCT02815280|454976534|FG000|Double-Blind Phase|Adverse Event|1|||
126549722|NCT00313911|455307567|FG001|Overall Study|Did not meet age criteria|1|||
126549723|NCT01533714|455307568|FG000|Overall Study|Adverse Event|0|||
126549724|NCT01533714|455307569|FG001|Overall Study|Adverse Event|1|||
126549725|NCT01533714|455307570|FG002|Overall Study|Adverse Event|2|||
126288653|NCT01026194|454343999|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
126288654|NCT01026194|454344000|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
126288655|NCT01750190|454344001|FG000|Overall Study|Adverse Event|47|||
126288656|NCT01750190|454344002|FG001|Overall Study|Adverse Event|19|||
126288657|NCT01750190|454344001|FG000|Overall Study|Death|38|||
126288658|NCT01750190|454344002|FG001|Overall Study|Death|11|||
126549726|NCT01533714|455307571|FG003|Overall Study|Adverse Event|2|||
126457558|NCT02815280|454976535|FG001|Double-Blind Phase|Adverse Event|1|||
126457559|NCT02815280|454976534|FG000|Double-Blind Phase|Lost to Follow-up|10|||
126457560|NCT02815280|454976535|FG001|Double-Blind Phase|Lost to Follow-up|9|||
126710471|NCT00685178|455891625|FG003|Overall Study|Adverse Event|4|||
126288659|NCT01750190|454344001|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
126288660|NCT01750190|454344002|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
126288661|NCT01750190|454344001|FG000|Overall Study|Lost to Follow-up|28|||
126288662|NCT01750190|454344002|FG001|Overall Study|Lost to Follow-up|7|||
126288663|NCT01750190|454344001|FG000|Overall Study|Physician Decision|16|||
126288664|NCT01750190|454344002|FG001|Overall Study|Physician Decision|17|||
126288665|NCT01750190|454344001|FG000|Overall Study|Protocol Violation|6|||
126288666|NCT01750190|454344002|FG001|Overall Study|Protocol Violation|5|||
126288667|NCT01750190|454344001|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
126288668|NCT01750190|454344002|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
126288669|NCT01750190|454344001|FG000|Overall Study|Withdrawal by Subject|83|||
126288670|NCT01750190|454344002|FG001|Overall Study|Withdrawal by Subject|89|||
126288671|NCT01750190|454344001|FG000|Overall Study|Kidney Transplant|8|||
126288672|NCT01750190|454344002|FG001|Overall Study|Kidney Transplant|4|||
126288673|NCT01750190|454344001|FG000|Overall Study|Dialysis|22|||
126288674|NCT01750190|454344002|FG001|Overall Study|Dialysis|8|||
126288675|NCT01750190|454344001|FG000|Overall Study|Other than Specified|13|||
126288676|NCT01750190|454344002|FG001|Overall Study|Other than Specified|4|||
126288677|NCT02009722|454344009|FG000|Overall Study|Protocol Violation|1|||
126288678|NCT02009722|454344010|FG001|Overall Study|Protocol Violation|2|||
126288679|NCT02009722|454344009|FG000|Overall Study|Did not receive intervention|0|||
126288680|NCT02009722|454344010|FG001|Overall Study|Did not receive intervention|1|||
126288681|NCT02955212|454344011|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
126288682|NCT02955212|454344012|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
126288683|NCT02955212|454344011|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
126288684|NCT02955212|454344012|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
126288685|NCT02955212|454344011|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
126288686|NCT02955212|454344012|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
126288687|NCT02955212|454344011|FG000|Period 1: Double-blind Treatment Period|Other|3|||
126288688|NCT02955212|454344012|FG001|Period 1: Double-blind Treatment Period|Other|2|||
126288689|NCT02955212|454344011|FG000|Period 2: Open-label Extension|Adverse Event|11|||
126288690|NCT02955212|454344012|FG001|Period 2: Open-label Extension|Adverse Event|7|||
126288691|NCT02955212|454344011|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
126288692|NCT02955212|454344012|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
126288693|NCT02955212|454344011|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
126288694|NCT02955212|454344012|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
126288695|NCT02955212|454344011|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
126288696|NCT02955212|454344012|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
126288697|NCT02955212|454344011|FG000|Period 2: Open-label Extension|Other|2|||
126288698|NCT02955212|454344012|FG001|Period 2: Open-label Extension|Other|4|||
126288699|NCT00545714|454344015|FG000|Induction Phase (6 Months)|Physician Decision|3|||
126288700|NCT00545714|454344015|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
126288701|NCT00545714|454344015|FG000|Induction Phase (6 Months)|Disease Progression|1|||
126288702|NCT00545714|454344015|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
126288703|NCT00545714|454344015|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
126288704|NCT00545714|454344015|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
126288705|NCT00545714|454344015|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
126288706|NCT00545714|454344015|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
126288707|NCT00545714|454344015|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
126288708|NCT00545714|454344015|FG000|Maintenance Phase (36 Months)|Death|2|||
126288709|NCT04428034|454344020|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
126288710|NCT00560391|454344023|FG000|Overall Study|Still on treatment|0|||
126288711|NCT00560391|454344024|FG001|Overall Study|Still on treatment|0|||
126288712|NCT00560391|454344025|FG002|Overall Study|Still on treatment|0|||
126288713|NCT00560391|454344026|FG003|Overall Study|Still on treatment|1|||
126288714|NCT00560391|454344027|FG004|Overall Study|Still on treatment|2|||
126288715|NCT02556801|454344028|FG000|Overall Study|Lost to Follow-up|1|||
126288716|NCT02556801|454344029|FG001|Overall Study|Lost to Follow-up|0|||
126288717|NCT02556801|454344030|FG002|Overall Study|Lost to Follow-up|2|||
126288718|NCT02556801|454344031|FG003|Overall Study|Lost to Follow-up|0|||
126288719|NCT02556801|454344028|FG000|Overall Study|Withdrawal by Subject|1|||
126288720|NCT02556801|454344029|FG001|Overall Study|Withdrawal by Subject|1|||
126288721|NCT02556801|454344030|FG002|Overall Study|Withdrawal by Subject|1|||
126288722|NCT02556801|454344031|FG003|Overall Study|Withdrawal by Subject|0|||
126288723|NCT02556801|454344028|FG000|Overall Study|Protocol Violation|0|||
126288724|NCT02556801|454344029|FG001|Overall Study|Protocol Violation|3|||
126288725|NCT02556801|454344030|FG002|Overall Study|Protocol Violation|1|||
126288726|NCT02556801|454344031|FG003|Overall Study|Protocol Violation|1|||
126288727|NCT02556801|454344028|FG000|Overall Study|Adverse Event|0|||
126288728|NCT02556801|454344029|FG001|Overall Study|Adverse Event|2|||
126288729|NCT02556801|454344030|FG002|Overall Study|Adverse Event|0|||
126288730|NCT02556801|454344031|FG003|Overall Study|Adverse Event|3|||
126710472|NCT00685178|455891622|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
126710473|NCT00685178|455891623|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
126710474|NCT00685178|455891624|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
126288731|NCT02556801|454344028|FG000|Overall Study|Pregnancy|0|||
126288732|NCT02556801|454344029|FG001|Overall Study|Pregnancy|1|||
126288733|NCT02556801|454344030|FG002|Overall Study|Pregnancy|0|||
126288734|NCT02556801|454344031|FG003|Overall Study|Pregnancy|0|||
126288735|NCT02556801|454344028|FG000|Overall Study|Personal reasons patient|0|||
126288736|NCT02556801|454344029|FG001|Overall Study|Personal reasons patient|0|||
126288737|NCT02556801|454344030|FG002|Overall Study|Personal reasons patient|0|||
126288738|NCT02556801|454344031|FG003|Overall Study|Personal reasons patient|1|||
126288739|NCT03668808|454344032|FG000|First Intervention|Withdrawal by Subject|2|||
126288740|NCT03668808|454344033|FG001|First Intervention|Withdrawal by Subject|2|||
126288741|NCT00280735|454344041|FG000|Overall Study|Adverse Event|5|||
126288742|NCT00280735|454344041|FG000|Overall Study|Lack of Efficacy|3|||
126288743|NCT00280735|454344041|FG000|Overall Study|Withdrawal by Subject|8|||
126288744|NCT00280735|454344041|FG000|Overall Study|Intercurrent Illness|2|||
126288745|NCT01895777|454344042|FG000|Overall Study|Adverse Event|1|||
126288746|NCT01895777|454344043|FG001|Overall Study|Adverse Event|2|||
126288747|NCT01895777|454344042|FG000|Overall Study|Lost to Follow-up|2|||
126288748|NCT01895777|454344043|FG001|Overall Study|Lost to Follow-up|0|||
126288749|NCT01895777|454344042|FG000|Overall Study|Not treated|1|||
126288750|NCT01895777|454344043|FG001|Overall Study|Not treated|0|||
126288751|NCT01895777|454344042|FG000|Overall Study|Other reasons|3|||
126457561|NCT02815280|454976534|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
126288752|NCT01895777|454344043|FG001|Overall Study|Other reasons|2|||
126288753|NCT01895777|454344042|FG000|Overall Study|Non-compliance with the CTP|2|||
126288754|NCT01895777|454344043|FG001|Overall Study|Non-compliance with the CTP|1|||
126288755|NCT04542057|454344047|FG000|Overall Study|Death|3|||
126457562|NCT02815280|454976535|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
126288756|NCT04542057|454344048|FG001|Overall Study|Death|1|||
126288757|NCT04542057|454344047|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
126288758|NCT04542057|454344048|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
126288759|NCT04542057|454344047|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
126288760|NCT04542057|454344048|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
126288761|NCT04542057|454344047|FG000|Overall Study|Adverse Event|15|||
126288762|NCT04542057|454344048|FG001|Overall Study|Adverse Event|6|||
126288763|NCT04542057|454344047|FG000|Overall Study|COVID-19 adverse event|6|||
126288764|NCT04542057|454344048|FG001|Overall Study|COVID-19 adverse event|4|||
126288765|NCT04542057|454344047|FG000|Overall Study|Lack of Efficacy|2|||
126288766|NCT04542057|454344048|FG001|Overall Study|Lack of Efficacy|5|||
126457563|NCT02815280|454976534|FG000|Double-Blind Phase|Protocol Violation|2|||
126457564|NCT02815280|454976535|FG001|Double-Blind Phase|Protocol Violation|2|||
126457565|NCT02815280|454976534|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
126457566|NCT02815280|454976535|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
126457567|NCT02815280|454976534|FG000|Open-Label Phase|Adverse Event|2|||
126457568|NCT02815280|454976535|FG001|Open-Label Phase|Adverse Event|3|||
126457569|NCT02815280|454976534|FG000|Open-Label Phase|Lost to Follow-up|18|||
126457570|NCT02815280|454976535|FG001|Open-Label Phase|Lost to Follow-up|9|||
126457571|NCT02815280|454976534|FG000|Open-Label Phase|Withdrawal by Subject|33|||
126457572|NCT02815280|454976535|FG001|Open-Label Phase|Withdrawal by Subject|18|||
126457573|NCT02815280|454976534|FG000|Open-Label Phase|Protocol Violation|3|||
126457574|NCT02815280|454976535|FG001|Open-Label Phase|Protocol Violation|0|||
126457575|NCT02815280|454976534|FG000|Open-Label Phase|Administrative|26|||
126457576|NCT02815280|454976535|FG001|Open-Label Phase|Administrative|12|||
126457577|NCT02815280|454976534|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
126457578|NCT02815280|454976535|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
126549727|NCT01533714|455307572|FG004|Overall Study|Adverse Event|2|||
126288767|NCT04542057|454344047|FG000|Overall Study|Study terminated by sponsor|1|||
126288768|NCT04542057|454344048|FG001|Overall Study|Study terminated by sponsor|0|||
126457579|NCT02514473|454976548|FG000|Overall Study|Adverse Event|0|||
126457580|NCT02514473|454976549|FG001|Overall Study|Adverse Event|2|||
126457581|NCT02514473|454976548|FG000|Overall Study|Withdrawal by Subject|2|||
126549728|NCT01533714|455307573|FG005|Overall Study|Adverse Event|1|||
126457582|NCT02514473|454976549|FG001|Overall Study|Withdrawal by Subject|1|||
126457583|NCT02514473|454976548|FG000|Overall Study|Lost to Follow-up|0|||
126288769|NCT04542057|454344047|FG000|Overall Study|Investigator discretion|2|||
126288770|NCT04542057|454344048|FG001|Overall Study|Investigator discretion|1|||
126288771|NCT04542057|454344047|FG000|Overall Study|Withdrawal by Subject|52|||
126288772|NCT04542057|454344048|FG001|Overall Study|Withdrawal by Subject|30|||
126288773|NCT04542057|454344047|FG000|Overall Study|Lost to Follow-up|8|||
126288774|NCT04542057|454344048|FG001|Overall Study|Lost to Follow-up|11|||
126288775|NCT04542057|454344047|FG000|Overall Study|Other|2|||
126288776|NCT04542057|454344048|FG001|Overall Study|Other|2|||
126288777|NCT01277211|454344051|FG000|Overall Study|Adverse Event|60|||
126288778|NCT01277211|454344052|FG001|Overall Study|Adverse Event|22|||
126288779|NCT01277211|454344051|FG000|Overall Study|Pregnancy|9|||
126288780|NCT01277211|454344052|FG001|Overall Study|Pregnancy|4|||
126288781|NCT01277211|454344051|FG000|Overall Study|Lost to Follow-up|14|||
126288782|NCT01277211|454344052|FG001|Overall Study|Lost to Follow-up|9|||
126288783|NCT01277211|454344051|FG000|Overall Study|Did not wish to continue|17|||
126288784|NCT01277211|454344052|FG001|Overall Study|Did not wish to continue|0|||
126288785|NCT01277211|454344051|FG000|Overall Study|Withdrew Consent|9|||
126288786|NCT01277211|454344052|FG001|Overall Study|Withdrew Consent|9|||
126288787|NCT01277211|454344051|FG000|Overall Study|Non-compliance with protocol|13|||
126288788|NCT01277211|454344052|FG001|Overall Study|Non-compliance with protocol|4|||
126288789|NCT01277211|454344051|FG000|Overall Study|Did not meet protocol eligibility|1|||
126288790|NCT01277211|454344052|FG001|Overall Study|Did not meet protocol eligibility|0|||
126288791|NCT01277211|454344051|FG000|Overall Study|Administrative|3|||
126288792|NCT01277211|454344052|FG001|Overall Study|Administrative|0|||
126288793|NCT01277211|454344051|FG000|Overall Study|Pregnancy wish|0|||
126288794|NCT01277211|454344052|FG001|Overall Study|Pregnancy wish|2|||
126288795|NCT01277211|454344051|FG000|Overall Study|Discontinued prior to treatment|24|||
126288796|NCT01277211|454344052|FG001|Overall Study|Discontinued prior to treatment|13|||
126288797|NCT03452943|454344053|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
126288798|NCT03452943|454344054|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
126288799|NCT03452943|454344053|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
126288800|NCT03452943|454344054|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
126288801|NCT03452943|454344053|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
126288802|NCT03452943|454344054|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
126288803|NCT03452943|454344053|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
126288804|NCT03452943|454344054|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
126288805|NCT03452943|454344053|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
126288806|NCT03452943|454344054|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
126288807|NCT03452943|454344053|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
126288808|NCT03452943|454344054|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
126288809|NCT01130493|454344055|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
126288810|NCT01130493|454344056|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
126288811|NCT01130493|454344057|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
126288812|NCT01130493|454344055|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
126288813|NCT01130493|454344056|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
126288814|NCT01130493|454344057|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
126288815|NCT01130493|454344055|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
126288816|NCT01130493|454344056|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
126288817|NCT01130493|454344057|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
126288818|NCT01130493|454344055|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
126288819|NCT01130493|454344056|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
126288820|NCT01130493|454344057|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
126288821|NCT01130493|454344055|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
126288822|NCT01130493|454344056|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
126288823|NCT01130493|454344057|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
126288824|NCT01130493|454344055|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
126288825|NCT01130493|454344056|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
126288826|NCT01130493|454344057|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
126288827|NCT01130493|454344055|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
126288828|NCT01130493|454344056|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
126288829|NCT01130493|454344057|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
126365796|NCT03164356|454632898|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
126288830|NCT01130493|454344055|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
126288831|NCT01130493|454344056|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
126288832|NCT01130493|454344057|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
126288833|NCT01130493|454344055|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
126365797|NCT03164356|454632899|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
126365798|NCT03164356|454632900|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
126365799|NCT03164356|454632901|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
126365800|NCT03164356|454632898|FG000|Overall Study|Subject Incarcerated|0|||
126365801|NCT03164356|454632899|FG001|Overall Study|Subject Incarcerated|1|||
126365802|NCT03164356|454632900|FG002|Overall Study|Subject Incarcerated|0|||
126365803|NCT03164356|454632901|FG003|Overall Study|Subject Incarcerated|0|||
126288834|NCT01130493|454344056|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
126288835|NCT01130493|454344057|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
126288836|NCT01130493|454344055|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
126288837|NCT01130493|454344056|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
126288838|NCT01130493|454344057|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
126288839|NCT01130493|454344055|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
126288840|NCT01130493|454344056|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
126288841|NCT01130493|454344057|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
126288842|NCT01130493|454344055|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
126288843|NCT01130493|454344056|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
126288844|NCT01130493|454344057|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
126288845|NCT01130493|454344055|FG000|Part 2: OLE|Adverse Event|0|||
126288846|NCT01130493|454344056|FG001|Part 2: OLE|Adverse Event|2|||
126288847|NCT01130493|454344057|FG002|Part 2: OLE|Adverse Event|1|||
126288848|NCT01130493|454344055|FG000|Part 2: OLE|Withdrawal by Subject|0|||
126288849|NCT01130493|454344056|FG001|Part 2: OLE|Withdrawal by Subject|1|||
126288850|NCT01130493|454344057|FG002|Part 2: OLE|Withdrawal by Subject|4|||
126288851|NCT03541317|454344060|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
126288852|NCT03541317|454344061|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
126288853|NCT03541317|454344062|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
126288854|NCT03541317|454344063|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
126288855|NCT03541317|454344064|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
126288856|NCT03541317|454344065|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
126288857|NCT00879086|454344066|FG000|Overall Study|Adverse Event|3|||
126288858|NCT00879086|454344067|FG001|Overall Study|Adverse Event|15|||
126288859|NCT00879086|454344066|FG000|Overall Study|Participant choice|2|||
126288860|NCT00879086|454344067|FG001|Overall Study|Participant choice|2|||
126288861|NCT00879086|454344066|FG000|Overall Study|Progression of disease|40|||
126288862|NCT00879086|454344067|FG001|Overall Study|Progression of disease|26|||
126288863|NCT00879086|454344066|FG000|Overall Study|Withdrawal of consent|2|||
126288864|NCT00879086|454344067|FG001|Overall Study|Withdrawal of consent|1|||
126288865|NCT00879086|454344066|FG000|Overall Study|Other|4|||
126288866|NCT00879086|454344067|FG001|Overall Study|Other|6|||
126288867|NCT00879086|454344066|FG000|Overall Study|Death|1|||
126288868|NCT00879086|454344067|FG001|Overall Study|Death|2|||
126288869|NCT02536846|454344068|FG000|Overall Study|Withdrawal by Subject|1|||
126288870|NCT02123446|454344069|FG000|Washout Period (1 Day)|Physician Decision|1|||
126288871|NCT02123446|454344070|FG001|Washout Period (1 Day)|Physician Decision|0|||
126288872|NCT04388553|454344071|FG000|Overall Study|Protocol Violation|1|||
126288873|NCT04388553|454344072|FG001|Overall Study|Protocol Violation|0|||
126288874|NCT04604795|454344073|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
126288875|NCT04604795|454344074|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
126288876|NCT04604795|454344075|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288877|NCT04604795|454344076|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288878|NCT04604795|454344077|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288879|NCT04604795|454344078|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288880|NCT04604795|454344079|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288881|NCT04604795|454344080|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288882|NCT04604795|454344081|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288883|NCT04604795|454344082|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
126288884|NCT04604795|454344073|FG000|Part B: Up to Day 14|Adverse Event|0|||
126288885|NCT04604795|454344074|FG001|Part B: Up to Day 14|Adverse Event|0|||
126288886|NCT04604795|454344075|FG002|Part B: Up to Day 14|Adverse Event|0|||
126288887|NCT04604795|454344076|FG003|Part B: Up to Day 14|Adverse Event|0|||
126710475|NCT00685178|455891625|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
126710476|NCT00685178|455891622|FG000|Overall Study|voluntary study discharge|4|||
126710477|NCT00685178|455891623|FG001|Overall Study|voluntary study discharge|5|||
126710478|NCT00685178|455891624|FG002|Overall Study|voluntary study discharge|1|||
126288888|NCT04604795|454344077|FG004|Part B: Up to Day 14|Adverse Event|2|||
126288889|NCT04604795|454344078|FG005|Part B: Up to Day 14|Adverse Event|1|||
126288890|NCT04604795|454344079|FG006|Part B: Up to Day 14|Adverse Event|0|||
126288891|NCT04604795|454344080|FG007|Part B: Up to Day 14|Adverse Event|0|||
126288892|NCT04604795|454344081|FG008|Part B: Up to Day 14|Adverse Event|0|||
126288893|NCT04604795|454344082|FG009|Part B: Up to Day 14|Adverse Event|0|||
126288894|NCT04604795|454344073|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288895|NCT04604795|454344074|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288896|NCT04604795|454344075|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288897|NCT04604795|454344076|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288898|NCT04604795|454344077|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288899|NCT04604795|454344078|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288900|NCT04604795|454344079|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288901|NCT04604795|454344080|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288902|NCT04604795|454344081|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
126288903|NCT04604795|454344082|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
126288904|NCT04604795|454344073|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288905|NCT04604795|454344074|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288906|NCT04604795|454344075|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288907|NCT04604795|454344076|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288908|NCT04604795|454344077|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288909|NCT04604795|454344078|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288910|NCT04604795|454344079|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288911|NCT04604795|454344080|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288912|NCT04604795|454344081|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
126288913|NCT04604795|454344082|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
126288914|NCT04604795|454344073|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288915|NCT04604795|454344074|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288916|NCT04604795|454344075|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288917|NCT04604795|454344076|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288918|NCT04604795|454344077|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288919|NCT04604795|454344078|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288920|NCT04604795|454344079|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288921|NCT04604795|454344080|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288922|NCT04604795|454344081|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
126288923|NCT04604795|454344082|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
126288924|NCT04604795|454344073|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288925|NCT04604795|454344074|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288926|NCT04604795|454344075|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288927|NCT04604795|454344076|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288928|NCT04604795|454344077|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288929|NCT04604795|454344078|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288930|NCT04604795|454344079|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288931|NCT04604795|454344080|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288932|NCT04604795|454344081|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
126288933|NCT04604795|454344082|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
126288934|NCT00111241|454344092|FG000|Overall Study|Lost to Follow-up|1|||
126288935|NCT00111241|454344093|FG001|Overall Study|Lost to Follow-up|0|||
126288936|NCT00111241|454344092|FG000|Overall Study|Withdrawal by Subject|4|||
126288937|NCT00111241|454344093|FG001|Overall Study|Withdrawal by Subject|0|||
126288938|NCT00111241|454344092|FG000|Overall Study|Protocol Violation|9|||
126288939|NCT00111241|454344093|FG001|Overall Study|Protocol Violation|8|||
126288940|NCT00111241|454344092|FG000|Overall Study|Adverse Event|1|||
126288941|NCT00111241|454344093|FG001|Overall Study|Adverse Event|0|||
126288942|NCT04502212|454344094|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
126288943|NCT04502212|454344094|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
126288944|NCT02096744|454344095|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
126288945|NCT02096744|454344096|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
126288946|NCT02096744|454344095|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
126288947|NCT02096744|454344096|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
126288948|NCT02096744|454344095|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
126288949|NCT02096744|454344096|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
126288950|NCT00952731|454344098|FG000|Overall Study|Drug supply expired|1|||
126288951|NCT00952731|454344099|FG001|Overall Study|Drug supply expired|0|||
126288952|NCT01450683|454344111|FG000|Overall Study|Adverse Event|2|||
126288953|NCT02108912|454344113|FG000|Overall Study|Lost to Follow-up|1|||
126288954|NCT02108912|454344114|FG001|Overall Study|Lost to Follow-up|1|||
126288955|NCT02108912|454344113|FG000|Overall Study|lack of transportation|1|||
126288956|NCT02108912|454344114|FG001|Overall Study|lack of transportation|0|||
126288957|NCT02108912|454344113|FG000|Overall Study|high blood pressure|1|||
126288958|NCT02108912|454344114|FG001|Overall Study|high blood pressure|0|||
126288959|NCT00625872|454344119|FG000|Overall Study|Withdrawal by Subject|1|||
126288960|NCT00625872|454344120|FG001|Overall Study|Withdrawal by Subject|0|||
126288961|NCT00625872|454344119|FG000|Overall Study|Does not meet inclusion criteria|1|||
126288962|NCT00625872|454344120|FG001|Overall Study|Does not meet inclusion criteria|0|||
126288963|NCT00625872|454344119|FG000|Overall Study|Terminated by sponsor|2|||
126288964|NCT00625872|454344120|FG001|Overall Study|Terminated by sponsor|5|||
126288965|NCT00625872|454344119|FG000|Overall Study|Randomized but not treated|0|||
126288966|NCT00625872|454344120|FG001|Overall Study|Randomized but not treated|1|||
126288967|NCT04208750|454344121|FG000|Overall Study|Lost to Follow-up|16|||
126288968|NCT04208750|454344122|FG001|Overall Study|Lost to Follow-up|15|||
126288969|NCT03485352|454344126|FG000|Overall Study|Lost to Follow-up|9|||
126288970|NCT00852202|454344127|FG000|Overall Study|Adverse Event|2|||
126288971|NCT00852202|454344128|FG001|Overall Study|Adverse Event|3|||
126288972|NCT00852202|454344129|FG002|Overall Study|Adverse Event|7|||
126288973|NCT00852202|454344127|FG000|Overall Study|Lack of Efficacy|4|||
126288974|NCT00852202|454344128|FG001|Overall Study|Lack of Efficacy|1|||
126549729|NCT01533714|455307568|FG000|Overall Study|Lack of Efficacy|0|||
126549730|NCT01533714|455307569|FG001|Overall Study|Lack of Efficacy|0|||
126549731|NCT01533714|455307570|FG002|Overall Study|Lack of Efficacy|0|||
126549732|NCT01533714|455307571|FG003|Overall Study|Lack of Efficacy|0|||
126549733|NCT01533714|455307572|FG004|Overall Study|Lack of Efficacy|0|||
126549734|NCT01533714|455307573|FG005|Overall Study|Lack of Efficacy|1|||
126549735|NCT01533714|455307568|FG000|Overall Study|Withdrawal by Subject|0|||
126549736|NCT01533714|455307569|FG001|Overall Study|Withdrawal by Subject|1|||
126549737|NCT01533714|455307570|FG002|Overall Study|Withdrawal by Subject|0|||
126549738|NCT01533714|455307571|FG003|Overall Study|Withdrawal by Subject|1|||
126549739|NCT01533714|455307572|FG004|Overall Study|Withdrawal by Subject|1|||
126710479|NCT00685178|455891625|FG003|Overall Study|voluntary study discharge|1|||
126710480|NCT00685178|455891622|FG000|Overall Study|incarcerated|1|||
126710481|NCT00685178|455891623|FG001|Overall Study|incarcerated|3|||
126710482|NCT00685178|455891624|FG002|Overall Study|incarcerated|7|||
126710483|NCT00685178|455891625|FG003|Overall Study|incarcerated|0|||
126710484|NCT00685178|455891622|FG000|Overall Study|administrative (disciplinary) discharge|0|||
126710485|NCT00685178|455891623|FG001|Overall Study|administrative (disciplinary) discharge|1|||
126710486|NCT00685178|455891624|FG002|Overall Study|administrative (disciplinary) discharge|0|||
126710487|NCT00685178|455891625|FG003|Overall Study|administrative (disciplinary) discharge|2|||
126710488|NCT00685178|455891622|FG000|Overall Study|Pregnancy|0|||
126710489|NCT00685178|455891623|FG001|Overall Study|Pregnancy|0|||
126710490|NCT00685178|455891624|FG002|Overall Study|Pregnancy|0|||
126710491|NCT00685178|455891625|FG003|Overall Study|Pregnancy|1|||
126710492|NCT00077623|455891626|FG000|Overall Study|Adverse Event|1|||
126710493|NCT00077623|455891627|FG001|Overall Study|Adverse Event|0|||
126710494|NCT00077623|455891628|FG002|Overall Study|Adverse Event|1|||
126710495|NCT00077623|455891626|FG000|Overall Study|Withdrawal by Subject|2|||
126710496|NCT00077623|455891627|FG001|Overall Study|Withdrawal by Subject|10|||
126710497|NCT00077623|455891628|FG002|Overall Study|Withdrawal by Subject|1|||
126710498|NCT00077623|455891626|FG000|Overall Study|Other-Non safety reason|18|||
126710499|NCT00077623|455891627|FG001|Overall Study|Other-Non safety reason|15|||
126710500|NCT00077623|455891628|FG002|Overall Study|Other-Non safety reason|19|||
126710501|NCT00077623|455891626|FG000|Overall Study|Insufficient therapeutic response|2|||
126710502|NCT00077623|455891627|FG001|Overall Study|Insufficient therapeutic response|0|||
126710503|NCT00077623|455891628|FG002|Overall Study|Insufficient therapeutic response|0|||
126710504|NCT00077623|455891626|FG000|Overall Study|Death|12|||
126288975|NCT00852202|454344129|FG002|Overall Study|Lack of Efficacy|2|||
126288976|NCT00852202|454344127|FG000|Overall Study|Protocol Violation|2|||
126288977|NCT00852202|454344128|FG001|Overall Study|Protocol Violation|2|||
126288978|NCT00852202|454344129|FG002|Overall Study|Protocol Violation|7|||
126288979|NCT00852202|454344127|FG000|Overall Study|Withdrawal by Subject|3|||
126288980|NCT00852202|454344128|FG001|Overall Study|Withdrawal by Subject|1|||
126288981|NCT00852202|454344129|FG002|Overall Study|Withdrawal by Subject|2|||
126288982|NCT00852202|454344127|FG000|Overall Study|Lost to Follow-up|5|||
126288983|NCT00852202|454344128|FG001|Overall Study|Lost to Follow-up|5|||
126288984|NCT00852202|454344129|FG002|Overall Study|Lost to Follow-up|6|||
126288985|NCT00852202|454344127|FG000|Overall Study|pregnancy,moving away and surgery|1|||
126288986|NCT00852202|454344128|FG001|Overall Study|pregnancy,moving away and surgery|0|||
126288987|NCT00852202|454344129|FG002|Overall Study|pregnancy,moving away and surgery|2|||
126288988|NCT05022212|454344132|FG000|Overall Study|Lost to Follow-up|0|||
126288989|NCT05022212|454344133|FG001|Overall Study|Lost to Follow-up|2|||
126288990|NCT01682811|454344134|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
126288991|NCT01682811|454344135|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
126288992|NCT01682811|454344136|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
126288993|NCT01682811|454344137|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
126710505|NCT00077623|455891627|FG001|Overall Study|Death|18|||
126710506|NCT00077623|455891628|FG002|Overall Study|Death|11|||
126288994|NCT01682811|454344138|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
126288995|NCT01682811|454344139|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
126288996|NCT01682811|454344140|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
126288997|NCT01682811|454344134|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
126288998|NCT01682811|454344135|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
126288999|NCT01682811|454344136|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
126289000|NCT01682811|454344137|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
126289001|NCT01682811|454344138|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
126289002|NCT01682811|454344139|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
126549740|NCT01533714|455307573|FG005|Overall Study|Withdrawal by Subject|0|||
126549741|NCT01533714|455307568|FG000|Overall Study|Exclusion criteria|0|||
126549742|NCT01533714|455307569|FG001|Overall Study|Exclusion criteria|1|||
126549743|NCT01533714|455307570|FG002|Overall Study|Exclusion criteria|0|||
126710507|NCT00077623|455891626|FG000|Overall Study|Failure to return|1|||
126710508|NCT00077623|455891627|FG001|Overall Study|Failure to return|0|||
126710509|NCT00077623|455891628|FG002|Overall Study|Failure to return|0|||
126289003|NCT01682811|454344140|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
126549744|NCT01533714|455307571|FG003|Overall Study|Exclusion criteria|0|||
126549745|NCT01533714|455307572|FG004|Overall Study|Exclusion criteria|0|||
126710510|NCT04220866|455891631|FG000|Overall Study|Death|4|||
126289004|NCT01682811|454344134|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
126289005|NCT01682811|454344135|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
126289006|NCT01682811|454344136|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
126289007|NCT01682811|454344137|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
126289008|NCT01682811|454344138|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
126289009|NCT01682811|454344139|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
126289010|NCT01682811|454344140|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
126289011|NCT01682811|454344134|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
126289012|NCT01682811|454344135|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
126289013|NCT01682811|454344136|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
126289014|NCT01682811|454344137|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
126289015|NCT01682811|454344138|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
126289016|NCT01682811|454344139|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
126289017|NCT01682811|454344140|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
126289018|NCT02694328|454344141|FG000|Overall Study|Adverse Event|27|||
126289019|NCT02694328|454344142|FG001|Overall Study|Adverse Event|33|||
126289020|NCT02694328|454344141|FG000|Overall Study|Withdrawal by Subject|27|||
126289021|NCT02694328|454344142|FG001|Overall Study|Withdrawal by Subject|23|||
126289022|NCT02694328|454344141|FG000|Overall Study|Lost to Follow-up|26|||
126289023|NCT02694328|454344142|FG001|Overall Study|Lost to Follow-up|22|||
126289024|NCT02694328|454344141|FG000|Overall Study|Noncompliant with study drug|11|||
126289025|NCT02694328|454344142|FG001|Overall Study|Noncompliant with study drug|8|||
126289026|NCT02694328|454344141|FG000|Overall Study|Incarceration|1|||
126289027|NCT02694328|454344142|FG001|Overall Study|Incarceration|1|||
126289028|NCT02694328|454344141|FG000|Overall Study|Lack of Efficacy|1|||
126289029|NCT02694328|454344142|FG001|Overall Study|Lack of Efficacy|2|||
126289030|NCT02694328|454344141|FG000|Overall Study|Pregnancy|1|||
126289031|NCT02694328|454344142|FG001|Overall Study|Pregnancy|1|||
126289032|NCT02694328|454344141|FG000|Overall Study|Protocol Violation|6|||
126289033|NCT02694328|454344142|FG001|Overall Study|Protocol Violation|5|||
126289034|NCT02694328|454344141|FG000|Overall Study|Abnormal Laboratory Value|0|||
126289035|NCT02694328|454344142|FG001|Overall Study|Abnormal Laboratory Value|3|||
126289036|NCT01260701|454344143|FG000|Overall Study|Adverse Event|9|||
126289037|NCT01260701|454344143|FG000|Overall Study|Withdrawal by Subject|2|||
126289038|NCT01260701|454344143|FG000|Overall Study|Progression|53|||
126289039|NCT01260701|454344143|FG000|Overall Study|Death|2|||
126289040|NCT01260701|454344143|FG000|Overall Study|Not protocol specified|3|||
126289041|NCT01260701|454344143|FG000|Overall Study|Under review|1|||
126289042|NCT01260701|454344143|FG000|Overall Study|Ineligible|4|||
126289043|NCT01260701|454344143|FG000|Overall Study|Did not begin protocol therapy|1|||
126289044|NCT02731638|454345910|FG000|Overall Study|Lost to Follow-up|6|||
126289045|NCT02731638|454345911|FG001|Overall Study|Lost to Follow-up|9|||
126289046|NCT06195930|454345912|FG000|Overall Study|Adverse Event|4|||
126289047|NCT05878093|454345913|FG000|Overall Study|Withdrawal by Subject|3|||
126289048|NCT05878093|454345914|FG001|Overall Study|Withdrawal by Subject|1|||
126289049|NCT04100018|454345917|FG000|Pre-Treatment Period|Not Reported|0|||
126289050|NCT04100018|454345918|FG001|Pre-Treatment Period|Not Reported|4|||
126289051|NCT04100018|454345917|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
126289052|NCT04100018|454345918|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
126289053|NCT04100018|454345917|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
126289054|NCT04100018|454345918|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
126289055|NCT04100018|454345917|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
126289056|NCT04100018|454345918|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
126289057|NCT04100018|454345917|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
126289058|NCT04100018|454345918|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
126289059|NCT04100018|454345917|FG000|Treatment Period|Ongoing Treatment|1|||
126289060|NCT04100018|454345918|FG001|Treatment Period|Ongoing Treatment|0|||
126289061|NCT04100018|454345917|FG000|Treatment Period|Other Reason|26|||
126289062|NCT04100018|454345918|FG001|Treatment Period|Other Reason|37|||
126289063|NCT04100018|454345917|FG000|Treatment Period|Completed treatment as per protocol|1|||
126710511|NCT04220866|455891632|FG001|Overall Study|Death|5|||
126710512|NCT04220866|455891631|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
126710513|NCT04220866|455891632|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
126710514|NCT04220866|455891631|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
126289064|NCT04100018|454345918|FG001|Treatment Period|Completed treatment as per protocol|2|||
126710515|NCT04220866|455891632|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
126710516|NCT04220866|455891631|FG000|Overall Study|Withdrawal by Subject|0|||
126289065|NCT04100018|454345917|FG000|Treatment Period|Maximum clinical benefit|3|||
126289066|NCT04100018|454345918|FG001|Treatment Period|Maximum clinical benefit|0|||
126289067|NCT04100018|454345917|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
126289068|NCT04100018|454345918|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
126289069|NCT04100018|454345917|FG000|Treatment Period|Study drug toxicity|67|||
126289070|NCT04100018|454345918|FG001|Treatment Period|Study drug toxicity|28|||
126710517|NCT04220866|455891632|FG001|Overall Study|Withdrawal by Subject|1|||
126289071|NCT04100018|454345917|FG000|Treatment Period|Disease Progression|284|||
126289072|NCT04100018|454345918|FG001|Treatment Period|Disease Progression|327|||
126289073|NCT04100018|454345917|FG000|Treatment Period|Administrative reasons by sponsor|16|||
126289074|NCT04100018|454345918|FG001|Treatment Period|Administrative reasons by sponsor|30|||
126289075|NCT04100018|454345917|FG000|Treatment Period|Poor/Non-Compliance|1|||
126289076|NCT04100018|454345918|FG001|Treatment Period|Poor/Non-Compliance|0|||
126289077|NCT04100018|454345917|FG000|Treatment Period|Lost to Follow-up|2|||
126289078|NCT04100018|454345918|FG001|Treatment Period|Lost to Follow-up|2|||
126289079|NCT04100018|454345917|FG000|Treatment Period|Death|16|||
126289080|NCT04100018|454345918|FG001|Treatment Period|Death|11|||
126289081|NCT04100018|454345917|FG000|Treatment Period|Participant withdrew consent|10|||
126289082|NCT04100018|454345918|FG001|Treatment Period|Participant withdrew consent|10|||
126289083|NCT04100018|454345917|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
126289084|NCT04100018|454345918|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
126289085|NCT04100018|454345917|FG000|Treatment Period|Adverse Event|14|||
126289086|NCT04100018|454345918|FG001|Treatment Period|Adverse Event|6|||
126289087|NCT04100018|454345917|FG000|Treatment Period|Lack of Efficacy|4|||
126289088|NCT04100018|454345918|FG001|Treatment Period|Lack of Efficacy|2|||
126289089|NCT02653625|454345923|FG000|Overall Study|Adverse Event|1|||
126289090|NCT02653625|454345923|FG000|Overall Study|Non-compliance with Study Drug|1|||
126289091|NCT02653625|454345923|FG000|Overall Study|Protocol Violation|1|||
126289092|NCT02653625|454345923|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
126289093|NCT02090725|454345926|FG000|Overall Study|Withdrawal by Subject|1|||
126289094|NCT02090725|454345926|FG000|Overall Study|participants moved from area|3|||
126289095|NCT01499095|454345927|FG000|Overall Study|Randomized But Not Treated|1|||
126289096|NCT01499095|454345928|FG001|Overall Study|Randomized But Not Treated|1|||
126289097|NCT01499095|454345927|FG000|Overall Study|Adverse Event|12|||
126289098|NCT01499095|454345928|FG001|Overall Study|Adverse Event|7|||
126289099|NCT01499095|454345927|FG000|Overall Study|Lack of Efficacy|2|||
126289100|NCT01499095|454345928|FG001|Overall Study|Lack of Efficacy|1|||
126289101|NCT01499095|454345927|FG000|Overall Study|Protocol Violation|6|||
126289102|NCT01499095|454345928|FG001|Overall Study|Protocol Violation|7|||
126289103|NCT01499095|454345927|FG000|Overall Study|Received Rescue Therapy|32|||
126289104|NCT01499095|454345928|FG001|Overall Study|Received Rescue Therapy|40|||
126289105|NCT01499095|454345927|FG000|Overall Study|Diverse Reasons|22|||
126289106|NCT01499095|454345928|FG001|Overall Study|Diverse Reasons|25|||
126289107|NCT01499095|454345927|FG000|Overall Study|Lost to Follow-up|6|||
126289108|NCT01499095|454345928|FG001|Overall Study|Lost to Follow-up|4|||
126289109|NCT01499095|454345927|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
126289110|NCT01499095|454345928|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
126289111|NCT01499095|454345927|FG000|Overall Study|Hypoglycemia|3|||
126289112|NCT01499095|454345928|FG001|Overall Study|Hypoglycemia|1|||
126289113|NCT01499095|454345927|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
126289114|NCT01499095|454345928|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
126289115|NCT01499095|454345927|FG000|Overall Study|Change in Injection Schedule|2|||
126289116|NCT01499095|454345928|FG001|Overall Study|Change in Injection Schedule|0|||
126457584|NCT02514473|454976549|FG001|Overall Study|Lost to Follow-up|1|||
126289117|NCT01499095|454345927|FG000|Overall Study|Perceived Lack of Efficacy|1|||
126457585|NCT02514473|454976548|FG000|Overall Study|Other|1|||
126457586|NCT02514473|454976549|FG001|Overall Study|Other|1|||
126457587|NCT02158364|454976550|FG000|Overall Study|Case report forms uncollected|10|||
126457588|NCT02158364|454976550|FG000|Overall Study|Protocol Deviation|50|||
126457589|NCT01944839|454976553|FG000|Overall Study|Physician Decision|2|||
126457590|NCT01944839|454976554|FG001|Overall Study|Physician Decision|2|||
126457591|NCT01944839|454976553|FG000|Overall Study|Protocol Violation|0|||
126457592|NCT01944839|454976554|FG001|Overall Study|Protocol Violation|1|||
126457593|NCT01944839|454976553|FG000|Overall Study|Adverse Event|10|||
126457594|NCT01944839|454976554|FG001|Overall Study|Adverse Event|5|||
126457595|NCT01944839|454976553|FG000|Overall Study|Withdrawal by Subject|9|||
126457596|NCT01944839|454976554|FG001|Overall Study|Withdrawal by Subject|17|||
126457597|NCT01944839|454976553|FG000|Overall Study|Lost to Follow-up|1|||
126457598|NCT01944839|454976554|FG001|Overall Study|Lost to Follow-up|0|||
126457599|NCT01944839|454976553|FG000|Overall Study|Subject non-compliance|0|||
126457600|NCT01944839|454976554|FG001|Overall Study|Subject non-compliance|3|||
126457601|NCT00674154|454976555|FG000|Overall Study|Withdrawal by Subject|3|||
126457602|NCT00674154|454976556|FG001|Overall Study|Withdrawal by Subject|1|||
126457603|NCT00674154|454976555|FG000|Overall Study|Did not want parathyroidectomy|0|||
126457604|NCT00674154|454976556|FG001|Overall Study|Did not want parathyroidectomy|2|||
126457605|NCT05093790|454976560|FG000|Overall Study|Failure to meet continuation criteria|0|||
126457606|NCT05093790|454976561|FG001|Overall Study|Failure to meet continuation criteria|0|||
126457607|NCT05093790|454976562|FG002|Overall Study|Failure to meet continuation criteria|1|||
126457608|NCT05093790|454976563|FG003|Overall Study|Failure to meet continuation criteria|0|||
126457609|NCT05093790|454976560|FG000|Overall Study|Adverse Event|1|||
126457610|NCT05093790|454976561|FG001|Overall Study|Adverse Event|0|||
126457611|NCT05093790|454976562|FG002|Overall Study|Adverse Event|0|||
126457612|NCT05093790|454976563|FG003|Overall Study|Adverse Event|0|||
126457613|NCT00924170|454976564|FG000|Overall Study|Refused further treatment|0|||
126457614|NCT00924170|454976565|FG001|Overall Study|Refused further treatment|1|||
126457615|NCT00924170|454976564|FG000|Overall Study|Physician Decision|0|||
126457616|NCT00924170|454976565|FG001|Overall Study|Physician Decision|1|||
126457617|NCT00924170|454976564|FG000|Overall Study|Progressive disease|3|||
126457618|NCT00924170|454976565|FG001|Overall Study|Progressive disease|6|||
126457619|NCT00924170|454976564|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
126457620|NCT00924170|454976565|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
126457621|NCT00924170|454976564|FG000|Overall Study|Death|1|||
126457622|NCT00924170|454976565|FG001|Overall Study|Death|0|||
126457623|NCT04449029|454976568|FG000|Overall Study|Adverse Event|0|||
126457624|NCT04449029|454976569|FG001|Overall Study|Adverse Event|1|||
126457625|NCT04449029|454976570|FG002|Overall Study|Adverse Event|1|||
126457626|NCT04449029|454976571|FG003|Overall Study|Adverse Event|0|||
126457627|NCT04449029|454976572|FG004|Overall Study|Adverse Event|1|||
126457628|NCT04449029|454976573|FG005|Overall Study|Adverse Event|0|||
126457629|NCT04449029|454976574|FG006|Overall Study|Adverse Event|1|||
126457630|NCT04449029|454976575|FG007|Overall Study|Adverse Event|0|||
126457631|NCT04449029|454976568|FG000|Overall Study|Lost to Follow-up|0|||
126457632|NCT04449029|454976569|FG001|Overall Study|Lost to Follow-up|1|||
126457633|NCT04449029|454976570|FG002|Overall Study|Lost to Follow-up|0|||
126457634|NCT04449029|454976571|FG003|Overall Study|Lost to Follow-up|0|||
126457635|NCT04449029|454976572|FG004|Overall Study|Lost to Follow-up|0|||
126457636|NCT04449029|454976573|FG005|Overall Study|Lost to Follow-up|0|||
126457637|NCT04449029|454976574|FG006|Overall Study|Lost to Follow-up|0|||
126457638|NCT04449029|454976575|FG007|Overall Study|Lost to Follow-up|0|||
126457639|NCT04449029|454976568|FG000|Overall Study|Protocol Violation|0|||
126457640|NCT04449029|454976569|FG001|Overall Study|Protocol Violation|1|||
126457641|NCT04449029|454976570|FG002|Overall Study|Protocol Violation|0|||
126457642|NCT04449029|454976571|FG003|Overall Study|Protocol Violation|0|||
126457643|NCT04449029|454976572|FG004|Overall Study|Protocol Violation|0|||
126457644|NCT04449029|454976573|FG005|Overall Study|Protocol Violation|0|||
126457645|NCT04449029|454976574|FG006|Overall Study|Protocol Violation|0|||
126289118|NCT01499095|454345928|FG001|Overall Study|Perceived Lack of Efficacy|1|||
126289119|NCT04358081|454345930|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
126289120|NCT04358081|454345931|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
126289121|NCT04358081|454345932|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
126289122|NCT04358081|454345930|FG000|Treatment Phase of Study|Adverse Event|1|||
126289123|NCT04358081|454345931|FG001|Treatment Phase of Study|Adverse Event|0|||
126289124|NCT04358081|454345932|FG002|Treatment Phase of Study|Adverse Event|1|||
126289125|NCT04358081|454345930|FG000|Treatment Phase of Study|Physician Decision|2|||
126289126|NCT04358081|454345931|FG001|Treatment Phase of Study|Physician Decision|0|||
126289127|NCT04358081|454345932|FG002|Treatment Phase of Study|Physician Decision|1|||
126289128|NCT04358081|454345930|FG000|Treatment Phase of Study|Protocol Violation|1|||
126289129|NCT04358081|454345931|FG001|Treatment Phase of Study|Protocol Violation|0|||
126289130|NCT04358081|454345932|FG002|Treatment Phase of Study|Protocol Violation|0|||
126289131|NCT04358081|454345930|FG000|Study Completion Phase|Death|0|||
126289132|NCT04358081|454345931|FG001|Study Completion Phase|Death|0|||
126289133|NCT04358081|454345932|FG002|Study Completion Phase|Death|1|||
126289134|NCT04358081|454345930|FG000|Study Completion Phase|Lost to Follow-up|1|||
126289135|NCT04358081|454345931|FG001|Study Completion Phase|Lost to Follow-up|0|||
126289136|NCT04358081|454345932|FG002|Study Completion Phase|Lost to Follow-up|1|||
126289137|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
126289138|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
126289139|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
126289140|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
126289141|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
126289142|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
126289143|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
126289144|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
126457646|NCT04449029|454976575|FG007|Overall Study|Protocol Violation|0|||
126457647|NCT04449029|454976568|FG000|Overall Study|Physician Decision|0|||
126289145|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
126289146|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
126289147|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
126457648|NCT04449029|454976569|FG001|Overall Study|Physician Decision|0|||
126457649|NCT04449029|454976570|FG002|Overall Study|Physician Decision|0|||
126457650|NCT04449029|454976571|FG003|Overall Study|Physician Decision|0|||
126457651|NCT04449029|454976572|FG004|Overall Study|Physician Decision|0|||
126457652|NCT04449029|454976573|FG005|Overall Study|Physician Decision|1|||
126457653|NCT04449029|454976574|FG006|Overall Study|Physician Decision|0|||
126457654|NCT04449029|454976575|FG007|Overall Study|Physician Decision|0|||
126457655|NCT04449029|454976568|FG000|Overall Study|Withdrawal by Subject|3|||
126457656|NCT04449029|454976569|FG001|Overall Study|Withdrawal by Subject|0|||
126457657|NCT04449029|454976570|FG002|Overall Study|Withdrawal by Subject|1|||
126289148|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
126289149|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
126289150|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
126289151|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
126289152|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
126289153|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
126289154|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
126289155|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
126289156|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
126289157|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
126289158|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
126289159|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
126289160|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
126289161|NCT01130532|454345933|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
126289162|NCT01130532|454345934|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
126289163|NCT01130532|454345935|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
126289164|NCT01130532|454345936|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
126289165|NCT01130532|454345933|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
126289166|NCT01130532|454345934|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
126289167|NCT01130532|454345935|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
126289168|NCT01130532|454345936|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
126289169|NCT01130532|454345933|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
126289170|NCT01130532|454345934|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
126289171|NCT01130532|454345935|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
126289172|NCT01130532|454345936|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
126289173|NCT01130532|454345933|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
126289174|NCT01130532|454345934|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
126289175|NCT01130532|454345935|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
126289176|NCT01130532|454345936|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
126289177|NCT01130532|454345933|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
126289178|NCT01130532|454345934|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
126289179|NCT01130532|454345935|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
126289180|NCT01130532|454345936|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
126289181|NCT02762929|454345937|FG000|Overall Study|Adverse Event|0|||
126289182|NCT02762929|454345938|FG001|Overall Study|Adverse Event|0|||
126289183|NCT02762929|454345939|FG002|Overall Study|Adverse Event|0|||
126289184|NCT02762929|454345940|FG003|Overall Study|Adverse Event|1|||
126289185|NCT02762929|454345941|FG004|Overall Study|Adverse Event|0|||
126289186|NCT02762929|454345942|FG005|Overall Study|Adverse Event|0|||
126289187|NCT02762929|454345937|FG000|Overall Study|Lost to Follow-up|1|||
126289188|NCT02762929|454345938|FG001|Overall Study|Lost to Follow-up|2|||
126289189|NCT02762929|454345939|FG002|Overall Study|Lost to Follow-up|0|||
126457658|NCT04449029|454976571|FG003|Overall Study|Withdrawal by Subject|1|||
126457659|NCT04449029|454976572|FG004|Overall Study|Withdrawal by Subject|5|||
126457660|NCT04449029|454976573|FG005|Overall Study|Withdrawal by Subject|1|||
126457661|NCT04449029|454976574|FG006|Overall Study|Withdrawal by Subject|4|||
126457662|NCT04449029|454976575|FG007|Overall Study|Withdrawal by Subject|0|||
126457663|NCT02025556|454976577|FG000|Overall Study|Adverse Event|0|||
126457664|NCT02025556|454976578|FG001|Overall Study|Adverse Event|4|||
126457665|NCT02025556|454976579|FG002|Overall Study|Adverse Event|2|||
126457666|NCT02025556|454976577|FG000|Overall Study|Lack of Efficacy|2|||
126457667|NCT02025556|454976578|FG001|Overall Study|Lack of Efficacy|1|||
126457668|NCT02025556|454976579|FG002|Overall Study|Lack of Efficacy|0|||
126457669|NCT02025556|454976577|FG000|Overall Study|Protocol Violation|2|||
126457670|NCT02025556|454976578|FG001|Overall Study|Protocol Violation|1|||
126457671|NCT02025556|454976579|FG002|Overall Study|Protocol Violation|0|||
126457672|NCT02025556|454976577|FG000|Overall Study|Withdrawal by Subject|0|||
126457673|NCT02025556|454976578|FG001|Overall Study|Withdrawal by Subject|3|||
126457674|NCT02025556|454976579|FG002|Overall Study|Withdrawal by Subject|6|||
126710518|NCT02138110|455891633|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
126289190|NCT02762929|454345940|FG003|Overall Study|Lost to Follow-up|1|||
126710519|NCT02138110|455891633|FG000|Overall Scaffold Implantation|Death|3|||
126289191|NCT02762929|454345941|FG004|Overall Study|Lost to Follow-up|0|||
126289192|NCT02762929|454345942|FG005|Overall Study|Lost to Follow-up|0|||
126457675|NCT02025556|454976577|FG000|Overall Study|Lost to Follow-up|2|||
126457676|NCT02025556|454976578|FG001|Overall Study|Lost to Follow-up|4|||
126710520|NCT00882713|455891634|FG000|Overall Study|Adverse Event|2|||
126289193|NCT02762929|454345937|FG000|Overall Study|Withdrawal by Subject|0|||
126289194|NCT02762929|454345938|FG001|Overall Study|Withdrawal by Subject|1|||
126289195|NCT02762929|454345939|FG002|Overall Study|Withdrawal by Subject|0|||
126289196|NCT02762929|454345940|FG003|Overall Study|Withdrawal by Subject|0|||
126289197|NCT02762929|454345941|FG004|Overall Study|Withdrawal by Subject|0|||
126289198|NCT02762929|454345942|FG005|Overall Study|Withdrawal by Subject|0|||
126289199|NCT02762929|454345937|FG000|Overall Study|exclusionary medication disclosed late|0|||
126457677|NCT02025556|454976579|FG002|Overall Study|Lost to Follow-up|0|||
126457678|NCT02025556|454976577|FG000|Overall Study|Reason not reported|0|||
126289200|NCT02762929|454345938|FG001|Overall Study|exclusionary medication disclosed late|0|||
126289201|NCT02762929|454345939|FG002|Overall Study|exclusionary medication disclosed late|0|||
126289202|NCT02762929|454345940|FG003|Overall Study|exclusionary medication disclosed late|1|||
126289203|NCT02762929|454345941|FG004|Overall Study|exclusionary medication disclosed late|0|||
126289204|NCT02762929|454345942|FG005|Overall Study|exclusionary medication disclosed late|0|||
126289205|NCT02656303|454345943|FG000|Overall Study|Adverse Event|3|||
126289206|NCT02656303|454345944|FG001|Overall Study|Adverse Event|2|||
126289207|NCT02656303|454345945|FG002|Overall Study|Adverse Event|0|||
126289208|NCT02656303|454345943|FG000|Overall Study|Death|12|||
126289209|NCT02656303|454345944|FG001|Overall Study|Death|4|||
126289210|NCT02656303|454345945|FG002|Overall Study|Death|1|||
126289211|NCT02656303|454345943|FG000|Overall Study|Lack of Efficacy|1|||
126289212|NCT02656303|454345944|FG001|Overall Study|Lack of Efficacy|0|||
126289213|NCT02656303|454345945|FG002|Overall Study|Lack of Efficacy|0|||
126289214|NCT02656303|454345943|FG000|Overall Study|Non-Compliance with Study|1|||
126289215|NCT02656303|454345944|FG001|Overall Study|Non-Compliance with Study|1|||
126289216|NCT02656303|454345945|FG002|Overall Study|Non-Compliance with Study|0|||
126289217|NCT02656303|454345943|FG000|Overall Study|Investigator Decision|2|||
126289218|NCT02656303|454345944|FG001|Overall Study|Investigator Decision|1|||
126289219|NCT02656303|454345945|FG002|Overall Study|Investigator Decision|0|||
126289220|NCT02656303|454345943|FG000|Overall Study|Progressive Disease|25|||
126289221|NCT02656303|454345944|FG001|Overall Study|Progressive Disease|14|||
126289222|NCT02656303|454345945|FG002|Overall Study|Progressive Disease|10|||
126289223|NCT02656303|454345943|FG000|Overall Study|Study Terminated by Sponsor|20|||
126289224|NCT02656303|454345944|FG001|Overall Study|Study Terminated by Sponsor|7|||
126289225|NCT02656303|454345945|FG002|Overall Study|Study Terminated by Sponsor|5|||
126289226|NCT02656303|454345943|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
126289227|NCT02656303|454345944|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
126289228|NCT02656303|454345945|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
126289229|NCT02656303|454345943|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
126289230|NCT02656303|454345944|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
126289231|NCT02656303|454345945|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
126289232|NCT02656303|454345943|FG000|Overall Study|Reason not Specified|1|||
126289233|NCT02656303|454345944|FG001|Overall Study|Reason not Specified|1|||
126289234|NCT02656303|454345945|FG002|Overall Study|Reason not Specified|2|||
126289235|NCT03041311|454345948|FG000|Overall Study|Death|39|||
126289236|NCT03041311|454345949|FG001|Overall Study|Death|42|||
126457679|NCT02025556|454976578|FG001|Overall Study|Reason not reported|0|||
126457680|NCT02025556|454976579|FG002|Overall Study|Reason not reported|1|||
126457681|NCT00627445|454976580|FG000|Overall Study|Adverse Event|3|||
126457682|NCT00627445|454976581|FG001|Overall Study|Adverse Event|3|||
126457683|NCT00627445|454976580|FG000|Overall Study|Lack of Efficacy|0|||
126457684|NCT00627445|454976581|FG001|Overall Study|Lack of Efficacy|1|||
126457685|NCT00627445|454976580|FG000|Overall Study|Other|6|||
126457686|NCT00627445|454976581|FG001|Overall Study|Other|8|||
126457687|NCT02217527|454976582|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
126457688|NCT02217527|454976583|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
126457689|NCT02217527|454976582|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
126457690|NCT02217527|454976583|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
126457691|NCT01203852|454976584|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
126457692|NCT01203852|454976584|FG000|Washout 2 Weeks|Physician Decision|46|||
126457693|NCT00247611|454976586|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
126457694|NCT00247611|454976587|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
126457695|NCT00247611|454976586|FG000|Baselined|Completed baseline only|9|||
126457696|NCT00247611|454976587|FG001|Baselined|Completed baseline only|8|||
126457697|NCT02395302|454976589|FG000|Overall Study|Screen Failure|3|||
126457698|NCT02395302|454976589|FG000|Overall Study|Run In Failure|7|||
126457699|NCT02395302|454976589|FG000|Overall Study|Withdrawal by Subject|2|||
126457700|NCT02395302|454976589|FG000|Overall Study|Physician Decision|2|||
126457701|NCT01306929|454976592|FG000|Overall Study|Withdrawal by Subject|23|||
126457702|NCT01306929|454976592|FG000|Overall Study|Adverse Event|21|||
126457703|NCT01306929|454976592|FG000|Overall Study|Physician Decision|13|||
126457704|NCT01306929|454976592|FG000|Overall Study|Death|8|||
126457705|NCT01306929|454976592|FG000|Overall Study|Withdrawal by parent/guardian|5|||
126457706|NCT01306929|454976592|FG000|Overall Study|Protocol Violation|3|||
126289237|NCT03041311|454345948|FG000|Overall Study|Lost to Follow-up|0|||
126289238|NCT03041311|454345949|FG001|Overall Study|Lost to Follow-up|1|||
126457707|NCT01306929|454976592|FG000|Overall Study|Non-compliance with study drug|2|||
126289239|NCT03041311|454345948|FG000|Overall Study|Withdrawal by Subject|8|||
126289240|NCT03041311|454345949|FG001|Overall Study|Withdrawal by Subject|5|||
126289241|NCT03041311|454345948|FG000|Overall Study|Sponsor Terminated Study|2|||
126289242|NCT03041311|454345949|FG001|Overall Study|Sponsor Terminated Study|4|||
126289243|NCT03041311|454345948|FG000|Overall Study|Disease Progression|3|||
126457708|NCT01306929|454976592|FG000|Overall Study|Lost to Follow-up|2|||
126457709|NCT01306929|454976592|FG000|Overall Study|Various|17|||
126457710|NCT01829243|454976606|FG000|First Intervention|Screen Failure|4|||
126549746|NCT01533714|455307573|FG005|Overall Study|Exclusion criteria|0|||
126549747|NCT01533714|455307568|FG000|Overall Study|Positive for purified protein derivative|0|||
126549748|NCT01533714|455307569|FG001|Overall Study|Positive for purified protein derivative|0|||
126549749|NCT01533714|455307570|FG002|Overall Study|Positive for purified protein derivative|1|||
126549750|NCT01533714|455307571|FG003|Overall Study|Positive for purified protein derivative|0|||
126549751|NCT01533714|455307572|FG004|Overall Study|Positive for purified protein derivative|1|||
126549752|NCT01533714|455307573|FG005|Overall Study|Positive for purified protein derivative|0|||
126549753|NCT01533714|455307568|FG000|Overall Study|Withdrawal criteria|0|||
126549754|NCT01533714|455307569|FG001|Overall Study|Withdrawal criteria|0|||
126549755|NCT01533714|455307570|FG002|Overall Study|Withdrawal criteria|1|||
126549756|NCT01533714|455307571|FG003|Overall Study|Withdrawal criteria|0|||
126549757|NCT01533714|455307572|FG004|Overall Study|Withdrawal criteria|3|||
126549758|NCT01533714|455307573|FG005|Overall Study|Withdrawal criteria|1|||
126549759|NCT01533714|455307568|FG000|Overall Study|Ineligibility reason|0|||
126710521|NCT00882713|455891634|FG000|Overall Study|Death|3|||
126710522|NCT00882713|455891634|FG000|Overall Study|Administrative reasons|4|||
126710523|NCT00882713|455891634|FG000|Overall Study|refused treatment/withdrew consent|4|||
126710524|NCT00882713|455891634|FG000|Overall Study|Blood transfusion|2|||
126710525|NCT00882713|455891634|FG000|Overall Study|Insufficient therapeutic response|3|||
126710526|NCT00882713|455891634|FG000|Overall Study|Failure to return|2|||
126710527|NCT00882713|455891634|FG000|Overall Study|Other - Reasons|2|||
126710528|NCT00401973|455891635|FG000|Overall Study|Adverse Event|2|||
126710529|NCT00401973|455891636|FG001|Overall Study|Adverse Event|8|||
126710530|NCT00401973|455891637|FG002|Overall Study|Adverse Event|4|||
126549760|NCT01533714|455307569|FG001|Overall Study|Ineligibility reason|0|||
126549761|NCT01533714|455307570|FG002|Overall Study|Ineligibility reason|0|||
126549762|NCT01533714|455307571|FG003|Overall Study|Ineligibility reason|1|||
126710531|NCT00401973|455891635|FG000|Overall Study|Clinical Relapse|0|||
126710532|NCT00401973|455891636|FG001|Overall Study|Clinical Relapse|1|||
126710533|NCT00401973|455891637|FG002|Overall Study|Clinical Relapse|1|||
126710534|NCT00401973|455891635|FG000|Overall Study|Lack of Efficacy|0|||
126710535|NCT00401973|455891636|FG001|Overall Study|Lack of Efficacy|0|||
126710536|NCT00401973|455891637|FG002|Overall Study|Lack of Efficacy|3|||
126710537|NCT00401973|455891635|FG000|Overall Study|Lost to Follow-up|2|||
126710538|NCT00401973|455891636|FG001|Overall Study|Lost to Follow-up|2|||
126710539|NCT00401973|455891637|FG002|Overall Study|Lost to Follow-up|2|||
126710540|NCT00401973|455891635|FG000|Overall Study|Physician Decision|2|||
126710541|NCT00401973|455891636|FG001|Overall Study|Physician Decision|0|||
126710542|NCT00401973|455891637|FG002|Overall Study|Physician Decision|1|||
126289244|NCT03041311|454345949|FG001|Overall Study|Disease Progression|1|||
126289245|NCT03041311|454345948|FG000|Overall Study|Randomized in error, did not receive drug|2|||
126289246|NCT03041311|454345949|FG001|Overall Study|Randomized in error, did not receive drug|0|||
126289247|NCT00782626|454345953|FG000|Overall Study|Adverse Event|1|||
126289248|NCT00782626|454345953|FG000|Overall Study|Progressive Disease|5|||
126289249|NCT00782626|454345953|FG000|Overall Study|Other Complicating Disease|1|||
126289250|NCT04182490|454345957|FG000|Overall Study|Withdrawal by Subject|3|||
126289251|NCT04182490|454345958|FG001|Overall Study|Withdrawal by Subject|3|||
126289252|NCT04182490|454345957|FG000|Overall Study|Lost to Follow-up|0|||
126289253|NCT04182490|454345958|FG001|Overall Study|Lost to Follow-up|1|||
126289254|NCT04182490|454345957|FG000|Overall Study|Physician Decision|0|||
126289255|NCT04182490|454345958|FG001|Overall Study|Physician Decision|1|||
126289256|NCT00853099|454345959|FG000|Double-blind Period|Adverse Event|7|||
126289257|NCT00853099|454345960|FG001|Double-blind Period|Adverse Event|9|||
126289258|NCT00853099|454345961|FG002|Double-blind Period|Adverse Event|13|||
126289259|NCT00853099|454345962|FG003|Double-blind Period|Adverse Event|0|||
126289260|NCT00853099|454345959|FG000|Double-blind Period|Withdrawal by Subject|2|||
126289261|NCT00853099|454345960|FG001|Double-blind Period|Withdrawal by Subject|3|||
126289262|NCT00853099|454345961|FG002|Double-blind Period|Withdrawal by Subject|0|||
126289263|NCT00853099|454345962|FG003|Double-blind Period|Withdrawal by Subject|0|||
126289264|NCT00853099|454345959|FG000|Double-blind Period|Lack of Efficacy|14|||
126289265|NCT00853099|454345960|FG001|Double-blind Period|Lack of Efficacy|17|||
126289266|NCT00853099|454345961|FG002|Double-blind Period|Lack of Efficacy|16|||
126289267|NCT00853099|454345962|FG003|Double-blind Period|Lack of Efficacy|0|||
126289268|NCT00853099|454345959|FG000|Double-blind Period|Other|0|||
126289269|NCT00853099|454345960|FG001|Double-blind Period|Other|0|||
126289270|NCT00853099|454345961|FG002|Double-blind Period|Other|1|||
126289271|NCT00853099|454345962|FG003|Double-blind Period|Other|0|||
126289272|NCT00853099|454345959|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
126710543|NCT00401973|455891635|FG000|Overall Study|Protocol Violation|1|||
126710544|NCT00401973|455891636|FG001|Overall Study|Protocol Violation|2|||
126710545|NCT00401973|455891637|FG002|Overall Study|Protocol Violation|3|||
126710546|NCT00401973|455891635|FG000|Overall Study|Sponsor Decision|0|||
126710547|NCT00401973|455891636|FG001|Overall Study|Sponsor Decision|1|||
126289273|NCT00853099|454345960|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
126289274|NCT00853099|454345961|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
126289275|NCT00853099|454345962|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
126289276|NCT00853099|454345959|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
126289277|NCT00853099|454345960|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
126289278|NCT00853099|454345961|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
126289279|NCT00853099|454345962|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
126289280|NCT00853099|454345959|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
126289281|NCT00853099|454345960|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
126289282|NCT00853099|454345961|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
126289283|NCT00853099|454345962|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
126289284|NCT00853099|454345959|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
126289285|NCT00853099|454345960|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
126289286|NCT00853099|454345961|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
126289287|NCT00853099|454345962|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
126289288|NCT00853099|454345959|FG000|Double-blind + Open-label Periods|Other|0|||
126289289|NCT00853099|454345960|FG001|Double-blind + Open-label Periods|Other|0|||
126289290|NCT00853099|454345961|FG002|Double-blind + Open-label Periods|Other|0|||
126289291|NCT00853099|454345962|FG003|Double-blind + Open-label Periods|Other|6|||
126289292|NCT01811472|454345963|FG000|Overall Study|Adverse Event|1|||
126289293|NCT01811472|454345964|FG001|Overall Study|Adverse Event|0|||
126289294|NCT01811472|454345965|FG002|Overall Study|Adverse Event|4|||
126289295|NCT01811472|454345963|FG000|Overall Study|Lost to Follow-up|0|||
126289296|NCT01811472|454345964|FG001|Overall Study|Lost to Follow-up|0|||
126289297|NCT01811472|454345965|FG002|Overall Study|Lost to Follow-up|1|||
126289298|NCT01811472|454345963|FG000|Overall Study|Subject/guardian decision|1|||
126289299|NCT01811472|454345964|FG001|Overall Study|Subject/guardian decision|0|||
126289300|NCT01811472|454345965|FG002|Overall Study|Subject/guardian decision|0|||
126289301|NCT03280264|454345966|FG000|Overall Study|Adverse Event|1|||
126289302|NCT03280264|454345966|FG000|Overall Study|Physician Decision|1|||
126289303|NCT03280264|454345966|FG000|Overall Study|Withdrawal by Subject|1|||
126289304|NCT02738138|454345968|FG000|Overall Study|Adverse Event|0|||
126289305|NCT02738138|454345969|FG001|Overall Study|Adverse Event|1|||
126289306|NCT02738138|454345968|FG000|Overall Study|Lost to Follow-up|2|||
126289307|NCT02738138|454345969|FG001|Overall Study|Lost to Follow-up|0|||
126289308|NCT02738138|454345968|FG000|Overall Study|Other - not further specified|1|||
126289309|NCT02738138|454345969|FG001|Overall Study|Other - not further specified|0|||
126289310|NCT02071225|454345980|FG000|Overall Study|Withdrawal of Consent|2|||
126289311|NCT02071225|454345980|FG000|Overall Study|Protocol Deviation|1|||
126289312|NCT02071225|454345980|FG000|Overall Study|Lost to Follow-up|2|||
126289313|NCT02071225|454345980|FG000|Overall Study|Death|25|||
126289314|NCT02064296|454345985|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
126289315|NCT02064296|454345986|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
126289316|NCT02064296|454345987|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
126289317|NCT02064296|454345985|FG000|Intervention|Withdrawal by Subject|0|||
126289318|NCT02064296|454345986|FG001|Intervention|Withdrawal by Subject|1|||
126289319|NCT02064296|454345987|FG002|Intervention|Withdrawal by Subject|2|||
126289320|NCT03885661|454345996|FG000|Overall Study|Withdrawal by Subject|0|||
126289321|NCT03885661|454345997|FG001|Overall Study|Withdrawal by Subject|1|||
126289322|NCT03885661|454345996|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
126289323|NCT03885661|454345997|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
126289324|NCT03934541|454346002|FG000|Overall Study|Study Terminated by Sponsor|0|||
126289325|NCT03934541|454346003|FG001|Overall Study|Study Terminated by Sponsor|1|||
126289326|NCT03934541|454346004|FG002|Overall Study|Study Terminated by Sponsor|0|||
126289327|NCT03934541|454346005|FG003|Overall Study|Study Terminated by Sponsor|0|||
126457711|NCT01829243|454976607|FG001|First Intervention|Screen Failure|2|||
126457712|NCT01077375|454976615|FG000|Overall Study|Adverse Event|2|||
126457713|NCT01077375|454976616|FG001|Overall Study|Adverse Event|15|||
126457714|NCT01077375|454976615|FG000|Overall Study|Lack of Efficacy|6|||
126457715|NCT01077375|454976616|FG001|Overall Study|Lack of Efficacy|8|||
126457716|NCT01077375|454976615|FG000|Overall Study|Withdrawal by Subject|0|||
126457717|NCT01077375|454976616|FG001|Overall Study|Withdrawal by Subject|6|||
126457718|NCT01077375|454976615|FG000|Overall Study|Lost to Follow-up|2|||
126457719|NCT01077375|454976616|FG001|Overall Study|Lost to Follow-up|5|||
126457720|NCT01077375|454976615|FG000|Overall Study|Other Reason|0|||
126457721|NCT01077375|454976616|FG001|Overall Study|Other Reason|1|||
126289328|NCT02673775|454346006|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
126289329|NCT02673775|454346007|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
126289330|NCT02673775|454346006|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
126289331|NCT02673775|454346007|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
126289332|NCT02673775|454346006|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
126289333|NCT02673775|454346007|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
126289334|NCT02673775|454346006|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
126457722|NCT00545129|454976617|FG000|Overall Study|Lack of Efficacy|2|||
126549763|NCT01533714|455307572|FG004|Overall Study|Ineligibility reason|0|||
126457723|NCT00545129|454976618|FG001|Overall Study|Lack of Efficacy|5|||
126457724|NCT00545129|454976617|FG000|Overall Study|Death|2|||
126457725|NCT00545129|454976618|FG001|Overall Study|Death|1|||
126289335|NCT02673775|454346007|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
126289336|NCT02441686|454346008|FG000|Induction|Adverse Event|4|||
126289337|NCT02441686|454346008|FG000|Induction|Complicating disease|1|||
126289338|NCT02441686|454346008|FG000|Induction|Physician Decision|1|||
126289339|NCT02441686|454346008|FG000|Induction|Withdrawal by Subject|1|||
126289340|NCT02441686|454346008|FG000|Induction|Did not receive treatment|1|||
126289341|NCT02441686|454346008|FG000|Maintenance|Remaining on Treatment|23|||
126289342|NCT02441686|454346008|FG000|Maintenance|Physician Decision|1|||
126289343|NCT02441686|454346008|FG000|Maintenance|Adverse Event|3|||
126289344|NCT02441686|454346008|FG000|Maintenance|Progressive Disease|10|||
126289345|NCT02441686|454346008|FG000|Maintenance|Withdrawal by Subject|1|||
126289346|NCT03151304|454346009|FG000|Overall Study|Termination of study by Sponsor|23|||
126289347|NCT03151304|454346009|FG000|Overall Study|missing|3|||
126289348|NCT03151304|454346009|FG000|Overall Study|Withdrawal by Subject|8|||
126289349|NCT03151304|454346009|FG000|Overall Study|multiple reasons|30|||
126289350|NCT03519087|454346010|FG000|Clinic Evaluation|Physician Decision|15|||
126289351|NCT03519087|454346011|FG001|Clinic Evaluation|Physician Decision|18|||
126289352|NCT03519087|454346012|FG002|Clinic Evaluation|Physician Decision|0|||
126289353|NCT03519087|454346013|FG003|Clinic Evaluation|Physician Decision|0|||
126289354|NCT03519087|454346014|FG004|Clinic Evaluation|Physician Decision|0|||
126289355|NCT03519087|454346010|FG000|Clinic Evaluation|Protocol Violation|1|||
126289356|NCT03519087|454346011|FG001|Clinic Evaluation|Protocol Violation|0|||
126289357|NCT03519087|454346012|FG002|Clinic Evaluation|Protocol Violation|0|||
126289358|NCT03519087|454346013|FG003|Clinic Evaluation|Protocol Violation|0|||
126289359|NCT03519087|454346014|FG004|Clinic Evaluation|Protocol Violation|0|||
126289360|NCT03519087|454346010|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
126289361|NCT03519087|454346011|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
126289362|NCT03519087|454346012|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
126289363|NCT03519087|454346013|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
126289364|NCT03519087|454346014|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
126289365|NCT03519087|454346010|FG000|Re-randomization for Treatment|Not appropriate|2|||
126289366|NCT03519087|454346011|FG001|Re-randomization for Treatment|Not appropriate|3|||
126289367|NCT03519087|454346012|FG002|Re-randomization for Treatment|Not appropriate|0|||
126289368|NCT03519087|454346013|FG003|Re-randomization for Treatment|Not appropriate|0|||
126289369|NCT03519087|454346014|FG004|Re-randomization for Treatment|Not appropriate|0|||
126289370|NCT03519087|454346010|FG000|Laboratory Testing|Lost to Follow-up|0|||
126289371|NCT03519087|454346011|FG001|Laboratory Testing|Lost to Follow-up|0|||
126289372|NCT03519087|454346012|FG002|Laboratory Testing|Lost to Follow-up|2|||
126289373|NCT03519087|454346013|FG003|Laboratory Testing|Lost to Follow-up|3|||
126289374|NCT03519087|454346014|FG004|Laboratory Testing|Lost to Follow-up|6|||
126289375|NCT03519087|454346010|FG000|Laboratory Testing|Protocol Violation|0|||
126289376|NCT03519087|454346011|FG001|Laboratory Testing|Protocol Violation|0|||
126289377|NCT03519087|454346012|FG002|Laboratory Testing|Protocol Violation|0|||
126289378|NCT03519087|454346013|FG003|Laboratory Testing|Protocol Violation|1|||
126289379|NCT03519087|454346014|FG004|Laboratory Testing|Protocol Violation|0|||
126289380|NCT01137071|454346015|FG000|Overall Study|Disease Progression|11|||
126289381|NCT01137071|454346015|FG000|Overall Study|Withdrawal by Subject|2|||
126289382|NCT01137071|454346015|FG000|Overall Study|Wrongly Included|1|||
126289383|NCT04194645|454346016|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289384|NCT04194645|454346017|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289385|NCT04194645|454346018|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126365804|NCT03164356|454632898|FG000|Overall Study|Prosthetist unable to participate|0|||
126365805|NCT03164356|454632899|FG001|Overall Study|Prosthetist unable to participate|2|||
126365806|NCT03164356|454632900|FG002|Overall Study|Prosthetist unable to participate|1|||
126365807|NCT03164356|454632901|FG003|Overall Study|Prosthetist unable to participate|0|||
126365808|NCT00561821|454632902|FG000|Overall Study|Not treated|0|||
126365809|NCT00561821|454632903|FG001|Overall Study|Not treated|0|||
126365810|NCT00561821|454632904|FG002|Overall Study|Not treated|1|||
126365811|NCT00561821|454632905|FG003|Overall Study|Not treated|0|||
126365812|NCT00561821|454632902|FG000|Overall Study|Withdrawal by Subject|0|||
126365813|NCT00561821|454632903|FG001|Overall Study|Withdrawal by Subject|1|||
126365814|NCT00561821|454632904|FG002|Overall Study|Withdrawal by Subject|0|||
126365815|NCT00561821|454632905|FG003|Overall Study|Withdrawal by Subject|2|||
126365816|NCT00561821|454632902|FG000|Overall Study|Reasons not related to trial|2|||
126365817|NCT00561821|454632903|FG001|Overall Study|Reasons not related to trial|1|||
126365818|NCT00561821|454632904|FG002|Overall Study|Reasons not related to trial|0|||
126365819|NCT00561821|454632905|FG003|Overall Study|Reasons not related to trial|0|||
126365820|NCT00561821|454632902|FG000|Overall Study|Other (reason not specified)|1|||
126365821|NCT00561821|454632903|FG001|Overall Study|Other (reason not specified)|1|||
126365822|NCT00561821|454632904|FG002|Overall Study|Other (reason not specified)|0|||
126365823|NCT00561821|454632905|FG003|Overall Study|Other (reason not specified)|0|||
126365824|NCT00561821|454632902|FG000|Overall Study|Adverse Event|2|||
126365825|NCT00561821|454632903|FG001|Overall Study|Adverse Event|3|||
126365826|NCT00561821|454632904|FG002|Overall Study|Adverse Event|1|||
126289386|NCT04194645|454346019|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289387|NCT04194645|454346020|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289388|NCT04194645|454346021|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289389|NCT04194645|454346022|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289390|NCT04194645|454346023|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289391|NCT04194645|454346024|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289392|NCT04194645|454346025|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
126289393|NCT04194645|454346026|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289394|NCT04194645|454346027|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289395|NCT04194645|454346028|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289396|NCT04194645|454346029|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289397|NCT04194645|454346030|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
126289398|NCT01783886|454346031|FG000|Overall Study|Lost to Follow-up|0|||
126289399|NCT01783886|454346032|FG001|Overall Study|Lost to Follow-up|3|||
126289400|NCT01783886|454346033|FG002|Overall Study|Lost to Follow-up|0|||
126289401|NCT01783886|454346031|FG000|Overall Study|Protocol deviation|0|||
126289402|NCT01783886|454346032|FG001|Overall Study|Protocol deviation|0|||
126289403|NCT01783886|454346033|FG002|Overall Study|Protocol deviation|2|||
126289404|NCT01783886|454346031|FG000|Overall Study|Withdrawal of consent by participant|1|||
126289405|NCT01783886|454346032|FG001|Overall Study|Withdrawal of consent by participant|3|||
126289406|NCT01783886|454346033|FG002|Overall Study|Withdrawal of consent by participant|4|||
126289407|NCT01783886|454346031|FG000|Overall Study|Adverse Event|4|||
126289408|NCT01783886|454346032|FG001|Overall Study|Adverse Event|5|||
126289409|NCT01783886|454346033|FG002|Overall Study|Adverse Event|4|||
126289410|NCT00104572|454346034|FG000|Overall Study|Withdrawal by Subject|3|||
126289411|NCT00104572|454346035|FG001|Overall Study|Withdrawal by Subject|3|||
126289412|NCT00104572|454346036|FG002|Overall Study|Withdrawal by Subject|0|||
126289413|NCT00940316|454346037|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
126289414|NCT00940316|454346038|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
126289415|NCT00940316|454346039|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
126289416|NCT00940316|454346037|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
126289417|NCT00940316|454346038|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
126289418|NCT00940316|454346039|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
126289419|NCT00940316|454346037|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
126289420|NCT00940316|454346038|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
126289421|NCT00940316|454346039|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
126289422|NCT00940316|454346037|FG000|Treated After Cycle 5|Adverse Event|0|||
126289423|NCT00940316|454346038|FG001|Treated After Cycle 5|Adverse Event|0|||
126289424|NCT00940316|454346039|FG002|Treated After Cycle 5|Adverse Event|1|||
126289425|NCT00940316|454346037|FG000|Treated After Cycle 5|Progressive disease|0|||
126289426|NCT00940316|454346038|FG001|Treated After Cycle 5|Progressive disease|1|||
126289427|NCT00940316|454346039|FG002|Treated After Cycle 5|Progressive disease|0|||
126289428|NCT02290405|454346040|FG000|Overall Study|Withdrawal by Subject|1|||
126289429|NCT02290405|454346041|FG001|Overall Study|Withdrawal by Subject|0|||
126289430|NCT02016183|454346042|FG000|Overall Study|Case Report Forms Uncollected|13|||
126289431|NCT02016183|454346042|FG000|Overall Study|Protocol Violation|52|||
126289432|NCT00996489|454346043|FG000|Overall Study|Device failure|45|||
126289433|NCT00996489|454346043|FG000|Overall Study|Discontinued|116|||
126289434|NCT03142191|454346044|FG000|Placebo Controlled Period|Death|0|||
126289435|NCT03142191|454346045|FG001|Placebo Controlled Period|Death|1|||
126289436|NCT03142191|454346046|FG002|Placebo Controlled Period|Death|1|||
126289437|NCT03142191|454346047|FG003|Placebo Controlled Period|Death|0|||
126289438|NCT03142191|454346048|FG004|Placebo Controlled Period|Death|0|||
126289439|NCT03142191|454346044|FG000|Placebo Controlled Period|Adverse Event|4|||
126289440|NCT03142191|454346045|FG001|Placebo Controlled Period|Adverse Event|5|||
126289441|NCT03142191|454346046|FG002|Placebo Controlled Period|Adverse Event|1|||
126289442|NCT03142191|454346047|FG003|Placebo Controlled Period|Adverse Event|0|||
126289443|NCT03142191|454346048|FG004|Placebo Controlled Period|Adverse Event|0|||
126289444|NCT03142191|454346044|FG000|Placebo Controlled Period|Progressive Disease|1|||
126289445|NCT03142191|454346045|FG001|Placebo Controlled Period|Progressive Disease|0|||
126289446|NCT03142191|454346046|FG002|Placebo Controlled Period|Progressive Disease|1|||
126365827|NCT00561821|454632905|FG003|Overall Study|Adverse Event|1|||
126365828|NCT02520154|454632907|FG000|Overall Study|Death|1|||
126365829|NCT02520154|454632907|FG000|Overall Study|Withdrawal by Subject|2|||
126365830|NCT02520154|454632907|FG000|Overall Study|Physician Decision|2|||
126365831|NCT03443401|454634231|FG000|Overall Study|Lost to Follow-up|13|||
126365832|NCT03443401|454634231|FG000|Overall Study|Influential outlier|1|||
126365833|NCT02904265|454634232|FG000|Overall Study|Physician Decision|1|||
126365834|NCT02904265|454634233|FG001|Overall Study|Physician Decision|2|||
126365835|NCT00267488|454634237|FG000|Overall Study|Sponsor Terminated Study|9|||
126365836|NCT00267488|454634237|FG000|Overall Study|Protocol Violation|1|||
126365837|NCT00267488|454634237|FG000|Overall Study|Other (Disease Progression)|1|||
126365838|NCT01557569|454634238|FG000|Overall Study|Adverse Event|2|||
126365839|NCT01557569|454634239|FG001|Overall Study|Adverse Event|0|||
126365840|NCT01557569|454634238|FG000|Overall Study|high blood pressure|0|||
126457726|NCT00545129|454976617|FG000|Overall Study|Adverse Event|1|||
126457727|NCT00545129|454976618|FG001|Overall Study|Adverse Event|1|||
126289447|NCT03142191|454346047|FG003|Placebo Controlled Period|Progressive Disease|0|||
126289448|NCT03142191|454346048|FG004|Placebo Controlled Period|Progressive Disease|0|||
126289449|NCT03142191|454346044|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
126289450|NCT03142191|454346045|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
126289451|NCT03142191|454346046|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
126289452|NCT03142191|454346047|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
126289453|NCT03142191|454346048|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
126289454|NCT03142191|454346044|FG000|Placebo Controlled Period|Other Reasons|1|||
126289455|NCT03142191|454346045|FG001|Placebo Controlled Period|Other Reasons|0|||
126289456|NCT03142191|454346046|FG002|Placebo Controlled Period|Other Reasons|0|||
126289457|NCT03142191|454346047|FG003|Placebo Controlled Period|Other Reasons|0|||
126289458|NCT03142191|454346048|FG004|Placebo Controlled Period|Other Reasons|0|||
126289459|NCT03142191|454346044|FG000|Active Treatment Extension Period|Death|2|||
126289460|NCT03142191|454346045|FG001|Active Treatment Extension Period|Death|1|||
126289461|NCT03142191|454346046|FG002|Active Treatment Extension Period|Death|1|||
126289462|NCT03142191|454346047|FG003|Active Treatment Extension Period|Death|1|||
126289463|NCT03142191|454346048|FG004|Active Treatment Extension Period|Death|0|||
126289464|NCT03142191|454346044|FG000|Active Treatment Extension Period|Adverse Event|6|||
126289465|NCT03142191|454346045|FG001|Active Treatment Extension Period|Adverse Event|5|||
126289466|NCT03142191|454346046|FG002|Active Treatment Extension Period|Adverse Event|4|||
126289467|NCT03142191|454346047|FG003|Active Treatment Extension Period|Adverse Event|1|||
126289468|NCT03142191|454346048|FG004|Active Treatment Extension Period|Adverse Event|0|||
126289469|NCT03142191|454346044|FG000|Active Treatment Extension Period|Progressive Disease|10|||
126289470|NCT03142191|454346045|FG001|Active Treatment Extension Period|Progressive Disease|5|||
126289471|NCT03142191|454346046|FG002|Active Treatment Extension Period|Progressive Disease|4|||
126289472|NCT03142191|454346047|FG003|Active Treatment Extension Period|Progressive Disease|1|||
126289473|NCT03142191|454346048|FG004|Active Treatment Extension Period|Progressive Disease|2|||
126289474|NCT03142191|454346044|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
126289475|NCT03142191|454346045|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
126289476|NCT03142191|454346046|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
126289477|NCT03142191|454346047|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
126289478|NCT03142191|454346048|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
126289479|NCT03142191|454346044|FG000|Active Treatment Extension Period|Physician Decision|2|||
126289480|NCT03142191|454346045|FG001|Active Treatment Extension Period|Physician Decision|0|||
126289481|NCT03142191|454346046|FG002|Active Treatment Extension Period|Physician Decision|0|||
126289482|NCT03142191|454346047|FG003|Active Treatment Extension Period|Physician Decision|0|||
126289483|NCT03142191|454346048|FG004|Active Treatment Extension Period|Physician Decision|0|||
126289484|NCT03142191|454346044|FG000|Active Treatment Extension Period|Other Reasons|3|||
126289485|NCT03142191|454346045|FG001|Active Treatment Extension Period|Other Reasons|3|||
126289486|NCT03142191|454346046|FG002|Active Treatment Extension Period|Other Reasons|3|||
126289487|NCT03142191|454346047|FG003|Active Treatment Extension Period|Other Reasons|8|||
126289488|NCT03142191|454346048|FG004|Active Treatment Extension Period|Other Reasons|3|||
126289489|NCT03142191|454346044|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
126289490|NCT03142191|454346045|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
126289491|NCT03142191|454346046|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
126289492|NCT03142191|454346047|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
126289493|NCT03142191|454346048|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
126289494|NCT00770328|454346051|FG000|Overall Study|Adverse Event|11|||
126289495|NCT00770328|454346052|FG001|Overall Study|Adverse Event|2|||
126289496|NCT00770328|454346051|FG000|Overall Study|Lost to Follow-up|2|||
126289497|NCT00770328|454346052|FG001|Overall Study|Lost to Follow-up|2|||
126289498|NCT02286843|454346053|FG000|Overall Study|Not Treated|4|||
126289499|NCT02286843|454346053|FG000|Overall Study|Protocol Violation|1|||
126289500|NCT02286843|454346053|FG000|Overall Study|Withdrawal by Subject|1|||
126289501|NCT02593110|454346054|FG000|Overall Study|Withdrawal by Subject|0|||
126289502|NCT02593110|454346055|FG001|Overall Study|Withdrawal by Subject|3|||
126289503|NCT02593110|454346056|FG002|Overall Study|Withdrawal by Subject|3|||
126365841|NCT01557569|454634239|FG001|Overall Study|high blood pressure|1|||
126365842|NCT01557569|454634238|FG000|Overall Study|Withdrawal by Subject|3|||
126365843|NCT01557569|454634239|FG001|Overall Study|Withdrawal by Subject|5|||
126365844|NCT01557569|454634238|FG000|Overall Study|noncompliance with rules of residential|0|||
126365845|NCT01557569|454634239|FG001|Overall Study|noncompliance with rules of residential|1|||
126365846|NCT02254460|454634240|FG000|Overall Study|Adverse Event|1|||
126365847|NCT02254460|454634241|FG001|Overall Study|Adverse Event|0|||
126365848|NCT00137449|454634242|FG000|Overall Study|Disease Progression|8|||
126289504|NCT02593110|454346057|FG003|Overall Study|Withdrawal by Subject|2|||
126289505|NCT02593110|454346054|FG000|Overall Study|Death|0|||
126365849|NCT00137449|454634243|FG001|Overall Study|Disease Progression|13|||
126365850|NCT00137449|454634242|FG000|Overall Study|Death|4|||
126457728|NCT00545129|454976617|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
126457729|NCT00545129|454976618|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
126457730|NCT00545129|454976617|FG000|Overall Study|Other|3|||
126710548|NCT00401973|455891637|FG002|Overall Study|Sponsor Decision|0|||
126289506|NCT02593110|454346055|FG001|Overall Study|Death|0|||
126289507|NCT02593110|454346056|FG002|Overall Study|Death|1|||
126289508|NCT02593110|454346057|FG003|Overall Study|Death|0|||
126289509|NCT03172494|454346062|FG000|Overall Study|Adverse Event|5|||
126289510|NCT03172494|454346063|FG001|Overall Study|Adverse Event|1|||
126289511|NCT03172494|454346064|FG002|Overall Study|Adverse Event|15|||
126289512|NCT03172494|454346062|FG000|Overall Study|Protocol Violation|3|||
126289513|NCT03172494|454346063|FG001|Overall Study|Protocol Violation|2|||
126289514|NCT03172494|454346064|FG002|Overall Study|Protocol Violation|1|||
126289515|NCT03172494|454346062|FG000|Overall Study|Lack of Efficacy|0|||
126289516|NCT03172494|454346063|FG001|Overall Study|Lack of Efficacy|0|||
126289517|NCT03172494|454346064|FG002|Overall Study|Lack of Efficacy|4|||
126289518|NCT03172494|454346062|FG000|Overall Study|Pregnancy|0|||
126289519|NCT03172494|454346063|FG001|Overall Study|Pregnancy|1|||
126289520|NCT03172494|454346064|FG002|Overall Study|Pregnancy|0|||
126289521|NCT03172494|454346062|FG000|Overall Study|Withdrawal by Subject|10|||
126289522|NCT03172494|454346063|FG001|Overall Study|Withdrawal by Subject|8|||
126289523|NCT03172494|454346064|FG002|Overall Study|Withdrawal by Subject|8|||
126289524|NCT03172494|454346062|FG000|Overall Study|Severe hypoglycaemic episode|0|||
126289525|NCT03172494|454346063|FG001|Overall Study|Severe hypoglycaemic episode|0|||
126289526|NCT03172494|454346064|FG002|Overall Study|Severe hypoglycaemic episode|1|||
126289527|NCT03172494|454346062|FG000|Overall Study|Non-compliance towards treatment|2|||
126289528|NCT03172494|454346063|FG001|Overall Study|Non-compliance towards treatment|0|||
126289529|NCT03172494|454346064|FG002|Overall Study|Non-compliance towards treatment|0|||
126289530|NCT02764151|454346065|FG000|Overall Study|Subject refused further follow-up|0|||
126289531|NCT02764151|454346066|FG001|Overall Study|Subject refused further follow-up|0|||
126289532|NCT02764151|454346067|FG002|Overall Study|Subject refused further follow-up|0|||
126289533|NCT02764151|454346068|FG003|Overall Study|Subject refused further follow-up|1|||
126289534|NCT02764151|454346065|FG000|Overall Study|Other|0|||
126289535|NCT02764151|454346066|FG001|Overall Study|Other|0|||
126289536|NCT02764151|454346067|FG002|Overall Study|Other|0|||
126289537|NCT02764151|454346068|FG003|Overall Study|Other|2|||
126289538|NCT03086551|454346069|FG000|First Intervention|Failure to meet inclusion criterion|1|||
126289539|NCT03086551|454346070|FG001|First Intervention|Failure to meet inclusion criterion|0|||
126289540|NCT03086551|454346069|FG000|First Intervention|Lost to Follow-up|0|||
126289541|NCT03086551|454346070|FG001|First Intervention|Lost to Follow-up|1|||
126289542|NCT03086551|454346069|FG000|Washout|Lost to Follow-up|1|||
126289543|NCT03086551|454346070|FG001|Washout|Lost to Follow-up|2|||
126289544|NCT03086551|454346069|FG000|Washout|Withdrawal by Subject|2|||
126289545|NCT03086551|454346070|FG001|Washout|Withdrawal by Subject|1|||
126289546|NCT02201277|454346071|FG000|Overall Study|Death|3|||
126289547|NCT02201277|454346072|FG001|Overall Study|Death|4|||
126289548|NCT02201277|454346071|FG000|Overall Study|Lost to Follow-up|2|||
126289549|NCT02201277|454346072|FG001|Overall Study|Lost to Follow-up|1|||
126289550|NCT02201277|454346071|FG000|Overall Study|Failed retrieval|1|||
126289551|NCT02201277|454346072|FG001|Overall Study|Failed retrieval|0|||
126289552|NCT02201277|454346071|FG000|Overall Study|Physician Decision|1|||
126289553|NCT02201277|454346072|FG001|Overall Study|Physician Decision|0|||
126289554|NCT01512160|454346073|FG000|Overall Study|Lost to Follow-up|1|||
126289555|NCT01512160|454346074|FG001|Overall Study|Lost to Follow-up|0|||
126289556|NCT01512160|454346075|FG002|Overall Study|Lost to Follow-up|0|||
126289557|NCT01512160|454346076|FG003|Overall Study|Lost to Follow-up|0|||
126289558|NCT01512160|454346073|FG000|Overall Study|Withdrawal by Subject|1|||
126289559|NCT01512160|454346074|FG001|Overall Study|Withdrawal by Subject|0|||
126289560|NCT01512160|454346075|FG002|Overall Study|Withdrawal by Subject|0|||
126289561|NCT01512160|454346076|FG003|Overall Study|Withdrawal by Subject|1|||
126289562|NCT04205812|454347685|FG000|Randomized Treatment Period|Ongoing|28|||
126289563|NCT04205812|454347686|FG001|Randomized Treatment Period|Ongoing|138|||
126710549|NCT00401973|455891635|FG000|Overall Study|Withdrawal by Subject|4|||
126289564|NCT04205812|454347685|FG000|Randomized Treatment Period|Death|94|||
126289565|NCT04205812|454347686|FG001|Randomized Treatment Period|Death|226|||
126289566|NCT04205812|454347685|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
126289567|NCT04205812|454347686|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
126457731|NCT00545129|454976618|FG001|Overall Study|Other|3|||
126289568|NCT04205812|454347685|FG000|Randomized Treatment Period|Physician Decision|1|||
126289569|NCT04205812|454347686|FG001|Randomized Treatment Period|Physician Decision|4|||
126289570|NCT04205812|454347685|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
126289571|NCT04205812|454347686|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
126289572|NCT04205812|454347685|FG000|Randomized Treatment Period|Progressive Disease|0|||
126289573|NCT04205812|454347686|FG001|Randomized Treatment Period|Progressive Disease|1|||
126289574|NCT04205812|454347685|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
126289575|NCT04205812|454347686|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
126289576|NCT04205812|454347685|FG000|Monotherapy Treatment Period|Ongoing|17|||
126457732|NCT01894568|454976619|FG000|Overall Study|Adverse Event|2|||
126457733|NCT01894568|454976620|FG001|Overall Study|Adverse Event|3|||
126365851|NCT00137449|454634243|FG001|Overall Study|Death|3|||
126365852|NCT00137449|454634242|FG000|Overall Study|Adverse Event|3|||
126365853|NCT00137449|454634243|FG001|Overall Study|Adverse Event|1|||
126365854|NCT00137449|454634242|FG000|Overall Study|Withdrawal by Subject|1|||
126365855|NCT00137449|454634243|FG001|Overall Study|Withdrawal by Subject|1|||
126365856|NCT01356940|454634244|FG000|First Intervention (28 Days)|Adverse Event|1|||
126365857|NCT01356940|454634245|FG001|First Intervention (28 Days)|Adverse Event|0|||
126365858|NCT01356940|454634244|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
126365859|NCT01356940|454634245|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
126365860|NCT00505687|454634248|FG000|Overall Study|Important protocol violation|2|||
126365861|NCT00505687|454634248|FG000|Overall Study|Lack of Efficacy|15|||
126365862|NCT00505687|454634248|FG000|Overall Study|Adverse Event|48|||
126365863|NCT00505687|454634248|FG000|Overall Study|Subject withdrew consent|15|||
126365864|NCT00505687|454634248|FG000|Overall Study|Lost to Follow-up|1|||
126365865|NCT00505687|454634248|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
126365866|NCT00505687|454634248|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
126365867|NCT00505687|454634248|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
126365868|NCT00505687|454634248|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
126365869|NCT00505687|454634248|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
126365870|NCT00505687|454634248|FG000|Overall Study|Other: Disease Progression|1|||
126365871|NCT00505687|454634248|FG000|Overall Study|Other: As Per Sponsor|8|||
126365872|NCT00278161|454634249|FG000|Overall Study|Death|11|||
126365873|NCT00443456|454634250|FG000|Overall Study|Adverse Event|16|||
126365874|NCT00443456|454634250|FG000|Overall Study|Move|1|||
126365875|NCT00443456|454634250|FG000|Overall Study|Withdrawal by Subject|1|||
126457734|NCT01894568|454976619|FG000|Overall Study|Protocol required discontinuation|2|||
126457735|NCT01894568|454976620|FG001|Overall Study|Protocol required discontinuation|1|||
126457736|NCT01894568|454976619|FG000|Overall Study|Withdrawal by Subject|5|||
126457737|NCT01894568|454976620|FG001|Overall Study|Withdrawal by Subject|5|||
126457738|NCT01894568|454976619|FG000|Overall Study|Physician Decision|1|||
126457739|NCT01894568|454976620|FG001|Overall Study|Physician Decision|0|||
126457740|NCT01894568|454976619|FG000|Overall Study|Lost to Follow-up|0|||
126457741|NCT01894568|454976620|FG001|Overall Study|Lost to Follow-up|1|||
126457742|NCT01514370|454976623|FG000|Overall Study|Protocol Violation|2|||
126457743|NCT01514370|454976624|FG001|Overall Study|Protocol Violation|3|||
126457744|NCT01514370|454976623|FG000|Overall Study|Lost to Follow-up|0|||
126457745|NCT01514370|454976624|FG001|Overall Study|Lost to Follow-up|2|||
126457746|NCT01514370|454976623|FG000|Overall Study|Withdrawal by Subject|2|||
126457747|NCT01514370|454976624|FG001|Overall Study|Withdrawal by Subject|1|||
126457748|NCT01514370|454976623|FG000|Overall Study|Adverse Event|1|||
126457749|NCT01514370|454976624|FG001|Overall Study|Adverse Event|3|||
126457750|NCT01514370|454976623|FG000|Overall Study|Other|6|||
126457751|NCT01514370|454976624|FG001|Overall Study|Other|7|||
126365876|NCT02157610|454634251|FG000|Overall Study|Death|4|||
126365877|NCT02157610|454634252|FG001|Overall Study|Death|4|||
126365878|NCT01935947|454634253|FG000|Overall Study|Adverse Event|0|||
126365879|NCT01935947|454634254|FG001|Overall Study|Adverse Event|2|||
126365880|NCT01935947|454634255|FG002|Overall Study|Adverse Event|0|||
126365881|NCT01935947|454634253|FG000|Overall Study|Diease Progression|2|||
126457752|NCT01551420|454976625|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
126457753|NCT01551420|454976626|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
126457754|NCT01551420|454976625|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
126457755|NCT01551420|454976626|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
126710550|NCT00401973|455891636|FG001|Overall Study|Withdrawal by Subject|12|||
126710551|NCT00401973|455891637|FG002|Overall Study|Withdrawal by Subject|9|||
126710552|NCT05523362|455891638|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
126365882|NCT01935947|454634254|FG001|Overall Study|Diease Progression|2|||
126365883|NCT01935947|454634255|FG002|Overall Study|Diease Progression|2|||
126365884|NCT01935947|454634253|FG000|Overall Study|Death|1|||
126365885|NCT01935947|454634254|FG001|Overall Study|Death|0|||
126365886|NCT01935947|454634255|FG002|Overall Study|Death|0|||
126365887|NCT04507763|454634256|FG000|Overall Study|Participants did not meet entrance criteria|201|||
126365888|NCT03427619|454634257|FG000|Overall Study|Physician Decision|3|||
126365889|NCT03427619|454634257|FG000|Overall Study|Withdrawal by Subject|4|||
126365890|NCT03427619|454634257|FG000|Overall Study|Lost to Follow-up|5|||
126365891|NCT03427619|454634257|FG000|Overall Study|Administrative|4|||
126365892|NCT03427619|454634257|FG000|Overall Study|Other|2|||
126365893|NCT03427619|454634257|FG000|Overall Study|Unknown or Missing Completion Status|48|||
126365894|NCT00425555|454634258|FG000|Overall Study|Withdrawal by Subject|11|||
126365895|NCT00425555|454634259|FG001|Overall Study|Withdrawal by Subject|8|||
126457756|NCT01551420|454976625|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
126457757|NCT01551420|454976626|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
126457758|NCT01551420|454976625|FG000|Screened for Part B Eligibility|Declined participation|8|||
126457759|NCT01551420|454976626|FG001|Screened for Part B Eligibility|Declined participation|1|||
126289577|NCT04205812|454347686|FG001|Monotherapy Treatment Period|Ongoing|0|||
126289578|NCT04205812|454347685|FG000|Monotherapy Treatment Period|Death|39|||
126289579|NCT04205812|454347686|FG001|Monotherapy Treatment Period|Death|0|||
126289580|NCT04205812|454347685|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
126289581|NCT04205812|454347686|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
126289582|NCT04205812|454347685|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
126289583|NCT04205812|454347686|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
126289584|NCT05221320|454347687|FG000|Overall Study|Lack of Efficacy|3|||
126710553|NCT05523362|455891638|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
126710554|NCT05523362|455891638|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
126710555|NCT05523362|455891638|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
126710556|NCT03515538|455891639|FG000|Overall Study|Lack of Efficacy|2|||
126289585|NCT05221320|454347688|FG001|Overall Study|Lack of Efficacy|7|||
126289586|NCT05221320|454347689|FG002|Overall Study|Lack of Efficacy|10|||
126289587|NCT05221320|454347690|FG003|Overall Study|Lack of Efficacy|1|||
126289588|NCT05221320|454347691|FG004|Overall Study|Lack of Efficacy|0|||
126289589|NCT05221320|454347692|FG005|Overall Study|Lack of Efficacy|0|||
126289590|NCT05221320|454347687|FG000|Overall Study|Physician Decision|1|||
126289591|NCT05221320|454347688|FG001|Overall Study|Physician Decision|0|||
126289592|NCT05221320|454347689|FG002|Overall Study|Physician Decision|3|||
126289593|NCT05221320|454347690|FG003|Overall Study|Physician Decision|1|||
126710557|NCT03515538|455891640|FG001|Overall Study|Lack of Efficacy|0|||
126710558|NCT03515538|455891641|FG002|Overall Study|Lack of Efficacy|2|||
126710559|NCT03515538|455891642|FG003|Overall Study|Lack of Efficacy|0|||
126710560|NCT03515538|455891639|FG000|Overall Study|Death|0|||
126289594|NCT05221320|454347691|FG004|Overall Study|Physician Decision|0|||
126289595|NCT05221320|454347692|FG005|Overall Study|Physician Decision|0|||
126289596|NCT05221320|454347687|FG000|Overall Study|Withdrawal by Subject|0|||
126289597|NCT05221320|454347688|FG001|Overall Study|Withdrawal by Subject|3|||
126289598|NCT05221320|454347689|FG002|Overall Study|Withdrawal by Subject|1|||
126289599|NCT05221320|454347690|FG003|Overall Study|Withdrawal by Subject|0|||
126289600|NCT05221320|454347691|FG004|Overall Study|Withdrawal by Subject|0|||
126289601|NCT05221320|454347692|FG005|Overall Study|Withdrawal by Subject|0|||
126289602|NCT05221320|454347687|FG000|Overall Study|Death|0|||
126289603|NCT05221320|454347688|FG001|Overall Study|Death|5|||
126289604|NCT05221320|454347689|FG002|Overall Study|Death|6|||
126289605|NCT05221320|454347690|FG003|Overall Study|Death|0|||
126289606|NCT05221320|454347691|FG004|Overall Study|Death|1|||
126289607|NCT05221320|454347692|FG005|Overall Study|Death|0|||
126289608|NCT06473519|454347693|FG000|Overall Study|Lost to Follow-up|2|||
126289609|NCT06473519|454347694|FG001|Overall Study|Lost to Follow-up|5|||
126289610|NCT06473519|454347693|FG000|Overall Study|Withdrawal by Subject|1|||
126289611|NCT06473519|454347694|FG001|Overall Study|Withdrawal by Subject|4|||
126289612|NCT06473519|454347693|FG000|Overall Study|Randomized but not vaccinated|1|||
126289613|NCT06473519|454347694|FG001|Overall Study|Randomized but not vaccinated|2|||
126289614|NCT02514447|454347699|FG000|Overall Study|Withdrawal by Subject|3|||
126289615|NCT02514447|454347700|FG001|Overall Study|Withdrawal by Subject|1|||
126289616|NCT02514447|454347701|FG002|Overall Study|Withdrawal by Subject|1|||
126289617|NCT02514447|454347702|FG003|Overall Study|Withdrawal by Subject|0|||
126289618|NCT02514447|454347703|FG004|Overall Study|Withdrawal by Subject|0|||
126289619|NCT02514447|454347704|FG005|Overall Study|Withdrawal by Subject|0|||
126289620|NCT02514447|454347705|FG006|Overall Study|Withdrawal by Subject|0|||
126289621|NCT02514447|454347706|FG007|Overall Study|Withdrawal by Subject|1|||
126289622|NCT02514447|454347707|FG008|Overall Study|Withdrawal by Subject|1|||
126289623|NCT02514447|454347699|FG000|Overall Study|Death|24|||
126289624|NCT02514447|454347700|FG001|Overall Study|Death|28|||
126289625|NCT02514447|454347701|FG002|Overall Study|Death|29|||
126289626|NCT02514447|454347702|FG003|Overall Study|Death|0|||
126289627|NCT02514447|454347703|FG004|Overall Study|Death|3|||
126289628|NCT02514447|454347704|FG005|Overall Study|Death|4|||
126289629|NCT02514447|454347705|FG006|Overall Study|Death|8|||
126289630|NCT02514447|454347706|FG007|Overall Study|Death|6|||
126289631|NCT02514447|454347707|FG008|Overall Study|Death|5|||
126289632|NCT02514447|454347699|FG000|Overall Study|Lost to Follow-up|1|||
126710561|NCT03515538|455891640|FG001|Overall Study|Death|0|||
126710562|NCT03515538|455891641|FG002|Overall Study|Death|1|||
126289633|NCT02514447|454347700|FG001|Overall Study|Lost to Follow-up|0|||
126289634|NCT02514447|454347701|FG002|Overall Study|Lost to Follow-up|0|||
126289635|NCT02514447|454347702|FG003|Overall Study|Lost to Follow-up|0|||
126289636|NCT02514447|454347703|FG004|Overall Study|Lost to Follow-up|0|||
126289637|NCT02514447|454347704|FG005|Overall Study|Lost to Follow-up|0|||
126289638|NCT02514447|454347705|FG006|Overall Study|Lost to Follow-up|0|||
126289639|NCT02514447|454347706|FG007|Overall Study|Lost to Follow-up|0|||
126289640|NCT02514447|454347707|FG008|Overall Study|Lost to Follow-up|1|||
126289641|NCT02514447|454347699|FG000|Overall Study|Sponsor Termination of Study|0|||
126289642|NCT02514447|454347700|FG001|Overall Study|Sponsor Termination of Study|1|||
126289643|NCT02514447|454347701|FG002|Overall Study|Sponsor Termination of Study|1|||
126289644|NCT02514447|454347702|FG003|Overall Study|Sponsor Termination of Study|0|||
126710563|NCT03515538|455891642|FG003|Overall Study|Death|0|||
126710564|NCT03515538|455891639|FG000|Overall Study|Protocol Violation|0|||
126710565|NCT03515538|455891640|FG001|Overall Study|Protocol Violation|0|||
126710566|NCT03515538|455891641|FG002|Overall Study|Protocol Violation|0|||
126710567|NCT03515538|455891642|FG003|Overall Study|Protocol Violation|1|||
126710568|NCT03515538|455891639|FG000|Overall Study|Screen failure (baseline dropout)|0|||
126710569|NCT03515538|455891640|FG001|Overall Study|Screen failure (baseline dropout)|1|||
126710570|NCT03515538|455891641|FG002|Overall Study|Screen failure (baseline dropout)|0|||
126710571|NCT03515538|455891642|FG003|Overall Study|Screen failure (baseline dropout)|0|||
126710572|NCT03515538|455891639|FG000|Overall Study|Withdrawal by Subject|2|||
126710573|NCT03515538|455891640|FG001|Overall Study|Withdrawal by Subject|2|||
126710574|NCT03515538|455891641|FG002|Overall Study|Withdrawal by Subject|1|||
126710575|NCT03515538|455891642|FG003|Overall Study|Withdrawal by Subject|3|||
126710576|NCT03515538|455891639|FG000|Overall Study|Physician Decision|1|||
126710577|NCT03515538|455891640|FG001|Overall Study|Physician Decision|0|||
126710578|NCT03515538|455891641|FG002|Overall Study|Physician Decision|0|||
126710579|NCT03515538|455891642|FG003|Overall Study|Physician Decision|1|||
126289645|NCT02514447|454347703|FG004|Overall Study|Sponsor Termination of Study|0|||
126289646|NCT02514447|454347704|FG005|Overall Study|Sponsor Termination of Study|0|||
126289647|NCT02514447|454347705|FG006|Overall Study|Sponsor Termination of Study|0|||
126289648|NCT02514447|454347706|FG007|Overall Study|Sponsor Termination of Study|0|||
126289649|NCT02514447|454347707|FG008|Overall Study|Sponsor Termination of Study|0|||
126289650|NCT02514447|454347699|FG000|Overall Study|Study completion per Investigator|1|||
126289651|NCT02514447|454347700|FG001|Overall Study|Study completion per Investigator|0|||
126289652|NCT02514447|454347701|FG002|Overall Study|Study completion per Investigator|1|||
126289653|NCT02514447|454347702|FG003|Overall Study|Study completion per Investigator|2|||
126289654|NCT02514447|454347703|FG004|Overall Study|Study completion per Investigator|0|||
126289655|NCT02514447|454347704|FG005|Overall Study|Study completion per Investigator|0|||
126289656|NCT02514447|454347705|FG006|Overall Study|Study completion per Investigator|0|||
126289657|NCT02514447|454347706|FG007|Overall Study|Study completion per Investigator|0|||
126289658|NCT02514447|454347707|FG008|Overall Study|Study completion per Investigator|1|||
126289659|NCT04903288|454347708|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
126289660|NCT04903288|454347708|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
126289661|NCT04903288|454347708|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
126289662|NCT04903288|454347708|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
126289663|NCT04776148|454347709|FG000|Overall Study|Death|249|||
126289664|NCT04776148|454347710|FG001|Overall Study|Death|260|||
126289665|NCT04776148|454347709|FG000|Overall Study|Lost to Follow-up|0|||
126289666|NCT04776148|454347710|FG001|Overall Study|Lost to Follow-up|1|||
126289667|NCT04776148|454347709|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126289668|NCT04776148|454347710|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126289669|NCT04776148|454347709|FG000|Overall Study|Withdrawal by Subject|3|||
126289670|NCT04776148|454347710|FG001|Overall Study|Withdrawal by Subject|4|||
126289671|NCT04776148|454347709|FG000|Overall Study|Sponsor Decision|30|||
126289672|NCT04776148|454347710|FG001|Overall Study|Sponsor Decision|15|||
126289673|NCT05109611|454347715|FG000|Overall Study|Adverse Event|13|||
126289674|NCT05109611|454347716|FG001|Overall Study|Adverse Event|10|||
126289675|NCT05109611|454347715|FG000|Overall Study|Withdrawal by Subject|1|||
126289676|NCT05109611|454347716|FG001|Overall Study|Withdrawal by Subject|0|||
126289677|NCT05109611|454347715|FG000|Overall Study|Lost to Follow-up|1|||
126289678|NCT05109611|454347716|FG001|Overall Study|Lost to Follow-up|2|||
126289679|NCT05109611|454347715|FG000|Overall Study|Protocol Violation|0|||
126289680|NCT05109611|454347716|FG001|Overall Study|Protocol Violation|4|||
126289681|NCT05109611|454347715|FG000|Overall Study|Information unavailable|1|||
126289682|NCT05109611|454347716|FG001|Overall Study|Information unavailable|1|||
126289683|NCT05626231|454347717|FG000|Provider Enrollment|Worked part-time|4|||
126289684|NCT05626231|454347717|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
126289685|NCT05626231|454347717|FG000|Provider Enrollment|Non-clinical employee|1|||
126289686|NCT05626231|454347717|FG000|Provider Enrollment|Provider does not see clients|3|||
126289687|NCT05626231|454347717|FG000|Provider Enrollment|Other|5|||
126289688|NCT04995029|454347718|FG000|Induction Phase|Did not meet eligibility criteria|5|||
126289689|NCT04995029|454347719|FG001|Induction Phase|Did not meet eligibility criteria|2|||
126710580|NCT04075604|455891643|FG000|Overall Study|Adverse Event|0|||
126289690|NCT04995029|454347720|FG002|Induction Phase|Did not meet eligibility criteria|0|||
126289691|NCT04995029|454347721|FG003|Induction Phase|Did not meet eligibility criteria|0|||
126289692|NCT04995029|454347718|FG000|Induction Phase|Withdrawal by Subject|85|||
126289693|NCT04995029|454347719|FG001|Induction Phase|Withdrawal by Subject|42|||
126289694|NCT04995029|454347720|FG002|Induction Phase|Withdrawal by Subject|0|||
126710581|NCT04075604|455891644|FG001|Overall Study|Adverse Event|0|||
126710582|NCT04075604|455891645|FG002|Overall Study|Adverse Event|3|||
126710583|NCT04075604|455891643|FG000|Overall Study|Participant request to discontinue study treatment|0|||
126289695|NCT04995029|454347721|FG003|Induction Phase|Withdrawal by Subject|0|||
126289696|NCT04995029|454347718|FG000|Induction Phase|Lost to Follow-up|103|||
126289697|NCT04995029|454347719|FG001|Induction Phase|Lost to Follow-up|67|||
126289698|NCT04995029|454347720|FG002|Induction Phase|Lost to Follow-up|0|||
126289699|NCT04995029|454347721|FG003|Induction Phase|Lost to Follow-up|0|||
126289700|NCT04995029|454347718|FG000|Induction Phase|Adverse Event|5|||
126289701|NCT04995029|454347719|FG001|Induction Phase|Adverse Event|3|||
126289702|NCT04995029|454347720|FG002|Induction Phase|Adverse Event|0|||
126289703|NCT04995029|454347721|FG003|Induction Phase|Adverse Event|0|||
126289704|NCT04995029|454347718|FG000|Induction Phase|Physician Decision|11|||
126289705|NCT04995029|454347719|FG001|Induction Phase|Physician Decision|8|||
126289706|NCT04995029|454347720|FG002|Induction Phase|Physician Decision|0|||
126289707|NCT04995029|454347721|FG003|Induction Phase|Physician Decision|0|||
126289708|NCT04995029|454347718|FG000|Induction Phase|Incarceration|6|||
126289709|NCT04995029|454347719|FG001|Induction Phase|Incarceration|3|||
126289710|NCT04995029|454347720|FG002|Induction Phase|Incarceration|0|||
126289711|NCT04995029|454347721|FG003|Induction Phase|Incarceration|0|||
126289712|NCT04995029|454347718|FG000|Induction Phase|Not otherwise described|5|||
126710584|NCT04075604|455891644|FG001|Overall Study|Participant request to discontinue study treatment|0|||
126710585|NCT04075604|455891645|FG002|Overall Study|Participant request to discontinue study treatment|1|||
126289713|NCT04995029|454347719|FG001|Induction Phase|Not otherwise described|5|||
126289714|NCT04995029|454347720|FG002|Induction Phase|Not otherwise described|0|||
126289715|NCT04995029|454347721|FG003|Induction Phase|Not otherwise described|0|||
126289716|NCT04995029|454347718|FG000|Maintenance Phase|Lost to Follow-up|0|||
126289717|NCT04995029|454347719|FG001|Maintenance Phase|Lost to Follow-up|0|||
126289718|NCT04995029|454347720|FG002|Maintenance Phase|Lost to Follow-up|51|||
126289719|NCT04995029|454347721|FG003|Maintenance Phase|Lost to Follow-up|44|||
126289720|NCT04995029|454347718|FG000|Maintenance Phase|Did not meet eligibility criteria|0|||
126289721|NCT04995029|454347719|FG001|Maintenance Phase|Did not meet eligibility criteria|0|||
126289722|NCT04995029|454347720|FG002|Maintenance Phase|Did not meet eligibility criteria|0|||
126289723|NCT04995029|454347721|FG003|Maintenance Phase|Did not meet eligibility criteria|1|||
126289724|NCT04995029|454347718|FG000|Maintenance Phase|Adverse Event|0|||
126289725|NCT04995029|454347719|FG001|Maintenance Phase|Adverse Event|0|||
126289726|NCT04995029|454347720|FG002|Maintenance Phase|Adverse Event|0|||
126289727|NCT04995029|454347721|FG003|Maintenance Phase|Adverse Event|1|||
126289728|NCT04995029|454347718|FG000|Maintenance Phase|Physician Decision|0|||
126289729|NCT04995029|454347719|FG001|Maintenance Phase|Physician Decision|0|||
126289730|NCT04995029|454347720|FG002|Maintenance Phase|Physician Decision|8|||
126289731|NCT04995029|454347721|FG003|Maintenance Phase|Physician Decision|4|||
126289732|NCT04995029|454347718|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126289733|NCT04995029|454347719|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126289734|NCT04995029|454347720|FG002|Maintenance Phase|Withdrawal by Subject|17|||
126289735|NCT04995029|454347721|FG003|Maintenance Phase|Withdrawal by Subject|31|||
126289736|NCT04995029|454347718|FG000|Maintenance Phase|Incarceration|0|||
126289737|NCT04995029|454347719|FG001|Maintenance Phase|Incarceration|0|||
126289738|NCT04995029|454347720|FG002|Maintenance Phase|Incarceration|4|||
126710586|NCT04075604|455891643|FG000|Overall Study|Participant withdrew consent|0|||
126710587|NCT04075604|455891644|FG001|Overall Study|Participant withdrew consent|0|||
126710588|NCT04075604|455891645|FG002|Overall Study|Participant withdrew consent|1|||
126710589|NCT04075604|455891643|FG000|Overall Study|Other reasons|1|||
126710590|NCT04075604|455891644|FG001|Overall Study|Other reasons|0|||
126710591|NCT04075604|455891645|FG002|Overall Study|Other reasons|0|||
126710592|NCT04075604|455891643|FG000|Overall Study|Disease progression|0|||
126710593|NCT04075604|455891644|FG001|Overall Study|Disease progression|1|||
126710594|NCT04075604|455891645|FG002|Overall Study|Disease progression|0|||
126710595|NCT04075604|455891643|FG000|Overall Study|Study drug toxicity|0|||
126710596|NCT04075604|455891644|FG001|Overall Study|Study drug toxicity|5|||
126710597|NCT04075604|455891645|FG002|Overall Study|Study drug toxicity|1|||
126710598|NCT01650779|455891652|FG000|Overall Study|Withdrawal by Subject|1|||
126710599|NCT03842709|455891655|FG000|Overall Study|Withdrawal by Subject|3|||
126289739|NCT04995029|454347721|FG003|Maintenance Phase|Incarceration|3|||
126289740|NCT04995029|454347718|FG000|Maintenance Phase|Not otherwise described|0|||
126289741|NCT04995029|454347719|FG001|Maintenance Phase|Not otherwise described|0|||
126289742|NCT04995029|454347720|FG002|Maintenance Phase|Not otherwise described|2|||
126289743|NCT04995029|454347721|FG003|Maintenance Phase|Not otherwise described|3|||
126289744|NCT04995029|454347718|FG000|Maintenance Phase|Pregnancy|0|||
126289745|NCT04995029|454347719|FG001|Maintenance Phase|Pregnancy|0|||
126289746|NCT04995029|454347720|FG002|Maintenance Phase|Pregnancy|2|||
126289747|NCT04995029|454347721|FG003|Maintenance Phase|Pregnancy|2|||
126289748|NCT03690388|454347722|FG000|Overall Study|Adverse Event|8|||
126289749|NCT03690388|454347723|FG001|Overall Study|Adverse Event|1|||
126289750|NCT03690388|454347722|FG000|Overall Study|Radiographic Progression|14|||
126289751|NCT03690388|454347723|FG001|Overall Study|Radiographic Progression|29|||
126365896|NCT00425555|454634258|FG000|Overall Study|Lost to Follow-up|0|||
126710600|NCT03842709|455891656|FG001|Overall Study|Withdrawal by Subject|3|||
126710601|NCT03842709|455891655|FG000|Overall Study|Lost to Follow-up|1|||
126767020|NCT00539006|456100206|FG000|Treatment Period 1|Lost to Follow-up|0|||
126289752|NCT03690388|454347722|FG000|Overall Study|Clinical deterioration|10|||
126289753|NCT03690388|454347723|FG001|Overall Study|Clinical deterioration|6|||
126365897|NCT00425555|454634259|FG001|Overall Study|Lost to Follow-up|1|||
126549764|NCT01533714|455307573|FG005|Overall Study|Ineligibility reason|0|||
126549765|NCT00251927|455307578|FG000|Overall Study|Adverse Event|3|||
126549766|NCT00251927|455307579|FG001|Overall Study|Adverse Event|15|||
126549767|NCT00251927|455307578|FG000|Overall Study|Lack of Efficacy|22|||
126549768|NCT00251927|455307579|FG001|Overall Study|Lack of Efficacy|16|||
126549769|NCT00251927|455307578|FG000|Overall Study|Lost to Follow-up|22|||
126549770|NCT00251927|455307579|FG001|Overall Study|Lost to Follow-up|8|||
126549771|NCT00251927|455307578|FG000|Overall Study|Protocol Violation|1|||
126289754|NCT03690388|454347722|FG000|Overall Study|Withdrawal by Subject|2|||
126289755|NCT03690388|454347723|FG001|Overall Study|Withdrawal by Subject|0|||
126289756|NCT03690388|454347722|FG000|Overall Study|Lack of Efficacy|1|||
126289757|NCT03690388|454347723|FG001|Overall Study|Lack of Efficacy|0|||
126289758|NCT03690388|454347722|FG000|Overall Study|Lost to Follow-up|1|||
126289759|NCT03690388|454347723|FG001|Overall Study|Lost to Follow-up|0|||
126289760|NCT01842438|454347729|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
126289761|NCT01842438|454347730|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
126289762|NCT01842438|454347729|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
126289763|NCT01842438|454347730|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
126289764|NCT01842438|454347729|FG000|T2: 6month Follow-up|Death|0|||
126289765|NCT01842438|454347730|FG001|T2: 6month Follow-up|Death|1|||
126289766|NCT04909853|454347731|FG000|Part 1|Assigned but not treated|0|||
126289767|NCT04909853|454347732|FG001|Part 1|Assigned but not treated|0|||
126289768|NCT04909853|454347733|FG002|Part 1|Assigned but not treated|1|||
126289769|NCT04909853|454347734|FG003|Part 1|Assigned but not treated|0|||
126289770|NCT04909853|454347731|FG000|Part 2|Adverse Event|0|||
126289771|NCT04909853|454347732|FG001|Part 2|Adverse Event|0|||
126289772|NCT04909853|454347733|FG002|Part 2|Adverse Event|0|||
126289773|NCT04909853|454347734|FG003|Part 2|Adverse Event|1|||
126289774|NCT04054765|454347735|FG000|Baseline|Withdrawal by Subject|5|||
126289775|NCT04054765|454347736|FG001|Baseline|Withdrawal by Subject|3|||
126289776|NCT04054765|454347735|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
126289777|NCT04054765|454347736|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
126289778|NCT04054765|454347735|FG000|3-month Follow up|Withdrawal by Subject|0|||
126289779|NCT04054765|454347736|FG001|3-month Follow up|Withdrawal by Subject|3|||
126365898|NCT00425555|454634258|FG000|Overall Study|Administrative problems|3|||
126365899|NCT00425555|454634259|FG001|Overall Study|Administrative problems|0|||
126365900|NCT00425555|454634258|FG000|Overall Study|Death|1|||
126365901|NCT00425555|454634259|FG001|Overall Study|Death|2|||
126365902|NCT00425555|454634258|FG000|Overall Study|New cancer therapy|2|||
126365903|NCT00425555|454634259|FG001|Overall Study|New cancer therapy|1|||
126365904|NCT00425555|454634258|FG000|Overall Study|Disease progression|36|||
126365905|NCT00425555|454634259|FG001|Overall Study|Disease progression|33|||
126365906|NCT00425555|454634258|FG000|Overall Study|Adverse Event|25|||
126365907|NCT00425555|454634259|FG001|Overall Study|Adverse Event|15|||
126365908|NCT00425555|454634258|FG000|Overall Study|Protocol Violation|1|||
126365909|NCT00425555|454634259|FG001|Overall Study|Protocol Violation|0|||
126365910|NCT05763381|454634260|FG000|Overall Study|Lost to Follow-up|2|||
126365911|NCT05763381|454634261|FG001|Overall Study|Lost to Follow-up|3|||
126365912|NCT05763381|454634260|FG000|Overall Study|Withdrawal by Subject|1|||
126365913|NCT05763381|454634261|FG001|Overall Study|Withdrawal by Subject|2|||
126365914|NCT01674062|454634262|FG000|Overall Study|Insufficient Therapeutic Response|56|||
126365915|NCT01674062|454634263|FG001|Overall Study|Insufficient Therapeutic Response|26|||
126365916|NCT01674062|454634262|FG000|Overall Study|Other|8|||
126365917|NCT01674062|454634263|FG001|Overall Study|Other|1|||
126365918|NCT01674062|454634262|FG000|Overall Study|Adverse Event|1|||
126365919|NCT01674062|454634263|FG001|Overall Study|Adverse Event|1|||
126365920|NCT01674062|454634262|FG000|Overall Study|Death|0|||
126365921|NCT01674062|454634263|FG001|Overall Study|Death|1|||
126365922|NCT01674062|454634262|FG000|Overall Study|Programming Error|1|||
126365923|NCT01674062|454634263|FG001|Overall Study|Programming Error|0|||
126365924|NCT01443026|454634267|FG000|Overall Study|Physician Decision|1|||
126365925|NCT01443026|454634268|FG001|Overall Study|Physician Decision|0|||
126365926|NCT01443026|454634267|FG000|Overall Study|Death|0|||
126365927|NCT01443026|454634268|FG001|Overall Study|Death|1|||
126365928|NCT01443026|454634267|FG000|Overall Study|Withdrawal by Subject|0|||
126365929|NCT01443026|454634268|FG001|Overall Study|Withdrawal by Subject|3|||
126289780|NCT04054765|454347735|FG000|6-month Follow up|Lost to Follow-up|32|||
126289781|NCT04054765|454347736|FG001|6-month Follow up|Lost to Follow-up|32|||
126289782|NCT00077207|454347737|FG000|Overall Study|Adverse Event|5|||
126289783|NCT00077207|454347737|FG000|Overall Study|Lack of Efficacy|12|||
126289784|NCT00077207|454347737|FG000|Overall Study|Physician Decision|6|||
126365930|NCT01443026|454634267|FG000|Overall Study|Lost to Follow-up|2|||
126365931|NCT01443026|454634268|FG001|Overall Study|Lost to Follow-up|1|||
126549772|NCT00251927|455307579|FG001|Overall Study|Protocol Violation|2|||
126289785|NCT00077207|454347737|FG000|Overall Study|Withdrawal by Subject|6|||
126289786|NCT00077207|454347737|FG000|Overall Study|Ineligible|1|||
126365932|NCT00581919|454634269|FG000|Overall Study|Adverse Event|8|||
126365933|NCT00581919|454634269|FG000|Overall Study|Death|1|||
126365934|NCT00581919|454634269|FG000|Overall Study|Disease Progression|10|||
126457760|NCT01551420|454976625|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
126457761|NCT01551420|454976626|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
126457762|NCT01551420|454976625|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
126457763|NCT01551420|454976626|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
126457764|NCT01551420|454976625|FG000|Home Use (Part B)|Withdrawal by staff|0|||
126710602|NCT03842709|455891656|FG001|Overall Study|Lost to Follow-up|0|||
126710603|NCT00609609|455891659|FG000|Overall Study|Withdrawal by Subject|2|||
126710604|NCT00609609|455891660|FG001|Overall Study|Withdrawal by Subject|0|||
126289787|NCT00666328|454347738|FG000|Overall Study|Death|2|||
126289788|NCT00666328|454347738|FG000|Overall Study|Lost to Follow-up|2|||
126289789|NCT00666328|454347738|FG000|Overall Study|No longer met eligibility criteria|1|||
126289790|NCT05064397|454347739|FG000|Overall Study|Adverse Event|4|||
126289791|NCT05064397|454347739|FG000|Overall Study|Lack of Efficacy|12|||
126289792|NCT05064397|454347739|FG000|Overall Study|Withdrawal by Subject|3|||
126289793|NCT05064397|454347739|FG000|Overall Study|Lost to Follow-up|1|||
126289794|NCT05064397|454347739|FG000|Overall Study|Other reasons|3|||
126289795|NCT02232984|454347740|FG000|Overall Study|Withdrawal by Subject|5|||
126289796|NCT02232984|454347740|FG000|Overall Study|Death|1|||
126289797|NCT02232984|454347740|FG000|Overall Study|Investigator withdrawal|10|||
126289798|NCT02232984|454347740|FG000|Overall Study|Device implant unsuccessful|53|||
126289799|NCT02232984|454347740|FG000|Overall Study|not disclosed by site|7|||
126289800|NCT02232984|454347740|FG000|Overall Study|Protocol Violation|1|||
126289801|NCT00535405|454347743|FG000|Overall Study|Adverse Event|6|||
126289802|NCT00535405|454347744|FG001|Overall Study|Adverse Event|8|||
126289803|NCT00535405|454347745|FG002|Overall Study|Adverse Event|3|||
126289804|NCT00535405|454347746|FG003|Overall Study|Adverse Event|8|||
126289805|NCT00535405|454347747|FG004|Overall Study|Adverse Event|6|||
126289806|NCT00535405|454347743|FG000|Overall Study|Lost to Follow-up|1|||
126289807|NCT00535405|454347744|FG001|Overall Study|Lost to Follow-up|3|||
126289808|NCT00535405|454347745|FG002|Overall Study|Lost to Follow-up|3|||
126289809|NCT00535405|454347746|FG003|Overall Study|Lost to Follow-up|2|||
126289810|NCT00535405|454347747|FG004|Overall Study|Lost to Follow-up|1|||
126289811|NCT00535405|454347743|FG000|Overall Study|Physician Decision|3|||
126289812|NCT00535405|454347744|FG001|Overall Study|Physician Decision|2|||
126289813|NCT00535405|454347745|FG002|Overall Study|Physician Decision|0|||
126289814|NCT00535405|454347746|FG003|Overall Study|Physician Decision|1|||
126289815|NCT00535405|454347747|FG004|Overall Study|Physician Decision|1|||
126289816|NCT00535405|454347743|FG000|Overall Study|Protocol Violation|2|||
126289817|NCT00535405|454347744|FG001|Overall Study|Protocol Violation|2|||
126289818|NCT00535405|454347745|FG002|Overall Study|Protocol Violation|2|||
126289819|NCT00535405|454347746|FG003|Overall Study|Protocol Violation|1|||
126289820|NCT00535405|454347747|FG004|Overall Study|Protocol Violation|0|||
126289821|NCT00535405|454347743|FG000|Overall Study|Withdrawal by Subject|5|||
126289822|NCT00535405|454347744|FG001|Overall Study|Withdrawal by Subject|11|||
126289823|NCT00535405|454347745|FG002|Overall Study|Withdrawal by Subject|10|||
126289824|NCT00535405|454347746|FG003|Overall Study|Withdrawal by Subject|10|||
126289825|NCT00535405|454347747|FG004|Overall Study|Withdrawal by Subject|8|||
126289826|NCT03404674|454347748|FG000|Overall Study|Inability to Attend Future Visits|0|||
126289827|NCT03404674|454347749|FG001|Overall Study|Inability to Attend Future Visits|1|||
126289828|NCT03404674|454347750|FG002|Overall Study|Inability to Attend Future Visits|1|||
126289829|NCT03404674|454347751|FG003|Overall Study|Inability to Attend Future Visits|0|||
126289830|NCT03404674|454347752|FG004|Overall Study|Inability to Attend Future Visits|0|||
126289831|NCT03404674|454347753|FG005|Overall Study|Inability to Attend Future Visits|0|||
126289832|NCT03404674|454347748|FG000|Overall Study|Behavioral Problems|0|||
126289833|NCT03404674|454347749|FG001|Overall Study|Behavioral Problems|0|||
126289834|NCT03404674|454347750|FG002|Overall Study|Behavioral Problems|1|||
126289835|NCT03404674|454347751|FG003|Overall Study|Behavioral Problems|0|||
126365935|NCT00581919|454634269|FG000|Overall Study|Physician Decision|1|||
126365936|NCT00581919|454634269|FG000|Overall Study|Other Complicating Disease|1|||
126365937|NCT00581919|454634269|FG000|Overall Study|Started Non-Protocol Therapy|2|||
126365938|NCT00581919|454634269|FG000|Overall Study|Withdrawal by Subject|1|||
126365939|NCT02655601|454634270|FG000|Overall Study|Adverse Event|0|||
126365940|NCT02655601|454634271|FG001|Overall Study|Adverse Event|0|||
126365941|NCT02655601|454634272|FG002|Overall Study|Adverse Event|0|||
126365942|NCT02655601|454634273|FG003|Overall Study|Adverse Event|1|||
126365943|NCT02655601|454634274|FG004|Overall Study|Adverse Event|1|||
126365944|NCT02655601|454634275|FG005|Overall Study|Adverse Event|0|||
126365945|NCT02655601|454634270|FG000|Overall Study|Physician Decision|0|||
126365946|NCT02655601|454634271|FG001|Overall Study|Physician Decision|0|||
126365947|NCT02655601|454634272|FG002|Overall Study|Physician Decision|0|||
126365948|NCT02655601|454634273|FG003|Overall Study|Physician Decision|0|||
126365949|NCT02655601|454634274|FG004|Overall Study|Physician Decision|1|||
126365950|NCT02655601|454634275|FG005|Overall Study|Physician Decision|1|||
126365951|NCT02655601|454634270|FG000|Overall Study|Withdrawal by Subject|0|||
126365952|NCT02655601|454634271|FG001|Overall Study|Withdrawal by Subject|0|||
126365953|NCT02655601|454634272|FG002|Overall Study|Withdrawal by Subject|0|||
126365954|NCT02655601|454634273|FG003|Overall Study|Withdrawal by Subject|0|||
126365955|NCT02655601|454634274|FG004|Overall Study|Withdrawal by Subject|4|||
126365956|NCT02655601|454634275|FG005|Overall Study|Withdrawal by Subject|8|||
126365957|NCT02655601|454634270|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
126365958|NCT02655601|454634271|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
126365959|NCT02655601|454634272|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
126365960|NCT02655601|454634273|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
126365961|NCT02655601|454634274|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
126365962|NCT02655601|454634275|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
126365963|NCT03829683|454634280|FG000|Overall Study|Lost to Follow-up|1|||
126365964|NCT03829683|454634281|FG001|Overall Study|Lost to Follow-up|0|||
126365965|NCT03829683|454634280|FG000|Overall Study|Physician Decision|3|||
126365966|NCT03829683|454634281|FG001|Overall Study|Physician Decision|1|||
126365967|NCT03829683|454634280|FG000|Overall Study|Withdrawal by Subject|0|||
126365968|NCT03829683|454634281|FG001|Overall Study|Withdrawal by Subject|1|||
126365969|NCT03829683|454634280|FG000|Overall Study|Discharge from hospital|1|||
126365970|NCT03829683|454634281|FG001|Overall Study|Discharge from hospital|0|||
126365971|NCT02796651|454634285|FG000|Overall Study|Adverse Event|6|||
126365972|NCT02796651|454634285|FG000|Overall Study|Lost to Follow-up|1|||
126365973|NCT02796651|454634285|FG000|Overall Study|Withdrawal by Subject|4|||
126365974|NCT02796651|454634285|FG000|Overall Study|Protocol Violation|4|||
126365975|NCT02796651|454634285|FG000|Overall Study|Lack of Efficacy|1|||
126365976|NCT02796651|454634285|FG000|Overall Study|Other|10|||
126365977|NCT05430919|454634289|FG000|Overall Study|Protocol Violation|0|||
126365978|NCT05430919|454634290|FG001|Overall Study|Protocol Violation|0|||
126365979|NCT05430919|454634291|FG002|Overall Study|Protocol Violation|1|||
126365980|NCT05430919|454634292|FG003|Overall Study|Protocol Violation|0|||
126365981|NCT05430919|454634289|FG000|Overall Study|Lost to Follow-up|0|||
126365982|NCT05430919|454634290|FG001|Overall Study|Lost to Follow-up|1|||
126365983|NCT05430919|454634291|FG002|Overall Study|Lost to Follow-up|0|||
126365984|NCT05430919|454634292|FG003|Overall Study|Lost to Follow-up|0|||
126365985|NCT05430919|454634289|FG000|Overall Study|Withdrawal by Subject|3|||
126365986|NCT05430919|454634290|FG001|Overall Study|Withdrawal by Subject|0|||
126365987|NCT05430919|454634291|FG002|Overall Study|Withdrawal by Subject|0|||
126365988|NCT05430919|454634292|FG003|Overall Study|Withdrawal by Subject|1|||
126365989|NCT05014919|454634293|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
126365990|NCT05014919|454634294|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
126365991|NCT05014919|454634295|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
126365992|NCT05014919|454634293|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
126365993|NCT05014919|454634294|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
126365994|NCT05014919|454634295|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
126365995|NCT05014919|454634293|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
126365996|NCT05014919|454634294|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
126365997|NCT05014919|454634295|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
126365998|NCT05014919|454634293|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
126365999|NCT05014919|454634294|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
126366000|NCT05014919|454634295|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
126366001|NCT05014919|454634293|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
126366002|NCT05014919|454634294|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
126366003|NCT05014919|454634295|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
126289836|NCT03404674|454347752|FG004|Overall Study|Behavioral Problems|0|||
126289837|NCT03404674|454347753|FG005|Overall Study|Behavioral Problems|0|||
126289838|NCT03404674|454347748|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
126289839|NCT03404674|454347749|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
126289840|NCT03404674|454347750|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
126289841|NCT03404674|454347751|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
126289842|NCT03404674|454347752|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
126289843|NCT03404674|454347753|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
126366004|NCT05014919|454634293|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
126366005|NCT05014919|454634294|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
126366006|NCT05014919|454634295|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
126366007|NCT05014919|454634293|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
126366008|NCT05014919|454634294|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
126366009|NCT05014919|454634295|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
126366010|NCT05014919|454634293|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
126366011|NCT05014919|454634294|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
126366012|NCT05014919|454634295|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
126366013|NCT02971163|454634298|FG000|Overall Study|Lost to Follow-up|4|||
126366014|NCT02971163|454634299|FG001|Overall Study|Lost to Follow-up|2|||
126366015|NCT01491919|454634300|FG000|Overall Study|Insufficient PK sampling|1|||
126289844|NCT04728802|454347758|FG000|Overall Study|Withdrawal by Subject|4|||
126289845|NCT04728802|454347759|FG001|Overall Study|Withdrawal by Subject|20|||
126289846|NCT04728802|454347758|FG000|Overall Study|Physician Decision|7|||
126289847|NCT04728802|454347759|FG001|Overall Study|Physician Decision|7|||
126289848|NCT04728802|454347758|FG000|Overall Study|Protocol Violation|10|||
126289849|NCT04728802|454347759|FG001|Overall Study|Protocol Violation|4|||
126289850|NCT04728802|454347758|FG000|Overall Study|Transfer|1|||
126289851|NCT04728802|454347759|FG001|Overall Study|Transfer|0|||
126289852|NCT04728802|454347758|FG000|Overall Study|Death|4|||
126289853|NCT04728802|454347759|FG001|Overall Study|Death|5|||
126289854|NCT04728802|454347758|FG000|Overall Study|Other|3|||
126289855|NCT04728802|454347759|FG001|Overall Study|Other|0|||
126289856|NCT01176513|454347760|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
126289857|NCT03164616|454347764|FG000|Overall Study|Death|250|||
126289858|NCT03164616|454347765|FG001|Overall Study|Death|264|||
126289859|NCT03164616|454347766|FG002|Overall Study|Death|279|||
126289860|NCT03164616|454347764|FG000|Overall Study|Lost to Follow-up|2|||
126289861|NCT03164616|454347765|FG001|Overall Study|Lost to Follow-up|2|||
126289862|NCT03164616|454347766|FG002|Overall Study|Lost to Follow-up|2|||
126289863|NCT03164616|454347764|FG000|Overall Study|Withdrawal by Subject|6|||
126289864|NCT03164616|454347765|FG001|Overall Study|Withdrawal by Subject|7|||
126289865|NCT03164616|454347766|FG002|Overall Study|Withdrawal by Subject|16|||
126289866|NCT00489255|454347778|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
126289867|NCT00489255|454347779|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
126289868|NCT00489255|454347778|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
126289869|NCT00489255|454347779|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
126289870|NCT00489255|454347778|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
126289871|NCT00489255|454347779|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
126289872|NCT00489255|454347778|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
126289873|NCT00489255|454347779|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
126289874|NCT00489255|454347778|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
126289875|NCT00489255|454347779|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
126289876|NCT00489255|454347778|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
126289877|NCT00489255|454347779|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
126289878|NCT00489255|454347778|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
126289879|NCT00489255|454347779|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
126289880|NCT00489255|454347778|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
126289881|NCT00489255|454347779|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
126289882|NCT00489255|454347778|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
126289883|NCT00489255|454347779|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
126289884|NCT00489255|454347778|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
126289885|NCT00489255|454347779|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
126289886|NCT06018129|454347782|FG000|Overall Study|Death|1|||
126289887|NCT06018129|454347783|FG001|Overall Study|Death|1|||
126289888|NCT06018129|454347784|FG002|Overall Study|Death|2|||
126289889|NCT06018129|454347782|FG000|Overall Study|Sponsor Decision|2|||
126289890|NCT06018129|454347783|FG001|Overall Study|Sponsor Decision|2|||
126289891|NCT06018129|454347784|FG002|Overall Study|Sponsor Decision|1|||
126289892|NCT01959295|454347785|FG000|Overall Study|Adverse Event|2|||
126289893|NCT01959295|454347786|FG001|Overall Study|Adverse Event|0|||
126289894|NCT01959295|454347785|FG000|Overall Study|Lost to Follow-up|0|||
126289895|NCT01959295|454347786|FG001|Overall Study|Lost to Follow-up|2|||
126289896|NCT01959295|454347785|FG000|Overall Study|Physician Decision|2|||
126289897|NCT01959295|454347786|FG001|Overall Study|Physician Decision|3|||
126289898|NCT01959295|454347785|FG000|Overall Study|Protocol Violation|16|||
126289899|NCT01959295|454347786|FG001|Overall Study|Protocol Violation|5|||
126289900|NCT01959295|454347785|FG000|Overall Study|Withdrawal by Subject|3|||
126289901|NCT01959295|454347786|FG001|Overall Study|Withdrawal by Subject|1|||
126289902|NCT01959295|454347785|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
126289903|NCT01959295|454347786|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
126289904|NCT04917861|454347788|FG000|Main Study (196 Days)|Adverse Event|0|||
126289905|NCT04917861|454347789|FG001|Main Study (196 Days)|Adverse Event|1|||
126289906|NCT04917861|454347790|FG002|Main Study (196 Days)|Adverse Event|0|||
126289907|NCT04917861|454347791|FG003|Main Study (196 Days)|Adverse Event|0|||
126289908|NCT04917861|454347788|FG000|Main Study (196 Days)|Death|0|||
126289909|NCT04917861|454347789|FG001|Main Study (196 Days)|Death|0|||
126289910|NCT04917861|454347790|FG002|Main Study (196 Days)|Death|0|||
126289911|NCT04917861|454347791|FG003|Main Study (196 Days)|Death|1|||
126289912|NCT04917861|454347788|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
126289913|NCT04917861|454347789|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
126289914|NCT04917861|454347790|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
126289915|NCT04917861|454347791|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
126289916|NCT04917861|454347788|FG000|Main Study (196 Days)|Physician Decision|0|||
126289917|NCT04917861|454347789|FG001|Main Study (196 Days)|Physician Decision|0|||
126289918|NCT04917861|454347790|FG002|Main Study (196 Days)|Physician Decision|0|||
126289919|NCT04917861|454347791|FG003|Main Study (196 Days)|Physician Decision|1|||
126289920|NCT04917861|454347788|FG000|Main Study (196 Days)|Pregnancy|1|||
126289921|NCT04917861|454347789|FG001|Main Study (196 Days)|Pregnancy|1|||
126289922|NCT04917861|454347790|FG002|Main Study (196 Days)|Pregnancy|0|||
126289923|NCT04917861|454347791|FG003|Main Study (196 Days)|Pregnancy|0|||
126289924|NCT04917861|454347788|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
126289925|NCT04917861|454347789|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
126289926|NCT04917861|454347790|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
126289927|NCT04917861|454347791|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
126289928|NCT04917861|454347788|FG000|Main Study (196 Days)|Other Than Specified|1|||
126289929|NCT04917861|454347789|FG001|Main Study (196 Days)|Other Than Specified|0|||
126289930|NCT04917861|454347790|FG002|Main Study (196 Days)|Other Than Specified|1|||
126289931|NCT04917861|454347791|FG003|Main Study (196 Days)|Other Than Specified|2|||
126289932|NCT04917861|454347788|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
126289933|NCT04917861|454347789|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
126289934|NCT04917861|454347790|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
126289935|NCT04917861|454347791|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
126289936|NCT04917861|454347788|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
126289937|NCT04917861|454347789|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
126289938|NCT04917861|454347790|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
126289939|NCT04917861|454347791|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
126289940|NCT04917861|454347788|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
126289941|NCT04917861|454347789|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
126289942|NCT04917861|454347790|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
126289943|NCT04917861|454347791|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
126289944|NCT04917861|454347788|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
126289945|NCT04917861|454347789|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
126289946|NCT04917861|454347790|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
126289947|NCT04917861|454347791|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
126289948|NCT04917861|454347788|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
126289949|NCT04917861|454347789|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
126289950|NCT04917861|454347790|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
126289951|NCT04917861|454347791|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
126289952|NCT04917861|454347788|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
126289953|NCT04917861|454347789|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
126289954|NCT04917861|454347790|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
126289955|NCT04917861|454347791|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
126289956|NCT06389487|454347792|FG000|Overall Study|Lost to Follow-up|9|||
126289957|NCT06389487|454347793|FG001|Overall Study|Lost to Follow-up|5|||
126289958|NCT06389487|454347794|FG002|Overall Study|Lost to Follow-up|13|||
126289959|NCT06389487|454347792|FG000|Overall Study|Protocol Violation|0|||
126289960|NCT06389487|454347793|FG001|Overall Study|Protocol Violation|0|||
126289961|NCT06389487|454347794|FG002|Overall Study|Protocol Violation|2|||
126289962|NCT06389487|454347792|FG000|Overall Study|Withdrawal by Subject|2|||
126289963|NCT06389487|454347793|FG001|Overall Study|Withdrawal by Subject|2|||
126289964|NCT06389487|454347794|FG002|Overall Study|Withdrawal by Subject|1|||
126289965|NCT06389487|454347792|FG000|Overall Study|Other|1|||
126289966|NCT06389487|454347793|FG001|Overall Study|Other|0|||
126289967|NCT06389487|454347794|FG002|Overall Study|Other|1|||
126289968|NCT03713593|454348782|FG000|Overall Study|Sponsor Decision|73|||
126289969|NCT03713593|454348783|FG001|Overall Study|Sponsor Decision|41|||
126289970|NCT03713593|454348782|FG000|Overall Study|Lost to Follow-up|2|||
126289971|NCT03713593|454348783|FG001|Overall Study|Lost to Follow-up|1|||
126289972|NCT03713593|454348782|FG000|Overall Study|Death|314|||
126289973|NCT03713593|454348783|FG001|Overall Study|Death|349|||
126289974|NCT03713593|454348782|FG000|Overall Study|Withdrawal by Subject|6|||
126289975|NCT03713593|454348783|FG001|Overall Study|Withdrawal by Subject|8|||
126289976|NCT03130777|454348784|FG000|Overall Study|Death|0|||
126289977|NCT03130777|454348785|FG001|Overall Study|Death|1|||
126289978|NCT03130777|454348784|FG000|Overall Study|Did not meet eligibility criteria|1|||
126289979|NCT03130777|454348785|FG001|Overall Study|Did not meet eligibility criteria|0|||
126289980|NCT02498613|454348786|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
126289981|NCT02498613|454348787|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
126289982|NCT02498613|454348788|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
126289983|NCT02498613|454348789|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
126289984|NCT02498613|454348786|FG000|Overall Study|Withdrawal by Subject|3|||
126289985|NCT02498613|454348787|FG001|Overall Study|Withdrawal by Subject|1|||
126289986|NCT02498613|454348788|FG002|Overall Study|Withdrawal by Subject|0|||
126289987|NCT02498613|454348789|FG003|Overall Study|Withdrawal by Subject|0|||
126289988|NCT05168202|454348790|FG000|Overall Study|Progressive Disease|4|||
126289989|NCT05168202|454348791|FG001|Overall Study|Progressive Disease|4|||
126289990|NCT05168202|454348792|FG002|Overall Study|Progressive Disease|2|||
126289991|NCT05168202|454348793|FG003|Overall Study|Progressive Disease|3|||
126289992|NCT05168202|454348794|FG004|Overall Study|Progressive Disease|2|||
126549773|NCT00251927|455307578|FG000|Overall Study|Pregnancy|2|||
126767021|NCT00539006|456100207|FG001|Treatment Period 1|Lost to Follow-up|0|||
126457765|NCT01551420|454976626|FG001|Home Use (Part B)|Withdrawal by staff|1|||
126457766|NCT00278915|454976627|FG000|Overall Study|Disease progression|1|||
126457767|NCT02520089|454976628|FG000|Overall Study|Lost to Follow-up|3|||
126457768|NCT02520089|454976629|FG001|Overall Study|Lost to Follow-up|4|||
126457769|NCT03353740|454976635|FG000|Overall Study|Images for these participants not viable|52|||
126457770|NCT02232880|454976637|FG000|Overall Study|study stopped prior to randomization|1|||
126457771|NCT02545543|454976638|FG000|Overall Study|Lost to Follow-up|67|||
126457772|NCT02545543|454976639|FG001|Overall Study|Lost to Follow-up|25|||
126457773|NCT02545543|454976638|FG000|Overall Study|Physician Decision|3|||
126457774|NCT02545543|454976639|FG001|Overall Study|Physician Decision|0|||
126457775|NCT02545543|454976638|FG000|Overall Study|Withdrawal by Subject|9|||
126457776|NCT02545543|454976639|FG001|Overall Study|Withdrawal by Subject|8|||
126457777|NCT02545543|454976638|FG000|Overall Study|Noncomplaince|1|||
126457778|NCT02545543|454976639|FG001|Overall Study|Noncomplaince|0|||
126457779|NCT02545543|454976638|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
126457780|NCT02545543|454976639|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
126710605|NCT00609609|455891659|FG000|Overall Study|Progression|4|||
126710606|NCT00609609|455891660|FG001|Overall Study|Progression|2|||
126289993|NCT05168202|454348795|FG005|Overall Study|Progressive Disease|3|||
126289994|NCT05168202|454348796|FG006|Overall Study|Progressive Disease|2|||
126289995|NCT05168202|454348790|FG000|Overall Study|Adverse Event|2|||
126289996|NCT05168202|454348791|FG001|Overall Study|Adverse Event|1|||
126289997|NCT05168202|454348792|FG002|Overall Study|Adverse Event|4|||
126289998|NCT05168202|454348793|FG003|Overall Study|Adverse Event|4|||
126289999|NCT05168202|454348794|FG004|Overall Study|Adverse Event|3|||
126290000|NCT05168202|454348795|FG005|Overall Study|Adverse Event|2|||
126290001|NCT05168202|454348796|FG006|Overall Study|Adverse Event|0|||
126290002|NCT05168202|454348790|FG000|Overall Study|Lack of Efficacy|0|||
126290003|NCT05168202|454348791|FG001|Overall Study|Lack of Efficacy|1|||
126290004|NCT05168202|454348792|FG002|Overall Study|Lack of Efficacy|1|||
126290005|NCT05168202|454348793|FG003|Overall Study|Lack of Efficacy|0|||
126290006|NCT05168202|454348794|FG004|Overall Study|Lack of Efficacy|1|||
126290007|NCT05168202|454348795|FG005|Overall Study|Lack of Efficacy|2|||
126290008|NCT05168202|454348796|FG006|Overall Study|Lack of Efficacy|2|||
126290009|NCT05168202|454348790|FG000|Overall Study|Withdrawal by Subject|0|||
126290010|NCT05168202|454348791|FG001|Overall Study|Withdrawal by Subject|0|||
126290011|NCT05168202|454348792|FG002|Overall Study|Withdrawal by Subject|1|||
126290012|NCT05168202|454348793|FG003|Overall Study|Withdrawal by Subject|1|||
126290013|NCT05168202|454348794|FG004|Overall Study|Withdrawal by Subject|1|||
126290014|NCT05168202|454348795|FG005|Overall Study|Withdrawal by Subject|1|||
126290015|NCT05168202|454348796|FG006|Overall Study|Withdrawal by Subject|0|||
126290016|NCT05168202|454348790|FG000|Overall Study|Disease Relapse|0|||
126290017|NCT05168202|454348791|FG001|Overall Study|Disease Relapse|1|||
126290018|NCT05168202|454348792|FG002|Overall Study|Disease Relapse|0|||
126290019|NCT05168202|454348793|FG003|Overall Study|Disease Relapse|1|||
126290020|NCT05168202|454348794|FG004|Overall Study|Disease Relapse|1|||
126290021|NCT05168202|454348795|FG005|Overall Study|Disease Relapse|0|||
126290022|NCT05168202|454348796|FG006|Overall Study|Disease Relapse|0|||
126290023|NCT05168202|454348790|FG000|Overall Study|Other Reasons|0|||
126290024|NCT05168202|454348791|FG001|Overall Study|Other Reasons|0|||
126290025|NCT05168202|454348792|FG002|Overall Study|Other Reasons|0|||
126290026|NCT05168202|454348793|FG003|Overall Study|Other Reasons|0|||
126290027|NCT05168202|454348794|FG004|Overall Study|Other Reasons|0|||
126290028|NCT05168202|454348795|FG005|Overall Study|Other Reasons|2|||
126290029|NCT05168202|454348796|FG006|Overall Study|Other Reasons|1|||
126290030|NCT05168202|454348790|FG000|Overall Study|Physician Decision|0|||
126290031|NCT05168202|454348791|FG001|Overall Study|Physician Decision|1|||
126290032|NCT05168202|454348792|FG002|Overall Study|Physician Decision|1|||
126290033|NCT05168202|454348793|FG003|Overall Study|Physician Decision|0|||
126290034|NCT05168202|454348794|FG004|Overall Study|Physician Decision|0|||
126290035|NCT05168202|454348795|FG005|Overall Study|Physician Decision|0|||
126290036|NCT05168202|454348796|FG006|Overall Study|Physician Decision|0|||
126290037|NCT05168202|454348790|FG000|Overall Study|Study Terminated by Sponsor|0|||
126290038|NCT05168202|454348791|FG001|Overall Study|Study Terminated by Sponsor|0|||
126290039|NCT05168202|454348792|FG002|Overall Study|Study Terminated by Sponsor|0|||
126290040|NCT05168202|454348793|FG003|Overall Study|Study Terminated by Sponsor|1|||
126290041|NCT05168202|454348794|FG004|Overall Study|Study Terminated by Sponsor|0|||
126290042|NCT05168202|454348795|FG005|Overall Study|Study Terminated by Sponsor|0|||
126290043|NCT05168202|454348796|FG006|Overall Study|Study Terminated by Sponsor|0|||
126290044|NCT00001521|454348801|FG000|Overall Study|Withdrawal by Subject|3|||
126290045|NCT00001521|454348802|FG001|Overall Study|Withdrawal by Subject|3|||
126290046|NCT00001521|454348801|FG000|Overall Study|Physician Decision|1|||
126457781|NCT02829944|454976640|FG000|Overall Study|Physician Decision|0|||
126710607|NCT00537823|455891663|FG000|Overall Study|Adverse Event|2|||
126290047|NCT00001521|454348802|FG001|Overall Study|Physician Decision|1|||
126290048|NCT00001521|454348801|FG000|Overall Study|Noncompliant|6|||
126290049|NCT00001521|454348802|FG001|Overall Study|Noncompliant|3|||
126290050|NCT00970593|454348810|FG000|Overall Study|Adverse Event|1|||
126457782|NCT02829944|454976641|FG001|Overall Study|Physician Decision|1|||
126290051|NCT00970593|454348811|FG001|Overall Study|Adverse Event|1|||
126290052|NCT00970593|454348812|FG002|Overall Study|Adverse Event|0|||
126290053|NCT00970593|454348813|FG003|Overall Study|Adverse Event|0|||
126290054|NCT00970593|454348814|FG004|Overall Study|Adverse Event|0|||
126290055|NCT00970593|454348815|FG005|Overall Study|Adverse Event|0|||
126290056|NCT00970593|454348816|FG006|Overall Study|Adverse Event|0|||
126290057|NCT00970593|454348810|FG000|Overall Study|Discontinuation of study by sponsor|0|||
126290058|NCT00970593|454348811|FG001|Overall Study|Discontinuation of study by sponsor|0|||
126290059|NCT00970593|454348812|FG002|Overall Study|Discontinuation of study by sponsor|5|||
126290060|NCT00970593|454348813|FG003|Overall Study|Discontinuation of study by sponsor|0|||
126290061|NCT00970593|454348814|FG004|Overall Study|Discontinuation of study by sponsor|0|||
126290062|NCT00970593|454348815|FG005|Overall Study|Discontinuation of study by sponsor|0|||
126290063|NCT00970593|454348816|FG006|Overall Study|Discontinuation of study by sponsor|2|||
126290064|NCT00970593|454348810|FG000|Overall Study|Withdrawal by Subject|0|||
126290065|NCT00970593|454348811|FG001|Overall Study|Withdrawal by Subject|0|||
126290066|NCT00970593|454348812|FG002|Overall Study|Withdrawal by Subject|1|||
126290067|NCT00970593|454348813|FG003|Overall Study|Withdrawal by Subject|0|||
126290068|NCT00970593|454348814|FG004|Overall Study|Withdrawal by Subject|0|||
126290069|NCT00970593|454348815|FG005|Overall Study|Withdrawal by Subject|0|||
126290070|NCT00970593|454348816|FG006|Overall Study|Withdrawal by Subject|0|||
126290071|NCT01342081|454348830|FG000|Overall Study|Did not receive allocated intervention|0|||
126290072|NCT01342081|454348831|FG001|Overall Study|Did not receive allocated intervention|0|||
126290073|NCT01342081|454348832|FG002|Overall Study|Did not receive allocated intervention|1|||
126290074|NCT01342081|454348830|FG000|Overall Study|Adverse Event|1|||
126290075|NCT01342081|454348831|FG001|Overall Study|Adverse Event|0|||
126290076|NCT01342081|454348832|FG002|Overall Study|Adverse Event|0|||
126290077|NCT01342081|454348830|FG000|Overall Study|Physician Decision|0|||
126290078|NCT01342081|454348831|FG001|Overall Study|Physician Decision|1|||
126290079|NCT01342081|454348832|FG002|Overall Study|Physician Decision|0|||
126290080|NCT01342081|454348830|FG000|Overall Study|Withdrawal by Subject|1|||
126290081|NCT01342081|454348831|FG001|Overall Study|Withdrawal by Subject|1|||
126290082|NCT01342081|454348832|FG002|Overall Study|Withdrawal by Subject|0|||
126290083|NCT01202175|454348833|FG000|Overall Study|Lost to Follow-up|2|||
126290084|NCT01202175|454348833|FG000|Overall Study|Withdrawal by Subject|1|||
126290085|NCT01202175|454348833|FG000|Overall Study|Adverse Event|2|||
126290086|NCT02790437|454348834|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
126290087|NCT02790437|454348835|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
126290088|NCT02790437|454348834|FG000|Overall Study|Adverse Event|1|||
126290089|NCT02790437|454348835|FG001|Overall Study|Adverse Event|0|||
126290090|NCT02790437|454348834|FG000|Overall Study|Withdrawal by Subject|1|||
126290091|NCT02790437|454348835|FG001|Overall Study|Withdrawal by Subject|0|||
126290092|NCT04720053|454348840|FG000|Overall Study|Lost to Follow-up|12|||
126290093|NCT01942993|454348841|FG000|Overall Study|Lost to Follow-up|1|||
126290094|NCT01942993|454348841|FG000|Overall Study|Physician Decision|1|||
126290095|NCT01350271|454348842|FG000|Overall Study|Lost to Follow-up|21|||
126290096|NCT01350271|454348843|FG001|Overall Study|Lost to Follow-up|17|||
126290097|NCT01350271|454348844|FG002|Overall Study|Lost to Follow-up|26|||
126290098|NCT02906670|454348848|FG000|Cohort 1, QW|Radiological Progression|1|||
126290099|NCT02906670|454348849|FG001|Cohort 1, QW|Radiological Progression|0|||
126290100|NCT02906670|454348850|FG002|Cohort 1, QW|Radiological Progression|0|||
126290101|NCT02906670|454348851|FG003|Cohort 1, QW|Radiological Progression|0|||
126290102|NCT02906670|454348852|FG004|Cohort 1, QW|Radiological Progression|0|||
126290103|NCT02906670|454348853|FG005|Cohort 1, QW|Radiological Progression|0|||
126290104|NCT02906670|454348854|FG006|Cohort 1, QW|Radiological Progression|0|||
126290105|NCT02906670|454348855|FG007|Cohort 1, QW|Radiological Progression|0|||
126290106|NCT02906670|454348856|FG008|Cohort 1, QW|Radiological Progression|0|||
126290107|NCT02906670|454348857|FG009|Cohort 1, QW|Radiological Progression|0|||
126290108|NCT02906670|454348848|FG000|Cohort 2, QW|Radiological Progression|0|||
126290109|NCT02906670|454348849|FG001|Cohort 2, QW|Radiological Progression|1|||
126290110|NCT02906670|454348850|FG002|Cohort 2, QW|Radiological Progression|0|||
126290111|NCT02906670|454348851|FG003|Cohort 2, QW|Radiological Progression|0|||
126290112|NCT02906670|454348852|FG004|Cohort 2, QW|Radiological Progression|0|||
126290113|NCT02906670|454348853|FG005|Cohort 2, QW|Radiological Progression|0|||
126290114|NCT02906670|454348854|FG006|Cohort 2, QW|Radiological Progression|0|||
126290115|NCT02906670|454348855|FG007|Cohort 2, QW|Radiological Progression|0|||
126290116|NCT02906670|454348856|FG008|Cohort 2, QW|Radiological Progression|0|||
126290117|NCT02906670|454348857|FG009|Cohort 2, QW|Radiological Progression|0|||
126290118|NCT02906670|454348848|FG000|Cohort 3, QW|Radiological Progression|0|||
126290119|NCT02906670|454348849|FG001|Cohort 3, QW|Radiological Progression|0|||
126290120|NCT02906670|454348850|FG002|Cohort 3, QW|Radiological Progression|2|||
126290121|NCT02906670|454348851|FG003|Cohort 3, QW|Radiological Progression|0|||
126290122|NCT02906670|454348852|FG004|Cohort 3, QW|Radiological Progression|0|||
126290123|NCT02906670|454348853|FG005|Cohort 3, QW|Radiological Progression|0|||
126290124|NCT02906670|454348854|FG006|Cohort 3, QW|Radiological Progression|0|||
126290125|NCT02906670|454348855|FG007|Cohort 3, QW|Radiological Progression|0|||
126290126|NCT02906670|454348856|FG008|Cohort 3, QW|Radiological Progression|0|||
126290127|NCT02906670|454348857|FG009|Cohort 3, QW|Radiological Progression|0|||
126290128|NCT02906670|454348848|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290129|NCT02906670|454348849|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290130|NCT02906670|454348850|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
126290131|NCT02906670|454348851|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290132|NCT02906670|454348852|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290133|NCT02906670|454348853|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290134|NCT02906670|454348854|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290135|NCT02906670|454348855|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290136|NCT02906670|454348856|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290137|NCT02906670|454348857|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
126290138|NCT02906670|454348848|FG000|Cohort 4, Q2W|Radiological Progression|0|||
126290139|NCT02906670|454348849|FG001|Cohort 4, Q2W|Radiological Progression|0|||
126290140|NCT02906670|454348850|FG002|Cohort 4, Q2W|Radiological Progression|0|||
126290141|NCT02906670|454348851|FG003|Cohort 4, Q2W|Radiological Progression|0|||
126290142|NCT02906670|454348852|FG004|Cohort 4, Q2W|Radiological Progression|0|||
126290143|NCT02906670|454348853|FG005|Cohort 4, Q2W|Radiological Progression|1|||
126290144|NCT02906670|454348854|FG006|Cohort 4, Q2W|Radiological Progression|0|||
126290145|NCT02906670|454348855|FG007|Cohort 4, Q2W|Radiological Progression|0|||
126290146|NCT02906670|454348856|FG008|Cohort 4, Q2W|Radiological Progression|0|||
126290147|NCT02906670|454348857|FG009|Cohort 4, Q2W|Radiological Progression|0|||
126290148|NCT02906670|454348848|FG000|Cohort 4, Q2W|Clinical Progression|0|||
126290149|NCT02906670|454348849|FG001|Cohort 4, Q2W|Clinical Progression|0|||
126290150|NCT02906670|454348850|FG002|Cohort 4, Q2W|Clinical Progression|0|||
126290151|NCT02906670|454348851|FG003|Cohort 4, Q2W|Clinical Progression|0|||
126290152|NCT02906670|454348852|FG004|Cohort 4, Q2W|Clinical Progression|0|||
126290153|NCT02906670|454348853|FG005|Cohort 4, Q2W|Clinical Progression|2|||
126366016|NCT01491919|454634301|FG001|Overall Study|Insufficient PK sampling|2|||
126366017|NCT01491919|454634302|FG002|Overall Study|Insufficient PK sampling|1|||
126366018|NCT02871219|454634303|FG000|Overall Study|Adverse Event|15|||
126366019|NCT02871219|454634303|FG000|Overall Study|Death|3|||
126366020|NCT02871219|454634303|FG000|Overall Study|Progression|3|||
126366021|NCT02871219|454634303|FG000|Overall Study|Infections|7|||
126366022|NCT02871219|454634303|FG000|Overall Study|Infusion Related|4|||
126366023|NCT02298946|454634307|FG000|Overall Study|Did not receive treatment|2|||
126366024|NCT02298946|454634308|FG001|Overall Study|Did not receive treatment|0|||
126366025|NCT02298946|454634307|FG000|Overall Study|Unevaluable|2|||
126366026|NCT02298946|454634308|FG001|Overall Study|Unevaluable|1|||
126366027|NCT05375929|454634316|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
126366028|NCT05375929|454634317|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
126366029|NCT05375929|454634318|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
126366030|NCT05375929|454634319|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
126366031|NCT05375929|454634316|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
126366032|NCT05375929|454634317|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
126366033|NCT05375929|454634318|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
126366034|NCT05375929|454634319|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
126366035|NCT05375929|454634316|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
126366036|NCT05375929|454634317|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
126366037|NCT05375929|454634318|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
126366038|NCT05375929|454634319|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
126366039|NCT05375929|454634316|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
126366040|NCT05375929|454634317|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
126366041|NCT05375929|454634318|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
126366042|NCT05375929|454634319|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
126366043|NCT05375929|454634316|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
126366044|NCT05375929|454634317|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
126366045|NCT05375929|454634318|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
126366046|NCT05375929|454634319|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
126366047|NCT05375929|454634316|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
126366048|NCT05375929|454634317|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
126366049|NCT05375929|454634318|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
126366050|NCT05375929|454634319|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
126366051|NCT05375929|454634316|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
126366052|NCT05375929|454634317|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
126366053|NCT05375929|454634318|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
126366054|NCT05375929|454634319|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
126366055|NCT05375929|454634316|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
126457783|NCT02829944|454976640|FG000|Overall Study|Screen Failure|2|||
126457784|NCT02829944|454976641|FG001|Overall Study|Screen Failure|2|||
126457785|NCT02829944|454976640|FG000|Overall Study|Inadequate Neuraxial Block|1|||
126290154|NCT02906670|454348854|FG006|Cohort 4, Q2W|Clinical Progression|0|||
126290155|NCT02906670|454348855|FG007|Cohort 4, Q2W|Clinical Progression|0|||
126290156|NCT02906670|454348856|FG008|Cohort 4, Q2W|Clinical Progression|0|||
126290157|NCT02906670|454348857|FG009|Cohort 4, Q2W|Clinical Progression|0|||
126290158|NCT02906670|454348848|FG000|Cohort 5, Q2W|Radiological Progression|0|||
126290159|NCT02906670|454348849|FG001|Cohort 5, Q2W|Radiological Progression|0|||
126290160|NCT02906670|454348850|FG002|Cohort 5, Q2W|Radiological Progression|0|||
126290161|NCT02906670|454348851|FG003|Cohort 5, Q2W|Radiological Progression|0|||
126290162|NCT02906670|454348852|FG004|Cohort 5, Q2W|Radiological Progression|0|||
126290163|NCT02906670|454348853|FG005|Cohort 5, Q2W|Radiological Progression|0|||
126290164|NCT02906670|454348854|FG006|Cohort 5, Q2W|Radiological Progression|4|||
126290165|NCT02906670|454348855|FG007|Cohort 5, Q2W|Radiological Progression|0|||
126290166|NCT02906670|454348856|FG008|Cohort 5, Q2W|Radiological Progression|0|||
126290167|NCT02906670|454348857|FG009|Cohort 5, Q2W|Radiological Progression|0|||
126290168|NCT02906670|454348848|FG000|Cohort 5, Q2W|Clinical Progression|0|||
126290169|NCT02906670|454348849|FG001|Cohort 5, Q2W|Clinical Progression|0|||
126290170|NCT02906670|454348850|FG002|Cohort 5, Q2W|Clinical Progression|0|||
126290171|NCT02906670|454348851|FG003|Cohort 5, Q2W|Clinical Progression|0|||
126290172|NCT02906670|454348852|FG004|Cohort 5, Q2W|Clinical Progression|0|||
126290173|NCT02906670|454348853|FG005|Cohort 5, Q2W|Clinical Progression|0|||
126290174|NCT02906670|454348854|FG006|Cohort 5, Q2W|Clinical Progression|1|||
126290175|NCT02906670|454348855|FG007|Cohort 5, Q2W|Clinical Progression|0|||
126290176|NCT02906670|454348856|FG008|Cohort 5, Q2W|Clinical Progression|0|||
126290177|NCT02906670|454348857|FG009|Cohort 5, Q2W|Clinical Progression|0|||
126290178|NCT02906670|454348848|FG000|Cohort 5, Q2W|Adverse Event|0|||
126290179|NCT02906670|454348849|FG001|Cohort 5, Q2W|Adverse Event|0|||
126290180|NCT02906670|454348850|FG002|Cohort 5, Q2W|Adverse Event|0|||
126290181|NCT02906670|454348851|FG003|Cohort 5, Q2W|Adverse Event|0|||
126290182|NCT02906670|454348852|FG004|Cohort 5, Q2W|Adverse Event|0|||
126290183|NCT02906670|454348853|FG005|Cohort 5, Q2W|Adverse Event|0|||
126290184|NCT02906670|454348854|FG006|Cohort 5, Q2W|Adverse Event|1|||
126290185|NCT02906670|454348855|FG007|Cohort 5, Q2W|Adverse Event|0|||
126290186|NCT02906670|454348856|FG008|Cohort 5, Q2W|Adverse Event|0|||
126290187|NCT02906670|454348857|FG009|Cohort 5, Q2W|Adverse Event|0|||
126290188|NCT02906670|454348848|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290189|NCT02906670|454348849|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290190|NCT02906670|454348850|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290191|NCT02906670|454348851|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290192|NCT02906670|454348852|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126366056|NCT05375929|454634317|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
126366057|NCT05375929|454634318|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
126366058|NCT05375929|454634319|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
126366059|NCT05375929|454634316|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
126366060|NCT05375929|454634317|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
126366061|NCT05375929|454634318|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
126366062|NCT05375929|454634319|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
126366063|NCT05375929|454634316|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
126366064|NCT05375929|454634317|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
126366065|NCT05375929|454634318|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
126366066|NCT05375929|454634319|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
126366067|NCT00773461|454634324|FG000|Overall Study|Adverse Event|1|||
126366068|NCT00773461|454634325|FG001|Overall Study|Adverse Event|3|||
126366069|NCT00773461|454634324|FG000|Overall Study|Withdrawal by Subject|4|||
126366070|NCT00773461|454634325|FG001|Overall Study|Withdrawal by Subject|1|||
126366071|NCT00322218|454634328|FG000|Overall Study|Death|3|||
126366072|NCT00322218|454634329|FG001|Overall Study|Death|6|||
126366073|NCT01385995|454634331|FG000|Period 1, 2 Months|Physician Decision|1|||
126366074|NCT01385995|454634332|FG001|Period 1, 2 Months|Physician Decision|0|||
126366075|NCT00112385|454634333|FG000|Overall Study|Lost to Follow-up|1|||
126366076|NCT00112385|454634334|FG001|Overall Study|Lost to Follow-up|0|||
126366077|NCT00112385|454634333|FG000|Overall Study|Withdrawal by Subject|0|||
126366078|NCT00112385|454634334|FG001|Overall Study|Withdrawal by Subject|1|||
126366079|NCT00964678|454634345|FG000|Overall Study|Physician Decision|4|||
126366080|NCT00908141|454634346|FG000|Overall Study|Withdrawal by Subject|0|||
126366081|NCT00908141|454634347|FG001|Overall Study|Withdrawal by Subject|1|||
126366082|NCT00980044|454635698|FG000|Overall Study|Withdrawal by Subject|5|||
126366083|NCT00980044|454635699|FG001|Overall Study|Withdrawal by Subject|7|||
126366084|NCT00980044|454635700|FG002|Overall Study|Withdrawal by Subject|3|||
126366085|NCT00980044|454635698|FG000|Overall Study|Protocol Violation|0|||
126366086|NCT00980044|454635699|FG001|Overall Study|Protocol Violation|0|||
126366087|NCT00980044|454635700|FG002|Overall Study|Protocol Violation|2|||
126366088|NCT02254291|454635701|FG000|Overall Study|Withdrawal by Subject|0|||
126290193|NCT02906670|454348853|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290194|NCT02906670|454348854|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
126290195|NCT02906670|454348855|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290196|NCT02906670|454348856|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126457786|NCT02829944|454976641|FG001|Overall Study|Inadequate Neuraxial Block|1|||
126457787|NCT02829944|454976640|FG000|Overall Study|Withdrawal by Subject|2|||
126457788|NCT02829944|454976641|FG001|Overall Study|Withdrawal by Subject|1|||
126457789|NCT02829944|454976640|FG000|Overall Study|Catheter Displacement|1|||
126457790|NCT02829944|454976641|FG001|Overall Study|Catheter Displacement|0|||
126457791|NCT02829944|454976640|FG000|Overall Study|Catheter broke|0|||
126457792|NCT02829944|454976641|FG001|Overall Study|Catheter broke|1|||
126457793|NCT02829944|454976640|FG000|Overall Study|Staff unavailable|0|||
126457794|NCT02829944|454976641|FG001|Overall Study|Staff unavailable|1|||
126457795|NCT01395784|454976642|FG000|Overall Study|Lost to Follow-up|7|||
126457796|NCT01395784|454976642|FG000|Overall Study|Withdrawal by Subject|3|||
126457797|NCT01395784|454976642|FG000|Overall Study|Physician Decision|5|||
126457798|NCT04268823|454976643|FG000|Overall Study|Adverse Event|1|||
126457799|NCT04268823|454976644|FG001|Overall Study|Adverse Event|0|||
126457800|NCT04268823|454976643|FG000|Overall Study|Participant Decision|1|||
126457801|NCT04268823|454976644|FG001|Overall Study|Participant Decision|0|||
126457802|NCT02519855|454978168|FG000|Overall Study|Adverse Event|0|||
126457803|NCT02519855|454978169|FG001|Overall Study|Adverse Event|1|||
126457804|NCT02519855|454978168|FG000|Overall Study|Lost to Follow-up|3|||
126457805|NCT02519855|454978169|FG001|Overall Study|Lost to Follow-up|3|||
126457806|NCT00003830|454978183|FG000|Overall Study|No follow up data|3|||
126457807|NCT00003830|454978184|FG001|Overall Study|No follow up data|0|||
126457808|NCT00003830|454978183|FG000|Overall Study|Sentinel node positive patients|829|||
126457809|NCT00003830|454978184|FG001|Overall Study|Sentinel node positive patients|793|||
126457810|NCT00603590|454978188|FG000|Overall Study|Did not attend study clinic|39|||
126457811|NCT00603590|454978189|FG001|Overall Study|Did not attend study clinic|30|||
126457812|NCT00603590|454978188|FG000|Overall Study|Refused blood test|5|||
126457813|NCT00603590|454978189|FG001|Overall Study|Refused blood test|1|||
126457814|NCT00603590|454978188|FG000|Overall Study|Patient discontinued study drug|22|||
126457815|NCT00603590|454978189|FG001|Overall Study|Patient discontinued study drug|15|||
126457816|NCT00603590|454978188|FG000|Overall Study|Adverse Event|2|||
126457817|NCT00603590|454978189|FG001|Overall Study|Adverse Event|0|||
126457818|NCT00603590|454978188|FG000|Overall Study|Lost to Follow-up|8|||
126457819|NCT00603590|454978189|FG001|Overall Study|Lost to Follow-up|4|||
126457820|NCT00603590|454978188|FG000|Overall Study|Cardiovascular event|0|||
126457821|NCT00603590|454978189|FG001|Overall Study|Cardiovascular event|1|||
126457822|NCT03699475|454978195|FG000|Overall Study|Death|1|||
126457823|NCT00137839|454978196|FG000|Overall Study|Adverse Event|7|||
126457824|NCT00137839|454978196|FG000|Overall Study|Physician Decision|7|||
126457825|NCT00137839|454978196|FG000|Overall Study|Death|8|||
126457826|NCT00137839|454978196|FG000|Overall Study|Disease Progression|60|||
126457827|NCT00137839|454978196|FG000|Overall Study|Not Start Treatment|1|||
126457828|NCT00137839|454978196|FG000|Overall Study|Prolonged Treatment Delay|1|||
126457829|NCT02882152|454978201|FG000|Overall Study|Lost to Follow-up|1|||
126457830|NCT02882152|454978202|FG001|Overall Study|Lost to Follow-up|0|||
126457831|NCT03739242|454978205|FG000|Overall Study|Withdrawal by Subject|1|||
126457832|NCT03739242|454978206|FG001|Overall Study|Withdrawal by Subject|1|||
126457833|NCT03739242|454978205|FG000|Overall Study|Protocol Violation|0|||
126457834|NCT03739242|454978206|FG001|Overall Study|Protocol Violation|1|||
126457835|NCT01475071|454978213|FG000|Overall Study|Physician Decision|1|||
126457836|NCT01475071|454978213|FG000|Overall Study|Withdrawal by Subject|6|||
126457837|NCT01475071|454978213|FG000|Overall Study|Lost to Follow-up|1|||
126457838|NCT01343823|454978214|FG000|Overall Study|Study Terminated|1|||
126457839|NCT01343823|454978215|FG001|Overall Study|Study Terminated|0|||
126457840|NCT01343823|454978216|FG002|Overall Study|Study Terminated|0|||
126457841|NCT01343823|454978217|FG003|Overall Study|Study Terminated|1|||
126457842|NCT01343823|454978214|FG000|Overall Study|Withdrawal by Subject|1|||
126457843|NCT01343823|454978215|FG001|Overall Study|Withdrawal by Subject|0|||
126457844|NCT01343823|454978216|FG002|Overall Study|Withdrawal by Subject|0|||
126457845|NCT01343823|454978217|FG003|Overall Study|Withdrawal by Subject|0|||
126290197|NCT02906670|454348857|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
126290198|NCT02906670|454348848|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
126290199|NCT02906670|454348849|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
126457846|NCT00923364|454978218|FG000|Overall Study|Death|3|||
126457847|NCT00923364|454978219|FG001|Overall Study|Death|0|||
126457848|NCT00923364|454978218|FG000|Overall Study|Did not go to transplant|1|||
126457849|NCT00923364|454978219|FG001|Overall Study|Did not go to transplant|0|||
126457850|NCT01752036|454978220|FG000|Overall Study|Death|2|||
126457851|NCT01011478|454978221|FG000|Overall Study|No follow up data|12|||
126457852|NCT01011478|454978222|FG001|Overall Study|No follow up data|7|||
126457853|NCT01437995|454978224|FG000|Overall Study|Lost to Follow-up|11|||
126457854|NCT01437995|454978225|FG001|Overall Study|Lost to Follow-up|18|||
126457855|NCT01437995|454978226|FG002|Overall Study|Lost to Follow-up|20|||
126457856|NCT00978432|454978227|FG000|Overall Study|Withdrawal by Subject|0|||
126457857|NCT00978432|454978228|FG001|Overall Study|Withdrawal by Subject|0|||
126549774|NCT00251927|455307579|FG001|Overall Study|Pregnancy|0|||
126457858|NCT00978432|454978229|FG002|Overall Study|Withdrawal by Subject|1|||
126457859|NCT00978432|454978227|FG000|Overall Study|Lack of Efficacy|1|||
126457860|NCT00978432|454978228|FG001|Overall Study|Lack of Efficacy|1|||
126457861|NCT00978432|454978229|FG002|Overall Study|Lack of Efficacy|3|||
126457862|NCT00978432|454978227|FG000|Overall Study|Adverse Event|2|||
126457863|NCT00978432|454978228|FG001|Overall Study|Adverse Event|0|||
126457864|NCT00978432|454978229|FG002|Overall Study|Adverse Event|1|||
126457865|NCT04456673|454978230|FG000|Overall Study|Adverse Event|7|||
126457866|NCT04456673|454978231|FG001|Overall Study|Adverse Event|14|||
126457867|NCT04456673|454978230|FG000|Overall Study|Poor compliance to protocol|1|||
126457868|NCT04456673|454978231|FG001|Overall Study|Poor compliance to protocol|0|||
126457869|NCT04456673|454978230|FG000|Overall Study|Withdrawal by Subject|31|||
126457870|NCT04456673|454978231|FG001|Overall Study|Withdrawal by Subject|23|||
126457871|NCT04456673|454978230|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
126457872|NCT04456673|454978231|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
126457873|NCT04391049|454978232|FG000|Overall Study|Protocol Violation|1|||
126457874|NCT00246571|454978235|FG000|Overall Study|Adverse Event|7|||
126457875|NCT00246571|454978236|FG001|Overall Study|Adverse Event|0|||
126457876|NCT00246571|454978235|FG000|Overall Study|Protocol Violation|0|||
126457877|NCT00246571|454978236|FG001|Overall Study|Protocol Violation|1|||
126457878|NCT00246571|454978235|FG000|Overall Study|Withdrawal by Subject|2|||
126457879|NCT00246571|454978236|FG001|Overall Study|Withdrawal by Subject|3|||
126457880|NCT00246571|454978235|FG000|Overall Study|Lack of Efficacy|84|||
126457881|NCT00246571|454978236|FG001|Overall Study|Lack of Efficacy|21|||
126457882|NCT00246571|454978235|FG000|Overall Study|Death|17|||
126457883|NCT00246571|454978236|FG001|Overall Study|Death|3|||
126457884|NCT00246571|454978235|FG000|Overall Study|Sponsor|0|||
126457885|NCT00246571|454978236|FG001|Overall Study|Sponsor|1|||
126457886|NCT00246571|454978235|FG000|Overall Study|Did not meet entrance criteria|2|||
126457887|NCT00246571|454978236|FG001|Overall Study|Did not meet entrance criteria|1|||
126457888|NCT00246571|454978235|FG000|Overall Study|Laboratory abnormalities|1|||
126457889|NCT00246571|454978236|FG001|Overall Study|Laboratory abnormalities|0|||
126457890|NCT00246571|454978235|FG000|Overall Study|Crossover participants|0|||
126457891|NCT00246571|454978236|FG001|Overall Study|Crossover participants|74|||
126457892|NCT02160002|454978237|FG000|Overall Study|Withdrawal by Subject|2|||
126457893|NCT02160002|454978238|FG001|Overall Study|Withdrawal by Subject|1|||
126457894|NCT04896229|454978240|FG000|Overall Study|Lost to Follow-up|113|||
126457895|NCT04896229|454978241|FG001|Overall Study|Lost to Follow-up|113|||
126457896|NCT04418661|454978242|FG000|Overall Study|Adverse Event|0|||
126457897|NCT04418661|454978243|FG001|Overall Study|Adverse Event|1|||
126457898|NCT04418661|454978244|FG002|Overall Study|Adverse Event|5|||
126457899|NCT04418661|454978245|FG003|Overall Study|Adverse Event|3|||
126457900|NCT04418661|454978246|FG004|Overall Study|Adverse Event|0|||
126457901|NCT04418661|454978247|FG005|Overall Study|Adverse Event|2|||
126457902|NCT04418661|454978242|FG000|Overall Study|Progressive disease|4|||
126457903|NCT04418661|454978243|FG001|Overall Study|Progressive disease|11|||
126457904|NCT04418661|454978244|FG002|Overall Study|Progressive disease|6|||
126457905|NCT04418661|454978245|FG003|Overall Study|Progressive disease|11|||
126457906|NCT04418661|454978246|FG004|Overall Study|Progressive disease|1|||
126457907|NCT04418661|454978247|FG005|Overall Study|Progressive disease|12|||
126457908|NCT04418661|454978242|FG000|Overall Study|Withdrawal by Subject|0|||
126457909|NCT04418661|454978243|FG001|Overall Study|Withdrawal by Subject|1|||
126457910|NCT04418661|454978244|FG002|Overall Study|Withdrawal by Subject|0|||
126457911|NCT04418661|454978245|FG003|Overall Study|Withdrawal by Subject|1|||
126457912|NCT04418661|454978246|FG004|Overall Study|Withdrawal by Subject|0|||
126457913|NCT04418661|454978247|FG005|Overall Study|Withdrawal by Subject|0|||
126457914|NCT04418661|454978242|FG000|Overall Study|Other|0|||
126457915|NCT04418661|454978243|FG001|Overall Study|Other|0|||
126457916|NCT04418661|454978244|FG002|Overall Study|Other|1|||
126457917|NCT04418661|454978245|FG003|Overall Study|Other|3|||
126457918|NCT04418661|454978246|FG004|Overall Study|Other|0|||
126457919|NCT04418661|454978247|FG005|Overall Study|Other|1|||
126457920|NCT00159822|454978250|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
126457921|NCT00159822|454978250|FG000|Voriconazole Treatment Period|Adverse Event|9|||
126457922|NCT00159822|454978250|FG000|Voriconazole Treatment Period|Death|4|||
126457923|NCT00159822|454978250|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
126710608|NCT00537823|455891664|FG001|Overall Study|Adverse Event|0|||
126710609|NCT03065530|455891665|FG000|Overall Study|Lack of Efficacy|1|||
126457924|NCT00159822|454978250|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
126457925|NCT00159822|454978250|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
126710610|NCT03065530|455891666|FG001|Overall Study|Lack of Efficacy|1|||
126710611|NCT03065530|455891667|FG002|Overall Study|Lack of Efficacy|0|||
126710612|NCT03065530|455891668|FG003|Overall Study|Lack of Efficacy|1|||
126457926|NCT00159822|454978250|FG000|Post-treatment Follow-up Period|Death|1|||
126457927|NCT00159822|454978250|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
126457928|NCT00159822|454978250|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
126457929|NCT00713310|454978251|FG000|Overall Study|Adverse Event|5|||
126457930|NCT00713310|454978252|FG001|Overall Study|Adverse Event|2|||
126457931|NCT00713310|454978251|FG000|Overall Study|Lack of Efficacy|0|||
126457932|NCT00713310|454978252|FG001|Overall Study|Lack of Efficacy|2|||
126457933|NCT00713310|454978251|FG000|Overall Study|Withdrawal by Subject|0|||
126710613|NCT03065530|455891665|FG000|Overall Study|Protocol Violation|1|||
126710614|NCT03065530|455891666|FG001|Overall Study|Protocol Violation|0|||
126710615|NCT03065530|455891667|FG002|Overall Study|Protocol Violation|1|||
126710616|NCT03065530|455891668|FG003|Overall Study|Protocol Violation|1|||
126710617|NCT00852930|455891669|FG000|Overall Study|Withdrawal by Subject|1|||
126710618|NCT00852930|455891670|FG001|Overall Study|Withdrawal by Subject|1|||
126710619|NCT00852930|455891671|FG002|Overall Study|Withdrawal by Subject|1|||
126710620|NCT00852930|455891669|FG000|Overall Study|Physician Decision|0|||
126710621|NCT00852930|455891670|FG001|Overall Study|Physician Decision|0|||
126710622|NCT00852930|455891671|FG002|Overall Study|Physician Decision|1|||
126290200|NCT02906670|454348850|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
126290201|NCT02906670|454348851|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
126290202|NCT02906670|454348852|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
126290203|NCT02906670|454348853|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
126290204|NCT02906670|454348854|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
126290205|NCT02906670|454348855|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
126290206|NCT02906670|454348856|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
126290207|NCT02906670|454348857|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
126290208|NCT02906670|454348848|FG000|Cohort 5P, Q2W|Adverse Event|0|||
126290209|NCT02906670|454348849|FG001|Cohort 5P, Q2W|Adverse Event|0|||
126290210|NCT02906670|454348850|FG002|Cohort 5P, Q2W|Adverse Event|0|||
126290211|NCT02906670|454348851|FG003|Cohort 5P, Q2W|Adverse Event|0|||
126290212|NCT02906670|454348852|FG004|Cohort 5P, Q2W|Adverse Event|0|||
126290213|NCT02906670|454348853|FG005|Cohort 5P, Q2W|Adverse Event|0|||
126290214|NCT02906670|454348854|FG006|Cohort 5P, Q2W|Adverse Event|0|||
126290215|NCT02906670|454348855|FG007|Cohort 5P, Q2W|Adverse Event|1|||
126290216|NCT02906670|454348856|FG008|Cohort 5P, Q2W|Adverse Event|0|||
126290217|NCT02906670|454348857|FG009|Cohort 5P, Q2W|Adverse Event|0|||
126290218|NCT02906670|454348848|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
126290219|NCT02906670|454348849|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
126290220|NCT02906670|454348850|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
126290221|NCT02906670|454348851|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
126290222|NCT02906670|454348852|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
126290223|NCT02906670|454348853|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
126290224|NCT02906670|454348854|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
126290225|NCT02906670|454348855|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
126290226|NCT02906670|454348856|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
126290227|NCT02906670|454348857|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
126290228|NCT02906670|454348848|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
126290229|NCT02906670|454348849|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
126290230|NCT02906670|454348850|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
126290231|NCT02906670|454348851|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
126290232|NCT02906670|454348852|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
126290233|NCT02906670|454348853|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
126290234|NCT02906670|454348854|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
126290235|NCT02906670|454348855|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
126290236|NCT02906670|454348856|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
126290237|NCT02906670|454348857|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
126290238|NCT02906670|454348848|FG000|Cohort 4P, QW|Radiological Progression|0|||
126290239|NCT02906670|454348849|FG001|Cohort 4P, QW|Radiological Progression|0|||
126290240|NCT02906670|454348850|FG002|Cohort 4P, QW|Radiological Progression|0|||
126290241|NCT02906670|454348851|FG003|Cohort 4P, QW|Radiological Progression|3|||
126290242|NCT02906670|454348852|FG004|Cohort 4P, QW|Radiological Progression|0|||
126290243|NCT02906670|454348853|FG005|Cohort 4P, QW|Radiological Progression|0|||
126290244|NCT02906670|454348854|FG006|Cohort 4P, QW|Radiological Progression|0|||
126290245|NCT02906670|454348855|FG007|Cohort 4P, QW|Radiological Progression|0|||
126290246|NCT02906670|454348856|FG008|Cohort 4P, QW|Radiological Progression|0|||
126290247|NCT02906670|454348857|FG009|Cohort 4P, QW|Radiological Progression|0|||
126290248|NCT02906670|454348848|FG000|Cohort 7P, Q2W|Adverse Event|0|||
126290249|NCT02906670|454348849|FG001|Cohort 7P, Q2W|Adverse Event|0|||
126290250|NCT02906670|454348850|FG002|Cohort 7P, Q2W|Adverse Event|0|||
126290251|NCT02906670|454348851|FG003|Cohort 7P, Q2W|Adverse Event|0|||
126457934|NCT00713310|454978252|FG001|Overall Study|Withdrawal by Subject|2|||
126710623|NCT01512368|455891675|FG000|Overall Study|Protocol Violation|3|||
126710624|NCT02717546|455891680|FG000|Overall Study|Lost to Follow-up|12|||
126710625|NCT02460822|455891687|FG000|Overall Study|Withdrawal by Subject|1|||
126290252|NCT02906670|454348852|FG004|Cohort 7P, Q2W|Adverse Event|0|||
126457935|NCT00275821|454978254|FG000|Overall Study|Adverse Event|4|||
126710626|NCT02498821|455891688|FG000|Overall Study|Screen failure|3|||
126457936|NCT00275821|454978255|FG001|Overall Study|Adverse Event|12|||
126457937|NCT00275821|454978256|FG002|Overall Study|Adverse Event|5|||
126710627|NCT02498821|455891689|FG001|Overall Study|Screen failure|5|||
126710628|NCT05258058|455891697|FG000|Overall Study|Withdrawal by Subject|2|||
126290253|NCT02906670|454348853|FG005|Cohort 7P, Q2W|Adverse Event|0|||
126290254|NCT02906670|454348854|FG006|Cohort 7P, Q2W|Adverse Event|0|||
126290255|NCT02906670|454348855|FG007|Cohort 7P, Q2W|Adverse Event|0|||
126290256|NCT02906670|454348856|FG008|Cohort 7P, Q2W|Adverse Event|0|||
126710629|NCT01787591|455891704|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
126290257|NCT02906670|454348857|FG009|Cohort 7P, Q2W|Adverse Event|1|||
126290258|NCT02906670|454348848|FG000|Cohort 7P, Q2W|Physician Decision|0|||
126290259|NCT02906670|454348849|FG001|Cohort 7P, Q2W|Physician Decision|0|||
126290260|NCT02906670|454348850|FG002|Cohort 7P, Q2W|Physician Decision|0|||
126290261|NCT02906670|454348851|FG003|Cohort 7P, Q2W|Physician Decision|0|||
126290262|NCT02906670|454348852|FG004|Cohort 7P, Q2W|Physician Decision|0|||
126290263|NCT02906670|454348853|FG005|Cohort 7P, Q2W|Physician Decision|0|||
126290264|NCT02906670|454348854|FG006|Cohort 7P, Q2W|Physician Decision|0|||
126290265|NCT02906670|454348855|FG007|Cohort 7P, Q2W|Physician Decision|0|||
126290266|NCT02906670|454348856|FG008|Cohort 7P, Q2W|Physician Decision|0|||
126290267|NCT02906670|454348857|FG009|Cohort 7P, Q2W|Physician Decision|1|||
126290268|NCT02906670|454348848|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290269|NCT02906670|454348849|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290270|NCT02906670|454348850|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290271|NCT02906670|454348851|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290272|NCT02906670|454348852|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290273|NCT02906670|454348853|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290274|NCT02906670|454348854|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290275|NCT02906670|454348855|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290276|NCT02906670|454348856|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
126290277|NCT02906670|454348857|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
126290278|NCT02906670|454348848|FG000|Cohort 5P, QW|Radiological Progression|0|||
126290279|NCT02906670|454348849|FG001|Cohort 5P, QW|Radiological Progression|0|||
126290280|NCT02906670|454348850|FG002|Cohort 5P, QW|Radiological Progression|0|||
126290281|NCT02906670|454348851|FG003|Cohort 5P, QW|Radiological Progression|0|||
126290282|NCT02906670|454348852|FG004|Cohort 5P, QW|Radiological Progression|3|||
126290283|NCT02906670|454348853|FG005|Cohort 5P, QW|Radiological Progression|0|||
126290284|NCT02906670|454348854|FG006|Cohort 5P, QW|Radiological Progression|0|||
126290285|NCT02906670|454348855|FG007|Cohort 5P, QW|Radiological Progression|0|||
126290286|NCT02906670|454348856|FG008|Cohort 5P, QW|Radiological Progression|0|||
126457938|NCT00275821|454978254|FG000|Overall Study|Administrative problems|3|||
126457939|NCT00275821|454978255|FG001|Overall Study|Administrative problems|4|||
126290287|NCT02906670|454348857|FG009|Cohort 5P, QW|Radiological Progression|0|||
126290288|NCT01349192|454348858|FG000|Overall Study|Protocol Violation|0|||
126290289|NCT01349192|454348859|FG001|Overall Study|Protocol Violation|1|||
126290290|NCT01349192|454348858|FG000|Overall Study|Withdrawal by Subject|0|||
126290291|NCT01349192|454348859|FG001|Overall Study|Withdrawal by Subject|2|||
126290292|NCT01349192|454348858|FG000|Overall Study|Lost to Follow-up|1|||
126290293|NCT01349192|454348859|FG001|Overall Study|Lost to Follow-up|3|||
126290294|NCT01349192|454348858|FG000|Overall Study|Failure to adhere to Protocol|2|||
126290295|NCT01349192|454348859|FG001|Overall Study|Failure to adhere to Protocol|0|||
126290296|NCT03749330|454348860|FG000|Overall Study|Clinicians left work in the CICU|0|||
126290297|NCT03749330|454348861|FG001|Overall Study|Clinicians left work in the CICU|2|||
126290298|NCT03749330|454348862|FG002|Overall Study|Clinicians left work in the CICU|0|||
126290299|NCT03749330|454348863|FG003|Overall Study|Clinicians left work in the CICU|0|||
126290300|NCT03749330|454348864|FG004|Overall Study|Clinicians left work in the CICU|0|||
126290301|NCT03749330|454348865|FG005|Overall Study|Clinicians left work in the CICU|0|||
126457940|NCT00275821|454978256|FG002|Overall Study|Administrative problems|4|||
126457941|NCT00275821|454978254|FG000|Overall Study|Withdrawal by Subject|0|||
126457942|NCT00275821|454978255|FG001|Overall Study|Withdrawal by Subject|2|||
126457943|NCT00275821|454978256|FG002|Overall Study|Withdrawal by Subject|1|||
126457944|NCT00275821|454978254|FG000|Overall Study|Lost to Follow-up|0|||
126457945|NCT00275821|454978255|FG001|Overall Study|Lost to Follow-up|1|||
126457946|NCT00275821|454978256|FG002|Overall Study|Lost to Follow-up|1|||
126457947|NCT00275821|454978254|FG000|Overall Study|Death|0|||
126457948|NCT00275821|454978255|FG001|Overall Study|Death|2|||
126457949|NCT00275821|454978256|FG002|Overall Study|Death|1|||
126457950|NCT00275821|454978254|FG000|Overall Study|Lack of Efficacy|2|||
126457951|NCT00275821|454978255|FG001|Overall Study|Lack of Efficacy|1|||
126457952|NCT00275821|454978256|FG002|Overall Study|Lack of Efficacy|0|||
126457953|NCT00275821|454978254|FG000|Overall Study|Protocol Violation|5|||
126457954|NCT00275821|454978255|FG001|Overall Study|Protocol Violation|1|||
126290302|NCT03908125|454348871|FG000|Overall Study|Withdrawal by Subject|92|||
126290303|NCT03908125|454348871|FG000|Overall Study|Lost to Follow-up|8|||
126290304|NCT02262325|454348872|FG000|Overall Study|Death|16|||
126290305|NCT02262325|454348872|FG000|Overall Study|Lost to Follow-up|1|||
126549775|NCT00251927|455307578|FG000|Overall Study|Withdrawal by Subject|40|||
126290306|NCT01071915|454348873|FG000|Overall Study|Adverse Event|3|||
126290307|NCT01071915|454348873|FG000|Overall Study|Physician Decision|2|||
126290308|NCT01071915|454348873|FG000|Overall Study|Withdrawal by Subject|2|||
126290309|NCT01071915|454348873|FG000|Overall Study|Miscellaneous Reasons|2|||
126290310|NCT00114140|454348874|FG000|Overall Study|Protocol Violation|7|||
126290311|NCT04011722|454350529|FG000|30 Days|Death|5|||
126457955|NCT00275821|454978256|FG002|Overall Study|Protocol Violation|0|||
126457956|NCT00329901|454978257|FG000|Overall Study|Withdrawal by Subject|4|||
126290312|NCT04011722|454350530|FG001|30 Days|Death|1|||
126290313|NCT04011722|454350529|FG000|1 Year|Death|13|||
126290314|NCT04011722|454350530|FG001|1 Year|Death|5|||
126290315|NCT04011722|454350529|FG000|1 Year|Withdrawal by Subject|8|||
126290316|NCT04011722|454350530|FG001|1 Year|Withdrawal by Subject|2|||
126290317|NCT04011722|454350529|FG000|1 Year|Missed Visit|6|||
126290318|NCT04011722|454350530|FG001|1 Year|Missed Visit|1|||
126290319|NCT04011722|454350529|FG000|1 Year|Pending Visit|0|||
126290320|NCT04011722|454350530|FG001|1 Year|Pending Visit|11|||
126290321|NCT04011722|454350529|FG000|1 Year|Not Yet Due|0|||
126290322|NCT04011722|454350530|FG001|1 Year|Not Yet Due|9|||
126290323|NCT04011722|454350529|FG000|2 Year|Death|16|||
126290324|NCT04011722|454350530|FG001|2 Year|Death|1|||
126290325|NCT04011722|454350529|FG000|2 Year|Withdrawal by Subject|10|||
126290326|NCT04011722|454350530|FG001|2 Year|Withdrawal by Subject|1|||
126290327|NCT04011722|454350529|FG000|2 Year|Missed Visit|9|||
126290328|NCT04011722|454350530|FG001|2 Year|Missed Visit|0|||
126290329|NCT04011722|454350529|FG000|2 Year|Visit Pending|1|||
126290330|NCT04011722|454350530|FG001|2 Year|Visit Pending|3|||
126290331|NCT04011722|454350529|FG000|2 Year|Not Yet Due|43|||
126290332|NCT04011722|454350530|FG001|2 Year|Not Yet Due|54|||
126290333|NCT04011722|454350529|FG000|3 Year|Death|10|||
126290334|NCT04011722|454350530|FG001|3 Year|Death|0|||
126290335|NCT04011722|454350529|FG000|3 Year|Withdrawal by Subject|2|||
126290336|NCT04011722|454350530|FG001|3 Year|Withdrawal by Subject|0|||
126290337|NCT04011722|454350529|FG000|3 Year|Missed Visit|2|||
126290338|NCT04011722|454350530|FG001|3 Year|Missed Visit|0|||
126290339|NCT04011722|454350529|FG000|3 Year|Pending Visit|34|||
126290340|NCT04011722|454350530|FG001|3 Year|Pending Visit|0|||
126290341|NCT04011722|454350529|FG000|3 Year|Not Yet Due|99|||
126290342|NCT04011722|454350530|FG001|3 Year|Not Yet Due|0|||
126290343|NCT05061134|454350531|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
126290344|NCT05061134|454350532|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
126290345|NCT05061134|454350533|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
126290346|NCT05061134|454350531|FG000|Overall Study|Subject not treated|0|||
126290347|NCT05061134|454350532|FG001|Overall Study|Subject not treated|0|||
126290348|NCT05061134|454350533|FG002|Overall Study|Subject not treated|2|||
126290349|NCT05061134|454350531|FG000|Overall Study|Other|0|||
126290350|NCT05061134|454350532|FG001|Overall Study|Other|0|||
126290351|NCT05061134|454350533|FG002|Overall Study|Other|9|||
126290352|NCT05061134|454350531|FG000|Overall Study|Withdrawal by Subject|9|||
126290353|NCT05061134|454350532|FG001|Overall Study|Withdrawal by Subject|8|||
126290354|NCT05061134|454350533|FG002|Overall Study|Withdrawal by Subject|5|||
126290355|NCT05061134|454350531|FG000|Overall Study|Study Terminated by Sponsor|22|||
126290356|NCT05061134|454350532|FG001|Overall Study|Study Terminated by Sponsor|14|||
126290357|NCT05061134|454350533|FG002|Overall Study|Study Terminated by Sponsor|7|||
126290358|NCT05061134|454350531|FG000|Overall Study|Progressive Disease|1|||
126290359|NCT05061134|454350532|FG001|Overall Study|Progressive Disease|2|||
126290360|NCT05061134|454350533|FG002|Overall Study|Progressive Disease|0|||
126290361|NCT05061134|454350531|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
126290362|NCT05061134|454350532|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
126290363|NCT05061134|454350533|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
126290364|NCT05061134|454350531|FG000|Overall Study|Lost to Follow-up|1|||
126290365|NCT05061134|454350532|FG001|Overall Study|Lost to Follow-up|0|||
126290366|NCT05061134|454350533|FG002|Overall Study|Lost to Follow-up|0|||
126290367|NCT05061134|454350531|FG000|Overall Study|Physician Decision|1|||
126290368|NCT05061134|454350532|FG001|Overall Study|Physician Decision|1|||
126290369|NCT05061134|454350533|FG002|Overall Study|Physician Decision|0|||
126290370|NCT05061134|454350531|FG000|Overall Study|Disease progression|1|||
126290371|NCT05061134|454350532|FG001|Overall Study|Disease progression|0|||
126290372|NCT05061134|454350533|FG002|Overall Study|Disease progression|0|||
126290373|NCT05061134|454350531|FG000|Overall Study|Death|43|||
126290374|NCT05061134|454350532|FG001|Overall Study|Death|23|||
126290375|NCT05061134|454350533|FG002|Overall Study|Death|14|||
126290376|NCT05061134|454350531|FG000|Overall Study|Database lock|2|||
126290377|NCT05061134|454350532|FG001|Overall Study|Database lock|0|||
126290378|NCT05061134|454350533|FG002|Overall Study|Database lock|0|||
126290379|NCT04848480|454350539|FG000|Main Phase (26 Weeks)|Death|1|||
126290380|NCT04848480|454350540|FG001|Main Phase (26 Weeks)|Death|0|||
126290381|NCT04848480|454350539|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
126290382|NCT04848480|454350540|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
126290383|NCT04848480|454350539|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
126290384|NCT04848480|454350540|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
126290385|NCT04848480|454350539|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
126290386|NCT04848480|454350540|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
126290387|NCT04848480|454350539|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
126290388|NCT04848480|454350540|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
126290389|NCT04848480|454350539|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
126290390|NCT04848480|454350540|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
126290391|NCT01368497|454350541|FG000|Overall Study|Lost to Follow-up|2|||
126290392|NCT02366689|454350543|FG000|Overall Study|Withdrawal by Subject|1|||
126710630|NCT01787591|455891705|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
126710631|NCT01787591|455891706|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
126710632|NCT01787591|455891707|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
126710633|NCT02725177|455891713|FG000|Overall Study|Physician Decision|4|||
126710634|NCT02725177|455891713|FG000|Overall Study|Adverse Event|1|||
126710635|NCT00793585|455891714|FG000|Overall Study|Adverse Event|1|||
126710636|NCT00793585|455891715|FG001|Overall Study|Adverse Event|1|||
126710637|NCT00793585|455891714|FG000|Overall Study|Protocol Violation|1|||
126710638|NCT00793585|455891715|FG001|Overall Study|Protocol Violation|2|||
126710639|NCT00377299|455891716|FG000|Overall Study|Lost to Follow-up|14|||
126710640|NCT00377299|455891717|FG001|Overall Study|Lost to Follow-up|19|||
126710641|NCT00377299|455891716|FG000|Overall Study|Adverse Event|0|||
126710642|NCT00377299|455891717|FG001|Overall Study|Adverse Event|1|||
126710643|NCT00377299|455891716|FG000|Overall Study|Withdrawal by Subject|5|||
126710644|NCT00377299|455891717|FG001|Overall Study|Withdrawal by Subject|4|||
126290393|NCT02366689|454350544|FG001|Overall Study|Withdrawal by Subject|0|||
126290394|NCT02366689|454350545|FG002|Overall Study|Withdrawal by Subject|1|||
126290395|NCT02366689|454350543|FG000|Overall Study|Lost to Follow-up|3|||
126290396|NCT02366689|454350544|FG001|Overall Study|Lost to Follow-up|2|||
126290397|NCT02366689|454350545|FG002|Overall Study|Lost to Follow-up|0|||
126290398|NCT02366689|454350543|FG000|Overall Study|Pregnancy|0|||
126290399|NCT02366689|454350544|FG001|Overall Study|Pregnancy|1|||
126290400|NCT02366689|454350545|FG002|Overall Study|Pregnancy|1|||
126290401|NCT03283566|454350546|FG000|Overall Study|Lost to Follow-up|1|||
126290402|NCT03283566|454350547|FG001|Overall Study|Lost to Follow-up|2|||
126290403|NCT04882241|454350550|FG000|Overall Study|Ongoing in study|46|||
126290404|NCT04882241|454350551|FG001|Overall Study|Ongoing in study|48|||
126290405|NCT04882241|454350552|FG002|Overall Study|Ongoing in study|0|||
126290406|NCT04882241|454350553|FG003|Overall Study|Ongoing in study|0|||
126290407|NCT04882241|454350550|FG000|Overall Study|Death|13|||
126290408|NCT04882241|454350551|FG001|Overall Study|Death|13|||
126290409|NCT04882241|454350552|FG002|Overall Study|Death|0|||
126290410|NCT04882241|454350553|FG003|Overall Study|Death|0|||
126290411|NCT00470535|454350562|FG000|Overall Study|Disease Progression|13|||
126290412|NCT00470535|454350562|FG000|Overall Study|Withdrawal by Subject|1|||
126290413|NCT00470535|454350562|FG000|Overall Study|Adverse Event|1|||
126290414|NCT00470535|454350562|FG000|Overall Study|Death|1|||
126290415|NCT00470535|454350562|FG000|Overall Study|Other|2|||
126290416|NCT02070965|454350567|FG000|Overall Study|Lost to Follow-up|0|||
126290417|NCT02070965|454350568|FG001|Overall Study|Lost to Follow-up|1|||
126290418|NCT02070965|454350569|FG002|Overall Study|Lost to Follow-up|0|||
126290419|NCT02070965|454350567|FG000|Overall Study|Withdrawal by Subject|1|||
126290420|NCT02070965|454350568|FG001|Overall Study|Withdrawal by Subject|1|||
126290421|NCT02070965|454350569|FG002|Overall Study|Withdrawal by Subject|1|||
126290422|NCT02070965|454350567|FG000|Overall Study|Subject moved|1|||
126290423|NCT02070965|454350568|FG001|Overall Study|Subject moved|0|||
126290424|NCT02070965|454350569|FG002|Overall Study|Subject moved|0|||
126290425|NCT02515331|454350570|FG000|Overall Study|Withdrawal by Subject|0|||
126290426|NCT02515331|454350571|FG001|Overall Study|Withdrawal by Subject|0|||
126290427|NCT02515331|454350572|FG002|Overall Study|Withdrawal by Subject|1|||
126290428|NCT02515331|454350570|FG000|Overall Study|Protocol deviation|0|||
126290429|NCT02515331|454350571|FG001|Overall Study|Protocol deviation|0|||
126290430|NCT02515331|454350572|FG002|Overall Study|Protocol deviation|3|||
126290431|NCT02515331|454350570|FG000|Overall Study|Adverse Event|2|||
126290432|NCT02515331|454350571|FG001|Overall Study|Adverse Event|0|||
126290433|NCT02515331|454350572|FG002|Overall Study|Adverse Event|0|||
126290434|NCT00124748|454350573|FG000|Overall Study|Adverse Event|8|||
126290435|NCT00124748|454350574|FG001|Overall Study|Adverse Event|39|||
126710645|NCT00035815|455891719|FG000|Overall Study|Withdrawal by Subject|17|||
126710646|NCT00035815|455891720|FG001|Overall Study|Withdrawal by Subject|11|||
126710647|NCT03666143|455893503|FG000|Overall Study|Death|158|||
126710648|NCT03666143|455893503|FG000|Overall Study|Sponsor Decision|31|||
126710649|NCT03666143|455893503|FG000|Overall Study|Withdrawal by Subject|11|||
126290436|NCT00124748|454350573|FG000|Overall Study|Abnormal laboratory Value|2|||
126549776|NCT00251927|455307579|FG001|Overall Study|Withdrawal by Subject|25|||
126549777|NCT00251927|455307578|FG000|Overall Study|Study-specific discont. achieved|13|||
126290437|NCT00124748|454350574|FG001|Overall Study|Abnormal laboratory Value|2|||
126710650|NCT03666143|455893503|FG000|Overall Study|Lost to Follow-up|5|||
126710651|NCT03666143|455893503|FG000|Overall Study|Physician Decision|1|||
126290438|NCT00124748|454350573|FG000|Overall Study|Abnormal Procedure|0|||
126290439|NCT00124748|454350574|FG001|Overall Study|Abnormal Procedure|1|||
126290440|NCT00124748|454350573|FG000|Overall Study|Lack of Efficacy|20|||
126290441|NCT00124748|454350574|FG001|Overall Study|Lack of Efficacy|41|||
126290442|NCT00124748|454350573|FG000|Overall Study|No longer requires study drug|1|||
126290443|NCT00124748|454350574|FG001|Overall Study|No longer requires study drug|1|||
126290444|NCT00124748|454350573|FG000|Overall Study|Protocol Violation|3|||
126290445|NCT00124748|454350574|FG001|Overall Study|Protocol Violation|1|||
126290446|NCT00124748|454350573|FG000|Overall Study|Withdrawal by Subject|5|||
126290447|NCT00124748|454350574|FG001|Overall Study|Withdrawal by Subject|15|||
126710652|NCT03666143|455893503|FG000|Overall Study|Rolled into extension study|9|||
126710653|NCT03666143|455893503|FG000|Overall Study|Progressive Disease|1|||
126710654|NCT00283712|455893504|FG000|Overall Study|Death|0|||
126290448|NCT00124748|454350573|FG000|Overall Study|Lost to Follow-up|2|||
126290449|NCT00124748|454350574|FG001|Overall Study|Lost to Follow-up|7|||
126290450|NCT00124748|454350573|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
126290451|NCT00124748|454350574|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
126290452|NCT00124748|454350573|FG000|Overall Study|Death|1|||
126290453|NCT00124748|454350574|FG001|Overall Study|Death|3|||
126290454|NCT00322712|454350575|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
126290455|NCT03889886|454350576|FG000|Overall Study|Other|0|||
126290456|NCT03889886|454350577|FG001|Overall Study|Other|1|||
126290457|NCT03889886|454350578|FG002|Overall Study|Other|0|||
126290458|NCT03889886|454350579|FG003|Overall Study|Other|1|||
126290459|NCT03889886|454350576|FG000|Overall Study|Withdrawal by Subject|0|||
126290460|NCT03889886|454350577|FG001|Overall Study|Withdrawal by Subject|0|||
126290461|NCT03889886|454350578|FG002|Overall Study|Withdrawal by Subject|1|||
126290462|NCT03889886|454350579|FG003|Overall Study|Withdrawal by Subject|0|||
126290463|NCT03889886|454350576|FG000|Overall Study|Adverse Event|0|||
126290464|NCT03889886|454350577|FG001|Overall Study|Adverse Event|0|||
126290465|NCT03889886|454350578|FG002|Overall Study|Adverse Event|0|||
126290466|NCT03889886|454350579|FG003|Overall Study|Adverse Event|6|||
126290467|NCT04176250|454350580|FG000|Overall Study|Adverse Event|0|||
126290468|NCT04176250|454350581|FG001|Overall Study|Adverse Event|1|||
126290469|NCT04176250|454350582|FG002|Overall Study|Adverse Event|0|||
126290470|NCT04176250|454350583|FG003|Overall Study|Adverse Event|1|||
126290471|NCT04176250|454350584|FG004|Overall Study|Adverse Event|0|||
126290472|NCT04176250|454350585|FG005|Overall Study|Adverse Event|1|||
126290473|NCT04176250|454350580|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
126290474|NCT04176250|454350581|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
126290475|NCT04176250|454350582|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
126290476|NCT04176250|454350583|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
126290477|NCT04176250|454350584|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
126290478|NCT04176250|454350585|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
126290479|NCT04176250|454350580|FG000|Overall Study|Withdrawal by Subject|0|||
126290480|NCT04176250|454350581|FG001|Overall Study|Withdrawal by Subject|0|||
126290481|NCT04176250|454350582|FG002|Overall Study|Withdrawal by Subject|0|||
126290482|NCT04176250|454350583|FG003|Overall Study|Withdrawal by Subject|0|||
126290483|NCT04176250|454350584|FG004|Overall Study|Withdrawal by Subject|0|||
126290484|NCT04176250|454350585|FG005|Overall Study|Withdrawal by Subject|1|||
126290485|NCT04176250|454350580|FG000|Overall Study|Randomized in error|0|||
126290486|NCT04176250|454350581|FG001|Overall Study|Randomized in error|0|||
126290487|NCT04176250|454350582|FG002|Overall Study|Randomized in error|0|||
126290488|NCT04176250|454350583|FG003|Overall Study|Randomized in error|0|||
126290489|NCT04176250|454350584|FG004|Overall Study|Randomized in error|1|||
126290490|NCT04176250|454350585|FG005|Overall Study|Randomized in error|0|||
126290491|NCT04747470|454350597|FG000|Overall Study|Death|0|||
126290492|NCT04747470|454350598|FG001|Overall Study|Death|3|||
126290493|NCT04747470|454350599|FG002|Overall Study|Death|2|||
126290494|NCT04747470|454350600|FG003|Overall Study|Death|2|||
126290495|NCT04747470|454350601|FG004|Overall Study|Death|2|||
126290496|NCT04747470|454350602|FG005|Overall Study|Death|0|||
126290497|NCT04747470|454350603|FG006|Overall Study|Death|0|||
126290498|NCT04747470|454350604|FG007|Overall Study|Death|0|||
126290499|NCT04747470|454350605|FG008|Overall Study|Death|0|||
126290500|NCT04747470|454350606|FG009|Overall Study|Death|0|||
126290501|NCT04747470|454350607|FG010|Overall Study|Death|0|||
126290502|NCT04747470|454350597|FG000|Overall Study|Withdrew Consent|0|||
126290503|NCT04747470|454350598|FG001|Overall Study|Withdrew Consent|0|||
126290504|NCT04747470|454350599|FG002|Overall Study|Withdrew Consent|0|||
126290505|NCT04747470|454350600|FG003|Overall Study|Withdrew Consent|1|||
126710655|NCT00283712|455893505|FG001|Overall Study|Death|1|||
126710656|NCT04329923|455893506|FG000|Overall Study|Withdrawal by Subject|1|||
126710657|NCT04329923|455893507|FG001|Overall Study|Withdrawal by Subject|4|||
126710658|NCT04329923|455893508|FG002|Overall Study|Withdrawal by Subject|1|||
126710659|NCT04329923|455893509|FG003|Overall Study|Withdrawal by Subject|1|||
126710660|NCT04329923|455893510|FG004|Overall Study|Withdrawal by Subject|1|||
126290506|NCT04747470|454350601|FG004|Overall Study|Withdrew Consent|0|||
126290507|NCT04747470|454350602|FG005|Overall Study|Withdrew Consent|0|||
126290508|NCT04747470|454350603|FG006|Overall Study|Withdrew Consent|0|||
126710661|NCT04329923|455893511|FG005|Overall Study|Withdrawal by Subject|1|||
126710662|NCT04329923|455893506|FG000|Overall Study|early termination of study|0|||
126767022|NCT00539006|456100208|FG002|Treatment Period 1|Lost to Follow-up|1|||
126290509|NCT04747470|454350604|FG007|Overall Study|Withdrew Consent|0|||
126290510|NCT04747470|454350605|FG008|Overall Study|Withdrew Consent|0|||
126290511|NCT04747470|454350606|FG009|Overall Study|Withdrew Consent|0|||
126290512|NCT04747470|454350607|FG010|Overall Study|Withdrew Consent|0|||
126290513|NCT04747470|454350597|FG000|Overall Study|Study Terminated by Sponsor|0|||
126290514|NCT04747470|454350598|FG001|Overall Study|Study Terminated by Sponsor|0|||
126290515|NCT04747470|454350599|FG002|Overall Study|Study Terminated by Sponsor|1|||
126290516|NCT04747470|454350600|FG003|Overall Study|Study Terminated by Sponsor|0|||
126290517|NCT04747470|454350601|FG004|Overall Study|Study Terminated by Sponsor|2|||
126290518|NCT04747470|454350602|FG005|Overall Study|Study Terminated by Sponsor|0|||
126290519|NCT04747470|454350603|FG006|Overall Study|Study Terminated by Sponsor|0|||
126290520|NCT04747470|454350604|FG007|Overall Study|Study Terminated by Sponsor|0|||
126290521|NCT04747470|454350605|FG008|Overall Study|Study Terminated by Sponsor|0|||
126290522|NCT04747470|454350606|FG009|Overall Study|Study Terminated by Sponsor|0|||
126290523|NCT04747470|454350607|FG010|Overall Study|Study Terminated by Sponsor|0|||
126290524|NCT01269918|454350610|FG000|Overall Study|Did not receive study drug|0|||
126290525|NCT01269918|454350611|FG001|Overall Study|Did not receive study drug|3|||
126290526|NCT00769379|454350612|FG000|Overall Study|No follow up data mapped to Other.|3|||
126290527|NCT00769379|454350613|FG001|Overall Study|No follow up data mapped to Other.|13|||
126290528|NCT01928472|454350614|FG000|Overall Study|Death|0|||
126290529|NCT01928472|454350615|FG001|Overall Study|Death|0|||
126290530|NCT01928472|454350616|FG002|Overall Study|Death|1|||
126290531|NCT01928472|454350617|FG003|Overall Study|Death|0|||
126290532|NCT01928472|454350614|FG000|Overall Study|Withdrawal by Subject|4|||
126290533|NCT01928472|454350615|FG001|Overall Study|Withdrawal by Subject|4|||
126290534|NCT01928472|454350616|FG002|Overall Study|Withdrawal by Subject|1|||
126290535|NCT01928472|454350617|FG003|Overall Study|Withdrawal by Subject|2|||
126290536|NCT01928472|454350614|FG000|Overall Study|Lost to Follow-up|2|||
126290537|NCT01928472|454350615|FG001|Overall Study|Lost to Follow-up|3|||
126290538|NCT01928472|454350616|FG002|Overall Study|Lost to Follow-up|4|||
126290539|NCT01928472|454350617|FG003|Overall Study|Lost to Follow-up|0|||
126290540|NCT01928472|454350614|FG000|Overall Study|Administrative Reason|2|||
126290541|NCT01928472|454350615|FG001|Overall Study|Administrative Reason|1|||
126290542|NCT01928472|454350616|FG002|Overall Study|Administrative Reason|0|||
126290543|NCT01928472|454350617|FG003|Overall Study|Administrative Reason|0|||
126290544|NCT01928472|454350614|FG000|Overall Study|Unclassified|0|||
126290545|NCT01928472|454350615|FG001|Overall Study|Unclassified|0|||
126290546|NCT01928472|454350616|FG002|Overall Study|Unclassified|1|||
126290547|NCT01928472|454350617|FG003|Overall Study|Unclassified|0|||
126290548|NCT01308424|454350618|FG000|Baseline Eligibility|Screen Failures|71|||
126290549|NCT01308424|454350619|FG001|Baseline Eligibility|Screen Failures|0|||
126290550|NCT01308424|454350620|FG002|Baseline Eligibility|Screen Failures|0|||
126290551|NCT01308424|454350618|FG000|Randomization|Adverse Event|0|||
126710663|NCT04329923|455893507|FG001|Overall Study|early termination of study|0|||
126710664|NCT04329923|455893508|FG002|Overall Study|early termination of study|0|||
126710665|NCT04329923|455893509|FG003|Overall Study|early termination of study|0|||
126290552|NCT01308424|454350619|FG001|Randomization|Adverse Event|1|||
126290553|NCT01308424|454350620|FG002|Randomization|Adverse Event|1|||
126290554|NCT01308424|454350618|FG000|Randomization|Lost to Follow-up|0|||
126290555|NCT01308424|454350619|FG001|Randomization|Lost to Follow-up|1|||
126290556|NCT01308424|454350620|FG002|Randomization|Lost to Follow-up|0|||
126457957|NCT00329901|454978258|FG001|Overall Study|Withdrawal by Subject|3|||
126457958|NCT00329901|454978259|FG002|Overall Study|Withdrawal by Subject|2|||
126457959|NCT00329901|454978257|FG000|Overall Study|Lost to Follow-up|2|||
126457960|NCT00329901|454978258|FG001|Overall Study|Lost to Follow-up|0|||
126457961|NCT00329901|454978259|FG002|Overall Study|Lost to Follow-up|1|||
126457962|NCT00329901|454978257|FG000|Overall Study|Protocol Violation|1|||
126290557|NCT01308424|454350618|FG000|Randomization|Physician Decision|0|||
126290558|NCT01308424|454350619|FG001|Randomization|Physician Decision|1|||
126290559|NCT01308424|454350620|FG002|Randomization|Physician Decision|1|||
126290560|NCT04471428|454350624|FG000|Overall Study|Withdrawal by Subject|29|||
126290561|NCT04471428|454350625|FG001|Overall Study|Withdrawal by Subject|1|||
126290562|NCT04471428|454350624|FG000|Overall Study|Physician Decision|0|||
126290563|NCT04471428|454350625|FG001|Overall Study|Physician Decision|1|||
126290564|NCT04471428|454350624|FG000|Overall Study|Reason Not Specified|0|||
126290565|NCT04471428|454350625|FG001|Overall Study|Reason Not Specified|2|||
126290566|NCT04471428|454350624|FG000|Overall Study|Death|106|||
126457963|NCT00329901|454978258|FG001|Overall Study|Protocol Violation|0|||
126457964|NCT00329901|454978259|FG002|Overall Study|Protocol Violation|1|||
126710666|NCT04329923|455893510|FG004|Overall Study|early termination of study|1|||
126290567|NCT04471428|454350625|FG001|Overall Study|Death|114|||
126290568|NCT04471428|454350624|FG000|Overall Study|Ongoing in the study|45|||
126290569|NCT04471428|454350625|FG001|Overall Study|Ongoing in the study|68|||
126290570|NCT00129545|454350628|FG000|Overall Study|Death|5|||
126290571|NCT00129545|454350629|FG001|Overall Study|Death|60|||
126290572|NCT00129545|454350630|FG002|Overall Study|Death|44|||
126290573|NCT00129545|454350628|FG000|Overall Study|Withdrawal by Subject|3|||
126290574|NCT00129545|454350629|FG001|Overall Study|Withdrawal by Subject|18|||
126290575|NCT00129545|454350630|FG002|Overall Study|Withdrawal by Subject|44|||
126710667|NCT04329923|455893511|FG005|Overall Study|early termination of study|2|||
126549778|NCT00251927|455307579|FG001|Overall Study|Study-specific discont. achieved|2|||
126710668|NCT04329923|455893506|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
126710669|NCT04329923|455893507|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
126290576|NCT00129545|454350628|FG000|Overall Study|Lost to Follow-up|2|||
126290577|NCT00129545|454350629|FG001|Overall Study|Lost to Follow-up|22|||
126290578|NCT00129545|454350630|FG002|Overall Study|Lost to Follow-up|13|||
126290579|NCT00129545|454350628|FG000|Overall Study|Physician Decision|0|||
126290580|NCT00129545|454350629|FG001|Overall Study|Physician Decision|3|||
126290581|NCT00129545|454350630|FG002|Overall Study|Physician Decision|10|||
126290582|NCT00129545|454350628|FG000|Overall Study|Device not implanted|16|||
126290583|NCT00129545|454350629|FG001|Overall Study|Device not implanted|61|||
126290584|NCT00129545|454350630|FG002|Overall Study|Device not implanted|0|||
126290585|NCT01841593|454350631|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
126290586|NCT01841593|454350632|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
126290587|NCT01841593|454350631|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
126290588|NCT01841593|454350632|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
126290589|NCT00307086|454350635|FG000|Overall Study|ineligible|5|||
126290590|NCT02969044|454350636|FG000|Overall Study|Withdrawal by Subject|2|||
126290591|NCT02969044|454350637|FG001|Overall Study|Withdrawal by Subject|6|||
126290592|NCT02969044|454350636|FG000|Overall Study|Adverse Event|3|||
126290593|NCT02969044|454350637|FG001|Overall Study|Adverse Event|0|||
126290594|NCT00312338|454350641|FG000|Overall Study|Adverse Event|7|||
126290595|NCT00312338|454350642|FG001|Overall Study|Adverse Event|2|||
126290596|NCT00312338|454350641|FG000|Overall Study|Lost to Follow-up|9|||
126290597|NCT00312338|454350642|FG001|Overall Study|Lost to Follow-up|1|||
126290598|NCT00312338|454350641|FG000|Overall Study|Withdrawal by Subject|4|||
126290599|NCT00312338|454350642|FG001|Overall Study|Withdrawal by Subject|0|||
126290600|NCT00312338|454350641|FG000|Overall Study|Subsequent infection|2|||
126290601|NCT00312338|454350642|FG001|Overall Study|Subsequent infection|0|||
126290602|NCT00262028|454350643|FG000|Overall Study|Withdrawal by Subject|6|||
126290603|NCT00262028|454350644|FG001|Overall Study|Withdrawal by Subject|3|||
126290604|NCT00262028|454350645|FG002|Overall Study|Withdrawal by Subject|6|||
126290605|NCT00262028|454350646|FG003|Overall Study|Withdrawal by Subject|5|||
126290606|NCT00262028|454350647|FG004|Overall Study|Withdrawal by Subject|2|||
126290607|NCT00262028|454350648|FG005|Overall Study|Withdrawal by Subject|3|||
126290608|NCT00262028|454350649|FG006|Overall Study|Withdrawal by Subject|5|||
126290609|NCT00262028|454350650|FG007|Overall Study|Withdrawal by Subject|7|||
126290610|NCT00262028|454350651|FG008|Overall Study|Withdrawal by Subject|2|||
126290611|NCT00262028|454350643|FG000|Overall Study|Lost to Follow-up|7|||
126290612|NCT00262028|454350644|FG001|Overall Study|Lost to Follow-up|7|||
126290613|NCT00262028|454350645|FG002|Overall Study|Lost to Follow-up|5|||
126290614|NCT00262028|454350646|FG003|Overall Study|Lost to Follow-up|5|||
126290615|NCT00262028|454350647|FG004|Overall Study|Lost to Follow-up|4|||
126290616|NCT00262028|454350648|FG005|Overall Study|Lost to Follow-up|3|||
126290617|NCT00262028|454350649|FG006|Overall Study|Lost to Follow-up|3|||
126290618|NCT00262028|454350650|FG007|Overall Study|Lost to Follow-up|5|||
126290619|NCT00262028|454350651|FG008|Overall Study|Lost to Follow-up|6|||
126290620|NCT00262028|454350643|FG000|Overall Study|Administrative Reason|11|||
126290621|NCT00262028|454350644|FG001|Overall Study|Administrative Reason|14|||
126290622|NCT00262028|454350645|FG002|Overall Study|Administrative Reason|9|||
126290623|NCT00262028|454350646|FG003|Overall Study|Administrative Reason|12|||
126290624|NCT00262028|454350647|FG004|Overall Study|Administrative Reason|6|||
126290625|NCT00262028|454350648|FG005|Overall Study|Administrative Reason|7|||
126290626|NCT00262028|454350649|FG006|Overall Study|Administrative Reason|4|||
126290627|NCT00262028|454350650|FG007|Overall Study|Administrative Reason|6|||
126290628|NCT00262028|454350651|FG008|Overall Study|Administrative Reason|10|||
126290629|NCT00262028|454350643|FG000|Overall Study|Protocol Violation|0|||
126290630|NCT00262028|454350644|FG001|Overall Study|Protocol Violation|0|||
126290631|NCT00262028|454350645|FG002|Overall Study|Protocol Violation|0|||
126290632|NCT00262028|454350646|FG003|Overall Study|Protocol Violation|1|||
126290633|NCT00262028|454350647|FG004|Overall Study|Protocol Violation|0|||
126290634|NCT00262028|454350648|FG005|Overall Study|Protocol Violation|0|||
126290635|NCT00262028|454350649|FG006|Overall Study|Protocol Violation|0|||
126290636|NCT00262028|454350650|FG007|Overall Study|Protocol Violation|0|||
126366089|NCT02254291|454635702|FG001|Overall Study|Withdrawal by Subject|3|||
126366090|NCT02254291|454635703|FG002|Overall Study|Withdrawal by Subject|1|||
126366091|NCT02254291|454635701|FG000|Overall Study|Missing follow-up information|0|||
126366092|NCT02254291|454635702|FG001|Overall Study|Missing follow-up information|0|||
126366093|NCT02254291|454635703|FG002|Overall Study|Missing follow-up information|1|||
126366094|NCT00833703|454635713|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
126366095|NCT00833703|454635714|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
126366096|NCT01904279|454635715|FG000|Overall Study|Lack of Efficacy|2|||
126366097|NCT01904279|454635716|FG001|Overall Study|Lack of Efficacy|3|||
126366098|NCT01904279|454635715|FG000|Overall Study|Withdrawal by Subject|1|||
126710670|NCT04329923|455893508|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
126290637|NCT00262028|454350651|FG008|Overall Study|Protocol Violation|0|||
126290638|NCT00262028|454350643|FG000|Overall Study|Unable to classify|0|||
126457965|NCT00329901|454978257|FG000|Overall Study|Unable to classify|2|||
126457966|NCT00329901|454978258|FG001|Overall Study|Unable to classify|2|||
126457967|NCT00329901|454978259|FG002|Overall Study|Unable to classify|0|||
126366099|NCT01904279|454635716|FG001|Overall Study|Withdrawal by Subject|0|||
126366100|NCT02489279|454635719|FG000|Overall Study|Lost to Follow-up|12|||
126366101|NCT02489279|454635720|FG001|Overall Study|Lost to Follow-up|10|||
126366102|NCT02263547|454635721|FG000|Overall Study|Adverse Event|1|||
126366103|NCT02263547|454635721|FG000|Overall Study|Lost to Follow-up|2|||
126366104|NCT01344356|454635722|FG000|Overall Study|Physician Decision|0|||
126366105|NCT01344356|454635723|FG001|Overall Study|Physician Decision|3|||
126366106|NCT01344356|454635722|FG000|Overall Study|Lost to Follow-up|0|||
126366107|NCT01344356|454635723|FG001|Overall Study|Lost to Follow-up|6|||
126366108|NCT00095576|454635724|FG000|Overall Study|Adverse Event|5|||
126366109|NCT00095576|454635725|FG001|Overall Study|Adverse Event|3|||
126366110|NCT00095576|454635724|FG000|Overall Study|Lost to Follow-up|233|||
126366111|NCT00095576|454635725|FG001|Overall Study|Lost to Follow-up|229|||
126366112|NCT00095576|454635724|FG000|Overall Study|Protocol Violation|1|||
126366113|NCT00095576|454635725|FG001|Overall Study|Protocol Violation|0|||
126366114|NCT00095576|454635724|FG000|Overall Study|Withdrawal by Subject|34|||
126366115|NCT00095576|454635725|FG001|Overall Study|Withdrawal by Subject|47|||
126366116|NCT00095576|454635724|FG000|Overall Study|Option to switch to a rollover study|1097|||
126366117|NCT00095576|454635725|FG001|Overall Study|Option to switch to a rollover study|1099|||
126366118|NCT00095576|454635724|FG000|Overall Study|Site terminated|75|||
126366119|NCT00095576|454635725|FG001|Overall Study|Site terminated|67|||
126366120|NCT00095576|454635724|FG000|Overall Study|Subject moved|30|||
126366121|NCT00095576|454635725|FG001|Overall Study|Subject moved|36|||
126457968|NCT00992589|454978260|FG000|Open-Label Phase|Adverse Event|4|||
126457969|NCT00992589|454978261|FG001|Open-Label Phase|Adverse Event|0|||
126457970|NCT00992589|454978262|FG002|Open-Label Phase|Adverse Event|0|||
126457971|NCT00992589|454978263|FG003|Open-Label Phase|Adverse Event|0|||
126457972|NCT00992589|454978260|FG000|Open-Label Phase|Withdrawal by Subject|20|||
126457973|NCT00992589|454978261|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126290639|NCT00262028|454350644|FG001|Overall Study|Unable to classify|3|||
126290640|NCT00262028|454350645|FG002|Overall Study|Unable to classify|0|||
126290641|NCT00262028|454350646|FG003|Overall Study|Unable to classify|0|||
126290642|NCT00262028|454350647|FG004|Overall Study|Unable to classify|0|||
126290643|NCT00262028|454350648|FG005|Overall Study|Unable to classify|0|||
126290644|NCT00262028|454350649|FG006|Overall Study|Unable to classify|0|||
126290645|NCT00262028|454350650|FG007|Overall Study|Unable to classify|0|||
126290646|NCT00262028|454350651|FG008|Overall Study|Unable to classify|1|||
126290647|NCT02308124|454350652|FG000|Overall Study|Lost to Follow-up|6|||
126290648|NCT02308124|454350653|FG001|Overall Study|Lost to Follow-up|6|||
126290649|NCT02308124|454350654|FG002|Overall Study|Lost to Follow-up|6|||
126290650|NCT02308124|454350652|FG000|Overall Study|Adverse Event|0|||
126290651|NCT02308124|454350653|FG001|Overall Study|Adverse Event|2|||
126290652|NCT02308124|454350654|FG002|Overall Study|Adverse Event|2|||
126290653|NCT02553772|454350655|FG000|Overall Study|Adverse Event|2|||
126290654|NCT02553772|454350656|FG001|Overall Study|Adverse Event|3|||
126290655|NCT02553772|454350655|FG000|Overall Study|Lost to Follow-up|2|||
126290656|NCT02553772|454350656|FG001|Overall Study|Lost to Follow-up|1|||
126290657|NCT02553772|454350655|FG000|Overall Study|Withdrawal of Consent|1|||
126290658|NCT02553772|454350656|FG001|Overall Study|Withdrawal of Consent|1|||
126290659|NCT02553772|454350655|FG000|Overall Study|Lack of Efficacy|1|||
126290660|NCT02553772|454350656|FG001|Overall Study|Lack of Efficacy|0|||
126290661|NCT02553772|454350655|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126290662|NCT02553772|454350656|FG001|Overall Study|Other Miscellaneous Reasons|1|||
126290663|NCT01329900|454350657|FG000|Overall Study|Elevated creatinine/renal function|1|||
126290664|NCT01184079|454350661|FG000|Overall Study|Lost to Follow-up|14|||
126290665|NCT01184079|454350662|FG001|Overall Study|Lost to Follow-up|2|||
126290666|NCT04233073|454350667|FG000|Overall Study|Death|5|||
126290667|NCT00143390|454350668|FG000|Overall Study|Death|2|||
126290668|NCT00143390|454350669|FG001|Overall Study|Death|0|||
126290669|NCT00143390|454350668|FG000|Overall Study|Not meeting entry criteria|2|||
126290670|NCT00143390|454350669|FG001|Overall Study|Not meeting entry criteria|5|||
126290671|NCT00143390|454350668|FG000|Overall Study|Withdrawal by Subject|4|||
126457974|NCT00992589|454978262|FG002|Open-Label Phase|Withdrawal by Subject|0|||
126457975|NCT00992589|454978263|FG003|Open-Label Phase|Withdrawal by Subject|0|||
126290672|NCT00143390|454350669|FG001|Overall Study|Withdrawal by Subject|4|||
126290673|NCT00143390|454350668|FG000|Overall Study|Progressive disease|119|||
126290674|NCT00143390|454350669|FG001|Overall Study|Progressive disease|115|||
126290675|NCT00143390|454350668|FG000|Overall Study|Protocol Violation|2|||
126366122|NCT02014467|454635728|FG000|Overall Study|Adverse Event|4|||
126366123|NCT02014467|454635729|FG001|Overall Study|Adverse Event|0|||
126366124|NCT02014467|454635728|FG000|Overall Study|Protocol Violation|3|||
126457976|NCT00992589|454978260|FG000|Open-Label Phase|Lost to Follow-up|1|||
126290676|NCT00143390|454350669|FG001|Overall Study|Protocol Violation|0|||
126366125|NCT02014467|454635729|FG001|Overall Study|Protocol Violation|0|||
126366126|NCT02014467|454635728|FG000|Overall Study|Physician Decision|2|||
126366127|NCT02014467|454635729|FG001|Overall Study|Physician Decision|3|||
126710671|NCT04329923|455893509|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
126710672|NCT04329923|455893510|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
126710673|NCT04329923|455893511|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
126290677|NCT00143390|454350668|FG000|Overall Study|Study termination|10|||
126290678|NCT00143390|454350669|FG001|Overall Study|Study termination|15|||
126290679|NCT00143390|454350668|FG000|Overall Study|Adverse Event|9|||
126290680|NCT00143390|454350669|FG001|Overall Study|Adverse Event|8|||
126290681|NCT00143390|454350668|FG000|Overall Study|Other|1|||
126290682|NCT00143390|454350669|FG001|Overall Study|Other|2|||
126290683|NCT00041132|454350672|FG000|Overall Study|Adverse Event|19|||
126290684|NCT00041132|454350672|FG000|Overall Study|Death|1|||
126290685|NCT00041132|454350672|FG000|Overall Study|Not Eligible|7|||
126290686|NCT00041132|454350672|FG000|Overall Study|Withdrawal by Subject|1|||
126290687|NCT00041132|454350672|FG000|Overall Study|Physician Decision|2|||
126290688|NCT03200717|454350678|FG000|Overall Study|Progressive disease|24|||
126290689|NCT03200717|454350679|FG001|Overall Study|Progressive disease|5|||
126290690|NCT03200717|454350678|FG000|Overall Study|Adverse Event|11|||
126290691|NCT03200717|454350679|FG001|Overall Study|Adverse Event|8|||
126290692|NCT03200717|454350678|FG000|Overall Study|Physician Decision|3|||
126290693|NCT03200717|454350679|FG001|Overall Study|Physician Decision|2|||
126290694|NCT03200717|454350678|FG000|Overall Study|Death|2|||
126290695|NCT03200717|454350679|FG001|Overall Study|Death|0|||
126290696|NCT03200717|454350678|FG000|Overall Study|Subject/Guardian Decision|1|||
126290697|NCT03200717|454350679|FG001|Overall Study|Subject/Guardian Decision|0|||
126290698|NCT00866359|454350680|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
126290699|NCT00866359|454350681|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
126290700|NCT00866359|454350682|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
126290701|NCT00866359|454350683|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
126290702|NCT00866359|454350680|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
126290703|NCT00866359|454350681|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
126290704|NCT00866359|454350682|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
126290705|NCT00866359|454350683|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
126290706|NCT00866359|454350680|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
126290707|NCT00866359|454350681|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
126290708|NCT00866359|454350682|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
126290709|NCT00866359|454350683|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
126290710|NCT00866359|454350680|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
126290711|NCT00866359|454350681|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
126290712|NCT00866359|454350682|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
126290713|NCT00866359|454350683|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
126290714|NCT00866359|454350680|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
126290715|NCT00866359|454350681|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
126290716|NCT00866359|454350682|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
126290717|NCT00866359|454350683|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
126290718|NCT00866359|454350680|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
126290719|NCT00866359|454350681|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
126290720|NCT00866359|454350682|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
126290721|NCT00866359|454350683|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
126290722|NCT01625091|454350684|FG000|Intervention|Death|1|||
126290723|NCT01625091|454350685|FG001|Intervention|Death|1|||
126290724|NCT01625091|454350684|FG000|Intervention|Withdrawal by Subject|4|||
126290725|NCT01625091|454350685|FG001|Intervention|Withdrawal by Subject|1|||
126290726|NCT01625091|454350684|FG000|Intervention|Adverse Event|0|||
126290727|NCT01625091|454350685|FG001|Intervention|Adverse Event|2|||
126290728|NCT01625091|454350684|FG000|Intervention|Lost to Follow-up|4|||
126290729|NCT01625091|454350685|FG001|Intervention|Lost to Follow-up|4|||
126290730|NCT01625091|454350684|FG000|Intervention|Study termination|2|||
126290731|NCT01625091|454350685|FG001|Intervention|Study termination|3|||
126290732|NCT01625091|454350684|FG000|Post-intervention|Death|0|||
126290733|NCT01625091|454350685|FG001|Post-intervention|Death|1|||
126290734|NCT01625091|454350684|FG000|Post-intervention|Lost to Follow-up|2|||
126710674|NCT01272180|455893512|FG000|Overall Study|Adverse Event|0|||
126710675|NCT01272180|455893513|FG001|Overall Study|Adverse Event|0|||
126710676|NCT01272180|455893514|FG002|Overall Study|Adverse Event|1|||
126710677|NCT01272180|455893515|FG003|Overall Study|Adverse Event|0|||
126710678|NCT01272180|455893512|FG000|Overall Study|Withdrawal by Subject|2|||
126290735|NCT01625091|454350685|FG001|Post-intervention|Lost to Follow-up|0|||
126290736|NCT01625091|454350684|FG000|Post-intervention|Study termination|2|||
126290737|NCT01625091|454350685|FG001|Post-intervention|Study termination|1|||
126290738|NCT02163057|454350686|FG000|Overall Study|Participant Refusal to Continue|2|||
126290739|NCT02163057|454350687|FG001|Overall Study|Participant Refusal to Continue|2|||
126290740|NCT02163057|454350686|FG000|Overall Study|Participant Significant Noncompliance|0|||
126290741|NCT02163057|454350687|FG001|Overall Study|Participant Significant Noncompliance|1|||
126290742|NCT02163057|454350686|FG000|Overall Study|Progression of Disease|1|||
126710679|NCT01272180|455893513|FG001|Overall Study|Withdrawal by Subject|6|||
126457977|NCT00992589|454978261|FG001|Open-Label Phase|Lost to Follow-up|0|||
126290743|NCT02163057|454350687|FG001|Overall Study|Progression of Disease|2|||
126290744|NCT00768248|454350688|FG000|Overall Study|Research coordinator didn't collect data|1|||
126290745|NCT00768248|454350689|FG001|Overall Study|Research coordinator didn't collect data|1|||
126290746|NCT01547390|454350694|FG000|Overall Study|Withdrawal by Subject|10|||
126290747|NCT01547390|454350695|FG001|Overall Study|Withdrawal by Subject|7|||
126290748|NCT01547390|454350694|FG000|Overall Study|termination of pregnancy|0|||
126290749|NCT01547390|454350695|FG001|Overall Study|termination of pregnancy|1|||
126290750|NCT01547390|454350694|FG000|Overall Study|Lost to Follow-up|0|||
126290751|NCT01547390|454350695|FG001|Overall Study|Lost to Follow-up|2|||
126290752|NCT01547390|454350694|FG000|Overall Study|Adverse Event|3|||
126290753|NCT01547390|454350695|FG001|Overall Study|Adverse Event|0|||
126290754|NCT01459783|454350696|FG000|Baseline to 6 Months|Death|1|||
126290755|NCT01459783|454350697|FG001|Baseline to 6 Months|Death|0|||
126290756|NCT01459783|454350696|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
126290757|NCT01459783|454350697|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
126290758|NCT01459783|454350696|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
126290759|NCT01459783|454350697|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
126290760|NCT01459783|454350696|FG000|6 Months to 12 Months|Death|0|||
126290761|NCT01459783|454350697|FG001|6 Months to 12 Months|Death|1|||
126290762|NCT01459783|454350696|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
126290763|NCT01459783|454350697|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
126290764|NCT01459783|454350696|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
126290765|NCT01459783|454350697|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
126290766|NCT01459783|454350696|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
126290767|NCT01459783|454350697|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
126290768|NCT04211831|454350698|FG000|Overall Study|Withdrawal by Subject|4|||
126290769|NCT04211831|454350699|FG001|Overall Study|Withdrawal by Subject|1|||
126290770|NCT04211831|454350700|FG002|Overall Study|Withdrawal by Subject|1|||
126290771|NCT04211831|454350698|FG000|Overall Study|Protocol Violation|0|||
126290772|NCT04211831|454350699|FG001|Overall Study|Protocol Violation|0|||
126290773|NCT04211831|454350700|FG002|Overall Study|Protocol Violation|1|||
126290774|NCT04211831|454350698|FG000|Overall Study|Adverse Event|0|||
126290775|NCT04211831|454350699|FG001|Overall Study|Adverse Event|1|||
126290776|NCT04211831|454350700|FG002|Overall Study|Adverse Event|0|||
126290777|NCT04211831|454350698|FG000|Overall Study|Lack of Efficacy|0|||
126290778|NCT04211831|454350699|FG001|Overall Study|Lack of Efficacy|0|||
126290779|NCT04211831|454350700|FG002|Overall Study|Lack of Efficacy|1|||
126290780|NCT04211831|454350698|FG000|Overall Study|Lost to Follow-up|0|||
126290781|NCT04211831|454350699|FG001|Overall Study|Lost to Follow-up|0|||
126290782|NCT04211831|454350700|FG002|Overall Study|Lost to Follow-up|2|||
126290783|NCT04211831|454350698|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
126290784|NCT04211831|454350699|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
126290785|NCT04211831|454350700|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
126290786|NCT04211831|454350698|FG000|Overall Study|Other|0|||
126290787|NCT04211831|454350699|FG001|Overall Study|Other|1|||
126290788|NCT04211831|454350700|FG002|Overall Study|Other|0|||
126290789|NCT01256879|454350701|FG000|Overall Study|Withdrawal by Subject|1|||
126290790|NCT00640315|454350702|FG000|Overall Study|Withdrawal by Subject|0|||
126290791|NCT00640315|454350703|FG001|Overall Study|Withdrawal by Subject|1|||
126290792|NCT00397514|454350704|FG000|Overall Study|Withdrawal by Subject|1|||
126290793|NCT00397514|454350704|FG000|Overall Study|Pacing wire malfunction|1|||
126290794|NCT00397514|454350704|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
126290795|NCT00397514|454350704|FG000|Overall Study|early extubation|2|||
126290796|NCT00397514|454350704|FG000|Overall Study|poor echocardiographic windows|1|||
126290797|NCT03493685|454352791|FG000|Overall Study|Death|4|||
126290798|NCT03493685|454352792|FG001|Overall Study|Death|3|||
126290799|NCT03493685|454352791|FG000|Overall Study|Lost to Follow-up|3|||
126290800|NCT03493685|454352792|FG001|Overall Study|Lost to Follow-up|2|||
126290801|NCT03493685|454352791|FG000|Overall Study|Physician Decision|2|||
126290802|NCT03493685|454352792|FG001|Overall Study|Physician Decision|0|||
126290803|NCT03493685|454352791|FG000|Overall Study|Withdrawal by Subject|7|||
126290804|NCT03493685|454352792|FG001|Overall Study|Withdrawal by Subject|11|||
126290805|NCT04452669|454352793|FG000|Overall Study|Death|1|||
126290806|NCT04452669|454352794|FG001|Overall Study|Death|4|||
126457978|NCT00992589|454978262|FG002|Open-Label Phase|Lost to Follow-up|0|||
126290807|NCT03300817|454352795|FG000|Overall Study|Withdrawal by Subject|1|||
126290808|NCT03300817|454352795|FG000|Overall Study|Adverse Event|1|||
126290809|NCT03300817|454352795|FG000|Overall Study|Subject Found to be Ineligible|2|||
126290810|NCT00265759|454352796|FG000|Overall Study|Withdrawal by Subject|0|||
126290811|NCT00265759|454352797|FG001|Overall Study|Withdrawal by Subject|1|||
126290812|NCT00265759|454352798|FG002|Overall Study|Withdrawal by Subject|2|||
126290813|NCT00265759|454352799|FG003|Overall Study|Withdrawal by Subject|2|||
126290814|NCT00265759|454352796|FG000|Overall Study|Cancel|0|||
126290815|NCT00265759|454352797|FG001|Overall Study|Cancel|0|||
126457979|NCT00992589|454978263|FG003|Open-Label Phase|Lost to Follow-up|0|||
126366128|NCT02014467|454635728|FG000|Overall Study|Withdrawal by Subject|16|||
126366129|NCT02014467|454635729|FG001|Overall Study|Withdrawal by Subject|4|||
126366130|NCT00831389|454635732|FG000|Overall Study|Withdrawal by Subject|0|||
126366131|NCT00831389|454635733|FG001|Overall Study|Withdrawal by Subject|1|||
126366132|NCT00124657|454635735|FG000|Overall Study|Toxicity|0|||
126366133|NCT00124657|454635736|FG001|Overall Study|Toxicity|0|||
126366134|NCT00124657|454635737|FG002|Overall Study|Toxicity|1|||
126366135|NCT00124657|454635735|FG000|Overall Study|Non-compliance|1|||
126366136|NCT00124657|454635736|FG001|Overall Study|Non-compliance|0|||
126366137|NCT00124657|454635737|FG002|Overall Study|Non-compliance|4|||
126366138|NCT00124657|454635735|FG000|Overall Study|Progressive disease|14|||
126366139|NCT00124657|454635736|FG001|Overall Study|Progressive disease|5|||
126366140|NCT00124657|454635737|FG002|Overall Study|Progressive disease|27|||
126366141|NCT00124657|454635735|FG000|Overall Study|Intercurrent illness|1|||
126366142|NCT00124657|454635736|FG001|Overall Study|Intercurrent illness|0|||
126366143|NCT00124657|454635737|FG002|Overall Study|Intercurrent illness|0|||
126366144|NCT01378195|454635738|FG000|Overall Study|Lost to Follow-up|29|||
126366145|NCT01378195|454635739|FG001|Overall Study|Lost to Follow-up|18|||
126366146|NCT00841815|454635746|FG000|Washout|Withdrawal by Subject|0|||
126366147|NCT00841815|454635747|FG001|Washout|Withdrawal by Subject|1|||
126366148|NCT01148771|454635749|FG000|Washout Period|Withdrawal by Subject|0|||
126366149|NCT01148771|454635750|FG001|Washout Period|Withdrawal by Subject|1|||
126366150|NCT03787615|454635751|FG000|Overall Study|Withdrawal by Subject|2|||
126366151|NCT03787615|454635751|FG000|Overall Study|Lost to Follow-up|2|||
126366152|NCT03464461|454635752|FG000|Overall Study|exclusionary medication given ,|1|||
126366153|NCT03464461|454635753|FG001|Overall Study|exclusionary medication given ,|2|||
126366154|NCT03464461|454635754|FG002|Overall Study|exclusionary medication given ,|0|||
126366155|NCT03464461|454635752|FG000|Overall Study|Physician Decision|0|||
126366156|NCT03464461|454635753|FG001|Overall Study|Physician Decision|1|||
126366157|NCT03464461|454635754|FG002|Overall Study|Physician Decision|0|||
126366158|NCT03685149|454635756|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
126366159|NCT03685149|454635757|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
126366160|NCT03685149|454635756|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
126366161|NCT03685149|454635757|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
126366162|NCT03685149|454635756|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
126366163|NCT03685149|454635757|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
126366164|NCT02609503|454635758|FG000|Overall Study|Adverse Event|1|||
126366165|NCT02609503|454635758|FG000|Overall Study|Death|1|||
126366166|NCT02609503|454635758|FG000|Overall Study|Withdrawal by Subject|1|||
126366167|NCT02609503|454635758|FG000|Overall Study|Disease progression|1|||
126366168|NCT03647137|454635759|FG000|Overall Study|Scan Limitation|2|||
126366169|NCT03647137|454635760|FG001|Overall Study|Scan Limitation|1|||
126366170|NCT03647137|454635761|FG002|Overall Study|Scan Limitation|1|||
126366171|NCT03647137|454635762|FG003|Overall Study|Scan Limitation|2|||
126366172|NCT02226653|454635763|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
126366173|NCT02226653|454635764|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
126366174|NCT02226653|454635763|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
126366175|NCT02226653|454635764|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
126366176|NCT04876391|454635766|FG000|Overall Study|Withdrawal by Subject|1|||
126366177|NCT04876391|454635767|FG001|Overall Study|Withdrawal by Subject|10|||
126366178|NCT04876391|454635766|FG000|Overall Study|Lost to Follow-up|2|||
126366179|NCT04876391|454635767|FG001|Overall Study|Lost to Follow-up|4|||
126366180|NCT04876391|454635766|FG000|Overall Study|Lack of Efficacy|0|||
126366181|NCT04876391|454635767|FG001|Overall Study|Lack of Efficacy|2|||
126366182|NCT04876391|454635766|FG000|Overall Study|Adverse Event|3|||
126366183|NCT04876391|454635767|FG001|Overall Study|Adverse Event|1|||
126366184|NCT04876391|454635766|FG000|Overall Study|Patient non-compliance|0|||
126366185|NCT04876391|454635767|FG001|Overall Study|Patient non-compliance|1|||
126366186|NCT04876391|454635766|FG000|Overall Study|Personal reasons|0|||
126366187|NCT04876391|454635767|FG001|Overall Study|Personal reasons|1|||
126366188|NCT04876391|454635766|FG000|Overall Study|Withdrawn as per protocol|2|||
126366189|NCT04876391|454635767|FG001|Overall Study|Withdrawn as per protocol|2|||
126366190|NCT00209131|454635773|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
126366191|NCT00209131|454635774|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
126549779|NCT00251927|455307578|FG000|Overall Study|Study procedure non-compliance|5|||
126366192|NCT05360784|454635775|FG000|Overall Study|Discontinued|25|||
126767023|NCT00539006|456100209|FG003|Treatment Period 1|Lost to Follow-up|0|||
126366193|NCT05360784|454635776|FG001|Overall Study|Discontinued|11|||
126366194|NCT05142306|454635777|FG000|Overall Study|Withdrawal by Subject|0|||
126366195|NCT05142306|454635778|FG001|Overall Study|Withdrawal by Subject|0|||
126366196|NCT05142306|454635779|FG002|Overall Study|Withdrawal by Subject|1|||
126366197|NCT02251041|454635780|FG000|Overall Study|Did not receive intervention|15|||
126366198|NCT02251041|454635781|FG001|Overall Study|Did not receive intervention|4|||
126366199|NCT04079920|454635782|FG000|Overall Study|Adverse event, not related to study drug|2|||
126366200|NCT04079920|454635782|FG000|Overall Study|Adverse event related to study drug|10|||
126366201|NCT04079920|454635782|FG000|Overall Study|Death|2|||
126290816|NCT00265759|454352798|FG002|Overall Study|Cancel|0|||
126290817|NCT00265759|454352799|FG003|Overall Study|Cancel|3|||
126290818|NCT00265759|454352796|FG000|Overall Study|Ineligible|0|||
126290819|NCT00265759|454352797|FG001|Overall Study|Ineligible|0|||
126290820|NCT00265759|454352798|FG002|Overall Study|Ineligible|0|||
126290821|NCT00265759|454352799|FG003|Overall Study|Ineligible|1|||
126290822|NCT00265759|454352796|FG000|Overall Study|Bilateral disease|0|||
126290823|NCT00265759|454352797|FG001|Overall Study|Bilateral disease|0|||
126290824|NCT00265759|454352798|FG002|Overall Study|Bilateral disease|0|||
126290825|NCT00265759|454352799|FG003|Overall Study|Bilateral disease|2|||
126290826|NCT00265759|454352796|FG000|Overall Study|Discontinued due to intolerability|0|||
126290827|NCT00265759|454352797|FG001|Overall Study|Discontinued due to intolerability|0|||
126290828|NCT00265759|454352798|FG002|Overall Study|Discontinued due to intolerability|0|||
126290829|NCT00265759|454352799|FG003|Overall Study|Discontinued due to intolerability|1|||
126290830|NCT03729596|454352802|FG000|Overall Study|Death|3|||
126290831|NCT03729596|454352803|FG001|Overall Study|Death|5|||
126290832|NCT03729596|454352804|FG002|Overall Study|Death|4|||
126290833|NCT03729596|454352805|FG003|Overall Study|Death|1|||
126290834|NCT03729596|454352806|FG004|Overall Study|Death|0|||
126290835|NCT03729596|454352807|FG005|Overall Study|Death|34|||
126290836|NCT03729596|454352808|FG006|Overall Study|Death|18|||
126290837|NCT03729596|454352809|FG007|Overall Study|Death|14|||
126290838|NCT03729596|454352810|FG008|Overall Study|Death|19|||
126290839|NCT03729596|454352811|FG009|Overall Study|Death|9|||
126290840|NCT03729596|454352802|FG000|Overall Study|Lost to Follow-up|0|||
126290841|NCT03729596|454352803|FG001|Overall Study|Lost to Follow-up|0|||
126290842|NCT03729596|454352804|FG002|Overall Study|Lost to Follow-up|0|||
126290843|NCT03729596|454352805|FG003|Overall Study|Lost to Follow-up|0|||
126290844|NCT03729596|454352806|FG004|Overall Study|Lost to Follow-up|0|||
126290845|NCT03729596|454352807|FG005|Overall Study|Lost to Follow-up|0|||
126290846|NCT03729596|454352808|FG006|Overall Study|Lost to Follow-up|1|||
126290847|NCT03729596|454352809|FG007|Overall Study|Lost to Follow-up|0|||
126290848|NCT03729596|454352810|FG008|Overall Study|Lost to Follow-up|0|||
126290849|NCT03729596|454352811|FG009|Overall Study|Lost to Follow-up|1|||
126290850|NCT03729596|454352802|FG000|Overall Study|protocol amendment|0|||
126290851|NCT03729596|454352803|FG001|Overall Study|protocol amendment|1|||
126290852|NCT03729596|454352804|FG002|Overall Study|protocol amendment|3|||
126290853|NCT03729596|454352805|FG003|Overall Study|protocol amendment|6|||
126290854|NCT03729596|454352806|FG004|Overall Study|protocol amendment|5|||
126290855|NCT03729596|454352807|FG005|Overall Study|protocol amendment|0|||
126290856|NCT03729596|454352808|FG006|Overall Study|protocol amendment|0|||
126290857|NCT03729596|454352809|FG007|Overall Study|protocol amendment|0|||
126290858|NCT03729596|454352810|FG008|Overall Study|protocol amendment|0|||
126290859|NCT03729596|454352811|FG009|Overall Study|protocol amendment|0|||
126290860|NCT03729596|454352802|FG000|Overall Study|Withdrawal by Subject|0|||
126290861|NCT03729596|454352803|FG001|Overall Study|Withdrawal by Subject|0|||
126290862|NCT03729596|454352804|FG002|Overall Study|Withdrawal by Subject|0|||
126290863|NCT03729596|454352805|FG003|Overall Study|Withdrawal by Subject|0|||
126290864|NCT03729596|454352806|FG004|Overall Study|Withdrawal by Subject|0|||
126290865|NCT03729596|454352807|FG005|Overall Study|Withdrawal by Subject|4|||
126290866|NCT03729596|454352808|FG006|Overall Study|Withdrawal by Subject|2|||
126290867|NCT03729596|454352809|FG007|Overall Study|Withdrawal by Subject|3|||
126290868|NCT03729596|454352810|FG008|Overall Study|Withdrawal by Subject|2|||
126290869|NCT03729596|454352811|FG009|Overall Study|Withdrawal by Subject|3|||
126290870|NCT03729596|454352802|FG000|Overall Study|study terminated by sponsor|0|||
126290871|NCT03729596|454352803|FG001|Overall Study|study terminated by sponsor|0|||
126290872|NCT03729596|454352804|FG002|Overall Study|study terminated by sponsor|0|||
126290873|NCT03729596|454352805|FG003|Overall Study|study terminated by sponsor|0|||
126290874|NCT03729596|454352806|FG004|Overall Study|study terminated by sponsor|1|||
126290875|NCT03729596|454352807|FG005|Overall Study|study terminated by sponsor|3|||
126290876|NCT03729596|454352808|FG006|Overall Study|study terminated by sponsor|0|||
126290877|NCT03729596|454352809|FG007|Overall Study|study terminated by sponsor|1|||
126290878|NCT03729596|454352810|FG008|Overall Study|study terminated by sponsor|0|||
126290879|NCT03729596|454352811|FG009|Overall Study|study terminated by sponsor|0|||
126290880|NCT04467840|454352812|FG000|Overall Study|Death|35|||
126290881|NCT04467840|454352813|FG001|Overall Study|Death|39|||
126290882|NCT04467840|454352812|FG000|Overall Study|Withdrawal by Subject|8|||
126290883|NCT04467840|454352813|FG001|Overall Study|Withdrawal by Subject|4|||
126290884|NCT04467840|454352812|FG000|Overall Study|Adverse Event|2|||
126290885|NCT04467840|454352813|FG001|Overall Study|Adverse Event|0|||
126290886|NCT04467840|454352812|FG000|Overall Study|Lost to Follow-up|1|||
126290887|NCT04467840|454352813|FG001|Overall Study|Lost to Follow-up|3|||
126290888|NCT04467840|454352812|FG000|Overall Study|Physician Decision|1|||
126290889|NCT04467840|454352813|FG001|Overall Study|Physician Decision|0|||
126290890|NCT04467840|454352812|FG000|Overall Study|Other|1|||
126290891|NCT04467840|454352813|FG001|Overall Study|Other|5|||
126290892|NCT04467840|454352812|FG000|Overall Study|Missing study completion status|3|||
126290893|NCT04467840|454352813|FG001|Overall Study|Missing study completion status|1|||
126290894|NCT05201794|454352816|FG000|Overall Study|Withdrawal by Subject|13|||
126290895|NCT05201794|454352817|FG001|Overall Study|Withdrawal by Subject|12|||
126457980|NCT00992589|454978260|FG000|Open-Label Phase|Protocol Violation|3|||
126457981|NCT00992589|454978261|FG001|Open-Label Phase|Protocol Violation|0|||
126457982|NCT00992589|454978262|FG002|Open-Label Phase|Protocol Violation|0|||
126457983|NCT00992589|454978263|FG003|Open-Label Phase|Protocol Violation|0|||
126457984|NCT00992589|454978260|FG000|Open-Label Phase|Physician Decision|4|||
126457985|NCT00992589|454978261|FG001|Open-Label Phase|Physician Decision|0|||
126290896|NCT05201794|454352818|FG002|Overall Study|Withdrawal by Subject|14|||
126290897|NCT05201794|454352819|FG003|Overall Study|Withdrawal by Subject|0|||
126290898|NCT05201794|454352816|FG000|Overall Study|Adverse Event|5|||
126290899|NCT05201794|454352817|FG001|Overall Study|Adverse Event|5|||
126290900|NCT05201794|454352818|FG002|Overall Study|Adverse Event|4|||
126290901|NCT05201794|454352819|FG003|Overall Study|Adverse Event|0|||
126290902|NCT05201794|454352816|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
126290903|NCT05201794|454352817|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
126290904|NCT05201794|454352818|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
126290905|NCT05201794|454352819|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126290906|NCT05201794|454352816|FG000|Overall Study|Non-Compliance With Study Drug|2|||
126290907|NCT05201794|454352817|FG001|Overall Study|Non-Compliance With Study Drug|3|||
126290908|NCT05201794|454352818|FG002|Overall Study|Non-Compliance With Study Drug|3|||
126290909|NCT05201794|454352819|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126290910|NCT05201794|454352816|FG000|Overall Study|Physician Decision|1|||
126290911|NCT05201794|454352817|FG001|Overall Study|Physician Decision|3|||
126290912|NCT05201794|454352818|FG002|Overall Study|Physician Decision|2|||
126290913|NCT05201794|454352819|FG003|Overall Study|Physician Decision|0|||
126290914|NCT05201794|454352816|FG000|Overall Study|Lost to Follow-up|2|||
126290915|NCT05201794|454352817|FG001|Overall Study|Lost to Follow-up|2|||
126290916|NCT05201794|454352818|FG002|Overall Study|Lost to Follow-up|0|||
126290917|NCT05201794|454352819|FG003|Overall Study|Lost to Follow-up|0|||
126290918|NCT05201794|454352816|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
126290919|NCT05201794|454352817|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
126290920|NCT05201794|454352818|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
126290921|NCT05201794|454352819|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
126290922|NCT05201794|454352816|FG000|Overall Study|Protocol Violation|2|||
126290923|NCT05201794|454352817|FG001|Overall Study|Protocol Violation|0|||
126290924|NCT05201794|454352818|FG002|Overall Study|Protocol Violation|1|||
126290925|NCT05201794|454352819|FG003|Overall Study|Protocol Violation|0|||
126290926|NCT05201794|454352816|FG000|Overall Study|Death|1|||
126290927|NCT05201794|454352817|FG001|Overall Study|Death|0|||
126290928|NCT05201794|454352818|FG002|Overall Study|Death|0|||
126290929|NCT05201794|454352819|FG003|Overall Study|Death|0|||
126290930|NCT05201794|454352816|FG000|Overall Study|Site Terminated By Sponsor|0|||
126290931|NCT05201794|454352817|FG001|Overall Study|Site Terminated By Sponsor|1|||
126290932|NCT05201794|454352818|FG002|Overall Study|Site Terminated By Sponsor|0|||
126290933|NCT05201794|454352819|FG003|Overall Study|Site Terminated By Sponsor|0|||
126290934|NCT05201794|454352816|FG000|Overall Study|Other|3|||
126290935|NCT05201794|454352817|FG001|Overall Study|Other|3|||
126290936|NCT05201794|454352818|FG002|Overall Study|Other|3|||
126290937|NCT05201794|454352819|FG003|Overall Study|Other|0|||
126290938|NCT05201794|454352816|FG000|Overall Study|Randomized But Not Treated|1|||
126290939|NCT05201794|454352817|FG001|Overall Study|Randomized But Not Treated|2|||
126290940|NCT05201794|454352818|FG002|Overall Study|Randomized But Not Treated|1|||
126290941|NCT05201794|454352819|FG003|Overall Study|Randomized But Not Treated|0|||
126290942|NCT04653454|454352824|FG000|Overall Study|Withdrawal by Subject|1|||
126290943|NCT04653454|454352824|FG000|Overall Study|Physician Decision|40|||
126290944|NCT03620708|454352825|FG000|Overall Study|Lost to Follow-up|1|||
126290945|NCT03620708|454352826|FG001|Overall Study|Lost to Follow-up|1|||
126290946|NCT03620708|454352827|FG002|Overall Study|Lost to Follow-up|2|||
126290947|NCT03620708|454352825|FG000|Overall Study|Withdrawal by Subject|0|||
126290948|NCT03620708|454352826|FG001|Overall Study|Withdrawal by Subject|0|||
126457986|NCT00992589|454978262|FG002|Open-Label Phase|Physician Decision|0|||
126457987|NCT00992589|454978263|FG003|Open-Label Phase|Physician Decision|0|||
126457988|NCT00992589|454978260|FG000|Open-Label Phase|Other|45|||
126457989|NCT00992589|454978261|FG001|Open-Label Phase|Other|0|||
126457990|NCT00992589|454978262|FG002|Open-Label Phase|Other|0|||
126457991|NCT00992589|454978263|FG003|Open-Label Phase|Other|0|||
126457992|NCT00992589|454978260|FG000|Double-Blind Phase|Adverse Event|0|||
126457993|NCT00992589|454978261|FG001|Double-Blind Phase|Adverse Event|6|||
126457994|NCT00992589|454978262|FG002|Double-Blind Phase|Adverse Event|2|||
126290949|NCT03620708|454352827|FG002|Overall Study|Withdrawal by Subject|1|||
126290950|NCT05126693|454352828|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
126290951|NCT05126693|454352829|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
126290952|NCT05126693|454352828|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
126290953|NCT05126693|454352829|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
126290954|NCT05126693|454352828|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
126290955|NCT05126693|454352829|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
126290956|NCT06082843|454352834|FG000|Overall Study|Withdrawal by Subject|0|||
126290957|NCT06082843|454352835|FG001|Overall Study|Withdrawal by Subject|2|||
126290958|NCT06082843|454352834|FG000|Overall Study|Study terminated by sponsor|12|||
126290959|NCT06082843|454352835|FG001|Overall Study|Study terminated by sponsor|8|||
126290960|NCT05525520|454352837|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
126290961|NCT05525520|454352838|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
126290962|NCT05525520|454352837|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
126290963|NCT05525520|454352838|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
126290964|NCT03176134|454352839|FG000|Overall Study|Lost to Follow-up|0|||
126290965|NCT03176134|454352840|FG001|Overall Study|Lost to Follow-up|2|||
126290966|NCT03176134|454352841|FG002|Overall Study|Lost to Follow-up|0|||
126290967|NCT03176134|454352842|FG003|Overall Study|Lost to Follow-up|0|||
126290968|NCT03176134|454352843|FG004|Overall Study|Lost to Follow-up|0|||
126290969|NCT03176134|454352844|FG005|Overall Study|Lost to Follow-up|0|||
126290970|NCT03176134|454352845|FG006|Overall Study|Lost to Follow-up|0|||
126290971|NCT03176134|454352846|FG007|Overall Study|Lost to Follow-up|0|||
126290972|NCT03176134|454352839|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126290973|NCT03176134|454352840|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126290974|NCT03176134|454352841|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
126290975|NCT03176134|454352842|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126290976|NCT03176134|454352843|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126290977|NCT03176134|454352844|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126290978|NCT03176134|454352845|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
126290979|NCT03176134|454352846|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
126290980|NCT05989672|454352847|FG000|Overall Study|Adverse Event|3|||
126290981|NCT05989672|454352848|FG001|Overall Study|Adverse Event|0|||
126290982|NCT05989672|454352849|FG002|Overall Study|Adverse Event|0|||
126290983|NCT00443729|454352850|FG000|Overall Study|Never Treated|0|||
126290984|NCT00443729|454352851|FG001|Overall Study|Never Treated|1|||
126290985|NCT00443729|454352850|FG000|Overall Study|Lack of Efficacy|4|||
126290986|NCT00443729|454352851|FG001|Overall Study|Lack of Efficacy|2|||
126290987|NCT00443729|454352850|FG000|Overall Study|Lost to Follow-up|0|||
126290988|NCT00443729|454352851|FG001|Overall Study|Lost to Follow-up|1|||
126290989|NCT00443729|454352850|FG000|Overall Study|Physician Decision|2|||
126290990|NCT00443729|454352851|FG001|Overall Study|Physician Decision|1|||
126290991|NCT00443729|454352850|FG000|Overall Study|Protocol Violation|1|||
126290992|NCT00443729|454352851|FG001|Overall Study|Protocol Violation|1|||
126290993|NCT00443729|454352850|FG000|Overall Study|Withdrawal by Subject|3|||
126290994|NCT00443729|454352851|FG001|Overall Study|Withdrawal by Subject|1|||
126290995|NCT03642262|454352852|FG000|Period 1|Withdrawal by Subject|1|||
126290996|NCT03642262|454352853|FG001|Period 1|Withdrawal by Subject|1|||
126290997|NCT03642262|454352852|FG000|Period 1|Adverse Event|0|||
126290998|NCT03642262|454352853|FG001|Period 1|Adverse Event|1|||
126290999|NCT03718832|454352860|FG000|Analysis Sample|Withdrawal by Subject|18|||
126291000|NCT03718832|454352861|FG001|Analysis Sample|Withdrawal by Subject|15|||
126291001|NCT03718832|454352860|FG000|Analysis Sample|Legal hold on data|1|||
126291002|NCT03718832|454352861|FG001|Analysis Sample|Legal hold on data|0|||
126291003|NCT03718832|454352860|FG000|Analysis Sample|Participant from treated household|0|||
126291004|NCT03718832|454352861|FG001|Analysis Sample|Participant from treated household|1|||
126291005|NCT03718832|454352860|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
126291006|NCT03718832|454352861|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
126291007|NCT02760004|454352865|FG000|Overall Study|Lost to Follow-up|13|||
126291008|NCT02760004|454352866|FG001|Overall Study|Lost to Follow-up|22|||
126366202|NCT04079920|454635782|FG000|Overall Study|Lost to Follow-up|22|||
126366203|NCT04079920|454635782|FG000|Overall Study|Physician Decision|1|||
126366204|NCT04079920|454635782|FG000|Overall Study|Withdrawal by Subject|11|||
126366205|NCT04918771|454635783|FG000|Overall Study|Withdrawal by Subject|4|||
126366206|NCT04918771|454635784|FG001|Overall Study|Withdrawal by Subject|5|||
126366207|NCT04918771|454635783|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
126366208|NCT04918771|454635784|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
126366209|NCT00680914|454635789|FG000|Overall Study|Consent withdrawal|6|||
126710680|NCT01272180|455893514|FG002|Overall Study|Withdrawal by Subject|3|||
126710681|NCT01272180|455893515|FG003|Overall Study|Withdrawal by Subject|2|||
126710682|NCT01272180|455893512|FG000|Overall Study|Lost to Follow-up|15|||
126710683|NCT01272180|455893513|FG001|Overall Study|Lost to Follow-up|14|||
126291009|NCT03288714|454352869|FG000|Overall Study|Lost to Follow-up|2|||
126291010|NCT03288714|454352870|FG001|Overall Study|Lost to Follow-up|1|||
126291011|NCT03288714|454352869|FG000|Overall Study|Non-compliance with study schedule|2|||
126291012|NCT03288714|454352870|FG001|Overall Study|Non-compliance with study schedule|0|||
126291013|NCT03288714|454352869|FG000|Overall Study|Withdrawal by Subject|3|||
126291014|NCT03288714|454352870|FG001|Overall Study|Withdrawal by Subject|1|||
126291015|NCT03288714|454352869|FG000|Overall Study|Clinical Worsening|2|||
126366210|NCT00680914|454635790|FG001|Overall Study|Consent withdrawal|3|||
126366211|NCT00680914|454635789|FG000|Overall Study|Lost to Follow-up|4|||
126291016|NCT03288714|454352870|FG001|Overall Study|Clinical Worsening|1|||
126366212|NCT00680914|454635790|FG001|Overall Study|Lost to Follow-up|0|||
126291017|NCT03288714|454352869|FG000|Overall Study|Adverse Event|1|||
126710684|NCT01272180|455893514|FG002|Overall Study|Lost to Follow-up|8|||
126291018|NCT03288714|454352870|FG001|Overall Study|Adverse Event|0|||
126291019|NCT02203357|454352873|FG000|Overall Study|Lost to Follow-up|58|||
126291020|NCT02203357|454352874|FG001|Overall Study|Lost to Follow-up|66|||
126291021|NCT02203357|454352875|FG002|Overall Study|Lost to Follow-up|70|||
126291022|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
126291023|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
126291024|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
126291025|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291026|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
126291027|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
126291028|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291029|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291030|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291031|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291032|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291033|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291034|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291035|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291036|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291037|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291038|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
126291039|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
126291040|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291041|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
126291042|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
126291043|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
126291044|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
126291045|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291046|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291047|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291048|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291049|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291050|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291051|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291052|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291053|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291054|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291055|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
126291056|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
126291057|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
126291058|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
126291059|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
126291060|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
126291061|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
126291062|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291063|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291064|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291065|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291066|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291067|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291068|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291069|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291070|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291071|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291072|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
126291073|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291074|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
126366213|NCT00680914|454635789|FG000|Overall Study|serious adverse event (SAE)|0|||
126291075|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
126291076|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291077|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
126291078|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
126291079|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291080|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126366214|NCT00680914|454635790|FG001|Overall Study|serious adverse event (SAE)|1|||
126366215|NCT00539500|454635791|FG000|Overall Study|Disease Progression|1|||
126366216|NCT00539500|454635791|FG000|Overall Study|Lost to Follow-up|2|||
126366217|NCT01299961|454635794|FG000|Overall Study|Adverse Event|3|||
126291081|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291082|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126767024|NCT00539006|456100206|FG000|Treatment Period 1|Protocol Violation|0|||
126767025|NCT00539006|456100207|FG001|Treatment Period 1|Protocol Violation|0|||
126767026|NCT00539006|456100208|FG002|Treatment Period 1|Protocol Violation|1|||
126767027|NCT00539006|456100209|FG003|Treatment Period 1|Protocol Violation|0|||
126767028|NCT00539006|456100206|FG000|Treatment Period 1|Lack of Efficacy|0|||
126767029|NCT00539006|456100207|FG001|Treatment Period 1|Lack of Efficacy|0|||
126767030|NCT00539006|456100208|FG002|Treatment Period 1|Lack of Efficacy|0|||
126767031|NCT00539006|456100209|FG003|Treatment Period 1|Lack of Efficacy|1|||
126767032|NCT00539006|456100206|FG000|Washout|Adverse Event|2|||
126767033|NCT00539006|456100207|FG001|Washout|Adverse Event|1|||
126767034|NCT00539006|456100208|FG002|Washout|Adverse Event|0|||
126767035|NCT00539006|456100209|FG003|Washout|Adverse Event|0|||
126767036|NCT00539006|456100206|FG000|Washout|Protocol Violation|1|||
126767037|NCT00539006|456100207|FG001|Washout|Protocol Violation|1|||
126767038|NCT00539006|456100208|FG002|Washout|Protocol Violation|0|||
126767039|NCT00539006|456100209|FG003|Washout|Protocol Violation|0|||
126767040|NCT00539006|456100206|FG000|Washout|Withdrawal by Subject|0|||
126767041|NCT00539006|456100207|FG001|Washout|Withdrawal by Subject|2|||
126767042|NCT00539006|456100208|FG002|Washout|Withdrawal by Subject|0|||
126767043|NCT00539006|456100209|FG003|Washout|Withdrawal by Subject|0|||
126767044|NCT00539006|456100206|FG000|Washout|Failed to meet continuation criteria|16|||
126767045|NCT00539006|456100207|FG001|Washout|Failed to meet continuation criteria|5|||
126767046|NCT00539006|456100208|FG002|Washout|Failed to meet continuation criteria|14|||
126291083|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291084|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291085|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291086|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291087|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291088|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291089|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
126291090|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291091|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291092|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
126291093|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
126291094|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291095|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291096|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291097|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291098|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291099|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291100|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291101|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291102|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291103|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291104|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291105|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291106|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
126291107|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291108|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291109|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291110|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291111|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
126291112|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291113|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291114|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291115|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291116|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291117|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291118|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291119|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291120|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291121|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126291122|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126767047|NCT00539006|456100209|FG003|Washout|Failed to meet continuation criteria|6|||
126767048|NCT00539006|456100206|FG000|Washout|Other|1|||
126767049|NCT00539006|456100207|FG001|Washout|Other|1|||
126767050|NCT00539006|456100208|FG002|Washout|Other|2|||
126767051|NCT00539006|456100209|FG003|Washout|Other|3|||
126767052|NCT00539006|456100206|FG000|Treatment Period 2|Protocol Violation|1|||
126291123|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
126366218|NCT01299961|454635794|FG000|Overall Study|Lack of Efficacy|2|||
126291124|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291125|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
126291126|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291127|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291128|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291129|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291130|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291131|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291132|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291133|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291134|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291135|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291136|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291137|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291138|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291139|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291140|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
126291141|NCT00758524|454352877|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291142|NCT00758524|454352878|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
126291143|NCT00758524|454352879|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291144|NCT00758524|454352880|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291145|NCT00758524|454352881|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291146|NCT00758524|454352882|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291147|NCT00758524|454352883|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291148|NCT00758524|454352884|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291149|NCT00758524|454352885|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291150|NCT00758524|454352886|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291151|NCT00758524|454352887|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291152|NCT00758524|454352888|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291153|NCT00758524|454352889|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291154|NCT00758524|454352890|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291155|NCT00758524|454352891|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291156|NCT00758524|454352892|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291157|NCT00758524|454352893|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
126291158|NCT00758524|454352877|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291159|NCT00758524|454352878|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291160|NCT00758524|454352879|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291161|NCT00758524|454352880|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291162|NCT00758524|454352881|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291163|NCT00758524|454352882|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291164|NCT00758524|454352883|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291165|NCT00758524|454352884|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291166|NCT00758524|454352885|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
126291167|NCT00758524|454352886|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291168|NCT00758524|454352887|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291169|NCT00758524|454352888|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291170|NCT00758524|454352889|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291171|NCT00758524|454352890|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291172|NCT00758524|454352891|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291173|NCT00758524|454352892|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291174|NCT00758524|454352893|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
126291175|NCT00758524|454352877|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291176|NCT00758524|454352878|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291177|NCT00758524|454352879|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291178|NCT00758524|454352880|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291179|NCT00758524|454352881|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291180|NCT00758524|454352882|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291181|NCT00758524|454352883|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
126291182|NCT00758524|454352884|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291183|NCT00758524|454352885|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126366219|NCT01299961|454635794|FG000|Overall Study|Lost to Follow-up|1|||
126366220|NCT02904096|454635795|FG000|Overall Study|Adverse Event|1|||
126366221|NCT02904096|454635796|FG001|Overall Study|Adverse Event|0|||
126457995|NCT00992589|454978263|FG003|Double-Blind Phase|Adverse Event|3|||
126457996|NCT00992589|454978260|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
126457997|NCT00992589|454978261|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
126457998|NCT00992589|454978262|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
126457999|NCT00992589|454978263|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
126458000|NCT00992589|454978260|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126458001|NCT00992589|454978261|FG001|Double-Blind Phase|Lost to Follow-up|0|||
126291184|NCT00758524|454352886|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291185|NCT00758524|454352887|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291186|NCT00758524|454352888|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126458002|NCT00992589|454978262|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126458003|NCT00992589|454978263|FG003|Double-Blind Phase|Lost to Follow-up|2|||
126458004|NCT00992589|454978260|FG000|Double-Blind Phase|Other|0|||
126458005|NCT00992589|454978261|FG001|Double-Blind Phase|Other|1|||
126458006|NCT00992589|454978262|FG002|Double-Blind Phase|Other|6|||
126458007|NCT00992589|454978263|FG003|Double-Blind Phase|Other|3|||
126291187|NCT00758524|454352889|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291188|NCT00758524|454352890|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291189|NCT00758524|454352891|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291190|NCT00758524|454352892|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291191|NCT00758524|454352893|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
126291192|NCT01973439|454352897|FG000|Overall Study|Lost samples from one PK Day|2|||
126291193|NCT01973439|454352897|FG000|Overall Study|Vomiting after commencing once daily|1|||
126291194|NCT01973439|454352897|FG000|Overall Study|PK curve incomplete|2|||
126291195|NCT02038010|454352898|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
126291196|NCT02038010|454352899|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
126291197|NCT02038010|454352900|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
126291198|NCT02038010|454352901|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
126291199|NCT02038010|454352898|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
126291200|NCT02038010|454352899|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
126291201|NCT02038010|454352900|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
126291202|NCT02038010|454352901|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
126291203|NCT02038010|454352898|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
126291204|NCT02038010|454352899|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
126291205|NCT02038010|454352900|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
126291206|NCT02038010|454352901|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
126291207|NCT02038010|454352898|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
126291208|NCT02038010|454352899|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
126291209|NCT02038010|454352900|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
126291210|NCT02038010|454352901|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
126291211|NCT02038010|454352898|FG000|Follow Up|Death|4|||
126291212|NCT02038010|454352899|FG001|Follow Up|Death|3|||
126291213|NCT02038010|454352900|FG002|Follow Up|Death|0|||
126291214|NCT02038010|454352901|FG003|Follow Up|Death|0|||
126291215|NCT02038010|454352898|FG000|Follow Up|Other|3|||
126291216|NCT02038010|454352899|FG001|Follow Up|Other|0|||
126291217|NCT02038010|454352900|FG002|Follow Up|Other|0|||
126291218|NCT02038010|454352901|FG003|Follow Up|Other|0|||
126291219|NCT02815995|454352902|FG000|Overall Study|Disease Progression|3|||
126291220|NCT02815995|454352903|FG001|Overall Study|Disease Progression|7|||
126291221|NCT02815995|454352904|FG002|Overall Study|Disease Progression|2|||
126291222|NCT02815995|454352905|FG003|Overall Study|Disease Progression|4|||
126291223|NCT02815995|454352906|FG004|Overall Study|Disease Progression|3|||
126458008|NCT01215916|454978264|FG000|Overall Study|Progressive Disease|0|||
126458009|NCT01215916|454978265|FG001|Overall Study|Progressive Disease|2|||
126458010|NCT01215916|454978266|FG002|Overall Study|Progressive Disease|1|||
126458011|NCT01215916|454978267|FG003|Overall Study|Progressive Disease|2|||
126458012|NCT01215916|454978268|FG004|Overall Study|Progressive Disease|5|||
126458013|NCT01215916|454978269|FG005|Overall Study|Progressive Disease|4|||
126458014|NCT01215916|454978270|FG006|Overall Study|Progressive Disease|5|||
126291224|NCT02815995|454352907|FG005|Overall Study|Disease Progression|9|||
126291225|NCT02815995|454352908|FG006|Overall Study|Disease Progression|3|||
126291226|NCT02815995|454352909|FG007|Overall Study|Disease Progression|1|||
126291227|NCT02815995|454352902|FG000|Overall Study|Adverse Event|1|||
126291228|NCT02815995|454352903|FG001|Overall Study|Adverse Event|2|||
126291229|NCT02815995|454352904|FG002|Overall Study|Adverse Event|2|||
126291230|NCT02815995|454352905|FG003|Overall Study|Adverse Event|0|||
126458015|NCT01215916|454978271|FG007|Overall Study|Progressive Disease|3|||
126458016|NCT01215916|454978272|FG008|Overall Study|Progressive Disease|1|||
126458017|NCT01215916|454978264|FG000|Overall Study|Adverse Event|1|||
126458018|NCT01215916|454978265|FG001|Overall Study|Adverse Event|1|||
126458019|NCT01215916|454978266|FG002|Overall Study|Adverse Event|0|||
126458020|NCT01215916|454978267|FG003|Overall Study|Adverse Event|1|||
126710685|NCT01272180|455893515|FG003|Overall Study|Lost to Follow-up|10|||
126458021|NCT01215916|454978268|FG004|Overall Study|Adverse Event|0|||
126291231|NCT02815995|454352906|FG004|Overall Study|Adverse Event|0|||
126291232|NCT02815995|454352907|FG005|Overall Study|Adverse Event|1|||
126291233|NCT02815995|454352908|FG006|Overall Study|Adverse Event|0|||
126291234|NCT02815995|454352909|FG007|Overall Study|Adverse Event|0|||
126291235|NCT02815995|454352902|FG000|Overall Study|Pregnancy|0|||
126291236|NCT02815995|454352903|FG001|Overall Study|Pregnancy|0|||
126291237|NCT02815995|454352904|FG002|Overall Study|Pregnancy|0|||
126291238|NCT02815995|454352905|FG003|Overall Study|Pregnancy|0|||
126291239|NCT02815995|454352906|FG004|Overall Study|Pregnancy|0|||
126291240|NCT02815995|454352907|FG005|Overall Study|Pregnancy|0|||
126291241|NCT02815995|454352908|FG006|Overall Study|Pregnancy|1|||
126291242|NCT02815995|454352909|FG007|Overall Study|Pregnancy|0|||
126291243|NCT03571828|454352910|FG000|Overall Study|Withdrawal by Subject|1|||
126291244|NCT03571828|454352911|FG001|Overall Study|Withdrawal by Subject|0|||
126291245|NCT03571828|454352910|FG000|Overall Study|Decision by sponsor|5|||
126291246|NCT03571828|454352911|FG001|Overall Study|Decision by sponsor|1|||
126291247|NCT03571828|454352910|FG000|Overall Study|Death|2|||
126291248|NCT03571828|454352911|FG001|Overall Study|Death|0|||
126291249|NCT01870778|454352912|FG000|Overall Study|Withdrawal by Subject|8|||
126291250|NCT01870778|454352913|FG001|Overall Study|Withdrawal by Subject|7|||
126291251|NCT01870778|454352912|FG000|Overall Study|Lost to Follow-up|0|||
126291252|NCT01870778|454352913|FG001|Overall Study|Lost to Follow-up|2|||
126291253|NCT00786409|454352917|FG000|Overall Study|Withdrawal by Subject|2|||
126291254|NCT00786409|454352917|FG000|Overall Study|Adverse Event|2|||
126291255|NCT00786409|454352917|FG000|Overall Study|Pregnancy|2|||
126291256|NCT00786409|454352917|FG000|Overall Study|Lost to Follow-up|1|||
126291257|NCT00610129|454352918|FG000|Overall Study|Not treated since patients ineligible|3|||
126291258|NCT02198963|454352924|FG000|Overall Study|Adverse Event|1|||
126291259|NCT02198963|454352924|FG000|Overall Study|Withdrawal by Subject|6|||
126291260|NCT00281957|454352929|FG000|Overall Study|Adverse Event|7|||
126291261|NCT00281957|454352930|FG001|Overall Study|Adverse Event|2|||
126291262|NCT00281957|454352929|FG000|Overall Study|Death|1|||
126291263|NCT00281957|454352930|FG001|Overall Study|Death|0|||
126291264|NCT00281957|454352929|FG000|Overall Study|Progression/relapse|47|||
126291265|NCT00281957|454352930|FG001|Overall Study|Progression/relapse|35|||
126291266|NCT00281957|454352929|FG000|Overall Study|Not protocol specified|8|||
126291267|NCT00281957|454352930|FG001|Overall Study|Not protocol specified|1|||
126291268|NCT00281957|454352929|FG000|Overall Study|Not eligible|1|||
126291269|NCT00281957|454352930|FG001|Overall Study|Not eligible|2|||
126291270|NCT00281957|454352929|FG000|Overall Study|Did not start treatment|3|||
126291271|NCT00281957|454352930|FG001|Overall Study|Did not start treatment|1|||
126291272|NCT00281957|454352929|FG000|Overall Study|Refusal unrelated to adverse events|0|||
126291273|NCT00281957|454352930|FG001|Overall Study|Refusal unrelated to adverse events|1|||
126291274|NCT01876446|454352931|FG000|Overall Study|Death|0|||
126291275|NCT01876446|454352932|FG001|Overall Study|Death|1|||
126291276|NCT01876446|454352931|FG000|Overall Study|Withdrawal by Subject|1|||
126291277|NCT01876446|454352932|FG001|Overall Study|Withdrawal by Subject|2|||
126291278|NCT01876446|454352931|FG000|Overall Study|Physician Decision|1|||
126291279|NCT01876446|454352932|FG001|Overall Study|Physician Decision|3|||
126291280|NCT03180645|454352934|FG000|Overall Study|Adverse Event|0|||
126291281|NCT03180645|454352935|FG001|Overall Study|Adverse Event|1|||
126291282|NCT03180645|454352936|FG002|Overall Study|Adverse Event|2|||
126291283|NCT01808573|454352937|FG000|Overall Study|Death|212|||
126291284|NCT01808573|454352938|FG001|Overall Study|Death|240|||
126291285|NCT01808573|454352937|FG000|Overall Study|Withdrawal by Subject|12|||
126291286|NCT01808573|454352938|FG001|Overall Study|Withdrawal by Subject|10|||
126291287|NCT01808573|454352937|FG000|Overall Study|Lost to Follow-up|3|||
126291288|NCT01808573|454352938|FG001|Overall Study|Lost to Follow-up|0|||
126291289|NCT01808573|454352937|FG000|Overall Study|Discontinuation of study by sponsor|79|||
126291290|NCT01808573|454352938|FG001|Overall Study|Discontinuation of study by sponsor|64|||
126291291|NCT01808573|454352937|FG000|Overall Study|Randomized in Error|1|||
126291292|NCT01808573|454352938|FG001|Overall Study|Randomized in Error|0|||
126291293|NCT00995774|454352939|FG000|Training Period 2|Withdrawal by Subject|2|||
126291294|NCT00995774|454352940|FG001|Training Period 2|Withdrawal by Subject|0|||
126291295|NCT03953612|454352941|FG000|Overall Study|Randomized but did not start|1|||
126291296|NCT03953612|454352942|FG001|Overall Study|Randomized but did not start|1|||
126291297|NCT03953612|454352943|FG002|Overall Study|Randomized but did not start|1|||
126291298|NCT03953612|454352941|FG000|Overall Study|Withdrawal by Subject|2|||
126291299|NCT03953612|454352942|FG001|Overall Study|Withdrawal by Subject|1|||
126291300|NCT03953612|454352943|FG002|Overall Study|Withdrawal by Subject|0|||
126291301|NCT01461538|454352959|FG000|Overall Study|Death|15|||
126291302|NCT01461538|454352960|FG001|Overall Study|Death|6|||
126291303|NCT01461538|454352961|FG002|Overall Study|Death|2|||
126291304|NCT01461538|454352959|FG000|Overall Study|Study Stopped by Sponsor|2|||
126291305|NCT01461538|454352960|FG001|Overall Study|Study Stopped by Sponsor|1|||
126291306|NCT01461538|454352961|FG002|Overall Study|Study Stopped by Sponsor|0|||
126291307|NCT01461538|454352959|FG000|Overall Study|Withdrawal by Subject|1|||
126291308|NCT01461538|454352960|FG001|Overall Study|Withdrawal by Subject|1|||
126366222|NCT02904096|454635795|FG000|Overall Study|Withdrawal by Subject|4|||
126291309|NCT01461538|454352961|FG002|Overall Study|Withdrawal by Subject|0|||
126291310|NCT00141778|454352962|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
126291311|NCT00141778|454352963|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
126291312|NCT00141778|454352964|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
126291313|NCT00141778|454352962|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
126291314|NCT00141778|454352963|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
126291315|NCT00141778|454352964|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
126291316|NCT00141778|454352962|FG000|Started Study Medication|Withdrawal by Subject|0|||
126291317|NCT00141778|454352963|FG001|Started Study Medication|Withdrawal by Subject|2|||
126291318|NCT00141778|454352964|FG002|Started Study Medication|Withdrawal by Subject|0|||
126291319|NCT00141778|454352962|FG000|Started Study Medication|Difficulty Swallowing|0|||
126291320|NCT00141778|454352963|FG001|Started Study Medication|Difficulty Swallowing|1|||
126291321|NCT00141778|454352964|FG002|Started Study Medication|Difficulty Swallowing|0|||
126291322|NCT00141778|454352962|FG000|Started Study Medication|Chest Discomfort|0|||
126291323|NCT00141778|454352963|FG001|Started Study Medication|Chest Discomfort|0|||
126291324|NCT00141778|454352964|FG002|Started Study Medication|Chest Discomfort|1|||
126291325|NCT02729909|454352965|FG000|Overall Study|Lost to Follow-up|0|||
126291326|NCT02729909|454352966|FG001|Overall Study|Lost to Follow-up|1|||
126291327|NCT02729909|454352965|FG000|Overall Study|Lack of Efficacy|0|||
126291328|NCT02729909|454352966|FG001|Overall Study|Lack of Efficacy|2|||
126291329|NCT02729909|454352965|FG000|Overall Study|Significant Protocol Deviation|0|||
126291330|NCT02729909|454352966|FG001|Overall Study|Significant Protocol Deviation|2|||
126291331|NCT02729909|454352965|FG000|Overall Study|Voluntary Withdrawal|1|||
126291332|NCT02729909|454352966|FG001|Overall Study|Voluntary Withdrawal|0|||
126291333|NCT01245283|454352971|FG000|Overall Study|Lost to Follow-up|14|||
126291334|NCT01245283|454352972|FG001|Overall Study|Lost to Follow-up|11|||
126291335|NCT01245283|454352973|FG002|Overall Study|Lost to Follow-up|11|||
126291336|NCT01610492|454352976|FG000|Overall Study|Adverse Event|1|||
126291337|NCT01610492|454352976|FG000|Overall Study|Lack of Efficacy|3|||
126291338|NCT01610492|454352976|FG000|Overall Study|Other: Reached stopping criteria|1|||
126291339|NCT01610492|454352976|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
126291340|NCT01982955|454352977|FG000|Overall Study|Randomized but not treated|0|||
126291341|NCT01982955|454352978|FG001|Overall Study|Randomized but not treated|0|||
126291342|NCT01982955|454352979|FG002|Overall Study|Randomized but not treated|0|||
126291343|NCT01982955|454352980|FG003|Overall Study|Randomized but not treated|1|||
126291344|NCT01982955|454352981|FG004|Overall Study|Randomized but not treated|0|||
126291345|NCT03657797|454355104|FG000|Overall Study|Lost to Follow-up|0|||
126291346|NCT03657797|454355105|FG001|Overall Study|Lost to Follow-up|1|||
126291347|NCT03657797|454355106|FG002|Overall Study|Lost to Follow-up|1|||
126291348|NCT03657797|454355107|FG003|Overall Study|Lost to Follow-up|0|||
126291349|NCT03657797|454355104|FG000|Overall Study|Physician Decision|0|||
126291350|NCT03657797|454355105|FG001|Overall Study|Physician Decision|1|||
126291351|NCT03657797|454355106|FG002|Overall Study|Physician Decision|0|||
126291352|NCT03657797|454355107|FG003|Overall Study|Physician Decision|0|||
126291353|NCT03657797|454355104|FG000|Overall Study|Withdrawal by Subject|0|||
126291354|NCT03657797|454355105|FG001|Overall Study|Withdrawal by Subject|1|||
126291355|NCT03657797|454355106|FG002|Overall Study|Withdrawal by Subject|2|||
126291356|NCT03657797|454355107|FG003|Overall Study|Withdrawal by Subject|0|||
126291357|NCT03657797|454355104|FG000|Overall Study|Adverse Event|0|||
126291358|NCT03657797|454355105|FG001|Overall Study|Adverse Event|0|||
126291359|NCT03657797|454355106|FG002|Overall Study|Adverse Event|2|||
126291360|NCT03657797|454355107|FG003|Overall Study|Adverse Event|0|||
126291361|NCT00118157|454355108|FG000|Overall Study|Adverse Event|2|||
126291362|NCT00118157|454355108|FG000|Overall Study|Death|8|||
126291363|NCT00118157|454355108|FG000|Overall Study|Withdrawal by Subject|2|||
126291364|NCT00696423|454355109|FG000|Overall Study|Lost to Follow-up|0|||
126291365|NCT00696423|454355110|FG001|Overall Study|Lost to Follow-up|5|||
126291366|NCT03989102|454355111|FG000|Year 1|Withdrawal by Subject|6|||
126291367|NCT03989102|454355112|FG001|Year 1|Withdrawal by Subject|2|||
126291368|NCT03989102|454355113|FG002|Year 1|Withdrawal by Subject|7|||
126291369|NCT03989102|454355111|FG000|Year 1|Lost to Follow-up|5|||
126291370|NCT03989102|454355112|FG001|Year 1|Lost to Follow-up|2|||
126549780|NCT00251927|455307579|FG001|Overall Study|Study procedure non-compliance|6|||
126549781|NCT02406261|455307589|FG000|Period 1|Lost to Follow-up|2|||
126291371|NCT03989102|454355113|FG002|Year 1|Lost to Follow-up|5|||
126291372|NCT03989102|454355111|FG000|Year 1|Subject met withdrawal criteria|1|||
126291373|NCT03989102|454355112|FG001|Year 1|Subject met withdrawal criteria|0|||
126291374|NCT03989102|454355113|FG002|Year 1|Subject met withdrawal criteria|1|||
126291375|NCT03989102|454355111|FG000|Year 2|Lost to Follow-up|7|||
126291376|NCT03989102|454355112|FG001|Year 2|Lost to Follow-up|3|||
126291377|NCT03989102|454355113|FG002|Year 2|Lost to Follow-up|4|||
126291378|NCT03989102|454355111|FG000|Year 2|Withdrawal by Subject|3|||
126291379|NCT03989102|454355112|FG001|Year 2|Withdrawal by Subject|1|||
126291380|NCT03989102|454355113|FG002|Year 2|Withdrawal by Subject|2|||
126291381|NCT03989102|454355111|FG000|Year 2|Subject non-compliant|3|||
126291382|NCT03989102|454355112|FG001|Year 2|Subject non-compliant|2|||
126291383|NCT03989102|454355113|FG002|Year 2|Subject non-compliant|0|||
126291384|NCT03989102|454355111|FG000|Year 2|Travel|1|||
126291385|NCT03989102|454355112|FG001|Year 2|Travel|0|||
126291386|NCT03989102|454355113|FG002|Year 2|Travel|1|||
126291387|NCT03989102|454355111|FG000|Year 2|P16 missing|4|||
126291388|NCT03989102|454355112|FG001|Year 2|P16 missing|2|||
126291389|NCT03989102|454355113|FG002|Year 2|P16 missing|1|||
126291390|NCT03989102|454355111|FG000|Year 2|P11 missing|1|||
126291391|NCT03989102|454355112|FG001|Year 2|P11 missing|3|||
126291392|NCT03989102|454355113|FG002|Year 2|P11 missing|7|||
126291393|NCT03989102|454355111|FG000|Year 2|Definitive displacement outside the study site|0|||
126291394|NCT03989102|454355112|FG001|Year 2|Definitive displacement outside the study site|1|||
126291395|NCT03989102|454355113|FG002|Year 2|Definitive displacement outside the study site|0|||
126291396|NCT03989102|454355111|FG000|Year 2|Subject missed last study visit|0|||
126291397|NCT03989102|454355112|FG001|Year 2|Subject missed last study visit|1|||
126291398|NCT03989102|454355113|FG002|Year 2|Subject missed last study visit|0|||
126291399|NCT03989102|454355111|FG000|Year 2|Death|0|||
126291400|NCT03989102|454355112|FG001|Year 2|Death|1|||
126291401|NCT03989102|454355113|FG002|Year 2|Death|0|||
126291402|NCT03989102|454355111|FG000|Year 2|Subject not reachable|0|||
126291403|NCT03989102|454355112|FG001|Year 2|Subject not reachable|0|||
126291404|NCT03989102|454355113|FG002|Year 2|Subject not reachable|1|||
126291405|NCT03989102|454355111|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
126291406|NCT03989102|454355112|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
126291407|NCT03989102|454355113|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
126291408|NCT03989102|454355111|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
126291409|NCT03989102|454355112|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
126291410|NCT03989102|454355113|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
126291411|NCT03989102|454355111|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
126291412|NCT03989102|454355112|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
126291413|NCT03989102|454355113|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
126291414|NCT03989102|454355111|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
126291415|NCT03989102|454355112|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
126291416|NCT03989102|454355113|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
126291417|NCT03989102|454355111|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
126291418|NCT03989102|454355112|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
126291419|NCT03989102|454355113|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
126291420|NCT03989102|454355111|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
126291421|NCT03989102|454355112|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
126291422|NCT03989102|454355113|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
126291423|NCT01050530|454355114|FG000|Overall Study|Adverse Event|6|||
126291424|NCT01050530|454355115|FG001|Overall Study|Adverse Event|3|||
126291425|NCT01050530|454355114|FG000|Overall Study|Lack of Efficacy|1|||
126291426|NCT01050530|454355115|FG001|Overall Study|Lack of Efficacy|4|||
126291427|NCT01050530|454355114|FG000|Overall Study|Withdrawal by Subject|0|||
126291428|NCT01050530|454355115|FG001|Overall Study|Withdrawal by Subject|3|||
126291429|NCT01050530|454355114|FG000|Overall Study|Protocol Violation|1|||
126291430|NCT01050530|454355115|FG001|Overall Study|Protocol Violation|0|||
126291431|NCT02288312|454355116|FG000|Overall Study|Pregnancy|1|||
126291432|NCT02288312|454355117|FG001|Overall Study|Pregnancy|0|||
126291433|NCT02288312|454355118|FG002|Overall Study|Pregnancy|0|||
126291434|NCT01276041|454355119|FG000|Overall Study|Adverse Event|2|||
126291435|NCT01276041|454355119|FG000|Overall Study|Protocol Violation|1|||
126291436|NCT00485264|454355120|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
126291437|NCT00485264|454355121|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
126291438|NCT00485264|454355122|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
126291439|NCT00485264|454355123|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
126291440|NCT00485264|454355124|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
126291441|NCT00485264|454355125|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
126291442|NCT00485264|454355120|FG000|Overall Study|Death|1|||
126291443|NCT00485264|454355121|FG001|Overall Study|Death|0|||
126291444|NCT00485264|454355122|FG002|Overall Study|Death|0|||
126291445|NCT00485264|454355123|FG003|Overall Study|Death|0|||
126291446|NCT00485264|454355124|FG004|Overall Study|Death|1|||
126291447|NCT00485264|454355125|FG005|Overall Study|Death|0|||
126291448|NCT00485264|454355120|FG000|Overall Study|Adverse Event|1|||
126291449|NCT00485264|454355121|FG001|Overall Study|Adverse Event|0|||
126291450|NCT00485264|454355122|FG002|Overall Study|Adverse Event|2|||
126291451|NCT00485264|454355123|FG003|Overall Study|Adverse Event|3|||
126291452|NCT00485264|454355124|FG004|Overall Study|Adverse Event|1|||
126549782|NCT02406261|455307590|FG001|Period 1|Lost to Follow-up|0|||
126549783|NCT02406261|455307589|FG000|Period 1|Adverse Event|1|||
126291453|NCT00485264|454355125|FG005|Overall Study|Adverse Event|3|||
126291454|NCT00485264|454355120|FG000|Overall Study|Pregnancy|4|||
126549784|NCT02406261|455307590|FG001|Period 1|Adverse Event|0|||
126291455|NCT00485264|454355121|FG001|Overall Study|Pregnancy|0|||
126291456|NCT00485264|454355122|FG002|Overall Study|Pregnancy|0|||
126291457|NCT00485264|454355123|FG003|Overall Study|Pregnancy|0|||
126291458|NCT00485264|454355124|FG004|Overall Study|Pregnancy|0|||
126710686|NCT01272180|455893512|FG000|Overall Study|Inappropriate enrollment|0|||
126710687|NCT01272180|455893513|FG001|Overall Study|Inappropriate enrollment|0|||
126710688|NCT01272180|455893514|FG002|Overall Study|Inappropriate enrollment|1|||
126291459|NCT00485264|454355125|FG005|Overall Study|Pregnancy|0|||
126291460|NCT00485264|454355120|FG000|Overall Study|Disallowed Medication|0|||
126291461|NCT00485264|454355121|FG001|Overall Study|Disallowed Medication|0|||
126291462|NCT00485264|454355122|FG002|Overall Study|Disallowed Medication|0|||
126291463|NCT00485264|454355123|FG003|Overall Study|Disallowed Medication|0|||
126291464|NCT00485264|454355124|FG004|Overall Study|Disallowed Medication|0|||
126291465|NCT00485264|454355125|FG005|Overall Study|Disallowed Medication|1|||
126291466|NCT00485264|454355120|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
126291467|NCT00485264|454355121|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
126291468|NCT00485264|454355122|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
126291469|NCT00485264|454355123|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
126291470|NCT00485264|454355124|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
126291471|NCT00485264|454355125|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
126291472|NCT00485264|454355120|FG000|Overall Study|Lack of Efficacy|0|||
126291473|NCT00485264|454355121|FG001|Overall Study|Lack of Efficacy|1|||
126291474|NCT00485264|454355122|FG002|Overall Study|Lack of Efficacy|0|||
126291475|NCT00485264|454355123|FG003|Overall Study|Lack of Efficacy|0|||
126291476|NCT00485264|454355124|FG004|Overall Study|Lack of Efficacy|0|||
126291477|NCT00485264|454355125|FG005|Overall Study|Lack of Efficacy|0|||
126291478|NCT00485264|454355120|FG000|Overall Study|Guardian Consent Withdrawn|1|||
126291479|NCT00485264|454355121|FG001|Overall Study|Guardian Consent Withdrawn|0|||
126291480|NCT00485264|454355122|FG002|Overall Study|Guardian Consent Withdrawn|0|||
126291481|NCT00485264|454355123|FG003|Overall Study|Guardian Consent Withdrawn|0|||
126291482|NCT00485264|454355124|FG004|Overall Study|Guardian Consent Withdrawn|1|||
126291483|NCT00485264|454355125|FG005|Overall Study|Guardian Consent Withdrawn|0|||
126291484|NCT00485264|454355120|FG000|Overall Study|Physician Decision|0|||
126291485|NCT00485264|454355121|FG001|Overall Study|Physician Decision|2|||
126291486|NCT00485264|454355122|FG002|Overall Study|Physician Decision|0|||
126291487|NCT00485264|454355123|FG003|Overall Study|Physician Decision|0|||
126291488|NCT00485264|454355124|FG004|Overall Study|Physician Decision|0|||
126291489|NCT00485264|454355125|FG005|Overall Study|Physician Decision|0|||
126291490|NCT00485264|454355120|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
126291491|NCT00485264|454355121|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
126291492|NCT00485264|454355122|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
126291493|NCT00485264|454355123|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
126291494|NCT00485264|454355124|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
126291495|NCT00485264|454355125|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
126291496|NCT00485264|454355120|FG000|Overall Study|Not Able to Attend Clinic|5|||
126291497|NCT00485264|454355121|FG001|Overall Study|Not Able to Attend Clinic|0|||
126291498|NCT00485264|454355122|FG002|Overall Study|Not Able to Attend Clinic|0|||
126291499|NCT00485264|454355123|FG003|Overall Study|Not Able to Attend Clinic|1|||
126291500|NCT00485264|454355124|FG004|Overall Study|Not Able to Attend Clinic|1|||
126291501|NCT00485264|454355125|FG005|Overall Study|Not Able to Attend Clinic|2|||
126291502|NCT00485264|454355120|FG000|Overall Study|Non-Compliant|17|||
126291503|NCT00485264|454355121|FG001|Overall Study|Non-Compliant|2|||
126291504|NCT00485264|454355122|FG002|Overall Study|Non-Compliant|1|||
126291505|NCT00485264|454355123|FG003|Overall Study|Non-Compliant|0|||
126291506|NCT00485264|454355124|FG004|Overall Study|Non-Compliant|1|||
126291507|NCT00485264|454355125|FG005|Overall Study|Non-Compliant|0|||
126291508|NCT00485264|454355120|FG000|Overall Study|Lost to Follow-up|2|||
126291509|NCT00485264|454355121|FG001|Overall Study|Lost to Follow-up|1|||
126291510|NCT00485264|454355122|FG002|Overall Study|Lost to Follow-up|1|||
126291511|NCT00485264|454355123|FG003|Overall Study|Lost to Follow-up|0|||
126291512|NCT00485264|454355124|FG004|Overall Study|Lost to Follow-up|0|||
126291513|NCT00485264|454355125|FG005|Overall Study|Lost to Follow-up|1|||
126291514|NCT00485264|454355120|FG000|Overall Study|Other Reason|3|||
126291515|NCT00485264|454355121|FG001|Overall Study|Other Reason|0|||
126291516|NCT00485264|454355122|FG002|Overall Study|Other Reason|0|||
126291517|NCT00485264|454355123|FG003|Overall Study|Other Reason|0|||
126291518|NCT00485264|454355124|FG004|Overall Study|Other Reason|0|||
126291519|NCT00485264|454355125|FG005|Overall Study|Other Reason|0|||
126291520|NCT00276484|454355126|FG000|Overall Study|Adverse Event|4|||
126458022|NCT01215916|454978269|FG005|Overall Study|Adverse Event|0|||
126291521|NCT00276484|454355127|FG001|Overall Study|Adverse Event|7|||
126291522|NCT00276484|454355126|FG000|Overall Study|Lost to Follow-up|1|||
126291523|NCT00276484|454355127|FG001|Overall Study|Lost to Follow-up|1|||
126291524|NCT00276484|454355126|FG000|Overall Study|Protocol Violation|0|||
126291525|NCT00276484|454355127|FG001|Overall Study|Protocol Violation|1|||
126291526|NCT00276484|454355126|FG000|Overall Study|Withdrawal by Subject|4|||
126291527|NCT00276484|454355127|FG001|Overall Study|Withdrawal by Subject|3|||
126291528|NCT00276484|454355126|FG000|Overall Study|Could not take time off work|0|||
126291529|NCT00276484|454355127|FG001|Overall Study|Could not take time off work|1|||
126291530|NCT02440464|454355128|FG000|Overall Study|Withdrawal by Subject|3|||
126291531|NCT02440464|454355129|FG001|Overall Study|Withdrawal by Subject|2|||
126291532|NCT01626690|454355130|FG000|Overall Study|Protocol Violation|1|||
126291533|NCT01626690|454355131|FG001|Overall Study|Protocol Violation|0|||
126291534|NCT01626690|454355130|FG000|Overall Study|Adverse Event|1|||
126291535|NCT01626690|454355131|FG001|Overall Study|Adverse Event|0|||
126291536|NCT04688671|454355132|FG000|Overall Study|Adverse Event|3|||
126291537|NCT04688671|454355133|FG001|Overall Study|Adverse Event|1|||
126291538|NCT04688671|454355132|FG000|Overall Study|Withdrawal by Subject|3|||
126291539|NCT04688671|454355133|FG001|Overall Study|Withdrawal by Subject|1|||
126291540|NCT04688671|454355132|FG000|Overall Study|Lack of Efficacy|1|||
126291541|NCT04688671|454355133|FG001|Overall Study|Lack of Efficacy|1|||
126291542|NCT04688671|454355132|FG000|Overall Study|Protocol Violation|1|||
126291543|NCT04688671|454355133|FG001|Overall Study|Protocol Violation|0|||
126291544|NCT04688671|454355132|FG000|Overall Study|Lost to Follow-up|0|||
126291545|NCT04688671|454355133|FG001|Overall Study|Lost to Follow-up|1|||
126291546|NCT02414958|454355137|FG000|Overall Study|Adverse Event|6|||
126291547|NCT02414958|454355138|FG001|Overall Study|Adverse Event|6|||
126291548|NCT02414958|454355139|FG002|Overall Study|Adverse Event|3|||
126291549|NCT02414958|454355137|FG000|Overall Study|Protocol Violation|10|||
126291550|NCT02414958|454355138|FG001|Overall Study|Protocol Violation|3|||
126291551|NCT02414958|454355139|FG002|Overall Study|Protocol Violation|1|||
126291552|NCT02414958|454355137|FG000|Overall Study|Lost to Follow-up|7|||
126291553|NCT02414958|454355138|FG001|Overall Study|Lost to Follow-up|4|||
126291554|NCT02414958|454355139|FG002|Overall Study|Lost to Follow-up|0|||
126291555|NCT02414958|454355137|FG000|Overall Study|Withdrawal by Subject|5|||
126291556|NCT02414958|454355138|FG001|Overall Study|Withdrawal by Subject|3|||
126291557|NCT02414958|454355139|FG002|Overall Study|Withdrawal by Subject|5|||
126291558|NCT02414958|454355137|FG000|Overall Study|Other than specified|4|||
126291559|NCT02414958|454355138|FG001|Overall Study|Other than specified|4|||
126291560|NCT02414958|454355139|FG002|Overall Study|Other than specified|5|||
126291561|NCT05767905|454355142|FG000|Overall Study|Adverse Event|0|||
126291562|NCT05767905|454355143|FG001|Overall Study|Adverse Event|0|||
126291563|NCT05767905|454355144|FG002|Overall Study|Adverse Event|1|||
126291564|NCT03762239|454355145|FG000|Overall Study|Appointment to the doctor|1|||
126291565|NCT03762239|454355146|FG001|Overall Study|Appointment to the doctor|1|||
126291566|NCT03645863|454355147|FG000|Overall Study|Withdrawal by Subject|1|||
126291567|NCT03645863|454355148|FG001|Overall Study|Withdrawal by Subject|0|||
126291568|NCT03645863|454355149|FG002|Overall Study|Withdrawal by Subject|0|||
126291569|NCT03624192|454355163|FG000|Overall Study|Lost to Follow-up|1|||
126291570|NCT03624192|454355164|FG001|Overall Study|Lost to Follow-up|1|||
126291571|NCT04660331|454355165|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
126291572|NCT04660331|454355166|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
126291573|NCT04660331|454355167|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
126291574|NCT02635984|454355168|FG000|Overall Study|Lost to Follow-up|2|||
126291575|NCT02635984|454355169|FG001|Overall Study|Lost to Follow-up|4|||
126291576|NCT02635984|454355168|FG000|Overall Study|Study Arm Closed|1|||
126291577|NCT02635984|454355169|FG001|Overall Study|Study Arm Closed|0|||
126291578|NCT01640249|454355171|FG000|Period 1|Withdrawal by Subject|1|||
126291579|NCT01640249|454355172|FG001|Period 1|Withdrawal by Subject|0|||
126291580|NCT01640249|454355173|FG002|Period 1|Withdrawal by Subject|0|||
126291581|NCT01640249|454355174|FG003|Period 1|Withdrawal by Subject|0|||
126291582|NCT01640249|454355175|FG004|Period 1|Withdrawal by Subject|0|||
126291583|NCT01640249|454355176|FG005|Period 1|Withdrawal by Subject|1|||
126291584|NCT01640249|454355177|FG006|Period 1|Withdrawal by Subject|0|||
126291585|NCT01215136|454355180|FG000|Overall Study|Adverse Event|2|||
126291586|NCT01215136|454355181|FG001|Overall Study|Adverse Event|9|||
126291587|NCT01215136|454355180|FG000|Overall Study|Disease Progression|3|||
126291588|NCT01215136|454355181|FG001|Overall Study|Disease Progression|14|||
126291589|NCT01215136|454355180|FG000|Overall Study|Symptomatic Deterioration|1|||
126291590|NCT01215136|454355181|FG001|Overall Study|Symptomatic Deterioration|1|||
126291591|NCT01215136|454355180|FG000|Overall Study|Death|0|||
126291592|NCT01215136|454355181|FG001|Overall Study|Death|2|||
126291593|NCT01215136|454355180|FG000|Overall Study|Withdrawal by Subject|0|||
126291594|NCT01215136|454355181|FG001|Overall Study|Withdrawal by Subject|1|||
126291595|NCT00613171|454355186|FG000|Overall Study|Adverse Event|7|||
126291596|NCT00613171|454355186|FG000|Overall Study|Withdrawal by Subject|3|||
126291597|NCT00613171|454355186|FG000|Overall Study|Reason not Specified|4|||
126291598|NCT00951496|454355187|FG000|Overall Study|Did not initiate study treatment|10|||
126710689|NCT01272180|455893515|FG003|Overall Study|Inappropriate enrollment|1|||
126291599|NCT00951496|454355188|FG001|Overall Study|Did not initiate study treatment|8|||
126291600|NCT00951496|454355189|FG002|Overall Study|Did not initiate study treatment|13|||
126291601|NCT01526057|454355190|FG000|Overall Study|Withdrawal by Subject|3|||
126291602|NCT01526057|454355191|FG001|Overall Study|Withdrawal by Subject|2|||
126291603|NCT01526057|454355192|FG002|Overall Study|Withdrawal by Subject|2|||
126710690|NCT01272180|455893512|FG000|Overall Study|Protocol Violation|0|||
126291604|NCT01526057|454355190|FG000|Overall Study|Adverse Event|3|||
126291605|NCT01526057|454355191|FG001|Overall Study|Adverse Event|1|||
126291606|NCT01526057|454355192|FG002|Overall Study|Adverse Event|1|||
126291607|NCT01526057|454355190|FG000|Overall Study|Death|1|||
126291608|NCT01526057|454355191|FG001|Overall Study|Death|0|||
126291609|NCT01526057|454355192|FG002|Overall Study|Death|0|||
126291610|NCT01526057|454355190|FG000|Overall Study|Lost to Follow-up|1|||
126291611|NCT01526057|454355191|FG001|Overall Study|Lost to Follow-up|0|||
126291612|NCT01526057|454355192|FG002|Overall Study|Lost to Follow-up|1|||
126291613|NCT01526057|454355190|FG000|Overall Study|Other|1|||
126291614|NCT01526057|454355191|FG001|Overall Study|Other|0|||
126291615|NCT01526057|454355192|FG002|Overall Study|Other|1|||
126291616|NCT01526057|454355190|FG000|Overall Study|Protocol Violation|0|||
126291617|NCT01526057|454355191|FG001|Overall Study|Protocol Violation|0|||
126291618|NCT01526057|454355192|FG002|Overall Study|Protocol Violation|1|||
126291619|NCT02289729|454355203|FG000|Overall Study|Lack of Efficacy|3|||
126291620|NCT02289729|454355203|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
126291621|NCT02289729|454355203|FG000|Overall Study|Withdrawal by Subject|1|||
126291622|NCT02289729|454355203|FG000|Overall Study|Death|1|||
126291623|NCT04870710|454355209|FG000|Overall Study|Lost to Follow-up|3|||
126291624|NCT00476190|454355210|FG000|Overall Study|Ineligible|1|||
126291625|NCT00476190|454355211|FG001|Overall Study|Ineligible|1|||
126291626|NCT00476190|454355210|FG000|Overall Study|Induction Death|2|||
126291627|NCT00476190|454355211|FG001|Overall Study|Induction Death|0|||
126291628|NCT00476190|454355210|FG000|Overall Study|Induction Failure|2|||
126291629|NCT00476190|454355211|FG001|Overall Study|Induction Failure|4|||
126291630|NCT00476190|454355210|FG000|Overall Study|Lost to Follow-up|1|||
126291631|NCT00476190|454355211|FG001|Overall Study|Lost to Follow-up|0|||
126291632|NCT00476190|454355210|FG000|Overall Study|Relapse/Progression|5|||
126291633|NCT00476190|454355211|FG001|Overall Study|Relapse/Progression|2|||
126291634|NCT00476190|454355210|FG000|Overall Study|Remission Death|0|||
126291635|NCT00476190|454355211|FG001|Overall Study|Remission Death|1|||
126291636|NCT00476190|454355210|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
126291637|NCT00476190|454355211|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
126291638|NCT00476190|454355210|FG000|Overall Study|Withdrawal by Subject|6|||
126291639|NCT00476190|454355211|FG001|Overall Study|Withdrawal by Subject|2|||
126291640|NCT00476190|454355210|FG000|Overall Study|Other|9|||
126291641|NCT00476190|454355211|FG001|Overall Study|Other|10|||
126291642|NCT05724589|454355212|FG000|Overall Study|Lost to Follow-up|1|||
126291643|NCT02273388|454355221|FG000|Overall Study|Adverse Event|0|||
126291644|NCT02273388|454355222|FG001|Overall Study|Adverse Event|0|||
126291645|NCT02273388|454355223|FG002|Overall Study|Adverse Event|0|||
126291646|NCT02273388|454355224|FG003|Overall Study|Adverse Event|0|||
126291647|NCT02273388|454355225|FG004|Overall Study|Adverse Event|0|||
126291648|NCT02273388|454355226|FG005|Overall Study|Adverse Event|0|||
126291649|NCT02273388|454355227|FG006|Overall Study|Adverse Event|1|||
126291650|NCT02273388|454355228|FG007|Overall Study|Adverse Event|2|||
126291651|NCT02273388|454355229|FG008|Overall Study|Adverse Event|0|||
126291652|NCT02273388|454355230|FG009|Overall Study|Adverse Event|0|||
126291653|NCT02273388|454355231|FG010|Overall Study|Adverse Event|0|||
126291654|NCT02273388|454355232|FG011|Overall Study|Adverse Event|0|||
126291655|NCT02273388|454355221|FG000|Overall Study|Adverse Event study disease worse|4|||
126291656|NCT02273388|454355222|FG001|Overall Study|Adverse Event study disease worse|3|||
126291657|NCT02273388|454355223|FG002|Overall Study|Adverse Event study disease worse|3|||
126291658|NCT02273388|454355224|FG003|Overall Study|Adverse Event study disease worse|2|||
126291659|NCT02273388|454355225|FG004|Overall Study|Adverse Event study disease worse|4|||
126291660|NCT02273388|454355226|FG005|Overall Study|Adverse Event study disease worse|3|||
126291661|NCT02273388|454355227|FG006|Overall Study|Adverse Event study disease worse|14|||
126291662|NCT02273388|454355228|FG007|Overall Study|Adverse Event study disease worse|6|||
126291663|NCT02273388|454355229|FG008|Overall Study|Adverse Event study disease worse|6|||
126291664|NCT02273388|454355230|FG009|Overall Study|Adverse Event study disease worse|5|||
126291665|NCT02273388|454355231|FG010|Overall Study|Adverse Event study disease worse|10|||
126291666|NCT02273388|454355232|FG011|Overall Study|Adverse Event study disease worse|1|||
126291667|NCT02273388|454355221|FG000|Overall Study|Sponsor decision|0|||
126291668|NCT02273388|454355222|FG001|Overall Study|Sponsor decision|0|||
126291669|NCT02273388|454355223|FG002|Overall Study|Sponsor decision|0|||
126291670|NCT02273388|454355224|FG003|Overall Study|Sponsor decision|0|||
126291671|NCT02273388|454355225|FG004|Overall Study|Sponsor decision|0|||
126291672|NCT02273388|454355226|FG005|Overall Study|Sponsor decision|0|||
126291673|NCT02273388|454355227|FG006|Overall Study|Sponsor decision|0|||
126291674|NCT02273388|454355228|FG007|Overall Study|Sponsor decision|0|||
126291675|NCT02273388|454355229|FG008|Overall Study|Sponsor decision|0|||
126291676|NCT02273388|454355230|FG009|Overall Study|Sponsor decision|0|||
126291677|NCT02273388|454355231|FG010|Overall Study|Sponsor decision|0|||
126366223|NCT02904096|454635796|FG001|Overall Study|Withdrawal by Subject|3|||
126366224|NCT02904096|454635795|FG000|Overall Study|Lost to Follow-up|10|||
126291678|NCT02273388|454355232|FG011|Overall Study|Sponsor decision|1|||
126366225|NCT02904096|454635796|FG001|Overall Study|Lost to Follow-up|17|||
126291679|NCT01042093|454355233|FG000|Overall Study|Protocol Violation|2|||
126291680|NCT01042093|454355234|FG001|Overall Study|Protocol Violation|2|||
126291681|NCT01042093|454355235|FG002|Overall Study|Protocol Violation|2|||
126291682|NCT01042093|454355236|FG003|Overall Study|Protocol Violation|3|||
126291683|NCT01042093|454355233|FG000|Overall Study|Withdrawal by Subject|0|||
126291684|NCT01042093|454355234|FG001|Overall Study|Withdrawal by Subject|0|||
126291685|NCT01042093|454355235|FG002|Overall Study|Withdrawal by Subject|0|||
126291686|NCT01042093|454355236|FG003|Overall Study|Withdrawal by Subject|1|||
126291687|NCT04331808|454355237|FG000|Overall Study|Withdrew consent|1|||
126291688|NCT04331808|454355238|FG001|Overall Study|Withdrew consent|0|||
126291689|NCT04331808|454355239|FG002|Overall Study|Withdrew consent|2|||
126291690|NCT04331808|454355240|FG003|Overall Study|Withdrew consent|3|||
126291691|NCT02189837|454355244|FG000|Overall Study|Withdrawal by Subject|2|||
126291692|NCT02189837|454355245|FG001|Overall Study|Withdrawal by Subject|1|||
126291693|NCT02189837|454355246|FG002|Overall Study|Withdrawal by Subject|3|||
126291694|NCT02189837|454355247|FG003|Overall Study|Withdrawal by Subject|1|||
126291695|NCT02189837|454355244|FG000|Overall Study|Sponsor Decision|0|||
126291696|NCT02189837|454355245|FG001|Overall Study|Sponsor Decision|0|||
126291697|NCT02189837|454355246|FG002|Overall Study|Sponsor Decision|0|||
126291698|NCT02189837|454355247|FG003|Overall Study|Sponsor Decision|1|||
126291699|NCT00822692|454355253|FG000|Overall Study|Lost to Follow-up|17|||
126291700|NCT00822692|454355254|FG001|Overall Study|Lost to Follow-up|25|||
126291701|NCT01256502|454355257|FG000|Overall Study|Had scaffold removed|4|||
126291702|NCT01256502|454355257|FG000|Overall Study|Personal reasons|5|||
126291703|NCT01256502|454355257|FG000|Overall Study|Protocol deviation|1|||
126291704|NCT01523002|454355258|FG000|Period 1|Withdrawal by Subject|1|||
126291705|NCT01523002|454355259|FG001|Period 1|Withdrawal by Subject|3|||
126291706|NCT01523002|454355258|FG000|Period 1|Lost to Follow-up|1|||
126291707|NCT01523002|454355259|FG001|Period 1|Lost to Follow-up|0|||
126291708|NCT01523002|454355258|FG000|Period 1|Adverse Event|0|||
126291709|NCT01523002|454355259|FG001|Period 1|Adverse Event|8|||
126291710|NCT01523002|454355258|FG000|Period 2|Withdrawal by Subject|4|||
126291711|NCT01523002|454355259|FG001|Period 2|Withdrawal by Subject|1|||
126291712|NCT01523002|454355258|FG000|Period 2|Adverse Event|2|||
126291713|NCT01523002|454355259|FG001|Period 2|Adverse Event|5|||
126291714|NCT01523002|454355258|FG000|Period 3|Withdrawal by Subject|1|||
126291715|NCT01523002|454355259|FG001|Period 3|Withdrawal by Subject|0|||
126291716|NCT01523002|454355258|FG000|Period 3|Adverse Event|3|||
126291717|NCT01523002|454355259|FG001|Period 3|Adverse Event|0|||
126291718|NCT03281876|454355260|FG000|Overall Study|Adverse Event|4|||
126291719|NCT03281876|454355261|FG001|Overall Study|Adverse Event|15|||
126291720|NCT03281876|454355260|FG000|Overall Study|Lost to Follow-up|1|||
126291721|NCT03281876|454355261|FG001|Overall Study|Lost to Follow-up|4|||
126291722|NCT03281876|454355260|FG000|Overall Study|Withdrawal by Subject|11|||
126291723|NCT03281876|454355261|FG001|Overall Study|Withdrawal by Subject|15|||
126291724|NCT03281876|454355260|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
126291725|NCT03281876|454355261|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126291726|NCT03281876|454355260|FG000|Overall Study|OTHER|5|||
126291727|NCT03281876|454355261|FG001|Overall Study|OTHER|5|||
126291728|NCT02208089|454355262|FG000|Overall Study|Withdrawal by Subject|1|||
126291729|NCT02208089|454355263|FG001|Overall Study|Withdrawal by Subject|0|||
126291730|NCT02208089|454355262|FG000|Overall Study|Lost to Follow-up|6|||
126291731|NCT02208089|454355263|FG001|Overall Study|Lost to Follow-up|0|||
126291732|NCT00972595|454355264|FG000|Period 1|Adverse Event|1|||
126291733|NCT00972595|454355265|FG001|Period 1|Adverse Event|0|||
126291734|NCT03629184|454355266|FG000|Overall Study|Withdrawal by Subject|2|||
126291735|NCT03629184|454355267|FG001|Overall Study|Withdrawal by Subject|1|||
126291736|NCT03629184|454355266|FG000|Overall Study|Physician Decision|1|||
126291737|NCT03629184|454355267|FG001|Overall Study|Physician Decision|0|||
126291738|NCT05101343|454355270|FG000|Overall Study|Withdrawal by Subject|2|||
126291739|NCT05101343|454355271|FG001|Overall Study|Withdrawal by Subject|1|||
126291740|NCT02046603|454355272|FG000|Overall Study|Other|11|||
126291741|NCT02046603|454355273|FG001|Overall Study|Other|66|||
126291742|NCT02046603|454355272|FG000|Overall Study|Protocol Violation|0|||
126291743|NCT02046603|454355273|FG001|Overall Study|Protocol Violation|1|||
126291744|NCT02046603|454355272|FG000|Overall Study|Participant/legal guardian decision|1|||
126291745|NCT02046603|454355273|FG001|Overall Study|Participant/legal guardian decision|3|||
126291746|NCT02046603|454355272|FG000|Overall Study|Physician Decision|2|||
126291747|NCT02046603|454355273|FG001|Overall Study|Physician Decision|1|||
126291748|NCT02046603|454355272|FG000|Overall Study|Lost to Follow-up|1|||
126291749|NCT02046603|454355273|FG001|Overall Study|Lost to Follow-up|2|||
126291750|NCT02046603|454355272|FG000|Overall Study|Death|0|||
126291751|NCT02046603|454355273|FG001|Overall Study|Death|1|||
126291752|NCT02046603|454355272|FG000|Overall Study|Adverse Event|0|||
126291753|NCT02046603|454355273|FG001|Overall Study|Adverse Event|1|||
126710691|NCT01272180|455893513|FG001|Overall Study|Protocol Violation|1|||
126291754|NCT02461160|454355274|FG000|Overall Study|Lost to Follow-up|0|||
126291755|NCT02461160|454355275|FG001|Overall Study|Lost to Follow-up|0|||
126291756|NCT02461160|454355276|FG002|Overall Study|Lost to Follow-up|0|||
126291757|NCT02461160|454355277|FG003|Overall Study|Lost to Follow-up|0|||
126291758|NCT02461160|454355278|FG004|Overall Study|Lost to Follow-up|0|||
126291759|NCT02461160|454355279|FG005|Overall Study|Lost to Follow-up|0|||
126291760|NCT02461160|454355280|FG006|Overall Study|Lost to Follow-up|0|||
126291761|NCT02461160|454355281|FG007|Overall Study|Lost to Follow-up|1|||
126291762|NCT02461160|454355282|FG008|Overall Study|Lost to Follow-up|0|||
126291763|NCT02461160|454355283|FG009|Overall Study|Lost to Follow-up|0|||
126291764|NCT02461160|454355284|FG010|Overall Study|Lost to Follow-up|0|||
126291765|NCT02461160|454355285|FG011|Overall Study|Lost to Follow-up|0|||
126291766|NCT02461160|454355286|FG012|Overall Study|Lost to Follow-up|0|||
126291767|NCT00193050|454355287|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
126291768|NCT00193050|454355287|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
126291769|NCT00193050|454355287|FG000|Neoadjuvant Treatment|Physician Decision|2|||
126291770|NCT00193050|454355287|FG000|Neoadjuvant Treatment|Adverse Event|2|||
126291771|NCT00193050|454355287|FG000|Adjuvant|Physician Decision|5|||
126291772|NCT00193050|454355287|FG000|Adjuvant|Intercurrent Hospitalization|3|||
126291773|NCT00193050|454355287|FG000|Adjuvant|Lack of Efficacy|2|||
126291774|NCT00061932|454355288|FG000|Overall Study|Withdrawal by Subject|13|||
126291775|NCT00061932|454355289|FG001|Overall Study|Withdrawal by Subject|4|||
126291776|NCT02899962|454355290|FG000|Open-label Phase|Adverse Event|2|||
126291777|NCT02899962|454355291|FG001|Open-label Phase|Adverse Event|0|||
126291778|NCT02899962|454355292|FG002|Open-label Phase|Adverse Event|0|||
126291779|NCT02899962|454355290|FG000|Open-label Phase|Lost to Follow-up|9|||
126291780|NCT02899962|454355291|FG001|Open-label Phase|Lost to Follow-up|0|||
126291781|NCT02899962|454355292|FG002|Open-label Phase|Lost to Follow-up|0|||
126291782|NCT02899962|454355290|FG000|Open-label Phase|Other reasons|9|||
126291783|NCT02899962|454355291|FG001|Open-label Phase|Other reasons|0|||
126291784|NCT02899962|454355292|FG002|Open-label Phase|Other reasons|0|||
126291785|NCT02899962|454355290|FG000|Open-label Phase|Withdrawal by Subject|7|||
126291786|NCT02899962|454355291|FG001|Open-label Phase|Withdrawal by Subject|0|||
126291787|NCT02899962|454355292|FG002|Open-label Phase|Withdrawal by Subject|0|||
126291788|NCT02899962|454355290|FG000|Maintenance Phase|Adverse Event|0|||
126291789|NCT02899962|454355291|FG001|Maintenance Phase|Adverse Event|2|||
126291790|NCT02899962|454355292|FG002|Maintenance Phase|Adverse Event|1|||
126291791|NCT02899962|454355290|FG000|Maintenance Phase|Death|0|||
126291792|NCT02899962|454355291|FG001|Maintenance Phase|Death|0|||
126291793|NCT02899962|454355292|FG002|Maintenance Phase|Death|1|||
126291794|NCT02899962|454355290|FG000|Maintenance Phase|Lack of Efficacy|0|||
126291795|NCT02899962|454355291|FG001|Maintenance Phase|Lack of Efficacy|20|||
126291796|NCT02899962|454355292|FG002|Maintenance Phase|Lack of Efficacy|16|||
126291797|NCT02899962|454355290|FG000|Maintenance Phase|Lost to Follow-up|0|||
126291798|NCT02899962|454355291|FG001|Maintenance Phase|Lost to Follow-up|12|||
126291799|NCT02899962|454355292|FG002|Maintenance Phase|Lost to Follow-up|14|||
126291800|NCT02899962|454355290|FG000|Maintenance Phase|Other reasons|0|||
126291801|NCT02899962|454355291|FG001|Maintenance Phase|Other reasons|9|||
126291802|NCT02899962|454355292|FG002|Maintenance Phase|Other reasons|13|||
126291803|NCT02899962|454355290|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
126291804|NCT02899962|454355291|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
126291805|NCT02899962|454355292|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
126291806|NCT02899962|454355290|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
126291807|NCT02899962|454355291|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
126291808|NCT02899962|454355292|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
126291809|NCT02899962|454355290|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126291810|NCT02899962|454355291|FG001|Maintenance Phase|Withdrawal by Subject|30|||
126291811|NCT02899962|454355292|FG002|Maintenance Phase|Withdrawal by Subject|36|||
126291812|NCT02603146|454357366|FG000|Overall Study|Lost to Follow-up|5|||
126291813|NCT02603146|454357367|FG001|Overall Study|Lost to Follow-up|6|||
126291814|NCT02603146|454357366|FG000|Overall Study|Withdrawal by Subject|8|||
126291815|NCT02603146|454357367|FG001|Overall Study|Withdrawal by Subject|10|||
126291816|NCT02603146|454357366|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
126291817|NCT02603146|454357367|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
126291818|NCT02603146|454357366|FG000|Overall Study|Participant moved|2|||
126291819|NCT02603146|454357367|FG001|Overall Study|Participant moved|0|||
126291820|NCT02603146|454357366|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
126291821|NCT02603146|454357367|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
126291822|NCT00654095|454357376|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
126291823|NCT00654095|454357376|FG000|Overall Study|Elevated triglyceride level (2)|1|||
126291824|NCT00654095|454357376|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
126291825|NCT00654095|454357376|FG000|Overall Study|Adverse Event|11|||
126291826|NCT00654095|454357376|FG000|Overall Study|Withdrawal by Subject|5|||
126291827|NCT00654095|454357376|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
126291828|NCT00654095|454357376|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
126291829|NCT00654095|454357376|FG000|Overall Study|Did not meet inclusion criteria|1|||
126291830|NCT01431079|454357377|FG000|Overall Study|Lost to Follow-up|35|||
126291831|NCT01431079|454357378|FG001|Overall Study|Lost to Follow-up|39|||
126291832|NCT03347110|454357383|FG000|Overall Study|Other (Participant is incarcerated)|1|||
126291833|NCT03347110|454357383|FG000|Overall Study|Withdrawal by Subject|9|||
126291834|NCT03347110|454357383|FG000|Overall Study|Lost to Follow-up|1|||
126291835|NCT03347110|454357383|FG000|Overall Study|Lack of Efficacy|2|||
126291836|NCT03347110|454357383|FG000|Overall Study|Adverse Event, non-fatal|9|||
126291837|NCT00110396|454357384|FG000|Overall Study|Adverse Event|15|||
126291838|NCT00110396|454357384|FG000|Overall Study|Lost to Follow-up|1|||
126710692|NCT01272180|455893514|FG002|Overall Study|Protocol Violation|0|||
126291839|NCT00110396|454357384|FG000|Overall Study|Administration of plasmapheresis|1|||
126291840|NCT00110396|454357384|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
126291841|NCT00110396|454357384|FG000|Overall Study|Lack of Efficacy|1|||
126291842|NCT00110396|454357384|FG000|Overall Study|Decided not to continue treatment|1|||
126291843|NCT00110396|454357384|FG000|Overall Study|Patient non-compliance|1|||
126291844|NCT00110396|454357384|FG000|Overall Study|Patient refused to continue|1|||
126291845|NCT00110396|454357384|FG000|Overall Study|Patient refused to participate|1|||
126291846|NCT00110396|454357384|FG000|Overall Study|Patient will|1|||
126291847|NCT00110396|454357384|FG000|Overall Study|Patient's decision|1|||
126291848|NCT00110396|454357384|FG000|Overall Study|Participation in MS vaccine study|1|||
126291849|NCT00110396|454357384|FG000|Overall Study|Pregnancy|1|||
126291850|NCT00110396|454357384|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
126291851|NCT00110396|454357384|FG000|Overall Study|Protocol Violation|2|||
126291852|NCT00110396|454357384|FG000|Overall Study|Patient refused to come back|1|||
126291853|NCT00110396|454357384|FG000|Overall Study|The patient has refused|2|||
126291854|NCT00110396|454357384|FG000|Overall Study|The patient has refused to visit site|1|||
126291855|NCT00110396|454357384|FG000|Overall Study|Patient is to be administered copaxone|1|||
126710693|NCT01272180|455893515|FG003|Overall Study|Protocol Violation|1|||
126710694|NCT01183858|455893516|FG000|Overall Study|Death not related to Progressive Disease|5|||
126710695|NCT01183858|455893517|FG001|Overall Study|Death not related to Progressive Disease|6|||
126710696|NCT01183858|455893516|FG000|Overall Study|Adverse Event|14|||
126710697|NCT01183858|455893517|FG001|Overall Study|Adverse Event|11|||
126710698|NCT01183858|455893516|FG000|Overall Study|Investigator's Decision|0|||
126710699|NCT01183858|455893517|FG001|Overall Study|Investigator's Decision|3|||
126291856|NCT00882518|454357385|FG000|Overall Study|Adverse Event|9|||
126291857|NCT00882518|454357386|FG001|Overall Study|Adverse Event|18|||
126291858|NCT00882518|454357385|FG000|Overall Study|Withdrawal by Subject|9|||
126291859|NCT00882518|454357386|FG001|Overall Study|Withdrawal by Subject|13|||
126291860|NCT00882518|454357385|FG000|Overall Study|Lack of Efficacy|12|||
126291861|NCT00882518|454357386|FG001|Overall Study|Lack of Efficacy|9|||
126291862|NCT00882518|454357385|FG000|Overall Study|Severe non-compliance to protocol|3|||
126291863|NCT00882518|454357386|FG001|Overall Study|Severe non-compliance to protocol|1|||
126291864|NCT00882518|454357385|FG000|Overall Study|Incorrect enrolment|4|||
126291865|NCT00882518|454357386|FG001|Overall Study|Incorrect enrolment|2|||
126291866|NCT00882518|454357385|FG000|Overall Study|Central lab closure for National day|1|||
126291867|NCT00882518|454357386|FG001|Overall Study|Central lab closure for National day|0|||
126291868|NCT00882518|454357385|FG000|Overall Study|Allocating random number by mistake|0|||
126291869|NCT00882518|454357386|FG001|Overall Study|Allocating random number by mistake|1|||
126291870|NCT02137252|454357388|FG000|Overall Study|trial terminated early|2|||
126291871|NCT02137252|454357389|FG001|Overall Study|trial terminated early|1|||
126291872|NCT00245466|454357390|FG000|Overall Study|Adverse Event|2|||
126291873|NCT00245466|454357391|FG001|Overall Study|Adverse Event|8|||
126291874|NCT00245466|454357392|FG002|Overall Study|Adverse Event|4|||
126291875|NCT00245466|454357390|FG000|Overall Study|Low prostate specific antigen suppr|16|||
126291876|NCT00245466|454357391|FG001|Overall Study|Low prostate specific antigen suppr|14|||
126291877|NCT00245466|454357392|FG002|Overall Study|Low prostate specific antigen suppr|5|||
126291878|NCT00245466|454357390|FG000|Overall Study|Insufficient testosterone suppr|12|||
126291879|NCT00245466|454357391|FG001|Overall Study|Insufficient testosterone suppr|12|||
126291880|NCT00245466|454357392|FG002|Overall Study|Insufficient testosterone suppr|21|||
126291881|NCT00245466|454357390|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
126291882|NCT00245466|454357391|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
126291883|NCT00245466|454357392|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
126291884|NCT00245466|454357390|FG000|Overall Study|Withdrawal by Subject|2|||
126291885|NCT00245466|454357391|FG001|Overall Study|Withdrawal by Subject|2|||
126291886|NCT00245466|454357392|FG002|Overall Study|Withdrawal by Subject|1|||
126291887|NCT00245466|454357390|FG000|Overall Study|Lost to Follow-up|3|||
126291888|NCT00245466|454357391|FG001|Overall Study|Lost to Follow-up|0|||
126291889|NCT00245466|454357392|FG002|Overall Study|Lost to Follow-up|0|||
126366226|NCT02904096|454635795|FG000|Overall Study|Non-compliant|3|||
126366227|NCT02904096|454635796|FG001|Overall Study|Non-compliant|1|||
126710700|NCT01183858|455893516|FG000|Overall Study|Insufficient Therapeutic Response|2|||
126291890|NCT00245466|454357390|FG000|Overall Study|Disease progression|0|||
126291891|NCT00245466|454357391|FG001|Overall Study|Disease progression|3|||
126291892|NCT00245466|454357392|FG002|Overall Study|Disease progression|1|||
126291893|NCT00245466|454357390|FG000|Overall Study|Protocol Violation|1|||
126291894|NCT00245466|454357391|FG001|Overall Study|Protocol Violation|2|||
126291895|NCT00245466|454357392|FG002|Overall Study|Protocol Violation|2|||
126291896|NCT00245466|454357390|FG000|Overall Study|Death|0|||
126291897|NCT00245466|454357391|FG001|Overall Study|Death|2|||
126291898|NCT00245466|454357392|FG002|Overall Study|Death|0|||
126291899|NCT00245466|454357390|FG000|Overall Study|Administrative reasons|0|||
126291900|NCT00245466|454357391|FG001|Overall Study|Administrative reasons|1|||
126366228|NCT02904096|454635795|FG000|Overall Study|Sponsor instructed|1|||
126366229|NCT02904096|454635796|FG001|Overall Study|Sponsor instructed|0|||
126291901|NCT00245466|454357392|FG002|Overall Study|Administrative reasons|0|||
126291902|NCT01958437|454357393|FG000|Overall Study|Incidental MRI findings|0|||
126291903|NCT01958437|454357394|FG001|Overall Study|Incidental MRI findings|0|||
126291904|NCT01958437|454357395|FG002|Overall Study|Incidental MRI findings|1|||
126291905|NCT01958437|454357396|FG003|Overall Study|Incidental MRI findings|1|||
126291906|NCT04886596|454357399|FG000|Overall Study|Adverse Event|442|||
126291907|NCT04886596|454357400|FG001|Overall Study|Adverse Event|441|||
126291908|NCT04886596|454357399|FG000|Overall Study|Lost to Follow-up|448|||
126291909|NCT04886596|454357400|FG001|Overall Study|Lost to Follow-up|465|||
126291910|NCT04886596|454357399|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
126291911|NCT04886596|454357400|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
126291912|NCT04886596|454357399|FG000|Overall Study|Migrated/moved from the study area|201|||
126291913|NCT04886596|454357400|FG001|Overall Study|Migrated/moved from the study area|184|||
126291914|NCT04886596|454357399|FG000|Overall Study|Other|298|||
126291915|NCT04886596|454357400|FG001|Overall Study|Other|326|||
126291916|NCT00948155|454357402|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
126291917|NCT00948155|454357403|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
126291918|NCT00948155|454357402|FG000|Washout 14 Days|Lost to Follow-up|1|||
126291919|NCT00948155|454357403|FG001|Washout 14 Days|Lost to Follow-up|2|||
126291920|NCT04620746|454357404|FG000|Overall Study|Adverse Event|2|||
126291921|NCT04620746|454357405|FG001|Overall Study|Adverse Event|0|||
126291922|NCT04620746|454357404|FG000|Overall Study|Uniterpretable skin test|1|||
126291923|NCT04620746|454357405|FG001|Overall Study|Uniterpretable skin test|0|||
126291924|NCT04620746|454357404|FG000|Overall Study|Withdrawal by Subject|0|||
126291925|NCT04620746|454357405|FG001|Overall Study|Withdrawal by Subject|1|||
126291926|NCT03473925|454357406|FG000|Overall Study|Death|48|||
126291927|NCT03473925|454357407|FG001|Overall Study|Death|44|||
126291928|NCT03473925|454357406|FG000|Overall Study|Sponsor Decision|2|||
126291929|NCT03473925|454357407|FG001|Overall Study|Sponsor Decision|7|||
126291930|NCT03473925|454357406|FG000|Overall Study|Withdrawal by Subject|1|||
126291931|NCT03473925|454357407|FG001|Overall Study|Withdrawal by Subject|3|||
126291932|NCT03473925|454357406|FG000|Overall Study|Not Treated|1|||
126291933|NCT03473925|454357407|FG001|Overall Study|Not Treated|1|||
126291934|NCT03411863|454357408|FG000|Overall Study|Withdrawal by Subject|3|||
126291935|NCT03411863|454357409|FG001|Overall Study|Withdrawal by Subject|1|||
126291936|NCT03411863|454357408|FG000|Overall Study|Physician Decision|0|||
126291937|NCT03411863|454357409|FG001|Overall Study|Physician Decision|1|||
126291938|NCT04661150|454357414|FG000|Overall Study|Ongoing in study|19|||
126366230|NCT05305651|454635797|FG000|Overall Study|Death|1|||
126366231|NCT05305651|454635797|FG000|Overall Study|Withdrawal by Subject|4|||
126366232|NCT05305651|454635797|FG000|Overall Study|Lost to Follow-up|4|||
126366233|NCT00526799|454635798|FG000|Overall Study|Withdrawal by Subject|1|||
126366234|NCT00526799|454635799|FG001|Overall Study|Withdrawal by Subject|0|||
126366235|NCT00526799|454635798|FG000|Overall Study|Intercurrent Complicating Disease|0|||
126366236|NCT00526799|454635799|FG001|Overall Study|Intercurrent Complicating Disease|1|||
126366237|NCT04003389|454635800|FG000|Overall Study|Adverse Event|27|||
126366238|NCT04003389|454635801|FG001|Overall Study|Adverse Event|34|||
126366239|NCT04003389|454635802|FG002|Overall Study|Adverse Event|28|||
126366240|NCT04003389|454635800|FG000|Overall Study|Lost to Follow-up|39|||
126366241|NCT04003389|454635801|FG001|Overall Study|Lost to Follow-up|30|||
126366242|NCT04003389|454635802|FG002|Overall Study|Lost to Follow-up|33|||
126366243|NCT04003389|454635800|FG000|Overall Study|Protocol Violation|1|||
126366244|NCT04003389|454635801|FG001|Overall Study|Protocol Violation|6|||
126366245|NCT04003389|454635802|FG002|Overall Study|Protocol Violation|5|||
126366246|NCT04003389|454635800|FG000|Overall Study|Withdrawal by Subject|119|||
126366247|NCT04003389|454635801|FG001|Overall Study|Withdrawal by Subject|79|||
126291939|NCT04661150|454357415|FG001|Overall Study|Ongoing in study|20|||
126291940|NCT04661150|454357414|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
126291941|NCT04661150|454357415|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
126366248|NCT04003389|454635802|FG002|Overall Study|Withdrawal by Subject|85|||
126366249|NCT04003389|454635800|FG000|Overall Study|Miscellaneous|14|||
126458023|NCT01215916|454978270|FG006|Overall Study|Adverse Event|3|||
126458024|NCT01215916|454978271|FG007|Overall Study|Adverse Event|0|||
126458025|NCT01215916|454978272|FG008|Overall Study|Adverse Event|0|||
126291942|NCT04661150|454357414|FG000|Overall Study|Death|2|||
126366250|NCT04003389|454635801|FG001|Overall Study|Miscellaneous|11|||
126458026|NCT01215916|454978264|FG000|Overall Study|Withdrawal by Subject|0|||
126291943|NCT04661150|454357415|FG001|Overall Study|Death|0|||
126291944|NCT03535740|454357416|FG000|Overall Study|Death|44|||
126291945|NCT03535740|454357416|FG000|Overall Study|Lost to Follow-up|1|||
126291946|NCT03535740|454357416|FG000|Overall Study|Withdrawal by Subject|13|||
126291947|NCT03535740|454357416|FG000|Overall Study|Site terminated by Sponsor|45|||
126366251|NCT04003389|454635802|FG002|Overall Study|Miscellaneous|14|||
126291948|NCT05198518|454357421|FG000|Screening Visit|Deemed unable to participate|58|||
126291949|NCT05198518|454357422|FG001|Screening Visit|Deemed unable to participate|0|||
126366252|NCT04003389|454635800|FG000|Overall Study|Participant did not receive study drug|1|||
126366253|NCT04003389|454635801|FG001|Overall Study|Participant did not receive study drug|0|||
126291950|NCT05198518|454357423|FG002|Screening Visit|Deemed unable to participate|0|||
126291951|NCT02756611|454357427|FG000|Overall Study|Death|70|||
126291952|NCT02756611|454357427|FG000|Overall Study|Withdrawal by Subject|2|||
126291953|NCT02756611|454357427|FG000|Overall Study|Lost to Follow-up|3|||
126291954|NCT02756611|454357427|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
126291955|NCT02756611|454357427|FG000|Overall Study|Other|10|||
126291956|NCT03125798|454357428|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
126291957|NCT03125798|454357429|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
126291958|NCT03125798|454357428|FG000|Overall Study|Conversion to thoracotomy|7|||
126291959|NCT03125798|454357429|FG001|Overall Study|Conversion to thoracotomy|7|||
126291960|NCT00065156|454357433|FG000|Overall Study|Adverse Event|37|||
126291961|NCT00065156|454357433|FG000|Overall Study|Lack of Efficacy|52|||
126291962|NCT00065156|454357433|FG000|Overall Study|Withdrawal by Subject|8|||
126291963|NCT00065156|454357433|FG000|Overall Study|Lost to Follow-up|1|||
126291964|NCT00065156|454357433|FG000|Overall Study|Death|11|||
126291965|NCT00065156|454357433|FG000|Overall Study|Study Closed by Sponsor|2|||
126291966|NCT00065156|454357433|FG000|Overall Study|Disease Progression|7|||
126291967|NCT00065156|454357433|FG000|Overall Study|Investigator Decision|2|||
126291968|NCT00065156|454357433|FG000|Overall Study|Non-Compliance|2|||
126291969|NCT00065156|454357433|FG000|Overall Study|Loss of Response|1|||
126291970|NCT00065156|454357433|FG000|Overall Study|Secondary Malign Disease|1|||
126291971|NCT00100828|454357434|FG000|Overall Study|Physician Decision|6|||
126291972|NCT01197911|454357435|FG000|Overall Study|Adverse Event|0|||
126291973|NCT01197911|454357436|FG001|Overall Study|Adverse Event|0|||
126291974|NCT01197911|454357437|FG002|Overall Study|Adverse Event|1|||
126291975|NCT02443740|454357439|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291976|NCT02443740|454357440|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291977|NCT02443740|454357441|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291978|NCT02443740|454357442|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291979|NCT02443740|454357443|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291980|NCT02443740|454357444|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
126291981|NCT02443740|454357445|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291982|NCT02443740|454357446|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291983|NCT02443740|454357447|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291984|NCT02443740|454357448|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291985|NCT02443740|454357449|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
126291986|NCT02443740|454357439|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
126291987|NCT02443740|454357440|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291988|NCT02443740|454357441|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291989|NCT02443740|454357442|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291990|NCT02443740|454357443|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291991|NCT02443740|454357444|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291992|NCT02443740|454357445|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
126291993|NCT02443740|454357446|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291994|NCT02443740|454357447|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291995|NCT02443740|454357448|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291996|NCT02443740|454357449|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
126291997|NCT02443740|454357439|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126291998|NCT02443740|454357440|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126291999|NCT02443740|454357441|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292000|NCT02443740|454357442|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292001|NCT02443740|454357443|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292002|NCT02443740|454357444|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
126292003|NCT02443740|454357445|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292004|NCT02443740|454357446|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292005|NCT02443740|454357447|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292006|NCT02443740|454357448|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292007|NCT02443740|454357449|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
126292008|NCT00456300|454357450|FG000|Overall Study|Adverse Event|1|||
126292009|NCT00456300|454357451|FG001|Overall Study|Adverse Event|0|||
126292010|NCT01478373|454357453|FG000|Treatment Phase|Protocol Violation|1|||
126292011|NCT01478373|454357453|FG000|Survival Phase|Adverse Event|8|||
126292012|NCT01478373|454357453|FG000|Survival Phase|Protocol Violation|1|||
126292013|NCT01478373|454357453|FG000|Survival Phase|crossover to another study|2|||
126292014|NCT01478373|454357453|FG000|Survival Phase|Progressive Disease|27|||
126292015|NCT01074944|454357456|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
126292016|NCT01074944|454357457|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
126292017|NCT01074944|454357458|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
126292018|NCT01074944|454357459|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
126292019|NCT01074944|454357460|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
126292020|NCT01074944|454357456|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
126292021|NCT01074944|454357457|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
126292022|NCT01074944|454357458|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
126292023|NCT01074944|454357459|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
126292024|NCT01074944|454357460|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
126458027|NCT01215916|454978265|FG001|Overall Study|Withdrawal by Subject|1|||
126366254|NCT04003389|454635802|FG002|Overall Study|Participant did not receive study drug|0|||
126366255|NCT04629196|454635803|FG000|Overall Study|Subject discontinued study drug|1|||
126366256|NCT04629196|454635804|FG001|Overall Study|Subject discontinued study drug|0|||
126366257|NCT04629196|454635803|FG000|Overall Study|Subject study drug dosing increased|1|||
126366258|NCT04629196|454635804|FG001|Overall Study|Subject study drug dosing increased|1|||
126366259|NCT04629196|454635803|FG000|Overall Study|Withdrawal by Subject|1|||
126366260|NCT04629196|454635804|FG001|Overall Study|Withdrawal by Subject|2|||
126366261|NCT01450631|454635808|FG000|Overall Study|Lost to Follow-up|2|||
126366262|NCT01450631|454635809|FG001|Overall Study|Lost to Follow-up|4|||
126292025|NCT01074944|454357456|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
126292026|NCT01074944|454357457|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
126292027|NCT01074944|454357458|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
126292028|NCT01074944|454357459|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
126292029|NCT01074944|454357460|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
126292030|NCT01074944|454357456|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
126292031|NCT01074944|454357457|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
126292032|NCT01074944|454357458|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
126292033|NCT01074944|454357459|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
126292034|NCT01074944|454357460|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
126710701|NCT01183858|455893517|FG001|Overall Study|Insufficient Therapeutic Response|0|||
126710702|NCT01183858|455893516|FG000|Overall Study|Refused Treatment|1|||
126366263|NCT01450631|454635808|FG000|Overall Study|Withdrawal by Subject|1|||
126366264|NCT01450631|454635809|FG001|Overall Study|Withdrawal by Subject|0|||
126366265|NCT00835354|454635810|FG000|First Intervention|Adverse Event|0|||
126366266|NCT00835354|454635811|FG001|First Intervention|Adverse Event|1|||
126366267|NCT03204812|454635812|FG000|Overall Study|Adverse Event|3|||
126366268|NCT03648372|454635814|FG000|Overall Study|Withdrawal by Subject|2|||
126366269|NCT03648372|454635815|FG001|Overall Study|Withdrawal by Subject|0|||
126366270|NCT03648372|454635816|FG002|Overall Study|Withdrawal by Subject|0|||
126366271|NCT03648372|454635817|FG003|Overall Study|Withdrawal by Subject|0|||
126366272|NCT03648372|454635818|FG004|Overall Study|Withdrawal by Subject|0|||
126366273|NCT03648372|454635819|FG005|Overall Study|Withdrawal by Subject|1|||
126366274|NCT03648372|454635820|FG006|Overall Study|Withdrawal by Subject|2|||
126366275|NCT03648372|454635821|FG007|Overall Study|Withdrawal by Subject|0|||
126366276|NCT03648372|454635822|FG008|Overall Study|Withdrawal by Subject|0|||
126366277|NCT03648372|454635823|FG009|Overall Study|Withdrawal by Subject|0|||
126366278|NCT03648372|454635824|FG010|Overall Study|Withdrawal by Subject|2|||
126366279|NCT03648372|454635825|FG011|Overall Study|Withdrawal by Subject|0|||
126366280|NCT03648372|454635826|FG012|Overall Study|Withdrawal by Subject|2|||
126366281|NCT03648372|454635827|FG013|Overall Study|Withdrawal by Subject|0|||
126366282|NCT03648372|454635828|FG014|Overall Study|Withdrawal by Subject|0|||
126366283|NCT03648372|454635829|FG015|Overall Study|Withdrawal by Subject|0|||
126366284|NCT03648372|454635830|FG016|Overall Study|Withdrawal by Subject|1|||
126366285|NCT03648372|454635831|FG017|Overall Study|Withdrawal by Subject|0|||
126366286|NCT03648372|454635832|FG018|Overall Study|Withdrawal by Subject|0|||
126366287|NCT03648372|454635833|FG019|Overall Study|Withdrawal by Subject|0|||
126366288|NCT03648372|454635834|FG020|Overall Study|Withdrawal by Subject|0|||
126366289|NCT03648372|454635814|FG000|Overall Study|Progressive Disease|2|||
126710703|NCT01183858|455893517|FG001|Overall Study|Refused Treatment|4|||
126292035|NCT01074944|454357456|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
126366290|NCT03648372|454635815|FG001|Overall Study|Progressive Disease|3|||
126366291|NCT03648372|454635816|FG002|Overall Study|Progressive Disease|4|||
126366292|NCT03648372|454635817|FG003|Overall Study|Progressive Disease|3|||
126366293|NCT03648372|454635818|FG004|Overall Study|Progressive Disease|2|||
126366294|NCT03648372|454635819|FG005|Overall Study|Progressive Disease|2|||
126292036|NCT01074944|454357457|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
126292037|NCT01074944|454357458|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
126292038|NCT01074944|454357459|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
126366295|NCT03648372|454635820|FG006|Overall Study|Progressive Disease|3|||
126366296|NCT03648372|454635821|FG007|Overall Study|Progressive Disease|3|||
126366297|NCT03648372|454635822|FG008|Overall Study|Progressive Disease|5|||
126458028|NCT01215916|454978266|FG002|Overall Study|Withdrawal by Subject|1|||
126366298|NCT03648372|454635823|FG009|Overall Study|Progressive Disease|5|||
126366299|NCT03648372|454635824|FG010|Overall Study|Progressive Disease|2|||
126366300|NCT03648372|454635825|FG011|Overall Study|Progressive Disease|3|||
126366301|NCT03648372|454635826|FG012|Overall Study|Progressive Disease|3|||
126458029|NCT01215916|454978267|FG003|Overall Study|Withdrawal by Subject|2|||
126366302|NCT03648372|454635827|FG013|Overall Study|Progressive Disease|3|||
126458030|NCT01215916|454978268|FG004|Overall Study|Withdrawal by Subject|0|||
126366303|NCT03648372|454635828|FG014|Overall Study|Progressive Disease|6|||
126292039|NCT01074944|454357460|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
126292040|NCT01074944|454357456|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
126292041|NCT01074944|454357457|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
126292042|NCT01074944|454357458|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
126292043|NCT01074944|454357459|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
126292044|NCT01074944|454357460|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
126292045|NCT01074944|454357456|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
126292046|NCT01074944|454357457|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
126292047|NCT01074944|454357458|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
126292048|NCT01074944|454357459|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
126292049|NCT01074944|454357460|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
126292050|NCT01074944|454357456|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
126292051|NCT01074944|454357457|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
126292052|NCT01074944|454357458|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
126292053|NCT01074944|454357459|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
126292054|NCT01074944|454357460|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
126292055|NCT01074944|454357456|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
126292056|NCT01074944|454357457|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
126292057|NCT01074944|454357458|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
126292058|NCT01074944|454357459|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
126292059|NCT01074944|454357460|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
126292060|NCT01074944|454357456|FG000|Long Term Treatment|Adverse Event|0|||
126292061|NCT01074944|454357457|FG001|Long Term Treatment|Adverse Event|0|||
126292062|NCT01074944|454357458|FG002|Long Term Treatment|Adverse Event|0|||
126292063|NCT01074944|454357459|FG003|Long Term Treatment|Adverse Event|3|||
126292064|NCT01074944|454357460|FG004|Long Term Treatment|Adverse Event|0|||
126292065|NCT01074944|454357456|FG000|Long Term Treatment|Lost to Follow-up|0|||
126292066|NCT01074944|454357457|FG001|Long Term Treatment|Lost to Follow-up|0|||
126292067|NCT01074944|454357458|FG002|Long Term Treatment|Lost to Follow-up|0|||
126292068|NCT01074944|454357459|FG003|Long Term Treatment|Lost to Follow-up|2|||
126292069|NCT01074944|454357460|FG004|Long Term Treatment|Lost to Follow-up|0|||
126292070|NCT01074944|454357456|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
126292071|NCT01074944|454357457|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
126292072|NCT01074944|454357458|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
126292073|NCT01074944|454357459|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
126292074|NCT01074944|454357460|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
126292075|NCT01074944|454357456|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
126292076|NCT01074944|454357457|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
126292077|NCT01074944|454357458|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
126292078|NCT01074944|454357459|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
126292079|NCT01074944|454357460|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
126292080|NCT01074944|454357456|FG000|Long Term Treatment|Withdrawal by Subject|0|||
126292081|NCT01074944|454357457|FG001|Long Term Treatment|Withdrawal by Subject|0|||
126292082|NCT01074944|454357458|FG002|Long Term Treatment|Withdrawal by Subject|0|||
126292083|NCT01074944|454357459|FG003|Long Term Treatment|Withdrawal by Subject|2|||
126292084|NCT01074944|454357460|FG004|Long Term Treatment|Withdrawal by Subject|0|||
126292085|NCT01074944|454357456|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
126292086|NCT01074944|454357457|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
126292087|NCT01074944|454357458|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
126292088|NCT01074944|454357459|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
126292089|NCT01074944|454357460|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
126292090|NCT01074944|454357456|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
126292091|NCT01074944|454357457|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
126292092|NCT01074944|454357458|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
126292093|NCT01074944|454357459|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
126292094|NCT01074944|454357460|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
126292095|NCT02348112|454357462|FG000|Overall Study|Withdrawal by Subject|32|||
126292096|NCT02348112|454357463|FG001|Overall Study|Withdrawal by Subject|29|||
126292097|NCT02348112|454357462|FG000|Overall Study|Lost to Follow-up|24|||
126292098|NCT02348112|454357463|FG001|Overall Study|Lost to Follow-up|20|||
126292099|NCT02348112|454357462|FG000|Overall Study|Physician Decision|17|||
126292100|NCT02348112|454357463|FG001|Overall Study|Physician Decision|15|||
126292101|NCT02348112|454357462|FG000|Overall Study|Site closed due to PI leaving|0|||
126292102|NCT02348112|454357463|FG001|Overall Study|Site closed due to PI leaving|30|||
126292103|NCT02348112|454357462|FG000|Overall Study|Sponsor withdrawal|0|||
126292104|NCT02348112|454357463|FG001|Overall Study|Sponsor withdrawal|7|||
126549785|NCT02406261|455307589|FG000|Period 2|Physician Decision|0|||
126549786|NCT02406261|455307590|FG001|Period 2|Physician Decision|1|||
126549787|NCT02406261|455307589|FG000|Period 2|Protocol Violation|0|||
126549788|NCT02406261|455307590|FG001|Period 2|Protocol Violation|1|||
126549789|NCT02406261|455307589|FG000|Period 2|Withdrawal by Subject|0|||
126549790|NCT02406261|455307590|FG001|Period 2|Withdrawal by Subject|1|||
126767053|NCT00539006|456100207|FG001|Treatment Period 2|Protocol Violation|0|||
126767054|NCT00539006|456100208|FG002|Treatment Period 2|Protocol Violation|0|||
126292105|NCT02348112|454357462|FG000|Overall Study|Death|0|||
126292106|NCT02348112|454357463|FG001|Overall Study|Death|1|||
126292107|NCT01998841|454357471|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
126292108|NCT01998841|454357472|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
126292109|NCT01998841|454357473|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
126292110|NCT01998841|454357474|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
126292111|NCT01998841|454357475|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
126292112|NCT01998841|454357471|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
126292113|NCT01998841|454357472|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
126292114|NCT01998841|454357473|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
126292115|NCT01998841|454357474|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
126292116|NCT01998841|454357475|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
126292117|NCT02552121|454357476|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
126292118|NCT02552121|454357477|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292119|NCT02552121|454357478|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292120|NCT02552121|454357479|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292121|NCT02552121|454357480|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292122|NCT02552121|454357481|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292123|NCT02552121|454357482|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292124|NCT02552121|454357483|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
126292125|NCT02552121|454357476|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
126292126|NCT02552121|454357477|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292127|NCT02552121|454357478|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292128|NCT02552121|454357479|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292129|NCT02552121|454357480|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292130|NCT02552121|454357481|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292131|NCT02552121|454357482|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292132|NCT02552121|454357483|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
126292133|NCT02552121|454357476|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292134|NCT02552121|454357477|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
126292135|NCT02552121|454357478|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292136|NCT02552121|454357479|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292137|NCT02552121|454357480|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292138|NCT02552121|454357481|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292139|NCT02552121|454357482|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292140|NCT02552121|454357483|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
126292141|NCT02552121|454357476|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292142|NCT02552121|454357477|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
126292143|NCT02552121|454357478|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292144|NCT02552121|454357479|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292145|NCT02552121|454357480|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292146|NCT02552121|454357481|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292147|NCT02552121|454357482|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292148|NCT02552121|454357483|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
126292149|NCT02552121|454357476|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126366304|NCT03648372|454635829|FG015|Overall Study|Progressive Disease|0|||
126366305|NCT03648372|454635830|FG016|Overall Study|Progressive Disease|0|||
126366306|NCT03648372|454635831|FG017|Overall Study|Progressive Disease|0|||
126366307|NCT03648372|454635832|FG018|Overall Study|Progressive Disease|0|||
126366308|NCT03648372|454635833|FG019|Overall Study|Progressive Disease|0|||
126366309|NCT03648372|454635834|FG020|Overall Study|Progressive Disease|0|||
126366310|NCT03648372|454635814|FG000|Overall Study|Other|0|||
126366311|NCT03648372|454635815|FG001|Overall Study|Other|0|||
126366312|NCT03648372|454635816|FG002|Overall Study|Other|0|||
126366313|NCT03648372|454635817|FG003|Overall Study|Other|0|||
126366314|NCT03648372|454635818|FG004|Overall Study|Other|1|||
126366315|NCT03648372|454635819|FG005|Overall Study|Other|0|||
126366316|NCT03648372|454635820|FG006|Overall Study|Other|0|||
126366317|NCT03648372|454635821|FG007|Overall Study|Other|0|||
126366318|NCT03648372|454635822|FG008|Overall Study|Other|0|||
126366319|NCT03648372|454635823|FG009|Overall Study|Other|0|||
126366320|NCT03648372|454635824|FG010|Overall Study|Other|1|||
126366321|NCT03648372|454635825|FG011|Overall Study|Other|2|||
126366322|NCT03648372|454635826|FG012|Overall Study|Other|1|||
126366323|NCT03648372|454635827|FG013|Overall Study|Other|3|||
126549791|NCT02222896|455307594|FG000|Abdomen|Did not qualify|34|||
126458031|NCT01215916|454978269|FG005|Overall Study|Withdrawal by Subject|0|||
126458032|NCT01215916|454978270|FG006|Overall Study|Withdrawal by Subject|1|||
126458033|NCT01215916|454978271|FG007|Overall Study|Withdrawal by Subject|0|||
126458034|NCT01215916|454978272|FG008|Overall Study|Withdrawal by Subject|0|||
126458035|NCT01215916|454978264|FG000|Overall Study|Death|0|||
126458036|NCT01215916|454978265|FG001|Overall Study|Death|1|||
126292150|NCT02552121|454357477|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
126292151|NCT02552121|454357478|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126292152|NCT02552121|454357479|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126292153|NCT02552121|454357480|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126292154|NCT02552121|454357481|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126292155|NCT02552121|454357482|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126292156|NCT02552121|454357483|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
126292157|NCT02552121|454357476|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292158|NCT02552121|454357477|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
126292159|NCT02552121|454357478|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292160|NCT02552121|454357479|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292161|NCT02552121|454357480|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292162|NCT02552121|454357481|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292163|NCT02552121|454357482|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292164|NCT02552121|454357483|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
126292165|NCT02552121|454357476|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
126292166|NCT02552121|454357477|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
126292167|NCT02552121|454357478|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
126292168|NCT02552121|454357479|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
126292169|NCT02552121|454357480|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
126292170|NCT02552121|454357481|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
126292171|NCT02552121|454357482|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
126292172|NCT02552121|454357483|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
126292173|NCT02552121|454357476|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
126292174|NCT02552121|454357477|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
126292175|NCT02552121|454357478|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
126292176|NCT02552121|454357479|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
126292177|NCT02552121|454357480|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
126292178|NCT02552121|454357481|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
126292179|NCT02552121|454357482|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
126292180|NCT02552121|454357483|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
126292181|NCT02552121|454357476|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
126292182|NCT02552121|454357477|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
126292183|NCT02552121|454357478|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
126292184|NCT02552121|454357479|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
126292185|NCT02552121|454357480|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
126292186|NCT02552121|454357481|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
126292187|NCT02552121|454357482|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
126292188|NCT02552121|454357483|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
126292189|NCT02552121|454357476|FG000|Part 2: Cohort Expansion|Death|0|||
126292190|NCT02552121|454357477|FG001|Part 2: Cohort Expansion|Death|0|||
126292191|NCT02552121|454357478|FG002|Part 2: Cohort Expansion|Death|1|||
126292192|NCT02552121|454357479|FG003|Part 2: Cohort Expansion|Death|0|||
126292193|NCT02552121|454357480|FG004|Part 2: Cohort Expansion|Death|0|||
126292194|NCT02552121|454357481|FG005|Part 2: Cohort Expansion|Death|0|||
126292195|NCT02552121|454357482|FG006|Part 2: Cohort Expansion|Death|0|||
126292196|NCT02552121|454357483|FG007|Part 2: Cohort Expansion|Death|0|||
126292197|NCT02905032|454357485|FG000|Overall Study|Withdrawal by Subject|2|||
126292198|NCT02905032|454357486|FG001|Overall Study|Withdrawal by Subject|0|||
126292199|NCT02905032|454357487|FG002|Overall Study|Withdrawal by Subject|0|||
126292200|NCT02905032|454357485|FG000|Overall Study|Protocol Violation|6|||
126292201|NCT02905032|454357486|FG001|Overall Study|Protocol Violation|12|||
126292202|NCT02905032|454357487|FG002|Overall Study|Protocol Violation|0|||
126292203|NCT03447743|454357488|FG000|Overall Study|Withdrawal by Subject|2|||
126292204|NCT03447743|454357488|FG000|Overall Study|Lost to Follow-up|3|||
126292205|NCT03447743|454357488|FG000|Overall Study|Adverse Event|1|||
126458037|NCT01215916|454978266|FG002|Overall Study|Death|0|||
126458038|NCT01215916|454978267|FG003|Overall Study|Death|0|||
126458039|NCT01215916|454978268|FG004|Overall Study|Death|1|||
126549792|NCT02222896|455307595|FG001|Abdomen|Did not qualify|10|||
126292206|NCT03447743|454357488|FG000|Overall Study|Did not meet criteria to continue|1|||
126292207|NCT02854527|454357489|FG000|Overall Study|Adverse Event|0|||
126292208|NCT02854527|454357490|FG001|Overall Study|Adverse Event|0|||
126292209|NCT02854527|454357491|FG002|Overall Study|Adverse Event|0|||
126292210|NCT02854527|454357492|FG003|Overall Study|Adverse Event|0|||
126292211|NCT02854527|454357493|FG004|Overall Study|Adverse Event|1|||
126458040|NCT01215916|454978269|FG005|Overall Study|Death|0|||
126458041|NCT01215916|454978270|FG006|Overall Study|Death|0|||
126549793|NCT02222896|455307596|FG002|Abdomen|Did not qualify|32|||
126549794|NCT02222896|455307594|FG000|Groin|Did not qualify|43|||
126458042|NCT01215916|454978271|FG007|Overall Study|Death|0|||
126458043|NCT01215916|454978272|FG008|Overall Study|Death|1|||
126292212|NCT02854527|454357494|FG005|Overall Study|Adverse Event|0|||
126292213|NCT02854527|454357495|FG006|Overall Study|Adverse Event|0|||
126292214|NCT02854527|454357496|FG007|Overall Study|Adverse Event|0|||
126292215|NCT02854527|454357497|FG008|Overall Study|Adverse Event|0|||
126292216|NCT02854527|454357498|FG009|Overall Study|Adverse Event|0|||
126292217|NCT02854527|454357489|FG000|Overall Study|Lost to Follow-up|0|||
126292218|NCT02854527|454357490|FG001|Overall Study|Lost to Follow-up|0|||
126292219|NCT02854527|454357491|FG002|Overall Study|Lost to Follow-up|0|||
126292220|NCT02854527|454357492|FG003|Overall Study|Lost to Follow-up|1|||
126292221|NCT02854527|454357493|FG004|Overall Study|Lost to Follow-up|0|||
126292222|NCT02854527|454357494|FG005|Overall Study|Lost to Follow-up|0|||
126292223|NCT02854527|454357495|FG006|Overall Study|Lost to Follow-up|0|||
126292224|NCT02854527|454357496|FG007|Overall Study|Lost to Follow-up|0|||
126292225|NCT02854527|454357497|FG008|Overall Study|Lost to Follow-up|0|||
126292226|NCT02854527|454357498|FG009|Overall Study|Lost to Follow-up|0|||
126292227|NCT03567980|454357499|FG000|Overall Study|Adverse Event|1|||
126292228|NCT03093259|454357501|FG000|Overall Study|Adverse Event|1|||
126292229|NCT03093259|454357502|FG001|Overall Study|Adverse Event|0|||
126292230|NCT03093259|454357501|FG000|Overall Study|Withdrawal by Subject|1|||
126292231|NCT03093259|454357502|FG001|Overall Study|Withdrawal by Subject|0|||
126292232|NCT02575833|454357503|FG000|Overall Study|Withdrawal by Subject|0|||
126292233|NCT02575833|454357504|FG001|Overall Study|Withdrawal by Subject|1|||
126292234|NCT02575833|454357503|FG000|Overall Study|Lost to Follow-up|1|||
126292235|NCT02575833|454357504|FG001|Overall Study|Lost to Follow-up|0|||
126292236|NCT01821807|454357505|FG000|Overall Study|Lost to Follow-up|3|||
126292237|NCT01821807|454357506|FG001|Overall Study|Lost to Follow-up|1|||
126292238|NCT00550459|454357508|FG000|Overall Study|Adverse Event|0|||
126292239|NCT00550459|454357509|FG001|Overall Study|Adverse Event|2|||
126292240|NCT00550459|454357508|FG000|Overall Study|Withdrawal by Subject|1|||
126292241|NCT00550459|454357509|FG001|Overall Study|Withdrawal by Subject|1|||
126292242|NCT02404805|454357510|FG000|Overall Study|Withdrawal by Subject|1|||
126292243|NCT02404805|454357511|FG001|Overall Study|Withdrawal by Subject|0|||
126292244|NCT02404805|454357512|FG002|Overall Study|Withdrawal by Subject|0|||
126292245|NCT02404805|454357513|FG003|Overall Study|Withdrawal by Subject|0|||
126292246|NCT02404805|454357514|FG004|Overall Study|Withdrawal by Subject|0|||
126292247|NCT02404805|454357515|FG005|Overall Study|Withdrawal by Subject|0|||
126292248|NCT00445146|454357516|FG000|Overall Study|Withdrew Consent|29|||
126292249|NCT00445146|454357516|FG000|Overall Study|Lack of Efficacy|28|||
126292250|NCT00445146|454357516|FG000|Overall Study|Investigator's Discretion|22|||
126292251|NCT00445146|454357516|FG000|Overall Study|Adverse Event|13|||
126292252|NCT00445146|454357516|FG000|Overall Study|Lost to Follow-up|13|||
126292253|NCT00445146|454357516|FG000|Overall Study|Death|9|||
126292254|NCT00445146|454357516|FG000|Overall Study|Protocol Violation|4|||
126292255|NCT00445146|454357516|FG000|Overall Study|Pregnancy|1|||
126292256|NCT00625820|454357517|FG000|Overall Study|Withdrawal by Subject|1|||
126292257|NCT02623725|454357518|FG000|Overall Study|Non compliance with protocol|9|||
126292258|NCT02623725|454357519|FG001|Overall Study|Non compliance with protocol|3|||
126292259|NCT02623725|454357518|FG000|Overall Study|Serious adverse event|0|||
126292260|NCT02623725|454357519|FG001|Overall Study|Serious adverse event|2|||
126292261|NCT02623725|454357518|FG000|Overall Study|Withdrawal by Subject|7|||
126292262|NCT02623725|454357519|FG001|Overall Study|Withdrawal by Subject|1|||
126292263|NCT00967330|454357520|FG000|Overall Study|Protocol Violation|3|||
126458044|NCT01215916|454978264|FG000|Overall Study|Physician Decision|0|||
126458045|NCT01215916|454978265|FG001|Overall Study|Physician Decision|0|||
126458046|NCT01215916|454978266|FG002|Overall Study|Physician Decision|1|||
126458047|NCT01215916|454978267|FG003|Overall Study|Physician Decision|1|||
126458048|NCT01215916|454978268|FG004|Overall Study|Physician Decision|0|||
126292264|NCT00967330|454357521|FG001|Overall Study|Protocol Violation|4|||
126292265|NCT00967330|454357520|FG000|Overall Study|Regular|10|||
126458049|NCT01215916|454978269|FG005|Overall Study|Physician Decision|0|||
126458050|NCT01215916|454978270|FG006|Overall Study|Physician Decision|0|||
126458051|NCT01215916|454978271|FG007|Overall Study|Physician Decision|0|||
126292266|NCT00967330|454357521|FG001|Overall Study|Regular|3|||
126292267|NCT00967330|454357520|FG000|Overall Study|Withdrawal by Subject|6|||
126292268|NCT00967330|454357521|FG001|Overall Study|Withdrawal by Subject|0|||
126292269|NCT00967330|454357520|FG000|Overall Study|Lost to Follow-up|1|||
126292270|NCT00967330|454357521|FG001|Overall Study|Lost to Follow-up|1|||
126292271|NCT00967330|454357520|FG000|Overall Study|Death|102|||
126292272|NCT00967330|454357521|FG001|Overall Study|Death|51|||
126292273|NCT00967330|454357520|FG000|Overall Study|Severe protocol deviation|0|||
126292274|NCT00967330|454357521|FG001|Overall Study|Severe protocol deviation|1|||
126292275|NCT03759392|454357523|FG000|Overall Study|Adverse Event|12|||
126458052|NCT01215916|454978272|FG008|Overall Study|Physician Decision|0|||
126458053|NCT02142387|454978273|FG000|Overall Study|<19 years old|49|||
126292276|NCT03759392|454357524|FG001|Overall Study|Adverse Event|4|||
126292277|NCT03759392|454357523|FG000|Overall Study|Death|2|||
126292278|NCT03759392|454357524|FG001|Overall Study|Death|1|||
126458054|NCT02142387|454978274|FG001|Overall Study|<19 years old|326|||
126458055|NCT02142387|454978273|FG000|Overall Study|non-cardiac etiology|504|||
126458056|NCT02142387|454978274|FG001|Overall Study|non-cardiac etiology|3431|||
126458057|NCT02142387|454978273|FG000|Overall Study|CPR not performed|74|||
126458058|NCT02142387|454978274|FG001|Overall Study|CPR not performed|473|||
126458059|NCT02142387|454978273|FG000|Overall Study|witnessed by paramedic|139|||
126458060|NCT02142387|454978274|FG001|Overall Study|witnessed by paramedic|917|||
126458061|NCT02142387|454978273|FG000|Overall Study|incomplete data|1|||
126458062|NCT02142387|454978274|FG001|Overall Study|incomplete data|9|||
126458063|NCT02142387|454978273|FG000|Overall Study|occurred not at home|298|||
126458064|NCT02142387|454978274|FG001|Overall Study|occurred not at home|2474|||
126458065|NCT05028361|454978275|FG000|Overall Study|Withdrawal by Subject|1|||
126458066|NCT05028361|454978276|FG001|Overall Study|Withdrawal by Subject|0|||
126458067|NCT01029405|454978284|FG000|Overall Study|Withdrawal by Subject|0|||
126458068|NCT01029405|454978285|FG001|Overall Study|Withdrawal by Subject|1|||
126458069|NCT01029405|454978286|FG002|Overall Study|Withdrawal by Subject|2|||
126458070|NCT01029405|454978287|FG003|Overall Study|Withdrawal by Subject|0|||
126458071|NCT01029405|454978284|FG000|Overall Study|Protocol Violation|0|||
126458072|NCT01029405|454978285|FG001|Overall Study|Protocol Violation|0|||
126458073|NCT01029405|454978286|FG002|Overall Study|Protocol Violation|0|||
126458074|NCT01029405|454978287|FG003|Overall Study|Protocol Violation|1|||
126292279|NCT03759392|454357523|FG000|Overall Study|Withdrawal by Subject|2|||
126292280|NCT03759392|454357524|FG001|Overall Study|Withdrawal by Subject|0|||
126292281|NCT03759392|454357523|FG000|Overall Study|Protocol Violation|2|||
126292282|NCT03759392|454357524|FG001|Overall Study|Protocol Violation|0|||
126292283|NCT03759392|454357523|FG000|Overall Study|Physician Decision|0|||
126292284|NCT03759392|454357524|FG001|Overall Study|Physician Decision|1|||
126292285|NCT03759392|454357523|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
126292286|NCT03759392|454357524|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
126292287|NCT03759392|454357523|FG000|Overall Study|No longer able to take medicines|1|||
126292288|NCT03759392|454357524|FG001|Overall Study|No longer able to take medicines|0|||
126292289|NCT03759392|454357523|FG000|Overall Study|Stopped taking study drug|1|||
126292290|NCT03759392|454357524|FG001|Overall Study|Stopped taking study drug|0|||
126292291|NCT02548143|454357525|FG000|Overall Study|Adverse Event|1|||
126292292|NCT02548143|454357526|FG001|Overall Study|Adverse Event|0|||
126292293|NCT02548143|454357525|FG000|Overall Study|Withdrawal by Subject|0|||
126292294|NCT02548143|454357526|FG001|Overall Study|Withdrawal by Subject|1|||
126292295|NCT04871776|454357527|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
126292296|NCT04871776|454357528|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
126292297|NCT04871776|454357529|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
126292298|NCT04871776|454357527|FG000|Overall Study|Did not meet eligibility criteria|1|||
126292299|NCT04871776|454357528|FG001|Overall Study|Did not meet eligibility criteria|1|||
126292300|NCT04871776|454357529|FG002|Overall Study|Did not meet eligibility criteria|1|||
126292301|NCT05620082|454357532|FG000|Overall Study|Discharged before study end|1|||
126292302|NCT05620082|454357533|FG001|Overall Study|Discharged before study end|4|||
126292303|NCT05620082|454357534|FG002|Overall Study|Discharged before study end|0|||
126292304|NCT05620082|454357532|FG000|Overall Study|Moved to a different ward|1|||
126292305|NCT05620082|454357533|FG001|Overall Study|Moved to a different ward|0|||
126292306|NCT05620082|454357534|FG002|Overall Study|Moved to a different ward|0|||
126292307|NCT05620082|454357532|FG000|Overall Study|Feeling too unwell|1|||
126292308|NCT05620082|454357533|FG001|Overall Study|Feeling too unwell|0|||
126292309|NCT05620082|454357534|FG002|Overall Study|Feeling too unwell|0|||
126292310|NCT04075487|454359249|FG000|Overall Study|Withdrawal by Subject|1|||
126292311|NCT00711243|454359252|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
126292312|NCT00711243|454359253|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
126458075|NCT01029405|454978284|FG000|Overall Study|Adverse Event|0|||
126458076|NCT01029405|454978285|FG001|Overall Study|Adverse Event|0|||
126458077|NCT01029405|454978286|FG002|Overall Study|Adverse Event|1|||
126458078|NCT01029405|454978287|FG003|Overall Study|Adverse Event|1|||
126292313|NCT00711243|454359254|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
126292314|NCT00711243|454359255|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
126292315|NCT00711243|454359256|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
126292316|NCT00711243|454359257|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
126292317|NCT00711243|454359252|FG000|Reached First Response/4 Cycles|Death|0|||
126292318|NCT00711243|454359253|FG001|Reached First Response/4 Cycles|Death|0|||
126292319|NCT00711243|454359254|FG002|Reached First Response/4 Cycles|Death|0|||
126458079|NCT01029405|454978284|FG000|Overall Study|Lost to Follow-up|2|||
126292320|NCT00711243|454359255|FG003|Reached First Response/4 Cycles|Death|0|||
126292321|NCT00711243|454359256|FG004|Reached First Response/4 Cycles|Death|0|||
126458080|NCT01029405|454978285|FG001|Overall Study|Lost to Follow-up|1|||
126458081|NCT01029405|454978286|FG002|Overall Study|Lost to Follow-up|1|||
126458082|NCT01029405|454978287|FG003|Overall Study|Lost to Follow-up|2|||
126458083|NCT01029405|454978284|FG000|Overall Study|Other|0|||
126458084|NCT01029405|454978285|FG001|Overall Study|Other|1|||
126458085|NCT01029405|454978286|FG002|Overall Study|Other|0|||
126292322|NCT00711243|454359257|FG005|Reached First Response/4 Cycles|Death|2|||
126292323|NCT00711243|454359252|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
126292324|NCT00711243|454359253|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
126292325|NCT00711243|454359254|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
126292326|NCT00711243|454359255|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
126292327|NCT00711243|454359256|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
126292328|NCT00711243|454359257|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
126292329|NCT00711243|454359252|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
126292330|NCT00711243|454359253|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
126292331|NCT00711243|454359254|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
126292332|NCT00711243|454359255|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
126292333|NCT00711243|454359256|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
126292334|NCT00711243|454359257|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
126292335|NCT00711243|454359252|FG000|Treated Cycle 5 After First Response|Death|0|||
126292336|NCT00711243|454359253|FG001|Treated Cycle 5 After First Response|Death|0|||
126292337|NCT00711243|454359254|FG002|Treated Cycle 5 After First Response|Death|0|||
126292338|NCT00711243|454359255|FG003|Treated Cycle 5 After First Response|Death|0|||
126292339|NCT00711243|454359256|FG004|Treated Cycle 5 After First Response|Death|0|||
126292340|NCT00711243|454359257|FG005|Treated Cycle 5 After First Response|Death|2|||
126292341|NCT00711243|454359252|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
126292342|NCT00711243|454359253|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
126292343|NCT00711243|454359254|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
126292344|NCT00711243|454359255|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
126292345|NCT00711243|454359256|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
126292346|NCT00711243|454359257|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
126292347|NCT00711243|454359252|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
126292348|NCT00711243|454359253|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
126292349|NCT00711243|454359254|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
126292350|NCT00711243|454359255|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
126292351|NCT00711243|454359256|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
126292352|NCT00711243|454359257|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
126292353|NCT01402570|454359258|FG000|Overall Study|Adverse Event|1|||
126292354|NCT04179838|454359262|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
126292355|NCT04179838|454359263|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
126292356|NCT04179838|454359262|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
126292357|NCT04179838|454359263|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
126292358|NCT01290068|454359268|FG000|Overall Study|Adverse Event|1|||
126292359|NCT01290068|454359269|FG001|Overall Study|Adverse Event|3|||
126292360|NCT01290068|454359268|FG000|Overall Study|Lost to Follow-up|3|||
126292361|NCT01290068|454359269|FG001|Overall Study|Lost to Follow-up|0|||
126292362|NCT01290068|454359268|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
126292363|NCT01290068|454359269|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
126292364|NCT01290068|454359268|FG000|Overall Study|Other|3|||
126292365|NCT01290068|454359269|FG001|Overall Study|Other|1|||
126292366|NCT01417156|454359274|FG000|Overall Study|Adverse Event|12|||
126292367|NCT01417156|454359274|FG000|Overall Study|Protocol Violation|2|||
126292368|NCT00818766|454359275|FG000|Overall Study|Could not be Contacted on Day 28|11|||
126292369|NCT00818766|454359276|FG001|Overall Study|Could not be Contacted on Day 28|10|||
126292370|NCT00818766|454359275|FG000|Overall Study|Death|1|||
126292371|NCT00818766|454359276|FG001|Overall Study|Death|0|||
126292372|NCT00818766|454359275|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
126292373|NCT00818766|454359276|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
126292374|NCT00086684|454359277|FG000|Overall Study|Adverse Event|12|||
126292375|NCT00086684|454359278|FG001|Overall Study|Adverse Event|17|||
126292376|NCT00086684|454359279|FG002|Overall Study|Adverse Event|14|||
126292377|NCT00086684|454359277|FG000|Overall Study|Lack of Efficacy|6|||
126292378|NCT00086684|454359278|FG001|Overall Study|Lack of Efficacy|6|||
126292379|NCT00086684|454359279|FG002|Overall Study|Lack of Efficacy|5|||
126292380|NCT00086684|454359277|FG000|Overall Study|Lost to Follow-up|15|||
126292381|NCT00086684|454359278|FG001|Overall Study|Lost to Follow-up|8|||
126292382|NCT00086684|454359279|FG002|Overall Study|Lost to Follow-up|10|||
126458086|NCT01029405|454978287|FG003|Overall Study|Other|1|||
126292383|NCT00086684|454359277|FG000|Overall Study|Protocol Violation|8|||
126458087|NCT00409175|454978288|FG000|Overall Study|Adverse Event|4|||
126458088|NCT00409175|454978289|FG001|Overall Study|Adverse Event|3|||
126458089|NCT00409175|454978288|FG000|Overall Study|Withdrawal by Subject|1|||
126292384|NCT00086684|454359278|FG001|Overall Study|Protocol Violation|3|||
126292385|NCT00086684|454359279|FG002|Overall Study|Protocol Violation|0|||
126292386|NCT00086684|454359277|FG000|Overall Study|Withdrawal by Subject|0|||
126292387|NCT00086684|454359278|FG001|Overall Study|Withdrawal by Subject|4|||
126458090|NCT00409175|454978289|FG001|Overall Study|Withdrawal by Subject|2|||
126458091|NCT00409175|454978288|FG000|Overall Study|Negative genotype|0|||
126292388|NCT00086684|454359279|FG002|Overall Study|Withdrawal by Subject|10|||
126292389|NCT00086684|454359277|FG000|Overall Study|NONCOMPLIANCE|5|||
126292390|NCT00086684|454359278|FG001|Overall Study|NONCOMPLIANCE|7|||
126292391|NCT00086684|454359279|FG002|Overall Study|NONCOMPLIANCE|6|||
126292392|NCT00086684|454359277|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126292393|NCT00086684|454359278|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
126292394|NCT00086684|454359279|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
126292395|NCT00086684|454359277|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
126292396|NCT00086684|454359278|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
126292397|NCT00086684|454359279|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
126292398|NCT00086684|454359277|FG000|Overall Study|Other|4|||
126292399|NCT00086684|454359278|FG001|Overall Study|Other|2|||
126292400|NCT00086684|454359279|FG002|Overall Study|Other|3|||
126292401|NCT01996241|454359281|FG000|Overall Study|Lost to Follow-up|252|||
126292402|NCT01996241|454359282|FG001|Overall Study|Lost to Follow-up|235|||
126292403|NCT04515147|454359283|FG000|Overall Study|Withdrawal by Subject|1|||
126292404|NCT04515147|454359284|FG001|Overall Study|Withdrawal by Subject|0|||
126292405|NCT04515147|454359285|FG002|Overall Study|Withdrawal by Subject|10|||
126292406|NCT04515147|454359286|FG003|Overall Study|Withdrawal by Subject|18|||
126292407|NCT04515147|454359287|FG004|Overall Study|Withdrawal by Subject|1|||
126292408|NCT04515147|454359288|FG005|Overall Study|Withdrawal by Subject|8|||
126292409|NCT04515147|454359283|FG000|Overall Study|Lost to Follow-up|0|||
126292410|NCT04515147|454359284|FG001|Overall Study|Lost to Follow-up|1|||
126292411|NCT04515147|454359285|FG002|Overall Study|Lost to Follow-up|5|||
126292412|NCT04515147|454359286|FG003|Overall Study|Lost to Follow-up|6|||
126292413|NCT04515147|454359287|FG004|Overall Study|Lost to Follow-up|2|||
126292414|NCT04515147|454359288|FG005|Overall Study|Lost to Follow-up|1|||
126292415|NCT04515147|454359283|FG000|Overall Study|Adverse Event|0|||
126292416|NCT04515147|454359284|FG001|Overall Study|Adverse Event|0|||
126292417|NCT04515147|454359285|FG002|Overall Study|Adverse Event|0|||
126292418|NCT04515147|454359286|FG003|Overall Study|Adverse Event|2|||
126292419|NCT04515147|454359287|FG004|Overall Study|Adverse Event|0|||
126292420|NCT04515147|454359288|FG005|Overall Study|Adverse Event|0|||
126292421|NCT04515147|454359283|FG000|Overall Study|Miscellaneous|0|||
126292422|NCT04515147|454359284|FG001|Overall Study|Miscellaneous|0|||
126292423|NCT04515147|454359285|FG002|Overall Study|Miscellaneous|0|||
126292424|NCT04515147|454359286|FG003|Overall Study|Miscellaneous|1|||
126292425|NCT04515147|454359287|FG004|Overall Study|Miscellaneous|0|||
126292426|NCT04515147|454359288|FG005|Overall Study|Miscellaneous|1|||
126292427|NCT02094300|454359293|FG000|Overall Study|Death|7|||
126292428|NCT02094300|454359293|FG000|Overall Study|Lost to Follow-up|10|||
126292429|NCT02094300|454359293|FG000|Overall Study|Still be eligible for follow-up|3|||
126292430|NCT03565900|454359299|FG000|Overall Study|Disposition Unknown|4|||
126292431|NCT03565900|454359300|FG001|Overall Study|Disposition Unknown|1|||
126292432|NCT03565900|454359299|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
126292433|NCT03565900|454359300|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
126292434|NCT03565900|454359299|FG000|Overall Study|Withdrawal by Subject|4|||
126292435|NCT03565900|454359300|FG001|Overall Study|Withdrawal by Subject|5|||
126292436|NCT03565900|454359299|FG000|Overall Study|Randomized By Mistake|0|||
126292437|NCT03565900|454359300|FG001|Overall Study|Randomized By Mistake|2|||
126292438|NCT03565900|454359299|FG000|Overall Study|Physician Decision|7|||
126292439|NCT03565900|454359300|FG001|Overall Study|Physician Decision|11|||
126292440|NCT03565900|454359299|FG000|Overall Study|Death|9|||
126292441|NCT03565900|454359300|FG001|Overall Study|Death|7|||
126292442|NCT00942357|454359313|FG000|Overall Study|Ineligible|37|||
126292443|NCT00942357|454359314|FG001|Overall Study|Ineligible|40|||
126292444|NCT01960257|454359315|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
126292445|NCT01960257|454359316|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
126292446|NCT01960257|454359317|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
126292447|NCT01960257|454359315|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
126292448|NCT01960257|454359316|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
126292449|NCT01960257|454359317|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
126292450|NCT01960257|454359315|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
126292451|NCT01960257|454359316|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
126292452|NCT01960257|454359317|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
126292453|NCT02002221|454359318|FG000|Overall Study|Adverse Event|2|||
126292454|NCT02002221|454359319|FG001|Overall Study|Adverse Event|1|||
126292455|NCT02002221|454359318|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126292456|NCT02002221|454359319|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126458092|NCT00409175|454978289|FG001|Overall Study|Negative genotype|1|||
126458093|NCT00409175|454978288|FG000|Overall Study|Liver transplantation|13|||
126458094|NCT00409175|454978289|FG001|Overall Study|Liver transplantation|13|||
126292457|NCT02002221|454359318|FG000|Overall Study|Patient withdrew consent|0|||
126292458|NCT02002221|454359319|FG001|Overall Study|Patient withdrew consent|1|||
126292459|NCT01518322|454359320|FG000|Overall Study|FeNO measurement was missing|13|||
126292460|NCT03518008|454359325|FG000|Period 2, Second Week of Wear|Family emergency|0|||
126292461|NCT03518008|454359326|FG001|Period 2, Second Week of Wear|Family emergency|1|||
126292462|NCT01169350|454359327|FG000|Overall Study|Physician Decision|3|||
126292463|NCT01169350|454359327|FG000|Overall Study|Lost to Follow-up|2|||
126292464|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
126292465|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
126292466|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
126292467|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
126292468|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
126292469|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
126292470|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
126292471|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
126292472|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
126292473|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
126292474|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
126292475|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
126292476|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
126292477|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
126292478|NCT04338022|454359328|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
126292479|NCT04338022|454359329|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
126292480|NCT04338022|454359328|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
126292481|NCT04338022|454359329|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
126292482|NCT04338022|454359328|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
126292483|NCT04338022|454359329|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
126292484|NCT04338022|454359328|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
126292485|NCT04338022|454359329|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
126292486|NCT04338022|454359328|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
126292487|NCT04338022|454359329|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
126292488|NCT04338022|454359328|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
126292489|NCT04338022|454359329|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
126292490|NCT04338022|454359328|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
126292491|NCT04338022|454359329|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
126292492|NCT02860546|454359331|FG000|Overall Study|Clinical Progression|6|||
126292493|NCT02860546|454359331|FG000|Overall Study|Radiological Progression|12|||
126292494|NCT02466321|454359332|FG000|Overall Study|Death|26|||
126292495|NCT02466321|454359332|FG000|Overall Study|Revision|6|||
126292496|NCT02466321|454359332|FG000|Overall Study|Lost to Follow-up|60|||
126292497|NCT02466321|454359332|FG000|Overall Study|Did not receive study device|1|||
126292498|NCT06071754|454359333|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
126292499|NCT00729937|454359334|FG000|Overall Study|Lost to Follow-up|49|||
126292500|NCT00729937|454359335|FG001|Overall Study|Lost to Follow-up|58|||
126292501|NCT00729937|454359336|FG002|Overall Study|Lost to Follow-up|18|||
126292502|NCT00729937|454359337|FG003|Overall Study|Lost to Follow-up|33|||
126292503|NCT00729937|454359338|FG004|Overall Study|Lost to Follow-up|18|||
126292504|NCT00729937|454359339|FG005|Overall Study|Lost to Follow-up|23|||
126292505|NCT00729937|454359334|FG000|Overall Study|Physician Decision|7|||
126292506|NCT00729937|454359335|FG001|Overall Study|Physician Decision|16|||
126292507|NCT00729937|454359336|FG002|Overall Study|Physician Decision|2|||
126292508|NCT00729937|454359337|FG003|Overall Study|Physician Decision|0|||
126292509|NCT00729937|454359338|FG004|Overall Study|Physician Decision|5|||
126292510|NCT00729937|454359339|FG005|Overall Study|Physician Decision|8|||
126292511|NCT00729937|454359334|FG000|Overall Study|Death|1|||
126292512|NCT00729937|454359335|FG001|Overall Study|Death|0|||
126292513|NCT00729937|454359336|FG002|Overall Study|Death|1|||
126292514|NCT00729937|454359337|FG003|Overall Study|Death|0|||
126292515|NCT00729937|454359338|FG004|Overall Study|Death|0|||
126292516|NCT00729937|454359339|FG005|Overall Study|Death|1|||
126292517|NCT00729937|454359334|FG000|Overall Study|Withdrawal by Subject|3|||
126292518|NCT00729937|454359335|FG001|Overall Study|Withdrawal by Subject|5|||
126292519|NCT00729937|454359336|FG002|Overall Study|Withdrawal by Subject|6|||
126292520|NCT00729937|454359337|FG003|Overall Study|Withdrawal by Subject|0|||
126292521|NCT00729937|454359338|FG004|Overall Study|Withdrawal by Subject|4|||
126292522|NCT00729937|454359339|FG005|Overall Study|Withdrawal by Subject|2|||
126292523|NCT00729937|454359334|FG000|Overall Study|Randomized but not treated|12|||
126292524|NCT00729937|454359335|FG001|Overall Study|Randomized but not treated|6|||
126366324|NCT03648372|454635828|FG014|Overall Study|Other|0|||
126366325|NCT03648372|454635829|FG015|Overall Study|Other|5|||
126366326|NCT03648372|454635830|FG016|Overall Study|Other|1|||
126366327|NCT03648372|454635831|FG017|Overall Study|Other|5|||
126366328|NCT03648372|454635832|FG018|Overall Study|Other|0|||
126366329|NCT03648372|454635833|FG019|Overall Study|Other|1|||
126366330|NCT03648372|454635834|FG020|Overall Study|Other|0|||
126366331|NCT03648372|454635814|FG000|Overall Study|Lost to Follow-up|0|||
126366332|NCT03648372|454635815|FG001|Overall Study|Lost to Follow-up|0|||
126366333|NCT03648372|454635816|FG002|Overall Study|Lost to Follow-up|0|||
126366334|NCT03648372|454635817|FG003|Overall Study|Lost to Follow-up|0|||
126366335|NCT03648372|454635818|FG004|Overall Study|Lost to Follow-up|0|||
126458095|NCT02108262|454978292|FG000|Overall Study|Non-compliance|0|||
126458096|NCT02108262|454978293|FG001|Overall Study|Non-compliance|2|||
126292525|NCT00729937|454359336|FG002|Overall Study|Randomized but not treated|1|||
126292526|NCT00729937|454359337|FG003|Overall Study|Randomized but not treated|0|||
126292527|NCT00729937|454359338|FG004|Overall Study|Randomized but not treated|1|||
126292528|NCT00729937|454359339|FG005|Overall Study|Randomized but not treated|3|||
126292529|NCT00729937|454359334|FG000|Overall Study|Did not meet eligibility criteria|2|||
126292530|NCT00729937|454359335|FG001|Overall Study|Did not meet eligibility criteria|1|||
126292531|NCT00729937|454359336|FG002|Overall Study|Did not meet eligibility criteria|0|||
126292532|NCT00729937|454359337|FG003|Overall Study|Did not meet eligibility criteria|0|||
126292533|NCT00729937|454359338|FG004|Overall Study|Did not meet eligibility criteria|0|||
126292534|NCT00729937|454359339|FG005|Overall Study|Did not meet eligibility criteria|0|||
126292535|NCT00729937|454359334|FG000|Overall Study|Incarcerated|0|||
126292536|NCT00729937|454359335|FG001|Overall Study|Incarcerated|2|||
126292537|NCT00729937|454359336|FG002|Overall Study|Incarcerated|1|||
126292538|NCT00729937|454359337|FG003|Overall Study|Incarcerated|1|||
126292539|NCT00729937|454359338|FG004|Overall Study|Incarcerated|0|||
126292540|NCT00729937|454359339|FG005|Overall Study|Incarcerated|0|||
126292541|NCT00243412|454359341|FG000|Overall Study|Death|0|||
126292542|NCT00243412|454359342|FG001|Overall Study|Death|1|||
126292543|NCT00243412|454359341|FG000|Overall Study|Adverse Event|4|||
126292544|NCT00243412|454359342|FG001|Overall Study|Adverse Event|2|||
126292545|NCT00243412|454359341|FG000|Overall Study|Lost to Follow-up|0|||
126292546|NCT00243412|454359342|FG001|Overall Study|Lost to Follow-up|1|||
126292547|NCT00243412|454359341|FG000|Overall Study|Physician Decision|1|||
126292548|NCT00243412|454359342|FG001|Overall Study|Physician Decision|1|||
126292549|NCT00243412|454359341|FG000|Overall Study|Withdrawal by Subject|4|||
126292550|NCT00243412|454359342|FG001|Overall Study|Withdrawal by Subject|5|||
126292551|NCT00243412|454359341|FG000|Overall Study|Other|1|||
126292552|NCT00243412|454359342|FG001|Overall Study|Other|1|||
126292553|NCT00683657|454359353|FG000|Overall Study|Adverse Event|0|||
126292554|NCT00683657|454359354|FG001|Overall Study|Adverse Event|1|||
126292555|NCT00683657|454359353|FG000|Overall Study|Subject Withdrew Consent|1|||
126292556|NCT00683657|454359354|FG001|Overall Study|Subject Withdrew Consent|0|||
126292557|NCT01408043|454359359|FG000|Overall Study|unable to collect cells|1|||
126292558|NCT02586155|454359360|FG000|Overall Study|Adverse Event|2|||
126292559|NCT02586155|454359361|FG001|Overall Study|Adverse Event|3|||
126292560|NCT02586155|454359360|FG000|Overall Study|Withdrawal by Subject|31|||
126292561|NCT02586155|454359361|FG001|Overall Study|Withdrawal by Subject|24|||
126292562|NCT02586155|454359360|FG000|Overall Study|Lost to Follow-up|7|||
126292563|NCT02586155|454359361|FG001|Overall Study|Lost to Follow-up|13|||
126292564|NCT02586155|454359360|FG000|Overall Study|Death|61|||
126292565|NCT02586155|454359361|FG001|Overall Study|Death|72|||
126292566|NCT02586155|454359360|FG000|Overall Study|Other reasons|26|||
126292567|NCT02586155|454359361|FG001|Overall Study|Other reasons|15|||
126292568|NCT00739063|454359362|FG000|Overall Study|Screen failures|8|||
126292569|NCT04779879|454359363|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
126292570|NCT04779879|454359364|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
126292571|NCT04779879|454359365|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
126292572|NCT04779879|454359366|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
126292573|NCT04779879|454359367|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
126292574|NCT04779879|454359368|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
126366336|NCT03648372|454635819|FG005|Overall Study|Lost to Follow-up|0|||
126366337|NCT03648372|454635820|FG006|Overall Study|Lost to Follow-up|0|||
126366338|NCT03648372|454635821|FG007|Overall Study|Lost to Follow-up|0|||
126366339|NCT03648372|454635822|FG008|Overall Study|Lost to Follow-up|0|||
126366340|NCT03648372|454635823|FG009|Overall Study|Lost to Follow-up|0|||
126366341|NCT03648372|454635824|FG010|Overall Study|Lost to Follow-up|0|||
126366342|NCT03648372|454635825|FG011|Overall Study|Lost to Follow-up|0|||
126366343|NCT03648372|454635826|FG012|Overall Study|Lost to Follow-up|0|||
126366344|NCT03648372|454635827|FG013|Overall Study|Lost to Follow-up|1|||
126366345|NCT03648372|454635828|FG014|Overall Study|Lost to Follow-up|0|||
126458097|NCT02108262|454978294|FG002|Overall Study|Non-compliance|1|||
126292575|NCT04779879|454359363|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
126292576|NCT04779879|454359364|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
126292577|NCT04779879|454359365|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
126292578|NCT04779879|454359366|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
126292579|NCT04779879|454359367|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
126292580|NCT04779879|454359368|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
126292581|NCT04779879|454359363|FG000|Part C: Up to Week 36|Death|0|||
126292582|NCT04779879|454359364|FG001|Part C: Up to Week 36|Death|0|||
126292583|NCT04779879|454359365|FG002|Part C: Up to Week 36|Death|0|||
126292584|NCT04779879|454359366|FG003|Part C: Up to Week 36|Death|0|||
126292585|NCT04779879|454359367|FG004|Part C: Up to Week 36|Death|0|||
126292586|NCT04779879|454359368|FG005|Part C: Up to Week 36|Death|1|||
126366346|NCT03648372|454635829|FG015|Overall Study|Lost to Follow-up|1|||
126366347|NCT03648372|454635830|FG016|Overall Study|Lost to Follow-up|0|||
126292587|NCT04779879|454359363|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
126292588|NCT04779879|454359364|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
126292589|NCT04779879|454359365|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
126292590|NCT04779879|454359366|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
126292591|NCT04779879|454359367|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
126292592|NCT04779879|454359368|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
126292593|NCT02072980|454359369|FG000|Period 2, Second Wear|Adverse Event|0|||
126292594|NCT02072980|454359370|FG001|Period 2, Second Wear|Adverse Event|1|||
126292595|NCT02633787|454359371|FG000|Overall Study|Withdrawal by Subject|1|||
126292596|NCT01742897|454359372|FG000|Overall Study|Adverse Event|3|||
126292597|NCT01742897|454359372|FG000|Overall Study|Withdrawal by Subject|1|||
126292598|NCT01742897|454359372|FG000|Overall Study|Other|1|||
126292599|NCT02601014|454359374|FG000|Overall Study|Adverse Event|3|||
126292600|NCT02601014|454359375|FG001|Overall Study|Adverse Event|3|||
126292601|NCT02601014|454359374|FG000|Overall Study|Death|3|||
126292602|NCT02601014|454359375|FG001|Overall Study|Death|1|||
126292603|NCT02601014|454359374|FG000|Overall Study|Disease progression|4|||
126292604|NCT02601014|454359375|FG001|Overall Study|Disease progression|8|||
126292605|NCT01168427|454359376|FG000|Overall Study|Patient exited prior to implant|1|||
126292606|NCT02456740|454359380|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
126292607|NCT02456740|454359381|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
126292608|NCT02456740|454359382|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
126292609|NCT02456740|454359383|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
126292610|NCT02456740|454359384|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
126292611|NCT02456740|454359385|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
126292612|NCT02456740|454359386|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
126292613|NCT02456740|454359387|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
126292614|NCT02456740|454359388|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
126292615|NCT02456740|454359380|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
126292616|NCT02456740|454359381|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
126292617|NCT02456740|454359382|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
126292618|NCT02456740|454359383|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
126292619|NCT02456740|454359384|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
126292620|NCT02456740|454359385|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
126292621|NCT02456740|454359386|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
126292622|NCT02456740|454359387|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
126292623|NCT02456740|454359388|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
126292624|NCT02456740|454359380|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
126292625|NCT02456740|454359381|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
126292626|NCT02456740|454359382|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
126292627|NCT02456740|454359383|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
126292628|NCT02456740|454359384|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
126292629|NCT02456740|454359385|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
126292630|NCT02456740|454359386|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
126292631|NCT02456740|454359387|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
126292632|NCT02456740|454359388|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
126292633|NCT02456740|454359380|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
126292634|NCT02456740|454359381|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
126292635|NCT02456740|454359382|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
126292636|NCT02456740|454359383|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
126292637|NCT02456740|454359384|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
126292638|NCT02456740|454359385|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
126292639|NCT02456740|454359386|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
126292640|NCT02456740|454359387|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
126292641|NCT02456740|454359388|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
126292642|NCT02456740|454359380|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126292643|NCT02456740|454359381|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126292644|NCT02456740|454359382|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126292645|NCT02456740|454359383|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
126366348|NCT03648372|454635831|FG017|Overall Study|Lost to Follow-up|1|||
126549795|NCT02222896|455307595|FG001|Groin|Did not qualify|9|||
126549796|NCT02222896|455307596|FG002|Groin|Did not qualify|40|||
126292646|NCT02456740|454359384|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
126292647|NCT02456740|454359385|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
126292648|NCT02456740|454359386|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
126366349|NCT03648372|454635832|FG018|Overall Study|Lost to Follow-up|0|||
126292649|NCT02456740|454359387|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
126292650|NCT02456740|454359388|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
126292651|NCT02456740|454359380|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292652|NCT02456740|454359381|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292653|NCT02456740|454359382|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292654|NCT02456740|454359383|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292655|NCT02456740|454359384|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292656|NCT02456740|454359385|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292657|NCT02456740|454359386|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292658|NCT02456740|454359387|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
126292659|NCT02456740|454359388|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
126292660|NCT02456740|454359380|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126292661|NCT02456740|454359381|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126292662|NCT02456740|454359382|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126292663|NCT02456740|454359383|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
126292664|NCT02456740|454359384|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
126292665|NCT02456740|454359385|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
126292666|NCT02456740|454359386|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
126292667|NCT02456740|454359387|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
126292668|NCT02456740|454359388|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
126292669|NCT00955617|454359397|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
126292670|NCT00955617|454359398|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
126292671|NCT00955617|454359397|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
126292672|NCT00955617|454359398|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
126292673|NCT00955617|454359397|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
126710704|NCT01183858|455893516|FG000|Overall Study|Withdrew Consent|4|||
126710705|NCT01183858|455893517|FG001|Overall Study|Withdrew Consent|4|||
126710706|NCT01183858|455893516|FG000|Overall Study|Discontinued Smoking|3|||
126292674|NCT00955617|454359398|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
126292675|NCT00955617|454359397|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
126292676|NCT00955617|454359398|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
126292677|NCT00931528|454361438|FG000|Overall Study|Protocol Violation|9|||
126292678|NCT00931528|454361439|FG001|Overall Study|Protocol Violation|12|||
126292679|NCT00931528|454361438|FG000|Overall Study|Withdrawal by Subject|4|||
126292680|NCT00931528|454361439|FG001|Overall Study|Withdrawal by Subject|12|||
126292681|NCT00931528|454361438|FG000|Overall Study|Lost to Follow-up|6|||
126292682|NCT00931528|454361439|FG001|Overall Study|Lost to Follow-up|13|||
126292683|NCT00931528|454361438|FG000|Overall Study|Assessment outside of Time Frame|22|||
126292684|NCT00931528|454361439|FG001|Overall Study|Assessment outside of Time Frame|23|||
126292685|NCT02721732|454361440|FG000|Overall Study|Adverse Event|2|||
126292686|NCT02721732|454361441|FG001|Overall Study|Adverse Event|0|||
126292687|NCT02721732|454361442|FG002|Overall Study|Adverse Event|2|||
126292688|NCT02721732|454361443|FG003|Overall Study|Adverse Event|0|||
126292689|NCT02721732|454361444|FG004|Overall Study|Adverse Event|1|||
126292690|NCT02721732|454361445|FG005|Overall Study|Adverse Event|0|||
126292691|NCT02721732|454361446|FG006|Overall Study|Adverse Event|1|||
126292692|NCT02721732|454361447|FG007|Overall Study|Adverse Event|0|||
126292693|NCT02721732|454361448|FG008|Overall Study|Adverse Event|1|||
126292694|NCT02721732|454361449|FG009|Overall Study|Adverse Event|1|||
126292695|NCT02721732|454361440|FG000|Overall Study|Death|0|||
126292696|NCT02721732|454361441|FG001|Overall Study|Death|0|||
126292697|NCT02721732|454361442|FG002|Overall Study|Death|0|||
126292698|NCT02721732|454361443|FG003|Overall Study|Death|0|||
126292699|NCT02721732|454361444|FG004|Overall Study|Death|1|||
126292700|NCT02721732|454361445|FG005|Overall Study|Death|0|||
126292701|NCT02721732|454361446|FG006|Overall Study|Death|1|||
126292702|NCT02721732|454361447|FG007|Overall Study|Death|0|||
126292703|NCT02721732|454361448|FG008|Overall Study|Death|0|||
126292704|NCT02721732|454361449|FG009|Overall Study|Death|1|||
126292705|NCT02721732|454361440|FG000|Overall Study|Lack of Efficacy|12|||
126292706|NCT02721732|454361441|FG001|Overall Study|Lack of Efficacy|11|||
126292707|NCT02721732|454361442|FG002|Overall Study|Lack of Efficacy|18|||
126292708|NCT02721732|454361443|FG003|Overall Study|Lack of Efficacy|5|||
126292709|NCT02721732|454361444|FG004|Overall Study|Lack of Efficacy|21|||
126292710|NCT02721732|454361445|FG005|Overall Study|Lack of Efficacy|2|||
126292711|NCT02721732|454361446|FG006|Overall Study|Lack of Efficacy|8|||
126292712|NCT02721732|454361447|FG007|Overall Study|Lack of Efficacy|11|||
126292713|NCT02721732|454361448|FG008|Overall Study|Lack of Efficacy|10|||
126292714|NCT02721732|454361449|FG009|Overall Study|Lack of Efficacy|20|||
126292715|NCT02721732|454361440|FG000|Overall Study|Physician Decision|0|||
126292716|NCT02721732|454361441|FG001|Overall Study|Physician Decision|0|||
126292717|NCT02721732|454361442|FG002|Overall Study|Physician Decision|1|||
126292718|NCT02721732|454361443|FG003|Overall Study|Physician Decision|0|||
126292719|NCT02721732|454361444|FG004|Overall Study|Physician Decision|0|||
126710707|NCT01183858|455893517|FG001|Overall Study|Discontinued Smoking|1|||
126549797|NCT01865617|455307603|FG000|Overall Study|Death|27|||
126549798|NCT01865617|455307604|FG001|Overall Study|Death|3|||
126292720|NCT02721732|454361445|FG005|Overall Study|Physician Decision|0|||
126292721|NCT02721732|454361446|FG006|Overall Study|Physician Decision|0|||
126292722|NCT02721732|454361447|FG007|Overall Study|Physician Decision|0|||
126292723|NCT02721732|454361448|FG008|Overall Study|Physician Decision|0|||
126292724|NCT02721732|454361449|FG009|Overall Study|Physician Decision|0|||
126292725|NCT02721732|454361440|FG000|Overall Study|Withdrawal by Subject|1|||
126292726|NCT02721732|454361441|FG001|Overall Study|Withdrawal by Subject|0|||
126292727|NCT02721732|454361442|FG002|Overall Study|Withdrawal by Subject|0|||
126292728|NCT02721732|454361443|FG003|Overall Study|Withdrawal by Subject|0|||
126292729|NCT02721732|454361444|FG004|Overall Study|Withdrawal by Subject|3|||
126292730|NCT02721732|454361445|FG005|Overall Study|Withdrawal by Subject|0|||
126292731|NCT02721732|454361446|FG006|Overall Study|Withdrawal by Subject|1|||
126292732|NCT02721732|454361447|FG007|Overall Study|Withdrawal by Subject|1|||
126292733|NCT02721732|454361448|FG008|Overall Study|Withdrawal by Subject|0|||
126292734|NCT02721732|454361449|FG009|Overall Study|Withdrawal by Subject|1|||
126292735|NCT02721732|454361440|FG000|Overall Study|Participant Choice|1|||
126292736|NCT02721732|454361441|FG001|Overall Study|Participant Choice|0|||
126292737|NCT02721732|454361442|FG002|Overall Study|Participant Choice|0|||
126292738|NCT02721732|454361443|FG003|Overall Study|Participant Choice|0|||
126292739|NCT02721732|454361444|FG004|Overall Study|Participant Choice|0|||
126292740|NCT02721732|454361445|FG005|Overall Study|Participant Choice|0|||
126292741|NCT02721732|454361446|FG006|Overall Study|Participant Choice|0|||
126292742|NCT02721732|454361447|FG007|Overall Study|Participant Choice|0|||
126292743|NCT02721732|454361448|FG008|Overall Study|Participant Choice|0|||
126292744|NCT02721732|454361449|FG009|Overall Study|Participant Choice|1|||
126292745|NCT02721732|454361440|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292746|NCT02721732|454361441|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292747|NCT02721732|454361442|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
126292748|NCT02721732|454361443|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292749|NCT02721732|454361444|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292750|NCT02721732|454361445|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292751|NCT02721732|454361446|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292752|NCT02721732|454361447|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292753|NCT02721732|454361448|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292754|NCT02721732|454361449|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
126292755|NCT02721732|454361440|FG000|Overall Study|Progression and withdrew consent|1|||
126292756|NCT02721732|454361441|FG001|Overall Study|Progression and withdrew consent|1|||
126292757|NCT02721732|454361442|FG002|Overall Study|Progression and withdrew consent|0|||
126292758|NCT02721732|454361443|FG003|Overall Study|Progression and withdrew consent|0|||
126292759|NCT02721732|454361444|FG004|Overall Study|Progression and withdrew consent|0|||
126292760|NCT02721732|454361445|FG005|Overall Study|Progression and withdrew consent|0|||
126292761|NCT02721732|454361446|FG006|Overall Study|Progression and withdrew consent|0|||
126292762|NCT02721732|454361447|FG007|Overall Study|Progression and withdrew consent|0|||
126292763|NCT02721732|454361448|FG008|Overall Study|Progression and withdrew consent|0|||
126292764|NCT02721732|454361449|FG009|Overall Study|Progression and withdrew consent|1|||
126292765|NCT02721732|454361440|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
126292766|NCT02721732|454361441|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
126292767|NCT02721732|454361442|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
126292768|NCT02721732|454361443|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
126292769|NCT02721732|454361444|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
126292770|NCT02721732|454361445|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
126292771|NCT02721732|454361446|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
126292772|NCT02721732|454361447|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
126292773|NCT02721732|454361448|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
126366350|NCT03648372|454635833|FG019|Overall Study|Lost to Follow-up|0|||
126366351|NCT03648372|454635834|FG020|Overall Study|Lost to Follow-up|0|||
126366352|NCT03648372|454635814|FG000|Overall Study|Start of a New Systemic Treatment|0|||
126366353|NCT03648372|454635815|FG001|Overall Study|Start of a New Systemic Treatment|0|||
126366354|NCT03648372|454635816|FG002|Overall Study|Start of a New Systemic Treatment|0|||
126366355|NCT03648372|454635817|FG003|Overall Study|Start of a New Systemic Treatment|0|||
126366356|NCT03648372|454635818|FG004|Overall Study|Start of a New Systemic Treatment|0|||
126366357|NCT03648372|454635819|FG005|Overall Study|Start of a New Systemic Treatment|0|||
126366358|NCT03648372|454635820|FG006|Overall Study|Start of a New Systemic Treatment|0|||
126366359|NCT03648372|454635821|FG007|Overall Study|Start of a New Systemic Treatment|2|||
126292774|NCT02721732|454361449|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
126292775|NCT02848001|454361450|FG000|Overall Study|other reasons|0|||
126366360|NCT03648372|454635822|FG008|Overall Study|Start of a New Systemic Treatment|0|||
126549799|NCT01865617|455307605|FG002|Overall Study|Death|1|||
126292776|NCT02848001|454361451|FG001|Overall Study|other reasons|0|||
126292777|NCT02848001|454361452|FG002|Overall Study|other reasons|1|||
126292778|NCT02848001|454361453|FG003|Overall Study|other reasons|0|||
126292779|NCT02848001|454361454|FG004|Overall Study|other reasons|4|||
126292780|NCT02848001|454361455|FG005|Overall Study|other reasons|1|||
126292781|NCT02848001|454361456|FG006|Overall Study|other reasons|0|||
126292782|NCT02848001|454361457|FG007|Overall Study|other reasons|2|||
126292783|NCT02848001|454361458|FG008|Overall Study|other reasons|2|||
126292784|NCT02848001|454361459|FG009|Overall Study|other reasons|3|||
126292785|NCT02848001|454361460|FG010|Overall Study|other reasons|0|||
126292786|NCT02848001|454361461|FG011|Overall Study|other reasons|1|||
126292787|NCT02848001|454361462|FG012|Overall Study|other reasons|1|||
126292788|NCT02848001|454361463|FG013|Overall Study|other reasons|0|||
126292789|NCT02848001|454361464|FG014|Overall Study|other reasons|0|||
126292790|NCT02848001|454361465|FG015|Overall Study|other reasons|2|||
126292791|NCT02848001|454361466|FG016|Overall Study|other reasons|1|||
126292792|NCT02848001|454361450|FG000|Overall Study|Lack of Efficacy|0|||
126292793|NCT02848001|454361451|FG001|Overall Study|Lack of Efficacy|1|||
126292794|NCT02848001|454361452|FG002|Overall Study|Lack of Efficacy|1|||
126292795|NCT02848001|454361453|FG003|Overall Study|Lack of Efficacy|2|||
126292796|NCT02848001|454361454|FG004|Overall Study|Lack of Efficacy|3|||
126292797|NCT02848001|454361455|FG005|Overall Study|Lack of Efficacy|0|||
126292798|NCT02848001|454361456|FG006|Overall Study|Lack of Efficacy|1|||
126292799|NCT02848001|454361457|FG007|Overall Study|Lack of Efficacy|0|||
126292800|NCT02848001|454361458|FG008|Overall Study|Lack of Efficacy|0|||
126292801|NCT02848001|454361459|FG009|Overall Study|Lack of Efficacy|1|||
126292802|NCT02848001|454361460|FG010|Overall Study|Lack of Efficacy|0|||
126292803|NCT02848001|454361461|FG011|Overall Study|Lack of Efficacy|2|||
126292804|NCT02848001|454361462|FG012|Overall Study|Lack of Efficacy|0|||
126292805|NCT02848001|454361463|FG013|Overall Study|Lack of Efficacy|2|||
126292806|NCT02848001|454361464|FG014|Overall Study|Lack of Efficacy|2|||
126292807|NCT02848001|454361465|FG015|Overall Study|Lack of Efficacy|0|||
126292808|NCT02848001|454361466|FG016|Overall Study|Lack of Efficacy|0|||
126292809|NCT02848001|454361450|FG000|Overall Study|Progressive Disease|2|||
126292810|NCT02848001|454361451|FG001|Overall Study|Progressive Disease|1|||
126292811|NCT02848001|454361452|FG002|Overall Study|Progressive Disease|0|||
126292812|NCT02848001|454361453|FG003|Overall Study|Progressive Disease|4|||
126292813|NCT02848001|454361454|FG004|Overall Study|Progressive Disease|3|||
126292814|NCT02848001|454361455|FG005|Overall Study|Progressive Disease|0|||
126292815|NCT02848001|454361456|FG006|Overall Study|Progressive Disease|4|||
126292816|NCT02848001|454361457|FG007|Overall Study|Progressive Disease|1|||
126292817|NCT02848001|454361458|FG008|Overall Study|Progressive Disease|0|||
126292818|NCT02848001|454361459|FG009|Overall Study|Progressive Disease|2|||
126292819|NCT02848001|454361460|FG010|Overall Study|Progressive Disease|3|||
126292820|NCT02848001|454361461|FG011|Overall Study|Progressive Disease|2|||
126292821|NCT02848001|454361462|FG012|Overall Study|Progressive Disease|1|||
126292822|NCT02848001|454361463|FG013|Overall Study|Progressive Disease|0|||
126292823|NCT02848001|454361464|FG014|Overall Study|Progressive Disease|2|||
126292824|NCT02848001|454361465|FG015|Overall Study|Progressive Disease|4|||
126292825|NCT02848001|454361466|FG016|Overall Study|Progressive Disease|0|||
126292826|NCT02848001|454361450|FG000|Overall Study|Adverse Event|0|||
126292827|NCT02848001|454361451|FG001|Overall Study|Adverse Event|0|||
126366361|NCT03648372|454635823|FG009|Overall Study|Start of a New Systemic Treatment|0|||
126366362|NCT03648372|454635824|FG010|Overall Study|Start of a New Systemic Treatment|1|||
126366363|NCT03648372|454635825|FG011|Overall Study|Start of a New Systemic Treatment|0|||
126366364|NCT03648372|454635826|FG012|Overall Study|Start of a New Systemic Treatment|0|||
126366365|NCT03648372|454635827|FG013|Overall Study|Start of a New Systemic Treatment|0|||
126366366|NCT03648372|454635828|FG014|Overall Study|Start of a New Systemic Treatment|0|||
126366367|NCT03648372|454635829|FG015|Overall Study|Start of a New Systemic Treatment|0|||
126366368|NCT03648372|454635830|FG016|Overall Study|Start of a New Systemic Treatment|0|||
126366369|NCT03648372|454635831|FG017|Overall Study|Start of a New Systemic Treatment|0|||
126366370|NCT03648372|454635832|FG018|Overall Study|Start of a New Systemic Treatment|0|||
126366371|NCT03648372|454635833|FG019|Overall Study|Start of a New Systemic Treatment|0|||
126366372|NCT03648372|454635834|FG020|Overall Study|Start of a New Systemic Treatment|0|||
126366373|NCT04280783|454636969|FG000|Overall Study|Family issues unrelated to the study.|1|||
126366374|NCT04280783|454636970|FG001|Overall Study|Family issues unrelated to the study.|0|||
126366375|NCT04280783|454636969|FG000|Overall Study|Withdrawal by Subject|0|||
126366376|NCT04280783|454636970|FG001|Overall Study|Withdrawal by Subject|1|||
126366377|NCT05654181|454636971|FG000|Overall Study|Adverse Event|1|||
126292828|NCT02848001|454361452|FG002|Overall Study|Adverse Event|0|||
126292829|NCT02848001|454361453|FG003|Overall Study|Adverse Event|0|||
126366378|NCT05654181|454636972|FG001|Overall Study|Adverse Event|0|||
126366379|NCT05654181|454636973|FG002|Overall Study|Adverse Event|0|||
126366380|NCT05654181|454636974|FG003|Overall Study|Adverse Event|0|||
126292830|NCT02848001|454361454|FG004|Overall Study|Adverse Event|2|||
126292831|NCT02848001|454361455|FG005|Overall Study|Adverse Event|0|||
126292832|NCT02848001|454361456|FG006|Overall Study|Adverse Event|0|||
126292833|NCT02848001|454361457|FG007|Overall Study|Adverse Event|0|||
126366381|NCT05654181|454636975|FG004|Overall Study|Adverse Event|0|||
126292834|NCT02848001|454361458|FG008|Overall Study|Adverse Event|0|||
126292835|NCT02848001|454361459|FG009|Overall Study|Adverse Event|1|||
126292836|NCT02848001|454361460|FG010|Overall Study|Adverse Event|0|||
126292837|NCT02848001|454361461|FG011|Overall Study|Adverse Event|1|||
126292838|NCT02848001|454361462|FG012|Overall Study|Adverse Event|1|||
126292839|NCT02848001|454361463|FG013|Overall Study|Adverse Event|0|||
126292840|NCT02848001|454361464|FG014|Overall Study|Adverse Event|2|||
126292841|NCT02848001|454361465|FG015|Overall Study|Adverse Event|0|||
126292842|NCT02848001|454361466|FG016|Overall Study|Adverse Event|0|||
126292843|NCT02848001|454361450|FG000|Overall Study|Death|0|||
126292844|NCT02848001|454361451|FG001|Overall Study|Death|0|||
126292845|NCT02848001|454361452|FG002|Overall Study|Death|0|||
126292846|NCT02848001|454361453|FG003|Overall Study|Death|1|||
126292847|NCT02848001|454361454|FG004|Overall Study|Death|3|||
126292848|NCT02848001|454361455|FG005|Overall Study|Death|1|||
126292849|NCT02848001|454361456|FG006|Overall Study|Death|2|||
126292850|NCT02848001|454361457|FG007|Overall Study|Death|3|||
126292851|NCT02848001|454361458|FG008|Overall Study|Death|4|||
126292852|NCT02848001|454361459|FG009|Overall Study|Death|1|||
126292853|NCT02848001|454361460|FG010|Overall Study|Death|0|||
126292854|NCT02848001|454361461|FG011|Overall Study|Death|1|||
126292855|NCT02848001|454361462|FG012|Overall Study|Death|3|||
126292856|NCT02848001|454361463|FG013|Overall Study|Death|0|||
126292857|NCT02848001|454361464|FG014|Overall Study|Death|2|||
126292858|NCT02848001|454361465|FG015|Overall Study|Death|3|||
126292859|NCT02848001|454361466|FG016|Overall Study|Death|0|||
126292860|NCT02848001|454361450|FG000|Overall Study|Physician Decision|0|||
126292861|NCT02848001|454361451|FG001|Overall Study|Physician Decision|0|||
126292862|NCT02848001|454361452|FG002|Overall Study|Physician Decision|0|||
126292863|NCT02848001|454361453|FG003|Overall Study|Physician Decision|0|||
126292864|NCT02848001|454361454|FG004|Overall Study|Physician Decision|0|||
126292865|NCT02848001|454361455|FG005|Overall Study|Physician Decision|0|||
126292866|NCT02848001|454361456|FG006|Overall Study|Physician Decision|0|||
126292867|NCT02848001|454361457|FG007|Overall Study|Physician Decision|0|||
126292868|NCT02848001|454361458|FG008|Overall Study|Physician Decision|1|||
126292869|NCT02848001|454361459|FG009|Overall Study|Physician Decision|1|||
126292870|NCT02848001|454361460|FG010|Overall Study|Physician Decision|0|||
126292871|NCT02848001|454361461|FG011|Overall Study|Physician Decision|0|||
126292872|NCT02848001|454361462|FG012|Overall Study|Physician Decision|2|||
126292873|NCT02848001|454361463|FG013|Overall Study|Physician Decision|0|||
126292874|NCT02848001|454361464|FG014|Overall Study|Physician Decision|0|||
126292875|NCT02848001|454361465|FG015|Overall Study|Physician Decision|0|||
126292876|NCT02848001|454361466|FG016|Overall Study|Physician Decision|0|||
126292877|NCT02848001|454361450|FG000|Overall Study|Withdrawal by Subject|0|||
126292878|NCT02848001|454361451|FG001|Overall Study|Withdrawal by Subject|0|||
126292879|NCT02848001|454361452|FG002|Overall Study|Withdrawal by Subject|0|||
126292880|NCT02848001|454361453|FG003|Overall Study|Withdrawal by Subject|0|||
126292881|NCT02848001|454361454|FG004|Overall Study|Withdrawal by Subject|0|||
126292882|NCT02848001|454361455|FG005|Overall Study|Withdrawal by Subject|1|||
126292883|NCT02848001|454361456|FG006|Overall Study|Withdrawal by Subject|1|||
126292884|NCT02848001|454361457|FG007|Overall Study|Withdrawal by Subject|1|||
126292885|NCT02848001|454361458|FG008|Overall Study|Withdrawal by Subject|0|||
126292886|NCT02848001|454361459|FG009|Overall Study|Withdrawal by Subject|0|||
126292887|NCT02848001|454361460|FG010|Overall Study|Withdrawal by Subject|0|||
126292888|NCT02848001|454361461|FG011|Overall Study|Withdrawal by Subject|0|||
126292889|NCT02848001|454361462|FG012|Overall Study|Withdrawal by Subject|0|||
126292890|NCT02848001|454361463|FG013|Overall Study|Withdrawal by Subject|0|||
126292891|NCT02848001|454361464|FG014|Overall Study|Withdrawal by Subject|0|||
126292892|NCT02848001|454361465|FG015|Overall Study|Withdrawal by Subject|0|||
126292893|NCT02848001|454361466|FG016|Overall Study|Withdrawal by Subject|0|||
126292894|NCT00725283|454361472|FG000|Overall Study|Missing Code|3|||
126292895|NCT00725283|454361472|FG000|Overall Study|Death|5|||
126292896|NCT00725283|454361472|FG000|Overall Study|Other|6|||
126292897|NCT00725283|454361472|FG000|Overall Study|Withdrawal by Subject|10|||
126292898|NCT02115269|454361473|FG000|Overall Study|Lost to Follow-up|43|||
126292899|NCT02115269|454361473|FG000|Overall Study|Did not complete patient diary|3|||
126292900|NCT02115269|454361473|FG000|Overall Study|Moved to another city|7|||
126292901|NCT02115269|454361473|FG000|Overall Study|Withdrawal by Subject|2|||
126292902|NCT02115269|454361473|FG000|Overall Study|Didn't take study drug|2|||
126292903|NCT01557504|454361476|FG000|Overall Study|Physician Decision|1|||
126292904|NCT01557504|454361477|FG001|Overall Study|Physician Decision|0|||
126292905|NCT01962103|454361478|FG000|Phase 1|Adverse Event|4|||
126292906|NCT01962103|454361479|FG001|Phase 1|Adverse Event|0|||
126292907|NCT01962103|454361480|FG002|Phase 1|Adverse Event|2|||
126292908|NCT01962103|454361481|FG003|Phase 1|Adverse Event|1|||
126292909|NCT01962103|454361482|FG004|Phase 1|Adverse Event|2|||
126292910|NCT01962103|454361483|FG005|Phase 1|Adverse Event|2|||
126292911|NCT01962103|454361484|FG006|Phase 1|Adverse Event|0|||
126292912|NCT01962103|454361485|FG007|Phase 1|Adverse Event|0|||
126292913|NCT01962103|454361486|FG008|Phase 1|Adverse Event|0|||
126292914|NCT01962103|454361478|FG000|Phase 1|Progressive Disease|8|||
126292915|NCT01962103|454361479|FG001|Phase 1|Progressive Disease|6|||
126292916|NCT01962103|454361480|FG002|Phase 1|Progressive Disease|8|||
126292917|NCT01962103|454361481|FG003|Phase 1|Progressive Disease|4|||
126292918|NCT01962103|454361482|FG004|Phase 1|Progressive Disease|5|||
126292919|NCT01962103|454361483|FG005|Phase 1|Progressive Disease|4|||
126292920|NCT01962103|454361484|FG006|Phase 1|Progressive Disease|0|||
126292921|NCT01962103|454361485|FG007|Phase 1|Progressive Disease|0|||
126292922|NCT01962103|454361486|FG008|Phase 1|Progressive Disease|0|||
126292923|NCT01962103|454361478|FG000|Phase 1|Withdrawal by Subject|0|||
126292924|NCT01962103|454361479|FG001|Phase 1|Withdrawal by Subject|0|||
126292925|NCT01962103|454361480|FG002|Phase 1|Withdrawal by Subject|0|||
126292926|NCT01962103|454361481|FG003|Phase 1|Withdrawal by Subject|2|||
126292927|NCT01962103|454361482|FG004|Phase 1|Withdrawal by Subject|0|||
126292928|NCT01962103|454361483|FG005|Phase 1|Withdrawal by Subject|0|||
126292929|NCT01962103|454361484|FG006|Phase 1|Withdrawal by Subject|0|||
126292930|NCT01962103|454361485|FG007|Phase 1|Withdrawal by Subject|0|||
126292931|NCT01962103|454361486|FG008|Phase 1|Withdrawal by Subject|0|||
126292932|NCT01962103|454361478|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
126292933|NCT01962103|454361479|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
126292934|NCT01962103|454361480|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
126292935|NCT01962103|454361481|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
126292936|NCT01962103|454361482|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
126292937|NCT01962103|454361483|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
126292938|NCT01962103|454361484|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
126292939|NCT01962103|454361485|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
126292940|NCT01962103|454361486|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
126292941|NCT01962103|454361478|FG000|Phase 1|Physician Decision|0|||
126292942|NCT01962103|454361479|FG001|Phase 1|Physician Decision|0|||
126292943|NCT01962103|454361480|FG002|Phase 1|Physician Decision|0|||
126292944|NCT01962103|454361481|FG003|Phase 1|Physician Decision|1|||
126292945|NCT01962103|454361482|FG004|Phase 1|Physician Decision|0|||
126292946|NCT01962103|454361483|FG005|Phase 1|Physician Decision|0|||
126292947|NCT01962103|454361484|FG006|Phase 1|Physician Decision|0|||
126292948|NCT01962103|454361485|FG007|Phase 1|Physician Decision|0|||
126292949|NCT01962103|454361486|FG008|Phase 1|Physician Decision|0|||
126292950|NCT01962103|454361478|FG000|Phase 1|Symptomatic Deterioration|3|||
126292951|NCT01962103|454361479|FG001|Phase 1|Symptomatic Deterioration|2|||
126292952|NCT01962103|454361480|FG002|Phase 1|Symptomatic Deterioration|2|||
126292953|NCT01962103|454361481|FG003|Phase 1|Symptomatic Deterioration|2|||
126292954|NCT01962103|454361482|FG004|Phase 1|Symptomatic Deterioration|1|||
126292955|NCT01962103|454361483|FG005|Phase 1|Symptomatic Deterioration|1|||
126292956|NCT01962103|454361484|FG006|Phase 1|Symptomatic Deterioration|0|||
126292957|NCT01962103|454361485|FG007|Phase 1|Symptomatic Deterioration|0|||
126292958|NCT01962103|454361486|FG008|Phase 1|Symptomatic Deterioration|0|||
126292959|NCT01962103|454361478|FG000|Phase 1|Miscellaneous|1|||
126292960|NCT01962103|454361479|FG001|Phase 1|Miscellaneous|0|||
126292961|NCT01962103|454361480|FG002|Phase 1|Miscellaneous|0|||
126292962|NCT01962103|454361481|FG003|Phase 1|Miscellaneous|0|||
126292963|NCT01962103|454361482|FG004|Phase 1|Miscellaneous|0|||
126292964|NCT01962103|454361483|FG005|Phase 1|Miscellaneous|0|||
126292965|NCT01962103|454361484|FG006|Phase 1|Miscellaneous|0|||
126292966|NCT01962103|454361485|FG007|Phase 1|Miscellaneous|0|||
126292967|NCT01962103|454361486|FG008|Phase 1|Miscellaneous|0|||
126292968|NCT01962103|454361478|FG000|Phase 2|Adverse Event|0|||
126292969|NCT01962103|454361479|FG001|Phase 2|Adverse Event|0|||
126292970|NCT01962103|454361480|FG002|Phase 2|Adverse Event|0|||
126292971|NCT01962103|454361481|FG003|Phase 2|Adverse Event|0|||
126292972|NCT01962103|454361482|FG004|Phase 2|Adverse Event|0|||
126292973|NCT01962103|454361483|FG005|Phase 2|Adverse Event|0|||
126292974|NCT01962103|454361484|FG006|Phase 2|Adverse Event|1|||
126292975|NCT01962103|454361485|FG007|Phase 2|Adverse Event|0|||
126292976|NCT01962103|454361486|FG008|Phase 2|Adverse Event|3|||
126292977|NCT01962103|454361478|FG000|Phase 2|Progressive Disease|0|||
126292978|NCT01962103|454361479|FG001|Phase 2|Progressive Disease|0|||
126292979|NCT01962103|454361480|FG002|Phase 2|Progressive Disease|0|||
126292980|NCT01962103|454361481|FG003|Phase 2|Progressive Disease|0|||
126292981|NCT01962103|454361482|FG004|Phase 2|Progressive Disease|0|||
126292982|NCT01962103|454361483|FG005|Phase 2|Progressive Disease|0|||
126292983|NCT01962103|454361484|FG006|Phase 2|Progressive Disease|11|||
126292984|NCT01962103|454361485|FG007|Phase 2|Progressive Disease|12|||
126292985|NCT01962103|454361486|FG008|Phase 2|Progressive Disease|11|||
126292986|NCT01962103|454361478|FG000|Phase 2|Symptomatic Deterioration|0|||
126292987|NCT01962103|454361479|FG001|Phase 2|Symptomatic Deterioration|0|||
126292988|NCT01962103|454361480|FG002|Phase 2|Symptomatic Deterioration|0|||
126292989|NCT01962103|454361481|FG003|Phase 2|Symptomatic Deterioration|0|||
126292990|NCT01962103|454361482|FG004|Phase 2|Symptomatic Deterioration|0|||
126292991|NCT01962103|454361483|FG005|Phase 2|Symptomatic Deterioration|0|||
126292992|NCT01962103|454361484|FG006|Phase 2|Symptomatic Deterioration|2|||
126292993|NCT01962103|454361485|FG007|Phase 2|Symptomatic Deterioration|2|||
126292994|NCT01962103|454361486|FG008|Phase 2|Symptomatic Deterioration|0|||
126292995|NCT01321749|454361487|FG000|Overall Study|Lost to Follow-up|4|||
126292996|NCT01321749|454361488|FG001|Overall Study|Lost to Follow-up|11|||
126292997|NCT01321749|454361487|FG000|Overall Study|Protocol Violation|4|||
126292998|NCT01321749|454361488|FG001|Overall Study|Protocol Violation|7|||
126292999|NCT01321749|454361487|FG000|Overall Study|Withdrawal by Subject|5|||
126293000|NCT01321749|454361488|FG001|Overall Study|Withdrawal by Subject|4|||
126293001|NCT02750618|454361492|FG000|Overall Study|Withdrawal by Subject|1|||
126293002|NCT02572570|454361498|FG000|Overall Study|Study Terminated|27|||
126293003|NCT02763046|454361499|FG000|Overall Study|Adverse Event|5|||
126293004|NCT02763046|454361500|FG001|Overall Study|Adverse Event|4|||
126293005|NCT02763046|454361501|FG002|Overall Study|Adverse Event|0|||
126293006|NCT02763046|454361499|FG000|Overall Study|Lack of Efficacy|1|||
126293007|NCT02763046|454361500|FG001|Overall Study|Lack of Efficacy|1|||
126293008|NCT02763046|454361501|FG002|Overall Study|Lack of Efficacy|3|||
126293009|NCT02763046|454361499|FG000|Overall Study|Physician Decision|1|||
126293010|NCT02763046|454361500|FG001|Overall Study|Physician Decision|0|||
126293011|NCT02763046|454361501|FG002|Overall Study|Physician Decision|1|||
126293012|NCT02763046|454361499|FG000|Overall Study|Subject/guardian decision|2|||
126293013|NCT02763046|454361500|FG001|Overall Study|Subject/guardian decision|0|||
126293014|NCT02763046|454361501|FG002|Overall Study|Subject/guardian decision|4|||
126293015|NCT00513695|454361502|FG000|Overall Study|Discontinued therapy|2|||
126293016|NCT00513695|454361502|FG000|Overall Study|Progression prior to surgery|3|||
126293017|NCT03052751|454361509|FG000|Dosing Period 1|Adverse Event|0|||
126293018|NCT03052751|454361510|FG001|Dosing Period 1|Adverse Event|1|||
126293019|NCT03052751|454361511|FG002|Dosing Period 1|Adverse Event|0|||
126293020|NCT03052751|454361512|FG003|Dosing Period 1|Adverse Event|0|||
126293021|NCT03052751|454361513|FG004|Dosing Period 1|Adverse Event|0|||
126293022|NCT03052751|454361514|FG005|Dosing Period 1|Adverse Event|0|||
126293023|NCT03052751|454361509|FG000|Dosing Period 2|Adverse Event|0|||
126293024|NCT03052751|454361510|FG001|Dosing Period 2|Adverse Event|0|||
126293025|NCT03052751|454361511|FG002|Dosing Period 2|Adverse Event|3|||
126293026|NCT03052751|454361512|FG003|Dosing Period 2|Adverse Event|0|||
126293027|NCT03052751|454361513|FG004|Dosing Period 2|Adverse Event|0|||
126293028|NCT03052751|454361514|FG005|Dosing Period 2|Adverse Event|0|||
126293029|NCT03052751|454361509|FG000|Observation Period|Adverse Event|0|||
126293030|NCT03052751|454361510|FG001|Observation Period|Adverse Event|0|||
126293031|NCT03052751|454361511|FG002|Observation Period|Adverse Event|0|||
126293032|NCT03052751|454361512|FG003|Observation Period|Adverse Event|0|||
126293033|NCT03052751|454361513|FG004|Observation Period|Adverse Event|1|||
126293034|NCT03052751|454361514|FG005|Observation Period|Adverse Event|0|||
126293035|NCT01067105|454361515|FG000|Overall Study|Adverse Event|14|||
126458098|NCT02108262|454978295|FG003|Overall Study|Non-compliance|1|||
126458099|NCT02108262|454978292|FG000|Overall Study|Randomized by error/screen failure|0|||
126458100|NCT02108262|454978293|FG001|Overall Study|Randomized by error/screen failure|0|||
126458101|NCT02108262|454978294|FG002|Overall Study|Randomized by error/screen failure|1|||
126458102|NCT02108262|454978295|FG003|Overall Study|Randomized by error/screen failure|0|||
126458103|NCT02108262|454978292|FG000|Overall Study|Distance to center|0|||
126458104|NCT02108262|454978293|FG001|Overall Study|Distance to center|1|||
126458105|NCT02108262|454978294|FG002|Overall Study|Distance to center|1|||
126458106|NCT02108262|454978295|FG003|Overall Study|Distance to center|0|||
126458107|NCT02108262|454978292|FG000|Overall Study|Adverse Event|0|||
126458108|NCT02108262|454978293|FG001|Overall Study|Adverse Event|11|||
126458109|NCT02108262|454978294|FG002|Overall Study|Adverse Event|6|||
126458110|NCT02108262|454978295|FG003|Overall Study|Adverse Event|12|||
126549800|NCT01865617|455307606|FG003|Overall Study|Death|1|||
126549801|NCT01865617|455307607|FG004|Overall Study|Death|5|||
126549802|NCT01865617|455307608|FG005|Overall Study|Death|1|||
126549803|NCT01865617|455307609|FG006|Overall Study|Death|11|||
126549804|NCT01865617|455307610|FG007|Overall Study|Death|1|||
126549805|NCT01865617|455307611|FG008|Overall Study|Death|11|||
126549806|NCT01865617|455307612|FG009|Overall Study|Death|3|||
126549807|NCT01865617|455307613|FG010|Overall Study|Death|32|||
126549808|NCT01865617|455307614|FG011|Overall Study|Death|6|||
126549809|NCT01865617|455307615|FG012|Overall Study|Death|13|||
126549810|NCT01865617|455307603|FG000|Overall Study|Lost to Follow-up|2|||
126549811|NCT01865617|455307604|FG001|Overall Study|Lost to Follow-up|0|||
126293036|NCT01067105|454361515|FG000|Overall Study|Protocol Violation|48|||
126549812|NCT01865617|455307605|FG002|Overall Study|Lost to Follow-up|0|||
126293037|NCT01067105|454361515|FG000|Overall Study|Withdrawal by Subject|36|||
126293038|NCT01067105|454361515|FG000|Overall Study|Lost to Follow-up|6|||
126458111|NCT02108262|454978292|FG000|Overall Study|Death|0|||
126458112|NCT02108262|454978293|FG001|Overall Study|Death|2|||
126458113|NCT02108262|454978294|FG002|Overall Study|Death|2|||
126458114|NCT02108262|454978295|FG003|Overall Study|Death|1|||
126549813|NCT01865617|455307606|FG003|Overall Study|Lost to Follow-up|0|||
126549814|NCT01865617|455307607|FG004|Overall Study|Lost to Follow-up|0|||
126293039|NCT01067105|454361515|FG000|Overall Study|Physician Decision|6|||
126293040|NCT01067105|454361515|FG000|Overall Study|Other|31|||
126293041|NCT02302833|454361518|FG000|Overall Study|Lost to Follow-up|3|||
126293042|NCT04878432|454361519|FG000|Overall Study|Adverse Event|1|||
126293043|NCT04878432|454361519|FG000|Overall Study|Death|2|||
126293044|NCT04878432|454361519|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126293045|NCT04878432|454361519|FG000|Overall Study|Withdrawal by Subject|6|||
126549815|NCT01865617|455307608|FG005|Overall Study|Lost to Follow-up|0|||
126710708|NCT01183858|455893516|FG000|Overall Study|Protocol Violation|1|||
126710709|NCT01183858|455893517|FG001|Overall Study|Protocol Violation|0|||
126710710|NCT01183858|455893516|FG000|Overall Study|Administrative/Other|6|||
126710711|NCT01183858|455893517|FG001|Overall Study|Administrative/Other|6|||
126710712|NCT01183858|455893516|FG000|Overall Study|Progressive Disease|112|||
126710713|NCT01183858|455893517|FG001|Overall Study|Progressive Disease|115|||
126710714|NCT01183858|455893516|FG000|Overall Study|Death related to Progressive Disease|4|||
126710715|NCT01183858|455893517|FG001|Overall Study|Death related to Progressive Disease|5|||
126293046|NCT04878432|454361519|FG000|Overall Study|Progressive Disease|7|||
126293047|NCT04878432|454361519|FG000|Overall Study|New Therapy for Study Indication|7|||
126293048|NCT04878432|454361519|FG000|Overall Study|Physician Decision|11|||
126293049|NCT02719184|454361522|FG000|Overall Study|Other than listed|1|||
126458115|NCT02108262|454978292|FG000|Overall Study|Lost to Follow-up|0|||
126458116|NCT02108262|454978293|FG001|Overall Study|Lost to Follow-up|0|||
126458117|NCT02108262|454978294|FG002|Overall Study|Lost to Follow-up|1|||
126458118|NCT02108262|454978295|FG003|Overall Study|Lost to Follow-up|0|||
126293050|NCT02719184|454361523|FG001|Overall Study|Other than listed|12|||
126293051|NCT02719184|454361524|FG002|Overall Study|Other than listed|13|||
126293052|NCT02719184|454361525|FG003|Overall Study|Other than listed|22|||
126293053|NCT02719184|454361526|FG004|Overall Study|Other than listed|9|||
126293054|NCT02719184|454361522|FG000|Overall Study|Withdrawal by Subject|5|||
126293055|NCT02719184|454361523|FG001|Overall Study|Withdrawal by Subject|3|||
126293056|NCT02719184|454361524|FG002|Overall Study|Withdrawal by Subject|6|||
126293057|NCT02719184|454361525|FG003|Overall Study|Withdrawal by Subject|6|||
126293058|NCT02719184|454361526|FG004|Overall Study|Withdrawal by Subject|0|||
126293059|NCT02719184|454361522|FG000|Overall Study|Lost to Follow-up|0|||
126293060|NCT02719184|454361523|FG001|Overall Study|Lost to Follow-up|4|||
126458119|NCT02108262|454978292|FG000|Overall Study|Physician Decision|0|||
126293061|NCT02719184|454361524|FG002|Overall Study|Lost to Follow-up|1|||
126293062|NCT02719184|454361525|FG003|Overall Study|Lost to Follow-up|3|||
126293063|NCT02719184|454361526|FG004|Overall Study|Lost to Follow-up|0|||
126293064|NCT02719184|454361522|FG000|Overall Study|Protocol Violation|0|||
126293065|NCT02719184|454361523|FG001|Overall Study|Protocol Violation|3|||
126293066|NCT02719184|454361524|FG002|Overall Study|Protocol Violation|0|||
126293067|NCT02719184|454361525|FG003|Overall Study|Protocol Violation|2|||
126293068|NCT02719184|454361526|FG004|Overall Study|Protocol Violation|0|||
126293069|NCT02719184|454361522|FG000|Overall Study|Adverse Event|0|||
126293070|NCT02719184|454361523|FG001|Overall Study|Adverse Event|0|||
126293071|NCT02719184|454361524|FG002|Overall Study|Adverse Event|0|||
126293072|NCT02719184|454361525|FG003|Overall Study|Adverse Event|3|||
126293073|NCT02719184|454361526|FG004|Overall Study|Adverse Event|0|||
126293074|NCT02439216|454361527|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
126293075|NCT02439216|454361528|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126458120|NCT02108262|454978293|FG001|Overall Study|Physician Decision|0|||
126458121|NCT02108262|454978294|FG002|Overall Study|Physician Decision|2|||
126458122|NCT02108262|454978295|FG003|Overall Study|Physician Decision|0|||
126710716|NCT01183858|455893516|FG000|Overall Study|Lost to Follow-up|1|||
126293076|NCT02439216|454361529|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293077|NCT02439216|454361530|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293078|NCT02439216|454361531|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293079|NCT02439216|454361532|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293080|NCT02439216|454361533|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293081|NCT02439216|454361534|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293082|NCT02439216|454361535|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
126293083|NCT02439216|454361527|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126293084|NCT02439216|454361528|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126293085|NCT02439216|454361529|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126458123|NCT02108262|454978292|FG000|Overall Study|Withdrawal by Subject|0|||
126710717|NCT01183858|455893517|FG001|Overall Study|Lost to Follow-up|1|||
126710718|NCT02747043|455893520|FG000|Overall Study|Other|1|||
126710719|NCT02747043|455893521|FG001|Overall Study|Other|1|||
126710720|NCT02747043|455893520|FG000|Overall Study|Adverse Event|3|||
126710721|NCT02747043|455893521|FG001|Overall Study|Adverse Event|1|||
126710722|NCT02747043|455893520|FG000|Overall Study|Withdrawal by Subject|1|||
126710723|NCT02747043|455893521|FG001|Overall Study|Withdrawal by Subject|1|||
126710724|NCT02747043|455893520|FG000|Overall Study|Physician Decision|1|||
126710725|NCT02747043|455893521|FG001|Overall Study|Physician Decision|1|||
126293086|NCT02439216|454361530|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126293087|NCT02439216|454361531|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126293088|NCT02439216|454361532|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126458124|NCT02108262|454978293|FG001|Overall Study|Withdrawal by Subject|7|||
126458125|NCT02108262|454978294|FG002|Overall Study|Withdrawal by Subject|3|||
126549816|NCT01865617|455307609|FG006|Overall Study|Lost to Follow-up|0|||
126710726|NCT02747043|455893520|FG000|Overall Study|Protocol Violation|0|||
126710727|NCT02747043|455893521|FG001|Overall Study|Protocol Violation|1|||
126710728|NCT02747043|455893520|FG000|Overall Study|Disease progression|4|||
126366382|NCT05654181|454636976|FG005|Overall Study|Adverse Event|0|||
126366383|NCT05654181|454636977|FG006|Overall Study|Adverse Event|0|||
126366384|NCT05654181|454636978|FG007|Overall Study|Adverse Event|1|||
126366385|NCT05654181|454636979|FG008|Overall Study|Adverse Event|0|||
126366386|NCT05654181|454636980|FG009|Overall Study|Adverse Event|0|||
126366387|NCT05654181|454636971|FG000|Overall Study|Withdrawal by Subject|0|||
126366388|NCT05654181|454636972|FG001|Overall Study|Withdrawal by Subject|0|||
126549817|NCT01865617|455307610|FG007|Overall Study|Lost to Follow-up|0|||
126549818|NCT01865617|455307611|FG008|Overall Study|Lost to Follow-up|0|||
126549819|NCT01865617|455307612|FG009|Overall Study|Lost to Follow-up|0|||
126549820|NCT01865617|455307613|FG010|Overall Study|Lost to Follow-up|0|||
126549821|NCT01865617|455307614|FG011|Overall Study|Lost to Follow-up|0|||
126549822|NCT01865617|455307615|FG012|Overall Study|Lost to Follow-up|0|||
126549823|NCT01865617|455307603|FG000|Overall Study|Withdrawal by Subject|1|||
126549824|NCT01865617|455307604|FG001|Overall Study|Withdrawal by Subject|0|||
126549825|NCT01865617|455307605|FG002|Overall Study|Withdrawal by Subject|0|||
126549826|NCT01865617|455307606|FG003|Overall Study|Withdrawal by Subject|0|||
126549827|NCT01865617|455307607|FG004|Overall Study|Withdrawal by Subject|0|||
126549828|NCT01865617|455307608|FG005|Overall Study|Withdrawal by Subject|0|||
126549829|NCT01865617|455307609|FG006|Overall Study|Withdrawal by Subject|0|||
126549830|NCT01865617|455307610|FG007|Overall Study|Withdrawal by Subject|0|||
126549831|NCT01865617|455307611|FG008|Overall Study|Withdrawal by Subject|0|||
126549832|NCT01865617|455307612|FG009|Overall Study|Withdrawal by Subject|0|||
126549833|NCT01865617|455307613|FG010|Overall Study|Withdrawal by Subject|0|||
126549834|NCT01865617|455307614|FG011|Overall Study|Withdrawal by Subject|0|||
126549835|NCT01865617|455307615|FG012|Overall Study|Withdrawal by Subject|0|||
126549836|NCT01865617|455307603|FG000|Overall Study|Patient proceeded to new therapy|0|||
126549837|NCT01865617|455307604|FG001|Overall Study|Patient proceeded to new therapy|0|||
126549838|NCT01865617|455307605|FG002|Overall Study|Patient proceeded to new therapy|0|||
126549839|NCT01865617|455307606|FG003|Overall Study|Patient proceeded to new therapy|0|||
126549840|NCT01865617|455307607|FG004|Overall Study|Patient proceeded to new therapy|2|||
126549841|NCT01865617|455307608|FG005|Overall Study|Patient proceeded to new therapy|0|||
126549842|NCT01865617|455307609|FG006|Overall Study|Patient proceeded to new therapy|0|||
126549843|NCT01865617|455307610|FG007|Overall Study|Patient proceeded to new therapy|0|||
126549844|NCT01865617|455307611|FG008|Overall Study|Patient proceeded to new therapy|0|||
126549845|NCT01865617|455307612|FG009|Overall Study|Patient proceeded to new therapy|0|||
126549846|NCT01865617|455307613|FG010|Overall Study|Patient proceeded to new therapy|0|||
126549847|NCT01865617|455307614|FG011|Overall Study|Patient proceeded to new therapy|0|||
126293089|NCT02439216|454361533|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126293090|NCT02439216|454361534|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
126293091|NCT02439216|454361535|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
126293092|NCT02439216|454361527|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293093|NCT02439216|454361528|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293094|NCT02439216|454361529|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293095|NCT02439216|454361530|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293096|NCT02439216|454361531|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293097|NCT02439216|454361532|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293098|NCT02439216|454361533|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
126293099|NCT02439216|454361534|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
126293100|NCT02439216|454361535|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
126293101|NCT02439216|454361527|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293102|NCT02439216|454361528|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293103|NCT02439216|454361529|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293104|NCT02439216|454361530|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293105|NCT02439216|454361531|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293106|NCT02439216|454361532|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293107|NCT02439216|454361533|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293108|NCT02439216|454361534|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
126293109|NCT02439216|454361535|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
126293110|NCT02439216|454361527|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126293111|NCT02439216|454361528|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126293112|NCT02439216|454361529|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126293113|NCT02439216|454361530|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126293114|NCT02439216|454361531|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126293115|NCT02439216|454361532|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126366389|NCT05654181|454636973|FG002|Overall Study|Withdrawal by Subject|0|||
126366390|NCT05654181|454636974|FG003|Overall Study|Withdrawal by Subject|0|||
126366391|NCT05654181|454636975|FG004|Overall Study|Withdrawal by Subject|0|||
126549848|NCT01865617|455307615|FG012|Overall Study|Patient proceeded to new therapy|0|||
126293116|NCT02439216|454361533|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
126293117|NCT02439216|454361534|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
126293118|NCT02439216|454361535|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
126293119|NCT00725491|454361537|FG000|Overall Study|Adverse Event|3|||
126293120|NCT00725491|454361538|FG001|Overall Study|Adverse Event|2|||
126293121|NCT00725491|454361537|FG000|Overall Study|Pregnancy|0|||
126293122|NCT00725491|454361538|FG001|Overall Study|Pregnancy|3|||
126293123|NCT00725491|454361537|FG000|Overall Study|Risk for hyperstimulation|2|||
126293124|NCT00725491|454361538|FG001|Overall Study|Risk for hyperstimulation|9|||
126293125|NCT00725491|454361537|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
126293126|NCT00725491|454361538|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
126293127|NCT00725491|454361537|FG000|Overall Study|Fertilization failure|0|||
126293128|NCT00725491|454361538|FG001|Overall Study|Fertilization failure|1|||
126293129|NCT00725491|454361537|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
126293130|NCT00725491|454361538|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
126293131|NCT01495000|454361539|FG000|Overall Study|Lost to Follow-up|2|||
126293132|NCT01495000|454361540|FG001|Overall Study|Lost to Follow-up|2|||
126293133|NCT01495000|454361539|FG000|Overall Study|Protocol Violation|1|||
126293134|NCT01495000|454361540|FG001|Overall Study|Protocol Violation|0|||
126293135|NCT01495000|454361539|FG000|Overall Study|Withdrawal by Subject|10|||
126293136|NCT01495000|454361540|FG001|Overall Study|Withdrawal by Subject|10|||
126293137|NCT01514461|454361541|FG000|Overall Study|Adverse Event|2|||
126293138|NCT01514461|454361542|FG001|Overall Study|Adverse Event|1|||
126293139|NCT01514461|454361543|FG002|Overall Study|Adverse Event|3|||
126293140|NCT01514461|454361541|FG000|Overall Study|Physician Decision|1|||
126293141|NCT01514461|454361542|FG001|Overall Study|Physician Decision|1|||
126293142|NCT01514461|454361543|FG002|Overall Study|Physician Decision|0|||
126293143|NCT01514461|454361541|FG000|Overall Study|Patient/guardian decision|1|||
126293144|NCT01514461|454361542|FG001|Overall Study|Patient/guardian decision|1|||
126293145|NCT01514461|454361543|FG002|Overall Study|Patient/guardian decision|1|||
126293146|NCT01514461|454361541|FG000|Overall Study|Death|1|||
126293147|NCT01514461|454361542|FG001|Overall Study|Death|0|||
126293148|NCT01514461|454361543|FG002|Overall Study|Death|0|||
126293149|NCT03499067|454361544|FG000|First Intervention|Physician Decision|2|||
126293150|NCT03499067|454361545|FG001|First Intervention|Physician Decision|1|||
126293151|NCT03499067|454361544|FG000|First Intervention|Withdrawal by Subject|3|||
126293152|NCT03499067|454361545|FG001|First Intervention|Withdrawal by Subject|6|||
126293153|NCT02548832|454361546|FG000|Overall Study|Lost to Follow-up|2|||
126293154|NCT02548832|454361547|FG001|Overall Study|Lost to Follow-up|2|||
126293155|NCT02548832|454361548|FG002|Overall Study|Lost to Follow-up|2|||
126293156|NCT03472014|454361563|FG000|Overall Study|Lost to Follow-up|4|||
126293157|NCT02792517|454361564|FG000|Overall Study|Withdrawal by Subject|10|||
126293158|NCT02792517|454361564|FG000|Overall Study|Decision by Sponsor|7|||
126293159|NCT02792517|454361564|FG000|Overall Study|Lost to Follow-up|3|||
126293160|NCT03743051|454361567|FG000|Overall Study|Adverse Event|5|||
126293161|NCT03743051|454361568|FG001|Overall Study|Adverse Event|9|||
126293162|NCT03743051|454361567|FG000|Overall Study|Death|27|||
126293163|NCT03743051|454361568|FG001|Overall Study|Death|26|||
126293164|NCT03743051|454361567|FG000|Overall Study|Lost to Follow-up|4|||
126293165|NCT03743051|454361568|FG001|Overall Study|Lost to Follow-up|8|||
126293166|NCT03743051|454361567|FG000|Overall Study|Withdrawal by Subject|32|||
126293167|NCT03743051|454361568|FG001|Overall Study|Withdrawal by Subject|19|||
126293168|NCT03743051|454361567|FG000|Overall Study|Physician Decision|10|||
126293169|NCT03743051|454361568|FG001|Overall Study|Physician Decision|15|||
126293170|NCT03743051|454361567|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
126293171|NCT03743051|454361568|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
126293172|NCT00711087|454361569|FG000|Overall Study|Lost to Follow-up|1|||
126366392|NCT05654181|454636976|FG005|Overall Study|Withdrawal by Subject|0|||
126366393|NCT05654181|454636977|FG006|Overall Study|Withdrawal by Subject|0|||
126710729|NCT02747043|455893521|FG001|Overall Study|Disease progression|0|||
126710730|NCT03707977|455893528|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
126710731|NCT03707977|455893529|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
126710732|NCT03707977|455893530|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
126710733|NCT03707977|455893528|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
126710734|NCT03707977|455893529|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
126293173|NCT00711087|454361570|FG001|Overall Study|Lost to Follow-up|0|||
126293174|NCT00811733|454361573|FG000|Overall Study|Investigator Discretion|10|||
126293175|NCT00811733|454361574|FG001|Overall Study|Investigator Discretion|8|||
126293176|NCT00811733|454361573|FG000|Overall Study|Withdrawal by Subject|1|||
126293177|NCT00811733|454361574|FG001|Overall Study|Withdrawal by Subject|2|||
126293178|NCT00793871|454361575|FG000|Overall Study|Death|50|||
126293179|NCT00793871|454361575|FG000|Overall Study|Lost to Follow-up|3|||
126366394|NCT05654181|454636978|FG007|Overall Study|Withdrawal by Subject|1|||
126549849|NCT01865617|455307603|FG000|Overall Study|Other|0|||
126293180|NCT00793871|454361575|FG000|Overall Study|Study terminated by the Sponsor|7|||
126293181|NCT00856193|454361576|FG000|Period 2|Abnormal test procedure results|0|||
126293182|NCT00856193|454361577|FG001|Period 2|Abnormal test procedure results|1|||
126293183|NCT00856193|454361576|FG000|Period 2|Lost to Follow-up|0|||
126293184|NCT00856193|454361577|FG001|Period 2|Lost to Follow-up|1|||
126293185|NCT02569801|454361578|FG000|Overall Study|Withdrawal by Subject|9|||
126293186|NCT02569801|454361579|FG001|Overall Study|Withdrawal by Subject|9|||
126293187|NCT02569801|454361578|FG000|Overall Study|Sponsor Decision|13|||
126293188|NCT02569801|454361579|FG001|Overall Study|Sponsor Decision|14|||
126293189|NCT02569801|454361578|FG000|Overall Study|Progressive Disease|2|||
126293190|NCT02569801|454361579|FG001|Overall Study|Progressive Disease|7|||
126293191|NCT02569801|454361578|FG000|Overall Study|Lost to Follow-up|0|||
126458126|NCT02108262|454978295|FG003|Overall Study|Withdrawal by Subject|4|||
126458127|NCT02108262|454978292|FG000|Overall Study|Due to key hepatic values|0|||
126458128|NCT02108262|454978293|FG001|Overall Study|Due to key hepatic values|1|||
126293192|NCT02569801|454361579|FG001|Overall Study|Lost to Follow-up|1|||
126293193|NCT02569801|454361578|FG000|Overall Study|Death|12|||
126293194|NCT02569801|454361579|FG001|Overall Study|Death|4|||
126293195|NCT00428246|454361580|FG000|Overall Study|Withdrawal by Subject|0|||
126293196|NCT00428246|454361581|FG001|Overall Study|Withdrawal by Subject|0|||
126293197|NCT00428246|454361582|FG002|Overall Study|Withdrawal by Subject|1|||
126293198|NCT00428246|454361580|FG000|Overall Study|Adverse Event|1|||
126293199|NCT00428246|454361581|FG001|Overall Study|Adverse Event|0|||
126293200|NCT00428246|454361582|FG002|Overall Study|Adverse Event|0|||
126293201|NCT03442751|454361583|FG000|Overall Study|Withdrawal by Subject|3|||
126293202|NCT03442751|454361584|FG001|Overall Study|Withdrawal by Subject|1|||
126293203|NCT03442751|454361583|FG000|Overall Study|Lost to Follow-up|3|||
126293204|NCT03442751|454361584|FG001|Overall Study|Lost to Follow-up|0|||
126293205|NCT02766335|454361586|FG000|Initial Registration|Adverse Event|6|||
126293206|NCT02766335|454361587|FG001|Initial Registration|Adverse Event|3|||
126293207|NCT02766335|454361588|FG002|Initial Registration|Adverse Event|0|||
126293208|NCT02766335|454361586|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
126293209|NCT02766335|454361587|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
126293210|NCT02766335|454361588|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
126293211|NCT02766335|454361586|FG000|Initial Registration|Progression/relapse|49|||
126293212|NCT02766335|454361587|FG001|Initial Registration|Progression/relapse|15|||
126293213|NCT02766335|454361588|FG002|Initial Registration|Progression/relapse|0|||
126293214|NCT02766335|454361586|FG000|Initial Registration|Death|1|||
126293215|NCT02766335|454361587|FG001|Initial Registration|Death|3|||
126293216|NCT02766335|454361588|FG002|Initial Registration|Death|0|||
126293217|NCT02766335|454361586|FG000|Initial Registration|not protocol specified|1|||
126293218|NCT02766335|454361587|FG001|Initial Registration|not protocol specified|9|||
126293219|NCT02766335|454361588|FG002|Initial Registration|not protocol specified|0|||
126293220|NCT02766335|454361586|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
126293221|NCT02766335|454361587|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
126293222|NCT02766335|454361588|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
126293223|NCT02766335|454361586|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
126293224|NCT02766335|454361587|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
126293225|NCT02766335|454361588|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
126293226|NCT04583735|454361595|FG000|Double-masked Treatment Period|Adverse Event|0|||
126458129|NCT02108262|454978294|FG002|Overall Study|Due to key hepatic values|0|||
126458130|NCT02108262|454978295|FG003|Overall Study|Due to key hepatic values|0|||
126458131|NCT02108262|454978292|FG000|Overall Study|Unable to contact patient|0|||
126458132|NCT02108262|454978293|FG001|Overall Study|Unable to contact patient|3|||
126458133|NCT02108262|454978294|FG002|Overall Study|Unable to contact patient|1|||
126458134|NCT02108262|454978295|FG003|Overall Study|Unable to contact patient|2|||
126458135|NCT02108262|454978292|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
126458136|NCT02108262|454978293|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
126458137|NCT02108262|454978294|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
126458138|NCT02108262|454978295|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
126458139|NCT02108262|454978292|FG000|Overall Study|Patient did not want another infusion|0|||
126458140|NCT02108262|454978293|FG001|Overall Study|Patient did not want another infusion|3|||
126458141|NCT02108262|454978294|FG002|Overall Study|Patient did not want another infusion|3|||
126767055|NCT00539006|456100209|FG003|Treatment Period 2|Protocol Violation|0|||
126293227|NCT04583735|454361596|FG001|Double-masked Treatment Period|Adverse Event|1|||
126767056|NCT00539006|456100206|FG000|Treatment Period 2|Other|0|||
126767057|NCT00539006|456100207|FG001|Treatment Period 2|Other|1|||
126767058|NCT00539006|456100208|FG002|Treatment Period 2|Other|0|||
126767059|NCT00539006|456100209|FG003|Treatment Period 2|Other|0|||
126767060|NCT02353572|456100210|FG000|Overall Study|Withdrawal by Subject|1|||
126767061|NCT02353572|456100210|FG000|Overall Study|Study terminated|2|||
126767062|NCT01036594|456100213|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
126458142|NCT02108262|454978295|FG003|Overall Study|Patient did not want another infusion|2|||
126767063|NCT01036594|456100214|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
126293228|NCT04583735|454361595|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
126293229|NCT04583735|454361596|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
126458143|NCT02108262|454978292|FG000|Overall Study|Vacation|0|||
126458144|NCT02108262|454978293|FG001|Overall Study|Vacation|1|||
126458145|NCT02108262|454978294|FG002|Overall Study|Vacation|0|||
126458146|NCT02108262|454978295|FG003|Overall Study|Vacation|0|||
126458147|NCT02108262|454978292|FG000|Overall Study|Patient decision|0|||
126458148|NCT02108262|454978293|FG001|Overall Study|Patient decision|7|||
126710735|NCT03707977|455893530|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
126710736|NCT02564120|455893531|FG000|Overall Study|Did not return release forms|160|||
126710737|NCT02564120|455893531|FG000|Overall Study|Death|58|||
126710738|NCT02564120|455893531|FG000|Overall Study|Withdrawal by Subject|204|||
126293230|NCT04583735|454361595|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
126293231|NCT04583735|454361596|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
126293232|NCT04583735|454361595|FG000|Open-label Treatment Period|Adverse Event|1|||
126293233|NCT04583735|454361596|FG001|Open-label Treatment Period|Adverse Event|1|||
126293234|NCT04583735|454361595|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
126293235|NCT04583735|454361596|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
126293236|NCT04583735|454361595|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
126293237|NCT04583735|454361596|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
126293238|NCT00124917|454361597|FG000|Overall Study|Physician Decision|3|||
126293239|NCT01515423|454361598|FG000|Open Label Phase|Adverse Event|57|||
126293240|NCT01515423|454361599|FG001|Open Label Phase|Adverse Event|0|||
126293241|NCT01515423|454361600|FG002|Open Label Phase|Adverse Event|0|||
126293242|NCT01515423|454361598|FG000|Open Label Phase|Death|2|||
126293243|NCT01515423|454361599|FG001|Open Label Phase|Death|0|||
126293244|NCT01515423|454361600|FG002|Open Label Phase|Death|0|||
126293245|NCT01515423|454361598|FG000|Open Label Phase|Lack of Efficacy|117|||
126293246|NCT01515423|454361599|FG001|Open Label Phase|Lack of Efficacy|0|||
126293247|NCT01515423|454361600|FG002|Open Label Phase|Lack of Efficacy|0|||
126293248|NCT01515423|454361598|FG000|Open Label Phase|Lost to Follow-up|21|||
126293249|NCT01515423|454361599|FG001|Open Label Phase|Lost to Follow-up|0|||
126293250|NCT01515423|454361600|FG002|Open Label Phase|Lost to Follow-up|0|||
126293251|NCT01515423|454361598|FG000|Open Label Phase|Withdrawal by Subject|118|||
126293252|NCT01515423|454361599|FG001|Open Label Phase|Withdrawal by Subject|0|||
126293253|NCT01515423|454361600|FG002|Open Label Phase|Withdrawal by Subject|0|||
126293254|NCT01515423|454361598|FG000|Open Label Phase|excluded from DB Phase|70|||
126293255|NCT01515423|454361599|FG001|Open Label Phase|excluded from DB Phase|0|||
126293256|NCT01515423|454361600|FG002|Open Label Phase|excluded from DB Phase|0|||
126293257|NCT01515423|454361598|FG000|Open Label Phase|Other|28|||
126293258|NCT01515423|454361599|FG001|Open Label Phase|Other|0|||
126293259|NCT01515423|454361600|FG002|Open Label Phase|Other|0|||
126293260|NCT01515423|454361598|FG000|DOUBLE BLIND|Adverse Event|0|||
126293261|NCT01515423|454361599|FG001|DOUBLE BLIND|Adverse Event|15|||
126293262|NCT01515423|454361600|FG002|DOUBLE BLIND|Adverse Event|13|||
126293263|NCT01515423|454361598|FG000|DOUBLE BLIND|Death|0|||
126293264|NCT01515423|454361599|FG001|DOUBLE BLIND|Death|1|||
126293265|NCT01515423|454361600|FG002|DOUBLE BLIND|Death|2|||
126293266|NCT01515423|454361598|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
126293267|NCT01515423|454361599|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
126293268|NCT01515423|454361600|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
126293269|NCT01515423|454361598|FG000|DOUBLE BLIND|Pregnancy|0|||
126293270|NCT01515423|454361599|FG001|DOUBLE BLIND|Pregnancy|2|||
126293271|NCT01515423|454361600|FG002|DOUBLE BLIND|Pregnancy|0|||
126293272|NCT01515423|454361598|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
126293273|NCT01515423|454361599|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
126293274|NCT01515423|454361600|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
126293275|NCT01515423|454361598|FG000|DOUBLE BLIND|Other|0|||
126293276|NCT01515423|454361599|FG001|DOUBLE BLIND|Other|6|||
126293277|NCT01515423|454361600|FG002|DOUBLE BLIND|Other|12|||
126293278|NCT01515423|454361598|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
126458149|NCT02108262|454978294|FG002|Overall Study|Patient decision|9|||
126710739|NCT02564120|455893531|FG000|Overall Study|Other medical condition|24|||
126293279|NCT01515423|454361599|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
126293280|NCT01515423|454361600|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
126293281|NCT01125917|454361601|FG000|Overall Study|Adverse Event|43|||
126293282|NCT01125917|454361601|FG000|Overall Study|Lost to Follow-up|23|||
126293283|NCT01125917|454361601|FG000|Overall Study|Withdrawal by Subject|31|||
126293284|NCT01125917|454361601|FG000|Overall Study|Administrative|223|||
126293285|NCT01125917|454361601|FG000|Overall Study|Lack of Efficacy|19|||
126293286|NCT04421131|454361602|FG000|Overall Study|Lost to Follow-up|1|||
126458150|NCT02108262|454978295|FG003|Overall Study|Patient decision|14|||
126293287|NCT04421131|454361602|FG000|Overall Study|Protocol Violation|2|||
126293288|NCT04421131|454361602|FG000|Overall Study|App crashed|5|||
126293289|NCT02501928|454361605|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
126293290|NCT02501928|454361606|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
126549850|NCT01865617|455307604|FG001|Overall Study|Other|0|||
126710740|NCT00641147|455893532|FG000|Completed 4 Months.|Physician Decision|1|||
126710741|NCT00641147|455893533|FG001|Completed 4 Months.|Physician Decision|0|||
126710742|NCT00641147|455893532|FG000|Completed 4 Months.|Adverse Event|1|||
126710743|NCT00641147|455893533|FG001|Completed 4 Months.|Adverse Event|0|||
126710744|NCT00641147|455893532|FG000|Completed 8 Months.|Physician Decision|2|||
126710745|NCT00641147|455893533|FG001|Completed 8 Months.|Physician Decision|1|||
126710746|NCT00641147|455893532|FG000|Completed 8 Months.|non compliance|1|||
126710747|NCT00641147|455893533|FG001|Completed 8 Months.|non compliance|0|||
126710748|NCT00641147|455893532|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
126710749|NCT00641147|455893533|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
126710750|NCT00641147|455893532|FG000|Completed 12 Months.|Physician Decision|1|||
126710751|NCT00641147|455893533|FG001|Completed 12 Months.|Physician Decision|1|||
126710752|NCT00641147|455893532|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
126710753|NCT00641147|455893533|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
126710754|NCT00641147|455893532|FG000|Completed 16 Months.|Physician Decision|1|||
126710755|NCT00641147|455893533|FG001|Completed 16 Months.|Physician Decision|0|||
126710756|NCT00641147|455893532|FG000|Completed 16 Months.|Lost to Follow-up|1|||
126710757|NCT00641147|455893533|FG001|Completed 16 Months.|Lost to Follow-up|0|||
126710758|NCT01629667|455893536|FG000|Overall Study|Lost to Follow-up|0|||
126710759|NCT01629667|455893537|FG001|Overall Study|Lost to Follow-up|1|||
126710760|NCT01629667|455893538|FG002|Overall Study|Lost to Follow-up|1|||
126710761|NCT01629667|455893536|FG000|Overall Study|Withdrawal by Subject|31|||
126710762|NCT01629667|455893537|FG001|Overall Study|Withdrawal by Subject|20|||
126710763|NCT01629667|455893538|FG002|Overall Study|Withdrawal by Subject|28|||
126710764|NCT01629667|455893536|FG000|Overall Study|Death|1|||
126710765|NCT01629667|455893537|FG001|Overall Study|Death|5|||
126710766|NCT01629667|455893538|FG002|Overall Study|Death|3|||
126710767|NCT01629667|455893536|FG000|Overall Study|Randomized, not treated|2|||
126710768|NCT01629667|455893537|FG001|Overall Study|Randomized, not treated|1|||
126710769|NCT01629667|455893538|FG002|Overall Study|Randomized, not treated|0|||
126710770|NCT01629667|455893536|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
126710771|NCT01629667|455893537|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
126710772|NCT01629667|455893538|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
126710773|NCT01629667|455893536|FG000|Overall Study|Requiring lung transplant|2|||
126710774|NCT01629667|455893537|FG001|Overall Study|Requiring lung transplant|1|||
126710775|NCT01629667|455893538|FG002|Overall Study|Requiring lung transplant|3|||
126710776|NCT01629667|455893536|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
126710777|NCT01629667|455893537|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
126710778|NCT01629667|455893538|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
126710779|NCT01629667|455893536|FG000|Overall Study|Started other medicine|1|||
126710780|NCT01629667|455893537|FG001|Overall Study|Started other medicine|0|||
126710781|NCT01629667|455893538|FG002|Overall Study|Started other medicine|1|||
126710782|NCT01629667|455893536|FG000|Overall Study|Site error in safety follow-up|0|||
126710783|NCT01629667|455893537|FG001|Overall Study|Site error in safety follow-up|0|||
126710784|NCT01629667|455893538|FG002|Overall Study|Site error in safety follow-up|1|||
126710785|NCT01629667|455893536|FG000|Overall Study|Enrolled in another clinical study|0|||
126710786|NCT01629667|455893537|FG001|Overall Study|Enrolled in another clinical study|1|||
126710787|NCT01629667|455893538|FG002|Overall Study|Enrolled in another clinical study|0|||
126710788|NCT01629667|455893536|FG000|Overall Study|Code break|1|||
126710789|NCT01629667|455893537|FG001|Overall Study|Code break|0|||
126710790|NCT01629667|455893538|FG002|Overall Study|Code break|0|||
126710791|NCT01966731|455893539|FG000|Overall Study|Death|2|||
126710792|NCT01966731|455893539|FG000|Overall Study|Lost to Follow-up|1|||
126710793|NCT01966731|455893539|FG000|Overall Study|Physician Decision|2|||
126710794|NCT01966731|455893539|FG000|Overall Study|Follow up is not complete|600|||
126710795|NCT01966731|455893539|FG000|Overall Study|Screening Failure|29|||
126710796|NCT01966731|455893539|FG000|Overall Study|Found to be ineligible|1|||
126710797|NCT01380093|455893541|FG000|Naloxone Challenge Phase|Screen failures|21|||
126710798|NCT01380093|455893542|FG001|Naloxone Challenge Phase|Screen failures|0|||
126767064|NCT01036594|456100213|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
126767065|NCT01036594|456100214|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
126293291|NCT02501928|454361607|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
126293292|NCT02501928|454361608|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
126293293|NCT02501928|454361609|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
126293294|NCT02501928|454361610|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
126293295|NCT00838526|454361618|FG000|Overall Study|Adverse Event|3|||
126293296|NCT00838526|454361619|FG001|Overall Study|Adverse Event|12|||
126293297|NCT00838526|454361618|FG000|Overall Study|Lost to Follow-up|4|||
126293298|NCT00838526|454361619|FG001|Overall Study|Lost to Follow-up|12|||
126710799|NCT01380093|455893543|FG002|Naloxone Challenge Phase|Screen failures|0|||
126710800|NCT01380093|455893544|FG003|Naloxone Challenge Phase|Screen failures|0|||
126710801|NCT01380093|455893545|FG004|Naloxone Challenge Phase|Screen failures|0|||
126710802|NCT01380093|455893546|FG005|Naloxone Challenge Phase|Screen failures|0|||
126710803|NCT01380093|455893547|FG006|Naloxone Challenge Phase|Screen failures|0|||
126710804|NCT01380093|455893548|FG007|Naloxone Challenge Phase|Screen failures|0|||
126710805|NCT01380093|455893549|FG008|Naloxone Challenge Phase|Screen failures|0|||
126710806|NCT01380093|455893541|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126458151|NCT02108262|454978292|FG000|Overall Study|Missed IV due to pharmacy error|0|||
126458152|NCT02108262|454978293|FG001|Overall Study|Missed IV due to pharmacy error|0|||
126458153|NCT02108262|454978294|FG002|Overall Study|Missed IV due to pharmacy error|1|||
126458154|NCT02108262|454978295|FG003|Overall Study|Missed IV due to pharmacy error|0|||
126458155|NCT00761150|454978296|FG000|Open-label Period|Adverse Event|36|||
126458156|NCT00761150|454978297|FG001|Open-label Period|Adverse Event|0|||
126458157|NCT00761150|454978298|FG002|Open-label Period|Adverse Event|0|||
126458158|NCT00761150|454978296|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
126458159|NCT00761150|454978297|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
126458160|NCT00761150|454978298|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
126458161|NCT00761150|454978296|FG000|Open-label Period|Lost to Follow-up|7|||
126458162|NCT00761150|454978297|FG001|Open-label Period|Lost to Follow-up|0|||
126458163|NCT00761150|454978298|FG002|Open-label Period|Lost to Follow-up|0|||
126458164|NCT00761150|454978296|FG000|Open-label Period|Lack of Efficacy|4|||
126458165|NCT00761150|454978297|FG001|Open-label Period|Lack of Efficacy|0|||
126458166|NCT00761150|454978298|FG002|Open-label Period|Lack of Efficacy|0|||
126458167|NCT00761150|454978296|FG000|Open-label Period|Withdrawal by Subject|5|||
126458168|NCT00761150|454978297|FG001|Open-label Period|Withdrawal by Subject|0|||
126458169|NCT00761150|454978298|FG002|Open-label Period|Withdrawal by Subject|0|||
126458170|NCT00761150|454978296|FG000|Open-label Period|Noncompliance|2|||
126458171|NCT00761150|454978297|FG001|Open-label Period|Noncompliance|0|||
126458172|NCT00761150|454978298|FG002|Open-label Period|Noncompliance|0|||
126458173|NCT00761150|454978296|FG000|Open-label Period|Other|5|||
126458174|NCT00761150|454978297|FG001|Open-label Period|Other|0|||
126458175|NCT00761150|454978298|FG002|Open-label Period|Other|0|||
126458176|NCT00761150|454978296|FG000|Double-blind Period|Lack of Efficacy|0|||
126458177|NCT00761150|454978297|FG001|Double-blind Period|Lack of Efficacy|2|||
126458178|NCT00761150|454978298|FG002|Double-blind Period|Lack of Efficacy|19|||
126458179|NCT00761150|454978296|FG000|Double-blind Period|Adverse Event|0|||
126458180|NCT00761150|454978297|FG001|Double-blind Period|Adverse Event|3|||
126458181|NCT00761150|454978298|FG002|Double-blind Period|Adverse Event|3|||
126458182|NCT00761150|454978296|FG000|Double-blind Period|Withdrawal by Subject|0|||
126458183|NCT00761150|454978297|FG001|Double-blind Period|Withdrawal by Subject|3|||
126458184|NCT00761150|454978298|FG002|Double-blind Period|Withdrawal by Subject|2|||
126458185|NCT00761150|454978296|FG000|Double-blind Period|Lost to Follow-up|0|||
126458186|NCT00761150|454978297|FG001|Double-blind Period|Lost to Follow-up|2|||
126458187|NCT00761150|454978298|FG002|Double-blind Period|Lost to Follow-up|1|||
126458188|NCT00761150|454978296|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
126458189|NCT00761150|454978297|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
126458190|NCT00761150|454978298|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
126458191|NCT00761150|454978296|FG000|Double-blind Period|Noncompliance|0|||
126458192|NCT00761150|454978297|FG001|Double-blind Period|Noncompliance|1|||
126458193|NCT00761150|454978298|FG002|Double-blind Period|Noncompliance|0|||
126458194|NCT00761150|454978296|FG000|Double-blind Period|Other|0|||
126458195|NCT00761150|454978297|FG001|Double-blind Period|Other|3|||
126458196|NCT00761150|454978298|FG002|Double-blind Period|Other|3|||
126458197|NCT05463198|454978299|FG000|Overall Study|Withdrawal by Subject|19|||
126458198|NCT05463198|454978299|FG000|Overall Study|Procedure Notes Missing|18|||
126458199|NCT01860846|454978300|FG000|Overall Study|Lost to Follow-up|33|||
126458200|NCT00466687|454978303|FG000|Overall Study|Adverse Event|1|||
126458201|NCT00466687|454978303|FG000|Overall Study|Other complicating illness|3|||
126458202|NCT00466687|454978303|FG000|Overall Study|Withdrawal by Subject|1|||
126458203|NCT00466687|454978303|FG000|Overall Study|Disease progression|29|||
126458204|NCT01925989|454978304|FG000|Period 1|Sponsor Decision|1|||
126458205|NCT01925989|454978305|FG001|Period 1|Sponsor Decision|1|||
126458206|NCT01925989|454978306|FG002|Period 1|Sponsor Decision|0|||
126458207|NCT01925989|454978304|FG000|Period 1|Withdrawal by Subject|0|||
126458208|NCT01925989|454978305|FG001|Period 1|Withdrawal by Subject|1|||
126458209|NCT01925989|454978306|FG002|Period 1|Withdrawal by Subject|0|||
126458210|NCT03985878|454978316|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
126458211|NCT03985878|454978316|FG000|Overall Study|Study Terminated by Sponsor|12|||
126458212|NCT03985878|454978316|FG000|Overall Study|Withdrawal by Subject|1|||
126458213|NCT00336583|454979779|FG000|Overall Study|Lost to Follow-up|1|||
126458214|NCT00336583|454979779|FG000|Overall Study|Death|1|||
126458215|NCT03039621|454979780|FG000|Overall Study|Violation of inclusion criteria|3|||
126458216|NCT03039621|454979781|FG001|Overall Study|Violation of inclusion criteria|2|||
126458217|NCT03039621|454979780|FG000|Overall Study|Non-compliance with protocol requirement|4|||
126458218|NCT03039621|454979781|FG001|Overall Study|Non-compliance with protocol requirement|5|||
126458219|NCT03039621|454979780|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
126458220|NCT03039621|454979781|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
126458221|NCT03039621|454979780|FG000|Overall Study|Violation of non-inclusion criteria|1|||
126458222|NCT03039621|454979781|FG001|Overall Study|Violation of non-inclusion criteria|2|||
126458223|NCT00002931|454979784|FG000|Overall Study|rapidly progressing disease during|2|||
126458224|NCT00814333|454979786|FG000|Enrollment|Lost to Follow-up|1|||
126549851|NCT01865617|455307605|FG002|Overall Study|Other|0|||
126549852|NCT01865617|455307606|FG003|Overall Study|Other|0|||
126458225|NCT00814333|454979787|FG001|Enrollment|Lost to Follow-up|0|||
126458226|NCT00910247|454979788|FG000|Overall Study|Adverse Event|15|||
126458227|NCT00910247|454979788|FG000|Overall Study|Death|2|||
126458228|NCT00910247|454979788|FG000|Overall Study|Lost to Follow-up|10|||
126458229|NCT00910247|454979788|FG000|Overall Study|Physician Decision|3|||
126458230|NCT00910247|454979788|FG000|Overall Study|Protocol Violation|10|||
126458231|NCT00910247|454979788|FG000|Overall Study|Withdrawal by Subject|25|||
126458232|NCT00910247|454979788|FG000|Overall Study|Not collected|4|||
126458233|NCT01879579|454979789|FG000|Overall Study|Phone incompatible with texting platform|3|||
126458234|NCT01879579|454979790|FG001|Overall Study|Phone incompatible with texting platform|0|||
126293299|NCT00838526|454361618|FG000|Overall Study|Withdrawal by Subject|4|||
126293300|NCT00838526|454361619|FG001|Overall Study|Withdrawal by Subject|5|||
126293301|NCT00838526|454361618|FG000|Overall Study|Lack of Efficacy|2|||
126293302|NCT00838526|454361619|FG001|Overall Study|Lack of Efficacy|3|||
126293303|NCT00838526|454361618|FG000|Overall Study|Other|11|||
126293304|NCT00838526|454361619|FG001|Overall Study|Other|7|||
126293305|NCT01320293|454361620|FG000|Overall Study|Lack of Efficacy|1|||
126293306|NCT01320293|454361620|FG000|Overall Study|Adverse Event|1|||
126293307|NCT00931411|454361621|FG000|First Intervention - 42 Days|Adverse Event|2|||
126293308|NCT00931411|454361622|FG001|First Intervention - 42 Days|Adverse Event|3|||
126293309|NCT00931411|454361621|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
126293310|NCT00931411|454361622|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
126293311|NCT00931411|454361621|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
126293312|NCT00931411|454361622|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
126293313|NCT03483012|454361625|FG000|Overall Study|Lack of Efficacy|6|||
126293314|NCT00070564|454362603|FG000|Overall Study|Progression|2|||
126293315|NCT00070564|454362604|FG001|Overall Study|Progression|4|||
126293316|NCT00070564|454362605|FG002|Overall Study|Progression|7|||
126293317|NCT00070564|454362606|FG003|Overall Study|Progression|7|||
126293318|NCT00070564|454362607|FG004|Overall Study|Progression|1|||
126293319|NCT00070564|454362608|FG005|Overall Study|Progression|0|||
126293320|NCT00070564|454362603|FG000|Overall Study|Delinquent|1|||
126293321|NCT00070564|454362604|FG001|Overall Study|Delinquent|4|||
126293322|NCT00070564|454362605|FG002|Overall Study|Delinquent|2|||
126293323|NCT00070564|454362606|FG003|Overall Study|Delinquent|0|||
126293324|NCT00070564|454362607|FG004|Overall Study|Delinquent|0|||
126293325|NCT00070564|454362608|FG005|Overall Study|Delinquent|0|||
126293326|NCT00070564|454362603|FG000|Overall Study|Adverse Event|150|||
126293327|NCT00070564|454362604|FG001|Overall Study|Adverse Event|142|||
126293328|NCT00070564|454362605|FG002|Overall Study|Adverse Event|120|||
126293329|NCT00070564|454362606|FG003|Overall Study|Adverse Event|108|||
126293330|NCT00070564|454362607|FG004|Overall Study|Adverse Event|63|||
126293331|NCT00070564|454362608|FG005|Overall Study|Adverse Event|36|||
126293332|NCT00070564|454362603|FG000|Overall Study|Death|4|||
126293333|NCT00070564|454362604|FG001|Overall Study|Death|1|||
126293334|NCT00070564|454362605|FG002|Overall Study|Death|5|||
126293335|NCT00070564|454362606|FG003|Overall Study|Death|3|||
126293336|NCT00070564|454362607|FG004|Overall Study|Death|0|||
126293337|NCT00070564|454362608|FG005|Overall Study|Death|1|||
126293338|NCT00070564|454362603|FG000|Overall Study|Other, not protocol specified|17|||
126293339|NCT00070564|454362604|FG001|Overall Study|Other, not protocol specified|15|||
126293340|NCT00070564|454362605|FG002|Overall Study|Other, not protocol specified|14|||
126293341|NCT00070564|454362606|FG003|Overall Study|Other, not protocol specified|19|||
126293342|NCT00070564|454362607|FG004|Overall Study|Other, not protocol specified|6|||
126293343|NCT00070564|454362608|FG005|Overall Study|Other, not protocol specified|7|||
126293344|NCT00070564|454362603|FG000|Overall Study|Withdrawal by Subject|26|||
126293345|NCT00070564|454362604|FG001|Overall Study|Withdrawal by Subject|37|||
126293346|NCT00070564|454362605|FG002|Overall Study|Withdrawal by Subject|23|||
126293347|NCT00070564|454362606|FG003|Overall Study|Withdrawal by Subject|30|||
126293348|NCT00070564|454362607|FG004|Overall Study|Withdrawal by Subject|8|||
126458235|NCT01879579|454979789|FG000|Overall Study|Did not enroll in texting platform|1|||
126458236|NCT01879579|454979790|FG001|Overall Study|Did not enroll in texting platform|0|||
126458237|NCT01879579|454979789|FG000|Overall Study|Did not initiate insulin treatment|1|||
126458238|NCT01879579|454979790|FG001|Overall Study|Did not initiate insulin treatment|0|||
126458239|NCT01879579|454979789|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
126458240|NCT01879579|454979790|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
126293349|NCT00070564|454362608|FG005|Overall Study|Withdrawal by Subject|8|||
126549853|NCT01865617|455307607|FG004|Overall Study|Other|0|||
126293350|NCT00070564|454362603|FG000|Overall Study|Not reported|0|||
126293351|NCT00070564|454362604|FG001|Overall Study|Not reported|0|||
126293352|NCT00070564|454362605|FG002|Overall Study|Not reported|0|||
126293353|NCT00070564|454362606|FG003|Overall Study|Not reported|0|||
126293354|NCT00070564|454362607|FG004|Overall Study|Not reported|1|||
126293355|NCT00070564|454362608|FG005|Overall Study|Not reported|0|||
126293356|NCT05017246|454362612|FG000|Overall Study|Withdrawal by Subject|5|||
126293357|NCT05017246|454362613|FG001|Overall Study|Withdrawal by Subject|3|||
126293358|NCT05017246|454362612|FG000|Overall Study|Determined to be ineligible|0|||
126293359|NCT05017246|454362613|FG001|Overall Study|Determined to be ineligible|1|||
126549854|NCT01865617|455307608|FG005|Overall Study|Other|0|||
126458241|NCT01879579|454979789|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
126458242|NCT01879579|454979790|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
126458243|NCT02927067|454979791|FG000|Overall Study|Withdrawn Consent|20|||
126458244|NCT02927067|454979792|FG001|Overall Study|Withdrawn Consent|12|||
126458245|NCT02927067|454979791|FG000|Overall Study|Death|18|||
126458246|NCT02927067|454979792|FG001|Overall Study|Death|31|||
126458247|NCT02927067|454979791|FG000|Overall Study|Adverse Event|13|||
126458248|NCT02927067|454979792|FG001|Overall Study|Adverse Event|10|||
126458249|NCT02927067|454979791|FG000|Overall Study|Noncompliance|5|||
126458250|NCT02927067|454979792|FG001|Overall Study|Noncompliance|2|||
126458251|NCT02927067|454979791|FG000|Overall Study|Reason not Specified|4|||
126458252|NCT02927067|454979792|FG001|Overall Study|Reason not Specified|6|||
126458253|NCT02716896|454979795|FG000|Overall Study|Physician Decision|0|||
126458254|NCT02716896|454979796|FG001|Overall Study|Physician Decision|1|||
126458255|NCT01727700|454979797|FG000|Overall Study|Adverse Event|0|||
126293360|NCT05017246|454362612|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
126293361|NCT05017246|454362613|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
126293362|NCT05017246|454362612|FG000|Overall Study|Technical failure|1|||
126293363|NCT05017246|454362613|FG001|Overall Study|Technical failure|3|||
126293364|NCT02058069|454362614|FG000|Overall Study|Exclusion due to implant size|5|||
126293365|NCT02058069|454362614|FG000|Overall Study|Withdrawal by Subject|6|||
126293366|NCT02500589|454362628|FG000|Overall Study|Withdrawal by Subject|11|||
126293367|NCT02500589|454362629|FG001|Overall Study|Withdrawal by Subject|14|||
126293368|NCT02500589|454362628|FG000|Overall Study|Lost to Follow-up|10|||
126293369|NCT02500589|454362629|FG001|Overall Study|Lost to Follow-up|12|||
126293370|NCT02500589|454362628|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
126293371|NCT02500589|454362629|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
126293372|NCT02500589|454362628|FG000|Overall Study|Death|7|||
126293373|NCT02500589|454362629|FG001|Overall Study|Death|5|||
126293374|NCT03652051|454362630|FG000|Stage 1|Adverse Event|0|||
126293375|NCT03652051|454362631|FG001|Stage 1|Adverse Event|5|||
126293376|NCT03652051|454362632|FG002|Stage 1|Adverse Event|7|||
126293377|NCT03652051|454362633|FG003|Stage 1|Adverse Event|1|||
126293378|NCT03652051|454362630|FG000|Stage 1|Withdrawal by Subject|0|||
126293379|NCT03652051|454362631|FG001|Stage 1|Withdrawal by Subject|0|||
126293380|NCT03652051|454362632|FG002|Stage 1|Withdrawal by Subject|1|||
126293381|NCT03652051|454362633|FG003|Stage 1|Withdrawal by Subject|0|||
126293382|NCT03652051|454362630|FG000|Stage 2|Adverse Event|0|||
126293383|NCT03652051|454362631|FG001|Stage 2|Adverse Event|2|||
126293384|NCT03652051|454362632|FG002|Stage 2|Adverse Event|1|||
126458256|NCT01727700|454979798|FG001|Overall Study|Adverse Event|7|||
126458257|NCT01727700|454979799|FG002|Overall Study|Adverse Event|1|||
126458258|NCT01727700|454979797|FG000|Overall Study|Particpant withdrew consent|0|||
126293385|NCT03652051|454362633|FG003|Stage 2|Adverse Event|0|||
126293386|NCT03652051|454362630|FG000|Stage 2|Protocol Violation|0|||
126458259|NCT01727700|454979798|FG001|Overall Study|Particpant withdrew consent|3|||
126458260|NCT01727700|454979799|FG002|Overall Study|Particpant withdrew consent|1|||
126458261|NCT01727700|454979797|FG000|Overall Study|Protocol Violation|2|||
126458262|NCT01727700|454979798|FG001|Overall Study|Protocol Violation|0|||
126458263|NCT01727700|454979799|FG002|Overall Study|Protocol Violation|0|||
126458264|NCT01757691|454979801|FG000|Overall Study|Administrative problems|2|||
126458265|NCT01757691|454979802|FG001|Overall Study|Administrative problems|0|||
126458266|NCT05347147|454979809|FG000|Overall Study|Lost to Follow-up|0|||
126458267|NCT05347147|454979810|FG001|Overall Study|Lost to Follow-up|1|||
126458268|NCT05347147|454979809|FG000|Overall Study|Sponsor request|3|||
126458269|NCT05347147|454979810|FG001|Overall Study|Sponsor request|3|||
126458270|NCT05347147|454979809|FG000|Overall Study|Study termination|2|||
126458271|NCT05347147|454979810|FG001|Overall Study|Study termination|1|||
126293387|NCT03652051|454362631|FG001|Stage 2|Protocol Violation|1|||
126293388|NCT03652051|454362632|FG002|Stage 2|Protocol Violation|6|||
126458272|NCT02446743|454979811|FG000|Overall Study|Withdrawal by Subject|1|||
126458273|NCT02446743|454979812|FG001|Overall Study|Withdrawal by Subject|1|||
126458274|NCT02446743|454979811|FG000|Overall Study|Lost to Follow-up|1|||
126458275|NCT02446743|454979812|FG001|Overall Study|Lost to Follow-up|0|||
126458276|NCT02446743|454979811|FG000|Overall Study|Adverse Event|1|||
126293389|NCT03652051|454362633|FG003|Stage 2|Protocol Violation|0|||
126293390|NCT03652051|454362630|FG000|Stage 2|Lost to Follow-up|0|||
126293391|NCT03652051|454362631|FG001|Stage 2|Lost to Follow-up|2|||
126293392|NCT03652051|454362632|FG002|Stage 2|Lost to Follow-up|0|||
126458277|NCT02446743|454979812|FG001|Overall Study|Adverse Event|1|||
126458278|NCT02446743|454979811|FG000|Overall Study|Other|2|||
126458279|NCT02446743|454979812|FG001|Overall Study|Other|3|||
126458280|NCT03718299|454979813|FG000|Overall Study|Adverse Event|1|||
126458281|NCT03718299|454979813|FG000|Overall Study|Withdrawal by Subject|6|||
126458282|NCT03718299|454979813|FG000|Overall Study|Physician Decision|2|||
126458283|NCT03718299|454979813|FG000|Overall Study|Lost to Follow-up|1|||
126293393|NCT03652051|454362633|FG003|Stage 2|Lost to Follow-up|3|||
126293394|NCT03652051|454362630|FG000|Stage 2|Withdrawal by Subject|0|||
126458284|NCT00976508|454979814|FG000|Overall Study|Death|7|||
126458285|NCT00976508|454979815|FG001|Overall Study|Death|1|||
126549855|NCT01865617|455307609|FG006|Overall Study|Other|1|||
126549856|NCT01865617|455307610|FG007|Overall Study|Other|0|||
126710807|NCT01380093|455893542|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
126710808|NCT01380093|455893543|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126710809|NCT01380093|455893544|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126710810|NCT01380093|455893545|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126710811|NCT01380093|455893546|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126710812|NCT01380093|455893547|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126710813|NCT01380093|455893548|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126710814|NCT01380093|455893549|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
126710815|NCT01380093|455893541|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126710816|NCT01380093|455893542|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
126710817|NCT01380093|455893543|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
126710818|NCT01380093|455893544|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126710819|NCT01380093|455893545|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126710820|NCT01380093|455893546|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126710821|NCT01380093|455893547|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126710822|NCT01380093|455893548|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126710823|NCT01380093|455893549|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
126710824|NCT01380093|455893541|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126710825|NCT01380093|455893542|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
126710826|NCT01380093|455893543|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126293395|NCT03652051|454362631|FG001|Stage 2|Withdrawal by Subject|11|||
126293396|NCT03652051|454362632|FG002|Stage 2|Withdrawal by Subject|9|||
126293397|NCT03652051|454362633|FG003|Stage 2|Withdrawal by Subject|3|||
126293398|NCT01113892|454362640|FG000|Overall Study|Lost to Follow-up|2|||
126293399|NCT01113892|454362641|FG001|Overall Study|Lost to Follow-up|2|||
126293400|NCT01113892|454362640|FG000|Overall Study|Withdrawal by Subject|1|||
126293401|NCT01113892|454362641|FG001|Overall Study|Withdrawal by Subject|1|||
126293402|NCT01113892|454362640|FG000|Overall Study|Death|2|||
126293403|NCT01113892|454362641|FG001|Overall Study|Death|4|||
126293404|NCT01113892|454362640|FG000|Overall Study|Graft no longer evaluable|9|||
126293405|NCT01113892|454362641|FG001|Overall Study|Graft no longer evaluable|9|||
126293406|NCT02603887|454362644|FG000|Stage 1|Adverse Event|4|||
126293407|NCT02603887|454362644|FG000|Stage 1|Disease progression|1|||
126293408|NCT02603887|454362644|FG000|Stage 2|FDA guidance|1|||
126293409|NCT00470470|454362654|FG000|Overall Study|Adverse Event|2|||
126293410|NCT00470470|454362654|FG000|Overall Study|Death|2|||
126293411|NCT00470470|454362654|FG000|Overall Study|Not treated|1|||
126293412|NCT04782076|454362659|FG000|Overall Study|Family Emergency|1|||
126293413|NCT01949662|454362664|FG000|Overall Study|Death|9|||
126293414|NCT01949662|454362665|FG001|Overall Study|Death|7|||
126293415|NCT01949662|454362664|FG000|Overall Study|Discharged before an agitation event|8|||
126293416|NCT01949662|454362665|FG001|Overall Study|Discharged before an agitation event|3|||
126293417|NCT01949662|454362664|FG000|Overall Study|Dropped out|1|||
126293418|NCT01949662|454362665|FG001|Overall Study|Dropped out|3|||
126293419|NCT01949662|454362664|FG000|Overall Study|Ineligible|0|||
126293420|NCT01949662|454362665|FG001|Overall Study|Ineligible|1|||
126366395|NCT05654181|454636979|FG008|Overall Study|Withdrawal by Subject|0|||
126293421|NCT02452476|454362670|FG000|Overall Study|Death|4|||
126293422|NCT02452476|454362671|FG001|Overall Study|Death|7|||
126293423|NCT02452476|454362670|FG000|Overall Study|Lost to Follow-up|1|||
126293424|NCT02452476|454362671|FG001|Overall Study|Lost to Follow-up|1|||
126366396|NCT05654181|454636980|FG009|Overall Study|Withdrawal by Subject|0|||
126366397|NCT05654181|454636971|FG000|Overall Study|Other|0|||
126366398|NCT05654181|454636972|FG001|Overall Study|Other|0|||
126366399|NCT05654181|454636973|FG002|Overall Study|Other|0|||
126366400|NCT05654181|454636974|FG003|Overall Study|Other|0|||
126366401|NCT05654181|454636975|FG004|Overall Study|Other|1|||
126366402|NCT05654181|454636976|FG005|Overall Study|Other|1|||
126293425|NCT02452476|454362670|FG000|Overall Study|Physician Decision|1|||
126293426|NCT02452476|454362671|FG001|Overall Study|Physician Decision|1|||
126293427|NCT02452476|454362670|FG000|Overall Study|Not treated|5|||
126293428|NCT02452476|454362671|FG001|Overall Study|Not treated|1|||
126293429|NCT02201784|454362672|FG000|Overall Study|Failure to achieve adequate block|2|||
126293430|NCT02201784|454362673|FG001|Overall Study|Failure to achieve adequate block|0|||
126293431|NCT01757275|454362674|FG000|Overall Study|Lost to Follow-up|1|||
126366403|NCT05654181|454636977|FG006|Overall Study|Other|0|||
126366404|NCT05654181|454636978|FG007|Overall Study|Other|0|||
126366405|NCT05654181|454636979|FG008|Overall Study|Other|0|||
126293432|NCT01757275|454362675|FG001|Overall Study|Lost to Follow-up|2|||
126366406|NCT05654181|454636980|FG009|Overall Study|Other|0|||
126366407|NCT04101331|454636981|FG000|Overall Study|Adverse Event|9|||
126710827|NCT01380093|455893544|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126710828|NCT01380093|455893545|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126710829|NCT01380093|455893546|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126767066|NCT01036594|456100213|FG000|Week 12 Evaluation|Adverse Event|5|||
126293433|NCT01757275|454362674|FG000|Overall Study|Adverse Event|3|||
126293434|NCT01757275|454362675|FG001|Overall Study|Adverse Event|3|||
126293435|NCT01757275|454362674|FG000|Overall Study|Withdrawal by Subject|2|||
126293436|NCT01757275|454362675|FG001|Overall Study|Withdrawal by Subject|4|||
126293437|NCT01757275|454362674|FG000|Overall Study|Not treated|3|||
126293438|NCT01757275|454362675|FG001|Overall Study|Not treated|4|||
126293439|NCT01401452|454362678|FG000|Overall Study|Adverse reaction|9|||
126293440|NCT01401452|454362678|FG000|Overall Study|Lost to Follow-up|12|||
126293441|NCT01401452|454362678|FG000|Overall Study|Lack of Efficacy|30|||
126293442|NCT01401452|454362678|FG000|Overall Study|Participant developed breast cancer|1|||
126293443|NCT01401452|454362678|FG000|Overall Study|Tx stopped due to financial reasons|1|||
126293444|NCT01401452|454362678|FG000|Overall Study|Tx stopped by psychiatrist|1|||
126293445|NCT01401452|454362678|FG000|Overall Study|No more visits within the 36 wk followup|4|||
126293446|NCT01401452|454362678|FG000|Overall Study|Subject did not come to follow up visits|2|||
126293447|NCT01401452|454362678|FG000|Overall Study|Subject didn't return for routine visits|1|||
126293448|NCT01401452|454362678|FG000|Overall Study|Subject moved to another city|1|||
126293449|NCT01401452|454362678|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
126293450|NCT01401452|454362678|FG000|Overall Study|Psoriatic arthritis|1|||
126293451|NCT01401452|454362678|FG000|Overall Study|Participant stopped Tx|2|||
126293452|NCT01401452|454362678|FG000|Overall Study|Discontinuation for personal reasons|1|||
126293453|NCT01401452|454362678|FG000|Overall Study|Treatment failure|1|||
126293454|NCT01401452|454362678|FG000|Overall Study|Unsatisfactory output|1|||
126293455|NCT01401452|454362678|FG000|Overall Study|Subject withdrew because of Tx success|1|||
126293456|NCT01401452|454362678|FG000|Overall Study|Subject chose to discontinue treatment|1|||
126293457|NCT01401452|454362678|FG000|Overall Study|Participant withdrew consent|1|||
126293458|NCT04720105|454362679|FG000|Overall Study|Lack of Efficacy|1|||
126293459|NCT04720105|454362679|FG000|Overall Study|Lost to Follow-up|1|||
126293460|NCT04720105|454362679|FG000|Overall Study|Withdrawal by Subject|3|||
126293461|NCT01133067|454362682|FG000|Overall Study|Death|136|||
126293462|NCT01133067|454362682|FG000|Overall Study|Lost to Follow-up|3|||
126293463|NCT04135937|454362686|FG000|Overall Study|Lost to Follow-up|2|||
126293464|NCT04135937|454362686|FG000|Overall Study|Withdrawal by Subject|1|||
126293465|NCT02654054|454362691|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
126293466|NCT02654054|454362692|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
126293467|NCT02654054|454362693|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
126293468|NCT02654054|454362691|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
126293469|NCT02654054|454362692|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126293470|NCT02654054|454362693|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
126293471|NCT02654054|454362691|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
126293472|NCT02654054|454362692|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
126293473|NCT02654054|454362693|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
126293474|NCT02654054|454362691|FG000|Post-Treatment Follow-Up Period|Other|1|||
126293475|NCT02654054|454362692|FG001|Post-Treatment Follow-Up Period|Other|0|||
126458286|NCT00976508|454979814|FG000|Overall Study|Lost to Follow-up|1|||
126458287|NCT00976508|454979815|FG001|Overall Study|Lost to Follow-up|0|||
126458288|NCT00976508|454979814|FG000|Overall Study|Withdrawal by Subject|1|||
126458289|NCT00976508|454979815|FG001|Overall Study|Withdrawal by Subject|0|||
126458290|NCT00976508|454979814|FG000|Overall Study|Disease Progression|4|||
126458291|NCT00976508|454979815|FG001|Overall Study|Disease Progression|4|||
126458292|NCT00976508|454979814|FG000|Overall Study|Subject Enrolled in Hospice|1|||
126458293|NCT00976508|454979815|FG001|Overall Study|Subject Enrolled in Hospice|0|||
126458294|NCT00976508|454979814|FG000|Overall Study|Terminated by the Sponsor|0|||
126458295|NCT00976508|454979815|FG001|Overall Study|Terminated by the Sponsor|1|||
126458296|NCT01205581|454979819|FG000|Overall Study|Withdrawal by Subject|1|||
126458297|NCT01205581|454979820|FG001|Overall Study|Withdrawal by Subject|0|||
126458298|NCT01205581|454979821|FG002|Overall Study|Withdrawal by Subject|0|||
126458299|NCT01205581|454979822|FG003|Overall Study|Withdrawal by Subject|0|||
126458300|NCT01205581|454979823|FG004|Overall Study|Withdrawal by Subject|0|||
126458301|NCT01205581|454979824|FG005|Overall Study|Withdrawal by Subject|0|||
126458302|NCT02278471|454979825|FG000|Overall Study|Lost to Follow-up|6|||
126458303|NCT02278471|454979826|FG001|Overall Study|Lost to Follow-up|15|||
126458304|NCT02278471|454979825|FG000|Overall Study|Death|2|||
126458305|NCT02278471|454979826|FG001|Overall Study|Death|2|||
126458306|NCT02278471|454979825|FG000|Overall Study|Withdrawal by Subject|0|||
126458307|NCT02278471|454979826|FG001|Overall Study|Withdrawal by Subject|3|||
126458308|NCT00640835|454979827|FG000|Overall Study|Adverse Event|5|||
126293476|NCT02654054|454362693|FG002|Post-Treatment Follow-Up Period|Other|4|||
126293477|NCT02654054|454362691|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
126293478|NCT02654054|454362692|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
126293479|NCT02654054|454362693|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
126293480|NCT00273182|454362694|FG000|Overall Study|Death|450|||
126293481|NCT00273182|454362694|FG000|Overall Study|Lost to Follow-up|88|||
126458309|NCT00640835|454979828|FG001|Overall Study|Adverse Event|3|||
126458310|NCT00640835|454979827|FG000|Overall Study|Withdrawal by Subject|12|||
126458311|NCT00640835|454979828|FG001|Overall Study|Withdrawal by Subject|14|||
126458312|NCT00640835|454979827|FG000|Overall Study|Physician Decision|10|||
126458313|NCT00640835|454979828|FG001|Overall Study|Physician Decision|14|||
126458314|NCT00640835|454979827|FG000|Overall Study|Sponsor's Decision|11|||
126458315|NCT00640835|454979828|FG001|Overall Study|Sponsor's Decision|7|||
126458316|NCT00640835|454979827|FG000|Overall Study|Protocol Violation|2|||
126458317|NCT00640835|454979828|FG001|Overall Study|Protocol Violation|2|||
126458318|NCT00640835|454979827|FG000|Overall Study|Lost to Follow-up|17|||
126458319|NCT00640835|454979828|FG001|Overall Study|Lost to Follow-up|13|||
126458320|NCT00640835|454979827|FG000|Overall Study|Other Reason|19|||
126458321|NCT00640835|454979828|FG001|Overall Study|Other Reason|4|||
126458322|NCT03468543|454979829|FG000|Overall Study|Protocol stopping rules met|3|||
126458323|NCT04618770|454979831|FG000|Overall Study|Censored from Analysis|12|||
126458324|NCT04618770|454979831|FG000|Overall Study|Early Termination|25|||
126458325|NCT00045942|454979836|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
126458326|NCT00045942|454979837|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
126458327|NCT00045942|454979838|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
126458328|NCT00045942|454979839|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
126458329|NCT00045942|454979840|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
126458330|NCT00045942|454979841|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
126458331|NCT00045942|454979842|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
126458332|NCT00045942|454979843|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
126458333|NCT00045942|454979844|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
126458334|NCT00045942|454979836|FG000|PKC412A2104 (Core)|Adverse Event|5|||
126458335|NCT00045942|454979837|FG001|PKC412A2104 (Core)|Adverse Event|0|||
126458336|NCT00045942|454979838|FG002|PKC412A2104 (Core)|Adverse Event|0|||
126458337|NCT00045942|454979839|FG003|PKC412A2104 (Core)|Adverse Event|0|||
126458338|NCT00045942|454979840|FG004|PKC412A2104 (Core)|Adverse Event|0|||
126458339|NCT00045942|454979841|FG005|PKC412A2104 (Core)|Adverse Event|0|||
126710830|NCT01380093|455893547|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126710831|NCT01380093|455893548|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126710832|NCT01380093|455893549|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
126710833|NCT01380093|455893541|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126710834|NCT01380093|455893542|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
126458340|NCT00045942|454979842|FG006|PKC412A2104 (Core)|Adverse Event|0|||
126710835|NCT01380093|455893543|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
126710836|NCT01380093|455893544|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126710837|NCT01380093|455893545|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126710838|NCT01380093|455893546|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126710839|NCT01380093|455893547|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126710840|NCT01380093|455893548|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126710841|NCT01380093|455893549|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
126710842|NCT01380093|455893541|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126710843|NCT01380093|455893542|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
126710844|NCT01380093|455893543|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
126710845|NCT01380093|455893544|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126710846|NCT01380093|455893545|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126710847|NCT01380093|455893546|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126710848|NCT01380093|455893547|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126710849|NCT01380093|455893548|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126710850|NCT01380093|455893549|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
126710851|NCT01380093|455893541|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
126293482|NCT00273182|454362694|FG000|Overall Study|Withdrawal by Subject|257|||
126293483|NCT00273182|454362694|FG000|Overall Study|Device/System Explant|154|||
126458341|NCT00045942|454979843|FG007|PKC412A2104 (Core)|Adverse Event|0|||
126458342|NCT00045942|454979844|FG008|PKC412A2104 (Core)|Adverse Event|0|||
126458343|NCT00045942|454979836|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
126458344|NCT00045942|454979837|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
126710852|NCT01380093|455893542|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
126710853|NCT01380093|455893543|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
126710854|NCT01380093|455893544|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
126710855|NCT01380093|455893545|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
126710856|NCT01380093|455893546|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
126710857|NCT01380093|455893547|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
126767067|NCT01036594|456100214|FG001|Week 12 Evaluation|Adverse Event|0|||
126458345|NCT00045942|454979838|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
126458346|NCT00045942|454979839|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
126458347|NCT00045942|454979840|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
126458348|NCT00045942|454979841|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
126458349|NCT00045942|454979842|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
126458350|NCT00045942|454979843|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
126458351|NCT00045942|454979844|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
126458352|NCT00045942|454979836|FG000|PKC412A2104 (Core)|Death|1|||
126458353|NCT00045942|454979837|FG001|PKC412A2104 (Core)|Death|0|||
126458354|NCT00045942|454979838|FG002|PKC412A2104 (Core)|Death|0|||
126458355|NCT00045942|454979839|FG003|PKC412A2104 (Core)|Death|0|||
126458356|NCT00045942|454979840|FG004|PKC412A2104 (Core)|Death|0|||
126458357|NCT00045942|454979841|FG005|PKC412A2104 (Core)|Death|0|||
126458358|NCT00045942|454979842|FG006|PKC412A2104 (Core)|Death|0|||
126458359|NCT00045942|454979843|FG007|PKC412A2104 (Core)|Death|0|||
126458360|NCT00045942|454979844|FG008|PKC412A2104 (Core)|Death|0|||
126549857|NCT01865617|455307611|FG008|Overall Study|Other|0|||
126549858|NCT01865617|455307612|FG009|Overall Study|Other|0|||
126549859|NCT01865617|455307613|FG010|Overall Study|Other|0|||
126549860|NCT01865617|455307614|FG011|Overall Study|Other|0|||
126549861|NCT01865617|455307615|FG012|Overall Study|Other|0|||
126549862|NCT02226172|455307616|FG000|Overall Study|Participant refused further follow-up|4|||
126549863|NCT02226172|455307616|FG000|Overall Study|Other|5|||
126458361|NCT00045942|454979836|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
126458362|NCT00045942|454979837|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
126458363|NCT00045942|454979838|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
126458364|NCT00045942|454979839|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
126458365|NCT00045942|454979840|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
126458366|NCT00045942|454979841|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
126458367|NCT00045942|454979842|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
126458368|NCT00045942|454979843|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
126458369|NCT00045942|454979844|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
126458370|NCT00045942|454979836|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
126458371|NCT00045942|454979837|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
126458372|NCT00045942|454979838|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
126458373|NCT00045942|454979839|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
126458374|NCT00045942|454979840|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
126458375|NCT00045942|454979841|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
126458376|NCT00045942|454979842|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
126458377|NCT00045942|454979843|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
126458378|NCT00045942|454979844|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
126458379|NCT00045942|454979836|FG000|PKC412A2104E1|Lack of Efficacy|0|||
126458380|NCT00045942|454979837|FG001|PKC412A2104E1|Lack of Efficacy|11|||
126458381|NCT00045942|454979838|FG002|PKC412A2104E1|Lack of Efficacy|11|||
126458382|NCT00045942|454979839|FG003|PKC412A2104E1|Lack of Efficacy|23|||
126458383|NCT00045942|454979840|FG004|PKC412A2104E1|Lack of Efficacy|17|||
126458384|NCT00045942|454979841|FG005|PKC412A2104E1|Lack of Efficacy|0|||
126458385|NCT00045942|454979842|FG006|PKC412A2104E1|Lack of Efficacy|0|||
126293484|NCT00273182|454362694|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
126293485|NCT00420420|454362695|FG000|Overall Study|Adverse Event|5|||
126293486|NCT00420420|454362696|FG001|Overall Study|Adverse Event|3|||
126293487|NCT00420420|454362695|FG000|Overall Study|Protocol Violation|1|||
126293488|NCT00420420|454362696|FG001|Overall Study|Protocol Violation|1|||
126293489|NCT00420420|454362695|FG000|Overall Study|Withdrawal by Subject|1|||
126293490|NCT00420420|454362696|FG001|Overall Study|Withdrawal by Subject|0|||
126293491|NCT00420420|454362695|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
126293492|NCT00420420|454362696|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
126293493|NCT00856492|454362697|FG000|Overall Study|Ineligible or withdrew consent|1|||
126293494|NCT00856492|454362698|FG001|Overall Study|Ineligible or withdrew consent|1|||
126293495|NCT00856492|454362699|FG002|Overall Study|Ineligible or withdrew consent|2|||
126293496|NCT00868530|454362703|FG000|Overall Study|Adverse Event|3|||
126293497|NCT00868530|454362703|FG000|Overall Study|Lost to Follow-up|1|||
126293498|NCT04576507|454364697|FG000|Overall Study|Adverse Event|4|||
126293499|NCT04576507|454364697|FG000|Overall Study|Withdrawal by Subject|1|||
126293500|NCT01749826|454364702|FG000|Overall Study|Study Terminated|20|||
126458386|NCT00045942|454979843|FG007|PKC412A2104E1|Lack of Efficacy|0|||
126458387|NCT00045942|454979844|FG008|PKC412A2104E1|Lack of Efficacy|0|||
126458388|NCT00045942|454979836|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
126458389|NCT00045942|454979837|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
126458390|NCT00045942|454979838|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
126549864|NCT02226172|455307616|FG000|Overall Study|Death|1|||
126549865|NCT02226172|455307616|FG000|Overall Study|Study terminated by sponsor|1|||
126549866|NCT02226172|455307616|FG000|Overall Study|Adverse Event|6|||
126710858|NCT01380093|455893548|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
126458391|NCT00045942|454979839|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
126458392|NCT00045942|454979840|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
126458393|NCT00045942|454979841|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
126549867|NCT00258440|455307622|FG000|Overall Study|Withdrawal by Subject|0|||
126293501|NCT01749826|454364703|FG001|Overall Study|Study Terminated|0|||
126293502|NCT05842967|454364704|FG000|Period 1: SSA|Adverse Event|1|||
126293503|NCT05842967|454364705|FG001|Period 1: SSA|Adverse Event|1|||
126458394|NCT00045942|454979842|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
126458395|NCT00045942|454979843|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
126549868|NCT00258440|455307623|FG001|Overall Study|Withdrawal by Subject|0|||
126458396|NCT00045942|454979844|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
126458397|NCT00045942|454979836|FG000|PKC412A2104E1|Adverse Event|0|||
126458398|NCT00045942|454979837|FG001|PKC412A2104E1|Adverse Event|1|||
126458399|NCT00045942|454979838|FG002|PKC412A2104E1|Adverse Event|1|||
126458400|NCT00045942|454979839|FG003|PKC412A2104E1|Adverse Event|3|||
126458401|NCT00045942|454979840|FG004|PKC412A2104E1|Adverse Event|6|||
126458402|NCT00045942|454979841|FG005|PKC412A2104E1|Adverse Event|0|||
126458403|NCT00045942|454979842|FG006|PKC412A2104E1|Adverse Event|0|||
126458404|NCT00045942|454979843|FG007|PKC412A2104E1|Adverse Event|0|||
126458405|NCT00045942|454979844|FG008|PKC412A2104E1|Adverse Event|0|||
126458406|NCT00045942|454979836|FG000|PKC412A2104E1|Death|0|||
126458407|NCT00045942|454979837|FG001|PKC412A2104E1|Death|4|||
126458408|NCT00045942|454979838|FG002|PKC412A2104E1|Death|1|||
126458409|NCT00045942|454979839|FG003|PKC412A2104E1|Death|1|||
126458410|NCT00045942|454979840|FG004|PKC412A2104E1|Death|1|||
126458411|NCT00045942|454979841|FG005|PKC412A2104E1|Death|0|||
126458412|NCT00045942|454979842|FG006|PKC412A2104E1|Death|0|||
126458413|NCT00045942|454979843|FG007|PKC412A2104E1|Death|0|||
126458414|NCT00045942|454979844|FG008|PKC412A2104E1|Death|0|||
126458415|NCT00045942|454979836|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
126458416|NCT00045942|454979837|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
126458417|NCT00045942|454979838|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
126458418|NCT00045942|454979839|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
126458419|NCT00045942|454979840|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
126458420|NCT00045942|454979841|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
126458421|NCT00045942|454979842|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
126458422|NCT00045942|454979843|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
126458423|NCT00045942|454979844|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
126458424|NCT00045942|454979836|FG000|PKC412A2104E2|Lost to Follow-up|0|||
126458425|NCT00045942|454979837|FG001|PKC412A2104E2|Lost to Follow-up|0|||
126458426|NCT00045942|454979838|FG002|PKC412A2104E2|Lost to Follow-up|0|||
126458427|NCT00045942|454979839|FG003|PKC412A2104E2|Lost to Follow-up|0|||
126458428|NCT00045942|454979840|FG004|PKC412A2104E2|Lost to Follow-up|0|||
126458429|NCT00045942|454979841|FG005|PKC412A2104E2|Lost to Follow-up|0|||
126458430|NCT00045942|454979842|FG006|PKC412A2104E2|Lost to Follow-up|0|||
126458431|NCT00045942|454979843|FG007|PKC412A2104E2|Lost to Follow-up|3|||
126458432|NCT00045942|454979844|FG008|PKC412A2104E2|Lost to Follow-up|0|||
126458433|NCT00045942|454979836|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
126458434|NCT00045942|454979837|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
126458435|NCT00045942|454979838|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
126458436|NCT00045942|454979839|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
126458437|NCT00045942|454979840|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
126458438|NCT00045942|454979841|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
126458439|NCT00045942|454979842|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
126458440|NCT00045942|454979843|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
126458441|NCT00045942|454979844|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
126458442|NCT00045942|454979836|FG000|PKC412A2104E2|Lack of Efficacy|0|||
126458443|NCT00045942|454979837|FG001|PKC412A2104E2|Lack of Efficacy|0|||
126293504|NCT05842967|454364706|FG002|Period 1: SSA|Adverse Event|0|||
126293505|NCT05842967|454364707|FG003|Period 1: SSA|Adverse Event|0|||
126293506|NCT05842967|454364704|FG000|Period 1: SSA|Death|1|||
126293507|NCT05842967|454364705|FG001|Period 1: SSA|Death|0|||
126293508|NCT05842967|454364706|FG002|Period 1: SSA|Death|0|||
126293509|NCT05842967|454364707|FG003|Period 1: SSA|Death|0|||
126293510|NCT05842967|454364704|FG000|Period 1: SSA|Lost to Follow-up|16|||
126293511|NCT05842967|454364705|FG001|Period 1: SSA|Lost to Follow-up|4|||
126293512|NCT05842967|454364706|FG002|Period 1: SSA|Lost to Follow-up|0|||
126293513|NCT05842967|454364707|FG003|Period 1: SSA|Lost to Follow-up|0|||
126458444|NCT00045942|454979838|FG002|PKC412A2104E2|Lack of Efficacy|0|||
126458445|NCT00045942|454979839|FG003|PKC412A2104E2|Lack of Efficacy|0|||
126458446|NCT00045942|454979840|FG004|PKC412A2104E2|Lack of Efficacy|0|||
126458447|NCT00045942|454979841|FG005|PKC412A2104E2|Lack of Efficacy|3|||
126458448|NCT00045942|454979842|FG006|PKC412A2104E2|Lack of Efficacy|2|||
126458449|NCT00045942|454979843|FG007|PKC412A2104E2|Lack of Efficacy|2|||
126293514|NCT05842967|454364704|FG000|Period 1: SSA|Physician Decision|1|||
126458450|NCT00045942|454979844|FG008|PKC412A2104E2|Lack of Efficacy|6|||
126458451|NCT00045942|454979836|FG000|PKC412A2104E2|Adverse Event|0|||
126458452|NCT00045942|454979837|FG001|PKC412A2104E2|Adverse Event|0|||
126458453|NCT00045942|454979838|FG002|PKC412A2104E2|Adverse Event|0|||
126293515|NCT05842967|454364705|FG001|Period 1: SSA|Physician Decision|0|||
126293516|NCT05842967|454364706|FG002|Period 1: SSA|Physician Decision|0|||
126293517|NCT05842967|454364707|FG003|Period 1: SSA|Physician Decision|0|||
126458454|NCT00045942|454979839|FG003|PKC412A2104E2|Adverse Event|0|||
126458455|NCT00045942|454979840|FG004|PKC412A2104E2|Adverse Event|0|||
126293518|NCT05842967|454364704|FG000|Period 1: SSA|Withdrawal by Subject|2|||
126458456|NCT00045942|454979841|FG005|PKC412A2104E2|Adverse Event|4|||
126458457|NCT00045942|454979842|FG006|PKC412A2104E2|Adverse Event|3|||
126458458|NCT00045942|454979843|FG007|PKC412A2104E2|Adverse Event|1|||
126458459|NCT00045942|454979844|FG008|PKC412A2104E2|Adverse Event|0|||
126458460|NCT00045942|454979836|FG000|PKC412A2104E2|Death|0|||
126458461|NCT00045942|454979837|FG001|PKC412A2104E2|Death|0|||
126458462|NCT00045942|454979838|FG002|PKC412A2104E2|Death|0|||
126458463|NCT00045942|454979839|FG003|PKC412A2104E2|Death|0|||
126458464|NCT00045942|454979840|FG004|PKC412A2104E2|Death|0|||
126458465|NCT00045942|454979841|FG005|PKC412A2104E2|Death|1|||
126458466|NCT00045942|454979842|FG006|PKC412A2104E2|Death|2|||
126458467|NCT00045942|454979843|FG007|PKC412A2104E2|Death|0|||
126458468|NCT00045942|454979844|FG008|PKC412A2104E2|Death|0|||
126458469|NCT02095132|454979845|FG000|Overall Study|Adverse Event|0|||
126458470|NCT02095132|454979846|FG001|Overall Study|Adverse Event|0|||
126458471|NCT02095132|454979847|FG002|Overall Study|Adverse Event|0|||
126458472|NCT02095132|454979848|FG003|Overall Study|Adverse Event|0|||
126458473|NCT02095132|454979849|FG004|Overall Study|Adverse Event|1|||
126458474|NCT02095132|454979850|FG005|Overall Study|Adverse Event|0|||
126458475|NCT02095132|454979851|FG006|Overall Study|Adverse Event|1|||
126458476|NCT02095132|454979852|FG007|Overall Study|Adverse Event|0|||
126458477|NCT02095132|454979853|FG008|Overall Study|Adverse Event|0|||
126458478|NCT02095132|454979845|FG000|Overall Study|Death|0|||
126458479|NCT02095132|454979846|FG001|Overall Study|Death|0|||
126458480|NCT02095132|454979847|FG002|Overall Study|Death|0|||
126458481|NCT02095132|454979848|FG003|Overall Study|Death|0|||
126458482|NCT02095132|454979849|FG004|Overall Study|Death|0|||
126458483|NCT02095132|454979850|FG005|Overall Study|Death|0|||
126458484|NCT02095132|454979851|FG006|Overall Study|Death|1|||
126458485|NCT02095132|454979852|FG007|Overall Study|Death|0|||
126458486|NCT02095132|454979853|FG008|Overall Study|Death|0|||
126458487|NCT02095132|454979845|FG000|Overall Study|Lack of Efficacy|3|||
126458488|NCT02095132|454979846|FG001|Overall Study|Lack of Efficacy|5|||
126458489|NCT02095132|454979847|FG002|Overall Study|Lack of Efficacy|2|||
126458490|NCT02095132|454979848|FG003|Overall Study|Lack of Efficacy|8|||
126458491|NCT02095132|454979849|FG004|Overall Study|Lack of Efficacy|3|||
126458492|NCT02095132|454979850|FG005|Overall Study|Lack of Efficacy|6|||
126458493|NCT02095132|454979851|FG006|Overall Study|Lack of Efficacy|10|||
126458494|NCT02095132|454979852|FG007|Overall Study|Lack of Efficacy|9|||
126458495|NCT02095132|454979853|FG008|Overall Study|Lack of Efficacy|8|||
126458496|NCT02095132|454979845|FG000|Overall Study|Physician Decision|1|||
126458497|NCT02095132|454979846|FG001|Overall Study|Physician Decision|0|||
126458498|NCT02095132|454979847|FG002|Overall Study|Physician Decision|0|||
126458499|NCT02095132|454979848|FG003|Overall Study|Physician Decision|0|||
126458500|NCT02095132|454979849|FG004|Overall Study|Physician Decision|0|||
126458501|NCT02095132|454979850|FG005|Overall Study|Physician Decision|0|||
126458502|NCT02095132|454979851|FG006|Overall Study|Physician Decision|1|||
126458503|NCT02095132|454979852|FG007|Overall Study|Physician Decision|0|||
126458504|NCT02095132|454979853|FG008|Overall Study|Physician Decision|2|||
126458505|NCT02095132|454979845|FG000|Overall Study|Withdrawal by Subject|0|||
126458506|NCT02095132|454979846|FG001|Overall Study|Withdrawal by Subject|0|||
126458507|NCT02095132|454979847|FG002|Overall Study|Withdrawal by Subject|2|||
126458508|NCT02095132|454979848|FG003|Overall Study|Withdrawal by Subject|2|||
126458509|NCT02095132|454979849|FG004|Overall Study|Withdrawal by Subject|3|||
126458510|NCT02095132|454979850|FG005|Overall Study|Withdrawal by Subject|0|||
126458511|NCT02095132|454979851|FG006|Overall Study|Withdrawal by Subject|5|||
126458512|NCT02095132|454979852|FG007|Overall Study|Withdrawal by Subject|0|||
126458513|NCT02095132|454979853|FG008|Overall Study|Withdrawal by Subject|0|||
126458514|NCT01895361|454979857|FG000|Overall Study|Adverse Event|1|||
126458515|NCT01895361|454979858|FG001|Overall Study|Adverse Event|1|||
126458516|NCT01895361|454979859|FG002|Overall Study|Adverse Event|3|||
126767068|NCT01036594|456100213|FG000|Week 12 Evaluation|Physician Decision|1|||
126293519|NCT05842967|454364705|FG001|Period 1: SSA|Withdrawal by Subject|2|||
126293520|NCT05842967|454364706|FG002|Period 1: SSA|Withdrawal by Subject|0|||
126293521|NCT05842967|454364707|FG003|Period 1: SSA|Withdrawal by Subject|0|||
126458517|NCT01895361|454979857|FG000|Overall Study|Death|2|||
126458518|NCT01895361|454979858|FG001|Overall Study|Death|1|||
126458519|NCT01895361|454979859|FG002|Overall Study|Death|2|||
126458520|NCT01895361|454979857|FG000|Overall Study|Lost to Follow-up|4|||
126293522|NCT05842967|454364704|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
126293523|NCT05842967|454364705|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
126458521|NCT01895361|454979858|FG001|Overall Study|Lost to Follow-up|4|||
126458522|NCT01895361|454979859|FG002|Overall Study|Lost to Follow-up|6|||
126458523|NCT01895361|454979857|FG000|Overall Study|Non-compliance with study|1|||
126458524|NCT01895361|454979858|FG001|Overall Study|Non-compliance with study|3|||
126458525|NCT01895361|454979859|FG002|Overall Study|Non-compliance with study|1|||
126458526|NCT01895361|454979857|FG000|Overall Study|Physician Decision|2|||
126458527|NCT01895361|454979858|FG001|Overall Study|Physician Decision|2|||
126458528|NCT01895361|454979859|FG002|Overall Study|Physician Decision|2|||
126458529|NCT01895361|454979857|FG000|Overall Study|Withdrawal by Subject|7|||
126458530|NCT01895361|454979858|FG001|Overall Study|Withdrawal by Subject|6|||
126458531|NCT01895361|454979859|FG002|Overall Study|Withdrawal by Subject|6|||
126458532|NCT01895361|454979857|FG000|Overall Study|Lack of Efficacy|0|||
126458533|NCT01895361|454979858|FG001|Overall Study|Lack of Efficacy|1|||
126458534|NCT01895361|454979859|FG002|Overall Study|Lack of Efficacy|0|||
126458535|NCT01895361|454979857|FG000|Overall Study|Reasons different from categories above|7|||
126767069|NCT01036594|456100214|FG001|Week 12 Evaluation|Physician Decision|0|||
126293524|NCT05842967|454364706|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
126293525|NCT05842967|454364707|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
126293526|NCT05842967|454364704|FG000|Period 2: SSB|Adverse Event|0|||
126293527|NCT05842967|454364705|FG001|Period 2: SSB|Adverse Event|0|||
126293528|NCT05842967|454364706|FG002|Period 2: SSB|Adverse Event|2|||
126293529|NCT05842967|454364707|FG003|Period 2: SSB|Adverse Event|0|||
126549869|NCT00258440|455307624|FG002|Overall Study|Withdrawal by Subject|1|||
126549870|NCT00737061|455307625|FG000|Waiting Period|Lost to Follow-up|6|||
126549871|NCT00737061|455307625|FG000|Waiting Period|Withdrawal by Subject|1|||
126549872|NCT00737061|455307625|FG000|Waiting Period|Bilateral placement failure|34|||
126549873|NCT00737061|455307625|FG000|Waiting Period|Deemed patent following HSG|26|||
126549874|NCT00737061|455307625|FG000|Waiting Period|Alternative contraception failure|3|||
126549875|NCT00737061|455307625|FG000|Waiting Period|Elected surgical tubal ligation|5|||
126549876|NCT00737061|455307625|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
126549877|NCT00737061|455307625|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
126549878|NCT00737061|455307625|FG000|1 Year Wearing Period|Discontinued reilance|3|||
126549879|NCT00737061|455307625|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
126549880|NCT00439179|455307627|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
126549881|NCT00439179|455307628|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
126549882|NCT00439179|455307629|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
126549883|NCT00439179|455307630|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
126549884|NCT01844115|455307634|FG000|Overall Study|Adverse Event|4|||
126549885|NCT01844115|455307635|FG001|Overall Study|Adverse Event|22|||
126549886|NCT01844115|455307634|FG000|Overall Study|Lack of Efficacy|1|||
126549887|NCT01844115|455307635|FG001|Overall Study|Lack of Efficacy|4|||
126549888|NCT01844115|455307634|FG000|Overall Study|Protocol Violation|12|||
126549889|NCT01844115|455307635|FG001|Overall Study|Protocol Violation|10|||
126549890|NCT01844115|455307634|FG000|Overall Study|Withdrawal by Subject|11|||
126549891|NCT01844115|455307635|FG001|Overall Study|Withdrawal by Subject|11|||
126549892|NCT01844115|455307634|FG000|Overall Study|Lost to Follow-up|11|||
126549893|NCT01844115|455307635|FG001|Overall Study|Lost to Follow-up|10|||
126549894|NCT01844115|455307634|FG000|Overall Study|Pregnancy|0|||
126549895|NCT01844115|455307635|FG001|Overall Study|Pregnancy|1|||
126549896|NCT00758160|455307636|FG000|Overall Study|No Longer Requires Study Medication|4|||
126767070|NCT01036594|456100213|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
126293530|NCT05842967|454364704|FG000|Period 2: SSB|Lost to Follow-up|0|||
126293531|NCT05842967|454364705|FG001|Period 2: SSB|Lost to Follow-up|0|||
126366408|NCT04101331|454636981|FG000|Overall Study|Disease progression|82|||
126366409|NCT04101331|454636981|FG000|Overall Study|Withdrawal by Subject|1|||
126366410|NCT04101331|454636981|FG000|Overall Study|Investigator decision|6|||
126366411|NCT04101331|454636981|FG000|Overall Study|Death|6|||
126366412|NCT04101331|454636981|FG000|Overall Study|Allogenic transplant|1|||
126366413|NCT04110145|454636982|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
126366414|NCT04110145|454636983|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
126366415|NCT04110145|454636984|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
126366416|NCT04110145|454636985|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
126366417|NCT04110145|454636986|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
126366418|NCT00488293|454636990|FG000|Overall Study|Lost to Follow-up|28|||
126366419|NCT00488293|454636991|FG001|Overall Study|Lost to Follow-up|25|||
126366420|NCT00488293|454636990|FG000|Overall Study|Withdrawal by Subject|5|||
126366421|NCT00488293|454636991|FG001|Overall Study|Withdrawal by Subject|3|||
126366422|NCT00488293|454636990|FG000|Overall Study|Death|2|||
126366423|NCT00488293|454636991|FG001|Overall Study|Death|1|||
126366424|NCT00488293|454636990|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
126366425|NCT00488293|454636991|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
126366426|NCT00500331|454636992|FG000|Overall Study|Adverse Event|0|||
126366427|NCT00500331|454636993|FG001|Overall Study|Adverse Event|2|||
126366428|NCT00500331|454636994|FG002|Overall Study|Adverse Event|0|||
126366429|NCT00500331|454636995|FG003|Overall Study|Adverse Event|1|||
126366430|NCT00500331|454636996|FG004|Overall Study|Adverse Event|2|||
126366431|NCT00500331|454636997|FG005|Overall Study|Adverse Event|2|||
126366432|NCT00500331|454636998|FG006|Overall Study|Adverse Event|0|||
126366433|NCT00500331|454636992|FG000|Overall Study|Lost to Follow-up|1|||
126366434|NCT00500331|454636993|FG001|Overall Study|Lost to Follow-up|1|||
126549897|NCT00758160|455307636|FG000|Overall Study|Administration Problems|3|||
126293532|NCT05842967|454364706|FG002|Period 2: SSB|Lost to Follow-up|4|||
126366435|NCT00500331|454636994|FG002|Overall Study|Lost to Follow-up|1|||
126366436|NCT00500331|454636995|FG003|Overall Study|Lost to Follow-up|2|||
126366437|NCT00500331|454636996|FG004|Overall Study|Lost to Follow-up|1|||
126366438|NCT00500331|454636997|FG005|Overall Study|Lost to Follow-up|0|||
126366439|NCT00500331|454636998|FG006|Overall Study|Lost to Follow-up|0|||
126549898|NCT00758160|455307636|FG000|Overall Study|Adverse Event|15|||
126549899|NCT00758160|455307636|FG000|Overall Study|Lack of Efficacy|10|||
126293533|NCT05842967|454364707|FG003|Period 2: SSB|Lost to Follow-up|3|||
126549900|NCT00758160|455307636|FG000|Overall Study|Lost to Follow-up|14|||
126549901|NCT00758160|455307636|FG000|Overall Study|Protocol Violation|12|||
126293534|NCT05842967|454364704|FG000|Period 2: SSB|Withdrawal by Subject|0|||
126293535|NCT05842967|454364705|FG001|Period 2: SSB|Withdrawal by Subject|0|||
126458536|NCT01895361|454979858|FG001|Overall Study|Reasons different from categories above|3|||
126458537|NCT01895361|454979859|FG002|Overall Study|Reasons different from categories above|4|||
126458538|NCT00761748|454979863|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
126458539|NCT00761748|454979864|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
126458540|NCT00761748|454979863|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
126458541|NCT00761748|454979864|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
126458542|NCT01268579|454979865|FG000|Overall Study|Adverse Event|1|||
126458543|NCT01268579|454979865|FG000|Overall Study|Withdrawal by Subject|2|||
126458544|NCT01209832|454979866|FG000|Period 1|Sponsor Decision and was not dosed|1|||
126458545|NCT01209832|454979866|FG000|Period 2|Sponsor Decision|1|||
126293536|NCT05842967|454364706|FG002|Period 2: SSB|Withdrawal by Subject|1|||
126293537|NCT05842967|454364707|FG003|Period 2: SSB|Withdrawal by Subject|0|||
126293538|NCT05842967|454364704|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
126293539|NCT05842967|454364705|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
126293540|NCT05842967|454364706|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
126293541|NCT05842967|454364707|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
126293542|NCT05842967|454364704|FG000|Period 2: SSB|Protocol Violation|0|||
126293543|NCT05842967|454364705|FG001|Period 2: SSB|Protocol Violation|0|||
126293544|NCT05842967|454364706|FG002|Period 2: SSB|Protocol Violation|0|||
126293545|NCT05842967|454364707|FG003|Period 2: SSB|Protocol Violation|1|||
126293546|NCT01103180|454364709|FG000|Overall Study|Withdrawal by Subject|8|||
126293547|NCT01103180|454364710|FG001|Overall Study|Withdrawal by Subject|13|||
126293548|NCT01103180|454364709|FG000|Overall Study|Lost to Follow-up|13|||
126293549|NCT01103180|454364710|FG001|Overall Study|Lost to Follow-up|7|||
126293550|NCT01103180|454364709|FG000|Overall Study|Physician Decision|1|||
126458546|NCT02692651|454979867|FG000|Study Treatment|Death|7|||
126458547|NCT02692651|454979868|FG001|Study Treatment|Death|3|||
126458548|NCT02692651|454979867|FG000|Study Treatment|comfort care|1|||
126293551|NCT01103180|454364710|FG001|Overall Study|Physician Decision|0|||
126293552|NCT01103180|454364709|FG000|Overall Study|Protocol Violation|0|||
126293553|NCT01103180|454364710|FG001|Overall Study|Protocol Violation|1|||
126293554|NCT01173523|454364711|FG000|Overall Study|Clinical Progression|1|||
126293555|NCT01173523|454364712|FG001|Overall Study|Clinical Progression|1|||
126293556|NCT01173523|454364711|FG000|Overall Study|Progressive Disease|10|||
126293557|NCT01173523|454364712|FG001|Overall Study|Progressive Disease|8|||
126293558|NCT01173523|454364711|FG000|Overall Study|Other|2|||
126293559|NCT01173523|454364712|FG001|Overall Study|Other|3|||
126293560|NCT01439802|454364717|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
126293561|NCT01439802|454364717|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
126293562|NCT01866826|454364718|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
126293563|NCT01866826|454364719|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
126293564|NCT01866826|454364718|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
126293565|NCT01866826|454364719|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
126293566|NCT01866826|454364718|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
126293567|NCT01866826|454364719|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
126293568|NCT02493660|454364722|FG000|Overall Study|Physician Decision|0|||
126293569|NCT02493660|454364723|FG001|Overall Study|Physician Decision|1|||
126293570|NCT02493660|454364722|FG000|Overall Study|Adverse Event|4|||
126293571|NCT02493660|454364723|FG001|Overall Study|Adverse Event|2|||
126293572|NCT02493660|454364722|FG000|Overall Study|Withdrawal by Subject|2|||
126293573|NCT02493660|454364723|FG001|Overall Study|Withdrawal by Subject|3|||
126293574|NCT02493660|454364722|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
126293575|NCT02493660|454364723|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
126293576|NCT02493660|454364722|FG000|Overall Study|Protocol Violation|0|||
126293577|NCT02493660|454364723|FG001|Overall Study|Protocol Violation|1|||
126293578|NCT02493660|454364722|FG000|Overall Study|Death|0|||
126710859|NCT01380093|455893549|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
126458549|NCT02692651|454979868|FG001|Study Treatment|comfort care|1|||
126458550|NCT02692651|454979867|FG000|Study Treatment|Protocol violation per treating team preference|8|||
126458551|NCT02692651|454979868|FG001|Study Treatment|Protocol violation per treating team preference|6|||
126458552|NCT02692651|454979867|FG000|Post Study Treatment Follow-up|Death|4|||
126458553|NCT02692651|454979868|FG001|Post Study Treatment Follow-up|Death|4|||
126710860|NCT01380093|455893541|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126458554|NCT02480712|454979869|FG000|Overall Study|Enrolled but Never Treated|1|||
126458555|NCT02480712|454979869|FG000|Overall Study|Lost to Follow-up|5|||
126293579|NCT02493660|454364723|FG001|Overall Study|Death|1|||
126293580|NCT02493660|454364722|FG000|Overall Study|Lost to Follow-up|2|||
126293581|NCT02493660|454364723|FG001|Overall Study|Lost to Follow-up|4|||
126293582|NCT00595621|454364725|FG000|Open Label Run in|Adverse Event|1|||
126293583|NCT00595621|454364726|FG001|Open Label Run in|Adverse Event|0|||
126293584|NCT00595621|454364725|FG000|Open Label Run in|Physician Decision|1|||
126293585|NCT00595621|454364726|FG001|Open Label Run in|Physician Decision|0|||
126293586|NCT00595621|454364725|FG000|Open Label Run in|Withdrawal by Subject|1|||
126710861|NCT01380093|455893542|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126710862|NCT01380093|455893543|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
126710863|NCT01380093|455893544|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126710864|NCT01380093|455893545|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126710865|NCT01380093|455893546|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126710866|NCT01380093|455893547|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126710867|NCT01380093|455893548|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126710868|NCT01380093|455893549|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
126710869|NCT01380093|455893541|FG000|Treatment Phase: Second Intervention|Other|0|||
126710870|NCT01380093|455893542|FG001|Treatment Phase: Second Intervention|Other|0|||
126710871|NCT01380093|455893543|FG002|Treatment Phase: Second Intervention|Other|0|||
126710872|NCT01380093|455893544|FG003|Treatment Phase: Second Intervention|Other|1|||
126710873|NCT01380093|455893545|FG004|Treatment Phase: Second Intervention|Other|0|||
126710874|NCT01380093|455893546|FG005|Treatment Phase: Second Intervention|Other|0|||
126710875|NCT01380093|455893547|FG006|Treatment Phase: Second Intervention|Other|0|||
126710876|NCT01380093|455893548|FG007|Treatment Phase: Second Intervention|Other|0|||
126710877|NCT01380093|455893549|FG008|Treatment Phase: Second Intervention|Other|0|||
126710878|NCT01380093|455893541|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
126710879|NCT01380093|455893542|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
126710880|NCT01380093|455893543|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
126710881|NCT01380093|455893544|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
126710882|NCT01380093|455893545|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
126710883|NCT01380093|455893546|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
126710884|NCT01380093|455893547|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
126710885|NCT01380093|455893548|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
126710886|NCT01380093|455893549|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
126710887|NCT01380093|455893541|FG000|Treatment Phase: Third Intervention|Other|0|||
126710888|NCT01380093|455893542|FG001|Treatment Phase: Third Intervention|Other|0|||
126710889|NCT01380093|455893543|FG002|Treatment Phase: Third Intervention|Other|0|||
126710890|NCT01380093|455893544|FG003|Treatment Phase: Third Intervention|Other|0|||
126293587|NCT00595621|454364726|FG001|Open Label Run in|Withdrawal by Subject|0|||
126293588|NCT00595621|454364725|FG000|Randomization and Study|Adverse Event|2|||
126293589|NCT00595621|454364726|FG001|Randomization and Study|Adverse Event|0|||
126366440|NCT00500331|454636992|FG000|Overall Study|Protocol Violation|3|||
126710891|NCT01380093|455893545|FG004|Treatment Phase: Third Intervention|Other|0|||
126710892|NCT01380093|455893546|FG005|Treatment Phase: Third Intervention|Other|0|||
126710893|NCT01380093|455893547|FG006|Treatment Phase: Third Intervention|Other|0|||
126366441|NCT00500331|454636993|FG001|Overall Study|Protocol Violation|1|||
126366442|NCT00500331|454636994|FG002|Overall Study|Protocol Violation|1|||
126366443|NCT00500331|454636995|FG003|Overall Study|Protocol Violation|0|||
126366444|NCT00500331|454636996|FG004|Overall Study|Protocol Violation|1|||
126366445|NCT00500331|454636997|FG005|Overall Study|Protocol Violation|1|||
126366446|NCT00500331|454636998|FG006|Overall Study|Protocol Violation|1|||
126366447|NCT00500331|454636992|FG000|Overall Study|Withdrawal by Subject|4|||
126366448|NCT00500331|454636993|FG001|Overall Study|Withdrawal by Subject|0|||
126366449|NCT00500331|454636994|FG002|Overall Study|Withdrawal by Subject|1|||
126366450|NCT00500331|454636995|FG003|Overall Study|Withdrawal by Subject|5|||
126366451|NCT00500331|454636996|FG004|Overall Study|Withdrawal by Subject|0|||
126366452|NCT00500331|454636997|FG005|Overall Study|Withdrawal by Subject|1|||
126366453|NCT00500331|454636998|FG006|Overall Study|Withdrawal by Subject|1|||
126366454|NCT00500331|454636992|FG000|Overall Study|Lack of Efficacy|3|||
126366455|NCT00500331|454636993|FG001|Overall Study|Lack of Efficacy|1|||
126366456|NCT00500331|454636994|FG002|Overall Study|Lack of Efficacy|0|||
126366457|NCT00500331|454636995|FG003|Overall Study|Lack of Efficacy|0|||
126366458|NCT00500331|454636996|FG004|Overall Study|Lack of Efficacy|0|||
126366459|NCT00500331|454636997|FG005|Overall Study|Lack of Efficacy|0|||
126366460|NCT00500331|454636998|FG006|Overall Study|Lack of Efficacy|0|||
126366461|NCT00500331|454636992|FG000|Overall Study|Liver function test abnormality|0|||
126366462|NCT00500331|454636993|FG001|Overall Study|Liver function test abnormality|0|||
126366463|NCT00500331|454636994|FG002|Overall Study|Liver function test abnormality|1|||
126366464|NCT00500331|454636995|FG003|Overall Study|Liver function test abnormality|0|||
126366465|NCT00500331|454636996|FG004|Overall Study|Liver function test abnormality|0|||
126366466|NCT00500331|454636997|FG005|Overall Study|Liver function test abnormality|0|||
126366467|NCT00500331|454636998|FG006|Overall Study|Liver function test abnormality|0|||
126366468|NCT00500331|454636992|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
126366469|NCT00500331|454636993|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
126366470|NCT00500331|454636994|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
126366471|NCT00500331|454636995|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
126366472|NCT00500331|454636996|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
126366473|NCT00500331|454636997|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
126366474|NCT00500331|454636998|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
126458556|NCT02480712|454979869|FG000|Overall Study|Withdrew Consent|3|||
126458557|NCT02480712|454979869|FG000|Overall Study|Death|1|||
126458558|NCT02480712|454979869|FG000|Overall Study|Lack of Efficacy|1|||
126458559|NCT02239120|454979870|FG000|Overall Study|Death|56|||
126458560|NCT02239120|454979871|FG001|Overall Study|Death|58|||
126458561|NCT02239120|454979870|FG000|Overall Study|Lost to Follow-up|19|||
126458562|NCT02239120|454979871|FG001|Overall Study|Lost to Follow-up|14|||
126458563|NCT01107379|454979872|FG000|Overall Study|Withdrawal by Subject|18|||
126458564|NCT01107379|454979872|FG000|Overall Study|Lost to Follow-up|3|||
126458565|NCT00609362|454979873|FG000|Overall Study|Withdrawal by Subject|2|||
126458566|NCT00609362|454979874|FG001|Overall Study|Withdrawal by Subject|1|||
126458567|NCT00609362|454979873|FG000|Overall Study|Adverse Event|1|||
126458568|NCT00609362|454979874|FG001|Overall Study|Adverse Event|0|||
126458569|NCT04559529|454979875|FG000|First Intervention (1 Day)|Adverse Event|0|||
126458570|NCT04559529|454979876|FG001|First Intervention (1 Day)|Adverse Event|0|||
126458571|NCT04559529|454979877|FG002|First Intervention (1 Day)|Adverse Event|0|||
126458572|NCT04559529|454979878|FG003|First Intervention (1 Day)|Adverse Event|1|||
126458573|NCT04559529|454979875|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
126458574|NCT04559529|454979876|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
126458575|NCT04559529|454979877|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
126458576|NCT04559529|454979878|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
126458577|NCT04559529|454979875|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
126458578|NCT04559529|454979876|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
126458579|NCT04559529|454979877|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
126458580|NCT04559529|454979878|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
126458581|NCT01009281|454979879|FG000|Overall Study|Administrative problems|7|||
126458582|NCT00548405|454979880|FG000|Overall Study|Adverse Event|6|||
126458583|NCT00548405|454979881|FG001|Overall Study|Adverse Event|2|||
126458584|NCT00548405|454979882|FG002|Overall Study|Adverse Event|0|||
126458585|NCT00548405|454979880|FG000|Overall Study|Lack of Efficacy|6|||
126458586|NCT00548405|454979881|FG001|Overall Study|Lack of Efficacy|0|||
126458587|NCT00548405|454979882|FG002|Overall Study|Lack of Efficacy|0|||
126458588|NCT00548405|454979880|FG000|Overall Study|Physician Decision|3|||
126458589|NCT00548405|454979881|FG001|Overall Study|Physician Decision|4|||
126458590|NCT00548405|454979882|FG002|Overall Study|Physician Decision|1|||
126458591|NCT00548405|454979880|FG000|Overall Study|Pregnancy|1|||
126458592|NCT00548405|454979881|FG001|Overall Study|Pregnancy|0|||
126458593|NCT00548405|454979882|FG002|Overall Study|Pregnancy|0|||
126458594|NCT00548405|454979880|FG000|Overall Study|Protocol Violation|1|||
126458595|NCT00548405|454979881|FG001|Overall Study|Protocol Violation|0|||
126458596|NCT00548405|454979882|FG002|Overall Study|Protocol Violation|0|||
126458597|NCT00548405|454979880|FG000|Overall Study|Withdrawal by Subject|36|||
126458598|NCT00548405|454979881|FG001|Overall Study|Withdrawal by Subject|12|||
126458599|NCT00548405|454979882|FG002|Overall Study|Withdrawal by Subject|5|||
126458600|NCT00548405|454979880|FG000|Overall Study|Lost to Follow-up|1|||
126458601|NCT00548405|454979881|FG001|Overall Study|Lost to Follow-up|1|||
126458602|NCT00548405|454979882|FG002|Overall Study|Lost to Follow-up|2|||
126458603|NCT00548405|454979880|FG000|Overall Study|Death|0|||
126458604|NCT00548405|454979881|FG001|Overall Study|Death|1|||
126458605|NCT00548405|454979882|FG002|Overall Study|Death|1|||
126458606|NCT00548405|454979880|FG000|Overall Study|Sponsor decision|1|||
126458607|NCT00548405|454979881|FG001|Overall Study|Sponsor decision|0|||
126458608|NCT00548405|454979882|FG002|Overall Study|Sponsor decision|0|||
126458609|NCT00548405|454979880|FG000|Overall Study|Randomized but not treated|1|||
126549902|NCT00758160|455307636|FG000|Overall Study|Withdrawal by Subject|8|||
126293590|NCT00595621|454364725|FG000|Randomization and Study|Withdrawal by Subject|0|||
126293591|NCT00595621|454364726|FG001|Randomization and Study|Withdrawal by Subject|1|||
126293592|NCT00324987|454364727|FG000|Overall Study|Adverse Event|2|||
126293593|NCT00324987|454364728|FG001|Overall Study|Adverse Event|1|||
126293594|NCT00324987|454364727|FG000|Overall Study|Withdrawal by Subject|1|||
126293595|NCT00324987|454364728|FG001|Overall Study|Withdrawal by Subject|1|||
126293596|NCT00324987|454364727|FG000|Overall Study|Progression|1|||
126293597|NCT00324987|454364728|FG001|Overall Study|Progression|1|||
126293598|NCT00324987|454364727|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
126293599|NCT00324987|454364728|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
126458610|NCT00548405|454979881|FG001|Overall Study|Randomized but not treated|0|||
126458611|NCT00548405|454979882|FG002|Overall Study|Randomized but not treated|0|||
126458612|NCT02582684|454979883|FG000|Overall Study|Unable to contact subject/parent|4|||
126458613|NCT02582684|454979883|FG000|Overall Study|Subject not able to get to clinic|10|||
126458614|NCT02582684|454979883|FG000|Overall Study|Subject withdrew consent|1|||
126458615|NCT02582684|454979883|FG000|Overall Study|Found to be ineligible after enrollment|2|||
126458616|NCT01878149|454979884|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
126458617|NCT01878149|454979885|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
126549903|NCT01613027|455307637|FG000|Overall Study|Lost to Follow-up|5|||
126293600|NCT02392481|454364729|FG000|Overall Study|Adverse Event|0|||
126293601|NCT02392481|454364730|FG001|Overall Study|Adverse Event|0|||
126293602|NCT02392481|454364731|FG002|Overall Study|Adverse Event|1|||
126458618|NCT00899392|454979895|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
126458619|NCT00899392|454979896|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
126458620|NCT01261780|454979903|FG000|Overall Study|Withdrawal by Subject|1|||
126458621|NCT01261780|454979904|FG001|Overall Study|Withdrawal by Subject|0|||
126458622|NCT01261780|454979903|FG000|Overall Study|Event not related to subject|1|||
126458623|NCT01261780|454979904|FG001|Overall Study|Event not related to subject|2|||
126458624|NCT01239732|454979905|FG000|Overall Study|Termination of study per protocol|667|||
126458625|NCT01239732|454979905|FG000|Overall Study|Death|226|||
126458626|NCT01239732|454979905|FG000|Overall Study|Withdrawal by Subject|87|||
126458627|NCT01239732|454979905|FG000|Overall Study|Adverse Event|6|||
126458628|NCT01239732|454979905|FG000|Overall Study|Protocol Violation|3|||
126458629|NCT01239732|454979905|FG000|Overall Study|Participant non compliance|5|||
126458630|NCT01239732|454979905|FG000|Overall Study|Study termination by sponsor|2|||
126458631|NCT01239732|454979905|FG000|Overall Study|Investigator's decision|4|||
126458632|NCT01239732|454979905|FG000|Overall Study|Treatment failure|2|||
126458633|NCT01239732|454979905|FG000|Overall Study|Other|19|||
126458634|NCT00732940|454979906|FG000|Overall Study|Withdrawal by Subject|1|||
126458635|NCT00732940|454979907|FG001|Overall Study|Withdrawal by Subject|2|||
126458636|NCT00732940|454979906|FG000|Overall Study|Adverse Event|0|||
126458637|NCT00732940|454979907|FG001|Overall Study|Adverse Event|1|||
126458638|NCT00732940|454979906|FG000|Overall Study|Lost to Follow-up|1|||
126458639|NCT00732940|454979907|FG001|Overall Study|Lost to Follow-up|0|||
126458640|NCT02241889|454979908|FG000|Overall Study|device issues|0|||
126458641|NCT02241889|454979909|FG001|Overall Study|device issues|0|||
126458642|NCT02241889|454979910|FG002|Overall Study|device issues|1|||
126458643|NCT02241889|454979911|FG003|Overall Study|device issues|0|||
126458644|NCT02241889|454979912|FG004|Overall Study|device issues|0|||
126458645|NCT02241889|454979913|FG005|Overall Study|device issues|0|||
126458646|NCT02241889|454979908|FG000|Overall Study|Withdrawal by Subject|0|||
126458647|NCT02241889|454979909|FG001|Overall Study|Withdrawal by Subject|0|||
126767071|NCT01036594|456100214|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
126767072|NCT01036594|456100213|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
126767073|NCT01036594|456100214|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
126767074|NCT01036594|456100213|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
126767075|NCT01036594|456100214|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
126767076|NCT01036594|456100213|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
126767077|NCT01036594|456100214|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
126293603|NCT02392481|454364732|FG003|Overall Study|Adverse Event|2|||
126293604|NCT02392481|454364729|FG000|Overall Study|Withdrawal by Subject|0|||
126293605|NCT02392481|454364730|FG001|Overall Study|Withdrawal by Subject|0|||
126293606|NCT02392481|454364731|FG002|Overall Study|Withdrawal by Subject|1|||
126767078|NCT01036594|456100213|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
126767079|NCT01036594|456100214|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
126767080|NCT00244881|456100216|FG000|Overall Study|Withdrawal by Subject|3|||
126767081|NCT03664024|456100220|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
126767082|NCT03664024|456100220|FG000|Overall Study|Lost to Follow-up|2|||
126767083|NCT03664024|456100220|FG000|Overall Study|Withdrawal by Subject|2|||
126767084|NCT03664024|456100220|FG000|Overall Study|Death|80|||
126767085|NCT03159611|456100221|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
126767086|NCT03159611|456100222|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
126767087|NCT03159611|456100221|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
126767088|NCT03159611|456100222|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
126767089|NCT03159611|456100221|FG000|Overall Study|Protocol Violation|7|||
126767090|NCT03159611|456100222|FG001|Overall Study|Protocol Violation|4|||
126767091|NCT03159611|456100221|FG000|Overall Study|Adverse Event|1|||
126767092|NCT03159611|456100222|FG001|Overall Study|Adverse Event|0|||
126767093|NCT03159611|456100221|FG000|Overall Study|Withdrawal by Subject|1|||
126293607|NCT02392481|454364732|FG003|Overall Study|Withdrawal by Subject|0|||
126293608|NCT02502149|454364734|FG000|Intermediate|Discontinued prematurely|1|||
126293609|NCT02502149|454364735|FG001|Intermediate|Discontinued prematurely|0|||
126293610|NCT02502149|454364736|FG002|Intermediate|Discontinued prematurely|0|||
126293611|NCT02502149|454364737|FG003|Intermediate|Discontinued prematurely|0|||
126458648|NCT02241889|454979910|FG002|Overall Study|Withdrawal by Subject|0|||
126767094|NCT03159611|456100222|FG001|Overall Study|Withdrawal by Subject|1|||
126293612|NCT02502149|454364738|FG004|Intermediate|Discontinued prematurely|0|||
126293613|NCT02968576|454364739|FG000|Overall Study|Pregnancy|0|||
126293614|NCT02968576|454364740|FG001|Overall Study|Pregnancy|1|||
126458649|NCT02241889|454979911|FG003|Overall Study|Withdrawal by Subject|0|||
126458650|NCT02241889|454979912|FG004|Overall Study|Withdrawal by Subject|0|||
126458651|NCT02241889|454979913|FG005|Overall Study|Withdrawal by Subject|1|||
126767095|NCT03159611|456100221|FG000|Overall Study|Non-compliance with protocol requirement|3|||
126293615|NCT02222922|454364741|FG000|Overall Study|Death|0|||
126767096|NCT03159611|456100222|FG001|Overall Study|Non-compliance with protocol requirement|2|||
126293616|NCT02222922|454364742|FG001|Overall Study|Death|0|||
126293617|NCT02222922|454364743|FG002|Overall Study|Death|0|||
126458652|NCT01120067|454979919|FG000|Overall Study|Lost to Follow-up|3|||
126458653|NCT01120067|454979920|FG001|Overall Study|Lost to Follow-up|1|||
126458654|NCT01120067|454979919|FG000|Overall Study|fail to engage >3 sessions|2|||
126458655|NCT01120067|454979920|FG001|Overall Study|fail to engage >3 sessions|0|||
126458656|NCT00266877|454979922|FG000|Overall Study|Death|1|||
126458657|NCT00266877|454979923|FG001|Overall Study|Death|1|||
126458658|NCT00266877|454979924|FG002|Overall Study|Death|1|||
126458659|NCT00266877|454979922|FG000|Overall Study|Adverse Event|6|||
126293618|NCT02222922|454364744|FG003|Overall Study|Death|0|||
126293619|NCT02222922|454364745|FG004|Overall Study|Death|13|||
126293620|NCT02222922|454364746|FG005|Overall Study|Death|0|||
126293621|NCT02222922|454364747|FG006|Overall Study|Death|0|||
126293622|NCT02222922|454364748|FG007|Overall Study|Death|0|||
126293623|NCT02222922|454364749|FG008|Overall Study|Death|2|||
126293624|NCT02222922|454364741|FG000|Overall Study|Lost to Follow-up|0|||
126293625|NCT02222922|454364742|FG001|Overall Study|Lost to Follow-up|0|||
126293626|NCT02222922|454364743|FG002|Overall Study|Lost to Follow-up|1|||
126293627|NCT02222922|454364744|FG003|Overall Study|Lost to Follow-up|0|||
126293628|NCT02222922|454364745|FG004|Overall Study|Lost to Follow-up|9|||
126293629|NCT02222922|454364746|FG005|Overall Study|Lost to Follow-up|1|||
126293630|NCT02222922|454364747|FG006|Overall Study|Lost to Follow-up|0|||
126293631|NCT02222922|454364748|FG007|Overall Study|Lost to Follow-up|0|||
126293632|NCT02222922|454364749|FG008|Overall Study|Lost to Follow-up|0|||
126293633|NCT02222922|454364741|FG000|Overall Study|Other|0|||
126458660|NCT00266877|454979923|FG001|Overall Study|Adverse Event|4|||
126458661|NCT00266877|454979924|FG002|Overall Study|Adverse Event|1|||
126458662|NCT00266877|454979922|FG000|Overall Study|Physician Decision|2|||
126458663|NCT00266877|454979923|FG001|Overall Study|Physician Decision|1|||
126458664|NCT00266877|454979924|FG002|Overall Study|Physician Decision|1|||
126458665|NCT00266877|454979922|FG000|Overall Study|Withdrawal by Subject|3|||
126458666|NCT00266877|454979923|FG001|Overall Study|Withdrawal by Subject|1|||
126458667|NCT00266877|454979924|FG002|Overall Study|Withdrawal by Subject|1|||
126458668|NCT00266877|454979922|FG000|Overall Study|Disease Progression|72|||
126458669|NCT00266877|454979923|FG001|Overall Study|Disease Progression|37|||
126458670|NCT00266877|454979924|FG002|Overall Study|Disease Progression|23|||
126458671|NCT00266877|454979922|FG000|Overall Study|Symptomatic Deterioration|6|||
126458672|NCT00266877|454979923|FG001|Overall Study|Symptomatic Deterioration|3|||
126458673|NCT00266877|454979924|FG002|Overall Study|Symptomatic Deterioration|1|||
126458674|NCT00266877|454979922|FG000|Overall Study|Hospitalization|1|||
126458675|NCT00266877|454979923|FG001|Overall Study|Hospitalization|0|||
126710894|NCT01380093|455893548|FG007|Treatment Phase: Third Intervention|Other|0|||
126710895|NCT01380093|455893549|FG008|Treatment Phase: Third Intervention|Other|1|||
126710896|NCT04734873|455893550|FG000|Overall Study|Lost to Follow-up|1|||
126710897|NCT04734873|455893551|FG001|Overall Study|Lost to Follow-up|3|||
126710898|NCT04734873|455893552|FG002|Overall Study|Lost to Follow-up|2|||
126710899|NCT04734873|455893550|FG000|Overall Study|Randomized but not dosed|1|||
126710900|NCT04734873|455893551|FG001|Overall Study|Randomized but not dosed|0|||
126710901|NCT04734873|455893552|FG002|Overall Study|Randomized but not dosed|1|||
126710902|NCT02441803|455893554|FG000|Overall Study|Physician Decision|0|||
126710903|NCT02441803|455893555|FG001|Overall Study|Physician Decision|2|||
126710904|NCT02441803|455893556|FG002|Overall Study|Physician Decision|2|||
126710905|NCT00328198|455893560|FG000|Treatment|Adverse Event|21|||
126710906|NCT00328198|455893560|FG000|Treatment|Death|1|||
126710907|NCT00328198|455893560|FG000|Treatment|Physician Decision|5|||
126710908|NCT00328198|455893560|FG000|Treatment|Withdrawal by Subject|5|||
126710909|NCT00328198|455893560|FG000|Treatment|Evidence of disease progression|2|||
126710910|NCT00328198|455893560|FG000|Treatment|Non-compliance|1|||
126710911|NCT00328198|455893560|FG000|Treatment|Confirmed complete response, MRD -|3|||
126710912|NCT00328198|455893560|FG000|Follow-up|Lost to Follow-up|4|||
126710913|NCT00328198|455893560|FG000|Follow-up|Death|31|||
126710914|NCT03396471|455893561|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
126710915|NCT03396471|455893561|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
126710916|NCT03396471|455893561|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
126710917|NCT03396471|455893561|FG000|Study Treatment - Up to 22 Months|Death|2|||
126710918|NCT03396471|455893561|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
126458676|NCT00266877|454979924|FG002|Overall Study|Hospitalization|0|||
126458677|NCT00266877|454979922|FG000|Overall Study|Concomitant Radiotherapy|0|||
126458678|NCT00266877|454979923|FG001|Overall Study|Concomitant Radiotherapy|1|||
126293634|NCT02222922|454364742|FG001|Overall Study|Other|0|||
126293635|NCT02222922|454364743|FG002|Overall Study|Other|0|||
126293636|NCT02222922|454364744|FG003|Overall Study|Other|2|||
126293637|NCT02222922|454364745|FG004|Overall Study|Other|10|||
126293638|NCT02222922|454364746|FG005|Overall Study|Other|2|||
126458679|NCT00266877|454979924|FG002|Overall Study|Concomitant Radiotherapy|0|||
126458680|NCT02919969|454981261|FG000|Overall Study|Lack of Efficacy|22|||
126458681|NCT02919969|454981261|FG000|Overall Study|Death|4|||
126710919|NCT03396471|455893561|FG000|Follow up - Up to 2 Years|Death|9|||
126293639|NCT02222922|454364747|FG006|Overall Study|Other|2|||
126710920|NCT03396471|455893561|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
126710921|NCT03396471|455893561|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
126767097|NCT03159611|456100221|FG000|Overall Study|Inability to perform procedures|1|||
126767098|NCT03159611|456100222|FG001|Overall Study|Inability to perform procedures|0|||
126767099|NCT02057549|456100224|FG000|Overall Study|Lost to Follow-up|1|||
126767100|NCT02057549|456100225|FG001|Overall Study|Lost to Follow-up|0|||
126767101|NCT02057549|456100224|FG000|Overall Study|Physician Decision|1|||
126767102|NCT02057549|456100225|FG001|Overall Study|Physician Decision|0|||
126767103|NCT02057549|456100224|FG000|Overall Study|Withdrawal by Subject|1|||
126767104|NCT02057549|456100225|FG001|Overall Study|Withdrawal by Subject|0|||
126458682|NCT02919969|454981261|FG000|Overall Study|Physician Decision|3|||
126458683|NCT02919969|454981261|FG000|Overall Study|Withdrawal by Subject|2|||
126458684|NCT01842633|454981262|FG000|Overall Study|Screen Failure|1|||
126458685|NCT01842633|454981263|FG001|Overall Study|Screen Failure|0|||
126458686|NCT01842633|454981264|FG002|Overall Study|Screen Failure|0|||
126458687|NCT01842633|454981262|FG000|Overall Study|Adverse Event|1|||
126767105|NCT01418365|456100226|FG000|First Intervention|Withdrawal by Subject|0|||
126458688|NCT01842633|454981263|FG001|Overall Study|Adverse Event|1|||
126458689|NCT01842633|454981264|FG002|Overall Study|Adverse Event|0|||
126458690|NCT01842633|454981262|FG000|Overall Study|Withdrawal by Subject|0|||
126458691|NCT01842633|454981263|FG001|Overall Study|Withdrawal by Subject|1|||
126458692|NCT01842633|454981264|FG002|Overall Study|Withdrawal by Subject|0|||
126458693|NCT01842633|454981262|FG000|Overall Study|Technical issues|1|||
126458694|NCT01842633|454981263|FG001|Overall Study|Technical issues|0|||
126458695|NCT01842633|454981264|FG002|Overall Study|Technical issues|0|||
126458696|NCT01122394|454981269|FG000|Overall Study|Withdrawal by Subject|1|||
126458697|NCT01122394|454981270|FG001|Overall Study|Withdrawal by Subject|1|||
126458698|NCT01122394|454981269|FG000|Overall Study|Lost to Follow-up|2|||
126458699|NCT01122394|454981270|FG001|Overall Study|Lost to Follow-up|2|||
126458700|NCT01122394|454981269|FG000|Overall Study|Adverse Event|0|||
126458701|NCT01122394|454981270|FG001|Overall Study|Adverse Event|1|||
126458702|NCT00718081|454981273|FG000|Overall Study|Adverse Event|0|||
126458703|NCT00718081|454981274|FG001|Overall Study|Adverse Event|1|||
126458704|NCT00718081|454981275|FG002|Overall Study|Adverse Event|0|||
126458705|NCT00718081|454981273|FG000|Overall Study|Lack of Efficacy|7|||
126458706|NCT00718081|454981274|FG001|Overall Study|Lack of Efficacy|3|||
126458707|NCT00718081|454981275|FG002|Overall Study|Lack of Efficacy|21|||
126458708|NCT01397825|454981277|FG000|Overall Study|Progressive Disease|10|||
126458709|NCT01397825|454981278|FG001|Overall Study|Progressive Disease|3|||
126458710|NCT01397825|454981279|FG002|Overall Study|Progressive Disease|11|||
126458711|NCT01397825|454981280|FG003|Overall Study|Progressive Disease|1|||
126458712|NCT01397825|454981281|FG004|Overall Study|Progressive Disease|0|||
126458713|NCT01397825|454981277|FG000|Overall Study|Symptomatic Deterioration|2|||
126458714|NCT01397825|454981278|FG001|Overall Study|Symptomatic Deterioration|0|||
126458715|NCT01397825|454981279|FG002|Overall Study|Symptomatic Deterioration|4|||
126458716|NCT01397825|454981280|FG003|Overall Study|Symptomatic Deterioration|0|||
126458717|NCT01397825|454981281|FG004|Overall Study|Symptomatic Deterioration|0|||
126458718|NCT01397825|454981277|FG000|Overall Study|Adverse Event|0|||
126458719|NCT01397825|454981278|FG001|Overall Study|Adverse Event|1|||
126458720|NCT01397825|454981279|FG002|Overall Study|Adverse Event|5|||
126458721|NCT01397825|454981280|FG003|Overall Study|Adverse Event|1|||
126458722|NCT01397825|454981281|FG004|Overall Study|Adverse Event|0|||
126458723|NCT01397825|454981277|FG000|Overall Study|Withdrawal by Subject|1|||
126458724|NCT01397825|454981278|FG001|Overall Study|Withdrawal by Subject|0|||
126458725|NCT01397825|454981279|FG002|Overall Study|Withdrawal by Subject|5|||
126458726|NCT01397825|454981280|FG003|Overall Study|Withdrawal by Subject|1|||
126458727|NCT01397825|454981281|FG004|Overall Study|Withdrawal by Subject|0|||
126458728|NCT01931670|454981282|FG000|Treatment Period|Exclusionary Medication Received|1|||
126458729|NCT01931670|454981283|FG001|Treatment Period|Exclusionary Medication Received|1|||
126458730|NCT01931670|454981284|FG002|Treatment Period|Exclusionary Medication Received|1|||
126458731|NCT01931670|454981282|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
126458732|NCT01931670|454981283|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
126549904|NCT01613027|455307637|FG000|Overall Study|Switched Physician|1|||
126549905|NCT01613027|455307637|FG000|Overall Study|Lack of Efficacy|1|||
126458733|NCT01931670|454981284|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
126458734|NCT01931670|454981282|FG000|Treatment Period|Subject Noncompliant|4|||
126549906|NCT01613027|455307637|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
126549907|NCT00993317|455307638|FG000|Overall Study|Adverse Event|2|||
126767106|NCT01418365|456100227|FG001|First Intervention|Withdrawal by Subject|1|||
126767107|NCT01418365|456100226|FG000|First Intervention|Non-compliance|1|||
126458735|NCT01931670|454981283|FG001|Treatment Period|Subject Noncompliant|9|||
126458736|NCT01931670|454981284|FG002|Treatment Period|Subject Noncompliant|5|||
126458737|NCT01931670|454981282|FG000|Treatment Period|Adverse Event|19|||
126767108|NCT01418365|456100227|FG001|First Intervention|Non-compliance|0|||
126458738|NCT01931670|454981283|FG001|Treatment Period|Adverse Event|8|||
126458739|NCT01931670|454981284|FG002|Treatment Period|Adverse Event|21|||
126458740|NCT01931670|454981282|FG000|Treatment Period|Lack of Efficacy|11|||
126767109|NCT01418365|456100226|FG000|Second Intervention|Withdrawal by Subject|0|||
126458741|NCT01931670|454981283|FG001|Treatment Period|Lack of Efficacy|2|||
126458742|NCT01931670|454981284|FG002|Treatment Period|Lack of Efficacy|2|||
126458743|NCT01931670|454981282|FG000|Treatment Period|Pregnancy|7|||
126458744|NCT01931670|454981283|FG001|Treatment Period|Pregnancy|2|||
126458745|NCT01931670|454981284|FG002|Treatment Period|Pregnancy|0|||
126458746|NCT01931670|454981282|FG000|Treatment Period|Other|8|||
126458747|NCT01931670|454981283|FG001|Treatment Period|Other|7|||
126458748|NCT01931670|454981284|FG002|Treatment Period|Other|2|||
126458749|NCT01931670|454981282|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
126458750|NCT01931670|454981283|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
126458751|NCT01931670|454981284|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
126458752|NCT01931670|454981282|FG000|Treatment Period|Lost to Follow-up|19|||
126458753|NCT01931670|454981283|FG001|Treatment Period|Lost to Follow-up|5|||
126458754|NCT01931670|454981284|FG002|Treatment Period|Lost to Follow-up|7|||
126458755|NCT01931670|454981282|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
126293640|NCT02222922|454364748|FG007|Overall Study|Other|4|||
126293641|NCT02222922|454364749|FG008|Overall Study|Other|1|||
126293642|NCT02222922|454364741|FG000|Overall Study|Participant refused further follow-up|1|||
126293643|NCT02222922|454364742|FG001|Overall Study|Participant refused further follow-up|0|||
126293644|NCT02222922|454364743|FG002|Overall Study|Participant refused further follow-up|0|||
126293645|NCT02222922|454364744|FG003|Overall Study|Participant refused further follow-up|1|||
126458756|NCT01931670|454981283|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
126458757|NCT01931670|454981284|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
126458758|NCT01931670|454981282|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
126458759|NCT01931670|454981283|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
126458760|NCT01931670|454981284|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
126458761|NCT01931670|454981282|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
126458762|NCT01931670|454981283|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
126458763|NCT01931670|454981284|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
126458764|NCT01931670|454981282|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
126458765|NCT01931670|454981283|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
126458766|NCT01931670|454981284|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
126458767|NCT01931670|454981282|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
126458768|NCT01931670|454981283|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
126458769|NCT01931670|454981284|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
126458770|NCT01931670|454981282|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
126458771|NCT01931670|454981283|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
126458772|NCT01931670|454981284|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
126458773|NCT00815516|454981285|FG000|Overall Study|Death|3|||
126458774|NCT00815516|454981286|FG001|Overall Study|Death|1|||
126458775|NCT00815516|454981285|FG000|Overall Study|Physician Decision|1|||
126458776|NCT00815516|454981286|FG001|Overall Study|Physician Decision|0|||
126458777|NCT01992159|454981293|FG000|Overall Study|Withdrawal by Subject|4|||
126458778|NCT01992159|454981294|FG001|Overall Study|Withdrawal by Subject|7|||
126458779|NCT01992159|454981295|FG002|Overall Study|Withdrawal by Subject|0|||
126458780|NCT01992159|454981296|FG003|Overall Study|Withdrawal by Subject|3|||
126458781|NCT01992159|454981293|FG000|Overall Study|Adverse Event|0|||
126458782|NCT01992159|454981294|FG001|Overall Study|Adverse Event|1|||
126458783|NCT01992159|454981295|FG002|Overall Study|Adverse Event|0|||
126458784|NCT01992159|454981296|FG003|Overall Study|Adverse Event|1|||
126458785|NCT01992159|454981293|FG000|Overall Study|Death|0|||
126458786|NCT01992159|454981294|FG001|Overall Study|Death|0|||
126458787|NCT01992159|454981295|FG002|Overall Study|Death|1|||
126458788|NCT01992159|454981296|FG003|Overall Study|Death|0|||
126458789|NCT03023046|454981297|FG000|Overall Study|Withdrawal by Subject|1|||
126458790|NCT01741012|454981298|FG000|Overall Study|Lost to Follow-up|1|||
126458791|NCT01741012|454981298|FG000|Overall Study|Withdrawal by Subject|2|||
126458792|NCT04393298|454981301|FG000|Overall Study|Adverse Event|0|||
126458793|NCT04393298|454981302|FG001|Overall Study|Adverse Event|0|||
126458794|NCT04393298|454981303|FG002|Overall Study|Adverse Event|0|||
126458795|NCT04393298|454981304|FG003|Overall Study|Adverse Event|0|||
126458796|NCT04393298|454981305|FG004|Overall Study|Adverse Event|1|||
126458797|NCT04393298|454981306|FG005|Overall Study|Adverse Event|0|||
126458798|NCT04393298|454981307|FG006|Overall Study|Adverse Event|0|||
126767110|NCT01418365|456100227|FG001|Second Intervention|Withdrawal by Subject|1|||
126293646|NCT02222922|454364745|FG004|Overall Study|Participant refused further follow-up|6|||
126293647|NCT02222922|454364746|FG005|Overall Study|Participant refused further follow-up|0|||
126458799|NCT04393298|454981308|FG007|Overall Study|Adverse Event|0|||
126458800|NCT04393298|454981309|FG008|Overall Study|Adverse Event|2|||
126458801|NCT04393298|454981310|FG009|Overall Study|Adverse Event|0|||
126458802|NCT04393298|454981311|FG010|Overall Study|Adverse Event|0|||
126458803|NCT04393298|454981312|FG011|Overall Study|Adverse Event|0|||
126458804|NCT04393298|454981313|FG012|Overall Study|Adverse Event|1|||
126458805|NCT04393298|454981314|FG013|Overall Study|Adverse Event|1|||
126458806|NCT04393298|454981315|FG014|Overall Study|Adverse Event|0|||
126549908|NCT00993317|455307639|FG001|Overall Study|Adverse Event|4|||
126458807|NCT04393298|454981301|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458808|NCT04393298|454981302|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458809|NCT04393298|454981303|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
126458810|NCT04393298|454981304|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458811|NCT04393298|454981305|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458812|NCT04393298|454981306|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458813|NCT04393298|454981307|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458814|NCT04393298|454981308|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458815|NCT04393298|454981309|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458816|NCT04393298|454981310|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458817|NCT04393298|454981311|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458818|NCT04393298|454981312|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458819|NCT04393298|454981313|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458820|NCT04393298|454981314|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
126458821|NCT04393298|454981315|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
126458822|NCT04393298|454981301|FG000|Overall Study|Lack of Efficacy|0|||
126458823|NCT04393298|454981302|FG001|Overall Study|Lack of Efficacy|0|||
126458824|NCT04393298|454981303|FG002|Overall Study|Lack of Efficacy|0|||
126458825|NCT04393298|454981304|FG003|Overall Study|Lack of Efficacy|0|||
126458826|NCT04393298|454981305|FG004|Overall Study|Lack of Efficacy|0|||
126458827|NCT04393298|454981306|FG005|Overall Study|Lack of Efficacy|0|||
126458828|NCT04393298|454981307|FG006|Overall Study|Lack of Efficacy|0|||
126458829|NCT04393298|454981308|FG007|Overall Study|Lack of Efficacy|0|||
126458830|NCT04393298|454981309|FG008|Overall Study|Lack of Efficacy|0|||
126458831|NCT04393298|454981310|FG009|Overall Study|Lack of Efficacy|0|||
126458832|NCT04393298|454981311|FG010|Overall Study|Lack of Efficacy|0|||
126458833|NCT04393298|454981312|FG011|Overall Study|Lack of Efficacy|0|||
126458834|NCT04393298|454981313|FG012|Overall Study|Lack of Efficacy|0|||
126458835|NCT04393298|454981314|FG013|Overall Study|Lack of Efficacy|0|||
126458836|NCT04393298|454981315|FG014|Overall Study|Lack of Efficacy|1|||
126458837|NCT04393298|454981301|FG000|Overall Study|Progression|1|||
126458838|NCT04393298|454981302|FG001|Overall Study|Progression|0|||
126458839|NCT04393298|454981303|FG002|Overall Study|Progression|0|||
126458840|NCT04393298|454981304|FG003|Overall Study|Progression|0|||
126458841|NCT04393298|454981305|FG004|Overall Study|Progression|0|||
126458842|NCT04393298|454981306|FG005|Overall Study|Progression|0|||
126458843|NCT04393298|454981307|FG006|Overall Study|Progression|0|||
126458844|NCT04393298|454981308|FG007|Overall Study|Progression|0|||
126458845|NCT04393298|454981309|FG008|Overall Study|Progression|0|||
126458846|NCT04393298|454981310|FG009|Overall Study|Progression|0|||
126458847|NCT04393298|454981311|FG010|Overall Study|Progression|1|||
126458848|NCT04393298|454981312|FG011|Overall Study|Progression|1|||
126458849|NCT04393298|454981313|FG012|Overall Study|Progression|0|||
126458850|NCT04393298|454981314|FG013|Overall Study|Progression|0|||
126458851|NCT04393298|454981315|FG014|Overall Study|Progression|0|||
126458852|NCT04393298|454981301|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
126458853|NCT04393298|454981302|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458854|NCT04393298|454981303|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458855|NCT04393298|454981304|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458856|NCT04393298|454981305|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458857|NCT04393298|454981306|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458858|NCT04393298|454981307|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458859|NCT04393298|454981308|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458860|NCT04393298|454981309|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458861|NCT04393298|454981310|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458862|NCT04393298|454981311|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458863|NCT04393298|454981312|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458864|NCT04393298|454981313|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458865|NCT04393298|454981314|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458866|NCT04393298|454981315|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
126458867|NCT04393298|454981301|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458868|NCT04393298|454981302|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
126458869|NCT04393298|454981303|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458870|NCT04393298|454981304|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458871|NCT04393298|454981305|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126293648|NCT02222922|454364747|FG006|Overall Study|Participant refused further follow-up|0|||
126293649|NCT02222922|454364748|FG007|Overall Study|Participant refused further follow-up|0|||
126293650|NCT02222922|454364749|FG008|Overall Study|Participant refused further follow-up|3|||
126458872|NCT04393298|454981306|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458873|NCT04393298|454981307|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458874|NCT04393298|454981308|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458875|NCT04393298|454981309|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458876|NCT04393298|454981310|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458877|NCT04393298|454981311|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458878|NCT04393298|454981312|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458879|NCT04393298|454981313|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458880|NCT04393298|454981314|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458881|NCT04393298|454981315|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
126458882|NCT04393298|454981301|FG000|Overall Study|Clinical Progression|0|||
126549909|NCT00993317|455307638|FG000|Overall Study|Lack of Efficacy|18|||
126549910|NCT00993317|455307639|FG001|Overall Study|Lack of Efficacy|18|||
126549911|NCT00993317|455307638|FG000|Overall Study|Withdrawal by Subject|0|||
126549912|NCT00993317|455307639|FG001|Overall Study|Withdrawal by Subject|2|||
126549913|NCT00993317|455307638|FG000|Overall Study|Investigator's opinion|0|||
126549914|NCT00993317|455307639|FG001|Overall Study|Investigator's opinion|1|||
126549915|NCT00993317|455307638|FG000|Overall Study|Early study termination at the site|1|||
126549916|NCT00993317|455307639|FG001|Overall Study|Early study termination at the site|0|||
126549917|NCT02153359|455307640|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
126549918|NCT02153359|455307641|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
126549919|NCT04422639|455307642|FG000|Overall Study|Death|1|||
126549920|NCT04422639|455307643|FG001|Overall Study|Death|0|||
126549921|NCT04422639|455307642|FG000|Overall Study|study closed prior to completion of FU visits|0|||
126549922|NCT04422639|455307643|FG001|Overall Study|study closed prior to completion of FU visits|2|||
126549923|NCT01964521|455307644|FG000|Overall Study|Lost to Follow-up|4|||
126549924|NCT01258660|455307646|FG000|Overall Study|Adverse Event|2|||
126549925|NCT01258660|455307647|FG001|Overall Study|Adverse Event|4|||
126549926|NCT01258660|455307646|FG000|Overall Study|Withdrawal by Subject|3|||
126549927|NCT01258660|455307647|FG001|Overall Study|Withdrawal by Subject|0|||
126549928|NCT01258660|455307646|FG000|Overall Study|due to relocation|2|||
126549929|NCT01258660|455307647|FG001|Overall Study|due to relocation|0|||
126549930|NCT01258660|455307646|FG000|Overall Study|Protocol Violation|0|||
126549931|NCT01258660|455307647|FG001|Overall Study|Protocol Violation|1|||
126549932|NCT01258660|455307646|FG000|Overall Study|Invalid for primary analysis data set|4|||
126549933|NCT01258660|455307647|FG001|Overall Study|Invalid for primary analysis data set|6|||
126549934|NCT01193582|455307648|FG000|Vaccination Series|Withdrawal by Subject|11|||
126549935|NCT01193582|455307649|FG001|Vaccination Series|Withdrawal by Subject|13|||
126549936|NCT01193582|455307650|FG002|Vaccination Series|Withdrawal by Subject|8|||
126549937|NCT01193582|455307651|FG003|Vaccination Series|Withdrawal by Subject|3|||
126549938|NCT01193582|455307648|FG000|12 Month Follow-up|Death|0|||
126458883|NCT04393298|454981302|FG001|Overall Study|Clinical Progression|2|||
126293651|NCT01254643|454364750|FG000|Overall Study|Withdrawal by Subject|1|||
126293652|NCT03359850|454364753|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
126293653|NCT03359850|454364754|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
126293654|NCT03359850|454364753|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
126293655|NCT03359850|454364754|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
126293656|NCT03359850|454364753|FG000|Extension Phase (Up to 28 Months)|Death|2|||
126293657|NCT03359850|454364754|FG001|Extension Phase (Up to 28 Months)|Death|4|||
126293658|NCT03359850|454364753|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
126293659|NCT03359850|454364754|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
126458884|NCT04393298|454981303|FG002|Overall Study|Clinical Progression|0|||
126458885|NCT04393298|454981304|FG003|Overall Study|Clinical Progression|0|||
126458886|NCT04393298|454981305|FG004|Overall Study|Clinical Progression|0|||
126458887|NCT04393298|454981306|FG005|Overall Study|Clinical Progression|0|||
126458888|NCT04393298|454981307|FG006|Overall Study|Clinical Progression|0|||
126458889|NCT04393298|454981308|FG007|Overall Study|Clinical Progression|0|||
126710922|NCT03396471|455893561|FG000|Follow up - Up to 2 Years|study terminated|1|||
126293660|NCT03359850|454364753|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
126293661|NCT03359850|454364754|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
126293662|NCT00116779|454364756|FG000|Overall Study|Adverse Event|4|||
126293663|NCT00116779|454364757|FG001|Overall Study|Adverse Event|2|||
126293664|NCT00116779|454364756|FG000|Overall Study|Protocol Violation|1|||
126293665|NCT00116779|454364757|FG001|Overall Study|Protocol Violation|4|||
126458890|NCT04393298|454981309|FG008|Overall Study|Clinical Progression|0|||
126458891|NCT04393298|454981310|FG009|Overall Study|Clinical Progression|0|||
126458892|NCT04393298|454981311|FG010|Overall Study|Clinical Progression|0|||
126710923|NCT03396471|455893561|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
126458893|NCT04393298|454981312|FG011|Overall Study|Clinical Progression|0|||
126458894|NCT04393298|454981313|FG012|Overall Study|Clinical Progression|0|||
126710924|NCT03396471|455893561|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
126549939|NCT01193582|455307649|FG001|12 Month Follow-up|Death|0|||
126549940|NCT01193582|455307650|FG002|12 Month Follow-up|Death|1|||
126549941|NCT01193582|455307651|FG003|12 Month Follow-up|Death|0|||
126293666|NCT00116779|454364756|FG000|Overall Study|Withdrawal by Subject|4|||
126293667|NCT00116779|454364757|FG001|Overall Study|Withdrawal by Subject|1|||
126293668|NCT00116779|454364756|FG000|Overall Study|Inadequate testosterone suppression|7|||
126458895|NCT04393298|454981314|FG013|Overall Study|Clinical Progression|0|||
126458896|NCT04393298|454981315|FG014|Overall Study|Clinical Progression|0|||
126458897|NCT04393298|454981301|FG000|Overall Study|Disease Progression|0|||
126458898|NCT04393298|454981302|FG001|Overall Study|Disease Progression|1|||
126458899|NCT04393298|454981303|FG002|Overall Study|Disease Progression|0|||
126458900|NCT04393298|454981304|FG003|Overall Study|Disease Progression|0|||
126458901|NCT04393298|454981305|FG004|Overall Study|Disease Progression|0|||
126458902|NCT04393298|454981306|FG005|Overall Study|Disease Progression|3|||
126458903|NCT04393298|454981307|FG006|Overall Study|Disease Progression|2|||
126458904|NCT04393298|454981308|FG007|Overall Study|Disease Progression|1|||
126458905|NCT04393298|454981309|FG008|Overall Study|Disease Progression|2|||
126458906|NCT04393298|454981310|FG009|Overall Study|Disease Progression|1|||
126458907|NCT04393298|454981311|FG010|Overall Study|Disease Progression|0|||
126458908|NCT04393298|454981312|FG011|Overall Study|Disease Progression|3|||
126458909|NCT04393298|454981313|FG012|Overall Study|Disease Progression|0|||
126458910|NCT04393298|454981314|FG013|Overall Study|Disease Progression|0|||
126458911|NCT04393298|454981315|FG014|Overall Study|Disease Progression|1|||
126458912|NCT04393298|454981301|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458913|NCT04393298|454981302|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458914|NCT04393298|454981303|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
126458915|NCT04393298|454981304|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458916|NCT04393298|454981305|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458917|NCT04393298|454981306|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458918|NCT04393298|454981307|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458919|NCT04393298|454981308|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458920|NCT04393298|454981309|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458921|NCT04393298|454981310|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458922|NCT04393298|454981311|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458923|NCT04393298|454981312|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458924|NCT04393298|454981313|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458925|NCT04393298|454981314|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458926|NCT04393298|454981315|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
126458927|NCT04393298|454981301|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458928|NCT04393298|454981302|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458929|NCT04393298|454981303|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
126458930|NCT04393298|454981304|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458931|NCT04393298|454981305|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458932|NCT04393298|454981306|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458933|NCT04393298|454981307|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458934|NCT04393298|454981308|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458935|NCT04393298|454981309|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458936|NCT04393298|454981310|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458937|NCT04393298|454981311|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458938|NCT04393298|454981312|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458939|NCT04393298|454981313|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458940|NCT04393298|454981314|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458941|NCT04393298|454981315|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
126458942|NCT04393298|454981301|FG000|Overall Study|Progressive Disease (PD)|0|||
126458943|NCT04393298|454981302|FG001|Overall Study|Progressive Disease (PD)|0|||
126458944|NCT04393298|454981303|FG002|Overall Study|Progressive Disease (PD)|0|||
126458945|NCT04393298|454981304|FG003|Overall Study|Progressive Disease (PD)|3|||
126458946|NCT04393298|454981305|FG004|Overall Study|Progressive Disease (PD)|0|||
126458947|NCT04393298|454981306|FG005|Overall Study|Progressive Disease (PD)|0|||
126458948|NCT04393298|454981307|FG006|Overall Study|Progressive Disease (PD)|0|||
126458949|NCT04393298|454981308|FG007|Overall Study|Progressive Disease (PD)|0|||
126458950|NCT04393298|454981309|FG008|Overall Study|Progressive Disease (PD)|0|||
126458951|NCT04393298|454981310|FG009|Overall Study|Progressive Disease (PD)|0|||
126458952|NCT04393298|454981311|FG010|Overall Study|Progressive Disease (PD)|0|||
126458953|NCT04393298|454981312|FG011|Overall Study|Progressive Disease (PD)|0|||
126458954|NCT04393298|454981313|FG012|Overall Study|Progressive Disease (PD)|0|||
126458955|NCT04393298|454981314|FG013|Overall Study|Progressive Disease (PD)|0|||
126458956|NCT04393298|454981315|FG014|Overall Study|Progressive Disease (PD)|0|||
126458957|NCT04393298|454981301|FG000|Overall Study|Started a New Cancer Treatment|0|||
126458958|NCT04393298|454981302|FG001|Overall Study|Started a New Cancer Treatment|0|||
126458959|NCT04393298|454981303|FG002|Overall Study|Started a New Cancer Treatment|0|||
126458960|NCT04393298|454981304|FG003|Overall Study|Started a New Cancer Treatment|0|||
126458961|NCT04393298|454981305|FG004|Overall Study|Started a New Cancer Treatment|1|||
126458962|NCT04393298|454981306|FG005|Overall Study|Started a New Cancer Treatment|0|||
126549942|NCT01193582|455307648|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
126458963|NCT04393298|454981307|FG006|Overall Study|Started a New Cancer Treatment|0|||
126458964|NCT04393298|454981308|FG007|Overall Study|Started a New Cancer Treatment|0|||
126458965|NCT04393298|454981309|FG008|Overall Study|Started a New Cancer Treatment|0|||
126458966|NCT04393298|454981310|FG009|Overall Study|Started a New Cancer Treatment|0|||
126458967|NCT04393298|454981311|FG010|Overall Study|Started a New Cancer Treatment|0|||
126458968|NCT04393298|454981312|FG011|Overall Study|Started a New Cancer Treatment|0|||
126458969|NCT04393298|454981313|FG012|Overall Study|Started a New Cancer Treatment|0|||
126458970|NCT04393298|454981314|FG013|Overall Study|Started a New Cancer Treatment|0|||
126458971|NCT04393298|454981315|FG014|Overall Study|Started a New Cancer Treatment|0|||
126458972|NCT04393298|454981301|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458973|NCT04393298|454981302|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458974|NCT04393298|454981303|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126366475|NCT00500331|454636992|FG000|Overall Study|Didn't return for continuation of study|1|||
126366476|NCT00500331|454636993|FG001|Overall Study|Didn't return for continuation of study|0|||
126366477|NCT00500331|454636994|FG002|Overall Study|Didn't return for continuation of study|0|||
126366478|NCT00500331|454636995|FG003|Overall Study|Didn't return for continuation of study|0|||
126366479|NCT00500331|454636996|FG004|Overall Study|Didn't return for continuation of study|0|||
126366480|NCT00500331|454636997|FG005|Overall Study|Didn't return for continuation of study|0|||
126366481|NCT00500331|454636998|FG006|Overall Study|Didn't return for continuation of study|0|||
126366482|NCT00500331|454636992|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
126366483|NCT00500331|454636993|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
126366484|NCT00500331|454636994|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
126366485|NCT00500331|454636995|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
126366486|NCT00500331|454636996|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
126366487|NCT00500331|454636997|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
126366488|NCT00500331|454636998|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
126366489|NCT00500331|454636992|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
126366490|NCT00500331|454636993|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
126366491|NCT00500331|454636994|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
126366492|NCT00500331|454636995|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
126366493|NCT00500331|454636996|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
126458975|NCT04393298|454981304|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458976|NCT04393298|454981305|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
126458977|NCT04393298|454981306|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458978|NCT04393298|454981307|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458979|NCT04393298|454981308|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458980|NCT04393298|454981309|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458981|NCT04393298|454981310|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458982|NCT04393298|454981311|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458983|NCT04393298|454981312|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458984|NCT04393298|454981313|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458985|NCT04393298|454981314|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458986|NCT04393298|454981315|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
126458987|NCT04393298|454981301|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126458988|NCT04393298|454981302|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126458989|NCT04393298|454981303|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126458990|NCT04393298|454981304|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126458991|NCT04393298|454981305|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126458992|NCT04393298|454981306|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
126458993|NCT04393298|454981307|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126458994|NCT04393298|454981308|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126458995|NCT04393298|454981309|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126458996|NCT04393298|454981310|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126458997|NCT04393298|454981311|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126458998|NCT04393298|454981312|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126458999|NCT04393298|454981313|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126459000|NCT04393298|454981314|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126459001|NCT04393298|454981315|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
126459002|NCT04393298|454981301|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126459003|NCT04393298|454981302|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126459004|NCT04393298|454981303|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126459005|NCT04393298|454981304|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126459006|NCT04393298|454981305|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126459007|NCT04393298|454981306|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
126459008|NCT04393298|454981307|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126710925|NCT00234104|455893563|FG000|Overall Study|Adverse Event|4|||
126459009|NCT04393298|454981308|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126459010|NCT04393298|454981309|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126459011|NCT04393298|454981310|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126459012|NCT04393298|454981311|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126459013|NCT04393298|454981312|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126459014|NCT04393298|454981313|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126459015|NCT04393298|454981314|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
126459016|NCT04393298|454981315|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
126293669|NCT00116779|454364757|FG001|Overall Study|Inadequate testosterone suppression|9|||
126293670|NCT00116779|454364756|FG000|Overall Study|Physician Decision|3|||
126293671|NCT00116779|454364757|FG001|Overall Study|Physician Decision|1|||
126293672|NCT00116779|454364756|FG000|Overall Study|Elevated PSA levels|2|||
126293673|NCT00116779|454364757|FG001|Overall Study|Elevated PSA levels|2|||
126293674|NCT02105467|454364758|FG000|Period 1|Lost to Follow-up|1|||
126293675|NCT02105467|454364759|FG001|Period 1|Lost to Follow-up|0|||
126293676|NCT02105467|454364758|FG000|Period 1|Death|1|||
126293677|NCT02105467|454364759|FG001|Period 1|Death|0|||
126293678|NCT02105467|454364758|FG000|Period 2|Lost to Follow-up|1|||
126293679|NCT02105467|454364759|FG001|Period 2|Lost to Follow-up|0|||
126293680|NCT02105467|454364758|FG000|Period 2|Death|1|||
126293681|NCT02105467|454364759|FG001|Period 2|Death|0|||
126293682|NCT02105467|454364758|FG000|Period 2|Withdrawal by Subject|0|||
126293683|NCT02105467|454364759|FG001|Period 2|Withdrawal by Subject|2|||
126293684|NCT02105467|454364758|FG000|Period 3|Lost to Follow-up|0|||
126293685|NCT02105467|454364759|FG001|Period 3|Lost to Follow-up|1|||
126293686|NCT01037218|454364760|FG000|Overall Study|Adverse Event|4|||
126293687|NCT01037218|454364761|FG001|Overall Study|Adverse Event|2|||
126293688|NCT01037218|454364762|FG002|Overall Study|Adverse Event|2|||
126293689|NCT01037218|454364763|FG003|Overall Study|Adverse Event|1|||
126293690|NCT01037218|454364760|FG000|Overall Study|Lack of Efficacy|0|||
126293691|NCT01037218|454364761|FG001|Overall Study|Lack of Efficacy|2|||
126293692|NCT01037218|454364762|FG002|Overall Study|Lack of Efficacy|1|||
126459017|NCT04393298|454981301|FG000|Overall Study|Death|0|||
126459018|NCT04393298|454981302|FG001|Overall Study|Death|0|||
126459019|NCT04393298|454981303|FG002|Overall Study|Death|0|||
126459020|NCT04393298|454981304|FG003|Overall Study|Death|0|||
126459021|NCT04393298|454981305|FG004|Overall Study|Death|0|||
126459022|NCT04393298|454981306|FG005|Overall Study|Death|1|||
126459023|NCT04393298|454981307|FG006|Overall Study|Death|1|||
126459024|NCT04393298|454981308|FG007|Overall Study|Death|0|||
126459025|NCT04393298|454981309|FG008|Overall Study|Death|1|||
126459026|NCT04393298|454981310|FG009|Overall Study|Death|1|||
126459027|NCT04393298|454981311|FG010|Overall Study|Death|0|||
126459028|NCT04393298|454981312|FG011|Overall Study|Death|1|||
126459029|NCT04393298|454981313|FG012|Overall Study|Death|1|||
126459030|NCT04393298|454981314|FG013|Overall Study|Death|0|||
126459031|NCT04393298|454981315|FG014|Overall Study|Death|1|||
126459032|NCT04393298|454981301|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459033|NCT04393298|454981302|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459034|NCT04393298|454981303|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459035|NCT04393298|454981304|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459036|NCT04393298|454981305|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459037|NCT04393298|454981306|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
126459038|NCT04393298|454981307|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459039|NCT04393298|454981308|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459040|NCT04393298|454981309|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459041|NCT04393298|454981310|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459042|NCT04393298|454981311|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459043|NCT04393298|454981312|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459044|NCT04393298|454981313|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459045|NCT04393298|454981314|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126767111|NCT03319368|456100228|FG000|Overall Study|Discharge swabs not collected from resident|57|||
126767112|NCT03319368|456100229|FG001|Overall Study|Discharge swabs not collected from resident|46|||
126767113|NCT03000075|456100230|FG000|Part A|Adverse Event|4|||
126293693|NCT01037218|454364763|FG003|Overall Study|Lack of Efficacy|5|||
126293694|NCT01037218|454364760|FG000|Overall Study|Lost to Follow-up|3|||
126293695|NCT01037218|454364761|FG001|Overall Study|Lost to Follow-up|5|||
126293696|NCT01037218|454364762|FG002|Overall Study|Lost to Follow-up|4|||
126293697|NCT01037218|454364763|FG003|Overall Study|Lost to Follow-up|2|||
126293698|NCT01037218|454364760|FG000|Overall Study|Withdrawal by Subject|6|||
126293699|NCT01037218|454364761|FG001|Overall Study|Withdrawal by Subject|7|||
126293700|NCT01037218|454364762|FG002|Overall Study|Withdrawal by Subject|7|||
126293701|NCT01037218|454364763|FG003|Overall Study|Withdrawal by Subject|4|||
126293702|NCT01037218|454364760|FG000|Overall Study|Partner Withdrew Consent|0|||
126293703|NCT01037218|454364761|FG001|Overall Study|Partner Withdrew Consent|3|||
126459046|NCT04393298|454981315|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
126459047|NCT04393298|454981301|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
126459048|NCT04393298|454981302|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
126459049|NCT04393298|454981303|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
126459050|NCT04393298|454981304|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
126459051|NCT04393298|454981305|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
126459052|NCT04393298|454981306|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
126459053|NCT04393298|454981307|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
126459054|NCT04393298|454981308|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
126459055|NCT04393298|454981309|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
126459056|NCT04393298|454981310|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
126459057|NCT04393298|454981311|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
126459058|NCT04393298|454981312|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
126459059|NCT04393298|454981313|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
126459060|NCT04393298|454981314|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
126459061|NCT04393298|454981315|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
126459062|NCT04393298|454981301|FG000|Overall Study|Patient Passed Away|0|||
126459063|NCT04393298|454981302|FG001|Overall Study|Patient Passed Away|0|||
126459064|NCT04393298|454981303|FG002|Overall Study|Patient Passed Away|0|||
126459065|NCT04393298|454981304|FG003|Overall Study|Patient Passed Away|0|||
126459066|NCT04393298|454981305|FG004|Overall Study|Patient Passed Away|0|||
126459067|NCT04393298|454981306|FG005|Overall Study|Patient Passed Away|0|||
126459068|NCT04393298|454981307|FG006|Overall Study|Patient Passed Away|0|||
126459069|NCT04393298|454981308|FG007|Overall Study|Patient Passed Away|1|||
126459070|NCT04393298|454981309|FG008|Overall Study|Patient Passed Away|0|||
126459071|NCT04393298|454981310|FG009|Overall Study|Patient Passed Away|0|||
126459072|NCT04393298|454981311|FG010|Overall Study|Patient Passed Away|0|||
126459073|NCT04393298|454981312|FG011|Overall Study|Patient Passed Away|0|||
126459074|NCT04393298|454981313|FG012|Overall Study|Patient Passed Away|0|||
126459075|NCT04393298|454981314|FG013|Overall Study|Patient Passed Away|0|||
126459076|NCT04393298|454981315|FG014|Overall Study|Patient Passed Away|0|||
126459077|NCT04393298|454981301|FG000|Overall Study|Patient Deceased|0|||
126459078|NCT04393298|454981302|FG001|Overall Study|Patient Deceased|0|||
126459079|NCT04393298|454981303|FG002|Overall Study|Patient Deceased|0|||
126459080|NCT04393298|454981304|FG003|Overall Study|Patient Deceased|0|||
126459081|NCT04393298|454981305|FG004|Overall Study|Patient Deceased|0|||
126459082|NCT04393298|454981306|FG005|Overall Study|Patient Deceased|0|||
126459083|NCT04393298|454981307|FG006|Overall Study|Patient Deceased|0|||
126459084|NCT04393298|454981308|FG007|Overall Study|Patient Deceased|1|||
126459085|NCT04393298|454981309|FG008|Overall Study|Patient Deceased|0|||
126459086|NCT04393298|454981310|FG009|Overall Study|Patient Deceased|0|||
126459087|NCT04393298|454981311|FG010|Overall Study|Patient Deceased|0|||
126459088|NCT04393298|454981312|FG011|Overall Study|Patient Deceased|0|||
126459089|NCT04393298|454981313|FG012|Overall Study|Patient Deceased|0|||
126459090|NCT04393298|454981314|FG013|Overall Study|Patient Deceased|0|||
126293704|NCT01037218|454364762|FG002|Overall Study|Partner Withdrew Consent|2|||
126293705|NCT01037218|454364763|FG003|Overall Study|Partner Withdrew Consent|1|||
126293706|NCT01037218|454364760|FG000|Overall Study|Protocol Violation|0|||
126293707|NCT01037218|454364761|FG001|Overall Study|Protocol Violation|0|||
126293708|NCT01037218|454364762|FG002|Overall Study|Protocol Violation|2|||
126293709|NCT01037218|454364763|FG003|Overall Study|Protocol Violation|2|||
126293710|NCT01037218|454364760|FG000|Overall Study|Various|3|||
126293711|NCT01037218|454364761|FG001|Overall Study|Various|2|||
126293712|NCT01037218|454364762|FG002|Overall Study|Various|3|||
126293713|NCT01037218|454364763|FG003|Overall Study|Various|1|||
126293714|NCT02676882|454364764|FG000|Overall Study|Adverse Event|1|||
126293715|NCT02676882|454364765|FG001|Overall Study|Adverse Event|0|||
126293716|NCT02676882|454364764|FG000|Overall Study|Lost to Follow-up|1|||
126293717|NCT02676882|454364765|FG001|Overall Study|Lost to Follow-up|0|||
126293718|NCT02676882|454364764|FG000|Overall Study|Withdrawal by Subject|1|||
126293719|NCT02676882|454364765|FG001|Overall Study|Withdrawal by Subject|2|||
126293720|NCT02568072|454364766|FG000|Overall Study|Unavailable for appointment|23|||
126293721|NCT02568072|454364766|FG000|Overall Study|Unable to contact|3|||
126293722|NCT02568072|454364766|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
126293723|NCT02568072|454364766|FG000|Overall Study|Withdrawal by Subject|1|||
126293724|NCT02568072|454364766|FG000|Overall Study|Sustained injury, marathon not run|24|||
126293725|NCT00958828|454364767|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
126293726|NCT00958828|454364768|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
126293727|NCT00958828|454364767|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
126293728|NCT00958828|454364768|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
126293729|NCT02687451|454364770|FG000|Overall Study|Withdrawal by Subject|1|||
126293730|NCT02687451|454364771|FG001|Overall Study|Withdrawal by Subject|0|||
126293731|NCT02687451|454364772|FG002|Overall Study|Withdrawal by Subject|0|||
126293732|NCT02687451|454364773|FG003|Overall Study|Withdrawal by Subject|0|||
126293733|NCT02687451|454364774|FG004|Overall Study|Withdrawal by Subject|0|||
126293734|NCT02687451|454364775|FG005|Overall Study|Withdrawal by Subject|1|||
126459091|NCT04393298|454981315|FG014|Overall Study|Patient Deceased|0|||
126459092|NCT04393298|454981301|FG000|Overall Study|Patient Discharged to Hospice|0|||
126459093|NCT04393298|454981302|FG001|Overall Study|Patient Discharged to Hospice|0|||
126459094|NCT04393298|454981303|FG002|Overall Study|Patient Discharged to Hospice|0|||
126459095|NCT04393298|454981304|FG003|Overall Study|Patient Discharged to Hospice|0|||
126459096|NCT04393298|454981305|FG004|Overall Study|Patient Discharged to Hospice|0|||
126459097|NCT04393298|454981306|FG005|Overall Study|Patient Discharged to Hospice|0|||
126459098|NCT04393298|454981307|FG006|Overall Study|Patient Discharged to Hospice|0|||
126459099|NCT04393298|454981308|FG007|Overall Study|Patient Discharged to Hospice|0|||
126459100|NCT04393298|454981309|FG008|Overall Study|Patient Discharged to Hospice|1|||
126459101|NCT04393298|454981310|FG009|Overall Study|Patient Discharged to Hospice|0|||
126459102|NCT04393298|454981311|FG010|Overall Study|Patient Discharged to Hospice|0|||
126459103|NCT04393298|454981312|FG011|Overall Study|Patient Discharged to Hospice|0|||
126459104|NCT04393298|454981313|FG012|Overall Study|Patient Discharged to Hospice|0|||
126459105|NCT04393298|454981314|FG013|Overall Study|Patient Discharged to Hospice|0|||
126459106|NCT04393298|454981315|FG014|Overall Study|Patient Discharged to Hospice|0|||
126459107|NCT04393298|454981301|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459108|NCT04393298|454981302|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459109|NCT04393298|454981303|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459110|NCT04393298|454981304|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459111|NCT04393298|454981305|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459112|NCT04393298|454981306|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459113|NCT04393298|454981307|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459114|NCT04393298|454981308|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459115|NCT04393298|454981309|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459116|NCT04393298|454981310|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
126459117|NCT04393298|454981311|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459118|NCT04393298|454981312|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459119|NCT04393298|454981313|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459120|NCT04393298|454981314|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459121|NCT04393298|454981315|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
126459122|NCT04393298|454981301|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
126459123|NCT04393298|454981302|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
126459124|NCT04393298|454981303|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
126459125|NCT04393298|454981304|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
126459126|NCT04393298|454981305|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
126459127|NCT04393298|454981306|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
126459128|NCT04393298|454981307|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
126459129|NCT04393298|454981308|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
126459130|NCT04393298|454981309|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
126459131|NCT04393298|454981310|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
126459132|NCT04393298|454981311|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
126459133|NCT04393298|454981312|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
126459134|NCT04393298|454981313|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
126459135|NCT04393298|454981314|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
126459136|NCT04393298|454981315|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
126459137|NCT02311582|454981316|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
126459138|NCT02311582|454981317|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
126459139|NCT02311582|454981318|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
126459140|NCT02311582|454981319|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
126459141|NCT02311582|454981320|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
126459142|NCT04972630|454981322|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
126459143|NCT04972630|454981323|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
126459144|NCT04972630|454981324|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
126459145|NCT01129024|454981332|FG000|Overall Study|Physician Decision|5|||
126459146|NCT01129024|454981332|FG000|Overall Study|Study Terminated by Sponsor|8|||
126459147|NCT01129024|454981332|FG000|Overall Study|Withdrawal by Subject|2|||
126459148|NCT01129024|454981332|FG000|Overall Study|Lack of Efficacy|3|||
126459149|NCT01129024|454981332|FG000|Overall Study|Needed a Platelet Transfusion|1|||
126459150|NCT00686634|454981335|FG000|Overall Study|Protocol Violation|6|||
126459151|NCT00924781|454981338|FG000|Overall Study|Study terminated by sponsor|12|||
126459152|NCT00924781|454981339|FG001|Overall Study|Study terminated by sponsor|10|||
126459153|NCT01653132|454981340|FG000|First Intervention|Protocol Violation|1|||
126459154|NCT01653132|454981341|FG001|First Intervention|Protocol Violation|0|||
126459155|NCT02677324|454981342|FG000|Overall Study|Disease Progression|6|||
126459156|NCT02677324|454981342|FG000|Overall Study|Inability to Swallow pills|1|||
126459157|NCT02677324|454981342|FG000|Overall Study|Non-compliance|1|||
126459158|NCT02677324|454981342|FG000|Overall Study|Lack of Efficacy|1|||
126459159|NCT02677324|454981342|FG000|Overall Study|Medical insurance coverage|1|||
126459160|NCT02677324|454981342|FG000|Overall Study|Adverse Event|1|||
126459161|NCT02677324|454981342|FG000|Overall Study|IgM Myeloma diagnosis|1|||
126459162|NCT03312751|454981345|FG000|Overall Study|Death|7|||
126459163|NCT03312751|454981346|FG001|Overall Study|Death|9|||
126459164|NCT03312751|454981345|FG000|Overall Study|Study discontinuation due to other reason|0|||
126459165|NCT03312751|454981346|FG001|Overall Study|Study discontinuation due to other reason|1|||
126459166|NCT00475423|454981353|FG000|Overall Study|Protocol Violation|5|||
126459167|NCT00475423|454981353|FG000|Overall Study|Adverse Event|4|||
126459168|NCT00475423|454981353|FG000|Overall Study|Withdrawal by Subject|6|||
126459169|NCT00475423|454981353|FG000|Overall Study|Lack of Efficacy|8|||
126459170|NCT00475423|454981353|FG000|Overall Study|Death|1|||
126459171|NCT00475423|454981353|FG000|Overall Study|Reason not specified|1|||
126459172|NCT00475423|454981353|FG000|Overall Study|Lost to Follow-up|7|||
126459173|NCT00046891|454981354|FG000|Overall Study|Cancels|5|||
126459174|NCT00046891|454981355|FG001|Overall Study|Cancels|9|||
126459175|NCT00046891|454981354|FG000|Overall Study|Ineligible|1|||
126459176|NCT00046891|454981355|FG001|Overall Study|Ineligible|1|||
126459177|NCT00046891|454981354|FG000|Overall Study|Withdrawal by Subject|18|||
126459178|NCT00046891|454981355|FG001|Overall Study|Withdrawal by Subject|15|||
126459179|NCT00046891|454981354|FG000|Overall Study|Adverse Event|5|||
126459180|NCT00046891|454981355|FG001|Overall Study|Adverse Event|5|||
126459181|NCT02496676|454981356|FG000|Phase 1 - Period 1|Adverse Event|0|||
126459182|NCT02496676|454981357|FG001|Phase 1 - Period 1|Adverse Event|1|||
126459183|NCT02496676|454981356|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
126459184|NCT02496676|454981357|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
126459185|NCT04381988|454981360|FG000|Overall Study|The study was terminated|4|||
126459186|NCT04381988|454981361|FG001|Overall Study|The study was terminated|0|||
126459187|NCT01624870|454981363|FG000|Overall Study|Death|19|||
126459188|NCT01624870|454981363|FG000|Overall Study|Withdrawal by Subject|1|||
126459189|NCT01624870|454981363|FG000|Overall Study|CoreValve not implanted|6|||
126459190|NCT01624870|454981363|FG000|Overall Study|Lost to follow up|1|||
126459191|NCT02048241|454981367|FG000|Overall Study|Withdrawal by Subject|0|||
126459192|NCT02048241|454981368|FG001|Overall Study|Withdrawal by Subject|1|||
126459193|NCT00402233|454981369|FG000|Overall Study|Adverse Event|1|||
126459194|NCT00402233|454981370|FG001|Overall Study|Adverse Event|7|||
126459195|NCT00402233|454981371|FG002|Overall Study|Adverse Event|9|||
126459196|NCT00402233|454981372|FG003|Overall Study|Adverse Event|9|||
126459197|NCT00402233|454981369|FG000|Overall Study|Protocol Violation|0|||
126459198|NCT00402233|454981370|FG001|Overall Study|Protocol Violation|1|||
126459199|NCT00402233|454981371|FG002|Overall Study|Protocol Violation|0|||
126459200|NCT00402233|454981372|FG003|Overall Study|Protocol Violation|0|||
126459201|NCT00402233|454981369|FG000|Overall Study|Withdrawal by Subject|2|||
126459202|NCT00402233|454981370|FG001|Overall Study|Withdrawal by Subject|1|||
126459203|NCT00402233|454981371|FG002|Overall Study|Withdrawal by Subject|2|||
126459204|NCT00402233|454981372|FG003|Overall Study|Withdrawal by Subject|2|||
126459205|NCT00402233|454981369|FG000|Overall Study|Worsening of disease under study|2|||
126459206|NCT00402233|454981370|FG001|Overall Study|Worsening of disease under study|0|||
126459207|NCT00402233|454981371|FG002|Overall Study|Worsening of disease under study|0|||
126459208|NCT00402233|454981372|FG003|Overall Study|Worsening of disease under study|0|||
126459209|NCT00402233|454981369|FG000|Overall Study|Worsening of other pre-existing disease|0|||
126459210|NCT00402233|454981370|FG001|Overall Study|Worsening of other pre-existing disease|1|||
126459211|NCT00402233|454981371|FG002|Overall Study|Worsening of other pre-existing disease|0|||
126459212|NCT00402233|454981372|FG003|Overall Study|Worsening of other pre-existing disease|0|||
126293735|NCT01125189|454364776|FG000|Treatment Period|Lack of Efficacy|15|||
126459213|NCT04658940|454981373|FG000|Overall Study|Withdrawal by Subject|1|||
126459214|NCT03579602|454981374|FG000|Overall Study|Subject unable to receive study drug|0|||
126459215|NCT03579602|454981375|FG001|Overall Study|Subject unable to receive study drug|2|||
126459216|NCT03579602|454981374|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
126459217|NCT03579602|454981375|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
126459218|NCT02518464|454981376|FG000|Overall Study|Adverse Event|2|||
126459219|NCT00604214|454981399|FG000|Baseline to Day 28|Death|223|||
126459220|NCT00604214|454981400|FG001|Baseline to Day 28|Death|202|||
126710926|NCT00234104|455893564|FG001|Overall Study|Adverse Event|0|||
126710927|NCT00234104|455893565|FG002|Overall Study|Adverse Event|3|||
126710928|NCT00234104|455893566|FG003|Overall Study|Adverse Event|5|||
126710929|NCT00234104|455893563|FG000|Overall Study|Protocol Violation|0|||
126710930|NCT00234104|455893564|FG001|Overall Study|Protocol Violation|0|||
126710931|NCT00234104|455893565|FG002|Overall Study|Protocol Violation|0|||
126710932|NCT00234104|455893566|FG003|Overall Study|Protocol Violation|1|||
126710933|NCT00234104|455893563|FG000|Overall Study|Physician Decision|0|||
126459221|NCT00604214|454981399|FG000|Baseline to Day 28|Lost to Follow-up|2|||
126459222|NCT00604214|454981400|FG001|Baseline to Day 28|Lost to Follow-up|4|||
126459223|NCT00604214|454981399|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
126459224|NCT00604214|454981400|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
126710934|NCT00234104|455893564|FG001|Overall Study|Physician Decision|1|||
126459225|NCT00604214|454981399|FG000|Day 29 to Day 90|Death|64|||
126459226|NCT00604214|454981400|FG001|Day 29 to Day 90|Death|67|||
126459227|NCT00604214|454981399|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
126459228|NCT00604214|454981400|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
126459229|NCT00604214|454981399|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
126459230|NCT00604214|454981400|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
126459231|NCT00604214|454981399|FG000|Day 91 to Day 180|Death|19|||
126459232|NCT00604214|454981400|FG001|Day 91 to Day 180|Death|23|||
126459233|NCT00604214|454981399|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
126459234|NCT00604214|454981400|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
126459235|NCT00604214|454981399|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
126459236|NCT00604214|454981400|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
126459237|NCT00686998|454981401|FG000|Overall Study|Adverse Event|3|||
126459238|NCT00686998|454981402|FG001|Overall Study|Adverse Event|2|||
126459239|NCT00686998|454981403|FG002|Overall Study|Adverse Event|1|||
126459240|NCT00686998|454981401|FG000|Overall Study|Withdrawal by Subject|2|||
126459241|NCT00686998|454981402|FG001|Overall Study|Withdrawal by Subject|1|||
126459242|NCT00686998|454981403|FG002|Overall Study|Withdrawal by Subject|2|||
126459243|NCT00686998|454981401|FG000|Overall Study|Lack of Efficacy|7|||
126459244|NCT00686998|454981402|FG001|Overall Study|Lack of Efficacy|5|||
126459245|NCT00686998|454981403|FG002|Overall Study|Lack of Efficacy|0|||
126459246|NCT00686998|454981401|FG000|Overall Study|Other|0|||
126459247|NCT00686998|454981402|FG001|Overall Study|Other|0|||
126459248|NCT00686998|454981403|FG002|Overall Study|Other|1|||
126459249|NCT00686998|454981401|FG000|Overall Study|Safety Reasons|1|||
126459250|NCT00686998|454981402|FG001|Overall Study|Safety Reasons|0|||
126459251|NCT00686998|454981403|FG002|Overall Study|Safety Reasons|0|||
126459252|NCT00130442|454982701|FG000|Overall Study|Withdrawal by Subject|0|||
126459253|NCT00130442|454982702|FG001|Overall Study|Withdrawal by Subject|1|||
126459254|NCT00130442|454982701|FG000|Overall Study|did not meet criteria|1|||
126459255|NCT00130442|454982702|FG001|Overall Study|did not meet criteria|1|||
126459256|NCT02233946|454982703|FG000|Baseline|Withdrawal by Subject|2|||
126459257|NCT02233946|454982704|FG001|Baseline|Withdrawal by Subject|0|||
126459258|NCT02233946|454982703|FG000|3-months Follow-up|Lost to Follow-up|53|||
126459259|NCT02233946|454982704|FG001|3-months Follow-up|Lost to Follow-up|29|||
126459260|NCT02233946|454982703|FG000|6-months Follow-up|Lost to Follow-up|21|||
126459261|NCT02233946|454982704|FG001|6-months Follow-up|Lost to Follow-up|2|||
126459262|NCT02233946|454982703|FG000|9-month Follow-up|Lost to Follow-up|20|||
126459263|NCT02233946|454982704|FG001|9-month Follow-up|Lost to Follow-up|11|||
126459264|NCT02233946|454982703|FG000|12-month Follow-up|Lost to Follow-up|28|||
126459265|NCT02233946|454982704|FG001|12-month Follow-up|Lost to Follow-up|11|||
126459266|NCT02054481|454982707|FG000|Overall Study|Adverse Event|1|||
126459267|NCT02054481|454982708|FG001|Overall Study|Adverse Event|1|||
126459268|NCT02054481|454982709|FG002|Overall Study|Adverse Event|0|||
126459269|NCT02054481|454982710|FG003|Overall Study|Adverse Event|1|||
126459270|NCT02054481|454982707|FG000|Overall Study|Lost to Follow-up|1|||
126459271|NCT02054481|454982708|FG001|Overall Study|Lost to Follow-up|0|||
126459272|NCT02054481|454982709|FG002|Overall Study|Lost to Follow-up|0|||
126459273|NCT02054481|454982710|FG003|Overall Study|Lost to Follow-up|0|||
126459274|NCT02054481|454982707|FG000|Overall Study|Other reason|2|||
126459275|NCT02054481|454982708|FG001|Overall Study|Other reason|1|||
126459276|NCT02054481|454982709|FG002|Overall Study|Other reason|2|||
126459277|NCT02054481|454982710|FG003|Overall Study|Other reason|0|||
126459278|NCT02320903|454982711|FG000|Overall Study|Withdrawal by Subject|0|||
126459279|NCT02320903|454982712|FG001|Overall Study|Withdrawal by Subject|9|||
126459280|NCT02320903|454982713|FG002|Overall Study|Withdrawal by Subject|9|||
126459281|NCT02320903|454982711|FG000|Overall Study|Exited therapy; no longer eligible|8|||
126767114|NCT03000075|456100231|FG001|Part A|Adverse Event|0|||
126767115|NCT03000075|456100232|FG002|Part A|Adverse Event|0|||
126767116|NCT03000075|456100233|FG003|Part A|Adverse Event|0|||
126459282|NCT02320903|454982712|FG001|Overall Study|Exited therapy; no longer eligible|2|||
126459283|NCT02320903|454982713|FG002|Overall Study|Exited therapy; no longer eligible|2|||
126459284|NCT02320903|454982711|FG000|Overall Study|Lost to Follow-up|0|||
126459285|NCT02320903|454982712|FG001|Overall Study|Lost to Follow-up|5|||
126459286|NCT02320903|454982713|FG002|Overall Study|Lost to Follow-up|5|||
126459287|NCT00773383|454982714|FG000|Overall Study|Adverse Event|4|||
126459288|NCT00773383|454982714|FG000|Overall Study|Death|1|||
126459289|NCT00773383|454982714|FG000|Overall Study|Progression of Disease|23|||
126459290|NCT00773383|454982714|FG000|Overall Study|Other|2|||
126459291|NCT00773383|454982714|FG000|Overall Study|No study dose received|1|||
126459292|NCT03384693|454982715|FG000|Overall Study|Adverse Event|3|||
126459293|NCT03621475|454982718|FG000|Overall Study|No longer required restraints at initiation|0|||
126459294|NCT03621475|454982719|FG001|Overall Study|No longer required restraints at initiation|1|||
126459295|NCT01095094|454982721|FG000|Overall Study|Withdrawal by Subject|1|||
126459296|NCT01095094|454982721|FG000|Overall Study|Death|1|||
126459297|NCT01095094|454982721|FG000|Overall Study|Physician Decision|1|||
126459298|NCT02093351|454982722|FG000|Part A|Adverse Event|0|||
126459299|NCT02093351|454982723|FG001|Part A|Adverse Event|1|||
126459300|NCT02093351|454982724|FG002|Part A|Adverse Event|1|||
126459301|NCT02093351|454982725|FG003|Part A|Adverse Event|0|||
126459302|NCT02093351|454982722|FG000|Part A|Condition under investigation worsened|2|||
126459303|NCT02093351|454982723|FG001|Part A|Condition under investigation worsened|0|||
126459304|NCT02093351|454982724|FG002|Part A|Condition under investigation worsened|2|||
126459305|NCT02093351|454982725|FG003|Part A|Condition under investigation worsened|0|||
126459306|NCT02093351|454982722|FG000|Part A|Death|0|||
126459307|NCT02093351|454982723|FG001|Part A|Death|1|||
126459308|NCT02093351|454982724|FG002|Part A|Death|0|||
126459309|NCT02093351|454982725|FG003|Part A|Death|0|||
126459310|NCT02093351|454982722|FG000|Part B|Patient decision|0|||
126459311|NCT02093351|454982723|FG001|Part B|Patient decision|0|||
126459312|NCT02093351|454982724|FG002|Part B|Patient decision|0|||
126459313|NCT02093351|454982725|FG003|Part B|Patient decision|3|||
126459314|NCT02093351|454982722|FG000|Part B|Disease progression|0|||
126459315|NCT02093351|454982723|FG001|Part B|Disease progression|0|||
126459316|NCT02093351|454982724|FG002|Part B|Disease progression|0|||
126459317|NCT02093351|454982725|FG003|Part B|Disease progression|4|||
126459318|NCT02093351|454982722|FG000|Part B|Complete response|0|||
126459319|NCT02093351|454982723|FG001|Part B|Complete response|0|||
126459320|NCT02093351|454982724|FG002|Part B|Complete response|0|||
126459321|NCT02093351|454982725|FG003|Part B|Complete response|1|||
126459322|NCT02093351|454982722|FG000|Part B|Adverse event + disease progression|0|||
126459323|NCT02093351|454982723|FG001|Part B|Adverse event + disease progression|0|||
126459324|NCT02093351|454982724|FG002|Part B|Adverse event + disease progression|0|||
126459325|NCT02093351|454982725|FG003|Part B|Adverse event + disease progression|1|||
126459326|NCT02093351|454982722|FG000|Part B|Lack of therapeutic response|0|||
126459327|NCT02093351|454982723|FG001|Part B|Lack of therapeutic response|0|||
126459328|NCT02093351|454982724|FG002|Part B|Lack of therapeutic response|0|||
126459329|NCT02093351|454982725|FG003|Part B|Lack of therapeutic response|12|||
126459330|NCT02093351|454982722|FG000|Part B|Condition under investigation worsened|0|||
126459331|NCT02093351|454982723|FG001|Part B|Condition under investigation worsened|0|||
126459332|NCT02093351|454982724|FG002|Part B|Condition under investigation worsened|0|||
126459333|NCT02093351|454982725|FG003|Part B|Condition under investigation worsened|39|||
126459334|NCT02093351|454982722|FG000|Part B|Adverse Event|0|||
126459335|NCT02093351|454982723|FG001|Part B|Adverse Event|0|||
126710935|NCT00234104|455893565|FG002|Overall Study|Physician Decision|2|||
126710936|NCT00234104|455893566|FG003|Overall Study|Physician Decision|2|||
126459336|NCT02093351|454982724|FG002|Part B|Adverse Event|0|||
126459337|NCT02093351|454982725|FG003|Part B|Adverse Event|2|||
126459338|NCT02093351|454982722|FG000|Part B|Death|0|||
126459339|NCT02093351|454982723|FG001|Part B|Death|0|||
126459340|NCT02093351|454982724|FG002|Part B|Death|0|||
126459341|NCT02093351|454982725|FG003|Part B|Death|1|||
126459342|NCT01099709|454982726|FG000|Period 1|Withdrawal by Subject|0|||
126459343|NCT01099709|454982727|FG001|Period 1|Withdrawal by Subject|1|||
126459344|NCT01099709|454982726|FG000|Period 1|Positive cotinine test|0|||
126459345|NCT01099709|454982727|FG001|Period 1|Positive cotinine test|1|||
126459346|NCT01099709|454982726|FG000|Period 1|Adverse Event|1|||
126459347|NCT01099709|454982727|FG001|Period 1|Adverse Event|0|||
126459348|NCT00039871|454982731|FG000|Overall Study|Adverse Event|165|||
126459349|NCT00039871|454982731|FG000|Overall Study|Lost to Follow-up|18|||
126459350|NCT00039871|454982731|FG000|Overall Study|Protocol Violation|24|||
126459351|NCT00039871|454982731|FG000|Overall Study|Withdrawal by Subject|97|||
126459352|NCT00039871|454982731|FG000|Overall Study|Did not meet eligibility criteria|11|||
126459353|NCT00039871|454982731|FG000|Overall Study|Administrative|1|||
126459354|NCT00039871|454982731|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
126459355|NCT00039871|454982731|FG000|Overall Study|Never entered follow-up|7|||
126459356|NCT01736657|454982736|FG000|Overall Study|insufficient vascular access|1|||
126459357|NCT01249118|454982749|FG000|First Washout Period|Physician Decision|0|||
126459358|NCT01249118|454982750|FG001|First Washout Period|Physician Decision|1|||
126459359|NCT01249118|454982751|FG002|First Washout Period|Physician Decision|0|||
126459360|NCT00880685|454982752|FG000|Memantine 10mg|Lost to Follow-up|2|||
126710937|NCT01716169|455893568|FG000|Overall Study|Adverse Event|1|||
126459361|NCT00880685|454982752|FG000|Memantine 20mg|Withdrawal by Subject|1|||
126459362|NCT00997438|454982753|FG000|Overall Study|Blood draw difficulty|2|||
126710938|NCT01716169|455893568|FG000|Overall Study|Lost to Follow-up|1|||
126459363|NCT00997438|454982754|FG001|Overall Study|Blood draw difficulty|0|||
126459364|NCT00997438|454982755|FG002|Overall Study|Blood draw difficulty|1|||
126459365|NCT00997438|454982753|FG000|Overall Study|Withdrawal by Subject|1|||
126459366|NCT00997438|454982754|FG001|Overall Study|Withdrawal by Subject|1|||
126459367|NCT00997438|454982755|FG002|Overall Study|Withdrawal by Subject|0|||
126459368|NCT00997438|454982753|FG000|Overall Study|Exclusion criteria at visit 1|2|||
126459369|NCT00997438|454982754|FG001|Overall Study|Exclusion criteria at visit 1|2|||
126459370|NCT00997438|454982755|FG002|Overall Study|Exclusion criteria at visit 1|3|||
126459371|NCT01236118|454982756|FG000|Overall Study|Adverse Event|2|||
126459372|NCT01236118|454982757|FG001|Overall Study|Adverse Event|0|||
126459373|NCT01236118|454982758|FG002|Overall Study|Adverse Event|2|||
126549943|NCT01193582|455307649|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
126459374|NCT01236118|454982756|FG000|Overall Study|Physician Decision|0|||
126459375|NCT01236118|454982757|FG001|Overall Study|Physician Decision|1|||
126459376|NCT01236118|454982758|FG002|Overall Study|Physician Decision|0|||
126459377|NCT01236118|454982756|FG000|Overall Study|Withdrawal by Subject|0|||
126459378|NCT01236118|454982757|FG001|Overall Study|Withdrawal by Subject|0|||
126459379|NCT01236118|454982758|FG002|Overall Study|Withdrawal by Subject|1|||
126459380|NCT00095238|454982759|FG000|Overall Study|Lack of Efficacy|9|||
126459381|NCT00095238|454982760|FG001|Overall Study|Lack of Efficacy|9|||
126459382|NCT00095238|454982759|FG000|Overall Study|Adverse Event|331|||
126459383|NCT00095238|454982760|FG001|Overall Study|Adverse Event|287|||
126459384|NCT00095238|454982759|FG000|Overall Study|Subject Withdrew Consent|208|||
126459385|NCT00095238|454982760|FG001|Overall Study|Subject Withdrew Consent|223|||
126459386|NCT00095238|454982759|FG000|Overall Study|Death|154|||
126459387|NCT00095238|454982760|FG001|Overall Study|Death|170|||
126459388|NCT00095238|454982759|FG000|Overall Study|Lost to Follow-up|19|||
126459389|NCT00095238|454982760|FG001|Overall Study|Lost to Follow-up|24|||
126459390|NCT00095238|454982759|FG000|Overall Study|Noncompliance|44|||
126459391|NCT00095238|454982760|FG001|Overall Study|Noncompliance|45|||
126459392|NCT00095238|454982759|FG000|Overall Study|No longer met study criteria|4|||
126459393|NCT00095238|454982760|FG001|Overall Study|No longer met study criteria|5|||
126459394|NCT00095238|454982759|FG000|Overall Study|Study terminated by sponsor|0|||
126459395|NCT00095238|454982760|FG001|Overall Study|Study terminated by sponsor|1|||
126459396|NCT00095238|454982759|FG000|Overall Study|Missing|1|||
126459397|NCT00095238|454982760|FG001|Overall Study|Missing|0|||
126459398|NCT00095238|454982759|FG000|Overall Study|Other Reasons|87|||
126459399|NCT00095238|454982760|FG001|Overall Study|Other Reasons|88|||
126459400|NCT04535167|454982763|FG000|Treatment|Adverse Event|0|||
126459401|NCT04535167|454982764|FG001|Treatment|Adverse Event|0|||
126459402|NCT04535167|454982765|FG002|Treatment|Adverse Event|0|||
126459403|NCT04535167|454982766|FG003|Treatment|Adverse Event|0|||
126459404|NCT04535167|454982767|FG004|Treatment|Adverse Event|0|||
126459405|NCT04535167|454982768|FG005|Treatment|Adverse Event|0|||
126459406|NCT04535167|454982769|FG006|Treatment|Adverse Event|1|||
126459407|NCT04535167|454982763|FG000|Follow-Up|Death|0|||
126459408|NCT04535167|454982764|FG001|Follow-Up|Death|0|||
126459409|NCT04535167|454982765|FG002|Follow-Up|Death|0|||
126459410|NCT04535167|454982766|FG003|Follow-Up|Death|0|||
126459411|NCT04535167|454982767|FG004|Follow-Up|Death|0|||
126459412|NCT04535167|454982768|FG005|Follow-Up|Death|0|||
126459413|NCT04535167|454982769|FG006|Follow-Up|Death|1|||
126293736|NCT01125189|454364777|FG001|Treatment Period|Lack of Efficacy|18|||
126293737|NCT01125189|454364778|FG002|Treatment Period|Lack of Efficacy|25|||
126293738|NCT01125189|454364776|FG000|Treatment Period|Adverse Event|7|||
126459414|NCT04535167|454982763|FG000|Follow-Up|Lost to Follow-up|0|||
126459415|NCT04535167|454982764|FG001|Follow-Up|Lost to Follow-up|0|||
126459416|NCT04535167|454982765|FG002|Follow-Up|Lost to Follow-up|0|||
126459417|NCT04535167|454982766|FG003|Follow-Up|Lost to Follow-up|1|||
126459418|NCT04535167|454982767|FG004|Follow-Up|Lost to Follow-up|0|||
126459419|NCT04535167|454982768|FG005|Follow-Up|Lost to Follow-up|0|||
126459420|NCT04535167|454982769|FG006|Follow-Up|Lost to Follow-up|0|||
126459421|NCT00075270|454982770|FG000|Overall Study|Withdrawal by Subject|28|||
126459422|NCT00075270|454982771|FG001|Overall Study|Withdrawal by Subject|21|||
126459423|NCT00075270|454982770|FG000|Overall Study|Lost to Follow-up|25|||
126459424|NCT00075270|454982771|FG001|Overall Study|Lost to Follow-up|28|||
126459425|NCT00075270|454982770|FG000|Overall Study|Protocol Violation|0|||
126459426|NCT00075270|454982771|FG001|Overall Study|Protocol Violation|2|||
126459427|NCT00075270|454982770|FG000|Overall Study|Death|198|||
126459428|NCT00075270|454982771|FG001|Overall Study|Death|215|||
126459429|NCT00075270|454982770|FG000|Overall Study|Other/Unknown|9|||
126459430|NCT00075270|454982771|FG001|Overall Study|Other/Unknown|5|||
126459431|NCT00075270|454982770|FG000|Overall Study|Missing|26|||
126459432|NCT00075270|454982771|FG001|Overall Study|Missing|13|||
126459433|NCT04656275|454982773|FG000|Overall Study|Study terminated by sponsor|2|||
126459434|NCT04656275|454982774|FG001|Overall Study|Study terminated by sponsor|4|||
126459435|NCT02361580|454982779|FG000|Overall Study|Lost to Follow-up|6|||
126459436|NCT02361580|454982780|FG001|Overall Study|Lost to Follow-up|3|||
126459437|NCT00708201|454982781|FG000|Overall Study|Adverse Event|4|||
126459438|NCT00708201|454982782|FG001|Overall Study|Adverse Event|4|||
126459439|NCT00708201|454982781|FG000|Overall Study|Withdrawal by Subject|1|||
126459440|NCT00708201|454982782|FG001|Overall Study|Withdrawal by Subject|1|||
126459441|NCT00708201|454982781|FG000|Overall Study|Lost to Follow-up|2|||
126459442|NCT00708201|454982782|FG001|Overall Study|Lost to Follow-up|0|||
126459443|NCT00708201|454982781|FG000|Overall Study|Protocol Violation|0|||
126459444|NCT00708201|454982782|FG001|Overall Study|Protocol Violation|1|||
126767117|NCT03000075|456100234|FG004|Part A|Adverse Event|0|||
126459445|NCT03828370|454982783|FG000|3 Month Follow-up|Lost to Follow-up|4|||
126459446|NCT03828370|454982784|FG001|3 Month Follow-up|Lost to Follow-up|12|||
126459447|NCT03828370|454982783|FG000|9 Month Follow up|Lost to Follow-up|12|||
126459448|NCT03828370|454982784|FG001|9 Month Follow up|Lost to Follow-up|20|||
126459449|NCT03490981|454982785|FG000|Overall Study|Lost to Follow-up|1|||
126459450|NCT03490981|454982786|FG001|Overall Study|Lost to Follow-up|2|||
126459451|NCT00282464|454982787|FG000|Overall Study|Adverse Event|26|||
126293739|NCT01125189|454364777|FG001|Treatment Period|Adverse Event|8|||
126549944|NCT01193582|455307650|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
126549945|NCT01193582|455307651|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
126549946|NCT03632434|455307664|FG000|Overall Study|Withdrawal by Subject|2|||
126549947|NCT01751113|455307665|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
126549948|NCT01751113|455307666|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
126549949|NCT01751113|455307667|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
126549950|NCT01751113|455307668|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
126549951|NCT01751113|455307669|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
126549952|NCT01751113|455307670|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
126366494|NCT00500331|454636997|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
126366495|NCT00500331|454636998|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
126366496|NCT00500331|454636992|FG000|Overall Study|Participant was randomized by mistake|1|||
126366497|NCT00500331|454636993|FG001|Overall Study|Participant was randomized by mistake|0|||
126549953|NCT01751113|455307665|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
126549954|NCT01751113|455307666|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
126549955|NCT01751113|455307667|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
126549956|NCT01751113|455307668|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
126549957|NCT01751113|455307669|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
126549958|NCT01751113|455307670|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
126549959|NCT01775930|455307671|FG000|Overall Study|Futility stopping boundary met|1|||
126549960|NCT01551303|455307673|FG000|Overall Study|failed awareness check on vision test|4|||
126549961|NCT01551303|455307674|FG001|Overall Study|failed awareness check on vision test|7|||
126549962|NCT00363896|455307675|FG000|Overall Study|Withdrawal by Subject|29|||
126549963|NCT00363896|455307676|FG001|Overall Study|Withdrawal by Subject|16|||
126549964|NCT00363896|455307675|FG000|Overall Study|Adverse Event|24|||
126549965|NCT00363896|455307676|FG001|Overall Study|Adverse Event|13|||
126549966|NCT00363896|455307675|FG000|Overall Study|COPD exacerbation|13|||
126549967|NCT00363896|455307676|FG001|Overall Study|COPD exacerbation|7|||
126549968|NCT00363896|455307675|FG000|Overall Study|Lack of Efficacy|12|||
126549969|NCT00363896|455307676|FG001|Overall Study|Lack of Efficacy|8|||
126549970|NCT00363896|455307675|FG000|Overall Study|Protocol Violation|6|||
126549971|NCT00363896|455307676|FG001|Overall Study|Protocol Violation|1|||
126549972|NCT00363896|455307675|FG000|Overall Study|Lost to Follow-up|3|||
126549973|NCT00363896|455307676|FG001|Overall Study|Lost to Follow-up|0|||
126549974|NCT00363896|455307675|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
126549975|NCT00363896|455307676|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
126549976|NCT00363896|455307675|FG000|Overall Study|Other|1|||
126549977|NCT00363896|455307676|FG001|Overall Study|Other|2|||
126549978|NCT03044353|455307681|FG000|Overall Study|Adverse Event|0|||
126549979|NCT03044353|455307682|FG001|Overall Study|Adverse Event|1|||
126549980|NCT03044353|455307683|FG002|Overall Study|Adverse Event|0|||
126549981|NCT02141659|455307696|FG000|Overall Study|Major Protocol Deviation|0|||
126549982|NCT02141659|455307697|FG001|Overall Study|Major Protocol Deviation|1|||
126549983|NCT02141659|455307698|FG002|Overall Study|Major Protocol Deviation|0|||
126549984|NCT02141659|455307699|FG003|Overall Study|Major Protocol Deviation|0|||
126549985|NCT02141659|455307700|FG004|Overall Study|Major Protocol Deviation|0|||
126549986|NCT02141659|455307701|FG005|Overall Study|Major Protocol Deviation|0|||
126549987|NCT02141659|455307696|FG000|Overall Study|Lack of Efficacy|0|||
126549988|NCT02141659|455307697|FG001|Overall Study|Lack of Efficacy|0|||
126549989|NCT02141659|455307698|FG002|Overall Study|Lack of Efficacy|0|||
126549990|NCT02141659|455307699|FG003|Overall Study|Lack of Efficacy|0|||
126710939|NCT01716169|455893568|FG000|Overall Study|Withdrawal by Subject|1|||
126710940|NCT01716169|455893568|FG000|Overall Study|inconsistent dressing application|1|||
126710941|NCT01088412|455893569|FG000|Overall Study|Adverse Event|38|||
126366498|NCT00500331|454636994|FG002|Overall Study|Participant was randomized by mistake|0|||
126366499|NCT00500331|454636995|FG003|Overall Study|Participant was randomized by mistake|0|||
126366500|NCT00500331|454636996|FG004|Overall Study|Participant was randomized by mistake|0|||
126366501|NCT00500331|454636997|FG005|Overall Study|Participant was randomized by mistake|0|||
126366502|NCT00500331|454636998|FG006|Overall Study|Participant was randomized by mistake|0|||
126366503|NCT00500331|454636992|FG000|Overall Study|Diabetologist nurse in the study|0|||
126366504|NCT00500331|454636993|FG001|Overall Study|Diabetologist nurse in the study|0|||
126366505|NCT00500331|454636994|FG002|Overall Study|Diabetologist nurse in the study|1|||
126366506|NCT00500331|454636995|FG003|Overall Study|Diabetologist nurse in the study|0|||
126366507|NCT00500331|454636996|FG004|Overall Study|Diabetologist nurse in the study|0|||
126366508|NCT00500331|454636997|FG005|Overall Study|Diabetologist nurse in the study|0|||
126366509|NCT00500331|454636998|FG006|Overall Study|Diabetologist nurse in the study|0|||
126366510|NCT00500331|454636992|FG000|Overall Study|State ban of biological samples export|0|||
126366511|NCT00500331|454636993|FG001|Overall Study|State ban of biological samples export|0|||
126366512|NCT00500331|454636994|FG002|Overall Study|State ban of biological samples export|0|||
126549991|NCT02141659|455307700|FG004|Overall Study|Lack of Efficacy|0|||
126549992|NCT02141659|455307701|FG005|Overall Study|Lack of Efficacy|1|||
126549993|NCT02141659|455307696|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
126710942|NCT01088412|455893570|FG001|Overall Study|Adverse Event|0|||
126459452|NCT00282464|454982788|FG001|Overall Study|Adverse Event|20|||
126459453|NCT00282464|454982787|FG000|Overall Study|Lack of Efficacy|8|||
126459454|NCT00282464|454982788|FG001|Overall Study|Lack of Efficacy|8|||
126459455|NCT00282464|454982787|FG000|Overall Study|Lost to Follow-up|10|||
126459456|NCT00282464|454982788|FG001|Overall Study|Lost to Follow-up|10|||
126459457|NCT00282464|454982787|FG000|Overall Study|Withdrawal by Subject|24|||
126459458|NCT00282464|454982788|FG001|Overall Study|Withdrawal by Subject|10|||
126459459|NCT00282464|454982787|FG000|Overall Study|laboratory abnormality|1|||
126459460|NCT00282464|454982788|FG001|Overall Study|laboratory abnormality|2|||
126459461|NCT00282464|454982787|FG000|Overall Study|Protocol Violation|0|||
126459462|NCT00282464|454982788|FG001|Overall Study|Protocol Violation|7|||
126459463|NCT00282464|454982787|FG000|Overall Study|Patient moved|1|||
126459464|NCT00282464|454982788|FG001|Overall Study|Patient moved|0|||
126459465|NCT00282464|454982787|FG000|Overall Study|patient non-compliant|3|||
126459466|NCT00282464|454982788|FG001|Overall Study|patient non-compliant|0|||
126459467|NCT00282464|454982787|FG000|Overall Study|patient no show|0|||
126459468|NCT00282464|454982788|FG001|Overall Study|patient no show|1|||
126459469|NCT00282464|454982787|FG000|Overall Study|patient incarcerated|0|||
126459470|NCT00282464|454982788|FG001|Overall Study|patient incarcerated|1|||
126459471|NCT00282464|454982787|FG000|Overall Study|family crisis|0|||
126459472|NCT00282464|454982788|FG001|Overall Study|family crisis|1|||
126459473|NCT00282464|454982787|FG000|Overall Study|dispensed wrong kit|0|||
126459474|NCT00282464|454982788|FG001|Overall Study|dispensed wrong kit|1|||
126459475|NCT00282464|454982787|FG000|Overall Study|dropped due to missed visits|0|||
126459476|NCT00282464|454982788|FG001|Overall Study|dropped due to missed visits|1|||
126459477|NCT00723203|454982789|FG000|Overall Study|Withdrawal by Subject|3|||
126459478|NCT01721577|454982790|FG000|Overall Study|Lack of Efficacy|1|||
126459479|NCT01721577|454982791|FG001|Overall Study|Lack of Efficacy|0|||
126459480|NCT01721577|454982790|FG000|Overall Study|Death|1|||
126459481|NCT01721577|454982791|FG001|Overall Study|Death|0|||
126459482|NCT01721577|454982790|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
126459483|NCT01721577|454982791|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
126710943|NCT01088412|455893571|FG002|Overall Study|Adverse Event|0|||
126710944|NCT01088412|455893569|FG000|Overall Study|Death|42|||
126459484|NCT01721577|454982790|FG000|Overall Study|Adverse Event|0|||
126459485|NCT01721577|454982791|FG001|Overall Study|Adverse Event|2|||
126459486|NCT04672252|454982798|FG000|Overall Study|Protocol Violation|1|||
126459487|NCT04672252|454982799|FG001|Overall Study|Protocol Violation|0|||
126459488|NCT04391569|454982800|FG000|Overall Study|Death|15|||
126459489|NCT04391569|454982801|FG001|Overall Study|Death|10|||
126459490|NCT04391569|454982800|FG000|Overall Study|Withdrawal by Subject|1|||
126459491|NCT04391569|454982801|FG001|Overall Study|Withdrawal by Subject|0|||
126459492|NCT04391569|454982800|FG000|Overall Study|Lost to Follow-up|3|||
126459493|NCT04391569|454982801|FG001|Overall Study|Lost to Follow-up|2|||
126459494|NCT04391569|454982800|FG000|Overall Study|Lack of Efficacy|0|||
126459495|NCT04391569|454982801|FG001|Overall Study|Lack of Efficacy|1|||
126459496|NCT04391569|454982800|FG000|Overall Study|Participant discharged to hospice facility|0|||
126459497|NCT04391569|454982801|FG001|Overall Study|Participant discharged to hospice facility|1|||
126459498|NCT04391569|454982800|FG000|Overall Study|Participant family decision|1|||
126459499|NCT04391569|454982801|FG001|Overall Study|Participant family decision|0|||
126459500|NCT04391569|454982800|FG000|Overall Study|Participant discharged prematurely|1|||
126459501|NCT04391569|454982801|FG001|Overall Study|Participant discharged prematurely|0|||
126459502|NCT03025035|454982802|FG000|Overall Study|Death|2|||
126459503|NCT03025035|454982802|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
126459504|NCT01431638|454982803|FG000|Overall Study|Adverse Event|1|||
126459505|NCT01431638|454982804|FG001|Overall Study|Adverse Event|3|||
126459506|NCT01431638|454982805|FG002|Overall Study|Adverse Event|1|||
126459507|NCT01431638|454982803|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126459508|NCT01431638|454982804|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126459509|NCT01431638|454982805|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
126459510|NCT01431638|454982803|FG000|Overall Study|Participants condition no longer requires study drug|0|||
126459511|NCT01431638|454982804|FG001|Overall Study|Participants condition no longer requires study drug|1|||
126459512|NCT01431638|454982805|FG002|Overall Study|Participants condition no longer requires study drug|0|||
126459513|NCT01431638|454982803|FG000|Overall Study|Participant withdrew consent|14|||
126710945|NCT01088412|455893570|FG001|Overall Study|Death|6|||
126710946|NCT01088412|455893571|FG002|Overall Study|Death|0|||
126710947|NCT01088412|455893569|FG000|Overall Study|Other Reason per Case Report Form|2089|||
126710948|NCT01088412|455893570|FG001|Overall Study|Other Reason per Case Report Form|103|||
126459514|NCT01431638|454982804|FG001|Overall Study|Participant withdrew consent|5|||
126459515|NCT01431638|454982805|FG002|Overall Study|Participant withdrew consent|8|||
126459516|NCT01431638|454982803|FG000|Overall Study|Lost to Follow-up|7|||
126459517|NCT01431638|454982804|FG001|Overall Study|Lost to Follow-up|9|||
126459518|NCT01431638|454982805|FG002|Overall Study|Lost to Follow-up|7|||
126459519|NCT01431638|454982803|FG000|Overall Study|Administrative problems|1|||
126459520|NCT01431638|454982804|FG001|Overall Study|Administrative problems|4|||
126710949|NCT01088412|455893571|FG002|Overall Study|Other Reason per Case Report Form|9|||
126459521|NCT01431638|454982805|FG002|Overall Study|Administrative problems|6|||
126459522|NCT01431638|454982803|FG000|Overall Study|Death|1|||
126459523|NCT01431638|454982804|FG001|Overall Study|Death|0|||
126459524|NCT01431638|454982805|FG002|Overall Study|Death|0|||
126459525|NCT01431638|454982803|FG000|Overall Study|Protocol deviation|1|||
126459526|NCT01431638|454982804|FG001|Overall Study|Protocol deviation|1|||
126459527|NCT01431638|454982805|FG002|Overall Study|Protocol deviation|4|||
126459528|NCT01431638|454982803|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
126459529|NCT01431638|454982804|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
126459530|NCT01431638|454982805|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
126459531|NCT00773838|454982806|FG000|Overall Study|Adverse Event|29|||
126459532|NCT00773838|454982806|FG000|Overall Study|Lost to Follow-up|1|||
126459533|NCT00773838|454982806|FG000|Overall Study|Physician Decision|8|||
126459534|NCT00773838|454982806|FG000|Overall Study|Progressive Disease|82|||
126459535|NCT00773838|454982806|FG000|Overall Study|Protocol Violation|2|||
126459536|NCT00773838|454982806|FG000|Overall Study|Withdrawal by Subject|21|||
126459537|NCT03562767|454982809|FG000|Overall Study|Physician Decision|2|||
126459538|NCT03562767|454982810|FG001|Overall Study|Physician Decision|0|||
126459539|NCT03562767|454982811|FG002|Overall Study|Physician Decision|0|||
126459540|NCT03562767|454982809|FG000|Overall Study|Logistic Reason|1|||
126459541|NCT03562767|454982810|FG001|Overall Study|Logistic Reason|3|||
126459542|NCT03562767|454982811|FG002|Overall Study|Logistic Reason|0|||
126459543|NCT01658813|454982812|FG000|Overall Study|Disease progression|3|||
126459544|NCT00938886|454982813|FG000|Overall Study|Death|0|||
126459545|NCT00938886|454982814|FG001|Overall Study|Death|1|||
126459546|NCT00938886|454982813|FG000|Overall Study|Withdrawal by Subject|4|||
126459547|NCT00938886|454982814|FG001|Overall Study|Withdrawal by Subject|7|||
126459548|NCT00938886|454982813|FG000|Overall Study|Lost to Follow-up|3|||
126459549|NCT00938886|454982814|FG001|Overall Study|Lost to Follow-up|2|||
126459550|NCT02674854|454982815|FG000|Overall Study|Adverse Event|17|||
126459551|NCT02674854|454982816|FG001|Overall Study|Adverse Event|15|||
126459552|NCT02674854|454982817|FG002|Overall Study|Adverse Event|5|||
126459553|NCT02674854|454982815|FG000|Overall Study|Withdrawal by Subject|1|||
126459554|NCT02674854|454982816|FG001|Overall Study|Withdrawal by Subject|5|||
126459555|NCT02674854|454982817|FG002|Overall Study|Withdrawal by Subject|4|||
126459556|NCT02674854|454982815|FG000|Overall Study|No-compliant subject|1|||
126459557|NCT02674854|454982816|FG001|Overall Study|No-compliant subject|0|||
126459558|NCT02674854|454982817|FG002|Overall Study|No-compliant subject|1|||
126459559|NCT02674854|454982815|FG000|Overall Study|Lost to Follow-up|1|||
126459560|NCT02674854|454982816|FG001|Overall Study|Lost to Follow-up|0|||
126459561|NCT02674854|454982817|FG002|Overall Study|Lost to Follow-up|2|||
126459562|NCT02674854|454982815|FG000|Overall Study|Lack of Efficacy|0|||
126459563|NCT02674854|454982816|FG001|Overall Study|Lack of Efficacy|3|||
126459564|NCT02674854|454982817|FG002|Overall Study|Lack of Efficacy|0|||
126459565|NCT02674854|454982815|FG000|Overall Study|Disallowed Concurrent Medication|2|||
126459566|NCT02674854|454982816|FG001|Overall Study|Disallowed Concurrent Medication|2|||
126459567|NCT02674854|454982817|FG002|Overall Study|Disallowed Concurrent Medication|0|||
126459568|NCT02674854|454982815|FG000|Overall Study|Protocol Violation|1|||
126459569|NCT02674854|454982816|FG001|Overall Study|Protocol Violation|1|||
126459570|NCT02674854|454982817|FG002|Overall Study|Protocol Violation|2|||
126459571|NCT02674854|454982815|FG000|Overall Study|Death|0|||
126459572|NCT02674854|454982816|FG001|Overall Study|Death|1|||
126459573|NCT02674854|454982817|FG002|Overall Study|Death|0|||
126459574|NCT02674854|454982815|FG000|Overall Study|Subject missed V6.2|1|||
126459575|NCT02674854|454982816|FG001|Overall Study|Subject missed V6.2|0|||
126459576|NCT02674854|454982817|FG002|Overall Study|Subject missed V6.2|0|||
126710950|NCT01088412|455893569|FG000|Overall Study|Withdrawal by Subject|1761|||
126710951|NCT01088412|455893570|FG001|Overall Study|Withdrawal by Subject|25|||
126710952|NCT01088412|455893571|FG002|Overall Study|Withdrawal by Subject|1|||
126710953|NCT01088412|455893569|FG000|Overall Study|Received Another GH Product|79|||
126710954|NCT01088412|455893570|FG001|Overall Study|Received Another GH Product|0|||
126459577|NCT00913692|454982818|FG000|Screening (4 Months)|Physician Decision|3|||
126710955|NCT01088412|455893571|FG002|Overall Study|Received Another GH Product|0|||
126710956|NCT01088412|455893569|FG000|Overall Study|Participant Moved|601|||
126459578|NCT00913692|454982818|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
126459579|NCT00913692|454982818|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
126459580|NCT04231981|454982819|FG000|Overall Study|Adverse Event|1|||
126459581|NCT04231981|454982819|FG000|Overall Study|Death|16|||
126459582|NCT04231981|454982819|FG000|Overall Study|Lost to Follow-up|1|||
126459583|NCT02889562|454982820|FG000|Overall Study|Physician Decision|0|||
126459584|NCT02889562|454982821|FG001|Overall Study|Physician Decision|1|||
126459585|NCT02889562|454982820|FG000|Overall Study|Withdrawal by Subject|0|||
126459586|NCT02889562|454982821|FG001|Overall Study|Withdrawal by Subject|1|||
126459587|NCT01470989|454982824|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
126459588|NCT01470989|454982825|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
126459589|NCT01470989|454982824|FG000|Overall Study|Adverse Event|2|||
126459590|NCT01470989|454982825|FG001|Overall Study|Adverse Event|5|||
126710957|NCT01088412|455893570|FG001|Overall Study|Participant Moved|21|||
126293740|NCT01125189|454364778|FG002|Treatment Period|Adverse Event|8|||
126293741|NCT01125189|454364776|FG000|Treatment Period|Withdrawal by Subject|3|||
126293742|NCT01125189|454364777|FG001|Treatment Period|Withdrawal by Subject|1|||
126293743|NCT01125189|454364778|FG002|Treatment Period|Withdrawal by Subject|1|||
126293744|NCT01125189|454364776|FG000|Treatment Period|Death|1|||
126293745|NCT01125189|454364777|FG001|Treatment Period|Death|0|||
126293746|NCT01125189|454364778|FG002|Treatment Period|Death|0|||
126293747|NCT01125189|454364776|FG000|Treatment Period|Lost to Follow-up|1|||
126293748|NCT01125189|454364777|FG001|Treatment Period|Lost to Follow-up|2|||
126293749|NCT01125189|454364778|FG002|Treatment Period|Lost to Follow-up|1|||
126293750|NCT01125189|454364776|FG000|Treatment Period|Poor compliance/noncompliance|0|||
126293751|NCT01125189|454364777|FG001|Treatment Period|Poor compliance/noncompliance|1|||
126293752|NCT01125189|454364778|FG002|Treatment Period|Poor compliance/noncompliance|0|||
126293753|NCT01125189|454364776|FG000|Treatment Period|Participants requested to discontinue|1|||
126293754|NCT01125189|454364777|FG001|Treatment Period|Participants requested to discontinue|3|||
126293755|NCT01125189|454364778|FG002|Treatment Period|Participants requested to discontinue|4|||
126293756|NCT01125189|454364776|FG000|Treatment Period|Other reasons|1|||
126293757|NCT01125189|454364777|FG001|Treatment Period|Other reasons|1|||
126293758|NCT01125189|454364778|FG002|Treatment Period|Other reasons|0|||
126293759|NCT01125189|454364776|FG000|Treatment Period|Completed 24 week treatment period only|2|||
126293760|NCT01125189|454364777|FG001|Treatment Period|Completed 24 week treatment period only|1|||
126293761|NCT01125189|454364778|FG002|Treatment Period|Completed 24 week treatment period only|2|||
126293762|NCT01125189|454364776|FG000|Follow up Period|Withdrawal by Subject|3|||
126293763|NCT01125189|454364777|FG001|Follow up Period|Withdrawal by Subject|2|||
126293764|NCT01125189|454364778|FG002|Follow up Period|Withdrawal by Subject|5|||
126293765|NCT01125189|454364776|FG000|Follow up Period|Death|1|||
126293766|NCT01125189|454364777|FG001|Follow up Period|Death|0|||
126366513|NCT00500331|454636995|FG003|Overall Study|State ban of biological samples export|1|||
126366514|NCT00500331|454636996|FG004|Overall Study|State ban of biological samples export|0|||
126366515|NCT00500331|454636997|FG005|Overall Study|State ban of biological samples export|0|||
126366516|NCT00500331|454636998|FG006|Overall Study|State ban of biological samples export|0|||
126366517|NCT00500331|454636992|FG000|Overall Study|Protocol violated|0|||
126366518|NCT00500331|454636993|FG001|Overall Study|Protocol violated|0|||
126366519|NCT00500331|454636994|FG002|Overall Study|Protocol violated|0|||
126366520|NCT00500331|454636995|FG003|Overall Study|Protocol violated|1|||
126366521|NCT00500331|454636996|FG004|Overall Study|Protocol violated|0|||
126366522|NCT00500331|454636997|FG005|Overall Study|Protocol violated|0|||
126366523|NCT00500331|454636998|FG006|Overall Study|Protocol violated|0|||
126366524|NCT03436732|454636999|FG000|Overall Study|Not treated-enrolled in different study|1|||
126366525|NCT03436732|454637000|FG001|Overall Study|Not treated-enrolled in different study|0|||
126366526|NCT03436732|454636999|FG000|Overall Study|Off study after cycle 1|1|||
126366527|NCT03436732|454637000|FG001|Overall Study|Off study after cycle 1|0|||
126366528|NCT03436732|454636999|FG000|Overall Study|Adverse Event|2|||
126366529|NCT03436732|454637000|FG001|Overall Study|Adverse Event|0|||
126366530|NCT03436732|454636999|FG000|Overall Study|Death|0|||
126366531|NCT03436732|454637000|FG001|Overall Study|Death|1|||
126366532|NCT03345550|454637001|FG000|Overall Study|Withdrawal by Subject|1|||
126366533|NCT03345550|454637002|FG001|Overall Study|Withdrawal by Subject|0|||
126366534|NCT03345550|454637001|FG000|Overall Study|Lost to Follow-up|4|||
126366535|NCT03345550|454637002|FG001|Overall Study|Lost to Follow-up|5|||
126366536|NCT05538728|454637003|FG000|Overall Study|Withdrawal by Subject|1|||
126366537|NCT05538728|454637004|FG001|Overall Study|Withdrawal by Subject|1|||
126366538|NCT00959049|454637005|FG000|Overall Study|Adverse Event|1|||
126366539|NCT00959049|454637006|FG001|Overall Study|Adverse Event|0|||
126366540|NCT00959049|454637007|FG002|Overall Study|Adverse Event|0|||
126366541|NCT00959049|454637008|FG003|Overall Study|Adverse Event|0|||
126366542|NCT00959049|454637009|FG004|Overall Study|Adverse Event|0|||
126366543|NCT00959049|454637010|FG005|Overall Study|Adverse Event|0|||
126366544|NCT00959049|454637005|FG000|Overall Study|Lost to Follow-up|17|||
126366545|NCT00959049|454637006|FG001|Overall Study|Lost to Follow-up|5|||
126366546|NCT00959049|454637007|FG002|Overall Study|Lost to Follow-up|1|||
126366547|NCT00959049|454637008|FG003|Overall Study|Lost to Follow-up|10|||
126293767|NCT01125189|454364778|FG002|Follow up Period|Death|0|||
126293768|NCT01125189|454364776|FG000|Follow up Period|Lost to Follow-up|12|||
126293769|NCT01125189|454364777|FG001|Follow up Period|Lost to Follow-up|9|||
126293770|NCT01125189|454364778|FG002|Follow up Period|Lost to Follow-up|6|||
126366548|NCT00959049|454637009|FG004|Overall Study|Lost to Follow-up|9|||
126366549|NCT00959049|454637010|FG005|Overall Study|Lost to Follow-up|1|||
126366550|NCT00959049|454637005|FG000|Overall Study|Contraindicated medication|0|||
126366551|NCT00959049|454637006|FG001|Overall Study|Contraindicated medication|0|||
126366552|NCT00959049|454637007|FG002|Overall Study|Contraindicated medication|0|||
126293771|NCT01125189|454364776|FG000|Follow up Period|Other reasons|4|||
126293772|NCT01125189|454364777|FG001|Follow up Period|Other reasons|4|||
126293773|NCT01125189|454364778|FG002|Follow up Period|Other reasons|5|||
126366553|NCT00959049|454637008|FG003|Overall Study|Contraindicated medication|1|||
126366554|NCT00959049|454637009|FG004|Overall Study|Contraindicated medication|0|||
126366555|NCT00959049|454637010|FG005|Overall Study|Contraindicated medication|0|||
126459591|NCT01470989|454982824|FG000|Overall Study|Abnormal laboratory value|1|||
126459592|NCT01470989|454982825|FG001|Overall Study|Abnormal laboratory value|1|||
126459593|NCT01470989|454982824|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126459594|NCT01470989|454982825|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
126459595|NCT01470989|454982824|FG000|Overall Study|Withdrawal by Subject|19|||
126459596|NCT01470989|454982825|FG001|Overall Study|Withdrawal by Subject|17|||
126459597|NCT01470989|454982824|FG000|Overall Study|Lost to Follow-up|18|||
126459598|NCT01470989|454982825|FG001|Overall Study|Lost to Follow-up|13|||
126459599|NCT01470989|454982824|FG000|Overall Study|Administrative problems|2|||
126459600|NCT01470989|454982825|FG001|Overall Study|Administrative problems|4|||
126459601|NCT01470989|454982824|FG000|Overall Study|Death|2|||
126459602|NCT01470989|454982825|FG001|Overall Study|Death|2|||
126459603|NCT01470989|454982824|FG000|Overall Study|Protocol deviation|1|||
126459604|NCT01470989|454982825|FG001|Overall Study|Protocol deviation|2|||
126459605|NCT00969280|454982826|FG000|Overall Study|Protocol Violation|2|||
126459606|NCT00969280|454982827|FG001|Overall Study|Protocol Violation|1|||
126459607|NCT00969280|454982826|FG000|Overall Study|Withdrawal by Subject|0|||
126459608|NCT00969280|454982827|FG001|Overall Study|Withdrawal by Subject|1|||
126459609|NCT00969280|454982826|FG000|Overall Study|infection of influenza A(H1N1)|0|||
126459610|NCT00969280|454982827|FG001|Overall Study|infection of influenza A(H1N1)|1|||
126459611|NCT02119676|454982828|FG000|Overall Study|Adverse Event|9|||
126459612|NCT02119676|454982829|FG001|Overall Study|Adverse Event|17|||
126459613|NCT02119676|454982830|FG002|Overall Study|Adverse Event|10|||
126459614|NCT02119676|454982831|FG003|Overall Study|Adverse Event|10|||
126459615|NCT02119676|454982828|FG000|Overall Study|Disease progression|53|||
126459616|NCT02119676|454982829|FG001|Overall Study|Disease progression|55|||
126293774|NCT00927589|454364779|FG000|Overall Study|Death|1|||
126293775|NCT00927589|454364779|FG000|Overall Study|Physician Decision|1|||
126293776|NCT00927589|454364779|FG000|Overall Study|Withdrawal by Subject|3|||
126293777|NCT00927589|454364779|FG000|Overall Study|Adverse Event|2|||
126293778|NCT00927589|454364779|FG000|Overall Study|Disease Progression|8|||
126293779|NCT00927589|454364779|FG000|Overall Study|Non-compliance|1|||
126293780|NCT00707239|454364780|FG000|Overall Study|Adverse Event|5|||
126293781|NCT00707239|454364781|FG001|Overall Study|Adverse Event|3|||
126293782|NCT00707239|454364782|FG002|Overall Study|Adverse Event|2|||
126293783|NCT00707239|454364780|FG000|Overall Study|Death|3|||
126293784|NCT00707239|454364781|FG001|Overall Study|Death|1|||
126293785|NCT00707239|454364782|FG002|Overall Study|Death|3|||
126293786|NCT00707239|454364780|FG000|Overall Study|Physician Decision|1|||
126293787|NCT00707239|454364781|FG001|Overall Study|Physician Decision|1|||
126293788|NCT00707239|454364782|FG002|Overall Study|Physician Decision|2|||
126293789|NCT00707239|454364780|FG000|Overall Study|Protocol Violation|0|||
126293790|NCT00707239|454364781|FG001|Overall Study|Protocol Violation|0|||
126293791|NCT00707239|454364782|FG002|Overall Study|Protocol Violation|1|||
126293792|NCT00707239|454364780|FG000|Overall Study|Lack of Efficacy|1|||
126459617|NCT02119676|454982830|FG002|Overall Study|Disease progression|68|||
126459618|NCT02119676|454982831|FG003|Overall Study|Disease progression|73|||
126459619|NCT02119676|454982828|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
126459620|NCT02119676|454982829|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
126459621|NCT02119676|454982830|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
126459622|NCT02119676|454982831|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
126459623|NCT02119676|454982828|FG000|Overall Study|Physician Decision|4|||
126767118|NCT03000075|456100235|FG005|Part A|Adverse Event|0|||
126293793|NCT00707239|454364781|FG001|Overall Study|Lack of Efficacy|2|||
126293794|NCT00707239|454364782|FG002|Overall Study|Lack of Efficacy|0|||
126293795|NCT00707239|454364780|FG000|Overall Study|Randomized, but not treated|1|||
126293796|NCT00707239|454364781|FG001|Overall Study|Randomized, but not treated|1|||
126293797|NCT00707239|454364782|FG002|Overall Study|Randomized, but not treated|1|||
126293798|NCT00707239|454364780|FG000|Overall Study|Other|8|||
126293799|NCT00707239|454364781|FG001|Overall Study|Other|3|||
126293800|NCT00707239|454364782|FG002|Overall Study|Other|5|||
126293801|NCT01651117|454364785|FG000|Overall Study|Death|2|||
126459624|NCT02119676|454982829|FG001|Overall Study|Physician Decision|2|||
126459625|NCT02119676|454982830|FG002|Overall Study|Physician Decision|3|||
126459626|NCT02119676|454982831|FG003|Overall Study|Physician Decision|2|||
126459627|NCT02119676|454982828|FG000|Overall Study|Death|9|||
126459628|NCT02119676|454982829|FG001|Overall Study|Death|3|||
126459629|NCT02119676|454982830|FG002|Overall Study|Death|2|||
126459630|NCT02119676|454982831|FG003|Overall Study|Death|1|||
126459631|NCT02119676|454982828|FG000|Overall Study|Noncompliance|0|||
126459632|NCT02119676|454982829|FG001|Overall Study|Noncompliance|1|||
126459633|NCT02119676|454982830|FG002|Overall Study|Noncompliance|0|||
126459634|NCT02119676|454982831|FG003|Overall Study|Noncompliance|0|||
126459635|NCT02119676|454982828|FG000|Overall Study|Lost to Follow-up|0|||
126459636|NCT02119676|454982829|FG001|Overall Study|Lost to Follow-up|0|||
126459637|NCT02119676|454982830|FG002|Overall Study|Lost to Follow-up|1|||
126459638|NCT02119676|454982831|FG003|Overall Study|Lost to Follow-up|0|||
126459639|NCT02119676|454982828|FG000|Overall Study|Protocol deviation|0|||
126459640|NCT02119676|454982829|FG001|Overall Study|Protocol deviation|0|||
126459641|NCT02119676|454982830|FG002|Overall Study|Protocol deviation|1|||
126293802|NCT01651117|454364786|FG001|Overall Study|Death|3|||
126459642|NCT02119676|454982831|FG003|Overall Study|Protocol deviation|0|||
126459643|NCT02119676|454982828|FG000|Overall Study|Other, unspecified|2|||
126459644|NCT02119676|454982829|FG001|Overall Study|Other, unspecified|1|||
126459645|NCT02119676|454982830|FG002|Overall Study|Other, unspecified|3|||
126459646|NCT02119676|454982831|FG003|Overall Study|Other, unspecified|4|||
126459647|NCT02119676|454982828|FG000|Overall Study|Did not receive study med|2|||
126459648|NCT02119676|454982829|FG001|Overall Study|Did not receive study med|2|||
126459649|NCT02119676|454982830|FG002|Overall Study|Did not receive study med|4|||
126459650|NCT02119676|454982831|FG003|Overall Study|Did not receive study med|5|||
126459651|NCT00570232|454982832|FG000|Overall Study|Adverse Event|10|||
126459652|NCT00570232|454982832|FG000|Overall Study|discontinued due to medical condition|3|||
126459653|NCT00570232|454982832|FG000|Overall Study|discontinued due to recurrence|8|||
126459654|NCT00570232|454982832|FG000|Overall Study|discontinued due to noncompliance|2|||
126459655|NCT02216812|454982833|FG000|Overall Study|Lost to Follow-up|10|||
126459656|NCT02216812|454982834|FG001|Overall Study|Lost to Follow-up|5|||
126459657|NCT01585584|454982835|FG000|Overall Study|Lack of Efficacy|1|||
126459658|NCT01585584|454982835|FG000|Overall Study|Withdrawal by Subject|1|||
126459659|NCT01585584|454982835|FG000|Overall Study|Physician Decision|2|||
126459660|NCT00266864|454982836|FG000|Overall Study|Lost to Follow-up|4|||
126459661|NCT00266864|454982837|FG001|Overall Study|Lost to Follow-up|1|||
126459662|NCT00266864|454982836|FG000|Overall Study|Withdrawal by Subject|1|||
126459663|NCT00266864|454982837|FG001|Overall Study|Withdrawal by Subject|1|||
126459664|NCT01163318|454982838|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
126459665|NCT01163318|454982838|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
126459666|NCT01163318|454982838|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
126710958|NCT01088412|455893571|FG002|Overall Study|Participant Moved|2|||
126293803|NCT01651117|454364787|FG002|Overall Study|Death|2|||
126459667|NCT01163318|454982838|FG000|Overall Study|Participants Without Case Report Form|7|||
126459668|NCT01163318|454982838|FG000|Overall Study|Multiple Reasons Per Participant|224|||
126459669|NCT01006603|454982840|FG000|Overall Study|Withdrawal by Subject|17|||
126459670|NCT01006603|454982841|FG001|Overall Study|Withdrawal by Subject|19|||
126459671|NCT01006603|454982840|FG000|Overall Study|Lost to Follow-up|0|||
126459672|NCT01006603|454982841|FG001|Overall Study|Lost to Follow-up|1|||
126459673|NCT01006603|454982840|FG000|Overall Study|Safety reason|1|||
126459674|NCT01006603|454982841|FG001|Overall Study|Safety reason|1|||
126459675|NCT01006603|454982840|FG000|Overall Study|Protocol Violation|1|||
126459676|NCT01006603|454982841|FG001|Overall Study|Protocol Violation|3|||
126459677|NCT01006603|454982840|FG000|Overall Study|Incorrect enrolment|0|||
126459678|NCT01006603|454982841|FG001|Overall Study|Incorrect enrolment|2|||
126459679|NCT01006603|454982840|FG000|Overall Study|Adverse Event|15|||
126459680|NCT01006603|454982841|FG001|Overall Study|Adverse Event|7|||
126459681|NCT01006603|454982840|FG000|Overall Study|Death|1|||
126459682|NCT01006603|454982841|FG001|Overall Study|Death|1|||
126459683|NCT01006603|454982840|FG000|Overall Study|Study specific discontinuation criteria|33|||
126459684|NCT01006603|454982841|FG001|Overall Study|Study specific discontinuation criteria|34|||
126459685|NCT01006603|454982840|FG000|Overall Study|Other|3|||
126459686|NCT01006603|454982841|FG001|Overall Study|Other|7|||
126459687|NCT04085367|454984292|FG000|Overall Study|Adverse Event|1|||
126459688|NCT04085367|454984293|FG001|Overall Study|Adverse Event|1|||
126459689|NCT04085367|454984292|FG000|Overall Study|Withdrawal by Subject|13|||
126459690|NCT04085367|454984293|FG001|Overall Study|Withdrawal by Subject|4|||
126459691|NCT04085367|454984292|FG000|Overall Study|Lost to Follow-up|3|||
126459692|NCT04085367|454984293|FG001|Overall Study|Lost to Follow-up|1|||
126710959|NCT01088412|455893569|FG000|Overall Study|Physician Decision|1041|||
126459693|NCT04085367|454984292|FG000|Overall Study|Other unspecified|2|||
126459694|NCT04085367|454984293|FG001|Overall Study|Other unspecified|1|||
126459695|NCT04085367|454984292|FG000|Overall Study|Status Unknown|1|||
126459696|NCT04085367|454984293|FG001|Overall Study|Status Unknown|1|||
126459697|NCT00706849|454984304|FG000|Treatment Period|Adverse Event|0|||
126459698|NCT00706849|454984305|FG001|Treatment Period|Adverse Event|9|||
126293804|NCT01651117|454364788|FG003|Overall Study|Death|2|||
126293805|NCT02714218|454364789|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126459699|NCT00706849|454984304|FG000|Treatment Period|Other|0|||
126459700|NCT00706849|454984305|FG001|Treatment Period|Other|1|||
126459701|NCT00706849|454984304|FG000|Follow-up Period|Withdrawal by Subject|0|||
126459702|NCT00706849|454984305|FG001|Follow-up Period|Withdrawal by Subject|2|||
126459703|NCT00706849|454984304|FG000|Follow-up Period|Protocol non-compliance|0|||
126459704|NCT00706849|454984305|FG001|Follow-up Period|Protocol non-compliance|1|||
126459705|NCT01611454|454984307|FG000|Overall Study|Lack of Efficacy|18|||
126459706|NCT01611454|454984308|FG001|Overall Study|Lack of Efficacy|10|||
126459707|NCT03269552|454984309|FG000|Overall Study|Adverse Event|2|||
126459708|NCT00920907|454984310|FG000|Induction Period|Adverse Event|0|||
126459709|NCT00920907|454984311|FG001|Induction Period|Adverse Event|2|||
126459710|NCT00920907|454984310|FG000|Induction Period|Death|1|||
126459711|NCT00920907|454984311|FG001|Induction Period|Death|1|||
126459712|NCT00920907|454984310|FG000|Induction Period|Disease Progression|12|||
126459713|NCT00920907|454984311|FG001|Induction Period|Disease Progression|11|||
126459714|NCT00920907|454984310|FG000|Induction Period|Study Drug Toxicity|8|||
126459715|NCT00920907|454984311|FG001|Induction Period|Study Drug Toxicity|6|||
126459716|NCT00920907|454984310|FG000|Induction Period|No longer meets study criteria|0|||
126293806|NCT02714218|454364790|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126293807|NCT02714218|454364791|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126293808|NCT02714218|454364789|FG000|Pre-Treatment Period|Other reasons|0|||
126293809|NCT02714218|454364790|FG001|Pre-Treatment Period|Other reasons|1|||
126293810|NCT02714218|454364791|FG002|Pre-Treatment Period|Other reasons|0|||
126293811|NCT02714218|454364789|FG000|Treatment Period|Disease Progression|55|||
126293812|NCT02714218|454364790|FG001|Treatment Period|Disease Progression|52|||
126293813|NCT02714218|454364791|FG002|Treatment Period|Disease Progression|14|||
126293814|NCT02714218|454364789|FG000|Treatment Period|Study drug toxicity|46|||
126293815|NCT02714218|454364790|FG001|Treatment Period|Study drug toxicity|70|||
126293816|NCT02714218|454364791|FG002|Treatment Period|Study drug toxicity|6|||
126293817|NCT02714218|454364789|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
126293818|NCT02714218|454364790|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
126293819|NCT02714218|454364791|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
126293820|NCT02714218|454364789|FG000|Treatment Period|Request to discontinue treatment|1|||
126293821|NCT02714218|454364790|FG001|Treatment Period|Request to discontinue treatment|4|||
126293822|NCT02714218|454364791|FG002|Treatment Period|Request to discontinue treatment|1|||
126293823|NCT02714218|454364789|FG000|Treatment Period|Participant withdrew consent|2|||
126293824|NCT02714218|454364790|FG001|Treatment Period|Participant withdrew consent|2|||
126293825|NCT02714218|454364791|FG002|Treatment Period|Participant withdrew consent|0|||
126293826|NCT02714218|454364789|FG000|Treatment Period|Maximum clinical benefit|4|||
126293827|NCT02714218|454364790|FG001|Treatment Period|Maximum clinical benefit|2|||
126293828|NCT02714218|454364791|FG002|Treatment Period|Maximum clinical benefit|0|||
126293829|NCT02714218|454364789|FG000|Treatment Period|Administrative reason by sponsor|2|||
126293830|NCT02714218|454364790|FG001|Treatment Period|Administrative reason by sponsor|1|||
126293831|NCT02714218|454364791|FG002|Treatment Period|Administrative reason by sponsor|0|||
126293832|NCT02714218|454364789|FG000|Treatment Period|Other reasons|6|||
126293833|NCT02714218|454364790|FG001|Treatment Period|Other reasons|6|||
126293834|NCT02714218|454364791|FG002|Treatment Period|Other reasons|0|||
126293835|NCT02714218|454364789|FG000|Treatment Period|Completed treatment as per protocol|36|||
126293836|NCT02714218|454364790|FG001|Treatment Period|Completed treatment as per protocol|27|||
126293837|NCT02714218|454364791|FG002|Treatment Period|Completed treatment as per protocol|3|||
126293838|NCT02714218|454364789|FG000|Treatment Period|Not reported|9|||
126293839|NCT02714218|454364790|FG001|Treatment Period|Not reported|6|||
126293840|NCT02714218|454364791|FG002|Treatment Period|Not reported|0|||
126293841|NCT02088177|454364794|FG000|Overall Study|Lost to Follow-up|3|||
126293842|NCT01778530|454364796|FG000|Overall Study|Progression on study|1|||
126293843|NCT01778530|454364796|FG000|Overall Study|Adverse event/side effect|1|||
126293844|NCT01894919|454364797|FG000|Overall Study|Withdrawal by Subject|1|||
126293845|NCT01894919|454364798|FG001|Overall Study|Withdrawal by Subject|0|||
126293846|NCT01894919|454364799|FG002|Overall Study|Withdrawal by Subject|0|||
126293847|NCT01894919|454364800|FG003|Overall Study|Withdrawal by Subject|0|||
126293848|NCT01894919|454364801|FG004|Overall Study|Withdrawal by Subject|1|||
126293849|NCT01894919|454364802|FG005|Overall Study|Withdrawal by Subject|0|||
126293850|NCT01894919|454364803|FG006|Overall Study|Withdrawal by Subject|0|||
126293851|NCT01894919|454364804|FG007|Overall Study|Withdrawal by Subject|0|||
126293852|NCT01894919|454364805|FG008|Overall Study|Withdrawal by Subject|0|||
126293853|NCT01894919|454364806|FG009|Overall Study|Withdrawal by Subject|1|||
126293854|NCT01894919|454364807|FG010|Overall Study|Withdrawal by Subject|1|||
126293855|NCT01894919|454364808|FG011|Overall Study|Withdrawal by Subject|0|||
126293856|NCT01894919|454364809|FG012|Overall Study|Withdrawal by Subject|0|||
126293857|NCT01894919|454364797|FG000|Overall Study|Adverse Event|0|||
126293858|NCT01894919|454364798|FG001|Overall Study|Adverse Event|0|||
126293859|NCT01894919|454364799|FG002|Overall Study|Adverse Event|0|||
126293860|NCT01894919|454364800|FG003|Overall Study|Adverse Event|0|||
126293861|NCT01894919|454364801|FG004|Overall Study|Adverse Event|0|||
126293862|NCT01894919|454364802|FG005|Overall Study|Adverse Event|0|||
126293863|NCT01894919|454364803|FG006|Overall Study|Adverse Event|0|||
126293864|NCT01894919|454364804|FG007|Overall Study|Adverse Event|0|||
126293865|NCT01894919|454364805|FG008|Overall Study|Adverse Event|0|||
126293866|NCT01894919|454364806|FG009|Overall Study|Adverse Event|0|||
126293867|NCT01894919|454364807|FG010|Overall Study|Adverse Event|1|||
126293868|NCT01894919|454364808|FG011|Overall Study|Adverse Event|0|||
126293869|NCT01894919|454364809|FG012|Overall Study|Adverse Event|0|||
126293870|NCT01894919|454364797|FG000|Overall Study|Other-Unspecified|1|||
126293871|NCT01894919|454364798|FG001|Overall Study|Other-Unspecified|0|||
126293872|NCT01894919|454364799|FG002|Overall Study|Other-Unspecified|0|||
126293873|NCT01894919|454364800|FG003|Overall Study|Other-Unspecified|0|||
126293874|NCT01894919|454364801|FG004|Overall Study|Other-Unspecified|0|||
126293875|NCT01894919|454364802|FG005|Overall Study|Other-Unspecified|0|||
126293876|NCT01894919|454364803|FG006|Overall Study|Other-Unspecified|0|||
126459717|NCT00920907|454984311|FG001|Induction Period|No longer meets study criteria|1|||
126459718|NCT00920907|454984310|FG000|Induction Period|Withdrawal by Subject|1|||
126459719|NCT00920907|454984311|FG001|Induction Period|Withdrawal by Subject|1|||
126459720|NCT00920907|454984310|FG000|Maintenance Period|Disease Progression|3|||
126459721|NCT00920907|454984311|FG001|Maintenance Period|Disease Progression|7|||
126459722|NCT00920907|454984310|FG000|Maintenance Period|Administrative (study closure)|7|||
126459723|NCT00920907|454984311|FG001|Maintenance Period|Administrative (study closure)|2|||
126459724|NCT00920907|454984310|FG000|Maintenance Period|Study Drug Toxicity|0|||
126459725|NCT00920907|454984311|FG001|Maintenance Period|Study Drug Toxicity|2|||
126459726|NCT00920907|454984310|FG000|Maintenance Period|Death|1|||
126459727|NCT00920907|454984311|FG001|Maintenance Period|Death|1|||
126293877|NCT01894919|454364804|FG007|Overall Study|Other-Unspecified|0|||
126293878|NCT01894919|454364805|FG008|Overall Study|Other-Unspecified|0|||
126293879|NCT01894919|454364806|FG009|Overall Study|Other-Unspecified|0|||
126293880|NCT01894919|454364807|FG010|Overall Study|Other-Unspecified|0|||
126293881|NCT01894919|454364808|FG011|Overall Study|Other-Unspecified|0|||
126459728|NCT00920907|454984310|FG000|Maintenance Period|Withdrawal by Subject|1|||
126459729|NCT00920907|454984311|FG001|Maintenance Period|Withdrawal by Subject|0|||
126459730|NCT00920907|454984310|FG000|Maintenance Period|Adverse Event|0|||
126293882|NCT01894919|454364809|FG012|Overall Study|Other-Unspecified|0|||
126293883|NCT01894919|454364797|FG000|Overall Study|Lost to Follow-up|0|||
126293884|NCT01894919|454364798|FG001|Overall Study|Lost to Follow-up|0|||
126293885|NCT01894919|454364799|FG002|Overall Study|Lost to Follow-up|0|||
126293886|NCT01894919|454364800|FG003|Overall Study|Lost to Follow-up|0|||
126293887|NCT01894919|454364801|FG004|Overall Study|Lost to Follow-up|2|||
126293888|NCT01894919|454364802|FG005|Overall Study|Lost to Follow-up|0|||
126293889|NCT01894919|454364803|FG006|Overall Study|Lost to Follow-up|0|||
126549994|NCT02141659|455307697|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
126549995|NCT02141659|455307698|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
126549996|NCT02141659|455307699|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
126549997|NCT02141659|455307700|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
126549998|NCT02141659|455307701|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
126549999|NCT03856996|455307704|FG000|Overall Study|Withdrawal by Subject|1|||
126293890|NCT01894919|454364804|FG007|Overall Study|Lost to Follow-up|0|||
126293891|NCT01894919|454364805|FG008|Overall Study|Lost to Follow-up|0|||
126293892|NCT01894919|454364806|FG009|Overall Study|Lost to Follow-up|0|||
126293893|NCT01894919|454364807|FG010|Overall Study|Lost to Follow-up|0|||
126293894|NCT01894919|454364808|FG011|Overall Study|Lost to Follow-up|0|||
126293895|NCT01894919|454364809|FG012|Overall Study|Lost to Follow-up|0|||
126293896|NCT03711188|454364812|FG000|Overall Study|Disease progression|11|||
126293897|NCT03711188|454364812|FG000|Overall Study|Adverse Event|1|||
126459731|NCT00920907|454984311|FG001|Maintenance Period|Adverse Event|1|||
126459732|NCT02616601|454984312|FG000|Overall Study|Withdrawal by Subject|4|||
126459733|NCT02616601|454984313|FG001|Overall Study|Withdrawal by Subject|4|||
126459734|NCT02616601|454984314|FG002|Overall Study|Withdrawal by Subject|3|||
126459735|NCT02616601|454984312|FG000|Overall Study|Adverse Event|2|||
126459736|NCT02616601|454984313|FG001|Overall Study|Adverse Event|0|||
126459737|NCT02616601|454984314|FG002|Overall Study|Adverse Event|2|||
126459738|NCT02616601|454984312|FG000|Overall Study|Death|1|||
126459739|NCT02616601|454984313|FG001|Overall Study|Death|0|||
126459740|NCT02616601|454984314|FG002|Overall Study|Death|0|||
126459741|NCT02616601|454984312|FG000|Overall Study|Lost to Follow-up|1|||
126459742|NCT02616601|454984313|FG001|Overall Study|Lost to Follow-up|0|||
126550000|NCT03856996|455307705|FG001|Overall Study|Withdrawal by Subject|0|||
126550001|NCT03856996|455307704|FG000|Overall Study|Lost to Follow-up|0|||
126293898|NCT01433471|454364815|FG000|Overall Study|Withdrawal by Subject|0|||
126293899|NCT01433471|454364816|FG001|Overall Study|Withdrawal by Subject|1|||
126293900|NCT03238651|454364817|FG000|Overall Study|Other|0|||
126293901|NCT03238651|454364818|FG001|Overall Study|Other|0|||
126293902|NCT03238651|454364819|FG002|Overall Study|Other|0|||
126293903|NCT03238651|454364820|FG003|Overall Study|Other|0|||
126293904|NCT03238651|454364821|FG004|Overall Study|Other|1|||
126293905|NCT03238651|454364817|FG000|Overall Study|Progressive Disease|2|||
126293906|NCT03238651|454364818|FG001|Overall Study|Progressive Disease|2|||
126293907|NCT03238651|454364819|FG002|Overall Study|Progressive Disease|2|||
126293908|NCT03238651|454364820|FG003|Overall Study|Progressive Disease|2|||
126293909|NCT03238651|454364821|FG004|Overall Study|Progressive Disease|0|||
126459743|NCT02616601|454984314|FG002|Overall Study|Lost to Follow-up|1|||
126459744|NCT02616601|454984312|FG000|Overall Study|Non-Compliance with Test Article|1|||
126459745|NCT02616601|454984313|FG001|Overall Study|Non-Compliance with Test Article|0|||
126459746|NCT02616601|454984314|FG002|Overall Study|Non-Compliance with Test Article|1|||
126459747|NCT02186301|454984315|FG000|Overall Study|Progressive Disease|7|||
126459748|NCT02186301|454984316|FG001|Overall Study|Progressive Disease|22|||
126459749|NCT02186301|454984317|FG002|Overall Study|Progressive Disease|27|||
126459750|NCT02186301|454984315|FG000|Overall Study|Adverse Event|5|||
126459751|NCT02186301|454984316|FG001|Overall Study|Adverse Event|5|||
126459752|NCT02186301|454984317|FG002|Overall Study|Adverse Event|5|||
126459753|NCT02186301|454984315|FG000|Overall Study|Death|1|||
126459754|NCT02186301|454984316|FG001|Overall Study|Death|0|||
126459755|NCT02186301|454984317|FG002|Overall Study|Death|0|||
126293910|NCT03238651|454364817|FG000|Overall Study|Withdrawal by Subject|0|||
126293911|NCT03238651|454364818|FG001|Overall Study|Withdrawal by Subject|1|||
126293912|NCT03238651|454364819|FG002|Overall Study|Withdrawal by Subject|0|||
126293913|NCT03238651|454364820|FG003|Overall Study|Withdrawal by Subject|1|||
126293914|NCT03238651|454364821|FG004|Overall Study|Withdrawal by Subject|0|||
126293915|NCT03238651|454364817|FG000|Overall Study|Adverse Event|1|||
126293916|NCT03238651|454364818|FG001|Overall Study|Adverse Event|3|||
126293917|NCT03238651|454364819|FG002|Overall Study|Adverse Event|2|||
126293918|NCT03238651|454364820|FG003|Overall Study|Adverse Event|0|||
126293919|NCT03238651|454364821|FG004|Overall Study|Adverse Event|0|||
126293920|NCT03875508|454364822|FG000|Overall Study|Adverse Event|1|||
126293921|NCT03875508|454364822|FG000|Overall Study|Lost to Follow-up|8|||
126293922|NCT03875508|454364822|FG000|Overall Study|Lack of Efficacy|1|||
126293923|NCT03875508|454364822|FG000|Overall Study|Other, not specified|2|||
126293924|NCT03164551|454364826|FG000|Overall Study|Imaging discontinued prior completion|8|||
126293925|NCT03164551|454364827|FG001|Overall Study|Imaging discontinued prior completion|0|||
126293926|NCT03164551|454364826|FG000|Overall Study|Participant was non-compliant|1|||
126293927|NCT03164551|454364827|FG001|Overall Study|Participant was non-compliant|0|||
126293928|NCT03164551|454364826|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
126293929|NCT03164551|454364827|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
126293930|NCT03164551|454364826|FG000|Overall Study|Other|8|||
126293931|NCT03164551|454364827|FG001|Overall Study|Other|2|||
126293932|NCT01149863|454364836|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
126293933|NCT04052620|454364837|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
126293934|NCT04052620|454364838|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
126293935|NCT04052620|454364837|FG000|Overall Study|Withdrawal by Subject|1|||
126293936|NCT04052620|454364838|FG001|Overall Study|Withdrawal by Subject|0|||
126293937|NCT04052620|454364837|FG000|Overall Study|Lost to Follow-up|1|||
126293938|NCT04052620|454364838|FG001|Overall Study|Lost to Follow-up|1|||
126293939|NCT04052620|454364837|FG000|Overall Study|Adverse Event|1|||
126293940|NCT04052620|454364838|FG001|Overall Study|Adverse Event|0|||
126293941|NCT04052620|454364837|FG000|Overall Study|Subject did not meet study Criteria|0|||
126293942|NCT04052620|454364838|FG001|Overall Study|Subject did not meet study Criteria|1|||
126293943|NCT04052620|454364837|FG000|Overall Study|Screened failure, randomized by mistake|0|||
126293944|NCT04052620|454364838|FG001|Overall Study|Screened failure, randomized by mistake|1|||
126293945|NCT04052620|454364837|FG000|Overall Study|Personal reasons|2|||
126293946|NCT04052620|454364838|FG001|Overall Study|Personal reasons|4|||
126293947|NCT04052620|454364837|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
126293948|NCT04052620|454364838|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
126293949|NCT01406574|454364839|FG000|Overall Study|Adverse Event|0|||
126293950|NCT01406574|454364840|FG001|Overall Study|Adverse Event|0|||
126293951|NCT01406574|454364841|FG002|Overall Study|Adverse Event|1|||
126293952|NCT01406574|454364842|FG003|Overall Study|Adverse Event|3|||
126293953|NCT01406574|454364839|FG000|Overall Study|Physician Decision|0|||
126293954|NCT01406574|454364840|FG001|Overall Study|Physician Decision|0|||
126293955|NCT01406574|454364841|FG002|Overall Study|Physician Decision|0|||
126293956|NCT01406574|454364842|FG003|Overall Study|Physician Decision|1|||
126293957|NCT01406574|454364839|FG000|Overall Study|Withdrawal by Subject|0|||
126293958|NCT01406574|454364840|FG001|Overall Study|Withdrawal by Subject|1|||
126293959|NCT01406574|454364841|FG002|Overall Study|Withdrawal by Subject|0|||
126293960|NCT01406574|454364842|FG003|Overall Study|Withdrawal by Subject|0|||
126293961|NCT01406574|454364839|FG000|Overall Study|Definite progression of primary disease|1|||
126293962|NCT01406574|454364840|FG001|Overall Study|Definite progression of primary disease|0|||
126293963|NCT01406574|454364841|FG002|Overall Study|Definite progression of primary disease|0|||
126293964|NCT01406574|454364842|FG003|Overall Study|Definite progression of primary disease|0|||
126293965|NCT03552380|454364843|FG000|Study Treatment|Disease Progression|3|||
126293966|NCT03552380|454364844|FG001|Study Treatment|Disease Progression|4|||
126293967|NCT03552380|454364843|FG000|Study Treatment|Adverse Event|2|||
126293968|NCT03552380|454364844|FG001|Study Treatment|Adverse Event|2|||
126293969|NCT03552380|454364843|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
126293970|NCT03552380|454364844|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
126293971|NCT03552380|454364843|FG000|Follow up|Death|3|||
126293972|NCT03552380|454364844|FG001|Follow up|Death|4|||
126293973|NCT03552380|454364843|FG000|Follow up|Site IRB terminated|0|||
126293974|NCT03552380|454364844|FG001|Follow up|Site IRB terminated|1|||
126293975|NCT02431364|454364845|FG000|Overall Study|Adverse Event|0|||
126293976|NCT02431364|454364846|FG001|Overall Study|Adverse Event|1|||
126293977|NCT02431364|454364847|FG002|Overall Study|Adverse Event|0|||
126293978|NCT02431364|454364848|FG003|Overall Study|Adverse Event|0|||
126293979|NCT02431364|454364849|FG004|Overall Study|Adverse Event|0|||
126293980|NCT02431364|454364845|FG000|Overall Study|Randomized but never treated|0|||
126293981|NCT02431364|454364846|FG001|Overall Study|Randomized but never treated|0|||
126293982|NCT02431364|454364847|FG002|Overall Study|Randomized but never treated|0|||
126293983|NCT02431364|454364848|FG003|Overall Study|Randomized but never treated|1|||
126293984|NCT02431364|454364849|FG004|Overall Study|Randomized but never treated|0|||
126293985|NCT00916383|454364850|FG000|Overall Study|Adverse Event|1|||
126293986|NCT00916383|454364850|FG000|Overall Study|Death|1|||
126293987|NCT00916383|454364850|FG000|Overall Study|Protocol Violation|1|||
126293988|NCT00258960|454364851|FG000|Overall Study|Death|2|||
126293989|NCT00258960|454364851|FG000|Overall Study|Disease Progression|7|||
126293990|NCT00258960|454364851|FG000|Overall Study|Adverse Event|4|||
126293991|NCT00258960|454364851|FG000|Overall Study|Physician Decision|1|||
126293992|NCT00258960|454364851|FG000|Overall Study|Withdrawal by Subject|1|||
126293993|NCT00258960|454364851|FG000|Overall Study|Mistake|2|||
126293994|NCT00473590|454364852|FG000|Overall Study|Adverse Event|3|||
126293995|NCT00473590|454364853|FG001|Overall Study|Adverse Event|3|||
126293996|NCT00473590|454364852|FG000|Overall Study|Death|4|||
126293997|NCT00473590|454364853|FG001|Overall Study|Death|2|||
126293998|NCT00473590|454364852|FG000|Overall Study|Progression not resulting in death|24|||
126293999|NCT00473590|454364853|FG001|Overall Study|Progression not resulting in death|20|||
126294000|NCT00473590|454364852|FG000|Overall Study|Non-protocol-specified therapy|7|||
126294001|NCT00473590|454364853|FG001|Overall Study|Non-protocol-specified therapy|5|||
126366556|NCT00959049|454637005|FG000|Overall Study|Withdrawal by Subject|0|||
126366557|NCT00959049|454637006|FG001|Overall Study|Withdrawal by Subject|2|||
126366558|NCT00959049|454637007|FG002|Overall Study|Withdrawal by Subject|0|||
126366559|NCT00959049|454637008|FG003|Overall Study|Withdrawal by Subject|0|||
126366560|NCT00959049|454637009|FG004|Overall Study|Withdrawal by Subject|0|||
126366561|NCT00959049|454637010|FG005|Overall Study|Withdrawal by Subject|0|||
126366562|NCT00567502|454637011|FG000|Overall Study|Lost to Follow-up|91|||
126366563|NCT00567502|454637012|FG001|Overall Study|Lost to Follow-up|14|||
126366564|NCT00567502|454637013|FG002|Overall Study|Lost to Follow-up|351|||
126366565|NCT00567502|454637014|FG003|Overall Study|Lost to Follow-up|2|||
126366566|NCT00567502|454637011|FG000|Overall Study|Death|65|||
126366567|NCT00567502|454637012|FG001|Overall Study|Death|16|||
126366568|NCT00567502|454637013|FG002|Overall Study|Death|360|||
126366569|NCT00567502|454637014|FG003|Overall Study|Death|5|||
126366570|NCT00567502|454637011|FG000|Overall Study|Other|64|||
126366571|NCT00567502|454637012|FG001|Overall Study|Other|2|||
126366572|NCT00567502|454637013|FG002|Overall Study|Other|134|||
126366573|NCT00567502|454637014|FG003|Overall Study|Other|6|||
126366574|NCT00567502|454637011|FG000|Overall Study|Participant request|12|||
126366575|NCT00567502|454637012|FG001|Overall Study|Participant request|1|||
126366576|NCT00567502|454637013|FG002|Overall Study|Participant request|33|||
126366577|NCT00567502|454637014|FG003|Overall Study|Participant request|1|||
126366578|NCT00567502|454637011|FG000|Overall Study|Sponsor request|9|||
126366579|NCT00567502|454637012|FG001|Overall Study|Sponsor request|0|||
126366580|NCT00567502|454637013|FG002|Overall Study|Sponsor request|30|||
126366581|NCT00567502|454637014|FG003|Overall Study|Sponsor request|1|||
126366582|NCT00567502|454637011|FG000|Overall Study|Never Initiated Treatment|0|||
126366583|NCT00567502|454637012|FG001|Overall Study|Never Initiated Treatment|0|||
126366584|NCT00567502|454637013|FG002|Overall Study|Never Initiated Treatment|0|||
126366585|NCT00567502|454637014|FG003|Overall Study|Never Initiated Treatment|72|||
126366586|NCT00337168|454637015|FG000|Overall Study|Death|5|||
126366587|NCT00337168|454637015|FG000|Overall Study|Not protocol specified|2|||
126366588|NCT00337168|454637015|FG000|Overall Study|Did not start therapy|1|||
126366589|NCT00586157|454637018|FG000|First Intervention|Worsening behavior|1|||
126366590|NCT00586157|454637019|FG001|First Intervention|Worsening behavior|0|||
126366591|NCT00586157|454637018|FG000|Second Intervention|Withdrawal by Subject|1|||
126366592|NCT00586157|454637019|FG001|Second Intervention|Withdrawal by Subject|0|||
126366593|NCT00586157|454637018|FG000|Second Intervention|Worsening behavior|1|||
126366594|NCT00586157|454637019|FG001|Second Intervention|Worsening behavior|0|||
126366595|NCT00586157|454637018|FG000|Second Intervention|Adverse Event|0|||
126366596|NCT00586157|454637019|FG001|Second Intervention|Adverse Event|1|||
126366597|NCT01230060|454637023|FG000|Overall Study|Withdrawal by Subject|1|||
126366598|NCT03663582|454637026|FG000|Overall Study|Physician Decision|1|||
126366599|NCT00480532|454637027|FG000|Overall Study|Withdrawal by Subject|2|||
126366600|NCT00480532|454637028|FG001|Overall Study|Withdrawal by Subject|4|||
126366601|NCT00480532|454637029|FG002|Overall Study|Withdrawal by Subject|3|||
126366602|NCT00480532|454637030|FG003|Overall Study|Withdrawal by Subject|1|||
126459756|NCT02186301|454984315|FG000|Overall Study|Withdrawal by Subject|5|||
126767119|NCT03000075|456100236|FG006|Part A|Adverse Event|0|||
126294002|NCT00473590|454364852|FG000|Overall Study|Physician Decision|2|||
126294003|NCT00473590|454364853|FG001|Overall Study|Physician Decision|4|||
126294004|NCT00473590|454364852|FG000|Overall Study|Withdrawal by Subject|5|||
126366603|NCT00480532|454637027|FG000|Overall Study|Protocol Violation|0|||
126366604|NCT00480532|454637028|FG001|Overall Study|Protocol Violation|0|||
126366605|NCT00480532|454637029|FG002|Overall Study|Protocol Violation|1|||
126366606|NCT00480532|454637030|FG003|Overall Study|Protocol Violation|0|||
126366607|NCT03242434|454637040|FG000|Overall Study|Death|0|||
126366608|NCT03242434|454637041|FG001|Overall Study|Death|2|||
126294005|NCT00473590|454364853|FG001|Overall Study|Withdrawal by Subject|3|||
126366609|NCT01602484|454637042|FG000|Overall Study|Airway issues unrelated to study|0|||
126366610|NCT01602484|454637043|FG001|Overall Study|Airway issues unrelated to study|1|||
126459757|NCT02186301|454984316|FG001|Overall Study|Withdrawal by Subject|1|||
126459758|NCT02186301|454984317|FG002|Overall Study|Withdrawal by Subject|3|||
126459759|NCT02186301|454984315|FG000|Overall Study|Physician Decision|1|||
126459760|NCT02186301|454984316|FG001|Overall Study|Physician Decision|0|||
126459761|NCT02186301|454984317|FG002|Overall Study|Physician Decision|1|||
126459762|NCT02186301|454984315|FG000|Overall Study|Study Terminated by Sponsor|1|||
126459763|NCT02186301|454984316|FG001|Overall Study|Study Terminated by Sponsor|0|||
126459764|NCT02186301|454984317|FG002|Overall Study|Study Terminated by Sponsor|11|||
126459765|NCT02186301|454984315|FG000|Overall Study|Protocol Deviation|0|||
126459766|NCT02186301|454984316|FG001|Overall Study|Protocol Deviation|2|||
126459767|NCT02186301|454984317|FG002|Overall Study|Protocol Deviation|0|||
126459768|NCT02186301|454984315|FG000|Overall Study|Missing|0|||
126459769|NCT02186301|454984316|FG001|Overall Study|Missing|0|||
126459770|NCT02186301|454984317|FG002|Overall Study|Missing|2|||
126459771|NCT02186301|454984315|FG000|Overall Study|Other|0|||
126459772|NCT02186301|454984316|FG001|Overall Study|Other|0|||
126459773|NCT02186301|454984317|FG002|Overall Study|Other|1|||
126459774|NCT00371761|454984318|FG000|Overall Study|Adverse Event|1|||
126459775|NCT00371761|454984319|FG001|Overall Study|Adverse Event|1|||
126459776|NCT00371761|454984318|FG000|Overall Study|Withdrawal by Subject|1|||
126459777|NCT00371761|454984319|FG001|Overall Study|Withdrawal by Subject|3|||
126459778|NCT00371761|454984318|FG000|Overall Study|Investigator Judgment|2|||
126459779|NCT00371761|454984319|FG001|Overall Study|Investigator Judgment|3|||
126459780|NCT00371761|454984318|FG000|Overall Study|Study termination|4|||
126459781|NCT00371761|454984319|FG001|Overall Study|Study termination|3|||
126459782|NCT03560739|454984321|FG000|Overall Study|Adverse Event|0|||
126459783|NCT03560739|454984322|FG001|Overall Study|Adverse Event|1|||
126459784|NCT03560739|454984323|FG002|Overall Study|Adverse Event|0|||
126459785|NCT03560739|454984324|FG003|Overall Study|Adverse Event|0|||
126459786|NCT03361176|454984325|FG000|Overall Study|Lost to Follow-up|1|||
126459787|NCT03361176|454984326|FG001|Overall Study|Lost to Follow-up|2|||
126459788|NCT03361176|454984325|FG000|Overall Study|Adverse Event|0|||
126459789|NCT03361176|454984326|FG001|Overall Study|Adverse Event|2|||
126459790|NCT03361176|454984325|FG000|Overall Study|Withdrawal by Subject|0|||
126459791|NCT03361176|454984326|FG001|Overall Study|Withdrawal by Subject|1|||
126459792|NCT04389970|454984327|FG000|Overall Study|Lost to Follow-up|1|||
126294006|NCT00473590|454364852|FG000|Overall Study|Other|0|||
126294007|NCT00473590|454364853|FG001|Overall Study|Other|1|||
126294008|NCT01112059|454364856|FG000|Overall Study|Withdrawal by Subject|1|||
126294009|NCT01112059|454364857|FG001|Overall Study|Withdrawal by Subject|0|||
126294010|NCT00858273|454364860|FG000|Overall Study|Protocol Violation|3|||
126294011|NCT00858273|454364861|FG001|Overall Study|Protocol Violation|5|||
126294012|NCT04199104|454366543|FG000|Overall Study|Death|148|||
126294013|NCT04199104|454366544|FG001|Overall Study|Death|134|||
126459793|NCT03123185|454984328|FG000|Overall Study|Withdrawal by Subject|0|||
126459794|NCT03123185|454984329|FG001|Overall Study|Withdrawal by Subject|0|||
126459795|NCT03123185|454984330|FG002|Overall Study|Withdrawal by Subject|0|||
126294014|NCT04199104|454366543|FG000|Overall Study|Lost to Follow-up|1|||
126294015|NCT04199104|454366544|FG001|Overall Study|Lost to Follow-up|1|||
126294016|NCT04199104|454366543|FG000|Overall Study|Withdrawal by Subject|4|||
126294017|NCT04199104|454366544|FG001|Overall Study|Withdrawal by Subject|4|||
126294018|NCT04199104|454366543|FG000|Overall Study|Participants Ongoing|103|||
126294019|NCT04199104|454366544|FG001|Overall Study|Participants Ongoing|116|||
126294020|NCT02325973|454366545|FG000|Overall Study|Death|5|||
126294021|NCT02325973|454366545|FG000|Overall Study|Withdrawal by subject or investigator|16|||
126459796|NCT03123185|454984331|FG003|Overall Study|Withdrawal by Subject|0|||
126459797|NCT03123185|454984332|FG004|Overall Study|Withdrawal by Subject|0|||
126294022|NCT05655546|454366546|FG000|Overall Study|Withdrawal by Subject|2|||
126459798|NCT03123185|454984333|FG005|Overall Study|Withdrawal by Subject|0|||
126459799|NCT03123185|454984334|FG006|Overall Study|Withdrawal by Subject|0|||
126459800|NCT03123185|454984335|FG007|Overall Study|Withdrawal by Subject|0|||
126459801|NCT03123185|454984336|FG008|Overall Study|Withdrawal by Subject|0|||
126459802|NCT03123185|454984337|FG009|Overall Study|Withdrawal by Subject|0|||
126294023|NCT05655546|454366547|FG001|Overall Study|Withdrawal by Subject|4|||
126294024|NCT01168232|454366548|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
126294025|NCT01168232|454366548|FG000|Overall Study|Ineligible- Wrong cell type|6|||
126294026|NCT01168232|454366548|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
126459803|NCT03123185|454984338|FG010|Overall Study|Withdrawal by Subject|0|||
126459804|NCT03123185|454984339|FG011|Overall Study|Withdrawal by Subject|0|||
126459805|NCT03123185|454984340|FG012|Overall Study|Withdrawal by Subject|1|||
126459806|NCT03123185|454984341|FG013|Overall Study|Withdrawal by Subject|0|||
126459807|NCT00470158|454984342|FG000|Overall Study|Death|0|||
126459808|NCT00470158|454984343|FG001|Overall Study|Death|0|||
126459809|NCT00470158|454984344|FG002|Overall Study|Death|0|||
126459810|NCT00470158|454984345|FG003|Overall Study|Death|0|||
126459811|NCT00470158|454984346|FG004|Overall Study|Death|2|||
126459812|NCT00470158|454984342|FG000|Overall Study|Lost to Follow-up|7|||
126459813|NCT00470158|454984343|FG001|Overall Study|Lost to Follow-up|8|||
126459814|NCT00470158|454984344|FG002|Overall Study|Lost to Follow-up|8|||
126459815|NCT00470158|454984345|FG003|Overall Study|Lost to Follow-up|5|||
126459816|NCT00470158|454984346|FG004|Overall Study|Lost to Follow-up|4|||
126459817|NCT00470158|454984342|FG000|Overall Study|Protocol Violation|1|||
126459818|NCT00470158|454984343|FG001|Overall Study|Protocol Violation|0|||
126459819|NCT00470158|454984344|FG002|Overall Study|Protocol Violation|0|||
126459820|NCT00470158|454984345|FG003|Overall Study|Protocol Violation|0|||
126459821|NCT00470158|454984346|FG004|Overall Study|Protocol Violation|0|||
126459822|NCT03505671|454984347|FG000|Overall Study|Withdrawal by Subject|2|||
126459823|NCT03505671|454984348|FG001|Overall Study|Withdrawal by Subject|1|||
126459824|NCT03505671|454984347|FG000|Overall Study|Lost to Follow-up|1|||
126459825|NCT03505671|454984348|FG001|Overall Study|Lost to Follow-up|0|||
126459826|NCT02038829|454984349|FG000|Washout Period 1|Death|0|||
126459827|NCT02038829|454984350|FG001|Washout Period 1|Death|0|||
126459828|NCT02038829|454984351|FG002|Washout Period 1|Death|0|||
126459829|NCT02038829|454984352|FG003|Washout Period 1|Death|0|||
126459830|NCT02038829|454984353|FG004|Washout Period 1|Death|1|||
126459831|NCT02038829|454984354|FG005|Washout Period 1|Death|0|||
126459832|NCT02038829|454984355|FG006|Washout Period 1|Death|0|||
126459833|NCT02038829|454984356|FG007|Washout Period 1|Death|0|||
126459834|NCT02038829|454984357|FG008|Washout Period 1|Death|0|||
126294027|NCT05012098|454366551|FG000|Overall Study|Disease progression|5|||
126294028|NCT05012098|454366552|FG001|Overall Study|Disease progression|2|||
126294029|NCT05012098|454366551|FG000|Overall Study|Adverse Event|1|||
126294030|NCT05012098|454366552|FG001|Overall Study|Adverse Event|0|||
126294031|NCT05012098|454366551|FG000|Overall Study|Withdrawal by Subject|1|||
126294032|NCT05012098|454366552|FG001|Overall Study|Withdrawal by Subject|0|||
126294033|NCT05012098|454366551|FG000|Overall Study|Discontinuation per protocol|1|||
126294034|NCT05012098|454366552|FG001|Overall Study|Discontinuation per protocol|0|||
126294035|NCT05258773|454366553|FG000|Overall Study|Screen Failure|1|||
126294036|NCT05258773|454366554|FG001|Overall Study|Screen Failure|1|||
126294037|NCT05258773|454366553|FG000|Overall Study|Adverse Event|1|||
126294038|NCT05258773|454366554|FG001|Overall Study|Adverse Event|0|||
126294039|NCT05258773|454366553|FG000|Overall Study|Withdrawal by Subject|0|||
126294040|NCT05258773|454366554|FG001|Overall Study|Withdrawal by Subject|1|||
126294041|NCT03018288|454366557|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
126294042|NCT03018288|454366558|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
126294043|NCT03018288|454366559|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
126294044|NCT03018288|454366560|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
126294045|NCT03018288|454366557|FG000|Overall Study|Participant withdrew consent.|0|||
126294046|NCT03018288|454366558|FG001|Overall Study|Participant withdrew consent.|0|||
126294047|NCT03018288|454366559|FG002|Overall Study|Participant withdrew consent.|1|||
126294048|NCT03018288|454366560|FG003|Overall Study|Participant withdrew consent.|0|||
126294049|NCT03018288|454366557|FG000|Overall Study|Switched to alternative treatment.|0|||
126294050|NCT03018288|454366558|FG001|Overall Study|Switched to alternative treatment.|0|||
126294051|NCT03018288|454366559|FG002|Overall Study|Switched to alternative treatment.|1|||
126294052|NCT03018288|454366560|FG003|Overall Study|Switched to alternative treatment.|0|||
126294053|NCT03018288|454366557|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
126294054|NCT03018288|454366558|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
126294055|NCT03018288|454366559|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
126294056|NCT03018288|454366560|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
126294057|NCT03018288|454366557|FG000|Overall Study|Screen failures|0|||
126294058|NCT03018288|454366558|FG001|Overall Study|Screen failures|0|||
126294059|NCT03018288|454366559|FG002|Overall Study|Screen failures|0|||
126294060|NCT03018288|454366560|FG003|Overall Study|Screen failures|51|||
126294061|NCT03018288|454366557|FG000|Overall Study|Chose treatment outside of UNC|0|||
126294062|NCT03018288|454366558|FG001|Overall Study|Chose treatment outside of UNC|0|||
126294063|NCT03018288|454366559|FG002|Overall Study|Chose treatment outside of UNC|0|||
126294064|NCT03018288|454366560|FG003|Overall Study|Chose treatment outside of UNC|1|||
126294065|NCT03018288|454366557|FG000|Overall Study|Unable to comply with protocol requirements|1|||
126294066|NCT03018288|454366558|FG001|Overall Study|Unable to comply with protocol requirements|1|||
126459835|NCT02038829|454984358|FG009|Washout Period 1|Death|0|||
126294067|NCT03018288|454366559|FG002|Overall Study|Unable to comply with protocol requirements|0|||
126294068|NCT03018288|454366560|FG003|Overall Study|Unable to comply with protocol requirements|1|||
126294069|NCT03018288|454366557|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
126294070|NCT03018288|454366558|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
126294071|NCT03018288|454366559|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
126294072|NCT03018288|454366560|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
126459836|NCT02038829|454984359|FG010|Washout Period 1|Death|0|||
126459837|NCT02038829|454984360|FG011|Washout Period 1|Death|0|||
126459838|NCT02038829|454984349|FG000|Treatment Period 2|Adverse Event|0|||
126459839|NCT02038829|454984350|FG001|Treatment Period 2|Adverse Event|0|||
126459840|NCT02038829|454984351|FG002|Treatment Period 2|Adverse Event|0|||
126459841|NCT02038829|454984352|FG003|Treatment Period 2|Adverse Event|0|||
126459842|NCT02038829|454984353|FG004|Treatment Period 2|Adverse Event|0|||
126550002|NCT03856996|455307705|FG001|Overall Study|Lost to Follow-up|1|||
126550003|NCT03856996|455307704|FG000|Overall Study|Adverse Event|1|||
126550004|NCT03856996|455307705|FG001|Overall Study|Adverse Event|1|||
126550005|NCT03856996|455307704|FG000|Overall Study|Other|1|||
126550006|NCT03856996|455307705|FG001|Overall Study|Other|0|||
126550007|NCT02340520|455307706|FG000|Overall Study|Lost to Follow-up|1|||
126550008|NCT02340520|455307706|FG000|Overall Study|Patient did not take drug as specified|1|||
126550009|NCT02340520|455307706|FG000|Overall Study|Withdrawal by Subject|1|||
126294073|NCT03018288|454366557|FG000|Overall Study|Physician Decision|0|||
126294074|NCT03018288|454366558|FG001|Overall Study|Physician Decision|0|||
126294075|NCT03018288|454366559|FG002|Overall Study|Physician Decision|0|||
126294076|NCT03018288|454366560|FG003|Overall Study|Physician Decision|1|||
126294077|NCT01490086|454366562|FG000|Overall Study|Consent withdrawn|4|||
126294078|NCT01490086|454366563|FG001|Overall Study|Consent withdrawn|4|||
126294079|NCT01490086|454366564|FG002|Overall Study|Consent withdrawn|3|||
126294080|NCT01490086|454366565|FG003|Overall Study|Consent withdrawn|0|||
126294081|NCT01490086|454366566|FG004|Overall Study|Consent withdrawn|1|||
126294082|NCT01490086|454366562|FG000|Overall Study|Non-compliance|0|||
126294083|NCT01490086|454366563|FG001|Overall Study|Non-compliance|1|||
126294084|NCT01490086|454366564|FG002|Overall Study|Non-compliance|0|||
126366611|NCT03729609|454637044|FG000|Overall Study|Protocol Violation|1|||
126366612|NCT00605189|454637051|FG000|Overall Study|Adverse Event|1|||
126366613|NCT00605189|454637052|FG001|Overall Study|Adverse Event|0|||
126366614|NCT00605189|454637053|FG002|Overall Study|Adverse Event|0|||
126366615|NCT00605189|454637051|FG000|Overall Study|Other|2|||
126366616|NCT00605189|454637052|FG001|Overall Study|Other|2|||
126366617|NCT00605189|454637053|FG002|Overall Study|Other|0|||
126366618|NCT02697448|454637054|FG000|Overall Study|Protocol Violation|2|||
126366619|NCT02697448|454637055|FG001|Overall Study|Protocol Violation|4|||
126366620|NCT02697448|454637054|FG000|Overall Study|Clinical concerns during ablation|1|||
126366621|NCT02697448|454637055|FG001|Overall Study|Clinical concerns during ablation|1|||
126366622|NCT02697448|454637054|FG000|Overall Study|No data collected|2|||
126366623|NCT02697448|454637055|FG001|Overall Study|No data collected|0|||
126366624|NCT05473715|454637056|FG000|Overall Study|Trial terminate|2|||
126366625|NCT05473715|454637057|FG001|Overall Study|Trial terminate|1|||
126366626|NCT02919618|454637061|FG000|Overall Study|Death|1|||
126366627|NCT02592863|454637062|FG000|Overall Study|Withdrawal by Subject|2|||
126366628|NCT02592863|454637063|FG001|Overall Study|Withdrawal by Subject|2|||
126366629|NCT02592863|454637062|FG000|Overall Study|Lost to Follow-up|1|||
126366630|NCT02592863|454637063|FG001|Overall Study|Lost to Follow-up|1|||
126366631|NCT02743221|454637064|FG000|Overall Study|Progressive disease|29|||
126366632|NCT02743221|454637065|FG001|Overall Study|Progressive disease|38|||
126366633|NCT02743221|454637064|FG000|Overall Study|Adverse Event|17|||
126366634|NCT02743221|454637065|FG001|Overall Study|Adverse Event|14|||
126366635|NCT02743221|454637064|FG000|Overall Study|non medical reason|8|||
126366636|NCT02743221|454637065|FG001|Overall Study|non medical reason|2|||
126366637|NCT02743221|454637064|FG000|Overall Study|Physician Decision|2|||
126366638|NCT02743221|454637065|FG001|Overall Study|Physician Decision|5|||
126366639|NCT02743221|454637064|FG000|Overall Study|Patient not eligible, not treated|0|||
126366640|NCT02743221|454637065|FG001|Overall Study|Patient not eligible, not treated|1|||
126366641|NCT04770285|454637067|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
126366642|NCT04770285|454637068|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
126366643|NCT04770285|454637067|FG000|Overall Study|Lack of Efficacy|0|||
126550010|NCT01464255|455307707|FG000|Overall Study|unresolve corneal staining|0|||
126710960|NCT01088412|455893570|FG001|Overall Study|Physician Decision|8|||
126294085|NCT01490086|454366565|FG003|Overall Study|Non-compliance|0|||
126294086|NCT01490086|454366566|FG004|Overall Study|Non-compliance|0|||
126294087|NCT01490086|454366562|FG000|Overall Study|Abnormal laboratory findings|1|||
126294088|NCT01490086|454366563|FG001|Overall Study|Abnormal laboratory findings|0|||
126294089|NCT01490086|454366564|FG002|Overall Study|Abnormal laboratory findings|0|||
126366644|NCT04770285|454637068|FG001|Overall Study|Lack of Efficacy|1|||
126366645|NCT04770285|454637067|FG000|Overall Study|Lost to Follow-up|11|||
126366646|NCT04770285|454637068|FG001|Overall Study|Lost to Follow-up|8|||
126366647|NCT04770285|454637067|FG000|Overall Study|Protocol Deviation|6|||
126366648|NCT04770285|454637068|FG001|Overall Study|Protocol Deviation|6|||
126366649|NCT04770285|454637067|FG000|Overall Study|Technical Problem|0|||
126366650|NCT04770285|454637068|FG001|Overall Study|Technical Problem|1|||
126366651|NCT04770285|454637067|FG000|Overall Study|Withdrawal by Subject|9|||
126366652|NCT04770285|454637068|FG001|Overall Study|Withdrawal by Subject|8|||
126710961|NCT01088412|455893571|FG002|Overall Study|Physician Decision|4|||
126710962|NCT01088412|455893569|FG000|Overall Study|Sponsor Decision|4467|||
126710963|NCT01088412|455893570|FG001|Overall Study|Sponsor Decision|79|||
126710964|NCT01088412|455893571|FG002|Overall Study|Sponsor Decision|23|||
126710965|NCT01088412|455893569|FG000|Overall Study|Third Party Required to Change Brand|487|||
126710966|NCT01088412|455893570|FG001|Overall Study|Third Party Required to Change Brand|0|||
126710967|NCT01088412|455893571|FG002|Overall Study|Third Party Required to Change Brand|0|||
126710968|NCT01088412|455893569|FG000|Overall Study|Lost to Follow-up|3052|||
126710969|NCT01088412|455893570|FG001|Overall Study|Lost to Follow-up|130|||
126459843|NCT02038829|454984354|FG005|Treatment Period 2|Adverse Event|0|||
126459844|NCT02038829|454984355|FG006|Treatment Period 2|Adverse Event|0|||
126459845|NCT02038829|454984356|FG007|Treatment Period 2|Adverse Event|0|||
126459846|NCT02038829|454984357|FG008|Treatment Period 2|Adverse Event|0|||
126459847|NCT02038829|454984358|FG009|Treatment Period 2|Adverse Event|0|||
126459848|NCT02038829|454984359|FG010|Treatment Period 2|Adverse Event|1|||
126459849|NCT02038829|454984360|FG011|Treatment Period 2|Adverse Event|0|||
126459850|NCT02038829|454984349|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126459851|NCT02038829|454984350|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126459852|NCT02038829|454984351|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126459853|NCT02038829|454984352|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126459854|NCT02038829|454984353|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126459855|NCT02038829|454984354|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126459856|NCT02038829|454984355|FG006|Treatment Period 2|Withdrawal by Subject|0|||
126459857|NCT02038829|454984356|FG007|Treatment Period 2|Withdrawal by Subject|0|||
126459858|NCT02038829|454984357|FG008|Treatment Period 2|Withdrawal by Subject|0|||
126459859|NCT02038829|454984358|FG009|Treatment Period 2|Withdrawal by Subject|0|||
126459860|NCT02038829|454984359|FG010|Treatment Period 2|Withdrawal by Subject|0|||
126459861|NCT02038829|454984360|FG011|Treatment Period 2|Withdrawal by Subject|0|||
126459862|NCT02038829|454984349|FG000|Washout Period 2|Adverse Event|0|||
126459863|NCT02038829|454984350|FG001|Washout Period 2|Adverse Event|0|||
126459864|NCT02038829|454984351|FG002|Washout Period 2|Adverse Event|0|||
126459865|NCT02038829|454984352|FG003|Washout Period 2|Adverse Event|0|||
126459866|NCT02038829|454984353|FG004|Washout Period 2|Adverse Event|0|||
126459867|NCT02038829|454984354|FG005|Washout Period 2|Adverse Event|0|||
126459868|NCT02038829|454984355|FG006|Washout Period 2|Adverse Event|0|||
126459869|NCT02038829|454984356|FG007|Washout Period 2|Adverse Event|0|||
126459870|NCT02038829|454984357|FG008|Washout Period 2|Adverse Event|1|||
126459871|NCT02038829|454984358|FG009|Washout Period 2|Adverse Event|0|||
126459872|NCT02038829|454984359|FG010|Washout Period 2|Adverse Event|0|||
126459873|NCT02038829|454984360|FG011|Washout Period 2|Adverse Event|0|||
126459874|NCT02038829|454984349|FG000|Washout Period 2|Withdrawal by Subject|0|||
126459875|NCT02038829|454984350|FG001|Washout Period 2|Withdrawal by Subject|0|||
126459876|NCT02038829|454984351|FG002|Washout Period 2|Withdrawal by Subject|0|||
126459877|NCT02038829|454984352|FG003|Washout Period 2|Withdrawal by Subject|0|||
126459878|NCT02038829|454984353|FG004|Washout Period 2|Withdrawal by Subject|0|||
126459879|NCT02038829|454984354|FG005|Washout Period 2|Withdrawal by Subject|1|||
126459880|NCT02038829|454984355|FG006|Washout Period 2|Withdrawal by Subject|0|||
126459881|NCT02038829|454984356|FG007|Washout Period 2|Withdrawal by Subject|0|||
126459882|NCT02038829|454984357|FG008|Washout Period 2|Withdrawal by Subject|0|||
126459883|NCT02038829|454984358|FG009|Washout Period 2|Withdrawal by Subject|0|||
126459884|NCT02038829|454984359|FG010|Washout Period 2|Withdrawal by Subject|0|||
126459885|NCT02038829|454984360|FG011|Washout Period 2|Withdrawal by Subject|0|||
126459886|NCT02038829|454984349|FG000|Treatment Period 4|Adverse Event|0|||
126459887|NCT02038829|454984350|FG001|Treatment Period 4|Adverse Event|1|||
126459888|NCT02038829|454984351|FG002|Treatment Period 4|Adverse Event|0|||
126459889|NCT02038829|454984352|FG003|Treatment Period 4|Adverse Event|0|||
126459890|NCT02038829|454984353|FG004|Treatment Period 4|Adverse Event|0|||
126459891|NCT02038829|454984354|FG005|Treatment Period 4|Adverse Event|0|||
126459892|NCT02038829|454984355|FG006|Treatment Period 4|Adverse Event|0|||
126459893|NCT02038829|454984356|FG007|Treatment Period 4|Adverse Event|0|||
126459894|NCT02038829|454984357|FG008|Treatment Period 4|Adverse Event|0|||
126459895|NCT02038829|454984358|FG009|Treatment Period 4|Adverse Event|0|||
126459896|NCT02038829|454984359|FG010|Treatment Period 4|Adverse Event|0|||
126459897|NCT02038829|454984360|FG011|Treatment Period 4|Adverse Event|0|||
126459898|NCT02038829|454984349|FG000|Washout Period 4|Adverse Event|0|||
126459899|NCT02038829|454984350|FG001|Washout Period 4|Adverse Event|0|||
126459900|NCT02038829|454984351|FG002|Washout Period 4|Adverse Event|0|||
126459901|NCT02038829|454984352|FG003|Washout Period 4|Adverse Event|0|||
126459902|NCT02038829|454984353|FG004|Washout Period 4|Adverse Event|0|||
126459903|NCT02038829|454984354|FG005|Washout Period 4|Adverse Event|0|||
126459904|NCT02038829|454984355|FG006|Washout Period 4|Adverse Event|1|||
126459905|NCT02038829|454984356|FG007|Washout Period 4|Adverse Event|0|||
126550011|NCT01464255|455307708|FG001|Overall Study|unresolve corneal staining|1|||
126550012|NCT01231503|455307709|FG000|Overall Study|Adverse Event|0|||
126459906|NCT02038829|454984357|FG008|Washout Period 4|Adverse Event|0|||
126459907|NCT02038829|454984358|FG009|Washout Period 4|Adverse Event|0|||
126459908|NCT02038829|454984359|FG010|Washout Period 4|Adverse Event|0|||
126459909|NCT02038829|454984360|FG011|Washout Period 4|Adverse Event|0|||
126459910|NCT02038829|454984349|FG000|Treatment Period 6|Adverse Event|0|||
126459911|NCT02038829|454984350|FG001|Treatment Period 6|Adverse Event|0|||
126459912|NCT02038829|454984351|FG002|Treatment Period 6|Adverse Event|1|||
126459913|NCT02038829|454984352|FG003|Treatment Period 6|Adverse Event|0|||
126459914|NCT02038829|454984353|FG004|Treatment Period 6|Adverse Event|0|||
126459915|NCT02038829|454984354|FG005|Treatment Period 6|Adverse Event|0|||
126459916|NCT02038829|454984355|FG006|Treatment Period 6|Adverse Event|0|||
126550013|NCT01231503|455307710|FG001|Overall Study|Adverse Event|0|||
126459917|NCT02038829|454984356|FG007|Treatment Period 6|Adverse Event|0|||
126459918|NCT02038829|454984357|FG008|Treatment Period 6|Adverse Event|0|||
126294090|NCT01490086|454366565|FG003|Overall Study|Abnormal laboratory findings|0|||
126294091|NCT01490086|454366566|FG004|Overall Study|Abnormal laboratory findings|0|||
126294092|NCT01490086|454366562|FG000|Overall Study|Lost to Follow-up|0|||
126294093|NCT01490086|454366563|FG001|Overall Study|Lost to Follow-up|0|||
126294094|NCT01490086|454366564|FG002|Overall Study|Lost to Follow-up|0|||
126294095|NCT01490086|454366565|FG003|Overall Study|Lost to Follow-up|0|||
126294096|NCT01490086|454366566|FG004|Overall Study|Lost to Follow-up|1|||
126294097|NCT01490086|454366562|FG000|Overall Study|Physician Decision|3|||
126294098|NCT01490086|454366563|FG001|Overall Study|Physician Decision|4|||
126294099|NCT01490086|454366564|FG002|Overall Study|Physician Decision|2|||
126294100|NCT01490086|454366565|FG003|Overall Study|Physician Decision|3|||
126294101|NCT01490086|454366566|FG004|Overall Study|Physician Decision|1|||
126294102|NCT01490086|454366562|FG000|Overall Study|Adverse Event|0|||
126294103|NCT01490086|454366563|FG001|Overall Study|Adverse Event|0|||
126294104|NCT01490086|454366564|FG002|Overall Study|Adverse Event|1|||
126366653|NCT04770285|454637067|FG000|Overall Study|Reason Not Specified|0|||
126366654|NCT04770285|454637068|FG001|Overall Study|Reason Not Specified|1|||
126366655|NCT03411044|454637069|FG000|Overall Study|Death|30|||
126366656|NCT03411044|454637069|FG000|Overall Study|Withdrawal by Subject|48|||
126366657|NCT03411044|454637069|FG000|Overall Study|Lost to Follow-up|78|||
126366658|NCT03411044|454637069|FG000|Overall Study|Adverse Event|30|||
126366659|NCT03411044|454637069|FG000|Overall Study|Missing status|4|||
126366660|NCT01969409|454637070|FG000|Overall Study|Death|2|||
126366661|NCT01969409|454637071|FG001|Overall Study|Death|2|||
126366662|NCT01969409|454637070|FG000|Overall Study|Transplant|1|||
126366663|NCT01969409|454637071|FG001|Overall Study|Transplant|1|||
126366664|NCT01969409|454637070|FG000|Overall Study|Withdrawal by Subject|0|||
126366665|NCT01969409|454637071|FG001|Overall Study|Withdrawal by Subject|1|||
126366666|NCT03078868|454637074|FG000|Overall Study|Physician Decision|3|||
126366667|NCT01435356|454637075|FG000|Overall Study|Adverse Event|2|||
126366668|NCT01435356|454637076|FG001|Overall Study|Adverse Event|0|||
126366669|NCT01435356|454637075|FG000|Overall Study|Disease progression/recurrence|17|||
126366670|NCT01435356|454637076|FG001|Overall Study|Disease progression/recurrence|10|||
126366671|NCT01435356|454637075|FG000|Overall Study|Protocol Violation|0|||
126366672|NCT01435356|454637076|FG001|Overall Study|Protocol Violation|1|||
126366673|NCT01435356|454637075|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
126366674|NCT01435356|454637076|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
126366675|NCT01435356|454637075|FG000|Overall Study|Withdrawal by Subject|1|||
126366676|NCT01435356|454637076|FG001|Overall Study|Withdrawal by Subject|1|||
126366677|NCT01435356|454637075|FG000|Overall Study|Facial palsy|1|||
126366678|NCT01435356|454637076|FG001|Overall Study|Facial palsy|0|||
126366679|NCT01435356|454637075|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
126366680|NCT01435356|454637076|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
126366681|NCT01435356|454637075|FG000|Overall Study|Physician Decision|1|||
126366682|NCT01435356|454637076|FG001|Overall Study|Physician Decision|0|||
126366683|NCT01435356|454637075|FG000|Overall Study|Patient decision|3|||
126366684|NCT01435356|454637076|FG001|Overall Study|Patient decision|0|||
126366685|NCT01435356|454637075|FG000|Overall Study|Patient moved to another city|1|||
126366686|NCT01435356|454637076|FG001|Overall Study|Patient moved to another city|1|||
126366687|NCT00437073|454637077|FG000|Overall Study|Sponsor Terminated Study|1|||
126366688|NCT00437073|454637078|FG001|Overall Study|Sponsor Terminated Study|0|||
126366689|NCT00437073|454637077|FG000|Overall Study|Physician Decision|0|||
126366690|NCT00437073|454637078|FG001|Overall Study|Physician Decision|1|||
126366691|NCT04221438|454637081|FG000|Overall Study|Adverse Event|1|||
126366692|NCT04221438|454637081|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
126366693|NCT03673176|454639278|FG000|Overall Study|Death prior to intervention|1|||
126366694|NCT03673176|454639278|FG000|Overall Study|Death following intervention|3|||
126366695|NCT03673176|454639278|FG000|Overall Study|Withdrawal by Subject|1|||
126366696|NCT03283241|454639279|FG000|Overall Study|Adverse Event|4|||
126366697|NCT03283241|454639280|FG001|Overall Study|Adverse Event|1|||
126366698|NCT03283241|454639279|FG000|Overall Study|Withdrawal by Subject|0|||
126366699|NCT03283241|454639280|FG001|Overall Study|Withdrawal by Subject|1|||
126366700|NCT03283241|454639279|FG000|Overall Study|Subject relocated to Finland|0|||
126366701|NCT03283241|454639280|FG001|Overall Study|Subject relocated to Finland|1|||
126366702|NCT00666263|454639281|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
126366703|NCT00666263|454639282|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
126294105|NCT01490086|454366565|FG003|Overall Study|Adverse Event|2|||
126294106|NCT01490086|454366566|FG004|Overall Study|Adverse Event|0|||
126366704|NCT00666263|454639281|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
126366705|NCT00666263|454639282|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
126366706|NCT00666263|454639281|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
126366707|NCT00666263|454639282|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
126366708|NCT01225952|454639284|FG000|Overall Study|Lost to Follow-up|1|||
126366709|NCT01225952|454639285|FG001|Overall Study|Lost to Follow-up|0|||
126366710|NCT01225952|454639286|FG002|Overall Study|Lost to Follow-up|0|||
126294107|NCT01490086|454366562|FG000|Overall Study|Lack of Efficacy|0|||
126459919|NCT02038829|454984358|FG009|Treatment Period 6|Adverse Event|0|||
126459920|NCT02038829|454984359|FG010|Treatment Period 6|Adverse Event|0|||
126459921|NCT02038829|454984360|FG011|Treatment Period 6|Adverse Event|0|||
126459922|NCT00812487|454984361|FG000|Overall Study|Lost to Follow-up|2|||
126459923|NCT00812487|454984362|FG001|Overall Study|Lost to Follow-up|0|||
126459924|NCT00812487|454984361|FG000|Overall Study|Withdrawal by Subject|3|||
126459925|NCT00812487|454984362|FG001|Overall Study|Withdrawal by Subject|2|||
126459926|NCT00812487|454984361|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
126459927|NCT00812487|454984362|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
126459928|NCT00812487|454984361|FG000|Overall Study|Protocol Violation|0|||
126459929|NCT00812487|454984362|FG001|Overall Study|Protocol Violation|1|||
126459930|NCT02360605|454984363|FG000|Overall Study|Withdrawal by Subject|4|||
126459931|NCT02360605|454984364|FG001|Overall Study|Withdrawal by Subject|9|||
126459932|NCT02360605|454984363|FG000|Overall Study|Lost to Follow-up|7|||
126459933|NCT02360605|454984364|FG001|Overall Study|Lost to Follow-up|8|||
126459934|NCT02360605|454984363|FG000|Overall Study|Death|0|||
126459935|NCT02360605|454984364|FG001|Overall Study|Death|1|||
126459936|NCT00290407|454984367|FG000|Overall Study|Physician Decision|2|||
126459937|NCT01117792|454984369|FG000|Overall Study|Death|1|||
126459938|NCT01117792|454984369|FG000|Overall Study|Adverse Event|3|||
126459939|NCT00740051|454984372|FG000|Overall Study|Lack of Efficacy|2|||
126459940|NCT00740051|454984373|FG001|Overall Study|Lack of Efficacy|5|||
126459941|NCT00740051|454984372|FG000|Overall Study|Adverse Event|1|||
126459942|NCT00740051|454984373|FG001|Overall Study|Adverse Event|4|||
126459943|NCT00740051|454984372|FG000|Overall Study|Protocol Violation|2|||
126550014|NCT01231503|455307711|FG002|Overall Study|Adverse Event|0|||
126550015|NCT01231503|455307712|FG003|Overall Study|Adverse Event|0|||
126550016|NCT01231503|455307713|FG004|Overall Study|Adverse Event|0|||
126550017|NCT01231503|455307714|FG005|Overall Study|Adverse Event|1|||
126550018|NCT01231503|455307715|FG006|Overall Study|Adverse Event|0|||
126550019|NCT01231503|455307716|FG007|Overall Study|Adverse Event|0|||
126550020|NCT01231503|455307709|FG000|Overall Study|Adverse event, serious fatal|0|||
126550021|NCT01231503|455307710|FG001|Overall Study|Adverse event, serious fatal|0|||
126550022|NCT01231503|455307711|FG002|Overall Study|Adverse event, serious fatal|1|||
126550023|NCT01231503|455307712|FG003|Overall Study|Adverse event, serious fatal|1|||
126550024|NCT01231503|455307713|FG004|Overall Study|Adverse event, serious fatal|0|||
126550025|NCT01231503|455307714|FG005|Overall Study|Adverse event, serious fatal|1|||
126550026|NCT01231503|455307715|FG006|Overall Study|Adverse event, serious fatal|0|||
126550027|NCT01231503|455307716|FG007|Overall Study|Adverse event, serious fatal|0|||
126550028|NCT01231503|455307709|FG000|Overall Study|Withdrawal by Subject|6|||
126550029|NCT01231503|455307710|FG001|Overall Study|Withdrawal by Subject|3|||
126550030|NCT01231503|455307711|FG002|Overall Study|Withdrawal by Subject|3|||
126550031|NCT01231503|455307712|FG003|Overall Study|Withdrawal by Subject|1|||
126550032|NCT01231503|455307713|FG004|Overall Study|Withdrawal by Subject|3|||
126550033|NCT01231503|455307714|FG005|Overall Study|Withdrawal by Subject|5|||
126550034|NCT01231503|455307715|FG006|Overall Study|Withdrawal by Subject|1|||
126550035|NCT01231503|455307716|FG007|Overall Study|Withdrawal by Subject|2|||
126550036|NCT01231503|455307709|FG000|Overall Study|Lost to Follow-up|8|||
126550037|NCT01231503|455307710|FG001|Overall Study|Lost to Follow-up|10|||
126550038|NCT01231503|455307711|FG002|Overall Study|Lost to Follow-up|8|||
126550039|NCT01231503|455307712|FG003|Overall Study|Lost to Follow-up|5|||
126550040|NCT01231503|455307713|FG004|Overall Study|Lost to Follow-up|7|||
126550041|NCT01231503|455307714|FG005|Overall Study|Lost to Follow-up|9|||
126550042|NCT01231503|455307715|FG006|Overall Study|Lost to Follow-up|6|||
126550043|NCT01231503|455307716|FG007|Overall Study|Lost to Follow-up|6|||
126550044|NCT01231503|455307709|FG000|Overall Study|Protocol Violation|0|||
126550045|NCT01231503|455307710|FG001|Overall Study|Protocol Violation|0|||
126550046|NCT01231503|455307711|FG002|Overall Study|Protocol Violation|0|||
126550047|NCT01231503|455307712|FG003|Overall Study|Protocol Violation|1|||
126550048|NCT01231503|455307713|FG004|Overall Study|Protocol Violation|0|||
126550049|NCT01231503|455307714|FG005|Overall Study|Protocol Violation|0|||
126294108|NCT01490086|454366563|FG001|Overall Study|Lack of Efficacy|3|||
126459944|NCT00740051|454984373|FG001|Overall Study|Protocol Violation|6|||
126459945|NCT00740051|454984372|FG000|Overall Study|Lost to Follow-up|3|||
126459946|NCT00740051|454984373|FG001|Overall Study|Lost to Follow-up|8|||
126459947|NCT00740051|454984372|FG000|Overall Study|Withdrawal by Subject|6|||
126459948|NCT00740051|454984373|FG001|Overall Study|Withdrawal by Subject|8|||
126459949|NCT00740051|454984372|FG000|Overall Study|Other reason (not specified)|4|||
126459950|NCT00740051|454984373|FG001|Overall Study|Other reason (not specified)|1|||
126459951|NCT00274924|454984374|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
126459952|NCT00274924|454984375|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
126459953|NCT00274924|454984376|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
126459954|NCT00274924|454984374|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
126459955|NCT00274924|454984375|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
126550050|NCT01231503|455307715|FG006|Overall Study|Protocol Violation|0|||
126550051|NCT01231503|455307716|FG007|Overall Study|Protocol Violation|0|||
126550052|NCT01076088|455307717|FG000|Overall Study|Adverse Event|1|||
126459956|NCT00274924|454984376|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
126459957|NCT00274924|454984374|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
126459958|NCT00274924|454984375|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
126459959|NCT00274924|454984376|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
126459960|NCT00274924|454984374|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
126459961|NCT00274924|454984375|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
126459962|NCT00274924|454984376|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
126459963|NCT00274924|454984374|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
126459964|NCT00274924|454984375|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
126459965|NCT00274924|454984376|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
126459966|NCT00274924|454984374|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
126459967|NCT00274924|454984375|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
126459968|NCT00274924|454984376|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
126459969|NCT00274924|454984374|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
126459970|NCT00274924|454984375|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
126459971|NCT00274924|454984376|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
126459972|NCT00274924|454984374|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
126459973|NCT00274924|454984375|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
126459974|NCT00274924|454984376|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
126459975|NCT00274924|454984374|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
126459976|NCT00274924|454984375|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
126459977|NCT00274924|454984376|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
126459978|NCT00274924|454984374|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
126459979|NCT00274924|454984375|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
126459980|NCT00274924|454984376|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
126459981|NCT00274924|454984374|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
126459982|NCT00274924|454984375|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
126459983|NCT00274924|454984376|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
126459984|NCT00274924|454984374|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
126459985|NCT00274924|454984375|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
126459986|NCT00274924|454984376|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
126459987|NCT00274924|454984374|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
126459988|NCT00274924|454984375|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
126459989|NCT00274924|454984376|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
126459990|NCT01903525|454984380|FG000|Overall Study|Lost to Follow-up|5|||
126459991|NCT01903525|454984381|FG001|Overall Study|Lost to Follow-up|9|||
126459992|NCT01903525|454984380|FG000|Overall Study|Adverse Event|0|||
126459993|NCT01903525|454984381|FG001|Overall Study|Adverse Event|1|||
126459994|NCT02106923|454984387|FG000|Overall Study|Protocol Violation|0|||
126459995|NCT02106923|454984388|FG001|Overall Study|Protocol Violation|0|||
126459996|NCT02106923|454984389|FG002|Overall Study|Protocol Violation|0|||
126459997|NCT02106923|454984390|FG003|Overall Study|Protocol Violation|0|||
126459998|NCT02106923|454984391|FG004|Overall Study|Protocol Violation|0|||
126459999|NCT02106923|454984392|FG005|Overall Study|Protocol Violation|1|||
126460000|NCT03485495|454984393|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
126460001|NCT03485495|454984394|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
126460002|NCT02915874|454984396|FG000|Overall Study|Lost to Follow-up|5|||
126460003|NCT02915874|454984397|FG001|Overall Study|Lost to Follow-up|4|||
126460004|NCT02915874|454984396|FG000|Overall Study|Withdrawal by Subject|1|||
126460005|NCT02915874|454984397|FG001|Overall Study|Withdrawal by Subject|1|||
126460006|NCT02915874|454984396|FG000|Overall Study|Started New Anxiety Medication|0|||
126460007|NCT02915874|454984397|FG001|Overall Study|Started New Anxiety Medication|1|||
126460008|NCT01056380|454984399|FG000|Overall Study|Lost to Follow-up|2|||
126460009|NCT01056380|454984400|FG001|Overall Study|Lost to Follow-up|3|||
126460010|NCT03901456|454984401|FG000|Overall Study|Withdrawal by Subject|0|||
126710970|NCT01088412|455893571|FG002|Overall Study|Lost to Follow-up|11|||
126710971|NCT01088412|455893569|FG000|Overall Study|Study Summary Not Completed|4360|||
126710972|NCT01088412|455893570|FG001|Overall Study|Study Summary Not Completed|64|||
126710973|NCT01088412|455893571|FG002|Overall Study|Study Summary Not Completed|22|||
126710974|NCT02111811|455893572|FG000|Treatment Phase|Lost to Follow-up|22|||
126710975|NCT02111811|455893573|FG001|Treatment Phase|Lost to Follow-up|18|||
126710976|NCT02111811|455893572|FG000|Treatment Phase|Death|2|||
126460011|NCT03901456|454984402|FG001|Overall Study|Withdrawal by Subject|0|||
126460012|NCT03901456|454984403|FG002|Overall Study|Withdrawal by Subject|1|||
126460013|NCT03901456|454984401|FG000|Overall Study|Lost to Follow-up|0|||
126460014|NCT03901456|454984402|FG001|Overall Study|Lost to Follow-up|1|||
126460015|NCT03901456|454984403|FG002|Overall Study|Lost to Follow-up|0|||
126460016|NCT00509262|454984409|FG000|Overall Study|Adverse Event|16|||
126460017|NCT00509262|454984410|FG001|Overall Study|Adverse Event|18|||
126460018|NCT00509262|454984409|FG000|Overall Study|Other|2|||
126460019|NCT00509262|454984410|FG001|Overall Study|Other|2|||
126460020|NCT00509262|454984409|FG000|Overall Study|Lack of Efficacy|1|||
126460021|NCT00509262|454984410|FG001|Overall Study|Lack of Efficacy|0|||
126460022|NCT00509262|454984409|FG000|Overall Study|Lost to Follow-up|1|||
126460023|NCT00509262|454984410|FG001|Overall Study|Lost to Follow-up|6|||
126460024|NCT00509262|454984409|FG000|Overall Study|Physician Decision|1|||
126460025|NCT00509262|454984410|FG001|Overall Study|Physician Decision|3|||
126460026|NCT00509262|454984409|FG000|Overall Study|Protocol Violation|2|||
126460027|NCT00509262|454984410|FG001|Overall Study|Protocol Violation|2|||
126460028|NCT00509262|454984409|FG000|Overall Study|Withdrawal by Subject|24|||
126460029|NCT00509262|454984410|FG001|Overall Study|Withdrawal by Subject|11|||
126460030|NCT01589770|454984413|FG000|Overall Study|EGFR <60ml/min|6|||
126460031|NCT01589770|454984414|FG001|Overall Study|EGFR <60ml/min|4|||
126460032|NCT01589770|454984413|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
126460033|NCT01589770|454984414|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
126460034|NCT00725842|454984415|FG000|Overall Study|Lost to Follow-up|19|||
126460035|NCT00725842|454984415|FG000|Overall Study|Death|1|||
126460036|NCT00725842|454984415|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
126460037|NCT00725842|454984415|FG000|Overall Study|Consent date prior to study start date|5|||
126460038|NCT00725842|454984415|FG000|Overall Study|Inclusion criterion not met|1|||
126460039|NCT00725842|454984415|FG000|Overall Study|No Visit 1 data|1|||
126460040|NCT01853618|454984416|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
126460041|NCT01853618|454984417|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
126460042|NCT01853618|454984418|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
126460043|NCT01853618|454984419|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
126460044|NCT01853618|454984420|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
126460045|NCT01853618|454984416|FG000|Overall Study|Progressive disease|1|||
126460046|NCT01853618|454984417|FG001|Overall Study|Progressive disease|1|||
126460047|NCT01853618|454984418|FG002|Overall Study|Progressive disease|1|||
126460048|NCT01853618|454984419|FG003|Overall Study|Progressive disease|1|||
126460049|NCT01853618|454984420|FG004|Overall Study|Progressive disease|2|||
126460050|NCT01853618|454984416|FG000|Overall Study|Physician Decision|0|||
126460051|NCT01853618|454984417|FG001|Overall Study|Physician Decision|1|||
126460052|NCT01853618|454984418|FG002|Overall Study|Physician Decision|1|||
126460053|NCT01853618|454984419|FG003|Overall Study|Physician Decision|0|||
126460054|NCT01853618|454984420|FG004|Overall Study|Physician Decision|0|||
126460055|NCT01853618|454984416|FG000|Overall Study|Refused further treatment|0|||
126460056|NCT01853618|454984417|FG001|Overall Study|Refused further treatment|0|||
126460057|NCT01853618|454984418|FG002|Overall Study|Refused further treatment|0|||
126460058|NCT01853618|454984419|FG003|Overall Study|Refused further treatment|0|||
126460059|NCT01853618|454984420|FG004|Overall Study|Refused further treatment|1|||
126460060|NCT01715129|454984429|FG000|Overall Study|Adverse Event, fatal|1|||
126460061|NCT01715129|454984429|FG000|Overall Study|Lack of Efficacy|3|||
126460062|NCT01715129|454984429|FG000|Overall Study|Protocol Violation|1|||
126460063|NCT01715129|454984429|FG000|Overall Study|Consent Withdrawn|2|||
126460064|NCT01715129|454984429|FG000|Overall Study|Lost to Follow-up|1|||
126460065|NCT01715129|454984429|FG000|Overall Study|Other|1|||
126460066|NCT02793622|454984430|FG000|Overall Study|Lost to Follow-up|31|||
126460067|NCT02793622|454984431|FG001|Overall Study|Lost to Follow-up|19|||
126460068|NCT02793622|454984430|FG000|Overall Study|Withdrawal by Subject|21|||
126460069|NCT02793622|454984431|FG001|Overall Study|Withdrawal by Subject|17|||
126460070|NCT02793622|454984430|FG000|Overall Study|Adverse Event|0|||
126460071|NCT02793622|454984431|FG001|Overall Study|Adverse Event|1|||
126460072|NCT02793622|454984430|FG000|Overall Study|Protocol Violation|1|||
126460073|NCT02793622|454984431|FG001|Overall Study|Protocol Violation|5|||
126460074|NCT01075191|454984432|FG000|Overall Study|Death|1|||
126460075|NCT01075191|454984432|FG000|Overall Study|Intensification|3|||
126460076|NCT01075191|454984432|FG000|Overall Study|Co-morbidities|1|||
126460077|NCT01075191|454984432|FG000|Overall Study|Adverse Event|4|||
126460078|NCT01075191|454984432|FG000|Overall Study|Noncompliance|3|||
126460079|NCT01075191|454984432|FG000|Overall Study|Therapy Break|3|||
126460080|NCT01075191|454984432|FG000|Overall Study|Patient's Wish|2|||
126460081|NCT01075191|454984432|FG000|Overall Study|Unknown Reasons|1|||
126294109|NCT01490086|454366564|FG002|Overall Study|Lack of Efficacy|1|||
126294110|NCT01490086|454366565|FG003|Overall Study|Lack of Efficacy|0|||
126294111|NCT01490086|454366566|FG004|Overall Study|Lack of Efficacy|8|||
126460082|NCT02068768|454984433|FG000|Overall Study|Lost to Follow-up|5|||
126460083|NCT02068768|454984433|FG000|Overall Study|Early Termination by Sponsor|2|||
126460084|NCT04738318|454984434|FG000|Overall Study|Protocol Violation|1|||
126460085|NCT04738318|454984435|FG001|Overall Study|Protocol Violation|0|||
126460086|NCT01226121|454984436|FG000|Overall Study|Lost to Follow-up|2|||
126460087|NCT01226121|454984437|FG001|Overall Study|Lost to Follow-up|0|||
126460088|NCT01226121|454984438|FG002|Overall Study|Lost to Follow-up|1|||
126294112|NCT01490086|454366562|FG000|Overall Study|Worsening of symptoms|0|||
126294113|NCT01490086|454366563|FG001|Overall Study|Worsening of symptoms|1|||
126460089|NCT01037088|454984439|FG000|Overall Study|Withdrawal by Subject|3|||
126460090|NCT00527488|454984440|FG000|Overall Study|Withdrawn prior to dosing|0|||
126460091|NCT00527488|454984441|FG001|Overall Study|Withdrawn prior to dosing|1|||
126460092|NCT00527488|454984442|FG002|Overall Study|Withdrawn prior to dosing|1|||
126460093|NCT00527488|454984443|FG003|Overall Study|Withdrawn prior to dosing|0|||
126294114|NCT01490086|454366564|FG002|Overall Study|Worsening of symptoms|0|||
126294115|NCT01490086|454366565|FG003|Overall Study|Worsening of symptoms|1|||
126294116|NCT01490086|454366566|FG004|Overall Study|Worsening of symptoms|0|||
126460094|NCT01958827|454984444|FG000|Overall Study|Adverse Event|3|||
126294117|NCT01490086|454366562|FG000|Overall Study|Subject uncontrollable and abusive|0|||
126294118|NCT01490086|454366563|FG001|Overall Study|Subject uncontrollable and abusive|1|||
126294119|NCT01490086|454366564|FG002|Overall Study|Subject uncontrollable and abusive|0|||
126294120|NCT01490086|454366565|FG003|Overall Study|Subject uncontrollable and abusive|0|||
126294121|NCT01490086|454366566|FG004|Overall Study|Subject uncontrollable and abusive|0|||
126294122|NCT01490086|454366562|FG000|Overall Study|Subject left hospital|0|||
126294123|NCT01490086|454366563|FG001|Overall Study|Subject left hospital|1|||
126294124|NCT01490086|454366564|FG002|Overall Study|Subject left hospital|0|||
126294125|NCT01490086|454366565|FG003|Overall Study|Subject left hospital|1|||
126294126|NCT01490086|454366566|FG004|Overall Study|Subject left hospital|0|||
126294127|NCT06025721|454366567|FG000|Overall Study|Physician Decision|1|||
126294128|NCT06025721|454366567|FG000|Overall Study|Protocol Violation|1|||
126294129|NCT06025721|454366567|FG000|Overall Study|Incarceration|1|||
126460095|NCT01958827|454984444|FG000|Overall Study|Lack of Efficacy|6|||
126460096|NCT01958827|454984444|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
126460097|NCT03036800|454984445|FG000|Overall Study|Protocol Violation|1|||
126460098|NCT03036800|454984446|FG001|Overall Study|Protocol Violation|0|||
126460099|NCT03036800|454984445|FG000|Overall Study|Non-compliance|1|||
126460100|NCT03036800|454984446|FG001|Overall Study|Non-compliance|0|||
126460101|NCT03036800|454984445|FG000|Overall Study|Lost to Follow-up|1|||
126460102|NCT03036800|454984446|FG001|Overall Study|Lost to Follow-up|0|||
126460103|NCT03036800|454984445|FG000|Overall Study|Death|1|||
126460104|NCT03036800|454984446|FG001|Overall Study|Death|0|||
126460105|NCT03036800|454984445|FG000|Overall Study|Tolerance|5|||
126460106|NCT03036800|454984446|FG001|Overall Study|Tolerance|0|||
126460107|NCT03036800|454984445|FG000|Overall Study|Unknown/no reason given|50|||
126460108|NCT03036800|454984446|FG001|Overall Study|Unknown/no reason given|39|||
126460109|NCT01077154|454984447|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
126460110|NCT01077154|454984448|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
126460111|NCT01077154|454984447|FG000|Overall Study|Withdrawal by Subject|369|||
126460112|NCT01077154|454984448|FG001|Overall Study|Withdrawal by Subject|385|||
126460113|NCT01077154|454984447|FG000|Overall Study|Death|215|||
126460114|NCT01077154|454984448|FG001|Overall Study|Death|214|||
126460115|NCT01077154|454984447|FG000|Overall Study|Lost to Follow-up|43|||
126460116|NCT01077154|454984448|FG001|Overall Study|Lost to Follow-up|35|||
126460117|NCT01077154|454984447|FG000|Overall Study|Noncompliance|22|||
126460118|NCT01077154|454984448|FG001|Overall Study|Noncompliance|20|||
126460119|NCT01077154|454984447|FG000|Overall Study|Disease Progression|18|||
126460120|NCT01077154|454984448|FG001|Overall Study|Disease Progression|20|||
126460121|NCT01077154|454984447|FG000|Overall Study|Ineligibility Determined|10|||
126460122|NCT01077154|454984448|FG001|Overall Study|Ineligibility Determined|14|||
126460123|NCT01077154|454984447|FG000|Overall Study|Other|14|||
126460124|NCT01077154|454984448|FG001|Overall Study|Other|11|||
126460125|NCT01077154|454984447|FG000|Overall Study|Adverse Event|9|||
126460126|NCT01077154|454984448|FG001|Overall Study|Adverse Event|9|||
126460127|NCT01077154|454984447|FG000|Overall Study|Administrative Decision|1|||
126460128|NCT01077154|454984448|FG001|Overall Study|Administrative Decision|6|||
126460129|NCT01077154|454984447|FG000|Overall Study|Protocol Deviation|1|||
126460130|NCT01077154|454984448|FG001|Overall Study|Protocol Deviation|0|||
126460131|NCT05985980|454984449|FG000|Overall Study|Withdrawal by Subject|1|||
126460132|NCT05985980|454984449|FG000|Overall Study|Withdrawal by Subject|1|||
126460133|NCT05985980|454984449|FG000|Overall Study|Withdrawal by Subject|1|||
126460134|NCT05985980|454984449|FG000|Overall Study|Withdrawal by Subject|1|||
126460135|NCT02207946|454984450|FG000|Overall Study|Lost to Follow-up|1|||
126294130|NCT04510090|454366568|FG000|FE-HS|Withdrawal by Subject|0|||
126294131|NCT04510090|454366569|FG001|FE-HS|Withdrawal by Subject|0|||
126460136|NCT02207946|454984451|FG001|Overall Study|Lost to Follow-up|0|||
126460137|NCT02207946|454984450|FG000|Overall Study|Adverse Event|0|||
126460138|NCT02207946|454984451|FG001|Overall Study|Adverse Event|1|||
126460139|NCT00811642|454984452|FG000|Overall Study|Adverse Event|3|||
126294132|NCT04510090|454366570|FG002|FE-HS|Withdrawal by Subject|0|||
126294133|NCT04510090|454366571|FG003|FE-HS|Withdrawal by Subject|0|||
126294134|NCT04510090|454366572|FG004|FE-HS|Withdrawal by Subject|1|||
126460140|NCT00811642|454984452|FG000|Overall Study|Protocol Violation|1|||
126460141|NCT00811642|454984452|FG000|Overall Study|Death|2|||
126460142|NCT00811642|454984452|FG000|Overall Study|Withdrawal by Subject|7|||
126460143|NCT00811642|454984452|FG000|Overall Study|Cumulative use of antifungal agent|2|||
126294135|NCT04510090|454366573|FG005|FE-HS|Withdrawal by Subject|0|||
126294136|NCT04510090|454366574|FG006|FE-HS|Withdrawal by Subject|0|||
126294137|NCT04510090|454366575|FG007|FE-HS|Withdrawal by Subject|0|||
126460144|NCT04179890|454986237|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
126460145|NCT04179890|454986238|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
126460146|NCT04179890|454986237|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
126294138|NCT05825404|454366576|FG000|First Intervention (Weeks 2-5)|Death|0|||
126294139|NCT05825404|454366577|FG001|First Intervention (Weeks 2-5)|Death|1|||
126550053|NCT01076088|455307718|FG001|Overall Study|Adverse Event|6|||
126550054|NCT01076088|455307719|FG002|Overall Study|Adverse Event|3|||
126710977|NCT02111811|455893573|FG001|Treatment Phase|Death|0|||
126710978|NCT02111811|455893572|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
126710979|NCT02111811|455893573|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
126710980|NCT02111811|455893572|FG000|Follow up Period (Aim 2)|Death|2|||
126710981|NCT02111811|455893573|FG001|Follow up Period (Aim 2)|Death|0|||
126710982|NCT01478347|455893583|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
126710983|NCT01478347|455893583|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
126710984|NCT01478347|455893583|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
126710985|NCT00196937|455893584|FG000|Overall Study|Serious Adverse Event|1|||
126710986|NCT00196937|455893585|FG001|Overall Study|Serious Adverse Event|0|||
126710987|NCT00196937|455893586|FG002|Overall Study|Serious Adverse Event|0|||
126710988|NCT00196937|455893584|FG000|Overall Study|Non-serious adverse event|1|||
126710989|NCT00196937|455893585|FG001|Overall Study|Non-serious adverse event|1|||
126710990|NCT00196937|455893586|FG002|Overall Study|Non-serious adverse event|1|||
126710991|NCT00196937|455893584|FG000|Overall Study|Withdrawal by Subject|0|||
126710992|NCT00196937|455893585|FG001|Overall Study|Withdrawal by Subject|0|||
126710993|NCT00196937|455893586|FG002|Overall Study|Withdrawal by Subject|2|||
126710994|NCT00196937|455893584|FG000|Overall Study|Lost to Follow-up|4|||
126710995|NCT00196937|455893585|FG001|Overall Study|Lost to Follow-up|3|||
126710996|NCT00196937|455893586|FG002|Overall Study|Lost to Follow-up|3|||
126710997|NCT00196937|455893584|FG000|Overall Study|Other|3|||
126710998|NCT00196937|455893585|FG001|Overall Study|Other|1|||
126710999|NCT00196937|455893586|FG002|Overall Study|Other|1|||
126711000|NCT02973815|455893590|FG000|Post Intervention|Death|1|||
126711001|NCT02973815|455893591|FG001|Post Intervention|Death|0|||
126711002|NCT02973815|455893590|FG000|Post Intervention|Lost to Follow-up|7|||
126711003|NCT02973815|455893591|FG001|Post Intervention|Lost to Follow-up|24|||
126711004|NCT02973815|455893590|FG000|Follow-up|Lost to Follow-up|2|||
126711005|NCT02973815|455893591|FG001|Follow-up|Lost to Follow-up|0|||
126767120|NCT03000075|456100230|FG000|Part B|Not dosed due to AE|0|||
126366711|NCT01225952|454639284|FG000|Overall Study|Study Eye Explanted|0|||
126366712|NCT01225952|454639285|FG001|Overall Study|Study Eye Explanted|0|||
126366713|NCT01225952|454639286|FG002|Overall Study|Study Eye Explanted|1|||
126366714|NCT01225952|454639284|FG000|Overall Study|Withdrawal by Subject|4|||
126366715|NCT01225952|454639285|FG001|Overall Study|Withdrawal by Subject|4|||
126366716|NCT01225952|454639286|FG002|Overall Study|Withdrawal by Subject|5|||
126366717|NCT01225952|454639284|FG000|Overall Study|Surgical complications|1|||
126366718|NCT01225952|454639285|FG001|Overall Study|Surgical complications|0|||
126366719|NCT01225952|454639286|FG002|Overall Study|Surgical complications|0|||
126366720|NCT02378480|454639287|FG000|Overall Study|Physician Decision|1|||
126366721|NCT02378480|454639288|FG001|Overall Study|Physician Decision|1|||
126366722|NCT02378480|454639287|FG000|Overall Study|Death|1|||
126366723|NCT02378480|454639288|FG001|Overall Study|Death|2|||
126366724|NCT02378480|454639287|FG000|Overall Study|Randomized, but Not Treated|6|||
126366725|NCT02378480|454639288|FG001|Overall Study|Randomized, but Not Treated|4|||
126366726|NCT02378480|454639287|FG000|Overall Study|Adverse Event|0|||
126366727|NCT02378480|454639288|FG001|Overall Study|Adverse Event|1|||
126366728|NCT02378480|454639287|FG000|Overall Study|Missed EOT/PTE Visit|1|||
126366729|NCT02378480|454639288|FG001|Overall Study|Missed EOT/PTE Visit|2|||
126366730|NCT02378480|454639287|FG000|Overall Study|Withdrawal by Subject|9|||
126366731|NCT02378480|454639288|FG001|Overall Study|Withdrawal by Subject|4|||
126366732|NCT02378480|454639287|FG000|Overall Study|Lost to Follow-up|10|||
126366733|NCT02378480|454639288|FG001|Overall Study|Lost to Follow-up|18|||
126366734|NCT01217892|454639289|FG000|Overall Study|Adverse Event|1|||
126366735|NCT01217892|454639290|FG001|Overall Study|Adverse Event|1|||
126366736|NCT01217892|454639291|FG002|Overall Study|Adverse Event|1|||
126366737|NCT01217892|454639292|FG003|Overall Study|Adverse Event|0|||
126366738|NCT01217892|454639289|FG000|Overall Study|Withdrawal by Subject|0|||
126366739|NCT01217892|454639290|FG001|Overall Study|Withdrawal by Subject|2|||
126366740|NCT01217892|454639291|FG002|Overall Study|Withdrawal by Subject|1|||
126366741|NCT01217892|454639292|FG003|Overall Study|Withdrawal by Subject|0|||
126366742|NCT01217892|454639289|FG000|Overall Study|Lab value|1|||
126366743|NCT01217892|454639290|FG001|Overall Study|Lab value|0|||
126366744|NCT01217892|454639291|FG002|Overall Study|Lab value|1|||
126366745|NCT01217892|454639292|FG003|Overall Study|Lab value|0|||
126366746|NCT01217892|454639289|FG000|Overall Study|Subject no longer meets study criteria|5|||
126366747|NCT01217892|454639290|FG001|Overall Study|Subject no longer meets study criteria|2|||
126366748|NCT01217892|454639291|FG002|Overall Study|Subject no longer meets study criteria|4|||
126366749|NCT01217892|454639292|FG003|Overall Study|Subject no longer meets study criteria|8|||
126366750|NCT01217892|454639289|FG000|Overall Study|Incorrect enrollment|0|||
126366751|NCT01217892|454639290|FG001|Overall Study|Incorrect enrollment|1|||
126366752|NCT01217892|454639291|FG002|Overall Study|Incorrect enrollment|1|||
126460147|NCT04179890|454986238|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
126460148|NCT04179890|454986237|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
126460149|NCT04179890|454986238|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
126460150|NCT04179890|454986237|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
126460151|NCT04179890|454986238|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
126460152|NCT04179890|454986237|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
126460153|NCT04179890|454986238|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
126460154|NCT04179890|454986237|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
126460155|NCT04179890|454986238|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
126460156|NCT04179890|454986237|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
126460157|NCT04179890|454986238|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
126460158|NCT04179890|454986237|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
126460159|NCT04179890|454986238|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
126460160|NCT04179890|454986237|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
126460161|NCT04179890|454986238|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
126460162|NCT02579928|454986239|FG000|Overall Study|Withdrawal by Subject|1|||
126460163|NCT02579928|454986240|FG001|Overall Study|Withdrawal by Subject|0|||
126460164|NCT03754972|454986243|FG000|Overall Study|Protocol Violation|25|||
126460165|NCT03422627|454986244|FG000|Overall Study|Protocol-specified Criteria|1|||
126460166|NCT03422627|454986245|FG001|Overall Study|Protocol-specified Criteria|1|||
126460167|NCT03422627|454986246|FG002|Overall Study|Protocol-specified Criteria|0|||
126460168|NCT03422627|454986247|FG003|Overall Study|Protocol-specified Criteria|0|||
126460169|NCT03422627|454986248|FG004|Overall Study|Protocol-specified Criteria|2|||
126460170|NCT03422627|454986244|FG000|Overall Study|Requirement for Alternative Therapy|1|||
126460171|NCT03422627|454986245|FG001|Overall Study|Requirement for Alternative Therapy|1|||
126460172|NCT03422627|454986246|FG002|Overall Study|Requirement for Alternative Therapy|2|||
126460173|NCT03422627|454986247|FG003|Overall Study|Requirement for Alternative Therapy|0|||
126460174|NCT03422627|454986248|FG004|Overall Study|Requirement for Alternative Therapy|0|||
126460175|NCT03422627|454986244|FG000|Overall Study|Disease Progression|1|||
126460176|NCT03422627|454986245|FG001|Overall Study|Disease Progression|0|||
126460177|NCT03422627|454986246|FG002|Overall Study|Disease Progression|1|||
126460178|NCT03422627|454986247|FG003|Overall Study|Disease Progression|2|||
126460179|NCT03422627|454986248|FG004|Overall Study|Disease Progression|0|||
126460180|NCT03422627|454986244|FG000|Overall Study|Adverse Event|2|||
126460181|NCT03422627|454986245|FG001|Overall Study|Adverse Event|1|||
126460182|NCT03422627|454986246|FG002|Overall Study|Adverse Event|0|||
126460183|NCT03422627|454986247|FG003|Overall Study|Adverse Event|0|||
126460184|NCT03422627|454986248|FG004|Overall Study|Adverse Event|2|||
126460185|NCT03422627|454986244|FG000|Overall Study|Ineligibility Determined|0|||
126460186|NCT03422627|454986245|FG001|Overall Study|Ineligibility Determined|1|||
126460187|NCT03422627|454986246|FG002|Overall Study|Ineligibility Determined|0|||
126460188|NCT03422627|454986247|FG003|Overall Study|Ineligibility Determined|0|||
126460189|NCT03422627|454986248|FG004|Overall Study|Ineligibility Determined|0|||
126460190|NCT03422627|454986244|FG000|Overall Study|Death|0|||
126460191|NCT03422627|454986245|FG001|Overall Study|Death|1|||
126460192|NCT03422627|454986246|FG002|Overall Study|Death|1|||
126460193|NCT03422627|454986247|FG003|Overall Study|Death|0|||
126460194|NCT03422627|454986248|FG004|Overall Study|Death|0|||
126460195|NCT03422627|454986244|FG000|Overall Study|Withdrawal by Subject|0|||
126460196|NCT03422627|454986245|FG001|Overall Study|Withdrawal by Subject|0|||
126460197|NCT03422627|454986246|FG002|Overall Study|Withdrawal by Subject|0|||
126460198|NCT03422627|454986247|FG003|Overall Study|Withdrawal by Subject|1|||
126460199|NCT03422627|454986248|FG004|Overall Study|Withdrawal by Subject|0|||
126460200|NCT00934648|454986251|FG000|Overall Study|Failure to return|8|||
126460201|NCT00934648|454986251|FG000|Overall Study|Withdrawal by Subject|1|||
126460202|NCT01993836|454986252|FG000|Overall Study|Surgery Cancelled|3|||
126294140|NCT05825404|454366576|FG000|Second Intervention (Weeks 8-11)|Death|0|||
126294141|NCT05825404|454366577|FG001|Second Intervention (Weeks 8-11)|Death|1|||
126294142|NCT01127256|454366578|FG000|Overall Study|Adverse Event|13|||
126460203|NCT01993836|454986253|FG001|Overall Study|Surgery Cancelled|0|||
126460204|NCT01993836|454986254|FG002|Overall Study|Surgery Cancelled|0|||
126294143|NCT01127256|454366579|FG001|Overall Study|Adverse Event|13|||
126294144|NCT01127256|454366578|FG000|Overall Study|Lack of Efficacy|4|||
126294145|NCT01127256|454366579|FG001|Overall Study|Lack of Efficacy|0|||
126460205|NCT01993836|454986252|FG000|Overall Study|Physician Decision|2|||
126460206|NCT01993836|454986253|FG001|Overall Study|Physician Decision|1|||
126460207|NCT01993836|454986254|FG002|Overall Study|Physician Decision|0|||
126294146|NCT01127256|454366578|FG000|Overall Study|Lost to Follow-up|16|||
126294147|NCT01127256|454366579|FG001|Overall Study|Lost to Follow-up|17|||
126294148|NCT01127256|454366578|FG000|Overall Study|Withdrawal by Subject|5|||
126460208|NCT01993836|454986252|FG000|Overall Study|Death|0|||
126460209|NCT01993836|454986253|FG001|Overall Study|Death|2|||
126460210|NCT01993836|454986254|FG002|Overall Study|Death|0|||
126460211|NCT01993836|454986252|FG000|Overall Study|Withdrawal by Subject|12|||
126460212|NCT01993836|454986253|FG001|Overall Study|Withdrawal by Subject|10|||
126460213|NCT01993836|454986254|FG002|Overall Study|Withdrawal by Subject|5|||
126460214|NCT02195687|454986256|FG000|Overall Study|Personal Reasons|1|||
126460215|NCT02195687|454986257|FG001|Overall Study|Personal Reasons|1|||
126460216|NCT02195687|454986256|FG000|Overall Study|Lost to Follow-up|4|||
126460217|NCT02195687|454986257|FG001|Overall Study|Lost to Follow-up|1|||
126460218|NCT04369924|454986260|FG000|Overall Study|Lost to Follow-up|302|||
126460219|NCT04369924|454986261|FG001|Overall Study|Lost to Follow-up|339|||
126460220|NCT02554279|454986262|FG000|Overall Study|Adverse Event|2|||
126460221|NCT02554279|454986263|FG001|Overall Study|Adverse Event|5|||
126460222|NCT02554279|454986262|FG000|Overall Study|Lost to Follow-up|3|||
126460223|NCT02554279|454986263|FG001|Overall Study|Lost to Follow-up|2|||
126460224|NCT02554279|454986262|FG000|Overall Study|Withdrawal by Subject|6|||
126767121|NCT03000075|456100231|FG001|Part B|Not dosed due to AE|0|||
126767122|NCT03000075|456100232|FG002|Part B|Not dosed due to AE|0|||
126767123|NCT03000075|456100233|FG003|Part B|Not dosed due to AE|0|||
126767124|NCT03000075|456100234|FG004|Part B|Not dosed due to AE|0|||
126767125|NCT03000075|456100235|FG005|Part B|Not dosed due to AE|2|||
126767126|NCT03000075|456100236|FG006|Part B|Not dosed due to AE|1|||
126767127|NCT03000075|456100230|FG000|Part B|Adverse Event|0|||
126767128|NCT03000075|456100231|FG001|Part B|Adverse Event|0|||
126767129|NCT03000075|456100232|FG002|Part B|Adverse Event|0|||
126767130|NCT03000075|456100233|FG003|Part B|Adverse Event|0|||
126767131|NCT03000075|456100234|FG004|Part B|Adverse Event|1|||
126767132|NCT03000075|456100235|FG005|Part B|Adverse Event|0|||
126767133|NCT03000075|456100236|FG006|Part B|Adverse Event|0|||
126767134|NCT00440193|456100237|FG000|Treatment Period|Adverse Event|74|||
126767135|NCT00440193|456100238|FG001|Treatment Period|Adverse Event|67|||
126767136|NCT00440193|456100237|FG000|Treatment Period|Death|19|||
126767137|NCT00440193|456100238|FG001|Treatment Period|Death|22|||
126767138|NCT00440193|456100237|FG000|Treatment Period|Lack of Efficacy|0|||
126767139|NCT00440193|456100238|FG001|Treatment Period|Lack of Efficacy|1|||
126767140|NCT00440193|456100237|FG000|Treatment Period|Lost to Follow-up|12|||
126767141|NCT00440193|456100238|FG001|Treatment Period|Lost to Follow-up|18|||
126767142|NCT00440193|456100237|FG000|Treatment Period|Physician Decision|3|||
126767143|NCT00440193|456100238|FG001|Treatment Period|Physician Decision|6|||
126767144|NCT00440193|456100237|FG000|Treatment Period|Protocol Violation|16|||
126767145|NCT00440193|456100238|FG001|Treatment Period|Protocol Violation|19|||
126767146|NCT00440193|456100237|FG000|Treatment Period|Withdrawal by Subject|36|||
126767147|NCT00440193|456100238|FG001|Treatment Period|Withdrawal by Subject|77|||
126767148|NCT00440193|456100237|FG000|Treatment Period|Clinical endpoint reached|28|||
126767149|NCT00440193|456100238|FG001|Treatment Period|Clinical endpoint reached|25|||
126767150|NCT00440193|456100237|FG000|Treatment Period|Study terminated by sponsor|102|||
126767151|NCT00440193|456100238|FG001|Treatment Period|Study terminated by sponsor|94|||
126767152|NCT00440193|456100237|FG000|Treatment Period|Protocol driven decision point|2|||
126767153|NCT00440193|456100238|FG001|Treatment Period|Protocol driven decision point|2|||
126767154|NCT00440193|456100237|FG000|Treatment Period|Switch to commercial drug|0|||
126767155|NCT00440193|456100238|FG001|Treatment Period|Switch to commercial drug|2|||
126294149|NCT01127256|454366579|FG001|Overall Study|Withdrawal by Subject|9|||
126294150|NCT01127256|454366578|FG000|Overall Study|Protocol Violation|1|||
126294151|NCT01127256|454366579|FG001|Overall Study|Protocol Violation|0|||
126460225|NCT02554279|454986263|FG001|Overall Study|Withdrawal by Subject|4|||
126460226|NCT02554279|454986262|FG000|Overall Study|Protocol Violation|2|||
126460227|NCT02554279|454986263|FG001|Overall Study|Protocol Violation|1|||
126460228|NCT02554279|454986262|FG000|Overall Study|Other reason|19|||
126460229|NCT02554279|454986263|FG001|Overall Study|Other reason|6|||
126460230|NCT01933789|454986264|FG000|Overall Study|Death|0|||
126460231|NCT01933789|454986265|FG001|Overall Study|Death|0|||
126460232|NCT01933789|454986266|FG002|Overall Study|Death|0|||
126550055|NCT01076088|455307720|FG003|Overall Study|Adverse Event|2|||
126550056|NCT01076088|455307721|FG004|Overall Study|Adverse Event|3|||
126294152|NCT01415518|454366580|FG000|Overall Study|Withdrawal by Subject|2|||
126460233|NCT01933789|454986267|FG003|Overall Study|Death|0|||
126767156|NCT00440193|456100237|FG000|Treatment Period|Technical problems|1|||
126767157|NCT00440193|456100238|FG001|Treatment Period|Technical problems|1|||
126767158|NCT00440193|456100237|FG000|Treatment Period|Participant convenience|5|||
126294153|NCT01415518|454366581|FG001|Overall Study|Withdrawal by Subject|12|||
126294154|NCT01415518|454366580|FG000|Overall Study|Protocol Violation|6|||
126767159|NCT00440193|456100238|FG001|Treatment Period|Participant convenience|2|||
126767160|NCT00440193|456100237|FG000|Treatment Period|Participant did not receive treatment|7|||
126460234|NCT01933789|454986268|FG004|Overall Study|Death|21|||
126460235|NCT01933789|454986269|FG005|Overall Study|Death|32|||
126460236|NCT01933789|454986270|FG006|Overall Study|Death|0|||
126460237|NCT01933789|454986271|FG007|Overall Study|Death|0|||
126460238|NCT01933789|454986272|FG008|Overall Study|Death|0|||
126767161|NCT00440193|456100238|FG001|Treatment Period|Participant did not receive treatment|13|||
126711006|NCT00853905|455893596|FG000|Overall Study|Lost to Follow-up|1|||
126711007|NCT00853905|455893597|FG001|Overall Study|Lost to Follow-up|3|||
126711008|NCT00853905|455893596|FG000|Overall Study|Withdrawal by Subject|0|||
126711009|NCT00853905|455893597|FG001|Overall Study|Withdrawal by Subject|1|||
126711010|NCT00853905|455893596|FG000|Overall Study|never had surgery|1|||
126294155|NCT01415518|454366581|FG001|Overall Study|Protocol Violation|8|||
126294156|NCT01415518|454366580|FG000|Overall Study|Lost to Follow-up|3|||
126294157|NCT01415518|454366581|FG001|Overall Study|Lost to Follow-up|5|||
126294158|NCT01415518|454366580|FG000|Overall Study|Adverse Event|3|||
126294159|NCT01415518|454366581|FG001|Overall Study|Adverse Event|4|||
126294160|NCT01415518|454366580|FG000|Overall Study|Death|1|||
126294161|NCT01415518|454366581|FG001|Overall Study|Death|1|||
126294162|NCT01415518|454366580|FG000|Overall Study|Condition under Investigation Worsened|1|||
126294163|NCT01415518|454366581|FG001|Overall Study|Condition under Investigation Worsened|1|||
126294164|NCT00679211|454366582|FG000|Overall Study|Progressive disease|82|||
126366753|NCT01217892|454639292|FG003|Overall Study|Incorrect enrollment|0|||
126366754|NCT01217892|454639289|FG000|Overall Study|Poor/Non-Compliance|0|||
126366755|NCT01217892|454639290|FG001|Overall Study|Poor/Non-Compliance|0|||
126366756|NCT01217892|454639291|FG002|Overall Study|Poor/Non-Compliance|1|||
126366757|NCT01217892|454639292|FG003|Overall Study|Poor/Non-Compliance|0|||
126366758|NCT01052779|454639293|FG000|Overall Study|Adverse Event|1|||
126366759|NCT01052779|454639294|FG001|Overall Study|Adverse Event|4|||
126366760|NCT01052779|454639293|FG000|Overall Study|Withdrawal by Subject|1|||
126366761|NCT01052779|454639294|FG001|Overall Study|Withdrawal by Subject|2|||
126366762|NCT01052779|454639293|FG000|Overall Study|Other-Protocol Violation|1|||
126366763|NCT01052779|454639294|FG001|Overall Study|Other-Protocol Violation|1|||
126366764|NCT01052779|454639293|FG000|Overall Study|Other-Surgery|0|||
126366765|NCT01052779|454639294|FG001|Overall Study|Other-Surgery|2|||
126366766|NCT01052779|454639293|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
126366767|NCT01052779|454639294|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
126366768|NCT03802916|454639295|FG000|Overall Study|Adverse Event|0|||
126366769|NCT03802916|454639296|FG001|Overall Study|Adverse Event|1|||
126366770|NCT03802916|454639295|FG000|Overall Study|Withdrawal by Subject|0|||
126366771|NCT03802916|454639296|FG001|Overall Study|Withdrawal by Subject|1|||
126366772|NCT01285102|454639297|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
126366773|NCT01905540|454639298|FG000|Period 3|Other|1|||
126366774|NCT01905540|454639299|FG001|Period 3|Other|0|||
126366775|NCT01905540|454639300|FG002|Period 3|Other|1|||
126366776|NCT01905540|454639301|FG003|Period 3|Other|1|||
126366777|NCT02367885|454639302|FG000|Overall Study|Lost to Follow-up|1|||
126366778|NCT02367885|454639303|FG001|Overall Study|Lost to Follow-up|0|||
126366779|NCT02367885|454639304|FG002|Overall Study|Lost to Follow-up|0|||
126366780|NCT02367885|454639302|FG000|Overall Study|Withdrawal by Subject|1|||
126366781|NCT02367885|454639303|FG001|Overall Study|Withdrawal by Subject|0|||
126366782|NCT02367885|454639304|FG002|Overall Study|Withdrawal by Subject|0|||
126366783|NCT02743962|454639307|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
126366784|NCT02743962|454639308|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
126366785|NCT02327169|454639312|FG000|Overall Study|Progressive Disease|1|||
126366786|NCT02327169|454639313|FG001|Overall Study|Progressive Disease|3|||
126366787|NCT02327169|454639314|FG002|Overall Study|Progressive Disease|4|||
126366788|NCT02327169|454639315|FG003|Overall Study|Progressive Disease|3|||
126366789|NCT02327169|454639316|FG004|Overall Study|Progressive Disease|4|||
126366790|NCT02327169|454639317|FG005|Overall Study|Progressive Disease|3|||
126366791|NCT02327169|454639318|FG006|Overall Study|Progressive Disease|3|||
126366792|NCT02327169|454639319|FG007|Overall Study|Progressive Disease|3|||
126366793|NCT02327169|454639320|FG008|Overall Study|Progressive Disease|4|||
126366794|NCT02327169|454639321|FG009|Overall Study|Progressive Disease|4|||
126366795|NCT02327169|454639322|FG010|Overall Study|Progressive Disease|4|||
126366796|NCT02327169|454639323|FG011|Overall Study|Progressive Disease|3|||
126366797|NCT02327169|454639324|FG012|Overall Study|Progressive Disease|1|||
126366798|NCT02327169|454639325|FG013|Overall Study|Progressive Disease|3|||
126366799|NCT02327169|454639326|FG014|Overall Study|Progressive Disease|3|||
126366800|NCT02327169|454639312|FG000|Overall Study|Adverse Event|2|||
126366801|NCT02327169|454639313|FG001|Overall Study|Adverse Event|0|||
126366802|NCT02327169|454639314|FG002|Overall Study|Adverse Event|1|||
126366803|NCT02327169|454639315|FG003|Overall Study|Adverse Event|0|||
126366804|NCT02327169|454639316|FG004|Overall Study|Adverse Event|1|||
126366805|NCT02327169|454639317|FG005|Overall Study|Adverse Event|0|||
126366806|NCT02327169|454639318|FG006|Overall Study|Adverse Event|0|||
126366807|NCT02327169|454639319|FG007|Overall Study|Adverse Event|0|||
126366808|NCT02327169|454639320|FG008|Overall Study|Adverse Event|0|||
126366809|NCT02327169|454639321|FG009|Overall Study|Adverse Event|2|||
126366810|NCT02327169|454639322|FG010|Overall Study|Adverse Event|0|||
126366811|NCT02327169|454639323|FG011|Overall Study|Adverse Event|3|||
126366812|NCT02327169|454639324|FG012|Overall Study|Adverse Event|0|||
126366813|NCT02327169|454639325|FG013|Overall Study|Adverse Event|2|||
126366814|NCT02327169|454639326|FG014|Overall Study|Adverse Event|1|||
126366815|NCT02327169|454639312|FG000|Overall Study|Symptomatic Deterioration|0|||
126711011|NCT00853905|455893597|FG001|Overall Study|never had surgery|0|||
126294165|NCT00679211|454366582|FG000|Overall Study|Adverse Event|7|||
126460239|NCT01933789|454986264|FG000|Overall Study|Lost to Follow-up|0|||
126460240|NCT01933789|454986265|FG001|Overall Study|Lost to Follow-up|0|||
126460241|NCT01933789|454986266|FG002|Overall Study|Lost to Follow-up|0|||
126460242|NCT01933789|454986267|FG003|Overall Study|Lost to Follow-up|1|||
126460243|NCT01933789|454986268|FG004|Overall Study|Lost to Follow-up|8|||
126460244|NCT01933789|454986269|FG005|Overall Study|Lost to Follow-up|9|||
126460245|NCT01933789|454986270|FG006|Overall Study|Lost to Follow-up|1|||
126460246|NCT01933789|454986271|FG007|Overall Study|Lost to Follow-up|4|||
126460247|NCT01933789|454986272|FG008|Overall Study|Lost to Follow-up|0|||
126460248|NCT01933789|454986264|FG000|Overall Study|Withdrawal by Subject|2|||
126460249|NCT01933789|454986265|FG001|Overall Study|Withdrawal by Subject|1|||
126460250|NCT01933789|454986266|FG002|Overall Study|Withdrawal by Subject|0|||
126460251|NCT01933789|454986267|FG003|Overall Study|Withdrawal by Subject|0|||
126460252|NCT01933789|454986268|FG004|Overall Study|Withdrawal by Subject|17|||
126460253|NCT01933789|454986269|FG005|Overall Study|Withdrawal by Subject|16|||
126460254|NCT01933789|454986270|FG006|Overall Study|Withdrawal by Subject|1|||
126460255|NCT01933789|454986271|FG007|Overall Study|Withdrawal by Subject|4|||
126460256|NCT01933789|454986272|FG008|Overall Study|Withdrawal by Subject|0|||
126460257|NCT01933789|454986264|FG000|Overall Study|Became Ineligible|4|||
126460258|NCT01933789|454986265|FG001|Overall Study|Became Ineligible|0|||
126460259|NCT01933789|454986266|FG002|Overall Study|Became Ineligible|0|||
126460260|NCT01933789|454986267|FG003|Overall Study|Became Ineligible|0|||
126460261|NCT01933789|454986268|FG004|Overall Study|Became Ineligible|13|||
126460262|NCT01933789|454986269|FG005|Overall Study|Became Ineligible|10|||
126460263|NCT01933789|454986270|FG006|Overall Study|Became Ineligible|13|||
126460264|NCT01933789|454986271|FG007|Overall Study|Became Ineligible|6|||
126460265|NCT01933789|454986272|FG008|Overall Study|Became Ineligible|0|||
126460266|NCT01055496|454986273|FG000|Overall Study|Withdrawal by Subject|2|||
126460267|NCT01055496|454986274|FG001|Overall Study|Withdrawal by Subject|4|||
126460268|NCT01055496|454986273|FG000|Overall Study|Death|13|||
126460269|NCT01055496|454986274|FG001|Overall Study|Death|23|||
126460270|NCT01055496|454986273|FG000|Overall Study|Lost to Follow-up|0|||
126460271|NCT01055496|454986274|FG001|Overall Study|Lost to Follow-up|2|||
126460272|NCT01055496|454986273|FG000|Overall Study|Other - Unspecified|0|||
126460273|NCT01055496|454986274|FG001|Overall Study|Other - Unspecified|1|||
126460274|NCT01966432|454986275|FG000|Overall Study|Lost to Follow-up|3|||
126460275|NCT01966432|454986276|FG001|Overall Study|Lost to Follow-up|2|||
126460276|NCT01966432|454986277|FG002|Overall Study|Lost to Follow-up|5|||
126460277|NCT01966432|454986275|FG000|Overall Study|Withdrawal by Subject|1|||
126460278|NCT01966432|454986276|FG001|Overall Study|Withdrawal by Subject|3|||
126460279|NCT01966432|454986277|FG002|Overall Study|Withdrawal by Subject|0|||
126460280|NCT01966432|454986275|FG000|Overall Study|Subject Incarcerated|0|||
126460281|NCT01966432|454986276|FG001|Overall Study|Subject Incarcerated|0|||
126460282|NCT01966432|454986277|FG002|Overall Study|Subject Incarcerated|1|||
126460283|NCT01966432|454986275|FG000|Overall Study|SBIRT program ended|1|||
126460284|NCT01966432|454986276|FG001|Overall Study|SBIRT program ended|8|||
126460285|NCT01966432|454986277|FG002|Overall Study|SBIRT program ended|20|||
126460286|NCT01673282|454986278|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
126460287|NCT01673282|454986279|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
126460288|NCT01673282|454986278|FG000|Overall Study|Lack of Efficacy|9|||
126460289|NCT01673282|454986279|FG001|Overall Study|Lack of Efficacy|2|||
126550057|NCT01076088|455307722|FG005|Overall Study|Adverse Event|3|||
126711012|NCT04579393|455893604|FG000|Overall Study|Withdrawal by Subject|2|||
126711013|NCT04579393|455893605|FG001|Overall Study|Withdrawal by Subject|2|||
126711014|NCT04579393|455893604|FG000|Overall Study|Death|1|||
126711015|NCT04579393|455893605|FG001|Overall Study|Death|3|||
126711016|NCT01333189|455893606|FG000|Overall Study|Time constraints|1|||
126711017|NCT01333189|455893607|FG001|Overall Study|Time constraints|0|||
126711018|NCT01333189|455893606|FG000|Overall Study|Adverse Event|1|||
126711019|NCT01333189|455893607|FG001|Overall Study|Adverse Event|0|||
126711020|NCT01333189|455893606|FG000|Overall Study|Transportation difficulties|0|||
126711021|NCT01333189|455893607|FG001|Overall Study|Transportation difficulties|1|||
126294166|NCT00679211|454366582|FG000|Overall Study|Withdrawal by Subject|2|||
126294167|NCT00679211|454366582|FG000|Overall Study|Physician Decision|5|||
126460290|NCT01673282|454986278|FG000|Overall Study|Lost to Follow-up|11|||
126460291|NCT01673282|454986279|FG001|Overall Study|Lost to Follow-up|10|||
126460292|NCT01673282|454986278|FG000|Overall Study|Withdrawal by Subject|3|||
126460293|NCT01673282|454986279|FG001|Overall Study|Withdrawal by Subject|3|||
126460294|NCT01673282|454986278|FG000|Overall Study|Other|1|||
126460295|NCT01673282|454986279|FG001|Overall Study|Other|6|||
126460296|NCT01323920|454986285|FG000|Overall Study|Death|5|||
126460297|NCT01323920|454986285|FG000|Overall Study|Withdrawal by Subject|1|||
126460298|NCT01146860|454986286|FG000|Overall Study|Withdrawal by Subject|0|||
126460299|NCT01146860|454986287|FG001|Overall Study|Withdrawal by Subject|1|||
126711022|NCT01333189|455893606|FG000|Overall Study|Moved from region|0|||
126711023|NCT01333189|455893607|FG001|Overall Study|Moved from region|1|||
126711024|NCT00465738|455893610|FG000|Overall Study|Lost to Follow-up|2|||
126711025|NCT00465738|455893611|FG001|Overall Study|Lost to Follow-up|0|||
126460300|NCT00722371|454986288|FG000|Overall Study|Adverse Event|6|||
126460301|NCT00722371|454986289|FG001|Overall Study|Adverse Event|13|||
126460302|NCT00722371|454986290|FG002|Overall Study|Adverse Event|9|||
126460303|NCT00722371|454986291|FG003|Overall Study|Adverse Event|10|||
126460304|NCT00722371|454986292|FG004|Overall Study|Adverse Event|6|||
126460305|NCT00722371|454986293|FG005|Overall Study|Adverse Event|8|||
126460306|NCT00722371|454986294|FG006|Overall Study|Adverse Event|4|||
126460307|NCT00722371|454986288|FG000|Overall Study|Contraindication|0|||
126460308|NCT00722371|454986289|FG001|Overall Study|Contraindication|0|||
126460309|NCT00722371|454986290|FG002|Overall Study|Contraindication|1|||
126460310|NCT00722371|454986291|FG003|Overall Study|Contraindication|0|||
126460311|NCT00722371|454986292|FG004|Overall Study|Contraindication|0|||
126460312|NCT00722371|454986293|FG005|Overall Study|Contraindication|0|||
126460313|NCT00722371|454986294|FG006|Overall Study|Contraindication|0|||
126460314|NCT00722371|454986288|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
126460315|NCT00722371|454986289|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
126460316|NCT00722371|454986290|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
126460317|NCT00722371|454986291|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
126460318|NCT00722371|454986292|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
126460319|NCT00722371|454986293|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
126460320|NCT00722371|454986294|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
126460321|NCT00722371|454986288|FG000|Overall Study|Excluded medication|0|||
126460322|NCT00722371|454986289|FG001|Overall Study|Excluded medication|1|||
126460323|NCT00722371|454986290|FG002|Overall Study|Excluded medication|1|||
126460324|NCT00722371|454986291|FG003|Overall Study|Excluded medication|0|||
126460325|NCT00722371|454986292|FG004|Overall Study|Excluded medication|0|||
126460326|NCT00722371|454986293|FG005|Overall Study|Excluded medication|0|||
126460327|NCT00722371|454986294|FG006|Overall Study|Excluded medication|1|||
126460328|NCT00722371|454986288|FG000|Overall Study|Hyperglycemia|2|||
126460329|NCT00722371|454986289|FG001|Overall Study|Hyperglycemia|6|||
126460330|NCT00722371|454986290|FG002|Overall Study|Hyperglycemia|4|||
126460331|NCT00722371|454986291|FG003|Overall Study|Hyperglycemia|2|||
126460332|NCT00722371|454986292|FG004|Overall Study|Hyperglycemia|5|||
126460333|NCT00722371|454986293|FG005|Overall Study|Hyperglycemia|1|||
126460334|NCT00722371|454986294|FG006|Overall Study|Hyperglycemia|1|||
126460335|NCT00722371|454986288|FG000|Overall Study|Hypoglycemia|1|||
126460336|NCT00722371|454986289|FG001|Overall Study|Hypoglycemia|0|||
126460337|NCT00722371|454986290|FG002|Overall Study|Hypoglycemia|0|||
126460338|NCT00722371|454986291|FG003|Overall Study|Hypoglycemia|0|||
126460339|NCT00722371|454986292|FG004|Overall Study|Hypoglycemia|0|||
126460340|NCT00722371|454986293|FG005|Overall Study|Hypoglycemia|0|||
126460341|NCT00722371|454986294|FG006|Overall Study|Hypoglycemia|0|||
126460342|NCT00722371|454986288|FG000|Overall Study|Lack of Efficacy|4|||
126460343|NCT00722371|454986289|FG001|Overall Study|Lack of Efficacy|6|||
126460344|NCT00722371|454986290|FG002|Overall Study|Lack of Efficacy|6|||
126460345|NCT00722371|454986291|FG003|Overall Study|Lack of Efficacy|6|||
126460346|NCT00722371|454986292|FG004|Overall Study|Lack of Efficacy|2|||
126460347|NCT00722371|454986293|FG005|Overall Study|Lack of Efficacy|3|||
126460348|NCT00722371|454986294|FG006|Overall Study|Lack of Efficacy|0|||
126460349|NCT00722371|454986288|FG000|Overall Study|Lost to Follow-up|11|||
126550058|NCT01076088|455307717|FG000|Overall Study|Lost to Follow-up|1|||
126550059|NCT01076088|455307718|FG001|Overall Study|Lost to Follow-up|1|||
126550060|NCT01076088|455307719|FG002|Overall Study|Lost to Follow-up|0|||
126550061|NCT01076088|455307720|FG003|Overall Study|Lost to Follow-up|1|||
126294168|NCT00679211|454366582|FG000|Overall Study|Refused to undergo protocol procedures|1|||
126294169|NCT00679211|454366582|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
126550062|NCT01076088|455307721|FG004|Overall Study|Lost to Follow-up|1|||
126550063|NCT01076088|455307722|FG005|Overall Study|Lost to Follow-up|2|||
126460350|NCT00722371|454986289|FG001|Overall Study|Lost to Follow-up|14|||
126460351|NCT00722371|454986290|FG002|Overall Study|Lost to Follow-up|21|||
126460352|NCT00722371|454986291|FG003|Overall Study|Lost to Follow-up|13|||
126460353|NCT00722371|454986292|FG004|Overall Study|Lost to Follow-up|8|||
126460354|NCT00722371|454986293|FG005|Overall Study|Lost to Follow-up|16|||
126460355|NCT00722371|454986294|FG006|Overall Study|Lost to Follow-up|13|||
126460356|NCT00722371|454986288|FG000|Overall Study|Physician Decision|5|||
126460357|NCT00722371|454986289|FG001|Overall Study|Physician Decision|2|||
126711026|NCT00465738|455893610|FG000|Overall Study|Adverse Event|0|||
126711027|NCT00465738|455893611|FG001|Overall Study|Adverse Event|1|||
126711028|NCT00465738|455893610|FG000|Overall Study|Withdrawal by Subject|2|||
126711029|NCT00465738|455893611|FG001|Overall Study|Withdrawal by Subject|0|||
126711030|NCT00465738|455893610|FG000|Overall Study|Other|2|||
126711031|NCT00465738|455893611|FG001|Overall Study|Other|5|||
126711032|NCT02489630|455893612|FG000|Overall Study|Oversedation|1|||
126711033|NCT02489630|455893613|FG001|Overall Study|Oversedation|1|||
126711034|NCT02489630|455893612|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
126711035|NCT02489630|455893613|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
126711036|NCT03429556|455893614|FG000|Overall Study|Lost to Follow-up|0|||
126711037|NCT03429556|455893615|FG001|Overall Study|Lost to Follow-up|1|||
126711038|NCT03429556|455893616|FG002|Overall Study|Lost to Follow-up|0|||
126294170|NCT00679211|454366582|FG000|Overall Study|Other|1|||
126294171|NCT01730053|454366583|FG000|Overall Study|Participant moved|0|||
126294172|NCT01730053|454366584|FG001|Overall Study|Participant moved|0|||
126294173|NCT01730053|454366585|FG002|Overall Study|Participant moved|1|||
126294174|NCT01730053|454366586|FG003|Overall Study|Participant moved|0|||
126294175|NCT01730053|454366587|FG004|Overall Study|Participant moved|0|||
126294176|NCT01730053|454366588|FG005|Overall Study|Participant moved|0|||
126294177|NCT01730053|454366583|FG000|Overall Study|Physician Decision|0|||
126294178|NCT01730053|454366584|FG001|Overall Study|Physician Decision|0|||
126294179|NCT01730053|454366585|FG002|Overall Study|Physician Decision|0|||
126294180|NCT01730053|454366586|FG003|Overall Study|Physician Decision|1|||
126294181|NCT01730053|454366587|FG004|Overall Study|Physician Decision|0|||
126294182|NCT01730053|454366588|FG005|Overall Study|Physician Decision|0|||
126294183|NCT01730053|454366583|FG000|Overall Study|Adverse Event|2|||
126294184|NCT01730053|454366584|FG001|Overall Study|Adverse Event|6|||
126294185|NCT01730053|454366585|FG002|Overall Study|Adverse Event|3|||
126294186|NCT01730053|454366586|FG003|Overall Study|Adverse Event|3|||
126294187|NCT01730053|454366587|FG004|Overall Study|Adverse Event|2|||
126294188|NCT01730053|454366588|FG005|Overall Study|Adverse Event|2|||
126294189|NCT01730053|454366583|FG000|Overall Study|Poor compliance to protocol|1|||
126294190|NCT01730053|454366584|FG001|Overall Study|Poor compliance to protocol|2|||
126294191|NCT01730053|454366585|FG002|Overall Study|Poor compliance to protocol|2|||
126294192|NCT01730053|454366586|FG003|Overall Study|Poor compliance to protocol|0|||
126294193|NCT01730053|454366587|FG004|Overall Study|Poor compliance to protocol|0|||
126294194|NCT01730053|454366588|FG005|Overall Study|Poor compliance to protocol|2|||
126294195|NCT01730053|454366583|FG000|Overall Study|Other than specified|2|||
126294196|NCT01730053|454366584|FG001|Overall Study|Other than specified|6|||
126294197|NCT01730053|454366585|FG002|Overall Study|Other than specified|5|||
126294198|NCT01730053|454366586|FG003|Overall Study|Other than specified|4|||
126294199|NCT01730053|454366587|FG004|Overall Study|Other than specified|7|||
126294200|NCT01730053|454366588|FG005|Overall Study|Other than specified|9|||
126294201|NCT01470248|454366589|FG000|Overall Study|Withdrawal by Subject|1|||
126294202|NCT05085834|454366590|FG000|Overall Study|Lost to Follow-up|9|||
126294203|NCT05085834|454366591|FG001|Overall Study|Lost to Follow-up|2|||
126294204|NCT05085834|454366590|FG000|Overall Study|Adverse Event|6|||
126294205|NCT05085834|454366591|FG001|Overall Study|Adverse Event|0|||
126460358|NCT00722371|454986290|FG002|Overall Study|Physician Decision|2|||
126460359|NCT00722371|454986291|FG003|Overall Study|Physician Decision|5|||
126460360|NCT00722371|454986292|FG004|Overall Study|Physician Decision|2|||
126460361|NCT00722371|454986293|FG005|Overall Study|Physician Decision|3|||
126460362|NCT00722371|454986294|FG006|Overall Study|Physician Decision|4|||
126460363|NCT00722371|454986288|FG000|Overall Study|Pregnancy|1|||
126460364|NCT00722371|454986289|FG001|Overall Study|Pregnancy|1|||
126460365|NCT00722371|454986290|FG002|Overall Study|Pregnancy|0|||
126460366|NCT00722371|454986291|FG003|Overall Study|Pregnancy|0|||
126460367|NCT00722371|454986292|FG004|Overall Study|Pregnancy|0|||
126460368|NCT00722371|454986293|FG005|Overall Study|Pregnancy|1|||
126460369|NCT00722371|454986294|FG006|Overall Study|Pregnancy|0|||
126460370|NCT00722371|454986288|FG000|Overall Study|Protocol Violation|6|||
126460371|NCT00722371|454986289|FG001|Overall Study|Protocol Violation|1|||
126460372|NCT00722371|454986290|FG002|Overall Study|Protocol Violation|0|||
126460373|NCT00722371|454986291|FG003|Overall Study|Protocol Violation|1|||
126460374|NCT00722371|454986292|FG004|Overall Study|Protocol Violation|4|||
126460375|NCT00722371|454986293|FG005|Overall Study|Protocol Violation|2|||
126460376|NCT00722371|454986294|FG006|Overall Study|Protocol Violation|1|||
126460377|NCT00722371|454986288|FG000|Overall Study|Withdrawal by Subject|18|||
126711039|NCT03429556|455893617|FG003|Overall Study|Lost to Follow-up|0|||
126711040|NCT01863758|455893622|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
126711041|NCT01863758|455893622|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
126294206|NCT05085834|454366590|FG000|Overall Study|Death|1|||
126294207|NCT05085834|454366591|FG001|Overall Study|Death|0|||
126294208|NCT05085834|454366590|FG000|Overall Study|Inability to swallow the pill|0|||
126460378|NCT00722371|454986289|FG001|Overall Study|Withdrawal by Subject|27|||
126711042|NCT02369510|455893623|FG000|Overall Study|Spilled Medication|1|||
126294209|NCT05085834|454366591|FG001|Overall Study|Inability to swallow the pill|1|||
126294210|NCT02243605|454366592|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
126294211|NCT02243605|454366593|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
126294212|NCT02243605|454366592|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
126294213|NCT02243605|454366593|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
126294214|NCT02243605|454366592|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
126460379|NCT00722371|454986290|FG002|Overall Study|Withdrawal by Subject|19|||
126460380|NCT00722371|454986291|FG003|Overall Study|Withdrawal by Subject|23|||
126460381|NCT00722371|454986292|FG004|Overall Study|Withdrawal by Subject|19|||
126460382|NCT00722371|454986293|FG005|Overall Study|Withdrawal by Subject|18|||
126460383|NCT00722371|454986294|FG006|Overall Study|Withdrawal by Subject|26|||
126460384|NCT01092832|454986295|FG000|Overall Study|Other|1|||
126460385|NCT01092832|454986296|FG001|Overall Study|Other|0|||
126711043|NCT02369510|455893624|FG001|Overall Study|Spilled Medication|2|||
126294215|NCT02243605|454366593|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
126294216|NCT02243605|454366592|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
126294217|NCT02243605|454366593|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
126294218|NCT02243605|454366592|FG000|Stage 2 - Final Analysis Population|Progression|0|||
126294219|NCT02243605|454366593|FG001|Stage 2 - Final Analysis Population|Progression|1|||
126294220|NCT01823328|454366594|FG000|Overall Study|Withdrawal by Subject|8|||
126294221|NCT01823328|454366595|FG001|Overall Study|Withdrawal by Subject|6|||
126294222|NCT00742209|454366602|FG000|Overall Study|Adverse Event|11|||
126294223|NCT00742209|454366603|FG001|Overall Study|Adverse Event|4|||
126294224|NCT00742209|454366604|FG002|Overall Study|Adverse Event|17|||
126294225|NCT00742209|454366605|FG003|Overall Study|Adverse Event|16|||
126294226|NCT00742209|454366606|FG004|Overall Study|Adverse Event|13|||
126294227|NCT00742209|454366602|FG000|Overall Study|Participant Withdrew Consent|8|||
126294228|NCT00742209|454366603|FG001|Overall Study|Participant Withdrew Consent|4|||
126294229|NCT00742209|454366604|FG002|Overall Study|Participant Withdrew Consent|14|||
126294230|NCT00742209|454366605|FG003|Overall Study|Participant Withdrew Consent|7|||
126294231|NCT00742209|454366606|FG004|Overall Study|Participant Withdrew Consent|4|||
126294232|NCT00742209|454366602|FG000|Overall Study|Protocol Violation|6|||
126294233|NCT00742209|454366603|FG001|Overall Study|Protocol Violation|5|||
126294234|NCT00742209|454366604|FG002|Overall Study|Protocol Violation|4|||
126294235|NCT00742209|454366605|FG003|Overall Study|Protocol Violation|5|||
126294236|NCT00742209|454366606|FG004|Overall Study|Protocol Violation|3|||
126294237|NCT00742209|454366602|FG000|Overall Study|Lost to Follow-up|3|||
126294238|NCT00742209|454366603|FG001|Overall Study|Lost to Follow-up|4|||
126294239|NCT00742209|454366604|FG002|Overall Study|Lost to Follow-up|5|||
126294240|NCT00742209|454366605|FG003|Overall Study|Lost to Follow-up|5|||
126294241|NCT00742209|454366606|FG004|Overall Study|Lost to Follow-up|3|||
126294242|NCT00742209|454366602|FG000|Overall Study|Lack of Efficacy|6|||
126294243|NCT00742209|454366603|FG001|Overall Study|Lack of Efficacy|1|||
126294244|NCT00742209|454366604|FG002|Overall Study|Lack of Efficacy|1|||
126294245|NCT00742209|454366605|FG003|Overall Study|Lack of Efficacy|3|||
126294246|NCT00742209|454366606|FG004|Overall Study|Lack of Efficacy|1|||
126294247|NCT00742209|454366602|FG000|Overall Study|Investigator Discretion|0|||
126294248|NCT00742209|454366603|FG001|Overall Study|Investigator Discretion|0|||
126294249|NCT00742209|454366604|FG002|Overall Study|Investigator Discretion|5|||
126294250|NCT00742209|454366605|FG003|Overall Study|Investigator Discretion|1|||
126294251|NCT00742209|454366606|FG004|Overall Study|Investigator Discretion|1|||
126294252|NCT03817125|454366610|FG000|Overall Study|Adverse Event|1|||
126294253|NCT03817125|454366611|FG001|Overall Study|Adverse Event|0|||
126294254|NCT03817125|454366610|FG000|Overall Study|Physician Decision|0|||
126294255|NCT03817125|454366611|FG001|Overall Study|Physician Decision|1|||
126294256|NCT03817125|454366610|FG000|Overall Study|Lack of Efficacy|1|||
126294257|NCT03817125|454366611|FG001|Overall Study|Lack of Efficacy|5|||
126294258|NCT01998919|454366612|FG000|Overall Study|Death|2|||
126294259|NCT01998919|454366613|FG001|Overall Study|Death|2|||
126294260|NCT01998919|454366612|FG000|Overall Study|Adverse Event|0|||
126294261|NCT01998919|454366613|FG001|Overall Study|Adverse Event|5|||
126294262|NCT01998919|454366612|FG000|Overall Study|Disease progression|31|||
126294263|NCT01998919|454366613|FG001|Overall Study|Disease progression|22|||
126294264|NCT01998919|454366612|FG000|Overall Study|Withdrawal by Subject|2|||
126294265|NCT01998919|454366613|FG001|Overall Study|Withdrawal by Subject|4|||
126294266|NCT01998919|454366612|FG000|Overall Study|Lost to Follow-up|2|||
126294267|NCT01998919|454366613|FG001|Overall Study|Lost to Follow-up|0|||
126294268|NCT01998919|454366612|FG000|Overall Study|Other|5|||
126294269|NCT01998919|454366613|FG001|Overall Study|Other|2|||
126294270|NCT01321879|454366617|FG000|Overall Study|Lack of Efficacy|5|||
126294271|NCT01321879|454366617|FG000|Overall Study|Adverse Event|5|||
126294272|NCT01321879|454366617|FG000|Overall Study|Death|3|||
126294273|NCT01321879|454366617|FG000|Overall Study|Withdrawal by Subject|1|||
126294274|NCT00897715|454366618|FG000|Overall Study|Lost to Follow-up|0|||
126294275|NCT00897715|454366619|FG001|Overall Study|Lost to Follow-up|1|||
126294276|NCT00897715|454366618|FG000|Overall Study|Physician Decision|1|||
126294277|NCT00897715|454366619|FG001|Overall Study|Physician Decision|0|||
126294278|NCT00897715|454366618|FG000|Overall Study|increased risk of infection|1|||
126294279|NCT00897715|454366619|FG001|Overall Study|increased risk of infection|0|||
126294280|NCT01199939|454366626|FG000|Overall Study|Adverse Event|4|||
126294281|NCT01199939|454366626|FG000|Overall Study|Protocol Violation|3|||
126294282|NCT01199939|454366626|FG000|Overall Study|Lost to Follow-up|2|||
126294283|NCT01199939|454366626|FG000|Overall Study|Reached a virologic endpoint|4|||
126294284|NCT02550561|454366627|FG000|Overall Study|Lost to Follow-up|5|||
126294285|NCT02550561|454366627|FG000|Overall Study|Withdrawal by Subject|1|||
126294286|NCT02394600|454366628|FG000|Overall Study|Adverse Event|3|||
126294287|NCT02394600|454366629|FG001|Overall Study|Adverse Event|0|||
126294288|NCT02394600|454366628|FG000|Overall Study|Lost to Follow-up|0|||
126294289|NCT02394600|454366629|FG001|Overall Study|Lost to Follow-up|1|||
126294290|NCT02394600|454366628|FG000|Overall Study|Withdrawal by Subject|0|||
126294291|NCT02394600|454366629|FG001|Overall Study|Withdrawal by Subject|1|||
126294292|NCT02394600|454366628|FG000|Overall Study|Protocol Violation|1|||
126294293|NCT02394600|454366629|FG001|Overall Study|Protocol Violation|0|||
126460386|NCT00555425|454986301|FG000|Overall Study|Missed Medication > 1 wk|34|||
126460387|NCT00555425|454986302|FG001|Overall Study|Missed Medication > 1 wk|15|||
126460388|NCT00555425|454986301|FG000|Overall Study|Missed 3 physician management visits|1|||
126460389|NCT00555425|454986302|FG001|Overall Study|Missed 3 physician management visits|0|||
126460390|NCT00555425|454986301|FG000|Overall Study|Met criteria for protective transfer|16|||
126460391|NCT00555425|454986302|FG001|Overall Study|Met criteria for protective transfer|3|||
126294294|NCT01686373|454366630|FG000|Overall Study|Lost to Follow-up|3|||
126294295|NCT01686373|454366631|FG001|Overall Study|Lost to Follow-up|0|||
126294296|NCT01686373|454366630|FG000|Overall Study|Withdrawal by Subject|0|||
126294297|NCT01686373|454366631|FG001|Overall Study|Withdrawal by Subject|1|||
126294298|NCT01686373|454366630|FG000|Overall Study|Adverse Event|0|||
126294299|NCT01686373|454366631|FG001|Overall Study|Adverse Event|1|||
126294300|NCT00791778|454366632|FG000|Double-blind Treatment|Adverse Event|49|||
126294301|NCT00791778|454366633|FG001|Double-blind Treatment|Adverse Event|9|||
126294302|NCT00791778|454366632|FG000|Double-blind Treatment|Physician Decision|6|||
126294303|NCT00791778|454366633|FG001|Double-blind Treatment|Physician Decision|26|||
126294304|NCT00791778|454366632|FG000|Double-blind Treatment|Protocol Violation|0|||
126294305|NCT00791778|454366633|FG001|Double-blind Treatment|Protocol Violation|4|||
126294306|NCT00791778|454366632|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
126294307|NCT00791778|454366633|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
126294308|NCT00791778|454366632|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
126294309|NCT00791778|454366633|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
126294310|NCT00791778|454366632|FG000|Follow-up|Withdrawal by Subject|3|||
126294311|NCT00791778|454366633|FG001|Follow-up|Withdrawal by Subject|0|||
126294312|NCT00791778|454366632|FG000|Follow-up|Lost to Follow-up|2|||
126460392|NCT00555425|454986301|FG000|Overall Study|Became pregnant and transferred care|0|||
126460393|NCT00555425|454986302|FG001|Overall Study|Became pregnant and transferred care|1|||
126460394|NCT02635646|454986304|FG000|Overall Study|Lost to Follow-up|24|||
126460395|NCT02635646|454986305|FG001|Overall Study|Lost to Follow-up|25|||
126460396|NCT02635646|454986304|FG000|Overall Study|Pregnancy|1|||
126460397|NCT02635646|454986305|FG001|Overall Study|Pregnancy|1|||
126460398|NCT00400153|454986312|FG000|Overall Study|AE due to study disease worsening|14|||
126460399|NCT00400153|454986313|FG001|Overall Study|AE due to study disease worsening|19|||
126460400|NCT00400153|454986314|FG002|Overall Study|AE due to study disease worsening|20|||
126460401|NCT00400153|454986312|FG000|Overall Study|AE due to other disease worsening|2|||
126460402|NCT00400153|454986313|FG001|Overall Study|AE due to other disease worsening|1|||
126460403|NCT00400153|454986314|FG002|Overall Study|AE due to other disease worsening|0|||
126460404|NCT00400153|454986312|FG000|Overall Study|AE due to other condition|3|||
126460405|NCT00400153|454986313|FG001|Overall Study|AE due to other condition|14|||
126460406|NCT00400153|454986314|FG002|Overall Study|AE due to other condition|15|||
126460407|NCT00400153|454986312|FG000|Overall Study|Protocol Violation|7|||
126460408|NCT00400153|454986313|FG001|Overall Study|Protocol Violation|4|||
126460409|NCT00400153|454986314|FG002|Overall Study|Protocol Violation|9|||
126460410|NCT00400153|454986312|FG000|Overall Study|Lost to Follow-up|2|||
126460411|NCT00400153|454986313|FG001|Overall Study|Lost to Follow-up|1|||
126460412|NCT00400153|454986314|FG002|Overall Study|Lost to Follow-up|4|||
126460413|NCT00400153|454986312|FG000|Overall Study|Withdrawal by Subject|12|||
126460414|NCT00400153|454986313|FG001|Overall Study|Withdrawal by Subject|11|||
126460415|NCT00400153|454986314|FG002|Overall Study|Withdrawal by Subject|10|||
126460416|NCT00400153|454986312|FG000|Overall Study|Other reasons - not mentioned above|8|||
126460417|NCT00400153|454986313|FG001|Overall Study|Other reasons - not mentioned above|5|||
126460418|NCT00400153|454986314|FG002|Overall Study|Other reasons - not mentioned above|3|||
126460419|NCT00393042|454986315|FG000|First Intervention|Withdrawal by Subject|1|||
126460420|NCT00393042|454986316|FG001|First Intervention|Withdrawal by Subject|2|||
126460421|NCT00393042|454986315|FG000|First Intervention|Lost to Follow-up|3|||
126460422|NCT00393042|454986316|FG001|First Intervention|Lost to Follow-up|3|||
126460423|NCT00393042|454986315|FG000|First Intervention|Protocol Violation|1|||
126460424|NCT00393042|454986316|FG001|First Intervention|Protocol Violation|0|||
126767162|NCT00440193|456100237|FG000|Treatment Period|Site closed by investigator|0|||
126767163|NCT00440193|456100238|FG001|Treatment Period|Site closed by investigator|2|||
126294313|NCT00791778|454366633|FG001|Follow-up|Lost to Follow-up|1|||
126294314|NCT00235755|454366636|FG000|4-Week Titration Phase|Adverse Event|6|||
126294315|NCT00235755|454366637|FG001|4-Week Titration Phase|Adverse Event|14|||
126294316|NCT00235755|454366638|FG002|4-Week Titration Phase|Adverse Event|20|||
126294317|NCT00235755|454366636|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
126294318|NCT00235755|454366637|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
126460425|NCT00393042|454986315|FG000|First Intervention|Adverse Event|0|||
126460426|NCT00393042|454986316|FG001|First Intervention|Adverse Event|1|||
126460427|NCT00393042|454986315|FG000|Second Intervetion|Adverse Event|0|||
126294319|NCT00235755|454366638|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
126294320|NCT00235755|454366636|FG000|4-Week Titration Phase|Protocol Violation|2|||
126460428|NCT00393042|454986316|FG001|Second Intervetion|Adverse Event|3|||
126460429|NCT00393042|454986315|FG000|Second Intervetion|Withdrawal by Subject|0|||
126460430|NCT00393042|454986316|FG001|Second Intervetion|Withdrawal by Subject|2|||
126460431|NCT00393042|454986315|FG000|Second Intervetion|Lack of Efficacy|1|||
126460432|NCT00393042|454986316|FG001|Second Intervetion|Lack of Efficacy|0|||
126460433|NCT00393042|454986315|FG000|Second Intervetion|Lost to Follow-up|0|||
126460434|NCT00393042|454986316|FG001|Second Intervetion|Lost to Follow-up|2|||
126460435|NCT00393042|454986315|FG000|Second Intervetion|Protocol Violation|1|||
126460436|NCT00393042|454986316|FG001|Second Intervetion|Protocol Violation|1|||
126460437|NCT01150474|454986318|FG000|Overall Study|Withdrawal by Subject|5|||
126460438|NCT01150474|454986319|FG001|Overall Study|Withdrawal by Subject|2|||
126460439|NCT01150474|454986318|FG000|Overall Study|Cancer found|1|||
126460440|NCT01150474|454986319|FG001|Overall Study|Cancer found|0|||
126460441|NCT01150474|454986318|FG000|Overall Study|Multiple Studies|0|||
126460442|NCT01150474|454986319|FG001|Overall Study|Multiple Studies|1|||
126460443|NCT01150474|454986318|FG000|Overall Study|Rectotomy|1|||
126460444|NCT01150474|454986319|FG001|Overall Study|Rectotomy|0|||
126460445|NCT01150474|454986318|FG000|Overall Study|Drug did not arrive in time|1|||
126460446|NCT01150474|454986319|FG001|Overall Study|Drug did not arrive in time|0|||
126460447|NCT01150474|454986318|FG000|Overall Study|Drug not administered|1|||
126460448|NCT01150474|454986319|FG001|Overall Study|Drug not administered|0|||
126460449|NCT01150474|454986318|FG000|Overall Study|Surgery Changed|1|||
126460450|NCT01150474|454986319|FG001|Overall Study|Surgery Changed|0|||
126460451|NCT01423604|454986320|FG000|Safety Run-In|Adverse Event|3|||
126460452|NCT01423604|454986321|FG001|Safety Run-In|Adverse Event|0|||
126460453|NCT01423604|454986320|FG000|Safety Run-In|Death|1|||
126460454|NCT01423604|454986321|FG001|Safety Run-In|Death|0|||
126460455|NCT01423604|454986320|FG000|Safety Run-In|Physician Decision|1|||
126460456|NCT01423604|454986321|FG001|Safety Run-In|Physician Decision|0|||
126460457|NCT01423604|454986320|FG000|Safety Run-In|Disease progression|3|||
126460458|NCT01423604|454986321|FG001|Safety Run-In|Disease progression|0|||
126460459|NCT01423604|454986320|FG000|Safety Run-In|Patient decision|1|||
126460460|NCT01423604|454986321|FG001|Safety Run-In|Patient decision|0|||
126460461|NCT01423604|454986320|FG000|Randomized|Adverse Event|4|||
126460462|NCT01423604|454986321|FG001|Randomized|Adverse Event|10|||
126460463|NCT01423604|454986320|FG000|Randomized|Death|1|||
126460464|NCT01423604|454986321|FG001|Randomized|Death|0|||
126460465|NCT01423604|454986320|FG000|Randomized|Physician Decision|16|||
126460466|NCT01423604|454986321|FG001|Randomized|Physician Decision|13|||
126460467|NCT01423604|454986320|FG000|Randomized|Other - unspecified|37|||
126460468|NCT01423604|454986321|FG001|Randomized|Other - unspecified|31|||
126460469|NCT01423604|454986320|FG000|Randomized|Patient decision|5|||
126460470|NCT01423604|454986321|FG001|Randomized|Patient decision|9|||
126460471|NCT00424255|454986322|FG000|Overall Study|Death|115|||
126460472|NCT00424255|454986323|FG001|Overall Study|Death|111|||
126460473|NCT00424255|454986322|FG000|Overall Study|Lost to Follow-up|26|||
126767164|NCT00440193|456100237|FG000|Observational Period|Adverse Event|2|||
126767165|NCT00440193|456100238|FG001|Observational Period|Adverse Event|2|||
126294321|NCT00235755|454366637|FG001|4-Week Titration Phase|Protocol Violation|2|||
126460474|NCT00424255|454986323|FG001|Overall Study|Lost to Follow-up|20|||
126460475|NCT00424255|454986322|FG000|Overall Study|Protocol Violation|0|||
126460476|NCT00424255|454986323|FG001|Overall Study|Protocol Violation|1|||
126460477|NCT00424255|454986322|FG000|Overall Study|Withdrawal by Subject|34|||
126460478|NCT00424255|454986323|FG001|Overall Study|Withdrawal by Subject|38|||
126460479|NCT00424255|454986322|FG000|Overall Study|Physician Decision|3|||
126460480|NCT00424255|454986323|FG001|Overall Study|Physician Decision|7|||
126460481|NCT00424255|454986322|FG000|Overall Study|Cognitive Disturbance|1|||
126460482|NCT00424255|454986323|FG001|Overall Study|Cognitive Disturbance|0|||
126294322|NCT00235755|454366638|FG002|4-Week Titration Phase|Protocol Violation|1|||
126294323|NCT00235755|454366636|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
126294324|NCT00235755|454366637|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
126294325|NCT00235755|454366638|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
126294326|NCT00235755|454366636|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
126294327|NCT00235755|454366637|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
126294328|NCT00235755|454366638|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
126294329|NCT00235755|454366636|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
126294330|NCT00235755|454366637|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
126460483|NCT00424255|454986322|FG000|Overall Study|Non-compliance by Participants|1|||
126294331|NCT00235755|454366638|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
126294332|NCT00235755|454366636|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
126294333|NCT00235755|454366637|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
126460484|NCT00424255|454986323|FG001|Overall Study|Non-compliance by Participants|0|||
126550064|NCT01076088|455307717|FG000|Overall Study|Non-compliance with study drug|0|||
126767166|NCT00440193|456100237|FG000|Observational Period|Death|15|||
126460485|NCT00424255|454986322|FG000|Overall Study|Fatigue|1|||
126460486|NCT00424255|454986323|FG001|Overall Study|Fatigue|0|||
126767167|NCT00440193|456100238|FG001|Observational Period|Death|20|||
126460487|NCT00424255|454986322|FG000|Overall Study|Disease Progression|0|||
126460488|NCT00424255|454986323|FG001|Overall Study|Disease Progression|2|||
126460489|NCT00424255|454986322|FG000|Overall Study|Sponsor Terminated Study|161|||
126460490|NCT00424255|454986323|FG001|Overall Study|Sponsor Terminated Study|167|||
126294334|NCT00235755|454366638|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
126460491|NCT02290431|454986324|FG000|Overall Study|Adverse Event|20|||
126460492|NCT02290431|454986324|FG000|Overall Study|Progressive disease|4|||
126460493|NCT02290431|454986324|FG000|Overall Study|Study terminated by Sponsor|1|||
126460494|NCT02290431|454986324|FG000|Overall Study|Physician Decision|2|||
126460495|NCT00821327|454986327|FG000|Overall Study|Adverse Event|13|||
126460496|NCT00821327|454986327|FG000|Overall Study|Patient Request|1|||
126460497|NCT00821327|454986327|FG000|Overall Study|Investigator Request|2|||
126460498|NCT00821327|454986327|FG000|Overall Study|Sponsor Request|1|||
126460499|NCT00821327|454986327|FG000|Overall Study|Disease Progression|13|||
126460500|NCT00821327|454986327|FG000|Overall Study|Other/Unknown|5|||
126460501|NCT00459979|454986330|FG000|Overall Study|Withdrawal by Subject|1|||
126460502|NCT00459979|454986330|FG000|Overall Study|Protocol Violation|1|||
126460503|NCT01007253|454986333|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
126460504|NCT01007253|454986334|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
126460505|NCT01007253|454986335|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
126460506|NCT01007253|454986336|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
126460507|NCT00814801|454986337|FG000|Overall Study|Adverse Event|15|||
126460508|NCT00814801|454986338|FG001|Overall Study|Adverse Event|16|||
126460509|NCT00814801|454986339|FG002|Overall Study|Adverse Event|19|||
126460510|NCT00814801|454986337|FG000|Overall Study|Withdrawal by Subject|9|||
126460511|NCT00814801|454986338|FG001|Overall Study|Withdrawal by Subject|11|||
126460512|NCT00814801|454986339|FG002|Overall Study|Withdrawal by Subject|14|||
126460513|NCT00814801|454986337|FG000|Overall Study|Inappropriate as a subject|1|||
126460514|NCT00814801|454986338|FG001|Overall Study|Inappropriate as a subject|1|||
126460515|NCT00814801|454986339|FG002|Overall Study|Inappropriate as a subject|1|||
126460516|NCT00814801|454986337|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
126460517|NCT00814801|454986338|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
126460518|NCT00814801|454986339|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
126460519|NCT00814801|454986337|FG000|Overall Study|Missing or change of caregiver|6|||
126460520|NCT00814801|454986338|FG001|Overall Study|Missing or change of caregiver|2|||
126460521|NCT00814801|454986339|FG002|Overall Study|Missing or change of caregiver|4|||
126460522|NCT00814801|454986337|FG000|Overall Study|Non-compliance|0|||
126460523|NCT00814801|454986338|FG001|Overall Study|Non-compliance|1|||
126460524|NCT00814801|454986339|FG002|Overall Study|Non-compliance|1|||
126460525|NCT00814801|454986337|FG000|Overall Study|Other|2|||
126460526|NCT00814801|454986338|FG001|Overall Study|Other|6|||
126460527|NCT00814801|454986339|FG002|Overall Study|Other|4|||
126460528|NCT00586664|454986340|FG000|Overall Study|Withdrawal by Subject|3|||
126460529|NCT00586664|454986341|FG001|Overall Study|Withdrawal by Subject|7|||
126460530|NCT00586664|454986342|FG002|Overall Study|Withdrawal by Subject|1|||
126460531|NCT00586664|454986340|FG000|Overall Study|Exclusion criteria met|2|||
126460532|NCT00586664|454986341|FG001|Overall Study|Exclusion criteria met|0|||
126460533|NCT00586664|454986342|FG002|Overall Study|Exclusion criteria met|0|||
126460534|NCT01163032|454986343|FG000|Randomization Phase|Withdrawal by Subject|2|||
126460535|NCT01163032|454986344|FG001|Randomization Phase|Withdrawal by Subject|3|||
126460536|NCT01163032|454986345|FG002|Randomization Phase|Withdrawal by Subject|0|||
126460537|NCT01163032|454986343|FG000|Randomization Phase|Adverse Event|3|||
126460538|NCT01163032|454986344|FG001|Randomization Phase|Adverse Event|3|||
126460539|NCT01163032|454986345|FG002|Randomization Phase|Adverse Event|0|||
126460540|NCT01163032|454986343|FG000|Randomization Phase|Protocol Violation|0|||
126460541|NCT01163032|454986344|FG001|Randomization Phase|Protocol Violation|1|||
126460542|NCT01163032|454986345|FG002|Randomization Phase|Protocol Violation|0|||
126460543|NCT01163032|454986343|FG000|Randomization Phase|Various*|5|||
126460544|NCT01163032|454986344|FG001|Randomization Phase|Various*|4|||
126460545|NCT01163032|454986345|FG002|Randomization Phase|Various*|0|||
126460546|NCT01163032|454986343|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
126460547|NCT01163032|454986344|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
126460548|NCT01163032|454986345|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
126460549|NCT01163032|454986343|FG000|Open Label Extension Phase|Adverse Event|0|||
126460550|NCT01163032|454986344|FG001|Open Label Extension Phase|Adverse Event|0|||
126460551|NCT01163032|454986345|FG002|Open Label Extension Phase|Adverse Event|3|||
126294335|NCT00235755|454366636|FG000|12-Week Maintenance Phase|Adverse Event|8|||
126294336|NCT00235755|454366637|FG001|12-Week Maintenance Phase|Adverse Event|12|||
126460552|NCT01163032|454986343|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
126460553|NCT01163032|454986344|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
126460554|NCT01163032|454986345|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
126460555|NCT01163032|454986343|FG000|Open Label Extension Phase|Protocol Violation|0|||
126460556|NCT01163032|454986344|FG001|Open Label Extension Phase|Protocol Violation|0|||
126460557|NCT01163032|454986345|FG002|Open Label Extension Phase|Protocol Violation|1|||
126460558|NCT01163032|454986343|FG000|Open Label Extension Phase|Study Termination|0|||
126460559|NCT01163032|454986344|FG001|Open Label Extension Phase|Study Termination|0|||
126460560|NCT01163032|454986345|FG002|Open Label Extension Phase|Study Termination|7|||
126460561|NCT01163032|454986343|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
126460562|NCT01163032|454986344|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
126294337|NCT00235755|454366638|FG002|12-Week Maintenance Phase|Adverse Event|26|||
126294338|NCT00235755|454366636|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
126294339|NCT00235755|454366637|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
126294340|NCT00235755|454366638|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
126294341|NCT00235755|454366636|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
126460563|NCT01163032|454986345|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
126460564|NCT02751931|454986346|FG000|Overall Study|Adverse Event|3|||
126460565|NCT02751931|454986347|FG001|Overall Study|Adverse Event|0|||
126460566|NCT02751931|454986346|FG000|Overall Study|Other: Miscelleneous|10|||
126294342|NCT00235755|454366637|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
126294343|NCT00235755|454366638|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
126294344|NCT00235755|454366636|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
126294345|NCT00235755|454366637|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
126294346|NCT00235755|454366638|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
126294347|NCT00235755|454366636|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
126294348|NCT00235755|454366637|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
126294349|NCT00235755|454366638|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
126460567|NCT02751931|454986347|FG001|Overall Study|Other: Miscelleneous|8|||
126460568|NCT02380690|454986349|FG000|Overall Study|Lost to Follow-up|14|||
126460569|NCT02380690|454986350|FG001|Overall Study|Lost to Follow-up|4|||
126460570|NCT02380690|454986349|FG000|Overall Study|Withdrawal by Subject|20|||
126294350|NCT00235755|454366636|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
126294351|NCT00235755|454366637|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
126294352|NCT00235755|454366638|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
126294353|NCT02314026|454366639|FG000|Overall Study|Protocol Violation|28|||
126294354|NCT01532934|454366642|FG000|Overall Study|Lost to Follow-up|11|||
126294355|NCT01532934|454366643|FG001|Overall Study|Lost to Follow-up|11|||
126294356|NCT01532934|454366642|FG000|Overall Study|In controlled environment|3|||
126294357|NCT01532934|454366643|FG001|Overall Study|In controlled environment|2|||
126294358|NCT01147068|454366644|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
126294359|NCT01147068|454366645|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
126294360|NCT01147068|454366646|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
126294361|NCT01147068|454366647|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
126460571|NCT02380690|454986350|FG001|Overall Study|Withdrawal by Subject|8|||
126460572|NCT00727532|454986351|FG000|Overall Study|Adverse Event|1|||
126460573|NCT00727532|454986351|FG000|Overall Study|Withdrawal by Subject|1|||
126460574|NCT00829933|454986352|FG000|Overall Study|Adverse Event|2|||
126460575|NCT00829933|454986353|FG001|Overall Study|Adverse Event|3|||
126294362|NCT01147068|454366648|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
126294363|NCT01147068|454366649|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
126294364|NCT01147068|454366650|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
126294365|NCT01147068|454366644|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
126294366|NCT01147068|454366645|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
126460576|NCT00829933|454986354|FG002|Overall Study|Adverse Event|2|||
126460577|NCT00829933|454986355|FG003|Overall Study|Adverse Event|1|||
126460578|NCT00829933|454986352|FG000|Overall Study|Death|0|||
126460579|NCT00829933|454986353|FG001|Overall Study|Death|0|||
126460580|NCT00829933|454986354|FG002|Overall Study|Death|1|||
126460581|NCT00829933|454986355|FG003|Overall Study|Death|1|||
126460582|NCT00829933|454986352|FG000|Overall Study|Lack of Efficacy|0|||
126460583|NCT00829933|454986353|FG001|Overall Study|Lack of Efficacy|1|||
126460584|NCT00829933|454986354|FG002|Overall Study|Lack of Efficacy|0|||
126460585|NCT00829933|454986355|FG003|Overall Study|Lack of Efficacy|0|||
126460586|NCT00829933|454986352|FG000|Overall Study|Physician Decision|5|||
126460587|NCT00829933|454986353|FG001|Overall Study|Physician Decision|7|||
126460588|NCT00829933|454986354|FG002|Overall Study|Physician Decision|8|||
126460589|NCT00829933|454986355|FG003|Overall Study|Physician Decision|1|||
126294367|NCT01147068|454366646|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
126294368|NCT01147068|454366647|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
126294369|NCT01147068|454366648|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
126460590|NCT00829933|454986352|FG000|Overall Study|Pregnancy|0|||
126460591|NCT00829933|454986353|FG001|Overall Study|Pregnancy|0|||
126460592|NCT00829933|454986354|FG002|Overall Study|Pregnancy|0|||
126460593|NCT00829933|454986355|FG003|Overall Study|Pregnancy|2|||
126460594|NCT00829933|454986352|FG000|Overall Study|Protocol Violation|2|||
126460595|NCT00829933|454986353|FG001|Overall Study|Protocol Violation|1|||
126460596|NCT00829933|454986354|FG002|Overall Study|Protocol Violation|0|||
126460597|NCT00829933|454986355|FG003|Overall Study|Protocol Violation|0|||
126460598|NCT00829933|454986352|FG000|Overall Study|withdrew before treatment started|5|||
126294370|NCT01147068|454366649|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
126294371|NCT01147068|454366650|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
126460599|NCT00829933|454986353|FG001|Overall Study|withdrew before treatment started|1|||
126460600|NCT00829933|454986354|FG002|Overall Study|withdrew before treatment started|2|||
126460601|NCT00829933|454986355|FG003|Overall Study|withdrew before treatment started|9|||
126460602|NCT01986933|454986360|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
126460603|NCT01986933|454986361|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
126460604|NCT01986933|454986362|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
126460605|NCT01986933|454986363|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
126460606|NCT01986933|454986364|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
126460607|NCT01986933|454986360|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
126460608|NCT01986933|454986361|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
126460609|NCT01986933|454986362|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
126460610|NCT01986933|454986363|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
126460611|NCT01986933|454986364|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
126460612|NCT01986933|454986360|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
126460613|NCT01986933|454986361|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
126460614|NCT01986933|454986362|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
126460615|NCT01986933|454986363|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
126460616|NCT01986933|454986364|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
126460617|NCT01986933|454986360|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
126460618|NCT01986933|454986361|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
126460619|NCT01986933|454986362|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
126460620|NCT01986933|454986363|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
126460621|NCT01986933|454986364|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
126460622|NCT01986933|454986360|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
126460623|NCT01986933|454986361|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
126460624|NCT01986933|454986362|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
126460625|NCT01986933|454986363|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
126460626|NCT01986933|454986364|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
126460627|NCT01986933|454986360|FG000|Active-to-active (Part B)|Adverse Event|0|||
126460628|NCT01986933|454986361|FG001|Active-to-active (Part B)|Adverse Event|2|||
126460629|NCT01986933|454986362|FG002|Active-to-active (Part B)|Adverse Event|0|||
126460630|NCT01986933|454986363|FG003|Active-to-active (Part B)|Adverse Event|1|||
126460631|NCT01986933|454986364|FG004|Active-to-active (Part B)|Adverse Event|3|||
126460632|NCT01986933|454986360|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
126460633|NCT01986933|454986361|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
126460634|NCT01986933|454986362|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
126460635|NCT01986933|454986363|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
126460636|NCT01986933|454986364|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
126460637|NCT01986933|454986360|FG000|Active-to-active (Part B)|Pregnancy|0|||
126460638|NCT01986933|454986361|FG001|Active-to-active (Part B)|Pregnancy|0|||
126460639|NCT01986933|454986362|FG002|Active-to-active (Part B)|Pregnancy|0|||
126460640|NCT01986933|454986363|FG003|Active-to-active (Part B)|Pregnancy|0|||
126460641|NCT01986933|454986364|FG004|Active-to-active (Part B)|Pregnancy|1|||
126460642|NCT01986933|454986360|FG000|Active-to-active (Part B)|Physician Decision|0|||
126460643|NCT01986933|454986361|FG001|Active-to-active (Part B)|Physician Decision|0|||
126460644|NCT01986933|454986362|FG002|Active-to-active (Part B)|Physician Decision|1|||
126711044|NCT02369510|455893625|FG002|Overall Study|Spilled Medication|1|||
126711045|NCT02369510|455893623|FG000|Overall Study|Epidural Activation|1|||
126711046|NCT02369510|455893624|FG001|Overall Study|Epidural Activation|1|||
126711047|NCT02369510|455893625|FG002|Overall Study|Epidural Activation|5|||
126294372|NCT01147068|454366644|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
126294373|NCT01147068|454366645|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
126460645|NCT01986933|454986363|FG003|Active-to-active (Part B)|Physician Decision|1|||
126460646|NCT01986933|454986364|FG004|Active-to-active (Part B)|Physician Decision|0|||
126460647|NCT01986933|454986360|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
126460648|NCT01986933|454986361|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
126460649|NCT01986933|454986362|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
126460650|NCT01986933|454986363|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
126460651|NCT01986933|454986364|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
126460652|NCT01986933|454986360|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
126460653|NCT01986933|454986361|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
126460654|NCT01986933|454986362|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
126460655|NCT01986933|454986363|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
126460656|NCT01986933|454986364|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
126460657|NCT01986933|454986360|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
126460658|NCT01986933|454986361|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
126460659|NCT01986933|454986362|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
126460660|NCT01986933|454986363|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
126460661|NCT01986933|454986364|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
126460662|NCT01986933|454986360|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
126460663|NCT01986933|454986361|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
126460664|NCT01986933|454986362|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
126460665|NCT01986933|454986363|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
126711048|NCT04952389|455893626|FG000|Overall Study|Withdrawal by Subject|8|||
126767168|NCT00440193|456100237|FG000|Observational Period|Lost to Follow-up|12|||
126767169|NCT00440193|456100238|FG001|Observational Period|Lost to Follow-up|8|||
126767170|NCT00440193|456100237|FG000|Observational Period|Protocol Violation|1|||
126767171|NCT00440193|456100238|FG001|Observational Period|Protocol Violation|0|||
126767172|NCT00440193|456100237|FG000|Observational Period|Withdrawal by Subject|11|||
126767173|NCT00440193|456100238|FG001|Observational Period|Withdrawal by Subject|8|||
126767174|NCT00440193|456100237|FG000|Observational Period|Physician Decision|1|||
126767175|NCT00440193|456100238|FG001|Observational Period|Physician Decision|0|||
126767176|NCT00440193|456100237|FG000|Observational Period|Clinical endpoint reached|1|||
126767177|NCT00440193|456100238|FG001|Observational Period|Clinical endpoint reached|0|||
126767178|NCT00440193|456100237|FG000|Observational Period|Participant convenience|2|||
126767179|NCT00440193|456100238|FG001|Observational Period|Participant convenience|0|||
126767180|NCT00530621|456100244|FG000|Overall Study|Adverse Event|11|||
126767181|NCT00530621|456100245|FG001|Overall Study|Adverse Event|8|||
126767182|NCT00530621|456100244|FG000|Overall Study|Physician Decision|2|||
126767183|NCT00530621|456100245|FG001|Overall Study|Physician Decision|4|||
126767184|NCT00530621|456100244|FG000|Overall Study|Progressive Disease (PD)|47|||
126767185|NCT00530621|456100245|FG001|Overall Study|Progressive Disease (PD)|40|||
126767186|NCT00530621|456100244|FG000|Overall Study|Sponsor Decision|12|||
126767187|NCT00530621|456100245|FG001|Overall Study|Sponsor Decision|15|||
126767188|NCT00530621|456100244|FG000|Overall Study|Subject Decision|4|||
126767189|NCT00530621|456100245|FG001|Overall Study|Subject Decision|7|||
126767190|NCT00530621|456100244|FG000|Overall Study|Death|3|||
126767191|NCT00530621|456100245|FG001|Overall Study|Death|6|||
126767192|NCT00530621|456100244|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
126767193|NCT00530621|456100245|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
126767194|NCT03409328|456100246|FG000|Overall Study|Lost to Follow-up|6|||
126767195|NCT03409328|456100247|FG001|Overall Study|Lost to Follow-up|3|||
126460666|NCT01986933|454986364|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
126460667|NCT01986933|454986360|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
126460668|NCT01986933|454986361|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
126460669|NCT01986933|454986362|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
126460670|NCT01986933|454986363|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
126460671|NCT01986933|454986364|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
126460672|NCT01986933|454986360|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
126460673|NCT01986933|454986361|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
126460674|NCT01986933|454986362|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
126460675|NCT01986933|454986363|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
126460676|NCT01986933|454986364|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
126460677|NCT01986933|454986360|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
126460678|NCT01986933|454986361|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
126460679|NCT01986933|454986362|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
126460680|NCT01986933|454986363|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
126460681|NCT01986933|454986364|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
126460682|NCT01986933|454986360|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
126460683|NCT01986933|454986361|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
126460684|NCT01986933|454986362|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
126460685|NCT01986933|454986363|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
126460686|NCT01986933|454986364|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
126460687|NCT03119701|454986365|FG000|6-day Dosing|Death|4|||
126460688|NCT03119701|454986366|FG001|6-day Dosing|Death|1|||
126460689|NCT03119701|454986365|FG000|6-day Dosing|Adverse Event|3|||
126460690|NCT03119701|454986366|FG001|6-day Dosing|Adverse Event|0|||
126460691|NCT03119701|454986365|FG000|6-day Dosing|Physician Decision|0|||
126460692|NCT03119701|454986366|FG001|6-day Dosing|Physician Decision|1|||
126460693|NCT03119701|454986365|FG000|6-day Dosing|Withdrawal by Subject|0|||
126460694|NCT03119701|454986366|FG001|6-day Dosing|Withdrawal by Subject|1|||
126460695|NCT03119701|454986365|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
126460696|NCT03119701|454986366|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
126550065|NCT01076088|455307718|FG001|Overall Study|Non-compliance with study drug|0|||
126550066|NCT01076088|455307719|FG002|Overall Study|Non-compliance with study drug|0|||
126550067|NCT01076088|455307720|FG003|Overall Study|Non-compliance with study drug|1|||
126550068|NCT01076088|455307721|FG004|Overall Study|Non-compliance with study drug|0|||
126550069|NCT01076088|455307722|FG005|Overall Study|Non-compliance with study drug|0|||
126550070|NCT01076088|455307717|FG000|Overall Study|Physician Decision|1|||
126550071|NCT01076088|455307718|FG001|Overall Study|Physician Decision|3|||
126550072|NCT01076088|455307719|FG002|Overall Study|Physician Decision|0|||
126550073|NCT01076088|455307720|FG003|Overall Study|Physician Decision|1|||
126767196|NCT00518011|456100248|FG000|Overall Study|Death|1|||
126767197|NCT00518011|456100249|FG001|Overall Study|Death|1|||
126767198|NCT00518011|456100248|FG000|Overall Study|Adverse Event|2|||
126767199|NCT00518011|456100249|FG001|Overall Study|Adverse Event|3|||
126767200|NCT00518011|456100248|FG000|Overall Study|Disease Progression|2|||
126767201|NCT00518011|456100249|FG001|Overall Study|Disease Progression|2|||
126767202|NCT00518011|456100248|FG000|Overall Study|Other Reasons|3|||
126460697|NCT00817479|454986367|FG000|Overall Study|Physician Decision|1|||
126460698|NCT00817479|454986368|FG001|Overall Study|Physician Decision|1|||
126460699|NCT04030026|454986370|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
126460700|NCT04030026|454986371|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
126460701|NCT04030026|454986370|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
126460702|NCT04030026|454986371|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
126460703|NCT04030026|454986370|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
126460704|NCT04030026|454986371|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
126460705|NCT04030026|454986370|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
126460706|NCT04030026|454986371|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
126460707|NCT04030026|454986370|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
126460708|NCT04030026|454986371|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
126460709|NCT04030026|454986370|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
126460710|NCT04030026|454986371|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
126460711|NCT04030026|454986370|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
126460712|NCT04030026|454986371|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
126460713|NCT00523367|454986372|FG000|Overall Study|19 screen failures|19|||
126460714|NCT00523367|454986372|FG000|Overall Study|4 Withdrawn by PI|4|||
126460715|NCT01275339|454987851|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
126460716|NCT01275339|454987852|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
126460717|NCT01275339|454987853|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
126460718|NCT01275339|454987854|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
126460719|NCT01275339|454987851|FG000|Overall Study|Withdrawal by Subject|0|||
126460720|NCT01275339|454987852|FG001|Overall Study|Withdrawal by Subject|0|||
126460721|NCT01275339|454987853|FG002|Overall Study|Withdrawal by Subject|1|||
126460722|NCT01275339|454987854|FG003|Overall Study|Withdrawal by Subject|0|||
126460723|NCT02478398|454987855|FG000|Overall Study|Adverse Event|20|||
126460724|NCT02478398|454987856|FG001|Overall Study|Adverse Event|5|||
126460725|NCT02478398|454987855|FG000|Overall Study|Lost to Follow-up|5|||
126460726|NCT02478398|454987856|FG001|Overall Study|Lost to Follow-up|4|||
126460727|NCT02478398|454987855|FG000|Overall Study|Non-Compliance With Study Drug|5|||
126460728|NCT02478398|454987856|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126460729|NCT02478398|454987855|FG000|Overall Study|Protocol Violation|3|||
126460730|NCT02478398|454987856|FG001|Overall Study|Protocol Violation|1|||
126460731|NCT02478398|454987855|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
126460732|NCT02478398|454987856|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
126460733|NCT02478398|454987855|FG000|Overall Study|Withdrawal By Participant|10|||
126460734|NCT02478398|454987856|FG001|Overall Study|Withdrawal By Participant|4|||
126460735|NCT01362595|454987858|FG000|Overall Study|Screen failure|10|||
126460736|NCT01362595|454987858|FG000|Overall Study|Withdrawal by Subject|2|||
126460737|NCT02469038|454987859|FG000|Overall Study|Physician Decision|4|||
126460738|NCT02469038|454987860|FG001|Overall Study|Physician Decision|5|||
126460739|NCT02448680|454987861|FG000|Overall Study|Physician Decision|1|||
126460740|NCT02448680|454987862|FG001|Overall Study|Physician Decision|1|||
126460741|NCT02448680|454987861|FG000|Overall Study|Withdrawal by Subject|0|||
126460742|NCT02448680|454987862|FG001|Overall Study|Withdrawal by Subject|2|||
126460743|NCT00636987|454987863|FG000|Overall Study|Death|44|||
126460744|NCT00636987|454987863|FG000|Overall Study|Explanted|13|||
126460745|NCT00636987|454987863|FG000|Overall Study|Lost to Follow-up|63|||
126460746|NCT00636987|454987863|FG000|Overall Study|5 year visit window not complete|69|||
126460747|NCT01251146|454987864|FG000|Overall Study|Lost to Follow-up|3|||
126711049|NCT04952389|455893627|FG001|Overall Study|Withdrawal by Subject|4|||
126711050|NCT02050048|455893628|FG000|Overall Study|Lost to Follow-up|0|||
126294374|NCT01147068|454366646|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
126294375|NCT01147068|454366647|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
126294376|NCT01147068|454366648|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
126460748|NCT01251146|454987865|FG001|Overall Study|Lost to Follow-up|10|||
126460749|NCT01739400|454987868|FG000|Overall Study|Physician Decision|3|||
126460750|NCT01739400|454987869|FG001|Overall Study|Physician Decision|0|||
126460751|NCT01739400|454987868|FG000|Overall Study|Lost to Follow-up|2|||
126460752|NCT01739400|454987869|FG001|Overall Study|Lost to Follow-up|0|||
126460753|NCT01739400|454987868|FG000|Overall Study|Death|5|||
126460754|NCT01739400|454987869|FG001|Overall Study|Death|2|||
126460755|NCT01739400|454987868|FG000|Overall Study|Withdrawal by Subject|7|||
126460756|NCT01739400|454987869|FG001|Overall Study|Withdrawal by Subject|7|||
126460757|NCT01083173|454987876|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
126460758|NCT01083173|454987877|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
126460759|NCT01083173|454987876|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
126460760|NCT01083173|454987877|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
126460761|NCT01083173|454987876|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
126460762|NCT01083173|454987877|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
126711051|NCT02050048|455893629|FG001|Overall Study|Lost to Follow-up|1|||
126711052|NCT02050048|455893628|FG000|Overall Study|Death|1|||
126294377|NCT01147068|454366649|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
126294378|NCT01147068|454366650|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
126294379|NCT01147068|454366644|FG000|Subjects That Received 2nd Dose|Other|0|||
126294380|NCT01147068|454366645|FG001|Subjects That Received 2nd Dose|Other|3|||
126294381|NCT01147068|454366646|FG002|Subjects That Received 2nd Dose|Other|3|||
126294382|NCT01147068|454366647|FG003|Subjects That Received 2nd Dose|Other|0|||
126460763|NCT01083173|454987876|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
126460764|NCT01083173|454987877|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
126460765|NCT01083173|454987876|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
126460766|NCT01083173|454987877|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
126460767|NCT01083173|454987876|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
126460768|NCT01083173|454987877|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
126460769|NCT01083173|454987876|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
126460770|NCT01083173|454987877|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
126460771|NCT01083173|454987876|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
126460772|NCT01083173|454987877|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
126460773|NCT01083173|454987876|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
126460774|NCT01083173|454987877|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
126460775|NCT01083173|454987876|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
126460776|NCT01083173|454987877|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
126460777|NCT01083173|454987876|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
126460778|NCT01083173|454987877|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
126460779|NCT01850602|454987882|FG000|Overall Study|Adverse Event|7|||
126460780|NCT01850602|454987883|FG001|Overall Study|Adverse Event|10|||
126460781|NCT01850602|454987882|FG000|Overall Study|Physician Decision|2|||
126460782|NCT01850602|454987883|FG001|Overall Study|Physician Decision|1|||
126460783|NCT01850602|454987882|FG000|Overall Study|Withdrawal by Subject|2|||
126460784|NCT01850602|454987883|FG001|Overall Study|Withdrawal by Subject|4|||
126460785|NCT01850602|454987882|FG000|Overall Study|Decrease in serum calcium|2|||
126460786|NCT01850602|454987883|FG001|Overall Study|Decrease in serum calcium|3|||
126460787|NCT01850602|454987882|FG000|Overall Study|Increase in serum ferritin|1|||
126460788|NCT01850602|454987883|FG001|Overall Study|Increase in serum ferritin|0|||
126460789|NCT01857310|454987884|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
126460790|NCT01857310|454987885|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
126460791|NCT02497976|454987888|FG000|Overall Study|Withdrawal by Subject|2|||
126460792|NCT02497976|454987889|FG001|Overall Study|Withdrawal by Subject|0|||
126460793|NCT02497976|454987888|FG000|Overall Study|Moved out of area|0|||
126460794|NCT02497976|454987889|FG001|Overall Study|Moved out of area|1|||
126460795|NCT00584740|454987890|FG000|Overall Study|Adverse Event|1|||
126460796|NCT00584740|454987891|FG001|Overall Study|Adverse Event|1|||
126460797|NCT00584740|454987890|FG000|Overall Study|Lack of Efficacy|8|||
126460798|NCT00584740|454987891|FG001|Overall Study|Lack of Efficacy|2|||
126460799|NCT00584740|454987890|FG000|Overall Study|Withdrawal by Subject|3|||
126460800|NCT00584740|454987891|FG001|Overall Study|Withdrawal by Subject|2|||
126460801|NCT00584740|454987890|FG000|Overall Study|Lost to Follow-up|0|||
126294383|NCT01147068|454366648|FG004|Subjects That Received 2nd Dose|Other|1|||
126294384|NCT01147068|454366649|FG005|Subjects That Received 2nd Dose|Other|0|||
126294385|NCT01147068|454366650|FG006|Subjects That Received 2nd Dose|Other|0|||
126294386|NCT01147068|454366644|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
126294387|NCT01147068|454366645|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
126294388|NCT01147068|454366646|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
126294389|NCT01147068|454366647|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
126294390|NCT01147068|454366648|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
126294391|NCT01147068|454366649|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
126294392|NCT01147068|454366650|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
126294393|NCT01147068|454366644|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
126294394|NCT01147068|454366645|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
126294395|NCT01147068|454366646|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
126294396|NCT01147068|454366647|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
126294397|NCT01147068|454366648|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
126294398|NCT01147068|454366649|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
126294399|NCT01147068|454366650|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
126294400|NCT01147068|454366644|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
126460802|NCT00584740|454987891|FG001|Overall Study|Lost to Follow-up|1|||
126460803|NCT00930982|454987892|FG000|Overall Study|Adverse Event|19|||
126460804|NCT00930982|454987893|FG001|Overall Study|Adverse Event|23|||
126460805|NCT00930982|454987892|FG000|Overall Study|Protocol Violation|1|||
126294401|NCT01147068|454366645|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
126294402|NCT01147068|454366646|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
126294403|NCT01147068|454366647|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
126294404|NCT01147068|454366648|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
126294405|NCT01147068|454366649|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
126294406|NCT01147068|454366650|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
126294407|NCT02291237|454366651|FG000|Overall Study|Study Terminated by Sponsor|72|||
126294408|NCT02291237|454366652|FG001|Overall Study|Study Terminated by Sponsor|67|||
126294409|NCT02291237|454366651|FG000|Overall Study|Adverse Event|1|||
126294410|NCT02291237|454366652|FG001|Overall Study|Adverse Event|3|||
126294411|NCT02291237|454366651|FG000|Overall Study|Investigator's Discretion|0|||
126294412|NCT02291237|454366652|FG001|Overall Study|Investigator's Discretion|3|||
126294413|NCT02291237|454366651|FG000|Overall Study|Withdrew Consent|11|||
126294414|NCT02291237|454366652|FG001|Overall Study|Withdrew Consent|11|||
126294415|NCT02291237|454366651|FG000|Overall Study|Lost to Follow-up|0|||
126294416|NCT02291237|454366652|FG001|Overall Study|Lost to Follow-up|2|||
126294417|NCT02291237|454366651|FG000|Overall Study|Subject Required Prohibited Medication|2|||
126294418|NCT02291237|454366652|FG001|Overall Study|Subject Required Prohibited Medication|0|||
126294419|NCT01306305|454366653|FG000|Overall Study|Lost to Follow-up|1|||
126294420|NCT01306305|454366654|FG001|Overall Study|Lost to Follow-up|0|||
126294421|NCT01306305|454366653|FG000|Overall Study|Withdrew consent|1|||
126294422|NCT01306305|454366654|FG001|Overall Study|Withdrew consent|0|||
126294423|NCT03326193|454366655|FG000|Overall Study|Sponsor decision|35|||
126294424|NCT00699998|454366657|FG000|Overall Study|Withdrawal by Subject|194|||
126294425|NCT00699998|454366658|FG001|Overall Study|Withdrawal by Subject|83|||
126294426|NCT00699998|454366659|FG002|Overall Study|Withdrawal by Subject|202|||
126294427|NCT00699998|454366660|FG003|Overall Study|Withdrawal by Subject|80|||
126294428|NCT00699998|454366657|FG000|Overall Study|Physician Decision|3|||
126294429|NCT00699998|454366658|FG001|Overall Study|Physician Decision|2|||
126294430|NCT00699998|454366659|FG002|Overall Study|Physician Decision|1|||
126294431|NCT00699998|454366660|FG003|Overall Study|Physician Decision|1|||
126294432|NCT00699998|454366657|FG000|Overall Study|Lost to Follow-up|2|||
126294433|NCT00699998|454366658|FG001|Overall Study|Lost to Follow-up|1|||
126294434|NCT00699998|454366659|FG002|Overall Study|Lost to Follow-up|3|||
126294435|NCT00699998|454366660|FG003|Overall Study|Lost to Follow-up|1|||
126294436|NCT03367819|454366665|FG000|Overall Study|Adverse Event|4|||
126294437|NCT03367819|454366666|FG001|Overall Study|Adverse Event|4|||
126294438|NCT03367819|454366665|FG000|Overall Study|Progressive Disease|15|||
126294439|NCT03367819|454366666|FG001|Overall Study|Progressive Disease|13|||
126294440|NCT03367819|454366665|FG000|Overall Study|Withdrawal by Subject|1|||
126294441|NCT03367819|454366666|FG001|Overall Study|Withdrawal by Subject|0|||
126294442|NCT03367819|454366665|FG000|Overall Study|Other|4|||
126294443|NCT03367819|454366666|FG001|Overall Study|Other|2|||
126294444|NCT00584454|454366667|FG000|Overall Study|Adverse Event|1|||
126294445|NCT00584454|454366667|FG000|Overall Study|Relocation|1|||
126294446|NCT00584454|454366667|FG000|Overall Study|Clinical Hold|2|||
126294447|NCT01565889|454366668|FG000|Part A|Withdrawal by Subject|1|||
126294448|NCT01565889|454366669|FG001|Part A|Withdrawal by Subject|0|||
126294449|NCT01565889|454366670|FG002|Part A|Withdrawal by Subject|0|||
126294450|NCT01565889|454366671|FG003|Part A|Withdrawal by Subject|0|||
126294451|NCT01565889|454366672|FG004|Part A|Withdrawal by Subject|0|||
126294452|NCT01565889|454366673|FG005|Part A|Withdrawal by Subject|0|||
126294453|NCT01565889|454366668|FG000|Part B|Withdrawal by Subject|0|||
126294454|NCT01565889|454366669|FG001|Part B|Withdrawal by Subject|0|||
126294455|NCT01565889|454366670|FG002|Part B|Withdrawal by Subject|0|||
126294456|NCT01565889|454366671|FG003|Part B|Withdrawal by Subject|0|||
126294457|NCT01565889|454366672|FG004|Part B|Withdrawal by Subject|0|||
126294458|NCT01565889|454366673|FG005|Part B|Withdrawal by Subject|1|||
126294459|NCT01565889|454366668|FG000|Part B|Lack of Efficacy|0|||
126294460|NCT01565889|454366669|FG001|Part B|Lack of Efficacy|0|||
126294461|NCT01565889|454366670|FG002|Part B|Lack of Efficacy|0|||
126294462|NCT01565889|454366671|FG003|Part B|Lack of Efficacy|0|||
126294463|NCT01565889|454366672|FG004|Part B|Lack of Efficacy|0|||
126294464|NCT01565889|454366673|FG005|Part B|Lack of Efficacy|2|||
126294465|NCT01565889|454366668|FG000|Part B|Lost to Follow-up|0|||
126294466|NCT01565889|454366669|FG001|Part B|Lost to Follow-up|0|||
126294467|NCT01565889|454366670|FG002|Part B|Lost to Follow-up|0|||
126294468|NCT01565889|454366671|FG003|Part B|Lost to Follow-up|0|||
126294469|NCT01565889|454366672|FG004|Part B|Lost to Follow-up|0|||
126294470|NCT01565889|454366673|FG005|Part B|Lost to Follow-up|1|||
126294471|NCT01326845|454366674|FG000|Overall Study|Administrative Problems|5|||
126294472|NCT01326845|454366675|FG001|Overall Study|Administrative Problems|2|||
126294473|NCT01326845|454366674|FG000|Overall Study|Adverse Event|1|||
126294474|NCT01326845|454366675|FG001|Overall Study|Adverse Event|0|||
126294475|NCT01326845|454366674|FG000|Overall Study|Misisng|1|||
126294476|NCT01326845|454366675|FG001|Overall Study|Misisng|3|||
126294477|NCT00982657|454366676|FG000|Overall Study|Death|1|||
126294478|NCT00982657|454366677|FG001|Overall Study|Death|0|||
126294479|NCT00982657|454366678|FG002|Overall Study|Death|1|||
126294480|NCT00982657|454366679|FG003|Overall Study|Death|1|||
126294481|NCT00982657|454366676|FG000|Overall Study|Withdrawal by Subject|0|||
126294482|NCT00982657|454366677|FG001|Overall Study|Withdrawal by Subject|0|||
126294483|NCT00982657|454366678|FG002|Overall Study|Withdrawal by Subject|1|||
126294484|NCT00982657|454366679|FG003|Overall Study|Withdrawal by Subject|3|||
126294485|NCT00982657|454366676|FG000|Overall Study|Other|0|||
126294486|NCT00982657|454366677|FG001|Overall Study|Other|0|||
126294487|NCT00982657|454366678|FG002|Overall Study|Other|0|||
126294488|NCT00982657|454366679|FG003|Overall Study|Other|4|||
126294489|NCT00982657|454366676|FG000|Overall Study|On going at date of cut-off|0|||
126294490|NCT00982657|454366677|FG001|Overall Study|On going at date of cut-off|0|||
126294491|NCT00982657|454366678|FG002|Overall Study|On going at date of cut-off|0|||
126294492|NCT00982657|454366679|FG003|Overall Study|On going at date of cut-off|1|||
126294493|NCT00725920|454366680|FG000|Overall Study|Lack of Efficacy|3|||
126294494|NCT00725920|454366681|FG001|Overall Study|Lack of Efficacy|6|||
126294495|NCT03918629|454366682|FG000|Overall Study|Adverse Event|19|||
126294496|NCT03918629|454366683|FG001|Overall Study|Adverse Event|20|||
126294497|NCT03918629|454366682|FG000|Overall Study|Death|14|||
126294498|NCT03918629|454366683|FG001|Overall Study|Death|7|||
126294499|NCT03918629|454366682|FG000|Overall Study|Lost to Follow-up|36|||
126294500|NCT03918629|454366683|FG001|Overall Study|Lost to Follow-up|28|||
126294501|NCT03918629|454366682|FG000|Overall Study|Physician Decision|1|||
126294502|NCT03918629|454366683|FG001|Overall Study|Physician Decision|0|||
126294503|NCT03918629|454366682|FG000|Overall Study|Protocol Violation|7|||
126294504|NCT03918629|454366683|FG001|Overall Study|Protocol Violation|4|||
126294505|NCT03918629|454366682|FG000|Overall Study|Withdrawal by Subject|47|||
126294506|NCT03918629|454366683|FG001|Overall Study|Withdrawal by Subject|47|||
126294507|NCT03918629|454366682|FG000|Overall Study|Other|7|||
126294508|NCT03918629|454366683|FG001|Overall Study|Other|11|||
126294509|NCT03918629|454366682|FG000|Overall Study|Randomized but not vaccinated|2|||
126294510|NCT03918629|454366683|FG001|Overall Study|Randomized but not vaccinated|1|||
126294511|NCT01891864|454366686|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
126294512|NCT01891864|454366687|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
126294513|NCT01891864|454366688|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
126294514|NCT01891864|454366689|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
126294515|NCT01891864|454366690|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
126294516|NCT01891864|454366691|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
126294517|NCT01891864|454366686|FG000|Treatment Period 1|Physician Decision|0|||
126294518|NCT01891864|454366687|FG001|Treatment Period 1|Physician Decision|1|||
126294519|NCT01891864|454366688|FG002|Treatment Period 1|Physician Decision|0|||
126294520|NCT01891864|454366689|FG003|Treatment Period 1|Physician Decision|0|||
126294521|NCT01891864|454366690|FG004|Treatment Period 1|Physician Decision|0|||
126294522|NCT01891864|454366691|FG005|Treatment Period 1|Physician Decision|0|||
126294523|NCT01891864|454366686|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
126294524|NCT01891864|454366687|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
126294525|NCT01891864|454366688|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
126294526|NCT01891864|454366689|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
126294527|NCT01891864|454366690|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
126294528|NCT01891864|454366691|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
126294529|NCT01891864|454366686|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
126294530|NCT01891864|454366687|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
126294531|NCT01891864|454366688|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
126294532|NCT01891864|454366689|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
126294533|NCT01891864|454366690|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
126294534|NCT01891864|454366691|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
126294535|NCT01891864|454366686|FG000|Treatment Period 1|Withdrawal by Subject|2|||
126294536|NCT01891864|454366687|FG001|Treatment Period 1|Withdrawal by Subject|5|||
126294537|NCT01891864|454366688|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126294538|NCT01891864|454366689|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126294539|NCT01891864|454366690|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126294540|NCT01891864|454366691|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126294541|NCT01891864|454366686|FG000|Treatment Period 1|Lost to Follow-up|1|||
126294542|NCT01891864|454366687|FG001|Treatment Period 1|Lost to Follow-up|0|||
126294543|NCT01891864|454366688|FG002|Treatment Period 1|Lost to Follow-up|0|||
126294544|NCT01891864|454366689|FG003|Treatment Period 1|Lost to Follow-up|0|||
126294545|NCT01891864|454366690|FG004|Treatment Period 1|Lost to Follow-up|0|||
126294546|NCT01891864|454366691|FG005|Treatment Period 1|Lost to Follow-up|0|||
126294547|NCT01891864|454366686|FG000|Treatment Period 2|Protocol Violation|0|||
126294548|NCT01891864|454366687|FG001|Treatment Period 2|Protocol Violation|0|||
126294549|NCT01891864|454366688|FG002|Treatment Period 2|Protocol Violation|0|||
126294550|NCT01891864|454366689|FG003|Treatment Period 2|Protocol Violation|1|||
126550074|NCT01076088|455307721|FG004|Overall Study|Physician Decision|1|||
126294551|NCT01891864|454366690|FG004|Treatment Period 2|Protocol Violation|0|||
126550075|NCT01076088|455307722|FG005|Overall Study|Physician Decision|0|||
126711053|NCT02050048|455893629|FG001|Overall Study|Death|0|||
126294552|NCT01891864|454366691|FG005|Treatment Period 2|Protocol Violation|0|||
126294553|NCT01891864|454366686|FG000|Treatment Period 2|Physician Decision|0|||
126294554|NCT01891864|454366687|FG001|Treatment Period 2|Physician Decision|0|||
126294555|NCT01891864|454366688|FG002|Treatment Period 2|Physician Decision|1|||
126294556|NCT01891864|454366689|FG003|Treatment Period 2|Physician Decision|0|||
126294557|NCT01891864|454366690|FG004|Treatment Period 2|Physician Decision|0|||
126294558|NCT01891864|454366691|FG005|Treatment Period 2|Physician Decision|0|||
126294559|NCT01891864|454366686|FG000|Treatment Period 2|Site Termination|0|||
126294560|NCT01891864|454366687|FG001|Treatment Period 2|Site Termination|0|||
126294561|NCT01891864|454366688|FG002|Treatment Period 2|Site Termination|1|||
126294562|NCT01891864|454366689|FG003|Treatment Period 2|Site Termination|2|||
126294563|NCT01891864|454366690|FG004|Treatment Period 2|Site Termination|0|||
126294564|NCT01891864|454366691|FG005|Treatment Period 2|Site Termination|0|||
126294565|NCT01891864|454366686|FG000|Treatment Period 2|Lack of Efficacy|0|||
126294566|NCT01891864|454366687|FG001|Treatment Period 2|Lack of Efficacy|0|||
126294567|NCT01891864|454366688|FG002|Treatment Period 2|Lack of Efficacy|1|||
126294568|NCT01891864|454366689|FG003|Treatment Period 2|Lack of Efficacy|0|||
126294569|NCT01891864|454366690|FG004|Treatment Period 2|Lack of Efficacy|1|||
126294570|NCT01891864|454366691|FG005|Treatment Period 2|Lack of Efficacy|0|||
126294571|NCT01891864|454366686|FG000|Treatment Period 2|Adverse Event|0|||
126294572|NCT01891864|454366687|FG001|Treatment Period 2|Adverse Event|0|||
126294573|NCT01891864|454366688|FG002|Treatment Period 2|Adverse Event|1|||
126294574|NCT01891864|454366689|FG003|Treatment Period 2|Adverse Event|2|||
126294575|NCT01891864|454366690|FG004|Treatment Period 2|Adverse Event|0|||
126294576|NCT01891864|454366691|FG005|Treatment Period 2|Adverse Event|4|||
126294577|NCT01891864|454366686|FG000|Treatment Period 2|Termination of Site|0|||
126294578|NCT01891864|454366687|FG001|Treatment Period 2|Termination of Site|0|||
126294579|NCT01891864|454366688|FG002|Treatment Period 2|Termination of Site|0|||
126294580|NCT01891864|454366689|FG003|Treatment Period 2|Termination of Site|0|||
126294581|NCT01891864|454366690|FG004|Treatment Period 2|Termination of Site|2|||
126294582|NCT01891864|454366691|FG005|Treatment Period 2|Termination of Site|0|||
126294583|NCT01891864|454366686|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126294584|NCT01891864|454366687|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126294585|NCT01891864|454366688|FG002|Treatment Period 2|Withdrawal by Subject|3|||
126294586|NCT01891864|454366689|FG003|Treatment Period 2|Withdrawal by Subject|4|||
126294587|NCT01891864|454366690|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126294588|NCT01891864|454366691|FG005|Treatment Period 2|Withdrawal by Subject|1|||
126294589|NCT01891864|454366686|FG000|Extension Period|Lack of Efficacy|0|||
126294590|NCT01891864|454366687|FG001|Extension Period|Lack of Efficacy|0|||
126294591|NCT01891864|454366688|FG002|Extension Period|Lack of Efficacy|0|||
126294592|NCT01891864|454366689|FG003|Extension Period|Lack of Efficacy|1|||
126294593|NCT01891864|454366690|FG004|Extension Period|Lack of Efficacy|1|||
126294594|NCT01891864|454366691|FG005|Extension Period|Lack of Efficacy|0|||
126294595|NCT01891864|454366686|FG000|Extension Period|Pregnancy|0|||
126294596|NCT01891864|454366687|FG001|Extension Period|Pregnancy|0|||
126294597|NCT01891864|454366688|FG002|Extension Period|Pregnancy|1|||
126294598|NCT01891864|454366689|FG003|Extension Period|Pregnancy|0|||
126294599|NCT01891864|454366690|FG004|Extension Period|Pregnancy|0|||
126294600|NCT01891864|454366691|FG005|Extension Period|Pregnancy|0|||
126294601|NCT01891864|454366686|FG000|Extension Period|Adverse Event|0|||
126294602|NCT01891864|454366687|FG001|Extension Period|Adverse Event|0|||
126294603|NCT01891864|454366688|FG002|Extension Period|Adverse Event|4|||
126294604|NCT01891864|454366689|FG003|Extension Period|Adverse Event|2|||
126294605|NCT01891864|454366690|FG004|Extension Period|Adverse Event|2|||
126294606|NCT01891864|454366691|FG005|Extension Period|Adverse Event|0|||
126294607|NCT01891864|454366686|FG000|Extension Period|Withdrawal by Subject|0|||
126294608|NCT01891864|454366687|FG001|Extension Period|Withdrawal by Subject|0|||
126294609|NCT01891864|454366688|FG002|Extension Period|Withdrawal by Subject|1|||
126294610|NCT01891864|454366689|FG003|Extension Period|Withdrawal by Subject|2|||
126294611|NCT01891864|454366690|FG004|Extension Period|Withdrawal by Subject|4|||
126294612|NCT01891864|454366691|FG005|Extension Period|Withdrawal by Subject|0|||
126294613|NCT01891864|454366686|FG000|Extension Period|Lost to Follow-up|0|||
126294614|NCT01891864|454366687|FG001|Extension Period|Lost to Follow-up|0|||
126294615|NCT01891864|454366688|FG002|Extension Period|Lost to Follow-up|2|||
126294616|NCT01891864|454366689|FG003|Extension Period|Lost to Follow-up|0|||
126294617|NCT01891864|454366690|FG004|Extension Period|Lost to Follow-up|0|||
126294618|NCT01891864|454366691|FG005|Extension Period|Lost to Follow-up|0|||
126294619|NCT02698163|454366692|FG000|Overall Study|Lost to Follow-up|0|||
126294620|NCT02698163|454366693|FG001|Overall Study|Lost to Follow-up|1|||
126294621|NCT05373108|454366694|FG000|Overall Study|Withdrawal by Subject|2|||
126294622|NCT02892331|454366695|FG000|Overall Study|Withdrawal by Subject|0|||
126294623|NCT02892331|454366696|FG001|Overall Study|Withdrawal by Subject|1|||
126294624|NCT02892331|454366697|FG002|Overall Study|Withdrawal by Subject|1|||
126294625|NCT02892331|454366695|FG000|Overall Study|Sick family member|0|||
126294626|NCT02892331|454366696|FG001|Overall Study|Sick family member|0|||
126294627|NCT02892331|454366697|FG002|Overall Study|Sick family member|1|||
126460806|NCT00930982|454987893|FG001|Overall Study|Protocol Violation|5|||
126294628|NCT02892331|454366695|FG000|Overall Study|Corona virus pandemic|1|||
126294629|NCT02892331|454366696|FG001|Overall Study|Corona virus pandemic|0|||
126294630|NCT02892331|454366697|FG002|Overall Study|Corona virus pandemic|1|||
126294631|NCT02892331|454366695|FG000|Overall Study|Lost to Follow-up|1|||
126294632|NCT02892331|454366696|FG001|Overall Study|Lost to Follow-up|0|||
126294633|NCT02892331|454366697|FG002|Overall Study|Lost to Follow-up|1|||
126294634|NCT02892331|454366695|FG000|Overall Study|Blood pressure was too elevated|0|||
126294635|NCT02892331|454366696|FG001|Overall Study|Blood pressure was too elevated|1|||
126294636|NCT02892331|454366697|FG002|Overall Study|Blood pressure was too elevated|0|||
126294637|NCT02892331|454366695|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
126294638|NCT02892331|454366696|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
126294639|NCT02892331|454366697|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
126294640|NCT00752128|454366701|FG000|Overall Study|Withdrawal by Subject|4|||
126294641|NCT00349973|454366702|FG000|Overall Study|Adverse Event|3|||
126294642|NCT00349973|454366703|FG001|Overall Study|Adverse Event|3|||
126294643|NCT00349973|454366702|FG000|Overall Study|Withdrawal by Subject|1|||
126294644|NCT00349973|454366703|FG001|Overall Study|Withdrawal by Subject|0|||
126294645|NCT04314037|454366704|FG000|Treatment Period 2|Adverse Event|1|||
126294646|NCT04314037|454366705|FG001|Treatment Period 2|Adverse Event|0|||
126294647|NCT04314037|454366704|FG000|Treatment Period 3|Protocol Violation|1|||
126294648|NCT04314037|454366705|FG001|Treatment Period 3|Protocol Violation|0|||
126294649|NCT04314037|454366704|FG000|Treatment Period 3|Adverse Event|0|||
126294650|NCT04314037|454366705|FG001|Treatment Period 3|Adverse Event|1|||
126294651|NCT02235454|454366708|FG000|Overall Study|Withdrawal by Subject|2|||
126294652|NCT03323398|454366709|FG000|Overall Study|Other than Specified|0|||
126294653|NCT03323398|454366710|FG001|Overall Study|Other than Specified|1|||
126294654|NCT03323398|454366711|FG002|Overall Study|Other than Specified|2|||
126294655|NCT03323398|454366712|FG003|Overall Study|Other than Specified|0|||
126294656|NCT03323398|454366713|FG004|Overall Study|Other than Specified|0|||
126294657|NCT03323398|454366714|FG005|Overall Study|Other than Specified|0|||
126294658|NCT03323398|454366715|FG006|Overall Study|Other than Specified|1|||
126294659|NCT03323398|454366716|FG007|Overall Study|Other than Specified|0|||
126294660|NCT03323398|454366717|FG008|Overall Study|Other than Specified|2|||
126294661|NCT03323398|454366709|FG000|Overall Study|Lost to Follow-up|1|||
126294662|NCT03323398|454366710|FG001|Overall Study|Lost to Follow-up|2|||
126294663|NCT03323398|454366711|FG002|Overall Study|Lost to Follow-up|1|||
126294664|NCT03323398|454366712|FG003|Overall Study|Lost to Follow-up|0|||
126294665|NCT03323398|454366713|FG004|Overall Study|Lost to Follow-up|0|||
126294666|NCT03323398|454366714|FG005|Overall Study|Lost to Follow-up|0|||
126294667|NCT03323398|454366715|FG006|Overall Study|Lost to Follow-up|0|||
126294668|NCT03323398|454366716|FG007|Overall Study|Lost to Follow-up|0|||
126294669|NCT03323398|454366717|FG008|Overall Study|Lost to Follow-up|0|||
126294670|NCT03323398|454366709|FG000|Overall Study|Death|4|||
126294671|NCT03323398|454366710|FG001|Overall Study|Death|6|||
126294672|NCT03323398|454366711|FG002|Overall Study|Death|2|||
126294673|NCT03323398|454366712|FG003|Overall Study|Death|2|||
126294674|NCT03323398|454366713|FG004|Overall Study|Death|1|||
126294675|NCT03323398|454366714|FG005|Overall Study|Death|2|||
126294676|NCT03323398|454366715|FG006|Overall Study|Death|0|||
126294677|NCT03323398|454366716|FG007|Overall Study|Death|0|||
126294678|NCT03323398|454366717|FG008|Overall Study|Death|6|||
126294679|NCT03323398|454366709|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
126294680|NCT03323398|454366710|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
126294681|NCT03323398|454366711|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
126294682|NCT03323398|454366712|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
126294683|NCT03323398|454366713|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
126294684|NCT03323398|454366714|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
126294685|NCT03323398|454366715|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
126294686|NCT03323398|454366716|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
126294687|NCT03323398|454366717|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
126294688|NCT03323398|454366709|FG000|Overall Study|Withdrawal by Subject|2|||
126294689|NCT03323398|454366710|FG001|Overall Study|Withdrawal by Subject|1|||
126294690|NCT03323398|454366711|FG002|Overall Study|Withdrawal by Subject|3|||
126294691|NCT03323398|454366712|FG003|Overall Study|Withdrawal by Subject|0|||
126294692|NCT03323398|454366713|FG004|Overall Study|Withdrawal by Subject|0|||
126294693|NCT03323398|454366714|FG005|Overall Study|Withdrawal by Subject|1|||
126294694|NCT03323398|454366715|FG006|Overall Study|Withdrawal by Subject|0|||
126294695|NCT03323398|454366716|FG007|Overall Study|Withdrawal by Subject|0|||
126294696|NCT03323398|454366717|FG008|Overall Study|Withdrawal by Subject|0|||
126294697|NCT03323398|454366709|FG000|Overall Study|Participant was Put on Hospice|0|||
126294698|NCT03323398|454366710|FG001|Overall Study|Participant was Put on Hospice|0|||
126294699|NCT03323398|454366711|FG002|Overall Study|Participant was Put on Hospice|0|||
126294700|NCT03323398|454366712|FG003|Overall Study|Participant was Put on Hospice|0|||
126294701|NCT03323398|454366713|FG004|Overall Study|Participant was Put on Hospice|0|||
126294702|NCT03323398|454366714|FG005|Overall Study|Participant was Put on Hospice|0|||
126294703|NCT03323398|454366715|FG006|Overall Study|Participant was Put on Hospice|1|||
126294704|NCT03323398|454366716|FG007|Overall Study|Participant was Put on Hospice|0|||
126294705|NCT03323398|454366717|FG008|Overall Study|Participant was Put on Hospice|0|||
126294706|NCT03323398|454366709|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
126294707|NCT03323398|454366710|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
126294708|NCT03323398|454366711|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
126294709|NCT03323398|454366712|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
126767203|NCT00518011|456100249|FG001|Overall Study|Other Reasons|2|||
126767204|NCT00518011|456100248|FG000|Overall Study|Withdrawal by Subject|1|||
126767205|NCT00518011|456100249|FG001|Overall Study|Withdrawal by Subject|0|||
126767206|NCT03930615|456100252|FG000|Overall Study|Death|9|||
126767207|NCT03930615|456100253|FG001|Overall Study|Death|3|||
126767208|NCT03930615|456100252|FG000|Overall Study|Lost to Follow-up|1|||
126767209|NCT03930615|456100253|FG001|Overall Study|Lost to Follow-up|2|||
126767210|NCT03930615|456100252|FG000|Overall Study|Physician Decision|3|||
126294710|NCT03323398|454366713|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
126294711|NCT03323398|454366714|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
126294712|NCT03323398|454366715|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
126294713|NCT03323398|454366716|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
126294714|NCT03323398|454366717|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
126294715|NCT03641469|454366718|FG000|Overall Study|Ineligible|2|||
126767211|NCT03930615|456100253|FG001|Overall Study|Physician Decision|4|||
126767212|NCT03930615|456100252|FG000|Overall Study|Withdrawal by Subject|13|||
126767213|NCT03930615|456100253|FG001|Overall Study|Withdrawal by Subject|2|||
126767214|NCT03930615|456100252|FG000|Overall Study|Not treated|1|||
126767215|NCT03930615|456100253|FG001|Overall Study|Not treated|1|||
126294716|NCT03641469|454366718|FG000|Overall Study|Withdrawal by Subject|5|||
126294717|NCT03641469|454366718|FG000|Overall Study|Physician Decision|1|||
126294718|NCT03641469|454366718|FG000|Overall Study|Protocol Violation|1|||
126294719|NCT03641469|454366718|FG000|Overall Study|Lost to Follow-up|2|||
126294720|NCT02562235|454368423|FG000|Overall Study|Adverse Event|3|||
126294721|NCT02546986|454368424|FG000|Treatment Period|Progressive Disease|20|||
126294722|NCT02546986|454368425|FG001|Treatment Period|Progressive Disease|22|||
126294723|NCT02546986|454368424|FG000|Treatment Period|Adverse Event|14|||
126294724|NCT02546986|454368425|FG001|Treatment Period|Adverse Event|6|||
126294725|NCT02546986|454368424|FG000|Treatment Period|Symptomatic Deterioration|4|||
126294726|NCT02546986|454368425|FG001|Treatment Period|Symptomatic Deterioration|3|||
126294727|NCT02546986|454368424|FG000|Treatment Period|Death|3|||
126294728|NCT02546986|454368425|FG001|Treatment Period|Death|4|||
126294729|NCT02546986|454368424|FG000|Treatment Period|Physician Decision|1|||
126294730|NCT02546986|454368425|FG001|Treatment Period|Physician Decision|2|||
126294731|NCT02546986|454368424|FG000|Treatment Period|Protocol Violation|1|||
126294732|NCT02546986|454368425|FG001|Treatment Period|Protocol Violation|0|||
126294733|NCT02546986|454368424|FG000|Treatment Period|Withdrawal by Subject|1|||
126294734|NCT02546986|454368425|FG001|Treatment Period|Withdrawal by Subject|1|||
126294735|NCT02546986|454368424|FG000|Treatment Period|Non-compliance with Study Drug|0|||
126294736|NCT02546986|454368425|FG001|Treatment Period|Non-compliance with Study Drug|1|||
126294737|NCT02546986|454368424|FG000|Treatment Period|Study Terminated by Sponsor|0|||
126294738|NCT02546986|454368425|FG001|Treatment Period|Study Terminated by Sponsor|1|||
126294739|NCT02546986|454368424|FG000|Treatment Period|Miscellaneous|7|||
126294740|NCT02546986|454368425|FG001|Treatment Period|Miscellaneous|9|||
126294741|NCT02546986|454368424|FG000|Survival Follow-Up Phase|Missing Status|3|||
126294742|NCT02546986|454368425|FG001|Survival Follow-Up Phase|Missing Status|5|||
126294743|NCT02546986|454368424|FG000|Survival Follow-Up Phase|Death|18|||
126294744|NCT02546986|454368425|FG001|Survival Follow-Up Phase|Death|12|||
126294745|NCT02546986|454368424|FG000|Survival Follow-Up Phase|Alive|13|||
126294746|NCT02546986|454368425|FG001|Survival Follow-Up Phase|Alive|16|||
126294747|NCT02546986|454368424|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
126294748|NCT02546986|454368425|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
126294749|NCT05016960|454368426|FG000|Overall Study|Withdrawal by Subject|1|||
126294750|NCT05016960|454368427|FG001|Overall Study|Withdrawal by Subject|9|||
126294751|NCT04796961|454368428|FG000|Overall Study|Lost to Follow-up|10|||
126294752|NCT04796961|454368428|FG000|Overall Study|Withdrawal by Subject|3|||
126294753|NCT04796961|454368428|FG000|Overall Study|Left Organization|10|||
126767216|NCT04797637|456100259|FG000|Overall Study|Lost to Follow-up|23|||
126767217|NCT04797637|456100260|FG001|Overall Study|Lost to Follow-up|32|||
126767218|NCT04797637|456100259|FG000|Overall Study|Withdrawal by Subject|0|||
126767219|NCT04797637|456100260|FG001|Overall Study|Withdrawal by Subject|1|||
126767220|NCT01023022|456100263|FG000|Overall Study|Death|5|||
126767221|NCT01023022|456100263|FG000|Overall Study|Lost to Follow-up|7|||
126294754|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
126294755|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
126294756|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
126294757|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
126294758|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
126294759|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
126294760|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
126294761|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
126294762|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
126294763|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
126294764|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
126294765|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
126294766|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
126294767|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
126294768|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
126294769|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
126294770|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
126294771|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
126294772|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
126294773|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
126294774|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
126294775|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
126294776|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
126294777|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
126294778|NCT02513160|454368434|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
126294779|NCT02513160|454368435|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
126294780|NCT02513160|454368436|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
126294781|NCT02513160|454368437|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
126294782|NCT02513160|454368434|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
126294783|NCT02513160|454368435|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
126294784|NCT02513160|454368436|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
126294785|NCT02513160|454368437|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
126294786|NCT02513160|454368434|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
126294787|NCT02513160|454368435|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
126294788|NCT02513160|454368436|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
126294789|NCT02513160|454368437|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
126294790|NCT02513160|454368434|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
126294791|NCT02513160|454368435|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
126294792|NCT02513160|454368436|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
126294793|NCT02513160|454368437|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
126294794|NCT02513160|454368434|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
126294795|NCT02513160|454368435|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
126294796|NCT02513160|454368436|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
126294797|NCT02513160|454368437|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
126294798|NCT02513160|454368434|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
126294799|NCT02513160|454368435|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
126294800|NCT02513160|454368436|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
126294801|NCT02513160|454368437|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
126294802|NCT02068508|454368441|FG000|Overall Study|Case report forms uncollected|27|||
126294803|NCT02068508|454368441|FG000|Overall Study|Patient did not visit the study site|1|||
126294804|NCT02068508|454368441|FG000|Overall Study|Protocol Violation|4|||
126294805|NCT04173507|454368442|FG000|Overall Study|On Treatment|3|||
126294806|NCT04173507|454368442|FG000|Overall Study|Adverse Event|3|||
126294807|NCT04173507|454368442|FG000|Overall Study|Progression/Relapse|34|||
126294808|NCT04173507|454368442|FG000|Overall Study|Death|2|||
126294809|NCT02157935|454368443|FG000|Overall Study|Withdrawal by Subject|25|||
126294810|NCT02157935|454368444|FG001|Overall Study|Withdrawal by Subject|39|||
126711054|NCT02050048|455893628|FG000|Overall Study|Ineligible after ERCP|4|||
126294811|NCT02157935|454368443|FG000|Overall Study|Screen failure|1|||
126294812|NCT02157935|454368444|FG001|Overall Study|Screen failure|2|||
126294813|NCT02157935|454368443|FG000|Overall Study|Protocol Violation|1|||
126294814|NCT02157935|454368444|FG001|Overall Study|Protocol Violation|0|||
126294815|NCT02157935|454368443|FG000|Overall Study|Progressive disease|0|||
126294816|NCT02157935|454368444|FG001|Overall Study|Progressive disease|2|||
126294817|NCT02157935|454368443|FG000|Overall Study|Other|5|||
126294818|NCT02157935|454368444|FG001|Overall Study|Other|12|||
126294819|NCT02157935|454368443|FG000|Overall Study|Lack of Efficacy|0|||
126711055|NCT02050048|455893629|FG001|Overall Study|Ineligible after ERCP|1|||
126294820|NCT02157935|454368444|FG001|Overall Study|Lack of Efficacy|1|||
126294821|NCT02157935|454368443|FG000|Overall Study|Death|4|||
126460807|NCT00930982|454987892|FG000|Overall Study|Withdrawal by Subject|1|||
126711056|NCT04285723|455893633|FG000|Overall Study|Subject decision|1|||
126366816|NCT02327169|454639313|FG001|Overall Study|Symptomatic Deterioration|0|||
126366817|NCT02327169|454639314|FG002|Overall Study|Symptomatic Deterioration|1|||
126366818|NCT02327169|454639315|FG003|Overall Study|Symptomatic Deterioration|0|||
126366819|NCT02327169|454639316|FG004|Overall Study|Symptomatic Deterioration|1|||
126366820|NCT02327169|454639317|FG005|Overall Study|Symptomatic Deterioration|1|||
126366821|NCT02327169|454639318|FG006|Overall Study|Symptomatic Deterioration|0|||
126366822|NCT02327169|454639319|FG007|Overall Study|Symptomatic Deterioration|0|||
126366823|NCT02327169|454639320|FG008|Overall Study|Symptomatic Deterioration|2|||
126366824|NCT02327169|454639321|FG009|Overall Study|Symptomatic Deterioration|1|||
126366825|NCT02327169|454639322|FG010|Overall Study|Symptomatic Deterioration|0|||
126366826|NCT02327169|454639323|FG011|Overall Study|Symptomatic Deterioration|0|||
126366827|NCT02327169|454639324|FG012|Overall Study|Symptomatic Deterioration|0|||
126366828|NCT02327169|454639325|FG013|Overall Study|Symptomatic Deterioration|2|||
126366829|NCT02327169|454639326|FG014|Overall Study|Symptomatic Deterioration|1|||
126366830|NCT02327169|454639312|FG000|Overall Study|Reason Not Specified|0|||
126366831|NCT02327169|454639313|FG001|Overall Study|Reason Not Specified|0|||
126366832|NCT02327169|454639314|FG002|Overall Study|Reason Not Specified|1|||
126366833|NCT02327169|454639315|FG003|Overall Study|Reason Not Specified|0|||
126366834|NCT02327169|454639316|FG004|Overall Study|Reason Not Specified|0|||
126366835|NCT02327169|454639317|FG005|Overall Study|Reason Not Specified|0|||
126366836|NCT02327169|454639318|FG006|Overall Study|Reason Not Specified|0|||
126366837|NCT02327169|454639319|FG007|Overall Study|Reason Not Specified|0|||
126366838|NCT02327169|454639320|FG008|Overall Study|Reason Not Specified|0|||
126366839|NCT02327169|454639321|FG009|Overall Study|Reason Not Specified|1|||
126711057|NCT04285723|455893634|FG001|Overall Study|Subject decision|2|||
126711058|NCT04285723|455893633|FG000|Overall Study|Physician Decision|1|||
126711059|NCT04285723|455893634|FG001|Overall Study|Physician Decision|0|||
126294822|NCT02157935|454368444|FG001|Overall Study|Death|4|||
126294823|NCT02157935|454368443|FG000|Overall Study|Adverse Event|3|||
126294824|NCT02157935|454368444|FG001|Overall Study|Adverse Event|5|||
126294825|NCT02764762|454368445|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
126294826|NCT02764762|454368445|FG000|Overall Study|Lost to Follow-up|4|||
126294827|NCT02764762|454368445|FG000|Overall Study|Voluntary Withdrawal|8|||
126294828|NCT02764762|454368445|FG000|Overall Study|Site Termination|1|||
126294829|NCT02764762|454368445|FG000|Overall Study|Lack of Efficacy|16|||
126294830|NCT02764762|454368445|FG000|Overall Study|Reason not Specified|1|||
126294831|NCT02547428|454368452|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
126294832|NCT02547428|454368453|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
126294833|NCT02547428|454368452|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
126294834|NCT02547428|454368453|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
126294835|NCT02547428|454368452|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
126711060|NCT04285723|455893633|FG000|Overall Study|No efficiency|1|||
126711061|NCT04285723|455893634|FG001|Overall Study|No efficiency|0|||
126711062|NCT02903511|455893639|FG000|Overall Study|Withdrawal by Subject|1|||
126711063|NCT02903511|455893640|FG001|Overall Study|Withdrawal by Subject|0|||
126711064|NCT02903511|455893639|FG000|Overall Study|Lost to Follow-up|3|||
126711065|NCT02903511|455893640|FG001|Overall Study|Lost to Follow-up|2|||
126711066|NCT00969618|455893641|FG000|Overall Study|Adverse Event|29|||
126711067|NCT00969618|455893641|FG000|Overall Study|Entry Criteria Not Met|3|||
126711068|NCT00969618|455893641|FG000|Overall Study|Lack of Efficacy|2|||
126711069|NCT00969618|455893641|FG000|Overall Study|Lost to Follow-up|7|||
126711070|NCT00969618|455893641|FG000|Overall Study|Physician Decision|1|||
126711071|NCT00969618|455893641|FG000|Overall Study|Protocol Violation|9|||
126711072|NCT00969618|455893641|FG000|Overall Study|Withdrawal by Subject|27|||
126711073|NCT05363293|455893646|FG000|Overall Study|Withdrawal by Subject|1|||
126711074|NCT05363293|455893647|FG001|Overall Study|Withdrawal by Subject|0|||
126711075|NCT05363293|455893648|FG002|Overall Study|Withdrawal by Subject|0|||
126711076|NCT05363293|455893649|FG003|Overall Study|Withdrawal by Subject|0|||
126711077|NCT05363293|455893650|FG004|Overall Study|Withdrawal by Subject|0|||
126767222|NCT01023022|456100263|FG000|Overall Study|due to technical issues|2|||
126767223|NCT03917654|456100264|FG000|Year 1|Withdrawal by Subject|1|||
126767224|NCT03917654|456100265|FG001|Year 1|Withdrawal by Subject|0|||
126767225|NCT03917654|456100266|FG002|Year 1|Withdrawal by Subject|0|||
126294836|NCT02547428|454368453|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
126294837|NCT02547428|454368452|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
126366840|NCT02327169|454639322|FG010|Overall Study|Reason Not Specified|2|||
126366841|NCT02327169|454639323|FG011|Overall Study|Reason Not Specified|1|||
126366842|NCT02327169|454639324|FG012|Overall Study|Reason Not Specified|0|||
126366843|NCT02327169|454639325|FG013|Overall Study|Reason Not Specified|0|||
126366844|NCT02327169|454639326|FG014|Overall Study|Reason Not Specified|2|||
126711078|NCT05363293|455893651|FG005|Overall Study|Withdrawal by Subject|0|||
126366845|NCT02327169|454639312|FG000|Overall Study|Withdrawal by Subject|1|||
126711079|NCT05363293|455893652|FG006|Overall Study|Withdrawal by Subject|0|||
126711080|NCT05363293|455893653|FG007|Overall Study|Withdrawal by Subject|0|||
126711081|NCT05363293|455893654|FG008|Overall Study|Withdrawal by Subject|0|||
126366846|NCT02327169|454639313|FG001|Overall Study|Withdrawal by Subject|0|||
126366847|NCT02327169|454639314|FG002|Overall Study|Withdrawal by Subject|0|||
126366848|NCT02327169|454639315|FG003|Overall Study|Withdrawal by Subject|0|||
126366849|NCT02327169|454639316|FG004|Overall Study|Withdrawal by Subject|1|||
126366850|NCT02327169|454639317|FG005|Overall Study|Withdrawal by Subject|0|||
126366851|NCT02327169|454639318|FG006|Overall Study|Withdrawal by Subject|0|||
126366852|NCT02327169|454639319|FG007|Overall Study|Withdrawal by Subject|1|||
126366853|NCT02327169|454639320|FG008|Overall Study|Withdrawal by Subject|0|||
126366854|NCT02327169|454639321|FG009|Overall Study|Withdrawal by Subject|0|||
126366855|NCT02327169|454639322|FG010|Overall Study|Withdrawal by Subject|0|||
126366856|NCT02327169|454639323|FG011|Overall Study|Withdrawal by Subject|0|||
126366857|NCT02327169|454639324|FG012|Overall Study|Withdrawal by Subject|0|||
126366858|NCT02327169|454639325|FG013|Overall Study|Withdrawal by Subject|0|||
126366859|NCT02327169|454639326|FG014|Overall Study|Withdrawal by Subject|3|||
126366860|NCT02327169|454639312|FG000|Overall Study|Lost to Follow-up|0|||
126366861|NCT02327169|454639313|FG001|Overall Study|Lost to Follow-up|0|||
126366862|NCT02327169|454639314|FG002|Overall Study|Lost to Follow-up|0|||
126366863|NCT02327169|454639315|FG003|Overall Study|Lost to Follow-up|0|||
126366864|NCT02327169|454639316|FG004|Overall Study|Lost to Follow-up|1|||
126366865|NCT02327169|454639317|FG005|Overall Study|Lost to Follow-up|0|||
126366866|NCT02327169|454639318|FG006|Overall Study|Lost to Follow-up|0|||
126366867|NCT02327169|454639319|FG007|Overall Study|Lost to Follow-up|0|||
126366868|NCT02327169|454639320|FG008|Overall Study|Lost to Follow-up|0|||
126366869|NCT02327169|454639321|FG009|Overall Study|Lost to Follow-up|0|||
126366870|NCT02327169|454639322|FG010|Overall Study|Lost to Follow-up|0|||
126366871|NCT02327169|454639323|FG011|Overall Study|Lost to Follow-up|0|||
126366872|NCT02327169|454639324|FG012|Overall Study|Lost to Follow-up|0|||
126366873|NCT02327169|454639325|FG013|Overall Study|Lost to Follow-up|0|||
126366874|NCT02327169|454639326|FG014|Overall Study|Lost to Follow-up|0|||
126366875|NCT01381679|454639330|FG000|Overall Study|Adverse Event|3|||
126366876|NCT01381679|454639330|FG000|Overall Study|Lost to Follow-up|885|||
126366877|NCT04023487|454639331|FG000|Overall Study|Lost to Follow-up|5|||
126366878|NCT04023487|454639332|FG001|Overall Study|Lost to Follow-up|4|||
126366879|NCT04023487|454639331|FG000|Overall Study|Pregnancy|1|||
126366880|NCT04023487|454639332|FG001|Overall Study|Pregnancy|2|||
126366881|NCT04023487|454639331|FG000|Overall Study|Withdrawal by Subject|4|||
126366882|NCT04023487|454639332|FG001|Overall Study|Withdrawal by Subject|5|||
126366883|NCT04023487|454639331|FG000|Overall Study|Partially completed testing|8|||
126366884|NCT04023487|454639332|FG001|Overall Study|Partially completed testing|4|||
126366885|NCT03766399|454639335|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366886|NCT03766399|454639336|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366887|NCT03766399|454639337|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366888|NCT03766399|454639338|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126460808|NCT00930982|454987893|FG001|Overall Study|Withdrawal by Subject|1|||
126460809|NCT01609478|454987894|FG000|Overall Study|Adverse Event|3|||
126294838|NCT02547428|454368453|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
126294839|NCT02547428|454368452|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
126294840|NCT02547428|454368453|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
126294841|NCT02547428|454368452|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
126294842|NCT02547428|454368453|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
126294843|NCT02547428|454368452|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
126294844|NCT02547428|454368453|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
126294845|NCT02547428|454368452|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
126294846|NCT02547428|454368453|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
126294847|NCT01479465|454368454|FG000|Overall Study|Disease Progression|9|||
126294848|NCT01479465|454368455|FG001|Overall Study|Disease Progression|61|||
126294849|NCT01479465|454368456|FG002|Overall Study|Disease Progression|65|||
126294850|NCT01479465|454368457|FG003|Overall Study|Disease Progression|70|||
126294851|NCT01479465|454368454|FG000|Overall Study|Study Discontinued by Sponsor|0|||
126294852|NCT01479465|454368455|FG001|Overall Study|Study Discontinued by Sponsor|7|||
126294853|NCT01479465|454368456|FG002|Overall Study|Study Discontinued by Sponsor|5|||
126294854|NCT01479465|454368457|FG003|Overall Study|Study Discontinued by Sponsor|3|||
126460810|NCT01609478|454987895|FG001|Overall Study|Adverse Event|1|||
126366889|NCT03766399|454639339|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366890|NCT03766399|454639340|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366891|NCT03766399|454639341|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366892|NCT03766399|454639342|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366893|NCT03766399|454639343|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366894|NCT03766399|454639344|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126460811|NCT01609478|454987896|FG002|Overall Study|Adverse Event|5|||
126366895|NCT03766399|454639345|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366896|NCT03766399|454639346|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366897|NCT03766399|454639347|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126294855|NCT01479465|454368454|FG000|Overall Study|Adverse Event|0|||
126294856|NCT01479465|454368455|FG001|Overall Study|Adverse Event|3|||
126294857|NCT01479465|454368456|FG002|Overall Study|Adverse Event|6|||
126294858|NCT01479465|454368457|FG003|Overall Study|Adverse Event|4|||
126294859|NCT01479465|454368454|FG000|Overall Study|Investigator Discretion|1|||
126294860|NCT01479465|454368455|FG001|Overall Study|Investigator Discretion|4|||
126294861|NCT01479465|454368456|FG002|Overall Study|Investigator Discretion|2|||
126294862|NCT01479465|454368457|FG003|Overall Study|Investigator Discretion|4|||
126294863|NCT01479465|454368454|FG000|Overall Study|Subject Request|1|||
126294864|NCT01479465|454368455|FG001|Overall Study|Subject Request|3|||
126294865|NCT01479465|454368456|FG002|Overall Study|Subject Request|4|||
126294866|NCT01479465|454368457|FG003|Overall Study|Subject Request|2|||
126294867|NCT01479465|454368454|FG000|Overall Study|Subject Withdrew Consent|0|||
126294868|NCT01479465|454368455|FG001|Overall Study|Subject Withdrew Consent|5|||
126294869|NCT01479465|454368456|FG002|Overall Study|Subject Withdrew Consent|2|||
126294870|NCT01479465|454368457|FG003|Overall Study|Subject Withdrew Consent|1|||
126294871|NCT01479465|454368454|FG000|Overall Study|Protocol Violation|0|||
126711082|NCT05363293|455893655|FG009|Overall Study|Withdrawal by Subject|0|||
126711083|NCT01318902|455893656|FG000|Overall Study|Symptomatic Deterioration|0|||
126294872|NCT01479465|454368455|FG001|Overall Study|Protocol Violation|1|||
126294873|NCT01479465|454368456|FG002|Overall Study|Protocol Violation|1|||
126294874|NCT01479465|454368457|FG003|Overall Study|Protocol Violation|0|||
126294875|NCT01479465|454368454|FG000|Overall Study|Death|0|||
126294876|NCT01479465|454368455|FG001|Overall Study|Death|0|||
126294877|NCT01479465|454368456|FG002|Overall Study|Death|0|||
126294878|NCT01479465|454368457|FG003|Overall Study|Death|1|||
126294879|NCT01479465|454368454|FG000|Overall Study|Lost to Follow-up|0|||
126294880|NCT01479465|454368455|FG001|Overall Study|Lost to Follow-up|0|||
126294881|NCT01479465|454368456|FG002|Overall Study|Lost to Follow-up|1|||
126294882|NCT01479465|454368457|FG003|Overall Study|Lost to Follow-up|0|||
126294883|NCT04429503|454368462|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
126294884|NCT04429503|454368463|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
126294885|NCT04429503|454368464|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
126294886|NCT04429503|454368465|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
126294887|NCT04429503|454368466|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
126294888|NCT04429503|454368467|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
126294889|NCT04429503|454368462|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
126294890|NCT04429503|454368463|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
126294891|NCT04429503|454368464|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
126294892|NCT04429503|454368465|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
126294893|NCT04429503|454368466|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
126294894|NCT04429503|454368467|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
126294895|NCT04429503|454368462|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
126294896|NCT04429503|454368463|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
126294897|NCT04429503|454368464|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
126294898|NCT04429503|454368465|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
126294899|NCT04429503|454368466|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
126294900|NCT04429503|454368467|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
126294901|NCT04429503|454368462|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
126294902|NCT04429503|454368463|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
126294903|NCT04429503|454368464|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
126294904|NCT04429503|454368465|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
126294905|NCT04429503|454368466|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
126294906|NCT04429503|454368467|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
126294907|NCT04429503|454368462|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
126294908|NCT04429503|454368463|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
126294909|NCT04429503|454368464|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
126294910|NCT04429503|454368465|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
126294911|NCT04429503|454368466|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
126294912|NCT04429503|454368467|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
126294913|NCT04429503|454368462|FG000|Main Study (Up to Wk 96)|Death|9|||
126294914|NCT04429503|454368463|FG001|Main Study (Up to Wk 96)|Death|18|||
126294915|NCT04429503|454368464|FG002|Main Study (Up to Wk 96)|Death|5|||
126711084|NCT01318902|455893657|FG001|Overall Study|Symptomatic Deterioration|1|||
126711085|NCT01318902|455893658|FG002|Overall Study|Symptomatic Deterioration|1|||
126294916|NCT04429503|454368465|FG003|Main Study (Up to Wk 96)|Death|0|||
126294917|NCT04429503|454368466|FG004|Main Study (Up to Wk 96)|Death|0|||
126294918|NCT04429503|454368467|FG005|Main Study (Up to Wk 96)|Death|0|||
126294919|NCT04429503|454368462|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
126294920|NCT04429503|454368463|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
126294921|NCT04429503|454368464|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
126294922|NCT04429503|454368465|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
126711086|NCT01318902|455893659|FG003|Overall Study|Symptomatic Deterioration|2|||
126294923|NCT04429503|454368466|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
126294924|NCT04429503|454368467|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
126294925|NCT04429503|454368462|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
126294926|NCT04429503|454368463|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
126294927|NCT04429503|454368464|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
126294928|NCT04429503|454368465|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
126294929|NCT04429503|454368466|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
126294930|NCT04429503|454368467|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
126294931|NCT04429503|454368462|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
126294932|NCT04429503|454368463|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
126294933|NCT04429503|454368464|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
126294934|NCT04429503|454368465|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
126294935|NCT04429503|454368466|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
126294936|NCT04429503|454368467|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
126294937|NCT04429503|454368462|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
126294938|NCT04429503|454368463|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
126294939|NCT04429503|454368464|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
126294940|NCT04429503|454368465|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
126294941|NCT04429503|454368466|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
126294942|NCT04429503|454368467|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
126294943|NCT04429503|454368462|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
126294944|NCT04429503|454368463|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
126294945|NCT04429503|454368464|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
126294946|NCT04429503|454368465|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
126294947|NCT04429503|454368466|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
126294948|NCT04429503|454368467|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
126294949|NCT04429503|454368462|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
126294950|NCT04429503|454368463|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
126294951|NCT04429503|454368464|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
126294952|NCT04429503|454368465|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
126294953|NCT04429503|454368466|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
126294954|NCT04429503|454368467|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
126294955|NCT05516108|454368468|FG000|Overall Study|Time Commitment|3|||
126294956|NCT05516108|454368469|FG001|Overall Study|Time Commitment|1|||
126294957|NCT05516108|454368468|FG000|Overall Study|Reason Unknown|2|||
126294958|NCT05516108|454368469|FG001|Overall Study|Reason Unknown|4|||
126294959|NCT02717507|454368470|FG000|Overall Study|Lost to Follow-up|5|||
126294960|NCT02717507|454368471|FG001|Overall Study|Lost to Follow-up|8|||
126294961|NCT02717507|454368470|FG000|Overall Study|Pregnancy|1|||
126294962|NCT02717507|454368471|FG001|Overall Study|Pregnancy|1|||
126294963|NCT02717507|454368470|FG000|Overall Study|Protocol Violation|2|||
126294964|NCT02717507|454368471|FG001|Overall Study|Protocol Violation|2|||
126294965|NCT02717507|454368470|FG000|Overall Study|Withdrawal by Subject|20|||
126294966|NCT02717507|454368471|FG001|Overall Study|Withdrawal by Subject|20|||
126294967|NCT02717507|454368470|FG000|Overall Study|Relapse|1|||
126294968|NCT02717507|454368471|FG001|Overall Study|Relapse|1|||
126294969|NCT02717507|454368470|FG000|Overall Study|Cardiac Event|2|||
126294970|NCT02717507|454368471|FG001|Overall Study|Cardiac Event|6|||
126294971|NCT00709995|454368472|FG000|Overall Study|Adverse Event|4|||
126294972|NCT00709995|454368473|FG001|Overall Study|Adverse Event|2|||
126711087|NCT01318902|455893656|FG000|Overall Study|Withdrawal by Patient|0|||
126711088|NCT01318902|455893657|FG001|Overall Study|Withdrawal by Patient|1|||
126711089|NCT01318902|455893658|FG002|Overall Study|Withdrawal by Patient|0|||
126711090|NCT01318902|455893659|FG003|Overall Study|Withdrawal by Patient|3|||
126711091|NCT01318902|455893656|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
126711092|NCT01318902|455893657|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
126711093|NCT01318902|455893658|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
126294973|NCT00709995|454368472|FG000|Overall Study|Withdrawal by Subject|1|||
126294974|NCT00709995|454368473|FG001|Overall Study|Withdrawal by Subject|3|||
126294975|NCT02003209|454368474|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
126294976|NCT02003209|454368475|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
126294977|NCT00638508|454368476|FG000|Overall Study|Physician Decision|5|||
126294978|NCT00638508|454368477|FG001|Overall Study|Physician Decision|2|||
126294979|NCT00370552|454368478|FG000|Overall Study|Adverse Event|2|||
126294980|NCT00370552|454368479|FG001|Overall Study|Adverse Event|2|||
126294981|NCT00370552|454368480|FG002|Overall Study|Adverse Event|2|||
126294982|NCT00370552|454368478|FG000|Overall Study|Disease progression|23|||
126294983|NCT00370552|454368479|FG001|Overall Study|Disease progression|23|||
126294984|NCT00370552|454368480|FG002|Overall Study|Disease progression|15|||
126294985|NCT00370552|454368478|FG000|Overall Study|Maximum clinical benefit|3|||
126366898|NCT03766399|454639348|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
126460812|NCT01609478|454987894|FG000|Overall Study|Protocol Deviation|0|||
126294986|NCT00370552|454368479|FG001|Overall Study|Maximum clinical benefit|5|||
126294987|NCT00370552|454368480|FG002|Overall Study|Maximum clinical benefit|5|||
126294988|NCT00370552|454368478|FG000|Overall Study|Poor or noncompliance|0|||
126294989|NCT00370552|454368479|FG001|Overall Study|Poor or noncompliance|0|||
126294990|NCT00370552|454368480|FG002|Overall Study|Poor or noncompliance|1|||
126294991|NCT00370552|454368478|FG000|Overall Study|Study drug toxicity|11|||
126294992|NCT00370552|454368479|FG001|Overall Study|Study drug toxicity|8|||
126294993|NCT00370552|454368480|FG002|Overall Study|Study drug toxicity|6|||
126294994|NCT00370552|454368478|FG000|Overall Study|Withdrawal by Subject|2|||
126294995|NCT00370552|454368479|FG001|Overall Study|Withdrawal by Subject|0|||
126294996|NCT00370552|454368480|FG002|Overall Study|Withdrawal by Subject|1|||
126294997|NCT00370552|454368478|FG000|Overall Study|Still on treatment|1|||
126294998|NCT00370552|454368479|FG001|Overall Study|Still on treatment|3|||
126294999|NCT00370552|454368480|FG002|Overall Study|Still on treatment|2|||
126295000|NCT00370552|454368478|FG000|Overall Study|Never treated|1|||
126295001|NCT00370552|454368479|FG001|Overall Study|Never treated|0|||
126295002|NCT00370552|454368480|FG002|Overall Study|Never treated|0|||
126295003|NCT00370552|454368478|FG000|Overall Study|Physician Decision|1|||
126295004|NCT00370552|454368479|FG001|Overall Study|Physician Decision|1|||
126295005|NCT00370552|454368480|FG002|Overall Study|Physician Decision|0|||
126295006|NCT00370552|454368478|FG000|Overall Study|Investigator decision|2|||
126295007|NCT00370552|454368479|FG001|Overall Study|Investigator decision|1|||
126295008|NCT00370552|454368480|FG002|Overall Study|Investigator decision|0|||
126295009|NCT00370552|454368478|FG000|Overall Study|High risk of allergic reaction|0|||
126295010|NCT00370552|454368479|FG001|Overall Study|High risk of allergic reaction|1|||
126295011|NCT00370552|454368480|FG002|Overall Study|High risk of allergic reaction|0|||
126295012|NCT00370552|454368478|FG000|Overall Study|Planned radiation for palliation|0|||
126295013|NCT00370552|454368479|FG001|Overall Study|Planned radiation for palliation|1|||
126295014|NCT00370552|454368480|FG002|Overall Study|Planned radiation for palliation|0|||
126295015|NCT03500198|454368481|FG000|Overall Study|Lost to Follow-up|0|||
126295016|NCT03500198|454368482|FG001|Overall Study|Lost to Follow-up|1|||
126295017|NCT00942084|454368494|FG000|Overall Study|Death|2|||
126295018|NCT01641640|454368495|FG000|Overall Study|Enrolled but not treated|1|||
126295019|NCT01641640|454368495|FG000|Overall Study|Efficacy failure|29|||
126295020|NCT01641640|454368495|FG000|Overall Study|Lost to Follow-up|3|||
126295021|NCT01641640|454368495|FG000|Overall Study|Withdrawal by Subject|2|||
126295022|NCT01641640|454368495|FG000|Overall Study|Adverse Event|1|||
126295023|NCT01234350|454368496|FG000|Overall Study|Adverse Event|277|||
126295024|NCT01234350|454368497|FG001|Overall Study|Adverse Event|92|||
126295025|NCT01234350|454368496|FG000|Overall Study|Withdrawal by Subject|61|||
126295026|NCT01234350|454368497|FG001|Overall Study|Withdrawal by Subject|36|||
126295027|NCT01234350|454368496|FG000|Overall Study|Lost to Follow-up|115|||
126295028|NCT01234350|454368497|FG001|Overall Study|Lost to Follow-up|47|||
126295029|NCT01234350|454368496|FG000|Overall Study|Covers a diverse set of reasons|234|||
126295030|NCT01234350|454368497|FG001|Overall Study|Covers a diverse set of reasons|92|||
126295031|NCT03534687|454368498|FG000|Overall Study|Lost to Follow-up|7|||
126295032|NCT03534687|454368499|FG001|Overall Study|Lost to Follow-up|2|||
126295033|NCT01051960|454368500|FG000|Overall Study|Adverse Event|1|||
126295034|NCT01960413|454368509|FG000|Overall Study|Withdrawal by Subject|1|||
126295035|NCT01960413|454368510|FG001|Overall Study|Withdrawal by Subject|1|||
126295036|NCT01960413|454368509|FG000|Overall Study|Physician Decision|1|||
126295037|NCT01960413|454368510|FG001|Overall Study|Physician Decision|0|||
126295038|NCT01960413|454368509|FG000|Overall Study|Lost to Follow-up|2|||
126295039|NCT01960413|454368510|FG001|Overall Study|Lost to Follow-up|0|||
126295040|NCT01082328|454368514|FG000|Overall Study|Adverse Event|1|||
126295041|NCT02285361|454368515|FG000|Overall Study|Protocol Violation|43|||
126295042|NCT02285361|454368515|FG000|Overall Study|Lost to Follow-up|5|||
126295043|NCT02285361|454368515|FG000|Overall Study|Not taken GIOTRIF|2|||
126295044|NCT02285361|454368515|FG000|Overall Study|Consented prior to the contract date|1|||
126295045|NCT05506046|454368518|FG000|Overall Study|Lost to Follow-up|89|||
126295046|NCT05506046|454368519|FG001|Overall Study|Lost to Follow-up|101|||
126295047|NCT05506046|454368520|FG002|Overall Study|Lost to Follow-up|102|||
126295048|NCT05506046|454368521|FG003|Overall Study|Lost to Follow-up|99|||
126295049|NCT03335475|454368522|FG000|Overall Study|Did not wear accelerometer|4|||
126295050|NCT03335475|454368523|FG001|Overall Study|Did not wear accelerometer|0|||
126295051|NCT03335475|454368522|FG000|Overall Study|Withdrawal by Subject|0|||
126295052|NCT03335475|454368523|FG001|Overall Study|Withdrawal by Subject|1|||
126295053|NCT02755103|454368524|FG000|Overall Study|Lost to Follow-up|17|||
126295054|NCT02755103|454368525|FG001|Overall Study|Lost to Follow-up|15|||
126295055|NCT02755103|454368524|FG000|Overall Study|Death|0|||
126295056|NCT02755103|454368525|FG001|Overall Study|Death|1|||
126295057|NCT02755103|454368524|FG000|Overall Study|Physician Decision|0|||
126295058|NCT02755103|454368525|FG001|Overall Study|Physician Decision|1|||
126295059|NCT02755103|454368524|FG000|Overall Study|Pregnancy|0|||
126295060|NCT02755103|454368525|FG001|Overall Study|Pregnancy|1|||
126295061|NCT02755103|454368524|FG000|Overall Study|Withdrawal by Subject|3|||
126295062|NCT02755103|454368525|FG001|Overall Study|Withdrawal by Subject|0|||
126295063|NCT05366010|454368528|FG000|Overall Study|Withdrawal by Subject|1|||
126295064|NCT05366010|454368528|FG000|Overall Study|Protocol Violation|1|||
126295065|NCT05366010|454368528|FG000|Overall Study|Lost to Follow-up|2|||
126295066|NCT05366010|454368528|FG000|Overall Study|Screen Failure|2|||
126295067|NCT02224157|454368529|FG000|Overall Study|Severe non-compliance to protocol|2|||
126295068|NCT02224157|454368530|FG001|Overall Study|Severe non-compliance to protocol|2|||
126295069|NCT02224157|454368529|FG000|Overall Study|Other|13|||
126295070|NCT02224157|454368530|FG001|Overall Study|Other|10|||
126295071|NCT02224157|454368529|FG000|Overall Study|Subject decision|58|||
126295072|NCT02224157|454368530|FG001|Overall Study|Subject decision|50|||
126295073|NCT02224157|454368529|FG000|Overall Study|Prematurely closed site|4|||
126295074|NCT02224157|454368530|FG001|Overall Study|Prematurely closed site|2|||
126295075|NCT02224157|454368529|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
126295076|NCT02224157|454368530|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
126295077|NCT02224157|454368529|FG000|Overall Study|Lost to Follow-up|27|||
126295078|NCT02224157|454368530|FG001|Overall Study|Lost to Follow-up|35|||
126295079|NCT02224157|454368529|FG000|Overall Study|Death|1|||
126295080|NCT02224157|454368530|FG001|Overall Study|Death|1|||
126295081|NCT02224157|454368529|FG000|Overall Study|Adverse Event|1|||
126295082|NCT02224157|454368530|FG001|Overall Study|Adverse Event|3|||
126295083|NCT05906628|454368533|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
126295084|NCT05906628|454368534|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
126295085|NCT05906628|454368533|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
126295086|NCT05906628|454368534|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
126295087|NCT05906628|454368533|FG000|16-Week DBVC Period|Protocol Violation|4|||
126295088|NCT05906628|454368534|FG001|16-Week DBVC Period|Protocol Violation|2|||
126295089|NCT05906628|454368533|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
126295090|NCT05906628|454368534|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
126295091|NCT05906628|454368533|FG000|16-Week OLE Period|Death|1|||
126295092|NCT05906628|454368534|FG001|16-Week OLE Period|Death|0|||
126295093|NCT05906628|454368533|FG000|16-Week OLE Period|Lost to Follow-up|1|||
126295094|NCT05906628|454368534|FG001|16-Week OLE Period|Lost to Follow-up|1|||
126295095|NCT05906628|454368533|FG000|16-Week OLE Period|Protocol Violation|0|||
126295096|NCT05906628|454368534|FG001|16-Week OLE Period|Protocol Violation|1|||
126295097|NCT05906628|454368533|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
126295098|NCT05906628|454368534|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
126295099|NCT04578535|454368535|FG000|Overall Study|Lost to Follow-up|1|||
126295100|NCT04578535|454368536|FG001|Overall Study|Lost to Follow-up|0|||
126295101|NCT04578535|454368537|FG002|Overall Study|Lost to Follow-up|0|||
126295102|NCT04578535|454368538|FG003|Overall Study|Lost to Follow-up|1|||
126295103|NCT04578535|454368539|FG004|Overall Study|Lost to Follow-up|0|||
126295104|NCT04578535|454368540|FG005|Overall Study|Lost to Follow-up|2|||
126295105|NCT04578535|454368535|FG000|Overall Study|Pregnancy|1|||
126295106|NCT04578535|454368536|FG001|Overall Study|Pregnancy|0|||
126295107|NCT04578535|454368537|FG002|Overall Study|Pregnancy|0|||
126295108|NCT04578535|454368538|FG003|Overall Study|Pregnancy|0|||
126295109|NCT04578535|454368539|FG004|Overall Study|Pregnancy|0|||
126295110|NCT04578535|454368540|FG005|Overall Study|Pregnancy|0|||
126295111|NCT04578535|454368535|FG000|Overall Study|Withdrawal by Subject|0|||
126295112|NCT04578535|454368536|FG001|Overall Study|Withdrawal by Subject|0|||
126295113|NCT04578535|454368537|FG002|Overall Study|Withdrawal by Subject|0|||
126295114|NCT04578535|454368538|FG003|Overall Study|Withdrawal by Subject|1|||
126295115|NCT04578535|454368539|FG004|Overall Study|Withdrawal by Subject|1|||
126295116|NCT04578535|454368540|FG005|Overall Study|Withdrawal by Subject|5|||
126295117|NCT04578535|454368535|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
126295118|NCT04578535|454368536|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
126295119|NCT04578535|454368537|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
126295120|NCT04578535|454368538|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
126295121|NCT04578535|454368539|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
126295122|NCT04578535|454368540|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
126295123|NCT05317312|454368541|FG000|Overall Study|Withdrawal by Subject|0|||
126295124|NCT05317312|454368542|FG001|Overall Study|Withdrawal by Subject|1|||
126295125|NCT05317312|454368543|FG002|Overall Study|Withdrawal by Subject|0|||
126295126|NCT05317312|454368544|FG003|Overall Study|Withdrawal by Subject|0|||
126295127|NCT05317312|454368541|FG000|Overall Study|Lost to Follow-up|0|||
126295128|NCT05317312|454368542|FG001|Overall Study|Lost to Follow-up|0|||
126295129|NCT05317312|454368543|FG002|Overall Study|Lost to Follow-up|0|||
126295130|NCT05317312|454368544|FG003|Overall Study|Lost to Follow-up|1|||
126295131|NCT05317312|454368541|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
126295132|NCT05317312|454368542|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
126295133|NCT05317312|454368543|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
126295134|NCT05317312|454368544|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
126295135|NCT01060072|454368545|FG000|Overall Study|Adverse Event|1|||
126295136|NCT01060072|454368546|FG001|Overall Study|Adverse Event|1|||
126295137|NCT01060072|454368545|FG000|Overall Study|Physician Decision|0|||
126460813|NCT01609478|454987895|FG001|Overall Study|Protocol Deviation|1|||
126295138|NCT01060072|454368546|FG001|Overall Study|Physician Decision|2|||
126295139|NCT01060072|454368545|FG000|Overall Study|Protocol Violation|0|||
126295140|NCT01060072|454368546|FG001|Overall Study|Protocol Violation|1|||
126295141|NCT01060072|454368545|FG000|Overall Study|Acute cholecystitis|1|||
126295142|NCT01060072|454368546|FG001|Overall Study|Acute cholecystitis|0|||
126295143|NCT01060072|454368545|FG000|Overall Study|Excluded Medications|0|||
126295144|NCT01060072|454368546|FG001|Overall Study|Excluded Medications|1|||
126295145|NCT00837148|454368547|FG000|Overall Study|Adverse Event|1|||
126295146|NCT00837148|454368547|FG000|Overall Study|Death|1|||
126295147|NCT00380874|454368548|FG000|Overall Study|Adverse Event|7|||
126295148|NCT00380874|454368549|FG001|Overall Study|Adverse Event|7|||
126295149|NCT00380874|454368548|FG000|Overall Study|Death|1|||
126295150|NCT00380874|454368549|FG001|Overall Study|Death|0|||
126295151|NCT00380874|454368548|FG000|Overall Study|Withdrawal by Subject|2|||
126295152|NCT00380874|454368549|FG001|Overall Study|Withdrawal by Subject|1|||
126295153|NCT00380874|454368548|FG000|Overall Study|Not related to study drug|3|||
126295154|NCT00380874|454368549|FG001|Overall Study|Not related to study drug|2|||
126295155|NCT03839628|454368550|FG000|Overall Study|Withdrawal by Subject|1|||
126295156|NCT01707290|454368551|FG000|Overall Study|Adverse event (AE)|1|||
126295157|NCT01707290|454368552|FG001|Overall Study|Adverse event (AE)|0|||
126295158|NCT01707290|454368551|FG000|Overall Study|Physician Decision|1|||
126295159|NCT01707290|454368552|FG001|Overall Study|Physician Decision|0|||
126295160|NCT01707290|454368551|FG000|Overall Study|Lost to Follow-up|3|||
126295161|NCT01707290|454368552|FG001|Overall Study|Lost to Follow-up|0|||
126295162|NCT01707290|454368551|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
126295163|NCT01707290|454368552|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
126295164|NCT01707290|454368551|FG000|Overall Study|Commercial drug available|60|||
126295165|NCT01707290|454368552|FG001|Overall Study|Commercial drug available|1|||
126295166|NCT01707290|454368551|FG000|Overall Study|Other unspecified|17|||
126295167|NCT01707290|454368552|FG001|Overall Study|Other unspecified|0|||
126295168|NCT01964976|454368553|FG000|Overall Study|Protocol Violation|31|||
126295169|NCT02286713|454368559|FG000|One Week Follow-Up|Death|1|||
126295170|NCT02286713|454368560|FG001|One Week Follow-Up|Death|0|||
126295171|NCT02286713|454368559|FG000|One Week Follow-Up|Lost to Follow-up|17|||
126295172|NCT02286713|454368560|FG001|One Week Follow-Up|Lost to Follow-up|21|||
126295173|NCT02286713|454368559|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
126295174|NCT02286713|454368560|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
126295175|NCT02286713|454368559|FG000|Three Month Follow-Up|Death|1|||
126295176|NCT02286713|454368560|FG001|Three Month Follow-Up|Death|1|||
126295177|NCT02286713|454368559|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
126295178|NCT02286713|454368560|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
126295179|NCT02286713|454368559|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
126295180|NCT02286713|454368560|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
126295181|NCT02286713|454368559|FG000|Six Month Follow-Up|Death|2|||
126295182|NCT02286713|454368560|FG001|Six Month Follow-Up|Death|0|||
126295183|NCT02286713|454368559|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
126295184|NCT02286713|454368560|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
126295185|NCT05479435|454368561|FG000|Overall Study|Withdrawal by Subject|1|||
126295186|NCT05479435|454368562|FG001|Overall Study|Withdrawal by Subject|0|||
126295187|NCT05479435|454368563|FG002|Overall Study|Withdrawal by Subject|0|||
126295188|NCT05479435|454368561|FG000|Overall Study|Covid 19|0|||
126295189|NCT05479435|454368562|FG001|Overall Study|Covid 19|0|||
126295190|NCT05479435|454368563|FG002|Overall Study|Covid 19|2|||
126295191|NCT03428958|454370575|FG000|Overall Study|Adverse Event|0|||
126295192|NCT03428958|454370576|FG001|Overall Study|Adverse Event|0|||
126295193|NCT03428958|454370577|FG002|Overall Study|Adverse Event|0|||
126295194|NCT03428958|454370578|FG003|Overall Study|Adverse Event|1|||
126295195|NCT03428958|454370579|FG004|Overall Study|Adverse Event|0|||
126460814|NCT01609478|454987896|FG002|Overall Study|Protocol Deviation|1|||
126460815|NCT01609478|454987894|FG000|Overall Study|Non-Compliance with study treatment|1|||
126460816|NCT01609478|454987895|FG001|Overall Study|Non-Compliance with study treatment|0|||
126460817|NCT01609478|454987896|FG002|Overall Study|Non-Compliance with study treatment|0|||
126460818|NCT01609478|454987894|FG000|Overall Study|Physician Decision|1|||
126460819|NCT01609478|454987895|FG001|Overall Study|Physician Decision|0|||
126295196|NCT03428958|454370580|FG005|Overall Study|Adverse Event|2|||
126295197|NCT03428958|454370581|FG006|Overall Study|Adverse Event|1|||
126295198|NCT03428958|454370582|FG007|Overall Study|Adverse Event|0|||
126295199|NCT03428958|454370583|FG008|Overall Study|Adverse Event|0|||
126295200|NCT03428958|454370584|FG009|Overall Study|Adverse Event|0|||
126295201|NCT03428958|454370585|FG010|Overall Study|Adverse Event|0|||
126295202|NCT03428958|454370586|FG011|Overall Study|Adverse Event|0|||
126295203|NCT03428958|454370587|FG012|Overall Study|Adverse Event|0|||
126295204|NCT03428958|454370588|FG013|Overall Study|Adverse Event|0|||
126460820|NCT01609478|454987896|FG002|Overall Study|Physician Decision|1|||
126460821|NCT01609478|454987894|FG000|Overall Study|Withdrawal by Subject|2|||
126295205|NCT03428958|454370589|FG014|Overall Study|Adverse Event|0|||
126295206|NCT03428958|454370590|FG015|Overall Study|Adverse Event|0|||
126295207|NCT03428958|454370591|FG016|Overall Study|Adverse Event|0|||
126295208|NCT03428958|454370575|FG000|Overall Study|Clinical Progression|2|||
126295209|NCT03428958|454370576|FG001|Overall Study|Clinical Progression|3|||
126295210|NCT03428958|454370577|FG002|Overall Study|Clinical Progression|2|||
126295211|NCT03428958|454370578|FG003|Overall Study|Clinical Progression|1|||
126295212|NCT03428958|454370579|FG004|Overall Study|Clinical Progression|0|||
126295213|NCT03428958|454370580|FG005|Overall Study|Clinical Progression|2|||
126295214|NCT03428958|454370581|FG006|Overall Study|Clinical Progression|0|||
126295215|NCT03428958|454370582|FG007|Overall Study|Clinical Progression|0|||
126295216|NCT03428958|454370583|FG008|Overall Study|Clinical Progression|0|||
126295217|NCT03428958|454370584|FG009|Overall Study|Clinical Progression|0|||
126295218|NCT03428958|454370585|FG010|Overall Study|Clinical Progression|0|||
126295219|NCT03428958|454370586|FG011|Overall Study|Clinical Progression|0|||
126295220|NCT03428958|454370587|FG012|Overall Study|Clinical Progression|0|||
126295221|NCT03428958|454370588|FG013|Overall Study|Clinical Progression|0|||
126295222|NCT03428958|454370589|FG014|Overall Study|Clinical Progression|0|||
126295223|NCT03428958|454370590|FG015|Overall Study|Clinical Progression|0|||
126295224|NCT03428958|454370591|FG016|Overall Study|Clinical Progression|0|||
126295225|NCT03428958|454370575|FG000|Overall Study|Progression per RECIST|6|||
126295226|NCT03428958|454370576|FG001|Overall Study|Progression per RECIST|6|||
126295227|NCT03428958|454370577|FG002|Overall Study|Progression per RECIST|7|||
126295228|NCT03428958|454370578|FG003|Overall Study|Progression per RECIST|4|||
126295229|NCT03428958|454370579|FG004|Overall Study|Progression per RECIST|0|||
126295230|NCT03428958|454370580|FG005|Overall Study|Progression per RECIST|7|||
126295231|NCT03428958|454370581|FG006|Overall Study|Progression per RECIST|8|||
126295232|NCT03428958|454370582|FG007|Overall Study|Progression per RECIST|0|||
126295233|NCT03428958|454370583|FG008|Overall Study|Progression per RECIST|0|||
126295234|NCT03428958|454370584|FG009|Overall Study|Progression per RECIST|0|||
126295235|NCT03428958|454370585|FG010|Overall Study|Progression per RECIST|0|||
126295236|NCT03428958|454370586|FG011|Overall Study|Progression per RECIST|0|||
126295237|NCT03428958|454370587|FG012|Overall Study|Progression per RECIST|1|||
126295238|NCT03428958|454370588|FG013|Overall Study|Progression per RECIST|0|||
126295239|NCT03428958|454370589|FG014|Overall Study|Progression per RECIST|0|||
126295240|NCT03428958|454370590|FG015|Overall Study|Progression per RECIST|0|||
126295241|NCT03428958|454370591|FG016|Overall Study|Progression per RECIST|0|||
126295242|NCT03428958|454370575|FG000|Overall Study|Death|2|||
126295243|NCT03428958|454370576|FG001|Overall Study|Death|2|||
126295244|NCT03428958|454370577|FG002|Overall Study|Death|0|||
126295245|NCT03428958|454370578|FG003|Overall Study|Death|0|||
126295246|NCT03428958|454370579|FG004|Overall Study|Death|0|||
126295247|NCT03428958|454370580|FG005|Overall Study|Death|7|||
126295248|NCT03428958|454370581|FG006|Overall Study|Death|9|||
126295249|NCT03428958|454370582|FG007|Overall Study|Death|6|||
126295250|NCT03428958|454370583|FG008|Overall Study|Death|0|||
126295251|NCT03428958|454370584|FG009|Overall Study|Death|0|||
126295252|NCT03428958|454370585|FG010|Overall Study|Death|3|||
126295253|NCT03428958|454370586|FG011|Overall Study|Death|0|||
126295254|NCT03428958|454370587|FG012|Overall Study|Death|4|||
126295255|NCT03428958|454370588|FG013|Overall Study|Death|0|||
126295256|NCT03428958|454370589|FG014|Overall Study|Death|0|||
126295257|NCT03428958|454370590|FG015|Overall Study|Death|0|||
126295258|NCT03428958|454370591|FG016|Overall Study|Death|0|||
126295259|NCT03428958|454370575|FG000|Overall Study|Lost to Follow-up|0|||
126295260|NCT03428958|454370576|FG001|Overall Study|Lost to Follow-up|0|||
126295261|NCT03428958|454370577|FG002|Overall Study|Lost to Follow-up|0|||
126295262|NCT03428958|454370578|FG003|Overall Study|Lost to Follow-up|0|||
126295263|NCT03428958|454370579|FG004|Overall Study|Lost to Follow-up|0|||
126295264|NCT03428958|454370580|FG005|Overall Study|Lost to Follow-up|1|||
126295265|NCT03428958|454370581|FG006|Overall Study|Lost to Follow-up|1|||
126295266|NCT03428958|454370582|FG007|Overall Study|Lost to Follow-up|0|||
126295267|NCT03428958|454370583|FG008|Overall Study|Lost to Follow-up|0|||
126295268|NCT03428958|454370584|FG009|Overall Study|Lost to Follow-up|0|||
126295269|NCT03428958|454370585|FG010|Overall Study|Lost to Follow-up|0|||
126295270|NCT03428958|454370586|FG011|Overall Study|Lost to Follow-up|0|||
126295271|NCT03428958|454370587|FG012|Overall Study|Lost to Follow-up|0|||
126295272|NCT03428958|454370588|FG013|Overall Study|Lost to Follow-up|0|||
126295273|NCT03428958|454370589|FG014|Overall Study|Lost to Follow-up|0|||
126295274|NCT03428958|454370590|FG015|Overall Study|Lost to Follow-up|0|||
126295275|NCT03428958|454370591|FG016|Overall Study|Lost to Follow-up|0|||
126295276|NCT03428958|454370575|FG000|Overall Study|Physician/Sponsor Decision|1|||
126295277|NCT03428958|454370576|FG001|Overall Study|Physician/Sponsor Decision|0|||
126295278|NCT03428958|454370577|FG002|Overall Study|Physician/Sponsor Decision|1|||
126295279|NCT03428958|454370578|FG003|Overall Study|Physician/Sponsor Decision|0|||
126295280|NCT03428958|454370579|FG004|Overall Study|Physician/Sponsor Decision|0|||
126295281|NCT03428958|454370580|FG005|Overall Study|Physician/Sponsor Decision|2|||
126295282|NCT03428958|454370581|FG006|Overall Study|Physician/Sponsor Decision|2|||
126295283|NCT03428958|454370582|FG007|Overall Study|Physician/Sponsor Decision|2|||
126295284|NCT03428958|454370583|FG008|Overall Study|Physician/Sponsor Decision|0|||
126295285|NCT03428958|454370584|FG009|Overall Study|Physician/Sponsor Decision|0|||
126295286|NCT03428958|454370585|FG010|Overall Study|Physician/Sponsor Decision|2|||
126295287|NCT03428958|454370586|FG011|Overall Study|Physician/Sponsor Decision|0|||
126295288|NCT03428958|454370587|FG012|Overall Study|Physician/Sponsor Decision|4|||
126295289|NCT03428958|454370588|FG013|Overall Study|Physician/Sponsor Decision|0|||
126366899|NCT03766399|454639349|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366900|NCT03766399|454639350|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366901|NCT03766399|454639351|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366902|NCT03766399|454639352|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
126366903|NCT02014376|454639353|FG000|Overall Study|Adverse Event|1|||
126366904|NCT02014376|454639354|FG001|Overall Study|Adverse Event|1|||
126366905|NCT02014376|454639355|FG002|Overall Study|Adverse Event|0|||
126366906|NCT02014376|454639353|FG000|Overall Study|Lost to Follow-up|2|||
126295290|NCT03428958|454370589|FG014|Overall Study|Physician/Sponsor Decision|0|||
126295291|NCT03428958|454370590|FG015|Overall Study|Physician/Sponsor Decision|0|||
126295292|NCT03428958|454370591|FG016|Overall Study|Physician/Sponsor Decision|0|||
126295293|NCT03428958|454370575|FG000|Overall Study|Withdrawal by Subject|0|||
126295294|NCT03428958|454370576|FG001|Overall Study|Withdrawal by Subject|0|||
126295295|NCT03428958|454370577|FG002|Overall Study|Withdrawal by Subject|2|||
126295296|NCT03428958|454370578|FG003|Overall Study|Withdrawal by Subject|0|||
126295297|NCT03428958|454370579|FG004|Overall Study|Withdrawal by Subject|0|||
126295298|NCT03428958|454370580|FG005|Overall Study|Withdrawal by Subject|2|||
126295299|NCT03428958|454370581|FG006|Overall Study|Withdrawal by Subject|4|||
126295300|NCT03428958|454370582|FG007|Overall Study|Withdrawal by Subject|1|||
126366907|NCT02014376|454639354|FG001|Overall Study|Lost to Follow-up|0|||
126295301|NCT03428958|454370583|FG008|Overall Study|Withdrawal by Subject|0|||
126295302|NCT03428958|454370584|FG009|Overall Study|Withdrawal by Subject|0|||
126295303|NCT03428958|454370585|FG010|Overall Study|Withdrawal by Subject|0|||
126295304|NCT03428958|454370586|FG011|Overall Study|Withdrawal by Subject|0|||
126295305|NCT03428958|454370587|FG012|Overall Study|Withdrawal by Subject|0|||
126295306|NCT03428958|454370588|FG013|Overall Study|Withdrawal by Subject|0|||
126295307|NCT03428958|454370589|FG014|Overall Study|Withdrawal by Subject|0|||
126295308|NCT03428958|454370590|FG015|Overall Study|Withdrawal by Subject|0|||
126295309|NCT03428958|454370591|FG016|Overall Study|Withdrawal by Subject|0|||
126295310|NCT03874117|454370592|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
126295311|NCT03874117|454370593|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
126295312|NCT03874117|454370592|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
126295313|NCT03874117|454370593|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
126366908|NCT02014376|454639355|FG002|Overall Study|Lost to Follow-up|0|||
126366909|NCT01051661|454639361|FG000|Overall Study|Adverse Event|1|||
126366910|NCT01051661|454639362|FG001|Overall Study|Adverse Event|1|||
126366911|NCT01051661|454639363|FG002|Overall Study|Adverse Event|1|||
126366912|NCT01051661|454639364|FG003|Overall Study|Adverse Event|1|||
126366913|NCT01051661|454639365|FG004|Overall Study|Adverse Event|0|||
126366914|NCT01051661|454639366|FG005|Overall Study|Adverse Event|0|||
126366915|NCT01051661|454639361|FG000|Overall Study|Lost to Follow-up|13|||
126366916|NCT01051661|454639362|FG001|Overall Study|Lost to Follow-up|22|||
126366917|NCT01051661|454639363|FG002|Overall Study|Lost to Follow-up|15|||
126366918|NCT01051661|454639364|FG003|Overall Study|Lost to Follow-up|17|||
126550076|NCT01076088|455307717|FG000|Overall Study|Withdrawal by Subject|8|||
126550077|NCT01076088|455307718|FG001|Overall Study|Withdrawal by Subject|8|||
126711094|NCT01318902|455893659|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
126295314|NCT03874117|454370592|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
126295315|NCT03874117|454370593|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
126295316|NCT03874117|454370592|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
126295317|NCT03874117|454370593|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
126295318|NCT03874117|454370592|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126295319|NCT03874117|454370593|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
126295320|NCT01922037|454370594|FG000|Overall Study|Withdrawal by Subject|2|||
126295321|NCT01922037|454370595|FG001|Overall Study|Withdrawal by Subject|44|||
126295322|NCT01922037|454370594|FG000|Overall Study|Adverse Event|1|||
126295323|NCT01922037|454370595|FG001|Overall Study|Adverse Event|7|||
126295324|NCT01922037|454370594|FG000|Overall Study|Death|0|||
126295325|NCT01922037|454370595|FG001|Overall Study|Death|5|||
126295326|NCT01922037|454370594|FG000|Overall Study|Pregnancy|0|||
126295327|NCT01922037|454370595|FG001|Overall Study|Pregnancy|2|||
126711095|NCT01318902|455893656|FG000|Overall Study|Adverse Event|0|||
126711096|NCT01318902|455893657|FG001|Overall Study|Adverse Event|1|||
126295328|NCT01922037|454370594|FG000|Overall Study|Participant non-compliance|4|||
126295329|NCT01922037|454370595|FG001|Overall Study|Participant non-compliance|46|||
126550078|NCT01076088|455307719|FG002|Overall Study|Withdrawal by Subject|14|||
126711097|NCT01318902|455893658|FG002|Overall Study|Adverse Event|0|||
126295330|NCT01922037|454370594|FG000|Overall Study|Investigator/Sponsor decision|1|||
126295331|NCT01922037|454370595|FG001|Overall Study|Investigator/Sponsor decision|4|||
126366919|NCT01051661|454639365|FG004|Overall Study|Lost to Follow-up|10|||
126366920|NCT01051661|454639366|FG005|Overall Study|Lost to Follow-up|24|||
126366921|NCT01051661|454639361|FG000|Overall Study|Migrated/moved from study area|1|||
126366922|NCT01051661|454639362|FG001|Overall Study|Migrated/moved from study area|6|||
126550079|NCT01076088|455307720|FG003|Overall Study|Withdrawal by Subject|10|||
126295332|NCT01922037|454370594|FG000|Overall Study|Other unspecified|2|||
126295333|NCT01922037|454370595|FG001|Overall Study|Other unspecified|66|||
126295334|NCT00413699|454370601|FG000|Initial Period|Death|25|||
126295335|NCT00413699|454370602|FG001|Initial Period|Death|30|||
126295336|NCT00413699|454370603|FG002|Initial Period|Death|0|||
126295337|NCT00413699|454370601|FG000|Initial Period|Lack of Efficacy|59|||
126295338|NCT00413699|454370602|FG001|Initial Period|Lack of Efficacy|115|||
126295339|NCT00413699|454370603|FG002|Initial Period|Lack of Efficacy|0|||
126295340|NCT00413699|454370601|FG000|Initial Period|Lost to Follow-up|31|||
126295341|NCT00413699|454370602|FG001|Initial Period|Lost to Follow-up|101|||
126295342|NCT00413699|454370603|FG002|Initial Period|Lost to Follow-up|0|||
126295343|NCT00413699|454370601|FG000|Initial Period|Protocol Violation|38|||
126295344|NCT00413699|454370602|FG001|Initial Period|Protocol Violation|89|||
126295345|NCT00413699|454370603|FG002|Initial Period|Protocol Violation|0|||
126295346|NCT00413699|454370601|FG000|Initial Period|Pregnancy|10|||
126295347|NCT00413699|454370602|FG001|Initial Period|Pregnancy|8|||
126295348|NCT00413699|454370603|FG002|Initial Period|Pregnancy|0|||
126295349|NCT00413699|454370601|FG000|Initial Period|Did not meet entrance criteria|2|||
126295350|NCT00413699|454370602|FG001|Initial Period|Did not meet entrance criteria|2|||
126295351|NCT00413699|454370603|FG002|Initial Period|Did not meet entrance criteria|0|||
126295352|NCT00413699|454370601|FG000|Initial Period|Medication error without adverse event|0|||
126295353|NCT00413699|454370602|FG001|Initial Period|Medication error without adverse event|1|||
126295354|NCT00413699|454370603|FG002|Initial Period|Medication error without adverse event|0|||
126295355|NCT00413699|454370601|FG000|Initial Period|Study terminated by Sponsor|0|||
126295356|NCT00413699|454370602|FG001|Initial Period|Study terminated by Sponsor|1|||
126295357|NCT00413699|454370603|FG002|Initial Period|Study terminated by Sponsor|0|||
126295358|NCT00413699|454370601|FG000|Initial Period|Other|67|||
126295359|NCT00413699|454370602|FG001|Initial Period|Other|211|||
126295360|NCT00413699|454370603|FG002|Initial Period|Other|0|||
126295361|NCT00413699|454370601|FG000|Initial Period|Adverse event related to study drug|178|||
126295362|NCT00413699|454370602|FG001|Initial Period|Adverse event related to study drug|527|||
126295363|NCT00413699|454370603|FG002|Initial Period|Adverse event related to study drug|0|||
126295364|NCT00413699|454370601|FG000|Initial Period|Adverse event not related to study drug|113|||
126295365|NCT00413699|454370602|FG001|Initial Period|Adverse event not related to study drug|248|||
126295366|NCT00413699|454370603|FG002|Initial Period|Adverse event not related to study drug|0|||
126295367|NCT00413699|454370601|FG000|Initial Period|Missing end of study page|0|||
126295368|NCT00413699|454370602|FG001|Initial Period|Missing end of study page|4|||
126295369|NCT00413699|454370603|FG002|Initial Period|Missing end of study page|0|||
126295370|NCT00413699|454370601|FG000|Initial Period|No longer willing to participate|116|||
126295371|NCT00413699|454370602|FG001|Initial Period|No longer willing to participate|368|||
126295372|NCT00413699|454370603|FG002|Initial Period|No longer willing to participate|0|||
126295373|NCT00413699|454370601|FG000|Extension Period|No Longer Willing to Participate|0|||
126295374|NCT00413699|454370602|FG001|Extension Period|No Longer Willing to Participate|0|||
126295375|NCT00413699|454370603|FG002|Extension Period|No Longer Willing to Participate|2|||
126295376|NCT00413699|454370601|FG000|Extension Period|Protocol Violation|0|||
126295377|NCT00413699|454370602|FG001|Extension Period|Protocol Violation|0|||
126295378|NCT00413699|454370603|FG002|Extension Period|Protocol Violation|1|||
126295379|NCT00413699|454370601|FG000|Extension Period|Adverse Event|0|||
126295380|NCT00413699|454370602|FG001|Extension Period|Adverse Event|0|||
126295381|NCT00413699|454370603|FG002|Extension Period|Adverse Event|2|||
126295382|NCT03511105|454370604|FG000|Overall Study|Adverse Event|1|||
126295383|NCT03511105|454370605|FG001|Overall Study|Adverse Event|0|||
126295384|NCT03511105|454370604|FG000|Overall Study|Withdrew consent|1|||
126295385|NCT03511105|454370605|FG001|Overall Study|Withdrew consent|0|||
126295386|NCT02810457|454370606|FG000|Overall Study|Randomised but no treatment received|2|||
126295387|NCT02810457|454370607|FG001|Overall Study|Randomised but no treatment received|1|||
126295388|NCT02810457|454370606|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
126295389|NCT02810457|454370607|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
126295390|NCT02810457|454370606|FG000|Overall Study|Adverse Event|37|||
126295391|NCT02810457|454370607|FG001|Overall Study|Adverse Event|43|||
126295392|NCT02810457|454370606|FG000|Overall Study|Patient decision|31|||
126295393|NCT02810457|454370607|FG001|Overall Study|Patient decision|35|||
126295394|NCT02810457|454370606|FG000|Overall Study|Patient lost to follow-up|2|||
126295395|NCT02810457|454370607|FG001|Overall Study|Patient lost to follow-up|2|||
126295396|NCT02810457|454370606|FG000|Overall Study|Death|39|||
126295397|NCT02810457|454370607|FG001|Overall Study|Death|28|||
126295398|NCT02810457|454370606|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
126295399|NCT02810457|454370607|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
126295400|NCT02810457|454370606|FG000|Overall Study|Clinical progression|15|||
126295401|NCT02810457|454370607|FG001|Overall Study|Clinical progression|16|||
126295402|NCT02810457|454370606|FG000|Overall Study|Investigator decision|3|||
126295403|NCT02810457|454370607|FG001|Overall Study|Investigator decision|2|||
126295404|NCT02810457|454370606|FG000|Overall Study|Patient ineligibility|3|||
126295405|NCT02810457|454370607|FG001|Overall Study|Patient ineligibility|0|||
126366923|NCT01051661|454639363|FG002|Overall Study|Migrated/moved from study area|6|||
126767226|NCT03917654|456100267|FG003|Year 1|Withdrawal by Subject|0|||
126767227|NCT03917654|456100268|FG004|Year 1|Withdrawal by Subject|0|||
126767228|NCT03917654|456100269|FG005|Year 1|Withdrawal by Subject|1|||
126295406|NCT02810457|454370606|FG000|Overall Study|Miscalculated PD|1|||
126295407|NCT02810457|454370607|FG001|Overall Study|Miscalculated PD|0|||
126295408|NCT02810457|454370606|FG000|Overall Study|Physician Decision|0|||
126295409|NCT02810457|454370607|FG001|Overall Study|Physician Decision|1|||
126295410|NCT02832687|454370608|FG000|Overall Study|Adverse Event|0|||
126295411|NCT02832687|454370609|FG001|Overall Study|Adverse Event|2|||
126295412|NCT04231825|454370610|FG000|Overall Study|Protocol Violation|3|||
126295413|NCT04231825|454370611|FG001|Overall Study|Protocol Violation|3|||
126295414|NCT04231825|454370610|FG000|Overall Study|Lost to Follow-up|0|||
126295415|NCT04231825|454370611|FG001|Overall Study|Lost to Follow-up|1|||
126295416|NCT02019472|454370612|FG000|Overall Study|Adverse Event|14|||
126295417|NCT02019472|454370613|FG001|Overall Study|Adverse Event|23|||
126295418|NCT02019472|454370614|FG002|Overall Study|Adverse Event|17|||
126295419|NCT02019472|454370612|FG000|Overall Study|Death|0|||
126295420|NCT02019472|454370613|FG001|Overall Study|Death|1|||
126295421|NCT02019472|454370614|FG002|Overall Study|Death|1|||
126295422|NCT02019472|454370612|FG000|Overall Study|Lack of Efficacy|7|||
126295423|NCT02019472|454370613|FG001|Overall Study|Lack of Efficacy|4|||
126295424|NCT02019472|454370614|FG002|Overall Study|Lack of Efficacy|4|||
126295425|NCT02019472|454370612|FG000|Overall Study|Lost to Follow-up|0|||
126295426|NCT02019472|454370613|FG001|Overall Study|Lost to Follow-up|2|||
126295427|NCT02019472|454370614|FG002|Overall Study|Lost to Follow-up|1|||
126295428|NCT02019472|454370612|FG000|Overall Study|Physician Decision|1|||
126295429|NCT02019472|454370613|FG001|Overall Study|Physician Decision|2|||
126295430|NCT02019472|454370614|FG002|Overall Study|Physician Decision|0|||
126295431|NCT02019472|454370612|FG000|Overall Study|Pregnancy|1|||
126295432|NCT02019472|454370613|FG001|Overall Study|Pregnancy|2|||
126295433|NCT02019472|454370614|FG002|Overall Study|Pregnancy|2|||
126295434|NCT02019472|454370612|FG000|Overall Study|Withdrawal by Subject|11|||
126295435|NCT02019472|454370613|FG001|Overall Study|Withdrawal by Subject|10|||
126295436|NCT02019472|454370614|FG002|Overall Study|Withdrawal by Subject|11|||
126295437|NCT02019472|454370612|FG000|Overall Study|Other|3|||
126295438|NCT02019472|454370613|FG001|Overall Study|Other|8|||
126295439|NCT02019472|454370614|FG002|Overall Study|Other|6|||
126295440|NCT01217112|454370617|FG000|Overall Study|Adverse Event|0|||
126295441|NCT01217112|454370618|FG001|Overall Study|Adverse Event|2|||
126295442|NCT01217112|454370619|FG002|Overall Study|Adverse Event|0|||
126295443|NCT01217112|454370620|FG003|Overall Study|Adverse Event|2|||
126295444|NCT01217112|454370621|FG004|Overall Study|Adverse Event|0|||
126295445|NCT01217112|454370617|FG000|Overall Study|Withdrawal by Subject|0|||
126295446|NCT01217112|454370618|FG001|Overall Study|Withdrawal by Subject|0|||
126295447|NCT01217112|454370619|FG002|Overall Study|Withdrawal by Subject|1|||
126295448|NCT01217112|454370620|FG003|Overall Study|Withdrawal by Subject|0|||
126295449|NCT01217112|454370621|FG004|Overall Study|Withdrawal by Subject|0|||
126295450|NCT01217112|454370617|FG000|Overall Study|Physician Decision|0|||
126295451|NCT01217112|454370618|FG001|Overall Study|Physician Decision|0|||
126295452|NCT01217112|454370619|FG002|Overall Study|Physician Decision|0|||
126295453|NCT01217112|454370620|FG003|Overall Study|Physician Decision|0|||
126295454|NCT01217112|454370621|FG004|Overall Study|Physician Decision|1|||
126295455|NCT03192488|454370622|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
126295456|NCT03192488|454370623|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
126295457|NCT03192488|454370624|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
126295458|NCT03192488|454370625|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
126295459|NCT03192488|454370626|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
126295460|NCT03192488|454370627|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
126295461|NCT03192488|454370622|FG000|Third Intervention (d1)|Adverse Event|0|||
126295462|NCT03192488|454370623|FG001|Third Intervention (d1)|Adverse Event|0|||
126295463|NCT03192488|454370624|FG002|Third Intervention (d1)|Adverse Event|0|||
126295464|NCT03192488|454370625|FG003|Third Intervention (d1)|Adverse Event|0|||
126295465|NCT03192488|454370626|FG004|Third Intervention (d1)|Adverse Event|1|||
126295466|NCT03192488|454370627|FG005|Third Intervention (d1)|Adverse Event|0|||
126295467|NCT01401361|454370628|FG000|Overall Study|Withdrawal by Subject|16|||
126295468|NCT01401361|454370628|FG000|Overall Study|Lack of Efficacy|6|||
126295469|NCT01401361|454370628|FG000|Overall Study|Physician Decision|1|||
126295470|NCT01401361|454370628|FG000|Overall Study|Lost to Follow-up|3|||
126295471|NCT01401361|454370628|FG000|Overall Study|Subject/family decision post procedure|2|||
126295472|NCT02512302|454370630|FG000|Period 1|Adverse Event|0|||
126295473|NCT02512302|454370631|FG001|Period 1|Adverse Event|1|||
126295474|NCT02512302|454370632|FG002|Period 1|Adverse Event|0|||
126767229|NCT03917654|456100270|FG006|Year 1|Withdrawal by Subject|6|||
126295475|NCT02512302|454370633|FG003|Period 1|Adverse Event|0|||
126295476|NCT02512302|454370634|FG004|Period 1|Adverse Event|0|||
126295477|NCT02512302|454370635|FG005|Period 1|Adverse Event|0|||
126295478|NCT02512302|454370636|FG006|Period 1|Adverse Event|0|||
126295479|NCT02512302|454370637|FG007|Period 1|Adverse Event|0|||
126295480|NCT02512302|454370638|FG008|Period 1|Adverse Event|0|||
126295481|NCT02512302|454370639|FG009|Period 1|Adverse Event|0|||
126767230|NCT03917654|456100271|FG007|Year 1|Withdrawal by Subject|2|||
126295482|NCT02512302|454370630|FG000|Period 2|Adverse Event|0|||
126295483|NCT02512302|454370631|FG001|Period 2|Adverse Event|0|||
126295484|NCT02512302|454370632|FG002|Period 2|Adverse Event|0|||
126295485|NCT02512302|454370633|FG003|Period 2|Adverse Event|0|||
126295486|NCT02512302|454370634|FG004|Period 2|Adverse Event|0|||
126295487|NCT02512302|454370635|FG005|Period 2|Adverse Event|0|||
126295488|NCT02512302|454370636|FG006|Period 2|Adverse Event|0|||
126295489|NCT02512302|454370637|FG007|Period 2|Adverse Event|0|||
126295490|NCT02512302|454370638|FG008|Period 2|Adverse Event|0|||
126295491|NCT02512302|454370639|FG009|Period 2|Adverse Event|1|||
126295492|NCT02512302|454370630|FG000|Period 3|Lost to Follow-up|0|||
126295493|NCT02512302|454370631|FG001|Period 3|Lost to Follow-up|0|||
126295494|NCT02512302|454370632|FG002|Period 3|Lost to Follow-up|1|||
126295495|NCT02512302|454370633|FG003|Period 3|Lost to Follow-up|0|||
126295496|NCT02512302|454370634|FG004|Period 3|Lost to Follow-up|0|||
126295497|NCT02512302|454370635|FG005|Period 3|Lost to Follow-up|0|||
126295498|NCT02512302|454370636|FG006|Period 3|Lost to Follow-up|0|||
126295499|NCT02512302|454370637|FG007|Period 3|Lost to Follow-up|0|||
126295500|NCT02512302|454370638|FG008|Period 3|Lost to Follow-up|0|||
126295501|NCT02512302|454370639|FG009|Period 3|Lost to Follow-up|0|||
126295502|NCT02512302|454370630|FG000|Period 4|Adverse Event|0|||
126295503|NCT02512302|454370631|FG001|Period 4|Adverse Event|0|||
126295504|NCT02512302|454370632|FG002|Period 4|Adverse Event|0|||
126295505|NCT02512302|454370633|FG003|Period 4|Adverse Event|0|||
126295506|NCT02512302|454370634|FG004|Period 4|Adverse Event|0|||
126295507|NCT02512302|454370635|FG005|Period 4|Adverse Event|0|||
126295508|NCT02512302|454370636|FG006|Period 4|Adverse Event|1|||
126295509|NCT02512302|454370637|FG007|Period 4|Adverse Event|0|||
126295510|NCT02512302|454370638|FG008|Period 4|Adverse Event|0|||
126295511|NCT02512302|454370639|FG009|Period 4|Adverse Event|0|||
126295512|NCT01002989|454370643|FG000|Overall Study|exclusion criteria, no consent|5|||
126295513|NCT01892501|454370644|FG000|Overall Study|Protocol Violation|2|||
126295514|NCT01892501|454370644|FG000|Overall Study|Puncture not carried out|9|||
126295515|NCT01892501|454370644|FG000|Overall Study|Radiological monitoring not carried out|5|||
126295516|NCT01892501|454370644|FG000|Overall Study|Non-contributory histological result|12|||
126295517|NCT00063934|454370648|FG000|Overall Study|Ineligible|1|||
126295518|NCT04341363|454370649|FG000|Overall Study|Adverse Event|1|||
126295519|NCT04341363|454370649|FG000|Overall Study|Withdrawal by Subject|1|||
126295520|NCT00840749|454370653|FG000|Overall Study|Death|1|||
126295521|NCT00840749|454370654|FG001|Overall Study|Death|2|||
126295522|NCT00840749|454370653|FG000|Overall Study|not treated on study arm|11|||
126295523|NCT00840749|454370654|FG001|Overall Study|not treated on study arm|11|||
126295524|NCT00840749|454370653|FG000|Overall Study|study closed|19|||
126295525|NCT00840749|454370654|FG001|Overall Study|study closed|14|||
126295526|NCT00395629|454370655|FG000|Core Study|Adverse Event|0|||
126295527|NCT00395629|454370656|FG001|Core Study|Adverse Event|3|||
126295528|NCT00395629|454370657|FG002|Core Study|Adverse Event|4|||
126295529|NCT00395629|454370655|FG000|Core Study|Abnormal laboratory value(s)|0|||
126295530|NCT00395629|454370656|FG001|Core Study|Abnormal laboratory value(s)|0|||
126295531|NCT00395629|454370657|FG002|Core Study|Abnormal laboratory value(s)|1|||
126295532|NCT00395629|454370655|FG000|Core Study|Protocol Violation|1|||
126295533|NCT00395629|454370656|FG001|Core Study|Protocol Violation|0|||
126295534|NCT00395629|454370657|FG002|Core Study|Protocol Violation|0|||
126295535|NCT00395629|454370655|FG000|Core Study|Withdrawal by Subject|0|||
126295536|NCT00395629|454370656|FG001|Core Study|Withdrawal by Subject|1|||
126295537|NCT00395629|454370657|FG002|Core Study|Withdrawal by Subject|1|||
126295538|NCT00395629|454370655|FG000|Core Study|Lost to Follow-up|0|||
126295539|NCT00395629|454370656|FG001|Core Study|Lost to Follow-up|0|||
126295540|NCT00395629|454370657|FG002|Core Study|Lost to Follow-up|1|||
126295541|NCT00395629|454370655|FG000|Extension Study|Adverse Event|0|||
126295542|NCT00395629|454370656|FG001|Extension Study|Adverse Event|0|||
126295543|NCT00395629|454370657|FG002|Extension Study|Adverse Event|2|||
126295544|NCT00395629|454370655|FG000|Extension Study|Administrative problems|0|||
126295545|NCT00395629|454370656|FG001|Extension Study|Administrative problems|0|||
126295546|NCT00395629|454370657|FG002|Extension Study|Administrative problems|1|||
126295547|NCT01836471|454370660|FG000|Overall Study|Pregnancy|1|||
126295548|NCT01836471|454370661|FG001|Overall Study|Pregnancy|0|||
126295549|NCT01836471|454370662|FG002|Overall Study|Pregnancy|0|||
126295550|NCT01836471|454370663|FG003|Overall Study|Pregnancy|0|||
126295551|NCT01836471|454370664|FG004|Overall Study|Pregnancy|0|||
126295552|NCT01836471|454370660|FG000|Overall Study|Withdrawal by Subject|3|||
126295553|NCT01836471|454370661|FG001|Overall Study|Withdrawal by Subject|4|||
126295554|NCT01836471|454370662|FG002|Overall Study|Withdrawal by Subject|1|||
126295555|NCT01836471|454370663|FG003|Overall Study|Withdrawal by Subject|0|||
126295556|NCT01836471|454370664|FG004|Overall Study|Withdrawal by Subject|2|||
126295557|NCT01836471|454370660|FG000|Overall Study|Physician Decision|0|||
126295558|NCT01836471|454370661|FG001|Overall Study|Physician Decision|1|||
126295559|NCT01836471|454370662|FG002|Overall Study|Physician Decision|0|||
126295560|NCT01836471|454370663|FG003|Overall Study|Physician Decision|0|||
126295561|NCT01836471|454370664|FG004|Overall Study|Physician Decision|0|||
126295562|NCT01836471|454370660|FG000|Overall Study|Lost to Follow-up|0|||
126295563|NCT01836471|454370661|FG001|Overall Study|Lost to Follow-up|0|||
126295564|NCT01836471|454370662|FG002|Overall Study|Lost to Follow-up|0|||
126295565|NCT01836471|454370663|FG003|Overall Study|Lost to Follow-up|1|||
126295566|NCT01836471|454370664|FG004|Overall Study|Lost to Follow-up|1|||
126295567|NCT01836471|454370660|FG000|Overall Study|Adverse Event|6|||
126295568|NCT01836471|454370661|FG001|Overall Study|Adverse Event|3|||
126295569|NCT01836471|454370662|FG002|Overall Study|Adverse Event|1|||
126295570|NCT01836471|454370663|FG003|Overall Study|Adverse Event|1|||
126295571|NCT01836471|454370664|FG004|Overall Study|Adverse Event|2|||
126295572|NCT01836471|454370660|FG000|Overall Study|Non compliance with tx|1|||
126295573|NCT01836471|454370661|FG001|Overall Study|Non compliance with tx|1|||
126295574|NCT01836471|454370662|FG002|Overall Study|Non compliance with tx|0|||
126295575|NCT01836471|454370663|FG003|Overall Study|Non compliance with tx|0|||
126295576|NCT01836471|454370664|FG004|Overall Study|Non compliance with tx|0|||
126295577|NCT03051100|454370666|FG000|Overall Study|Withdrawal by Subject|1|||
126295578|NCT03051100|454370667|FG001|Overall Study|Withdrawal by Subject|0|||
126295579|NCT02059135|454370668|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
126295580|NCT02059135|454370669|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
126295581|NCT02059135|454370668|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
126295582|NCT02059135|454370669|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
126295583|NCT02059135|454370668|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
126295584|NCT02059135|454370669|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
126295585|NCT02059135|454370668|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
126295586|NCT02059135|454370669|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
126295587|NCT02059135|454370668|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
126295588|NCT02059135|454370669|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
126295589|NCT02059135|454370668|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
126295590|NCT02059135|454370669|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
126295591|NCT02059135|454370668|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
126295592|NCT02059135|454370669|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
126295593|NCT02059135|454370668|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
126295594|NCT02059135|454370669|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
126295595|NCT03776357|454370671|FG000|Overall Study|Lost to Follow-up|3|||
126295596|NCT00658723|454370677|FG000|Overall Study|Lost to Follow-up|0|||
126295597|NCT00658723|454370678|FG001|Overall Study|Lost to Follow-up|2|||
126295598|NCT00658723|454370679|FG002|Overall Study|Lost to Follow-up|2|||
126295599|NCT00658723|454370677|FG000|Overall Study|Death|2|||
126295600|NCT00658723|454370678|FG001|Overall Study|Death|1|||
126295601|NCT00658723|454370679|FG002|Overall Study|Death|4|||
126295602|NCT00658723|454370677|FG000|Overall Study|Scheduling Issue|1|||
126295603|NCT00658723|454370678|FG001|Overall Study|Scheduling Issue|1|||
126295604|NCT00658723|454370679|FG002|Overall Study|Scheduling Issue|0|||
126295605|NCT00658723|454370677|FG000|Overall Study|Withdrawal by Subject|1|||
126295606|NCT00658723|454370678|FG001|Overall Study|Withdrawal by Subject|0|||
126295607|NCT00658723|454370679|FG002|Overall Study|Withdrawal by Subject|1|||
126295608|NCT02411656|454370680|FG000|Overall Study|Adverse Event|4|||
126295609|NCT02411656|454370680|FG000|Overall Study|Clinical Progression|33|||
126295610|NCT06481709|454370681|FG000|Overall Study|Withdrawal by Subject|0|||
126295611|NCT06481709|454370682|FG001|Overall Study|Withdrawal by Subject|0|||
126295612|NCT06481709|454370683|FG002|Overall Study|Withdrawal by Subject|2|||
126295613|NCT06481709|454370684|FG003|Overall Study|Withdrawal by Subject|0|||
126295614|NCT05921903|454370685|FG000|Overall Study|Unsolicited non-SAE|0|||
126295615|NCT05921903|454370686|FG001|Overall Study|Unsolicited non-SAE|1|||
126295616|NCT05921903|454370687|FG002|Overall Study|Unsolicited non-SAE|0|||
126295617|NCT05921903|454370685|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
126295618|NCT05921903|454370686|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
126295619|NCT05921903|454370687|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
126295620|NCT05921903|454370685|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
126295621|NCT05921903|454370686|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
126295622|NCT05921903|454370687|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
126295623|NCT03305848|454370688|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
126295624|NCT03305848|454370688|FG000|Overall Study|Physician Decision|2|||
126711098|NCT01318902|455893659|FG003|Overall Study|Adverse Event|0|||
126711099|NCT01318902|455893656|FG000|Overall Study|Terminated by Sponsor|0|||
126295625|NCT00789854|454370691|FG000|Overall Study|Adverse Event|28|||
126295626|NCT00789854|454370692|FG001|Overall Study|Adverse Event|23|||
126295627|NCT00789854|454370693|FG002|Overall Study|Adverse Event|18|||
126295628|NCT00789854|454370691|FG000|Overall Study|Lost to Follow-up|1|||
126711100|NCT01318902|455893657|FG001|Overall Study|Terminated by Sponsor|0|||
126711101|NCT01318902|455893658|FG002|Overall Study|Terminated by Sponsor|1|||
126295629|NCT00789854|454370692|FG001|Overall Study|Lost to Follow-up|1|||
126295630|NCT00789854|454370693|FG002|Overall Study|Lost to Follow-up|4|||
126295631|NCT00789854|454370691|FG000|Overall Study|Withdrawal by Subject|9|||
126711102|NCT01318902|455893659|FG003|Overall Study|Terminated by Sponsor|0|||
126295632|NCT00789854|454370692|FG001|Overall Study|Withdrawal by Subject|6|||
126295633|NCT00789854|454370693|FG002|Overall Study|Withdrawal by Subject|17|||
126295634|NCT00789854|454370691|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
126295635|NCT00789854|454370692|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
126295636|NCT00789854|454370693|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
126295637|NCT00789854|454370691|FG000|Overall Study|Severe non-compliance to the protocol|3|||
126295638|NCT00789854|454370692|FG001|Overall Study|Severe non-compliance to the protocol|0|||
126295639|NCT00789854|454370693|FG002|Overall Study|Severe non-compliance to the protocol|0|||
126295640|NCT00789854|454370691|FG000|Overall Study|Safety reasons|0|||
126295641|NCT00789854|454370692|FG001|Overall Study|Safety reasons|0|||
126295642|NCT00789854|454370693|FG002|Overall Study|Safety reasons|2|||
126550080|NCT01076088|455307721|FG004|Overall Study|Withdrawal by Subject|11|||
126295643|NCT00789854|454370691|FG000|Overall Study|Other|6|||
126295644|NCT00789854|454370692|FG001|Overall Study|Other|0|||
126295645|NCT00789854|454370693|FG002|Overall Study|Other|5|||
126295646|NCT00923013|454370694|FG000|Overall Study|Refused further treatment|0|||
126295647|NCT00923013|454370695|FG001|Overall Study|Refused further treatment|1|||
126295648|NCT00923013|454370696|FG002|Overall Study|Refused further treatment|2|||
126295649|NCT00923013|454370697|FG003|Overall Study|Refused further treatment|0|||
126295650|NCT00923013|454370698|FG004|Overall Study|Refused further treatment|0|||
126295651|NCT00923013|454370699|FG005|Overall Study|Refused further treatment|0|||
126295652|NCT00923013|454370694|FG000|Overall Study|Switched to alternative treatment|0|||
126295653|NCT00923013|454370695|FG001|Overall Study|Switched to alternative treatment|1|||
126295654|NCT00923013|454370696|FG002|Overall Study|Switched to alternative treatment|0|||
126295655|NCT00923013|454370697|FG003|Overall Study|Switched to alternative treatment|0|||
126295656|NCT00923013|454370698|FG004|Overall Study|Switched to alternative treatment|0|||
126295657|NCT00923013|454370699|FG005|Overall Study|Switched to alternative treatment|0|||
126295658|NCT00923013|454370694|FG000|Overall Study|Death on study|2|||
126295659|NCT00923013|454370695|FG001|Overall Study|Death on study|2|||
126295660|NCT00923013|454370696|FG002|Overall Study|Death on study|0|||
126295661|NCT00923013|454370697|FG003|Overall Study|Death on study|1|||
126295662|NCT00923013|454370698|FG004|Overall Study|Death on study|0|||
126295663|NCT00923013|454370699|FG005|Overall Study|Death on study|0|||
126295664|NCT02301169|454370702|FG000|Overall Study|Adverse Event|1|||
126295665|NCT02301169|454370703|FG001|Overall Study|Adverse Event|0|||
126295666|NCT01198470|454370708|FG000|Overall Study|Adverse Event|2|||
126295667|NCT02949973|454370709|FG000|Overall Study|Physician Decision|1|||
126295668|NCT01422213|454370710|FG000|Overall Study|Adverse Event|8|||
126295669|NCT01422213|454370711|FG001|Overall Study|Adverse Event|7|||
126295670|NCT01422213|454370712|FG002|Overall Study|Adverse Event|11|||
126295671|NCT01422213|454370710|FG000|Overall Study|Lack of Efficacy|10|||
126295672|NCT01422213|454370711|FG001|Overall Study|Lack of Efficacy|2|||
126295673|NCT01422213|454370712|FG002|Overall Study|Lack of Efficacy|2|||
126295674|NCT01422213|454370710|FG000|Overall Study|Non-compliance with study drug|0|||
126295675|NCT01422213|454370711|FG001|Overall Study|Non-compliance with study drug|1|||
126295676|NCT01422213|454370712|FG002|Overall Study|Non-compliance with study drug|0|||
126295677|NCT01422213|454370710|FG000|Overall Study|Protocol Violation|0|||
126295678|NCT01422213|454370711|FG001|Overall Study|Protocol Violation|2|||
126295679|NCT01422213|454370712|FG002|Overall Study|Protocol Violation|4|||
126295680|NCT01422213|454370710|FG000|Overall Study|Withdrawal of Consent|7|||
126295681|NCT01422213|454370711|FG001|Overall Study|Withdrawal of Consent|3|||
126295682|NCT01422213|454370712|FG002|Overall Study|Withdrawal of Consent|5|||
126295683|NCT01422213|454370710|FG000|Overall Study|Lost to Follow-up|3|||
126295684|NCT01422213|454370711|FG001|Overall Study|Lost to Follow-up|3|||
126711103|NCT02699515|455895398|FG000|Overall Study|Death|3|||
126711104|NCT02699515|455895399|FG001|Overall Study|Death|3|||
126295685|NCT01422213|454370712|FG002|Overall Study|Lost to Follow-up|5|||
126295686|NCT01422213|454370710|FG000|Overall Study|Administrative or Other Reason(s)|5|||
126295687|NCT01422213|454370711|FG001|Overall Study|Administrative or Other Reason(s)|4|||
126295688|NCT01422213|454370712|FG002|Overall Study|Administrative or Other Reason(s)|2|||
126295689|NCT04129125|454370719|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
126295690|NCT04129125|454370719|FG000|Overall Study|Study device was not used|3|||
126295691|NCT04484142|454370720|FG000|Overall Study|Adverse Event|13|||
126295692|NCT04484142|454370720|FG000|Overall Study|Progressive Disease|87|||
126295693|NCT04484142|454370720|FG000|Overall Study|Clinical Progression|10|||
126295694|NCT04484142|454370720|FG000|Overall Study|Withdrawal by Subject|6|||
126550081|NCT01076088|455307722|FG005|Overall Study|Withdrawal by Subject|17|||
126711105|NCT02699515|455895400|FG002|Overall Study|Death|3|||
126295695|NCT04484142|454370720|FG000|Overall Study|Physician Decision|1|||
126295696|NCT03181633|454370721|FG000|Overall Study|Withdrawal by Subject|1|||
126295697|NCT03181633|454370721|FG000|Overall Study|Missing follow-up visit|1|||
126295698|NCT05303194|454370722|FG000|Overall Study|Lost to Follow-up|1|||
126295699|NCT05303194|454370723|FG001|Overall Study|Lost to Follow-up|1|||
126295700|NCT05303194|454370722|FG000|Overall Study|Withdrawal by Subject|0|||
126295701|NCT05303194|454370723|FG001|Overall Study|Withdrawal by Subject|1|||
126711106|NCT02699515|455895401|FG003|Overall Study|Death|23|||
126711107|NCT02699515|455895402|FG004|Overall Study|Death|22|||
126295702|NCT04837196|454370733|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
126295703|NCT04837196|454370734|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
126295704|NCT04837196|454370735|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
126295705|NCT04837196|454370736|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
126295706|NCT04837196|454370737|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
126295707|NCT04837196|454370733|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
126295708|NCT04837196|454370734|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
126295709|NCT04837196|454370735|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
126295710|NCT04837196|454370736|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
126295711|NCT04837196|454370737|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
126295712|NCT04837196|454370733|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
126295713|NCT04837196|454370734|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
126295714|NCT04837196|454370735|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
126295715|NCT04837196|454370736|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
126295716|NCT04837196|454370737|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
126295717|NCT04837196|454370733|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
126295718|NCT04837196|454370734|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
126295719|NCT04837196|454370735|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
126295720|NCT04837196|454370736|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
126295721|NCT04837196|454370737|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
126295722|NCT04837196|454370733|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
126295723|NCT04837196|454370734|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
126295724|NCT04837196|454370735|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
126295725|NCT04837196|454370736|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
126295726|NCT04837196|454370737|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
126295727|NCT05271175|454370738|FG000|One Week Follow up|Lost to Follow-up|10|||
126295728|NCT05271175|454370739|FG001|One Week Follow up|Lost to Follow-up|7|||
126295729|NCT05271175|454370740|FG002|One Week Follow up|Lost to Follow-up|5|||
126295730|NCT05271175|454370738|FG000|One Month Follow up|Lost to Follow-up|12|||
126767231|NCT03917654|456100272|FG008|Year 1|Withdrawal by Subject|5|||
126767232|NCT03917654|456100273|FG009|Year 1|Withdrawal by Subject|3|||
126295731|NCT05271175|454370739|FG001|One Month Follow up|Lost to Follow-up|7|||
126295732|NCT05271175|454370740|FG002|One Month Follow up|Lost to Follow-up|9|||
126295733|NCT05271175|454370738|FG000|Six Months Follow up|Lost to Follow-up|8|||
126295734|NCT05271175|454370739|FG001|Six Months Follow up|Lost to Follow-up|2|||
126295735|NCT05271175|454370740|FG002|Six Months Follow up|Lost to Follow-up|2|||
126295736|NCT00991887|454370741|FG000|Overall Study|Lost to Follow-up|2|||
126295737|NCT00991887|454370742|FG001|Overall Study|Lost to Follow-up|1|||
126295738|NCT01522456|454370743|FG000|Overall Study|Adverse Event|2|||
126295739|NCT01522456|454370743|FG000|Overall Study|Lost to Follow-up|2|||
126295740|NCT01522456|454370743|FG000|Overall Study|Withdrawal by Subject|2|||
126295741|NCT01522456|454370743|FG000|Overall Study|Pregnancy|1|||
126295742|NCT01522456|454370743|FG000|Overall Study|Tolerability Assessment|1|||
126295743|NCT00740636|454370747|FG000|Overall Study|Adverse Event|0|||
126295744|NCT00740636|454370748|FG001|Overall Study|Adverse Event|2|||
126295745|NCT00740636|454370747|FG000|Overall Study|Patient Ineligible|0|||
126295746|NCT00740636|454370748|FG001|Overall Study|Patient Ineligible|1|||
126295747|NCT00740636|454370747|FG000|Overall Study|Patient Not Treated|0|||
126295748|NCT00740636|454370748|FG001|Overall Study|Patient Not Treated|1|||
126295749|NCT00740636|454370747|FG000|Overall Study|Progressive Disease|1|||
126295750|NCT00740636|454370748|FG001|Overall Study|Progressive Disease|0|||
126295751|NCT00740636|454370747|FG000|Overall Study|Death|1|||
126295752|NCT00740636|454370748|FG001|Overall Study|Death|0|||
126295753|NCT03832686|454370749|FG000|Overall Study|Lost to Follow-up|6|||
126295754|NCT03832686|454370750|FG001|Overall Study|Lost to Follow-up|9|||
126295755|NCT03832686|454370749|FG000|Overall Study|Discontinued Intervention|5|||
126295756|NCT03832686|454370750|FG001|Overall Study|Discontinued Intervention|4|||
126295757|NCT02844543|454372502|FG000|Overall Study|Withdrawal by Subject|4|||
126295758|NCT02844543|454372502|FG000|Overall Study|Did not meet eligibility criteria|1|||
126295759|NCT04710576|454372508|FG000|Overall Study|Participants still in the study|73|||
126295760|NCT04710576|454372509|FG001|Overall Study|Participants still in the study|70|||
126295761|NCT04710576|454372510|FG002|Overall Study|Participants still in the study|60|||
126295762|NCT04710576|454372508|FG000|Overall Study|Death|2|||
126295763|NCT04710576|454372509|FG001|Overall Study|Death|7|||
126366924|NCT01051661|454639364|FG003|Overall Study|Migrated/moved from study area|8|||
126366925|NCT01051661|454639365|FG004|Overall Study|Migrated/moved from study area|7|||
126295764|NCT04710576|454372510|FG002|Overall Study|Death|12|||
126295765|NCT04710576|454372508|FG000|Overall Study|Withdrawal by Subject|4|||
126295766|NCT04710576|454372509|FG001|Overall Study|Withdrawal by Subject|3|||
126295767|NCT04710576|454372510|FG002|Overall Study|Withdrawal by Subject|7|||
126295768|NCT04710576|454372508|FG000|Overall Study|Sponsor decision|1|||
126295769|NCT04710576|454372509|FG001|Overall Study|Sponsor decision|0|||
126295770|NCT04710576|454372510|FG002|Overall Study|Sponsor decision|0|||
126295771|NCT04581824|454372511|FG000|Overall Study|Lost to Follow-up|1|||
126295772|NCT04581824|454372512|FG001|Overall Study|Lost to Follow-up|0|||
126295773|NCT04581824|454372511|FG000|Overall Study|Withdrawal by Subject|2|||
126295774|NCT04581824|454372512|FG001|Overall Study|Withdrawal by Subject|7|||
126295775|NCT04581824|454372511|FG000|Overall Study|Study terminated by sponsor|37|||
126295776|NCT04581824|454372512|FG001|Overall Study|Study terminated by sponsor|23|||
126295777|NCT04796909|454372513|FG000|Overall Study|Withdrawal by Subject|1|||
126295778|NCT04796909|454372514|FG001|Overall Study|Withdrawal by Subject|1|||
126295779|NCT03879135|454372515|FG000|Overall Study|Physician Decision|0|||
126295780|NCT03879135|454372516|FG001|Overall Study|Physician Decision|0|||
126295781|NCT03879135|454372517|FG002|Overall Study|Physician Decision|0|||
126295782|NCT03879135|454372518|FG003|Overall Study|Physician Decision|1|||
126295783|NCT03879135|454372519|FG004|Overall Study|Physician Decision|0|||
126295784|NCT03879135|454372520|FG005|Overall Study|Physician Decision|0|||
126295785|NCT03879135|454372515|FG000|Overall Study|Withdrawal by Subject|0|||
126295786|NCT03879135|454372516|FG001|Overall Study|Withdrawal by Subject|0|||
126295787|NCT03879135|454372517|FG002|Overall Study|Withdrawal by Subject|0|||
126295788|NCT03879135|454372518|FG003|Overall Study|Withdrawal by Subject|0|||
126295789|NCT03879135|454372519|FG004|Overall Study|Withdrawal by Subject|0|||
126295790|NCT03879135|454372520|FG005|Overall Study|Withdrawal by Subject|1|||
126295791|NCT03879135|454372515|FG000|Overall Study|Site Closed by Sponsor|0|||
126295792|NCT03879135|454372516|FG001|Overall Study|Site Closed by Sponsor|0|||
126295793|NCT03879135|454372517|FG002|Overall Study|Site Closed by Sponsor|0|||
126295794|NCT03879135|454372518|FG003|Overall Study|Site Closed by Sponsor|1|||
126295795|NCT03879135|454372519|FG004|Overall Study|Site Closed by Sponsor|1|||
126295796|NCT03879135|454372520|FG005|Overall Study|Site Closed by Sponsor|0|||
126295797|NCT04162847|454372521|FG000|Overall Study|Withdrawal by Subject|7|||
126295798|NCT04162847|454372522|FG001|Overall Study|Withdrawal by Subject|1|||
126295799|NCT00813150|454372527|FG000|Treatment Period|Adverse Event|16|||
126295800|NCT00813150|454372528|FG001|Treatment Period|Adverse Event|15|||
126295801|NCT00813150|454372527|FG000|Treatment Period|Death|2|||
126295802|NCT00813150|454372528|FG001|Treatment Period|Death|0|||
126295803|NCT00813150|454372527|FG000|Treatment Period|Progressive disease|1|||
126295804|NCT00813150|454372528|FG001|Treatment Period|Progressive disease|0|||
126295805|NCT00813150|454372527|FG000|Treatment Period|Complete response|0|||
126295806|NCT00813150|454372528|FG001|Treatment Period|Complete response|1|||
126295807|NCT00813150|454372527|FG000|Treatment Period|Stable disease|1|||
126295808|NCT00813150|454372528|FG001|Treatment Period|Stable disease|2|||
126295809|NCT00813150|454372527|FG000|Treatment Period|Protocol Violation|3|||
126295810|NCT00813150|454372528|FG001|Treatment Period|Protocol Violation|4|||
126295811|NCT00813150|454372527|FG000|Treatment Period|Withdrawal by Subject|5|||
126295812|NCT00813150|454372528|FG001|Treatment Period|Withdrawal by Subject|3|||
126295813|NCT00813150|454372527|FG000|Treatment Period|Non compliance|0|||
126295814|NCT00813150|454372528|FG001|Treatment Period|Non compliance|1|||
126295815|NCT00813150|454372527|FG000|Treatment Period|Reason not specified|3|||
126295816|NCT00813150|454372528|FG001|Treatment Period|Reason not specified|4|||
126295817|NCT00813150|454372527|FG000|Treatment Period|Data not available|1|||
126366926|NCT01051661|454639366|FG005|Overall Study|Migrated/moved from study area|3|||
126366927|NCT01051661|454639361|FG000|Overall Study|Refused blood sampling|0|||
126366928|NCT01051661|454639362|FG001|Overall Study|Refused blood sampling|0|||
126366929|NCT01051661|454639363|FG002|Overall Study|Refused blood sampling|0|||
126295818|NCT00813150|454372528|FG001|Treatment Period|Data not available|2|||
126295819|NCT00813150|454372527|FG000|Long Term Follow-up|Death|0|||
126295820|NCT00813150|454372528|FG001|Long Term Follow-up|Death|4|||
126295821|NCT00813150|454372527|FG000|Long Term Follow-up|Other|0|||
126366930|NCT01051661|454639364|FG003|Overall Study|Refused blood sampling|0|||
126366931|NCT01051661|454639365|FG004|Overall Study|Refused blood sampling|0|||
126366932|NCT01051661|454639366|FG005|Overall Study|Refused blood sampling|1|||
126366933|NCT01051661|454639361|FG000|Overall Study|Data not reliable|1|||
126366934|NCT01051661|454639362|FG001|Overall Study|Data not reliable|0|||
126550082|NCT01076088|455307717|FG000|Overall Study|Other protocol specified criteria|0|||
126711108|NCT02699515|455895403|FG005|Overall Study|Death|23|||
126295822|NCT00813150|454372528|FG001|Long Term Follow-up|Other|3|||
126366935|NCT01051661|454639363|FG002|Overall Study|Data not reliable|0|||
126366936|NCT01051661|454639364|FG003|Overall Study|Data not reliable|0|||
126295823|NCT00813150|454372527|FG000|Long Term Follow-up|Lost to Follow-up|2|||
126366937|NCT01051661|454639365|FG004|Overall Study|Data not reliable|0|||
126550083|NCT01076088|455307718|FG001|Overall Study|Other protocol specified criteria|0|||
126295824|NCT00813150|454372528|FG001|Long Term Follow-up|Lost to Follow-up|0|||
126295825|NCT00813150|454372527|FG000|Long Term Follow-up|Progression/Relapse|22|||
126295826|NCT00813150|454372528|FG001|Long Term Follow-up|Progression/Relapse|24|||
126295827|NCT03593525|454372540|FG000|Overall Study|Withdrawal by Subject|1|||
126366938|NCT01051661|454639366|FG005|Overall Study|Data not reliable|1|||
126366939|NCT01051661|454639361|FG000|Overall Study|Unable to attend visit(s)|2|||
126550084|NCT01076088|455307719|FG002|Overall Study|Other protocol specified criteria|0|||
126295828|NCT03593525|454372541|FG001|Overall Study|Withdrawal by Subject|0|||
126711109|NCT02699515|455895404|FG006|Overall Study|Death|3|||
126295829|NCT03593525|454372540|FG000|Overall Study|Lost to Follow-up|7|||
126767233|NCT03917654|456100274|FG010|Year 1|Withdrawal by Subject|1|||
126767234|NCT03917654|456100275|FG011|Year 1|Withdrawal by Subject|0|||
126767235|NCT03917654|456100264|FG000|Year 1|Travel|0|||
126767236|NCT03917654|456100265|FG001|Year 1|Travel|1|||
126767237|NCT03917654|456100266|FG002|Year 1|Travel|1|||
126767238|NCT03917654|456100267|FG003|Year 1|Travel|0|||
126767239|NCT03917654|456100268|FG004|Year 1|Travel|4|||
126767240|NCT03917654|456100269|FG005|Year 1|Travel|4|||
126767241|NCT03917654|456100270|FG006|Year 1|Travel|10|||
126767242|NCT03917654|456100271|FG007|Year 1|Travel|8|||
126767243|NCT03917654|456100272|FG008|Year 1|Travel|2|||
126295830|NCT03593525|454372541|FG001|Overall Study|Lost to Follow-up|5|||
126295831|NCT03103087|454372542|FG000|Overall Study|Did not receive any study drug|1|||
126767244|NCT03917654|456100273|FG009|Year 1|Travel|5|||
126767245|NCT03917654|456100274|FG010|Year 1|Travel|3|||
126767246|NCT03917654|456100275|FG011|Year 1|Travel|3|||
126767247|NCT03917654|456100264|FG000|Year 1|Subject moved away from site|0|||
126767248|NCT03917654|456100265|FG001|Year 1|Subject moved away from site|1|||
126295832|NCT03103087|454372543|FG001|Overall Study|Did not receive any study drug|0|||
126295833|NCT03103087|454372544|FG002|Overall Study|Did not receive any study drug|0|||
126295834|NCT03103087|454372542|FG000|Overall Study|Protocol Violation|1|||
126295835|NCT03103087|454372543|FG001|Overall Study|Protocol Violation|2|||
126295836|NCT03103087|454372544|FG002|Overall Study|Protocol Violation|1|||
126295837|NCT03103087|454372542|FG000|Overall Study|Lack of Efficacy|2|||
126295838|NCT03103087|454372543|FG001|Overall Study|Lack of Efficacy|1|||
126295839|NCT03103087|454372544|FG002|Overall Study|Lack of Efficacy|1|||
126295840|NCT03103087|454372542|FG000|Overall Study|Pregnancy|0|||
126767249|NCT03917654|456100266|FG002|Year 1|Subject moved away from site|0|||
126767250|NCT03917654|456100267|FG003|Year 1|Subject moved away from site|0|||
126767251|NCT03917654|456100268|FG004|Year 1|Subject moved away from site|0|||
126767252|NCT03917654|456100269|FG005|Year 1|Subject moved away from site|0|||
126767253|NCT03917654|456100270|FG006|Year 1|Subject moved away from site|1|||
126767254|NCT03917654|456100271|FG007|Year 1|Subject moved away from site|2|||
126767255|NCT03917654|456100272|FG008|Year 1|Subject moved away from site|1|||
126767256|NCT03917654|456100273|FG009|Year 1|Subject moved away from site|0|||
126767257|NCT03917654|456100274|FG010|Year 1|Subject moved away from site|0|||
126767258|NCT03917654|456100275|FG011|Year 1|Subject moved away from site|3|||
126767259|NCT03917654|456100264|FG000|Year 1|Spouse/Family member request|0|||
126767260|NCT03917654|456100265|FG001|Year 1|Spouse/Family member request|0|||
126767261|NCT03917654|456100266|FG002|Year 1|Spouse/Family member request|1|||
126767262|NCT03917654|456100267|FG003|Year 1|Spouse/Family member request|0|||
126767263|NCT03917654|456100268|FG004|Year 1|Spouse/Family member request|1|||
126767264|NCT03917654|456100269|FG005|Year 1|Spouse/Family member request|0|||
126767265|NCT03917654|456100270|FG006|Year 1|Spouse/Family member request|0|||
126767266|NCT03917654|456100271|FG007|Year 1|Spouse/Family member request|2|||
126295841|NCT03103087|454372543|FG001|Overall Study|Pregnancy|0|||
126295842|NCT03103087|454372544|FG002|Overall Study|Pregnancy|1|||
126295843|NCT03103087|454372542|FG000|Overall Study|Adverse Event|2|||
126295844|NCT03103087|454372543|FG001|Overall Study|Adverse Event|15|||
126295845|NCT03103087|454372544|FG002|Overall Study|Adverse Event|6|||
126295846|NCT03103087|454372542|FG000|Overall Study|Withdrawal by Subject|13|||
126295847|NCT03103087|454372543|FG001|Overall Study|Withdrawal by Subject|6|||
126295848|NCT03103087|454372544|FG002|Overall Study|Withdrawal by Subject|6|||
126295849|NCT03103087|454372542|FG000|Overall Study|Lost to Follow-up|4|||
126295850|NCT03103087|454372543|FG001|Overall Study|Lost to Follow-up|2|||
126295851|NCT03103087|454372544|FG002|Overall Study|Lost to Follow-up|7|||
126295852|NCT03103087|454372542|FG000|Overall Study|Other reason not reported|1|||
126767267|NCT03917654|456100272|FG008|Year 1|Spouse/Family member request|0|||
126767268|NCT03917654|456100273|FG009|Year 1|Spouse/Family member request|0|||
126767269|NCT03917654|456100274|FG010|Year 1|Spouse/Family member request|0|||
126767270|NCT03917654|456100275|FG011|Year 1|Spouse/Family member request|1|||
126767271|NCT03917654|456100264|FG000|Year 1|Death|0|||
126767272|NCT03917654|456100265|FG001|Year 1|Death|0|||
126767273|NCT03917654|456100266|FG002|Year 1|Death|0|||
126295853|NCT03103087|454372543|FG001|Overall Study|Other reason not reported|3|||
126295854|NCT03103087|454372544|FG002|Overall Study|Other reason not reported|5|||
126295855|NCT00075816|454372545|FG000|Overall Study|Did not undergo transplantation|14|||
126767274|NCT03917654|456100267|FG003|Year 1|Death|0|||
126767275|NCT03917654|456100268|FG004|Year 1|Death|0|||
126767276|NCT03917654|456100269|FG005|Year 1|Death|0|||
126767277|NCT03917654|456100270|FG006|Year 1|Death|0|||
126767278|NCT03917654|456100271|FG007|Year 1|Death|0|||
126767279|NCT03917654|456100272|FG008|Year 1|Death|1|||
126767280|NCT03917654|456100273|FG009|Year 1|Death|1|||
126295856|NCT00075816|454372546|FG001|Overall Study|Did not undergo transplantation|11|||
126295857|NCT00471822|454372547|FG000|Overall Study|Protocol Violation|2|||
126767281|NCT03917654|456100274|FG010|Year 1|Death|0|||
126767282|NCT03917654|456100275|FG011|Year 1|Death|0|||
126767283|NCT03917654|456100264|FG000|Year 1|Lost to Follow-up|0|||
126767284|NCT03917654|456100265|FG001|Year 1|Lost to Follow-up|0|||
126767285|NCT03917654|456100266|FG002|Year 1|Lost to Follow-up|0|||
126295858|NCT02549859|454372548|FG000|Long-term 60 Hz DBS|Study Closed|1|||
126295859|NCT03664232|454372550|FG000|Overall Study|Withdrawal by Subject|0|||
126295860|NCT03664232|454372551|FG001|Overall Study|Withdrawal by Subject|1|||
126295861|NCT03664232|454372552|FG002|Overall Study|Withdrawal by Subject|0|||
126295862|NCT03664232|454372553|FG003|Overall Study|Withdrawal by Subject|1|||
126295863|NCT03664232|454372550|FG000|Overall Study|Adverse Event|0|||
126295864|NCT03664232|454372551|FG001|Overall Study|Adverse Event|0|||
126295865|NCT03664232|454372552|FG002|Overall Study|Adverse Event|1|||
126295866|NCT03664232|454372553|FG003|Overall Study|Adverse Event|0|||
126295867|NCT03664232|454372550|FG000|Overall Study|Other-Non-compliance with study drug|0|||
126295868|NCT03664232|454372551|FG001|Overall Study|Other-Non-compliance with study drug|1|||
126295869|NCT03664232|454372552|FG002|Overall Study|Other-Non-compliance with study drug|0|||
126295870|NCT03664232|454372553|FG003|Overall Study|Other-Non-compliance with study drug|2|||
126295871|NCT03664232|454372550|FG000|Overall Study|Other-Unspecified|0|||
126295872|NCT03664232|454372551|FG001|Overall Study|Other-Unspecified|3|||
126295873|NCT03664232|454372552|FG002|Overall Study|Other-Unspecified|0|||
126295874|NCT03664232|454372553|FG003|Overall Study|Other-Unspecified|1|||
126295875|NCT03664232|454372550|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
126295876|NCT03664232|454372551|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
126295877|NCT03664232|454372552|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
126295878|NCT03664232|454372553|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
126295879|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
126295880|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
126295881|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
126295882|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
126295883|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
126295884|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295885|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295886|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295887|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295888|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295889|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295890|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295891|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295892|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295893|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
126295894|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
126295895|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
126295896|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
126295897|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
126295898|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
126295899|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295900|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295901|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295902|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295903|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295904|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295905|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295906|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126366940|NCT01051661|454639362|FG001|Overall Study|Unable to attend visit(s)|4|||
126366941|NCT01051661|454639363|FG002|Overall Study|Unable to attend visit(s)|2|||
126366942|NCT01051661|454639364|FG003|Overall Study|Unable to attend visit(s)|1|||
126366943|NCT01051661|454639365|FG004|Overall Study|Unable to attend visit(s)|3|||
126711110|NCT02699515|455895405|FG007|Overall Study|Death|5|||
126711111|NCT02699515|455895398|FG000|Overall Study|Withdrawal by Subject|0|||
126711112|NCT02699515|455895399|FG001|Overall Study|Withdrawal by Subject|0|||
126366944|NCT01051661|454639366|FG005|Overall Study|Unable to attend visit(s)|2|||
126366945|NCT01051661|454639361|FG000|Overall Study|Consent not received from both parents|0|||
126711113|NCT02699515|455895400|FG002|Overall Study|Withdrawal by Subject|3|||
126711114|NCT02699515|455895401|FG003|Overall Study|Withdrawal by Subject|1|||
126295907|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295908|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
126295909|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
126295910|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
126295911|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
126295912|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
126295913|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
126295914|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295915|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295916|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295917|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295918|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295919|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295920|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295921|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295922|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295923|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
126295924|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
126295925|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
126295926|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
126295927|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
126295928|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
126295929|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295930|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295931|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295932|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295933|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295934|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295935|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295936|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295937|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295938|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
126295939|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
126295940|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295941|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
126295942|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
126295943|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
126295944|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295945|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295946|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295947|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295948|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295949|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295950|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295951|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295952|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295953|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
126295954|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295955|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295956|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295957|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
126295958|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295959|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295960|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295961|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295962|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295963|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295964|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295965|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295966|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295967|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
126366946|NCT01051661|454639362|FG001|Overall Study|Consent not received from both parents|0|||
126366947|NCT01051661|454639363|FG002|Overall Study|Consent not received from both parents|0|||
126366948|NCT01051661|454639364|FG003|Overall Study|Consent not received from both parents|0|||
126550085|NCT01076088|455307720|FG003|Overall Study|Other protocol specified criteria|0|||
126767286|NCT03917654|456100267|FG003|Year 1|Lost to Follow-up|0|||
126295968|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
126295969|NCT03334435|454372554|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295970|NCT03334435|454372555|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
126295971|NCT03334435|454372556|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
126295972|NCT03334435|454372557|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
126295973|NCT03334435|454372558|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
126295974|NCT03334435|454372559|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295975|NCT03334435|454372560|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295976|NCT03334435|454372561|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295977|NCT03334435|454372562|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295978|NCT03334435|454372563|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295979|NCT03334435|454372564|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295980|NCT03334435|454372565|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295981|NCT03334435|454372566|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295982|NCT03334435|454372567|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295983|NCT03334435|454372568|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
126295984|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
126295985|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
126295986|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
126295987|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
126295988|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
126295989|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
126295990|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
126295991|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
126295992|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
126295993|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
126295994|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
126295995|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
126295996|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
126295997|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
126295998|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
126295999|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
126296000|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
126296001|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
126296002|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
126296003|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
126296004|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
126296005|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
126296006|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
126296007|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
126296008|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
126296009|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
126296010|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
126296011|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
126296012|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
126296013|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
126296014|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
126296015|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
126296016|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
126296017|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
126296018|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
126296019|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
126296020|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
126296021|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
126296022|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
126296023|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
126296024|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
126296025|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
126711115|NCT02699515|455895402|FG004|Overall Study|Withdrawal by Subject|5|||
126711116|NCT02699515|455895403|FG005|Overall Study|Withdrawal by Subject|3|||
126711117|NCT02699515|455895404|FG006|Overall Study|Withdrawal by Subject|0|||
126711118|NCT02699515|455895405|FG007|Overall Study|Withdrawal by Subject|1|||
126711119|NCT02699515|455895398|FG000|Overall Study|Other|1|||
126711120|NCT02699515|455895399|FG001|Overall Study|Other|0|||
126711121|NCT02699515|455895400|FG002|Overall Study|Other|1|||
126296026|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
126296027|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
126296028|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
126296029|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
126296030|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
126296031|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
126296032|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
126296033|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
126296034|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
126296035|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
126296036|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
126767287|NCT03917654|456100268|FG004|Year 1|Lost to Follow-up|0|||
126767288|NCT03917654|456100269|FG005|Year 1|Lost to Follow-up|0|||
126767289|NCT03917654|456100270|FG006|Year 1|Lost to Follow-up|2|||
126767290|NCT03917654|456100271|FG007|Year 1|Lost to Follow-up|0|||
126767291|NCT03917654|456100272|FG008|Year 1|Lost to Follow-up|0|||
126767292|NCT03917654|456100273|FG009|Year 1|Lost to Follow-up|0|||
126296037|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
126296038|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
126296039|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
126296040|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
126296041|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
126296042|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
126296043|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
126296044|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126296045|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126296046|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126767293|NCT03917654|456100274|FG010|Year 1|Lost to Follow-up|0|||
126767294|NCT03917654|456100275|FG011|Year 1|Lost to Follow-up|0|||
126767295|NCT03917654|456100264|FG000|Year 1|Missed visits|0|||
126767296|NCT03917654|456100265|FG001|Year 1|Missed visits|0|||
126767297|NCT03917654|456100266|FG002|Year 1|Missed visits|0|||
126767298|NCT03917654|456100267|FG003|Year 1|Missed visits|0|||
126767299|NCT03917654|456100268|FG004|Year 1|Missed visits|0|||
126767300|NCT03917654|456100269|FG005|Year 1|Missed visits|0|||
126767301|NCT03917654|456100270|FG006|Year 1|Missed visits|0|||
126767302|NCT03917654|456100271|FG007|Year 1|Missed visits|0|||
126767303|NCT03917654|456100272|FG008|Year 1|Missed visits|0|||
126767304|NCT03917654|456100273|FG009|Year 1|Missed visits|0|||
126767305|NCT03917654|456100274|FG010|Year 1|Missed visits|1|||
126767306|NCT03917654|456100275|FG011|Year 1|Missed visits|1|||
126767307|NCT03917654|456100264|FG000|Year 1|Pregnancy|0|||
126767308|NCT03917654|456100265|FG001|Year 1|Pregnancy|0|||
126767309|NCT03917654|456100266|FG002|Year 1|Pregnancy|0|||
126767310|NCT03917654|456100267|FG003|Year 1|Pregnancy|0|||
126767311|NCT03917654|456100268|FG004|Year 1|Pregnancy|0|||
126767312|NCT03917654|456100269|FG005|Year 1|Pregnancy|0|||
126767313|NCT03917654|456100270|FG006|Year 1|Pregnancy|0|||
126767314|NCT03917654|456100271|FG007|Year 1|Pregnancy|1|||
126767315|NCT03917654|456100272|FG008|Year 1|Pregnancy|0|||
126767316|NCT03917654|456100273|FG009|Year 1|Pregnancy|1|||
126767317|NCT03917654|456100274|FG010|Year 1|Pregnancy|0|||
126767318|NCT03917654|456100275|FG011|Year 1|Pregnancy|0|||
126767319|NCT03917654|456100264|FG000|Year 2|Travel|1|||
126767320|NCT03917654|456100265|FG001|Year 2|Travel|0|||
126767321|NCT03917654|456100266|FG002|Year 2|Travel|0|||
126767322|NCT03917654|456100267|FG003|Year 2|Travel|0|||
126767323|NCT03917654|456100268|FG004|Year 2|Travel|1|||
126767324|NCT03917654|456100269|FG005|Year 2|Travel|1|||
126767325|NCT03917654|456100270|FG006|Year 2|Travel|2|||
126767326|NCT03917654|456100271|FG007|Year 2|Travel|1|||
126767327|NCT03917654|456100272|FG008|Year 2|Travel|0|||
126767328|NCT03917654|456100273|FG009|Year 2|Travel|1|||
126767329|NCT03917654|456100274|FG010|Year 2|Travel|0|||
126767330|NCT03917654|456100275|FG011|Year 2|Travel|1|||
126767331|NCT03917654|456100264|FG000|Year 2|Married|1|||
126767332|NCT03917654|456100265|FG001|Year 2|Married|0|||
126767333|NCT03917654|456100266|FG002|Year 2|Married|0|||
126767334|NCT03917654|456100267|FG003|Year 2|Married|0|||
126767335|NCT03917654|456100268|FG004|Year 2|Married|0|||
126767336|NCT03917654|456100269|FG005|Year 2|Married|0|||
126767337|NCT03917654|456100270|FG006|Year 2|Married|1|||
126767338|NCT03917654|456100271|FG007|Year 2|Married|1|||
126767339|NCT03917654|456100272|FG008|Year 2|Married|0|||
126767340|NCT03917654|456100273|FG009|Year 2|Married|0|||
126767341|NCT03917654|456100274|FG010|Year 2|Married|0|||
126767342|NCT03917654|456100275|FG011|Year 2|Married|0|||
126767343|NCT03917654|456100264|FG000|Year 2|Subject moved away from site|1|||
126767344|NCT03917654|456100265|FG001|Year 2|Subject moved away from site|0|||
126767345|NCT03917654|456100266|FG002|Year 2|Subject moved away from site|0|||
126767346|NCT03917654|456100267|FG003|Year 2|Subject moved away from site|0|||
126767347|NCT03917654|456100268|FG004|Year 2|Subject moved away from site|1|||
126767348|NCT03917654|456100269|FG005|Year 2|Subject moved away from site|0|||
126296047|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126296048|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126296049|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126296050|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
126296051|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
126296052|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
126296053|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
126296054|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
126296055|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
126296056|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
126296057|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
126296058|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
126296059|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296060|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296061|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296062|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296063|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296064|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296065|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296066|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296067|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296068|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296069|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296070|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
126296071|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296072|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
126296073|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
126296074|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296075|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296076|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296077|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
126711122|NCT02699515|455895401|FG003|Overall Study|Other|6|||
126711123|NCT02699515|455895402|FG004|Overall Study|Other|4|||
126711124|NCT02699515|455895403|FG005|Overall Study|Other|3|||
126711125|NCT02699515|455895404|FG006|Overall Study|Other|0|||
126711126|NCT02699515|455895405|FG007|Overall Study|Other|0|||
126711127|NCT00375934|455895408|FG000|Overall Study|Adverse Event|1|||
126711128|NCT00375934|455895409|FG001|Overall Study|Adverse Event|1|||
126711129|NCT00375934|455895408|FG000|Overall Study|Withdrawal by Subject|2|||
126711130|NCT00375934|455895409|FG001|Overall Study|Withdrawal by Subject|2|||
126711131|NCT00375934|455895408|FG000|Overall Study|Lack of Efficacy|0|||
126711132|NCT00375934|455895409|FG001|Overall Study|Lack of Efficacy|2|||
126711133|NCT00375934|455895408|FG000|Overall Study|Physician Decision|0|||
126711134|NCT00375934|455895409|FG001|Overall Study|Physician Decision|1|||
126711135|NCT03270085|455895410|FG000|Overall Study|Withdrawal by Subject|1|||
126711136|NCT03270085|455895411|FG001|Overall Study|Withdrawal by Subject|0|||
126711137|NCT02400346|455895412|FG000|Overall Study|Adverse Event|24|||
126711138|NCT02400346|455895412|FG000|Overall Study|Lack of Efficacy|9|||
126711139|NCT02400346|455895412|FG000|Overall Study|Non-compliance with IMP|1|||
126711140|NCT02400346|455895412|FG000|Overall Study|Withdrawal by Subject|7|||
126711141|NCT02400346|455895412|FG000|Overall Study|Administrative or other reason(s)|2|||
126711142|NCT02400346|455895412|FG000|Overall Study|Lost to Follow-up|1|||
126711143|NCT01269125|455895413|FG000|Overall Study|Adverse Event|3|||
126711144|NCT01269125|455895414|FG001|Overall Study|Adverse Event|5|||
126711145|NCT01269125|455895415|FG002|Overall Study|Adverse Event|0|||
126711146|NCT01269125|455895413|FG000|Overall Study|Lost to Follow-up|4|||
126711147|NCT01269125|455895414|FG001|Overall Study|Lost to Follow-up|0|||
126711148|NCT01269125|455895415|FG002|Overall Study|Lost to Follow-up|0|||
126711149|NCT01283581|455895418|FG000|Overall Study|Lost to Follow-up|8|||
126711150|NCT01283581|455895419|FG001|Overall Study|Lost to Follow-up|6|||
126711151|NCT01283581|455895420|FG002|Overall Study|Lost to Follow-up|8|||
126711152|NCT01283581|455895418|FG000|Overall Study|Withdrawal by Subject|2|||
126711153|NCT01283581|455895419|FG001|Overall Study|Withdrawal by Subject|5|||
126711154|NCT01283581|455895420|FG002|Overall Study|Withdrawal by Subject|2|||
126711155|NCT01283581|455895418|FG000|Overall Study|Adverse Event|1|||
126711156|NCT01283581|455895419|FG001|Overall Study|Adverse Event|1|||
126711157|NCT01283581|455895420|FG002|Overall Study|Adverse Event|4|||
126711158|NCT01283581|455895418|FG000|Overall Study|Physician Decision|0|||
126711159|NCT01283581|455895419|FG001|Overall Study|Physician Decision|1|||
126711160|NCT01283581|455895420|FG002|Overall Study|Physician Decision|2|||
126296078|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296079|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
126296080|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296081|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296082|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296083|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296084|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296085|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296086|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296087|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
126296088|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
126296089|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126460822|NCT01609478|454987895|FG001|Overall Study|Withdrawal by Subject|0|||
126711161|NCT01283581|455895418|FG000|Overall Study|Protocol Violation|0|||
126711162|NCT01283581|455895419|FG001|Overall Study|Protocol Violation|1|||
126711163|NCT01283581|455895420|FG002|Overall Study|Protocol Violation|2|||
126711164|NCT01283581|455895418|FG000|Overall Study|Noncompliance|1|||
126711165|NCT01283581|455895419|FG001|Overall Study|Noncompliance|0|||
126711166|NCT01283581|455895420|FG002|Overall Study|Noncompliance|0|||
126711167|NCT01283581|455895418|FG000|Overall Study|Investigator unblinded|0|||
126711168|NCT01283581|455895419|FG001|Overall Study|Investigator unblinded|0|||
126711169|NCT01283581|455895420|FG002|Overall Study|Investigator unblinded|1|||
126711170|NCT01283581|455895418|FG000|Overall Study|"Early termination"|0|||
126711171|NCT01283581|455895419|FG001|Overall Study|"Early termination"|0|||
126711172|NCT01283581|455895420|FG002|Overall Study|"Early termination"|1|||
126711173|NCT00486226|455895421|FG000|Overall Study|Death|3|||
126711174|NCT00486226|455895421|FG000|Overall Study|Adverse Event|1|||
126711175|NCT00486226|455895421|FG000|Overall Study|Withdrawal by Subject|1|||
126711176|NCT00486226|455895421|FG000|Overall Study|Lost to Follow-up|8|||
126711177|NCT01259492|455895422|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
126711178|NCT01259492|455895423|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
126711179|NCT01259492|455895424|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
126711180|NCT01259492|455895425|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
126711181|NCT01259492|455895422|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
126711182|NCT01259492|455895423|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
126711183|NCT01259492|455895424|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
126711184|NCT01259492|455895425|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
126711185|NCT01259492|455895422|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
126711186|NCT01259492|455895423|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
126711187|NCT01259492|455895424|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
126711188|NCT01259492|455895425|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
126711189|NCT01259492|455895422|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
126711190|NCT01259492|455895423|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
126711191|NCT01259492|455895424|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
126711192|NCT01259492|455895425|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
126711193|NCT01259492|455895422|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
126711194|NCT01259492|455895423|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
126711195|NCT01259492|455895424|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
126711196|NCT01259492|455895425|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
126711197|NCT01259492|455895422|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
126711198|NCT01259492|455895423|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
126711199|NCT01259492|455895424|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
126711200|NCT01259492|455895425|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
126711201|NCT01259492|455895422|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
126711202|NCT01259492|455895423|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
126711203|NCT01259492|455895424|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
126711204|NCT01259492|455895425|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
126711205|NCT01259492|455895422|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
126711206|NCT01259492|455895423|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
126711207|NCT01259492|455895424|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
126767349|NCT03917654|456100270|FG006|Year 2|Subject moved away from site|2|||
126711208|NCT01259492|455895425|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
126711209|NCT01259492|455895422|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
126711210|NCT01259492|455895423|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
126711211|NCT01259492|455895424|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
126711212|NCT01259492|455895425|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
126711213|NCT01259492|455895422|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
126711214|NCT01259492|455895423|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
126711215|NCT01259492|455895424|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
126711216|NCT01259492|455895425|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
126711217|NCT01259492|455895422|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
126296090|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126460823|NCT01609478|454987896|FG002|Overall Study|Withdrawal by Subject|2|||
126296091|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126296092|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126296093|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126296094|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
126296095|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
126296096|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
126296097|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
126296098|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
126296099|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
126296100|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
126296101|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126296102|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126767350|NCT03917654|456100271|FG007|Year 2|Subject moved away from site|3|||
126767351|NCT03917654|456100272|FG008|Year 2|Subject moved away from site|0|||
126767352|NCT03917654|456100273|FG009|Year 2|Subject moved away from site|2|||
126767353|NCT03917654|456100274|FG010|Year 2|Subject moved away from site|0|||
126767354|NCT03917654|456100275|FG011|Year 2|Subject moved away from site|1|||
126767355|NCT03917654|456100264|FG000|Year 2|Year 2 Screening failure|0|||
126767356|NCT03917654|456100265|FG001|Year 2|Year 2 Screening failure|1|||
126767357|NCT03917654|456100266|FG002|Year 2|Year 2 Screening failure|0|||
126767358|NCT03917654|456100267|FG003|Year 2|Year 2 Screening failure|0|||
126767359|NCT03917654|456100268|FG004|Year 2|Year 2 Screening failure|2|||
126767360|NCT03917654|456100269|FG005|Year 2|Year 2 Screening failure|0|||
126767361|NCT03917654|456100270|FG006|Year 2|Year 2 Screening failure|4|||
126767362|NCT03917654|456100271|FG007|Year 2|Year 2 Screening failure|3|||
126767363|NCT03917654|456100272|FG008|Year 2|Year 2 Screening failure|10|||
126767364|NCT03917654|456100273|FG009|Year 2|Year 2 Screening failure|2|||
126767365|NCT03917654|456100274|FG010|Year 2|Year 2 Screening failure|1|||
126767366|NCT03917654|456100275|FG011|Year 2|Year 2 Screening failure|1|||
126767367|NCT03917654|456100264|FG000|Year 2|Death|0|||
126767368|NCT03917654|456100265|FG001|Year 2|Death|0|||
126767369|NCT03917654|456100266|FG002|Year 2|Death|0|||
126767370|NCT03917654|456100267|FG003|Year 2|Death|0|||
126767371|NCT03917654|456100268|FG004|Year 2|Death|0|||
126767372|NCT03917654|456100269|FG005|Year 2|Death|1|||
126767373|NCT03917654|456100270|FG006|Year 2|Death|0|||
126767374|NCT03917654|456100271|FG007|Year 2|Death|0|||
126767375|NCT03917654|456100272|FG008|Year 2|Death|1|||
126767376|NCT03917654|456100273|FG009|Year 2|Death|1|||
126767377|NCT03917654|456100274|FG010|Year 2|Death|0|||
126767378|NCT03917654|456100275|FG011|Year 2|Death|0|||
126767379|NCT03917654|456100264|FG000|Year 2|Withdrawal by Subject|0|||
126767380|NCT03917654|456100265|FG001|Year 2|Withdrawal by Subject|0|||
126767381|NCT03917654|456100266|FG002|Year 2|Withdrawal by Subject|0|||
126767382|NCT03917654|456100267|FG003|Year 2|Withdrawal by Subject|0|||
126767383|NCT03917654|456100268|FG004|Year 2|Withdrawal by Subject|0|||
126767384|NCT03917654|456100269|FG005|Year 2|Withdrawal by Subject|0|||
126767385|NCT03917654|456100270|FG006|Year 2|Withdrawal by Subject|3|||
126767386|NCT03917654|456100271|FG007|Year 2|Withdrawal by Subject|0|||
126767387|NCT03917654|456100272|FG008|Year 2|Withdrawal by Subject|2|||
126767388|NCT03917654|456100273|FG009|Year 2|Withdrawal by Subject|5|||
126767389|NCT03917654|456100274|FG010|Year 2|Withdrawal by Subject|0|||
126767390|NCT03917654|456100275|FG011|Year 2|Withdrawal by Subject|0|||
126767391|NCT03917654|456100264|FG000|Year 2|Spouse/family member request|0|||
126767392|NCT03917654|456100265|FG001|Year 2|Spouse/family member request|0|||
126366949|NCT01051661|454639365|FG004|Overall Study|Consent not received from both parents|0|||
126767393|NCT03917654|456100266|FG002|Year 2|Spouse/family member request|0|||
126767394|NCT03917654|456100267|FG003|Year 2|Spouse/family member request|0|||
126767395|NCT03917654|456100268|FG004|Year 2|Spouse/family member request|0|||
126767396|NCT03917654|456100269|FG005|Year 2|Spouse/family member request|0|||
126296103|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
126296104|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296105|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126366950|NCT01051661|454639366|FG005|Overall Study|Consent not received from both parents|1|||
126366951|NCT01051661|454639361|FG000|Overall Study|Failure to comply with protocol|0|||
126460824|NCT00768469|454987898|FG000|Overall Study|Adverse Event|0|||
126767397|NCT03917654|456100270|FG006|Year 2|Spouse/family member request|1|||
126767398|NCT03917654|456100271|FG007|Year 2|Spouse/family member request|0|||
126767399|NCT03917654|456100272|FG008|Year 2|Spouse/family member request|0|||
126767400|NCT03917654|456100273|FG009|Year 2|Spouse/family member request|0|||
126767401|NCT03917654|456100274|FG010|Year 2|Spouse/family member request|0|||
126767402|NCT03917654|456100275|FG011|Year 2|Spouse/family member request|0|||
126767403|NCT03917654|456100264|FG000|Year 2|Lost to Follow-up|0|||
126767404|NCT03917654|456100265|FG001|Year 2|Lost to Follow-up|0|||
126767405|NCT03917654|456100266|FG002|Year 2|Lost to Follow-up|0|||
126767406|NCT03917654|456100267|FG003|Year 2|Lost to Follow-up|0|||
126767407|NCT03917654|456100268|FG004|Year 2|Lost to Follow-up|0|||
126296106|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296107|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296108|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296109|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
126296110|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
126296111|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296112|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296113|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296114|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
126296115|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
126296116|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
126296117|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
126296118|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
126296119|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296120|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296121|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296122|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296123|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296124|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
126296125|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296126|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296127|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296128|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296129|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
126296130|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296131|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296132|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
126296133|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
126296134|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296135|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296136|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296137|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296138|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296139|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296140|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296141|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
126296142|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
126296143|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296144|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
126296145|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
126296146|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
126296147|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296148|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
126296149|NCT03334435|454372554|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296150|NCT03334435|454372555|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126366952|NCT01051661|454639362|FG001|Overall Study|Failure to comply with protocol|0|||
126366953|NCT01051661|454639363|FG002|Overall Study|Failure to comply with protocol|2|||
126711218|NCT01259492|455895423|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
126711219|NCT01259492|455895424|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
126711220|NCT01259492|455895425|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
126767408|NCT03917654|456100269|FG005|Year 2|Lost to Follow-up|0|||
126767409|NCT03917654|456100270|FG006|Year 2|Lost to Follow-up|1|||
126711221|NCT01259492|455895422|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
126711222|NCT01259492|455895423|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
126711223|NCT01259492|455895424|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
126711224|NCT01259492|455895425|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
126711225|NCT01259492|455895422|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
126711226|NCT01259492|455895423|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
126711227|NCT01259492|455895424|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
126711228|NCT01259492|455895425|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
126711229|NCT01259492|455895422|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
126711230|NCT01259492|455895423|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
126711231|NCT01259492|455895424|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
126767410|NCT03917654|456100271|FG007|Year 2|Lost to Follow-up|0|||
126296151|NCT03334435|454372556|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296152|NCT03334435|454372557|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296153|NCT03334435|454372558|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296154|NCT03334435|454372559|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296155|NCT03334435|454372560|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296156|NCT03334435|454372561|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296157|NCT03334435|454372562|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296158|NCT03334435|454372563|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296159|NCT03334435|454372564|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126296160|NCT03334435|454372565|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
126296161|NCT03334435|454372566|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
126767411|NCT03917654|456100272|FG008|Year 2|Lost to Follow-up|1|||
126767412|NCT03917654|456100273|FG009|Year 2|Lost to Follow-up|0|||
126767413|NCT03917654|456100274|FG010|Year 2|Lost to Follow-up|0|||
126767414|NCT03917654|456100275|FG011|Year 2|Lost to Follow-up|1|||
126767415|NCT03917654|456100264|FG000|Year 2|Adverse Event|0|||
126767416|NCT03917654|456100265|FG001|Year 2|Adverse Event|0|||
126767417|NCT03917654|456100266|FG002|Year 2|Adverse Event|0|||
126767418|NCT03917654|456100267|FG003|Year 2|Adverse Event|0|||
126767419|NCT03917654|456100268|FG004|Year 2|Adverse Event|0|||
126767420|NCT03917654|456100269|FG005|Year 2|Adverse Event|0|||
126767421|NCT03917654|456100270|FG006|Year 2|Adverse Event|0|||
126767422|NCT03917654|456100271|FG007|Year 2|Adverse Event|0|||
126767423|NCT03917654|456100272|FG008|Year 2|Adverse Event|0|||
126767424|NCT03917654|456100273|FG009|Year 2|Adverse Event|1|||
126767425|NCT03917654|456100274|FG010|Year 2|Adverse Event|0|||
126767426|NCT03917654|456100275|FG011|Year 2|Adverse Event|0|||
126767427|NCT03128931|456100277|FG000|Overall Study|Physician Decision|1|||
126767428|NCT03128931|456100277|FG000|Overall Study|Equipment Issues|3|||
126767429|NCT01329562|456100278|FG000|Overall Study|Protocol Violation|5|||
126767430|NCT01329562|456100279|FG001|Overall Study|Protocol Violation|3|||
126767431|NCT01329562|456100278|FG000|Overall Study|Lost to Follow-up|1|||
126767432|NCT01329562|456100279|FG001|Overall Study|Lost to Follow-up|1|||
126767433|NCT01329562|456100278|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
126767434|NCT01329562|456100279|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
126767435|NCT01329562|456100278|FG000|Overall Study|Physician Decision|0|||
126767436|NCT01329562|456100279|FG001|Overall Study|Physician Decision|1|||
126767437|NCT00061568|456100280|FG000|Overall Study|Lost to Follow-up|12|||
126767438|NCT00061568|456100281|FG001|Overall Study|Lost to Follow-up|0|||
126767439|NCT00061568|456100280|FG000|Overall Study|Death|6|||
126767440|NCT00061568|456100281|FG001|Overall Study|Death|0|||
126767441|NCT00061568|456100280|FG000|Overall Study|Withdrawal by Subject|1|||
126767442|NCT00061568|456100281|FG001|Overall Study|Withdrawal by Subject|0|||
126767443|NCT00903409|456100282|FG000|Overall Study|Adverse Event|11|||
126767444|NCT00903409|456100283|FG001|Overall Study|Adverse Event|9|||
126767445|NCT00903409|456100282|FG000|Overall Study|Non-compliance with Protocol|1|||
126767446|NCT00903409|456100283|FG001|Overall Study|Non-compliance with Protocol|1|||
126767447|NCT00903409|456100282|FG000|Overall Study|Laboratory Abnormality|2|||
126767448|NCT00903409|456100283|FG001|Overall Study|Laboratory Abnormality|0|||
126767449|NCT00903409|456100282|FG000|Overall Study|Withdrawal by Subject|8|||
126767450|NCT00903409|456100283|FG001|Overall Study|Withdrawal by Subject|8|||
126767451|NCT00903409|456100282|FG000|Overall Study|Other|2|||
126767452|NCT00903409|456100283|FG001|Overall Study|Other|3|||
126767453|NCT00903409|456100282|FG000|Overall Study|Lost to Follow-up|2|||
126767454|NCT00903409|456100283|FG001|Overall Study|Lost to Follow-up|6|||
126767455|NCT00797316|456100284|FG000|Overall Study|Administrative problems|1|||
126767456|NCT00797316|456100285|FG001|Overall Study|Administrative problems|0|||
126767457|NCT00797316|456100284|FG000|Overall Study|Adverse Event|5|||
126767458|NCT00797316|456100285|FG001|Overall Study|Adverse Event|3|||
126767459|NCT00797316|456100284|FG000|Overall Study|Lost to Follow-up|4|||
126767460|NCT00797316|456100285|FG001|Overall Study|Lost to Follow-up|8|||
126767461|NCT00797316|456100284|FG000|Overall Study|Protocol Deviation|1|||
126767462|NCT00797316|456100285|FG001|Overall Study|Protocol Deviation|2|||
126767463|NCT00797316|456100284|FG000|Overall Study|Patient withdrew consent|12|||
126767464|NCT00797316|456100285|FG001|Overall Study|Patient withdrew consent|6|||
126767465|NCT00797316|456100284|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126767466|NCT00797316|456100285|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
126767467|NCT03239340|456100288|FG000|Overall Study|Other|26|||
126767468|NCT03239340|456100288|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
126767469|NCT03239340|456100288|FG000|Overall Study|Death|40|||
126767470|NCT03239340|456100288|FG000|Overall Study|Lost to Follow-up|2|||
126767471|NCT03239340|456100288|FG000|Overall Study|Physician Decision|16|||
126767472|NCT03239340|456100288|FG000|Overall Study|Withdrawal by Subject|27|||
126767473|NCT02061293|456100292|FG000|Overall Study|Elevated Blood Pressure|1|||
126767474|NCT02061293|456100293|FG001|Overall Study|Elevated Blood Pressure|1|||
126767475|NCT04066894|456100294|FG000|Overall Study|Lack of Efficacy|1|||
126767476|NCT04066894|456100294|FG000|Overall Study|Screen Failure|1|||
126296162|NCT03334435|454372567|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
126767477|NCT03494816|456100296|FG000|Overall Study|Protocol Violation|2|||
126767478|NCT03494816|456100296|FG000|Overall Study|Physician Decision|2|||
126767479|NCT03494816|456100296|FG000|Overall Study|Did not start trial treatment|1|||
126767480|NCT03494816|456100296|FG000|Overall Study|Adverse Event|1|||
126767481|NCT03878108|456100297|FG000|Overall Study|Adverse Event|1|||
126767482|NCT03878108|456100298|FG001|Overall Study|Adverse Event|0|||
126767483|NCT01682681|456100299|FG000|Overall Study|Lack of Efficacy|62|||
126767484|NCT01682681|456100299|FG000|Overall Study|Withdrawal by Subject|1|||
126767485|NCT01682681|456100299|FG000|Overall Study|Moved to other hospital|10|||
126767486|NCT01682681|456100299|FG000|Overall Study|Lost to Follow-up|174|||
126767487|NCT01682681|456100299|FG000|Overall Study|Adverse Event|46|||
126767488|NCT01682681|456100299|FG000|Overall Study|tapering of topiramate|5|||
126767489|NCT01682681|456100299|FG000|Overall Study|Other|21|||
126767490|NCT01682681|456100299|FG000|Overall Study|Low compliance|13|||
126767491|NCT00975000|456100300|FG000|Overall Study|Other|1|||
126767492|NCT00975000|456100301|FG001|Overall Study|Other|0|||
126767493|NCT00975000|456100300|FG000|Overall Study|Adverse Event|1|||
126767494|NCT00975000|456100301|FG001|Overall Study|Adverse Event|1|||
126767495|NCT00975000|456100300|FG000|Overall Study|Withdrawal by Subject|2|||
126767496|NCT00975000|456100301|FG001|Overall Study|Withdrawal by Subject|2|||
126767497|NCT00975000|456100300|FG000|Overall Study|Lost to Follow-up|0|||
126767498|NCT00975000|456100301|FG001|Overall Study|Lost to Follow-up|1|||
126767499|NCT00975000|456100300|FG000|Overall Study|Protocol-specified Criteria|1|||
126767500|NCT00975000|456100301|FG001|Overall Study|Protocol-specified Criteria|0|||
126767501|NCT00975000|456100300|FG000|Overall Study|Non-compliance|0|||
126767502|NCT00975000|456100301|FG001|Overall Study|Non-compliance|1|||
126767503|NCT01126359|456100302|FG000|First Intervention (20-minutes)|Physician Decision|0|||
126767504|NCT01126359|456100303|FG001|First Intervention (20-minutes)|Physician Decision|1|||
126767505|NCT00902486|456100304|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
126767506|NCT00902486|456100305|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
126767507|NCT00902486|456100306|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
126767508|NCT00902486|456100307|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
126767509|NCT00902486|456100308|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
126767510|NCT00902486|456100309|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
126767511|NCT00902486|456100304|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
126767512|NCT00902486|456100305|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
126767513|NCT00902486|456100306|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
126767514|NCT00902486|456100307|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
126767515|NCT00902486|456100308|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
126767516|NCT00902486|456100309|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
126767517|NCT00902486|456100304|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
126767518|NCT00902486|456100305|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
126767519|NCT00902486|456100306|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
126767520|NCT00902486|456100307|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
126767521|NCT00902486|456100308|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
126767522|NCT00902486|456100309|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
126767523|NCT00902486|456100304|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
126767524|NCT00902486|456100305|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
126767525|NCT00902486|456100306|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
126767526|NCT00902486|456100307|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
126767527|NCT00902486|456100308|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
126767528|NCT00902486|456100309|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
126767529|NCT00902486|456100304|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
126767530|NCT00902486|456100305|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
126767531|NCT00902486|456100306|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
126767532|NCT00902486|456100307|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
126767533|NCT00902486|456100308|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
126767534|NCT00902486|456100309|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
126767535|NCT00902486|456100304|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
126767536|NCT00902486|456100305|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
126767537|NCT00902486|456100306|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
126767538|NCT00902486|456100307|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
126767539|NCT00902486|456100308|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
126767540|NCT00902486|456100309|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
126767541|NCT00902486|456100304|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
126767542|NCT00902486|456100305|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
126767543|NCT00902486|456100306|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
126767544|NCT00902486|456100307|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
126767545|NCT00902486|456100308|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
126460825|NCT00768469|454987899|FG001|Overall Study|Adverse Event|2|||
126767546|NCT00902486|456100309|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
126767547|NCT00902486|456100304|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
126767548|NCT00902486|456100305|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
126767549|NCT00902486|456100306|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
126767550|NCT00902486|456100307|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
126767551|NCT00902486|456100308|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
126767552|NCT00902486|456100309|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
126767553|NCT00902486|456100304|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
126767554|NCT00902486|456100305|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
126767555|NCT00902486|456100306|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
126767556|NCT00902486|456100307|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
126767557|NCT00902486|456100308|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
126767558|NCT00902486|456100309|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
126767559|NCT00902486|456100304|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
126767560|NCT00902486|456100305|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
126767561|NCT00902486|456100306|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
126767562|NCT00902486|456100307|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
126767563|NCT00902486|456100308|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
126767564|NCT00902486|456100309|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
126767565|NCT00902486|456100304|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
126767566|NCT00902486|456100305|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
126767567|NCT00902486|456100306|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
126767568|NCT00902486|456100307|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
126767569|NCT00902486|456100308|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
126767570|NCT00902486|456100309|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
126767571|NCT02332655|456100310|FG000|Overall Study|Lack of Efficacy|1|||
126767572|NCT01808508|456102181|FG000|Overall Study|Lost to Follow-up|1|||
126767573|NCT01808508|456102182|FG001|Overall Study|Lost to Follow-up|0|||
126767574|NCT01808508|456102183|FG002|Overall Study|Lost to Follow-up|0|||
126767575|NCT00242567|456102186|FG000|Overall Study|Adverse Event|70|||
126767576|NCT00242567|456102187|FG001|Overall Study|Adverse Event|43|||
126767577|NCT00242567|456102186|FG000|Overall Study|Disease Progression|17|||
126767578|NCT00242567|456102187|FG001|Overall Study|Disease Progression|22|||
126767579|NCT00242567|456102186|FG000|Overall Study|Symptomatic deterioration|9|||
126767580|NCT00242567|456102187|FG001|Overall Study|Symptomatic deterioration|3|||
126767581|NCT00242567|456102186|FG000|Overall Study|Lack of Efficacy|2|||
126767582|NCT00242567|456102187|FG001|Overall Study|Lack of Efficacy|2|||
126767583|NCT00242567|456102186|FG000|Overall Study|Lost to Follow-up|9|||
126767584|NCT00242567|456102187|FG001|Overall Study|Lost to Follow-up|19|||
126767585|NCT00242567|456102186|FG000|Overall Study|Withdrawal by Subject|33|||
126767586|NCT00242567|456102187|FG001|Overall Study|Withdrawal by Subject|28|||
126767587|NCT00242567|456102186|FG000|Overall Study|Protocol Violation|12|||
126767588|NCT00242567|456102187|FG001|Overall Study|Protocol Violation|12|||
126767589|NCT00242567|456102186|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
126767590|NCT00242567|456102187|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
126767591|NCT00242567|456102186|FG000|Overall Study|Other|14|||
126767592|NCT00242567|456102187|FG001|Overall Study|Other|9|||
126767593|NCT03079869|456102196|FG000|Overall Study|Adverse Event|6|||
126767594|NCT03079869|456102197|FG001|Overall Study|Adverse Event|8|||
126767595|NCT03079869|456102196|FG000|Overall Study|Withdrawal by Subject|4|||
126767596|NCT03079869|456102197|FG001|Overall Study|Withdrawal by Subject|1|||
126767597|NCT03079869|456102196|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
126767598|NCT03079869|456102197|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
126767599|NCT02411110|456102198|FG000|Treatment Period 1|Adverse Event|4|||
126767600|NCT02411110|456102199|FG001|Treatment Period 1|Adverse Event|2|||
126767601|NCT02411110|456102198|FG000|Treatment Period 1|Lost to Follow-up|1|||
126767602|NCT02411110|456102199|FG001|Treatment Period 1|Lost to Follow-up|0|||
126767603|NCT02411110|456102198|FG000|Treatment Period 1|Personal Reasons|2|||
126767604|NCT02411110|456102199|FG001|Treatment Period 1|Personal Reasons|5|||
126767605|NCT02411110|456102198|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
126366954|NCT01051661|454639364|FG003|Overall Study|Failure to comply with protocol|0|||
126767606|NCT02411110|456102199|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
126767607|NCT02411110|456102198|FG000|Treatment Period 2|Adverse Event|1|||
126767608|NCT02411110|456102199|FG001|Treatment Period 2|Adverse Event|0|||
126767609|NCT02411110|456102198|FG000|Treatment Period 2|Lost to Follow-up|0|||
126767610|NCT02411110|456102199|FG001|Treatment Period 2|Lost to Follow-up|2|||
126767611|NCT02411110|456102198|FG000|Treatment Period 2|Personal Reasons|0|||
126767612|NCT02411110|456102199|FG001|Treatment Period 2|Personal Reasons|2|||
126767613|NCT02871921|456102210|FG000|Overall Study|Withdrawal by Subject|34|||
126767614|NCT02871921|456102211|FG001|Overall Study|Withdrawal by Subject|27|||
126767615|NCT02871921|456102212|FG002|Overall Study|Withdrawal by Subject|27|||
126366955|NCT01051661|454639365|FG004|Overall Study|Failure to comply with protocol|0|||
126711232|NCT01259492|455895425|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
126711233|NCT01259492|455895422|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
126711234|NCT01259492|455895423|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
126711235|NCT01259492|455895424|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
126711236|NCT01259492|455895425|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
126711237|NCT01259492|455895422|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
126711238|NCT01259492|455895423|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
126711239|NCT01259492|455895424|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
126711240|NCT01259492|455895425|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
126711241|NCT01259492|455895422|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
126711242|NCT01259492|455895423|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
126711243|NCT01259492|455895424|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
126711244|NCT01259492|455895425|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
126711245|NCT01259492|455895422|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
126711246|NCT01259492|455895423|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
126711247|NCT01259492|455895424|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
126711248|NCT01259492|455895425|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
126711249|NCT01259492|455895422|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
126711250|NCT01259492|455895423|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
126711251|NCT01259492|455895424|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
126711252|NCT01259492|455895425|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
126711253|NCT01259492|455895422|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
126711254|NCT01259492|455895423|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
126711255|NCT01259492|455895424|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
126711256|NCT01259492|455895425|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
126711257|NCT00663858|455895428|FG000|Overall Study|Adverse Event|9|||
126711258|NCT00663858|455895429|FG001|Overall Study|Adverse Event|1|||
126711259|NCT00663858|455895430|FG002|Overall Study|Adverse Event|6|||
126711260|NCT00663858|455895428|FG000|Overall Study|Lack of Efficacy|5|||
126711261|NCT00663858|455895429|FG001|Overall Study|Lack of Efficacy|1|||
126711262|NCT00663858|455895430|FG002|Overall Study|Lack of Efficacy|3|||
126711263|NCT00663858|455895428|FG000|Overall Study|Withdrawal by Subject|7|||
126711264|NCT00663858|455895429|FG001|Overall Study|Withdrawal by Subject|3|||
126711265|NCT00663858|455895430|FG002|Overall Study|Withdrawal by Subject|3|||
126711266|NCT00663858|455895428|FG000|Overall Study|Protocol Violation|5|||
126711267|NCT00663858|455895429|FG001|Overall Study|Protocol Violation|3|||
126711268|NCT00663858|455895430|FG002|Overall Study|Protocol Violation|4|||
126711269|NCT00663858|455895428|FG000|Overall Study|Other|8|||
126711270|NCT00663858|455895429|FG001|Overall Study|Other|2|||
126711271|NCT00663858|455895430|FG002|Overall Study|Other|4|||
126711272|NCT01166659|455895437|FG000|Overall Study|Subject Decision|8|||
126711273|NCT01166659|455895437|FG000|Overall Study|Investigator Decision|2|||
126711274|NCT01166659|455895437|FG000|Overall Study|Death|1|||
126711275|NCT01166659|455895437|FG000|Overall Study|Lost to Follow-up|1|||
126711276|NCT01166659|455895437|FG000|Overall Study|Study Closed at Site|1|||
126711277|NCT01371838|455895456|FG000|Overall Study|Withdrawal by Subject|27|||
126711278|NCT01371838|455895457|FG001|Overall Study|Withdrawal by Subject|33|||
126711279|NCT01371838|455895456|FG000|Overall Study|Lost to Follow-up|10|||
126711280|NCT01371838|455895457|FG001|Overall Study|Lost to Follow-up|20|||
126711281|NCT01371838|455895456|FG000|Overall Study|Death|3|||
126711282|NCT01371838|455895457|FG001|Overall Study|Death|4|||
126711283|NCT01371838|455895456|FG000|Overall Study|Protocol Violation|3|||
126711284|NCT01371838|455895457|FG001|Overall Study|Protocol Violation|0|||
126711285|NCT01371838|455895456|FG000|Overall Study|Investigator Decision|3|||
126711286|NCT01371838|455895457|FG001|Overall Study|Investigator Decision|8|||
126711287|NCT01371838|455895456|FG000|Overall Study|Last follow-up visit not conducted|2|||
126711288|NCT01371838|455895457|FG001|Overall Study|Last follow-up visit not conducted|0|||
126711289|NCT01371838|455895456|FG000|Overall Study|Lack of therapeutic response|0|||
126711290|NCT01371838|455895457|FG001|Overall Study|Lack of therapeutic response|1|||
126711291|NCT01371838|455895456|FG000|Overall Study|Surgery|1|||
126711292|NCT01371838|455895457|FG001|Overall Study|Surgery|0|||
126711293|NCT01334125|455895460|FG000|Overall Study|Lost to Follow-up|3|||
126711294|NCT01334125|455895461|FG001|Overall Study|Lost to Follow-up|3|||
126711295|NCT00641043|455895468|FG000|Overall Study|Adverse Event|6|||
126711296|NCT00641043|455895469|FG001|Overall Study|Adverse Event|4|||
126711297|NCT00641043|455895468|FG000|Overall Study|Protocol Violation|2|||
126711298|NCT00641043|455895469|FG001|Overall Study|Protocol Violation|3|||
126711299|NCT00641043|455895468|FG000|Overall Study|Lost to Follow-up|3|||
126296163|NCT03334435|454372568|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
126296164|NCT03922321|454372569|FG000|Overall Study|Participant Moved|1|||
126711300|NCT00641043|455895469|FG001|Overall Study|Lost to Follow-up|2|||
126711301|NCT00641043|455895468|FG000|Overall Study|Withdrawal by Subject|4|||
126767616|NCT02871921|456102213|FG003|Overall Study|Withdrawal by Subject|30|||
126767617|NCT01803464|456102216|FG000|Overall Study|Incomplete data|0|||
126767618|NCT01803464|456102217|FG001|Overall Study|Incomplete data|0|||
126767619|NCT01803464|456102218|FG002|Overall Study|Incomplete data|4|||
126767620|NCT01803464|456102219|FG003|Overall Study|Incomplete data|0|||
126767621|NCT01803464|456102216|FG000|Overall Study|Withdrawal by Subject|1|||
126767622|NCT01803464|456102217|FG001|Overall Study|Withdrawal by Subject|0|||
126296165|NCT03922321|454372569|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
126296166|NCT04067050|454372577|FG000|One Month|Lost to Follow-up|4|||
126296167|NCT04067050|454372578|FG001|One Month|Lost to Follow-up|0|||
126296168|NCT04067050|454372577|FG000|Two Month|Lost to Follow-up|1|||
126296169|NCT04067050|454372578|FG001|Two Month|Lost to Follow-up|0|||
126296170|NCT04067050|454372577|FG000|Two Month|Adverse Event|1|||
126296171|NCT04067050|454372578|FG001|Two Month|Adverse Event|0|||
126296172|NCT01062425|454372583|FG000|Overall Study|Protocol Violation|3|||
126296173|NCT01062425|454372584|FG001|Overall Study|Protocol Violation|6|||
126296174|NCT02342678|454372585|FG000|Overall Study|Lost to Follow-up|0|||
126296175|NCT02342678|454372586|FG001|Overall Study|Lost to Follow-up|1|||
126296176|NCT02342678|454372585|FG000|Overall Study|Too busy to complete study|0|||
126296177|NCT02342678|454372586|FG001|Overall Study|Too busy to complete study|2|||
126767623|NCT01803464|456102218|FG002|Overall Study|Withdrawal by Subject|0|||
126767624|NCT01803464|456102219|FG003|Overall Study|Withdrawal by Subject|0|||
126767625|NCT02860039|456102225|FG000|Overall Study|Death|4|||
126767626|NCT02860039|456102226|FG001|Overall Study|Death|0|||
126767627|NCT02860039|456102225|FG000|Overall Study|Lost to Follow-up|2|||
126767628|NCT02860039|456102226|FG001|Overall Study|Lost to Follow-up|2|||
126767629|NCT02860039|456102225|FG000|Overall Study|Protocol Violation|3|||
126767630|NCT02860039|456102226|FG001|Overall Study|Protocol Violation|1|||
126767631|NCT02860039|456102225|FG000|Overall Study|Withdrawal by Subject|1|||
126767632|NCT02860039|456102226|FG001|Overall Study|Withdrawal by Subject|0|||
126767633|NCT02860039|456102225|FG000|Overall Study|Not otherwise eligible|1|||
126767634|NCT02860039|456102226|FG001|Overall Study|Not otherwise eligible|1|||
126767635|NCT01360021|456102227|FG000|Overall Study|Eligibility criteria + other|2|||
126767636|NCT01360021|456102228|FG001|Overall Study|Eligibility criteria + other|1|||
126767637|NCT01360021|456102229|FG002|Overall Study|Eligibility criteria + other|1|||
126767638|NCT01360021|456102227|FG000|Overall Study|Protocol Violation|0|||
126767639|NCT01360021|456102228|FG001|Overall Study|Protocol Violation|0|||
126767640|NCT01360021|456102229|FG002|Overall Study|Protocol Violation|1|||
126767641|NCT01360021|456102227|FG000|Overall Study|Withdrawal by Subject|4|||
126767642|NCT01360021|456102228|FG001|Overall Study|Withdrawal by Subject|0|||
126767643|NCT01360021|456102229|FG002|Overall Study|Withdrawal by Subject|2|||
126767644|NCT01360021|456102227|FG000|Overall Study|Adverse Event|2|||
126767645|NCT01360021|456102228|FG001|Overall Study|Adverse Event|3|||
126767646|NCT01360021|456102229|FG002|Overall Study|Adverse Event|3|||
126767647|NCT01257737|456102231|FG000|Overall Study|Lost to Follow-up|1|||
126767648|NCT01257737|456102232|FG001|Overall Study|Lost to Follow-up|2|||
126767649|NCT01257737|456102231|FG000|Overall Study|Liver transplant|1|||
126767650|NCT01257737|456102232|FG001|Overall Study|Liver transplant|0|||
126767651|NCT01257737|456102231|FG000|Overall Study|Relocation out of the country|0|||
126767652|NCT01257737|456102232|FG001|Overall Study|Relocation out of the country|1|||
126767653|NCT01257737|456102231|FG000|Overall Study|Withdrew from study|0|||
126767654|NCT01257737|456102232|FG001|Overall Study|Withdrew from study|1|||
126767655|NCT03170271|456102236|FG000|Overall Study|Adverse Event|7|||
126767656|NCT03170271|456102237|FG001|Overall Study|Adverse Event|2|||
126767657|NCT03170271|456102236|FG000|Overall Study|Lost to Follow-up|0|||
126767658|NCT03170271|456102237|FG001|Overall Study|Lost to Follow-up|1|||
126767659|NCT03170271|456102236|FG000|Overall Study|Physician Decision|1|||
126767660|NCT03170271|456102237|FG001|Overall Study|Physician Decision|0|||
126767661|NCT03170271|456102236|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
126767662|NCT03170271|456102237|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
126767663|NCT03170271|456102236|FG000|Overall Study|Withdrawal by Subject|17|||
126767664|NCT03170271|456102237|FG001|Overall Study|Withdrawal by Subject|5|||
126767665|NCT03170271|456102236|FG000|Overall Study|Other|2|||
126767666|NCT03170271|456102237|FG001|Overall Study|Other|2|||
126767667|NCT03170271|456102236|FG000|Overall Study|Randomized in error|4|||
126767668|NCT03170271|456102237|FG001|Overall Study|Randomized in error|0|||
126767669|NCT01244516|456102244|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
126767670|NCT01244516|456102245|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
126767671|NCT01244516|456102246|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
126767672|NCT01244516|456102244|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
126767673|NCT01244516|456102245|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
126767674|NCT01244516|456102246|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
126767675|NCT01244516|456102244|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
126296178|NCT02342678|454372585|FG000|Overall Study|Family illness/emergency|0|||
126767676|NCT01244516|456102245|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
126767677|NCT01244516|456102246|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
126767678|NCT01244516|456102244|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
126767679|NCT01244516|456102245|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
126767680|NCT01244516|456102246|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
126767681|NCT01244516|456102244|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
126767682|NCT01244516|456102245|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
126767683|NCT01244516|456102246|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
126767684|NCT01244516|456102244|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
126767685|NCT01244516|456102245|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
126767686|NCT01244516|456102246|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
126767687|NCT01244516|456102244|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
126767688|NCT01244516|456102245|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
126767689|NCT01244516|456102246|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
126767690|NCT04935931|456102249|FG000|Overall Study|Withdrawal by Subject|1|||
126767691|NCT05168657|456102250|FG000|Overall Study|Adverse Event|0|||
126767692|NCT05168657|456102251|FG001|Overall Study|Adverse Event|0|||
126767693|NCT05168657|456102252|FG002|Overall Study|Adverse Event|1|||
126767694|NCT05168657|456102253|FG003|Overall Study|Adverse Event|0|||
126767695|NCT05168657|456102254|FG004|Overall Study|Adverse Event|0|||
126767696|NCT05168657|456102255|FG005|Overall Study|Adverse Event|0|||
126767697|NCT05168657|456102256|FG006|Overall Study|Adverse Event|0|||
126767698|NCT05168657|456102257|FG007|Overall Study|Adverse Event|0|||
126767699|NCT00424632|456102260|FG000|Overall Study|Death|0|||
126767700|NCT00424632|456102261|FG001|Overall Study|Death|0|||
126767701|NCT00424632|456102262|FG002|Overall Study|Death|0|||
126767702|NCT00424632|456102263|FG003|Overall Study|Death|0|||
126767703|NCT00424632|456102264|FG004|Overall Study|Death|0|||
126767704|NCT00424632|456102265|FG005|Overall Study|Death|2|||
126767705|NCT00424632|456102266|FG006|Overall Study|Death|0|||
126767706|NCT00424632|456102267|FG007|Overall Study|Death|0|||
126767707|NCT00424632|456102268|FG008|Overall Study|Death|0|||
126767708|NCT00424632|456102269|FG009|Overall Study|Death|0|||
126767709|NCT00424632|456102260|FG000|Overall Study|Adverse Event|0|||
126767710|NCT00424632|456102261|FG001|Overall Study|Adverse Event|0|||
126767711|NCT00424632|456102262|FG002|Overall Study|Adverse Event|0|||
126767712|NCT00424632|456102263|FG003|Overall Study|Adverse Event|0|||
126767713|NCT00424632|456102264|FG004|Overall Study|Adverse Event|0|||
126767714|NCT00424632|456102265|FG005|Overall Study|Adverse Event|0|||
126767715|NCT00424632|456102266|FG006|Overall Study|Adverse Event|0|||
126767716|NCT00424632|456102267|FG007|Overall Study|Adverse Event|0|||
126767717|NCT00424632|456102268|FG008|Overall Study|Adverse Event|3|||
126767718|NCT00424632|456102269|FG009|Overall Study|Adverse Event|2|||
126767719|NCT00424632|456102260|FG000|Overall Study|Global deterioration of health status|0|||
126767720|NCT00424632|456102261|FG001|Overall Study|Global deterioration of health status|0|||
126767721|NCT00424632|456102262|FG002|Overall Study|Global deterioration of health status|0|||
126767722|NCT00424632|456102263|FG003|Overall Study|Global deterioration of health status|1|||
126767723|NCT00424632|456102264|FG004|Overall Study|Global deterioration of health status|1|||
126767724|NCT00424632|456102265|FG005|Overall Study|Global deterioration of health status|0|||
126767725|NCT00424632|456102266|FG006|Overall Study|Global deterioration of health status|0|||
126767726|NCT00424632|456102267|FG007|Overall Study|Global deterioration of health status|0|||
126767727|NCT00424632|456102268|FG008|Overall Study|Global deterioration of health status|0|||
126296179|NCT02342678|454372586|FG001|Overall Study|Family illness/emergency|1|||
126296180|NCT02342678|454372585|FG000|Overall Study|Illness/medical reason|1|||
126296181|NCT02342678|454372586|FG001|Overall Study|Illness/medical reason|1|||
126296182|NCT02383017|454372587|FG000|Overall Study|Injury Sustained Outside Study|1|||
126767728|NCT00424632|456102269|FG009|Overall Study|Global deterioration of health status|0|||
126767729|NCT00424632|456102260|FG000|Overall Study|Objective progression or relapse|1|||
126767730|NCT00424632|456102261|FG001|Overall Study|Objective progression or relapse|1|||
126767731|NCT00424632|456102262|FG002|Overall Study|Objective progression or relapse|1|||
126767732|NCT00424632|456102263|FG003|Overall Study|Objective progression or relapse|2|||
126767733|NCT00424632|456102264|FG004|Overall Study|Objective progression or relapse|2|||
126767734|NCT00424632|456102265|FG005|Overall Study|Objective progression or relapse|13|||
126767735|NCT00424632|456102266|FG006|Overall Study|Objective progression or relapse|7|||
126767736|NCT00424632|456102267|FG007|Overall Study|Objective progression or relapse|3|||
126767737|NCT00424632|456102268|FG008|Overall Study|Objective progression or relapse|12|||
126767738|NCT00424632|456102269|FG009|Overall Study|Objective progression or relapse|4|||
126767739|NCT00424632|456102260|FG000|Overall Study|Other|0|||
126767740|NCT00424632|456102261|FG001|Overall Study|Other|0|||
126767741|NCT00424632|456102262|FG002|Overall Study|Other|0|||
126767742|NCT00424632|456102263|FG003|Overall Study|Other|1|||
126767743|NCT00424632|456102264|FG004|Overall Study|Other|0|||
126296183|NCT02383017|454372588|FG001|Overall Study|Injury Sustained Outside Study|0|||
126296184|NCT02383017|454372587|FG000|Overall Study|Compliance|3|||
126296185|NCT02383017|454372588|FG001|Overall Study|Compliance|2|||
126767744|NCT00424632|456102265|FG005|Overall Study|Other|0|||
126767745|NCT00424632|456102266|FG006|Overall Study|Other|0|||
126767746|NCT00424632|456102267|FG007|Overall Study|Other|0|||
126767747|NCT00424632|456102268|FG008|Overall Study|Other|1|||
126296186|NCT02383017|454372587|FG000|Overall Study|Found to be Hypogonadal|1|||
126711302|NCT00641043|455895469|FG001|Overall Study|Withdrawal by Subject|4|||
126711303|NCT00641043|455895468|FG000|Overall Study|Other incl. lack of efficacy|4|||
126711304|NCT00641043|455895469|FG001|Overall Study|Other incl. lack of efficacy|2|||
126711305|NCT02584634|455895470|FG000|Overall Study|Adverse Event|3|||
126711306|NCT02584634|455895471|FG001|Overall Study|Adverse Event|5|||
126711307|NCT02584634|455895470|FG000|Overall Study|Death|0|||
126711308|NCT02584634|455895471|FG001|Overall Study|Death|1|||
126711309|NCT02584634|455895470|FG000|Overall Study|Lost to Follow-up|0|||
126711310|NCT02584634|455895471|FG001|Overall Study|Lost to Follow-up|1|||
126711311|NCT02584634|455895470|FG000|Overall Study|Physician Decision|1|||
126711312|NCT02584634|455895471|FG001|Overall Study|Physician Decision|2|||
126711313|NCT02584634|455895470|FG000|Overall Study|Progressive disease|7|||
126711314|NCT02584634|455895471|FG001|Overall Study|Progressive disease|15|||
126711315|NCT02584634|455895470|FG000|Overall Study|Withdrawal by Subject|1|||
126711316|NCT02584634|455895471|FG001|Overall Study|Withdrawal by Subject|1|||
126711317|NCT02584634|455895470|FG000|Overall Study|Other|0|||
126711318|NCT02584634|455895471|FG001|Overall Study|Other|6|||
126711319|NCT04275310|455895472|FG000|Overall Study|Non-randomized due to running out of funding|4|||
126711320|NCT04275310|455895473|FG001|Overall Study|Non-randomized due to running out of funding|0|||
126711321|NCT03088605|455895474|FG000|Overall Study|Withdrawal by Subject|1|||
126711322|NCT03088605|455895475|FG001|Overall Study|Withdrawal by Subject|0|||
126711323|NCT00098345|455895477|FG000|Overall Study|Adverse Event|7|||
126711324|NCT00098345|455895477|FG000|Overall Study|Withdrawal by Subject|2|||
126711325|NCT00098345|455895477|FG000|Overall Study|progression|4|||
126711326|NCT01936649|455895478|FG000|Overall Study|Withdrawal by Subject|4|||
126711327|NCT01936649|455895478|FG000|Overall Study|Physician Decision|2|||
126711328|NCT01936649|455895478|FG000|Overall Study|Protocol Violation|2|||
126711329|NCT01936649|455895478|FG000|Overall Study|Other than specified above|5|||
126711330|NCT04655586|455895485|FG000|Overall Study|Physician Decision|1|||
126711331|NCT04655586|455895486|FG001|Overall Study|Physician Decision|3|||
126711332|NCT04655586|455895487|FG002|Overall Study|Physician Decision|4|||
126711333|NCT04655586|455895485|FG000|Overall Study|Withdrawal by Subject|1|||
126711334|NCT04655586|455895486|FG001|Overall Study|Withdrawal by Subject|3|||
126711335|NCT04655586|455895487|FG002|Overall Study|Withdrawal by Subject|1|||
126711336|NCT00201201|455895490|FG000|Overall Study|Death|0|||
126711337|NCT00201201|455895491|FG001|Overall Study|Death|2|||
126711338|NCT00201201|455895490|FG000|Overall Study|Withdrawal by Subject|5|||
126711339|NCT00201201|455895491|FG001|Overall Study|Withdrawal by Subject|5|||
126711340|NCT01342640|455895493|FG000|Overall Study|Adverse Event|3|||
126711341|NCT01342640|455895493|FG000|Overall Study|Protocol Violation|16|||
126711342|NCT01342640|455895493|FG000|Overall Study|Lost to Follow-up|21|||
126711343|NCT01342640|455895493|FG000|Overall Study|Other|1|||
126711344|NCT04101422|455895495|FG000|Overall Study|Ineligible|1|||
126711345|NCT04101422|455895496|FG001|Overall Study|Ineligible|0|||
126711346|NCT04101422|455895497|FG002|Overall Study|Ineligible|9|||
126711347|NCT04101422|455895498|FG003|Overall Study|Ineligible|0|||
126711348|NCT04101422|455895495|FG000|Overall Study|Withdrawal by Subject|0|||
126711349|NCT04101422|455895496|FG001|Overall Study|Withdrawal by Subject|0|||
126711350|NCT04101422|455895497|FG002|Overall Study|Withdrawal by Subject|1|||
126711351|NCT04101422|455895498|FG003|Overall Study|Withdrawal by Subject|0|||
126711352|NCT04101422|455895495|FG000|Overall Study|Not attending to the stimuli|0|||
126711353|NCT04101422|455895496|FG001|Overall Study|Not attending to the stimuli|0|||
126711354|NCT04101422|455895497|FG002|Overall Study|Not attending to the stimuli|4|||
126711355|NCT04101422|455895498|FG003|Overall Study|Not attending to the stimuli|0|||
126711356|NCT04101422|455895495|FG000|Overall Study|Did not download app|0|||
126711357|NCT04101422|455895496|FG001|Overall Study|Did not download app|0|||
126711358|NCT04101422|455895497|FG002|Overall Study|Did not download app|0|||
126711359|NCT04101422|455895498|FG003|Overall Study|Did not download app|17|||
126711360|NCT04101422|455895495|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
126711361|NCT04101422|455895496|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
126711362|NCT04101422|455895497|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
126711363|NCT04101422|455895498|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
126711364|NCT02640612|455895499|FG000|Overall Study|Adverse Event|6|||
126711365|NCT02640612|455895500|FG001|Overall Study|Adverse Event|7|||
126711366|NCT02640612|455895501|FG002|Overall Study|Adverse Event|2|||
126711367|NCT02640612|455895499|FG000|Overall Study|Death|1|||
126711368|NCT02640612|455895500|FG001|Overall Study|Death|0|||
126711369|NCT02640612|455895501|FG002|Overall Study|Death|0|||
126711370|NCT02640612|455895499|FG000|Overall Study|Withdrawal by Subject|10|||
126711371|NCT02640612|455895500|FG001|Overall Study|Withdrawal by Subject|3|||
126711372|NCT02640612|455895501|FG002|Overall Study|Withdrawal by Subject|3|||
126711373|NCT02640612|455895499|FG000|Overall Study|Lost to Follow-up|4|||
126711374|NCT02640612|455895500|FG001|Overall Study|Lost to Follow-up|1|||
126711375|NCT02640612|455895501|FG002|Overall Study|Lost to Follow-up|1|||
126711376|NCT02640612|455895499|FG000|Overall Study|Protocol Violation|0|||
126711377|NCT02640612|455895500|FG001|Overall Study|Protocol Violation|2|||
126711378|NCT02640612|455895501|FG002|Overall Study|Protocol Violation|0|||
126767748|NCT00424632|456102269|FG009|Overall Study|Other|0|||
126767749|NCT01984229|456102270|FG000|Safety Follow-up Period|Adverse Event|1|||
126767750|NCT01984229|456102271|FG001|Safety Follow-up Period|Adverse Event|1|||
126767751|NCT01984229|456102270|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
126767752|NCT01984229|456102271|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
126767753|NCT02325739|456102272|FG000|Phase I Part|Adverse Event|1|||
126767754|NCT02325739|456102273|FG001|Phase I Part|Adverse Event|0|||
126767755|NCT02325739|456102274|FG002|Phase I Part|Adverse Event|1|||
126767756|NCT02325739|456102275|FG003|Phase I Part|Adverse Event|2|||
126767757|NCT02325739|456102276|FG004|Phase I Part|Adverse Event|3|||
126767758|NCT02325739|456102277|FG005|Phase I Part|Adverse Event|1|||
126767759|NCT02325739|456102278|FG006|Phase I Part|Adverse Event|0|||
126767760|NCT02325739|456102279|FG007|Phase I Part|Adverse Event|2|||
126767761|NCT02325739|456102280|FG008|Phase I Part|Adverse Event|0|||
126767762|NCT02325739|456102281|FG009|Phase I Part|Adverse Event|0|||
126767763|NCT02325739|456102282|FG010|Phase I Part|Adverse Event|0|||
126767764|NCT02325739|456102272|FG000|Phase I Part|Progressive disease|9|||
126767765|NCT02325739|456102273|FG001|Phase I Part|Progressive disease|6|||
126767766|NCT02325739|456102274|FG002|Phase I Part|Progressive disease|3|||
126767767|NCT02325739|456102275|FG003|Phase I Part|Progressive disease|23|||
126767768|NCT02325739|456102276|FG004|Phase I Part|Progressive disease|14|||
126767769|NCT02325739|456102277|FG005|Phase I Part|Progressive disease|6|||
126767770|NCT02325739|456102278|FG006|Phase I Part|Progressive disease|6|||
126767771|NCT02325739|456102279|FG007|Phase I Part|Progressive disease|3|||
126767772|NCT02325739|456102280|FG008|Phase I Part|Progressive disease|0|||
126767773|NCT02325739|456102281|FG009|Phase I Part|Progressive disease|0|||
126767774|NCT02325739|456102282|FG010|Phase I Part|Progressive disease|0|||
126767775|NCT02325739|456102272|FG000|Phase I Part|Subject/guardian decision|1|||
126767776|NCT02325739|456102273|FG001|Phase I Part|Subject/guardian decision|0|||
126460826|NCT00768469|454987898|FG000|Overall Study|Disease Progression|3|||
126767777|NCT02325739|456102274|FG002|Phase I Part|Subject/guardian decision|1|||
126767778|NCT02325739|456102275|FG003|Phase I Part|Subject/guardian decision|1|||
126767779|NCT02325739|456102276|FG004|Phase I Part|Subject/guardian decision|0|||
126767780|NCT02325739|456102277|FG005|Phase I Part|Subject/guardian decision|0|||
126767781|NCT02325739|456102278|FG006|Phase I Part|Subject/guardian decision|0|||
126460827|NCT00768469|454987899|FG001|Overall Study|Disease Progression|4|||
126460828|NCT00768469|454987898|FG000|Overall Study|Withdrawal by Subject|0|||
126460829|NCT00768469|454987899|FG001|Overall Study|Withdrawal by Subject|1|||
126460830|NCT04966741|454987900|FG000|Overall Study|Lost to Follow-up|1|||
126460831|NCT04966741|454987901|FG001|Overall Study|Lost to Follow-up|0|||
126460832|NCT02953509|454987909|FG000|Overall Study|Death|1|||
126460833|NCT02953509|454987910|FG001|Overall Study|Death|3|||
126460834|NCT02953509|454987911|FG002|Overall Study|Death|3|||
126460835|NCT02953509|454987912|FG003|Overall Study|Death|4|||
126460836|NCT02953509|454987913|FG004|Overall Study|Death|12|||
126460837|NCT02953509|454987914|FG005|Overall Study|Death|3|||
126460838|NCT02953509|454987915|FG006|Overall Study|Death|25|||
126460839|NCT02953509|454987916|FG007|Overall Study|Death|10|||
126460840|NCT02953509|454987917|FG008|Overall Study|Death|21|||
126460841|NCT02953509|454987918|FG009|Overall Study|Death|20|||
126460842|NCT02953509|454987909|FG000|Overall Study|Reason Not Specified|0|||
126460843|NCT02953509|454987910|FG001|Overall Study|Reason Not Specified|2|||
126460844|NCT02953509|454987911|FG002|Overall Study|Reason Not Specified|8|||
126460845|NCT02953509|454987912|FG003|Overall Study|Reason Not Specified|2|||
126460846|NCT02953509|454987913|FG004|Overall Study|Reason Not Specified|11|||
126460847|NCT02953509|454987914|FG005|Overall Study|Reason Not Specified|4|||
126460848|NCT02953509|454987915|FG006|Overall Study|Reason Not Specified|12|||
126460849|NCT02953509|454987916|FG007|Overall Study|Reason Not Specified|2|||
126460850|NCT02953509|454987917|FG008|Overall Study|Reason Not Specified|7|||
126460851|NCT02953509|454987918|FG009|Overall Study|Reason Not Specified|2|||
126460852|NCT02953509|454987909|FG000|Overall Study|Consent Withdrawn|1|||
126460853|NCT02953509|454987910|FG001|Overall Study|Consent Withdrawn|1|||
126460854|NCT02953509|454987911|FG002|Overall Study|Consent Withdrawn|2|||
126460855|NCT02953509|454987912|FG003|Overall Study|Consent Withdrawn|1|||
126460856|NCT02953509|454987913|FG004|Overall Study|Consent Withdrawn|3|||
126460857|NCT02953509|454987914|FG005|Overall Study|Consent Withdrawn|0|||
126460858|NCT02953509|454987915|FG006|Overall Study|Consent Withdrawn|4|||
126460859|NCT02953509|454987916|FG007|Overall Study|Consent Withdrawn|1|||
126460860|NCT02953509|454987917|FG008|Overall Study|Consent Withdrawn|1|||
126460861|NCT02953509|454987918|FG009|Overall Study|Consent Withdrawn|4|||
126767782|NCT02325739|456102279|FG007|Phase I Part|Subject/guardian decision|1|||
126767783|NCT02325739|456102280|FG008|Phase I Part|Subject/guardian decision|0|||
126296187|NCT02383017|454372588|FG001|Overall Study|Found to be Hypogonadal|0|||
126460862|NCT02953509|454987909|FG000|Overall Study|Lost to Follow-up|0|||
126767784|NCT02325739|456102281|FG009|Phase I Part|Subject/guardian decision|0|||
126460863|NCT02953509|454987910|FG001|Overall Study|Lost to Follow-up|0|||
126460864|NCT02953509|454987911|FG002|Overall Study|Lost to Follow-up|0|||
126460865|NCT02953509|454987912|FG003|Overall Study|Lost to Follow-up|0|||
126460866|NCT02953509|454987913|FG004|Overall Study|Lost to Follow-up|0|||
126767785|NCT02325739|456102282|FG010|Phase I Part|Subject/guardian decision|0|||
126767786|NCT02325739|456102272|FG000|Phase I Part|Death|0|||
126767787|NCT02325739|456102273|FG001|Phase I Part|Death|0|||
126767788|NCT02325739|456102274|FG002|Phase I Part|Death|0|||
126767789|NCT02325739|456102275|FG003|Phase I Part|Death|0|||
126767790|NCT02325739|456102276|FG004|Phase I Part|Death|2|||
126767791|NCT02325739|456102277|FG005|Phase I Part|Death|0|||
126767792|NCT02325739|456102278|FG006|Phase I Part|Death|0|||
126767793|NCT02325739|456102279|FG007|Phase I Part|Death|0|||
126767794|NCT02325739|456102280|FG008|Phase I Part|Death|0|||
126767795|NCT02325739|456102281|FG009|Phase I Part|Death|0|||
126767796|NCT02325739|456102282|FG010|Phase I Part|Death|0|||
126767797|NCT02325739|456102272|FG000|Phase II Part|Adverse Event|0|||
126767798|NCT02325739|456102273|FG001|Phase II Part|Adverse Event|0|||
126767799|NCT02325739|456102274|FG002|Phase II Part|Adverse Event|0|||
126767800|NCT02325739|456102275|FG003|Phase II Part|Adverse Event|0|||
126767801|NCT02325739|456102276|FG004|Phase II Part|Adverse Event|0|||
126767802|NCT02325739|456102277|FG005|Phase II Part|Adverse Event|0|||
126767803|NCT02325739|456102278|FG006|Phase II Part|Adverse Event|0|||
126767804|NCT02325739|456102279|FG007|Phase II Part|Adverse Event|0|||
126767805|NCT02325739|456102280|FG008|Phase II Part|Adverse Event|4|||
126767806|NCT02325739|456102281|FG009|Phase II Part|Adverse Event|5|||
126767807|NCT02325739|456102282|FG010|Phase II Part|Adverse Event|1|||
126767808|NCT02325739|456102272|FG000|Phase II Part|Physician Decision|0|||
126767809|NCT02325739|456102273|FG001|Phase II Part|Physician Decision|0|||
126767810|NCT02325739|456102274|FG002|Phase II Part|Physician Decision|0|||
126767811|NCT02325739|456102275|FG003|Phase II Part|Physician Decision|0|||
126767812|NCT02325739|456102276|FG004|Phase II Part|Physician Decision|0|||
126767813|NCT02325739|456102277|FG005|Phase II Part|Physician Decision|0|||
126767814|NCT02325739|456102278|FG006|Phase II Part|Physician Decision|0|||
126767815|NCT02325739|456102279|FG007|Phase II Part|Physician Decision|0|||
126767816|NCT02325739|456102280|FG008|Phase II Part|Physician Decision|0|||
126767817|NCT02325739|456102281|FG009|Phase II Part|Physician Decision|1|||
126767818|NCT02325739|456102282|FG010|Phase II Part|Physician Decision|0|||
126767819|NCT02325739|456102272|FG000|Phase II Part|Progressive disease|0|||
126767820|NCT02325739|456102273|FG001|Phase II Part|Progressive disease|0|||
126767821|NCT02325739|456102274|FG002|Phase II Part|Progressive disease|0|||
126767822|NCT02325739|456102275|FG003|Phase II Part|Progressive disease|0|||
126767823|NCT02325739|456102276|FG004|Phase II Part|Progressive disease|0|||
126767824|NCT02325739|456102277|FG005|Phase II Part|Progressive disease|0|||
126767825|NCT02325739|456102278|FG006|Phase II Part|Progressive disease|0|||
126767826|NCT02325739|456102279|FG007|Phase II Part|Progressive disease|0|||
126767827|NCT02325739|456102280|FG008|Phase II Part|Progressive disease|22|||
126767828|NCT02325739|456102281|FG009|Phase II Part|Progressive disease|29|||
126767829|NCT02325739|456102282|FG010|Phase II Part|Progressive disease|18|||
126767830|NCT02325739|456102272|FG000|Phase II Part|Subject/guardian decision|0|||
126767831|NCT02325739|456102273|FG001|Phase II Part|Subject/guardian decision|0|||
126767832|NCT02325739|456102274|FG002|Phase II Part|Subject/guardian decision|0|||
126767833|NCT02325739|456102275|FG003|Phase II Part|Subject/guardian decision|0|||
126767834|NCT02325739|456102276|FG004|Phase II Part|Subject/guardian decision|0|||
126767835|NCT02325739|456102277|FG005|Phase II Part|Subject/guardian decision|0|||
126767836|NCT02325739|456102278|FG006|Phase II Part|Subject/guardian decision|0|||
126767837|NCT02325739|456102279|FG007|Phase II Part|Subject/guardian decision|0|||
126767838|NCT02325739|456102280|FG008|Phase II Part|Subject/guardian decision|4|||
126767839|NCT02325739|456102281|FG009|Phase II Part|Subject/guardian decision|1|||
126767840|NCT02325739|456102282|FG010|Phase II Part|Subject/guardian decision|1|||
126767841|NCT00824993|456102291|FG000|Overall Study|Withdrawal by Subject|1|||
126767842|NCT00824993|456102292|FG001|Overall Study|Withdrawal by Subject|1|||
126767843|NCT00824993|456102291|FG000|Overall Study|Malignancy Relapse|9|||
126767844|NCT00824993|456102292|FG001|Overall Study|Malignancy Relapse|10|||
126767845|NCT00824993|456102291|FG000|Overall Study|Rapid Bone Loss|0|||
126767846|NCT00824993|456102292|FG001|Overall Study|Rapid Bone Loss|1|||
126767847|NCT00824993|456102291|FG000|Overall Study|Non-Compliant|2|||
126767848|NCT00824993|456102292|FG001|Overall Study|Non-Compliant|1|||
126767849|NCT00824993|456102291|FG000|Overall Study|Insurance Issue|2|||
126767850|NCT00824993|456102292|FG001|Overall Study|Insurance Issue|1|||
126767851|NCT00824993|456102291|FG000|Overall Study|Death|0|||
126296188|NCT01068860|454372589|FG000|Overall Study|Withdrawal by Subject|0|||
126296189|NCT01068860|454372590|FG001|Overall Study|Withdrawal by Subject|0|||
126767852|NCT00824993|456102292|FG001|Overall Study|Death|3|||
126767853|NCT02596009|456102293|FG000|Overall Study|Administrative problems|0|||
126767854|NCT02596009|456102294|FG001|Overall Study|Administrative problems|1|||
126767855|NCT02596009|456102295|FG002|Overall Study|Administrative problems|0|||
126767856|NCT02596009|456102296|FG003|Overall Study|Administrative problems|0|||
126767857|NCT02596009|456102297|FG004|Overall Study|Administrative problems|0|||
126767858|NCT02596009|456102298|FG005|Overall Study|Administrative problems|0|||
126767859|NCT02998645|456102299|FG000|Treatment Period 1|Adverse Event|6|||
126767860|NCT02998645|456102299|FG000|Treatment Period 1|Death|5|||
126767861|NCT02998645|456102299|FG000|Treatment Period 1|Technical Problems|4|||
126767862|NCT02998645|456102299|FG000|Treatment Period 1|Lack of Efficacy|2|||
126767863|NCT02998645|456102299|FG000|Treatment Period 1|Progressive disease|1|||
126767864|NCT02998645|456102299|FG000|Treatment Period 1|Subject/guardian decision|1|||
126767865|NCT02998645|456102299|FG000|Treatment Period 2|Lack of Efficacy|5|||
126767866|NCT02998645|456102299|FG000|Treatment Period 2|Adverse Event|2|||
126767867|NCT02998645|456102299|FG000|Treatment Period 2|Progressive disease|2|||
126767868|NCT02998645|456102299|FG000|Treatment Period 2|Physician Decision|1|||
126767869|NCT04611152|456102304|FG000|Overall Study|Adverse Event|9|||
126767870|NCT04611152|456102305|FG001|Overall Study|Adverse Event|8|||
126767871|NCT04611152|456102304|FG000|Overall Study|Non-compliance with study schedule|1|||
126767872|NCT04611152|456102305|FG001|Overall Study|Non-compliance with study schedule|3|||
126767873|NCT04611152|456102304|FG000|Overall Study|Withdrawal by Subject|5|||
126767874|NCT04611152|456102305|FG001|Overall Study|Withdrawal by Subject|6|||
126767875|NCT04611152|456102304|FG000|Overall Study|Lost to Follow-up|11|||
126767876|NCT04611152|456102305|FG001|Overall Study|Lost to Follow-up|2|||
126767877|NCT03644927|456102306|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
126767878|NCT03644927|456102307|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
126767879|NCT00956813|456102308|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
126767880|NCT00956813|456102309|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
126767881|NCT00956813|456102308|FG000|Flaxseed and Placebo|Ineligible|3|||
126767882|NCT00956813|456102309|FG001|Flaxseed and Placebo|Ineligible|1|||
126767883|NCT01275170|456102314|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
126767884|NCT01275170|456102315|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
126767885|NCT01275170|456102316|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
126767886|NCT01275170|456102317|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
126767887|NCT01275170|456102318|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
126767888|NCT01275170|456102319|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
126767889|NCT01275170|456102320|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
126767890|NCT01275170|456102321|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
126767891|NCT00905437|456102323|FG000|Overall Study|Adverse Event|3|||
126767892|NCT00905437|456102324|FG001|Overall Study|Adverse Event|2|||
126767893|NCT00905437|456102323|FG000|Overall Study|Lost to Follow-up|0|||
126767894|NCT00905437|456102324|FG001|Overall Study|Lost to Follow-up|1|||
126767895|NCT00905437|456102323|FG000|Overall Study|Withdrawal by Subject|0|||
126767896|NCT00905437|456102324|FG001|Overall Study|Withdrawal by Subject|1|||
126296190|NCT01068860|454372591|FG002|Overall Study|Withdrawal by Subject|0|||
126296191|NCT01068860|454372592|FG003|Overall Study|Withdrawal by Subject|0|||
126296192|NCT01068860|454372593|FG004|Overall Study|Withdrawal by Subject|0|||
126296193|NCT01068860|454372594|FG005|Overall Study|Withdrawal by Subject|2|||
126296194|NCT01068860|454372595|FG006|Overall Study|Withdrawal by Subject|0|||
126296195|NCT01068860|454372596|FG007|Overall Study|Withdrawal by Subject|0|||
126296196|NCT01068860|454372597|FG008|Overall Study|Withdrawal by Subject|0|||
126296197|NCT01068860|454372598|FG009|Overall Study|Withdrawal by Subject|3|||
126296198|NCT01068860|454372589|FG000|Overall Study|Administrative problems; misrandomized|0|||
126296199|NCT01068860|454372590|FG001|Overall Study|Administrative problems; misrandomized|0|||
126296200|NCT01068860|454372591|FG002|Overall Study|Administrative problems; misrandomized|0|||
126296201|NCT01068860|454372592|FG003|Overall Study|Administrative problems; misrandomized|1|||
126296202|NCT01068860|454372593|FG004|Overall Study|Administrative problems; misrandomized|0|||
126296203|NCT01068860|454372594|FG005|Overall Study|Administrative problems; misrandomized|0|||
126296204|NCT01068860|454372595|FG006|Overall Study|Administrative problems; misrandomized|0|||
126296205|NCT01068860|454372596|FG007|Overall Study|Administrative problems; misrandomized|0|||
126296206|NCT01068860|454372597|FG008|Overall Study|Administrative problems; misrandomized|0|||
126296207|NCT01068860|454372598|FG009|Overall Study|Administrative problems; misrandomized|1|||
126296208|NCT01068860|454372589|FG000|Overall Study|Lost to Follow-up|0|||
126296209|NCT01068860|454372590|FG001|Overall Study|Lost to Follow-up|1|||
126296210|NCT01068860|454372591|FG002|Overall Study|Lost to Follow-up|0|||
126296211|NCT01068860|454372592|FG003|Overall Study|Lost to Follow-up|0|||
126296212|NCT01068860|454372593|FG004|Overall Study|Lost to Follow-up|0|||
126296213|NCT01068860|454372594|FG005|Overall Study|Lost to Follow-up|0|||
126296214|NCT01068860|454372595|FG006|Overall Study|Lost to Follow-up|0|||
126296215|NCT01068860|454372596|FG007|Overall Study|Lost to Follow-up|0|||
126767897|NCT00905437|456102323|FG000|Overall Study|Other|5|||
126767898|NCT00905437|456102324|FG001|Overall Study|Other|6|||
126767899|NCT01306968|456102327|FG000|Overall Study|Lost to Follow-up|1|||
126767900|NCT01306968|456102328|FG001|Overall Study|Lost to Follow-up|1|||
126767901|NCT01306968|456102329|FG002|Overall Study|Lost to Follow-up|0|||
126767902|NCT01306968|456102330|FG003|Overall Study|Lost to Follow-up|0|||
126767903|NCT01306968|456102327|FG000|Overall Study|Physician Decision|0|||
126767904|NCT01306968|456102328|FG001|Overall Study|Physician Decision|1|||
126767905|NCT01306968|456102329|FG002|Overall Study|Physician Decision|0|||
126767906|NCT01306968|456102330|FG003|Overall Study|Physician Decision|0|||
126767907|NCT01306968|456102327|FG000|Overall Study|Relocated and left active duty|0|||
126767908|NCT01306968|456102328|FG001|Overall Study|Relocated and left active duty|1|||
126767909|NCT01306968|456102329|FG002|Overall Study|Relocated and left active duty|1|||
126767910|NCT01306968|456102330|FG003|Overall Study|Relocated and left active duty|1|||
126767911|NCT01306968|456102327|FG000|Overall Study|Withdrew - time commitment|0|||
126767912|NCT01306968|456102328|FG001|Overall Study|Withdrew - time commitment|0|||
126767913|NCT01306968|456102329|FG002|Overall Study|Withdrew - time commitment|0|||
126767914|NCT01306968|456102330|FG003|Overall Study|Withdrew - time commitment|2|||
126767915|NCT01306968|456102327|FG000|Overall Study|Withdrew over privacy concerns|0|||
126767916|NCT01306968|456102328|FG001|Overall Study|Withdrew over privacy concerns|0|||
126767917|NCT01306968|456102329|FG002|Overall Study|Withdrew over privacy concerns|0|||
126767918|NCT01306968|456102330|FG003|Overall Study|Withdrew over privacy concerns|1|||
126767919|NCT03252015|456102333|FG000|Overall Study|Withdrawal by Subject|0|||
126767920|NCT03252015|456102334|FG001|Overall Study|Withdrawal by Subject|1|||
126767921|NCT03252015|456102335|FG002|Overall Study|Withdrawal by Subject|1|||
126767922|NCT03252015|456102336|FG003|Overall Study|Withdrawal by Subject|0|||
126767923|NCT03252015|456102333|FG000|Overall Study|Adverse Event|1|||
126767924|NCT03252015|456102334|FG001|Overall Study|Adverse Event|0|||
126767925|NCT03252015|456102335|FG002|Overall Study|Adverse Event|0|||
126767926|NCT03252015|456102336|FG003|Overall Study|Adverse Event|1|||
126767927|NCT04993339|456102337|FG000|Overall Study|Lost to Follow-up|0|||
126767928|NCT04993339|456102338|FG001|Overall Study|Lost to Follow-up|1|||
126767929|NCT04993339|456102337|FG000|Overall Study|no MRI scan|3|||
126767930|NCT04993339|456102338|FG001|Overall Study|no MRI scan|1|||
126767931|NCT01071278|456102344|FG000|Overall Study|Premature Discontinuation|254|||
126767932|NCT01071278|456102344|FG000|Overall Study|Completion Status Unknown|459|||
126767933|NCT03868059|456102345|FG000|Overall Study|Adverse Event|3|||
126767934|NCT03868059|456102345|FG000|Overall Study|Lost to Follow-up|3|||
126767935|NCT03868059|456102345|FG000|Overall Study|Withdrawal by Subject|6|||
126767936|NCT00314262|456102356|FG000|Overall Study|Adverse Event|2|||
126767937|NCT00314262|456102356|FG000|Overall Study|Withdrawal by Subject|2|||
126767938|NCT00314262|456102356|FG000|Overall Study|Physician Decision|1|||
126767939|NCT02044094|456102363|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
126767940|NCT02044094|456102363|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
126767941|NCT02044094|456102363|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
126767942|NCT02044094|456102363|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
126767943|NCT02044094|456102363|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
126767944|NCT02044094|456102363|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
126767945|NCT02044094|456102363|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
126767946|NCT02044094|456102363|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
126767947|NCT03353415|456102366|FG000|Masked CGM Wear|Lost to Follow-up|2|||
126767948|NCT03353415|456102366|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
126767949|NCT01298661|456102367|FG000|Overall Study|Withdrawal by Subject|2|||
126767950|NCT01298661|456102368|FG001|Overall Study|Withdrawal by Subject|0|||
126767951|NCT01298661|456102369|FG002|Overall Study|Withdrawal by Subject|2|||
126767952|NCT01017731|456104331|FG000|Overall Study|Lost to Follow-up|2|||
126767953|NCT01017731|456104331|FG000|Overall Study|Withdrawal by Subject|3|||
126767954|NCT01017731|456104331|FG000|Overall Study|Physician Decision|2|||
126767955|NCT01017731|456104331|FG000|Overall Study|Adverse Event|1|||
126767956|NCT05378269|456104332|FG000|Overall Study|Protocol Violation|1|||
126296216|NCT01068860|454372597|FG008|Overall Study|Lost to Follow-up|0|||
126296217|NCT01068860|454372598|FG009|Overall Study|Lost to Follow-up|0|||
126296218|NCT00460603|454372599|FG000|Phase 1|Death|1|||
126296219|NCT00460603|454372600|FG001|Phase 1|Death|0|||
126296220|NCT00460603|454372601|FG002|Phase 1|Death|0|||
126296221|NCT00460603|454372602|FG003|Phase 1|Death|2|||
126296222|NCT00460603|454372603|FG004|Phase 1|Death|0|||
126296223|NCT00460603|454372604|FG005|Phase 1|Death|0|||
126296224|NCT00460603|454372605|FG006|Phase 1|Death|0|||
126296225|NCT00460603|454372606|FG007|Phase 1|Death|0|||
126296226|NCT00460603|454372607|FG008|Phase 1|Death|1|||
126296227|NCT00460603|454372608|FG009|Phase 1|Death|0|||
126296228|NCT00460603|454372609|FG010|Phase 1|Death|0|||
126296229|NCT00460603|454372610|FG011|Phase 1|Death|0|||
126296230|NCT00460603|454372599|FG000|Phase 1|Adverse Event|3|||
126296231|NCT00460603|454372600|FG001|Phase 1|Adverse Event|1|||
126296232|NCT00460603|454372601|FG002|Phase 1|Adverse Event|1|||
126296233|NCT00460603|454372602|FG003|Phase 1|Adverse Event|2|||
126296234|NCT00460603|454372603|FG004|Phase 1|Adverse Event|0|||
126296235|NCT00460603|454372604|FG005|Phase 1|Adverse Event|0|||
126296236|NCT00460603|454372605|FG006|Phase 1|Adverse Event|3|||
126296237|NCT00460603|454372606|FG007|Phase 1|Adverse Event|0|||
126296238|NCT00460603|454372607|FG008|Phase 1|Adverse Event|4|||
126296239|NCT00460603|454372608|FG009|Phase 1|Adverse Event|0|||
126296240|NCT00460603|454372609|FG010|Phase 1|Adverse Event|0|||
126296241|NCT00460603|454372610|FG011|Phase 1|Adverse Event|0|||
126296242|NCT00460603|454372599|FG000|Phase 1|Lack of Efficacy|1|||
126296243|NCT00460603|454372600|FG001|Phase 1|Lack of Efficacy|0|||
126296244|NCT00460603|454372601|FG002|Phase 1|Lack of Efficacy|1|||
126296245|NCT00460603|454372602|FG003|Phase 1|Lack of Efficacy|2|||
126296246|NCT00460603|454372603|FG004|Phase 1|Lack of Efficacy|2|||
126296247|NCT00460603|454372604|FG005|Phase 1|Lack of Efficacy|2|||
126296248|NCT00460603|454372605|FG006|Phase 1|Lack of Efficacy|2|||
126296249|NCT00460603|454372606|FG007|Phase 1|Lack of Efficacy|2|||
126296250|NCT00460603|454372607|FG008|Phase 1|Lack of Efficacy|11|||
126296251|NCT00460603|454372608|FG009|Phase 1|Lack of Efficacy|0|||
126296252|NCT00460603|454372609|FG010|Phase 1|Lack of Efficacy|0|||
126296253|NCT00460603|454372610|FG011|Phase 1|Lack of Efficacy|0|||
126296254|NCT00460603|454372599|FG000|Phase 1|Withdrawal by Subject|1|||
126296255|NCT00460603|454372600|FG001|Phase 1|Withdrawal by Subject|2|||
126296256|NCT00460603|454372601|FG002|Phase 1|Withdrawal by Subject|1|||
126296257|NCT00460603|454372602|FG003|Phase 1|Withdrawal by Subject|1|||
126296258|NCT00460603|454372603|FG004|Phase 1|Withdrawal by Subject|3|||
126296259|NCT00460603|454372604|FG005|Phase 1|Withdrawal by Subject|0|||
126296260|NCT00460603|454372605|FG006|Phase 1|Withdrawal by Subject|1|||
126296261|NCT00460603|454372606|FG007|Phase 1|Withdrawal by Subject|0|||
126296262|NCT00460603|454372607|FG008|Phase 1|Withdrawal by Subject|2|||
126296263|NCT00460603|454372608|FG009|Phase 1|Withdrawal by Subject|0|||
126296264|NCT00460603|454372609|FG010|Phase 1|Withdrawal by Subject|0|||
126296265|NCT00460603|454372610|FG011|Phase 1|Withdrawal by Subject|0|||
126296266|NCT00460603|454372599|FG000|Phase 1|Other|0|||
126296267|NCT00460603|454372600|FG001|Phase 1|Other|3|||
126296268|NCT00460603|454372601|FG002|Phase 1|Other|1|||
126296269|NCT00460603|454372602|FG003|Phase 1|Other|1|||
126296270|NCT00460603|454372603|FG004|Phase 1|Other|1|||
126296271|NCT00460603|454372604|FG005|Phase 1|Other|2|||
126296272|NCT00460603|454372605|FG006|Phase 1|Other|0|||
126296273|NCT00460603|454372606|FG007|Phase 1|Other|1|||
126296274|NCT00460603|454372607|FG008|Phase 1|Other|0|||
126296275|NCT00460603|454372608|FG009|Phase 1|Other|0|||
126296276|NCT00460603|454372609|FG010|Phase 1|Other|0|||
126550086|NCT01076088|455307721|FG004|Overall Study|Other protocol specified criteria|0|||
126767957|NCT05378269|456104333|FG001|Overall Study|Protocol Violation|0|||
126767958|NCT05378269|456104334|FG002|Overall Study|Protocol Violation|2|||
126767959|NCT05378269|456104335|FG003|Overall Study|Protocol Violation|0|||
126767960|NCT05378269|456104336|FG004|Overall Study|Protocol Violation|0|||
126767961|NCT01721200|456104337|FG000|Overall Study|Lost to Follow-up|3|||
126767962|NCT01721200|456104338|FG001|Overall Study|Lost to Follow-up|5|||
126767963|NCT03926728|456104339|FG000|Overall Study|Withdrawal by Subject|0|||
126767964|NCT03926728|456104340|FG001|Overall Study|Withdrawal by Subject|1|||
126767965|NCT03926728|456104341|FG002|Overall Study|Withdrawal by Subject|1|||
126767966|NCT03926728|456104342|FG003|Overall Study|Withdrawal by Subject|0|||
126767967|NCT03926728|456104343|FG004|Overall Study|Withdrawal by Subject|0|||
126767968|NCT03926728|456104344|FG005|Overall Study|Withdrawal by Subject|1|||
126767969|NCT03926728|456104345|FG006|Overall Study|Withdrawal by Subject|1|||
126767970|NCT03926728|456104346|FG007|Overall Study|Withdrawal by Subject|0|||
126767971|NCT03926728|456104347|FG008|Overall Study|Withdrawal by Subject|0|||
126767972|NCT03926728|456104348|FG009|Overall Study|Withdrawal by Subject|1|||
126767973|NCT03926728|456104349|FG010|Overall Study|Withdrawal by Subject|0|||
126767974|NCT03926728|456104350|FG011|Overall Study|Withdrawal by Subject|0|||
126767975|NCT02729545|456104353|FG000|Overall Study|Pregnancy|1|||
126767976|NCT02729545|456104354|FG001|Overall Study|Pregnancy|1|||
126767977|NCT02729545|456104353|FG000|Overall Study|Lost to Follow-up|0|||
126767978|NCT02729545|456104354|FG001|Overall Study|Lost to Follow-up|1|||
126767979|NCT02729545|456104353|FG000|Overall Study|Withdrawal by Subject|2|||
126767980|NCT02729545|456104354|FG001|Overall Study|Withdrawal by Subject|3|||
126767981|NCT01956123|456104355|FG000|COS Cycle 2|Protocol Violation|8|||
126767982|NCT01956123|456104356|FG001|COS Cycle 2|Protocol Violation|3|||
126767983|NCT01956123|456104357|FG002|COS Cycle 2|Protocol Violation|0|||
126767984|NCT01956123|456104358|FG003|COS Cycle 2|Protocol Violation|0|||
126767985|NCT01956123|456104355|FG000|COS Cycle 2|Adverse Event|3|||
126767986|NCT01956123|456104356|FG001|COS Cycle 2|Adverse Event|4|||
126767987|NCT01956123|456104357|FG002|COS Cycle 2|Adverse Event|0|||
126767988|NCT01956123|456104358|FG003|COS Cycle 2|Adverse Event|0|||
126767989|NCT01956123|456104355|FG000|COS Cycle 2|Personal Reasons|2|||
126767990|NCT01956123|456104356|FG001|COS Cycle 2|Personal Reasons|0|||
126767991|NCT01956123|456104357|FG002|COS Cycle 2|Personal Reasons|0|||
126767992|NCT01956123|456104358|FG003|COS Cycle 2|Personal Reasons|0|||
126296277|NCT00460603|454372610|FG011|Phase 1|Other|0|||
126296278|NCT00460603|454372599|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296279|NCT00460603|454372600|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126767993|NCT01956123|456104355|FG000|COS Cycle 2|Withdrawal by Subject|1|||
126767994|NCT01956123|456104356|FG001|COS Cycle 2|Withdrawal by Subject|0|||
126767995|NCT01956123|456104357|FG002|COS Cycle 2|Withdrawal by Subject|0|||
126767996|NCT01956123|456104358|FG003|COS Cycle 2|Withdrawal by Subject|0|||
126767997|NCT01956123|456104355|FG000|COS Cycle 3|Protocol Violation|0|||
126767998|NCT01956123|456104356|FG001|COS Cycle 3|Protocol Violation|0|||
126296280|NCT00460603|454372601|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296281|NCT00460603|454372602|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296282|NCT00460603|454372603|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126767999|NCT01956123|456104357|FG002|COS Cycle 3|Protocol Violation|2|||
126768000|NCT01956123|456104358|FG003|COS Cycle 3|Protocol Violation|1|||
126768001|NCT01956123|456104355|FG000|COS Cycle 3|Adverse Event|0|||
126296283|NCT00460603|454372604|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126768002|NCT01956123|456104356|FG001|COS Cycle 3|Adverse Event|0|||
126768003|NCT01956123|456104357|FG002|COS Cycle 3|Adverse Event|3|||
126768004|NCT01956123|456104358|FG003|COS Cycle 3|Adverse Event|0|||
126296284|NCT00460603|454372605|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296285|NCT00460603|454372606|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296286|NCT00460603|454372607|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296287|NCT00460603|454372608|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
126296288|NCT00460603|454372609|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296289|NCT00460603|454372610|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
126296290|NCT00460603|454372599|FG000|Phase 2|Adverse Event|0|||
126296291|NCT00460603|454372600|FG001|Phase 2|Adverse Event|0|||
126296292|NCT00460603|454372601|FG002|Phase 2|Adverse Event|0|||
126768005|NCT01956123|456104355|FG000|COS Cycle 3|Personal Reasons|0|||
126768006|NCT01956123|456104356|FG001|COS Cycle 3|Personal Reasons|0|||
126768007|NCT01956123|456104357|FG002|COS Cycle 3|Personal Reasons|1|||
126768008|NCT01956123|456104358|FG003|COS Cycle 3|Personal Reasons|0|||
126768009|NCT01956123|456104355|FG000|COS Cycle 3|Withdrawal by Subject|0|||
126768010|NCT01956123|456104356|FG001|COS Cycle 3|Withdrawal by Subject|0|||
126768011|NCT01956123|456104357|FG002|COS Cycle 3|Withdrawal by Subject|0|||
126768012|NCT01956123|456104358|FG003|COS Cycle 3|Withdrawal by Subject|1|||
126768013|NCT00398632|456104359|FG000|Overall Study|Withdrawal by Subject|1|||
126768014|NCT00398632|456104359|FG000|Overall Study|Lack of Efficacy|1|||
126768015|NCT02118896|456104360|FG000|Overall Study|Death|4|||
126768016|NCT02118896|456104361|FG001|Overall Study|Death|0|||
126768017|NCT02118896|456104362|FG002|Overall Study|Death|4|||
126768018|NCT02118896|456104363|FG003|Overall Study|Death|6|||
126768019|NCT02118896|456104364|FG004|Overall Study|Death|3|||
126768020|NCT02118896|456104365|FG005|Overall Study|Death|1|||
126768021|NCT02118896|456104366|FG006|Overall Study|Death|0|||
126768022|NCT02118896|456104367|FG007|Overall Study|Death|0|||
126768023|NCT02118896|456104368|FG008|Overall Study|Death|0|||
126768024|NCT02118896|456104369|FG009|Overall Study|Death|0|||
126768025|NCT02118896|456104360|FG000|Overall Study|Adverse Event|5|||
126296293|NCT00460603|454372602|FG003|Phase 2|Adverse Event|0|||
126296294|NCT00460603|454372603|FG004|Phase 2|Adverse Event|0|||
126296295|NCT00460603|454372604|FG005|Phase 2|Adverse Event|0|||
126768026|NCT02118896|456104361|FG001|Overall Study|Adverse Event|4|||
126768027|NCT02118896|456104362|FG002|Overall Study|Adverse Event|4|||
126768028|NCT02118896|456104363|FG003|Overall Study|Adverse Event|5|||
126768029|NCT02118896|456104364|FG004|Overall Study|Adverse Event|5|||
126768030|NCT02118896|456104365|FG005|Overall Study|Adverse Event|9|||
126768031|NCT02118896|456104366|FG006|Overall Study|Adverse Event|1|||
126768032|NCT02118896|456104367|FG007|Overall Study|Adverse Event|1|||
126768033|NCT02118896|456104368|FG008|Overall Study|Adverse Event|4|||
126768034|NCT02118896|456104369|FG009|Overall Study|Adverse Event|0|||
126768035|NCT02118896|456104360|FG000|Overall Study|Consent withdrawn|2|||
126768036|NCT02118896|456104361|FG001|Overall Study|Consent withdrawn|0|||
126768037|NCT02118896|456104362|FG002|Overall Study|Consent withdrawn|3|||
126768038|NCT02118896|456104363|FG003|Overall Study|Consent withdrawn|4|||
126768039|NCT02118896|456104364|FG004|Overall Study|Consent withdrawn|1|||
126768040|NCT02118896|456104365|FG005|Overall Study|Consent withdrawn|4|||
126768041|NCT02118896|456104366|FG006|Overall Study|Consent withdrawn|0|||
126768042|NCT02118896|456104367|FG007|Overall Study|Consent withdrawn|0|||
126768043|NCT02118896|456104368|FG008|Overall Study|Consent withdrawn|0|||
126768044|NCT02118896|456104369|FG009|Overall Study|Consent withdrawn|0|||
126768045|NCT02118896|456104360|FG000|Overall Study|Non-compliance|2|||
126768046|NCT02118896|456104361|FG001|Overall Study|Non-compliance|1|||
126768047|NCT02118896|456104362|FG002|Overall Study|Non-compliance|1|||
126768048|NCT02118896|456104363|FG003|Overall Study|Non-compliance|5|||
126768049|NCT02118896|456104364|FG004|Overall Study|Non-compliance|0|||
126768050|NCT02118896|456104365|FG005|Overall Study|Non-compliance|1|||
126768051|NCT02118896|456104366|FG006|Overall Study|Non-compliance|0|||
126768052|NCT02118896|456104367|FG007|Overall Study|Non-compliance|1|||
126768053|NCT02118896|456104368|FG008|Overall Study|Non-compliance|0|||
126768054|NCT02118896|456104369|FG009|Overall Study|Non-compliance|0|||
126768055|NCT02118896|456104360|FG000|Overall Study|Pregnancy|1|||
126768056|NCT02118896|456104361|FG001|Overall Study|Pregnancy|1|||
126768057|NCT02118896|456104362|FG002|Overall Study|Pregnancy|0|||
126768058|NCT02118896|456104363|FG003|Overall Study|Pregnancy|0|||
126768059|NCT02118896|456104364|FG004|Overall Study|Pregnancy|1|||
126768060|NCT02118896|456104365|FG005|Overall Study|Pregnancy|3|||
126768061|NCT02118896|456104366|FG006|Overall Study|Pregnancy|1|||
126296296|NCT00460603|454372605|FG006|Phase 2|Adverse Event|0|||
126768062|NCT02118896|456104367|FG007|Overall Study|Pregnancy|0|||
126768063|NCT02118896|456104368|FG008|Overall Study|Pregnancy|0|||
126768064|NCT02118896|456104369|FG009|Overall Study|Pregnancy|0|||
126768065|NCT02118896|456104360|FG000|Overall Study|Lost to Follow-up|1|||
126768066|NCT02118896|456104361|FG001|Overall Study|Lost to Follow-up|2|||
126768067|NCT02118896|456104362|FG002|Overall Study|Lost to Follow-up|1|||
126768068|NCT02118896|456104363|FG003|Overall Study|Lost to Follow-up|0|||
126296297|NCT00460603|454372606|FG007|Phase 2|Adverse Event|0|||
126768069|NCT02118896|456104364|FG004|Overall Study|Lost to Follow-up|2|||
126768070|NCT02118896|456104365|FG005|Overall Study|Lost to Follow-up|1|||
126768071|NCT02118896|456104366|FG006|Overall Study|Lost to Follow-up|0|||
126768072|NCT02118896|456104367|FG007|Overall Study|Lost to Follow-up|0|||
126768073|NCT02118896|456104368|FG008|Overall Study|Lost to Follow-up|0|||
126768074|NCT02118896|456104369|FG009|Overall Study|Lost to Follow-up|0|||
126768075|NCT02118896|456104360|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
126768076|NCT02118896|456104361|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
126768077|NCT02118896|456104362|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
126768078|NCT02118896|456104363|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
126768079|NCT02118896|456104364|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
126768080|NCT02118896|456104365|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
126768081|NCT02118896|456104366|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
126768082|NCT02118896|456104367|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
126768083|NCT02118896|456104368|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
126768084|NCT02118896|456104369|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
126768085|NCT02118896|456104360|FG000|Overall Study|Prohibited medication|0|||
126768086|NCT02118896|456104361|FG001|Overall Study|Prohibited medication|0|||
126768087|NCT02118896|456104362|FG002|Overall Study|Prohibited medication|0|||
126768088|NCT02118896|456104363|FG003|Overall Study|Prohibited medication|0|||
126296298|NCT00460603|454372607|FG008|Phase 2|Adverse Event|0|||
126296299|NCT00460603|454372608|FG009|Phase 2|Adverse Event|12|||
126296300|NCT00460603|454372609|FG010|Phase 2|Adverse Event|9|||
126296301|NCT00460603|454372610|FG011|Phase 2|Adverse Event|10|||
126296302|NCT00460603|454372599|FG000|Phase 2|Death|0|||
126296303|NCT00460603|454372600|FG001|Phase 2|Death|0|||
126296304|NCT00460603|454372601|FG002|Phase 2|Death|0|||
126296305|NCT00460603|454372602|FG003|Phase 2|Death|0|||
126296306|NCT00460603|454372603|FG004|Phase 2|Death|0|||
126296307|NCT00460603|454372604|FG005|Phase 2|Death|0|||
126296308|NCT00460603|454372605|FG006|Phase 2|Death|0|||
126296309|NCT00460603|454372606|FG007|Phase 2|Death|0|||
126296310|NCT00460603|454372607|FG008|Phase 2|Death|0|||
126296311|NCT00460603|454372608|FG009|Phase 2|Death|4|||
126296312|NCT00460603|454372609|FG010|Phase 2|Death|2|||
126296313|NCT00460603|454372610|FG011|Phase 2|Death|2|||
126296314|NCT00460603|454372599|FG000|Phase 2|Protocol Violation|0|||
126296315|NCT00460603|454372600|FG001|Phase 2|Protocol Violation|0|||
126296316|NCT00460603|454372601|FG002|Phase 2|Protocol Violation|0|||
126296317|NCT00460603|454372602|FG003|Phase 2|Protocol Violation|0|||
126296318|NCT00460603|454372603|FG004|Phase 2|Protocol Violation|0|||
126296319|NCT00460603|454372604|FG005|Phase 2|Protocol Violation|0|||
126296320|NCT00460603|454372605|FG006|Phase 2|Protocol Violation|0|||
126296321|NCT00460603|454372606|FG007|Phase 2|Protocol Violation|0|||
126296322|NCT00460603|454372607|FG008|Phase 2|Protocol Violation|0|||
126460867|NCT02953509|454987914|FG005|Overall Study|Lost to Follow-up|0|||
126460868|NCT02953509|454987915|FG006|Overall Study|Lost to Follow-up|1|||
126460869|NCT02953509|454987916|FG007|Overall Study|Lost to Follow-up|1|||
126460870|NCT02953509|454987917|FG008|Overall Study|Lost to Follow-up|1|||
126460871|NCT02953509|454987918|FG009|Overall Study|Lost to Follow-up|1|||
126460872|NCT02953509|454987909|FG000|Overall Study|Study terminated by sponsor|1|||
126460873|NCT02953509|454987910|FG001|Overall Study|Study terminated by sponsor|0|||
126460874|NCT02953509|454987911|FG002|Overall Study|Study terminated by sponsor|0|||
126460875|NCT02953509|454987912|FG003|Overall Study|Study terminated by sponsor|0|||
126460876|NCT02953509|454987913|FG004|Overall Study|Study terminated by sponsor|0|||
126460877|NCT02953509|454987914|FG005|Overall Study|Study terminated by sponsor|0|||
126460878|NCT02953509|454987915|FG006|Overall Study|Study terminated by sponsor|1|||
126460879|NCT02953509|454987916|FG007|Overall Study|Study terminated by sponsor|0|||
126460880|NCT02953509|454987917|FG008|Overall Study|Study terminated by sponsor|1|||
126460881|NCT02953509|454987918|FG009|Overall Study|Study terminated by sponsor|1|||
126460882|NCT00484185|454987919|FG000|Overall Study|Lost to Follow-up|44|||
126460883|NCT00484185|454987919|FG000|Overall Study|Other|20|||
126460884|NCT00484185|454987919|FG000|Overall Study|Randomized but not treated|5|||
126460885|NCT00484185|454987919|FG000|Overall Study|Death|2|||
126460886|NCT00459056|454987920|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
126460887|NCT00459056|454987921|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
126460888|NCT02522871|454987922|FG000|Overall Study|Protocol Violation|1|||
126460889|NCT02522871|454987923|FG001|Overall Study|Protocol Violation|4|||
126460890|NCT02522871|454987922|FG000|Overall Study|Treated without randomization|1|||
126460891|NCT02522871|454987923|FG001|Overall Study|Treated without randomization|0|||
126460892|NCT02522871|454987922|FG000|Overall Study|Death|9|||
126460893|NCT02522871|454987923|FG001|Overall Study|Death|9|||
126460894|NCT02522871|454987922|FG000|Overall Study|Died in operating room prior to transplant|0|||
126460895|NCT02522871|454987923|FG001|Overall Study|Died in operating room prior to transplant|1|||
126460896|NCT03021564|454987925|FG000|Overall Study|Death|84|||
126460897|NCT03021564|454987926|FG001|Overall Study|Death|466|||
126460898|NCT03021564|454987925|FG000|Overall Study|Lost to Follow-up|0|||
126460899|NCT03021564|454987926|FG001|Overall Study|Lost to Follow-up|2|||
126460900|NCT00219544|454987927|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
126460901|NCT00219544|454987928|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
126460902|NCT00219544|454987927|FG000|Single Blind Treatment Period|Adverse Event|9|||
126296323|NCT00460603|454372608|FG009|Phase 2|Protocol Violation|1|||
126296324|NCT00460603|454372609|FG010|Phase 2|Protocol Violation|1|||
126296325|NCT00460603|454372610|FG011|Phase 2|Protocol Violation|0|||
126296326|NCT00460603|454372599|FG000|Phase 2|Lost to Follow-up|0|||
126296327|NCT00460603|454372600|FG001|Phase 2|Lost to Follow-up|0|||
126296328|NCT00460603|454372601|FG002|Phase 2|Lost to Follow-up|0|||
126296329|NCT00460603|454372602|FG003|Phase 2|Lost to Follow-up|0|||
126296330|NCT00460603|454372603|FG004|Phase 2|Lost to Follow-up|0|||
126296331|NCT00460603|454372604|FG005|Phase 2|Lost to Follow-up|0|||
126296332|NCT00460603|454372605|FG006|Phase 2|Lost to Follow-up|0|||
126296333|NCT00460603|454372606|FG007|Phase 2|Lost to Follow-up|0|||
126296334|NCT00460603|454372607|FG008|Phase 2|Lost to Follow-up|0|||
126296335|NCT00460603|454372608|FG009|Phase 2|Lost to Follow-up|1|||
126296336|NCT00460603|454372609|FG010|Phase 2|Lost to Follow-up|0|||
126296337|NCT00460603|454372610|FG011|Phase 2|Lost to Follow-up|0|||
126296338|NCT00460603|454372599|FG000|Phase 2|Other|0|||
126768089|NCT02118896|456104364|FG004|Overall Study|Prohibited medication|1|||
126768090|NCT02118896|456104365|FG005|Overall Study|Prohibited medication|3|||
126768091|NCT02118896|456104366|FG006|Overall Study|Prohibited medication|0|||
126768092|NCT02118896|456104367|FG007|Overall Study|Prohibited medication|0|||
126768093|NCT02118896|456104368|FG008|Overall Study|Prohibited medication|0|||
126768094|NCT02118896|456104369|FG009|Overall Study|Prohibited medication|0|||
126768095|NCT02118896|456104360|FG000|Overall Study|Miscellaneous|1|||
126768096|NCT02118896|456104361|FG001|Overall Study|Miscellaneous|2|||
126768097|NCT02118896|456104362|FG002|Overall Study|Miscellaneous|0|||
126768098|NCT02118896|456104363|FG003|Overall Study|Miscellaneous|2|||
126768099|NCT02118896|456104364|FG004|Overall Study|Miscellaneous|0|||
126768100|NCT02118896|456104365|FG005|Overall Study|Miscellaneous|4|||
126768101|NCT02118896|456104366|FG006|Overall Study|Miscellaneous|0|||
126768102|NCT02118896|456104367|FG007|Overall Study|Miscellaneous|0|||
126768103|NCT02118896|456104368|FG008|Overall Study|Miscellaneous|0|||
126768104|NCT02118896|456104369|FG009|Overall Study|Miscellaneous|0|||
126768105|NCT03292731|456104370|FG000|Overall Study|Protocol Violation|4|||
126768106|NCT03292731|456104371|FG001|Overall Study|Protocol Violation|11|||
126768107|NCT03292731|456104372|FG002|Overall Study|Protocol Violation|1|||
126768108|NCT03901352|456104373|FG000|Double-blind Phase|Adverse Event|6|||
126768109|NCT03901352|456104374|FG001|Double-blind Phase|Adverse Event|4|||
126768110|NCT03901352|456104373|FG000|Double-blind Phase|Death|1|||
126768111|NCT03901352|456104374|FG001|Double-blind Phase|Death|0|||
126768112|NCT03901352|456104373|FG000|Double-blind Phase|Lack of Efficacy|0|||
126768113|NCT03901352|456104374|FG001|Double-blind Phase|Lack of Efficacy|1|||
126768114|NCT03901352|456104373|FG000|Double-blind Phase|Protocol Violation|0|||
126768115|NCT03901352|456104374|FG001|Double-blind Phase|Protocol Violation|1|||
126768116|NCT03901352|456104373|FG000|Double-blind Phase|Withdrawal by Subject|10|||
126768117|NCT03901352|456104374|FG001|Double-blind Phase|Withdrawal by Subject|8|||
126768118|NCT03901352|456104373|FG000|Open-label Extension Phase|Adverse Event|24|||
126768119|NCT03901352|456104374|FG001|Open-label Extension Phase|Adverse Event|0|||
126768120|NCT03901352|456104373|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
126768121|NCT03901352|456104374|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
126768122|NCT03901352|456104373|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
126768123|NCT03901352|456104374|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
126296339|NCT00460603|454372600|FG001|Phase 2|Other|0|||
126296340|NCT00460603|454372601|FG002|Phase 2|Other|0|||
126296341|NCT00460603|454372602|FG003|Phase 2|Other|0|||
126296342|NCT00460603|454372603|FG004|Phase 2|Other|0|||
126296343|NCT00460603|454372604|FG005|Phase 2|Other|0|||
126296344|NCT00460603|454372605|FG006|Phase 2|Other|0|||
126296345|NCT00460603|454372606|FG007|Phase 2|Other|0|||
126768124|NCT03901352|456104373|FG000|Open-label Extension Phase|Other|1|||
126296346|NCT00460603|454372607|FG008|Phase 2|Other|0|||
126296347|NCT00460603|454372608|FG009|Phase 2|Other|6|||
126296348|NCT00460603|454372609|FG010|Phase 2|Other|16|||
126296349|NCT00460603|454372610|FG011|Phase 2|Other|7|||
126296350|NCT00460603|454372599|FG000|Phase 2|Objective Progression or Relapse|0|||
126296351|NCT00460603|454372600|FG001|Phase 2|Objective Progression or Relapse|0|||
126296352|NCT00460603|454372601|FG002|Phase 2|Objective Progression or Relapse|0|||
126768125|NCT03901352|456104374|FG001|Open-label Extension Phase|Other|0|||
126768126|NCT02050373|456104375|FG000|Overall Study|Adverse Event|4|||
126768127|NCT02050373|456104376|FG001|Overall Study|Adverse Event|7|||
126768128|NCT02050373|456104375|FG000|Overall Study|Death|3|||
126768129|NCT02050373|456104376|FG001|Overall Study|Death|3|||
126768130|NCT00572910|456104379|FG000|Overall Study|Adverse Event|1|||
126296353|NCT00460603|454372602|FG003|Phase 2|Objective Progression or Relapse|0|||
126296354|NCT00460603|454372603|FG004|Phase 2|Objective Progression or Relapse|0|||
126296355|NCT00460603|454372604|FG005|Phase 2|Objective Progression or Relapse|0|||
126296356|NCT00460603|454372605|FG006|Phase 2|Objective Progression or Relapse|0|||
126460903|NCT00219544|454987928|FG001|Single Blind Treatment Period|Adverse Event|0|||
126296357|NCT00460603|454372606|FG007|Phase 2|Objective Progression or Relapse|0|||
126296358|NCT00460603|454372607|FG008|Phase 2|Objective Progression or Relapse|0|||
126296359|NCT00460603|454372608|FG009|Phase 2|Objective Progression or Relapse|9|||
126768131|NCT00572910|456104380|FG001|Overall Study|Adverse Event|2|||
126768132|NCT00572910|456104381|FG002|Overall Study|Adverse Event|0|||
126296360|NCT00460603|454372609|FG010|Phase 2|Objective Progression or Relapse|10|||
126768133|NCT00572910|456104382|FG003|Overall Study|Adverse Event|2|||
126296361|NCT00460603|454372610|FG011|Phase 2|Objective Progression or Relapse|17|||
126296362|NCT00460603|454372599|FG000|Phase 2|Global Deterioration of Health Status|0|||
126296363|NCT00460603|454372600|FG001|Phase 2|Global Deterioration of Health Status|0|||
126296364|NCT00460603|454372601|FG002|Phase 2|Global Deterioration of Health Status|0|||
126296365|NCT00460603|454372602|FG003|Phase 2|Global Deterioration of Health Status|0|||
126296366|NCT00460603|454372603|FG004|Phase 2|Global Deterioration of Health Status|0|||
126296367|NCT00460603|454372604|FG005|Phase 2|Global Deterioration of Health Status|0|||
126296368|NCT00460603|454372605|FG006|Phase 2|Global Deterioration of Health Status|0|||
126550087|NCT01076088|455307722|FG005|Overall Study|Other protocol specified criteria|1|||
126550088|NCT04921969|455307724|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
126711379|NCT02640612|455895499|FG000|Overall Study|Lack of Efficacy|1|||
126711380|NCT02640612|455895500|FG001|Overall Study|Lack of Efficacy|1|||
126711381|NCT02640612|455895501|FG002|Overall Study|Lack of Efficacy|0|||
126711382|NCT00718861|455895502|FG000|Overall Study|Withdrawal by Subject|15|||
126711383|NCT00718861|455895503|FG001|Overall Study|Withdrawal by Subject|10|||
126711384|NCT00718861|455895502|FG000|Overall Study|Adverse Event|2|||
126711385|NCT00718861|455895503|FG001|Overall Study|Adverse Event|1|||
126711386|NCT00718861|455895502|FG000|Overall Study|Lost to Follow-up|2|||
126711387|NCT00718861|455895503|FG001|Overall Study|Lost to Follow-up|1|||
126711388|NCT00718861|455895502|FG000|Overall Study|Administrative Problems|1|||
126711389|NCT00718861|455895503|FG001|Overall Study|Administrative Problems|1|||
126711390|NCT00718861|455895502|FG000|Overall Study|Death|1|||
126711391|NCT00718861|455895503|FG001|Overall Study|Death|5|||
126711392|NCT03237845|455895504|FG000|Overall Study|Adverse Event|0|||
126711393|NCT03237845|455895505|FG001|Overall Study|Adverse Event|1|||
126711394|NCT03237845|455895504|FG000|Overall Study|Lost to Follow-up|13|||
126711395|NCT03237845|455895505|FG001|Overall Study|Lost to Follow-up|10|||
126711396|NCT03237845|455895504|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
126711397|NCT03237845|455895505|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
126711398|NCT03237845|455895504|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
126711399|NCT03237845|455895505|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
126711400|NCT03237845|455895504|FG000|Overall Study|Physician Decision|1|||
126711401|NCT03237845|455895505|FG001|Overall Study|Physician Decision|2|||
126711402|NCT03237845|455895504|FG000|Overall Study|Pregnancy|1|||
126711403|NCT03237845|455895505|FG001|Overall Study|Pregnancy|0|||
126711404|NCT03237845|455895504|FG000|Overall Study|Protocol Deviation|0|||
126711405|NCT03237845|455895505|FG001|Overall Study|Protocol Deviation|1|||
126711406|NCT03237845|455895504|FG000|Overall Study|Technical Problems|8|||
126711407|NCT03237845|455895505|FG001|Overall Study|Technical Problems|1|||
126711408|NCT03237845|455895504|FG000|Overall Study|Withdrawal by Subject|3|||
126711409|NCT03237845|455895505|FG001|Overall Study|Withdrawal by Subject|3|||
126711410|NCT03237845|455895504|FG000|Overall Study|Other Reasons|4|||
126711411|NCT03237845|455895505|FG001|Overall Study|Other Reasons|0|||
126711412|NCT03865407|455895508|FG000|Overall Study|Adverse Event|1|||
126711413|NCT03865407|455895509|FG001|Overall Study|Adverse Event|0|||
126711414|NCT03865407|455895508|FG000|Overall Study|Withdrawal by Subject|1|||
126711415|NCT03865407|455895509|FG001|Overall Study|Withdrawal by Subject|0|||
126711416|NCT03865407|455895508|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
126711417|NCT03865407|455895509|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
126711418|NCT02117050|455895510|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
126711419|NCT01645280|455895511|FG000|Overall Study|Death|0|||
126711420|NCT01645280|455895512|FG001|Overall Study|Death|1|||
126711421|NCT01645280|455895513|FG002|Overall Study|Death|0|||
126711422|NCT01645280|455895514|FG003|Overall Study|Death|0|||
126711423|NCT01645280|455895515|FG004|Overall Study|Death|0|||
126711424|NCT01645280|455895511|FG000|Overall Study|Withdrawal by Subject|4|||
126711425|NCT01645280|455895512|FG001|Overall Study|Withdrawal by Subject|0|||
126711426|NCT01645280|455895513|FG002|Overall Study|Withdrawal by Subject|2|||
126711427|NCT01645280|455895514|FG003|Overall Study|Withdrawal by Subject|4|||
126711428|NCT01645280|455895515|FG004|Overall Study|Withdrawal by Subject|5|||
126711429|NCT01645280|455895511|FG000|Overall Study|Lost to Follow-up|0|||
126711430|NCT01645280|455895512|FG001|Overall Study|Lost to Follow-up|0|||
126711431|NCT01645280|455895513|FG002|Overall Study|Lost to Follow-up|0|||
126711432|NCT01645280|455895514|FG003|Overall Study|Lost to Follow-up|2|||
126711433|NCT01645280|455895515|FG004|Overall Study|Lost to Follow-up|1|||
126711434|NCT01645280|455895511|FG000|Overall Study|Other|1|||
126711435|NCT01645280|455895512|FG001|Overall Study|Other|1|||
126711436|NCT01645280|455895513|FG002|Overall Study|Other|2|||
126711437|NCT01645280|455895514|FG003|Overall Study|Other|0|||
126711438|NCT01645280|455895515|FG004|Overall Study|Other|0|||
126711439|NCT01645280|455895511|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
126711440|NCT01645280|455895512|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
126296369|NCT00460603|454372606|FG007|Phase 2|Global Deterioration of Health Status|0|||
126296370|NCT00460603|454372607|FG008|Phase 2|Global Deterioration of Health Status|0|||
126711441|NCT01645280|455895513|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
126711442|NCT01645280|455895514|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
126768134|NCT00572910|456104383|FG004|Overall Study|Adverse Event|0|||
126768135|NCT00572910|456104384|FG005|Overall Study|Adverse Event|0|||
126768136|NCT00572910|456104385|FG006|Overall Study|Adverse Event|4|||
126768137|NCT00572910|456104386|FG007|Overall Study|Adverse Event|2|||
126296371|NCT00460603|454372608|FG009|Phase 2|Global Deterioration of Health Status|0|||
126768138|NCT00572910|456104387|FG008|Overall Study|Adverse Event|1|||
126768139|NCT00572910|456104388|FG009|Overall Study|Adverse Event|3|||
126768140|NCT00572910|456104389|FG010|Overall Study|Adverse Event|2|||
126768141|NCT00572910|456104379|FG000|Overall Study|Lost to Follow-up|0|||
126768142|NCT00572910|456104380|FG001|Overall Study|Lost to Follow-up|1|||
126768143|NCT00572910|456104381|FG002|Overall Study|Lost to Follow-up|1|||
126296372|NCT00460603|454372609|FG010|Phase 2|Global Deterioration of Health Status|1|||
126296373|NCT00460603|454372610|FG011|Phase 2|Global Deterioration of Health Status|0|||
126296374|NCT00460603|454372599|FG000|Phase 2|Withdrawal by Subject|0|||
126296375|NCT00460603|454372600|FG001|Phase 2|Withdrawal by Subject|0|||
126296376|NCT00460603|454372601|FG002|Phase 2|Withdrawal by Subject|0|||
126296377|NCT00460603|454372602|FG003|Phase 2|Withdrawal by Subject|0|||
126296378|NCT00460603|454372603|FG004|Phase 2|Withdrawal by Subject|0|||
126296379|NCT00460603|454372604|FG005|Phase 2|Withdrawal by Subject|0|||
126296380|NCT00460603|454372605|FG006|Phase 2|Withdrawal by Subject|0|||
126296381|NCT00460603|454372606|FG007|Phase 2|Withdrawal by Subject|0|||
126296382|NCT00460603|454372607|FG008|Phase 2|Withdrawal by Subject|0|||
126296383|NCT00460603|454372608|FG009|Phase 2|Withdrawal by Subject|5|||
126296384|NCT00460603|454372609|FG010|Phase 2|Withdrawal by Subject|4|||
126296385|NCT00460603|454372610|FG011|Phase 2|Withdrawal by Subject|5|||
126296386|NCT00460603|454372599|FG000|Phase 2|Randomized, but not treated|0|||
126296387|NCT00460603|454372600|FG001|Phase 2|Randomized, but not treated|0|||
126296388|NCT00460603|454372601|FG002|Phase 2|Randomized, but not treated|0|||
126296389|NCT00460603|454372602|FG003|Phase 2|Randomized, but not treated|0|||
126550089|NCT04921969|455307725|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
126768144|NCT00572910|456104382|FG003|Overall Study|Lost to Follow-up|2|||
126768145|NCT00572910|456104383|FG004|Overall Study|Lost to Follow-up|1|||
126768146|NCT00572910|456104384|FG005|Overall Study|Lost to Follow-up|0|||
126768147|NCT00572910|456104385|FG006|Overall Study|Lost to Follow-up|0|||
126768148|NCT00572910|456104386|FG007|Overall Study|Lost to Follow-up|0|||
126768149|NCT00572910|456104387|FG008|Overall Study|Lost to Follow-up|0|||
126768150|NCT00572910|456104388|FG009|Overall Study|Lost to Follow-up|1|||
126768151|NCT00572910|456104389|FG010|Overall Study|Lost to Follow-up|0|||
126768152|NCT00572910|456104379|FG000|Overall Study|Withdrawal by Subject|3|||
126768153|NCT00572910|456104380|FG001|Overall Study|Withdrawal by Subject|0|||
126768154|NCT00572910|456104381|FG002|Overall Study|Withdrawal by Subject|1|||
126768155|NCT00572910|456104382|FG003|Overall Study|Withdrawal by Subject|0|||
126768156|NCT00572910|456104383|FG004|Overall Study|Withdrawal by Subject|1|||
126768157|NCT00572910|456104384|FG005|Overall Study|Withdrawal by Subject|3|||
126768158|NCT00572910|456104385|FG006|Overall Study|Withdrawal by Subject|0|||
126768159|NCT00572910|456104386|FG007|Overall Study|Withdrawal by Subject|2|||
126768160|NCT00572910|456104387|FG008|Overall Study|Withdrawal by Subject|2|||
126768161|NCT00572910|456104388|FG009|Overall Study|Withdrawal by Subject|2|||
126768162|NCT00572910|456104389|FG010|Overall Study|Withdrawal by Subject|1|||
126768163|NCT00592007|456104394|FG000|Overall Study|Withdrawal by Subject|1|||
126768164|NCT00592007|456104394|FG000|Overall Study|patient ineligible (out of lab range)|1|||
126768165|NCT00595127|456104395|FG000|Overall Study|Death|6|||
126768166|NCT00595127|456104395|FG000|Overall Study|Relapsed|3|||
126768167|NCT00595127|456104395|FG000|Overall Study|joined another trial|1|||
126768168|NCT01569074|456104398|FG000|Overall Study|Study stopped|6|||
126768169|NCT01569074|456104399|FG001|Overall Study|Study stopped|6|||
126768170|NCT01569074|456104400|FG002|Overall Study|Study stopped|8|||
126768171|NCT01569074|456104401|FG003|Overall Study|Study stopped|7|||
126768172|NCT01569074|456104402|FG004|Overall Study|Study stopped|7|||
126768173|NCT01569074|456104398|FG000|Overall Study|Study-specific discontinuation criteria|0|||
126768174|NCT01569074|456104399|FG001|Overall Study|Study-specific discontinuation criteria|1|||
126768175|NCT01569074|456104400|FG002|Overall Study|Study-specific discontinuation criteria|0|||
126768176|NCT01569074|456104401|FG003|Overall Study|Study-specific discontinuation criteria|0|||
126768177|NCT01569074|456104402|FG004|Overall Study|Study-specific discontinuation criteria|0|||
126768178|NCT01569074|456104398|FG000|Overall Study|Severe non-compliance to protocol|0|||
126768179|NCT01569074|456104399|FG001|Overall Study|Severe non-compliance to protocol|0|||
126768180|NCT01569074|456104400|FG002|Overall Study|Severe non-compliance to protocol|1|||
126768181|NCT01569074|456104401|FG003|Overall Study|Severe non-compliance to protocol|0|||
126296390|NCT00460603|454372603|FG004|Phase 2|Randomized, but not treated|0|||
126296391|NCT00460603|454372604|FG005|Phase 2|Randomized, but not treated|0|||
126768182|NCT01569074|456104402|FG004|Overall Study|Severe non-compliance to protocol|0|||
126768183|NCT01569074|456104398|FG000|Overall Study|eg change in circumstances|0|||
126296392|NCT00460603|454372605|FG006|Phase 2|Randomized, but not treated|0|||
126296393|NCT00460603|454372606|FG007|Phase 2|Randomized, but not treated|0|||
126296394|NCT00460603|454372607|FG008|Phase 2|Randomized, but not treated|0|||
126768184|NCT01569074|456104399|FG001|Overall Study|eg change in circumstances|2|||
126768185|NCT01569074|456104400|FG002|Overall Study|eg change in circumstances|0|||
126768186|NCT01569074|456104401|FG003|Overall Study|eg change in circumstances|1|||
126768187|NCT01569074|456104402|FG004|Overall Study|eg change in circumstances|1|||
126768188|NCT01569074|456104398|FG000|Overall Study|Adverse Event|1|||
126768189|NCT01569074|456104399|FG001|Overall Study|Adverse Event|0|||
126768190|NCT01569074|456104400|FG002|Overall Study|Adverse Event|3|||
126768191|NCT01569074|456104401|FG003|Overall Study|Adverse Event|0|||
126768192|NCT01569074|456104402|FG004|Overall Study|Adverse Event|0|||
126768193|NCT02723786|456104403|FG000|Overall Study|Lost to Follow-up|1|||
126296395|NCT00460603|454372608|FG009|Phase 2|Randomized, but not treated|3|||
126296396|NCT00460603|454372609|FG010|Phase 2|Randomized, but not treated|0|||
126296397|NCT00460603|454372610|FG011|Phase 2|Randomized, but not treated|0|||
126296398|NCT00513240|454372611|FG000|Overall Study|Did not have intended surgery|3|||
126296399|NCT00513240|454372612|FG001|Overall Study|Did not have intended surgery|0|||
126296400|NCT00513240|454372611|FG000|Overall Study|Death|3|||
126296401|NCT00513240|454372612|FG001|Overall Study|Death|3|||
126296402|NCT00513240|454372611|FG000|Overall Study|Withdrawal by Subject|7|||
126296403|NCT00513240|454372612|FG001|Overall Study|Withdrawal by Subject|4|||
126768194|NCT00203892|456104404|FG000|Overall Study|Physician Decision|1|||
126768195|NCT00203892|456104405|FG001|Overall Study|Physician Decision|2|||
126768196|NCT00203892|456104406|FG002|Overall Study|Physician Decision|0|||
126768197|NCT00203892|456104404|FG000|Overall Study|Death|1|||
126768198|NCT00203892|456104405|FG001|Overall Study|Death|0|||
126768199|NCT00203892|456104406|FG002|Overall Study|Death|0|||
126768200|NCT03345485|456104410|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
126768201|NCT03345485|456104411|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
126768202|NCT03345485|456104412|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
126296404|NCT05263908|454372613|FG000|Overall Study|No informed consent for publication of study results|397|||
126296405|NCT05263908|454372613|FG000|Overall Study|CRF not collected|1|||
126296406|NCT00289848|454372615|FG000|Overall Study|Adverse Event|6|||
126296407|NCT00289848|454372616|FG001|Overall Study|Adverse Event|4|||
126296408|NCT00289848|454372615|FG000|Overall Study|Death|1|||
126296409|NCT00289848|454372616|FG001|Overall Study|Death|0|||
126296410|NCT00289848|454372615|FG000|Overall Study|Lack of Efficacy|20|||
126296411|NCT00289848|454372616|FG001|Overall Study|Lack of Efficacy|24|||
126296412|NCT00289848|454372615|FG000|Overall Study|Lost to Follow-up|3|||
126296413|NCT00289848|454372616|FG001|Overall Study|Lost to Follow-up|1|||
126296414|NCT00289848|454372615|FG000|Overall Study|Protocol Violation|5|||
126296415|NCT00289848|454372616|FG001|Overall Study|Protocol Violation|2|||
126296416|NCT00289848|454372615|FG000|Overall Study|Withdrawal by Subject|5|||
126296417|NCT00289848|454372616|FG001|Overall Study|Withdrawal by Subject|11|||
126296418|NCT00289848|454372615|FG000|Overall Study|Patient Moved|6|||
126296419|NCT00289848|454372616|FG001|Overall Study|Patient Moved|2|||
126296420|NCT00289848|454372615|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
126296421|NCT00289848|454372616|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
126296422|NCT03871543|454372619|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
126296423|NCT03871543|454372619|FG000|Period 1|Investigator Error|1|||
126296424|NCT03871543|454372619|FG000|Period 1|Protocol Violation|2|||
126296425|NCT03871543|454372619|FG000|Period 1|COVID-19 Related|1|||
126296426|NCT03871543|454372619|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
126296427|NCT03871543|454372619|FG000|Period 1|Withdrawal by Subject|10|||
126296428|NCT03871543|454372619|FG000|Period 2|Adverse Event|1|||
126296429|NCT03871543|454372619|FG000|Period 2|Withdrawal by Subject|1|||
126296430|NCT01930162|454372621|FG000|Overall Study|Abnormal test procedure result(s)|4|||
126296431|NCT01930162|454372621|FG000|Overall Study|Death|1|||
126296432|NCT02069015|454372623|FG000|Overall Study|Lost to Follow-up|39|||
126768203|NCT03345485|456104413|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
126768204|NCT03345485|456104414|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
126768205|NCT03345485|456104415|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
126768206|NCT03345485|456104416|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
126768207|NCT03345485|456104417|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
126768208|NCT03345485|456104418|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
126768209|NCT03345485|456104419|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
126768210|NCT03345485|456104420|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
126768211|NCT03345485|456104421|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
126768212|NCT03345485|456104422|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
126768213|NCT03359473|456104423|FG000|Overall Study|Adverse Event|0|||
126296433|NCT02069015|454372624|FG001|Overall Study|Lost to Follow-up|32|||
126296434|NCT02069015|454372623|FG000|Overall Study|Withdrawal by Subject|1|||
126296435|NCT02069015|454372624|FG001|Overall Study|Withdrawal by Subject|1|||
126296436|NCT00031590|454372625|FG000|Overall Study|Adverse Event|1|||
126296437|NCT00031590|454372625|FG000|Overall Study|Withdrawal by parents|2|||
126296438|NCT00586703|454372630|FG000|Overall Study|Death|12|||
126296439|NCT00765102|454372631|FG000|Overall Study|Progressive disease|18|||
126768214|NCT03359473|456104424|FG001|Overall Study|Adverse Event|2|||
126296440|NCT00765102|454372631|FG000|Overall Study|Adverse Event|6|||
126296441|NCT00765102|454372631|FG000|Overall Study|Physician Decision|4|||
126768215|NCT03359473|456104425|FG002|Overall Study|Adverse Event|5|||
126768216|NCT03359473|456104426|FG003|Overall Study|Adverse Event|3|||
126296442|NCT00765102|454372631|FG000|Overall Study|Withdrawal by Subject|2|||
126296443|NCT00765102|454372631|FG000|Overall Study|Protocol Violation|1|||
126296444|NCT02857816|454372632|FG000|Overall Study|Screen Failure|33|||
126296445|NCT02857816|454372632|FG000|Overall Study|Withdrawal by Subject|4|||
126296446|NCT02857816|454372632|FG000|Overall Study|Lost to Follow-up|1|||
126296447|NCT02723344|454372635|FG000|Overall Study|Lost to Follow-up|0|||
126296448|NCT02723344|454372636|FG001|Overall Study|Lost to Follow-up|4|||
126296449|NCT02964247|454372638|FG000|Overall Study|Lost to Follow-up|2|||
126296450|NCT02964247|454372639|FG001|Overall Study|Lost to Follow-up|0|||
126296451|NCT02964247|454372638|FG000|Overall Study|Withdrawal by Subject|1|||
126296452|NCT02964247|454372639|FG001|Overall Study|Withdrawal by Subject|2|||
126296453|NCT01709500|454372640|FG000|Overall Study|Randomized but not treated|0|||
126296454|NCT01709500|454372641|FG001|Overall Study|Randomized but not treated|1|||
126296455|NCT01709500|454372640|FG000|Overall Study|Adverse Event|5|||
126296456|NCT01709500|454372641|FG001|Overall Study|Adverse Event|1|||
126296457|NCT01709500|454372640|FG000|Overall Study|Poor compliance to protocol|2|||
126768217|NCT03359473|456104423|FG000|Overall Study|Lost to Follow-up|0|||
126768218|NCT03359473|456104424|FG001|Overall Study|Lost to Follow-up|1|||
126768219|NCT03359473|456104425|FG002|Overall Study|Lost to Follow-up|0|||
126768220|NCT03359473|456104426|FG003|Overall Study|Lost to Follow-up|0|||
126768221|NCT03359473|456104423|FG000|Overall Study|Physician Decision|0|||
126768222|NCT03359473|456104424|FG001|Overall Study|Physician Decision|1|||
126768223|NCT03359473|456104425|FG002|Overall Study|Physician Decision|0|||
126768224|NCT03359473|456104426|FG003|Overall Study|Physician Decision|1|||
126768225|NCT03359473|456104423|FG000|Overall Study|Withdrawal by Subject|1|||
126768226|NCT03359473|456104424|FG001|Overall Study|Withdrawal by Subject|2|||
126768227|NCT03359473|456104425|FG002|Overall Study|Withdrawal by Subject|1|||
126768228|NCT03359473|456104426|FG003|Overall Study|Withdrawal by Subject|0|||
126768229|NCT03359473|456104423|FG000|Overall Study|Protocol-defined stopping criteria|1|||
126768230|NCT03359473|456104424|FG001|Overall Study|Protocol-defined stopping criteria|0|||
126296458|NCT01709500|454372641|FG001|Overall Study|Poor compliance to protocol|1|||
126296459|NCT01709500|454372640|FG000|Overall Study|Other|3|||
126296460|NCT01709500|454372641|FG001|Overall Study|Other|1|||
126296461|NCT01709500|454372640|FG000|Overall Study|Related to IMP administration|1|||
126296462|NCT01709500|454372641|FG001|Overall Study|Related to IMP administration|0|||
126296463|NCT01709500|454372640|FG000|Overall Study|Treatment ongoing|156|||
126296464|NCT01709500|454372641|FG001|Overall Study|Treatment ongoing|78|||
126296465|NCT01609790|454372642|FG000|Overall Study|Protocol Violation|1|||
126296466|NCT01609790|454372643|FG001|Overall Study|Protocol Violation|7|||
126296467|NCT01609790|454372644|FG002|Overall Study|Protocol Violation|8|||
126296468|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Adverse Event|7|||
126296469|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
126296470|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Non-compliance|3|||
126296471|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Other|17|||
126296472|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Physician Decision|2|||
126296473|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Pregnancy|1|||
126296474|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
126296475|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
126296476|NCT05207865|454373908|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
126296477|NCT05207865|454373908|FG000|Follow-up Phase|Lost to Follow-up|1|||
126296478|NCT05207865|454373908|FG000|Follow-up Phase|Non-compliance|1|||
126296479|NCT05207865|454373908|FG000|Follow-up Phase|Not reported|2|||
126296480|NCT05207865|454373908|FG000|Follow-up Phase|Not collected|11|||
126296481|NCT00739882|454373911|FG000|Double-blind Period|Adverse Event|1|||
126296482|NCT00739882|454373912|FG001|Double-blind Period|Adverse Event|2|||
126296483|NCT00739882|454373911|FG000|Double-blind Period|Protocol Violation|1|||
126296484|NCT00739882|454373912|FG001|Double-blind Period|Protocol Violation|0|||
126296485|NCT00739882|454373911|FG000|Double-blind Period|Lack of Efficacy|1|||
126296486|NCT00739882|454373912|FG001|Double-blind Period|Lack of Efficacy|1|||
126296487|NCT00739882|454373911|FG000|Double-blind Period|Other|16|||
126296488|NCT00739882|454373912|FG001|Double-blind Period|Other|8|||
126768231|NCT03359473|456104425|FG002|Overall Study|Protocol-defined stopping criteria|0|||
126768232|NCT03359473|456104426|FG003|Overall Study|Protocol-defined stopping criteria|1|||
126768233|NCT05302414|456104427|FG000|Pretest to Posttest|Lost to Follow-up|12|||
126768234|NCT05302414|456104428|FG001|Pretest to Posttest|Lost to Follow-up|8|||
126768235|NCT05302414|456104429|FG002|Pretest to Posttest|Lost to Follow-up|8|||
126768236|NCT05302414|456104427|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
126768237|NCT05302414|456104428|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
126768238|NCT05302414|456104429|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
126768239|NCT01610284|456104430|FG000|Randomization Phase|Adverse Event|1|||
126768240|NCT01610284|456104431|FG001|Randomization Phase|Adverse Event|0|||
126296489|NCT00739882|454373911|FG000|Open-label Period|Adverse Event|1|||
126296490|NCT00739882|454373912|FG001|Open-label Period|Adverse Event|0|||
126296491|NCT00739882|454373911|FG000|Open-label Period|Other|9|||
126296492|NCT00739882|454373912|FG001|Open-label Period|Other|5|||
126768241|NCT01610284|456104430|FG000|Randomization Phase|Physician Decision|1|||
126768242|NCT01610284|456104431|FG001|Randomization Phase|Physician Decision|1|||
126768243|NCT01610284|456104430|FG000|Randomization Phase|Death|0|||
126768244|NCT01610284|456104431|FG001|Randomization Phase|Death|1|||
126768245|NCT01610284|456104430|FG000|Treatment Phase|Adverse Event|80|||
126768246|NCT01610284|456104431|FG001|Treatment Phase|Adverse Event|12|||
126768247|NCT01610284|456104430|FG000|Treatment Phase|Lost to Follow-up|1|||
126768248|NCT01610284|456104431|FG001|Treatment Phase|Lost to Follow-up|0|||
126768249|NCT01610284|456104430|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
126768250|NCT01610284|456104431|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
126768251|NCT01610284|456104430|FG000|Treatment Phase|Physician Decision|27|||
126768252|NCT01610284|456104431|FG001|Treatment Phase|Physician Decision|24|||
126768253|NCT01610284|456104430|FG000|Treatment Phase|Progressive Disease|377|||
126768254|NCT01610284|456104431|FG001|Treatment Phase|Progressive Disease|486|||
126768255|NCT01610284|456104430|FG000|Treatment Phase|Protocol Deviation|2|||
126768256|NCT01610284|456104431|FG001|Treatment Phase|Protocol Deviation|3|||
126768257|NCT01610284|456104430|FG000|Treatment Phase|Study terminated by Sponsor|18|||
126768258|NCT01610284|456104431|FG001|Treatment Phase|Study terminated by Sponsor|15|||
126768259|NCT01610284|456104430|FG000|Treatment Phase|Subject/Guardian Decision|55|||
126768260|NCT01610284|456104431|FG001|Treatment Phase|Subject/Guardian Decision|23|||
126768261|NCT01610284|456104430|FG000|Treatment Phase|Death|6|||
126768262|NCT01610284|456104431|FG001|Treatment Phase|Death|5|||
126768263|NCT01610284|456104430|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
126768264|NCT01610284|456104431|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126768265|NCT01610284|456104430|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
126768266|NCT01610284|456104431|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
126768267|NCT01610284|456104430|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
126768268|NCT01610284|456104431|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
126768269|NCT01610284|456104430|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
126768270|NCT01610284|456104431|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
126768271|NCT01610284|456104430|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
126768272|NCT01610284|456104431|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
126768273|NCT01610284|456104430|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
126768274|NCT01610284|456104431|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
126768275|NCT01102972|456104434|FG000|Overall Study|Adverse Event|8|||
126768276|NCT01102972|456104435|FG001|Overall Study|Adverse Event|2|||
126768277|NCT01102972|456104434|FG000|Overall Study|Lack of Efficacy|2|||
126768278|NCT01102972|456104435|FG001|Overall Study|Lack of Efficacy|1|||
126768279|NCT01102972|456104434|FG000|Overall Study|Protocol Violation|1|||
126768280|NCT01102972|456104435|FG001|Overall Study|Protocol Violation|0|||
126768281|NCT01102972|456104434|FG000|Overall Study|Lost to Follow-up|10|||
126768282|NCT01102972|456104435|FG001|Overall Study|Lost to Follow-up|5|||
126768283|NCT01102972|456104434|FG000|Overall Study|Investigator Discretion|2|||
126768284|NCT01102972|456104435|FG001|Overall Study|Investigator Discretion|0|||
126768285|NCT01102972|456104434|FG000|Overall Study|Withdrawal by Subject|6|||
126768286|NCT01102972|456104435|FG001|Overall Study|Withdrawal by Subject|6|||
126768287|NCT01856257|456104439|FG000|Overall Study|Death|2|||
126768288|NCT01856257|456104440|FG001|Overall Study|Death|0|||
126768289|NCT01856257|456104441|FG002|Overall Study|Death|0|||
126768290|NCT01856257|456104442|FG003|Overall Study|Death|0|||
126768291|NCT01856257|456104439|FG000|Overall Study|Physician Decision|0|||
126768292|NCT01856257|456104440|FG001|Overall Study|Physician Decision|0|||
126768293|NCT01856257|456104441|FG002|Overall Study|Physician Decision|0|||
126768294|NCT01856257|456104442|FG003|Overall Study|Physician Decision|1|||
126768295|NCT01856257|456104439|FG000|Overall Study|Withdrawal by Subject|1|||
126768296|NCT01856257|456104440|FG001|Overall Study|Withdrawal by Subject|1|||
126768297|NCT01856257|456104441|FG002|Overall Study|Withdrawal by Subject|0|||
126768298|NCT01856257|456104442|FG003|Overall Study|Withdrawal by Subject|0|||
126768299|NCT01856257|456104439|FG000|Overall Study|Donor complication|0|||
126768300|NCT01856257|456104440|FG001|Overall Study|Donor complication|0|||
126768301|NCT01856257|456104441|FG002|Overall Study|Donor complication|0|||
126768302|NCT01856257|456104442|FG003|Overall Study|Donor complication|1|||
126768303|NCT01060007|456104443|FG000|Overall Study|Withdrawal by Subject|1|||
126768304|NCT01060007|456104443|FG000|Overall Study|Inevaluable for response at surgery|3|||
126768305|NCT00742859|456104448|FG000|Overall Study|Adverse Event|5|||
126768306|NCT00742859|456104449|FG001|Overall Study|Adverse Event|6|||
126768307|NCT00742859|456104450|FG002|Overall Study|Adverse Event|3|||
126768308|NCT00742859|456104451|FG003|Overall Study|Adverse Event|1|||
126768309|NCT00742859|456104448|FG000|Overall Study|Death|1|||
126768310|NCT00742859|456104449|FG001|Overall Study|Death|0|||
126768311|NCT00742859|456104450|FG002|Overall Study|Death|0|||
126768312|NCT00742859|456104451|FG003|Overall Study|Death|1|||
126768313|NCT00742859|456104448|FG000|Overall Study|Physician Decision|1|||
126768314|NCT00742859|456104449|FG001|Overall Study|Physician Decision|2|||
126768315|NCT00742859|456104450|FG002|Overall Study|Physician Decision|0|||
126768316|NCT00742859|456104451|FG003|Overall Study|Physician Decision|0|||
126768317|NCT00742859|456104448|FG000|Overall Study|Withdrawal by Subject|4|||
126768318|NCT00742859|456104449|FG001|Overall Study|Withdrawal by Subject|2|||
126768319|NCT00742859|456104450|FG002|Overall Study|Withdrawal by Subject|4|||
126768320|NCT00742859|456104451|FG003|Overall Study|Withdrawal by Subject|1|||
126768321|NCT00742859|456104448|FG000|Overall Study|Endpoint|0|||
126768322|NCT00742859|456104449|FG001|Overall Study|Endpoint|1|||
126296493|NCT05423093|454373913|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
126296494|NCT05423093|454373913|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
126768323|NCT00742859|456104450|FG002|Overall Study|Endpoint|1|||
126768324|NCT00742859|456104451|FG003|Overall Study|Endpoint|2|||
126768325|NCT00742859|456104448|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
126768326|NCT00742859|456104449|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
126768327|NCT00742859|456104450|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
126768328|NCT00742859|456104451|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
126296495|NCT05423093|454373913|FG000|Attended Intervention Session|Lost to Follow-up|3|||
126296496|NCT05423093|454373913|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
126296497|NCT05423093|454373913|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
126296498|NCT02445248|454373914|FG000|Overall Study|Death|45|||
126296499|NCT02445248|454373915|FG001|Overall Study|Death|12|||
126296500|NCT02445248|454373914|FG000|Overall Study|Progressive disease|13|||
126296501|NCT02445248|454373915|FG001|Overall Study|Progressive disease|1|||
126296502|NCT02445248|454373914|FG000|Overall Study|Subject decision|8|||
126296503|NCT02445248|454373915|FG001|Overall Study|Subject decision|0|||
126296504|NCT02445248|454373914|FG000|Overall Study|Physician Decision|5|||
126296505|NCT02445248|454373915|FG001|Overall Study|Physician Decision|0|||
126296506|NCT02445248|454373914|FG000|Overall Study|Adverse Event|1|||
126296507|NCT02445248|454373915|FG001|Overall Study|Adverse Event|0|||
126296508|NCT02445248|454373914|FG000|Overall Study|Lost to Follow-up|1|||
126296509|NCT02445248|454373915|FG001|Overall Study|Lost to Follow-up|0|||
126296510|NCT02596971|454373916|FG000|Overall Study|Death|5|||
126296511|NCT02596971|454373917|FG001|Overall Study|Death|1|||
126296512|NCT02596971|454373918|FG002|Overall Study|Death|5|||
126296513|NCT02596971|454373916|FG000|Overall Study|Withdrawal by Subject|5|||
126296514|NCT02596971|454373917|FG001|Overall Study|Withdrawal by Subject|1|||
126296515|NCT02596971|454373918|FG002|Overall Study|Withdrawal by Subject|4|||
126296516|NCT00595920|454373921|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
126296517|NCT03588910|454373922|FG000|Overall Study|Withdrawal by Subject|1|||
126296518|NCT03588910|454373923|FG001|Overall Study|Withdrawal by Subject|0|||
126296519|NCT03588910|454373922|FG000|Overall Study|Allergy|2|||
126296520|NCT03588910|454373923|FG001|Overall Study|Allergy|0|||
126296521|NCT03588910|454373922|FG000|Overall Study|Protocol Violation|0|||
126296522|NCT03588910|454373923|FG001|Overall Study|Protocol Violation|3|||
126296523|NCT03588910|454373922|FG000|Overall Study|Did not complete Day 1 Survey|5|||
126296524|NCT03588910|454373923|FG001|Overall Study|Did not complete Day 1 Survey|10|||
126296525|NCT03588910|454373922|FG000|Overall Study|Did not complete Day 7 Survey|5|||
126296526|NCT03588910|454373923|FG001|Overall Study|Did not complete Day 7 Survey|2|||
126296527|NCT04565145|454373924|FG000|Overall Study|Withdrawal by Subject|1|||
126296528|NCT04565145|454373925|FG001|Overall Study|Withdrawal by Subject|1|||
126296529|NCT04570670|454373926|FG000|Overall Study|Withdrawal by Subject|1|||
126296530|NCT04570670|454373927|FG001|Overall Study|Withdrawal by Subject|0|||
126296531|NCT00683618|454373928|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
126296532|NCT00683618|454373929|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
126296533|NCT00683618|454373930|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
126296534|NCT00683618|454373928|FG000|Randomised Treatment Period|Protocol Violation|0|||
126296535|NCT00683618|454373929|FG001|Randomised Treatment Period|Protocol Violation|1|||
126296536|NCT00683618|454373930|FG002|Randomised Treatment Period|Protocol Violation|0|||
126296537|NCT00683618|454373928|FG000|Randomised Treatment Period|Adverse Event|2|||
126296538|NCT00683618|454373929|FG001|Randomised Treatment Period|Adverse Event|0|||
126296539|NCT00683618|454373930|FG002|Randomised Treatment Period|Adverse Event|2|||
126296540|NCT00683618|454373928|FG000|Randomised Treatment Period|Reason not provided|0|||
126460904|NCT00219544|454987927|FG000|Single Blind Treatment Period|Protocol Violation|4|||
126768329|NCT00742859|456104448|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
126768330|NCT00742859|456104449|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
126768331|NCT00742859|456104450|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
126768332|NCT00742859|456104451|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
126296541|NCT00683618|454373929|FG001|Randomised Treatment Period|Reason not provided|0|||
126296542|NCT00683618|454373930|FG002|Randomised Treatment Period|Reason not provided|2|||
126296543|NCT00683618|454373928|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
126296544|NCT00683618|454373929|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
126296545|NCT00683618|454373930|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
126296546|NCT00683618|454373928|FG000|Extension Treatment Period|Adverse Event|1|||
126296547|NCT00683618|454373929|FG001|Extension Treatment Period|Adverse Event|0|||
126768333|NCT00742859|456104448|FG000|Overall Study|Sponsor request patient out of town|0|||
126768334|NCT00742859|456104449|FG001|Overall Study|Sponsor request patient out of town|0|||
126768335|NCT00742859|456104450|FG002|Overall Study|Sponsor request patient out of town|1|||
126768336|NCT00742859|456104451|FG003|Overall Study|Sponsor request patient out of town|1|||
126296548|NCT00683618|454373930|FG002|Extension Treatment Period|Adverse Event|0|||
126296549|NCT00683618|454373928|FG000|Extension Treatment Period|Protocol Violation|1|||
126296550|NCT00683618|454373929|FG001|Extension Treatment Period|Protocol Violation|0|||
126296551|NCT00683618|454373930|FG002|Extension Treatment Period|Protocol Violation|0|||
126296552|NCT03802825|454373932|FG000|Overall Study|Lost to follow-up for intervention|12|||
126296553|NCT03802825|454373933|FG001|Overall Study|Lost to follow-up for intervention|3|||
126296554|NCT03802825|454373932|FG000|Overall Study|Received only 1 component of intervention|0|||
126550090|NCT04921969|455307726|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
126550091|NCT04921969|455307727|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
126711443|NCT01645280|455895515|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
126768337|NCT00742859|456104448|FG000|Overall Study|Site error|0|||
126768338|NCT00742859|456104449|FG001|Overall Study|Site error|0|||
126768339|NCT00742859|456104450|FG002|Overall Study|Site error|1|||
126768340|NCT00742859|456104451|FG003|Overall Study|Site error|1|||
126768341|NCT00445458|456104460|FG000|Overall Study|Disease Progression|3|||
126768342|NCT00445458|456104461|FG001|Overall Study|Disease Progression|4|||
126768343|NCT00445458|456104462|FG002|Overall Study|Disease Progression|54|||
126768344|NCT00445458|456104463|FG003|Overall Study|Disease Progression|27|||
126768345|NCT00445458|456104460|FG000|Overall Study|Withdrawal by Subject|0|||
126768346|NCT00445458|456104461|FG001|Overall Study|Withdrawal by Subject|0|||
126768347|NCT00445458|456104462|FG002|Overall Study|Withdrawal by Subject|7|||
126768348|NCT00445458|456104463|FG003|Overall Study|Withdrawal by Subject|0|||
126768349|NCT00445458|456104460|FG000|Overall Study|Adverse Event|0|||
126768350|NCT00445458|456104461|FG001|Overall Study|Adverse Event|0|||
126768351|NCT00445458|456104462|FG002|Overall Study|Adverse Event|3|||
126768352|NCT00445458|456104463|FG003|Overall Study|Adverse Event|0|||
126768353|NCT00445458|456104460|FG000|Overall Study|Death|0|||
126768354|NCT00445458|456104461|FG001|Overall Study|Death|1|||
126768355|NCT00445458|456104462|FG002|Overall Study|Death|2|||
126768356|NCT00445458|456104463|FG003|Overall Study|Death|0|||
126768357|NCT00445458|456104460|FG000|Overall Study|Physician Decision|0|||
126768358|NCT00445458|456104461|FG001|Overall Study|Physician Decision|0|||
126711444|NCT00546819|455895522|FG000|Overall Study|Adverse Event|2|||
126711445|NCT00546819|455895523|FG001|Overall Study|Adverse Event|3|||
126711446|NCT00546819|455895522|FG000|Overall Study|Lost to Follow-up|2|||
126711447|NCT00546819|455895523|FG001|Overall Study|Lost to Follow-up|1|||
126711448|NCT00546819|455895522|FG000|Overall Study|Withdrawal by Subject|4|||
126711449|NCT00546819|455895523|FG001|Overall Study|Withdrawal by Subject|2|||
126711450|NCT02052960|455895525|FG000|Overall Study|Adverse Event|19|||
126711451|NCT02052960|455895526|FG001|Overall Study|Adverse Event|17|||
126711452|NCT02052960|455895525|FG000|Overall Study|Protocol Violation|4|||
126711453|NCT02052960|455895526|FG001|Overall Study|Protocol Violation|3|||
126711454|NCT02052960|455895525|FG000|Overall Study|Withdrawal by Subject|6|||
126711455|NCT02052960|455895526|FG001|Overall Study|Withdrawal by Subject|11|||
126711456|NCT02052960|455895525|FG000|Overall Study|Other|25|||
126711457|NCT02052960|455895526|FG001|Overall Study|Other|15|||
126711458|NCT03849560|455895527|FG000|Overall Study|Withdrawal by Subject|1|||
126711459|NCT03849560|455895528|FG001|Overall Study|Withdrawal by Subject|0|||
126711460|NCT03849560|455895529|FG002|Overall Study|Withdrawal by Subject|0|||
126711461|NCT04045613|455895530|FG000|Overall Study|Adverse Event|2|||
126711462|NCT04045613|455895531|FG001|Overall Study|Adverse Event|2|||
126711463|NCT04045613|455895532|FG002|Overall Study|Adverse Event|1|||
126711464|NCT04045613|455895533|FG003|Overall Study|Adverse Event|1|||
126711465|NCT04045613|455895534|FG004|Overall Study|Adverse Event|0|||
126711466|NCT04045613|455895535|FG005|Overall Study|Adverse Event|0|||
126711467|NCT04045613|455895536|FG006|Overall Study|Adverse Event|1|||
126711468|NCT04045613|455895530|FG000|Overall Study|Withdrawal by Subject|0|||
126711469|NCT04045613|455895531|FG001|Overall Study|Withdrawal by Subject|5|||
126711470|NCT04045613|455895532|FG002|Overall Study|Withdrawal by Subject|0|||
126711471|NCT04045613|455895533|FG003|Overall Study|Withdrawal by Subject|0|||
126711472|NCT04045613|455895534|FG004|Overall Study|Withdrawal by Subject|0|||
126768359|NCT00445458|456104462|FG002|Overall Study|Physician Decision|1|||
126711473|NCT04045613|455895535|FG005|Overall Study|Withdrawal by Subject|1|||
126711474|NCT04045613|455895536|FG006|Overall Study|Withdrawal by Subject|0|||
126711475|NCT04045613|455895530|FG000|Overall Study|Physician Decision|2|||
126711476|NCT04045613|455895531|FG001|Overall Study|Physician Decision|0|||
126768360|NCT00445458|456104463|FG003|Overall Study|Physician Decision|1|||
126768361|NCT00445458|456104460|FG000|Overall Study|Surgery|0|||
126768362|NCT00445458|456104461|FG001|Overall Study|Surgery|0|||
126768363|NCT00445458|456104462|FG002|Overall Study|Surgery|1|||
126768364|NCT00445458|456104463|FG003|Overall Study|Surgery|0|||
126768365|NCT00728988|456104468|FG000|Overall Study|Not Treated|2|||
126296555|NCT03802825|454373933|FG001|Overall Study|Received only 1 component of intervention|13|||
126711477|NCT04045613|455895532|FG002|Overall Study|Physician Decision|0|||
126711478|NCT04045613|455895533|FG003|Overall Study|Physician Decision|0|||
126711479|NCT04045613|455895534|FG004|Overall Study|Physician Decision|1|||
126768366|NCT00728988|456104469|FG001|Overall Study|Not Treated|2|||
126768367|NCT00728988|456104468|FG000|Overall Study|Death|1|||
126768368|NCT00728988|456104469|FG001|Overall Study|Death|1|||
126768369|NCT00728988|456104468|FG000|Overall Study|Adverse Event|3|||
126768370|NCT00728988|456104469|FG001|Overall Study|Adverse Event|2|||
126768371|NCT00728988|456104468|FG000|Overall Study|Other|85|||
126768372|NCT00728988|456104469|FG001|Overall Study|Other|77|||
126768373|NCT00728988|456104468|FG000|Overall Study|Withdrawal by Subject|2|||
126768374|NCT00728988|456104469|FG001|Overall Study|Withdrawal by Subject|6|||
126768375|NCT03186794|456104473|FG000|Overall Study|Physician Decision|2|||
126768376|NCT03186794|456104473|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
126768377|NCT00111007|456104475|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
126768378|NCT00111007|456104476|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
126768379|NCT00111007|456104475|FG000|Double-blind (DB) Treatment|Death|5|||
126768380|NCT00111007|456104476|FG001|Double-blind (DB) Treatment|Death|2|||
126768381|NCT00111007|456104475|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
126768382|NCT00111007|456104476|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
126768383|NCT00111007|456104475|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
126768384|NCT00111007|456104476|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
126768385|NCT00111007|456104475|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
126768386|NCT00111007|456104476|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
126768387|NCT00111007|456104475|FG000|Double-blind (DB) Treatment|Relapse|1|||
126768388|NCT00111007|456104476|FG001|Double-blind (DB) Treatment|Relapse|0|||
126768389|NCT00111007|456104475|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
126768390|NCT00111007|456104476|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
126768391|NCT00111007|456104475|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
126768392|NCT00111007|456104476|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
126768393|NCT00111007|456104475|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
126768394|NCT00111007|456104476|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
126768395|NCT00111007|456104475|FG000|Active Follow-up|Adverse Event|1|||
126768396|NCT00111007|456104476|FG001|Active Follow-up|Adverse Event|0|||
126768397|NCT00111007|456104475|FG000|Active Follow-up|Death|2|||
126768398|NCT00111007|456104476|FG001|Active Follow-up|Death|0|||
126768399|NCT00111007|456104475|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
126768400|NCT00111007|456104476|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
126768401|NCT00111007|456104475|FG000|Long Term Follow-up|Death|34|||
126768402|NCT00111007|456104476|FG001|Long Term Follow-up|Death|39|||
126768403|NCT00111007|456104475|FG000|Long Term Follow-up|Lost to Follow-up|1|||
126768404|NCT00111007|456104476|FG001|Long Term Follow-up|Lost to Follow-up|1|||
126768405|NCT00111007|456104475|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
126768406|NCT00111007|456104476|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
126768407|NCT00111007|456104475|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
126768408|NCT00111007|456104476|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
126768409|NCT00111007|456104475|FG000|Long Term Follow-up|Missing|10|||
126768410|NCT00111007|456104476|FG001|Long Term Follow-up|Missing|3|||
126768411|NCT02380248|456104477|FG000|Overall Study|Lost to Follow-up|11|||
126768412|NCT02380248|456104477|FG000|Overall Study|Withdrawal by Subject|3|||
126768413|NCT00605839|456104478|FG000|Overall Study|Protocol Violation|1|||
126768414|NCT00605839|456104479|FG001|Overall Study|Protocol Violation|0|||
126768415|NCT00605839|456104480|FG002|Overall Study|Protocol Violation|0|||
126768416|NCT02864953|456104481|FG000|Overall Study|Adverse Event|22|||
126768417|NCT02864953|456104482|FG001|Overall Study|Adverse Event|19|||
126768418|NCT02864953|456104481|FG000|Overall Study|Withdrawal by Subject|1|||
126768419|NCT02864953|456104482|FG001|Overall Study|Withdrawal by Subject|0|||
126768420|NCT02864953|456104481|FG000|Overall Study|Physician Decision|4|||
126768421|NCT02864953|456104482|FG001|Overall Study|Physician Decision|2|||
126768422|NCT02864953|456104481|FG000|Overall Study|Death|3|||
126768423|NCT02864953|456104482|FG001|Overall Study|Death|13|||
126768424|NCT02864953|456104481|FG000|Overall Study|Reason not specified|14|||
126768425|NCT02864953|456104482|FG001|Overall Study|Reason not specified|12|||
126550092|NCT04921969|455307728|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
126550093|NCT04921969|455307729|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
126550094|NCT04921969|455307730|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
126550095|NCT04921969|455307724|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
126768426|NCT02864953|456104481|FG000|Overall Study|Withdrew Prior to Dosing|9|||
126768427|NCT02864953|456104482|FG001|Overall Study|Withdrew Prior to Dosing|8|||
126768428|NCT03728257|456104483|FG000|Overall Study|Death|3|||
126768429|NCT03728257|456104484|FG001|Overall Study|Death|0|||
126768430|NCT00621309|456104485|FG000|Overall Study|Withdrawal by Subject|2|||
126768431|NCT00621309|456104486|FG001|Overall Study|Withdrawal by Subject|0|||
126768432|NCT00621309|456104487|FG002|Overall Study|Withdrawal by Subject|1|||
126768433|NCT00621309|456104488|FG003|Overall Study|Withdrawal by Subject|1|||
126768434|NCT00621309|456104489|FG004|Overall Study|Withdrawal by Subject|1|||
126768435|NCT00621309|456104490|FG005|Overall Study|Withdrawal by Subject|1|||
126768436|NCT01381068|456104491|FG000|Overall Study|Death|1|||
126768437|NCT01381068|456104492|FG001|Overall Study|Death|0|||
126768438|NCT02949219|456104500|FG000|Overall Study|Withdrawal by Subject|1|||
126768439|NCT00083226|456104501|FG000|Overall Study|Lack of Efficacy|19|||
126768440|NCT00083226|456104501|FG000|Overall Study|Adverse Event|9|||
126768441|NCT00083226|456104501|FG000|Overall Study|Death|4|||
126768442|NCT00083226|456104501|FG000|Overall Study|Withdrawal by Subject|4|||
126768443|NCT00083226|456104501|FG000|Overall Study|Other|2|||
126768444|NCT00083226|456104501|FG000|Overall Study|ineligible or not receiving treatment|4|||
126768445|NCT00909857|456104502|FG000|Overall Study|Withdrawal by Subject|6|||
126768446|NCT00909857|456104503|FG001|Overall Study|Withdrawal by Subject|10|||
126768447|NCT00909857|456104502|FG000|Overall Study|Adverse Event|5|||
126768448|NCT00909857|456104503|FG001|Overall Study|Adverse Event|5|||
126768449|NCT00909857|456104502|FG000|Overall Study|Lost to Follow-up|2|||
126768450|NCT00909857|456104503|FG001|Overall Study|Lost to Follow-up|5|||
126768451|NCT00909857|456104502|FG000|Overall Study|Protocol Violation|2|||
126711480|NCT04045613|455895535|FG005|Overall Study|Physician Decision|0|||
126711481|NCT04045613|455895536|FG006|Overall Study|Physician Decision|0|||
126711482|NCT04045613|455895530|FG000|Overall Study|Death|3|||
126711483|NCT04045613|455895531|FG001|Overall Study|Death|0|||
126711484|NCT04045613|455895532|FG002|Overall Study|Death|0|||
126711485|NCT04045613|455895533|FG003|Overall Study|Death|0|||
126711486|NCT04045613|455895534|FG004|Overall Study|Death|0|||
126711487|NCT04045613|455895535|FG005|Overall Study|Death|0|||
126711488|NCT04045613|455895536|FG006|Overall Study|Death|1|||
126711489|NCT04045613|455895530|FG000|Overall Study|Other reasons|0|||
126711490|NCT04045613|455895531|FG001|Overall Study|Other reasons|1|||
126711491|NCT04045613|455895532|FG002|Overall Study|Other reasons|0|||
126711492|NCT04045613|455895533|FG003|Overall Study|Other reasons|0|||
126711493|NCT04045613|455895534|FG004|Overall Study|Other reasons|0|||
126711494|NCT04045613|455895535|FG005|Overall Study|Other reasons|0|||
126711495|NCT04045613|455895536|FG006|Overall Study|Other reasons|1|||
126711496|NCT04045613|455895530|FG000|Overall Study|Progressive disease: Clinical progression|1|||
126711497|NCT04045613|455895531|FG001|Overall Study|Progressive disease: Clinical progression|0|||
126711498|NCT04045613|455895532|FG002|Overall Study|Progressive disease: Clinical progression|3|||
126711499|NCT04045613|455895533|FG003|Overall Study|Progressive disease: Clinical progression|1|||
126711500|NCT04045613|455895534|FG004|Overall Study|Progressive disease: Clinical progression|1|||
126711501|NCT04045613|455895535|FG005|Overall Study|Progressive disease: Clinical progression|3|||
126711502|NCT04045613|455895536|FG006|Overall Study|Progressive disease: Clinical progression|3|||
126711503|NCT04045613|455895530|FG000|Overall Study|Progressive disease: Radiological progression|24|||
126711504|NCT04045613|455895531|FG001|Overall Study|Progressive disease: Radiological progression|6|||
126711505|NCT04045613|455895532|FG002|Overall Study|Progressive disease: Radiological progression|8|||
126711506|NCT04045613|455895533|FG003|Overall Study|Progressive disease: Radiological progression|0|||
126711507|NCT04045613|455895534|FG004|Overall Study|Progressive disease: Radiological progression|6|||
126711508|NCT04045613|455895535|FG005|Overall Study|Progressive disease: Radiological progression|6|||
126711509|NCT04045613|455895536|FG006|Overall Study|Progressive disease: Radiological progression|11|||
126711510|NCT04983901|455895537|FG000|Overall Study|Death|1|||
126711511|NCT04983901|455895538|FG001|Overall Study|Death|4|||
126711512|NCT04983901|455895537|FG000|Overall Study|Lost to Follow-up|3|||
126711513|NCT04983901|455895538|FG001|Overall Study|Lost to Follow-up|0|||
126711514|NCT04983901|455895537|FG000|Overall Study|Protocol Violation|1|||
126711515|NCT04983901|455895538|FG001|Overall Study|Protocol Violation|0|||
126711516|NCT04983901|455895537|FG000|Overall Study|Withdrawal by Subject|1|||
126711517|NCT04983901|455895538|FG001|Overall Study|Withdrawal by Subject|2|||
126711518|NCT02859415|455895546|FG000|Overall Study|Physician Decision|1|||
126711519|NCT02859415|455895547|FG001|Overall Study|Physician Decision|0|||
126711520|NCT02859415|455895546|FG000|Overall Study|Off treatment due to cardiac event|0|||
126711521|NCT02859415|455895547|FG001|Overall Study|Off treatment due to cardiac event|1|||
126711522|NCT01174784|455895548|FG000|Overall Study|Screen fails|4|||
126768452|NCT00909857|456104503|FG001|Overall Study|Protocol Violation|1|||
126768453|NCT00909857|456104502|FG000|Overall Study|Pregnancy|1|||
126768454|NCT00909857|456104503|FG001|Overall Study|Pregnancy|0|||
126768455|NCT00909857|456104502|FG000|Overall Study|Other|1|||
126296556|NCT01108718|454373935|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
126296557|NCT01108718|454373936|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
126711523|NCT01507545|455895553|FG000|Overall Study|Withdrawal by Subject|6|||
126711524|NCT01507545|455895554|FG001|Overall Study|Withdrawal by Subject|2|||
126711525|NCT01507545|455895553|FG000|Overall Study|Lost to Follow-up|1|||
126711526|NCT01507545|455895554|FG001|Overall Study|Lost to Follow-up|0|||
126768456|NCT00909857|456104503|FG001|Overall Study|Other|0|||
126711527|NCT01507545|455895553|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
126711528|NCT01507545|455895554|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
126711529|NCT01507545|455895553|FG000|Overall Study|Progressive disease|60|||
126711530|NCT01507545|455895554|FG001|Overall Study|Progressive disease|27|||
126711531|NCT01507545|455895553|FG000|Overall Study|Other|6|||
126768457|NCT00909857|456104502|FG000|Overall Study|Did not receive study medication|19|||
126768458|NCT00909857|456104503|FG001|Overall Study|Did not receive study medication|24|||
126768459|NCT00604175|456104504|FG000|Entry Through Week 28|Death|2|||
126550096|NCT04921969|455307725|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126550097|NCT04921969|455307726|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126550098|NCT04921969|455307727|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126550099|NCT04921969|455307728|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126550100|NCT04921969|455307729|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126550101|NCT04921969|455307730|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126550102|NCT04921969|455307724|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
126550103|NCT04921969|455307725|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
126550104|NCT04921969|455307726|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
126550105|NCT04921969|455307727|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126550106|NCT04921969|455307728|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126550107|NCT04921969|455307729|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126550108|NCT04921969|455307730|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126550109|NCT04921969|455307724|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
126550110|NCT04921969|455307725|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
126550111|NCT04921969|455307726|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
126550112|NCT04921969|455307727|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
126550113|NCT04921969|455307728|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
126550114|NCT04921969|455307729|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
126550115|NCT04921969|455307730|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
126550116|NCT04921969|455307724|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
126550117|NCT04921969|455307725|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
126550118|NCT04921969|455307726|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
126550119|NCT04921969|455307727|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
126550120|NCT04921969|455307728|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
126550121|NCT04921969|455307729|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
126550122|NCT04921969|455307730|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
126550123|NCT04921969|455307724|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
126550124|NCT04921969|455307725|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
126550125|NCT04921969|455307726|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
126550126|NCT04921969|455307727|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126550127|NCT04921969|455307728|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126550128|NCT04921969|455307729|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126550129|NCT04921969|455307730|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126550130|NCT04921969|455307724|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
126550131|NCT04921969|455307725|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
126550132|NCT04921969|455307726|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
126550133|NCT04921969|455307727|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
126550134|NCT04921969|455307728|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
126550135|NCT04921969|455307729|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
126550136|NCT04921969|455307730|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
126550137|NCT04921969|455307724|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
126711532|NCT01507545|455895554|FG001|Overall Study|Other|4|||
126711533|NCT00450866|455895555|FG000|Overall Study|Adverse Event|0|||
126711534|NCT00450866|455895556|FG001|Overall Study|Adverse Event|1|||
126711535|NCT00450866|455895555|FG000|Overall Study|Withdrawal by Subject|5|||
126711536|NCT00450866|455895556|FG001|Overall Study|Withdrawal by Subject|2|||
126711537|NCT00450866|455895555|FG000|Overall Study|Death|1|||
126711538|NCT00450866|455895556|FG001|Overall Study|Death|0|||
126711539|NCT00450866|455895555|FG000|Overall Study|Physician Decision|1|||
126711540|NCT00450866|455895556|FG001|Overall Study|Physician Decision|0|||
126711541|NCT00553787|455895557|FG000|Overall Study|Adverse Event|34|||
126711542|NCT00553787|455895558|FG001|Overall Study|Adverse Event|21|||
126711543|NCT00553787|455895559|FG002|Overall Study|Adverse Event|67|||
126711544|NCT00553787|455895557|FG000|Overall Study|Lost to Follow-up|132|||
126711545|NCT00553787|455895558|FG001|Overall Study|Lost to Follow-up|44|||
126711546|NCT00553787|455895559|FG002|Overall Study|Lost to Follow-up|78|||
126711547|NCT00553787|455895557|FG000|Overall Study|Withdrawal by Subject|151|||
126711548|NCT00553787|455895558|FG001|Overall Study|Withdrawal by Subject|40|||
126711549|NCT00553787|455895559|FG002|Overall Study|Withdrawal by Subject|83|||
126711550|NCT00553787|455895557|FG000|Overall Study|Lack of Efficacy|31|||
126711551|NCT00553787|455895558|FG001|Overall Study|Lack of Efficacy|1|||
126711552|NCT00553787|455895559|FG002|Overall Study|Lack of Efficacy|3|||
126711553|NCT00553787|455895557|FG000|Overall Study|Pregnancy|0|||
126711554|NCT00553787|455895558|FG001|Overall Study|Pregnancy|1|||
126711555|NCT00553787|455895559|FG002|Overall Study|Pregnancy|2|||
126711556|NCT00553787|455895557|FG000|Overall Study|non compliance|4|||
126711557|NCT00553787|455895558|FG001|Overall Study|non compliance|0|||
126711558|NCT00553787|455895559|FG002|Overall Study|non compliance|11|||
126711559|NCT00553787|455895557|FG000|Overall Study|Requirement for restricted medication|8|||
126711560|NCT00553787|455895558|FG001|Overall Study|Requirement for restricted medication|7|||
126711561|NCT00553787|455895559|FG002|Overall Study|Requirement for restricted medication|5|||
126296558|NCT00806403|454373939|FG000|Overall Study|Death|4|||
126296559|NCT00806403|454373940|FG001|Overall Study|Death|3|||
126296560|NCT01882985|454373941|FG000|Overall Study|Lost to Follow-up|1|||
126296561|NCT01882985|454373941|FG000|Overall Study|Withdrawal by Subject|1|||
126296562|NCT01827111|454373942|FG000|Overall Study|Disease Progression|1|||
126296563|NCT02962648|454373943|FG000|Overall Study|Withdrawal by Subject|3|||
126296564|NCT02962648|454373943|FG000|Overall Study|Lost to Follow-up|3|||
126296565|NCT02962648|454373943|FG000|Overall Study|Physician Decision|1|||
126296566|NCT02962648|454373943|FG000|Overall Study|Subject had problems with transportation|2|||
126296567|NCT01597778|454373944|FG000|Overall Study|Death|7|||
126296568|NCT01597778|454373945|FG001|Overall Study|Death|10|||
126296569|NCT01597778|454373944|FG000|Overall Study|Withdrawal by Subject|3|||
126296570|NCT01597778|454373945|FG001|Overall Study|Withdrawal by Subject|4|||
126296571|NCT01597778|454373944|FG000|Overall Study|Adverse Event|1|||
126296572|NCT01597778|454373945|FG001|Overall Study|Adverse Event|1|||
126296573|NCT01597778|454373944|FG000|Overall Study|Protocol Violation|1|||
126296574|NCT01597778|454373945|FG001|Overall Study|Protocol Violation|11|||
126296575|NCT01597778|454373944|FG000|Overall Study|Transplanted off protocol|2|||
126296576|NCT01597778|454373945|FG001|Overall Study|Transplanted off protocol|3|||
126296577|NCT04383327|454373947|FG000|Overall Study|Lost to Follow-up|112|||
126296578|NCT04383327|454373948|FG001|Overall Study|Lost to Follow-up|14|||
126296579|NCT04383327|454373949|FG002|Overall Study|Lost to Follow-up|78|||
126296580|NCT04383327|454373950|FG003|Overall Study|Lost to Follow-up|13|||
126296581|NCT04383327|454373951|FG004|Overall Study|Lost to Follow-up|110|||
126296582|NCT04383327|454373952|FG005|Overall Study|Lost to Follow-up|13|||
126296583|NCT04383327|454373953|FG006|Overall Study|Lost to Follow-up|74|||
126296584|NCT04383327|454373954|FG007|Overall Study|Lost to Follow-up|13|||
126296585|NCT04383327|454373955|FG008|Overall Study|Lost to Follow-up|78|||
126296586|NCT04383327|454373956|FG009|Overall Study|Lost to Follow-up|10|||
126296587|NCT04383327|454373957|FG010|Overall Study|Lost to Follow-up|160|||
126296588|NCT04383327|454373958|FG011|Overall Study|Lost to Follow-up|13|||
126296589|NCT01289678|454373959|FG000|Overall Study|Physician Decision|6|||
126296590|NCT00468819|454373960|FG000|Overall Study|Withdrawal by Subject|4|||
126296591|NCT00468819|454373961|FG001|Overall Study|Withdrawal by Subject|0|||
126296592|NCT00468819|454373962|FG002|Overall Study|Withdrawal by Subject|1|||
126296593|NCT00468819|454373960|FG000|Overall Study|Lost to Follow-up|0|||
126296594|NCT00468819|454373961|FG001|Overall Study|Lost to Follow-up|0|||
126296595|NCT00468819|454373962|FG002|Overall Study|Lost to Follow-up|1|||
126296596|NCT00468819|454373960|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
126296597|NCT00468819|454373961|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
126296598|NCT00468819|454373962|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
126296599|NCT04030299|454373963|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
126296600|NCT04030299|454373963|FG000|Overall Study|Withdrawal by Subject|3|||
126296601|NCT04740918|454373964|FG000|Overall Study|Study Terminated by Sponsor|41|||
126296602|NCT04740918|454373965|FG001|Overall Study|Study Terminated by Sponsor|32|||
126296603|NCT04740918|454373964|FG000|Overall Study|Death|3|||
126296604|NCT04740918|454373965|FG001|Overall Study|Death|6|||
126296605|NCT04740918|454373964|FG000|Overall Study|Withdrawal by Subject|5|||
126296606|NCT04740918|454373965|FG001|Overall Study|Withdrawal by Subject|4|||
126296607|NCT04740918|454373964|FG000|Overall Study|Lost to Follow-up|1|||
126296608|NCT04740918|454373965|FG001|Overall Study|Lost to Follow-up|3|||
126550138|NCT04921969|455307725|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
126550139|NCT04921969|455307726|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
126550140|NCT04921969|455307727|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
126296609|NCT04740918|454373964|FG000|Overall Study|Progressive disease|0|||
126296610|NCT04740918|454373965|FG001|Overall Study|Progressive disease|1|||
126296611|NCT02524847|454373966|FG000|Overall Study|Adverse Event|4|||
126296612|NCT02524847|454373966|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
126296613|NCT02524847|454373966|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
126711562|NCT00553787|455895557|FG000|Overall Study|Other|18|||
126296614|NCT02524847|454373966|FG000|Overall Study|Death|1|||
126296615|NCT02524847|454373966|FG000|Overall Study|Reason not Specified|1|||
126296616|NCT04352101|454373967|FG000|Overall Study|Physician Decision|2|||
126296617|NCT04352101|454373968|FG001|Overall Study|Physician Decision|1|||
126550141|NCT04921969|455307728|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
126711563|NCT00553787|455895558|FG001|Overall Study|Other|10|||
126711564|NCT00553787|455895559|FG002|Overall Study|Other|13|||
126711565|NCT02285010|455895560|FG000|Overall Study|not abdominal hysterectomy|2|||
126711566|NCT02285010|455895561|FG001|Overall Study|not abdominal hysterectomy|0|||
126711567|NCT02285010|455895560|FG000|Overall Study|Not spinal anesthesia|3|||
126711568|NCT02285010|455895561|FG001|Overall Study|Not spinal anesthesia|1|||
126711569|NCT01426386|455895565|FG000|Overall Study|Adverse Event|0|||
126711570|NCT01426386|455895566|FG001|Overall Study|Adverse Event|1|||
126711571|NCT01426386|455895567|FG002|Overall Study|Adverse Event|0|||
126711572|NCT01426386|455895568|FG003|Overall Study|Adverse Event|0|||
126711573|NCT01426386|455895569|FG004|Overall Study|Adverse Event|0|||
126711574|NCT01426386|455895570|FG005|Overall Study|Adverse Event|0|||
126711575|NCT01426386|455895565|FG000|Overall Study|Did not attend scheduled visit|1|||
126550142|NCT04921969|455307729|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
126550143|NCT04921969|455307730|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
126550144|NCT04921969|455307724|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126550145|NCT04921969|455307725|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126550146|NCT04921969|455307726|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126296618|NCT01288079|454373976|FG000|Overall Study|Withdrawal by Subject|2|||
126296619|NCT01288079|454373977|FG001|Overall Study|Withdrawal by Subject|4|||
126296620|NCT01288079|454373978|FG002|Overall Study|Withdrawal by Subject|1|||
126296621|NCT01288079|454373979|FG003|Overall Study|Withdrawal by Subject|0|||
126296622|NCT01288079|454373976|FG000|Overall Study|Adverse Event|2|||
126296623|NCT01288079|454373977|FG001|Overall Study|Adverse Event|1|||
126296624|NCT01288079|454373978|FG002|Overall Study|Adverse Event|2|||
126296625|NCT01288079|454373979|FG003|Overall Study|Adverse Event|3|||
126296626|NCT01288079|454373976|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
126296627|NCT01288079|454373977|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
126296628|NCT01288079|454373978|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
126296629|NCT01288079|454373979|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
126296630|NCT01288079|454373976|FG000|Overall Study|Condition under Investigation Worsened|0|||
126296631|NCT01288079|454373977|FG001|Overall Study|Condition under Investigation Worsened|0|||
126296632|NCT01288079|454373978|FG002|Overall Study|Condition under Investigation Worsened|0|||
126366956|NCT01051661|454639366|FG005|Overall Study|Failure to comply with protocol|0|||
126550147|NCT04921969|455307727|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
126550148|NCT04921969|455307728|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126550149|NCT04921969|455307729|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
126550150|NCT04921969|455307730|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
126550151|NCT04921969|455307724|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126550152|NCT04921969|455307725|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126550153|NCT04921969|455307726|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126550154|NCT04921969|455307727|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
126550155|NCT04921969|455307728|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
126550156|NCT04921969|455307729|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
126550157|NCT04921969|455307730|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
126550158|NCT04921969|455307724|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
126550159|NCT04921969|455307725|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
126550160|NCT04921969|455307726|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
126550161|NCT04921969|455307727|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
126550162|NCT04921969|455307728|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
126550163|NCT04921969|455307729|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
126550164|NCT04921969|455307730|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
126550165|NCT04921969|455307724|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126550166|NCT04921969|455307725|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126550167|NCT04921969|455307726|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126550168|NCT04921969|455307727|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
126550169|NCT04921969|455307728|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
126550170|NCT04921969|455307729|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
126550171|NCT04921969|455307730|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
126550172|NCT04921969|455307724|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
126550173|NCT04921969|455307725|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
126550174|NCT04921969|455307726|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
126550175|NCT04921969|455307727|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
126550176|NCT04921969|455307728|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
126550177|NCT04921969|455307729|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
126550178|NCT04921969|455307730|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
126711576|NCT01426386|455895566|FG001|Overall Study|Did not attend scheduled visit|4|||
126711577|NCT01426386|455895567|FG002|Overall Study|Did not attend scheduled visit|0|||
126711578|NCT01426386|455895568|FG003|Overall Study|Did not attend scheduled visit|0|||
126711579|NCT01426386|455895569|FG004|Overall Study|Did not attend scheduled visit|2|||
126711580|NCT01426386|455895570|FG005|Overall Study|Did not attend scheduled visit|1|||
126711581|NCT01426386|455895565|FG000|Overall Study|Poor response|2|||
126711582|NCT01426386|455895566|FG001|Overall Study|Poor response|1|||
126711583|NCT01426386|455895567|FG002|Overall Study|Poor response|2|||
126711584|NCT01426386|455895568|FG003|Overall Study|Poor response|0|||
126711585|NCT01426386|455895569|FG004|Overall Study|Poor response|1|||
126711586|NCT01426386|455895570|FG005|Overall Study|Poor response|0|||
126711587|NCT01426386|455895565|FG000|Overall Study|Personal reasons|0|||
126711588|NCT01426386|455895566|FG001|Overall Study|Personal reasons|0|||
126711589|NCT01426386|455895567|FG002|Overall Study|Personal reasons|0|||
126711590|NCT01426386|455895568|FG003|Overall Study|Personal reasons|0|||
126711591|NCT01426386|455895569|FG004|Overall Study|Personal reasons|1|||
126296633|NCT01288079|454373979|FG003|Overall Study|Condition under Investigation Worsened|1|||
126296634|NCT01288079|454373976|FG000|Overall Study|Lack of Efficacy|2|||
126296635|NCT01288079|454373977|FG001|Overall Study|Lack of Efficacy|2|||
126296636|NCT01288079|454373978|FG002|Overall Study|Lack of Efficacy|0|||
126296637|NCT01288079|454373979|FG003|Overall Study|Lack of Efficacy|2|||
126296638|NCT01288079|454373976|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
126296639|NCT01288079|454373977|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
126296640|NCT01288079|454373978|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
126296641|NCT01288079|454373979|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
126296642|NCT01288079|454373976|FG000|Overall Study|Lost to Follow-up|1|||
126296643|NCT01288079|454373977|FG001|Overall Study|Lost to Follow-up|1|||
126296644|NCT01288079|454373978|FG002|Overall Study|Lost to Follow-up|1|||
126296645|NCT01288079|454373979|FG003|Overall Study|Lost to Follow-up|0|||
126296646|NCT01288079|454373976|FG000|Overall Study|Other or Study Termination|11|||
126296647|NCT01288079|454373977|FG001|Overall Study|Other or Study Termination|15|||
126296648|NCT01288079|454373978|FG002|Overall Study|Other or Study Termination|14|||
126296649|NCT01288079|454373979|FG003|Overall Study|Other or Study Termination|8|||
126296650|NCT01530464|454373980|FG000|Washout (24h)|Withdrawal by Subject|1|||
126296651|NCT01530464|454373981|FG001|Washout (24h)|Withdrawal by Subject|0|||
126296652|NCT01530464|454373980|FG000|Washout (24h)|Withdrawal by Subject|0|||
126296653|NCT01530464|454373981|FG001|Washout (24h)|Withdrawal by Subject|1|||
126296654|NCT03170544|454373982|FG000|Part 1|Lost to Follow-up|1|||
126296655|NCT03170544|454373983|FG001|Part 1|Lost to Follow-up|0|||
126296656|NCT03170544|454373984|FG002|Part 1|Lost to Follow-up|0|||
126296657|NCT03170544|454373985|FG003|Part 1|Lost to Follow-up|0|||
126296658|NCT03170544|454373986|FG004|Part 1|Lost to Follow-up|0|||
126296659|NCT03170544|454373987|FG005|Part 1|Lost to Follow-up|0|||
126296660|NCT03170544|454373988|FG006|Part 1|Lost to Follow-up|0|||
126296661|NCT03170544|454373989|FG007|Part 1|Lost to Follow-up|0|||
126296662|NCT03170544|454373990|FG008|Part 1|Lost to Follow-up|0|||
126296663|NCT03170544|454373991|FG009|Part 1|Lost to Follow-up|0|||
126296664|NCT03170544|454373992|FG010|Part 1|Lost to Follow-up|0|||
126296665|NCT03170544|454373993|FG011|Part 1|Lost to Follow-up|0|||
126296666|NCT03170544|454373982|FG000|Part 1|Not treated|0|||
126296667|NCT03170544|454373983|FG001|Part 1|Not treated|0|||
126296668|NCT03170544|454373984|FG002|Part 1|Not treated|0|||
126296669|NCT03170544|454373985|FG003|Part 1|Not treated|1|||
126296670|NCT03170544|454373986|FG004|Part 1|Not treated|0|||
126296671|NCT03170544|454373987|FG005|Part 1|Not treated|0|||
126296672|NCT03170544|454373988|FG006|Part 1|Not treated|0|||
126296673|NCT03170544|454373989|FG007|Part 1|Not treated|0|||
126296674|NCT03170544|454373990|FG008|Part 1|Not treated|0|||
126296675|NCT03170544|454373991|FG009|Part 1|Not treated|0|||
126296676|NCT03170544|454373992|FG010|Part 1|Not treated|0|||
126296677|NCT03170544|454373993|FG011|Part 1|Not treated|0|||
126296678|NCT00908544|454373994|FG000|Overall Study|Withdrawal by Subject|2|||
126296679|NCT00908544|454373995|FG001|Overall Study|Withdrawal by Subject|4|||
126296680|NCT00908544|454373994|FG000|Overall Study|Lack of Efficacy|0|||
126296681|NCT00908544|454373995|FG001|Overall Study|Lack of Efficacy|1|||
126296682|NCT00908544|454373994|FG000|Overall Study|Pregnancy|1|||
126296683|NCT00908544|454373995|FG001|Overall Study|Pregnancy|0|||
126296684|NCT00908544|454373994|FG000|Overall Study|Relocation abroad|1|||
126296685|NCT00908544|454373995|FG001|Overall Study|Relocation abroad|1|||
126296686|NCT00908544|454373994|FG000|Overall Study|Unable to visit sutdy center|1|||
126296687|NCT00908544|454373995|FG001|Overall Study|Unable to visit sutdy center|0|||
126296688|NCT02387840|454373996|FG000|Overall Study|Death|0|||
126296689|NCT02387840|454373997|FG001|Overall Study|Death|0|||
126296690|NCT02387840|454373998|FG002|Overall Study|Death|0|||
126296691|NCT02387840|454373999|FG003|Overall Study|Death|0|||
126296692|NCT02387840|454374000|FG004|Overall Study|Death|0|||
126296693|NCT02387840|454374001|FG005|Overall Study|Death|1|||
126296694|NCT03539302|454374009|FG000|Overall Study|Spontaneous cardio version|0|||
126296695|NCT03539302|454374010|FG001|Overall Study|Spontaneous cardio version|0|||
126296696|NCT03539302|454374011|FG002|Overall Study|Spontaneous cardio version|0|||
126296697|NCT03539302|454374012|FG003|Overall Study|Spontaneous cardio version|0|||
126296698|NCT03539302|454374013|FG004|Overall Study|Spontaneous cardio version|0|||
126296699|NCT03539302|454374014|FG005|Overall Study|Spontaneous cardio version|1|||
126296700|NCT03539302|454374015|FG006|Overall Study|Spontaneous cardio version|1|||
126296701|NCT02174627|454374019|FG000|Overall Study|Missing|0|||
126296702|NCT02174627|454374020|FG001|Overall Study|Missing|1|||
126296703|NCT02174627|454374019|FG000|Overall Study|Incorrect enrolment before randomization|0|||
126296704|NCT02174627|454374020|FG001|Overall Study|Incorrect enrolment before randomization|1|||
126296705|NCT02174627|454374019|FG000|Overall Study|Participant decision|84|||
126296706|NCT02174627|454374020|FG001|Overall Study|Participant decision|128|||
126296707|NCT04564092|454374021|FG000|Overall Study|Withdrawal by Subject|1|||
126296708|NCT00071110|454374022|FG000|Overall Study|Protocol Violation|0|||
126296709|NCT00071110|454374023|FG001|Overall Study|Protocol Violation|4|||
126296710|NCT02107131|454374024|FG000|Overall Study|Lost to Follow-up|4|||
126296711|NCT02107131|454374025|FG001|Overall Study|Lost to Follow-up|4|||
126296712|NCT02107131|454374024|FG000|Overall Study|Physician Decision|1|||
126296713|NCT02107131|454374025|FG001|Overall Study|Physician Decision|0|||
126296714|NCT02107131|454374024|FG000|Overall Study|Withdrawal by Subject|2|||
126296715|NCT02107131|454374025|FG001|Overall Study|Withdrawal by Subject|0|||
126296716|NCT02107131|454374024|FG000|Overall Study|mental instability|1|||
126296717|NCT02107131|454374025|FG001|Overall Study|mental instability|0|||
126296718|NCT02107131|454374024|FG000|Overall Study|Death|0|||
126296719|NCT02107131|454374025|FG001|Overall Study|Death|1|||
126296720|NCT02107131|454374024|FG000|Overall Study|Protocol Violation|0|||
126296721|NCT02107131|454374025|FG001|Overall Study|Protocol Violation|4|||
126296722|NCT02389829|454374028|FG000|Overall Study|Lost to Follow-up|0|||
126296723|NCT02389829|454374029|FG001|Overall Study|Lost to Follow-up|1|||
126296724|NCT02362360|454374030|FG000|Period 1|Lack of Efficacy|1|||
126296725|NCT02362360|454374031|FG001|Period 1|Lack of Efficacy|0|||
126296726|NCT02362360|454374030|FG000|Period 1|Withdrawal by Subject|2|||
126296727|NCT02362360|454374031|FG001|Period 1|Withdrawal by Subject|1|||
126296728|NCT03578367|454374032|FG000|Overall Study|Adverse Event|0|||
126296729|NCT03578367|454374033|FG001|Overall Study|Adverse Event|3|||
126296730|NCT03578367|454374034|FG002|Overall Study|Adverse Event|0|||
126296731|NCT03578367|454374035|FG003|Overall Study|Adverse Event|5|||
126296732|NCT03578367|454374032|FG000|Overall Study|Withdrawal by Subject|2|||
126296733|NCT03578367|454374033|FG001|Overall Study|Withdrawal by Subject|2|||
126296734|NCT03578367|454374034|FG002|Overall Study|Withdrawal by Subject|1|||
126296735|NCT03578367|454374035|FG003|Overall Study|Withdrawal by Subject|3|||
126296736|NCT03578367|454374032|FG000|Overall Study|Physician Decision|0|||
126296737|NCT03578367|454374033|FG001|Overall Study|Physician Decision|0|||
126296738|NCT03578367|454374034|FG002|Overall Study|Physician Decision|14|||
126296739|NCT03578367|454374035|FG003|Overall Study|Physician Decision|0|||
126296740|NCT03578367|454374032|FG000|Overall Study|Death|1|||
126296741|NCT03578367|454374033|FG001|Overall Study|Death|0|||
126296742|NCT03578367|454374034|FG002|Overall Study|Death|0|||
126296743|NCT03578367|454374035|FG003|Overall Study|Death|0|||
126296744|NCT03578367|454374032|FG000|Overall Study|Not treated|0|||
126296745|NCT03578367|454374033|FG001|Overall Study|Not treated|0|||
126296746|NCT03578367|454374034|FG002|Overall Study|Not treated|1|||
126296747|NCT03578367|454374035|FG003|Overall Study|Not treated|0|||
126296748|NCT02729025|454374036|FG000|Overall Study|Sponsor Decision|0|||
126296749|NCT02729025|454374037|FG001|Overall Study|Sponsor Decision|1|||
126296750|NCT04815083|454375316|FG000|Overall Study|Physician Decision|1|||
126296751|NCT04815083|454375316|FG000|Overall Study|Study pause|2|||
126296752|NCT04815083|454375316|FG000|Overall Study|Screening failure|4|||
126296753|NCT05364931|454375319|FG000|Overall Study|Adverse Event|0|||
126711592|NCT01426386|455895570|FG005|Overall Study|Personal reasons|0|||
126711593|NCT01096667|455895571|FG000|Overall Study|Lost to Follow-up|1|||
126711594|NCT01096667|455895572|FG001|Overall Study|Lost to Follow-up|1|||
126711595|NCT01096667|455895573|FG002|Overall Study|Lost to Follow-up|1|||
126711596|NCT01096667|455895574|FG003|Overall Study|Lost to Follow-up|0|||
126711597|NCT01096667|455895575|FG004|Overall Study|Lost to Follow-up|0|||
126711598|NCT01096667|455895571|FG000|Overall Study|Withdrawal by Subject|1|||
126711599|NCT01096667|455895572|FG001|Overall Study|Withdrawal by Subject|0|||
126711600|NCT01096667|455895573|FG002|Overall Study|Withdrawal by Subject|0|||
126711601|NCT01096667|455895574|FG003|Overall Study|Withdrawal by Subject|1|||
126711602|NCT01096667|455895575|FG004|Overall Study|Withdrawal by Subject|0|||
126711603|NCT01096667|455895571|FG000|Overall Study|Reason not available|0|||
126711604|NCT01096667|455895572|FG001|Overall Study|Reason not available|1|||
126711605|NCT01096667|455895573|FG002|Overall Study|Reason not available|1|||
126711606|NCT01096667|455895574|FG003|Overall Study|Reason not available|1|||
126711607|NCT01096667|455895575|FG004|Overall Study|Reason not available|0|||
126711608|NCT01096667|455895571|FG000|Overall Study|Protocol Violation|0|||
126296754|NCT05364931|454375320|FG001|Overall Study|Adverse Event|2|||
126296755|NCT05364931|454375321|FG002|Overall Study|Adverse Event|1|||
126296756|NCT05364931|454375322|FG003|Overall Study|Adverse Event|0|||
126296757|NCT05364931|454375319|FG000|Overall Study|Lost to Follow-up|1|||
126296758|NCT05364931|454375320|FG001|Overall Study|Lost to Follow-up|0|||
126296759|NCT05364931|454375321|FG002|Overall Study|Lost to Follow-up|0|||
126296760|NCT05364931|454375322|FG003|Overall Study|Lost to Follow-up|0|||
126296761|NCT05364931|454375319|FG000|Overall Study|Withdrawal by Subject|1|||
126296762|NCT05364931|454375320|FG001|Overall Study|Withdrawal by Subject|1|||
126296763|NCT05364931|454375321|FG002|Overall Study|Withdrawal by Subject|3|||
126711609|NCT01096667|455895572|FG001|Overall Study|Protocol Violation|0|||
126711610|NCT01096667|455895573|FG002|Overall Study|Protocol Violation|0|||
126711611|NCT01096667|455895574|FG003|Overall Study|Protocol Violation|1|||
126711612|NCT01096667|455895575|FG004|Overall Study|Protocol Violation|0|||
126296764|NCT05364931|454375322|FG003|Overall Study|Withdrawal by Subject|2|||
126296765|NCT05364931|454375319|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
126296766|NCT05364931|454375320|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
126296767|NCT05364931|454375321|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
126711613|NCT01096667|455895571|FG000|Overall Study|Not treated|1|||
126296768|NCT05364931|454375322|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
126296769|NCT05364931|454375319|FG000|Overall Study|Discontinued|1|||
126296770|NCT05364931|454375320|FG001|Overall Study|Discontinued|0|||
126296771|NCT05364931|454375321|FG002|Overall Study|Discontinued|0|||
126296772|NCT05364931|454375322|FG003|Overall Study|Discontinued|0|||
126296773|NCT03504397|454375330|FG000|Overall Study|Progressive Disease|151|||
126296774|NCT03504397|454375331|FG001|Overall Study|Progressive Disease|199|||
126296775|NCT03504397|454375330|FG000|Overall Study|Withdrawal by Subject|29|||
126296776|NCT03504397|454375331|FG001|Overall Study|Withdrawal by Subject|17|||
126296777|NCT03504397|454375330|FG000|Overall Study|Lost to Follow-up|1|||
126296778|NCT03504397|454375331|FG001|Overall Study|Lost to Follow-up|0|||
126296779|NCT03504397|454375330|FG000|Overall Study|Death|14|||
126296780|NCT03504397|454375331|FG001|Overall Study|Death|16|||
126296781|NCT03504397|454375330|FG000|Overall Study|Adverse Event|40|||
126296782|NCT03504397|454375331|FG001|Overall Study|Adverse Event|14|||
126296783|NCT03504397|454375330|FG000|Overall Study|miscellaneous|17|||
126296784|NCT03504397|454375331|FG001|Overall Study|miscellaneous|15|||
126296785|NCT03504397|454375330|FG000|Overall Study|Protocol deviation|1|||
126296786|NCT03504397|454375331|FG001|Overall Study|Protocol deviation|0|||
126296787|NCT03504397|454375330|FG000|Overall Study|Participants who did not take the study drug|4|||
126296788|NCT03504397|454375331|FG001|Overall Study|Participants who did not take the study drug|4|||
126296789|NCT01662635|454375332|FG000|Overall Study|scarce samples for evaluation|30|||
126296790|NCT00351468|454375333|FG000|Overall Study|Adverse Event|42|||
126296791|NCT00351468|454375333|FG000|Overall Study|Withdrawal by Subject|39|||
126296792|NCT00351468|454375333|FG000|Overall Study|Various -follow up w clinical team|39|||
126768460|NCT00604175|456104505|FG001|Entry Through Week 28|Death|0|||
126768461|NCT00604175|456104506|FG002|Entry Through Week 28|Death|0|||
126768462|NCT00604175|456104504|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
126768463|NCT00604175|456104505|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
126768464|NCT00604175|456104506|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
126768465|NCT00604175|456104504|FG000|Entry Through Week 28|Lost to Follow-up|4|||
126768466|NCT00604175|456104505|FG001|Entry Through Week 28|Lost to Follow-up|3|||
126768467|NCT00604175|456104506|FG002|Entry Through Week 28|Lost to Follow-up|0|||
126296793|NCT00351468|454375333|FG000|Overall Study|Lack of Efficacy|32|||
126550179|NCT04921969|455307724|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
126550180|NCT04921969|455307725|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
126768468|NCT00604175|456104504|FG000|Entry Through Week 28|Ineligible|1|||
126768469|NCT00604175|456104505|FG001|Entry Through Week 28|Ineligible|0|||
126768470|NCT00604175|456104506|FG002|Entry Through Week 28|Ineligible|0|||
126768471|NCT00604175|456104504|FG000|Entry Through Week 28|Did not start intervention|2|||
126768472|NCT00604175|456104505|FG001|Entry Through Week 28|Did not start intervention|0|||
126768473|NCT00604175|456104506|FG002|Entry Through Week 28|Did not start intervention|1|||
126768474|NCT00604175|456104504|FG000|Week 29 Through Week 72|Death|0|||
126768475|NCT00604175|456104505|FG001|Week 29 Through Week 72|Death|0|||
126768476|NCT00604175|456104506|FG002|Week 29 Through Week 72|Death|1|||
126768477|NCT00604175|456104504|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
126768478|NCT00604175|456104505|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
126768479|NCT00604175|456104506|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
126768480|NCT00604175|456104504|FG000|Week 29 Through Week 72|Site closure|0|||
126768481|NCT00604175|456104505|FG001|Week 29 Through Week 72|Site closure|1|||
126768482|NCT00604175|456104506|FG002|Week 29 Through Week 72|Site closure|0|||
126768483|NCT00604175|456104504|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
126768484|NCT00604175|456104505|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
126768485|NCT00604175|456104506|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
126768486|NCT03205163|456104507|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
126768487|NCT03205163|456104508|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
126768488|NCT00359073|456106824|FG000|Overall Study|Withdrawal by Subject|1|||
126768489|NCT00359073|456106825|FG001|Overall Study|Withdrawal by Subject|1|||
126768490|NCT00359073|456106824|FG000|Overall Study|Eligibility criteria no longer met|3|||
126768491|NCT00359073|456106825|FG001|Overall Study|Eligibility criteria no longer met|0|||
126296794|NCT00351468|454375333|FG000|Overall Study|Non-compliance|8|||
126296795|NCT00351468|454375333|FG000|Overall Study|Lost to Follow-up|4|||
126296796|NCT00351468|454375333|FG000|Overall Study|Protocol Violation|3|||
126296797|NCT00611923|454375334|FG000|Overall Study|Withdrawal by Subject|2|||
126296798|NCT00611923|454375335|FG001|Overall Study|Withdrawal by Subject|2|||
126296799|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
126296800|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
126296801|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
126296802|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
126296803|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
126296804|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
126296805|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
126550181|NCT04921969|455307726|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
126768492|NCT00359073|456106824|FG000|Overall Study|developed RV16 antibody|0|||
126768493|NCT00359073|456106825|FG001|Overall Study|developed RV16 antibody|1|||
126768494|NCT03387423|456106826|FG000|Overall Study|Lost to Follow-up|16|||
126768495|NCT03387423|456106827|FG001|Overall Study|Lost to Follow-up|12|||
126296806|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
126768496|NCT03387423|456106828|FG002|Overall Study|Lost to Follow-up|1|||
126768497|NCT03387423|456106829|FG003|Overall Study|Lost to Follow-up|0|||
126768498|NCT03387423|456106826|FG000|Overall Study|Other|0|||
126296807|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
126296808|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
126296809|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
126296810|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
126296811|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
126296812|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
126296813|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
126296814|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
126768499|NCT03387423|456106827|FG001|Overall Study|Other|3|||
126768500|NCT03387423|456106828|FG002|Overall Study|Other|0|||
126768501|NCT03387423|456106829|FG003|Overall Study|Other|0|||
126768502|NCT03387423|456106826|FG000|Overall Study|Administrative Reason|166|||
126768503|NCT03387423|456106827|FG001|Overall Study|Administrative Reason|89|||
126768504|NCT03387423|456106828|FG002|Overall Study|Administrative Reason|17|||
126296815|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
126296816|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
126296817|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
126296818|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
126296819|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
126296820|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
126296821|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
126296822|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
126296823|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
126296824|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
126296825|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
126296826|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
126296827|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
126296828|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
126296829|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
126296830|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
126296831|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
126550182|NCT04921969|455307727|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
126550183|NCT04921969|455307728|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
126550184|NCT04921969|455307729|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
126550185|NCT04921969|455307730|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
126550186|NCT04921969|455307724|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
126550187|NCT04921969|455307725|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
126550188|NCT04921969|455307726|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
126550189|NCT04921969|455307727|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
126550190|NCT04921969|455307728|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
126768505|NCT03387423|456106829|FG003|Overall Study|Administrative Reason|19|||
126768506|NCT03387423|456106826|FG000|Overall Study|Revocation Consent|76|||
126768507|NCT03387423|456106827|FG001|Overall Study|Revocation Consent|32|||
126768508|NCT03387423|456106828|FG002|Overall Study|Revocation Consent|3|||
126768509|NCT03387423|456106829|FG003|Overall Study|Revocation Consent|5|||
126768510|NCT01371006|456106830|FG000|Overall Study|Adverse Event|1|||
126768511|NCT01371006|456106831|FG001|Overall Study|Adverse Event|0|||
126768512|NCT03515837|456106832|FG000|Overall Study|Death|219|||
126768513|NCT03515837|456106833|FG001|Overall Study|Death|227|||
126768514|NCT03515837|456106832|FG000|Overall Study|Lost to Follow-up|0|||
126768515|NCT03515837|456106833|FG001|Overall Study|Lost to Follow-up|1|||
126768516|NCT03515837|456106832|FG000|Overall Study|Withdrawal by Subject|0|||
126768517|NCT03515837|456106833|FG001|Overall Study|Withdrawal by Subject|4|||
126768518|NCT03515837|456106832|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
126768519|NCT03515837|456106833|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
126768520|NCT01964898|456106834|FG000|Overall Study|ineligible post-randomization|1|||
126768521|NCT01964898|456106835|FG001|Overall Study|ineligible post-randomization|1|||
126296832|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
126296833|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
126296834|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
126296835|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
126296836|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
126296837|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
126768522|NCT01964898|456106834|FG000|Overall Study|did not receive the allocated interventi|2|||
126768523|NCT01964898|456106835|FG001|Overall Study|did not receive the allocated interventi|1|||
126768524|NCT01964898|456106834|FG000|Overall Study|Lost to Follow-up|3|||
126768525|NCT01964898|456106835|FG001|Overall Study|Lost to Follow-up|5|||
126768526|NCT01964898|456106834|FG000|Overall Study|Withdrawal by Subject|1|||
126768527|NCT01964898|456106835|FG001|Overall Study|Withdrawal by Subject|0|||
126768528|NCT02325401|456106838|FG000|Overall Study|Withdrawal by Subject|0|||
126768529|NCT02325401|456106839|FG001|Overall Study|Withdrawal by Subject|1|||
126768530|NCT02325401|456106840|FG002|Overall Study|Withdrawal by Subject|1|||
126768531|NCT02209454|456106844|FG000|Second Period|Adverse Event|1|||
126768532|NCT02209454|456106845|FG001|Second Period|Adverse Event|0|||
126768533|NCT00366678|456106850|FG000|Infant Series|Withdrawal by Subject|8|||
126768534|NCT00366678|456106851|FG001|Infant Series|Withdrawal by Subject|6|||
126768535|NCT00366678|456106852|FG002|Infant Series|Withdrawal by Subject|0|||
126768536|NCT00366678|456106850|FG000|Infant Series|Protocol Violation|4|||
126768537|NCT00366678|456106851|FG001|Infant Series|Protocol Violation|3|||
126768538|NCT00366678|456106852|FG002|Infant Series|Protocol Violation|0|||
126768539|NCT00366678|456106850|FG000|Infant Series|Failed to return|1|||
126768540|NCT00366678|456106851|FG001|Infant Series|Failed to return|1|||
126768541|NCT00366678|456106852|FG002|Infant Series|Failed to return|0|||
126768542|NCT00366678|456106850|FG000|Infant Series|Adverse Event|1|||
126768543|NCT00366678|456106851|FG001|Infant Series|Adverse Event|0|||
126768544|NCT00366678|456106852|FG002|Infant Series|Adverse Event|0|||
126296838|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
126296839|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
126296840|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
126296841|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
126296842|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
126296843|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
126768545|NCT00366678|456106850|FG000|After Infant|Withdrawal by Subject|8|||
126768546|NCT00366678|456106851|FG001|After Infant|Withdrawal by Subject|4|||
126768547|NCT00366678|456106852|FG002|After Infant|Withdrawal by Subject|0|||
126768548|NCT00366678|456106850|FG000|After Infant|Lost to Follow-up|2|||
126768549|NCT00366678|456106851|FG001|After Infant|Lost to Follow-up|1|||
126768550|NCT00366678|456106852|FG002|After Infant|Lost to Follow-up|0|||
126768551|NCT00366678|456106850|FG000|After Infant|Failed to return|5|||
126768552|NCT00366678|456106851|FG001|After Infant|Failed to return|5|||
126768553|NCT00366678|456106852|FG002|After Infant|Failed to return|0|||
126768554|NCT00366678|456106850|FG000|After Infant|Adverse Event|1|||
126768555|NCT00366678|456106851|FG001|After Infant|Adverse Event|0|||
126768556|NCT00366678|456106852|FG002|After Infant|Adverse Event|0|||
126768557|NCT00366678|456106850|FG000|After Infant|Protocol Violation|1|||
126768558|NCT00366678|456106851|FG001|After Infant|Protocol Violation|0|||
126768559|NCT00366678|456106852|FG002|After Infant|Protocol Violation|0|||
126768560|NCT00366678|456106850|FG000|Toddler Dose|Protocol Violation|2|||
126768561|NCT00366678|456106851|FG001|Toddler Dose|Protocol Violation|1|||
126768562|NCT00366678|456106852|FG002|Toddler Dose|Protocol Violation|0|||
126768563|NCT00366678|456106850|FG000|Toddler Dose|Failed to return|1|||
126768564|NCT00366678|456106851|FG001|Toddler Dose|Failed to return|0|||
126768565|NCT00366678|456106852|FG002|Toddler Dose|Failed to return|0|||
126768566|NCT00366678|456106850|FG000|Toddler Dose|Withdrawal by Subject|1|||
126768567|NCT00366678|456106851|FG001|Toddler Dose|Withdrawal by Subject|0|||
126768568|NCT00366678|456106852|FG002|Toddler Dose|Withdrawal by Subject|0|||
126768569|NCT00366678|456106850|FG000|Toddler Dose|protocol deviation|1|||
126768570|NCT00366678|456106851|FG001|Toddler Dose|protocol deviation|0|||
126768571|NCT00366678|456106852|FG002|Toddler Dose|protocol deviation|0|||
126768572|NCT04292171|456106853|FG000|Overall Study|Pharmacy error|2|||
126768573|NCT04292171|456106854|FG001|Overall Study|Pharmacy error|0|||
126768574|NCT04292171|456106853|FG000|Overall Study|Delivered prior to procedure|0|||
126768575|NCT04292171|456106854|FG001|Overall Study|Delivered prior to procedure|1|||
126768576|NCT02545868|456106855|FG000|Overall Study|Lack of Efficacy|1|||
126768577|NCT02545868|456106856|FG001|Overall Study|Lack of Efficacy|1|||
126768578|NCT02545868|456106857|FG002|Overall Study|Lack of Efficacy|0|||
126768579|NCT02545868|456106855|FG000|Overall Study|Lost to Follow-up|1|||
126768580|NCT02545868|456106856|FG001|Overall Study|Lost to Follow-up|5|||
126768581|NCT02545868|456106857|FG002|Overall Study|Lost to Follow-up|1|||
126768582|NCT02545868|456106855|FG000|Overall Study|Non-compliance|1|||
126768583|NCT02545868|456106856|FG001|Overall Study|Non-compliance|1|||
126768584|NCT02545868|456106857|FG002|Overall Study|Non-compliance|1|||
126768585|NCT02545868|456106855|FG000|Overall Study|Treatment change|21|||
126768586|NCT02545868|456106856|FG001|Overall Study|Treatment change|19|||
126768587|NCT02545868|456106857|FG002|Overall Study|Treatment change|22|||
126768588|NCT02545868|456106855|FG000|Overall Study|Physician Decision|1|||
126768589|NCT02545868|456106856|FG001|Overall Study|Physician Decision|1|||
126768590|NCT02545868|456106857|FG002|Overall Study|Physician Decision|1|||
126768591|NCT02545868|456106855|FG000|Overall Study|Withdrawal by Subject|6|||
126768592|NCT02545868|456106856|FG001|Overall Study|Withdrawal by Subject|7|||
126768593|NCT02545868|456106857|FG002|Overall Study|Withdrawal by Subject|9|||
126768594|NCT01777191|456106858|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
126768595|NCT01777191|456106859|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
126768596|NCT01777191|456106858|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
126296844|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
126296845|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
126296846|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
126296847|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
126296848|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
126296849|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
126296850|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
126296851|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Site closed|0|||
126296852|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Site closed|0|||
126296853|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Site closed|1|||
126296854|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Site closed|0|||
126296855|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
126296856|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
126296857|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
126711614|NCT01096667|455895572|FG001|Overall Study|Not treated|0|||
126711615|NCT01096667|455895573|FG002|Overall Study|Not treated|0|||
126711616|NCT01096667|455895574|FG003|Overall Study|Not treated|0|||
126711617|NCT01096667|455895575|FG004|Overall Study|Not treated|0|||
126711618|NCT01326962|455895577|FG000|Overall Study|Adverse Event|1|||
126711619|NCT01326962|455895577|FG000|Overall Study|Withdrawal by Subject|1|||
126711620|NCT01326962|455895577|FG000|Overall Study|Lost to Follow-up|3|||
126711621|NCT01326962|455895577|FG000|Overall Study|Other|2|||
126711622|NCT01056523|455895578|FG000|Overall Study|Death|1|||
126711623|NCT01056523|455895579|FG001|Overall Study|Death|0|||
126711624|NCT01056523|455895580|FG002|Overall Study|Death|2|||
126711625|NCT01056523|455895581|FG003|Overall Study|Death|3|||
126711626|NCT01056523|455895582|FG004|Overall Study|Death|0|||
126711627|NCT01056523|455895583|FG005|Overall Study|Death|0|||
126711628|NCT01056523|455895584|FG006|Overall Study|Death|1|||
126711629|NCT01507246|455895587|FG000|Overall Study|Required different surgical procedures|2|||
126711630|NCT01507246|455895588|FG001|Overall Study|Required different surgical procedures|1|||
126711631|NCT05243550|455897462|FG000|Overall Study|Ongoing in the Study|171|||
126711632|NCT05243550|455897462|FG000|Overall Study|Withdrawal by Subject|10|||
126711633|NCT05243550|455897462|FG000|Overall Study|Lost to Follow-up|7|||
126711634|NCT05243550|455897462|FG000|Overall Study|Adverse Event|3|||
126711635|NCT05243550|455897462|FG000|Overall Study|Noncompliance|1|||
126711636|NCT05243550|455897462|FG000|Overall Study|Physician Decision|1|||
126711637|NCT05243550|455897462|FG000|Overall Study|Other Reason|4|||
126711638|NCT02452970|455897469|FG000|Overall Study|Adverse Event|1|||
126711639|NCT00893113|455897470|FG000|Overall Study|Lost to Follow-up|4|||
126711640|NCT00893113|455897471|FG001|Overall Study|Lost to Follow-up|8|||
126711641|NCT00893113|455897470|FG000|Overall Study|Early Termination|1|||
126711642|NCT00893113|455897471|FG001|Overall Study|Early Termination|1|||
126711643|NCT00893113|455897470|FG000|Overall Study|Withdrew Consent|8|||
126711644|NCT00893113|455897471|FG001|Overall Study|Withdrew Consent|7|||
126711645|NCT00128206|455897480|FG000|Overall Study|Lost to Follow-up|137|||
126711646|NCT00128206|455897481|FG001|Overall Study|Lost to Follow-up|118|||
126711647|NCT00128206|455897480|FG000|Overall Study|Adverse Event|0|||
126711648|NCT00128206|455897481|FG001|Overall Study|Adverse Event|2|||
126711649|NCT02940886|455897482|FG000|Overall Study|Adverse Event|7|||
126711650|NCT02940886|455897483|FG001|Overall Study|Adverse Event|3|||
126711651|NCT02940886|455897482|FG000|Overall Study|Protocol Violation|0|||
126711652|NCT02940886|455897483|FG001|Overall Study|Protocol Violation|2|||
126711653|NCT02940886|455897482|FG000|Overall Study|Withdrawal by Subject|28|||
126711654|NCT02940886|455897483|FG001|Overall Study|Withdrawal by Subject|20|||
126711655|NCT02940886|455897482|FG000|Overall Study|Death|1|||
126711656|NCT02940886|455897483|FG001|Overall Study|Death|0|||
126711657|NCT02940886|455897482|FG000|Overall Study|Lack of Efficacy|1|||
126711658|NCT02940886|455897483|FG001|Overall Study|Lack of Efficacy|0|||
126711659|NCT02940886|455897482|FG000|Overall Study|Lost to Follow-up|49|||
126711660|NCT02940886|455897483|FG001|Overall Study|Lost to Follow-up|21|||
126711661|NCT02940886|455897482|FG000|Overall Study|Physician Decision|9|||
126711662|NCT02940886|455897483|FG001|Overall Study|Physician Decision|4|||
126711663|NCT02940886|455897482|FG000|Overall Study|Sponsor decision|0|||
126711664|NCT02940886|455897483|FG001|Overall Study|Sponsor decision|1|||
126711665|NCT02940886|455897482|FG000|Overall Study|No treatment|7|||
126711666|NCT02940886|455897483|FG001|Overall Study|No treatment|2|||
126711667|NCT02940886|455897482|FG000|Overall Study|Enrolment error|0|||
126711668|NCT02940886|455897483|FG001|Overall Study|Enrolment error|1|||
126711669|NCT01306058|455897484|FG000|Overall Study|Death|1|||
126711670|NCT01306058|455897484|FG000|Overall Study|Enrolled but did not get treatment|1|||
126711671|NCT01666444|455897485|FG000|Overall Study|Did not initiate treatment|2|||
126711672|NCT01666444|455897486|FG001|Overall Study|Did not initiate treatment|1|||
126711673|NCT00592358|455897487|FG000|Overall Study|Withdrawal by Subject|2|||
126711674|NCT00592358|455897487|FG000|Overall Study|Adverse Event|1|||
126711675|NCT00592358|455897487|FG000|Overall Study|Lack of Efficacy|2|||
126768597|NCT01777191|456106859|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
126768598|NCT01777191|456106858|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
126768599|NCT01777191|456106859|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
126768600|NCT01777191|456106858|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
126768601|NCT01777191|456106859|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
126768602|NCT01777191|456106858|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
126768603|NCT01777191|456106859|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
126768604|NCT01777191|456106858|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
126768605|NCT01777191|456106859|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
126768606|NCT01777191|456106858|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
126768607|NCT01777191|456106859|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
126768608|NCT01777191|456106858|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
126768609|NCT01777191|456106859|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
126768610|NCT01777191|456106858|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
126768611|NCT01777191|456106859|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
126768612|NCT01777191|456106858|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
126768613|NCT01777191|456106859|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
126768614|NCT01777191|456106858|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
126768615|NCT01777191|456106859|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
126768616|NCT04465916|456106864|FG000|Overall Study|Withdrawal by Subject|0|||
126550191|NCT04921969|455307729|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
126550192|NCT04921969|455307730|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
126550193|NCT01242176|455309482|FG000|Washout Period of 7 Days|Adverse Event|0|||
126550194|NCT01242176|455309483|FG001|Washout Period of 7 Days|Adverse Event|2|||
126550195|NCT01242176|455309482|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
126550196|NCT01242176|455309483|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
126711676|NCT00592358|455897487|FG000|Overall Study|Inability to swallow pills|1|||
126711677|NCT00084682|455897488|FG000|Overall Study|Withdrawal by Subject|1|||
126711678|NCT03238248|455897496|FG000|Overall Study|Death|5|||
126711679|NCT03238248|455897496|FG000|Overall Study|Withdrawal by Subject|7|||
126711680|NCT03238248|455897496|FG000|Overall Study|Participant proceeding to transplant|10|||
126711681|NCT03238248|455897496|FG000|Overall Study|Lack of Efficacy|4|||
126711682|NCT03238248|455897496|FG000|Overall Study|Physician Decision|3|||
126711683|NCT03238248|455897496|FG000|Overall Study|Transitioning to another study|1|||
126711684|NCT03238248|455897496|FG000|Overall Study|No longer benefiting|1|||
126711685|NCT03238248|455897496|FG000|Overall Study|Other complicating disease|1|||
126711686|NCT03238248|455897496|FG000|Overall Study|Adverse Event|5|||
126711687|NCT03238248|455897496|FG000|Overall Study|Disease progression|26|||
126711688|NCT03238248|455897496|FG000|Overall Study|N/A participant is still on treatment|1|||
126711689|NCT03238248|455897496|FG000|Overall Study|Decline in condition|1|||
126711690|NCT03238248|455897496|FG000|Overall Study|Alternative therapy|2|||
126711691|NCT01013883|455897497|FG000|Overall Study|Lost to Follow-up|2|||
126711692|NCT01013883|455897498|FG001|Overall Study|Lost to Follow-up|2|||
126711693|NCT02241512|455897499|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
126711694|NCT02241512|455897500|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
126711695|NCT00474630|455897501|FG000|Overall Study|Adverse Event|98|||
126711696|NCT00474630|455897502|FG001|Overall Study|Adverse Event|26|||
126711697|NCT00474630|455897501|FG000|Overall Study|Lost to Follow-up|22|||
126711698|NCT00474630|455897502|FG001|Overall Study|Lost to Follow-up|15|||
126711699|NCT00474630|455897501|FG000|Overall Study|Withdrawal by Subject|21|||
126711700|NCT00474630|455897502|FG001|Overall Study|Withdrawal by Subject|15|||
126711701|NCT00474630|455897501|FG000|Overall Study|Protocol Violation|3|||
126711702|NCT00474630|455897502|FG001|Overall Study|Protocol Violation|4|||
126711703|NCT00474630|455897501|FG000|Overall Study|Lack of Efficacy|5|||
126711704|NCT00474630|455897502|FG001|Overall Study|Lack of Efficacy|6|||
126711705|NCT00474630|455897501|FG000|Overall Study|Drug noncompliance, other|11|||
126711706|NCT00474630|455897502|FG001|Overall Study|Drug noncompliance, other|4|||
126711707|NCT02225223|455897503|FG000|Overall Study|Death|10|||
126711708|NCT02225223|455897504|FG001|Overall Study|Death|1|||
126711709|NCT02225223|455897503|FG000|Overall Study|Lost to Follow-up|5|||
126711710|NCT02225223|455897504|FG001|Overall Study|Lost to Follow-up|0|||
126711711|NCT02225223|455897503|FG000|Overall Study|Other|1|||
126711712|NCT02225223|455897504|FG001|Overall Study|Other|2|||
126711713|NCT02225223|455897503|FG000|Overall Study|Physician Decision|1|||
126550197|NCT03390036|455309484|FG000|Overall Study|Lost to Follow-up|1|||
126711714|NCT02225223|455897504|FG001|Overall Study|Physician Decision|0|||
126711715|NCT02225223|455897503|FG000|Overall Study|Withdrawal by Subject|2|||
126711716|NCT02225223|455897504|FG001|Overall Study|Withdrawal by Subject|2|||
126711717|NCT00958568|455897506|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
126711718|NCT00958568|455897507|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
126711719|NCT00958568|455897508|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
126711720|NCT00958568|455897509|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
126768617|NCT04465916|456106865|FG001|Overall Study|Withdrawal by Subject|1|||
126768618|NCT00468312|456106867|FG000|Overall Study|Adverse Event|2|||
126296858|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
126296859|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
126296860|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
126296861|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
126296862|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
126296863|NCT00838903|454375336|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
126296864|NCT00838903|454375337|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
126296865|NCT00838903|454375338|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
126296866|NCT00838903|454375339|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
126296867|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
126296868|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
126296869|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
126296870|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
126296871|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
126296872|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
126296873|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
126296874|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
126296875|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
126296876|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
126296877|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
126296878|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
126296879|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
126296880|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
126296881|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
126296882|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
126296883|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
126296884|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
126296885|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
126296886|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
126296887|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
126296888|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
126296889|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
126296890|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
126296891|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
126296892|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
126296893|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
126296894|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
126296895|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
126296896|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
126296897|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
126296898|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
126296899|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
126296900|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
126460905|NCT00219544|454987928|FG001|Single Blind Treatment Period|Protocol Violation|0|||
126460906|NCT00219544|454987927|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
126768619|NCT00468312|456106868|FG001|Overall Study|Adverse Event|1|||
126768620|NCT00468312|456106867|FG000|Overall Study|Lack of Efficacy|0|||
126768621|NCT00468312|456106868|FG001|Overall Study|Lack of Efficacy|1|||
126768622|NCT00468312|456106867|FG000|Overall Study|Withdrawal by Subject|0|||
126768623|NCT00468312|456106868|FG001|Overall Study|Withdrawal by Subject|1|||
126768624|NCT00468312|456106867|FG000|Overall Study|Protocol Violation|2|||
126768625|NCT00468312|456106868|FG001|Overall Study|Protocol Violation|1|||
126768626|NCT00468312|456106867|FG000|Overall Study|Did not meet protocol eligibility|0|||
126768627|NCT00468312|456106868|FG001|Overall Study|Did not meet protocol eligibility|1|||
126768628|NCT01052038|456106869|FG000|Overall Study|Lost to Follow-up|2|||
126296901|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
126296902|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
126296903|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
126296904|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
126296905|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
126296906|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
126296907|NCT00838903|454375336|FG000|Follow-up Period (8 Weeks)|Missing|1|||
126296908|NCT00838903|454375337|FG001|Follow-up Period (8 Weeks)|Missing|2|||
126296909|NCT00838903|454375338|FG002|Follow-up Period (8 Weeks)|Missing|1|||
126768629|NCT01052038|456106870|FG001|Overall Study|Lost to Follow-up|3|||
126768630|NCT01052038|456106871|FG002|Overall Study|Lost to Follow-up|1|||
126768631|NCT01052038|456106869|FG000|Overall Study|Protocol Violation|2|||
126768632|NCT01052038|456106870|FG001|Overall Study|Protocol Violation|3|||
126768633|NCT01052038|456106871|FG002|Overall Study|Protocol Violation|3|||
126768634|NCT03976076|456106872|FG000|Overall Study|Withdrawal by Subject|2|||
126768635|NCT01325701|456106873|FG000|Overall Study|Adverse Event|12|||
126768636|NCT01325701|456106874|FG001|Overall Study|Adverse Event|0|||
126768637|NCT01325701|456106873|FG000|Overall Study|Protocol Violation|1|||
126768638|NCT01325701|456106874|FG001|Overall Study|Protocol Violation|0|||
126768639|NCT01325701|456106873|FG000|Overall Study|Physician Decision|2|||
126768640|NCT01325701|456106874|FG001|Overall Study|Physician Decision|2|||
126768641|NCT01325701|456106873|FG000|Overall Study|Withdrawal by Subject|2|||
126768642|NCT01325701|456106874|FG001|Overall Study|Withdrawal by Subject|1|||
126768643|NCT01325701|456106873|FG000|Overall Study|Rollerover Extension Study|4|||
126768644|NCT01325701|456106874|FG001|Overall Study|Rollerover Extension Study|0|||
126768645|NCT00388674|456106884|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
126768646|NCT00388674|456106885|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
126768647|NCT00388674|456106884|FG000|Initial Treatment|Adverse Event|22|||
126768648|NCT00388674|456106885|FG001|Initial Treatment|Adverse Event|87|||
126768649|NCT00388674|456106884|FG000|Initial Treatment|Death|215|||
126768650|NCT00388674|456106885|FG001|Initial Treatment|Death|216|||
126768651|NCT00388674|456106884|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
126768652|NCT00388674|456106885|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
126768653|NCT00388674|456106884|FG000|Initial Treatment|HCC|12|||
126768654|NCT00388674|456106885|FG001|Initial Treatment|HCC|20|||
126768655|NCT00388674|456106884|FG000|Initial Treatment|Lost to Follow-up|526|||
126768656|NCT00388674|456106885|FG001|Initial Treatment|Lost to Follow-up|624|||
126768657|NCT00388674|456106884|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
126768658|NCT00388674|456106885|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
126768659|NCT00388674|456106884|FG000|Initial Treatment|Never Treated with Study Medication|1|||
126768660|NCT00388674|456106885|FG001|Initial Treatment|Never Treated with Study Medication|7|||
126768661|NCT00388674|456106884|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
126768662|NCT00388674|456106885|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
126768663|NCT00388674|456106884|FG000|Initial Treatment|Not Defined|125|||
126768664|NCT00388674|456106885|FG001|Initial Treatment|Not Defined|172|||
126768665|NCT00388674|456106884|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
126768666|NCT00388674|456106885|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
126768667|NCT00388674|456106884|FG000|Initial Treatment|Pregnancy|26|||
126768668|NCT00388674|456106885|FG001|Initial Treatment|Pregnancy|16|||
126768669|NCT00388674|456106884|FG000|Initial Treatment|Study Drug Toxicity|5|||
126768670|NCT00388674|456106885|FG001|Initial Treatment|Study Drug Toxicity|92|||
126768671|NCT00388674|456106884|FG000|Initial Treatment|Participant Request|501|||
126768672|NCT00388674|456106885|FG001|Initial Treatment|Participant Request|673|||
126768673|NCT00388674|456106884|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
126768674|NCT00388674|456106885|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
126768675|NCT00388674|456106884|FG000|Initial Treatment|Not Reported|10|||
126768676|NCT00388674|456106885|FG001|Initial Treatment|Not Reported|12|||
126768677|NCT00388674|456106884|FG000|End of Study|Administrative Reason By Sponsor|299|||
126768678|NCT00388674|456106885|FG001|End of Study|Administrative Reason By Sponsor|253|||
126768679|NCT00388674|456106884|FG000|End of Study|Death|239|||
126768680|NCT00388674|456106885|FG001|End of Study|Death|262|||
126768681|NCT00388674|456106884|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
126768682|NCT00388674|456106885|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
126768683|NCT00388674|456106884|FG000|End of Study|HCC|8|||
126768684|NCT00388674|456106885|FG001|End of Study|HCC|7|||
126768685|NCT00388674|456106884|FG000|End of Study|Lost to Follow-up|587|||
126768686|NCT00388674|456106885|FG001|End of Study|Lost to Follow-up|715|||
126768687|NCT00388674|456106884|FG000|End of Study|Malignancy (Non-HCC)|1|||
126768688|NCT00388674|456106885|FG001|End of Study|Malignancy (Non-HCC)|1|||
126768689|NCT00388674|456106884|FG000|End of Study|Non-Study Related Comorbidities|3|||
126768690|NCT00388674|456106885|FG001|End of Study|Non-Study Related Comorbidities|4|||
126768691|NCT00388674|456106884|FG000|End of Study|Not Defined|135|||
126768692|NCT00388674|456106885|FG001|End of Study|Not Defined|214|||
126768693|NCT00388674|456106884|FG000|End of Study|Participant Withdrew Consent|437|||
126768694|NCT00388674|456106885|FG001|End of Study|Participant Withdrew Consent|673|||
126768695|NCT00388674|456106884|FG000|End of Study|No Off-Treatment Status Data|22|||
126768696|NCT00388674|456106885|FG001|End of Study|No Off-Treatment Status Data|30|||
126768697|NCT00388674|456106884|FG000|End of Study|Not Reported|0|||
126768698|NCT00388674|456106885|FG001|End of Study|Not Reported|1|||
126768699|NCT00759174|456106886|FG000|Overall Study|Other|0|||
126768700|NCT00759174|456106887|FG001|Overall Study|Other|2|||
126768701|NCT01643928|456106888|FG000|Overall Study|Lost to Follow-up|1|||
126768702|NCT01643928|456106889|FG001|Overall Study|Lost to Follow-up|0|||
126768703|NCT01643928|456106890|FG002|Overall Study|Lost to Follow-up|2|||
126768704|NCT01643928|456106891|FG003|Overall Study|Lost to Follow-up|0|||
126768705|NCT01643928|456106892|FG004|Overall Study|Lost to Follow-up|0|||
126550198|NCT03390036|455309485|FG001|Overall Study|Lost to Follow-up|0|||
126768706|NCT01643928|456106888|FG000|Overall Study|Withdrawal by Subject|2|||
126768707|NCT01643928|456106889|FG001|Overall Study|Withdrawal by Subject|0|||
126768708|NCT01643928|456106890|FG002|Overall Study|Withdrawal by Subject|0|||
126768709|NCT01643928|456106891|FG003|Overall Study|Withdrawal by Subject|1|||
126768710|NCT01643928|456106892|FG004|Overall Study|Withdrawal by Subject|0|||
126768711|NCT01643928|456106888|FG000|Overall Study|Pregnancy|0|||
126768712|NCT01643928|456106889|FG001|Overall Study|Pregnancy|0|||
126768713|NCT01643928|456106890|FG002|Overall Study|Pregnancy|0|||
126768714|NCT01643928|456106891|FG003|Overall Study|Pregnancy|1|||
126768715|NCT01643928|456106892|FG004|Overall Study|Pregnancy|0|||
126768716|NCT01643928|456106888|FG000|Overall Study|Other|5|||
126768717|NCT01643928|456106889|FG001|Overall Study|Other|1|||
126768718|NCT01643928|456106890|FG002|Overall Study|Other|1|||
126768719|NCT01643928|456106891|FG003|Overall Study|Other|0|||
126768720|NCT01643928|456106892|FG004|Overall Study|Other|0|||
126768721|NCT01643928|456106888|FG000|Overall Study|Adverse Event|2|||
126768722|NCT01643928|456106889|FG001|Overall Study|Adverse Event|1|||
126768723|NCT01643928|456106890|FG002|Overall Study|Adverse Event|0|||
126768724|NCT01643928|456106891|FG003|Overall Study|Adverse Event|1|||
126768725|NCT01643928|456106892|FG004|Overall Study|Adverse Event|2|||
126768726|NCT00568776|456106893|FG000|Overall Study|Adverse Event|8|||
126768727|NCT00568776|456106894|FG001|Overall Study|Adverse Event|8|||
126768728|NCT00568776|456106895|FG002|Overall Study|Adverse Event|10|||
126768729|NCT00568776|456106896|FG003|Overall Study|Adverse Event|8|||
126768730|NCT00568776|456106893|FG000|Overall Study|Death|0|||
126768731|NCT00568776|456106894|FG001|Overall Study|Death|1|||
126768732|NCT00568776|456106895|FG002|Overall Study|Death|4|||
126768733|NCT00568776|456106896|FG003|Overall Study|Death|3|||
126768734|NCT00568776|456106893|FG000|Overall Study|Physician Decision|0|||
126768735|NCT00568776|456106894|FG001|Overall Study|Physician Decision|2|||
126296910|NCT00838903|454375339|FG003|Follow-up Period (8 Weeks)|Missing|1|||
126296911|NCT03096314|454375340|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
126296912|NCT03096314|454375341|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
126296913|NCT03003962|454375342|FG000|Overall Study|Withdrawal by Subject|5|||
126296914|NCT03003962|454375343|FG001|Overall Study|Withdrawal by Subject|17|||
126296915|NCT03003962|454375342|FG000|Overall Study|Death|274|||
126296916|NCT03003962|454375343|FG001|Overall Study|Death|277|||
126296917|NCT03003962|454375342|FG000|Overall Study|Participants ongoing at DCO|55|||
126711721|NCT00958568|455897506|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
126711722|NCT00958568|455897507|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
126711723|NCT00958568|455897508|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
126711724|NCT00958568|455897509|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
126711725|NCT00958568|455897506|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
126711726|NCT00958568|455897507|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
126711727|NCT00958568|455897508|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
126711728|NCT00958568|455897509|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
126711729|NCT00958568|455897506|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
126711730|NCT00958568|455897507|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
126711731|NCT00958568|455897508|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
126711732|NCT00958568|455897509|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
126711733|NCT00958568|455897506|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
126711734|NCT00958568|455897507|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
126711735|NCT00958568|455897508|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
126711736|NCT00958568|455897509|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
126711737|NCT00958568|455897506|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
126711738|NCT00958568|455897507|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
126711739|NCT00958568|455897508|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
126711740|NCT00958568|455897509|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
126711741|NCT00958568|455897506|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
126711742|NCT00958568|455897507|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
126711743|NCT00958568|455897508|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
126711744|NCT00958568|455897509|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
126711745|NCT00958568|455897506|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
126711746|NCT00958568|455897507|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
126711747|NCT00958568|455897508|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
126711748|NCT00958568|455897509|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
126711749|NCT00958568|455897506|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
126768736|NCT00568776|456106895|FG002|Overall Study|Physician Decision|0|||
126768737|NCT00568776|456106896|FG003|Overall Study|Physician Decision|0|||
126768738|NCT00568776|456106893|FG000|Overall Study|Lack of Efficacy|2|||
126768739|NCT00568776|456106894|FG001|Overall Study|Lack of Efficacy|2|||
126768740|NCT00568776|456106895|FG002|Overall Study|Lack of Efficacy|2|||
126768741|NCT00568776|456106896|FG003|Overall Study|Lack of Efficacy|4|||
126768742|NCT00568776|456106893|FG000|Overall Study|Lost to Follow-up|1|||
126296918|NCT03003962|454375343|FG001|Overall Study|Participants ongoing at DCO|40|||
126460907|NCT00219544|454987928|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
126768743|NCT00568776|456106894|FG001|Overall Study|Lost to Follow-up|1|||
126768744|NCT00568776|456106895|FG002|Overall Study|Lost to Follow-up|1|||
126768745|NCT00568776|456106896|FG003|Overall Study|Lost to Follow-up|1|||
126768746|NCT00568776|456106893|FG000|Overall Study|Protocol Violation|1|||
126768747|NCT00568776|456106894|FG001|Overall Study|Protocol Violation|0|||
126768748|NCT00568776|456106895|FG002|Overall Study|Protocol Violation|1|||
126768749|NCT00568776|456106896|FG003|Overall Study|Protocol Violation|1|||
126768750|NCT00568776|456106893|FG000|Overall Study|Withdrawal by Subject|13|||
126768751|NCT00568776|456106894|FG001|Overall Study|Withdrawal by Subject|15|||
126768752|NCT00568776|456106895|FG002|Overall Study|Withdrawal by Subject|13|||
126768753|NCT00568776|456106896|FG003|Overall Study|Withdrawal by Subject|7|||
126768754|NCT00568776|456106893|FG000|Overall Study|Loss of Caregiver|0|||
126768755|NCT00568776|456106894|FG001|Overall Study|Loss of Caregiver|2|||
126768756|NCT00568776|456106895|FG002|Overall Study|Loss of Caregiver|1|||
126768757|NCT00568776|456106896|FG003|Overall Study|Loss of Caregiver|2|||
126768758|NCT00568776|456106893|FG000|Overall Study|Sponsor Decision|2|||
126768759|NCT00568776|456106894|FG001|Overall Study|Sponsor Decision|2|||
126296919|NCT03428152|454375351|FG000|Overall Study|Physician Decision|4|||
126711750|NCT00958568|455897507|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
126768760|NCT00568776|456106895|FG002|Overall Study|Sponsor Decision|41|||
126768761|NCT00568776|456106896|FG003|Overall Study|Sponsor Decision|42|||
126296920|NCT03428152|454375352|FG001|Overall Study|Physician Decision|2|||
126296921|NCT03428152|454375351|FG000|Overall Study|Protocol Violation|3|||
126296922|NCT03428152|454375352|FG001|Overall Study|Protocol Violation|5|||
126296923|NCT03428152|454375351|FG000|Overall Study|Lack of Efficacy|0|||
126296924|NCT03428152|454375352|FG001|Overall Study|Lack of Efficacy|4|||
126296925|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
126296926|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
126296927|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
126296928|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126711751|NCT00958568|455897508|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
126711752|NCT00958568|455897509|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
126711753|NCT00958568|455897506|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
126711754|NCT00958568|455897507|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
126711755|NCT00958568|455897508|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
126711756|NCT00958568|455897509|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
126711757|NCT00958568|455897506|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
126711758|NCT00958568|455897507|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
126711759|NCT00958568|455897508|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
126711760|NCT00958568|455897509|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
126711761|NCT00958568|455897506|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
126711762|NCT00958568|455897507|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
126711763|NCT00958568|455897508|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
126711764|NCT00958568|455897509|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
126711765|NCT00958568|455897506|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
126711766|NCT00958568|455897507|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
126711767|NCT00958568|455897508|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
126711768|NCT00958568|455897509|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
126711769|NCT00958568|455897506|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
126711770|NCT00958568|455897507|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
126711771|NCT00958568|455897508|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
126711772|NCT00958568|455897509|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
126711773|NCT00958568|455897506|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
126711774|NCT00958568|455897507|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
126711775|NCT00958568|455897508|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
126711776|NCT00958568|455897509|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
126711777|NCT00958568|455897506|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
126711778|NCT00958568|455897507|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
126711779|NCT00958568|455897508|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
126711780|NCT00958568|455897509|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
126711781|NCT00958568|455897506|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
126711782|NCT00958568|455897507|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
126296929|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126460908|NCT00219544|454987927|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
126768762|NCT00568776|456106893|FG000|Overall Study|Miscellaeneous|3|||
126768763|NCT00568776|456106894|FG001|Overall Study|Miscellaeneous|3|||
126768764|NCT00568776|456106895|FG002|Overall Study|Miscellaeneous|1|||
126768765|NCT00568776|456106896|FG003|Overall Study|Miscellaeneous|4|||
126768766|NCT03692078|456106897|FG000|Overall Study|Adverse Event|0|||
126768767|NCT03692078|456106898|FG001|Overall Study|Adverse Event|0|||
126768768|NCT03692078|456106899|FG002|Overall Study|Adverse Event|0|||
126296930|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126768769|NCT03692078|456106900|FG003|Overall Study|Adverse Event|0|||
126768770|NCT03692078|456106901|FG004|Overall Study|Adverse Event|0|||
126768771|NCT03692078|456106902|FG005|Overall Study|Adverse Event|1|||
126768772|NCT03692078|456106903|FG006|Overall Study|Adverse Event|0|||
126768773|NCT03692078|456106897|FG000|Overall Study|Enrollment Closed|5|||
126768774|NCT03692078|456106898|FG001|Overall Study|Enrollment Closed|0|||
126296931|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126296932|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
126296933|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
126296934|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
126296935|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
126296936|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
126296937|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
126296938|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
126296939|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
126296940|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126296941|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
126296942|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126296943|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126296944|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126296945|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126296946|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
126296947|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126296948|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
126296949|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126296950|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126296951|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126296952|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126296953|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
126296954|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
126296955|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
126296956|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126296957|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126768775|NCT03692078|456106899|FG002|Overall Study|Enrollment Closed|0|||
126768776|NCT03692078|456106900|FG003|Overall Study|Enrollment Closed|0|||
126768777|NCT03692078|456106901|FG004|Overall Study|Enrollment Closed|0|||
126768778|NCT03692078|456106902|FG005|Overall Study|Enrollment Closed|0|||
126768779|NCT03692078|456106903|FG006|Overall Study|Enrollment Closed|0|||
126768780|NCT03692078|456106897|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
126768781|NCT03692078|456106898|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
126768782|NCT03692078|456106899|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
126768783|NCT03692078|456106900|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
126768784|NCT03692078|456106901|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
126296958|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126296959|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126768785|NCT03692078|456106902|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
126768786|NCT03692078|456106903|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
126296960|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
126550199|NCT03390036|455309486|FG002|Overall Study|Lost to Follow-up|0|||
126768787|NCT03692078|456106897|FG000|Overall Study|Withdrawal by Subject|0|||
126768788|NCT03692078|456106898|FG001|Overall Study|Withdrawal by Subject|2|||
126768789|NCT03692078|456106899|FG002|Overall Study|Withdrawal by Subject|0|||
126768790|NCT03692078|456106900|FG003|Overall Study|Withdrawal by Subject|1|||
126768791|NCT03692078|456106901|FG004|Overall Study|Withdrawal by Subject|5|||
126768792|NCT03692078|456106902|FG005|Overall Study|Withdrawal by Subject|3|||
126768793|NCT03692078|456106903|FG006|Overall Study|Withdrawal by Subject|3|||
126768794|NCT01005680|456106904|FG000|Overall Study|Lost to Follow-up|4|||
126768795|NCT01005680|456106905|FG001|Overall Study|Lost to Follow-up|6|||
126768796|NCT01005680|456106904|FG000|Overall Study|Withdrawal by Subject|1|||
126768797|NCT01005680|456106905|FG001|Overall Study|Withdrawal by Subject|4|||
126768798|NCT01005680|456106904|FG000|Overall Study|Physician Decision|1|||
126768799|NCT01005680|456106905|FG001|Overall Study|Physician Decision|1|||
126768800|NCT03576131|456106906|FG000|Overall Study|Investigator decision|0|||
126768801|NCT03576131|456106907|FG001|Overall Study|Investigator decision|0|||
126768802|NCT03576131|456106908|FG002|Overall Study|Investigator decision|0|||
126768803|NCT03576131|456106909|FG003|Overall Study|Investigator decision|1|||
126768804|NCT03576131|456106910|FG004|Overall Study|Investigator decision|0|||
126768805|NCT03576131|456106911|FG005|Overall Study|Investigator decision|1|||
126296961|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
126296962|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
126296963|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
126296964|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
126296965|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
126768806|NCT03576131|456106912|FG006|Overall Study|Investigator decision|0|||
126768807|NCT03576131|456106913|FG007|Overall Study|Investigator decision|0|||
126768808|NCT03576131|456106906|FG000|Overall Study|Withdrawal by Subject|1|||
126768809|NCT03576131|456106907|FG001|Overall Study|Withdrawal by Subject|1|||
126768810|NCT03576131|456106908|FG002|Overall Study|Withdrawal by Subject|0|||
126768811|NCT03576131|456106909|FG003|Overall Study|Withdrawal by Subject|1|||
126768812|NCT03576131|456106910|FG004|Overall Study|Withdrawal by Subject|2|||
126768813|NCT03576131|456106911|FG005|Overall Study|Withdrawal by Subject|3|||
126768814|NCT03576131|456106912|FG006|Overall Study|Withdrawal by Subject|1|||
126768815|NCT03576131|456106913|FG007|Overall Study|Withdrawal by Subject|0|||
126768816|NCT03576131|456106906|FG000|Overall Study|Death|3|||
126768817|NCT03576131|456106907|FG001|Overall Study|Death|3|||
126768818|NCT03576131|456106908|FG002|Overall Study|Death|1|||
126306332|NCT02244463|454410274|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
126768819|NCT03576131|456106909|FG003|Overall Study|Death|5|||
126768820|NCT03576131|456106910|FG004|Overall Study|Death|4|||
126768821|NCT03576131|456106911|FG005|Overall Study|Death|1|||
126768822|NCT03576131|456106912|FG006|Overall Study|Death|0|||
126768823|NCT03576131|456106913|FG007|Overall Study|Death|1|||
126768824|NCT03576131|456106906|FG000|Overall Study|New anti-cancer treatment|5|||
126768825|NCT03576131|456106907|FG001|Overall Study|New anti-cancer treatment|1|||
126768826|NCT03576131|456106908|FG002|Overall Study|New anti-cancer treatment|2|||
126768827|NCT03576131|456106909|FG003|Overall Study|New anti-cancer treatment|3|||
126768828|NCT03576131|456106910|FG004|Overall Study|New anti-cancer treatment|0|||
126768829|NCT03576131|456106911|FG005|Overall Study|New anti-cancer treatment|0|||
126768830|NCT03576131|456106912|FG006|Overall Study|New anti-cancer treatment|0|||
126768831|NCT03576131|456106913|FG007|Overall Study|New anti-cancer treatment|0|||
126768832|NCT03576131|456106906|FG000|Overall Study|Unspecified reason|0|||
126768833|NCT03576131|456106907|FG001|Overall Study|Unspecified reason|0|||
126768834|NCT03576131|456106908|FG002|Overall Study|Unspecified reason|1|||
126768835|NCT03576131|456106909|FG003|Overall Study|Unspecified reason|1|||
126768836|NCT03576131|456106910|FG004|Overall Study|Unspecified reason|1|||
126768837|NCT03576131|456106911|FG005|Overall Study|Unspecified reason|1|||
126768838|NCT03576131|456106912|FG006|Overall Study|Unspecified reason|0|||
126768839|NCT03576131|456106913|FG007|Overall Study|Unspecified reason|0|||
126768840|NCT03576131|456106906|FG000|Overall Study|Subject non-compliance|0|||
126768841|NCT03576131|456106907|FG001|Overall Study|Subject non-compliance|0|||
126768842|NCT03576131|456106908|FG002|Overall Study|Subject non-compliance|0|||
126768843|NCT03576131|456106909|FG003|Overall Study|Subject non-compliance|0|||
126768844|NCT03576131|456106910|FG004|Overall Study|Subject non-compliance|0|||
126768845|NCT03576131|456106911|FG005|Overall Study|Subject non-compliance|1|||
126768846|NCT03576131|456106912|FG006|Overall Study|Subject non-compliance|0|||
126768847|NCT03576131|456106913|FG007|Overall Study|Subject non-compliance|0|||
126768848|NCT03069365|456106930|FG000|Overall Study|Adverse Event|1|||
126768849|NCT01965431|456106931|FG000|Overall Study|Adverse Event|0|||
126768850|NCT01965431|456106932|FG001|Overall Study|Adverse Event|1|||
126768851|NCT01965431|456106933|FG002|Overall Study|Adverse Event|0|||
126768852|NCT01965431|456106934|FG003|Overall Study|Adverse Event|0|||
126768853|NCT01965431|456106935|FG004|Overall Study|Adverse Event|0|||
126768854|NCT01965431|456106936|FG005|Overall Study|Adverse Event|0|||
126768855|NCT01965431|456106931|FG000|Overall Study|Other than stated above|6|||
126768856|NCT01965431|456106932|FG001|Overall Study|Other than stated above|5|||
126768857|NCT01965431|456106933|FG002|Overall Study|Other than stated above|6|||
126768858|NCT01965431|456106934|FG003|Overall Study|Other than stated above|6|||
126768859|NCT01965431|456106935|FG004|Overall Study|Other than stated above|6|||
126768860|NCT01965431|456106936|FG005|Overall Study|Other than stated above|6|||
126768861|NCT04635631|456106937|FG000|Overall Study|Adverse Event|1|||
126768862|NCT04635631|456106937|FG000|Overall Study|Progressive disease|13|||
126768863|NCT04635631|456106937|FG000|Overall Study|Withdrawal by Subject|1|||
126768864|NCT03901339|456106939|FG000|Overall Study|Death|220|||
126768865|NCT03901339|456106940|FG001|Overall Study|Death|192|||
126768866|NCT03901339|456106939|FG000|Overall Study|Informed consent withdrawn|13|||
126768867|NCT03901339|456106940|FG001|Overall Study|Informed consent withdrawn|40|||
126768868|NCT03901339|456106939|FG000|Overall Study|Sponsor request|30|||
126768869|NCT03901339|456106940|FG001|Overall Study|Sponsor request|23|||
126768870|NCT03901339|456106939|FG000|Overall Study|Reason not specified|5|||
126768871|NCT03901339|456106940|FG001|Overall Study|Reason not specified|7|||
126768872|NCT03901339|456106939|FG000|Overall Study|Lost to Follow-up|4|||
126768873|NCT03901339|456106940|FG001|Overall Study|Lost to Follow-up|7|||
126768874|NCT03901339|456106939|FG000|Overall Study|Covid19|0|||
126768875|NCT03901339|456106940|FG001|Overall Study|Covid19|2|||
126768876|NCT02886494|456106941|FG000|Overall Study|Adverse Event|1|||
126768877|NCT02886494|456106942|FG001|Overall Study|Adverse Event|0|||
126768878|NCT02886494|456106941|FG000|Overall Study|Withdrawal by Subject|12|||
126768879|NCT02886494|456106942|FG001|Overall Study|Withdrawal by Subject|3|||
126768880|NCT02886494|456106941|FG000|Overall Study|Protocol Violation|4|||
126768881|NCT02886494|456106942|FG001|Overall Study|Protocol Violation|1|||
126768882|NCT00457418|456106943|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
126768883|NCT00457418|456106943|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
126768884|NCT00457418|456106943|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
126768885|NCT00457418|456106943|FG000|Post PK Maintenance|Adverse Event|10|||
126768886|NCT00457418|456106943|FG000|Post PK Maintenance|Progression of Disease|6|||
126768887|NCT00457418|456106943|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
126768888|NCT00457418|456106943|FG000|Post PK Maintenance|Lost to Follow-up|1|||
126768889|NCT02086968|456106944|FG000|Overall Study|Adverse Event|1|||
126768890|NCT02086968|456106945|FG001|Overall Study|Adverse Event|5|||
126768891|NCT02086968|456106944|FG000|Overall Study|Lost to Follow-up|2|||
126768892|NCT02086968|456106945|FG001|Overall Study|Lost to Follow-up|3|||
126768893|NCT02086968|456106944|FG000|Overall Study|Study drug received outside protocol|0|||
126768894|NCT02086968|456106945|FG001|Overall Study|Study drug received outside protocol|1|||
126768895|NCT02086968|456106944|FG000|Overall Study|Physician Decision|4|||
126768896|NCT02086968|456106945|FG001|Overall Study|Physician Decision|0|||
126768897|NCT02086968|456106944|FG000|Overall Study|Withdrawal by Subject|1|||
126768898|NCT02086968|456106945|FG001|Overall Study|Withdrawal by Subject|4|||
126768899|NCT03099161|456106946|FG000|Overall Study|Adverse Event|0|||
126768900|NCT03099161|456106947|FG001|Overall Study|Adverse Event|0|||
126768901|NCT03099161|456106948|FG002|Overall Study|Adverse Event|2|||
126768902|NCT03099161|456106946|FG000|Overall Study|Physician Decision|2|||
126768903|NCT03099161|456106947|FG001|Overall Study|Physician Decision|0|||
126768904|NCT03099161|456106948|FG002|Overall Study|Physician Decision|0|||
126768905|NCT03099161|456106946|FG000|Overall Study|Progressive Disease|1|||
126768906|NCT03099161|456106947|FG001|Overall Study|Progressive Disease|4|||
126768907|NCT03099161|456106948|FG002|Overall Study|Progressive Disease|1|||
126768908|NCT03123120|456106950|FG000|Overall Study|Lost to Follow-up|0|||
126768909|NCT03123120|456106951|FG001|Overall Study|Lost to Follow-up|1|||
126768910|NCT03123120|456106950|FG000|Overall Study|Withdrawal by Subject|0|||
126768911|NCT03123120|456106951|FG001|Overall Study|Withdrawal by Subject|1|||
126768912|NCT00806416|456106952|FG000|Period 1 - Part I|Adverse Event|0|||
126768913|NCT00806416|456106953|FG001|Period 1 - Part I|Adverse Event|1|||
126768914|NCT00806416|456106954|FG002|Period 1 - Part I|Adverse Event|0|||
126768915|NCT00806416|456106955|FG003|Period 1 - Part I|Adverse Event|0|||
126768916|NCT00806416|456106952|FG000|Period 1 - Part I|Lost to Follow-up|0|||
126768917|NCT00806416|456106953|FG001|Period 1 - Part I|Lost to Follow-up|2|||
126768918|NCT00806416|456106954|FG002|Period 1 - Part I|Lost to Follow-up|0|||
126768919|NCT00806416|456106955|FG003|Period 1 - Part I|Lost to Follow-up|0|||
126768920|NCT00806416|456106952|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
126768921|NCT00806416|456106953|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
126768922|NCT00806416|456106954|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
126768923|NCT00806416|456106955|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
126768924|NCT00806416|456106952|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
126768925|NCT00806416|456106953|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
126768926|NCT00806416|456106954|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
126768927|NCT00806416|456106955|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
126768928|NCT01125358|456106968|FG000|Overall Study|Adverse Event|3|||
126768929|NCT01125358|456106969|FG001|Overall Study|Adverse Event|0|||
126768930|NCT01125358|456106970|FG002|Overall Study|Adverse Event|0|||
126768931|NCT01125358|456106971|FG003|Overall Study|Adverse Event|2|||
126768932|NCT01125358|456106968|FG000|Overall Study|Perceived Lack of Efficacy|6|||
126768933|NCT01125358|456106969|FG001|Overall Study|Perceived Lack of Efficacy|3|||
126768934|NCT01125358|456106970|FG002|Overall Study|Perceived Lack of Efficacy|7|||
126768935|NCT01125358|456106971|FG003|Overall Study|Perceived Lack of Efficacy|4|||
126768936|NCT01125358|456106968|FG000|Overall Study|Protocol Violation|1|||
126768937|NCT01125358|456106969|FG001|Overall Study|Protocol Violation|0|||
126768938|NCT01125358|456106970|FG002|Overall Study|Protocol Violation|0|||
126768939|NCT01125358|456106971|FG003|Overall Study|Protocol Violation|0|||
126768940|NCT01125358|456106968|FG000|Overall Study|Sponsor Decision|0|||
126296966|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
126296967|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
126768941|NCT01125358|456106969|FG001|Overall Study|Sponsor Decision|0|||
126768942|NCT01125358|456106970|FG002|Overall Study|Sponsor Decision|1|||
126768943|NCT01125358|456106971|FG003|Overall Study|Sponsor Decision|1|||
126768944|NCT01125358|456106968|FG000|Overall Study|Withdrawal by Subject|2|||
126768945|NCT01125358|456106969|FG001|Overall Study|Withdrawal by Subject|1|||
126768946|NCT01125358|456106970|FG002|Overall Study|Withdrawal by Subject|1|||
126768947|NCT01125358|456106971|FG003|Overall Study|Withdrawal by Subject|1|||
126768948|NCT01157065|456106972|FG000|Overall Study|Death|0|||
126768949|NCT01157065|456106973|FG001|Overall Study|Death|1|||
126768950|NCT00962013|456106974|FG000|Overall Study|Did not have surgery|1|||
126768951|NCT00962013|456106974|FG000|Overall Study|Death|8|||
126768952|NCT00962013|456106974|FG000|Overall Study|Lost to Follow-up|12|||
126768953|NCT00962013|456106974|FG000|Overall Study|Unable/Unwilling to return|6|||
126768954|NCT00962013|456106974|FG000|Overall Study|Withdrawal by Subject|8|||
126768955|NCT00962013|456106974|FG000|Overall Study|Removal of study device|3|||
126768956|NCT00962013|456106974|FG000|Overall Study|Site Termination|24|||
126768957|NCT00962013|456106974|FG000|Overall Study|No 5 year evaluation|6|||
126768958|NCT04527549|456106975|FG000|Overall Study|Withdrawal by Subject|1|||
126768959|NCT04527549|456106976|FG001|Overall Study|Withdrawal by Subject|1|||
126768960|NCT03972709|456106983|FG000|Overall Study|Withdrawal by Subject|18|||
126768961|NCT03972709|456106984|FG001|Overall Study|Withdrawal by Subject|7|||
126768962|NCT03972709|456106985|FG002|Overall Study|Withdrawal by Subject|14|||
126768963|NCT03972709|456106983|FG000|Overall Study|Study Terminated by Sponsor|48|||
126768964|NCT03972709|456106984|FG001|Overall Study|Study Terminated by Sponsor|25|||
126768965|NCT03972709|456106985|FG002|Overall Study|Study Terminated by Sponsor|50|||
126768966|NCT03972709|456106983|FG000|Overall Study|Physician Decision|1|||
126768967|NCT03972709|456106984|FG001|Overall Study|Physician Decision|0|||
126768968|NCT03972709|456106985|FG002|Overall Study|Physician Decision|0|||
126768969|NCT03972709|456106983|FG000|Overall Study|COVID-19|0|||
126768970|NCT03972709|456106984|FG001|Overall Study|COVID-19|1|||
126768971|NCT03972709|456106985|FG002|Overall Study|COVID-19|1|||
126768972|NCT03972709|456106983|FG000|Overall Study|Lost to Follow-up|6|||
126768973|NCT03972709|456106984|FG001|Overall Study|Lost to Follow-up|1|||
126768974|NCT03972709|456106985|FG002|Overall Study|Lost to Follow-up|2|||
126768975|NCT03972709|456106983|FG000|Overall Study|Death|5|||
126768976|NCT03972709|456106984|FG001|Overall Study|Death|1|||
126768977|NCT03972709|456106985|FG002|Overall Study|Death|4|||
126768978|NCT03972709|456106983|FG000|Overall Study|Adverse Event|3|||
126768979|NCT03972709|456106984|FG001|Overall Study|Adverse Event|1|||
126296968|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
126296969|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
126296970|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
126296971|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
126460909|NCT00219544|454987928|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
126768980|NCT03972709|456106985|FG002|Overall Study|Adverse Event|4|||
126768981|NCT03972709|456106983|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
126768982|NCT03972709|456106984|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
126768983|NCT03972709|456106985|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
126768984|NCT03972709|456106983|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
126768985|NCT03972709|456106984|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
126768986|NCT03972709|456106985|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
126768987|NCT03972709|456106983|FG000|Overall Study|Subject Unable to be Contacted|0|||
126768988|NCT03972709|456106984|FG001|Overall Study|Subject Unable to be Contacted|1|||
126768989|NCT03972709|456106985|FG002|Overall Study|Subject Unable to be Contacted|0|||
126768990|NCT03972709|456106983|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
126768991|NCT03972709|456106984|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
126768992|NCT03972709|456106985|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
126768993|NCT03972709|456106983|FG000|Overall Study|Subject Moved|0|||
126768994|NCT03972709|456106984|FG001|Overall Study|Subject Moved|1|||
126768995|NCT03972709|456106985|FG002|Overall Study|Subject Moved|0|||
126768996|NCT03972709|456106983|FG000|Overall Study|Missed Study Visits|1|||
126768997|NCT03972709|456106984|FG001|Overall Study|Missed Study Visits|0|||
126768998|NCT03972709|456106985|FG002|Overall Study|Missed Study Visits|0|||
126768999|NCT02873195|456106990|FG000|Overall Study|Ineligible|5|||
126769000|NCT02873195|456106991|FG001|Overall Study|Ineligible|0|||
126769001|NCT04278872|456106992|FG000|Overall Study|Adverse Event|1|||
126769002|NCT04278872|456106993|FG001|Overall Study|Adverse Event|0|||
126769003|NCT04278872|456106992|FG000|Overall Study|Protocol Violation|0|||
126769004|NCT04278872|456106993|FG001|Overall Study|Protocol Violation|1|||
126769005|NCT04278872|456106992|FG000|Overall Study|Study Termination|2|||
126769006|NCT04278872|456106993|FG001|Overall Study|Study Termination|0|||
126769007|NCT00752895|456106994|FG000|Overall Study|Withdrawal by Subject|8|||
126769008|NCT00752895|456106995|FG001|Overall Study|Withdrawal by Subject|3|||
126769009|NCT00096031|456106996|FG000|Overall Study|Adverse Event|3|||
126769010|NCT00096031|456106996|FG000|Overall Study|Lack of Efficacy|42|||
126769011|NCT00096031|456106996|FG000|Overall Study|Death|4|||
126769012|NCT00096031|456106996|FG000|Overall Study|Withdrawal by Subject|1|||
126769013|NCT00096031|456106996|FG000|Overall Study|Ineligible|8|||
126769014|NCT00096031|456106996|FG000|Overall Study|Not protocol specified|5|||
126769015|NCT02392377|456106997|FG000|Overall Study|Withdrawal by Subject|0|||
126769016|NCT02392377|456106998|FG001|Overall Study|Withdrawal by Subject|1|||
126769017|NCT05257109|456107001|FG000|Overall Study|Withdrawal by Subject|1|||
126769018|NCT05257109|456107002|FG001|Overall Study|Withdrawal by Subject|0|||
126769019|NCT05257109|456107003|FG002|Overall Study|Withdrawal by Subject|0|||
126769020|NCT05257109|456107004|FG003|Overall Study|Withdrawal by Subject|0|||
126769021|NCT00915473|456108213|FG000|Screening|Withdrawal by Subject|1|||
126769022|NCT00915473|456108214|FG001|Screening|Withdrawal by Subject|0|||
126769023|NCT00915473|456108213|FG000|4-week Follow Up|Lost to Follow-up|1|||
126769024|NCT00915473|456108214|FG001|4-week Follow Up|Lost to Follow-up|5|||
126769025|NCT03526679|456108215|FG000|Overall Study|still under treatment|2|||
126769026|NCT03443973|456108216|FG000|Double-blind Treatment Period|Adverse Event|5|||
126769027|NCT03443973|456108217|FG001|Double-blind Treatment Period|Adverse Event|19|||
126769028|NCT03443973|456108218|FG002|Double-blind Treatment Period|Adverse Event|0|||
126769029|NCT03443973|456108219|FG003|Double-blind Treatment Period|Adverse Event|0|||
126769030|NCT03443973|456108216|FG000|Double-blind Treatment Period|Death|5|||
126769031|NCT03443973|456108217|FG001|Double-blind Treatment Period|Death|7|||
126769032|NCT03443973|456108218|FG002|Double-blind Treatment Period|Death|0|||
126769033|NCT03443973|456108219|FG003|Double-blind Treatment Period|Death|0|||
126769034|NCT03443973|456108216|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
126769035|NCT03443973|456108217|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
126769036|NCT03443973|456108218|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
126769037|NCT03443973|456108219|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
126769038|NCT03443973|456108216|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126769039|NCT03443973|456108217|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
126769040|NCT03443973|456108218|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
126769041|NCT03443973|456108219|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
126769042|NCT03443973|456108216|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
126769043|NCT03443973|456108217|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
126769044|NCT03443973|456108218|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
126769045|NCT03443973|456108219|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
126769046|NCT03443973|456108216|FG000|Double-blind Treatment Period|Physician Decision|5|||
126769047|NCT03443973|456108217|FG001|Double-blind Treatment Period|Physician Decision|6|||
126769048|NCT03443973|456108218|FG002|Double-blind Treatment Period|Physician Decision|0|||
126769049|NCT03443973|456108219|FG003|Double-blind Treatment Period|Physician Decision|0|||
126769050|NCT03443973|456108216|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
126769051|NCT03443973|456108217|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
126769052|NCT03443973|456108218|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
126769053|NCT03443973|456108219|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
126769054|NCT03443973|456108216|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
126769055|NCT03443973|456108217|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
126769056|NCT03443973|456108218|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126769057|NCT03443973|456108219|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
126769058|NCT03443973|456108216|FG000|Open-label Extension Period|Reason Not Specified|0|||
126769059|NCT03443973|456108217|FG001|Open-label Extension Period|Reason Not Specified|0|||
126769060|NCT03443973|456108218|FG002|Open-label Extension Period|Reason Not Specified|3|||
126769061|NCT03443973|456108219|FG003|Open-label Extension Period|Reason Not Specified|0|||
126769062|NCT03443973|456108216|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
126769063|NCT03443973|456108217|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
126769064|NCT03443973|456108218|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
126769065|NCT03443973|456108219|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
126769066|NCT00734617|456108226|FG000|Overall Study|Adverse Event|4|||
126769067|NCT00734617|456108227|FG001|Overall Study|Adverse Event|7|||
126769068|NCT00734617|456108226|FG000|Overall Study|Withdrawal by Subject|103|||
126769069|NCT00734617|456108227|FG001|Overall Study|Withdrawal by Subject|95|||
126769070|NCT02367729|456108228|FG000|Overall Study|Organic disorder diagnosed|2|||
126769071|NCT02367729|456108229|FG001|Overall Study|Organic disorder diagnosed|1|||
126769072|NCT02367729|456108228|FG000|Overall Study|Adverse Event|1|||
126769073|NCT02367729|456108229|FG001|Overall Study|Adverse Event|2|||
126769074|NCT02367729|456108228|FG000|Overall Study|Withdrawal by Subject|0|||
126769075|NCT02367729|456108229|FG001|Overall Study|Withdrawal by Subject|5|||
126769076|NCT01890109|456108234|FG000|Overall Study|Withdrawal by Subject|0|||
126769077|NCT01890109|456108235|FG001|Overall Study|Withdrawal by Subject|3|||
126769078|NCT01890109|456108234|FG000|Overall Study|Lost to Follow-up|1|||
126769079|NCT01890109|456108235|FG001|Overall Study|Lost to Follow-up|2|||
126769080|NCT00996632|456108238|FG000|Overall Study|Physician Decision|0|||
126769081|NCT00996632|456108239|FG001|Overall Study|Physician Decision|0|||
126769082|NCT02861534|456108244|FG000|Overall Study|Death|541|||
126769083|NCT02861534|456108245|FG001|Overall Study|Death|552|||
126769084|NCT02861534|456108244|FG000|Overall Study|Lost to Follow-up|14|||
126769085|NCT02861534|456108245|FG001|Overall Study|Lost to Follow-up|14|||
126769086|NCT02861534|456108244|FG000|Overall Study|Site Terminated by Sponsor|4|||
126769087|NCT02861534|456108245|FG001|Overall Study|Site Terminated by Sponsor|3|||
126769088|NCT02861534|456108244|FG000|Overall Study|Withdrawal by Subject|15|||
126769089|NCT02861534|456108245|FG001|Overall Study|Withdrawal by Subject|18|||
126769090|NCT02780115|456108246|FG000|Overall Study|Withdrawal by Subject|0|||
126769091|NCT02780115|456108247|FG001|Overall Study|Withdrawal by Subject|1|||
126769092|NCT02780115|456108248|FG002|Overall Study|Withdrawal by Subject|1|||
126769093|NCT02780115|456108249|FG003|Overall Study|Withdrawal by Subject|0|||
126769094|NCT02780115|456108250|FG004|Overall Study|Withdrawal by Subject|0|||
126769095|NCT02780115|456108246|FG000|Overall Study|Adverse Event|0|||
126769096|NCT02780115|456108247|FG001|Overall Study|Adverse Event|0|||
126769097|NCT02780115|456108248|FG002|Overall Study|Adverse Event|0|||
126769098|NCT02780115|456108249|FG003|Overall Study|Adverse Event|1|||
126769099|NCT02780115|456108250|FG004|Overall Study|Adverse Event|1|||
126769100|NCT01179191|456108251|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
126769101|NCT01179191|456108251|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
126769102|NCT01179191|456108251|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
126769103|NCT01179191|456108251|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
126769104|NCT01179191|456108251|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
126769105|NCT01179191|456108251|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
126769106|NCT01179191|456108251|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
126769107|NCT01179191|456108251|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
126769108|NCT01179191|456108251|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
126769109|NCT01179191|456108251|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
126769110|NCT01179191|456108251|FG000|Maintenance Phase (8 Weeks)|Other|66|||
126769111|NCT00916617|456108255|FG000|Overall Study|Adverse Event|3|||
126769112|NCT00916617|456108256|FG001|Overall Study|Adverse Event|2|||
126769113|NCT00916617|456108257|FG002|Overall Study|Adverse Event|6|||
126769114|NCT00916617|456108258|FG003|Overall Study|Adverse Event|3|||
126769115|NCT00916617|456108255|FG000|Overall Study|Withdrawal by Subject|3|||
126769116|NCT00916617|456108256|FG001|Overall Study|Withdrawal by Subject|2|||
126769117|NCT00916617|456108257|FG002|Overall Study|Withdrawal by Subject|0|||
126769118|NCT00916617|456108258|FG003|Overall Study|Withdrawal by Subject|1|||
126769119|NCT00916617|456108255|FG000|Overall Study|Caregiver Request|3|||
126769120|NCT00916617|456108256|FG001|Overall Study|Caregiver Request|2|||
126769121|NCT00916617|456108257|FG002|Overall Study|Caregiver Request|1|||
126769122|NCT00916617|456108258|FG003|Overall Study|Caregiver Request|0|||
126769123|NCT00916617|456108255|FG000|Overall Study|Physician Decision|1|||
126769124|NCT00916617|456108256|FG001|Overall Study|Physician Decision|1|||
126769125|NCT00916617|456108257|FG002|Overall Study|Physician Decision|0|||
126769126|NCT00916617|456108258|FG003|Overall Study|Physician Decision|0|||
126769127|NCT00916617|456108255|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
126769128|NCT00916617|456108256|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
126769129|NCT00916617|456108257|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
126769130|NCT00916617|456108258|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
126769131|NCT00916617|456108255|FG000|Overall Study|Lost to Follow-up|2|||
126769132|NCT00916617|456108256|FG001|Overall Study|Lost to Follow-up|1|||
126769133|NCT00916617|456108257|FG002|Overall Study|Lost to Follow-up|0|||
126769134|NCT00916617|456108258|FG003|Overall Study|Lost to Follow-up|0|||
126769135|NCT00916617|456108255|FG000|Overall Study|Lack of Efficacy|1|||
126769136|NCT00916617|456108256|FG001|Overall Study|Lack of Efficacy|0|||
126769137|NCT00916617|456108257|FG002|Overall Study|Lack of Efficacy|0|||
126769138|NCT00916617|456108258|FG003|Overall Study|Lack of Efficacy|0|||
126769139|NCT00916617|456108255|FG000|Overall Study|Other|2|||
126769140|NCT00916617|456108256|FG001|Overall Study|Other|0|||
126769141|NCT00916617|456108257|FG002|Overall Study|Other|0|||
126769142|NCT00916617|456108258|FG003|Overall Study|Other|2|||
126769143|NCT01988337|456108261|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
126769144|NCT02742818|456108262|FG000|Overall Study|Adverse Event|0|||
126769145|NCT02742818|456108263|FG001|Overall Study|Adverse Event|1|||
126769146|NCT02742818|456108262|FG000|Overall Study|Protocol Violation|0|||
126769147|NCT02742818|456108263|FG001|Overall Study|Protocol Violation|1|||
126769148|NCT01260194|456108264|FG000|Overall Study|Withdrawal of Consent|1|||
126769149|NCT01785472|456108266|FG000|Overall Study|Adverse Event|5|||
126769150|NCT01785472|456108267|FG001|Overall Study|Adverse Event|4|||
126769151|NCT01785472|456108268|FG002|Overall Study|Adverse Event|6|||
126769152|NCT01785472|456108266|FG000|Overall Study|Lack of Efficacy|2|||
126769153|NCT01785472|456108267|FG001|Overall Study|Lack of Efficacy|0|||
126769154|NCT01785472|456108268|FG002|Overall Study|Lack of Efficacy|1|||
126769155|NCT01785472|456108266|FG000|Overall Study|Lost to Follow-up|1|||
126769156|NCT01785472|456108267|FG001|Overall Study|Lost to Follow-up|2|||
126769157|NCT01785472|456108268|FG002|Overall Study|Lost to Follow-up|0|||
126769158|NCT01785472|456108266|FG000|Overall Study|Physician Decision|1|||
126769159|NCT01785472|456108267|FG001|Overall Study|Physician Decision|1|||
126769160|NCT01785472|456108268|FG002|Overall Study|Physician Decision|1|||
126769161|NCT01785472|456108266|FG000|Overall Study|Protocol deviation|0|||
126769162|NCT01785472|456108267|FG001|Overall Study|Protocol deviation|2|||
126769163|NCT01785472|456108268|FG002|Overall Study|Protocol deviation|2|||
126769164|NCT01785472|456108266|FG000|Overall Study|Subject/guardian decision|15|||
126769165|NCT01785472|456108267|FG001|Overall Study|Subject/guardian decision|10|||
126769166|NCT01785472|456108268|FG002|Overall Study|Subject/guardian decision|11|||
126769167|NCT01785472|456108266|FG000|Overall Study|Technical problems|0|||
126769168|NCT01785472|456108267|FG001|Overall Study|Technical problems|0|||
126769169|NCT01785472|456108268|FG002|Overall Study|Technical problems|1|||
126769170|NCT04854707|456108274|FG000|Overall Study|Lack of Efficacy|78|||
126769171|NCT04854707|456108275|FG001|Overall Study|Lack of Efficacy|59|||
126769172|NCT04854707|456108276|FG002|Overall Study|Lack of Efficacy|30|||
126769173|NCT03466060|456108282|FG000|Period 1|Test Lens Damage|0|||
126296972|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
126296973|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
126296974|NCT04242498|454375353|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126296975|NCT04242498|454375354|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
126296976|NCT04242498|454375355|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
126296977|NCT04242498|454375356|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126296978|NCT04242498|454375357|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126296979|NCT04242498|454375358|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126296980|NCT04242498|454375359|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126296981|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126296982|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126296983|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126296984|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126296985|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
126296986|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
126296987|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
126296988|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126296989|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126296990|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126296991|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126296992|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
126296993|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
126296994|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
126296995|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126296996|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126296997|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126296998|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126460910|NCT00219544|454987927|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
126711783|NCT00958568|455897508|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
126711784|NCT00958568|455897509|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
126711785|NCT00958568|455897506|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
126711786|NCT00958568|455897507|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
126711787|NCT00958568|455897508|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
126711788|NCT00958568|455897509|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
126711789|NCT00958568|455897506|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
126711790|NCT00958568|455897507|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
126711791|NCT00958568|455897508|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
126711792|NCT00958568|455897509|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
126711793|NCT00958568|455897506|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
126711794|NCT00958568|455897507|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
126711795|NCT00958568|455897508|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
126711796|NCT00958568|455897509|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
126711797|NCT00958568|455897506|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
126711798|NCT00958568|455897507|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
126769174|NCT03466060|456108283|FG001|Period 1|Test Lens Damage|2|||
126769175|NCT03466060|456108284|FG002|Period 1|Test Lens Damage|0|||
126769176|NCT03466060|456108285|FG003|Period 1|Test Lens Damage|0|||
126769177|NCT03466060|456108286|FG004|Period 1|Test Lens Damage|0|||
126769178|NCT03466060|456108287|FG005|Period 1|Test Lens Damage|0|||
126769179|NCT03466060|456108282|FG000|Period 1|Withdrawal by Subject|0|||
126769180|NCT03466060|456108283|FG001|Period 1|Withdrawal by Subject|0|||
126769181|NCT03466060|456108284|FG002|Period 1|Withdrawal by Subject|2|||
126769182|NCT03466060|456108285|FG003|Period 1|Withdrawal by Subject|0|||
126769183|NCT03466060|456108286|FG004|Period 1|Withdrawal by Subject|0|||
126769184|NCT03466060|456108287|FG005|Period 1|Withdrawal by Subject|0|||
126769185|NCT03466060|456108282|FG000|Period 1|Lost to Follow-up|0|||
126769186|NCT03466060|456108283|FG001|Period 1|Lost to Follow-up|0|||
126296999|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126297000|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
126297001|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
126297002|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
126297003|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
126550200|NCT03390036|455309484|FG000|Overall Study|Lack of Efficacy|1|||
126297004|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
126297005|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
126297006|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
126297007|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
126297008|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
126297009|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
126297010|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
126769187|NCT03466060|456108284|FG002|Period 1|Lost to Follow-up|0|||
126769188|NCT03466060|456108285|FG003|Period 1|Lost to Follow-up|1|||
126769189|NCT03466060|456108286|FG004|Period 1|Lost to Follow-up|0|||
126769190|NCT03466060|456108287|FG005|Period 1|Lost to Follow-up|0|||
126769191|NCT03466060|456108282|FG000|Period 1|Grade 2 Conjunctivitis|0|||
126769192|NCT03466060|456108283|FG001|Period 1|Grade 2 Conjunctivitis|0|||
126769193|NCT03466060|456108284|FG002|Period 1|Grade 2 Conjunctivitis|1|||
126769194|NCT03466060|456108285|FG003|Period 1|Grade 2 Conjunctivitis|0|||
126769195|NCT03466060|456108286|FG004|Period 1|Grade 2 Conjunctivitis|0|||
126769196|NCT03466060|456108287|FG005|Period 1|Grade 2 Conjunctivitis|0|||
126769197|NCT03466060|456108282|FG000|Period 2|Lens Handling Difficulties|0|||
126769198|NCT03466060|456108283|FG001|Period 2|Lens Handling Difficulties|0|||
126769199|NCT03466060|456108284|FG002|Period 2|Lens Handling Difficulties|1|||
126769200|NCT03466060|456108285|FG003|Period 2|Lens Handling Difficulties|0|||
126769201|NCT03466060|456108286|FG004|Period 2|Lens Handling Difficulties|0|||
126769202|NCT03466060|456108287|FG005|Period 2|Lens Handling Difficulties|0|||
126769203|NCT00556166|456108288|FG000|Overall Study|Withdrawal by Subject|1|||
126769204|NCT01612780|456108289|FG000|Overall Study|Treatment not completed|1|||
126769205|NCT01612780|456108289|FG000|Overall Study|Withdrawal by Subject|5|||
126769206|NCT02985515|456108292|FG000|Olfaction Testing|Lost to Follow-up|0|||
126769207|NCT02985515|456108293|FG001|Olfaction Testing|Lost to Follow-up|5|||
126769208|NCT02985515|456108292|FG000|Olfaction Testing|Protocol Violation|0|||
126769209|NCT02985515|456108293|FG001|Olfaction Testing|Protocol Violation|3|||
126769210|NCT01339000|456108299|FG000|Overall Study|study closed due to lack of drug supply|1|||
126769211|NCT01339000|456108300|FG001|Overall Study|study closed due to lack of drug supply|0|||
126769212|NCT05674721|456108302|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
126769213|NCT05674721|456108303|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
126769214|NCT05674721|456108302|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
126769215|NCT05674721|456108303|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
126769216|NCT05013749|456108313|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
126769217|NCT05013749|456108314|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
126769218|NCT05013749|456108313|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
126769219|NCT05013749|456108314|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
126769220|NCT02017535|456108317|FG000|Overall Study|Withdrawal by Subject|1|||
126769221|NCT02017535|456108318|FG001|Overall Study|Withdrawal by Subject|0|||
126769222|NCT02017535|456108319|FG002|Overall Study|Withdrawal by Subject|0|||
126769223|NCT02017535|456108320|FG003|Overall Study|Withdrawal by Subject|0|||
126769224|NCT03506425|456108321|FG000|Overall Study|Adverse Event|1|||
126769225|NCT03506425|456108322|FG001|Overall Study|Adverse Event|3|||
126769226|NCT03506425|456108323|FG002|Overall Study|Adverse Event|0|||
126769227|NCT03506425|456108321|FG000|Overall Study|Death|1|||
126769228|NCT03506425|456108322|FG001|Overall Study|Death|0|||
126769229|NCT03506425|456108323|FG002|Overall Study|Death|0|||
126769230|NCT03506425|456108321|FG000|Overall Study|Withdrawal by Subject|0|||
126769231|NCT03506425|456108322|FG001|Overall Study|Withdrawal by Subject|0|||
126769232|NCT03506425|456108323|FG002|Overall Study|Withdrawal by Subject|1|||
126769233|NCT02643394|456108326|FG000|Overall Study|Protocol Violation|4|||
126769234|NCT02643394|456108327|FG001|Overall Study|Protocol Violation|5|||
126769235|NCT04088734|456108328|FG000|Overall Study|Other, Not Specified|5|||
126769236|NCT00834366|456108334|FG000|Treatment Period 1|Adverse Event|1|||
126769237|NCT00834366|456108335|FG001|Treatment Period 1|Adverse Event|1|||
126769238|NCT00090259|456108336|FG000|Overall Study|Lost to Follow-up|30|||
126769239|NCT00090259|456108337|FG001|Overall Study|Lost to Follow-up|26|||
126769240|NCT00090259|456108336|FG000|Overall Study|Withdrawal by Subject|21|||
126769241|NCT00090259|456108337|FG001|Overall Study|Withdrawal by Subject|15|||
126297011|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
126297012|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
126297013|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
126769242|NCT00090259|456108336|FG000|Overall Study|Investigator site closed|11|||
126769243|NCT00090259|456108337|FG001|Overall Study|Investigator site closed|7|||
126769244|NCT00960687|456108338|FG000|Washout Period of 7 Days|Adverse Event|3|||
126769245|NCT00960687|456108339|FG001|Washout Period of 7 Days|Adverse Event|2|||
126769246|NCT00960687|456108338|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
126769247|NCT00960687|456108339|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126769248|NCT02704130|456108340|FG000|Overall Study|Physician Decision|5|||
126769249|NCT02704130|456108341|FG001|Overall Study|Physician Decision|3|||
126769250|NCT02666768|456108342|FG000|Overall Study|Withdrawal by Subject|4|||
126769251|NCT00285012|456108345|FG000|Assigned to Study Treatment (Tx)|Other|2|||
126769252|NCT00285012|456108346|FG001|Assigned to Study Treatment (Tx)|Other|3|||
126769253|NCT00285012|456108345|FG000|Received Study Tx|Death|2|||
126769254|NCT00285012|456108346|FG001|Received Study Tx|Death|1|||
126769255|NCT00285012|456108345|FG000|Received Study Tx|Adverse Event|5|||
126769256|NCT00285012|456108346|FG001|Received Study Tx|Adverse Event|11|||
126769257|NCT00285012|456108345|FG000|Received Study Tx|Lack of Efficacy|0|||
126769258|NCT00285012|456108346|FG001|Received Study Tx|Lack of Efficacy|3|||
126769259|NCT00285012|456108345|FG000|Received Study Tx|Lost to Follow-up|29|||
126769260|NCT00285012|456108346|FG001|Received Study Tx|Lost to Follow-up|31|||
126769261|NCT00285012|456108345|FG000|Received Study Tx|Withdrawal by Subject|31|||
126769262|NCT00285012|456108346|FG001|Received Study Tx|Withdrawal by Subject|43|||
126769263|NCT00285012|456108345|FG000|Received Study Tx|Other|5|||
126769264|NCT00285012|456108346|FG001|Received Study Tx|Other|5|||
126769265|NCT05004181|456108347|FG000|Overall Study|Withdrawal of consent|0|||
126769266|NCT05004181|456108348|FG001|Overall Study|Withdrawal of consent|0|||
126769267|NCT05004181|456108349|FG002|Overall Study|Withdrawal of consent|1|||
126769268|NCT05004181|456108350|FG003|Overall Study|Withdrawal of consent|3|||
126769269|NCT05004181|456108351|FG004|Overall Study|Withdrawal of consent|3|||
126769270|NCT05004181|456108352|FG005|Overall Study|Withdrawal of consent|0|||
126769271|NCT05004181|456108353|FG006|Overall Study|Withdrawal of consent|30|||
126769272|NCT05004181|456108354|FG007|Overall Study|Withdrawal of consent|9|||
126769273|NCT05004181|456108355|FG008|Overall Study|Withdrawal of consent|3|||
126769274|NCT05004181|456108356|FG009|Overall Study|Withdrawal of consent|2|||
126769275|NCT05004181|456108357|FG010|Overall Study|Withdrawal of consent|5|||
126769276|NCT05004181|456108358|FG011|Overall Study|Withdrawal of consent|1|||
126769277|NCT05004181|456108347|FG000|Overall Study|Lost to Follow-up|2|||
126769278|NCT05004181|456108348|FG001|Overall Study|Lost to Follow-up|4|||
126769279|NCT05004181|456108349|FG002|Overall Study|Lost to Follow-up|2|||
126769280|NCT05004181|456108350|FG003|Overall Study|Lost to Follow-up|3|||
126769281|NCT05004181|456108351|FG004|Overall Study|Lost to Follow-up|5|||
126769282|NCT05004181|456108352|FG005|Overall Study|Lost to Follow-up|2|||
126769283|NCT05004181|456108353|FG006|Overall Study|Lost to Follow-up|15|||
126297014|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
126297015|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
126297016|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
126297017|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
126297018|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
126297019|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
126297020|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
126297021|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
126297022|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
126297023|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
126297024|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
126297025|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
126297026|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
126297027|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
126297028|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
126297029|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
126297030|NCT04242498|454375353|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
126297031|NCT04242498|454375354|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
126297032|NCT04242498|454375355|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
126297033|NCT04242498|454375356|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
126297034|NCT04242498|454375357|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
126550201|NCT03390036|455309485|FG001|Overall Study|Lack of Efficacy|0|||
126769284|NCT05004181|456108354|FG007|Overall Study|Lost to Follow-up|12|||
126769285|NCT05004181|456108355|FG008|Overall Study|Lost to Follow-up|38|||
126769286|NCT05004181|456108356|FG009|Overall Study|Lost to Follow-up|6|||
126769287|NCT05004181|456108357|FG010|Overall Study|Lost to Follow-up|6|||
126769288|NCT05004181|456108358|FG011|Overall Study|Lost to Follow-up|0|||
126769289|NCT05004181|456108347|FG000|Overall Study|Death|0|||
126769290|NCT05004181|456108348|FG001|Overall Study|Death|0|||
126769291|NCT05004181|456108349|FG002|Overall Study|Death|0|||
126769292|NCT05004181|456108350|FG003|Overall Study|Death|0|||
126769293|NCT05004181|456108351|FG004|Overall Study|Death|0|||
126769294|NCT05004181|456108352|FG005|Overall Study|Death|0|||
126297035|NCT04242498|454375358|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
126297036|NCT04242498|454375359|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
126297037|NCT04426006|454375360|FG000|Inclusion|Protocol Violation|1|||
126550202|NCT03390036|455309486|FG002|Overall Study|Lack of Efficacy|0|||
126711799|NCT00958568|455897508|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
126711800|NCT00958568|455897509|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
126711801|NCT00958568|455897506|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
126711802|NCT00958568|455897507|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
126711803|NCT00958568|455897508|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
126711804|NCT00958568|455897509|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
126711805|NCT00958568|455897506|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
126711806|NCT00958568|455897507|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
126711807|NCT00958568|455897508|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
126711808|NCT00958568|455897509|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
126711809|NCT00958568|455897506|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
126711810|NCT00958568|455897507|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
126711811|NCT00958568|455897508|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
126711812|NCT00958568|455897509|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
126711813|NCT00958568|455897506|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
126711814|NCT00958568|455897507|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
126711815|NCT00958568|455897508|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
126711816|NCT00958568|455897509|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
126711817|NCT00958568|455897506|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
126711818|NCT00958568|455897507|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
126711819|NCT00958568|455897508|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
126711820|NCT00958568|455897509|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
126711821|NCT00958568|455897506|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
126711822|NCT00958568|455897507|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
126711823|NCT00958568|455897508|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
126711824|NCT00958568|455897509|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
126711825|NCT00958568|455897506|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
126711826|NCT00958568|455897507|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
126711827|NCT00958568|455897508|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
126711828|NCT00958568|455897509|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
126711829|NCT00958568|455897506|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
126711830|NCT00958568|455897507|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
126711831|NCT00958568|455897508|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
126711832|NCT00958568|455897509|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
126711833|NCT03268746|455897522|FG000|Overall Study|Withdrawal by Subject|1|||
126711834|NCT00891657|455897529|FG000|Overall Study|Withdrawal by Subject|1|||
126711835|NCT00891657|455897530|FG001|Overall Study|Withdrawal by Subject|1|||
126711836|NCT02927171|455897533|FG000|Overall Study|Lost to Follow-up|0|||
126711837|NCT02927171|455897534|FG001|Overall Study|Lost to Follow-up|1|||
126711838|NCT01720667|455897540|FG000|Overall Study|Adverse Event|1|||
126711839|NCT01720667|455897541|FG001|Overall Study|Adverse Event|1|||
126711840|NCT01720667|455897540|FG000|Overall Study|Withdrawal by Subject|3|||
126711841|NCT01720667|455897541|FG001|Overall Study|Withdrawal by Subject|0|||
126711842|NCT03472534|455897542|FG000|Overall Study|Withdrawal by Subject|9|||
126711843|NCT03472534|455897542|FG000|Overall Study|Adverse Event|2|||
126711844|NCT00552305|455897543|FG000|Overall Study|Adverse Event|43|||
126711845|NCT00552305|455897543|FG000|Overall Study|Lack of Efficacy|120|||
126711846|NCT00552305|455897543|FG000|Overall Study|Lost to Follow-up|4|||
126711847|NCT00552305|455897543|FG000|Overall Study|Protocol Violation|3|||
126711848|NCT00552305|455897543|FG000|Overall Study|Withdrawal by Subject|44|||
126711849|NCT00552305|455897543|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
126711850|NCT00552305|455897543|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
126711851|NCT00552305|455897543|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
126711852|NCT00552305|455897543|FG000|Overall Study|Unsatisfactory compliance|11|||
126711853|NCT00552305|455897543|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
126711854|NCT00552305|455897543|FG000|Overall Study|AE/Other: prohibited drug required|1|||
126711855|NCT00552305|455897543|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
126711856|NCT00552305|455897543|FG000|Overall Study|Other: Site closed|4|||
126711857|NCT00552305|455897543|FG000|Overall Study|Other: Personal problems|1|||
126711858|NCT00552305|455897543|FG000|Overall Study|Other: Unable to attend visits|1|||
126711859|NCT00552305|455897543|FG000|Overall Study|Other: Subject underwent surgery|4|||
126711860|NCT00552305|455897543|FG000|Overall Study|Other: Subject became pregnant|1|||
126711861|NCT00552305|455897543|FG000|Overall Study|Other: Health problems, not drug related|1|||
126711862|NCT00552305|455897543|FG000|Overall Study|Other: Subject moved from area|2|||
126769295|NCT05004181|456108353|FG006|Overall Study|Death|1|||
126297038|NCT04426006|454375360|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
126297039|NCT04426006|454375360|FG000|Inclusion|Blood sample at inclusion not done|1|||
126297040|NCT04426006|454375360|FG000|3 Months|Lost to Follow-up|17|||
126297041|NCT04426006|454375360|FG000|12 Months|Lost to Follow-up|38|||
126769296|NCT05004181|456108354|FG007|Overall Study|Death|0|||
126769297|NCT05004181|456108355|FG008|Overall Study|Death|2|||
126769298|NCT05004181|456108356|FG009|Overall Study|Death|0|||
126769299|NCT05004181|456108357|FG010|Overall Study|Death|0|||
126769300|NCT05004181|456108358|FG011|Overall Study|Death|0|||
126769301|NCT05004181|456108347|FG000|Overall Study|Physician Decision|0|||
126297042|NCT03380429|454375363|FG000|Overall Study|Physician Decision|0|||
126297043|NCT03380429|454375364|FG001|Overall Study|Physician Decision|1|||
126297044|NCT03380429|454375365|FG002|Overall Study|Physician Decision|0|||
126297045|NCT03380429|454375366|FG003|Overall Study|Physician Decision|1|||
126297046|NCT03380429|454375367|FG004|Overall Study|Physician Decision|1|||
126297047|NCT03380429|454375363|FG000|Overall Study|Withdrawal by Subject|3|||
126297048|NCT03380429|454375364|FG001|Overall Study|Withdrawal by Subject|3|||
126297049|NCT03380429|454375365|FG002|Overall Study|Withdrawal by Subject|5|||
126297050|NCT03380429|454375366|FG003|Overall Study|Withdrawal by Subject|2|||
126297051|NCT03380429|454375367|FG004|Overall Study|Withdrawal by Subject|1|||
126297052|NCT03380429|454375363|FG000|Overall Study|Lost to Follow-up|0|||
126297053|NCT03380429|454375364|FG001|Overall Study|Lost to Follow-up|2|||
126297054|NCT03380429|454375365|FG002|Overall Study|Lost to Follow-up|4|||
126297055|NCT03380429|454375366|FG003|Overall Study|Lost to Follow-up|3|||
126297056|NCT03380429|454375367|FG004|Overall Study|Lost to Follow-up|1|||
126297057|NCT03380429|454375363|FG000|Overall Study|Protocol Violation|1|||
126297058|NCT03380429|454375364|FG001|Overall Study|Protocol Violation|0|||
126297059|NCT03380429|454375365|FG002|Overall Study|Protocol Violation|1|||
126297060|NCT03380429|454375366|FG003|Overall Study|Protocol Violation|0|||
126297061|NCT03380429|454375367|FG004|Overall Study|Protocol Violation|1|||
126297062|NCT03380429|454375363|FG000|Overall Study|Lack of Efficacy|0|||
126297063|NCT03380429|454375364|FG001|Overall Study|Lack of Efficacy|0|||
126297064|NCT03380429|454375365|FG002|Overall Study|Lack of Efficacy|0|||
126297065|NCT03380429|454375366|FG003|Overall Study|Lack of Efficacy|2|||
126297066|NCT03380429|454375367|FG004|Overall Study|Lack of Efficacy|1|||
126297067|NCT03380429|454375363|FG000|Overall Study|Adverse Event|1|||
126297068|NCT03380429|454375364|FG001|Overall Study|Adverse Event|1|||
126297069|NCT03380429|454375365|FG002|Overall Study|Adverse Event|1|||
126297070|NCT03380429|454375366|FG003|Overall Study|Adverse Event|2|||
126297071|NCT03380429|454375367|FG004|Overall Study|Adverse Event|0|||
126297072|NCT03762265|454375370|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
126297073|NCT03762265|454375371|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
126769302|NCT05004181|456108348|FG001|Overall Study|Physician Decision|0|||
126769303|NCT05004181|456108349|FG002|Overall Study|Physician Decision|0|||
126769304|NCT05004181|456108350|FG003|Overall Study|Physician Decision|0|||
126769305|NCT05004181|456108351|FG004|Overall Study|Physician Decision|0|||
126769306|NCT05004181|456108352|FG005|Overall Study|Physician Decision|0|||
126769307|NCT05004181|456108353|FG006|Overall Study|Physician Decision|2|||
126769308|NCT05004181|456108354|FG007|Overall Study|Physician Decision|0|||
126769309|NCT05004181|456108355|FG008|Overall Study|Physician Decision|7|||
126769310|NCT05004181|456108356|FG009|Overall Study|Physician Decision|0|||
126769311|NCT05004181|456108357|FG010|Overall Study|Physician Decision|0|||
126769312|NCT05004181|456108358|FG011|Overall Study|Physician Decision|0|||
126769313|NCT05004181|456108347|FG000|Overall Study|Withdrawal by Subject|2|||
126769314|NCT05004181|456108348|FG001|Overall Study|Withdrawal by Subject|3|||
126769315|NCT05004181|456108349|FG002|Overall Study|Withdrawal by Subject|2|||
126769316|NCT05004181|456108350|FG003|Overall Study|Withdrawal by Subject|2|||
126769317|NCT05004181|456108351|FG004|Overall Study|Withdrawal by Subject|4|||
126769318|NCT05004181|456108352|FG005|Overall Study|Withdrawal by Subject|2|||
126769319|NCT05004181|456108353|FG006|Overall Study|Withdrawal by Subject|4|||
126769320|NCT05004181|456108354|FG007|Overall Study|Withdrawal by Subject|22|||
126769321|NCT05004181|456108355|FG008|Overall Study|Withdrawal by Subject|8|||
126769322|NCT05004181|456108356|FG009|Overall Study|Withdrawal by Subject|1|||
126297074|NCT03762265|454375370|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
126297075|NCT03762265|454375371|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
126297076|NCT03762265|454375370|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
126297077|NCT03762265|454375371|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
126297078|NCT03762265|454375370|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
126297079|NCT03762265|454375371|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
126769323|NCT05004181|456108357|FG010|Overall Study|Withdrawal by Subject|3|||
126769324|NCT05004181|456108358|FG011|Overall Study|Withdrawal by Subject|2|||
126769325|NCT05004181|456108347|FG000|Overall Study|Protocol Violation|2|||
126769326|NCT05004181|456108348|FG001|Overall Study|Protocol Violation|3|||
126769327|NCT05004181|456108349|FG002|Overall Study|Protocol Violation|0|||
126297080|NCT03762265|454375370|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
126297081|NCT03762265|454375371|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
126297082|NCT03762265|454375370|FG000|BT Period: Weeks 1 to 37|Other|0|||
126297083|NCT03762265|454375371|FG001|BT Period: Weeks 1 to 37|Other|1|||
126297084|NCT03762265|454375370|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
126297085|NCT03762265|454375371|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
126297086|NCT03762265|454375370|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
126297087|NCT03762265|454375371|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
126297088|NCT03762265|454375370|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
126297089|NCT03762265|454375371|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
126297090|NCT03762265|454375370|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
126711863|NCT00552305|455897543|FG000|Overall Study|Other: Subject incarcerated|1|||
126711864|NCT00552305|455897543|FG000|Overall Study|Other: Subject went to rehab|1|||
126711865|NCT01319929|455897549|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
126711866|NCT01319929|455897550|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
126711867|NCT01319929|455897549|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
126711868|NCT01319929|455897550|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
126711869|NCT01319929|455897549|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
126711870|NCT01319929|455897550|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
126711871|NCT01319929|455897549|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
126711872|NCT01319929|455897550|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
126711873|NCT01319929|455897549|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
126711874|NCT01319929|455897550|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
126711875|NCT01749735|455897552|FG000|Overall Study|Withdrawal by Subject|1|||
126711876|NCT01749735|455897553|FG001|Overall Study|Withdrawal by Subject|0|||
126711877|NCT01221233|455897554|FG000|Overall Study|Withdrawal by Subject|3|||
126711878|NCT01221233|455897555|FG001|Overall Study|Withdrawal by Subject|1|||
126711879|NCT00611455|455897558|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
126711880|NCT00611455|455897559|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
126711881|NCT00611455|455897560|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126711882|NCT00611455|455897558|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
126711883|NCT00611455|455897559|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126711884|NCT00611455|455897560|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126711885|NCT00611455|455897558|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
126711886|NCT00611455|455897559|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
126711887|NCT00611455|455897560|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126711888|NCT00611455|455897558|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
126711889|NCT00611455|455897559|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
126711890|NCT00611455|455897560|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126711891|NCT00611455|455897558|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
126711892|NCT00611455|455897559|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
126711893|NCT00611455|455897560|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
126711894|NCT00611455|455897558|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
126711895|NCT00611455|455897559|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
126711896|NCT00611455|455897560|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
126711897|NCT00611455|455897558|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
126711898|NCT00611455|455897559|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
126711899|NCT00611455|455897560|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
126711900|NCT00611455|455897558|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
126711901|NCT00611455|455897559|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
126711902|NCT00611455|455897560|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
126711903|NCT00611455|455897558|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
126711904|NCT00611455|455897559|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
126711905|NCT00611455|455897560|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
126711906|NCT00611455|455897558|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
126711907|NCT00611455|455897559|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
126711908|NCT00611455|455897560|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
126711909|NCT00611455|455897558|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
126711910|NCT00611455|455897559|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
126711911|NCT00611455|455897560|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
126711912|NCT00611455|455897558|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
126711913|NCT00611455|455897559|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
126711914|NCT00611455|455897560|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
126711915|NCT00611455|455897558|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
126711916|NCT00611455|455897559|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
126711917|NCT00611455|455897560|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
126711918|NCT00611455|455897558|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
126711919|NCT00611455|455897559|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
126711920|NCT00611455|455897560|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
126711921|NCT00611455|455897558|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
126711922|NCT00611455|455897559|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
126769328|NCT05004181|456108350|FG003|Overall Study|Protocol Violation|0|||
126769329|NCT05004181|456108351|FG004|Overall Study|Protocol Violation|1|||
126769330|NCT05004181|456108352|FG005|Overall Study|Protocol Violation|0|||
126769331|NCT05004181|456108353|FG006|Overall Study|Protocol Violation|16|||
126769332|NCT05004181|456108354|FG007|Overall Study|Protocol Violation|18|||
126769333|NCT05004181|456108355|FG008|Overall Study|Protocol Violation|2|||
126769334|NCT05004181|456108356|FG009|Overall Study|Protocol Violation|2|||
126769335|NCT05004181|456108357|FG010|Overall Study|Protocol Violation|2|||
126769336|NCT05004181|456108358|FG011|Overall Study|Protocol Violation|1|||
126769337|NCT05004181|456108347|FG000|Overall Study|Not further specified|1|||
126769338|NCT05004181|456108348|FG001|Overall Study|Not further specified|0|||
126769339|NCT05004181|456108349|FG002|Overall Study|Not further specified|0|||
126769340|NCT05004181|456108350|FG003|Overall Study|Not further specified|0|||
126769341|NCT05004181|456108351|FG004|Overall Study|Not further specified|0|||
126769342|NCT05004181|456108352|FG005|Overall Study|Not further specified|0|||
126769343|NCT05004181|456108353|FG006|Overall Study|Not further specified|1|||
126769344|NCT05004181|456108354|FG007|Overall Study|Not further specified|0|||
126769345|NCT05004181|456108355|FG008|Overall Study|Not further specified|2|||
126769346|NCT05004181|456108356|FG009|Overall Study|Not further specified|1|||
126769347|NCT05004181|456108357|FG010|Overall Study|Not further specified|0|||
126769348|NCT05004181|456108358|FG011|Overall Study|Not further specified|1|||
126769349|NCT00891527|456110302|FG000|Overall Study|Withdrawal by Subject|2|||
126769350|NCT03993288|456110303|FG000|Overall Study|Lost to Follow-up|2|||
126769351|NCT03993288|456110304|FG001|Overall Study|Lost to Follow-up|1|||
126769352|NCT03993288|456110303|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
126769353|NCT03993288|456110304|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
126769354|NCT03993288|456110303|FG000|Overall Study|wrong randomization|0|||
126769355|NCT03993288|456110304|FG001|Overall Study|wrong randomization|1|||
126769356|NCT03993288|456110303|FG000|Overall Study|improper enrollment|0|||
126769357|NCT03993288|456110304|FG001|Overall Study|improper enrollment|1|||
126769358|NCT03993288|456110303|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
126769359|NCT03993288|456110304|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
126769360|NCT03993288|456110303|FG000|Overall Study|developed SAE|2|||
126769361|NCT03993288|456110304|FG001|Overall Study|developed SAE|0|||
126769362|NCT03993288|456110303|FG000|Overall Study|consent withdrawal|1|||
126769363|NCT03993288|456110304|FG001|Overall Study|consent withdrawal|0|||
126769364|NCT03993288|456110303|FG000|Overall Study|did not follow the treatment schedule|1|||
126769365|NCT03993288|456110304|FG001|Overall Study|did not follow the treatment schedule|0|||
126769366|NCT03993288|456110303|FG000|Overall Study|did not follow the treatment regimen|1|||
126297091|NCT03762265|454375371|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
126297092|NCT03762265|454375370|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
126297093|NCT03762265|454375371|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
126297094|NCT03762265|454375370|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
126297095|NCT03762265|454375371|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
126297096|NCT03762265|454375370|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
126297097|NCT03762265|454375371|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
126297098|NCT03762265|454375370|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
126297099|NCT03762265|454375371|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
126297100|NCT03762265|454375370|FG000|LTE Period: Weeks 61 to 109|Other|1|||
126297101|NCT03762265|454375371|FG001|LTE Period: Weeks 61 to 109|Other|0|||
126297102|NCT01383174|454375374|FG000|3 Month Assessment|Death|0|||
126297103|NCT01383174|454375375|FG001|3 Month Assessment|Death|1|||
126297104|NCT01383174|454375374|FG000|3 Month Assessment|Lost to Follow-up|2|||
126297105|NCT01383174|454375375|FG001|3 Month Assessment|Lost to Follow-up|0|||
126297106|NCT01383174|454375374|FG000|3 Month Assessment|Refused to complete|4|||
126297107|NCT01383174|454375375|FG001|3 Month Assessment|Refused to complete|0|||
126297108|NCT01383174|454375374|FG000|6 Month Assessment|Lost to Follow-up|1|||
126297109|NCT01383174|454375375|FG001|6 Month Assessment|Lost to Follow-up|1|||
126297110|NCT01383174|454375374|FG000|6 Month Assessment|Refused to complete|4|||
126297111|NCT01383174|454375375|FG001|6 Month Assessment|Refused to complete|0|||
126297112|NCT01787292|454375376|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
126297113|NCT01787292|454375377|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
126769367|NCT03993288|456110304|FG001|Overall Study|did not follow the treatment regimen|0|||
126297114|NCT01787292|454375376|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
126297115|NCT01787292|454375377|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
126297116|NCT02169271|454375378|FG000|Overall Study|Protocol Violation|1|||
126297117|NCT02169271|454375379|FG001|Overall Study|Protocol Violation|2|||
126297118|NCT00226499|454375383|FG000|Overall Study|Adverse Event|10|||
126769368|NCT03993288|456110303|FG000|Overall Study|Adverse Event|1|||
126769369|NCT03993288|456110304|FG001|Overall Study|Adverse Event|0|||
126769370|NCT03993288|456110303|FG000|Overall Study|Withdrawal by Subject|1|||
126769371|NCT03993288|456110304|FG001|Overall Study|Withdrawal by Subject|1|||
126769372|NCT01389024|456110306|FG000|Overall Study|Withdrawal by Subject|0|||
126769373|NCT01389024|456110307|FG001|Overall Study|Withdrawal by Subject|1|||
126297119|NCT00226499|454375384|FG001|Overall Study|Adverse Event|6|||
126297120|NCT00226499|454375385|FG002|Overall Study|Adverse Event|3|||
126297121|NCT00226499|454375383|FG000|Overall Study|Others|1064|||
126297122|NCT00226499|454375384|FG001|Overall Study|Others|1066|||
126297123|NCT00226499|454375385|FG002|Overall Study|Others|356|||
126297124|NCT00946920|454375388|FG000|Overall Study|Withdrawal by Subject|28|||
126297125|NCT00946920|454375389|FG001|Overall Study|Withdrawal by Subject|15|||
126297126|NCT00946920|454375388|FG000|Overall Study|Lost to Follow-up|2|||
126297127|NCT00946920|454375389|FG001|Overall Study|Lost to Follow-up|2|||
126297128|NCT00946920|454375388|FG000|Overall Study|Physician Decision|5|||
126297129|NCT00946920|454375389|FG001|Overall Study|Physician Decision|2|||
126297130|NCT00946920|454375388|FG000|Overall Study|Adverse Event|41|||
126297131|NCT00946920|454375389|FG001|Overall Study|Adverse Event|14|||
126297132|NCT00946920|454375388|FG000|Overall Study|Protocol Violation|16|||
126297133|NCT00946920|454375389|FG001|Overall Study|Protocol Violation|8|||
126297134|NCT00946920|454375388|FG000|Overall Study|Miscellaneous reasons|18|||
126297135|NCT00946920|454375389|FG001|Overall Study|Miscellaneous reasons|3|||
126297136|NCT04616612|454375390|FG000|Overall Study|Lost to Follow-up|6|||
126297137|NCT04616612|454375391|FG001|Overall Study|Lost to Follow-up|3|||
126297138|NCT01597973|454375392|FG000|Overall Study|Found ineligible before study medication started|4|||
126297139|NCT01597973|454375393|FG001|Overall Study|Found ineligible before study medication started|2|||
126769374|NCT01389024|456110306|FG000|Overall Study|Lost to Follow-up|1|||
126297140|NCT01597973|454375392|FG000|Overall Study|Eligible pathogen not confirmed|14|||
126297141|NCT01597973|454375393|FG001|Overall Study|Eligible pathogen not confirmed|15|||
126297142|NCT01597973|454375392|FG000|Overall Study|LAR not authorized to consent|0|||
126297143|NCT01597973|454375393|FG001|Overall Study|LAR not authorized to consent|1|||
126297144|NCT01597973|454375392|FG000|Overall Study|Ineligible due to early seizures|1|||
126297145|NCT01597973|454375393|FG001|Overall Study|Ineligible due to early seizures|0|||
126297146|NCT01597973|454375392|FG000|Overall Study|Ineligible due to non-target infection|1|||
126297147|NCT01597973|454375393|FG001|Overall Study|Ineligible due to non-target infection|1|||
126297148|NCT00503698|454375399|FG000|Overall Study|Protocol Violation|5|||
126297149|NCT00503698|454375400|FG001|Overall Study|Protocol Violation|6|||
126297150|NCT00503698|454375399|FG000|Overall Study|Adverse Event|52|||
126297151|NCT00503698|454375400|FG001|Overall Study|Adverse Event|41|||
126297152|NCT00503698|454375399|FG000|Overall Study|Death|1|||
126297153|NCT00503698|454375400|FG001|Overall Study|Death|0|||
126297154|NCT00503698|454375399|FG000|Overall Study|Lack of Efficacy|3|||
126297155|NCT00503698|454375400|FG001|Overall Study|Lack of Efficacy|4|||
126297156|NCT00503698|454375399|FG000|Overall Study|Trial terminated|216|||
126297157|NCT00503698|454375400|FG001|Overall Study|Trial terminated|253|||
126297158|NCT00503698|454375399|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
126297159|NCT00503698|454375400|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
126297160|NCT00503698|454375399|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
126297161|NCT00503698|454375400|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
126297162|NCT00503698|454375399|FG000|Overall Study|Any condition in exclusion criteria|4|||
126297163|NCT00503698|454375400|FG001|Overall Study|Any condition in exclusion criteria|6|||
126297164|NCT00503698|454375399|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
126297165|NCT00503698|454375400|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
126297166|NCT00503698|454375399|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
126297167|NCT00503698|454375400|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
126297168|NCT00503698|454375399|FG000|Overall Study|Critically ill|2|||
126297169|NCT00503698|454375400|FG001|Overall Study|Critically ill|0|||
126769375|NCT01389024|456110307|FG001|Overall Study|Lost to Follow-up|0|||
126769376|NCT00819091|456110308|FG000|Overall Study|Adverse Event|3|||
126769377|NCT00819091|456110309|FG001|Overall Study|Adverse Event|5|||
126297170|NCT00503698|454375399|FG000|Overall Study|Unclassified|48|||
126297171|NCT00503698|454375400|FG001|Overall Study|Unclassified|32|||
126297172|NCT00503698|454375399|FG000|Overall Study|Not exposed to trial drug|11|||
126297173|NCT00503698|454375400|FG001|Overall Study|Not exposed to trial drug|6|||
126297174|NCT02259010|454375403|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
126297175|NCT03830333|454375404|FG000|Overall Study|Death|0|||
126297176|NCT03830333|454375405|FG001|Overall Study|Death|1|||
126297177|NCT03830333|454375404|FG000|Overall Study|Withdrawal by Subject|5|||
126297178|NCT03830333|454375405|FG001|Overall Study|Withdrawal by Subject|1|||
126297179|NCT03830333|454375404|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
126297180|NCT03830333|454375405|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
126297181|NCT02208362|454375413|FG000|Overall Study|Participant did not complete treatment|0|||
126297182|NCT02208362|454375414|FG001|Overall Study|Participant did not complete treatment|1|||
126297183|NCT02208362|454375415|FG002|Overall Study|Participant did not complete treatment|0|||
126297184|NCT02208362|454375416|FG003|Overall Study|Participant did not complete treatment|0|||
126297185|NCT02208362|454375417|FG004|Overall Study|Participant did not complete treatment|0|||
126297186|NCT02208362|454375418|FG005|Overall Study|Participant did not complete treatment|0|||
126297187|NCT02208362|454375419|FG006|Overall Study|Participant did not complete treatment|1|||
126769378|NCT00819091|456110308|FG000|Overall Study|Protocol Violation|0|||
126769379|NCT00819091|456110309|FG001|Overall Study|Protocol Violation|1|||
126769380|NCT00819091|456110308|FG000|Overall Study|Lost to Follow-up|2|||
126769381|NCT00819091|456110309|FG001|Overall Study|Lost to Follow-up|0|||
126769382|NCT00819091|456110308|FG000|Overall Study|Withdrawal by Subject|1|||
126769383|NCT00819091|456110309|FG001|Overall Study|Withdrawal by Subject|2|||
126769384|NCT00819091|456110308|FG000|Overall Study|Other|1|||
126769385|NCT00819091|456110309|FG001|Overall Study|Other|2|||
126769386|NCT02953262|456110311|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
126769387|NCT02953262|456110312|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
126769388|NCT02953262|456110313|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
126769389|NCT02953262|456110314|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
126769390|NCT00740480|456110315|FG000|Overall Study|Adverse Event|1|||
126769391|NCT00740480|456110315|FG000|Overall Study|Physician Decision|1|||
126769392|NCT03349437|456110320|FG000|Screening|Screen Fail|4|||
126769393|NCT03349437|456110321|FG001|Screening|Screen Fail|0|||
126769394|NCT03349437|456110322|FG002|Screening|Screen Fail|0|||
126769395|NCT03349437|456110320|FG000|Screening|Withdrawn|1|||
126769396|NCT03349437|456110321|FG001|Screening|Withdrawn|0|||
126769397|NCT03349437|456110322|FG002|Screening|Withdrawn|0|||
126769398|NCT01461369|456110323|FG000|Overall Study|Lack of Efficacy|2|||
126769399|NCT01461369|456110324|FG001|Overall Study|Lack of Efficacy|0|||
126769400|NCT01461369|456110325|FG002|Overall Study|Lack of Efficacy|6|||
126769401|NCT01461369|456110323|FG000|Overall Study|Lost to Follow-up|0|||
126769402|NCT01461369|456110324|FG001|Overall Study|Lost to Follow-up|0|||
126769403|NCT01461369|456110325|FG002|Overall Study|Lost to Follow-up|3|||
126769404|NCT01461369|456110323|FG000|Overall Study|Adverse Event|9|||
126769405|NCT01461369|456110324|FG001|Overall Study|Adverse Event|12|||
126769406|NCT01461369|456110325|FG002|Overall Study|Adverse Event|4|||
126769407|NCT01461369|456110323|FG000|Overall Study|Protocol Violation|1|||
126297188|NCT02208362|454375420|FG007|Overall Study|Participant did not complete treatment|1|||
126297189|NCT02208362|454375421|FG008|Overall Study|Participant did not complete treatment|2|||
126297190|NCT02208362|454375422|FG009|Overall Study|Participant did not complete treatment|0|||
126297191|NCT02208362|454375423|FG010|Overall Study|Participant did not complete treatment|1|||
126297192|NCT02208362|454375424|FG011|Overall Study|Participant did not complete treatment|0|||
126297193|NCT02208362|454375413|FG000|Overall Study|Participant received disallowed treatment|0|||
126297194|NCT02208362|454375414|FG001|Overall Study|Participant received disallowed treatment|0|||
126297195|NCT02208362|454375415|FG002|Overall Study|Participant received disallowed treatment|0|||
126297196|NCT02208362|454375416|FG003|Overall Study|Participant received disallowed treatment|0|||
126297197|NCT02208362|454375417|FG004|Overall Study|Participant received disallowed treatment|0|||
126297198|NCT02208362|454375418|FG005|Overall Study|Participant received disallowed treatment|0|||
126297199|NCT02208362|454375419|FG006|Overall Study|Participant received disallowed treatment|0|||
126297200|NCT02208362|454375420|FG007|Overall Study|Participant received disallowed treatment|0|||
126297201|NCT02208362|454375421|FG008|Overall Study|Participant received disallowed treatment|1|||
126297202|NCT02208362|454375422|FG009|Overall Study|Participant received disallowed treatment|0|||
126297203|NCT02208362|454375423|FG010|Overall Study|Participant received disallowed treatment|0|||
126297204|NCT02208362|454375424|FG011|Overall Study|Participant received disallowed treatment|0|||
126297205|NCT01546025|454375425|FG000|Overall Study|Lost to Follow-up|0|||
126297206|NCT01546025|454375426|FG001|Overall Study|Lost to Follow-up|1|||
126297207|NCT05966584|454375433|FG000|Overall Study|Lost to Follow-up|1|||
126297208|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
126297209|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
126297210|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
126297211|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126297212|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126297213|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126297214|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
126297215|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126297216|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
126297217|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
126297218|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126297219|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126297220|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126297221|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
126297222|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
126550203|NCT00358215|455309487|FG000|Overall Study|Ineligibility determined|4|||
126550204|NCT00358215|455309488|FG001|Overall Study|Ineligibility determined|3|||
126550205|NCT00358215|455309487|FG000|Overall Study|Adverse Event|83|||
126769408|NCT01461369|456110324|FG001|Overall Study|Protocol Violation|2|||
126769409|NCT01461369|456110325|FG002|Overall Study|Protocol Violation|2|||
126769410|NCT01461369|456110323|FG000|Overall Study|Withdrawal by Subject|1|||
126769411|NCT01461369|456110324|FG001|Overall Study|Withdrawal by Subject|3|||
126769412|NCT01461369|456110325|FG002|Overall Study|Withdrawal by Subject|2|||
126769413|NCT02406742|456110332|FG000|Overall Study|Progression of Disease|5|||
126297223|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
126297224|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
126297225|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126297226|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126297227|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126297228|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
126297229|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
126297230|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
126297231|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
126297232|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126297233|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126297234|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126297235|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
126297236|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
126297237|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
126297238|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
126297239|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
126297240|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
126297241|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
126297242|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
126297243|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
126297244|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
126297245|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
126297246|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
126297247|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
126297248|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
126297249|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
126297250|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
126297251|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
126297252|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
126297253|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
126297254|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
126297255|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
126297256|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
126297257|NCT04242446|454376963|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126297258|NCT04242446|454376964|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
126297259|NCT04242446|454376965|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
126297260|NCT04242446|454376966|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126297261|NCT04242446|454376967|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126297262|NCT04242446|454376968|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126297263|NCT04242446|454376969|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
126297264|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126297265|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126297266|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
126297267|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
126297268|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
126297269|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
126297270|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
126297271|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126297272|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126297273|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
126297274|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
126297275|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
126297276|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
126297277|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
126297278|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126297279|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126297280|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
126297281|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
126297282|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
126550206|NCT00358215|455309488|FG001|Overall Study|Adverse Event|65|||
126297283|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
126297284|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
126297285|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
126297286|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
126297287|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
126297288|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
126297289|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
126297290|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
126297291|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
126297292|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
126297293|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
126297294|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
126297295|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
126297296|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
126297297|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
126297298|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
126297299|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
126297300|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
126297301|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
126297302|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
126297303|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
126297304|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
126297305|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
126297306|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
126297307|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
126297308|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
126297309|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
126297310|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
126297311|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
126297312|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
126297313|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
126297314|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
126297315|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
126297316|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
126297317|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
126297318|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
126297319|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
126297320|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
126297321|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
126297322|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
126297323|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
126297324|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
126769414|NCT02406742|456110333|FG001|Overall Study|Progression of Disease|1|||
126769415|NCT02406742|456110334|FG002|Overall Study|Progression of Disease|6|||
126769416|NCT02406742|456110332|FG000|Overall Study|Adverse Event|3|||
126769417|NCT02406742|456110333|FG001|Overall Study|Adverse Event|0|||
126769418|NCT02406742|456110334|FG002|Overall Study|Adverse Event|2|||
126769419|NCT02406742|456110332|FG000|Overall Study|Death|1|||
126769420|NCT02406742|456110333|FG001|Overall Study|Death|0|||
126769421|NCT02406742|456110334|FG002|Overall Study|Death|0|||
126769422|NCT02406742|456110332|FG000|Overall Study|Lack of Efficacy|0|||
126769423|NCT02406742|456110333|FG001|Overall Study|Lack of Efficacy|0|||
126769424|NCT02406742|456110334|FG002|Overall Study|Lack of Efficacy|1|||
126769425|NCT02406742|456110332|FG000|Overall Study|Withdrawal by Participant|1|||
126769426|NCT02406742|456110333|FG001|Overall Study|Withdrawal by Participant|2|||
126769427|NCT02406742|456110334|FG002|Overall Study|Withdrawal by Participant|0|||
126769428|NCT02406742|456110332|FG000|Overall Study|Physician Decision|1|||
126769429|NCT02406742|456110333|FG001|Overall Study|Physician Decision|2|||
126769430|NCT02406742|456110334|FG002|Overall Study|Physician Decision|1|||
126769431|NCT02406742|456110332|FG000|Overall Study|Transition to other treatment|2|||
126769432|NCT02406742|456110333|FG001|Overall Study|Transition to other treatment|0|||
126769433|NCT02406742|456110334|FG002|Overall Study|Transition to other treatment|1|||
126769434|NCT02406742|456110332|FG000|Overall Study|Other Reasons|1|||
126769435|NCT02406742|456110333|FG001|Overall Study|Other Reasons|11|||
126769436|NCT02406742|456110334|FG002|Overall Study|Other Reasons|5|||
126769437|NCT01563029|456110337|FG000|Overall Study|Adverse Event|1|||
126769438|NCT01563029|456110338|FG001|Overall Study|Adverse Event|0|||
126769439|NCT01563029|456110339|FG002|Overall Study|Adverse Event|1|||
126769440|NCT01563029|456110340|FG003|Overall Study|Adverse Event|2|||
126297325|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
126297326|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
126297327|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
126297328|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
126297329|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
126297330|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
126297331|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
126297332|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
126297333|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
126297334|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
126769441|NCT01563029|456110341|FG004|Overall Study|Adverse Event|1|||
126769442|NCT01563029|456110337|FG000|Overall Study|Lack of Efficacy|42|||
126769443|NCT01563029|456110338|FG001|Overall Study|Lack of Efficacy|16|||
126769444|NCT01563029|456110339|FG002|Overall Study|Lack of Efficacy|23|||
126769445|NCT01563029|456110340|FG003|Overall Study|Lack of Efficacy|21|||
126769446|NCT01563029|456110341|FG004|Overall Study|Lack of Efficacy|19|||
126769447|NCT01563029|456110337|FG000|Overall Study|Protocol Violation|1|||
126769448|NCT01563029|456110338|FG001|Overall Study|Protocol Violation|2|||
126769449|NCT01563029|456110339|FG002|Overall Study|Protocol Violation|3|||
126769450|NCT01563029|456110340|FG003|Overall Study|Protocol Violation|1|||
126769451|NCT01563029|456110341|FG004|Overall Study|Protocol Violation|3|||
126769452|NCT01563029|456110337|FG000|Overall Study|Protocol defined stopping criteria|1|||
126769453|NCT01563029|456110338|FG001|Overall Study|Protocol defined stopping criteria|0|||
126769454|NCT01563029|456110339|FG002|Overall Study|Protocol defined stopping criteria|0|||
126769455|NCT01563029|456110340|FG003|Overall Study|Protocol defined stopping criteria|0|||
126769456|NCT01563029|456110341|FG004|Overall Study|Protocol defined stopping criteria|0|||
126769457|NCT01563029|456110337|FG000|Overall Study|Lost to Follow-up|1|||
126769458|NCT01563029|456110338|FG001|Overall Study|Lost to Follow-up|0|||
126769459|NCT01563029|456110339|FG002|Overall Study|Lost to Follow-up|1|||
126769460|NCT01563029|456110340|FG003|Overall Study|Lost to Follow-up|1|||
126769461|NCT01563029|456110341|FG004|Overall Study|Lost to Follow-up|1|||
126769462|NCT01563029|456110337|FG000|Overall Study|Physician Decision|3|||
126769463|NCT01563029|456110338|FG001|Overall Study|Physician Decision|5|||
126769464|NCT01563029|456110339|FG002|Overall Study|Physician Decision|2|||
126769465|NCT01563029|456110340|FG003|Overall Study|Physician Decision|4|||
126769466|NCT01563029|456110341|FG004|Overall Study|Physician Decision|2|||
126769467|NCT01563029|456110337|FG000|Overall Study|Withdrawal by Subject|4|||
126769468|NCT01563029|456110338|FG001|Overall Study|Withdrawal by Subject|1|||
126769469|NCT01563029|456110339|FG002|Overall Study|Withdrawal by Subject|3|||
126769470|NCT01563029|456110340|FG003|Overall Study|Withdrawal by Subject|4|||
126769471|NCT01563029|456110341|FG004|Overall Study|Withdrawal by Subject|3|||
126769472|NCT01569594|456110342|FG000|Overall Study|Physician Decision|4|||
126769473|NCT01569594|456110342|FG000|Overall Study|Death|13|||
126769474|NCT01569594|456110342|FG000|Overall Study|Lost to Follow-up|22|||
126769475|NCT01569594|456110342|FG000|Overall Study|Adverse Event|2|||
126769476|NCT01569594|456110342|FG000|Overall Study|Withdrawal by Subject|13|||
126769477|NCT01569594|456110342|FG000|Overall Study|Other|4|||
126769478|NCT01569594|456110342|FG000|Overall Study|No ECM used|9|||
126769479|NCT01071083|456110349|FG000|Overall Study|Adverse Event|1|||
126769480|NCT01071083|456110350|FG001|Overall Study|Adverse Event|0|||
126769481|NCT01071083|456110351|FG002|Overall Study|Adverse Event|1|||
126769482|NCT01071083|456110352|FG003|Overall Study|Adverse Event|0|||
126769483|NCT01071083|456110353|FG004|Overall Study|Adverse Event|1|||
126769484|NCT01071083|456110349|FG000|Overall Study|Withdrawal by Subject|3|||
126297335|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
126297336|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
126769485|NCT01071083|456110350|FG001|Overall Study|Withdrawal by Subject|0|||
126769486|NCT01071083|456110351|FG002|Overall Study|Withdrawal by Subject|2|||
126769487|NCT01071083|456110352|FG003|Overall Study|Withdrawal by Subject|0|||
126769488|NCT01071083|456110353|FG004|Overall Study|Withdrawal by Subject|3|||
126769489|NCT01071083|456110349|FG000|Overall Study|Physician Decision|1|||
126769490|NCT01071083|456110350|FG001|Overall Study|Physician Decision|0|||
126769491|NCT01071083|456110351|FG002|Overall Study|Physician Decision|0|||
126769492|NCT01071083|456110352|FG003|Overall Study|Physician Decision|1|||
126769493|NCT01071083|456110353|FG004|Overall Study|Physician Decision|1|||
126297337|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
126297338|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
126297339|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
126297340|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
126297341|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
126297342|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
126297343|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
126297344|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
126297345|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
126297346|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
126297347|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
126297348|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
126297349|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
126297350|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
126297351|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
126297352|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
126297353|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
126297354|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
126769494|NCT01071083|456110349|FG000|Overall Study|Early Rescue|1|||
126297355|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
126297356|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
126297357|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
126297358|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
126297359|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
126297360|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
126769495|NCT01071083|456110350|FG001|Overall Study|Early Rescue|0|||
126769496|NCT01071083|456110351|FG002|Overall Study|Early Rescue|0|||
126769497|NCT01071083|456110352|FG003|Overall Study|Early Rescue|0|||
126297361|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
126297362|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
126297363|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
126297364|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
126297365|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
126297366|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
126297367|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
126297368|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
126297369|NCT04242446|454376963|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
126297370|NCT04242446|454376964|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
126297371|NCT04242446|454376965|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
126297372|NCT04242446|454376966|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
126297373|NCT04242446|454376967|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
126297374|NCT04242446|454376968|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
126297375|NCT04242446|454376969|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
126297376|NCT04563754|454376973|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
126297377|NCT04563754|454376974|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
126297378|NCT04563754|454376975|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
126297379|NCT04563754|454376973|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
126297380|NCT04563754|454376974|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
126297381|NCT04563754|454376975|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
126297382|NCT04563754|454376973|FG000|Follow up|Lost to Follow-up|61|||
126297383|NCT04563754|454376974|FG001|Follow up|Lost to Follow-up|23|||
126297384|NCT04563754|454376975|FG002|Follow up|Lost to Follow-up|5|||
126297385|NCT04563754|454376973|FG000|Follow up|Death|0|||
126297386|NCT04563754|454376974|FG001|Follow up|Death|2|||
126297387|NCT04563754|454376975|FG002|Follow up|Death|0|||
126769498|NCT01071083|456110353|FG004|Overall Study|Early Rescue|1|||
126769499|NCT01071083|456110349|FG000|Overall Study|Subject Moved|0|||
126769500|NCT01071083|456110350|FG001|Overall Study|Subject Moved|1|||
126769501|NCT01071083|456110351|FG002|Overall Study|Subject Moved|0|||
126769502|NCT01071083|456110352|FG003|Overall Study|Subject Moved|0|||
126297388|NCT04563754|454376973|FG000|Follow up|Ongoing|0|||
126297389|NCT04563754|454376974|FG001|Follow up|Ongoing|28|||
126297390|NCT04563754|454376975|FG002|Follow up|Ongoing|0|||
126297391|NCT04023396|454376976|FG000|Overall Study|Adverse Event|16|||
126297392|NCT04023396|454376976|FG000|Overall Study|Death|1|||
126297393|NCT04023396|454376976|FG000|Overall Study|Lost to Follow-up|1|||
126297394|NCT04023396|454376976|FG000|Overall Study|Withdrawal by Subject|14|||
126297395|NCT04023396|454376976|FG000|Overall Study|Pregnancy|4|||
126297396|NCT04023396|454376976|FG000|Overall Study|Lack of Efficacy|3|||
126297397|NCT04023396|454376976|FG000|Overall Study|Physician Decision|4|||
126297398|NCT04023396|454376976|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
126297399|NCT04075825|454376977|FG000|Overall Study|Withdrawal by Subject|6|||
126297400|NCT04075825|454376978|FG001|Overall Study|Withdrawal by Subject|8|||
126297401|NCT04075825|454376977|FG000|Overall Study|Physician Decision|3|||
126297402|NCT04075825|454376978|FG001|Overall Study|Physician Decision|1|||
126297403|NCT04075825|454376977|FG000|Overall Study|Lost to Follow-up|5|||
126297404|NCT04075825|454376978|FG001|Overall Study|Lost to Follow-up|1|||
126297405|NCT04075825|454376977|FG000|Overall Study|Participation in New Clinical Trial|1|||
126297406|NCT04075825|454376978|FG001|Overall Study|Participation in New Clinical Trial|1|||
126297407|NCT04075825|454376977|FG000|Overall Study|Reason Not Specified|2|||
126297408|NCT04075825|454376978|FG001|Overall Study|Reason Not Specified|2|||
126297409|NCT04021914|454376979|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
126297410|NCT03349060|454376980|FG000|Overall Study|Adverse Event|9|||
126297411|NCT03349060|454376981|FG001|Overall Study|Adverse Event|9|||
126297412|NCT03349060|454376982|FG002|Overall Study|Adverse Event|7|||
126297413|NCT03349060|454376980|FG000|Overall Study|Lack of Efficacy|1|||
126297414|NCT03349060|454376981|FG001|Overall Study|Lack of Efficacy|0|||
126297415|NCT03349060|454376982|FG002|Overall Study|Lack of Efficacy|2|||
126297416|NCT03349060|454376980|FG000|Overall Study|Lost to Follow-up|2|||
126297417|NCT03349060|454376981|FG001|Overall Study|Lost to Follow-up|1|||
126297418|NCT03349060|454376982|FG002|Overall Study|Lost to Follow-up|1|||
126297419|NCT03349060|454376980|FG000|Overall Study|Protocol Violation|2|||
126297420|NCT03349060|454376981|FG001|Overall Study|Protocol Violation|2|||
126297421|NCT03349060|454376982|FG002|Overall Study|Protocol Violation|1|||
126297422|NCT03349060|454376980|FG000|Overall Study|Withdrawal by Subject|5|||
126297423|NCT03349060|454376981|FG001|Overall Study|Withdrawal by Subject|3|||
126297424|NCT03349060|454376982|FG002|Overall Study|Withdrawal by Subject|4|||
126297425|NCT03349060|454376980|FG000|Overall Study|Medication error,no linked adverse event|0|||
126297426|NCT03349060|454376981|FG001|Overall Study|Medication error,no linked adverse event|0|||
126297427|NCT03349060|454376982|FG002|Overall Study|Medication error,no linked adverse event|1|||
126297428|NCT03349060|454376980|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
126297429|NCT03349060|454376981|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
126297430|NCT03349060|454376982|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
126297431|NCT03349060|454376980|FG000|Overall Study|Other|2|||
126297432|NCT03349060|454376981|FG001|Overall Study|Other|1|||
126297433|NCT03349060|454376982|FG002|Overall Study|Other|0|||
126297434|NCT02861586|454376983|FG000|Overall Study|Withdrawal by Subject|1|||
126297435|NCT02861586|454376984|FG001|Overall Study|Withdrawal by Subject|2|||
126297436|NCT02861586|454376985|FG002|Overall Study|Withdrawal by Subject|0|||
126297437|NCT02861586|454376986|FG003|Overall Study|Withdrawal by Subject|0|||
126297438|NCT02861586|454376987|FG004|Overall Study|Withdrawal by Subject|0|||
126297439|NCT02861586|454376988|FG005|Overall Study|Withdrawal by Subject|1|||
126297440|NCT02861586|454376989|FG006|Overall Study|Withdrawal by Subject|1|||
126297441|NCT02861586|454376990|FG007|Overall Study|Withdrawal by Subject|0|||
126297442|NCT02861586|454376983|FG000|Overall Study|Lost to Follow-up|3|||
126297443|NCT02861586|454376984|FG001|Overall Study|Lost to Follow-up|1|||
126297444|NCT02861586|454376985|FG002|Overall Study|Lost to Follow-up|1|||
126297445|NCT02861586|454376986|FG003|Overall Study|Lost to Follow-up|0|||
126297446|NCT02861586|454376987|FG004|Overall Study|Lost to Follow-up|0|||
126297447|NCT02861586|454376988|FG005|Overall Study|Lost to Follow-up|3|||
126297448|NCT02861586|454376989|FG006|Overall Study|Lost to Follow-up|0|||
126711923|NCT00611455|455897560|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
126297449|NCT02861586|454376990|FG007|Overall Study|Lost to Follow-up|0|||
126297450|NCT02861586|454376983|FG000|Overall Study|Adverse Event|0|||
126297451|NCT02861586|454376984|FG001|Overall Study|Adverse Event|0|||
126297452|NCT02861586|454376985|FG002|Overall Study|Adverse Event|0|||
126297453|NCT02861586|454376986|FG003|Overall Study|Adverse Event|0|||
126297454|NCT02861586|454376987|FG004|Overall Study|Adverse Event|0|||
126297455|NCT02861586|454376988|FG005|Overall Study|Adverse Event|1|||
126297456|NCT02861586|454376989|FG006|Overall Study|Adverse Event|0|||
126297457|NCT02861586|454376990|FG007|Overall Study|Adverse Event|0|||
126297458|NCT00955409|454376991|FG000|Overall Study|Lack of Efficacy|1|||
126297459|NCT00955409|454376992|FG001|Overall Study|Lack of Efficacy|0|||
126297460|NCT00955409|454376993|FG002|Overall Study|Lack of Efficacy|0|||
126297461|NCT00955409|454376994|FG003|Overall Study|Lack of Efficacy|0|||
126297462|NCT00955409|454376995|FG004|Overall Study|Lack of Efficacy|0|||
126297463|NCT00955409|454376996|FG005|Overall Study|Lack of Efficacy|0|||
126297464|NCT00955409|454376997|FG006|Overall Study|Lack of Efficacy|0|||
126297465|NCT00955409|454376998|FG007|Overall Study|Lack of Efficacy|0|||
126297466|NCT00955409|454376999|FG008|Overall Study|Lack of Efficacy|0|||
126297467|NCT00955409|454377000|FG009|Overall Study|Lack of Efficacy|0|||
126297468|NCT00955409|454376991|FG000|Overall Study|Withdrawal by Subject|1|||
126297469|NCT00955409|454376992|FG001|Overall Study|Withdrawal by Subject|0|||
126297470|NCT00955409|454376993|FG002|Overall Study|Withdrawal by Subject|5|||
126297471|NCT00955409|454376994|FG003|Overall Study|Withdrawal by Subject|2|||
126297472|NCT00955409|454376995|FG004|Overall Study|Withdrawal by Subject|0|||
126297473|NCT00955409|454376996|FG005|Overall Study|Withdrawal by Subject|0|||
126297474|NCT00955409|454376997|FG006|Overall Study|Withdrawal by Subject|2|||
126297475|NCT00955409|454376998|FG007|Overall Study|Withdrawal by Subject|0|||
126297476|NCT00955409|454376999|FG008|Overall Study|Withdrawal by Subject|1|||
126297477|NCT00955409|454377000|FG009|Overall Study|Withdrawal by Subject|0|||
126297478|NCT00955409|454376991|FG000|Overall Study|Caregiver Request|2|||
126297479|NCT00955409|454376992|FG001|Overall Study|Caregiver Request|0|||
126297480|NCT00955409|454376993|FG002|Overall Study|Caregiver Request|6|||
126297481|NCT00955409|454376994|FG003|Overall Study|Caregiver Request|5|||
126297482|NCT00955409|454376995|FG004|Overall Study|Caregiver Request|0|||
126297483|NCT00955409|454376996|FG005|Overall Study|Caregiver Request|2|||
126297484|NCT00955409|454376997|FG006|Overall Study|Caregiver Request|3|||
126297485|NCT00955409|454376998|FG007|Overall Study|Caregiver Request|1|||
126297486|NCT00955409|454376999|FG008|Overall Study|Caregiver Request|3|||
126297487|NCT00955409|454377000|FG009|Overall Study|Caregiver Request|0|||
126297488|NCT00955409|454376991|FG000|Overall Study|Investigator Request|0|||
126297489|NCT00955409|454376992|FG001|Overall Study|Investigator Request|0|||
126297490|NCT00955409|454376993|FG002|Overall Study|Investigator Request|1|||
126297491|NCT00955409|454376994|FG003|Overall Study|Investigator Request|0|||
126297492|NCT00955409|454376995|FG004|Overall Study|Investigator Request|0|||
126550207|NCT00358215|455309487|FG000|Overall Study|Withdrawal by Subject|111|||
126297493|NCT00955409|454376996|FG005|Overall Study|Investigator Request|0|||
126297494|NCT00955409|454376997|FG006|Overall Study|Investigator Request|0|||
126297495|NCT00955409|454376998|FG007|Overall Study|Investigator Request|0|||
126297496|NCT00955409|454376999|FG008|Overall Study|Investigator Request|0|||
126297497|NCT00955409|454377000|FG009|Overall Study|Investigator Request|0|||
126297498|NCT00955409|454376991|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
126550208|NCT00358215|455309488|FG001|Overall Study|Withdrawal by Subject|102|||
126297499|NCT00955409|454376992|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
126711924|NCT00611455|455897558|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
126711925|NCT00611455|455897559|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
126711926|NCT00611455|455897560|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
126711927|NCT00611455|455897558|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
126711928|NCT00611455|455897559|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
126711929|NCT00611455|455897560|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
126711930|NCT00611455|455897558|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
126711931|NCT00611455|455897559|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
126711932|NCT00611455|455897560|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
126711933|NCT00611455|455897558|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
126711934|NCT00611455|455897559|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
126711935|NCT00611455|455897560|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
126711936|NCT00611455|455897558|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
126711937|NCT00611455|455897559|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
126711938|NCT00611455|455897560|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
126711939|NCT00611455|455897558|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
126711940|NCT00611455|455897559|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
126711941|NCT00611455|455897560|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
126711942|NCT00491530|455897561|FG000|Overall Study|Adverse Event|6|||
126711943|NCT00491530|455897562|FG001|Overall Study|Adverse Event|1|||
126711944|NCT00491530|455897563|FG002|Overall Study|Adverse Event|2|||
126711945|NCT00491530|455897561|FG000|Overall Study|Withdrawal by Subject|3|||
126711946|NCT00491530|455897562|FG001|Overall Study|Withdrawal by Subject|0|||
126711947|NCT00491530|455897563|FG002|Overall Study|Withdrawal by Subject|0|||
126711948|NCT00491530|455897561|FG000|Overall Study|Lost to Follow-up|3|||
126711949|NCT00491530|455897562|FG001|Overall Study|Lost to Follow-up|2|||
126711950|NCT00491530|455897563|FG002|Overall Study|Lost to Follow-up|2|||
126711951|NCT00491530|455897561|FG000|Overall Study|Lack of Efficacy|0|||
126711952|NCT00491530|455897562|FG001|Overall Study|Lack of Efficacy|1|||
126711953|NCT00491530|455897563|FG002|Overall Study|Lack of Efficacy|0|||
126297500|NCT00955409|454376993|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
126297501|NCT00955409|454376994|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
126297502|NCT00955409|454376995|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
126297503|NCT00955409|454376996|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
126297504|NCT00955409|454376997|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
126297505|NCT00955409|454376998|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
126297506|NCT00955409|454376999|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
126297507|NCT00955409|454377000|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
126297508|NCT00955409|454376991|FG000|Overall Study|Lost to Follow-up|0|||
126297509|NCT00955409|454376992|FG001|Overall Study|Lost to Follow-up|0|||
126297510|NCT00955409|454376993|FG002|Overall Study|Lost to Follow-up|1|||
126297511|NCT00955409|454376994|FG003|Overall Study|Lost to Follow-up|0|||
126297512|NCT00955409|454376995|FG004|Overall Study|Lost to Follow-up|0|||
126297513|NCT00955409|454376996|FG005|Overall Study|Lost to Follow-up|0|||
126297514|NCT00955409|454376997|FG006|Overall Study|Lost to Follow-up|1|||
126297515|NCT00955409|454376998|FG007|Overall Study|Lost to Follow-up|0|||
126297516|NCT00955409|454376999|FG008|Overall Study|Lost to Follow-up|0|||
126297517|NCT00955409|454377000|FG009|Overall Study|Lost to Follow-up|0|||
126297518|NCT00955409|454376991|FG000|Overall Study|Failed to Return|2|||
126297519|NCT00955409|454376992|FG001|Overall Study|Failed to Return|0|||
126297520|NCT00955409|454376993|FG002|Overall Study|Failed to Return|0|||
126297521|NCT00955409|454376994|FG003|Overall Study|Failed to Return|0|||
126297522|NCT00955409|454376995|FG004|Overall Study|Failed to Return|0|||
126297523|NCT00955409|454376996|FG005|Overall Study|Failed to Return|0|||
126297524|NCT00955409|454376997|FG006|Overall Study|Failed to Return|0|||
126366957|NCT01051661|454639361|FG000|Overall Study|Subject lost legal representation|0|||
126711954|NCT00491530|455897561|FG000|Overall Study|Investigator Discretion|0|||
126711955|NCT00491530|455897562|FG001|Overall Study|Investigator Discretion|1|||
126711956|NCT00491530|455897563|FG002|Overall Study|Investigator Discretion|0|||
126711957|NCT00491530|455897561|FG000|Overall Study|Patient Request|0|||
126711958|NCT00491530|455897562|FG001|Overall Study|Patient Request|1|||
126711959|NCT00491530|455897563|FG002|Overall Study|Patient Request|0|||
126711960|NCT00491530|455897561|FG000|Overall Study|Use of Prohibited Medication|0|||
126711961|NCT00491530|455897562|FG001|Overall Study|Use of Prohibited Medication|0|||
126711962|NCT00491530|455897563|FG002|Overall Study|Use of Prohibited Medication|1|||
126711963|NCT03671369|455897566|FG000|Overall Study|Other|1|||
126711964|NCT03671369|455897566|FG000|Overall Study|Withdrawal by Subject|289|||
126711965|NCT03671369|455897566|FG000|Overall Study|Not willing to be vaccinated|1|||
126711966|NCT04382651|455897567|FG000|Overall Study|Death|26|||
126711967|NCT04382651|455897568|FG001|Overall Study|Death|23|||
126711968|NCT04382651|455897567|FG000|Overall Study|Lost to Follow-up|3|||
126711969|NCT04382651|455897568|FG001|Overall Study|Lost to Follow-up|4|||
126711970|NCT04382651|455897567|FG000|Overall Study|Withdrawal by Subject|2|||
126711971|NCT04382651|455897568|FG001|Overall Study|Withdrawal by Subject|0|||
126711972|NCT04382651|455897567|FG000|Overall Study|Physician Decision|0|||
126711973|NCT04382651|455897568|FG001|Overall Study|Physician Decision|1|||
126711974|NCT02732912|455897569|FG000|Overall Study|Discharged before night|2|||
126711975|NCT02732912|455897570|FG001|Overall Study|Discharged before night|6|||
126711976|NCT02732912|455897569|FG000|Overall Study|Incomplete completion of questionnaire|2|||
126711977|NCT02732912|455897570|FG001|Overall Study|Incomplete completion of questionnaire|3|||
126711978|NCT02732912|455897569|FG000|Overall Study|No outcome; discharged or refused|6|||
126711979|NCT02732912|455897570|FG001|Overall Study|No outcome; discharged or refused|9|||
126711980|NCT01873742|455897571|FG000|Overall Study|Lost to Follow-up|68|||
126711981|NCT01873742|455897572|FG001|Overall Study|Lost to Follow-up|76|||
126711982|NCT00790296|455897574|FG000|Overall Study|Did not meet study eligibility criteria|1|||
126711983|NCT00790296|455897575|FG001|Overall Study|Did not meet study eligibility criteria|1|||
126711984|NCT00790296|455897574|FG000|Overall Study|Adverse Event|0|||
126711985|NCT00790296|455897575|FG001|Overall Study|Adverse Event|1|||
126711986|NCT01671488|455897576|FG000|Overall Study|Withdrawal by Subject|1|||
126711987|NCT02612077|455897577|FG000|Overall Study|Adverse Event|3|||
126711988|NCT02612077|455897577|FG000|Overall Study|Withdrawal by Subject|9|||
126711989|NCT02612077|455897577|FG000|Overall Study|Protocol Violation|28|||
126711990|NCT02612077|455897577|FG000|Overall Study|Lost to Follow-up|20|||
126711991|NCT02612077|455897577|FG000|Overall Study|Death|377|||
126711992|NCT02612077|455897577|FG000|Overall Study|Moved or Changed Medical Team|23|||
126711993|NCT02612077|455897577|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
126711994|NCT02612077|455897577|FG000|Overall Study|Disease Progression|3|||
126711995|NCT02612077|455897577|FG000|Overall Study|Unknown reason|2|||
126711996|NCT01022853|455897578|FG000|Overall Study|Progressive disease|2|||
126711997|NCT01022853|455897579|FG001|Overall Study|Progressive disease|3|||
126711998|NCT01022853|455897580|FG002|Overall Study|Progressive disease|11|||
126711999|NCT01022853|455897581|FG003|Overall Study|Progressive disease|7|||
126712000|NCT01022853|455897582|FG004|Overall Study|Progressive disease|1|||
126712001|NCT01022853|455897578|FG000|Overall Study|Dose-limiting toxicity|0|||
126712002|NCT01022853|455897579|FG001|Overall Study|Dose-limiting toxicity|0|||
126712003|NCT01022853|455897580|FG002|Overall Study|Dose-limiting toxicity|0|||
126712004|NCT01022853|455897581|FG003|Overall Study|Dose-limiting toxicity|0|||
126712005|NCT01022853|455897582|FG004|Overall Study|Dose-limiting toxicity|1|||
126712006|NCT01022853|455897578|FG000|Overall Study|Withdrawal by Subject|0|||
126712007|NCT01022853|455897579|FG001|Overall Study|Withdrawal by Subject|1|||
126712008|NCT01022853|455897580|FG002|Overall Study|Withdrawal by Subject|1|||
126297525|NCT00955409|454376998|FG007|Overall Study|Failed to Return|2|||
126297526|NCT00955409|454376999|FG008|Overall Study|Failed to Return|0|||
126297527|NCT00955409|454377000|FG009|Overall Study|Failed to Return|0|||
126297528|NCT00955409|454376991|FG000|Overall Study|Adverse Event (AE)|2|||
126297529|NCT00955409|454376992|FG001|Overall Study|Adverse Event (AE)|0|||
126297530|NCT00955409|454376993|FG002|Overall Study|Adverse Event (AE)|0|||
126297531|NCT00955409|454376994|FG003|Overall Study|Adverse Event (AE)|0|||
126297532|NCT00955409|454376995|FG004|Overall Study|Adverse Event (AE)|0|||
126297533|NCT00955409|454376996|FG005|Overall Study|Adverse Event (AE)|1|||
126297534|NCT00955409|454376997|FG006|Overall Study|Adverse Event (AE)|2|||
126297535|NCT00955409|454376998|FG007|Overall Study|Adverse Event (AE)|0|||
126297536|NCT00955409|454376999|FG008|Overall Study|Adverse Event (AE)|2|||
126297537|NCT00955409|454377000|FG009|Overall Study|Adverse Event (AE)|0|||
126297538|NCT00955409|454376991|FG000|Overall Study|Reason not Specified|2|||
126297539|NCT00955409|454376992|FG001|Overall Study|Reason not Specified|1|||
126297540|NCT00955409|454376993|FG002|Overall Study|Reason not Specified|13|||
126297541|NCT00955409|454376994|FG003|Overall Study|Reason not Specified|1|||
126297542|NCT00955409|454376995|FG004|Overall Study|Reason not Specified|2|||
126297543|NCT00955409|454376996|FG005|Overall Study|Reason not Specified|0|||
126297544|NCT00955409|454376997|FG006|Overall Study|Reason not Specified|16|||
126297545|NCT00955409|454376998|FG007|Overall Study|Reason not Specified|0|||
126297546|NCT00955409|454376999|FG008|Overall Study|Reason not Specified|8|||
126297547|NCT00955409|454377000|FG009|Overall Study|Reason not Specified|1|||
126297548|NCT00485732|454377001|FG000|Overall Study|Protocol Violation|1|||
126297549|NCT00485732|454377002|FG001|Overall Study|Protocol Violation|3|||
126297550|NCT00485732|454377001|FG000|Overall Study|Withdrawal by Subject|5|||
126297551|NCT00485732|454377002|FG001|Overall Study|Withdrawal by Subject|4|||
126297552|NCT00485732|454377001|FG000|Overall Study|Lost to Follow-up|2|||
126769503|NCT01071083|456110353|FG004|Overall Study|Subject Moved|0|||
126769504|NCT01071083|456110349|FG000|Overall Study|Images Not Usable (Motion)|0|||
126769505|NCT01071083|456110350|FG001|Overall Study|Images Not Usable (Motion)|1|||
126769506|NCT01071083|456110351|FG002|Overall Study|Images Not Usable (Motion)|0|||
126769507|NCT01071083|456110352|FG003|Overall Study|Images Not Usable (Motion)|0|||
126769508|NCT01071083|456110353|FG004|Overall Study|Images Not Usable (Motion)|0|||
126769509|NCT01071083|456110349|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
126769510|NCT01071083|456110350|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
126769511|NCT01071083|456110351|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
126769512|NCT01071083|456110352|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
126297553|NCT00485732|454377002|FG001|Overall Study|Lost to Follow-up|2|||
126297554|NCT00803790|454377003|FG000|Period 1|Adverse Event|0|||
126297555|NCT00803790|454377004|FG001|Period 1|Adverse Event|1|||
126297556|NCT00803790|454377005|FG002|Period 1|Adverse Event|0|||
126297557|NCT00803790|454377006|FG003|Period 1|Adverse Event|0|||
126297558|NCT00803790|454377003|FG000|Period 1|Lost to Follow-up|1|||
126297559|NCT00803790|454377004|FG001|Period 1|Lost to Follow-up|2|||
126297560|NCT00803790|454377005|FG002|Period 1|Lost to Follow-up|0|||
126297561|NCT00803790|454377006|FG003|Period 1|Lost to Follow-up|0|||
126297562|NCT00803790|454377003|FG000|Period 1|Withdrawal by Subject|8|||
126297563|NCT00803790|454377004|FG001|Period 1|Withdrawal by Subject|6|||
126297564|NCT00803790|454377005|FG002|Period 1|Withdrawal by Subject|0|||
126297565|NCT00803790|454377006|FG003|Period 1|Withdrawal by Subject|0|||
126297566|NCT00803790|454377003|FG000|Period 1|positive drug screen or personal reasons|0|||
126297567|NCT00803790|454377004|FG001|Period 1|positive drug screen or personal reasons|3|||
126297568|NCT00803790|454377005|FG002|Period 1|positive drug screen or personal reasons|0|||
126297569|NCT00803790|454377006|FG003|Period 1|positive drug screen or personal reasons|4|||
126297570|NCT00803790|454377003|FG000|Period 1|Protocol Violation|0|||
126297571|NCT00803790|454377004|FG001|Period 1|Protocol Violation|0|||
126297572|NCT00803790|454377005|FG002|Period 1|Protocol Violation|1|||
126297573|NCT00803790|454377006|FG003|Period 1|Protocol Violation|0|||
126297574|NCT00803790|454377003|FG000|Period 2|Adverse Event|0|||
126297575|NCT00803790|454377004|FG001|Period 2|Adverse Event|0|||
126297576|NCT00803790|454377005|FG002|Period 2|Adverse Event|1|||
126297577|NCT00803790|454377006|FG003|Period 2|Adverse Event|1|||
126550209|NCT00358215|455309487|FG000|Overall Study|Participant request|65|||
126297578|NCT00803790|454377003|FG000|Period 2|Withdrawal by Subject|1|||
126297579|NCT00803790|454377004|FG001|Period 2|Withdrawal by Subject|0|||
126366958|NCT01051661|454639362|FG001|Overall Study|Subject lost legal representation|0|||
126366959|NCT01051661|454639363|FG002|Overall Study|Subject lost legal representation|0|||
126366960|NCT01051661|454639364|FG003|Overall Study|Subject lost legal representation|0|||
126550210|NCT00358215|455309488|FG001|Overall Study|Participant request|64|||
126297580|NCT00803790|454377005|FG002|Period 2|Withdrawal by Subject|0|||
126297581|NCT00803790|454377006|FG003|Period 2|Withdrawal by Subject|0|||
126297582|NCT00803790|454377003|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
126297583|NCT00803790|454377004|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
126297584|NCT00803790|454377005|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
126297585|NCT00803790|454377006|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
126297586|NCT01880554|454377007|FG000|Overall Study|Protocol Violation|14|||
126366961|NCT01051661|454639365|FG004|Overall Study|Subject lost legal representation|1|||
126769513|NCT01071083|456110353|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
126297587|NCT01880554|454377007|FG000|Overall Study|Simon's design requirements|2|||
126297588|NCT05161481|454377008|FG000|Overall Study|Withdrawal of consent|0|||
126297589|NCT05161481|454377009|FG001|Overall Study|Withdrawal of consent|1|||
126297590|NCT05161481|454377010|FG002|Overall Study|Withdrawal of consent|1|||
126297591|NCT05161481|454377008|FG000|Overall Study|Study terminated by sponsor|3|||
126297592|NCT05161481|454377009|FG001|Overall Study|Study terminated by sponsor|3|||
126297593|NCT05161481|454377010|FG002|Overall Study|Study terminated by sponsor|2|||
126297594|NCT05161481|454377008|FG000|Overall Study|Adverse Event|3|||
126297595|NCT05161481|454377009|FG001|Overall Study|Adverse Event|0|||
126297596|NCT05161481|454377010|FG002|Overall Study|Adverse Event|6|||
126297597|NCT05161481|454377008|FG000|Overall Study|Randomised in error and was not treated|1|||
126297598|NCT05161481|454377009|FG001|Overall Study|Randomised in error and was not treated|0|||
126297599|NCT05161481|454377010|FG002|Overall Study|Randomised in error and was not treated|0|||
126297600|NCT05161481|454377008|FG000|Overall Study|Subject decision|0|||
126297601|NCT05161481|454377009|FG001|Overall Study|Subject decision|0|||
126297602|NCT05161481|454377010|FG002|Overall Study|Subject decision|1|||
126297603|NCT03985800|454377011|FG000|Overall Study|Death|1|||
126297604|NCT03985800|454377012|FG001|Overall Study|Death|2|||
126297605|NCT03985800|454377011|FG000|Overall Study|Withdrawal by Subject|3|||
126297606|NCT03985800|454377012|FG001|Overall Study|Withdrawal by Subject|6|||
126297607|NCT03985800|454377011|FG000|Overall Study|Protocol Violation|2|||
126297608|NCT03985800|454377012|FG001|Overall Study|Protocol Violation|0|||
126297609|NCT04281485|454377013|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
126297610|NCT04281485|454377014|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
126297611|NCT04281485|454377013|FG000|Overall Study|Ongoing (Safety data collection)|10|||
126297612|NCT04281485|454377014|FG001|Overall Study|Ongoing (Safety data collection)|5|||
126297613|NCT04335123|454377018|FG000|Overall Study|Withdrawal by Subject|2|||
126297614|NCT04335123|454377019|FG001|Overall Study|Withdrawal by Subject|0|||
126297615|NCT04335123|454377018|FG000|Overall Study|Physician Decision|2|||
126297616|NCT04335123|454377019|FG001|Overall Study|Physician Decision|0|||
126297617|NCT01293695|454377028|FG000|Overall Study|Withdrawal by Subject|7|||
126297618|NCT01293695|454377029|FG001|Overall Study|Withdrawal by Subject|1|||
126297619|NCT01293695|454377028|FG000|Overall Study|Lost to Follow-up|8|||
126297620|NCT01293695|454377029|FG001|Overall Study|Lost to Follow-up|6|||
126297621|NCT02570308|454377030|FG000|Overall Study|Death|1|||
126297622|NCT02570308|454377031|FG001|Overall Study|Death|5|||
126297623|NCT02570308|454377032|FG002|Overall Study|Death|4|||
126297624|NCT02570308|454377033|FG003|Overall Study|Death|4|||
126297625|NCT02570308|454377034|FG004|Overall Study|Death|69|||
126297626|NCT02570308|454377030|FG000|Overall Study|Lost to Follow-up|0|||
126297627|NCT02570308|454377031|FG001|Overall Study|Lost to Follow-up|0|||
126297628|NCT02570308|454377032|FG002|Overall Study|Lost to Follow-up|0|||
126297629|NCT02570308|454377033|FG003|Overall Study|Lost to Follow-up|0|||
126297630|NCT02570308|454377034|FG004|Overall Study|Lost to Follow-up|2|||
126297631|NCT02570308|454377030|FG000|Overall Study|Withdrawal by Subject|0|||
126297632|NCT02570308|454377031|FG001|Overall Study|Withdrawal by Subject|0|||
126297633|NCT02570308|454377032|FG002|Overall Study|Withdrawal by Subject|0|||
126297634|NCT02570308|454377033|FG003|Overall Study|Withdrawal by Subject|0|||
126297635|NCT02570308|454377034|FG004|Overall Study|Withdrawal by Subject|1|||
126297636|NCT02570308|454377030|FG000|Overall Study|Other|0|||
126297637|NCT02570308|454377031|FG001|Overall Study|Other|0|||
126297638|NCT02570308|454377032|FG002|Overall Study|Other|0|||
126297639|NCT02570308|454377033|FG003|Overall Study|Other|0|||
126297640|NCT02570308|454377034|FG004|Overall Study|Other|2|||
126297641|NCT00957801|454377035|FG000|Overall Study|Withdrawal by Subject|0|||
126297642|NCT00957801|454377036|FG001|Overall Study|Withdrawal by Subject|0|||
126297643|NCT00957801|454377037|FG002|Overall Study|Withdrawal by Subject|0|||
126297644|NCT00957801|454377038|FG003|Overall Study|Withdrawal by Subject|1|||
126297645|NCT01283464|454377039|FG000|Overall Study|Lost to Follow-up|0|||
126297646|NCT01283464|454377040|FG001|Overall Study|Lost to Follow-up|1|||
126297647|NCT01283464|454377039|FG000|Overall Study|Withdrawal by Subject|1|||
126297648|NCT01283464|454377040|FG001|Overall Study|Withdrawal by Subject|0|||
126297649|NCT01283464|454377039|FG000|Overall Study|Physician Decision|1|||
126297650|NCT01283464|454377040|FG001|Overall Study|Physician Decision|0|||
126297651|NCT02626026|454377041|FG000|Overall Study|Randomized but Never Treated|0|||
126297652|NCT02626026|454377042|FG001|Overall Study|Randomized but Never Treated|0|||
126297653|NCT02626026|454377043|FG002|Overall Study|Randomized but Never Treated|0|||
126297654|NCT02626026|454377044|FG003|Overall Study|Randomized but Never Treated|0|||
126297655|NCT02626026|454377045|FG004|Overall Study|Randomized but Never Treated|1|||
126297656|NCT02626026|454377046|FG005|Overall Study|Randomized but Never Treated|0|||
126297657|NCT01778855|454377047|FG000|Overall Study|Death|0|||
126297658|NCT01778855|454377048|FG001|Overall Study|Death|1|||
126297659|NCT00191477|454377050|FG000|Overall Study|Tumor Recurrence|49|||
126297660|NCT00191477|454377051|FG001|Overall Study|Tumor Recurrence|48|||
126297661|NCT00191477|454377050|FG000|Overall Study|Death, Study Disease|1|||
126297662|NCT00191477|454377051|FG001|Overall Study|Death, Study Disease|1|||
126297663|NCT00191477|454377050|FG000|Overall Study|Death, Other Cause|3|||
126297664|NCT00191477|454377051|FG001|Overall Study|Death, Other Cause|6|||
126550211|NCT00358215|455309487|FG000|Overall Study|Physician Decision|47|||
126769514|NCT01071083|456110349|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
126769515|NCT01071083|456110350|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
126769516|NCT01071083|456110351|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
126769517|NCT01071083|456110352|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
126769518|NCT01071083|456110353|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
126769519|NCT01071083|456110349|FG000|Overall Study|Subject Refused to Continue|1|||
126297665|NCT00191477|454377050|FG000|Overall Study|Lost to Follow-up|23|||
126769520|NCT01071083|456110350|FG001|Overall Study|Subject Refused to Continue|0|||
126769521|NCT01071083|456110351|FG002|Overall Study|Subject Refused to Continue|0|||
126769522|NCT01071083|456110352|FG003|Overall Study|Subject Refused to Continue|0|||
126769523|NCT01071083|456110353|FG004|Overall Study|Subject Refused to Continue|0|||
126297666|NCT00191477|454377051|FG001|Overall Study|Lost to Follow-up|21|||
126297667|NCT00191477|454377050|FG000|Overall Study|Protocol Violation|1|||
126297668|NCT00191477|454377051|FG001|Overall Study|Protocol Violation|1|||
126297669|NCT00191477|454377050|FG000|Overall Study|Treatment Change|2|||
126297670|NCT00191477|454377051|FG001|Overall Study|Treatment Change|0|||
126769524|NCT04732728|456110354|FG000|Overall Study|Death|12|||
126297671|NCT00191477|454377050|FG000|Overall Study|Withdrawal by Subject|2|||
126297672|NCT00191477|454377051|FG001|Overall Study|Withdrawal by Subject|0|||
126297673|NCT00191477|454377050|FG000|Overall Study|Other|2|||
126297674|NCT00191477|454377051|FG001|Overall Study|Other|0|||
126297675|NCT00191477|454377050|FG000|Overall Study|Not Eligible|41|||
126297676|NCT00191477|454377051|FG001|Overall Study|Not Eligible|38|||
126297677|NCT00191477|454377050|FG000|Overall Study|Pathological Specimen Lost|1|||
126297678|NCT00191477|454377051|FG001|Overall Study|Pathological Specimen Lost|0|||
126297679|NCT00191477|454377050|FG000|Overall Study|Discontinued Prior to Instillation|13|||
126297680|NCT00191477|454377051|FG001|Overall Study|Discontinued Prior to Instillation|14|||
126297681|NCT01286467|454377056|FG000|Overall Study|Death|1|||
126297682|NCT01286467|454377057|FG001|Overall Study|Death|1|||
126297683|NCT01286467|454377058|FG002|Overall Study|Death|1|||
126297684|NCT01286467|454377059|FG003|Overall Study|Death|0|||
126297685|NCT01286467|454377056|FG000|Overall Study|Lost to Follow-up|0|||
126297686|NCT01286467|454377057|FG001|Overall Study|Lost to Follow-up|0|||
126297687|NCT01286467|454377058|FG002|Overall Study|Lost to Follow-up|0|||
126297688|NCT01286467|454377059|FG003|Overall Study|Lost to Follow-up|1|||
126297689|NCT01286467|454377056|FG000|Overall Study|Withdrawal by Subject|0|||
126297690|NCT01286467|454377057|FG001|Overall Study|Withdrawal by Subject|0|||
126297691|NCT01286467|454377058|FG002|Overall Study|Withdrawal by Subject|1|||
126297692|NCT01286467|454377059|FG003|Overall Study|Withdrawal by Subject|0|||
126297693|NCT01286467|454377056|FG000|Overall Study|Physician Decision|0|||
126297694|NCT01286467|454377057|FG001|Overall Study|Physician Decision|0|||
126297695|NCT01286467|454377058|FG002|Overall Study|Physician Decision|0|||
126297696|NCT01286467|454377059|FG003|Overall Study|Physician Decision|1|||
126297697|NCT01286467|454377056|FG000|Overall Study|Disease progression|3|||
126297698|NCT01286467|454377057|FG001|Overall Study|Disease progression|2|||
126297699|NCT01286467|454377058|FG002|Overall Study|Disease progression|2|||
126297700|NCT01286467|454377059|FG003|Overall Study|Disease progression|3|||
126297701|NCT01286467|454377056|FG000|Overall Study|Adverse Event|0|||
126297702|NCT01286467|454377057|FG001|Overall Study|Adverse Event|1|||
126297703|NCT01286467|454377058|FG002|Overall Study|Adverse Event|2|||
126297704|NCT01286467|454377059|FG003|Overall Study|Adverse Event|3|||
126297705|NCT01286467|454377056|FG000|Overall Study|Study drug stop longer than 14 days|0|||
126297706|NCT01286467|454377057|FG001|Overall Study|Study drug stop longer than 14 days|0|||
126297707|NCT01286467|454377058|FG002|Overall Study|Study drug stop longer than 14 days|1|||
126297708|NCT01286467|454377059|FG003|Overall Study|Study drug stop longer than 14 days|0|||
126297709|NCT01058642|454377060|FG000|Treatment Period 1|Adverse Event|0|||
126297710|NCT01058642|454377061|FG001|Treatment Period 1|Adverse Event|1|||
126297711|NCT01058642|454377062|FG002|Treatment Period 1|Adverse Event|1|||
126297712|NCT01058642|454377063|FG003|Treatment Period 1|Adverse Event|0|||
126297713|NCT01058642|454377060|FG000|Treatment Period 1|Physician Decision|0|||
126297714|NCT01058642|454377061|FG001|Treatment Period 1|Physician Decision|0|||
126297715|NCT01058642|454377062|FG002|Treatment Period 1|Physician Decision|1|||
126297716|NCT01058642|454377063|FG003|Treatment Period 1|Physician Decision|0|||
126297717|NCT01058642|454377060|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126769525|NCT04732728|456110354|FG000|Overall Study|Withdrawn|136|||
126297718|NCT01058642|454377061|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126297719|NCT01058642|454377062|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126297720|NCT01058642|454377063|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126297721|NCT01058642|454377060|FG000|Treatment Period 1|Lack of Efficacy|0|||
126297722|NCT01058642|454377061|FG001|Treatment Period 1|Lack of Efficacy|0|||
126297723|NCT01058642|454377062|FG002|Treatment Period 1|Lack of Efficacy|0|||
126297724|NCT01058642|454377063|FG003|Treatment Period 1|Lack of Efficacy|1|||
126297725|NCT01058642|454377060|FG000|Treatment Period 1|Protocol Violation|0|||
126297726|NCT01058642|454377061|FG001|Treatment Period 1|Protocol Violation|0|||
126297727|NCT01058642|454377062|FG002|Treatment Period 1|Protocol Violation|0|||
126297728|NCT01058642|454377063|FG003|Treatment Period 1|Protocol Violation|1|||
126769526|NCT02072174|456110355|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
126297729|NCT01058642|454377060|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
126297730|NCT01058642|454377061|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
126297731|NCT01058642|454377062|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
126297732|NCT01058642|454377063|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
126297733|NCT01256450|454377064|FG000|Open-label Titration|Adverse Event|39|||
126297734|NCT01256450|454377065|FG001|Open-label Titration|Adverse Event|0|||
126460911|NCT00219544|454987928|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
126460912|NCT00745615|454987933|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
126460913|NCT00745615|454987934|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
126460914|NCT00745615|454987935|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
126460915|NCT00745615|454987936|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
126460916|NCT00745615|454987937|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
126460917|NCT00745615|454987938|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
126460918|NCT00745615|454987933|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
126460919|NCT00745615|454987934|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
126460920|NCT00745615|454987935|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
126460921|NCT00745615|454987936|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
126460922|NCT00745615|454987937|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
126460923|NCT00745615|454987938|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
126297735|NCT01256450|454377066|FG002|Open-label Titration|Adverse Event|0|||
126297736|NCT01256450|454377064|FG000|Open-label Titration|Lost to Follow-up|7|||
126297737|NCT01256450|454377065|FG001|Open-label Titration|Lost to Follow-up|0|||
126297738|NCT01256450|454377066|FG002|Open-label Titration|Lost to Follow-up|0|||
126297739|NCT01256450|454377064|FG000|Open-label Titration|Lack of analgesic effect|30|||
126297740|NCT01256450|454377065|FG001|Open-label Titration|Lack of analgesic effect|0|||
126297741|NCT01256450|454377066|FG002|Open-label Titration|Lack of analgesic effect|0|||
126297742|NCT01256450|454377064|FG000|Open-label Titration|Non-compliance|9|||
126297743|NCT01256450|454377065|FG001|Open-label Titration|Non-compliance|0|||
126297744|NCT01256450|454377066|FG002|Open-label Titration|Non-compliance|0|||
126297745|NCT01256450|454377064|FG000|Open-label Titration|Screen failure|1|||
126297746|NCT01256450|454377065|FG001|Open-label Titration|Screen failure|0|||
126297747|NCT01256450|454377066|FG002|Open-label Titration|Screen failure|0|||
126297748|NCT01256450|454377064|FG000|Open-label Titration|Other|13|||
126297749|NCT01256450|454377065|FG001|Open-label Titration|Other|0|||
126297750|NCT01256450|454377066|FG002|Open-label Titration|Other|0|||
126297751|NCT01256450|454377064|FG000|Double-blind Treatment|Adverse Event|0|||
126297752|NCT01256450|454377065|FG001|Double-blind Treatment|Adverse Event|8|||
126297753|NCT01256450|454377066|FG002|Double-blind Treatment|Adverse Event|6|||
126297754|NCT01256450|454377064|FG000|Double-blind Treatment|Lost to Follow-up|0|||
126297755|NCT01256450|454377065|FG001|Double-blind Treatment|Lost to Follow-up|1|||
126297756|NCT01256450|454377066|FG002|Double-blind Treatment|Lost to Follow-up|7|||
126297757|NCT01256450|454377064|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
126297758|NCT01256450|454377065|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
126297759|NCT01256450|454377066|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
126297760|NCT01256450|454377064|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
126297761|NCT01256450|454377065|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
126297762|NCT01256450|454377066|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
126297763|NCT01256450|454377064|FG000|Double-blind Treatment|Non-compliance|0|||
126297764|NCT01256450|454377065|FG001|Double-blind Treatment|Non-compliance|5|||
126297765|NCT01256450|454377066|FG002|Double-blind Treatment|Non-compliance|4|||
126297766|NCT01256450|454377064|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
126297767|NCT01256450|454377065|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
126297768|NCT01256450|454377066|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
126297769|NCT01256450|454377064|FG000|Double-blind Treatment|Other|0|||
126297770|NCT01256450|454377065|FG001|Double-blind Treatment|Other|9|||
126297771|NCT01256450|454377066|FG002|Double-blind Treatment|Other|12|||
126297772|NCT03376789|454377067|FG000|Overall Study|Withdrawal by Subject|3|||
126297773|NCT03376789|454377068|FG001|Overall Study|Withdrawal by Subject|5|||
126460924|NCT00745615|454987933|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
126460925|NCT00745615|454987934|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
126297774|NCT03376789|454377067|FG000|Overall Study|Protocol Violation|0|||
126297775|NCT03376789|454377068|FG001|Overall Study|Protocol Violation|1|||
126297776|NCT03376789|454377067|FG000|Overall Study|Adverse Event|0|||
126460926|NCT00745615|454987935|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
126460927|NCT00745615|454987936|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
126297777|NCT03376789|454377068|FG001|Overall Study|Adverse Event|1|||
126297778|NCT03376789|454377067|FG000|Overall Study|Lost to Follow-up|1|||
126297779|NCT03376789|454377068|FG001|Overall Study|Lost to Follow-up|1|||
126297780|NCT03376789|454377067|FG000|Overall Study|Per sponsor due to noncompliance|1|||
126297781|NCT03376789|454377068|FG001|Overall Study|Per sponsor due to noncompliance|0|||
126297782|NCT03376789|454377067|FG000|Overall Study|Subject off study medication|0|||
126297783|NCT03376789|454377068|FG001|Overall Study|Subject off study medication|1|||
126769527|NCT02072174|456110356|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
126769528|NCT02072174|456110355|FG000|Overall Study|Protocol Violation|16|||
126769529|NCT02072174|456110356|FG001|Overall Study|Protocol Violation|23|||
126769530|NCT02072174|456110355|FG000|Overall Study|Physician Decision|0|||
126769531|NCT02072174|456110356|FG001|Overall Study|Physician Decision|1|||
126769532|NCT02072174|456110355|FG000|Overall Study|Non-compliance with protocol requirement|2|||
126769533|NCT02072174|456110356|FG001|Overall Study|Non-compliance with protocol requirement|0|||
126769534|NCT03891875|456110357|FG000|Overall Study|Withdrawal by Subject|20|||
126769535|NCT03891875|456110358|FG001|Overall Study|Withdrawal by Subject|3|||
126769536|NCT03891875|456110357|FG000|Overall Study|Adverse Event|10|||
126769537|NCT03891875|456110358|FG001|Overall Study|Adverse Event|4|||
126769538|NCT03891875|456110357|FG000|Overall Study|Physician Decision|1|||
126769539|NCT03891875|456110358|FG001|Overall Study|Physician Decision|1|||
126769540|NCT03891875|456110357|FG000|Overall Study|Protocol Violation|1|||
126769541|NCT03891875|456110358|FG001|Overall Study|Protocol Violation|0|||
126769542|NCT03891875|456110357|FG000|Overall Study|Lost to Follow-up|1|||
126769543|NCT03891875|456110358|FG001|Overall Study|Lost to Follow-up|0|||
126769544|NCT03891875|456110357|FG000|Overall Study|COVID-19 infection|1|||
126769545|NCT03891875|456110358|FG001|Overall Study|COVID-19 infection|0|||
126769546|NCT01393626|456110363|FG000|Overall Study|Adverse Event|2|||
126769547|NCT01393626|456110364|FG001|Overall Study|Adverse Event|1|||
126769548|NCT01393626|456110365|FG002|Overall Study|Adverse Event|5|||
126769549|NCT01393626|456110366|FG003|Overall Study|Adverse Event|0|||
126769550|NCT01393626|456110363|FG000|Overall Study|Did not meet entrance criteria|1|||
126769551|NCT01393626|456110364|FG001|Overall Study|Did not meet entrance criteria|0|||
126769552|NCT01393626|456110365|FG002|Overall Study|Did not meet entrance criteria|0|||
126769553|NCT01393626|456110366|FG003|Overall Study|Did not meet entrance criteria|0|||
126769554|NCT01393626|456110363|FG000|Overall Study|Lack of Efficacy|6|||
126769555|NCT01393626|456110364|FG001|Overall Study|Lack of Efficacy|6|||
126769556|NCT01393626|456110365|FG002|Overall Study|Lack of Efficacy|4|||
126769557|NCT01393626|456110366|FG003|Overall Study|Lack of Efficacy|1|||
126769558|NCT01393626|456110363|FG000|Overall Study|Lost to Follow-up|1|||
126769559|NCT01393626|456110364|FG001|Overall Study|Lost to Follow-up|1|||
126769560|NCT01393626|456110365|FG002|Overall Study|Lost to Follow-up|1|||
126769561|NCT01393626|456110366|FG003|Overall Study|Lost to Follow-up|0|||
126769562|NCT01393626|456110363|FG000|Overall Study|Withdrawal by Subject|6|||
126769563|NCT01393626|456110364|FG001|Overall Study|Withdrawal by Subject|4|||
126769564|NCT01393626|456110365|FG002|Overall Study|Withdrawal by Subject|0|||
126769565|NCT01393626|456110366|FG003|Overall Study|Withdrawal by Subject|0|||
126769566|NCT01393626|456110363|FG000|Overall Study|Other|1|||
126769567|NCT01393626|456110364|FG001|Overall Study|Other|0|||
126769568|NCT01393626|456110365|FG002|Overall Study|Other|0|||
126769569|NCT01393626|456110366|FG003|Overall Study|Other|0|||
126769570|NCT01393626|456110363|FG000|Overall Study|Protocol Violation|1|||
126769571|NCT01393626|456110364|FG001|Overall Study|Protocol Violation|0|||
126769572|NCT01393626|456110365|FG002|Overall Study|Protocol Violation|2|||
126769573|NCT01393626|456110366|FG003|Overall Study|Protocol Violation|0|||
126769574|NCT02426125|456110367|FG000|Overall Study|Lost to Follow-up|14|||
126769575|NCT02426125|456110368|FG001|Overall Study|Lost to Follow-up|12|||
126460928|NCT00745615|454987937|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
126460929|NCT00745615|454987938|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
126460930|NCT00745615|454987933|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
126460931|NCT00745615|454987934|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
126460932|NCT00745615|454987935|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
126460933|NCT00745615|454987936|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
126460934|NCT00745615|454987937|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
126460935|NCT00745615|454987938|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
126460936|NCT00745615|454987933|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
126460937|NCT00745615|454987934|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
126769576|NCT02426125|456110367|FG000|Overall Study|Withdrawal by Subject|13|||
126769577|NCT02426125|456110368|FG001|Overall Study|Withdrawal by Subject|14|||
126769578|NCT02426125|456110367|FG000|Overall Study|Death|185|||
126769579|NCT02426125|456110368|FG001|Overall Study|Death|200|||
126769580|NCT02426125|456110367|FG000|Overall Study|Randomized, But Never Treated|5|||
126769581|NCT02426125|456110368|FG001|Overall Study|Randomized, But Never Treated|2|||
126769582|NCT02858076|456110369|FG000|Overall Study|Death|6|||
126769583|NCT02858076|456110370|FG001|Overall Study|Death|3|||
126297784|NCT03876743|454377076|FG000|Overall Study|Lost to Follow-up|6|||
126297785|NCT03876743|454377077|FG001|Overall Study|Lost to Follow-up|4|||
126297786|NCT03876743|454377078|FG002|Overall Study|Lost to Follow-up|4|||
126297787|NCT03876743|454377079|FG003|Overall Study|Lost to Follow-up|7|||
126297788|NCT03889418|454377080|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
126297789|NCT03889418|454377081|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297790|NCT03889418|454377082|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297791|NCT03889418|454377083|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297792|NCT03889418|454377084|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297793|NCT03889418|454377085|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126460938|NCT00745615|454987935|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
126460939|NCT00745615|454987936|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
126297794|NCT03889418|454377086|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297795|NCT03889418|454377087|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297796|NCT03889418|454377088|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297797|NCT03889418|454377089|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
126297798|NCT03889418|454377080|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297799|NCT03889418|454377081|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
126297800|NCT03889418|454377082|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
126297801|NCT03889418|454377083|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297802|NCT03889418|454377084|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297803|NCT03889418|454377085|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297804|NCT03889418|454377086|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297805|NCT03889418|454377087|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297806|NCT03889418|454377088|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297807|NCT03889418|454377089|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
126297808|NCT03889418|454377080|FG000|October-December 2019 (Month 7-9)|Death|0|||
126297809|NCT03889418|454377081|FG001|October-December 2019 (Month 7-9)|Death|0|||
126297810|NCT03889418|454377082|FG002|October-December 2019 (Month 7-9)|Death|0|||
126297811|NCT03889418|454377083|FG003|October-December 2019 (Month 7-9)|Death|0|||
126297812|NCT03889418|454377084|FG004|October-December 2019 (Month 7-9)|Death|0|||
126297813|NCT03889418|454377085|FG005|October-December 2019 (Month 7-9)|Death|0|||
126297814|NCT03889418|454377086|FG006|October-December 2019 (Month 7-9)|Death|0|||
126297815|NCT03889418|454377087|FG007|October-December 2019 (Month 7-9)|Death|0|||
126297816|NCT03889418|454377088|FG008|October-December 2019 (Month 7-9)|Death|1|||
126297817|NCT03889418|454377089|FG009|October-December 2019 (Month 7-9)|Death|0|||
126297818|NCT03889418|454377080|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297819|NCT03889418|454377081|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297820|NCT03889418|454377082|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297821|NCT03889418|454377083|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
126297822|NCT03889418|454377084|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297823|NCT03889418|454377085|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297824|NCT03889418|454377086|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297825|NCT03889418|454377087|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
126297826|NCT03889418|454377088|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297827|NCT03889418|454377089|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
126297828|NCT03889418|454377080|FG000|April - June 2020 (Month 13-15)|Death|0|||
126297829|NCT03889418|454377081|FG001|April - June 2020 (Month 13-15)|Death|1|||
126297830|NCT03889418|454377082|FG002|April - June 2020 (Month 13-15)|Death|0|||
126297831|NCT03889418|454377083|FG003|April - June 2020 (Month 13-15)|Death|0|||
126297832|NCT03889418|454377084|FG004|April - June 2020 (Month 13-15)|Death|0|||
126297833|NCT03889418|454377085|FG005|April - June 2020 (Month 13-15)|Death|0|||
126297834|NCT03889418|454377086|FG006|April - June 2020 (Month 13-15)|Death|0|||
126297835|NCT03889418|454377087|FG007|April - June 2020 (Month 13-15)|Death|0|||
126297836|NCT03889418|454377088|FG008|April - June 2020 (Month 13-15)|Death|0|||
126297837|NCT03889418|454377089|FG009|April - June 2020 (Month 13-15)|Death|0|||
126297838|NCT03889418|454377080|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297839|NCT03889418|454377081|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297840|NCT03889418|454377082|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297841|NCT03889418|454377083|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
126297842|NCT03889418|454377084|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126460940|NCT00745615|454987937|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
126460941|NCT00745615|454987938|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
126297843|NCT03889418|454377085|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297844|NCT03889418|454377086|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297845|NCT03889418|454377087|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297846|NCT03889418|454377088|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297847|NCT03889418|454377089|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
126297848|NCT03889418|454377080|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
126297849|NCT03889418|454377081|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
126297850|NCT03889418|454377082|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
126297851|NCT03889418|454377083|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
126297852|NCT03889418|454377084|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
126297853|NCT03889418|454377085|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
126297854|NCT03889418|454377086|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
126297855|NCT03889418|454377087|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
126297856|NCT03889418|454377088|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
126297857|NCT03889418|454377089|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
126297858|NCT03889418|454377080|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
126460942|NCT00745615|454987933|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
126460943|NCT00745615|454987934|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
126460944|NCT00745615|454987935|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
126460945|NCT00745615|454987936|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
126460946|NCT00745615|454987937|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
126460947|NCT00745615|454987938|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
126460948|NCT00745615|454987933|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
126460949|NCT00745615|454987934|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
126460950|NCT00745615|454987935|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
126460951|NCT00745615|454987936|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
126460952|NCT00745615|454987937|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
126460953|NCT00745615|454987938|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
126460954|NCT00745615|454987933|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
126460955|NCT00745615|454987934|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
126460956|NCT00745615|454987935|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
126460957|NCT00745615|454987936|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
126460958|NCT00745615|454987937|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
126460959|NCT00745615|454987938|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
126460960|NCT00745615|454987933|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
126460961|NCT00745615|454987934|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
126460962|NCT00745615|454987935|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
126460963|NCT00745615|454987936|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
126460964|NCT00745615|454987937|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
126460965|NCT00745615|454987938|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
126460966|NCT00745615|454987933|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
126460967|NCT00745615|454987934|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
126460968|NCT00745615|454987935|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
126460969|NCT00745615|454987936|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
126460970|NCT00745615|454987937|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
126460971|NCT00745615|454987938|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
126460972|NCT00745615|454987933|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
126460973|NCT00745615|454987934|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
126460974|NCT00745615|454987935|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
126460975|NCT00745615|454987936|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
126460976|NCT00745615|454987937|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
126460977|NCT00745615|454987938|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
126460978|NCT00745615|454987933|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
126460979|NCT00745615|454987934|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
126460980|NCT00745615|454987935|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
126769584|NCT02858076|456110369|FG000|Overall Study|Withdrawal by Subject|1|||
126769585|NCT02858076|456110370|FG001|Overall Study|Withdrawal by Subject|5|||
126297859|NCT03889418|454377081|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
126297860|NCT03889418|454377082|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
126297861|NCT03889418|454377083|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
126297862|NCT03889418|454377084|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
126297863|NCT03889418|454377085|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
126297864|NCT03889418|454377086|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
126297865|NCT03889418|454377087|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
126297866|NCT03889418|454377088|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
126297867|NCT03889418|454377089|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
126297868|NCT00092118|454377090|FG000|Overall Study|Adverse Event|35|||
126297869|NCT00092118|454377091|FG001|Overall Study|Adverse Event|32|||
126297870|NCT00092118|454377090|FG000|Overall Study|Lack of Efficacy|12|||
126297871|NCT00092118|454377091|FG001|Overall Study|Lack of Efficacy|14|||
126297872|NCT00092118|454377090|FG000|Overall Study|Lost to Follow-up|4|||
126297873|NCT00092118|454377091|FG001|Overall Study|Lost to Follow-up|3|||
126297874|NCT00092118|454377090|FG000|Overall Study|Protocol Violation|23|||
126297875|NCT00092118|454377091|FG001|Overall Study|Protocol Violation|25|||
126297876|NCT00092118|454377090|FG000|Overall Study|Withdrawal by Subject|4|||
126460981|NCT00745615|454987936|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
126460982|NCT00745615|454987937|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
126460983|NCT00745615|454987938|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
126550212|NCT00358215|455309488|FG001|Overall Study|Physician Decision|39|||
126550213|NCT00358215|455309487|FG000|Overall Study|Lost to Follow-up|16|||
126550214|NCT00358215|455309488|FG001|Overall Study|Lost to Follow-up|22|||
126297877|NCT00092118|454377091|FG001|Overall Study|Withdrawal by Subject|10|||
126297878|NCT00092118|454377090|FG000|Overall Study|Other|6|||
126297879|NCT00092118|454377091|FG001|Overall Study|Other|5|||
126297880|NCT01139125|454377093|FG000|Overall Study|Withdrawal by Subject|1|||
126297881|NCT03751098|454377094|FG000|Overall Study|Withdrawal by Subject|0|||
126297882|NCT03751098|454377095|FG001|Overall Study|Withdrawal by Subject|1|||
126297883|NCT04760626|454377101|FG000|Overall Study|Withdrawal by Subject|24|||
126297884|NCT04760626|454377102|FG001|Overall Study|Withdrawal by Subject|20|||
126297885|NCT04760626|454377101|FG000|Overall Study|Lost to Follow-up|14|||
126297886|NCT04760626|454377102|FG001|Overall Study|Lost to Follow-up|19|||
126297887|NCT04760626|454377101|FG000|Overall Study|Physician Decision|3|||
126297888|NCT04760626|454377102|FG001|Overall Study|Physician Decision|5|||
126297889|NCT04760626|454377101|FG000|Overall Study|Death|3|||
126297890|NCT04760626|454377102|FG001|Overall Study|Death|6|||
126297891|NCT04760626|454377101|FG000|Overall Study|Site closure|1|||
126297892|NCT04760626|454377102|FG001|Overall Study|Site closure|0|||
126297893|NCT02946463|454377103|FG000|Primary Evaluation Period|Physician Decision|0|||
126297894|NCT02946463|454377104|FG001|Primary Evaluation Period|Physician Decision|1|||
126297895|NCT02946463|454377105|FG002|Primary Evaluation Period|Physician Decision|0|||
126297896|NCT02946463|454377106|FG003|Primary Evaluation Period|Physician Decision|0|||
126297897|NCT02946463|454377103|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
126297898|NCT02946463|454377104|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
126297899|NCT02946463|454377105|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
126297900|NCT02946463|454377106|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
126297901|NCT02946463|454377103|FG000|Extension Period|Death|4|||
126297902|NCT02946463|454377104|FG001|Extension Period|Death|4|||
126297903|NCT02946463|454377105|FG002|Extension Period|Death|0|||
126297904|NCT02946463|454377106|FG003|Extension Period|Death|0|||
126297905|NCT02946463|454377103|FG000|Extension Period|Withdrawal by Subject|4|||
126297906|NCT02946463|454377104|FG001|Extension Period|Withdrawal by Subject|3|||
126297907|NCT02946463|454377105|FG002|Extension Period|Withdrawal by Subject|0|||
126297908|NCT02946463|454377106|FG003|Extension Period|Withdrawal by Subject|0|||
126297909|NCT02946463|454377103|FG000|Extension Period|Other than specified|2|||
126297910|NCT02946463|454377104|FG001|Extension Period|Other than specified|3|||
126297911|NCT02946463|454377105|FG002|Extension Period|Other than specified|2|||
126297912|NCT02946463|454377106|FG003|Extension Period|Other than specified|0|||
126297913|NCT02946463|454377103|FG000|Extension Period|Physician Decision|1|||
126297914|NCT02946463|454377104|FG001|Extension Period|Physician Decision|4|||
126297915|NCT02946463|454377105|FG002|Extension Period|Physician Decision|0|||
126297916|NCT02946463|454377106|FG003|Extension Period|Physician Decision|0|||
126297917|NCT02946463|454377103|FG000|Extension Period|Pregnancy|3|||
126297918|NCT02946463|454377104|FG001|Extension Period|Pregnancy|1|||
126297919|NCT02946463|454377105|FG002|Extension Period|Pregnancy|0|||
126297920|NCT02946463|454377106|FG003|Extension Period|Pregnancy|0|||
126297921|NCT02946463|454377103|FG000|Extension Period|Adverse Event|1|||
126297922|NCT02946463|454377104|FG001|Extension Period|Adverse Event|2|||
126297923|NCT02946463|454377105|FG002|Extension Period|Adverse Event|0|||
126297924|NCT02946463|454377106|FG003|Extension Period|Adverse Event|0|||
126297925|NCT02946463|454377103|FG000|Extension Period|Lost to Follow-up|1|||
126297926|NCT02946463|454377104|FG001|Extension Period|Lost to Follow-up|0|||
126297927|NCT02946463|454377105|FG002|Extension Period|Lost to Follow-up|0|||
126297928|NCT02946463|454377106|FG003|Extension Period|Lost to Follow-up|0|||
126297929|NCT01924689|454377107|FG000|Overall Study|Death|0|||
126297930|NCT01924689|454377108|FG001|Overall Study|Death|1|||
126297931|NCT01924689|454377109|FG002|Overall Study|Death|0|||
126297932|NCT01924689|454377110|FG003|Overall Study|Death|1|||
126297933|NCT01924689|454377111|FG004|Overall Study|Death|0|||
126297934|NCT01924689|454377112|FG005|Overall Study|Death|0|||
126297935|NCT01924689|454377107|FG000|Overall Study|Disease progression|0|||
126297936|NCT01924689|454377108|FG001|Overall Study|Disease progression|0|||
126460984|NCT00745615|454987933|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
126460985|NCT00745615|454987934|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
126460986|NCT00745615|454987935|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
126297937|NCT01924689|454377109|FG002|Overall Study|Disease progression|2|||
126297938|NCT01924689|454377110|FG003|Overall Study|Disease progression|0|||
126297939|NCT01924689|454377111|FG004|Overall Study|Disease progression|3|||
126297940|NCT01924689|454377112|FG005|Overall Study|Disease progression|2|||
126297941|NCT01924689|454377107|FG000|Overall Study|New therapy or study|3|||
126297942|NCT01924689|454377108|FG001|Overall Study|New therapy or study|2|||
126297943|NCT01924689|454377109|FG002|Overall Study|New therapy or study|1|||
126297944|NCT01924689|454377110|FG003|Overall Study|New therapy or study|4|||
126297945|NCT01924689|454377111|FG004|Overall Study|New therapy or study|2|||
126297946|NCT01924689|454377112|FG005|Overall Study|New therapy or study|0|||
126460987|NCT00745615|454987936|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
126297947|NCT01924689|454377107|FG000|Overall Study|Withdrawal of consent|0|||
126297948|NCT01924689|454377108|FG001|Overall Study|Withdrawal of consent|0|||
126297949|NCT01924689|454377109|FG002|Overall Study|Withdrawal of consent|1|||
126297950|NCT01924689|454377110|FG003|Overall Study|Withdrawal of consent|1|||
126297951|NCT01924689|454377111|FG004|Overall Study|Withdrawal of consent|0|||
126297952|NCT01924689|454377112|FG005|Overall Study|Withdrawal of consent|0|||
126297953|NCT01924689|454377107|FG000|Overall Study|Other|0|||
126460988|NCT00745615|454987937|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
126460989|NCT00745615|454987938|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
126460990|NCT00745615|454987933|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
126460991|NCT00745615|454987934|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
126460992|NCT00745615|454987935|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
126460993|NCT00745615|454987936|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
126460994|NCT00745615|454987937|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
126460995|NCT00745615|454987938|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
126460996|NCT00282347|454987947|FG000|Treatment Period|Death|2|||
126460997|NCT00282347|454987948|FG001|Treatment Period|Death|0|||
126460998|NCT00282347|454987947|FG000|Treatment Period|Lost to Follow-up|2|||
126460999|NCT00282347|454987948|FG001|Treatment Period|Lost to Follow-up|5|||
126461000|NCT00282347|454987947|FG000|Treatment Period|Withdrawal by Subject|1|||
126461001|NCT00282347|454987948|FG001|Treatment Period|Withdrawal by Subject|3|||
126461002|NCT00282347|454987947|FG000|Treatment Period|Physician Decision|0|||
126461003|NCT00282347|454987948|FG001|Treatment Period|Physician Decision|1|||
126461004|NCT00282347|454987947|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
126461005|NCT00282347|454987948|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
126461006|NCT00282347|454987947|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
126461007|NCT00282347|454987948|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
126461008|NCT00282347|454987947|FG000|Safety Follow-up Period|Physician Decision|1|||
126461009|NCT00282347|454987948|FG001|Safety Follow-up Period|Physician Decision|1|||
126461010|NCT00282347|454987947|FG000|Safety Follow-up Period|Protocol Deviation|0|||
126461011|NCT00282347|454987948|FG001|Safety Follow-up Period|Protocol Deviation|2|||
126461012|NCT00282347|454987947|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
126461013|NCT00282347|454987948|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
126461014|NCT00282347|454987947|FG000|B Cell Follow-up Period|Physician Decision|1|||
126461015|NCT00282347|454987948|FG001|B Cell Follow-up Period|Physician Decision|0|||
126461016|NCT00282347|454987947|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
126461017|NCT00282347|454987948|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
126461018|NCT02361346|454987949|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
126461019|NCT02361346|454987950|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
126461020|NCT02361346|454987951|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
126461021|NCT02361346|454987952|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
126712009|NCT01022853|455897581|FG003|Overall Study|Withdrawal by Subject|1|||
126297954|NCT01924689|454377108|FG001|Overall Study|Other|0|||
126297955|NCT01924689|454377109|FG002|Overall Study|Other|0|||
126297956|NCT01924689|454377110|FG003|Overall Study|Other|0|||
126297957|NCT01924689|454377111|FG004|Overall Study|Other|1|||
126297958|NCT01924689|454377112|FG005|Overall Study|Other|0|||
126297959|NCT03267212|454377113|FG000|First Intervention|Lost to Follow-up|0|||
126297960|NCT03267212|454377114|FG001|First Intervention|Lost to Follow-up|2|||
126297961|NCT03267212|454377113|FG000|First Intervention|Withdrawal by Subject|1|||
126297962|NCT03267212|454377114|FG001|First Intervention|Withdrawal by Subject|1|||
126297963|NCT03267212|454377113|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
126297964|NCT03267212|454377114|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
126297965|NCT05691712|454377116|FG000|Overall Study|Adverse Event|0|||
126297966|NCT05691712|454377117|FG001|Overall Study|Adverse Event|1|||
126297967|NCT05691712|454377118|FG002|Overall Study|Adverse Event|2|||
126297968|NCT05691712|454377119|FG003|Overall Study|Adverse Event|1|||
126297969|NCT05691712|454377116|FG000|Overall Study|Withdrawal by Subject|2|||
126297970|NCT05691712|454377117|FG001|Overall Study|Withdrawal by Subject|3|||
126297971|NCT05691712|454377118|FG002|Overall Study|Withdrawal by Subject|3|||
126297972|NCT05691712|454377119|FG003|Overall Study|Withdrawal by Subject|1|||
126297973|NCT05691712|454377116|FG000|Overall Study|Death|1|||
126297974|NCT05691712|454377117|FG001|Overall Study|Death|0|||
126297975|NCT05691712|454377118|FG002|Overall Study|Death|0|||
126297976|NCT05691712|454377119|FG003|Overall Study|Death|0|||
126461022|NCT02361346|454987953|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
126461023|NCT02361346|454987954|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
126712010|NCT01022853|455897582|FG004|Overall Study|Withdrawal by Subject|0|||
126297977|NCT05691712|454377116|FG000|Overall Study|Pregnancy|0|||
126297978|NCT05691712|454377117|FG001|Overall Study|Pregnancy|1|||
126297979|NCT05691712|454377118|FG002|Overall Study|Pregnancy|0|||
126297980|NCT05691712|454377119|FG003|Overall Study|Pregnancy|0|||
126461024|NCT02361346|454987955|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
126461025|NCT02361346|454987956|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
126550215|NCT00358215|455309487|FG000|Overall Study|Death|265|||
126712011|NCT01022853|455897578|FG000|Overall Study|Other not stated above|1|||
126297981|NCT05691712|454377116|FG000|Overall Study|Assigned Treatment by Mistake|1|||
126297982|NCT05691712|454377117|FG001|Overall Study|Assigned Treatment by Mistake|0|||
126297983|NCT05691712|454377118|FG002|Overall Study|Assigned Treatment by Mistake|0|||
126297984|NCT05691712|454377119|FG003|Overall Study|Assigned Treatment by Mistake|1|||
126297985|NCT04225715|454378649|FG000|Overall Study|Reason not Specified|1|||
126297986|NCT04225715|454378650|FG001|Overall Study|Reason not Specified|0|||
126461026|NCT02361346|454987957|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
126461027|NCT02361346|454987949|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
126461028|NCT02361346|454987950|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
126461029|NCT02361346|454987951|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
126461030|NCT02361346|454987952|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
126461031|NCT02361346|454987953|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
126297987|NCT04225715|454378651|FG002|Overall Study|Reason not Specified|0|||
126297988|NCT04225715|454378652|FG003|Overall Study|Reason not Specified|0|||
126297989|NCT04225715|454378653|FG004|Overall Study|Reason not Specified|0|||
126297990|NCT04225715|454378654|FG005|Overall Study|Reason not Specified|0|||
126297991|NCT04225715|454378655|FG006|Overall Study|Reason not Specified|0|||
126297992|NCT04225715|454378656|FG007|Overall Study|Reason not Specified|0|||
126297993|NCT04225715|454378657|FG008|Overall Study|Reason not Specified|0|||
126297994|NCT04225715|454378649|FG000|Overall Study|Protocol Violation|1|||
126297995|NCT04225715|454378650|FG001|Overall Study|Protocol Violation|0|||
126297996|NCT04225715|454378651|FG002|Overall Study|Protocol Violation|0|||
126297997|NCT04225715|454378652|FG003|Overall Study|Protocol Violation|0|||
126297998|NCT04225715|454378653|FG004|Overall Study|Protocol Violation|0|||
126297999|NCT04225715|454378654|FG005|Overall Study|Protocol Violation|9|||
126298000|NCT04225715|454378655|FG006|Overall Study|Protocol Violation|0|||
126298001|NCT04225715|454378656|FG007|Overall Study|Protocol Violation|0|||
126298002|NCT04225715|454378657|FG008|Overall Study|Protocol Violation|0|||
126298003|NCT04225715|454378649|FG000|Overall Study|Withdrawal by Subject|4|||
126298004|NCT04225715|454378650|FG001|Overall Study|Withdrawal by Subject|1|||
126298005|NCT04225715|454378651|FG002|Overall Study|Withdrawal by Subject|1|||
126298006|NCT04225715|454378652|FG003|Overall Study|Withdrawal by Subject|0|||
126298007|NCT04225715|454378653|FG004|Overall Study|Withdrawal by Subject|3|||
126298008|NCT04225715|454378654|FG005|Overall Study|Withdrawal by Subject|1|||
126298009|NCT04225715|454378655|FG006|Overall Study|Withdrawal by Subject|1|||
126298010|NCT04225715|454378656|FG007|Overall Study|Withdrawal by Subject|1|||
126298011|NCT04225715|454378657|FG008|Overall Study|Withdrawal by Subject|0|||
126298012|NCT04225715|454378649|FG000|Overall Study|Adverse Event|0|||
126298013|NCT04225715|454378650|FG001|Overall Study|Adverse Event|0|||
126298014|NCT04225715|454378651|FG002|Overall Study|Adverse Event|0|||
126298015|NCT04225715|454378652|FG003|Overall Study|Adverse Event|0|||
126298016|NCT04225715|454378653|FG004|Overall Study|Adverse Event|0|||
126298017|NCT04225715|454378654|FG005|Overall Study|Adverse Event|0|||
126298018|NCT04225715|454378655|FG006|Overall Study|Adverse Event|0|||
126298019|NCT04225715|454378656|FG007|Overall Study|Adverse Event|0|||
126298020|NCT04225715|454378657|FG008|Overall Study|Adverse Event|1|||
126298021|NCT04225715|454378649|FG000|Overall Study|Arm Terminated By Sponsor|0|||
126298022|NCT04225715|454378650|FG001|Overall Study|Arm Terminated By Sponsor|0|||
126298023|NCT04225715|454378651|FG002|Overall Study|Arm Terminated By Sponsor|0|||
126298024|NCT04225715|454378652|FG003|Overall Study|Arm Terminated By Sponsor|0|||
126298025|NCT04225715|454378653|FG004|Overall Study|Arm Terminated By Sponsor|0|||
126298026|NCT04225715|454378654|FG005|Overall Study|Arm Terminated By Sponsor|0|||
126298027|NCT04225715|454378655|FG006|Overall Study|Arm Terminated By Sponsor|0|||
126298028|NCT04225715|454378656|FG007|Overall Study|Arm Terminated By Sponsor|17|||
126298029|NCT04225715|454378657|FG008|Overall Study|Arm Terminated By Sponsor|18|||
126298030|NCT03318861|454378665|FG000|Overall Study|Death|2|||
126298031|NCT03318861|454378666|FG001|Overall Study|Death|3|||
126298032|NCT03318861|454378667|FG002|Overall Study|Death|3|||
126298033|NCT03318861|454378668|FG003|Overall Study|Death|2|||
126298034|NCT03318861|454378669|FG004|Overall Study|Death|2|||
126298035|NCT03318861|454378665|FG000|Overall Study|Enrolled But Never Treated|0|||
126298036|NCT03318861|454378666|FG001|Overall Study|Enrolled But Never Treated|1|||
126298037|NCT03318861|454378667|FG002|Overall Study|Enrolled But Never Treated|0|||
126298038|NCT03318861|454378668|FG003|Overall Study|Enrolled But Never Treated|1|||
126298039|NCT03318861|454378669|FG004|Overall Study|Enrolled But Never Treated|1|||
126298040|NCT03318861|454378665|FG000|Overall Study|Informed Consent Withdraw|0|||
126298041|NCT03318861|454378666|FG001|Overall Study|Informed Consent Withdraw|0|||
126298042|NCT03318861|454378667|FG002|Overall Study|Informed Consent Withdraw|0|||
126298043|NCT03318861|454378668|FG003|Overall Study|Informed Consent Withdraw|1|||
126298044|NCT03318861|454378669|FG004|Overall Study|Informed Consent Withdraw|0|||
126298045|NCT03318861|454378665|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
126298046|NCT03318861|454378666|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
126298047|NCT03318861|454378667|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
126298048|NCT03318861|454378668|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
126298049|NCT03318861|454378669|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
126461032|NCT02361346|454987954|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
126461033|NCT02361346|454987955|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
126461034|NCT02361346|454987956|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
126298050|NCT00917852|454378670|FG000|Overall Study|Death|6|||
126298051|NCT00471081|454378671|FG000|Active Phase|Protocol Violation|1|||
126298052|NCT00471081|454378672|FG001|Active Phase|Protocol Violation|1|||
126298053|NCT00471081|454378671|FG000|Active Phase|Withdrawal by Subject|0|||
126769586|NCT02858076|456110369|FG000|Overall Study|Lost to Follow-up|2|||
126769587|NCT02858076|456110370|FG001|Overall Study|Lost to Follow-up|7|||
126769588|NCT02858076|456110369|FG000|Overall Study|Completed Out of Window|1|||
126769589|NCT02858076|456110370|FG001|Overall Study|Completed Out of Window|3|||
126769590|NCT00096200|456110371|FG000|Overall Study|Adverse Event|0|||
126769591|NCT00096200|456110372|FG001|Overall Study|Adverse Event|4|||
126461035|NCT02361346|454987957|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
126769592|NCT00096200|456110373|FG002|Overall Study|Adverse Event|0|||
126769593|NCT00096200|456110371|FG000|Overall Study|Withdrawal by Subject|1|||
126769594|NCT00096200|456110372|FG001|Overall Study|Withdrawal by Subject|2|||
126769595|NCT00096200|456110373|FG002|Overall Study|Withdrawal by Subject|0|||
126769596|NCT00096200|456110371|FG000|Overall Study|Ineligible pathology|0|||
126769597|NCT00096200|456110372|FG001|Overall Study|Ineligible pathology|1|||
126769598|NCT00096200|456110373|FG002|Overall Study|Ineligible pathology|0|||
126769599|NCT00938015|456110374|FG000|Overall Study|Death|2|||
126769600|NCT00938015|456110374|FG000|Overall Study|Lost to Follow-up|32|||
126769601|NCT00938015|456110374|FG000|Overall Study|Adverse Event|32|||
126769602|NCT00938015|456110374|FG000|Overall Study|Non-responder|52|||
126769603|NCT00938015|456110374|FG000|Overall Study|Reason not related to Etanercept|29|||
126769604|NCT02341482|456110375|FG000|Overall Study|Adverse Event|1|||
126769605|NCT00664066|456110379|FG000|Overall Study|Study terminated|3|||
126769606|NCT01495793|456110380|FG000|Overall Study|Lost to Follow-up|1|||
126769607|NCT01495793|456110380|FG000|Overall Study|Violation of inclusion criteria|1|||
126769608|NCT00478673|456110381|FG000|30-Days Post-Procedure|Death|2|||
126769609|NCT00478673|456110381|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
126769610|NCT00478673|456110381|FG000|30-Days Post-Procedure|Missed Visit|7|||
126769611|NCT00478673|456110381|FG000|12-Months Post-Procedure|Death|23|||
126769612|NCT00478673|456110381|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
126769613|NCT00478673|456110381|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
126769614|NCT00478673|456110381|FG000|12-Months Post-Procedure|Missed Visit|25|||
126769615|NCT00478673|456110381|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
126769616|NCT03701516|456110382|FG000|Period 1|Lost to Follow-up|0|||
126769617|NCT03701516|456110383|FG001|Period 1|Lost to Follow-up|1|||
126769618|NCT03701516|456110382|FG000|Period 1|Adverse Event|0|||
126769619|NCT03701516|456110383|FG001|Period 1|Adverse Event|2|||
126769620|NCT03701516|456110382|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
126769621|NCT03701516|456110383|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
126461036|NCT02361346|454987949|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
126461037|NCT02361346|454987950|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
126461038|NCT02361346|454987951|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
126461039|NCT02361346|454987952|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
126461040|NCT02361346|454987953|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
126461041|NCT02361346|454987954|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
126461042|NCT02361346|454987955|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
126461043|NCT02361346|454987956|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
126461044|NCT02361346|454987957|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
126461045|NCT02361346|454987949|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
126461046|NCT02361346|454987950|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
126461047|NCT02361346|454987951|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
126461048|NCT02361346|454987952|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
126461049|NCT02361346|454987953|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
126461050|NCT02361346|454987954|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
126461051|NCT02361346|454987955|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
126461052|NCT02361346|454987956|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
126461053|NCT02361346|454987957|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
126461054|NCT02361346|454987949|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
126461055|NCT02361346|454987950|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
126461056|NCT02361346|454987951|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
126461057|NCT02361346|454987952|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
126461058|NCT02361346|454987953|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
126461059|NCT02361346|454987954|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
126769622|NCT03701516|456110382|FG000|Period 1|Non Compliance to Protocol|2|||
126769623|NCT03701516|456110383|FG001|Period 1|Non Compliance to Protocol|1|||
126461060|NCT02361346|454987955|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
126461061|NCT02361346|454987956|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
126461062|NCT02361346|454987957|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
126769624|NCT03701516|456110382|FG000|Period 1|Withdrawal by Subject|0|||
126769625|NCT03701516|456110383|FG001|Period 1|Withdrawal by Subject|1|||
126769626|NCT03701516|456110382|FG000|Period 2|failed to meet all eligibility creiteria|1|||
126769627|NCT03701516|456110383|FG001|Period 2|failed to meet all eligibility creiteria|0|||
126769628|NCT03701516|456110382|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
126769629|NCT03701516|456110383|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
126461063|NCT02361346|454987949|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
126461064|NCT02361346|454987950|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
126461065|NCT02361346|454987951|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
126461066|NCT02361346|454987952|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
126461067|NCT02361346|454987953|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
126461068|NCT02361346|454987954|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
126461069|NCT02361346|454987955|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
126461070|NCT02361346|454987956|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
126461071|NCT02361346|454987957|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
126461072|NCT00782795|454987958|FG000|Overall Study|Withdrawal by Subject|1|||
126461073|NCT00782795|454987959|FG001|Overall Study|Withdrawal by Subject|2|||
126461074|NCT04480424|454987960|FG000|Overall Study|Withdrawal by Subject|0|||
126461075|NCT04480424|454987961|FG001|Overall Study|Withdrawal by Subject|2|||
126461076|NCT04480424|454987960|FG000|Overall Study|Lost to Follow-up|3|||
126461077|NCT04480424|454987961|FG001|Overall Study|Lost to Follow-up|3|||
126461078|NCT04480424|454987960|FG000|Overall Study|Death|14|||
126461079|NCT04480424|454987961|FG001|Overall Study|Death|16|||
126461080|NCT04480424|454987960|FG000|Overall Study|Reason not Specified|5|||
126461081|NCT04480424|454987961|FG001|Overall Study|Reason not Specified|5|||
126461082|NCT02782923|454987962|FG000|Overall Study|Lost to Follow-up|15|||
126461083|NCT00993044|454987964|FG000|Irinotecan 50 mg|Physician Decision|1|||
126461084|NCT00734747|454987965|FG000|SRS Procedure|No staples placed|3|||
126461085|NCT00734747|454987965|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
126461086|NCT05772702|454987976|FG000|Overall Study|Adverse Event|1|||
126461087|NCT01909453|454987977|FG000|Overall Study|Ongoing|118|||
126461088|NCT01909453|454987978|FG001|Overall Study|Ongoing|103|||
126461089|NCT01909453|454987979|FG002|Overall Study|Ongoing|83|||
126461090|NCT01909453|454987980|FG003|Overall Study|Ongoing|164|||
126461091|NCT01909453|454987981|FG004|Overall Study|Ongoing|50|||
126461092|NCT01909453|454987977|FG000|Overall Study|Death|69|||
126461093|NCT01909453|454987978|FG001|Overall Study|Death|74|||
126461094|NCT01909453|454987979|FG002|Overall Study|Death|88|||
126461095|NCT01909453|454987980|FG003|Overall Study|Death|86|||
126461096|NCT01909453|454987981|FG004|Overall Study|Death|29|||
126461097|NCT01909453|454987977|FG000|Overall Study|Lost to Follow-up|3|||
126461098|NCT01909453|454987978|FG001|Overall Study|Lost to Follow-up|4|||
126461099|NCT01909453|454987979|FG002|Overall Study|Lost to Follow-up|4|||
126461100|NCT01909453|454987980|FG003|Overall Study|Lost to Follow-up|3|||
126461101|NCT01909453|454987981|FG004|Overall Study|Lost to Follow-up|3|||
126461102|NCT01909453|454987977|FG000|Overall Study|Withdrawal by Subject|2|||
126461103|NCT01909453|454987978|FG001|Overall Study|Withdrawal by Subject|13|||
126461104|NCT01909453|454987979|FG002|Overall Study|Withdrawal by Subject|16|||
126461105|NCT01909453|454987980|FG003|Overall Study|Withdrawal by Subject|5|||
126461106|NCT01909453|454987981|FG004|Overall Study|Withdrawal by Subject|4|||
126461107|NCT00884377|454989451|FG000|Overall Study|Withdrawal by Subject|1|||
126461108|NCT00884377|454989452|FG001|Overall Study|Withdrawal by Subject|0|||
126461109|NCT00884377|454989451|FG000|Overall Study|Could not confirm diagnosis|1|||
126461110|NCT00884377|454989452|FG001|Overall Study|Could not confirm diagnosis|0|||
126461111|NCT00884377|454989451|FG000|Overall Study|Physician Decision|0|||
126461112|NCT00884377|454989452|FG001|Overall Study|Physician Decision|1|||
126461113|NCT02003365|454989453|FG000|Overall Study|Lost to Follow-up|0|||
126461114|NCT02003365|454989454|FG001|Overall Study|Lost to Follow-up|0|||
126461115|NCT02003365|454989455|FG002|Overall Study|Lost to Follow-up|1|||
126461116|NCT00622739|454989456|FG000|Overall Study|Physician Decision|1|||
126461117|NCT00622739|454989457|FG001|Overall Study|Physician Decision|0|||
126298054|NCT00471081|454378672|FG001|Active Phase|Withdrawal by Subject|3|||
126298055|NCT00471081|454378671|FG000|Active Phase|Lost to Follow-up|0|||
126298056|NCT00471081|454378672|FG001|Active Phase|Lost to Follow-up|1|||
126298057|NCT00471081|454378671|FG000|Active Phase|Lost health plan/insurance|1|||
126298058|NCT00471081|454378672|FG001|Active Phase|Lost health plan/insurance|8|||
126298059|NCT00471081|454378671|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
126298060|NCT00471081|454378672|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
126298061|NCT00471081|454378671|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
126298062|NCT00471081|454378672|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
126298063|NCT00471081|454378671|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
126461118|NCT00622739|454989456|FG000|Overall Study|Adverse Event|1|||
126298064|NCT00471081|454378672|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
126461119|NCT00622739|454989457|FG001|Overall Study|Adverse Event|2|||
126461120|NCT00622739|454989456|FG000|Overall Study|Lack of Efficacy|0|||
126461121|NCT00622739|454989457|FG001|Overall Study|Lack of Efficacy|2|||
126461122|NCT00622739|454989456|FG000|Overall Study|Withdrawal by Subject|0|||
126461123|NCT00622739|454989457|FG001|Overall Study|Withdrawal by Subject|1|||
126461124|NCT00622739|454989456|FG000|Overall Study|Lost to Follow-up|0|||
126461125|NCT00622739|454989457|FG001|Overall Study|Lost to Follow-up|1|||
126461126|NCT03150485|454989465|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
126461127|NCT03150485|454989466|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
126461128|NCT03150485|454989467|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
126298065|NCT02844933|454378673|FG000|Overall Study|Discontinued due to premature termination of study|3|||
126298066|NCT02844933|454378674|FG001|Overall Study|Discontinued due to premature termination of study|2|||
126298067|NCT02393950|454378675|FG000|Overall Study|Adverse Event|1|||
126461129|NCT03150485|454989468|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
126461130|NCT03150485|454989469|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
126461131|NCT03150485|454989470|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
126461132|NCT01394718|454989472|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
126461133|NCT01394718|454989473|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
126461134|NCT03387150|454989474|FG000|Overall Study|Withdrawal by Subject|3|||
126461135|NCT03387150|454989475|FG001|Overall Study|Withdrawal by Subject|0|||
126461136|NCT03387150|454989476|FG002|Overall Study|Withdrawal by Subject|3|||
126461137|NCT03387150|454989477|FG003|Overall Study|Withdrawal by Subject|4|||
126461138|NCT03387150|454989478|FG004|Overall Study|Withdrawal by Subject|1|||
126461139|NCT03387150|454989479|FG005|Overall Study|Withdrawal by Subject|2|||
126461140|NCT03387150|454989480|FG006|Overall Study|Withdrawal by Subject|0|||
126461141|NCT03387150|454989474|FG000|Overall Study|Lost to Follow-up|3|||
126461142|NCT03387150|454989475|FG001|Overall Study|Lost to Follow-up|2|||
126461143|NCT03387150|454989476|FG002|Overall Study|Lost to Follow-up|2|||
126461144|NCT03387150|454989477|FG003|Overall Study|Lost to Follow-up|3|||
126461145|NCT03387150|454989478|FG004|Overall Study|Lost to Follow-up|3|||
126461146|NCT03387150|454989479|FG005|Overall Study|Lost to Follow-up|3|||
126461147|NCT03387150|454989480|FG006|Overall Study|Lost to Follow-up|0|||
126461148|NCT03387150|454989474|FG000|Overall Study|Participant unable to adhere to visit|0|||
126461149|NCT03387150|454989475|FG001|Overall Study|Participant unable to adhere to visit|1|||
126461150|NCT03387150|454989476|FG002|Overall Study|Participant unable to adhere to visit|0|||
126461151|NCT03387150|454989477|FG003|Overall Study|Participant unable to adhere to visit|0|||
126461152|NCT03387150|454989478|FG004|Overall Study|Participant unable to adhere to visit|2|||
126461153|NCT03387150|454989479|FG005|Overall Study|Participant unable to adhere to visit|2|||
126461154|NCT03387150|454989480|FG006|Overall Study|Participant unable to adhere to visit|0|||
126461155|NCT04617795|454989481|FG000|Main Study|Lost to Follow-up|1|||
126461156|NCT04617795|454989482|FG001|Main Study|Lost to Follow-up|0|||
126461157|NCT02395016|454989483|FG000|Overall Study|Adverse Event|4|||
126461158|NCT02395016|454989484|FG001|Overall Study|Adverse Event|3|||
126461159|NCT02395016|454989483|FG000|Overall Study|Withdrawal by Subject|9|||
126461160|NCT02395016|454989484|FG001|Overall Study|Withdrawal by Subject|6|||
126461161|NCT02395016|454989483|FG000|Overall Study|Protocol Violation|2|||
126461162|NCT02395016|454989484|FG001|Overall Study|Protocol Violation|3|||
126461163|NCT01547780|454989485|FG000|Baseline PET Scan|Physician Decision|1|||
126461164|NCT01547780|454989486|FG001|Baseline PET Scan|Physician Decision|0|||
126461165|NCT01547780|454989487|FG002|Baseline PET Scan|Physician Decision|1|||
126461166|NCT01547780|454989488|FG003|Baseline PET Scan|Physician Decision|0|||
126550216|NCT00358215|455309488|FG001|Overall Study|Death|281|||
126712012|NCT01022853|455897579|FG001|Overall Study|Other not stated above|0|||
126712013|NCT01022853|455897580|FG002|Overall Study|Other not stated above|1|||
126712014|NCT01022853|455897581|FG003|Overall Study|Other not stated above|0|||
126712015|NCT01022853|455897582|FG004|Overall Study|Other not stated above|0|||
126712016|NCT01753518|455897583|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
126712017|NCT01753518|455897584|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
126712018|NCT01753518|455897583|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
126712019|NCT01753518|455897584|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
126712020|NCT01753518|455897583|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
126712021|NCT01753518|455897584|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
126712022|NCT01753518|455897583|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
126712023|NCT01753518|455897584|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
126712024|NCT01971476|455897585|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
126712025|NCT01971476|455897586|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
126712026|NCT01971476|455897587|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
126712027|NCT01971476|455897585|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
126712028|NCT01971476|455897586|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
126712029|NCT01971476|455897587|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
126712030|NCT01971476|455897585|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
126712031|NCT01971476|455897586|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
126461167|NCT01547780|454989485|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
126461168|NCT01547780|454989486|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
126461169|NCT01547780|454989487|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
126461170|NCT01547780|454989488|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
126461171|NCT00959374|454989496|FG000|Overall Study|Withdrawal by Subject|2|||
126461172|NCT00959374|454989496|FG000|Overall Study|Lost to Follow-up|14|||
126550217|NCT00358215|455309487|FG000|Overall Study|Protocol Violation|64|||
126550218|NCT00358215|455309488|FG001|Overall Study|Protocol Violation|59|||
126712032|NCT01971476|455897587|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
126712033|NCT02075255|455897588|FG000|Overall Study|Study specific withdrawal criteria|0|||
126712034|NCT02075255|455897589|FG001|Overall Study|Study specific withdrawal criteria|1|||
126712035|NCT02075255|455897590|FG002|Overall Study|Study specific withdrawal criteria|1|||
126366962|NCT01051661|454639366|FG005|Overall Study|Subject lost legal representation|0|||
126366963|NCT01051661|454639361|FG000|Overall Study|Protocol Violation|0|||
126366964|NCT01051661|454639362|FG001|Overall Study|Protocol Violation|0|||
126366965|NCT01051661|454639363|FG002|Overall Study|Protocol Violation|0|||
126366966|NCT01051661|454639364|FG003|Overall Study|Protocol Violation|1|||
126366967|NCT01051661|454639365|FG004|Overall Study|Protocol Violation|2|||
126366968|NCT01051661|454639366|FG005|Overall Study|Protocol Violation|1|||
126366969|NCT01051661|454639361|FG000|Overall Study|Withdrawal by Subject|16|||
126366970|NCT01051661|454639362|FG001|Overall Study|Withdrawal by Subject|30|||
126366971|NCT01051661|454639363|FG002|Overall Study|Withdrawal by Subject|13|||
126366972|NCT01051661|454639364|FG003|Overall Study|Withdrawal by Subject|28|||
126366973|NCT01051661|454639365|FG004|Overall Study|Withdrawal by Subject|12|||
126366974|NCT01051661|454639366|FG005|Overall Study|Withdrawal by Subject|34|||
126366975|NCT04642079|454639367|FG000|Overall Study|Lost to Follow-up|2|||
126366976|NCT04642079|454639368|FG001|Overall Study|Lost to Follow-up|5|||
126461173|NCT00959374|454989496|FG000|Overall Study|Death|1|||
126461174|NCT00959374|454989496|FG000|Overall Study|Protocol Violation|1|||
126461175|NCT00959374|454989496|FG000|Overall Study|Implant Removed/Not Replaced|4|||
126461176|NCT00959374|454989496|FG000|Overall Study|Physician Decision|1|||
126461177|NCT03584373|454989498|FG000|Overall Study|Lost to Follow-up|7|||
126712036|NCT02075255|455897588|FG000|Overall Study|Withdrawal by Subject|4|||
126712037|NCT02075255|455897589|FG001|Overall Study|Withdrawal by Subject|1|||
126712038|NCT02075255|455897590|FG002|Overall Study|Withdrawal by Subject|0|||
126712039|NCT02075255|455897588|FG000|Overall Study|Lost to Follow-up|0|||
126712040|NCT02075255|455897589|FG001|Overall Study|Lost to Follow-up|0|||
126712041|NCT02075255|455897590|FG002|Overall Study|Lost to Follow-up|1|||
126712042|NCT02075255|455897588|FG000|Overall Study|Adverse Event|0|||
126712043|NCT02075255|455897589|FG001|Overall Study|Adverse Event|0|||
126712044|NCT02075255|455897590|FG002|Overall Study|Adverse Event|1|||
126712045|NCT02075255|455897588|FG000|Overall Study|Death|0|||
126712046|NCT02075255|455897589|FG001|Overall Study|Death|2|||
126712047|NCT02075255|455897590|FG002|Overall Study|Death|0|||
126712048|NCT03503773|455897591|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
126712049|NCT03503773|455897592|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
126712050|NCT03503773|455897591|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
126712051|NCT03503773|455897592|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
126712052|NCT03503773|455897591|FG000|Overall Study|Not completing the primary ABPM|3|||
126712053|NCT03503773|455897592|FG001|Overall Study|Not completing the primary ABPM|1|||
126712054|NCT03503773|455897591|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
126712055|NCT03503773|455897592|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
126712056|NCT02675517|455897595|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
126712057|NCT02675517|455897595|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
126712058|NCT00425438|455897596|FG000|Overall Study|Termination by Sponsor|25|||
126712059|NCT00425438|455897597|FG001|Overall Study|Termination by Sponsor|27|||
126712060|NCT02619253|455897598|FG000|Overall Study|Adverse Event|0|||
126712061|NCT02619253|455897599|FG001|Overall Study|Adverse Event|0|||
126712062|NCT02619253|455897600|FG002|Overall Study|Adverse Event|1|||
126712063|NCT02619253|455897601|FG003|Overall Study|Adverse Event|1|||
126712064|NCT02619253|455897602|FG004|Overall Study|Adverse Event|3|||
126712065|NCT02619253|455897598|FG000|Overall Study|Alternative Therapy|0|||
126712066|NCT02619253|455897599|FG001|Overall Study|Alternative Therapy|0|||
126712067|NCT02619253|455897600|FG002|Overall Study|Alternative Therapy|1|||
126712068|NCT02619253|455897601|FG003|Overall Study|Alternative Therapy|0|||
126712069|NCT02619253|455897602|FG004|Overall Study|Alternative Therapy|0|||
126712070|NCT02619253|455897598|FG000|Overall Study|Death|0|||
126712071|NCT02619253|455897599|FG001|Overall Study|Death|0|||
126712072|NCT02619253|455897600|FG002|Overall Study|Death|0|||
126712073|NCT02619253|455897601|FG003|Overall Study|Death|1|||
126712074|NCT02619253|455897602|FG004|Overall Study|Death|0|||
126712075|NCT02619253|455897598|FG000|Overall Study|Disease Progression|4|||
126769630|NCT03083639|456110387|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
126769631|NCT03083639|456110388|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
126366977|NCT04642079|454639369|FG002|Overall Study|Lost to Follow-up|2|||
126366978|NCT04642079|454639370|FG003|Overall Study|Lost to Follow-up|0|||
126461178|NCT03584373|454989499|FG001|Overall Study|Lost to Follow-up|8|||
126461179|NCT01487577|454989500|FG000|Overall Study|Became ineligible after signing consent|1|||
126712076|NCT02619253|455897599|FG001|Overall Study|Disease Progression|2|||
126712077|NCT02619253|455897600|FG002|Overall Study|Disease Progression|8|||
126461180|NCT01155479|454989503|FG000|Part I|Adverse Event|13|||
126712078|NCT02619253|455897601|FG003|Overall Study|Disease Progression|9|||
126712079|NCT02619253|455897602|FG004|Overall Study|Disease Progression|10|||
126769632|NCT03083639|456110387|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
126366979|NCT04642079|454639367|FG000|Overall Study|Withdrawal by Subject|0|||
126366980|NCT04642079|454639368|FG001|Overall Study|Withdrawal by Subject|4|||
126461181|NCT01155479|454989504|FG001|Part I|Adverse Event|8|||
126366981|NCT04642079|454639369|FG002|Overall Study|Withdrawal by Subject|1|||
126712080|NCT02619253|455897598|FG000|Overall Study|Needed a disqualifying therapy|0|||
126712081|NCT02619253|455897599|FG001|Overall Study|Needed a disqualifying therapy|0|||
126712082|NCT02619253|455897600|FG002|Overall Study|Needed a disqualifying therapy|1|||
126712083|NCT02619253|455897601|FG003|Overall Study|Needed a disqualifying therapy|0|||
126712084|NCT02619253|455897602|FG004|Overall Study|Needed a disqualifying therapy|0|||
126712085|NCT02619253|455897598|FG000|Overall Study|Transferred to hospice|0|||
126366982|NCT04642079|454639370|FG003|Overall Study|Withdrawal by Subject|2|||
126712086|NCT02619253|455897599|FG001|Overall Study|Transferred to hospice|0|||
126712087|NCT02619253|455897600|FG002|Overall Study|Transferred to hospice|1|||
126712088|NCT02619253|455897601|FG003|Overall Study|Transferred to hospice|0|||
126712089|NCT02619253|455897602|FG004|Overall Study|Transferred to hospice|0|||
126712090|NCT02619253|455897598|FG000|Overall Study|Physician Decision|0|||
126712091|NCT02619253|455897599|FG001|Overall Study|Physician Decision|1|||
126712092|NCT02619253|455897600|FG002|Overall Study|Physician Decision|2|||
126712093|NCT02619253|455897601|FG003|Overall Study|Physician Decision|3|||
126712094|NCT02619253|455897602|FG004|Overall Study|Physician Decision|0|||
126712095|NCT02619253|455897598|FG000|Overall Study|Withdrawal by Subject|0|||
126712096|NCT02619253|455897599|FG001|Overall Study|Withdrawal by Subject|1|||
126712097|NCT02619253|455897600|FG002|Overall Study|Withdrawal by Subject|0|||
126712098|NCT02619253|455897601|FG003|Overall Study|Withdrawal by Subject|0|||
126712099|NCT02619253|455897602|FG004|Overall Study|Withdrawal by Subject|2|||
126712100|NCT01208181|455897605|FG000|Part 1|Withdrawal by Subject|11|||
126712101|NCT01208181|455897606|FG001|Part 1|Withdrawal by Subject|10|||
126712102|NCT01208181|455897607|FG002|Part 1|Withdrawal by Subject|0|||
126712103|NCT01208181|455897608|FG003|Part 1|Withdrawal by Subject|0|||
126712104|NCT01208181|455897609|FG004|Part 1|Withdrawal by Subject|0|||
126712105|NCT01208181|455897605|FG000|Part 1|Technical problem|5|||
126366983|NCT04642079|454639367|FG000|Overall Study|Other|0|||
126366984|NCT04642079|454639368|FG001|Overall Study|Other|0|||
126366985|NCT04642079|454639369|FG002|Overall Study|Other|0|||
126366986|NCT04642079|454639370|FG003|Overall Study|Other|1|||
126366987|NCT04642079|454639367|FG000|Overall Study|No longer met eligibility criteria|1|||
126366988|NCT04642079|454639368|FG001|Overall Study|No longer met eligibility criteria|0|||
126366989|NCT04642079|454639369|FG002|Overall Study|No longer met eligibility criteria|1|||
126366990|NCT04642079|454639370|FG003|Overall Study|No longer met eligibility criteria|1|||
126366991|NCT03038620|454639373|FG000|Overall Study|Lost to Follow-up|18|||
126366992|NCT03038620|454639374|FG001|Overall Study|Lost to Follow-up|23|||
126366993|NCT03038620|454639373|FG000|Overall Study|Withdrawal by Subject|0|||
126366994|NCT03038620|454639374|FG001|Overall Study|Withdrawal by Subject|15|||
126366995|NCT03038620|454639373|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
126366996|NCT03038620|454639374|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
126366997|NCT04875533|454639380|FG000|Overall Study|Adverse Event|6|||
126366998|NCT04875533|454639381|FG001|Overall Study|Adverse Event|4|||
126366999|NCT04875533|454639380|FG000|Overall Study|Protocol Violation|4|||
126367000|NCT04875533|454639381|FG001|Overall Study|Protocol Violation|0|||
126367001|NCT04875533|454639380|FG000|Overall Study|Withdrawal by Subject|8|||
126367002|NCT04875533|454639381|FG001|Overall Study|Withdrawal by Subject|5|||
126367003|NCT04875533|454639380|FG000|Overall Study|No longer meets eligibility criteria|1|||
126367004|NCT04875533|454639381|FG001|Overall Study|No longer meets eligibility criteria|0|||
126367005|NCT04875533|454639380|FG000|Overall Study|Other|0|||
126367006|NCT04875533|454639381|FG001|Overall Study|Other|2|||
126367007|NCT02657343|454639385|FG000|Overall Study|Death|0|||
126367008|NCT02657343|454639386|FG001|Overall Study|Death|2|||
126367009|NCT02657343|454639387|FG002|Overall Study|Death|0|||
126367010|NCT02657343|454639388|FG003|Overall Study|Death|0|||
126367011|NCT02657343|454639389|FG004|Overall Study|Death|0|||
126367012|NCT02657343|454639390|FG005|Overall Study|Death|0|||
126367013|NCT02657343|454639385|FG000|Overall Study|Patient went to hospice|1|||
126367014|NCT02657343|454639386|FG001|Overall Study|Patient went to hospice|0|||
126367015|NCT02657343|454639387|FG002|Overall Study|Patient went to hospice|0|||
126367016|NCT02657343|454639388|FG003|Overall Study|Patient went to hospice|0|||
126367017|NCT02657343|454639389|FG004|Overall Study|Patient went to hospice|0|||
126367018|NCT02657343|454639390|FG005|Overall Study|Patient went to hospice|0|||
126367019|NCT02657343|454639385|FG000|Overall Study|Withdrawal by Subject|0|||
126367020|NCT02657343|454639386|FG001|Overall Study|Withdrawal by Subject|0|||
126367021|NCT02657343|454639387|FG002|Overall Study|Withdrawal by Subject|0|||
126712106|NCT01208181|455897606|FG001|Part 1|Technical problem|0|||
126712107|NCT01208181|455897607|FG002|Part 1|Technical problem|0|||
126367022|NCT02657343|454639388|FG003|Overall Study|Withdrawal by Subject|0|||
126367023|NCT02657343|454639389|FG004|Overall Study|Withdrawal by Subject|1|||
126367024|NCT02657343|454639390|FG005|Overall Study|Withdrawal by Subject|0|||
126367025|NCT02011542|454639392|FG000|Overall Study|Physician Decision|1|||
126367026|NCT00982280|454639396|FG000|Observation Period|Not eligible to be dosed|19|||
126367027|NCT00982280|454639396|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
126461182|NCT01155479|454989505|FG002|Part I|Adverse Event|18|||
126712108|NCT01208181|455897608|FG003|Part 1|Technical problem|0|||
126712109|NCT01208181|455897609|FG004|Part 1|Technical problem|0|||
126712110|NCT01208181|455897605|FG000|Part 1|Protocol Violation|10|||
126769633|NCT03083639|456110388|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
126769634|NCT02125734|456110389|FG000|Period 2|Adverse Event|0|||
126769635|NCT02125734|456110390|FG001|Period 2|Adverse Event|1|||
126769636|NCT01591499|456110391|FG000|Baseline Visit|Withdrawal by Subject|0|||
126769637|NCT01591499|456110392|FG001|Baseline Visit|Withdrawal by Subject|2|||
126769638|NCT01591499|456110393|FG002|Baseline Visit|Withdrawal by Subject|0|||
126769639|NCT01591499|456110394|FG003|Baseline Visit|Withdrawal by Subject|2|||
126769640|NCT01591499|456110391|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
126769641|NCT01591499|456110392|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
126769642|NCT01591499|456110393|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
126769643|NCT01591499|456110394|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
126769644|NCT01591499|456110391|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
126769645|NCT01591499|456110392|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
126769646|NCT01591499|456110393|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
126769647|NCT01591499|456110394|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
126769648|NCT00358670|456110395|FG000|Overall Study|Adverse Event|26|||
126769649|NCT00358670|456110396|FG001|Overall Study|Adverse Event|29|||
126769650|NCT00358670|456110395|FG000|Overall Study|Lack of Efficacy|20|||
126769651|NCT00358670|456110396|FG001|Overall Study|Lack of Efficacy|23|||
126769652|NCT00358670|456110395|FG000|Overall Study|Protocol Violation|6|||
126769653|NCT00358670|456110396|FG001|Overall Study|Protocol Violation|9|||
126769654|NCT00358670|456110395|FG000|Overall Study|Lost to Follow-up|4|||
126769655|NCT00358670|456110396|FG001|Overall Study|Lost to Follow-up|5|||
126769656|NCT00358670|456110395|FG000|Overall Study|Withdrawal by Subject|13|||
126769657|NCT00358670|456110396|FG001|Overall Study|Withdrawal by Subject|24|||
126769658|NCT00358670|456110395|FG000|Overall Study|Protocol Defined Clinical Event|0|||
126769659|NCT00358670|456110396|FG001|Overall Study|Protocol Defined Clinical Event|1|||
126769660|NCT00358670|456110395|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
126769661|NCT00358670|456110396|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
126769662|NCT00358670|456110395|FG000|Overall Study|Administrative|153|||
126769663|NCT00358670|456110396|FG001|Overall Study|Administrative|125|||
126769664|NCT00981019|456110397|FG000|Overall Study|Did not respond|65|||
126769665|NCT00981019|456110397|FG000|Overall Study|Did not match target population|94|||
126769666|NCT00981019|456110397|FG000|Overall Study|Inadvertent exclusion|239|||
126769667|NCT00981019|456110397|FG000|Overall Study|Hit the survey after closure|79|||
126769668|NCT05083559|456110398|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
126769669|NCT05083559|456110399|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
126769670|NCT05083559|456110398|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
126769671|NCT05083559|456110399|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
126769672|NCT05083559|456110398|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
126769673|NCT05083559|456110399|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
126769674|NCT03940742|456110401|FG000|Overall Study|Lost to Follow-up|0|||
126769675|NCT03940742|456110402|FG001|Overall Study|Lost to Follow-up|0|||
126769676|NCT03940742|456110403|FG002|Overall Study|Lost to Follow-up|0|||
126769677|NCT03940742|456110404|FG003|Overall Study|Lost to Follow-up|1|||
126769678|NCT02032823|456110405|FG000|Overall Study|Death|75|||
126769679|NCT02032823|456110406|FG001|Overall Study|Death|109|||
126769680|NCT02032823|456110405|FG000|Overall Study|Lost to Follow-up|18|||
126769681|NCT02032823|456110406|FG001|Overall Study|Lost to Follow-up|17|||
126769682|NCT02032823|456110405|FG000|Overall Study|Withdrawal by Subject|70|||
126769683|NCT02032823|456110406|FG001|Overall Study|Withdrawal by Subject|53|||
126769684|NCT02032823|456110405|FG000|Overall Study|Ongoing study at data cut-off|755|||
126769685|NCT02032823|456110406|FG001|Overall Study|Ongoing study at data cut-off|731|||
126367028|NCT00982280|454639396|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
126367029|NCT00982280|454639396|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
126367030|NCT00982280|454639396|FG000|Maintenance Period|Adverse Event|1|||
126769686|NCT02032823|456110405|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
126769687|NCT02032823|456110406|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
126769688|NCT03428217|456110407|FG000|Overall Study|Death|89|||
126769689|NCT03428217|456110408|FG001|Overall Study|Death|93|||
126769690|NCT03428217|456110407|FG000|Overall Study|Withdrawal by Subject|8|||
126769691|NCT03428217|456110408|FG001|Overall Study|Withdrawal by Subject|7|||
126769692|NCT03428217|456110407|FG000|Overall Study|Lost to Follow-up|1|||
126769693|NCT03428217|456110408|FG001|Overall Study|Lost to Follow-up|3|||
126769694|NCT03428217|456110407|FG000|Overall Study|Study terminated by sponsor|124|||
126769695|NCT03428217|456110408|FG001|Overall Study|Study terminated by sponsor|118|||
126769696|NCT03428217|456110407|FG000|Overall Study|Other, Not Specified|1|||
126769697|NCT03428217|456110408|FG001|Overall Study|Other, Not Specified|0|||
126769698|NCT03889197|456110409|FG000|Overall Study|Withdrawal by Subject|1|||
126769699|NCT03889197|456110410|FG001|Overall Study|Withdrawal by Subject|0|||
126769700|NCT03889197|456110409|FG000|Overall Study|Physician Decision|0|||
126769701|NCT03889197|456110410|FG001|Overall Study|Physician Decision|1|||
126769702|NCT03889197|456110409|FG000|Overall Study|met exclusion criteria|0|||
126461183|NCT01155479|454989506|FG003|Part I|Adverse Event|7|||
126461184|NCT01155479|454989507|FG004|Part I|Adverse Event|6|||
126461185|NCT01155479|454989503|FG000|Part I|Administrative|2|||
126461186|NCT01155479|454989504|FG001|Part I|Administrative|2|||
126461187|NCT01155479|454989505|FG002|Part I|Administrative|2|||
126461188|NCT01155479|454989506|FG003|Part I|Administrative|0|||
126461189|NCT01155479|454989507|FG004|Part I|Administrative|0|||
126461190|NCT01155479|454989503|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
126461191|NCT01155479|454989504|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
126461192|NCT01155479|454989505|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
126461193|NCT01155479|454989506|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
126769703|NCT03889197|456110410|FG001|Overall Study|met exclusion criteria|1|||
126769704|NCT03889197|456110409|FG000|Overall Study|Protocol Violation|1|||
126769705|NCT03889197|456110410|FG001|Overall Study|Protocol Violation|0|||
126769706|NCT05899218|456110411|FG000|Overall Study|Lost to Follow-up|2|||
126769707|NCT05899218|456110412|FG001|Overall Study|Lost to Follow-up|2|||
126769708|NCT05899218|456110411|FG000|Overall Study|deemed ineligible out of country|1|||
126461194|NCT01155479|454989507|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
126461195|NCT01155479|454989503|FG000|Part I|Withdrawal by Subject|11|||
126461196|NCT01155479|454989504|FG001|Part I|Withdrawal by Subject|13|||
126461197|NCT01155479|454989505|FG002|Part I|Withdrawal by Subject|8|||
126769709|NCT05899218|456110412|FG001|Overall Study|deemed ineligible out of country|0|||
126298068|NCT02393950|454378676|FG001|Overall Study|Adverse Event|0|||
126461198|NCT01155479|454989506|FG003|Part I|Withdrawal by Subject|8|||
126461199|NCT01155479|454989507|FG004|Part I|Withdrawal by Subject|9|||
126461200|NCT01155479|454989503|FG000|Part I|Lost to Follow-up|0|||
126461201|NCT01155479|454989504|FG001|Part I|Lost to Follow-up|0|||
126461202|NCT01155479|454989505|FG002|Part I|Lost to Follow-up|1|||
126461203|NCT01155479|454989506|FG003|Part I|Lost to Follow-up|1|||
126461204|NCT01155479|454989507|FG004|Part I|Lost to Follow-up|0|||
126461205|NCT01155479|454989503|FG000|Part I|Treatment Failure|3|||
126461206|NCT01155479|454989504|FG001|Part I|Treatment Failure|0|||
126461207|NCT01155479|454989505|FG002|Part I|Treatment Failure|3|||
126461208|NCT01155479|454989506|FG003|Part I|Treatment Failure|1|||
126461209|NCT01155479|454989507|FG004|Part I|Treatment Failure|2|||
126461210|NCT01155479|454989503|FG000|Part I|Did Not Receive Treatment|4|||
126461211|NCT01155479|454989504|FG001|Part I|Did Not Receive Treatment|2|||
126461212|NCT01155479|454989505|FG002|Part I|Did Not Receive Treatment|2|||
126461213|NCT01155479|454989506|FG003|Part I|Did Not Receive Treatment|6|||
126461214|NCT01155479|454989507|FG004|Part I|Did Not Receive Treatment|1|||
126461215|NCT01155479|454989503|FG000|Part I|Non-Compliance with Protocol|2|||
126461216|NCT01155479|454989504|FG001|Part I|Non-Compliance with Protocol|1|||
126461217|NCT01155479|454989505|FG002|Part I|Non-Compliance with Protocol|3|||
126769710|NCT05246111|456110413|FG000|Period 01|NOT ELIGIBLE IC5|1|||
126298069|NCT02393950|454378675|FG000|Overall Study|Withdrawal by Subject|0|||
126298070|NCT02393950|454378676|FG001|Overall Study|Withdrawal by Subject|1|||
126298071|NCT04537078|454378677|FG000|Overall Study|Protocol Violation|3|||
126298072|NCT04537078|454378678|FG001|Overall Study|Protocol Violation|2|||
126298073|NCT04537078|454378677|FG000|Overall Study|Lost to Follow-up|1|||
126298074|NCT04537078|454378678|FG001|Overall Study|Lost to Follow-up|0|||
126298075|NCT04537078|454378677|FG000|Overall Study|Withdrawal by Subject|0|||
126298076|NCT04537078|454378678|FG001|Overall Study|Withdrawal by Subject|1|||
126298077|NCT01568892|454378679|FG000|Open-label Phase|Adverse Event|2|||
126298078|NCT01568892|454378680|FG001|Open-label Phase|Adverse Event|0|||
126298079|NCT01568892|454378679|FG000|Open-label Phase|Lack of Efficacy|4|||
126298080|NCT01568892|454378680|FG001|Open-label Phase|Lack of Efficacy|2|||
126298081|NCT01568892|454378679|FG000|Open-label Phase|Lost to Follow-up|0|||
126298082|NCT01568892|454378680|FG001|Open-label Phase|Lost to Follow-up|1|||
126298083|NCT03922308|454378687|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
126298084|NCT03922308|454378688|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
126298085|NCT03922308|454378689|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
126298086|NCT03922308|454378687|FG000|Overall Study|Lost to Follow-up|1|||
126298087|NCT03922308|454378688|FG001|Overall Study|Lost to Follow-up|0|||
126298088|NCT03922308|454378689|FG002|Overall Study|Lost to Follow-up|0|||
126298089|NCT03922308|454378687|FG000|Overall Study|Reason not Specified|0|||
126298090|NCT03922308|454378688|FG001|Overall Study|Reason not Specified|2|||
126461218|NCT01155479|454989506|FG003|Part I|Non-Compliance with Protocol|3|||
126461219|NCT01155479|454989507|FG004|Part I|Non-Compliance with Protocol|2|||
126461220|NCT01155479|454989503|FG000|Part II|Adverse Event|7|||
126461221|NCT01155479|454989504|FG001|Part II|Adverse Event|6|||
126461222|NCT01155479|454989505|FG002|Part II|Adverse Event|8|||
126461223|NCT01155479|454989506|FG003|Part II|Adverse Event|3|||
126461224|NCT01155479|454989507|FG004|Part II|Adverse Event|4|||
126550219|NCT00358215|455309487|FG000|Overall Study|Pregnancy|1|||
126769711|NCT05246111|456110414|FG001|Period 01|NOT ELIGIBLE IC5|0|||
126298091|NCT03922308|454378689|FG002|Overall Study|Reason not Specified|1|||
126461225|NCT01155479|454989503|FG000|Part II|Administrative|43|||
126461226|NCT01155479|454989504|FG001|Part II|Administrative|49|||
126461227|NCT01155479|454989505|FG002|Part II|Administrative|36|||
126461228|NCT01155479|454989506|FG003|Part II|Administrative|38|||
126550220|NCT00358215|455309488|FG001|Overall Study|Pregnancy|0|||
126461229|NCT01155479|454989507|FG004|Part II|Administrative|46|||
126461230|NCT01155479|454989503|FG000|Part II|Withdrawal by Subject|8|||
126461231|NCT01155479|454989504|FG001|Part II|Withdrawal by Subject|4|||
126461232|NCT01155479|454989505|FG002|Part II|Withdrawal by Subject|12|||
126461233|NCT01155479|454989506|FG003|Part II|Withdrawal by Subject|7|||
126461234|NCT01155479|454989507|FG004|Part II|Withdrawal by Subject|3|||
126461235|NCT01155479|454989503|FG000|Part II|Lost to Follow-up|1|||
126461236|NCT01155479|454989504|FG001|Part II|Lost to Follow-up|0|||
126461237|NCT01155479|454989505|FG002|Part II|Lost to Follow-up|0|||
126461238|NCT01155479|454989506|FG003|Part II|Lost to Follow-up|0|||
126461239|NCT01155479|454989507|FG004|Part II|Lost to Follow-up|1|||
126461240|NCT01155479|454989503|FG000|Part II|Treatment Failure|0|||
126461241|NCT01155479|454989504|FG001|Part II|Treatment Failure|1|||
126461242|NCT01155479|454989505|FG002|Part II|Treatment Failure|2|||
126461243|NCT01155479|454989506|FG003|Part II|Treatment Failure|0|||
126461244|NCT01155479|454989507|FG004|Part II|Treatment Failure|1|||
126461245|NCT01155479|454989503|FG000|Part II|Non-Compliance with Protocol|0|||
126461246|NCT01155479|454989504|FG001|Part II|Non-Compliance with Protocol|1|||
126461247|NCT01155479|454989505|FG002|Part II|Non-Compliance with Protocol|0|||
126712111|NCT01208181|455897606|FG001|Part 1|Protocol Violation|5|||
126712112|NCT01208181|455897607|FG002|Part 1|Protocol Violation|0|||
126712113|NCT01208181|455897608|FG003|Part 1|Protocol Violation|0|||
126712114|NCT01208181|455897609|FG004|Part 1|Protocol Violation|0|||
126712115|NCT01208181|455897605|FG000|Part 1|Physician Decision|4|||
126712116|NCT01208181|455897606|FG001|Part 1|Physician Decision|0|||
126712117|NCT01208181|455897607|FG002|Part 1|Physician Decision|0|||
126712118|NCT01208181|455897608|FG003|Part 1|Physician Decision|0|||
126712119|NCT01208181|455897609|FG004|Part 1|Physician Decision|0|||
126712120|NCT01208181|455897605|FG000|Part 1|Non-compliance with study drug|1|||
126712121|NCT01208181|455897606|FG001|Part 1|Non-compliance with study drug|1|||
126712122|NCT01208181|455897607|FG002|Part 1|Non-compliance with study drug|0|||
126712123|NCT01208181|455897608|FG003|Part 1|Non-compliance with study drug|0|||
126298092|NCT01697748|454378690|FG000|Overall Study|ineligible skin incision|1|||
126298093|NCT01697748|454378691|FG001|Overall Study|ineligible skin incision|2|||
126298094|NCT01697748|454378690|FG000|Overall Study|ineligible uterine incision|4|||
126298095|NCT01697748|454378691|FG001|Overall Study|ineligible uterine incision|1|||
126298096|NCT01697748|454378690|FG000|Overall Study|Lost to Follow-up|53|||
126298097|NCT01697748|454378691|FG001|Overall Study|Lost to Follow-up|65|||
126298098|NCT01704495|454378695|FG000|Subjects Randomized|Other Reason|3|||
126298099|NCT01704495|454378696|FG001|Subjects Randomized|Other Reason|2|||
126298100|NCT01704495|454378697|FG002|Subjects Randomized|Other Reason|3|||
126298101|NCT01704495|454378698|FG003|Subjects Randomized|Other Reason|2|||
126298102|NCT01704495|454378695|FG000|Subjects Randomized|Discontinuation criteria met|4|||
126298103|NCT01704495|454378696|FG001|Subjects Randomized|Discontinuation criteria met|2|||
126298104|NCT01704495|454378697|FG002|Subjects Randomized|Discontinuation criteria met|2|||
126298105|NCT01704495|454378698|FG003|Subjects Randomized|Discontinuation criteria met|0|||
126298106|NCT01704495|454378695|FG000|Subjects Randomized|Adverse Event|8|||
126298107|NCT01704495|454378696|FG001|Subjects Randomized|Adverse Event|2|||
126298108|NCT01704495|454378697|FG002|Subjects Randomized|Adverse Event|0|||
126298109|NCT01704495|454378698|FG003|Subjects Randomized|Adverse Event|7|||
126298110|NCT01704495|454378695|FG000|Subjects Randomized|Withdrawal by Subject|5|||
126298111|NCT01704495|454378696|FG001|Subjects Randomized|Withdrawal by Subject|5|||
126298112|NCT01704495|454378697|FG002|Subjects Randomized|Withdrawal by Subject|5|||
126298113|NCT01704495|454378698|FG003|Subjects Randomized|Withdrawal by Subject|5|||
126298114|NCT01704495|454378695|FG000|Subjects Randomized|Protocol Violation|1|||
126298115|NCT01704495|454378696|FG001|Subjects Randomized|Protocol Violation|1|||
126298116|NCT01704495|454378697|FG002|Subjects Randomized|Protocol Violation|2|||
126461248|NCT01155479|454989506|FG003|Part II|Non-Compliance with Protocol|2|||
126461249|NCT01155479|454989507|FG004|Part II|Non-Compliance with Protocol|0|||
126461250|NCT00998764|454989508|FG000|Overall Study|Lack of Efficacy|3|||
126712124|NCT01208181|455897609|FG004|Part 1|Non-compliance with study drug|0|||
126712125|NCT01208181|455897605|FG000|Part 1|Lost to Follow-up|5|||
126712126|NCT01208181|455897606|FG001|Part 1|Lost to Follow-up|3|||
126298117|NCT01704495|454378698|FG003|Subjects Randomized|Protocol Violation|0|||
126298118|NCT01704495|454378695|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
126298119|NCT01704495|454378696|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
126298120|NCT01704495|454378697|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
126298121|NCT01704495|454378698|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
126298122|NCT01704495|454378695|FG000|Optional Safety Extension|Adverse Event|0|||
126298123|NCT01704495|454378696|FG001|Optional Safety Extension|Adverse Event|4|||
126298124|NCT01704495|454378697|FG002|Optional Safety Extension|Adverse Event|0|||
126298125|NCT01704495|454378698|FG003|Optional Safety Extension|Adverse Event|1|||
126298126|NCT01704495|454378695|FG000|Optional Safety Extension|Other reason|27|||
126461251|NCT00998764|454989509|FG001|Overall Study|Lack of Efficacy|6|||
126461252|NCT00998764|454989508|FG000|Overall Study|Adverse Event|17|||
126712127|NCT01208181|455897607|FG002|Part 1|Lost to Follow-up|0|||
126712128|NCT01208181|455897608|FG003|Part 1|Lost to Follow-up|0|||
126461253|NCT00998764|454989509|FG001|Overall Study|Adverse Event|12|||
126461254|NCT00998764|454989508|FG000|Overall Study|Withdrawal by Subject|19|||
126712129|NCT01208181|455897609|FG004|Part 1|Lost to Follow-up|1|||
126712130|NCT01208181|455897605|FG000|Part 1|Lack of Efficacy|37|||
126298127|NCT01704495|454378696|FG001|Optional Safety Extension|Other reason|29|||
126298128|NCT01704495|454378697|FG002|Optional Safety Extension|Other reason|30|||
126298129|NCT01704495|454378698|FG003|Optional Safety Extension|Other reason|28|||
126298130|NCT01704495|454378695|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
126298131|NCT01704495|454378696|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
126298132|NCT01704495|454378697|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
126298133|NCT01704495|454378698|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
126298134|NCT03866512|454378699|FG000|Overall Study|Lost to Follow-up|1|||
126298135|NCT03866512|454378700|FG001|Overall Study|Lost to Follow-up|2|||
126298136|NCT03866512|454378701|FG002|Overall Study|Lost to Follow-up|1|||
126298137|NCT03866512|454378699|FG000|Overall Study|Cannulation issues|0|||
126298138|NCT03866512|454378700|FG001|Overall Study|Cannulation issues|1|||
126298139|NCT03866512|454378701|FG002|Overall Study|Cannulation issues|2|||
126298140|NCT00997373|454378706|FG000|Overall Study|Withdrawal by Subject|5|||
126298141|NCT00997373|454378707|FG001|Overall Study|Withdrawal by Subject|0|||
126298142|NCT00997373|454378706|FG000|Overall Study|wrong tumor type|4|||
126298143|NCT00997373|454378707|FG001|Overall Study|wrong tumor type|0|||
126298144|NCT00997373|454378706|FG000|Overall Study|could not have hysterectomy|6|||
126298145|NCT00997373|454378707|FG001|Overall Study|could not have hysterectomy|0|||
126298146|NCT04177095|454378711|FG000|Overall Study|Withdrawal by Subject|3|||
126298147|NCT04177095|454378711|FG000|Overall Study|Screen Failure|3|||
126298148|NCT04177095|454378711|FG000|Overall Study|Problems with the Trugraf assay|1|||
126298149|NCT00777296|454378712|FG000|Overall Study|Adverse Event|0|||
126298150|NCT00777296|454378713|FG001|Overall Study|Adverse Event|1|||
126298151|NCT00777296|454378714|FG002|Overall Study|Adverse Event|0|||
126298152|NCT00777296|454378715|FG003|Overall Study|Adverse Event|1|||
126298153|NCT00777296|454378712|FG000|Overall Study|Withdrawal by Subject|1|||
126298154|NCT00777296|454378713|FG001|Overall Study|Withdrawal by Subject|0|||
126298155|NCT00777296|454378714|FG002|Overall Study|Withdrawal by Subject|0|||
126298156|NCT00777296|454378715|FG003|Overall Study|Withdrawal by Subject|0|||
126298157|NCT00777296|454378712|FG000|Overall Study|CRF form not completed|0|||
126298158|NCT00777296|454378713|FG001|Overall Study|CRF form not completed|0|||
126298159|NCT00777296|454378714|FG002|Overall Study|CRF form not completed|2|||
126298160|NCT00777296|454378715|FG003|Overall Study|CRF form not completed|0|||
126298161|NCT01592786|454378718|FG000|Overall Study|Adverse Event|60|||
126298162|NCT01592786|454378718|FG000|Overall Study|Lack of Efficacy|19|||
126298163|NCT01592786|454378718|FG000|Overall Study|Protocol Violation|14|||
126298164|NCT01592786|454378718|FG000|Overall Study|Withdrawal by Subject|23|||
126298165|NCT01592786|454378718|FG000|Overall Study|Lost to Follow-up|19|||
126298166|NCT01592786|454378718|FG000|Overall Study|Other|3|||
126298167|NCT02172664|454378721|FG000|Overall Study|Lost to Follow-up|4|||
126298168|NCT02172664|454378722|FG001|Overall Study|Lost to Follow-up|4|||
126298169|NCT02172664|454378721|FG000|Overall Study|Death|1|||
126298170|NCT02172664|454378722|FG001|Overall Study|Death|1|||
126298171|NCT02172664|454378721|FG000|Overall Study|Moved out of area|1|||
126298172|NCT02172664|454378722|FG001|Overall Study|Moved out of area|1|||
126298173|NCT01753310|454378724|FG000|Overall Study|Entered into open label extension study|25|||
126298174|NCT01753310|454378725|FG001|Overall Study|Entered into open label extension study|22|||
126298175|NCT01753310|454378724|FG000|Overall Study|Adverse Event|1|||
126298176|NCT01753310|454378725|FG001|Overall Study|Adverse Event|0|||
126298177|NCT01753310|454378724|FG000|Overall Study|Lost to Follow-up|2|||
126298178|NCT01753310|454378725|FG001|Overall Study|Lost to Follow-up|0|||
126298179|NCT01753310|454378724|FG000|Overall Study|Subject decision|2|||
126298180|NCT01753310|454378725|FG001|Overall Study|Subject decision|2|||
126298181|NCT01753310|454378724|FG000|Overall Study|Sponsor decision|1|||
126298182|NCT01753310|454378725|FG001|Overall Study|Sponsor decision|0|||
126298183|NCT01753310|454378724|FG000|Overall Study|Withdrawal by Subject|1|||
126298184|NCT01753310|454378725|FG001|Overall Study|Withdrawal by Subject|0|||
126298185|NCT02022202|454378726|FG000|Overall Study|Withdrawal by Subject|2|||
126298186|NCT02022202|454378726|FG000|Overall Study|Disease Progression|3|||
126298187|NCT02022202|454378726|FG000|Overall Study|Desire go to immediately to surgery|3|||
126461255|NCT00998764|454989509|FG001|Overall Study|Withdrawal by Subject|25|||
126461256|NCT00998764|454989508|FG000|Overall Study|Physician Decision|3|||
126298188|NCT05581641|454378727|FG000|Overall Study|Withdrawal by Subject|0|||
126298189|NCT05581641|454378728|FG001|Overall Study|Withdrawal by Subject|1|||
126298190|NCT05581641|454378729|FG002|Overall Study|Withdrawal by Subject|3|||
126298191|NCT05581641|454378730|FG003|Overall Study|Withdrawal by Subject|1|||
126298192|NCT05581641|454378727|FG000|Overall Study|Lost to Follow-up|0|||
126298193|NCT05581641|454378728|FG001|Overall Study|Lost to Follow-up|1|||
126298194|NCT05581641|454378729|FG002|Overall Study|Lost to Follow-up|0|||
126298195|NCT05581641|454378730|FG003|Overall Study|Lost to Follow-up|1|||
126298196|NCT05581641|454378727|FG000|Overall Study|Protocol Violation|1|||
126298197|NCT05581641|454378728|FG001|Overall Study|Protocol Violation|0|||
126298198|NCT05581641|454378729|FG002|Overall Study|Protocol Violation|0|||
126298199|NCT05581641|454378730|FG003|Overall Study|Protocol Violation|0|||
126298200|NCT05581641|454378727|FG000|Overall Study|Other|1|||
126712131|NCT01208181|455897606|FG001|Part 1|Lack of Efficacy|12|||
126712132|NCT01208181|455897607|FG002|Part 1|Lack of Efficacy|0|||
126712133|NCT01208181|455897608|FG003|Part 1|Lack of Efficacy|0|||
126712134|NCT01208181|455897609|FG004|Part 1|Lack of Efficacy|17|||
126298201|NCT05581641|454378728|FG001|Overall Study|Other|0|||
126298202|NCT05581641|454378729|FG002|Overall Study|Other|2|||
126298203|NCT05581641|454378730|FG003|Overall Study|Other|1|||
126298204|NCT02166333|454378731|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
126298205|NCT02166333|454378732|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
126298206|NCT02166333|454378733|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
126298207|NCT02166333|454378734|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
126298208|NCT02166333|454378735|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
126298209|NCT02166333|454378736|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
126298210|NCT02166333|454378731|FG000|Stage 1|Death|4|||
126298211|NCT02166333|454378732|FG001|Stage 1|Death|0|||
126298212|NCT02166333|454378733|FG002|Stage 1|Death|2|||
126298213|NCT02166333|454378734|FG003|Stage 1|Death|0|||
126298214|NCT02166333|454378735|FG004|Stage 1|Death|3|||
126298215|NCT02166333|454378736|FG005|Stage 1|Death|2|||
126298216|NCT02166333|454378731|FG000|Stage 1|Lost to Follow-up|12|||
126298217|NCT02166333|454378732|FG001|Stage 1|Lost to Follow-up|0|||
126298218|NCT02166333|454378733|FG002|Stage 1|Lost to Follow-up|6|||
126298219|NCT02166333|454378734|FG003|Stage 1|Lost to Follow-up|0|||
126298220|NCT02166333|454378735|FG004|Stage 1|Lost to Follow-up|3|||
126298221|NCT02166333|454378736|FG005|Stage 1|Lost to Follow-up|3|||
126298222|NCT02166333|454378731|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
126298223|NCT02166333|454378732|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
126298224|NCT02166333|454378733|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
126298225|NCT02166333|454378734|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
126298226|NCT02166333|454378735|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
126298227|NCT02166333|454378736|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
126298228|NCT02166333|454378731|FG000|Stage 2|Death|4|||
126298229|NCT02166333|454378732|FG001|Stage 2|Death|2|||
126298230|NCT02166333|454378733|FG002|Stage 2|Death|1|||
126298231|NCT02166333|454378734|FG003|Stage 2|Death|0|||
126298232|NCT02166333|454378735|FG004|Stage 2|Death|0|||
126298233|NCT02166333|454378736|FG005|Stage 2|Death|1|||
126298234|NCT02166333|454378731|FG000|Stage 2|Lost to Follow-up|23|||
126298235|NCT02166333|454378732|FG001|Stage 2|Lost to Follow-up|4|||
126298236|NCT02166333|454378733|FG002|Stage 2|Lost to Follow-up|11|||
126367031|NCT01979185|454639397|FG000|Period 2|Other|0|||
126367032|NCT01979185|454639398|FG001|Period 2|Other|1|||
126367033|NCT00980798|454639399|FG000|Overall Study|Adverse Event|7|||
126367034|NCT00980798|454639400|FG001|Overall Study|Adverse Event|36|||
126367035|NCT00980798|454639399|FG000|Overall Study|Lack of Efficacy|16|||
126367036|NCT00980798|454639400|FG001|Overall Study|Lack of Efficacy|5|||
126367037|NCT00980798|454639399|FG000|Overall Study|Lost to Follow-up|0|||
126367038|NCT00980798|454639400|FG001|Overall Study|Lost to Follow-up|1|||
126367039|NCT00980798|454639399|FG000|Overall Study|Physician Decision|2|||
126367040|NCT00980798|454639400|FG001|Overall Study|Physician Decision|1|||
126367041|NCT00980798|454639399|FG000|Overall Study|Withdrawal by Subject|8|||
126367042|NCT00980798|454639400|FG001|Overall Study|Withdrawal by Subject|11|||
126367043|NCT00980798|454639399|FG000|Overall Study|Other|0|||
126367044|NCT00980798|454639400|FG001|Overall Study|Other|1|||
126367045|NCT04724837|454639401|FG000|Overall Study|Other|4|||
126367046|NCT04724837|454639402|FG001|Overall Study|Other|16|||
126367047|NCT04724837|454639403|FG002|Overall Study|Other|0|||
126367048|NCT04724837|454639401|FG000|Overall Study|Withdrawal by Subject|2|||
126367049|NCT04724837|454639402|FG001|Overall Study|Withdrawal by Subject|9|||
126367050|NCT04724837|454639403|FG002|Overall Study|Withdrawal by Subject|9|||
126367051|NCT04724837|454639401|FG000|Overall Study|Adverse Event|2|||
126367052|NCT04724837|454639402|FG001|Overall Study|Adverse Event|7|||
126367053|NCT04724837|454639403|FG002|Overall Study|Adverse Event|4|||
126367054|NCT04724837|454639401|FG000|Overall Study|Lost to Follow-up|0|||
126367055|NCT04724837|454639402|FG001|Overall Study|Lost to Follow-up|1|||
126367056|NCT04724837|454639403|FG002|Overall Study|Lost to Follow-up|3|||
126367057|NCT04724837|454639401|FG000|Overall Study|Physician Decision|1|||
126367058|NCT04724837|454639402|FG001|Overall Study|Physician Decision|2|||
126367059|NCT04724837|454639403|FG002|Overall Study|Physician Decision|0|||
126367060|NCT04724837|454639401|FG000|Overall Study|Death|0|||
126367061|NCT04724837|454639402|FG001|Overall Study|Death|0|||
126367062|NCT04724837|454639403|FG002|Overall Study|Death|1|||
126367063|NCT04724837|454639401|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
126367064|NCT04724837|454639402|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
126367065|NCT04724837|454639403|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
126367066|NCT04724837|454639401|FG000|Overall Study|Study Terminated by Sponsor|0|||
126367067|NCT04724837|454639402|FG001|Overall Study|Study Terminated by Sponsor|1|||
126461257|NCT00998764|454989509|FG001|Overall Study|Physician Decision|3|||
126461258|NCT00998764|454989508|FG000|Overall Study|Death|3|||
126461259|NCT00998764|454989509|FG001|Overall Study|Death|1|||
126461260|NCT00998764|454989508|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
126461261|NCT00998764|454989509|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
126461262|NCT00998764|454989508|FG000|Overall Study|Protocol Violation|0|||
126461263|NCT00998764|454989509|FG001|Overall Study|Protocol Violation|1|||
126461264|NCT00998764|454989508|FG000|Overall Study|Failed to Return|1|||
126461265|NCT00998764|454989509|FG001|Overall Study|Failed to Return|1|||
126461266|NCT00998764|454989508|FG000|Overall Study|Lost to Follow-up|1|||
126461267|NCT00998764|454989509|FG001|Overall Study|Lost to Follow-up|1|||
126461268|NCT00998764|454989508|FG000|Overall Study|Loss of Caregiver|0|||
126461269|NCT00998764|454989509|FG001|Overall Study|Loss of Caregiver|3|||
126712135|NCT01208181|455897605|FG000|Part 1|Adverse Event|26|||
126712136|NCT01208181|455897606|FG001|Part 1|Adverse Event|24|||
126298237|NCT02166333|454378734|FG003|Stage 2|Lost to Follow-up|9|||
126298238|NCT02166333|454378735|FG004|Stage 2|Lost to Follow-up|3|||
126298239|NCT02166333|454378736|FG005|Stage 2|Lost to Follow-up|6|||
126298240|NCT00682786|454378741|FG000|Overall Study|Withdrawal by Subject|2|||
126298241|NCT00682786|454378742|FG001|Overall Study|Withdrawal by Subject|2|||
126298242|NCT00682786|454378741|FG000|Overall Study|Did not receive irinotecan|0|||
126298243|NCT00682786|454378742|FG001|Overall Study|Did not receive irinotecan|1|||
126298244|NCT00359424|454378743|FG000|Overall Study|Death|99|||
126298245|NCT00359424|454378744|FG001|Overall Study|Death|58|||
126298246|NCT00359424|454378743|FG000|Overall Study|Lost to Follow-up|19|||
126298247|NCT00359424|454378744|FG001|Overall Study|Lost to Follow-up|7|||
126298248|NCT00359424|454378743|FG000|Overall Study|Withdrawal by Subject|10|||
126298249|NCT00359424|454378744|FG001|Overall Study|Withdrawal by Subject|2|||
126298250|NCT00359424|454378743|FG000|Overall Study|follow up not conducted|2|||
126298251|NCT00359424|454378744|FG001|Overall Study|follow up not conducted|0|||
126298252|NCT02462603|454378747|FG000|Overall Study|Investigator Decision|1|||
126298253|NCT02462603|454378747|FG000|Overall Study|Non-Compliance|1|||
126298254|NCT02462603|454378747|FG000|Overall Study|Withdrawal by Subject|2|||
126298255|NCT01591096|454378749|FG000|Overall Study|Adverse Event|1|||
126298256|NCT01831635|454378750|FG000|Overall Study|Withdrawal by Subject|0|||
126298257|NCT01831635|454378751|FG001|Overall Study|Withdrawal by Subject|2|||
126298258|NCT01831635|454378752|FG002|Overall Study|Withdrawal by Subject|0|||
126298259|NCT03805412|454378755|FG000|Overall Study|Lost to Follow-up|0|||
126298260|NCT03805412|454378756|FG001|Overall Study|Lost to Follow-up|1|||
126298261|NCT05514873|454378762|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
126298262|NCT05514873|454378762|FG000|Main Treatment Period|Adverse Event|2|||
126298263|NCT05514873|454378762|FG000|Extension Treatment Period|Lost to Follow-up|3|||
126298264|NCT03525678|454378765|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
126298265|NCT03525678|454378766|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
126298266|NCT03525678|454378767|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
126298267|NCT03525678|454378768|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
126298268|NCT03525678|454378769|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
126298269|NCT03525678|454378765|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
126298270|NCT03525678|454378766|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
126298271|NCT03525678|454378767|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
126298272|NCT03525678|454378768|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
126298273|NCT03525678|454378769|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
126298274|NCT03525678|454378765|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
126298275|NCT03525678|454378766|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
126298276|NCT03525678|454378767|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
126298277|NCT03525678|454378768|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
126298278|NCT03525678|454378769|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
126298279|NCT03525678|454378765|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
126298280|NCT03525678|454378766|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
126298281|NCT03525678|454378767|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
126298282|NCT03525678|454378768|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
126298283|NCT03525678|454378769|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
126298284|NCT03525678|454378765|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
126298285|NCT03525678|454378766|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
126298286|NCT03525678|454378767|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
126298287|NCT03525678|454378768|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
126298288|NCT03525678|454378769|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
126298289|NCT03525678|454378765|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
126298290|NCT03525678|454378766|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
126298291|NCT03525678|454378767|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
126461270|NCT00998764|454989508|FG000|Overall Study|Other|4|||
126461271|NCT00998764|454989509|FG001|Overall Study|Other|4|||
126298292|NCT03525678|454378768|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
126461272|NCT00998764|454989508|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
126298293|NCT03525678|454378769|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
126298294|NCT02747108|454378770|FG000|Overall Study|Death|2|||
126298295|NCT02747108|454378771|FG001|Overall Study|Death|2|||
126298296|NCT02747108|454378770|FG000|Overall Study|Withdrawal by Subject|1|||
126298297|NCT02747108|454378771|FG001|Overall Study|Withdrawal by Subject|0|||
126298298|NCT02747108|454378770|FG000|Overall Study|Protocol Violation|2|||
126298299|NCT02747108|454378771|FG001|Overall Study|Protocol Violation|0|||
126298300|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
126298301|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
126298302|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
126298303|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
126298304|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
126298305|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
126298306|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
126298307|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
126298308|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
126298309|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
126298310|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
126298311|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
126298312|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
126298313|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
126298314|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
126298315|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
126298316|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
126298317|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
126298318|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
126298319|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
126298320|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
126298321|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
126298322|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
126298323|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
126298324|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
126298325|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
126298326|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
126298327|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
126298328|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
126298329|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
126298330|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
126298331|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
126298332|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298333|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298334|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
126298335|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298336|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298337|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298338|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
126298339|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298340|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
126298341|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
126298342|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
126298343|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
126298344|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
126298345|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
126298346|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
126298347|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
126298348|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
126298349|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
126298350|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
126298351|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
126298352|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
126550221|NCT00358215|455309487|FG000|Overall Study|Other|21|||
126550222|NCT00358215|455309488|FG001|Overall Study|Other|14|||
126461273|NCT00998764|454989509|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
126461274|NCT04761627|454989510|FG000|Run-in Period|Death|1|||
126461275|NCT04761627|454989511|FG001|Run-in Period|Death|0|||
126461276|NCT04761627|454989512|FG002|Run-in Period|Death|0|||
126461277|NCT04761627|454989510|FG000|Run-in Period|Required alternative therapy|2|||
126461278|NCT04761627|454989511|FG001|Run-in Period|Required alternative therapy|0|||
126461279|NCT04761627|454989512|FG002|Run-in Period|Required alternative therapy|0|||
126461280|NCT04761627|454989510|FG000|Run-in Period|Lost to Follow-up|2|||
126461281|NCT04761627|454989511|FG001|Run-in Period|Lost to Follow-up|0|||
126298353|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
126298354|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
126298355|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
126298356|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298357|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
126298358|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298359|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298360|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298361|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298362|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298363|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
126298364|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298365|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298366|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298367|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298368|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
126298369|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298370|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298371|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
126298372|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298373|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298374|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298375|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298376|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298377|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
126298378|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298379|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
126298380|NCT03896503|454380150|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
126298381|NCT03896503|454380151|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
126298382|NCT03896503|454380152|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
126298383|NCT03896503|454380153|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
126298384|NCT03896503|454380154|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
126298385|NCT03896503|454380155|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
126298386|NCT03896503|454380156|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
126298387|NCT03896503|454380157|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
126298388|NCT00210210|454380161|FG000|Overall Study|Withdrawal by Subject|3|||
126298389|NCT00210210|454380162|FG001|Overall Study|Withdrawal by Subject|2|||
126298390|NCT00210210|454380161|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
126298391|NCT00210210|454380162|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
126298392|NCT02275546|454380171|FG000|Treatment Period 2|Withdrawal by Subject|2|||
126298393|NCT02275546|454380172|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126298394|NCT02275546|454380171|FG000|Treatment Period 2|Protocol Violation|0|||
126298395|NCT02275546|454380172|FG001|Treatment Period 2|Protocol Violation|1|||
126298396|NCT02955355|454380176|FG000|Overall Study|Adverse Event|4|||
126298397|NCT02955355|454380176|FG000|Overall Study|Death|1|||
126298398|NCT02955355|454380176|FG000|Overall Study|Physician Decision|21|||
126298399|NCT02955355|454380176|FG000|Overall Study|Site Terminated by Sponsor|35|||
126298400|NCT02955355|454380176|FG000|Overall Study|Withdrawal by Subject|19|||
126298401|NCT02955355|454380176|FG000|Overall Study|Reason Not Specified|5|||
126298402|NCT02612623|454380177|FG000|Overall Study|Withdrawal by Subject|0|||
126461282|NCT04761627|454989512|FG002|Run-in Period|Lost to Follow-up|0|||
126461283|NCT04761627|454989510|FG000|Run-in Period|Protocol Violation|3|||
126461284|NCT04761627|454989511|FG001|Run-in Period|Protocol Violation|0|||
126461285|NCT04761627|454989512|FG002|Run-in Period|Protocol Violation|0|||
126712137|NCT01208181|455897607|FG002|Part 1|Adverse Event|0|||
126712138|NCT01208181|455897608|FG003|Part 1|Adverse Event|0|||
126298403|NCT02612623|454380178|FG001|Overall Study|Withdrawal by Subject|1|||
126298404|NCT02612623|454380179|FG002|Overall Study|Withdrawal by Subject|0|||
126298405|NCT02612623|454380180|FG003|Overall Study|Withdrawal by Subject|0|||
126298406|NCT02612623|454380177|FG000|Overall Study|Adverse Event|1|||
126298407|NCT02612623|454380178|FG001|Overall Study|Adverse Event|0|||
126298408|NCT02612623|454380179|FG002|Overall Study|Adverse Event|1|||
126298409|NCT02612623|454380180|FG003|Overall Study|Adverse Event|0|||
126298410|NCT05177484|454380181|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
126298411|NCT05177484|454380182|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
126298412|NCT05177484|454380181|FG000|Overall Study|Inadvertently withdrawn|3|||
126298413|NCT05177484|454380182|FG001|Overall Study|Inadvertently withdrawn|1|||
126298414|NCT05177484|454380181|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
126298415|NCT05177484|454380182|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
126298416|NCT05486091|454380187|FG000|Overall Study|Withdrawal by Subject|1|||
126298417|NCT05486091|454380187|FG000|Overall Study|Lost to Follow-up|2|||
126298418|NCT03971071|454380188|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
126298419|NCT03971071|454380189|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
126298420|NCT03971071|454380190|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
126298421|NCT03971071|454380191|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
126298422|NCT03971071|454380192|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
126298423|NCT03971071|454380188|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
126298424|NCT03971071|454380189|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
126298425|NCT03971071|454380190|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
126298426|NCT03971071|454380191|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126298427|NCT03971071|454380192|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126298428|NCT03971071|454380188|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
126298429|NCT03971071|454380189|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
126298430|NCT03971071|454380190|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
126298431|NCT03971071|454380191|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
126298432|NCT03971071|454380192|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
126298433|NCT03971071|454380188|FG000|Open-label Treatment Period|Sponsor decision|0|||
126298434|NCT03971071|454380189|FG001|Open-label Treatment Period|Sponsor decision|0|||
126298435|NCT03971071|454380190|FG002|Open-label Treatment Period|Sponsor decision|0|||
126298436|NCT03971071|454380191|FG003|Open-label Treatment Period|Sponsor decision|0|||
126298437|NCT03971071|454380192|FG004|Open-label Treatment Period|Sponsor decision|1|||
126298438|NCT03971071|454380188|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
126298439|NCT03971071|454380189|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
126298440|NCT03971071|454380190|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
126298441|NCT03971071|454380191|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
126298442|NCT03971071|454380192|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
126298443|NCT03971071|454380188|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
126298444|NCT03971071|454380189|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
126298445|NCT03971071|454380190|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
126298446|NCT03971071|454380191|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
126298447|NCT03971071|454380192|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
126298448|NCT03210714|454380195|FG000|Overall Study|Adverse Event|6|||
126298449|NCT03210714|454380195|FG000|Overall Study|Physician Decision|1|||
126367068|NCT04724837|454639403|FG002|Overall Study|Study Terminated by Sponsor|0|||
126367069|NCT00522379|454639404|FG000|Overall Study|Adverse Event|12|||
126367070|NCT00522379|454639405|FG001|Overall Study|Adverse Event|15|||
126367071|NCT00522379|454639406|FG002|Overall Study|Adverse Event|12|||
126367072|NCT00522379|454639407|FG003|Overall Study|Adverse Event|5|||
126367073|NCT00522379|454639408|FG004|Overall Study|Adverse Event|17|||
126367074|NCT00522379|454639404|FG000|Overall Study|Lack of Efficacy|3|||
126367075|NCT00522379|454639405|FG001|Overall Study|Lack of Efficacy|0|||
126367076|NCT00522379|454639406|FG002|Overall Study|Lack of Efficacy|2|||
126367077|NCT00522379|454639407|FG003|Overall Study|Lack of Efficacy|2|||
126367078|NCT00522379|454639408|FG004|Overall Study|Lack of Efficacy|7|||
126367079|NCT00522379|454639404|FG000|Overall Study|Withdrawal by Subject|2|||
126367080|NCT00522379|454639405|FG001|Overall Study|Withdrawal by Subject|3|||
126367081|NCT00522379|454639406|FG002|Overall Study|Withdrawal by Subject|1|||
126367082|NCT00522379|454639407|FG003|Overall Study|Withdrawal by Subject|2|||
126367083|NCT00522379|454639408|FG004|Overall Study|Withdrawal by Subject|0|||
126712139|NCT01208181|455897609|FG004|Part 1|Adverse Event|4|||
126298450|NCT03210714|454380195|FG000|Overall Study|Progressive disease|11|||
126367084|NCT00522379|454639404|FG000|Overall Study|Protocol Violation|1|||
126367085|NCT00522379|454639405|FG001|Overall Study|Protocol Violation|1|||
126367086|NCT00522379|454639406|FG002|Overall Study|Protocol Violation|2|||
126367087|NCT00522379|454639407|FG003|Overall Study|Protocol Violation|0|||
126367088|NCT00522379|454639408|FG004|Overall Study|Protocol Violation|0|||
126298451|NCT03210714|454380195|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
126298452|NCT01909934|454380196|FG000|Overall Study|Withdrawal by Subject|3|||
126298453|NCT01909934|454380196|FG000|Overall Study|Lost to Follow-up|1|||
126298454|NCT01909934|454380196|FG000|Overall Study|Death|25|||
126298455|NCT01909934|454380196|FG000|Overall Study|Withdrawal of Informed Consent|1|||
126298456|NCT01909934|454380196|FG000|Overall Study|Reason Not Specified|1|||
126298457|NCT03810092|454380197|FG000|Overall Study|no ground support|17|||
126298458|NCT03810092|454380197|FG000|Overall Study|ADL not done at J0|16|||
126298459|NCT03810092|454380197|FG000|Overall Study|No hemoglobin measure at J5|27|||
126298460|NCT01139775|454380200|FG000|Overall Study|Adverse Event|0|||
126298461|NCT01139775|454380201|FG001|Overall Study|Adverse Event|6|||
126298462|NCT01139775|454380202|FG002|Overall Study|Adverse Event|2|||
126298463|NCT01139775|454380200|FG000|Overall Study|Protocol Violation|0|||
126298464|NCT01139775|454380201|FG001|Overall Study|Protocol Violation|5|||
126298465|NCT01139775|454380202|FG002|Overall Study|Protocol Violation|0|||
126298466|NCT01139775|454380200|FG000|Overall Study|Withdrawal by Subject|1|||
126298467|NCT01139775|454380201|FG001|Overall Study|Withdrawal by Subject|0|||
126298468|NCT01139775|454380202|FG002|Overall Study|Withdrawal by Subject|2|||
126298469|NCT01139775|454380200|FG000|Overall Study|Physician Decision|0|||
126298470|NCT01139775|454380201|FG001|Overall Study|Physician Decision|2|||
126298471|NCT01139775|454380202|FG002|Overall Study|Physician Decision|2|||
126298472|NCT03193853|454380205|FG000|Overall Study|Death|6|||
126298473|NCT01956773|454380213|FG000|Overall Study|Lost to Follow-up|628|||
126298474|NCT01956773|454380214|FG001|Overall Study|Lost to Follow-up|1|||
126298475|NCT00450437|454380219|FG000|Overall Study|Withdrawal by Subject|10|||
126298476|NCT00450437|454380220|FG001|Overall Study|Withdrawal by Subject|2|||
126298477|NCT00450437|454380221|FG002|Overall Study|Withdrawal by Subject|0|||
126298478|NCT00450437|454380222|FG003|Overall Study|Withdrawal by Subject|1|||
126298479|NCT00450437|454380219|FG000|Overall Study|Lost to Follow-up|31|||
126298480|NCT00450437|454380220|FG001|Overall Study|Lost to Follow-up|12|||
126298481|NCT00450437|454380221|FG002|Overall Study|Lost to Follow-up|19|||
126298482|NCT00450437|454380222|FG003|Overall Study|Lost to Follow-up|9|||
126298483|NCT00450437|454380219|FG000|Overall Study|Protocol Violation|0|||
126298484|NCT00450437|454380220|FG001|Overall Study|Protocol Violation|1|||
126298485|NCT00450437|454380221|FG002|Overall Study|Protocol Violation|0|||
126298486|NCT00450437|454380222|FG003|Overall Study|Protocol Violation|1|||
126298487|NCT00450437|454380219|FG000|Overall Study|Inappropriate enrollment|4|||
126298488|NCT00450437|454380220|FG001|Overall Study|Inappropriate enrollment|1|||
126298489|NCT00450437|454380221|FG002|Overall Study|Inappropriate enrollment|3|||
126298490|NCT00450437|454380222|FG003|Overall Study|Inappropriate enrollment|0|||
126298491|NCT00450437|454380219|FG000|Overall Study|Administrative reason|0|||
126298492|NCT00450437|454380220|FG001|Overall Study|Administrative reason|0|||
126298493|NCT00450437|454380221|FG002|Overall Study|Administrative reason|1|||
126298494|NCT00450437|454380222|FG003|Overall Study|Administrative reason|0|||
126298495|NCT00450437|454380219|FG000|Overall Study|Unable to Classify|1|||
126298496|NCT00450437|454380220|FG001|Overall Study|Unable to Classify|0|||
126298497|NCT00450437|454380221|FG002|Overall Study|Unable to Classify|1|||
126298498|NCT00450437|454380222|FG003|Overall Study|Unable to Classify|0|||
126298499|NCT02492867|454380223|FG000|Overall Study|Alternate therapy|1|||
126298500|NCT02492867|454380223|FG000|Overall Study|Withdrawal by Subject|2|||
126298501|NCT02492867|454380223|FG000|Overall Study|Disease progression after treatment started|1|||
126298502|NCT02492867|454380223|FG000|Overall Study|Death|1|||
126298503|NCT03296527|454380224|FG000|Overall Study|Adverse Event|15|||
126298504|NCT03296527|454380225|FG001|Overall Study|Adverse Event|33|||
126298505|NCT03296527|454380224|FG000|Overall Study|Protocol Deviation|4|||
126298506|NCT03296527|454380225|FG001|Overall Study|Protocol Deviation|0|||
126298507|NCT03296527|454380224|FG000|Overall Study|Participant withdrew consent|3|||
126298508|NCT03296527|454380225|FG001|Overall Study|Participant withdrew consent|1|||
126298509|NCT03296527|454380224|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
126298510|NCT03296527|454380225|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
126712140|NCT01208181|455897605|FG000|Part 2|Adverse Event|0|||
126712141|NCT01208181|455897606|FG001|Part 2|Adverse Event|0|||
126712142|NCT01208181|455897607|FG002|Part 2|Adverse Event|6|||
126298511|NCT03296527|454380224|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
126298512|NCT03296527|454380225|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
126298513|NCT03296527|454380224|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
126298514|NCT03296527|454380225|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
126298515|NCT03296527|454380224|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
126298516|NCT03296527|454380225|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
126298517|NCT03296527|454380224|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
126298518|NCT03296527|454380225|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
126298519|NCT00122382|454380226|FG000|Double-Blind Study|Adverse Event|9|||
126298520|NCT00122382|454380227|FG001|Double-Blind Study|Adverse Event|11|||
126712143|NCT01208181|455897608|FG003|Part 2|Adverse Event|7|||
126298521|NCT00122382|454380228|FG002|Double-Blind Study|Adverse Event|0|||
126298522|NCT00122382|454380226|FG000|Double-Blind Study|Death|2|||
126298523|NCT00122382|454380227|FG001|Double-Blind Study|Death|2|||
126712144|NCT01208181|455897609|FG004|Part 2|Adverse Event|0|||
126461286|NCT04761627|454989510|FG000|Run-in Period|Abnormal liver function|1|||
126461287|NCT04761627|454989511|FG001|Run-in Period|Abnormal liver function|0|||
126461288|NCT04761627|454989512|FG002|Run-in Period|Abnormal liver function|0|||
126298524|NCT00122382|454380228|FG002|Double-Blind Study|Death|0|||
126298525|NCT00122382|454380226|FG000|Double-Blind Study|Lack of Efficacy|0|||
126298526|NCT00122382|454380227|FG001|Double-Blind Study|Lack of Efficacy|8|||
126298527|NCT00122382|454380228|FG002|Double-Blind Study|Lack of Efficacy|0|||
126298528|NCT00122382|454380226|FG000|Double-Blind Study|Lost to Follow-up|2|||
126298529|NCT00122382|454380227|FG001|Double-Blind Study|Lost to Follow-up|1|||
126298530|NCT00122382|454380228|FG002|Double-Blind Study|Lost to Follow-up|0|||
126298531|NCT00122382|454380226|FG000|Double-Blind Study|Pregnancy|2|||
126298532|NCT00122382|454380227|FG001|Double-Blind Study|Pregnancy|0|||
126298533|NCT00122382|454380228|FG002|Double-Blind Study|Pregnancy|0|||
126298534|NCT00122382|454380226|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
126298535|NCT00122382|454380227|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
126298536|NCT00122382|454380228|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
126298537|NCT00122382|454380226|FG000|Double-Blind Study|Withdrawal of Consent|7|||
126298538|NCT00122382|454380227|FG001|Double-Blind Study|Withdrawal of Consent|3|||
126298539|NCT00122382|454380228|FG002|Double-Blind Study|Withdrawal of Consent|0|||
126298540|NCT00122382|454380226|FG000|Double-Blind Study|Protocol Violation|1|||
126298541|NCT00122382|454380227|FG001|Double-Blind Study|Protocol Violation|0|||
126298542|NCT00122382|454380228|FG002|Double-Blind Study|Protocol Violation|0|||
126298543|NCT00122382|454380226|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
126298544|NCT00122382|454380227|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
126298545|NCT00122382|454380228|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
126298546|NCT00122382|454380226|FG000|Double-Blind Study|Randomized but not treated|0|||
126298547|NCT00122382|454380227|FG001|Double-Blind Study|Randomized but not treated|2|||
126298548|NCT00122382|454380228|FG002|Double-Blind Study|Randomized but not treated|0|||
126298549|NCT00122382|454380226|FG000|Open-Label Study|Adverse Event|0|||
126298550|NCT00122382|454380227|FG001|Open-Label Study|Adverse Event|0|||
126298551|NCT00122382|454380228|FG002|Open-Label Study|Adverse Event|11|||
126298552|NCT00122382|454380226|FG000|Open-Label Study|Death|0|||
126298553|NCT00122382|454380227|FG001|Open-Label Study|Death|0|||
126298554|NCT00122382|454380228|FG002|Open-Label Study|Death|2|||
126298555|NCT00122382|454380226|FG000|Open-Label Study|Lack of Efficacy|0|||
126298556|NCT00122382|454380227|FG001|Open-Label Study|Lack of Efficacy|0|||
126298557|NCT00122382|454380228|FG002|Open-Label Study|Lack of Efficacy|3|||
126298558|NCT00122382|454380226|FG000|Open-Label Study|Lost to Follow-up|0|||
126298559|NCT00122382|454380227|FG001|Open-Label Study|Lost to Follow-up|0|||
126298560|NCT00122382|454380228|FG002|Open-Label Study|Lost to Follow-up|3|||
126298561|NCT00122382|454380226|FG000|Open-Label Study|Pregnancy|0|||
126298562|NCT00122382|454380227|FG001|Open-Label Study|Pregnancy|0|||
126298563|NCT00122382|454380228|FG002|Open-Label Study|Pregnancy|2|||
126298564|NCT00122382|454380226|FG000|Open-Label Study|Poor/Non-Compliance|0|||
126298565|NCT00122382|454380227|FG001|Open-Label Study|Poor/Non-Compliance|0|||
126298566|NCT00122382|454380228|FG002|Open-Label Study|Poor/Non-Compliance|1|||
126298567|NCT00122382|454380226|FG000|Open-Label Study|Withdrawal of Consent|0|||
126298568|NCT00122382|454380227|FG001|Open-Label Study|Withdrawal of Consent|0|||
126298569|NCT00122382|454380228|FG002|Open-Label Study|Withdrawal of Consent|4|||
126298570|NCT02040805|454380229|FG000|Overall Study|Lost to Follow-up|14|||
126298571|NCT02040805|454380230|FG001|Overall Study|Lost to Follow-up|9|||
126298572|NCT02040805|454380229|FG000|Overall Study|Withdrawal by Subject|28|||
126298573|NCT02040805|454380230|FG001|Overall Study|Withdrawal by Subject|41|||
126298574|NCT01213966|454380232|FG000|Overall Study|Protocol Violation|1|||
126298575|NCT01213966|454380233|FG001|Overall Study|Protocol Violation|0|||
126298576|NCT01213966|454380234|FG002|Overall Study|Protocol Violation|3|||
126298577|NCT01213966|454380235|FG003|Overall Study|Protocol Violation|1|||
126298578|NCT03591874|454380236|FG000|Overall Study|Adverse Event|4|||
126298579|NCT03591874|454380237|FG001|Overall Study|Adverse Event|0|||
126298580|NCT03591874|454380236|FG000|Overall Study|Withdrawal by Subject|2|||
126298581|NCT03591874|454380237|FG001|Overall Study|Withdrawal by Subject|1|||
126298582|NCT03591874|454380236|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
126298583|NCT03591874|454380237|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
126298584|NCT03591874|454380236|FG000|Overall Study|On Study at Time of Study Termination|12|||
126298585|NCT03591874|454380237|FG001|Overall Study|On Study at Time of Study Termination|6|||
126298586|NCT03644342|454380240|FG000|Overall Study|Adverse Event|2|||
126298587|NCT03644342|454380241|FG001|Overall Study|Adverse Event|0|||
126298588|NCT03644342|454380240|FG000|Overall Study|Protocol Violation|0|||
126298589|NCT03644342|454380241|FG001|Overall Study|Protocol Violation|1|||
126298590|NCT04762160|454380244|FG000|Overall Study|Study terminated early due to business reasons|5|||
126298591|NCT03655405|454380247|FG000|Overall Study|Death after initial data collection|4|||
126298592|NCT03655405|454380248|FG001|Overall Study|Death after initial data collection|2|||
126298593|NCT03655405|454380247|FG000|Overall Study|Died before initial data collection|1|||
126298594|NCT03655405|454380248|FG001|Overall Study|Died before initial data collection|2|||
126461289|NCT04761627|454989510|FG000|Run-in Period|Adverse Event|6|||
126461290|NCT04761627|454989511|FG001|Run-in Period|Adverse Event|0|||
126712145|NCT01208181|455897605|FG000|Part 2|Withdrawal by Subject|0|||
126298595|NCT03655405|454380247|FG000|Overall Study|Protocol Violation|0|||
126298596|NCT03655405|454380248|FG001|Overall Study|Protocol Violation|1|||
126298597|NCT01991743|454380251|FG000|Overall Study|external cephalic version not performed|0|||
126298598|NCT01991743|454380252|FG001|Overall Study|external cephalic version not performed|0|||
126298599|NCT01991743|454380253|FG002|Overall Study|external cephalic version not performed|1|||
126298600|NCT01991743|454380254|FG003|Overall Study|external cephalic version not performed|0|||
126298601|NCT02859337|454380255|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
126298602|NCT02859337|454380256|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
126298603|NCT02859337|454380257|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
126298604|NCT02859337|454380255|FG000|Overall Study|Withdrawal by Subject|3|||
126298605|NCT02859337|454380256|FG001|Overall Study|Withdrawal by Subject|1|||
126298606|NCT02859337|454380257|FG002|Overall Study|Withdrawal by Subject|0|||
126298607|NCT02859337|454380255|FG000|Overall Study|Lost to Follow-up|1|||
126298608|NCT02859337|454380256|FG001|Overall Study|Lost to Follow-up|0|||
126298609|NCT02859337|454380257|FG002|Overall Study|Lost to Follow-up|0|||
126298610|NCT01445730|454380258|FG000|Overall Study|Adverse Event|1|||
126298611|NCT01445730|454380258|FG000|Overall Study|For the advice of a dentist|1|||
126298612|NCT01445730|454380258|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
126298613|NCT01167140|454380259|FG000|Overall Study|Withdrawal by Subject|1|||
126298614|NCT04390113|454380264|FG000|Overall Study|Not Treated|0|||
126298615|NCT04390113|454380265|FG001|Overall Study|Not Treated|1|||
126298616|NCT04390113|454380264|FG000|Overall Study|Adverse Event|1|||
126298617|NCT04390113|454380265|FG001|Overall Study|Adverse Event|0|||
126298618|NCT04390113|454380264|FG000|Overall Study|Death|2|||
126298619|NCT04390113|454380265|FG001|Overall Study|Death|1|||
126298620|NCT04390113|454380264|FG000|Overall Study|Physician Decision|1|||
126298621|NCT04390113|454380265|FG001|Overall Study|Physician Decision|3|||
126298622|NCT04390113|454380264|FG000|Overall Study|Study Terminated by Sponsor|5|||
126298623|NCT04390113|454380265|FG001|Overall Study|Study Terminated by Sponsor|3|||
126298624|NCT04390113|454380264|FG000|Overall Study|Withdrawal by Subject|10|||
126298625|NCT04390113|454380265|FG001|Overall Study|Withdrawal by Subject|5|||
126298626|NCT04390113|454380264|FG000|Overall Study|Other|1|||
126298627|NCT04390113|454380265|FG001|Overall Study|Other|0|||
126298628|NCT04390113|454380264|FG000|Overall Study|Missing|0|||
126298629|NCT04390113|454380265|FG001|Overall Study|Missing|1|||
126298630|NCT00030901|454380268|FG000|Initial Registration|Ineligible|167|||
126298631|NCT00030901|454380269|FG001|Initial Registration|Ineligible|0|||
126298632|NCT00030901|454380270|FG002|Initial Registration|Ineligible|0|||
126298633|NCT00030901|454380268|FG000|Randomization|Adverse Event|0|||
126298634|NCT00030901|454380269|FG001|Randomization|Adverse Event|11|||
126298635|NCT00030901|454380270|FG002|Randomization|Adverse Event|7|||
126298636|NCT00030901|454380268|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
126298637|NCT00030901|454380269|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
126298638|NCT00030901|454380270|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
126298639|NCT00030901|454380268|FG000|Randomization|Progression/Relapse|0|||
126298640|NCT00030901|454380269|FG001|Randomization|Progression/Relapse|22|||
126298641|NCT00030901|454380270|FG002|Randomization|Progression/Relapse|21|||
126298642|NCT00030901|454380268|FG000|Randomization|Death|0|||
126298643|NCT00030901|454380269|FG001|Randomization|Death|1|||
126298644|NCT00030901|454380270|FG002|Randomization|Death|3|||
126298645|NCT00030901|454380268|FG000|Randomization|Other|0|||
126298646|NCT00030901|454380269|FG001|Randomization|Other|36|||
126298647|NCT00030901|454380270|FG002|Randomization|Other|33|||
126298648|NCT00030901|454380268|FG000|Randomization|Ineligible|0|||
126298649|NCT00030901|454380269|FG001|Randomization|Ineligible|15|||
126298650|NCT00030901|454380270|FG002|Randomization|Ineligible|14|||
126298651|NCT02576847|454380271|FG000|Overall Study|Adverse Event|27|||
126461291|NCT04761627|454989512|FG002|Run-in Period|Adverse Event|0|||
126461292|NCT04761627|454989510|FG000|Run-in Period|Withdrawal by Subject|7|||
126461293|NCT04761627|454989511|FG001|Run-in Period|Withdrawal by Subject|0|||
126461294|NCT04761627|454989512|FG002|Run-in Period|Withdrawal by Subject|0|||
126461295|NCT04761627|454989510|FG000|Run-in Period|Did not meet PASI 50|15|||
126461296|NCT04761627|454989511|FG001|Run-in Period|Did not meet PASI 50|0|||
126298652|NCT02576847|454380271|FG000|Overall Study|Lost to Follow-up|22|||
126298653|NCT02576847|454380271|FG000|Overall Study|Physician Decision|1|||
126298654|NCT02576847|454380271|FG000|Overall Study|Pregnancy|1|||
126298655|NCT02576847|454380271|FG000|Overall Study|Protocol Violation|3|||
126298656|NCT02576847|454380271|FG000|Overall Study|Withdrawal by Subject|78|||
126298657|NCT02576847|454380271|FG000|Overall Study|Other|5|||
126298658|NCT01806051|454380272|FG000|Overall Study|Withdrawal by Subject|6|||
126298659|NCT01205776|454380273|FG000|Overall Study|Lost to Follow-up|53|||
126298660|NCT01205776|454380274|FG001|Overall Study|Lost to Follow-up|61|||
126298661|NCT01205776|454380273|FG000|Overall Study|Withdrawal by Subject|11|||
126298662|NCT01205776|454380274|FG001|Overall Study|Withdrawal by Subject|34|||
126298663|NCT00734994|454380277|FG000|Overall Study|Withdrawal by Subject|1|||
126298664|NCT03817190|454380278|FG000|Overall Study|Early Termination|13|||
126461297|NCT04761627|454989512|FG002|Run-in Period|Did not meet PASI 50|0|||
126461298|NCT04761627|454989510|FG000|Run-in Period|Study site closure|2|||
126461299|NCT04761627|454989511|FG001|Run-in Period|Study site closure|0|||
126461300|NCT04761627|454989512|FG002|Run-in Period|Study site closure|0|||
126298665|NCT03817190|454380279|FG001|Overall Study|Early Termination|20|||
126298666|NCT03817190|454380278|FG000|Overall Study|Adverse Event|10|||
126298667|NCT03817190|454380279|FG001|Overall Study|Adverse Event|17|||
126298668|NCT03817190|454380278|FG000|Overall Study|Withdrawal by Subject|12|||
126298669|NCT03817190|454380279|FG001|Overall Study|Withdrawal by Subject|8|||
126298670|NCT03817190|454380278|FG000|Overall Study|Lost to Follow-up|11|||
126298671|NCT03817190|454380279|FG001|Overall Study|Lost to Follow-up|7|||
126298672|NCT03817190|454380278|FG000|Overall Study|Lack of Efficacy|7|||
126298673|NCT03817190|454380279|FG001|Overall Study|Lack of Efficacy|5|||
126298674|NCT03817190|454380278|FG000|Overall Study|Investigator Decision|5|||
126298675|NCT03817190|454380279|FG001|Overall Study|Investigator Decision|1|||
126298676|NCT03817190|454380278|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
126298677|NCT03817190|454380279|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
126298678|NCT03817190|454380278|FG000|Overall Study|Lack of Contact|1|||
126298679|NCT03817190|454380279|FG001|Overall Study|Lack of Contact|0|||
126298680|NCT03817190|454380278|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
126298681|NCT03817190|454380279|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
126298682|NCT00437021|454380872|FG000|Overall Study|Adverse Event|0|||
126298683|NCT00437021|454380873|FG001|Overall Study|Adverse Event|0|||
126298684|NCT00437021|454380874|FG002|Overall Study|Adverse Event|0|||
126298685|NCT00437021|454380875|FG003|Overall Study|Adverse Event|0|||
126298686|NCT00437021|454380876|FG004|Overall Study|Adverse Event|0|||
126298687|NCT00437021|454380877|FG005|Overall Study|Adverse Event|0|||
126298688|NCT00437021|454380878|FG006|Overall Study|Adverse Event|1|||
126298689|NCT00437021|454380879|FG007|Overall Study|Adverse Event|0|||
126298690|NCT00437021|454380880|FG008|Overall Study|Adverse Event|0|||
126298691|NCT00437021|454380881|FG009|Overall Study|Adverse Event|0|||
126298692|NCT00437021|454380882|FG010|Overall Study|Adverse Event|0|||
126298693|NCT00437021|454380883|FG011|Overall Study|Adverse Event|0|||
126298694|NCT00437021|454380872|FG000|Overall Study|Lost to Follow-up|0|||
126298695|NCT00437021|454380873|FG001|Overall Study|Lost to Follow-up|3|||
126298696|NCT00437021|454380874|FG002|Overall Study|Lost to Follow-up|0|||
126298697|NCT00437021|454380875|FG003|Overall Study|Lost to Follow-up|0|||
126298698|NCT00437021|454380876|FG004|Overall Study|Lost to Follow-up|0|||
126298699|NCT00437021|454380877|FG005|Overall Study|Lost to Follow-up|2|||
126298700|NCT00437021|454380878|FG006|Overall Study|Lost to Follow-up|0|||
126298701|NCT00437021|454380879|FG007|Overall Study|Lost to Follow-up|1|||
126298702|NCT00437021|454380880|FG008|Overall Study|Lost to Follow-up|0|||
126298703|NCT00437021|454380881|FG009|Overall Study|Lost to Follow-up|0|||
126298704|NCT00437021|454380882|FG010|Overall Study|Lost to Follow-up|0|||
126298705|NCT00437021|454380883|FG011|Overall Study|Lost to Follow-up|0|||
126298706|NCT00437021|454380872|FG000|Overall Study|Withdrawal by Subject|2|||
126298707|NCT00437021|454380873|FG001|Overall Study|Withdrawal by Subject|1|||
126298708|NCT00437021|454380874|FG002|Overall Study|Withdrawal by Subject|0|||
126298709|NCT00437021|454380875|FG003|Overall Study|Withdrawal by Subject|0|||
126298710|NCT00437021|454380876|FG004|Overall Study|Withdrawal by Subject|0|||
126298711|NCT00437021|454380877|FG005|Overall Study|Withdrawal by Subject|0|||
126298712|NCT00437021|454380878|FG006|Overall Study|Withdrawal by Subject|0|||
126298713|NCT00437021|454380879|FG007|Overall Study|Withdrawal by Subject|0|||
126298714|NCT00437021|454380880|FG008|Overall Study|Withdrawal by Subject|0|||
126298715|NCT00437021|454380881|FG009|Overall Study|Withdrawal by Subject|0|||
126298716|NCT00437021|454380882|FG010|Overall Study|Withdrawal by Subject|0|||
126298717|NCT00437021|454380883|FG011|Overall Study|Withdrawal by Subject|0|||
126298718|NCT05573464|454380884|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
126298719|NCT05573464|454380885|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
126712146|NCT01208181|455897606|FG001|Part 2|Withdrawal by Subject|0|||
126298720|NCT05573464|454380884|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
126298721|NCT05573464|454380885|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
126298722|NCT05573464|454380884|FG000|12-week Treatment Period|Protocol Violation|3|||
126298723|NCT05573464|454380885|FG001|12-week Treatment Period|Protocol Violation|1|||
126298724|NCT05573464|454380884|FG000|12-week Treatment Period|Physician Decision|1|||
126712147|NCT01208181|455897607|FG002|Part 2|Withdrawal by Subject|1|||
126298725|NCT05573464|454380885|FG001|12-week Treatment Period|Physician Decision|2|||
126298726|NCT05573464|454380884|FG000|12-week Treatment Period|Lost to Follow-up|2|||
126298727|NCT05573464|454380885|FG001|12-week Treatment Period|Lost to Follow-up|0|||
126298728|NCT05573464|454380884|FG000|12-week Treatment Period|Adverse Event|20|||
126298729|NCT05573464|454380885|FG001|12-week Treatment Period|Adverse Event|9|||
126298730|NCT05573464|454380884|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
126298731|NCT05573464|454380885|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
126298732|NCT05573464|454380884|FG000|12-week Treatment Period|Randomised, not treated|0|||
126712148|NCT01208181|455897608|FG003|Part 2|Withdrawal by Subject|1|||
126712149|NCT01208181|455897609|FG004|Part 2|Withdrawal by Subject|0|||
126367089|NCT00522379|454639404|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
126367090|NCT00522379|454639405|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
126367091|NCT00522379|454639406|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
126367092|NCT00522379|454639407|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
126367093|NCT00522379|454639408|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
126367094|NCT00522379|454639404|FG000|Overall Study|Lost to Follow-up|1|||
126367095|NCT00522379|454639405|FG001|Overall Study|Lost to Follow-up|0|||
126367096|NCT00522379|454639406|FG002|Overall Study|Lost to Follow-up|4|||
126367097|NCT00522379|454639407|FG003|Overall Study|Lost to Follow-up|2|||
126367098|NCT00522379|454639408|FG004|Overall Study|Lost to Follow-up|2|||
126367099|NCT00522379|454639404|FG000|Overall Study|Randomization error|0|||
126367100|NCT00522379|454639405|FG001|Overall Study|Randomization error|0|||
126367101|NCT00522379|454639406|FG002|Overall Study|Randomization error|0|||
126367102|NCT00522379|454639407|FG003|Overall Study|Randomization error|0|||
126367103|NCT00522379|454639408|FG004|Overall Study|Randomization error|1|||
126367104|NCT00522379|454639404|FG000|Overall Study|Dispensing error|1|||
126367105|NCT00522379|454639405|FG001|Overall Study|Dispensing error|0|||
126367106|NCT00522379|454639406|FG002|Overall Study|Dispensing error|0|||
126367107|NCT00522379|454639407|FG003|Overall Study|Dispensing error|1|||
126367108|NCT00522379|454639408|FG004|Overall Study|Dispensing error|0|||
126367109|NCT00522379|454639404|FG000|Overall Study|Subject Moved|1|||
126367110|NCT00522379|454639405|FG001|Overall Study|Subject Moved|1|||
126367111|NCT00522379|454639406|FG002|Overall Study|Subject Moved|0|||
126367112|NCT00522379|454639407|FG003|Overall Study|Subject Moved|0|||
126367113|NCT00522379|454639408|FG004|Overall Study|Subject Moved|0|||
126367114|NCT00522379|454639404|FG000|Overall Study|Sponsor Request|0|||
126367115|NCT00522379|454639405|FG001|Overall Study|Sponsor Request|1|||
126367116|NCT00522379|454639406|FG002|Overall Study|Sponsor Request|0|||
126367117|NCT00522379|454639407|FG003|Overall Study|Sponsor Request|0|||
126367118|NCT00522379|454639408|FG004|Overall Study|Sponsor Request|0|||
126367119|NCT00522379|454639404|FG000|Overall Study|Family Problem|0|||
126367120|NCT00522379|454639405|FG001|Overall Study|Family Problem|0|||
126367121|NCT00522379|454639406|FG002|Overall Study|Family Problem|1|||
126367122|NCT00522379|454639407|FG003|Overall Study|Family Problem|0|||
126367123|NCT00522379|454639408|FG004|Overall Study|Family Problem|0|||
126367124|NCT00522379|454639404|FG000|Overall Study|Site Closed|0|||
126367125|NCT00522379|454639405|FG001|Overall Study|Site Closed|0|||
126367126|NCT00522379|454639406|FG002|Overall Study|Site Closed|0|||
126367127|NCT00522379|454639407|FG003|Overall Study|Site Closed|1|||
126367128|NCT00522379|454639408|FG004|Overall Study|Site Closed|0|||
126367129|NCT00522379|454639404|FG000|Overall Study|Subject Withdrawal|0|||
126367130|NCT00522379|454639405|FG001|Overall Study|Subject Withdrawal|0|||
126367131|NCT00522379|454639406|FG002|Overall Study|Subject Withdrawal|0|||
126367132|NCT00522379|454639407|FG003|Overall Study|Subject Withdrawal|1|||
126367133|NCT00522379|454639408|FG004|Overall Study|Subject Withdrawal|0|||
126367134|NCT00967499|454639413|FG000|Overall Study|Adverse Event|0|||
126367135|NCT00967499|454639414|FG001|Overall Study|Adverse Event|1|||
126367136|NCT00967499|454639413|FG000|Overall Study|Protocol Violation|1|||
126367137|NCT00967499|454639414|FG001|Overall Study|Protocol Violation|0|||
126367138|NCT00967499|454639413|FG000|Overall Study|Sponsor Decision|1|||
126367139|NCT00967499|454639414|FG001|Overall Study|Sponsor Decision|0|||
126367140|NCT00967499|454639413|FG000|Overall Study|Randomized but not treated|63|||
126367141|NCT00967499|454639414|FG001|Overall Study|Randomized but not treated|59|||
126367142|NCT02607722|454639416|FG000|Overall Study|No data reliability|1|||
126367143|NCT02607722|454639416|FG000|Overall Study|no patient visit|18|||
126367144|NCT02607722|454639416|FG000|Overall Study|missing info in CRF|13|||
126367145|NCT02607722|454639416|FG000|Overall Study|Withdrawal by Subject|616|||
126367146|NCT02607722|454639416|FG000|Overall Study|Lost to Follow-up|312|||
126367147|NCT02607722|454639416|FG000|Overall Study|Improved|22|||
126367148|NCT02607722|454639416|FG000|Overall Study|Lack of Efficacy|316|||
126367149|NCT02607722|454639416|FG000|Overall Study|Adverse Event|2553|||
126367150|NCT02607722|454639416|FG000|Overall Study|Not treated|1|||
126367151|NCT02607722|454639416|FG000|Overall Study|No CRF collected|138|||
126367152|NCT02607722|454639416|FG000|Overall Study|without CRF|4225|||
126367153|NCT02607722|454639416|FG000|Overall Study|Physician Decision|367|||
126367154|NCT04562090|454639417|FG000|Overall Study|Withdrawal by Subject|3|||
126367155|NCT04562090|454639418|FG001|Overall Study|Withdrawal by Subject|4|||
126367156|NCT04562090|454639417|FG000|Overall Study|Protocol Violation|2|||
126367157|NCT04562090|454639418|FG001|Overall Study|Protocol Violation|0|||
126367158|NCT04562090|454639417|FG000|Overall Study|Lack of Efficacy|0|||
126367159|NCT04562090|454639418|FG001|Overall Study|Lack of Efficacy|1|||
126367160|NCT04562090|454639417|FG000|Overall Study|Adverse Event|1|||
126367161|NCT04562090|454639418|FG001|Overall Study|Adverse Event|4|||
126367162|NCT04562090|454639417|FG000|Overall Study|Miscellaneous|0|||
126367163|NCT04562090|454639418|FG001|Overall Study|Miscellaneous|3|||
126367164|NCT03633058|454639419|FG000|Overall Study|Adverse Event|0|||
126367165|NCT03633058|454639420|FG001|Overall Study|Adverse Event|0|||
126367166|NCT03633058|454639421|FG002|Overall Study|Adverse Event|1|||
126367167|NCT03633058|454639422|FG003|Overall Study|Adverse Event|0|||
126367168|NCT03034044|454639423|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
126461301|NCT04761627|454989510|FG000|Run-in Period|Pregnancy|2|||
126298733|NCT05573464|454380885|FG001|12-week Treatment Period|Randomised, not treated|1|||
126298734|NCT05573464|454380884|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
126298735|NCT05573464|454380885|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
126298736|NCT05573464|454380884|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
126298737|NCT05573464|454380885|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
126298738|NCT05573464|454380884|FG000|52-week Treatment Period|Protocol Violation|1|||
126298739|NCT05573464|454380885|FG001|52-week Treatment Period|Protocol Violation|1|||
126298740|NCT05573464|454380884|FG000|52-week Treatment Period|Physician Decision|2|||
126298741|NCT05573464|454380885|FG001|52-week Treatment Period|Physician Decision|2|||
126298742|NCT05573464|454380884|FG000|52-week Treatment Period|Lost to Follow-up|1|||
126298743|NCT05573464|454380885|FG001|52-week Treatment Period|Lost to Follow-up|1|||
126298744|NCT05573464|454380884|FG000|52-week Treatment Period|Adverse Event|11|||
126298745|NCT05573464|454380885|FG001|52-week Treatment Period|Adverse Event|8|||
126298746|NCT05573464|454380884|FG000|52-week Treatment Period|Death|1|||
126298747|NCT05573464|454380885|FG001|52-week Treatment Period|Death|1|||
126298748|NCT05734157|454380886|FG000|Overall Study|Death|3|||
126298749|NCT05734157|454380886|FG000|Overall Study|Withdrawal by Subject|2|||
126298750|NCT05734157|454380886|FG000|Overall Study|Lost to Follow-up|1|||
126298751|NCT05734157|454380886|FG000|Overall Study|Telephone call|3|||
126298752|NCT01611935|454380887|FG000|Overall Study|Family Declined Participation|1|||
126298753|NCT01611935|454380888|FG001|Overall Study|Family Declined Participation|0|||
126298754|NCT03817853|454380892|FG000|Induction Phase|Adverse Event|5|||
126298755|NCT03817853|454380893|FG001|Induction Phase|Adverse Event|0|||
126298756|NCT03817853|454380894|FG002|Induction Phase|Adverse Event|0|||
126298757|NCT03817853|454380892|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
126298758|NCT03817853|454380893|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
126298759|NCT03817853|454380894|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
126298760|NCT03817853|454380892|FG000|Induction Phase|Physician Decision|2|||
126298761|NCT03817853|454380893|FG001|Induction Phase|Physician Decision|0|||
126298762|NCT03817853|454380894|FG002|Induction Phase|Physician Decision|0|||
126298763|NCT03817853|454380892|FG000|Induction Phase|Progressive Disease|6|||
126298764|NCT03817853|454380893|FG001|Induction Phase|Progressive Disease|0|||
126298765|NCT03817853|454380894|FG002|Induction Phase|Progressive Disease|0|||
126298766|NCT03817853|454380892|FG000|Induction Phase|Withdrawal by Subject|4|||
126298767|NCT03817853|454380893|FG001|Induction Phase|Withdrawal by Subject|0|||
126298768|NCT03817853|454380894|FG002|Induction Phase|Withdrawal by Subject|0|||
126298769|NCT03817853|454380892|FG000|Maintenance Phase|Adverse Event|0|||
126298770|NCT03817853|454380893|FG001|Maintenance Phase|Adverse Event|8|||
126298771|NCT03817853|454380894|FG002|Maintenance Phase|Adverse Event|0|||
126298772|NCT03817853|454380892|FG000|Maintenance Phase|Death|0|||
126298773|NCT03817853|454380893|FG001|Maintenance Phase|Death|5|||
126298774|NCT03817853|454380894|FG002|Maintenance Phase|Death|0|||
126298775|NCT03817853|454380892|FG000|Maintenance Phase|Progressive Disease|0|||
126298776|NCT03817853|454380893|FG001|Maintenance Phase|Progressive Disease|7|||
126298777|NCT03817853|454380894|FG002|Maintenance Phase|Progressive Disease|0|||
126298778|NCT03817853|454380892|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126298779|NCT03817853|454380893|FG001|Maintenance Phase|Withdrawal by Subject|2|||
126298780|NCT03817853|454380894|FG002|Maintenance Phase|Withdrawal by Subject|0|||
126298781|NCT03817853|454380892|FG000|Maintenance Phase|Physician Decision|0|||
126298782|NCT03817853|454380893|FG001|Maintenance Phase|Physician Decision|1|||
126298783|NCT03817853|454380894|FG002|Maintenance Phase|Physician Decision|0|||
126298784|NCT03817853|454380892|FG000|Maintenance Phase|Various reasons|0|||
126298785|NCT03817853|454380893|FG001|Maintenance Phase|Various reasons|4|||
126298786|NCT03817853|454380894|FG002|Maintenance Phase|Various reasons|0|||
126298787|NCT03817853|454380892|FG000|Maintenance Phase|Protocol Deviation|0|||
126298788|NCT03817853|454380893|FG001|Maintenance Phase|Protocol Deviation|1|||
126298789|NCT03817853|454380894|FG002|Maintenance Phase|Protocol Deviation|0|||
126298790|NCT03817853|454380892|FG000|Follow-up Phase|Adverse Event|0|||
126298791|NCT03817853|454380893|FG001|Follow-up Phase|Adverse Event|0|||
126298792|NCT03817853|454380894|FG002|Follow-up Phase|Adverse Event|2|||
126298793|NCT03817853|454380892|FG000|Follow-up Phase|Death|0|||
126298794|NCT03817853|454380893|FG001|Follow-up Phase|Death|0|||
126298795|NCT03817853|454380894|FG002|Follow-up Phase|Death|1|||
126298796|NCT03817853|454380892|FG000|Follow-up Phase|Progressive Disease|0|||
126298797|NCT03817853|454380893|FG001|Follow-up Phase|Progressive Disease|0|||
126461302|NCT04761627|454989511|FG001|Run-in Period|Pregnancy|0|||
126461303|NCT04761627|454989512|FG002|Run-in Period|Pregnancy|0|||
126461304|NCT04761627|454989510|FG000|Post-randomization Period|Military service|0|||
126298798|NCT03817853|454380894|FG002|Follow-up Phase|Progressive Disease|3|||
126298799|NCT03817853|454380892|FG000|Follow-up Phase|Withdrawal by Subject|0|||
126298800|NCT03817853|454380893|FG001|Follow-up Phase|Withdrawal by Subject|0|||
126298801|NCT03817853|454380894|FG002|Follow-up Phase|Withdrawal by Subject|1|||
126298802|NCT00314340|454380895|FG000|Overall Study|lost interest|1|||
126461305|NCT04761627|454989511|FG001|Post-randomization Period|Military service|1|||
126461306|NCT04761627|454989512|FG002|Post-randomization Period|Military service|0|||
126461307|NCT04761627|454989510|FG000|Post-randomization Period|Adverse Event|0|||
126461308|NCT04761627|454989511|FG001|Post-randomization Period|Adverse Event|4|||
126461309|NCT04761627|454989512|FG002|Post-randomization Period|Adverse Event|2|||
126461310|NCT04761627|454989510|FG000|Post-randomization Period|Lost to Follow-up|0|||
126461311|NCT04761627|454989511|FG001|Post-randomization Period|Lost to Follow-up|6|||
126712150|NCT01208181|455897605|FG000|Part 2|Protocol Violation|0|||
126298803|NCT01620138|454380898|FG000|Overall Study|Withdrawal by Subject|3|||
126298804|NCT01620138|454380899|FG001|Overall Study|Withdrawal by Subject|0|||
126298805|NCT01620138|454380898|FG000|Overall Study|Lack of Efficacy|1|||
126298806|NCT01620138|454380899|FG001|Overall Study|Lack of Efficacy|0|||
126298807|NCT01620138|454380898|FG000|Overall Study|Adverse Event|2|||
126298808|NCT01620138|454380899|FG001|Overall Study|Adverse Event|0|||
126298809|NCT03252535|454380900|FG000|Overall Study|Withdrawal by Subject|1|||
126298810|NCT03252535|454380901|FG001|Overall Study|Withdrawal by Subject|0|||
126298811|NCT03252535|454380902|FG002|Overall Study|Withdrawal by Subject|0|||
126298812|NCT03252535|454380900|FG000|Overall Study|Physician Decision|0|||
126298813|NCT03252535|454380901|FG001|Overall Study|Physician Decision|1|||
126298814|NCT03252535|454380902|FG002|Overall Study|Physician Decision|0|||
126298815|NCT03252535|454380900|FG000|Overall Study|Met discontinuation criteria|0|||
126298816|NCT03252535|454380901|FG001|Overall Study|Met discontinuation criteria|1|||
126298817|NCT03252535|454380902|FG002|Overall Study|Met discontinuation criteria|0|||
126298818|NCT05600283|454380903|FG000|Overall Study|Withdrawal by Subject|3|||
126298819|NCT05600283|454380904|FG001|Overall Study|Withdrawal by Subject|8|||
126298820|NCT05600283|454380903|FG000|Overall Study|invalid individual swab|1|||
126298821|NCT05600283|454380904|FG001|Overall Study|invalid individual swab|0|||
126298822|NCT05600283|454380903|FG000|Overall Study|missing clinician collection|3|||
126298823|NCT05600283|454380904|FG001|Overall Study|missing clinician collection|0|||
126298824|NCT05600283|454380903|FG000|Overall Study|screening failure|0|||
126298825|NCT05600283|454380904|FG001|Overall Study|screening failure|2|||
126298826|NCT03907488|454380905|FG000|Overall Study|Adverse Event|20|||
126298827|NCT03907488|454380906|FG001|Overall Study|Adverse Event|20|||
126298828|NCT03907488|454380905|FG000|Overall Study|Withdrawal by Subject|9|||
126298829|NCT03907488|454380906|FG001|Overall Study|Withdrawal by Subject|13|||
126298830|NCT03907488|454380905|FG000|Overall Study|Lack of Efficacy|0|||
126298831|NCT03907488|454380906|FG001|Overall Study|Lack of Efficacy|9|||
126298832|NCT03907488|454380905|FG000|Overall Study|Death|3|||
126298833|NCT03907488|454380906|FG001|Overall Study|Death|8|||
126298834|NCT03907488|454380905|FG000|Overall Study|not protocol specified|5|||
126298835|NCT03907488|454380906|FG001|Overall Study|not protocol specified|8|||
126298836|NCT03907488|454380905|FG000|Overall Study|Ineligible|9|||
126298837|NCT03907488|454380906|FG001|Overall Study|Ineligible|15|||
126298838|NCT02269098|454380907|FG000|Overall Study|Lost to Follow-up|14|||
126298839|NCT02269098|454380908|FG001|Overall Study|Lost to Follow-up|9|||
126298840|NCT03194542|454380911|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
126298841|NCT03194542|454380912|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
126298842|NCT03194542|454380913|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
126298843|NCT03194542|454380914|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
126298844|NCT03194542|454380911|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
126298845|NCT03194542|454380912|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
126298846|NCT03194542|454380913|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
126298847|NCT03194542|454380914|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
126298848|NCT03194542|454380911|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
126298849|NCT03194542|454380912|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
126298850|NCT03194542|454380913|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
126461312|NCT04761627|454989512|FG002|Post-randomization Period|Lost to Follow-up|6|||
126461313|NCT04761627|454989510|FG000|Post-randomization Period|Withdrawal by Subject|0|||
126461314|NCT04761627|454989511|FG001|Post-randomization Period|Withdrawal by Subject|7|||
126461315|NCT04761627|454989512|FG002|Post-randomization Period|Withdrawal by Subject|6|||
126712151|NCT01208181|455897606|FG001|Part 2|Protocol Violation|0|||
126712152|NCT01208181|455897607|FG002|Part 2|Protocol Violation|1|||
126461316|NCT04761627|454989510|FG000|Post-randomization Period|Pregnancy|0|||
126461317|NCT04761627|454989511|FG001|Post-randomization Period|Pregnancy|0|||
126461318|NCT04761627|454989512|FG002|Post-randomization Period|Pregnancy|1|||
126461319|NCT04761627|454989510|FG000|Post-randomization Period|Study site closure|0|||
126298851|NCT03194542|454380914|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
126298852|NCT03194542|454380911|FG000|Overall Study|Loss of Response|4|||
126298853|NCT03194542|454380912|FG001|Overall Study|Loss of Response|2|||
126298854|NCT03194542|454380913|FG002|Overall Study|Loss of Response|3|||
126298855|NCT03194542|454380914|FG003|Overall Study|Loss of Response|4|||
126298856|NCT03194542|454380911|FG000|Overall Study|Physician Decision|0|||
126298857|NCT03194542|454380912|FG001|Overall Study|Physician Decision|1|||
126298858|NCT03194542|454380913|FG002|Overall Study|Physician Decision|0|||
126461320|NCT04761627|454989511|FG001|Post-randomization Period|Study site closure|0|||
126367169|NCT03312543|454639424|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
126367170|NCT03312543|454639425|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
126367171|NCT03312543|454639424|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
126367172|NCT03312543|454639425|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
126367173|NCT03312543|454639424|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
126367174|NCT03312543|454639425|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
126367175|NCT03312543|454639424|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
126367176|NCT03312543|454639425|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
126367177|NCT03312543|454639424|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
126367178|NCT03312543|454639425|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
126367179|NCT03312543|454639424|FG000|Regression (Week 12 to Week 24)|Death|0|||
126367180|NCT03312543|454639425|FG001|Regression (Week 12 to Week 24)|Death|1|||
126367181|NCT05535972|454639426|FG000|Overall Study|Withdrawal by Subject|31|||
126367182|NCT05535972|454639426|FG000|Overall Study|Lost to Follow-up|5|||
126367183|NCT05535972|454639426|FG000|Overall Study|Adverse Event|6|||
126367184|NCT05535972|454639426|FG000|Overall Study|Protocol Deviation|2|||
126367185|NCT02402647|454639429|FG000|Overall Study|Lost to Follow-up|13|||
126367186|NCT02402647|454639430|FG001|Overall Study|Lost to Follow-up|7|||
126769712|NCT03151226|456110415|FG000|Overall Study|Withdrawal by Subject|2|||
126769713|NCT03151226|456110415|FG000|Overall Study|not wear device correctly|1|||
126769714|NCT02304302|456110418|FG000|Overall Study|Adverse Event|2|||
126769715|NCT02304302|456110419|FG001|Overall Study|Adverse Event|3|||
126769716|NCT02304302|456110418|FG000|Overall Study|Lost to Follow-up|1|||
126769717|NCT02304302|456110419|FG001|Overall Study|Lost to Follow-up|4|||
126769718|NCT02304302|456110418|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
126769719|NCT02304302|456110419|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
126769720|NCT00391118|456110420|FG000|Overall Study|Adverse Event|3|||
126769721|NCT00391118|456110421|FG001|Overall Study|Adverse Event|10|||
126769722|NCT00391118|456110422|FG002|Overall Study|Adverse Event|7|||
126769723|NCT00391118|456110420|FG000|Overall Study|Lost to Follow-up|0|||
126769724|NCT00391118|456110421|FG001|Overall Study|Lost to Follow-up|2|||
126769725|NCT00391118|456110422|FG002|Overall Study|Lost to Follow-up|3|||
126769726|NCT00391118|456110420|FG000|Overall Study|Withdrawal by Subject|0|||
126769727|NCT00391118|456110421|FG001|Overall Study|Withdrawal by Subject|9|||
126769728|NCT00391118|456110422|FG002|Overall Study|Withdrawal by Subject|1|||
126769729|NCT00391118|456110420|FG000|Overall Study|Death|0|||
126769730|NCT00391118|456110421|FG001|Overall Study|Death|1|||
126769731|NCT00391118|456110422|FG002|Overall Study|Death|0|||
126769732|NCT00391118|456110420|FG000|Overall Study|Physician Decision|0|||
126769733|NCT00391118|456110421|FG001|Overall Study|Physician Decision|3|||
126769734|NCT00391118|456110422|FG002|Overall Study|Physician Decision|0|||
126367187|NCT02402647|454639429|FG000|Overall Study|Protocol Violation|1|||
126367188|NCT02402647|454639430|FG001|Overall Study|Protocol Violation|1|||
126367189|NCT02402647|454639429|FG000|Overall Study|scheduled and timed out|2|||
126367190|NCT02402647|454639430|FG001|Overall Study|scheduled and timed out|1|||
126367191|NCT02402647|454639429|FG000|Overall Study|medical illness|2|||
126367192|NCT02402647|454639430|FG001|Overall Study|medical illness|4|||
126367193|NCT02402647|454639429|FG000|Overall Study|Moved|2|||
126367194|NCT02402647|454639430|FG001|Overall Study|Moved|0|||
126367195|NCT02402647|454639429|FG000|Overall Study|loved one illness|1|||
126367196|NCT02402647|454639430|FG001|Overall Study|loved one illness|0|||
126367197|NCT02402647|454639429|FG000|Overall Study|deceased preexisting condition|2|||
126367198|NCT02402647|454639430|FG001|Overall Study|deceased preexisting condition|0|||
126367199|NCT02402647|454639429|FG000|Overall Study|Other|2|||
126367200|NCT02402647|454639430|FG001|Overall Study|Other|1|||
126367201|NCT04197583|454639431|FG000|Overall Study|Study Stent Replacement|34|||
126769735|NCT00391118|456110420|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
126769736|NCT00391118|456110421|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
126769737|NCT00391118|456110422|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
126769738|NCT00391118|456110420|FG000|Overall Study|Progressive Disease|7|||
126769739|NCT00391118|456110421|FG001|Overall Study|Progressive Disease|26|||
126769740|NCT00391118|456110422|FG002|Overall Study|Progressive Disease|43|||
126769741|NCT00391118|456110420|FG000|Overall Study|Sponsor Decision|0|||
126769742|NCT00391118|456110421|FG001|Overall Study|Sponsor Decision|1|||
126769743|NCT00391118|456110422|FG002|Overall Study|Sponsor Decision|3|||
126769744|NCT00391118|456110420|FG000|Overall Study|Protocol Violation|1|||
126769745|NCT00391118|456110421|FG001|Overall Study|Protocol Violation|0|||
126769746|NCT00391118|456110422|FG002|Overall Study|Protocol Violation|0|||
126769747|NCT03078192|456110424|FG000|Overall Study|Withdrawal by Subject|2|||
126769748|NCT03078192|456110425|FG001|Overall Study|Withdrawal by Subject|1|||
126769749|NCT03078192|456110424|FG000|Overall Study|screen failure|0|||
126769750|NCT03078192|456110425|FG001|Overall Study|screen failure|3|||
126367202|NCT04197583|454639432|FG001|Overall Study|Study Stent Replacement|8|||
126367203|NCT04197583|454639431|FG000|Overall Study|Lost to Follow-up|14|||
126367204|NCT04197583|454639432|FG001|Overall Study|Lost to Follow-up|3|||
126367205|NCT04197583|454639431|FG000|Overall Study|Death|3|||
126298859|NCT03194542|454380914|FG003|Overall Study|Physician Decision|0|||
126298860|NCT03194542|454380911|FG000|Overall Study|Lack of Efficacy|2|||
126298861|NCT03194542|454380912|FG001|Overall Study|Lack of Efficacy|2|||
126550223|NCT00358215|455309487|FG000|Overall Study|Did not receive investigational product|2|||
126550224|NCT00358215|455309488|FG001|Overall Study|Did not receive investigational product|3|||
126550225|NCT04329104|455309495|FG000|Efficacy Study|Withdrawal by Subject|0|||
126550226|NCT04329104|455309496|FG001|Efficacy Study|Withdrawal by Subject|0|||
126550227|NCT04329104|455309497|FG002|Efficacy Study|Withdrawal by Subject|0|||
126550228|NCT04329104|455309498|FG003|Efficacy Study|Withdrawal by Subject|5|||
126550229|NCT04329104|455309499|FG004|Efficacy Study|Withdrawal by Subject|6|||
126712153|NCT01208181|455897608|FG003|Part 2|Protocol Violation|0|||
126712154|NCT01208181|455897609|FG004|Part 2|Protocol Violation|0|||
126712155|NCT01208181|455897605|FG000|Part 2|Physician Decision|0|||
126298862|NCT03194542|454380913|FG002|Overall Study|Lack of Efficacy|2|||
126298863|NCT03194542|454380914|FG003|Overall Study|Lack of Efficacy|6|||
126298864|NCT03194542|454380911|FG000|Overall Study|Withdrawal by Subject|2|||
126298865|NCT03194542|454380912|FG001|Overall Study|Withdrawal by Subject|1|||
126298866|NCT03194542|454380913|FG002|Overall Study|Withdrawal by Subject|5|||
126298867|NCT03194542|454380914|FG003|Overall Study|Withdrawal by Subject|4|||
126298868|NCT03194542|454380911|FG000|Overall Study|Progressive Disease|1|||
126298869|NCT03194542|454380912|FG001|Overall Study|Progressive Disease|0|||
126298870|NCT03194542|454380913|FG002|Overall Study|Progressive Disease|1|||
126298871|NCT03194542|454380914|FG003|Overall Study|Progressive Disease|1|||
126298872|NCT03194542|454380911|FG000|Overall Study|Adverse Event|1|||
126298873|NCT03194542|454380912|FG001|Overall Study|Adverse Event|2|||
126298874|NCT03194542|454380913|FG002|Overall Study|Adverse Event|0|||
126298875|NCT03194542|454380914|FG003|Overall Study|Adverse Event|5|||
126298876|NCT03194542|454380911|FG000|Overall Study|Death|1|||
126298877|NCT03194542|454380912|FG001|Overall Study|Death|2|||
126712156|NCT01208181|455897606|FG001|Part 2|Physician Decision|0|||
126712157|NCT01208181|455897607|FG002|Part 2|Physician Decision|1|||
126712158|NCT01208181|455897608|FG003|Part 2|Physician Decision|2|||
126712159|NCT01208181|455897609|FG004|Part 2|Physician Decision|0|||
126712160|NCT01208181|455897605|FG000|Part 2|Non-compliance with study drug|0|||
126712161|NCT01208181|455897606|FG001|Part 2|Non-compliance with study drug|0|||
126712162|NCT01208181|455897607|FG002|Part 2|Non-compliance with study drug|1|||
126712163|NCT01208181|455897608|FG003|Part 2|Non-compliance with study drug|1|||
126712164|NCT01208181|455897609|FG004|Part 2|Non-compliance with study drug|0|||
126712165|NCT01208181|455897605|FG000|Part 2|Lost to Follow-up|0|||
126712166|NCT01208181|455897606|FG001|Part 2|Lost to Follow-up|0|||
126712167|NCT01208181|455897607|FG002|Part 2|Lost to Follow-up|1|||
126712168|NCT01208181|455897608|FG003|Part 2|Lost to Follow-up|2|||
126712169|NCT01208181|455897609|FG004|Part 2|Lost to Follow-up|0|||
126712170|NCT01208181|455897605|FG000|Part 2|Lack of Efficacy|0|||
126712171|NCT01208181|455897606|FG001|Part 2|Lack of Efficacy|0|||
126712172|NCT01208181|455897607|FG002|Part 2|Lack of Efficacy|5|||
126712173|NCT01208181|455897608|FG003|Part 2|Lack of Efficacy|7|||
126712174|NCT01208181|455897609|FG004|Part 2|Lack of Efficacy|0|||
126712175|NCT03694522|455897615|FG000|Overall Study|Withdrawal by Subject|8|||
126712176|NCT03694522|455897616|FG001|Overall Study|Withdrawal by Subject|10|||
126712177|NCT03694522|455897615|FG000|Overall Study|Physician Decision|53|||
126712178|NCT03694522|455897616|FG001|Overall Study|Physician Decision|54|||
126712179|NCT03694522|455897615|FG000|Overall Study|Other|1|||
126712180|NCT03694522|455897616|FG001|Overall Study|Other|1|||
126712181|NCT03694522|455897615|FG000|Overall Study|Lost to Follow-up|0|||
126712182|NCT03694522|455897616|FG001|Overall Study|Lost to Follow-up|1|||
126712183|NCT01748760|455897617|FG000|Overall Study|Withdrawal by Subject|1|||
126712184|NCT01748760|455897618|FG001|Overall Study|Withdrawal by Subject|1|||
126298878|NCT03194542|454380913|FG002|Overall Study|Death|0|||
126298879|NCT03194542|454380914|FG003|Overall Study|Death|5|||
126298880|NCT03194542|454380911|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
126298881|NCT03194542|454380912|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
126367206|NCT04197583|454639432|FG001|Overall Study|Death|0|||
126367207|NCT04197583|454639431|FG000|Overall Study|Physician Decision|1|||
126367208|NCT04197583|454639432|FG001|Overall Study|Physician Decision|0|||
126367209|NCT04197583|454639431|FG000|Overall Study|Withdrawal by Subject|1|||
126367210|NCT04197583|454639432|FG001|Overall Study|Withdrawal by Subject|1|||
126367211|NCT04197583|454639431|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
126367212|NCT04197583|454639432|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
126367213|NCT04197583|454639431|FG000|Overall Study|Screen Failure|0|||
126367214|NCT04197583|454639432|FG001|Overall Study|Screen Failure|20|||
126367215|NCT04134936|454639434|FG000|Overall Study|Adverse Event|3|||
126367216|NCT04134936|454639435|FG001|Overall Study|Adverse Event|2|||
126367217|NCT04134936|454639434|FG000|Overall Study|Withdrawal by Subject|2|||
126367218|NCT04134936|454639435|FG001|Overall Study|Withdrawal by Subject|3|||
126367219|NCT04134936|454639434|FG000|Overall Study|Physician Decision|0|||
126367220|NCT04134936|454639435|FG001|Overall Study|Physician Decision|1|||
126367221|NCT04134936|454639434|FG000|Overall Study|Progressive disease, joined another trial|1|||
126769751|NCT02508649|456110428|FG000|Overall Study|Withdrawal by Subject|4|||
126769752|NCT02508649|456110429|FG001|Overall Study|Withdrawal by Subject|6|||
126769753|NCT02508649|456110430|FG002|Overall Study|Withdrawal by Subject|5|||
126769754|NCT02508649|456110431|FG003|Overall Study|Withdrawal by Subject|6|||
126769755|NCT02508649|456110428|FG000|Overall Study|Investigator withdrew the subject|1|||
126769756|NCT02508649|456110429|FG001|Overall Study|Investigator withdrew the subject|2|||
126769757|NCT02508649|456110430|FG002|Overall Study|Investigator withdrew the subject|1|||
126769758|NCT02508649|456110431|FG003|Overall Study|Investigator withdrew the subject|0|||
126769759|NCT02508649|456110428|FG000|Overall Study|Post randomization screening failure|12|||
126769760|NCT02508649|456110429|FG001|Overall Study|Post randomization screening failure|4|||
126769761|NCT02508649|456110430|FG002|Overall Study|Post randomization screening failure|9|||
126769762|NCT02508649|456110431|FG003|Overall Study|Post randomization screening failure|3|||
126769763|NCT02508649|456110428|FG000|Overall Study|Lost to Follow-up|1|||
126769764|NCT02508649|456110429|FG001|Overall Study|Lost to Follow-up|1|||
126769765|NCT02508649|456110430|FG002|Overall Study|Lost to Follow-up|0|||
126769766|NCT02508649|456110431|FG003|Overall Study|Lost to Follow-up|1|||
126769767|NCT03594175|456110439|FG000|Overall Study|Not treated|8|||
126769768|NCT03594175|456110440|FG001|Overall Study|Not treated|1|||
126769769|NCT03594175|456110441|FG002|Overall Study|Not treated|5|||
126769770|NCT03594175|456110439|FG000|Overall Study|Adverse Event|3|||
126769771|NCT03594175|456110440|FG001|Overall Study|Adverse Event|0|||
126769772|NCT03594175|456110441|FG002|Overall Study|Adverse Event|0|||
126769773|NCT03594175|456110439|FG000|Overall Study|Withdrawal by Subject|3|||
126769774|NCT03594175|456110440|FG001|Overall Study|Withdrawal by Subject|0|||
126461321|NCT04761627|454989512|FG002|Post-randomization Period|Study site closure|1|||
126461322|NCT04761627|454989510|FG000|Post-randomization Period|Family planning|0|||
126769775|NCT03594175|456110441|FG002|Overall Study|Withdrawal by Subject|0|||
126769776|NCT03594175|456110439|FG000|Overall Study|Protocol Violation|2|||
126769777|NCT03594175|456110440|FG001|Overall Study|Protocol Violation|2|||
126769778|NCT03594175|456110441|FG002|Overall Study|Protocol Violation|2|||
126461323|NCT04761627|454989511|FG001|Post-randomization Period|Family planning|1|||
126769779|NCT01915498|456110442|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126461324|NCT04761627|454989512|FG002|Post-randomization Period|Family planning|0|||
126461325|NCT01214174|454989513|FG000|Overall Study|Withdrawal by Subject|0|||
126367222|NCT04134936|454639435|FG001|Overall Study|Progressive disease, joined another trial|0|||
126367223|NCT04134936|454639434|FG000|Overall Study|Progressive disease|1|||
126367224|NCT04134936|454639435|FG001|Overall Study|Progressive disease|0|||
126367225|NCT00323622|454639438|FG000|Overall Study|Other|30|||
126367226|NCT00323622|454639439|FG001|Overall Study|Other|91|||
126367227|NCT00323622|454639440|FG002|Overall Study|Other|4|||
126367228|NCT00323622|454639441|FG003|Overall Study|Other|12|||
126367229|NCT00323622|454639442|FG004|Overall Study|Other|32|||
126367230|NCT00323622|454639443|FG005|Overall Study|Other|74|||
126367231|NCT00323622|454639444|FG006|Overall Study|Other|5|||
126367232|NCT00323622|454639445|FG007|Overall Study|Other|13|||
126367233|NCT00323622|454639438|FG000|Overall Study|Death|1|||
126367234|NCT00323622|454639439|FG001|Overall Study|Death|1|||
126367235|NCT00323622|454639440|FG002|Overall Study|Death|0|||
126367236|NCT00323622|454639441|FG003|Overall Study|Death|0|||
126367237|NCT00323622|454639442|FG004|Overall Study|Death|7|||
126367238|NCT00323622|454639443|FG005|Overall Study|Death|0|||
126367239|NCT00323622|454639444|FG006|Overall Study|Death|0|||
126367240|NCT00323622|454639445|FG007|Overall Study|Death|2|||
126367241|NCT02420717|454639446|FG000|Overall Study|Did not receive all study medication|2|||
126367242|NCT02420717|454639447|FG001|Overall Study|Did not receive all study medication|0|||
126367243|NCT02420717|454639448|FG002|Overall Study|Did not receive all study medication|0|||
126367244|NCT04191135|454639465|FG000|Induction Treatment|Not Treated|2|||
126367245|NCT04191135|454639466|FG001|Induction Treatment|Not Treated|0|||
126367246|NCT04191135|454639467|FG002|Induction Treatment|Not Treated|0|||
126367247|NCT04191135|454639465|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
126367248|NCT04191135|454639466|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
126367249|NCT04191135|454639467|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
126367250|NCT04191135|454639465|FG000|Induction Treatment|Adverse Event|25|||
126367251|NCT04191135|454639466|FG001|Induction Treatment|Adverse Event|0|||
126367252|NCT04191135|454639467|FG002|Induction Treatment|Adverse Event|0|||
126367253|NCT04191135|454639465|FG000|Induction Treatment|Clinical Progression|8|||
126367254|NCT04191135|454639466|FG001|Induction Treatment|Clinical Progression|0|||
126367255|NCT04191135|454639467|FG002|Induction Treatment|Clinical Progression|0|||
126367256|NCT04191135|454639465|FG000|Induction Treatment|Excluded Medication|1|||
126367257|NCT04191135|454639466|FG001|Induction Treatment|Excluded Medication|0|||
126367258|NCT04191135|454639467|FG002|Induction Treatment|Excluded Medication|0|||
126367259|NCT04191135|454639465|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
126461326|NCT01214174|454989514|FG001|Overall Study|Withdrawal by Subject|0|||
126769780|NCT01915498|456110443|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126769781|NCT01915498|456110444|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126769782|NCT01915498|456110445|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
126461327|NCT01214174|454989515|FG002|Overall Study|Withdrawal by Subject|1|||
126461328|NCT01634178|454989518|FG000|Treatment Period 1|Adverse Event|0|||
126461329|NCT01634178|454989519|FG001|Treatment Period 1|Adverse Event|1|||
126461330|NCT01634178|454989518|FG000|Treatment Period 2|Adverse Event|1|||
126461331|NCT01634178|454989519|FG001|Treatment Period 2|Adverse Event|0|||
126461332|NCT00991952|454989532|FG000|Overall Study|Adverse Event|0|||
126461333|NCT00991952|454989533|FG001|Overall Study|Adverse Event|1|||
126461334|NCT02483533|454989535|FG000|Overall Study|Lack of Efficacy|50|||
126461335|NCT02483533|454989536|FG001|Overall Study|Lack of Efficacy|50|||
126461336|NCT03452527|454989537|FG000|Overall Study|Withdrawal by Subject|1|||
126461337|NCT03452527|454989538|FG001|Overall Study|Withdrawal by Subject|1|||
126461338|NCT03452527|454989537|FG000|Overall Study|Study Terminated|2|||
126461339|NCT03452527|454989538|FG001|Overall Study|Study Terminated|3|||
126461340|NCT00582816|454989539|FG000|Overall Study|Engraftment Failure|3|||
126461341|NCT03915860|454989547|FG000|Overall Study|Adverse Event|3|||
126461342|NCT03915860|454989547|FG000|Overall Study|Withdrawal by Subject|6|||
126461343|NCT03915860|454989547|FG000|Overall Study|Lost to Follow-up|2|||
126461344|NCT03915860|454989547|FG000|Overall Study|Other than specified|3|||
126461345|NCT02195011|454989548|FG000|Overall Study|Adverse Event|4|||
126461346|NCT02195011|454989549|FG001|Overall Study|Adverse Event|0|||
126461347|NCT02195011|454989548|FG000|Overall Study|Progressive Disease|18|||
126461348|NCT02195011|454989549|FG001|Overall Study|Progressive Disease|1|||
126461349|NCT02195011|454989548|FG000|Overall Study|Withdrawal by Subject|3|||
126461350|NCT02195011|454989549|FG001|Overall Study|Withdrawal by Subject|0|||
126461351|NCT03189381|454989550|FG000|Overall Study|Death|1|||
126461352|NCT03189381|454989551|FG001|Overall Study|Death|0|||
126461353|NCT03761797|454989552|FG000|Overall Study|Changing hospital|11|||
126461354|NCT03761797|454989552|FG000|Overall Study|Improvement/remission|6|||
126461355|NCT03761797|454989552|FG000|Overall Study|Withdrawal by Subject|19|||
126461356|NCT03761797|454989552|FG000|Overall Study|Lost to Follow-up|33|||
126461357|NCT03761797|454989552|FG000|Overall Study|Adverse Event|37|||
126461358|NCT03761797|454989552|FG000|Overall Study|Case report form (CRF) not collected|5|||
126461359|NCT03761797|454989552|FG000|Overall Study|No patient visit after entry|13|||
126461360|NCT03761797|454989552|FG000|Overall Study|Switch to other diabetes medication|10|||
126461361|NCT03761797|454989552|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
126461362|NCT03761797|454989552|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
126461363|NCT03761797|454989552|FG000|Overall Study|Insufficient effectives|2|||
126461364|NCT03761797|454989552|FG000|Overall Study|Excessive alcohol intake|1|||
126461365|NCT00251004|454989553|FG000|Overall Study|Withdrawal by Subject|23|||
126461366|NCT00251004|454989554|FG001|Overall Study|Withdrawal by Subject|16|||
126461367|NCT00251004|454989555|FG002|Overall Study|Withdrawal by Subject|14|||
126461368|NCT00251004|454989553|FG000|Overall Study|Death|9|||
126461369|NCT00251004|454989554|FG001|Overall Study|Death|10|||
126461370|NCT00251004|454989555|FG002|Overall Study|Death|8|||
126461371|NCT00251004|454989553|FG000|Overall Study|Lost to Follow-up|1|||
126461372|NCT00251004|454989554|FG001|Overall Study|Lost to Follow-up|2|||
126712185|NCT01748760|455897617|FG000|Overall Study|Lost to Follow-up|5|||
126712186|NCT01748760|455897618|FG001|Overall Study|Lost to Follow-up|1|||
126712187|NCT01164501|455897619|FG000|Overall Study|Not treated|2|||
126712188|NCT01164501|455897620|FG001|Overall Study|Not treated|0|||
126712189|NCT01164501|455897621|FG002|Overall Study|Not treated|1|||
126298882|NCT03194542|454380913|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
126298883|NCT03194542|454380914|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
126298884|NCT01611883|454380917|FG000|Overall Study|Adverse Event|1|||
126298885|NCT01611883|454380918|FG001|Overall Study|Adverse Event|1|||
126298886|NCT01622673|454380919|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126298887|NCT01622673|454380920|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126298888|NCT01622673|454380921|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126298889|NCT01622673|454380922|FG003|Treatment Period 1|Withdrawal by Subject|1|||
126298890|NCT01622673|454380923|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126298891|NCT01622673|454380924|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126298892|NCT01622673|454380919|FG000|Treatment Period 1|Protocol Violation|0|||
126298893|NCT01622673|454380920|FG001|Treatment Period 1|Protocol Violation|1|||
126298894|NCT01622673|454380921|FG002|Treatment Period 1|Protocol Violation|0|||
126298895|NCT01622673|454380922|FG003|Treatment Period 1|Protocol Violation|0|||
126298896|NCT01622673|454380923|FG004|Treatment Period 1|Protocol Violation|0|||
126298897|NCT01622673|454380924|FG005|Treatment Period 1|Protocol Violation|0|||
126298898|NCT01622673|454380919|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126298899|NCT01622673|454380920|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126461373|NCT00251004|454989555|FG002|Overall Study|Lost to Follow-up|1|||
126461374|NCT00251004|454989553|FG000|Overall Study|Graft Loss|12|||
126461375|NCT00251004|454989554|FG001|Overall Study|Graft Loss|13|||
126461376|NCT00251004|454989555|FG002|Overall Study|Graft Loss|8|||
126461377|NCT00645788|454989556|FG000|Overall Study|Did not receive study drug|1|||
126712190|NCT01164501|455897619|FG000|Overall Study|Adverse Event|18|||
126298900|NCT01622673|454380921|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126298901|NCT01622673|454380922|FG003|Treatment Period 2|Withdrawal by Subject|1|||
126769783|NCT01915498|456110446|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
126298902|NCT01622673|454380923|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126298903|NCT01622673|454380924|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126298904|NCT01622673|454380919|FG000|Treatment Period 3|Protocol Violation|0|||
126298905|NCT01622673|454380920|FG001|Treatment Period 3|Protocol Violation|1|||
126298906|NCT01622673|454380921|FG002|Treatment Period 3|Protocol Violation|0|||
126298907|NCT01622673|454380922|FG003|Treatment Period 3|Protocol Violation|0|||
126298908|NCT01622673|454380923|FG004|Treatment Period 3|Protocol Violation|0|||
126298909|NCT01622673|454380924|FG005|Treatment Period 3|Protocol Violation|0|||
126298910|NCT04146012|454380927|FG000|Overall Study|Study Terminated|30|||
126298911|NCT04146012|454380928|FG001|Overall Study|Study Terminated|15|||
126298912|NCT05142722|454381640|FG000|Overall Study|Lost to Follow-up|16|||
126298913|NCT05142722|454381641|FG001|Overall Study|Lost to Follow-up|38|||
126298914|NCT05142722|454381640|FG000|Overall Study|Withdrawal by Subject|20|||
126298915|NCT05142722|454381641|FG001|Overall Study|Withdrawal by Subject|27|||
126298916|NCT05142722|454381640|FG000|Overall Study|Death|11|||
126298917|NCT05142722|454381641|FG001|Overall Study|Death|17|||
126298918|NCT05142722|454381640|FG000|Overall Study|Physician Decision|0|||
126298919|NCT05142722|454381641|FG001|Overall Study|Physician Decision|1|||
126298920|NCT05142722|454381640|FG000|Overall Study|Participant Moved Away|0|||
126298921|NCT05142722|454381641|FG001|Overall Study|Participant Moved Away|2|||
126298922|NCT05142722|454381640|FG000|Overall Study|Adverse Event|2|||
126298923|NCT05142722|454381641|FG001|Overall Study|Adverse Event|1|||
126298924|NCT05731700|454381642|FG000|Overall Study|Death|1|||
126298925|NCT05468164|454381659|FG000|Treatment Period 4|Adverse Event|0|||
126298926|NCT05468164|454381660|FG001|Treatment Period 4|Adverse Event|0|||
126298927|NCT05468164|454381661|FG002|Treatment Period 4|Adverse Event|0|||
126298928|NCT05468164|454381662|FG003|Treatment Period 4|Adverse Event|1|||
126298929|NCT01467713|454381663|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
126298930|NCT01467713|454381664|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
126298931|NCT01467713|454381665|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
126298932|NCT01467713|454381666|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
126298933|NCT01467713|454381663|FG000|Overall Study|Major Protocol Deviation|2|||
126298934|NCT01467713|454381664|FG001|Overall Study|Major Protocol Deviation|4|||
126298935|NCT01467713|454381665|FG002|Overall Study|Major Protocol Deviation|4|||
126298936|NCT01467713|454381666|FG003|Overall Study|Major Protocol Deviation|1|||
126298937|NCT01467713|454381663|FG000|Overall Study|Lost to Follow-up|9|||
126298938|NCT01467713|454381664|FG001|Overall Study|Lost to Follow-up|12|||
126298939|NCT01467713|454381665|FG002|Overall Study|Lost to Follow-up|6|||
126298940|NCT01467713|454381666|FG003|Overall Study|Lost to Follow-up|9|||
126298941|NCT01467713|454381663|FG000|Overall Study|Voluntary Withdrawal|18|||
126298942|NCT01467713|454381664|FG001|Overall Study|Voluntary Withdrawal|14|||
126298943|NCT01467713|454381665|FG002|Overall Study|Voluntary Withdrawal|21|||
126298944|NCT01467713|454381666|FG003|Overall Study|Voluntary Withdrawal|20|||
126298945|NCT01467713|454381663|FG000|Overall Study|Study Termination|23|||
126298946|NCT01467713|454381664|FG001|Overall Study|Study Termination|33|||
126298947|NCT01467713|454381665|FG002|Overall Study|Study Termination|28|||
126298948|NCT01467713|454381666|FG003|Overall Study|Study Termination|29|||
126298949|NCT01467713|454381663|FG000|Overall Study|Pregnancy|0|||
126298950|NCT01467713|454381664|FG001|Overall Study|Pregnancy|1|||
126298951|NCT01467713|454381665|FG002|Overall Study|Pregnancy|1|||
126298952|NCT01467713|454381666|FG003|Overall Study|Pregnancy|3|||
126298953|NCT01467713|454381663|FG000|Overall Study|Relapse|35|||
126367260|NCT04191135|454639466|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
126298954|NCT01467713|454381664|FG001|Overall Study|Relapse|25|||
126298955|NCT01467713|454381665|FG002|Overall Study|Relapse|28|||
126298956|NCT01467713|454381666|FG003|Overall Study|Relapse|35|||
126367261|NCT04191135|454639467|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
126367262|NCT04191135|454639465|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
126367263|NCT04191135|454639466|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
126367264|NCT04191135|454639467|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
126367265|NCT04191135|454639465|FG000|Induction Treatment|Physician Decision|2|||
126367266|NCT04191135|454639466|FG001|Induction Treatment|Physician Decision|0|||
126367267|NCT04191135|454639467|FG002|Induction Treatment|Physician Decision|0|||
126367268|NCT04191135|454639465|FG000|Induction Treatment|Progressive Disease|135|||
126367269|NCT04191135|454639466|FG001|Induction Treatment|Progressive Disease|0|||
126367270|NCT04191135|454639467|FG002|Induction Treatment|Progressive Disease|0|||
126367271|NCT04191135|454639465|FG000|Induction Treatment|Protocol Violation|10|||
126367272|NCT04191135|454639466|FG001|Induction Treatment|Protocol Violation|0|||
126298957|NCT01467713|454381663|FG000|Overall Study|Reason not Specified|6|||
126367273|NCT04191135|454639467|FG002|Induction Treatment|Protocol Violation|0|||
126298958|NCT01467713|454381664|FG001|Overall Study|Reason not Specified|11|||
126298959|NCT01467713|454381665|FG002|Overall Study|Reason not Specified|8|||
126367274|NCT04191135|454639465|FG000|Induction Treatment|Withdrawal by Subject|4|||
126298960|NCT01467713|454381666|FG003|Overall Study|Reason not Specified|7|||
126298961|NCT04846569|454381667|FG000|Overall Study|Withdrawal by Subject|3|||
126298962|NCT04846569|454381668|FG001|Overall Study|Withdrawal by Subject|1|||
126712191|NCT01164501|455897620|FG001|Overall Study|Adverse Event|4|||
126298963|NCT00536939|454381669|FG000|Overall Study|Withdrawal by Subject|1|||
126298964|NCT00536939|454381670|FG001|Overall Study|Withdrawal by Subject|0|||
126298965|NCT00536939|454381669|FG000|Overall Study|Other Complicating Disease|1|||
126298966|NCT00536939|454381670|FG001|Overall Study|Other Complicating Disease|0|||
126298967|NCT01100086|454381673|FG000|Period 1|Withdrawal by Subject|1|||
126298968|NCT01100086|454381674|FG001|Period 1|Withdrawal by Subject|0|||
126298969|NCT02954601|454381675|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
126298970|NCT02954601|454381676|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
126298971|NCT02954601|454381677|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
126298972|NCT02954601|454381678|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
126298973|NCT02075203|454381679|FG000|Overall Study|Withdrawal by Subject|1|||
126298974|NCT02075203|454381680|FG001|Overall Study|Withdrawal by Subject|0|||
126298975|NCT02075203|454381681|FG002|Overall Study|Withdrawal by Subject|1|||
126298976|NCT02075203|454381679|FG000|Overall Study|Adverse Event|1|||
126298977|NCT02075203|454381680|FG001|Overall Study|Adverse Event|0|||
126298978|NCT02075203|454381681|FG002|Overall Study|Adverse Event|0|||
126298979|NCT02075203|454381679|FG000|Overall Study|participant refused to use contraception|1|||
126298980|NCT02075203|454381680|FG001|Overall Study|participant refused to use contraception|0|||
126298981|NCT02075203|454381681|FG002|Overall Study|participant refused to use contraception|0|||
126298982|NCT05344560|454381682|FG000|Period 1|Subject out of visit window|1|||
126298983|NCT05344560|454381683|FG001|Period 1|Subject out of visit window|1|||
126298984|NCT05344560|454381682|FG000|Period 2|Covid-19 Related|1|||
126298985|NCT05344560|454381683|FG001|Period 2|Covid-19 Related|0|||
126298986|NCT05344560|454381682|FG000|Period 2|Adverse Event|1|||
126298987|NCT05344560|454381683|FG001|Period 2|Adverse Event|0|||
126298988|NCT05344560|454381682|FG000|Period 2|Subject out of visit window|1|||
126298989|NCT05344560|454381683|FG001|Period 2|Subject out of visit window|1|||
126298990|NCT05344560|454381682|FG000|Period 3|Subject out of visit window|1|||
126298991|NCT05344560|454381683|FG001|Period 3|Subject out of visit window|0|||
126298992|NCT00360282|454381684|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
126298993|NCT00360282|454381685|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
126298994|NCT00360282|454381686|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
126298995|NCT00360282|454381687|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
126298996|NCT00360282|454381684|FG000|Second Intervention|Adverse Event|0|||
126298997|NCT00360282|454381685|FG001|Second Intervention|Adverse Event|1|||
126298998|NCT00360282|454381686|FG002|Second Intervention|Adverse Event|0|||
126298999|NCT00360282|454381687|FG003|Second Intervention|Adverse Event|0|||
126299000|NCT00558467|454381693|FG000|Overall Study|Adverse Event|1|||
126299001|NCT00558467|454381694|FG001|Overall Study|Adverse Event|2|||
126299002|NCT00558467|454381693|FG000|Overall Study|Lack of Efficacy|0|||
126299003|NCT00558467|454381694|FG001|Overall Study|Lack of Efficacy|1|||
126299004|NCT00558467|454381693|FG000|Overall Study|Patient moving out of state|0|||
126299005|NCT00558467|454381694|FG001|Overall Study|Patient moving out of state|1|||
126299006|NCT02025725|454381697|FG000|Overall Study|Adverse Event|5|||
126299007|NCT02025725|454381698|FG001|Overall Study|Adverse Event|0|||
126299008|NCT02025725|454381697|FG000|Overall Study|Lost to Follow-up|2|||
126299009|NCT02025725|454381698|FG001|Overall Study|Lost to Follow-up|0|||
126299010|NCT02025725|454381697|FG000|Overall Study|Protocol Violation|1|||
126299011|NCT02025725|454381698|FG001|Overall Study|Protocol Violation|1|||
126299012|NCT02025725|454381697|FG000|Overall Study|Withdrawal by Subject|3|||
126299013|NCT02025725|454381698|FG001|Overall Study|Withdrawal by Subject|2|||
126299014|NCT02025725|454381697|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
126299015|NCT02025725|454381698|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
126299016|NCT02867592|454381699|FG000|Overall Study|Adverse Event|3|||
126299017|NCT02867592|454381700|FG001|Overall Study|Adverse Event|0|||
126712192|NCT01164501|455897621|FG002|Overall Study|Adverse Event|21|||
126712193|NCT01164501|455897619|FG000|Overall Study|Lack of Efficacy|0|||
126299018|NCT02867592|454381701|FG002|Overall Study|Adverse Event|2|||
126299019|NCT02867592|454381702|FG003|Overall Study|Adverse Event|1|||
126299020|NCT02867592|454381703|FG004|Overall Study|Adverse Event|1|||
126299021|NCT02867592|454381704|FG005|Overall Study|Adverse Event|5|||
126712194|NCT01164501|455897620|FG001|Overall Study|Lack of Efficacy|0|||
126299022|NCT02867592|454381699|FG000|Overall Study|Death|0|||
126299023|NCT02867592|454381700|FG001|Overall Study|Death|0|||
126299024|NCT02867592|454381701|FG002|Overall Study|Death|0|||
126299025|NCT02867592|454381702|FG003|Overall Study|Death|1|||
126299026|NCT02867592|454381703|FG004|Overall Study|Death|0|||
126299027|NCT02867592|454381704|FG005|Overall Study|Death|1|||
126299028|NCT02867592|454381699|FG000|Overall Study|Lack of Efficacy|8|||
126299029|NCT02867592|454381700|FG001|Overall Study|Lack of Efficacy|10|||
126299030|NCT02867592|454381701|FG002|Overall Study|Lack of Efficacy|8|||
126299031|NCT02867592|454381702|FG003|Overall Study|Lack of Efficacy|8|||
126299032|NCT02867592|454381703|FG004|Overall Study|Lack of Efficacy|12|||
126299033|NCT02867592|454381704|FG005|Overall Study|Lack of Efficacy|17|||
126299034|NCT02867592|454381699|FG000|Overall Study|Physician Decision|1|||
126299035|NCT02867592|454381700|FG001|Overall Study|Physician Decision|2|||
126299036|NCT02867592|454381701|FG002|Overall Study|Physician Decision|2|||
126461378|NCT00645788|454989557|FG001|Overall Study|Did not receive study drug|1|||
126461379|NCT00645788|454989558|FG002|Overall Study|Did not receive study drug|0|||
126461380|NCT00645788|454989559|FG003|Overall Study|Did not receive study drug|0|||
126769784|NCT01915498|456110447|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126769785|NCT01915498|456110448|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126769786|NCT01915498|456110449|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126769787|NCT01915498|456110450|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126769788|NCT01915498|456110451|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
126461381|NCT00645788|454989556|FG000|Overall Study|Adverse Event|4|||
126461382|NCT00645788|454989557|FG001|Overall Study|Adverse Event|9|||
126769789|NCT01915498|456110452|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126769790|NCT01915498|456110453|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126769791|NCT01915498|456110454|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
126769792|NCT01915498|456110455|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
126769793|NCT01915498|456110456|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
126769794|NCT01915498|456110457|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
126769795|NCT01915498|456110458|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
126769796|NCT01915498|456110459|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
126769797|NCT01915498|456110460|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
126769798|NCT01915498|456110442|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126769799|NCT01915498|456110443|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126769800|NCT01915498|456110444|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126769801|NCT01915498|456110445|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126769802|NCT01915498|456110446|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126769803|NCT01915498|456110447|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
126769804|NCT01915498|456110448|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126769805|NCT01915498|456110449|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126769806|NCT01915498|456110450|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126769807|NCT01915498|456110451|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
126769808|NCT01915498|456110452|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126769809|NCT01915498|456110453|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126769810|NCT01915498|456110454|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126769811|NCT01915498|456110455|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
126769812|NCT01915498|456110456|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
126769813|NCT01915498|456110457|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
126769814|NCT01915498|456110458|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
126769815|NCT01915498|456110459|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
126769816|NCT01915498|456110460|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
126769817|NCT01915498|456110442|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
126769818|NCT01915498|456110443|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126769819|NCT01915498|456110444|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126769820|NCT01915498|456110445|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126769821|NCT01915498|456110446|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126769822|NCT01915498|456110447|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
126769823|NCT01915498|456110448|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126769824|NCT01915498|456110449|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126299037|NCT02867592|454381702|FG003|Overall Study|Physician Decision|0|||
126299038|NCT02867592|454381703|FG004|Overall Study|Physician Decision|5|||
126299039|NCT02867592|454381704|FG005|Overall Study|Physician Decision|1|||
126299040|NCT02867592|454381699|FG000|Overall Study|Protocol Violation|0|||
126299041|NCT02867592|454381700|FG001|Overall Study|Protocol Violation|0|||
126299042|NCT02867592|454381701|FG002|Overall Study|Protocol Violation|0|||
126299043|NCT02867592|454381702|FG003|Overall Study|Protocol Violation|0|||
126299044|NCT02867592|454381703|FG004|Overall Study|Protocol Violation|1|||
126299045|NCT02867592|454381704|FG005|Overall Study|Protocol Violation|1|||
126299046|NCT02867592|454381699|FG000|Overall Study|Withdrawal by Subject|0|||
126299047|NCT02867592|454381700|FG001|Overall Study|Withdrawal by Subject|1|||
126299048|NCT02867592|454381701|FG002|Overall Study|Withdrawal by Subject|0|||
126299049|NCT02867592|454381702|FG003|Overall Study|Withdrawal by Subject|1|||
126461383|NCT00645788|454989558|FG002|Overall Study|Adverse Event|5|||
126461384|NCT00645788|454989559|FG003|Overall Study|Adverse Event|3|||
126461385|NCT00645788|454989556|FG000|Overall Study|Lost to Follow-up|1|||
126550230|NCT04329104|455309500|FG005|Efficacy Study|Withdrawal by Subject|8|||
126299050|NCT02867592|454381703|FG004|Overall Study|Withdrawal by Subject|3|||
126299051|NCT02867592|454381704|FG005|Overall Study|Withdrawal by Subject|3|||
126299052|NCT02867592|454381699|FG000|Overall Study|Ineligible|1|||
126299053|NCT02867592|454381700|FG001|Overall Study|Ineligible|1|||
126299054|NCT02867592|454381701|FG002|Overall Study|Ineligible|0|||
126299055|NCT02867592|454381702|FG003|Overall Study|Ineligible|0|||
126461386|NCT00645788|454989557|FG001|Overall Study|Lost to Follow-up|0|||
126461387|NCT00645788|454989558|FG002|Overall Study|Lost to Follow-up|0|||
126461388|NCT00645788|454989559|FG003|Overall Study|Lost to Follow-up|0|||
126461389|NCT00645788|454989556|FG000|Overall Study|Protocol Violation|1|||
126461390|NCT00645788|454989557|FG001|Overall Study|Protocol Violation|0|||
126299056|NCT02867592|454381703|FG004|Overall Study|Ineligible|2|||
126299057|NCT02867592|454381704|FG005|Overall Study|Ineligible|0|||
126299058|NCT02867592|454381699|FG000|Overall Study|No Treatment|1|||
126299059|NCT02867592|454381700|FG001|Overall Study|No Treatment|0|||
126299060|NCT02867592|454381701|FG002|Overall Study|No Treatment|0|||
126461391|NCT00645788|454989558|FG002|Overall Study|Protocol Violation|2|||
126461392|NCT00645788|454989559|FG003|Overall Study|Protocol Violation|0|||
126461393|NCT00645788|454989556|FG000|Overall Study|Withdrawal by Subject|0|||
126461394|NCT00645788|454989557|FG001|Overall Study|Withdrawal by Subject|1|||
126461395|NCT00645788|454989558|FG002|Overall Study|Withdrawal by Subject|0|||
126461396|NCT00645788|454989559|FG003|Overall Study|Withdrawal by Subject|2|||
126712195|NCT01164501|455897621|FG002|Overall Study|Lack of Efficacy|1|||
126712196|NCT01164501|455897619|FG000|Overall Study|Non compliant with protocol|1|||
126712197|NCT01164501|455897620|FG001|Overall Study|Non compliant with protocol|1|||
126712198|NCT01164501|455897621|FG002|Overall Study|Non compliant with protocol|4|||
126712199|NCT01164501|455897619|FG000|Overall Study|Lost to Follow-up|3|||
126712200|NCT01164501|455897620|FG001|Overall Study|Lost to Follow-up|0|||
126712201|NCT01164501|455897621|FG002|Overall Study|Lost to Follow-up|3|||
126712202|NCT01164501|455897619|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
126712203|NCT01164501|455897620|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
126712204|NCT01164501|455897621|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
126712205|NCT01164501|455897619|FG000|Overall Study|Other reason not defined above|9|||
126712206|NCT01164501|455897620|FG001|Overall Study|Other reason not defined above|1|||
126712207|NCT01164501|455897621|FG002|Overall Study|Other reason not defined above|4|||
126712208|NCT00306891|455897622|FG000|Part A|Withdrawal by Subject|1|||
126712209|NCT00306891|455897623|FG001|Part A|Withdrawal by Subject|1|||
126712210|NCT00306891|455897624|FG002|Part A|Withdrawal by Subject|0|||
126712211|NCT00306891|455897625|FG003|Part A|Withdrawal by Subject|0|||
126712212|NCT00306891|455897622|FG000|Part A|Condition under investigation worsened|2|||
126712213|NCT00306891|455897623|FG001|Part A|Condition under investigation worsened|2|||
126712214|NCT00306891|455897624|FG002|Part A|Condition under investigation worsened|0|||
126712215|NCT00306891|455897625|FG003|Part A|Condition under investigation worsened|0|||
126712216|NCT00306891|455897622|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
126712217|NCT00306891|455897623|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
126712218|NCT00306891|455897624|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
126712219|NCT00306891|455897625|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
126712220|NCT00306891|455897622|FG000|Part A|Partial bowel obstruction|1|||
126712221|NCT00306891|455897623|FG001|Part A|Partial bowel obstruction|0|||
126712222|NCT00306891|455897624|FG002|Part A|Partial bowel obstruction|0|||
126712223|NCT00306891|455897625|FG003|Part A|Partial bowel obstruction|0|||
126712224|NCT00306891|455897622|FG000|Part A|Reaccumul. of ascites following drainage|0|||
126712225|NCT00306891|455897623|FG001|Part A|Reaccumul. of ascites following drainage|1|||
126712226|NCT00306891|455897624|FG002|Part A|Reaccumul. of ascites following drainage|0|||
126712227|NCT00306891|455897625|FG003|Part A|Reaccumul. of ascites following drainage|0|||
126712228|NCT00306891|455897622|FG000|Part A|Suspicion of second malignancy|0|||
126712229|NCT00306891|455897623|FG001|Part A|Suspicion of second malignancy|1|||
126712230|NCT00306891|455897624|FG002|Part A|Suspicion of second malignancy|0|||
126712231|NCT00306891|455897625|FG003|Part A|Suspicion of second malignancy|0|||
126712232|NCT00306891|455897622|FG000|Part A|QTC interval outwith elig. criteria|1|||
126712233|NCT00306891|455897623|FG001|Part A|QTC interval outwith elig. criteria|0|||
126712234|NCT00306891|455897624|FG002|Part A|QTC interval outwith elig. criteria|0|||
126712235|NCT00306891|455897625|FG003|Part A|QTC interval outwith elig. criteria|0|||
126712236|NCT00306891|455897622|FG000|Part B|Death|0|||
126712237|NCT00306891|455897623|FG001|Part B|Death|0|||
126769825|NCT01915498|456110450|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126299061|NCT02867592|454381702|FG003|Overall Study|No Treatment|0|||
126299062|NCT02867592|454381703|FG004|Overall Study|No Treatment|0|||
126299063|NCT02867592|454381704|FG005|Overall Study|No Treatment|0|||
126299064|NCT02867592|454381699|FG000|Overall Study|Still on Therapy|0|||
126461397|NCT00645788|454989556|FG000|Overall Study|Pulmonary exacerbation|13|||
126461398|NCT00645788|454989557|FG001|Overall Study|Pulmonary exacerbation|16|||
126461399|NCT00645788|454989558|FG002|Overall Study|Pulmonary exacerbation|11|||
126712238|NCT00306891|455897624|FG002|Part B|Death|1|||
126712239|NCT00306891|455897625|FG003|Part B|Death|2|||
126299065|NCT02867592|454381700|FG001|Overall Study|Still on Therapy|0|||
126299066|NCT02867592|454381701|FG002|Overall Study|Still on Therapy|0|||
126461400|NCT00645788|454989559|FG003|Overall Study|Pulmonary exacerbation|9|||
126712240|NCT00306891|455897622|FG000|Part B|Adverse Event|0|||
126712241|NCT00306891|455897623|FG001|Part B|Adverse Event|0|||
126712242|NCT00306891|455897624|FG002|Part B|Adverse Event|5|||
126712243|NCT00306891|455897625|FG003|Part B|Adverse Event|5|||
126712244|NCT00306891|455897622|FG000|Part B|Withdrawal by Subject|0|||
126299067|NCT02867592|454381702|FG003|Overall Study|Still on Therapy|0|||
126299068|NCT02867592|454381703|FG004|Overall Study|Still on Therapy|1|||
126299069|NCT02867592|454381704|FG005|Overall Study|Still on Therapy|0|||
126299070|NCT02867592|454381699|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
126299071|NCT02867592|454381700|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
126299072|NCT02867592|454381701|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
126299073|NCT02867592|454381702|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
126299074|NCT02867592|454381703|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
126299075|NCT02867592|454381704|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
126299076|NCT02867592|454381699|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
126299077|NCT02867592|454381700|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
126299078|NCT02867592|454381701|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
126299079|NCT02867592|454381702|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
126299080|NCT02867592|454381703|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
126299081|NCT02867592|454381704|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
126299082|NCT00571727|454381714|FG000|Overall Study|Did not enter in this study|1|||
126299083|NCT00571727|454381714|FG000|Overall Study|Non-compliance|4|||
126299084|NCT00571727|454381714|FG000|Overall Study|Lost to Follow-up|30|||
126299085|NCT00571727|454381714|FG000|Overall Study|Poor growth|1|||
126299086|NCT00571727|454381714|FG000|Overall Study|Parent/patient decision|2|||
126299087|NCT00571727|454381714|FG000|Overall Study|Participant transferred to commercial drug|14|||
126299088|NCT00571727|454381714|FG000|Overall Study|Unable to provide study drug|6|||
126299089|NCT00571727|454381714|FG000|Overall Study|On-treatment at end of study|8|||
126299090|NCT03581292|454381715|FG000|Overall Study|Physician Decision|9|||
126299091|NCT03581292|454381716|FG001|Overall Study|Physician Decision|5|||
126299092|NCT03581292|454381715|FG000|Overall Study|Withdrawal by Subject|3|||
126299093|NCT03581292|454381716|FG001|Overall Study|Withdrawal by Subject|0|||
126299094|NCT03581292|454381715|FG000|Overall Study|Withdrawal before Therapy Start|1|||
126299095|NCT03581292|454381716|FG001|Overall Study|Withdrawal before Therapy Start|0|||
126299096|NCT01735916|454383365|FG000|Overall Study|Subject not eligible to be randomized|11|||
126299097|NCT01735916|454383366|FG001|Overall Study|Subject not eligible to be randomized|0|||
126299098|NCT01735916|454383367|FG002|Overall Study|Subject not eligible to be randomized|0|||
126299099|NCT01735916|454383365|FG000|Overall Study|Early termination of study by sponsor|4|||
126299100|NCT01735916|454383366|FG001|Overall Study|Early termination of study by sponsor|19|||
126299101|NCT01735916|454383367|FG002|Overall Study|Early termination of study by sponsor|7|||
126299102|NCT01735916|454383365|FG000|Overall Study|Withdrawal by Subject|3|||
126299103|NCT01735916|454383366|FG001|Overall Study|Withdrawal by Subject|0|||
126299104|NCT01735916|454383367|FG002|Overall Study|Withdrawal by Subject|0|||
126299105|NCT04227197|454383371|FG000|Randomization|Protocol Violation|1|||
126299106|NCT04227197|454383372|FG001|Randomization|Protocol Violation|0|||
126299107|NCT04227197|454383371|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
126299108|NCT04227197|454383372|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
126299109|NCT04227197|454383371|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
126299110|NCT04227197|454383372|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
126299111|NCT04227197|454383371|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
126299112|NCT04227197|454383372|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
126299113|NCT04227197|454383371|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
126299114|NCT04227197|454383372|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
126299115|NCT04227197|454383371|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
126299116|NCT04227197|454383372|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
126299117|NCT04227197|454383371|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
126299118|NCT04227197|454383372|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
126299119|NCT00333983|454383373|FG000|Overall Study|Lost to Follow-up|2|||
126299120|NCT00333983|454383374|FG001|Overall Study|Lost to Follow-up|1|||
126299121|NCT00333983|454383375|FG002|Overall Study|Lost to Follow-up|0|||
126299122|NCT00333983|454383373|FG000|Overall Study|Adverse Event|1|||
126299123|NCT00333983|454383374|FG001|Overall Study|Adverse Event|1|||
126299124|NCT00333983|454383375|FG002|Overall Study|Adverse Event|1|||
126299125|NCT00333983|454383373|FG000|Overall Study|Withdrawal by Subject|0|||
126299126|NCT00333983|454383374|FG001|Overall Study|Withdrawal by Subject|3|||
126299127|NCT00333983|454383375|FG002|Overall Study|Withdrawal by Subject|1|||
126299128|NCT00833105|454383376|FG000|Overall Study|Withdrawal by Subject|1|||
126299129|NCT00833105|454383376|FG000|Overall Study|Adverse Event|2|||
126461401|NCT03149848|454989560|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
126461402|NCT03149848|454989560|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
126461403|NCT01244490|454989561|FG000|Overall Study|Lack of Efficacy|14|||
126299130|NCT00570141|454383381|FG000|Overall Study|Adverse Event|1|||
126299131|NCT00570141|454383381|FG000|Overall Study|Missed visits|1|||
126299132|NCT00570141|454383381|FG000|Overall Study|Lost to Follow-up|1|||
126299133|NCT01209949|454383393|FG000|Overall Study|Lost to Follow-up|3|||
126299134|NCT00729612|454383398|FG000|Overall Study|Non evaluable for response|10|||
126299135|NCT03214224|454383407|FG000|Overall Study|Protocol Violation|1|||
126299136|NCT03214224|454383407|FG000|Overall Study|Withdrawal by Subject|2|||
126299137|NCT03214224|454383407|FG000|Overall Study|Practice controls or therapists|6|||
126299138|NCT02712320|454383408|FG000|Overall Study|Lost to Follow-up|1|||
126299139|NCT02712320|454383408|FG000|Overall Study|Withdrawal by Subject|1|||
126299140|NCT02712320|454383408|FG000|Overall Study|Transferred to another facility|1|||
126299141|NCT02712320|454383408|FG000|Overall Study|Treating with the prohibited medications|2|||
126299142|NCT00568451|454383409|FG000|Overall Study|Disease Progression|0|||
126299143|NCT00568451|454383410|FG001|Overall Study|Disease Progression|0|||
126299144|NCT00568451|454383411|FG002|Overall Study|Disease Progression|2|||
126299145|NCT00568451|454383412|FG003|Overall Study|Disease Progression|7|||
126299146|NCT05266053|454383415|FG000|Overall Study|Withdrawal by Subject|8|||
126299147|NCT05266053|454383416|FG001|Overall Study|Withdrawal by Subject|4|||
126299148|NCT01343043|454383419|FG000|Overall Study|Disease progression before treatment|1|||
126299149|NCT01343043|454383420|FG001|Overall Study|Disease progression before treatment|0|||
126299150|NCT01343043|454383421|FG002|Overall Study|Disease progression before treatment|0|||
126299151|NCT01343043|454383422|FG003|Overall Study|Disease progression before treatment|0|||
126299152|NCT01343043|454383419|FG000|Overall Study|Withdrawal by Subject|1|||
126299153|NCT01343043|454383420|FG001|Overall Study|Withdrawal by Subject|0|||
126299154|NCT01343043|454383421|FG002|Overall Study|Withdrawal by Subject|0|||
126299155|NCT01343043|454383422|FG003|Overall Study|Withdrawal by Subject|0|||
126299156|NCT01343043|454383419|FG000|Overall Study|Death|1|||
126299157|NCT01343043|454383420|FG001|Overall Study|Death|1|||
126299158|NCT01343043|454383421|FG002|Overall Study|Death|0|||
126299159|NCT01343043|454383422|FG003|Overall Study|Death|1|||
126299160|NCT00925704|454383423|FG000|First Intervention|Withdrew consent|0|||
126299161|NCT00925704|454383424|FG001|First Intervention|Withdrew consent|0|||
126299162|NCT00925704|454383425|FG002|First Intervention|Withdrew consent|0|||
126299163|NCT00925704|454383426|FG003|First Intervention|Withdrew consent|1|||
126299164|NCT00925704|454383427|FG004|First Intervention|Withdrew consent|1|||
126299165|NCT00925704|454383428|FG005|First Intervention|Withdrew consent|0|||
126299166|NCT00925704|454383423|FG000|Second Intervention|Withdrawal by Subject|1|||
126299167|NCT00925704|454383424|FG001|Second Intervention|Withdrawal by Subject|0|||
126299168|NCT00925704|454383425|FG002|Second Intervention|Withdrawal by Subject|0|||
126299169|NCT00925704|454383426|FG003|Second Intervention|Withdrawal by Subject|0|||
126299170|NCT00925704|454383427|FG004|Second Intervention|Withdrawal by Subject|1|||
126299171|NCT00925704|454383428|FG005|Second Intervention|Withdrawal by Subject|0|||
126299172|NCT00925704|454383423|FG000|Third Intervention|Withdrew consent|0|||
126299173|NCT00925704|454383424|FG001|Third Intervention|Withdrew consent|0|||
126299174|NCT00925704|454383425|FG002|Third Intervention|Withdrew consent|0|||
126299175|NCT00925704|454383426|FG003|Third Intervention|Withdrew consent|0|||
126299176|NCT00925704|454383427|FG004|Third Intervention|Withdrew consent|0|||
126299177|NCT00925704|454383428|FG005|Third Intervention|Withdrew consent|1|||
126299178|NCT02996968|454383429|FG000|Overall Study|Withdrawal by Subject|1|||
126299179|NCT02996968|454383430|FG001|Overall Study|Withdrawal by Subject|0|||
126299180|NCT02044302|454383434|FG000|Overall Study|study terminated|2|||
126299181|NCT02044302|454383435|FG001|Overall Study|study terminated|0|||
126299182|NCT03207815|454383438|FG000|Overall Study|Protocol Violation|3|||
126299183|NCT03207815|454383439|FG001|Overall Study|Protocol Violation|1|||
126299184|NCT03207815|454383438|FG000|Overall Study|Adverse Event|1|||
126299185|NCT03207815|454383439|FG001|Overall Study|Adverse Event|2|||
126299186|NCT03207815|454383438|FG000|Overall Study|Lost to Follow-up|1|||
126299187|NCT03207815|454383439|FG001|Overall Study|Lost to Follow-up|2|||
126299188|NCT03207815|454383438|FG000|Overall Study|Investigator's Discretion|1|||
126299189|NCT03207815|454383439|FG001|Overall Study|Investigator's Discretion|1|||
126299190|NCT03207815|454383438|FG000|Overall Study|Lack of Efficacy|0|||
126299191|NCT03207815|454383439|FG001|Overall Study|Lack of Efficacy|1|||
126769826|NCT01915498|456110451|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126299192|NCT03207815|454383438|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
126299193|NCT03207815|454383439|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
126299194|NCT03207815|454383438|FG000|Overall Study|Withdrew Consent|1|||
126299195|NCT03207815|454383439|FG001|Overall Study|Withdrew Consent|0|||
126299196|NCT01671007|454383440|FG000|Overall Study|Other reasons than listed|166|||
126299197|NCT01671007|454383441|FG001|Overall Study|Other reasons than listed|373|||
126299198|NCT01671007|454383442|FG002|Overall Study|Other reasons than listed|197|||
126299199|NCT01671007|454383443|FG003|Overall Study|Other reasons than listed|228|||
126299200|NCT01671007|454383444|FG004|Overall Study|Other reasons than listed|14|||
126299201|NCT01671007|454383445|FG005|Overall Study|Other reasons than listed|71|||
126299202|NCT01671007|454383446|FG006|Overall Study|Other reasons than listed|17|||
126299203|NCT01671007|454383447|FG007|Overall Study|Other reasons than listed|66|||
126299204|NCT01671007|454383448|FG008|Overall Study|Other reasons than listed|0|||
126461404|NCT01244490|454989562|FG001|Overall Study|Lack of Efficacy|5|||
126461405|NCT01244490|454989563|FG002|Overall Study|Lack of Efficacy|5|||
126461406|NCT01244490|454989561|FG000|Overall Study|Withdrawal by Subject|4|||
126769827|NCT01915498|456110452|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126769828|NCT01915498|456110453|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126769829|NCT01915498|456110454|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126769830|NCT01915498|456110455|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126769831|NCT01915498|456110456|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
126299205|NCT01671007|454383440|FG000|Overall Study|Withdrawal by Subject|36|||
126299206|NCT01671007|454383441|FG001|Overall Study|Withdrawal by Subject|59|||
126299207|NCT01671007|454383442|FG002|Overall Study|Withdrawal by Subject|53|||
126299208|NCT01671007|454383443|FG003|Overall Study|Withdrawal by Subject|58|||
126299209|NCT01671007|454383444|FG004|Overall Study|Withdrawal by Subject|4|||
126299210|NCT01671007|454383445|FG005|Overall Study|Withdrawal by Subject|15|||
126299211|NCT01671007|454383446|FG006|Overall Study|Withdrawal by Subject|1|||
126299212|NCT01671007|454383447|FG007|Overall Study|Withdrawal by Subject|19|||
126299213|NCT01671007|454383448|FG008|Overall Study|Withdrawal by Subject|0|||
126299214|NCT01671007|454383440|FG000|Overall Study|Lost to Follow-up|93|||
126299215|NCT01671007|454383441|FG001|Overall Study|Lost to Follow-up|142|||
126299216|NCT01671007|454383442|FG002|Overall Study|Lost to Follow-up|91|||
126299217|NCT01671007|454383443|FG003|Overall Study|Lost to Follow-up|63|||
126299218|NCT01671007|454383444|FG004|Overall Study|Lost to Follow-up|7|||
126299219|NCT01671007|454383445|FG005|Overall Study|Lost to Follow-up|20|||
126299220|NCT01671007|454383446|FG006|Overall Study|Lost to Follow-up|2|||
126299221|NCT01671007|454383447|FG007|Overall Study|Lost to Follow-up|28|||
126299222|NCT01671007|454383448|FG008|Overall Study|Lost to Follow-up|0|||
126299223|NCT01671007|454383440|FG000|Overall Study|No end of study case report form|3|||
126299224|NCT01671007|454383441|FG001|Overall Study|No end of study case report form|1|||
126299225|NCT01671007|454383442|FG002|Overall Study|No end of study case report form|0|||
126299226|NCT01671007|454383443|FG003|Overall Study|No end of study case report form|2|||
126299227|NCT01671007|454383444|FG004|Overall Study|No end of study case report form|0|||
126299228|NCT01671007|454383445|FG005|Overall Study|No end of study case report form|0|||
126299229|NCT01671007|454383446|FG006|Overall Study|No end of study case report form|0|||
126299230|NCT01671007|454383447|FG007|Overall Study|No end of study case report form|0|||
126299231|NCT01671007|454383448|FG008|Overall Study|No end of study case report form|0|||
126299232|NCT01671007|454383440|FG000|Overall Study|Not eligible|23|||
126299233|NCT01671007|454383441|FG001|Overall Study|Not eligible|76|||
126299234|NCT01671007|454383442|FG002|Overall Study|Not eligible|25|||
126299235|NCT01671007|454383443|FG003|Overall Study|Not eligible|17|||
126299236|NCT01671007|454383444|FG004|Overall Study|Not eligible|0|||
126299237|NCT01671007|454383445|FG005|Overall Study|Not eligible|6|||
126299238|NCT01671007|454383446|FG006|Overall Study|Not eligible|1|||
126367275|NCT04191135|454639466|FG001|Induction Treatment|Withdrawal by Subject|0|||
126367276|NCT04191135|454639467|FG002|Induction Treatment|Withdrawal by Subject|0|||
126367277|NCT04191135|454639465|FG000|Randomized Treatment|Death|0|||
126367278|NCT04191135|454639466|FG001|Randomized Treatment|Death|50|||
126367279|NCT04191135|454639467|FG002|Randomized Treatment|Death|54|||
126367280|NCT04191135|454639465|FG000|Randomized Treatment|Lost to Follow-up|0|||
126367281|NCT04191135|454639466|FG001|Randomized Treatment|Lost to Follow-up|0|||
126367282|NCT04191135|454639467|FG002|Randomized Treatment|Lost to Follow-up|1|||
126367283|NCT04191135|454639465|FG000|Randomized Treatment|Withdrawal by Subject|0|||
126367284|NCT04191135|454639466|FG001|Randomized Treatment|Withdrawal by Subject|2|||
126367285|NCT04191135|454639467|FG002|Randomized Treatment|Withdrawal by Subject|0|||
126367286|NCT04191135|454639465|FG000|Randomized Treatment|Ongoing in Trial|0|||
126367287|NCT04191135|454639466|FG001|Randomized Treatment|Ongoing in Trial|83|||
126367288|NCT04191135|454639467|FG002|Randomized Treatment|Ongoing in Trial|81|||
126369557|NCT01497197|454650597|FG001|Overall Study|Excessive/lack of response to treatment|0|||
126369558|NCT01497197|454650596|FG000|Overall Study|Risk of OHSS|1|||
126369559|NCT01497197|454650597|FG001|Overall Study|Risk of OHSS|0|||
126369560|NCT01497197|454650596|FG000|Overall Study|No oocytes retrieved|3|||
126369561|NCT01497197|454650597|FG001|Overall Study|No oocytes retrieved|2|||
126369562|NCT01497197|454650596|FG000|Overall Study|No fertilisation|6|||
126369563|NCT01497197|454650597|FG001|Overall Study|No fertilisation|5|||
126369564|NCT01497197|454650596|FG000|Overall Study|Intention to freeze all embryos|0|||
126369565|NCT01497197|454650597|FG001|Overall Study|Intention to freeze all embryos|1|||
126369566|NCT01497197|454650596|FG000|Overall Study|All embryos discarded|0|||
126369567|NCT01497197|454650597|FG001|Overall Study|All embryos discarded|3|||
126369568|NCT01497197|454650596|FG000|Overall Study|Other|3|||
126369569|NCT01497197|454650597|FG001|Overall Study|Other|1|||
126369570|NCT00565747|454650603|FG000|Overall Study|No embryo transfer|67|||
126369571|NCT00565747|454650604|FG001|Overall Study|No embryo transfer|73|||
126299239|NCT01671007|454383447|FG007|Overall Study|Not eligible|19|||
126299240|NCT01671007|454383448|FG008|Overall Study|Not eligible|0|||
126299241|NCT00391768|454383449|FG000|Overall Study|Withdrawal by Subject|0|||
126299242|NCT00391768|454383450|FG001|Overall Study|Withdrawal by Subject|0|||
126461407|NCT01244490|454989562|FG001|Overall Study|Withdrawal by Subject|4|||
126461408|NCT01244490|454989563|FG002|Overall Study|Withdrawal by Subject|9|||
126461409|NCT01244490|454989561|FG000|Overall Study|Adverse Event|1|||
126299243|NCT00391768|454383451|FG002|Overall Study|Withdrawal by Subject|1|||
126299244|NCT00391768|454383452|FG003|Overall Study|Withdrawal by Subject|0|||
126299245|NCT00391768|454383453|FG004|Overall Study|Withdrawal by Subject|0|||
126299246|NCT00391768|454383454|FG005|Overall Study|Withdrawal by Subject|1|||
126299247|NCT00391768|454383455|FG006|Overall Study|Withdrawal by Subject|1|||
126299248|NCT00391768|454383449|FG000|Overall Study|Lost to Follow-up|0|||
126299249|NCT00391768|454383450|FG001|Overall Study|Lost to Follow-up|0|||
126299250|NCT00391768|454383451|FG002|Overall Study|Lost to Follow-up|0|||
126299251|NCT00391768|454383452|FG003|Overall Study|Lost to Follow-up|1|||
126299252|NCT00391768|454383453|FG004|Overall Study|Lost to Follow-up|2|||
126299253|NCT00391768|454383454|FG005|Overall Study|Lost to Follow-up|2|||
126299254|NCT00391768|454383455|FG006|Overall Study|Lost to Follow-up|3|||
126299255|NCT00449865|454383456|FG000|Overall Study|Withdrawal by Subject|110|||
126299256|NCT00449865|454383457|FG001|Overall Study|Withdrawal by Subject|110|||
126299257|NCT00449865|454383456|FG000|Overall Study|Lost to Follow-up|36|||
126299258|NCT00449865|454383457|FG001|Overall Study|Lost to Follow-up|37|||
126299259|NCT00449865|454383456|FG000|Overall Study|Physician Decision|13|||
126299260|NCT00449865|454383457|FG001|Overall Study|Physician Decision|12|||
126299261|NCT00449865|454383456|FG000|Overall Study|Death|31|||
126299262|NCT00449865|454383457|FG001|Overall Study|Death|40|||
126299263|NCT00449865|454383456|FG000|Overall Study|Protocol Violation|8|||
126299264|NCT00449865|454383457|FG001|Overall Study|Protocol Violation|7|||
126299265|NCT00449865|454383456|FG000|Overall Study|Study was stopped|324|||
126299266|NCT00449865|454383457|FG001|Overall Study|Study was stopped|328|||
126299267|NCT00444535|454383458|FG000|Overall Study|Withdrawal by Subject|5|||
126299268|NCT00444535|454383458|FG000|Overall Study|Physician Decision|5|||
126299269|NCT00444535|454383458|FG000|Overall Study|progressive disease|1|||
126299270|NCT00444535|454383458|FG000|Overall Study|Adverse Event|2|||
126299271|NCT00406367|454383459|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
126299272|NCT00406367|454383460|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
126299273|NCT00406367|454383459|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
126299274|NCT00406367|454383460|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
126299275|NCT00406367|454383459|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
126299276|NCT00406367|454383460|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
126299277|NCT00406367|454383459|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
126299278|NCT00406367|454383460|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
126299279|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
126299280|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
126299281|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
126299282|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
126299283|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
126299284|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
126299285|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
126299286|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
126299287|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
126299288|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
126299289|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
126299290|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
126299291|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
126299292|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
126461410|NCT01244490|454989562|FG001|Overall Study|Adverse Event|9|||
126461411|NCT01244490|454989563|FG002|Overall Study|Adverse Event|5|||
126461412|NCT01244490|454989561|FG000|Overall Study|Lost to Follow-up|0|||
126461413|NCT01244490|454989562|FG001|Overall Study|Lost to Follow-up|6|||
126461414|NCT01244490|454989563|FG002|Overall Study|Lost to Follow-up|3|||
126461415|NCT01244490|454989561|FG000|Overall Study|Other|0|||
126461416|NCT01244490|454989562|FG001|Overall Study|Other|0|||
126461417|NCT01244490|454989563|FG002|Overall Study|Other|1|||
126712245|NCT00306891|455897623|FG001|Part B|Withdrawal by Subject|0|||
126712246|NCT00306891|455897624|FG002|Part B|Withdrawal by Subject|3|||
126712247|NCT00306891|455897625|FG003|Part B|Withdrawal by Subject|1|||
126712248|NCT00306891|455897622|FG000|Part B|Condition under investigation worsened|0|||
126712249|NCT00306891|455897623|FG001|Part B|Condition under investigation worsened|0|||
126712250|NCT00306891|455897624|FG002|Part B|Condition under investigation worsened|2|||
126299293|NCT00406367|454383459|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
126299294|NCT00406367|454383460|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
126461418|NCT00256282|454989571|FG000|Overall Study|Disease progression, relapse during acti|12|||
126461419|NCT00256282|454989571|FG000|Overall Study|Adverse Event|3|||
126299295|NCT00171210|454383461|FG000|Overall Study|Adverse Event|16|||
126461420|NCT00256282|454989571|FG000|Overall Study|Physician Decision|1|||
126712251|NCT00306891|455897625|FG003|Part B|Condition under investigation worsened|8|||
126367289|NCT03514134|454640892|FG000|Overall Study|Lost to Follow-up|0|||
126367290|NCT03514134|454640893|FG001|Overall Study|Lost to Follow-up|1|||
126367291|NCT02471144|454640894|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
126367292|NCT02471144|454640895|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
126367293|NCT02471144|454640896|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
126367294|NCT02471144|454640897|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
126367295|NCT02471144|454640898|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
126367296|NCT02471144|454640899|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
126367297|NCT02471144|454640900|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
126367298|NCT02471144|454640901|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
126367299|NCT02471144|454640902|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
126367300|NCT02471144|454640903|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
126367301|NCT02471144|454640904|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
126367302|NCT02471144|454640894|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367303|NCT02471144|454640895|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367304|NCT02471144|454640896|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367305|NCT02471144|454640897|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
126367306|NCT02471144|454640898|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367307|NCT02471144|454640899|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367308|NCT02471144|454640900|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367309|NCT02471144|454640901|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367310|NCT02471144|454640902|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367311|NCT02471144|454640903|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367312|NCT02471144|454640904|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
126367313|NCT02471144|454640894|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367314|NCT02471144|454640895|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367315|NCT02471144|454640896|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
126367316|NCT02471144|454640897|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367317|NCT02471144|454640898|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367318|NCT02471144|454640899|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367319|NCT02471144|454640900|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367320|NCT02471144|454640901|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367321|NCT02471144|454640902|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367322|NCT02471144|454640903|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367323|NCT02471144|454640904|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
126367324|NCT02471144|454640894|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
126367325|NCT02471144|454640895|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
126367326|NCT02471144|454640896|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367327|NCT02471144|454640897|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367328|NCT02471144|454640898|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367329|NCT02471144|454640899|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367330|NCT02471144|454640900|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367331|NCT02471144|454640901|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367332|NCT02471144|454640902|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367333|NCT02471144|454640903|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367334|NCT02471144|454640904|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
126367335|NCT02471144|454640894|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367336|NCT02471144|454640895|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367337|NCT02471144|454640896|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367338|NCT02471144|454640897|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367339|NCT02471144|454640898|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
126367340|NCT02471144|454640899|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367341|NCT02471144|454640900|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
126367342|NCT02471144|454640901|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367343|NCT02471144|454640902|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
126367344|NCT02471144|454640903|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367345|NCT02471144|454640904|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
126367346|NCT02471144|454640894|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367347|NCT02471144|454640895|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367348|NCT02471144|454640896|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367349|NCT02471144|454640897|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367350|NCT02471144|454640898|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367351|NCT02471144|454640899|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
126367352|NCT02471144|454640900|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367353|NCT02471144|454640901|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367354|NCT02471144|454640902|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
126369572|NCT00183248|454650605|FG000|Overall Study|Lost to Follow-up|0|||
126367355|NCT02471144|454640903|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367356|NCT02471144|454640904|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
126367357|NCT02471144|454640894|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126367358|NCT02471144|454640895|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126712252|NCT00306891|455897622|FG000|Part B|Development of study specific disc crit.|0|||
126712253|NCT00306891|455897623|FG001|Part B|Development of study specific disc crit.|0|||
126712254|NCT00306891|455897624|FG002|Part B|Development of study specific disc crit.|0|||
126712255|NCT00306891|455897625|FG003|Part B|Development of study specific disc crit.|1|||
126712256|NCT00673673|455897626|FG000|Overall Study|Progressive disease|27|||
126712257|NCT00673673|455897626|FG000|Overall Study|Adverse Event|4|||
126712258|NCT00673673|455897626|FG000|Overall Study|Withdrawal by Subject|3|||
126712259|NCT00673673|455897626|FG000|Overall Study|Investigators' discretion|2|||
126712260|NCT01751646|455897627|FG000|Overall Study|Lost to Follow-up|5|||
126712261|NCT01751646|455897628|FG001|Overall Study|Lost to Follow-up|1|||
126712262|NCT01751646|455897627|FG000|Overall Study|Withdrawal by Subject|0|||
126712263|NCT01751646|455897628|FG001|Overall Study|Withdrawal by Subject|4|||
126712264|NCT01751646|455897627|FG000|Overall Study|Starting hormone therapy|1|||
126712265|NCT01751646|455897628|FG001|Overall Study|Starting hormone therapy|0|||
126712266|NCT01751646|455897627|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
126712267|NCT01751646|455897628|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
126712268|NCT01751646|455897627|FG000|Overall Study|Inadvertent enrollment|1|||
126712269|NCT01751646|455897628|FG001|Overall Study|Inadvertent enrollment|1|||
126712270|NCT01751646|455897627|FG000|Overall Study|Moved out of the area|1|||
126712271|NCT01751646|455897628|FG001|Overall Study|Moved out of the area|5|||
126712272|NCT01751646|455897627|FG000|Overall Study|Inability to attend required visits|0|||
126712273|NCT01751646|455897628|FG001|Overall Study|Inability to attend required visits|1|||
126712274|NCT01751646|455897627|FG000|Overall Study|Off study due to multiple obligations|0|||
126712275|NCT01751646|455897628|FG001|Overall Study|Off study due to multiple obligations|1|||
126712276|NCT01751646|455897627|FG000|Overall Study|Fails to comply with study requirements|0|||
126712277|NCT01751646|455897628|FG001|Overall Study|Fails to comply with study requirements|1|||
126712278|NCT01751646|455897627|FG000|Overall Study|Childcare issues|1|||
126712279|NCT01751646|455897628|FG001|Overall Study|Childcare issues|1|||
126712280|NCT02335450|455897629|FG000|Overall Study|Pregnancy|1|||
126712281|NCT02613572|455897630|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
126712282|NCT02613572|455897631|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
126712283|NCT02613572|455897632|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
126712284|NCT02613572|455897630|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
126712285|NCT02613572|455897631|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
126712286|NCT02613572|455897632|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
126712287|NCT04542291|455897633|FG000|Overall Study|Adverse Event|1|||
126712288|NCT04542291|455897633|FG000|Overall Study|Physician Decision|2|||
126712289|NCT04538950|455897634|FG000|Overall Study|Pulmonary Issues|2|||
126712290|NCT04538950|455897634|FG000|Overall Study|illness|2|||
126712291|NCT01004146|455897635|FG000|Overall Study|Withdrawal by Subject|4|||
126712292|NCT01004146|455897636|FG001|Overall Study|Withdrawal by Subject|5|||
126712293|NCT00970294|455897639|FG000|Overall Study|Physician Decision|4|||
126712294|NCT00970294|455897639|FG000|Overall Study|Withdrawal by Subject|1|||
126712295|NCT00847561|455897640|FG000|Overall Study|Withdrawal by Subject|4|||
126712296|NCT00847561|455897641|FG001|Overall Study|Withdrawal by Subject|3|||
126712297|NCT00847561|455897640|FG000|Overall Study|Unable to schedule|9|||
126712298|NCT00847561|455897641|FG001|Overall Study|Unable to schedule|1|||
126712299|NCT00447421|455897642|FG000|Overall Study|Lack of Efficacy|1|||
126712300|NCT00447421|455897642|FG000|Overall Study|Adverse Event|3|||
126712301|NCT00447421|455897642|FG000|Overall Study|Sponsor Decision|2|||
126712302|NCT01707147|455897643|FG000|Overall Study|Administered Trajenta prior to contract|5|||
126712303|NCT01707147|455897643|FG000|Overall Study|Patients who have not taken Trajenta|1|||
126712304|NCT01707147|455897643|FG000|Overall Study|Follow-up failure|17|||
126299296|NCT00171210|454383462|FG001|Overall Study|Adverse Event|27|||
126299297|NCT00171210|454383461|FG000|Overall Study|Abnormal laboratory value(s)|6|||
126299298|NCT00171210|454383462|FG001|Overall Study|Abnormal laboratory value(s)|3|||
126299299|NCT00171210|454383461|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126299300|NCT00171210|454383462|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126299301|NCT00171210|454383461|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
126299302|NCT00171210|454383462|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
126299303|NCT00171210|454383461|FG000|Overall Study|Protocol Violation|0|||
126299304|NCT00171210|454383462|FG001|Overall Study|Protocol Violation|2|||
126299305|NCT00171210|454383461|FG000|Overall Study|Withdrawal by Subject|32|||
126299306|NCT00171210|454383462|FG001|Overall Study|Withdrawal by Subject|30|||
126299307|NCT00171210|454383461|FG000|Overall Study|Lost to Follow-up|1|||
126299308|NCT00171210|454383462|FG001|Overall Study|Lost to Follow-up|0|||
126299309|NCT00171210|454383461|FG000|Overall Study|Administrative problems|1|||
126299310|NCT00171210|454383462|FG001|Overall Study|Administrative problems|1|||
126299311|NCT00171210|454383461|FG000|Overall Study|Death|2|||
126769832|NCT01915498|456110457|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126769833|NCT01915498|456110458|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126769834|NCT01915498|456110459|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
126769835|NCT01915498|456110460|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
126769836|NCT01915498|456110442|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769837|NCT01915498|456110443|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769838|NCT01915498|456110444|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769839|NCT01915498|456110445|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769840|NCT01915498|456110446|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769841|NCT01915498|456110447|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769842|NCT01915498|456110448|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769843|NCT01915498|456110449|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769844|NCT01915498|456110450|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769845|NCT01915498|456110451|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769846|NCT01915498|456110452|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
126769847|NCT01915498|456110453|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769848|NCT01915498|456110454|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769849|NCT01915498|456110455|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
126461421|NCT00327470|454989574|FG000|Overall Study|Randomized, but not treated|0|||
126769850|NCT01915498|456110456|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769851|NCT01915498|456110457|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769852|NCT01915498|456110458|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
126769853|NCT01915498|456110459|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
126769854|NCT01915498|456110460|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
126769855|NCT01915498|456110442|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
126769856|NCT01915498|456110443|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
126769857|NCT01915498|456110444|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126769858|NCT01915498|456110445|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
126769859|NCT01915498|456110446|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126769860|NCT01915498|456110447|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126769861|NCT01915498|456110448|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
126769862|NCT01915498|456110449|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126769863|NCT01915498|456110450|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126769864|NCT01915498|456110451|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126769865|NCT01915498|456110452|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
126769866|NCT01915498|456110453|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126769867|NCT01915498|456110454|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
126769868|NCT01915498|456110455|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
126769869|NCT01915498|456110456|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
126769870|NCT01915498|456110457|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
126769871|NCT01915498|456110458|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
126769872|NCT01915498|456110459|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
126769873|NCT01915498|456110460|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
126769874|NCT01915498|456110442|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126769875|NCT01915498|456110443|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126769876|NCT01915498|456110444|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
126769877|NCT01915498|456110445|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126769878|NCT01915498|456110446|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126769879|NCT01915498|456110447|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126769880|NCT01915498|456110448|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126299312|NCT00171210|454383462|FG001|Overall Study|Death|3|||
126299313|NCT00171210|454383461|FG000|Overall Study|Stopped at end of core|0|||
126299314|NCT00171210|454383462|FG001|Overall Study|Stopped at end of core|32|||
126299315|NCT00171210|454383461|FG000|Overall Study|Stopped at end of extension 1|0|||
126299316|NCT00171210|454383462|FG001|Overall Study|Stopped at end of extension 1|1|||
126299317|NCT03187301|454383465|FG000|Titration Period|Adverse Event|0|||
126299318|NCT03187301|454383466|FG001|Titration Period|Adverse Event|0|||
126461422|NCT00327470|454989575|FG001|Overall Study|Randomized, but not treated|2|||
126461423|NCT00327470|454989574|FG000|Overall Study|Adverse Event|9|||
126299319|NCT03187301|454383467|FG002|Titration Period|Adverse Event|0|||
126299320|NCT03187301|454383468|FG003|Titration Period|Adverse Event|0|||
126299321|NCT03187301|454383469|FG004|Titration Period|Adverse Event|0|||
126299322|NCT03187301|454383470|FG005|Titration Period|Adverse Event|0|||
126299323|NCT03187301|454383471|FG006|Titration Period|Adverse Event|5|||
126299324|NCT03187301|454383465|FG000|Titration Period|Withdrawal by Subject|0|||
126299325|NCT03187301|454383466|FG001|Titration Period|Withdrawal by Subject|0|||
126299326|NCT03187301|454383467|FG002|Titration Period|Withdrawal by Subject|0|||
126299327|NCT03187301|454383468|FG003|Titration Period|Withdrawal by Subject|0|||
126299328|NCT03187301|454383469|FG004|Titration Period|Withdrawal by Subject|0|||
126299329|NCT03187301|454383470|FG005|Titration Period|Withdrawal by Subject|0|||
126299330|NCT03187301|454383471|FG006|Titration Period|Withdrawal by Subject|1|||
126299331|NCT03187301|454383465|FG000|Titration Period|Exclusion Criteria Met|0|||
126299332|NCT03187301|454383466|FG001|Titration Period|Exclusion Criteria Met|0|||
126299333|NCT03187301|454383467|FG002|Titration Period|Exclusion Criteria Met|0|||
126299334|NCT03187301|454383468|FG003|Titration Period|Exclusion Criteria Met|0|||
126299335|NCT03187301|454383469|FG004|Titration Period|Exclusion Criteria Met|0|||
126299336|NCT03187301|454383470|FG005|Titration Period|Exclusion Criteria Met|0|||
126299337|NCT03187301|454383471|FG006|Titration Period|Exclusion Criteria Met|1|||
126299338|NCT03187301|454383465|FG000|Pre-Intervention|Withdrawal by Subject|1|||
126299339|NCT03187301|454383466|FG001|Pre-Intervention|Withdrawal by Subject|0|||
126299340|NCT03187301|454383467|FG002|Pre-Intervention|Withdrawal by Subject|0|||
126299341|NCT03187301|454383468|FG003|Pre-Intervention|Withdrawal by Subject|0|||
126299342|NCT03187301|454383469|FG004|Pre-Intervention|Withdrawal by Subject|0|||
126299343|NCT03187301|454383470|FG005|Pre-Intervention|Withdrawal by Subject|0|||
126299344|NCT03187301|454383471|FG006|Pre-Intervention|Withdrawal by Subject|0|||
126299345|NCT05005507|454383477|FG000|Overall Study|Premature termination of study|1|||
126299346|NCT04630002|454383482|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
126299347|NCT04630002|454383483|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
126299348|NCT04630002|454383484|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
126299349|NCT04630002|454383482|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
126299350|NCT04630002|454383483|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
126299351|NCT04630002|454383484|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
126299352|NCT04630002|454383482|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
126299353|NCT04630002|454383483|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
126299354|NCT04630002|454383484|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
126299355|NCT04630002|454383482|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
126299356|NCT04630002|454383483|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
126299357|NCT04630002|454383484|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
126299358|NCT04630002|454383482|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
126299359|NCT04630002|454383483|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
126299360|NCT04630002|454383484|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
126769881|NCT01915498|456110449|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126769882|NCT01915498|456110450|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126769883|NCT01915498|456110451|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126769884|NCT01915498|456110452|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126769885|NCT01915498|456110453|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126769886|NCT01915498|456110454|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126769887|NCT01915498|456110455|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126769888|NCT01915498|456110456|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126769889|NCT01915498|456110457|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
126769890|NCT01915498|456110458|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
126769891|NCT01915498|456110459|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
126769892|NCT01915498|456110460|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
126769893|NCT01915498|456110442|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769894|NCT01915498|456110443|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769895|NCT01915498|456110444|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769896|NCT01915498|456110445|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769897|NCT01915498|456110446|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
126769898|NCT01915498|456110447|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769899|NCT01915498|456110448|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769900|NCT01915498|456110449|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769901|NCT01915498|456110450|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769902|NCT01915498|456110451|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
126299361|NCT04630002|454383482|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
126367359|NCT02471144|454640896|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126299362|NCT04630002|454383483|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
126299363|NCT04630002|454383484|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
126299364|NCT04630002|454383482|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
126367360|NCT02471144|454640897|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126550231|NCT03884231|455309501|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
126550232|NCT03884231|455309501|FG000|Overall Study|Subject Withdrew Consent|1|||
126712305|NCT01707147|455897643|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
126712306|NCT02792777|455897644|FG000|Overall Study|Withdrawal by Subject|2|||
126712307|NCT02792777|455897645|FG001|Overall Study|Withdrawal by Subject|0|||
126712308|NCT02792777|455897644|FG000|Overall Study|Recording malfunction|2|||
126712309|NCT02792777|455897645|FG001|Overall Study|Recording malfunction|0|||
126712310|NCT02792777|455897644|FG000|Overall Study|Later determined to be ineligible|2|||
126712311|NCT02792777|455897645|FG001|Overall Study|Later determined to be ineligible|0|||
126712312|NCT02792777|455897644|FG000|Overall Study|Participant interviewed twice|1|||
126712313|NCT02792777|455897645|FG001|Overall Study|Participant interviewed twice|0|||
126712314|NCT01040832|455899000|FG000|Overall Study|Adverse Event|4|||
126712315|NCT01040832|455899001|FG001|Overall Study|Adverse Event|5|||
126712316|NCT01040832|455899000|FG000|Overall Study|Death|4|||
126712317|NCT01040832|455899001|FG001|Overall Study|Death|6|||
126712318|NCT01040832|455899000|FG000|Overall Study|Withdrawal by Subject|2|||
126712319|NCT01040832|455899001|FG001|Overall Study|Withdrawal by Subject|3|||
126712320|NCT01040832|455899000|FG000|Overall Study|Progressive disease|32|||
126712321|NCT01040832|455899001|FG001|Overall Study|Progressive disease|17|||
126712322|NCT01040832|455899000|FG000|Overall Study|Symptomatic deterioration|2|||
126712323|NCT01040832|455899001|FG001|Overall Study|Symptomatic deterioration|5|||
126712324|NCT01040832|455899000|FG000|Overall Study|Other|2|||
126712325|NCT01040832|455899001|FG001|Overall Study|Other|1|||
126712326|NCT01058369|455899007|FG000|Overall Study|Adverse Event|1|||
126712327|NCT01058369|455899007|FG000|Overall Study|Early termination study|1|||
126712328|NCT04530825|455899011|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
126712329|NCT04530825|455899012|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
126712330|NCT04530825|455899013|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
126712331|NCT04530825|455899014|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
126712332|NCT04530825|455899011|FG000|Overall Study|Did not complete follow-up|3|||
126712333|NCT04530825|455899012|FG001|Overall Study|Did not complete follow-up|0|||
126712334|NCT04530825|455899013|FG002|Overall Study|Did not complete follow-up|0|||
126712335|NCT04530825|455899014|FG003|Overall Study|Did not complete follow-up|0|||
126712336|NCT00850499|455899015|FG000|Overall Study|Adverse Event|3|||
126712337|NCT00850499|455899016|FG001|Overall Study|Adverse Event|1|||
126712338|NCT00850499|455899015|FG000|Overall Study|Lack of Efficacy|0|||
126712339|NCT00850499|455899016|FG001|Overall Study|Lack of Efficacy|1|||
126712340|NCT00909090|455899017|FG000|Overall Study|Lost to Follow-up|17|||
126712341|NCT00909090|455899018|FG001|Overall Study|Lost to Follow-up|17|||
126712342|NCT00858702|455899022|FG000|Overall Study|Lack of Efficacy|1|||
126712343|NCT00858702|455899023|FG001|Overall Study|Lack of Efficacy|0|||
126712344|NCT00858702|455899022|FG000|Overall Study|Protocol Violation|1|||
126712345|NCT00858702|455899023|FG001|Overall Study|Protocol Violation|1|||
126712346|NCT00858702|455899022|FG000|Overall Study|Other|2|||
126712347|NCT00858702|455899023|FG001|Overall Study|Other|1|||
126712348|NCT00858702|455899022|FG000|Overall Study|Withdrawal by Subject|1|||
126712349|NCT00858702|455899023|FG001|Overall Study|Withdrawal by Subject|0|||
126712350|NCT01214434|455899030|FG000|Overall Study|Withdrawal by Subject|1|||
126712351|NCT01214434|455899031|FG001|Overall Study|Withdrawal by Subject|0|||
126712352|NCT01214434|455899030|FG000|Overall Study|Lost to Follow-up|2|||
126712353|NCT01214434|455899031|FG001|Overall Study|Lost to Follow-up|2|||
126712354|NCT01214434|455899030|FG000|Overall Study|Site error|1|||
126712355|NCT01214434|455899031|FG001|Overall Study|Site error|0|||
126712356|NCT03792750|455899033|FG000|Overall Study|Death|3|||
126712357|NCT00138151|455899034|FG000|Overall Study|Withdrawal by Subject|3|||
126712358|NCT00138151|455899034|FG000|Overall Study|Physician Decision|1|||
126712359|NCT02902809|455899038|FG000|Overall Study|Discontinuation of asthma program|28|||
126712360|NCT00532259|455899039|FG000|Overall Study|Withdrawal by Subject|2|||
126712361|NCT00532259|455899039|FG000|Overall Study|Adverse Event|1|||
126712362|NCT00532259|455899039|FG000|Overall Study|Death|1|||
126712363|NCT00532259|455899039|FG000|Overall Study|Lack of Efficacy|21|||
126712364|NCT00532259|455899039|FG000|Overall Study|Lost to Follow-up|3|||
126712365|NCT00532259|455899039|FG000|Overall Study|Physician Decision|3|||
126712366|NCT00532259|455899039|FG000|Overall Study|Protocol Violation|1|||
126712367|NCT00793104|455899040|FG000|Overall Study|Lost to Follow-up|1|||
126712368|NCT03494725|455899041|FG000|Overall Study|Withdrawal by Subject|0|||
126712369|NCT03494725|455899042|FG001|Overall Study|Withdrawal by Subject|2|||
126712370|NCT03494725|455899041|FG000|Overall Study|Antibiotic use|1|||
126712371|NCT03494725|455899042|FG001|Overall Study|Antibiotic use|0|||
126712372|NCT04983940|455899043|FG000|Overall Study|Lost to Follow-up|14|||
126712373|NCT04983940|455899043|FG000|Overall Study|Lack of Efficacy|2|||
126712374|NCT00514449|455899044|FG000|Overall Study|Withdrawal by Subject|1|||
126712375|NCT00514449|455899045|FG001|Overall Study|Withdrawal by Subject|2|||
126712376|NCT00514449|455899044|FG000|Overall Study|Protocol Violation|1|||
126712377|NCT00514449|455899045|FG001|Overall Study|Protocol Violation|2|||
126712378|NCT00514449|455899044|FG000|Overall Study|Lost to Follow-up|1|||
126712379|NCT00514449|455899045|FG001|Overall Study|Lost to Follow-up|0|||
126769903|NCT01915498|456110452|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769904|NCT01915498|456110453|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769905|NCT01915498|456110454|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769906|NCT01915498|456110455|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769907|NCT01915498|456110456|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769908|NCT01915498|456110457|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769909|NCT01915498|456110458|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769910|NCT01915498|456110459|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769911|NCT01915498|456110460|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
126769912|NCT01915498|456110442|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
126769913|NCT01915498|456110443|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
126769914|NCT01915498|456110444|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
126769915|NCT01915498|456110445|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
126769916|NCT01915498|456110446|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
126769917|NCT01915498|456110447|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
126769918|NCT01915498|456110448|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
126769919|NCT01915498|456110449|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
126769920|NCT01915498|456110450|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
126769921|NCT01915498|456110451|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
126769922|NCT01915498|456110452|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
126769923|NCT01915498|456110453|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
126769924|NCT01915498|456110454|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
126769925|NCT01915498|456110455|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
126769926|NCT01915498|456110456|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
126769927|NCT01915498|456110457|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
126769928|NCT01915498|456110458|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
126769929|NCT01915498|456110459|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
126769930|NCT01915498|456110460|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
126769931|NCT01915498|456110442|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769932|NCT01915498|456110443|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769933|NCT01915498|456110444|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769934|NCT01915498|456110445|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769935|NCT01915498|456110446|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769936|NCT01915498|456110447|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769937|NCT01915498|456110448|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769938|NCT01915498|456110449|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769939|NCT01915498|456110450|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769940|NCT01915498|456110451|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769941|NCT01915498|456110452|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
126769942|NCT01915498|456110453|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769943|NCT01915498|456110454|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769944|NCT01915498|456110455|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769945|NCT01915498|456110456|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769946|NCT01915498|456110457|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769947|NCT01915498|456110458|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126461424|NCT00327470|454989575|FG001|Overall Study|Adverse Event|14|||
126461425|NCT00327470|454989574|FG000|Overall Study|Lack of Efficacy|7|||
126461426|NCT00327470|454989575|FG001|Overall Study|Lack of Efficacy|19|||
126461427|NCT00327470|454989574|FG000|Overall Study|Other|5|||
126461428|NCT00327470|454989575|FG001|Overall Study|Other|9|||
126769948|NCT01915498|456110459|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769949|NCT01915498|456110460|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
126769950|NCT01915498|456110442|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
126461429|NCT00327470|454989574|FG000|Overall Study|Lost to Follow-up|1|||
126461430|NCT00327470|454989575|FG001|Overall Study|Lost to Follow-up|3|||
126461431|NCT00327470|454989574|FG000|Overall Study|Withdrawal by Subject|6|||
126461432|NCT00327470|454989575|FG001|Overall Study|Withdrawal by Subject|12|||
126461433|NCT00327470|454989574|FG000|Overall Study|Death|1|||
126461434|NCT00327470|454989575|FG001|Overall Study|Death|4|||
126461435|NCT02581943|454989578|FG000|Overall Study|Death|5|||
126461436|NCT02581943|454989579|FG001|Overall Study|Death|2|||
126461437|NCT02581943|454989578|FG000|Overall Study|Disease Progression|12|||
126769951|NCT01915498|456110443|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
126461438|NCT02581943|454989579|FG001|Overall Study|Disease Progression|15|||
126461439|NCT02581943|454989578|FG000|Overall Study|Withdrawal by Subject|1|||
126461440|NCT02581943|454989579|FG001|Overall Study|Withdrawal by Subject|2|||
126461441|NCT01307020|454989581|FG000|Overall Study|Lost to Follow-up|0|||
126461442|NCT01307020|454989582|FG001|Overall Study|Lost to Follow-up|0|||
126461443|NCT01307020|454989583|FG002|Overall Study|Lost to Follow-up|1|||
126461444|NCT01307020|454989584|FG003|Overall Study|Lost to Follow-up|1|||
126461445|NCT01307020|454989585|FG004|Overall Study|Lost to Follow-up|0|||
126461446|NCT01307020|454989586|FG005|Overall Study|Lost to Follow-up|0|||
126461447|NCT01307020|454989587|FG006|Overall Study|Lost to Follow-up|1|||
126461448|NCT01307020|454989588|FG007|Overall Study|Lost to Follow-up|0|||
126461449|NCT01307020|454989589|FG008|Overall Study|Lost to Follow-up|0|||
126461450|NCT01307020|454989590|FG009|Overall Study|Lost to Follow-up|0|||
126461451|NCT01307020|454989581|FG000|Overall Study|Electronic data capture failure|0|||
126461452|NCT01307020|454989582|FG001|Overall Study|Electronic data capture failure|1|||
126461453|NCT01307020|454989583|FG002|Overall Study|Electronic data capture failure|0|||
126461454|NCT01307020|454989584|FG003|Overall Study|Electronic data capture failure|0|||
126461455|NCT01307020|454989585|FG004|Overall Study|Electronic data capture failure|0|||
126461456|NCT01307020|454989586|FG005|Overall Study|Electronic data capture failure|0|||
126461457|NCT01307020|454989587|FG006|Overall Study|Electronic data capture failure|0|||
126461458|NCT01307020|454989588|FG007|Overall Study|Electronic data capture failure|0|||
126461459|NCT01307020|454989589|FG008|Overall Study|Electronic data capture failure|0|||
126461460|NCT01307020|454989590|FG009|Overall Study|Electronic data capture failure|0|||
126461461|NCT02021656|454989591|FG000|Overall Study|Adverse Event|1|||
126769952|NCT01915498|456110444|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126769953|NCT01915498|456110445|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126769954|NCT01915498|456110446|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
126769955|NCT01915498|456110447|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
126461462|NCT02021656|454989591|FG000|Overall Study|Lack of Efficacy|2|||
126461463|NCT02021656|454989591|FG000|Overall Study|Lost to Follow-up|1|||
126769956|NCT01915498|456110448|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126769957|NCT01915498|456110449|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
126769958|NCT01915498|456110450|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126769959|NCT01915498|456110451|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
126769960|NCT01915498|456110452|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126769961|NCT01915498|456110453|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126769962|NCT01915498|456110454|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
126769963|NCT01915498|456110455|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
126769964|NCT01915498|456110456|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
126769965|NCT01915498|456110457|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
126769966|NCT01915498|456110458|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
126769967|NCT01915498|456110459|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
126769968|NCT01915498|456110460|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
126769969|NCT01915498|456110442|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
126769970|NCT01915498|456110443|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
126769971|NCT01915498|456110444|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
126769972|NCT01915498|456110445|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
126769973|NCT01915498|456110446|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
126769974|NCT01915498|456110447|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
126769975|NCT01915498|456110448|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
126769976|NCT01915498|456110449|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
126769977|NCT01915498|456110450|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
126299365|NCT04630002|454383483|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
126461464|NCT02021656|454989591|FG000|Overall Study|Withdrew Consent|2|||
126461465|NCT00596362|454989600|FG000|Overall Study|Progressive Disease|1|||
126461466|NCT00356122|454989603|FG000|TREATMENT|Lack of Efficacy|26|||
126461467|NCT00356122|454989603|FG000|TREATMENT|Adverse Event|10|||
126461468|NCT00356122|454989603|FG000|TREATMENT|Subject's request|4|||
126461469|NCT00356122|454989603|FG000|TREATMENT|Other|4|||
126461470|NCT00356122|454989603|FG000|TREATMENT|Did not receive study medication|1|||
126461471|NCT00356122|454989603|FG000|FOLLOW-UP|Death|37|||
126461472|NCT00356122|454989603|FG000|FOLLOW-UP|Lost to Follow-up|2|||
126461473|NCT00356122|454989603|FG000|FOLLOW-UP|Other|2|||
126461474|NCT00491556|454989604|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
126461475|NCT00491556|454989605|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
126299366|NCT04630002|454383484|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
126299367|NCT04630002|454383482|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
126299368|NCT04630002|454383483|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
126299369|NCT04630002|454383484|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
126299370|NCT02375971|454383486|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
126299371|NCT02375971|454383487|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
126299372|NCT02375971|454383488|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
126299373|NCT02375971|454383486|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
126299374|NCT02375971|454383487|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
126299375|NCT02375971|454383488|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
126299376|NCT02375971|454383486|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
126461476|NCT00491556|454989604|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
126461477|NCT00491556|454989605|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
126769978|NCT01915498|456110451|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
126299377|NCT02375971|454383487|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
126769979|NCT01915498|456110452|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
126299378|NCT02375971|454383488|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
126299379|NCT02375971|454383486|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
126299380|NCT02375971|454383487|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
126299381|NCT02375971|454383488|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
126299382|NCT02375971|454383486|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
126299383|NCT02375971|454383487|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
126299384|NCT02375971|454383488|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
126299385|NCT02375971|454383486|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
126299386|NCT02375971|454383487|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
126299387|NCT02375971|454383488|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
126299388|NCT02375971|454383486|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
126299389|NCT02375971|454383487|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
126299390|NCT02375971|454383488|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
126299391|NCT02375971|454383486|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
126299392|NCT02375971|454383487|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
126299393|NCT02375971|454383488|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
126299394|NCT02556775|454383489|FG000|Overall Study|Withdrawal by Subject|1|||
126299395|NCT02556775|454383490|FG001|Overall Study|Withdrawal by Subject|0|||
126299396|NCT02556775|454383491|FG002|Overall Study|Withdrawal by Subject|1|||
126299397|NCT02556775|454383492|FG003|Overall Study|Withdrawal by Subject|0|||
126299398|NCT02556775|454383489|FG000|Overall Study|Lost to Follow-up|1|||
126299399|NCT02556775|454383490|FG001|Overall Study|Lost to Follow-up|0|||
126299400|NCT02556775|454383491|FG002|Overall Study|Lost to Follow-up|0|||
126299401|NCT02556775|454383492|FG003|Overall Study|Lost to Follow-up|0|||
126299402|NCT01346059|454383493|FG000|Overall Study|Withdrawal by Subject|1|||
126299403|NCT01346059|454383494|FG001|Overall Study|Withdrawal by Subject|0|||
126299404|NCT05047211|454383504|FG000|Overall Study|Lost to Follow-up|8|||
126299405|NCT05047211|454383505|FG001|Overall Study|Lost to Follow-up|5|||
126299406|NCT00561392|454383506|FG000|Overall Study|Adverse Event|38|||
126299407|NCT00561392|454383506|FG000|Overall Study|Lack of Efficacy|2|||
126299408|NCT00561392|454383506|FG000|Overall Study|Protocol Violation|1|||
126299409|NCT00561392|454383506|FG000|Overall Study|Withdrawal by Subject|8|||
126299410|NCT00561392|454383506|FG000|Overall Study|Administrative problems|4|||
126299411|NCT00594165|454383507|FG000|Overall Study|Major protocol violation|1|||
126299412|NCT00594165|454383507|FG000|Overall Study|Lack of Efficacy|12|||
126299413|NCT00594165|454383507|FG000|Overall Study|Adverse Event|52|||
126299414|NCT00594165|454383507|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
126299415|NCT00594165|454383507|FG000|Overall Study|Subject withdrew consent|27|||
126299416|NCT00594165|454383507|FG000|Overall Study|Study ended per sponsor|102|||
126299417|NCT00594165|454383507|FG000|Overall Study|Lost to Follow-up|4|||
126299418|NCT00594165|454383507|FG000|Overall Study|Other: PI discretion|5|||
126299419|NCT00594165|454383507|FG000|Overall Study|Other: Subject moving|3|||
126299420|NCT00594165|454383507|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
126299421|NCT00594165|454383507|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
126299422|NCT00594165|454383507|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
126299423|NCT00594165|454383507|FG000|Overall Study|Other: Site terminated participation|2|||
126299424|NCT01662492|454383508|FG000|Overall Study|Other miscellaneous reasons.|1|||
126299425|NCT01662492|454383509|FG001|Overall Study|Other miscellaneous reasons.|0|||
126299426|NCT01662492|454383510|FG002|Overall Study|Other miscellaneous reasons.|1|||
126299427|NCT01662492|454383508|FG000|Overall Study|Withdrawal by Subject|0|||
126299428|NCT01662492|454383509|FG001|Overall Study|Withdrawal by Subject|0|||
126299429|NCT01662492|454383510|FG002|Overall Study|Withdrawal by Subject|1|||
126299430|NCT01662492|454383508|FG000|Overall Study|Protocol Violation|1|||
126299431|NCT01662492|454383509|FG001|Overall Study|Protocol Violation|0|||
126299432|NCT01662492|454383510|FG002|Overall Study|Protocol Violation|0|||
126299433|NCT01662492|454383508|FG000|Overall Study|Lost to Follow-up|0|||
126299434|NCT01662492|454383509|FG001|Overall Study|Lost to Follow-up|0|||
126299435|NCT01662492|454383510|FG002|Overall Study|Lost to Follow-up|2|||
126299436|NCT01662492|454383508|FG000|Overall Study|Lack of Efficacy|1|||
126299437|NCT01662492|454383509|FG001|Overall Study|Lack of Efficacy|1|||
126299438|NCT01662492|454383510|FG002|Overall Study|Lack of Efficacy|2|||
126299439|NCT04509076|454385072|FG000|Overall Study|Withdrawal by Subject|1|||
126299440|NCT04509076|454385073|FG001|Overall Study|Withdrawal by Subject|2|||
126299441|NCT04509076|454385072|FG000|Overall Study|Lost to Follow-up|1|||
126299442|NCT04509076|454385073|FG001|Overall Study|Lost to Follow-up|2|||
126299443|NCT01812109|454385074|FG000|Overall Study|research personnel delay|16|||
126299444|NCT01812109|454385074|FG000|Overall Study|NIRS Unattainable|17|||
126299445|NCT00442897|454385075|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
126299446|NCT00442897|454385076|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
126299447|NCT00442897|454385075|FG000|Base Study (12 Week Follow-up)|Death|0|||
126769980|NCT01915498|456110453|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
126461478|NCT00491556|454989604|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
126461479|NCT00491556|454989605|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
126461480|NCT00491556|454989604|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
126461481|NCT00491556|454989605|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
126461482|NCT00491556|454989604|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
126461483|NCT00491556|454989605|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
126461484|NCT00491556|454989604|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
126461485|NCT00491556|454989605|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
126461486|NCT00491556|454989604|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
126461487|NCT00491556|454989605|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
126769981|NCT01915498|456110454|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
126299448|NCT00442897|454385076|FG001|Base Study (12 Week Follow-up)|Death|1|||
126299449|NCT00442897|454385075|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
126299450|NCT00442897|454385076|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
126299451|NCT00442897|454385075|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
126299452|NCT00442897|454385076|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
126299453|NCT00442897|454385075|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
126299454|NCT00442897|454385076|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
126299455|NCT00442897|454385075|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
126299456|NCT00442897|454385076|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
126299457|NCT00442897|454385075|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
126299458|NCT00442897|454385076|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
126299459|NCT00442897|454385075|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
126299460|NCT00442897|454385076|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
126299461|NCT04498182|454385077|FG000|Overall Study|Adverse Event|2|||
126299462|NCT04498182|454385078|FG001|Overall Study|Adverse Event|3|||
126299463|NCT04498182|454385079|FG002|Overall Study|Adverse Event|2|||
126299464|NCT04498182|454385077|FG000|Overall Study|Withdrawal of Consent|3|||
126299465|NCT04498182|454385078|FG001|Overall Study|Withdrawal of Consent|4|||
126299466|NCT04498182|454385079|FG002|Overall Study|Withdrawal of Consent|3|||
126299467|NCT04498182|454385077|FG000|Overall Study|Non-Compliant|1|||
126299468|NCT04498182|454385078|FG001|Overall Study|Non-Compliant|0|||
126299469|NCT04498182|454385079|FG002|Overall Study|Non-Compliant|1|||
126299470|NCT04498182|454385077|FG000|Overall Study|Lost to Follow-up|0|||
126299471|NCT04498182|454385078|FG001|Overall Study|Lost to Follow-up|0|||
126299472|NCT04498182|454385079|FG002|Overall Study|Lost to Follow-up|1|||
126299473|NCT04498182|454385077|FG000|Overall Study|Investigator Decision|0|||
126299474|NCT04498182|454385078|FG001|Overall Study|Investigator Decision|0|||
126299475|NCT04498182|454385079|FG002|Overall Study|Investigator Decision|1|||
126299476|NCT04498182|454385077|FG000|Overall Study|Protocol Violation|1|||
126299477|NCT04498182|454385078|FG001|Overall Study|Protocol Violation|0|||
126299478|NCT04498182|454385079|FG002|Overall Study|Protocol Violation|2|||
126299479|NCT02182843|454385080|FG000|Overall Study|Withdrawal by Subject|7|||
126299480|NCT02182843|454385080|FG000|Overall Study|Lost to Follow-up|2|||
126299481|NCT02182843|454385080|FG000|Overall Study|Adverse Event|1|||
126299482|NCT00832455|454385083|FG000|Overall Study|Adverse Event|13|||
126299483|NCT00832455|454385083|FG000|Overall Study|Lost to Follow-up|26|||
126299484|NCT00832455|454385083|FG000|Overall Study|Protocol Violation|4|||
126299485|NCT00832455|454385083|FG000|Overall Study|Withdrawal by Subject|17|||
126299486|NCT00832455|454385083|FG000|Overall Study|Screening Failure|2|||
126299487|NCT00832455|454385083|FG000|Overall Study|Stopped Medication|4|||
126299488|NCT00832455|454385083|FG000|Overall Study|Parent misunderstood study|1|||
126299489|NCT00832455|454385083|FG000|Overall Study|Parent dissatisfied|1|||
126299490|NCT00832455|454385083|FG000|Overall Study|No improvement|3|||
126299491|NCT00832455|454385083|FG000|Overall Study|Patient moved|1|||
126299492|NCT04548193|454385085|FG000|Overall Study|Lost to Follow-up|0|||
126299493|NCT04548193|454385086|FG001|Overall Study|Lost to Follow-up|1|||
126299494|NCT04548193|454385085|FG000|Overall Study|Death|0|||
126299495|NCT04548193|454385086|FG001|Overall Study|Death|1|||
126299496|NCT04548193|454385085|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
126299497|NCT04548193|454385086|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
126299498|NCT04548193|454385085|FG000|Overall Study|Withdrawal by Subject|2|||
126299499|NCT04548193|454385086|FG001|Overall Study|Withdrawal by Subject|2|||
126299500|NCT02275819|454385088|FG000|Overall Study|Adverse Event|0|||
126299501|NCT02275819|454385089|FG001|Overall Study|Adverse Event|1|||
126299502|NCT02211209|454385090|FG000|Overall Study|Investigator judgment|0|||
126299503|NCT02211209|454385091|FG001|Overall Study|Investigator judgment|1|||
126299504|NCT02211209|454385090|FG000|Overall Study|Voluntary withdrawal|1|||
126299505|NCT02211209|454385091|FG001|Overall Study|Voluntary withdrawal|4|||
126461488|NCT00491556|454989604|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
126461489|NCT00491556|454989605|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
126299506|NCT02211209|454385090|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
126299507|NCT02211209|454385091|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
126299508|NCT02211209|454385090|FG000|Overall Study|Reason Not Specified|1|||
126299509|NCT02211209|454385091|FG001|Overall Study|Reason Not Specified|0|||
126299510|NCT00931255|454385092|FG000|Overall Study|Follow up biopsy not done|2|||
126299511|NCT00931255|454385093|FG001|Overall Study|Follow up biopsy not done|3|||
126299512|NCT01372995|454385094|FG000|Overall Study|Spouse withdrew participant from study|0|||
126299513|NCT01372995|454385095|FG001|Overall Study|Spouse withdrew participant from study|1|||
126299514|NCT01372995|454385096|FG002|Overall Study|Spouse withdrew participant from study|0|||
126299515|NCT01372995|454385094|FG000|Overall Study|Physician Decision|0|||
126299516|NCT01372995|454385095|FG001|Overall Study|Physician Decision|0|||
126299517|NCT01372995|454385096|FG002|Overall Study|Physician Decision|1|||
126299518|NCT01575834|454385097|FG000|Overall Study|Withdrawal by Subject|352|||
126299519|NCT01575834|454385098|FG001|Overall Study|Withdrawal by Subject|390|||
126299520|NCT01575834|454385097|FG000|Overall Study|Death|81|||
126299521|NCT01575834|454385098|FG001|Overall Study|Death|74|||
126299522|NCT01575834|454385097|FG000|Overall Study|Other|70|||
126299523|NCT01575834|454385098|FG001|Overall Study|Other|70|||
126299524|NCT01575834|454385097|FG000|Overall Study|Adverse Event|63|||
126299525|NCT01575834|454385098|FG001|Overall Study|Adverse Event|61|||
126299526|NCT01575834|454385097|FG000|Overall Study|Lost to Follow-up|55|||
126299527|NCT01575834|454385098|FG001|Overall Study|Lost to Follow-up|68|||
126461490|NCT00491556|454989604|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
126461491|NCT00491556|454989605|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
126461492|NCT00491556|454989604|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
126461493|NCT00491556|454989605|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
126461494|NCT00491556|454989604|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
126299528|NCT01575834|454385097|FG000|Overall Study|Noncompliance|52|||
126299529|NCT01575834|454385098|FG001|Overall Study|Noncompliance|27|||
126299530|NCT01575834|454385097|FG000|Overall Study|Administrative decision|15|||
126299531|NCT01575834|454385098|FG001|Overall Study|Administrative decision|33|||
126299532|NCT01575834|454385097|FG000|Overall Study|Ineligibility Determined|5|||
126299533|NCT01575834|454385098|FG001|Overall Study|Ineligibility Determined|8|||
126461495|NCT00491556|454989605|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
126299534|NCT01575834|454385097|FG000|Overall Study|Protocol Deviation|4|||
126461496|NCT00491556|454989604|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
126461497|NCT00491556|454989605|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
126712380|NCT00301067|455899047|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
126712381|NCT00301067|455899048|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
126712382|NCT00301067|455899049|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
126712383|NCT00301067|455899050|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
126712384|NCT00301067|455899047|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
126712385|NCT00301067|455899048|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
126712386|NCT00301067|455899049|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
126712387|NCT00301067|455899050|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
126712388|NCT00301067|455899047|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
126712389|NCT00301067|455899048|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
126712390|NCT00301067|455899049|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
126712391|NCT00301067|455899050|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
126712392|NCT00301067|455899047|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
126712393|NCT00301067|455899048|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
126712394|NCT00301067|455899049|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
126712395|NCT00301067|455899050|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
126712396|NCT00301067|455899047|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
126712397|NCT00301067|455899048|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
126712398|NCT00301067|455899049|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
126712399|NCT00301067|455899050|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
126712400|NCT00301067|455899047|FG000|Follow up Until Death|Alive at last data cut point|1|||
126712401|NCT00301067|455899048|FG001|Follow up Until Death|Alive at last data cut point|0|||
126712402|NCT00301067|455899049|FG002|Follow up Until Death|Alive at last data cut point|0|||
126712403|NCT00301067|455899050|FG003|Follow up Until Death|Alive at last data cut point|1|||
126712404|NCT00149825|455899051|FG000|Overall Study|Intolerance to medication side effects|1|||
126712405|NCT00149825|455899052|FG001|Overall Study|Intolerance to medication side effects|2|||
126712406|NCT00149825|455899051|FG000|Overall Study|Time commitments|2|||
126299535|NCT01575834|454385098|FG001|Overall Study|Protocol Deviation|3|||
126299536|NCT01575834|454385097|FG000|Overall Study|Requirement for Alternative Therapy|2|||
126299537|NCT01575834|454385098|FG001|Overall Study|Requirement for Alternative Therapy|4|||
126299538|NCT01741688|454385100|FG000|Overall Study|Lack of insurance coverage|2|||
126299539|NCT01741688|454385100|FG000|Overall Study|Withdrawal by Subject|1|||
126461498|NCT00491556|454989604|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
126299540|NCT02220764|454385106|FG000|Overall Study|Lost to Follow-up|3|||
126299541|NCT02220764|454385107|FG001|Overall Study|Lost to Follow-up|1|||
126299542|NCT02220764|454385106|FG000|Overall Study|Death|1|||
126461499|NCT00491556|454989605|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
126461500|NCT00491556|454989604|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
126461501|NCT00491556|454989605|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
126461502|NCT00491556|454989604|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
126461503|NCT00491556|454989605|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
126461504|NCT00491556|454989604|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
126461505|NCT00491556|454989605|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
126461506|NCT00491556|454989604|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
126461507|NCT00491556|454989605|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
126461508|NCT00491556|454989604|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
126461509|NCT00491556|454989605|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
126461510|NCT00491556|454989604|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
126461511|NCT00491556|454989605|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
126461512|NCT00491556|454989604|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
126461513|NCT00491556|454989605|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
126461514|NCT02418156|454989606|FG000|Overall Study|Lost to Follow-up|12|||
126461515|NCT02418156|454989606|FG000|Overall Study|Death|2|||
126461516|NCT02418156|454989606|FG000|Overall Study|Physician Decision|1|||
126461517|NCT02418156|454989606|FG000|Overall Study|Withdrawal by Subject|1|||
126461518|NCT02418156|454989606|FG000|Overall Study|Subject refused to return|1|||
126461519|NCT04854642|454991400|FG000|Overall Study|Adverse Event|1|||
126550233|NCT03884231|455309501|FG000|Overall Study|MRI Scan Not Performed|1|||
126550234|NCT01853254|455309502|FG000|Overall Study|Abnormal Laboratory Test|1|||
126712407|NCT00149825|455899052|FG001|Overall Study|Time commitments|1|||
126299543|NCT02220764|454385107|FG001|Overall Study|Death|0|||
126299544|NCT05000164|454385108|FG000|Overall Study|Adverse Event|1|||
126299545|NCT05000164|454385108|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
126299546|NCT05000164|454385108|FG000|Overall Study|Lens Discomfort|3|||
126299547|NCT05000164|454385108|FG000|Overall Study|Withdrew Consent during Study|2|||
126299548|NCT05000164|454385108|FG000|Overall Study|Subject Withdrawn by PI|2|||
126299549|NCT05000164|454385108|FG000|Overall Study|Other Fractured Test Article|1|||
126299550|NCT02198664|454385111|FG000|Overall Study|Adverse Event|2|||
126299551|NCT02198664|454385112|FG001|Overall Study|Adverse Event|0|||
126299552|NCT02198664|454385111|FG000|Overall Study|Withdrawal by Subject|11|||
126299553|NCT02198664|454385112|FG001|Overall Study|Withdrawal by Subject|8|||
126299554|NCT02198664|454385111|FG000|Overall Study|Failure to tolerate|2|||
126299555|NCT02198664|454385112|FG001|Overall Study|Failure to tolerate|0|||
126299556|NCT02198664|454385111|FG000|Overall Study|Not stated|1|||
126299557|NCT02198664|454385112|FG001|Overall Study|Not stated|0|||
126299558|NCT06509438|454385115|FG000|Overall Study|Adverse Event|1|||
126299559|NCT06509438|454385115|FG000|Overall Study|Lost to Follow-up|3|||
126299560|NCT03331796|454385116|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
126299561|NCT03331796|454385117|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
126299562|NCT03331796|454385118|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
126299563|NCT03331796|454385116|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
126299564|NCT03331796|454385117|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
126299565|NCT03331796|454385118|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
126299566|NCT03331796|454385116|FG000|Extended Follow-up|Adverse Event|1|||
126299567|NCT03331796|454385117|FG001|Extended Follow-up|Adverse Event|0|||
126299568|NCT03331796|454385118|FG002|Extended Follow-up|Adverse Event|1|||
126299569|NCT03331796|454385116|FG000|Extended Follow-up|Lost to Follow-up|0|||
126299570|NCT03331796|454385117|FG001|Extended Follow-up|Lost to Follow-up|0|||
126299571|NCT03331796|454385118|FG002|Extended Follow-up|Lost to Follow-up|1|||
126461520|NCT04854642|454991401|FG001|Overall Study|Adverse Event|2|||
126461521|NCT04854642|454991400|FG000|Overall Study|Withdrawal by Subject|0|||
126461522|NCT04854642|454991401|FG001|Overall Study|Withdrawal by Subject|1|||
126461523|NCT00562627|454991402|FG000|Overall Study|Protocol Violation|1|||
126461524|NCT00562627|454991403|FG001|Overall Study|Protocol Violation|1|||
126461525|NCT00562627|454991404|FG002|Overall Study|Protocol Violation|1|||
126461526|NCT00625742|454991405|FG000|Overall Study|Disease Progression|2|||
126461527|NCT00625742|454991405|FG000|Overall Study|Withdrawal by Subject|1|||
126461528|NCT00625742|454991405|FG000|Overall Study|Adverse Event|4|||
126461529|NCT00625742|454991405|FG000|Overall Study|Lost to Follow-up|4|||
126299572|NCT03331796|454385116|FG000|Extended Follow-up|Withdrawal by Subject|1|||
126299573|NCT03331796|454385117|FG001|Extended Follow-up|Withdrawal by Subject|0|||
126299574|NCT03331796|454385118|FG002|Extended Follow-up|Withdrawal by Subject|0|||
126299575|NCT03331796|454385116|FG000|Extended Follow-up|Termination of Funding|0|||
126299576|NCT03331796|454385117|FG001|Extended Follow-up|Termination of Funding|1|||
126299577|NCT03331796|454385118|FG002|Extended Follow-up|Termination of Funding|0|||
126299578|NCT01262872|454385120|FG000|Step 2|Death|0|||
126461530|NCT00625742|454991405|FG000|Overall Study|Ineligible|1|||
126461531|NCT01709578|454991406|FG000|Overall Study|Rescued and entered in long term safety|63|||
126461532|NCT01709578|454991407|FG001|Overall Study|Rescued and entered in long term safety|25|||
126299579|NCT01262872|454385121|FG001|Step 2|Death|0|||
126769982|NCT01915498|456110455|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
126769983|NCT01915498|456110456|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
126769984|NCT01915498|456110457|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
126769985|NCT01915498|456110458|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
126769986|NCT01915498|456110459|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
126769987|NCT01915498|456110460|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
126769988|NCT01915498|456110442|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126769989|NCT01915498|456110443|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126769990|NCT01915498|456110444|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126769991|NCT01915498|456110445|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126769992|NCT01915498|456110446|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126769993|NCT01915498|456110447|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126769994|NCT01915498|456110448|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126769995|NCT01915498|456110449|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126769996|NCT01915498|456110450|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126769997|NCT01915498|456110451|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126769998|NCT01915498|456110452|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126769999|NCT01915498|456110453|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126770000|NCT01915498|456110454|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126770001|NCT01915498|456110455|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126770002|NCT01915498|456110456|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126770003|NCT01915498|456110457|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126770004|NCT01915498|456110458|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126770005|NCT01915498|456110459|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
126770006|NCT01915498|456110460|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
126770007|NCT01915498|456110442|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770008|NCT01915498|456110443|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770009|NCT01915498|456110444|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770010|NCT01915498|456110445|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770011|NCT01915498|456110446|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770012|NCT01915498|456110447|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770013|NCT01915498|456110448|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770014|NCT01915498|456110449|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770015|NCT01915498|456110450|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770016|NCT01915498|456110451|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770017|NCT01915498|456110452|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770018|NCT01915498|456110453|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770019|NCT01915498|456110454|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770020|NCT01915498|456110455|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770021|NCT01915498|456110456|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770022|NCT01915498|456110457|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770023|NCT01915498|456110458|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770024|NCT01915498|456110459|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
126770025|NCT01915498|456110460|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
126770026|NCT01915498|456110442|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770027|NCT01915498|456110443|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770028|NCT01915498|456110444|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770029|NCT01915498|456110445|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770030|NCT01915498|456110446|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770031|NCT01915498|456110447|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770032|NCT01915498|456110448|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770033|NCT01915498|456110449|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126712408|NCT00149825|455899051|FG000|Overall Study|Not liking insomnia therapy|1|||
126712409|NCT00149825|455899052|FG001|Overall Study|Not liking insomnia therapy|0|||
126712410|NCT00149825|455899051|FG000|Overall Study|Other|1|||
126712411|NCT00149825|455899052|FG001|Overall Study|Other|0|||
126712412|NCT01359982|455899053|FG000|Overall Study|Adverse Event|2|||
126712413|NCT01359982|455899054|FG001|Overall Study|Adverse Event|0|||
126712414|NCT01359982|455899055|FG002|Overall Study|Adverse Event|0|||
126712415|NCT01359982|455899056|FG003|Overall Study|Adverse Event|1|||
126712416|NCT01359982|455899057|FG004|Overall Study|Adverse Event|0|||
126712417|NCT01359982|455899058|FG005|Overall Study|Adverse Event|0|||
126712418|NCT01359982|455899053|FG000|Overall Study|Death|1|||
126712419|NCT01359982|455899054|FG001|Overall Study|Death|0|||
126712420|NCT01359982|455899055|FG002|Overall Study|Death|0|||
126712421|NCT01359982|455899056|FG003|Overall Study|Death|0|||
126461533|NCT01709578|454991408|FG002|Overall Study|Rescued and entered in long term safety|26|||
126461534|NCT01709578|454991406|FG000|Overall Study|Adverse Event|9|||
126461535|NCT01709578|454991407|FG001|Overall Study|Adverse Event|18|||
126461536|NCT01709578|454991408|FG002|Overall Study|Adverse Event|17|||
126461537|NCT01709578|454991406|FG000|Overall Study|Lack of Efficacy|5|||
126461538|NCT01709578|454991407|FG001|Overall Study|Lack of Efficacy|4|||
126461539|NCT01709578|454991408|FG002|Overall Study|Lack of Efficacy|2|||
126712422|NCT01359982|455899057|FG004|Overall Study|Death|0|||
126712423|NCT01359982|455899058|FG005|Overall Study|Death|0|||
126712424|NCT00942708|455899059|FG000|Overall Study|Withdrawal by Subject|1|||
126712425|NCT01457339|455899060|FG000|Period 3 (100 mg)|Adverse Event|0|||
126712426|NCT01457339|455899061|FG001|Period 3 (100 mg)|Adverse Event|1|||
126712427|NCT01457339|455899060|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
126712428|NCT01457339|455899061|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
126712429|NCT01457339|455899060|FG000|Period 6 (250 mg)|Family Emergency|1|||
126712430|NCT01457339|455899061|FG001|Period 6 (250 mg)|Family Emergency|0|||
126712431|NCT01457339|455899060|FG000|Period 6 (250 mg)|Personal appointment|0|||
126712432|NCT01457339|455899061|FG001|Period 6 (250 mg)|Personal appointment|1|||
126712433|NCT02760407|455899062|FG000|Overall Study|Death|2|||
126712434|NCT02760407|455899063|FG001|Overall Study|Death|3|||
126712435|NCT02760407|455899064|FG002|Overall Study|Death|1|||
126712436|NCT02760407|455899065|FG003|Overall Study|Death|1|||
126712437|NCT02760407|455899062|FG000|Overall Study|Lost to Follow-up|1|||
126712438|NCT02760407|455899063|FG001|Overall Study|Lost to Follow-up|7|||
126712439|NCT02760407|455899064|FG002|Overall Study|Lost to Follow-up|4|||
126712440|NCT02760407|455899065|FG003|Overall Study|Lost to Follow-up|6|||
126712441|NCT02760407|455899062|FG000|Overall Study|Withdrawal by Subject|25|||
126712442|NCT02760407|455899063|FG001|Overall Study|Withdrawal by Subject|31|||
126712443|NCT02760407|455899064|FG002|Overall Study|Withdrawal by Subject|37|||
126712444|NCT02760407|455899065|FG003|Overall Study|Withdrawal by Subject|25|||
126712445|NCT02760407|455899062|FG000|Overall Study|Violation of Eligibility criteria|0|||
126712446|NCT02760407|455899063|FG001|Overall Study|Violation of Eligibility criteria|0|||
126712447|NCT02760407|455899064|FG002|Overall Study|Violation of Eligibility criteria|1|||
126712448|NCT02760407|455899065|FG003|Overall Study|Violation of Eligibility criteria|1|||
126712449|NCT02760407|455899062|FG000|Overall Study|Personal reasons|0|||
126712450|NCT02760407|455899063|FG001|Overall Study|Personal reasons|0|||
126712451|NCT02760407|455899064|FG002|Overall Study|Personal reasons|0|||
126712452|NCT02760407|455899065|FG003|Overall Study|Personal reasons|1|||
126712453|NCT02760407|455899062|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
126712454|NCT02760407|455899063|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
126712455|NCT02760407|455899064|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
126712456|NCT02760407|455899065|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
126712457|NCT02760407|455899062|FG000|Overall Study|Use of prohibited Medication|0|||
126712458|NCT02760407|455899063|FG001|Overall Study|Use of prohibited Medication|0|||
126712459|NCT02760407|455899064|FG002|Overall Study|Use of prohibited Medication|1|||
126712460|NCT02760407|455899065|FG003|Overall Study|Use of prohibited Medication|0|||
126712461|NCT02760407|455899062|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
126712462|NCT02760407|455899063|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
126712463|NCT02760407|455899064|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
126712464|NCT02760407|455899065|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
126712465|NCT02760407|455899062|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
126712466|NCT02760407|455899063|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
126712467|NCT02760407|455899064|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
126712468|NCT02760407|455899065|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
126712469|NCT02760407|455899062|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
126712470|NCT02760407|455899063|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
126712471|NCT02760407|455899064|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
126712472|NCT02760407|455899065|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
126712473|NCT02760407|455899062|FG000|Overall Study|Inadequately Enrolled|0|||
126712474|NCT02760407|455899063|FG001|Overall Study|Inadequately Enrolled|0|||
126712475|NCT02760407|455899064|FG002|Overall Study|Inadequately Enrolled|0|||
126712476|NCT02760407|455899065|FG003|Overall Study|Inadequately Enrolled|1|||
126712477|NCT02760407|455899062|FG000|Overall Study|Withdrawal By PI's Decision|0|||
126712478|NCT02760407|455899063|FG001|Overall Study|Withdrawal By PI's Decision|1|||
126712479|NCT02760407|455899064|FG002|Overall Study|Withdrawal By PI's Decision|0|||
126712480|NCT02760407|455899065|FG003|Overall Study|Withdrawal By PI's Decision|0|||
126712481|NCT02760407|455899062|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
126712482|NCT02760407|455899063|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
126461540|NCT01709578|454991406|FG000|Overall Study|Poor compliance to protocol|1|||
126461541|NCT01709578|454991407|FG001|Overall Study|Poor compliance to protocol|2|||
126461542|NCT01709578|454991408|FG002|Overall Study|Poor compliance to protocol|1|||
126461543|NCT01709578|454991406|FG000|Overall Study|Other, not related to safety or efficacy|2|||
126461544|NCT01709578|454991407|FG001|Overall Study|Other, not related to safety or efficacy|7|||
126461545|NCT01709578|454991408|FG002|Overall Study|Other, not related to safety or efficacy|5|||
126461546|NCT04050371|454991409|FG000|Overall Study|Withdrawal by Subject|1|||
126461547|NCT04050371|454991410|FG001|Overall Study|Withdrawal by Subject|0|||
126461548|NCT01107418|454991411|FG000|Overall Study|Disease Progression|45|||
126461549|NCT01107418|454991411|FG000|Overall Study|Adverse Event|3|||
126461550|NCT01107418|454991411|FG000|Overall Study|Withdrawal by Subject|1|||
126461551|NCT01107418|454991411|FG000|Overall Study|Study Closing|1|||
126461552|NCT01107418|454991411|FG000|Overall Study|Started Other Therapy|1|||
126461553|NCT01107418|454991411|FG000|Overall Study|Entered Extension Study|1|||
126461554|NCT00597701|454991412|FG000|Overall Study|Withdrawal by Subject|5|||
126461555|NCT00597701|454991413|FG001|Overall Study|Withdrawal by Subject|5|||
126461556|NCT00597701|454991412|FG000|Overall Study|Death|0|||
126461557|NCT00597701|454991413|FG001|Overall Study|Death|1|||
126461558|NCT00597701|454991412|FG000|Overall Study|Physician Decision|2|||
126461559|NCT00597701|454991413|FG001|Overall Study|Physician Decision|0|||
126461560|NCT00597701|454991412|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
126461561|NCT00597701|454991413|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
126461562|NCT00301821|454991417|FG000|Overall Study|Ineligible|25|||
126461563|NCT00301821|454991417|FG000|Overall Study|Cancel|1|||
126299580|NCT01262872|454385122|FG002|Step 2|Death|0|||
126299581|NCT01262872|454385123|FG003|Step 2|Death|1|||
126299582|NCT01262872|454385124|FG004|Step 2|Death|0|||
126299583|NCT01262872|454385125|FG005|Step 2|Death|2|||
126299584|NCT01262872|454385126|FG006|Step 2|Death|2|||
126299585|NCT01262872|454385127|FG007|Step 2|Death|1|||
126299586|NCT01262872|454385120|FG000|Step 2|Protocol Violation|0|||
126299587|NCT01262872|454385121|FG001|Step 2|Protocol Violation|0|||
126299588|NCT01262872|454385122|FG002|Step 2|Protocol Violation|1|||
126299589|NCT01262872|454385123|FG003|Step 2|Protocol Violation|0|||
126299590|NCT01262872|454385124|FG004|Step 2|Protocol Violation|0|||
126299591|NCT01262872|454385125|FG005|Step 2|Protocol Violation|0|||
126299592|NCT01262872|454385126|FG006|Step 2|Protocol Violation|3|||
126299593|NCT01262872|454385127|FG007|Step 2|Protocol Violation|1|||
126299594|NCT01262872|454385120|FG000|Step 2|Withdrawal by Subject|0|||
126299595|NCT01262872|454385121|FG001|Step 2|Withdrawal by Subject|0|||
126299596|NCT01262872|454385122|FG002|Step 2|Withdrawal by Subject|4|||
126299597|NCT01262872|454385123|FG003|Step 2|Withdrawal by Subject|6|||
126299598|NCT01262872|454385124|FG004|Step 2|Withdrawal by Subject|3|||
126299599|NCT01262872|454385125|FG005|Step 2|Withdrawal by Subject|1|||
126299600|NCT01262872|454385126|FG006|Step 2|Withdrawal by Subject|2|||
126299601|NCT01262872|454385127|FG007|Step 2|Withdrawal by Subject|1|||
126299602|NCT01262872|454385120|FG000|Step 2|Migrated/moved from study area|0|||
126299603|NCT01262872|454385121|FG001|Step 2|Migrated/moved from study area|0|||
126299604|NCT01262872|454385122|FG002|Step 2|Migrated/moved from study area|4|||
126299605|NCT01262872|454385123|FG003|Step 2|Migrated/moved from study area|3|||
126299606|NCT01262872|454385124|FG004|Step 2|Migrated/moved from study area|2|||
126299607|NCT01262872|454385125|FG005|Step 2|Migrated/moved from study area|6|||
126299608|NCT01262872|454385126|FG006|Step 2|Migrated/moved from study area|2|||
126299609|NCT01262872|454385127|FG007|Step 2|Migrated/moved from study area|3|||
126299610|NCT01753570|454385128|FG000|Overall Study|Adverse Event|1|||
126299611|NCT01753570|454385129|FG001|Overall Study|Adverse Event|0|||
126299612|NCT01753570|454385130|FG002|Overall Study|Adverse Event|1|||
126299613|NCT01753570|454385128|FG000|Overall Study|Physician Decision|0|||
126299614|NCT01753570|454385129|FG001|Overall Study|Physician Decision|1|||
126299615|NCT01753570|454385130|FG002|Overall Study|Physician Decision|0|||
126461564|NCT01314911|454991419|FG000|Overall Study|Lost to Follow-up|3|||
126461565|NCT01314911|454991420|FG001|Overall Study|Lost to Follow-up|2|||
126550235|NCT01853254|455309502|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
126299616|NCT01753570|454385128|FG000|Overall Study|Withdrawal by Subject|1|||
126299617|NCT01753570|454385129|FG001|Overall Study|Withdrawal by Subject|4|||
126299618|NCT01753570|454385130|FG002|Overall Study|Withdrawal by Subject|0|||
126299619|NCT01000155|454385133|FG000|Overall Study|Withdrawal by Subject|1|||
126299620|NCT01000155|454385133|FG000|Overall Study|Adverse Event|1|||
126299621|NCT00720213|454385136|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
126299622|NCT00720213|454385137|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
126461566|NCT01314911|454991419|FG000|Overall Study|Withdrawal by Subject|1|||
126550236|NCT01853254|455309502|FG000|Overall Study|Death|1|||
126299623|NCT00720213|454385138|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
126299624|NCT01808066|454385143|FG000|Overall Study|Withdrawal by Subject|15|||
126299625|NCT00365794|454385144|FG000|Overall Study|Withdrawal by Subject|2|||
126299626|NCT00745901|454385145|FG000|Overall Study|Adverse Event|3|||
126299627|NCT00745901|454385146|FG001|Overall Study|Adverse Event|4|||
126461567|NCT01314911|454991420|FG001|Overall Study|Withdrawal by Subject|3|||
126550237|NCT01853254|455309502|FG000|Overall Study|Failure to Return|43|||
126461568|NCT01314911|454991419|FG000|Overall Study|Received Non-randomized Study Drug|0|||
126461569|NCT01314911|454991420|FG001|Overall Study|Received Non-randomized Study Drug|1|||
126461570|NCT01314911|454991419|FG000|Overall Study|Never Started Treatment|1|||
126461571|NCT01314911|454991420|FG001|Overall Study|Never Started Treatment|0|||
126461572|NCT04078178|454991426|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
126461573|NCT04078178|454991427|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
126461574|NCT04078178|454991426|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
126461575|NCT04078178|454991427|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
126461576|NCT04078178|454991426|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
126461577|NCT04078178|454991427|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
126461578|NCT04078178|454991426|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
126461579|NCT04078178|454991427|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
126461580|NCT04078178|454991426|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
126461581|NCT04078178|454991427|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
126461582|NCT04006119|454991428|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
126461583|NCT04006119|454991428|FG000|End of Treatment Veledimex|Adverse Event|2|||
126461584|NCT04006119|454991428|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
126461585|NCT04006119|454991428|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
126461586|NCT04006119|454991428|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
126299628|NCT00745901|454385145|FG000|Overall Study|Protocol Violation|0|||
126299629|NCT00745901|454385146|FG001|Overall Study|Protocol Violation|1|||
126299630|NCT00745901|454385145|FG000|Overall Study|Withdrawal by Subject|1|||
126299631|NCT00745901|454385146|FG001|Overall Study|Withdrawal by Subject|0|||
126299632|NCT00745901|454385145|FG000|Overall Study|Lost to Follow-up|7|||
126299633|NCT00745901|454385146|FG001|Overall Study|Lost to Follow-up|4|||
126299634|NCT00745901|454385145|FG000|Overall Study|Pregnancy|2|||
126299635|NCT00745901|454385146|FG001|Overall Study|Pregnancy|4|||
126299636|NCT00745901|454385145|FG000|Overall Study|Lack of compliance|2|||
126299637|NCT00745901|454385146|FG001|Overall Study|Lack of compliance|2|||
126299638|NCT00745901|454385145|FG000|Overall Study|Patient's next menses did not start with|1|||
126299639|NCT00745901|454385146|FG001|Overall Study|Patient's next menses did not start with|0|||
126299640|NCT00745901|454385145|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
126299641|NCT00745901|454385146|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
126299642|NCT00745901|454385145|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
126299643|NCT00745901|454385146|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
126299644|NCT00745901|454385145|FG000|Overall Study|Patient didn't take any study medication|7|||
126299645|NCT00745901|454385146|FG001|Overall Study|Patient didn't take any study medication|3|||
126299646|NCT00884117|454385149|FG000|Overall Study|Adverse Event|2|||
126299647|NCT00884117|454385149|FG000|Overall Study|Withdrawal by Subject|89|||
126299648|NCT00884117|454385149|FG000|Overall Study|Death|3|||
126299649|NCT00884117|454385149|FG000|Overall Study|Lost to Follow-up|143|||
126299650|NCT00884117|454385149|FG000|Overall Study|Other|12|||
126299651|NCT03859427|454385151|FG000|Overall Study|Withdrawal by Subject|4|||
126299652|NCT03859427|454385152|FG001|Overall Study|Withdrawal by Subject|7|||
126299653|NCT03859427|454385151|FG000|Overall Study|Decision by sponsor|0|||
126299654|NCT03859427|454385152|FG001|Overall Study|Decision by sponsor|3|||
126299655|NCT03859427|454385151|FG000|Overall Study|Lost to Follow-up|3|||
126299656|NCT03859427|454385152|FG001|Overall Study|Lost to Follow-up|2|||
126299657|NCT03859427|454385151|FG000|Overall Study|Death|22|||
126299658|NCT03859427|454385152|FG001|Overall Study|Death|25|||
126299659|NCT02503540|454385153|FG000|Overall Study|Death|2|||
126299660|NCT02503540|454385153|FG000|Overall Study|Withdrawal by Subject|1|||
126299661|NCT01804946|454385154|FG000|Overall Study|Protocol Violation|1|||
126299662|NCT01804946|454385155|FG001|Overall Study|Protocol Violation|0|||
126299663|NCT01804946|454385154|FG000|Overall Study|Adverse Event|0|||
126299664|NCT01804946|454385155|FG001|Overall Study|Adverse Event|1|||
126299665|NCT01804946|454385154|FG000|Overall Study|Insufficient data available|0|||
126299666|NCT01804946|454385155|FG001|Overall Study|Insufficient data available|1|||
126299667|NCT01804946|454385154|FG000|Overall Study|Do not meet inclusion criteria|1|||
126299668|NCT01804946|454385155|FG001|Overall Study|Do not meet inclusion criteria|2|||
126299669|NCT00722137|454385156|FG000|Overall Study|Overt Disease Progression|5|||
126299670|NCT00722137|454385157|FG001|Overall Study|Overt Disease Progression|4|||
126299671|NCT00722137|454385156|FG000|Overall Study|Adverse Event|17|||
126299672|NCT00722137|454385157|FG001|Overall Study|Adverse Event|21|||
126299673|NCT00722137|454385156|FG000|Overall Study|Death|12|||
126299674|NCT00722137|454385157|FG001|Overall Study|Death|7|||
126299675|NCT00722137|454385156|FG000|Overall Study|Withdrawal by Subject|6|||
126461587|NCT04006119|454991428|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
126299676|NCT00722137|454385157|FG001|Overall Study|Withdrawal by Subject|9|||
126299677|NCT00722137|454385156|FG000|Overall Study|Other Reason Unknown|3|||
126299678|NCT00722137|454385157|FG001|Overall Study|Other Reason Unknown|4|||
126299679|NCT00722137|454385156|FG000|Overall Study|Randomized But Not Treated|2|||
126299680|NCT00722137|454385157|FG001|Overall Study|Randomized But Not Treated|3|||
126299681|NCT01129557|454385158|FG000|Overall Study|Adverse Event|1|||
126299682|NCT01129557|454385159|FG001|Overall Study|Adverse Event|2|||
126461588|NCT00472459|454991429|FG000|Overall Study|Adverse Event|13|||
126461589|NCT00472459|454991430|FG001|Overall Study|Adverse Event|13|||
126461590|NCT00472459|454991429|FG000|Overall Study|Withdrawal by Subject|5|||
126712483|NCT02760407|455899064|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
126712484|NCT02760407|455899065|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
126712485|NCT02760407|455899062|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
126712486|NCT02760407|455899063|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
126712487|NCT02760407|455899064|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
126712488|NCT02760407|455899065|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
126712489|NCT02760407|455899062|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
126712490|NCT02760407|455899063|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
126712491|NCT02760407|455899064|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
126712492|NCT02760407|455899065|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
126712493|NCT02760407|455899062|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
126712494|NCT02760407|455899063|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
126712495|NCT02760407|455899064|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
126712496|NCT02760407|455899065|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
126712497|NCT02760407|455899062|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
126712498|NCT02760407|455899063|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
126712499|NCT02760407|455899064|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
126712500|NCT02760407|455899065|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
126712501|NCT02760407|455899062|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
126712502|NCT02760407|455899063|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
126712503|NCT02760407|455899064|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
126712504|NCT02760407|455899065|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
126712505|NCT02760407|455899062|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
126712506|NCT02760407|455899063|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
126712507|NCT02760407|455899064|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
126712508|NCT02760407|455899065|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
126712509|NCT02760407|455899062|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
126712510|NCT02760407|455899063|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
126712511|NCT02760407|455899064|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
126712512|NCT02760407|455899065|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
126712513|NCT02760407|455899062|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
126712514|NCT02760407|455899063|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
126712515|NCT02760407|455899064|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
126712516|NCT02760407|455899065|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
126712517|NCT01645930|455899066|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
126712518|NCT01645930|455899066|FG000|Overall Study|Progressive Disease|12|||
126712519|NCT01645930|455899066|FG000|Overall Study|Adverse Event|4|||
126712520|NCT01645930|455899066|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
126712521|NCT01645930|455899066|FG000|Overall Study|Withdrawal by Participant|2|||
126712522|NCT01645930|455899066|FG000|Overall Study|Reason not Defined|1|||
126712523|NCT03245814|455899067|FG000|Overall Study|Lost to Follow-up|5|||
126712524|NCT03245814|455899068|FG001|Overall Study|Lost to Follow-up|8|||
126712525|NCT03245814|455899067|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
126712526|NCT03245814|455899068|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
126712527|NCT02522377|455899069|FG000|Overall Study|Withdrawal by Subject|1|||
126712528|NCT02522377|455899070|FG001|Overall Study|Withdrawal by Subject|0|||
126712529|NCT02522377|455899069|FG000|Overall Study|Remission Achieved|3|||
126712530|NCT02522377|455899070|FG001|Overall Study|Remission Achieved|0|||
126712531|NCT01158950|455899071|FG000|1st Intervention (1 Day)|Physician Decision|1|||
126712532|NCT01158950|455899072|FG001|1st Intervention (1 Day)|Physician Decision|2|||
126712533|NCT02263365|455899073|FG000|Overall Study|Physician Decision|22|||
126712534|NCT02263365|455899074|FG001|Overall Study|Physician Decision|18|||
126712535|NCT00945191|455899075|FG000|Overall Study|Did not achieve a complete response|18|||
126712536|NCT00945191|455899075|FG000|Overall Study|Participant relocated to another state|1|||
126712537|NCT00945191|455899075|FG000|Overall Study|Disease progression|3|||
126712538|NCT00945191|455899075|FG000|Overall Study|Serious adverse event or adverse event|1|||
126712539|NCT00945191|455899075|FG000|Overall Study|Investigator's discretion|1|||
126712540|NCT00206518|455899076|FG000|Overall Study|Lack of Efficacy|6|||
126712541|NCT00206518|455899077|FG001|Overall Study|Lack of Efficacy|4|||
126712542|NCT00206518|455899076|FG000|Overall Study|Adverse Event|2|||
126770034|NCT01915498|456110450|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770035|NCT01915498|456110451|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770036|NCT01915498|456110452|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770037|NCT01915498|456110453|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770038|NCT01915498|456110454|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770039|NCT01915498|456110455|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770040|NCT01915498|456110456|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770041|NCT01915498|456110457|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770042|NCT01915498|456110458|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770043|NCT01915498|456110459|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
126770044|NCT01915498|456110460|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
126770045|NCT01907516|456110461|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
126770046|NCT01907516|456110462|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
126770047|NCT01907516|456110461|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
126770048|NCT01907516|456110462|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
126770049|NCT01907516|456110461|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
126770050|NCT01907516|456110462|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
126770051|NCT01907516|456110461|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
126770052|NCT01907516|456110462|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
126770053|NCT00633217|456110465|FG000|Overall Study|Adverse Event|5|||
126770054|NCT00633217|456110466|FG001|Overall Study|Adverse Event|9|||
126770055|NCT00633217|456110465|FG000|Overall Study|Lack of Efficacy|0|||
126367361|NCT02471144|454640898|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126367362|NCT02471144|454640899|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126550238|NCT01853254|455309502|FG000|Overall Study|Insufficient Therapeutic Response|22|||
126770056|NCT00633217|456110466|FG001|Overall Study|Lack of Efficacy|2|||
126770057|NCT00633217|456110465|FG000|Overall Study|Protocol Violation|3|||
126770058|NCT00633217|456110466|FG001|Overall Study|Protocol Violation|7|||
126770059|NCT00633217|456110465|FG000|Overall Study|Lost to Follow-up|2|||
126770060|NCT00633217|456110466|FG001|Overall Study|Lost to Follow-up|2|||
126770061|NCT00633217|456110465|FG000|Overall Study|Investigator Discretion|2|||
126770062|NCT00633217|456110466|FG001|Overall Study|Investigator Discretion|0|||
126770063|NCT00633217|456110465|FG000|Overall Study|Withdrew Consent|3|||
126770064|NCT00633217|456110466|FG001|Overall Study|Withdrew Consent|3|||
126770065|NCT01186744|456112383|FG000|Overall Study|Lack of Efficacy|156|||
126770066|NCT01186744|456112384|FG001|Overall Study|Lack of Efficacy|99|||
126770067|NCT01186744|456112385|FG002|Overall Study|Lack of Efficacy|0|||
126770068|NCT01186744|456112386|FG003|Overall Study|Lack of Efficacy|2|||
126770069|NCT01186744|456112387|FG004|Overall Study|Lack of Efficacy|2|||
126770070|NCT01186744|456112388|FG005|Overall Study|Lack of Efficacy|5|||
126770071|NCT01186744|456112383|FG000|Overall Study|Protocol Violation|1|||
126770072|NCT01186744|456112384|FG001|Overall Study|Protocol Violation|2|||
126770073|NCT01186744|456112385|FG002|Overall Study|Protocol Violation|0|||
126770074|NCT01186744|456112386|FG003|Overall Study|Protocol Violation|1|||
126770075|NCT01186744|456112387|FG004|Overall Study|Protocol Violation|1|||
126770076|NCT01186744|456112388|FG005|Overall Study|Protocol Violation|2|||
126770077|NCT01186744|456112383|FG000|Overall Study|Lost to Follow-up|15|||
126770078|NCT01186744|456112384|FG001|Overall Study|Lost to Follow-up|16|||
126770079|NCT01186744|456112385|FG002|Overall Study|Lost to Follow-up|2|||
126770080|NCT01186744|456112386|FG003|Overall Study|Lost to Follow-up|1|||
126770081|NCT01186744|456112387|FG004|Overall Study|Lost to Follow-up|1|||
126770082|NCT01186744|456112388|FG005|Overall Study|Lost to Follow-up|4|||
126770083|NCT01186744|456112383|FG000|Overall Study|Screen failure|1|||
126770084|NCT01186744|456112384|FG001|Overall Study|Screen failure|1|||
126770085|NCT01186744|456112385|FG002|Overall Study|Screen failure|0|||
126367363|NCT02471144|454640900|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126367364|NCT02471144|454640901|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126367365|NCT02471144|454640902|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
126367366|NCT02471144|454640903|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126367367|NCT02471144|454640904|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
126367368|NCT02471144|454640894|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367369|NCT02471144|454640895|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367370|NCT02471144|454640896|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367371|NCT02471144|454640897|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367372|NCT02471144|454640898|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126369573|NCT00183248|454650606|FG001|Overall Study|Lost to Follow-up|1|||
126550239|NCT01853254|455309502|FG000|Overall Study|Refusal of Treatment|1|||
126770086|NCT01186744|456112386|FG003|Overall Study|Screen failure|1|||
126770087|NCT01186744|456112387|FG004|Overall Study|Screen failure|0|||
126770088|NCT01186744|456112388|FG005|Overall Study|Screen failure|0|||
126770089|NCT01186744|456112383|FG000|Overall Study|Withdrawal by Subject|14|||
126770090|NCT01186744|456112384|FG001|Overall Study|Withdrawal by Subject|10|||
126770091|NCT01186744|456112385|FG002|Overall Study|Withdrawal by Subject|2|||
126299683|NCT01129557|454385160|FG002|Overall Study|Adverse Event|2|||
126299684|NCT01129557|454385158|FG000|Overall Study|Novartis terminated study early|3|||
126299685|NCT01129557|454385159|FG001|Overall Study|Novartis terminated study early|3|||
126299686|NCT01129557|454385160|FG002|Overall Study|Novartis terminated study early|2|||
126299687|NCT00669669|454385161|FG000|Overall Study|To late to start treatment|1|||
126299688|NCT00848718|454385162|FG000|Overall Study|Adverse Event|2|||
126299689|NCT00848718|454385163|FG001|Overall Study|Adverse Event|2|||
126712543|NCT00206518|455899077|FG001|Overall Study|Adverse Event|1|||
126712544|NCT00206518|455899076|FG000|Overall Study|Physician Decision|1|||
126712545|NCT00206518|455899077|FG001|Overall Study|Physician Decision|0|||
126712546|NCT00206518|455899076|FG000|Overall Study|Protocol Violation|1|||
126712547|NCT00206518|455899077|FG001|Overall Study|Protocol Violation|1|||
126712548|NCT00408681|455899078|FG000|Overall Study|Lack of Efficacy|2|||
126712549|NCT00408681|455899078|FG000|Overall Study|Adverse Event|7|||
126712550|NCT01171521|455899084|FG000|Overall Study|Lost to Follow-up|5|||
126712551|NCT01171521|455899084|FG000|Overall Study|screen failure|1|||
126712552|NCT00734929|455899089|FG000|Overall Study|Lost to Follow-up|1|||
126712553|NCT00734929|455899090|FG001|Overall Study|Lost to Follow-up|2|||
126712554|NCT00734929|455899089|FG000|Overall Study|No intervention/ screen fail|5|||
126712555|NCT00734929|455899090|FG001|Overall Study|No intervention/ screen fail|3|||
126712556|NCT01422304|455899091|FG000|Overall Study|Adverse Event|0|||
126712557|NCT01422304|455899092|FG001|Overall Study|Adverse Event|1|||
126712558|NCT01422304|455899091|FG000|Overall Study|Lost to Follow-up|14|||
126712559|NCT01422304|455899092|FG001|Overall Study|Lost to Follow-up|20|||
126712560|NCT01422304|455899091|FG000|Overall Study|Never Entered Follow-up|2|||
126712561|NCT01422304|455899092|FG001|Overall Study|Never Entered Follow-up|1|||
126712562|NCT01422304|455899091|FG000|Overall Study|Protocol Violation|1|||
126712563|NCT01422304|455899092|FG001|Overall Study|Protocol Violation|0|||
126712564|NCT01422304|455899091|FG000|Overall Study|Withdrawal by Subject|4|||
126712565|NCT01422304|455899092|FG001|Overall Study|Withdrawal by Subject|2|||
126712566|NCT01422304|455899091|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
126712567|NCT01422304|455899092|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
126712568|NCT01422304|455899091|FG000|Overall Study|Not Treated|3|||
126712569|NCT01422304|455899092|FG001|Overall Study|Not Treated|11|||
126712570|NCT04799782|455899093|FG000|Washout|Physician Decision|2|||
126712571|NCT04799782|455899094|FG001|Washout|Physician Decision|0|||
126712572|NCT04799782|455899093|FG000|Washout|Withdrawal by Subject|0|||
126712573|NCT04799782|455899094|FG001|Washout|Withdrawal by Subject|2|||
126712574|NCT04799782|455899093|FG000|Washout|Lost to Follow-up|0|||
126712575|NCT04799782|455899094|FG001|Washout|Lost to Follow-up|1|||
126712576|NCT02606877|455899095|FG000|Overall Study|Adverse Event|3|||
126712577|NCT02606877|455899096|FG001|Overall Study|Adverse Event|0|||
126712578|NCT02606877|455899095|FG000|Overall Study|Non-compliance with protocol|0|||
126712579|NCT02606877|455899096|FG001|Overall Study|Non-compliance with protocol|1|||
126712580|NCT02606877|455899095|FG000|Overall Study|Other than listed above|1|||
126712581|NCT02606877|455899096|FG001|Overall Study|Other than listed above|0|||
126712582|NCT00515463|455899108|FG000|Overall Study|Physician Decision|4|||
126712583|NCT00515463|455899109|FG001|Overall Study|Physician Decision|2|||
126712584|NCT00515463|455899108|FG000|Overall Study|Adverse Event|1|||
126712585|NCT00515463|455899109|FG001|Overall Study|Adverse Event|2|||
126712586|NCT00515463|455899108|FG000|Overall Study|Withdrawal by Subject|3|||
126712587|NCT00515463|455899109|FG001|Overall Study|Withdrawal by Subject|4|||
126712588|NCT00515463|455899108|FG000|Overall Study|Lost to Follow-up|6|||
126712589|NCT00515463|455899109|FG001|Overall Study|Lost to Follow-up|5|||
126712590|NCT00515463|455899108|FG000|Overall Study|Other|0|||
126712591|NCT00515463|455899109|FG001|Overall Study|Other|1|||
126712592|NCT01558089|455899110|FG000|Overall Study|Adverse Event|1|||
126712593|NCT01558089|455899110|FG000|Overall Study|Lack of Efficacy|1|||
126712594|NCT01558089|455899110|FG000|Overall Study|Lost to Follow-up|5|||
126712595|NCT01558089|455899110|FG000|Overall Study|Withdrawal by Subject|6|||
126712596|NCT01903434|455899113|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
126712597|NCT01903434|455899114|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
126712598|NCT01903434|455899113|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
126299690|NCT00848718|454385164|FG002|Overall Study|Adverse Event|1|||
126299691|NCT00848718|454385165|FG003|Overall Study|Adverse Event|1|||
126299692|NCT00848718|454385166|FG004|Overall Study|Adverse Event|1|||
126299693|NCT00848718|454385167|FG005|Overall Study|Adverse Event|0|||
126712599|NCT01903434|455899114|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
126712600|NCT02190435|455899115|FG000|Overall Study|First 12 patients were lead-ins|12|||
126712601|NCT02190435|455899116|FG001|Overall Study|First 12 patients were lead-ins|0|||
126712602|NCT02190435|455899115|FG000|Overall Study|3 consented screen fails|3|||
126712603|NCT02190435|455899116|FG001|Overall Study|3 consented screen fails|0|||
126712604|NCT01781026|455899117|FG000|Overall Study|Lack of Efficacy|2|||
126299694|NCT00848718|454385168|FG006|Overall Study|Adverse Event|0|||
126712605|NCT02269319|455899118|FG000|Overall Study|Lost to Follow-up|4|||
126712606|NCT02269319|455899119|FG001|Overall Study|Lost to Follow-up|3|||
126712607|NCT02269319|455899118|FG000|Overall Study|Adverse Event|0|||
126712608|NCT02269319|455899119|FG001|Overall Study|Adverse Event|1|||
126461591|NCT00472459|454991430|FG001|Overall Study|Withdrawal by Subject|5|||
126461592|NCT00472459|454991429|FG000|Overall Study|Protocol Violation|3|||
126461593|NCT00472459|454991430|FG001|Overall Study|Protocol Violation|3|||
126461594|NCT00472459|454991429|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
126461595|NCT00472459|454991430|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
126461596|NCT00472459|454991429|FG000|Overall Study|Lost to Follow-up|1|||
126461597|NCT00472459|454991430|FG001|Overall Study|Lost to Follow-up|1|||
126461598|NCT03442764|454991431|FG000|Overall Study|Adverse Event|1|||
126461599|NCT03442764|454991432|FG001|Overall Study|Adverse Event|0|||
126299695|NCT00848718|454385169|FG007|Overall Study|Adverse Event|1|||
126299696|NCT00848718|454385170|FG008|Overall Study|Adverse Event|1|||
126299697|NCT00848718|454385171|FG009|Overall Study|Adverse Event|0|||
126299698|NCT00848718|454385172|FG010|Overall Study|Adverse Event|0|||
126299699|NCT00848718|454385173|FG011|Overall Study|Adverse Event|0|||
126299700|NCT00848718|454385174|FG012|Overall Study|Adverse Event|2|||
126299701|NCT00848718|454385162|FG000|Overall Study|Lack of Efficacy|0|||
126299702|NCT00848718|454385163|FG001|Overall Study|Lack of Efficacy|0|||
126299703|NCT00848718|454385164|FG002|Overall Study|Lack of Efficacy|1|||
126299704|NCT00848718|454385165|FG003|Overall Study|Lack of Efficacy|0|||
126299705|NCT00848718|454385166|FG004|Overall Study|Lack of Efficacy|0|||
126299706|NCT00848718|454385167|FG005|Overall Study|Lack of Efficacy|0|||
126299707|NCT00848718|454385168|FG006|Overall Study|Lack of Efficacy|1|||
126299708|NCT00848718|454385169|FG007|Overall Study|Lack of Efficacy|0|||
126461600|NCT03442764|454991433|FG002|Overall Study|Adverse Event|0|||
126461601|NCT04850313|454991434|FG000|Overall Study|Withdrawal by Subject|0|||
126461602|NCT04850313|454991435|FG001|Overall Study|Withdrawal by Subject|1|||
126461603|NCT00814879|454991436|FG000|By Week 24|Cancer Diagnosis|1|||
126461604|NCT00814879|454991437|FG001|By Week 24|Cancer Diagnosis|0|||
126461605|NCT00814879|454991436|FG000|By Week 24|Incarceration|0|||
126461606|NCT00814879|454991437|FG001|By Week 24|Incarceration|1|||
126550240|NCT01853254|455309502|FG000|Overall Study|Other Protocol Violation|1|||
126550241|NCT01853254|455309502|FG000|Overall Study|Withdrawal of Consent|16|||
126461607|NCT00814879|454991436|FG000|By Week 48|Lost to Follow-up|2|||
126550242|NCT01853254|455309502|FG000|Overall Study|Administrative/Other|16|||
126550243|NCT01017120|455309513|FG000|Overall Study|Adverse Event|9|||
126299709|NCT00848718|454385170|FG008|Overall Study|Lack of Efficacy|0|||
126299710|NCT00848718|454385171|FG009|Overall Study|Lack of Efficacy|0|||
126299711|NCT00848718|454385172|FG010|Overall Study|Lack of Efficacy|0|||
126299712|NCT00848718|454385173|FG011|Overall Study|Lack of Efficacy|0|||
126299713|NCT00848718|454385174|FG012|Overall Study|Lack of Efficacy|0|||
126299714|NCT00848718|454385162|FG000|Overall Study|Physician Decision|0|||
126299715|NCT00848718|454385163|FG001|Overall Study|Physician Decision|1|||
126299716|NCT00848718|454385164|FG002|Overall Study|Physician Decision|0|||
126299717|NCT00848718|454385165|FG003|Overall Study|Physician Decision|0|||
126299718|NCT00848718|454385166|FG004|Overall Study|Physician Decision|1|||
126299719|NCT00848718|454385167|FG005|Overall Study|Physician Decision|1|||
126299720|NCT00848718|454385168|FG006|Overall Study|Physician Decision|0|||
126299721|NCT00848718|454385169|FG007|Overall Study|Physician Decision|0|||
126461608|NCT00814879|454991437|FG001|By Week 48|Lost to Follow-up|2|||
126550244|NCT01017120|455309514|FG001|Overall Study|Adverse Event|0|||
126770092|NCT01186744|456112386|FG003|Overall Study|Withdrawal by Subject|5|||
126770093|NCT01186744|456112387|FG004|Overall Study|Withdrawal by Subject|0|||
126770094|NCT01186744|456112388|FG005|Overall Study|Withdrawal by Subject|6|||
126770095|NCT01186744|456112383|FG000|Overall Study|Study terminated by Sponsor|1|||
126770096|NCT01186744|456112384|FG001|Overall Study|Study terminated by Sponsor|0|||
126770097|NCT01186744|456112385|FG002|Overall Study|Study terminated by Sponsor|0|||
126770098|NCT01186744|456112386|FG003|Overall Study|Study terminated by Sponsor|0|||
126770099|NCT01186744|456112387|FG004|Overall Study|Study terminated by Sponsor|0|||
126770100|NCT01186744|456112388|FG005|Overall Study|Study terminated by Sponsor|0|||
126461609|NCT00814879|454991436|FG000|By Week 48|Death|0|||
126461610|NCT00814879|454991437|FG001|By Week 48|Death|1|||
126461611|NCT00588952|454991438|FG000|Overall Study|Adverse Event|0|||
126461612|NCT00588952|454991439|FG001|Overall Study|Adverse Event|2|||
126461613|NCT00588952|454991438|FG000|Overall Study|Withdrawal by Subject|3|||
126461614|NCT00588952|454991439|FG001|Overall Study|Withdrawal by Subject|5|||
126770101|NCT01186744|456112383|FG000|Overall Study|Other|9|||
126770102|NCT01186744|456112384|FG001|Overall Study|Other|10|||
126770103|NCT01186744|456112385|FG002|Overall Study|Other|1|||
126461615|NCT01277042|454991440|FG000|Overall Study|Adverse Event|4|||
126770104|NCT01186744|456112386|FG003|Overall Study|Other|2|||
126299722|NCT00848718|454385170|FG008|Overall Study|Physician Decision|1|||
126299723|NCT00848718|454385171|FG009|Overall Study|Physician Decision|2|||
126770105|NCT01186744|456112387|FG004|Overall Study|Other|1|||
126299724|NCT00848718|454385172|FG010|Overall Study|Physician Decision|0|||
126299725|NCT00848718|454385173|FG011|Overall Study|Physician Decision|0|||
126299726|NCT00848718|454385174|FG012|Overall Study|Physician Decision|1|||
126461616|NCT01277042|454991441|FG001|Overall Study|Adverse Event|3|||
126461617|NCT01277042|454991440|FG000|Overall Study|Lost to Follow-up|2|||
126550245|NCT01017120|455309513|FG000|Overall Study|Lost to Follow-up|13|||
126770106|NCT01186744|456112388|FG005|Overall Study|Other|5|||
126550246|NCT01017120|455309514|FG001|Overall Study|Lost to Follow-up|11|||
126550247|NCT01017120|455309513|FG000|Overall Study|Lack of Efficacy|1|||
126550248|NCT01017120|455309514|FG001|Overall Study|Lack of Efficacy|0|||
126550249|NCT01017120|455309513|FG000|Overall Study|Withdrawal by Subject|39|||
126550250|NCT01017120|455309514|FG001|Overall Study|Withdrawal by Subject|21|||
126550251|NCT01017120|455309513|FG000|Overall Study|Pregnancy|1|||
126770107|NCT01186744|456112383|FG000|Overall Study|Adverse Event|10|||
126770108|NCT01186744|456112384|FG001|Overall Study|Adverse Event|14|||
126770109|NCT01186744|456112385|FG002|Overall Study|Adverse Event|1|||
126770110|NCT01186744|456112386|FG003|Overall Study|Adverse Event|0|||
126770111|NCT01186744|456112387|FG004|Overall Study|Adverse Event|1|||
126770112|NCT01186744|456112388|FG005|Overall Study|Adverse Event|4|||
126770113|NCT01186744|456112383|FG000|Overall Study|Death|1|||
126299727|NCT00848718|454385162|FG000|Overall Study|Progressive disease before treatment|1|||
126299728|NCT00848718|454385163|FG001|Overall Study|Progressive disease before treatment|5|||
126299729|NCT00848718|454385164|FG002|Overall Study|Progressive disease before treatment|1|||
126299730|NCT00848718|454385165|FG003|Overall Study|Progressive disease before treatment|3|||
126299731|NCT00848718|454385166|FG004|Overall Study|Progressive disease before treatment|4|||
126299732|NCT00848718|454385167|FG005|Overall Study|Progressive disease before treatment|4|||
126299733|NCT00848718|454385168|FG006|Overall Study|Progressive disease before treatment|2|||
126299734|NCT00848718|454385169|FG007|Overall Study|Progressive disease before treatment|1|||
126299735|NCT00848718|454385170|FG008|Overall Study|Progressive disease before treatment|2|||
126299736|NCT00848718|454385171|FG009|Overall Study|Progressive disease before treatment|7|||
126299737|NCT00848718|454385172|FG010|Overall Study|Progressive disease before treatment|3|||
126299738|NCT00848718|454385173|FG011|Overall Study|Progressive disease before treatment|6|||
126299739|NCT00848718|454385174|FG012|Overall Study|Progressive disease before treatment|2|||
126299740|NCT00848718|454385162|FG000|Overall Study|Protocol Violation|0|||
126299741|NCT00848718|454385163|FG001|Overall Study|Protocol Violation|1|||
126299742|NCT00848718|454385164|FG002|Overall Study|Protocol Violation|0|||
126299743|NCT00848718|454385165|FG003|Overall Study|Protocol Violation|0|||
126299744|NCT00848718|454385166|FG004|Overall Study|Protocol Violation|0|||
126299745|NCT00848718|454385167|FG005|Overall Study|Protocol Violation|0|||
126299746|NCT00848718|454385168|FG006|Overall Study|Protocol Violation|0|||
126299747|NCT00848718|454385169|FG007|Overall Study|Protocol Violation|1|||
126299748|NCT00848718|454385170|FG008|Overall Study|Protocol Violation|0|||
126299749|NCT00848718|454385171|FG009|Overall Study|Protocol Violation|0|||
126299750|NCT00848718|454385172|FG010|Overall Study|Protocol Violation|0|||
126299751|NCT00848718|454385173|FG011|Overall Study|Protocol Violation|0|||
126299752|NCT00848718|454385174|FG012|Overall Study|Protocol Violation|1|||
126299753|NCT00848718|454385162|FG000|Overall Study|Withdrawal by Subject|1|||
126299754|NCT00848718|454385163|FG001|Overall Study|Withdrawal by Subject|0|||
126299755|NCT00848718|454385164|FG002|Overall Study|Withdrawal by Subject|0|||
126299756|NCT00848718|454385165|FG003|Overall Study|Withdrawal by Subject|1|||
126299757|NCT00848718|454385166|FG004|Overall Study|Withdrawal by Subject|0|||
126299758|NCT00848718|454385167|FG005|Overall Study|Withdrawal by Subject|0|||
126299759|NCT00848718|454385168|FG006|Overall Study|Withdrawal by Subject|0|||
126299760|NCT00848718|454385169|FG007|Overall Study|Withdrawal by Subject|0|||
126299761|NCT00848718|454385170|FG008|Overall Study|Withdrawal by Subject|0|||
126299762|NCT00848718|454385171|FG009|Overall Study|Withdrawal by Subject|0|||
126299763|NCT00848718|454385172|FG010|Overall Study|Withdrawal by Subject|1|||
126299764|NCT00848718|454385173|FG011|Overall Study|Withdrawal by Subject|0|||
126299765|NCT00848718|454385174|FG012|Overall Study|Withdrawal by Subject|0|||
126299766|NCT00848718|454385162|FG000|Overall Study|Progressive disease during treatment|3|||
126299767|NCT00848718|454385163|FG001|Overall Study|Progressive disease during treatment|0|||
126299768|NCT00848718|454385164|FG002|Overall Study|Progressive disease during treatment|3|||
126299769|NCT00848718|454385165|FG003|Overall Study|Progressive disease during treatment|0|||
126299770|NCT00848718|454385166|FG004|Overall Study|Progressive disease during treatment|0|||
126299771|NCT00848718|454385167|FG005|Overall Study|Progressive disease during treatment|0|||
126299772|NCT00848718|454385168|FG006|Overall Study|Progressive disease during treatment|0|||
126299773|NCT00848718|454385169|FG007|Overall Study|Progressive disease during treatment|2|||
126299774|NCT00848718|454385170|FG008|Overall Study|Progressive disease during treatment|0|||
126299775|NCT00848718|454385171|FG009|Overall Study|Progressive disease during treatment|0|||
126299776|NCT00848718|454385172|FG010|Overall Study|Progressive disease during treatment|0|||
126299777|NCT00848718|454385173|FG011|Overall Study|Progressive disease during treatment|0|||
126299778|NCT00848718|454385174|FG012|Overall Study|Progressive disease during treatment|2|||
126299779|NCT02418182|454385176|FG000|Overall Study|Unable to re-consent|18|||
126770114|NCT01186744|456112384|FG001|Overall Study|Death|0|||
126770115|NCT01186744|456112385|FG002|Overall Study|Death|0|||
126770116|NCT01186744|456112386|FG003|Overall Study|Death|0|||
126299780|NCT02418182|454385177|FG001|Overall Study|Unable to re-consent|15|||
126299781|NCT02418182|454385176|FG000|Overall Study|Lost to Follow-up|0|||
126299782|NCT02418182|454385177|FG001|Overall Study|Lost to Follow-up|2|||
126550252|NCT01017120|455309514|FG001|Overall Study|Pregnancy|1|||
126770117|NCT01186744|456112387|FG004|Overall Study|Death|0|||
126299783|NCT02431676|454385180|FG000|Overall Study|no lab obtained|0|||
126299784|NCT02431676|454385181|FG001|Overall Study|no lab obtained|1|||
126299785|NCT02431676|454385182|FG002|Overall Study|no lab obtained|2|||
126299786|NCT00570687|454387006|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299787|NCT00570687|454387007|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299788|NCT00570687|454387008|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299789|NCT00570687|454387009|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299790|NCT00570687|454387010|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
126299791|NCT00570687|454387011|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
126299792|NCT00570687|454387012|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
126299793|NCT00570687|454387013|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
126299794|NCT00570687|454387014|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
126299795|NCT00570687|454387015|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
126461618|NCT01277042|454991441|FG001|Overall Study|Lost to Follow-up|2|||
126461619|NCT01277042|454991440|FG000|Overall Study|Withdrawal by Subject|2|||
126461620|NCT01277042|454991441|FG001|Overall Study|Withdrawal by Subject|0|||
126461621|NCT01461057|454991442|FG000|Overall Study|Death|10|||
126461622|NCT01461057|454991443|FG001|Overall Study|Death|9|||
126461623|NCT01461057|454991442|FG000|Overall Study|Withdrawal by Subject|2|||
126461624|NCT01461057|454991443|FG001|Overall Study|Withdrawal by Subject|3|||
126461625|NCT01461057|454991442|FG000|Overall Study|Physician Decision|0|||
126461626|NCT01461057|454991443|FG001|Overall Study|Physician Decision|2|||
126461627|NCT01461057|454991442|FG000|Overall Study|Adverse Event|0|||
126461628|NCT01461057|454991443|FG001|Overall Study|Adverse Event|1|||
126461629|NCT01461057|454991442|FG000|Overall Study|Progression of Disease|1|||
126461630|NCT01461057|454991443|FG001|Overall Study|Progression of Disease|0|||
126299796|NCT00570687|454387006|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126461631|NCT01461057|454991442|FG000|Overall Study|Study Terminated by Sponsor|2|||
126461632|NCT01461057|454991443|FG001|Overall Study|Study Terminated by Sponsor|0|||
126461633|NCT01288976|454991444|FG000|Overall Study|Withdrawal by Subject|58|||
126461634|NCT01288976|454991445|FG001|Overall Study|Withdrawal by Subject|12|||
126461635|NCT01288976|454991446|FG002|Overall Study|Withdrawal by Subject|9|||
126461636|NCT01288976|454991444|FG000|Overall Study|Death|98|||
126461637|NCT01288976|454991445|FG001|Overall Study|Death|6|||
126461638|NCT01288976|454991446|FG002|Overall Study|Death|4|||
126461639|NCT01288976|454991444|FG000|Overall Study|Data unavailable|22|||
126461640|NCT01288976|454991445|FG001|Overall Study|Data unavailable|9|||
126461641|NCT01288976|454991446|FG002|Overall Study|Data unavailable|7|||
126461642|NCT03350984|454991449|FG000|Overall Study|Death|1|||
126461643|NCT03350984|454991450|FG001|Overall Study|Death|0|||
126461644|NCT03350984|454991449|FG000|Overall Study|Lost to Follow-up|5|||
126461645|NCT03350984|454991450|FG001|Overall Study|Lost to Follow-up|6|||
126461646|NCT03350984|454991449|FG000|Overall Study|Protocol Violation|1|||
126461647|NCT03350984|454991450|FG001|Overall Study|Protocol Violation|2|||
126461648|NCT03350984|454991449|FG000|Overall Study|Physician Decision|1|||
126299797|NCT00570687|454387007|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299798|NCT00570687|454387008|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299799|NCT00570687|454387009|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299800|NCT00570687|454387010|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299801|NCT00570687|454387011|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126461649|NCT03350984|454991450|FG001|Overall Study|Physician Decision|0|||
126461650|NCT00642473|454991451|FG000|Overall Study|Withdrawal by Subject|0|||
126461651|NCT00642473|454991452|FG001|Overall Study|Withdrawal by Subject|5|||
126461652|NCT00642473|454991451|FG000|Overall Study|Progression or death|2|||
126461653|NCT00642473|454991452|FG001|Overall Study|Progression or death|4|||
126461654|NCT00642473|454991451|FG000|Overall Study|Other|2|||
126461655|NCT00642473|454991452|FG001|Overall Study|Other|2|||
126461656|NCT01483690|454991456|FG000|Overall Study|Adverse Event|1|||
126461657|NCT01483690|454991457|FG001|Overall Study|Adverse Event|2|||
126461658|NCT01483690|454991456|FG000|Overall Study|clinical deterioration|1|||
126461659|NCT01483690|454991457|FG001|Overall Study|clinical deterioration|0|||
126461660|NCT01483690|454991456|FG000|Overall Study|Physician Decision|0|||
126461661|NCT01483690|454991457|FG001|Overall Study|Physician Decision|2|||
126461662|NCT01483690|454991456|FG000|Overall Study|exclusionary procedure|0|||
126461663|NCT01483690|454991457|FG001|Overall Study|exclusionary procedure|1|||
126461664|NCT00478881|454991463|FG000|Overall Study|Adverse Event|31|||
126461665|NCT00478881|454991464|FG001|Overall Study|Adverse Event|12|||
126461666|NCT00478881|454991463|FG000|Overall Study|Lack of Efficacy|0|||
126461667|NCT00478881|454991464|FG001|Overall Study|Lack of Efficacy|3|||
126461668|NCT00478881|454991463|FG000|Overall Study|Lost to Follow-up|0|||
126461669|NCT00478881|454991464|FG001|Overall Study|Lost to Follow-up|1|||
126461670|NCT00478881|454991463|FG000|Overall Study|Protocol Violation|2|||
126461671|NCT00478881|454991464|FG001|Overall Study|Protocol Violation|2|||
126461672|NCT00478881|454991463|FG000|Overall Study|Withdrawal by Subject|6|||
126461673|NCT00478881|454991464|FG001|Overall Study|Withdrawal by Subject|2|||
126299802|NCT00570687|454387012|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126461674|NCT00478881|454991463|FG000|Overall Study|Non-Compliance with Study Medication|0|||
126461675|NCT00478881|454991464|FG001|Overall Study|Non-Compliance with Study Medication|2|||
126299803|NCT00570687|454387013|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299804|NCT00570687|454387014|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
126299805|NCT00570687|454387015|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299806|NCT00570687|454387006|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299807|NCT00570687|454387007|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299808|NCT00570687|454387008|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299809|NCT00570687|454387009|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299810|NCT00570687|454387010|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299811|NCT00570687|454387011|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299812|NCT00570687|454387012|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
126299813|NCT00570687|454387013|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299814|NCT00570687|454387014|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299815|NCT00570687|454387015|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
126299816|NCT01120184|454387016|FG000|Overall Study|Adverse Event|0|||
126299817|NCT01120184|454387017|FG001|Overall Study|Adverse Event|1|||
126299818|NCT01120184|454387018|FG002|Overall Study|Adverse Event|0|||
126299819|NCT01120184|454387016|FG000|Overall Study|Lost to Follow-up|13|||
126299820|NCT01120184|454387017|FG001|Overall Study|Lost to Follow-up|13|||
126461676|NCT00737464|454991465|FG000|Overall Study|Adverse Event|1|||
126461677|NCT00737464|454991465|FG000|Overall Study|Death|6|||
126461678|NCT00737464|454991465|FG000|Overall Study|Other - Failure to Return|1|||
126461679|NCT00737464|454991465|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
126461680|NCT00737464|454991465|FG000|Overall Study|Other reasons|4|||
126461681|NCT03410823|454991468|FG000|Overall Study|Death|1|||
126461682|NCT03410823|454991468|FG000|Overall Study|Withdrawal by Subject|2|||
126461683|NCT03410823|454991468|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
126461684|NCT03569293|454991469|FG000|Overall Study|Adverse Event|4|||
126461685|NCT03569293|454991470|FG001|Overall Study|Adverse Event|1|||
126461686|NCT03569293|454991471|FG002|Overall Study|Adverse Event|5|||
126461687|NCT03569293|454991472|FG003|Overall Study|Adverse Event|1|||
126461688|NCT03569293|454991473|FG004|Overall Study|Adverse Event|0|||
126461689|NCT03569293|454991474|FG005|Overall Study|Adverse Event|0|||
126461690|NCT03569293|454991469|FG000|Overall Study|Withdrawal by Subject|16|||
126461691|NCT03569293|454991470|FG001|Overall Study|Withdrawal by Subject|2|||
126461692|NCT03569293|454991471|FG002|Overall Study|Withdrawal by Subject|4|||
126461693|NCT03569293|454991472|FG003|Overall Study|Withdrawal by Subject|1|||
126461694|NCT03569293|454991473|FG004|Overall Study|Withdrawal by Subject|0|||
126461695|NCT03569293|454991474|FG005|Overall Study|Withdrawal by Subject|0|||
126461696|NCT03569293|454991469|FG000|Overall Study|Lost to Follow-up|1|||
126461697|NCT03569293|454991470|FG001|Overall Study|Lost to Follow-up|3|||
126299821|NCT01120184|454387018|FG002|Overall Study|Lost to Follow-up|11|||
126461698|NCT03569293|454991471|FG002|Overall Study|Lost to Follow-up|1|||
126461699|NCT03569293|454991472|FG003|Overall Study|Lost to Follow-up|1|||
126461700|NCT03569293|454991473|FG004|Overall Study|Lost to Follow-up|0|||
126461701|NCT03569293|454991474|FG005|Overall Study|Lost to Follow-up|0|||
126461702|NCT03569293|454991469|FG000|Overall Study|Other|8|||
126461703|NCT03569293|454991470|FG001|Overall Study|Other|2|||
126299822|NCT01120184|454387016|FG000|Overall Study|Physician Decision|9|||
126299823|NCT01120184|454387017|FG001|Overall Study|Physician Decision|1|||
126367373|NCT02471144|454640899|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367374|NCT02471144|454640900|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367375|NCT02471144|454640901|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
126367376|NCT02471144|454640902|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
126367377|NCT02471144|454640903|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367378|NCT02471144|454640904|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
126367379|NCT02471144|454640894|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367380|NCT02471144|454640895|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367381|NCT02471144|454640896|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367382|NCT02471144|454640897|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367383|NCT02471144|454640898|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367384|NCT02471144|454640899|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367385|NCT02471144|454640900|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367386|NCT02471144|454640901|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126461704|NCT03569293|454991471|FG002|Overall Study|Other|1|||
126461705|NCT03569293|454991472|FG003|Overall Study|Other|1|||
126461706|NCT03569293|454991473|FG004|Overall Study|Other|0|||
126461707|NCT03569293|454991474|FG005|Overall Study|Other|0|||
126461708|NCT03569293|454991469|FG000|Overall Study|Ongoing at Time of Analysis|8|||
126770118|NCT01186744|456112388|FG005|Overall Study|Death|0|||
126299824|NCT01120184|454387018|FG002|Overall Study|Physician Decision|3|||
126299825|NCT01120184|454387016|FG000|Overall Study|Reason not Specified|8|||
126299826|NCT01120184|454387017|FG001|Overall Study|Reason not Specified|3|||
126299827|NCT01120184|454387018|FG002|Overall Study|Reason not Specified|12|||
126299828|NCT01120184|454387016|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
126299829|NCT01120184|454387017|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
126299830|NCT01120184|454387018|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
126299831|NCT01120184|454387016|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
126299832|NCT01120184|454387017|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
126299833|NCT01120184|454387018|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
126299834|NCT01120184|454387016|FG000|Overall Study|Death|170|||
126299835|NCT01120184|454387017|FG001|Overall Study|Death|176|||
126299836|NCT01120184|454387018|FG002|Overall Study|Death|169|||
126299837|NCT04003636|454387019|FG000|Overall Study|Death|409|||
126299838|NCT04003636|454387020|FG001|Overall Study|Death|443|||
126299839|NCT04003636|454387019|FG000|Overall Study|Lost to Follow-up|0|||
126299840|NCT04003636|454387020|FG001|Overall Study|Lost to Follow-up|1|||
126299841|NCT04003636|454387019|FG000|Overall Study|Withdrawal by Subject|5|||
126299842|NCT04003636|454387020|FG001|Overall Study|Withdrawal by Subject|2|||
126299843|NCT04003636|454387019|FG000|Overall Study|Participant On-going|119|||
126299844|NCT04003636|454387020|FG001|Overall Study|Participant On-going|90|||
126299845|NCT00824772|454387021|FG000|Overall Study|Withdrawal by Subject|8|||
126299846|NCT03656068|454387022|FG000|Overall Study|Withdrawal by Subject|4|||
126299847|NCT03656068|454387022|FG000|Overall Study|Adverse Event|1|||
126299848|NCT03270657|454387023|FG000|Overall Study|Withdrawal by Subject|1|||
126299849|NCT00162981|454387024|FG000|Overall Study|Adverse Event|2|||
126299850|NCT00162981|454387025|FG001|Overall Study|Adverse Event|5|||
126299851|NCT00162981|454387024|FG000|Overall Study|Withdrawal by Subject|1|||
126299852|NCT00162981|454387025|FG001|Overall Study|Withdrawal by Subject|1|||
126299853|NCT00162981|454387024|FG000|Overall Study|Physician Decision|1|||
126299854|NCT00162981|454387025|FG001|Overall Study|Physician Decision|0|||
126299855|NCT00455403|454387032|FG000|Overall Study|Lost to Follow-up|2|||
126299856|NCT00455403|454387033|FG001|Overall Study|Lost to Follow-up|1|||
126299857|NCT00455403|454387032|FG000|Overall Study|Withdrawal by Subject|1|||
126299858|NCT00455403|454387033|FG001|Overall Study|Withdrawal by Subject|3|||
126299859|NCT00455403|454387032|FG000|Overall Study|Protocol Violation|0|||
126299860|NCT00455403|454387033|FG001|Overall Study|Protocol Violation|2|||
126299861|NCT00350207|454387034|FG000|Overall Study|Adverse Event|5|||
126299862|NCT00350207|454387035|FG001|Overall Study|Adverse Event|2|||
126299863|NCT00350207|454387036|FG002|Overall Study|Adverse Event|2|||
126299864|NCT00350207|454387034|FG000|Overall Study|Lack of Efficacy|1|||
126299865|NCT00350207|454387035|FG001|Overall Study|Lack of Efficacy|0|||
126299866|NCT00350207|454387036|FG002|Overall Study|Lack of Efficacy|2|||
126299867|NCT00350207|454387034|FG000|Overall Study|Lost to Follow-up|1|||
126299868|NCT00350207|454387035|FG001|Overall Study|Lost to Follow-up|0|||
126299869|NCT00350207|454387036|FG002|Overall Study|Lost to Follow-up|1|||
126299870|NCT00350207|454387034|FG000|Overall Study|Withdrawal by Subject|0|||
126299871|NCT00350207|454387035|FG001|Overall Study|Withdrawal by Subject|1|||
126770119|NCT01020773|456112391|FG000|Overall Study|Withdrawal by Subject|4|||
126770120|NCT01020773|456112392|FG001|Overall Study|Withdrawal by Subject|3|||
126770121|NCT02675426|456112393|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
126770122|NCT02675426|456112394|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
126770123|NCT02675426|456112395|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
126770124|NCT02675426|456112396|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
126770125|NCT02675426|456112393|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
126770126|NCT02675426|456112394|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
126770127|NCT02675426|456112395|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
126770128|NCT02675426|456112396|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
126770129|NCT02675426|456112393|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
126770130|NCT02675426|456112394|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
126770131|NCT02675426|456112395|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
126299872|NCT00350207|454387036|FG002|Overall Study|Withdrawal by Subject|1|||
126299873|NCT00350207|454387034|FG000|Overall Study|Other|1|||
126299874|NCT00350207|454387035|FG001|Overall Study|Other|3|||
126299875|NCT00350207|454387036|FG002|Overall Study|Other|1|||
126299876|NCT00495391|454387037|FG000|Overall Study|Lack of Efficacy|34|||
126299877|NCT00495391|454387038|FG001|Overall Study|Lack of Efficacy|18|||
126367387|NCT02471144|454640902|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
126367388|NCT02471144|454640903|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
126770132|NCT02675426|456112396|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
126299878|NCT00495391|454387037|FG000|Overall Study|Withdrawal by Subject|2|||
126299879|NCT00495391|454387038|FG001|Overall Study|Withdrawal by Subject|3|||
126299880|NCT00502242|454387051|FG000|Overall Study|Lack of Efficacy|1|||
126367389|NCT02471144|454640904|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
126770133|NCT02675426|456112393|FG000|Period 1: Week 1 to Week 12|Other|2|||
126299881|NCT00502242|454387052|FG001|Overall Study|Lack of Efficacy|11|||
126299882|NCT00502242|454387051|FG000|Overall Study|Adverse Event|31|||
126770134|NCT02675426|456112394|FG001|Period 1: Week 1 to Week 12|Other|1|||
126299883|NCT00502242|454387052|FG001|Overall Study|Adverse Event|20|||
126299884|NCT00502242|454387051|FG000|Overall Study|Physician Decision|2|||
126299885|NCT00502242|454387052|FG001|Overall Study|Physician Decision|3|||
126299886|NCT00502242|454387051|FG000|Overall Study|Other - Unspecified|8|||
126712609|NCT02269319|455899118|FG000|Overall Study|Instructions not followed|1|||
126712610|NCT02269319|455899119|FG001|Overall Study|Instructions not followed|0|||
126299887|NCT00502242|454387052|FG001|Overall Study|Other - Unspecified|14|||
126299888|NCT00502242|454387051|FG000|Overall Study|Protocol Violation|3|||
126299889|NCT00502242|454387052|FG001|Overall Study|Protocol Violation|1|||
126299890|NCT00502242|454387051|FG000|Overall Study|Withdrawal by Subject|6|||
126299891|NCT00502242|454387052|FG001|Overall Study|Withdrawal by Subject|7|||
126299892|NCT03313180|454387053|FG000|Overall Study|Adverse Event|120|||
126299893|NCT03313180|454387053|FG000|Overall Study|Lost to Follow-up|3|||
126299894|NCT03313180|454387053|FG000|Overall Study|Withdrawal by Subject|39|||
126299895|NCT03313180|454387053|FG000|Overall Study|Other than listed above|15|||
126299896|NCT03313180|454387053|FG000|Overall Study|Covid-19 related|2|||
126299897|NCT01966120|454387054|FG000|Overall Study|Withdrawal by Subject|0|||
126299898|NCT01966120|454387055|FG001|Overall Study|Withdrawal by Subject|5|||
126299899|NCT01966120|454387054|FG000|Overall Study|Lost to Follow-up|1|||
126299900|NCT01966120|454387055|FG001|Overall Study|Lost to Follow-up|1|||
126299901|NCT00461630|454387056|FG000|Overall Study|Death|798|||
126299902|NCT00461630|454387057|FG001|Overall Study|Death|732|||
126712611|NCT01589094|455899120|FG000|Overall Study|Did not receive treatment|2|||
126712612|NCT03575468|455899121|FG000|Overall Study|Withdrawal by Subject|3|||
126712613|NCT03575468|455899122|FG001|Overall Study|Withdrawal by Subject|0|||
126712614|NCT03575468|455899121|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
126712615|NCT03575468|455899122|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
126712616|NCT03575468|455899121|FG000|Overall Study|Lost to Follow-up|13|||
126712617|NCT03575468|455899122|FG001|Overall Study|Lost to Follow-up|17|||
126712618|NCT05270694|455900366|FG000|Overall Study|Death|1|||
126712619|NCT05270694|455900366|FG000|Overall Study|Medical issues impacted ability to participate|2|||
126712620|NCT05270694|455900366|FG000|Overall Study|Lost to Follow-up|3|||
126712621|NCT05270694|455900366|FG000|Overall Study|Withdrawal by Subject|3|||
126712622|NCT01991977|455900369|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
126712623|NCT01991977|455900369|FG000|Overall Study|Withdrew after start of treatment|5|||
126712624|NCT02531035|455900376|FG000|Overall Study|Death|0|||
126712625|NCT02531035|455900377|FG001|Overall Study|Death|1|||
126712626|NCT02531035|455900376|FG000|Overall Study|Protocol Violation|1|||
126712627|NCT02531035|455900377|FG001|Overall Study|Protocol Violation|1|||
126712628|NCT02531035|455900376|FG000|Overall Study|Noncompliance with study drug|8|||
126712629|NCT02531035|455900377|FG001|Overall Study|Noncompliance with study drug|3|||
126712630|NCT02531035|455900376|FG000|Overall Study|Physician Decision|1|||
126712631|NCT02531035|455900377|FG001|Overall Study|Physician Decision|0|||
126712632|NCT02531035|455900376|FG000|Overall Study|Adverse Event|16|||
126712633|NCT02531035|455900377|FG001|Overall Study|Adverse Event|45|||
126712634|NCT02531035|455900376|FG000|Overall Study|Other|3|||
126712635|NCT02531035|455900377|FG001|Overall Study|Other|2|||
126712636|NCT02531035|455900376|FG000|Overall Study|Withdrawal by Subject|42|||
126712637|NCT02531035|455900377|FG001|Overall Study|Withdrawal by Subject|32|||
126712638|NCT02531035|455900376|FG000|Overall Study|Lost to Follow-up|8|||
126712639|NCT02531035|455900377|FG001|Overall Study|Lost to Follow-up|10|||
126712640|NCT02531035|455900376|FG000|Overall Study|Randomized, not treated|2|||
126712641|NCT02531035|455900377|FG001|Overall Study|Randomized, not treated|1|||
126712642|NCT03032068|455900387|FG000|Overall Study|Adverse Event|1|||
126712643|NCT01597622|455900388|FG000|Overall Study|Adverse Event|7|||
126712644|NCT01597622|455900388|FG000|Overall Study|Lack of Efficacy|3|||
126712645|NCT01597622|455900388|FG000|Overall Study|Protocol Violation|1|||
126712646|NCT01597622|455900388|FG000|Overall Study|Lost to Follow-up|1|||
126712647|NCT01597622|455900388|FG000|Overall Study|Investigator Discretion|5|||
126712648|NCT01597622|455900388|FG000|Overall Study|Withdrawal by Subject|20|||
126299903|NCT00461630|454387056|FG000|Overall Study|Lost to Follow-up|108|||
126299904|NCT00461630|454387057|FG001|Overall Study|Lost to Follow-up|95|||
126299905|NCT00891020|454387062|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
126299906|NCT00891020|454387063|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
126712649|NCT01597622|455900388|FG000|Overall Study|Death|1|||
126712650|NCT03567291|455900395|FG000|Period I|Adverse Event|14|||
126770135|NCT02675426|456112395|FG002|Period 1: Week 1 to Week 12|Other|0|||
126461709|NCT03569293|454991470|FG001|Overall Study|Ongoing at Time of Analysis|1|||
126712651|NCT03567291|455900396|FG001|Period I|Adverse Event|0|||
126712652|NCT03567291|455900397|FG002|Period I|Adverse Event|0|||
126461710|NCT03569293|454991471|FG002|Overall Study|Ongoing at Time of Analysis|3|||
126461711|NCT03569293|454991472|FG003|Overall Study|Ongoing at Time of Analysis|0|||
126712653|NCT03567291|455900398|FG003|Period I|Adverse Event|0|||
126712654|NCT03567291|455900395|FG000|Period I|Protocol Violation|1|||
126712655|NCT03567291|455900396|FG001|Period I|Protocol Violation|0|||
126712656|NCT03567291|455900397|FG002|Period I|Protocol Violation|0|||
126712657|NCT03567291|455900398|FG003|Period I|Protocol Violation|0|||
126299907|NCT00891020|454387064|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
126461712|NCT03569293|454991473|FG004|Overall Study|Ongoing at Time of Analysis|0|||
126770136|NCT02675426|456112396|FG003|Period 1: Week 1 to Week 12|Other|2|||
126770137|NCT02675426|456112393|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
126770138|NCT02675426|456112394|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
126770139|NCT02675426|456112395|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
126770140|NCT02675426|456112396|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
126770141|NCT02675426|456112393|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
126770142|NCT02675426|456112394|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
126770143|NCT02675426|456112395|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
126770144|NCT02675426|456112396|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
126770145|NCT02675426|456112393|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
126770146|NCT02675426|456112394|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
126770147|NCT02675426|456112395|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
126770148|NCT02675426|456112396|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
126770149|NCT02675426|456112393|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
126770150|NCT02675426|456112394|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
126770151|NCT02675426|456112395|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
126770152|NCT02675426|456112396|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
126770153|NCT02675426|456112393|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
126770154|NCT02675426|456112394|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
126770155|NCT02675426|456112395|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
126770156|NCT02675426|456112396|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
126770157|NCT02675426|456112393|FG000|Period 2: Week 12 to Week 260|Other|8|||
126770158|NCT02675426|456112394|FG001|Period 2: Week 12 to Week 260|Other|12|||
126770159|NCT02675426|456112395|FG002|Period 2: Week 12 to Week 260|Other|23|||
126770160|NCT02675426|456112396|FG003|Period 2: Week 12 to Week 260|Other|15|||
126770161|NCT00953927|456112397|FG000|Overall Study|Lost to Follow-up|61|||
126770162|NCT00953927|456112398|FG001|Overall Study|Lost to Follow-up|65|||
126770163|NCT00953927|456112397|FG000|Overall Study|Withdrawal by Subject|36|||
126770164|NCT00953927|456112398|FG001|Overall Study|Withdrawal by Subject|25|||
126770165|NCT00953927|456112397|FG000|Overall Study|Death|7|||
126770166|NCT00953927|456112398|FG001|Overall Study|Death|4|||
126770167|NCT00953927|456112397|FG000|Overall Study|Other study discontinuation|1|||
126770168|NCT00953927|456112398|FG001|Overall Study|Other study discontinuation|1|||
126770169|NCT01652573|456112399|FG000|Overall Study|Adverse Event|0|||
126770170|NCT01652573|456112400|FG001|Overall Study|Adverse Event|1|||
126770171|NCT00934622|456112401|FG000|Overall Study|Lost to Follow-up|7|||
126770172|NCT00934622|456112401|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
126770173|NCT01856686|456112406|FG000|Overall Study|Lost to Follow-up|5|||
126770174|NCT01856686|456112407|FG001|Overall Study|Lost to Follow-up|11|||
126770175|NCT03284424|456112408|FG000|Overall Study|Death|70|||
126770176|NCT03284424|456112409|FG001|Overall Study|Death|24|||
126770177|NCT03284424|456112408|FG000|Overall Study|Lost to Follow-up|3|||
126770178|NCT03284424|456112409|FG001|Overall Study|Lost to Follow-up|1|||
126770179|NCT03284424|456112408|FG000|Overall Study|Physician Decision|1|||
126770180|NCT03284424|456112409|FG001|Overall Study|Physician Decision|2|||
126770181|NCT03284424|456112408|FG000|Overall Study|Withdrawal by Subject|4|||
126770182|NCT03284424|456112409|FG001|Overall Study|Withdrawal by Subject|5|||
126770183|NCT03284424|456112408|FG000|Overall Study|Sponsor's decision|27|||
126770184|NCT03284424|456112409|FG001|Overall Study|Sponsor's decision|22|||
126770185|NCT00602979|456112412|FG000|Overall Study|Lost to Follow-up|3|||
126770186|NCT00602979|456112413|FG001|Overall Study|Lost to Follow-up|2|||
126770187|NCT00602979|456112414|FG002|Overall Study|Lost to Follow-up|3|||
126770188|NCT00602979|456112415|FG003|Overall Study|Lost to Follow-up|2|||
126461713|NCT03569293|454991474|FG005|Overall Study|Ongoing at Time of Analysis|0|||
126770189|NCT00602979|456112416|FG004|Overall Study|Lost to Follow-up|3|||
126770190|NCT00602979|456112412|FG000|Overall Study|Failed Intubation|0|||
126770191|NCT00602979|456112413|FG001|Overall Study|Failed Intubation|1|||
126770192|NCT00602979|456112414|FG002|Overall Study|Failed Intubation|0|||
126770193|NCT00602979|456112415|FG003|Overall Study|Failed Intubation|1|||
126770194|NCT00602979|456112416|FG004|Overall Study|Failed Intubation|0|||
126770195|NCT02962739|456112417|FG000|Overall Study|Withdrawal by Subject|0|||
126770196|NCT02962739|456112418|FG001|Overall Study|Withdrawal by Subject|1|||
126770197|NCT02962739|456112419|FG002|Overall Study|Withdrawal by Subject|0|||
126770198|NCT02962739|456112420|FG003|Overall Study|Withdrawal by Subject|0|||
126461714|NCT05128929|454991476|FG000|Overall Study|Adverse Event|0|||
126461715|NCT05128929|454991477|FG001|Overall Study|Adverse Event|1|||
126770199|NCT02962739|456112421|FG004|Overall Study|Withdrawal by Subject|0|||
126770200|NCT02962739|456112422|FG005|Overall Study|Withdrawal by Subject|0|||
126770201|NCT02962739|456112417|FG000|Overall Study|Protocol Violation|0|||
126770202|NCT02962739|456112418|FG001|Overall Study|Protocol Violation|0|||
126770203|NCT02962739|456112419|FG002|Overall Study|Protocol Violation|1|||
126770204|NCT02962739|456112420|FG003|Overall Study|Protocol Violation|0|||
126770205|NCT02962739|456112421|FG004|Overall Study|Protocol Violation|1|||
126770206|NCT02962739|456112422|FG005|Overall Study|Protocol Violation|0|||
126770207|NCT01268683|456112426|FG000|Overall Study|Lost to Follow-up|1|||
126770208|NCT01268683|456112426|FG000|Overall Study|Death|1|||
126770209|NCT02216214|456112427|FG000|Overall Study|Randomized Never Received Study Drug|1|||
126770210|NCT02216214|456112428|FG001|Overall Study|Randomized Never Received Study Drug|0|||
126770211|NCT02216214|456112427|FG000|Overall Study|Adverse Event|10|||
126770212|NCT02216214|456112428|FG001|Overall Study|Adverse Event|8|||
126770213|NCT02216214|456112427|FG000|Overall Study|Lack of Efficacy|2|||
126770214|NCT02216214|456112428|FG001|Overall Study|Lack of Efficacy|2|||
126770215|NCT02216214|456112427|FG000|Overall Study|Lost to Follow-up|3|||
126770216|NCT02216214|456112428|FG001|Overall Study|Lost to Follow-up|2|||
126770217|NCT02216214|456112427|FG000|Overall Study|Protocol Violation|4|||
126770218|NCT02216214|456112428|FG001|Overall Study|Protocol Violation|2|||
126770219|NCT02216214|456112427|FG000|Overall Study|Withdrawal by Subject|22|||
126770220|NCT02216214|456112428|FG001|Overall Study|Withdrawal by Subject|20|||
126770221|NCT02216214|456112427|FG000|Overall Study|Study Terminated By Sponsor|0|||
126770222|NCT02216214|456112428|FG001|Overall Study|Study Terminated By Sponsor|1|||
126770223|NCT02216214|456112427|FG000|Overall Study|Miscellaneous|1|||
126770224|NCT02216214|456112428|FG001|Overall Study|Miscellaneous|1|||
126770225|NCT00713830|456112429|FG000|Overall Study|Adverse Event|23|||
126770226|NCT00713830|456112430|FG001|Overall Study|Adverse Event|71|||
126770227|NCT00713830|456112429|FG000|Overall Study|Lack of Efficacy|24|||
126770228|NCT00713830|456112430|FG001|Overall Study|Lack of Efficacy|16|||
126770229|NCT00713830|456112429|FG000|Overall Study|Lost to Follow-up|2|||
126770230|NCT00713830|456112430|FG001|Overall Study|Lost to Follow-up|9|||
126367390|NCT02471144|454640894|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126367391|NCT02471144|454640895|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126550253|NCT01017120|455309513|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
126550254|NCT01017120|455309514|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
126550255|NCT01017120|455309513|FG000|Overall Study|Relocated Out of Town|0|||
126550256|NCT01017120|455309514|FG001|Overall Study|Relocated Out of Town|2|||
126550257|NCT01017120|455309513|FG000|Overall Study|Protocol Violation|1|||
126550258|NCT01017120|455309514|FG001|Overall Study|Protocol Violation|0|||
126550259|NCT01017120|455309513|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
126550260|NCT01017120|455309514|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
126550261|NCT01087723|455309516|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
126550262|NCT01087723|455309517|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
126550263|NCT01087723|455309516|FG000|Overall Study|Withdrawal by Subject|10|||
126550264|NCT01087723|455309517|FG001|Overall Study|Withdrawal by Subject|13|||
126550265|NCT01087723|455309516|FG000|Overall Study|Physician Decision|2|||
126550266|NCT01087723|455309517|FG001|Overall Study|Physician Decision|0|||
126550267|NCT01087723|455309516|FG000|Overall Study|Lost to Follow-up|1|||
126550268|NCT01087723|455309517|FG001|Overall Study|Lost to Follow-up|4|||
126550269|NCT01087723|455309516|FG000|Overall Study|Reason Not Specified|1|||
126550270|NCT01087723|455309517|FG001|Overall Study|Reason Not Specified|2|||
126550271|NCT00289770|455309522|FG000|Year 15|Withdrawal by Subject|1|||
126550272|NCT00806624|455309523|FG000|Overall Study|Adverse Event|2|||
126550273|NCT00806624|455309524|FG001|Overall Study|Adverse Event|8|||
126550274|NCT00806624|455309525|FG002|Overall Study|Adverse Event|0|||
126550275|NCT00806624|455309523|FG000|Overall Study|Death|0|||
126550276|NCT00806624|455309524|FG001|Overall Study|Death|1|||
126550277|NCT00806624|455309525|FG002|Overall Study|Death|1|||
126712658|NCT03567291|455900395|FG000|Period I|Withdrawal by Subject|23|||
126712659|NCT03567291|455900396|FG001|Period I|Withdrawal by Subject|0|||
126712660|NCT03567291|455900397|FG002|Period I|Withdrawal by Subject|0|||
126712661|NCT03567291|455900398|FG003|Period I|Withdrawal by Subject|0|||
126712662|NCT03567291|455900395|FG000|Period I|Lost to Follow-up|2|||
126712663|NCT03567291|455900396|FG001|Period I|Lost to Follow-up|0|||
126712664|NCT03567291|455900397|FG002|Period I|Lost to Follow-up|0|||
126712665|NCT03567291|455900398|FG003|Period I|Lost to Follow-up|0|||
126712666|NCT03567291|455900395|FG000|Period I|Terminated by sponsor|44|||
126712667|NCT03567291|455900396|FG001|Period I|Terminated by sponsor|0|||
126712668|NCT03567291|455900397|FG002|Period I|Terminated by sponsor|0|||
126712669|NCT03567291|455900398|FG003|Period I|Terminated by sponsor|0|||
126770231|NCT00713830|456112429|FG000|Overall Study|Withdrawal by Subject|13|||
126770232|NCT00713830|456112430|FG001|Overall Study|Withdrawal by Subject|23|||
126770233|NCT00713830|456112429|FG000|Overall Study|Poor Compliance to Protocol|7|||
126770234|NCT00713830|456112430|FG001|Overall Study|Poor Compliance to Protocol|14|||
126770235|NCT00713830|456112429|FG000|Overall Study|Familial and Personal Reasons|9|||
126770236|NCT00713830|456112430|FG001|Overall Study|Familial and Personal Reasons|34|||
126770237|NCT00713830|456112429|FG000|Overall Study|Sponsor Decision|4|||
126550278|NCT00806624|455309523|FG000|Overall Study|Lost to Follow-up|1|||
126712670|NCT03567291|455900395|FG000|Period I|Missing or unknown|7|||
126550279|NCT00806624|455309524|FG001|Overall Study|Lost to Follow-up|0|||
126550280|NCT00806624|455309525|FG002|Overall Study|Lost to Follow-up|1|||
126550281|NCT00806624|455309523|FG000|Overall Study|Withdrawal by Subject|6|||
126550282|NCT00806624|455309524|FG001|Overall Study|Withdrawal by Subject|3|||
126550283|NCT00806624|455309525|FG002|Overall Study|Withdrawal by Subject|3|||
126712671|NCT03567291|455900396|FG001|Period I|Missing or unknown|0|||
126299908|NCT00891020|454387062|FG000|24 Week Treatment Period|Death|0|||
126299909|NCT00891020|454387063|FG001|24 Week Treatment Period|Death|2|||
126299910|NCT00891020|454387064|FG002|24 Week Treatment Period|Death|0|||
126299911|NCT00891020|454387062|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
126299912|NCT00891020|454387063|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
126299913|NCT00891020|454387064|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
126299914|NCT00891020|454387062|FG000|24 Week Treatment Period|Failure to return|4|||
126299915|NCT00891020|454387063|FG001|24 Week Treatment Period|Failure to return|5|||
126299916|NCT00891020|454387064|FG002|24 Week Treatment Period|Failure to return|5|||
126299917|NCT00891020|454387062|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
126299918|NCT00891020|454387063|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
126299919|NCT00891020|454387064|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
126299920|NCT00891020|454387062|FG000|24 Week Treatment Period|Other protocol violation|1|||
126299921|NCT00891020|454387063|FG001|24 Week Treatment Period|Other protocol violation|1|||
126299922|NCT00891020|454387064|FG002|24 Week Treatment Period|Other protocol violation|2|||
126299923|NCT00891020|454387062|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
126299924|NCT00891020|454387063|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
126299925|NCT00891020|454387064|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
126299926|NCT00891020|454387062|FG000|24 Week Treatment Period|Withdrew consent|6|||
126299927|NCT00891020|454387063|FG001|24 Week Treatment Period|Withdrew consent|3|||
126299928|NCT00891020|454387064|FG002|24 Week Treatment Period|Withdrew consent|15|||
126299929|NCT00891020|454387062|FG000|24 Week Treatment Period|Administrative/Other|5|||
126299930|NCT00891020|454387063|FG001|24 Week Treatment Period|Administrative/Other|6|||
126299931|NCT00891020|454387064|FG002|24 Week Treatment Period|Administrative/Other|1|||
126299932|NCT00891020|454387062|FG000|Long-term Extension Period|Adverse Event|1|||
126712672|NCT03567291|455900397|FG002|Period I|Missing or unknown|0|||
126712673|NCT03567291|455900398|FG003|Period I|Missing or unknown|0|||
126712674|NCT03567291|455900395|FG000|Period II|Adverse Event|0|||
126712675|NCT03567291|455900396|FG001|Period II|Adverse Event|1|||
126712676|NCT03567291|455900397|FG002|Period II|Adverse Event|0|||
126712677|NCT03567291|455900398|FG003|Period II|Adverse Event|0|||
126712678|NCT03567291|455900395|FG000|Period II|Missing or unknown|0|||
126712679|NCT03567291|455900396|FG001|Period II|Missing or unknown|2|||
126712680|NCT03567291|455900397|FG002|Period II|Missing or unknown|1|||
126712681|NCT03567291|455900398|FG003|Period II|Missing or unknown|0|||
126712682|NCT03567291|455900395|FG000|Period III|Adverse Event|0|||
126712683|NCT03567291|455900396|FG001|Period III|Adverse Event|0|||
126712684|NCT03567291|455900397|FG002|Period III|Adverse Event|0|||
126712685|NCT03567291|455900398|FG003|Period III|Adverse Event|4|||
126712686|NCT03567291|455900395|FG000|Period III|Withdrawal by Subject|0|||
126712687|NCT03567291|455900396|FG001|Period III|Withdrawal by Subject|0|||
126712688|NCT03567291|455900397|FG002|Period III|Withdrawal by Subject|0|||
126712689|NCT03567291|455900398|FG003|Period III|Withdrawal by Subject|4|||
126712690|NCT03567291|455900395|FG000|Period III|Lost to Follow-up|0|||
126712691|NCT03567291|455900396|FG001|Period III|Lost to Follow-up|0|||
126712692|NCT03567291|455900397|FG002|Period III|Lost to Follow-up|0|||
126712693|NCT03567291|455900398|FG003|Period III|Lost to Follow-up|1|||
126712694|NCT03567291|455900395|FG000|Period III|Terminated by sponsor|0|||
126712695|NCT03567291|455900396|FG001|Period III|Terminated by sponsor|0|||
126712696|NCT03567291|455900397|FG002|Period III|Terminated by sponsor|0|||
126712697|NCT03567291|455900398|FG003|Period III|Terminated by sponsor|68|||
126712698|NCT03567291|455900395|FG000|Period III|Missing or unknown|0|||
126712699|NCT03567291|455900396|FG001|Period III|Missing or unknown|0|||
126712700|NCT03567291|455900397|FG002|Period III|Missing or unknown|0|||
126712701|NCT03567291|455900398|FG003|Period III|Missing or unknown|8|||
126712702|NCT01103349|455900399|FG000|Overall Study|Adverse Event|8|||
126712703|NCT01103349|455900400|FG001|Overall Study|Adverse Event|5|||
126712704|NCT01103349|455900401|FG002|Overall Study|Adverse Event|3|||
126712705|NCT01103349|455900399|FG000|Overall Study|Consent withdrawn|1|||
126712706|NCT01103349|455900400|FG001|Overall Study|Consent withdrawn|0|||
126712707|NCT01103349|455900401|FG002|Overall Study|Consent withdrawn|0|||
126712708|NCT01103349|455900399|FG000|Overall Study|Incorrectly included in the trial|1|||
126712709|NCT01103349|455900400|FG001|Overall Study|Incorrectly included in the trial|0|||
126712710|NCT01103349|455900401|FG002|Overall Study|Incorrectly included in the trial|0|||
126712711|NCT01103349|455900399|FG000|Overall Study|Withdrawal by Subject|1|||
126712712|NCT01103349|455900400|FG001|Overall Study|Withdrawal by Subject|1|||
126367392|NCT02471144|454640896|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126367393|NCT02471144|454640897|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126712713|NCT01103349|455900401|FG002|Overall Study|Withdrawal by Subject|0|||
126712714|NCT01103349|455900399|FG000|Overall Study|did not want to take trial medication|0|||
126712715|NCT01103349|455900400|FG001|Overall Study|did not want to take trial medication|1|||
126712716|NCT01103349|455900401|FG002|Overall Study|did not want to take trial medication|0|||
126712717|NCT01103349|455900399|FG000|Overall Study|forgot to take medication|0|||
126712718|NCT01103349|455900400|FG001|Overall Study|forgot to take medication|0|||
126770238|NCT00713830|456112430|FG001|Overall Study|Sponsor Decision|10|||
126770239|NCT01826201|456112433|FG000|Overall Study|Non compliance with protocol|4|||
126770240|NCT01615822|456112434|FG000|Period 1|Withdrawal by Subject|0|||
126299933|NCT00891020|454387063|FG001|Long-term Extension Period|Adverse Event|11|||
126299934|NCT00891020|454387064|FG002|Long-term Extension Period|Adverse Event|10|||
126299935|NCT00891020|454387062|FG000|Long-term Extension Period|Death|0|||
126299936|NCT00891020|454387063|FG001|Long-term Extension Period|Death|0|||
126299937|NCT00891020|454387064|FG002|Long-term Extension Period|Death|1|||
126299938|NCT00891020|454387062|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
126299939|NCT00891020|454387063|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
126299940|NCT00891020|454387064|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
126299941|NCT00891020|454387062|FG000|Long-term Extension Period|Protocol Violation|0|||
126299942|NCT00891020|454387063|FG001|Long-term Extension Period|Protocol Violation|1|||
126299943|NCT00891020|454387064|FG002|Long-term Extension Period|Protocol Violation|1|||
126299944|NCT00891020|454387062|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
126299945|NCT00891020|454387063|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
126299946|NCT00891020|454387064|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
126299947|NCT00891020|454387062|FG000|Long-term Extension Period|Failure to return|0|||
126299948|NCT00891020|454387063|FG001|Long-term Extension Period|Failure to return|2|||
126299949|NCT00891020|454387064|FG002|Long-term Extension Period|Failure to return|3|||
126299950|NCT00891020|454387062|FG000|Long-term Extension Period|Administrative|1|||
126299951|NCT00891020|454387063|FG001|Long-term Extension Period|Administrative|2|||
126299952|NCT00891020|454387064|FG002|Long-term Extension Period|Administrative|2|||
126299953|NCT00320710|454387072|FG000|Overall Study|Disease progression|24|||
126299954|NCT00320710|454387073|FG001|Overall Study|Disease progression|19|||
126299955|NCT00320710|454387074|FG002|Overall Study|Disease progression|2|||
126299956|NCT00320710|454387072|FG000|Overall Study|Death|10|||
126299957|NCT00320710|454387073|FG001|Overall Study|Death|7|||
126299958|NCT00320710|454387074|FG002|Overall Study|Death|1|||
126299959|NCT00320710|454387072|FG000|Overall Study|Administrative problems|1|||
126299960|NCT00320710|454387073|FG001|Overall Study|Administrative problems|2|||
126299961|NCT00320710|454387074|FG002|Overall Study|Administrative problems|0|||
126299962|NCT00320710|454387072|FG000|Overall Study|Withdrawal by Subject|20|||
126299963|NCT00320710|454387073|FG001|Overall Study|Withdrawal by Subject|26|||
126299964|NCT00320710|454387074|FG002|Overall Study|Withdrawal by Subject|1|||
126299965|NCT00320710|454387072|FG000|Overall Study|Protocol Violation|6|||
126299966|NCT00320710|454387073|FG001|Overall Study|Protocol Violation|5|||
126299967|NCT00320710|454387074|FG002|Overall Study|Protocol Violation|0|||
126299968|NCT00320710|454387072|FG000|Overall Study|Abnormal test procedure result(s)|2|||
126299969|NCT00320710|454387073|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126299970|NCT00320710|454387074|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126299971|NCT00320710|454387072|FG000|Overall Study|Abnormal laboratory value(s)|12|||
126299972|NCT00320710|454387073|FG001|Overall Study|Abnormal laboratory value(s)|3|||
126299973|NCT00320710|454387074|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126299974|NCT00320710|454387072|FG000|Overall Study|Adverse Event|18|||
126299975|NCT00320710|454387073|FG001|Overall Study|Adverse Event|14|||
126299976|NCT00320710|454387074|FG002|Overall Study|Adverse Event|1|||
126299977|NCT00320710|454387072|FG000|Overall Study|Lost to Follow-up|1|||
126299978|NCT00320710|454387073|FG001|Overall Study|Lost to Follow-up|0|||
126299979|NCT00320710|454387074|FG002|Overall Study|Lost to Follow-up|0|||
126299980|NCT03448419|454387075|FG000|Overall Study|Adverse Event|10|||
126299981|NCT03448419|454387076|FG001|Overall Study|Adverse Event|9|||
126299982|NCT03448419|454387075|FG000|Overall Study|Lost to Follow-up|0|||
126299983|NCT03448419|454387076|FG001|Overall Study|Lost to Follow-up|2|||
126299984|NCT03448419|454387075|FG000|Overall Study|Withdrawal by Subject|3|||
126299985|NCT03448419|454387076|FG001|Overall Study|Withdrawal by Subject|1|||
126299986|NCT03448419|454387075|FG000|Overall Study|Not treated|0|||
126770241|NCT01615822|456112435|FG001|Period 1|Withdrawal by Subject|1|||
126770242|NCT01615822|456112436|FG002|Period 1|Withdrawal by Subject|0|||
126770243|NCT01615822|456112434|FG000|Period 1|Adverse Event|1|||
126770244|NCT01615822|456112435|FG001|Period 1|Adverse Event|1|||
126770245|NCT01615822|456112436|FG002|Period 1|Adverse Event|0|||
126770246|NCT01615822|456112434|FG000|Period 2|Lost to Follow-up|0|||
126299987|NCT03448419|454387076|FG001|Overall Study|Not treated|1|||
126299988|NCT03448419|454387075|FG000|Overall Study|Patient did not attend all visits|0|||
126299989|NCT03448419|454387076|FG001|Overall Study|Patient did not attend all visits|2|||
126299990|NCT03448419|454387075|FG000|Overall Study|Withdrawn by Sponsor|0|||
126299991|NCT03448419|454387076|FG001|Overall Study|Withdrawn by Sponsor|1|||
126770247|NCT01615822|456112435|FG001|Period 2|Lost to Follow-up|1|||
126770248|NCT01615822|456112436|FG002|Period 2|Lost to Follow-up|2|||
126299992|NCT02841995|454387077|FG000|Overall Study|Disease progression|5|||
126299993|NCT02841995|454387078|FG001|Overall Study|Disease progression|11|||
126299994|NCT02841995|454387079|FG002|Overall Study|Disease progression|8|||
126299995|NCT02841995|454387077|FG000|Overall Study|Withdrawal by Subject|2|||
126299996|NCT02841995|454387078|FG001|Overall Study|Withdrawal by Subject|4|||
126299997|NCT02841995|454387079|FG002|Overall Study|Withdrawal by Subject|4|||
126770249|NCT00499252|456112437|FG000|Overall Study|Adverse Event|3|||
126770250|NCT00499252|456112437|FG000|Overall Study|Refused further treatment|2|||
126770251|NCT00499252|456112437|FG000|Overall Study|Ineligible|4|||
126770252|NCT00499252|456112437|FG000|Overall Study|<no further label>|3|||
126770253|NCT00566631|456112438|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
126770254|NCT00566631|456112438|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
126770255|NCT00566631|456112438|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
126770256|NCT00566631|456112438|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
126770257|NCT00566631|456112438|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
126770258|NCT00566631|456112438|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
126367394|NCT02471144|454640898|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126770259|NCT00566631|456112438|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
126770260|NCT00566631|456112438|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
126770261|NCT00566631|456112438|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
126770262|NCT00566631|456112438|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
126770263|NCT00566631|456112438|FG000|Part 2: Extension Phase|Adverse Event|11|||
126770264|NCT00566631|456112438|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
126770265|NCT00566631|456112438|FG000|Part 2: Extension Phase|Death|1|||
126770266|NCT00566631|456112438|FG000|Part 2: Extension Phase|Other|5|||
126367395|NCT02471144|454640899|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126367396|NCT02471144|454640900|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126367397|NCT02471144|454640901|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126367398|NCT02471144|454640902|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126367399|NCT02471144|454640903|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
126712719|NCT01103349|455900401|FG002|Overall Study|forgot to take medication|1|||
126712720|NCT00090285|455900402|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
126712721|NCT00090285|455900403|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
126712722|NCT00090285|455900404|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
126712723|NCT00090285|455900405|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
126712724|NCT00090285|455900406|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
126712725|NCT00090285|455900407|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
126712726|NCT00090285|455900402|FG000|Base Study Vaccination Period|Adverse Event|2|||
126712727|NCT00090285|455900403|FG001|Base Study Vaccination Period|Adverse Event|4|||
126712728|NCT00090285|455900404|FG002|Base Study Vaccination Period|Adverse Event|0|||
126712729|NCT00090285|455900405|FG003|Base Study Vaccination Period|Adverse Event|0|||
126712730|NCT00090285|455900406|FG004|Base Study Vaccination Period|Adverse Event|0|||
126712731|NCT00090285|455900407|FG005|Base Study Vaccination Period|Adverse Event|0|||
126712732|NCT00090285|455900402|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
126712733|NCT00090285|455900403|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
126712734|NCT00090285|455900404|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
126712735|NCT00090285|455900405|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
126712736|NCT00090285|455900406|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
126712737|NCT00090285|455900407|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
126712738|NCT00090285|455900402|FG000|Base Study Vaccination Period|Protocol Violation|2|||
126712739|NCT00090285|455900403|FG001|Base Study Vaccination Period|Protocol Violation|3|||
126712740|NCT00090285|455900404|FG002|Base Study Vaccination Period|Protocol Violation|0|||
126712741|NCT00090285|455900405|FG003|Base Study Vaccination Period|Protocol Violation|0|||
126712742|NCT00090285|455900406|FG004|Base Study Vaccination Period|Protocol Violation|0|||
126712743|NCT00090285|455900407|FG005|Base Study Vaccination Period|Protocol Violation|0|||
126712744|NCT00090285|455900402|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
126712745|NCT00090285|455900403|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
126712746|NCT00090285|455900404|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
126712747|NCT00090285|455900405|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
126712748|NCT00090285|455900406|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
126712749|NCT00090285|455900407|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
126712750|NCT00090285|455900402|FG000|Base Study Vaccination Period|Uncooperative|2|||
126712751|NCT00090285|455900403|FG001|Base Study Vaccination Period|Uncooperative|2|||
126712752|NCT00090285|455900404|FG002|Base Study Vaccination Period|Uncooperative|0|||
126712753|NCT00090285|455900405|FG003|Base Study Vaccination Period|Uncooperative|0|||
126712754|NCT00090285|455900406|FG004|Base Study Vaccination Period|Uncooperative|0|||
126712755|NCT00090285|455900407|FG005|Base Study Vaccination Period|Uncooperative|0|||
126770267|NCT00537056|456112439|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
126770268|NCT03020966|456112443|FG000|Overall Study|Withdrawal by Subject|2|||
126770269|NCT03020966|456112444|FG001|Overall Study|Withdrawal by Subject|0|||
126770270|NCT02628418|456112445|FG000|Overall Study|Lost to Follow-up|1|||
126770271|NCT02628418|456112446|FG001|Overall Study|Lost to Follow-up|2|||
126770272|NCT01215955|456112447|FG000|Overall Study|Adverse Event|1|||
126367400|NCT02471144|454640904|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
126712756|NCT00090285|455900402|FG000|Base Study Vaccination Period|Moved|20|||
126712757|NCT00090285|455900403|FG001|Base Study Vaccination Period|Moved|21|||
126770273|NCT01215955|456112448|FG001|Overall Study|Adverse Event|4|||
126770274|NCT01215955|456112449|FG002|Overall Study|Adverse Event|2|||
126770275|NCT01215955|456112450|FG003|Overall Study|Adverse Event|3|||
126770276|NCT01215955|456112447|FG000|Overall Study|Death|2|||
126770277|NCT01215955|456112448|FG001|Overall Study|Death|0|||
126770278|NCT01215955|456112449|FG002|Overall Study|Death|1|||
126770279|NCT01215955|456112450|FG003|Overall Study|Death|3|||
126770280|NCT01215955|456112447|FG000|Overall Study|Entry Criteria Not Met|1|||
126770281|NCT01215955|456112448|FG001|Overall Study|Entry Criteria Not Met|3|||
126770282|NCT01215955|456112449|FG002|Overall Study|Entry Criteria Not Met|4|||
126770283|NCT01215955|456112450|FG003|Overall Study|Entry Criteria Not Met|7|||
126770284|NCT01215955|456112447|FG000|Overall Study|Lack of Efficacy|1|||
126770285|NCT01215955|456112448|FG001|Overall Study|Lack of Efficacy|2|||
126770286|NCT01215955|456112449|FG002|Overall Study|Lack of Efficacy|1|||
126770287|NCT01215955|456112450|FG003|Overall Study|Lack of Efficacy|0|||
126770288|NCT01215955|456112447|FG000|Overall Study|Lost to Follow-up|4|||
126770289|NCT01215955|456112448|FG001|Overall Study|Lost to Follow-up|4|||
126770290|NCT01215955|456112449|FG002|Overall Study|Lost to Follow-up|8|||
126770291|NCT01215955|456112450|FG003|Overall Study|Lost to Follow-up|9|||
126770292|NCT01215955|456112447|FG000|Overall Study|Physician Decision|4|||
126770293|NCT01215955|456112448|FG001|Overall Study|Physician Decision|10|||
126770294|NCT01215955|456112449|FG002|Overall Study|Physician Decision|8|||
126770295|NCT01215955|456112450|FG003|Overall Study|Physician Decision|11|||
126770296|NCT01215955|456112447|FG000|Overall Study|Protocol Violation|17|||
126770297|NCT01215955|456112448|FG001|Overall Study|Protocol Violation|13|||
126770298|NCT01215955|456112449|FG002|Overall Study|Protocol Violation|8|||
126770299|NCT01215955|456112450|FG003|Overall Study|Protocol Violation|8|||
126770300|NCT01215955|456112447|FG000|Overall Study|Sponsor Decision|1|||
126770301|NCT01215955|456112448|FG001|Overall Study|Sponsor Decision|2|||
126770302|NCT01215955|456112449|FG002|Overall Study|Sponsor Decision|0|||
126770303|NCT01215955|456112450|FG003|Overall Study|Sponsor Decision|1|||
126770304|NCT01215955|456112447|FG000|Overall Study|Withdrawal by Subject|14|||
126770305|NCT01215955|456112448|FG001|Overall Study|Withdrawal by Subject|15|||
126712758|NCT00090285|455900404|FG002|Base Study Vaccination Period|Moved|0|||
126712759|NCT00090285|455900405|FG003|Base Study Vaccination Period|Moved|0|||
126712760|NCT00090285|455900406|FG004|Base Study Vaccination Period|Moved|0|||
126712761|NCT00090285|455900407|FG005|Base Study Vaccination Period|Moved|0|||
126712762|NCT00090285|455900402|FG000|Base Study Vaccination Period|Site Terminated|1|||
126712763|NCT00090285|455900403|FG001|Base Study Vaccination Period|Site Terminated|0|||
126712764|NCT00090285|455900404|FG002|Base Study Vaccination Period|Site Terminated|0|||
126712765|NCT00090285|455900405|FG003|Base Study Vaccination Period|Site Terminated|0|||
126712766|NCT00090285|455900406|FG004|Base Study Vaccination Period|Site Terminated|0|||
126712767|NCT00090285|455900407|FG005|Base Study Vaccination Period|Site Terminated|0|||
126712768|NCT00090285|455900402|FG000|Base Study Vaccination Period|Other|2|||
126712769|NCT00090285|455900403|FG001|Base Study Vaccination Period|Other|2|||
126712770|NCT00090285|455900404|FG002|Base Study Vaccination Period|Other|0|||
126712771|NCT00090285|455900405|FG003|Base Study Vaccination Period|Other|0|||
126712772|NCT00090285|455900406|FG004|Base Study Vaccination Period|Other|0|||
126712773|NCT00090285|455900407|FG005|Base Study Vaccination Period|Other|0|||
126712774|NCT00090285|455900402|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
126712775|NCT00090285|455900403|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
126712776|NCT00090285|455900404|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
126712777|NCT00090285|455900405|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
126712778|NCT00090285|455900406|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
126712779|NCT00090285|455900407|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
126712780|NCT00090285|455900402|FG000|Base Study Vaccination Period|HIV positive|1|||
126712781|NCT00090285|455900403|FG001|Base Study Vaccination Period|HIV positive|1|||
126712782|NCT00090285|455900404|FG002|Base Study Vaccination Period|HIV positive|0|||
126712783|NCT00090285|455900405|FG003|Base Study Vaccination Period|HIV positive|0|||
126712784|NCT00090285|455900406|FG004|Base Study Vaccination Period|HIV positive|0|||
126712785|NCT00090285|455900407|FG005|Base Study Vaccination Period|HIV positive|0|||
126712786|NCT00090285|455900402|FG000|Base Study Follow-up Period|Adverse Event|3|||
126712787|NCT00090285|455900403|FG001|Base Study Follow-up Period|Adverse Event|10|||
126770306|NCT01215955|456112449|FG002|Overall Study|Withdrawal by Subject|13|||
126770307|NCT01215955|456112450|FG003|Overall Study|Withdrawal by Subject|9|||
126770308|NCT01215955|456112447|FG000|Overall Study|Quality Issues|0|||
126770309|NCT01215955|456112448|FG001|Overall Study|Quality Issues|0|||
126770310|NCT01215955|456112449|FG002|Overall Study|Quality Issues|3|||
126770311|NCT01215955|456112450|FG003|Overall Study|Quality Issues|2|||
126712788|NCT00090285|455900404|FG002|Base Study Follow-up Period|Adverse Event|0|||
126770312|NCT02494583|456112453|FG000|Overall Study|Death|224|||
126712789|NCT00090285|455900405|FG003|Base Study Follow-up Period|Adverse Event|0|||
126712790|NCT00090285|455900406|FG004|Base Study Follow-up Period|Adverse Event|0|||
126712791|NCT00090285|455900407|FG005|Base Study Follow-up Period|Adverse Event|0|||
126770313|NCT02494583|456112454|FG001|Overall Study|Death|214|||
126770314|NCT02494583|456112455|FG002|Overall Study|Death|225|||
126770315|NCT02494583|456112453|FG000|Overall Study|Lost to Follow-up|1|||
126770316|NCT02494583|456112454|FG001|Overall Study|Lost to Follow-up|0|||
126770317|NCT02494583|456112455|FG002|Overall Study|Lost to Follow-up|0|||
126770318|NCT02494583|456112453|FG000|Overall Study|Protocol Violation|1|||
126770319|NCT02494583|456112454|FG001|Overall Study|Protocol Violation|2|||
126770320|NCT02494583|456112455|FG002|Overall Study|Protocol Violation|0|||
126770321|NCT02494583|456112453|FG000|Overall Study|Screen Failure|0|||
126770322|NCT02494583|456112454|FG001|Overall Study|Screen Failure|1|||
126770323|NCT02494583|456112455|FG002|Overall Study|Screen Failure|0|||
126770324|NCT02494583|456112453|FG000|Overall Study|Transferred to Extension Study|15|||
126770325|NCT02494583|456112454|FG001|Overall Study|Transferred to Extension Study|15|||
126770326|NCT02494583|456112455|FG002|Overall Study|Transferred to Extension Study|6|||
126770327|NCT02494583|456112453|FG000|Overall Study|Did Not Continue on Extension Study|8|||
126770328|NCT02494583|456112454|FG001|Overall Study|Did Not Continue on Extension Study|10|||
126770329|NCT02494583|456112455|FG002|Overall Study|Did Not Continue on Extension Study|4|||
126550284|NCT00806624|455309523|FG000|Overall Study|discontinued before start of treatment|0|||
126550285|NCT00806624|455309524|FG001|Overall Study|discontinued before start of treatment|0|||
126550286|NCT00806624|455309525|FG002|Overall Study|discontinued before start of treatment|1|||
126550287|NCT01702428|455309527|FG000|Overall Study|Adverse Event|2|||
126550288|NCT01702428|455309528|FG001|Overall Study|Adverse Event|0|||
126550289|NCT01702428|455309529|FG002|Overall Study|Adverse Event|0|||
126712792|NCT00090285|455900402|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
126712793|NCT00090285|455900403|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
126712794|NCT00090285|455900404|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
126712795|NCT00090285|455900405|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
126712796|NCT00090285|455900406|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
126712797|NCT00090285|455900407|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
126712798|NCT00090285|455900402|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
126712799|NCT00090285|455900403|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
126712800|NCT00090285|455900404|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
126712801|NCT00090285|455900405|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
126712802|NCT00090285|455900406|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
126712803|NCT00090285|455900407|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
126712804|NCT00090285|455900402|FG000|Base Study Follow-up Period|Moved|41|||
126712805|NCT00090285|455900403|FG001|Base Study Follow-up Period|Moved|36|||
126712806|NCT00090285|455900404|FG002|Base Study Follow-up Period|Moved|0|||
126712807|NCT00090285|455900405|FG003|Base Study Follow-up Period|Moved|0|||
126712808|NCT00090285|455900406|FG004|Base Study Follow-up Period|Moved|0|||
126712809|NCT00090285|455900407|FG005|Base Study Follow-up Period|Moved|0|||
126712810|NCT00090285|455900402|FG000|Base Study Follow-up Period|Other|2|||
126712811|NCT00090285|455900403|FG001|Base Study Follow-up Period|Other|0|||
126712812|NCT00090285|455900404|FG002|Base Study Follow-up Period|Other|0|||
126712813|NCT00090285|455900405|FG003|Base Study Follow-up Period|Other|0|||
126712814|NCT00090285|455900406|FG004|Base Study Follow-up Period|Other|0|||
126712815|NCT00090285|455900407|FG005|Base Study Follow-up Period|Other|0|||
126712816|NCT00090285|455900402|FG000|Base Study Follow-up Period|Protocol Violation|1|||
126712817|NCT00090285|455900403|FG001|Base Study Follow-up Period|Protocol Violation|0|||
126712818|NCT00090285|455900404|FG002|Base Study Follow-up Period|Protocol Violation|0|||
126712819|NCT00090285|455900405|FG003|Base Study Follow-up Period|Protocol Violation|0|||
126712820|NCT00090285|455900406|FG004|Base Study Follow-up Period|Protocol Violation|0|||
126712821|NCT00090285|455900407|FG005|Base Study Follow-up Period|Protocol Violation|0|||
126712822|NCT00090285|455900402|FG000|Base Study Follow-up Period|Uncooperative|3|||
126712823|NCT00090285|455900403|FG001|Base Study Follow-up Period|Uncooperative|4|||
126712824|NCT00090285|455900404|FG002|Base Study Follow-up Period|Uncooperative|0|||
126712825|NCT00090285|455900405|FG003|Base Study Follow-up Period|Uncooperative|0|||
126712826|NCT00090285|455900406|FG004|Base Study Follow-up Period|Uncooperative|0|||
126712827|NCT00090285|455900407|FG005|Base Study Follow-up Period|Uncooperative|0|||
126712828|NCT00090285|455900402|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
126712829|NCT00090285|455900403|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
126712830|NCT00090285|455900404|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
126712831|NCT00090285|455900405|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
126712832|NCT00090285|455900406|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
126712833|NCT00090285|455900407|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
126712834|NCT00090285|455900402|FG000|Extension 1|Adverse Event|0|||
126712835|NCT00090285|455900403|FG001|Extension 1|Adverse Event|0|||
126712836|NCT00090285|455900404|FG002|Extension 1|Adverse Event|2|||
126712837|NCT00090285|455900405|FG003|Extension 1|Adverse Event|0|||
126550290|NCT01702428|455309530|FG003|Overall Study|Adverse Event|0|||
126550291|NCT01702428|455309527|FG000|Overall Study|Lost to Follow-up|33|||
126712838|NCT00090285|455900406|FG004|Extension 1|Adverse Event|0|||
126712839|NCT00090285|455900407|FG005|Extension 1|Adverse Event|0|||
126770330|NCT02494583|456112453|FG000|Overall Study|Withdrawal by Subject|7|||
126550292|NCT01702428|455309528|FG001|Overall Study|Lost to Follow-up|41|||
126712840|NCT00090285|455900402|FG000|Extension 1|Lost to Follow-up|0|||
126712841|NCT00090285|455900403|FG001|Extension 1|Lost to Follow-up|0|||
126299998|NCT02841995|454387077|FG000|Overall Study|Adverse Event|2|||
126299999|NCT02841995|454387078|FG001|Overall Study|Adverse Event|0|||
126300000|NCT02841995|454387079|FG002|Overall Study|Adverse Event|1|||
126300001|NCT02841995|454387077|FG000|Overall Study|Investigator decision|2|||
126300002|NCT02841995|454387078|FG001|Overall Study|Investigator decision|0|||
126300003|NCT02841995|454387079|FG002|Overall Study|Investigator decision|1|||
126300004|NCT02841995|454387077|FG000|Overall Study|Death|0|||
126300005|NCT02841995|454387078|FG001|Overall Study|Death|0|||
126300006|NCT02841995|454387079|FG002|Overall Study|Death|2|||
126300007|NCT02841995|454387077|FG000|Overall Study|Noncompliance to protocol|1|||
126300008|NCT02841995|454387078|FG001|Overall Study|Noncompliance to protocol|0|||
126300009|NCT02841995|454387079|FG002|Overall Study|Noncompliance to protocol|0|||
126300010|NCT02841995|454387077|FG000|Overall Study|Sponsor decision|1|||
126300011|NCT02841995|454387078|FG001|Overall Study|Sponsor decision|0|||
126300012|NCT02841995|454387079|FG002|Overall Study|Sponsor decision|0|||
126300013|NCT02841995|454387077|FG000|Overall Study|Other|4|||
126300014|NCT02841995|454387078|FG001|Overall Study|Other|1|||
126300015|NCT02841995|454387079|FG002|Overall Study|Other|5|||
126300016|NCT01703260|454387080|FG000|Overall Study|Adverse Event|1|||
126300017|NCT01703260|454387081|FG001|Overall Study|Adverse Event|2|||
126300018|NCT01703260|454387082|FG002|Overall Study|Adverse Event|2|||
126300019|NCT01703260|454387080|FG000|Overall Study|Lost to Follow-up|1|||
126300020|NCT01703260|454387081|FG001|Overall Study|Lost to Follow-up|0|||
126300021|NCT01703260|454387082|FG002|Overall Study|Lost to Follow-up|0|||
126300022|NCT01703260|454387080|FG000|Overall Study|Withdrawal by Subject|0|||
126300023|NCT01703260|454387081|FG001|Overall Study|Withdrawal by Subject|0|||
126300024|NCT01703260|454387082|FG002|Overall Study|Withdrawal by Subject|1|||
126300025|NCT01703260|454387080|FG000|Overall Study|Study Termination|1|||
126300026|NCT01703260|454387081|FG001|Overall Study|Study Termination|2|||
126300027|NCT01703260|454387082|FG002|Overall Study|Study Termination|0|||
126300028|NCT00630825|454387084|FG000|Overall Study|Adverse Event|4|||
126300029|NCT00630825|454387085|FG001|Overall Study|Adverse Event|4|||
126300030|NCT00630825|454387086|FG002|Overall Study|Adverse Event|3|||
126300031|NCT00630825|454387087|FG003|Overall Study|Adverse Event|1|||
126300032|NCT00630825|454387084|FG000|Overall Study|Entry Criteria Not Met|1|||
126300033|NCT00630825|454387085|FG001|Overall Study|Entry Criteria Not Met|0|||
126300034|NCT00630825|454387086|FG002|Overall Study|Entry Criteria Not Met|2|||
126300035|NCT00630825|454387087|FG003|Overall Study|Entry Criteria Not Met|1|||
126300036|NCT00630825|454387084|FG000|Overall Study|Lost to Follow-up|1|||
126300037|NCT00630825|454387085|FG001|Overall Study|Lost to Follow-up|1|||
126300038|NCT00630825|454387086|FG002|Overall Study|Lost to Follow-up|1|||
126461716|NCT02742246|454991478|FG000|Overall Study|Never initiated treatment|5|||
126461717|NCT02742246|454991479|FG001|Overall Study|Never initiated treatment|3|||
126461718|NCT02742246|454991480|FG002|Overall Study|Never initiated treatment|1|||
126461719|NCT02742246|454991478|FG000|Overall Study|dropped out during treatment|7|||
126461720|NCT02742246|454991479|FG001|Overall Study|dropped out during treatment|13|||
126461721|NCT02742246|454991480|FG002|Overall Study|dropped out during treatment|10|||
126461722|NCT02742246|454991478|FG000|Overall Study|Death|1|||
126461723|NCT02742246|454991479|FG001|Overall Study|Death|0|||
126461724|NCT02742246|454991480|FG002|Overall Study|Death|0|||
126461725|NCT03553836|454991481|FG000|Overall Study|Ongoing in Study|460|||
126461726|NCT03553836|454991482|FG001|Overall Study|Ongoing in Study|459|||
126461727|NCT03553836|454991481|FG000|Overall Study|Withdrawal by Subject|9|||
126461728|NCT03553836|454991482|FG001|Overall Study|Withdrawal by Subject|10|||
126461729|NCT03553836|454991481|FG000|Overall Study|Lost to Follow-up|1|||
126461730|NCT03553836|454991482|FG001|Overall Study|Lost to Follow-up|3|||
126461731|NCT03553836|454991481|FG000|Overall Study|Death|17|||
126461732|NCT03553836|454991482|FG001|Overall Study|Death|17|||
126461733|NCT03220438|454991483|FG000|Overall Study|Lost to Follow-up|0|||
126461734|NCT03220438|454991484|FG001|Overall Study|Lost to Follow-up|0|||
126461735|NCT03220438|454991485|FG002|Overall Study|Lost to Follow-up|1|||
126461736|NCT03220438|454991486|FG003|Overall Study|Lost to Follow-up|0|||
126461737|NCT04062123|454991487|FG000|Overall Study|Withdrawal by Subject|0|||
126461738|NCT04062123|454991488|FG001|Overall Study|Withdrawal by Subject|1|||
126461739|NCT04062123|454991489|FG002|Overall Study|Withdrawal by Subject|0|||
126300039|NCT00630825|454387087|FG003|Overall Study|Lost to Follow-up|1|||
126300040|NCT00630825|454387084|FG000|Overall Study|Physician Decision|1|||
126300041|NCT00630825|454387085|FG001|Overall Study|Physician Decision|0|||
126300042|NCT00630825|454387086|FG002|Overall Study|Physician Decision|0|||
126300043|NCT00630825|454387087|FG003|Overall Study|Physician Decision|0|||
126300044|NCT00630825|454387084|FG000|Overall Study|Withdrawal by Subject|2|||
126300045|NCT00630825|454387085|FG001|Overall Study|Withdrawal by Subject|2|||
126300046|NCT00630825|454387086|FG002|Overall Study|Withdrawal by Subject|2|||
126300047|NCT00630825|454387087|FG003|Overall Study|Withdrawal by Subject|3|||
126300048|NCT02792062|454387091|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
126300049|NCT02792062|454387092|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
126300050|NCT02792062|454387093|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
126461740|NCT00662532|454991492|FG000|Overall Study|Adverse Event|0|||
126461741|NCT00662532|454991493|FG001|Overall Study|Adverse Event|1|||
126461742|NCT00662532|454991492|FG000|Overall Study|Lost to Follow-up|0|||
126461743|NCT00662532|454991493|FG001|Overall Study|Lost to Follow-up|1|||
126461744|NCT00367770|454991494|FG000|Overall Study|Adverse Event|1|||
126300051|NCT02792062|454387094|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
126300052|NCT02792062|454387095|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
126300053|NCT02792062|454387096|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
126300054|NCT03309943|454387099|FG000|Overall Study|Withdrawal by Subject|0|||
126300055|NCT03309943|454387100|FG001|Overall Study|Withdrawal by Subject|1|||
126300056|NCT03309943|454387099|FG000|Overall Study|Inappropriate behavior towards staff|0|||
126300057|NCT03309943|454387100|FG001|Overall Study|Inappropriate behavior towards staff|1|||
126300058|NCT03123393|454387106|FG000|Overall Study|Study Terminated by Sponsor|6|||
126300059|NCT03123393|454387107|FG001|Overall Study|Study Terminated by Sponsor|9|||
126300060|NCT03123393|454387106|FG000|Overall Study|Withdrawal by Subject|2|||
126300061|NCT03123393|454387107|FG001|Overall Study|Withdrawal by Subject|1|||
126300062|NCT03123393|454387106|FG000|Overall Study|Reason not Specified|13|||
126300063|NCT03123393|454387107|FG001|Overall Study|Reason not Specified|13|||
126300064|NCT00427648|454387108|FG000|Overall Study|Protocol Violation|1|||
126300065|NCT00427648|454387109|FG001|Overall Study|Protocol Violation|2|||
126300066|NCT00427648|454387108|FG000|Overall Study|Adverse Event|0|||
126300067|NCT00427648|454387109|FG001|Overall Study|Adverse Event|1|||
126300068|NCT01297517|454387110|FG000|Overall Study|Adverse Event|21|||
126300069|NCT01297517|454387111|FG001|Overall Study|Adverse Event|7|||
126300070|NCT01297517|454387112|FG002|Overall Study|Adverse Event|16|||
126300071|NCT01297517|454387110|FG000|Overall Study|Lost to Follow-up|1|||
126300072|NCT01297517|454387111|FG001|Overall Study|Lost to Follow-up|0|||
126300073|NCT01297517|454387112|FG002|Overall Study|Lost to Follow-up|1|||
126300074|NCT01297517|454387110|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
126300075|NCT01297517|454387111|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
126300076|NCT01297517|454387112|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
126300077|NCT01297517|454387110|FG000|Overall Study|Noncompliance|1|||
126300078|NCT01297517|454387111|FG001|Overall Study|Noncompliance|0|||
126300079|NCT01297517|454387112|FG002|Overall Study|Noncompliance|0|||
126300080|NCT01297517|454387110|FG000|Overall Study|Protocol Violation|1|||
126300081|NCT01297517|454387111|FG001|Overall Study|Protocol Violation|1|||
126300082|NCT01297517|454387112|FG002|Overall Study|Protocol Violation|1|||
126300083|NCT01297517|454387110|FG000|Overall Study|Inadequate Control of IOP|1|||
126300084|NCT01297517|454387111|FG001|Overall Study|Inadequate Control of IOP|1|||
126300085|NCT01297517|454387112|FG002|Overall Study|Inadequate Control of IOP|2|||
126300086|NCT01681212|454387115|FG000|Overall Study|No longer met study criteria|5|||
126300087|NCT01681212|454387115|FG000|Overall Study|Administrative reason by sponsor|1|||
126300088|NCT01464424|454387116|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
126300089|NCT01464424|454387117|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
126300090|NCT01464333|454387118|FG000|Overall Study|Adverse Event|34|||
126300091|NCT01464333|454387118|FG000|Overall Study|Lack of Efficacy|72|||
126300092|NCT01464333|454387118|FG000|Overall Study|Withdrawal by Subject|11|||
126300093|NCT01464333|454387118|FG000|Overall Study|Other|4|||
126300094|NCT01464333|454387118|FG000|Overall Study|No Hospital Visit|42|||
126300095|NCT02282813|454387119|FG000|Overall Study|Withdrawal by Subject|4|||
126300096|NCT02282813|454387120|FG001|Overall Study|Withdrawal by Subject|5|||
126300097|NCT02282813|454387121|FG002|Overall Study|Withdrawal by Subject|0|||
126300098|NCT02282813|454387119|FG000|Overall Study|Adverse Event|3|||
126300099|NCT02282813|454387120|FG001|Overall Study|Adverse Event|10|||
126300100|NCT02282813|454387121|FG002|Overall Study|Adverse Event|1|||
126300101|NCT02282813|454387119|FG000|Overall Study|Subject non-compliance|1|||
126300102|NCT02282813|454387120|FG001|Overall Study|Subject non-compliance|4|||
126300103|NCT02282813|454387121|FG002|Overall Study|Subject non-compliance|0|||
126300104|NCT02282813|454387119|FG000|Overall Study|Physician Decision|0|||
126300105|NCT02282813|454387120|FG001|Overall Study|Physician Decision|3|||
126300106|NCT02282813|454387121|FG002|Overall Study|Physician Decision|1|||
126300107|NCT02282813|454387119|FG000|Overall Study|Lost to Follow-up|2|||
126461745|NCT00367770|454991494|FG000|Overall Study|Withdrawal by Subject|1|||
126300108|NCT02282813|454387120|FG001|Overall Study|Lost to Follow-up|0|||
126300109|NCT02282813|454387121|FG002|Overall Study|Lost to Follow-up|1|||
126300110|NCT02282813|454387119|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
126300111|NCT02282813|454387120|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
126300112|NCT02282813|454387121|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
126300113|NCT02282813|454387119|FG000|Overall Study|Lack of Efficacy|1|||
126300114|NCT02282813|454387120|FG001|Overall Study|Lack of Efficacy|0|||
126300115|NCT02282813|454387121|FG002|Overall Study|Lack of Efficacy|0|||
126300116|NCT02282813|454387119|FG000|Overall Study|Administrative reasons|0|||
126300117|NCT02282813|454387120|FG001|Overall Study|Administrative reasons|1|||
126300118|NCT02282813|454387121|FG002|Overall Study|Administrative reasons|0|||
126300119|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
126300120|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
126461746|NCT00174291|454991501|FG000|Overall Study|Lost to Follow-up|1|||
126461747|NCT00174291|454991502|FG001|Overall Study|Lost to Follow-up|1|||
126461748|NCT00174291|454991501|FG000|Overall Study|Protocol Violation|0|||
126300121|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
126300122|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
126300123|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
126300124|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
126300125|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
126300126|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
126300127|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
126300128|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
126300129|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
126300130|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
126300131|NCT03493854|454387124|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
126300132|NCT03493854|454387125|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
126300133|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
126300134|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
126300135|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
126300136|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
126300137|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
126300138|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
126300139|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
126300140|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
126300141|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
126300142|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
126300143|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
126300144|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
126300145|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
126300146|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
126300147|NCT03493854|454387124|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
126300148|NCT03493854|454387125|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
126300149|NCT03493854|454387124|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
126300150|NCT03493854|454387125|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
126300151|NCT03493854|454387124|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
126300152|NCT03493854|454387125|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
126300153|NCT03493854|454387124|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
126300154|NCT03493854|454387125|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
126300155|NCT00739661|454387126|FG000|Overall Study|Adverse Event|2|||
126300156|NCT00739661|454387127|FG001|Overall Study|Adverse Event|0|||
126300157|NCT00739661|454387126|FG000|Overall Study|Physician decision to withdraw patient|1|||
126300158|NCT00739661|454387127|FG001|Overall Study|Physician decision to withdraw patient|0|||
126300159|NCT00739661|454387126|FG000|Overall Study|Patient decision to withdraw|9|||
126300160|NCT00739661|454387127|FG001|Overall Study|Patient decision to withdraw|4|||
126300161|NCT00739661|454387126|FG000|Overall Study|Disease progression, radiographic|33|||
126300162|NCT00739661|454387127|FG001|Overall Study|Disease progression, radiographic|37|||
126300163|NCT00739661|454387126|FG000|Overall Study|Reason for discontinuation not available|1|||
126300164|NCT00739661|454387127|FG001|Overall Study|Reason for discontinuation not available|1|||
126300165|NCT05343364|454387129|FG000|Overall Study|Miscellaneous|0|||
126300166|NCT05343364|454387130|FG001|Overall Study|Miscellaneous|1|||
126300167|NCT02105987|454387131|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
126300168|NCT02105987|454387132|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
126300169|NCT02105987|454387133|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
126300170|NCT02105987|454387134|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
126300171|NCT02105987|454387135|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
126300172|NCT02105987|454387136|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
126300173|NCT02105987|454387131|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
126300174|NCT02105987|454387132|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
126300175|NCT02105987|454387133|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
126300176|NCT02105987|454387134|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
126300177|NCT02105987|454387135|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
126300178|NCT02105987|454387136|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
126300179|NCT02105987|454387131|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
126300180|NCT02105987|454387132|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
126300181|NCT02105987|454387133|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300182|NCT02105987|454387134|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300183|NCT02105987|454387135|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300184|NCT02105987|454387136|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300185|NCT02105987|454387131|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
126300186|NCT02105987|454387132|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
126300187|NCT02105987|454387133|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126550293|NCT01702428|455309529|FG002|Overall Study|Lost to Follow-up|37|||
126550294|NCT01702428|455309530|FG003|Overall Study|Lost to Follow-up|44|||
126550295|NCT01702428|455309527|FG000|Overall Study|Parents cannot assist to site|1|||
126550296|NCT01702428|455309528|FG001|Overall Study|Parents cannot assist to site|0|||
126550297|NCT01702428|455309529|FG002|Overall Study|Parents cannot assist to site|1|||
126550298|NCT01702428|455309530|FG003|Overall Study|Parents cannot assist to site|0|||
126550299|NCT01702428|455309527|FG000|Overall Study|Lost Coverage|0|||
126550300|NCT01702428|455309528|FG001|Overall Study|Lost Coverage|0|||
126550301|NCT01702428|455309529|FG002|Overall Study|Lost Coverage|0|||
126550302|NCT01702428|455309530|FG003|Overall Study|Lost Coverage|1|||
126550303|NCT01702428|455309527|FG000|Overall Study|Lost Health Plan|3|||
126550304|NCT01702428|455309528|FG001|Overall Study|Lost Health Plan|5|||
126550305|NCT01702428|455309529|FG002|Overall Study|Lost Health Plan|0|||
126550306|NCT01702428|455309530|FG003|Overall Study|Lost Health Plan|2|||
126550307|NCT01702428|455309527|FG000|Overall Study|Mother transferred care|0|||
126550308|NCT01702428|455309528|FG001|Overall Study|Mother transferred care|1|||
126550309|NCT01702428|455309529|FG002|Overall Study|Mother transferred care|0|||
126550310|NCT01702428|455309530|FG003|Overall Study|Mother transferred care|0|||
126550311|NCT01702428|455309527|FG000|Overall Study|Parents too busy|1|||
126550312|NCT01702428|455309528|FG001|Overall Study|Parents too busy|0|||
126550313|NCT01702428|455309529|FG002|Overall Study|Parents too busy|0|||
126550314|NCT01702428|455309530|FG003|Overall Study|Parents too busy|0|||
126550315|NCT01702428|455309527|FG000|Overall Study|Protocol Violation|3|||
126550316|NCT01702428|455309528|FG001|Overall Study|Protocol Violation|0|||
126550317|NCT01702428|455309529|FG002|Overall Study|Protocol Violation|1|||
126550318|NCT01702428|455309530|FG003|Overall Study|Protocol Violation|0|||
126550319|NCT01702428|455309527|FG000|Overall Study|Withdrawal by Subject|21|||
126550320|NCT01702428|455309528|FG001|Overall Study|Withdrawal by Subject|23|||
126550321|NCT01702428|455309529|FG002|Overall Study|Withdrawal by Subject|14|||
126550322|NCT01702428|455309530|FG003|Overall Study|Withdrawal by Subject|10|||
126550323|NCT00154063|455309533|FG000|Overall Study|Adverse Event|4|||
126550324|NCT00154063|455309534|FG001|Overall Study|Adverse Event|8|||
126550325|NCT00154063|455309533|FG000|Overall Study|Protocol Violation|1|||
126550326|NCT00154063|455309534|FG001|Overall Study|Protocol Violation|1|||
126550327|NCT00154063|455309533|FG000|Overall Study|Investigator or Sponsor Request|0|||
126550328|NCT00154063|455309534|FG001|Overall Study|Investigator or Sponsor Request|1|||
126550329|NCT00154063|455309533|FG000|Overall Study|Withdrawal by Subject|4|||
126550330|NCT00154063|455309534|FG001|Overall Study|Withdrawal by Subject|9|||
126550331|NCT00154063|455309533|FG000|Overall Study|Other|3|||
126550332|NCT00154063|455309534|FG001|Overall Study|Other|3|||
126550333|NCT02091869|455309535|FG000|Overall Study|Withdrawal by Subject|0|||
126550334|NCT02091869|455309536|FG001|Overall Study|Withdrawal by Subject|3|||
126550335|NCT01804673|455309537|FG000|Overall Study|Adverse Event|4|||
126550336|NCT01804673|455309537|FG000|Overall Study|Withdrawal by Subject|1|||
126550337|NCT01804673|455309537|FG000|Overall Study|Lack of Efficacy|9|||
126550338|NCT01804673|455309537|FG000|Overall Study|Change to Oral Therapy|37|||
126550339|NCT01804673|455309537|FG000|Overall Study|No Further Therapy Required|84|||
126712842|NCT00090285|455900404|FG002|Extension 1|Lost to Follow-up|35|||
126550340|NCT01804673|455309537|FG000|Overall Study|Use of Prohibited Medication|1|||
126550341|NCT01804673|455309537|FG000|Overall Study|Other|4|||
126550342|NCT00451217|455309541|FG000|Overall Study|Lost to Follow-up|0|||
126550343|NCT00451217|455309542|FG001|Overall Study|Lost to Follow-up|1|||
126550344|NCT00451217|455309543|FG002|Overall Study|Lost to Follow-up|1|||
126550345|NCT00451217|455309544|FG003|Overall Study|Lost to Follow-up|1|||
126550346|NCT00451217|455309541|FG000|Overall Study|Withdrawal by Subject|1|||
126550347|NCT00451217|455309542|FG001|Overall Study|Withdrawal by Subject|0|||
126550348|NCT00451217|455309543|FG002|Overall Study|Withdrawal by Subject|0|||
126712843|NCT00090285|455900405|FG003|Extension 1|Lost to Follow-up|0|||
126712844|NCT00090285|455900406|FG004|Extension 1|Lost to Follow-up|0|||
126712845|NCT00090285|455900407|FG005|Extension 1|Lost to Follow-up|0|||
126712846|NCT00090285|455900402|FG000|Extension 1|Withdrawal by Subject|0|||
126712847|NCT00090285|455900403|FG001|Extension 1|Withdrawal by Subject|0|||
126712848|NCT00090285|455900404|FG002|Extension 1|Withdrawal by Subject|13|||
126712849|NCT00090285|455900405|FG003|Extension 1|Withdrawal by Subject|1|||
126712850|NCT00090285|455900406|FG004|Extension 1|Withdrawal by Subject|0|||
126712851|NCT00090285|455900407|FG005|Extension 1|Withdrawal by Subject|0|||
126712852|NCT00090285|455900402|FG000|Extension 1|Other|0|||
126712853|NCT00090285|455900403|FG001|Extension 1|Other|0|||
126712854|NCT00090285|455900404|FG002|Extension 1|Other|4|||
126550349|NCT00451217|455309544|FG003|Overall Study|Withdrawal by Subject|0|||
126550350|NCT00451217|455309541|FG000|Overall Study|Not Treated|1|||
126550351|NCT00451217|455309542|FG001|Overall Study|Not Treated|1|||
126550352|NCT00451217|455309543|FG002|Overall Study|Not Treated|3|||
126550353|NCT00451217|455309544|FG003|Overall Study|Not Treated|4|||
126550354|NCT01586338|455309545|FG000|Overall Study|Adverse Event|3|||
126550355|NCT01586338|455309545|FG000|Overall Study|Lost to Follow-up|1|||
126550356|NCT01586338|455309545|FG000|Overall Study|Withdrawal by participant|3|||
126550357|NCT01586338|455309545|FG000|Overall Study|Other|1|||
126550358|NCT00284089|455309548|FG000|Multiple Dose Phase|Adverse Event|1|||
126712855|NCT00090285|455900405|FG003|Extension 1|Other|0|||
126550359|NCT00284089|455309549|FG001|Multiple Dose Phase|Adverse Event|0|||
126550360|NCT00284089|455309550|FG002|Multiple Dose Phase|Adverse Event|1|||
126550361|NCT00284089|455309551|FG003|Multiple Dose Phase|Adverse Event|1|||
126550362|NCT00284089|455309548|FG000|Multiple Dose Phase|Protocol Violation|0|||
126712856|NCT00090285|455900406|FG004|Extension 1|Other|0|||
126550363|NCT00284089|455309549|FG001|Multiple Dose Phase|Protocol Violation|0|||
126550364|NCT00284089|455309550|FG002|Multiple Dose Phase|Protocol Violation|1|||
126550365|NCT00284089|455309551|FG003|Multiple Dose Phase|Protocol Violation|0|||
126550366|NCT00284089|455309548|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
126550367|NCT00284089|455309549|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
126550368|NCT00284089|455309550|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
126550369|NCT00284089|455309551|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
126550370|NCT00284089|455309548|FG000|Multiple Dose Phase|Death|0|||
126550371|NCT00284089|455309549|FG001|Multiple Dose Phase|Death|0|||
126550372|NCT00284089|455309550|FG002|Multiple Dose Phase|Death|1|||
126550373|NCT00284089|455309551|FG003|Multiple Dose Phase|Death|1|||
126550374|NCT00284089|455309548|FG000|Extension Phase|Adverse Event|0|||
126550375|NCT00284089|455309549|FG001|Extension Phase|Adverse Event|0|||
126550376|NCT00284089|455309550|FG002|Extension Phase|Adverse Event|2|||
126461749|NCT00174291|454991502|FG001|Overall Study|Protocol Violation|2|||
126461750|NCT00174291|454991501|FG000|Overall Study|Study terminated by sponsor|1|||
126461751|NCT00174291|454991502|FG001|Overall Study|Study terminated by sponsor|0|||
126461752|NCT00174291|454991501|FG000|Overall Study|Withdrawal by Subject|3|||
126461753|NCT00174291|454991502|FG001|Overall Study|Withdrawal by Subject|3|||
126461754|NCT03116347|454991505|FG000|Overall Study|Withdrawal by Subject|1|||
126461755|NCT03116347|454991506|FG001|Overall Study|Withdrawal by Subject|2|||
126461756|NCT03170232|454991507|FG000|Overall Study|Adverse Event|0|||
126461757|NCT03170232|454991508|FG001|Overall Study|Adverse Event|1|||
126461758|NCT03170232|454991507|FG000|Overall Study|Protocol Violation|0|||
126461759|NCT03170232|454991508|FG001|Overall Study|Protocol Violation|1|||
126461760|NCT03170232|454991507|FG000|Overall Study|Lack of Efficacy|0|||
126461761|NCT03170232|454991508|FG001|Overall Study|Lack of Efficacy|1|||
126461762|NCT03170232|454991507|FG000|Overall Study|Study closed/terminated|26|||
126461763|NCT03170232|454991508|FG001|Overall Study|Study closed/terminated|23|||
126550377|NCT00284089|455309551|FG003|Extension Phase|Adverse Event|2|||
126550378|NCT00284089|455309548|FG000|Extension Phase|condition no longer requires study drug|2|||
126712857|NCT00090285|455900407|FG005|Extension 1|Other|0|||
126712858|NCT00090285|455900402|FG000|Extension 1|Moved|0|||
126712859|NCT00090285|455900403|FG001|Extension 1|Moved|0|||
126712860|NCT00090285|455900404|FG002|Extension 1|Moved|3|||
126712861|NCT00090285|455900405|FG003|Extension 1|Moved|0|||
126712862|NCT00090285|455900406|FG004|Extension 1|Moved|0|||
126712863|NCT00090285|455900407|FG005|Extension 1|Moved|0|||
126712864|NCT00090285|455900402|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
126712865|NCT00090285|455900403|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
126712866|NCT00090285|455900404|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
126712867|NCT00090285|455900405|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
126712868|NCT00090285|455900406|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
126712869|NCT00090285|455900407|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
126712870|NCT00090285|455900402|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126712871|NCT00090285|455900403|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126712872|NCT00090285|455900404|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126712873|NCT00090285|455900405|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126712874|NCT00090285|455900406|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
126712875|NCT00090285|455900407|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
126712876|NCT00090285|455900402|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126712877|NCT00090285|455900403|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126712878|NCT00090285|455900404|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126712879|NCT00090285|455900405|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126712880|NCT00090285|455900406|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
126712881|NCT00090285|455900407|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
126712882|NCT00090285|455900402|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
126712883|NCT00090285|455900403|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
126712884|NCT00090285|455900404|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
126712885|NCT00090285|455900405|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
126712886|NCT00090285|455900406|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
126712887|NCT00090285|455900407|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
126712888|NCT00907478|455900408|FG000|Overall Study|Ineligibility determined|0|||
126712889|NCT00907478|455900409|FG001|Overall Study|Ineligibility determined|0|||
126712890|NCT00907478|455900410|FG002|Overall Study|Ineligibility determined|1|||
126712891|NCT00907478|455900408|FG000|Overall Study|Noncompliance|0|||
126461764|NCT03170232|454991507|FG000|Overall Study|Lost to Follow-up|1|||
126461765|NCT03170232|454991508|FG001|Overall Study|Lost to Follow-up|0|||
126461766|NCT03170232|454991507|FG000|Overall Study|Withdrawal by Subject|0|||
126550379|NCT00284089|455309549|FG001|Extension Phase|condition no longer requires study drug|0|||
126550380|NCT00284089|455309550|FG002|Extension Phase|condition no longer requires study drug|2|||
126550381|NCT00284089|455309551|FG003|Extension Phase|condition no longer requires study drug|7|||
126712892|NCT00907478|455900409|FG001|Overall Study|Noncompliance|0|||
126367401|NCT02471144|454640894|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367402|NCT02471144|454640895|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367403|NCT02471144|454640896|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367404|NCT02471144|454640897|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367405|NCT02471144|454640898|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367406|NCT02471144|454640899|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367407|NCT02471144|454640900|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367408|NCT02471144|454640901|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367409|NCT02471144|454640902|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367410|NCT02471144|454640903|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
126367411|NCT02471144|454640904|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
126367412|NCT02471144|454640894|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126367413|NCT02471144|454640895|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126461767|NCT03170232|454991508|FG001|Overall Study|Withdrawal by Subject|1|||
126461768|NCT00586326|454991509|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
126461769|NCT00586326|454991509|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
126461770|NCT00586326|454991509|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
126461771|NCT00586326|454991509|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
126461772|NCT00586326|454991509|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
126461773|NCT00586326|454991509|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
126461774|NCT00586326|454991509|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
126461775|NCT00586326|454991509|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
126461776|NCT00586326|454991509|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
126461777|NCT00586326|454991509|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
126461778|NCT00586326|454991509|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
126461779|NCT00586326|454991509|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
126461780|NCT00586326|454991509|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
126461781|NCT00586326|454991509|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
126461782|NCT00586326|454991509|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
126461783|NCT00586326|454991509|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
126461784|NCT00586326|454991509|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
126461785|NCT01439347|454991510|FG000|Overall Study|Death|10|||
126461786|NCT01439347|454991511|FG001|Overall Study|Death|9|||
126461787|NCT01439347|454991510|FG000|Overall Study|Withdrawal by Subject|0|||
126461788|NCT01439347|454991511|FG001|Overall Study|Withdrawal by Subject|1|||
126461789|NCT01439347|454991510|FG000|Overall Study|Physician Decision|1|||
126461790|NCT01439347|454991511|FG001|Overall Study|Physician Decision|0|||
126461791|NCT01439347|454991510|FG000|Overall Study|Sponsor Terminated Study|2|||
126461792|NCT01439347|454991511|FG001|Overall Study|Sponsor Terminated Study|3|||
126461793|NCT04068896|454991513|FG000|Overall Study|Adverse Event|2|||
126461794|NCT04068896|454991514|FG001|Overall Study|Adverse Event|0|||
126461795|NCT04068896|454991515|FG002|Overall Study|Adverse Event|1|||
126461796|NCT04068896|454991516|FG003|Overall Study|Adverse Event|0|||
126461797|NCT04068896|454991517|FG004|Overall Study|Adverse Event|0|||
126461798|NCT04068896|454991518|FG005|Overall Study|Adverse Event|0|||
126461799|NCT04068896|454991513|FG000|Overall Study|Death|3|||
126461800|NCT04068896|454991514|FG001|Overall Study|Death|1|||
126461801|NCT04068896|454991515|FG002|Overall Study|Death|3|||
126461802|NCT04068896|454991516|FG003|Overall Study|Death|19|||
126461803|NCT04068896|454991517|FG004|Overall Study|Death|17|||
126461804|NCT04068896|454991518|FG005|Overall Study|Death|0|||
126461805|NCT04068896|454991513|FG000|Overall Study|Physician Decision|0|||
126461806|NCT04068896|454991514|FG001|Overall Study|Physician Decision|0|||
126461807|NCT04068896|454991515|FG002|Overall Study|Physician Decision|0|||
126461808|NCT04068896|454991516|FG003|Overall Study|Physician Decision|1|||
126461809|NCT04068896|454991517|FG004|Overall Study|Physician Decision|0|||
126461810|NCT04068896|454991518|FG005|Overall Study|Physician Decision|0|||
126461811|NCT04068896|454991513|FG000|Overall Study|progressive disease|3|||
126461812|NCT04068896|454991514|FG001|Overall Study|progressive disease|5|||
126461813|NCT04068896|454991515|FG002|Overall Study|progressive disease|3|||
126461814|NCT04068896|454991516|FG003|Overall Study|progressive disease|2|||
126461815|NCT04068896|454991517|FG004|Overall Study|progressive disease|1|||
126461816|NCT04068896|454991518|FG005|Overall Study|progressive disease|2|||
126461817|NCT04068896|454991513|FG000|Overall Study|Study terminated by sponsor|0|||
126461818|NCT04068896|454991514|FG001|Overall Study|Study terminated by sponsor|0|||
126461819|NCT04068896|454991515|FG002|Overall Study|Study terminated by sponsor|1|||
126461820|NCT04068896|454991516|FG003|Overall Study|Study terminated by sponsor|2|||
126461821|NCT04068896|454991517|FG004|Overall Study|Study terminated by sponsor|1|||
126461822|NCT04068896|454991518|FG005|Overall Study|Study terminated by sponsor|4|||
126461823|NCT04068896|454991513|FG000|Overall Study|Protocol Violation|0|||
126461824|NCT04068896|454991514|FG001|Overall Study|Protocol Violation|0|||
126461825|NCT04068896|454991515|FG002|Overall Study|Protocol Violation|0|||
126461826|NCT04068896|454991516|FG003|Overall Study|Protocol Violation|1|||
126300188|NCT02105987|454387134|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300189|NCT02105987|454387135|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300190|NCT02105987|454387136|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300191|NCT02105987|454387131|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
126300192|NCT02105987|454387132|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
126300193|NCT02105987|454387133|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
126300194|NCT02105987|454387134|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
126300195|NCT02105987|454387135|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
126300196|NCT02105987|454387136|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
126300197|NCT02105987|454387131|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
126300198|NCT02105987|454387132|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
126300199|NCT02105987|454387133|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
126300200|NCT02105987|454387134|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
126300201|NCT02105987|454387135|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
126300202|NCT02105987|454387136|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
126300203|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
126300204|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
126300205|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
126300206|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
126300207|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
126300208|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
126300209|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
126300210|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
126300211|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
126300212|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
126300213|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
126300214|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
126300215|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300216|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300217|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
126300218|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
126300219|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300220|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
126300221|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300222|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300223|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
126300224|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
126300225|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300226|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
126300227|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
126300228|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
126300229|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
126300230|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
126300231|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
126300232|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
126300233|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
126300234|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
126300235|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
126300236|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
126300237|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
126300238|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
126300239|NCT02105987|454387131|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
126300240|NCT02105987|454387132|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
126300241|NCT02105987|454387133|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
126300242|NCT02105987|454387134|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
126300243|NCT02105987|454387135|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
126367414|NCT02471144|454640896|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126367415|NCT02471144|454640897|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126367416|NCT02471144|454640898|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126367417|NCT02471144|454640899|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126367418|NCT02471144|454640900|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126300244|NCT02105987|454387136|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
126300245|NCT02105987|454387131|FG000|Continuation Phase|Protocol Violation|0|||
126300246|NCT02105987|454387132|FG001|Continuation Phase|Protocol Violation|0|||
126367419|NCT02471144|454640901|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126300247|NCT02105987|454387133|FG002|Continuation Phase|Protocol Violation|0|||
126300248|NCT02105987|454387134|FG003|Continuation Phase|Protocol Violation|0|||
126300249|NCT02105987|454387135|FG004|Continuation Phase|Protocol Violation|1|||
126712893|NCT00907478|455900410|FG002|Overall Study|Noncompliance|1|||
126712894|NCT00907478|455900408|FG000|Overall Study|Adverse Event|3|||
126712895|NCT00907478|455900409|FG001|Overall Study|Adverse Event|1|||
126712896|NCT00907478|455900410|FG002|Overall Study|Adverse Event|2|||
126712897|NCT00907478|455900408|FG000|Overall Study|Withdrawal by Subject|8|||
126712898|NCT00907478|455900409|FG001|Overall Study|Withdrawal by Subject|9|||
126712899|NCT00907478|455900410|FG002|Overall Study|Withdrawal by Subject|6|||
126712900|NCT00907478|455900408|FG000|Overall Study|Requirement for alternative therapy|1|||
126712901|NCT00907478|455900409|FG001|Overall Study|Requirement for alternative therapy|2|||
126712902|NCT00907478|455900410|FG002|Overall Study|Requirement for alternative therapy|3|||
126712903|NCT00907478|455900408|FG000|Overall Study|Physician Decision|2|||
126712904|NCT00907478|455900409|FG001|Overall Study|Physician Decision|0|||
126712905|NCT00907478|455900410|FG002|Overall Study|Physician Decision|3|||
126712906|NCT00907478|455900408|FG000|Overall Study|Death|4|||
126712907|NCT00907478|455900409|FG001|Overall Study|Death|2|||
126712908|NCT00907478|455900410|FG002|Overall Study|Death|1|||
126712909|NCT00907478|455900408|FG000|Overall Study|Protocol-specified criteria|5|||
126712910|NCT00907478|455900409|FG001|Overall Study|Protocol-specified criteria|2|||
126712911|NCT00907478|455900410|FG002|Overall Study|Protocol-specified criteria|3|||
126712912|NCT00907478|455900408|FG000|Overall Study|Pregnancy|0|||
126712913|NCT00907478|455900409|FG001|Overall Study|Pregnancy|1|||
126712914|NCT00907478|455900410|FG002|Overall Study|Pregnancy|1|||
126712915|NCT00907478|455900408|FG000|Overall Study|Lost to Follow-up|1|||
126712916|NCT00907478|455900409|FG001|Overall Study|Lost to Follow-up|0|||
126712917|NCT00907478|455900410|FG002|Overall Study|Lost to Follow-up|0|||
126712918|NCT00907478|455900408|FG000|Overall Study|Other|3|||
126712919|NCT00907478|455900409|FG001|Overall Study|Other|0|||
126712920|NCT00907478|455900410|FG002|Overall Study|Other|1|||
126712921|NCT02639182|455900411|FG000|Overall Study|Disease Progression|50|||
126300250|NCT02105987|454387136|FG005|Continuation Phase|Protocol Violation|0|||
126300251|NCT01420068|454387138|FG000|Overall Study|Administrative problems|1|||
126300252|NCT01420068|454387139|FG001|Overall Study|Administrative problems|3|||
126300253|NCT01420068|454387138|FG000|Overall Study|Withdrawal by Subject|1|||
126300254|NCT01420068|454387139|FG001|Overall Study|Withdrawal by Subject|2|||
126300255|NCT01252095|454387140|FG000|Overall Study|Disease progression|1|||
126300256|NCT01252095|454387141|FG001|Overall Study|Disease progression|0|||
126300257|NCT04830969|454387144|FG000|Overall Study|Withdrawal by Subject|6|||
126300258|NCT04830969|454387145|FG001|Overall Study|Withdrawal by Subject|2|||
126300259|NCT04830969|454387144|FG000|Overall Study|Protocol Violation|3|||
126300260|NCT04830969|454387145|FG001|Overall Study|Protocol Violation|9|||
126300261|NCT04830969|454387144|FG000|Overall Study|Lost to Follow-up|4|||
126300262|NCT04830969|454387145|FG001|Overall Study|Lost to Follow-up|4|||
126300263|NCT01153815|454387149|FG000|Overall Study|Adverse Event|3|||
126300264|NCT01153815|454387150|FG001|Overall Study|Adverse Event|1|||
126300265|NCT01153815|454387149|FG000|Overall Study|Withdrawal by Subject|6|||
126300266|NCT01153815|454387150|FG001|Overall Study|Withdrawal by Subject|4|||
126300267|NCT01786993|454387151|FG000|Overall Study|Death|6|||
126300268|NCT01786993|454387152|FG001|Overall Study|Death|7|||
126300269|NCT01786993|454387151|FG000|Overall Study|Withdrawal by Subject|3|||
126300270|NCT01786993|454387152|FG001|Overall Study|Withdrawal by Subject|2|||
126300271|NCT01786993|454387151|FG000|Overall Study|Lost to Follow-up|0|||
126300272|NCT01786993|454387152|FG001|Overall Study|Lost to Follow-up|1|||
126300273|NCT01786993|454387151|FG000|Overall Study|Subject Non-Compliance|1|||
126300274|NCT01786993|454387152|FG001|Overall Study|Subject Non-Compliance|0|||
126300275|NCT01786993|454387151|FG000|Overall Study|System Explant|1|||
126300276|NCT01786993|454387152|FG001|Overall Study|System Explant|0|||
126300277|NCT01786993|454387151|FG000|Overall Study|Hospice Admission|1|||
126300278|NCT01786993|454387152|FG001|Overall Study|Hospice Admission|0|||
126300279|NCT01890122|454387153|FG000|Overall Study|Adverse Event|1|||
126300280|NCT01890122|454387154|FG001|Overall Study|Adverse Event|1|||
126300281|NCT01890122|454387155|FG002|Overall Study|Adverse Event|1|||
126300282|NCT01890122|454387156|FG003|Overall Study|Adverse Event|2|||
126300283|NCT01890122|454387153|FG000|Overall Study|Major Protocol Deviation|3|||
126300284|NCT01890122|454387154|FG001|Overall Study|Major Protocol Deviation|1|||
126712922|NCT02639182|455900412|FG001|Overall Study|Disease Progression|49|||
126712923|NCT02639182|455900411|FG000|Overall Study|Adverse Event|7|||
126712924|NCT02639182|455900412|FG001|Overall Study|Adverse Event|5|||
126712925|NCT02639182|455900411|FG000|Overall Study|Physician Decision|3|||
126712926|NCT02639182|455900412|FG001|Overall Study|Physician Decision|3|||
126712927|NCT02639182|455900411|FG000|Overall Study|Withdrew Consent|5|||
126712928|NCT02639182|455900412|FG001|Overall Study|Withdrew Consent|4|||
126712929|NCT02639182|455900411|FG000|Overall Study|Lost to Follow-up|0|||
126300285|NCT01890122|454387155|FG002|Overall Study|Major Protocol Deviation|0|||
126300286|NCT01890122|454387156|FG003|Overall Study|Major Protocol Deviation|1|||
126300287|NCT01890122|454387153|FG000|Overall Study|Lost to Follow-up|0|||
126300288|NCT01890122|454387154|FG001|Overall Study|Lost to Follow-up|1|||
126300289|NCT01890122|454387155|FG002|Overall Study|Lost to Follow-up|2|||
126300290|NCT01890122|454387156|FG003|Overall Study|Lost to Follow-up|2|||
126712930|NCT02639182|455900412|FG001|Overall Study|Lost to Follow-up|1|||
126300291|NCT01890122|454387153|FG000|Overall Study|Voluntary Withdrawal|8|||
126550382|NCT00284089|455309548|FG000|Extension Phase|Protocol Violation|0|||
126550383|NCT00284089|455309549|FG001|Extension Phase|Protocol Violation|0|||
126550384|NCT00284089|455309550|FG002|Extension Phase|Protocol Violation|1|||
126550385|NCT00284089|455309551|FG003|Extension Phase|Protocol Violation|0|||
126550386|NCT00284089|455309548|FG000|Extension Phase|Withdrawal by Subject|0|||
126550387|NCT00284089|455309549|FG001|Extension Phase|Withdrawal by Subject|0|||
126550388|NCT00284089|455309550|FG002|Extension Phase|Withdrawal by Subject|1|||
126550389|NCT00284089|455309551|FG003|Extension Phase|Withdrawal by Subject|3|||
126550390|NCT01146574|455309552|FG000|Overall Study|Death|0|||
126550391|NCT01146574|455309553|FG001|Overall Study|Death|1|||
126550392|NCT01146574|455309554|FG002|Overall Study|Death|1|||
126550393|NCT01146574|455309555|FG003|Overall Study|Death|0|||
126550394|NCT01146574|455309556|FG004|Overall Study|Death|0|||
126300292|NCT01890122|454387154|FG001|Overall Study|Voluntary Withdrawal|8|||
126300293|NCT01890122|454387155|FG002|Overall Study|Voluntary Withdrawal|2|||
126300294|NCT01890122|454387156|FG003|Overall Study|Voluntary Withdrawal|11|||
126300295|NCT01890122|454387153|FG000|Overall Study|Lack of Efficacy|14|||
126300296|NCT01890122|454387154|FG001|Overall Study|Lack of Efficacy|24|||
126300297|NCT01890122|454387155|FG002|Overall Study|Lack of Efficacy|7|||
126300298|NCT01890122|454387156|FG003|Overall Study|Lack of Efficacy|41|||
126300299|NCT01890122|454387153|FG000|Overall Study|Reason not Specified|0|||
126300300|NCT01890122|454387154|FG001|Overall Study|Reason not Specified|1|||
126300301|NCT01890122|454387155|FG002|Overall Study|Reason not Specified|1|||
126300302|NCT01890122|454387156|FG003|Overall Study|Reason not Specified|2|||
126300303|NCT01890122|454387153|FG000|Overall Study|Randomized but not Treated|1|||
126300304|NCT01890122|454387154|FG001|Overall Study|Randomized but not Treated|1|||
126300305|NCT01890122|454387155|FG002|Overall Study|Randomized but not Treated|0|||
126300306|NCT01890122|454387156|FG003|Overall Study|Randomized but not Treated|0|||
126300307|NCT02062450|454387157|FG000|Overall Study|No follow-up visit|124|||
126300308|NCT02907177|454387161|FG000|Overall Study|Death|0|||
126300309|NCT02907177|454387162|FG001|Overall Study|Death|1|||
126300310|NCT02907177|454387161|FG000|Overall Study|Physician Decision|3|||
126300311|NCT02907177|454387162|FG001|Overall Study|Physician Decision|3|||
126300312|NCT02907177|454387161|FG000|Overall Study|Withdrawal by Subject|15|||
126300313|NCT02907177|454387162|FG001|Overall Study|Withdrawal by Subject|7|||
126300314|NCT02907177|454387161|FG000|Overall Study|Sponsor's Decision|50|||
126300315|NCT02907177|454387162|FG001|Overall Study|Sponsor's Decision|57|||
126300316|NCT02505217|454387163|FG000|Overall Study|Withdrawal by Subject|1|||
126300317|NCT02505217|454387164|FG001|Overall Study|Withdrawal by Subject|2|||
126300318|NCT00153179|454387165|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
126300319|NCT00153179|454387166|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
126300320|NCT00153179|454387167|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
126300321|NCT00153179|454387168|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
126300322|NCT04495829|454387169|FG000|Overall Study|Lost to Follow-up|2|||
126300323|NCT04495829|454387169|FG000|Overall Study|Inclusion criterion not met|3|||
126300324|NCT02712554|454387171|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
126300325|NCT02712554|454387172|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
126300326|NCT02712554|454387171|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
126300327|NCT02712554|454387172|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
126300328|NCT02712554|454387171|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
126300329|NCT02712554|454387172|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
126300330|NCT02712554|454387171|FG000|Part B: Qualification Phase|Adverse Event|0|||
126300331|NCT02712554|454387172|FG001|Part B: Qualification Phase|Adverse Event|1|||
126300332|NCT02712554|454387171|FG000|Part B: Treatment Phase|Adverse Event|0|||
126300333|NCT02712554|454387172|FG001|Part B: Treatment Phase|Adverse Event|1|||
126300334|NCT02712554|454387171|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
126300335|NCT02712554|454387172|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
126300336|NCT02712554|454387171|FG000|Part B: Treatment Phase|Other|0|||
126300337|NCT02712554|454387172|FG001|Part B: Treatment Phase|Other|1|||
126300338|NCT01102257|454388986|FG000|Overall Study|Adverse Event|1|||
126300339|NCT01102257|454388987|FG001|Overall Study|Adverse Event|0|||
126550395|NCT01146574|455309557|FG005|Overall Study|Death|0|||
126550396|NCT01146574|455309558|FG006|Overall Study|Death|0|||
126550397|NCT01146574|455309552|FG000|Overall Study|Other reasons|0|||
126300340|NCT01102257|454388986|FG000|Overall Study|Adverse Event|1|||
126300341|NCT01102257|454388987|FG001|Overall Study|Adverse Event|0|||
126300342|NCT02525783|454388988|FG000|Overall Study|Lost to Follow-up|10|||
126300343|NCT03048747|454388989|FG000|Overall Study|Adverse Event|2|||
126300344|NCT03048747|454388989|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
126300345|NCT03048747|454388989|FG000|Overall Study|Physician Decision|1|||
126550398|NCT01146574|455309553|FG001|Overall Study|Other reasons|0|||
126550399|NCT01146574|455309554|FG002|Overall Study|Other reasons|3|||
126550400|NCT01146574|455309555|FG003|Overall Study|Other reasons|0|||
126550401|NCT01146574|455309556|FG004|Overall Study|Other reasons|0|||
126550402|NCT01146574|455309557|FG005|Overall Study|Other reasons|0|||
126300346|NCT00866281|454388990|FG000|Overall Study|Adverse Event|1|||
126300347|NCT00866281|454388991|FG001|Overall Study|Adverse Event|0|||
126550403|NCT01146574|455309558|FG006|Overall Study|Other reasons|0|||
126300348|NCT00866281|454388990|FG000|Overall Study|Withdrawal by participants|3|||
126300349|NCT00866281|454388991|FG001|Overall Study|Withdrawal by participants|0|||
126300350|NCT00866281|454388990|FG000|Overall Study|Disease progression|3|||
126300351|NCT00866281|454388991|FG001|Overall Study|Disease progression|11|||
126300352|NCT00866281|454388990|FG000|Overall Study|New cancer therapy|0|||
126300353|NCT00866281|454388991|FG001|Overall Study|New cancer therapy|4|||
126300354|NCT01894841|454388992|FG000|Overall Study|Withdrawal by Subject|9|||
126300355|NCT01894841|454388993|FG001|Overall Study|Withdrawal by Subject|4|||
126300356|NCT01894841|454388992|FG000|Overall Study|Withdrawn by investigator|2|||
126300357|NCT01894841|454388993|FG001|Overall Study|Withdrawn by investigator|2|||
126300358|NCT01894841|454388992|FG000|Overall Study|Lost to Follow-up|7|||
126300359|NCT01894841|454388993|FG001|Overall Study|Lost to Follow-up|3|||
126300360|NCT00529087|454388997|FG000|Overall Study|Adverse Event|10|||
126300361|NCT00529087|454388998|FG001|Overall Study|Adverse Event|13|||
126300362|NCT00529087|454388999|FG002|Overall Study|Adverse Event|4|||
126300363|NCT00529087|454388997|FG000|Overall Study|Lost to Follow-up|6|||
126300364|NCT00529087|454388998|FG001|Overall Study|Lost to Follow-up|4|||
126300365|NCT00529087|454388999|FG002|Overall Study|Lost to Follow-up|1|||
126300366|NCT00529087|454388997|FG000|Overall Study|Protocol Violation|8|||
126300367|NCT00529087|454388998|FG001|Overall Study|Protocol Violation|7|||
126300368|NCT00529087|454388999|FG002|Overall Study|Protocol Violation|6|||
126300369|NCT00529087|454388997|FG000|Overall Study|Withdrawal by Subject|3|||
126300370|NCT00529087|454388998|FG001|Overall Study|Withdrawal by Subject|3|||
126300371|NCT00529087|454388999|FG002|Overall Study|Withdrawal by Subject|3|||
126300372|NCT00529087|454388997|FG000|Overall Study|Protocol deviation|1|||
126300373|NCT00529087|454388998|FG001|Overall Study|Protocol deviation|1|||
126300374|NCT00529087|454388999|FG002|Overall Study|Protocol deviation|2|||
126300375|NCT00318474|454389000|FG000|Overall Study|Adverse Event|1|||
126300376|NCT00318474|454389001|FG001|Overall Study|Adverse Event|1|||
126300377|NCT00318474|454389000|FG000|Overall Study|Lost to Follow-up|0|||
126300378|NCT00318474|454389001|FG001|Overall Study|Lost to Follow-up|1|||
126300379|NCT00318474|454389000|FG000|Overall Study|Pregnancy|0|||
126300380|NCT00318474|454389001|FG001|Overall Study|Pregnancy|2|||
126300381|NCT00318474|454389000|FG000|Overall Study|Protocol Violation|1|||
126300382|NCT00318474|454389001|FG001|Overall Study|Protocol Violation|0|||
126300383|NCT00318474|454389000|FG000|Overall Study|Withdrawal by Subject|3|||
126300384|NCT00318474|454389001|FG001|Overall Study|Withdrawal by Subject|2|||
126300385|NCT00318474|454389000|FG000|Overall Study|Fall in GFR|3|||
126300386|NCT00318474|454389001|FG001|Overall Study|Fall in GFR|3|||
126300387|NCT00318474|454389000|FG000|Overall Study|Post-therapy hyperflycemia|0|||
126300388|NCT00318474|454389001|FG001|Overall Study|Post-therapy hyperflycemia|1|||
126300389|NCT00318474|454389000|FG000|Overall Study|Trial terminated|10|||
126300390|NCT00318474|454389001|FG001|Overall Study|Trial terminated|7|||
126300391|NCT00457002|454389006|FG000|Overall Study|Death|40|||
126300392|NCT00457002|454389007|FG001|Overall Study|Death|47|||
126300393|NCT00457002|454389006|FG000|Overall Study|Adverse Event|284|||
126300394|NCT00457002|454389007|FG001|Overall Study|Adverse Event|260|||
126300395|NCT00457002|454389006|FG000|Overall Study|Withdrawal by Subject|299|||
126300396|NCT00457002|454389007|FG001|Overall Study|Withdrawal by Subject|271|||
126300397|NCT00457002|454389006|FG000|Overall Study|Lost to Follow-up|72|||
126300398|NCT00457002|454389007|FG001|Overall Study|Lost to Follow-up|71|||
126300399|NCT00457002|454389006|FG000|Overall Study|Poor/Non-compliance|46|||
126300400|NCT00457002|454389007|FG001|Overall Study|Poor/Non-compliance|33|||
126300401|NCT00457002|454389006|FG000|Overall Study|No longer met criteria|41|||
126300402|NCT00457002|454389007|FG001|Overall Study|No longer met criteria|37|||
126300403|NCT00457002|454389006|FG000|Overall Study|Administrative reason by Sponsor|1|||
126300404|NCT00457002|454389007|FG001|Overall Study|Administrative reason by Sponsor|0|||
126300405|NCT00457002|454389006|FG000|Overall Study|non-specified|29|||
126300406|NCT00457002|454389007|FG001|Overall Study|non-specified|38|||
126300407|NCT00457002|454389006|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
126300408|NCT00457002|454389007|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
126300409|NCT00454246|454389013|FG000|Overall Study|Adverse Event|2|||
126300410|NCT00454246|454389014|FG001|Overall Study|Adverse Event|2|||
126300411|NCT00454246|454389015|FG002|Overall Study|Adverse Event|0|||
126300412|NCT00454246|454389013|FG000|Overall Study|Violation of selection criteria at entry|6|||
126300413|NCT00454246|454389014|FG001|Overall Study|Violation of selection criteria at entry|0|||
126300414|NCT00454246|454389015|FG002|Overall Study|Violation of selection criteria at entry|0|||
126300415|NCT00454246|454389013|FG000|Overall Study|Protocol Violation|1|||
126300416|NCT00454246|454389014|FG001|Overall Study|Protocol Violation|0|||
126300417|NCT00454246|454389015|FG002|Overall Study|Protocol Violation|0|||
126300418|NCT00454246|454389013|FG000|Overall Study|Refused Treatment|1|||
126300419|NCT00454246|454389014|FG001|Overall Study|Refused Treatment|1|||
126300420|NCT00454246|454389015|FG002|Overall Study|Refused Treatment|0|||
126300421|NCT00454246|454389013|FG000|Overall Study|Failure to return|1|||
126550404|NCT01146574|455309552|FG000|Overall Study|Kidney transplant|0|||
126300422|NCT00454246|454389014|FG001|Overall Study|Failure to return|0|||
126300423|NCT00454246|454389015|FG002|Overall Study|Failure to return|0|||
126300424|NCT00454246|454389013|FG000|Overall Study|Early termination of study|62|||
126300425|NCT00454246|454389014|FG001|Overall Study|Early termination of study|26|||
126300426|NCT00454246|454389015|FG002|Overall Study|Early termination of study|9|||
126300427|NCT02283268|454389016|FG000|Overall Study|Withdrawal by Subject|1|||
126300428|NCT05326529|454389017|FG000|Overall Study|Lack of Efficacy|0|||
126300429|NCT05326529|454389018|FG001|Overall Study|Lack of Efficacy|1|||
126300430|NCT05326529|454389019|FG002|Overall Study|Lack of Efficacy|0|||
126300431|NCT05326529|454389017|FG000|Overall Study|Physician Decision|0|||
126300432|NCT05326529|454389018|FG001|Overall Study|Physician Decision|0|||
126300433|NCT05326529|454389019|FG002|Overall Study|Physician Decision|2|||
126300434|NCT01379768|454389020|FG000|Overall Study|Adverse Event|1|||
126300435|NCT01379768|454389021|FG001|Overall Study|Adverse Event|1|||
126300436|NCT01379768|454389022|FG002|Overall Study|Adverse Event|0|||
126300437|NCT01379768|454389020|FG000|Overall Study|Lost to Follow-up|2|||
126300438|NCT01379768|454389021|FG001|Overall Study|Lost to Follow-up|0|||
126300439|NCT01379768|454389022|FG002|Overall Study|Lost to Follow-up|0|||
126300440|NCT00708552|454389028|FG000|Overall Study|Adverse Event|10|||
126300441|NCT00708552|454389029|FG001|Overall Study|Adverse Event|3|||
126300442|NCT00708552|454389030|FG002|Overall Study|Adverse Event|4|||
126300443|NCT00708552|454389031|FG003|Overall Study|Adverse Event|6|||
126300444|NCT00708552|454389028|FG000|Overall Study|Lack of Efficacy|0|||
126300445|NCT00708552|454389029|FG001|Overall Study|Lack of Efficacy|4|||
126300446|NCT00708552|454389030|FG002|Overall Study|Lack of Efficacy|1|||
126300447|NCT00708552|454389031|FG003|Overall Study|Lack of Efficacy|0|||
126300448|NCT00708552|454389028|FG000|Overall Study|Protocol Violation|0|||
126300449|NCT00708552|454389029|FG001|Overall Study|Protocol Violation|0|||
126300450|NCT00708552|454389030|FG002|Overall Study|Protocol Violation|2|||
126300451|NCT00708552|454389031|FG003|Overall Study|Protocol Violation|4|||
126300452|NCT00708552|454389028|FG000|Overall Study|Lost to Follow-up|4|||
126300453|NCT00708552|454389029|FG001|Overall Study|Lost to Follow-up|2|||
126300454|NCT00708552|454389030|FG002|Overall Study|Lost to Follow-up|0|||
126300455|NCT00708552|454389031|FG003|Overall Study|Lost to Follow-up|1|||
126300456|NCT00708552|454389028|FG000|Overall Study|Physician Decision|1|||
126300457|NCT00708552|454389029|FG001|Overall Study|Physician Decision|2|||
126300458|NCT00708552|454389030|FG002|Overall Study|Physician Decision|0|||
126300459|NCT00708552|454389031|FG003|Overall Study|Physician Decision|0|||
126300460|NCT00708552|454389028|FG000|Overall Study|Withdrawal by Subject|12|||
126300461|NCT00708552|454389029|FG001|Overall Study|Withdrawal by Subject|7|||
126300462|NCT00708552|454389030|FG002|Overall Study|Withdrawal by Subject|8|||
126300463|NCT00708552|454389031|FG003|Overall Study|Withdrawal by Subject|10|||
126300464|NCT01017874|454389032|FG000|Overall Study|Withdrawal by Subject|23|||
126300465|NCT01017874|454389033|FG001|Overall Study|Withdrawal by Subject|20|||
126300466|NCT01017874|454389032|FG000|Overall Study|Sponsor decision|3|||
126300467|NCT01017874|454389033|FG001|Overall Study|Sponsor decision|1|||
126300468|NCT01017874|454389032|FG000|Overall Study|Lost to Follow-up|3|||
126300469|NCT01017874|454389033|FG001|Overall Study|Lost to Follow-up|2|||
126300470|NCT01017874|454389032|FG000|Overall Study|Physician Decision|1|||
126300471|NCT01017874|454389033|FG001|Overall Study|Physician Decision|3|||
126300472|NCT02588612|454389034|FG000|Overall Study|Physician Decision|1|||
126300473|NCT02588612|454389034|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
126300474|NCT02588612|454389034|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
126300475|NCT02588612|454389034|FG000|Overall Study|Death prior to T-cell infusion|1|||
126300476|NCT03809663|454389042|FG000|Overall Study|Decision by sponsor|24|||
126300477|NCT03809663|454389043|FG001|Overall Study|Decision by sponsor|18|||
126300478|NCT03809663|454389044|FG002|Overall Study|Decision by sponsor|20|||
126300479|NCT03809663|454389045|FG003|Overall Study|Decision by sponsor|20|||
126300480|NCT03809663|454389046|FG004|Overall Study|Decision by sponsor|0|||
126300481|NCT03809663|454389047|FG005|Overall Study|Decision by sponsor|0|||
126300482|NCT03809663|454389042|FG000|Overall Study|Withdrawal by Subject|26|||
126300483|NCT03809663|454389043|FG001|Overall Study|Withdrawal by Subject|22|||
126300484|NCT03809663|454389044|FG002|Overall Study|Withdrawal by Subject|27|||
126300485|NCT03809663|454389045|FG003|Overall Study|Withdrawal by Subject|26|||
126300486|NCT03809663|454389046|FG004|Overall Study|Withdrawal by Subject|0|||
126300487|NCT03809663|454389047|FG005|Overall Study|Withdrawal by Subject|0|||
126300488|NCT03809663|454389042|FG000|Overall Study|Lost to Follow-up|1|||
126550405|NCT01146574|455309553|FG001|Overall Study|Kidney transplant|0|||
126550406|NCT01146574|455309554|FG002|Overall Study|Kidney transplant|1|||
126550407|NCT01146574|455309555|FG003|Overall Study|Kidney transplant|1|||
126300489|NCT03809663|454389043|FG001|Overall Study|Lost to Follow-up|4|||
126550408|NCT01146574|455309556|FG004|Overall Study|Kidney transplant|0|||
126300490|NCT03809663|454389044|FG002|Overall Study|Lost to Follow-up|1|||
126300491|NCT03809663|454389045|FG003|Overall Study|Lost to Follow-up|1|||
126300492|NCT03809663|454389046|FG004|Overall Study|Lost to Follow-up|0|||
126300493|NCT03809663|454389047|FG005|Overall Study|Lost to Follow-up|0|||
126550409|NCT01146574|455309557|FG005|Overall Study|Kidney transplant|0|||
126550410|NCT01146574|455309558|FG006|Overall Study|Kidney transplant|0|||
126550411|NCT01146574|455309552|FG000|Overall Study|Withdrew consent|0|||
126300494|NCT02042014|454389049|FG000|Overall Study|Adverse Event|1|||
126300495|NCT02042014|454389049|FG000|Overall Study|Physician Decision|7|||
126300496|NCT00558701|454389054|FG000|Overall Study|Protocol Deviations|1|||
126550412|NCT01146574|455309553|FG001|Overall Study|Withdrew consent|0|||
126300497|NCT00558701|454389055|FG001|Overall Study|Protocol Deviations|4|||
126300498|NCT00105079|454389056|FG000|Overall Study|Adverse Event|5|||
126300499|NCT00105079|454389057|FG001|Overall Study|Adverse Event|12|||
126300500|NCT00105079|454389056|FG000|Overall Study|Death|3|||
126300501|NCT00105079|454389057|FG001|Overall Study|Death|1|||
126300502|NCT00105079|454389056|FG000|Overall Study|Lost to Follow-up|12|||
126300503|NCT00105079|454389057|FG001|Overall Study|Lost to Follow-up|12|||
126300504|NCT00105079|454389056|FG000|Overall Study|Lack of Efficacy|9|||
126300505|NCT00105079|454389057|FG001|Overall Study|Lack of Efficacy|3|||
126300506|NCT00105079|454389056|FG000|Overall Study|Refused treatment|6|||
126300507|NCT00105079|454389057|FG001|Overall Study|Refused treatment|4|||
126300508|NCT00105079|454389056|FG000|Overall Study|Violation of selection criteria at entry|0|||
126300509|NCT00105079|454389057|FG001|Overall Study|Violation of selection criteria at entry|2|||
126300510|NCT00105079|454389056|FG000|Overall Study|Protocol Violation|1|||
126300511|NCT00105079|454389057|FG001|Overall Study|Protocol Violation|0|||
126300512|NCT00105079|454389056|FG000|Overall Study|Other|3|||
126300513|NCT00105079|454389057|FG001|Overall Study|Other|1|||
126300514|NCT00386360|454389058|FG000|Overall Study|Adverse Event|4|||
126300515|NCT00386360|454389059|FG001|Overall Study|Adverse Event|2|||
126300516|NCT00386360|454389058|FG000|Overall Study|Physician Decision|2|||
126300517|NCT00386360|454389059|FG001|Overall Study|Physician Decision|2|||
126300518|NCT00386360|454389058|FG000|Overall Study|Lost to Follow-up|0|||
126300519|NCT00386360|454389059|FG001|Overall Study|Lost to Follow-up|2|||
126300520|NCT00386360|454389058|FG000|Overall Study|Protocol Violation|0|||
126300521|NCT00386360|454389059|FG001|Overall Study|Protocol Violation|3|||
126300522|NCT00386360|454389058|FG000|Overall Study|Withdrawal by Subject|3|||
126300523|NCT00386360|454389059|FG001|Overall Study|Withdrawal by Subject|6|||
126300524|NCT00386360|454389058|FG000|Overall Study|Did not take any study medication|0|||
126300525|NCT00386360|454389059|FG001|Overall Study|Did not take any study medication|2|||
126300526|NCT02230904|454389062|FG000|Overall Study|Safety follow up could not take place|0|||
126300527|NCT02230904|454389063|FG001|Overall Study|Safety follow up could not take place|1|||
126300528|NCT00789373|454389067|FG000|Induction|Adverse Event|64|||
126300529|NCT00789373|454389068|FG001|Induction|Adverse Event|0|||
126300530|NCT00789373|454389069|FG002|Induction|Adverse Event|0|||
126300531|NCT00789373|454389067|FG000|Induction|Death Due to study disease|24|||
126300532|NCT00789373|454389068|FG001|Induction|Death Due to study disease|0|||
126300533|NCT00789373|454389069|FG002|Induction|Death Due to study disease|0|||
126300534|NCT00789373|454389067|FG000|Induction|Death due to adverse event|19|||
126300535|NCT00789373|454389068|FG001|Induction|Death due to adverse event|0|||
126300536|NCT00789373|454389069|FG002|Induction|Death due to adverse event|0|||
126300537|NCT00789373|454389067|FG000|Induction|Death due to toxicity|11|||
126300538|NCT00789373|454389068|FG001|Induction|Death due to toxicity|0|||
126300539|NCT00789373|454389069|FG002|Induction|Death due to toxicity|0|||
126300540|NCT00789373|454389067|FG000|Induction|Death due to procedure|1|||
126300541|NCT00789373|454389068|FG001|Induction|Death due to procedure|0|||
126300542|NCT00789373|454389069|FG002|Induction|Death due to procedure|0|||
126300543|NCT00789373|454389067|FG000|Induction|Investigator decision|7|||
126300544|NCT00789373|454389068|FG001|Induction|Investigator decision|0|||
126300545|NCT00789373|454389069|FG002|Induction|Investigator decision|0|||
126300546|NCT00789373|454389067|FG000|Induction|Protocol entry criteria not met|9|||
126300547|NCT00789373|454389068|FG001|Induction|Protocol entry criteria not met|0|||
126300548|NCT00789373|454389069|FG002|Induction|Protocol entry criteria not met|0|||
126300549|NCT00789373|454389067|FG000|Induction|Lost to Follow-up|6|||
126300550|NCT00789373|454389068|FG001|Induction|Lost to Follow-up|0|||
126300551|NCT00789373|454389069|FG002|Induction|Lost to Follow-up|0|||
126712931|NCT02639182|455900411|FG000|Overall Study|Study Closure|1|||
126300552|NCT00789373|454389067|FG000|Induction|Protocol Violation|1|||
126300553|NCT00789373|454389068|FG001|Induction|Protocol Violation|0|||
126300554|NCT00789373|454389069|FG002|Induction|Protocol Violation|0|||
126300555|NCT00789373|454389067|FG000|Induction|Progressive Disease|220|||
126300556|NCT00789373|454389068|FG001|Induction|Progressive Disease|0|||
126300557|NCT00789373|454389069|FG002|Induction|Progressive Disease|0|||
126300558|NCT00789373|454389067|FG000|Induction|Withdrawal by Subject|37|||
126712932|NCT02639182|455900412|FG001|Overall Study|Study Closure|2|||
126712933|NCT02639182|455900411|FG000|Overall Study|Sponsor Ended Study|0|||
126461827|NCT04068896|454991517|FG004|Overall Study|Protocol Violation|0|||
126461828|NCT04068896|454991518|FG005|Overall Study|Protocol Violation|0|||
126712934|NCT02639182|455900412|FG001|Overall Study|Sponsor Ended Study|1|||
126712935|NCT02639182|455900411|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
126712936|NCT02639182|455900412|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
126712937|NCT03069690|455900413|FG000|Pregnancy Intervention|Pregnancy loss|9|||
126300559|NCT00789373|454389068|FG001|Induction|Withdrawal by Subject|0|||
126300560|NCT00789373|454389069|FG002|Induction|Withdrawal by Subject|0|||
126300561|NCT00789373|454389067|FG000|Maintenance|Adverse Event|0|||
126300562|NCT00789373|454389068|FG001|Maintenance|Adverse Event|65|||
126300563|NCT00789373|454389069|FG002|Maintenance|Adverse Event|12|||
126300564|NCT00789373|454389067|FG000|Maintenance|Death due to study disease|0|||
126300565|NCT00789373|454389068|FG001|Maintenance|Death due to study disease|3|||
126461829|NCT04068896|454991513|FG000|Overall Study|Withdrawal by Subject|0|||
126712938|NCT03069690|455900414|FG001|Pregnancy Intervention|Pregnancy loss|4|||
126712939|NCT03069690|455900415|FG002|Pregnancy Intervention|Pregnancy loss|0|||
126712940|NCT03069690|455900416|FG003|Pregnancy Intervention|Pregnancy loss|0|||
126712941|NCT03069690|455900417|FG004|Pregnancy Intervention|Pregnancy loss|0|||
126712942|NCT03069690|455900418|FG005|Pregnancy Intervention|Pregnancy loss|0|||
126712943|NCT03069690|455900413|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
126712944|NCT03069690|455900414|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
126712945|NCT03069690|455900415|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
126300566|NCT00789373|454389069|FG002|Maintenance|Death due to study disease|1|||
126300567|NCT00789373|454389067|FG000|Maintenance|Death due to adverse event|0|||
126300568|NCT00789373|454389068|FG001|Maintenance|Death due to adverse event|4|||
126300569|NCT00789373|454389069|FG002|Maintenance|Death due to adverse event|1|||
126300570|NCT00789373|454389067|FG000|Maintenance|Death due to toxicity|0|||
126300571|NCT00789373|454389068|FG001|Maintenance|Death due to toxicity|1|||
126300572|NCT00789373|454389069|FG002|Maintenance|Death due to toxicity|2|||
126300573|NCT00789373|454389067|FG000|Maintenance|Investigator Decision|0|||
126300574|NCT00789373|454389068|FG001|Maintenance|Investigator Decision|4|||
126300575|NCT00789373|454389069|FG002|Maintenance|Investigator Decision|2|||
126300576|NCT00789373|454389067|FG000|Maintenance|Protocol entry criteria not met|0|||
126461830|NCT04068896|454991514|FG001|Overall Study|Withdrawal by Subject|3|||
126461831|NCT04068896|454991515|FG002|Overall Study|Withdrawal by Subject|0|||
126461832|NCT04068896|454991516|FG003|Overall Study|Withdrawal by Subject|2|||
126461833|NCT04068896|454991517|FG004|Overall Study|Withdrawal by Subject|1|||
126461834|NCT04068896|454991518|FG005|Overall Study|Withdrawal by Subject|0|||
126300577|NCT00789373|454389068|FG001|Maintenance|Protocol entry criteria not met|2|||
126300578|NCT00789373|454389069|FG002|Maintenance|Protocol entry criteria not met|0|||
126300579|NCT00789373|454389067|FG000|Maintenance|Lost to Follow-up|0|||
126300580|NCT00789373|454389068|FG001|Maintenance|Lost to Follow-up|2|||
126300581|NCT00789373|454389069|FG002|Maintenance|Lost to Follow-up|0|||
126300582|NCT00789373|454389067|FG000|Maintenance|Progressive Disease|0|||
126300583|NCT00789373|454389068|FG001|Maintenance|Progressive Disease|253|||
126300584|NCT00789373|454389069|FG002|Maintenance|Progressive Disease|152|||
126300585|NCT00789373|454389067|FG000|Maintenance|Withdrawal by Subject|0|||
126300586|NCT00789373|454389068|FG001|Maintenance|Withdrawal by Subject|21|||
126300587|NCT00789373|454389069|FG002|Maintenance|Withdrawal by Subject|8|||
126300588|NCT00789373|454389067|FG000|Maintenance|Sponsor Decision|0|||
126300589|NCT00789373|454389068|FG001|Maintenance|Sponsor Decision|0|||
126300590|NCT00789373|454389069|FG002|Maintenance|Sponsor Decision|2|||
126300591|NCT00789373|454389067|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
126300592|NCT00789373|454389068|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
126300593|NCT00789373|454389069|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
126300594|NCT03321968|454389070|FG000|Overall Study|Withdrawal by Subject|1|||
126300595|NCT03321968|454389071|FG001|Overall Study|Withdrawal by Subject|2|||
126300596|NCT03321968|454389072|FG002|Overall Study|Withdrawal by Subject|1|||
126300597|NCT03321968|454389070|FG000|Overall Study|Lost to Follow-up|2|||
126300598|NCT03321968|454389071|FG001|Overall Study|Lost to Follow-up|0|||
126300599|NCT03321968|454389072|FG002|Overall Study|Lost to Follow-up|1|||
126300600|NCT03321968|454389070|FG000|Overall Study|Other than specified|0|||
126300601|NCT03321968|454389071|FG001|Overall Study|Other than specified|0|||
126300602|NCT03321968|454389072|FG002|Overall Study|Other than specified|1|||
126300603|NCT01532518|454389073|FG000|Overall Study|Withdrawal by Subject|0|||
126300604|NCT01532518|454389074|FG001|Overall Study|Withdrawal by Subject|0|||
126300605|NCT01532518|454389075|FG002|Overall Study|Withdrawal by Subject|1|||
126461835|NCT04068896|454991513|FG000|Overall Study|Symptomatic deterioration|2|||
126461836|NCT04068896|454991514|FG001|Overall Study|Symptomatic deterioration|0|||
126461837|NCT04068896|454991515|FG002|Overall Study|Symptomatic deterioration|0|||
126712946|NCT03069690|455900416|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
126712947|NCT03069690|455900417|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
126712948|NCT03069690|455900418|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
126712949|NCT03069690|455900413|FG000|Postpartum Intervention|Lost to Follow-up|0|||
126712950|NCT03069690|455900414|FG001|Postpartum Intervention|Lost to Follow-up|0|||
126770331|NCT02494583|456112454|FG001|Overall Study|Withdrawal by Subject|15|||
126461838|NCT04068896|454991516|FG003|Overall Study|Symptomatic deterioration|0|||
126461839|NCT04068896|454991517|FG004|Overall Study|Symptomatic deterioration|0|||
126461840|NCT04068896|454991518|FG005|Overall Study|Symptomatic deterioration|0|||
126461841|NCT01101191|454991519|FG000|Period 1|Withdrawal by Subject|1|||
126461842|NCT01101191|454991520|FG001|Period 1|Withdrawal by Subject|0|||
126461843|NCT01101191|454991519|FG000|Period 1|Adverse Event|1|||
126461844|NCT01101191|454991520|FG001|Period 1|Adverse Event|2|||
126461845|NCT02009384|454991521|FG000|Overall Study|Death|2|||
126461846|NCT00718237|454991523|FG000|Overall Study|Adverse Event|1|||
126550413|NCT01146574|455309554|FG002|Overall Study|Withdrew consent|1|||
126300606|NCT02155283|454389078|FG000|Overall Study|Lost to Follow-up|3|||
126300607|NCT02155283|454389078|FG000|Overall Study|Withdrawal by Subject|1|||
126461847|NCT00718237|454991524|FG001|Overall Study|Adverse Event|3|||
126300608|NCT02155283|454389078|FG000|Overall Study|Protocol Violation|3|||
126300609|NCT00463047|454389083|FG000|Titration Period 1|Adverse Event|10|||
126300610|NCT00463047|454389084|FG001|Titration Period 1|Adverse Event|8|||
126300611|NCT00463047|454389083|FG000|Titration Period 1|Lack of Efficacy|10|||
126300612|NCT00463047|454389084|FG001|Titration Period 1|Lack of Efficacy|4|||
126300613|NCT00463047|454389083|FG000|Titration Period 1|Lost to Follow-up|2|||
126300614|NCT00463047|454389084|FG001|Titration Period 1|Lost to Follow-up|0|||
126300615|NCT00463047|454389083|FG000|Titration Period 1|Non-compliance with study medication|3|||
126300616|NCT00463047|454389084|FG001|Titration Period 1|Non-compliance with study medication|5|||
126300617|NCT00463047|454389083|FG000|Titration Period 1|Protocol Violation|5|||
126300618|NCT00463047|454389084|FG001|Titration Period 1|Protocol Violation|5|||
126300619|NCT00463047|454389083|FG000|Titration Period 1|Withdrawal by Subject|3|||
126300620|NCT00463047|454389084|FG001|Titration Period 1|Withdrawal by Subject|5|||
126300621|NCT00463047|454389083|FG000|Titration Period 1|Non-compliance procedures|4|||
126300622|NCT00463047|454389084|FG001|Titration Period 1|Non-compliance procedures|10|||
126300623|NCT00463047|454389083|FG000|Titration Period 1|Other|0|||
126300624|NCT00463047|454389084|FG001|Titration Period 1|Other|2|||
126300625|NCT00463047|454389083|FG000|Titration Period 2|Adverse Event|9|||
126300626|NCT00463047|454389084|FG001|Titration Period 2|Adverse Event|9|||
126300627|NCT00463047|454389083|FG000|Titration Period 2|Lack of Efficacy|6|||
126300628|NCT00463047|454389084|FG001|Titration Period 2|Lack of Efficacy|4|||
126300629|NCT00463047|454389083|FG000|Titration Period 2|Withdrawal by Subject|1|||
126300630|NCT00463047|454389084|FG001|Titration Period 2|Withdrawal by Subject|0|||
126300631|NCT00463047|454389083|FG000|Titration Period 2|Protocol Violation|2|||
126300632|NCT00463047|454389084|FG001|Titration Period 2|Protocol Violation|3|||
126300633|NCT00463047|454389083|FG000|Titration Period 2|Lost to Follow-up|1|||
126300634|NCT00463047|454389084|FG001|Titration Period 2|Lost to Follow-up|2|||
126300635|NCT00463047|454389083|FG000|Titration Period 2|Non-compliance study medication|4|||
126300636|NCT00463047|454389084|FG001|Titration Period 2|Non-compliance study medication|2|||
126300637|NCT00463047|454389083|FG000|Titration Period 2|Non-compliance procedures|4|||
126300638|NCT00463047|454389084|FG001|Titration Period 2|Non-compliance procedures|1|||
126300639|NCT00463047|454389083|FG000|Titration Period 2|Other|3|||
126300640|NCT00463047|454389084|FG001|Titration Period 2|Other|2|||
126300641|NCT00463047|454389083|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
126300642|NCT00463047|454389084|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
126300643|NCT00463047|454389083|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
126300644|NCT00463047|454389084|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
126300645|NCT00463047|454389083|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
126300646|NCT00463047|454389084|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
126300647|NCT00463047|454389083|FG000|Double-Blind Treatment Period 1|Other|1|||
126300648|NCT00463047|454389084|FG001|Double-Blind Treatment Period 1|Other|0|||
126300649|NCT00463047|454389083|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
126300650|NCT00463047|454389084|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
126300651|NCT00463047|454389083|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
126300652|NCT00463047|454389084|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
126300653|NCT00463047|454389083|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
126300654|NCT00463047|454389084|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
126300655|NCT02554682|454389090|FG000|Overall Study|Lost to Follow-up|11|||
126300656|NCT02554682|454389091|FG001|Overall Study|Lost to Follow-up|9|||
126300657|NCT02554682|454389092|FG002|Overall Study|Lost to Follow-up|4|||
126300658|NCT02554682|454389093|FG003|Overall Study|Lost to Follow-up|3|||
126300659|NCT02554682|454389094|FG004|Overall Study|Lost to Follow-up|2|||
126300660|NCT02554682|454389095|FG005|Overall Study|Lost to Follow-up|1|||
126300661|NCT02554682|454389096|FG006|Overall Study|Lost to Follow-up|6|||
126300662|NCT02554682|454389097|FG007|Overall Study|Lost to Follow-up|6|||
126300663|NCT02554682|454389098|FG008|Overall Study|Lost to Follow-up|2|||
126300664|NCT02554682|454389099|FG009|Overall Study|Lost to Follow-up|2|||
126300665|NCT02554682|454389090|FG000|Overall Study|Withdrawal by Subject|2|||
126300666|NCT02554682|454389091|FG001|Overall Study|Withdrawal by Subject|1|||
126300667|NCT02554682|454389092|FG002|Overall Study|Withdrawal by Subject|0|||
126300668|NCT02554682|454389093|FG003|Overall Study|Withdrawal by Subject|0|||
126300669|NCT02554682|454389094|FG004|Overall Study|Withdrawal by Subject|0|||
126300670|NCT02554682|454389095|FG005|Overall Study|Withdrawal by Subject|0|||
126300671|NCT02554682|454389096|FG006|Overall Study|Withdrawal by Subject|0|||
126300672|NCT02554682|454389097|FG007|Overall Study|Withdrawal by Subject|0|||
126300673|NCT02554682|454389098|FG008|Overall Study|Withdrawal by Subject|0|||
126300674|NCT02554682|454389099|FG009|Overall Study|Withdrawal by Subject|0|||
126300675|NCT02554682|454389090|FG000|Overall Study|Physician Decision|2|||
126300676|NCT02554682|454389091|FG001|Overall Study|Physician Decision|2|||
126300677|NCT02554682|454389092|FG002|Overall Study|Physician Decision|0|||
126300678|NCT02554682|454389093|FG003|Overall Study|Physician Decision|0|||
126300679|NCT02554682|454389094|FG004|Overall Study|Physician Decision|0|||
126461848|NCT00718237|454991523|FG000|Overall Study|Lost to Follow-up|2|||
126461849|NCT00718237|454991524|FG001|Overall Study|Lost to Follow-up|2|||
126461850|NCT00718237|454991523|FG000|Overall Study|Physician Decision|1|||
126461851|NCT00718237|454991524|FG001|Overall Study|Physician Decision|0|||
126461852|NCT00718237|454991523|FG000|Overall Study|Withdrawal by Subject|9|||
126300680|NCT02554682|454389095|FG005|Overall Study|Physician Decision|0|||
126300681|NCT02554682|454389096|FG006|Overall Study|Physician Decision|0|||
126300682|NCT02554682|454389097|FG007|Overall Study|Physician Decision|0|||
126300683|NCT02554682|454389098|FG008|Overall Study|Physician Decision|0|||
126300684|NCT02554682|454389099|FG009|Overall Study|Physician Decision|0|||
126300685|NCT01537042|454389117|FG000|Overall Study|Adverse Event|0|||
126300686|NCT01537042|454389118|FG001|Overall Study|Adverse Event|2|||
126300687|NCT01537042|454389117|FG000|Overall Study|Lack of Efficacy|0|||
126300688|NCT01537042|454389118|FG001|Overall Study|Lack of Efficacy|1|||
126300689|NCT01537042|454389117|FG000|Overall Study|Protocol Violation|0|||
126300690|NCT01537042|454389118|FG001|Overall Study|Protocol Violation|1|||
126300691|NCT01537042|454389117|FG000|Overall Study|Other|0|||
126300692|NCT01537042|454389118|FG001|Overall Study|Other|1|||
126300693|NCT00979654|454389119|FG000|Overall Study|Lost to Follow-up|1|||
126300694|NCT00979654|454389119|FG000|Overall Study|Withdrawal by Subject|22|||
126300695|NCT00979654|454389119|FG000|Overall Study|Death|1|||
126300696|NCT00979654|454389119|FG000|Overall Study|Lack of Efficacy|6|||
126300697|NCT00979654|454389119|FG000|Overall Study|Adverse Event|1|||
126300698|NCT00979654|454389119|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
126300699|NCT00979654|454389119|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
126300700|NCT00979654|454389119|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
126300701|NCT00979654|454389119|FG000|Overall Study|Serious Adverse Event|1|||
126300702|NCT00979654|454389119|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
126300703|NCT01779440|454389120|FG000|Overall Study|Withdrawal by Subject|3|||
126300704|NCT01779440|454389121|FG001|Overall Study|Withdrawal by Subject|5|||
126300705|NCT01205269|454389122|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
126300706|NCT01205269|454389123|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
126300707|NCT01205269|454389124|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
126461853|NCT00718237|454991524|FG001|Overall Study|Withdrawal by Subject|10|||
126461854|NCT02694718|454991525|FG000|Overall Study|Death|1|||
126461855|NCT02694718|454991525|FG000|Overall Study|Withdrawal by Subject|1|||
126461856|NCT02925793|454991526|FG000|Overall Study|Adverse Event|3|||
126461857|NCT02925793|454991527|FG001|Overall Study|Adverse Event|3|||
126461858|NCT02925793|454991528|FG002|Overall Study|Adverse Event|6|||
126461859|NCT02925793|454991526|FG000|Overall Study|Withdrawal by Subject|16|||
126461860|NCT02925793|454991527|FG001|Overall Study|Withdrawal by Subject|15|||
126461861|NCT02925793|454991528|FG002|Overall Study|Withdrawal by Subject|13|||
126461862|NCT02925793|454991526|FG000|Overall Study|Investigator Discretion|0|||
126461863|NCT02925793|454991527|FG001|Overall Study|Investigator Discretion|1|||
126461864|NCT02925793|454991528|FG002|Overall Study|Investigator Discretion|1|||
126461865|NCT02925793|454991526|FG000|Overall Study|Lost to Follow-up|2|||
126461866|NCT02925793|454991527|FG001|Overall Study|Lost to Follow-up|3|||
126461867|NCT02925793|454991528|FG002|Overall Study|Lost to Follow-up|1|||
126461868|NCT02925793|454991526|FG000|Overall Study|Lack of Efficacy|2|||
126461869|NCT02925793|454991527|FG001|Overall Study|Lack of Efficacy|6|||
126461870|NCT02925793|454991528|FG002|Overall Study|Lack of Efficacy|4|||
126461871|NCT02925793|454991526|FG000|Overall Study|Other:|2|||
126461872|NCT02925793|454991527|FG001|Overall Study|Other:|1|||
126461873|NCT02925793|454991528|FG002|Overall Study|Other:|3|||
126461874|NCT00879879|454991529|FG000|Overall Study|Death|1|||
126461875|NCT00879879|454991529|FG000|Overall Study|Withdrawal by Subject|1|||
126461876|NCT00879879|454991529|FG000|Overall Study|Physician Decision|1|||
126461877|NCT00667446|454991531|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
126461878|NCT00667446|454991532|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
126461879|NCT00667446|454991531|FG000|Treatment Period (36 Months)|Other|2|||
126461880|NCT00667446|454991532|FG001|Treatment Period (36 Months)|Other|2|||
126461881|NCT00667446|454991531|FG000|Treatment Period (36 Months)|Personal reasons|2|||
126461882|NCT00667446|454991532|FG001|Treatment Period (36 Months)|Personal reasons|2|||
126461883|NCT00667446|454991531|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
126461884|NCT00667446|454991532|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
126461885|NCT00667446|454991531|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
126461886|NCT00667446|454991532|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
126461887|NCT00667446|454991531|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
126461888|NCT00667446|454991532|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
126461889|NCT00667446|454991531|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
126461890|NCT00667446|454991532|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
126461891|NCT00667446|454991531|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
126461892|NCT00667446|454991532|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
126461893|NCT00667446|454991531|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
126461894|NCT00667446|454991532|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
126461895|NCT01343901|454991533|FG000|Overall Study|Death|85|||
126461896|NCT01343901|454991533|FG000|Overall Study|Physician Decision|4|||
126461897|NCT01343901|454991533|FG000|Overall Study|Lost to Follow-up|12|||
126461898|NCT01343901|454991533|FG000|Overall Study|Management by another medical team|11|||
126461899|NCT01343901|454991533|FG000|Overall Study|Participant decision|1|||
126461900|NCT03324581|454991539|FG000|Overall Study|Adverse Event|18|||
126461901|NCT03324581|454991540|FG001|Overall Study|Adverse Event|11|||
126461902|NCT03324581|454991541|FG002|Overall Study|Adverse Event|7|||
126461903|NCT03324581|454991539|FG000|Overall Study|Lack of Efficacy|0|||
126300708|NCT01205269|454389125|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
126300709|NCT01205269|454389126|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
126300710|NCT01205269|454389127|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
126300711|NCT01408303|454389128|FG000|Overall Study|Adverse Event|3|||
126300712|NCT01408303|454389129|FG001|Overall Study|Adverse Event|7|||
126300713|NCT01408303|454389130|FG002|Overall Study|Adverse Event|2|||
126300714|NCT01408303|454389128|FG000|Overall Study|Lost to Follow-up|0|||
126300715|NCT01408303|454389129|FG001|Overall Study|Lost to Follow-up|1|||
126300716|NCT01408303|454389130|FG002|Overall Study|Lost to Follow-up|2|||
126300717|NCT01408303|454389128|FG000|Overall Study|Withdrawal by Subject|2|||
126300718|NCT01408303|454389129|FG001|Overall Study|Withdrawal by Subject|3|||
126300719|NCT01408303|454389130|FG002|Overall Study|Withdrawal by Subject|1|||
126300720|NCT01408303|454389128|FG000|Overall Study|Protocol Violation|0|||
126300721|NCT01408303|454389129|FG001|Overall Study|Protocol Violation|1|||
126300722|NCT01408303|454389130|FG002|Overall Study|Protocol Violation|0|||
126300723|NCT01408303|454389128|FG000|Overall Study|Noncompliance|1|||
126300724|NCT01408303|454389129|FG001|Overall Study|Noncompliance|0|||
126300725|NCT01408303|454389130|FG002|Overall Study|Noncompliance|1|||
126300726|NCT01207687|454389131|FG000|Overall Study|Adverse Event|1|||
126300727|NCT01207687|454389131|FG000|Overall Study|Withdrawal by Subject|1|||
126300728|NCT01486446|454389132|FG000|Overall Study|Adverse Event|1|||
126300729|NCT01486446|454389133|FG001|Overall Study|Adverse Event|0|||
126300730|NCT01801865|454389134|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
126300731|NCT01801865|454389134|FG000|Overall Study|Physician Decision|7|||
126300732|NCT01367886|454389137|FG000|Overall Study|Lost to Follow-up|4|||
126300733|NCT01367886|454389137|FG000|Overall Study|Lack of Efficacy|2|||
126300734|NCT01367886|454389137|FG000|Overall Study|Death|1|||
126300735|NCT00985504|454389142|FG000|Acute Treatment Period|Adverse Event|3|||
126300736|NCT00985504|454389143|FG001|Acute Treatment Period|Adverse Event|4|||
126300737|NCT00985504|454389142|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
126300738|NCT00985504|454389143|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
126300739|NCT00985504|454389142|FG000|Acute Treatment Period|Protocol Violation|2|||
126300740|NCT00985504|454389143|FG001|Acute Treatment Period|Protocol Violation|0|||
126300741|NCT00985504|454389142|FG000|Acute Treatment Period|Sponsor Decision|0|||
126300742|NCT00985504|454389143|FG001|Acute Treatment Period|Sponsor Decision|1|||
126300743|NCT00985504|454389142|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
126300744|NCT00985504|454389143|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
126300745|NCT00985504|454389142|FG000|Optimization Period|Adverse Event|7|||
126300746|NCT00985504|454389143|FG001|Optimization Period|Adverse Event|9|||
126300747|NCT00985504|454389142|FG000|Optimization Period|Death|0|||
126300748|NCT00985504|454389143|FG001|Optimization Period|Death|1|||
126300749|NCT00985504|454389142|FG000|Optimization Period|Lack of Efficacy|5|||
126300750|NCT00985504|454389143|FG001|Optimization Period|Lack of Efficacy|3|||
126300751|NCT00985504|454389142|FG000|Optimization Period|Lost to Follow-up|0|||
126300752|NCT00985504|454389143|FG001|Optimization Period|Lost to Follow-up|1|||
126300753|NCT00985504|454389142|FG000|Optimization Period|Physician Decision|1|||
126300754|NCT00985504|454389143|FG001|Optimization Period|Physician Decision|0|||
126300755|NCT00985504|454389142|FG000|Optimization Period|Protocol Violation|3|||
126300756|NCT00985504|454389143|FG001|Optimization Period|Protocol Violation|1|||
126300757|NCT00985504|454389142|FG000|Optimization Period|Withdrawal by Subject|10|||
126300758|NCT00985504|454389143|FG001|Optimization Period|Withdrawal by Subject|8|||
126300759|NCT03711786|454389144|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
126300760|NCT03711786|454389145|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
126300761|NCT03711786|454389144|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
126300762|NCT03711786|454389145|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
126300763|NCT03711786|454389144|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
126300764|NCT03711786|454389145|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
126300765|NCT03711786|454389144|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
126300766|NCT03711786|454389145|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
126300767|NCT03711786|454389144|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
126300768|NCT03711786|454389145|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
126300769|NCT03711786|454389144|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
126461904|NCT03324581|454991540|FG001|Overall Study|Lack of Efficacy|1|||
126300770|NCT03711786|454389145|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
126461905|NCT03324581|454991541|FG002|Overall Study|Lack of Efficacy|0|||
126461906|NCT03324581|454991539|FG000|Overall Study|Lost to Follow-up|5|||
126461907|NCT03324581|454991540|FG001|Overall Study|Lost to Follow-up|3|||
126300771|NCT03379727|454389146|FG000|Overall Study|Lack of Efficacy|73|||
126300772|NCT03379727|454389146|FG000|Overall Study|Adverse Event|32|||
126300773|NCT03379727|454389146|FG000|Overall Study|Death|18|||
126461908|NCT03324581|454991541|FG002|Overall Study|Lost to Follow-up|6|||
126550414|NCT01146574|455309555|FG003|Overall Study|Withdrew consent|1|||
126550415|NCT01146574|455309556|FG004|Overall Study|Withdrew consent|2|||
126550416|NCT01146574|455309557|FG005|Overall Study|Withdrew consent|1|||
126550417|NCT01146574|455309558|FG006|Overall Study|Withdrew consent|1|||
126550418|NCT03051659|455309559|FG000|Treatment Period|Withdrawal by Subject|0|||
126550419|NCT03051659|455309560|FG001|Treatment Period|Withdrawal by Subject|2|||
126550420|NCT03051659|455309559|FG000|Survival Follow-up|Lost to Follow-up|23|||
126550421|NCT03051659|455309560|FG001|Survival Follow-up|Lost to Follow-up|22|||
126550422|NCT00786474|455309561|FG000|Overall Study|Death|5|||
126550423|NCT00786474|455309562|FG001|Overall Study|Death|4|||
126550424|NCT00786474|455309561|FG000|Overall Study|Withdrawal by Subject|23|||
126550425|NCT00786474|455309562|FG001|Overall Study|Withdrawal by Subject|31|||
126550426|NCT00786474|455309561|FG000|Overall Study|Lost to Follow-up|3|||
126550427|NCT00786474|455309562|FG001|Overall Study|Lost to Follow-up|3|||
126550428|NCT00786474|455309561|FG000|Overall Study|Physician Decision|2|||
126550429|NCT00786474|455309562|FG001|Overall Study|Physician Decision|1|||
126550430|NCT00786474|455309561|FG000|Overall Study|Other|4|||
126550431|NCT00786474|455309562|FG001|Overall Study|Other|4|||
126550432|NCT03053492|455309563|FG000|Overall Study|Adverse Event|1|||
126550433|NCT03053492|455309564|FG001|Overall Study|Adverse Event|1|||
126550434|NCT03053492|455309563|FG000|Overall Study|Withdrawal by Subject|7|||
126550435|NCT03053492|455309564|FG001|Overall Study|Withdrawal by Subject|5|||
126550436|NCT01868074|455309565|FG000|Overall Study|Lost to Follow-up|3|||
126550437|NCT01868074|455309566|FG001|Overall Study|Lost to Follow-up|2|||
126550438|NCT01868074|455309565|FG000|Overall Study|Withdrawal by Subject|4|||
126550439|NCT01868074|455309566|FG001|Overall Study|Withdrawal by Subject|2|||
126550440|NCT01544491|455309567|FG000|Overall Study|Withdrawal by Subject|3|||
126461909|NCT03324581|454991539|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
126461910|NCT03324581|454991540|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
126461911|NCT03324581|454991541|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
126461912|NCT03324581|454991539|FG000|Overall Study|Physician Decision|0|||
126461913|NCT03324581|454991540|FG001|Overall Study|Physician Decision|1|||
126461914|NCT03324581|454991541|FG002|Overall Study|Physician Decision|2|||
126461915|NCT03324581|454991539|FG000|Overall Study|Protocol Deviation|8|||
126461916|NCT03324581|454991540|FG001|Overall Study|Protocol Deviation|9|||
126461917|NCT03324581|454991541|FG002|Overall Study|Protocol Deviation|4|||
126461918|NCT03324581|454991539|FG000|Overall Study|Withdrawal by Subject|6|||
126550441|NCT01544491|455309568|FG001|Overall Study|Withdrawal by Subject|2|||
126550442|NCT01544491|455309567|FG000|Overall Study|Lost to Follow-up|0|||
126550443|NCT01544491|455309568|FG001|Overall Study|Lost to Follow-up|1|||
126550444|NCT01544491|455309567|FG000|Overall Study|administrative problems|2|||
126550445|NCT01544491|455309568|FG001|Overall Study|administrative problems|0|||
126550446|NCT00967018|455309569|FG000|Overall Study|Adverse Event|2|||
126550447|NCT00967018|455309569|FG000|Overall Study|Physician Decision|7|||
126550448|NCT00967018|455309569|FG000|Overall Study|Lost to Follow-up|2|||
126550449|NCT00967018|455309569|FG000|Overall Study|Withdrawal by Subject|1|||
126550450|NCT00967018|455309569|FG000|Overall Study|Miscellaneous Reasons|9|||
126550451|NCT04642469|455309574|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
126550452|NCT04642469|455309575|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
126550453|NCT04642469|455309574|FG000|Overall Study|Death|1|||
126550454|NCT04642469|455309575|FG001|Overall Study|Death|2|||
126550455|NCT04642469|455309574|FG000|Overall Study|Study/site closed following amendment 1|11|||
126550456|NCT04642469|455309575|FG001|Overall Study|Study/site closed following amendment 1|11|||
126550457|NCT04642469|455309574|FG000|Overall Study|Other|1|||
126550458|NCT04642469|455309575|FG001|Overall Study|Other|1|||
126300774|NCT03379727|454389146|FG000|Overall Study|Patient/guardian decision|17|||
126300775|NCT03379727|454389146|FG000|Overall Study|Physician Decision|104|||
126300776|NCT03379727|454389146|FG000|Overall Study|Protocol Violation|4|||
126300777|NCT03379727|454389146|FG000|Overall Study|Lost to Follow-up|1|||
126461919|NCT03324581|454991540|FG001|Overall Study|Withdrawal by Subject|8|||
126550459|NCT04642469|455309574|FG000|Overall Study|Withdrawal by Subject|1|||
126550460|NCT04642469|455309575|FG001|Overall Study|Withdrawal by Subject|0|||
126550461|NCT00680056|455309578|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
126770332|NCT02494583|456112455|FG002|Overall Study|Withdrawal by Subject|15|||
126770333|NCT01787188|456112456|FG000|Overall Study|Adverse Event|2|||
126300778|NCT04031846|454389150|FG000|Overall Study|Lost to Follow-up|4|||
126300779|NCT04031846|454389151|FG001|Overall Study|Lost to Follow-up|4|||
126300780|NCT04031846|454389150|FG000|Overall Study|Physician Decision|0|||
126300781|NCT04031846|454389151|FG001|Overall Study|Physician Decision|1|||
126300782|NCT04031846|454389150|FG000|Overall Study|Protocol Violation|1|||
126300783|NCT04031846|454389151|FG001|Overall Study|Protocol Violation|1|||
126461920|NCT03324581|454991541|FG002|Overall Study|Withdrawal by Subject|6|||
126550462|NCT00680056|455309579|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
126550463|NCT00680056|455309578|FG000|Second Intervention|Protocol Violation|3|||
126550464|NCT00680056|455309579|FG001|Second Intervention|Protocol Violation|1|||
126550465|NCT02733042|455309580|FG000|Overall Study|Adverse Event|1|||
126550466|NCT02733042|455309581|FG001|Overall Study|Adverse Event|0|||
126300784|NCT04031846|454389150|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
126300785|NCT04031846|454389151|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
126300786|NCT06868654|454389152|FG000|Overall Study|Death|4|||
126300787|NCT06868654|454389153|FG001|Overall Study|Death|14|||
126300788|NCT06868654|454389152|FG000|Overall Study|Lost to Follow-up|0|||
126300789|NCT06868654|454389153|FG001|Overall Study|Lost to Follow-up|1|||
126300790|NCT06868654|454389152|FG000|Overall Study|Withdrawal by Subject|5|||
126300791|NCT06868654|454389153|FG001|Overall Study|Withdrawal by Subject|3|||
126300792|NCT06868654|454389152|FG000|Overall Study|Physician Decision|0|||
126300793|NCT06868654|454389153|FG001|Overall Study|Physician Decision|1|||
126300794|NCT06868654|454389152|FG000|Overall Study|Ongoing|23|||
126300795|NCT06868654|454389153|FG001|Overall Study|Ongoing|21|||
126300796|NCT00764660|454389158|FG000|Overall Study|Adverse Event|6|||
126300797|NCT00764660|454389159|FG001|Overall Study|Adverse Event|3|||
126300798|NCT00764660|454389158|FG000|Overall Study|Lost to Follow-up|3|||
126300799|NCT00764660|454389159|FG001|Overall Study|Lost to Follow-up|4|||
126300800|NCT00764660|454389158|FG000|Overall Study|Withdrawal by Subject|7|||
126300801|NCT00764660|454389159|FG001|Overall Study|Withdrawal by Subject|3|||
126300802|NCT00764660|454389158|FG000|Overall Study|Noncompliance With Protocol|5|||
126300803|NCT00764660|454389159|FG001|Overall Study|Noncompliance With Protocol|1|||
126300804|NCT00764660|454389158|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
126300805|NCT00764660|454389159|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
126300806|NCT01131455|454389160|FG000|Overall Study|Death of PI|6|||
126300807|NCT01131455|454389161|FG001|Overall Study|Death of PI|4|||
126300808|NCT01131455|454389162|FG002|Overall Study|Death of PI|0|||
126300809|NCT03103152|454389163|FG000|Overall Study|Physician Decision|5|||
126300810|NCT03103152|454389164|FG001|Overall Study|Physician Decision|2|||
126300811|NCT03103152|454389165|FG002|Overall Study|Physician Decision|6|||
126300812|NCT03103152|454389166|FG003|Overall Study|Physician Decision|3|||
126300813|NCT03103152|454389167|FG004|Overall Study|Physician Decision|3|||
126300814|NCT03103152|454389168|FG005|Overall Study|Physician Decision|1|||
126300815|NCT03103152|454389163|FG000|Overall Study|Protocol Violation|2|||
126300816|NCT03103152|454389164|FG001|Overall Study|Protocol Violation|2|||
126300817|NCT03103152|454389165|FG002|Overall Study|Protocol Violation|1|||
126300818|NCT03103152|454389166|FG003|Overall Study|Protocol Violation|2|||
126300819|NCT03103152|454389167|FG004|Overall Study|Protocol Violation|1|||
126300820|NCT03103152|454389168|FG005|Overall Study|Protocol Violation|1|||
126300821|NCT03103152|454389163|FG000|Overall Study|Inter-current illness|0|||
126300822|NCT03103152|454389164|FG001|Overall Study|Inter-current illness|0|||
126300823|NCT03103152|454389165|FG002|Overall Study|Inter-current illness|1|||
126300824|NCT03103152|454389166|FG003|Overall Study|Inter-current illness|0|||
126300825|NCT03103152|454389167|FG004|Overall Study|Inter-current illness|0|||
126300826|NCT03103152|454389168|FG005|Overall Study|Inter-current illness|0|||
126300827|NCT03103152|454389163|FG000|Overall Study|Death|0|||
126300828|NCT03103152|454389164|FG001|Overall Study|Death|1|||
126300829|NCT03103152|454389165|FG002|Overall Study|Death|0|||
126300830|NCT03103152|454389166|FG003|Overall Study|Death|0|||
126300831|NCT03103152|454389167|FG004|Overall Study|Death|0|||
126300832|NCT03103152|454389168|FG005|Overall Study|Death|0|||
126300833|NCT03103152|454389163|FG000|Overall Study|Adverse Event|0|||
126300834|NCT03103152|454389164|FG001|Overall Study|Adverse Event|0|||
126300835|NCT03103152|454389165|FG002|Overall Study|Adverse Event|1|||
126300836|NCT03103152|454389166|FG003|Overall Study|Adverse Event|0|||
126300837|NCT03103152|454389167|FG004|Overall Study|Adverse Event|0|||
126300838|NCT03103152|454389168|FG005|Overall Study|Adverse Event|1|||
126300839|NCT03103152|454389163|FG000|Overall Study|Withdrawal by Subject|1|||
126300840|NCT03103152|454389164|FG001|Overall Study|Withdrawal by Subject|0|||
126300841|NCT03103152|454389165|FG002|Overall Study|Withdrawal by Subject|1|||
126300842|NCT03103152|454389166|FG003|Overall Study|Withdrawal by Subject|1|||
126300843|NCT03103152|454389167|FG004|Overall Study|Withdrawal by Subject|1|||
126300844|NCT03103152|454389168|FG005|Overall Study|Withdrawal by Subject|1|||
126300845|NCT03103152|454389163|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
126300846|NCT03103152|454389164|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
126300847|NCT03103152|454389165|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
126300848|NCT03103152|454389166|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
126300849|NCT03103152|454389167|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
126300850|NCT03103152|454389168|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
126300851|NCT03103152|454389163|FG000|Overall Study|Unacceptable side effects|0|||
126300852|NCT03103152|454389164|FG001|Overall Study|Unacceptable side effects|0|||
126300853|NCT03103152|454389165|FG002|Overall Study|Unacceptable side effects|0|||
126300854|NCT03103152|454389166|FG003|Overall Study|Unacceptable side effects|0|||
126300855|NCT03103152|454389167|FG004|Overall Study|Unacceptable side effects|0|||
126300856|NCT03103152|454389168|FG005|Overall Study|Unacceptable side effects|1|||
126300857|NCT03103152|454389163|FG000|Overall Study|Lost to Follow-up|0|||
126300858|NCT03103152|454389164|FG001|Overall Study|Lost to Follow-up|1|||
126300859|NCT03103152|454389165|FG002|Overall Study|Lost to Follow-up|0|||
126300860|NCT03103152|454389166|FG003|Overall Study|Lost to Follow-up|1|||
126300861|NCT03103152|454389167|FG004|Overall Study|Lost to Follow-up|0|||
126461921|NCT03324581|454991539|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
126461922|NCT03324581|454991540|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
126461923|NCT03324581|454991541|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
126461924|NCT02274038|454991542|FG000|Overall Study|Death|1|||
126461925|NCT03783702|454991543|FG000|Overall Study|Lost to Follow-up|6|||
126461926|NCT03783702|454991544|FG001|Overall Study|Lost to Follow-up|8|||
126461927|NCT03783702|454991543|FG000|Overall Study|Protocol Violation|1|||
126461928|NCT03783702|454991544|FG001|Overall Study|Protocol Violation|3|||
126461929|NCT00769483|454991545|FG000|Overall Study|Withdrawal by Subject|0|||
126461930|NCT00769483|454991546|FG001|Overall Study|Withdrawal by Subject|1|||
126461931|NCT00769483|454991547|FG002|Overall Study|Withdrawal by Subject|0|||
126461932|NCT00769483|454991548|FG003|Overall Study|Withdrawal by Subject|0|||
126461933|NCT00769483|454991549|FG004|Overall Study|Withdrawal by Subject|1|||
126461934|NCT00769483|454991550|FG005|Overall Study|Withdrawal by Subject|0|||
126461935|NCT03455764|454991551|FG000|Overall Study|Adverse Event|1|||
126461936|NCT03455764|454991552|FG001|Overall Study|Adverse Event|0|||
126461937|NCT03455764|454991553|FG002|Overall Study|Adverse Event|0|||
126461938|NCT03455764|454991554|FG003|Overall Study|Adverse Event|0|||
126461939|NCT03455764|454991555|FG004|Overall Study|Adverse Event|0|||
126712951|NCT03069690|455900415|FG002|Postpartum Intervention|Lost to Follow-up|5|||
126300862|NCT03103152|454389168|FG005|Overall Study|Lost to Follow-up|1|||
126300863|NCT03103152|454389163|FG000|Overall Study|Testicular pain|0|||
126300864|NCT03103152|454389164|FG001|Overall Study|Testicular pain|0|||
126300865|NCT03103152|454389165|FG002|Overall Study|Testicular pain|0|||
126300866|NCT03103152|454389166|FG003|Overall Study|Testicular pain|1|||
126300867|NCT03103152|454389167|FG004|Overall Study|Testicular pain|0|||
126300868|NCT03103152|454389168|FG005|Overall Study|Testicular pain|0|||
126300869|NCT01540487|454390816|FG000|Overall Study|Protocol Violation|1|||
126300870|NCT01540487|454390817|FG001|Overall Study|Protocol Violation|0|||
126300871|NCT03503370|454390818|FG000|Overall Study|Death|3|||
126300872|NCT03503370|454390819|FG001|Overall Study|Death|1|||
126300873|NCT00298272|454390824|FG000|Double-blind Phase|Adverse Event|2|||
126300874|NCT00298272|454390825|FG001|Double-blind Phase|Adverse Event|0|||
126300875|NCT00298272|454390824|FG000|Double-blind Phase|Failure to Return|2|||
126300876|NCT00298272|454390825|FG001|Double-blind Phase|Failure to Return|0|||
126300877|NCT00298272|454390824|FG000|Double-blind Phase|Protocol Violation|2|||
126300878|NCT00298272|454390825|FG001|Double-blind Phase|Protocol Violation|0|||
126300879|NCT00298272|454390824|FG000|Double-blind Phase|Withdrawal by Subject|2|||
126300880|NCT00298272|454390825|FG001|Double-blind Phase|Withdrawal by Subject|0|||
126300881|NCT00298272|454390824|FG000|Open Label Retreatment Phase|Adverse Event|1|||
126300882|NCT00298272|454390825|FG001|Open Label Retreatment Phase|Adverse Event|2|||
126300883|NCT00298272|454390824|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
126300884|NCT00298272|454390825|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
126300885|NCT00298272|454390824|FG000|Open Label Retreatment Phase|Failure to Return|1|||
126300886|NCT00298272|454390825|FG001|Open Label Retreatment Phase|Failure to Return|0|||
126300887|NCT00298272|454390824|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
126300888|NCT00298272|454390825|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
126300889|NCT00298272|454390824|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
126300890|NCT00298272|454390825|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
126300891|NCT00298272|454390824|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
126300892|NCT00298272|454390825|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
126300893|NCT00298272|454390824|FG000|Safety Follow-up Phase|Failure to Return|1|||
126300894|NCT00298272|454390825|FG001|Safety Follow-up Phase|Failure to Return|1|||
126300895|NCT00298272|454390824|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
126300896|NCT00298272|454390825|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
126300897|NCT00298272|454390824|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
126300898|NCT00298272|454390825|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
126300899|NCT04168112|454390826|FG000|Overall Study|Lost to Follow-up|1|||
126300900|NCT04168112|454390827|FG001|Overall Study|Lost to Follow-up|0|||
126300901|NCT04168112|454390826|FG000|Overall Study|Withdrawal by Subject|1|||
126300902|NCT04168112|454390827|FG001|Overall Study|Withdrawal by Subject|0|||
126461940|NCT03455764|454991551|FG000|Overall Study|Disease Progression|4|||
126461941|NCT03455764|454991552|FG001|Overall Study|Disease Progression|0|||
126300903|NCT01344824|454390830|FG000|Overall Study|Adverse Event|15|||
126300904|NCT01344824|454390830|FG000|Overall Study|Withdrawal by Subject|6|||
126300905|NCT01344824|454390830|FG000|Overall Study|Other complicating disease|1|||
126300906|NCT01344824|454390830|FG000|Overall Study|Progression|15|||
126300907|NCT01295671|454390838|FG000|Overall Study|Lost to Follow-up|4|||
126300908|NCT01295671|454390839|FG001|Overall Study|Lost to Follow-up|6|||
126461942|NCT03455764|454991553|FG002|Overall Study|Disease Progression|0|||
126770334|NCT01787188|456112457|FG001|Overall Study|Adverse Event|4|||
126300909|NCT01295671|454390840|FG002|Overall Study|Lost to Follow-up|3|||
126300910|NCT01295671|454390838|FG000|Overall Study|Withdrawal by Subject|3|||
126461943|NCT03455764|454991554|FG003|Overall Study|Disease Progression|0|||
126461944|NCT03455764|454991555|FG004|Overall Study|Disease Progression|0|||
126461945|NCT03455764|454991551|FG000|Overall Study|On Treatment|1|||
126550467|NCT02733042|455309582|FG002|Overall Study|Adverse Event|1|||
126550468|NCT02733042|455309583|FG003|Overall Study|Adverse Event|1|||
126550469|NCT02733042|455309584|FG004|Overall Study|Adverse Event|0|||
126550470|NCT02733042|455309585|FG005|Overall Study|Adverse Event|0|||
126550471|NCT02733042|455309586|FG006|Overall Study|Adverse Event|0|||
126550472|NCT02733042|455309587|FG007|Overall Study|Adverse Event|0|||
126550473|NCT02733042|455309588|FG008|Overall Study|Adverse Event|0|||
126550474|NCT02733042|455309589|FG009|Overall Study|Adverse Event|0|||
126550475|NCT02733042|455309590|FG010|Overall Study|Adverse Event|2|||
126550476|NCT02733042|455309591|FG011|Overall Study|Adverse Event|2|||
126550477|NCT02733042|455309592|FG012|Overall Study|Adverse Event|0|||
126550478|NCT02733042|455309593|FG013|Overall Study|Adverse Event|2|||
126550479|NCT02733042|455309594|FG014|Overall Study|Adverse Event|0|||
126550480|NCT02733042|455309595|FG015|Overall Study|Adverse Event|0|||
126550481|NCT02733042|455309596|FG016|Overall Study|Adverse Event|0|||
126550482|NCT02733042|455309597|FG017|Overall Study|Adverse Event|1|||
126550483|NCT02733042|455309598|FG018|Overall Study|Adverse Event|0|||
126550484|NCT02733042|455309580|FG000|Overall Study|Progressive Disease|2|||
126550485|NCT02733042|455309581|FG001|Overall Study|Progressive Disease|1|||
126550486|NCT02733042|455309582|FG002|Overall Study|Progressive Disease|3|||
126550487|NCT02733042|455309583|FG003|Overall Study|Progressive Disease|1|||
126550488|NCT02733042|455309584|FG004|Overall Study|Progressive Disease|2|||
126550489|NCT02733042|455309585|FG005|Overall Study|Progressive Disease|3|||
126550490|NCT02733042|455309586|FG006|Overall Study|Progressive Disease|0|||
126550491|NCT02733042|455309587|FG007|Overall Study|Progressive Disease|3|||
126550492|NCT02733042|455309588|FG008|Overall Study|Progressive Disease|3|||
126550493|NCT02733042|455309589|FG009|Overall Study|Progressive Disease|2|||
126550494|NCT02733042|455309590|FG010|Overall Study|Progressive Disease|2|||
126550495|NCT02733042|455309591|FG011|Overall Study|Progressive Disease|2|||
126550496|NCT02733042|455309592|FG012|Overall Study|Progressive Disease|8|||
126550497|NCT02733042|455309593|FG013|Overall Study|Progressive Disease|1|||
126550498|NCT02733042|455309594|FG014|Overall Study|Progressive Disease|4|||
126550499|NCT02733042|455309595|FG015|Overall Study|Progressive Disease|7|||
126550500|NCT02733042|455309596|FG016|Overall Study|Progressive Disease|2|||
126550501|NCT02733042|455309597|FG017|Overall Study|Progressive Disease|3|||
126550502|NCT02733042|455309598|FG018|Overall Study|Progressive Disease|4|||
126550503|NCT02733042|455309580|FG000|Overall Study|Withdrawal by Subject|0|||
126550504|NCT02733042|455309581|FG001|Overall Study|Withdrawal by Subject|1|||
126550505|NCT02733042|455309582|FG002|Overall Study|Withdrawal by Subject|2|||
126550506|NCT02733042|455309583|FG003|Overall Study|Withdrawal by Subject|1|||
126550507|NCT02733042|455309584|FG004|Overall Study|Withdrawal by Subject|1|||
126550508|NCT02733042|455309585|FG005|Overall Study|Withdrawal by Subject|0|||
126550509|NCT02733042|455309586|FG006|Overall Study|Withdrawal by Subject|0|||
126550510|NCT02733042|455309587|FG007|Overall Study|Withdrawal by Subject|0|||
126550511|NCT02733042|455309588|FG008|Overall Study|Withdrawal by Subject|1|||
126550512|NCT02733042|455309589|FG009|Overall Study|Withdrawal by Subject|1|||
126550513|NCT02733042|455309590|FG010|Overall Study|Withdrawal by Subject|0|||
126550514|NCT02733042|455309591|FG011|Overall Study|Withdrawal by Subject|2|||
126550515|NCT02733042|455309592|FG012|Overall Study|Withdrawal by Subject|1|||
126550516|NCT02733042|455309593|FG013|Overall Study|Withdrawal by Subject|1|||
126550517|NCT02733042|455309594|FG014|Overall Study|Withdrawal by Subject|0|||
126550518|NCT02733042|455309595|FG015|Overall Study|Withdrawal by Subject|0|||
126550519|NCT02733042|455309596|FG016|Overall Study|Withdrawal by Subject|0|||
126550520|NCT02733042|455309597|FG017|Overall Study|Withdrawal by Subject|0|||
126550521|NCT02733042|455309598|FG018|Overall Study|Withdrawal by Subject|0|||
126550522|NCT02733042|455309580|FG000|Overall Study|Other Reasons|0|||
126550523|NCT02733042|455309581|FG001|Overall Study|Other Reasons|0|||
126550524|NCT02733042|455309582|FG002|Overall Study|Other Reasons|1|||
126461946|NCT03455764|454991552|FG001|Overall Study|On Treatment|0|||
126461947|NCT03455764|454991553|FG002|Overall Study|On Treatment|0|||
126461948|NCT03455764|454991554|FG003|Overall Study|On Treatment|0|||
126461949|NCT03455764|454991555|FG004|Overall Study|On Treatment|0|||
126461950|NCT00995865|454991556|FG000|Overall Study|Protocol Violation|2|||
126461951|NCT00995865|454991557|FG001|Overall Study|Protocol Violation|0|||
126461952|NCT00995865|454991558|FG002|Overall Study|Protocol Violation|0|||
126461953|NCT00995865|454991556|FG000|Overall Study|Lost to Follow-up|0|||
126461954|NCT00995865|454991557|FG001|Overall Study|Lost to Follow-up|0|||
126461955|NCT00995865|454991558|FG002|Overall Study|Lost to Follow-up|1|||
126550525|NCT02733042|455309583|FG003|Overall Study|Other Reasons|0|||
126550526|NCT02733042|455309584|FG004|Overall Study|Other Reasons|0|||
126550527|NCT02733042|455309585|FG005|Overall Study|Other Reasons|0|||
126461956|NCT05080660|454991560|FG000|Overall Study|Adverse Event|4|||
126461957|NCT05080660|454991561|FG001|Overall Study|Adverse Event|0|||
126461958|NCT05080660|454991560|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
126550528|NCT02733042|455309586|FG006|Overall Study|Other Reasons|0|||
126550529|NCT02733042|455309587|FG007|Overall Study|Other Reasons|0|||
126550530|NCT02733042|455309588|FG008|Overall Study|Other Reasons|0|||
126550531|NCT02733042|455309589|FG009|Overall Study|Other Reasons|1|||
126550532|NCT02733042|455309590|FG010|Overall Study|Other Reasons|1|||
126550533|NCT02733042|455309591|FG011|Overall Study|Other Reasons|0|||
126550534|NCT02733042|455309592|FG012|Overall Study|Other Reasons|0|||
126550535|NCT02733042|455309593|FG013|Overall Study|Other Reasons|0|||
126550536|NCT02733042|455309594|FG014|Overall Study|Other Reasons|0|||
126550537|NCT02733042|455309595|FG015|Overall Study|Other Reasons|1|||
126550538|NCT02733042|455309596|FG016|Overall Study|Other Reasons|0|||
126550539|NCT02733042|455309597|FG017|Overall Study|Other Reasons|1|||
126550540|NCT02733042|455309598|FG018|Overall Study|Other Reasons|0|||
126550541|NCT02733042|455309580|FG000|Overall Study|Death|0|||
126550542|NCT02733042|455309581|FG001|Overall Study|Death|0|||
126550543|NCT02733042|455309582|FG002|Overall Study|Death|0|||
126550544|NCT02733042|455309583|FG003|Overall Study|Death|0|||
126550545|NCT02733042|455309584|FG004|Overall Study|Death|0|||
126550546|NCT02733042|455309585|FG005|Overall Study|Death|0|||
126550547|NCT02733042|455309586|FG006|Overall Study|Death|1|||
126550548|NCT02733042|455309587|FG007|Overall Study|Death|0|||
126550549|NCT02733042|455309588|FG008|Overall Study|Death|1|||
126550550|NCT02733042|455309589|FG009|Overall Study|Death|0|||
126550551|NCT02733042|455309590|FG010|Overall Study|Death|1|||
126550552|NCT02733042|455309591|FG011|Overall Study|Death|0|||
126550553|NCT02733042|455309592|FG012|Overall Study|Death|0|||
126550554|NCT02733042|455309593|FG013|Overall Study|Death|0|||
126550555|NCT02733042|455309594|FG014|Overall Study|Death|1|||
126550556|NCT02733042|455309595|FG015|Overall Study|Death|2|||
126550557|NCT02733042|455309596|FG016|Overall Study|Death|0|||
126550558|NCT02733042|455309597|FG017|Overall Study|Death|0|||
126550559|NCT02733042|455309598|FG018|Overall Study|Death|0|||
126550560|NCT01821898|455309599|FG000|Overall Study|Withdrawal by Subject|2|||
126550561|NCT01821898|455309600|FG001|Overall Study|Withdrawal by Subject|1|||
126550562|NCT00337662|455309603|FG000|Study Period II|Lost to Follow-up|0|||
126550563|NCT00337662|455309604|FG001|Study Period II|Lost to Follow-up|0|||
126550564|NCT00337662|455309605|FG002|Study Period II|Lost to Follow-up|0|||
126550565|NCT00337662|455309606|FG003|Study Period II|Lost to Follow-up|35|||
126461959|NCT05080660|454991561|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
126461960|NCT05080660|454991560|FG000|Overall Study|Physician Decision|1|||
126461961|NCT05080660|454991561|FG001|Overall Study|Physician Decision|0|||
126461962|NCT05080660|454991560|FG000|Overall Study|Protocol Deviation|2|||
126461963|NCT05080660|454991561|FG001|Overall Study|Protocol Deviation|0|||
126461964|NCT05080660|454991560|FG000|Overall Study|Withdrawal by Subject|5|||
126461965|NCT05080660|454991561|FG001|Overall Study|Withdrawal by Subject|2|||
126461966|NCT04221230|454991571|FG000|Overall Study|Lost to Follow-up|12|||
126461967|NCT04221230|454991572|FG001|Overall Study|Lost to Follow-up|12|||
126461968|NCT04221230|454991571|FG000|Overall Study|Protocol Violation|2|||
126461969|NCT04221230|454991572|FG001|Overall Study|Protocol Violation|2|||
126461970|NCT04221230|454991571|FG000|Overall Study|Adverse Event|0|||
126461971|NCT04221230|454991572|FG001|Overall Study|Adverse Event|8|||
126461972|NCT04221230|454991571|FG000|Overall Study|Physician Decision|1|||
126461973|NCT04221230|454991572|FG001|Overall Study|Physician Decision|0|||
126550566|NCT00337662|455309603|FG000|Study Period II|Withdrawal by Subject|0|||
126550567|NCT00337662|455309604|FG001|Study Period II|Withdrawal by Subject|0|||
126550568|NCT00337662|455309605|FG002|Study Period II|Withdrawal by Subject|0|||
126550569|NCT00337662|455309606|FG003|Study Period II|Withdrawal by Subject|20|||
126550570|NCT00337662|455309603|FG000|Study Period II|Adverse Event|0|||
126461974|NCT04221230|454991571|FG000|Overall Study|Withdrawal by Subject|13|||
126461975|NCT04221230|454991572|FG001|Overall Study|Withdrawal by Subject|11|||
126461976|NCT04221230|454991571|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126550571|NCT00337662|455309604|FG001|Study Period II|Adverse Event|0|||
126550572|NCT00337662|455309605|FG002|Study Period II|Adverse Event|0|||
126550573|NCT00337662|455309606|FG003|Study Period II|Adverse Event|16|||
126550574|NCT00337662|455309603|FG000|Study Period II|Physician Decision|0|||
126550575|NCT00337662|455309604|FG001|Study Period II|Physician Decision|0|||
126550576|NCT00337662|455309605|FG002|Study Period II|Physician Decision|0|||
126550577|NCT00337662|455309606|FG003|Study Period II|Physician Decision|13|||
126550578|NCT00337662|455309603|FG000|Study Period II|Entry Criteria Not Met|0|||
126550579|NCT00337662|455309604|FG001|Study Period II|Entry Criteria Not Met|0|||
126550580|NCT00337662|455309605|FG002|Study Period II|Entry Criteria Not Met|0|||
126550581|NCT00337662|455309606|FG003|Study Period II|Entry Criteria Not Met|6|||
126550582|NCT00337662|455309603|FG000|Study Period II|Protocol Violation|0|||
126550583|NCT00337662|455309604|FG001|Study Period II|Protocol Violation|0|||
126550584|NCT00337662|455309605|FG002|Study Period II|Protocol Violation|0|||
126550585|NCT00337662|455309606|FG003|Study Period II|Protocol Violation|6|||
126550586|NCT00337662|455309603|FG000|Study Period II|Lack of Efficacy|0|||
126461977|NCT04221230|454991572|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126461978|NCT04221230|454991571|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126461979|NCT04221230|454991572|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
126461980|NCT04221230|454991571|FG000|Overall Study|Pregnancy|0|||
126461981|NCT04221230|454991572|FG001|Overall Study|Pregnancy|1|||
126550587|NCT00337662|455309604|FG001|Study Period II|Lack of Efficacy|0|||
126550588|NCT00337662|455309605|FG002|Study Period II|Lack of Efficacy|0|||
126550589|NCT00337662|455309606|FG003|Study Period II|Lack of Efficacy|7|||
126300911|NCT01295671|454390839|FG001|Overall Study|Withdrawal by Subject|1|||
126300912|NCT01295671|454390840|FG002|Overall Study|Withdrawal by Subject|0|||
126300913|NCT01754129|454390841|FG000|Overall Study|Death|13|||
126300914|NCT01754129|454390841|FG000|Overall Study|Duodopa discontinuation|9|||
126300915|NCT01754129|454390841|FG000|Overall Study|Lost to Follow-up|7|||
126300916|NCT01754129|454390841|FG000|Overall Study|Withdrew consent|1|||
126300917|NCT01754129|454390841|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
126300918|NCT01609010|454390843|FG000|Overall Study|Stable disease (SD)|22|||
126300919|NCT01609010|454390844|FG001|Overall Study|Stable disease (SD)|16|||
126300920|NCT01609010|454390843|FG000|Overall Study|Progressive disease (PD)|8|||
126300921|NCT01609010|454390844|FG001|Overall Study|Progressive disease (PD)|10|||
126300922|NCT01609010|454390843|FG000|Overall Study|Adverse Event|3|||
126300923|NCT01609010|454390844|FG001|Overall Study|Adverse Event|6|||
126300924|NCT01609010|454390843|FG000|Overall Study|Withdrawal by Subject|2|||
126300925|NCT01609010|454390844|FG001|Overall Study|Withdrawal by Subject|2|||
126300926|NCT01609010|454390843|FG000|Overall Study|Other|2|||
126300927|NCT01609010|454390844|FG001|Overall Study|Other|0|||
126300928|NCT01609010|454390843|FG000|Overall Study|Other malignancy|1|||
126300929|NCT01609010|454390844|FG001|Overall Study|Other malignancy|0|||
126300930|NCT01609010|454390843|FG000|Overall Study|Pathology review|2|||
126300931|NCT01609010|454390844|FG001|Overall Study|Pathology review|1|||
126300932|NCT01609010|454390843|FG000|Overall Study|Protocol Violation|1|||
126300933|NCT01609010|454390844|FG001|Overall Study|Protocol Violation|1|||
126300934|NCT01609010|454390843|FG000|Overall Study|New cancer|1|||
126300935|NCT01609010|454390844|FG001|Overall Study|New cancer|0|||
126300936|NCT01609010|454390843|FG000|Overall Study|Lost to Follow-up|1|||
126300937|NCT01609010|454390844|FG001|Overall Study|Lost to Follow-up|1|||
126300938|NCT00808210|454390846|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
126300939|NCT00808210|454390847|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
126300940|NCT00808210|454390846|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
126300941|NCT00808210|454390847|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
126300942|NCT00808210|454390846|FG000|Double-Blind TX Period|Adverse Event|0|||
126300943|NCT00808210|454390847|FG001|Double-Blind TX Period|Adverse Event|1|||
126300944|NCT00808210|454390846|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
126300945|NCT00808210|454390847|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
126300946|NCT00808210|454390846|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
126300947|NCT00808210|454390847|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
126300948|NCT00808210|454390846|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
126300949|NCT00808210|454390847|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
126300950|NCT03150719|454390850|FG000|Overall Study|Adverse Event|0|||
126300951|NCT03150719|454390851|FG001|Overall Study|Adverse Event|1|||
126300952|NCT03150719|454390850|FG000|Overall Study|Death|0|||
126300953|NCT03150719|454390851|FG001|Overall Study|Death|1|||
126300954|NCT03150719|454390850|FG000|Overall Study|Other|1|||
126300955|NCT03150719|454390851|FG001|Overall Study|Other|0|||
126300956|NCT01790984|454390852|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
126300957|NCT01790984|454390853|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
126300958|NCT01790984|454390854|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
126300959|NCT01790984|454390855|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
126300960|NCT01346696|454390857|FG000|Overall Study|Death|1|||
126300961|NCT01051791|454390867|FG000|Overall Study|Failed screening|3|||
126300962|NCT01051791|454390867|FG000|Overall Study|Withdrawal by Subject|1|||
126300963|NCT00288626|454390868|FG000|Overall Study|Death|3|||
126300964|NCT00288626|454390868|FG000|Overall Study|Withdrawal by Subject|4|||
126300965|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
126300966|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
126300967|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
126300968|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
126300969|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
126300970|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
126300971|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
126300972|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
126300973|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
126300974|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
126300975|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
126300976|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
126300977|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
126300978|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
126300979|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
126461982|NCT04221230|454991571|FG000|Overall Study|Other|1|||
126461983|NCT04221230|454991572|FG001|Overall Study|Other|2|||
126300980|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
126300981|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
126300982|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
126300983|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
126300984|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
126300985|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
126300986|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
126300987|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
126300988|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
126300989|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
126300990|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
126300991|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
126300992|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
126300993|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
126300994|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
126300995|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
126300996|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
126300997|NCT00506415|454390879|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
126300998|NCT00506415|454390880|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
126300999|NCT00506415|454390881|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
126301000|NCT00506415|454390882|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
126301001|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
126301002|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
126301003|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
126301004|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
126301005|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
126301006|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
126301007|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
126301008|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
126301009|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
126301010|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
126301011|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
126301012|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
126301013|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
126301014|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
126301015|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
126301016|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
126301017|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
126301018|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
126301019|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
126301020|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
126301021|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
126301022|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
126301023|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
126301024|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
126301025|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
126301026|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
126301027|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
126301028|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
126301029|NCT00506415|454390879|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
126301030|NCT00506415|454390880|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
126301031|NCT00506415|454390881|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
126301032|NCT00506415|454390882|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
126301033|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
126301034|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
126301035|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
126301036|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
126301037|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
126301038|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
126301039|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
126367420|NCT02471144|454640902|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
126367421|NCT02471144|454640903|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
126367422|NCT02471144|454640904|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
126367423|NCT02471144|454640894|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126550590|NCT00337662|455309603|FG000|Study Period II|Sponsor Decision|0|||
126550591|NCT00337662|455309604|FG001|Study Period II|Sponsor Decision|0|||
126550592|NCT00337662|455309605|FG002|Study Period II|Sponsor Decision|0|||
126550593|NCT00337662|455309606|FG003|Study Period II|Sponsor Decision|2|||
126550594|NCT00337662|455309603|FG000|Study Period II|Parent/Caregiver Decision|0|||
126550595|NCT00337662|455309604|FG001|Study Period II|Parent/Caregiver Decision|0|||
126550596|NCT00337662|455309605|FG002|Study Period II|Parent/Caregiver Decision|0|||
126550597|NCT00337662|455309606|FG003|Study Period II|Parent/Caregiver Decision|1|||
126550598|NCT00337662|455309603|FG000|Study Period III|Lost to Follow-up|14|||
126550599|NCT00337662|455309604|FG001|Study Period III|Lost to Follow-up|16|||
126550600|NCT00337662|455309605|FG002|Study Period III|Lost to Follow-up|14|||
126550601|NCT00337662|455309606|FG003|Study Period III|Lost to Follow-up|0|||
126550602|NCT00337662|455309603|FG000|Study Period III|Withdrawal by Subject|18|||
126550603|NCT00337662|455309604|FG001|Study Period III|Withdrawal by Subject|14|||
126301040|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
126301041|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
126301042|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
126301043|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
126301044|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
126301045|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
126301046|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
126301047|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
126301048|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
126301049|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
126301050|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
126301051|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
126301052|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
126301053|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
126301054|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
126301055|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
126301056|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
126301057|NCT00506415|454390879|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
126301058|NCT00506415|454390880|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
126301059|NCT00506415|454390881|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
126301060|NCT00506415|454390882|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
126301061|NCT04578457|454390883|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
126301062|NCT04578457|454390883|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
126301063|NCT04578457|454390883|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
126301064|NCT04578457|454390883|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
126301065|NCT01609296|454390890|FG000|Overall Study|Death|253|||
126301066|NCT01609296|454390890|FG000|Overall Study|Withdrawal by Subject|151|||
126301067|NCT01609296|454390890|FG000|Overall Study|Lost to Follow-up|21|||
126301068|NCT01609296|454390890|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
126301069|NCT01609296|454390890|FG000|Overall Study|missed visit but known to be alive|28|||
126301070|NCT00628212|454390891|FG000|Overall Study|Adverse Event|2|||
126301071|NCT00628212|454390892|FG001|Overall Study|Adverse Event|0|||
126301072|NCT00628212|454390893|FG002|Overall Study|Adverse Event|1|||
126301073|NCT00628212|454390894|FG003|Overall Study|Adverse Event|2|||
126301074|NCT00628212|454390891|FG000|Overall Study|Physician Decision|1|||
126301075|NCT00628212|454390892|FG001|Overall Study|Physician Decision|1|||
126301076|NCT00628212|454390893|FG002|Overall Study|Physician Decision|2|||
126301077|NCT00628212|454390894|FG003|Overall Study|Physician Decision|3|||
126301078|NCT02187198|454390897|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
126301079|NCT02187198|454390898|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
126301080|NCT02187198|454390897|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
126301081|NCT02187198|454390898|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
126301082|NCT00546377|454390899|FG000|Overall Study|Deemed ineligible|1|||
126301083|NCT00546377|454390899|FG000|Overall Study|Adverse Event|6|||
126301084|NCT03020992|454390902|FG000|Overall Study|Adverse Event|5|||
126301085|NCT03020992|454390902|FG000|Overall Study|Withdrawal by Subject|1|||
126301086|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
126301087|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
126550604|NCT00337662|455309605|FG002|Study Period III|Withdrawal by Subject|12|||
126550605|NCT00337662|455309606|FG003|Study Period III|Withdrawal by Subject|0|||
126550606|NCT00337662|455309603|FG000|Study Period III|Adverse Event|9|||
126301088|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
126301089|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
126550607|NCT00337662|455309604|FG001|Study Period III|Adverse Event|10|||
126550608|NCT00337662|455309605|FG002|Study Period III|Adverse Event|8|||
126550609|NCT00337662|455309606|FG003|Study Period III|Adverse Event|0|||
126550610|NCT00337662|455309603|FG000|Study Period III|Protocol Violation|3|||
126301090|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Pregnancy|0|||
126301091|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Pregnancy|1|||
126301092|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
126301093|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
126301094|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
126301095|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
126301096|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
126301097|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
126301098|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Other|3|||
126301099|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Other|0|||
126301100|NCT01006122|454390903|FG000|First Double-blind Intervention Period|Adverse Event|0|||
126301101|NCT01006122|454390904|FG001|First Double-blind Intervention Period|Adverse Event|4|||
126301102|NCT01006122|454390903|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
126301103|NCT01006122|454390904|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
126301104|NCT01006122|454390903|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
126301105|NCT01006122|454390904|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
126301106|NCT01006122|454390903|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
126301107|NCT01006122|454390904|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
126301108|NCT01006122|454390903|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
126301109|NCT01006122|454390904|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
126301110|NCT01006122|454390903|FG000|Second Double-blind Intervention Period|Death|0|||
126301111|NCT01006122|454390904|FG001|Second Double-blind Intervention Period|Death|1|||
126301112|NCT00529308|454390907|FG000|Overall Study|Withdrawal by Subject|1|||
126301113|NCT00529308|454390908|FG001|Overall Study|Withdrawal by Subject|1|||
126301114|NCT01791894|454390919|FG000|Overall Study|Adverse Event|1|||
126301115|NCT02268916|454390920|FG000|Overall Study|Lost to Follow-up|1|||
126301116|NCT02268916|454390921|FG001|Overall Study|Lost to Follow-up|1|||
126301117|NCT02268916|454390920|FG000|Overall Study|Withdrawal by Subject|6|||
126301118|NCT02268916|454390921|FG001|Overall Study|Withdrawal by Subject|5|||
126301119|NCT02268916|454390920|FG000|Overall Study|Participant did not have diabetes|1|||
126301120|NCT02268916|454390921|FG001|Overall Study|Participant did not have diabetes|0|||
126301121|NCT02268916|454390920|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
126301122|NCT02268916|454390921|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
126301123|NCT02418949|454390922|FG000|Overall Study|Withdrawal by Subject|1|||
126301124|NCT02418949|454390923|FG001|Overall Study|Withdrawal by Subject|0|||
126301125|NCT02418949|454390924|FG002|Overall Study|Withdrawal by Subject|1|||
126301126|NCT02418949|454390925|FG003|Overall Study|Withdrawal by Subject|1|||
126301127|NCT02418949|454390922|FG000|Overall Study|Lost to Follow-up|1|||
126301128|NCT02418949|454390923|FG001|Overall Study|Lost to Follow-up|0|||
126301129|NCT02418949|454390924|FG002|Overall Study|Lost to Follow-up|1|||
126301130|NCT02418949|454390925|FG003|Overall Study|Lost to Follow-up|0|||
126301131|NCT02418949|454390922|FG000|Overall Study|Physician Decision|1|||
126301132|NCT02418949|454390923|FG001|Overall Study|Physician Decision|1|||
126301133|NCT02418949|454390924|FG002|Overall Study|Physician Decision|1|||
126301134|NCT02418949|454390925|FG003|Overall Study|Physician Decision|0|||
126301135|NCT03926117|454390926|FG000|Overall Study|Unclassified|1|||
126301136|NCT03926117|454390927|FG001|Overall Study|Unclassified|4|||
126301137|NCT03926117|454390928|FG002|Overall Study|Unclassified|1|||
126301138|NCT03926117|454390929|FG003|Overall Study|Unclassified|4|||
126301139|NCT03926117|454390926|FG000|Overall Study|Withdrawal by Subject|3|||
126301140|NCT03926117|454390927|FG001|Overall Study|Withdrawal by Subject|0|||
126301141|NCT03926117|454390928|FG002|Overall Study|Withdrawal by Subject|1|||
126301142|NCT03926117|454390929|FG003|Overall Study|Withdrawal by Subject|1|||
126301143|NCT03926117|454390926|FG000|Overall Study|Lost to Follow-up|0|||
126301144|NCT03926117|454390927|FG001|Overall Study|Lost to Follow-up|2|||
126301145|NCT03926117|454390928|FG002|Overall Study|Lost to Follow-up|1|||
126301146|NCT03926117|454390929|FG003|Overall Study|Lost to Follow-up|0|||
126301147|NCT03926117|454390926|FG000|Overall Study|Adverse Event|1|||
126301148|NCT03926117|454390927|FG001|Overall Study|Adverse Event|2|||
126301149|NCT03926117|454390928|FG002|Overall Study|Adverse Event|3|||
126301150|NCT03926117|454390929|FG003|Overall Study|Adverse Event|1|||
126301151|NCT03926117|454390926|FG000|Overall Study|Randomized but not treated|1|||
126301152|NCT03926117|454390927|FG001|Overall Study|Randomized but not treated|1|||
126301153|NCT03926117|454390928|FG002|Overall Study|Randomized but not treated|0|||
126301154|NCT03926117|454390929|FG003|Overall Study|Randomized but not treated|1|||
126301155|NCT04526288|454390933|FG000|Overall Study|Disease Progression|1|||
126301156|NCT04526288|454390934|FG001|Overall Study|Disease Progression|0|||
126301157|NCT02684097|454390937|FG000|Overall Study|Lack of Efficacy|13|||
126301158|NCT02684097|454390938|FG001|Overall Study|Lack of Efficacy|6|||
126301159|NCT00460811|454390939|FG000|Overall Study|Adverse Event|4|||
126367424|NCT02471144|454640895|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367425|NCT02471144|454640896|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126770335|NCT01787188|456112458|FG002|Overall Study|Adverse Event|6|||
126301160|NCT00460811|454390940|FG001|Overall Study|Adverse Event|6|||
126301161|NCT00460811|454390941|FG002|Overall Study|Adverse Event|3|||
126301162|NCT00460811|454390942|FG003|Overall Study|Adverse Event|10|||
126301163|NCT00460811|454390943|FG004|Overall Study|Adverse Event|2|||
126301164|NCT00460811|454390939|FG000|Overall Study|Noncompliance|1|||
126301165|NCT00460811|454390940|FG001|Overall Study|Noncompliance|0|||
126301166|NCT00460811|454390941|FG002|Overall Study|Noncompliance|0|||
126301167|NCT00460811|454390942|FG003|Overall Study|Noncompliance|2|||
126301168|NCT00460811|454390943|FG004|Overall Study|Noncompliance|1|||
126301169|NCT00460811|454390939|FG000|Overall Study|Withdrawal by Subject|7|||
126301170|NCT00460811|454390940|FG001|Overall Study|Withdrawal by Subject|7|||
126301171|NCT00460811|454390941|FG002|Overall Study|Withdrawal by Subject|6|||
126461984|NCT03687970|454991574|FG000|Overall Study|visit scheduling conflicts|2|||
126461985|NCT03687970|454991575|FG001|Overall Study|visit scheduling conflicts|0|||
126461986|NCT02284178|454992940|FG000|Overall Study|Met exclusion criteria|49|||
126461987|NCT02284178|454992941|FG001|Overall Study|Met exclusion criteria|54|||
126461988|NCT04704154|454992954|FG000|Overall Study|Adverse Event|3|||
126461989|NCT04704154|454992955|FG001|Overall Study|Adverse Event|2|||
126461990|NCT04704154|454992956|FG002|Overall Study|Adverse Event|4|||
126461991|NCT04704154|454992957|FG003|Overall Study|Adverse Event|2|||
126461992|NCT04704154|454992958|FG004|Overall Study|Adverse Event|3|||
126461993|NCT04704154|454992959|FG005|Overall Study|Adverse Event|0|||
126461994|NCT04704154|454992954|FG000|Overall Study|Death|3|||
126461995|NCT04704154|454992955|FG001|Overall Study|Death|0|||
126461996|NCT04704154|454992956|FG002|Overall Study|Death|0|||
126461997|NCT04704154|454992957|FG003|Overall Study|Death|0|||
126461998|NCT04704154|454992958|FG004|Overall Study|Death|3|||
126461999|NCT04704154|454992959|FG005|Overall Study|Death|0|||
126462000|NCT04704154|454992954|FG000|Overall Study|Physician Decision|1|||
126462001|NCT04704154|454992955|FG001|Overall Study|Physician Decision|0|||
126462002|NCT04704154|454992956|FG002|Overall Study|Physician Decision|1|||
126462003|NCT04704154|454992957|FG003|Overall Study|Physician Decision|0|||
126462004|NCT04704154|454992958|FG004|Overall Study|Physician Decision|2|||
126462005|NCT04704154|454992959|FG005|Overall Study|Physician Decision|0|||
126462006|NCT04704154|454992954|FG000|Overall Study|Participant Decision|1|||
126462007|NCT04704154|454992955|FG001|Overall Study|Participant Decision|1|||
126462008|NCT04704154|454992956|FG002|Overall Study|Participant Decision|0|||
126712952|NCT03069690|455900416|FG003|Postpartum Intervention|Lost to Follow-up|5|||
126712953|NCT03069690|455900417|FG004|Postpartum Intervention|Lost to Follow-up|2|||
126712954|NCT03069690|455900418|FG005|Postpartum Intervention|Lost to Follow-up|4|||
126712955|NCT01372878|455900419|FG000|Overall Study|Withdrawal by Subject|63|||
126712956|NCT01372878|455900419|FG000|Overall Study|Protocol Violation|17|||
126712957|NCT01372878|455900419|FG000|Overall Study|incomplete study procedure|104|||
126712958|NCT04498910|455900420|FG000|Overall Study|Lost to Follow-up|0|||
126712959|NCT04498910|455900421|FG001|Overall Study|Lost to Follow-up|1|||
126301172|NCT00460811|454390942|FG003|Overall Study|Withdrawal by Subject|3|||
126301173|NCT00460811|454390943|FG004|Overall Study|Withdrawal by Subject|11|||
126301174|NCT00460811|454390939|FG000|Overall Study|Physician Decision|1|||
126367426|NCT02471144|454640897|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367427|NCT02471144|454640898|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367428|NCT02471144|454640899|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367429|NCT02471144|454640900|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367430|NCT02471144|454640901|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367431|NCT02471144|454640902|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367432|NCT02471144|454640903|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
126367433|NCT02471144|454640904|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
126367434|NCT02471144|454640894|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126462009|NCT04704154|454992957|FG003|Overall Study|Participant Decision|0|||
126712960|NCT04498910|455900420|FG000|Overall Study|Withdrawal by Subject|2|||
126712961|NCT04498910|455900421|FG001|Overall Study|Withdrawal by Subject|1|||
126712962|NCT04498910|455900420|FG000|Overall Study|Adverse Event|1|||
126712963|NCT04498910|455900421|FG001|Overall Study|Adverse Event|0|||
126712964|NCT01849848|455900422|FG000|Overall Study|Physician Decision|1|||
126712965|NCT01849848|455900422|FG000|Overall Study|Progression of the primary disease|3|||
126712966|NCT01070303|455900423|FG000|Overall Study|Adverse Event|39|||
126712967|NCT01070303|455900423|FG000|Overall Study|Withdrawal by Subject|20|||
126712968|NCT01070303|455900423|FG000|Overall Study|Lost to Follow-up|9|||
126712969|NCT01070303|455900423|FG000|Overall Study|Protocol Violation|0|||
126712970|NCT01070303|455900423|FG000|Overall Study|Lack of Efficacy|2|||
126712971|NCT01070303|455900423|FG000|Overall Study|Administrative Reason|1|||
126301175|NCT00460811|454390940|FG001|Overall Study|Physician Decision|0|||
126462010|NCT04704154|454992958|FG004|Overall Study|Participant Decision|0|||
126462011|NCT04704154|454992959|FG005|Overall Study|Participant Decision|0|||
126301176|NCT00460811|454390941|FG002|Overall Study|Physician Decision|0|||
126301177|NCT00460811|454390942|FG003|Overall Study|Physician Decision|0|||
126301178|NCT00460811|454390943|FG004|Overall Study|Physician Decision|0|||
126301179|NCT00460811|454390939|FG000|Overall Study|Lost to Follow-up|3|||
126301180|NCT00460811|454390940|FG001|Overall Study|Lost to Follow-up|2|||
126301181|NCT00460811|454390941|FG002|Overall Study|Lost to Follow-up|5|||
126301182|NCT00460811|454390942|FG003|Overall Study|Lost to Follow-up|3|||
126301183|NCT00460811|454390943|FG004|Overall Study|Lost to Follow-up|6|||
126301184|NCT02748356|454390944|FG000|Overall Study|Withdrawal by Subject|1|||
126301185|NCT00996125|454390945|FG000|Overall Study|Adverse Event|0|||
126301186|NCT00996125|454390946|FG001|Overall Study|Adverse Event|2|||
126301187|NCT00996125|454390945|FG000|Overall Study|Lost to Follow-up|1|||
126301188|NCT00996125|454390946|FG001|Overall Study|Lost to Follow-up|6|||
126301189|NCT00996125|454390945|FG000|Overall Study|Withdrawal by Subject|4|||
126301190|NCT00996125|454390946|FG001|Overall Study|Withdrawal by Subject|3|||
126301191|NCT03515811|454390948|FG000|Overall Study|Lost to Follow-up|2|||
126301192|NCT03515811|454390949|FG001|Overall Study|Lost to Follow-up|1|||
126301193|NCT03515811|454390948|FG000|Overall Study|Protocol Violation|1|||
126301194|NCT03515811|454390949|FG001|Overall Study|Protocol Violation|1|||
126301195|NCT03515811|454390948|FG000|Overall Study|Death|1|||
126301196|NCT03515811|454390949|FG001|Overall Study|Death|1|||
126301197|NCT03515811|454390948|FG000|Overall Study|Withdrawal by Subject|0|||
126301198|NCT03515811|454390949|FG001|Overall Study|Withdrawal by Subject|2|||
126301199|NCT03515811|454390948|FG000|Overall Study|Technical Problems|1|||
126301200|NCT03515811|454390949|FG001|Overall Study|Technical Problems|0|||
126301201|NCT03515811|454390948|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
126301202|NCT03515811|454390949|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
126301203|NCT03515811|454390948|FG000|Overall Study|COVID-19|0|||
126301204|NCT03515811|454390949|FG001|Overall Study|COVID-19|1|||
126301205|NCT00237458|454390950|FG000|Overall Study|Lack of Efficacy|1|||
126301206|NCT00237458|454390950|FG000|Overall Study|Adverse Event|1|||
126301207|NCT00237458|454390950|FG000|Overall Study|Withdrawal by Subject|1|||
126301208|NCT00952068|454390951|FG000|Overall Study|Adverse Event|3|||
126301209|NCT00952068|454390951|FG000|Overall Study|Withdrawal by Subject|4|||
126301210|NCT04331067|454390952|FG000|Overall Study|Adverse Event|1|||
126301211|NCT04331067|454390953|FG001|Overall Study|Adverse Event|3|||
126301212|NCT04331067|454390954|FG002|Overall Study|Adverse Event|1|||
126301213|NCT04331067|454390952|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
126301214|NCT04331067|454390953|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
126301215|NCT04331067|454390954|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
126301216|NCT04339062|454390955|FG000|Overall Study|Death|0|||
126301217|NCT04339062|454390956|FG001|Overall Study|Death|1|||
126301218|NCT05870371|454390957|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
126301219|NCT05870371|454390958|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
126301220|NCT00708461|454390962|FG000|Overall Study|Lost to Follow-up|18|||
126301221|NCT00708461|454390963|FG001|Overall Study|Lost to Follow-up|11|||
126301222|NCT00708461|454390962|FG000|Overall Study|Withdrawal by Subject|8|||
126301223|NCT00708461|454390963|FG001|Overall Study|Withdrawal by Subject|9|||
126301224|NCT00708461|454390962|FG000|Overall Study|left workforce|115|||
126301225|NCT00708461|454390963|FG001|Overall Study|left workforce|180|||
126301226|NCT01796392|454390968|FG000|Overall Study|Withdrawal by Subject|2|||
126301227|NCT01796392|454390969|FG001|Overall Study|Withdrawal by Subject|0|||
126301228|NCT01796392|454390968|FG000|Overall Study|Death|5|||
126301229|NCT01796392|454390969|FG001|Overall Study|Death|1|||
126301230|NCT01796392|454390968|FG000|Overall Study|Excluded for medical reasons|1|||
126301231|NCT01796392|454390969|FG001|Overall Study|Excluded for medical reasons|2|||
126550611|NCT00337662|455309604|FG001|Study Period III|Protocol Violation|8|||
126550612|NCT00337662|455309605|FG002|Study Period III|Protocol Violation|2|||
126550613|NCT00337662|455309606|FG003|Study Period III|Protocol Violation|0|||
126301232|NCT01796392|454390968|FG000|Overall Study|Lost to Follow-up|1|||
126301233|NCT01796392|454390969|FG001|Overall Study|Lost to Follow-up|0|||
126301234|NCT03517540|454390972|FG000|Overall Study|Protocol Violation|2|||
126301235|NCT03517540|454390973|FG001|Overall Study|Protocol Violation|0|||
126301236|NCT03517540|454390974|FG002|Overall Study|Protocol Violation|0|||
126301237|NCT03517540|454390975|FG003|Overall Study|Protocol Violation|1|||
126301238|NCT03517540|454390972|FG000|Overall Study|Adverse Event|9|||
126301239|NCT03517540|454390973|FG001|Overall Study|Adverse Event|3|||
126301240|NCT03517540|454390974|FG002|Overall Study|Adverse Event|8|||
126367435|NCT02471144|454640895|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126301241|NCT03517540|454390975|FG003|Overall Study|Adverse Event|1|||
126301242|NCT03517540|454390972|FG000|Overall Study|Withdrawal by Subject|3|||
126301243|NCT03517540|454390973|FG001|Overall Study|Withdrawal by Subject|4|||
126301244|NCT03517540|454390974|FG002|Overall Study|Withdrawal by Subject|1|||
126301245|NCT03517540|454390975|FG003|Overall Study|Withdrawal by Subject|3|||
126301246|NCT00523848|454390976|FG000|Overall Study|Adverse Event|11|||
126301247|NCT00523848|454390976|FG000|Overall Study|Withdrawal by Subject|2|||
126301248|NCT00523848|454390976|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
126301249|NCT00523848|454390976|FG000|Overall Study|Disease Progression|5|||
126301250|NCT00523848|454390976|FG000|Overall Study|Other, unspecified|4|||
126301251|NCT01777282|454390977|FG000|Overall Study|Persistent Hyperglycemia|0|||
126301252|NCT01777282|454390978|FG001|Overall Study|Persistent Hyperglycemia|0|||
126301253|NCT01777282|454390979|FG002|Overall Study|Persistent Hyperglycemia|1|||
126301254|NCT01777282|454390980|FG003|Overall Study|Persistent Hyperglycemia|0|||
126301255|NCT01777282|454390981|FG004|Overall Study|Persistent Hyperglycemia|0|||
126301256|NCT01777282|454390977|FG000|Overall Study|New Antidiabetic Medication|0|||
126301257|NCT01777282|454390978|FG001|Overall Study|New Antidiabetic Medication|0|||
126301258|NCT01777282|454390979|FG002|Overall Study|New Antidiabetic Medication|1|||
126301259|NCT01777282|454390980|FG003|Overall Study|New Antidiabetic Medication|0|||
126301260|NCT01777282|454390981|FG004|Overall Study|New Antidiabetic Medication|0|||
126301261|NCT01777282|454390977|FG000|Overall Study|Adverse Event|4|||
126301262|NCT01777282|454390978|FG001|Overall Study|Adverse Event|4|||
126301263|NCT01777282|454390979|FG002|Overall Study|Adverse Event|2|||
126462012|NCT04704154|454992954|FG000|Overall Study|Progressive Disease|19|||
126462013|NCT04704154|454992955|FG001|Overall Study|Progressive Disease|17|||
126462014|NCT04704154|454992956|FG002|Overall Study|Progressive Disease|20|||
126462015|NCT04704154|454992957|FG003|Overall Study|Progressive Disease|18|||
126462016|NCT04704154|454992958|FG004|Overall Study|Progressive Disease|36|||
126462017|NCT04704154|454992959|FG005|Overall Study|Progressive Disease|30|||
126462018|NCT04704154|454992954|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
126462019|NCT04704154|454992955|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
126462020|NCT04704154|454992956|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
126462021|NCT04704154|454992957|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
126462022|NCT04704154|454992958|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
126462023|NCT04704154|454992959|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
126462024|NCT04704154|454992954|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
126462025|NCT04704154|454992955|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
126462026|NCT04704154|454992956|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
126462027|NCT04704154|454992957|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
126462028|NCT04704154|454992958|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
126462029|NCT04704154|454992959|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
126462030|NCT04251156|454992960|FG000|Overall Study|Lost to Follow-up|1|||
126462031|NCT04251156|454992961|FG001|Overall Study|Lost to Follow-up|1|||
126462032|NCT04251156|454992960|FG000|Overall Study|Withdrawal by Subject|4|||
126462033|NCT04251156|454992961|FG001|Overall Study|Withdrawal by Subject|4|||
126462034|NCT01041495|454992962|FG000|Overall Study|Withdrawal by Subject|2|||
126462035|NCT01041495|454992963|FG001|Overall Study|Withdrawal by Subject|5|||
126462036|NCT01041495|454992962|FG000|Overall Study|Adverse Event|2|||
126462037|NCT01041495|454992963|FG001|Overall Study|Adverse Event|1|||
126462038|NCT01041495|454992962|FG000|Overall Study|Lost to Follow-up|0|||
126462039|NCT01041495|454992963|FG001|Overall Study|Lost to Follow-up|1|||
126462040|NCT03780400|454992967|FG000|Overall Study|Lost to Follow-up|5|||
126462041|NCT03780400|454992967|FG000|Overall Study|Withdrawal by Subject|2|||
126462042|NCT01479985|454992968|FG000|Overall Study|Tablet malfunction, no data saved|1|||
126462043|NCT01479985|454992969|FG001|Overall Study|Tablet malfunction, no data saved|1|||
126462044|NCT01479985|454992968|FG000|Overall Study|No decisional conflict scale responses|0|||
126462045|NCT01479985|454992969|FG001|Overall Study|No decisional conflict scale responses|2|||
126462046|NCT01479985|454992968|FG000|Overall Study|No post-visit survey|5|||
126462047|NCT01479985|454992969|FG001|Overall Study|No post-visit survey|3|||
126462048|NCT01653782|454992970|FG000|Overall Study|Withdrawal by Subject|9|||
126462049|NCT01653782|454992971|FG001|Overall Study|Withdrawal by Subject|15|||
126462050|NCT01653782|454992972|FG002|Overall Study|Withdrawal by Subject|4|||
126462051|NCT01653782|454992970|FG000|Overall Study|Lost to Follow-up|7|||
126462052|NCT01653782|454992971|FG001|Overall Study|Lost to Follow-up|3|||
126462053|NCT01653782|454992972|FG002|Overall Study|Lost to Follow-up|2|||
126462054|NCT01142128|454992973|FG000|Overall Study|Physician Decision|1|||
126462055|NCT01142128|454992973|FG000|Overall Study|Lost to Follow-up|1|||
126462056|NCT01142128|454992973|FG000|Overall Study|Withdrawal by Subject|2|||
126462057|NCT00442468|454992974|FG000|Overall Study|Adverse Event|4|||
126462058|NCT00442468|454992974|FG000|Overall Study|Withdrawal by Subject|91|||
126462059|NCT00442468|454992974|FG000|Overall Study|Did not complete all study procedures|88|||
126462060|NCT05867342|454992977|FG000|Overall Study|Investigator Decision|3|||
126462061|NCT05867342|454992978|FG001|Overall Study|Investigator Decision|3|||
126462062|NCT00470184|454992979|FG000|Overall Study|Not Treated(became ineligible)|4|||
126462063|NCT00470184|454992979|FG000|Overall Study|Not treated (other)|1|||
126462064|NCT00470184|454992979|FG000|Overall Study|disease Progression|4|||
126462065|NCT00470184|454992979|FG000|Overall Study|Adverse Event|3|||
126301264|NCT01777282|454390980|FG003|Overall Study|Adverse Event|1|||
126301265|NCT01777282|454390981|FG004|Overall Study|Adverse Event|3|||
126301266|NCT01777282|454390977|FG000|Overall Study|Withdrawal by Subject|4|||
126462066|NCT00470184|454992979|FG000|Overall Study|Withdrawal by Subject|4|||
126462067|NCT00470184|454992979|FG000|Overall Study|other|5|||
126462068|NCT00470184|454992979|FG000|Overall Study|recurrence|1|||
126367436|NCT02471144|454640896|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367437|NCT02471144|454640897|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367438|NCT02471144|454640898|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367439|NCT02471144|454640899|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367440|NCT02471144|454640900|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367441|NCT02471144|454640901|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367442|NCT02471144|454640902|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
126367443|NCT02471144|454640903|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
126367444|NCT02471144|454640904|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
126367445|NCT00003645|454640905|FG000|Overall Study|Death|4|||
126367446|NCT00003645|454640906|FG001|Overall Study|Death|1|||
126367447|NCT00003645|454640905|FG000|Overall Study|Lost to Follow-up|7|||
126367448|NCT00003645|454640906|FG001|Overall Study|Lost to Follow-up|8|||
126367449|NCT00003645|454640905|FG000|Overall Study|Withdrawal by Subject|1|||
126367450|NCT00003645|454640906|FG001|Overall Study|Withdrawal by Subject|3|||
126367451|NCT03768336|454640909|FG000|Overall Study|Lost to Follow-up|3|||
126367452|NCT03768336|454640910|FG001|Overall Study|Lost to Follow-up|2|||
126367453|NCT03768336|454640909|FG000|Overall Study|Became Ineligible|2|||
126367454|NCT03768336|454640910|FG001|Overall Study|Became Ineligible|0|||
126712972|NCT01070303|455900423|FG000|Overall Study|Other|18|||
126712973|NCT02345434|455900424|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
126712974|NCT02345434|455900425|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
126712975|NCT02926573|455900427|FG000|Overall Study|Nausea|1|||
126712976|NCT02926573|455900428|FG001|Overall Study|Nausea|0|||
126712977|NCT02926573|455900427|FG000|Overall Study|Remain intubated|2|||
126712978|NCT02926573|455900428|FG001|Overall Study|Remain intubated|2|||
126712979|NCT02926573|455900427|FG000|Overall Study|Change in surgery plan|3|||
126712980|NCT02926573|455900428|FG001|Overall Study|Change in surgery plan|1|||
126712981|NCT02926573|455900427|FG000|Overall Study|Change to outpatient status|5|||
126712982|NCT02926573|455900428|FG001|Overall Study|Change to outpatient status|1|||
126712983|NCT02926573|455900427|FG000|Overall Study|Withdrawal by Subject|0|||
126712984|NCT02926573|455900428|FG001|Overall Study|Withdrawal by Subject|2|||
126712985|NCT02926573|455900427|FG000|Overall Study|Return to operating room|0|||
126712986|NCT02926573|455900428|FG001|Overall Study|Return to operating room|2|||
126712987|NCT02926573|455900427|FG000|Overall Study|Delirium|0|||
126712988|NCT02926573|455900428|FG001|Overall Study|Delirium|1|||
126712989|NCT01302769|455900437|FG000|Overall Study|Lost to Follow-up|1|||
126712990|NCT01302769|455900438|FG001|Overall Study|Lost to Follow-up|1|||
126712991|NCT00394914|455900448|FG000|Treatment Period|Adverse Event|0|||
126712992|NCT00394914|455900449|FG001|Treatment Period|Adverse Event|3|||
126712993|NCT00394914|455900450|FG002|Treatment Period|Adverse Event|1|||
126712994|NCT00394914|455900448|FG000|Treatment Period|Lost to Follow-up|0|||
126712995|NCT00394914|455900449|FG001|Treatment Period|Lost to Follow-up|1|||
126712996|NCT00394914|455900450|FG002|Treatment Period|Lost to Follow-up|0|||
126712997|NCT00394914|455900448|FG000|Treatment Period|Withdrawal by Subject|0|||
126712998|NCT00394914|455900449|FG001|Treatment Period|Withdrawal by Subject|2|||
126712999|NCT00394914|455900450|FG002|Treatment Period|Withdrawal by Subject|2|||
126713000|NCT00394914|455900448|FG000|Treatment Period|Noncompliance with protocol|0|||
126713001|NCT00394914|455900449|FG001|Treatment Period|Noncompliance with protocol|3|||
126713002|NCT00394914|455900450|FG002|Treatment Period|Noncompliance with protocol|2|||
126713003|NCT00394914|455900448|FG000|Treatment Period|Did not meet protocol eligibility|0|||
126713004|NCT00394914|455900449|FG001|Treatment Period|Did not meet protocol eligibility|1|||
126713005|NCT00394914|455900450|FG002|Treatment Period|Did not meet protocol eligibility|1|||
126713006|NCT00312377|455900456|FG000|Overall Study|Death|403|||
126713007|NCT00312377|455900457|FG001|Overall Study|Death|418|||
126713008|NCT00312377|455900456|FG000|Overall Study|Withdrawal by Subject|23|||
126713009|NCT00312377|455900457|FG001|Overall Study|Withdrawal by Subject|30|||
126713010|NCT00312377|455900456|FG000|Overall Study|Lost to Follow-up|9|||
126713011|NCT00312377|455900457|FG001|Overall Study|Lost to Follow-up|12|||
126713012|NCT00312377|455900456|FG000|Overall Study|Non-compliance|0|||
126713013|NCT00312377|455900457|FG001|Overall Study|Non-compliance|2|||
126713014|NCT00312377|455900456|FG000|Overall Study|Randomised but never received treatment|6|||
126713015|NCT00312377|455900457|FG001|Overall Study|Randomised but never received treatment|6|||
126713016|NCT00312377|455900456|FG000|Overall Study|Discontinue treatment survival follow up|202|||
126713017|NCT00312377|455900457|FG001|Overall Study|Discontinue treatment survival follow up|200|||
126713018|NCT00312377|455900456|FG000|Overall Study|Site ended participation in study|1|||
126713019|NCT00312377|455900457|FG001|Overall Study|Site ended participation in study|0|||
126713020|NCT00872898|455900458|FG000|Part Two - Double Blind|Adverse Event|4|||
126713021|NCT00872898|455900459|FG001|Part Two - Double Blind|Adverse Event|3|||
126713022|NCT00872898|455900458|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
126713023|NCT00872898|455900459|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
126713024|NCT00872898|455900458|FG000|Part Two - Double Blind|Protocol Violation|1|||
126713025|NCT00872898|455900459|FG001|Part Two - Double Blind|Protocol Violation|0|||
126713026|NCT00872898|455900458|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
126367455|NCT03768336|454640909|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
126367456|NCT03768336|454640910|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
126367457|NCT03768336|454640909|FG000|Overall Study|Missed final survey (post-treatment|0|||
126367458|NCT03768336|454640910|FG001|Overall Study|Missed final survey (post-treatment|1|||
126367459|NCT03977155|454640911|FG000|Overall Study|Adverse Event|3|||
126367460|NCT03977155|454640912|FG001|Overall Study|Adverse Event|0|||
126367461|NCT03977155|454640913|FG002|Overall Study|Adverse Event|0|||
126367462|NCT03977155|454640911|FG000|Overall Study|Lost to Follow-up|0|||
126367463|NCT03977155|454640912|FG001|Overall Study|Lost to Follow-up|1|||
126367464|NCT03977155|454640913|FG002|Overall Study|Lost to Follow-up|0|||
126367465|NCT03977155|454640911|FG000|Overall Study|Withdrawal by Subject|1|||
126367466|NCT03977155|454640912|FG001|Overall Study|Withdrawal by Subject|1|||
126367467|NCT03977155|454640913|FG002|Overall Study|Withdrawal by Subject|2|||
126367468|NCT03977155|454640911|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
126367469|NCT03977155|454640912|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
126367470|NCT03977155|454640913|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
126367471|NCT03502681|454640916|FG000|Overall Study|Adverse Event|1|||
126367472|NCT03502681|454640917|FG001|Overall Study|Adverse Event|1|||
126462069|NCT03823378|454992980|FG000|Overall Study|Adverse Event|2|||
126462070|NCT03823378|454992981|FG001|Overall Study|Adverse Event|2|||
126462071|NCT03823378|454992982|FG002|Overall Study|Adverse Event|0|||
126462072|NCT03823378|454992983|FG003|Overall Study|Adverse Event|0|||
126462073|NCT03823378|454992984|FG004|Overall Study|Adverse Event|0|||
126462074|NCT03823378|454992985|FG005|Overall Study|Adverse Event|0|||
126462075|NCT03823378|454992980|FG000|Overall Study|Lost to Follow-up|0|||
126713027|NCT00872898|455900459|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
126713028|NCT00872898|455900458|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
126713029|NCT00872898|455900459|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
126713030|NCT00872898|455900458|FG000|Part Two - Double Blind|Other reasons|2|||
126713031|NCT00872898|455900459|FG001|Part Two - Double Blind|Other reasons|0|||
126713032|NCT01001494|455900474|FG000|Overall Study|Adverse Event|8|||
126713033|NCT01001494|455900475|FG001|Overall Study|Adverse Event|4|||
126713034|NCT01001494|455900476|FG002|Overall Study|Adverse Event|6|||
126713035|NCT01001494|455900474|FG000|Overall Study|Protocol Violation|0|||
126713036|NCT01001494|455900475|FG001|Overall Study|Protocol Violation|1|||
126713037|NCT01001494|455900476|FG002|Overall Study|Protocol Violation|1|||
126713038|NCT01001494|455900474|FG000|Overall Study|Lost to Follow-up|2|||
126713039|NCT01001494|455900475|FG001|Overall Study|Lost to Follow-up|0|||
126713040|NCT01001494|455900476|FG002|Overall Study|Lost to Follow-up|1|||
126713041|NCT01001494|455900474|FG000|Overall Study|Withdrawal by Subject|9|||
126713042|NCT01001494|455900475|FG001|Overall Study|Withdrawal by Subject|7|||
126713043|NCT01001494|455900476|FG002|Overall Study|Withdrawal by Subject|17|||
126713044|NCT01001494|455900474|FG000|Overall Study|COPD exacerbation|3|||
126713045|NCT01001494|455900475|FG001|Overall Study|COPD exacerbation|4|||
126713046|NCT01001494|455900476|FG002|Overall Study|COPD exacerbation|5|||
126713047|NCT01001494|455900474|FG000|Overall Study|Lack of Efficacy|2|||
126713048|NCT01001494|455900475|FG001|Overall Study|Lack of Efficacy|0|||
126713049|NCT01001494|455900476|FG002|Overall Study|Lack of Efficacy|8|||
126713050|NCT01001494|455900474|FG000|Overall Study|Other|0|||
126713051|NCT01001494|455900475|FG001|Overall Study|Other|1|||
126713052|NCT01001494|455900476|FG002|Overall Study|Other|3|||
126713053|NCT02179398|455900477|FG000|Overall Study|Lack of obligatory data|3|||
126713054|NCT02179398|455900478|FG001|Overall Study|Lack of obligatory data|3|||
126713055|NCT02179398|455900477|FG000|Overall Study|Lost to Follow-up|0|||
126713056|NCT02179398|455900478|FG001|Overall Study|Lost to Follow-up|1|||
126713057|NCT02519231|455900485|FG000|Overall Study|Lost to Follow-up|2|||
126713058|NCT02519231|455900486|FG001|Overall Study|Lost to Follow-up|5|||
126713059|NCT02519231|455900485|FG000|Overall Study|Withdrawal by Subject|0|||
126713060|NCT02519231|455900486|FG001|Overall Study|Withdrawal by Subject|1|||
126713061|NCT02124798|455900488|FG000|Overall Study|Adverse Event|3|||
126713062|NCT02124798|455900488|FG000|Overall Study|Lost to Follow-up|1|||
126713063|NCT02053246|455900492|FG000|Overall Study|Withdrawal by Subject|3|||
126713064|NCT02053246|455900492|FG000|Overall Study|Physician Decision|1|||
126713065|NCT02795156|455900493|FG000|Overall Study|Progressive Disease|22|||
126713066|NCT02795156|455900494|FG001|Overall Study|Progressive Disease|7|||
126713067|NCT02795156|455900495|FG002|Overall Study|Progressive Disease|34|||
126713068|NCT02795156|455900496|FG003|Overall Study|Progressive Disease|7|||
126713069|NCT02795156|455900493|FG000|Overall Study|Adverse Event|13|||
126713070|NCT02795156|455900494|FG001|Overall Study|Adverse Event|2|||
126713071|NCT02795156|455900495|FG002|Overall Study|Adverse Event|3|||
126713072|NCT02795156|455900496|FG003|Overall Study|Adverse Event|2|||
126713073|NCT02795156|455900493|FG000|Overall Study|Death|1|||
126713074|NCT02795156|455900494|FG001|Overall Study|Death|1|||
126713075|NCT02795156|455900495|FG002|Overall Study|Death|1|||
126713076|NCT02795156|455900496|FG003|Overall Study|Death|0|||
126713077|NCT02795156|455900493|FG000|Overall Study|Physician Decision|1|||
126713078|NCT02795156|455900494|FG001|Overall Study|Physician Decision|0|||
126713079|NCT02795156|455900495|FG002|Overall Study|Physician Decision|1|||
126713080|NCT02795156|455900496|FG003|Overall Study|Physician Decision|0|||
126301267|NCT01777282|454390978|FG001|Overall Study|Withdrawal by Subject|0|||
126301268|NCT01777282|454390979|FG002|Overall Study|Withdrawal by Subject|0|||
126301269|NCT01777282|454390980|FG003|Overall Study|Withdrawal by Subject|1|||
126301270|NCT01777282|454390981|FG004|Overall Study|Withdrawal by Subject|2|||
126301271|NCT01777282|454390977|FG000|Overall Study|Protocol Violation|2|||
126301272|NCT01777282|454390978|FG001|Overall Study|Protocol Violation|0|||
126301273|NCT01777282|454390979|FG002|Overall Study|Protocol Violation|1|||
126301274|NCT01777282|454390980|FG003|Overall Study|Protocol Violation|0|||
126301275|NCT01777282|454390981|FG004|Overall Study|Protocol Violation|2|||
126301276|NCT01777282|454390977|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
126301277|NCT01777282|454390978|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
126301278|NCT01777282|454390979|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
126301279|NCT01777282|454390980|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
126301280|NCT01777282|454390981|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
126301281|NCT01068678|454392566|FG000|Overall Study|Lack of Efficacy|3|||
126301282|NCT01068678|454392567|FG001|Overall Study|Lack of Efficacy|2|||
126301283|NCT01068678|454392566|FG000|Overall Study|Protocol Violation|5|||
126301284|NCT01068678|454392567|FG001|Overall Study|Protocol Violation|1|||
126301285|NCT01068678|454392566|FG000|Overall Study|Withdrawal criteria|12|||
126301286|NCT01068678|454392567|FG001|Overall Study|Withdrawal criteria|6|||
126301287|NCT01068678|454392566|FG000|Overall Study|Unclassified|18|||
126301288|NCT01068678|454392567|FG001|Overall Study|Unclassified|15|||
126301289|NCT03055338|454392568|FG000|Overall Study|Lost to Follow-up|9|||
126301290|NCT03055338|454392569|FG001|Overall Study|Lost to Follow-up|2|||
126301291|NCT03055338|454392570|FG002|Overall Study|Lost to Follow-up|3|||
126301292|NCT03055338|454392568|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
126301293|NCT03055338|454392569|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
126301294|NCT03055338|454392570|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
126301295|NCT03055338|454392568|FG000|Overall Study|Physician Decision|0|||
126301296|NCT03055338|454392569|FG001|Overall Study|Physician Decision|0|||
126301297|NCT03055338|454392570|FG002|Overall Study|Physician Decision|2|||
126301298|NCT03055338|454392568|FG000|Overall Study|Withdrawal by Subject|9|||
126301299|NCT03055338|454392569|FG001|Overall Study|Withdrawal by Subject|8|||
126301300|NCT03055338|454392570|FG002|Overall Study|Withdrawal by Subject|7|||
126301301|NCT00975611|454392571|FG000|Overall Study|Screen Fail|16|||
126301302|NCT00975611|454392571|FG000|Overall Study|Physician Decision|1|||
126301303|NCT03058705|454392572|FG000|Overall Study|Withdrawal by Subject|2|||
126301304|NCT03058705|454392572|FG000|Overall Study|Physician Decision|2|||
126301305|NCT01682226|454392573|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
126301306|NCT01682226|454392573|FG000|Overall Study|Participants did not receive treatment|2|||
126301307|NCT01682226|454392573|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
126301308|NCT02151851|454392574|FG000|Overall Study|Lack of Efficacy|67|||
126301309|NCT02151851|454392575|FG001|Overall Study|Lack of Efficacy|94|||
126301310|NCT02151851|454392574|FG000|Overall Study|Protocol Violation|0|||
126301311|NCT02151851|454392575|FG001|Overall Study|Protocol Violation|1|||
126301312|NCT02151851|454392574|FG000|Overall Study|Withdrawal by Subject|2|||
126301313|NCT02151851|454392575|FG001|Overall Study|Withdrawal by Subject|5|||
126301314|NCT02151851|454392574|FG000|Overall Study|Medical impairment|1|||
126301315|NCT02151851|454392575|FG001|Overall Study|Medical impairment|0|||
126301316|NCT02151851|454392574|FG000|Overall Study|Low compliance to study visits|0|||
126301317|NCT02151851|454392575|FG001|Overall Study|Low compliance to study visits|1|||
126301318|NCT02151851|454392574|FG000|Overall Study|Subject entered into study in error|0|||
126301319|NCT02151851|454392575|FG001|Overall Study|Subject entered into study in error|1|||
126301320|NCT02151851|454392574|FG000|Overall Study|Adverse Event|6|||
126301321|NCT02151851|454392575|FG001|Overall Study|Adverse Event|28|||
126301322|NCT02159053|454392576|FG000|Overall Study|Death|2|||
126301323|NCT02159053|454392577|FG001|Overall Study|Death|0|||
126301324|NCT02159053|454392578|FG002|Overall Study|Death|1|||
126301325|NCT02159053|454392576|FG000|Overall Study|Physician Decision|0|||
126301326|NCT02159053|454392577|FG001|Overall Study|Physician Decision|1|||
126301327|NCT02159053|454392578|FG002|Overall Study|Physician Decision|1|||
126301328|NCT02159053|454392576|FG000|Overall Study|Lack of Efficacy|3|||
126301329|NCT02159053|454392577|FG001|Overall Study|Lack of Efficacy|4|||
126301330|NCT02159053|454392578|FG002|Overall Study|Lack of Efficacy|7|||
126301331|NCT02159053|454392576|FG000|Overall Study|Adverse Event|7|||
126301332|NCT02159053|454392577|FG001|Overall Study|Adverse Event|6|||
126301333|NCT02159053|454392578|FG002|Overall Study|Adverse Event|5|||
126301334|NCT02159053|454392576|FG000|Overall Study|Participants/guardian decision|8|||
126301335|NCT02159053|454392577|FG001|Overall Study|Participants/guardian decision|10|||
126301336|NCT02159053|454392578|FG002|Overall Study|Participants/guardian decision|6|||
126301337|NCT01436370|454392586|FG000|Overall Study|Lost to Follow-up|0|||
126301338|NCT01436370|454392587|FG001|Overall Study|Lost to Follow-up|0|||
126301339|NCT01436370|454392588|FG002|Overall Study|Lost to Follow-up|0|||
126301340|NCT01436370|454392589|FG003|Overall Study|Lost to Follow-up|0|||
126301341|NCT01436370|454392590|FG004|Overall Study|Lost to Follow-up|1|||
126301342|NCT01436370|454392591|FG005|Overall Study|Lost to Follow-up|0|||
126301343|NCT01436370|454392592|FG006|Overall Study|Lost to Follow-up|0|||
126550614|NCT00337662|455309603|FG000|Study Period III|Physician Decision|6|||
126550615|NCT00337662|455309604|FG001|Study Period III|Physician Decision|5|||
126550616|NCT00337662|455309605|FG002|Study Period III|Physician Decision|0|||
126550617|NCT00337662|455309606|FG003|Study Period III|Physician Decision|0|||
126550618|NCT00337662|455309603|FG000|Study Period III|Entry Criteria Not Met|4|||
126550619|NCT00337662|455309604|FG001|Study Period III|Entry Criteria Not Met|1|||
126550620|NCT00337662|455309605|FG002|Study Period III|Entry Criteria Not Met|3|||
126550621|NCT00337662|455309606|FG003|Study Period III|Entry Criteria Not Met|0|||
126550622|NCT00337662|455309603|FG000|Study Period III|Lack of Efficacy|4|||
126550623|NCT00337662|455309604|FG001|Study Period III|Lack of Efficacy|4|||
126550624|NCT00337662|455309605|FG002|Study Period III|Lack of Efficacy|2|||
126550625|NCT00337662|455309606|FG003|Study Period III|Lack of Efficacy|0|||
126550626|NCT00337662|455309603|FG000|Study Period III|Parent/Caregiver Decision|0|||
126550627|NCT00337662|455309604|FG001|Study Period III|Parent/Caregiver Decision|0|||
126550628|NCT00337662|455309605|FG002|Study Period III|Parent/Caregiver Decision|2|||
126550629|NCT00337662|455309606|FG003|Study Period III|Parent/Caregiver Decision|0|||
126550630|NCT00337662|455309603|FG000|Study Period III|Sponsor Decision|1|||
126550631|NCT00337662|455309604|FG001|Study Period III|Sponsor Decision|0|||
126550632|NCT00337662|455309605|FG002|Study Period III|Sponsor Decision|1|||
126550633|NCT00337662|455309606|FG003|Study Period III|Sponsor Decision|0|||
126550634|NCT00337662|455309603|FG000|Study Period III|Clinical Relapse|1|||
126550635|NCT00337662|455309604|FG001|Study Period III|Clinical Relapse|0|||
126550636|NCT00337662|455309605|FG002|Study Period III|Clinical Relapse|0|||
126550637|NCT00337662|455309606|FG003|Study Period III|Clinical Relapse|0|||
126550638|NCT03691948|455309607|FG000|Overall Study|Lost to Follow-up|1|||
126301344|NCT01436370|454392593|FG007|Overall Study|Lost to Follow-up|0|||
126301345|NCT02395848|454392594|FG000|Overall Study|Lost to Follow-up|2|||
126301346|NCT02058537|454392595|FG000|Overall Study|Withdrawal by Subject|1|||
126301347|NCT02126579|454392596|FG000|Overall Study|disease progression|0|||
126301348|NCT02126579|454392597|FG001|Overall Study|disease progression|0|||
126301349|NCT02126579|454392598|FG002|Overall Study|disease progression|0|||
126301350|NCT02126579|454392599|FG003|Overall Study|disease progression|1|||
126301351|NCT02126579|454392600|FG004|Overall Study|disease progression|0|||
126301352|NCT02126579|454392601|FG005|Overall Study|disease progression|0|||
126301353|NCT02126579|454392602|FG006|Overall Study|disease progression|1|||
126301354|NCT01780038|454392606|FG000|Overall Study|Lost to Follow-up|4|||
126301355|NCT01780038|454392607|FG001|Overall Study|Lost to Follow-up|1|||
126301356|NCT01085630|454392608|FG000|Overall Study|Insufficient data|1|||
126301357|NCT01085630|454392609|FG001|Overall Study|Insufficient data|0|||
126301358|NCT01085630|454392608|FG000|Overall Study|Ineligible|3|||
126301359|NCT01085630|454392609|FG001|Overall Study|Ineligible|0|||
126301360|NCT02609607|454392615|FG000|Overall Study|Lost to Follow-up|0|||
126301361|NCT02609607|454392616|FG001|Overall Study|Lost to Follow-up|1|||
126301362|NCT03168711|454392619|FG000|Overall Study|Adverse Event|2|||
126301363|NCT03168711|454392620|FG001|Overall Study|Adverse Event|0|||
126301364|NCT03168711|454392619|FG000|Overall Study|Withdrawal by Subject|0|||
126301365|NCT03168711|454392620|FG001|Overall Study|Withdrawal by Subject|1|||
126301366|NCT03168711|454392619|FG000|Overall Study|Death|0|||
126301367|NCT03168711|454392620|FG001|Overall Study|Death|1|||
126301368|NCT00651261|454392621|FG000|Overall Study|Adverse Event|32|||
126301369|NCT00651261|454392622|FG001|Overall Study|Adverse Event|22|||
126301370|NCT00651261|454392621|FG000|Overall Study|Death|18|||
126301371|NCT00651261|454392622|FG001|Overall Study|Death|18|||
126301372|NCT00651261|454392621|FG000|Overall Study|Withdrawal by Subject|22|||
126301373|NCT00651261|454392622|FG001|Overall Study|Withdrawal by Subject|40|||
126301374|NCT00651261|454392621|FG000|Overall Study|Induction failure|24|||
126301375|NCT00651261|454392622|FG001|Overall Study|Induction failure|35|||
126301376|NCT00651261|454392621|FG000|Overall Study|Disease progression|58|||
126301377|NCT00651261|454392622|FG001|Overall Study|Disease progression|58|||
126301378|NCT00651261|454392621|FG000|Overall Study|Alternative therapy|109|||
126301379|NCT00651261|454392622|FG001|Overall Study|Alternative therapy|107|||
126301380|NCT00651261|454392621|FG000|Overall Study|Other disease or participant decisions|23|||
126367473|NCT03502681|454640916|FG000|Overall Study|Disease Progression|2|||
126550639|NCT03691948|455309608|FG001|Overall Study|Lost to Follow-up|3|||
126550640|NCT02344537|455309610|FG000|Overall Study|Protocol Violation|1|||
126550641|NCT02344537|455309611|FG001|Overall Study|Protocol Violation|1|||
126713081|NCT02795156|455900493|FG000|Overall Study|Withdrawal by Subject|2|||
126550642|NCT02344537|455309610|FG000|Overall Study|Subject started another treatment after wk 6|1|||
126550643|NCT02344537|455309611|FG001|Overall Study|Subject started another treatment after wk 6|0|||
126713082|NCT02795156|455900494|FG001|Overall Study|Withdrawal by Subject|0|||
126301381|NCT00651261|454392622|FG001|Overall Study|Other disease or participant decisions|23|||
126301382|NCT00651261|454392621|FG000|Overall Study|Never treated|5|||
126301383|NCT00651261|454392622|FG001|Overall Study|Never treated|3|||
126301384|NCT05483686|454392623|FG000|Overall Study|Lost to Follow-up|5|||
126301385|NCT05483686|454392624|FG001|Overall Study|Lost to Follow-up|7|||
126301386|NCT03351608|454392633|FG000|Overall Study|Lost to Follow-up|0|||
126301387|NCT03351608|454392634|FG001|Overall Study|Lost to Follow-up|1|||
126301388|NCT03351608|454392635|FG002|Overall Study|Lost to Follow-up|1|||
126301389|NCT03351608|454392636|FG003|Overall Study|Lost to Follow-up|1|||
126462076|NCT03823378|454992981|FG001|Overall Study|Lost to Follow-up|1|||
126462077|NCT03823378|454992982|FG002|Overall Study|Lost to Follow-up|0|||
126462078|NCT03823378|454992983|FG003|Overall Study|Lost to Follow-up|0|||
126462079|NCT03823378|454992984|FG004|Overall Study|Lost to Follow-up|1|||
126462080|NCT03823378|454992985|FG005|Overall Study|Lost to Follow-up|0|||
126462081|NCT03823378|454992980|FG000|Overall Study|Withdrawal by Subject|0|||
126462082|NCT03823378|454992981|FG001|Overall Study|Withdrawal by Subject|1|||
126462083|NCT03823378|454992982|FG002|Overall Study|Withdrawal by Subject|4|||
126462084|NCT03823378|454992983|FG003|Overall Study|Withdrawal by Subject|2|||
126462085|NCT03823378|454992984|FG004|Overall Study|Withdrawal by Subject|0|||
126462086|NCT03823378|454992985|FG005|Overall Study|Withdrawal by Subject|1|||
126713083|NCT02795156|455900495|FG002|Overall Study|Withdrawal by Subject|3|||
126301390|NCT03351608|454392637|FG004|Overall Study|Lost to Follow-up|1|||
126301391|NCT03351608|454392633|FG000|Overall Study|Physician Decision|1|||
126301392|NCT03351608|454392634|FG001|Overall Study|Physician Decision|0|||
126301393|NCT03351608|454392635|FG002|Overall Study|Physician Decision|0|||
126301394|NCT03351608|454392636|FG003|Overall Study|Physician Decision|2|||
126301395|NCT03351608|454392637|FG004|Overall Study|Physician Decision|1|||
126301396|NCT03351608|454392633|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
126301397|NCT03351608|454392634|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
126301398|NCT03351608|454392635|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
126301399|NCT03351608|454392636|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
126301400|NCT03351608|454392637|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
126301401|NCT03351608|454392633|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126301402|NCT03351608|454392634|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126301403|NCT03351608|454392635|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126301404|NCT03351608|454392636|FG003|Overall Study|Withdrawal by parent/guardian|1|||
126301405|NCT03351608|454392637|FG004|Overall Study|Withdrawal by parent/guardian|0|||
126301406|NCT03351608|454392633|FG000|Overall Study|Other|0|||
126301407|NCT03351608|454392634|FG001|Overall Study|Other|1|||
126301408|NCT03351608|454392635|FG002|Overall Study|Other|1|||
126301409|NCT03351608|454392636|FG003|Overall Study|Other|3|||
126301410|NCT03351608|454392637|FG004|Overall Study|Other|0|||
126301411|NCT02877004|454392638|FG000|Overall Study|Pregnancy|0|||
126301412|NCT02877004|454392639|FG001|Overall Study|Pregnancy|0|||
126301413|NCT02877004|454392640|FG002|Overall Study|Pregnancy|1|||
126301414|NCT02727478|454392641|FG000|Overall Study|Withdrawal by Subject|8|||
126301415|NCT02727478|454392642|FG001|Overall Study|Withdrawal by Subject|10|||
126301416|NCT02633293|454392643|FG000|Overall Study|Death|56|||
126301417|NCT02633293|454392643|FG000|Overall Study|Progressive Disease|12|||
126301418|NCT02633293|454392643|FG000|Overall Study|Adverse Event|29|||
126301419|NCT02633293|454392643|FG000|Overall Study|Withdrawal by Subject|41|||
126301420|NCT02633293|454392643|FG000|Overall Study|Protocol Violation|1|||
126301421|NCT02633293|454392643|FG000|Overall Study|Lost to Follow-up|1|||
126301422|NCT02633293|454392643|FG000|Overall Study|Study Terminated by Sponsor|24|||
126301423|NCT02633293|454392643|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
126301424|NCT02633293|454392643|FG000|Overall Study|Lung Transplant|5|||
126301425|NCT02633293|454392643|FG000|Overall Study|Lack of Efficacy|2|||
126301426|NCT02633293|454392643|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
126301427|NCT03877068|454392647|FG000|Overall Study|Physician Decision|9|||
126301428|NCT03877068|454392648|FG001|Overall Study|Physician Decision|3|||
126301429|NCT00778817|454392649|FG000|Overall Study|Adverse Event|2|||
126301430|NCT00778817|454392649|FG000|Overall Study|Withdrawal by Subject|2|||
126301431|NCT02356588|454392650|FG000|Overall Study|Lack of Efficacy|4|||
126301432|NCT02356588|454392651|FG001|Overall Study|Lack of Efficacy|10|||
126301433|NCT02356588|454392650|FG000|Overall Study|Adverse Event|0|||
126301434|NCT02356588|454392651|FG001|Overall Study|Adverse Event|2|||
126301435|NCT02356588|454392650|FG000|Overall Study|Withdrawal by Subject|1|||
126301436|NCT02356588|454392651|FG001|Overall Study|Withdrawal by Subject|0|||
126301437|NCT02356588|454392650|FG000|Overall Study|Protocol Violation|0|||
126301438|NCT02356588|454392651|FG001|Overall Study|Protocol Violation|1|||
126301439|NCT01418378|454392652|FG000|Overall Study|Death|1|||
126301440|NCT01418378|454392653|FG001|Overall Study|Death|2|||
126301441|NCT01418378|454392652|FG000|Overall Study|Physician Decision|0|||
126462087|NCT03823378|454992980|FG000|Overall Study|Other, not specified|19|||
126462088|NCT03823378|454992981|FG001|Overall Study|Other, not specified|12|||
126301442|NCT01418378|454392653|FG001|Overall Study|Physician Decision|1|||
126301443|NCT01418378|454392652|FG000|Overall Study|ligament imbalance|0|||
126301444|NCT01418378|454392653|FG001|Overall Study|ligament imbalance|1|||
126301445|NCT01418378|454392652|FG000|Overall Study|developed chronic myopathy|0|||
126301446|NCT01418378|454392653|FG001|Overall Study|developed chronic myopathy|1|||
126301447|NCT01081769|454392655|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
126301448|NCT01081769|454392656|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
126301449|NCT01081769|454392655|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
126301450|NCT01081769|454392656|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
126462089|NCT03823378|454992982|FG002|Overall Study|Other, not specified|6|||
126713084|NCT02795156|455900496|FG003|Overall Study|Withdrawal by Subject|0|||
126301451|NCT01081769|454392655|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
126301452|NCT01081769|454392656|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
126301453|NCT01081769|454392655|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
126301454|NCT01081769|454392656|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
126301455|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Adverse Event|14|||
126301456|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Adverse Event|11|||
126301457|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Death|1|||
126301458|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Death|1|||
126301459|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
126301460|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
126301461|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
126301462|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
126301463|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Pregnancy|1|||
126301464|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Pregnancy|0|||
126301465|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
126301466|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
126301467|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
126301468|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
126301469|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Other|0|||
126301470|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Other|1|||
126301471|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Ineligibility|3|||
126301472|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Ineligibility|4|||
126301473|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
126301474|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
126301475|NCT01081769|454392655|FG000|CORE Intent-To-Treat|Patient Moved|2|||
126301476|NCT01081769|454392656|FG001|CORE Intent-To-Treat|Patient Moved|2|||
126301477|NCT00507455|454392657|FG000|Overall Study|Adverse Event|3|||
126301478|NCT00507455|454392658|FG001|Overall Study|Adverse Event|3|||
126301479|NCT00507455|454392659|FG002|Overall Study|Adverse Event|6|||
126301480|NCT00507455|454392657|FG000|Overall Study|Withdrawal by Subject|2|||
126301481|NCT00507455|454392658|FG001|Overall Study|Withdrawal by Subject|1|||
126301482|NCT00507455|454392659|FG002|Overall Study|Withdrawal by Subject|2|||
126301483|NCT00507455|454392657|FG000|Overall Study|Protocol Violation|4|||
126301484|NCT00507455|454392658|FG001|Overall Study|Protocol Violation|1|||
126301485|NCT00507455|454392659|FG002|Overall Study|Protocol Violation|1|||
126301486|NCT00507455|454392657|FG000|Overall Study|Lost to Follow-up|2|||
126301487|NCT00507455|454392658|FG001|Overall Study|Lost to Follow-up|0|||
126301488|NCT00507455|454392659|FG002|Overall Study|Lost to Follow-up|2|||
126301489|NCT00507455|454392657|FG000|Overall Study|Lack of Efficacy|0|||
126301490|NCT00507455|454392658|FG001|Overall Study|Lack of Efficacy|1|||
126301491|NCT00507455|454392659|FG002|Overall Study|Lack of Efficacy|0|||
126301492|NCT00507455|454392657|FG000|Overall Study|Other - miscellaneous reason|1|||
126301493|NCT00507455|454392658|FG001|Overall Study|Other - miscellaneous reason|0|||
126301494|NCT00507455|454392659|FG002|Overall Study|Other - miscellaneous reason|1|||
126301495|NCT02019264|454392660|FG000|Overall Study|Not treated|6|||
126301496|NCT02019264|454392661|FG001|Overall Study|Not treated|4|||
126367474|NCT03502681|454640917|FG001|Overall Study|Disease Progression|1|||
126367475|NCT06790303|454640918|FG000|Overall Study|Study Terminated by sponsor|4|||
126367476|NCT06790303|454640918|FG000|Overall Study|Death|4|||
126367477|NCT02374255|454640927|FG000|Overall Study|Withdrawal by Subject|2|||
126367478|NCT02374255|454640928|FG001|Overall Study|Withdrawal by Subject|0|||
126367479|NCT02374255|454640929|FG002|Overall Study|Withdrawal by Subject|0|||
126367480|NCT02374255|454640930|FG003|Overall Study|Withdrawal by Subject|0|||
126367481|NCT02093520|454640931|FG000|Overall Study|Not treated|6|||
126367482|NCT02093520|454640932|FG001|Overall Study|Not treated|22|||
126367483|NCT03014089|454640933|FG000|Overall Study|Withdrawal by Subject|0|||
126367484|NCT03014089|454640934|FG001|Overall Study|Withdrawal by Subject|1|||
126367485|NCT03014089|454640935|FG002|Overall Study|Withdrawal by Subject|1|||
126367486|NCT03014089|454640936|FG003|Overall Study|Withdrawal by Subject|1|||
126367487|NCT03014089|454640933|FG000|Overall Study|Lost to Follow-up|1|||
126367488|NCT03014089|454640934|FG001|Overall Study|Lost to Follow-up|0|||
126367489|NCT03014089|454640935|FG002|Overall Study|Lost to Follow-up|0|||
126367490|NCT03014089|454640936|FG003|Overall Study|Lost to Follow-up|0|||
126367491|NCT03014089|454640933|FG000|Overall Study|Adverse Event|1|||
126367492|NCT03014089|454640934|FG001|Overall Study|Adverse Event|0|||
126367493|NCT03014089|454640935|FG002|Overall Study|Adverse Event|1|||
126367494|NCT03014089|454640936|FG003|Overall Study|Adverse Event|0|||
126367495|NCT00321932|454640937|FG000|Overall Study|Death|3|||
126367496|NCT00321932|454640938|FG001|Overall Study|Death|6|||
126367497|NCT00321932|454640937|FG000|Overall Study|Withdrawal by Subject|3|||
126301497|NCT02019264|454392660|FG000|Overall Study|Lost to Follow-up|50|||
126301498|NCT02019264|454392661|FG001|Overall Study|Lost to Follow-up|47|||
126367498|NCT00321932|454640938|FG001|Overall Study|Withdrawal by Subject|6|||
126367499|NCT00321932|454640937|FG000|Overall Study|Early relapse|2|||
126367500|NCT00321932|454640938|FG001|Overall Study|Early relapse|8|||
126367501|NCT00321932|454640937|FG000|Overall Study|Missing data|2|||
126367502|NCT00321932|454640938|FG001|Overall Study|Missing data|1|||
126367503|NCT03257657|454640940|FG000|Overall Study|Lost to Follow-up|0|||
126367504|NCT03257657|454640941|FG001|Overall Study|Lost to Follow-up|3|||
126367505|NCT03257657|454640940|FG000|Overall Study|Withdrawn|0|||
126367506|NCT03257657|454640941|FG001|Overall Study|Withdrawn|1|||
126367507|NCT03257657|454640940|FG000|Overall Study|Noted not eligible right after enrolled|0|||
126367508|NCT03257657|454640941|FG001|Overall Study|Noted not eligible right after enrolled|1|||
126367509|NCT01992757|454640956|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
126367510|NCT04992273|454640957|FG000|Overall Study|Lost to Follow-up|0|||
126367511|NCT04992273|454640958|FG001|Overall Study|Lost to Follow-up|1|||
126367512|NCT00688740|454640959|FG000|Overall Study|Adverse Event|45|||
126367513|NCT00688740|454640960|FG001|Overall Study|Adverse Event|8|||
126367514|NCT00688740|454640959|FG000|Overall Study|Death|2|||
126367515|NCT00688740|454640960|FG001|Overall Study|Death|2|||
126367516|NCT00688740|454640959|FG000|Overall Study|Lost to Follow-up|0|||
126367517|NCT00688740|454640960|FG001|Overall Study|Lost to Follow-up|1|||
126550644|NCT02344537|455309610|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
126550645|NCT02344537|455309611|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
126550646|NCT00960752|455309613|FG000|Overall Study|Adverse Event|0|||
126550647|NCT00960752|455309614|FG001|Overall Study|Adverse Event|0|||
126550648|NCT00960752|455309615|FG002|Overall Study|Adverse Event|1|||
126550649|NCT00960752|455309613|FG000|Overall Study|Progression|0|||
126550650|NCT00960752|455309614|FG001|Overall Study|Progression|0|||
126550651|NCT00960752|455309615|FG002|Overall Study|Progression|1|||
126550652|NCT02180438|455309621|FG000|Overall Study|Lost to Follow-up|1|||
126550653|NCT00180713|455309624|FG000|Overall Study|Withdrawal by Subject|2|||
126550654|NCT00180713|455309625|FG001|Overall Study|Withdrawal by Subject|0|||
126550655|NCT00180713|455309624|FG000|Overall Study|Adverse Event|3|||
126550656|NCT00180713|455309625|FG001|Overall Study|Adverse Event|3|||
126550657|NCT00514046|455309631|FG000|Overall Study|transferred to another protocol|2|||
126550658|NCT00514046|455309632|FG001|Overall Study|transferred to another protocol|1|||
126550659|NCT00514046|455309633|FG002|Overall Study|transferred to another protocol|3|||
126550660|NCT00514046|455309634|FG003|Overall Study|transferred to another protocol|0|||
126550661|NCT00514046|455309635|FG004|Overall Study|transferred to another protocol|1|||
126550662|NCT00514046|455309636|FG005|Overall Study|transferred to another protocol|0|||
126550663|NCT00514046|455309637|FG006|Overall Study|transferred to another protocol|0|||
126367518|NCT00688740|454640959|FG000|Overall Study|Consent Withdrawn|17|||
126367519|NCT00688740|454640960|FG001|Overall Study|Consent Withdrawn|17|||
126367520|NCT00688740|454640959|FG000|Overall Study|Breast Cancer Relapse|1|||
126367521|NCT00688740|454640960|FG001|Overall Study|Breast Cancer Relapse|4|||
126367522|NCT00688740|454640959|FG000|Overall Study|Violation of Inclusion Criteria|1|||
126367523|NCT00688740|454640960|FG001|Overall Study|Violation of Inclusion Criteria|3|||
126550664|NCT00514046|455309638|FG007|Overall Study|transferred to another protocol|0|||
126550665|NCT00514046|455309639|FG008|Overall Study|transferred to another protocol|0|||
126550666|NCT00514046|455309631|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
126550667|NCT00514046|455309632|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
126550668|NCT00514046|455309633|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
126550669|NCT00514046|455309634|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
126550670|NCT00514046|455309635|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
126367524|NCT00856557|454640963|FG000|Overall Study|No patients with contextual flags|12|||
126367525|NCT00856557|454640964|FG001|Overall Study|No patients with contextual flags|16|||
126367526|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
126367527|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
126367528|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
126367529|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
126367530|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
126367531|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
126367532|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
126367533|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
126367534|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
126367535|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
126367536|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
126367537|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
126367538|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
126367539|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
126367540|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
126367541|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
126367542|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
126367543|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
126367544|NCT01432444|454640965|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
126367545|NCT01432444|454640966|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
126550671|NCT00514046|455309636|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
126301499|NCT02019264|454392660|FG000|Overall Study|Withdrawal by Subject|142|||
126301500|NCT02019264|454392661|FG001|Overall Study|Withdrawal by Subject|117|||
126301501|NCT02019264|454392660|FG000|Overall Study|Administrative reason|36|||
126301502|NCT02019264|454392661|FG001|Overall Study|Administrative reason|28|||
126301503|NCT02019264|454392660|FG000|Overall Study|Missing|14|||
126301504|NCT02019264|454392661|FG001|Overall Study|Missing|11|||
126301505|NCT01964222|454392662|FG000|Overall Study|Lost to Follow-up|7|||
126301506|NCT01964222|454392663|FG001|Overall Study|Lost to Follow-up|5|||
126301507|NCT01964222|454392662|FG000|Overall Study|Withdrawal by Subject|6|||
126301508|NCT01964222|454392663|FG001|Overall Study|Withdrawal by Subject|6|||
126301509|NCT01964222|454392662|FG000|Overall Study|Screening Failure|2|||
126301510|NCT01964222|454392663|FG001|Overall Study|Screening Failure|0|||
126301511|NCT01737710|454392671|FG000|Overall Study|Lost to Follow-up|0|||
126301512|NCT01737710|454392672|FG001|Overall Study|Lost to Follow-up|2|||
126301513|NCT01737710|454392673|FG002|Overall Study|Lost to Follow-up|2|||
126301514|NCT01737710|454392674|FG003|Overall Study|Lost to Follow-up|0|||
126301515|NCT01737710|454392675|FG004|Overall Study|Lost to Follow-up|0|||
126301516|NCT01737710|454392671|FG000|Overall Study|Withdrawal by Subject|1|||
126301517|NCT01737710|454392672|FG001|Overall Study|Withdrawal by Subject|1|||
126301518|NCT01737710|454392673|FG002|Overall Study|Withdrawal by Subject|1|||
126301519|NCT01737710|454392674|FG003|Overall Study|Withdrawal by Subject|0|||
126301520|NCT01737710|454392675|FG004|Overall Study|Withdrawal by Subject|0|||
126301521|NCT01737710|454392671|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
126301522|NCT01737710|454392672|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
126301523|NCT01737710|454392673|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
126301524|NCT01737710|454392674|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
126301525|NCT01737710|454392675|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
126301526|NCT03363776|454392676|FG000|Overall Study|Progressive disease|2|||
126301527|NCT03363776|454392677|FG001|Overall Study|Progressive disease|3|||
126301528|NCT03363776|454392678|FG002|Overall Study|Progressive disease|1|||
126301529|NCT03363776|454392676|FG000|Overall Study|Study drug toxicity|0|||
126301530|NCT03363776|454392677|FG001|Overall Study|Study drug toxicity|0|||
126301531|NCT03363776|454392678|FG002|Overall Study|Study drug toxicity|1|||
126301532|NCT03363776|454392676|FG000|Overall Study|Death|1|||
126301533|NCT03363776|454392677|FG001|Overall Study|Death|0|||
126301534|NCT03363776|454392678|FG002|Overall Study|Death|0|||
126301535|NCT02097238|454392685|FG000|Overall Study|Death|1|||
126301536|NCT02097238|454392685|FG000|Overall Study|Physician Decision|1|||
126301537|NCT02097238|454392685|FG000|Overall Study|Progressive Disease|17|||
126301538|NCT01106911|454392686|FG000|Overall Study|Physician Decision|2|||
126301539|NCT01106911|454392686|FG000|Overall Study|deemed ineligible after screening|3|||
126301540|NCT01814696|454392688|FG000|Overall Study|Withdrawal by Subject|1|||
126301541|NCT01814696|454392689|FG001|Overall Study|Withdrawal by Subject|0|||
126301542|NCT01814696|454392688|FG000|Overall Study|Randomized to wrong group|1|||
126301543|NCT01814696|454392689|FG001|Overall Study|Randomized to wrong group|0|||
126301544|NCT02861807|454392690|FG000|Overall Study|Lost to Follow-up|7|||
126301545|NCT02861807|454392691|FG001|Overall Study|Lost to Follow-up|6|||
126301546|NCT02861807|454392690|FG000|Overall Study|Withdrawal by Subject|5|||
126301547|NCT02861807|454392691|FG001|Overall Study|Withdrawal by Subject|8|||
126301548|NCT00410813|454392692|FG000|Overall Study|Adverse Event|6|||
126301549|NCT00410813|454392693|FG001|Overall Study|Adverse Event|11|||
126301550|NCT00410813|454392692|FG000|Overall Study|Progression|32|||
126301551|NCT00410813|454392693|FG001|Overall Study|Progression|21|||
126301552|NCT00410813|454392692|FG000|Overall Study|Not protocol specified|3|||
126301553|NCT00410813|454392693|FG001|Overall Study|Not protocol specified|4|||
126301554|NCT00410813|454392692|FG000|Overall Study|Ineligible|2|||
126301555|NCT00410813|454392693|FG001|Overall Study|Ineligible|4|||
126301556|NCT00410813|454392692|FG000|Overall Study|Death|0|||
126301557|NCT00410813|454392693|FG001|Overall Study|Death|2|||
126301558|NCT00812981|454392694|FG000|Overall Study|Other|0|||
126301559|NCT00812981|454392695|FG001|Overall Study|Other|1|||
126301560|NCT02199795|454392696|FG000|Overall Study|no longer met inclusion criteria|1|||
126301561|NCT02199795|454392697|FG001|Overall Study|no longer met inclusion criteria|0|||
126301562|NCT02199795|454392696|FG000|Overall Study|withdrew due to shoulder pain|1|||
126301563|NCT02199795|454392697|FG001|Overall Study|withdrew due to shoulder pain|0|||
126301564|NCT02677922|454392702|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
126301565|NCT02677922|454392703|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
126301566|NCT02677922|454392704|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
126301567|NCT02677922|454392705|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
126301568|NCT02677922|454392706|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
126301569|NCT02677922|454392707|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
126301570|NCT02677922|454392702|FG000|Treatment Period|Adverse Event|0|||
126301571|NCT02677922|454392703|FG001|Treatment Period|Adverse Event|0|||
126301572|NCT02677922|454392704|FG002|Treatment Period|Adverse Event|1|||
126301573|NCT02677922|454392705|FG003|Treatment Period|Adverse Event|3|||
126301574|NCT02677922|454392706|FG004|Treatment Period|Adverse Event|5|||
126367546|NCT01432444|454640967|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
126770336|NCT01787188|456112456|FG000|Overall Study|Lack of Efficacy|7|||
126713085|NCT02707757|455900497|FG000|Overall Study|Protocol Violation|3|||
126713086|NCT02707757|455900498|FG001|Overall Study|Protocol Violation|2|||
126367547|NCT01432444|454640965|FG000|Treatment Phase|Lost to Follow-up|0|||
126367548|NCT01432444|454640966|FG001|Treatment Phase|Lost to Follow-up|33|||
126367549|NCT01432444|454640967|FG002|Treatment Phase|Lost to Follow-up|0|||
126367550|NCT01432444|454640965|FG000|Treatment Phase|Adverse Event|0|||
126367551|NCT01432444|454640966|FG001|Treatment Phase|Adverse Event|37|||
126367552|NCT01432444|454640967|FG002|Treatment Phase|Adverse Event|0|||
126713087|NCT02707757|455900497|FG000|Overall Study|Withdrawal by Subject|2|||
126367553|NCT01432444|454640965|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
126367554|NCT01432444|454640966|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
126367555|NCT01432444|454640967|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
126367556|NCT01432444|454640965|FG000|Treatment Phase|Physician Decision|0|||
126367557|NCT01432444|454640966|FG001|Treatment Phase|Physician Decision|5|||
126367558|NCT01432444|454640967|FG002|Treatment Phase|Physician Decision|0|||
126367559|NCT01432444|454640965|FG000|Treatment Phase|Withdrawal by Subject|0|||
126367560|NCT01432444|454640966|FG001|Treatment Phase|Withdrawal by Subject|41|||
126367561|NCT01432444|454640967|FG002|Treatment Phase|Withdrawal by Subject|0|||
126367562|NCT01432444|454640965|FG000|Treatment Phase|Protocol Deviation|0|||
126367563|NCT01432444|454640966|FG001|Treatment Phase|Protocol Deviation|3|||
126367564|NCT01432444|454640967|FG002|Treatment Phase|Protocol Deviation|0|||
126713088|NCT02707757|455900498|FG001|Overall Study|Withdrawal by Subject|0|||
126713089|NCT02707757|455900497|FG000|Overall Study|Death|0|||
126713090|NCT02707757|455900498|FG001|Overall Study|Death|1|||
126713091|NCT02707757|455900497|FG000|Overall Study|Adverse Event|6|||
126713092|NCT02707757|455900498|FG001|Overall Study|Adverse Event|4|||
126713093|NCT02707757|455900497|FG000|Overall Study|Renal transplant/elective operation|1|||
126713094|NCT02707757|455900498|FG001|Overall Study|Renal transplant/elective operation|5|||
126713095|NCT00815308|455900499|FG000|Overall Study|Adverse Event|4|||
126713096|NCT00815308|455900499|FG000|Overall Study|Withdrawal by Subject|0|||
126713097|NCT00815308|455900499|FG000|Overall Study|Protocol Violation|6|||
126713098|NCT00638846|455900503|FG000|Overall Study|Adverse Event|0|||
126713099|NCT00638846|455900504|FG001|Overall Study|Adverse Event|1|||
126713100|NCT00638846|455900503|FG000|Overall Study|Lost to Follow-up|3|||
126713101|NCT00638846|455900504|FG001|Overall Study|Lost to Follow-up|2|||
126713102|NCT00638846|455900503|FG000|Overall Study|lens issue|1|||
126713103|NCT00638846|455900504|FG001|Overall Study|lens issue|3|||
126713104|NCT02746679|455900505|FG000|Overall Study|Lost to Follow-up|4|||
126713105|NCT02746679|455900506|FG001|Overall Study|Lost to Follow-up|6|||
126713106|NCT00492921|455900507|FG000|Overall Study|Death|1|||
126713107|NCT00492921|455900508|FG001|Overall Study|Death|0|||
126713108|NCT00492921|455900509|FG002|Overall Study|Death|1|||
126713109|NCT00399802|455900510|FG000|Overall Study|Adverse Event|0|||
126713110|NCT00399802|455900511|FG001|Overall Study|Adverse Event|2|||
126713111|NCT00399802|455900510|FG000|Overall Study|Participant discontinued by mistake|0|||
126713112|NCT00399802|455900511|FG001|Overall Study|Participant discontinued by mistake|1|||
126713113|NCT02955186|455900512|FG000|Overall Study|Withdrawal by Subject|6|||
126713114|NCT02955186|455900513|FG001|Overall Study|Withdrawal by Subject|2|||
126713115|NCT02955186|455900512|FG000|Overall Study|Protocol Violation|1|||
126713116|NCT02955186|455900513|FG001|Overall Study|Protocol Violation|0|||
126713117|NCT00866294|455900514|FG000|Overall Study|Adverse Event|12|||
126713118|NCT00866294|455900515|FG001|Overall Study|Adverse Event|13|||
126713119|NCT00866294|455900516|FG002|Overall Study|Adverse Event|9|||
126713120|NCT00866294|455900514|FG000|Overall Study|Lack of Efficacy|7|||
126713121|NCT00866294|455900515|FG001|Overall Study|Lack of Efficacy|1|||
126713122|NCT00866294|455900516|FG002|Overall Study|Lack of Efficacy|0|||
126713123|NCT00866294|455900514|FG000|Overall Study|Protocol Violation|2|||
126713124|NCT00866294|455900515|FG001|Overall Study|Protocol Violation|0|||
126713125|NCT00866294|455900516|FG002|Overall Study|Protocol Violation|0|||
126713126|NCT00866294|455900514|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
126713127|NCT00866294|455900515|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126713128|NCT00866294|455900516|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126713129|NCT00866294|455900514|FG000|Overall Study|Lost to Follow-up|1|||
126713130|NCT00866294|455900515|FG001|Overall Study|Lost to Follow-up|3|||
126713131|NCT00866294|455900516|FG002|Overall Study|Lost to Follow-up|0|||
126713132|NCT00866294|455900514|FG000|Overall Study|Physician Decision|6|||
126713133|NCT00866294|455900515|FG001|Overall Study|Physician Decision|2|||
126367565|NCT01432444|454640965|FG000|Treatment Phase|Lack of Efficacy|0|||
126367566|NCT01432444|454640966|FG001|Treatment Phase|Lack of Efficacy|10|||
126462090|NCT03823378|454992983|FG003|Overall Study|Other, not specified|8|||
126713134|NCT00866294|455900516|FG002|Overall Study|Physician Decision|1|||
126713135|NCT03123939|455900517|FG000|Overall Study|Lack of Efficacy|6|||
126713136|NCT03123939|455900517|FG000|Overall Study|Death|5|||
126713137|NCT03123939|455900517|FG000|Overall Study|Physician Decision|2|||
126713138|NCT03123939|455900517|FG000|Overall Study|Subject/guardian decision|2|||
126713139|NCT03123939|455900517|FG000|Overall Study|Lost to Follow-up|1|||
126713140|NCT03123939|455900517|FG000|Overall Study|New therapy for study indication|1|||
126713141|NCT03123939|455900517|FG000|Overall Study|Protocol deviation|1|||
126713142|NCT03123939|455900517|FG000|Overall Study|Progressive disease|18|||
126550672|NCT00514046|455309637|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
126550673|NCT00514046|455309638|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
126550674|NCT00514046|455309639|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
126550675|NCT00514046|455309631|FG000|Overall Study|Disease progression on study|0|||
126550676|NCT00514046|455309632|FG001|Overall Study|Disease progression on study|0|||
126550677|NCT00514046|455309633|FG002|Overall Study|Disease progression on study|2|||
126550678|NCT00514046|455309634|FG003|Overall Study|Disease progression on study|0|||
126550679|NCT00514046|455309635|FG004|Overall Study|Disease progression on study|0|||
126550680|NCT00514046|455309636|FG005|Overall Study|Disease progression on study|1|||
126550681|NCT00514046|455309637|FG006|Overall Study|Disease progression on study|0|||
126550682|NCT00514046|455309638|FG007|Overall Study|Disease progression on study|0|||
126550683|NCT00514046|455309639|FG008|Overall Study|Disease progression on study|0|||
126550684|NCT00655551|455309640|FG000|All Periods Combined|Adverse Event|0|||
126550685|NCT00655551|455309641|FG001|All Periods Combined|Adverse Event|3|||
126550686|NCT00655551|455309642|FG002|All Periods Combined|Adverse Event|4|||
126550687|NCT00655551|455309640|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
126550688|NCT00655551|455309641|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
126550689|NCT00655551|455309642|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
126550690|NCT00655551|455309640|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
126550691|NCT00655551|455309641|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
126550692|NCT00655551|455309642|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
126550693|NCT00655551|455309640|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
126550694|NCT00655551|455309641|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
126550695|NCT00655551|455309642|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
126550696|NCT00876460|455309644|FG000|Combination Therapy Phase|Progressive disease|2|||
126550697|NCT00876460|455309645|FG001|Combination Therapy Phase|Progressive disease|3|||
126550698|NCT00876460|455309646|FG002|Combination Therapy Phase|Progressive disease|3|||
126550699|NCT00876460|455309647|FG003|Combination Therapy Phase|Progressive disease|3|||
126550700|NCT00876460|455309648|FG004|Combination Therapy Phase|Progressive disease|3|||
126550701|NCT00876460|455309649|FG005|Combination Therapy Phase|Progressive disease|1|||
126550702|NCT00876460|455309650|FG006|Combination Therapy Phase|Progressive disease|1|||
126550703|NCT00876460|455309651|FG007|Combination Therapy Phase|Progressive disease|1|||
126550704|NCT00876460|455309644|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
126550705|NCT00876460|455309645|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
126550706|NCT00876460|455309646|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
126550707|NCT00876460|455309647|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
126550708|NCT00876460|455309648|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
126462091|NCT03823378|454992984|FG004|Overall Study|Other, not specified|17|||
126462092|NCT03823378|454992985|FG005|Overall Study|Other, not specified|7|||
126462093|NCT05442775|454992986|FG000|Overall Study|Trial terminated|61|||
126462094|NCT05442775|454992986|FG000|Overall Study|Lack of Efficacy|4|||
126462095|NCT05442775|454992986|FG000|Overall Study|Withdrawal by Subject|4|||
126462096|NCT05442775|454992986|FG000|Overall Study|Death|1|||
126462097|NCT05442775|454992986|FG000|Overall Study|Participant removed at Sponsor request|1|||
126462098|NCT00058539|454992988|FG000|Overall Study|Disease progression|24|||
126462099|NCT00058539|454992988|FG000|Overall Study|Adverse Event|3|||
126713143|NCT03123939|455900517|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
126713144|NCT03123939|455900517|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
126713145|NCT01118143|455900518|FG000|Overall Study|Withdrawal by Subject|2|||
126713146|NCT01118143|455900519|FG001|Overall Study|Withdrawal by Subject|5|||
126462100|NCT00058539|454992988|FG000|Overall Study|Withdrawal by Subject|5|||
126713147|NCT02112448|455900520|FG000|Overall Study|lab values precluding use of ketorolac|2|||
126713148|NCT02112448|455900521|FG001|Overall Study|lab values precluding use of ketorolac|2|||
126713149|NCT02112448|455900520|FG000|Overall Study|Protocol Violation|1|||
126713150|NCT02112448|455900521|FG001|Overall Study|Protocol Violation|2|||
126713151|NCT02112448|455900520|FG000|Overall Study|Physician Decision|4|||
126713152|NCT02112448|455900521|FG001|Overall Study|Physician Decision|6|||
126713153|NCT02112448|455900520|FG000|Overall Study|required heparin so could not use ketoro|1|||
126462101|NCT00058539|454992988|FG000|Overall Study|Physician Decision|9|||
126550709|NCT00876460|455309649|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
126550710|NCT00876460|455309650|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
126550711|NCT00876460|455309651|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
126462102|NCT00058539|454992988|FG000|Overall Study|Death|1|||
126550712|NCT00876460|455309644|FG000|Combination Therapy Phase|Adverse Event|0|||
126550713|NCT00876460|455309645|FG001|Combination Therapy Phase|Adverse Event|2|||
126462103|NCT03190369|454992989|FG000|Overall Study|Poor compliance to protocol|0|||
126462104|NCT03190369|454992990|FG001|Overall Study|Poor compliance to protocol|1|||
126462105|NCT03190369|454992989|FG000|Overall Study|Withdraw before treatment|1|||
126462106|NCT03190369|454992990|FG001|Overall Study|Withdraw before treatment|5|||
126462107|NCT03190369|454992989|FG000|Overall Study|Randomized but not treated|0|||
126462108|NCT03190369|454992990|FG001|Overall Study|Randomized but not treated|2|||
126550714|NCT00876460|455309646|FG002|Combination Therapy Phase|Adverse Event|0|||
126550715|NCT00876460|455309647|FG003|Combination Therapy Phase|Adverse Event|2|||
126301575|NCT02677922|454392707|FG005|Treatment Period|Adverse Event|2|||
126301576|NCT02677922|454392702|FG000|Treatment Period|Progressive Disease|1|||
126301577|NCT02677922|454392703|FG001|Treatment Period|Progressive Disease|1|||
126301578|NCT02677922|454392704|FG002|Treatment Period|Progressive Disease|0|||
126301579|NCT02677922|454392705|FG003|Treatment Period|Progressive Disease|0|||
126301580|NCT02677922|454392706|FG004|Treatment Period|Progressive Disease|8|||
126301581|NCT02677922|454392707|FG005|Treatment Period|Progressive Disease|7|||
126301582|NCT02677922|454392702|FG000|Treatment Period|Lack of Efficacy|0|||
126301583|NCT02677922|454392703|FG001|Treatment Period|Lack of Efficacy|0|||
126301584|NCT02677922|454392704|FG002|Treatment Period|Lack of Efficacy|0|||
126301585|NCT02677922|454392705|FG003|Treatment Period|Lack of Efficacy|1|||
126301586|NCT02677922|454392706|FG004|Treatment Period|Lack of Efficacy|1|||
126301587|NCT02677922|454392707|FG005|Treatment Period|Lack of Efficacy|6|||
126301588|NCT02677922|454392702|FG000|Treatment Period|Withdrawal by Subject|0|||
126301589|NCT02677922|454392703|FG001|Treatment Period|Withdrawal by Subject|0|||
126301590|NCT02677922|454392704|FG002|Treatment Period|Withdrawal by Subject|1|||
126301591|NCT02677922|454392705|FG003|Treatment Period|Withdrawal by Subject|3|||
126301592|NCT02677922|454392706|FG004|Treatment Period|Withdrawal by Subject|5|||
126301593|NCT02677922|454392707|FG005|Treatment Period|Withdrawal by Subject|5|||
126301594|NCT02677922|454392702|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
126301595|NCT02677922|454392703|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
126301596|NCT02677922|454392704|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
126301597|NCT02677922|454392705|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
126301598|NCT02677922|454392706|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
126301599|NCT02677922|454392707|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
126301600|NCT02677922|454392702|FG000|Treatment Period|Disease Relapse|0|||
126301601|NCT02677922|454392703|FG001|Treatment Period|Disease Relapse|0|||
126301602|NCT02677922|454392704|FG002|Treatment Period|Disease Relapse|0|||
126301603|NCT02677922|454392705|FG003|Treatment Period|Disease Relapse|3|||
126301604|NCT02677922|454392706|FG004|Treatment Period|Disease Relapse|6|||
126301605|NCT02677922|454392707|FG005|Treatment Period|Disease Relapse|1|||
126301606|NCT02677922|454392702|FG000|Treatment Period|Allogeneic HSCT|1|||
126301607|NCT02677922|454392703|FG001|Treatment Period|Allogeneic HSCT|0|||
126301608|NCT02677922|454392704|FG002|Treatment Period|Allogeneic HSCT|0|||
126301609|NCT02677922|454392705|FG003|Treatment Period|Allogeneic HSCT|1|||
126301610|NCT02677922|454392706|FG004|Treatment Period|Allogeneic HSCT|4|||
126301611|NCT02677922|454392707|FG005|Treatment Period|Allogeneic HSCT|1|||
126301612|NCT02677922|454392702|FG000|Treatment Period|Other Reasons|0|||
126301613|NCT02677922|454392703|FG001|Treatment Period|Other Reasons|0|||
126301614|NCT02677922|454392704|FG002|Treatment Period|Other Reasons|0|||
126301615|NCT02677922|454392705|FG003|Treatment Period|Other Reasons|1|||
126301616|NCT02677922|454392706|FG004|Treatment Period|Other Reasons|3|||
126301617|NCT02677922|454392707|FG005|Treatment Period|Other Reasons|5|||
126301618|NCT02677922|454392702|FG000|Treatment Period|Death|0|||
126301619|NCT02677922|454392703|FG001|Treatment Period|Death|0|||
126301620|NCT02677922|454392704|FG002|Treatment Period|Death|0|||
126301621|NCT02677922|454392705|FG003|Treatment Period|Death|0|||
126301622|NCT02677922|454392706|FG004|Treatment Period|Death|12|||
126301623|NCT02677922|454392707|FG005|Treatment Period|Death|1|||
126301624|NCT02677922|454392702|FG000|Treatment Period|Non-compliance with Study Drug|0|||
126301625|NCT02677922|454392703|FG001|Treatment Period|Non-compliance with Study Drug|0|||
126301626|NCT02677922|454392704|FG002|Treatment Period|Non-compliance with Study Drug|0|||
126301627|NCT02677922|454392705|FG003|Treatment Period|Non-compliance with Study Drug|0|||
126301628|NCT02677922|454392706|FG004|Treatment Period|Non-compliance with Study Drug|1|||
126301629|NCT02677922|454392707|FG005|Treatment Period|Non-compliance with Study Drug|0|||
126301630|NCT02677922|454392702|FG000|Treatment Period|Physician Decision|0|||
126301631|NCT02677922|454392703|FG001|Treatment Period|Physician Decision|0|||
126301632|NCT02677922|454392704|FG002|Treatment Period|Physician Decision|0|||
126301633|NCT02677922|454392705|FG003|Treatment Period|Physician Decision|0|||
126301634|NCT02677922|454392706|FG004|Treatment Period|Physician Decision|0|||
126301635|NCT02677922|454392707|FG005|Treatment Period|Physician Decision|1|||
126301636|NCT02677922|454392702|FG000|Treatment Period|Symptomatic Deterioration|0|||
126301637|NCT02677922|454392703|FG001|Treatment Period|Symptomatic Deterioration|0|||
126301638|NCT02677922|454392704|FG002|Treatment Period|Symptomatic Deterioration|0|||
126301639|NCT02677922|454392705|FG003|Treatment Period|Symptomatic Deterioration|0|||
126301640|NCT02677922|454392706|FG004|Treatment Period|Symptomatic Deterioration|1|||
126301641|NCT02677922|454392707|FG005|Treatment Period|Symptomatic Deterioration|0|||
126301642|NCT05310071|454392708|FG000|Overall Study|Death|0|||
126301643|NCT05310071|454392709|FG001|Overall Study|Death|3|||
126301644|NCT05310071|454392708|FG000|Overall Study|Adverse Event|4|||
126301645|NCT05310071|454392709|FG001|Overall Study|Adverse Event|31|||
126301646|NCT05310071|454392708|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
126301647|NCT05310071|454392709|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
126301648|NCT05310071|454392708|FG000|Overall Study|Protocol Deviation|2|||
126301649|NCT05310071|454392709|FG001|Overall Study|Protocol Deviation|0|||
126301650|NCT05310071|454392708|FG000|Overall Study|Randomized by Mistake|0|||
126301651|NCT05310071|454392709|FG001|Overall Study|Randomized by Mistake|1|||
126301652|NCT05310071|454392708|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
126301653|NCT05310071|454392709|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
126301654|NCT05310071|454392708|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
126301655|NCT05310071|454392709|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
126301656|NCT05310071|454392708|FG000|Overall Study|Site Terminated by Sponsor|0|||
126301657|NCT05310071|454392709|FG001|Overall Study|Site Terminated by Sponsor|2|||
126301658|NCT05310071|454392708|FG000|Overall Study|Study Terminated by Sponsor|282|||
126301659|NCT05310071|454392709|FG001|Overall Study|Study Terminated by Sponsor|559|||
126301660|NCT05310071|454392708|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
126301661|NCT05310071|454392709|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
126301662|NCT05310071|454392708|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
126301663|NCT05310071|454392709|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
126301664|NCT05310071|454392708|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
126301665|NCT05310071|454392709|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
126301666|NCT05310071|454392708|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
126301667|NCT05310071|454392709|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
126301668|NCT05310071|454392708|FG000|Overall Study|Withdrawal by Participant - Other|25|||
126301669|NCT05310071|454392709|FG001|Overall Study|Withdrawal by Participant - Other|30|||
126301670|NCT05310071|454392708|FG000|Overall Study|Lost to Follow-up|2|||
126301671|NCT05310071|454392709|FG001|Overall Study|Lost to Follow-up|4|||
126301672|NCT05310071|454392708|FG000|Overall Study|Reason Not Specified|1|||
126301673|NCT05310071|454392709|FG001|Overall Study|Reason Not Specified|3|||
126301674|NCT02203721|454392715|FG000|Overall Study|Lost to Follow-up|1|||
126301675|NCT02203721|454392716|FG001|Overall Study|Lost to Follow-up|0|||
126301676|NCT02203721|454392715|FG000|Overall Study|Death|0|||
126301677|NCT02203721|454392716|FG001|Overall Study|Death|2|||
126301678|NCT02203721|454392715|FG000|Overall Study|Illness|0|||
126301679|NCT02203721|454392716|FG001|Overall Study|Illness|1|||
126301680|NCT02630251|454392717|FG000|Overall Study|Physician Decision|0|||
126301681|NCT02630251|454392718|FG001|Overall Study|Physician Decision|0|||
126301682|NCT02630251|454392719|FG002|Overall Study|Physician Decision|1|||
126301683|NCT02630251|454392720|FG003|Overall Study|Physician Decision|0|||
126301684|NCT00961350|454392721|FG000|Overall Study|Adverse Event|18|||
126301685|NCT00961350|454392722|FG001|Overall Study|Adverse Event|33|||
126301686|NCT00961350|454392721|FG000|Overall Study|Withdrawal by Subject|10|||
126301687|NCT00961350|454392722|FG001|Overall Study|Withdrawal by Subject|10|||
126301688|NCT00961350|454392721|FG000|Overall Study|Lost to Follow-up|3|||
126301689|NCT00961350|454392722|FG001|Overall Study|Lost to Follow-up|3|||
126301690|NCT00961350|454392721|FG000|Overall Study|Misc|16|||
126301691|NCT00961350|454392722|FG001|Overall Study|Misc|21|||
126301692|NCT02134015|454392723|FG000|Overall Study|Protocol Violation|0|||
126301693|NCT02134015|454392724|FG001|Overall Study|Protocol Violation|1|||
126301694|NCT02134015|454392723|FG000|Overall Study|Death|2|||
126301695|NCT02134015|454392724|FG001|Overall Study|Death|1|||
126301696|NCT02134015|454392723|FG000|Overall Study|Reason not provided|1|||
126301697|NCT02134015|454392724|FG001|Overall Study|Reason not provided|2|||
126301698|NCT02134015|454392723|FG000|Overall Study|Clinical progression|14|||
126301699|NCT02134015|454392724|FG001|Overall Study|Clinical progression|7|||
126301700|NCT02134015|454392723|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
126301701|NCT02134015|454392724|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
126301702|NCT02134015|454392723|FG000|Overall Study|Study terminated by sponsor|2|||
126301703|NCT02134015|454392724|FG001|Overall Study|Study terminated by sponsor|3|||
126301704|NCT02134015|454392723|FG000|Overall Study|Adverse Event|9|||
126301705|NCT02134015|454392724|FG001|Overall Study|Adverse Event|10|||
126301706|NCT02134015|454392723|FG000|Overall Study|Withdrawal by Subject|3|||
126301707|NCT02134015|454392724|FG001|Overall Study|Withdrawal by Subject|7|||
126301708|NCT03668119|454394757|FG000|Pre-treatment|Disease Progression|1|||
126301709|NCT03668119|454394758|FG001|Pre-treatment|Disease Progression|0|||
126301710|NCT03668119|454394757|FG000|Treatment|Disease Progression|76|||
126367567|NCT01432444|454640967|FG002|Treatment Phase|Lack of Efficacy|0|||
126367568|NCT01432444|454640965|FG000|Extension Phase|Lost to Follow-up|0|||
126367569|NCT01432444|454640966|FG001|Extension Phase|Lost to Follow-up|0|||
126367570|NCT01432444|454640967|FG002|Extension Phase|Lost to Follow-up|17|||
126367571|NCT01432444|454640965|FG000|Extension Phase|Adverse Event|0|||
126367572|NCT01432444|454640966|FG001|Extension Phase|Adverse Event|0|||
126367573|NCT01432444|454640967|FG002|Extension Phase|Adverse Event|10|||
126367574|NCT01432444|454640965|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
126301711|NCT03668119|454394758|FG001|Treatment|Disease Progression|57|||
126301712|NCT03668119|454394757|FG000|Treatment|Study drug toxicity|19|||
126301713|NCT03668119|454394758|FG001|Treatment|Study drug toxicity|1|||
126301714|NCT03668119|454394757|FG000|Treatment|Death|3|||
126301715|NCT03668119|454394758|FG001|Treatment|Death|0|||
126301716|NCT03668119|454394757|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
126462109|NCT02963831|454992991|FG000|Overall Study|Progressive Disease|3|||
126301717|NCT03668119|454394758|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
126301718|NCT03668119|454394757|FG000|Treatment|Withdrawal by Subject|1|||
126301719|NCT03668119|454394758|FG001|Treatment|Withdrawal by Subject|1|||
126301720|NCT03668119|454394757|FG000|Treatment|Participant request to discontinue study treatment|3|||
126301721|NCT03668119|454394758|FG001|Treatment|Participant request to discontinue study treatment|1|||
126301722|NCT03668119|454394757|FG000|Treatment|Maximum Clinical Benefit|0|||
126301723|NCT03668119|454394758|FG001|Treatment|Maximum Clinical Benefit|1|||
126301724|NCT03668119|454394757|FG000|Treatment|Participants completed treatment|27|||
126301725|NCT03668119|454394758|FG001|Treatment|Participants completed treatment|11|||
126301726|NCT03668119|454394757|FG000|Treatment|Other reasons|2|||
126301727|NCT03668119|454394758|FG001|Treatment|Other reasons|1|||
126301728|NCT05336227|454394759|FG000|Overall Study|Adverse Event|1|||
126301729|NCT05336227|454394760|FG001|Overall Study|Adverse Event|0|||
126301730|NCT05336227|454394759|FG000|Overall Study|Lost to Follow-up|2|||
126301731|NCT05336227|454394760|FG001|Overall Study|Lost to Follow-up|0|||
126301732|NCT05336227|454394759|FG000|Overall Study|Withdrawal by Subject|1|||
126301733|NCT05336227|454394760|FG001|Overall Study|Withdrawal by Subject|0|||
126301734|NCT00347958|454394763|FG000|Overall Study|Adverse Event|1|||
126301735|NCT00347958|454394763|FG000|Overall Study|Protocol Violation|2|||
126301736|NCT00347958|454394763|FG000|Overall Study|Withdrawal by Subject|1|||
126301737|NCT00754234|454394764|FG000|Overall Study|Withdrawal by Subject|3|||
126301738|NCT00326716|454394765|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
126301739|NCT00326716|454394766|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
126301740|NCT00326716|454394767|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
126301741|NCT00326716|454394768|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
126301742|NCT00684411|454394769|FG000|Overall Study|New Primary Cancer|1|||
126301743|NCT00684411|454394769|FG000|Overall Study|Disease Progression|10|||
126301744|NCT00684411|454394769|FG000|Overall Study|Adverse Event|1|||
126301745|NCT05253573|454394770|FG000|Overall Study|Death|1|||
126301746|NCT05253573|454394771|FG001|Overall Study|Death|0|||
126301747|NCT02276560|454394772|FG000|Overall Study|Adverse Event|1|||
126301748|NCT02276560|454394773|FG001|Overall Study|Adverse Event|0|||
126301749|NCT02276560|454394774|FG002|Overall Study|Adverse Event|0|||
126301750|NCT00687271|454394775|FG000|Overall Study|Adverse Event|1|||
126301751|NCT00687271|454394776|FG001|Overall Study|Adverse Event|3|||
126301752|NCT00687271|454394777|FG002|Overall Study|Adverse Event|1|||
126301753|NCT00687271|454394778|FG003|Overall Study|Adverse Event|0|||
126301754|NCT00687271|454394775|FG000|Overall Study|Lost to Follow-up|0|||
126301755|NCT00687271|454394776|FG001|Overall Study|Lost to Follow-up|1|||
126301756|NCT00687271|454394777|FG002|Overall Study|Lost to Follow-up|0|||
126301757|NCT00687271|454394778|FG003|Overall Study|Lost to Follow-up|0|||
126301758|NCT00687271|454394775|FG000|Overall Study|Protocol Violation|2|||
126301759|NCT00687271|454394776|FG001|Overall Study|Protocol Violation|1|||
126301760|NCT00687271|454394777|FG002|Overall Study|Protocol Violation|1|||
126301761|NCT00687271|454394778|FG003|Overall Study|Protocol Violation|0|||
126301762|NCT00687271|454394775|FG000|Overall Study|Withdrawal by Subject|0|||
126301763|NCT00687271|454394776|FG001|Overall Study|Withdrawal by Subject|1|||
126301764|NCT00687271|454394777|FG002|Overall Study|Withdrawal by Subject|3|||
126301765|NCT00687271|454394778|FG003|Overall Study|Withdrawal by Subject|0|||
126301766|NCT03850496|454394785|FG000|Overall Study|Withdrawal by Subject|1|||
126301767|NCT03850496|454394786|FG001|Overall Study|Withdrawal by Subject|0|||
126301768|NCT03850496|454394787|FG002|Overall Study|Withdrawal by Subject|0|||
126301769|NCT03850496|454394785|FG000|Overall Study|Lost to Follow-up|0|||
126301770|NCT03850496|454394786|FG001|Overall Study|Lost to Follow-up|1|||
126301771|NCT03850496|454394787|FG002|Overall Study|Lost to Follow-up|4|||
126301772|NCT03777436|454394788|FG000|Placebo-controlled Phase|Adverse Event|8|||
126301773|NCT03777436|454394789|FG001|Placebo-controlled Phase|Adverse Event|10|||
126301774|NCT03777436|454394790|FG002|Placebo-controlled Phase|Adverse Event|0|||
126301775|NCT03777436|454394788|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
126301776|NCT03777436|454394789|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
126301777|NCT03777436|454394790|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
126301778|NCT03777436|454394788|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
126301779|NCT03777436|454394789|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
126301780|NCT03777436|454394790|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
126301781|NCT03777436|454394788|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
126301782|NCT03777436|454394789|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
126301783|NCT03777436|454394790|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
126301784|NCT03777436|454394788|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
126301785|NCT03777436|454394789|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
126301786|NCT03777436|454394790|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
126301787|NCT03777436|454394788|FG000|Placebo-controlled Phase|Physician Decision|0|||
126301788|NCT03777436|454394789|FG001|Placebo-controlled Phase|Physician Decision|1|||
126301789|NCT03777436|454394790|FG002|Placebo-controlled Phase|Physician Decision|0|||
126301790|NCT03777436|454394788|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
126462110|NCT02963831|454992992|FG001|Overall Study|Progressive Disease|3|||
126301791|NCT03777436|454394789|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
126301792|NCT03777436|454394790|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
126301793|NCT03777436|454394788|FG000|Apremilast Extension Phase|Adverse Event|0|||
126301794|NCT03777436|454394789|FG001|Apremilast Extension Phase|Adverse Event|0|||
126301795|NCT03777436|454394790|FG002|Apremilast Extension Phase|Adverse Event|6|||
126301796|NCT03777436|454394788|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
126301797|NCT03777436|454394789|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
126301798|NCT03777436|454394790|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
126301799|NCT03777436|454394788|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
126301800|NCT03777436|454394789|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
126301801|NCT03777436|454394790|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
126301802|NCT03777436|454394788|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
126301803|NCT03777436|454394789|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
126301804|NCT03777436|454394790|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
126301805|NCT03777436|454394788|FG000|Apremilast Extension Phase|Miscellaneous|0|||
126301806|NCT03777436|454394789|FG001|Apremilast Extension Phase|Miscellaneous|0|||
126301807|NCT03777436|454394790|FG002|Apremilast Extension Phase|Miscellaneous|1|||
126301808|NCT00869999|454394793|FG000|Overall Study|Withdrawal by Subject|1|||
126301809|NCT00869999|454394793|FG000|Overall Study|removed prior to starting therapy|1|||
126301810|NCT04478695|454394794|FG000|Overall Study|Death|1|||
126301811|NCT04478695|454394795|FG001|Overall Study|Death|0|||
126301812|NCT00644917|454394796|FG000|Overall Study|Withdrawal by Subject|2|||
126301813|NCT00758485|454394797|FG000|Overall Study|Lost to Follow-up|0|||
126301814|NCT00758485|454394798|FG001|Overall Study|Lost to Follow-up|1|||
126301815|NCT00758485|454394797|FG000|Overall Study|Not Treated|1|||
126301816|NCT00758485|454394798|FG001|Overall Study|Not Treated|2|||
126301817|NCT02347774|454394799|FG000|Study Participation|Lost to Follow-up|3|||
126301818|NCT02347774|454394800|FG001|Study Participation|Lost to Follow-up|6|||
126301819|NCT02347774|454394801|FG002|Study Participation|Lost to Follow-up|2|||
126301820|NCT02347774|454394799|FG000|Study Participation|Withdrawal by Subject|8|||
126301821|NCT02347774|454394800|FG001|Study Participation|Withdrawal by Subject|9|||
126301822|NCT02347774|454394801|FG002|Study Participation|Withdrawal by Subject|15|||
126301823|NCT02347774|454394799|FG000|Study Participation|Adverse Event|1|||
126301824|NCT02347774|454394800|FG001|Study Participation|Adverse Event|4|||
126301825|NCT02347774|454394801|FG002|Study Participation|Adverse Event|6|||
126301826|NCT02347774|454394799|FG000|Study Participation|withdrew consent|1|||
126301827|NCT02347774|454394800|FG001|Study Participation|withdrew consent|1|||
126301828|NCT02347774|454394801|FG002|Study Participation|withdrew consent|1|||
126301829|NCT02347774|454394799|FG000|Study Participation|Met Prolonged QT criteria|1|||
126301830|NCT02347774|454394800|FG001|Study Participation|Met Prolonged QT criteria|0|||
126301831|NCT02347774|454394801|FG002|Study Participation|Met Prolonged QT criteria|0|||
126301832|NCT02347774|454394799|FG000|Study Participation|non-compliance with study drug|0|||
126301833|NCT02347774|454394800|FG001|Study Participation|non-compliance with study drug|1|||
126301834|NCT02347774|454394801|FG002|Study Participation|non-compliance with study drug|0|||
126301835|NCT02347774|454394799|FG000|Study Participation|incarceration|1|||
126301836|NCT02347774|454394800|FG001|Study Participation|incarceration|0|||
126301837|NCT02347774|454394801|FG002|Study Participation|incarceration|0|||
126301838|NCT02347774|454394799|FG000|Study Participation|randomized in error|0|||
126301839|NCT02347774|454394800|FG001|Study Participation|randomized in error|0|||
126301840|NCT02347774|454394801|FG002|Study Participation|randomized in error|1|||
126301841|NCT02347774|454394799|FG000|On Study Treatment|Adverse Event|9|||
126301842|NCT02347774|454394800|FG001|On Study Treatment|Adverse Event|15|||
126301843|NCT02347774|454394801|FG002|On Study Treatment|Adverse Event|19|||
126301844|NCT02347774|454394799|FG000|On Study Treatment|Lack of Efficacy|3|||
126301845|NCT02347774|454394800|FG001|On Study Treatment|Lack of Efficacy|0|||
126301846|NCT02347774|454394801|FG002|On Study Treatment|Lack of Efficacy|2|||
126301847|NCT02347774|454394799|FG000|On Study Treatment|non-complicance with study medication|0|||
126301848|NCT02347774|454394800|FG001|On Study Treatment|non-complicance with study medication|2|||
126301849|NCT02347774|454394801|FG002|On Study Treatment|non-complicance with study medication|0|||
126301850|NCT02347774|454394799|FG000|On Study Treatment|Protocol Violation|0|||
126301851|NCT02347774|454394800|FG001|On Study Treatment|Protocol Violation|0|||
126301852|NCT02347774|454394801|FG002|On Study Treatment|Protocol Violation|1|||
126301853|NCT02347774|454394799|FG000|On Study Treatment|withdrew consent|9|||
126301854|NCT02347774|454394800|FG001|On Study Treatment|withdrew consent|8|||
126301855|NCT02347774|454394801|FG002|On Study Treatment|withdrew consent|12|||
126301856|NCT02347774|454394799|FG000|On Study Treatment|Lost to Follow-up|2|||
126301857|NCT02347774|454394800|FG001|On Study Treatment|Lost to Follow-up|6|||
126301858|NCT02347774|454394801|FG002|On Study Treatment|Lost to Follow-up|1|||
126301859|NCT02347774|454394799|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
126301860|NCT02347774|454394800|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
126301861|NCT02347774|454394801|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
126301862|NCT02347774|454394799|FG000|On Study Treatment|ranomized in error|0|||
126301863|NCT02347774|454394800|FG001|On Study Treatment|ranomized in error|0|||
126301864|NCT02347774|454394801|FG002|On Study Treatment|ranomized in error|1|||
126550716|NCT00876460|455309648|FG004|Combination Therapy Phase|Adverse Event|2|||
126550717|NCT00876460|455309649|FG005|Combination Therapy Phase|Adverse Event|0|||
126550718|NCT00876460|455309650|FG006|Combination Therapy Phase|Adverse Event|3|||
126550719|NCT00876460|455309651|FG007|Combination Therapy Phase|Adverse Event|2|||
126550720|NCT00876460|455309644|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
126550721|NCT00876460|455309645|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
126550722|NCT00876460|455309646|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
126550723|NCT00876460|455309647|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
126550724|NCT00876460|455309648|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
126550725|NCT00876460|455309649|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
126550726|NCT00876460|455309650|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
126713154|NCT02112448|455900521|FG001|Overall Study|required heparin so could not use ketoro|0|||
126367575|NCT01432444|454640966|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
126367576|NCT01432444|454640967|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
126367577|NCT01432444|454640965|FG000|Extension Phase|Met Withdrawal Criteria|0|||
126367578|NCT01432444|454640966|FG001|Extension Phase|Met Withdrawal Criteria|0|||
126367579|NCT01432444|454640967|FG002|Extension Phase|Met Withdrawal Criteria|144|||
126367580|NCT01432444|454640965|FG000|Extension Phase|Physician Decision|0|||
126367581|NCT01432444|454640966|FG001|Extension Phase|Physician Decision|0|||
126713155|NCT01937130|455902002|FG000|Overall Study|Withdrawal by Subject|0|||
126713156|NCT01937130|455902003|FG001|Overall Study|Withdrawal by Subject|0|||
126301865|NCT00921557|454394802|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
126301866|NCT00921557|454394803|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
126301867|NCT00921557|454394804|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
126301868|NCT00921557|454394802|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
126301869|NCT00921557|454394803|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
126301870|NCT00921557|454394804|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
126301871|NCT00921557|454394802|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
126301872|NCT00921557|454394803|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
126301873|NCT00921557|454394804|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
126301874|NCT00921557|454394802|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
126301875|NCT00921557|454394803|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
126301876|NCT00921557|454394804|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
126301877|NCT00921557|454394802|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
126301878|NCT00921557|454394803|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
126301879|NCT00921557|454394804|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
126301880|NCT00656292|454394805|FG000|Overall Study|Withdrawal by Subject|2|||
126301881|NCT00656292|454394806|FG001|Overall Study|Withdrawal by Subject|3|||
126301882|NCT00656292|454394805|FG000|Overall Study|Screen failure|1|||
126301883|NCT00656292|454394806|FG001|Overall Study|Screen failure|2|||
126301884|NCT01431716|454394814|FG000|Overall Study|Withdrawal of consent|1|||
126301885|NCT00954941|454394815|FG000|Overall Study|Received treatment at home|1|||
126301886|NCT00954941|454394816|FG001|Overall Study|Received treatment at home|0|||
126367582|NCT01432444|454640967|FG002|Extension Phase|Physician Decision|1|||
126367583|NCT01432444|454640965|FG000|Extension Phase|Withdrawal by Subject|0|||
126367584|NCT01432444|454640966|FG001|Extension Phase|Withdrawal by Subject|0|||
126367585|NCT01432444|454640967|FG002|Extension Phase|Withdrawal by Subject|13|||
126713157|NCT01937130|455902004|FG002|Overall Study|Withdrawal by Subject|0|||
126713158|NCT01937130|455902005|FG003|Overall Study|Withdrawal by Subject|1|||
126713159|NCT01937130|455902002|FG000|Overall Study|Adverse Event|0|||
126713160|NCT01937130|455902003|FG001|Overall Study|Adverse Event|1|||
126713161|NCT01937130|455902004|FG002|Overall Study|Adverse Event|0|||
126713162|NCT01937130|455902005|FG003|Overall Study|Adverse Event|1|||
126713163|NCT01937130|455902002|FG000|Overall Study|Death|1|||
126713164|NCT01937130|455902003|FG001|Overall Study|Death|1|||
126713165|NCT01937130|455902004|FG002|Overall Study|Death|1|||
126713166|NCT01937130|455902005|FG003|Overall Study|Death|0|||
126713167|NCT01937130|455902002|FG000|Overall Study|Lost to Follow-up|2|||
126713168|NCT01937130|455902003|FG001|Overall Study|Lost to Follow-up|0|||
126713169|NCT01937130|455902004|FG002|Overall Study|Lost to Follow-up|2|||
126713170|NCT01937130|455902005|FG003|Overall Study|Lost to Follow-up|0|||
126713171|NCT01937130|455902002|FG000|Overall Study|Physician Decision|0|||
126713172|NCT01937130|455902003|FG001|Overall Study|Physician Decision|1|||
126301887|NCT00954941|454394815|FG000|Overall Study|Withdrawal by Subject|1|||
126301888|NCT00954941|454394816|FG001|Overall Study|Withdrawal by Subject|0|||
126367586|NCT02301897|454640968|FG000|Treatment Course 1|Non-Compliance|0|||
126713173|NCT01937130|455902004|FG002|Overall Study|Physician Decision|0|||
126713174|NCT01937130|455902005|FG003|Overall Study|Physician Decision|0|||
126713175|NCT01937130|455902002|FG000|Overall Study|Patients unable to swallow|0|||
126713176|NCT01937130|455902003|FG001|Overall Study|Patients unable to swallow|1|||
126301889|NCT00954941|454394815|FG000|Overall Study|Insurance Denial|2|||
126367587|NCT02301897|454640969|FG001|Treatment Course 1|Non-Compliance|0|||
126550727|NCT00876460|455309651|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
126713177|NCT01937130|455902004|FG002|Overall Study|Patients unable to swallow|0|||
126713178|NCT01937130|455902005|FG003|Overall Study|Patients unable to swallow|0|||
126713179|NCT01937130|455902002|FG000|Overall Study|Patient lost to FU due to death|2|||
126713180|NCT01937130|455902003|FG001|Overall Study|Patient lost to FU due to death|0|||
126462111|NCT02963831|454992993|FG002|Overall Study|Progressive Disease|16|||
126462112|NCT02963831|454992994|FG003|Overall Study|Progressive Disease|27|||
126462113|NCT02963831|454992991|FG000|Overall Study|Withdrawal by Subject|1|||
126462114|NCT02963831|454992992|FG001|Overall Study|Withdrawal by Subject|0|||
126301890|NCT00954941|454394816|FG001|Overall Study|Insurance Denial|2|||
126301891|NCT00954941|454394815|FG000|Overall Study|Physician Decision|2|||
126301892|NCT00954941|454394816|FG001|Overall Study|Physician Decision|2|||
126301893|NCT00954941|454394815|FG000|Overall Study|Ineligible|2|||
126301894|NCT00954941|454394816|FG001|Overall Study|Ineligible|2|||
126301895|NCT00954941|454394815|FG000|Overall Study|Adverse Event|0|||
126301896|NCT00954941|454394816|FG001|Overall Study|Adverse Event|1|||
126301897|NCT05027451|454394817|FG000|Overall Study|Lost to Follow-up|1|||
126301898|NCT05027451|454394818|FG001|Overall Study|Lost to Follow-up|1|||
126301899|NCT02097745|454394835|FG000|Overall Study|Adverse Event|25|||
126301900|NCT02097745|454394835|FG000|Overall Study|Death|16|||
126301901|NCT02097745|454394835|FG000|Overall Study|Failure to Return|14|||
126301902|NCT02097745|454394835|FG000|Overall Study|Administrative/Other|27|||
126301903|NCT02097745|454394835|FG000|Overall Study|Reason Not Specified|96|||
126301904|NCT00425750|454394836|FG000|Overall Study|Death|1|||
126301905|NCT00425750|454394836|FG000|Overall Study|Withdrawal by Subject|3|||
126301906|NCT00425750|454394836|FG000|Overall Study|Adverse Event|3|||
126301907|NCT00425750|454394836|FG000|Overall Study|Progression of disease|18|||
126301908|NCT01757184|454394841|FG000|Double-blind Period|Adverse Event|1|||
126301909|NCT01757184|454394842|FG001|Double-blind Period|Adverse Event|0|||
126301910|NCT01757184|454394843|FG002|Double-blind Period|Adverse Event|0|||
126301911|NCT01757184|454394844|FG003|Double-blind Period|Adverse Event|0|||
126301912|NCT01757184|454394841|FG000|Open-label Period|Lost to Follow-up|0|||
126301913|NCT01757184|454394842|FG001|Open-label Period|Lost to Follow-up|0|||
126301914|NCT01757184|454394843|FG002|Open-label Period|Lost to Follow-up|2|||
126301915|NCT01757184|454394844|FG003|Open-label Period|Lost to Follow-up|0|||
126301916|NCT01757184|454394841|FG000|Open-label Period|Withdrawal by Subject|0|||
126301917|NCT01757184|454394842|FG001|Open-label Period|Withdrawal by Subject|0|||
126301918|NCT01757184|454394843|FG002|Open-label Period|Withdrawal by Subject|1|||
126301919|NCT01757184|454394844|FG003|Open-label Period|Withdrawal by Subject|1|||
126301920|NCT01757184|454394841|FG000|Open-label Period|Discontinued by Sponsor|0|||
126301921|NCT01757184|454394842|FG001|Open-label Period|Discontinued by Sponsor|0|||
126301922|NCT01757184|454394843|FG002|Open-label Period|Discontinued by Sponsor|1|||
126301923|NCT01757184|454394844|FG003|Open-label Period|Discontinued by Sponsor|2|||
126301924|NCT00488644|454394845|FG000|Overall Study|Not Eligible|1|||
126301925|NCT00488644|454394845|FG000|Overall Study|Not Evaluable|1|||
126301926|NCT02977572|454394846|FG000|Overall Study|Exclusion criterion|2|||
126301927|NCT02977572|454394847|FG001|Overall Study|Exclusion criterion|2|||
126301928|NCT05107492|454394848|FG000|Overall Study|Lost to Follow-up|1|||
126301929|NCT05107492|454394849|FG001|Overall Study|Lost to Follow-up|0|||
126301930|NCT01197534|454394851|FG000|Overall Study|Not reported|16|||
126301931|NCT01197534|454394852|FG001|Overall Study|Not reported|10|||
126301932|NCT01197534|454394853|FG002|Overall Study|Not reported|16|||
126301933|NCT01197534|454394851|FG000|Overall Study|Enrolment in long term extension|57|||
126462115|NCT02963831|454992993|FG002|Overall Study|Withdrawal by Subject|2|||
126462116|NCT02963831|454992994|FG003|Overall Study|Withdrawal by Subject|4|||
126462117|NCT02963831|454992991|FG000|Overall Study|Adverse Event|0|||
126462118|NCT02963831|454992992|FG001|Overall Study|Adverse Event|1|||
126301934|NCT01197534|454394852|FG001|Overall Study|Enrolment in long term extension|66|||
126301935|NCT01197534|454394853|FG002|Overall Study|Enrolment in long term extension|119|||
126301936|NCT01197534|454394851|FG000|Overall Study|Severe non-compliance to protocol|3|||
126301937|NCT01197534|454394852|FG001|Overall Study|Severe non-compliance to protocol|4|||
126301938|NCT01197534|454394853|FG002|Overall Study|Severe non-compliance to protocol|1|||
126301939|NCT01197534|454394851|FG000|Overall Study|Lack of therapeutic response|9|||
126301940|NCT01197534|454394852|FG001|Overall Study|Lack of therapeutic response|4|||
126301941|NCT01197534|454394853|FG002|Overall Study|Lack of therapeutic response|9|||
126301942|NCT01197534|454394851|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
126301943|NCT01197534|454394852|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
126301944|NCT01197534|454394853|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
126301945|NCT01197534|454394851|FG000|Overall Study|Lost to Follow-up|1|||
126301946|NCT01197534|454394852|FG001|Overall Study|Lost to Follow-up|4|||
126301947|NCT01197534|454394853|FG002|Overall Study|Lost to Follow-up|2|||
126301948|NCT01197534|454394851|FG000|Overall Study|Adverse Event|35|||
126301949|NCT01197534|454394852|FG001|Overall Study|Adverse Event|36|||
126301950|NCT01197534|454394853|FG002|Overall Study|Adverse Event|24|||
126301951|NCT02589639|454394864|FG000|Overall Study|Lost to Follow-up|1|||
126462119|NCT02963831|454992993|FG002|Overall Study|Adverse Event|1|||
126462120|NCT02963831|454992994|FG003|Overall Study|Adverse Event|2|||
126462121|NCT02963831|454992991|FG000|Overall Study|Death|0|||
126713181|NCT01937130|455902004|FG002|Overall Study|Patient lost to FU due to death|0|||
126301952|NCT02589639|454394865|FG001|Overall Study|Lost to Follow-up|0|||
126301953|NCT02589639|454394866|FG002|Overall Study|Lost to Follow-up|0|||
126301954|NCT02589639|454394864|FG000|Overall Study|Protocol Violation|1|||
126301955|NCT02589639|454394865|FG001|Overall Study|Protocol Violation|0|||
126301956|NCT02589639|454394866|FG002|Overall Study|Protocol Violation|0|||
126301957|NCT02589639|454394864|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
126301958|NCT02589639|454394865|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
126301959|NCT02589639|454394866|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
126301960|NCT02589639|454394864|FG000|Overall Study|Adverse Event|4|||
126301961|NCT02589639|454394865|FG001|Overall Study|Adverse Event|5|||
126301962|NCT02589639|454394866|FG002|Overall Study|Adverse Event|3|||
126301963|NCT02589639|454394864|FG000|Overall Study|Other reason than specified above|1|||
126301964|NCT02589639|454394865|FG001|Overall Study|Other reason than specified above|2|||
126301965|NCT02589639|454394866|FG002|Overall Study|Other reason than specified above|1|||
126301966|NCT02589639|454394864|FG000|Overall Study|Not Treated|0|||
126301967|NCT02589639|454394865|FG001|Overall Study|Not Treated|3|||
126301968|NCT02589639|454394866|FG002|Overall Study|Not Treated|0|||
126301969|NCT01276756|454394867|FG000|Overall Study|Lost to Follow-up|2|||
126301970|NCT01276756|454394868|FG001|Overall Study|Lost to Follow-up|0|||
126301971|NCT01276756|454394867|FG000|Overall Study|Adverse Event|3|||
126301972|NCT01276756|454394868|FG001|Overall Study|Adverse Event|2|||
126301973|NCT02593097|454394878|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
126301974|NCT02593097|454394879|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
126301975|NCT02593097|454394878|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
126301976|NCT02593097|454394879|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
126301977|NCT02593097|454394878|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
126301978|NCT02593097|454394879|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
126301979|NCT02593097|454394878|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
126301980|NCT02593097|454394879|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
126301981|NCT02593097|454394878|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
126301982|NCT02593097|454394879|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
126301983|NCT00703157|454394880|FG000|Overall Study|Lost to Follow-up|0|||
126301984|NCT00703157|454394881|FG001|Overall Study|Lost to Follow-up|1|||
126301985|NCT00703157|454394880|FG000|Overall Study|source data permanently lost/ other|4|||
126301986|NCT00703157|454394881|FG001|Overall Study|source data permanently lost/ other|1|||
126301987|NCT02522884|454394882|FG000|Overall Study|Withdrawal by Subject|6|||
126301988|NCT02522884|454394882|FG000|Overall Study|Death|3|||
126301989|NCT02522884|454394882|FG000|Overall Study|Missed 12-month Follow-up|9|||
126301990|NCT02968173|454394883|FG000|Overall Study|Withdrawal by Subject|1|||
126301991|NCT02670525|454394884|FG000|Overall Study|Death|94|||
126301992|NCT02670525|454394885|FG001|Overall Study|Death|14|||
126301993|NCT02670525|454394884|FG000|Overall Study|Lost to Follow-up|4|||
126301994|NCT02670525|454394885|FG001|Overall Study|Lost to Follow-up|1|||
126301995|NCT02670525|454394884|FG000|Overall Study|Subject withdrew consent|1|||
126301996|NCT02670525|454394885|FG001|Overall Study|Subject withdrew consent|0|||
126301997|NCT02670525|454394884|FG000|Overall Study|Unknown, data entry delayed|123|||
126301998|NCT02670525|454394885|FG001|Overall Study|Unknown, data entry delayed|78|||
126301999|NCT00591565|454394886|FG000|Overall Study|lost follow up, withdrawn|5|||
126302000|NCT03564119|454394890|FG000|Overall Study|Adverse Event|4|||
126302001|NCT03564119|454394891|FG001|Overall Study|Adverse Event|0|||
126302002|NCT03564119|454394890|FG000|Overall Study|Lost to Follow-up|1|||
126302003|NCT03564119|454394891|FG001|Overall Study|Lost to Follow-up|4|||
126302004|NCT03564119|454394890|FG000|Overall Study|Protocol Violation|1|||
126302005|NCT03564119|454394891|FG001|Overall Study|Protocol Violation|0|||
126302006|NCT03564119|454394890|FG000|Overall Study|Withdrawal by Subject|9|||
126302007|NCT03564119|454394891|FG001|Overall Study|Withdrawal by Subject|4|||
126302008|NCT03564119|454394890|FG000|Overall Study|Other Than Specified|0|||
126302009|NCT03564119|454394891|FG001|Overall Study|Other Than Specified|1|||
126302010|NCT00634036|454394892|FG000|Overall Study|Lost to Follow-up|1|||
126302011|NCT00634036|454394893|FG001|Overall Study|Lost to Follow-up|1|||
126302012|NCT00634036|454394892|FG000|Overall Study|Withdrawal by Subject|1|||
126302013|NCT00634036|454394893|FG001|Overall Study|Withdrawal by Subject|1|||
126302014|NCT03896022|454394894|FG000|Overall Study|Withdrawal by Subject|1|||
126302015|NCT03896022|454394895|FG001|Overall Study|Withdrawal by Subject|0|||
126462122|NCT02963831|454992992|FG001|Overall Study|Death|0|||
126462123|NCT02963831|454992993|FG002|Overall Study|Death|0|||
126302016|NCT03896022|454394896|FG002|Overall Study|Withdrawal by Subject|0|||
126302017|NCT03896022|454394894|FG000|Overall Study|Did not have procedure|3|||
126302018|NCT03896022|454394895|FG001|Overall Study|Did not have procedure|0|||
126302019|NCT03896022|454394896|FG002|Overall Study|Did not have procedure|0|||
126302020|NCT01554527|454394906|FG000|Overall Study|Withdrawal by Subject|1|||
126302021|NCT01554527|454394907|FG001|Overall Study|Withdrawal by Subject|0|||
126302022|NCT01554527|454394908|FG002|Overall Study|Withdrawal by Subject|3|||
126302023|NCT01554527|454394906|FG000|Overall Study|Lost to Follow-up|0|||
126302024|NCT01554527|454394907|FG001|Overall Study|Lost to Follow-up|0|||
126770337|NCT01787188|456112457|FG001|Overall Study|Lack of Efficacy|3|||
126462124|NCT02963831|454992994|FG003|Overall Study|Death|2|||
126302025|NCT01554527|454394908|FG002|Overall Study|Lost to Follow-up|4|||
126302026|NCT01554527|454394906|FG000|Overall Study|Physician Decision|0|||
126302027|NCT01554527|454394907|FG001|Overall Study|Physician Decision|0|||
126302028|NCT01554527|454394908|FG002|Overall Study|Physician Decision|1|||
126302029|NCT01052480|454394909|FG000|Overall Study|Lost to Follow-up|3|||
126302030|NCT01052480|454394910|FG001|Overall Study|Lost to Follow-up|3|||
126302031|NCT01052480|454394909|FG000|Overall Study|Protocol Violation|1|||
126302032|NCT01052480|454394910|FG001|Overall Study|Protocol Violation|0|||
126302033|NCT01052480|454394909|FG000|Overall Study|Withdrawal by Subject|3|||
126302034|NCT01052480|454394910|FG001|Overall Study|Withdrawal by Subject|7|||
126302035|NCT01052480|454394909|FG000|Overall Study|Physician Decision|0|||
126302036|NCT01052480|454394910|FG001|Overall Study|Physician Decision|2|||
126302037|NCT01052480|454394909|FG000|Overall Study|Death|1|||
126302038|NCT01052480|454394910|FG001|Overall Study|Death|5|||
126302039|NCT00529373|454394911|FG000|Base Study|Adverse Event|525|||
126302040|NCT00529373|454394912|FG001|Base Study|Adverse Event|470|||
126302041|NCT00529373|454394911|FG000|Base Study|Lack of Efficacy|16|||
126302042|NCT00529373|454394912|FG001|Base Study|Lack of Efficacy|75|||
126302043|NCT00529373|454394911|FG000|Base Study|Lost to Follow-up|221|||
126302044|NCT00529373|454394912|FG001|Base Study|Lost to Follow-up|208|||
126302045|NCT00529373|454394911|FG000|Base Study|Other Protocol Specified Criteria|19|||
126302046|NCT00529373|454394912|FG001|Base Study|Other Protocol Specified Criteria|20|||
126302047|NCT00529373|454394911|FG000|Base Study|Physician Decision|60|||
126302048|NCT00529373|454394912|FG001|Base Study|Physician Decision|52|||
126302049|NCT00529373|454394911|FG000|Base Study|Protocol Violation|48|||
126302050|NCT00529373|454394912|FG001|Base Study|Protocol Violation|38|||
126302051|NCT00529373|454394911|FG000|Base Study|Withdrawal by Subject|1062|||
126302052|NCT00529373|454394912|FG001|Base Study|Withdrawal by Subject|967|||
126302053|NCT00529373|454394911|FG000|Base Study|Did not continue into Extension|1795|||
126302054|NCT00529373|454394912|FG001|Base Study|Did not continue into Extension|2238|||
126302055|NCT00529373|454394911|FG000|First Extension Study|Adverse Event|162|||
126302056|NCT00529373|454394912|FG001|First Extension Study|Adverse Event|142|||
126302057|NCT00529373|454394911|FG000|First Extension Study|Lack of Efficacy|65|||
126302058|NCT00529373|454394912|FG001|First Extension Study|Lack of Efficacy|427|||
126302059|NCT00529373|454394911|FG000|First Extension Study|Lost to Follow-up|41|||
126302060|NCT00529373|454394912|FG001|First Extension Study|Lost to Follow-up|37|||
126302061|NCT00529373|454394911|FG000|First Extension Study|Other|27|||
126302062|NCT00529373|454394912|FG001|First Extension Study|Other|47|||
126302063|NCT00529373|454394911|FG000|First Extension Study|Physician Decision|50|||
126302064|NCT00529373|454394912|FG001|First Extension Study|Physician Decision|45|||
126302065|NCT00529373|454394911|FG000|First Extension Study|Protocol Violation|16|||
126302066|NCT00529373|454394912|FG001|First Extension Study|Protocol Violation|13|||
126302067|NCT00529373|454394911|FG000|First Extension Study|Withdrawal by Subject|296|||
126302068|NCT00529373|454394912|FG001|First Extension Study|Withdrawal by Subject|287|||
126302069|NCT00529373|454394911|FG000|First Extension Study|Disposition record non-existing|0|||
126302070|NCT00529373|454394912|FG001|First Extension Study|Disposition record non-existing|1|||
126302071|NCT00529373|454394911|FG000|First Extension Study|Discontinued after 5 years completion|208|||
126302072|NCT00529373|454394912|FG001|First Extension Study|Discontinued after 5 years completion|346|||
126302073|NCT00529373|454394911|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
126302074|NCT00529373|454394912|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
126302075|NCT00529373|454394911|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
126302076|NCT00529373|454394912|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
126302077|NCT00529373|454394911|FG000|Second Extension Study|Adverse Event|101|||
126302078|NCT00529373|454394912|FG001|Second Extension Study|Adverse Event|51|||
126302079|NCT00529373|454394911|FG000|Second Extension Study|Lack of Efficacy|7|||
126367588|NCT02301897|454640970|FG002|Treatment Course 1|Non-Compliance|1|||
126367589|NCT02301897|454640968|FG000|Treatment Course 1|Adverse Event|1|||
126367590|NCT02301897|454640969|FG001|Treatment Course 1|Adverse Event|1|||
126367591|NCT02301897|454640970|FG002|Treatment Course 1|Adverse Event|0|||
126367592|NCT02301897|454640968|FG000|Treatment Course 1|Lost to Follow-up|1|||
126367593|NCT02301897|454640969|FG001|Treatment Course 1|Lost to Follow-up|2|||
126367594|NCT02301897|454640970|FG002|Treatment Course 1|Lost to Follow-up|1|||
126367595|NCT02301897|454640968|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
126367596|NCT02301897|454640969|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
126302080|NCT00529373|454394912|FG001|Second Extension Study|Lack of Efficacy|15|||
126302081|NCT00529373|454394911|FG000|Second Extension Study|Lost to Follow-up|18|||
126302082|NCT00529373|454394912|FG001|Second Extension Study|Lost to Follow-up|12|||
126302083|NCT00529373|454394911|FG000|Second Extension Study|Other|7|||
126302084|NCT00529373|454394912|FG001|Second Extension Study|Other|12|||
126302085|NCT00529373|454394911|FG000|Second Extension Study|Physician Decision|63|||
126302086|NCT00529373|454394912|FG001|Second Extension Study|Physician Decision|26|||
126302087|NCT00529373|454394911|FG000|Second Extension Study|Protocol Violation|2|||
126302088|NCT00529373|454394912|FG001|Second Extension Study|Protocol Violation|1|||
126367597|NCT02301897|454640970|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
126462125|NCT02093026|454992995|FG000|Overall Study|Adverse Event|26|||
126462126|NCT02093026|454992995|FG000|Overall Study|Death|10|||
126713182|NCT01937130|455902005|FG003|Overall Study|Patient lost to FU due to death|0|||
126302089|NCT00529373|454394911|FG000|Second Extension Study|Withdrawal by Subject|97|||
126302090|NCT00529373|454394912|FG001|Second Extension Study|Withdrawal by Subject|75|||
126302091|NCT00529373|454394911|FG000|Second Extension Study|Status Missing|5|||
126302092|NCT00529373|454394912|FG001|Second Extension Study|Status Missing|5|||
126302093|NCT01863667|454394919|FG000|Overall Study|Adverse Event|1|||
126302094|NCT01863667|454394920|FG001|Overall Study|Adverse Event|0|||
126302095|NCT01863667|454394919|FG000|Overall Study|Study terminated by Sponsor|30|||
126302096|NCT01863667|454394920|FG001|Overall Study|Study terminated by Sponsor|30|||
126302097|NCT01863667|454394919|FG000|Overall Study|Withdrawal by Subject|2|||
126302098|NCT01863667|454394920|FG001|Overall Study|Withdrawal by Subject|2|||
126302099|NCT03627546|454394921|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
126302100|NCT03627546|454394922|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
126302101|NCT03627546|454394923|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
126302102|NCT03627546|454394921|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
126302103|NCT03627546|454394922|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
126302104|NCT03627546|454394923|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
126302105|NCT00615550|454394924|FG000|Overall Study|Lost to Follow-up|6|||
126302106|NCT00615550|454394925|FG001|Overall Study|Lost to Follow-up|1|||
126302107|NCT00564850|454394926|FG000|Overall Study|Protocol Violation|2|||
126302108|NCT02640664|454394927|FG000|Epoch 1|Withdrawal of informed consent|1|||
126302109|NCT02640664|454394928|FG001|Epoch 1|Withdrawal of informed consent|0|||
126302110|NCT02640664|454394929|FG002|Epoch 1|Withdrawal of informed consent|0|||
126302111|NCT02640664|454394927|FG000|Epoch 1|Death|0|||
126302112|NCT02640664|454394928|FG001|Epoch 1|Death|0|||
126302113|NCT02640664|454394929|FG002|Epoch 1|Death|1|||
126302114|NCT02640664|454394927|FG000|Epoch 2|Withdrawal of informed consent|3|||
126302115|NCT02640664|454394928|FG001|Epoch 2|Withdrawal of informed consent|4|||
126302116|NCT02640664|454394929|FG002|Epoch 2|Withdrawal of informed consent|2|||
126302117|NCT02640664|454394927|FG000|Epoch 2|Subject/guardian decision|0|||
126302118|NCT02640664|454394928|FG001|Epoch 2|Subject/guardian decision|2|||
126302119|NCT02640664|454394929|FG002|Epoch 2|Subject/guardian decision|2|||
126302120|NCT02640664|454394927|FG000|Epoch 2|Lost to Follow-up|3|||
126302121|NCT02640664|454394928|FG001|Epoch 2|Lost to Follow-up|4|||
126302122|NCT02640664|454394929|FG002|Epoch 2|Lost to Follow-up|1|||
126302123|NCT02640664|454394927|FG000|Epoch 2|Death|0|||
126302124|NCT02640664|454394928|FG001|Epoch 2|Death|0|||
126302125|NCT02640664|454394929|FG002|Epoch 2|Death|1|||
126302126|NCT00314327|454394930|FG000|Overall Study|Withdrawal by Subject|1|||
126302127|NCT02741076|454394933|FG000|Overall Study|Adverse Event|0|||
126302128|NCT02741076|454394934|FG001|Overall Study|Adverse Event|1|||
126302129|NCT02741076|454394935|FG002|Overall Study|Adverse Event|1|||
126302130|NCT02741076|454394936|FG003|Overall Study|Adverse Event|0|||
126302131|NCT02741076|454394933|FG000|Overall Study|Lack of Efficacy|1|||
126302132|NCT02741076|454394934|FG001|Overall Study|Lack of Efficacy|0|||
126302133|NCT02741076|454394935|FG002|Overall Study|Lack of Efficacy|0|||
126302134|NCT02741076|454394936|FG003|Overall Study|Lack of Efficacy|0|||
126302135|NCT02741076|454394933|FG000|Overall Study|Withdrawal by Subject|0|||
126302136|NCT02741076|454394934|FG001|Overall Study|Withdrawal by Subject|1|||
126302137|NCT02741076|454394935|FG002|Overall Study|Withdrawal by Subject|0|||
126302138|NCT02741076|454394936|FG003|Overall Study|Withdrawal by Subject|0|||
126302139|NCT02741076|454394933|FG000|Overall Study|Sponsor Request|2|||
126302140|NCT02741076|454394934|FG001|Overall Study|Sponsor Request|3|||
126302141|NCT02741076|454394935|FG002|Overall Study|Sponsor Request|0|||
126302142|NCT02741076|454394936|FG003|Overall Study|Sponsor Request|1|||
126302143|NCT02741076|454394933|FG000|Overall Study|No additional information available|0|||
126302144|NCT02741076|454394934|FG001|Overall Study|No additional information available|0|||
126302145|NCT02741076|454394935|FG002|Overall Study|No additional information available|1|||
126302146|NCT02741076|454394936|FG003|Overall Study|No additional information available|1|||
126302147|NCT02965573|454394939|FG000|Overall Study|Lack of Efficacy|1|||
126302148|NCT02965573|454394940|FG001|Overall Study|Lack of Efficacy|0|||
126302149|NCT00086619|454394941|FG000|Overall Study|Withdrawal by Subject|6|||
126302150|NCT00086619|454394942|FG001|Overall Study|Withdrawal by Subject|6|||
126302151|NCT00086619|454394941|FG000|Overall Study|Adverse Event|8|||
126302152|NCT00086619|454394942|FG001|Overall Study|Adverse Event|10|||
126302153|NCT00086619|454394941|FG000|Overall Study|Protocol Violation|1|||
126302154|NCT00086619|454394942|FG001|Overall Study|Protocol Violation|1|||
126302155|NCT01209520|454394943|FG000|Overall Study|Withdrawal by Subject|3|||
126302156|NCT00617890|454396198|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
126302157|NCT00617890|454396199|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
126302158|NCT00617890|454396200|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
126302159|NCT00617890|454396201|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
126302160|NCT00617890|454396198|FG000|Overall Study|Lack of Efficacy|23|||
126302161|NCT00617890|454396199|FG001|Overall Study|Lack of Efficacy|26|||
126302162|NCT00617890|454396200|FG002|Overall Study|Lack of Efficacy|30|||
126302163|NCT00617890|454396201|FG003|Overall Study|Lack of Efficacy|97|||
126302164|NCT00617890|454396198|FG000|Overall Study|Lost to Follow-up|0|||
126462127|NCT02093026|454992995|FG000|Overall Study|Other|157|||
126462128|NCT01923168|454992996|FG000|Overall Study|Protocol Violation|1|||
126462129|NCT01923168|454992997|FG001|Overall Study|Protocol Violation|1|||
126462130|NCT01923168|454992998|FG002|Overall Study|Protocol Violation|0|||
126302165|NCT00617890|454396199|FG001|Overall Study|Lost to Follow-up|0|||
126302166|NCT00617890|454396200|FG002|Overall Study|Lost to Follow-up|1|||
126302167|NCT00617890|454396201|FG003|Overall Study|Lost to Follow-up|2|||
126302168|NCT00617890|454396198|FG000|Overall Study|Withdrawal by Subject|4|||
126302169|NCT00617890|454396199|FG001|Overall Study|Withdrawal by Subject|1|||
126302170|NCT00617890|454396200|FG002|Overall Study|Withdrawal by Subject|0|||
126302171|NCT00617890|454396201|FG003|Overall Study|Withdrawal by Subject|2|||
126302172|NCT00617890|454396198|FG000|Overall Study|Protocol Violation|2|||
126302173|NCT00617890|454396199|FG001|Overall Study|Protocol Violation|1|||
126302174|NCT00617890|454396200|FG002|Overall Study|Protocol Violation|0|||
126302175|NCT00617890|454396201|FG003|Overall Study|Protocol Violation|0|||
126302176|NCT00617890|454396198|FG000|Overall Study|Adverse Event|1|||
126302177|NCT00617890|454396199|FG001|Overall Study|Adverse Event|0|||
126302178|NCT00617890|454396200|FG002|Overall Study|Adverse Event|3|||
126302179|NCT00617890|454396201|FG003|Overall Study|Adverse Event|8|||
126302180|NCT00617890|454396198|FG000|Overall Study|Not treated|1|||
126302181|NCT00617890|454396199|FG001|Overall Study|Not treated|0|||
126302182|NCT00617890|454396200|FG002|Overall Study|Not treated|1|||
126302183|NCT00617890|454396201|FG003|Overall Study|Not treated|1|||
126302184|NCT02640950|454396203|FG000|Overall Study|Adverse Event|1|||
126302185|NCT02640950|454396203|FG000|Overall Study|Withdrawal by Subject|1|||
126302186|NCT00915018|454396204|FG000|Overall Study|Death|75|||
126302187|NCT00915018|454396205|FG001|Overall Study|Death|70|||
126302188|NCT00915018|454396204|FG000|Overall Study|Lost to Follow-up|10|||
126302189|NCT00915018|454396205|FG001|Overall Study|Lost to Follow-up|5|||
126302190|NCT00915018|454396204|FG000|Overall Study|Withdrawal by Subject|38|||
126302191|NCT00915018|454396205|FG001|Overall Study|Withdrawal by Subject|27|||
126302192|NCT00915018|454396204|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
126302193|NCT00915018|454396205|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
126302194|NCT00154284|454396206|FG000|Overall Study|Adverse Event|6|||
126302195|NCT00154284|454396207|FG001|Overall Study|Adverse Event|9|||
126302196|NCT00154284|454396206|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126302197|NCT00154284|454396207|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126302198|NCT00154284|454396206|FG000|Overall Study|Lack of Efficacy|1|||
126302199|NCT00154284|454396207|FG001|Overall Study|Lack of Efficacy|2|||
126302200|NCT00154284|454396206|FG000|Overall Study|Protocol Violation|0|||
126302201|NCT00154284|454396207|FG001|Overall Study|Protocol Violation|1|||
126302202|NCT00566020|454396208|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
126302203|NCT00566020|454396209|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
126302204|NCT00566020|454396208|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
126302205|NCT00566020|454396209|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
126302206|NCT00566020|454396208|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
126302207|NCT00566020|454396209|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
126302208|NCT00566020|454396208|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
126302209|NCT00566020|454396209|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
126302210|NCT00566020|454396208|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
126302211|NCT00566020|454396209|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
126302212|NCT00566020|454396208|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
126302213|NCT00566020|454396209|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
126302214|NCT06098339|454396210|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
126302215|NCT06098339|454396211|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
126302216|NCT06098339|454396210|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
126302217|NCT06098339|454396211|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
126462131|NCT01923168|454992996|FG000|Overall Study|Subject/guardian decision|14|||
126462132|NCT01923168|454992997|FG001|Overall Study|Subject/guardian decision|14|||
126302218|NCT04134767|454396212|FG000|Overall Study|Death|0|||
126302219|NCT04134767|454396213|FG001|Overall Study|Death|1|||
126462133|NCT01923168|454992998|FG002|Overall Study|Subject/guardian decision|4|||
126713183|NCT03825042|455902008|FG000|Overall Study|Adverse Event|1|||
126302220|NCT04134767|454396212|FG000|Overall Study|Removed for harassing staff|0|||
126302221|NCT04134767|454396213|FG001|Overall Study|Removed for harassing staff|1|||
126302222|NCT04134767|454396212|FG000|Overall Study|Lost to Follow-up|44|||
126302223|NCT04134767|454396213|FG001|Overall Study|Lost to Follow-up|40|||
126302224|NCT00300885|454396214|FG000|Treatment|Adverse Event|134|||
126302225|NCT00300885|454396215|FG001|Treatment|Adverse Event|82|||
126302226|NCT00300885|454396214|FG000|Treatment|Death|20|||
126462134|NCT01923168|454992996|FG000|Overall Study|Adverse Event|12|||
126302227|NCT00300885|454396215|FG001|Treatment|Death|7|||
126302228|NCT00300885|454396214|FG000|Treatment|Lack of Efficacy|1|||
126302229|NCT00300885|454396215|FG001|Treatment|Lack of Efficacy|1|||
126462135|NCT01923168|454992997|FG001|Overall Study|Adverse Event|12|||
126713184|NCT03825042|455902009|FG001|Overall Study|Adverse Event|0|||
126302230|NCT00300885|454396214|FG000|Treatment|Lost to Follow-up|3|||
126302231|NCT00300885|454396215|FG001|Treatment|Lost to Follow-up|2|||
126302232|NCT00300885|454396214|FG000|Treatment|Physician Decision|4|||
126302233|NCT00300885|454396215|FG001|Treatment|Physician Decision|5|||
126302234|NCT00300885|454396214|FG000|Treatment|Protocol Violation|11|||
126302235|NCT00300885|454396215|FG001|Treatment|Protocol Violation|11|||
126302236|NCT00300885|454396214|FG000|Treatment|Withdrawal by Subject|26|||
126302237|NCT00300885|454396215|FG001|Treatment|Withdrawal by Subject|23|||
126302238|NCT00300885|454396214|FG000|Treatment|Disease progression|171|||
126302239|NCT00300885|454396215|FG001|Treatment|Disease progression|238|||
126302240|NCT00300885|454396214|FG000|Treatment|Random code broken (subject died)|0|||
126302241|NCT00300885|454396215|FG001|Treatment|Random code broken (subject died)|1|||
126302242|NCT00300885|454396214|FG000|Treatment|Non-compliant with study medication|3|||
126302243|NCT00300885|454396215|FG001|Treatment|Non-compliant with study medication|4|||
126302244|NCT00300885|454396214|FG000|Follow-up|Death|141|||
126302245|NCT00300885|454396215|FG001|Follow-up|Death|163|||
126302246|NCT00300885|454396214|FG000|Follow-up|Lost to Follow-up|11|||
126302247|NCT00300885|454396215|FG001|Follow-up|Lost to Follow-up|7|||
126302248|NCT00300885|454396214|FG000|Follow-up|Withdrawal by Subject|26|||
126302249|NCT00300885|454396215|FG001|Follow-up|Withdrawal by Subject|25|||
126302250|NCT02582242|454396216|FG000|Overall Study|Adverse Event|4|||
126302251|NCT02582242|454396217|FG001|Overall Study|Adverse Event|3|||
126302252|NCT02582242|454396216|FG000|Overall Study|Protocol Violation|3|||
126302253|NCT02582242|454396217|FG001|Overall Study|Protocol Violation|1|||
126302254|NCT02582242|454396216|FG000|Overall Study|Lost to Follow-up|0|||
126302255|NCT02582242|454396217|FG001|Overall Study|Lost to Follow-up|1|||
126302256|NCT02582242|454396216|FG000|Overall Study|Withdrawal by Subject|11|||
126302257|NCT02582242|454396217|FG001|Overall Study|Withdrawal by Subject|11|||
126302258|NCT02582242|454396216|FG000|Overall Study|Unclassified|2|||
126302259|NCT02582242|454396217|FG001|Overall Study|Unclassified|1|||
126302260|NCT02101736|454396221|FG000|Overall Study|Protocol Violation|3|||
126302261|NCT02101736|454396222|FG001|Overall Study|Protocol Violation|0|||
126302262|NCT02101736|454396221|FG000|Overall Study|Withdrawal by Subject|1|||
126302263|NCT02101736|454396222|FG001|Overall Study|Withdrawal by Subject|1|||
126302264|NCT00459290|454396223|FG000|Overall Study|Adverse Event|3|||
126302265|NCT00459290|454396223|FG000|Overall Study|Ineligible|2|||
126302266|NCT02366637|454396224|FG000|First Intervention Period|Adverse Event|0|||
126302267|NCT02366637|454396225|FG001|First Intervention Period|Adverse Event|1|||
126302268|NCT02366637|454396224|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
126302269|NCT02366637|454396225|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
126302270|NCT02366637|454396224|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
126302271|NCT02366637|454396225|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
126302272|NCT02309411|454396231|FG000|Overall Study|Physician Decision|1|||
126302273|NCT02309411|454396232|FG001|Overall Study|Physician Decision|0|||
126302274|NCT02309411|454396233|FG002|Overall Study|Physician Decision|0|||
126302275|NCT02309411|454396231|FG000|Overall Study|Withdrawal by Subject|1|||
126302276|NCT02309411|454396232|FG001|Overall Study|Withdrawal by Subject|1|||
126302277|NCT02309411|454396233|FG002|Overall Study|Withdrawal by Subject|0|||
126302278|NCT01134107|454396234|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
126302279|NCT01134107|454396235|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
126302280|NCT01134107|454396234|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
126302281|NCT01134107|454396235|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
126302282|NCT01134107|454396234|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
126302283|NCT01134107|454396235|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
126302284|NCT01134107|454396234|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
126302285|NCT01134107|454396235|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
126302286|NCT01134107|454396234|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
126302287|NCT01134107|454396235|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
126302288|NCT01134107|454396234|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
126302289|NCT01134107|454396235|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
126367598|NCT02301897|454640968|FG000|Treatment Course 1|Withdrawal by Subject|0|||
126367599|NCT02301897|454640969|FG001|Treatment Course 1|Withdrawal by Subject|0|||
126367600|NCT02301897|454640970|FG002|Treatment Course 1|Withdrawal by Subject|2|||
126367601|NCT02301897|454640968|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
126367602|NCT02301897|454640969|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
126367603|NCT02301897|454640970|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
126367604|NCT02301897|454640968|FG000|Treatment Course 2|Lost to Follow-up|0|||
126367605|NCT02301897|454640969|FG001|Treatment Course 2|Lost to Follow-up|2|||
126367606|NCT02301897|454640970|FG002|Treatment Course 2|Lost to Follow-up|0|||
126367607|NCT02301897|454640968|FG000|Treatment Course 2|Pregnancy|0|||
126367608|NCT02301897|454640969|FG001|Treatment Course 2|Pregnancy|1|||
126302290|NCT01134107|454396234|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
126302291|NCT01134107|454396235|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
126713185|NCT03825042|455902008|FG000|Overall Study|Withdrawal by Subject|1|||
126302292|NCT03656692|454396236|FG000|Overall Study|Worsening of disease activity|2|||
126302293|NCT03656692|454396236|FG000|Overall Study|Physician Decision|1|||
126302294|NCT02801617|454396247|FG000|Overall Study|Protocol Violation|2|||
126302295|NCT02801617|454396248|FG001|Overall Study|Protocol Violation|6|||
126302296|NCT01372618|454396249|FG000|Overall Study|PI Died. Study Terminated|9|||
126302297|NCT01954056|454396250|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
126302298|NCT01954056|454396251|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
126302299|NCT06110494|454396252|FG000|Overall Study|Protocol Violation|2|||
126302300|NCT06110494|454396253|FG001|Overall Study|Protocol Violation|0|||
126302301|NCT06110494|454396254|FG002|Overall Study|Protocol Violation|1|||
126302302|NCT06110494|454396252|FG000|Overall Study|Dixon's test for outlier analysis|1|||
126302303|NCT06110494|454396253|FG001|Overall Study|Dixon's test for outlier analysis|1|||
126302304|NCT06110494|454396254|FG002|Overall Study|Dixon's test for outlier analysis|0|||
126302305|NCT02914613|454396255|FG000|Overall Study|Withdrawal by Subject|1|||
126302306|NCT02914613|454396256|FG001|Overall Study|Withdrawal by Subject|2|||
126302307|NCT02914613|454396255|FG000|Overall Study|Adverse Event|1|||
126302308|NCT02914613|454396256|FG001|Overall Study|Adverse Event|0|||
126302309|NCT00984542|454396265|FG000|Overall Study|disease progression|19|||
126302310|NCT00984542|454396265|FG000|Overall Study|toxicity|7|||
126302311|NCT00984542|454396265|FG000|Overall Study|Death|7|||
126302312|NCT00984542|454396265|FG000|Overall Study|complicating disease|3|||
126302313|NCT00984542|454396265|FG000|Overall Study|Withdrawal by Subject|3|||
126302314|NCT00984542|454396265|FG000|Overall Study|clinical deterioration|2|||
126302315|NCT01422889|454396268|FG000|Overall Study|No Data Entered for Study Stent|9|||
126302316|NCT02929589|454396269|FG000|Overall Study|Withdrawal by Subject|1|||
126302317|NCT02929589|454396270|FG001|Overall Study|Withdrawal by Subject|0|||
126302318|NCT02929589|454396271|FG002|Overall Study|Withdrawal by Subject|0|||
126302319|NCT02929589|454396272|FG003|Overall Study|Withdrawal by Subject|0|||
126302320|NCT02929589|454396269|FG000|Overall Study|Physician Decision|2|||
126302321|NCT02929589|454396270|FG001|Overall Study|Physician Decision|0|||
126302322|NCT02929589|454396271|FG002|Overall Study|Physician Decision|0|||
126302323|NCT02929589|454396272|FG003|Overall Study|Physician Decision|0|||
126302324|NCT02091089|454396273|FG000|Overall Study|Lost to Follow-up|2|||
126302325|NCT02343939|454396274|FG000|Overall Study|Death|0|||
126302326|NCT02343939|454396275|FG001|Overall Study|Death|15|||
126302327|NCT02343939|454396276|FG002|Overall Study|Death|4|||
126302328|NCT02343939|454396277|FG003|Overall Study|Death|2|||
126302329|NCT02343939|454396278|FG004|Overall Study|Death|5|||
126302330|NCT02343939|454396279|FG005|Overall Study|Death|11|||
126302331|NCT02343939|454396280|FG006|Overall Study|Death|8|||
126302332|NCT02343939|454396281|FG007|Overall Study|Death|22|||
126302333|NCT02343939|454396282|FG008|Overall Study|Death|1|||
126302334|NCT02343939|454396274|FG000|Overall Study|Study terminated by sponsor|0|||
126302335|NCT02343939|454396275|FG001|Overall Study|Study terminated by sponsor|27|||
126302336|NCT02343939|454396276|FG002|Overall Study|Study terminated by sponsor|0|||
126302337|NCT02343939|454396277|FG003|Overall Study|Study terminated by sponsor|1|||
126302338|NCT02343939|454396278|FG004|Overall Study|Study terminated by sponsor|1|||
126302339|NCT02343939|454396279|FG005|Overall Study|Study terminated by sponsor|5|||
126302340|NCT02343939|454396280|FG006|Overall Study|Study terminated by sponsor|3|||
126302341|NCT02343939|454396281|FG007|Overall Study|Study terminated by sponsor|4|||
126302342|NCT02343939|454396282|FG008|Overall Study|Study terminated by sponsor|0|||
126302343|NCT02343939|454396274|FG000|Overall Study|Withdrew consent|3|||
126302344|NCT02343939|454396275|FG001|Overall Study|Withdrew consent|6|||
126302345|NCT02343939|454396276|FG002|Overall Study|Withdrew consent|1|||
126302346|NCT02343939|454396277|FG003|Overall Study|Withdrew consent|2|||
126302347|NCT02343939|454396278|FG004|Overall Study|Withdrew consent|2|||
126302348|NCT02343939|454396279|FG005|Overall Study|Withdrew consent|0|||
126302349|NCT02343939|454396280|FG006|Overall Study|Withdrew consent|0|||
126302350|NCT02343939|454396281|FG007|Overall Study|Withdrew consent|8|||
126302351|NCT02343939|454396282|FG008|Overall Study|Withdrew consent|6|||
126302352|NCT02343939|454396274|FG000|Overall Study|Treatment failure|0|||
126302353|NCT02343939|454396275|FG001|Overall Study|Treatment failure|0|||
126302354|NCT02343939|454396276|FG002|Overall Study|Treatment failure|0|||
126302355|NCT02343939|454396277|FG003|Overall Study|Treatment failure|0|||
126302356|NCT02343939|454396278|FG004|Overall Study|Treatment failure|0|||
126770338|NCT01787188|456112458|FG002|Overall Study|Lack of Efficacy|5|||
126302357|NCT02343939|454396279|FG005|Overall Study|Treatment failure|0|||
126302358|NCT02343939|454396280|FG006|Overall Study|Treatment failure|2|||
126302359|NCT02343939|454396281|FG007|Overall Study|Treatment failure|1|||
126302360|NCT02343939|454396282|FG008|Overall Study|Treatment failure|0|||
126302361|NCT02343939|454396274|FG000|Overall Study|Investigator's discretion|0|||
126302362|NCT02343939|454396275|FG001|Overall Study|Investigator's discretion|0|||
126302363|NCT02343939|454396276|FG002|Overall Study|Investigator's discretion|0|||
126302364|NCT02343939|454396277|FG003|Overall Study|Investigator's discretion|1|||
126302365|NCT02343939|454396278|FG004|Overall Study|Investigator's discretion|0|||
126302366|NCT02343939|454396279|FG005|Overall Study|Investigator's discretion|0|||
126302367|NCT02343939|454396280|FG006|Overall Study|Investigator's discretion|1|||
126302368|NCT02343939|454396281|FG007|Overall Study|Investigator's discretion|0|||
126302369|NCT02343939|454396282|FG008|Overall Study|Investigator's discretion|0|||
126302370|NCT02343939|454396274|FG000|Overall Study|Adverse Event|0|||
126302371|NCT02343939|454396275|FG001|Overall Study|Adverse Event|0|||
126302372|NCT02343939|454396276|FG002|Overall Study|Adverse Event|0|||
126302373|NCT02343939|454396277|FG003|Overall Study|Adverse Event|0|||
126302374|NCT02343939|454396278|FG004|Overall Study|Adverse Event|0|||
126302375|NCT02343939|454396279|FG005|Overall Study|Adverse Event|1|||
126302376|NCT02343939|454396280|FG006|Overall Study|Adverse Event|0|||
126302377|NCT02343939|454396281|FG007|Overall Study|Adverse Event|0|||
126302378|NCT02343939|454396282|FG008|Overall Study|Adverse Event|0|||
126302379|NCT02343939|454396274|FG000|Overall Study|Never Treated With ENTO|0|||
126302380|NCT02343939|454396275|FG001|Overall Study|Never Treated With ENTO|0|||
126302381|NCT02343939|454396276|FG002|Overall Study|Never Treated With ENTO|0|||
126302382|NCT02343939|454396277|FG003|Overall Study|Never Treated With ENTO|0|||
126302383|NCT02343939|454396278|FG004|Overall Study|Never Treated With ENTO|0|||
126302384|NCT02343939|454396279|FG005|Overall Study|Never Treated With ENTO|0|||
126302385|NCT02343939|454396280|FG006|Overall Study|Never Treated With ENTO|1|||
126302386|NCT02343939|454396281|FG007|Overall Study|Never Treated With ENTO|2|||
126302387|NCT02343939|454396282|FG008|Overall Study|Never Treated With ENTO|0|||
126302388|NCT01303172|454396289|FG000|Overall Study|Physician Decision|9|||
126302389|NCT01303172|454396290|FG001|Overall Study|Physician Decision|6|||
126302390|NCT01303172|454396289|FG000|Overall Study|Adverse Event|5|||
126302391|NCT01303172|454396290|FG001|Overall Study|Adverse Event|2|||
126302392|NCT01303172|454396289|FG000|Overall Study|Withdrawal by Subject|4|||
126302393|NCT01303172|454396290|FG001|Overall Study|Withdrawal by Subject|2|||
126302394|NCT01303172|454396289|FG000|Overall Study|Death|20|||
126302395|NCT01303172|454396290|FG001|Overall Study|Death|7|||
126302396|NCT01303172|454396289|FG000|Overall Study|Lack of Efficacy|25|||
126302397|NCT01303172|454396290|FG001|Overall Study|Lack of Efficacy|17|||
126302398|NCT01580670|454396293|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
126302399|NCT01580670|454396293|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
126302400|NCT00462709|454396294|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
126302401|NCT00462709|454396294|FG000|Overall Study|Lost to Follow-up|10|||
126302402|NCT00462709|454396294|FG000|Overall Study|Withdrawal by Subject|8|||
126302403|NCT00462709|454396294|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
126302404|NCT00462709|454396294|FG000|Overall Study|Death|2|||
126302405|NCT00462709|454396294|FG000|Overall Study|Logistical reasons|2|||
126302406|NCT00462709|454396294|FG000|Overall Study|Physician Decision|1|||
126302407|NCT00462709|454396294|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
126302408|NCT04468347|454396295|FG000|Overall Study|Withdrawal by Subject|0|||
126302409|NCT04468347|454396296|FG001|Overall Study|Withdrawal by Subject|1|||
126302410|NCT04468347|454396297|FG002|Overall Study|Withdrawal by Subject|3|||
126302411|NCT04468347|454396298|FG003|Overall Study|Withdrawal by Subject|3|||
126302412|NCT04468347|454396295|FG000|Overall Study|Lost to Follow-up|0|||
126302413|NCT04468347|454396296|FG001|Overall Study|Lost to Follow-up|0|||
126302414|NCT04468347|454396297|FG002|Overall Study|Lost to Follow-up|1|||
126302415|NCT04468347|454396298|FG003|Overall Study|Lost to Follow-up|1|||
126302416|NCT04468347|454396295|FG000|Overall Study|Physician Decision|1|||
126302417|NCT04468347|454396296|FG001|Overall Study|Physician Decision|0|||
126302418|NCT04468347|454396297|FG002|Overall Study|Physician Decision|2|||
126302419|NCT04468347|454396298|FG003|Overall Study|Physician Decision|0|||
126302420|NCT04468347|454396295|FG000|Overall Study|Protocol Violation|1|||
126302421|NCT04468347|454396296|FG001|Overall Study|Protocol Violation|0|||
126302422|NCT04468347|454396297|FG002|Overall Study|Protocol Violation|0|||
126302423|NCT04468347|454396298|FG003|Overall Study|Protocol Violation|0|||
126302424|NCT00554515|454396299|FG000|Overall Study|Withdrawal by Subject|3|||
126302425|NCT00554515|454396299|FG000|Overall Study|Disease progression|52|||
126302426|NCT00554515|454396299|FG000|Overall Study|Physician Decision|18|||
126302427|NCT00554515|454396299|FG000|Overall Study|Withdrawal by Subject|11|||
126302428|NCT00554515|454396299|FG000|Overall Study|Adverse Event|9|||
126302429|NCT00554515|454396299|FG000|Overall Study|Death|2|||
126302430|NCT00554515|454396299|FG000|Overall Study|Achieved Stable Disease|7|||
126302431|NCT00554515|454396299|FG000|Overall Study|Other|1|||
126302432|NCT00554515|454396299|FG000|Overall Study|Misc|15|||
126302433|NCT00665431|454396302|FG000|Overall Study|Adverse Event|16|||
126302434|NCT00665431|454396303|FG001|Overall Study|Adverse Event|22|||
126302435|NCT00665431|454396304|FG002|Overall Study|Adverse Event|6|||
126302436|NCT00665431|454396302|FG000|Overall Study|Withdrawal by Subject|17|||
126367609|NCT02301897|454640970|FG002|Treatment Course 2|Pregnancy|1|||
126367610|NCT02301897|454640968|FG000|Treatment Course 2|Withdrawal by Subject|0|||
126367611|NCT02301897|454640969|FG001|Treatment Course 2|Withdrawal by Subject|2|||
126367612|NCT02301897|454640970|FG002|Treatment Course 2|Withdrawal by Subject|0|||
126367613|NCT02301897|454640968|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
126367614|NCT02301897|454640969|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
126367615|NCT02301897|454640970|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
126367616|NCT02439957|454640971|FG000|Overall Study|Study Terminated|3|||
126367617|NCT02439957|454640972|FG001|Overall Study|Study Terminated|3|||
126367618|NCT00478257|454640973|FG000|Overall Study|Withdrawal by Subject|8|||
126302437|NCT00665431|454396303|FG001|Overall Study|Withdrawal by Subject|25|||
126302438|NCT00665431|454396304|FG002|Overall Study|Withdrawal by Subject|15|||
126302439|NCT00665431|454396302|FG000|Overall Study|Lost to Follow-up|3|||
126302440|NCT00665431|454396303|FG001|Overall Study|Lost to Follow-up|3|||
126302441|NCT00665431|454396304|FG002|Overall Study|Lost to Follow-up|1|||
126302442|NCT00665431|454396302|FG000|Overall Study|Other|4|||
126302443|NCT00665431|454396303|FG001|Overall Study|Other|7|||
126302444|NCT00665431|454396304|FG002|Overall Study|Other|2|||
126302445|NCT00315458|454396310|FG000|Overall Study|Administrative|0|||
126302446|NCT00315458|454396311|FG001|Overall Study|Administrative|3|||
126302447|NCT00315458|454396312|FG002|Overall Study|Administrative|8|||
126302448|NCT00315458|454396313|FG003|Overall Study|Administrative|21|||
126302449|NCT00315458|454396310|FG000|Overall Study|Adverse Event|2|||
126302450|NCT00315458|454396311|FG001|Overall Study|Adverse Event|4|||
126302451|NCT00315458|454396312|FG002|Overall Study|Adverse Event|23|||
126302452|NCT00315458|454396313|FG003|Overall Study|Adverse Event|3|||
126302453|NCT00315458|454396310|FG000|Overall Study|Lost to Follow-up|1|||
126302454|NCT00315458|454396311|FG001|Overall Study|Lost to Follow-up|2|||
126302455|NCT00315458|454396312|FG002|Overall Study|Lost to Follow-up|0|||
126302456|NCT00315458|454396313|FG003|Overall Study|Lost to Follow-up|2|||
126302457|NCT00315458|454396310|FG000|Overall Study|Withdrawal by Subject|0|||
126302458|NCT00315458|454396311|FG001|Overall Study|Withdrawal by Subject|3|||
126302459|NCT00315458|454396312|FG002|Overall Study|Withdrawal by Subject|0|||
126302460|NCT00315458|454396313|FG003|Overall Study|Withdrawal by Subject|2|||
126302461|NCT00315458|454396310|FG000|Overall Study|Lack of Efficacy|0|||
126302462|NCT00315458|454396311|FG001|Overall Study|Lack of Efficacy|0|||
126302463|NCT00315458|454396312|FG002|Overall Study|Lack of Efficacy|20|||
126302464|NCT00315458|454396313|FG003|Overall Study|Lack of Efficacy|1|||
126302465|NCT00315458|454396310|FG000|Overall Study|Did not qualify|0|||
126302466|NCT00315458|454396311|FG001|Overall Study|Did not qualify|0|||
126302467|NCT00315458|454396312|FG002|Overall Study|Did not qualify|1|||
126302468|NCT00315458|454396313|FG003|Overall Study|Did not qualify|0|||
126302469|NCT00987337|454396314|FG000|Overall Study|Adverse Event|10|||
126302470|NCT00987337|454396315|FG001|Overall Study|Adverse Event|9|||
126302471|NCT00987337|454396316|FG002|Overall Study|Adverse Event|8|||
126302472|NCT00987337|454396314|FG000|Overall Study|Insufficient Virologic Response|10|||
126302473|NCT00987337|454396315|FG001|Overall Study|Insufficient Virologic Response|7|||
126302474|NCT00987337|454396316|FG002|Overall Study|Insufficient Virologic Response|12|||
126302475|NCT00987337|454396314|FG000|Overall Study|Virologic Breakthrough|2|||
126302476|NCT00987337|454396315|FG001|Overall Study|Virologic Breakthrough|2|||
126302477|NCT00987337|454396316|FG002|Overall Study|Virologic Breakthrough|8|||
126302478|NCT00987337|454396314|FG000|Overall Study|Lost to Follow-up|10|||
126302479|NCT00987337|454396315|FG001|Overall Study|Lost to Follow-up|6|||
126302480|NCT00987337|454396316|FG002|Overall Study|Lost to Follow-up|2|||
126302481|NCT00987337|454396314|FG000|Overall Study|Withdrawal by Subject|6|||
126302482|NCT00987337|454396315|FG001|Overall Study|Withdrawal by Subject|9|||
126302483|NCT00987337|454396316|FG002|Overall Study|Withdrawal by Subject|9|||
126302484|NCT00987337|454396314|FG000|Overall Study|Other|0|||
126302485|NCT00987337|454396315|FG001|Overall Study|Other|2|||
126302486|NCT00987337|454396316|FG002|Overall Study|Other|5|||
126302487|NCT00987337|454396314|FG000|Overall Study|Protocol Violation|1|||
126302488|NCT00987337|454396315|FG001|Overall Study|Protocol Violation|0|||
126302489|NCT00987337|454396316|FG002|Overall Study|Protocol Violation|2|||
126302490|NCT00987337|454396314|FG000|Overall Study|Participant Relapsed|18|||
126302491|NCT00987337|454396315|FG001|Overall Study|Participant Relapsed|20|||
126302492|NCT00987337|454396316|FG002|Overall Study|Participant Relapsed|5|||
126302493|NCT00489918|454396320|FG000|Overall Study|Withdrawal by Subject|2|||
126302494|NCT00489918|454396321|FG001|Overall Study|Withdrawal by Subject|1|||
126302495|NCT00489918|454396322|FG002|Overall Study|Withdrawal by Subject|1|||
126302496|NCT00489918|454396323|FG003|Overall Study|Withdrawal by Subject|0|||
126302497|NCT00489918|454396324|FG004|Overall Study|Withdrawal by Subject|1|||
126302498|NCT00489918|454396320|FG000|Overall Study|Adverse Event|0|||
126302499|NCT00489918|454396321|FG001|Overall Study|Adverse Event|1|||
126302500|NCT00489918|454396322|FG002|Overall Study|Adverse Event|1|||
126302501|NCT00489918|454396323|FG003|Overall Study|Adverse Event|0|||
126302502|NCT00489918|454396324|FG004|Overall Study|Adverse Event|0|||
126302503|NCT00489918|454396320|FG000|Overall Study|Lost to Follow-up|0|||
126302504|NCT00489918|454396321|FG001|Overall Study|Lost to Follow-up|0|||
126302505|NCT00489918|454396322|FG002|Overall Study|Lost to Follow-up|1|||
126302506|NCT00489918|454396323|FG003|Overall Study|Lost to Follow-up|1|||
126302507|NCT00489918|454396324|FG004|Overall Study|Lost to Follow-up|0|||
126302508|NCT00489918|454396320|FG000|Overall Study|Physician Decision|0|||
126302509|NCT00489918|454396321|FG001|Overall Study|Physician Decision|0|||
126302510|NCT00489918|454396322|FG002|Overall Study|Physician Decision|1|||
126302511|NCT00489918|454396323|FG003|Overall Study|Physician Decision|0|||
126302512|NCT00489918|454396324|FG004|Overall Study|Physician Decision|0|||
126302513|NCT02748213|454396325|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
126302514|NCT02748213|454396326|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
126302515|NCT02748213|454396325|FG000|Overall Study|Abnormal Laboratory Test|1|||
126367619|NCT00478257|454640974|FG001|Overall Study|Withdrawal by Subject|3|||
126367620|NCT03931330|454640975|FG000|Overall Study|Physician Decision|1|||
126367621|NCT03412929|454640976|FG000|Overall Study|Protocol Violation|3|||
126367622|NCT00023595|454640981|FG000|5 Year Follow up|Lost to Follow-up|2|||
126367623|NCT00023595|454640982|FG001|5 Year Follow up|Lost to Follow-up|2|||
126367624|NCT00023595|454640983|FG002|5 Year Follow up|Lost to Follow-up|1|||
126367625|NCT00023595|454640984|FG003|5 Year Follow up|Lost to Follow-up|7|||
126367626|NCT00023595|454640985|FG004|5 Year Follow up|Lost to Follow-up|3|||
126367627|NCT00023595|454640981|FG000|10 Year Follow up|Lost to Follow-up|12|||
126367628|NCT00023595|454640982|FG001|10 Year Follow up|Lost to Follow-up|10|||
126367629|NCT00023595|454640983|FG002|10 Year Follow up|Lost to Follow-up|3|||
126367630|NCT00023595|454640984|FG003|10 Year Follow up|Lost to Follow-up|0|||
126367631|NCT00023595|454640985|FG004|10 Year Follow up|Lost to Follow-up|0|||
126367632|NCT01472185|454640986|FG000|Overall Study|Randomized but Not Treated|0|||
126367633|NCT01472185|454640987|FG001|Overall Study|Randomized but Not Treated|1|||
126367634|NCT01472185|454640986|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
126367635|NCT01472185|454640987|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
126367636|NCT01472185|454640986|FG000|Overall Study|Hyperglycemia|5|||
126367637|NCT01472185|454640987|FG001|Overall Study|Hyperglycemia|2|||
126367638|NCT01472185|454640986|FG000|Overall Study|Investigator's Discretion|3|||
126367639|NCT01472185|454640987|FG001|Overall Study|Investigator's Discretion|1|||
126367640|NCT01472185|454640986|FG000|Overall Study|Lost to Follow-up|4|||
126367641|NCT01472185|454640987|FG001|Overall Study|Lost to Follow-up|1|||
126367642|NCT01472185|454640986|FG000|Overall Study|Protocol Violation|5|||
126367643|NCT01472185|454640987|FG001|Overall Study|Protocol Violation|1|||
126462136|NCT01923168|454992998|FG002|Overall Study|Adverse Event|0|||
126462137|NCT01923168|454992996|FG000|Overall Study|Physician Decision|6|||
126462138|NCT01923168|454992997|FG001|Overall Study|Physician Decision|9|||
126462139|NCT01923168|454992998|FG002|Overall Study|Physician Decision|5|||
126462140|NCT01923168|454992996|FG000|Overall Study|Progressive disease|4|||
126462141|NCT01923168|454992997|FG001|Overall Study|Progressive disease|3|||
126462142|NCT01923168|454992998|FG002|Overall Study|Progressive disease|7|||
126367644|NCT01472185|454640986|FG000|Overall Study|Subject Noncompliance|8|||
126462143|NCT01923168|454992996|FG000|Overall Study|Death|0|||
126462144|NCT01923168|454992997|FG001|Overall Study|Death|0|||
126367645|NCT01472185|454640987|FG001|Overall Study|Subject Noncompliance|15|||
126367646|NCT01472185|454640986|FG000|Overall Study|Subject Withdrew Consent|6|||
126367647|NCT01472185|454640987|FG001|Overall Study|Subject Withdrew Consent|3|||
126367648|NCT00635050|454640992|FG000|Overall Study|Withdrawal by Subject|1|||
126367649|NCT00759395|454640993|FG000|Overall Study|Adverse Event|1|||
126462145|NCT01923168|454992998|FG002|Overall Study|Death|1|||
126462146|NCT03418571|454992999|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
126462147|NCT03418571|454993000|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
126367650|NCT00759395|454640994|FG001|Overall Study|Adverse Event|0|||
126367651|NCT00759395|454640993|FG000|Overall Study|Withdrawal by Subject|1|||
126367652|NCT00759395|454640994|FG001|Overall Study|Withdrawal by Subject|0|||
126367653|NCT00759395|454640993|FG000|Overall Study|Lack of Efficacy|0|||
126367654|NCT00759395|454640994|FG001|Overall Study|Lack of Efficacy|2|||
126462148|NCT02376829|454993001|FG000|Overall Study|Withdrawal by Subject|27|||
126462149|NCT02376829|454993002|FG001|Overall Study|Withdrawal by Subject|44|||
126302516|NCT02748213|454396326|FG001|Overall Study|Abnormal Laboratory Test|0|||
126302517|NCT02748213|454396325|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
126302518|NCT02748213|454396326|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
126302519|NCT02748213|454396325|FG000|Overall Study|Death|5|||
126302520|NCT02748213|454396326|FG001|Overall Study|Death|3|||
126302521|NCT02748213|454396325|FG000|Overall Study|Insufficient Therapeutic Response|56|||
126302522|NCT02748213|454396326|FG001|Overall Study|Insufficient Therapeutic Response|57|||
126302523|NCT02748213|454396325|FG000|Overall Study|Violation of Selection Criteria|2|||
126302524|NCT02748213|454396326|FG001|Overall Study|Violation of Selection Criteria|0|||
126302525|NCT02748213|454396325|FG000|Overall Study|Protocol Violation|6|||
126302526|NCT02748213|454396326|FG001|Overall Study|Protocol Violation|4|||
126367655|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
126462150|NCT01255787|454993003|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
126462151|NCT01255787|454993004|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
126462152|NCT01255787|454993005|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
126302527|NCT02748213|454396325|FG000|Overall Study|Refused Treatment*|6|||
126302528|NCT02748213|454396326|FG001|Overall Study|Refused Treatment*|6|||
126462153|NCT01255787|454993006|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
126302529|NCT02748213|454396325|FG000|Overall Study|Failure to Return|1|||
126302530|NCT02748213|454396326|FG001|Overall Study|Failure to Return|0|||
126302531|NCT02748213|454396325|FG000|Overall Study|Other|30|||
126302532|NCT02748213|454396326|FG001|Overall Study|Other|29|||
126367656|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
126367657|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
126367658|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
126367659|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
126302533|NCT04200651|454396327|FG000|Overall Study|Moved to another country during follow-up|2|||
126302534|NCT04200651|454396328|FG001|Overall Study|Moved to another country during follow-up|2|||
126302535|NCT04200651|454396327|FG000|Overall Study|Lost to Follow-up|1|||
126302536|NCT04200651|454396328|FG001|Overall Study|Lost to Follow-up|3|||
126302537|NCT01500382|454396333|FG000|Washout Period|Study site went out of business|0|||
126302538|NCT01500382|454396334|FG001|Washout Period|Study site went out of business|0|||
126302539|NCT01500382|454396335|FG002|Washout Period|Study site went out of business|1|||
126302540|NCT01500382|454396336|FG003|Washout Period|Study site went out of business|0|||
126302541|NCT01870973|454396337|FG000|Overall Study|Lost to Follow-up|10|||
126302542|NCT01870973|454396338|FG001|Overall Study|Lost to Follow-up|3|||
126302543|NCT01266291|454396339|FG000|Overall Study|Adverse Event|1|||
126302544|NCT03291431|454396340|FG000|Overall Study|Protocol Violation|2|||
126302545|NCT03291431|454396341|FG001|Overall Study|Protocol Violation|1|||
126302546|NCT03291431|454396340|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
126302547|NCT03291431|454396341|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
126302548|NCT03291431|454396340|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
126302549|NCT03291431|454396341|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
126302550|NCT00550745|454396344|FG000|Overall Study|Death|20|||
126302551|NCT00550745|454396345|FG001|Overall Study|Death|16|||
126302552|NCT00550745|454396344|FG000|Overall Study|Lost to Follow-up|45|||
126302553|NCT00550745|454396345|FG001|Overall Study|Lost to Follow-up|30|||
126302554|NCT00550745|454396344|FG000|Overall Study|Physician Decision|0|||
126302555|NCT00550745|454396345|FG001|Overall Study|Physician Decision|2|||
126302556|NCT00550745|454396344|FG000|Overall Study|Protocol Violation|4|||
126302557|NCT00550745|454396345|FG001|Overall Study|Protocol Violation|2|||
126302558|NCT00550745|454396344|FG000|Overall Study|Withdrawal by Subject|17|||
126302559|NCT00550745|454396345|FG001|Overall Study|Withdrawal by Subject|10|||
126302560|NCT00550745|454396344|FG000|Overall Study|Screen failure|1|||
126302561|NCT00550745|454396345|FG001|Overall Study|Screen failure|0|||
126302562|NCT02498444|454398379|FG000|Overall Study|Withdrawal by Subject|3|||
126302563|NCT02498444|454398380|FG001|Overall Study|Withdrawal by Subject|0|||
126302564|NCT02498444|454398379|FG000|Overall Study|Physician Decision|1|||
126302565|NCT02498444|454398380|FG001|Overall Study|Physician Decision|0|||
126302566|NCT02027545|454398381|FG000|Overall Study|Failed to sign HIPAA|0|||
126302567|NCT02027545|454398382|FG001|Overall Study|Failed to sign HIPAA|2|||
126302568|NCT02027545|454398381|FG000|Overall Study|Failed to attend study visit|2|||
126302569|NCT02027545|454398382|FG001|Overall Study|Failed to attend study visit|0|||
126302570|NCT02027545|454398381|FG000|Overall Study|Protocol Violation|1|||
126302571|NCT02027545|454398382|FG001|Overall Study|Protocol Violation|0|||
126302572|NCT02453334|454398383|FG000|Overall Study|Death|15|||
126302573|NCT02453334|454398384|FG001|Overall Study|Death|13|||
126302574|NCT02453334|454398383|FG000|Overall Study|Adverse Event|2|||
126302575|NCT02453334|454398384|FG001|Overall Study|Adverse Event|1|||
126302576|NCT02453334|454398383|FG000|Overall Study|Lost to Follow-up|5|||
126302577|NCT02453334|454398384|FG001|Overall Study|Lost to Follow-up|9|||
126302578|NCT02453334|454398383|FG000|Overall Study|Physician Decision|1|||
126302579|NCT02453334|454398384|FG001|Overall Study|Physician Decision|0|||
126302580|NCT02453334|454398383|FG000|Overall Study|Withdrawal by Subject|17|||
126302581|NCT02453334|454398384|FG001|Overall Study|Withdrawal by Subject|13|||
126302582|NCT02453334|454398383|FG000|Overall Study|Other reason|1|||
126302583|NCT02453334|454398384|FG001|Overall Study|Other reason|4|||
126302584|NCT02693106|454398387|FG000|Overall Study|No time|3|||
126302585|NCT02509507|454398388|FG000|Overall Study|Death|21|||
126302586|NCT02509507|454398389|FG001|Overall Study|Death|3|||
126302587|NCT02509507|454398390|FG002|Overall Study|Death|22|||
126302588|NCT02509507|454398391|FG003|Overall Study|Death|14|||
126302589|NCT02509507|454398392|FG004|Overall Study|Death|8|||
126302590|NCT02509507|454398393|FG005|Overall Study|Death|12|||
126302591|NCT02509507|454398394|FG006|Overall Study|Death|5|||
126302592|NCT02509507|454398395|FG007|Overall Study|Death|4|||
126302593|NCT02509507|454398396|FG008|Overall Study|Death|8|||
126302594|NCT02509507|454398388|FG000|Overall Study|Lost to Follow-up|0|||
126302595|NCT02509507|454398389|FG001|Overall Study|Lost to Follow-up|1|||
126302596|NCT02509507|454398390|FG002|Overall Study|Lost to Follow-up|0|||
126302597|NCT02509507|454398391|FG003|Overall Study|Lost to Follow-up|0|||
126302598|NCT02509507|454398392|FG004|Overall Study|Lost to Follow-up|0|||
126302599|NCT02509507|454398393|FG005|Overall Study|Lost to Follow-up|2|||
126302600|NCT02509507|454398394|FG006|Overall Study|Lost to Follow-up|0|||
126302601|NCT02509507|454398395|FG007|Overall Study|Lost to Follow-up|0|||
126462154|NCT01255787|454993003|FG000|Overall Study|Major Protocol Deviation|1|||
126302602|NCT02509507|454398396|FG008|Overall Study|Lost to Follow-up|0|||
126302603|NCT02509507|454398388|FG000|Overall Study|Withdrawal by Subject|2|||
126302604|NCT02509507|454398389|FG001|Overall Study|Withdrawal by Subject|0|||
126302605|NCT02509507|454398390|FG002|Overall Study|Withdrawal by Subject|1|||
126302606|NCT02509507|454398391|FG003|Overall Study|Withdrawal by Subject|4|||
126302607|NCT02509507|454398392|FG004|Overall Study|Withdrawal by Subject|1|||
126302608|NCT02509507|454398393|FG005|Overall Study|Withdrawal by Subject|3|||
126302609|NCT02509507|454398394|FG006|Overall Study|Withdrawal by Subject|4|||
126302610|NCT02509507|454398395|FG007|Overall Study|Withdrawal by Subject|0|||
126302611|NCT02509507|454398396|FG008|Overall Study|Withdrawal by Subject|1|||
126302612|NCT00839800|454398400|FG000|Overall Study|Adverse Event|8|||
126302613|NCT00839800|454398401|FG001|Overall Study|Adverse Event|12|||
126302614|NCT00839800|454398400|FG000|Overall Study|Lost to Follow-up|31|||
126302615|NCT00839800|454398401|FG001|Overall Study|Lost to Follow-up|26|||
126302616|NCT00839800|454398400|FG000|Overall Study|Withdrawal by Subject|28|||
126302617|NCT00839800|454398401|FG001|Overall Study|Withdrawal by Subject|34|||
126302618|NCT00839800|454398400|FG000|Overall Study|Incorrect Enrolment|3|||
126302619|NCT00839800|454398401|FG001|Overall Study|Incorrect Enrolment|3|||
126302620|NCT00839800|454398400|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
126302621|NCT00839800|454398401|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
126302622|NCT00839800|454398400|FG000|Overall Study|Safety Reasons|2|||
126302623|NCT00839800|454398401|FG001|Overall Study|Safety Reasons|1|||
126302624|NCT00839800|454398400|FG000|Overall Study|Other|8|||
126302625|NCT00839800|454398401|FG001|Overall Study|Other|14|||
126302626|NCT00839800|454398400|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
126302627|NCT00839800|454398401|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
126302628|NCT02510664|454398402|FG000|Overall Study|Transferred Care|9|||
126302629|NCT02510664|454398403|FG001|Overall Study|Transferred Care|9|||
126302630|NCT02510664|454398404|FG002|Overall Study|Transferred Care|0|||
126302631|NCT02510664|454398402|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
126302632|NCT02510664|454398403|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
126302633|NCT02510664|454398404|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
126302634|NCT02510664|454398402|FG000|Overall Study|Time Constraints|1|||
126302635|NCT02510664|454398403|FG001|Overall Study|Time Constraints|1|||
126302636|NCT02510664|454398404|FG002|Overall Study|Time Constraints|0|||
126302637|NCT03337113|454398407|FG000|Overall Study|Adverse Event|1|||
126302638|NCT03337113|454398408|FG001|Overall Study|Adverse Event|1|||
126302639|NCT03337113|454398409|FG002|Overall Study|Adverse Event|0|||
126302640|NCT03337113|454398410|FG003|Overall Study|Adverse Event|1|||
126302641|NCT03337113|454398407|FG000|Overall Study|Physician Decision|0|||
126302642|NCT03337113|454398408|FG001|Overall Study|Physician Decision|2|||
126302643|NCT03337113|454398409|FG002|Overall Study|Physician Decision|0|||
126302644|NCT03337113|454398410|FG003|Overall Study|Physician Decision|1|||
126302645|NCT03337113|454398407|FG000|Overall Study|Withdrawal by Subject|0|||
126302646|NCT03337113|454398408|FG001|Overall Study|Withdrawal by Subject|0|||
126302647|NCT03337113|454398409|FG002|Overall Study|Withdrawal by Subject|1|||
126302648|NCT03337113|454398410|FG003|Overall Study|Withdrawal by Subject|0|||
126302649|NCT02176655|454398415|FG000|Overall Study|Subjects did not treat|6|||
126302650|NCT01464593|454398420|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
126302651|NCT01019694|454398431|FG000|Overall Study|Adverse Event|12|||
126302652|NCT01019694|454398432|FG001|Overall Study|Adverse Event|16|||
126302653|NCT01019694|454398433|FG002|Overall Study|Adverse Event|19|||
126302654|NCT01019694|454398431|FG000|Overall Study|Protocol Violation|2|||
126302655|NCT01019694|454398432|FG001|Overall Study|Protocol Violation|6|||
126302656|NCT01019694|454398433|FG002|Overall Study|Protocol Violation|4|||
126302657|NCT01019694|454398431|FG000|Overall Study|Lost to Follow-up|5|||
126302658|NCT01019694|454398432|FG001|Overall Study|Lost to Follow-up|3|||
126302659|NCT01019694|454398433|FG002|Overall Study|Lost to Follow-up|3|||
126302660|NCT01019694|454398431|FG000|Overall Study|Withdrawal by Subject|4|||
126302661|NCT01019694|454398432|FG001|Overall Study|Withdrawal by Subject|6|||
126302662|NCT01019694|454398433|FG002|Overall Study|Withdrawal by Subject|12|||
126302663|NCT01019694|454398431|FG000|Overall Study|Not treated|0|||
126302664|NCT01019694|454398432|FG001|Overall Study|Not treated|2|||
126302665|NCT01019694|454398433|FG002|Overall Study|Not treated|3|||
126302666|NCT01019694|454398431|FG000|Overall Study|Other reason (not specified)|1|||
126302667|NCT01019694|454398432|FG001|Overall Study|Other reason (not specified)|5|||
126302668|NCT01019694|454398433|FG002|Overall Study|Other reason (not specified)|6|||
126302669|NCT00026494|454398436|FG000|Overall Study|Withdrawal by Subject|1|||
126302670|NCT00026494|454398437|FG001|Overall Study|Withdrawal by Subject|0|||
126302671|NCT00026494|454398438|FG002|Overall Study|Withdrawal by Subject|1|||
126302672|NCT00026494|454398439|FG003|Overall Study|Withdrawal by Subject|0|||
126302673|NCT00026494|454398436|FG000|Overall Study|Patient non-compliance|1|||
126302674|NCT00026494|454398437|FG001|Overall Study|Patient non-compliance|0|||
126302675|NCT00026494|454398438|FG002|Overall Study|Patient non-compliance|0|||
126302676|NCT00026494|454398439|FG003|Overall Study|Patient non-compliance|0|||
126550728|NCT00876460|455309644|FG000|Combination Therapy Phase|Other reason not defined above|0|||
126550729|NCT00876460|455309645|FG001|Combination Therapy Phase|Other reason not defined above|0|||
126713186|NCT03825042|455902009|FG001|Overall Study|Withdrawal by Subject|0|||
126302677|NCT00026494|454398436|FG000|Overall Study|Patient not treated|0|||
126713187|NCT01988012|455902016|FG000|Overall Study|Adverse Event|5|||
126302678|NCT00026494|454398437|FG001|Overall Study|Patient not treated|0|||
126302679|NCT00026494|454398438|FG002|Overall Study|Patient not treated|2|||
126302680|NCT00026494|454398439|FG003|Overall Study|Patient not treated|0|||
126550730|NCT00876460|455309646|FG002|Combination Therapy Phase|Other reason not defined above|0|||
126550731|NCT00876460|455309647|FG003|Combination Therapy Phase|Other reason not defined above|0|||
126550732|NCT00876460|455309648|FG004|Combination Therapy Phase|Other reason not defined above|0|||
126550733|NCT00876460|455309649|FG005|Combination Therapy Phase|Other reason not defined above|0|||
126550734|NCT00876460|455309650|FG006|Combination Therapy Phase|Other reason not defined above|1|||
126550735|NCT00876460|455309651|FG007|Combination Therapy Phase|Other reason not defined above|2|||
126550736|NCT00876460|455309644|FG000|Combination Therapy Phase|Not treated|0|||
126550737|NCT00876460|455309645|FG001|Combination Therapy Phase|Not treated|0|||
126550738|NCT00876460|455309646|FG002|Combination Therapy Phase|Not treated|0|||
126550739|NCT00876460|455309647|FG003|Combination Therapy Phase|Not treated|0|||
126550740|NCT00876460|455309648|FG004|Combination Therapy Phase|Not treated|0|||
126550741|NCT00876460|455309649|FG005|Combination Therapy Phase|Not treated|0|||
126550742|NCT00876460|455309650|FG006|Combination Therapy Phase|Not treated|1|||
126550743|NCT00876460|455309651|FG007|Combination Therapy Phase|Not treated|0|||
126550744|NCT00876460|455309644|FG000|Mono Therapy Phase|Progressive disease|0|||
126550745|NCT00876460|455309645|FG001|Mono Therapy Phase|Progressive disease|0|||
126550746|NCT00876460|455309646|FG002|Mono Therapy Phase|Progressive disease|0|||
126550747|NCT00876460|455309647|FG003|Mono Therapy Phase|Progressive disease|0|||
126550748|NCT00876460|455309648|FG004|Mono Therapy Phase|Progressive disease|2|||
126550749|NCT00876460|455309649|FG005|Mono Therapy Phase|Progressive disease|0|||
126550750|NCT00876460|455309650|FG006|Mono Therapy Phase|Progressive disease|1|||
126550751|NCT00876460|455309651|FG007|Mono Therapy Phase|Progressive disease|3|||
126550752|NCT00876460|455309644|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
126550753|NCT00876460|455309645|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
126550754|NCT00876460|455309646|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
126550755|NCT00876460|455309647|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
126550756|NCT00876460|455309648|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
126550757|NCT00876460|455309649|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
126550758|NCT00876460|455309650|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
126550759|NCT00876460|455309651|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
126550760|NCT00876460|455309644|FG000|Mono Therapy Phase|Adverse Event|0|||
126550761|NCT00876460|455309645|FG001|Mono Therapy Phase|Adverse Event|0|||
126550762|NCT00876460|455309646|FG002|Mono Therapy Phase|Adverse Event|0|||
126550763|NCT00876460|455309647|FG003|Mono Therapy Phase|Adverse Event|1|||
126550764|NCT00876460|455309648|FG004|Mono Therapy Phase|Adverse Event|0|||
126550765|NCT00876460|455309649|FG005|Mono Therapy Phase|Adverse Event|0|||
126550766|NCT00876460|455309650|FG006|Mono Therapy Phase|Adverse Event|0|||
126550767|NCT00876460|455309651|FG007|Mono Therapy Phase|Adverse Event|0|||
126550768|NCT01051063|455309652|FG000|Overall Study|Death|2|||
126550769|NCT01051063|455309653|FG001|Overall Study|Death|2|||
126550770|NCT01051063|455309652|FG000|Overall Study|Withdrawal by Subject|1|||
126550771|NCT01051063|455309653|FG001|Overall Study|Withdrawal by Subject|1|||
126550772|NCT01051063|455309652|FG000|Overall Study|Termination of the study|5|||
126550773|NCT01051063|455309653|FG001|Overall Study|Termination of the study|0|||
126550774|NCT01051063|455309652|FG000|Overall Study|Moved from the study site area|1|||
126550775|NCT01051063|455309653|FG001|Overall Study|Moved from the study site area|0|||
126550776|NCT01051063|455309652|FG000|Overall Study|Other|1|||
126550777|NCT01051063|455309653|FG001|Overall Study|Other|0|||
126550778|NCT01051063|455309652|FG000|Overall Study|Lost to Follow-up|0|||
126550779|NCT01051063|455309653|FG001|Overall Study|Lost to Follow-up|1|||
126550780|NCT03857841|455309657|FG000|Overall Study|Death|1|||
126550781|NCT03857841|455309658|FG001|Overall Study|Death|0|||
126713188|NCT01988012|455902016|FG000|Overall Study|Insufficient Therapeutic Response|3|||
126367660|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
126367661|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
126367662|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
126367663|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
126367664|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
126367665|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
126367666|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
126367667|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
126367668|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
126550782|NCT03857841|455309659|FG002|Overall Study|Death|0|||
126550783|NCT03857841|455309660|FG003|Overall Study|Death|0|||
126550784|NCT03857841|455309657|FG000|Overall Study|Study Terminated by Sponsor|1|||
126550785|NCT03857841|455309658|FG001|Overall Study|Study Terminated by Sponsor|0|||
126550786|NCT03857841|455309659|FG002|Overall Study|Study Terminated by Sponsor|0|||
126550787|NCT03857841|455309660|FG003|Overall Study|Study Terminated by Sponsor|0|||
126550788|NCT01091428|455311655|FG000|Phase 1|Progressive Disease|24|||
126550789|NCT01091428|455311656|FG001|Phase 1|Progressive Disease|8|||
126550790|NCT01091428|455311657|FG002|Phase 1|Progressive Disease|0|||
126550791|NCT01091428|455311658|FG003|Phase 1|Progressive Disease|0|||
126550792|NCT01091428|455311655|FG000|Phase 1|Symptomatic Deterioration|3|||
126550793|NCT01091428|455311656|FG001|Phase 1|Symptomatic Deterioration|2|||
126550794|NCT01091428|455311657|FG002|Phase 1|Symptomatic Deterioration|0|||
126550795|NCT01091428|455311658|FG003|Phase 1|Symptomatic Deterioration|0|||
126367669|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
126367670|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
126367671|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
126550796|NCT01091428|455311655|FG000|Phase 1|Adverse Event|2|||
126550797|NCT01091428|455311656|FG001|Phase 1|Adverse Event|0|||
126550798|NCT01091428|455311657|FG002|Phase 1|Adverse Event|0|||
126550799|NCT01091428|455311658|FG003|Phase 1|Adverse Event|0|||
126550800|NCT01091428|455311655|FG000|Phase 1|Withdrawal by Subject|7|||
126367672|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
126367673|NCT00086515|454640995|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
126367674|NCT00086515|454640996|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
126367675|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
126367676|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
126367677|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
126367678|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
126367679|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
126367680|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
126367681|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
126367682|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
126462155|NCT01255787|454993004|FG001|Overall Study|Major Protocol Deviation|1|||
126462156|NCT01255787|454993005|FG002|Overall Study|Major Protocol Deviation|0|||
126462157|NCT01255787|454993006|FG003|Overall Study|Major Protocol Deviation|4|||
126462158|NCT01255787|454993003|FG000|Overall Study|Lost to Follow-up|1|||
126462159|NCT01255787|454993004|FG001|Overall Study|Lost to Follow-up|2|||
126462160|NCT01255787|454993005|FG002|Overall Study|Lost to Follow-up|4|||
126462161|NCT01255787|454993006|FG003|Overall Study|Lost to Follow-up|2|||
126462162|NCT01255787|454993003|FG000|Overall Study|Withdrawal of Consent|3|||
126462163|NCT01255787|454993004|FG001|Overall Study|Withdrawal of Consent|9|||
126462164|NCT01255787|454993005|FG002|Overall Study|Withdrawal of Consent|3|||
126462165|NCT01255787|454993006|FG003|Overall Study|Withdrawal of Consent|4|||
126462166|NCT01255787|454993003|FG000|Overall Study|Pregnancy|0|||
126462167|NCT01255787|454993004|FG001|Overall Study|Pregnancy|0|||
126462168|NCT01255787|454993005|FG002|Overall Study|Pregnancy|0|||
126462169|NCT01255787|454993006|FG003|Overall Study|Pregnancy|1|||
126462170|NCT01255787|454993003|FG000|Overall Study|Lack of Efficacy|2|||
126462171|NCT01255787|454993004|FG001|Overall Study|Lack of Efficacy|2|||
126462172|NCT01255787|454993005|FG002|Overall Study|Lack of Efficacy|2|||
126462173|NCT01255787|454993006|FG003|Overall Study|Lack of Efficacy|2|||
126462174|NCT01255787|454993003|FG000|Overall Study|Noncompliance with Study Drug|3|||
126462175|NCT01255787|454993004|FG001|Overall Study|Noncompliance with Study Drug|1|||
126462176|NCT01255787|454993005|FG002|Overall Study|Noncompliance with Study Drug|0|||
126462177|NCT01255787|454993006|FG003|Overall Study|Noncompliance with Study Drug|0|||
126462178|NCT00476047|454993007|FG000|Overall Study|Lost to Follow-up|1|||
126462179|NCT03882008|454993008|FG000|Overall Study|Withdrawal by Subject|1|||
126462180|NCT03882008|454993008|FG000|Overall Study|Lost to Follow-up|1|||
126462181|NCT05153473|454993009|FG000|Overall Study|Death|46|||
126462182|NCT05153473|454993009|FG000|Overall Study|Lost to Follow-up|3|||
126462183|NCT03519386|454993010|FG000|Overall Study|Withdrawal by Subject|4|||
126462184|NCT03519386|454993011|FG001|Overall Study|Withdrawal by Subject|1|||
126462185|NCT03519386|454993012|FG002|Overall Study|Withdrawal by Subject|2|||
126462186|NCT03519386|454993010|FG000|Overall Study|Physician Decision|1|||
126462187|NCT03519386|454993011|FG001|Overall Study|Physician Decision|1|||
126462188|NCT03519386|454993012|FG002|Overall Study|Physician Decision|1|||
126462189|NCT03519386|454993010|FG000|Overall Study|Lost to Follow-up|0|||
126462190|NCT03519386|454993011|FG001|Overall Study|Lost to Follow-up|1|||
126462191|NCT03519386|454993012|FG002|Overall Study|Lost to Follow-up|1|||
126462192|NCT03519386|454993010|FG000|Overall Study|Death|1|||
126462193|NCT03519386|454993011|FG001|Overall Study|Death|0|||
126462194|NCT03519386|454993012|FG002|Overall Study|Death|4|||
126462195|NCT03519386|454993010|FG000|Overall Study|Adverse Event|2|||
126462196|NCT03519386|454993011|FG001|Overall Study|Adverse Event|1|||
126462197|NCT03519386|454993012|FG002|Overall Study|Adverse Event|2|||
126462198|NCT03519386|454993010|FG000|Overall Study|Explanted|2|||
126462199|NCT03519386|454993011|FG001|Overall Study|Explanted|1|||
126462200|NCT03519386|454993012|FG002|Overall Study|Explanted|0|||
126462201|NCT03519386|454993010|FG000|Overall Study|Ongoing in study|190|||
126462202|NCT03519386|454993011|FG001|Overall Study|Ongoing in study|192|||
126462203|NCT03519386|454993012|FG002|Overall Study|Ongoing in study|183|||
126462204|NCT04341662|454993014|FG000|Overall Study|Did not have source-verified blood loss data|423|||
126462205|NCT04341662|454993015|FG001|Overall Study|Did not have source-verified blood loss data|514|||
126462206|NCT02283177|454993016|FG000|Overall Study|Withdrawal by Subject|1|||
126462207|NCT02283177|454993017|FG001|Overall Study|Withdrawal by Subject|1|||
126462208|NCT02398227|454993018|FG000|Overall Study|Lost to Follow-up|21|||
126550801|NCT01091428|455311656|FG001|Phase 1|Withdrawal by Subject|0|||
126550802|NCT01091428|455311657|FG002|Phase 1|Withdrawal by Subject|0|||
126462209|NCT02398227|454993019|FG001|Overall Study|Lost to Follow-up|12|||
126462210|NCT02398227|454993018|FG000|Overall Study|Withdrawal by Subject|5|||
126367683|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
126367684|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
126550803|NCT01091428|455311658|FG003|Phase 1|Withdrawal by Subject|0|||
126550804|NCT01091428|455311655|FG000|Phase 1|Reason not specified|0|||
126550805|NCT01091428|455311656|FG001|Phase 1|Reason not specified|1|||
126550806|NCT01091428|455311657|FG002|Phase 1|Reason not specified|0|||
126550807|NCT01091428|455311658|FG003|Phase 1|Reason not specified|0|||
126550808|NCT01091428|455311655|FG000|Phase 1|Single-Patient IND|2|||
126550809|NCT01091428|455311656|FG001|Phase 1|Single-Patient IND|0|||
126550810|NCT01091428|455311657|FG002|Phase 1|Single-Patient IND|0|||
126550811|NCT01091428|455311658|FG003|Phase 1|Single-Patient IND|0|||
126550812|NCT01091428|455311655|FG000|Phase 2|Progressive Disease|0|||
126550813|NCT01091428|455311656|FG001|Phase 2|Progressive Disease|0|||
126550814|NCT01091428|455311657|FG002|Phase 2|Progressive Disease|44|||
126550815|NCT01091428|455311658|FG003|Phase 2|Progressive Disease|46|||
126550816|NCT01091428|455311655|FG000|Phase 2|Symptomatic Deterioration|0|||
126550817|NCT01091428|455311656|FG001|Phase 2|Symptomatic Deterioration|0|||
126550818|NCT01091428|455311657|FG002|Phase 2|Symptomatic Deterioration|1|||
126550819|NCT01091428|455311658|FG003|Phase 2|Symptomatic Deterioration|6|||
126550820|NCT01091428|455311655|FG000|Phase 2|Adverse Event|0|||
126550821|NCT01091428|455311656|FG001|Phase 2|Adverse Event|0|||
126550822|NCT01091428|455311657|FG002|Phase 2|Adverse Event|12|||
126550823|NCT01091428|455311658|FG003|Phase 2|Adverse Event|5|||
126550824|NCT01091428|455311655|FG000|Phase 2|Withdrawal by Subject|0|||
126550825|NCT01091428|455311656|FG001|Phase 2|Withdrawal by Subject|0|||
126550826|NCT01091428|455311657|FG002|Phase 2|Withdrawal by Subject|9|||
126550827|NCT01091428|455311658|FG003|Phase 2|Withdrawal by Subject|8|||
126550828|NCT01091428|455311655|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
126550829|NCT01091428|455311656|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
126550830|NCT01091428|455311657|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
126550831|NCT01091428|455311658|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
126550832|NCT01091428|455311655|FG000|Phase 2|Reason not specified|0|||
126550833|NCT01091428|455311656|FG001|Phase 2|Reason not specified|0|||
126550834|NCT01091428|455311657|FG002|Phase 2|Reason not specified|4|||
126550835|NCT01091428|455311658|FG003|Phase 2|Reason not specified|3|||
126550836|NCT01091428|455311655|FG000|Phase 2|Physician Decision|0|||
126550837|NCT01091428|455311656|FG001|Phase 2|Physician Decision|0|||
126550838|NCT01091428|455311657|FG002|Phase 2|Physician Decision|2|||
126550839|NCT01091428|455311658|FG003|Phase 2|Physician Decision|0|||
126550840|NCT02531295|455311659|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
126550841|NCT02531295|455311660|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
126550842|NCT02531295|455311661|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
126550843|NCT02531295|455311662|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
126550844|NCT02531295|455311663|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
126550845|NCT02531295|455311664|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
126550846|NCT04424290|455311666|FG000|Overall Study|Not treated|0|||
126550847|NCT04424290|455311667|FG001|Overall Study|Not treated|0|||
126550848|NCT04424290|455311668|FG002|Overall Study|Not treated|1|||
126550849|NCT04424290|455311669|FG003|Overall Study|Not treated|0|||
126550850|NCT04424290|455311670|FG004|Overall Study|Not treated|1|||
126550851|NCT04424290|455311666|FG000|Overall Study|Adverse Event|0|||
126550852|NCT04424290|455311667|FG001|Overall Study|Adverse Event|0|||
126550853|NCT04424290|455311668|FG002|Overall Study|Adverse Event|0|||
126550854|NCT04424290|455311669|FG003|Overall Study|Adverse Event|2|||
126550855|NCT04424290|455311670|FG004|Overall Study|Adverse Event|0|||
126550856|NCT04424290|455311666|FG000|Overall Study|Withdrawal by Subject|0|||
126550857|NCT04424290|455311667|FG001|Overall Study|Withdrawal by Subject|0|||
126550858|NCT04424290|455311668|FG002|Overall Study|Withdrawal by Subject|0|||
126550859|NCT04424290|455311669|FG003|Overall Study|Withdrawal by Subject|0|||
126550860|NCT04424290|455311670|FG004|Overall Study|Withdrawal by Subject|1|||
126367685|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
126367686|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
126367687|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
126367688|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
126367689|NCT00086515|454640995|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
126369574|NCT00183248|454650605|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
126550861|NCT04424290|455311666|FG000|Overall Study|Other than listed|0|||
126550862|NCT04424290|455311667|FG001|Overall Study|Other than listed|0|||
126550863|NCT04424290|455311668|FG002|Overall Study|Other than listed|0|||
126550864|NCT04424290|455311669|FG003|Overall Study|Other than listed|1|||
126550865|NCT04424290|455311670|FG004|Overall Study|Other than listed|0|||
126550866|NCT04249336|455311673|FG000|Overall Study|Lost to Follow-up|3|||
126550867|NCT04249336|455311674|FG001|Overall Study|Lost to Follow-up|3|||
126550868|NCT04249336|455311675|FG002|Overall Study|Lost to Follow-up|3|||
126550869|NCT04249336|455311676|FG003|Overall Study|Lost to Follow-up|3|||
126550870|NCT01987596|455311686|FG000|Overall Study|Physician Decision|1|||
126302681|NCT00026494|454398436|FG000|Overall Study|Clinical progression|0|||
126302682|NCT00026494|454398437|FG001|Overall Study|Clinical progression|0|||
126302683|NCT00026494|454398438|FG002|Overall Study|Clinical progression|3|||
126302684|NCT00026494|454398439|FG003|Overall Study|Clinical progression|0|||
126302685|NCT01684423|454398440|FG000|Overall Study|Withdrawal by Subject|0|||
126302686|NCT01684423|454398441|FG001|Overall Study|Withdrawal by Subject|0|||
126302687|NCT01684423|454398442|FG002|Overall Study|Withdrawal by Subject|1|||
126302688|NCT01684423|454398443|FG003|Overall Study|Withdrawal by Subject|0|||
126302689|NCT01684423|454398444|FG004|Overall Study|Withdrawal by Subject|0|||
126302690|NCT01455597|454398445|FG000|Overall Study|Adverse Event|7|||
126302691|NCT01455597|454398446|FG001|Overall Study|Adverse Event|0|||
126302692|NCT01455597|454398447|FG002|Overall Study|Adverse Event|5|||
126302693|NCT01455597|454398448|FG003|Overall Study|Adverse Event|1|||
126302694|NCT01455597|454398445|FG000|Overall Study|Lack of Efficacy|0|||
126302695|NCT01455597|454398446|FG001|Overall Study|Lack of Efficacy|1|||
126302696|NCT01455597|454398447|FG002|Overall Study|Lack of Efficacy|2|||
126302697|NCT01455597|454398448|FG003|Overall Study|Lack of Efficacy|0|||
126302698|NCT01455597|454398445|FG000|Overall Study|Lost to Follow-up|3|||
126302699|NCT01455597|454398446|FG001|Overall Study|Lost to Follow-up|0|||
126302700|NCT01455597|454398447|FG002|Overall Study|Lost to Follow-up|2|||
126302701|NCT01455597|454398448|FG003|Overall Study|Lost to Follow-up|1|||
126302702|NCT01455597|454398445|FG000|Overall Study|Withdrew Consent|6|||
126302703|NCT01455597|454398446|FG001|Overall Study|Withdrew Consent|5|||
126302704|NCT01455597|454398447|FG002|Overall Study|Withdrew Consent|8|||
126302705|NCT01455597|454398448|FG003|Overall Study|Withdrew Consent|5|||
126302706|NCT01455597|454398445|FG000|Overall Study|Reason not Specified|1|||
126302707|NCT01455597|454398446|FG001|Overall Study|Reason not Specified|2|||
126302708|NCT01455597|454398447|FG002|Overall Study|Reason not Specified|3|||
126302709|NCT01455597|454398448|FG003|Overall Study|Reason not Specified|3|||
126302710|NCT03412734|454398451|FG000|Overall Study|Incorrect labeling of samples|2|||
126302711|NCT03412734|454398452|FG001|Overall Study|Incorrect labeling of samples|0|||
126302712|NCT03412734|454398451|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
126302713|NCT03412734|454398452|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
126302714|NCT00423332|454398453|FG000|Overall Study|Adverse Event|6|||
126302715|NCT00423332|454398454|FG001|Overall Study|Adverse Event|2|||
126302716|NCT00423332|454398453|FG000|Overall Study|Withdrawal by Subject|1|||
126302717|NCT00423332|454398454|FG001|Overall Study|Withdrawal by Subject|0|||
126302718|NCT00423332|454398453|FG000|Overall Study|Condition under investigation worsened|1|||
126302719|NCT00423332|454398454|FG001|Overall Study|Condition under investigation worsened|1|||
126302720|NCT00423332|454398453|FG000|Overall Study|Progressive at Week 6|0|||
126302721|NCT00423332|454398454|FG001|Overall Study|Progressive at Week 6|1|||
126302722|NCT00423332|454398453|FG000|Overall Study|Unblinded before 12 weeks|1|||
126302723|NCT00423332|454398454|FG001|Overall Study|Unblinded before 12 weeks|3|||
126302724|NCT04747886|454398455|FG000|Overall Study|Withdrawal by Subject|1|||
126302725|NCT04747886|454398456|FG001|Overall Study|Withdrawal by Subject|4|||
126302726|NCT01136356|454398459|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
126302727|NCT01136356|454398460|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
126302728|NCT01136356|454398459|FG000|First 18-day Withdrawal|Physician Decision|1|||
126302729|NCT01136356|454398460|FG001|First 18-day Withdrawal|Physician Decision|0|||
126302730|NCT01136356|454398459|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
126302731|NCT01136356|454398460|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
126302732|NCT00402688|454398461|FG000|Overall Study|Adverse Event|12|||
126302733|NCT00402688|454398462|FG001|Overall Study|Adverse Event|9|||
126302734|NCT00402688|454398463|FG002|Overall Study|Adverse Event|3|||
126302735|NCT00402688|454398461|FG000|Overall Study|Withdrawal by Subject|3|||
126302736|NCT00402688|454398462|FG001|Overall Study|Withdrawal by Subject|1|||
126302737|NCT00402688|454398463|FG002|Overall Study|Withdrawal by Subject|1|||
126302738|NCT00402688|454398461|FG000|Overall Study|Physician Decision|0|||
126302739|NCT00402688|454398462|FG001|Overall Study|Physician Decision|0|||
126302740|NCT00402688|454398463|FG002|Overall Study|Physician Decision|1|||
126302741|NCT00402688|454398461|FG000|Overall Study|Lack of Efficacy|4|||
126302742|NCT00402688|454398462|FG001|Overall Study|Lack of Efficacy|4|||
126302743|NCT00402688|454398463|FG002|Overall Study|Lack of Efficacy|5|||
126302744|NCT00402688|454398461|FG000|Overall Study|Protocol Violation|1|||
126302745|NCT00402688|454398462|FG001|Overall Study|Protocol Violation|1|||
126302746|NCT00402688|454398463|FG002|Overall Study|Protocol Violation|1|||
126302747|NCT00402688|454398461|FG000|Overall Study|Lost to Follow-up|1|||
126302748|NCT00402688|454398462|FG001|Overall Study|Lost to Follow-up|0|||
126302749|NCT00402688|454398463|FG002|Overall Study|Lost to Follow-up|2|||
126302750|NCT00402688|454398461|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
126302751|NCT00402688|454398462|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
126367690|NCT00086515|454640996|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
126302752|NCT00402688|454398463|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
126302753|NCT00402688|454398461|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
126302754|NCT00402688|454398462|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
126302755|NCT00402688|454398463|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
126302756|NCT00402688|454398461|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
126302757|NCT00402688|454398462|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
126302758|NCT00402688|454398463|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
126302759|NCT00927862|454398464|FG000|Overall Study|Missing data needed for endpt analyses|27|||
126302760|NCT00927862|454398465|FG001|Overall Study|Missing data needed for endpt analyses|45|||
126302761|NCT00820248|454398467|FG000|Overall Study|No treated|4|||
126302762|NCT00820248|454398468|FG001|Overall Study|No treated|1|||
126302763|NCT03259425|454398469|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
126302764|NCT04112043|454398470|FG000|Overall Study|Withdrawal by Subject|1|||
126302765|NCT04112043|454398471|FG001|Overall Study|Withdrawal by Subject|1|||
126302766|NCT04112043|454398472|FG002|Overall Study|Withdrawal by Subject|1|||
126302767|NCT04112043|454398470|FG000|Overall Study|Taking NR supplement|1|||
126302768|NCT04112043|454398471|FG001|Overall Study|Taking NR supplement|0|||
126302769|NCT04112043|454398472|FG002|Overall Study|Taking NR supplement|0|||
126302770|NCT04112043|454398470|FG000|Overall Study|Adverse Event|0|||
126302771|NCT04112043|454398471|FG001|Overall Study|Adverse Event|1|||
126302772|NCT04112043|454398472|FG002|Overall Study|Adverse Event|0|||
126713189|NCT01988012|455902016|FG000|Overall Study|Patient Withdrawal of Consent|4|||
126713190|NCT01988012|455902016|FG000|Overall Study|Lost to Follow-up|1|||
126713191|NCT01988012|455902016|FG000|Overall Study|Physician Decision|1|||
126713192|NCT01988012|455902016|FG000|Overall Study|Protocol Violation|1|||
126302773|NCT04157296|454398473|FG000|Overall Study|Withdrawal by Subject|0|||
126302774|NCT04157296|454398474|FG001|Overall Study|Withdrawal by Subject|1|||
126302775|NCT04157296|454398473|FG000|Overall Study|Did not obtain second fMRI.|0|||
126302776|NCT04157296|454398474|FG001|Overall Study|Did not obtain second fMRI.|1|||
126302777|NCT04157296|454398473|FG000|Overall Study|MRI failed/no second fMRI|0|||
126302778|NCT04157296|454398474|FG001|Overall Study|MRI failed/no second fMRI|1|||
126302779|NCT02237196|454398475|FG000|Overall Study|Adverse Event|0|||
126302780|NCT02237196|454398476|FG001|Overall Study|Adverse Event|1|||
126302781|NCT02237196|454398477|FG002|Overall Study|Adverse Event|1|||
126302782|NCT02237196|454398478|FG003|Overall Study|Adverse Event|0|||
126302783|NCT02237196|454398475|FG000|Overall Study|Lost to Follow-up|4|||
126302784|NCT02237196|454398476|FG001|Overall Study|Lost to Follow-up|2|||
126302785|NCT02237196|454398477|FG002|Overall Study|Lost to Follow-up|4|||
126302786|NCT02237196|454398478|FG003|Overall Study|Lost to Follow-up|6|||
126302787|NCT02237196|454398475|FG000|Overall Study|Physician Decision|2|||
126302788|NCT02237196|454398476|FG001|Overall Study|Physician Decision|0|||
126302789|NCT02237196|454398477|FG002|Overall Study|Physician Decision|0|||
126302790|NCT02237196|454398478|FG003|Overall Study|Physician Decision|1|||
126302791|NCT02237196|454398475|FG000|Overall Study|Pregnancy|0|||
126302792|NCT02237196|454398476|FG001|Overall Study|Pregnancy|0|||
126713193|NCT03042611|455902017|FG000|Core Phase|Withdrawal by Subject|13|||
126713194|NCT03042611|455902018|FG001|Core Phase|Withdrawal by Subject|4|||
126713195|NCT03042611|455902019|FG002|Core Phase|Withdrawal by Subject|0|||
126713196|NCT03042611|455902020|FG003|Core Phase|Withdrawal by Subject|0|||
126713197|NCT03042611|455902017|FG000|Core Phase|Death|232|||
126713198|NCT03042611|455902018|FG001|Core Phase|Death|110|||
126713199|NCT03042611|455902019|FG002|Core Phase|Death|0|||
126713200|NCT03042611|455902020|FG003|Core Phase|Death|0|||
126713201|NCT03042611|455902017|FG000|Core Phase|Lost to Follow-up|4|||
126713202|NCT03042611|455902018|FG001|Core Phase|Lost to Follow-up|7|||
126713203|NCT03042611|455902019|FG002|Core Phase|Lost to Follow-up|0|||
126713204|NCT03042611|455902020|FG003|Core Phase|Lost to Follow-up|0|||
126713205|NCT03042611|455902017|FG000|Core Phase|Physician Decision|7|||
126713206|NCT03042611|455902018|FG001|Core Phase|Physician Decision|2|||
126713207|NCT03042611|455902019|FG002|Core Phase|Physician Decision|0|||
126713208|NCT03042611|455902020|FG003|Core Phase|Physician Decision|0|||
126713209|NCT03042611|455902017|FG000|Core Phase|Study Closed|0|||
126713210|NCT03042611|455902018|FG001|Core Phase|Study Closed|1|||
126713211|NCT03042611|455902019|FG002|Core Phase|Study Closed|0|||
126713212|NCT03042611|455902020|FG003|Core Phase|Study Closed|0|||
126713213|NCT03042611|455902017|FG000|Extension Phase|Death|0|||
126713214|NCT03042611|455902018|FG001|Extension Phase|Death|0|||
126713215|NCT03042611|455902019|FG002|Extension Phase|Death|34|||
126713216|NCT03042611|455902020|FG003|Extension Phase|Death|16|||
126713217|NCT03042611|455902017|FG000|Extension Phase|Lost to Follow-up|0|||
126713218|NCT03042611|455902018|FG001|Extension Phase|Lost to Follow-up|0|||
126713219|NCT03042611|455902019|FG002|Extension Phase|Lost to Follow-up|1|||
126713220|NCT03042611|455902020|FG003|Extension Phase|Lost to Follow-up|1|||
126713221|NCT03042611|455902017|FG000|Extension Phase|Study Closed|0|||
126713222|NCT03042611|455902018|FG001|Extension Phase|Study Closed|0|||
126713223|NCT03042611|455902019|FG002|Extension Phase|Study Closed|17|||
126713224|NCT03042611|455902020|FG003|Extension Phase|Study Closed|11|||
126302793|NCT02237196|454398477|FG002|Overall Study|Pregnancy|1|||
126302794|NCT02237196|454398478|FG003|Overall Study|Pregnancy|1|||
126302795|NCT02237196|454398475|FG000|Overall Study|Withdrawal by Subject|1|||
126302796|NCT02237196|454398476|FG001|Overall Study|Withdrawal by Subject|1|||
126713225|NCT02385123|455902023|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
126302797|NCT02237196|454398477|FG002|Overall Study|Withdrawal by Subject|4|||
126302798|NCT02237196|454398478|FG003|Overall Study|Withdrawal by Subject|1|||
126302799|NCT02237196|454398475|FG000|Overall Study|Site Error|1|||
126302800|NCT02237196|454398476|FG001|Overall Study|Site Error|2|||
126302801|NCT02237196|454398477|FG002|Overall Study|Site Error|0|||
126302802|NCT02237196|454398478|FG003|Overall Study|Site Error|2|||
126302803|NCT01750697|454398481|FG000|Overall Study|Transferred Back to Local Hospital|1|||
126302804|NCT01750697|454398481|FG000|Overall Study|Physician and Family Decision|1|||
126302805|NCT01750697|454398481|FG000|Overall Study|Transferred to Adult Services|5|||
126302806|NCT01750697|454398481|FG000|Overall Study|Physician Decision|1|||
126302807|NCT01750697|454398481|FG000|Overall Study|Withdrawal by Subject|1|||
126302808|NCT00862823|454398491|FG000|First Intervention|Withdrawal by Subject|1|||
126302809|NCT00862823|454398492|FG001|First Intervention|Withdrawal by Subject|1|||
126302810|NCT03674112|454398493|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
126302811|NCT03674112|454398494|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
126302812|NCT03674112|454398493|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
126302813|NCT03674112|454398494|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
126302814|NCT03674112|454398493|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
126302815|NCT03674112|454398494|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
126302816|NCT03674112|454398493|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
126302817|NCT03674112|454398494|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
126302818|NCT03674112|454398493|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
126302819|NCT03674112|454398494|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
126302820|NCT03674112|454398493|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
126302821|NCT03674112|454398494|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
126302822|NCT03674112|454398493|FG000|Follow-Up Period (≥3 Years)|Death|2|||
126302823|NCT03674112|454398494|FG001|Follow-Up Period (≥3 Years)|Death|0|||
126302824|NCT03674112|454398493|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
126302825|NCT03674112|454398494|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
126302826|NCT01421225|454398499|FG000|Overall Study|Withdrawal by Subject|0|||
126302827|NCT01421225|454398500|FG001|Overall Study|Withdrawal by Subject|1|||
126302828|NCT02049814|454398502|FG000|Overall Study|Reason not Specified|4|||
126302829|NCT02049814|454398503|FG001|Overall Study|Reason not Specified|3|||
126302830|NCT02049814|454398502|FG000|Overall Study|Pregnancy|1|||
126302831|NCT02049814|454398503|FG001|Overall Study|Pregnancy|0|||
126302832|NCT02049814|454398502|FG000|Overall Study|Lost to Follow-up|2|||
126302833|NCT02049814|454398503|FG001|Overall Study|Lost to Follow-up|3|||
126302834|NCT02049814|454398502|FG000|Overall Study|Serious Protocol Violation|5|||
126302835|NCT02049814|454398503|FG001|Overall Study|Serious Protocol Violation|7|||
126302836|NCT02049814|454398502|FG000|Overall Study|Study Termination|0|||
126302837|NCT02049814|454398503|FG001|Overall Study|Study Termination|1|||
126302838|NCT02049814|454398502|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
126302839|NCT02049814|454398503|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
126302840|NCT02049814|454398502|FG000|Overall Study|Voluntary withdrawal|9|||
126302841|NCT02049814|454398503|FG001|Overall Study|Voluntary withdrawal|8|||
126302842|NCT01282372|454398504|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
126302843|NCT01282372|454398504|FG000|Overall Study|Lost to Follow-up|23|||
126302844|NCT01282372|454398504|FG000|Overall Study|Withdrawal by Subject|11|||
126302845|NCT01282372|454398504|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
126302846|NCT01282372|454398504|FG000|Overall Study|Death|1|||
126302847|NCT01282372|454398504|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
126302848|NCT01282372|454398504|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
126302849|NCT01282372|454398504|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
126302850|NCT01282372|454398504|FG000|Overall Study|Adverse Event|12|||
126302851|NCT01322490|454398506|FG000|Treatment Period|Adverse Event|12|||
126302852|NCT01322490|454398507|FG001|Treatment Period|Adverse Event|18|||
126302853|NCT01322490|454398508|FG002|Treatment Period|Adverse Event|15|||
126302854|NCT01322490|454398506|FG000|Treatment Period|Death|5|||
126302855|NCT01322490|454398507|FG001|Treatment Period|Death|7|||
126302856|NCT01322490|454398508|FG002|Treatment Period|Death|3|||
126302857|NCT01322490|454398506|FG000|Treatment Period|Lack of Efficacy|89|||
126302858|NCT01322490|454398507|FG001|Treatment Period|Lack of Efficacy|100|||
126302859|NCT01322490|454398508|FG002|Treatment Period|Lack of Efficacy|112|||
126302860|NCT01322490|454398506|FG000|Treatment Period|Physician Decision|0|||
126302861|NCT01322490|454398507|FG001|Treatment Period|Physician Decision|2|||
126302862|NCT01322490|454398508|FG002|Treatment Period|Physician Decision|1|||
126302863|NCT01322490|454398506|FG000|Treatment Period|Protocol Violation|7|||
126302864|NCT01322490|454398507|FG001|Treatment Period|Protocol Violation|5|||
126302865|NCT01322490|454398508|FG002|Treatment Period|Protocol Violation|4|||
126302866|NCT01322490|454398506|FG000|Treatment Period|Withdrawal by Subject|14|||
126302867|NCT01322490|454398507|FG001|Treatment Period|Withdrawal by Subject|16|||
126302868|NCT01322490|454398508|FG002|Treatment Period|Withdrawal by Subject|11|||
126302869|NCT01322490|454398506|FG000|Treatment Period|Non-compliance with study drug|0|||
126302870|NCT01322490|454398507|FG001|Treatment Period|Non-compliance with study drug|0|||
126550871|NCT01987596|455311687|FG001|Overall Study|Physician Decision|0|||
126550872|NCT01987596|455311686|FG000|Overall Study|Progressive Disease; missing all period|0|||
126550873|NCT01987596|455311687|FG001|Overall Study|Progressive Disease; missing all period|1|||
126550874|NCT00358150|455311688|FG000|Overall Study|Adverse Event|3|||
126550875|NCT00358150|455311688|FG000|Overall Study|Withdrawal by Subject|1|||
126550876|NCT00358150|455311688|FG000|Overall Study|Undefined|3|||
126550877|NCT04668989|455311692|FG000|First Intervention|Covid-19 related self-isolation|0|||
126550878|NCT04668989|455311693|FG001|First Intervention|Covid-19 related self-isolation|1|||
126550879|NCT04668989|455311692|FG000|Second Intervention|Adverse Event|0|||
126550880|NCT04668989|455311693|FG001|Second Intervention|Adverse Event|1|||
126550881|NCT01622348|455311695|FG000|Overall Study|Withdrawal by Subject|1|||
126550882|NCT01622348|455311696|FG001|Overall Study|Withdrawal by Subject|0|||
126367691|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
126367692|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
126367693|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
126367694|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
126367695|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
126367696|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
126367697|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
126367698|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
126367699|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
126367700|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
126367701|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
126367702|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
126367703|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
126367704|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
126367705|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
126367706|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
126550883|NCT01622348|455311697|FG002|Overall Study|Withdrawal by Subject|1|||
126550884|NCT00179010|455311698|FG000|Overall Study|Muscle probe defective|1|||
126550885|NCT00179010|455311699|FG001|Overall Study|Muscle probe defective|1|||
126550886|NCT00179010|455311698|FG000|Overall Study|Failure to place arterial line|0|||
126550887|NCT00179010|455311699|FG001|Overall Study|Failure to place arterial line|1|||
126367707|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
126367708|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
126550888|NCT01592695|455311708|FG000|Overall Study|Lost to Follow-up|8|||
126550889|NCT01592695|455311709|FG001|Overall Study|Lost to Follow-up|4|||
126550890|NCT00467142|455311716|FG000|Overall Study|Withdrawal by Subject|1|||
126550891|NCT00467142|455311716|FG000|Overall Study|Adverse Event|1|||
126367709|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
126367710|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
126367711|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
126367712|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
126550892|NCT00467142|455311716|FG000|Overall Study|Protocol Violation|1|||
126550893|NCT01763788|455311722|FG000|Overall Study|Lost to Follow-up|0|||
126550894|NCT01763788|455311723|FG001|Overall Study|Lost to Follow-up|0|||
126550895|NCT01763788|455311724|FG002|Overall Study|Lost to Follow-up|1|||
126550896|NCT01763788|455311725|FG003|Overall Study|Lost to Follow-up|0|||
126550897|NCT03893825|455311726|FG000|Overall Study|Death|2|||
126550898|NCT03893825|455311727|FG001|Overall Study|Death|1|||
126550899|NCT03893825|455311726|FG000|Overall Study|Adverse Event|0|||
126550900|NCT03893825|455311727|FG001|Overall Study|Adverse Event|2|||
126550901|NCT03893825|455311726|FG000|Overall Study|Withdrawal by Subject|19|||
126550902|NCT03893825|455311727|FG001|Overall Study|Withdrawal by Subject|21|||
126550903|NCT03893825|455311726|FG000|Overall Study|Protocol deviation|1|||
126550904|NCT03893825|455311727|FG001|Overall Study|Protocol deviation|0|||
126550905|NCT03893825|455311726|FG000|Overall Study|Lost to Follow-up|10|||
126550906|NCT03893825|455311727|FG001|Overall Study|Lost to Follow-up|10|||
126550907|NCT03893825|455311726|FG000|Overall Study|Other than specified|7|||
126550908|NCT03893825|455311727|FG001|Overall Study|Other than specified|6|||
126550909|NCT02771210|455311734|FG000|Period 1|Adverse Event|5|||
126550910|NCT02771210|455311735|FG001|Period 1|Adverse Event|3|||
126550911|NCT02771210|455311734|FG000|Period 1|Lack of Efficacy|3|||
126367713|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
126367714|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
126550912|NCT02771210|455311735|FG001|Period 1|Lack of Efficacy|6|||
126550913|NCT02771210|455311734|FG000|Period 1|Lost to Follow-up|2|||
126550914|NCT02771210|455311735|FG001|Period 1|Lost to Follow-up|0|||
126550915|NCT02771210|455311734|FG000|Period 1|Physician Decision|0|||
126550916|NCT02771210|455311735|FG001|Period 1|Physician Decision|1|||
126550917|NCT02771210|455311734|FG000|Period 1|Withdrawal by Subject|0|||
126550918|NCT02771210|455311735|FG001|Period 1|Withdrawal by Subject|3|||
126550919|NCT02771210|455311734|FG000|Period 1|Withdrawal of informed consent|1|||
126550920|NCT02771210|455311735|FG001|Period 1|Withdrawal of informed consent|5|||
126550921|NCT02771210|455311734|FG000|Period 2|Adverse Event|1|||
126550922|NCT02771210|455311735|FG001|Period 2|Adverse Event|0|||
126550923|NCT02771210|455311734|FG000|Period 2|Lack of Efficacy|0|||
126550924|NCT02771210|455311735|FG001|Period 2|Lack of Efficacy|1|||
126550925|NCT02771210|455311734|FG000|Period 2|Withdrawal by Subject|1|||
126550926|NCT02771210|455311735|FG001|Period 2|Withdrawal by Subject|0|||
126550927|NCT02771210|455311734|FG000|Period 2|Withdrawal of informed consent|0|||
126550928|NCT02771210|455311735|FG001|Period 2|Withdrawal of informed consent|2|||
126550929|NCT04397523|455311737|FG000|Overall Study|Lost to Follow-up|3|||
126550930|NCT04397523|455311737|FG000|Overall Study|Transfer from/to other hospital|8|||
126550931|NCT01275196|455311738|FG000|Overall Study|Adverse Event|3|||
126550932|NCT01275196|455311739|FG001|Overall Study|Adverse Event|5|||
126550933|NCT01275196|455311738|FG000|Overall Study|Withdrawal by Subject|4|||
126550934|NCT01275196|455311739|FG001|Overall Study|Withdrawal by Subject|5|||
126550935|NCT01275196|455311738|FG000|Overall Study|Lost to Follow-up|1|||
126550936|NCT01275196|455311739|FG001|Overall Study|Lost to Follow-up|0|||
126550937|NCT01275196|455311738|FG000|Overall Study|Disease Progression|6|||
126550938|NCT01275196|455311739|FG001|Overall Study|Disease Progression|5|||
126550939|NCT01275196|455311738|FG000|Overall Study|Protocol Violation|1|||
126550940|NCT01275196|455311739|FG001|Overall Study|Protocol Violation|0|||
126550941|NCT01275196|455311738|FG000|Overall Study|Suboptimal response/treatment failure|5|||
126550942|NCT01275196|455311739|FG001|Overall Study|Suboptimal response/treatment failure|6|||
126550943|NCT00684762|455311765|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
126550944|NCT00684762|455311766|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
126550945|NCT02572817|455311767|FG000|Overall Study|Death|6|||
126550946|NCT02572817|455311768|FG001|Overall Study|Death|3|||
126550947|NCT02572817|455311767|FG000|Overall Study|Lost to Follow-up|3|||
126550948|NCT02572817|455311768|FG001|Overall Study|Lost to Follow-up|3|||
126550949|NCT02441946|455311771|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
126462211|NCT02398227|454993019|FG001|Overall Study|Withdrawal by Subject|6|||
126462212|NCT02398227|454993018|FG000|Overall Study|Removed from treatment and dropped out|1|||
126462213|NCT02398227|454993019|FG001|Overall Study|Removed from treatment and dropped out|0|||
126462214|NCT01185834|454993020|FG000|Overall Study|Lost to Follow-up|2|||
126462215|NCT01185834|454993020|FG000|Overall Study|Discomfort|4|||
126302871|NCT01322490|454398508|FG002|Treatment Period|Non-compliance with study drug|1|||
126302872|NCT01322490|454398506|FG000|Treatment Period|Other per report|2|||
126302873|NCT01322490|454398507|FG001|Treatment Period|Other per report|2|||
126302874|NCT01322490|454398508|FG002|Treatment Period|Other per report|1|||
126302875|NCT01322490|454398506|FG000|Treatment Period|Randomized but Not Treated|3|||
126302876|NCT01322490|454398507|FG001|Treatment Period|Randomized but Not Treated|3|||
126462216|NCT01185834|454993020|FG000|Overall Study|Biomicroscopy|4|||
126462217|NCT01185834|454993020|FG000|Overall Study|Time/Job Conflict|2|||
126462218|NCT01185834|454993020|FG000|Overall Study|Early exit - Site error|2|||
126462219|NCT01975831|454993021|FG000|Overall Study|Adverse Event|1|||
126462220|NCT01975831|454993022|FG001|Overall Study|Adverse Event|2|||
126462221|NCT01975831|454993023|FG002|Overall Study|Adverse Event|2|||
126462222|NCT01975831|454993024|FG003|Overall Study|Adverse Event|0|||
126462223|NCT01975831|454993025|FG004|Overall Study|Adverse Event|1|||
126462224|NCT01975831|454993026|FG005|Overall Study|Adverse Event|1|||
126462225|NCT01975831|454993027|FG006|Overall Study|Adverse Event|3|||
126462226|NCT01975831|454993028|FG007|Overall Study|Adverse Event|4|||
126462227|NCT01975831|454993029|FG008|Overall Study|Adverse Event|1|||
126462228|NCT01975831|454993021|FG000|Overall Study|Death|1|||
126462229|NCT01975831|454993022|FG001|Overall Study|Death|1|||
126462230|NCT01975831|454993023|FG002|Overall Study|Death|0|||
126462231|NCT01975831|454993024|FG003|Overall Study|Death|0|||
126462232|NCT01975831|454993025|FG004|Overall Study|Death|1|||
126462233|NCT01975831|454993026|FG005|Overall Study|Death|0|||
126462234|NCT01975831|454993027|FG006|Overall Study|Death|1|||
126462235|NCT01975831|454993028|FG007|Overall Study|Death|0|||
126462236|NCT01975831|454993029|FG008|Overall Study|Death|0|||
126462237|NCT01975831|454993021|FG000|Overall Study|Progressive Disease|1|||
126462238|NCT01975831|454993022|FG001|Overall Study|Progressive Disease|3|||
126462239|NCT01975831|454993023|FG002|Overall Study|Progressive Disease|2|||
126462240|NCT01975831|454993024|FG003|Overall Study|Progressive Disease|4|||
126462241|NCT01975831|454993025|FG004|Overall Study|Progressive Disease|13|||
126462242|NCT01975831|454993026|FG005|Overall Study|Progressive Disease|9|||
126462243|NCT01975831|454993027|FG006|Overall Study|Progressive Disease|10|||
126462244|NCT01975831|454993028|FG007|Overall Study|Progressive Disease|8|||
126462245|NCT01975831|454993029|FG008|Overall Study|Progressive Disease|10|||
126462246|NCT01975831|454993021|FG000|Overall Study|Withdrawal by Subject|0|||
126550950|NCT02441946|455311772|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
126550951|NCT02441946|455311773|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
126550952|NCT02441946|455311771|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
126550953|NCT02441946|455311772|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
126550954|NCT02441946|455311773|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
126550955|NCT02441946|455311771|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
126302877|NCT01322490|454398508|FG002|Treatment Period|Randomized but Not Treated|5|||
126462247|NCT01975831|454993022|FG001|Overall Study|Withdrawal by Subject|3|||
126462248|NCT01975831|454993023|FG002|Overall Study|Withdrawal by Subject|0|||
126462249|NCT01975831|454993024|FG003|Overall Study|Withdrawal by Subject|0|||
126550956|NCT02441946|455311772|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
126550957|NCT02441946|455311773|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
126550958|NCT02441946|455311771|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
126550959|NCT02441946|455311772|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
126550960|NCT02441946|455311773|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
126550961|NCT02441946|455311771|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
126550962|NCT02441946|455311772|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
126550963|NCT02441946|455311773|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
126550964|NCT02441946|455311771|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
126550965|NCT02441946|455311772|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
126462250|NCT01975831|454993025|FG004|Overall Study|Withdrawal by Subject|3|||
126462251|NCT01975831|454993026|FG005|Overall Study|Withdrawal by Subject|1|||
126550966|NCT02441946|455311773|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
126550967|NCT02441946|455311771|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
126550968|NCT02441946|455311772|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
126550969|NCT02441946|455311773|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
126550970|NCT02441946|455311771|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
126462252|NCT01975831|454993027|FG006|Overall Study|Withdrawal by Subject|1|||
126462253|NCT01975831|454993028|FG007|Overall Study|Withdrawal by Subject|0|||
126550971|NCT02441946|455311772|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
126550972|NCT02441946|455311773|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
126550973|NCT02441946|455311771|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
126550974|NCT02441946|455311772|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
126550975|NCT02441946|455311773|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
126550976|NCT02441946|455311771|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
126550977|NCT02441946|455311772|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
126550978|NCT02441946|455311773|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
126550979|NCT02441946|455311771|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
126550980|NCT02441946|455311772|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126550981|NCT02441946|455311773|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126550982|NCT02111213|455311774|FG000|Overall Study|Withdrawal by Subject|3|||
126550983|NCT02111213|455311775|FG001|Overall Study|Withdrawal by Subject|2|||
126550984|NCT02111213|455311774|FG000|Overall Study|Lost to Follow-up|3|||
126550985|NCT02111213|455311775|FG001|Overall Study|Lost to Follow-up|4|||
126550986|NCT02761629|455311776|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
126550987|NCT02761629|455311777|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
126550988|NCT02761629|455311776|FG000|Overall Study|Insufficient Therapeutic Response|2|||
126550989|NCT02761629|455311777|FG001|Overall Study|Insufficient Therapeutic Response|7|||
126550990|NCT02761629|455311776|FG000|Overall Study|Failure to Return|2|||
126550991|NCT02761629|455311777|FG001|Overall Study|Failure to Return|4|||
126550992|NCT02761629|455311776|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
126550993|NCT02761629|455311777|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
126550994|NCT02761629|455311776|FG000|Overall Study|Protocol Violation|2|||
126550995|NCT02761629|455311777|FG001|Overall Study|Protocol Violation|2|||
126550996|NCT02761629|455311776|FG000|Overall Study|Withdrawal by Subject|0|||
126367715|NCT00086515|454640995|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
126367716|NCT00086515|454640996|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
126367717|NCT00049543|454640997|FG000|Overall Study|still on treatment|2|||
126367718|NCT00049543|454640998|FG001|Overall Study|still on treatment|9|||
126367719|NCT02106832|454640999|FG000|Overall Study|Adverse Event|1|||
126367720|NCT02106832|454641000|FG001|Overall Study|Adverse Event|2|||
126462254|NCT01975831|454993029|FG008|Overall Study|Withdrawal by Subject|0|||
126462255|NCT01975831|454993021|FG000|Overall Study|Physician Decision|0|||
126462256|NCT01975831|454993022|FG001|Overall Study|Physician Decision|0|||
126462257|NCT01975831|454993023|FG002|Overall Study|Physician Decision|0|||
126462258|NCT01975831|454993024|FG003|Overall Study|Physician Decision|0|||
126462259|NCT01975831|454993025|FG004|Overall Study|Physician Decision|0|||
126462260|NCT01975831|454993026|FG005|Overall Study|Physician Decision|1|||
126462261|NCT01975831|454993027|FG006|Overall Study|Physician Decision|0|||
126462262|NCT01975831|454993028|FG007|Overall Study|Physician Decision|1|||
126367721|NCT02106832|454641001|FG002|Overall Study|Adverse Event|3|||
126367722|NCT02106832|454641002|FG003|Overall Study|Adverse Event|0|||
126367723|NCT02106832|454640999|FG000|Overall Study|Death|4|||
126367724|NCT02106832|454641000|FG001|Overall Study|Death|4|||
126367725|NCT02106832|454641001|FG002|Overall Study|Death|1|||
126367726|NCT02106832|454641002|FG003|Overall Study|Death|4|||
126367727|NCT02106832|454640999|FG000|Overall Study|Deterioration of general conditions|0|||
126462263|NCT01975831|454993029|FG008|Overall Study|Physician Decision|0|||
126462264|NCT01975831|454993021|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
126550997|NCT02761629|455311777|FG001|Overall Study|Withdrawal by Subject|3|||
126550998|NCT02761629|455311776|FG000|Overall Study|Other|0|||
126367728|NCT02106832|454641000|FG001|Overall Study|Deterioration of general conditions|0|||
126367729|NCT02106832|454641001|FG002|Overall Study|Deterioration of general conditions|1|||
126462265|NCT01975831|454993022|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
126462266|NCT01975831|454993023|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
126462267|NCT01975831|454993024|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
126462268|NCT01975831|454993025|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
126462269|NCT01975831|454993026|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
126462270|NCT01975831|454993027|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
126462271|NCT01975831|454993028|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
126462272|NCT01975831|454993029|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
126462273|NCT01975831|454993021|FG000|Overall Study|Entered Hospice|0|||
126462274|NCT01975831|454993022|FG001|Overall Study|Entered Hospice|0|||
126462275|NCT01975831|454993023|FG002|Overall Study|Entered Hospice|0|||
126462276|NCT01975831|454993024|FG003|Overall Study|Entered Hospice|0|||
126462277|NCT01975831|454993025|FG004|Overall Study|Entered Hospice|0|||
126462278|NCT01975831|454993026|FG005|Overall Study|Entered Hospice|1|||
126713226|NCT04504032|455902026|FG000|Overall Study|Adverse Event|1|||
126713227|NCT04504032|455902027|FG001|Overall Study|Adverse Event|2|||
126713228|NCT04504032|455902026|FG000|Overall Study|Lost to Follow-up|6|||
126302878|NCT01322490|454398506|FG000|Long Term Follow-up Period|Death|235|||
126302879|NCT01322490|454398507|FG001|Long Term Follow-up Period|Death|239|||
126302880|NCT01322490|454398508|FG002|Long Term Follow-up Period|Death|236|||
126302881|NCT01322490|454398506|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
126302882|NCT01322490|454398507|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
126302883|NCT01322490|454398508|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
126302884|NCT01322490|454398506|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
126302885|NCT01322490|454398507|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
126302886|NCT01322490|454398508|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
126302887|NCT01322490|454398506|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
126302888|NCT01322490|454398507|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
126302889|NCT01322490|454398508|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
126302890|NCT01322490|454398506|FG000|Long Term Follow-up Period|Other per report|3|||
126302891|NCT01322490|454398507|FG001|Long Term Follow-up Period|Other per report|2|||
126302892|NCT01322490|454398508|FG002|Long Term Follow-up Period|Other per report|2|||
126302893|NCT01322490|454398506|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
126302894|NCT01322490|454398507|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
126302895|NCT01322490|454398508|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
126302896|NCT00356148|454398509|FG000|Overall Study|Reoperation within 30 days|2|||
126302897|NCT00356148|454398510|FG001|Overall Study|Reoperation within 30 days|1|||
126302898|NCT02693002|454398511|FG000|Overall Study|Withdrawal by Subject|1|||
126302899|NCT02693002|454398512|FG001|Overall Study|Withdrawal by Subject|0|||
126302900|NCT00014495|454398513|FG000|Overall Study|Death|0|||
126302901|NCT00014495|454398514|FG001|Overall Study|Death|0|||
126302902|NCT00014495|454398515|FG002|Overall Study|Death|1|||
126302903|NCT00014495|454398516|FG003|Overall Study|Death|0|||
126302904|NCT00014495|454398513|FG000|Overall Study|Clinical deterioration|0|||
126302905|NCT00014495|454398514|FG001|Overall Study|Clinical deterioration|0|||
126302906|NCT00014495|454398515|FG002|Overall Study|Clinical deterioration|0|||
126302907|NCT00014495|454398516|FG003|Overall Study|Clinical deterioration|1|||
126302908|NCT03225105|454398550|FG000|Overall Study|Withdrawal by Subject|1|||
126302909|NCT03225105|454398551|FG001|Overall Study|Withdrawal by Subject|0|||
126302910|NCT03225105|454398552|FG002|Overall Study|Withdrawal by Subject|0|||
126302911|NCT03225105|454398553|FG003|Overall Study|Withdrawal by Subject|0|||
126302912|NCT03225105|454398550|FG000|Overall Study|Death|0|||
126302913|NCT03225105|454398551|FG001|Overall Study|Death|4|||
126367730|NCT02106832|454641002|FG003|Overall Study|Deterioration of general conditions|0|||
126367731|NCT02106832|454640999|FG000|Overall Study|Lost to Follow-up|0|||
126367732|NCT02106832|454641000|FG001|Overall Study|Lost to Follow-up|1|||
126367733|NCT02106832|454641001|FG002|Overall Study|Lost to Follow-up|1|||
126367734|NCT02106832|454641002|FG003|Overall Study|Lost to Follow-up|3|||
126367735|NCT02106832|454640999|FG000|Overall Study|Physician Decision|1|||
126367736|NCT02106832|454641000|FG001|Overall Study|Physician Decision|0|||
126367737|NCT02106832|454641001|FG002|Overall Study|Physician Decision|0|||
126367738|NCT02106832|454641002|FG003|Overall Study|Physician Decision|0|||
126367739|NCT02106832|454640999|FG000|Overall Study|Protocol Violation|0|||
126367740|NCT02106832|454641000|FG001|Overall Study|Protocol Violation|0|||
126367741|NCT02106832|454641001|FG002|Overall Study|Protocol Violation|0|||
126367742|NCT02106832|454641002|FG003|Overall Study|Protocol Violation|1|||
126367743|NCT02106832|454640999|FG000|Overall Study|Withdrawal by Subject|17|||
126367744|NCT02106832|454641000|FG001|Overall Study|Withdrawal by Subject|17|||
126367745|NCT02106832|454641001|FG002|Overall Study|Withdrawal by Subject|10|||
126367746|NCT02106832|454641002|FG003|Overall Study|Withdrawal by Subject|7|||
126462279|NCT01975831|454993027|FG006|Overall Study|Entered Hospice|0|||
126462280|NCT01975831|454993028|FG007|Overall Study|Entered Hospice|0|||
126367747|NCT02106832|454640999|FG000|Overall Study|Technical problems|0|||
126462281|NCT01975831|454993029|FG008|Overall Study|Entered Hospice|0|||
126462282|NCT01975831|454993021|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
126462283|NCT01975831|454993022|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
126713229|NCT04504032|455902027|FG001|Overall Study|Lost to Follow-up|9|||
126367748|NCT02106832|454641000|FG001|Overall Study|Technical problems|1|||
126367749|NCT02106832|454641001|FG002|Overall Study|Technical problems|0|||
126367750|NCT02106832|454641002|FG003|Overall Study|Technical problems|0|||
126367751|NCT03485157|454641003|FG000|Double Blind Phase|Lost to Follow-up|4|||
126367752|NCT03485157|454641004|FG001|Double Blind Phase|Lost to Follow-up|4|||
126367753|NCT03485157|454641003|FG000|Double Blind Phase|Adverse Event|2|||
126367754|NCT03485157|454641004|FG001|Double Blind Phase|Adverse Event|1|||
126367755|NCT03485157|454641003|FG000|Double Blind Phase|Withdrawal by Subject|6|||
126367756|NCT03485157|454641004|FG001|Double Blind Phase|Withdrawal by Subject|9|||
126367757|NCT03485157|454641003|FG000|Double Blind Phase|Removal by PI|3|||
126367758|NCT03485157|454641004|FG001|Double Blind Phase|Removal by PI|7|||
126367759|NCT03485157|454641003|FG000|Open Label Phase|Lost to Follow-up|1|||
126367760|NCT03485157|454641004|FG001|Open Label Phase|Lost to Follow-up|2|||
126367761|NCT03485157|454641003|FG000|Open Label Phase|Adverse Event|0|||
126367762|NCT03485157|454641004|FG001|Open Label Phase|Adverse Event|1|||
126367763|NCT03485157|454641003|FG000|Open Label Phase|Withdrawal by Subject|1|||
126367764|NCT03485157|454641004|FG001|Open Label Phase|Withdrawal by Subject|2|||
126367765|NCT03485157|454641003|FG000|Open Label Phase|Removal by PI|2|||
126367766|NCT03485157|454641004|FG001|Open Label Phase|Removal by PI|0|||
126367767|NCT00265122|454641005|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
126367768|NCT00265122|454641006|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
126367769|NCT00265122|454641007|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
126367770|NCT00265122|454641008|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
126367771|NCT00265122|454641009|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
126367772|NCT00265122|454641010|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
126367773|NCT00265122|454641005|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
126367774|NCT00265122|454641006|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
126367775|NCT00265122|454641007|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
126367776|NCT00265122|454641008|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
126367777|NCT00265122|454641009|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
126367778|NCT00265122|454641010|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
126550999|NCT02761629|455311777|FG001|Overall Study|Other|2|||
126551000|NCT02761629|455311776|FG000|Overall Study|Lost to Follow-up|4|||
126551001|NCT02761629|455311777|FG001|Overall Study|Lost to Follow-up|1|||
126551002|NCT02761629|455311776|FG000|Overall Study|Randomized But Not Treated|8|||
126367779|NCT00265122|454641005|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
126367780|NCT00265122|454641006|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
126367781|NCT00265122|454641007|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
126367782|NCT00265122|454641008|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
126367783|NCT00265122|454641009|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
126367784|NCT00265122|454641010|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
126367785|NCT00265122|454641005|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
126367786|NCT00265122|454641006|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
126367787|NCT00265122|454641007|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
126367788|NCT00265122|454641008|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
126367789|NCT00265122|454641009|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
126367790|NCT00265122|454641010|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
126367791|NCT00265122|454641005|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
126367792|NCT00265122|454641006|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
126367793|NCT00265122|454641007|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
126367794|NCT00265122|454641008|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
126367795|NCT00265122|454641009|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
126367796|NCT00265122|454641010|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
126367797|NCT00265122|454641005|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
126367798|NCT00265122|454641006|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
126367799|NCT00265122|454641007|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
126367800|NCT00265122|454641008|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
126367801|NCT00265122|454641009|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
126367802|NCT00265122|454641010|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
126367803|NCT05205616|454641017|FG000|Overall Study|Lost to Follow-up|4|||
126367804|NCT05205616|454641018|FG001|Overall Study|Lost to Follow-up|4|||
126367805|NCT00663260|454641024|FG000|Overall Study|Lack of Efficacy|2|||
126367806|NCT00663260|454641025|FG001|Overall Study|Lack of Efficacy|0|||
126367807|NCT00663260|454641026|FG002|Overall Study|Lack of Efficacy|0|||
126367808|NCT00663260|454641024|FG000|Overall Study|Adverse Event|12|||
126367809|NCT00663260|454641025|FG001|Overall Study|Adverse Event|7|||
126367810|NCT00663260|454641026|FG002|Overall Study|Adverse Event|6|||
126367811|NCT00663260|454641024|FG000|Overall Study|Withdrawal by Subject|3|||
126367812|NCT00663260|454641025|FG001|Overall Study|Withdrawal by Subject|1|||
126367813|NCT00663260|454641026|FG002|Overall Study|Withdrawal by Subject|6|||
126367814|NCT00663260|454641024|FG000|Overall Study|Death|1|||
126367815|NCT00663260|454641025|FG001|Overall Study|Death|0|||
126302914|NCT03225105|454398552|FG002|Overall Study|Death|2|||
126302915|NCT03225105|454398553|FG003|Overall Study|Death|0|||
126302916|NCT03225105|454398550|FG000|Overall Study|Study termination per Sponsor Decision|2|||
126302917|NCT03225105|454398551|FG001|Overall Study|Study termination per Sponsor Decision|0|||
126302918|NCT03225105|454398552|FG002|Overall Study|Study termination per Sponsor Decision|3|||
126302919|NCT03225105|454398553|FG003|Overall Study|Study termination per Sponsor Decision|3|||
126302920|NCT00757042|454398554|FG000|Overall Study|Lost to Follow-up|0|||
126302921|NCT00757042|454398555|FG001|Overall Study|Lost to Follow-up|0|||
126302922|NCT00757042|454398556|FG002|Overall Study|Lost to Follow-up|0|||
126302923|NCT00757042|454398557|FG003|Overall Study|Lost to Follow-up|0|||
126302924|NCT00757042|454398558|FG004|Overall Study|Lost to Follow-up|0|||
126302925|NCT00757042|454398559|FG005|Overall Study|Lost to Follow-up|0|||
126302926|NCT00757042|454398560|FG006|Overall Study|Lost to Follow-up|0|||
126302927|NCT00757042|454398561|FG007|Overall Study|Lost to Follow-up|0|||
126302928|NCT00757042|454398562|FG008|Overall Study|Lost to Follow-up|1|||
126302929|NCT00757042|454398563|FG009|Overall Study|Lost to Follow-up|0|||
126302930|NCT00757042|454398564|FG010|Overall Study|Lost to Follow-up|0|||
126302931|NCT00757042|454398554|FG000|Overall Study|Ineligibility Determined|0|||
126302932|NCT00757042|454398555|FG001|Overall Study|Ineligibility Determined|0|||
126302933|NCT00757042|454398556|FG002|Overall Study|Ineligibility Determined|0|||
126302934|NCT00757042|454398557|FG003|Overall Study|Ineligibility Determined|0|||
126302935|NCT00757042|454398558|FG004|Overall Study|Ineligibility Determined|0|||
126302936|NCT00757042|454398559|FG005|Overall Study|Ineligibility Determined|0|||
126302937|NCT00757042|454398560|FG006|Overall Study|Ineligibility Determined|0|||
126302938|NCT00757042|454398561|FG007|Overall Study|Ineligibility Determined|0|||
126302939|NCT00757042|454398562|FG008|Overall Study|Ineligibility Determined|0|||
126302940|NCT00757042|454398563|FG009|Overall Study|Ineligibility Determined|0|||
126302941|NCT00757042|454398564|FG010|Overall Study|Ineligibility Determined|1|||
126302942|NCT00757042|454398554|FG000|Overall Study|Withdrawal by Subject|0|||
126302943|NCT00757042|454398555|FG001|Overall Study|Withdrawal by Subject|0|||
126302944|NCT00757042|454398556|FG002|Overall Study|Withdrawal by Subject|0|||
126302945|NCT00757042|454398557|FG003|Overall Study|Withdrawal by Subject|0|||
126302946|NCT00757042|454398558|FG004|Overall Study|Withdrawal by Subject|0|||
126462284|NCT01975831|454993023|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
126462285|NCT01975831|454993024|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
126462286|NCT01975831|454993025|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
126462287|NCT01975831|454993026|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
126462288|NCT01975831|454993027|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
126462289|NCT01975831|454993028|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
126462290|NCT01975831|454993029|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
126462291|NCT00887744|454993030|FG000|Overall Study|Adverse Event|3|||
126462292|NCT00887744|454993030|FG000|Overall Study|Death|1|||
126462293|NCT00887744|454993030|FG000|Overall Study|Lost to Follow-up|3|||
126462294|NCT00887744|454993030|FG000|Overall Study|Withdrawal by Subject|18|||
126462295|NCT00887744|454993030|FG000|Overall Study|Various reasons|9|||
126462296|NCT04473482|454993031|FG000|Overall Study|Death|0|||
126462297|NCT04473482|454993032|FG001|Overall Study|Death|3|||
126462298|NCT04473482|454993031|FG000|Overall Study|Lost to Follow-up|9|||
126462299|NCT04473482|454993032|FG001|Overall Study|Lost to Follow-up|7|||
126462300|NCT04473482|454993031|FG000|Overall Study|Withdrawal by Subject|2|||
126462301|NCT04473482|454993032|FG001|Overall Study|Withdrawal by Subject|1|||
126462302|NCT00321893|454993034|FG000|Overall Study|Non-Compliance/Refusal|16|||
126462303|NCT00321893|454993035|FG001|Overall Study|Non-Compliance/Refusal|10|||
126462304|NCT00321893|454993034|FG000|Overall Study|Lost to Follow-up|2|||
126462305|NCT00321893|454993035|FG001|Overall Study|Lost to Follow-up|1|||
126462306|NCT00321893|454993034|FG000|Overall Study|Adverse Event|6|||
126462307|NCT00321893|454993035|FG001|Overall Study|Adverse Event|3|||
126462308|NCT01306877|454993036|FG000|Overall Study|Lost to Follow-up|3|||
126462309|NCT01306877|454993037|FG001|Overall Study|Lost to Follow-up|3|||
126462310|NCT01306877|454993036|FG000|Overall Study|Physician Decision|0|||
126462311|NCT01306877|454993037|FG001|Overall Study|Physician Decision|1|||
126302947|NCT00757042|454398559|FG005|Overall Study|Withdrawal by Subject|0|||
126462312|NCT00999921|454993042|FG000|Overall Study|Lost to Follow-up|10|||
126462313|NCT00999921|454993043|FG001|Overall Study|Lost to Follow-up|19|||
126462314|NCT00989573|454993044|FG000|Overall Study|Adverse Event|8|||
126462315|NCT00989573|454993045|FG001|Overall Study|Adverse Event|12|||
126462316|NCT00989573|454993046|FG002|Overall Study|Adverse Event|4|||
126462317|NCT00989573|454993044|FG000|Overall Study|Physician Decision|0|||
126462318|NCT00989573|454993045|FG001|Overall Study|Physician Decision|2|||
126462319|NCT00989573|454993046|FG002|Overall Study|Physician Decision|0|||
126302948|NCT00757042|454398560|FG006|Overall Study|Withdrawal by Subject|0|||
126462320|NCT00989573|454993044|FG000|Overall Study|Protocol Violation|1|||
126462321|NCT00989573|454993045|FG001|Overall Study|Protocol Violation|1|||
126462322|NCT00989573|454993046|FG002|Overall Study|Protocol Violation|1|||
126462323|NCT00989573|454993044|FG000|Overall Study|Withdrawal by Subject|4|||
126462324|NCT00989573|454993045|FG001|Overall Study|Withdrawal by Subject|7|||
126551003|NCT02761629|455311777|FG001|Overall Study|Randomized But Not Treated|4|||
126462325|NCT00989573|454993046|FG002|Overall Study|Withdrawal by Subject|3|||
126462326|NCT01076075|454993051|FG000|Overall Study|Adverse Event|3|||
126302949|NCT00757042|454398561|FG007|Overall Study|Withdrawal by Subject|0|||
126302950|NCT00757042|454398562|FG008|Overall Study|Withdrawal by Subject|0|||
126302951|NCT00757042|454398563|FG009|Overall Study|Withdrawal by Subject|1|||
126713230|NCT04504032|455902026|FG000|Overall Study|Protocol Violation|2|||
126713231|NCT04504032|455902027|FG001|Overall Study|Protocol Violation|0|||
126713232|NCT04504032|455902026|FG000|Overall Study|Study terminated by sponsor|1|||
126713233|NCT04504032|455902027|FG001|Overall Study|Study terminated by sponsor|2|||
126713234|NCT04504032|455902026|FG000|Overall Study|Withdrawal by Subject|9|||
126713235|NCT04504032|455902027|FG001|Overall Study|Withdrawal by Subject|11|||
126713236|NCT04504032|455902026|FG000|Overall Study|Disease progression prior to dosing|15|||
126713237|NCT04504032|455902027|FG001|Overall Study|Disease progression prior to dosing|3|||
126713238|NCT04504032|455902026|FG000|Overall Study|Drug supply issues|1|||
126713239|NCT04504032|455902027|FG001|Overall Study|Drug supply issues|1|||
126713240|NCT04504032|455902026|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
126713241|NCT04504032|455902027|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
126713242|NCT01839188|455902028|FG000|Overall Study|Withdrawal by Subject|1|||
126713243|NCT02416908|455902036|FG000|Dose Escalation Phase|Adverse Event|0|||
126713244|NCT02416908|455902037|FG001|Dose Escalation Phase|Adverse Event|0|||
126713245|NCT02416908|455902038|FG002|Dose Escalation Phase|Adverse Event|3|||
126713246|NCT02416908|455902039|FG003|Dose Escalation Phase|Adverse Event|0|||
126713247|NCT02416908|455902036|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
126713248|NCT02416908|455902037|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
126713249|NCT02416908|455902038|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
126713250|NCT02416908|455902039|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126713251|NCT00940342|455902040|FG000|Overall Study|Adverse Event|0|||
126713252|NCT00940342|455902041|FG001|Overall Study|Adverse Event|2|||
126713253|NCT00940342|455902042|FG002|Overall Study|Adverse Event|1|||
126713254|NCT01327339|455902043|FG000|Overall Study|Protocol Violation|8|||
126713255|NCT00700752|455902048|FG000|First Intervention|Withdrawal by Subject|0|||
126713256|NCT00700752|455902049|FG001|First Intervention|Withdrawal by Subject|2|||
126302952|NCT00757042|454398564|FG010|Overall Study|Withdrawal by Subject|0|||
126302953|NCT03850483|454398568|FG000|Treatment for Stage 1|Adverse Event|1|||
126302954|NCT03850483|454398569|FG001|Treatment for Stage 1|Adverse Event|1|||
126302955|NCT03850483|454398570|FG002|Treatment for Stage 1|Adverse Event|3|||
126302956|NCT03850483|454398571|FG003|Treatment for Stage 1|Adverse Event|0|||
126302957|NCT03850483|454398572|FG004|Treatment for Stage 1|Adverse Event|2|||
126302958|NCT03850483|454398573|FG005|Treatment for Stage 1|Adverse Event|0|||
126302959|NCT03850483|454398574|FG006|Treatment for Stage 1|Adverse Event|2|||
126302960|NCT03850483|454398575|FG007|Treatment for Stage 1|Adverse Event|2|||
126302961|NCT03850483|454398576|FG008|Treatment for Stage 1|Adverse Event|0|||
126302962|NCT03850483|454398577|FG009|Treatment for Stage 1|Adverse Event|0|||
126302963|NCT03850483|454398568|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
126302964|NCT03850483|454398569|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
126302965|NCT03850483|454398570|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
126302966|NCT03850483|454398571|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
126302967|NCT03850483|454398572|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
126302968|NCT03850483|454398573|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
126302969|NCT03850483|454398574|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
126302970|NCT03850483|454398575|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
126302971|NCT03850483|454398576|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
126302972|NCT03850483|454398577|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
126302973|NCT03850483|454398568|FG000|Treatment for Stage 1|Protocol Violation|1|||
126302974|NCT03850483|454398569|FG001|Treatment for Stage 1|Protocol Violation|0|||
126302975|NCT03850483|454398570|FG002|Treatment for Stage 1|Protocol Violation|0|||
126302976|NCT03850483|454398571|FG003|Treatment for Stage 1|Protocol Violation|0|||
126302977|NCT03850483|454398572|FG004|Treatment for Stage 1|Protocol Violation|0|||
126302978|NCT03850483|454398573|FG005|Treatment for Stage 1|Protocol Violation|0|||
126302979|NCT03850483|454398574|FG006|Treatment for Stage 1|Protocol Violation|1|||
126302980|NCT03850483|454398575|FG007|Treatment for Stage 1|Protocol Violation|0|||
126302981|NCT03850483|454398576|FG008|Treatment for Stage 1|Protocol Violation|0|||
126302982|NCT03850483|454398577|FG009|Treatment for Stage 1|Protocol Violation|0|||
126302983|NCT03850483|454398568|FG000|Treatment for Stage 1|Physician Decision|0|||
126462327|NCT01076075|454993052|FG001|Overall Study|Adverse Event|9|||
126462328|NCT01076075|454993051|FG000|Overall Study|Lack of Efficacy|5|||
126462329|NCT01076075|454993052|FG001|Overall Study|Lack of Efficacy|4|||
126462330|NCT01076075|454993051|FG000|Overall Study|Lost to Follow-up|6|||
126302984|NCT03850483|454398569|FG001|Treatment for Stage 1|Physician Decision|0|||
126302985|NCT03850483|454398570|FG002|Treatment for Stage 1|Physician Decision|0|||
126302986|NCT03850483|454398571|FG003|Treatment for Stage 1|Physician Decision|0|||
126302987|NCT03850483|454398572|FG004|Treatment for Stage 1|Physician Decision|0|||
126462331|NCT01076075|454993052|FG001|Overall Study|Lost to Follow-up|5|||
126713257|NCT01097330|455902052|FG000|Overall Study|Study terminated early|7|||
126713258|NCT01097330|455902053|FG001|Overall Study|Study terminated early|5|||
126302988|NCT03850483|454398573|FG005|Treatment for Stage 1|Physician Decision|1|||
126302989|NCT03850483|454398574|FG006|Treatment for Stage 1|Physician Decision|0|||
126302990|NCT03850483|454398575|FG007|Treatment for Stage 1|Physician Decision|0|||
126302991|NCT03850483|454398576|FG008|Treatment for Stage 1|Physician Decision|0|||
126302992|NCT03850483|454398577|FG009|Treatment for Stage 1|Physician Decision|0|||
126302993|NCT03850483|454398568|FG000|Treatment for Stage 1|Other|0|||
126302994|NCT03850483|454398569|FG001|Treatment for Stage 1|Other|0|||
126302995|NCT03850483|454398570|FG002|Treatment for Stage 1|Other|0|||
126302996|NCT03850483|454398571|FG003|Treatment for Stage 1|Other|0|||
126302997|NCT03850483|454398572|FG004|Treatment for Stage 1|Other|2|||
126302998|NCT03850483|454398573|FG005|Treatment for Stage 1|Other|1|||
126302999|NCT03850483|454398574|FG006|Treatment for Stage 1|Other|0|||
126303000|NCT03850483|454398575|FG007|Treatment for Stage 1|Other|0|||
126303001|NCT03850483|454398576|FG008|Treatment for Stage 1|Other|0|||
126303002|NCT03850483|454398577|FG009|Treatment for Stage 1|Other|0|||
126303003|NCT03850483|454398568|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303004|NCT03850483|454398569|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303005|NCT03850483|454398570|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
126303006|NCT03850483|454398571|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303007|NCT03850483|454398572|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303008|NCT03850483|454398573|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303009|NCT03850483|454398574|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303010|NCT03850483|454398575|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303011|NCT03850483|454398576|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303012|NCT03850483|454398577|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
126303013|NCT03850483|454398568|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303014|NCT03850483|454398569|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303015|NCT03850483|454398570|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303016|NCT03850483|454398571|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303017|NCT03850483|454398572|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303018|NCT03850483|454398573|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
126303019|NCT03850483|454398574|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303020|NCT03850483|454398575|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303021|NCT03850483|454398576|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303022|NCT03850483|454398577|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
126303023|NCT03850483|454398568|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
126303024|NCT03850483|454398569|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
126303025|NCT03850483|454398570|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
126303026|NCT03850483|454398571|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
126303027|NCT03850483|454398572|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
126303028|NCT03850483|454398573|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
126303029|NCT03850483|454398574|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
126303030|NCT03850483|454398575|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
126303031|NCT03850483|454398576|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
126303032|NCT03850483|454398577|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
126303033|NCT03850483|454398568|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
126303034|NCT03850483|454398569|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
126303035|NCT03850483|454398570|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
126303036|NCT03850483|454398571|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
126303037|NCT03850483|454398572|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
126303038|NCT03850483|454398573|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
126303039|NCT03850483|454398574|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
126303040|NCT03850483|454398575|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
126303041|NCT03850483|454398576|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
126303042|NCT03850483|454398577|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
126303043|NCT03850483|454398568|FG000|Treatment for Stage 1|Death|0|||
126303044|NCT03850483|454398569|FG001|Treatment for Stage 1|Death|0|||
126303045|NCT03850483|454398570|FG002|Treatment for Stage 1|Death|0|||
126462332|NCT01076075|454993051|FG000|Overall Study|other|19|||
126462333|NCT01076075|454993052|FG001|Overall Study|other|9|||
126462334|NCT01076075|454993051|FG000|Overall Study|Protocol Violation|0|||
126462335|NCT01076075|454993052|FG001|Overall Study|Protocol Violation|1|||
126462336|NCT01076075|454993051|FG000|Overall Study|Withdrawal by Subject|8|||
126462337|NCT01076075|454993052|FG001|Overall Study|Withdrawal by Subject|19|||
126303046|NCT03850483|454398571|FG003|Treatment for Stage 1|Death|0|||
126462338|NCT02359851|454993058|FG000|Overall Study|Death|1|||
126462339|NCT02359851|454993058|FG000|Overall Study|Disease progression|1|||
126462340|NCT01888003|454993059|FG000|Overall Study|Study Terminated|5|||
126462341|NCT01888003|454993060|FG001|Overall Study|Study Terminated|6|||
126462342|NCT01888003|454993061|FG002|Overall Study|Study Terminated|40|||
126462343|NCT00055471|454993062|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
126303047|NCT03850483|454398572|FG004|Treatment for Stage 1|Death|0|||
126303048|NCT03850483|454398573|FG005|Treatment for Stage 1|Death|1|||
126303049|NCT03850483|454398574|FG006|Treatment for Stage 1|Death|0|||
126367816|NCT00663260|454641026|FG002|Overall Study|Death|1|||
126367817|NCT00663260|454641024|FG000|Overall Study|Lost to Follow-up|0|||
126367818|NCT00663260|454641025|FG001|Overall Study|Lost to Follow-up|1|||
126367819|NCT00663260|454641026|FG002|Overall Study|Lost to Follow-up|0|||
126367820|NCT00663260|454641024|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
126367821|NCT00663260|454641025|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
126367822|NCT00663260|454641026|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
126367823|NCT02231580|454641033|FG000|Overall Study|Adverse Event|5|||
126367824|NCT02231580|454641034|FG001|Overall Study|Adverse Event|0|||
126367825|NCT03620981|454641035|FG000|Overall Study|Adverse Event|14|||
126367826|NCT03620981|454641036|FG001|Overall Study|Adverse Event|38|||
126367827|NCT03620981|454641037|FG002|Overall Study|Adverse Event|25|||
126367828|NCT03620981|454641035|FG000|Overall Study|Lack of Efficacy|2|||
126367829|NCT03620981|454641036|FG001|Overall Study|Lack of Efficacy|1|||
126367830|NCT03620981|454641037|FG002|Overall Study|Lack of Efficacy|1|||
126367831|NCT03620981|454641035|FG000|Overall Study|Physician Decision|7|||
126367832|NCT03620981|454641036|FG001|Overall Study|Physician Decision|4|||
126367833|NCT03620981|454641037|FG002|Overall Study|Physician Decision|4|||
126367834|NCT03620981|454641035|FG000|Overall Study|Protocol Violation|1|||
126367835|NCT03620981|454641036|FG001|Overall Study|Protocol Violation|2|||
126367836|NCT03620981|454641037|FG002|Overall Study|Protocol Violation|1|||
126367837|NCT03620981|454641035|FG000|Overall Study|Withdrawal by Legal Representative|2|||
126367838|NCT03620981|454641036|FG001|Overall Study|Withdrawal by Legal Representative|1|||
126367839|NCT03620981|454641037|FG002|Overall Study|Withdrawal by Legal Representative|1|||
126367840|NCT03620981|454641035|FG000|Overall Study|Withdrawal by Care Giver|2|||
126713259|NCT00510692|455902055|FG000|Overall Study|Adverse Event|1|||
126713260|NCT00510692|455902056|FG001|Overall Study|Adverse Event|3|||
126713261|NCT00510692|455902055|FG000|Overall Study|Withdrawal by Subject|1|||
126303050|NCT03850483|454398575|FG007|Treatment for Stage 1|Death|0|||
126303051|NCT03850483|454398576|FG008|Treatment for Stage 1|Death|0|||
126303052|NCT03850483|454398577|FG009|Treatment for Stage 1|Death|0|||
126303053|NCT03850483|454398568|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
126303054|NCT03850483|454398569|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
126303055|NCT03850483|454398570|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
126303056|NCT03850483|454398571|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
126303057|NCT03850483|454398572|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
126303058|NCT03850483|454398573|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
126303059|NCT03850483|454398574|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
126303060|NCT03850483|454398575|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
126303061|NCT03850483|454398576|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
126303062|NCT03850483|454398577|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
126303063|NCT03850483|454398568|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
126303064|NCT03850483|454398569|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
126303065|NCT03850483|454398570|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
126303066|NCT03850483|454398571|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
126303067|NCT03850483|454398572|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
126303068|NCT03850483|454398573|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
126303069|NCT03850483|454398574|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
126303070|NCT03850483|454398575|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
126303071|NCT03850483|454398576|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
126303072|NCT03850483|454398577|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
126303073|NCT03850483|454398568|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303074|NCT03850483|454398569|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303075|NCT03850483|454398570|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303076|NCT03850483|454398571|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303077|NCT03850483|454398572|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303078|NCT03850483|454398573|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303079|NCT03850483|454398574|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
126303080|NCT03850483|454398575|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
126367841|NCT03620981|454641036|FG001|Overall Study|Withdrawal by Care Giver|0|||
126367842|NCT03620981|454641037|FG002|Overall Study|Withdrawal by Care Giver|1|||
126367843|NCT03620981|454641035|FG000|Overall Study|Non-compliance with Study Drug|1|||
126367844|NCT03620981|454641036|FG001|Overall Study|Non-compliance with Study Drug|1|||
126367845|NCT03620981|454641037|FG002|Overall Study|Non-compliance with Study Drug|0|||
126713262|NCT00510692|455902056|FG001|Overall Study|Withdrawal by Subject|0|||
126713263|NCT01845077|455902057|FG000|Washout Period|Lost to Follow-up|0|||
126303081|NCT03850483|454398576|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
126303082|NCT03850483|454398577|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
126367846|NCT03238196|454641040|FG000|Overall Study|Adverse Event|3|||
126367847|NCT03238196|454641041|FG001|Overall Study|Adverse Event|0|||
126367848|NCT03238196|454641042|FG002|Overall Study|Adverse Event|2|||
126367849|NCT03238196|454641043|FG003|Overall Study|Adverse Event|2|||
126367850|NCT03238196|454641040|FG000|Overall Study|Withdrawal by Subject|4|||
126713264|NCT01845077|455902058|FG001|Washout Period|Lost to Follow-up|1|||
126303083|NCT03850483|454398568|FG000|Follow-up for Stage 1|Physician Decision|0|||
126303084|NCT03850483|454398569|FG001|Follow-up for Stage 1|Physician Decision|0|||
126303085|NCT03850483|454398570|FG002|Follow-up for Stage 1|Physician Decision|0|||
126303086|NCT03850483|454398571|FG003|Follow-up for Stage 1|Physician Decision|0|||
126303087|NCT03850483|454398572|FG004|Follow-up for Stage 1|Physician Decision|1|||
126303088|NCT03850483|454398573|FG005|Follow-up for Stage 1|Physician Decision|0|||
126303089|NCT03850483|454398574|FG006|Follow-up for Stage 1|Physician Decision|1|||
126303090|NCT03850483|454398575|FG007|Follow-up for Stage 1|Physician Decision|0|||
126303091|NCT03850483|454398576|FG008|Follow-up for Stage 1|Physician Decision|0|||
126303092|NCT03850483|454398577|FG009|Follow-up for Stage 1|Physician Decision|0|||
126303093|NCT03850483|454398568|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
126303094|NCT03850483|454398569|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
126303095|NCT03850483|454398570|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
126303096|NCT03850483|454398571|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
126303097|NCT03850483|454398572|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
126303098|NCT03850483|454398573|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
126303099|NCT03850483|454398574|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
126303100|NCT03850483|454398575|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
126303101|NCT03850483|454398576|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
126303102|NCT03850483|454398577|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
126303103|NCT03850483|454398568|FG000|Follow-up for Stage 1|Adverse Event|0|||
126303104|NCT03850483|454398569|FG001|Follow-up for Stage 1|Adverse Event|0|||
126303105|NCT03850483|454398570|FG002|Follow-up for Stage 1|Adverse Event|1|||
126303106|NCT03850483|454398571|FG003|Follow-up for Stage 1|Adverse Event|0|||
126303107|NCT03850483|454398572|FG004|Follow-up for Stage 1|Adverse Event|0|||
126303108|NCT03850483|454398573|FG005|Follow-up for Stage 1|Adverse Event|1|||
126303109|NCT03850483|454398574|FG006|Follow-up for Stage 1|Adverse Event|0|||
126303110|NCT03850483|454398575|FG007|Follow-up for Stage 1|Adverse Event|0|||
126303111|NCT03850483|454398576|FG008|Follow-up for Stage 1|Adverse Event|0|||
126303112|NCT03850483|454398577|FG009|Follow-up for Stage 1|Adverse Event|0|||
126303113|NCT03850483|454398568|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303114|NCT03850483|454398569|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
126303115|NCT03850483|454398570|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303116|NCT03850483|454398571|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303117|NCT03850483|454398572|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
126303118|NCT03850483|454398573|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
126303119|NCT03850483|454398574|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303120|NCT03850483|454398575|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303121|NCT03850483|454398576|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303122|NCT03850483|454398577|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
126303123|NCT03850483|454398568|FG000|Follow-up for Stage 1|Other|0|||
126303124|NCT03850483|454398569|FG001|Follow-up for Stage 1|Other|2|||
126303125|NCT03850483|454398570|FG002|Follow-up for Stage 1|Other|0|||
126303126|NCT03850483|454398571|FG003|Follow-up for Stage 1|Other|2|||
126303127|NCT03850483|454398572|FG004|Follow-up for Stage 1|Other|0|||
126303128|NCT03850483|454398573|FG005|Follow-up for Stage 1|Other|1|||
126303129|NCT03850483|454398574|FG006|Follow-up for Stage 1|Other|0|||
126303130|NCT03850483|454398575|FG007|Follow-up for Stage 1|Other|0|||
126303131|NCT03850483|454398576|FG008|Follow-up for Stage 1|Other|0|||
126303132|NCT03850483|454398577|FG009|Follow-up for Stage 1|Other|0|||
126303133|NCT03850483|454398568|FG000|Treatment for Stage 2|Adverse Event|0|||
126303134|NCT03850483|454398569|FG001|Treatment for Stage 2|Adverse Event|0|||
126303135|NCT03850483|454398570|FG002|Treatment for Stage 2|Adverse Event|0|||
126303136|NCT03850483|454398571|FG003|Treatment for Stage 2|Adverse Event|0|||
126303137|NCT03850483|454398572|FG004|Treatment for Stage 2|Adverse Event|0|||
126303138|NCT03850483|454398573|FG005|Treatment for Stage 2|Adverse Event|0|||
126303139|NCT03850483|454398574|FG006|Treatment for Stage 2|Adverse Event|0|||
126303140|NCT03850483|454398575|FG007|Treatment for Stage 2|Adverse Event|0|||
126303141|NCT03850483|454398576|FG008|Treatment for Stage 2|Adverse Event|0|||
126303142|NCT03850483|454398577|FG009|Treatment for Stage 2|Adverse Event|1|||
126303143|NCT03850483|454398568|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
126303144|NCT03850483|454398569|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
126303145|NCT03850483|454398570|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
126303146|NCT03850483|454398571|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
126303147|NCT03850483|454398572|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
126303148|NCT03850483|454398573|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
126303149|NCT03850483|454398574|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
126303150|NCT03850483|454398575|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
126303151|NCT03850483|454398576|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
126367851|NCT03238196|454641041|FG001|Overall Study|Withdrawal by Subject|1|||
126367852|NCT03238196|454641042|FG002|Overall Study|Withdrawal by Subject|1|||
126367853|NCT03238196|454641043|FG003|Overall Study|Withdrawal by Subject|0|||
126367854|NCT03238196|454641040|FG000|Overall Study|Disease progression|14|||
126367855|NCT03238196|454641041|FG001|Overall Study|Disease progression|2|||
126303152|NCT03850483|454398577|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
126303153|NCT03850483|454398568|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
126303154|NCT03850483|454398569|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
126303155|NCT03850483|454398570|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
126303156|NCT03850483|454398571|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
126303157|NCT03850483|454398572|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
126303158|NCT03850483|454398573|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
126303159|NCT03850483|454398574|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
126303160|NCT03850483|454398575|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
126303161|NCT03850483|454398576|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
126303162|NCT03850483|454398577|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
126303163|NCT03850483|454398568|FG000|Treatment for Stage 2|Physician Decision|0|||
126303164|NCT03850483|454398569|FG001|Treatment for Stage 2|Physician Decision|0|||
126303165|NCT03850483|454398570|FG002|Treatment for Stage 2|Physician Decision|0|||
126303166|NCT03850483|454398571|FG003|Treatment for Stage 2|Physician Decision|0|||
126303167|NCT03850483|454398572|FG004|Treatment for Stage 2|Physician Decision|0|||
126303168|NCT03850483|454398573|FG005|Treatment for Stage 2|Physician Decision|0|||
126303169|NCT03850483|454398574|FG006|Treatment for Stage 2|Physician Decision|0|||
126303170|NCT03850483|454398575|FG007|Treatment for Stage 2|Physician Decision|0|||
126303171|NCT03850483|454398576|FG008|Treatment for Stage 2|Physician Decision|0|||
126303172|NCT03850483|454398577|FG009|Treatment for Stage 2|Physician Decision|1|||
126303173|NCT03850483|454398568|FG000|Treatment for Stage 2|Protocol Violation|0|||
126303174|NCT03850483|454398569|FG001|Treatment for Stage 2|Protocol Violation|0|||
126303175|NCT03850483|454398570|FG002|Treatment for Stage 2|Protocol Violation|0|||
126303176|NCT03850483|454398571|FG003|Treatment for Stage 2|Protocol Violation|0|||
126303177|NCT03850483|454398572|FG004|Treatment for Stage 2|Protocol Violation|0|||
126303178|NCT03850483|454398573|FG005|Treatment for Stage 2|Protocol Violation|0|||
126303179|NCT03850483|454398574|FG006|Treatment for Stage 2|Protocol Violation|0|||
126303180|NCT03850483|454398575|FG007|Treatment for Stage 2|Protocol Violation|0|||
126303181|NCT03850483|454398576|FG008|Treatment for Stage 2|Protocol Violation|1|||
126303182|NCT03850483|454398577|FG009|Treatment for Stage 2|Protocol Violation|0|||
126303183|NCT03850483|454398568|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
126303184|NCT03850483|454398569|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
126303185|NCT03850483|454398570|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
126303186|NCT03850483|454398571|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
126303187|NCT03850483|454398572|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
126303188|NCT03850483|454398573|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
126303189|NCT03850483|454398574|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
126303190|NCT03850483|454398575|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
126303191|NCT03850483|454398576|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
126303192|NCT03850483|454398577|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
126303193|NCT03850483|454398568|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303194|NCT03850483|454398569|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303195|NCT03850483|454398570|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303196|NCT03850483|454398571|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303197|NCT03850483|454398572|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303198|NCT03850483|454398573|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303199|NCT03850483|454398574|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303200|NCT03850483|454398575|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303201|NCT03850483|454398576|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
126303202|NCT03850483|454398577|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
126303203|NCT03850483|454398568|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
126303204|NCT03850483|454398569|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
126303205|NCT03850483|454398570|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
126303206|NCT03850483|454398571|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
126303207|NCT03850483|454398572|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
126367856|NCT03238196|454641042|FG002|Overall Study|Disease progression|3|||
126367857|NCT03238196|454641043|FG003|Overall Study|Disease progression|2|||
126367858|NCT03238196|454641040|FG000|Overall Study|Still on treatment|1|||
126367859|NCT03238196|454641041|FG001|Overall Study|Still on treatment|0|||
126303208|NCT03850483|454398573|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
126303209|NCT03850483|454398574|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
126303210|NCT03850483|454398575|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
126303211|NCT03850483|454398576|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
126303212|NCT03850483|454398577|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
126303213|NCT03850483|454398568|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
126303214|NCT03850483|454398569|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
126303215|NCT03850483|454398570|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
126303216|NCT03850483|454398571|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
126367860|NCT03238196|454641042|FG002|Overall Study|Still on treatment|0|||
126367861|NCT03238196|454641043|FG003|Overall Study|Still on treatment|0|||
126303217|NCT03850483|454398572|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
126367862|NCT04938427|454641044|FG000|Overall Study|Adverse Event|5|||
126367863|NCT04938427|454641045|FG001|Overall Study|Adverse Event|19|||
126367864|NCT04938427|454641044|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126367865|NCT04938427|454641045|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126367866|NCT04938427|454641044|FG000|Overall Study|Withdrawal by Subject|1|||
126367867|NCT04938427|454641045|FG001|Overall Study|Withdrawal by Subject|0|||
126367868|NCT04938427|454641044|FG000|Overall Study|Reason Not Specified|2|||
126367869|NCT04938427|454641045|FG001|Overall Study|Reason Not Specified|1|||
126367870|NCT05852470|454641046|FG000|Overall Study|Withdrawal by Subject|0|||
126367871|NCT05852470|454641047|FG001|Overall Study|Withdrawal by Subject|1|||
126367872|NCT01373281|454642828|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
126367873|NCT01373281|454642829|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
126367874|NCT01373281|454642828|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
126367875|NCT01373281|454642829|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
126367876|NCT01373281|454642828|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
126367877|NCT01373281|454642829|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
126367878|NCT01373281|454642828|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
126367879|NCT01373281|454642829|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
126367880|NCT01373281|454642828|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
126367881|NCT01373281|454642829|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
126367882|NCT01373281|454642828|FG000|Surveillance Expansion Period|Protocol Violation|9|||
126367883|NCT01373281|454642829|FG001|Surveillance Expansion Period|Protocol Violation|1|||
126367884|NCT01373281|454642828|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
126367885|NCT01373281|454642829|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
126367886|NCT01373281|454642828|FG000|Surveillance Expansion Period|Serious adverse event|3|||
126367887|NCT01373281|454642829|FG001|Surveillance Expansion Period|Serious adverse event|4|||
126367888|NCT01444781|454642830|FG000|Overall Study|Lost to Follow-up|0|||
126367889|NCT01444781|454642831|FG001|Overall Study|Lost to Follow-up|3|||
126367890|NCT01444781|454642832|FG002|Overall Study|Lost to Follow-up|1|||
126367891|NCT01444781|454642830|FG000|Overall Study|Withdrawal by Subject|3|||
126367892|NCT01444781|454642831|FG001|Overall Study|Withdrawal by Subject|1|||
126367893|NCT01444781|454642832|FG002|Overall Study|Withdrawal by Subject|2|||
126367894|NCT03033784|454642833|FG000|Overall Study|Anxiety related to MRI scanner|0|||
126367895|NCT03033784|454642834|FG001|Overall Study|Anxiety related to MRI scanner|1|||
126367896|NCT03033784|454642835|FG002|Overall Study|Anxiety related to MRI scanner|0|||
126367897|NCT03033784|454642836|FG003|Overall Study|Anxiety related to MRI scanner|0|||
126367898|NCT03033784|454642837|FG004|Overall Study|Anxiety related to MRI scanner|0|||
126367899|NCT03033784|454642838|FG005|Overall Study|Anxiety related to MRI scanner|0|||
126367900|NCT03033784|454642839|FG006|Overall Study|Anxiety related to MRI scanner|0|||
126367901|NCT03033784|454642840|FG007|Overall Study|Anxiety related to MRI scanner|0|||
126367902|NCT03033784|454642841|FG008|Overall Study|Anxiety related to MRI scanner|0|||
126367903|NCT03033784|454642842|FG009|Overall Study|Anxiety related to MRI scanner|0|||
126367904|NCT03033784|454642843|FG010|Overall Study|Anxiety related to MRI scanner|0|||
126367905|NCT03033784|454642844|FG011|Overall Study|Anxiety related to MRI scanner|0|||
126367906|NCT03033784|454642845|FG012|Overall Study|Anxiety related to MRI scanner|0|||
126367907|NCT03033784|454642833|FG000|Overall Study|Withdrawal by Subject|0|||
126367908|NCT03033784|454642834|FG001|Overall Study|Withdrawal by Subject|0|||
126367909|NCT03033784|454642835|FG002|Overall Study|Withdrawal by Subject|0|||
126367910|NCT03033784|454642836|FG003|Overall Study|Withdrawal by Subject|0|||
126367911|NCT03033784|454642837|FG004|Overall Study|Withdrawal by Subject|0|||
126367912|NCT03033784|454642838|FG005|Overall Study|Withdrawal by Subject|0|||
126367913|NCT03033784|454642839|FG006|Overall Study|Withdrawal by Subject|0|||
126367914|NCT03033784|454642840|FG007|Overall Study|Withdrawal by Subject|0|||
126367915|NCT03033784|454642841|FG008|Overall Study|Withdrawal by Subject|0|||
126367916|NCT03033784|454642842|FG009|Overall Study|Withdrawal by Subject|0|||
126367917|NCT03033784|454642843|FG010|Overall Study|Withdrawal by Subject|0|||
126367918|NCT03033784|454642844|FG011|Overall Study|Withdrawal by Subject|0|||
126367919|NCT03033784|454642845|FG012|Overall Study|Withdrawal by Subject|2|||
126367920|NCT03332056|454642846|FG000|Overall Study|Incomplete questionnaires|8|||
126367921|NCT03332056|454642847|FG001|Overall Study|Incomplete questionnaires|9|||
126367922|NCT03332056|454642846|FG000|Overall Study|Passed stone prior to surgery date|1|||
126367923|NCT03332056|454642847|FG001|Overall Study|Passed stone prior to surgery date|0|||
126367924|NCT03332056|454642846|FG000|Overall Study|Did not require a ureteral stent|0|||
126367925|NCT03332056|454642847|FG001|Overall Study|Did not require a ureteral stent|1|||
126367926|NCT00851084|454642848|FG000|Overall Study|Randomized but not treated|1|||
126367927|NCT00851084|454642849|FG001|Overall Study|Randomized but not treated|0|||
126367928|NCT00851084|454642848|FG000|Overall Study|Adverse Event|26|||
126367929|NCT00851084|454642849|FG001|Overall Study|Adverse Event|36|||
126367930|NCT00851084|454642848|FG000|Overall Study|Disease progression|52|||
126367931|NCT00851084|454642849|FG001|Overall Study|Disease progression|47|||
126367932|NCT00851084|454642848|FG000|Overall Study|Poor compliance to protocol|1|||
126367933|NCT00851084|454642849|FG001|Overall Study|Poor compliance to protocol|1|||
126303218|NCT03850483|454398573|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
126303219|NCT03850483|454398574|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
126303220|NCT03850483|454398575|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
126303221|NCT03850483|454398576|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
126303222|NCT03850483|454398577|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
126303223|NCT03850483|454398568|FG000|Follow-up For Stage 2|Other|0|||
126303224|NCT03850483|454398569|FG001|Follow-up For Stage 2|Other|0|||
126303225|NCT03850483|454398570|FG002|Follow-up For Stage 2|Other|0|||
126303226|NCT03850483|454398571|FG003|Follow-up For Stage 2|Other|0|||
126303227|NCT03850483|454398572|FG004|Follow-up For Stage 2|Other|0|||
126303228|NCT03850483|454398573|FG005|Follow-up For Stage 2|Other|0|||
126303229|NCT03850483|454398574|FG006|Follow-up For Stage 2|Other|0|||
126303230|NCT03850483|454398575|FG007|Follow-up For Stage 2|Other|0|||
126303231|NCT03850483|454398576|FG008|Follow-up For Stage 2|Other|0|||
126303232|NCT03850483|454398577|FG009|Follow-up For Stage 2|Other|1|||
126303233|NCT04432831|454400273|FG000|Overall Study|Withdrawal by Subject|24|||
126303234|NCT04432831|454400274|FG001|Overall Study|Withdrawal by Subject|28|||
126303235|NCT04432831|454400275|FG002|Overall Study|Withdrawal by Subject|21|||
126303236|NCT04432831|454400273|FG000|Overall Study|Death|23|||
126303237|NCT04432831|454400274|FG001|Overall Study|Death|23|||
126303238|NCT04432831|454400275|FG002|Overall Study|Death|17|||
126303239|NCT04432831|454400273|FG000|Overall Study|Lost to Follow-up|15|||
126303240|NCT04432831|454400274|FG001|Overall Study|Lost to Follow-up|15|||
126303241|NCT04432831|454400275|FG002|Overall Study|Lost to Follow-up|12|||
126303242|NCT04432831|454400273|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
126303243|NCT04432831|454400274|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
126303244|NCT04432831|454400275|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
126303245|NCT04432831|454400273|FG000|Overall Study|Reason Not Specified|7|||
126303246|NCT04432831|454400274|FG001|Overall Study|Reason Not Specified|11|||
126303247|NCT04432831|454400275|FG002|Overall Study|Reason Not Specified|9|||
126303248|NCT04432831|454400273|FG000|Overall Study|Adverse Event|7|||
126303249|NCT04432831|454400274|FG001|Overall Study|Adverse Event|7|||
126303250|NCT04432831|454400275|FG002|Overall Study|Adverse Event|7|||
126303251|NCT04432831|454400273|FG000|Overall Study|Physician Decision|1|||
126303252|NCT04432831|454400274|FG001|Overall Study|Physician Decision|3|||
126303253|NCT04432831|454400275|FG002|Overall Study|Physician Decision|6|||
126303254|NCT04432831|454400273|FG000|Overall Study|Protocol Violation|1|||
126303255|NCT04432831|454400274|FG001|Overall Study|Protocol Violation|0|||
126303256|NCT04432831|454400275|FG002|Overall Study|Protocol Violation|2|||
126303257|NCT04432831|454400273|FG000|Overall Study|Pregnancy|0|||
126303258|NCT04432831|454400274|FG001|Overall Study|Pregnancy|1|||
126303259|NCT04432831|454400275|FG002|Overall Study|Pregnancy|0|||
126303260|NCT04432831|454400273|FG000|Overall Study|Lack of Efficacy|0|||
126303261|NCT04432831|454400274|FG001|Overall Study|Lack of Efficacy|0|||
126303262|NCT04432831|454400275|FG002|Overall Study|Lack of Efficacy|2|||
126303263|NCT00652626|454400278|FG000|Initial Treatment Phase|Adverse Event|0|||
126303264|NCT00652626|454400279|FG001|Initial Treatment Phase|Adverse Event|0|||
126303265|NCT00652626|454400280|FG002|Initial Treatment Phase|Adverse Event|0|||
126303266|NCT00652626|454400281|FG003|Initial Treatment Phase|Adverse Event|0|||
126303267|NCT00652626|454400282|FG004|Initial Treatment Phase|Adverse Event|1|||
126303268|NCT00652626|454400283|FG005|Initial Treatment Phase|Adverse Event|0|||
126303269|NCT00652626|454400284|FG006|Initial Treatment Phase|Adverse Event|0|||
126303270|NCT00652626|454400278|FG000|Initial Treatment Phase|Protocol Violation|0|||
126303271|NCT00652626|454400279|FG001|Initial Treatment Phase|Protocol Violation|0|||
126303272|NCT00652626|454400280|FG002|Initial Treatment Phase|Protocol Violation|0|||
126303273|NCT00652626|454400281|FG003|Initial Treatment Phase|Protocol Violation|1|||
126303274|NCT00652626|454400282|FG004|Initial Treatment Phase|Protocol Violation|0|||
126303275|NCT00652626|454400283|FG005|Initial Treatment Phase|Protocol Violation|0|||
126303276|NCT00652626|454400284|FG006|Initial Treatment Phase|Protocol Violation|0|||
126303277|NCT00652626|454400278|FG000|Initial Treatment Phase|Physician Decision|0|||
126303278|NCT00652626|454400279|FG001|Initial Treatment Phase|Physician Decision|0|||
126303279|NCT00652626|454400280|FG002|Initial Treatment Phase|Physician Decision|0|||
126303280|NCT00652626|454400281|FG003|Initial Treatment Phase|Physician Decision|0|||
126303281|NCT00652626|454400282|FG004|Initial Treatment Phase|Physician Decision|1|||
126303282|NCT00652626|454400283|FG005|Initial Treatment Phase|Physician Decision|0|||
126303283|NCT00652626|454400284|FG006|Initial Treatment Phase|Physician Decision|0|||
126303284|NCT00652626|454400278|FG000|Initial Treatment Phase|Sponsor Request|0|||
126303285|NCT00652626|454400279|FG001|Initial Treatment Phase|Sponsor Request|0|||
126303286|NCT00652626|454400280|FG002|Initial Treatment Phase|Sponsor Request|1|||
126303287|NCT00652626|454400281|FG003|Initial Treatment Phase|Sponsor Request|0|||
126303288|NCT00652626|454400282|FG004|Initial Treatment Phase|Sponsor Request|0|||
126303289|NCT00652626|454400283|FG005|Initial Treatment Phase|Sponsor Request|0|||
126303290|NCT00652626|454400284|FG006|Initial Treatment Phase|Sponsor Request|0|||
126303291|NCT00652626|454400278|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
126303292|NCT00652626|454400279|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
126303293|NCT00652626|454400280|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
126303294|NCT00652626|454400281|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
126303295|NCT00652626|454400282|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
126303296|NCT00652626|454400283|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
126303297|NCT00652626|454400284|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
126303298|NCT00652626|454400278|FG000|Extension Phase|Withdrawal by Subject|0|||
126303299|NCT00652626|454400279|FG001|Extension Phase|Withdrawal by Subject|0|||
126303300|NCT00652626|454400280|FG002|Extension Phase|Withdrawal by Subject|0|||
126303301|NCT00652626|454400281|FG003|Extension Phase|Withdrawal by Subject|0|||
126303302|NCT00652626|454400282|FG004|Extension Phase|Withdrawal by Subject|0|||
126303303|NCT00652626|454400283|FG005|Extension Phase|Withdrawal by Subject|2|||
126303304|NCT00652626|454400284|FG006|Extension Phase|Withdrawal by Subject|0|||
126303305|NCT00652626|454400278|FG000|Extension Phase|Adverse Event|0|||
126303306|NCT00652626|454400279|FG001|Extension Phase|Adverse Event|0|||
126303307|NCT00652626|454400280|FG002|Extension Phase|Adverse Event|0|||
126303308|NCT00652626|454400281|FG003|Extension Phase|Adverse Event|0|||
126303309|NCT00652626|454400282|FG004|Extension Phase|Adverse Event|0|||
126303310|NCT00652626|454400283|FG005|Extension Phase|Adverse Event|2|||
126303311|NCT00652626|454400284|FG006|Extension Phase|Adverse Event|1|||
126303312|NCT00652626|454400278|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
126303313|NCT00652626|454400279|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
126303314|NCT00652626|454400280|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
126303315|NCT00652626|454400281|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
126303316|NCT00652626|454400282|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
126303317|NCT00652626|454400283|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
126303318|NCT00652626|454400284|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
126303319|NCT00652626|454400278|FG000|Extension Phase|Physician Decision|0|||
126303320|NCT00652626|454400279|FG001|Extension Phase|Physician Decision|0|||
126303321|NCT00652626|454400280|FG002|Extension Phase|Physician Decision|0|||
126303322|NCT00652626|454400281|FG003|Extension Phase|Physician Decision|0|||
126303323|NCT00652626|454400282|FG004|Extension Phase|Physician Decision|0|||
126303324|NCT00652626|454400283|FG005|Extension Phase|Physician Decision|1|||
126303325|NCT00652626|454400284|FG006|Extension Phase|Physician Decision|1|||
126303326|NCT00652626|454400278|FG000|Extension Phase|Death|0|||
126303327|NCT00652626|454400279|FG001|Extension Phase|Death|0|||
126303328|NCT00652626|454400280|FG002|Extension Phase|Death|0|||
126303329|NCT00652626|454400281|FG003|Extension Phase|Death|0|||
126303330|NCT00652626|454400282|FG004|Extension Phase|Death|0|||
126303331|NCT00652626|454400283|FG005|Extension Phase|Death|1|||
126303332|NCT00652626|454400284|FG006|Extension Phase|Death|1|||
126303333|NCT01623310|454400285|FG000|Overall Study|Adverse Event|21|||
126303334|NCT01623310|454400285|FG000|Overall Study|Lost to Follow-up|18|||
126303335|NCT01623310|454400285|FG000|Overall Study|Lack of Efficacy|6|||
126303336|NCT01623310|454400285|FG000|Overall Study|Protocol Violation|6|||
126303337|NCT01623310|454400285|FG000|Overall Study|Withdrawal by Subject|25|||
126303338|NCT01623310|454400285|FG000|Overall Study|Became potentially child-bearing|1|||
126303339|NCT01623310|454400285|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
126303340|NCT01623310|454400285|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
126303341|NCT02898597|454400286|FG000|Overall Study|Protocol Violation|4|||
126303342|NCT02898597|454400287|FG001|Overall Study|Protocol Violation|2|||
126303343|NCT02898597|454400286|FG000|Overall Study|Lost to Follow-up|0|||
126303344|NCT02898597|454400287|FG001|Overall Study|Lost to Follow-up|9|||
126303345|NCT02898597|454400286|FG000|Overall Study|Death|0|||
126303346|NCT02898597|454400287|FG001|Overall Study|Death|1|||
126303347|NCT02530125|454400288|FG000|Completed Treatment|Early termination of study|1|||
126303348|NCT02530125|454400288|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
126303349|NCT00356603|454400289|FG000|Overall Study|Other|6|||
126303350|NCT00356603|454400290|FG001|Overall Study|Other|3|||
126303351|NCT01568034|454400292|FG000|Overall Study|Withdrawal by Subject|1|||
126303352|NCT01568034|454400293|FG001|Overall Study|Withdrawal by Subject|0|||
126303353|NCT01568034|454400294|FG002|Overall Study|Withdrawal by Subject|0|||
126303354|NCT01568034|454400295|FG003|Overall Study|Withdrawal by Subject|0|||
126303355|NCT00728468|454400296|FG000|Overall Study|Enrolled but not treated|1|||
126303356|NCT00728468|454400296|FG000|Overall Study|Death|1|||
126367934|NCT00851084|454642848|FG000|Overall Study|Physician Decision|13|||
126367935|NCT00851084|454642849|FG001|Overall Study|Physician Decision|14|||
126367936|NCT00851084|454642848|FG000|Overall Study|Consent withdrawn|0|||
126367937|NCT00851084|454642849|FG001|Overall Study|Consent withdrawn|2|||
126367938|NCT00851084|454642848|FG000|Overall Study|Withdrawal by Subject|11|||
126367939|NCT00851084|454642849|FG001|Overall Study|Withdrawal by Subject|12|||
126367940|NCT00851084|454642848|FG000|Overall Study|Metastatic surgery|6|||
126367941|NCT00851084|454642849|FG001|Overall Study|Metastatic surgery|6|||
126367942|NCT00851084|454642848|FG000|Overall Study|Other|7|||
126303357|NCT00728468|454400296|FG000|Overall Study|Protocol Violation|4|||
126367943|NCT00851084|454642849|FG001|Overall Study|Other|1|||
126367944|NCT00734032|454642850|FG000|Overall Study|Adverse Event|0|||
126367945|NCT00734032|454642851|FG001|Overall Study|Adverse Event|1|||
126303358|NCT00728468|454400296|FG000|Overall Study|Objective progression or relapse|9|||
126303359|NCT00728468|454400296|FG000|Overall Study|Study terminated by sponsor|1|||
126303360|NCT01262287|454400297|FG000|Overall Study|Lost to Follow-up|2|||
126303361|NCT01262287|454400298|FG001|Overall Study|Lost to Follow-up|1|||
126303362|NCT00932373|454400299|FG000|Overall Study|Progressive disease|3|||
126303363|NCT00932373|454400300|FG001|Overall Study|Progressive disease|1|||
126303364|NCT00932373|454400301|FG002|Overall Study|Progressive disease|0|||
126303365|NCT00932373|454400302|FG003|Overall Study|Progressive disease|0|||
126303366|NCT00932373|454400303|FG004|Overall Study|Progressive disease|10|||
126303367|NCT00932373|454400304|FG005|Overall Study|Progressive disease|1|||
126303368|NCT00932373|454400305|FG006|Overall Study|Progressive disease|0|||
126303369|NCT00932373|454400306|FG007|Overall Study|Progressive disease|2|||
126303370|NCT00932373|454400307|FG008|Overall Study|Progressive disease|1|||
126303371|NCT00932373|454400308|FG009|Overall Study|Progressive disease|9|||
126303372|NCT00932373|454400309|FG010|Overall Study|Progressive disease|2|||
126303373|NCT00932373|454400299|FG000|Overall Study|Adverse Event|0|||
126303374|NCT00932373|454400300|FG001|Overall Study|Adverse Event|0|||
126303375|NCT00932373|454400301|FG002|Overall Study|Adverse Event|0|||
126303376|NCT00932373|454400302|FG003|Overall Study|Adverse Event|0|||
126303377|NCT00932373|454400303|FG004|Overall Study|Adverse Event|2|||
126303378|NCT00932373|454400304|FG005|Overall Study|Adverse Event|1|||
126303379|NCT00932373|454400305|FG006|Overall Study|Adverse Event|0|||
126303380|NCT00932373|454400306|FG007|Overall Study|Adverse Event|1|||
126303381|NCT00932373|454400307|FG008|Overall Study|Adverse Event|0|||
126303382|NCT00932373|454400308|FG009|Overall Study|Adverse Event|2|||
126303383|NCT00932373|454400309|FG010|Overall Study|Adverse Event|1|||
126303384|NCT00932373|454400299|FG000|Overall Study|Physician Decision|0|||
126303385|NCT00932373|454400300|FG001|Overall Study|Physician Decision|0|||
126303386|NCT00932373|454400301|FG002|Overall Study|Physician Decision|1|||
126303387|NCT00932373|454400302|FG003|Overall Study|Physician Decision|0|||
126303388|NCT00932373|454400303|FG004|Overall Study|Physician Decision|2|||
126303389|NCT00932373|454400304|FG005|Overall Study|Physician Decision|0|||
126303390|NCT00932373|454400305|FG006|Overall Study|Physician Decision|0|||
126303391|NCT00932373|454400306|FG007|Overall Study|Physician Decision|0|||
126303392|NCT00932373|454400307|FG008|Overall Study|Physician Decision|0|||
126303393|NCT00932373|454400308|FG009|Overall Study|Physician Decision|1|||
126303394|NCT00932373|454400309|FG010|Overall Study|Physician Decision|0|||
126303395|NCT00932373|454400299|FG000|Overall Study|Dose limiting toxicity|0|||
126303396|NCT00932373|454400300|FG001|Overall Study|Dose limiting toxicity|0|||
126303397|NCT00932373|454400301|FG002|Overall Study|Dose limiting toxicity|0|||
126303398|NCT00932373|454400302|FG003|Overall Study|Dose limiting toxicity|0|||
126303399|NCT00932373|454400303|FG004|Overall Study|Dose limiting toxicity|0|||
126303400|NCT00932373|454400304|FG005|Overall Study|Dose limiting toxicity|1|||
126303401|NCT00932373|454400305|FG006|Overall Study|Dose limiting toxicity|0|||
126303402|NCT00932373|454400306|FG007|Overall Study|Dose limiting toxicity|0|||
126303403|NCT00932373|454400307|FG008|Overall Study|Dose limiting toxicity|0|||
126303404|NCT00932373|454400308|FG009|Overall Study|Dose limiting toxicity|0|||
126303405|NCT00932373|454400309|FG010|Overall Study|Dose limiting toxicity|0|||
126303406|NCT00932373|454400299|FG000|Overall Study|Withdrawal by Subject|0|||
126303407|NCT00932373|454400300|FG001|Overall Study|Withdrawal by Subject|0|||
126303408|NCT00932373|454400301|FG002|Overall Study|Withdrawal by Subject|0|||
126303409|NCT00932373|454400302|FG003|Overall Study|Withdrawal by Subject|0|||
126303410|NCT00932373|454400303|FG004|Overall Study|Withdrawal by Subject|0|||
126303411|NCT00932373|454400304|FG005|Overall Study|Withdrawal by Subject|0|||
126303412|NCT00932373|454400305|FG006|Overall Study|Withdrawal by Subject|0|||
126367946|NCT00734032|454642852|FG002|Overall Study|Adverse Event|0|||
126367947|NCT00734032|454642853|FG003|Overall Study|Adverse Event|0|||
126367948|NCT03360344|454642858|FG000|Overall Study|Withdrawal by Subject|0|||
126367949|NCT03360344|454642859|FG001|Overall Study|Withdrawal by Subject|1|||
126367950|NCT03360344|454642860|FG002|Overall Study|Withdrawal by Subject|1|||
126367951|NCT00133705|454642865|FG000|Overall Study|Withdrawal by Subject|2|||
126367952|NCT00133705|454642866|FG001|Overall Study|Withdrawal by Subject|3|||
126367953|NCT03847519|454642876|FG000|Overall Study|Death|5|||
126367954|NCT03847519|454642877|FG001|Overall Study|Death|8|||
126367955|NCT03847519|454642878|FG002|Overall Study|Death|1|||
126367956|NCT03847519|454642876|FG000|Overall Study|Lost to Follow-up|1|||
126303413|NCT00932373|454400306|FG007|Overall Study|Withdrawal by Subject|0|||
126303414|NCT00932373|454400307|FG008|Overall Study|Withdrawal by Subject|1|||
126367957|NCT03847519|454642877|FG001|Overall Study|Lost to Follow-up|2|||
126367958|NCT03847519|454642878|FG002|Overall Study|Lost to Follow-up|0|||
126303415|NCT00932373|454400308|FG009|Overall Study|Withdrawal by Subject|0|||
126303416|NCT00932373|454400309|FG010|Overall Study|Withdrawal by Subject|0|||
126303417|NCT00932373|454400299|FG000|Overall Study|Clinical progression|0|||
126303418|NCT00932373|454400300|FG001|Overall Study|Clinical progression|0|||
126303419|NCT00932373|454400301|FG002|Overall Study|Clinical progression|0|||
126367959|NCT03847519|454642876|FG000|Overall Study|Study Terminated by Sponsor|0|||
126367960|NCT03847519|454642877|FG001|Overall Study|Study Terminated by Sponsor|3|||
126367961|NCT03847519|454642878|FG002|Overall Study|Study Terminated by Sponsor|2|||
126303420|NCT00932373|454400302|FG003|Overall Study|Clinical progression|0|||
126303421|NCT00932373|454400303|FG004|Overall Study|Clinical progression|0|||
126303422|NCT00932373|454400304|FG005|Overall Study|Clinical progression|0|||
126303423|NCT00932373|454400305|FG006|Overall Study|Clinical progression|1|||
126303424|NCT00932373|454400306|FG007|Overall Study|Clinical progression|0|||
126303425|NCT00932373|454400307|FG008|Overall Study|Clinical progression|0|||
126303426|NCT00932373|454400308|FG009|Overall Study|Clinical progression|0|||
126303427|NCT00932373|454400309|FG010|Overall Study|Clinical progression|0|||
126303428|NCT00932373|454400299|FG000|Overall Study|Lack of Efficacy|0|||
126303429|NCT00932373|454400300|FG001|Overall Study|Lack of Efficacy|0|||
126303430|NCT00932373|454400301|FG002|Overall Study|Lack of Efficacy|0|||
126303431|NCT00932373|454400302|FG003|Overall Study|Lack of Efficacy|0|||
126303432|NCT00932373|454400303|FG004|Overall Study|Lack of Efficacy|0|||
126303433|NCT00932373|454400304|FG005|Overall Study|Lack of Efficacy|0|||
126303434|NCT00932373|454400305|FG006|Overall Study|Lack of Efficacy|0|||
126303435|NCT00932373|454400306|FG007|Overall Study|Lack of Efficacy|0|||
126303436|NCT00932373|454400307|FG008|Overall Study|Lack of Efficacy|0|||
126303437|NCT00932373|454400308|FG009|Overall Study|Lack of Efficacy|1|||
126303438|NCT00932373|454400309|FG010|Overall Study|Lack of Efficacy|0|||
126303439|NCT01637922|454400310|FG000|Overall Study|Adverse Event|0|||
126303440|NCT01637922|454400311|FG001|Overall Study|Adverse Event|1|||
126303441|NCT01637922|454400310|FG000|Overall Study|Protocol Violation|0|||
126303442|NCT01637922|454400311|FG001|Overall Study|Protocol Violation|1|||
126303443|NCT01637922|454400310|FG000|Overall Study|Withdrawal by Subject|0|||
126303444|NCT01637922|454400311|FG001|Overall Study|Withdrawal by Subject|3|||
126303445|NCT01637922|454400310|FG000|Overall Study|Lost to Follow-up|2|||
126303446|NCT01637922|454400311|FG001|Overall Study|Lost to Follow-up|0|||
126303447|NCT00638404|454400312|FG000|Overall Study|Physician Decision|8|||
126303448|NCT00638404|454400313|FG001|Overall Study|Physician Decision|0|||
126303449|NCT02492984|454400314|FG000|Overall Study|Adverse Event|1|||
126303450|NCT02492984|454400315|FG001|Overall Study|Adverse Event|0|||
126303451|NCT02492984|454400314|FG000|Overall Study|Protocol Violation|1|||
126303452|NCT02492984|454400315|FG001|Overall Study|Protocol Violation|0|||
126303453|NCT02492984|454400314|FG000|Overall Study|Withdrawal by Subject|1|||
126303454|NCT02492984|454400315|FG001|Overall Study|Withdrawal by Subject|0|||
126303455|NCT04090060|454400321|FG000|Overall Study|Lost to Follow-up|76|||
126303456|NCT04090060|454400322|FG001|Overall Study|Lost to Follow-up|77|||
126303457|NCT01164579|454400329|FG000|Overall Study|Lack of Efficacy|0|||
126303458|NCT01164579|454400330|FG001|Overall Study|Lack of Efficacy|0|||
126303459|NCT01164579|454400331|FG002|Overall Study|Lack of Efficacy|6|||
126303460|NCT01164579|454400329|FG000|Overall Study|Lost to Follow-up|1|||
126303461|NCT01164579|454400330|FG001|Overall Study|Lost to Follow-up|1|||
126303462|NCT01164579|454400331|FG002|Overall Study|Lost to Follow-up|0|||
126303463|NCT01164579|454400329|FG000|Overall Study|Withdrawal by Subject|2|||
126303464|NCT01164579|454400330|FG001|Overall Study|Withdrawal by Subject|5|||
126303465|NCT01164579|454400331|FG002|Overall Study|Withdrawal by Subject|3|||
126303466|NCT01164579|454400329|FG000|Overall Study|Protocol Violation|0|||
126303467|NCT01164579|454400330|FG001|Overall Study|Protocol Violation|1|||
126303468|NCT01164579|454400331|FG002|Overall Study|Protocol Violation|2|||
126303469|NCT01164579|454400329|FG000|Overall Study|Adverse Event|4|||
126303470|NCT01164579|454400330|FG001|Overall Study|Adverse Event|2|||
126303471|NCT01164579|454400331|FG002|Overall Study|Adverse Event|5|||
126303472|NCT01164579|454400329|FG000|Overall Study|Reason not specified|1|||
126303473|NCT01164579|454400330|FG001|Overall Study|Reason not specified|0|||
126303474|NCT01164579|454400331|FG002|Overall Study|Reason not specified|0|||
126303475|NCT00302328|454400338|FG000|Overall Study|Physician Decision|0|||
126303476|NCT00302328|454400339|FG001|Overall Study|Physician Decision|1|||
126303477|NCT00302328|454400340|FG002|Overall Study|Physician Decision|0|||
126303478|NCT01288937|454400347|FG000|Overall Study|Adverse Event|1|||
126303479|NCT01288937|454400348|FG001|Overall Study|Adverse Event|0|||
126303480|NCT02490371|454400349|FG000|Overall Study|Lost to Follow-up|1|||
126551004|NCT02001974|455311778|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
126551005|NCT02001974|455311779|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
126551006|NCT02001974|455311780|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
126551007|NCT02001974|455311778|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
126551008|NCT02001974|455311779|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
126551009|NCT02001974|455311780|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
126713265|NCT01845077|455902059|FG002|Washout Period|Lost to Follow-up|0|||
126303481|NCT02490371|454400350|FG001|Overall Study|Lost to Follow-up|1|||
126303482|NCT02476578|454400353|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
126303483|NCT02476578|454400354|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
126303484|NCT02476578|454400353|FG000|Overall Study|Lost to Follow-up|6|||
126303485|NCT02476578|454400354|FG001|Overall Study|Lost to Follow-up|13|||
126303486|NCT03491462|454400355|FG000|Overall Study|Lost to Follow-up|2|||
126303487|NCT03491462|454400356|FG001|Overall Study|Lost to Follow-up|0|||
126303488|NCT03491462|454400355|FG000|Overall Study|Adverse Event|11|||
126303489|NCT03491462|454400356|FG001|Overall Study|Adverse Event|1|||
126303490|NCT03491462|454400355|FG000|Overall Study|Physician Decision|3|||
126303491|NCT03491462|454400356|FG001|Overall Study|Physician Decision|0|||
126303492|NCT03491462|454400355|FG000|Overall Study|Withdrawal by Subject|22|||
126303493|NCT03491462|454400356|FG001|Overall Study|Withdrawal by Subject|15|||
126303494|NCT04938180|454400357|FG000|Overall Study|Adverse Event|1|||
126303495|NCT03018080|454400358|FG000|Overall Study|Death|12|||
126303496|NCT03018080|454400359|FG001|Overall Study|Death|19|||
126303497|NCT00740792|454400360|FG000|Overall Study|Adverse Event|3|||
126303498|NCT00740792|454400361|FG001|Overall Study|Adverse Event|1|||
126303499|NCT00740792|454400362|FG002|Overall Study|Adverse Event|1|||
126303500|NCT00740792|454400363|FG003|Overall Study|Adverse Event|3|||
126303501|NCT00740792|454400360|FG000|Overall Study|Lack of Efficacy|1|||
126303502|NCT00740792|454400361|FG001|Overall Study|Lack of Efficacy|1|||
126303503|NCT00740792|454400362|FG002|Overall Study|Lack of Efficacy|0|||
126303504|NCT00740792|454400363|FG003|Overall Study|Lack of Efficacy|3|||
126303505|NCT00740792|454400360|FG000|Overall Study|Lost to Follow-up|2|||
126303506|NCT00740792|454400361|FG001|Overall Study|Lost to Follow-up|1|||
126303507|NCT00740792|454400362|FG002|Overall Study|Lost to Follow-up|0|||
126303508|NCT00740792|454400363|FG003|Overall Study|Lost to Follow-up|0|||
126303509|NCT00740792|454400360|FG000|Overall Study|Protocol Violation|0|||
126303510|NCT00740792|454400361|FG001|Overall Study|Protocol Violation|1|||
126303511|NCT00740792|454400362|FG002|Overall Study|Protocol Violation|0|||
126303512|NCT00740792|454400363|FG003|Overall Study|Protocol Violation|2|||
126303513|NCT00740792|454400360|FG000|Overall Study|Withdrawal by Subject|1|||
126303514|NCT00740792|454400361|FG001|Overall Study|Withdrawal by Subject|1|||
126303515|NCT00740792|454400362|FG002|Overall Study|Withdrawal by Subject|0|||
126303516|NCT00740792|454400363|FG003|Overall Study|Withdrawal by Subject|0|||
126303517|NCT00740792|454400360|FG000|Overall Study|administrative|3|||
126303518|NCT00740792|454400361|FG001|Overall Study|administrative|3|||
126303519|NCT00740792|454400362|FG002|Overall Study|administrative|8|||
126303520|NCT00740792|454400363|FG003|Overall Study|administrative|2|||
126303521|NCT00441129|454400368|FG000|Overall Study|Withdrawal by Subject|6|||
126303522|NCT00441129|454400369|FG001|Overall Study|Withdrawal by Subject|14|||
126303523|NCT00912743|454400370|FG000|Overall Study|Adverse Event|3|||
126303524|NCT00912743|454400371|FG001|Overall Study|Adverse Event|1|||
126303525|NCT00912743|454400370|FG000|Overall Study|Lack of Efficacy|9|||
126303526|NCT00912743|454400371|FG001|Overall Study|Lack of Efficacy|18|||
126303527|NCT00912743|454400370|FG000|Overall Study|Toxicity|0|||
126462344|NCT00055471|454993063|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
126713266|NCT01845077|455902060|FG003|Washout Period|Lost to Follow-up|1|||
126713267|NCT01845077|455902061|FG004|Washout Period|Lost to Follow-up|0|||
126713268|NCT01845077|455902062|FG005|Washout Period|Lost to Follow-up|1|||
126713269|NCT01845077|455902057|FG000|Washout Period|Adverse Event|1|||
126713270|NCT01845077|455902058|FG001|Washout Period|Adverse Event|0|||
126713271|NCT01845077|455902059|FG002|Washout Period|Adverse Event|0|||
126713272|NCT01845077|455902060|FG003|Washout Period|Adverse Event|0|||
126713273|NCT01845077|455902061|FG004|Washout Period|Adverse Event|0|||
126713274|NCT01845077|455902062|FG005|Washout Period|Adverse Event|0|||
126713275|NCT01845077|455902057|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
126713276|NCT01845077|455902058|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
126713277|NCT01845077|455902059|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
126713278|NCT01845077|455902060|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
126713279|NCT01845077|455902061|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
126713280|NCT01845077|455902062|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
126713281|NCT01845077|455902057|FG000|Washout Period|Protocol Violation|0|||
126713282|NCT01845077|455902058|FG001|Washout Period|Protocol Violation|0|||
126713283|NCT01845077|455902059|FG002|Washout Period|Protocol Violation|0|||
126713284|NCT01845077|455902060|FG003|Washout Period|Protocol Violation|1|||
126713285|NCT01845077|455902061|FG004|Washout Period|Protocol Violation|1|||
126713286|NCT01845077|455902062|FG005|Washout Period|Protocol Violation|0|||
126713287|NCT01797432|455902063|FG000|Overall Study|Lost to Follow-up|1|||
126713288|NCT01797432|455902063|FG000|Overall Study|Adverse Event|1|||
126713289|NCT01797432|455902063|FG000|Overall Study|Withdrawal by Subject|1|||
126713290|NCT01797432|455902063|FG000|Overall Study|lived too far from study site|1|||
126713291|NCT01137435|455902064|FG000|Overall Study|Lost to Follow-up|24|||
126713292|NCT01137435|455902064|FG000|Overall Study|Off label usage|4|||
126713293|NCT00487279|455902073|FG000|Overall Study|Death|1|||
126713294|NCT00487279|455902074|FG001|Overall Study|Death|0|||
126713295|NCT00487279|455902073|FG000|Overall Study|Withdrawal by Subject|0|||
126713296|NCT00487279|455902074|FG001|Overall Study|Withdrawal by Subject|2|||
126713297|NCT00501852|455902075|FG000|Overall Study|Adverse Event|3|||
126713298|NCT00501852|455902075|FG000|Overall Study|Withdrawal by Subject|2|||
126303528|NCT00912743|454400371|FG001|Overall Study|Toxicity|1|||
126303529|NCT00912743|454400370|FG000|Overall Study|End of treatment form was not collected|1|||
126303530|NCT00912743|454400371|FG001|Overall Study|End of treatment form was not collected|0|||
126303531|NCT00179660|454400381|FG000|Overall Study|Adverse Event|7|||
126303532|NCT00179660|454400381|FG000|Overall Study|Lack of therapeutic effect|28|||
126303533|NCT00179660|454400381|FG000|Overall Study|Withdrawal by Subject|2|||
126713299|NCT01416610|455902078|FG000|Overall Study|Adverse Event|4|||
126713300|NCT01416610|455902078|FG000|Overall Study|Adverse Event -Patient decision|3|||
126713301|NCT01416610|455902078|FG000|Overall Study|Lack of Efficacy|4|||
126367962|NCT02314923|454642879|FG000|Overall Study|Death|0|||
126367963|NCT02314923|454642880|FG001|Overall Study|Death|0|||
126367964|NCT02314923|454642881|FG002|Overall Study|Death|0|||
126367965|NCT02314923|454642882|FG003|Overall Study|Death|1|||
126367966|NCT02314923|454642883|FG004|Overall Study|Death|0|||
126367967|NCT02314923|454642884|FG005|Overall Study|Death|0|||
126367968|NCT02314923|454642885|FG006|Overall Study|Death|0|||
126367969|NCT02314923|454642886|FG007|Overall Study|Death|0|||
126462345|NCT00055471|454993064|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
126462346|NCT00055471|454993062|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
126462347|NCT00055471|454993063|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
126462348|NCT00055471|454993064|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
126462349|NCT00055471|454993062|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
126462350|NCT00055471|454993063|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
126462351|NCT00055471|454993064|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
126462352|NCT01854944|454993065|FG000|Overall Study|Withdrawal by Subject|0|||
126462353|NCT01854944|454993066|FG001|Overall Study|Withdrawal by Subject|0|||
126462354|NCT01854944|454993067|FG002|Overall Study|Withdrawal by Subject|1|||
126462355|NCT02101112|454993068|FG000|Overall Study|Adverse Event|0|||
126303534|NCT00179660|454400381|FG000|Overall Study|Lost to Follow-up|1|||
126303535|NCT00179660|454400381|FG000|Overall Study|Death|3|||
126303536|NCT00179660|454400381|FG000|Overall Study|Other - Unspecified|9|||
126303537|NCT00685399|454400387|FG000|Treatment Period 1|Withdrawal by Subject|2|||
126303538|NCT00685399|454400388|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126303539|NCT00685399|454400389|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126303540|NCT00685399|454400390|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126303541|NCT00685399|454400391|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126303542|NCT00685399|454400392|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126303543|NCT00685399|454400393|FG006|Treatment Period 1|Withdrawal by Subject|0|||
126303544|NCT00685399|454400394|FG007|Treatment Period 1|Withdrawal by Subject|0|||
126303545|NCT00685399|454400387|FG000|Treatment Period 1|Protocol Violation|1|||
126303546|NCT00685399|454400388|FG001|Treatment Period 1|Protocol Violation|0|||
126303547|NCT00685399|454400389|FG002|Treatment Period 1|Protocol Violation|0|||
126303548|NCT00685399|454400390|FG003|Treatment Period 1|Protocol Violation|0|||
126303549|NCT00685399|454400391|FG004|Treatment Period 1|Protocol Violation|0|||
126303550|NCT00685399|454400392|FG005|Treatment Period 1|Protocol Violation|0|||
126303551|NCT00685399|454400393|FG006|Treatment Period 1|Protocol Violation|0|||
126303552|NCT00685399|454400394|FG007|Treatment Period 1|Protocol Violation|0|||
126303553|NCT00685399|454400387|FG000|Treatment Period 1|Administrative|2|||
126303554|NCT00685399|454400388|FG001|Treatment Period 1|Administrative|0|||
126303555|NCT00685399|454400389|FG002|Treatment Period 1|Administrative|0|||
126303556|NCT00685399|454400390|FG003|Treatment Period 1|Administrative|0|||
126303557|NCT00685399|454400391|FG004|Treatment Period 1|Administrative|0|||
126303558|NCT00685399|454400392|FG005|Treatment Period 1|Administrative|0|||
126303559|NCT00685399|454400393|FG006|Treatment Period 1|Administrative|0|||
126303560|NCT00685399|454400394|FG007|Treatment Period 1|Administrative|0|||
126303561|NCT00685399|454400387|FG000|Treatment Period 1|Lack of Efficacy|1|||
126303562|NCT00685399|454400388|FG001|Treatment Period 1|Lack of Efficacy|0|||
126303563|NCT00685399|454400389|FG002|Treatment Period 1|Lack of Efficacy|0|||
126303564|NCT00685399|454400390|FG003|Treatment Period 1|Lack of Efficacy|0|||
126303565|NCT00685399|454400391|FG004|Treatment Period 1|Lack of Efficacy|0|||
126303566|NCT00685399|454400392|FG005|Treatment Period 1|Lack of Efficacy|0|||
126303567|NCT00685399|454400393|FG006|Treatment Period 1|Lack of Efficacy|0|||
126303568|NCT00685399|454400394|FG007|Treatment Period 1|Lack of Efficacy|0|||
126303569|NCT00685399|454400387|FG000|Treatment Period 2|Administrative Problems|0|||
126303570|NCT00685399|454400388|FG001|Treatment Period 2|Administrative Problems|2|||
126367970|NCT02314923|454642887|FG008|Overall Study|Death|0|||
126367971|NCT02314923|454642888|FG009|Overall Study|Death|0|||
126367972|NCT02314923|454642879|FG000|Overall Study|Lost to Follow-up|2|||
126462356|NCT02101112|454993069|FG001|Overall Study|Adverse Event|0|||
126462357|NCT02101112|454993070|FG002|Overall Study|Adverse Event|1|||
126462358|NCT02101112|454993071|FG003|Overall Study|Adverse Event|0|||
126303571|NCT00685399|454400389|FG002|Treatment Period 2|Administrative Problems|1|||
126303572|NCT00685399|454400390|FG003|Treatment Period 2|Administrative Problems|0|||
126303573|NCT00685399|454400391|FG004|Treatment Period 2|Administrative Problems|0|||
126303574|NCT00685399|454400392|FG005|Treatment Period 2|Administrative Problems|0|||
126303575|NCT00685399|454400393|FG006|Treatment Period 2|Administrative Problems|0|||
126303576|NCT00685399|454400394|FG007|Treatment Period 2|Administrative Problems|0|||
126303577|NCT00685399|454400387|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126303578|NCT00685399|454400388|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126303579|NCT00685399|454400389|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126303580|NCT00685399|454400390|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126367973|NCT02314923|454642880|FG001|Overall Study|Lost to Follow-up|3|||
126367974|NCT02314923|454642881|FG002|Overall Study|Lost to Follow-up|1|||
126367975|NCT02314923|454642882|FG003|Overall Study|Lost to Follow-up|0|||
126367976|NCT02314923|454642883|FG004|Overall Study|Lost to Follow-up|0|||
126303581|NCT00685399|454400391|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126303582|NCT00685399|454400392|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126303583|NCT00685399|454400393|FG006|Treatment Period 2|Withdrawal by Subject|0|||
126303584|NCT00685399|454400394|FG007|Treatment Period 2|Withdrawal by Subject|2|||
126303585|NCT00685399|454400387|FG000|Treatment Period 2|Adverse Event|0|||
126303586|NCT00685399|454400388|FG001|Treatment Period 2|Adverse Event|0|||
126303587|NCT00685399|454400389|FG002|Treatment Period 2|Adverse Event|0|||
126303588|NCT00685399|454400390|FG003|Treatment Period 2|Adverse Event|0|||
126303589|NCT00685399|454400391|FG004|Treatment Period 2|Adverse Event|0|||
126303590|NCT00685399|454400392|FG005|Treatment Period 2|Adverse Event|1|||
126303591|NCT00685399|454400393|FG006|Treatment Period 2|Adverse Event|0|||
126303592|NCT00685399|454400394|FG007|Treatment Period 2|Adverse Event|0|||
126303593|NCT00685399|454400387|FG000|Treatment Period 2|Lack of Efficacy|0|||
126303594|NCT00685399|454400388|FG001|Treatment Period 2|Lack of Efficacy|10|||
126303595|NCT00685399|454400389|FG002|Treatment Period 2|Lack of Efficacy|2|||
126303596|NCT00685399|454400390|FG003|Treatment Period 2|Lack of Efficacy|0|||
126303597|NCT00685399|454400391|FG004|Treatment Period 2|Lack of Efficacy|0|||
126303598|NCT00685399|454400392|FG005|Treatment Period 2|Lack of Efficacy|1|||
126303599|NCT00685399|454400393|FG006|Treatment Period 2|Lack of Efficacy|0|||
126303600|NCT00685399|454400394|FG007|Treatment Period 2|Lack of Efficacy|0|||
126303601|NCT00685399|454400387|FG000|Extension|Administrative Issues|0|||
126303602|NCT00685399|454400388|FG001|Extension|Administrative Issues|0|||
126303603|NCT00685399|454400389|FG002|Extension|Administrative Issues|0|||
126303604|NCT00685399|454400390|FG003|Extension|Administrative Issues|1|||
126303605|NCT00685399|454400391|FG004|Extension|Administrative Issues|0|||
126303606|NCT00685399|454400392|FG005|Extension|Administrative Issues|0|||
126303607|NCT00685399|454400393|FG006|Extension|Administrative Issues|0|||
126303608|NCT00685399|454400394|FG007|Extension|Administrative Issues|0|||
126303609|NCT00685399|454400387|FG000|Extension|Withdrawal by Subject|0|||
126303610|NCT00685399|454400388|FG001|Extension|Withdrawal by Subject|0|||
126303611|NCT00685399|454400389|FG002|Extension|Withdrawal by Subject|0|||
126303612|NCT00685399|454400390|FG003|Extension|Withdrawal by Subject|1|||
126303613|NCT00685399|454400391|FG004|Extension|Withdrawal by Subject|0|||
126303614|NCT00685399|454400392|FG005|Extension|Withdrawal by Subject|0|||
126303615|NCT00685399|454400393|FG006|Extension|Withdrawal by Subject|0|||
126303616|NCT00685399|454400394|FG007|Extension|Withdrawal by Subject|0|||
126303617|NCT00685399|454400387|FG000|Extension|Protocol Violation|0|||
126303618|NCT00685399|454400388|FG001|Extension|Protocol Violation|0|||
126303619|NCT00685399|454400389|FG002|Extension|Protocol Violation|0|||
126303620|NCT00685399|454400390|FG003|Extension|Protocol Violation|1|||
126303621|NCT00685399|454400391|FG004|Extension|Protocol Violation|0|||
126303622|NCT00685399|454400392|FG005|Extension|Protocol Violation|0|||
126303623|NCT00685399|454400393|FG006|Extension|Protocol Violation|0|||
126303624|NCT00685399|454400394|FG007|Extension|Protocol Violation|0|||
126303625|NCT00685399|454400387|FG000|Extension|Lack of Efficacy|0|||
126303626|NCT00685399|454400388|FG001|Extension|Lack of Efficacy|0|||
126303627|NCT00685399|454400389|FG002|Extension|Lack of Efficacy|0|||
126303628|NCT00685399|454400390|FG003|Extension|Lack of Efficacy|2|||
126303629|NCT00685399|454400391|FG004|Extension|Lack of Efficacy|0|||
126303630|NCT00685399|454400392|FG005|Extension|Lack of Efficacy|0|||
126303631|NCT00685399|454400393|FG006|Extension|Lack of Efficacy|0|||
126303632|NCT00685399|454400394|FG007|Extension|Lack of Efficacy|0|||
126303633|NCT00685399|454400387|FG000|Extension|Adverse Event|0|||
126303634|NCT00685399|454400388|FG001|Extension|Adverse Event|0|||
126303635|NCT00685399|454400389|FG002|Extension|Adverse Event|0|||
126303636|NCT00685399|454400390|FG003|Extension|Adverse Event|2|||
126303637|NCT00685399|454400391|FG004|Extension|Adverse Event|0|||
126303638|NCT00685399|454400392|FG005|Extension|Adverse Event|0|||
126303639|NCT00685399|454400393|FG006|Extension|Adverse Event|0|||
126303640|NCT00685399|454400394|FG007|Extension|Adverse Event|0|||
126303641|NCT00178685|454400395|FG000|Overall Study|Death|3|||
126303642|NCT00178685|454400396|FG001|Overall Study|Death|3|||
126303643|NCT00178685|454400397|FG002|Overall Study|Death|6|||
126303644|NCT00178685|454400395|FG000|Overall Study|Lost to Follow-up|100|||
126303645|NCT00178685|454400396|FG001|Overall Study|Lost to Follow-up|187|||
126303646|NCT00178685|454400397|FG002|Overall Study|Lost to Follow-up|183|||
126303647|NCT00178685|454400395|FG000|Overall Study|Withdrawal by Subject|8|||
126303648|NCT00178685|454400396|FG001|Overall Study|Withdrawal by Subject|14|||
126303649|NCT00178685|454400397|FG002|Overall Study|Withdrawal by Subject|7|||
126367977|NCT02314923|454642884|FG005|Overall Study|Lost to Follow-up|0|||
126367978|NCT02314923|454642885|FG006|Overall Study|Lost to Follow-up|3|||
126303650|NCT01562782|454400400|FG000|Overall Study|Withdrawal by Subject|3|||
126303651|NCT01562782|454400401|FG001|Overall Study|Withdrawal by Subject|3|||
126303652|NCT01562782|454400400|FG000|Overall Study|screen failure|1|||
126303653|NCT01562782|454400401|FG001|Overall Study|screen failure|2|||
126303654|NCT02993250|454400406|FG000|Overall Study|Lost to Follow-up|0|||
126303655|NCT02993250|454400407|FG001|Overall Study|Lost to Follow-up|1|||
126303656|NCT02527434|454400408|FG000|Overall Study|Lost to Follow-up|2|||
126303657|NCT02527434|454400409|FG001|Overall Study|Lost to Follow-up|2|||
126303658|NCT02527434|454400410|FG002|Overall Study|Lost to Follow-up|0|||
126303659|NCT02527434|454400408|FG000|Overall Study|Death|19|||
126367979|NCT02314923|454642886|FG007|Overall Study|Lost to Follow-up|4|||
126367980|NCT02314923|454642887|FG008|Overall Study|Lost to Follow-up|2|||
126367981|NCT02314923|454642888|FG009|Overall Study|Lost to Follow-up|0|||
126367982|NCT02314923|454642879|FG000|Overall Study|Withdrawal by Subject|0|||
126367983|NCT02314923|454642880|FG001|Overall Study|Withdrawal by Subject|0|||
126367984|NCT02314923|454642881|FG002|Overall Study|Withdrawal by Subject|1|||
126367985|NCT02314923|454642882|FG003|Overall Study|Withdrawal by Subject|0|||
126367986|NCT02314923|454642883|FG004|Overall Study|Withdrawal by Subject|1|||
126367987|NCT02314923|454642884|FG005|Overall Study|Withdrawal by Subject|0|||
126367988|NCT02314923|454642885|FG006|Overall Study|Withdrawal by Subject|1|||
126367989|NCT02314923|454642886|FG007|Overall Study|Withdrawal by Subject|0|||
126367990|NCT02314923|454642887|FG008|Overall Study|Withdrawal by Subject|0|||
126367991|NCT02314923|454642888|FG009|Overall Study|Withdrawal by Subject|0|||
126367992|NCT02314923|454642879|FG000|Overall Study|Physician Decision|0|||
126367993|NCT02314923|454642880|FG001|Overall Study|Physician Decision|1|||
126367994|NCT02314923|454642881|FG002|Overall Study|Physician Decision|0|||
126367995|NCT02314923|454642882|FG003|Overall Study|Physician Decision|0|||
126367996|NCT02314923|454642883|FG004|Overall Study|Physician Decision|0|||
126367997|NCT02314923|454642884|FG005|Overall Study|Physician Decision|0|||
126367998|NCT02314923|454642885|FG006|Overall Study|Physician Decision|0|||
126367999|NCT02314923|454642886|FG007|Overall Study|Physician Decision|0|||
126368000|NCT02314923|454642887|FG008|Overall Study|Physician Decision|0|||
126368001|NCT02314923|454642888|FG009|Overall Study|Physician Decision|0|||
126368002|NCT02314923|454642879|FG000|Overall Study|Participant unavailable|0|||
126368003|NCT02314923|454642880|FG001|Overall Study|Participant unavailable|0|||
126368004|NCT02314923|454642881|FG002|Overall Study|Participant unavailable|0|||
126368005|NCT02314923|454642882|FG003|Overall Study|Participant unavailable|0|||
126368006|NCT02314923|454642883|FG004|Overall Study|Participant unavailable|0|||
126368007|NCT02314923|454642884|FG005|Overall Study|Participant unavailable|1|||
126368008|NCT02314923|454642885|FG006|Overall Study|Participant unavailable|0|||
126368009|NCT02314923|454642886|FG007|Overall Study|Participant unavailable|0|||
126368010|NCT02314923|454642887|FG008|Overall Study|Participant unavailable|0|||
126368011|NCT02314923|454642888|FG009|Overall Study|Participant unavailable|0|||
126368012|NCT02314923|454642879|FG000|Overall Study|Screen failure|0|||
126368013|NCT02314923|454642880|FG001|Overall Study|Screen failure|0|||
126368014|NCT02314923|454642881|FG002|Overall Study|Screen failure|0|||
126368015|NCT02314923|454642882|FG003|Overall Study|Screen failure|0|||
126368016|NCT02314923|454642883|FG004|Overall Study|Screen failure|0|||
126368017|NCT02314923|454642884|FG005|Overall Study|Screen failure|0|||
126368018|NCT02314923|454642885|FG006|Overall Study|Screen failure|1|||
126368019|NCT02314923|454642886|FG007|Overall Study|Screen failure|0|||
126368020|NCT02314923|454642887|FG008|Overall Study|Screen failure|0|||
126368021|NCT02314923|454642888|FG009|Overall Study|Screen failure|0|||
126368022|NCT02314923|454642879|FG000|Overall Study|Participant relocation|1|||
126368023|NCT02314923|454642880|FG001|Overall Study|Participant relocation|0|||
126368024|NCT02314923|454642881|FG002|Overall Study|Participant relocation|0|||
126368025|NCT02314923|454642882|FG003|Overall Study|Participant relocation|0|||
126368026|NCT02314923|454642883|FG004|Overall Study|Participant relocation|0|||
126368027|NCT02314923|454642884|FG005|Overall Study|Participant relocation|0|||
126368028|NCT02314923|454642885|FG006|Overall Study|Participant relocation|0|||
126551010|NCT02001974|455311778|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
126368029|NCT02314923|454642886|FG007|Overall Study|Participant relocation|1|||
126368030|NCT02314923|454642887|FG008|Overall Study|Participant relocation|0|||
126368031|NCT02314923|454642888|FG009|Overall Study|Participant relocation|0|||
126368032|NCT00725985|454642889|FG000|ITP- Treatment Disposition|Adverse Event|20|||
126368033|NCT00725985|454642890|FG001|ITP- Treatment Disposition|Adverse Event|10|||
126368034|NCT00725985|454642891|FG002|ITP- Treatment Disposition|Adverse Event|5|||
126368035|NCT00725985|454642892|FG003|ITP- Treatment Disposition|Adverse Event|0|||
126368036|NCT00725985|454642893|FG004|ITP- Treatment Disposition|Adverse Event|0|||
126368037|NCT00725985|454642894|FG005|ITP- Treatment Disposition|Adverse Event|0|||
126368038|NCT00725985|454642895|FG006|ITP- Treatment Disposition|Adverse Event|0|||
126368039|NCT00725985|454642896|FG007|ITP- Treatment Disposition|Adverse Event|0|||
126368040|NCT00725985|454642897|FG008|ITP- Treatment Disposition|Adverse Event|0|||
126368041|NCT00725985|454642898|FG009|ITP- Treatment Disposition|Adverse Event|0|||
126368042|NCT00725985|454642899|FG010|ITP- Treatment Disposition|Adverse Event|0|||
126368043|NCT00725985|454642900|FG011|ITP- Treatment Disposition|Adverse Event|0|||
126368044|NCT00725985|454642889|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368045|NCT00725985|454642890|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368046|NCT00725985|454642891|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
126368047|NCT00725985|454642892|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368048|NCT00725985|454642893|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368049|NCT00725985|454642894|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368050|NCT00725985|454642895|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368051|NCT00725985|454642896|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368052|NCT00725985|454642897|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368053|NCT00725985|454642898|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
126462359|NCT02101112|454993072|FG004|Overall Study|Adverse Event|0|||
126462360|NCT02101112|454993073|FG005|Overall Study|Adverse Event|0|||
126462361|NCT02101112|454993068|FG000|Overall Study|Withdrawal by Subject|0|||
126462362|NCT02101112|454993069|FG001|Overall Study|Withdrawal by Subject|0|||
126303660|NCT02527434|454400409|FG001|Overall Study|Death|6|||
126303661|NCT02527434|454400410|FG002|Overall Study|Death|17|||
126303662|NCT02527434|454400408|FG000|Overall Study|Withdrawal by Subject|5|||
126303663|NCT02527434|454400409|FG001|Overall Study|Withdrawal by Subject|3|||
126303664|NCT02527434|454400410|FG002|Overall Study|Withdrawal by Subject|3|||
126303665|NCT02527434|454400408|FG000|Overall Study|Reason Not Specified|1|||
126303666|NCT02527434|454400409|FG001|Overall Study|Reason Not Specified|0|||
126303667|NCT02527434|454400410|FG002|Overall Study|Reason Not Specified|0|||
126303668|NCT02527434|454400408|FG000|Overall Study|Site closure|1|||
126303669|NCT02527434|454400409|FG001|Overall Study|Site closure|0|||
126303670|NCT02527434|454400410|FG002|Overall Study|Site closure|0|||
126303671|NCT00568061|454400411|FG000|Overall Study|Inclusion / exclusion criteria|5|||
126303672|NCT00568061|454400412|FG001|Overall Study|Inclusion / exclusion criteria|1|||
126303673|NCT00568061|454400411|FG000|Overall Study|Adverse Event|0|||
126303674|NCT00568061|454400412|FG001|Overall Study|Adverse Event|1|||
126303675|NCT01896128|454400413|FG000|Overall Study|Withdrawal by Subject|3|||
126303676|NCT01896128|454400414|FG001|Overall Study|Withdrawal by Subject|3|||
126303677|NCT02484456|454400417|FG000|Washout Period|Withdrawal by Subject|0|||
126303678|NCT02484456|454400418|FG001|Washout Period|Withdrawal by Subject|1|||
126303679|NCT02484456|454400417|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
126303680|NCT02484456|454400418|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
126303681|NCT02484456|454400417|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
126303682|NCT02484456|454400418|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
126303683|NCT02484456|454400417|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
126303684|NCT02484456|454400418|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
126303685|NCT01996254|454400419|FG000|Overall Study|Change in Eligibility|0|||
126303686|NCT01996254|454400420|FG001|Overall Study|Change in Eligibility|2|||
126303687|NCT01996254|454400421|FG002|Overall Study|Change in Eligibility|0|||
126303688|NCT01996254|454400419|FG000|Overall Study|Withdrawal by Subject|0|||
126303689|NCT01996254|454400420|FG001|Overall Study|Withdrawal by Subject|3|||
126303690|NCT01996254|454400421|FG002|Overall Study|Withdrawal by Subject|4|||
126303691|NCT01996254|454400419|FG000|Overall Study|Lost to Follow-up|1|||
126303692|NCT01996254|454400420|FG001|Overall Study|Lost to Follow-up|0|||
126303693|NCT01996254|454400421|FG002|Overall Study|Lost to Follow-up|4|||
126303694|NCT03348930|454400424|FG000|Washout (1 Week)|Lost to Follow-up|1|||
126303695|NCT03348930|454400425|FG001|Washout (1 Week)|Lost to Follow-up|1|||
126303696|NCT00708214|454400428|FG000|Overall Study|Other Adverse Event|3|||
126303697|NCT00708214|454400429|FG001|Overall Study|Other Adverse Event|6|||
126303698|NCT00708214|454400430|FG002|Overall Study|Other Adverse Event|2|||
126303699|NCT00708214|454400428|FG000|Overall Study|Other|0|||
126303700|NCT00708214|454400429|FG001|Overall Study|Other|1|||
126303701|NCT00708214|454400430|FG002|Overall Study|Other|1|||
126303702|NCT00708214|454400428|FG000|Overall Study|Progressive Disease|4|||
126462363|NCT02101112|454993070|FG002|Overall Study|Withdrawal by Subject|0|||
126462364|NCT02101112|454993071|FG003|Overall Study|Withdrawal by Subject|0|||
126462365|NCT02101112|454993072|FG004|Overall Study|Withdrawal by Subject|1|||
126462366|NCT02101112|454993073|FG005|Overall Study|Withdrawal by Subject|0|||
126462367|NCT04340063|454993074|FG000|Overall Study|Withdrawal by Subject|1|||
126462368|NCT04340063|454993075|FG001|Overall Study|Withdrawal by Subject|2|||
126462369|NCT04340063|454993074|FG000|Overall Study|Lost to Follow-up|3|||
126462370|NCT04340063|454993075|FG001|Overall Study|Lost to Follow-up|1|||
126462371|NCT04340063|454993074|FG000|Overall Study|Protocol Violation|0|||
126462372|NCT04340063|454993075|FG001|Overall Study|Protocol Violation|1|||
126462373|NCT01857583|454993076|FG000|Overall Study|Adverse Event|0|||
126303703|NCT00708214|454400429|FG001|Overall Study|Progressive Disease|6|||
126303704|NCT00708214|454400430|FG002|Overall Study|Progressive Disease|5|||
126303705|NCT02411396|454400431|FG000|Overall Study|Lost to Follow-up|31|||
126303706|NCT02411396|454400431|FG000|Overall Study|Death|10|||
126303707|NCT02865499|454400432|FG000|Baseline|Adverse Event|1|||
126303708|NCT02865499|454400432|FG000|Baseline|Withdrawal by Subject|1|||
126303709|NCT01931995|454400433|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
126303710|NCT01931995|454400434|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
126462374|NCT01857583|454993077|FG001|Overall Study|Adverse Event|0|||
126462375|NCT01857583|454993078|FG002|Overall Study|Adverse Event|1|||
126462376|NCT01857583|454993079|FG003|Overall Study|Adverse Event|1|||
126770339|NCT01787188|456112456|FG000|Overall Study|Non-compliance with Study Drug|0|||
126303711|NCT01931995|454400433|FG000|First Intervention (1 Day)|Physician Decision|1|||
126303712|NCT01931995|454400434|FG001|First Intervention (1 Day)|Physician Decision|1|||
126303713|NCT01931995|454400433|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
126303714|NCT01931995|454400434|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
126303715|NCT02064816|454400438|FG000|Overall Study|Adverse Event|3|||
126303716|NCT02064816|454400439|FG001|Overall Study|Adverse Event|2|||
126303717|NCT02064816|454400438|FG000|Overall Study|Withdrawal by Subject|2|||
126303718|NCT02064816|454400439|FG001|Overall Study|Withdrawal by Subject|1|||
126303719|NCT02064816|454400438|FG000|Overall Study|Lost to Follow-up|2|||
126303720|NCT02064816|454400439|FG001|Overall Study|Lost to Follow-up|1|||
126303721|NCT02064816|454400438|FG000|Overall Study|Therapeutic failure|0|||
126303722|NCT02064816|454400439|FG001|Overall Study|Therapeutic failure|1|||
126303723|NCT02064816|454400438|FG000|Overall Study|Other|1|||
126303724|NCT02064816|454400439|FG001|Overall Study|Other|3|||
126303725|NCT01732458|454400440|FG000|Overall Study|Lost to Follow-up|0|||
126303726|NCT01732458|454400441|FG001|Overall Study|Lost to Follow-up|2|||
126303727|NCT01732458|454400442|FG002|Overall Study|Lost to Follow-up|0|||
126303728|NCT01732458|454400443|FG003|Overall Study|Lost to Follow-up|0|||
126303729|NCT01732458|454400440|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126303730|NCT01732458|454400441|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126303731|NCT01732458|454400442|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126303732|NCT01732458|454400443|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126303733|NCT01732458|454400440|FG000|Overall Study|Physician Decision|1|||
126303734|NCT01732458|454400441|FG001|Overall Study|Physician Decision|2|||
126303735|NCT01732458|454400442|FG002|Overall Study|Physician Decision|2|||
126303736|NCT01732458|454400443|FG003|Overall Study|Physician Decision|0|||
126303737|NCT01732458|454400440|FG000|Overall Study|Protocol Violation|2|||
126303738|NCT01732458|454400441|FG001|Overall Study|Protocol Violation|0|||
126303739|NCT01732458|454400442|FG002|Overall Study|Protocol Violation|0|||
126303740|NCT01732458|454400443|FG003|Overall Study|Protocol Violation|2|||
126303741|NCT01732458|454400440|FG000|Overall Study|Screen Failure|0|||
126303742|NCT01732458|454400441|FG001|Overall Study|Screen Failure|1|||
126303743|NCT01732458|454400442|FG002|Overall Study|Screen Failure|0|||
126303744|NCT01732458|454400443|FG003|Overall Study|Screen Failure|0|||
126303745|NCT03759587|454400444|FG000|Overall Study|Adverse Event|5|||
126303746|NCT03759587|454400444|FG000|Overall Study|Progressive Disease|10|||
126303747|NCT03759587|454400444|FG000|Overall Study|Site Terminated by Sponsor|3|||
126303748|NCT03759587|454400444|FG000|Overall Study|Withdrawal by Subject|1|||
126303749|NCT04615403|454400445|FG000|Overall Study|Death|1|||
126462377|NCT01857583|454993076|FG000|Overall Study|Death|0|||
126462378|NCT01857583|454993077|FG001|Overall Study|Death|1|||
126462379|NCT01857583|454993078|FG002|Overall Study|Death|1|||
126462380|NCT01857583|454993079|FG003|Overall Study|Death|0|||
126462381|NCT01857583|454993076|FG000|Overall Study|Physician Decision|0|||
126462382|NCT01857583|454993077|FG001|Overall Study|Physician Decision|0|||
126462383|NCT01857583|454993078|FG002|Overall Study|Physician Decision|0|||
126462384|NCT01857583|454993079|FG003|Overall Study|Physician Decision|1|||
126462385|NCT01857583|454993076|FG000|Overall Study|Withdrawal by Subject|1|||
126462386|NCT01857583|454993077|FG001|Overall Study|Withdrawal by Subject|0|||
126462387|NCT01857583|454993078|FG002|Overall Study|Withdrawal by Subject|1|||
126462388|NCT01857583|454993079|FG003|Overall Study|Withdrawal by Subject|2|||
126462389|NCT00458536|454993082|FG000|Overall Study|Disease progression prior to treatment|7|||
126462390|NCT00458536|454993082|FG000|Overall Study|Unable to make vaccine|3|||
126462391|NCT00458536|454993082|FG000|Overall Study|No measurable disease after surgery|2|||
126462392|NCT00458536|454993082|FG000|Overall Study|Did not have renal cell carcinoma|2|||
126462393|NCT00458536|454993082|FG000|Overall Study|Patient did not have surgery|1|||
126462394|NCT00458536|454993082|FG000|Overall Study|Ineligible due to toxicity|1|||
126462395|NCT00458536|454993082|FG000|Overall Study|Withdrawal by Subject|1|||
126462396|NCT00458536|454993082|FG000|Overall Study|Progressive disease during treatment|2|||
126462397|NCT04285580|454994958|FG000|Overall Study|Protocol Violation|0|||
126462398|NCT04285580|454994959|FG001|Overall Study|Protocol Violation|1|||
126462399|NCT00076024|454994960|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
126462400|NCT00076024|454994961|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
126462401|NCT00076024|454994962|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
126303750|NCT05119595|454402444|FG000|Overall Study|Death|1|||
126303751|NCT05119595|454402444|FG000|Overall Study|Lost to Follow-up|7|||
126303752|NCT03483961|454402445|FG000|Overall Study|Lost to Follow-up|7|||
126303753|NCT03483961|454402446|FG001|Overall Study|Lost to Follow-up|6|||
126303754|NCT03483961|454402447|FG002|Overall Study|Lost to Follow-up|6|||
126462402|NCT00076024|454994963|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
126462403|NCT00076024|454994960|FG000|Phase 1, Lead-in|Adverse Event|1|||
126462404|NCT00076024|454994961|FG001|Phase 1, Lead-in|Adverse Event|0|||
126462405|NCT00076024|454994962|FG002|Phase 1, Lead-in|Adverse Event|0|||
126462406|NCT00076024|454994963|FG003|Phase 1, Lead-in|Adverse Event|0|||
126462407|NCT00076024|454994960|FG000|Phase 1, Lead-in|Clinical progression|1|||
126462408|NCT00076024|454994961|FG001|Phase 1, Lead-in|Clinical progression|0|||
126462409|NCT00076024|454994962|FG002|Phase 1, Lead-in|Clinical progression|0|||
126303755|NCT03483961|454402448|FG003|Overall Study|Lost to Follow-up|6|||
126303756|NCT03483961|454402449|FG004|Overall Study|Lost to Follow-up|6|||
126303757|NCT03483961|454402450|FG005|Overall Study|Lost to Follow-up|4|||
126303758|NCT03483961|454402451|FG006|Overall Study|Lost to Follow-up|4|||
126303759|NCT03483961|454402452|FG007|Overall Study|Lost to Follow-up|11|||
126303760|NCT03483961|454402453|FG008|Overall Study|Lost to Follow-up|1|||
126303761|NCT03483961|454402454|FG009|Overall Study|Lost to Follow-up|0|||
126303762|NCT03483961|454402445|FG000|Overall Study|Withdrawal by Subject|3|||
126303763|NCT03483961|454402446|FG001|Overall Study|Withdrawal by Subject|4|||
126462410|NCT00076024|454994963|FG003|Phase 1, Lead-in|Clinical progression|0|||
126462411|NCT00076024|454994960|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
126462412|NCT00076024|454994961|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
126462413|NCT00076024|454994962|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
126462414|NCT00076024|454994963|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
126462415|NCT00076024|454994960|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
126462416|NCT00076024|454994961|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
126462417|NCT00076024|454994962|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
126462418|NCT00076024|454994963|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
126462419|NCT00076024|454994960|FG000|Phase 2, Double-blind|Adverse Event|0|||
126462420|NCT00076024|454994961|FG001|Phase 2, Double-blind|Adverse Event|25|||
126462421|NCT00076024|454994962|FG002|Phase 2, Double-blind|Adverse Event|6|||
126462422|NCT00076024|454994963|FG003|Phase 2, Double-blind|Adverse Event|0|||
126462423|NCT00076024|454994960|FG000|Phase 2, Double-blind|Un-specified|0|||
126462424|NCT00076024|454994961|FG001|Phase 2, Double-blind|Un-specified|14|||
126462425|NCT00076024|454994962|FG002|Phase 2, Double-blind|Un-specified|6|||
126462426|NCT00076024|454994963|FG003|Phase 2, Double-blind|Un-specified|0|||
126462427|NCT00076024|454994960|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
126462428|NCT00076024|454994961|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
126462429|NCT00076024|454994962|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
126462430|NCT00076024|454994963|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
126462431|NCT00076024|454994960|FG000|Phase 2, Open-label|Adverse Event|0|||
126462432|NCT00076024|454994961|FG001|Phase 2, Open-label|Adverse Event|0|||
126462433|NCT00076024|454994962|FG002|Phase 2, Open-label|Adverse Event|0|||
126462434|NCT00076024|454994963|FG003|Phase 2, Open-label|Adverse Event|2|||
126462435|NCT00076024|454994960|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
126462436|NCT00076024|454994961|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
126462437|NCT00076024|454994962|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
126462438|NCT00076024|454994963|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
126462439|NCT00076024|454994960|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
126462440|NCT00076024|454994961|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
126462441|NCT00076024|454994962|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
126462442|NCT00076024|454994963|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
126462443|NCT00076024|454994960|FG000|Phase 2, Open-label|Other|0|||
126462444|NCT00076024|454994961|FG001|Phase 2, Open-label|Other|0|||
126462445|NCT00076024|454994962|FG002|Phase 2, Open-label|Other|0|||
126462446|NCT00076024|454994963|FG003|Phase 2, Open-label|Other|2|||
126462447|NCT03981822|454994964|FG000|Overall Study|Lost to Follow-up|0|||
126462448|NCT03981822|454994965|FG001|Overall Study|Lost to Follow-up|1|||
126462449|NCT03981822|454994966|FG002|Overall Study|Lost to Follow-up|1|||
126462450|NCT03981822|454994967|FG003|Overall Study|Lost to Follow-up|0|||
126462451|NCT03981822|454994968|FG004|Overall Study|Lost to Follow-up|6|||
126303764|NCT03483961|454402447|FG002|Overall Study|Withdrawal by Subject|5|||
126303765|NCT03483961|454402448|FG003|Overall Study|Withdrawal by Subject|3|||
126462452|NCT03981822|454994969|FG005|Overall Study|Lost to Follow-up|4|||
126462453|NCT03981822|454994970|FG006|Overall Study|Lost to Follow-up|4|||
126462454|NCT03981822|454994971|FG007|Overall Study|Lost to Follow-up|2|||
126462455|NCT03981822|454994964|FG000|Overall Study|Withdrawal by Subject|0|||
126462456|NCT03981822|454994965|FG001|Overall Study|Withdrawal by Subject|1|||
126462457|NCT03981822|454994966|FG002|Overall Study|Withdrawal by Subject|0|||
126462458|NCT03981822|454994967|FG003|Overall Study|Withdrawal by Subject|0|||
126462459|NCT03981822|454994968|FG004|Overall Study|Withdrawal by Subject|0|||
126462460|NCT03981822|454994969|FG005|Overall Study|Withdrawal by Subject|1|||
126462461|NCT03981822|454994970|FG006|Overall Study|Withdrawal by Subject|0|||
126462462|NCT03981822|454994971|FG007|Overall Study|Withdrawal by Subject|2|||
126462463|NCT03981822|454994964|FG000|Overall Study|COVID-19 Related|0|||
126462464|NCT03981822|454994965|FG001|Overall Study|COVID-19 Related|0|||
126462465|NCT03981822|454994966|FG002|Overall Study|COVID-19 Related|0|||
126462466|NCT03981822|454994967|FG003|Overall Study|COVID-19 Related|0|||
126462467|NCT03981822|454994968|FG004|Overall Study|COVID-19 Related|2|||
126462468|NCT03981822|454994969|FG005|Overall Study|COVID-19 Related|1|||
126462469|NCT03981822|454994970|FG006|Overall Study|COVID-19 Related|2|||
126462470|NCT03981822|454994971|FG007|Overall Study|COVID-19 Related|1|||
126462471|NCT06460493|454994972|FG000|Overall Study|Withdrawal by Subject|2|||
126462472|NCT02987660|454994973|FG000|Overall Study|Study terminated by sponsor|10|||
126462473|NCT02987660|454994974|FG001|Overall Study|Study terminated by sponsor|10|||
126462474|NCT03707184|454994975|FG000|Overall Study|Withdrawal by Subject|2|||
126462475|NCT01282203|454994979|FG000|Overall Study|Adverse Event|1|||
126462476|NCT01606254|454994982|FG000|Overall Study|Withdrawal by Subject|1|||
126462477|NCT01606254|454994983|FG001|Overall Study|Withdrawal by Subject|3|||
126462478|NCT01606254|454994984|FG002|Overall Study|Withdrawal by Subject|0|||
126462479|NCT01606254|454994985|FG003|Overall Study|Withdrawal by Subject|2|||
126462480|NCT01606254|454994982|FG000|Overall Study|Adverse Event|1|||
126462481|NCT01606254|454994983|FG001|Overall Study|Adverse Event|1|||
126462482|NCT01606254|454994984|FG002|Overall Study|Adverse Event|0|||
126462483|NCT01606254|454994985|FG003|Overall Study|Adverse Event|1|||
126462484|NCT03977454|454994986|FG000|Overall Study|immediate postoperative revision|2|||
126462485|NCT03977454|454994987|FG001|Overall Study|immediate postoperative revision|2|||
126462486|NCT04543409|454994988|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126462487|NCT04543409|454994989|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126462488|NCT04543409|454994988|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
126462489|NCT04543409|454994989|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
126462490|NCT04543409|454994988|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
126462491|NCT04543409|454994989|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
126462492|NCT04543409|454994988|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
126462493|NCT04543409|454994989|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
126462494|NCT04543409|454994988|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
126462495|NCT04543409|454994989|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
126462496|NCT04543409|454994988|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
126462497|NCT04543409|454994989|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
126462498|NCT04543409|454994988|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
126462499|NCT04543409|454994989|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
126462500|NCT04543409|454994988|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
126462501|NCT04543409|454994989|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
126462502|NCT04543409|454994988|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
126462503|NCT04543409|454994989|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
126462504|NCT04543409|454994988|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
126462505|NCT04543409|454994989|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
126462506|NCT04543409|454994988|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
126462507|NCT04543409|454994989|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
126462508|NCT04365257|454994990|FG000|Overall Study|Physician Decision|1|||
126462509|NCT04365257|454994991|FG001|Overall Study|Physician Decision|0|||
126462510|NCT04365257|454994990|FG000|Overall Study|Patient Noncompliance|1|||
126462511|NCT04365257|454994991|FG001|Overall Study|Patient Noncompliance|0|||
126462512|NCT04365257|454994990|FG000|Overall Study|Withdrawal by Subject|0|||
126462513|NCT04365257|454994991|FG001|Overall Study|Withdrawal by Subject|1|||
126462514|NCT00518973|454994992|FG000|Overall Study|Withdrawal by Subject|3|||
126462515|NCT00518973|454994993|FG001|Overall Study|Withdrawal by Subject|2|||
126462516|NCT02129777|454994994|FG000|Double-Blind Period|Adverse Event|0|||
126462517|NCT02129777|454994995|FG001|Double-Blind Period|Adverse Event|0|||
126462518|NCT02129777|454994996|FG002|Double-Blind Period|Adverse Event|0|||
126462519|NCT02129777|454994997|FG003|Double-Blind Period|Adverse Event|0|||
126462520|NCT02129777|454994998|FG004|Double-Blind Period|Adverse Event|1|||
126462521|NCT02129777|454994999|FG005|Double-Blind Period|Adverse Event|0|||
126462522|NCT02129777|454995000|FG006|Double-Blind Period|Adverse Event|0|||
126462523|NCT02129777|454994994|FG000|Double-Blind Period|Lost to Follow-up|1|||
126462524|NCT02129777|454994995|FG001|Double-Blind Period|Lost to Follow-up|1|||
126462525|NCT02129777|454994996|FG002|Double-Blind Period|Lost to Follow-up|1|||
126462526|NCT02129777|454994997|FG003|Double-Blind Period|Lost to Follow-up|2|||
126462527|NCT02129777|454994998|FG004|Double-Blind Period|Lost to Follow-up|0|||
126462528|NCT02129777|454994999|FG005|Double-Blind Period|Lost to Follow-up|0|||
126462529|NCT02129777|454995000|FG006|Double-Blind Period|Lost to Follow-up|0|||
126462530|NCT02129777|454994994|FG000|Double-Blind Period|Withdrawal by Subject|2|||
126462531|NCT02129777|454994995|FG001|Double-Blind Period|Withdrawal by Subject|4|||
126462532|NCT02129777|454994996|FG002|Double-Blind Period|Withdrawal by Subject|3|||
126462533|NCT02129777|454994997|FG003|Double-Blind Period|Withdrawal by Subject|2|||
126462534|NCT02129777|454994998|FG004|Double-Blind Period|Withdrawal by Subject|3|||
126462535|NCT02129777|454994999|FG005|Double-Blind Period|Withdrawal by Subject|0|||
126462536|NCT02129777|454995000|FG006|Double-Blind Period|Withdrawal by Subject|0|||
126462537|NCT02129777|454994994|FG000|Double-Blind Period|Pregnancy|0|||
126462538|NCT02129777|454994995|FG001|Double-Blind Period|Pregnancy|0|||
126462539|NCT02129777|454994996|FG002|Double-Blind Period|Pregnancy|0|||
126462540|NCT02129777|454994997|FG003|Double-Blind Period|Pregnancy|0|||
126462541|NCT02129777|454994998|FG004|Double-Blind Period|Pregnancy|1|||
126462542|NCT02129777|454994999|FG005|Double-Blind Period|Pregnancy|0|||
126462543|NCT02129777|454995000|FG006|Double-Blind Period|Pregnancy|0|||
126462544|NCT02129777|454994994|FG000|Double-Blind Period|Lack of Efficacy|3|||
126462545|NCT02129777|454994995|FG001|Double-Blind Period|Lack of Efficacy|1|||
126462546|NCT02129777|454994996|FG002|Double-Blind Period|Lack of Efficacy|0|||
126462547|NCT02129777|454994997|FG003|Double-Blind Period|Lack of Efficacy|3|||
126462548|NCT02129777|454994998|FG004|Double-Blind Period|Lack of Efficacy|2|||
126462549|NCT02129777|454994999|FG005|Double-Blind Period|Lack of Efficacy|0|||
126462550|NCT02129777|454995000|FG006|Double-Blind Period|Lack of Efficacy|0|||
126462551|NCT02129777|454994994|FG000|Double-Blind Period|Other|1|||
126462552|NCT02129777|454994995|FG001|Double-Blind Period|Other|2|||
126462553|NCT02129777|454994996|FG002|Double-Blind Period|Other|0|||
126462554|NCT02129777|454994997|FG003|Double-Blind Period|Other|0|||
126462555|NCT02129777|454994998|FG004|Double-Blind Period|Other|0|||
126462556|NCT02129777|454994999|FG005|Double-Blind Period|Other|0|||
126462557|NCT02129777|454995000|FG006|Double-Blind Period|Other|0|||
126303766|NCT03483961|454402449|FG004|Overall Study|Withdrawal by Subject|4|||
126303767|NCT03483961|454402450|FG005|Overall Study|Withdrawal by Subject|2|||
126303768|NCT03483961|454402451|FG006|Overall Study|Withdrawal by Subject|1|||
126303769|NCT03483961|454402452|FG007|Overall Study|Withdrawal by Subject|2|||
126303770|NCT03483961|454402453|FG008|Overall Study|Withdrawal by Subject|1|||
126462558|NCT02129777|454994994|FG000|Open-Label Period|Lack of Efficacy|0|||
126462559|NCT02129777|454994995|FG001|Open-Label Period|Lack of Efficacy|0|||
126462560|NCT02129777|454994996|FG002|Open-Label Period|Lack of Efficacy|0|||
126462561|NCT02129777|454994997|FG003|Open-Label Period|Lack of Efficacy|0|||
126462562|NCT02129777|454994998|FG004|Open-Label Period|Lack of Efficacy|0|||
126462563|NCT02129777|454994999|FG005|Open-Label Period|Lack of Efficacy|0|||
126462564|NCT02129777|454995000|FG006|Open-Label Period|Lack of Efficacy|5|||
126462565|NCT02129777|454994994|FG000|Open-Label Period|Lost to Follow-up|0|||
126462566|NCT02129777|454994995|FG001|Open-Label Period|Lost to Follow-up|0|||
126462567|NCT02129777|454994996|FG002|Open-Label Period|Lost to Follow-up|0|||
126462568|NCT02129777|454994997|FG003|Open-Label Period|Lost to Follow-up|0|||
126462569|NCT02129777|454994998|FG004|Open-Label Period|Lost to Follow-up|0|||
126462570|NCT02129777|454994999|FG005|Open-Label Period|Lost to Follow-up|1|||
126462571|NCT02129777|454995000|FG006|Open-Label Period|Lost to Follow-up|1|||
126462572|NCT02129777|454994994|FG000|Open-Label Period|Withdrawal by Subject|0|||
126462573|NCT02129777|454994995|FG001|Open-Label Period|Withdrawal by Subject|0|||
126462574|NCT02129777|454994996|FG002|Open-Label Period|Withdrawal by Subject|0|||
126462575|NCT02129777|454994997|FG003|Open-Label Period|Withdrawal by Subject|0|||
126462576|NCT02129777|454994998|FG004|Open-Label Period|Withdrawal by Subject|0|||
126462577|NCT02129777|454994999|FG005|Open-Label Period|Withdrawal by Subject|1|||
126462578|NCT02129777|454995000|FG006|Open-Label Period|Withdrawal by Subject|3|||
126462579|NCT02129777|454994994|FG000|Open-Label Period|Study Termination|0|||
126462580|NCT02129777|454994995|FG001|Open-Label Period|Study Termination|0|||
126462581|NCT02129777|454994996|FG002|Open-Label Period|Study Termination|0|||
126462582|NCT02129777|454994997|FG003|Open-Label Period|Study Termination|0|||
126462583|NCT02129777|454994998|FG004|Open-Label Period|Study Termination|0|||
126462584|NCT02129777|454994999|FG005|Open-Label Period|Study Termination|10|||
126462585|NCT02129777|454995000|FG006|Open-Label Period|Study Termination|39|||
126462586|NCT01001299|454995001|FG000|Overall Study|Insufficient Therapeutic Response|20|||
126462587|NCT01001299|454995001|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
126462588|NCT01001299|454995001|FG000|Overall Study|Death|1|||
126462589|NCT01001299|454995001|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
126462590|NCT01001299|454995001|FG000|Overall Study|Withdrew Consent|1|||
126462591|NCT01565499|454995006|FG000|Overall Study|Physician Decision|1|||
126462592|NCT01565499|454995006|FG000|Overall Study|Adverse Event|5|||
126713302|NCT01416610|455902078|FG000|Overall Study|No reason given|5|||
126713303|NCT01416610|455902078|FG000|Overall Study|Withdrawal by Subject|13|||
126713304|NCT01416610|455902078|FG000|Overall Study|Lost to Follow-up|7|||
126713305|NCT01416610|455902078|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
126713306|NCT01927562|455902080|FG000|Overall Study|Lost to Follow-up|30|||
126713307|NCT01927562|455902080|FG000|Overall Study|Withdrawal by Subject|3|||
126713308|NCT01927562|455902080|FG000|Overall Study|Physician Decision|5|||
126713309|NCT00642616|455902081|FG000|Overall Study|Adverse Event|2|||
126713310|NCT00642616|455902082|FG001|Overall Study|Adverse Event|0|||
126713311|NCT00642616|455902083|FG002|Overall Study|Adverse Event|1|||
126713312|NCT00642616|455902084|FG003|Overall Study|Adverse Event|0|||
126713313|NCT00642616|455902081|FG000|Overall Study|Study Terminated by Sponsor|7|||
126713314|NCT00642616|455902082|FG001|Overall Study|Study Terminated by Sponsor|6|||
126713315|NCT00642616|455902083|FG002|Overall Study|Study Terminated by Sponsor|4|||
126713316|NCT00642616|455902084|FG003|Overall Study|Study Terminated by Sponsor|5|||
126713317|NCT00642616|455902081|FG000|Overall Study|Withdrawal by Subject|0|||
126713318|NCT00642616|455902082|FG001|Overall Study|Withdrawal by Subject|1|||
126713319|NCT00642616|455902083|FG002|Overall Study|Withdrawal by Subject|1|||
126713320|NCT00642616|455902084|FG003|Overall Study|Withdrawal by Subject|1|||
126713321|NCT00642616|455902081|FG000|Overall Study|Protocol Violation|0|||
126713322|NCT00642616|455902082|FG001|Overall Study|Protocol Violation|0|||
126713323|NCT00642616|455902083|FG002|Overall Study|Protocol Violation|2|||
126713324|NCT00642616|455902084|FG003|Overall Study|Protocol Violation|0|||
126713325|NCT00642616|455902081|FG000|Overall Study|Physician Decision|0|||
126303771|NCT03483961|454402454|FG009|Overall Study|Withdrawal by Subject|0|||
126462593|NCT01565499|454995006|FG000|Overall Study|Withdrawal by Subject|2|||
126462594|NCT03101267|454995010|FG000|Primary Study Period|Withdrawal by Subject|1|||
126462595|NCT03101267|454995011|FG001|Primary Study Period|Withdrawal by Subject|2|||
126462596|NCT03101267|454995012|FG002|Primary Study Period|Withdrawal by Subject|3|||
126462597|NCT03101267|454995010|FG000|Primary Study Period|Miscellaneous|2|||
126713326|NCT00642616|455902082|FG001|Overall Study|Physician Decision|0|||
126713327|NCT00642616|455902083|FG002|Overall Study|Physician Decision|1|||
126713328|NCT00642616|455902084|FG003|Overall Study|Physician Decision|1|||
126713329|NCT00652093|455902085|FG000|Overall Study|Withdrawal by Subject|0|||
126713330|NCT00652093|455902086|FG001|Overall Study|Withdrawal by Subject|0|||
126713331|NCT00652093|455902087|FG002|Overall Study|Withdrawal by Subject|1|||
126462598|NCT03101267|454995011|FG001|Primary Study Period|Miscellaneous|0|||
126462599|NCT03101267|454995012|FG002|Primary Study Period|Miscellaneous|0|||
126462600|NCT01222403|454995013|FG000|Overall Study|Inappropriate enrollment|0|||
126462601|NCT01222403|454995014|FG001|Overall Study|Inappropriate enrollment|2|||
126462602|NCT01028378|454995016|FG000|Overall Study|Lost to Follow-up|12|||
126462603|NCT01028378|454995016|FG000|Overall Study|Withdrawal by Subject|1|||
126462604|NCT01028378|454995016|FG000|Overall Study|Adminstrative Reasons|4|||
126462605|NCT01262352|454995017|FG000|Period 1|Illness after randomization|1|||
126462606|NCT01262352|454995018|FG001|Period 1|Illness after randomization|0|||
126462607|NCT01262352|454995017|FG000|Washout|Adverse Event|1|||
126462608|NCT01262352|454995018|FG001|Washout|Adverse Event|1|||
126462609|NCT01262352|454995017|FG000|Washout|Extended Washout|0|||
126462610|NCT01262352|454995018|FG001|Washout|Extended Washout|1|||
126462611|NCT00107952|454995022|FG000|Overall Study|Death|75|||
126462612|NCT00107952|454995023|FG001|Overall Study|Death|61|||
126462613|NCT00107952|454995022|FG000|Overall Study|Lost to Follow-up|0|||
126462614|NCT00107952|454995023|FG001|Overall Study|Lost to Follow-up|3|||
126462615|NCT00107952|454995022|FG000|Overall Study|Withdrawal by Subject|9|||
126462616|NCT00107952|454995023|FG001|Overall Study|Withdrawal by Subject|6|||
126462617|NCT00107952|454995022|FG000|Overall Study|Other|2|||
126462618|NCT00107952|454995023|FG001|Overall Study|Other|5|||
126462619|NCT00107952|454995022|FG000|Overall Study|Never received study treatment|9|||
126462620|NCT00107952|454995023|FG001|Overall Study|Never received study treatment|6|||
126462621|NCT01401959|454995024|FG000|Enrolled|Withdrawal by Subject|1|||
126462622|NCT01401959|454995025|FG001|Enrolled|Withdrawal by Subject|0|||
126462623|NCT01401959|454995026|FG002|Enrolled|Withdrawal by Subject|0|||
126462624|NCT01401959|454995024|FG000|Treated|Disease Progression|2|||
126462625|NCT01401959|454995025|FG001|Treated|Disease Progression|2|||
126462626|NCT01401959|454995026|FG002|Treated|Disease Progression|1|||
126462627|NCT01401959|454995024|FG000|Treated|Adverse Event|4|||
126462628|NCT01401959|454995025|FG001|Treated|Adverse Event|3|||
126462629|NCT01401959|454995026|FG002|Treated|Adverse Event|2|||
126462630|NCT01401959|454995024|FG000|Treated|Withdrawal by Subject|1|||
126462631|NCT01401959|454995025|FG001|Treated|Withdrawal by Subject|2|||
126462632|NCT01401959|454995026|FG002|Treated|Withdrawal by Subject|2|||
126462633|NCT01401959|454995024|FG000|Treated|Protocol Violation|0|||
126462634|NCT01401959|454995025|FG001|Treated|Protocol Violation|1|||
126462635|NCT01401959|454995026|FG002|Treated|Protocol Violation|0|||
126462636|NCT00064298|454995033|FG000|Overall Study|Withdrawal by Subject|2|||
126462637|NCT00064298|454995034|FG001|Overall Study|Withdrawal by Subject|1|||
126462638|NCT00064298|454995033|FG000|Overall Study|Lost to Follow-up|2|||
126462639|NCT00064298|454995034|FG001|Overall Study|Lost to Follow-up|2|||
126462640|NCT00064298|454995033|FG000|Overall Study|Death|0|||
126462641|NCT00064298|454995034|FG001|Overall Study|Death|1|||
126462642|NCT00064298|454995033|FG000|Overall Study|Disease Progression|2|||
126462643|NCT00064298|454995034|FG001|Overall Study|Disease Progression|1|||
126462644|NCT03614975|454995035|FG000|Overall Study|Physician Decision|7|||
126462645|NCT03614975|454995036|FG001|Overall Study|Physician Decision|5|||
126462646|NCT03614975|454995035|FG000|Overall Study|Withdrawal by Subject|2|||
126462647|NCT03614975|454995036|FG001|Overall Study|Withdrawal by Subject|2|||
126462648|NCT03614975|454995035|FG000|Overall Study|Specimens not in lab batch shipment|1|||
126462649|NCT03614975|454995036|FG001|Overall Study|Specimens not in lab batch shipment|1|||
126462650|NCT00450385|454995037|FG000|Overall Study|Death|3|||
126462651|NCT00450385|454995037|FG000|Overall Study|Protocol Violation|1|||
126462652|NCT00450385|454995037|FG000|Overall Study|Withdrawal by Subject|2|||
126462653|NCT00450385|454995037|FG000|Overall Study|Lack of Efficacy|2|||
126462654|NCT00450385|454995037|FG000|Overall Study|Adverse Event|1|||
126462655|NCT00450385|454995037|FG000|Overall Study|Physician Decision|1|||
126462656|NCT00450385|454995037|FG000|Overall Study|Other|3|||
126303772|NCT03483961|454402445|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
126303773|NCT03483961|454402446|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303774|NCT03483961|454402447|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126462657|NCT01569464|454995038|FG000|Overall Study|Adverse Event|4|||
126462658|NCT01569464|454995039|FG001|Overall Study|Adverse Event|0|||
126462659|NCT01569464|454995038|FG000|Overall Study|Lack of Efficacy|1|||
126462660|NCT01569464|454995039|FG001|Overall Study|Lack of Efficacy|0|||
126462661|NCT01569464|454995038|FG000|Overall Study|Protocol Violation|1|||
126462662|NCT01569464|454995039|FG001|Overall Study|Protocol Violation|0|||
126462663|NCT01569464|454995038|FG000|Overall Study|Lost to Follow-up|2|||
126462664|NCT01569464|454995039|FG001|Overall Study|Lost to Follow-up|3|||
126462665|NCT01569464|454995038|FG000|Overall Study|Withdrawal by Subject|1|||
126462666|NCT01569464|454995039|FG001|Overall Study|Withdrawal by Subject|1|||
126462667|NCT01569464|454995038|FG000|Overall Study|Other|1|||
126462668|NCT01569464|454995039|FG001|Overall Study|Other|1|||
126462669|NCT01390220|454995045|FG000|Test Dose Phase|Adverse Event|17|||
126462670|NCT01390220|454995046|FG001|Test Dose Phase|Adverse Event|0|||
126462671|NCT01390220|454995047|FG002|Test Dose Phase|Adverse Event|0|||
126462672|NCT01390220|454995045|FG000|Test Dose Phase|Withdrawal by Subject|8|||
126462673|NCT01390220|454995046|FG001|Test Dose Phase|Withdrawal by Subject|0|||
126462674|NCT01390220|454995047|FG002|Test Dose Phase|Withdrawal by Subject|0|||
126462675|NCT01390220|454995045|FG000|Test Dose Phase|Lost to Follow-up|2|||
126462676|NCT01390220|454995046|FG001|Test Dose Phase|Lost to Follow-up|0|||
126462677|NCT01390220|454995047|FG002|Test Dose Phase|Lost to Follow-up|0|||
126462678|NCT01390220|454995045|FG000|Test Dose Phase|Protocol Violation|8|||
126462679|NCT01390220|454995046|FG001|Test Dose Phase|Protocol Violation|0|||
126462680|NCT01390220|454995047|FG002|Test Dose Phase|Protocol Violation|0|||
126462681|NCT01390220|454995045|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
126462682|NCT01390220|454995046|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
126462683|NCT01390220|454995047|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
126462684|NCT01390220|454995045|FG000|Test Dose Phase|Study/Site closure|6|||
126462685|NCT01390220|454995046|FG001|Test Dose Phase|Study/Site closure|0|||
126462686|NCT01390220|454995047|FG002|Test Dose Phase|Study/Site closure|0|||
126462687|NCT01390220|454995045|FG000|Test Dose Phase|Caregiver no longer available|5|||
126462688|NCT01390220|454995046|FG001|Test Dose Phase|Caregiver no longer available|0|||
126462689|NCT01390220|454995047|FG002|Test Dose Phase|Caregiver no longer available|0|||
126462690|NCT01390220|454995045|FG000|Test Dose Phase|Noncompliance|2|||
126462691|NCT01390220|454995046|FG001|Test Dose Phase|Noncompliance|0|||
126462692|NCT01390220|454995047|FG002|Test Dose Phase|Noncompliance|0|||
126462693|NCT01390220|454995045|FG000|Test Dose Phase|Logistical|6|||
126462694|NCT01390220|454995046|FG001|Test Dose Phase|Logistical|0|||
126462695|NCT01390220|454995047|FG002|Test Dose Phase|Logistical|0|||
126462696|NCT01390220|454995045|FG000|Comparative Phase|Withdrawal by Subject|0|||
126462697|NCT01390220|454995046|FG001|Comparative Phase|Withdrawal by Subject|1|||
126462698|NCT01390220|454995047|FG002|Comparative Phase|Withdrawal by Subject|0|||
126462699|NCT03063203|454995048|FG000|Overall Study|Chose alternative therapy|3|||
126462700|NCT03063203|454995048|FG000|Overall Study|Death|2|||
126462701|NCT03063203|454995048|FG000|Overall Study|Disease progression|4|||
126462702|NCT03063203|454995048|FG000|Overall Study|Physician Decision|5|||
126462703|NCT02045303|454995049|FG000|Overall Study|Protocol Violation|2|||
126462704|NCT02045303|454995050|FG001|Overall Study|Protocol Violation|1|||
126462705|NCT02045303|454995051|FG002|Overall Study|Protocol Violation|0|||
126462706|NCT02045303|454995049|FG000|Overall Study|Withdrawal by Subject|0|||
126462707|NCT02045303|454995050|FG001|Overall Study|Withdrawal by Subject|2|||
126462708|NCT02045303|454995051|FG002|Overall Study|Withdrawal by Subject|0|||
126462709|NCT01642407|454995052|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
126462710|NCT01642407|454995052|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
126462711|NCT01642407|454995052|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
126462712|NCT03533686|454995055|FG000|Overall Study|Withdrawal by Subject|1|||
126462713|NCT03533686|454995056|FG001|Overall Study|Withdrawal by Subject|0|||
126462714|NCT03533686|454995057|FG002|Overall Study|Withdrawal by Subject|0|||
126462715|NCT03533686|454995058|FG003|Overall Study|Withdrawal by Subject|3|||
126462716|NCT03533686|454995059|FG004|Overall Study|Withdrawal by Subject|5|||
126462717|NCT03533686|454995060|FG005|Overall Study|Withdrawal by Subject|1|||
126462718|NCT03533686|454995055|FG000|Overall Study|Lost to Follow-up|0|||
126462719|NCT03533686|454995056|FG001|Overall Study|Lost to Follow-up|1|||
126462720|NCT03533686|454995057|FG002|Overall Study|Lost to Follow-up|0|||
126462721|NCT03533686|454995058|FG003|Overall Study|Lost to Follow-up|0|||
126462722|NCT03533686|454995059|FG004|Overall Study|Lost to Follow-up|2|||
126462723|NCT03533686|454995060|FG005|Overall Study|Lost to Follow-up|0|||
126462724|NCT03533686|454995055|FG000|Overall Study|Screen Failure|0|||
126462725|NCT03533686|454995056|FG001|Overall Study|Screen Failure|0|||
126462726|NCT03533686|454995057|FG002|Overall Study|Screen Failure|0|||
126462727|NCT03533686|454995058|FG003|Overall Study|Screen Failure|2|||
126462728|NCT03533686|454995059|FG004|Overall Study|Screen Failure|0|||
126462729|NCT03533686|454995060|FG005|Overall Study|Screen Failure|0|||
126462730|NCT01856023|454995061|FG000|Overall Study|Death|1|||
126462731|NCT01856023|454995062|FG001|Overall Study|Death|2|||
126462732|NCT01856023|454995061|FG000|Overall Study|Adverse Event|2|||
126462733|NCT01856023|454995062|FG001|Overall Study|Adverse Event|1|||
126462734|NCT01856023|454995061|FG000|Overall Study|Lack of Efficacy|5|||
126462735|NCT01856023|454995062|FG001|Overall Study|Lack of Efficacy|5|||
126462736|NCT01856023|454995061|FG000|Overall Study|non compliance, study closure|1|||
126462737|NCT01856023|454995062|FG001|Overall Study|non compliance, study closure|3|||
126462738|NCT01856023|454995061|FG000|Overall Study|Withdrawal by Subject|1|||
126462739|NCT01856023|454995062|FG001|Overall Study|Withdrawal by Subject|1|||
126462740|NCT00245583|454995063|FG000|Overall Study|Lost to Follow-up|1|||
126462741|NCT00245583|454995064|FG001|Overall Study|Lost to Follow-up|5|||
126462742|NCT00245583|454995063|FG000|Overall Study|Adverse Event|2|||
126462743|NCT00245583|454995064|FG001|Overall Study|Adverse Event|1|||
126462744|NCT00245583|454995063|FG000|Overall Study|Lack of Efficacy|1|||
126462745|NCT00245583|454995064|FG001|Overall Study|Lack of Efficacy|0|||
126462746|NCT00245583|454995063|FG000|Overall Study|Withdrawal by Subject|2|||
126462747|NCT00245583|454995064|FG001|Overall Study|Withdrawal by Subject|3|||
126462748|NCT00829283|454995065|FG000|Overall Study|Lost to Follow-up|7|||
126462749|NCT00829283|454995066|FG001|Overall Study|Lost to Follow-up|25|||
126462750|NCT04718103|454995067|FG000|Overall Study|Adverse Event|1|||
126462751|NCT04718103|454995068|FG001|Overall Study|Adverse Event|1|||
126462752|NCT04718103|454995067|FG000|Overall Study|Lack of Efficacy|4|||
126462753|NCT04718103|454995068|FG001|Overall Study|Lack of Efficacy|1|||
126462754|NCT04718103|454995067|FG000|Overall Study|Lost to Follow-up|2|||
126462755|NCT04718103|454995068|FG001|Overall Study|Lost to Follow-up|2|||
126462756|NCT04718103|454995067|FG000|Overall Study|Physician Decision|2|||
126462757|NCT04718103|454995068|FG001|Overall Study|Physician Decision|0|||
126462758|NCT04718103|454995067|FG000|Overall Study|Pregnancy|0|||
126462759|NCT04718103|454995068|FG001|Overall Study|Pregnancy|1|||
126462760|NCT04718103|454995067|FG000|Overall Study|Withdrawal by Subject|10|||
126462761|NCT04718103|454995068|FG001|Overall Study|Withdrawal by Subject|6|||
126462762|NCT04718103|454995067|FG000|Overall Study|Randomized, not treated|4|||
126462763|NCT04718103|454995068|FG001|Overall Study|Randomized, not treated|1|||
126462764|NCT04718103|454995067|FG000|Overall Study|GCP violations|7|||
126462765|NCT04718103|454995068|FG001|Overall Study|GCP violations|5|||
126462766|NCT00136604|454995071|FG000|Overall Study|Lost to Follow-up|1|||
126462767|NCT00136604|454995072|FG001|Overall Study|Lost to Follow-up|0|||
126462768|NCT00136604|454995073|FG002|Overall Study|Lost to Follow-up|0|||
126462769|NCT00136604|454995074|FG003|Overall Study|Lost to Follow-up|0|||
126462770|NCT00136604|454995075|FG004|Overall Study|Lost to Follow-up|1|||
126462771|NCT00136604|454995071|FG000|Overall Study|Migrated/moved from study area|0|||
126462772|NCT00136604|454995072|FG001|Overall Study|Migrated/moved from study area|1|||
126462773|NCT00136604|454995073|FG002|Overall Study|Migrated/moved from study area|0|||
126462774|NCT00136604|454995074|FG003|Overall Study|Migrated/moved from study area|0|||
126462775|NCT00136604|454995075|FG004|Overall Study|Migrated/moved from study area|0|||
126462776|NCT00591578|454995078|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
126462777|NCT00591578|454995079|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
126462778|NCT00591578|454995080|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
126462779|NCT00591578|454995078|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
126462780|NCT00591578|454995079|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
126462781|NCT00591578|454995080|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
126462782|NCT00591578|454995078|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
126462783|NCT00591578|454995079|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
126462784|NCT00591578|454995080|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
126462785|NCT00591578|454995078|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
126462786|NCT00591578|454995079|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
126462787|NCT00591578|454995080|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
126462788|NCT00591578|454995078|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
126462789|NCT00591578|454995079|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
126462790|NCT00591578|454995080|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
126462791|NCT00591578|454995078|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
126462792|NCT00591578|454995079|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
126462793|NCT00591578|454995080|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
126462794|NCT00591578|454995078|FG000|Double-Blind Treatment Phase|Other|4|||
126462795|NCT00591578|454995079|FG001|Double-Blind Treatment Phase|Other|9|||
126462796|NCT00591578|454995080|FG002|Double-Blind Treatment Phase|Other|4|||
126462797|NCT00591578|454995078|FG000|Open-Label Extension Phase|Adverse Event|3|||
126462798|NCT00591578|454995079|FG001|Open-Label Extension Phase|Adverse Event|5|||
126462799|NCT00591578|454995080|FG002|Open-Label Extension Phase|Adverse Event|0|||
126462800|NCT00591578|454995078|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
126462801|NCT00591578|454995079|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
126462802|NCT00591578|454995080|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
126462803|NCT00591578|454995078|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
126462804|NCT00591578|454995079|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
126462805|NCT00591578|454995080|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
126462806|NCT00591578|454995078|FG000|Open-Label Extension Phase|Other|1|||
126462807|NCT00591578|454995079|FG001|Open-Label Extension Phase|Other|0|||
126462808|NCT00591578|454995080|FG002|Open-Label Extension Phase|Other|0|||
126462809|NCT03945175|454995081|FG000|Overall Study|Did not meet inclusion criteria|31|||
126462810|NCT03945175|454995081|FG000|Overall Study|Withdrew consent|2|||
126462811|NCT03945175|454995081|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
126462812|NCT03945175|454995081|FG000|Overall Study|Early termination during Mydayis treatment|1|||
126462813|NCT00870233|454995082|FG000|Overall Study|Withdrawal by Subject|18|||
126462814|NCT00870233|454995082|FG000|Overall Study|Did not undergo laparotomy|3|||
126462815|NCT00870233|454995082|FG000|Overall Study|Incompatible internet browser|2|||
126462816|NCT00870233|454995082|FG000|Overall Study|Death|1|||
126462817|NCT00378079|454995083|FG000|Overall Study|Lost to Follow-up|6|||
126551011|NCT02001974|455311779|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
126462818|NCT00378079|454995084|FG001|Overall Study|Lost to Follow-up|1|||
126462819|NCT00378079|454995085|FG002|Overall Study|Lost to Follow-up|0|||
126462820|NCT00006389|454995086|FG000|Overall Study|Adverse Event|1|||
126462821|NCT01445886|454995095|FG000|Overall Study|Lost to Follow-up|2|||
126462822|NCT01445886|454995095|FG000|Overall Study|Protocol Violation|3|||
126462823|NCT03500679|454995096|FG000|Overall Study|Lost to Follow-up|6|||
126462824|NCT03500679|454995097|FG001|Overall Study|Lost to Follow-up|3|||
126462825|NCT03500679|454995096|FG000|Overall Study|Withdrawal by Subject|3|||
126462826|NCT03500679|454995097|FG001|Overall Study|Withdrawal by Subject|0|||
126462827|NCT01962922|454995098|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
126462828|NCT01962922|454995099|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
126462829|NCT01962922|454995098|FG000|PK Portion Day 7|non-compliance|1|||
126462830|NCT01962922|454995099|FG001|PK Portion Day 7|non-compliance|0|||
126462831|NCT01962922|454995098|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
126462832|NCT01962922|454995099|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
126462833|NCT01962922|454995098|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
126462834|NCT01962922|454995099|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
126462835|NCT03224546|454995100|FG000|Overall Study|Lost to Follow-up|9|||
126462836|NCT03224546|454995101|FG001|Overall Study|Lost to Follow-up|8|||
126462837|NCT03224546|454995102|FG002|Overall Study|Lost to Follow-up|3|||
126462838|NCT03224546|454995100|FG000|Overall Study|Withdrawal by Subject|7|||
126462839|NCT03224546|454995101|FG001|Overall Study|Withdrawal by Subject|14|||
126462840|NCT03224546|454995102|FG002|Overall Study|Withdrawal by Subject|12|||
126462841|NCT02730208|454995103|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
126462842|NCT02730208|454995104|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
126462843|NCT00510952|454995110|FG000|Overall Study|Adverse Event|1|||
126462844|NCT00510952|454995111|FG001|Overall Study|Adverse Event|0|||
126462845|NCT00510952|454995110|FG000|Overall Study|Entry Criteria Not Met|3|||
126462846|NCT00510952|454995111|FG001|Overall Study|Entry Criteria Not Met|1|||
126462847|NCT00510952|454995110|FG000|Overall Study|Lost to Follow-up|5|||
126462848|NCT00510952|454995111|FG001|Overall Study|Lost to Follow-up|3|||
126462849|NCT00510952|454995110|FG000|Overall Study|Physician Decision|1|||
126462850|NCT00510952|454995111|FG001|Overall Study|Physician Decision|1|||
126462851|NCT00510952|454995110|FG000|Overall Study|Protocol Violation|7|||
126462852|NCT00510952|454995111|FG001|Overall Study|Protocol Violation|4|||
126462853|NCT00510952|454995110|FG000|Overall Study|Sponsor Decision|1|||
126462854|NCT00510952|454995111|FG001|Overall Study|Sponsor Decision|0|||
126462855|NCT00510952|454995110|FG000|Overall Study|Withdrawal by Subject|6|||
126462856|NCT00510952|454995111|FG001|Overall Study|Withdrawal by Subject|7|||
126462857|NCT00510952|454995110|FG000|Overall Study|Did Not Receive Study Drug|2|||
126462858|NCT00510952|454995111|FG001|Overall Study|Did Not Receive Study Drug|0|||
126462859|NCT02793128|454995115|FG000|Overall Study|Death|4|||
126462860|NCT02793128|454995115|FG000|Overall Study|Withdrawal by Subject|2|||
126462861|NCT02793128|454995115|FG000|Overall Study|Physician Decision|1|||
126462862|NCT02793128|454995115|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
126462863|NCT02793128|454995115|FG000|Overall Study|Patient elected nephroureterectomy|1|||
126462864|NCT03670836|454995119|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
126462865|NCT03670836|454995120|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
126462866|NCT03670836|454995119|FG000|Per Protocol Population (PP)|Physician Decision|9|||
126462867|NCT03670836|454995120|FG001|Per Protocol Population (PP)|Physician Decision|10|||
126462868|NCT03670836|454995119|FG000|Per Protocol Population (PP)|Physician Decision|4|||
126713332|NCT00652093|455902088|FG003|Overall Study|Withdrawal by Subject|0|||
126713333|NCT00652093|455902089|FG004|Overall Study|Withdrawal by Subject|1|||
126713334|NCT00652093|455902090|FG005|Overall Study|Withdrawal by Subject|0|||
126713335|NCT00652093|455902085|FG000|Overall Study|Physician Decision|0|||
126713336|NCT00652093|455902086|FG001|Overall Study|Physician Decision|0|||
126713337|NCT00652093|455902087|FG002|Overall Study|Physician Decision|0|||
126303775|NCT03483961|454402448|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303776|NCT03483961|454402449|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303777|NCT03483961|454402450|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303778|NCT03483961|454402451|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303779|NCT03483961|454402452|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303780|NCT03483961|454402453|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303781|NCT03483961|454402454|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
126303782|NCT03483961|454402445|FG000|Overall Study|Adverse Event|0|||
126303783|NCT03483961|454402446|FG001|Overall Study|Adverse Event|0|||
126303784|NCT03483961|454402447|FG002|Overall Study|Adverse Event|1|||
126303785|NCT03483961|454402448|FG003|Overall Study|Adverse Event|0|||
126303786|NCT03483961|454402449|FG004|Overall Study|Adverse Event|0|||
126303787|NCT03483961|454402450|FG005|Overall Study|Adverse Event|0|||
126303788|NCT03483961|454402451|FG006|Overall Study|Adverse Event|0|||
126303789|NCT03483961|454402452|FG007|Overall Study|Adverse Event|0|||
126303790|NCT03483961|454402453|FG008|Overall Study|Adverse Event|0|||
126303791|NCT03483961|454402454|FG009|Overall Study|Adverse Event|0|||
126303792|NCT00443079|454402455|FG000|Overall Study|Lost to Follow-up|0|||
126303793|NCT00443079|454402456|FG001|Overall Study|Lost to Follow-up|1|||
126462869|NCT03670836|454995120|FG001|Per Protocol Population (PP)|Physician Decision|6|||
126462870|NCT03670836|454995119|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
126462871|NCT03670836|454995120|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
126462872|NCT03287635|454995121|FG000|Overall Study|Lost to Follow-up|5|||
126462873|NCT03287635|454995121|FG000|Overall Study|Withdrawal by Subject|1|||
126462874|NCT03287635|454995121|FG000|Overall Study|Physician Decision|1|||
126462875|NCT02582255|454996913|FG000|Overall Study|Protocol Violation|0|||
126462876|NCT02582255|454996914|FG001|Overall Study|Protocol Violation|3|||
126462877|NCT01155219|454996918|FG000|Overall Study|Adverse Event|3|||
126462878|NCT01155219|454996919|FG001|Overall Study|Adverse Event|1|||
126462879|NCT01155219|454996918|FG000|Overall Study|non-medical reason|1|||
126462880|NCT01155219|454996919|FG001|Overall Study|non-medical reason|2|||
126462881|NCT00719264|454996921|FG000|Overall Study|Adverse Event|41|||
126462882|NCT00719264|454996922|FG001|Overall Study|Adverse Event|49|||
126462883|NCT00719264|454996921|FG000|Overall Study|Death|13|||
126462884|NCT00719264|454996922|FG001|Overall Study|Death|10|||
126462885|NCT00719264|454996921|FG000|Overall Study|Administrative Problems|6|||
126462886|NCT00719264|454996922|FG001|Overall Study|Administrative Problems|4|||
126462887|NCT00719264|454996921|FG000|Overall Study|Lost to Follow-up|1|||
126462888|NCT00719264|454996922|FG001|Overall Study|Lost to Follow-up|1|||
126713338|NCT00652093|455902088|FG003|Overall Study|Physician Decision|0|||
126713339|NCT00652093|455902089|FG004|Overall Study|Physician Decision|1|||
126713340|NCT00652093|455902090|FG005|Overall Study|Physician Decision|0|||
126713341|NCT00542815|455902091|FG000|Overall Study|Adverse Event|19|||
126713342|NCT00542815|455902092|FG001|Overall Study|Adverse Event|6|||
126713343|NCT00542815|455902093|FG002|Overall Study|Adverse Event|9|||
126713344|NCT00542815|455902091|FG000|Overall Study|Death|10|||
126713345|NCT00542815|455902092|FG001|Overall Study|Death|7|||
126713346|NCT00542815|455902093|FG002|Overall Study|Death|3|||
126713347|NCT00542815|455902091|FG000|Overall Study|Lack of Efficacy|9|||
126713348|NCT00542815|455902092|FG001|Overall Study|Lack of Efficacy|2|||
126713349|NCT00542815|455902093|FG002|Overall Study|Lack of Efficacy|0|||
126713350|NCT00542815|455902091|FG000|Overall Study|Physician Decision|2|||
126713351|NCT00542815|455902092|FG001|Overall Study|Physician Decision|1|||
126713352|NCT00542815|455902093|FG002|Overall Study|Physician Decision|0|||
126713353|NCT00542815|455902091|FG000|Overall Study|Protocol Violation|1|||
126713354|NCT00542815|455902092|FG001|Overall Study|Protocol Violation|1|||
126713355|NCT00542815|455902093|FG002|Overall Study|Protocol Violation|2|||
126713356|NCT00542815|455902091|FG000|Overall Study|Withdrawal by Subject|41|||
126713357|NCT00542815|455902092|FG001|Overall Study|Withdrawal by Subject|5|||
126713358|NCT00542815|455902093|FG002|Overall Study|Withdrawal by Subject|8|||
126713359|NCT00542815|455902091|FG000|Overall Study|Other reasons|24|||
126713360|NCT00542815|455902092|FG001|Overall Study|Other reasons|10|||
126713361|NCT00542815|455902093|FG002|Overall Study|Other reasons|10|||
126713362|NCT03176966|455902094|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
126713363|NCT03176966|455902095|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
126713364|NCT03176966|455902094|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
126713365|NCT03176966|455902095|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
126713366|NCT03176966|455902094|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
126713367|NCT03176966|455902095|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
126713368|NCT03176966|455902094|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
126713369|NCT03176966|455902095|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
126713370|NCT03176966|455902094|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
126713371|NCT03176966|455902095|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
126713372|NCT03176966|455902094|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
126713373|NCT03176966|455902095|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
126713374|NCT03176966|455902094|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
126713375|NCT03176966|455902095|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
126713376|NCT01696877|455902101|FG000|Overall Study|Adverse Event|0|||
126713377|NCT01696877|455902102|FG001|Overall Study|Adverse Event|1|||
126713378|NCT02961764|455902103|FG000|Overall Study|Protocol Violation|0|||
126713379|NCT02961764|455902104|FG001|Overall Study|Protocol Violation|1|||
126713380|NCT02961764|455902103|FG000|Overall Study|Death|2|||
126713381|NCT02961764|455902104|FG001|Overall Study|Death|0|||
126713382|NCT02961764|455902103|FG000|Overall Study|Lost to Follow-up|35|||
126713383|NCT02961764|455902104|FG001|Overall Study|Lost to Follow-up|24|||
126713384|NCT02961764|455902103|FG000|Overall Study|Withdrawal by Subject|2|||
126713385|NCT02961764|455902104|FG001|Overall Study|Withdrawal by Subject|0|||
126713386|NCT00469014|455902105|FG000|Initial Phase Randomization|Disease Progression|0|||
126713387|NCT00469014|455902106|FG001|Initial Phase Randomization|Disease Progression|1|||
126713388|NCT00469014|455902107|FG002|Initial Phase Randomization|Disease Progression|1|||
126462889|NCT00719264|454996921|FG000|Overall Study|Withdrawal by Subject|12|||
126462890|NCT00719264|454996922|FG001|Overall Study|Withdrawal by Subject|7|||
126462891|NCT00719264|454996921|FG000|Overall Study|Protocol Deviation|1|||
126462892|NCT00719264|454996922|FG001|Overall Study|Protocol Deviation|3|||
126713389|NCT00469014|455902108|FG003|Initial Phase Randomization|Disease Progression|0|||
126462893|NCT00719264|454996921|FG000|Overall Study|New Cancer Therapy|4|||
126462894|NCT00719264|454996922|FG001|Overall Study|New Cancer Therapy|2|||
126462895|NCT00719264|454996921|FG000|Overall Study|Disease Progression|104|||
126462896|NCT00719264|454996922|FG001|Overall Study|Disease Progression|107|||
126462897|NCT03034200|454996923|FG000|Overall Study|Disease progression|8|||
126462898|NCT03034200|454996924|FG001|Overall Study|Disease progression|10|||
126303794|NCT02649439|454402457|FG000|Overall Study|Switched to alternative treatment|6|||
126303795|NCT02649439|454402458|FG001|Overall Study|Switched to alternative treatment|4|||
126303796|NCT02649439|454402457|FG000|Overall Study|Patient decision|1|||
126303797|NCT02649439|454402458|FG001|Overall Study|Patient decision|0|||
126303798|NCT02649439|454402457|FG000|Overall Study|Patient going out of country|1|||
126303799|NCT02649439|454402458|FG001|Overall Study|Patient going out of country|0|||
126303800|NCT02649439|454402457|FG000|Overall Study|To start finasteride|1|||
126303801|NCT02649439|454402458|FG001|Overall Study|To start finasteride|0|||
126303802|NCT02649439|454402457|FG000|Overall Study|Physician Decision|1|||
126303803|NCT02649439|454402458|FG001|Overall Study|Physician Decision|0|||
126303804|NCT02649439|454402457|FG000|Overall Study|Disease progression on study|12|||
126303805|NCT02649439|454402458|FG001|Overall Study|Disease progression on study|13|||
126303806|NCT02649439|454402457|FG000|Overall Study|Refused further treatment|1|||
126303807|NCT02649439|454402458|FG001|Overall Study|Refused further treatment|0|||
126303808|NCT02649439|454402457|FG000|Overall Study|Refused further follow up|2|||
126303809|NCT02649439|454402458|FG001|Overall Study|Refused further follow up|7|||
126303810|NCT02649439|454402457|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
126462899|NCT03034200|454996925|FG002|Overall Study|Disease progression|4|||
126462900|NCT03034200|454996923|FG000|Overall Study|Physician Decision|2|||
126462901|NCT03034200|454996924|FG001|Overall Study|Physician Decision|0|||
126462902|NCT03034200|454996925|FG002|Overall Study|Physician Decision|3|||
126462903|NCT03034200|454996923|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
126462904|NCT03034200|454996924|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
126462905|NCT03034200|454996925|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
126462906|NCT03034200|454996923|FG000|Overall Study|Adjuvant Therapy|0|||
126462907|NCT03034200|454996924|FG001|Overall Study|Adjuvant Therapy|0|||
126462908|NCT03034200|454996925|FG002|Overall Study|Adjuvant Therapy|1|||
126462909|NCT05523323|454996926|FG000|Overall Study|Death|26|||
126462910|NCT05523323|454996927|FG001|Overall Study|Death|21|||
126462911|NCT05523323|454996926|FG000|Overall Study|Ongoing participants|35|||
126462912|NCT05523323|454996927|FG001|Overall Study|Ongoing participants|30|||
126462913|NCT03435640|454996928|FG000|Overall Study|Withdrawal by Subject|0|||
126462914|NCT03435640|454996929|FG001|Overall Study|Withdrawal by Subject|1|||
126462915|NCT03435640|454996930|FG002|Overall Study|Withdrawal by Subject|0|||
126462916|NCT03435640|454996931|FG003|Overall Study|Withdrawal by Subject|2|||
126462917|NCT03435640|454996932|FG004|Overall Study|Withdrawal by Subject|0|||
126462918|NCT03435640|454996933|FG005|Overall Study|Withdrawal by Subject|0|||
126462919|NCT03435640|454996934|FG006|Overall Study|Withdrawal by Subject|3|||
126462920|NCT03435640|454996935|FG007|Overall Study|Withdrawal by Subject|0|||
126462921|NCT03435640|454996936|FG008|Overall Study|Withdrawal by Subject|0|||
126462922|NCT03435640|454996937|FG009|Overall Study|Withdrawal by Subject|2|||
126462923|NCT03435640|454996938|FG010|Overall Study|Withdrawal by Subject|3|||
126462924|NCT03435640|454996928|FG000|Overall Study|Lost to Follow-up|0|||
126462925|NCT03435640|454996929|FG001|Overall Study|Lost to Follow-up|0|||
126462926|NCT03435640|454996930|FG002|Overall Study|Lost to Follow-up|1|||
126462927|NCT03435640|454996931|FG003|Overall Study|Lost to Follow-up|0|||
126551012|NCT02001974|455311780|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
126551013|NCT02001974|455311778|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
126551014|NCT02001974|455311779|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
126551015|NCT02001974|455311780|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
126551016|NCT00119262|455311781|FG000|Overall Study|Lack of Efficacy|0|||
126551017|NCT00119262|455311782|FG001|Overall Study|Lack of Efficacy|3|||
126551018|NCT00119262|455311781|FG000|Overall Study|Withdrawal by Subject|12|||
126551019|NCT00119262|455311782|FG001|Overall Study|Withdrawal by Subject|11|||
126303811|NCT02649439|454402458|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
126303812|NCT02649439|454402457|FG000|Overall Study|No treatment, per protocol|1|||
126303813|NCT02649439|454402458|FG001|Overall Study|No treatment, per protocol|0|||
126303814|NCT02649439|454402457|FG000|Overall Study|PSA DT makes ineligible|0|||
126303815|NCT02649439|454402458|FG001|Overall Study|PSA DT makes ineligible|1|||
126303816|NCT02649439|454402457|FG000|Overall Study|Rising PSA No Mets|0|||
126303817|NCT02649439|454402458|FG001|Overall Study|Rising PSA No Mets|1|||
126462928|NCT03435640|454996932|FG004|Overall Study|Lost to Follow-up|0|||
126462929|NCT03435640|454996933|FG005|Overall Study|Lost to Follow-up|0|||
126462930|NCT03435640|454996934|FG006|Overall Study|Lost to Follow-up|0|||
126462931|NCT03435640|454996935|FG007|Overall Study|Lost to Follow-up|0|||
126462932|NCT03435640|454996936|FG008|Overall Study|Lost to Follow-up|0|||
126462933|NCT03435640|454996937|FG009|Overall Study|Lost to Follow-up|0|||
126462934|NCT03435640|454996938|FG010|Overall Study|Lost to Follow-up|0|||
126462935|NCT00920829|454996946|FG000|Allocation|No post randomization data|3|||
126462936|NCT00920829|454996947|FG001|Allocation|No post randomization data|1|||
126462937|NCT00920829|454996948|FG002|Allocation|No post randomization data|0|||
126303818|NCT02649439|454402457|FG000|Overall Study|Rising PSA|0|||
126303819|NCT02649439|454402458|FG001|Overall Study|Rising PSA|1|||
126303820|NCT02649439|454402457|FG000|Overall Study|Signed follow up protocol|0|||
126303821|NCT02649439|454402458|FG001|Overall Study|Signed follow up protocol|1|||
126462938|NCT00920829|454996949|FG003|Allocation|No post randomization data|2|||
126462939|NCT00920829|454996946|FG000|Available for Analysis|Withdrawal by Subject|6|||
126462940|NCT00920829|454996947|FG001|Available for Analysis|Withdrawal by Subject|6|||
126462941|NCT00920829|454996948|FG002|Available for Analysis|Withdrawal by Subject|6|||
126462942|NCT00920829|454996949|FG003|Available for Analysis|Withdrawal by Subject|10|||
126462943|NCT00920829|454996946|FG000|Available for Analysis|Required Medical Treatment|0|||
126462944|NCT00920829|454996947|FG001|Available for Analysis|Required Medical Treatment|1|||
126462945|NCT00920829|454996948|FG002|Available for Analysis|Required Medical Treatment|2|||
126462946|NCT00920829|454996949|FG003|Available for Analysis|Required Medical Treatment|0|||
126462947|NCT00920829|454996946|FG000|Available for Analysis|Adverse Event|1|||
126462948|NCT00920829|454996947|FG001|Available for Analysis|Adverse Event|2|||
126462949|NCT00920829|454996948|FG002|Available for Analysis|Adverse Event|1|||
126462950|NCT00920829|454996949|FG003|Available for Analysis|Adverse Event|0|||
126462951|NCT00920829|454996946|FG000|Available for Analysis|Death|1|||
126462952|NCT00920829|454996947|FG001|Available for Analysis|Death|0|||
126462953|NCT00920829|454996948|FG002|Available for Analysis|Death|0|||
126462954|NCT00920829|454996949|FG003|Available for Analysis|Death|0|||
126462955|NCT00920829|454996946|FG000|Available for Analysis|Protocol Violation|0|||
126462956|NCT00920829|454996947|FG001|Available for Analysis|Protocol Violation|0|||
126462957|NCT00920829|454996948|FG002|Available for Analysis|Protocol Violation|1|||
126462958|NCT00920829|454996949|FG003|Available for Analysis|Protocol Violation|0|||
126462959|NCT00920829|454996946|FG000|Available for Analysis|Required more treatment|0|||
126462960|NCT00920829|454996947|FG001|Available for Analysis|Required more treatment|2|||
126303822|NCT02714595|454402462|FG000|Overall Study|Lost to Follow-up|1|||
126303823|NCT02714595|454402463|FG001|Overall Study|Lost to Follow-up|0|||
126303824|NCT02714595|454402462|FG000|Overall Study|Withdrawal by Subject|1|||
126303825|NCT02714595|454402463|FG001|Overall Study|Withdrawal by Subject|2|||
126303826|NCT02714595|454402462|FG000|Overall Study|Lack of Efficacy|0|||
126303827|NCT02714595|454402463|FG001|Overall Study|Lack of Efficacy|1|||
126303828|NCT02714595|454402462|FG000|Overall Study|Death|30|||
126303829|NCT02714595|454402463|FG001|Overall Study|Death|9|||
126303830|NCT02714595|454402462|FG000|Overall Study|Other-Miscellaneous|0|||
126303831|NCT02714595|454402463|FG001|Overall Study|Other-Miscellaneous|1|||
126303832|NCT00713258|454402464|FG000|Overall Study|Adverse Event|2|||
126303833|NCT00713258|454402465|FG001|Overall Study|Adverse Event|4|||
126303834|NCT00713258|454402464|FG000|Overall Study|Non-Compliance|2|||
126303835|NCT00713258|454402465|FG001|Overall Study|Non-Compliance|1|||
126303836|NCT00713258|454402464|FG000|Overall Study|Other|1|||
126303837|NCT00713258|454402465|FG001|Overall Study|Other|1|||
126303838|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
126303839|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
126303840|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
126303841|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
126303842|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
126303843|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
126303844|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
126303845|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
126303846|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
126303847|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
126462961|NCT00920829|454996948|FG002|Available for Analysis|Required more treatment|0|||
126462962|NCT00920829|454996949|FG003|Available for Analysis|Required more treatment|1|||
126462963|NCT04533880|454996950|FG000|Overall Study|Lost to Follow-up|0|||
126462964|NCT04533880|454996951|FG001|Overall Study|Lost to Follow-up|1|||
126462965|NCT04533880|454996952|FG002|Overall Study|Lost to Follow-up|1|||
126462966|NCT01711879|454996957|FG000|Overall Study|Death|1|||
126462967|NCT01711879|454996958|FG001|Overall Study|Death|0|||
126303848|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
126303849|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
126303850|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
126303851|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
126303852|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
126303853|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
126303854|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
126303855|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
126303856|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
126303857|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
126303858|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
126462968|NCT02239224|454996961|FG000|Overall Study|Administrative|0|||
126462969|NCT02239224|454996962|FG001|Overall Study|Administrative|0|||
126462970|NCT02239224|454996963|FG002|Overall Study|Administrative|3|||
126462971|NCT02239224|454996964|FG003|Overall Study|Administrative|1|||
126303859|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
126303860|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
126303861|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
126303862|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
126303863|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
126303864|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
126303865|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
126303866|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
126303867|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
126303868|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
126303869|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
126303870|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
126303871|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
126303872|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
126303873|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
126303874|NCT02016105|454402466|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
126303875|NCT02016105|454402467|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
126303876|NCT02016105|454402468|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
126303877|NCT02016105|454402469|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
126303878|NCT02016105|454402470|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
126303879|NCT02016105|454402471|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
126303880|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
126303881|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
126303882|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
126303883|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
126303884|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
126303885|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
126303886|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
126303887|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
126303888|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
126303889|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
126303890|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
126303891|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
126303892|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
126303893|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
126303894|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
126303895|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
126303896|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
126303897|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
126303898|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Death|0|||
126303899|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Death|0|||
126303900|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Death|0|||
126303901|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Death|0|||
126303902|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Death|0|||
126303903|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Death|1|||
126303904|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
126303905|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
126303906|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
126303907|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
126303908|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
126303909|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
126303910|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
126303911|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
126303912|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
126303913|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
126303914|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
126303915|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
126303916|NCT02016105|454402466|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
126303917|NCT02016105|454402467|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
126303918|NCT02016105|454402468|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
126303919|NCT02016105|454402469|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
126303920|NCT02016105|454402470|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
126303921|NCT02016105|454402471|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
126303922|NCT02016105|454402466|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
126303923|NCT02016105|454402467|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
126303924|NCT02016105|454402468|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
126303925|NCT02016105|454402469|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
126303926|NCT02016105|454402470|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
126303927|NCT02016105|454402471|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
126303928|NCT02016105|454402466|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
126303929|NCT02016105|454402467|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
126303930|NCT02016105|454402468|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
126303931|NCT02016105|454402469|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
126303932|NCT02016105|454402470|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
126303933|NCT02016105|454402471|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
126303934|NCT02016105|454402466|FG000|EXTENSION PERIOD|Adverse Event|0|||
126303935|NCT02016105|454402467|FG001|EXTENSION PERIOD|Adverse Event|0|||
126303936|NCT02016105|454402468|FG002|EXTENSION PERIOD|Adverse Event|2|||
126303937|NCT02016105|454402469|FG003|EXTENSION PERIOD|Adverse Event|0|||
126303938|NCT02016105|454402470|FG004|EXTENSION PERIOD|Adverse Event|1|||
126303939|NCT02016105|454402471|FG005|EXTENSION PERIOD|Adverse Event|0|||
126303940|NCT02016105|454402466|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
126303941|NCT02016105|454402467|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
126303942|NCT02016105|454402468|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
126303943|NCT02016105|454402469|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
126303944|NCT02016105|454402470|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
126303945|NCT02016105|454402471|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
126303946|NCT02016105|454402466|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
126303947|NCT02016105|454402467|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
126303948|NCT02016105|454402468|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
126303949|NCT02016105|454402469|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
126303950|NCT02016105|454402470|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
126303951|NCT02016105|454402471|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
126303952|NCT02016105|454402466|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
126303953|NCT02016105|454402467|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
126303954|NCT02016105|454402468|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
126303955|NCT02016105|454402469|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
126303956|NCT02016105|454402470|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
126303957|NCT02016105|454402471|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
126303958|NCT01908829|454402475|FG000|Overall Study|Adverse Event|13|||
126303959|NCT01908829|454402476|FG001|Overall Study|Adverse Event|11|||
126303960|NCT01908829|454402477|FG002|Overall Study|Adverse Event|13|||
126303961|NCT01908829|454402475|FG000|Overall Study|Lost to Follow-up|4|||
126303962|NCT01908829|454402476|FG001|Overall Study|Lost to Follow-up|2|||
126303963|NCT01908829|454402477|FG002|Overall Study|Lost to Follow-up|1|||
126303964|NCT01908829|454402475|FG000|Overall Study|Randomized no double-blind drug received|1|||
126303965|NCT01908829|454402476|FG001|Overall Study|Randomized no double-blind drug received|0|||
126303966|NCT01908829|454402477|FG002|Overall Study|Randomized no double-blind drug received|1|||
126303967|NCT01908829|454402475|FG000|Overall Study|Discontinued (no EoT page)|2|||
126303968|NCT01908829|454402476|FG001|Overall Study|Discontinued (no EoT page)|0|||
126303969|NCT01908829|454402477|FG002|Overall Study|Discontinued (no EoT page)|0|||
126303970|NCT01908829|454402475|FG000|Overall Study|Miscellaneous|0|||
126303971|NCT01908829|454402476|FG001|Overall Study|Miscellaneous|2|||
126303972|NCT01908829|454402477|FG002|Overall Study|Miscellaneous|0|||
126303973|NCT01908829|454402475|FG000|Overall Study|Protocol Violation|2|||
126303974|NCT01908829|454402476|FG001|Overall Study|Protocol Violation|2|||
126303975|NCT01908829|454402477|FG002|Overall Study|Protocol Violation|0|||
126303976|NCT01908829|454402475|FG000|Overall Study|Lack of Efficacy|1|||
126368054|NCT00725985|454642899|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
126551020|NCT00119262|455311781|FG000|Overall Study|Adverse Event|33|||
126303977|NCT01908829|454402476|FG001|Overall Study|Lack of Efficacy|3|||
126303978|NCT01908829|454402477|FG002|Overall Study|Lack of Efficacy|2|||
126303979|NCT01908829|454402475|FG000|Overall Study|Withdrawal by Subject|26|||
126303980|NCT01908829|454402476|FG001|Overall Study|Withdrawal by Subject|29|||
126368055|NCT00725985|454642900|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
126368056|NCT00725985|454642889|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
126368057|NCT00725985|454642890|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
126368058|NCT00725985|454642891|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
126368059|NCT00725985|454642892|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
126368060|NCT00725985|454642893|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
126368061|NCT00725985|454642894|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
126368062|NCT00725985|454642895|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
126368063|NCT00725985|454642896|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
126368064|NCT00725985|454642897|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
126368065|NCT00725985|454642898|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
126368066|NCT00725985|454642899|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
126368067|NCT00725985|454642900|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
126368068|NCT00725985|454642889|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
126368069|NCT00725985|454642890|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
126368070|NCT00725985|454642891|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
126368071|NCT00725985|454642892|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
126368072|NCT00725985|454642893|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
126368073|NCT00725985|454642894|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
126368074|NCT00725985|454642895|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
126368075|NCT00725985|454642896|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
126368076|NCT00725985|454642897|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
126368077|NCT00725985|454642898|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
126368078|NCT00725985|454642899|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
126368079|NCT00725985|454642900|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
126368080|NCT00725985|454642889|FG000|ITP- Treatment Disposition|Other|50|||
126303981|NCT01908829|454402477|FG002|Overall Study|Withdrawal by Subject|22|||
126303982|NCT02247440|454402478|FG000|Overall Study|Withdrawal by Subject|1|||
126303983|NCT02247440|454402478|FG000|Overall Study|Lack of Efficacy|3|||
126303984|NCT02320058|454402479|FG000|Overall Study|Death|25|||
126303985|NCT02320058|454402480|FG001|Overall Study|Death|10|||
126303986|NCT02320058|454402479|FG000|Overall Study|Lost to Follow-up|4|||
126303987|NCT02320058|454402480|FG001|Overall Study|Lost to Follow-up|0|||
126303988|NCT02320058|454402479|FG000|Overall Study|Other reasons|4|||
126462972|NCT03183778|454996968|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
126462973|NCT01466179|454996969|FG000|Overall Study|Ongoing in core study|2|||
126462974|NCT01466179|454996969|FG000|Overall Study|Physician Decision|46|||
126462975|NCT01466179|454996969|FG000|Overall Study|Progressive disease|43|||
126462976|NCT01466179|454996969|FG000|Overall Study|Adverse Event|32|||
126462977|NCT01466179|454996969|FG000|Overall Study|Disease relapse|23|||
126462978|NCT01466179|454996969|FG000|Overall Study|Lack of Efficacy|14|||
126462979|NCT01466179|454996969|FG000|Overall Study|Death|7|||
126462980|NCT01466179|454996969|FG000|Overall Study|Withdrawal by Subject|7|||
126462981|NCT01466179|454996969|FG000|Overall Study|Protocol Violation|2|||
126462982|NCT01466179|454996969|FG000|Overall Study|Other|3|||
126462983|NCT03489551|454996970|FG000|Overall Study|Withdrawal by Subject|2|||
126462984|NCT00054717|454996971|FG000|Overall Study|Randomized but not treated|2|||
126462985|NCT00054717|454996972|FG001|Overall Study|Randomized but not treated|8|||
126462986|NCT00054717|454996971|FG000|Overall Study|Adverse Event|70|||
126303989|NCT02320058|454402480|FG001|Overall Study|Other reasons|1|||
126303990|NCT02320058|454402479|FG000|Overall Study|Withdrawal by Subject|8|||
126303991|NCT02320058|454402480|FG001|Overall Study|Withdrawal by Subject|2|||
126303992|NCT02320058|454402479|FG000|Overall Study|Not reported|1|||
126303993|NCT02320058|454402480|FG001|Overall Study|Not reported|0|||
126303994|NCT01339923|454402481|FG000|Overall Study|Adverse Event|1|||
126303995|NCT01339923|454402482|FG001|Overall Study|Adverse Event|1|||
126303996|NCT01339923|454402483|FG002|Overall Study|Adverse Event|1|||
126303997|NCT01339923|454402484|FG003|Overall Study|Adverse Event|0|||
126303998|NCT01339923|454402485|FG004|Overall Study|Adverse Event|0|||
126303999|NCT01339923|454402486|FG005|Overall Study|Adverse Event|0|||
126304000|NCT01339923|454402487|FG006|Overall Study|Adverse Event|1|||
126304001|NCT01339923|454402481|FG000|Overall Study|Inappropriate Enrollment|1|||
126304002|NCT01339923|454402482|FG001|Overall Study|Inappropriate Enrollment|0|||
126304003|NCT01339923|454402483|FG002|Overall Study|Inappropriate Enrollment|0|||
126304004|NCT01339923|454402484|FG003|Overall Study|Inappropriate Enrollment|0|||
126304005|NCT01339923|454402485|FG004|Overall Study|Inappropriate Enrollment|0|||
126304006|NCT01339923|454402486|FG005|Overall Study|Inappropriate Enrollment|1|||
126304007|NCT01339923|454402487|FG006|Overall Study|Inappropriate Enrollment|0|||
126304008|NCT01339923|454402481|FG000|Overall Study|Lost to Follow-up|4|||
126304009|NCT01339923|454402482|FG001|Overall Study|Lost to Follow-up|4|||
126304010|NCT01339923|454402483|FG002|Overall Study|Lost to Follow-up|0|||
126304011|NCT01339923|454402484|FG003|Overall Study|Lost to Follow-up|3|||
126304012|NCT01339923|454402485|FG004|Overall Study|Lost to Follow-up|1|||
126304013|NCT01339923|454402486|FG005|Overall Study|Lost to Follow-up|1|||
126551021|NCT00119262|455311782|FG001|Overall Study|Adverse Event|35|||
126551022|NCT00119262|455311781|FG000|Overall Study|other disease|0|||
126551023|NCT00119262|455311782|FG001|Overall Study|other disease|2|||
126551024|NCT00119262|455311781|FG000|Overall Study|ineligble|1|||
126551025|NCT00119262|455311782|FG001|Overall Study|ineligble|2|||
126551026|NCT00119262|455311781|FG000|Overall Study|others|0|||
126551027|NCT00119262|455311782|FG001|Overall Study|others|5|||
126551028|NCT00734214|455311783|FG000|Overall Study|Withdrawal by Subject|3|||
126551029|NCT00734214|455311784|FG001|Overall Study|Withdrawal by Subject|4|||
126551030|NCT00734214|455311783|FG000|Overall Study|MD withdrawal|1|||
126551031|NCT00734214|455311784|FG001|Overall Study|MD withdrawal|0|||
126551032|NCT04844918|455311785|FG000|Overall Study|Adverse Event|7|||
126551033|NCT04844918|455311786|FG001|Overall Study|Adverse Event|8|||
126304014|NCT01339923|454402487|FG006|Overall Study|Lost to Follow-up|5|||
126304015|NCT01339923|454402481|FG000|Overall Study|Protocol Violation|0|||
126462987|NCT00054717|454996972|FG001|Overall Study|Adverse Event|22|||
126551034|NCT04844918|455311787|FG002|Overall Study|Adverse Event|5|||
126551035|NCT04844918|455311785|FG000|Overall Study|Physician Decision|0|||
126304016|NCT01339923|454402482|FG001|Overall Study|Protocol Violation|0|||
126304017|NCT01339923|454402483|FG002|Overall Study|Protocol Violation|0|||
126304018|NCT01339923|454402484|FG003|Overall Study|Protocol Violation|0|||
126304019|NCT01339923|454402485|FG004|Overall Study|Protocol Violation|0|||
126304020|NCT01339923|454402486|FG005|Overall Study|Protocol Violation|3|||
126304021|NCT01339923|454402487|FG006|Overall Study|Protocol Violation|1|||
126304022|NCT01339923|454402481|FG000|Overall Study|Unable to Classify|1|||
126304023|NCT01339923|454402482|FG001|Overall Study|Unable to Classify|0|||
126304024|NCT01339923|454402483|FG002|Overall Study|Unable to Classify|1|||
126462988|NCT00054717|454996971|FG000|Overall Study|Protocol Violation|18|||
126462989|NCT00054717|454996972|FG001|Overall Study|Protocol Violation|19|||
126462990|NCT00054717|454996971|FG000|Overall Study|Lost to Follow-up|23|||
126462991|NCT00054717|454996972|FG001|Overall Study|Lost to Follow-up|13|||
126551036|NCT04844918|455311786|FG001|Overall Study|Physician Decision|1|||
126304025|NCT01339923|454402484|FG003|Overall Study|Unable to Classify|0|||
126304026|NCT01339923|454402485|FG004|Overall Study|Unable to Classify|0|||
126304027|NCT01339923|454402486|FG005|Overall Study|Unable to Classify|1|||
126304028|NCT01339923|454402487|FG006|Overall Study|Unable to Classify|5|||
126304029|NCT01339923|454402481|FG000|Overall Study|Withdrawal by Subject|7|||
126304030|NCT01339923|454402482|FG001|Overall Study|Withdrawal by Subject|11|||
126304031|NCT01339923|454402483|FG002|Overall Study|Withdrawal by Subject|6|||
126304032|NCT01339923|454402484|FG003|Overall Study|Withdrawal by Subject|1|||
126304033|NCT01339923|454402485|FG004|Overall Study|Withdrawal by Subject|4|||
126304034|NCT01339923|454402486|FG005|Overall Study|Withdrawal by Subject|3|||
126304035|NCT01339923|454402487|FG006|Overall Study|Withdrawal by Subject|2|||
126304036|NCT01430403|454402491|FG000|Overall Study|Lost to Follow-up|5|||
126304037|NCT01430403|454402492|FG001|Overall Study|Lost to Follow-up|5|||
126551037|NCT04844918|455311787|FG002|Overall Study|Physician Decision|0|||
126551038|NCT04844918|455311785|FG000|Overall Study|Withdrawal by Subject|6|||
126551039|NCT04844918|455311786|FG001|Overall Study|Withdrawal by Subject|3|||
126551040|NCT04844918|455311787|FG002|Overall Study|Withdrawal by Subject|3|||
126551041|NCT04844918|455311785|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
126551042|NCT04844918|455311786|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
126551043|NCT04844918|455311787|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
126551044|NCT00924469|455311794|FG000|Overall Study|Adverse Event|2|||
126551045|NCT00924469|455311795|FG001|Overall Study|Adverse Event|0|||
126551046|NCT00924469|455311794|FG000|Overall Study|Withdrawal by Subject|0|||
126304038|NCT01430403|454402493|FG002|Overall Study|Lost to Follow-up|3|||
126304039|NCT01430403|454402491|FG000|Overall Study|Physician Decision|1|||
126304040|NCT01430403|454402492|FG001|Overall Study|Physician Decision|0|||
126304041|NCT01430403|454402493|FG002|Overall Study|Physician Decision|0|||
126304042|NCT01430403|454402491|FG000|Overall Study|Protocol Violation|2|||
126304043|NCT01430403|454402492|FG001|Overall Study|Protocol Violation|3|||
126304044|NCT01430403|454402493|FG002|Overall Study|Protocol Violation|2|||
126304045|NCT01430403|454402491|FG000|Overall Study|Withdrawal by Subject|9|||
126304046|NCT01430403|454402492|FG001|Overall Study|Withdrawal by Subject|1|||
126304047|NCT01430403|454402493|FG002|Overall Study|Withdrawal by Subject|3|||
126304048|NCT02099110|454402498|FG000|Overall Study|Protocol Violation|2|||
126304049|NCT02099110|454402499|FG001|Overall Study|Protocol Violation|1|||
126304050|NCT02099110|454402500|FG002|Overall Study|Protocol Violation|0|||
126304051|NCT02099110|454402501|FG003|Overall Study|Protocol Violation|3|||
126304052|NCT02099110|454402502|FG004|Overall Study|Protocol Violation|1|||
126304053|NCT02099110|454402498|FG000|Overall Study|Participant moved|1|||
126304054|NCT02099110|454402499|FG001|Overall Study|Participant moved|1|||
126304055|NCT02099110|454402500|FG002|Overall Study|Participant moved|1|||
126304056|NCT02099110|454402501|FG003|Overall Study|Participant moved|0|||
126304057|NCT02099110|454402502|FG004|Overall Study|Participant moved|2|||
126304058|NCT02099110|454402498|FG000|Overall Study|Withdrawal by Subject|7|||
126304059|NCT02099110|454402499|FG001|Overall Study|Withdrawal by Subject|11|||
126551047|NCT00924469|455311795|FG001|Overall Study|Withdrawal by Subject|1|||
126551048|NCT00924469|455311794|FG000|Overall Study|Lost to Follow-up|0|||
126551049|NCT00924469|455311795|FG001|Overall Study|Lost to Follow-up|1|||
126551050|NCT00630058|455311796|FG000|Overall Study|Adverse Event|1|||
126713390|NCT00469014|455902105|FG000|Initial Phase Randomization|No Response|1|||
126304060|NCT02099110|454402500|FG002|Overall Study|Withdrawal by Subject|13|||
126304061|NCT02099110|454402501|FG003|Overall Study|Withdrawal by Subject|9|||
126304062|NCT02099110|454402502|FG004|Overall Study|Withdrawal by Subject|13|||
126304063|NCT02099110|454402498|FG000|Overall Study|Adverse Event|3|||
126368081|NCT00725985|454642890|FG001|ITP- Treatment Disposition|Other|38|||
126368082|NCT00725985|454642891|FG002|ITP- Treatment Disposition|Other|24|||
126368083|NCT00725985|454642892|FG003|ITP- Treatment Disposition|Other|0|||
126368084|NCT00725985|454642893|FG004|ITP- Treatment Disposition|Other|0|||
126368085|NCT00725985|454642894|FG005|ITP- Treatment Disposition|Other|0|||
126368086|NCT00725985|454642895|FG006|ITP- Treatment Disposition|Other|0|||
126368087|NCT00725985|454642896|FG007|ITP- Treatment Disposition|Other|0|||
126368088|NCT00725985|454642897|FG008|ITP- Treatment Disposition|Other|0|||
126368089|NCT00725985|454642898|FG009|ITP- Treatment Disposition|Other|0|||
126368090|NCT00725985|454642899|FG010|ITP- Treatment Disposition|Other|0|||
126368091|NCT00725985|454642900|FG011|ITP- Treatment Disposition|Other|0|||
126368092|NCT00725985|454642889|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368093|NCT00725985|454642890|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368094|NCT00725985|454642891|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368095|NCT00725985|454642892|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
126368096|NCT00725985|454642893|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
126368097|NCT00725985|454642894|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
126368098|NCT00725985|454642895|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368099|NCT00725985|454642896|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126304064|NCT02099110|454402499|FG001|Overall Study|Adverse Event|5|||
126304065|NCT02099110|454402500|FG002|Overall Study|Adverse Event|2|||
126304066|NCT02099110|454402501|FG003|Overall Study|Adverse Event|3|||
126368100|NCT00725985|454642897|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126551051|NCT00630058|455311797|FG001|Overall Study|Adverse Event|1|||
126304067|NCT02099110|454402502|FG004|Overall Study|Adverse Event|2|||
126304068|NCT02099110|454402498|FG000|Overall Study|Lost to Follow-up|6|||
126304069|NCT02099110|454402499|FG001|Overall Study|Lost to Follow-up|12|||
126304070|NCT02099110|454402500|FG002|Overall Study|Lost to Follow-up|11|||
126304071|NCT02099110|454402501|FG003|Overall Study|Lost to Follow-up|5|||
126304072|NCT02099110|454402502|FG004|Overall Study|Lost to Follow-up|6|||
126304073|NCT02099110|454402498|FG000|Overall Study|Death|0|||
126304074|NCT02099110|454402499|FG001|Overall Study|Death|1|||
126304075|NCT02099110|454402500|FG002|Overall Study|Death|0|||
126304076|NCT02099110|454402501|FG003|Overall Study|Death|0|||
126304077|NCT02099110|454402502|FG004|Overall Study|Death|0|||
126304078|NCT02099110|454402498|FG000|Overall Study|Screen failure|0|||
126304079|NCT02099110|454402499|FG001|Overall Study|Screen failure|0|||
126304080|NCT02099110|454402500|FG002|Overall Study|Screen failure|0|||
126304081|NCT02099110|454402501|FG003|Overall Study|Screen failure|0|||
126304082|NCT02099110|454402502|FG004|Overall Study|Screen failure|1|||
126304083|NCT02099110|454402498|FG000|Overall Study|Non-compliance with study drug|2|||
126304084|NCT02099110|454402499|FG001|Overall Study|Non-compliance with study drug|0|||
126304085|NCT02099110|454402500|FG002|Overall Study|Non-compliance with study drug|0|||
126304086|NCT02099110|454402501|FG003|Overall Study|Non-compliance with study drug|0|||
126304087|NCT02099110|454402502|FG004|Overall Study|Non-compliance with study drug|1|||
126304088|NCT02099110|454402498|FG000|Overall Study|Physician Decision|3|||
126304089|NCT02099110|454402499|FG001|Overall Study|Physician Decision|0|||
126304090|NCT02099110|454402500|FG002|Overall Study|Physician Decision|1|||
126304091|NCT02099110|454402501|FG003|Overall Study|Physician Decision|2|||
126304092|NCT02099110|454402502|FG004|Overall Study|Physician Decision|1|||
126304093|NCT00994461|454402506|FG000|Overall Study|Adverse Event|2|||
126304094|NCT00994461|454402507|FG001|Overall Study|Adverse Event|1|||
126304095|NCT00994461|454402508|FG002|Overall Study|Adverse Event|0|||
126304096|NCT02887248|454402509|FG000|Overall Study|Withdrawal by Subject|1|||
126304097|NCT02887248|454402509|FG000|Overall Study|Adverse Event|1|||
126304098|NCT02887248|454402509|FG000|Overall Study|Progressive Disease|1|||
126304099|NCT01166438|454402510|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
126304100|NCT01166438|454402511|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
126304101|NCT01166438|454402510|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
126304102|NCT01166438|454402511|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
126304103|NCT01166438|454402510|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
126304104|NCT01166438|454402511|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
126304105|NCT01166438|454402510|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
126304106|NCT01166438|454402511|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
126304107|NCT01166438|454402510|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
126304108|NCT01166438|454402511|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
126304109|NCT01166438|454402510|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
126304110|NCT01166438|454402511|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
126304111|NCT01377922|454402516|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
126304112|NCT01377922|454402517|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
126304113|NCT03170362|454402518|FG000|Overall Study|Death|2|||
126304114|NCT03170362|454402519|FG001|Overall Study|Death|2|||
126304115|NCT03170362|454402518|FG000|Overall Study|Withdrawal by Subject|23|||
126304116|NCT03170362|454402519|FG001|Overall Study|Withdrawal by Subject|22|||
126304117|NCT03170362|454402518|FG000|Overall Study|Lost to Follow-up|187|||
126304118|NCT03170362|454402519|FG001|Overall Study|Lost to Follow-up|167|||
126304119|NCT03340454|454402522|FG000|Overall Study|Lost to Follow-up|0|||
126304120|NCT03340454|454402523|FG001|Overall Study|Lost to Follow-up|4|||
126304121|NCT01464164|454402524|FG000|Overall Study|Screen failure|0|||
126304122|NCT01464164|454402525|FG001|Overall Study|Screen failure|1|||
126462992|NCT00054717|454996971|FG000|Overall Study|Withdrawal by Subject|32|||
126304123|NCT01464164|454402526|FG002|Overall Study|Screen failure|2|||
126304124|NCT01464164|454402527|FG003|Overall Study|Screen failure|0|||
126304125|NCT01464164|454402528|FG004|Overall Study|Screen failure|0|||
126304126|NCT01464164|454402529|FG005|Overall Study|Screen failure|0|||
126304127|NCT01464164|454402530|FG006|Overall Study|Screen failure|0|||
126304128|NCT01464164|454402524|FG000|Overall Study|Physician Decision|0|||
126368101|NCT00725985|454642898|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368102|NCT00725985|454642899|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368103|NCT00725985|454642900|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
126368104|NCT00725985|454642889|FG000|OLMP (Up to 96 Weeks)|Death|0|||
126368105|NCT00725985|454642890|FG001|OLMP (Up to 96 Weeks)|Death|0|||
126368106|NCT00725985|454642891|FG002|OLMP (Up to 96 Weeks)|Death|0|||
126368107|NCT00725985|454642892|FG003|OLMP (Up to 96 Weeks)|Death|0|||
126368108|NCT00725985|454642893|FG004|OLMP (Up to 96 Weeks)|Death|1|||
126368109|NCT00725985|454642894|FG005|OLMP (Up to 96 Weeks)|Death|0|||
126368110|NCT00725985|454642895|FG006|OLMP (Up to 96 Weeks)|Death|0|||
126304129|NCT01464164|454402525|FG001|Overall Study|Physician Decision|1|||
126304130|NCT01464164|454402526|FG002|Overall Study|Physician Decision|0|||
126304131|NCT01464164|454402527|FG003|Overall Study|Physician Decision|0|||
126304132|NCT01464164|454402528|FG004|Overall Study|Physician Decision|0|||
126304133|NCT01464164|454402529|FG005|Overall Study|Physician Decision|0|||
126304134|NCT01464164|454402530|FG006|Overall Study|Physician Decision|2|||
126304135|NCT03682848|454402531|FG000|Overall Study|Withdrawal by Subject|2|||
126304136|NCT03682848|454402531|FG000|Overall Study|Site closed|5|||
126304137|NCT03682848|454402531|FG000|Overall Study|Protocol Deviation|1|||
126304138|NCT03682848|454402531|FG000|Overall Study|Adverse Event|1|||
126304139|NCT00454363|454402532|FG000|Overall Study|Adverse Event|1|||
126304140|NCT00454363|454402533|FG001|Overall Study|Adverse Event|2|||
126304141|NCT00454363|454402532|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
126304142|NCT00454363|454402533|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
126304143|NCT00570063|454402534|FG000|Overall Study|Adverse Event|4|||
126304144|NCT00570063|454402535|FG001|Overall Study|Adverse Event|1|||
126304145|NCT00570063|454402534|FG000|Overall Study|Lack of Efficacy|0|||
126304146|NCT00570063|454402535|FG001|Overall Study|Lack of Efficacy|1|||
126304147|NCT00570063|454402534|FG000|Overall Study|Withdrawal by Subject|4|||
126304148|NCT00570063|454402535|FG001|Overall Study|Withdrawal by Subject|3|||
126304149|NCT00570063|454402534|FG000|Overall Study|Sponsor's Decision|7|||
126304150|NCT00570063|454402535|FG001|Overall Study|Sponsor's Decision|3|||
126304151|NCT00697463|454402536|FG000|Overall Study|Withdrawal by Subject|1|||
126304152|NCT03307252|454402537|FG000|Part 2, Period 1|Treatment not received|0|||
126304153|NCT03307252|454402538|FG001|Part 2, Period 1|Treatment not received|0|||
126304154|NCT03307252|454402539|FG002|Part 2, Period 1|Treatment not received|0|||
126304155|NCT03307252|454402540|FG003|Part 2, Period 1|Treatment not received|0|||
126304156|NCT03307252|454402541|FG004|Part 2, Period 1|Treatment not received|0|||
126304157|NCT03307252|454402542|FG005|Part 2, Period 1|Treatment not received|1|||
126304158|NCT03307252|454402543|FG006|Part 2, Period 1|Treatment not received|0|||
126304159|NCT03307252|454402544|FG007|Part 2, Period 1|Treatment not received|0|||
126304160|NCT03307252|454402545|FG008|Part 2, Period 1|Treatment not received|0|||
126304161|NCT03307252|454402546|FG009|Part 2, Period 1|Treatment not received|0|||
126304162|NCT03307252|454402547|FG010|Part 2, Period 1|Treatment not received|0|||
126304163|NCT03307252|454402537|FG000|Part 2, Period 3|Other than listed|0|||
126304164|NCT03307252|454402538|FG001|Part 2, Period 3|Other than listed|0|||
126304165|NCT03307252|454402539|FG002|Part 2, Period 3|Other than listed|0|||
126304166|NCT03307252|454402540|FG003|Part 2, Period 3|Other than listed|0|||
126304167|NCT03307252|454402541|FG004|Part 2, Period 3|Other than listed|1|||
126304168|NCT03307252|454402542|FG005|Part 2, Period 3|Other than listed|0|||
126304169|NCT03307252|454402543|FG006|Part 2, Period 3|Other than listed|0|||
126304170|NCT03307252|454402544|FG007|Part 2, Period 3|Other than listed|0|||
126304171|NCT03307252|454402545|FG008|Part 2, Period 3|Other than listed|0|||
126304172|NCT03307252|454402546|FG009|Part 2, Period 3|Other than listed|0|||
126304173|NCT03307252|454402547|FG010|Part 2, Period 3|Other than listed|0|||
126304174|NCT03307252|454402537|FG000|Part 2, Period 4|Other than listed|0|||
126304175|NCT03307252|454402538|FG001|Part 2, Period 4|Other than listed|0|||
126304176|NCT03307252|454402539|FG002|Part 2, Period 4|Other than listed|0|||
126304177|NCT03307252|454402540|FG003|Part 2, Period 4|Other than listed|0|||
126304178|NCT03307252|454402541|FG004|Part 2, Period 4|Other than listed|0|||
126304179|NCT03307252|454402542|FG005|Part 2, Period 4|Other than listed|0|||
126304180|NCT03307252|454402543|FG006|Part 2, Period 4|Other than listed|1|||
126304181|NCT03307252|454402544|FG007|Part 2, Period 4|Other than listed|0|||
126304182|NCT03307252|454402545|FG008|Part 2, Period 4|Other than listed|0|||
126304183|NCT03307252|454402546|FG009|Part 2, Period 4|Other than listed|0|||
126304184|NCT03307252|454402547|FG010|Part 2, Period 4|Other than listed|0|||
126304185|NCT03307252|454402537|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126462993|NCT00054717|454996972|FG001|Overall Study|Withdrawal by Subject|20|||
126462994|NCT00054717|454996971|FG000|Overall Study|Other reason not defined above|117|||
126462995|NCT00054717|454996972|FG001|Overall Study|Other reason not defined above|217|||
126462996|NCT04209426|454996973|FG000|Overall Study|Lost to Follow-up|3|||
126462997|NCT04209426|454996974|FG001|Overall Study|Lost to Follow-up|2|||
126462998|NCT04423939|454996975|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
126462999|NCT04423939|454996976|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
126463000|NCT04423939|454996975|FG000|Overall Study|Death|3|||
126713391|NCT00469014|455902106|FG001|Initial Phase Randomization|No Response|0|||
126713392|NCT00469014|455902107|FG002|Initial Phase Randomization|No Response|0|||
126713393|NCT00469014|455902108|FG003|Initial Phase Randomization|No Response|1|||
126713394|NCT00469014|455902105|FG000|Adaptive Randomization|Not Evaluable|1|||
126304186|NCT03307252|454402538|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304187|NCT03307252|454402539|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304188|NCT03307252|454402540|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304189|NCT03307252|454402541|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304190|NCT03307252|454402542|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304191|NCT03307252|454402543|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304192|NCT03307252|454402544|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126463001|NCT04423939|454996976|FG001|Overall Study|Death|0|||
126304193|NCT03307252|454402545|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304194|NCT03307252|454402546|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
126304195|NCT03307252|454402547|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
126304196|NCT03482453|454402548|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304197|NCT03482453|454402549|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304198|NCT03482453|454402550|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304199|NCT03482453|454402551|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304200|NCT03482453|454402552|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304201|NCT03482453|454402553|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304202|NCT03482453|454402554|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304203|NCT03482453|454402555|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304204|NCT03482453|454402556|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304205|NCT03482453|454402557|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304206|NCT03482453|454402558|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
126304207|NCT03482453|454402559|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
126304208|NCT02568189|454402560|FG000|Overall Study|Protocol Violation|0|||
126304209|NCT02568189|454402561|FG001|Overall Study|Protocol Violation|0|||
126304210|NCT02568189|454402562|FG002|Overall Study|Protocol Violation|19|||
126304211|NCT02568189|454402563|FG003|Overall Study|Protocol Violation|18|||
126304212|NCT02157376|454402564|FG000|Overall Study|Death|10|||
126304213|NCT02157376|454402565|FG001|Overall Study|Death|4|||
126304214|NCT02157376|454402564|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126304215|NCT02157376|454402565|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126304216|NCT02157376|454402564|FG000|Overall Study|Withdrawal by Subject|3|||
126304217|NCT02157376|454402565|FG001|Overall Study|Withdrawal by Subject|8|||
126304218|NCT02157376|454402564|FG000|Overall Study|Not treated|8|||
126304219|NCT02157376|454402565|FG001|Overall Study|Not treated|3|||
126304220|NCT02157376|454402564|FG000|Overall Study|Investigator's misjudgement|1|||
126304221|NCT02157376|454402565|FG001|Overall Study|Investigator's misjudgement|2|||
126304222|NCT01074268|454402566|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
126304223|NCT01074268|454402567|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
126304224|NCT01074268|454402566|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
126304225|NCT01074268|454402567|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
126304226|NCT01074268|454402566|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
126304227|NCT01074268|454402567|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
126304228|NCT01074268|454402566|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
126304229|NCT01074268|454402567|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
126304230|NCT01074268|454402566|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
126304231|NCT01074268|454402567|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
126304232|NCT01074268|454402566|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
126304233|NCT01074268|454402567|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
126304234|NCT01074268|454402566|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
126304235|NCT01074268|454402567|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
126304236|NCT01074268|454402566|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
126304237|NCT01074268|454402567|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
126304238|NCT01074268|454402566|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
126304239|NCT01074268|454402567|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
126304240|NCT01578239|454402570|FG000|Treatment Period|Progressive Disease|19|||
126304241|NCT01578239|454402571|FG001|Treatment Period|Progressive Disease|64|||
126304242|NCT01578239|454402570|FG000|Treatment Period|Physician Decision|17|||
126304243|NCT01578239|454402571|FG001|Treatment Period|Physician Decision|17|||
126304244|NCT01578239|454402570|FG000|Treatment Period|Adverse Event|13|||
126304245|NCT01578239|454402571|FG001|Treatment Period|Adverse Event|10|||
126304246|NCT01578239|454402570|FG000|Treatment Period|Non-compliance|2|||
126304247|NCT01578239|454402571|FG001|Treatment Period|Non-compliance|0|||
126304248|NCT01578239|454402570|FG000|Treatment Period|Withdrawal by Subject|10|||
126304249|NCT01578239|454402571|FG001|Treatment Period|Withdrawal by Subject|9|||
126304250|NCT01578239|454402570|FG000|Treatment Period|Other|6|||
126304251|NCT01578239|454402571|FG001|Treatment Period|Other|1|||
126304252|NCT01578239|454402570|FG000|Long-term Follow-Up Period|Death|69|||
126304253|NCT01578239|454402571|FG001|Long-term Follow-Up Period|Death|64|||
126304254|NCT01578239|454402570|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
126304255|NCT01578239|454402571|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
126304256|NCT01578239|454402570|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
126304257|NCT01578239|454402571|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
126304258|NCT01578239|454402570|FG000|Long-term Follow-Up Period|Other|2|||
126304259|NCT01578239|454402571|FG001|Long-term Follow-Up Period|Other|2|||
126304260|NCT02347813|454402575|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
126304261|NCT02347813|454402576|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
126304262|NCT02347813|454402575|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
126304263|NCT02347813|454402576|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
126551052|NCT00630058|455311796|FG000|Overall Study|Withdrawal by Subject|0|||
126551053|NCT00630058|455311797|FG001|Overall Study|Withdrawal by Subject|1|||
126551054|NCT00630058|455311796|FG000|Overall Study|stopping criteria|3|||
126551055|NCT00630058|455311797|FG001|Overall Study|stopping criteria|2|||
126551056|NCT01651936|455311798|FG000|Base Study|Adverse Event|3|||
126551057|NCT01651936|455311799|FG001|Base Study|Adverse Event|0|||
126551058|NCT01651936|455311800|FG002|Base Study|Adverse Event|0|||
126551059|NCT01651936|455311798|FG000|Base Study|Withdrawal by Subject|1|||
126551060|NCT01651936|455311799|FG001|Base Study|Withdrawal by Subject|1|||
126551061|NCT01651936|455311800|FG002|Base Study|Withdrawal by Subject|0|||
126551062|NCT01651936|455311798|FG000|Base Study|Early Escape|2|||
126551063|NCT01651936|455311799|FG001|Base Study|Early Escape|8|||
126551064|NCT01651936|455311800|FG002|Base Study|Early Escape|0|||
126551065|NCT01651936|455311798|FG000|Base Study|Study terminated by sponsor|21|||
126551066|NCT01651936|455311799|FG001|Base Study|Study terminated by sponsor|16|||
126551067|NCT01651936|455311800|FG002|Base Study|Study terminated by sponsor|0|||
126551068|NCT01651936|455311798|FG000|Extension Study|Lack of Efficacy|0|||
126551069|NCT01651936|455311799|FG001|Extension Study|Lack of Efficacy|0|||
126551070|NCT01651936|455311800|FG002|Extension Study|Lack of Efficacy|1|||
126551071|NCT01651936|455311798|FG000|Extension Study|Study terminated by sponsor|0|||
126551072|NCT01651936|455311799|FG001|Extension Study|Study terminated by sponsor|0|||
126551073|NCT01651936|455311800|FG002|Extension Study|Study terminated by sponsor|13|||
126551074|NCT02743793|455311805|FG000|Overall Study|Death|1|||
126551075|NCT02743793|455311806|FG001|Overall Study|Death|1|||
126551076|NCT02743793|455311805|FG000|Overall Study|Withdrawal by Subject|0|||
126551077|NCT02743793|455311806|FG001|Overall Study|Withdrawal by Subject|1|||
126551078|NCT02743793|455311805|FG000|Overall Study|Screen Failure|4|||
126551079|NCT02743793|455311806|FG001|Overall Study|Screen Failure|0|||
126551080|NCT02743793|455311805|FG000|Overall Study|No Primary Care Physician|0|||
126551081|NCT02743793|455311806|FG001|Overall Study|No Primary Care Physician|1|||
126551082|NCT02743793|455311805|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
126551083|NCT02743793|455311806|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
126551084|NCT02743793|455311805|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
126551085|NCT02743793|455311806|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
126551086|NCT01461993|455311812|FG000|Overall Study|Withdrawal by Subject|60|||
126551087|NCT01461993|455311813|FG001|Overall Study|Withdrawal by Subject|53|||
126551088|NCT01461993|455311814|FG002|Overall Study|Withdrawal by Subject|16|||
126551089|NCT01461993|455311812|FG000|Overall Study|Lost to Follow-up|44|||
126551090|NCT01461993|455311813|FG001|Overall Study|Lost to Follow-up|48|||
126551091|NCT01461993|455311814|FG002|Overall Study|Lost to Follow-up|22|||
126551092|NCT01461993|455311812|FG000|Overall Study|Protocol Violation|10|||
126551093|NCT01461993|455311813|FG001|Overall Study|Protocol Violation|9|||
126304264|NCT02837731|454402581|FG000|Allocation|Admitted to General Floor|3|||
126304265|NCT02837731|454402582|FG001|Allocation|Admitted to General Floor|4|||
126304266|NCT02837731|454402581|FG000|Allocation|Immediate surgery/withdrew|2|||
126304267|NCT02837731|454402582|FG001|Allocation|Immediate surgery/withdrew|0|||
126304268|NCT02837731|454402581|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
126304269|NCT02837731|454402582|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
126304270|NCT02837731|454402581|FG000|Allocation|Withdrawal by Subject|2|||
126304271|NCT02837731|454402582|FG001|Allocation|Withdrawal by Subject|0|||
126304272|NCT02837731|454402581|FG000|Allocation|Device not available|1|||
126304273|NCT02837731|454402582|FG001|Allocation|Device not available|0|||
126304274|NCT02837731|454402581|FG000|Allocation|Protocol not implemented|7|||
126304275|NCT02837731|454402582|FG001|Allocation|Protocol not implemented|0|||
126551094|NCT01461993|455311814|FG002|Overall Study|Protocol Violation|7|||
126304276|NCT02837731|454402581|FG000|Allocation|Moribund/Do not resuscitate|2|||
126551095|NCT01461993|455311812|FG000|Overall Study|Adverse Event|9|||
126551096|NCT01461993|455311813|FG001|Overall Study|Adverse Event|11|||
126551097|NCT01461993|455311814|FG002|Overall Study|Adverse Event|3|||
126551098|NCT01461993|455311812|FG000|Overall Study|No longer met eligibility criteria|13|||
126551099|NCT01461993|455311813|FG001|Overall Study|No longer met eligibility criteria|18|||
126551100|NCT01461993|455311814|FG002|Overall Study|No longer met eligibility criteria|10|||
126551101|NCT01461993|455311812|FG000|Overall Study|Did not meet entrance criteria|2|||
126551102|NCT01461993|455311813|FG001|Overall Study|Did not meet entrance criteria|3|||
126304277|NCT02837731|454402582|FG001|Allocation|Moribund/Do not resuscitate|0|||
126304278|NCT02837731|454402581|FG000|Allocation|Did not meet sepsis criteria|1|||
126304279|NCT02837731|454402582|FG001|Allocation|Did not meet sepsis criteria|2|||
126551103|NCT01461993|455311814|FG002|Overall Study|Did not meet entrance criteria|0|||
126551104|NCT01461993|455311812|FG000|Overall Study|Other|13|||
126551105|NCT01461993|455311813|FG001|Overall Study|Other|15|||
126551106|NCT01461993|455311814|FG002|Overall Study|Other|6|||
126551107|NCT00219141|455311816|FG000|Overall Study|Adverse Event|4|||
126551108|NCT00219141|455311817|FG001|Overall Study|Adverse Event|10|||
126551109|NCT00219141|455311818|FG002|Overall Study|Adverse Event|5|||
126304280|NCT02837731|454402581|FG000|Allocation|Known aortic abnormalities|0|||
126304281|NCT02837731|454402582|FG001|Allocation|Known aortic abnormalities|1|||
126551110|NCT00219141|455311816|FG000|Overall Study|Lack of Efficacy|3|||
126304282|NCT01119859|454402583|FG000|Overall Study|Adverse Event|9|||
126304283|NCT01119859|454402584|FG001|Overall Study|Adverse Event|10|||
126304284|NCT01119859|454402583|FG000|Overall Study|Death|2|||
126304285|NCT01119859|454402584|FG001|Overall Study|Death|0|||
126304286|NCT01119859|454402583|FG000|Overall Study|Insufficient therapeutic response|7|||
126304287|NCT01119859|454402584|FG001|Overall Study|Insufficient therapeutic response|14|||
126304288|NCT01119859|454402583|FG000|Overall Study|Refused treatment|3|||
126304289|NCT01119859|454402584|FG001|Overall Study|Refused treatment|6|||
126304290|NCT01119859|454402583|FG000|Overall Study|Failure to return|3|||
126304291|NCT01119859|454402584|FG001|Overall Study|Failure to return|0|||
126304292|NCT00603473|454402585|FG000|Overall Study|Adverse Event|4|||
126304293|NCT00603473|454402585|FG000|Overall Study|Lack of Efficacy|4|||
126304294|NCT00603473|454402585|FG000|Overall Study|Protocol Violation|1|||
126304295|NCT02644668|454402589|FG000|Overall Study|Adverse Event|2|||
126304296|NCT02644668|454402590|FG001|Overall Study|Adverse Event|0|||
126304297|NCT02644668|454402591|FG002|Overall Study|Adverse Event|1|||
126304298|NCT02644668|454402589|FG000|Overall Study|Protocol Violation|0|||
126368111|NCT00725985|454642896|FG007|OLMP (Up to 96 Weeks)|Death|0|||
126368112|NCT00725985|454642897|FG008|OLMP (Up to 96 Weeks)|Death|0|||
126368113|NCT00725985|454642898|FG009|OLMP (Up to 96 Weeks)|Death|0|||
126368114|NCT00725985|454642899|FG010|OLMP (Up to 96 Weeks)|Death|0|||
126368115|NCT00725985|454642900|FG011|OLMP (Up to 96 Weeks)|Death|0|||
126713395|NCT00469014|455902106|FG001|Adaptive Randomization|Not Evaluable|0|||
126713396|NCT00469014|455902107|FG002|Adaptive Randomization|Not Evaluable|0|||
126713397|NCT00469014|455902108|FG003|Adaptive Randomization|Not Evaluable|1|||
126713398|NCT00469014|455902105|FG000|Adaptive Randomization|No Response|0|||
126713399|NCT00469014|455902106|FG001|Adaptive Randomization|No Response|1|||
126713400|NCT00469014|455902107|FG002|Adaptive Randomization|No Response|0|||
126713401|NCT00469014|455902108|FG003|Adaptive Randomization|No Response|0|||
126713402|NCT00469014|455902105|FG000|Adaptive Randomization|Death|0|||
126713403|NCT00469014|455902106|FG001|Adaptive Randomization|Death|0|||
126713404|NCT00469014|455902107|FG002|Adaptive Randomization|Death|1|||
126713405|NCT00469014|455902108|FG003|Adaptive Randomization|Death|0|||
126713406|NCT01632878|455902111|FG000|Screening|Physician Decision|268|||
126713407|NCT01632878|455902111|FG000|Treatment|Lost to Follow-up|41|||
126713408|NCT01632878|455902111|FG000|Treatment|Withdrawal by Subject|36|||
126713409|NCT01632878|455902111|FG000|Treatment|Physician Decision|34|||
126713410|NCT01632878|455902111|FG000|Treatment|missing information|4|||
126713411|NCT01632878|455902111|FG000|Treatment|no information on study completion|43|||
126713412|NCT00081289|455902112|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
126713413|NCT00081289|455902113|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
126713414|NCT00081289|455902112|FG000|Overall Study|Ineligible / no protocol treatment|3|||
126304299|NCT02644668|454402590|FG001|Overall Study|Protocol Violation|0|||
126304300|NCT02644668|454402591|FG002|Overall Study|Protocol Violation|1|||
126304301|NCT02644668|454402589|FG000|Overall Study|Withdrawal by Subject|0|||
126304302|NCT02644668|454402590|FG001|Overall Study|Withdrawal by Subject|0|||
126304303|NCT02644668|454402591|FG002|Overall Study|Withdrawal by Subject|1|||
126304304|NCT01134939|454402592|FG000|Overall Study|Adverse Event|9|||
126368116|NCT00725985|454642889|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368117|NCT00725985|454642890|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368118|NCT00725985|454642891|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368119|NCT00725985|454642892|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
126368120|NCT00725985|454642893|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368121|NCT00725985|454642894|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368122|NCT00725985|454642895|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368123|NCT00725985|454642896|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368124|NCT00725985|454642897|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368125|NCT00725985|454642898|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368126|NCT00725985|454642899|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368127|NCT00725985|454642900|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
126368128|NCT00725985|454642889|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368129|NCT00725985|454642890|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368130|NCT00725985|454642891|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368131|NCT00725985|454642892|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368132|NCT00725985|454642893|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368133|NCT00725985|454642894|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
126368134|NCT00725985|454642895|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368135|NCT00725985|454642896|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368136|NCT00725985|454642897|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368137|NCT00725985|454642898|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368138|NCT00725985|454642899|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368139|NCT00725985|454642900|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
126368140|NCT00725985|454642889|FG000|OLMP (Up to 96 Weeks)|Other|0|||
126368141|NCT00725985|454642890|FG001|OLMP (Up to 96 Weeks)|Other|0|||
126368142|NCT00725985|454642891|FG002|OLMP (Up to 96 Weeks)|Other|0|||
126713415|NCT00081289|455902113|FG001|Overall Study|Ineligible / no protocol treatment|4|||
126713416|NCT00916721|455902114|FG000|Overall Study|Lost to Follow-up|0|||
126304305|NCT01134939|454402593|FG001|Overall Study|Adverse Event|3|||
126304306|NCT01134939|454402594|FG002|Overall Study|Adverse Event|4|||
126463002|NCT04423939|454996975|FG000|Overall Study|Withdrawal by Subject|3|||
126463003|NCT04423939|454996976|FG001|Overall Study|Withdrawal by Subject|0|||
126304307|NCT01134939|454402595|FG003|Overall Study|Adverse Event|5|||
126304308|NCT01134939|454402596|FG004|Overall Study|Adverse Event|5|||
126304309|NCT01134939|454402597|FG005|Overall Study|Adverse Event|5|||
126304310|NCT01134939|454402598|FG006|Overall Study|Adverse Event|1|||
126304311|NCT01134939|454402599|FG007|Overall Study|Adverse Event|0|||
126304312|NCT01134939|454402592|FG000|Overall Study|Lack of Efficacy|2|||
126304313|NCT01134939|454402593|FG001|Overall Study|Lack of Efficacy|5|||
126304314|NCT01134939|454402594|FG002|Overall Study|Lack of Efficacy|1|||
126304315|NCT01134939|454402595|FG003|Overall Study|Lack of Efficacy|0|||
126304316|NCT01134939|454402596|FG004|Overall Study|Lack of Efficacy|3|||
126304317|NCT01134939|454402597|FG005|Overall Study|Lack of Efficacy|0|||
126304318|NCT01134939|454402598|FG006|Overall Study|Lack of Efficacy|1|||
126304319|NCT01134939|454402599|FG007|Overall Study|Lack of Efficacy|0|||
126304320|NCT01134939|454402592|FG000|Overall Study|Lost to Follow-up|2|||
126304321|NCT01134939|454402593|FG001|Overall Study|Lost to Follow-up|3|||
126304322|NCT01134939|454402594|FG002|Overall Study|Lost to Follow-up|0|||
126304323|NCT01134939|454402595|FG003|Overall Study|Lost to Follow-up|1|||
126304324|NCT01134939|454402596|FG004|Overall Study|Lost to Follow-up|2|||
126304325|NCT01134939|454402597|FG005|Overall Study|Lost to Follow-up|1|||
126304326|NCT01134939|454402598|FG006|Overall Study|Lost to Follow-up|0|||
126463004|NCT04423939|454996975|FG000|Overall Study|Caregiver to patient who died|0|||
126463005|NCT04423939|454996976|FG001|Overall Study|Caregiver to patient who died|3|||
126463006|NCT04423939|454996975|FG000|Overall Study|Caregiver to patient who withdrew|0|||
126463007|NCT04423939|454996976|FG001|Overall Study|Caregiver to patient who withdrew|3|||
126463008|NCT04626310|454996979|FG000|Overall Study|4-miss from treatment|6|||
126463009|NCT04626310|454996980|FG001|Overall Study|4-miss from treatment|5|||
126463010|NCT04626310|454996981|FG002|Overall Study|4-miss from treatment|5|||
126713417|NCT00916721|455902115|FG001|Overall Study|Lost to Follow-up|1|||
126713418|NCT00916721|455902114|FG000|Overall Study|Adverse Event|6|||
126713419|NCT00916721|455902115|FG001|Overall Study|Adverse Event|3|||
126304327|NCT01134939|454402599|FG007|Overall Study|Lost to Follow-up|0|||
126304328|NCT01134939|454402592|FG000|Overall Study|Death|0|||
126304329|NCT01134939|454402593|FG001|Overall Study|Death|1|||
126304330|NCT01134939|454402594|FG002|Overall Study|Death|0|||
126304331|NCT01134939|454402595|FG003|Overall Study|Death|0|||
126304332|NCT01134939|454402596|FG004|Overall Study|Death|0|||
126304333|NCT01134939|454402597|FG005|Overall Study|Death|0|||
126304334|NCT01134939|454402598|FG006|Overall Study|Death|0|||
126304335|NCT01134939|454402599|FG007|Overall Study|Death|0|||
126463011|NCT04626310|454996979|FG000|Overall Study|Withdrawal by Subject|1|||
126463012|NCT04626310|454996980|FG001|Overall Study|Withdrawal by Subject|0|||
126713420|NCT00916721|455902114|FG000|Overall Study|Withdrawal by Subject|2|||
126713421|NCT00916721|455902115|FG001|Overall Study|Withdrawal by Subject|2|||
126713422|NCT00916721|455902114|FG000|Overall Study|Protocol Violation|2|||
126713423|NCT00916721|455902115|FG001|Overall Study|Protocol Violation|4|||
126713424|NCT01469052|455902123|FG000|Overall Study|Adverse Event|2|||
126713425|NCT01469052|455902124|FG001|Overall Study|Adverse Event|3|||
126713426|NCT01469052|455902125|FG002|Overall Study|Adverse Event|0|||
126713427|NCT01469052|455902126|FG003|Overall Study|Adverse Event|2|||
126713428|NCT01469052|455902127|FG004|Overall Study|Adverse Event|0|||
126713429|NCT01469052|455902128|FG005|Overall Study|Adverse Event|1|||
126713430|NCT01469052|455902123|FG000|Overall Study|Progressive disease|3|||
126713431|NCT01469052|455902124|FG001|Overall Study|Progressive disease|0|||
126713432|NCT01469052|455902125|FG002|Overall Study|Progressive disease|5|||
126713433|NCT01469052|455902126|FG003|Overall Study|Progressive disease|3|||
126713434|NCT01469052|455902127|FG004|Overall Study|Progressive disease|7|||
126713435|NCT01469052|455902128|FG005|Overall Study|Progressive disease|2|||
126713436|NCT01469052|455902123|FG000|Overall Study|Lack of Efficacy|0|||
126713437|NCT01469052|455902124|FG001|Overall Study|Lack of Efficacy|0|||
126304336|NCT01134939|454402592|FG000|Overall Study|Termination page not available|4|||
126304337|NCT01134939|454402593|FG001|Overall Study|Termination page not available|6|||
126304338|NCT01134939|454402594|FG002|Overall Study|Termination page not available|5|||
126304339|NCT01134939|454402595|FG003|Overall Study|Termination page not available|8|||
126463013|NCT04626310|454996981|FG002|Overall Study|Withdrawal by Subject|3|||
126463014|NCT02278341|454996982|FG000|Overall Study|Randomized but never received study drug|1|||
126463015|NCT02278341|454996983|FG001|Overall Study|Randomized but never received study drug|1|||
126304340|NCT01134939|454402596|FG004|Overall Study|Termination page not available|0|||
126304341|NCT01134939|454402597|FG005|Overall Study|Termination page not available|3|||
126304342|NCT01134939|454402598|FG006|Overall Study|Termination page not available|7|||
126463016|NCT02278341|454996982|FG000|Overall Study|Adverse Event|3|||
126304343|NCT01134939|454402599|FG007|Overall Study|Termination page not available|0|||
126463017|NCT02278341|454996983|FG001|Overall Study|Adverse Event|0|||
126713438|NCT01469052|455902125|FG002|Overall Study|Lack of Efficacy|0|||
126713439|NCT01469052|455902126|FG003|Overall Study|Lack of Efficacy|0|||
126713440|NCT01469052|455902127|FG004|Overall Study|Lack of Efficacy|0|||
126551111|NCT00219141|455311817|FG001|Overall Study|Lack of Efficacy|2|||
126551112|NCT00219141|455311818|FG002|Overall Study|Lack of Efficacy|0|||
126551113|NCT00219141|455311816|FG000|Overall Study|Administrative problems|0|||
126551114|NCT00219141|455311817|FG001|Overall Study|Administrative problems|1|||
126551115|NCT00219141|455311818|FG002|Overall Study|Administrative problems|0|||
126304344|NCT00733421|454402600|FG000|Overall Study|Withdrawal by Subject|1|||
126304345|NCT00733421|454402601|FG001|Overall Study|Withdrawal by Subject|1|||
126304346|NCT02547220|454402607|FG000|Overall Study|Withdrawal by Subject|1|||
126304347|NCT02547220|454402608|FG001|Overall Study|Withdrawal by Subject|0|||
126304348|NCT02547220|454402607|FG000|Overall Study|Study terminated by sponsor|18|||
126304349|NCT02547220|454402608|FG001|Overall Study|Study terminated by sponsor|20|||
126304350|NCT00550043|454402609|FG000|Overall Study|Adverse Event|0|||
126304351|NCT00550043|454402610|FG001|Overall Study|Adverse Event|0|||
126551116|NCT00219141|455311816|FG000|Overall Study|Lost to Follow-up|2|||
126551117|NCT00219141|455311817|FG001|Overall Study|Lost to Follow-up|4|||
126551118|NCT00219141|455311818|FG002|Overall Study|Lost to Follow-up|1|||
126551119|NCT00219141|455311816|FG000|Overall Study|Protocol Violation|3|||
126551120|NCT00219141|455311817|FG001|Overall Study|Protocol Violation|1|||
126551121|NCT00219141|455311818|FG002|Overall Study|Protocol Violation|1|||
126551122|NCT00219141|455311816|FG000|Overall Study|Withdrawal by Subject|1|||
126551123|NCT00219141|455311817|FG001|Overall Study|Withdrawal by Subject|3|||
126551124|NCT00219141|455311818|FG002|Overall Study|Withdrawal by Subject|5|||
126551125|NCT00219141|455311816|FG000|Overall Study|Condition no longer requires study drug|1|||
126551126|NCT00219141|455311817|FG001|Overall Study|Condition no longer requires study drug|0|||
126551127|NCT00219141|455311818|FG002|Overall Study|Condition no longer requires study drug|0|||
126551128|NCT01088529|455311819|FG000|Overall Study|Did not receive study treatment|0|||
126551129|NCT01088529|455311820|FG001|Overall Study|Did not receive study treatment|1|||
126551130|NCT02838628|455311822|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
126551131|NCT02838628|455311823|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
126551132|NCT02838628|455311822|FG000|Recurrence Follow-up Period|Adverse Event|1|||
126551133|NCT02838628|455311823|FG001|Recurrence Follow-up Period|Adverse Event|0|||
126551134|NCT02838628|455311822|FG000|Recurrence Follow-up Period|Non-compliance|0|||
126551135|NCT02838628|455311823|FG001|Recurrence Follow-up Period|Non-compliance|1|||
126304352|NCT00550043|454402611|FG002|Overall Study|Adverse Event|0|||
126304353|NCT00550043|454402612|FG003|Overall Study|Adverse Event|1|||
126551136|NCT02838628|455311822|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
126551137|NCT02838628|455311823|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
126551138|NCT02838628|455311822|FG000|Recurrence Follow-up Period|Other un-specified|1|||
126551139|NCT02838628|455311823|FG001|Recurrence Follow-up Period|Other un-specified|1|||
126551140|NCT02066532|455311826|FG000|Phase II|Withdrawal by Subject|1|||
126551141|NCT02066532|455311827|FG001|Phase II|Withdrawal by Subject|0|||
126551142|NCT02066532|455311828|FG002|Phase II|Withdrawal by Subject|0|||
126551143|NCT02066532|455311829|FG003|Phase II|Withdrawal by Subject|0|||
126551144|NCT03560245|455311830|FG000|Overall Study|Withdrawal by Subject|3|||
126551145|NCT03560245|455311831|FG001|Overall Study|Withdrawal by Subject|2|||
126551146|NCT03560245|455311830|FG000|Overall Study|Adverse Event|1|||
126551147|NCT03560245|455311831|FG001|Overall Study|Adverse Event|1|||
126551148|NCT03560245|455311830|FG000|Overall Study|Protocol Violation|1|||
126551149|NCT03560245|455311831|FG001|Overall Study|Protocol Violation|0|||
126551150|NCT03560245|455311830|FG000|Overall Study|Death|0|||
126551151|NCT03560245|455311831|FG001|Overall Study|Death|1|||
126551152|NCT03560245|455311830|FG000|Overall Study|Lost to Follow-up|0|||
126551153|NCT03560245|455311831|FG001|Overall Study|Lost to Follow-up|1|||
126551154|NCT03560245|455311830|FG000|Overall Study|Physician Decision|0|||
126551155|NCT03560245|455311831|FG001|Overall Study|Physician Decision|1|||
126551156|NCT03560245|455311830|FG000|Overall Study|Other|0|||
126551157|NCT03560245|455311831|FG001|Overall Study|Other|1|||
126551158|NCT01265823|455311832|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
126551159|NCT01265823|455311832|FG000|Overall Study|Failure to Return|4|||
126304354|NCT00550043|454402613|FG004|Overall Study|Adverse Event|1|||
126304355|NCT00550043|454402609|FG000|Overall Study|Subject Withdrew Consent|0|||
126304356|NCT00550043|454402610|FG001|Overall Study|Subject Withdrew Consent|2|||
126551160|NCT01265823|455311832|FG000|Overall Study|Protocol Violation|1|||
126304357|NCT00550043|454402611|FG002|Overall Study|Subject Withdrew Consent|1|||
126304358|NCT00550043|454402612|FG003|Overall Study|Subject Withdrew Consent|0|||
126304359|NCT00550043|454402613|FG004|Overall Study|Subject Withdrew Consent|0|||
126304360|NCT00550043|454402609|FG000|Overall Study|Other Reasons- Unspecified|0|||
126304361|NCT00550043|454402610|FG001|Overall Study|Other Reasons- Unspecified|1|||
126304362|NCT00550043|454402611|FG002|Overall Study|Other Reasons- Unspecified|0|||
126304363|NCT00550043|454402612|FG003|Overall Study|Other Reasons- Unspecified|1|||
126551161|NCT01265823|455311832|FG000|Overall Study|Participant Request|1|||
126551162|NCT01018563|455311835|FG000|Overall Study|Termination of the study by Sponsor|2|||
126551163|NCT01018563|455311836|FG001|Overall Study|Termination of the study by Sponsor|1|||
126551164|NCT02855164|455311837|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
126304364|NCT00550043|454402613|FG004|Overall Study|Other Reasons- Unspecified|0|||
126304365|NCT02887183|454402615|FG000|Overall Study|Adverse Event|44|||
126551165|NCT02855164|455311838|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
126551166|NCT02855164|455311839|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
126551167|NCT02855164|455311840|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
126551168|NCT02855164|455311841|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
126551169|NCT02855164|455311842|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
126551170|NCT02855164|455311843|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
126551171|NCT02855164|455311844|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
126551172|NCT02855164|455311837|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
126551173|NCT02855164|455311838|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
126551174|NCT02855164|455311839|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
126551175|NCT02855164|455311840|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
126551176|NCT02855164|455311841|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
126551177|NCT02855164|455311842|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
126551178|NCT02855164|455311843|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
126713441|NCT01469052|455902128|FG005|Overall Study|Lack of Efficacy|2|||
126713442|NCT01469052|455902123|FG000|Overall Study|Moved to rollover protocol|1|||
126713443|NCT01469052|455902124|FG001|Overall Study|Moved to rollover protocol|0|||
126713444|NCT01469052|455902125|FG002|Overall Study|Moved to rollover protocol|1|||
126713445|NCT01469052|455902126|FG003|Overall Study|Moved to rollover protocol|0|||
126713446|NCT01469052|455902127|FG004|Overall Study|Moved to rollover protocol|0|||
126713447|NCT01469052|455902128|FG005|Overall Study|Moved to rollover protocol|1|||
126713448|NCT01469052|455902123|FG000|Overall Study|Other|0|||
126713449|NCT01469052|455902124|FG001|Overall Study|Other|1|||
126713450|NCT01469052|455902125|FG002|Overall Study|Other|0|||
126713451|NCT01469052|455902126|FG003|Overall Study|Other|0|||
126713452|NCT01469052|455902127|FG004|Overall Study|Other|1|||
126713453|NCT01469052|455902128|FG005|Overall Study|Other|0|||
126713454|NCT02749370|455902132|FG000|Overall Study|Withdrawal by Subject|11|||
126713455|NCT02749370|455902132|FG000|Overall Study|Lost to Follow-up|3|||
126713456|NCT01519427|455902136|FG000|Overall Study|disease progression|2|||
126713457|NCT03894904|455902137|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
126713458|NCT03894904|455902138|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
126713459|NCT03894904|455902137|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
126713460|NCT03894904|455902138|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
126713461|NCT03242759|455902139|FG000|Overall Study|Adverse Event|5|||
126713462|NCT03242759|455902140|FG001|Overall Study|Adverse Event|1|||
126713463|NCT03242759|455902139|FG000|Overall Study|Withdrawal by Subject|4|||
126713464|NCT03242759|455902140|FG001|Overall Study|Withdrawal by Subject|3|||
126713465|NCT03242759|455902139|FG000|Overall Study|Lost to Follow-up|3|||
126713466|NCT03242759|455902140|FG001|Overall Study|Lost to Follow-up|1|||
126713467|NCT03242759|455902139|FG000|Overall Study|Administrative problems|1|||
126713468|NCT03242759|455902140|FG001|Overall Study|Administrative problems|1|||
126713469|NCT03242759|455902139|FG000|Overall Study|Death|22|||
126713470|NCT03242759|455902140|FG001|Overall Study|Death|0|||
126713471|NCT03242759|455902139|FG000|Overall Study|Change visit schedule|0|||
126713472|NCT03242759|455902140|FG001|Overall Study|Change visit schedule|1|||
126713473|NCT00336492|455902149|FG000|Overall Study|Adverse Event|4|||
126713474|NCT00336492|455902150|FG001|Overall Study|Adverse Event|3|||
126713475|NCT00336492|455902151|FG002|Overall Study|Adverse Event|6|||
126713476|NCT00336492|455902149|FG000|Overall Study|Lack of Efficacy|6|||
126713477|NCT00336492|455902150|FG001|Overall Study|Lack of Efficacy|1|||
126713478|NCT00336492|455902151|FG002|Overall Study|Lack of Efficacy|4|||
126713479|NCT00336492|455902149|FG000|Overall Study|Other|5|||
126713480|NCT00336492|455902150|FG001|Overall Study|Other|0|||
126713481|NCT00336492|455902151|FG002|Overall Study|Other|1|||
126713482|NCT00227877|455902152|FG000|Pre-visit Assessment|Technical difficulties|7|||
126713483|NCT00227877|455902153|FG001|Pre-visit Assessment|Technical difficulties|3|||
126713484|NCT00227877|455902154|FG002|Pre-visit Assessment|Technical difficulties|0|||
126713485|NCT00227877|455902155|FG003|Pre-visit Assessment|Technical difficulties|0|||
126713486|NCT00227877|455902152|FG000|Post-visit Checklist|Lost to Follow-up|24|||
126713487|NCT00227877|455902153|FG001|Post-visit Checklist|Lost to Follow-up|13|||
126551179|NCT02855164|455311844|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
126551180|NCT02855164|455311837|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
126551181|NCT02855164|455311838|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
126713488|NCT00227877|455902154|FG002|Post-visit Checklist|Lost to Follow-up|1|||
126713489|NCT00227877|455902155|FG003|Post-visit Checklist|Lost to Follow-up|0|||
126713490|NCT00227877|455902152|FG000|3-months Follow-up|Completed late|135|||
126713491|NCT00227877|455902153|FG001|3-months Follow-up|Completed late|128|||
126713492|NCT00227877|455902154|FG002|3-months Follow-up|Completed late|34|||
126713493|NCT00227877|455902155|FG003|3-months Follow-up|Completed late|8|||
126713494|NCT00227877|455902152|FG000|3-months Follow-up|Lost to Follow-up|178|||
126713495|NCT00227877|455902153|FG001|3-months Follow-up|Lost to Follow-up|139|||
126713496|NCT00227877|455902154|FG002|3-months Follow-up|Lost to Follow-up|18|||
126713497|NCT00227877|455902155|FG003|3-months Follow-up|Lost to Follow-up|13|||
126304366|NCT02887183|454402615|FG000|Overall Study|Death|30|||
126304367|NCT02887183|454402615|FG000|Overall Study|Pregnancy|1|||
126304368|NCT02887183|454402615|FG000|Overall Study|Protocol Violation|6|||
126304369|NCT02887183|454402615|FG000|Overall Study|Technical Problems|2|||
126304370|NCT02887183|454402615|FG000|Overall Study|Lost to Follow-up|13|||
126304371|NCT02887183|454402615|FG000|Overall Study|Physician Decision|10|||
126304372|NCT02887183|454402615|FG000|Overall Study|Withdrawal by Subject|35|||
126304373|NCT01031680|454402616|FG000|Overall Study|Adverse Event|8|||
126713498|NCT00227877|455902152|FG000|12-months Follow-up|Completed late|78|||
126713499|NCT00227877|455902153|FG001|12-months Follow-up|Completed late|74|||
126713500|NCT00227877|455902154|FG002|12-months Follow-up|Completed late|1|||
126713501|NCT00227877|455902155|FG003|12-months Follow-up|Completed late|0|||
126713502|NCT00227877|455902152|FG000|12-months Follow-up|Lost to Follow-up|232|||
126713503|NCT00227877|455902153|FG001|12-months Follow-up|Lost to Follow-up|189|||
126713504|NCT00227877|455902154|FG002|12-months Follow-up|Lost to Follow-up|30|||
126713505|NCT00227877|455902155|FG003|12-months Follow-up|Lost to Follow-up|26|||
126713506|NCT02522481|455902158|FG000|Overall Study|discontinued|1|||
126713507|NCT02522481|455902158|FG000|Overall Study|Not dosed|2|||
126713508|NCT00404768|455902161|FG000|Part A and B|Withdrawn due to labor progression|1|||
126713509|NCT00404768|455902162|FG001|Part A and B|Withdrawn due to labor progression|0|||
126713510|NCT00404768|455902163|FG002|Part A and B|Withdrawn due to labor progression|0|||
126713511|NCT00404768|455902164|FG003|Part A and B|Withdrawn due to labor progression|0|||
126713512|NCT00404768|455902161|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
126713513|NCT00404768|455902162|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
126713514|NCT00404768|455902163|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
126713515|NCT00404768|455902164|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
126713516|NCT00404768|455902161|FG000|Part C|Adverse Event|0|||
126713517|NCT00404768|455902162|FG001|Part C|Adverse Event|0|||
126713518|NCT00404768|455902163|FG002|Part C|Adverse Event|0|||
126713519|NCT00404768|455902164|FG003|Part C|Adverse Event|3|||
126713520|NCT00404768|455902161|FG000|Part C|Lost to Follow-up|0|||
126713521|NCT00404768|455902162|FG001|Part C|Lost to Follow-up|0|||
126713522|NCT00404768|455902163|FG002|Part C|Lost to Follow-up|3|||
126713523|NCT00404768|455902164|FG003|Part C|Lost to Follow-up|1|||
126713524|NCT00404768|455902161|FG000|Part C|Withdrawal by Subject|0|||
126713525|NCT00404768|455902162|FG001|Part C|Withdrawal by Subject|0|||
126713526|NCT00404768|455902163|FG002|Part C|Withdrawal by Subject|2|||
126713527|NCT00404768|455902164|FG003|Part C|Withdrawal by Subject|1|||
126713528|NCT00404768|455902161|FG000|Part C|Early withdrawal from study medication|0|||
126713529|NCT00404768|455902162|FG001|Part C|Early withdrawal from study medication|0|||
126713530|NCT00404768|455902163|FG002|Part C|Early withdrawal from study medication|1|||
126713531|NCT00404768|455902164|FG003|Part C|Early withdrawal from study medication|0|||
126713532|NCT00404768|455902161|FG000|Part C|Participant did not respond to therapy|0|||
126713533|NCT00404768|455902162|FG001|Part C|Participant did not respond to therapy|0|||
126713534|NCT00404768|455902163|FG002|Part C|Participant did not respond to therapy|1|||
126713535|NCT00404768|455902164|FG003|Part C|Participant did not respond to therapy|1|||
126713536|NCT00404768|455902161|FG000|Part C|Physician withdrew the study medication|0|||
126713537|NCT00404768|455902162|FG001|Part C|Physician withdrew the study medication|0|||
126713538|NCT00404768|455902163|FG002|Part C|Physician withdrew the study medication|1|||
126713539|NCT00404768|455902164|FG003|Part C|Physician withdrew the study medication|0|||
126713540|NCT00404768|455902161|FG000|Part C|Participant delivered baby|0|||
126713541|NCT00404768|455902162|FG001|Part C|Participant delivered baby|0|||
126713542|NCT00404768|455902163|FG002|Part C|Participant delivered baby|0|||
126713543|NCT00404768|455902164|FG003|Part C|Participant delivered baby|1|||
126713544|NCT00404768|455902161|FG000|Part C|Unsatisfactory uterine response to IP|0|||
126713545|NCT00404768|455902162|FG001|Part C|Unsatisfactory uterine response to IP|0|||
126713546|NCT00404768|455902163|FG002|Part C|Unsatisfactory uterine response to IP|0|||
126713547|NCT00404768|455902164|FG003|Part C|Unsatisfactory uterine response to IP|1|||
126713548|NCT00404768|455902161|FG000|Part C|Active labor|0|||
126713549|NCT00404768|455902162|FG001|Part C|Active labor|0|||
126713550|NCT00404768|455902163|FG002|Part C|Active labor|0|||
126713551|NCT00404768|455902164|FG003|Part C|Active labor|1|||
126713552|NCT00404768|455902161|FG000|Part C|Lack of Efficacy|0|||
126713553|NCT00404768|455902162|FG001|Part C|Lack of Efficacy|0|||
126713554|NCT00404768|455902163|FG002|Part C|Lack of Efficacy|0|||
126713555|NCT00404768|455902164|FG003|Part C|Lack of Efficacy|2|||
126713556|NCT00404768|455902161|FG000|Part C|Treatment failure|0|||
126713557|NCT00404768|455902162|FG001|Part C|Treatment failure|0|||
126713558|NCT00404768|455902163|FG002|Part C|Treatment failure|0|||
126713559|NCT00404768|455902164|FG003|Part C|Treatment failure|1|||
126713560|NCT00404768|455902161|FG000|Part C|Investigator discretion|0|||
126713561|NCT00404768|455902162|FG001|Part C|Investigator discretion|0|||
126304374|NCT01031680|454402617|FG001|Overall Study|Adverse Event|3|||
126713562|NCT00404768|455902163|FG002|Part C|Investigator discretion|0|||
126713563|NCT00404768|455902164|FG003|Part C|Investigator discretion|1|||
126713564|NCT00404768|455902161|FG000|Part C|Researcher suspended study medication|0|||
126713565|NCT00404768|455902162|FG001|Part C|Researcher suspended study medication|0|||
126713566|NCT00404768|455902163|FG002|Part C|Researcher suspended study medication|0|||
126551182|NCT02855164|455311839|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
126551183|NCT02855164|455311840|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
126551184|NCT02855164|455311841|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
126551185|NCT02855164|455311842|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
126551186|NCT02855164|455311843|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
126551187|NCT02855164|455311844|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
126551188|NCT02855164|455311837|FG000|Part C (Randomized Set)|Adverse Event|0|||
126551189|NCT02855164|455311838|FG001|Part C (Randomized Set)|Adverse Event|0|||
126551190|NCT02855164|455311839|FG002|Part C (Randomized Set)|Adverse Event|0|||
126551191|NCT02855164|455311840|FG003|Part C (Randomized Set)|Adverse Event|0|||
126551192|NCT02855164|455311841|FG004|Part C (Randomized Set)|Adverse Event|0|||
126551193|NCT02855164|455311842|FG005|Part C (Randomized Set)|Adverse Event|5|||
126551194|NCT02855164|455311843|FG006|Part C (Randomized Set)|Adverse Event|9|||
126551195|NCT02855164|455311844|FG007|Part C (Randomized Set)|Adverse Event|2|||
126304375|NCT01031680|454402616|FG000|Overall Study|Lost to Follow-up|2|||
126304376|NCT01031680|454402617|FG001|Overall Study|Lost to Follow-up|10|||
126304377|NCT01031680|454402616|FG000|Overall Study|Withdrawal by Subject|12|||
126304378|NCT01031680|454402617|FG001|Overall Study|Withdrawal by Subject|16|||
126551196|NCT02855164|455311837|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
126551197|NCT02855164|455311838|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
126551198|NCT02855164|455311839|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
126551199|NCT02855164|455311840|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
126551200|NCT02855164|455311841|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
126551201|NCT02855164|455311842|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
126551202|NCT02855164|455311843|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
126551203|NCT02855164|455311844|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
126551204|NCT02855164|455311837|FG000|Part C (Randomized Set)|Physician Decision|0|||
126713567|NCT00404768|455902164|FG003|Part C|Researcher suspended study medication|1|||
126304379|NCT01031680|454402616|FG000|Overall Study|Death|2|||
126304380|NCT01031680|454402617|FG001|Overall Study|Death|1|||
126304381|NCT01031680|454402616|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
126304382|NCT01031680|454402617|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
126304383|NCT01031680|454402616|FG000|Overall Study|Poor/Non-compliance|5|||
126304384|NCT01031680|454402617|FG001|Overall Study|Poor/Non-compliance|6|||
126304385|NCT01031680|454402616|FG000|Overall Study|Safety|1|||
126551205|NCT02855164|455311838|FG001|Part C (Randomized Set)|Physician Decision|0|||
126304386|NCT01031680|454402617|FG001|Overall Study|Safety|0|||
126368143|NCT00725985|454642892|FG003|OLMP (Up to 96 Weeks)|Other|15|||
126368144|NCT00725985|454642893|FG004|OLMP (Up to 96 Weeks)|Other|20|||
126368145|NCT00725985|454642894|FG005|OLMP (Up to 96 Weeks)|Other|44|||
126368146|NCT00725985|454642895|FG006|OLMP (Up to 96 Weeks)|Other|0|||
126368147|NCT00725985|454642896|FG007|OLMP (Up to 96 Weeks)|Other|0|||
126368148|NCT00725985|454642897|FG008|OLMP (Up to 96 Weeks)|Other|0|||
126368149|NCT00725985|454642898|FG009|OLMP (Up to 96 Weeks)|Other|0|||
126368150|NCT00725985|454642899|FG010|OLMP (Up to 96 Weeks)|Other|0|||
126368151|NCT00725985|454642900|FG011|OLMP (Up to 96 Weeks)|Other|0|||
126368152|NCT00725985|454642889|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368153|NCT00725985|454642890|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368154|NCT00725985|454642891|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368155|NCT00725985|454642892|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368156|NCT00725985|454642893|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368157|NCT00725985|454642894|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368158|NCT00725985|454642895|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368159|NCT00725985|454642896|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
126368160|NCT00725985|454642897|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368161|NCT00725985|454642898|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368162|NCT00725985|454642899|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368163|NCT00725985|454642900|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
126368164|NCT00725985|454642889|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368165|NCT00725985|454642890|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368166|NCT00725985|454642891|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368167|NCT00725985|454642892|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368168|NCT00725985|454642893|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368169|NCT00725985|454642894|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368170|NCT00725985|454642895|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368171|NCT00725985|454642896|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368172|NCT00725985|454642897|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
126368173|NCT00725985|454642898|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368174|NCT00725985|454642899|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368175|NCT00725985|454642900|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
126368176|NCT00725985|454642889|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368177|NCT00725985|454642890|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368178|NCT00725985|454642891|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368179|NCT00725985|454642892|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368180|NCT00725985|454642893|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368181|NCT00725985|454642894|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368182|NCT00725985|454642895|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
126368183|NCT00725985|454642896|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
126463018|NCT02278341|454996982|FG000|Overall Study|Death|68|||
126463019|NCT02278341|454996983|FG001|Overall Study|Death|56|||
126463020|NCT02278341|454996982|FG000|Overall Study|Withdrawal by Subject|30|||
126463021|NCT02278341|454996983|FG001|Overall Study|Withdrawal by Subject|19|||
126463022|NCT02278341|454996982|FG000|Overall Study|Lost to Follow-up|0|||
126463023|NCT02278341|454996983|FG001|Overall Study|Lost to Follow-up|1|||
126463024|NCT02278341|454996982|FG000|Overall Study|Physician Decision|1|||
126463025|NCT02278341|454996983|FG001|Overall Study|Physician Decision|1|||
126463026|NCT02278341|454996982|FG000|Overall Study|Miscellaneous|15|||
126463027|NCT02278341|454996983|FG001|Overall Study|Miscellaneous|14|||
126463028|NCT02604017|454996984|FG000|Overall Study|Withdrew Consent|0|||
126463029|NCT02604017|454996985|FG001|Overall Study|Withdrew Consent|2|||
126463030|NCT02604017|454996984|FG000|Overall Study|Lost to Follow-up|5|||
126463031|NCT02604017|454996985|FG001|Overall Study|Lost to Follow-up|6|||
126463032|NCT02604017|454996984|FG000|Overall Study|Other|1|||
126463033|NCT02604017|454996985|FG001|Overall Study|Other|0|||
126463034|NCT00740246|454996986|FG000|Overall Study|Received Blood Transfusion|0|||
126463035|NCT00740246|454996987|FG001|Overall Study|Received Blood Transfusion|1|||
126463036|NCT00740246|454996986|FG000|Overall Study|Adverse Event|1|||
126463037|NCT00740246|454996987|FG001|Overall Study|Adverse Event|2|||
126463038|NCT00740246|454996986|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
126463039|NCT00740246|454996987|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
126463040|NCT00740246|454996986|FG000|Overall Study|Lost to Follow-up|2|||
126463041|NCT00740246|454996987|FG001|Overall Study|Lost to Follow-up|2|||
126463042|NCT00740246|454996986|FG000|Overall Study|Withdrawal by Subject|4|||
126463043|NCT00740246|454996987|FG001|Overall Study|Withdrawal by Subject|3|||
126463044|NCT00740246|454996986|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
126463045|NCT00740246|454996987|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
126463046|NCT00740246|454996986|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
126463047|NCT00740246|454996987|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
126463048|NCT00740246|454996986|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
126463049|NCT00740246|454996987|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
126463050|NCT00740246|454996986|FG000|Overall Study|Unable To Comply With Study Visits|2|||
126463051|NCT00740246|454996987|FG001|Overall Study|Unable To Comply With Study Visits|0|||
126463052|NCT00740246|454996986|FG000|Overall Study|Unable to Access Vein|0|||
126463053|NCT00740246|454996987|FG001|Overall Study|Unable to Access Vein|2|||
126463054|NCT00740246|454996986|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
126463055|NCT00740246|454996987|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
126463056|NCT02821910|454996990|FG000|Overall Study|Withdrawal by Subject|0|||
126463057|NCT02821910|454996991|FG001|Overall Study|Withdrawal by Subject|0|||
126463058|NCT02821910|454996992|FG002|Overall Study|Withdrawal by Subject|1|||
126463059|NCT02821910|454996993|FG003|Overall Study|Withdrawal by Subject|0|||
126463060|NCT02821910|454996994|FG004|Overall Study|Withdrawal by Subject|0|||
126463061|NCT02821910|454996995|FG005|Overall Study|Withdrawal by Subject|1|||
126463062|NCT02821910|454996990|FG000|Overall Study|Other than specified|1|||
126463063|NCT02821910|454996991|FG001|Overall Study|Other than specified|0|||
126463064|NCT02821910|454996992|FG002|Overall Study|Other than specified|1|||
126463065|NCT02821910|454996993|FG003|Overall Study|Other than specified|0|||
126463066|NCT02821910|454996994|FG004|Overall Study|Other than specified|0|||
126463067|NCT02821910|454996995|FG005|Overall Study|Other than specified|0|||
126463068|NCT00287079|454996996|FG000|Overall Study|Qualifying relapse|12|||
126463069|NCT00287079|454996997|FG001|Overall Study|Qualifying relapse|1|||
126463070|NCT00287079|454996996|FG000|Overall Study|Non-qualifying relapse|1|||
126463071|NCT00287079|454996997|FG001|Overall Study|Non-qualifying relapse|0|||
126463072|NCT00287079|454996996|FG000|Overall Study|Adverse Event|5|||
126463073|NCT00287079|454996997|FG001|Overall Study|Adverse Event|0|||
126463074|NCT00287079|454996996|FG000|Overall Study|Protocol Violation|1|||
126463075|NCT00287079|454996997|FG001|Overall Study|Protocol Violation|0|||
126463076|NCT00287079|454996996|FG000|Overall Study|Other|3|||
126368184|NCT00725985|454642897|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
126368185|NCT00725985|454642898|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368186|NCT00725985|454642899|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126463077|NCT00287079|454996997|FG001|Overall Study|Other|0|||
126463078|NCT01082640|454996998|FG000|Overall Study|Adverse Event|9|||
126463079|NCT01082640|454996999|FG001|Overall Study|Adverse Event|5|||
126463080|NCT01082640|454997000|FG002|Overall Study|Adverse Event|3|||
126463081|NCT01082640|454996998|FG000|Overall Study|Withdrawal by Subject|3|||
126463082|NCT01082640|454996999|FG001|Overall Study|Withdrawal by Subject|3|||
126551206|NCT02855164|455311839|FG002|Part C (Randomized Set)|Physician Decision|0|||
126551207|NCT02855164|455311840|FG003|Part C (Randomized Set)|Physician Decision|0|||
126551208|NCT02855164|455311841|FG004|Part C (Randomized Set)|Physician Decision|0|||
126551209|NCT02855164|455311842|FG005|Part C (Randomized Set)|Physician Decision|1|||
126551210|NCT02855164|455311843|FG006|Part C (Randomized Set)|Physician Decision|0|||
126551211|NCT02855164|455311844|FG007|Part C (Randomized Set)|Physician Decision|1|||
126551212|NCT02855164|455311837|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
126551213|NCT02855164|455311838|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
126551214|NCT02855164|455311839|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
126551215|NCT02855164|455311840|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
126551216|NCT02855164|455311841|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
126551217|NCT02855164|455311842|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
126551218|NCT02855164|455311843|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
126551219|NCT02855164|455311844|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
126551220|NCT00383240|455311845|FG000|Overall Study|Adverse Event|4|||
126551221|NCT00383240|455311846|FG001|Overall Study|Adverse Event|6|||
126551222|NCT00383240|455311847|FG002|Overall Study|Adverse Event|9|||
126551223|NCT00383240|455311848|FG003|Overall Study|Adverse Event|7|||
126551224|NCT00383240|455311845|FG000|Overall Study|Treatment Failure|8|||
126551225|NCT00383240|455311846|FG001|Overall Study|Treatment Failure|13|||
126551226|NCT00383240|455311847|FG002|Overall Study|Treatment Failure|47|||
126551227|NCT00383240|455311848|FG003|Overall Study|Treatment Failure|46|||
126551228|NCT00383240|455311845|FG000|Overall Study|Lost to Follow-up|3|||
126304387|NCT01031680|454402616|FG000|Overall Study|Incorrect Enrolment|1|||
126304388|NCT01031680|454402617|FG001|Overall Study|Incorrect Enrolment|2|||
126304389|NCT01031680|454402616|FG000|Overall Study|Administrative Reason by Sponsor|0|||
126551229|NCT00383240|455311846|FG001|Overall Study|Lost to Follow-up|0|||
126551230|NCT00383240|455311847|FG002|Overall Study|Lost to Follow-up|0|||
126551231|NCT00383240|455311848|FG003|Overall Study|Lost to Follow-up|2|||
126304390|NCT01031680|454402617|FG001|Overall Study|Administrative Reason by Sponsor|1|||
126304391|NCT01031680|454402616|FG000|Overall Study|Various|0|||
126304392|NCT01031680|454402617|FG001|Overall Study|Various|2|||
126551232|NCT00383240|455311845|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
126551233|NCT00383240|455311846|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
126551234|NCT00383240|455311847|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
126551235|NCT00383240|455311848|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
126551236|NCT00383240|455311845|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
126304393|NCT02654977|454402622|FG000|Overall Study|Death|1|||
126551237|NCT00383240|455311846|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
126551238|NCT00383240|455311847|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
126304394|NCT02654977|454402622|FG000|Overall Study|Lost to Follow-up|1|||
126304395|NCT02654977|454402622|FG000|Overall Study|Adverse Event|1|||
126304396|NCT02654977|454402622|FG000|Overall Study|Withdrawal by Subject|1|||
126304397|NCT02654977|454402622|FG000|Overall Study|Lack of Efficacy|3|||
126304398|NCT01921101|454402623|FG000|Overall Study|Death|16|||
126304399|NCT01921101|454402624|FG001|Overall Study|Death|6|||
126304400|NCT01483027|454402625|FG000|Overall Study|Administrative Reasons|2|||
126304401|NCT01483027|454402626|FG001|Overall Study|Administrative Reasons|1|||
126304402|NCT01483027|454402625|FG000|Overall Study|Withdrawal by Subject|21|||
126304403|NCT01483027|454402626|FG001|Overall Study|Withdrawal by Subject|32|||
126304404|NCT01483027|454402625|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
126304405|NCT01483027|454402626|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
126304406|NCT01483027|454402625|FG000|Overall Study|Lost to Follow-up|1|||
126304407|NCT01483027|454402626|FG001|Overall Study|Lost to Follow-up|1|||
126304408|NCT01483027|454402625|FG000|Overall Study|Adverse Event|0|||
126304409|NCT01483027|454402626|FG001|Overall Study|Adverse Event|1|||
126304410|NCT01483027|454402625|FG000|Overall Study|Withdrawal by Subject|0|||
126304411|NCT01483027|454402626|FG001|Overall Study|Withdrawal by Subject|1|||
126304412|NCT03300505|454404208|FG000|Overall Study|Death|0|||
126304413|NCT03300505|454404209|FG001|Overall Study|Death|1|||
126304414|NCT03300505|454404210|FG002|Overall Study|Death|0|||
126304415|NCT03300505|454404208|FG000|Overall Study|Withdrawal by Subject|0|||
126304416|NCT03300505|454404209|FG001|Overall Study|Withdrawal by Subject|1|||
126304417|NCT03300505|454404210|FG002|Overall Study|Withdrawal by Subject|1|||
126304418|NCT03300505|454404208|FG000|Overall Study|Sponsor Termination|0|||
126304419|NCT03300505|454404209|FG001|Overall Study|Sponsor Termination|1|||
126304420|NCT03300505|454404210|FG002|Overall Study|Sponsor Termination|0|||
126304421|NCT03300505|454404208|FG000|Overall Study|Adverse Event|0|||
126304422|NCT03300505|454404209|FG001|Overall Study|Adverse Event|0|||
126304423|NCT03300505|454404210|FG002|Overall Study|Adverse Event|2|||
126304424|NCT00679029|454404211|FG000|Overall Study|Adverse Event|3|||
126304425|NCT00679029|454404211|FG000|Overall Study|Withdrawal by Subject|1|||
126304426|NCT00679029|454404211|FG000|Overall Study|Lost to Follow-up|1|||
126304427|NCT01108341|454404212|FG000|Overall Study|Death|2|||
126304428|NCT01108341|454404212|FG000|Overall Study|Withdrawal by Subject|1|||
126304429|NCT01108341|454404212|FG000|Overall Study|Lost to Follow-up|1|||
126304430|NCT01108341|454404212|FG000|Overall Study|Other|1|||
126304431|NCT01718535|454404215|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
126304432|NCT01718535|454404216|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
126304433|NCT01718535|454404217|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
126304434|NCT01718535|454404218|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
126304435|NCT01718535|454404219|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
126463083|NCT01082640|454997000|FG002|Overall Study|Withdrawal by Subject|2|||
126463084|NCT01082640|454996998|FG000|Overall Study|Major protocol deviation|3|||
126463085|NCT01082640|454996999|FG001|Overall Study|Major protocol deviation|3|||
126463086|NCT01082640|454997000|FG002|Overall Study|Major protocol deviation|0|||
126463087|NCT01082640|454996998|FG000|Overall Study|Lost to Follow-up|0|||
126463088|NCT01082640|454996999|FG001|Overall Study|Lost to Follow-up|3|||
126463089|NCT01082640|454997000|FG002|Overall Study|Lost to Follow-up|0|||
126463090|NCT01082640|454996998|FG000|Overall Study|Other|2|||
126463091|NCT01082640|454996999|FG001|Overall Study|Other|1|||
126463092|NCT01082640|454997000|FG002|Overall Study|Other|3|||
126463093|NCT02011893|454997003|FG000|Enrollment to Randomization|Adverse Event|2|||
126463094|NCT02011893|454997004|FG001|Enrollment to Randomization|Adverse Event|0|||
126463095|NCT02011893|454997005|FG002|Enrollment to Randomization|Adverse Event|0|||
126463096|NCT02011893|454997003|FG000|Enrollment to Randomization|Physician Decision|10|||
126463097|NCT02011893|454997004|FG001|Enrollment to Randomization|Physician Decision|0|||
126463098|NCT02011893|454997005|FG002|Enrollment to Randomization|Physician Decision|0|||
126463099|NCT02011893|454997003|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
126463100|NCT02011893|454997004|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
126463101|NCT02011893|454997005|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
126463102|NCT02011893|454997003|FG000|Enrollment to Randomization|Screening Failure|29|||
126463103|NCT02011893|454997004|FG001|Enrollment to Randomization|Screening Failure|0|||
126463104|NCT02011893|454997005|FG002|Enrollment to Randomization|Screening Failure|0|||
126463105|NCT02011893|454997003|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
126463106|NCT02011893|454997004|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
126463107|NCT02011893|454997005|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
126463108|NCT02011893|454997003|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
126463109|NCT02011893|454997004|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
126463110|NCT02011893|454997005|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
126463111|NCT02011893|454997003|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
126463112|NCT02011893|454997004|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
126463113|NCT02011893|454997005|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
126463114|NCT02011893|454997003|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
126304436|NCT01718535|454404220|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
126463115|NCT02011893|454997004|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
126463116|NCT02011893|454997005|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
126463117|NCT02011893|454997003|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
126463118|NCT02011893|454997004|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
126463119|NCT02011893|454997005|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
126463120|NCT01289782|454997006|FG000|Overall Study|Lost to Follow-up|14|||
126463121|NCT01289782|454997007|FG001|Overall Study|Lost to Follow-up|7|||
126463122|NCT01289782|454997006|FG000|Overall Study|Protocol Violation|1|||
126463123|NCT01289782|454997007|FG001|Overall Study|Protocol Violation|1|||
126463124|NCT01289782|454997006|FG000|Overall Study|Withdrawal by Subject|8|||
126463125|NCT01289782|454997007|FG001|Overall Study|Withdrawal by Subject|2|||
126463126|NCT01289782|454997006|FG000|Overall Study|Sponsor's Decision|1|||
126463127|NCT01289782|454997007|FG001|Overall Study|Sponsor's Decision|0|||
126463128|NCT01289782|454997006|FG000|Overall Study|Reason not specified|1|||
126463129|NCT01289782|454997007|FG001|Overall Study|Reason not specified|2|||
126463130|NCT01241240|454997008|FG000|Overall Study|Adverse Event|5|||
126463131|NCT01241240|454997009|FG001|Overall Study|Adverse Event|4|||
126463132|NCT01241240|454997008|FG000|Overall Study|Lost to Follow-up|2|||
126463133|NCT01241240|454997009|FG001|Overall Study|Lost to Follow-up|4|||
126463134|NCT01241240|454997008|FG000|Overall Study|Personal Reasons|1|||
126463135|NCT01241240|454997009|FG001|Overall Study|Personal Reasons|1|||
126463136|NCT00542451|454997017|FG000|Overall Study|Adverse Event|31|||
126715190|NCT01052012|455908711|FG005|Overall Study|Withdrawal by Subject|1|||
126304437|NCT01718535|454404221|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
126304438|NCT01718535|454404222|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
126304439|NCT01718535|454404223|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
126463137|NCT00542451|454997017|FG000|Overall Study|Withdrawal by Subject|30|||
126463138|NCT00542451|454997017|FG000|Overall Study|Physician Decision|4|||
126463139|NCT00542451|454997017|FG000|Overall Study|Recurrent disease|1|||
126463140|NCT00542451|454997017|FG000|Overall Study|unknown reason|1|||
126463141|NCT00542451|454997017|FG000|Overall Study|Death|2|||
126715191|NCT01052012|455908706|FG000|Overall Study|Physician Decision|0|||
126304440|NCT01718535|454404224|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
126551239|NCT00383240|455311848|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
126551240|NCT00383240|455311845|FG000|Overall Study|Protocol Violation|4|||
126551241|NCT00383240|455311846|FG001|Overall Study|Protocol Violation|5|||
126551242|NCT00383240|455311847|FG002|Overall Study|Protocol Violation|9|||
126551243|NCT00383240|455311848|FG003|Overall Study|Protocol Violation|6|||
126551244|NCT00383240|455311845|FG000|Overall Study|Did not meet protocol eligibility|9|||
126551245|NCT00383240|455311846|FG001|Overall Study|Did not meet protocol eligibility|4|||
126551246|NCT00383240|455311847|FG002|Overall Study|Did not meet protocol eligibility|9|||
126551247|NCT00383240|455311848|FG003|Overall Study|Did not meet protocol eligibility|3|||
126551248|NCT00383240|455311845|FG000|Overall Study|Administrative|1|||
126551249|NCT00383240|455311846|FG001|Overall Study|Administrative|1|||
126551250|NCT00383240|455311847|FG002|Overall Study|Administrative|0|||
126551251|NCT00383240|455311848|FG003|Overall Study|Administrative|0|||
126551252|NCT00547911|455311852|FG000|Overall Study|Adverse Event|0|||
126551253|NCT00547911|455311853|FG001|Overall Study|Adverse Event|0|||
126551254|NCT00547911|455311854|FG002|Overall Study|Adverse Event|0|||
126551255|NCT00547911|455311855|FG003|Overall Study|Adverse Event|1|||
126551256|NCT00547911|455311856|FG004|Overall Study|Adverse Event|0|||
126551257|NCT00547911|455311857|FG005|Overall Study|Adverse Event|0|||
126551258|NCT01644474|455311858|FG000|Overall Study|Poor compliance to protocol|1|||
126551259|NCT01644474|455311859|FG001|Overall Study|Poor compliance to protocol|0|||
126551260|NCT01644474|455311858|FG000|Overall Study|Consent withdrawn by participant|0|||
126551261|NCT01644474|455311859|FG001|Overall Study|Consent withdrawn by participant|1|||
126551262|NCT01644474|455311858|FG000|Overall Study|Participant moved|0|||
126551263|NCT01644474|455311859|FG001|Overall Study|Participant moved|1|||
126551264|NCT01644474|455311858|FG000|Overall Study|Adverse Event|4|||
126551265|NCT01644474|455311859|FG001|Overall Study|Adverse Event|5|||
126551266|NCT01644474|455311858|FG000|Overall Study|Site scheduling error|1|||
126551267|NCT01644474|455311859|FG001|Overall Study|Site scheduling error|1|||
126551268|NCT01644474|455311858|FG000|Overall Study|Protocol Violation|1|||
126551269|NCT01644474|455311859|FG001|Overall Study|Protocol Violation|0|||
126551270|NCT02023879|455311860|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
126551271|NCT02023879|455311861|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
126551272|NCT02023879|455311862|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
126551273|NCT02023879|455311860|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
126551274|NCT02023879|455311861|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
126551275|NCT02023879|455311862|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
126551276|NCT02023879|455311860|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
126551277|NCT02023879|455311861|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
126551278|NCT02023879|455311862|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
126551279|NCT02023879|455311860|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
126551280|NCT02023879|455311861|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
126551281|NCT02023879|455311862|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
126551282|NCT02023879|455311860|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
126304441|NCT01073605|454404228|FG000|Overall Study|Ongoing at Cutoff Date|1|||
126304442|NCT01073605|454404229|FG001|Overall Study|Ongoing at Cutoff Date|1|||
126304443|NCT01073605|454404230|FG002|Overall Study|Ongoing at Cutoff Date|0|||
126304444|NCT01073605|454404228|FG000|Overall Study|Adverse Event|2|||
126463142|NCT00542451|454997017|FG000|Overall Study|Lost to Follow-up|10|||
126463143|NCT01582854|454997018|FG000|Overall Study|Death|8|||
126463144|NCT01582854|454997019|FG001|Overall Study|Death|5|||
126463145|NCT01582854|454997018|FG000|Overall Study|Adverse Event|2|||
126463146|NCT01582854|454997019|FG001|Overall Study|Adverse Event|3|||
126463147|NCT01582854|454997018|FG000|Overall Study|Withdrawal by Participant|8|||
126463148|NCT01582854|454997019|FG001|Overall Study|Withdrawal by Participant|11|||
126463149|NCT01582854|454997018|FG000|Overall Study|Lost to Follow-up|1|||
126463150|NCT01582854|454997019|FG001|Overall Study|Lost to Follow-up|2|||
126463151|NCT01582854|454997018|FG000|Overall Study|Physician Decision|0|||
126463152|NCT01582854|454997019|FG001|Overall Study|Physician Decision|1|||
126463153|NCT01582854|454997018|FG000|Overall Study|Recurrent Stroke|13|||
126463154|NCT01582854|454997019|FG001|Overall Study|Recurrent Stroke|8|||
126463155|NCT01582854|454997018|FG000|Overall Study|Disallowed Concomitant Medication|3|||
126463156|NCT01582854|454997019|FG001|Overall Study|Disallowed Concomitant Medication|2|||
126463157|NCT01582854|454997018|FG000|Overall Study|Carotid or Neurosurgery|0|||
126463158|NCT01582854|454997019|FG001|Overall Study|Carotid or Neurosurgery|1|||
126463159|NCT01582854|454997018|FG000|Overall Study|General Anaesthesia|0|||
126463160|NCT01582854|454997019|FG001|Overall Study|General Anaesthesia|1|||
126463161|NCT01582854|454997018|FG000|Overall Study|Other Miscellaneous Reason|1|||
126463162|NCT01582854|454997019|FG001|Overall Study|Other Miscellaneous Reason|0|||
126551283|NCT02023879|455311861|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
126551284|NCT02023879|455311862|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
126551285|NCT02023879|455311860|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
126551286|NCT02023879|455311861|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
126551287|NCT02023879|455311862|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
126551288|NCT02023879|455311860|FG000|Extension Open Label Treatment|Adverse Event|1|||
126551289|NCT02023879|455311861|FG001|Extension Open Label Treatment|Adverse Event|7|||
126551290|NCT02023879|455311862|FG002|Extension Open Label Treatment|Adverse Event|3|||
126551291|NCT02023879|455311860|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
126551292|NCT02023879|455311861|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
126551293|NCT02023879|455311862|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
126551294|NCT02023879|455311860|FG000|Extension Open Label Treatment|Participant moved|1|||
126551295|NCT02023879|455311861|FG001|Extension Open Label Treatment|Participant moved|2|||
126551296|NCT02023879|455311862|FG002|Extension Open Label Treatment|Participant moved|0|||
126551297|NCT02023879|455311860|FG000|Extension Open Label Treatment|Other than specified above|2|||
126551298|NCT02023879|455311861|FG001|Extension Open Label Treatment|Other than specified above|7|||
126551299|NCT02023879|455311862|FG002|Extension Open Label Treatment|Other than specified above|2|||
126551300|NCT02044458|455311866|FG000|Overall Study|Protocol Violation|3|||
126551301|NCT02044458|455311867|FG001|Overall Study|Protocol Violation|8|||
126551302|NCT02601937|455311868|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
126551303|NCT02601937|455311869|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
126551304|NCT02601937|455311870|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
126551305|NCT02601937|455311871|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
126551306|NCT02601937|455311872|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
126551307|NCT02601937|455311873|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
126551308|NCT02601937|455311874|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
126551309|NCT02601937|455311875|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
126551310|NCT02601937|455311876|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
126551311|NCT02601937|455311877|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
126551312|NCT02601937|455311878|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
126551313|NCT02601937|455311868|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
126551314|NCT02601937|455311869|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
126551315|NCT02601937|455311870|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
126551316|NCT02601937|455311871|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
126551317|NCT02601937|455311872|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
126551318|NCT02601937|455311873|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
126551319|NCT02601937|455311874|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
126551320|NCT02601937|455311875|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
126551321|NCT02601937|455311876|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
126551322|NCT02601937|455311877|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
126551323|NCT02601937|455311878|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
126551324|NCT02601937|455311868|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
126551325|NCT02601937|455311869|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
126551326|NCT02601937|455311870|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
126551327|NCT02601937|455311871|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
126551328|NCT02601937|455311872|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
126551329|NCT02601937|455311873|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
126551330|NCT02601937|455311874|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
126551331|NCT02601937|455311875|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
126551332|NCT02601937|455311876|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
126551333|NCT02601937|455311877|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
126551334|NCT02601937|455311878|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
126551335|NCT02601937|455311868|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
126551336|NCT02601937|455311869|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
126551337|NCT02601937|455311870|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
126551338|NCT02601937|455311871|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
126551339|NCT02601937|455311872|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
126551340|NCT02601937|455311873|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
126551341|NCT02601937|455311874|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
126551342|NCT02601937|455311875|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
126551343|NCT02601937|455311876|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
126551344|NCT02601937|455311877|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
126551345|NCT02601937|455311878|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
126551346|NCT02601937|455311868|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
126551347|NCT02601937|455311869|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
126551348|NCT02601937|455311870|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
126551349|NCT02601937|455311871|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
126551350|NCT02601937|455311872|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
126463163|NCT02652767|454997024|FG000|Overall Study|Death|2|||
126463164|NCT02652767|454997024|FG000|Overall Study|Lost to Follow-up|1|||
126463165|NCT02652767|454997024|FG000|Overall Study|Withdrawal by Subject|1|||
126463166|NCT00322153|454997033|FG000|Overall Study|Adverse Event|21|||
126463167|NCT00322153|454997034|FG001|Overall Study|Adverse Event|34|||
126463168|NCT00322153|454997033|FG000|Overall Study|Protocol Violation|6|||
126463169|NCT00322153|454997034|FG001|Overall Study|Protocol Violation|14|||
126463170|NCT00322153|454997033|FG000|Overall Study|Withdrawal by Subject|18|||
126463171|NCT00322153|454997034|FG001|Overall Study|Withdrawal by Subject|10|||
126463172|NCT00322153|454997033|FG000|Overall Study|Lack of Efficacy|8|||
126463173|NCT00322153|454997034|FG001|Overall Study|Lack of Efficacy|3|||
126463174|NCT00322153|454997033|FG000|Overall Study|Lost to Follow-up|5|||
126463175|NCT00322153|454997034|FG001|Overall Study|Lost to Follow-up|4|||
126463176|NCT00322153|454997033|FG000|Overall Study|Withdrawn for other reasons|5|||
126463177|NCT00322153|454997034|FG001|Overall Study|Withdrawn for other reasons|4|||
126463178|NCT01309893|454997035|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
126463179|NCT01309893|454997036|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
126463180|NCT01309893|454997035|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
126463181|NCT01309893|454997036|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
126463182|NCT02632838|454997037|FG000|Overall Study|Withdrawal by Subject|3|||
126463183|NCT02632838|454997038|FG001|Overall Study|Withdrawal by Subject|0|||
126463184|NCT02632838|454997037|FG000|Overall Study|Lost to Follow-up|0|||
126463185|NCT02632838|454997038|FG001|Overall Study|Lost to Follow-up|2|||
126463186|NCT03631355|454997039|FG000|Overall Study|Lost to Follow-up|1|||
126463187|NCT03631355|454997040|FG001|Overall Study|Lost to Follow-up|2|||
126463188|NCT02810340|454997041|FG000|Overall Study|Withdrawal by Subject|1|||
126463189|NCT02810340|454997042|FG001|Overall Study|Withdrawal by Subject|0|||
126463190|NCT02810340|454997043|FG002|Overall Study|Withdrawal by Subject|0|||
126463191|NCT02810340|454997041|FG000|Overall Study|Incarceration|0|||
126463192|NCT02810340|454997042|FG001|Overall Study|Incarceration|1|||
126463193|NCT02810340|454997043|FG002|Overall Study|Incarceration|0|||
126463194|NCT02810340|454997041|FG000|Overall Study|Lost to Follow-up|0|||
126463195|NCT02810340|454997042|FG001|Overall Study|Lost to Follow-up|0|||
126463196|NCT02810340|454997043|FG002|Overall Study|Lost to Follow-up|1|||
126463197|NCT01233687|454997045|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
126463198|NCT01233687|454997045|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
126463199|NCT01233687|454997045|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
126463200|NCT02942576|454997046|FG000|Overall Study|Adverse Event|28|||
126463201|NCT02942576|454997047|FG001|Overall Study|Adverse Event|6|||
126463202|NCT02942576|454997046|FG000|Overall Study|Withdrawal by Subject|7|||
126463203|NCT02942576|454997047|FG001|Overall Study|Withdrawal by Subject|5|||
126463204|NCT02942576|454997046|FG000|Overall Study|Physician Decision|1|||
126463205|NCT02942576|454997047|FG001|Overall Study|Physician Decision|4|||
126463206|NCT02942576|454997046|FG000|Overall Study|Other|10|||
126463207|NCT02942576|454997047|FG001|Overall Study|Other|8|||
126463208|NCT01227564|454997051|FG000|Overall Study|No Longer Willing to Participate|4|||
126463209|NCT01227564|454997052|FG001|Overall Study|No Longer Willing to Participate|2|||
126463210|NCT01227564|454997053|FG002|Overall Study|No Longer Willing to Participate|5|||
126463211|NCT01227564|454997051|FG000|Overall Study|Participant moved to another town|0|||
126463212|NCT01227564|454997052|FG001|Overall Study|Participant moved to another town|0|||
126463213|NCT01227564|454997053|FG002|Overall Study|Participant moved to another town|1|||
126463214|NCT01017575|454997056|FG000|Overall Study|Lack of Efficacy|0|||
126463215|NCT01017575|454997057|FG001|Overall Study|Lack of Efficacy|1|||
126463216|NCT01017575|454997058|FG002|Overall Study|Lack of Efficacy|0|||
126463217|NCT01017575|454997059|FG003|Overall Study|Lack of Efficacy|1|||
126463218|NCT01017575|454997060|FG004|Overall Study|Lack of Efficacy|1|||
126463219|NCT01017575|454997056|FG000|Overall Study|Adverse Event|0|||
126463220|NCT01017575|454997057|FG001|Overall Study|Adverse Event|1|||
126463221|NCT01017575|454997058|FG002|Overall Study|Adverse Event|0|||
126463222|NCT01017575|454997059|FG003|Overall Study|Adverse Event|0|||
126463223|NCT01017575|454997060|FG004|Overall Study|Adverse Event|2|||
126463224|NCT01017575|454997056|FG000|Overall Study|Withdrawal by Subject|1|||
126463225|NCT01017575|454997057|FG001|Overall Study|Withdrawal by Subject|0|||
126463226|NCT01017575|454997058|FG002|Overall Study|Withdrawal by Subject|0|||
126713568|NCT05094154|455903758|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
126463227|NCT01017575|454997059|FG003|Overall Study|Withdrawal by Subject|0|||
126463228|NCT01017575|454997060|FG004|Overall Study|Withdrawal by Subject|0|||
126463229|NCT00495131|454997061|FG000|Overall Study|Adverse Event|6|||
126463230|NCT00495131|454997062|FG001|Overall Study|Adverse Event|2|||
126463231|NCT00495131|454997061|FG000|Overall Study|Lack of Efficacy|0|||
126463232|NCT00495131|454997062|FG001|Overall Study|Lack of Efficacy|2|||
126463233|NCT00495131|454997061|FG000|Overall Study|Lost to Follow-up|0|||
126463234|NCT00495131|454997062|FG001|Overall Study|Lost to Follow-up|2|||
126463235|NCT00495131|454997061|FG000|Overall Study|Withdrawal by Subject|1|||
126463236|NCT00495131|454997062|FG001|Overall Study|Withdrawal by Subject|0|||
126463237|NCT00744471|454997063|FG000|Overall Study|Randomized but not treated|1|||
126463238|NCT00744471|454997064|FG001|Overall Study|Randomized but not treated|1|||
126304445|NCT01073605|454404229|FG001|Overall Study|Adverse Event|1|||
126304446|NCT01073605|454404230|FG002|Overall Study|Adverse Event|0|||
126304447|NCT01073605|454404228|FG000|Overall Study|Lost to Follow-up|3|||
126304448|NCT01073605|454404229|FG001|Overall Study|Lost to Follow-up|4|||
126304449|NCT01073605|454404230|FG002|Overall Study|Lost to Follow-up|9|||
126304450|NCT01073605|454404228|FG000|Overall Study|Other|25|||
126304451|NCT01073605|454404229|FG001|Overall Study|Other|21|||
126304452|NCT01073605|454404230|FG002|Overall Study|Other|29|||
126304453|NCT01073605|454404228|FG000|Overall Study|Withdrawal by Subject|31|||
126304454|NCT01073605|454404229|FG001|Overall Study|Withdrawal by Subject|39|||
126304455|NCT01073605|454404230|FG002|Overall Study|Withdrawal by Subject|22|||
126304456|NCT01073605|454404228|FG000|Overall Study|Randomized But Not Treated|0|||
126304457|NCT01073605|454404229|FG001|Overall Study|Randomized But Not Treated|1|||
126304458|NCT01073605|454404230|FG002|Overall Study|Randomized But Not Treated|1|||
126304459|NCT02035202|454404231|FG000|Overall Study|Lost to Follow-up|8|||
126304460|NCT02035202|454404232|FG001|Overall Study|Lost to Follow-up|16|||
126304461|NCT02035202|454404233|FG002|Overall Study|Lost to Follow-up|2|||
126304462|NCT00083759|454404234|FG000|Overall Study|Adverse Event|5|||
126304463|NCT00083759|454404235|FG001|Overall Study|Adverse Event|3|||
126304464|NCT00083759|454404234|FG000|Overall Study|Lost to Follow-up|1|||
126304465|NCT00083759|454404235|FG001|Overall Study|Lost to Follow-up|0|||
126304466|NCT00083759|454404234|FG000|Overall Study|Death|1|||
126304467|NCT00083759|454404235|FG001|Overall Study|Death|1|||
126304468|NCT00083759|454404234|FG000|Overall Study|Inadequate Therapeutic Response|32|||
126304469|NCT00083759|454404235|FG001|Overall Study|Inadequate Therapeutic Response|35|||
126304470|NCT00083759|454404234|FG000|Overall Study|Subject Withdrew Consent|2|||
126304471|NCT00083759|454404235|FG001|Overall Study|Subject Withdrew Consent|2|||
126304472|NCT00083759|454404234|FG000|Overall Study|Non-Compliance|1|||
126304473|NCT00083759|454404235|FG001|Overall Study|Non-Compliance|0|||
126304474|NCT00083759|454404234|FG000|Overall Study|Sponsor's Discretion|28|||
126304475|NCT00083759|454404235|FG001|Overall Study|Sponsor's Discretion|29|||
126304476|NCT00083759|454404234|FG000|Overall Study|Other|14|||
126304477|NCT00083759|454404235|FG001|Overall Study|Other|13|||
126304478|NCT02875613|454404236|FG000|Overall Study|Withdrawal by Subject|1|||
126304479|NCT02875613|454404236|FG000|Overall Study|Screen Failure|1|||
126304480|NCT00267969|454404246|FG000|Controlled Period|Adverse Event|6|||
126304481|NCT00267969|454404247|FG001|Controlled Period|Adverse Event|0|||
126304482|NCT00267969|454404248|FG002|Controlled Period|Adverse Event|2|||
126304483|NCT00267969|454404249|FG003|Controlled Period|Adverse Event|0|||
126304484|NCT00267969|454404250|FG004|Controlled Period|Adverse Event|0|||
126304485|NCT00267969|454404251|FG005|Controlled Period|Adverse Event|0|||
126304486|NCT00267969|454404252|FG006|Controlled Period|Adverse Event|0|||
126304487|NCT00267969|454404246|FG000|Controlled Period|Lack of Efficacy|3|||
126304488|NCT00267969|454404247|FG001|Controlled Period|Lack of Efficacy|0|||
126304489|NCT00267969|454404248|FG002|Controlled Period|Lack of Efficacy|1|||
126304490|NCT00267969|454404249|FG003|Controlled Period|Lack of Efficacy|0|||
126304491|NCT00267969|454404250|FG004|Controlled Period|Lack of Efficacy|0|||
126304492|NCT00267969|454404251|FG005|Controlled Period|Lack of Efficacy|0|||
126304493|NCT00267969|454404252|FG006|Controlled Period|Lack of Efficacy|0|||
126304494|NCT00267969|454404246|FG000|Controlled Period|Lost to Follow-up|1|||
126304495|NCT00267969|454404247|FG001|Controlled Period|Lost to Follow-up|0|||
126304496|NCT00267969|454404248|FG002|Controlled Period|Lost to Follow-up|1|||
126304497|NCT00267969|454404249|FG003|Controlled Period|Lost to Follow-up|0|||
126304498|NCT00267969|454404250|FG004|Controlled Period|Lost to Follow-up|0|||
126304499|NCT00267969|454404251|FG005|Controlled Period|Lost to Follow-up|0|||
126304500|NCT00267969|454404252|FG006|Controlled Period|Lost to Follow-up|0|||
126304501|NCT00267969|454404246|FG000|Controlled Period|Randomized but not treated|0|||
126713569|NCT05094154|455903759|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
126304502|NCT00267969|454404247|FG001|Controlled Period|Randomized but not treated|0|||
126304503|NCT00267969|454404248|FG002|Controlled Period|Randomized but not treated|1|||
126304504|NCT00267969|454404249|FG003|Controlled Period|Randomized but not treated|0|||
126304505|NCT00267969|454404250|FG004|Controlled Period|Randomized but not treated|0|||
126304506|NCT00267969|454404251|FG005|Controlled Period|Randomized but not treated|0|||
126304507|NCT00267969|454404252|FG006|Controlled Period|Randomized but not treated|0|||
126304508|NCT00267969|454404246|FG000|Controlled Period|Other|2|||
126304509|NCT00267969|454404247|FG001|Controlled Period|Other|1|||
126304510|NCT00267969|454404248|FG002|Controlled Period|Other|6|||
126304511|NCT00267969|454404249|FG003|Controlled Period|Other|0|||
126304512|NCT00267969|454404250|FG004|Controlled Period|Other|0|||
126304513|NCT00267969|454404251|FG005|Controlled Period|Other|0|||
126304514|NCT00267969|454404252|FG006|Controlled Period|Other|0|||
126304515|NCT00267969|454404246|FG000|After Controlled Period|Adverse Event|0|||
126304516|NCT00267969|454404247|FG001|After Controlled Period|Adverse Event|0|||
126304517|NCT00267969|454404248|FG002|After Controlled Period|Adverse Event|0|||
126304518|NCT00267969|454404249|FG003|After Controlled Period|Adverse Event|7|||
126304519|NCT00267969|454404250|FG004|After Controlled Period|Adverse Event|8|||
126304520|NCT00267969|454404251|FG005|After Controlled Period|Adverse Event|23|||
126304521|NCT00267969|454404252|FG006|After Controlled Period|Adverse Event|21|||
126463239|NCT00744471|454997065|FG002|Overall Study|Randomized but not treated|4|||
126463240|NCT00744471|454997066|FG003|Overall Study|Randomized but not treated|0|||
126463241|NCT00744471|454997063|FG000|Overall Study|Death|0|||
126463242|NCT00744471|454997064|FG001|Overall Study|Death|0|||
126713570|NCT05094154|455903758|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
126713571|NCT05094154|455903759|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
126713572|NCT01240811|455903762|FG000|Overall Study|Physician Decision|0|||
126713573|NCT01240811|455903763|FG001|Overall Study|Physician Decision|1|||
126713574|NCT01240811|455903764|FG002|Overall Study|Physician Decision|0|||
126713575|NCT01240811|455903762|FG000|Overall Study|Withdrawal by Subject|0|||
126713576|NCT01240811|455903763|FG001|Overall Study|Withdrawal by Subject|0|||
126713577|NCT01240811|455903764|FG002|Overall Study|Withdrawal by Subject|1|||
126713578|NCT01543490|455903765|FG000|Overall Study|Adverse Event|4|||
126713579|NCT01543490|455903766|FG001|Overall Study|Adverse Event|0|||
126713580|NCT01543490|455903765|FG000|Overall Study|Physician Decision|1|||
126713581|NCT01543490|455903766|FG001|Overall Study|Physician Decision|0|||
126713582|NCT01543490|455903765|FG000|Overall Study|Lack of Efficacy|3|||
126304522|NCT00267969|454404246|FG000|After Controlled Period|Death|0|||
126304523|NCT00267969|454404247|FG001|After Controlled Period|Death|0|||
126304524|NCT00267969|454404248|FG002|After Controlled Period|Death|0|||
126304525|NCT00267969|454404249|FG003|After Controlled Period|Death|1|||
126713583|NCT01543490|455903766|FG001|Overall Study|Lack of Efficacy|3|||
126713584|NCT01543490|455903765|FG000|Overall Study|Lost to Follow-up|5|||
126713585|NCT01543490|455903766|FG001|Overall Study|Lost to Follow-up|0|||
126713586|NCT01543490|455903765|FG000|Overall Study|Withdrawal by Subject|2|||
126304526|NCT00267969|454404250|FG004|After Controlled Period|Death|2|||
126304527|NCT00267969|454404251|FG005|After Controlled Period|Death|0|||
126304528|NCT00267969|454404252|FG006|After Controlled Period|Death|1|||
126304529|NCT00267969|454404246|FG000|After Controlled Period|Lack of Efficacy|0|||
126304530|NCT00267969|454404247|FG001|After Controlled Period|Lack of Efficacy|0|||
126304531|NCT00267969|454404248|FG002|After Controlled Period|Lack of Efficacy|0|||
126304532|NCT00267969|454404249|FG003|After Controlled Period|Lack of Efficacy|10|||
126304533|NCT00267969|454404250|FG004|After Controlled Period|Lack of Efficacy|6|||
126304534|NCT00267969|454404251|FG005|After Controlled Period|Lack of Efficacy|28|||
126304535|NCT00267969|454404252|FG006|After Controlled Period|Lack of Efficacy|15|||
126304536|NCT00267969|454404246|FG000|After Controlled Period|Lost to Follow-up|0|||
126304537|NCT00267969|454404247|FG001|After Controlled Period|Lost to Follow-up|0|||
126304538|NCT00267969|454404248|FG002|After Controlled Period|Lost to Follow-up|0|||
126304539|NCT00267969|454404249|FG003|After Controlled Period|Lost to Follow-up|5|||
126304540|NCT00267969|454404250|FG004|After Controlled Period|Lost to Follow-up|8|||
126463243|NCT00744471|454997065|FG002|Overall Study|Death|0|||
126463244|NCT00744471|454997066|FG003|Overall Study|Death|1|||
126463245|NCT00744471|454997063|FG000|Overall Study|Adverse Event|6|||
126463246|NCT00744471|454997064|FG001|Overall Study|Adverse Event|7|||
126463247|NCT00744471|454997065|FG002|Overall Study|Adverse Event|5|||
126463248|NCT00744471|454997066|FG003|Overall Study|Adverse Event|9|||
126463249|NCT00744471|454997063|FG000|Overall Study|Withdrawal by Subject|9|||
126463250|NCT00744471|454997064|FG001|Overall Study|Withdrawal by Subject|9|||
126463251|NCT00744471|454997065|FG002|Overall Study|Withdrawal by Subject|15|||
126463252|NCT00744471|454997066|FG003|Overall Study|Withdrawal by Subject|12|||
126463253|NCT00744471|454997063|FG000|Overall Study|Protocol Violation|1|||
126463254|NCT00744471|454997064|FG001|Overall Study|Protocol Violation|4|||
126463255|NCT00744471|454997065|FG002|Overall Study|Protocol Violation|1|||
126463256|NCT00744471|454997066|FG003|Overall Study|Protocol Violation|2|||
126463257|NCT00744471|454997063|FG000|Overall Study|Entered extension study|41|||
126463258|NCT00744471|454997064|FG001|Overall Study|Entered extension study|84|||
126463259|NCT00744471|454997065|FG002|Overall Study|Entered extension study|100|||
126463260|NCT00744471|454997066|FG003|Overall Study|Entered extension study|91|||
126463261|NCT00744471|454997063|FG000|Overall Study|Other|2|||
126463262|NCT00744471|454997064|FG001|Overall Study|Other|3|||
126463263|NCT00744471|454997065|FG002|Overall Study|Other|6|||
126463264|NCT00744471|454997066|FG003|Overall Study|Other|2|||
126463265|NCT00744471|454997063|FG000|Overall Study|Lack of Efficacy|83|||
126463266|NCT00744471|454997064|FG001|Overall Study|Lack of Efficacy|37|||
126463267|NCT00744471|454997065|FG002|Overall Study|Lack of Efficacy|19|||
126463268|NCT00744471|454997066|FG003|Overall Study|Lack of Efficacy|31|||
126463269|NCT00744471|454997063|FG000|Overall Study|Lost to Follow-up|0|||
126463270|NCT00744471|454997064|FG001|Overall Study|Lost to Follow-up|0|||
126463271|NCT00744471|454997065|FG002|Overall Study|Lost to Follow-up|2|||
126463272|NCT00744471|454997066|FG003|Overall Study|Lost to Follow-up|0|||
126463273|NCT03640559|454997069|FG000|Overall Study|Physician Decision|1|||
126463274|NCT03640559|454997070|FG001|Overall Study|Physician Decision|1|||
126463275|NCT03640559|454997069|FG000|Overall Study|Withdrawal by Subject|1|||
126463276|NCT03640559|454997070|FG001|Overall Study|Withdrawal by Subject|0|||
126713587|NCT01543490|455903766|FG001|Overall Study|Withdrawal by Subject|0|||
126304541|NCT00267969|454404251|FG005|After Controlled Period|Lost to Follow-up|9|||
126463277|NCT02125604|454997071|FG000|Overall Study|Other|4|||
126713588|NCT01543490|455903765|FG000|Overall Study|Other-Various Administrative Reasons|1|||
126304542|NCT00267969|454404252|FG006|After Controlled Period|Lost to Follow-up|10|||
126304543|NCT00267969|454404246|FG000|After Controlled Period|Other|0|||
126304544|NCT00267969|454404247|FG001|After Controlled Period|Other|0|||
126304545|NCT00267969|454404248|FG002|After Controlled Period|Other|0|||
126304546|NCT00267969|454404249|FG003|After Controlled Period|Other|13|||
126304547|NCT00267969|454404250|FG004|After Controlled Period|Other|11|||
126304548|NCT00267969|454404251|FG005|After Controlled Period|Other|22|||
126463278|NCT02125604|454997071|FG000|Overall Study|Investigator Decision|1|||
126463279|NCT02125604|454997071|FG000|Overall Study|Lost to Follow-up|2|||
126713589|NCT01543490|455903766|FG001|Overall Study|Other-Various Administrative Reasons|2|||
126713590|NCT04168645|455903769|FG000|Overall Study|Lost to Follow-up|23|||
126713591|NCT04168645|455903770|FG001|Overall Study|Lost to Follow-up|28|||
126713592|NCT04168645|455903771|FG002|Overall Study|Lost to Follow-up|15|||
126713593|NCT04168645|455903772|FG003|Overall Study|Lost to Follow-up|12|||
126713594|NCT04168645|455903769|FG000|Overall Study|Death|1|||
126713595|NCT04168645|455903770|FG001|Overall Study|Death|1|||
126713596|NCT04168645|455903771|FG002|Overall Study|Death|0|||
126713597|NCT04168645|455903772|FG003|Overall Study|Death|0|||
126713598|NCT04168645|455903769|FG000|Overall Study|Withdrawal by Subject|5|||
126713599|NCT04168645|455903770|FG001|Overall Study|Withdrawal by Subject|2|||
126713600|NCT04168645|455903771|FG002|Overall Study|Withdrawal by Subject|2|||
126713601|NCT04168645|455903772|FG003|Overall Study|Withdrawal by Subject|2|||
126713602|NCT04168645|455903769|FG000|Overall Study|Administrative Withdrawal|3|||
126713603|NCT04168645|455903770|FG001|Overall Study|Administrative Withdrawal|1|||
126713604|NCT04168645|455903771|FG002|Overall Study|Administrative Withdrawal|1|||
126713605|NCT04168645|455903772|FG003|Overall Study|Administrative Withdrawal|3|||
126713606|NCT03132805|455903775|FG000|Overall Study|Lost to Follow-up|142|||
126713607|NCT03132805|455903776|FG001|Overall Study|Lost to Follow-up|141|||
126713608|NCT03132805|455903777|FG002|Overall Study|Lost to Follow-up|113|||
126713609|NCT03918642|455903778|FG000|Overall Study|Lost to Follow-up|12|||
126713610|NCT03918642|455903779|FG001|Overall Study|Lost to Follow-up|10|||
126713611|NCT00500149|455903780|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
126713612|NCT00500149|455903781|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
126713613|NCT00500149|455903780|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
126713614|NCT00500149|455903781|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
126713615|NCT00500149|455903780|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
126713616|NCT00500149|455903781|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
126713617|NCT00500149|455903780|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
126713618|NCT00500149|455903781|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
126713619|NCT00500149|455903780|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
126713620|NCT00500149|455903781|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
126713621|NCT00500149|455903780|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
126713622|NCT00500149|455903781|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
126713623|NCT00500149|455903780|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
126713624|NCT00500149|455903781|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
126713625|NCT01158534|455903782|FG000|Overall Study|Withdrawal by Subject|1|||
126713626|NCT01158534|455903782|FG000|Overall Study|Death|1|||
126713627|NCT01158534|455903782|FG000|Overall Study|Other|1|||
126713628|NCT00521339|455903783|FG000|Treatment Phase|Adverse Event|2|||
126713629|NCT00521339|455903784|FG001|Treatment Phase|Adverse Event|0|||
126713630|NCT00521339|455903785|FG002|Treatment Phase|Adverse Event|0|||
126713631|NCT00521339|455903783|FG000|Treatment Phase|Intolerability to study drug|2|||
126713632|NCT00521339|455903784|FG001|Treatment Phase|Intolerability to study drug|0|||
126713633|NCT00521339|455903785|FG002|Treatment Phase|Intolerability to study drug|0|||
126713634|NCT00521339|455903783|FG000|Treatment Phase|Lack of Efficacy|3|||
126713635|NCT00521339|455903784|FG001|Treatment Phase|Lack of Efficacy|0|||
126713636|NCT00521339|455903785|FG002|Treatment Phase|Lack of Efficacy|0|||
126713637|NCT00521339|455903783|FG000|Treatment Phase|Withdrawal by Subject|3|||
126713638|NCT00521339|455903784|FG001|Treatment Phase|Withdrawal by Subject|0|||
126713639|NCT00521339|455903785|FG002|Treatment Phase|Withdrawal by Subject|0|||
126304549|NCT00267969|454404252|FG006|After Controlled Period|Other|25|||
126304550|NCT02308540|454404257|FG000|Overall Study|Lost to Follow-up|0|||
126713640|NCT00521339|455903783|FG000|Treatment Phase|Lost to Follow-up|1|||
126713641|NCT00521339|455903784|FG001|Treatment Phase|Lost to Follow-up|0|||
126713642|NCT00521339|455903785|FG002|Treatment Phase|Lost to Follow-up|0|||
126713643|NCT00521339|455903783|FG000|Treatment Phase|Protocol Violation|1|||
126304551|NCT02308540|454404258|FG001|Overall Study|Lost to Follow-up|0|||
126304552|NCT02308540|454404259|FG002|Overall Study|Lost to Follow-up|0|||
126713644|NCT00521339|455903784|FG001|Treatment Phase|Protocol Violation|0|||
126713645|NCT00521339|455903785|FG002|Treatment Phase|Protocol Violation|0|||
126713646|NCT00521339|455903783|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
126713647|NCT00521339|455903784|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
126713648|NCT00521339|455903785|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
126713649|NCT00521339|455903783|FG000|Treatment Extension Phase|Death|0|||
126304553|NCT02308540|454404260|FG003|Overall Study|Lost to Follow-up|0|||
126713650|NCT00521339|455903784|FG001|Treatment Extension Phase|Death|0|||
126713651|NCT00521339|455903785|FG002|Treatment Extension Phase|Death|1|||
126713652|NCT00089843|455903786|FG000|Overall Study|Withdrawal by Subject|1|||
126713653|NCT00089843|455903787|FG001|Overall Study|Withdrawal by Subject|4|||
126713654|NCT00089843|455903788|FG002|Overall Study|Withdrawal by Subject|5|||
126713655|NCT00089843|455903789|FG003|Overall Study|Withdrawal by Subject|6|||
126713656|NCT00089843|455903786|FG000|Overall Study|Physician Decision|1|||
126713657|NCT00089843|455903787|FG001|Overall Study|Physician Decision|0|||
126713658|NCT00089843|455903788|FG002|Overall Study|Physician Decision|0|||
126713659|NCT00089843|455903789|FG003|Overall Study|Physician Decision|1|||
126713660|NCT02115815|455903790|FG000|Overall Study|Withdrawal by Subject|2|||
126713661|NCT02115815|455903791|FG001|Overall Study|Withdrawal by Subject|0|||
126713662|NCT02115815|455903792|FG002|Overall Study|Withdrawal by Subject|0|||
126713663|NCT02115815|455903793|FG003|Overall Study|Withdrawal by Subject|0|||
126713664|NCT02115815|455903794|FG004|Overall Study|Withdrawal by Subject|0|||
126713665|NCT02115815|455903795|FG005|Overall Study|Withdrawal by Subject|0|||
126713666|NCT02115815|455903796|FG006|Overall Study|Withdrawal by Subject|0|||
126713667|NCT02115815|455903790|FG000|Overall Study|Not enough drug to dose participant|0|||
126713668|NCT02115815|455903791|FG001|Overall Study|Not enough drug to dose participant|0|||
126713669|NCT02115815|455903792|FG002|Overall Study|Not enough drug to dose participant|0|||
126713670|NCT02115815|455903793|FG003|Overall Study|Not enough drug to dose participant|0|||
126463280|NCT02125604|454997071|FG000|Overall Study|Consent Withdrawn|4|||
126463281|NCT02125604|454997071|FG000|Overall Study|Adverse Event|20|||
126463282|NCT01876810|454997074|FG000|Overall Study|Physician Decision|0|||
126463283|NCT01876810|454997075|FG001|Overall Study|Physician Decision|1|||
126463284|NCT00323869|454997079|FG000|Overall Study|Death|1|||
126463285|NCT01683019|454998628|FG000|Overall Study|Withdrawal by Subject|2|||
126713671|NCT02115815|455903794|FG004|Overall Study|Not enough drug to dose participant|0|||
126713672|NCT02115815|455903795|FG005|Overall Study|Not enough drug to dose participant|1|||
126713673|NCT02115815|455903796|FG006|Overall Study|Not enough drug to dose participant|0|||
126713674|NCT02115815|455903790|FG000|Overall Study|Missed appointment, randomized in error|0|||
126463286|NCT01683019|454998629|FG001|Overall Study|Withdrawal by Subject|1|||
126463287|NCT01683019|454998630|FG002|Overall Study|Withdrawal by Subject|4|||
126463288|NCT04444895|454998631|FG000|Overall Study|Adverse Event|2|||
126463289|NCT04444895|454998631|FG000|Overall Study|Lost to Follow-up|2|||
126463290|NCT04444895|454998631|FG000|Overall Study|Withdrawal by Subject|5|||
126463291|NCT00749580|454998632|FG000|Overall Study|Lost to Follow-up|4|||
126463292|NCT00749580|454998633|FG001|Overall Study|Lost to Follow-up|8|||
126463293|NCT00749580|454998632|FG000|Overall Study|Adverse Event|0|||
126463294|NCT00749580|454998633|FG001|Overall Study|Adverse Event|1|||
126463295|NCT03868124|454998645|FG000|Overall Study|Withdrawal by Subject|4|||
126713675|NCT02115815|455903791|FG001|Overall Study|Missed appointment, randomized in error|0|||
126713676|NCT02115815|455903792|FG002|Overall Study|Missed appointment, randomized in error|0|||
126463296|NCT03868124|454998646|FG001|Overall Study|Withdrawal by Subject|0|||
126551351|NCT02601937|455311873|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
126551352|NCT02601937|455311874|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
126713677|NCT02115815|455903793|FG003|Overall Study|Missed appointment, randomized in error|0|||
126713678|NCT02115815|455903794|FG004|Overall Study|Missed appointment, randomized in error|0|||
126713679|NCT02115815|455903795|FG005|Overall Study|Missed appointment, randomized in error|1|||
126713680|NCT02115815|455903796|FG006|Overall Study|Missed appointment, randomized in error|0|||
126713681|NCT01228071|455903797|FG000|Overall Study|Protocol Violation|1|||
126713682|NCT01228071|455903797|FG000|Overall Study|Withdrawal by Subject|1|||
126713683|NCT03314519|455903798|FG000|Overall Study|Protocol Violation|3|||
126713684|NCT03314519|455903799|FG001|Overall Study|Protocol Violation|2|||
126713685|NCT04003155|455903800|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
126713686|NCT04003155|455903801|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
126713687|NCT04003155|455903802|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
126713688|NCT04003155|455903803|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
126713689|NCT04003155|455903804|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
126713690|NCT04003155|455903800|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
126713691|NCT04003155|455903801|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
126713692|NCT04003155|455903802|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
126713693|NCT04003155|455903803|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
126713694|NCT04003155|455903804|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
126713695|NCT04003155|455903800|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
126463297|NCT03868124|454998647|FG002|Overall Study|Withdrawal by Subject|1|||
126551353|NCT02601937|455311875|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
126551354|NCT02601937|455311876|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
126713696|NCT04003155|455903801|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
126713697|NCT04003155|455903802|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
126713698|NCT04003155|455903803|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
126713699|NCT04003155|455903804|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
126713700|NCT04003155|455903800|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
126463298|NCT03868124|454998645|FG000|Overall Study|Physician Decision|1|||
126713701|NCT04003155|455903801|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
126713702|NCT04003155|455903802|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
126713703|NCT04003155|455903803|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
126713704|NCT04003155|455903804|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
126713705|NCT04003155|455903800|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
126713706|NCT04003155|455903801|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
126713707|NCT04003155|455903802|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
126713708|NCT04003155|455903803|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
126713709|NCT04003155|455903804|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
126713710|NCT04003155|455903800|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
126713711|NCT04003155|455903801|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
126713712|NCT04003155|455903802|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
126713713|NCT04003155|455903803|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
126713714|NCT04003155|455903804|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
126713715|NCT04003155|455903800|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
126713716|NCT04003155|455903801|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
126713717|NCT04003155|455903802|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
126713718|NCT04003155|455903803|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
126713719|NCT04003155|455903804|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
126713720|NCT04003155|455903800|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
126713721|NCT04003155|455903801|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
126713722|NCT04003155|455903802|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
126713723|NCT04003155|455903803|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
126713724|NCT04003155|455903804|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
126713725|NCT04003155|455903800|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
126713726|NCT04003155|455903801|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
126713727|NCT04003155|455903802|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
126713728|NCT04003155|455903803|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
126713729|NCT04003155|455903804|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
126713730|NCT01912872|455903805|FG000|Overall Study|Lost to Follow-up|2|||
126713731|NCT01912872|455903806|FG001|Overall Study|Lost to Follow-up|3|||
126713732|NCT01912872|455903807|FG002|Overall Study|Lost to Follow-up|5|||
126304554|NCT02308540|454404261|FG004|Overall Study|Lost to Follow-up|0|||
126304555|NCT02308540|454404262|FG005|Overall Study|Lost to Follow-up|1|||
126304556|NCT01053663|454404263|FG000|Overall Study|Death|2|||
126304557|NCT01053663|454404263|FG000|Overall Study|Lost to Follow-up|1|||
126304558|NCT01053663|454404263|FG000|Overall Study|Poor IV Access|1|||
126304559|NCT01053663|454404263|FG000|Overall Study|Transferred to Another Hospital|1|||
126304560|NCT01053663|454404263|FG000|Overall Study|Negative Influenza Diagnosis|1|||
126463299|NCT03868124|454998646|FG001|Overall Study|Physician Decision|0|||
126463300|NCT03868124|454998647|FG002|Overall Study|Physician Decision|1|||
126463301|NCT03868124|454998645|FG000|Overall Study|Lost to Follow-up|1|||
126463302|NCT03868124|454998646|FG001|Overall Study|Lost to Follow-up|1|||
126463303|NCT03868124|454998647|FG002|Overall Study|Lost to Follow-up|2|||
126463304|NCT03868124|454998645|FG000|Overall Study|Death|1|||
126463305|NCT03868124|454998646|FG001|Overall Study|Death|1|||
126463306|NCT03868124|454998647|FG002|Overall Study|Death|2|||
126463307|NCT03868124|454998645|FG000|Overall Study|Adverse Event|0|||
126463308|NCT03868124|454998646|FG001|Overall Study|Adverse Event|0|||
126463309|NCT03868124|454998647|FG002|Overall Study|Adverse Event|3|||
126463310|NCT03868124|454998645|FG000|Overall Study|Explanted|2|||
126463311|NCT03868124|454998646|FG001|Overall Study|Explanted|1|||
126463312|NCT03868124|454998647|FG002|Overall Study|Explanted|0|||
126463313|NCT03868124|454998645|FG000|Overall Study|Ongoing in study|176|||
126463314|NCT03868124|454998646|FG001|Overall Study|Ongoing in study|180|||
126463315|NCT03868124|454998647|FG002|Overall Study|Ongoing in study|183|||
126463316|NCT04565236|454998648|FG000|Overall Study|Patient/Guardian Decision|0|||
126463317|NCT04565236|454998649|FG001|Overall Study|Patient/Guardian Decision|0|||
126463318|NCT04565236|454998650|FG002|Overall Study|Patient/Guardian Decision|1|||
126463319|NCT04565236|454998651|FG003|Overall Study|Patient/Guardian Decision|0|||
126463320|NCT04902326|454998652|FG000|Overall Study|Withdrawal by Subject|1|||
126463321|NCT04902326|454998653|FG001|Overall Study|Withdrawal by Subject|3|||
126463322|NCT04902326|454998654|FG002|Overall Study|Withdrawal by Subject|0|||
126463323|NCT04902326|454998655|FG003|Overall Study|Withdrawal by Subject|1|||
126463324|NCT04902326|454998652|FG000|Overall Study|Lost to Follow-up|14|||
126463325|NCT04902326|454998653|FG001|Overall Study|Lost to Follow-up|14|||
126463326|NCT04902326|454998654|FG002|Overall Study|Lost to Follow-up|14|||
126463327|NCT04902326|454998655|FG003|Overall Study|Lost to Follow-up|6|||
126463328|NCT01117051|454998656|FG000|Overall Study|Withdrawal by Subject|5|||
126463329|NCT01117051|454998657|FG001|Overall Study|Withdrawal by Subject|3|||
126463330|NCT01117051|454998656|FG000|Overall Study|Adverse Event|4|||
126463331|NCT01117051|454998657|FG001|Overall Study|Adverse Event|3|||
126713733|NCT01912872|455903808|FG003|Overall Study|Lost to Follow-up|5|||
126713734|NCT01912872|455903805|FG000|Overall Study|Other unspecified|3|||
126463332|NCT01117051|454998656|FG000|Overall Study|Lost to Follow-up|0|||
126304561|NCT03533114|454404264|FG000|Overall|Adverse Event|16|||
126304562|NCT03533114|454404265|FG001|Overall|Adverse Event|11|||
126304563|NCT03533114|454404264|FG000|Overall|Consent Withdrawal by Participant|7|||
126713735|NCT01912872|455903806|FG001|Overall Study|Other unspecified|1|||
126713736|NCT01912872|455903807|FG002|Overall Study|Other unspecified|3|||
126713737|NCT01912872|455903808|FG003|Overall Study|Other unspecified|0|||
126713738|NCT01912872|455903805|FG000|Overall Study|Informed consent withdrawn|0|||
126713739|NCT01912872|455903806|FG001|Overall Study|Informed consent withdrawn|0|||
126713740|NCT01912872|455903807|FG002|Overall Study|Informed consent withdrawn|1|||
126713741|NCT01912872|455903808|FG003|Overall Study|Informed consent withdrawn|1|||
126713742|NCT01912872|455903805|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
126713743|NCT01912872|455903806|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
126713744|NCT01912872|455903807|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
126713745|NCT01912872|455903808|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
126713746|NCT01912872|455903805|FG000|Overall Study|Protocol Violation|0|||
126713747|NCT01912872|455903806|FG001|Overall Study|Protocol Violation|0|||
126713748|NCT01912872|455903807|FG002|Overall Study|Protocol Violation|1|||
126713749|NCT01912872|455903808|FG003|Overall Study|Protocol Violation|0|||
126713750|NCT01912872|455903805|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126713751|NCT01912872|455903806|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126713752|NCT01912872|455903807|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126713753|NCT01912872|455903808|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
126713754|NCT01912872|455903805|FG000|Overall Study|Withdrawal of study medication|0|||
126713755|NCT01912872|455903806|FG001|Overall Study|Withdrawal of study medication|0|||
126304564|NCT03533114|454404265|FG001|Overall|Consent Withdrawal by Participant|6|||
126304565|NCT03533114|454404264|FG000|Overall|Lack of Efficacy|5|||
126304566|NCT03533114|454404265|FG001|Overall|Lack of Efficacy|3|||
126304567|NCT03533114|454404264|FG000|Overall|Lost to Follow-up|1|||
126304568|NCT03533114|454404265|FG001|Overall|Lost to Follow-up|1|||
126304569|NCT03533114|454404264|FG000|Overall|Physician Decision|0|||
126304570|NCT03533114|454404265|FG001|Overall|Physician Decision|2|||
126304571|NCT03533114|454404264|FG000|Overall|Protocol deviation|1|||
126304572|NCT03533114|454404265|FG001|Overall|Protocol deviation|1|||
126304573|NCT03533114|454404264|FG000|Overall|Failure to meet randomization criteria|1|||
126304574|NCT03533114|454404265|FG001|Overall|Failure to meet randomization criteria|2|||
126304575|NCT03533114|454404264|FG000|Overall|Non-Compliance with study drug|0|||
126304576|NCT03533114|454404265|FG001|Overall|Non-Compliance with study drug|1|||
126304577|NCT03533114|454404264|FG000|Overall|Other|0|||
126304578|NCT03533114|454404265|FG001|Overall|Other|1|||
126304579|NCT03533114|454404264|FG000|Open Label Titration and Optimization|Adverse Event|11|||
126304580|NCT03533114|454404265|FG001|Open Label Titration and Optimization|Adverse Event|8|||
126304581|NCT03533114|454404264|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
126304582|NCT03533114|454404265|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
126304583|NCT03533114|454404264|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
126304584|NCT03533114|454404265|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
126304585|NCT03533114|454404264|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
126304586|NCT03533114|454404265|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
126304587|NCT03533114|454404264|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
126304588|NCT03533114|454404265|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
126304589|NCT03533114|454404264|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
126304590|NCT03533114|454404265|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
126304591|NCT03533114|454404264|FG000|Stable Dose|Adverse Event|0|||
126304592|NCT03533114|454404265|FG001|Stable Dose|Adverse Event|2|||
126304593|NCT03533114|454404264|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
126304594|NCT03533114|454404265|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
126304595|NCT03533114|454404264|FG000|Stable Dose|Lack of Efficacy|1|||
126304596|NCT03533114|454404265|FG001|Stable Dose|Lack of Efficacy|0|||
126304597|NCT03533114|454404264|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
126304598|NCT03533114|454404265|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
126304599|NCT03533114|454404264|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
126304600|NCT03533114|454404265|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
126304601|NCT03533114|454404264|FG000|Open-Label Safety Extension|Adverse Event|3|||
126304602|NCT03533114|454404265|FG001|Open-Label Safety Extension|Adverse Event|0|||
126304603|NCT03533114|454404264|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
126304604|NCT03533114|454404265|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
126304605|NCT03533114|454404264|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
126368187|NCT00725985|454642900|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
126368188|NCT00725985|454642889|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126713756|NCT01912872|455903807|FG002|Overall Study|Withdrawal of study medication|0|||
126713757|NCT01912872|455903808|FG003|Overall Study|Withdrawal of study medication|2|||
126713758|NCT01912872|455903805|FG000|Overall Study|Missing|0|||
126713759|NCT01912872|455903806|FG001|Overall Study|Missing|0|||
126304606|NCT03533114|454404265|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
126304607|NCT03533114|454404264|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
126304608|NCT03533114|454404265|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
126304609|NCT03533114|454404264|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
126304610|NCT03533114|454404265|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
126304611|NCT01862250|454404266|FG000|Overall Study|Adverse Event|4|||
126304612|NCT02423343|454404267|FG000|Overall Study|Withdrawal by Subject|0|||
126304613|NCT02423343|454404268|FG001|Overall Study|Withdrawal by Subject|1|||
126304614|NCT02423343|454404269|FG002|Overall Study|Withdrawal by Subject|0|||
126304615|NCT02423343|454404270|FG003|Overall Study|Withdrawal by Subject|0|||
126713760|NCT01912872|455903807|FG002|Overall Study|Missing|0|||
126713761|NCT01912872|455903808|FG003|Overall Study|Missing|1|||
126713762|NCT00950690|455903809|FG000|Overall Study|Death|4|||
126713763|NCT00950690|455903809|FG000|Overall Study|Adverse Event|15|||
126713764|NCT00950690|455903809|FG000|Overall Study|Lack of Efficacy|22|||
126713765|NCT00950690|455903809|FG000|Overall Study|Lost to Follow-up|40|||
126713766|NCT00950690|455903809|FG000|Overall Study|Other|163|||
126713767|NCT01713036|455903810|FG000|Overall Study|Death|1|||
126713768|NCT02778867|455903811|FG000|Phase 1|Withdrawal by Subject|2|||
126713769|NCT02778867|455903812|FG001|Phase 1|Withdrawal by Subject|3|||
126713770|NCT02778867|455903813|FG002|Phase 1|Withdrawal by Subject|0|||
126713771|NCT02778867|455903814|FG003|Phase 1|Withdrawal by Subject|0|||
126713772|NCT02778867|455903811|FG000|Phase 2|Withdrawal by Subject|0|||
126713773|NCT02778867|455903812|FG001|Phase 2|Withdrawal by Subject|0|||
126713774|NCT02778867|455903813|FG002|Phase 2|Withdrawal by Subject|1|||
126713775|NCT02778867|455903814|FG003|Phase 2|Withdrawal by Subject|0|||
126713776|NCT02778867|455903811|FG000|Phase 2|Physician Decision|0|||
126713777|NCT02778867|455903812|FG001|Phase 2|Physician Decision|0|||
126713778|NCT02778867|455903813|FG002|Phase 2|Physician Decision|0|||
126713779|NCT02778867|455903814|FG003|Phase 2|Physician Decision|1|||
126713780|NCT02778867|455903811|FG000|Phase 2|Adverse Event|0|||
126713781|NCT02778867|455903812|FG001|Phase 2|Adverse Event|0|||
126713782|NCT02778867|455903813|FG002|Phase 2|Adverse Event|0|||
126713783|NCT02778867|455903814|FG003|Phase 2|Adverse Event|1|||
126713784|NCT00305006|455903820|FG000|Overall Study|Withdrawal by Subject|1|||
126713785|NCT00305006|455903821|FG001|Overall Study|Withdrawal by Subject|0|||
126713786|NCT00305006|455903820|FG000|Overall Study|Failure to complete pretest|0|||
126713787|NCT00305006|455903821|FG001|Overall Study|Failure to complete pretest|1|||
126713788|NCT00631488|455903822|FG000|Overall Study|Adverse Event|1|||
126713789|NCT00631488|455903823|FG001|Overall Study|Adverse Event|0|||
126713790|NCT00631488|455903824|FG002|Overall Study|Adverse Event|0|||
126713791|NCT00631488|455903822|FG000|Overall Study|Lost to Follow-up|2|||
126713792|NCT00631488|455903823|FG001|Overall Study|Lost to Follow-up|2|||
126713793|NCT00631488|455903824|FG002|Overall Study|Lost to Follow-up|0|||
126713794|NCT00631488|455903822|FG000|Overall Study|Physician Decision|1|||
126713795|NCT00631488|455903823|FG001|Overall Study|Physician Decision|0|||
126713796|NCT00631488|455903824|FG002|Overall Study|Physician Decision|1|||
126713797|NCT00631488|455903822|FG000|Overall Study|Protocol Violation|0|||
126713798|NCT00631488|455903823|FG001|Overall Study|Protocol Violation|0|||
126713799|NCT00631488|455903824|FG002|Overall Study|Protocol Violation|1|||
126713800|NCT03648476|455903826|FG000|Overall Study|Withdrawal by Subject|2|||
126713801|NCT03648476|455903827|FG001|Overall Study|Withdrawal by Subject|1|||
126713802|NCT02546856|455903832|FG000|4 Months Evaluation|Death|2|||
126713803|NCT02546856|455903833|FG001|4 Months Evaluation|Death|3|||
126713804|NCT02546856|455903832|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
126713805|NCT02546856|455903833|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
126713806|NCT02546856|455903832|FG000|4 Months Evaluation|Lost to Follow-up|3|||
126713807|NCT02546856|455903833|FG001|4 Months Evaluation|Lost to Follow-up|3|||
126713808|NCT02546856|455903832|FG000|4 Months Evaluation|Physician Decision|3|||
126713809|NCT02546856|455903833|FG001|4 Months Evaluation|Physician Decision|0|||
126713810|NCT02546856|455903832|FG000|4 Months Evaluation|Working or living abroad|5|||
126713811|NCT02546856|455903833|FG001|4 Months Evaluation|Working or living abroad|1|||
126713812|NCT02546856|455903832|FG000|4 Months Evaluation|reasons not due to titration|4|||
126713813|NCT02546856|455903833|FG001|4 Months Evaluation|reasons not due to titration|1|||
126713814|NCT02546856|455903832|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
126304616|NCT02423343|454404271|FG004|Overall Study|Withdrawal by Subject|0|||
126713815|NCT02546856|455903833|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
126713816|NCT02546856|455903832|FG000|6 Months Evaluation|Death|1|||
126713817|NCT02546856|455903833|FG001|6 Months Evaluation|Death|1|||
126713818|NCT02546856|455903832|FG000|6 Months Evaluation|Lost to Follow-up|1|||
126713819|NCT02546856|455903833|FG001|6 Months Evaluation|Lost to Follow-up|1|||
126713820|NCT02546856|455903832|FG000|6 Months Evaluation|Working or living abroad|6|||
126713821|NCT02546856|455903833|FG001|6 Months Evaluation|Working or living abroad|4|||
126713822|NCT02546856|455903832|FG000|6 Months Evaluation|reasons not due to titration|0|||
126713823|NCT02546856|455903833|FG001|6 Months Evaluation|reasons not due to titration|1|||
126713824|NCT01097616|455903835|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
126713825|NCT01097616|455903836|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
126713826|NCT01097616|455903837|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
126304617|NCT02423343|454404272|FG005|Overall Study|Withdrawal by Subject|0|||
126304618|NCT02423343|454404267|FG000|Overall Study|Progressive Disease|0|||
126304619|NCT02423343|454404268|FG001|Overall Study|Progressive Disease|0|||
126304620|NCT02423343|454404269|FG002|Overall Study|Progressive Disease|0|||
126304621|NCT02423343|454404270|FG003|Overall Study|Progressive Disease|0|||
126304622|NCT02423343|454404271|FG004|Overall Study|Progressive Disease|2|||
126304623|NCT02423343|454404272|FG005|Overall Study|Progressive Disease|0|||
126304624|NCT02423343|454404267|FG000|Overall Study|Adverse Event|0|||
126304625|NCT02423343|454404268|FG001|Overall Study|Adverse Event|0|||
126304626|NCT02423343|454404269|FG002|Overall Study|Adverse Event|0|||
126304627|NCT02423343|454404270|FG003|Overall Study|Adverse Event|0|||
126304628|NCT02423343|454404271|FG004|Overall Study|Adverse Event|2|||
126304629|NCT02423343|454404272|FG005|Overall Study|Adverse Event|0|||
126304630|NCT02423343|454404267|FG000|Overall Study|Death|0|||
126304631|NCT02423343|454404268|FG001|Overall Study|Death|0|||
126304632|NCT02423343|454404269|FG002|Overall Study|Death|0|||
126304633|NCT02423343|454404270|FG003|Overall Study|Death|0|||
126304634|NCT02423343|454404271|FG004|Overall Study|Death|1|||
126304635|NCT02423343|454404272|FG005|Overall Study|Death|0|||
126304636|NCT00090493|454404273|FG000|Overall Study|Physician Decision|2|||
126304637|NCT02071706|454404274|FG000|Overall Study|Adverse Event|1|||
126304638|NCT02071706|454404274|FG000|Overall Study|Withdrawal by Subject|2|||
126304639|NCT02792192|454404277|FG000|Overall Study|Death|1|||
126463333|NCT01117051|454998657|FG001|Overall Study|Lost to Follow-up|1|||
126463334|NCT01117051|454998656|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
126463335|NCT01117051|454998657|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
126463336|NCT01117051|454998656|FG000|Overall Study|Sponsor's decision|3|||
126463337|NCT01117051|454998657|FG001|Overall Study|Sponsor's decision|1|||
126463338|NCT01117051|454998656|FG000|Overall Study|Surgical procedure|0|||
126463339|NCT01117051|454998657|FG001|Overall Study|Surgical procedure|1|||
126463340|NCT01117051|454998656|FG000|Overall Study|Randomized by mistake|0|||
126713827|NCT01097616|455903838|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126713828|NCT01097616|455903839|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126713829|NCT01097616|455903840|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126713830|NCT01097616|455903841|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126713831|NCT01097616|455903842|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
126713832|NCT01097616|455903835|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
126713833|NCT01097616|455903836|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
126304640|NCT02792192|454404278|FG001|Overall Study|Death|0|||
126304641|NCT02792192|454404279|FG002|Overall Study|Death|0|||
126304642|NCT02792192|454404280|FG003|Overall Study|Death|0|||
126304643|NCT02792192|454404277|FG000|Overall Study|Informed Consent Withdrawn|4|||
126304644|NCT02792192|454404278|FG001|Overall Study|Informed Consent Withdrawn|0|||
126304645|NCT02792192|454404279|FG002|Overall Study|Informed Consent Withdrawn|0|||
126304646|NCT02792192|454404280|FG003|Overall Study|Informed Consent Withdrawn|0|||
126304647|NCT02792192|454404277|FG000|Overall Study|Physician Decision|1|||
126304648|NCT02792192|454404278|FG001|Overall Study|Physician Decision|0|||
126304649|NCT02792192|454404279|FG002|Overall Study|Physician Decision|0|||
126304650|NCT02792192|454404280|FG003|Overall Study|Physician Decision|0|||
126304651|NCT02792192|454404277|FG000|Overall Study|Progressive Disease|0|||
126304652|NCT02792192|454404278|FG001|Overall Study|Progressive Disease|1|||
126304653|NCT02792192|454404279|FG002|Overall Study|Progressive Disease|0|||
126304654|NCT02792192|454404280|FG003|Overall Study|Progressive Disease|0|||
126304655|NCT02792192|454404277|FG000|Overall Study|Study Terminated By Sponsor|6|||
126304656|NCT02792192|454404278|FG001|Overall Study|Study Terminated By Sponsor|10|||
126304657|NCT02792192|454404279|FG002|Overall Study|Study Terminated By Sponsor|0|||
126304658|NCT02792192|454404280|FG003|Overall Study|Study Terminated By Sponsor|0|||
126304659|NCT04481789|454404283|FG000|Period 1|Withdrawal by Subject|1|||
126304660|NCT04481789|454404284|FG001|Period 1|Withdrawal by Subject|0|||
126304661|NCT04481789|454404285|FG002|Period 1|Withdrawal by Subject|0|||
126304662|NCT04481789|454404286|FG003|Period 1|Withdrawal by Subject|0|||
126463341|NCT01117051|454998657|FG001|Overall Study|Randomized by mistake|1|||
126463342|NCT01117051|454998656|FG000|Overall Study|Convenience issue|1|||
126304663|NCT04481789|454404287|FG004|Period 1|Withdrawal by Subject|0|||
126304664|NCT04481789|454404288|FG005|Period 1|Withdrawal by Subject|0|||
126304665|NCT02751450|454404289|FG000|Overall Study|Adverse Event|1|||
126304666|NCT02751450|454404290|FG001|Overall Study|Adverse Event|0|||
126304667|NCT00562302|454404291|FG000|Overall Study|Lost to Follow-up|3|||
126304668|NCT00562302|454404292|FG001|Overall Study|Lost to Follow-up|3|||
126304669|NCT00562302|454404291|FG000|Overall Study|Adverse Event|0|||
126463343|NCT01117051|454998657|FG001|Overall Study|Convenience issue|0|||
126304670|NCT00562302|454404292|FG001|Overall Study|Adverse Event|6|||
126304671|NCT00562302|454404291|FG000|Overall Study|Non-compliance|1|||
126304672|NCT00562302|454404292|FG001|Overall Study|Non-compliance|2|||
126463344|NCT00206076|454998659|FG000|Overall Study|Physician Decision|2|||
126304673|NCT00562302|454404291|FG000|Overall Study|Withdrawal by Subject|7|||
126304674|NCT00562302|454404292|FG001|Overall Study|Withdrawal by Subject|8|||
126304675|NCT00562302|454404291|FG000|Overall Study|Death|1|||
126304676|NCT00562302|454404292|FG001|Overall Study|Death|2|||
126304677|NCT00562302|454404291|FG000|Overall Study|Lung resection prior to study completion|7|||
126713834|NCT01097616|455903837|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
126713835|NCT01097616|455903838|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126713836|NCT01097616|455903839|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126713837|NCT01097616|455903840|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126713838|NCT01097616|455903841|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126713839|NCT01097616|455903842|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
126713840|NCT01097616|455903835|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
126713841|NCT01097616|455903836|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
126713842|NCT01097616|455903837|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
126713843|NCT01097616|455903838|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126713844|NCT01097616|455903839|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126713845|NCT01097616|455903840|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126713846|NCT01097616|455903841|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126713847|NCT01097616|455903842|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
126713848|NCT01097616|455903835|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
126713849|NCT01097616|455903836|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
126713850|NCT01097616|455903837|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126713851|NCT01097616|455903838|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126713852|NCT01097616|455903839|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126713853|NCT01097616|455903840|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126713854|NCT01097616|455903841|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126713855|NCT01097616|455903842|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
126551355|NCT02601937|455311877|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
126551356|NCT02601937|455311878|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
126304678|NCT00562302|454404292|FG001|Overall Study|Lung resection prior to study completion|7|||
126304679|NCT00562302|454404291|FG000|Overall Study|Not stated|1|||
126304680|NCT00562302|454404292|FG001|Overall Study|Not stated|4|||
126304681|NCT01290679|454404293|FG000|Overall Study|Adverse Event|2|||
126304682|NCT01290679|454404294|FG001|Overall Study|Adverse Event|0|||
126304683|NCT01290679|454404293|FG000|Overall Study|Lost to Follow-up|8|||
126551357|NCT02601937|455311868|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
126551358|NCT02601937|455311869|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
126551359|NCT02601937|455311870|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
126551360|NCT02601937|455311871|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
126551361|NCT02601937|455311872|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
126551362|NCT02601937|455311873|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
126551363|NCT02601937|455311874|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
126551364|NCT02601937|455311875|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
126304684|NCT01290679|454404294|FG001|Overall Study|Lost to Follow-up|10|||
126304685|NCT01290679|454404293|FG000|Overall Study|Protocol Violation|0|||
126304686|NCT01290679|454404294|FG001|Overall Study|Protocol Violation|1|||
126304687|NCT01290679|454404293|FG000|Overall Study|Withdrawal by Subject|6|||
126304688|NCT01290679|454404294|FG001|Overall Study|Withdrawal by Subject|5|||
126304689|NCT01290679|454404293|FG000|Overall Study|Subject Entered Another Trial|0|||
126304690|NCT01290679|454404294|FG001|Overall Study|Subject Entered Another Trial|5|||
126304691|NCT03124407|454404300|FG000|Overall Study|Lost to Follow-up|1|||
126304692|NCT03124407|454404301|FG001|Overall Study|Lost to Follow-up|0|||
126304693|NCT03124407|454404302|FG002|Overall Study|Lost to Follow-up|0|||
126304694|NCT03124407|454404303|FG003|Overall Study|Lost to Follow-up|0|||
126304695|NCT03124407|454404300|FG000|Overall Study|Adverse Event|0|||
126304696|NCT03124407|454404301|FG001|Overall Study|Adverse Event|0|||
126304697|NCT03124407|454404302|FG002|Overall Study|Adverse Event|1|||
126304698|NCT03124407|454404303|FG003|Overall Study|Adverse Event|0|||
126304699|NCT01860040|454404306|FG000|Overall Study|Withdrawal by Subject|1|||
126304700|NCT01860040|454404307|FG001|Overall Study|Withdrawal by Subject|0|||
126304701|NCT00403481|454404308|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
126304702|NCT00403481|454404308|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
126368189|NCT00725985|454642890|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126713856|NCT01097616|455903835|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
126304703|NCT00403481|454404308|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
126304704|NCT00403481|454404308|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
126304705|NCT00403481|454404308|FG000|Olm 40 mg|Adverse Event|2|||
126304706|NCT00403481|454404308|FG000|Olm 40 mg|Protocol Violation|1|||
126304707|NCT00403481|454404308|FG000|Olm 40 mg|Withdrawal by Subject|1|||
126304708|NCT00403481|454404308|FG000|Olm 40 mg|Other|1|||
126304709|NCT00403481|454404308|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
126304710|NCT00403481|454404308|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
126368190|NCT00725985|454642891|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126304711|NCT00403481|454404308|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
126304712|NCT00403481|454404308|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
126304713|NCT00403481|454404308|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
126304714|NCT00403481|454404308|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
126304715|NCT02821754|454404309|FG000|Overall Study|Procedure not required prior to amendment change|13|||
126304716|NCT02821754|454404310|FG001|Overall Study|Procedure not required prior to amendment change|11|||
126304717|NCT02821754|454404311|FG002|Overall Study|Procedure not required prior to amendment change|0|||
126304718|NCT02821754|454404309|FG000|Overall Study|Participant's Clinical status|2|||
126304719|NCT02821754|454404310|FG001|Overall Study|Participant's Clinical status|0|||
126304720|NCT02821754|454404311|FG002|Overall Study|Participant's Clinical status|0|||
126304721|NCT02821754|454404309|FG000|Overall Study|Participant removed for noncompliance|1|||
126304722|NCT02821754|454404310|FG001|Overall Study|Participant removed for noncompliance|0|||
126304723|NCT02821754|454404311|FG002|Overall Study|Participant removed for noncompliance|0|||
126304724|NCT02821754|454404309|FG000|Overall Study|Drug not available.|0|||
126304725|NCT02821754|454404310|FG001|Overall Study|Drug not available.|0|||
126304726|NCT02821754|454404311|FG002|Overall Study|Drug not available.|1|||
126304727|NCT02821754|454404309|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
126304728|NCT02821754|454404310|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
126304729|NCT02821754|454404311|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
126304730|NCT03793842|454404327|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
126304731|NCT03793842|454404328|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
126304732|NCT03793842|454404327|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
126304733|NCT03793842|454404328|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
126304734|NCT04657198|454404329|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
126304735|NCT04657198|454404330|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
126304736|NCT04657198|454404331|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
126304737|NCT00427921|454404337|FG000|Overall Study|Adverse Event|26|||
126304738|NCT00427921|454404337|FG000|Overall Study|Withdrawal by Subject|4|||
126304739|NCT00427921|454404337|FG000|Overall Study|Lost to Follow-up|2|||
126304740|NCT00427921|454404337|FG000|Overall Study|Other reason not specified|10|||
126304741|NCT00427921|454404337|FG000|Overall Study|Adverse Event + Hospitalization|1|||
126463345|NCT00206076|454998660|FG001|Overall Study|Physician Decision|0|||
126463346|NCT00206076|454998659|FG000|Overall Study|Withdrawal by Subject|1|||
126463347|NCT00206076|454998660|FG001|Overall Study|Withdrawal by Subject|1|||
126463348|NCT00366340|454998663|FG000|Infant Series|Protocol Violation|3|||
126463349|NCT00366340|454998664|FG001|Infant Series|Protocol Violation|4|||
126463350|NCT00366340|454998663|FG000|Infant Series|Withdrawal by Subject|3|||
126463351|NCT00366340|454998664|FG001|Infant Series|Withdrawal by Subject|3|||
126463352|NCT00366340|454998663|FG000|Infant Series|Adverse Event|0|||
126463353|NCT00366340|454998664|FG001|Infant Series|Adverse Event|2|||
126463354|NCT00366340|454998663|FG000|Infant Series|Lost to Follow-up|1|||
126463355|NCT00366340|454998664|FG001|Infant Series|Lost to Follow-up|1|||
126463356|NCT00366340|454998663|FG000|Infant Series|Failure to return|1|||
126463357|NCT00366340|454998664|FG001|Infant Series|Failure to return|0|||
126463358|NCT00366340|454998663|FG000|After the Infant Series|Parent/legal guardian request|1|||
126463359|NCT00366340|454998664|FG001|After the Infant Series|Parent/legal guardian request|1|||
126463360|NCT00366340|454998663|FG000|After the Infant Series|Failed to return|0|||
126463361|NCT00366340|454998664|FG001|After the Infant Series|Failed to return|1|||
126463362|NCT00366340|454998663|FG000|After the Infant Series|Protocol Violation|2|||
126463363|NCT00366340|454998664|FG001|After the Infant Series|Protocol Violation|2|||
126463364|NCT00366340|454998663|FG000|After the Infant Series|Adverse Event|0|||
126463365|NCT00366340|454998664|FG001|After the Infant Series|Adverse Event|1|||
126463366|NCT00366340|454998663|FG000|After the Infant Series|Lost to Follow-up|0|||
126463367|NCT00366340|454998664|FG001|After the Infant Series|Lost to Follow-up|1|||
126463368|NCT00366340|454998663|FG000|Toddler Dose|Failed to return|1|||
126463369|NCT00366340|454998664|FG001|Toddler Dose|Failed to return|0|||
126463370|NCT00366340|454998663|FG000|Toddler Dose|Parent/legal guardian request|0|||
126463371|NCT00366340|454998664|FG001|Toddler Dose|Parent/legal guardian request|1|||
126463372|NCT03355664|454998665|FG000|Overall Study|Adverse Event|1|||
126463373|NCT03355664|454998666|FG001|Overall Study|Adverse Event|2|||
126463374|NCT03355664|454998665|FG000|Overall Study|Lost to Follow-up|11|||
126463375|NCT03355664|454998666|FG001|Overall Study|Lost to Follow-up|7|||
126463376|NCT03355664|454998665|FG000|Overall Study|Protocol Violation|1|||
126463377|NCT03355664|454998666|FG001|Overall Study|Protocol Violation|2|||
126463378|NCT03355664|454998665|FG000|Overall Study|Withdrawal by Subject|2|||
126463379|NCT03355664|454998666|FG001|Overall Study|Withdrawal by Subject|1|||
126463380|NCT01315236|454998672|FG000|Double-blind Phase|Death|1|||
126463381|NCT01315236|454998673|FG001|Double-blind Phase|Death|0|||
126463382|NCT01315236|454998672|FG000|Double-blind Phase|Adverse Event|1|||
126463383|NCT01315236|454998673|FG001|Double-blind Phase|Adverse Event|0|||
126463384|NCT01315236|454998672|FG000|Double-blind Phase|Withdrawal of Consent|1|||
126463385|NCT01315236|454998673|FG001|Double-blind Phase|Withdrawal of Consent|0|||
126713857|NCT01097616|455903836|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
126713858|NCT01097616|455903837|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
126713859|NCT01097616|455903838|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126713860|NCT01097616|455903839|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126713861|NCT01097616|455903840|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126713862|NCT01097616|455903841|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126713863|NCT01097616|455903842|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
126713864|NCT01097616|455903835|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
126713865|NCT01097616|455903836|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
126713866|NCT01097616|455903837|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
126713867|NCT01097616|455903838|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
126713868|NCT01097616|455903839|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
126713869|NCT01097616|455903840|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
126713870|NCT01097616|455903841|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
126713871|NCT01097616|455903842|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
126713872|NCT01097616|455903835|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
126713873|NCT01097616|455903836|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
126713874|NCT01097616|455903837|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126713875|NCT01097616|455903838|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126713876|NCT01097616|455903839|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126713877|NCT01097616|455903840|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126715192|NCT01052012|455908707|FG001|Overall Study|Physician Decision|0|||
126304742|NCT00427921|454404337|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
126304743|NCT00427921|454404337|FG000|Overall Study|Adverse Event + No Response|1|||
126304744|NCT00427921|454404337|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
126304745|NCT00427921|454404337|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
126304746|NCT00427921|454404337|FG000|Overall Study|Adverse Event + Lost Response|1|||
126304747|NCT00427921|454404337|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
126304748|NCT00427921|454404337|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
126304749|NCT00900159|454404338|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
126304750|NCT00900159|454404339|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
126304751|NCT01075256|454404340|FG000|Overall Study|Withdrawal by Subject|1|||
126304752|NCT01075256|454404341|FG001|Overall Study|Withdrawal by Subject|0|||
126304753|NCT01075256|454404342|FG002|Overall Study|Withdrawal by Subject|0|||
126304754|NCT02858583|454404345|FG000|Overall Study|Declined consent|1|||
126304755|NCT02858583|454404346|FG001|Overall Study|Declined consent|1|||
126304756|NCT00347009|454404347|FG000|Overall Study|Death|1|||
126304757|NCT00347009|454404347|FG000|Overall Study|Adverse Event|6|||
126368191|NCT00725985|454642892|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126368192|NCT00725985|454642893|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126368193|NCT00725985|454642894|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126368194|NCT00725985|454642895|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126368195|NCT00725985|454642896|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126368196|NCT00725985|454642897|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
126368197|NCT00725985|454642898|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
126368198|NCT00725985|454642899|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
126368199|NCT00725985|454642900|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
126368200|NCT04476784|454642901|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
126368201|NCT04476784|454642902|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
126368202|NCT00863304|454642903|FG000|Overall Study|Adverse Event|10|||
126368203|NCT00863304|454642904|FG001|Overall Study|Adverse Event|4|||
126368204|NCT00863304|454642905|FG002|Overall Study|Adverse Event|14|||
126368205|NCT00863304|454642906|FG003|Overall Study|Adverse Event|16|||
126368206|NCT00863304|454642903|FG000|Overall Study|Lost to Follow-up|1|||
126368207|NCT00863304|454642904|FG001|Overall Study|Lost to Follow-up|5|||
126368208|NCT00863304|454642905|FG002|Overall Study|Lost to Follow-up|4|||
126368209|NCT00863304|454642906|FG003|Overall Study|Lost to Follow-up|2|||
126368210|NCT00863304|454642903|FG000|Overall Study|Lack of Efficacy|57|||
126368211|NCT00863304|454642904|FG001|Overall Study|Lack of Efficacy|26|||
126368212|NCT00863304|454642905|FG002|Overall Study|Lack of Efficacy|30|||
126368213|NCT00863304|454642906|FG003|Overall Study|Lack of Efficacy|28|||
126368214|NCT00863304|454642903|FG000|Overall Study|Withdrawal by Subject|19|||
126368215|NCT00863304|454642904|FG001|Overall Study|Withdrawal by Subject|14|||
126368216|NCT00863304|454642905|FG002|Overall Study|Withdrawal by Subject|20|||
126368217|NCT00863304|454642906|FG003|Overall Study|Withdrawal by Subject|18|||
126368218|NCT00863304|454642903|FG000|Overall Study|Other|1|||
126368219|NCT00863304|454642904|FG001|Overall Study|Other|0|||
126368220|NCT00863304|454642905|FG002|Overall Study|Other|0|||
126368221|NCT00863304|454642906|FG003|Overall Study|Other|1|||
126304758|NCT00347009|454404347|FG000|Overall Study|Withdrawal by Subject|3|||
126304759|NCT00347009|454404347|FG000|Overall Study|Physician Decision|5|||
126368222|NCT00863304|454642903|FG000|Overall Study|Protocol Violation|2|||
126368223|NCT00863304|454642904|FG001|Overall Study|Protocol Violation|6|||
126304760|NCT00347009|454404347|FG000|Overall Study|Lost to Follow-up|4|||
126304761|NCT00347009|454404347|FG000|Overall Study|Protocol Violation|2|||
126304762|NCT00347009|454404347|FG000|Overall Study|Adverse Laboratory Experience|1|||
126713878|NCT01097616|455903841|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126713879|NCT01097616|455903842|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
126713880|NCT01097616|455903835|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126713881|NCT01097616|455903836|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126713882|NCT01097616|455903837|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
126713883|NCT01097616|455903838|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126713884|NCT01097616|455903839|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126713885|NCT01097616|455903840|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126713886|NCT01097616|455903841|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126713887|NCT01097616|455903842|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
126713888|NCT01097616|455903835|FG000|Optional DB EXT Phase|Adverse Event|0|||
126713889|NCT01097616|455903836|FG001|Optional DB EXT Phase|Adverse Event|7|||
126713890|NCT01097616|455903837|FG002|Optional DB EXT Phase|Adverse Event|2|||
126713891|NCT01097616|455903838|FG003|Optional DB EXT Phase|Adverse Event|0|||
126713892|NCT01097616|455903839|FG004|Optional DB EXT Phase|Adverse Event|0|||
126713893|NCT01097616|455903840|FG005|Optional DB EXT Phase|Adverse Event|0|||
126713894|NCT01097616|455903841|FG006|Optional DB EXT Phase|Adverse Event|0|||
126713895|NCT01097616|455903842|FG007|Optional DB EXT Phase|Adverse Event|0|||
126713896|NCT01097616|455903835|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
126713897|NCT01097616|455903836|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
126713898|NCT01097616|455903837|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
126713899|NCT01097616|455903838|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
126713900|NCT01097616|455903839|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
126713901|NCT01097616|455903840|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
126713902|NCT01097616|455903841|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
126713903|NCT01097616|455903842|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
126713904|NCT01097616|455903835|FG000|Optional DB EXT Phase|Protocol Violation|0|||
126713905|NCT01097616|455903836|FG001|Optional DB EXT Phase|Protocol Violation|2|||
126713906|NCT01097616|455903837|FG002|Optional DB EXT Phase|Protocol Violation|3|||
126713907|NCT01097616|455903838|FG003|Optional DB EXT Phase|Protocol Violation|0|||
126713908|NCT01097616|455903839|FG004|Optional DB EXT Phase|Protocol Violation|0|||
126713909|NCT01097616|455903840|FG005|Optional DB EXT Phase|Protocol Violation|0|||
126713910|NCT01097616|455903841|FG006|Optional DB EXT Phase|Protocol Violation|0|||
126713911|NCT01097616|455903842|FG007|Optional DB EXT Phase|Protocol Violation|0|||
126713912|NCT01097616|455903835|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
126713913|NCT01097616|455903836|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
126713914|NCT01097616|455903837|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
126713915|NCT01097616|455903838|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
126713916|NCT01097616|455903839|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
126713917|NCT01097616|455903840|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
126713918|NCT01097616|455903841|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
126713919|NCT01097616|455903842|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
126713920|NCT01097616|455903835|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
126713921|NCT01097616|455903836|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
126713922|NCT01097616|455903837|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
126713923|NCT01097616|455903838|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
126713924|NCT01097616|455903839|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
126713925|NCT01097616|455903840|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
126713926|NCT01097616|455903841|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
126713927|NCT01097616|455903842|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
126713928|NCT01097616|455903835|FG000|Optional DB EXT Phase|Physician Decision|1|||
126713929|NCT01097616|455903836|FG001|Optional DB EXT Phase|Physician Decision|0|||
126713930|NCT01097616|455903837|FG002|Optional DB EXT Phase|Physician Decision|0|||
126713931|NCT01097616|455903838|FG003|Optional DB EXT Phase|Physician Decision|0|||
126713932|NCT01097616|455903839|FG004|Optional DB EXT Phase|Physician Decision|0|||
126713933|NCT01097616|455903840|FG005|Optional DB EXT Phase|Physician Decision|0|||
126713934|NCT01097616|455903841|FG006|Optional DB EXT Phase|Physician Decision|0|||
126713935|NCT01097616|455903842|FG007|Optional DB EXT Phase|Physician Decision|0|||
126713936|NCT01097616|455903835|FG000|DB RO Phase|Adverse Event|0|||
126304763|NCT00347009|454404347|FG000|Overall Study|Insufficient Viral Suppression|3|||
126304764|NCT00347009|454404347|FG000|Overall Study|Increased ALT/HBV DNA|1|||
126304765|NCT00347009|454404347|FG000|Overall Study|Serious Adverse Event|1|||
126713937|NCT01097616|455903836|FG001|DB RO Phase|Adverse Event|0|||
126713938|NCT01097616|455903837|FG002|DB RO Phase|Adverse Event|0|||
126770340|NCT01787188|456112457|FG001|Overall Study|Non-compliance with Study Drug|1|||
126770341|NCT01787188|456112458|FG002|Overall Study|Non-compliance with Study Drug|0|||
126770342|NCT01787188|456112456|FG000|Overall Study|Withdrawal by Subject|4|||
126770343|NCT01787188|456112457|FG001|Overall Study|Withdrawal by Subject|3|||
126304766|NCT03478644|454404353|FG000|Phase 2|Withdrawal by Subject|2|||
126304767|NCT03478644|454404354|FG001|Phase 2|Withdrawal by Subject|1|||
126551365|NCT02601937|455311876|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
126551366|NCT02601937|455311877|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
126551367|NCT02601937|455311878|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
126551368|NCT02601937|455311868|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
126551369|NCT02601937|455311869|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
126551370|NCT02601937|455311870|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
126551371|NCT02601937|455311871|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
126551372|NCT02601937|455311872|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
126551373|NCT02601937|455311873|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
126551374|NCT02601937|455311874|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
126551375|NCT02601937|455311875|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
126551376|NCT02601937|455311876|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
126551377|NCT02601937|455311877|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
126551378|NCT02601937|455311878|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
126551379|NCT02601937|455311868|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
126551380|NCT02601937|455311869|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
126551381|NCT02601937|455311870|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
126551382|NCT02601937|455311871|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
126551383|NCT02601937|455311872|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
126551384|NCT02601937|455311873|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
126551385|NCT02601937|455311874|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
126551386|NCT02601937|455311875|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
126551387|NCT02601937|455311876|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
126551388|NCT02601937|455311877|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
126551389|NCT02601937|455311878|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
126551390|NCT02601937|455311868|FG000|Period 2: Dose Expansion Cohort|Other|0|||
126551391|NCT02601937|455311869|FG001|Period 2: Dose Expansion Cohort|Other|0|||
126551392|NCT02601937|455311870|FG002|Period 2: Dose Expansion Cohort|Other|0|||
126551393|NCT02601937|455311871|FG003|Period 2: Dose Expansion Cohort|Other|0|||
126551394|NCT02601937|455311872|FG004|Period 2: Dose Expansion Cohort|Other|0|||
126304768|NCT03478644|454404353|FG000|Phase 2|Lost to Follow-up|1|||
126304769|NCT03478644|454404354|FG001|Phase 2|Lost to Follow-up|0|||
126304770|NCT01029782|454404355|FG000|Overall Study|Lost to Follow-up|2|||
126770344|NCT01787188|456112458|FG002|Overall Study|Withdrawal by Subject|2|||
126770345|NCT01787188|456112456|FG000|Overall Study|Protocol Violation|3|||
126770346|NCT01787188|456112457|FG001|Overall Study|Protocol Violation|2|||
126770347|NCT01787188|456112458|FG002|Overall Study|Protocol Violation|3|||
126770348|NCT01787188|456112456|FG000|Overall Study|Lost to Follow-up|1|||
126770349|NCT01787188|456112457|FG001|Overall Study|Lost to Follow-up|2|||
126770350|NCT01787188|456112458|FG002|Overall Study|Lost to Follow-up|2|||
126770351|NCT01787188|456112456|FG000|Overall Study|Other, including patient moved|0|||
126770352|NCT01787188|456112457|FG001|Overall Study|Other, including patient moved|3|||
126770353|NCT01787188|456112458|FG002|Overall Study|Other, including patient moved|0|||
126770354|NCT02756078|456112461|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
126770355|NCT02756078|456112462|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
126770356|NCT02756078|456112461|FG000|Period 1|Lost to Follow-up|0|||
126770357|NCT02756078|456112462|FG001|Period 1|Lost to Follow-up|2|||
126770358|NCT02756078|456112461|FG000|Period 1|Protocol Violation|0|||
126713939|NCT01097616|455903838|FG003|DB RO Phase|Adverse Event|0|||
126713940|NCT01097616|455903839|FG004|DB RO Phase|Adverse Event|0|||
126713941|NCT01097616|455903840|FG005|DB RO Phase|Adverse Event|0|||
126713942|NCT01097616|455903841|FG006|DB RO Phase|Adverse Event|1|||
126713943|NCT01097616|455903842|FG007|DB RO Phase|Adverse Event|0|||
126713944|NCT01097616|455903835|FG000|DB RO Phase|Withdrawal by Subject|0|||
126713945|NCT01097616|455903836|FG001|DB RO Phase|Withdrawal by Subject|0|||
126713946|NCT01097616|455903837|FG002|DB RO Phase|Withdrawal by Subject|0|||
126713947|NCT01097616|455903838|FG003|DB RO Phase|Withdrawal by Subject|0|||
126713948|NCT01097616|455903839|FG004|DB RO Phase|Withdrawal by Subject|0|||
126713949|NCT01097616|455903840|FG005|DB RO Phase|Withdrawal by Subject|1|||
126713950|NCT01097616|455903841|FG006|DB RO Phase|Withdrawal by Subject|0|||
126713951|NCT01097616|455903842|FG007|DB RO Phase|Withdrawal by Subject|0|||
126304771|NCT01029782|454404356|FG001|Overall Study|Lost to Follow-up|2|||
126304772|NCT01029782|454404355|FG000|Overall Study|Diagnosis changed|1|||
126713952|NCT01097616|455903835|FG000|DB RO Phase|Lost to Follow-up|0|||
126713953|NCT01097616|455903836|FG001|DB RO Phase|Lost to Follow-up|0|||
126713954|NCT01097616|455903837|FG002|DB RO Phase|Lost to Follow-up|0|||
126551395|NCT02601937|455311873|FG005|Period 2: Dose Expansion Cohort|Other|0|||
126551396|NCT02601937|455311874|FG006|Period 2: Dose Expansion Cohort|Other|0|||
126713955|NCT01097616|455903838|FG003|DB RO Phase|Lost to Follow-up|1|||
126713956|NCT01097616|455903839|FG004|DB RO Phase|Lost to Follow-up|1|||
126770359|NCT02756078|456112462|FG001|Period 1|Protocol Violation|1|||
126304773|NCT01029782|454404356|FG001|Overall Study|Diagnosis changed|1|||
126713957|NCT01097616|455903840|FG005|DB RO Phase|Lost to Follow-up|0|||
126770360|NCT02756078|456112461|FG000|Period 1|Adverse Event|1|||
126551397|NCT02601937|455311875|FG007|Period 2: Dose Expansion Cohort|Other|0|||
126551398|NCT02601937|455311876|FG008|Period 2: Dose Expansion Cohort|Other|2|||
126551399|NCT02601937|455311877|FG009|Period 2: Dose Expansion Cohort|Other|2|||
126551400|NCT02601937|455311878|FG010|Period 2: Dose Expansion Cohort|Other|0|||
126551401|NCT02601937|455311868|FG000|Period 2: Dose Expansion Cohort|Death|0|||
126551402|NCT02601937|455311869|FG001|Period 2: Dose Expansion Cohort|Death|0|||
126551403|NCT02601937|455311870|FG002|Period 2: Dose Expansion Cohort|Death|0|||
126551404|NCT02601937|455311871|FG003|Period 2: Dose Expansion Cohort|Death|0|||
126551405|NCT02601937|455311872|FG004|Period 2: Dose Expansion Cohort|Death|0|||
126551406|NCT02601937|455311873|FG005|Period 2: Dose Expansion Cohort|Death|0|||
126551407|NCT02601937|455311874|FG006|Period 2: Dose Expansion Cohort|Death|0|||
126551408|NCT02601937|455311875|FG007|Period 2: Dose Expansion Cohort|Death|0|||
126551409|NCT02601937|455311876|FG008|Period 2: Dose Expansion Cohort|Death|1|||
126551410|NCT02601937|455311877|FG009|Period 2: Dose Expansion Cohort|Death|0|||
126551411|NCT02601937|455311878|FG010|Period 2: Dose Expansion Cohort|Death|0|||
126551412|NCT02924389|455311879|FG000|Overall Study|Lost to Follow-up|1|||
126551413|NCT02924389|455311880|FG001|Overall Study|Lost to Follow-up|0|||
126551414|NCT02924389|455311879|FG000|Overall Study|Physician Decision|2|||
126551415|NCT02924389|455311880|FG001|Overall Study|Physician Decision|0|||
126551416|NCT02924389|455311879|FG000|Overall Study|Withdrawal by Subject|3|||
126551417|NCT02924389|455311880|FG001|Overall Study|Withdrawal by Subject|0|||
126551418|NCT02924389|455311879|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
126551419|NCT02924389|455311880|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
126551420|NCT03918239|455313657|FG000|Overall Study|Lost to Follow-up|3|||
126551421|NCT03918239|455313658|FG001|Overall Study|Lost to Follow-up|1|||
126551422|NCT03918239|455313657|FG000|Overall Study|Pregnancy|0|||
126551423|NCT03918239|455313658|FG001|Overall Study|Pregnancy|2|||
126551424|NCT03918239|455313657|FG000|Overall Study|Withdrawal by Subject|3|||
126551425|NCT03918239|455313658|FG001|Overall Study|Withdrawal by Subject|3|||
126551426|NCT03918239|455313657|FG000|Overall Study|positive urine drug screening results|4|||
126551427|NCT03918239|455313658|FG001|Overall Study|positive urine drug screening results|1|||
126551428|NCT02930122|455313659|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
126551429|NCT02930122|455313660|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
126551430|NCT00593554|455313664|FG000|Overall Study|Death|1|||
126551431|NCT00593554|455313665|FG001|Overall Study|Death|2|||
126551432|NCT00593554|455313664|FG000|Overall Study|Physician Decision|0|||
126551433|NCT00593554|455313665|FG001|Overall Study|Physician Decision|1|||
126551434|NCT00593554|455313664|FG000|Overall Study|Withdrawal by Subject|1|||
126551435|NCT00593554|455313665|FG001|Overall Study|Withdrawal by Subject|0|||
126551436|NCT00593554|455313664|FG000|Overall Study|Disease Progression|1|||
126551437|NCT00593554|455313665|FG001|Overall Study|Disease Progression|2|||
126551438|NCT01024959|455313666|FG000|Overall Study|ineligible|12|||
126551439|NCT01024959|455313666|FG000|Overall Study|results not evaluable|12|||
126304774|NCT01029782|454404355|FG000|Overall Study|Adverse Event|0|||
126304775|NCT01029782|454404356|FG001|Overall Study|Adverse Event|1|||
126304776|NCT01029782|454404355|FG000|Overall Study|Physician Decision|0|||
126551440|NCT01024959|455313666|FG000|Overall Study|missing results required for analysis|17|||
126551441|NCT00636792|455313667|FG000|Overall Study|Adverse Event|16|||
126551442|NCT00636792|455313667|FG000|Overall Study|Physician Decision|7|||
126551443|NCT00636792|455313667|FG000|Overall Study|Progressive Disease|4|||
126551444|NCT00636792|455313667|FG000|Overall Study|Withdrawal by Subject|3|||
126713958|NCT01097616|455903841|FG006|DB RO Phase|Lost to Follow-up|0|||
126713959|NCT01097616|455903842|FG007|DB RO Phase|Lost to Follow-up|1|||
126713960|NCT01097616|455903835|FG000|DB RO Phase|Not Treated in RO|0|||
126713961|NCT01097616|455903836|FG001|DB RO Phase|Not Treated in RO|0|||
126713962|NCT01097616|455903837|FG002|DB RO Phase|Not Treated in RO|0|||
126713963|NCT01097616|455903838|FG003|DB RO Phase|Not Treated in RO|0|||
126713964|NCT01097616|455903839|FG004|DB RO Phase|Not Treated in RO|0|||
126713965|NCT01097616|455903840|FG005|DB RO Phase|Not Treated in RO|1|||
126713966|NCT01097616|455903841|FG006|DB RO Phase|Not Treated in RO|0|||
126713967|NCT01097616|455903842|FG007|DB RO Phase|Not Treated in RO|0|||
126713968|NCT01996319|455903843|FG000|Overall Study|Protocol Violation|1|||
126713969|NCT01996319|455903844|FG001|Overall Study|Protocol Violation|0|||
126713970|NCT01996319|455903843|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
126713971|NCT01996319|455903844|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
126713972|NCT01996319|455903843|FG000|Overall Study|Adverse Event|2|||
126713973|NCT01996319|455903844|FG001|Overall Study|Adverse Event|2|||
126713974|NCT00117338|455903845|FG000|Overall Study|Adverse Event|0|||
126713975|NCT00117338|455903846|FG001|Overall Study|Adverse Event|1|||
126304777|NCT01029782|454404356|FG001|Overall Study|Physician Decision|1|||
126551445|NCT00636792|455313667|FG000|Overall Study|Other|3|||
126551446|NCT00709592|455313670|FG000|Overall Study|Unable to proceed to transplant|0|||
126713976|NCT00117338|455903845|FG000|Overall Study|Protocol Violation|3|||
126304778|NCT01029782|454404355|FG000|Overall Study|Protocol Violation|0|||
126551447|NCT00709592|455313671|FG001|Overall Study|Unable to proceed to transplant|1|||
126713977|NCT00117338|455903846|FG001|Overall Study|Protocol Violation|2|||
126713978|NCT00117338|455903845|FG000|Overall Study|Withdrawal by Subject|1|||
126713979|NCT00117338|455903846|FG001|Overall Study|Withdrawal by Subject|0|||
126713980|NCT00117338|455903845|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
126713981|NCT00117338|455903846|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
126713982|NCT00117338|455903845|FG000|Overall Study|Lack of Efficacy|0|||
126713983|NCT00117338|455903846|FG001|Overall Study|Lack of Efficacy|1|||
126713984|NCT02240628|455903848|FG000|Overall Study|Physician Decision|6|||
126713985|NCT02240628|455903849|FG001|Overall Study|Physician Decision|5|||
126713986|NCT01703819|455903853|FG000|Overall Study|Adverse Event|0|||
126713987|NCT01703819|455903854|FG001|Overall Study|Adverse Event|1|||
126713988|NCT01703819|455903853|FG000|Overall Study|Withdrawal by Subject|0|||
126368224|NCT00863304|454642905|FG002|Overall Study|Protocol Violation|2|||
126368225|NCT00863304|454642906|FG003|Overall Study|Protocol Violation|0|||
126368226|NCT00863304|454642903|FG000|Overall Study|Randomized, but not Treated|3|||
126368227|NCT00863304|454642904|FG001|Overall Study|Randomized, but not Treated|1|||
126368228|NCT00863304|454642905|FG002|Overall Study|Randomized, but not Treated|4|||
126368229|NCT00863304|454642906|FG003|Overall Study|Randomized, but not Treated|1|||
126368230|NCT00863304|454642903|FG000|Overall Study|Entered extension study|101|||
126368231|NCT00863304|454642904|FG001|Overall Study|Entered extension study|129|||
126368232|NCT00863304|454642905|FG002|Overall Study|Entered extension study|113|||
126368233|NCT00863304|454642906|FG003|Overall Study|Entered extension study|125|||
126368234|NCT06582732|454642907|FG000|Initial Study Period|Adverse Event|0|||
126368235|NCT06582732|454642908|FG001|Initial Study Period|Adverse Event|0|||
126368236|NCT06582732|454642909|FG002|Initial Study Period|Adverse Event|0|||
126368237|NCT06582732|454642910|FG003|Initial Study Period|Adverse Event|2|||
126368238|NCT06582732|454642911|FG004|Initial Study Period|Adverse Event|0|||
126368239|NCT06582732|454642912|FG005|Initial Study Period|Adverse Event|0|||
126368240|NCT06582732|454642913|FG006|Initial Study Period|Adverse Event|0|||
126368241|NCT06582732|454642907|FG000|Initial Study Period|Death|1|||
126368242|NCT06582732|454642908|FG001|Initial Study Period|Death|0|||
126368243|NCT06582732|454642909|FG002|Initial Study Period|Death|0|||
126368244|NCT06582732|454642910|FG003|Initial Study Period|Death|0|||
126368245|NCT06582732|454642911|FG004|Initial Study Period|Death|1|||
126368246|NCT06582732|454642912|FG005|Initial Study Period|Death|0|||
126368247|NCT06582732|454642913|FG006|Initial Study Period|Death|0|||
126368248|NCT06582732|454642907|FG000|Initial Study Period|Lost to Follow-up|0|||
126368249|NCT06582732|454642908|FG001|Initial Study Period|Lost to Follow-up|0|||
126368250|NCT06582732|454642909|FG002|Initial Study Period|Lost to Follow-up|2|||
126368251|NCT06582732|454642910|FG003|Initial Study Period|Lost to Follow-up|0|||
126368252|NCT06582732|454642911|FG004|Initial Study Period|Lost to Follow-up|0|||
126368253|NCT06582732|454642912|FG005|Initial Study Period|Lost to Follow-up|0|||
126368254|NCT06582732|454642913|FG006|Initial Study Period|Lost to Follow-up|0|||
126368255|NCT06582732|454642907|FG000|Initial Study Period|Withdrawal by Subject|0|||
126368256|NCT06582732|454642908|FG001|Initial Study Period|Withdrawal by Subject|1|||
126368257|NCT06582732|454642909|FG002|Initial Study Period|Withdrawal by Subject|0|||
126368258|NCT06582732|454642910|FG003|Initial Study Period|Withdrawal by Subject|1|||
126368259|NCT06582732|454642911|FG004|Initial Study Period|Withdrawal by Subject|3|||
126368260|NCT06582732|454642912|FG005|Initial Study Period|Withdrawal by Subject|1|||
126368261|NCT06582732|454642913|FG006|Initial Study Period|Withdrawal by Subject|2|||
126368262|NCT06582732|454642907|FG000|Initial Study Period|Moved Away|0|||
126368263|NCT06582732|454642908|FG001|Initial Study Period|Moved Away|0|||
126368264|NCT06582732|454642909|FG002|Initial Study Period|Moved Away|0|||
126368265|NCT06582732|454642910|FG003|Initial Study Period|Moved Away|0|||
126368266|NCT06582732|454642911|FG004|Initial Study Period|Moved Away|1|||
126368267|NCT06582732|454642912|FG005|Initial Study Period|Moved Away|0|||
126368268|NCT06582732|454642913|FG006|Initial Study Period|Moved Away|0|||
126368269|NCT03528902|454642916|FG000|Overall Study|Adverse Event|1|||
126368270|NCT03528902|454642917|FG001|Overall Study|Adverse Event|0|||
126368271|NCT05030766|454642918|FG000|Phase 1 Participants|Lost to Follow-up|12|||
126368272|NCT05030766|454642919|FG001|Phase 1 Participants|Lost to Follow-up|22|||
126368273|NCT05030766|454642920|FG002|Phase 1 Participants|Lost to Follow-up|0|||
126368274|NCT05030766|454642921|FG003|Phase 1 Participants|Lost to Follow-up|0|||
126368275|NCT05030766|454642918|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
126368276|NCT05030766|454642919|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
126368277|NCT05030766|454642920|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
126368278|NCT05030766|454642921|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
126368279|NCT05030766|454642918|FG000|Phase 2 Participants|Lost to Follow-up|0|||
126368280|NCT05030766|454642919|FG001|Phase 2 Participants|Lost to Follow-up|0|||
126368281|NCT05030766|454642920|FG002|Phase 2 Participants|Lost to Follow-up|6|||
126368282|NCT05030766|454642921|FG003|Phase 2 Participants|Lost to Follow-up|2|||
126368283|NCT00645658|454642922|FG000|Overall Study|Withdrawal by Subject|1|||
126368284|NCT00645658|454642923|FG001|Overall Study|Withdrawal by Subject|0|||
126368285|NCT00645658|454642922|FG000|Overall Study|Did not complete all assesments|0|||
126713989|NCT01703819|455903854|FG001|Overall Study|Withdrawal by Subject|1|||
126463386|NCT01315236|454998672|FG000|Double-blind Phase|Lost to Follow-up|1|||
126551448|NCT01129336|455313672|FG000|Overall Study|Protocol Violation|1|||
126551449|NCT01129336|455313673|FG001|Overall Study|Protocol Violation|0|||
126551450|NCT01129336|455313672|FG000|Overall Study|Disease Progression|1|||
126551451|NCT01129336|455313673|FG001|Overall Study|Disease Progression|4|||
126551452|NCT01129336|455313672|FG000|Overall Study|Lost to Follow-up|1|||
126551453|NCT01129336|455313673|FG001|Overall Study|Lost to Follow-up|0|||
126551454|NCT01129336|455313672|FG000|Overall Study|Withdrawal by Subject|7|||
126551455|NCT01129336|455313673|FG001|Overall Study|Withdrawal by Subject|4|||
126551456|NCT01129336|455313672|FG000|Overall Study|Adverse Event|0|||
126551457|NCT01129336|455313673|FG001|Overall Study|Adverse Event|1|||
126551458|NCT01129336|455313672|FG000|Overall Study|Missing Study Completion Status|2|||
126551459|NCT01129336|455313673|FG001|Overall Study|Missing Study Completion Status|3|||
126551460|NCT01129336|455313672|FG000|Overall Study|Death|0|||
126551461|NCT01129336|455313673|FG001|Overall Study|Death|4|||
126551462|NCT00919893|455313674|FG000|Overall Study|Protocol Violation|19|||
126551463|NCT00919893|455313675|FG001|Overall Study|Protocol Violation|9|||
126551464|NCT01375959|455313676|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
126551465|NCT01375959|455313677|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
126551466|NCT01375959|455313676|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
126551467|NCT01375959|455313677|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
126551468|NCT01375959|455313676|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
126551469|NCT01375959|455313677|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
126551470|NCT00178256|455313678|FG000|Overall Study|Adverse Event|2|||
126551471|NCT00178256|455313679|FG001|Overall Study|Adverse Event|0|||
126551472|NCT00178256|455313680|FG002|Overall Study|Adverse Event|0|||
126551473|NCT00178256|455313681|FG003|Overall Study|Adverse Event|0|||
126551474|NCT00178256|455313678|FG000|Overall Study|Death|0|||
126551475|NCT00178256|455313679|FG001|Overall Study|Death|1|||
126551476|NCT00178256|455313680|FG002|Overall Study|Death|0|||
126551477|NCT00178256|455313681|FG003|Overall Study|Death|1|||
126551478|NCT00178256|455313678|FG000|Overall Study|Cancer progression|2|||
126551479|NCT00178256|455313679|FG001|Overall Study|Cancer progression|0|||
126551480|NCT00178256|455313680|FG002|Overall Study|Cancer progression|0|||
126551481|NCT00178256|455313681|FG003|Overall Study|Cancer progression|1|||
126551482|NCT02086552|455313682|FG000|Overall Study|Withdrawal by Subject|1|||
126551483|NCT00708305|455313683|FG000|Period 1|Protocol Violation|1|||
126551484|NCT00708305|455313684|FG001|Period 1|Protocol Violation|0|||
126551485|NCT00708305|455313685|FG002|Period 1|Protocol Violation|1|||
126551486|NCT00708305|455313686|FG003|Period 1|Protocol Violation|0|||
126551487|NCT00708305|455313683|FG000|Period 1|Other Reason|0|||
126551488|NCT00708305|455313684|FG001|Period 1|Other Reason|0|||
126551489|NCT00708305|455313685|FG002|Period 1|Other Reason|0|||
126551490|NCT00708305|455313686|FG003|Period 1|Other Reason|2|||
126551491|NCT00708305|455313683|FG000|Period 2|Lost to Follow-up|0|||
126551492|NCT00708305|455313684|FG001|Period 2|Lost to Follow-up|1|||
126551493|NCT00708305|455313685|FG002|Period 2|Lost to Follow-up|0|||
126551494|NCT00708305|455313686|FG003|Period 2|Lost to Follow-up|0|||
126551495|NCT00708305|455313683|FG000|Period 2|Protocol Violation|0|||
126551496|NCT00708305|455313684|FG001|Period 2|Protocol Violation|1|||
126551497|NCT00708305|455313685|FG002|Period 2|Protocol Violation|0|||
126551498|NCT00708305|455313686|FG003|Period 2|Protocol Violation|0|||
126713990|NCT00859898|455903855|FG000|Overall Study|Lack of Efficacy|0|||
126713991|NCT00859898|455903856|FG001|Overall Study|Lack of Efficacy|1|||
126713992|NCT00859898|455903857|FG002|Overall Study|Lack of Efficacy|1|||
126463387|NCT01315236|454998673|FG001|Double-blind Phase|Lost to Follow-up|0|||
126463388|NCT01315236|454998672|FG000|Open-label Phase|Death|1|||
126463389|NCT01315236|454998673|FG001|Open-label Phase|Death|0|||
126463390|NCT01315236|454998672|FG000|Open-label Phase|Adverse Event|0|||
126463391|NCT01315236|454998673|FG001|Open-label Phase|Adverse Event|1|||
126463392|NCT01315236|454998672|FG000|Open-label Phase|Other|0|||
126463393|NCT01315236|454998673|FG001|Open-label Phase|Other|1|||
126713993|NCT00859898|455903855|FG000|Overall Study|Adverse Event|4|||
126713994|NCT00859898|455903856|FG001|Overall Study|Adverse Event|9|||
126713995|NCT00859898|455903857|FG002|Overall Study|Adverse Event|8|||
126713996|NCT00859898|455903855|FG000|Overall Study|Withdrawal by Subject|11|||
126713997|NCT00859898|455903856|FG001|Overall Study|Withdrawal by Subject|8|||
126713998|NCT00859898|455903857|FG002|Overall Study|Withdrawal by Subject|11|||
126713999|NCT00859898|455903855|FG000|Overall Study|Death|0|||
126714000|NCT00859898|455903856|FG001|Overall Study|Death|0|||
126463394|NCT01315236|454998672|FG000|12-Month Follow-up Period|Death|0|||
126463395|NCT01315236|454998673|FG001|12-Month Follow-up Period|Death|1|||
126463396|NCT01315236|454998672|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
126551499|NCT00708305|455313683|FG000|Period 2|Other Reason|1|||
126551500|NCT00708305|455313684|FG001|Period 2|Other Reason|0|||
126551501|NCT00708305|455313685|FG002|Period 2|Other Reason|0|||
126551502|NCT00708305|455313686|FG003|Period 2|Other Reason|1|||
126551503|NCT00708305|455313683|FG000|Period 3|Protocol Violation|0|||
126551504|NCT00708305|455313684|FG001|Period 3|Protocol Violation|2|||
126551505|NCT00708305|455313685|FG002|Period 3|Protocol Violation|0|||
126714001|NCT00859898|455903857|FG002|Overall Study|Death|1|||
126714002|NCT00859898|455903855|FG000|Overall Study|Lost to Follow-up|10|||
126714003|NCT00859898|455903856|FG001|Overall Study|Lost to Follow-up|11|||
126714004|NCT00859898|455903857|FG002|Overall Study|Lost to Follow-up|5|||
126714005|NCT00859898|455903855|FG000|Overall Study|poor/non-compliance|2|||
126714006|NCT00859898|455903856|FG001|Overall Study|poor/non-compliance|0|||
126714007|NCT00859898|455903857|FG002|Overall Study|poor/non-compliance|0|||
126714008|NCT00859898|455903855|FG000|Overall Study|No longer meets criteria|0|||
126714009|NCT00859898|455903856|FG001|Overall Study|No longer meets criteria|1|||
126714010|NCT00859898|455903857|FG002|Overall Study|No longer meets criteria|0|||
126714011|NCT00859898|455903855|FG000|Overall Study|non-specified|1|||
126714012|NCT00859898|455903856|FG001|Overall Study|non-specified|1|||
126714013|NCT00859898|455903857|FG002|Overall Study|non-specified|1|||
126714014|NCT02145156|455903858|FG000|Overall Study|No match to vaccination records|60|||
126714015|NCT02145156|455903859|FG001|Overall Study|No match to vaccination records|52|||
126714016|NCT02145156|455903860|FG002|Overall Study|No match to vaccination records|41|||
126714017|NCT01302041|455903861|FG000|Overall Study|Death|5|||
126714018|NCT01302041|455903861|FG000|Overall Study|Withdrawal by Subject|4|||
126714019|NCT01302041|455903861|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
126714020|NCT01302041|455903861|FG000|Overall Study|Other-Miscellaneous Reason|2|||
126714021|NCT00771030|455903862|FG000|Overall Study|Adverse Event|0|||
126714022|NCT00771030|455903863|FG001|Overall Study|Adverse Event|1|||
126714023|NCT00771030|455903864|FG002|Overall Study|Adverse Event|0|||
126714024|NCT00771030|455903865|FG003|Overall Study|Adverse Event|0|||
126714025|NCT00771030|455903866|FG004|Overall Study|Adverse Event|0|||
126714026|NCT00771030|455903867|FG005|Overall Study|Adverse Event|0|||
126714027|NCT00771030|455903868|FG006|Overall Study|Adverse Event|0|||
126714028|NCT01797783|455903869|FG000|Overall Study|Adverse Event|1|||
126714029|NCT01797783|455903870|FG001|Overall Study|Adverse Event|1|||
126714030|NCT01797783|455903869|FG000|Overall Study|Withdrawal by Subject|1|||
126714031|NCT01797783|455903870|FG001|Overall Study|Withdrawal by Subject|0|||
126714032|NCT05232097|455903873|FG000|Overall Study|Physician Decision|1|||
126714033|NCT00871858|455903874|FG000|Overall Study|Protocol Violation|3|||
126714034|NCT00871858|455903875|FG001|Overall Study|Protocol Violation|4|||
126714035|NCT00871858|455903874|FG000|Overall Study|Adverse Event|1|||
126714036|NCT00871858|455903875|FG001|Overall Study|Adverse Event|1|||
126714037|NCT00871858|455903874|FG000|Overall Study|Withdrawal by Subject|1|||
126714038|NCT00871858|455903875|FG001|Overall Study|Withdrawal by Subject|1|||
126714039|NCT00871858|455903874|FG000|Overall Study|Lost to Follow-up|0|||
126714040|NCT00871858|455903875|FG001|Overall Study|Lost to Follow-up|1|||
126714041|NCT03662334|455903876|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
126714042|NCT03662334|455903877|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
126714043|NCT02853331|455903887|FG000|Overall Study|Death|59|||
126714044|NCT02853331|455903888|FG001|Overall Study|Death|95|||
126714045|NCT02853331|455903887|FG000|Overall Study|Withdrawal by Subject|5|||
126714046|NCT02853331|455903888|FG001|Overall Study|Withdrawal by Subject|9|||
126714047|NCT02853331|455903887|FG000|Overall Study|Ongoing in study|368|||
126714048|NCT02853331|455903888|FG001|Overall Study|Ongoing in study|325|||
126714049|NCT03290300|455903895|FG000|Overall Study|Lost to Follow-up|3|||
126714050|NCT01520922|455903896|FG000|Treatment Phase|Physician Decision|2|||
126714051|NCT01520922|455903897|FG001|Treatment Phase|Physician Decision|1|||
126714052|NCT01520922|455903896|FG000|Treatment Phase|Progression|0|||
126714053|NCT01520922|455903897|FG001|Treatment Phase|Progression|2|||
126714054|NCT01520922|455903896|FG000|Treatment Phase|Adverse Event|3|||
126714055|NCT01520922|455903897|FG001|Treatment Phase|Adverse Event|5|||
126714056|NCT01520922|455903896|FG000|Follow up|Lost to Follow-up|0|||
126714057|NCT01520922|455903897|FG001|Follow up|Lost to Follow-up|1|||
126714058|NCT01520922|455903896|FG000|Survival Follow-up|Withdrawal by Subject|1|||
126714059|NCT01520922|455903897|FG001|Survival Follow-up|Withdrawal by Subject|0|||
126714060|NCT01618656|455903899|FG000|Overall Study|Withdrawal by Subject|7|||
126714061|NCT01618656|455903900|FG001|Overall Study|Withdrawal by Subject|3|||
126714062|NCT01618656|455903899|FG000|Overall Study|Physician Decision|1|||
126714063|NCT01618656|455903900|FG001|Overall Study|Physician Decision|1|||
126714064|NCT04770155|455903905|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126714065|NCT04770155|455903906|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126714066|NCT04770155|455903907|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126714067|NCT04770155|455903908|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126714068|NCT04770155|455903909|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126714069|NCT04770155|455903910|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126714070|NCT04770155|455903911|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126714071|NCT04770155|455903912|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
126714072|NCT00864227|455903914|FG000|Overall Study|Withdrawal by Subject|1|||
126714073|NCT00864227|455903914|FG000|Overall Study|Disease Relapse/Progression|3|||
126714074|NCT03461289|455903915|FG000|Overall Study|Death|1|||
126551506|NCT00708305|455313686|FG003|Period 3|Protocol Violation|0|||
126551507|NCT00708305|455313683|FG000|Period 3|Other Reason|1|||
126551508|NCT00708305|455313684|FG001|Period 3|Other Reason|0|||
126551509|NCT00708305|455313685|FG002|Period 3|Other Reason|0|||
126551510|NCT00708305|455313686|FG003|Period 3|Other Reason|0|||
126551511|NCT04012814|455313688|FG000|Overall Study|Lost to Follow-up|4|||
126551512|NCT04012814|455313688|FG000|Overall Study|Withdrawal by Subject|2|||
126551513|NCT04012814|455313688|FG000|Overall Study|Protocol Violation|1|||
126551514|NCT04012814|455313688|FG000|Overall Study|Adverse Event|1|||
126304779|NCT01029782|454404356|FG001|Overall Study|Protocol Violation|2|||
126304780|NCT01029782|454404355|FG000|Overall Study|Withdrawal by Subject|0|||
126304781|NCT01029782|454404356|FG001|Overall Study|Withdrawal by Subject|1|||
126304782|NCT00596817|454404358|FG000|Open-label Period|Adverse Event|0|||
126304783|NCT00596817|454404359|FG001|Open-label Period|Adverse Event|49|||
126304784|NCT00596817|454404358|FG000|Open-label Period|Lack of Efficacy|0|||
126463397|NCT01315236|454998673|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
126463398|NCT01751802|454998674|FG000|Overall Study|Adverse Event|4|||
126463399|NCT01751802|454998675|FG001|Overall Study|Adverse Event|2|||
126463400|NCT00589784|454998679|FG000|Overall Study|Withdrawal by Subject|0|||
126463401|NCT00589784|454998680|FG001|Overall Study|Withdrawal by Subject|6|||
126463402|NCT00589784|454998679|FG000|Overall Study|Patient inevaluable|1|||
126463403|NCT00589784|454998680|FG001|Overall Study|Patient inevaluable|0|||
126463404|NCT00589784|454998679|FG000|Overall Study|Adverse Event|0|||
126463405|NCT00589784|454998680|FG001|Overall Study|Adverse Event|4|||
126463406|NCT00521001|454998682|FG000|Overall Study|Ineligible|1|||
126463407|NCT01025154|454998686|FG000|Overall Study|Lost to Follow-up|1|||
126304785|NCT00596817|454404359|FG001|Open-label Period|Lack of Efficacy|33|||
126463408|NCT01025154|454998686|FG000|Overall Study|Withdrawal by Subject|1|||
126463409|NCT02414139|454998687|FG000|Treatment Period|Adverse Event|11|||
126714075|NCT03321929|455903916|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
126714076|NCT04773041|455903923|FG000|Overall Study|Unable to data match|1|||
126714077|NCT04773041|455903924|FG001|Overall Study|Unable to data match|0|||
126714078|NCT04773041|455903925|FG002|Overall Study|Unable to data match|0|||
126714079|NCT00710034|455905201|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
126714080|NCT00710034|455905202|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
126714081|NCT00710034|455905201|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
126714082|NCT00710034|455905202|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
126714083|NCT00710034|455905201|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
126714084|NCT00710034|455905202|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
126714085|NCT00710034|455905201|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
126714086|NCT00710034|455905202|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
126714087|NCT00710034|455905201|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
126714088|NCT00710034|455905202|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
126714089|NCT00710034|455905201|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
126714090|NCT00710034|455905202|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
126714091|NCT00710034|455905201|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
126714092|NCT00710034|455905202|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
126714093|NCT00710034|455905201|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
126714094|NCT00710034|455905202|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
126714095|NCT00710034|455905201|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
126714096|NCT00710034|455905202|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
126714097|NCT00710034|455905201|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
126714098|NCT00710034|455905202|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
126714099|NCT00710034|455905201|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
126714100|NCT00710034|455905202|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
126714101|NCT02601001|455905203|FG000|Dosing Period 2|Adverse Event|0|||
126714102|NCT02601001|455905204|FG001|Dosing Period 2|Adverse Event|0|||
126714103|NCT02601001|455905205|FG002|Dosing Period 2|Adverse Event|0|||
126714104|NCT02601001|455905206|FG003|Dosing Period 2|Adverse Event|0|||
126714105|NCT02601001|455905207|FG004|Dosing Period 2|Adverse Event|0|||
126714106|NCT02601001|455905208|FG005|Dosing Period 2|Adverse Event|0|||
126714107|NCT02601001|455905209|FG006|Dosing Period 2|Adverse Event|1|||
126714108|NCT03504774|455905210|FG000|Overall Study|Adverse Event|2|||
126714109|NCT03504774|455905211|FG001|Overall Study|Adverse Event|0|||
126714110|NCT03504774|455905210|FG000|Overall Study|Lost to Follow-up|0|||
126463410|NCT02414139|454998688|FG001|Treatment Period|Adverse Event|6|||
126463411|NCT02414139|454998689|FG002|Treatment Period|Adverse Event|8|||
126551515|NCT00210119|455313691|FG000|Overall Study|Protocol Violation|1|||
126714111|NCT03504774|455905211|FG001|Overall Study|Lost to Follow-up|1|||
126714112|NCT03504774|455905210|FG000|Overall Study|Protocol Violation|11|||
126304786|NCT00596817|454404358|FG000|Open-label Period|Other Reasons|0|||
126463412|NCT02414139|454998690|FG003|Treatment Period|Adverse Event|5|||
126463413|NCT02414139|454998691|FG004|Treatment Period|Adverse Event|14|||
126551516|NCT00210119|455313691|FG000|Overall Study|Withdrawal by Subject|1|||
126551517|NCT04827134|455313692|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
126714113|NCT03504774|455905211|FG001|Overall Study|Protocol Violation|3|||
126551518|NCT04827134|455313693|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
126551519|NCT04827134|455313694|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
126551520|NCT04827134|455313695|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
126551521|NCT01830881|455313696|FG000|Overall Study|Changed decision to have an abortion|0|||
126551522|NCT01830881|455313697|FG001|Overall Study|Changed decision to have an abortion|1|||
126551523|NCT00988351|455313698|FG000|Overall Study|Withdrawal by Subject|8|||
126551524|NCT00988351|455313699|FG001|Overall Study|Withdrawal by Subject|0|||
126551525|NCT00988351|455313698|FG000|Overall Study|Lost to Follow-up|6|||
126551526|NCT00988351|455313699|FG001|Overall Study|Lost to Follow-up|9|||
126551527|NCT00988351|455313698|FG000|Overall Study|not using CPAP|5|||
126551528|NCT00988351|455313699|FG001|Overall Study|not using CPAP|3|||
126551529|NCT02038764|455313700|FG000|Overall Study|Adverse Event|0|||
126551530|NCT02038764|455313701|FG001|Overall Study|Adverse Event|0|||
126551531|NCT02038764|455313702|FG002|Overall Study|Adverse Event|1|||
126551532|NCT02038764|455313703|FG003|Overall Study|Adverse Event|0|||
126551533|NCT02038764|455313704|FG004|Overall Study|Adverse Event|0|||
126551534|NCT02038764|455313700|FG000|Overall Study|Lost to Follow-up|0|||
126551535|NCT02038764|455313701|FG001|Overall Study|Lost to Follow-up|1|||
126551536|NCT02038764|455313702|FG002|Overall Study|Lost to Follow-up|0|||
126551537|NCT02038764|455313703|FG003|Overall Study|Lost to Follow-up|0|||
126551538|NCT02038764|455313704|FG004|Overall Study|Lost to Follow-up|0|||
126551539|NCT02038764|455313700|FG000|Overall Study|Withdrawal by Subject|0|||
126551540|NCT02038764|455313701|FG001|Overall Study|Withdrawal by Subject|0|||
126551541|NCT02038764|455313702|FG002|Overall Study|Withdrawal by Subject|0|||
126551542|NCT02038764|455313703|FG003|Overall Study|Withdrawal by Subject|0|||
126551543|NCT02038764|455313704|FG004|Overall Study|Withdrawal by Subject|1|||
126551544|NCT02038764|455313700|FG000|Overall Study|Other|1|||
126551545|NCT02038764|455313701|FG001|Overall Study|Other|0|||
126551546|NCT02038764|455313702|FG002|Overall Study|Other|1|||
126714114|NCT03504774|455905210|FG000|Overall Study|failed wk 52 DBPCFC|1|||
126714115|NCT03504774|455905211|FG001|Overall Study|failed wk 52 DBPCFC|0|||
126714116|NCT00915005|455905217|FG000|Overall Study|Withdrawal by Subject|4|||
126714117|NCT00915005|455905218|FG001|Overall Study|Withdrawal by Subject|4|||
126714118|NCT00915005|455905217|FG000|Overall Study|Patient preferred protons therapy|6|||
126714119|NCT00915005|455905218|FG001|Overall Study|Patient preferred protons therapy|0|||
126714120|NCT00915005|455905217|FG000|Overall Study|Insurance denial|3|||
126714121|NCT00915005|455905218|FG001|Overall Study|Insurance denial|15|||
126714122|NCT00130208|455905221|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
126714123|NCT00130208|455905222|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
126714124|NCT00130208|455905221|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
126714125|NCT00130208|455905222|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
126714126|NCT00130208|455905221|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
126714127|NCT00130208|455905222|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
126714128|NCT00130208|455905221|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
126714129|NCT00130208|455905222|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
126714130|NCT00130208|455905221|FG000|Maintenance Period (26 Weeks)|Other|1|||
126714131|NCT00130208|455905222|FG001|Maintenance Period (26 Weeks)|Other|1|||
126714132|NCT00130208|455905221|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
126714133|NCT00130208|455905222|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
126714134|NCT00130208|455905221|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
126714135|NCT00130208|455905222|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
126714136|NCT00130208|455905221|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
126714137|NCT00130208|455905222|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
126714138|NCT00130208|455905221|FG000|Washout Period (8 Weeks)|Other|1|||
126714139|NCT00130208|455905222|FG001|Washout Period (8 Weeks)|Other|1|||
126714140|NCT00589472|455905224|FG000|Overall Study|Adverse Event|1|||
126714141|NCT00553059|455905225|FG000|Overall Study|Deemed ineligible|1|||
126714142|NCT00553059|455905226|FG001|Overall Study|Deemed ineligible|1|||
126714143|NCT00553059|455905225|FG000|Overall Study|Drug supply not available|0|||
126714144|NCT00553059|455905226|FG001|Overall Study|Drug supply not available|1|||
126714145|NCT04230486|455905237|FG000|Overall Study|Screen Failure|1|||
126714146|NCT03215264|455905238|FG000|Dose Level 2|Adverse Event|0|||
126714147|NCT03215264|455905239|FG001|Dose Level 2|Adverse Event|1|||
126714148|NCT03215264|455905240|FG002|Dose Level 2|Adverse Event|0|||
126714149|NCT03215264|455905238|FG000|Dose Level 3|Withdrawal by Subject|0|||
126551547|NCT02038764|455313703|FG003|Overall Study|Other|0|||
126714150|NCT03215264|455905239|FG001|Dose Level 3|Withdrawal by Subject|0|||
126714151|NCT03215264|455905240|FG002|Dose Level 3|Withdrawal by Subject|1|||
126714152|NCT02234583|455905243|FG000|Overall Study|Adverse Event|172|||
126551548|NCT02038764|455313704|FG004|Overall Study|Other|0|||
126551549|NCT05033080|455313721|FG000|Overall Study|Adverse Event|4|||
126551550|NCT05033080|455313722|FG001|Overall Study|Adverse Event|4|||
126551551|NCT05033080|455313721|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
126551552|NCT05033080|455313722|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
126551553|NCT05033080|455313721|FG000|Overall Study|Lost to Follow-up|1|||
126551554|NCT05033080|455313722|FG001|Overall Study|Lost to Follow-up|0|||
126551555|NCT05033080|455313721|FG000|Overall Study|Other non-compliance|0|||
126551556|NCT05033080|455313722|FG001|Overall Study|Other non-compliance|1|||
126551557|NCT05033080|455313721|FG000|Overall Study|Physician Decision|0|||
126551558|NCT05033080|455313722|FG001|Overall Study|Physician Decision|1|||
126551559|NCT05033080|455313721|FG000|Overall Study|Other|1|||
126551560|NCT05033080|455313722|FG001|Overall Study|Other|1|||
126551561|NCT01263106|455313729|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
126551562|NCT01263106|455313730|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
126551563|NCT01680458|455313738|FG000|Overall Study|Protocol Violation|3|||
126551564|NCT02611830|455313748|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
126551565|NCT02611830|455313749|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
126551566|NCT02611830|455313750|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
126551567|NCT02611830|455313751|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
126551568|NCT02611830|455313748|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
126551569|NCT02611830|455313749|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
126551570|NCT02611830|455313750|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
126551571|NCT02611830|455313751|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
126551572|NCT02611830|455313748|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
126551573|NCT02611830|455313749|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
126551574|NCT02611830|455313750|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
126551575|NCT02611830|455313751|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
126551576|NCT02611830|455313748|FG000|OL Induction Phase|Lack of Efficacy|9|||
126551577|NCT02611830|455313749|FG001|OL Induction Phase|Lack of Efficacy|0|||
126551578|NCT02611830|455313750|FG002|OL Induction Phase|Lack of Efficacy|0|||
126551579|NCT02611830|455313751|FG003|OL Induction Phase|Lack of Efficacy|0|||
126551580|NCT02611830|455313748|FG000|OL Induction Phase|Reason not specified|3|||
126551581|NCT02611830|455313749|FG001|OL Induction Phase|Reason not specified|0|||
126551582|NCT02611830|455313750|FG002|OL Induction Phase|Reason not specified|0|||
126551583|NCT02611830|455313751|FG003|OL Induction Phase|Reason not specified|0|||
126551584|NCT02611830|455313748|FG000|Maintenance Phase|Lack of Efficacy|0|||
126551585|NCT02611830|455313749|FG001|Maintenance Phase|Lack of Efficacy|29|||
126551586|NCT02611830|455313750|FG002|Maintenance Phase|Lack of Efficacy|18|||
126551587|NCT02611830|455313751|FG003|Maintenance Phase|Lack of Efficacy|6|||
126551588|NCT02611830|455313748|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
126551589|NCT02611830|455313749|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
126551590|NCT02611830|455313750|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
126551591|NCT02611830|455313751|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
126551592|NCT02611830|455313748|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
126551593|NCT02611830|455313749|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
126551594|NCT02611830|455313750|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
126551595|NCT02611830|455313751|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
126551596|NCT02611830|455313748|FG000|Maintenance Phase|Lost to Follow-up|0|||
126551597|NCT02611830|455313749|FG001|Maintenance Phase|Lost to Follow-up|0|||
126551598|NCT02611830|455313750|FG002|Maintenance Phase|Lost to Follow-up|0|||
126551599|NCT02611830|455313751|FG003|Maintenance Phase|Lost to Follow-up|1|||
126551600|NCT02611830|455313748|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
126551601|NCT02611830|455313749|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
126551602|NCT02611830|455313750|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
126551603|NCT02611830|455313751|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
126551604|NCT02611830|455313748|FG000|Maintenance Phase|Pregnancy|0|||
126551605|NCT02611830|455313749|FG001|Maintenance Phase|Pregnancy|0|||
126551606|NCT02611830|455313750|FG002|Maintenance Phase|Pregnancy|1|||
126551607|NCT02611830|455313751|FG003|Maintenance Phase|Pregnancy|0|||
126551608|NCT02611830|455313748|FG000|Maintenance Phase|Reason not specified|0|||
126551609|NCT02611830|455313749|FG001|Maintenance Phase|Reason not specified|1|||
126551610|NCT02611830|455313750|FG002|Maintenance Phase|Reason not specified|4|||
126551611|NCT02611830|455313751|FG003|Maintenance Phase|Reason not specified|0|||
126551612|NCT00903786|455313757|FG000|Overall Study|Physician Decision|6|||
126551613|NCT00903786|455313757|FG000|Overall Study|Lack of Efficacy|5|||
126551614|NCT00903786|455313757|FG000|Overall Study|Reason other than lack of efficacy|4|||
126551615|NCT02058290|455313760|FG000|Overall Study|Protocol Violation|2|||
126551616|NCT02058290|455313761|FG001|Overall Study|Protocol Violation|1|||
126304787|NCT00596817|454404359|FG001|Open-label Period|Other Reasons|65|||
126304788|NCT00596817|454404358|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
126551617|NCT02058290|455313760|FG000|Overall Study|Physician Decision|1|||
126551618|NCT02058290|455313761|FG001|Overall Study|Physician Decision|0|||
126551619|NCT02058290|455313760|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
126551620|NCT02058290|455313761|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
126551621|NCT02058290|455313760|FG000|Overall Study|Withdrawal by Subject|0|||
126551622|NCT02058290|455313761|FG001|Overall Study|Withdrawal by Subject|1|||
126551623|NCT03012061|455313769|FG000|Overall Study|Withdrawal by Subject|1|||
126551624|NCT03012061|455313770|FG001|Overall Study|Withdrawal by Subject|5|||
126551625|NCT03012061|455313771|FG002|Overall Study|Withdrawal by Subject|4|||
126551626|NCT03012061|455313769|FG000|Overall Study|Investigator Site Closed|1|||
126714153|NCT02234583|455905244|FG001|Overall Study|Adverse Event|156|||
126714154|NCT02234583|455905243|FG000|Overall Study|Withdrawal by Subject|109|||
126714155|NCT02234583|455905244|FG001|Overall Study|Withdrawal by Subject|157|||
126714156|NCT02234583|455905243|FG000|Overall Study|Lost to Follow-up|0|||
126714157|NCT02234583|455905244|FG001|Overall Study|Lost to Follow-up|1|||
126714158|NCT02234583|455905243|FG000|Overall Study|Lack of Efficacy|58|||
126714159|NCT02234583|455905244|FG001|Overall Study|Lack of Efficacy|103|||
126714160|NCT02234583|455905243|FG000|Overall Study|Protocol Violation|35|||
126714161|NCT02234583|455905244|FG001|Overall Study|Protocol Violation|42|||
126714162|NCT02234583|455905243|FG000|Overall Study|Other|39|||
126714163|NCT02234583|455905244|FG001|Overall Study|Other|97|||
126714164|NCT01740440|455905245|FG000|Overall Study|Lost to Follow-up|3|||
126714165|NCT02805907|455905246|FG000|Overall Study|Lost to Follow-up|3|||
126714166|NCT02805907|455905247|FG001|Overall Study|Lost to Follow-up|3|||
126714167|NCT01264965|455905248|FG000|Overall Study|Withdrawal by Subject|10|||
126714168|NCT00532883|455905249|FG000|Overall Study|Adverse Event|1|||
126714169|NCT00532883|455905250|FG001|Overall Study|Adverse Event|0|||
126714170|NCT00532883|455905251|FG002|Overall Study|Adverse Event|0|||
126714171|NCT00532883|455905252|FG003|Overall Study|Adverse Event|1|||
126714172|NCT00532883|455905249|FG000|Overall Study|Lost to Follow-up|1|||
126714173|NCT00532883|455905250|FG001|Overall Study|Lost to Follow-up|1|||
126714174|NCT00532883|455905251|FG002|Overall Study|Lost to Follow-up|1|||
126714175|NCT00532883|455905252|FG003|Overall Study|Lost to Follow-up|0|||
126714176|NCT00532883|455905249|FG000|Overall Study|Withdrawal by Subject|0|||
126714177|NCT00532883|455905250|FG001|Overall Study|Withdrawal by Subject|1|||
126714178|NCT00532883|455905251|FG002|Overall Study|Withdrawal by Subject|1|||
126714179|NCT00532883|455905252|FG003|Overall Study|Withdrawal by Subject|0|||
126714180|NCT00532883|455905249|FG000|Overall Study|Subject was Nonadherent|0|||
126714181|NCT00532883|455905250|FG001|Overall Study|Subject was Nonadherent|1|||
126714182|NCT00532883|455905251|FG002|Overall Study|Subject was Nonadherent|1|||
126714183|NCT00532883|455905252|FG003|Overall Study|Subject was Nonadherent|0|||
126714184|NCT00532883|455905249|FG000|Overall Study|Early Study Termination|4|||
126714185|NCT00532883|455905250|FG001|Overall Study|Early Study Termination|4|||
126714186|NCT00532883|455905251|FG002|Overall Study|Early Study Termination|1|||
126714187|NCT00532883|455905252|FG003|Overall Study|Early Study Termination|4|||
126714188|NCT02202031|455905253|FG000|Overall Study|Lost to Follow-up|1|||
126714189|NCT02202031|455905254|FG001|Overall Study|Lost to Follow-up|0|||
126714190|NCT02202031|455905253|FG000|Overall Study|Too Busy|1|||
126714191|NCT02202031|455905254|FG001|Overall Study|Too Busy|3|||
126714192|NCT02202031|455905253|FG000|Overall Study|Illness/Medical Reason|0|||
126714193|NCT02202031|455905254|FG001|Overall Study|Illness/Medical Reason|2|||
126714194|NCT02202031|455905253|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
126714195|NCT02202031|455905254|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
126714196|NCT01172288|455905257|FG000|Overall Study|Adverse Event|1|||
126714197|NCT01172288|455905258|FG001|Overall Study|Adverse Event|0|||
126714198|NCT01172288|455905257|FG000|Overall Study|Protocol Violation|0|||
126714199|NCT01172288|455905258|FG001|Overall Study|Protocol Violation|1|||
126714200|NCT01276847|455905265|FG000|Overall Study|Withdrawal by Subject|1|||
126714201|NCT01276847|455905266|FG001|Overall Study|Withdrawal by Subject|0|||
126714202|NCT01276847|455905267|FG002|Overall Study|Withdrawal by Subject|0|||
126714203|NCT01899144|455905268|FG000|Treatment Period 2|Other|1|||
126714204|NCT01899144|455905268|FG000|Treatment Period 3|Other|2|||
126714205|NCT01899144|455905268|FG000|Treatment Period 5|Other|1|||
126714206|NCT00751881|455905271|FG000|Core Treatment Period|Not treated|1|||
126714207|NCT00751881|455905272|FG001|Core Treatment Period|Not treated|1|||
126714208|NCT00751881|455905273|FG002|Core Treatment Period|Not treated|2|||
126714209|NCT00751881|455905271|FG000|Core Treatment Period|Adverse Event|26|||
126714210|NCT00751881|455905272|FG001|Core Treatment Period|Adverse Event|54|||
126714211|NCT00751881|455905273|FG002|Core Treatment Period|Adverse Event|58|||
126714212|NCT00751881|455905271|FG000|Core Treatment Period|Lack of Efficacy|37|||
126714213|NCT00751881|455905272|FG001|Core Treatment Period|Lack of Efficacy|30|||
126714214|NCT00751881|455905273|FG002|Core Treatment Period|Lack of Efficacy|20|||
126714215|NCT00751881|455905271|FG000|Core Treatment Period|Poor compliance to protocol|15|||
126714216|NCT00751881|455905272|FG001|Core Treatment Period|Poor compliance to protocol|3|||
126714217|NCT00751881|455905273|FG002|Core Treatment Period|Poor compliance to protocol|4|||
126714218|NCT00751881|455905271|FG000|Core Treatment Period|Lost to Follow-up|6|||
126714219|NCT00751881|455905272|FG001|Core Treatment Period|Lost to Follow-up|4|||
126714220|NCT00751881|455905273|FG002|Core Treatment Period|Lost to Follow-up|3|||
126714221|NCT00751881|455905271|FG000|Core Treatment Period|Other: protocol deviation|3|||
126714222|NCT00751881|455905272|FG001|Core Treatment Period|Other: protocol deviation|3|||
126714223|NCT00751881|455905273|FG002|Core Treatment Period|Other: protocol deviation|7|||
126714224|NCT00751881|455905271|FG000|Core Treatment Period|Other: wish to parent|5|||
126714225|NCT00751881|455905272|FG001|Core Treatment Period|Other: wish to parent|7|||
126714226|NCT00751881|455905273|FG002|Core Treatment Period|Other: wish to parent|4|||
126714227|NCT00751881|455905271|FG000|Core Treatment Period|Other: personal/family constraints|6|||
126714228|NCT00751881|455905272|FG001|Core Treatment Period|Other: personal/family constraints|7|||
126770361|NCT02756078|456112462|FG001|Period 1|Adverse Event|10|||
126714229|NCT00751881|455905273|FG002|Core Treatment Period|Other: personal/family constraints|10|||
126714230|NCT00751881|455905271|FG000|Core Treatment Period|Other: MS treatment change|6|||
126714231|NCT00751881|455905272|FG001|Core Treatment Period|Other: MS treatment change|4|||
126714232|NCT00751881|455905273|FG002|Core Treatment Period|Other: MS treatment change|4|||
126714233|NCT00751881|455905271|FG000|Core Treatment Period|Other: tolerability complaints|2|||
126714234|NCT00751881|455905272|FG001|Core Treatment Period|Other: tolerability complaints|0|||
126714235|NCT00751881|455905273|FG002|Core Treatment Period|Other: tolerability complaints|0|||
126714236|NCT00751881|455905271|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
126714237|NCT00751881|455905272|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
126714238|NCT00751881|455905273|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
126714239|NCT00751881|455905271|FG000|Extension Study Period|Adverse Event|18|||
126714240|NCT00751881|455905272|FG001|Extension Study Period|Adverse Event|20|||
126714241|NCT00751881|455905273|FG002|Extension Study Period|Adverse Event|21|||
126714242|NCT00751881|455905271|FG000|Extension Study Period|Lack of Efficacy|14|||
126714243|NCT00751881|455905272|FG001|Extension Study Period|Lack of Efficacy|10|||
126714244|NCT00751881|455905273|FG002|Extension Study Period|Lack of Efficacy|20|||
126714245|NCT00751881|455905271|FG000|Extension Study Period|Lost to Follow-up|4|||
126714246|NCT00751881|455905272|FG001|Extension Study Period|Lost to Follow-up|9|||
126714247|NCT00751881|455905273|FG002|Extension Study Period|Lost to Follow-up|6|||
126714248|NCT00751881|455905271|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
126714249|NCT00751881|455905272|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
126714250|NCT00751881|455905273|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
126714251|NCT00751881|455905271|FG000|Extension Study Period|Other than specified above|26|||
126714252|NCT00751881|455905272|FG001|Extension Study Period|Other than specified above|30|||
126714253|NCT00751881|455905273|FG002|Extension Study Period|Other than specified above|18|||
126714254|NCT02119104|455905274|FG000|Overall Study|Protocol Violation|16|||
126714255|NCT00530712|455905277|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
126714256|NCT00530712|455905277|FG000|30 Day Follow-up Visit|Missed Visit|5|||
126714257|NCT00530712|455905277|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
126714258|NCT00530712|455905277|FG000|6 Month Follow-up Visit|Missed Visit|3|||
126714259|NCT00530712|455905277|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
126714260|NCT00530712|455905277|FG000|6 Month Follow-up Visit|Death|2|||
126714261|NCT00530712|455905277|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
126714262|NCT00530712|455905277|FG000|12 Month Follow-up Visit|Missed Visit|3|||
126714263|NCT00530712|455905277|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
126714264|NCT00530712|455905277|FG000|12 Month Follow-up Visit|Death|9|||
126714265|NCT00651118|455905285|FG000|Overall Study|Adverse Event|4|||
126714266|NCT00651118|455905286|FG001|Overall Study|Adverse Event|0|||
126714267|NCT00651118|455905287|FG002|Overall Study|Adverse Event|1|||
126714268|NCT00651118|455905288|FG003|Overall Study|Adverse Event|1|||
126714269|NCT00651118|455905285|FG000|Overall Study|Protocol Violation|2|||
126714270|NCT00651118|455905286|FG001|Overall Study|Protocol Violation|2|||
126714271|NCT00651118|455905287|FG002|Overall Study|Protocol Violation|6|||
126714272|NCT00651118|455905288|FG003|Overall Study|Protocol Violation|2|||
126714273|NCT00651118|455905285|FG000|Overall Study|Lost to Follow-up|2|||
126714274|NCT00651118|455905286|FG001|Overall Study|Lost to Follow-up|0|||
126714275|NCT00651118|455905287|FG002|Overall Study|Lost to Follow-up|1|||
126714276|NCT00651118|455905288|FG003|Overall Study|Lost to Follow-up|2|||
126714277|NCT00651118|455905285|FG000|Overall Study|administrative|1|||
126714278|NCT00651118|455905286|FG001|Overall Study|administrative|4|||
126714279|NCT00651118|455905287|FG002|Overall Study|administrative|2|||
126714280|NCT00651118|455905288|FG003|Overall Study|administrative|1|||
126714281|NCT00651118|455905285|FG000|Overall Study|Withdrawal by Subject|0|||
126714282|NCT00651118|455905286|FG001|Overall Study|Withdrawal by Subject|1|||
126714283|NCT00651118|455905287|FG002|Overall Study|Withdrawal by Subject|1|||
126714284|NCT00651118|455905288|FG003|Overall Study|Withdrawal by Subject|1|||
126714285|NCT03117049|455905289|FG000|Overall Study|Continued the follow-up period|109|||
126714286|NCT03117049|455905290|FG001|Overall Study|Continued the follow-up period|129|||
126714287|NCT03117049|455905289|FG000|Overall Study|Died|82|||
126714288|NCT03117049|455905290|FG001|Overall Study|Died|93|||
126714289|NCT03117049|455905289|FG000|Overall Study|Consent withdrawal|7|||
126714290|NCT03117049|455905290|FG001|Overall Study|Consent withdrawal|6|||
126714291|NCT03117049|455905289|FG000|Overall Study|Missing contact|3|||
126714292|NCT03117049|455905290|FG001|Overall Study|Missing contact|3|||
126714293|NCT00839098|455905291|FG000|Overall Study|Withdrawal by Subject|2|||
126714294|NCT00839098|455905292|FG001|Overall Study|Withdrawal by Subject|1|||
126714295|NCT00839098|455905293|FG002|Overall Study|Withdrawal by Subject|7|||
126714296|NCT00365976|455905296|FG000|Overall Study|Withdrawal by Subject|1|||
126714297|NCT00365976|455905297|FG001|Overall Study|Withdrawal by Subject|5|||
126714298|NCT02260193|455905298|FG000|Overall Study|Lack of Efficacy|0|||
126714299|NCT02260193|455905299|FG001|Overall Study|Lack of Efficacy|1|||
126463414|NCT02414139|454998692|FG005|Treatment Period|Adverse Event|3|||
126714300|NCT02260193|455905300|FG002|Overall Study|Lack of Efficacy|6|||
126463415|NCT02414139|454998693|FG006|Treatment Period|Adverse Event|6|||
126714301|NCT02260193|455905298|FG000|Overall Study|Adverse Event|3|||
126714302|NCT02260193|455905299|FG001|Overall Study|Adverse Event|4|||
126714303|NCT02260193|455905300|FG002|Overall Study|Adverse Event|1|||
126304789|NCT00596817|454404359|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
126304790|NCT00596817|454404358|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
126304791|NCT00596817|454404359|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
126304792|NCT00596817|454404358|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
126304793|NCT00596817|454404359|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
126714304|NCT02260193|455905298|FG000|Overall Study|Protocol Violation|0|||
126714305|NCT02260193|455905299|FG001|Overall Study|Protocol Violation|4|||
126714306|NCT02260193|455905300|FG002|Overall Study|Protocol Violation|0|||
126714307|NCT02260193|455905298|FG000|Overall Study|Withdrawal by Subject|3|||
126714308|NCT02260193|455905299|FG001|Overall Study|Withdrawal by Subject|0|||
126714309|NCT02260193|455905300|FG002|Overall Study|Withdrawal by Subject|2|||
126714310|NCT02260193|455905298|FG000|Overall Study|Kidney Transplantation|0|||
126714311|NCT02260193|455905299|FG001|Overall Study|Kidney Transplantation|0|||
126714312|NCT02260193|455905300|FG002|Overall Study|Kidney Transplantation|1|||
126714313|NCT00633139|455905307|FG000|Overall Study|Non compliance|0|||
126714314|NCT00633139|455905308|FG001|Overall Study|Non compliance|0|||
126714315|NCT00633139|455905309|FG002|Overall Study|Non compliance|1|||
126714316|NCT00633139|455905307|FG000|Overall Study|Withdrawal by Subject|0|||
126714317|NCT00633139|455905308|FG001|Overall Study|Withdrawal by Subject|1|||
126714318|NCT00633139|455905309|FG002|Overall Study|Withdrawal by Subject|0|||
126714319|NCT04430582|455905310|FG000|Overall Study|Found to meet exclusionary criteria|1|||
126714320|NCT04430582|455905311|FG001|Overall Study|Found to meet exclusionary criteria|0|||
126714321|NCT04430582|455905310|FG000|Overall Study|Withdrawal by Subject|0|||
126714322|NCT04430582|455905311|FG001|Overall Study|Withdrawal by Subject|1|||
126714323|NCT01522651|455905314|FG000|Overall Study|Adverse Event|3|||
126714324|NCT01522651|455905315|FG001|Overall Study|Adverse Event|4|||
126714325|NCT01522651|455905316|FG002|Overall Study|Adverse Event|4|||
126714326|NCT01522651|455905317|FG003|Overall Study|Adverse Event|5|||
126714327|NCT01522651|455905318|FG004|Overall Study|Adverse Event|4|||
126714328|NCT01522651|455905314|FG000|Overall Study|Cardioversion|1|||
126714329|NCT01522651|455905315|FG001|Overall Study|Cardioversion|0|||
126714330|NCT01522651|455905316|FG002|Overall Study|Cardioversion|0|||
126714331|NCT01522651|455905317|FG003|Overall Study|Cardioversion|0|||
126714332|NCT01522651|455905318|FG004|Overall Study|Cardioversion|0|||
126714333|NCT01522651|455905314|FG000|Overall Study|Device Malfunction|0|||
126714334|NCT01522651|455905315|FG001|Overall Study|Device Malfunction|1|||
126714335|NCT01522651|455905316|FG002|Overall Study|Device Malfunction|0|||
126714336|NCT01522651|455905317|FG003|Overall Study|Device Malfunction|0|||
126714337|NCT01522651|455905318|FG004|Overall Study|Device Malfunction|0|||
126714338|NCT01522651|455905314|FG000|Overall Study|Investigator's Discretion|0|||
126714339|NCT01522651|455905315|FG001|Overall Study|Investigator's Discretion|1|||
126714340|NCT01522651|455905316|FG002|Overall Study|Investigator's Discretion|0|||
126714341|NCT01522651|455905317|FG003|Overall Study|Investigator's Discretion|0|||
126714342|NCT01522651|455905318|FG004|Overall Study|Investigator's Discretion|0|||
126714343|NCT01522651|455905314|FG000|Overall Study|Protocol Violation|3|||
126714344|NCT01522651|455905315|FG001|Overall Study|Protocol Violation|0|||
126714345|NCT01522651|455905316|FG002|Overall Study|Protocol Violation|0|||
126714346|NCT01522651|455905317|FG003|Overall Study|Protocol Violation|0|||
126714347|NCT01522651|455905318|FG004|Overall Study|Protocol Violation|0|||
126714348|NCT01522651|455905314|FG000|Overall Study|Reason Not Specified|0|||
126714349|NCT01522651|455905315|FG001|Overall Study|Reason Not Specified|0|||
126714350|NCT01522651|455905316|FG002|Overall Study|Reason Not Specified|0|||
126714351|NCT01522651|455905317|FG003|Overall Study|Reason Not Specified|1|||
126714352|NCT01522651|455905318|FG004|Overall Study|Reason Not Specified|0|||
126714353|NCT01522651|455905314|FG000|Overall Study|Participant Non-Compliance|1|||
126714354|NCT01522651|455905315|FG001|Overall Study|Participant Non-Compliance|0|||
126714355|NCT01522651|455905316|FG002|Overall Study|Participant Non-Compliance|0|||
126714356|NCT01522651|455905317|FG003|Overall Study|Participant Non-Compliance|0|||
126714357|NCT01522651|455905318|FG004|Overall Study|Participant Non-Compliance|0|||
126714358|NCT01522651|455905314|FG000|Overall Study|Withdrew Consent|1|||
126714359|NCT01522651|455905315|FG001|Overall Study|Withdrew Consent|1|||
126714360|NCT01522651|455905316|FG002|Overall Study|Withdrew Consent|0|||
126714361|NCT01522651|455905317|FG003|Overall Study|Withdrew Consent|1|||
126714362|NCT01522651|455905318|FG004|Overall Study|Withdrew Consent|1|||
126714363|NCT01522651|455905314|FG000|Overall Study|Randomized but Never Treated|0|||
126714364|NCT01522651|455905315|FG001|Overall Study|Randomized but Never Treated|1|||
126304794|NCT00596817|454404358|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
126304795|NCT00596817|454404359|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
126714365|NCT01522651|455905316|FG002|Overall Study|Randomized but Never Treated|0|||
126714366|NCT01522651|455905317|FG003|Overall Study|Randomized but Never Treated|1|||
126714367|NCT01522651|455905318|FG004|Overall Study|Randomized but Never Treated|1|||
126714368|NCT02658656|455905319|FG000|Screening|Failed eligibility criteria|0|||
126714369|NCT02658656|455905320|FG001|Screening|Failed eligibility criteria|0|||
126714370|NCT02658656|455905321|FG002|Screening|Failed eligibility criteria|263|||
126304796|NCT00596817|454404358|FG000|Double-blind Period|Adverse Event|5|||
126304797|NCT00596817|454404359|FG001|Double-blind Period|Adverse Event|16|||
126304798|NCT00596817|454404358|FG000|Double-blind Period|Lack of Efficacy|52|||
126304799|NCT00596817|454404359|FG001|Double-blind Period|Lack of Efficacy|28|||
126304800|NCT00596817|454404358|FG000|Double-blind Period|Non-compliance With Study Product|3|||
126304801|NCT00596817|454404359|FG001|Double-blind Period|Non-compliance With Study Product|4|||
126304802|NCT00596817|454404358|FG000|Double-blind Period|Protocol Violation|11|||
126304803|NCT00596817|454404359|FG001|Double-blind Period|Protocol Violation|8|||
126304804|NCT00596817|454404358|FG000|Double-blind Period|Withdrawal of Consent|7|||
126304805|NCT00596817|454404359|FG001|Double-blind Period|Withdrawal of Consent|3|||
126304806|NCT00596817|454404358|FG000|Double-blind Period|Lost to Follow-up|0|||
126304807|NCT00596817|454404359|FG001|Double-blind Period|Lost to Follow-up|2|||
126304808|NCT00596817|454404358|FG000|Double-blind Period|Other Reasons|10|||
126304809|NCT00596817|454404359|FG001|Double-blind Period|Other Reasons|18|||
126304810|NCT04402138|454405508|FG000|Overall Study|Progressive Disease|2|||
126304811|NCT04402138|454405508|FG000|Overall Study|Adverse Event|1|||
126304812|NCT03056638|454405511|FG000|Overall Study|Death|1|||
126304813|NCT03056638|454405512|FG001|Overall Study|Death|0|||
126304814|NCT03508726|454405513|FG000|Overall Study|Withdrawal by Subject|0|||
126304815|NCT03508726|454405514|FG001|Overall Study|Withdrawal by Subject|1|||
126304816|NCT01515865|454405516|FG000|Part A (Open-label)|Other|3|||
126304817|NCT01515865|454405517|FG001|Part A (Open-label)|Other|0|||
126304818|NCT01515865|454405518|FG002|Part A (Open-label)|Other|0|||
126304819|NCT01515865|454405516|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
126304820|NCT01515865|454405517|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
126304821|NCT01515865|454405518|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
126368286|NCT00645658|454642923|FG001|Overall Study|Did not complete all assesments|2|||
126368287|NCT03605693|454642930|FG000|Overall Study|Lost to Follow-up|4|||
126714371|NCT02658656|455905319|FG000|Randomization|Withdrawal by Subject|8|||
126714372|NCT02658656|455905320|FG001|Randomization|Withdrawal by Subject|7|||
126714373|NCT02658656|455905321|FG002|Randomization|Withdrawal by Subject|0|||
126714374|NCT02658656|455905319|FG000|Randomization|Lost to Follow-up|1|||
126714375|NCT02658656|455905320|FG001|Randomization|Lost to Follow-up|3|||
126714376|NCT02658656|455905321|FG002|Randomization|Lost to Follow-up|0|||
126714377|NCT02658656|455905319|FG000|Randomization|Adverse Event|4|||
126714378|NCT02658656|455905320|FG001|Randomization|Adverse Event|0|||
126714379|NCT02658656|455905321|FG002|Randomization|Adverse Event|0|||
126714380|NCT02658656|455905319|FG000|Randomization|Administrative Termination|3|||
126714381|NCT02658656|455905320|FG001|Randomization|Administrative Termination|1|||
126714382|NCT02658656|455905321|FG002|Randomization|Administrative Termination|0|||
126714383|NCT02658656|455905319|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
126714384|NCT02658656|455905320|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
126714385|NCT02658656|455905321|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
126714386|NCT02658656|455905319|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
126714387|NCT02658656|455905320|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
126714388|NCT02658656|455905321|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
126714389|NCT02658656|455905319|FG000|Randomization|Not eligible for Randomization|1|||
126714390|NCT02658656|455905320|FG001|Randomization|Not eligible for Randomization|0|||
126714391|NCT02658656|455905321|FG002|Randomization|Not eligible for Randomization|0|||
126714392|NCT02658656|455905319|FG000|Randomization|Protocol Violation|1|||
126714393|NCT02658656|455905320|FG001|Randomization|Protocol Violation|0|||
126714394|NCT02658656|455905321|FG002|Randomization|Protocol Violation|0|||
126714395|NCT02100657|455906837|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
126714396|NCT02100657|455906838|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
126714397|NCT02100657|455906839|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
126714398|NCT02100657|455906837|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
126714399|NCT02100657|455906838|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
126714400|NCT02100657|455906839|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
126304822|NCT01515865|454405516|FG000|Part B (Open-label)|Other|1|||
126304823|NCT01515865|454405517|FG001|Part B (Open-label)|Other|0|||
126304824|NCT01515865|454405518|FG002|Part B (Open-label)|Other|0|||
126304825|NCT03691207|454405520|FG000|Overall Study|Death|41|||
126304826|NCT03691207|454405521|FG001|Overall Study|Death|26|||
126368288|NCT03605693|454642931|FG001|Overall Study|Lost to Follow-up|0|||
126368289|NCT03605693|454642930|FG000|Overall Study|Physician Decision|1|||
126368290|NCT03605693|454642931|FG001|Overall Study|Physician Decision|0|||
126368291|NCT03895372|454642934|FG000|Investigational Treatment Period|Adverse Event|1|||
126368292|NCT03895372|454642935|FG001|Investigational Treatment Period|Adverse Event|0|||
126368293|NCT03895372|454642936|FG002|Investigational Treatment Period|Adverse Event|0|||
126368294|NCT03895372|454642937|FG003|Investigational Treatment Period|Adverse Event|0|||
126368295|NCT03895372|454642938|FG004|Investigational Treatment Period|Adverse Event|0|||
126368296|NCT03895372|454642939|FG005|Investigational Treatment Period|Adverse Event|0|||
126368297|NCT03895372|454642940|FG006|Investigational Treatment Period|Adverse Event|4|||
126304827|NCT03691207|454405520|FG000|Overall Study|Lost to Follow-up|1|||
126368298|NCT03895372|454642941|FG007|Investigational Treatment Period|Adverse Event|3|||
126714401|NCT02100657|455906837|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
126714402|NCT02100657|455906838|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
126714403|NCT02100657|455906839|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
126714404|NCT02100657|455906837|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
126714405|NCT02100657|455906838|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
126714406|NCT02100657|455906839|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
126714407|NCT02100657|455906837|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
126714408|NCT02100657|455906838|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
126714409|NCT02100657|455906839|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
126714410|NCT02100657|455906837|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
126714411|NCT02100657|455906838|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
126714412|NCT02100657|455906839|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
126714413|NCT02100657|455906837|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
126714414|NCT02100657|455906838|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
126714415|NCT02100657|455906839|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
126714416|NCT02100657|455906837|FG000|Cohort 3: Dose Level 3|Death|0|||
126714417|NCT02100657|455906838|FG001|Cohort 3: Dose Level 3|Death|0|||
126714418|NCT02100657|455906839|FG002|Cohort 3: Dose Level 3|Death|1|||
126714419|NCT02100657|455906837|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
126714420|NCT02100657|455906838|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
126714421|NCT02100657|455906839|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
126714422|NCT02100657|455906837|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
126714423|NCT02100657|455906838|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
126714424|NCT02100657|455906839|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
126714425|NCT02100657|455906837|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
126714426|NCT02100657|455906838|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
126368299|NCT03895372|454642934|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
126714427|NCT02100657|455906839|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
126714428|NCT02100657|455906837|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
126714429|NCT02100657|455906838|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
126714430|NCT02100657|455906839|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
126368300|NCT03895372|454642935|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
126368301|NCT03895372|454642936|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
126368302|NCT03895372|454642937|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
126368303|NCT03895372|454642938|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
126368304|NCT03895372|454642939|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
126368305|NCT03895372|454642940|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
126368306|NCT03895372|454642941|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
126368307|NCT03895372|454642934|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
126368308|NCT03895372|454642935|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
126368309|NCT03895372|454642936|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
126368310|NCT03895372|454642937|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
126368311|NCT03895372|454642938|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
126368312|NCT03895372|454642939|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
126368313|NCT03895372|454642940|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
126368314|NCT03895372|454642941|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
126368315|NCT03895372|454642934|FG000|Investigational Treatment Period|Other|0|||
126368316|NCT03895372|454642935|FG001|Investigational Treatment Period|Other|0|||
126368317|NCT03895372|454642936|FG002|Investigational Treatment Period|Other|0|||
126368318|NCT03895372|454642937|FG003|Investigational Treatment Period|Other|0|||
126368319|NCT03895372|454642938|FG004|Investigational Treatment Period|Other|0|||
126368320|NCT03895372|454642939|FG005|Investigational Treatment Period|Other|1|||
126368321|NCT03895372|454642940|FG006|Investigational Treatment Period|Other|0|||
126368322|NCT03895372|454642941|FG007|Investigational Treatment Period|Other|2|||
126368323|NCT03895372|454642934|FG000|Investigational Treatment Period|Protocol Violation|0|||
126368324|NCT03895372|454642935|FG001|Investigational Treatment Period|Protocol Violation|0|||
126368325|NCT03895372|454642936|FG002|Investigational Treatment Period|Protocol Violation|0|||
126368326|NCT03895372|454642937|FG003|Investigational Treatment Period|Protocol Violation|1|||
126368327|NCT03895372|454642938|FG004|Investigational Treatment Period|Protocol Violation|0|||
126368328|NCT03895372|454642939|FG005|Investigational Treatment Period|Protocol Violation|0|||
126368329|NCT03895372|454642940|FG006|Investigational Treatment Period|Protocol Violation|0|||
126368330|NCT03895372|454642941|FG007|Investigational Treatment Period|Protocol Violation|0|||
126368331|NCT03895372|454642934|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
126368332|NCT03895372|454642935|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
126368333|NCT03895372|454642936|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
126368334|NCT03895372|454642937|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
126368335|NCT03895372|454642938|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
126368336|NCT03895372|454642939|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
126714431|NCT02100657|455906837|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
126714432|NCT02100657|455906838|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
126714433|NCT02100657|455906839|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
126714434|NCT04359823|455906840|FG000|Overall Study|Lost to Follow-up|0|||
126714435|NCT04359823|455906841|FG001|Overall Study|Lost to Follow-up|1|||
126714436|NCT04359823|455906840|FG000|Overall Study|Withdrawal by Subject|0|||
126714437|NCT04359823|455906841|FG001|Overall Study|Withdrawal by Subject|1|||
126714438|NCT01850563|455906842|FG000|Overall Study|Not eligible|3|||
126714439|NCT01850563|455906843|FG001|Overall Study|Not eligible|0|||
126714440|NCT00408421|455906849|FG000|Treatment Initial Randomization|Adverse Event|5|||
126714441|NCT00408421|455906850|FG001|Treatment Initial Randomization|Adverse Event|9|||
126714442|NCT00408421|455906851|FG002|Treatment Initial Randomization|Adverse Event|0|||
126714443|NCT00408421|455906849|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
126714444|NCT00408421|455906850|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
126714445|NCT00408421|455906851|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
126714446|NCT00408421|455906849|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
126714447|NCT00408421|455906850|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
126714448|NCT00408421|455906851|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
126714449|NCT00408421|455906849|FG000|Treatment Initial Randomization|Physician Decision|1|||
126714450|NCT00408421|455906850|FG001|Treatment Initial Randomization|Physician Decision|0|||
126714451|NCT00408421|455906851|FG002|Treatment Initial Randomization|Physician Decision|0|||
126714452|NCT00408421|455906849|FG000|Treatment Initial Randomization|Protocol Violation|0|||
126714453|NCT00408421|455906850|FG001|Treatment Initial Randomization|Protocol Violation|1|||
126714454|NCT00408421|455906851|FG002|Treatment Initial Randomization|Protocol Violation|0|||
126714455|NCT00408421|455906849|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
126714456|NCT00408421|455906850|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
126714457|NCT00408421|455906851|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
126714458|NCT00408421|455906849|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
126714459|NCT00408421|455906850|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
126714460|NCT00408421|455906851|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
126714461|NCT00408421|455906849|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
126714462|NCT00408421|455906850|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
126714463|NCT00408421|455906851|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
126714464|NCT00408421|455906849|FG000|Treatment Re-Randomization|Adverse Event|2|||
126714465|NCT00408421|455906850|FG001|Treatment Re-Randomization|Adverse Event|2|||
126714466|NCT00408421|455906851|FG002|Treatment Re-Randomization|Adverse Event|4|||
126714467|NCT00408421|455906849|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
126714468|NCT00408421|455906850|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
126714469|NCT00408421|455906851|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
126714470|NCT00408421|455906849|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
126714471|NCT00408421|455906850|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
126714472|NCT00408421|455906851|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
126714473|NCT00408421|455906849|FG000|Treatment Re-Randomization|Physician Decision|1|||
126714474|NCT00408421|455906850|FG001|Treatment Re-Randomization|Physician Decision|3|||
126714475|NCT00408421|455906851|FG002|Treatment Re-Randomization|Physician Decision|0|||
126714476|NCT00408421|455906849|FG000|Treatment Re-Randomization|Protocol Violation|1|||
126714477|NCT00408421|455906850|FG001|Treatment Re-Randomization|Protocol Violation|1|||
126368337|NCT03895372|454642940|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
126368338|NCT03895372|454642941|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
126368339|NCT03895372|454642934|FG000|Extension Treatment Period|Adverse Event|0|||
126368340|NCT03895372|454642935|FG001|Extension Treatment Period|Adverse Event|1|||
126368341|NCT03895372|454642936|FG002|Extension Treatment Period|Adverse Event|0|||
126368342|NCT03895372|454642937|FG003|Extension Treatment Period|Adverse Event|1|||
126368343|NCT03895372|454642938|FG004|Extension Treatment Period|Adverse Event|0|||
126368344|NCT03895372|454642939|FG005|Extension Treatment Period|Adverse Event|0|||
126368345|NCT03895372|454642940|FG006|Extension Treatment Period|Adverse Event|3|||
126368346|NCT03895372|454642941|FG007|Extension Treatment Period|Adverse Event|3|||
126368347|NCT03895372|454642934|FG000|Extension Treatment Period|Other|1|||
126368348|NCT03895372|454642935|FG001|Extension Treatment Period|Other|3|||
126368349|NCT03895372|454642936|FG002|Extension Treatment Period|Other|0|||
126368350|NCT03895372|454642937|FG003|Extension Treatment Period|Other|0|||
126368351|NCT03895372|454642938|FG004|Extension Treatment Period|Other|1|||
126463416|NCT02414139|454998694|FG007|Treatment Period|Adverse Event|1|||
126463417|NCT02414139|454998695|FG008|Treatment Period|Adverse Event|6|||
126463418|NCT02414139|454998696|FG009|Treatment Period|Adverse Event|8|||
126463419|NCT02414139|454998687|FG000|Treatment Period|Death|0|||
126463420|NCT02414139|454998688|FG001|Treatment Period|Death|0|||
126463421|NCT02414139|454998689|FG002|Treatment Period|Death|1|||
126463422|NCT02414139|454998690|FG003|Treatment Period|Death|1|||
126463423|NCT02414139|454998691|FG004|Treatment Period|Death|0|||
126463424|NCT02414139|454998692|FG005|Treatment Period|Death|0|||
126463425|NCT02414139|454998693|FG006|Treatment Period|Death|0|||
126463426|NCT02414139|454998694|FG007|Treatment Period|Death|0|||
126368352|NCT03895372|454642939|FG005|Extension Treatment Period|Other|0|||
126368353|NCT03895372|454642940|FG006|Extension Treatment Period|Other|0|||
126368354|NCT03895372|454642941|FG007|Extension Treatment Period|Other|2|||
126368355|NCT03895372|454642934|FG000|Extension Treatment Period|Pregnancy|0|||
126368356|NCT03895372|454642935|FG001|Extension Treatment Period|Pregnancy|0|||
126368357|NCT03895372|454642936|FG002|Extension Treatment Period|Pregnancy|0|||
126368358|NCT03895372|454642937|FG003|Extension Treatment Period|Pregnancy|0|||
126368359|NCT03895372|454642938|FG004|Extension Treatment Period|Pregnancy|1|||
126368360|NCT03895372|454642939|FG005|Extension Treatment Period|Pregnancy|0|||
126368361|NCT03895372|454642940|FG006|Extension Treatment Period|Pregnancy|0|||
126368362|NCT03895372|454642941|FG007|Extension Treatment Period|Pregnancy|0|||
126551627|NCT03012061|455313770|FG001|Overall Study|Investigator Site Closed|2|||
126551628|NCT03012061|455313771|FG002|Overall Study|Investigator Site Closed|0|||
126551629|NCT03012061|455313769|FG000|Overall Study|Lost to Follow-up|2|||
126551630|NCT03012061|455313770|FG001|Overall Study|Lost to Follow-up|1|||
126551631|NCT03012061|455313771|FG002|Overall Study|Lost to Follow-up|0|||
126551632|NCT03012061|455313769|FG000|Overall Study|Study closed/ Terminated|0|||
126551633|NCT03012061|455313770|FG001|Overall Study|Study closed/ Terminated|0|||
126551634|NCT03012061|455313771|FG002|Overall Study|Study closed/ Terminated|1|||
126551635|NCT03012061|455313769|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
126551636|NCT03012061|455313770|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
126551637|NCT03012061|455313771|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
126551638|NCT03012061|455313769|FG000|Overall Study|Protocol Violation|0|||
126551639|NCT03012061|455313770|FG001|Overall Study|Protocol Violation|0|||
126551640|NCT03012061|455313771|FG002|Overall Study|Protocol Violation|2|||
126551641|NCT03012061|455313769|FG000|Overall Study|Lack of Efficacy|0|||
126551642|NCT03012061|455313770|FG001|Overall Study|Lack of Efficacy|1|||
126551643|NCT03012061|455313771|FG002|Overall Study|Lack of Efficacy|0|||
126551644|NCT03012061|455313769|FG000|Overall Study|Adverse Event|2|||
126551645|NCT03012061|455313770|FG001|Overall Study|Adverse Event|0|||
126551646|NCT03012061|455313771|FG002|Overall Study|Adverse Event|0|||
126368363|NCT03895372|454642934|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
126368364|NCT03895372|454642935|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
126368365|NCT03895372|454642936|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
126368366|NCT03895372|454642937|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
126368367|NCT03895372|454642938|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
126368368|NCT03895372|454642939|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
126368369|NCT03895372|454642940|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
126368370|NCT03895372|454642941|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
126463427|NCT02414139|454998695|FG008|Treatment Period|Death|0|||
126463428|NCT02414139|454998696|FG009|Treatment Period|Death|1|||
126463429|NCT02414139|454998687|FG000|Treatment Period|Physician Decision|5|||
126463430|NCT02414139|454998688|FG001|Treatment Period|Physician Decision|4|||
126463431|NCT02414139|454998689|FG002|Treatment Period|Physician Decision|6|||
126463432|NCT02414139|454998690|FG003|Treatment Period|Physician Decision|1|||
126463433|NCT02414139|454998691|FG004|Treatment Period|Physician Decision|4|||
126463434|NCT02414139|454998692|FG005|Treatment Period|Physician Decision|0|||
126463435|NCT02414139|454998693|FG006|Treatment Period|Physician Decision|2|||
126463436|NCT02414139|454998694|FG007|Treatment Period|Physician Decision|0|||
126463437|NCT02414139|454998695|FG008|Treatment Period|Physician Decision|1|||
126463438|NCT02414139|454998696|FG009|Treatment Period|Physician Decision|4|||
126463439|NCT02414139|454998687|FG000|Treatment Period|Progressive disease|48|||
126463440|NCT02414139|454998688|FG001|Treatment Period|Progressive disease|31|||
126463441|NCT02414139|454998689|FG002|Treatment Period|Progressive disease|37|||
126463442|NCT02414139|454998690|FG003|Treatment Period|Progressive disease|21|||
126463443|NCT02414139|454998691|FG004|Treatment Period|Progressive disease|43|||
126463444|NCT02414139|454998692|FG005|Treatment Period|Progressive disease|12|||
126463445|NCT02414139|454998693|FG006|Treatment Period|Progressive disease|16|||
126368371|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
126368372|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
126368373|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
126368374|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
126368375|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
126463446|NCT02414139|454998694|FG007|Treatment Period|Progressive disease|2|||
126463447|NCT02414139|454998695|FG008|Treatment Period|Progressive disease|20|||
126463448|NCT02414139|454998696|FG009|Treatment Period|Progressive disease|14|||
126463449|NCT02414139|454998687|FG000|Treatment Period|Protocol deviation|0|||
126463450|NCT02414139|454998688|FG001|Treatment Period|Protocol deviation|0|||
126551647|NCT02696902|455313772|FG000|Overall Study|Lost to Follow-up|0|||
126551648|NCT02696902|455313773|FG001|Overall Study|Lost to Follow-up|1|||
126368376|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
126368377|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
126551649|NCT02696902|455313774|FG002|Overall Study|Lost to Follow-up|1|||
126551650|NCT02696902|455313772|FG000|Overall Study|Withdrawal by Subject|0|||
126304828|NCT03691207|454405521|FG001|Overall Study|Lost to Follow-up|1|||
126304829|NCT03691207|454405520|FG000|Overall Study|Withdrawal by Subject|2|||
126304830|NCT03691207|454405521|FG001|Overall Study|Withdrawal by Subject|8|||
126463451|NCT02414139|454998689|FG002|Treatment Period|Protocol deviation|1|||
126463452|NCT02414139|454998690|FG003|Treatment Period|Protocol deviation|0|||
126463453|NCT02414139|454998691|FG004|Treatment Period|Protocol deviation|0|||
126463454|NCT02414139|454998692|FG005|Treatment Period|Protocol deviation|0|||
126463455|NCT02414139|454998693|FG006|Treatment Period|Protocol deviation|0|||
126463456|NCT02414139|454998694|FG007|Treatment Period|Protocol deviation|0|||
126463457|NCT02414139|454998695|FG008|Treatment Period|Protocol deviation|0|||
126463458|NCT02414139|454998696|FG009|Treatment Period|Protocol deviation|0|||
126463459|NCT02414139|454998687|FG000|Treatment Period|Subject/Guardian decision|5|||
126463460|NCT02414139|454998688|FG001|Treatment Period|Subject/Guardian decision|1|||
126463461|NCT02414139|454998689|FG002|Treatment Period|Subject/Guardian decision|1|||
126463462|NCT02414139|454998690|FG003|Treatment Period|Subject/Guardian decision|2|||
126463463|NCT02414139|454998691|FG004|Treatment Period|Subject/Guardian decision|5|||
126463464|NCT02414139|454998692|FG005|Treatment Period|Subject/Guardian decision|0|||
126463465|NCT02414139|454998693|FG006|Treatment Period|Subject/Guardian decision|2|||
126463466|NCT02414139|454998694|FG007|Treatment Period|Subject/Guardian decision|0|||
126463467|NCT02414139|454998695|FG008|Treatment Period|Subject/Guardian decision|1|||
126463468|NCT02414139|454998696|FG009|Treatment Period|Subject/Guardian decision|1|||
126463469|NCT02414139|454998687|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
126463470|NCT02414139|454998688|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
126463471|NCT02414139|454998689|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
126463472|NCT02414139|454998690|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
126463473|NCT02414139|454998691|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
126463474|NCT02414139|454998692|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
126463475|NCT02414139|454998693|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
126463476|NCT02414139|454998694|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
126463477|NCT02414139|454998695|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
126463478|NCT02414139|454998696|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
126463479|NCT02414139|454998687|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
126463480|NCT02414139|454998688|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126463481|NCT02414139|454998689|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126463482|NCT02414139|454998690|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126463483|NCT02414139|454998691|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
126463484|NCT02414139|454998692|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126463485|NCT02414139|454998693|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126463486|NCT02414139|454998694|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126463487|NCT02414139|454998695|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126463488|NCT02414139|454998696|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126463489|NCT02414139|454998687|FG000|Post-treatment Efficacy Follow-up|Death|0|||
126463490|NCT02414139|454998688|FG001|Post-treatment Efficacy Follow-up|Death|1|||
126463491|NCT02414139|454998689|FG002|Post-treatment Efficacy Follow-up|Death|0|||
126463492|NCT02414139|454998690|FG003|Post-treatment Efficacy Follow-up|Death|0|||
126463493|NCT02414139|454998691|FG004|Post-treatment Efficacy Follow-up|Death|1|||
126463494|NCT02414139|454998692|FG005|Post-treatment Efficacy Follow-up|Death|0|||
126463495|NCT02414139|454998693|FG006|Post-treatment Efficacy Follow-up|Death|0|||
126463496|NCT02414139|454998694|FG007|Post-treatment Efficacy Follow-up|Death|0|||
126463497|NCT02414139|454998695|FG008|Post-treatment Efficacy Follow-up|Death|0|||
126463498|NCT02414139|454998696|FG009|Post-treatment Efficacy Follow-up|Death|1|||
126463499|NCT02414139|454998687|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
126463500|NCT02414139|454998688|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126463501|NCT02414139|454998689|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126463502|NCT02414139|454998690|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126463503|NCT02414139|454998691|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126463504|NCT02414139|454998692|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126463505|NCT02414139|454998693|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126463506|NCT02414139|454998694|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126463507|NCT02414139|454998695|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126463508|NCT02414139|454998696|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126463509|NCT02414139|454998687|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
126463510|NCT02414139|454998688|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
126463511|NCT02414139|454998689|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
126463512|NCT02414139|454998690|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
126463513|NCT02414139|454998691|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
126463514|NCT02414139|454998692|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
126463515|NCT02414139|454998693|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126463516|NCT02414139|454998694|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
126714478|NCT00408421|455906851|FG002|Treatment Re-Randomization|Protocol Violation|0|||
126714479|NCT00408421|455906849|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
126304831|NCT03691207|454405520|FG000|Overall Study|Sponsor decision|1|||
126304832|NCT03691207|454405521|FG001|Overall Study|Sponsor decision|7|||
126304833|NCT01736397|454405522|FG000|Overall Study|Lack of Efficacy|1|||
126304834|NCT01736397|454405523|FG001|Overall Study|Lack of Efficacy|11|||
126304835|NCT01736397|454405522|FG000|Overall Study|Withdrawal by Subject|6|||
126463517|NCT02414139|454998695|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
126463518|NCT02414139|454998696|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126463519|NCT02414139|454998687|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
126463520|NCT02414139|454998688|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
126463521|NCT02414139|454998689|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
126463522|NCT02414139|454998690|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
126463523|NCT02414139|454998691|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
126463524|NCT02414139|454998692|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
126463525|NCT02414139|454998693|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
126463526|NCT02414139|454998694|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
126463527|NCT02414139|454998695|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
126463528|NCT02414139|454998696|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
126463529|NCT02414139|454998687|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
126463530|NCT02414139|454998688|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
126463531|NCT02414139|454998689|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
126463532|NCT02414139|454998690|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
126463533|NCT02414139|454998691|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
126463534|NCT02414139|454998692|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
126463535|NCT02414139|454998693|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
126463536|NCT02414139|454998694|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
126463537|NCT02414139|454998695|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
126463538|NCT02414139|454998696|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
126463539|NCT02414139|454998687|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
126463540|NCT02414139|454998688|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
126463541|NCT02414139|454998689|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
126463542|NCT02414139|454998690|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
126463543|NCT02414139|454998691|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
126463544|NCT02414139|454998692|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
126463545|NCT02414139|454998693|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
126463546|NCT02414139|454998694|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
126463547|NCT02414139|454998695|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
126463548|NCT02414139|454998696|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
126463549|NCT01484938|454998701|FG000|Overall Study|Adverse Event|2|||
126463550|NCT01484938|454998701|FG000|Overall Study|Lost to Follow-up|1|||
126463551|NCT01484938|454998701|FG000|Overall Study|Noncompliance|1|||
126463552|NCT00938964|454998702|FG000|Overall Study|Death|3|||
126463553|NCT00938964|454998703|FG001|Overall Study|Death|3|||
126463554|NCT00938964|454998702|FG000|Overall Study|Lost to Follow-up|2|||
126463555|NCT00938964|454998703|FG001|Overall Study|Lost to Follow-up|3|||
126463556|NCT00938964|454998702|FG000|Overall Study|Withdrawal by Subject|22|||
126463557|NCT00938964|454998703|FG001|Overall Study|Withdrawal by Subject|18|||
126463558|NCT00938964|454998702|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
126463559|NCT00938964|454998703|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
126463560|NCT02862600|454998711|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
126463561|NCT02862600|454998711|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
126463562|NCT02862600|454998711|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
126463563|NCT02862600|454998711|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
126463564|NCT00772070|454998728|FG000|Overall Study|Lost to Follow-up|0|||
126463565|NCT00772070|454998729|FG001|Overall Study|Lost to Follow-up|8|||
126463566|NCT00772070|454998728|FG000|Overall Study|Withdrawal by Subject|0|||
126463567|NCT00772070|454998729|FG001|Overall Study|Withdrawal by Subject|2|||
126463568|NCT00772070|454998728|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
126463569|NCT00772070|454998729|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
126463570|NCT01309308|454998730|FG000|Overall Study|Lost to Follow-up|6|||
126463571|NCT01309308|454998731|FG001|Overall Study|Lost to Follow-up|4|||
126463572|NCT01476644|454998732|FG000|Overall Study|Death|5|||
126463573|NCT01476644|454998732|FG000|Overall Study|moved to another state|2|||
126463574|NCT01476644|454998732|FG000|Overall Study|Lost to Follow-up|19|||
126463575|NCT01476644|454998732|FG000|Overall Study|Withdrawal by Subject|13|||
126463576|NCT00095628|454998733|FG000|Overall Study|Disease progression prior to treatment|1|||
126463577|NCT04271280|454998734|FG000|Overall Study|Lost to Follow-up|300|||
126463578|NCT04271280|454998734|FG000|Overall Study|Death|153|||
126714480|NCT00408421|455906850|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
126714481|NCT00408421|455906851|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
126714482|NCT02322892|455906854|FG000|Overall Study|Surgery cancelled|1|||
126714483|NCT02322892|455906855|FG001|Overall Study|Surgery cancelled|2|||
126714484|NCT02322892|455906854|FG000|Overall Study|Met exclusion criteria|0|||
126714485|NCT02322892|455906855|FG001|Overall Study|Met exclusion criteria|1|||
126714486|NCT02322892|455906854|FG000|Overall Study|Protocol Violation|1|||
126714487|NCT02322892|455906855|FG001|Overall Study|Protocol Violation|0|||
126714488|NCT02125331|455906858|FG000|Overall Study|Protocol Violation|1|||
126714489|NCT02125331|455906859|FG001|Overall Study|Protocol Violation|0|||
126714490|NCT02125331|455906858|FG000|Overall Study|technical problem|2|||
126714491|NCT02125331|455906859|FG001|Overall Study|technical problem|0|||
126714492|NCT02125331|455906858|FG000|Overall Study|screen failure|2|||
126304836|NCT01736397|454405523|FG001|Overall Study|Withdrawal by Subject|5|||
126304837|NCT01736397|454405522|FG000|Overall Study|Lost to Follow-up|0|||
126463579|NCT04271280|454998734|FG000|Overall Study|Withdrawal of consent by patient|59|||
126463580|NCT04271280|454998734|FG000|Overall Study|Other|51|||
126463581|NCT04271280|454998734|FG000|Overall Study|No end of study information|42|||
126714493|NCT02125331|455906859|FG001|Overall Study|screen failure|0|||
126714494|NCT03123354|455906862|FG000|Overall Study|Physician Decision|6|||
126714495|NCT02421120|455906863|FG000|Overall Study|Adverse Event|1|||
126714496|NCT03554005|455906866|FG000|Overall Study|Not in participant's best interest|0|||
126714497|NCT03554005|455906867|FG001|Overall Study|Not in participant's best interest|0|||
126714498|NCT03554005|455906868|FG002|Overall Study|Not in participant's best interest|0|||
126714499|NCT03554005|455906869|FG003|Overall Study|Not in participant's best interest|0|||
126714500|NCT03554005|455906870|FG004|Overall Study|Not in participant's best interest|0|||
126714501|NCT03554005|455906871|FG005|Overall Study|Not in participant's best interest|1|||
126714502|NCT03554005|455906866|FG000|Overall Study|Disease Progression|1|||
126714503|NCT03554005|455906867|FG001|Overall Study|Disease Progression|1|||
126714504|NCT03554005|455906868|FG002|Overall Study|Disease Progression|1|||
126714505|NCT03554005|455906869|FG003|Overall Study|Disease Progression|1|||
126714506|NCT03554005|455906870|FG004|Overall Study|Disease Progression|5|||
126714507|NCT03554005|455906871|FG005|Overall Study|Disease Progression|6|||
126714508|NCT03554005|455906866|FG000|Overall Study|Adverse Event|0|||
126714509|NCT03554005|455906867|FG001|Overall Study|Adverse Event|0|||
126714510|NCT03554005|455906868|FG002|Overall Study|Adverse Event|0|||
126714511|NCT03554005|455906869|FG003|Overall Study|Adverse Event|0|||
126714512|NCT03554005|455906870|FG004|Overall Study|Adverse Event|0|||
126714513|NCT03554005|455906871|FG005|Overall Study|Adverse Event|3|||
126714514|NCT03554005|455906866|FG000|Overall Study|Physician Decision|0|||
126714515|NCT03554005|455906867|FG001|Overall Study|Physician Decision|0|||
126714516|NCT03554005|455906868|FG002|Overall Study|Physician Decision|0|||
126714517|NCT03554005|455906869|FG003|Overall Study|Physician Decision|0|||
126714518|NCT03554005|455906870|FG004|Overall Study|Physician Decision|1|||
126714519|NCT03554005|455906871|FG005|Overall Study|Physician Decision|0|||
126714520|NCT03554005|455906866|FG000|Overall Study|Other|0|||
126714521|NCT03554005|455906867|FG001|Overall Study|Other|0|||
126714522|NCT03554005|455906868|FG002|Overall Study|Other|0|||
126714523|NCT03554005|455906869|FG003|Overall Study|Other|0|||
126714524|NCT03554005|455906870|FG004|Overall Study|Other|0|||
126714525|NCT03554005|455906871|FG005|Overall Study|Other|1|||
126714526|NCT02855411|455906875|FG000|Overall Study|Study terminated by sponsor|21|||
126714527|NCT02855411|455906875|FG000|Overall Study|Does not meet entrance criteria|14|||
126714528|NCT02606045|455906876|FG000|Overall Study|Study closed before treament could begin|1|||
126714529|NCT02606045|455906877|FG001|Overall Study|Study closed before treament could begin|2|||
126714530|NCT00907881|455906878|FG000|Overall Study|Lost to Follow-up|59|||
126714531|NCT00907881|455906878|FG000|Overall Study|Noncompliance|5|||
126714532|NCT00907881|455906878|FG000|Overall Study|Withdrawal by Subject|5|||
126714533|NCT00907881|455906878|FG000|Overall Study|Protocol Violation|1|||
126714534|NCT00907881|455906878|FG000|Overall Study|Missing discontinuation information|15|||
126714535|NCT01671085|455906879|FG000|Overall Study|Withdrawal by Subject|1|||
126714536|NCT01671085|455906880|FG001|Overall Study|Withdrawal by Subject|0|||
126714537|NCT00637273|455906881|FG000|Overall Study|Adverse Event|11|||
126714538|NCT00637273|455906882|FG001|Overall Study|Adverse Event|5|||
126714539|NCT00637273|455906883|FG002|Overall Study|Adverse Event|7|||
126714540|NCT00637273|455906881|FG000|Overall Study|Lost to Follow-up|8|||
126714541|NCT00637273|455906882|FG001|Overall Study|Lost to Follow-up|9|||
126714542|NCT00637273|455906883|FG002|Overall Study|Lost to Follow-up|13|||
126714543|NCT00637273|455906881|FG000|Overall Study|Protocol Violation|2|||
126714544|NCT00637273|455906882|FG001|Overall Study|Protocol Violation|4|||
126714545|NCT00637273|455906883|FG002|Overall Study|Protocol Violation|1|||
126714546|NCT00637273|455906881|FG000|Overall Study|Withdrawal of Consent|18|||
126714547|NCT00637273|455906882|FG001|Overall Study|Withdrawal of Consent|6|||
126714548|NCT00637273|455906883|FG002|Overall Study|Withdrawal of Consent|18|||
126714549|NCT00637273|455906881|FG000|Overall Study|Investigator Decision|1|||
126714550|NCT00637273|455906882|FG001|Overall Study|Investigator Decision|3|||
126714551|NCT00637273|455906883|FG002|Overall Study|Investigator Decision|1|||
126714552|NCT00637273|455906881|FG000|Overall Study|Administrative|2|||
126714553|NCT00637273|455906882|FG001|Overall Study|Administrative|0|||
126714554|NCT00637273|455906883|FG002|Overall Study|Administrative|0|||
126714555|NCT00637273|455906881|FG000|Overall Study|Loss of Glucose Control|1|||
126714556|NCT00637273|455906882|FG001|Overall Study|Loss of Glucose Control|1|||
126714557|NCT00637273|455906883|FG002|Overall Study|Loss of Glucose Control|1|||
126714558|NCT00986258|455906884|FG000|Observation Period|Not eligible to be dosed|11|||
126714559|NCT00986258|455906884|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
126714560|NCT00986258|455906884|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
126714561|NCT00986258|455906884|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
126714562|NCT00986258|455906884|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
126714563|NCT00986258|455906884|FG000|Titration and Optimal Dose Period|Other|1|||
126714564|NCT00986258|455906884|FG000|Maintenance Period|Adverse Event|5|||
126714565|NCT00986258|455906884|FG000|Maintenance Period|Lack of Efficacy|2|||
126714566|NCT00986258|455906884|FG000|Maintenance Period|Withdrawal by Subject|2|||
126714567|NCT02616029|455906886|FG000|Overall Study|Adverse Event|1|||
126714568|NCT02616029|455906887|FG001|Overall Study|Adverse Event|0|||
126714569|NCT02616029|455906886|FG000|Overall Study|Death|0|||
126714570|NCT02616029|455906887|FG001|Overall Study|Death|1|||
126714571|NCT02616029|455906886|FG000|Overall Study|Protocol Violation|1|||
126714572|NCT02616029|455906887|FG001|Overall Study|Protocol Violation|0|||
126714573|NCT02616029|455906886|FG000|Overall Study|Withdrew Consent|1|||
126714574|NCT02616029|455906887|FG001|Overall Study|Withdrew Consent|0|||
126714575|NCT02616029|455906886|FG000|Overall Study|Enrolled and Never Treated|1|||
126714576|NCT02616029|455906887|FG001|Overall Study|Enrolled and Never Treated|1|||
126714577|NCT01188798|455906888|FG000|Overall Study|Death|0|||
126714578|NCT01188798|455906889|FG001|Overall Study|Death|1|||
126714579|NCT01188798|455906888|FG000|Overall Study|Required additional transplant|1|||
126714580|NCT01188798|455906889|FG001|Overall Study|Required additional transplant|1|||
126714581|NCT01188798|455906888|FG000|Overall Study|Protocol closure|1|||
126714582|NCT01188798|455906889|FG001|Overall Study|Protocol closure|1|||
126714583|NCT02795767|455906890|FG000|Overall Study|Received Commercial Emicizumab|1|||
126714584|NCT02795767|455906891|FG001|Overall Study|Received Commercial Emicizumab|0|||
126714585|NCT02795767|455906892|FG002|Overall Study|Received Commercial Emicizumab|0|||
126714586|NCT03078608|455906902|FG000|Overall Study|Death|1|||
126714587|NCT03078608|455906903|FG001|Overall Study|Death|2|||
126714588|NCT03078608|455906904|FG002|Overall Study|Death|0|||
126714589|NCT03078608|455906905|FG003|Overall Study|Death|0|||
126714590|NCT03078608|455906902|FG000|Overall Study|Withdrawal by Subject|8|||
126714591|NCT03078608|455906903|FG001|Overall Study|Withdrawal by Subject|1|||
126714592|NCT03078608|455906904|FG002|Overall Study|Withdrawal by Subject|0|||
126714593|NCT03078608|455906905|FG003|Overall Study|Withdrawal by Subject|0|||
126714594|NCT03078608|455906902|FG000|Overall Study|Lost to Follow-up|5|||
126714595|NCT03078608|455906903|FG001|Overall Study|Lost to Follow-up|8|||
126714596|NCT03078608|455906904|FG002|Overall Study|Lost to Follow-up|4|||
126714597|NCT03078608|455906905|FG003|Overall Study|Lost to Follow-up|1|||
126304838|NCT01736397|454405523|FG001|Overall Study|Lost to Follow-up|1|||
126304839|NCT01736397|454405522|FG000|Overall Study|Adverse Event|6|||
126304840|NCT01736397|454405523|FG001|Overall Study|Adverse Event|3|||
126714598|NCT00723840|455906906|FG000|Overall Study|Lost to Follow-up|2|||
126304841|NCT01736397|454405522|FG000|Overall Study|Not stated|1|||
126304842|NCT01736397|454405523|FG001|Overall Study|Not stated|4|||
126304843|NCT02448537|454405528|FG000|Overall Study|Withdrawal by Subject|1|||
126304844|NCT02448537|454405529|FG001|Overall Study|Withdrawal by Subject|1|||
126304845|NCT02448537|454405530|FG002|Overall Study|Withdrawal by Subject|1|||
126304846|NCT04696055|454405534|FG000|Overall Study|Adverse Event|10|||
126304847|NCT04696055|454405535|FG001|Overall Study|Adverse Event|2|||
126304848|NCT04696055|454405534|FG000|Overall Study|Death|4|||
126304849|NCT04696055|454405535|FG001|Overall Study|Death|0|||
126304850|NCT04696055|454405534|FG000|Overall Study|Other|7|||
126304851|NCT04696055|454405535|FG001|Overall Study|Other|2|||
126304852|NCT04696055|454405534|FG000|Overall Study|Physician Decision|3|||
126304853|NCT04696055|454405535|FG001|Overall Study|Physician Decision|0|||
126304854|NCT04696055|454405534|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
126304855|NCT04696055|454405535|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
126304856|NCT04696055|454405534|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
126304857|NCT04696055|454405535|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
126714599|NCT00723840|455906906|FG000|Overall Study|Failure to return|18|||
126714600|NCT00723840|455906906|FG000|Overall Study|Withdrawal by Subject|55|||
126714601|NCT00723840|455906906|FG000|Overall Study|Serious Adverse Events|3|||
126714602|NCT00723840|455906906|FG000|Overall Study|Other Medical Event|2|||
126714603|NCT00723840|455906906|FG000|Overall Study|Unspecified reason|2|||
126714604|NCT04156646|455906907|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
126304858|NCT04696055|454405534|FG000|Overall Study|Subject Decision|1|||
126304859|NCT04696055|454405535|FG001|Overall Study|Subject Decision|2|||
126304860|NCT04411810|454405536|FG000|Overall Study|Screen failure|1|||
126304861|NCT04411810|454405536|FG000|Overall Study|Withdrawal by Subject|1|||
126715193|NCT01052012|455908708|FG002|Overall Study|Physician Decision|0|||
126304862|NCT01920958|454405537|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
126368378|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
126368379|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
126368380|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
126368381|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
126368382|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
126368383|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
126368384|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
126368385|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
126368386|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
126368387|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
126368388|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
126368389|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
126368390|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
126368391|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
126368392|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
126368393|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
126368394|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
126368395|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
126368396|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
126368397|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
126368398|NCT03093415|454642942|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
126368399|NCT03093415|454642943|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
126368400|NCT03093415|454642944|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
126368401|NCT03093415|454642942|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
126368402|NCT03093415|454642943|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
126368403|NCT03093415|454642944|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
126368404|NCT03331354|454642945|FG000|Overall Study|Withdrawal by Subject|1|||
126368405|NCT03331354|454642946|FG001|Overall Study|Withdrawal by Subject|3|||
126368406|NCT03331354|454642945|FG000|Overall Study|Lost to Follow-up|3|||
126368407|NCT03331354|454642946|FG001|Overall Study|Lost to Follow-up|3|||
126368408|NCT03331354|454642945|FG000|Overall Study|Found employment before initiated active intervention|0|||
126368409|NCT03331354|454642946|FG001|Overall Study|Found employment before initiated active intervention|4|||
126368410|NCT05889468|454642953|FG000|Overall Study|Lost to Follow-up|9|||
126368411|NCT05889468|454642954|FG001|Overall Study|Lost to Follow-up|2|||
126368412|NCT05889468|454642953|FG000|Overall Study|Withdrawal by Subject|2|||
126368413|NCT05889468|454642954|FG001|Overall Study|Withdrawal by Subject|2|||
126368414|NCT01309230|454642955|FG000|Overall Study|Withdrawal by Subject|0|||
126368415|NCT01309230|454642956|FG001|Overall Study|Withdrawal by Subject|2|||
126368416|NCT01309230|454642955|FG000|Overall Study|Observation arm closed|0|||
126368417|NCT01309230|454642956|FG001|Overall Study|Observation arm closed|2|||
126368418|NCT03900650|454642961|FG000|Overall Study|Withdrawal by Subject|1|||
126368419|NCT03900650|454642962|FG001|Overall Study|Withdrawal by Subject|1|||
126368420|NCT03900650|454642963|FG002|Overall Study|Withdrawal by Subject|0|||
126368421|NCT03900650|454642964|FG003|Overall Study|Withdrawal by Subject|0|||
126368422|NCT03900650|454642961|FG000|Overall Study|Withdrawn by staff|1|||
126368423|NCT03900650|454642962|FG001|Overall Study|Withdrawn by staff|0|||
126368424|NCT03900650|454642963|FG002|Overall Study|Withdrawn by staff|0|||
126368425|NCT03900650|454642964|FG003|Overall Study|Withdrawn by staff|0|||
126368426|NCT00427700|454642965|FG000|Overall Study|Lost to Follow-up|2|||
126368427|NCT00427700|454642966|FG001|Overall Study|Lost to Follow-up|5|||
126368428|NCT00427700|454642965|FG000|Overall Study|no induction of menses|1|||
126368429|NCT00427700|454642966|FG001|Overall Study|no induction of menses|4|||
126463582|NCT04706416|454998737|FG000|Overall Study|Lost to Follow-up|2|||
126463583|NCT04706416|454998738|FG001|Overall Study|Lost to Follow-up|0|||
126714605|NCT04156646|455906908|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
126714606|NCT00751101|455906909|FG000|Overall Study|Withdrawal by Subject|1|||
126714607|NCT00751101|455906910|FG001|Overall Study|Withdrawal by Subject|0|||
126714608|NCT00751101|455906909|FG000|Overall Study|No HFS / Never Started Patch/|0|||
126714609|NCT00751101|455906910|FG001|Overall Study|No HFS / Never Started Patch/|4|||
126714610|NCT00751101|455906909|FG000|Overall Study|Never began capecitabine|1|||
126714611|NCT00751101|455906910|FG001|Overall Study|Never began capecitabine|0|||
126714612|NCT00751101|455906909|FG000|Overall Study|Physician Decision|0|||
126368430|NCT00427700|454642965|FG000|Overall Study|Pregnancy|0|||
126714613|NCT00751101|455906910|FG001|Overall Study|Physician Decision|1|||
126368431|NCT00427700|454642966|FG001|Overall Study|Pregnancy|2|||
126714614|NCT00784784|455906911|FG000|Overall Study|Withdrawal by Subject|2|||
126714615|NCT00784784|455906912|FG001|Overall Study|Withdrawal by Subject|2|||
126714616|NCT01905397|455906913|FG000|Overall Study|Death|0|||
126368432|NCT04581395|454642967|FG000|Overall Study|Protocol Violation|4|||
126368433|NCT04581395|454642968|FG001|Overall Study|Protocol Violation|3|||
126368434|NCT04581395|454642969|FG002|Overall Study|Protocol Violation|2|||
126368435|NCT04581395|454642967|FG000|Overall Study|Physician Decision|0|||
126368436|NCT04581395|454642968|FG001|Overall Study|Physician Decision|1|||
126368437|NCT04581395|454642969|FG002|Overall Study|Physician Decision|0|||
126368438|NCT00815633|454642972|FG000|Overall Study|study terminated|1|||
126368439|NCT00721110|454642973|FG000|Overall Study|Ultram use|1|||
126368440|NCT00721110|454642974|FG001|Overall Study|Ultram use|0|||
126368441|NCT00721110|454642975|FG002|Overall Study|Ultram use|0|||
126368442|NCT00721110|454642976|FG003|Overall Study|Ultram use|0|||
126368443|NCT00721110|454642973|FG000|Overall Study|vertical incision|0|||
126368444|NCT00721110|454642974|FG001|Overall Study|vertical incision|0|||
126368445|NCT00721110|454642975|FG002|Overall Study|vertical incision|1|||
126368446|NCT00721110|454642976|FG003|Overall Study|vertical incision|0|||
126368447|NCT01554904|454642977|FG000|Overall Study|Withdrawal by Subject|3|||
126368448|NCT01554904|454642977|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
126368449|NCT01605097|454642978|FG000|Overall Study|Protocol Violation|1|||
126368450|NCT02038647|454642979|FG000|Overall Study|Progressive Disease|50|||
126368451|NCT02038647|454642980|FG001|Overall Study|Progressive Disease|59|||
126368452|NCT02038647|454642979|FG000|Overall Study|Adverse Event|18|||
126368453|NCT02038647|454642980|FG001|Overall Study|Adverse Event|10|||
126368454|NCT02038647|454642979|FG000|Overall Study|Symptomatic Deterioration|7|||
126368455|NCT02038647|454642980|FG001|Overall Study|Symptomatic Deterioration|7|||
126368456|NCT02038647|454642979|FG000|Overall Study|Withdrawal by Subject|5|||
126368457|NCT02038647|454642980|FG001|Overall Study|Withdrawal by Subject|2|||
126368458|NCT02038647|454642979|FG000|Overall Study|Not Reported|0|||
126368459|NCT02038647|454642980|FG001|Overall Study|Not Reported|1|||
126368460|NCT02038647|454642979|FG000|Overall Study|Ongoing at Datacut|9|||
126368461|NCT02038647|454642980|FG001|Overall Study|Ongoing at Datacut|10|||
126368462|NCT02757430|454642981|FG000|Overall Study|Physician Decision|6|||
126368463|NCT02757430|454642981|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
126368464|NCT02757430|454642981|FG000|Overall Study|No informed consent|1|||
126368465|NCT02757430|454642981|FG000|Overall Study|No procedure performed|2|||
126368466|NCT02082977|454642982|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
126368467|NCT02082977|454642983|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
126368468|NCT02082977|454642984|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
126368469|NCT02082977|454642985|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
126368470|NCT02082977|454642986|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
126368471|NCT02082977|454642987|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
126368472|NCT02082977|454642988|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
126368473|NCT02082977|454642989|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
126368474|NCT02082977|454642990|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
126368475|NCT02082977|454642991|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
126368476|NCT02082977|454642982|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368477|NCT02082977|454642983|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368478|NCT02082977|454642984|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368479|NCT02082977|454642985|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368480|NCT02082977|454642986|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368481|NCT02082977|454642987|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368482|NCT02082977|454642988|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368483|NCT02082977|454642989|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
126368484|NCT02082977|454642990|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368485|NCT02082977|454642991|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
126368486|NCT02082977|454642982|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368487|NCT02082977|454642983|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368488|NCT02082977|454642984|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368489|NCT02082977|454642985|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368490|NCT02082977|454642986|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368491|NCT02082977|454642987|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
126368492|NCT02082977|454642988|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368493|NCT02082977|454642989|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368494|NCT02082977|454642990|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368495|NCT02082977|454642991|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
126368496|NCT02082977|454642982|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
126368497|NCT02082977|454642983|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
126368498|NCT02082977|454642984|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
126368499|NCT02082977|454642985|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
126368500|NCT02082977|454642986|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
126368501|NCT02082977|454642987|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
126368502|NCT02082977|454642988|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
126368503|NCT02082977|454642989|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
126368504|NCT02082977|454642990|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
126368505|NCT02082977|454642991|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
126368506|NCT02082977|454642982|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368507|NCT02082977|454642983|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368508|NCT02082977|454642984|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368509|NCT02082977|454642985|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368510|NCT02082977|454642986|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368511|NCT02082977|454642987|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368512|NCT02082977|454642988|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368513|NCT02082977|454642989|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
126368514|NCT02082977|454642990|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368515|NCT02082977|454642991|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
126368516|NCT05852340|454642994|FG000|Period 5|Not completing the meal|0|||
126368517|NCT05852340|454642995|FG001|Period 5|Not completing the meal|1|||
126368518|NCT05852340|454642996|FG002|Period 5|Not completing the meal|0|||
126368519|NCT05852340|454642997|FG003|Period 5|Not completing the meal|0|||
126368520|NCT05852340|454642994|FG000|Period 5|Adverse Event|0|||
126368521|NCT05852340|454642995|FG001|Period 5|Adverse Event|0|||
126368522|NCT05852340|454642996|FG002|Period 5|Adverse Event|0|||
126368523|NCT05852340|454642997|FG003|Period 5|Adverse Event|1|||
126368524|NCT01903863|454642998|FG000|Overall Study|Physician Decision|2|||
126368525|NCT01903863|454642999|FG001|Overall Study|Physician Decision|0|||
126551651|NCT02696902|455313773|FG001|Overall Study|Withdrawal by Subject|0|||
126551652|NCT02696902|455313774|FG002|Overall Study|Withdrawal by Subject|1|||
126551653|NCT02696902|455313772|FG000|Overall Study|Death|19|||
126551654|NCT02696902|455313773|FG001|Overall Study|Death|3|||
126551655|NCT02696902|455313774|FG002|Overall Study|Death|24|||
126551656|NCT02696902|455313772|FG000|Overall Study|Participant not fit post-randomization|0|||
126551657|NCT02696902|455313773|FG001|Overall Study|Participant not fit post-randomization|0|||
126551658|NCT02696902|455313774|FG002|Overall Study|Participant not fit post-randomization|1|||
126368526|NCT04144517|454643002|FG000|Overall Study|Physician Decision|0|||
126368527|NCT04144517|454643003|FG001|Overall Study|Physician Decision|1|||
126368528|NCT04144517|454643002|FG000|Overall Study|Other|2|||
126368529|NCT04144517|454643003|FG001|Overall Study|Other|2|||
126368530|NCT04144517|454643002|FG000|Overall Study|Death|6|||
126368531|NCT04144517|454643003|FG001|Overall Study|Death|3|||
126368532|NCT00835367|454643006|FG000|Washout|Adverse Event|2|||
126368533|NCT00835367|454643007|FG001|Washout|Adverse Event|0|||
126368534|NCT00835367|454643006|FG000|Washout|Withdrawal by Subject|1|||
126368535|NCT00835367|454643007|FG001|Washout|Withdrawal by Subject|0|||
126368536|NCT00835367|454643006|FG000|Second Intervention|Adverse Event|1|||
126368537|NCT00835367|454643007|FG001|Second Intervention|Adverse Event|1|||
126368538|NCT00936936|454644352|FG000|Overall Study|Adverse Event|7|||
126368539|NCT00936936|454644353|FG001|Overall Study|Adverse Event|1|||
126368540|NCT00936936|454644352|FG000|Overall Study|Disease Progression|2|||
126368541|NCT00936936|454644353|FG001|Overall Study|Disease Progression|2|||
126368542|NCT00936936|454644352|FG000|Overall Study|Unrelated|3|||
126368543|NCT00936936|454644353|FG001|Overall Study|Unrelated|1|||
126368544|NCT01397253|454644354|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
126368545|NCT01397253|454644355|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
126368546|NCT01892189|454644356|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
126368547|NCT01892189|454644357|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
126368548|NCT01892189|454644358|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
126368549|NCT01892189|454644359|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
126368550|NCT01892189|454644360|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
126551659|NCT02696902|455313772|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
126551660|NCT02696902|455313773|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
126551661|NCT02696902|455313774|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
126551662|NCT02696902|455313772|FG000|Overall Study|Principal investigator's decision|1|||
126551663|NCT02696902|455313773|FG001|Overall Study|Principal investigator's decision|0|||
126714617|NCT01905397|455906914|FG001|Overall Study|Death|1|||
126714618|NCT01905397|455906913|FG000|Overall Study|Withdrawal by Subject|2|||
126714619|NCT01905397|455906914|FG001|Overall Study|Withdrawal by Subject|0|||
126714620|NCT01905397|455906913|FG000|Overall Study|Surgery canceled/aborted|9|||
126714621|NCT01905397|455906914|FG001|Overall Study|Surgery canceled/aborted|5|||
126368551|NCT01892189|454644361|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
126368552|NCT01892189|454644362|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
126368553|NCT01892189|454644363|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
126368554|NCT01892189|454644364|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
126368555|NCT01892189|454644356|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126368556|NCT01892189|454644357|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126368557|NCT01892189|454644358|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
126551664|NCT02696902|455313774|FG002|Overall Study|Principal investigator's decision|0|||
126551665|NCT02696902|455313772|FG000|Overall Study|Sponsor's decision|1|||
126551666|NCT02696902|455313773|FG001|Overall Study|Sponsor's decision|0|||
126551667|NCT02696902|455313774|FG002|Overall Study|Sponsor's decision|0|||
126368558|NCT01892189|454644359|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
126368559|NCT01892189|454644360|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126714622|NCT01905397|455906913|FG000|Overall Study|Incision < 7 cm|2|||
126714623|NCT01905397|455906914|FG001|Overall Study|Incision < 7 cm|0|||
126368560|NCT01892189|454644361|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126368561|NCT01892189|454644362|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
126368562|NCT01892189|454644363|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126368563|NCT01892189|454644364|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
126368564|NCT01892189|454644356|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368565|NCT01892189|454644357|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368566|NCT01892189|454644358|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368567|NCT01892189|454644359|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368568|NCT01892189|454644360|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368569|NCT01892189|454644361|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
126368570|NCT01892189|454644362|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368571|NCT01892189|454644363|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368572|NCT01892189|454644364|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
126368573|NCT03440411|454644365|FG000|Overall Study|Adverse Event|0|||
126368574|NCT03440411|454644366|FG001|Overall Study|Adverse Event|0|||
126368575|NCT03440411|454644367|FG002|Overall Study|Adverse Event|1|||
126368576|NCT03440411|454644368|FG003|Overall Study|Adverse Event|0|||
126368577|NCT03440411|454644365|FG000|Overall Study|PD|2|||
126368578|NCT03440411|454644366|FG001|Overall Study|PD|1|||
126368579|NCT03440411|454644367|FG002|Overall Study|PD|1|||
126368580|NCT03440411|454644368|FG003|Overall Study|PD|1|||
126368581|NCT03440411|454644365|FG000|Overall Study|Withdrawal by Subject|1|||
126368582|NCT03440411|454644366|FG001|Overall Study|Withdrawal by Subject|0|||
126368583|NCT03440411|454644367|FG002|Overall Study|Withdrawal by Subject|0|||
126368584|NCT03440411|454644368|FG003|Overall Study|Withdrawal by Subject|0|||
126368585|NCT03440411|454644365|FG000|Overall Study|Closed study by sponsor|0|||
126368586|NCT03440411|454644366|FG001|Overall Study|Closed study by sponsor|0|||
126368587|NCT03440411|454644367|FG002|Overall Study|Closed study by sponsor|0|||
126368588|NCT03440411|454644368|FG003|Overall Study|Closed study by sponsor|1|||
126368589|NCT03322566|454644378|FG000|Overall Study|Death|34|||
126368590|NCT03322566|454644379|FG001|Overall Study|Death|35|||
126368591|NCT03322566|454644380|FG002|Overall Study|Death|23|||
126368592|NCT03322566|454644378|FG000|Overall Study|Physician Decision|6|||
126368593|NCT03322566|454644379|FG001|Overall Study|Physician Decision|7|||
126368594|NCT03322566|454644380|FG002|Overall Study|Physician Decision|2|||
126368595|NCT03322566|454644378|FG000|Overall Study|Withdrawal by Subject|4|||
126368596|NCT03322566|454644379|FG001|Overall Study|Withdrawal by Subject|3|||
126368597|NCT03322566|454644380|FG002|Overall Study|Withdrawal by Subject|6|||
126368598|NCT03322566|454644378|FG000|Overall Study|Lost to Follow-up|0|||
126368599|NCT03322566|454644379|FG001|Overall Study|Lost to Follow-up|0|||
126368600|NCT03322566|454644380|FG002|Overall Study|Lost to Follow-up|1|||
126368601|NCT03322566|454644378|FG000|Overall Study|Study terminated by sponsor|1|||
126368602|NCT03322566|454644379|FG001|Overall Study|Study terminated by sponsor|0|||
126368603|NCT03322566|454644380|FG002|Overall Study|Study terminated by sponsor|1|||
126368604|NCT02546323|454644386|FG000|Overall Study|Withdrawal by Subject|36|||
126368605|NCT02546323|454644387|FG001|Overall Study|Withdrawal by Subject|33|||
126368606|NCT02546323|454644386|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
126368607|NCT02546323|454644387|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
126368608|NCT02546323|454644386|FG000|Overall Study|Adverse Event|17|||
126368609|NCT02546323|454644387|FG001|Overall Study|Adverse Event|11|||
126368610|NCT02546323|454644386|FG000|Overall Study|Patient Specific Reasons|1|||
126368611|NCT02546323|454644387|FG001|Overall Study|Patient Specific Reasons|2|||
126368612|NCT02546323|454644386|FG000|Overall Study|Lost to Follow-up|2|||
126368613|NCT02546323|454644387|FG001|Overall Study|Lost to Follow-up|3|||
126368614|NCT02546323|454644386|FG000|Overall Study|Non-compliance with Study Drug|2|||
126368615|NCT02546323|454644387|FG001|Overall Study|Non-compliance with Study Drug|2|||
126368616|NCT02546323|454644386|FG000|Overall Study|Met Withdrawal Criteria|2|||
126368617|NCT02546323|454644387|FG001|Overall Study|Met Withdrawal Criteria|14|||
126368618|NCT01055028|454644388|FG000|Screening|Screen Failure|1|||
126368619|NCT01055028|454644389|FG001|Screening|Screen Failure|1|||
126368620|NCT01055028|454644388|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
126551668|NCT02696902|455313772|FG000|Overall Study|Transferred to other hospital|1|||
126368621|NCT01055028|454644389|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
126368622|NCT01055028|454644388|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
126368623|NCT01055028|454644389|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
126368624|NCT01055028|454644388|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
126368625|NCT01055028|454644389|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
126368626|NCT02507934|454644390|FG000|Overall Study|Lost to Follow-up|2|||
126368627|NCT02507934|454644391|FG001|Overall Study|Lost to Follow-up|0|||
126368628|NCT02507934|454644390|FG000|Overall Study|Withdrawal by Subject|2|||
126368629|NCT02507934|454644391|FG001|Overall Study|Withdrawal by Subject|0|||
126368630|NCT03559530|454644392|FG000|Overall Study|non-location of medical records|44|||
126368631|NCT03559530|454644393|FG001|Overall Study|non-location of medical records|0|||
126368632|NCT03559530|454644392|FG000|Overall Study|culture results not considered for treat|29|||
126368633|NCT03559530|454644393|FG001|Overall Study|culture results not considered for treat|0|||
126368634|NCT03559530|454644392|FG000|Overall Study|duplicate cases|8|||
126368635|NCT03559530|454644393|FG001|Overall Study|duplicate cases|0|||
126368636|NCT03559530|454644392|FG000|Overall Study|other species of Acinetobacte|7|||
126714624|NCT01905397|455906913|FG000|Overall Study|Wrong treatment|1|||
126714625|NCT01905397|455906914|FG001|Overall Study|Wrong treatment|1|||
126714626|NCT01905397|455906913|FG000|Overall Study|Device not applied|3|||
126714627|NCT01905397|455906914|FG001|Overall Study|Device not applied|0|||
126714628|NCT01905397|455906913|FG000|Overall Study|Dressing not applied in operating room|1|||
126714629|NCT01905397|455906914|FG001|Overall Study|Dressing not applied in operating room|0|||
126368637|NCT03559530|454644393|FG001|Overall Study|other species of Acinetobacte|0|||
126368638|NCT03559530|454644392|FG000|Overall Study|contamination / colonization|3|||
126368639|NCT03559530|454644393|FG001|Overall Study|contamination / colonization|0|||
126368640|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
126368641|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
126368642|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
126368643|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
126368644|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
126368645|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
126368646|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
126368647|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
126368648|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
126368649|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
126368650|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
126368651|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
126368652|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
126368653|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
126368654|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
126368655|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
126368656|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
126368657|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
126368658|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
126368659|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
126368660|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
126368661|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
126368662|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
126368663|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
126368664|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
126368665|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
126368666|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
126368667|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
126463584|NCT01539317|454998742|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
126463585|NCT01539317|454998743|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
126463586|NCT00976573|454998750|FG000|Overall Study|Ineligible|0|||
126463587|NCT00976573|454998751|FG001|Overall Study|Ineligible|1|||
126463588|NCT00976573|454998750|FG000|Overall Study|Cancel prior to receiving treatment|4|||
126463589|NCT00976573|454998751|FG001|Overall Study|Cancel prior to receiving treatment|2|||
126463590|NCT02117427|454998752|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
126463591|NCT02117427|454998753|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
126463592|NCT02117427|454998754|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
126463593|NCT02117427|454998752|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
126463594|NCT02117427|454998753|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
126463595|NCT02117427|454998754|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
126714630|NCT01905397|455906913|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
126714631|NCT01905397|455906914|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
126714632|NCT00844428|455906915|FG000|Screening Period|Screen Failure|3|||
126714633|NCT00844428|455906915|FG000|Extension Treatment Period|Death|1|||
126368668|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
126368669|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
126368670|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
126368671|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
126368672|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
126368673|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
126368674|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
126368675|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
126368676|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
126551669|NCT02696902|455313773|FG001|Overall Study|Transferred to other hospital|0|||
126714634|NCT00844428|455906915|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
126368677|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
126368678|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
126368679|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
126368680|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
126368681|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
126714635|NCT00863928|455906918|FG000|Overall Study|Protocol Violation|26|||
126551670|NCT02696902|455313774|FG002|Overall Study|Transferred to other hospital|0|||
126551671|NCT05822921|455313777|FG000|Overall Study|Lost to Follow-up|1|||
126551672|NCT05822921|455313778|FG001|Overall Study|Lost to Follow-up|1|||
126551673|NCT00544544|455313779|FG000|Overall Study|Withdrawal by Subject|1|||
126551674|NCT00544544|455313779|FG000|Overall Study|Adverse Event|1|||
126551675|NCT00544544|455313779|FG000|Overall Study|Lost to Follow-up|1|||
126551676|NCT03406702|455313780|FG000|Overall Study|Missed Day 27 Dosing|1|||
126551677|NCT01857622|455313785|FG000|Overall Study|Adverse Event|5|||
126551678|NCT01857622|455313786|FG001|Overall Study|Adverse Event|0|||
126551679|NCT01857622|455313787|FG002|Overall Study|Adverse Event|2|||
126551680|NCT01857622|455313785|FG000|Overall Study|Physician Decision|1|||
126551681|NCT01857622|455313786|FG001|Overall Study|Physician Decision|0|||
126551682|NCT01857622|455313787|FG002|Overall Study|Physician Decision|0|||
126551683|NCT01857622|455313785|FG000|Overall Study|Protocol Violation|4|||
126551684|NCT01857622|455313786|FG001|Overall Study|Protocol Violation|1|||
126551685|NCT01857622|455313787|FG002|Overall Study|Protocol Violation|0|||
126551686|NCT01857622|455313785|FG000|Overall Study|Withdrawal by Subject|1|||
126551687|NCT01857622|455313786|FG001|Overall Study|Withdrawal by Subject|0|||
126551688|NCT01857622|455313787|FG002|Overall Study|Withdrawal by Subject|0|||
126551689|NCT01291225|455313789|FG000|Overall Study|Lost to Follow-up|85|||
126551690|NCT01291225|455313790|FG001|Overall Study|Lost to Follow-up|39|||
126551691|NCT01267253|455313791|FG000|Overall Study|Ineligible - required test not done|1|||
126551692|NCT01267253|455313791|FG000|Overall Study|Inevaluable-never received study treatme|2|||
126551693|NCT04318093|455313794|FG000|Overall Study|Adverse Event|2|||
126551694|NCT04318093|455313795|FG001|Overall Study|Adverse Event|2|||
126551695|NCT04318093|455313794|FG000|Overall Study|Participant withdrew consent|1|||
126551696|NCT04318093|455313795|FG001|Overall Study|Participant withdrew consent|0|||
126551697|NCT04318093|455313794|FG000|Overall Study|Other reasons|0|||
126551698|NCT04318093|455313795|FG001|Overall Study|Other reasons|1|||
126551699|NCT00127413|455313797|FG000|Overall Study|Lost to Follow-up|6|||
126551700|NCT00127413|455313798|FG001|Overall Study|Lost to Follow-up|4|||
126551701|NCT00127413|455313799|FG002|Overall Study|Lost to Follow-up|8|||
126551702|NCT00127413|455313800|FG003|Overall Study|Lost to Follow-up|2|||
126551703|NCT03363659|455313804|FG000|Overall Study|Adverse Event|1|||
126551704|NCT03363659|455313804|FG000|Overall Study|Screen fail|1|||
126551705|NCT03363659|455313804|FG000|Overall Study|Withdrawal by Subject|1|||
126551706|NCT03872388|455313805|FG000|Overall Study|Disease Progression|0|||
126551707|NCT03872388|455313806|FG001|Overall Study|Disease Progression|0|||
126551708|NCT03872388|455313807|FG002|Overall Study|Disease Progression|0|||
126551709|NCT03872388|455313808|FG003|Overall Study|Disease Progression|0|||
126551710|NCT03872388|455313809|FG004|Overall Study|Disease Progression|0|||
126551711|NCT03872388|455313810|FG005|Overall Study|Disease Progression|0|||
126551712|NCT03872388|455313811|FG006|Overall Study|Disease Progression|1|||
126551713|NCT03872388|455313812|FG007|Overall Study|Disease Progression|1|||
126551714|NCT01040780|455315824|FG000|Overall Study|Protocol Violation|1|||
126551715|NCT01040780|455315825|FG001|Overall Study|Protocol Violation|3|||
126551716|NCT00802737|455315826|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
126551717|NCT00802737|455315827|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
126551718|NCT00802737|455315828|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
126551719|NCT00802737|455315826|FG000|Overall Study|Death|6|||
126551720|NCT00802737|455315827|FG001|Overall Study|Death|5|||
126551721|NCT00802737|455315828|FG002|Overall Study|Death|1|||
126551722|NCT00802737|455315826|FG000|Overall Study|Adverse Event|1|||
126551723|NCT00802737|455315827|FG001|Overall Study|Adverse Event|0|||
126551724|NCT00802737|455315828|FG002|Overall Study|Adverse Event|0|||
126551725|NCT00802737|455315826|FG000|Overall Study|Received Prohibited Therapy|1|||
126551726|NCT00802737|455315827|FG001|Overall Study|Received Prohibited Therapy|0|||
126551727|NCT00802737|455315828|FG002|Overall Study|Received Prohibited Therapy|0|||
126551728|NCT00802737|455315826|FG000|Overall Study|Ongoing CLL-Treatment|0|||
126551729|NCT00802737|455315827|FG001|Overall Study|Ongoing CLL-Treatment|1|||
126551730|NCT00802737|455315828|FG002|Overall Study|Ongoing CLL-Treatment|0|||
126551731|NCT00802737|455315826|FG000|Overall Study|Participant too Unwell|0|||
126551732|NCT00802737|455315827|FG001|Overall Study|Participant too Unwell|2|||
126551733|NCT00802737|455315828|FG002|Overall Study|Participant too Unwell|0|||
126551734|NCT03864926|455315836|FG000|Overall Study|Death|0|||
126551735|NCT03864926|455315837|FG001|Overall Study|Death|2|||
126551736|NCT00445601|455315838|FG000|Overall Study|Withdrawal by Subject|11|||
126551737|NCT00445601|455315839|FG001|Overall Study|Withdrawal by Subject|11|||
126551738|NCT00445601|455315838|FG000|Overall Study|TURBT Complication|12|||
126551739|NCT00445601|455315839|FG001|Overall Study|TURBT Complication|8|||
126551740|NCT00445601|455315838|FG000|Overall Study|Incorrect Disease Status|6|||
126551741|NCT00445601|455315839|FG001|Overall Study|Incorrect Disease Status|6|||
126551742|NCT00445601|455315838|FG000|Overall Study|Drug Delivery Issue|2|||
126551743|NCT00445601|455315839|FG001|Overall Study|Drug Delivery Issue|2|||
126551744|NCT00445601|455315838|FG000|Overall Study|Adverse Event|2|||
126551745|NCT00445601|455315839|FG001|Overall Study|Adverse Event|0|||
126551746|NCT00445601|455315838|FG000|Overall Study|Death prior to TURBT|0|||
126551747|NCT00445601|455315839|FG001|Overall Study|Death prior to TURBT|1|||
126368682|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
126368683|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
126368684|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
126368685|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
126368686|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
126368687|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
126368688|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
126368689|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
126368690|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
126368691|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
126368692|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
126368693|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
126368694|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
126368695|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
126368696|NCT01362790|454644396|FG000|Pilot Phase & Phase 2|Death on study|0|||
126368697|NCT01362790|454644397|FG001|Pilot Phase & Phase 2|Death on study|0|||
126368698|NCT01362790|454644398|FG002|Pilot Phase & Phase 2|Death on study|0|||
126368699|NCT01362790|454644399|FG003|Pilot Phase & Phase 2|Death on study|1|||
126368700|NCT01362790|454644400|FG004|Pilot Phase & Phase 2|Death on study|0|||
126368701|NCT01362790|454644401|FG005|Pilot Phase & Phase 2|Death on study|0|||
126368702|NCT01362790|454644402|FG006|Pilot Phase & Phase 2|Death on study|0|||
126368703|NCT01362790|454644396|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
126368704|NCT01362790|454644397|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
126368705|NCT01362790|454644398|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
126368706|NCT01362790|454644399|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
126368707|NCT01362790|454644400|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
126368708|NCT01362790|454644401|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
126368709|NCT01362790|454644402|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
126368710|NCT01362790|454644396|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
126368711|NCT01362790|454644397|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
126368712|NCT01362790|454644398|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
126368713|NCT01362790|454644399|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
126368714|NCT01362790|454644400|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
126368715|NCT01362790|454644401|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
126368716|NCT01362790|454644402|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
126368717|NCT01362790|454644396|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
126368718|NCT01362790|454644397|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
126368719|NCT01362790|454644398|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
126368720|NCT01362790|454644399|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
126368721|NCT01362790|454644400|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
126368722|NCT01362790|454644401|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
126368723|NCT01362790|454644402|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
126368724|NCT02457065|454644403|FG000|Overall Study|Lost to Follow-up|9|||
126368725|NCT02457065|454644404|FG001|Overall Study|Lost to Follow-up|11|||
126368726|NCT05805150|454644406|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
126368727|NCT05805150|454644407|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
126368728|NCT01506726|454644413|FG000|Overall Study|Adverse Event|1|||
126368729|NCT01506726|454644414|FG001|Overall Study|Adverse Event|2|||
126368730|NCT04347538|454644418|FG000|Overall Study|Lost to Follow-up|4|||
126368731|NCT04347538|454644419|FG001|Overall Study|Lost to Follow-up|5|||
126368732|NCT04347538|454644420|FG002|Overall Study|Lost to Follow-up|7|||
126368733|NCT02135133|454644421|FG000|Overall Study|Adverse Event|10|||
126368734|NCT02135133|454644421|FG000|Overall Study|regulatory mandate|5|||
126368735|NCT05081843|454644422|FG000|Overall Study|Lost to Follow-up|135|||
126368736|NCT05081843|454644423|FG001|Overall Study|Lost to Follow-up|145|||
126368737|NCT02303821|454644424|FG000|Overall Study|Withdrawal by Subject|0|||
126368738|NCT02303821|454644425|FG001|Overall Study|Withdrawal by Subject|0|||
126368739|NCT02303821|454644426|FG002|Overall Study|Withdrawal by Subject|0|||
126368740|NCT02303821|454644427|FG003|Overall Study|Withdrawal by Subject|0|||
126368741|NCT02303821|454644428|FG004|Overall Study|Withdrawal by Subject|0|||
126368742|NCT02303821|454644429|FG005|Overall Study|Withdrawal by Subject|0|||
126368743|NCT02303821|454644430|FG006|Overall Study|Withdrawal by Subject|0|||
126368744|NCT02303821|454644431|FG007|Overall Study|Withdrawal by Subject|2|||
126463596|NCT02117427|454998752|FG000|Overall Study|Physician Decision|0|||
126463597|NCT02117427|454998753|FG001|Overall Study|Physician Decision|2|||
126368745|NCT02303821|454644424|FG000|Overall Study|Death|0|||
126368746|NCT02303821|454644425|FG001|Overall Study|Death|2|||
126368747|NCT02303821|454644426|FG002|Overall Study|Death|0|||
126368748|NCT02303821|454644427|FG003|Overall Study|Death|0|||
126368749|NCT02303821|454644428|FG004|Overall Study|Death|0|||
126368750|NCT02303821|454644429|FG005|Overall Study|Death|3|||
126463598|NCT02117427|454998754|FG002|Overall Study|Physician Decision|0|||
126714636|NCT00863928|455906919|FG001|Overall Study|Protocol Violation|0|||
126714637|NCT00863928|455906918|FG000|Overall Study|Withdrawal by Subject|3|||
126714638|NCT00863928|455906919|FG001|Overall Study|Withdrawal by Subject|0|||
126714639|NCT00863928|455906918|FG000|Overall Study|surgery cancellation|4|||
126714640|NCT00863928|455906919|FG001|Overall Study|surgery cancellation|0|||
126714641|NCT00863928|455906918|FG000|Overall Study|medication allergy|3|||
126714642|NCT00863928|455906919|FG001|Overall Study|medication allergy|0|||
126714643|NCT00772967|455906920|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
126714644|NCT00772967|455906921|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
126714645|NCT00772967|455906922|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
126714646|NCT00772967|455906923|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
126714647|NCT00772967|455906924|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
126714648|NCT00772967|455906925|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
126714649|NCT00772967|455906920|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
126714650|NCT00772967|455906921|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
126714651|NCT00772967|455906922|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
126714652|NCT00772967|455906923|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
126714653|NCT00772967|455906924|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
126714654|NCT00772967|455906925|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
126714655|NCT00772967|455906920|FG000|Crossover Treatment 3|Adverse Event|0|||
126714656|NCT00772967|455906921|FG001|Crossover Treatment 3|Adverse Event|0|||
126714657|NCT00772967|455906922|FG002|Crossover Treatment 3|Adverse Event|0|||
126714658|NCT00772967|455906923|FG003|Crossover Treatment 3|Adverse Event|0|||
126714659|NCT00772967|455906924|FG004|Crossover Treatment 3|Adverse Event|1|||
126714660|NCT00772967|455906925|FG005|Crossover Treatment 3|Adverse Event|0|||
126714661|NCT01041573|455906927|FG000|Overall Study|Withdrawal by Subject|2|||
126714662|NCT01041573|455906928|FG001|Overall Study|Withdrawal by Subject|5|||
126714663|NCT01041573|455906929|FG002|Overall Study|Withdrawal by Subject|2|||
126714664|NCT01041573|455906930|FG003|Overall Study|Withdrawal by Subject|0|||
126714665|NCT01041573|455906927|FG000|Overall Study|Death|1|||
126714666|NCT01041573|455906928|FG001|Overall Study|Death|0|||
126714667|NCT01041573|455906929|FG002|Overall Study|Death|0|||
126714668|NCT01041573|455906930|FG003|Overall Study|Death|0|||
126714669|NCT01041573|455906927|FG000|Overall Study|Lost to Follow-up|0|||
126714670|NCT01041573|455906928|FG001|Overall Study|Lost to Follow-up|1|||
126714671|NCT01041573|455906929|FG002|Overall Study|Lost to Follow-up|2|||
126714672|NCT01041573|455906930|FG003|Overall Study|Lost to Follow-up|1|||
126714673|NCT01041573|455906927|FG000|Overall Study|Adverse Event|0|||
126714674|NCT01041573|455906928|FG001|Overall Study|Adverse Event|2|||
126714675|NCT01041573|455906929|FG002|Overall Study|Adverse Event|0|||
126714676|NCT01041573|455906930|FG003|Overall Study|Adverse Event|0|||
126714677|NCT01041573|455906927|FG000|Overall Study|relocation|1|||
126714678|NCT01041573|455906928|FG001|Overall Study|relocation|4|||
126714679|NCT01041573|455906929|FG002|Overall Study|relocation|3|||
126714680|NCT01041573|455906930|FG003|Overall Study|relocation|1|||
126714681|NCT01041573|455906927|FG000|Overall Study|further blood extraction|0|||
126714682|NCT01041573|455906928|FG001|Overall Study|further blood extraction|1|||
126714683|NCT01041573|455906929|FG002|Overall Study|further blood extraction|0|||
126714684|NCT01041573|455906930|FG003|Overall Study|further blood extraction|0|||
126304863|NCT00610155|454405538|FG000|Period 1|Withdrawal by Subject|0|||
126304864|NCT00610155|454405539|FG001|Period 1|Withdrawal by Subject|0|||
126304865|NCT00610155|454405540|FG002|Period 1|Withdrawal by Subject|1|||
126304866|NCT00610155|454405541|FG003|Period 1|Withdrawal by Subject|0|||
126304867|NCT00610155|454405542|FG004|Period 1|Withdrawal by Subject|0|||
126304868|NCT00610155|454405543|FG005|Period 1|Withdrawal by Subject|0|||
126304869|NCT00610155|454405538|FG000|Period 3|Adverse Event|1|||
126304870|NCT00610155|454405539|FG001|Period 3|Adverse Event|0|||
126304871|NCT00610155|454405540|FG002|Period 3|Adverse Event|0|||
126463599|NCT02117427|454998752|FG000|Overall Study|No longer meets inclusion criteria|0|||
126463600|NCT02117427|454998753|FG001|Overall Study|No longer meets inclusion criteria|1|||
126463601|NCT02117427|454998754|FG002|Overall Study|No longer meets inclusion criteria|0|||
126463602|NCT02117427|454998752|FG000|Overall Study|Death|0|||
126463603|NCT02117427|454998753|FG001|Overall Study|Death|1|||
126714685|NCT01041573|455906927|FG000|Overall Study|positive to anti-HCV|1|||
126463604|NCT02117427|454998754|FG002|Overall Study|Death|0|||
126714686|NCT01041573|455906928|FG001|Overall Study|positive to anti-HCV|0|||
126714687|NCT01041573|455906929|FG002|Overall Study|positive to anti-HCV|0|||
126714688|NCT01041573|455906930|FG003|Overall Study|positive to anti-HCV|0|||
126463605|NCT00937391|454998763|FG000|Stage 2|Withdrawal by Subject|1|||
126463606|NCT02211638|454998764|FG000|Overall Study|Case Report Forms Uncollected|291|||
126714689|NCT04172831|455906931|FG000|Overall Study|Adverse Event|21|||
126714690|NCT04172831|455906932|FG001|Overall Study|Adverse Event|9|||
126714691|NCT04172831|455906931|FG000|Overall Study|Lack of Efficacy|2|||
126714692|NCT04172831|455906932|FG001|Overall Study|Lack of Efficacy|8|||
126714693|NCT04172831|455906931|FG000|Overall Study|Physician Decision|0|||
126304872|NCT00610155|454405541|FG003|Period 3|Adverse Event|0|||
126304873|NCT00610155|454405542|FG004|Period 3|Adverse Event|0|||
126714694|NCT04172831|455906932|FG001|Overall Study|Physician Decision|1|||
126714695|NCT04172831|455906931|FG000|Overall Study|Withdrawal by Subject|12|||
126551748|NCT01625910|455315846|FG000|Overall Study|Lost to Follow-up|3|||
126551749|NCT01625910|455315847|FG001|Overall Study|Lost to Follow-up|4|||
126714696|NCT04172831|455906932|FG001|Overall Study|Withdrawal by Subject|11|||
126714697|NCT04172831|455906931|FG000|Overall Study|Lost to Follow-up|4|||
126304874|NCT00610155|454405543|FG005|Period 3|Adverse Event|0|||
126304875|NCT01560234|454405544|FG000|Overall Study|Lost to Follow-up|3|||
126304876|NCT01560234|454405545|FG001|Overall Study|Lost to Follow-up|0|||
126304877|NCT01560234|454405546|FG002|Overall Study|Lost to Follow-up|1|||
126304878|NCT01560234|454405547|FG003|Overall Study|Lost to Follow-up|0|||
126304879|NCT01560234|454405548|FG004|Overall Study|Lost to Follow-up|0|||
126304880|NCT01560234|454405549|FG005|Overall Study|Lost to Follow-up|2|||
126304881|NCT01560234|454405550|FG006|Overall Study|Lost to Follow-up|0|||
126304882|NCT01560234|454405551|FG007|Overall Study|Lost to Follow-up|2|||
126304883|NCT01284348|454405552|FG000|Overall Study|Death|1|||
126304884|NCT01284348|454405553|FG001|Overall Study|Death|1|||
126304885|NCT01284348|454405552|FG000|Overall Study|Withdrew consent|0|||
126304886|NCT01284348|454405553|FG001|Overall Study|Withdrew consent|1|||
126304887|NCT01284348|454405552|FG000|Overall Study|Status not recorded|9|||
126304888|NCT01284348|454405553|FG001|Overall Study|Status not recorded|10|||
126304889|NCT03645395|454405560|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
126304890|NCT03645395|454405561|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
126304891|NCT03645395|454405562|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
126304892|NCT03645395|454405563|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
126304893|NCT03645395|454405560|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
126304894|NCT03645395|454405561|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
126304895|NCT03645395|454405562|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
126304896|NCT03645395|454405563|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
126304897|NCT03645395|454405560|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
126304898|NCT03645395|454405561|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
126304899|NCT03645395|454405562|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
126304900|NCT03645395|454405563|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
126304901|NCT03645395|454405560|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
126304902|NCT03645395|454405561|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
126304903|NCT03645395|454405562|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
126304904|NCT03645395|454405563|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
126304905|NCT02088905|454405564|FG000|Overall Study|Withdrawal by Subject|5|||
126304906|NCT02088905|454405565|FG001|Overall Study|Withdrawal by Subject|1|||
126304907|NCT02285166|454405567|FG000|Overall Study|Case Report Forms Uncollected|564|||
126304908|NCT02285166|454405567|FG000|Overall Study|Protocol Deviation|402|||
126304909|NCT00384839|454405570|FG000|Overall Study|Adverse Event|4|||
126304910|NCT00384839|454405570|FG000|Overall Study|Investigator Request|1|||
126304911|NCT00384839|454405570|FG000|Overall Study|Patient Request|1|||
126304912|NCT00384839|454405570|FG000|Overall Study|Ineligible|2|||
126304913|NCT04606394|454405571|FG000|Overall Study|Withdrawal by Subject|3|||
126304914|NCT04606394|454405571|FG000|Overall Study|Exclusion criteria screen failure|12|||
126304915|NCT03423173|454405572|FG000|Overall Study|Randomized but not vaccinated|1|||
126304916|NCT03423173|454405573|FG001|Overall Study|Randomized but not vaccinated|0|||
126304917|NCT03423173|454405574|FG002|Overall Study|Randomized but not vaccinated|2|||
126304918|NCT03423173|454405575|FG003|Overall Study|Randomized but not vaccinated|1|||
126304919|NCT03423173|454405572|FG000|Overall Study|Adverse Event|1|||
126463607|NCT02211638|454998764|FG000|Overall Study|Protocol Violation|692|||
126463608|NCT04041700|454998767|FG000|Overall Study|Pregnancy|1|||
126463609|NCT04041700|454998767|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
126463610|NCT02775903|454998768|FG000|Overall Study|Death|7|||
126463611|NCT02775903|454998769|FG001|Overall Study|Death|11|||
126463612|NCT02775903|454998770|FG002|Overall Study|Death|12|||
126463613|NCT02775903|454998771|FG003|Overall Study|Death|11|||
126463614|NCT02775903|454998768|FG000|Overall Study|Adverse Event|0|||
126463615|NCT02775903|454998769|FG001|Overall Study|Adverse Event|1|||
126463616|NCT02775903|454998770|FG002|Overall Study|Adverse Event|12|||
126463617|NCT02775903|454998771|FG003|Overall Study|Adverse Event|3|||
126463618|NCT02775903|454998768|FG000|Overall Study|Progressive disease|15|||
126463619|NCT02775903|454998769|FG001|Overall Study|Progressive disease|14|||
126304920|NCT03423173|454405573|FG001|Overall Study|Adverse Event|1|||
126304921|NCT03423173|454405574|FG002|Overall Study|Adverse Event|1|||
126304922|NCT03423173|454405575|FG003|Overall Study|Adverse Event|1|||
126304923|NCT03423173|454405572|FG000|Overall Study|Lost to Follow-up|10|||
126304924|NCT03423173|454405573|FG001|Overall Study|Lost to Follow-up|19|||
126304925|NCT03423173|454405574|FG002|Overall Study|Lost to Follow-up|17|||
126551750|NCT02391038|455315848|FG000|Overall Study|Progressive disease|3|||
126551751|NCT02391038|455315849|FG001|Overall Study|Progressive disease|3|||
126304926|NCT03423173|454405575|FG003|Overall Study|Lost to Follow-up|22|||
126304927|NCT03423173|454405572|FG000|Overall Study|Withdrawal of consent|4|||
126304928|NCT03423173|454405573|FG001|Overall Study|Withdrawal of consent|10|||
126304929|NCT03423173|454405574|FG002|Overall Study|Withdrawal of consent|4|||
126304930|NCT03423173|454405575|FG003|Overall Study|Withdrawal of consent|5|||
126463620|NCT02775903|454998770|FG002|Overall Study|Progressive disease|30|||
126368751|NCT02303821|454644430|FG006|Overall Study|Death|41|||
126368752|NCT02303821|454644431|FG007|Overall Study|Death|29|||
126368753|NCT02303821|454644424|FG000|Overall Study|Lost to Follow-up|0|||
126368754|NCT02303821|454644425|FG001|Overall Study|Lost to Follow-up|0|||
126368755|NCT02303821|454644426|FG002|Overall Study|Lost to Follow-up|0|||
126368756|NCT02303821|454644427|FG003|Overall Study|Lost to Follow-up|0|||
126368757|NCT02303821|454644428|FG004|Overall Study|Lost to Follow-up|0|||
126368758|NCT02303821|454644429|FG005|Overall Study|Lost to Follow-up|0|||
126368759|NCT02303821|454644430|FG006|Overall Study|Lost to Follow-up|1|||
126368760|NCT02303821|454644431|FG007|Overall Study|Lost to Follow-up|0|||
126368761|NCT02303821|454644424|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368762|NCT02303821|454644425|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368763|NCT02303821|454644426|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368764|NCT02303821|454644427|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368765|NCT02303821|454644428|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368766|NCT02303821|454644429|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368767|NCT02303821|454644430|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
126368768|NCT02303821|454644431|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
126368769|NCT02303821|454644424|FG000|Overall Study|Decision by sponsor|0|||
126368770|NCT02303821|454644425|FG001|Overall Study|Decision by sponsor|0|||
126368771|NCT02303821|454644426|FG002|Overall Study|Decision by sponsor|0|||
126368772|NCT02303821|454644427|FG003|Overall Study|Decision by sponsor|0|||
126368773|NCT02303821|454644428|FG004|Overall Study|Decision by sponsor|0|||
126368774|NCT02303821|454644429|FG005|Overall Study|Decision by sponsor|1|||
126368775|NCT02303821|454644430|FG006|Overall Study|Decision by sponsor|0|||
126368776|NCT02303821|454644431|FG007|Overall Study|Decision by sponsor|0|||
126368777|NCT02303821|454644424|FG000|Overall Study|Protocol-specified criteria|0|||
126368778|NCT02303821|454644425|FG001|Overall Study|Protocol-specified criteria|1|||
126368779|NCT02303821|454644426|FG002|Overall Study|Protocol-specified criteria|0|||
126368780|NCT02303821|454644427|FG003|Overall Study|Protocol-specified criteria|0|||
126368781|NCT02303821|454644428|FG004|Overall Study|Protocol-specified criteria|0|||
126368782|NCT02303821|454644429|FG005|Overall Study|Protocol-specified criteria|1|||
126368783|NCT02303821|454644430|FG006|Overall Study|Protocol-specified criteria|0|||
126368784|NCT02303821|454644431|FG007|Overall Study|Protocol-specified criteria|0|||
126368785|NCT04116489|454644444|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
126368786|NCT04116489|454644444|FG000|Overall Study|Withdrawal by Subject|1|||
126368787|NCT03734536|454644445|FG000|Overall Study|Withdrew Consent|1|||
126368788|NCT03734536|454644446|FG001|Overall Study|Withdrew Consent|5|||
126368789|NCT03734536|454644445|FG000|Overall Study|Lost to Follow-up|10|||
126368790|NCT03734536|454644446|FG001|Overall Study|Lost to Follow-up|7|||
126368791|NCT04727151|454644447|FG000|Overall Study|Death|0|||
126368792|NCT04727151|454644448|FG001|Overall Study|Death|0|||
126368793|NCT04727151|454644449|FG002|Overall Study|Death|0|||
126368794|NCT04727151|454644450|FG003|Overall Study|Death|0|||
126368795|NCT04727151|454644451|FG004|Overall Study|Death|3|||
126368796|NCT04727151|454644447|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
126368797|NCT04727151|454644448|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
126368798|NCT04727151|454644449|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
126368799|NCT04727151|454644450|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
126368800|NCT04727151|454644451|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
126368801|NCT01346592|454644453|FG000|Overall Study|Lost to Follow-up|62|||
126368802|NCT01346592|454644454|FG001|Overall Study|Lost to Follow-up|29|||
126368803|NCT01346592|454644455|FG002|Overall Study|Lost to Follow-up|29|||
126368804|NCT01346592|454644453|FG000|Overall Study|Protocol Violation|2|||
126368805|NCT01346592|454644454|FG001|Overall Study|Protocol Violation|1|||
126368806|NCT01346592|454644455|FG002|Overall Study|Protocol Violation|0|||
126368807|NCT01346592|454644453|FG000|Overall Study|Death|1|||
126368808|NCT01346592|454644454|FG001|Overall Study|Death|3|||
126368809|NCT01346592|454644455|FG002|Overall Study|Death|4|||
126368810|NCT01346592|454644453|FG000|Overall Study|Adverse Event|0|||
126368811|NCT01346592|454644454|FG001|Overall Study|Adverse Event|1|||
126368812|NCT01346592|454644455|FG002|Overall Study|Adverse Event|0|||
126368813|NCT01346592|454644453|FG000|Overall Study|Withdrawal by Subject|77|||
126368814|NCT01346592|454644454|FG001|Overall Study|Withdrawal by Subject|51|||
126368815|NCT01346592|454644455|FG002|Overall Study|Withdrawal by Subject|38|||
126368816|NCT01346592|454644453|FG000|Overall Study|Inappropriate enrollment|3|||
126368817|NCT01346592|454644454|FG001|Overall Study|Inappropriate enrollment|1|||
126368818|NCT01346592|454644455|FG002|Overall Study|Inappropriate enrollment|1|||
126368819|NCT01346592|454644453|FG000|Overall Study|Administrative reason|1|||
126368820|NCT01346592|454644454|FG001|Overall Study|Administrative reason|0|||
126368821|NCT01346592|454644455|FG002|Overall Study|Administrative reason|0|||
126368822|NCT01346592|454644453|FG000|Overall Study|Unable to Classify|7|||
126368823|NCT01346592|454644454|FG001|Overall Study|Unable to Classify|3|||
126368824|NCT01346592|454644455|FG002|Overall Study|Unable to Classify|6|||
126368825|NCT02679274|454644456|FG000|Overall Study|Withdrawal by Subject|1|||
126368826|NCT02679274|454644457|FG001|Overall Study|Withdrawal by Subject|0|||
126368827|NCT02038036|454644462|FG000|Core Study|Adverse Event|7|||
126714698|NCT04172831|455906932|FG001|Overall Study|Lost to Follow-up|9|||
126714699|NCT04172831|455906931|FG000|Overall Study|COVID-19 related crisis|3|||
126714700|NCT04172831|455906932|FG001|Overall Study|COVID-19 related crisis|3|||
126714701|NCT04172831|455906931|FG000|Overall Study|Subject non-compliance|1|||
126714702|NCT04172831|455906932|FG001|Overall Study|Subject non-compliance|1|||
126714703|NCT04172831|455906931|FG000|Overall Study|Family emergency|1|||
126714704|NCT04172831|455906932|FG001|Overall Study|Family emergency|0|||
126714705|NCT01765764|455906937|FG000|Treatment Period|Adverse Event|1|||
126714706|NCT01765764|455906938|FG001|Treatment Period|Adverse Event|2|||
126714707|NCT01765764|455906939|FG002|Treatment Period|Adverse Event|1|||
126714708|NCT01765764|455906937|FG000|Treatment Period|Lost to Follow-up|0|||
126714709|NCT01765764|455906938|FG001|Treatment Period|Lost to Follow-up|3|||
126714710|NCT01765764|455906939|FG002|Treatment Period|Lost to Follow-up|2|||
126714711|NCT01765764|455906937|FG000|Treatment Period|Personal Reasons|1|||
126714712|NCT01765764|455906938|FG001|Treatment Period|Personal Reasons|2|||
126714713|NCT01765764|455906939|FG002|Treatment Period|Personal Reasons|1|||
126714714|NCT01765764|455906937|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
126714715|NCT01765764|455906938|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
126714716|NCT01765764|455906939|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
126714717|NCT01597193|455906941|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
126714718|NCT01597193|455906942|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
126714719|NCT01597193|455906943|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
126714720|NCT01597193|455906944|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
126714721|NCT01597193|455906945|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
126714722|NCT01597193|455906946|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
126714723|NCT01597193|455906947|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
126714724|NCT01597193|455906941|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
126714725|NCT01597193|455906942|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
126714726|NCT01597193|455906943|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
126714727|NCT01597193|455906944|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
126714728|NCT01597193|455906945|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
126304931|NCT03423173|454405572|FG000|Overall Study|Death|1|||
126304932|NCT03423173|454405573|FG001|Overall Study|Death|0|||
126304933|NCT03423173|454405574|FG002|Overall Study|Death|0|||
126304934|NCT03423173|454405575|FG003|Overall Study|Death|0|||
126304935|NCT03423173|454405572|FG000|Overall Study|Reason not Specified|2|||
126304936|NCT03423173|454405573|FG001|Overall Study|Reason not Specified|5|||
126304937|NCT03423173|454405574|FG002|Overall Study|Reason not Specified|3|||
126304938|NCT03423173|454405575|FG003|Overall Study|Reason not Specified|1|||
126304939|NCT01028014|454405577|FG000|Overall Study|Lost to Follow-up|1|||
126304940|NCT01028014|454405578|FG001|Overall Study|Lost to Follow-up|2|||
126304941|NCT01028014|454405579|FG002|Overall Study|Lost to Follow-up|0|||
126304942|NCT01028014|454405580|FG003|Overall Study|Lost to Follow-up|1|||
126304943|NCT01028014|454405581|FG004|Overall Study|Lost to Follow-up|1|||
126304944|NCT01028014|454405582|FG005|Overall Study|Lost to Follow-up|2|||
126304945|NCT00729157|454405587|FG000|Overall Study|Withdrawal by Subject|1|||
126304946|NCT00661609|454405588|FG000|Overall Study|Adverse Event|4|||
126304947|NCT00661609|454405588|FG000|Overall Study|Death|20|||
126304948|NCT00661609|454405588|FG000|Overall Study|Withdrawal by Subject|2|||
126304949|NCT00661609|454405588|FG000|Overall Study|PI Decision|1|||
126304950|NCT00661609|454405588|FG000|Overall Study|Survival follow up stage discontinued|11|||
126304951|NCT00661609|454405588|FG000|Overall Study|Disease progression|3|||
126304952|NCT01855243|454405589|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
126304953|NCT01855243|454405590|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
126368828|NCT02038036|454644463|FG001|Core Study|Adverse Event|7|||
126368829|NCT02038036|454644462|FG000|Core Study|Death|1|||
126368830|NCT02038036|454644463|FG001|Core Study|Death|1|||
126368831|NCT02038036|454644462|FG000|Core Study|Disease progression|2|||
126368832|NCT02038036|454644463|FG001|Core Study|Disease progression|2|||
126368833|NCT02038036|454644462|FG000|Core Study|Lost to Follow-up|0|||
126368834|NCT02038036|454644463|FG001|Core Study|Lost to Follow-up|1|||
126368835|NCT02038036|454644462|FG000|Core Study|Physician Decision|2|||
126368836|NCT02038036|454644463|FG001|Core Study|Physician Decision|1|||
126368837|NCT02038036|454644462|FG000|Core Study|Subject/guardian decision|0|||
126368838|NCT02038036|454644463|FG001|Core Study|Subject/guardian decision|1|||
126368839|NCT02038036|454644462|FG000|Core Study|Withdrawal by Subject|3|||
126368840|NCT02038036|454644463|FG001|Core Study|Withdrawal by Subject|1|||
126368841|NCT02038036|454644462|FG000|Crossover Period|Withdrawal by Subject|0|||
126368842|NCT02038036|454644463|FG001|Crossover Period|Withdrawal by Subject|3|||
126368843|NCT02038036|454644462|FG000|Crossover Period|Adverse Event|0|||
126368844|NCT02038036|454644463|FG001|Crossover Period|Adverse Event|9|||
126368845|NCT02038036|454644462|FG000|Crossover Period|Death|0|||
126368846|NCT02038036|454644463|FG001|Crossover Period|Death|2|||
126368847|NCT02038036|454644462|FG000|Crossover Period|Disease progression|0|||
126714729|NCT01597193|455906946|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
126368848|NCT02038036|454644463|FG001|Crossover Period|Disease progression|3|||
126368849|NCT02038036|454644462|FG000|Crossover Period|Lost to Follow-up|0|||
126551752|NCT02391038|455315850|FG002|Overall Study|Progressive disease|6|||
126551753|NCT02959138|455315851|FG000|Overall Study|Enrolled but Never Treated|0|||
126551754|NCT02959138|455315852|FG001|Overall Study|Enrolled but Never Treated|1|||
126551755|NCT02959138|455315853|FG002|Overall Study|Enrolled but Never Treated|0|||
126551756|NCT04213989|455315854|FG000|Overall Study|Withdrawal by Subject|3|||
126551757|NCT04213989|455315855|FG001|Overall Study|Withdrawal by Subject|2|||
126551758|NCT04213989|455315854|FG000|Overall Study|Physician Decision|1|||
126551759|NCT04213989|455315855|FG001|Overall Study|Physician Decision|0|||
126551760|NCT04213989|455315854|FG000|Overall Study|Lost to Follow-up|0|||
126551761|NCT04213989|455315855|FG001|Overall Study|Lost to Follow-up|4|||
126551762|NCT01681368|455315858|FG000|Overall Study|Refused further treatment|1|||
126551763|NCT01681368|455315858|FG000|Overall Study|Refused further follow up|1|||
126551764|NCT01189890|455315859|FG000|Overall Study|Adverse Event|3|||
126551765|NCT01189890|455315860|FG001|Overall Study|Adverse Event|4|||
126551766|NCT01189890|455315859|FG000|Overall Study|Lack of Efficacy|7|||
126551767|NCT01189890|455315860|FG001|Overall Study|Lack of Efficacy|2|||
126551768|NCT01189890|455315859|FG000|Overall Study|Lost to Follow-up|1|||
126551769|NCT01189890|455315860|FG001|Overall Study|Lost to Follow-up|7|||
126551770|NCT01189890|455315859|FG000|Overall Study|Protocol Violation|1|||
126551771|NCT01189890|455315860|FG001|Overall Study|Protocol Violation|5|||
126551772|NCT01189890|455315859|FG000|Overall Study|Withdrawal by Subject|15|||
126714730|NCT01597193|455906947|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
126714731|NCT01597193|455906941|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
126714732|NCT01597193|455906942|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
126714733|NCT01597193|455906943|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
126715194|NCT01052012|455908709|FG003|Overall Study|Physician Decision|0|||
126304954|NCT01855243|454405591|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
126304955|NCT03315286|454405594|FG000|Overall Study|Lost to Follow-up|0|||
126304956|NCT03315286|454405595|FG001|Overall Study|Lost to Follow-up|3|||
126304957|NCT03315286|454405594|FG000|Overall Study|Withdrawal by Subject|1|||
126304958|NCT03315286|454405595|FG001|Overall Study|Withdrawal by Subject|0|||
126304959|NCT03315286|454405594|FG000|Overall Study|Protocol Violation|0|||
126304960|NCT03315286|454405595|FG001|Overall Study|Protocol Violation|1|||
126304961|NCT03075891|454405596|FG000|Overall Study|Withdrawal by Subject|3|||
126304962|NCT03075891|454405597|FG001|Overall Study|Withdrawal by Subject|6|||
126304963|NCT03075891|454405596|FG000|Overall Study|Lost to Follow-up|1|||
126304964|NCT03075891|454405597|FG001|Overall Study|Lost to Follow-up|0|||
126304965|NCT03075891|454405596|FG000|Overall Study|Pregnancy|3|||
126304966|NCT03075891|454405597|FG001|Overall Study|Pregnancy|1|||
126304967|NCT03075891|454405596|FG000|Overall Study|visits not performed (no time)|1|||
126304968|NCT03075891|454405597|FG001|Overall Study|visits not performed (no time)|0|||
126304969|NCT03075891|454405596|FG000|Overall Study|Drug abuse relapse issue|0|||
126304970|NCT03075891|454405597|FG001|Overall Study|Drug abuse relapse issue|1|||
126304971|NCT03075891|454405596|FG000|Overall Study|Participant requiring study withdrawal|0|||
126304972|NCT03075891|454405597|FG001|Overall Study|Participant requiring study withdrawal|1|||
126304973|NCT03075891|454405596|FG000|Overall Study|Adverse event, non-fatal|1|||
126304974|NCT03075891|454405597|FG001|Overall Study|Adverse event, non-fatal|4|||
126304975|NCT00828568|454405600|FG000|Randomized|Withdrawal by Subject|1|||
126304976|NCT00828568|454405601|FG001|Randomized|Withdrawal by Subject|0|||
126304977|NCT00828568|454405602|FG002|Randomized|Withdrawal by Subject|2|||
126304978|NCT00828568|454405600|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
126304979|NCT00828568|454405601|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
126304980|NCT00828568|454405602|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
126304981|NCT00828568|454405600|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
126304982|NCT00828568|454405601|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
126304983|NCT00828568|454405602|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
126304984|NCT00828568|454405600|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
126304985|NCT00828568|454405601|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
126304986|NCT00828568|454405602|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
126304987|NCT00828568|454405600|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
126304988|NCT00828568|454405601|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
126304989|NCT00828568|454405602|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
126304990|NCT00766636|454405603|FG000|Overall Study|Withdrawal by Subject|1|||
126304991|NCT00766636|454405604|FG001|Overall Study|Withdrawal by Subject|1|||
126304992|NCT00766636|454405603|FG000|Overall Study|Incomplete Treatment|0|||
126304993|NCT00766636|454405604|FG001|Overall Study|Incomplete Treatment|1|||
126368850|NCT02038036|454644463|FG001|Crossover Period|Lost to Follow-up|1|||
126551773|NCT01189890|455315860|FG001|Overall Study|Withdrawal by Subject|11|||
126551774|NCT01189890|455315859|FG000|Overall Study|Non Compliance|0|||
126304994|NCT00766636|454405603|FG000|Overall Study|Adverse Event|1|||
126304995|NCT00766636|454405604|FG001|Overall Study|Adverse Event|0|||
126304996|NCT00766636|454405603|FG000|Overall Study|Disease Progression|1|||
126304997|NCT00766636|454405604|FG001|Overall Study|Disease Progression|0|||
126304998|NCT02477332|454405605|FG000|Overall Study|Adverse Event|0|||
126551775|NCT01189890|455315860|FG001|Overall Study|Non Compliance|1|||
126463621|NCT02775903|454998771|FG003|Overall Study|Progressive disease|20|||
126463622|NCT02775903|454998768|FG000|Overall Study|Lack of Efficacy|2|||
126463623|NCT02775903|454998769|FG001|Overall Study|Lack of Efficacy|2|||
126463624|NCT02775903|454998770|FG002|Overall Study|Lack of Efficacy|2|||
126463625|NCT02775903|454998771|FG003|Overall Study|Lack of Efficacy|6|||
126463626|NCT02775903|454998768|FG000|Overall Study|Withdrawal by Subject|7|||
126463627|NCT02775903|454998769|FG001|Overall Study|Withdrawal by Subject|5|||
126463628|NCT02775903|454998770|FG002|Overall Study|Withdrawal by Subject|5|||
126463629|NCT02775903|454998771|FG003|Overall Study|Withdrawal by Subject|8|||
126463630|NCT02775903|454998768|FG000|Overall Study|Other reasons|7|||
126463631|NCT02775903|454998769|FG001|Overall Study|Other reasons|8|||
126714734|NCT01597193|455906944|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
126714735|NCT01597193|455906945|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
126714736|NCT01597193|455906946|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
126304999|NCT02477332|454405606|FG001|Overall Study|Adverse Event|1|||
126305000|NCT02477332|454405607|FG002|Overall Study|Adverse Event|1|||
126305001|NCT02477332|454405608|FG003|Overall Study|Adverse Event|2|||
126305002|NCT02477332|454405609|FG004|Overall Study|Adverse Event|1|||
126305003|NCT02477332|454405610|FG005|Overall Study|Adverse Event|2|||
126305004|NCT02477332|454405605|FG000|Overall Study|Lack of Efficacy|1|||
126305005|NCT02477332|454405606|FG001|Overall Study|Lack of Efficacy|2|||
126305006|NCT02477332|454405607|FG002|Overall Study|Lack of Efficacy|1|||
126305007|NCT02477332|454405608|FG003|Overall Study|Lack of Efficacy|2|||
126305008|NCT02477332|454405609|FG004|Overall Study|Lack of Efficacy|1|||
126305009|NCT02477332|454405610|FG005|Overall Study|Lack of Efficacy|1|||
126305010|NCT02477332|454405605|FG000|Overall Study|Non-compliance with study treatment|0|||
126305011|NCT02477332|454405606|FG001|Overall Study|Non-compliance with study treatment|1|||
126305012|NCT02477332|454405607|FG002|Overall Study|Non-compliance with study treatment|2|||
126305013|NCT02477332|454405608|FG003|Overall Study|Non-compliance with study treatment|0|||
126305014|NCT02477332|454405609|FG004|Overall Study|Non-compliance with study treatment|0|||
126305015|NCT02477332|454405610|FG005|Overall Study|Non-compliance with study treatment|0|||
126305016|NCT02477332|454405605|FG000|Overall Study|Pregnancy|0|||
126305017|NCT02477332|454405606|FG001|Overall Study|Pregnancy|0|||
126305018|NCT02477332|454405607|FG002|Overall Study|Pregnancy|0|||
126305019|NCT02477332|454405608|FG003|Overall Study|Pregnancy|1|||
126305020|NCT02477332|454405609|FG004|Overall Study|Pregnancy|0|||
126305021|NCT02477332|454405610|FG005|Overall Study|Pregnancy|0|||
126305022|NCT02477332|454405605|FG000|Overall Study|Protocol Violation|2|||
126305023|NCT02477332|454405606|FG001|Overall Study|Protocol Violation|0|||
126305024|NCT02477332|454405607|FG002|Overall Study|Protocol Violation|3|||
126305025|NCT02477332|454405608|FG003|Overall Study|Protocol Violation|3|||
126305026|NCT02477332|454405609|FG004|Overall Study|Protocol Violation|1|||
126305027|NCT02477332|454405610|FG005|Overall Study|Protocol Violation|1|||
126305028|NCT02477332|454405605|FG000|Overall Study|Technical problems|0|||
126305029|NCT02477332|454405606|FG001|Overall Study|Technical problems|0|||
126305030|NCT02477332|454405607|FG002|Overall Study|Technical problems|1|||
126305031|NCT02477332|454405608|FG003|Overall Study|Technical problems|0|||
126305032|NCT02477332|454405609|FG004|Overall Study|Technical problems|0|||
126305033|NCT02477332|454405610|FG005|Overall Study|Technical problems|0|||
126305034|NCT02477332|454405605|FG000|Overall Study|Lost to Follow-up|0|||
126368851|NCT02038036|454644462|FG000|Crossover Period|Physician Decision|0|||
126368852|NCT02038036|454644463|FG001|Crossover Period|Physician Decision|2|||
126368853|NCT03537508|454644471|FG000|Overall Study|Adverse Event|2|||
126368854|NCT03537508|454644472|FG001|Overall Study|Adverse Event|1|||
126368855|NCT03537508|454644471|FG000|Overall Study|Protocol Violation|65|||
126368856|NCT03537508|454644472|FG001|Overall Study|Protocol Violation|48|||
126368857|NCT03537508|454644471|FG000|Overall Study|Lost to Follow-up|86|||
126368858|NCT03537508|454644472|FG001|Overall Study|Lost to Follow-up|60|||
126463632|NCT02775903|454998770|FG002|Overall Study|Other reasons|2|||
126463633|NCT02775903|454998771|FG003|Overall Study|Other reasons|12|||
126463634|NCT04571515|454998774|FG000|Overall Study|Physician Decision|0|||
126463635|NCT04571515|454998775|FG001|Overall Study|Physician Decision|0|||
126463636|NCT04571515|454998776|FG002|Overall Study|Physician Decision|0|||
126463637|NCT04571515|454998777|FG003|Overall Study|Physician Decision|0|||
126463638|NCT04571515|454998778|FG004|Overall Study|Physician Decision|1|||
126463639|NCT04571515|454998774|FG000|Overall Study|Withdrawal by Subject|0|||
126463640|NCT04571515|454998775|FG001|Overall Study|Withdrawal by Subject|0|||
126463641|NCT04571515|454998776|FG002|Overall Study|Withdrawal by Subject|0|||
126305035|NCT02477332|454405606|FG001|Overall Study|Lost to Follow-up|0|||
126305036|NCT02477332|454405607|FG002|Overall Study|Lost to Follow-up|2|||
126305037|NCT02477332|454405608|FG003|Overall Study|Lost to Follow-up|0|||
126305038|NCT02477332|454405609|FG004|Overall Study|Lost to Follow-up|0|||
126305039|NCT02477332|454405610|FG005|Overall Study|Lost to Follow-up|0|||
126305040|NCT02477332|454405605|FG000|Overall Study|Physician Decision|0|||
126305041|NCT02477332|454405606|FG001|Overall Study|Physician Decision|0|||
126305042|NCT02477332|454405607|FG002|Overall Study|Physician Decision|1|||
126368859|NCT03537508|454644471|FG000|Overall Study|Withdrawal by parent/guardian|263|||
126463642|NCT04571515|454998777|FG003|Overall Study|Withdrawal by Subject|0|||
126463643|NCT04571515|454998778|FG004|Overall Study|Withdrawal by Subject|1|||
126368860|NCT03537508|454644472|FG001|Overall Study|Withdrawal by parent/guardian|149|||
126368861|NCT01972659|454644473|FG000|Overall Study|Protocol Violation|2|||
126368862|NCT01972659|454644474|FG001|Overall Study|Protocol Violation|2|||
126368863|NCT01972659|454644473|FG000|Overall Study|problems realted to acceleromyograph|2|||
126368864|NCT01972659|454644474|FG001|Overall Study|problems realted to acceleromyograph|1|||
126368865|NCT02495883|454644481|FG000|Overall Study|Excessive head motion|1|||
126368866|NCT02495883|454644482|FG001|Overall Study|Excessive head motion|0|||
126368867|NCT02776735|454644483|FG000|Overall Study|Adverse Event|0|||
126368868|NCT02776735|454644484|FG001|Overall Study|Adverse Event|0|||
126368869|NCT02776735|454644485|FG002|Overall Study|Adverse Event|0|||
126368870|NCT02776735|454644486|FG003|Overall Study|Adverse Event|1|||
126368871|NCT02776735|454644487|FG004|Overall Study|Adverse Event|0|||
126368872|NCT02776735|454644488|FG005|Overall Study|Adverse Event|1|||
126368873|NCT02776735|454644483|FG000|Overall Study|Lost to Follow-up|0|||
126368874|NCT02776735|454644484|FG001|Overall Study|Lost to Follow-up|0|||
126368875|NCT02776735|454644485|FG002|Overall Study|Lost to Follow-up|0|||
126368876|NCT02776735|454644486|FG003|Overall Study|Lost to Follow-up|1|||
126368877|NCT02776735|454644487|FG004|Overall Study|Lost to Follow-up|0|||
126551776|NCT01189890|455315859|FG000|Overall Study|Physician Decision|5|||
126305043|NCT02477332|454405608|FG003|Overall Study|Physician Decision|3|||
126305044|NCT02477332|454405609|FG004|Overall Study|Physician Decision|0|||
126305045|NCT02477332|454405610|FG005|Overall Study|Physician Decision|1|||
126305046|NCT02477332|454405605|FG000|Overall Study|Withdrawal by Subject|0|||
126305047|NCT02477332|454405606|FG001|Overall Study|Withdrawal by Subject|3|||
126305048|NCT02477332|454405607|FG002|Overall Study|Withdrawal by Subject|1|||
126305049|NCT02477332|454405608|FG003|Overall Study|Withdrawal by Subject|2|||
126305050|NCT02477332|454405609|FG004|Overall Study|Withdrawal by Subject|1|||
126305051|NCT02477332|454405610|FG005|Overall Study|Withdrawal by Subject|0|||
126305052|NCT02549287|454405611|FG000|Overall Study|Lost to Follow-up|65|||
126305053|NCT02549287|454405612|FG001|Overall Study|Lost to Follow-up|26|||
126305054|NCT02549287|454405611|FG000|Overall Study|Withdrawal by Subject|15|||
126305055|NCT02549287|454405612|FG001|Overall Study|Withdrawal by Subject|6|||
126305056|NCT00765336|454405613|FG000|Overall Study|Protocol Violation|4|||
126305057|NCT00765336|454405614|FG001|Overall Study|Protocol Violation|2|||
126305058|NCT00765336|454405613|FG000|Overall Study|Withdrawal by Subject|6|||
126305059|NCT00765336|454405614|FG001|Overall Study|Withdrawal by Subject|4|||
126305060|NCT00765336|454405613|FG000|Overall Study|Lost to Follow-up|7|||
126305061|NCT00765336|454405614|FG001|Overall Study|Lost to Follow-up|9|||
126305062|NCT00765336|454405613|FG000|Overall Study|Adverse Event|2|||
126305063|NCT00765336|454405614|FG001|Overall Study|Adverse Event|1|||
126305064|NCT01972438|454405615|FG000|Baseline-Month 3 Crossover Period|Death|1|||
126305065|NCT01972438|454405616|FG001|Baseline-Month 3 Crossover Period|Death|0|||
126305066|NCT01972438|454405615|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
126305067|NCT01972438|454405616|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
126305068|NCT01972438|454405615|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
126305069|NCT01972438|454405616|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
126305070|NCT01972438|454405615|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
126305071|NCT01972438|454405616|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
126305072|NCT01972438|454405615|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
126305073|NCT01972438|454405616|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
126305074|NCT01972438|454405615|FG000|Months 6-12 Study Period|Death|1|||
126305075|NCT01972438|454405616|FG001|Months 6-12 Study Period|Death|0|||
126305076|NCT01972438|454405615|FG000|Months 6-12 Study Period|Early Study Closure|2|||
126305077|NCT01972438|454405616|FG001|Months 6-12 Study Period|Early Study Closure|2|||
126305078|NCT01972438|454405615|FG000|Post Month 12 Study Period|Early Study Closure|3|||
126368878|NCT02776735|454644488|FG005|Overall Study|Lost to Follow-up|0|||
126368879|NCT02776735|454644483|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126368880|NCT02776735|454644484|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126368881|NCT02776735|454644485|FG002|Overall Study|Withdrawal by parent/guardian|2|||
126368882|NCT02776735|454644486|FG003|Overall Study|Withdrawal by parent/guardian|2|||
126368883|NCT02776735|454644487|FG004|Overall Study|Withdrawal by parent/guardian|0|||
126368884|NCT02776735|454644488|FG005|Overall Study|Withdrawal by parent/guardian|0|||
126368885|NCT02776735|454644483|FG000|Overall Study|Withdrawal by Subject|1|||
126368886|NCT02776735|454644484|FG001|Overall Study|Withdrawal by Subject|0|||
126368887|NCT02776735|454644485|FG002|Overall Study|Withdrawal by Subject|0|||
126368888|NCT02776735|454644486|FG003|Overall Study|Withdrawal by Subject|0|||
126368889|NCT02776735|454644487|FG004|Overall Study|Withdrawal by Subject|0|||
126368890|NCT02776735|454644488|FG005|Overall Study|Withdrawal by Subject|1|||
126368891|NCT02776735|454644483|FG000|Overall Study|Other|0|||
126551777|NCT01189890|455315860|FG001|Overall Study|Physician Decision|4|||
126305079|NCT01972438|454405616|FG001|Post Month 12 Study Period|Early Study Closure|4|||
126305080|NCT02195869|454405621|FG000|Overall Study|cGVHD Progression|5|||
126305081|NCT02195869|454405621|FG000|Overall Study|Malignancy Progression/relapse|2|||
126305082|NCT02195869|454405621|FG000|Overall Study|Adverse Event|15|||
126368892|NCT02776735|454644484|FG001|Overall Study|Other|0|||
126551778|NCT01189890|455315859|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
126305083|NCT02195869|454405621|FG000|Overall Study|Withdrawal by Subject|7|||
126305084|NCT02195869|454405621|FG000|Overall Study|Physician Decision|4|||
126305085|NCT02195869|454405621|FG000|Overall Study|Study Terminated by Sponsor|7|||
126305086|NCT02195869|454405621|FG000|Overall Study|Noncompliance with study drug|2|||
126305087|NCT00789698|454405622|FG000|Overall Study|Lack of Efficacy|10|||
126305088|NCT00789698|454405623|FG001|Overall Study|Lack of Efficacy|4|||
126305089|NCT00789698|454405624|FG002|Overall Study|Lack of Efficacy|5|||
126305090|NCT00789698|454405625|FG003|Overall Study|Lack of Efficacy|18|||
126305091|NCT00789698|454405622|FG000|Overall Study|Adverse Event|5|||
126305092|NCT00789698|454405623|FG001|Overall Study|Adverse Event|5|||
126305093|NCT00789698|454405624|FG002|Overall Study|Adverse Event|3|||
126305094|NCT00789698|454405625|FG003|Overall Study|Adverse Event|4|||
126305095|NCT00789698|454405622|FG000|Overall Study|Lost to Follow-up|5|||
126305096|NCT00789698|454405623|FG001|Overall Study|Lost to Follow-up|5|||
126305097|NCT00789698|454405624|FG002|Overall Study|Lost to Follow-up|2|||
126305098|NCT00789698|454405625|FG003|Overall Study|Lost to Follow-up|9|||
126305099|NCT00789698|454405622|FG000|Overall Study|Protocol Violation|6|||
126305100|NCT00789698|454405623|FG001|Overall Study|Protocol Violation|1|||
126305101|NCT00789698|454405624|FG002|Overall Study|Protocol Violation|2|||
126305102|NCT00789698|454405625|FG003|Overall Study|Protocol Violation|1|||
126305103|NCT00789698|454405622|FG000|Overall Study|Withdrawal by Subject|14|||
126305104|NCT00789698|454405623|FG001|Overall Study|Withdrawal by Subject|15|||
126305105|NCT00789698|454405624|FG002|Overall Study|Withdrawal by Subject|12|||
126305106|NCT00789698|454405625|FG003|Overall Study|Withdrawal by Subject|19|||
126305107|NCT00789698|454405622|FG000|Overall Study|Administrative|0|||
126305108|NCT00789698|454405623|FG001|Overall Study|Administrative|3|||
126305109|NCT00789698|454405624|FG002|Overall Study|Administrative|3|||
126305110|NCT00789698|454405625|FG003|Overall Study|Administrative|1|||
126305111|NCT04981470|454407184|FG000|Overall Study|Device failure in all 4 patients|4|||
126305112|NCT04390503|454407186|FG000|Overall Study|Physician Decision|2|||
126305113|NCT04390503|454407187|FG001|Overall Study|Physician Decision|1|||
126305114|NCT04390503|454407186|FG000|Overall Study|Adverse Event|1|||
126305115|NCT04390503|454407187|FG001|Overall Study|Adverse Event|0|||
126305116|NCT00468481|454407188|FG000|Overall Study|Adverse Event|13|||
126305117|NCT00468481|454407189|FG001|Overall Study|Adverse Event|3|||
126305118|NCT00468481|454407188|FG000|Overall Study|Lost to Follow-up|25|||
126305119|NCT00468481|454407189|FG001|Overall Study|Lost to Follow-up|8|||
126305120|NCT00468481|454407188|FG000|Overall Study|Pregnancy|2|||
126305121|NCT00468481|454407189|FG001|Overall Study|Pregnancy|0|||
126305122|NCT00468481|454407188|FG000|Overall Study|Protocol Violation|18|||
126305123|NCT00468481|454407189|FG001|Overall Study|Protocol Violation|8|||
126305124|NCT00468481|454407188|FG000|Overall Study|Withdrawal by Subject|12|||
126305125|NCT00468481|454407189|FG001|Overall Study|Withdrawal by Subject|3|||
126305126|NCT00468481|454407188|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
126305127|NCT00468481|454407189|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
126305128|NCT00468481|454407188|FG000|Overall Study|Prohibited Medication|1|||
126305129|NCT00468481|454407189|FG001|Overall Study|Prohibited Medication|1|||
126305130|NCT00468481|454407188|FG000|Overall Study|Egg Donor|1|||
126305131|NCT00468481|454407189|FG001|Overall Study|Egg Donor|0|||
126305132|NCT00468481|454407188|FG000|Overall Study|Moved out of area|4|||
126305133|NCT00468481|454407189|FG001|Overall Study|Moved out of area|1|||
126305134|NCT00468481|454407188|FG000|Overall Study|Non-Compliance|5|||
126305135|NCT00468481|454407189|FG001|Overall Study|Non-Compliance|0|||
126305136|NCT00468481|454407188|FG000|Overall Study|Other|6|||
126305137|NCT00468481|454407189|FG001|Overall Study|Other|0|||
126305138|NCT00593684|454407191|FG000|Overall Study|Death|2|||
126305139|NCT00593684|454407192|FG001|Overall Study|Death|1|||
126305140|NCT00734162|454407193|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
126305141|NCT00734162|454407194|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
126305142|NCT00734162|454407195|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
126305143|NCT00734162|454407196|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
126305144|NCT00734162|454407193|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
126305145|NCT00734162|454407194|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
126305146|NCT00734162|454407195|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
126305147|NCT00734162|454407196|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
126305148|NCT00734162|454407193|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
126305149|NCT00734162|454407194|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
126305150|NCT00734162|454407195|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
126305151|NCT00734162|454407196|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
126305152|NCT00734162|454407193|FG000|Open-Label Phase|Withdrew Consent|1|||
126305153|NCT00734162|454407194|FG001|Open-Label Phase|Withdrew Consent|0|||
126305154|NCT00734162|454407195|FG002|Open-Label Phase|Withdrew Consent|1|||
126305155|NCT00734162|454407196|FG003|Open-Label Phase|Withdrew Consent|1|||
126305156|NCT00734162|454407193|FG000|Open-Label Phase|Lost to Follow-up|1|||
126305157|NCT00734162|454407194|FG001|Open-Label Phase|Lost to Follow-up|2|||
126368893|NCT02776735|454644485|FG002|Overall Study|Other|3|||
126368894|NCT02776735|454644486|FG003|Overall Study|Other|0|||
126368895|NCT02776735|454644487|FG004|Overall Study|Other|0|||
126368896|NCT02776735|454644488|FG005|Overall Study|Other|0|||
126368897|NCT00791648|454646490|FG000|Overall Study|Physician Decision|0|||
126368898|NCT00791648|454646491|FG001|Overall Study|Physician Decision|1|||
126368899|NCT00791648|454646490|FG000|Overall Study|Withdrawal by Subject|0|||
126368900|NCT00791648|454646491|FG001|Overall Study|Withdrawal by Subject|1|||
126368901|NCT00462826|454646492|FG000|Overall Study|Ineligible - second primary|1|||
126368902|NCT00462826|454646492|FG000|Overall Study|Ineligible - wrong cell type|1|||
126368903|NCT00462826|454646492|FG000|Overall Study|Ineligible - wrong primary|2|||
126368904|NCT00462826|454646492|FG000|Overall Study|Never treated|1|||
126368905|NCT04976777|454646493|FG000|Overall Study|COVID-19 Infection|1|||
126368906|NCT04976777|454646494|FG001|Overall Study|COVID-19 Infection|0|||
126368907|NCT02278003|454646495|FG000|Overall Study|Withdrawal by Subject|11|||
126368908|NCT02278003|454646496|FG001|Overall Study|Withdrawal by Subject|0|||
126368909|NCT02278003|454646495|FG000|Overall Study|Not Treated|1|||
126368910|NCT02278003|454646496|FG001|Overall Study|Not Treated|0|||
126368911|NCT02278003|454646495|FG000|Overall Study|Recognition task improperly completed|7|||
126368912|NCT02278003|454646496|FG001|Overall Study|Recognition task improperly completed|0|||
126368913|NCT04123704|454646511|FG000|Overall Study|Disease progression|2|||
126368914|NCT00939185|454646512|FG000|Overall Study|Adverse Event|3|||
126368915|NCT00939185|454646512|FG000|Overall Study|Lack of Efficacy|1|||
126368916|NCT00939185|454646512|FG000|Overall Study|Lost to Follow-up|6|||
126368917|NCT00939185|454646512|FG000|Overall Study|Other|3|||
126368918|NCT00939185|454646512|FG000|Overall Study|Withdrawal by Subject|2|||
126368919|NCT00939185|454646512|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
126368920|NCT00363298|454646513|FG000|First Study Week|Lack of Efficacy|6|||
126368921|NCT00363298|454646514|FG001|First Study Week|Lack of Efficacy|5|||
126368922|NCT00363298|454646513|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
126368923|NCT00363298|454646514|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
126368924|NCT00836706|454646515|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
126368925|NCT00836706|454646516|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
126368926|NCT04484857|454646525|FG000|Overall Study|Adverse Event|2|||
126368927|NCT04484857|454646525|FG000|Overall Study|Death|10|||
126368928|NCT04484857|454646525|FG000|Overall Study|Withdrawal by Subject|3|||
126368929|NCT04484857|454646525|FG000|Overall Study|Transferred/Relocation|5|||
126368930|NCT04484857|454646525|FG000|Overall Study|Kidney Transplant|7|||
126368931|NCT04484857|454646525|FG000|Overall Study|Other than specified|4|||
126368932|NCT04484857|454646525|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
126368933|NCT02390076|454646526|FG000|Overall Study|Lost to Follow-up|2|||
126368934|NCT02390076|454646527|FG001|Overall Study|Lost to Follow-up|1|||
126368935|NCT02390076|454646528|FG002|Overall Study|Lost to Follow-up|4|||
126714737|NCT01597193|455906947|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
126714738|NCT01597193|455906941|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
126714739|NCT01597193|455906942|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
126714740|NCT01597193|455906943|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
126714741|NCT01597193|455906944|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
126714742|NCT01597193|455906945|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
126714743|NCT01597193|455906946|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
126305158|NCT00734162|454407195|FG002|Open-Label Phase|Lost to Follow-up|0|||
126305159|NCT00734162|454407196|FG003|Open-Label Phase|Lost to Follow-up|1|||
126305160|NCT00734162|454407193|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
126305161|NCT00734162|454407194|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
126305162|NCT00734162|454407195|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
126305163|NCT00734162|454407196|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
126305164|NCT00596687|454407199|FG000|Overall Study|< 24 hours of insulin treatment|8|||
126305165|NCT00596687|454407200|FG001|Overall Study|< 24 hours of insulin treatment|6|||
126305166|NCT00596687|454407199|FG000|Overall Study|continuous insulin infusion during TPN|2|||
126305167|NCT00596687|454407200|FG001|Overall Study|continuous insulin infusion during TPN|1|||
126305168|NCT00596687|454407199|FG000|Overall Study|Withdrawal by Subject|3|||
126305169|NCT00596687|454407200|FG001|Overall Study|Withdrawal by Subject|1|||
126305170|NCT00596687|454407199|FG000|Overall Study|cancelled surgery|1|||
126305171|NCT00596687|454407200|FG001|Overall Study|cancelled surgery|1|||
126305172|NCT03831113|454407201|FG000|Overall Study|Withdrawal by Subject|0|||
126305173|NCT03831113|454407202|FG001|Overall Study|Withdrawal by Subject|2|||
126305174|NCT03831113|454407201|FG000|Overall Study|Protocol Violation|0|||
126305175|NCT03831113|454407202|FG001|Overall Study|Protocol Violation|9|||
126305176|NCT01068730|454407203|FG000|Period 3|Personal reason|1|||
126305177|NCT01068730|454407204|FG001|Period 3|Personal reason|0|||
126305178|NCT01068730|454407205|FG002|Period 3|Personal reason|0|||
126305179|NCT01068730|454407206|FG003|Period 3|Personal reason|0|||
126305180|NCT01068730|454407203|FG000|Period 4|Family emergency|0|||
126305181|NCT01068730|454407204|FG001|Period 4|Family emergency|1|||
126368936|NCT01358734|454646530|FG000|Overall Study|Adverse Event|4|||
126368937|NCT01358734|454646531|FG001|Overall Study|Adverse Event|7|||
126368938|NCT01358734|454646532|FG002|Overall Study|Adverse Event|3|||
126305182|NCT01068730|454407205|FG002|Period 4|Family emergency|0|||
126305183|NCT01068730|454407206|FG003|Period 4|Family emergency|0|||
126305184|NCT03981926|454407207|FG000|Overall Study|Lost to Follow-up|5|||
126305185|NCT03981926|454407208|FG001|Overall Study|Lost to Follow-up|9|||
126305186|NCT01057810|454407216|FG000|Overall Study|Disease progression|156|||
126305187|NCT01057810|454407217|FG001|Overall Study|Disease progression|197|||
126305188|NCT01057810|454407216|FG000|Overall Study|Study drug toxicity|5|||
126305189|NCT01057810|454407217|FG001|Overall Study|Study drug toxicity|114|||
126305190|NCT01057810|454407216|FG000|Overall Study|Adverse event unrelated to study drug|13|||
126305191|NCT01057810|454407217|FG001|Overall Study|Adverse event unrelated to study drug|29|||
126305192|NCT01057810|454407216|FG000|Overall Study|Withdrawal by Subject|10|||
126305193|NCT01057810|454407217|FG001|Overall Study|Withdrawal by Subject|25|||
126305194|NCT01057810|454407216|FG000|Overall Study|Death|2|||
126305195|NCT01057810|454407217|FG001|Overall Study|Death|12|||
126305196|NCT01057810|454407216|FG000|Overall Study|Maximum clinical benefit|5|||
126305197|NCT01057810|454407217|FG001|Overall Study|Maximum clinical benefit|5|||
126305198|NCT01057810|454407216|FG000|Overall Study|Poor/non-compliance|0|||
126305199|NCT01057810|454407217|FG001|Overall Study|Poor/non-compliance|1|||
126305200|NCT01057810|454407216|FG000|Overall Study|No longer met study criteria|0|||
126305201|NCT01057810|454407217|FG001|Overall Study|No longer met study criteria|1|||
126305202|NCT01057810|454407216|FG000|Overall Study|Other|7|||
126305203|NCT01057810|454407217|FG001|Overall Study|Other|14|||
126305204|NCT02564900|454407218|FG000|Dose Escalation|Progressive disease per RECIST|2|||
126305205|NCT02564900|454407219|FG001|Dose Escalation|Progressive disease per RECIST|3|||
126305206|NCT02564900|454407220|FG002|Dose Escalation|Progressive disease per RECIST|3|||
126305207|NCT02564900|454407221|FG003|Dose Escalation|Progressive disease per RECIST|3|||
126305208|NCT02564900|454407222|FG004|Dose Escalation|Progressive disease per RECIST|3|||
126305209|NCT02564900|454407223|FG005|Dose Escalation|Progressive disease per RECIST|1|||
126305210|NCT02564900|454407224|FG006|Dose Escalation|Progressive disease per RECIST|0|||
126305211|NCT02564900|454407225|FG007|Dose Escalation|Progressive disease per RECIST|0|||
126305212|NCT02564900|454407226|FG008|Dose Escalation|Progressive disease per RECIST|0|||
126305213|NCT02564900|454407227|FG009|Dose Escalation|Progressive disease per RECIST|0|||
126305214|NCT02564900|454407228|FG010|Dose Escalation|Progressive disease per RECIST|0|||
126305215|NCT02564900|454407229|FG011|Dose Escalation|Progressive disease per RECIST|0|||
126305216|NCT02564900|454407230|FG012|Dose Escalation|Progressive disease per RECIST|0|||
126305217|NCT02564900|454407231|FG013|Dose Escalation|Progressive disease per RECIST|0|||
126305218|NCT02564900|454407232|FG014|Dose Escalation|Progressive disease per RECIST|0|||
126305219|NCT02564900|454407218|FG000|Dose Escalation|Ongoing|1|||
126305220|NCT02564900|454407219|FG001|Dose Escalation|Ongoing|0|||
126305221|NCT02564900|454407220|FG002|Dose Escalation|Ongoing|0|||
126305222|NCT02564900|454407221|FG003|Dose Escalation|Ongoing|2|||
126305223|NCT02564900|454407222|FG004|Dose Escalation|Ongoing|2|||
126305224|NCT02564900|454407223|FG005|Dose Escalation|Ongoing|2|||
126305225|NCT02564900|454407224|FG006|Dose Escalation|Ongoing|0|||
126305226|NCT02564900|454407225|FG007|Dose Escalation|Ongoing|0|||
126305227|NCT02564900|454407226|FG008|Dose Escalation|Ongoing|0|||
126305228|NCT02564900|454407227|FG009|Dose Escalation|Ongoing|0|||
126305229|NCT02564900|454407228|FG010|Dose Escalation|Ongoing|0|||
126305230|NCT02564900|454407229|FG011|Dose Escalation|Ongoing|0|||
126305231|NCT02564900|454407230|FG012|Dose Escalation|Ongoing|0|||
126305232|NCT02564900|454407231|FG013|Dose Escalation|Ongoing|0|||
126305233|NCT02564900|454407232|FG014|Dose Escalation|Ongoing|0|||
126305234|NCT02564900|454407218|FG000|Dose Escalation|Adverse Event|0|||
126305235|NCT02564900|454407219|FG001|Dose Escalation|Adverse Event|0|||
126305236|NCT02564900|454407220|FG002|Dose Escalation|Adverse Event|0|||
126305237|NCT02564900|454407221|FG003|Dose Escalation|Adverse Event|1|||
126305238|NCT02564900|454407222|FG004|Dose Escalation|Adverse Event|1|||
126305239|NCT02564900|454407223|FG005|Dose Escalation|Adverse Event|3|||
126305240|NCT02564900|454407224|FG006|Dose Escalation|Adverse Event|0|||
126305241|NCT02564900|454407225|FG007|Dose Escalation|Adverse Event|0|||
126305242|NCT02564900|454407226|FG008|Dose Escalation|Adverse Event|0|||
126305243|NCT02564900|454407227|FG009|Dose Escalation|Adverse Event|0|||
126305244|NCT02564900|454407228|FG010|Dose Escalation|Adverse Event|0|||
126305245|NCT02564900|454407229|FG011|Dose Escalation|Adverse Event|0|||
126305246|NCT02564900|454407230|FG012|Dose Escalation|Adverse Event|0|||
126305247|NCT02564900|454407231|FG013|Dose Escalation|Adverse Event|0|||
126305248|NCT02564900|454407232|FG014|Dose Escalation|Adverse Event|0|||
126305249|NCT02564900|454407218|FG000|Dose Expansion|Progressive disease per RECIST|0|||
126305250|NCT02564900|454407219|FG001|Dose Expansion|Progressive disease per RECIST|0|||
126305251|NCT02564900|454407220|FG002|Dose Expansion|Progressive disease per RECIST|0|||
126305252|NCT02564900|454407221|FG003|Dose Expansion|Progressive disease per RECIST|0|||
126305253|NCT02564900|454407222|FG004|Dose Expansion|Progressive disease per RECIST|0|||
126305254|NCT02564900|454407223|FG005|Dose Expansion|Progressive disease per RECIST|0|||
126305255|NCT02564900|454407224|FG006|Dose Expansion|Progressive disease per RECIST|19|||
126305256|NCT02564900|454407225|FG007|Dose Expansion|Progressive disease per RECIST|17|||
126305257|NCT02564900|454407226|FG008|Dose Expansion|Progressive disease per RECIST|8|||
126305258|NCT02564900|454407227|FG009|Dose Expansion|Progressive disease per RECIST|16|||
126305259|NCT02564900|454407228|FG010|Dose Expansion|Progressive disease per RECIST|13|||
126305260|NCT02564900|454407229|FG011|Dose Expansion|Progressive disease per RECIST|19|||
126305261|NCT02564900|454407230|FG012|Dose Expansion|Progressive disease per RECIST|10|||
126305262|NCT02564900|454407231|FG013|Dose Expansion|Progressive disease per RECIST|13|||
126305263|NCT02564900|454407232|FG014|Dose Expansion|Progressive disease per RECIST|11|||
126305264|NCT02564900|454407218|FG000|Dose Expansion|Clinical progression|0|||
126305265|NCT02564900|454407219|FG001|Dose Expansion|Clinical progression|0|||
126305266|NCT02564900|454407220|FG002|Dose Expansion|Clinical progression|0|||
126305267|NCT02564900|454407221|FG003|Dose Expansion|Clinical progression|0|||
126305268|NCT02564900|454407222|FG004|Dose Expansion|Clinical progression|0|||
126305269|NCT02564900|454407223|FG005|Dose Expansion|Clinical progression|0|||
126305270|NCT02564900|454407224|FG006|Dose Expansion|Clinical progression|5|||
126305271|NCT02564900|454407225|FG007|Dose Expansion|Clinical progression|12|||
126305272|NCT02564900|454407226|FG008|Dose Expansion|Clinical progression|0|||
126305273|NCT02564900|454407227|FG009|Dose Expansion|Clinical progression|3|||
126305274|NCT02564900|454407228|FG010|Dose Expansion|Clinical progression|2|||
126305275|NCT02564900|454407229|FG011|Dose Expansion|Clinical progression|0|||
126305276|NCT02564900|454407230|FG012|Dose Expansion|Clinical progression|1|||
126305277|NCT02564900|454407231|FG013|Dose Expansion|Clinical progression|3|||
126305278|NCT02564900|454407232|FG014|Dose Expansion|Clinical progression|1|||
126305279|NCT02564900|454407218|FG000|Dose Expansion|Adverse Event|0|||
126305280|NCT02564900|454407219|FG001|Dose Expansion|Adverse Event|0|||
126305281|NCT02564900|454407220|FG002|Dose Expansion|Adverse Event|0|||
126305282|NCT02564900|454407221|FG003|Dose Expansion|Adverse Event|0|||
126305283|NCT02564900|454407222|FG004|Dose Expansion|Adverse Event|0|||
126305284|NCT02564900|454407223|FG005|Dose Expansion|Adverse Event|0|||
126305285|NCT02564900|454407224|FG006|Dose Expansion|Adverse Event|9|||
126305286|NCT02564900|454407225|FG007|Dose Expansion|Adverse Event|22|||
126305287|NCT02564900|454407226|FG008|Dose Expansion|Adverse Event|0|||
126305288|NCT02564900|454407227|FG009|Dose Expansion|Adverse Event|11|||
126305289|NCT02564900|454407228|FG010|Dose Expansion|Adverse Event|0|||
126305290|NCT02564900|454407229|FG011|Dose Expansion|Adverse Event|5|||
126305291|NCT02564900|454407230|FG012|Dose Expansion|Adverse Event|2|||
126305292|NCT02564900|454407231|FG013|Dose Expansion|Adverse Event|2|||
126305293|NCT02564900|454407232|FG014|Dose Expansion|Adverse Event|1|||
126305294|NCT02564900|454407218|FG000|Dose Expansion|Ongoing|0|||
126305295|NCT02564900|454407219|FG001|Dose Expansion|Ongoing|0|||
126305296|NCT02564900|454407220|FG002|Dose Expansion|Ongoing|0|||
126305297|NCT02564900|454407221|FG003|Dose Expansion|Ongoing|0|||
126305298|NCT02564900|454407222|FG004|Dose Expansion|Ongoing|0|||
126305299|NCT02564900|454407223|FG005|Dose Expansion|Ongoing|0|||
126305300|NCT02564900|454407224|FG006|Dose Expansion|Ongoing|9|||
126305301|NCT02564900|454407225|FG007|Dose Expansion|Ongoing|10|||
126305302|NCT02564900|454407226|FG008|Dose Expansion|Ongoing|11|||
126305303|NCT02564900|454407227|FG009|Dose Expansion|Ongoing|3|||
126305304|NCT02564900|454407228|FG010|Dose Expansion|Ongoing|0|||
126305305|NCT02564900|454407229|FG011|Dose Expansion|Ongoing|0|||
126305306|NCT02564900|454407230|FG012|Dose Expansion|Ongoing|4|||
126305307|NCT02564900|454407231|FG013|Dose Expansion|Ongoing|0|||
126305308|NCT02564900|454407232|FG014|Dose Expansion|Ongoing|6|||
126305309|NCT02564900|454407218|FG000|Dose Expansion|Death|0|||
126305310|NCT02564900|454407219|FG001|Dose Expansion|Death|0|||
126305311|NCT02564900|454407220|FG002|Dose Expansion|Death|0|||
126305312|NCT02564900|454407221|FG003|Dose Expansion|Death|0|||
126305313|NCT02564900|454407222|FG004|Dose Expansion|Death|0|||
126305314|NCT02564900|454407223|FG005|Dose Expansion|Death|0|||
126305315|NCT02564900|454407224|FG006|Dose Expansion|Death|1|||
126305316|NCT02564900|454407225|FG007|Dose Expansion|Death|0|||
126368939|NCT01358734|454646530|FG000|Overall Study|Lack of Efficacy|0|||
126368940|NCT01358734|454646531|FG001|Overall Study|Lack of Efficacy|1|||
126368941|NCT01358734|454646532|FG002|Overall Study|Lack of Efficacy|3|||
126368942|NCT01358734|454646530|FG000|Overall Study|Withdrawal by Subject|1|||
126305317|NCT02564900|454407226|FG008|Dose Expansion|Death|0|||
126368943|NCT01358734|454646531|FG001|Overall Study|Withdrawal by Subject|6|||
126368944|NCT01358734|454646532|FG002|Overall Study|Withdrawal by Subject|3|||
126368945|NCT01358734|454646530|FG000|Overall Study|Death|3|||
126305318|NCT02564900|454407227|FG009|Dose Expansion|Death|0|||
126305319|NCT02564900|454407228|FG010|Dose Expansion|Death|1|||
126305320|NCT02564900|454407229|FG011|Dose Expansion|Death|0|||
126305321|NCT02564900|454407230|FG012|Dose Expansion|Death|1|||
126305322|NCT02564900|454407231|FG013|Dose Expansion|Death|1|||
126305323|NCT02564900|454407232|FG014|Dose Expansion|Death|0|||
126305324|NCT02564900|454407218|FG000|Dose Expansion|Withdrawal by Subject|0|||
126305325|NCT02564900|454407219|FG001|Dose Expansion|Withdrawal by Subject|0|||
126368946|NCT01358734|454646531|FG001|Overall Study|Death|7|||
126305326|NCT02564900|454407220|FG002|Dose Expansion|Withdrawal by Subject|0|||
126305327|NCT02564900|454407221|FG003|Dose Expansion|Withdrawal by Subject|0|||
126305328|NCT02564900|454407222|FG004|Dose Expansion|Withdrawal by Subject|0|||
126305329|NCT02564900|454407223|FG005|Dose Expansion|Withdrawal by Subject|0|||
126305330|NCT02564900|454407224|FG006|Dose Expansion|Withdrawal by Subject|4|||
126305331|NCT02564900|454407225|FG007|Dose Expansion|Withdrawal by Subject|0|||
126305332|NCT02564900|454407226|FG008|Dose Expansion|Withdrawal by Subject|0|||
126463644|NCT04571515|454998774|FG000|Overall Study|insufficient pain|1|||
126463645|NCT04571515|454998775|FG001|Overall Study|insufficient pain|0|||
126463646|NCT04571515|454998776|FG002|Overall Study|insufficient pain|0|||
126463647|NCT04571515|454998777|FG003|Overall Study|insufficient pain|0|||
126463648|NCT04571515|454998778|FG004|Overall Study|insufficient pain|1|||
126463649|NCT05140382|454998779|FG000|Overall Study|Death|3|||
126463650|NCT05140382|454998780|FG001|Overall Study|Death|0|||
126305333|NCT02564900|454407227|FG009|Dose Expansion|Withdrawal by Subject|0|||
126305334|NCT02564900|454407228|FG010|Dose Expansion|Withdrawal by Subject|1|||
126305335|NCT02564900|454407229|FG011|Dose Expansion|Withdrawal by Subject|0|||
126305336|NCT02564900|454407230|FG012|Dose Expansion|Withdrawal by Subject|0|||
126305337|NCT02564900|454407231|FG013|Dose Expansion|Withdrawal by Subject|1|||
126305338|NCT02564900|454407232|FG014|Dose Expansion|Withdrawal by Subject|1|||
126305339|NCT02564900|454407218|FG000|Dose Expansion|Other|0|||
126305340|NCT02564900|454407219|FG001|Dose Expansion|Other|0|||
126305341|NCT02564900|454407220|FG002|Dose Expansion|Other|0|||
126305342|NCT02564900|454407221|FG003|Dose Expansion|Other|0|||
126305343|NCT02564900|454407222|FG004|Dose Expansion|Other|0|||
126305344|NCT02564900|454407223|FG005|Dose Expansion|Other|0|||
126305345|NCT02564900|454407224|FG006|Dose Expansion|Other|1|||
126305346|NCT02564900|454407225|FG007|Dose Expansion|Other|0|||
126305347|NCT02564900|454407226|FG008|Dose Expansion|Other|1|||
126305348|NCT02564900|454407227|FG009|Dose Expansion|Other|0|||
126305349|NCT02564900|454407228|FG010|Dose Expansion|Other|0|||
126305350|NCT02564900|454407229|FG011|Dose Expansion|Other|0|||
126305351|NCT02564900|454407230|FG012|Dose Expansion|Other|0|||
126305352|NCT02564900|454407231|FG013|Dose Expansion|Other|0|||
126305353|NCT02564900|454407232|FG014|Dose Expansion|Other|1|||
126305354|NCT02564900|454407218|FG000|Dose Expansion|Did not receive treatment|0|||
126305355|NCT02564900|454407219|FG001|Dose Expansion|Did not receive treatment|0|||
126305356|NCT02564900|454407220|FG002|Dose Expansion|Did not receive treatment|0|||
126305357|NCT02564900|454407221|FG003|Dose Expansion|Did not receive treatment|0|||
126305358|NCT02564900|454407222|FG004|Dose Expansion|Did not receive treatment|0|||
126305359|NCT02564900|454407223|FG005|Dose Expansion|Did not receive treatment|0|||
126305360|NCT02564900|454407224|FG006|Dose Expansion|Did not receive treatment|1|||
126305361|NCT02564900|454407225|FG007|Dose Expansion|Did not receive treatment|1|||
126305362|NCT02564900|454407226|FG008|Dose Expansion|Did not receive treatment|0|||
126305363|NCT02564900|454407227|FG009|Dose Expansion|Did not receive treatment|0|||
126305364|NCT02564900|454407228|FG010|Dose Expansion|Did not receive treatment|0|||
126305365|NCT02564900|454407229|FG011|Dose Expansion|Did not receive treatment|0|||
126305366|NCT02564900|454407230|FG012|Dose Expansion|Did not receive treatment|0|||
126305367|NCT02564900|454407231|FG013|Dose Expansion|Did not receive treatment|0|||
126305368|NCT02564900|454407232|FG014|Dose Expansion|Did not receive treatment|1|||
126305369|NCT00887315|454407234|FG000|Overall Study|Study termination|7|||
126305370|NCT00887315|454407235|FG001|Overall Study|Study termination|4|||
126305371|NCT00619892|454407236|FG000|Overall Study|Adverse Event|3|||
126305372|NCT00619892|454407237|FG001|Overall Study|Adverse Event|0|||
126305373|NCT00619892|454407236|FG000|Overall Study|Lost to Follow-up|0|||
126305374|NCT00619892|454407237|FG001|Overall Study|Lost to Follow-up|1|||
126305375|NCT00619892|454407236|FG000|Overall Study|Intercurrent illness|0|||
126305376|NCT00619892|454407237|FG001|Overall Study|Intercurrent illness|1|||
126305377|NCT00379080|454407238|FG000|Overall Study|Withdrawal by Subject|0|||
126305378|NCT00379080|454407239|FG001|Overall Study|Withdrawal by Subject|4|||
126305379|NCT00379080|454407240|FG002|Overall Study|Withdrawal by Subject|0|||
126305380|NCT00857896|454407246|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
126305381|NCT01091662|454407247|FG000|Overall Study|Adverse Event|1|||
126305382|NCT01091662|454407248|FG001|Overall Study|Adverse Event|9|||
126305383|NCT01091662|454407247|FG000|Overall Study|Physician Decision|1|||
126305384|NCT01091662|454407248|FG001|Overall Study|Physician Decision|1|||
126305385|NCT01091662|454407247|FG000|Overall Study|Withdrawal by Subject|7|||
126305386|NCT01091662|454407248|FG001|Overall Study|Withdrawal by Subject|6|||
126305387|NCT01091662|454407247|FG000|Overall Study|met exit criteria|7|||
126305388|NCT01091662|454407248|FG001|Overall Study|met exit criteria|13|||
126305389|NCT01091662|454407247|FG000|Overall Study|met exclusion criteria|1|||
126305390|NCT01091662|454407248|FG001|Overall Study|met exclusion criteria|0|||
126305391|NCT01091662|454407247|FG000|Overall Study|Lost to Follow-up|0|||
126305392|NCT01091662|454407248|FG001|Overall Study|Lost to Follow-up|1|||
126305393|NCT01091662|454407247|FG000|Overall Study|Pregnancy|0|||
126305394|NCT01091662|454407248|FG001|Overall Study|Pregnancy|1|||
126305395|NCT01091662|454407247|FG000|Overall Study|Protocol Violation|0|||
126463651|NCT05140382|454998781|FG002|Overall Study|Death|0|||
126463652|NCT05140382|454998779|FG000|Overall Study|Investigator decision|1|||
126305396|NCT01091662|454407248|FG001|Overall Study|Protocol Violation|2|||
126305397|NCT01091662|454407247|FG000|Overall Study|unable to swallow capsule|0|||
126305398|NCT01091662|454407248|FG001|Overall Study|unable to swallow capsule|1|||
126305399|NCT01222520|454407249|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
126305400|NCT01222520|454407250|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
126305401|NCT01222520|454407249|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
126463653|NCT05140382|454998780|FG001|Overall Study|Investigator decision|0|||
126305402|NCT01222520|454407250|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
126305403|NCT01222520|454407249|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
126305404|NCT01222520|454407250|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
126305405|NCT01222520|454407249|FG000|Double-blind Period|Adverse Event|0|||
126305406|NCT01222520|454407250|FG001|Double-blind Period|Adverse Event|1|||
126305407|NCT01222520|454407249|FG000|Double-blind Period|Lack of Efficacy|0|||
126305408|NCT01222520|454407250|FG001|Double-blind Period|Lack of Efficacy|1|||
126305409|NCT01222520|454407249|FG000|Double-blind Period|Study medication stolen|1|||
126305410|NCT01222520|454407250|FG001|Double-blind Period|Study medication stolen|0|||
126305411|NCT04109391|454407251|FG000|Overall Study|Adverse Event|2|||
126305412|NCT04109391|454407252|FG001|Overall Study|Adverse Event|2|||
126305413|NCT04109391|454407253|FG002|Overall Study|Adverse Event|0|||
126305414|NCT04109391|454407251|FG000|Overall Study|Withdrawal by Subject|2|||
126305415|NCT04109391|454407252|FG001|Overall Study|Withdrawal by Subject|0|||
126305416|NCT04109391|454407253|FG002|Overall Study|Withdrawal by Subject|0|||
126305417|NCT04109391|454407251|FG000|Overall Study|Pregnancy|1|||
126305418|NCT04109391|454407252|FG001|Overall Study|Pregnancy|0|||
126305419|NCT04109391|454407253|FG002|Overall Study|Pregnancy|0|||
126305420|NCT04109391|454407251|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
126305421|NCT04109391|454407252|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
126305422|NCT04109391|454407253|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
126305423|NCT04109391|454407251|FG000|Overall Study|Lost to Follow-up|0|||
126305424|NCT04109391|454407252|FG001|Overall Study|Lost to Follow-up|0|||
126305425|NCT04109391|454407253|FG002|Overall Study|Lost to Follow-up|1|||
126305426|NCT04109391|454407251|FG000|Overall Study|Lack of Efficacy|2|||
126305427|NCT04109391|454407252|FG001|Overall Study|Lack of Efficacy|2|||
126305428|NCT04109391|454407253|FG002|Overall Study|Lack of Efficacy|3|||
126305429|NCT01089608|454407256|FG000|Overall Study|Adverse Event|0|||
126305430|NCT01089608|454407257|FG001|Overall Study|Adverse Event|4|||
126305431|NCT01089608|454407256|FG000|Overall Study|Lost to Follow-up|0|||
126305432|NCT01089608|454407257|FG001|Overall Study|Lost to Follow-up|2|||
126305433|NCT00280397|454407258|FG000|Overall Study|Adverse Event|1|||
126305434|NCT02257489|454407259|FG000|Overall Study|Withdrawal by Subject|0|||
126305435|NCT02257489|454407260|FG001|Overall Study|Withdrawal by Subject|0|||
126305436|NCT02257489|454407261|FG002|Overall Study|Withdrawal by Subject|0|||
126305437|NCT02257489|454407262|FG003|Overall Study|Withdrawal by Subject|1|||
126305438|NCT02257489|454407263|FG004|Overall Study|Withdrawal by Subject|0|||
126305439|NCT02257489|454407264|FG005|Overall Study|Withdrawal by Subject|0|||
126305440|NCT02257489|454407265|FG006|Overall Study|Withdrawal by Subject|0|||
126305441|NCT02257489|454407266|FG007|Overall Study|Withdrawal by Subject|0|||
126305442|NCT02257489|454407267|FG008|Overall Study|Withdrawal by Subject|0|||
126305443|NCT00955955|454407270|FG000|Overall Study|Lost to Follow-up|2|||
126305444|NCT00955955|454407271|FG001|Overall Study|Lost to Follow-up|0|||
126305445|NCT00955955|454407272|FG002|Overall Study|Lost to Follow-up|0|||
126305446|NCT03169881|454407273|FG000|Overall Study|Incomplete Follow-up|10|||
126305447|NCT03169881|454407274|FG001|Overall Study|Incomplete Follow-up|15|||
126305448|NCT03169881|454407273|FG000|Overall Study|Lost to Follow-up|18|||
126305449|NCT03169881|454407274|FG001|Overall Study|Lost to Follow-up|20|||
126305450|NCT03169881|454407273|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
126305451|NCT03169881|454407274|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
126305452|NCT03852264|454407275|FG000|Third Research Visit|Lost to Follow-up|1|||
126305453|NCT03852264|454407276|FG001|Third Research Visit|Lost to Follow-up|0|||
126305454|NCT00637000|454407278|FG000|Overall Study|Withdrawal by Subject|4|||
126305455|NCT00637000|454407279|FG001|Overall Study|Withdrawal by Subject|3|||
126305456|NCT00396656|454407284|FG000|First Treatment Period|Withdrawal by Subject|0|||
126305457|NCT00396656|454407285|FG001|First Treatment Period|Withdrawal by Subject|2|||
126305458|NCT00396656|454407284|FG000|Second Treatment Period|Adverse Event|0|||
126305459|NCT00396656|454407285|FG001|Second Treatment Period|Adverse Event|1|||
126368947|NCT01358734|454646532|FG002|Overall Study|Death|2|||
126368948|NCT01358734|454646530|FG000|Overall Study|Progressive Disease|5|||
126368949|NCT01358734|454646531|FG001|Overall Study|Progressive Disease|13|||
126368950|NCT01358734|454646532|FG002|Overall Study|Progressive Disease|16|||
126368951|NCT01358734|454646530|FG000|Overall Study|Non-compliance with study drug|0|||
126305460|NCT00552396|454407286|FG000|Overall Study|protocol withdrawal criteria|3|||
126305461|NCT00552396|454407287|FG001|Overall Study|protocol withdrawal criteria|3|||
126305462|NCT00552396|454407288|FG002|Overall Study|protocol withdrawal criteria|3|||
126305463|NCT00552396|454407289|FG003|Overall Study|protocol withdrawal criteria|6|||
126305464|NCT00552396|454407290|FG004|Overall Study|protocol withdrawal criteria|3|||
126305465|NCT00552396|454407291|FG005|Overall Study|protocol withdrawal criteria|3|||
126305466|NCT00552396|454407292|FG006|Overall Study|protocol withdrawal criteria|9|||
126305467|NCT04185220|454407293|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
126305468|NCT04185220|454407294|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
126368952|NCT01358734|454646531|FG001|Overall Study|Non-compliance with study drug|0|||
126714744|NCT01597193|455906947|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
126714745|NCT01597193|455906941|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
126714746|NCT01597193|455906942|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
126714747|NCT01597193|455906943|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
126305469|NCT04185220|454407293|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
126305470|NCT04185220|454407294|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
126305471|NCT01186692|454407297|FG000|Overall Study|Not Catheterized|11|||
126305472|NCT01186692|454407297|FG000|Overall Study|Futher testing contraindicated implant|19|||
126305473|NCT01186692|454407297|FG000|Overall Study|Adverse Event|2|||
126305474|NCT00767455|454407298|FG000|Overall Study|Investigator error|19|||
126305475|NCT00022698|454407299|FG000|Overall Study|Adverse Event|5|||
126305476|NCT00022698|454407300|FG001|Overall Study|Adverse Event|9|||
126305477|NCT00022698|454407299|FG000|Overall Study|Death|0|||
126305478|NCT00022698|454407300|FG001|Overall Study|Death|2|||
126714748|NCT01597193|455906944|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
126714749|NCT01597193|455906945|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
126714750|NCT01597193|455906946|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
126714751|NCT01597193|455906947|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
126714752|NCT03184701|455906948|FG000|Overall Study|Death|3|||
126714753|NCT03184701|455906948|FG000|Overall Study|Physician Decision|3|||
126714754|NCT03184701|455906948|FG000|Overall Study|Withdrawal by Subject|6|||
126714755|NCT03184701|455906948|FG000|Overall Study|Lost to Follow-up|5|||
126551779|NCT01189890|455315860|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
126551780|NCT01807221|455315863|FG000|Overall Study|Progressive disease|1|||
126305479|NCT00022698|454407299|FG000|Overall Study|Failure to return|0|||
126305480|NCT00022698|454407300|FG001|Overall Study|Failure to return|1|||
126305481|NCT00022698|454407299|FG000|Overall Study|Refused treatment|0|||
126305482|NCT00022698|454407300|FG001|Overall Study|Refused treatment|2|||
126305483|NCT00022698|454407299|FG000|Overall Study|Insufficient therapeutic response|2|||
126305484|NCT00022698|454407300|FG001|Overall Study|Insufficient therapeutic response|14|||
126305485|NCT00022698|454407299|FG000|Overall Study|Administrative /other|1|||
126305486|NCT00022698|454407300|FG001|Overall Study|Administrative /other|7|||
126305487|NCT03425396|454407307|FG000|Overall Study|Lost to Follow-up|2|||
126305488|NCT03425396|454407308|FG001|Overall Study|Lost to Follow-up|5|||
126305489|NCT03425396|454407309|FG002|Overall Study|Lost to Follow-up|2|||
126305490|NCT03425396|454407310|FG003|Overall Study|Lost to Follow-up|0|||
126305491|NCT03425396|454407311|FG004|Overall Study|Lost to Follow-up|0|||
126305492|NCT03425396|454407307|FG000|Overall Study|Withdrawal by Subject|0|||
126305493|NCT03425396|454407308|FG001|Overall Study|Withdrawal by Subject|1|||
126305494|NCT03425396|454407309|FG002|Overall Study|Withdrawal by Subject|0|||
126305495|NCT03425396|454407310|FG003|Overall Study|Withdrawal by Subject|1|||
126305496|NCT03425396|454407311|FG004|Overall Study|Withdrawal by Subject|0|||
126305497|NCT03425396|454407307|FG000|Overall Study|Other|0|||
126305498|NCT03425396|454407308|FG001|Overall Study|Other|1|||
126305499|NCT03425396|454407309|FG002|Overall Study|Other|1|||
126305500|NCT03425396|454407310|FG003|Overall Study|Other|0|||
126305501|NCT03425396|454407311|FG004|Overall Study|Other|1|||
126305502|NCT04520997|454407315|FG000|Overall Study|Lost to Follow-up|1|||
126305503|NCT04520997|454407316|FG001|Overall Study|Lost to Follow-up|1|||
126305504|NCT04520997|454407315|FG000|Overall Study|Withdrawal by Subject|1|||
126305505|NCT04520997|454407316|FG001|Overall Study|Withdrawal by Subject|0|||
126305506|NCT04520997|454407315|FG000|Overall Study|Not Treated|0|||
126305507|NCT04520997|454407316|FG001|Overall Study|Not Treated|1|||
126305508|NCT02981082|454407317|FG000|Overall Study|Withdrawal by Subject|2|||
126305509|NCT02981082|454407318|FG001|Overall Study|Withdrawal by Subject|0|||
126305510|NCT02981082|454407317|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
126305511|NCT02981082|454407318|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
126305512|NCT02981082|454407317|FG000|Overall Study|Adverse Event|0|||
126305513|NCT02981082|454407318|FG001|Overall Study|Adverse Event|1|||
126305514|NCT05367973|454407319|FG000|Overall Study|Adverse Event|0|||
126714756|NCT00935220|455906959|FG000|Overall Study|Adverse Event|1|||
126714757|NCT00935220|455906959|FG000|Overall Study|Other reason (not specified)|1|||
126714758|NCT01000064|455906960|FG000|Overall Study|Withdrawal by Subject|1|||
126714759|NCT01000064|455906961|FG001|Overall Study|Withdrawal by Subject|1|||
126714760|NCT01518192|455906962|FG000|Overall Study|Lost to Follow-up|29|||
126714761|NCT01518192|455906963|FG001|Overall Study|Lost to Follow-up|26|||
126714762|NCT01518192|455906964|FG002|Overall Study|Lost to Follow-up|35|||
126305515|NCT05367973|454407320|FG001|Overall Study|Adverse Event|2|||
126305516|NCT01314872|454407324|FG000|Treatment Period 1|Protocol Violation|2|||
126305517|NCT01314872|454407325|FG001|Treatment Period 1|Protocol Violation|1|||
126305518|NCT01314872|454407326|FG002|Treatment Period 1|Protocol Violation|1|||
126305519|NCT01314872|454407327|FG003|Treatment Period 1|Protocol Violation|0|||
126305520|NCT01314872|454407328|FG004|Treatment Period 1|Protocol Violation|1|||
126305521|NCT01314872|454407329|FG005|Treatment Period 1|Protocol Violation|0|||
126551781|NCT01807221|455315864|FG001|Overall Study|Progressive disease|0|||
126368953|NCT01358734|454646532|FG002|Overall Study|Non-compliance with study drug|1|||
126368954|NCT01358734|454646530|FG000|Overall Study|Other|2|||
126368955|NCT01358734|454646531|FG001|Overall Study|Other|5|||
126368956|NCT01358734|454646532|FG002|Overall Study|Other|4|||
126368957|NCT01358734|454646530|FG000|Overall Study|Protocol Violation|0|||
126368958|NCT01358734|454646531|FG001|Overall Study|Protocol Violation|0|||
126368959|NCT01358734|454646532|FG002|Overall Study|Protocol Violation|2|||
126368960|NCT01822925|454646533|FG000|Overall Study|Adverse Event|1|||
126368961|NCT01822925|454646534|FG001|Overall Study|Adverse Event|1|||
126368962|NCT01822925|454646535|FG002|Overall Study|Adverse Event|1|||
126368963|NCT01822925|454646536|FG003|Overall Study|Adverse Event|1|||
126368964|NCT01822925|454646533|FG000|Overall Study|Lost to Follow-up|0|||
126368965|NCT01822925|454646534|FG001|Overall Study|Lost to Follow-up|1|||
126368966|NCT01822925|454646535|FG002|Overall Study|Lost to Follow-up|0|||
126368967|NCT01822925|454646536|FG003|Overall Study|Lost to Follow-up|0|||
126368968|NCT01822925|454646533|FG000|Overall Study|Protocol Violation|1|||
126368969|NCT01822925|454646534|FG001|Overall Study|Protocol Violation|0|||
126368970|NCT01822925|454646535|FG002|Overall Study|Protocol Violation|0|||
126368971|NCT01822925|454646536|FG003|Overall Study|Protocol Violation|1|||
126368972|NCT01822925|454646533|FG000|Overall Study|Withdrawal by Subject|2|||
126368973|NCT01822925|454646534|FG001|Overall Study|Withdrawal by Subject|0|||
126368974|NCT01822925|454646535|FG002|Overall Study|Withdrawal by Subject|2|||
126368975|NCT01822925|454646536|FG003|Overall Study|Withdrawal by Subject|2|||
126368976|NCT01822925|454646533|FG000|Overall Study|Taking prohibited medication|2|||
126368977|NCT01822925|454646534|FG001|Overall Study|Taking prohibited medication|0|||
126368978|NCT01822925|454646535|FG002|Overall Study|Taking prohibited medication|0|||
126368979|NCT01822925|454646536|FG003|Overall Study|Taking prohibited medication|1|||
126368980|NCT04617860|454646538|FG000|Overall Study|Adverse Event|0|||
126368981|NCT04617860|454646539|FG001|Overall Study|Adverse Event|2|||
126368982|NCT04617860|454646540|FG002|Overall Study|Adverse Event|2|||
126368983|NCT04617860|454646538|FG000|Overall Study|Withdrawal by Subject|0|||
126368984|NCT04617860|454646539|FG001|Overall Study|Withdrawal by Subject|0|||
126368985|NCT04617860|454646540|FG002|Overall Study|Withdrawal by Subject|2|||
126368986|NCT04617860|454646538|FG000|Overall Study|Physician Decision|0|||
126368987|NCT04617860|454646539|FG001|Overall Study|Physician Decision|1|||
126368988|NCT04617860|454646540|FG002|Overall Study|Physician Decision|0|||
126368989|NCT04617860|454646538|FG000|Overall Study|Sponsor Decision|0|||
126368990|NCT04617860|454646539|FG001|Overall Study|Sponsor Decision|3|||
126368991|NCT04617860|454646540|FG002|Overall Study|Sponsor Decision|1|||
126368992|NCT04617860|454646538|FG000|Overall Study|Termination of Study by Sponsor|8|||
126368993|NCT04617860|454646539|FG001|Overall Study|Termination of Study by Sponsor|4|||
126368994|NCT04617860|454646540|FG002|Overall Study|Termination of Study by Sponsor|13|||
126368995|NCT01182350|454646541|FG000|Overall Study|Adverse Event|5|||
126368996|NCT01182350|454646542|FG001|Overall Study|Adverse Event|0|||
126368997|NCT01182350|454646543|FG002|Overall Study|Adverse Event|0|||
126368998|NCT01182350|454646544|FG003|Overall Study|Adverse Event|0|||
126368999|NCT01182350|454646545|FG004|Overall Study|Adverse Event|0|||
126369000|NCT01182350|454646541|FG000|Overall Study|Disease Progression|15|||
126369001|NCT01182350|454646542|FG001|Overall Study|Disease Progression|12|||
126369002|NCT01182350|454646543|FG002|Overall Study|Disease Progression|0|||
126369003|NCT01182350|454646544|FG003|Overall Study|Disease Progression|1|||
126369004|NCT01182350|454646545|FG004|Overall Study|Disease Progression|0|||
126369005|NCT01182350|454646541|FG000|Overall Study|Death|0|||
126369006|NCT01182350|454646542|FG001|Overall Study|Death|1|||
126369007|NCT01182350|454646543|FG002|Overall Study|Death|1|||
126369008|NCT01182350|454646544|FG003|Overall Study|Death|0|||
126369009|NCT01182350|454646545|FG004|Overall Study|Death|0|||
126369010|NCT01182350|454646541|FG000|Overall Study|Withdrawal by Subject|3|||
126369011|NCT01182350|454646542|FG001|Overall Study|Withdrawal by Subject|1|||
126369012|NCT01182350|454646543|FG002|Overall Study|Withdrawal by Subject|0|||
126369013|NCT01182350|454646544|FG003|Overall Study|Withdrawal by Subject|1|||
126369014|NCT01182350|454646545|FG004|Overall Study|Withdrawal by Subject|0|||
126369015|NCT01182350|454646541|FG000|Overall Study|Alternative Therapy|2|||
126369016|NCT01182350|454646542|FG001|Overall Study|Alternative Therapy|0|||
126369017|NCT01182350|454646543|FG002|Overall Study|Alternative Therapy|1|||
126369018|NCT01182350|454646544|FG003|Overall Study|Alternative Therapy|0|||
126369019|NCT01182350|454646545|FG004|Overall Study|Alternative Therapy|0|||
126369020|NCT01182350|454646541|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
126369021|NCT01182350|454646542|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
126369022|NCT01182350|454646543|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
126369023|NCT01182350|454646544|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
126369024|NCT01182350|454646545|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
126369025|NCT01182350|454646541|FG000|Overall Study|Unevaluable for Biopsy|0|||
126369026|NCT01182350|454646542|FG001|Overall Study|Unevaluable for Biopsy|0|||
126369027|NCT01182350|454646543|FG002|Overall Study|Unevaluable for Biopsy|0|||
126369028|NCT01182350|454646544|FG003|Overall Study|Unevaluable for Biopsy|0|||
126369029|NCT01182350|454646545|FG004|Overall Study|Unevaluable for Biopsy|3|||
126369030|NCT03898180|454646546|FG000|Overall Study|Death|178|||
126714763|NCT00798967|455906965|FG000|Overall Study|Adverse Event|2|||
126714764|NCT00798967|455906966|FG001|Overall Study|Adverse Event|3|||
126714765|NCT00798967|455906965|FG000|Overall Study|Withdrawal by Subject|0|||
126714766|NCT00798967|455906966|FG001|Overall Study|Withdrawal by Subject|1|||
126714767|NCT00798967|455906965|FG000|Overall Study|Physician Decision|1|||
126714768|NCT00798967|455906966|FG001|Overall Study|Physician Decision|0|||
126714769|NCT00798967|455906965|FG000|Overall Study|Randomized in error by site|1|||
126714770|NCT00798967|455906966|FG001|Overall Study|Randomized in error by site|0|||
126714771|NCT01415440|455906967|FG000|Overall Study|Lost to Follow-up|0|||
126714772|NCT01415440|455906968|FG001|Overall Study|Lost to Follow-up|1|||
126714773|NCT01415440|455906969|FG002|Overall Study|Lost to Follow-up|2|||
126714774|NCT01415440|455906967|FG000|Overall Study|Physician Decision|3|||
126714775|NCT01415440|455906968|FG001|Overall Study|Physician Decision|0|||
126714776|NCT01415440|455906969|FG002|Overall Study|Physician Decision|0|||
126714777|NCT01415440|455906967|FG000|Overall Study|Withdrawal by Subject|1|||
126714778|NCT01415440|455906968|FG001|Overall Study|Withdrawal by Subject|0|||
126714779|NCT01415440|455906969|FG002|Overall Study|Withdrawal by Subject|0|||
126714780|NCT03141307|455906970|FG000|In-Hospital|Withdrawal by Subject|0|||
126714781|NCT03141307|455906971|FG001|In-Hospital|Withdrawal by Subject|2|||
126714782|NCT03141307|455906970|FG000|In-Hospital|Protocol Violation|4|||
126714783|NCT03141307|455906971|FG001|In-Hospital|Protocol Violation|0|||
126714784|NCT03141307|455906970|FG000|Follow-Up|Lost to Follow-up|97|||
126714785|NCT03141307|455906971|FG001|Follow-Up|Lost to Follow-up|54|||
126714786|NCT03090737|455906972|FG000|Overall Study|Other reasons|1|||
126714787|NCT03090737|455906972|FG000|Overall Study|Completed treatment as per protocol|17|||
126714788|NCT03090737|455906972|FG000|Overall Study|Maximum clinical benefit|2|||
126714789|NCT03090737|455906972|FG000|Overall Study|Adverse event unrelated to study drug|7|||
126714790|NCT03090737|455906972|FG000|Overall Study|Study drug toxicity|4|||
126714791|NCT03090737|455906972|FG000|Overall Study|Disease progression|98|||
126714792|NCT02160977|455906975|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
126714793|NCT02160977|455906976|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
126714794|NCT02160977|455906975|FG000|Three Months After Surgery|Lost to Follow-up|0|||
126714795|NCT02160977|455906976|FG001|Three Months After Surgery|Lost to Follow-up|2|||
126305522|NCT01314872|454407330|FG006|Treatment Period 1|Protocol Violation|0|||
126305523|NCT01314872|454407331|FG007|Treatment Period 1|Protocol Violation|0|||
126305524|NCT01314872|454407332|FG008|Treatment Period 1|Protocol Violation|0|||
126305525|NCT01314872|454407333|FG009|Treatment Period 1|Protocol Violation|1|||
126305526|NCT01314872|454407334|FG010|Treatment Period 1|Protocol Violation|1|||
126305527|NCT01314872|454407335|FG011|Treatment Period 1|Protocol Violation|0|||
126305528|NCT01314872|454407336|FG012|Treatment Period 1|Protocol Violation|0|||
126305529|NCT01314872|454407337|FG013|Treatment Period 1|Protocol Violation|0|||
126305530|NCT01314872|454407338|FG014|Treatment Period 1|Protocol Violation|0|||
126305531|NCT01314872|454407324|FG000|Treatment Period 1|Physician Decision|0|||
126305532|NCT01314872|454407325|FG001|Treatment Period 1|Physician Decision|1|||
126305533|NCT01314872|454407326|FG002|Treatment Period 1|Physician Decision|0|||
126305534|NCT01314872|454407327|FG003|Treatment Period 1|Physician Decision|1|||
126305535|NCT01314872|454407328|FG004|Treatment Period 1|Physician Decision|0|||
126305536|NCT01314872|454407329|FG005|Treatment Period 1|Physician Decision|0|||
126305537|NCT01314872|454407330|FG006|Treatment Period 1|Physician Decision|0|||
126305538|NCT01314872|454407331|FG007|Treatment Period 1|Physician Decision|0|||
126305539|NCT01314872|454407332|FG008|Treatment Period 1|Physician Decision|0|||
126305540|NCT01314872|454407333|FG009|Treatment Period 1|Physician Decision|1|||
126305541|NCT01314872|454407334|FG010|Treatment Period 1|Physician Decision|0|||
126305542|NCT01314872|454407335|FG011|Treatment Period 1|Physician Decision|0|||
126305543|NCT01314872|454407336|FG012|Treatment Period 1|Physician Decision|0|||
126305544|NCT01314872|454407337|FG013|Treatment Period 1|Physician Decision|0|||
126305545|NCT01314872|454407338|FG014|Treatment Period 1|Physician Decision|0|||
126463654|NCT05140382|454998781|FG002|Overall Study|Investigator decision|0|||
126714796|NCT02160977|455906975|FG000|Six Months After Surgery|Lost to Follow-up|2|||
126714797|NCT02160977|455906976|FG001|Six Months After Surgery|Lost to Follow-up|1|||
126714798|NCT01790438|455908583|FG000|Overall Study|Adverse Event|3|||
126305546|NCT01314872|454407324|FG000|Treatment Period 1|Lack of Efficacy|1|||
126305547|NCT01314872|454407325|FG001|Treatment Period 1|Lack of Efficacy|0|||
126714799|NCT01790438|455908584|FG001|Overall Study|Adverse Event|2|||
126714800|NCT01790438|455908583|FG000|Overall Study|Death|4|||
126714801|NCT01790438|455908584|FG001|Overall Study|Death|0|||
126714802|NCT01790438|455908583|FG000|Overall Study|Lost to Follow-up|5|||
126714803|NCT01790438|455908584|FG001|Overall Study|Lost to Follow-up|2|||
126714804|NCT01790438|455908583|FG000|Overall Study|Withdrawal by Subject|13|||
126305548|NCT01314872|454407326|FG002|Treatment Period 1|Lack of Efficacy|0|||
126305549|NCT01314872|454407327|FG003|Treatment Period 1|Lack of Efficacy|0|||
126305550|NCT01314872|454407328|FG004|Treatment Period 1|Lack of Efficacy|0|||
126305551|NCT01314872|454407329|FG005|Treatment Period 1|Lack of Efficacy|1|||
126305552|NCT01314872|454407330|FG006|Treatment Period 1|Lack of Efficacy|0|||
126463655|NCT05140382|454998779|FG000|Overall Study|Other|4|||
126714805|NCT01790438|455908584|FG001|Overall Study|Withdrawal by Subject|2|||
126714806|NCT01790438|455908583|FG000|Overall Study|Physician Decision|3|||
126551782|NCT01807221|455315865|FG002|Overall Study|Progressive disease|1|||
126369031|NCT03898180|454646547|FG001|Overall Study|Death|173|||
126369032|NCT03898180|454646546|FG000|Overall Study|Physician Decision|1|||
126369033|NCT03898180|454646547|FG001|Overall Study|Physician Decision|0|||
126369034|NCT03898180|454646546|FG000|Overall Study|Sponsor Decision|3|||
126369035|NCT03898180|454646547|FG001|Overall Study|Sponsor Decision|0|||
126369036|NCT03898180|454646546|FG000|Overall Study|Lost to Follow-up|1|||
126369037|NCT03898180|454646547|FG001|Overall Study|Lost to Follow-up|0|||
126369038|NCT03898180|454646546|FG000|Overall Study|Withdrawal by Subject|5|||
126369039|NCT03898180|454646547|FG001|Overall Study|Withdrawal by Subject|4|||
126369040|NCT01646827|454646548|FG000|Overall Study|Lost to Follow-up|0|||
126369041|NCT01646827|454646549|FG001|Overall Study|Lost to Follow-up|3|||
126369042|NCT01646827|454646548|FG000|Overall Study|Physician Decision|1|||
126369043|NCT01646827|454646549|FG001|Overall Study|Physician Decision|2|||
126369044|NCT01646827|454646548|FG000|Overall Study|Withdrawal by Subject|1|||
126369045|NCT01646827|454646549|FG001|Overall Study|Withdrawal by Subject|0|||
126369046|NCT00928668|454646550|FG000|Overall Study|Adverse Event|1|||
126369047|NCT00928668|454646551|FG001|Overall Study|Adverse Event|0|||
126369048|NCT00928668|454646552|FG002|Overall Study|Adverse Event|0|||
126369049|NCT00928668|454646553|FG003|Overall Study|Adverse Event|0|||
126369050|NCT00928668|454646554|FG004|Overall Study|Adverse Event|0|||
126369051|NCT00928668|454646550|FG000|Overall Study|Protocol Violation|0|||
126369052|NCT00928668|454646551|FG001|Overall Study|Protocol Violation|0|||
126369053|NCT00928668|454646552|FG002|Overall Study|Protocol Violation|0|||
126369054|NCT00928668|454646553|FG003|Overall Study|Protocol Violation|0|||
126369055|NCT00928668|454646554|FG004|Overall Study|Protocol Violation|1|||
126369056|NCT00928668|454646550|FG000|Overall Study|Withdrawal by Subject|0|||
126369057|NCT00928668|454646551|FG001|Overall Study|Withdrawal by Subject|1|||
126369058|NCT00928668|454646552|FG002|Overall Study|Withdrawal by Subject|1|||
126369059|NCT00928668|454646553|FG003|Overall Study|Withdrawal by Subject|0|||
126369060|NCT00928668|454646554|FG004|Overall Study|Withdrawal by Subject|0|||
126369061|NCT00928668|454646550|FG000|Overall Study|Other reasons not listed above|0|||
126369062|NCT00928668|454646551|FG001|Overall Study|Other reasons not listed above|0|||
126369063|NCT00928668|454646552|FG002|Overall Study|Other reasons not listed above|0|||
126369064|NCT00928668|454646553|FG003|Overall Study|Other reasons not listed above|1|||
126369065|NCT00928668|454646554|FG004|Overall Study|Other reasons not listed above|0|||
126369066|NCT01767987|454646558|FG000|Overall Study|Physician Decision|4|||
126369067|NCT01767987|454646559|FG001|Overall Study|Physician Decision|1|||
126369068|NCT03232567|454646560|FG000|Overall Study|Withdrawal by Subject|0|||
126369069|NCT03232567|454646561|FG001|Overall Study|Withdrawal by Subject|1|||
126369070|NCT03232567|454646562|FG002|Overall Study|Withdrawal by Subject|0|||
126369071|NCT03232567|454646563|FG003|Overall Study|Withdrawal by Subject|0|||
126369072|NCT05837481|454646564|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
126551783|NCT01807221|455315866|FG003|Overall Study|Progressive disease|0|||
126551784|NCT01807221|455315867|FG004|Overall Study|Progressive disease|0|||
126551785|NCT01807221|455315868|FG005|Overall Study|Progressive disease|0|||
126551786|NCT01807221|455315863|FG000|Overall Study|Death|7|||
126551787|NCT01807221|455315864|FG001|Overall Study|Death|9|||
126551788|NCT01807221|455315865|FG002|Overall Study|Death|4|||
126551789|NCT01807221|455315866|FG003|Overall Study|Death|2|||
126551790|NCT01807221|455315867|FG004|Overall Study|Death|1|||
126305553|NCT01314872|454407331|FG007|Treatment Period 1|Lack of Efficacy|2|||
126305554|NCT01314872|454407332|FG008|Treatment Period 1|Lack of Efficacy|0|||
126305555|NCT01314872|454407333|FG009|Treatment Period 1|Lack of Efficacy|0|||
126305556|NCT01314872|454407334|FG010|Treatment Period 1|Lack of Efficacy|0|||
126305557|NCT01314872|454407335|FG011|Treatment Period 1|Lack of Efficacy|0|||
126305558|NCT01314872|454407336|FG012|Treatment Period 1|Lack of Efficacy|0|||
126305559|NCT01314872|454407337|FG013|Treatment Period 1|Lack of Efficacy|0|||
126305560|NCT01314872|454407338|FG014|Treatment Period 1|Lack of Efficacy|0|||
126305561|NCT01314872|454407324|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
126305562|NCT01314872|454407325|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
126305563|NCT01314872|454407326|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
126305564|NCT01314872|454407327|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
126305565|NCT01314872|454407328|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
126305566|NCT01314872|454407329|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
126305567|NCT01314872|454407330|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
126305568|NCT01314872|454407331|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
126305569|NCT01314872|454407332|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
126305570|NCT01314872|454407333|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
126305571|NCT01314872|454407334|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
126305572|NCT01314872|454407335|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
126305573|NCT01314872|454407336|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
126305574|NCT01314872|454407337|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
126305575|NCT01314872|454407338|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
126305576|NCT01314872|454407324|FG000|Treatment Period 1|Withdrawal by Subject|3|||
126305577|NCT01314872|454407325|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126714807|NCT01790438|455908584|FG001|Overall Study|Physician Decision|1|||
126714808|NCT01790438|455908583|FG000|Overall Study|Sponsor Decision|0|||
126714809|NCT01790438|455908584|FG001|Overall Study|Sponsor Decision|3|||
126714810|NCT01790438|455908583|FG000|Overall Study|Protocol Required Discontinuation|7|||
126714811|NCT01790438|455908584|FG001|Overall Study|Protocol Required Discontinuation|1|||
126714812|NCT01614769|455908590|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
126714813|NCT01614769|455908591|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
126714814|NCT01614769|455908592|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
126714815|NCT01614769|455908593|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
126714816|NCT01614769|455908594|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
126714817|NCT01614769|455908595|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
126714818|NCT01614769|455908590|FG000|Period 1|Protocol Violation|0|||
126714819|NCT01614769|455908591|FG001|Period 1|Protocol Violation|0|||
126714820|NCT01614769|455908592|FG002|Period 1|Protocol Violation|0|||
126714821|NCT01614769|455908593|FG003|Period 1|Protocol Violation|1|||
126714822|NCT01614769|455908594|FG004|Period 1|Protocol Violation|0|||
126714823|NCT01614769|455908595|FG005|Period 1|Protocol Violation|0|||
126714824|NCT01614769|455908590|FG000|Period 1|Withdrawal by Subject|1|||
126369073|NCT05837481|454646565|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
126369074|NCT03038087|454646571|FG000|Overall Study|lost data|1|||
126369075|NCT00654355|454646572|FG000|Overall Study|Lost to Follow-up|2|||
126369076|NCT00654355|454646573|FG001|Overall Study|Lost to Follow-up|2|||
126369077|NCT02284893|454646582|FG000|26 Week (Short Term)|Adverse Event|1|||
126369078|NCT02284893|454646583|FG001|26 Week (Short Term)|Adverse Event|9|||
126369079|NCT02284893|454646582|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
126369080|NCT02284893|454646583|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
126369081|NCT02284893|454646582|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
126369082|NCT02284893|454646583|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
126369083|NCT02284893|454646582|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
126369084|NCT02284893|454646583|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
126369085|NCT02284893|454646582|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
126369086|NCT02284893|454646583|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
126369087|NCT02284893|454646582|FG000|26 Week (Short Term)|Other|1|||
126369088|NCT02284893|454646583|FG001|26 Week (Short Term)|Other|1|||
126369089|NCT02284893|454646582|FG000|52 Week (Long Term)|Adverse Event|3|||
126369090|NCT02284893|454646583|FG001|52 Week (Long Term)|Adverse Event|1|||
126369091|NCT02284893|454646582|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
126369092|NCT02284893|454646583|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
126369093|NCT02284893|454646582|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
126369094|NCT02284893|454646583|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
126369095|NCT02284893|454646582|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
126369096|NCT02284893|454646583|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
126369097|NCT02284893|454646582|FG000|52 Week (Long Term)|Non-Compliance|2|||
126369098|NCT02284893|454646583|FG001|52 Week (Long Term)|Non-Compliance|3|||
126369099|NCT00105066|454646586|FG000|Overall Study|Adverse Event|2|||
126369100|NCT00105066|454646587|FG001|Overall Study|Adverse Event|5|||
126369101|NCT02259231|454646620|FG000|Overall Study|Adverse Event|1|||
126369102|NCT02259231|454646621|FG001|Overall Study|Adverse Event|1|||
126369103|NCT02259231|454646622|FG002|Overall Study|Adverse Event|2|||
126369104|NCT02259231|454646623|FG003|Overall Study|Adverse Event|0|||
126369105|NCT02259231|454646624|FG004|Overall Study|Adverse Event|0|||
126714825|NCT01614769|455908591|FG001|Period 1|Withdrawal by Subject|0|||
126714826|NCT01614769|455908592|FG002|Period 1|Withdrawal by Subject|0|||
126369106|NCT02259231|454646625|FG005|Overall Study|Adverse Event|0|||
126369107|NCT02259231|454646626|FG006|Overall Study|Adverse Event|0|||
126369108|NCT02259231|454646620|FG000|Overall Study|Progressive Disease|4|||
126369109|NCT02259231|454646621|FG001|Overall Study|Progressive Disease|5|||
126369110|NCT02259231|454646622|FG002|Overall Study|Progressive Disease|4|||
126369111|NCT02259231|454646623|FG003|Overall Study|Progressive Disease|5|||
126369112|NCT02259231|454646624|FG004|Overall Study|Progressive Disease|4|||
126714827|NCT01614769|455908593|FG003|Period 1|Withdrawal by Subject|0|||
126714828|NCT01614769|455908594|FG004|Period 1|Withdrawal by Subject|0|||
126369113|NCT02259231|454646625|FG005|Overall Study|Progressive Disease|5|||
126369114|NCT02259231|454646626|FG006|Overall Study|Progressive Disease|4|||
126369115|NCT02259231|454646620|FG000|Overall Study|Sponsor termination of study|1|||
126714829|NCT01614769|455908595|FG005|Period 1|Withdrawal by Subject|0|||
126714830|NCT01614769|455908590|FG000|Period 3|Withdrawal by Subject|0|||
126714831|NCT01614769|455908591|FG001|Period 3|Withdrawal by Subject|0|||
126369116|NCT02259231|454646621|FG001|Overall Study|Sponsor termination of study|0|||
126369117|NCT02259231|454646622|FG002|Overall Study|Sponsor termination of study|0|||
126369118|NCT02259231|454646623|FG003|Overall Study|Sponsor termination of study|1|||
126369119|NCT02259231|454646624|FG004|Overall Study|Sponsor termination of study|2|||
126714832|NCT01614769|455908592|FG002|Period 3|Withdrawal by Subject|1|||
126714833|NCT01614769|455908593|FG003|Period 3|Withdrawal by Subject|0|||
126714834|NCT01614769|455908594|FG004|Period 3|Withdrawal by Subject|0|||
126463656|NCT05140382|454998780|FG001|Overall Study|Other|0|||
126463657|NCT05140382|454998781|FG002|Overall Study|Other|1|||
126463658|NCT05140382|454998779|FG000|Overall Study|Progressive disease|20|||
126463659|NCT05140382|454998780|FG001|Overall Study|Progressive disease|1|||
126714835|NCT01614769|455908595|FG005|Period 3|Withdrawal by Subject|0|||
126305578|NCT01314872|454407326|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126305579|NCT01314872|454407327|FG003|Treatment Period 1|Withdrawal by Subject|2|||
126305580|NCT01314872|454407328|FG004|Treatment Period 1|Withdrawal by Subject|3|||
126305581|NCT01314872|454407329|FG005|Treatment Period 1|Withdrawal by Subject|1|||
126305582|NCT01314872|454407330|FG006|Treatment Period 1|Withdrawal by Subject|3|||
126305583|NCT01314872|454407331|FG007|Treatment Period 1|Withdrawal by Subject|2|||
126305584|NCT01314872|454407332|FG008|Treatment Period 1|Withdrawal by Subject|2|||
126305585|NCT01314872|454407333|FG009|Treatment Period 1|Withdrawal by Subject|2|||
126305586|NCT01314872|454407334|FG010|Treatment Period 1|Withdrawal by Subject|1|||
126305587|NCT01314872|454407335|FG011|Treatment Period 1|Withdrawal by Subject|0|||
126305588|NCT01314872|454407336|FG012|Treatment Period 1|Withdrawal by Subject|0|||
126305589|NCT01314872|454407337|FG013|Treatment Period 1|Withdrawal by Subject|0|||
126305590|NCT01314872|454407338|FG014|Treatment Period 1|Withdrawal by Subject|0|||
126305591|NCT01314872|454407324|FG000|Treatment Period 1|Lost to Follow-up|0|||
126305592|NCT01314872|454407325|FG001|Treatment Period 1|Lost to Follow-up|1|||
126305593|NCT01314872|454407326|FG002|Treatment Period 1|Lost to Follow-up|2|||
126305594|NCT01314872|454407327|FG003|Treatment Period 1|Lost to Follow-up|2|||
126305595|NCT01314872|454407328|FG004|Treatment Period 1|Lost to Follow-up|1|||
126305596|NCT01314872|454407329|FG005|Treatment Period 1|Lost to Follow-up|1|||
126305597|NCT01314872|454407330|FG006|Treatment Period 1|Lost to Follow-up|1|||
126305598|NCT01314872|454407331|FG007|Treatment Period 1|Lost to Follow-up|1|||
126305599|NCT01314872|454407332|FG008|Treatment Period 1|Lost to Follow-up|1|||
126305600|NCT01314872|454407333|FG009|Treatment Period 1|Lost to Follow-up|0|||
126305601|NCT01314872|454407334|FG010|Treatment Period 1|Lost to Follow-up|0|||
126305602|NCT01314872|454407335|FG011|Treatment Period 1|Lost to Follow-up|0|||
126305603|NCT01314872|454407336|FG012|Treatment Period 1|Lost to Follow-up|0|||
126305604|NCT01314872|454407337|FG013|Treatment Period 1|Lost to Follow-up|0|||
126305605|NCT01314872|454407338|FG014|Treatment Period 1|Lost to Follow-up|0|||
126305606|NCT01314872|454407324|FG000|Period 2|Protocol Violation|0|||
126305607|NCT01314872|454407325|FG001|Period 2|Protocol Violation|0|||
126305608|NCT01314872|454407326|FG002|Period 2|Protocol Violation|0|||
126305609|NCT01314872|454407327|FG003|Period 2|Protocol Violation|0|||
126305610|NCT01314872|454407328|FG004|Period 2|Protocol Violation|0|||
126305611|NCT01314872|454407329|FG005|Period 2|Protocol Violation|0|||
126305612|NCT01314872|454407330|FG006|Period 2|Protocol Violation|0|||
126305613|NCT01314872|454407331|FG007|Period 2|Protocol Violation|0|||
126305614|NCT01314872|454407332|FG008|Period 2|Protocol Violation|0|||
126305615|NCT01314872|454407333|FG009|Period 2|Protocol Violation|0|||
126305616|NCT01314872|454407334|FG010|Period 2|Protocol Violation|0|||
126305617|NCT01314872|454407335|FG011|Period 2|Protocol Violation|3|||
126305618|NCT01314872|454407336|FG012|Period 2|Protocol Violation|3|||
126305619|NCT01314872|454407337|FG013|Period 2|Protocol Violation|2|||
126305620|NCT01314872|454407338|FG014|Period 2|Protocol Violation|0|||
126305621|NCT01314872|454407324|FG000|Period 2|Non-compliance with study drug|0|||
126305622|NCT01314872|454407325|FG001|Period 2|Non-compliance with study drug|0|||
126305623|NCT01314872|454407326|FG002|Period 2|Non-compliance with study drug|0|||
126305624|NCT01314872|454407327|FG003|Period 2|Non-compliance with study drug|0|||
126305625|NCT01314872|454407328|FG004|Period 2|Non-compliance with study drug|0|||
126305626|NCT01314872|454407329|FG005|Period 2|Non-compliance with study drug|0|||
126305627|NCT01314872|454407330|FG006|Period 2|Non-compliance with study drug|0|||
126305628|NCT01314872|454407331|FG007|Period 2|Non-compliance with study drug|0|||
126305629|NCT01314872|454407332|FG008|Period 2|Non-compliance with study drug|0|||
126305630|NCT01314872|454407333|FG009|Period 2|Non-compliance with study drug|0|||
126305631|NCT01314872|454407334|FG010|Period 2|Non-compliance with study drug|0|||
126305632|NCT01314872|454407335|FG011|Period 2|Non-compliance with study drug|3|||
126305633|NCT01314872|454407336|FG012|Period 2|Non-compliance with study drug|3|||
126305634|NCT01314872|454407337|FG013|Period 2|Non-compliance with study drug|1|||
126305635|NCT01314872|454407338|FG014|Period 2|Non-compliance with study drug|2|||
126305636|NCT01314872|454407324|FG000|Period 2|Lack of Efficacy|0|||
126305637|NCT01314872|454407325|FG001|Period 2|Lack of Efficacy|0|||
126305638|NCT01314872|454407326|FG002|Period 2|Lack of Efficacy|0|||
126305639|NCT01314872|454407327|FG003|Period 2|Lack of Efficacy|0|||
126305640|NCT01314872|454407328|FG004|Period 2|Lack of Efficacy|0|||
126305641|NCT01314872|454407329|FG005|Period 2|Lack of Efficacy|0|||
126305642|NCT01314872|454407330|FG006|Period 2|Lack of Efficacy|0|||
126305643|NCT01314872|454407331|FG007|Period 2|Lack of Efficacy|0|||
126305644|NCT01314872|454407332|FG008|Period 2|Lack of Efficacy|0|||
126305645|NCT01314872|454407333|FG009|Period 2|Lack of Efficacy|0|||
126305646|NCT01314872|454407334|FG010|Period 2|Lack of Efficacy|0|||
126305647|NCT01314872|454407335|FG011|Period 2|Lack of Efficacy|7|||
126305648|NCT01314872|454407336|FG012|Period 2|Lack of Efficacy|12|||
126305649|NCT01314872|454407337|FG013|Period 2|Lack of Efficacy|9|||
126305650|NCT01314872|454407338|FG014|Period 2|Lack of Efficacy|2|||
126305651|NCT01314872|454407324|FG000|Period 2|Pregnancy|0|||
126305652|NCT01314872|454407325|FG001|Period 2|Pregnancy|0|||
126305653|NCT01314872|454407326|FG002|Period 2|Pregnancy|0|||
126305654|NCT01314872|454407327|FG003|Period 2|Pregnancy|0|||
126305655|NCT01314872|454407328|FG004|Period 2|Pregnancy|0|||
126305656|NCT01314872|454407329|FG005|Period 2|Pregnancy|0|||
126305657|NCT01314872|454407330|FG006|Period 2|Pregnancy|0|||
126305658|NCT01314872|454407331|FG007|Period 2|Pregnancy|0|||
126305659|NCT01314872|454407332|FG008|Period 2|Pregnancy|0|||
126305660|NCT01314872|454407333|FG009|Period 2|Pregnancy|0|||
126305661|NCT01314872|454407334|FG010|Period 2|Pregnancy|0|||
126305662|NCT01314872|454407335|FG011|Period 2|Pregnancy|0|||
126305663|NCT01314872|454407336|FG012|Period 2|Pregnancy|0|||
126305664|NCT01314872|454407337|FG013|Period 2|Pregnancy|0|||
126305665|NCT01314872|454407338|FG014|Period 2|Pregnancy|1|||
126305666|NCT01314872|454407324|FG000|Period 2|Study terminated by Sponsor|0|||
126305667|NCT01314872|454407325|FG001|Period 2|Study terminated by Sponsor|0|||
126305668|NCT01314872|454407326|FG002|Period 2|Study terminated by Sponsor|0|||
126305669|NCT01314872|454407327|FG003|Period 2|Study terminated by Sponsor|0|||
126305670|NCT01314872|454407328|FG004|Period 2|Study terminated by Sponsor|0|||
126305671|NCT01314872|454407329|FG005|Period 2|Study terminated by Sponsor|0|||
126305672|NCT01314872|454407330|FG006|Period 2|Study terminated by Sponsor|0|||
126305673|NCT01314872|454407331|FG007|Period 2|Study terminated by Sponsor|0|||
126305674|NCT01314872|454407332|FG008|Period 2|Study terminated by Sponsor|0|||
126305675|NCT01314872|454407333|FG009|Period 2|Study terminated by Sponsor|0|||
126305676|NCT01314872|454407334|FG010|Period 2|Study terminated by Sponsor|0|||
126305677|NCT01314872|454407335|FG011|Period 2|Study terminated by Sponsor|2|||
126305678|NCT01314872|454407336|FG012|Period 2|Study terminated by Sponsor|2|||
126305679|NCT01314872|454407337|FG013|Period 2|Study terminated by Sponsor|3|||
126305680|NCT01314872|454407338|FG014|Period 2|Study terminated by Sponsor|0|||
126305681|NCT01314872|454407324|FG000|Period 2|Adverse event, non-fatal|0|||
126305682|NCT01314872|454407325|FG001|Period 2|Adverse event, non-fatal|0|||
126305683|NCT01314872|454407326|FG002|Period 2|Adverse event, non-fatal|0|||
126305684|NCT01314872|454407327|FG003|Period 2|Adverse event, non-fatal|0|||
126305685|NCT01314872|454407328|FG004|Period 2|Adverse event, non-fatal|0|||
126305686|NCT01314872|454407329|FG005|Period 2|Adverse event, non-fatal|0|||
126305687|NCT01314872|454407330|FG006|Period 2|Adverse event, non-fatal|0|||
126305688|NCT01314872|454407331|FG007|Period 2|Adverse event, non-fatal|0|||
126305689|NCT01314872|454407332|FG008|Period 2|Adverse event, non-fatal|0|||
126305690|NCT01314872|454407333|FG009|Period 2|Adverse event, non-fatal|0|||
126305691|NCT01314872|454407334|FG010|Period 2|Adverse event, non-fatal|0|||
126305692|NCT01314872|454407335|FG011|Period 2|Adverse event, non-fatal|13|||
126305693|NCT01314872|454407336|FG012|Period 2|Adverse event, non-fatal|16|||
126305694|NCT01314872|454407337|FG013|Period 2|Adverse event, non-fatal|24|||
126305695|NCT01314872|454407338|FG014|Period 2|Adverse event, non-fatal|9|||
126305696|NCT01314872|454407324|FG000|Period 2|Withdrawal by Subject|0|||
126305697|NCT01314872|454407325|FG001|Period 2|Withdrawal by Subject|0|||
126305698|NCT01314872|454407326|FG002|Period 2|Withdrawal by Subject|0|||
126305699|NCT01314872|454407327|FG003|Period 2|Withdrawal by Subject|0|||
126305700|NCT01314872|454407328|FG004|Period 2|Withdrawal by Subject|0|||
126305701|NCT01314872|454407329|FG005|Period 2|Withdrawal by Subject|0|||
126305702|NCT01314872|454407330|FG006|Period 2|Withdrawal by Subject|0|||
126305703|NCT01314872|454407331|FG007|Period 2|Withdrawal by Subject|0|||
126305704|NCT01314872|454407332|FG008|Period 2|Withdrawal by Subject|0|||
126305705|NCT01314872|454407333|FG009|Period 2|Withdrawal by Subject|0|||
126305706|NCT01314872|454407334|FG010|Period 2|Withdrawal by Subject|0|||
126305707|NCT01314872|454407335|FG011|Period 2|Withdrawal by Subject|14|||
126305708|NCT01314872|454407336|FG012|Period 2|Withdrawal by Subject|17|||
126305709|NCT01314872|454407337|FG013|Period 2|Withdrawal by Subject|12|||
126369120|NCT02259231|454646625|FG005|Overall Study|Sponsor termination of study|1|||
126369121|NCT02259231|454646626|FG006|Overall Study|Sponsor termination of study|1|||
126369122|NCT00847730|454646630|FG000|Overall Study|Multiple interruptions in therapy|8|||
126369123|NCT04507269|454646635|FG000|Overall Study|Withdrawal by Subject|1|||
126369124|NCT04507269|454646636|FG001|Overall Study|Withdrawal by Subject|1|||
126369125|NCT04507269|454646637|FG002|Overall Study|Withdrawal by Subject|0|||
126369126|NCT04507269|454646638|FG003|Overall Study|Withdrawal by Subject|0|||
126369127|NCT04507269|454646639|FG004|Overall Study|Withdrawal by Subject|0|||
126305710|NCT01314872|454407338|FG014|Period 2|Withdrawal by Subject|4|||
126305711|NCT01314872|454407324|FG000|Period 2|Lost to Follow-up|0|||
126305712|NCT01314872|454407325|FG001|Period 2|Lost to Follow-up|0|||
126305713|NCT01314872|454407326|FG002|Period 2|Lost to Follow-up|0|||
126305714|NCT01314872|454407327|FG003|Period 2|Lost to Follow-up|0|||
126305715|NCT01314872|454407328|FG004|Period 2|Lost to Follow-up|0|||
126305716|NCT01314872|454407329|FG005|Period 2|Lost to Follow-up|0|||
126305717|NCT01314872|454407330|FG006|Period 2|Lost to Follow-up|0|||
126305718|NCT01314872|454407331|FG007|Period 2|Lost to Follow-up|0|||
126305719|NCT01314872|454407332|FG008|Period 2|Lost to Follow-up|0|||
126305720|NCT01314872|454407333|FG009|Period 2|Lost to Follow-up|0|||
126305721|NCT01314872|454407334|FG010|Period 2|Lost to Follow-up|0|||
126305722|NCT01314872|454407335|FG011|Period 2|Lost to Follow-up|6|||
126369128|NCT04507269|454646640|FG005|Overall Study|Withdrawal by Subject|0|||
126305723|NCT01314872|454407336|FG012|Period 2|Lost to Follow-up|7|||
126305724|NCT01314872|454407337|FG013|Period 2|Lost to Follow-up|2|||
126305725|NCT01314872|454407338|FG014|Period 2|Lost to Follow-up|6|||
126305726|NCT03232931|454408764|FG000|Overall Study|Physician Decision|1|||
126305727|NCT03232931|454408765|FG001|Overall Study|Physician Decision|1|||
126305728|NCT03232931|454408764|FG000|Overall Study|Withdrawal by Subject|6|||
126305729|NCT03232931|454408765|FG001|Overall Study|Withdrawal by Subject|0|||
126305730|NCT03232931|454408764|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
126305731|NCT03232931|454408765|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
126305732|NCT03232931|454408764|FG000|Overall Study|Parent did not record voice|1|||
126305733|NCT03232931|454408765|FG001|Overall Study|Parent did not record voice|2|||
126305734|NCT03232931|454408764|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
126305735|NCT03232931|454408765|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
126305736|NCT04925557|454408766|FG000|Overall Study|Study closed|5|||
126305737|NCT04925557|454408767|FG001|Overall Study|Study closed|3|||
126305738|NCT05488470|454408768|FG000|Overall Study|Physician Decision|2|||
126305739|NCT05488470|454408768|FG000|Overall Study|Withdrawal by Subject|1|||
126305740|NCT05488470|454408768|FG000|Overall Study|Death|1|||
126305741|NCT00068393|454408773|FG000|Overall Study|Adverse Event|2|||
126305742|NCT00068393|454408773|FG000|Overall Study|Death|3|||
126305743|NCT00068393|454408773|FG000|Overall Study|Withdrawal by Subject|3|||
126305744|NCT00068393|454408773|FG000|Overall Study|Alternative treatment|1|||
126305745|NCT00068393|454408773|FG000|Overall Study|Quality of life worsening|1|||
126305746|NCT05088603|454408777|FG000|Overall Study|Protocol Violation|6|||
126305747|NCT05088603|454408778|FG001|Overall Study|Protocol Violation|1|||
126305748|NCT00594100|454408783|FG000|Procedure|Technical Failure|9|||
126305749|NCT00594100|454408783|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
126305750|NCT00594100|454408783|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
126305751|NCT00594100|454408783|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
126305752|NCT01270464|454408784|FG000|Overall Study|Protocol Violation|4|||
126305753|NCT01270464|454408785|FG001|Overall Study|Protocol Violation|3|||
126305754|NCT01270464|454408786|FG002|Overall Study|Protocol Violation|2|||
126305755|NCT01270464|454408784|FG000|Overall Study|Lack of Efficacy|2|||
126305756|NCT01270464|454408785|FG001|Overall Study|Lack of Efficacy|3|||
126305757|NCT01270464|454408786|FG002|Overall Study|Lack of Efficacy|1|||
126305758|NCT01270464|454408784|FG000|Overall Study|Adverse Event|9|||
126305759|NCT01270464|454408785|FG001|Overall Study|Adverse Event|1|||
126305760|NCT01270464|454408786|FG002|Overall Study|Adverse Event|7|||
126305761|NCT01270464|454408784|FG000|Overall Study|Withdrawal by Subject|2|||
126305762|NCT01270464|454408785|FG001|Overall Study|Withdrawal by Subject|1|||
126305763|NCT01270464|454408786|FG002|Overall Study|Withdrawal by Subject|4|||
126305764|NCT01270464|454408784|FG000|Overall Study|Lost to Follow-up|2|||
126305765|NCT01270464|454408785|FG001|Overall Study|Lost to Follow-up|3|||
126305766|NCT01270464|454408786|FG002|Overall Study|Lost to Follow-up|1|||
126305767|NCT01270464|454408784|FG000|Overall Study|Other|1|||
126305768|NCT01270464|454408785|FG001|Overall Study|Other|1|||
126305769|NCT01270464|454408786|FG002|Overall Study|Other|3|||
126305770|NCT03981900|454408787|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
126305771|NCT03981900|454408787|FG000|Overall Study|Adverse Event|5|||
126305772|NCT03981900|454408787|FG000|Overall Study|Protocol Violation|1|||
126305773|NCT03981900|454408787|FG000|Overall Study|Withdrawal by Subject|7|||
126305774|NCT03981900|454408787|FG000|Overall Study|Lost to Follow-up|46|||
126305775|NCT03981900|454408787|FG000|Overall Study|Decision of the researcher|3|||
126305776|NCT03981900|454408787|FG000|Overall Study|Death|3|||
126305777|NCT03981900|454408787|FG000|Overall Study|Other|5|||
126305778|NCT02162719|454408788|FG000|Overall Study|Death|41|||
126305779|NCT02162719|454408789|FG001|Overall Study|Death|46|||
126305780|NCT02162719|454408788|FG000|Overall Study|Lost to Follow-up|1|||
126305781|NCT02162719|454408789|FG001|Overall Study|Lost to Follow-up|3|||
126305782|NCT02162719|454408788|FG000|Overall Study|Disease Progression|2|||
126305783|NCT02162719|454408789|FG001|Overall Study|Disease Progression|1|||
126305784|NCT02162719|454408788|FG000|Overall Study|Withdrawal by Subject|8|||
126305785|NCT02162719|454408789|FG001|Overall Study|Withdrawal by Subject|2|||
126305786|NCT02162719|454408788|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
126305787|NCT02162719|454408789|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
126305788|NCT04725812|454408791|FG000|Overall Study|Withdrawal by Subject|1|||
126305789|NCT03969901|454408796|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126463660|NCT05140382|454998781|FG002|Overall Study|Progressive disease|12|||
126305790|NCT03969901|454408797|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126305791|NCT03969901|454408798|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126305792|NCT03969901|454408799|FG003|Overall Study|Withdrawal by parent/guardian|0|||
126305793|NCT03969901|454408800|FG004|Overall Study|Withdrawal by parent/guardian|1|||
126305794|NCT03969901|454408801|FG005|Overall Study|Withdrawal by parent/guardian|0|||
126305795|NCT03969901|454408802|FG006|Overall Study|Withdrawal by parent/guardian|0|||
126305796|NCT03969901|454408803|FG007|Overall Study|Withdrawal by parent/guardian|1|||
126305797|NCT03969901|454408804|FG008|Overall Study|Withdrawal by parent/guardian|1|||
126305798|NCT03969901|454408805|FG009|Overall Study|Withdrawal by parent/guardian|0|||
126305799|NCT02589626|454408809|FG000|Overall Study|Other than the reason specified|1|||
126305800|NCT02589626|454408810|FG001|Overall Study|Other than the reason specified|0|||
126305801|NCT02589626|454408809|FG000|Overall Study|Withdrawal by Subject|1|||
126305802|NCT02589626|454408810|FG001|Overall Study|Withdrawal by Subject|1|||
126305803|NCT02589626|454408809|FG000|Overall Study|Adverse Event|1|||
126305804|NCT02589626|454408810|FG001|Overall Study|Adverse Event|1|||
126305805|NCT00892151|454408811|FG000|Overall Study|Protocol Violation|1|||
126305806|NCT04075682|454408814|FG000|Overall Study|Lost to Follow-up|5|||
126305807|NCT04075682|454408815|FG001|Overall Study|Lost to Follow-up|5|||
126305808|NCT04075682|454408816|FG002|Overall Study|Lost to Follow-up|2|||
126305809|NCT04075682|454408817|FG003|Overall Study|Lost to Follow-up|2|||
126305810|NCT04075682|454408814|FG000|Overall Study|Withdrawal by Subject|1|||
126305811|NCT04075682|454408815|FG001|Overall Study|Withdrawal by Subject|0|||
126305812|NCT04075682|454408816|FG002|Overall Study|Withdrawal by Subject|1|||
126305813|NCT04075682|454408817|FG003|Overall Study|Withdrawal by Subject|0|||
126305814|NCT04075682|454408814|FG000|Overall Study|Protocol Violation|0|||
126305815|NCT04075682|454408815|FG001|Overall Study|Protocol Violation|1|||
126305816|NCT04075682|454408816|FG002|Overall Study|Protocol Violation|1|||
126305817|NCT04075682|454408817|FG003|Overall Study|Protocol Violation|0|||
126305818|NCT04075682|454408814|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
126305819|NCT04075682|454408815|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
126305820|NCT04075682|454408816|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
126305821|NCT04075682|454408817|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
126305822|NCT04075682|454408814|FG000|Overall Study|Lost study phone the first day of study participation|0|||
126305823|NCT04075682|454408815|FG001|Overall Study|Lost study phone the first day of study participation|1|||
126305824|NCT04075682|454408816|FG002|Overall Study|Lost study phone the first day of study participation|0|||
126305825|NCT04075682|454408817|FG003|Overall Study|Lost study phone the first day of study participation|0|||
126305826|NCT01931475|454408818|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
126305827|NCT01931475|454408819|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
126305828|NCT01931475|454408818|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
126305829|NCT01931475|454408819|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
126305830|NCT01931475|454408818|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
126305831|NCT01931475|454408819|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
126305832|NCT01931475|454408818|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
126305833|NCT01931475|454408819|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
126305834|NCT01931475|454408818|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
126305835|NCT01931475|454408819|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
126305836|NCT01931475|454408818|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
126305837|NCT01931475|454408819|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
126305838|NCT01931475|454408818|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
126305839|NCT01931475|454408819|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
126305840|NCT01931475|454408818|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
126305841|NCT01931475|454408819|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
126305842|NCT01931475|454408818|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
126305843|NCT01931475|454408819|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
126305844|NCT01931475|454408818|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
126305845|NCT01931475|454408819|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
126305846|NCT01931475|454408818|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
126551791|NCT01807221|455315868|FG005|Overall Study|Death|6|||
126305847|NCT01931475|454408819|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
126305848|NCT02920008|454408823|FG000|Overall Study|Death|117|||
126305849|NCT02920008|454408824|FG001|Overall Study|Death|127|||
126305850|NCT02920008|454408823|FG000|Overall Study|Withdrawal by Subject|3|||
126305851|NCT02920008|454408824|FG001|Overall Study|Withdrawal by Subject|6|||
126305852|NCT02920008|454408823|FG000|Overall Study|Lost to Follow-up|0|||
126305853|NCT02920008|454408824|FG001|Overall Study|Lost to Follow-up|1|||
126305854|NCT02737930|454408825|FG000|Overall Study|Withdrawal by Subject|0|||
126305855|NCT02737930|454408826|FG001|Overall Study|Withdrawal by Subject|1|||
126305856|NCT01127451|454408834|FG000|Overall Study|Other|2|||
126305857|NCT01127451|454408835|FG001|Overall Study|Other|1|||
126551792|NCT01807221|455315863|FG000|Overall Study|Physician Decision|2|||
126305858|NCT01127451|454408834|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
126305859|NCT01127451|454408835|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
126305860|NCT01127451|454408834|FG000|Overall Study|Death|22|||
126305861|NCT01127451|454408835|FG001|Overall Study|Death|17|||
126305862|NCT01127451|454408834|FG000|Overall Study|Lost to Follow-up|3|||
126305863|NCT01127451|454408835|FG001|Overall Study|Lost to Follow-up|0|||
126305864|NCT01127451|454408834|FG000|Overall Study|Administrative Reason by Sponsor|2|||
126551793|NCT01807221|455315864|FG001|Overall Study|Physician Decision|1|||
126714836|NCT04760314|455908598|FG000|Induction Period|Withdrawal by Subject|0|||
126714837|NCT04760314|455908599|FG001|Induction Period|Withdrawal by Subject|1|||
126714838|NCT04760314|455908600|FG002|Induction Period|Withdrawal by Subject|1|||
126714839|NCT04760314|455908601|FG003|Induction Period|Withdrawal by Subject|0|||
126714840|NCT04760314|455908602|FG004|Induction Period|Withdrawal by Subject|0|||
126714841|NCT04760314|455908603|FG005|Induction Period|Withdrawal by Subject|0|||
126714842|NCT04760314|455908604|FG006|Induction Period|Withdrawal by Subject|0|||
126714843|NCT04760314|455908605|FG007|Induction Period|Withdrawal by Subject|0|||
126714844|NCT04760314|455908606|FG008|Induction Period|Withdrawal by Subject|0|||
126714845|NCT04760314|455908607|FG009|Induction Period|Withdrawal by Subject|0|||
126714846|NCT04760314|455908608|FG010|Induction Period|Withdrawal by Subject|0|||
126714847|NCT04760314|455908598|FG000|Induction Period|Adverse Event|0|||
126714848|NCT04760314|455908599|FG001|Induction Period|Adverse Event|0|||
126714849|NCT04760314|455908600|FG002|Induction Period|Adverse Event|2|||
126714850|NCT04760314|455908601|FG003|Induction Period|Adverse Event|0|||
126714851|NCT04760314|455908602|FG004|Induction Period|Adverse Event|0|||
126714852|NCT04760314|455908603|FG005|Induction Period|Adverse Event|0|||
126714853|NCT04760314|455908604|FG006|Induction Period|Adverse Event|0|||
126714854|NCT04760314|455908605|FG007|Induction Period|Adverse Event|0|||
126305865|NCT01127451|454408835|FG001|Overall Study|Administrative Reason by Sponsor|2|||
126305866|NCT00930774|454408836|FG000|Overall Study|Withdrawal by Subject|1|||
126305867|NCT00930774|454408837|FG001|Overall Study|Withdrawal by Subject|9|||
126305868|NCT00930774|454408838|FG002|Overall Study|Withdrawal by Subject|2|||
126305869|NCT00930774|454408839|FG003|Overall Study|Withdrawal by Subject|0|||
126305870|NCT03200704|454408840|FG000|Overall Study|Withdrawal by Subject|1|||
126305871|NCT02217410|454408841|FG000|Overall Study|Graft Loss|0|||
126305872|NCT02217410|454408842|FG001|Overall Study|Graft Loss|0|||
126305873|NCT02217410|454408843|FG002|Overall Study|Graft Loss|2|||
126714855|NCT04760314|455908606|FG008|Induction Period|Adverse Event|0|||
126714856|NCT04760314|455908607|FG009|Induction Period|Adverse Event|0|||
126714857|NCT04760314|455908608|FG010|Induction Period|Adverse Event|0|||
126714858|NCT04760314|455908598|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
126714859|NCT04760314|455908599|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
126714860|NCT04760314|455908600|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
126714861|NCT04760314|455908601|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
126714862|NCT04760314|455908602|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
126714863|NCT04760314|455908603|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
126714864|NCT04760314|455908604|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
126714865|NCT04760314|455908605|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
126714866|NCT04760314|455908606|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
126714867|NCT04760314|455908607|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
126714868|NCT04760314|455908608|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
126714869|NCT04760314|455908598|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126714870|NCT04760314|455908599|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126714871|NCT04760314|455908600|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126714872|NCT04760314|455908601|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
126714873|NCT04760314|455908602|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126714874|NCT04760314|455908603|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
126714875|NCT04760314|455908604|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
126714876|NCT04760314|455908605|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126714877|NCT04760314|455908606|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126714878|NCT04760314|455908607|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126714879|NCT04760314|455908608|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
126714880|NCT04760314|455908598|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126714881|NCT04760314|455908599|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126714882|NCT04760314|455908600|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126714883|NCT04760314|455908601|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126305874|NCT02217410|454408841|FG000|Overall Study|Withdrawal by Subject|0|||
126305875|NCT02217410|454408842|FG001|Overall Study|Withdrawal by Subject|0|||
126305876|NCT02217410|454408843|FG002|Overall Study|Withdrawal by Subject|2|||
126714884|NCT04760314|455908602|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
126305877|NCT02217410|454408841|FG000|Overall Study|Lost to Follow-up|0|||
126714885|NCT04760314|455908603|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126551794|NCT01807221|455315865|FG002|Overall Study|Physician Decision|0|||
126551795|NCT01807221|455315866|FG003|Overall Study|Physician Decision|0|||
126551796|NCT01807221|455315867|FG004|Overall Study|Physician Decision|0|||
126714886|NCT04760314|455908604|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126714887|NCT04760314|455908605|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126714888|NCT04760314|455908606|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126305878|NCT02217410|454408842|FG001|Overall Study|Lost to Follow-up|0|||
126551797|NCT01807221|455315868|FG005|Overall Study|Physician Decision|0|||
126714889|NCT04760314|455908607|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126714890|NCT04760314|455908608|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
126715195|NCT01052012|455908710|FG004|Overall Study|Physician Decision|0|||
126551798|NCT01807221|455315863|FG000|Overall Study|Adverse Event|33|||
126551799|NCT01807221|455315864|FG001|Overall Study|Adverse Event|22|||
126305879|NCT02217410|454408843|FG002|Overall Study|Lost to Follow-up|1|||
126305880|NCT02217410|454408841|FG000|Overall Study|Lack of Efficacy|0|||
126305881|NCT02217410|454408842|FG001|Overall Study|Lack of Efficacy|1|||
126305882|NCT02217410|454408843|FG002|Overall Study|Lack of Efficacy|0|||
126305883|NCT02217410|454408841|FG000|Overall Study|Physician Decision|1|||
126305884|NCT02217410|454408842|FG001|Overall Study|Physician Decision|3|||
126305885|NCT02217410|454408843|FG002|Overall Study|Physician Decision|0|||
126305886|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
126305887|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
126305888|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
126305889|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
126305890|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
126305891|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
126305892|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
126305893|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
126305894|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
126305895|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
126305896|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
126305897|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
126305898|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
126305899|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
126305900|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
126305901|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
126305902|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
126305903|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
126305904|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
126305905|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
126305906|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
126305907|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
126305908|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
126305909|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
126305910|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
126305911|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
126305912|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
126305913|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
126305914|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
126305915|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
126305916|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
126305917|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
126305918|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
126305919|NCT00839527|454408845|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
126305920|NCT00839527|454408846|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
126305921|NCT00839527|454408847|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
126305922|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
126305923|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
126305924|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
126305925|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
126305926|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
126305927|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
126305928|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
126305929|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
126369129|NCT04507269|454646635|FG000|Overall Study|Lost to Follow-up|0|||
126369130|NCT04507269|454646636|FG001|Overall Study|Lost to Follow-up|0|||
126369131|NCT04507269|454646637|FG002|Overall Study|Lost to Follow-up|0|||
126369132|NCT04507269|454646638|FG003|Overall Study|Lost to Follow-up|0|||
126369133|NCT04507269|454646639|FG004|Overall Study|Lost to Follow-up|1|||
126369134|NCT04507269|454646640|FG005|Overall Study|Lost to Follow-up|0|||
126369135|NCT00071032|454646644|FG000|Overall Study|Lost to Follow-up|1|||
126369136|NCT00071032|454646645|FG001|Overall Study|Lost to Follow-up|1|||
126369137|NCT00071032|454646644|FG000|Overall Study|Withdrawal by Subject|8|||
126369138|NCT00071032|454646645|FG001|Overall Study|Withdrawal by Subject|6|||
126369139|NCT00071032|454646644|FG000|Overall Study|Missing Primary Outcome|0|||
126369140|NCT00071032|454646645|FG001|Overall Study|Missing Primary Outcome|1|||
126369141|NCT06071104|454646646|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
126369142|NCT03518060|454646647|FG000|Overall Study|Death|1|||
126369143|NCT03518060|454646647|FG000|Overall Study|Poor adherence|1|||
126369144|NCT03518060|454646647|FG000|Overall Study|Withdrawal of informed consent|2|||
126369145|NCT03518060|454646647|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
126463661|NCT05140382|454998779|FG000|Overall Study|Subjective disease progression|2|||
126463662|NCT05140382|454998780|FG001|Overall Study|Subjective disease progression|1|||
126463663|NCT05140382|454998781|FG002|Overall Study|Subjective disease progression|0|||
126463664|NCT05140382|454998779|FG000|Overall Study|Unknown at data cut-off|0|||
126463665|NCT05140382|454998780|FG001|Overall Study|Unknown at data cut-off|0|||
126463666|NCT05140382|454998781|FG002|Overall Study|Unknown at data cut-off|1|||
126463667|NCT05140382|454998779|FG000|Overall Study|Withdrawal by Subject|1|||
126463668|NCT05140382|454998780|FG001|Overall Study|Withdrawal by Subject|0|||
126463669|NCT05140382|454998781|FG002|Overall Study|Withdrawal by Subject|4|||
126463670|NCT05140382|454998779|FG000|Overall Study|Withdrawal of consent|0|||
126305930|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
126305931|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
126305932|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
126305933|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
126305934|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
126305935|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
126305936|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
126305937|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
126305938|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
126305939|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
126305940|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
126305941|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
126305942|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
126305943|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
126305944|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
126305945|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
126305946|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
126305947|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
126305948|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
126305949|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
126305950|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
126305951|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
126305952|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
126305953|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
126305954|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
126305955|NCT00839527|454408845|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
126305956|NCT00839527|454408846|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
126305957|NCT00839527|454408847|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
126305958|NCT01704651|454408848|FG000|Overall Study|Pre-op withdrawal by subject|1|||
126305959|NCT01704651|454408849|FG001|Overall Study|Pre-op withdrawal by subject|1|||
126305960|NCT01704651|454408848|FG000|Overall Study|Pre-op change in treatment plan|1|||
126305961|NCT01704651|454408849|FG001|Overall Study|Pre-op change in treatment plan|4|||
126305962|NCT01704651|454408848|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
126305963|NCT01704651|454408849|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
126305964|NCT01704651|454408848|FG000|Overall Study|Post-op did not have laparotomy|2|||
126305965|NCT01704651|454408849|FG001|Overall Study|Post-op did not have laparotomy|1|||
126305966|NCT00634803|454408851|FG000|Overall Study|Lost to Follow-up|6|||
126305967|NCT00634803|454408852|FG001|Overall Study|Lost to Follow-up|7|||
126305968|NCT00634803|454408853|FG002|Overall Study|Lost to Follow-up|7|||
126305969|NCT00364923|454408855|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
126305970|NCT00364923|454408855|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
126305971|NCT03474731|454408857|FG000|Overall Study|Withdrawal by Subject|36|||
126305972|NCT03474731|454408858|FG001|Overall Study|Withdrawal by Subject|29|||
126305973|NCT03474731|454408859|FG002|Overall Study|Withdrawal by Subject|11|||
126305974|NCT03474731|454408860|FG003|Overall Study|Withdrawal by Subject|27|||
126305975|NCT03474731|454408857|FG000|Overall Study|COVID|0|||
126305976|NCT03474731|454408858|FG001|Overall Study|COVID|23|||
126305977|NCT03474731|454408859|FG002|Overall Study|COVID|0|||
126305978|NCT03474731|454408860|FG003|Overall Study|COVID|0|||
126305979|NCT03474731|454408857|FG000|Overall Study|Participant moved from area|1|||
126305980|NCT03474731|454408858|FG001|Overall Study|Participant moved from area|0|||
126305981|NCT03474731|454408859|FG002|Overall Study|Participant moved from area|0|||
126305982|NCT03474731|454408860|FG003|Overall Study|Participant moved from area|0|||
126305983|NCT03474731|454408857|FG000|Overall Study|Lost to Follow-up|11|||
126305984|NCT03474731|454408858|FG001|Overall Study|Lost to Follow-up|3|||
126305985|NCT03474731|454408859|FG002|Overall Study|Lost to Follow-up|18|||
126305986|NCT03474731|454408860|FG003|Overall Study|Lost to Follow-up|17|||
126305987|NCT03474731|454408857|FG000|Overall Study|Death|0|||
126305988|NCT03474731|454408858|FG001|Overall Study|Death|1|||
126369146|NCT03518060|454646647|FG000|Overall Study|Physician Decision|7|||
126369147|NCT03518060|454646647|FG000|Overall Study|Adverse drug reactions|23|||
126369148|NCT03518060|454646647|FG000|Overall Study|Withdrawal by Subject|25|||
126369149|NCT03518060|454646647|FG000|Overall Study|Lost to Follow-up|13|||
126369150|NCT01969058|454646649|FG000|Overall Study|Withdrawal by Subject|2|||
126369151|NCT01969058|454646650|FG001|Overall Study|Withdrawal by Subject|0|||
126369152|NCT01969058|454646649|FG000|Overall Study|Adverse Event|1|||
126369153|NCT01969058|454646650|FG001|Overall Study|Adverse Event|0|||
126369154|NCT04976855|454646651|FG000|Part I|Withdrawal by Subject|0|||
126369155|NCT04976855|454646652|FG001|Part I|Withdrawal by Subject|1|||
126369156|NCT04976855|454646653|FG002|Part I|Withdrawal by Subject|0|||
126369157|NCT04976855|454646654|FG003|Part I|Withdrawal by Subject|0|||
126369158|NCT04976855|454646655|FG004|Part I|Withdrawal by Subject|0|||
126369159|NCT04976855|454646656|FG005|Part I|Withdrawal by Subject|0|||
126369160|NCT04976855|454646657|FG006|Part I|Withdrawal by Subject|0|||
126369161|NCT04976855|454646651|FG000|Part II|Adverse Event|0|||
126369162|NCT04976855|454646652|FG001|Part II|Adverse Event|0|||
126369163|NCT04976855|454646653|FG002|Part II|Adverse Event|0|||
126369164|NCT04976855|454646654|FG003|Part II|Adverse Event|1|||
126369165|NCT04976855|454646655|FG004|Part II|Adverse Event|0|||
126369166|NCT04976855|454646656|FG005|Part II|Adverse Event|0|||
126369167|NCT04976855|454646657|FG006|Part II|Adverse Event|0|||
126369168|NCT04976855|454646651|FG000|Part II|Withdrawal by Subject|0|||
126369169|NCT04976855|454646652|FG001|Part II|Withdrawal by Subject|0|||
126369170|NCT04976855|454646653|FG002|Part II|Withdrawal by Subject|0|||
126369171|NCT04976855|454646654|FG003|Part II|Withdrawal by Subject|0|||
126369172|NCT04976855|454646655|FG004|Part II|Withdrawal by Subject|1|||
126369173|NCT04976855|454646656|FG005|Part II|Withdrawal by Subject|0|||
126369174|NCT04976855|454646657|FG006|Part II|Withdrawal by Subject|0|||
126369175|NCT04976855|454646651|FG000|Part II|Lost to Follow-up|0|||
126369176|NCT04976855|454646652|FG001|Part II|Lost to Follow-up|0|||
126369177|NCT04976855|454646653|FG002|Part II|Lost to Follow-up|0|||
126369178|NCT04976855|454646654|FG003|Part II|Lost to Follow-up|0|||
126369179|NCT04976855|454646655|FG004|Part II|Lost to Follow-up|0|||
126369180|NCT04976855|454646656|FG005|Part II|Lost to Follow-up|1|||
126369181|NCT04976855|454646657|FG006|Part II|Lost to Follow-up|0|||
126369182|NCT02757768|454646672|FG000|Overall Study|Randomized Never Received Study Drug|3|||
126369183|NCT02757768|454646673|FG001|Overall Study|Randomized Never Received Study Drug|4|||
126369184|NCT02757768|454646672|FG000|Overall Study|Adverse Event|5|||
126369185|NCT02757768|454646673|FG001|Overall Study|Adverse Event|3|||
126369186|NCT02757768|454646672|FG000|Overall Study|Lack of Efficacy|2|||
126369187|NCT02757768|454646673|FG001|Overall Study|Lack of Efficacy|1|||
126369188|NCT02757768|454646672|FG000|Overall Study|Lost to Follow-up|1|||
126369189|NCT02757768|454646673|FG001|Overall Study|Lost to Follow-up|0|||
126369190|NCT02757768|454646672|FG000|Overall Study|Protocol Deviation|2|||
126369191|NCT02757768|454646673|FG001|Overall Study|Protocol Deviation|9|||
126369192|NCT02757768|454646672|FG000|Overall Study|Withdrawal by Subject|16|||
126369193|NCT02757768|454646673|FG001|Overall Study|Withdrawal by Subject|9|||
126369194|NCT02757768|454646672|FG000|Overall Study|Miscellaneous|4|||
126369195|NCT02757768|454646673|FG001|Overall Study|Miscellaneous|2|||
126369196|NCT00618787|454646687|FG000|Overall Study|Adverse Event|0|||
126369197|NCT00618787|454646688|FG001|Overall Study|Adverse Event|1|||
126369198|NCT00618787|454646687|FG000|Overall Study|Withdrawal by Subject|2|||
126369199|NCT00618787|454646688|FG001|Overall Study|Withdrawal by Subject|1|||
126369200|NCT00618787|454646687|FG000|Overall Study|Lost to Follow-up|1|||
126369201|NCT00618787|454646688|FG001|Overall Study|Lost to Follow-up|0|||
126369202|NCT01107886|454646689|FG000|Overall Study|Lost to Follow-up|15|||
126369203|NCT01107886|454646690|FG001|Overall Study|Lost to Follow-up|13|||
126369204|NCT01107886|454646689|FG000|Overall Study|Withdrawal by Subject|180|||
126369205|NCT01107886|454646690|FG001|Overall Study|Withdrawal by Subject|196|||
126369206|NCT01107886|454646689|FG000|Overall Study|Administrative withdrawal of consent|7|||
126369207|NCT01107886|454646690|FG001|Overall Study|Administrative withdrawal of consent|5|||
126369208|NCT01649869|454646695|FG000|Overall Study|Family member illness|1|||
126369209|NCT01649869|454646696|FG001|Overall Study|Family member illness|0|||
126369210|NCT01649869|454646695|FG000|Overall Study|Required treatment outside protocol|1|||
126369211|NCT01649869|454646696|FG001|Overall Study|Required treatment outside protocol|0|||
126369212|NCT01649869|454646695|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
126369213|NCT01649869|454646696|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
126369214|NCT03440385|454648144|FG000|Overall Study|Other Reason|4|||
126369215|NCT03440385|454648145|FG001|Overall Study|Other Reason|1|||
126369216|NCT03440385|454648144|FG000|Overall Study|Site Closed|1|||
126369217|NCT03440385|454648145|FG001|Overall Study|Site Closed|0|||
126369218|NCT03440385|454648144|FG000|Overall Study|Lost to Follow-up|2|||
126369219|NCT03440385|454648145|FG001|Overall Study|Lost to Follow-up|0|||
126369220|NCT03440385|454648144|FG000|Overall Study|Withdrawal by Subject|12|||
126369221|NCT03440385|454648145|FG001|Overall Study|Withdrawal by Subject|6|||
126369222|NCT03440385|454648144|FG000|Overall Study|Lack of Efficacy|9|||
126369223|NCT03440385|454648145|FG001|Overall Study|Lack of Efficacy|2|||
126369224|NCT03440385|454648144|FG000|Overall Study|Adverse Event|15|||
126714891|NCT04760314|455908598|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
126714892|NCT04760314|455908599|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
126714893|NCT04760314|455908600|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
126714894|NCT04760314|455908601|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
126714895|NCT04760314|455908602|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
126714896|NCT04760314|455908603|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
126305989|NCT03474731|454408859|FG002|Overall Study|Death|0|||
126305990|NCT03474731|454408860|FG003|Overall Study|Death|0|||
126305991|NCT03474731|454408857|FG000|Overall Study|Participant Removed|0|||
126305992|NCT03474731|454408858|FG001|Overall Study|Participant Removed|0|||
126305993|NCT03474731|454408859|FG002|Overall Study|Participant Removed|0|||
126305994|NCT03474731|454408860|FG003|Overall Study|Participant Removed|1|||
126305995|NCT00478777|454408866|FG000|Overall Study|Adverse Event|29|||
126305996|NCT00478777|454408866|FG000|Overall Study|Lack of Efficacy|23|||
126305997|NCT00478777|454408866|FG000|Overall Study|Withdrawal by Subject|4|||
126305998|NCT00478777|454408866|FG000|Overall Study|Death|3|||
126305999|NCT00478777|454408866|FG000|Overall Study|Protocol Violation|3|||
126306000|NCT00478777|454408866|FG000|Overall Study|Lost to Follow-up|3|||
126306001|NCT00478777|454408866|FG000|Overall Study|Physician Decision|1|||
126306002|NCT00478777|454408866|FG000|Overall Study|Intolerance of therapy|1|||
126306003|NCT00478777|454408866|FG000|Overall Study|Lack of compliance|1|||
126306004|NCT00478777|454408866|FG000|Overall Study|Lymphocytes infusion|1|||
126306005|NCT00478777|454408866|FG000|Overall Study|End of therapy|2|||
126306006|NCT00478777|454408866|FG000|Overall Study|Not treated with lenalidomide|6|||
126306007|NCT01218087|454408867|FG000|Overall Study|Death|2|||
126306008|NCT01218087|454408868|FG001|Overall Study|Death|1|||
126306009|NCT01218087|454408867|FG000|Overall Study|Withdrawal by Subject|5|||
126306010|NCT01218087|454408868|FG001|Overall Study|Withdrawal by Subject|0|||
126306011|NCT01218087|454408867|FG000|Overall Study|Transferred|8|||
126306012|NCT01218087|454408868|FG001|Overall Study|Transferred|5|||
126306013|NCT02553499|454408869|FG000|Overall Study|Adverse Event|0|||
126306014|NCT02553499|454408870|FG001|Overall Study|Adverse Event|0|||
126306015|NCT02553499|454408871|FG002|Overall Study|Adverse Event|0|||
126306016|NCT02553499|454408872|FG003|Overall Study|Adverse Event|0|||
126306017|NCT02553499|454408873|FG004|Overall Study|Adverse Event|0|||
126306018|NCT02553499|454408874|FG005|Overall Study|Adverse Event|0|||
126306019|NCT02553499|454408875|FG006|Overall Study|Adverse Event|1|||
126306020|NCT02553499|454408876|FG007|Overall Study|Adverse Event|1|||
126369225|NCT03440385|454648145|FG001|Overall Study|Adverse Event|11|||
126369226|NCT03552029|454648146|FG000|Overall Study|Death|3|||
126369227|NCT03552029|454648147|FG001|Overall Study|Death|0|||
126714897|NCT04760314|455908604|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
126714898|NCT04760314|455908605|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
126714899|NCT04760314|455908606|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
126714900|NCT04760314|455908607|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
126714901|NCT04760314|455908608|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
126714902|NCT04760314|455908598|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126714903|NCT04760314|455908599|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126714904|NCT04760314|455908600|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126714905|NCT04760314|455908601|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126714906|NCT04760314|455908602|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126714907|NCT04760314|455908603|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126714908|NCT04760314|455908604|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126714909|NCT04760314|455908605|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
126714910|NCT04760314|455908606|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
126714911|NCT04760314|455908607|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
126714912|NCT04760314|455908608|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
126714913|NCT04760314|455908598|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126369228|NCT03552029|454648146|FG000|Overall Study|Adverse Event|1|||
126369229|NCT03552029|454648147|FG001|Overall Study|Adverse Event|0|||
126369230|NCT03552029|454648146|FG000|Overall Study|Lack of Efficacy|0|||
126551800|NCT01807221|455315865|FG002|Overall Study|Adverse Event|26|||
126714914|NCT04760314|455908599|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126714915|NCT04760314|455908600|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126714916|NCT04760314|455908601|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126306021|NCT02553499|454408877|FG008|Overall Study|Adverse Event|0|||
126306022|NCT02553499|454408878|FG009|Overall Study|Adverse Event|0|||
126306023|NCT02553499|454408879|FG010|Overall Study|Adverse Event|0|||
126306024|NCT02553499|454408880|FG011|Overall Study|Adverse Event|0|||
126306025|NCT02553499|454408881|FG012|Overall Study|Adverse Event|0|||
126306026|NCT02553499|454408882|FG013|Overall Study|Adverse Event|1|||
126306027|NCT02553499|454408869|FG000|Overall Study|Death|0|||
126306028|NCT02553499|454408870|FG001|Overall Study|Death|1|||
126369231|NCT03552029|454648147|FG001|Overall Study|Lack of Efficacy|2|||
126369232|NCT03552029|454648146|FG000|Overall Study|Physician Decision|0|||
126369233|NCT03552029|454648147|FG001|Overall Study|Physician Decision|1|||
126463671|NCT05140382|454998780|FG001|Overall Study|Withdrawal of consent|0|||
126463672|NCT05140382|454998781|FG002|Overall Study|Withdrawal of consent|1|||
126463673|NCT00543855|455000220|FG000|Overall Study|Adverse Event|3|||
126463674|NCT00543855|455000221|FG001|Overall Study|Adverse Event|1|||
126463675|NCT00543855|455000222|FG002|Overall Study|Adverse Event|3|||
126463676|NCT00543855|455000223|FG003|Overall Study|Adverse Event|4|||
126463677|NCT00543855|455000220|FG000|Overall Study|Lost to Follow-up|0|||
126463678|NCT00543855|455000221|FG001|Overall Study|Lost to Follow-up|0|||
126463679|NCT00543855|455000222|FG002|Overall Study|Lost to Follow-up|1|||
126463680|NCT00543855|455000223|FG003|Overall Study|Lost to Follow-up|0|||
126463681|NCT00543855|455000220|FG000|Overall Study|Withdrawal by Subject|0|||
126463682|NCT00543855|455000221|FG001|Overall Study|Withdrawal by Subject|1|||
126463683|NCT00543855|455000222|FG002|Overall Study|Withdrawal by Subject|2|||
126463684|NCT00543855|455000223|FG003|Overall Study|Withdrawal by Subject|0|||
126463685|NCT00543855|455000220|FG000|Overall Study|Protocol Violation|1|||
126463686|NCT00543855|455000221|FG001|Overall Study|Protocol Violation|0|||
126463687|NCT00543855|455000222|FG002|Overall Study|Protocol Violation|0|||
126463688|NCT00543855|455000223|FG003|Overall Study|Protocol Violation|0|||
126463689|NCT03954041|455000225|FG000|Overall Study|Lost to Follow-up|3|||
126463690|NCT03954041|455000226|FG001|Overall Study|Lost to Follow-up|3|||
126463691|NCT03954041|455000227|FG002|Overall Study|Lost to Follow-up|6|||
126463692|NCT03954041|455000225|FG000|Overall Study|Death|4|||
126463693|NCT03954041|455000226|FG001|Overall Study|Death|0|||
126463694|NCT03954041|455000227|FG002|Overall Study|Death|1|||
126463695|NCT03954041|455000225|FG000|Overall Study|Death by neurologic criteria|0|||
126463696|NCT03954041|455000226|FG001|Overall Study|Death by neurologic criteria|0|||
126463697|NCT03954041|455000227|FG002|Overall Study|Death by neurologic criteria|1|||
126463698|NCT03954041|455000225|FG000|Overall Study|Reason not specified|7|||
126463699|NCT03954041|455000226|FG001|Overall Study|Reason not specified|4|||
126463700|NCT03954041|455000227|FG002|Overall Study|Reason not specified|2|||
126463701|NCT03954041|455000225|FG000|Overall Study|Withdrew prior to dosing|4|||
126463702|NCT03954041|455000226|FG001|Overall Study|Withdrew prior to dosing|2|||
126463703|NCT03954041|455000227|FG002|Overall Study|Withdrew prior to dosing|0|||
126463704|NCT00427960|455000229|FG000|Overall Study|Adverse Event|2|||
126463705|NCT00427960|455000230|FG001|Overall Study|Adverse Event|0|||
126463706|NCT00427960|455000229|FG000|Overall Study|Withdrawal by Subject|0|||
126463707|NCT00427960|455000230|FG001|Overall Study|Withdrawal by Subject|3|||
126463708|NCT00427960|455000229|FG000|Overall Study|Other|0|||
126463709|NCT00427960|455000230|FG001|Overall Study|Other|1|||
126463710|NCT00423670|455000231|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
126714917|NCT04760314|455908602|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126714918|NCT04760314|455908603|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126714919|NCT04760314|455908604|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126714920|NCT04760314|455908605|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
126714921|NCT04760314|455908606|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
126714922|NCT04760314|455908607|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
126714923|NCT04760314|455908608|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
126714924|NCT04760314|455908598|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126714925|NCT04760314|455908599|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126714926|NCT04760314|455908600|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126306029|NCT02553499|454408871|FG002|Overall Study|Death|1|||
126306030|NCT02553499|454408872|FG003|Overall Study|Death|0|||
126306031|NCT02553499|454408873|FG004|Overall Study|Death|1|||
126306032|NCT02553499|454408874|FG005|Overall Study|Death|2|||
126306033|NCT02553499|454408875|FG006|Overall Study|Death|0|||
126306034|NCT02553499|454408876|FG007|Overall Study|Death|0|||
126306035|NCT02553499|454408877|FG008|Overall Study|Death|0|||
126306036|NCT02553499|454408878|FG009|Overall Study|Death|0|||
126306037|NCT02553499|454408879|FG010|Overall Study|Death|1|||
126306038|NCT02553499|454408880|FG011|Overall Study|Death|0|||
126306039|NCT02553499|454408881|FG012|Overall Study|Death|0|||
126306040|NCT02553499|454408882|FG013|Overall Study|Death|0|||
126306041|NCT02553499|454408869|FG000|Overall Study|Lost to Follow-up|0|||
126463711|NCT00423670|455000232|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
126463712|NCT00423670|455000233|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
126463713|NCT00423670|455000234|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
126463714|NCT00423670|455000235|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
126463715|NCT00423670|455000236|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
126463716|NCT00423670|455000237|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
126463717|NCT00423670|455000238|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
126463718|NCT00423670|455000231|FG000|Treatment Period|Adverse Event|8|||
126463719|NCT00423670|455000232|FG001|Treatment Period|Adverse Event|12|||
126463720|NCT00423670|455000233|FG002|Treatment Period|Adverse Event|15|||
126463721|NCT00423670|455000234|FG003|Treatment Period|Adverse Event|20|||
126306042|NCT02553499|454408870|FG001|Overall Study|Lost to Follow-up|0|||
126306043|NCT02553499|454408871|FG002|Overall Study|Lost to Follow-up|0|||
126306044|NCT02553499|454408872|FG003|Overall Study|Lost to Follow-up|0|||
126369234|NCT03552029|454648146|FG000|Overall Study|Study terminated by Sponsor|0|||
126369235|NCT03552029|454648147|FG001|Overall Study|Study terminated by Sponsor|1|||
126369236|NCT03552029|454648146|FG000|Overall Study|Other|0|||
126369237|NCT03552029|454648147|FG001|Overall Study|Other|2|||
126369238|NCT03468998|454648153|FG000|Overall Study|Withdrawal by Subject|1|||
126369239|NCT03468998|454648154|FG001|Overall Study|Withdrawal by Subject|1|||
126369240|NCT03468998|454648155|FG002|Overall Study|Withdrawal by Subject|0|||
126369241|NCT03468998|454648156|FG003|Overall Study|Withdrawal by Subject|4|||
126369242|NCT03468998|454648157|FG004|Overall Study|Withdrawal by Subject|1|||
126369243|NCT03468998|454648158|FG005|Overall Study|Withdrawal by Subject|0|||
126369244|NCT00633126|454648163|FG000|Overall Study|Did not receive full dose|1|||
126369245|NCT02297516|454648168|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
126369246|NCT02297516|454648169|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
126369247|NCT02297516|454648168|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
126369248|NCT02297516|454648169|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
126369249|NCT02297516|454648168|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
126369250|NCT02297516|454648169|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
126369251|NCT02332928|454648171|FG000|Overall Study|Withdrawal by Subject|0|||
126369252|NCT02332928|454648172|FG001|Overall Study|Withdrawal by Subject|2|||
126369253|NCT02332928|454648171|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
126369254|NCT02332928|454648172|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
126369255|NCT01425814|454648173|FG000|Period 1|Stability criteria not fulfilled|0|||
126369256|NCT01425814|454648174|FG001|Period 1|Stability criteria not fulfilled|1|||
126369257|NCT01425814|454648175|FG002|Period 1|Stability criteria not fulfilled|0|||
126369258|NCT01425814|454648176|FG003|Period 1|Stability criteria not fulfilled|0|||
126369259|NCT01425814|454648177|FG004|Period 1|Stability criteria not fulfilled|0|||
126369260|NCT01425814|454648178|FG005|Period 1|Stability criteria not fulfilled|0|||
126369261|NCT01425814|454648173|FG000|Period 2|Stability criteria not fulfilled|0|||
126369262|NCT01425814|454648174|FG001|Period 2|Stability criteria not fulfilled|1|||
126369263|NCT01425814|454648175|FG002|Period 2|Stability criteria not fulfilled|0|||
126369264|NCT01425814|454648176|FG003|Period 2|Stability criteria not fulfilled|0|||
126369265|NCT01425814|454648177|FG004|Period 2|Stability criteria not fulfilled|0|||
126369266|NCT01425814|454648178|FG005|Period 2|Stability criteria not fulfilled|0|||
126369267|NCT01425814|454648173|FG000|Period 3|Adverse Event|0|||
126369268|NCT01425814|454648174|FG001|Period 3|Adverse Event|0|||
126369269|NCT01425814|454648175|FG002|Period 3|Adverse Event|0|||
126369270|NCT01425814|454648176|FG003|Period 3|Adverse Event|0|||
126369271|NCT01425814|454648177|FG004|Period 3|Adverse Event|0|||
126369272|NCT01425814|454648178|FG005|Period 3|Adverse Event|1|||
126369273|NCT01425814|454648173|FG000|Period 4|Adverse Event|1|||
126369274|NCT01425814|454648174|FG001|Period 4|Adverse Event|0|||
126369275|NCT01425814|454648175|FG002|Period 4|Adverse Event|1|||
126369276|NCT01425814|454648176|FG003|Period 4|Adverse Event|0|||
126369277|NCT01425814|454648177|FG004|Period 4|Adverse Event|0|||
126369278|NCT01425814|454648178|FG005|Period 4|Adverse Event|0|||
126369279|NCT01425814|454648173|FG000|Period 5|Stability criteria not fulfilled|0|||
126369280|NCT01425814|454648174|FG001|Period 5|Stability criteria not fulfilled|0|||
126369281|NCT01425814|454648175|FG002|Period 5|Stability criteria not fulfilled|1|||
126369282|NCT01425814|454648176|FG003|Period 5|Stability criteria not fulfilled|0|||
126369283|NCT01425814|454648177|FG004|Period 5|Stability criteria not fulfilled|0|||
126369284|NCT01425814|454648178|FG005|Period 5|Stability criteria not fulfilled|1|||
126369285|NCT00573768|454648183|FG000|Overall Study|Adverse Event|1|||
126369286|NCT00573768|454648184|FG001|Overall Study|Adverse Event|1|||
126369287|NCT00573768|454648185|FG002|Overall Study|Adverse Event|2|||
126369288|NCT00573768|454648183|FG000|Overall Study|Protocol Violation|1|||
126369289|NCT00573768|454648184|FG001|Overall Study|Protocol Violation|0|||
126369290|NCT00573768|454648185|FG002|Overall Study|Protocol Violation|1|||
126369291|NCT00573768|454648183|FG000|Overall Study|Withdrawal by Subject|0|||
126463722|NCT00423670|455000235|FG004|Treatment Period|Adverse Event|9|||
126463723|NCT00423670|455000236|FG005|Treatment Period|Adverse Event|4|||
126463724|NCT00423670|455000237|FG006|Treatment Period|Adverse Event|7|||
126463725|NCT00423670|455000238|FG007|Treatment Period|Adverse Event|2|||
126369292|NCT00573768|454648184|FG001|Overall Study|Withdrawal by Subject|1|||
126369293|NCT00573768|454648185|FG002|Overall Study|Withdrawal by Subject|0|||
126369294|NCT00573768|454648183|FG000|Overall Study|Lost to Follow-up|0|||
126369295|NCT00573768|454648184|FG001|Overall Study|Lost to Follow-up|0|||
126369296|NCT00573768|454648185|FG002|Overall Study|Lost to Follow-up|1|||
126369297|NCT03243084|454648186|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
126369298|NCT03243084|454648187|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
126369299|NCT02090764|454648190|FG000|Overall Study|Adverse Event|1|||
126369300|NCT02090764|454648191|FG001|Overall Study|Adverse Event|3|||
126369301|NCT02090764|454648190|FG000|Overall Study|Lack of Efficacy|0|||
126369302|NCT02090764|454648191|FG001|Overall Study|Lack of Efficacy|13|||
126369303|NCT02090764|454648190|FG000|Overall Study|Withdrawal by Subject|2|||
126369304|NCT02090764|454648191|FG001|Overall Study|Withdrawal by Subject|1|||
126463726|NCT00423670|455000231|FG000|Treatment Period|Protocol-defined clinical event|0|||
126369305|NCT02090764|454648190|FG000|Overall Study|Intercurrent illness and other|1|||
126714927|NCT04760314|455908601|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126714928|NCT04760314|455908602|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126714929|NCT04760314|455908603|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126714930|NCT04760314|455908604|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126714931|NCT04760314|455908605|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
126714932|NCT04760314|455908606|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126714933|NCT04760314|455908607|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126714934|NCT04760314|455908608|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
126714935|NCT04760314|455908598|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
126714936|NCT04760314|455908599|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
126714937|NCT04760314|455908600|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
126714938|NCT04760314|455908601|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
126714939|NCT04760314|455908602|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
126714940|NCT04760314|455908603|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
126714941|NCT04760314|455908604|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
126714942|NCT04760314|455908605|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
126714943|NCT04760314|455908606|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
126714944|NCT04760314|455908607|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
126714945|NCT04760314|455908608|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
126714946|NCT00960440|455908610|FG000|Overall Study|Death|0|||
126714947|NCT00960440|455908611|FG001|Overall Study|Death|0|||
126714948|NCT00960440|455908612|FG002|Overall Study|Death|0|||
126714949|NCT00960440|455908613|FG003|Overall Study|Death|1|||
126714950|NCT00960440|455908610|FG000|Overall Study|Adverse Event|12|||
126714951|NCT00960440|455908611|FG001|Overall Study|Adverse Event|12|||
126714952|NCT00960440|455908612|FG002|Overall Study|Adverse Event|4|||
126714953|NCT00960440|455908613|FG003|Overall Study|Adverse Event|4|||
126714954|NCT00960440|455908610|FG000|Overall Study|Lack of Efficacy|2|||
126714955|NCT00960440|455908611|FG001|Overall Study|Lack of Efficacy|5|||
126714956|NCT00960440|455908612|FG002|Overall Study|Lack of Efficacy|3|||
126714957|NCT00960440|455908613|FG003|Overall Study|Lack of Efficacy|8|||
126714958|NCT00960440|455908610|FG000|Overall Study|Protocol Violation|2|||
126714959|NCT00960440|455908611|FG001|Overall Study|Protocol Violation|8|||
126714960|NCT00960440|455908612|FG002|Overall Study|Protocol Violation|3|||
126714961|NCT00960440|455908613|FG003|Overall Study|Protocol Violation|4|||
126714962|NCT00960440|455908610|FG000|Overall Study|Withdrawal by Subject|9|||
126714963|NCT00960440|455908611|FG001|Overall Study|Withdrawal by Subject|5|||
126714964|NCT00960440|455908612|FG002|Overall Study|Withdrawal by Subject|2|||
126714965|NCT00960440|455908613|FG003|Overall Study|Withdrawal by Subject|1|||
126714966|NCT00960440|455908610|FG000|Overall Study|Other|1|||
126714967|NCT00960440|455908611|FG001|Overall Study|Other|1|||
126714968|NCT00960440|455908612|FG002|Overall Study|Other|1|||
126714969|NCT00960440|455908613|FG003|Overall Study|Other|0|||
126714970|NCT02207530|455908614|FG000|Overall Study|Worsening condition under investigation|78|||
126714971|NCT02207530|455908614|FG000|Overall Study|Patient decision to stop study treatment|5|||
126714972|NCT02207530|455908614|FG000|Overall Study|Adverse Event|8|||
126714973|NCT02345161|455908615|FG000|Overall Study|Withdrawal by Subject|25|||
126714974|NCT02345161|455908616|FG001|Overall Study|Withdrawal by Subject|33|||
126714975|NCT02345161|455908615|FG000|Overall Study|Adverse Event|16|||
126714976|NCT02345161|455908616|FG001|Overall Study|Adverse Event|19|||
126714977|NCT02345161|455908615|FG000|Overall Study|Physician Decision|4|||
126714978|NCT02345161|455908616|FG001|Overall Study|Physician Decision|4|||
126714979|NCT02345161|455908615|FG000|Overall Study|Lost to Follow-up|0|||
126714980|NCT02345161|455908616|FG001|Overall Study|Lost to Follow-up|1|||
126714981|NCT01505491|455908623|FG000|Overall Study|Other reason not listed|1|||
126714982|NCT01505491|455908624|FG001|Overall Study|Other reason not listed|0|||
126714983|NCT01505491|455908625|FG002|Overall Study|Other reason not listed|0|||
126714984|NCT01505491|455908623|FG000|Overall Study|Withdrawal by Subject|1|||
126714985|NCT01505491|455908624|FG001|Overall Study|Withdrawal by Subject|1|||
126463727|NCT00423670|455000232|FG001|Treatment Period|Protocol-defined clinical event|7|||
126463728|NCT00423670|455000233|FG002|Treatment Period|Protocol-defined clinical event|4|||
126714986|NCT01505491|455908625|FG002|Overall Study|Withdrawal by Subject|4|||
126714987|NCT01505491|455908623|FG000|Overall Study|Lost to Follow-up|0|||
126714988|NCT01505491|455908624|FG001|Overall Study|Lost to Follow-up|0|||
126714989|NCT01505491|455908625|FG002|Overall Study|Lost to Follow-up|1|||
126714990|NCT01063751|455908633|FG000|Overall Study|Censored from analyses|42|||
126714991|NCT01063751|455908633|FG000|Overall Study|Withdrawal by Subject|34|||
126714992|NCT01063751|455908633|FG000|Overall Study|Lost to Follow-up|30|||
126714993|NCT01063751|455908633|FG000|Overall Study|Death|13|||
126714994|NCT01063751|455908633|FG000|Overall Study|Sponsored Terminated Study|60|||
126714995|NCT01063751|455908633|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
126714996|NCT01063751|455908633|FG000|Overall Study|Investigator site closed|10|||
126551801|NCT01807221|455315866|FG003|Overall Study|Adverse Event|25|||
126714997|NCT01063751|455908633|FG000|Overall Study|Revision|6|||
126714998|NCT01063751|455908633|FG000|Overall Study|Physician Decision|4|||
126714999|NCT03408873|455908639|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
126551846|NCT01004250|455315872|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
126551847|NCT01004250|455315872|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
126551848|NCT01004250|455315872|FG000|Induction Therapy Period|Physician Decision|2|||
126551849|NCT01004250|455315872|FG000|Maintenance Therapy Period|Adverse Event|15|||
126551850|NCT01004250|455315872|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
126551851|NCT01004250|455315872|FG000|Maintenance Therapy Period|Protocol Violation|1|||
126551852|NCT01004250|455315872|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
126551853|NCT01004250|455315872|FG000|Maintenance Therapy Period|Physician Decision|4|||
126551854|NCT01004250|455315872|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
126551855|NCT03943589|455315873|FG000|Overall Study|Death|1|||
126551856|NCT03943589|455315873|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
126551857|NCT00900627|455315874|FG000|Overall Study|Condition under investigation worsened|4|||
126551858|NCT00900627|455315875|FG001|Overall Study|Condition under investigation worsened|0|||
126551859|NCT00900627|455315876|FG002|Overall Study|Condition under investigation worsened|5|||
126551860|NCT00900627|455315877|FG003|Overall Study|Condition under investigation worsened|3|||
126551861|NCT00900627|455315878|FG004|Overall Study|Condition under investigation worsened|0|||
126551862|NCT00900627|455315879|FG005|Overall Study|Condition under investigation worsened|0|||
126551863|NCT00900627|455315874|FG000|Overall Study|Withdrawal by Subject|1|||
126551864|NCT00900627|455315875|FG001|Overall Study|Withdrawal by Subject|0|||
126551865|NCT00900627|455315876|FG002|Overall Study|Withdrawal by Subject|1|||
126551866|NCT00900627|455315877|FG003|Overall Study|Withdrawal by Subject|0|||
126551867|NCT00900627|455315878|FG004|Overall Study|Withdrawal by Subject|1|||
126551868|NCT00900627|455315879|FG005|Overall Study|Withdrawal by Subject|2|||
126551869|NCT00900627|455315874|FG000|Overall Study|Adverse Event|1|||
126551870|NCT00900627|455315875|FG001|Overall Study|Adverse Event|2|||
126551871|NCT00900627|455315876|FG002|Overall Study|Adverse Event|0|||
126551872|NCT00900627|455315877|FG003|Overall Study|Adverse Event|3|||
126551873|NCT00900627|455315878|FG004|Overall Study|Adverse Event|0|||
126551874|NCT00900627|455315879|FG005|Overall Study|Adverse Event|0|||
126306335|NCT02244463|454410277|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
126306336|NCT02244463|454410278|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
126306337|NCT02244463|454410279|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
126306338|NCT02244463|454410274|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
126306339|NCT02244463|454410275|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
126306340|NCT02244463|454410276|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
126306341|NCT02244463|454410277|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
126306342|NCT02244463|454410278|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
126306343|NCT02244463|454410279|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
126306344|NCT02244463|454410274|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
126306345|NCT02244463|454410275|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
126306346|NCT02244463|454410276|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
126306347|NCT02244463|454410277|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
126306348|NCT02244463|454410278|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
126306349|NCT02244463|454410279|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
126306350|NCT02244463|454410274|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
126306351|NCT02244463|454410275|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
126306352|NCT02244463|454410276|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
126306353|NCT02244463|454410277|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
126306354|NCT02244463|454410278|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
126306355|NCT02244463|454410279|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
126306356|NCT02244463|454410274|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
126306357|NCT02244463|454410275|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
126306358|NCT02244463|454410276|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
126306359|NCT02244463|454410277|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
126306360|NCT02244463|454410278|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
126306361|NCT02244463|454410279|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
126306362|NCT02244463|454410274|FG000|Period 5: Phase II|Disease Progression|0|||
126306363|NCT02244463|454410275|FG001|Period 5: Phase II|Disease Progression|0|||
126306364|NCT02244463|454410276|FG002|Period 5: Phase II|Disease Progression|0|||
126306365|NCT02244463|454410277|FG003|Period 5: Phase II|Disease Progression|0|||
126306366|NCT02244463|454410278|FG004|Period 5: Phase II|Disease Progression|10|||
126306367|NCT02244463|454410279|FG005|Period 5: Phase II|Disease Progression|11|||
126306368|NCT02244463|454410274|FG000|Period 5: Phase II|Physician Decision|0|||
126306369|NCT02244463|454410275|FG001|Period 5: Phase II|Physician Decision|0|||
126306370|NCT02244463|454410276|FG002|Period 5: Phase II|Physician Decision|0|||
126551875|NCT00900627|455315874|FG000|Overall Study|Death|0|||
126306371|NCT02244463|454410277|FG003|Period 5: Phase II|Physician Decision|0|||
126306372|NCT02244463|454410278|FG004|Period 5: Phase II|Physician Decision|3|||
126306373|NCT02244463|454410279|FG005|Period 5: Phase II|Physician Decision|2|||
126306374|NCT02244463|454410274|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
126551876|NCT00900627|455315875|FG001|Overall Study|Death|0|||
126369575|NCT00183248|454650606|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
126369576|NCT03309202|454650607|FG000|Overall Study|Lost to Follow-up|1|||
126369577|NCT03309202|454650608|FG001|Overall Study|Lost to Follow-up|0|||
126369578|NCT03309202|454650609|FG002|Overall Study|Lost to Follow-up|0|||
126369579|NCT03309202|454650610|FG003|Overall Study|Lost to Follow-up|0|||
126369580|NCT00415636|454650613|FG000|Overall Study|Symptomatic deterioration|1|||
126369581|NCT00415636|454650614|FG001|Overall Study|Symptomatic deterioration|0|||
126369582|NCT00415636|454650615|FG002|Overall Study|Symptomatic deterioration|1|||
126369583|NCT00415636|454650616|FG003|Overall Study|Symptomatic deterioration|2|||
126369584|NCT00415636|454650617|FG004|Overall Study|Symptomatic deterioration|0|||
126369585|NCT00415636|454650618|FG005|Overall Study|Symptomatic deterioration|1|||
126369586|NCT00415636|454650613|FG000|Overall Study|Adverse Event|0|||
126369587|NCT00415636|454650614|FG001|Overall Study|Adverse Event|0|||
126369588|NCT00415636|454650615|FG002|Overall Study|Adverse Event|0|||
126369589|NCT00415636|454650616|FG003|Overall Study|Adverse Event|1|||
126369590|NCT00415636|454650617|FG004|Overall Study|Adverse Event|1|||
126369591|NCT00415636|454650618|FG005|Overall Study|Adverse Event|0|||
126369592|NCT00415636|454650613|FG000|Overall Study|Withdrawal by Subject|0|||
126369593|NCT00415636|454650614|FG001|Overall Study|Withdrawal by Subject|0|||
126369594|NCT00415636|454650615|FG002|Overall Study|Withdrawal by Subject|0|||
126369595|NCT00415636|454650616|FG003|Overall Study|Withdrawal by Subject|0|||
126369596|NCT00415636|454650617|FG004|Overall Study|Withdrawal by Subject|1|||
126369597|NCT00415636|454650618|FG005|Overall Study|Withdrawal by Subject|0|||
126369598|NCT00415636|454650613|FG000|Overall Study|Disease progression|0|||
126369599|NCT00415636|454650614|FG001|Overall Study|Disease progression|0|||
126369600|NCT00415636|454650615|FG002|Overall Study|Disease progression|0|||
126369601|NCT00415636|454650616|FG003|Overall Study|Disease progression|3|||
126369602|NCT00415636|454650617|FG004|Overall Study|Disease progression|0|||
126369603|NCT00415636|454650618|FG005|Overall Study|Disease progression|1|||
126369604|NCT04734210|454650619|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
126369605|NCT04734210|454650620|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
126369606|NCT04734210|454650621|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
126369607|NCT04734210|454650619|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
126369608|NCT04734210|454650620|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
126369609|NCT04734210|454650621|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
126369610|NCT04734210|454650619|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
126369611|NCT04734210|454650620|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
126369612|NCT04734210|454650621|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
126369613|NCT04734210|454650619|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
126369614|NCT04734210|454650620|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
126715205|NCT02873715|455908712|FG000|Overall Study|Withdrawal by Subject|7|||
126715206|NCT02873715|455908713|FG001|Overall Study|Withdrawal by Subject|26|||
126715207|NCT02021812|455908719|FG000|Overall Study|Death|8|||
126715208|NCT02021812|455908719|FG000|Overall Study|Withdrawal by Subject|3|||
126715209|NCT02021812|455908719|FG000|Overall Study|Lost to Follow-up|2|||
126715210|NCT02021812|455908719|FG000|Overall Study|Refuse to return, COVD 19|2|||
126369615|NCT04734210|454650621|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
126369616|NCT02684461|454650622|FG000|Overall Study|Adverse Event|1|||
126369617|NCT02684461|454650623|FG001|Overall Study|Adverse Event|0|||
126369618|NCT02684461|454650624|FG002|Overall Study|Adverse Event|0|||
126369619|NCT02684461|454650622|FG000|Overall Study|Lack of Efficacy|1|||
126369620|NCT02684461|454650623|FG001|Overall Study|Lack of Efficacy|2|||
126715211|NCT00564629|455908720|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
126715212|NCT00564629|455908721|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
126715213|NCT02698423|455908722|FG000|Overall Study|Lost to Follow-up|19|||
126369621|NCT02684461|454650624|FG002|Overall Study|Lack of Efficacy|0|||
126369622|NCT02138825|454650625|FG000|Main Study Treatment|Adverse Event|11|||
126369623|NCT02138825|454650626|FG001|Main Study Treatment|Adverse Event|3|||
126369624|NCT02138825|454650625|FG000|Main Study Treatment|Death|1|||
126369625|NCT02138825|454650626|FG001|Main Study Treatment|Death|2|||
126715214|NCT02698423|455908723|FG001|Overall Study|Lost to Follow-up|24|||
126715215|NCT03634072|455908724|FG000|Overall Study|Early termination of overall study|1|||
126715216|NCT03634072|455908725|FG001|Overall Study|Early termination of overall study|0|||
126715217|NCT01651260|455908726|FG000|Overall Study|unable to apply product|3|||
126715218|NCT01952015|455908729|FG000|Induction|Protocol Violation|1|||
126551877|NCT00900627|455315876|FG002|Overall Study|Death|0|||
126369626|NCT02138825|454650625|FG000|Main Study Treatment|Protocol Violation|2|||
126715219|NCT01952015|455908729|FG000|Maintenance|Adverse Event|2|||
126715220|NCT01952015|455908729|FG000|Treatment Period 3|Physician Decision|9|||
126369627|NCT02138825|454650626|FG001|Main Study Treatment|Protocol Violation|2|||
126551878|NCT00900627|455315877|FG003|Overall Study|Death|0|||
126369628|NCT02138825|454650625|FG000|Main Study Treatment|Sponsor decision|12|||
126369629|NCT02138825|454650626|FG001|Main Study Treatment|Sponsor decision|18|||
126369630|NCT02138825|454650625|FG000|Main Study Treatment|Study terminated by sponsor|10|||
126369631|NCT02138825|454650626|FG001|Main Study Treatment|Study terminated by sponsor|9|||
126369632|NCT02138825|454650625|FG000|Main Study Treatment|Withdrawal by Subject|3|||
126369633|NCT02138825|454650626|FG001|Main Study Treatment|Withdrawal by Subject|1|||
126369634|NCT02138825|454650625|FG000|Main Study Treatment|Medical decision|1|||
126369635|NCT02138825|454650626|FG001|Main Study Treatment|Medical decision|0|||
126369636|NCT02138825|454650625|FG000|Long-term Extension|Study termination by sponsor|32|||
126369637|NCT02138825|454650626|FG001|Long-term Extension|Study termination by sponsor|38|||
126369638|NCT02138825|454650625|FG000|Safety Follow-up|Adverse Event|4|||
126369639|NCT02138825|454650626|FG001|Safety Follow-up|Adverse Event|3|||
126369640|NCT02138825|454650625|FG000|Safety Follow-up|Death|11|||
126369641|NCT02138825|454650626|FG001|Safety Follow-up|Death|5|||
126369642|NCT02138825|454650625|FG000|Safety Follow-up|Withdrawal by Subject|5|||
126551879|NCT00900627|455315878|FG004|Overall Study|Death|28|||
126551880|NCT00900627|455315879|FG005|Overall Study|Death|24|||
126551881|NCT00373295|455315880|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
126551882|NCT00373295|455315881|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
126551883|NCT00373295|455315882|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
126551884|NCT00373295|455315883|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
126551885|NCT00373295|455315884|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
126551886|NCT00373295|455315885|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
126551887|NCT00830947|455315886|FG000|Overall Study|Lost to Follow-up|4|||
126551888|NCT00830947|455315887|FG001|Overall Study|Lost to Follow-up|4|||
126551889|NCT00962585|455315894|FG000|Overall Study|Adverse Event|0|||
126551890|NCT00962585|455315895|FG001|Overall Study|Adverse Event|2|||
126551891|NCT00962585|455315896|FG002|Overall Study|Adverse Event|1|||
126551892|NCT00962585|455315897|FG003|Overall Study|Adverse Event|0|||
126551893|NCT00962585|455315894|FG000|Overall Study|Lost to Follow-up|3|||
126551894|NCT00962585|455315895|FG001|Overall Study|Lost to Follow-up|0|||
126369643|NCT02138825|454650626|FG001|Safety Follow-up|Withdrawal by Subject|3|||
126369644|NCT02138825|454650625|FG000|Safety Follow-up|clinic worsening|1|||
126369645|NCT02138825|454650626|FG001|Safety Follow-up|clinic worsening|0|||
126369646|NCT02138825|454650625|FG000|Safety Follow-up|withdrawal by PI|1|||
126369647|NCT02138825|454650626|FG001|Safety Follow-up|withdrawal by PI|0|||
126369648|NCT02138825|454650625|FG000|Safety Follow-up|logistical difficulties|0|||
126369649|NCT02138825|454650626|FG001|Safety Follow-up|logistical difficulties|1|||
126369650|NCT02138825|454650625|FG000|Safety Follow-up|progressive disease|0|||
126369651|NCT02138825|454650626|FG001|Safety Follow-up|progressive disease|2|||
126369652|NCT02138825|454650625|FG000|Safety Follow-up|too unwell to attend the visit|0|||
126369653|NCT02138825|454650626|FG001|Safety Follow-up|too unwell to attend the visit|1|||
126369654|NCT02138825|454650625|FG000|Safety Follow-up|treatment unblinded|0|||
126369655|NCT02138825|454650626|FG001|Safety Follow-up|treatment unblinded|1|||
126369656|NCT02138825|454650625|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
126369657|NCT02138825|454650626|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
126369658|NCT05201807|454650630|FG000|Overall Study|Adverse Event|1|||
126369659|NCT05201807|454650630|FG000|Overall Study|COVID-19 Related|1|||
126463854|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
126463855|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
126463856|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
126463857|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
126463858|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
126463859|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
126463860|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
126463861|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
126463862|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
126463863|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
126463864|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
126551895|NCT00962585|455315896|FG002|Overall Study|Lost to Follow-up|1|||
126551896|NCT00962585|455315897|FG003|Overall Study|Lost to Follow-up|0|||
126551897|NCT00962585|455315894|FG000|Overall Study|Protocol Violation|0|||
126551898|NCT00962585|455315895|FG001|Overall Study|Protocol Violation|0|||
126551899|NCT00962585|455315896|FG002|Overall Study|Protocol Violation|1|||
126369660|NCT01209767|454650631|FG000|Overall Study|Withdrawal by Subject|1|||
126369661|NCT01209767|454650631|FG000|Overall Study|Lost to Follow-up|3|||
126369662|NCT01702298|454650632|FG000|Overall Study|Withdrawal by Subject|1|||
126369663|NCT01029535|454650634|FG000|Overall Study|Lost to Follow-up|24|||
126369664|NCT01029535|454650634|FG000|Overall Study|Protocol Violation|2|||
126369665|NCT01029535|454650634|FG000|Overall Study|Participant Withdrew Consent|2|||
126369666|NCT01029535|454650634|FG000|Overall Study|Adverse Event|1|||
126369667|NCT01029535|454650634|FG000|Overall Study|Use of Another Treatment|1|||
126369668|NCT01029535|454650634|FG000|Overall Study|Death|1|||
126369669|NCT00904371|454650639|FG000|Overall Study|Adverse Event|2|||
126369670|NCT00904371|454650639|FG000|Overall Study|Lost to Follow-up|4|||
126369671|NCT00904371|454650639|FG000|Overall Study|Discontinued at target blood pressure|2|||
126369672|NCT00904371|454650639|FG000|Overall Study|Continued with Tritace|1|||
126369673|NCT00583219|454650640|FG000|Phase 2|Withdrawal by Subject|1|||
126369674|NCT05448950|454650641|FG000|Overall Study|Death|2|||
126369675|NCT05448950|454650641|FG000|Overall Study|Withdrawal by Subject|1|||
126369676|NCT05448950|454650641|FG000|Overall Study|AVG abandoned|4|||
126369677|NCT02836249|454650642|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
126369678|NCT02836249|454650643|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
126369679|NCT02836249|454650644|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
126369680|NCT02836249|454650645|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
126369681|NCT02836249|454650642|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
126369682|NCT02836249|454650643|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
126369683|NCT02836249|454650644|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
126369684|NCT02836249|454650645|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
126369685|NCT02836249|454650642|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
126369686|NCT02836249|454650643|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
126369687|NCT02836249|454650644|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
126369688|NCT02836249|454650645|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
126369689|NCT02836249|454650642|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126369690|NCT02836249|454650643|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
126369691|NCT02836249|454650644|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126369692|NCT02836249|454650645|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126369693|NCT02836249|454650642|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
126369694|NCT02836249|454650643|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
126369695|NCT02836249|454650644|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
126369696|NCT02836249|454650645|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
126369697|NCT02836249|454650642|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
126369698|NCT02836249|454650643|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
126369699|NCT02836249|454650644|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
126369700|NCT02836249|454650645|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
126369701|NCT02836249|454650642|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
126369702|NCT02836249|454650643|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
126369703|NCT02836249|454650644|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
126369704|NCT02836249|454650645|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
126369705|NCT02836249|454650642|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
126369706|NCT02836249|454650643|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
126369707|NCT02836249|454650644|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
126369708|NCT02836249|454650645|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
126369709|NCT02836249|454650642|FG000|Open-Label TAF Treatment Phase|Death|0|||
126369710|NCT02836249|454650643|FG001|Open-Label TAF Treatment Phase|Death|0|||
126369711|NCT02836249|454650644|FG002|Open-Label TAF Treatment Phase|Death|1|||
126369712|NCT02836249|454650645|FG003|Open-Label TAF Treatment Phase|Death|0|||
126369713|NCT02836249|454650642|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
126369714|NCT02836249|454650643|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
126369715|NCT02836249|454650644|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
126369716|NCT02836249|454650645|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
126369717|NCT02836249|454650642|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
126369718|NCT02836249|454650643|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
126369719|NCT02836249|454650644|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
126369720|NCT02836249|454650645|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
126369721|NCT04752566|454650646|FG000|Overall Study|Protocol Violation|0|||
126369722|NCT04752566|454650647|FG001|Overall Study|Protocol Violation|1|||
126369723|NCT04752566|454650646|FG000|Overall Study|Death|1|||
126369724|NCT04752566|454650647|FG001|Overall Study|Death|0|||
126369725|NCT04752566|454650646|FG000|Overall Study|Adverse Event|1|||
126369726|NCT04752566|454650647|FG001|Overall Study|Adverse Event|0|||
126369727|NCT04752566|454650646|FG000|Overall Study|Withdrawal by Subject|2|||
126369728|NCT04752566|454650647|FG001|Overall Study|Withdrawal by Subject|0|||
126369729|NCT04752566|454650646|FG000|Overall Study|Physician Decision|1|||
126369730|NCT04752566|454650647|FG001|Overall Study|Physician Decision|1|||
126369731|NCT01728246|454650648|FG000|Overall Study|Participant needed rescue medication|1|||
126463865|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
126463866|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
126463867|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
126463868|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
126463869|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
126463870|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
126463871|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
126463872|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
126463873|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
126551900|NCT00962585|455315897|FG003|Overall Study|Protocol Violation|0|||
126369732|NCT01728246|454650649|FG001|Overall Study|Participant needed rescue medication|5|||
126369733|NCT01728246|454650648|FG000|Overall Study|Protocol Violation|1|||
126369734|NCT01728246|454650649|FG001|Overall Study|Protocol Violation|0|||
126369735|NCT01728246|454650648|FG000|Overall Study|Withdrawal by Subject|2|||
126369736|NCT01728246|454650649|FG001|Overall Study|Withdrawal by Subject|3|||
126369737|NCT01728246|454650648|FG000|Overall Study|Lost to Follow-up|23|||
126369738|NCT01728246|454650649|FG001|Overall Study|Lost to Follow-up|22|||
126369739|NCT01728246|454650648|FG000|Overall Study|Lack of Efficacy|1|||
126369740|NCT01728246|454650649|FG001|Overall Study|Lack of Efficacy|1|||
126369741|NCT01728246|454650648|FG000|Overall Study|Adverse Event|8|||
126369742|NCT01728246|454650649|FG001|Overall Study|Adverse Event|5|||
126369743|NCT01983111|454650650|FG000|Overall Study|Withdrawal by Subject|8|||
126369744|NCT01983111|454650651|FG001|Overall Study|Withdrawal by Subject|6|||
126369745|NCT01983111|454650650|FG000|Overall Study|Adverse Event|4|||
126369746|NCT01983111|454650651|FG001|Overall Study|Adverse Event|0|||
126369747|NCT01983111|454650650|FG000|Overall Study|Protocol Violation|0|||
126369748|NCT01983111|454650651|FG001|Overall Study|Protocol Violation|1|||
126369749|NCT00855335|454650652|FG000|Overall Study|Lost to Follow-up|0|||
126369750|NCT00855335|454650653|FG001|Overall Study|Lost to Follow-up|0|||
126369751|NCT00855335|454650654|FG002|Overall Study|Lost to Follow-up|3|||
126369752|NCT00855335|454650655|FG003|Overall Study|Lost to Follow-up|1|||
126369753|NCT00855335|454650656|FG004|Overall Study|Lost to Follow-up|0|||
126369754|NCT00855335|454650652|FG000|Overall Study|Withdrawal by Subject|0|||
126369755|NCT00855335|454650653|FG001|Overall Study|Withdrawal by Subject|0|||
126369756|NCT00855335|454650654|FG002|Overall Study|Withdrawal by Subject|0|||
126369757|NCT00855335|454650655|FG003|Overall Study|Withdrawal by Subject|1|||
126369758|NCT00855335|454650656|FG004|Overall Study|Withdrawal by Subject|0|||
126369759|NCT00855335|454650652|FG000|Overall Study|Adverse Event|2|||
126369760|NCT00855335|454650653|FG001|Overall Study|Adverse Event|0|||
126369761|NCT00855335|454650654|FG002|Overall Study|Adverse Event|0|||
126369762|NCT00855335|454650655|FG003|Overall Study|Adverse Event|0|||
126369763|NCT00855335|454650656|FG004|Overall Study|Adverse Event|0|||
126369764|NCT00855335|454650652|FG000|Overall Study|Physician Decision|1|||
126369765|NCT00855335|454650653|FG001|Overall Study|Physician Decision|1|||
126369766|NCT00855335|454650654|FG002|Overall Study|Physician Decision|0|||
126369767|NCT00855335|454650655|FG003|Overall Study|Physician Decision|0|||
126369768|NCT00855335|454650656|FG004|Overall Study|Physician Decision|0|||
126369769|NCT00855335|454650652|FG000|Overall Study|Other|2|||
126369770|NCT00855335|454650653|FG001|Overall Study|Other|1|||
126369771|NCT00855335|454650654|FG002|Overall Study|Other|2|||
126369772|NCT00855335|454650655|FG003|Overall Study|Other|5|||
126369773|NCT00855335|454650656|FG004|Overall Study|Other|1|||
126369774|NCT02706392|454650658|FG000|Overall Study|Death|1|||
126369775|NCT02706392|454650659|FG001|Overall Study|Death|0|||
126463874|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
126463875|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
126463876|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
126463877|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
126463878|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
126463879|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
126463880|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
126463881|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
126463882|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
126463883|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
126463884|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
126463885|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
126463886|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
126463887|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
126463888|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
126463889|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
126463890|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
126463891|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
126463892|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
126463893|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
126463894|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
126463895|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
126369776|NCT02706392|454650660|FG002|Overall Study|Death|2|||
126463896|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
126551901|NCT00962585|455315894|FG000|Overall Study|Withdrawal by Subject|1|||
126551902|NCT00962585|455315895|FG001|Overall Study|Withdrawal by Subject|0|||
126369777|NCT02706392|454650661|FG003|Overall Study|Death|2|||
126369778|NCT02706392|454650662|FG004|Overall Study|Death|5|||
126369779|NCT02706392|454650663|FG005|Overall Study|Death|2|||
126369780|NCT00619866|454650666|FG000|Weeks 1 - 12|Adverse Event|0|||
126369781|NCT00619866|454650667|FG001|Weeks 1 - 12|Adverse Event|1|||
126551903|NCT00962585|455315896|FG002|Overall Study|Withdrawal by Subject|0|||
126551904|NCT00962585|455315897|FG003|Overall Study|Withdrawal by Subject|0|||
126369782|NCT00619866|454650668|FG002|Weeks 1 - 12|Adverse Event|2|||
126369783|NCT00619866|454650669|FG003|Weeks 1 - 12|Adverse Event|0|||
126369784|NCT00619866|454650670|FG004|Weeks 1 - 12|Adverse Event|0|||
126369785|NCT00619866|454650666|FG000|Weeks 1 - 12|Non-compliance|0|||
126369786|NCT00619866|454650667|FG001|Weeks 1 - 12|Non-compliance|0|||
126369787|NCT00619866|454650668|FG002|Weeks 1 - 12|Non-compliance|1|||
126369788|NCT00619866|454650669|FG003|Weeks 1 - 12|Non-compliance|0|||
126369789|NCT00619866|454650670|FG004|Weeks 1 - 12|Non-compliance|0|||
126369790|NCT00619866|454650666|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
126369791|NCT00619866|454650667|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
126369792|NCT00619866|454650668|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
126369793|NCT00619866|454650669|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
126369794|NCT00619866|454650670|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
126369795|NCT00619866|454650666|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
126369796|NCT00619866|454650667|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
126369797|NCT00619866|454650668|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
126369798|NCT00619866|454650669|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
126369799|NCT00619866|454650670|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
126369800|NCT00619866|454650666|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
126369801|NCT00619866|454650667|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
126369802|NCT00619866|454650668|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
126369803|NCT00619866|454650669|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
126369804|NCT00619866|454650670|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
126369805|NCT00619866|454650666|FG000|Weeks 1 - 12|Sponsor Decision|0|||
126369806|NCT00619866|454650667|FG001|Weeks 1 - 12|Sponsor Decision|1|||
126369807|NCT00619866|454650668|FG002|Weeks 1 - 12|Sponsor Decision|0|||
126369808|NCT00619866|454650669|FG003|Weeks 1 - 12|Sponsor Decision|0|||
126369809|NCT00619866|454650670|FG004|Weeks 1 - 12|Sponsor Decision|0|||
126369810|NCT00619866|454650666|FG000|Weeks 13 - 24|Adverse Event|0|||
126369811|NCT00619866|454650667|FG001|Weeks 13 - 24|Adverse Event|0|||
126369812|NCT00619866|454650668|FG002|Weeks 13 - 24|Adverse Event|2|||
126369813|NCT00619866|454650669|FG003|Weeks 13 - 24|Adverse Event|1|||
126369814|NCT00619866|454650670|FG004|Weeks 13 - 24|Adverse Event|0|||
126369815|NCT00619866|454650666|FG000|Weeks 13 - 24|Protocol Deviation|0|||
126369816|NCT00619866|454650667|FG001|Weeks 13 - 24|Protocol Deviation|0|||
126369817|NCT00619866|454650668|FG002|Weeks 13 - 24|Protocol Deviation|0|||
126551905|NCT00962585|455315894|FG000|Overall Study|Withdrew Consent|2|||
126551906|NCT00962585|455315895|FG001|Overall Study|Withdrew Consent|0|||
126369818|NCT00619866|454650669|FG003|Weeks 13 - 24|Protocol Deviation|1|||
126369819|NCT00619866|454650670|FG004|Weeks 13 - 24|Protocol Deviation|0|||
126369820|NCT00619866|454650666|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
126369821|NCT00619866|454650667|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
126463897|NCT03739840|455000254|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
126463898|NCT03739840|455000255|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
126463899|NCT03739840|455000256|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
126463900|NCT03739840|455000257|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
126463901|NCT03739840|455000254|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
126463902|NCT03739840|455000255|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
126463903|NCT03739840|455000256|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
126463904|NCT03739840|455000257|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
126463905|NCT03739840|455000254|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
126463906|NCT03739840|455000255|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
126463907|NCT03739840|455000256|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
126463908|NCT03739840|455000257|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
126463909|NCT03739840|455000254|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
126463910|NCT03739840|455000255|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
126463911|NCT03739840|455000256|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
126463912|NCT03739840|455000257|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
126463913|NCT03739840|455000254|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
126463914|NCT03739840|455000255|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
126463915|NCT03739840|455000256|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
126551907|NCT00962585|455315896|FG002|Overall Study|Withdrew Consent|0|||
126551908|NCT00962585|455315897|FG003|Overall Study|Withdrew Consent|0|||
126551909|NCT02254421|455315900|FG000|Overall Study|Randomized but Not Treated|1|||
126369822|NCT00619866|454650668|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
126369823|NCT00619866|454650669|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
126369824|NCT00619866|454650670|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
126369825|NCT00619866|454650666|FG000|Weeks 13 - 24|Non-compliance|0|||
126369826|NCT00619866|454650667|FG001|Weeks 13 - 24|Non-compliance|1|||
126369827|NCT00619866|454650668|FG002|Weeks 13 - 24|Non-compliance|1|||
126369828|NCT00619866|454650669|FG003|Weeks 13 - 24|Non-compliance|0|||
126369829|NCT00619866|454650670|FG004|Weeks 13 - 24|Non-compliance|0|||
126369830|NCT00619866|454650666|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
126369831|NCT00619866|454650667|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
126369832|NCT00619866|454650668|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
126369833|NCT00619866|454650669|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
126369834|NCT00619866|454650670|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
126369835|NCT01968980|454650674|FG000|Overall Study|Death|0|||
126369836|NCT01968980|454650675|FG001|Overall Study|Death|1|||
126369837|NCT01968980|454650674|FG000|Overall Study|Adverse Event|1|||
126369838|NCT01968980|454650675|FG001|Overall Study|Adverse Event|3|||
126369839|NCT01968980|454650674|FG000|Overall Study|Does not meet entry criteria|1|||
126369840|NCT01968980|454650675|FG001|Overall Study|Does not meet entry criteria|3|||
126369841|NCT01968980|454650674|FG000|Overall Study|Withdrawal by Subject|13|||
126369842|NCT01968980|454650675|FG001|Overall Study|Withdrawal by Subject|5|||
126369843|NCT01968980|454650674|FG000|Overall Study|Other unspecified|1|||
126369844|NCT01968980|454650675|FG001|Overall Study|Other unspecified|2|||
126369845|NCT02589938|454650679|FG000|Overall Study|Withdrawal by Subject|11|||
126369846|NCT02589938|454650680|FG001|Overall Study|Withdrawal by Subject|5|||
126369847|NCT02589938|454650681|FG002|Overall Study|Withdrawal by Subject|6|||
126369848|NCT02589938|454650679|FG000|Overall Study|Lost to Follow-up|3|||
126369849|NCT02589938|454650680|FG001|Overall Study|Lost to Follow-up|3|||
126369850|NCT02589938|454650681|FG002|Overall Study|Lost to Follow-up|3|||
126369851|NCT02589938|454650679|FG000|Overall Study|Death|1|||
126369852|NCT02589938|454650680|FG001|Overall Study|Death|0|||
126369853|NCT02589938|454650681|FG002|Overall Study|Death|1|||
126369854|NCT02589938|454650679|FG000|Overall Study|Protocol Violation|6|||
126369855|NCT02589938|454650680|FG001|Overall Study|Protocol Violation|2|||
126369856|NCT02589938|454650681|FG002|Overall Study|Protocol Violation|3|||
126369857|NCT02589938|454650679|FG000|Overall Study|Physician Decision|1|||
126369858|NCT02589938|454650680|FG001|Overall Study|Physician Decision|0|||
126369859|NCT02589938|454650681|FG002|Overall Study|Physician Decision|0|||
126369860|NCT02589938|454650679|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
126369861|NCT02589938|454650680|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
126369862|NCT02589938|454650681|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
126369863|NCT02521285|454650682|FG000|Overall Study|Lost to Follow-up|1|||
126369864|NCT02521285|454650683|FG001|Overall Study|Lost to Follow-up|1|||
126369865|NCT02521285|454650682|FG000|Overall Study|Withdrawal by Subject|1|||
126369866|NCT02521285|454650683|FG001|Overall Study|Withdrawal by Subject|1|||
126369867|NCT02521285|454650682|FG000|Overall Study|Adverse Event|0|||
126369868|NCT02521285|454650683|FG001|Overall Study|Adverse Event|1|||
126369869|NCT00787150|454650690|FG000|Overall Study|Adverse Event|4|||
126369870|NCT00787150|454650691|FG001|Overall Study|Adverse Event|4|||
126369871|NCT00787150|454650692|FG002|Overall Study|Adverse Event|4|||
126369872|NCT00787150|454650690|FG000|Overall Study|Physician Decision|1|||
126369873|NCT00787150|454650691|FG001|Overall Study|Physician Decision|2|||
126369874|NCT00787150|454650692|FG002|Overall Study|Physician Decision|1|||
126369875|NCT00787150|454650690|FG000|Overall Study|Withdrawal by Subject|2|||
126369876|NCT00787150|454650691|FG001|Overall Study|Withdrawal by Subject|1|||
126369877|NCT00787150|454650692|FG002|Overall Study|Withdrawal by Subject|0|||
126369878|NCT00787150|454650690|FG000|Overall Study|Dosing incorrect study durg|2|||
126369879|NCT00787150|454650691|FG001|Overall Study|Dosing incorrect study durg|0|||
126369880|NCT00787150|454650692|FG002|Overall Study|Dosing incorrect study durg|0|||
126369881|NCT01849276|454650693|FG000|Followed for Survival for 5 Years|Death|1|||
126369882|NCT01849276|454650693|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
126369883|NCT00879398|454650696|FG000|Overall Study|Visit Stop|399|||
126369884|NCT00879398|454650696|FG000|Overall Study|Lack of Efficacy|64|||
126369885|NCT00879398|454650696|FG000|Overall Study|Adverse Event|41|||
126369886|NCT00879398|454650696|FG000|Overall Study|Other Reasons|171|||
126715221|NCT02239094|455908730|FG000|Overall Study|Withdrawal by Subject|1|||
126715222|NCT02239094|455908730|FG000|Overall Study|Remitted before started|1|||
126715223|NCT02508701|455908731|FG000|Overall Study|Lost to Follow-up|9|||
126715224|NCT02508701|455908732|FG001|Overall Study|Lost to Follow-up|5|||
126369887|NCT01722669|454650699|FG000|Overall Study|Withdrawal by Subject|0|||
126369888|NCT01722669|454650700|FG001|Overall Study|Withdrawal by Subject|0|||
126715225|NCT02508701|455908733|FG002|Overall Study|Lost to Follow-up|5|||
126715226|NCT02508701|455908734|FG003|Overall Study|Lost to Follow-up|3|||
126715227|NCT01259297|455908735|FG000|Double Blind Randomized Period|Death|1|||
126715228|NCT01259297|455908736|FG001|Double Blind Randomized Period|Death|1|||
126715229|NCT01259297|455908737|FG002|Double Blind Randomized Period|Death|1|||
126369889|NCT01722669|454650701|FG002|Overall Study|Withdrawal by Subject|0|||
126369890|NCT01722669|454650702|FG003|Overall Study|Withdrawal by Subject|0|||
126369891|NCT01722669|454650703|FG004|Overall Study|Withdrawal by Subject|0|||
126369892|NCT01722669|454650704|FG005|Overall Study|Withdrawal by Subject|2|||
126369893|NCT03012880|454650708|FG000|Overall Study|Withdrawal by Subject|1|||
126369894|NCT03012880|454650709|FG001|Overall Study|Withdrawal by Subject|0|||
126369895|NCT03012880|454650708|FG000|Overall Study|Ineligible|1|||
126369896|NCT03012880|454650709|FG001|Overall Study|Ineligible|0|||
126715230|NCT01259297|455908738|FG003|Double Blind Randomized Period|Death|2|||
126715231|NCT01259297|455908739|FG004|Double Blind Randomized Period|Death|1|||
126369897|NCT01587196|454650710|FG000|Overall Study|Lost to Follow-up|50|||
126306375|NCT02244463|454410275|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
126306376|NCT02244463|454410276|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
126306377|NCT02244463|454410277|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
126306378|NCT02244463|454410278|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
126306379|NCT02244463|454410279|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
126306380|NCT02244463|454410274|FG000|Period 5: Phase II|Intercurrent Illness|0|||
126306381|NCT02244463|454410275|FG001|Period 5: Phase II|Intercurrent Illness|0|||
126306382|NCT02244463|454410276|FG002|Period 5: Phase II|Intercurrent Illness|0|||
126306383|NCT02244463|454410277|FG003|Period 5: Phase II|Intercurrent Illness|0|||
126306384|NCT02244463|454410278|FG004|Period 5: Phase II|Intercurrent Illness|2|||
126306385|NCT02244463|454410279|FG005|Period 5: Phase II|Intercurrent Illness|0|||
126306386|NCT02244463|454410274|FG000|Period 5: Phase II|Adverse Event|0|||
126306387|NCT02244463|454410275|FG001|Period 5: Phase II|Adverse Event|0|||
126306388|NCT02244463|454410276|FG002|Period 5: Phase II|Adverse Event|0|||
126306389|NCT02244463|454410277|FG003|Period 5: Phase II|Adverse Event|0|||
126306390|NCT02244463|454410278|FG004|Period 5: Phase II|Adverse Event|0|||
126306391|NCT02244463|454410279|FG005|Period 5: Phase II|Adverse Event|2|||
126306392|NCT02244463|454410274|FG000|Period 5: Phase II|Still On treatment|0|||
126306393|NCT02244463|454410275|FG001|Period 5: Phase II|Still On treatment|0|||
126306394|NCT02244463|454410276|FG002|Period 5: Phase II|Still On treatment|0|||
126306395|NCT02244463|454410277|FG003|Period 5: Phase II|Still On treatment|0|||
126306396|NCT02244463|454410278|FG004|Period 5: Phase II|Still On treatment|0|||
126306397|NCT02244463|454410279|FG005|Period 5: Phase II|Still On treatment|3|||
126306398|NCT01769508|454410280|FG000|Overall Study|Death|3|||
126306399|NCT01769508|454410280|FG000|Overall Study|Withdrawal by Subject|1|||
126306400|NCT01769508|454410280|FG000|Overall Study|Adverse Event|1|||
126306401|NCT01769508|454410280|FG000|Overall Study|Lost to Follow-up|1|||
126306402|NCT01598090|454410281|FG000|Treatment Period|Poor/non-compliance|0|||
126306403|NCT01598090|454410282|FG001|Treatment Period|Poor/non-compliance|2|||
126306404|NCT01598090|454410283|FG002|Treatment Period|Poor/non-compliance|0|||
126306405|NCT01598090|454410281|FG000|Treatment Period|No longer meet study criteria|0|||
126306406|NCT01598090|454410282|FG001|Treatment Period|No longer meet study criteria|1|||
126306407|NCT01598090|454410283|FG002|Treatment Period|No longer meet study criteria|0|||
126306408|NCT01598090|454410281|FG000|Treatment Period|Lack of Efficacy|5|||
126306409|NCT01598090|454410282|FG001|Treatment Period|Lack of Efficacy|14|||
126306410|NCT01598090|454410283|FG002|Treatment Period|Lack of Efficacy|6|||
126306411|NCT01598090|454410281|FG000|Treatment Period|Adverse Event|2|||
126306412|NCT01598090|454410282|FG001|Treatment Period|Adverse Event|33|||
126306413|NCT01598090|454410283|FG002|Treatment Period|Adverse Event|17|||
126306414|NCT01598090|454410281|FG000|Treatment Period|Other reasons|0|||
126306415|NCT01598090|454410282|FG001|Treatment Period|Other reasons|4|||
126306416|NCT01598090|454410283|FG002|Treatment Period|Other reasons|1|||
126306417|NCT01598090|454410281|FG000|Treatment Period|Withdrawal by Subject|3|||
126306418|NCT01598090|454410282|FG001|Treatment Period|Withdrawal by Subject|13|||
126306419|NCT01598090|454410283|FG002|Treatment Period|Withdrawal by Subject|10|||
126306420|NCT01598090|454410281|FG000|Treatment Period|Lost to Follow-up|1|||
126306421|NCT01598090|454410282|FG001|Treatment Period|Lost to Follow-up|5|||
126306422|NCT01598090|454410283|FG002|Treatment Period|Lost to Follow-up|1|||
126306423|NCT01598090|454410281|FG000|Follow-up Period|Death|0|||
126306424|NCT01598090|454410282|FG001|Follow-up Period|Death|1|||
126306425|NCT01598090|454410283|FG002|Follow-up Period|Death|0|||
126369898|NCT01587196|454650710|FG000|Overall Study|Withdrawal by Subject|4|||
126551910|NCT02254421|455315901|FG001|Overall Study|Randomized but Not Treated|0|||
126551911|NCT02254421|455315900|FG000|Overall Study|Death|0|||
126551912|NCT02254421|455315901|FG001|Overall Study|Death|2|||
126551913|NCT02254421|455315900|FG000|Overall Study|Withdrew Consent|1|||
126551914|NCT02254421|455315901|FG001|Overall Study|Withdrew Consent|1|||
126551915|NCT00594906|455315904|FG000|Overall Study|Physician Decision|1|||
126551916|NCT00594906|455315905|FG001|Overall Study|Physician Decision|0|||
126551917|NCT00594906|455315904|FG000|Overall Study|Physician Decision|0|||
126551918|NCT00594906|455315905|FG001|Overall Study|Physician Decision|1|||
126551919|NCT00594906|455315904|FG000|Overall Study|Death|0|||
126551920|NCT00594906|455315905|FG001|Overall Study|Death|1|||
126551921|NCT00839917|455315907|FG000|Overall Study|Lost to Follow-up|1|||
126551922|NCT00839917|455315908|FG001|Overall Study|Lost to Follow-up|0|||
126551923|NCT00839917|455315907|FG000|Overall Study|Did not receive vaccine|0|||
126306426|NCT01598090|454410281|FG000|Follow-up Period|No longer required per protocol|1|||
126306427|NCT01598090|454410282|FG001|Follow-up Period|No longer required per protocol|3|||
126306428|NCT01598090|454410283|FG002|Follow-up Period|No longer required per protocol|2|||
126306429|NCT01598090|454410281|FG000|Follow-up Period|Not reported|0|||
126306430|NCT01598090|454410282|FG001|Follow-up Period|Not reported|10|||
126306431|NCT01598090|454410283|FG002|Follow-up Period|Not reported|4|||
126306432|NCT01598090|454410281|FG000|Follow-up Period|Withdrawal by Subject|0|||
126306433|NCT01598090|454410282|FG001|Follow-up Period|Withdrawal by Subject|3|||
126306434|NCT01598090|454410283|FG002|Follow-up Period|Withdrawal by Subject|2|||
126306435|NCT01598090|454410281|FG000|Follow-up Period|Other reasons|2|||
126306436|NCT01598090|454410282|FG001|Follow-up Period|Other reasons|8|||
126306437|NCT01598090|454410283|FG002|Follow-up Period|Other reasons|8|||
126463916|NCT03739840|455000257|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
126463917|NCT03739840|455000254|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
126463918|NCT03739840|455000255|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
126463919|NCT03739840|455000256|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
126463920|NCT03739840|455000257|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
126463921|NCT03739840|455000254|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
126463922|NCT03739840|455000255|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
126463923|NCT03739840|455000256|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
126463924|NCT03739840|455000257|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
126463925|NCT03739840|455000254|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
126463926|NCT03739840|455000255|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
126463927|NCT03739840|455000256|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
126463928|NCT03739840|455000257|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
126463929|NCT03739840|455000254|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
126369899|NCT02769481|454650711|FG000|Overall Study|Protocol Violation|1|||
126369900|NCT02769481|454650712|FG001|Overall Study|Protocol Violation|0|||
126463930|NCT03739840|455000255|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
126463931|NCT03739840|455000256|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
126463932|NCT03739840|455000257|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
126463933|NCT01058265|455000260|FG000|Overall Study|Lost to Follow-up|11|||
126463934|NCT01058265|455000261|FG001|Overall Study|Lost to Follow-up|12|||
126463935|NCT02962765|455000262|FG000|Overall Study|Protocol Violation|9|||
126463936|NCT02962765|455000262|FG000|Overall Study|Withdrawal by Subject|3|||
126463937|NCT02962765|455000262|FG000|Overall Study|Lost to Follow-up|1|||
126463938|NCT02962765|455000262|FG000|Overall Study|Death|1|||
126463939|NCT02962765|455000262|FG000|Overall Study|Limited access to study medication|3|||
126463940|NCT00750880|455000265|FG000|Overall Study|Adverse Event|76|||
126463941|NCT00750880|455000265|FG000|Overall Study|Death|4|||
126463942|NCT00750880|455000265|FG000|Overall Study|Lack of Efficacy|46|||
126463943|NCT00750880|455000265|FG000|Overall Study|Lost to Follow-up|10|||
126463944|NCT00750880|455000265|FG000|Overall Study|Protocol Violation|15|||
126463945|NCT00750880|455000265|FG000|Overall Study|Withdrawal by Subject|33|||
126463946|NCT00750880|455000265|FG000|Overall Study|Physician Decision|20|||
126463947|NCT00750880|455000265|FG000|Overall Study|Administrative|11|||
126463948|NCT00984568|455000269|FG000|Overall Study|Withdrawal by Subject|1|||
126463949|NCT00984568|455000270|FG001|Overall Study|Withdrawal by Subject|2|||
126463950|NCT00984568|455000269|FG000|Overall Study|Lack of Efficacy|2|||
126463951|NCT00984568|455000270|FG001|Overall Study|Lack of Efficacy|0|||
126463952|NCT00984568|455000269|FG000|Overall Study|Adverse Event|2|||
126463953|NCT00984568|455000270|FG001|Overall Study|Adverse Event|0|||
126369901|NCT02769481|454650711|FG000|Overall Study|Adverse Event|3|||
126369902|NCT02769481|454650712|FG001|Overall Study|Adverse Event|6|||
126369903|NCT02769481|454650711|FG000|Overall Study|Entry Criteria Not Met|1|||
126369904|NCT02769481|454650712|FG001|Overall Study|Entry Criteria Not Met|2|||
126369905|NCT02769481|454650711|FG000|Overall Study|Withdrawal by Subject|14|||
126369906|NCT02769481|454650712|FG001|Overall Study|Withdrawal by Subject|16|||
126369907|NCT02769481|454650711|FG000|Overall Study|Lost to Follow-up|9|||
126369908|NCT02769481|454650712|FG001|Overall Study|Lost to Follow-up|9|||
126369909|NCT02769481|454650711|FG000|Overall Study|Physician Decision|0|||
126463954|NCT00984568|455000269|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
126463955|NCT00984568|455000270|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
126463956|NCT00984568|455000269|FG000|Overall Study|Lost to Follow-up|0|||
126463957|NCT00984568|455000270|FG001|Overall Study|Lost to Follow-up|1|||
126463958|NCT00984568|455000269|FG000|Overall Study|Opportunistic Infection|1|||
126463959|NCT00984568|455000270|FG001|Overall Study|Opportunistic Infection|0|||
126463960|NCT00984568|455000269|FG000|Overall Study|Unknown Reason|1|||
126463961|NCT00984568|455000270|FG001|Overall Study|Unknown Reason|3|||
126463962|NCT02964507|455000271|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
126463963|NCT02964507|455000272|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
126463964|NCT02964507|455000273|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
126463965|NCT02964507|455000274|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
126463966|NCT02964507|455000275|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
126463967|NCT02964507|455000276|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
126463968|NCT02964507|455000277|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
126463969|NCT02964507|455000278|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
126463970|NCT02964507|455000271|FG000|Overall Study|Study terminated by Sponsor|9|||
126463971|NCT02964507|455000272|FG001|Overall Study|Study terminated by Sponsor|1|||
126551924|NCT00839917|455315908|FG001|Overall Study|Did not receive vaccine|1|||
126551925|NCT00867490|455315909|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
126551926|NCT00867490|455315909|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
126463972|NCT02964507|455000273|FG002|Overall Study|Study terminated by Sponsor|9|||
126463973|NCT02964507|455000274|FG003|Overall Study|Study terminated by Sponsor|3|||
126369910|NCT02769481|454650712|FG001|Overall Study|Physician Decision|1|||
126369911|NCT02769481|454650711|FG000|Overall Study|Terminated by Sponsor|1|||
126369912|NCT02769481|454650712|FG001|Overall Study|Terminated by Sponsor|0|||
126306438|NCT01598090|454410281|FG000|Follow-up Period|Lost to Follow-up|2|||
126306439|NCT01598090|454410282|FG001|Follow-up Period|Lost to Follow-up|10|||
126306440|NCT01598090|454410283|FG002|Follow-up Period|Lost to Follow-up|12|||
126306441|NCT04791319|454410284|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
126306442|NCT04791319|454410285|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
126306443|NCT04791319|454410286|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
126306444|NCT04791319|454410287|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
126306445|NCT04791319|454410288|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306446|NCT04791319|454410289|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306447|NCT04791319|454410290|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306448|NCT04791319|454410291|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306449|NCT04791319|454410292|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306450|NCT04791319|454410293|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306451|NCT04791319|454410294|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
126306452|NCT04791319|454410284|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
126306453|NCT04791319|454410285|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306454|NCT04791319|454410286|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
126306455|NCT04791319|454410287|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
126306456|NCT04791319|454410288|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306457|NCT04791319|454410289|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306458|NCT04791319|454410290|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306459|NCT04791319|454410291|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306460|NCT04791319|454410292|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306461|NCT04791319|454410293|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306462|NCT04791319|454410294|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
126306463|NCT04791319|454410284|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
126306464|NCT04791319|454410285|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
126306465|NCT04791319|454410286|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
126306466|NCT04791319|454410287|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
126306467|NCT04791319|454410288|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126306468|NCT04791319|454410289|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126306469|NCT04791319|454410290|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126369913|NCT02769481|454650711|FG000|Overall Study|Death|0|||
126369914|NCT02769481|454650712|FG001|Overall Study|Death|1|||
126369915|NCT02769481|454650711|FG000|Overall Study|Undefined|4|||
126369916|NCT02769481|454650712|FG001|Overall Study|Undefined|1|||
126369917|NCT03510715|454650713|FG000|Overall Study|Adverse Event|1|||
126369918|NCT03510715|454650714|FG001|Overall Study|Adverse Event|0|||
126369919|NCT00643279|454650719|FG000|Overall Study|Death|13|||
126369920|NCT00643279|454650720|FG001|Overall Study|Death|11|||
126369921|NCT00643279|454650719|FG000|Overall Study|Withdrawal by Subject|3|||
126369922|NCT00643279|454650720|FG001|Overall Study|Withdrawal by Subject|0|||
126369923|NCT00643279|454650719|FG000|Overall Study|Lost to Follow-up|0|||
126369924|NCT00643279|454650720|FG001|Overall Study|Lost to Follow-up|1|||
126369925|NCT00643279|454650719|FG000|Overall Study|Physician Decision|0|||
126369926|NCT00643279|454650720|FG001|Overall Study|Physician Decision|1|||
126369927|NCT05715827|454650727|FG000|Overall Study|Physician Decision|0|||
126369928|NCT05715827|454650728|FG001|Overall Study|Physician Decision|1|||
126369929|NCT05715827|454650727|FG000|Overall Study|console communication error|0|||
126369930|NCT05715827|454650728|FG001|Overall Study|console communication error|1|||
126551927|NCT00867490|455315909|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
126551928|NCT00867490|455315909|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
126551929|NCT00867490|455315909|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
126551930|NCT02823964|455315910|FG000|Overall Study|Adverse Event|2|||
126551931|NCT02823964|455315910|FG000|Overall Study|Physician Decision|1|||
126551932|NCT02823964|455315910|FG000|Overall Study|Lack of Efficacy|1|||
126551933|NCT02823964|455315910|FG000|Overall Study|Withdrawal by Subject|1|||
126551934|NCT00390455|455315911|FG000|Overall Study|Adverse Event|17|||
126551935|NCT00390455|455315912|FG001|Overall Study|Adverse Event|3|||
126551936|NCT00390455|455315911|FG000|Overall Study|Withdrawal by Subject|8|||
126715232|NCT01259297|455908740|FG005|Double Blind Randomized Period|Death|5|||
126715233|NCT01259297|455908741|FG006|Double Blind Randomized Period|Death|2|||
126306470|NCT04791319|454410291|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126369931|NCT03814044|454650729|FG000|Overall Study|Protocol deviation|1|||
126369932|NCT05929326|454650730|FG000|Overall Study|unqualified sample|2|||
126369933|NCT05929326|454650731|FG001|Overall Study|unqualified sample|3|||
126369934|NCT05929326|454650732|FG002|Overall Study|unqualified sample|7|||
126551937|NCT00390455|455315912|FG001|Overall Study|Withdrawal by Subject|8|||
126551938|NCT00390455|455315911|FG000|Overall Study|Alternate Treatment|0|||
126369935|NCT03557502|454650741|FG000|Protocol 2|Withdrawal by Subject|1|||
126369936|NCT03557502|454650742|FG001|Protocol 2|Withdrawal by Subject|1|||
126369937|NCT03557502|454650741|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
126369938|NCT03557502|454650742|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
126369939|NCT02333799|454652218|FG000|Treatment Period|Withdrawal by Subject|1|||
126369940|NCT02333799|454652218|FG000|Treatment Period|Death|6|||
126715234|NCT01259297|455908742|FG007|Double Blind Randomized Period|Death|1|||
126715235|NCT01259297|455908735|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
126715236|NCT01259297|455908736|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
126715237|NCT01259297|455908737|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
126715238|NCT01259297|455908738|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
126715239|NCT01259297|455908739|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
126715240|NCT01259297|455908740|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
126715241|NCT01259297|455908741|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
126715242|NCT01259297|455908742|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
126715243|NCT01259297|455908735|FG000|Double Blind Randomized Period|Other reasons|0|||
126715244|NCT01259297|455908736|FG001|Double Blind Randomized Period|Other reasons|1|||
126715245|NCT01259297|455908737|FG002|Double Blind Randomized Period|Other reasons|0|||
126715246|NCT01259297|455908738|FG003|Double Blind Randomized Period|Other reasons|0|||
126715247|NCT01259297|455908739|FG004|Double Blind Randomized Period|Other reasons|1|||
126715248|NCT01259297|455908740|FG005|Double Blind Randomized Period|Other reasons|2|||
126715249|NCT01259297|455908741|FG006|Double Blind Randomized Period|Other reasons|3|||
126715250|NCT01259297|455908742|FG007|Double Blind Randomized Period|Other reasons|1|||
126715251|NCT00592501|455908743|FG000|Overall Study|Withdrawal by Subject|1|||
126715252|NCT00592501|455908743|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
126715253|NCT03880227|455908747|FG000|First Visit|Withdrawal by Subject|1|||
126551939|NCT00390455|455315912|FG001|Overall Study|Alternate Treatment|1|||
126551940|NCT00390455|455315911|FG000|Overall Study|Other Medical Reasons|7|||
126551941|NCT00390455|455315912|FG001|Overall Study|Other Medical Reasons|11|||
126369941|NCT02333799|454652218|FG000|6 Month Follow Up Period|Physician Decision|1|||
126369942|NCT02333799|454652218|FG000|6 Month Follow Up Period|Death|1|||
126369943|NCT02333799|454652218|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
126369944|NCT02333799|454652218|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
126369945|NCT01657370|454652222|FG000|Overall Study|Withdrawal by Subject|0|||
126369946|NCT01657370|454652223|FG001|Overall Study|Withdrawal by Subject|0|||
126369947|NCT01657370|454652224|FG002|Overall Study|Withdrawal by Subject|1|||
126369948|NCT01657370|454652225|FG003|Overall Study|Withdrawal by Subject|0|||
126369949|NCT01657370|454652226|FG004|Overall Study|Withdrawal by Subject|0|||
126369950|NCT01657370|454652227|FG005|Overall Study|Withdrawal by Subject|1|||
126369951|NCT01657370|454652222|FG000|Overall Study|Physician Decision|2|||
126369952|NCT01657370|454652223|FG001|Overall Study|Physician Decision|3|||
126369953|NCT01657370|454652224|FG002|Overall Study|Physician Decision|1|||
126369954|NCT01657370|454652225|FG003|Overall Study|Physician Decision|2|||
126369955|NCT01657370|454652226|FG004|Overall Study|Physician Decision|5|||
126369956|NCT01657370|454652227|FG005|Overall Study|Physician Decision|0|||
126369957|NCT01657370|454652222|FG000|Overall Study|Lack of Qualifying Event|1|||
126369958|NCT01657370|454652223|FG001|Overall Study|Lack of Qualifying Event|0|||
126369959|NCT01657370|454652224|FG002|Overall Study|Lack of Qualifying Event|3|||
126369960|NCT01657370|454652225|FG003|Overall Study|Lack of Qualifying Event|2|||
126369961|NCT01657370|454652226|FG004|Overall Study|Lack of Qualifying Event|1|||
126369962|NCT01657370|454652227|FG005|Overall Study|Lack of Qualifying Event|2|||
126369963|NCT01657370|454652222|FG000|Overall Study|Adverse Event|0|||
126369964|NCT01657370|454652223|FG001|Overall Study|Adverse Event|0|||
126369965|NCT01657370|454652224|FG002|Overall Study|Adverse Event|0|||
126369966|NCT01657370|454652225|FG003|Overall Study|Adverse Event|0|||
126369967|NCT01657370|454652226|FG004|Overall Study|Adverse Event|1|||
126369968|NCT01657370|454652227|FG005|Overall Study|Adverse Event|0|||
126369969|NCT01657370|454652222|FG000|Overall Study|Protocol Violation|1|||
126369970|NCT01657370|454652223|FG001|Overall Study|Protocol Violation|1|||
126369971|NCT01657370|454652224|FG002|Overall Study|Protocol Violation|1|||
126369972|NCT01657370|454652225|FG003|Overall Study|Protocol Violation|1|||
126369973|NCT01657370|454652226|FG004|Overall Study|Protocol Violation|0|||
126715254|NCT03880227|455908748|FG001|First Visit|Withdrawal by Subject|0|||
126715255|NCT03880227|455908749|FG002|First Visit|Withdrawal by Subject|0|||
126369974|NCT01657370|454652227|FG005|Overall Study|Protocol Violation|0|||
126369975|NCT01657370|454652222|FG000|Overall Study|Lost to Follow-up|2|||
126369976|NCT01657370|454652223|FG001|Overall Study|Lost to Follow-up|0|||
126369977|NCT01657370|454652224|FG002|Overall Study|Lost to Follow-up|1|||
126369978|NCT01657370|454652225|FG003|Overall Study|Lost to Follow-up|0|||
126369979|NCT01657370|454652226|FG004|Overall Study|Lost to Follow-up|0|||
126369980|NCT01657370|454652227|FG005|Overall Study|Lost to Follow-up|1|||
126369981|NCT03021486|454652228|FG000|Overall Study|Withdrawal by Subject|1|||
126551942|NCT00794820|455315916|FG000|Overall Study|Adverse Event|11|||
126369982|NCT03021486|454652229|FG001|Overall Study|Withdrawal by Subject|1|||
126369983|NCT03021486|454652230|FG002|Overall Study|Withdrawal by Subject|3|||
126369984|NCT03021486|454652228|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
126369985|NCT03021486|454652229|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
126369986|NCT03021486|454652230|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
126369987|NCT04795531|454652231|FG000|Overall Study|Withdrawal by Subject|4|||
126369988|NCT04795531|454652232|FG001|Overall Study|Withdrawal by Subject|4|||
126369989|NCT04795531|454652231|FG000|Overall Study|Lost to Follow-up|0|||
126369990|NCT04795531|454652232|FG001|Overall Study|Lost to Follow-up|1|||
126369991|NCT04795531|454652231|FG000|Overall Study|Physician Decision|0|||
126369992|NCT04795531|454652232|FG001|Overall Study|Physician Decision|2|||
126369993|NCT04795531|454652231|FG000|Overall Study|Death|2|||
126369994|NCT04795531|454652232|FG001|Overall Study|Death|1|||
126369995|NCT04887831|454652233|FG000|Overall Study|Death|26|||
126369996|NCT04887831|454652234|FG001|Overall Study|Death|26|||
126369997|NCT04887831|454652233|FG000|Overall Study|Lost to Follow-up|0|||
126369998|NCT04887831|454652234|FG001|Overall Study|Lost to Follow-up|1|||
126369999|NCT04887831|454652233|FG000|Overall Study|Withdrawal by Subject|2|||
126370000|NCT04887831|454652234|FG001|Overall Study|Withdrawal by Subject|1|||
126370001|NCT04887831|454652233|FG000|Overall Study|Study Terminated by Sponsor|18|||
126370002|NCT04887831|454652234|FG001|Overall Study|Study Terminated by Sponsor|17|||
126370003|NCT04887831|454652233|FG000|Overall Study|Other|1|||
126370004|NCT04887831|454652234|FG001|Overall Study|Other|0|||
126370005|NCT00730327|454652235|FG000|Overall Study|Lost to Follow-up|14|||
126370006|NCT00730327|454652236|FG001|Overall Study|Lost to Follow-up|16|||
126370007|NCT00730327|454652235|FG000|Overall Study|Adverse Event|8|||
126370008|NCT00730327|454652236|FG001|Overall Study|Adverse Event|1|||
126370009|NCT00730327|454652235|FG000|Overall Study|Withdrawal by Subject|3|||
126370010|NCT00730327|454652236|FG001|Overall Study|Withdrawal by Subject|13|||
126370011|NCT00730327|454652235|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
126370012|NCT00730327|454652236|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
126370013|NCT02552225|454652237|FG000|Overall Study|Withdrawal by Subject|1|||
126370014|NCT02552225|454652238|FG001|Overall Study|Withdrawal by Subject|0|||
126370015|NCT04507204|454652241|FG000|Overall Study|Adverse Event|8|||
126370016|NCT04507204|454652242|FG001|Overall Study|Adverse Event|13|||
126370017|NCT04507204|454652241|FG000|Overall Study|Death|0|||
126370018|NCT04507204|454652242|FG001|Overall Study|Death|1|||
126370019|NCT04507204|454652241|FG000|Overall Study|Lost to Follow-up|15|||
126370020|NCT04507204|454652242|FG001|Overall Study|Lost to Follow-up|14|||
126370021|NCT04507204|454652241|FG000|Overall Study|Poor Compliance with Protocol|2|||
126370022|NCT04507204|454652242|FG001|Overall Study|Poor Compliance with Protocol|4|||
126370023|NCT04507204|454652241|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
126370024|NCT04507204|454652242|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
126370025|NCT04507204|454652241|FG000|Overall Study|Withdrawal of Patient Consent|21|||
126370026|NCT04507204|454652242|FG001|Overall Study|Withdrawal of Patient Consent|13|||
126370027|NCT01206517|454652247|FG000|Overall Study|Withdrawal by Subject|0|||
126370028|NCT01206517|454652248|FG001|Overall Study|Withdrawal by Subject|0|||
126370029|NCT01206517|454652249|FG002|Overall Study|Withdrawal by Subject|2|||
126370030|NCT01206517|454652250|FG003|Overall Study|Withdrawal by Subject|0|||
126370031|NCT01206517|454652251|FG004|Overall Study|Withdrawal by Subject|1|||
126370032|NCT01206517|454652252|FG005|Overall Study|Withdrawal by Subject|0|||
126370033|NCT03493958|454652253|FG000|Overall Study|Withdrawal by Subject|6|||
126370034|NCT03493958|454652253|FG000|Overall Study|Lost to Follow-up|7|||
126370035|NCT03493958|454652253|FG000|Overall Study|Did not complete all required study procedures|2|||
126370036|NCT04047446|454652254|FG000|Overall Study|Physician Decision|1|||
126715256|NCT03880227|455908750|FG003|First Visit|Withdrawal by Subject|0|||
126370037|NCT04047446|454652255|FG001|Overall Study|Physician Decision|0|||
126370038|NCT02367456|454652256|FG000|Overall Study|Death|8|||
126370039|NCT02367456|454652257|FG001|Overall Study|Death|24|||
126370040|NCT02367456|454652258|FG002|Overall Study|Death|17|||
126370041|NCT02367456|454652256|FG000|Overall Study|Lost to Follow-up|1|||
126370042|NCT02367456|454652257|FG001|Overall Study|Lost to Follow-up|3|||
126370043|NCT02367456|454652258|FG002|Overall Study|Lost to Follow-up|1|||
126370044|NCT02367456|454652256|FG000|Overall Study|Other reason|3|||
126370045|NCT02367456|454652257|FG001|Overall Study|Other reason|3|||
126370046|NCT02367456|454652258|FG002|Overall Study|Other reason|9|||
126463974|NCT02964507|455000275|FG004|Overall Study|Study terminated by Sponsor|3|||
126463975|NCT02964507|455000276|FG005|Overall Study|Study terminated by Sponsor|2|||
126463976|NCT02964507|455000277|FG006|Overall Study|Study terminated by Sponsor|0|||
126463977|NCT02964507|455000278|FG007|Overall Study|Study terminated by Sponsor|0|||
126463978|NCT02964507|455000271|FG000|Overall Study|Other|3|||
126463979|NCT02964507|455000272|FG001|Overall Study|Other|0|||
126463980|NCT02964507|455000273|FG002|Overall Study|Other|0|||
126370047|NCT02367456|454652256|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
126463981|NCT02964507|455000274|FG003|Overall Study|Other|0|||
126370048|NCT02367456|454652257|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
126463982|NCT02964507|455000275|FG004|Overall Study|Other|1|||
126551943|NCT00794820|455315916|FG000|Overall Study|Secondary Malignancies|2|||
126551944|NCT00794820|455315916|FG000|Overall Study|Resistant Disease|2|||
126551945|NCT00794820|455315916|FG000|Overall Study|Ineligible/Screen Failure|1|||
126551946|NCT04076020|455315917|FG000|Overall Study|Death|4|||
126551947|NCT04076020|455315918|FG001|Overall Study|Death|6|||
126551948|NCT04076020|455315917|FG000|Overall Study|Withdrawal by Subject|12|||
126551949|NCT04076020|455315918|FG001|Overall Study|Withdrawal by Subject|8|||
126551950|NCT02310126|455315920|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
126551951|NCT02310126|455315921|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
126551952|NCT02310126|455315920|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
126551953|NCT02310126|455315921|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
126551954|NCT03537261|455315931|FG000|Overall Study|Lost to Follow-up|4|||
126551955|NCT03537261|455315932|FG001|Overall Study|Lost to Follow-up|5|||
126551956|NCT03537261|455315931|FG000|Overall Study|Withdrawal by Subject|4|||
126551957|NCT03537261|455315932|FG001|Overall Study|Withdrawal by Subject|6|||
126551958|NCT03537261|455315931|FG000|Overall Study|Did not return study questionnaires|0|||
126551959|NCT03537261|455315932|FG001|Overall Study|Did not return study questionnaires|1|||
126551960|NCT03237013|455315933|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
126551961|NCT03237013|455315934|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
126551962|NCT03237013|455315935|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
126551963|NCT00502996|455315938|FG000|Overall Study|Lost to Follow-up|9|||
126551964|NCT00502996|455315938|FG000|Overall Study|Protocol Violation|2|||
126551965|NCT00502996|455315938|FG000|Overall Study|Treatment failure|25|||
126551966|NCT00502996|455315938|FG000|Overall Study|Withdrawal Informed Consent|6|||
126551967|NCT00502996|455315938|FG000|Overall Study|Adverse Event|2|||
126551968|NCT01729728|455315939|FG000|Overall Study|Adverse Event|0|||
126551969|NCT01729728|455315940|FG001|Overall Study|Adverse Event|6|||
126551970|NCT01729728|455315941|FG002|Overall Study|Adverse Event|0|||
126306471|NCT04791319|454410292|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126306472|NCT04791319|454410293|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126306473|NCT04791319|454410294|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
126306474|NCT04791319|454410284|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
126306475|NCT04791319|454410285|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
126306476|NCT04791319|454410286|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
126306477|NCT04791319|454410287|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
126306478|NCT04791319|454410288|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306479|NCT04791319|454410289|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306480|NCT04791319|454410290|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306481|NCT04791319|454410291|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306482|NCT04791319|454410292|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306483|NCT04791319|454410293|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306484|NCT04791319|454410294|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
126306485|NCT04791319|454410284|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306486|NCT04791319|454410285|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306487|NCT04791319|454410286|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306488|NCT04791319|454410287|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
126306489|NCT04791319|454410288|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306490|NCT04791319|454410289|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306491|NCT04791319|454410290|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306492|NCT04791319|454410291|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306493|NCT04791319|454410292|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306494|NCT04791319|454410293|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306495|NCT04791319|454410294|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
126306496|NCT04791319|454410284|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306497|NCT04791319|454410285|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306498|NCT04791319|454410286|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306499|NCT04791319|454410287|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306500|NCT04791319|454410288|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
126306501|NCT04791319|454410289|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
126306502|NCT04791319|454410290|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
126551971|NCT01729728|455315939|FG000|Overall Study|Protocol Violation|1|||
126551972|NCT01729728|455315940|FG001|Overall Study|Protocol Violation|0|||
126551973|NCT01729728|455315941|FG002|Overall Study|Protocol Violation|1|||
126551974|NCT02500979|455315942|FG000|Period 1|Hyperglycemia|1|||
126551975|NCT02500979|455315943|FG001|Period 1|Hyperglycemia|0|||
126551976|NCT02500979|455315942|FG000|Period 1|Severe non-compliance to protocol|0|||
126551977|NCT02500979|455315943|FG001|Period 1|Severe non-compliance to protocol|1|||
126551978|NCT02500979|455315942|FG000|Period 1|Adverse Event|1|||
126551979|NCT02500979|455315943|FG001|Period 1|Adverse Event|0|||
126370049|NCT02367456|454652258|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
126370050|NCT01198587|454652264|FG000|Overall Study|Lost to Follow-up|8|||
126370051|NCT01198587|454652265|FG001|Overall Study|Lost to Follow-up|0|||
126370052|NCT01198587|454652266|FG002|Overall Study|Lost to Follow-up|9|||
126370053|NCT01198587|454652267|FG003|Overall Study|Lost to Follow-up|0|||
126370054|NCT02095106|454652270|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
126370055|NCT02095106|454652271|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
126370056|NCT00553254|454652274|FG000|Overall Study|Death|3|||
126370057|NCT00553254|454652275|FG001|Overall Study|Death|6|||
126370058|NCT00553254|454652276|FG002|Overall Study|Death|25|||
126370059|NCT00553254|454652274|FG000|Overall Study|Lost to Follow-up|0|||
126370060|NCT00553254|454652275|FG001|Overall Study|Lost to Follow-up|0|||
126370061|NCT00553254|454652276|FG002|Overall Study|Lost to Follow-up|2|||
126370062|NCT00553254|454652274|FG000|Overall Study|Withdrawal by Subject|2|||
126370063|NCT00553254|454652275|FG001|Overall Study|Withdrawal by Subject|0|||
126370064|NCT00553254|454652276|FG002|Overall Study|Withdrawal by Subject|2|||
126370065|NCT00553254|454652274|FG000|Overall Study|Study terminated by Sponsor|0|||
126370066|NCT00553254|454652275|FG001|Overall Study|Study terminated by Sponsor|0|||
126370067|NCT00553254|454652276|FG002|Overall Study|Study terminated by Sponsor|1|||
126370068|NCT00553254|454652274|FG000|Overall Study|Other|1|||
126370069|NCT00553254|454652275|FG001|Overall Study|Other|0|||
126370070|NCT00553254|454652276|FG002|Overall Study|Other|13|||
126370071|NCT01500317|454652284|FG000|Overall Study|Withdrawal by Subject|3|||
126370072|NCT01500317|454652285|FG001|Overall Study|Withdrawal by Subject|2|||
126370073|NCT01500317|454652286|FG002|Overall Study|Withdrawal by Subject|0|||
126370074|NCT00754572|454652287|FG000|Overall Study|Adverse Event|19|||
126370075|NCT00754572|454652287|FG000|Overall Study|Other|39|||
126370076|NCT00754572|454652287|FG000|Overall Study|Protocol Violation|3|||
126370077|NCT00754572|454652287|FG000|Overall Study|Withdrawal by Subject|3|||
126370078|NCT00754572|454652287|FG000|Overall Study|Lack of Efficacy|2|||
126370079|NCT00754572|454652287|FG000|Overall Study|Death|1|||
126370080|NCT00754572|454652287|FG000|Overall Study|Administrative Reason|3|||
126370081|NCT00754572|454652287|FG000|Overall Study|Lost to Follow-up|1|||
126370082|NCT03746015|454652291|FG000|Overall Study|Withdrawal of Consent|1|||
126370083|NCT03746015|454652292|FG001|Overall Study|Withdrawal of Consent|0|||
126370084|NCT03746015|454652293|FG002|Overall Study|Withdrawal of Consent|0|||
126370085|NCT05134649|454652294|FG000|Overall Study|Lost to Follow-up|12|||
126370086|NCT05134649|454652294|FG000|Overall Study|Withdrawal by Subject|14|||
126370087|NCT05134649|454652294|FG000|Overall Study|Pregnancy|1|||
126370088|NCT05134649|454652294|FG000|Overall Study|Other, not specified|3|||
126370089|NCT01559935|454652295|FG000|Car Phase|Toxicity|4|||
126370090|NCT01559935|454652295|FG000|Car Phase|Death|1|||
126370091|NCT01559935|454652295|FG000|Car Phase|Lack of Efficacy|2|||
126370092|NCT01559935|454652295|FG000|Car Phase|Lost to Follow-up|1|||
126370093|NCT01559935|454652295|FG000|Car Phase|Physician Decision|1|||
126370094|NCT01559935|454652295|FG000|Car Phase|Withdrawal by Subject|2|||
126370095|NCT01559935|454652295|FG000|Car Phase|Per protocol|1|||
126370096|NCT01559935|454652295|FG000|Car Phase|Insurance|1|||
126370097|NCT01559935|454652295|FG000|Car Phase|non-compliance|1|||
126370098|NCT01559935|454652295|FG000|BiRD Phase|Toxicity|1|||
126370099|NCT01559935|454652295|FG000|BiRD Phase|Lack of Efficacy|1|||
126370100|NCT01559935|454652295|FG000|BiRD Phase|Withdrawal by Subject|2|||
126370101|NCT01559935|454652295|FG000|Maintenance Phase|Remains on study|28|||
126370102|NCT01559935|454652295|FG000|Maintenance Phase|Toxicity|1|||
126370103|NCT01559935|454652295|FG000|Maintenance Phase|Lack of Efficacy|18|||
126370104|NCT01559935|454652295|FG000|Maintenance Phase|Withdrawal by Subject|5|||
126370105|NCT01559935|454652295|FG000|Maintenance Phase|Non-compliance|2|||
126370106|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370107|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
126463983|NCT02964507|455000276|FG005|Overall Study|Other|0|||
126463984|NCT02964507|455000277|FG006|Overall Study|Other|0|||
126463985|NCT02964507|455000278|FG007|Overall Study|Other|0|||
126463986|NCT02964507|455000271|FG000|Overall Study|Death|11|||
126370108|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370109|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
126370110|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
126463987|NCT02964507|455000272|FG001|Overall Study|Death|9|||
126370111|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
126370112|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
126463988|NCT02964507|455000273|FG002|Overall Study|Death|12|||
126370113|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370114|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370115|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370116|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370117|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370118|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370119|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126463989|NCT02964507|455000274|FG003|Overall Study|Death|2|||
126463990|NCT02964507|455000275|FG004|Overall Study|Death|10|||
126715257|NCT03880227|455908747|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
126715258|NCT03880227|455908748|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
126715259|NCT03880227|455908749|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
126370120|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370121|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
126370122|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
126370123|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
126370124|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
126370125|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
126370126|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
126370127|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
126370128|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
126370129|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
126370130|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
126715260|NCT03880227|455908750|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
126370131|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
126370132|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
126370133|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
126370134|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
126370135|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
126370136|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
126370137|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
126370138|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
126370139|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
126370140|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370141|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370142|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370143|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370144|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370145|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370146|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370147|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370148|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370149|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370150|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370151|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370152|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370153|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
126370154|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
126370155|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370156|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
126370157|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
126370158|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
126370159|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
126370160|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
126370161|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370162|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370163|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370164|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370165|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370166|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370167|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370168|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370169|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126370170|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370171|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370172|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370173|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
126370174|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370175|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370176|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
126370177|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126463991|NCT02964507|455000276|FG005|Overall Study|Death|5|||
126463992|NCT02964507|455000277|FG006|Overall Study|Death|0|||
126463993|NCT02964507|455000278|FG007|Overall Study|Death|0|||
126715261|NCT03880227|455908747|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
126715262|NCT03880227|455908748|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
126715263|NCT03880227|455908749|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
126370178|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370179|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370180|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370181|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126551980|NCT02500979|455315942|FG000|Period 1|Subject decision|2|||
126551981|NCT02500979|455315943|FG001|Period 1|Subject decision|0|||
126551982|NCT02500979|455315942|FG000|Period 2|Change in risk|1|||
126551983|NCT02500979|455315943|FG001|Period 2|Change in risk|0|||
126551984|NCT00672958|455315944|FG000|Overall Study|Adverse Event|11|||
126551985|NCT00672958|455315945|FG001|Overall Study|Adverse Event|9|||
126551986|NCT00672958|455315944|FG000|Overall Study|Lack of Efficacy|6|||
126551987|NCT00672958|455315945|FG001|Overall Study|Lack of Efficacy|11|||
126551988|NCT00672958|455315944|FG000|Overall Study|Non-compliance with study drug|2|||
126551989|NCT00672958|455315945|FG001|Overall Study|Non-compliance with study drug|3|||
126551990|NCT00672958|455315944|FG000|Overall Study|Protocol deviations|11|||
126551991|NCT00672958|455315945|FG001|Overall Study|Protocol deviations|5|||
126551992|NCT00672958|455315944|FG000|Overall Study|Voluntary withdrawal|12|||
126551993|NCT00672958|455315945|FG001|Overall Study|Voluntary withdrawal|8|||
126551994|NCT00672958|455315944|FG000|Overall Study|Lost to Follow-up|22|||
126551995|NCT00672958|455315945|FG001|Overall Study|Lost to Follow-up|17|||
126551996|NCT00672958|455315944|FG000|Overall Study|Reason not specified|0|||
126551997|NCT00672958|455315945|FG001|Overall Study|Reason not specified|3|||
126551998|NCT01380990|455315946|FG000|Overall Study|Treatment Failure|1|||
126551999|NCT01380990|455315947|FG001|Overall Study|Treatment Failure|0|||
126552000|NCT01380990|455315946|FG000|Overall Study|Death|0|||
126552001|NCT01380990|455315947|FG001|Overall Study|Death|1|||
126552002|NCT02374593|455315948|FG000|Overall Study|non-compliant|2|||
126552003|NCT02374593|455315949|FG001|Overall Study|non-compliant|0|||
126552004|NCT04267614|455315951|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
126552005|NCT04267614|455315951|FG000|Overall Study|Lost to Follow-up|115|||
126552006|NCT01927731|455315957|FG000|Overall Study|Graft Failure|1|||
126552007|NCT01927731|455315958|FG001|Overall Study|Graft Failure|2|||
126552008|NCT01927731|455315957|FG000|Overall Study|Physician Decision|2|||
126552009|NCT01927731|455315958|FG001|Overall Study|Physician Decision|3|||
126552010|NCT01927731|455315957|FG000|Overall Study|Withdrawal by Subject|0|||
126552011|NCT01927731|455315958|FG001|Overall Study|Withdrawal by Subject|2|||
126552012|NCT01927731|455315957|FG000|Overall Study|Death|0|||
126552013|NCT01927731|455315958|FG001|Overall Study|Death|3|||
126552014|NCT01388530|455315959|FG000|Overall Study|Lost to Follow-up|5|||
126552015|NCT00305864|455315962|FG000|Overall Study|Ineligible / No protocol treatment|0|||
126552016|NCT00305864|455315963|FG001|Overall Study|Ineligible / No protocol treatment|1|||
126306503|NCT04791319|454410291|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306504|NCT04791319|454410292|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306505|NCT04791319|454410293|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
126306506|NCT04791319|454410294|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
126306507|NCT04791319|454410284|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306508|NCT04791319|454410285|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306509|NCT04791319|454410286|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306510|NCT04791319|454410287|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306511|NCT04791319|454410288|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306512|NCT04791319|454410289|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306513|NCT04791319|454410290|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306514|NCT04791319|454410291|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306515|NCT04791319|454410292|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306516|NCT04791319|454410293|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
126306517|NCT04791319|454410294|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
126306518|NCT04791319|454410284|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
126306519|NCT04791319|454410285|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
126306520|NCT04791319|454410286|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
126306521|NCT04791319|454410287|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
126306522|NCT04791319|454410288|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
126640391|NCT03445533|455642761|FG000|Overall Study|Lost to Follow-up|0|||
126640392|NCT03445533|455642762|FG001|Overall Study|Lost to Follow-up|1|||
126640393|NCT03445533|455642761|FG000|Overall Study|Never Received any Study Treatment|7|||
126640394|NCT03445533|455642762|FG001|Overall Study|Never Received any Study Treatment|4|||
126640395|NCT00968526|455642764|FG000|Overall Study|Adverse Event|2|||
126640396|NCT00968526|455642765|FG001|Overall Study|Adverse Event|0|||
126640397|NCT00968526|455642764|FG000|Overall Study|Migrated/moved from study area|1|||
126640398|NCT00968526|455642765|FG001|Overall Study|Migrated/moved from study area|0|||
126640399|NCT00945672|455642766|FG000|Overall Study|Withdrawal by Subject|0|||
126640400|NCT00945672|455642767|FG001|Overall Study|Withdrawal by Subject|0|||
126715264|NCT03880227|455908750|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
126715265|NCT03880227|455908747|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
126306523|NCT04791319|454410289|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
126306524|NCT04791319|454410290|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
126306525|NCT04791319|454410291|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
126306526|NCT04791319|454410292|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
126306527|NCT04791319|454410293|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
126306528|NCT04791319|454410294|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
126306529|NCT04791319|454410284|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
126306530|NCT04791319|454410285|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
126306531|NCT04791319|454410286|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
126306532|NCT04791319|454410287|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
126306533|NCT04791319|454410288|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
126306534|NCT04791319|454410289|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
126306535|NCT04791319|454410290|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
126306536|NCT04791319|454410291|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
126306537|NCT04791319|454410292|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
126306538|NCT04791319|454410293|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
126306539|NCT04791319|454410294|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
126306540|NCT04087720|454410301|FG000|Overall Study|Withdrawal by Subject|2|||
126306541|NCT04087720|454410301|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
126306542|NCT03706430|454410302|FG000|Overall Study|No A-Line placed|5|||
126306543|NCT03706430|454410302|FG000|Overall Study|Subject had gel nail polish|1|||
126306544|NCT03706430|454410302|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
126306545|NCT03706430|454410302|FG000|Overall Study|Cancelled Case|6|||
126306546|NCT03706430|454410302|FG000|Overall Study|Physician Decision|2|||
126306547|NCT00520533|454410303|FG000|Overall Study|Death|1|||
126306548|NCT00520533|454410303|FG000|Overall Study|Suspension of the study for safety reasons|1|||
126306549|NCT00520533|454410303|FG000|Overall Study|Withdrawal by Subject|1|||
126306550|NCT00520533|454410303|FG000|Overall Study|Physician Decision|1|||
126306551|NCT01726270|454410310|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
126306552|NCT01726270|454410310|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
126306553|NCT01726270|454410310|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
126306554|NCT01726270|454410310|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
126306555|NCT01726270|454410310|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
126306556|NCT01726270|454410310|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
126306557|NCT00582608|454410311|FG000|Overall Study|Not Treated|7|||
126306558|NCT00582608|454410311|FG000|Overall Study|Patient Ineligible|1|||
126306559|NCT00582608|454410311|FG000|Overall Study|Lack of accrual|4|||
126306560|NCT02504827|454410323|FG000|Overall Study|Could not produce sputum|1|||
126306561|NCT03386994|454410324|FG000|Overall Study|Lung transplant|1|||
126306562|NCT03386994|454410324|FG000|Overall Study|Adverse Event|14|||
126306563|NCT03386994|454410324|FG000|Overall Study|Lost to Follow-up|4|||
126306564|NCT03386994|454410324|FG000|Overall Study|Withdrawal by Subject|3|||
126306565|NCT03386994|454410324|FG000|Overall Study|Death|16|||
126306566|NCT01732640|454410330|FG000|Overall Study|Adverse Event|0|||
126306567|NCT01732640|454410331|FG001|Overall Study|Adverse Event|1|||
126306568|NCT01732640|454410330|FG000|Overall Study|Death|0|||
126306569|NCT01732640|454410331|FG001|Overall Study|Death|1|||
126306570|NCT00877487|454410332|FG000|Open-label Treatment Phase|Adverse Event|1|||
126306571|NCT00877487|454410333|FG001|Open-label Treatment Phase|Adverse Event|0|||
126306572|NCT00877487|454410332|FG000|Open-label Treatment Phase|Protocol Violation|3|||
126306573|NCT00877487|454410333|FG001|Open-label Treatment Phase|Protocol Violation|0|||
126306574|NCT00877487|454410332|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
126306575|NCT00877487|454410333|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
126306576|NCT00877487|454410332|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
126715266|NCT03880227|455908748|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
126756515|NCT02719028|456059454|FG003|Overall Study|Adverse Event|8|||
126306577|NCT00877487|454410333|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
126306578|NCT00877487|454410332|FG000|Open-label Treatment Phase|Out of country for business|1|||
126306579|NCT00877487|454410333|FG001|Open-label Treatment Phase|Out of country for business|0|||
126306580|NCT00877487|454410332|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
126306581|NCT00877487|454410333|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
126306582|NCT00877487|454410332|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
126306583|NCT00877487|454410333|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
126306584|NCT00877487|454410332|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
126306585|NCT00877487|454410333|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
126552017|NCT00305864|455315964|FG002|Overall Study|Ineligible / No protocol treatment|1|||
126552018|NCT00305864|455315965|FG003|Overall Study|Ineligible / No protocol treatment|13|||
126552019|NCT02836613|455315968|FG000|Overall Study|Accidental drowning|1|||
126552020|NCT02836613|455315969|FG001|Overall Study|Accidental drowning|0|||
126552021|NCT02836613|455315968|FG000|Overall Study|Lost to Follow-up|0|||
126552022|NCT02836613|455315969|FG001|Overall Study|Lost to Follow-up|1|||
126552023|NCT02836613|455315968|FG000|Overall Study|Withdrawal by Subject|0|||
126552024|NCT02836613|455315969|FG001|Overall Study|Withdrawal by Subject|2|||
126552025|NCT03881059|455315970|FG000|Treatment Period - Part A|Adverse Event|1|||
126552026|NCT03881059|455315971|FG001|Treatment Period - Part A|Adverse Event|3|||
126306586|NCT00877487|454410332|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
126306587|NCT00877487|454410333|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
126306588|NCT03070002|454410334|FG000|Follow up for 2 Years|Death|1|||
126306589|NCT00712543|454410335|FG000|Day 8-14|Lost to Follow-up|0|||
126306590|NCT00712543|454410336|FG001|Day 8-14|Lost to Follow-up|2|||
126306591|NCT02729051|454410339|FG000|Overall Study|Adverse Event|21|||
126552027|NCT03881059|455315972|FG002|Treatment Period - Part A|Adverse Event|4|||
126552028|NCT03881059|455315970|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
126552029|NCT03881059|455315971|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
126552030|NCT03881059|455315972|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
126552031|NCT03881059|455315970|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
126552032|NCT03881059|455315971|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
126552033|NCT03881059|455315972|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
126552034|NCT03881059|455315970|FG000|Treatment Period - Part A|Other reasons|2|||
126770400|NCT02575807|456112472|FG003|Overall Study|Terminated due to physician decision|0|||
126770401|NCT02575807|456112473|FG004|Overall Study|Terminated due to physician decision|0|||
126306592|NCT02729051|454410340|FG001|Overall Study|Adverse Event|11|||
126306593|NCT02729051|454410339|FG000|Overall Study|Lack of Efficacy|1|||
126306594|NCT02729051|454410340|FG001|Overall Study|Lack of Efficacy|1|||
126306595|NCT02729051|454410339|FG000|Overall Study|Lost to Follow-up|1|||
126306596|NCT02729051|454410340|FG001|Overall Study|Lost to Follow-up|2|||
126306597|NCT02729051|454410339|FG000|Overall Study|Physician Decision|1|||
126306598|NCT02729051|454410340|FG001|Overall Study|Physician Decision|1|||
126306599|NCT02729051|454410339|FG000|Overall Study|Withdrawal by Subject|6|||
126306600|NCT02729051|454410340|FG001|Overall Study|Withdrawal by Subject|17|||
126306601|NCT02702388|454410341|FG000|Overall Study|Disease Progression|18|||
126306602|NCT02702388|454410342|FG001|Overall Study|Disease Progression|25|||
126306603|NCT02702388|454410341|FG000|Overall Study|Withdrawal by Subject|9|||
126306604|NCT02702388|454410342|FG001|Overall Study|Withdrawal by Subject|7|||
126306605|NCT02702388|454410341|FG000|Overall Study|Adverse Event|11|||
126306606|NCT02702388|454410342|FG001|Overall Study|Adverse Event|15|||
126306607|NCT02702388|454410341|FG000|Overall Study|Other|2|||
126306608|NCT02702388|454410342|FG001|Overall Study|Other|4|||
126306609|NCT04740827|454410352|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
126306610|NCT04740827|454410353|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
126306611|NCT04740827|454410352|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
126306612|NCT04740827|454410353|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
126306613|NCT04740827|454410352|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
126306614|NCT04740827|454410353|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
126306615|NCT04740827|454410352|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
126370182|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370183|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370184|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370185|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
126370186|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370187|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370188|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
126370189|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370190|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370191|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370192|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126552035|NCT03881059|455315971|FG001|Treatment Period - Part A|Other reasons|1|||
126370193|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370194|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370195|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370196|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370197|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370198|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126370199|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126552036|NCT03881059|455315972|FG002|Treatment Period - Part A|Other reasons|0|||
126306616|NCT04740827|454410353|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
126306617|NCT04740827|454410352|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
126306618|NCT04740827|454410353|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
126306619|NCT04740827|454410352|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
126306620|NCT04740827|454410353|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
126306621|NCT02147158|454410354|FG000|Treatment Course 1|Adverse Event|1|||
126306622|NCT02147158|454410355|FG001|Treatment Course 1|Adverse Event|4|||
126306623|NCT02147158|454410356|FG002|Treatment Course 1|Adverse Event|3|||
126306624|NCT02147158|454410357|FG003|Treatment Course 1|Adverse Event|4|||
126306625|NCT02147158|454410358|FG004|Treatment Course 1|Adverse Event|1|||
126306626|NCT02147158|454410359|FG005|Treatment Course 1|Adverse Event|2|||
126306627|NCT02147158|454410354|FG000|Treatment Course 1|Lost to Follow-up|2|||
126306628|NCT02147158|454410355|FG001|Treatment Course 1|Lost to Follow-up|4|||
126306629|NCT02147158|454410356|FG002|Treatment Course 1|Lost to Follow-up|3|||
126306630|NCT02147158|454410357|FG003|Treatment Course 1|Lost to Follow-up|3|||
126306631|NCT02147158|454410358|FG004|Treatment Course 1|Lost to Follow-up|2|||
126306632|NCT02147158|454410359|FG005|Treatment Course 1|Lost to Follow-up|4|||
126306633|NCT02147158|454410354|FG000|Treatment Course 1|Protocol Violation|0|||
126306634|NCT02147158|454410355|FG001|Treatment Course 1|Protocol Violation|0|||
126306635|NCT02147158|454410356|FG002|Treatment Course 1|Protocol Violation|1|||
126306636|NCT02147158|454410357|FG003|Treatment Course 1|Protocol Violation|1|||
126306637|NCT02147158|454410358|FG004|Treatment Course 1|Protocol Violation|0|||
126306638|NCT02147158|454410359|FG005|Treatment Course 1|Protocol Violation|0|||
126306639|NCT02147158|454410354|FG000|Treatment Course 1|Withdrawal of Consent|1|||
126306640|NCT02147158|454410355|FG001|Treatment Course 1|Withdrawal of Consent|1|||
126306641|NCT02147158|454410356|FG002|Treatment Course 1|Withdrawal of Consent|1|||
126306642|NCT02147158|454410357|FG003|Treatment Course 1|Withdrawal of Consent|5|||
126306643|NCT02147158|454410358|FG004|Treatment Course 1|Withdrawal of Consent|3|||
126306644|NCT02147158|454410359|FG005|Treatment Course 1|Withdrawal of Consent|2|||
126306645|NCT02147158|454410354|FG000|Off-Treatment Interval 1|Adverse Event|1|||
126306646|NCT02147158|454410355|FG001|Off-Treatment Interval 1|Adverse Event|0|||
126306647|NCT02147158|454410356|FG002|Off-Treatment Interval 1|Adverse Event|0|||
126306648|NCT02147158|454410357|FG003|Off-Treatment Interval 1|Adverse Event|1|||
126306649|NCT02147158|454410358|FG004|Off-Treatment Interval 1|Adverse Event|0|||
126306650|NCT02147158|454410359|FG005|Off-Treatment Interval 1|Adverse Event|0|||
126306651|NCT02147158|454410354|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
126306652|NCT02147158|454410355|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
126306653|NCT02147158|454410356|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
126306654|NCT02147158|454410357|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
126306655|NCT02147158|454410358|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
126306656|NCT02147158|454410359|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
126306657|NCT02147158|454410354|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
126306658|NCT02147158|454410355|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
126306659|NCT02147158|454410356|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
126306660|NCT02147158|454410357|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
126306661|NCT02147158|454410358|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
126306662|NCT02147158|454410359|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
126306663|NCT02147158|454410354|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
126306664|NCT02147158|454410355|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
126306665|NCT02147158|454410356|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
126306666|NCT02147158|454410357|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
126306667|NCT02147158|454410358|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
126306668|NCT02147158|454410359|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
126306669|NCT02147158|454410354|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
126370200|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126306670|NCT02147158|454410355|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
126306671|NCT02147158|454410356|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
126306672|NCT02147158|454410357|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
126306673|NCT02147158|454410358|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
126306674|NCT02147158|454410359|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
126306675|NCT02147158|454410354|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
126306676|NCT02147158|454410355|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
126306677|NCT02147158|454410356|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
126306678|NCT02147158|454410357|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
126306679|NCT02147158|454410358|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
126370201|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
126756516|NCT02719028|456059451|FG000|Overall Study|Physician Decision|0|||
126756517|NCT02719028|456059452|FG001|Overall Study|Physician Decision|1|||
126756518|NCT02719028|456059453|FG002|Overall Study|Physician Decision|1|||
126756519|NCT02719028|456059454|FG003|Overall Study|Physician Decision|1|||
126756520|NCT02719028|456059451|FG000|Overall Study|Use of prohibited medication|0|||
126756521|NCT02719028|456059452|FG001|Overall Study|Use of prohibited medication|0|||
126370202|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
126370203|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
126370204|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
126370205|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370206|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370207|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370208|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370209|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370210|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370211|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370212|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370213|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370214|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370215|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370216|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370217|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126370218|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
126370219|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
126370220|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
126370221|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
126370222|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
126370223|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
126370224|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
126370225|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
126370226|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
126715267|NCT03880227|455908749|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
126715268|NCT03880227|455908750|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
126370227|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
126370228|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
126463994|NCT02964507|455000271|FG000|Overall Study|Withdrawal by Subject|1|||
126463995|NCT02964507|455000272|FG001|Overall Study|Withdrawal by Subject|0|||
126463996|NCT02964507|455000273|FG002|Overall Study|Withdrawal by Subject|1|||
126463997|NCT02964507|455000274|FG003|Overall Study|Withdrawal by Subject|1|||
126463998|NCT02964507|455000275|FG004|Overall Study|Withdrawal by Subject|0|||
126463999|NCT02964507|455000276|FG005|Overall Study|Withdrawal by Subject|1|||
126464000|NCT02964507|455000277|FG006|Overall Study|Withdrawal by Subject|0|||
126464001|NCT02964507|455000278|FG007|Overall Study|Withdrawal by Subject|0|||
126464002|NCT02964507|455000271|FG000|Overall Study|Physician Decision|2|||
126464003|NCT02964507|455000272|FG001|Overall Study|Physician Decision|0|||
126464004|NCT02964507|455000273|FG002|Overall Study|Physician Decision|3|||
126464005|NCT02964507|455000274|FG003|Overall Study|Physician Decision|0|||
126464006|NCT02964507|455000275|FG004|Overall Study|Physician Decision|1|||
126464007|NCT02964507|455000276|FG005|Overall Study|Physician Decision|0|||
126464008|NCT02964507|455000277|FG006|Overall Study|Physician Decision|0|||
126464009|NCT02964507|455000278|FG007|Overall Study|Physician Decision|0|||
126464010|NCT02675231|455000279|FG000|Overall Study|Withdrawal by Subject|2|||
126464011|NCT02675231|455000280|FG001|Overall Study|Withdrawal by Subject|4|||
126464012|NCT02675231|455000281|FG002|Overall Study|Withdrawal by Subject|2|||
126464013|NCT02675231|455000279|FG000|Overall Study|Lost to Follow-up|3|||
126464014|NCT02675231|455000280|FG001|Overall Study|Lost to Follow-up|4|||
126464015|NCT02675231|455000281|FG002|Overall Study|Lost to Follow-up|3|||
126464016|NCT02495233|455000284|FG000|Overall Study|Miscellaneous|0|||
126464017|NCT02495233|455000285|FG001|Overall Study|Miscellaneous|1|||
126464018|NCT03880461|455000287|FG000|Overall Study|Determined ineligible after enrollment|45|||
126464019|NCT03880461|455000288|FG001|Overall Study|Determined ineligible after enrollment|44|||
126464020|NCT03880461|455000287|FG000|Overall Study|No weight measurement after enrollment|24|||
126464021|NCT03880461|455000288|FG001|Overall Study|No weight measurement after enrollment|17|||
126464022|NCT04025710|455000292|FG000|Overall Study|Death|3|||
126464023|NCT04025710|455000292|FG000|Overall Study|Lost to Follow-up|5|||
126464024|NCT04025710|455000292|FG000|Overall Study|Withdrawal by Subject|1|||
126464025|NCT04025710|455000292|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
126464026|NCT04025710|455000292|FG000|Overall Study|Drop-out according to protocol|34|||
126464027|NCT02431247|455000293|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
126715269|NCT02399475|455908753|FG000|Overall Study|Physician Decision|1|||
126715270|NCT02399475|455908754|FG001|Overall Study|Physician Decision|0|||
126715271|NCT01963117|455908755|FG000|Overall Study|Death|1|||
126715272|NCT01605396|455908756|FG000|Overall Study|Adverse Event|5|||
126715273|NCT01605396|455908757|FG001|Overall Study|Adverse Event|3|||
126715274|NCT01605396|455908756|FG000|Overall Study|Lost to Follow-up|1|||
126370229|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
126370230|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
126464028|NCT02431247|455000294|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
126715275|NCT01605396|455908757|FG001|Overall Study|Lost to Follow-up|0|||
126370231|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
126370232|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
126370233|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
126370234|NCT02958865|454652296|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370235|NCT02958865|454652297|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370236|NCT02958865|454652298|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370237|NCT02958865|454652299|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370238|NCT02958865|454652300|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
126370239|NCT02958865|454652301|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370240|NCT02958865|454652302|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370241|NCT02958865|454652303|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370242|NCT02958865|454652304|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370243|NCT02958865|454652305|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370244|NCT02958865|454652306|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370245|NCT02958865|454652307|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370246|NCT02958865|454652308|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370247|NCT02958865|454652309|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370248|NCT02958865|454652310|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370249|NCT02958865|454652311|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126370250|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370251|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370252|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370253|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370254|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370255|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370256|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126370257|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
126370258|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
126370259|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
126370260|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
126464029|NCT02431247|455000295|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
126464030|NCT02431247|455000293|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
126715276|NCT01605396|455908756|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126715277|NCT01605396|455908757|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126715278|NCT01605396|455908756|FG000|Overall Study|Physician Decision|2|||
126464031|NCT02431247|455000294|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
126464032|NCT02431247|455000295|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
126464033|NCT02431247|455000293|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
126464034|NCT02431247|455000294|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
126464035|NCT02431247|455000295|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
126464036|NCT02431247|455000293|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
126464037|NCT02431247|455000294|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
126464038|NCT02431247|455000295|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
126464039|NCT02431247|455000293|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
126464040|NCT02431247|455000294|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
126464041|NCT02431247|455000295|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
126464042|NCT02431247|455000293|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
126464043|NCT02431247|455000294|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
126464044|NCT02431247|455000295|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
126464045|NCT02431247|455000293|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
126464046|NCT02431247|455000294|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
126464047|NCT02431247|455000295|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
126464048|NCT02431247|455000293|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
126464049|NCT02431247|455000294|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
126464050|NCT02431247|455000295|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
126464051|NCT02431247|455000293|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
126464052|NCT02431247|455000294|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
126464053|NCT02431247|455000295|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
126464054|NCT02431247|455000293|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
126464055|NCT02431247|455000294|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
126464056|NCT02431247|455000295|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
126464057|NCT02431247|455000293|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
126464058|NCT02431247|455000294|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
126464059|NCT02431247|455000295|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
126370261|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
126464060|NCT02431247|455000293|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
126715279|NCT01605396|455908757|FG001|Overall Study|Physician Decision|2|||
126306680|NCT02147158|454410359|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
126306681|NCT02147158|454410354|FG000|Treatment Course 2|Adverse Event|0|||
126306682|NCT02147158|454410355|FG001|Treatment Course 2|Adverse Event|4|||
126306683|NCT02147158|454410356|FG002|Treatment Course 2|Adverse Event|2|||
126306684|NCT02147158|454410357|FG003|Treatment Course 2|Adverse Event|1|||
126306685|NCT02147158|454410358|FG004|Treatment Course 2|Adverse Event|0|||
126306686|NCT02147158|454410359|FG005|Treatment Course 2|Adverse Event|1|||
126306687|NCT02147158|454410354|FG000|Treatment Course 2|Withdrawal of Consent|0|||
126306688|NCT02147158|454410355|FG001|Treatment Course 2|Withdrawal of Consent|1|||
126306689|NCT02147158|454410356|FG002|Treatment Course 2|Withdrawal of Consent|2|||
126306690|NCT02147158|454410357|FG003|Treatment Course 2|Withdrawal of Consent|3|||
126306691|NCT02147158|454410358|FG004|Treatment Course 2|Withdrawal of Consent|0|||
126306692|NCT02147158|454410359|FG005|Treatment Course 2|Withdrawal of Consent|0|||
126306693|NCT02147158|454410354|FG000|Treatment Course 2|Lost to Follow-up|1|||
126306694|NCT02147158|454410355|FG001|Treatment Course 2|Lost to Follow-up|0|||
126306695|NCT02147158|454410356|FG002|Treatment Course 2|Lost to Follow-up|1|||
126306696|NCT02147158|454410357|FG003|Treatment Course 2|Lost to Follow-up|1|||
126306697|NCT02147158|454410358|FG004|Treatment Course 2|Lost to Follow-up|0|||
126306698|NCT02147158|454410359|FG005|Treatment Course 2|Lost to Follow-up|1|||
126306699|NCT02147158|454410354|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
126306700|NCT02147158|454410355|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
126306701|NCT02147158|454410356|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
126306702|NCT02147158|454410357|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
126306703|NCT02147158|454410358|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
126306704|NCT02147158|454410359|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
126306705|NCT02147158|454410354|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
126306706|NCT02147158|454410355|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
126306707|NCT02147158|454410356|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
126306708|NCT02147158|454410357|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
126306709|NCT02147158|454410358|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
126306710|NCT02147158|454410359|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
126306711|NCT02147158|454410354|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
126306712|NCT02147158|454410355|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
126306713|NCT02147158|454410356|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
126306714|NCT02147158|454410357|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
126306715|NCT02147158|454410358|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
126306716|NCT02147158|454410359|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
126306717|NCT02147158|454410354|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
126306718|NCT02147158|454410355|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
126306719|NCT02147158|454410356|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
126306720|NCT02147158|454410357|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
126306721|NCT02147158|454410358|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
126306722|NCT02147158|454410359|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
126306723|NCT02147158|454410354|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
126306724|NCT02147158|454410355|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
126306725|NCT02147158|454410356|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
126306726|NCT02147158|454410357|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
126306727|NCT02147158|454410358|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
126306728|NCT02147158|454410359|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
126306729|NCT01441765|454410360|FG000|Overall Study|Death|1|||
126306730|NCT01441765|454410361|FG001|Overall Study|Death|0|||
126306731|NCT04445714|454410362|FG000|Overall Study|Discontinuation of the study|14|||
126306732|NCT04445714|454410362|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
126306733|NCT04445714|454410362|FG000|Overall Study|Withdrawal of Informed Consent|8|||
126306734|NCT02805660|454410363|FG000|Overall Study|Death|5|||
126306735|NCT02805660|454410364|FG001|Overall Study|Death|2|||
126306736|NCT02805660|454410365|FG002|Overall Study|Death|9|||
126306737|NCT02805660|454410366|FG003|Overall Study|Death|5|||
126306738|NCT02805660|454410367|FG004|Overall Study|Death|0|||
126306739|NCT02805660|454410368|FG005|Overall Study|Death|14|||
126306740|NCT02805660|454410369|FG006|Overall Study|Death|12|||
126306741|NCT02805660|454410363|FG000|Overall Study|Lost to Follow-up|0|||
126306742|NCT02805660|454410364|FG001|Overall Study|Lost to Follow-up|1|||
126306743|NCT02805660|454410365|FG002|Overall Study|Lost to Follow-up|1|||
126370262|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
126370263|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
126370264|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
126370265|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
126370266|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370267|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370268|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126464061|NCT02431247|455000294|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
126370269|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126306744|NCT02805660|454410366|FG003|Overall Study|Lost to Follow-up|2|||
126306745|NCT02805660|454410367|FG004|Overall Study|Lost to Follow-up|0|||
126306746|NCT02805660|454410368|FG005|Overall Study|Lost to Follow-up|0|||
126306747|NCT02805660|454410369|FG006|Overall Study|Lost to Follow-up|0|||
126306748|NCT02805660|454410363|FG000|Overall Study|Withdrawal by Subject|0|||
126306749|NCT02805660|454410364|FG001|Overall Study|Withdrawal by Subject|0|||
126306750|NCT02805660|454410365|FG002|Overall Study|Withdrawal by Subject|0|||
126306751|NCT02805660|454410366|FG003|Overall Study|Withdrawal by Subject|3|||
126306752|NCT02805660|454410367|FG004|Overall Study|Withdrawal by Subject|1|||
126306753|NCT02805660|454410368|FG005|Overall Study|Withdrawal by Subject|0|||
126306754|NCT02805660|454410369|FG006|Overall Study|Withdrawal by Subject|2|||
126306755|NCT02805660|454410363|FG000|Overall Study|Study terminated by Sponsor|0|||
126306756|NCT02805660|454410364|FG001|Overall Study|Study terminated by Sponsor|0|||
126306757|NCT02805660|454410365|FG002|Overall Study|Study terminated by Sponsor|1|||
126306758|NCT02805660|454410366|FG003|Overall Study|Study terminated by Sponsor|4|||
126306759|NCT02805660|454410367|FG004|Overall Study|Study terminated by Sponsor|2|||
126306760|NCT02805660|454410368|FG005|Overall Study|Study terminated by Sponsor|3|||
126306761|NCT02805660|454410369|FG006|Overall Study|Study terminated by Sponsor|1|||
126306762|NCT02805660|454410363|FG000|Overall Study|Miscellaneous|0|||
126306763|NCT02805660|454410364|FG001|Overall Study|Miscellaneous|1|||
126306764|NCT02805660|454410365|FG002|Overall Study|Miscellaneous|0|||
126306765|NCT02805660|454410366|FG003|Overall Study|Miscellaneous|4|||
126306766|NCT02805660|454410367|FG004|Overall Study|Miscellaneous|0|||
126306767|NCT02805660|454410368|FG005|Overall Study|Miscellaneous|6|||
126306768|NCT02805660|454410369|FG006|Overall Study|Miscellaneous|4|||
126306769|NCT01435018|454411886|FG000|Overall Study|Death|37|||
126306770|NCT01435018|454411887|FG001|Overall Study|Death|18|||
126306771|NCT01435018|454411888|FG002|Overall Study|Death|25|||
126306772|NCT01435018|454411886|FG000|Overall Study|Site is closing|4|||
126306773|NCT01435018|454411887|FG001|Overall Study|Site is closing|9|||
126306774|NCT01435018|454411888|FG002|Overall Study|Site is closing|7|||
126306775|NCT01435018|454411886|FG000|Overall Study|Withdrew consent|0|||
126306776|NCT01435018|454411887|FG001|Overall Study|Withdrew consent|3|||
126306777|NCT01435018|454411888|FG002|Overall Study|Withdrew consent|1|||
126306778|NCT01435018|454411886|FG000|Overall Study|Not willing to adhere to requirements|0|||
126306779|NCT01435018|454411887|FG001|Overall Study|Not willing to adhere to requirements|2|||
126306780|NCT01435018|454411888|FG002|Overall Study|Not willing to adhere to requirements|3|||
126306781|NCT01435018|454411886|FG000|Overall Study|Not able to get to clinic|2|||
126306782|NCT01435018|454411887|FG001|Overall Study|Not able to get to clinic|0|||
126306783|NCT01435018|454411888|FG002|Overall Study|Not able to get to clinic|2|||
126306784|NCT01435018|454411886|FG000|Overall Study|Severe debilitation, unable to continue|0|||
126306785|NCT01435018|454411887|FG001|Overall Study|Severe debilitation, unable to continue|0|||
126306786|NCT01435018|454411888|FG002|Overall Study|Severe debilitation, unable to continue|1|||
126306787|NCT01435018|454411886|FG000|Overall Study|Unable to contact participant/parent|1|||
126306788|NCT01435018|454411887|FG001|Overall Study|Unable to contact participant/parent|1|||
126306789|NCT01435018|454411888|FG002|Overall Study|Unable to contact participant/parent|1|||
126306790|NCT01435018|454411886|FG000|Overall Study|Enrollment Violation|0|||
126306791|NCT01435018|454411887|FG001|Overall Study|Enrollment Violation|1|||
126306792|NCT01435018|454411888|FG002|Overall Study|Enrollment Violation|0|||
126306793|NCT01435018|454411886|FG000|Overall Study|Never started chemotherapy|3|||
126306794|NCT01435018|454411887|FG001|Overall Study|Never started chemotherapy|0|||
126306795|NCT01435018|454411888|FG002|Overall Study|Never started chemotherapy|1|||
126306796|NCT00769067|454411889|FG000|Overall Study|Death|89|||
126306797|NCT00769067|454411890|FG001|Overall Study|Death|86|||
126306798|NCT00769067|454411889|FG000|Overall Study|Lost to Follow-up|3|||
126306799|NCT00769067|454411890|FG001|Overall Study|Lost to Follow-up|1|||
126306800|NCT00769067|454411889|FG000|Overall Study|Study terminated by sponsor|1|||
126306801|NCT00769067|454411890|FG001|Overall Study|Study terminated by sponsor|3|||
126306802|NCT00769067|454411889|FG000|Overall Study|Other|1|||
126306803|NCT00769067|454411890|FG001|Overall Study|Other|3|||
126306804|NCT00769067|454411889|FG000|Overall Study|Withdrawal by Subject|0|||
126306805|NCT00769067|454411890|FG001|Overall Study|Withdrawal by Subject|1|||
126306806|NCT03806933|454411891|FG000|Main Period|Physician Decision|0|||
126306807|NCT03806933|454411892|FG001|Main Period|Physician Decision|0|||
126306808|NCT03806933|454411893|FG002|Main Period|Physician Decision|0|||
126306809|NCT03806933|454411894|FG003|Main Period|Physician Decision|1|||
126306810|NCT03806933|454411891|FG000|Main Period|Pregnancy|0|||
126306811|NCT03806933|454411892|FG001|Main Period|Pregnancy|0|||
126306812|NCT03806933|454411893|FG002|Main Period|Pregnancy|1|||
126306813|NCT03806933|454411894|FG003|Main Period|Pregnancy|0|||
126306814|NCT03806933|454411891|FG000|Main Period|Withdrawal by Subject|2|||
126306815|NCT03806933|454411892|FG001|Main Period|Withdrawal by Subject|1|||
126306816|NCT03806933|454411893|FG002|Main Period|Withdrawal by Subject|1|||
126306817|NCT03806933|454411894|FG003|Main Period|Withdrawal by Subject|2|||
126306818|NCT03806933|454411891|FG000|Main Period|Lost to Follow-up|2|||
126306819|NCT03806933|454411892|FG001|Main Period|Lost to Follow-up|2|||
126306820|NCT03806933|454411893|FG002|Main Period|Lost to Follow-up|0|||
126306821|NCT03806933|454411894|FG003|Main Period|Lost to Follow-up|0|||
126370270|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370271|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370272|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370273|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370274|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
126370275|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
126370276|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370277|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
126370278|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370279|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
126370280|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
126370281|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
126370282|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370283|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370284|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370285|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370286|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370287|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370288|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370289|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370290|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370291|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
126370292|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370293|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370294|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370295|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370296|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
126370297|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
126370298|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370299|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370300|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370301|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370302|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370303|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370304|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370305|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370306|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370307|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370308|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
126370309|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
126370310|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
126370311|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
126370312|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
126370313|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
126370314|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
126370315|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
126370316|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
126370317|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
126370318|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
126370319|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
126370320|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
126370321|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
126370322|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
126370323|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
126370324|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
126370325|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
126715280|NCT01605396|455908756|FG000|Overall Study|Progressive Disease|23|||
126715281|NCT01605396|455908757|FG001|Overall Study|Progressive Disease|27|||
126715282|NCT01605396|455908756|FG000|Overall Study|Withdrawal by Subject|4|||
126715283|NCT01605396|455908757|FG001|Overall Study|Withdrawal by Subject|2|||
126715284|NCT01605396|455908756|FG000|Overall Study|Transfer Off Study|4|||
126715285|NCT01605396|455908757|FG001|Overall Study|Transfer Off Study|5|||
126715286|NCT03009539|455910520|FG000|Overall Study|Lost to Follow-up|132|||
126715287|NCT03009539|455910521|FG001|Overall Study|Lost to Follow-up|113|||
126715288|NCT03009539|455910522|FG002|Overall Study|Lost to Follow-up|132|||
126715289|NCT03009539|455910523|FG003|Overall Study|Lost to Follow-up|113|||
126715290|NCT03151148|455910524|FG000|Overall Study|Lost to Follow-up|1|||
126715291|NCT03151148|455910525|FG001|Overall Study|Lost to Follow-up|0|||
126715292|NCT03151148|455910524|FG000|Overall Study|Withdrawal by Subject|1|||
126715293|NCT03151148|455910525|FG001|Overall Study|Withdrawal by Subject|0|||
126464062|NCT02431247|455000295|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
126464063|NCT02431247|455000293|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
126464064|NCT02431247|455000294|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
126464065|NCT02431247|455000295|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
126464066|NCT02431247|455000293|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
126464067|NCT02431247|455000294|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
126464068|NCT02431247|455000295|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
126464069|NCT01562873|455000296|FG000|Overall Study|Disease Progression per RECIST|10|||
126464070|NCT01562873|455000297|FG001|Overall Study|Disease Progression per RECIST|0|||
126464071|NCT01562873|455000296|FG000|Overall Study|Adverse Event|1|||
126464072|NCT01562873|455000297|FG001|Overall Study|Adverse Event|0|||
126464073|NCT01562873|455000296|FG000|Overall Study|Clinical Disease Progression|9|||
126464074|NCT01562873|455000297|FG001|Overall Study|Clinical Disease Progression|0|||
126464075|NCT01562873|455000296|FG000|Overall Study|Clinical PD and adverse event|1|||
126464076|NCT01562873|455000297|FG001|Overall Study|Clinical PD and adverse event|0|||
126464077|NCT01369485|455000298|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
126464078|NCT01369485|455000299|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
126464079|NCT01369485|455000298|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
126464080|NCT01369485|455000299|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
126464081|NCT01369485|455000298|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
126464082|NCT01369485|455000299|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
126464083|NCT01369485|455000298|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
126464084|NCT01369485|455000299|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
126464085|NCT01369485|455000298|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
126464086|NCT01369485|455000299|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
126464087|NCT01369485|455000298|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
126464088|NCT01369485|455000299|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
126464089|NCT01369485|455000298|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
126464090|NCT01369485|455000299|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
126464091|NCT01369485|455000298|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
126464092|NCT01369485|455000299|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
126464093|NCT01369485|455000298|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
126464094|NCT01369485|455000299|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
126464095|NCT01369485|455000298|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
126464096|NCT01369485|455000299|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
126464097|NCT01858636|455000301|FG000|Overall Study|No Device Deployment Attempted|24|||
126464098|NCT01858636|455000301|FG000|Overall Study|Physician Decision|1|||
126464099|NCT01858636|455000301|FG000|Overall Study|Death|1|||
126464100|NCT01858636|455000301|FG000|Overall Study|Lost to Follow-up|1|||
126464101|NCT01858636|455000301|FG000|Overall Study|Withdrawal by Subject|1|||
126552037|NCT03881059|455315970|FG000|Treatment Period - Part B|Adverse Event|0|||
126552038|NCT03881059|455315971|FG001|Treatment Period - Part B|Adverse Event|0|||
126552039|NCT03881059|455315972|FG002|Treatment Period - Part B|Adverse Event|3|||
126552040|NCT03881059|455315970|FG000|Treatment Period - Part B|Death|0|||
126552041|NCT03881059|455315971|FG001|Treatment Period - Part B|Death|1|||
126552042|NCT03881059|455315972|FG002|Treatment Period - Part B|Death|1|||
126552043|NCT03881059|455315970|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
126552044|NCT03881059|455315971|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
126552045|NCT03881059|455315972|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
126552046|NCT03881059|455315970|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
126552047|NCT03881059|455315971|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
126552048|NCT03881059|455315972|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
126552049|NCT03881059|455315970|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
126552050|NCT03881059|455315971|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
126552051|NCT03881059|455315972|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
126552052|NCT03881059|455315970|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
126715294|NCT00494871|455910526|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
126715295|NCT00494871|455910527|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
126715296|NCT00494871|455910526|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
126715297|NCT00494871|455910527|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
126715298|NCT00494871|455910526|FG000|Double-blind (DB) Treatment Period|Death|8|||
126715299|NCT00494871|455910527|FG001|Double-blind (DB) Treatment Period|Death|3|||
126715300|NCT00494871|455910526|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
126715301|NCT00494871|455910527|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
126715302|NCT00494871|455910526|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
126715303|NCT00494871|455910527|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
126715304|NCT00494871|455910526|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
126715305|NCT00494871|455910527|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
126715306|NCT00494871|455910526|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
126370326|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
126370327|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
126370328|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
126370329|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
126370330|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370331|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370332|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370333|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370334|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370335|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370336|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370337|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370338|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370339|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370340|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370341|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370342|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370343|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
126370344|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370345|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
126370346|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370347|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370348|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370349|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370350|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370351|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370352|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370353|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370354|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370355|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370356|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370357|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370358|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370359|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
126370360|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370361|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
126370362|NCT02958865|454652296|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370363|NCT02958865|454652297|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370364|NCT02958865|454652298|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370365|NCT02958865|454652299|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370366|NCT02958865|454652300|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370367|NCT02958865|454652301|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370368|NCT02958865|454652302|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370369|NCT02958865|454652303|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370370|NCT02958865|454652304|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370371|NCT02958865|454652305|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
126370372|NCT02958865|454652306|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370373|NCT02958865|454652307|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370374|NCT02958865|454652308|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370375|NCT02958865|454652309|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370376|NCT02958865|454652310|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126715307|NCT00494871|455910527|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
126715308|NCT00494871|455910526|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
126715309|NCT00494871|455910527|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
126715310|NCT00494871|455910526|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
126370377|NCT02958865|454652311|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
126370378|NCT01038323|454652325|FG000|Overall Study|Withdrawal by Subject|3|||
126370379|NCT01038323|454652326|FG001|Overall Study|Withdrawal by Subject|2|||
126370380|NCT01038323|454652327|FG002|Overall Study|Withdrawal by Subject|4|||
126370381|NCT01143402|454652328|FG000|Overall Study|Rapid clinical decline|1|||
126370382|NCT01143402|454652329|FG001|Overall Study|Rapid clinical decline|1|||
126370383|NCT01143402|454652330|FG002|Overall Study|Rapid clinical decline|0|||
126370384|NCT01143402|454652328|FG000|Overall Study|Not Treated|0|||
126370385|NCT01143402|454652329|FG001|Overall Study|Not Treated|0|||
126306822|NCT03806933|454411891|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
126306823|NCT03806933|454411892|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
126306824|NCT03806933|454411893|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
126306825|NCT03806933|454411894|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
126306826|NCT03625466|454411895|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
126306827|NCT03625466|454411896|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
126306828|NCT03625466|454411897|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
126306829|NCT03625466|454411895|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
126306830|NCT03625466|454411896|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
126306831|NCT03625466|454411897|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
126306832|NCT03625466|454411895|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
126306833|NCT03625466|454411896|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
126306834|NCT03625466|454411897|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
126306835|NCT00809471|454411900|FG000|Overall Study|Protocol non-compliance|15|||
126306836|NCT00809471|454411901|FG001|Overall Study|Protocol non-compliance|15|||
126306837|NCT00809471|454411902|FG002|Overall Study|Protocol non-compliance|6|||
126306838|NCT00809471|454411900|FG000|Overall Study|Lost to Follow-up|4|||
126306839|NCT00809471|454411901|FG001|Overall Study|Lost to Follow-up|2|||
126306840|NCT00809471|454411902|FG002|Overall Study|Lost to Follow-up|9|||
126306841|NCT00809471|454411900|FG000|Overall Study|Adverse Event|0|||
126306842|NCT00809471|454411901|FG001|Overall Study|Adverse Event|2|||
126306843|NCT00809471|454411902|FG002|Overall Study|Adverse Event|2|||
126306844|NCT00809471|454411900|FG000|Overall Study|Requirement for restricted medication|1|||
126306845|NCT00809471|454411901|FG001|Overall Study|Requirement for restricted medication|1|||
126306846|NCT00809471|454411902|FG002|Overall Study|Requirement for restricted medication|0|||
126306847|NCT01868438|454411903|FG000|First Intervention|Withdrawal by Subject|5|||
126306848|NCT01868438|454411904|FG001|First Intervention|Withdrawal by Subject|1|||
126306849|NCT01868438|454411903|FG000|First Intervention|Lost to Follow-up|2|||
126306850|NCT01868438|454411904|FG001|First Intervention|Lost to Follow-up|3|||
126306851|NCT01868438|454411903|FG000|First Intervention|Meeting the non-redosing criteria|0|||
126306852|NCT01868438|454411904|FG001|First Intervention|Meeting the non-redosing criteria|1|||
126306853|NCT01868438|454411903|FG000|Second Intervention|Adverse Event|3|||
126306854|NCT01868438|454411904|FG001|Second Intervention|Adverse Event|3|||
126306855|NCT03528369|454411907|FG000|Overall Study|Withdrawal by Subject|2|||
126306856|NCT03528369|454411908|FG001|Overall Study|Withdrawal by Subject|0|||
126306857|NCT03528369|454411909|FG002|Overall Study|Withdrawal by Subject|0|||
126306858|NCT03528369|454411907|FG000|Overall Study|Lost to Follow-up|1|||
126306859|NCT03528369|454411908|FG001|Overall Study|Lost to Follow-up|0|||
126306860|NCT03528369|454411909|FG002|Overall Study|Lost to Follow-up|0|||
126306861|NCT03528369|454411907|FG000|Overall Study|Adverse Event|0|||
126306862|NCT03528369|454411908|FG001|Overall Study|Adverse Event|1|||
126306863|NCT03528369|454411909|FG002|Overall Study|Adverse Event|0|||
126306864|NCT03555565|454411910|FG000|Overall Study|Case Report Forms Uncollected|2|||
126306865|NCT03555565|454411910|FG000|Overall Study|Protocol Deviation|13|||
126306866|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
126306867|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
126306868|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
126306869|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
126306870|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
126306871|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
126306872|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
126306873|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
126306874|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Death|0|||
126306875|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Death|1|||
126306876|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
126306877|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
126306878|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
126306879|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
126306880|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
126306881|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
126306882|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
126306883|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
126306884|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
126306885|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
126306886|NCT00394836|454411911|FG000|Teatment or Follow-up Phase|Non compliance|0|||
126306887|NCT00394836|454411912|FG001|Teatment or Follow-up Phase|Non compliance|1|||
126370386|NCT01143402|454652330|FG002|Overall Study|Not Treated|1|||
126370387|NCT02526290|454652331|FG000|Overall Study|Adverse Event|3|||
126370388|NCT02526290|454652331|FG000|Overall Study|Withdrawal by Subject|4|||
126370389|NCT02526290|454652331|FG000|Overall Study|Physician Decision|1|||
126370390|NCT01380080|454652333|FG000|Overall Study|Death|36|||
126370391|NCT01380080|454652334|FG001|Overall Study|Death|44|||
126370392|NCT01380080|454652333|FG000|Overall Study|Site is closing|28|||
126370393|NCT01380080|454652334|FG001|Overall Study|Site is closing|31|||
126370394|NCT01380080|454652333|FG000|Overall Study|Not able to get to clinic|7|||
126370395|NCT01380080|454652334|FG001|Overall Study|Not able to get to clinic|1|||
126370396|NCT01380080|454652333|FG000|Overall Study|Not willing to adhere to requirements|6|||
126370397|NCT01380080|454652334|FG001|Overall Study|Not willing to adhere to requirements|2|||
126370398|NCT01380080|454652333|FG000|Overall Study|Withdrawal by Subject|5|||
126370399|NCT01380080|454652334|FG001|Overall Study|Withdrawal by Subject|2|||
126370400|NCT01380080|454652333|FG000|Overall Study|Lost to Follow-up|3|||
126370401|NCT01380080|454652334|FG001|Overall Study|Lost to Follow-up|3|||
126370402|NCT00210132|454652339|FG000|Overall Study|Protocol Violation|1|||
126370403|NCT00210132|454652340|FG001|Overall Study|Protocol Violation|4|||
126370404|NCT00432965|454652341|FG000|Overall Study|Lost to Follow-up|22|||
126370405|NCT00432965|454652342|FG001|Overall Study|Lost to Follow-up|19|||
126370406|NCT00432965|454652341|FG000|Overall Study|Withdrawal by Subject|13|||
126370407|NCT00432965|454652342|FG001|Overall Study|Withdrawal by Subject|13|||
126370408|NCT00432965|454652341|FG000|Overall Study|Physician Decision|14|||
126370409|NCT00432965|454652342|FG001|Overall Study|Physician Decision|13|||
126370410|NCT00432965|454652341|FG000|Overall Study|Lack of Efficacy|8|||
126370411|NCT00432965|454652342|FG001|Overall Study|Lack of Efficacy|13|||
126370412|NCT00432965|454652341|FG000|Overall Study|Non-compliance|7|||
126370413|NCT00432965|454652342|FG001|Overall Study|Non-compliance|0|||
126370414|NCT00432965|454652341|FG000|Overall Study|Adverse Event|22|||
126370415|NCT00432965|454652342|FG001|Overall Study|Adverse Event|19|||
126370416|NCT00432965|454652341|FG000|Overall Study|Death|3|||
126370417|NCT00432965|454652342|FG001|Overall Study|Death|4|||
126370418|NCT00432965|454652341|FG000|Overall Study|Exclusionary Methods|1|||
126370419|NCT00432965|454652342|FG001|Overall Study|Exclusionary Methods|2|||
126370420|NCT00432965|454652341|FG000|Overall Study|Incomplete Data|4|||
126370421|NCT00432965|454652342|FG001|Overall Study|Incomplete Data|3|||
126370422|NCT03636022|454652343|FG000|Overall Study|Withdrawal by Subject|1|||
126370423|NCT03636022|454652344|FG001|Overall Study|Withdrawal by Subject|3|||
126370424|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
126370425|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
126370426|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
126370427|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
126370428|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
126370429|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
126370430|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
126370431|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
126370432|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
126370433|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
126370434|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
126370435|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
126370436|NCT04532749|454652345|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
126370437|NCT04532749|454652346|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
126370438|NCT04532749|454652345|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
126370439|NCT04532749|454652346|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
126370440|NCT04532749|454652345|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
126370441|NCT04532749|454652346|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
126370442|NCT04532749|454652345|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
126370443|NCT04532749|454652346|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
126370444|NCT00642759|454652347|FG000|Overall Study|Protocol Violation|1|||
126370445|NCT03612570|454652352|FG000|Overall Study|Lost to Follow-up|1|||
126370446|NCT02255435|454653631|FG000|Overall Study|Patient's Limited Time Availability|0|||
126370447|NCT02255435|454653632|FG001|Overall Study|Patient's Limited Time Availability|0|||
126370448|NCT02255435|454653633|FG002|Overall Study|Patient's Limited Time Availability|0|||
126370449|NCT02255435|454653634|FG003|Overall Study|Patient's Limited Time Availability|0|||
126370450|NCT02255435|454653635|FG004|Overall Study|Patient's Limited Time Availability|0|||
126370451|NCT02255435|454653636|FG005|Overall Study|Patient's Limited Time Availability|0|||
126715311|NCT00494871|455910527|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
126715312|NCT00494871|455910526|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
126715313|NCT00494871|455910527|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
126370452|NCT02255435|454653637|FG006|Overall Study|Patient's Limited Time Availability|0|||
126370453|NCT02255435|454653638|FG007|Overall Study|Patient's Limited Time Availability|1|||
126370454|NCT02255435|454653639|FG008|Overall Study|Patient's Limited Time Availability|0|||
126715314|NCT00494871|455910526|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
126370455|NCT02255435|454653640|FG009|Overall Study|Patient's Limited Time Availability|0|||
126464102|NCT03523000|455000303|FG000|Overall Study|Withdrawal by Subject|3|||
126464103|NCT03523000|455000304|FG001|Overall Study|Withdrawal by Subject|0|||
126370456|NCT02255435|454653631|FG000|Overall Study|Withdrawal by Subject|0|||
126715315|NCT00494871|455910527|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
126306888|NCT00394836|454411911|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
126306889|NCT00394836|454411912|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
126306890|NCT00394836|454411911|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
126306891|NCT00394836|454411912|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
126306892|NCT00394836|454411911|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
126306893|NCT00394836|454411912|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
126306894|NCT00394836|454411911|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
126306895|NCT00394836|454411912|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
126306896|NCT01289639|454411927|FG000|Overall Study|Lost to Follow-up|1|||
126306897|NCT01289639|454411928|FG001|Overall Study|Lost to Follow-up|0|||
126306898|NCT01289639|454411929|FG002|Overall Study|Lost to Follow-up|0|||
126306899|NCT02780713|454411930|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
126306900|NCT02780713|454411931|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
126306901|NCT02780713|454411932|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
126306902|NCT02780713|454411933|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
126306903|NCT02780713|454411934|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
126306904|NCT02111577|454411935|FG000|Overall Study|Protocol Violation|2|||
126306905|NCT02111577|454411936|FG001|Overall Study|Protocol Violation|0|||
126306906|NCT02111577|454411935|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
126306907|NCT02111577|454411936|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
126306908|NCT02111577|454411935|FG000|Overall Study|Failure to produce study treatment|6|||
126306909|NCT02111577|454411936|FG001|Overall Study|Failure to produce study treatment|0|||
126306910|NCT02111577|454411935|FG000|Overall Study|Death|518|||
126306911|NCT02111577|454411936|FG001|Overall Study|Death|254|||
126306912|NCT02111577|454411935|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
126306913|NCT02111577|454411936|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
126306914|NCT02111577|454411935|FG000|Overall Study|Adverse Event|1|||
126306915|NCT02111577|454411936|FG001|Overall Study|Adverse Event|1|||
126306916|NCT02111577|454411935|FG000|Overall Study|Withdrawal by Subject|51|||
126306917|NCT02111577|454411936|FG001|Overall Study|Withdrawal by Subject|23|||
126306918|NCT02111577|454411935|FG000|Overall Study|Disease progression|0|||
126306919|NCT02111577|454411936|FG001|Overall Study|Disease progression|1|||
126306920|NCT02111577|454411935|FG000|Overall Study|Lost to Follow-up|19|||
126306921|NCT02111577|454411936|FG001|Overall Study|Lost to Follow-up|10|||
126306922|NCT02042950|454411937|FG000|Overall Study|Progressive Disease|4|||
126306923|NCT02429778|454411940|FG000|Overall Study|Lost to Follow-up|2|||
126306924|NCT02429778|454411941|FG001|Overall Study|Lost to Follow-up|0|||
126306925|NCT02429778|454411940|FG000|Overall Study|Withdrawal by Subject|5|||
126306926|NCT02429778|454411941|FG001|Overall Study|Withdrawal by Subject|0|||
126306927|NCT03521115|454411942|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
126306928|NCT03521115|454411943|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
126306929|NCT03521115|454411942|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
126306930|NCT03521115|454411943|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
126306931|NCT01981954|454411950|FG000|Titration Period|Protocol Deviation|1|||
126306932|NCT01981954|454411950|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
126306933|NCT03655470|454411951|FG000|Overall Study|Lost to Follow-up|6|||
126306934|NCT03655470|454411952|FG001|Overall Study|Lost to Follow-up|7|||
126306935|NCT01893281|454411953|FG000|Overall Study|Adverse Event|1|||
126306936|NCT01893281|454411953|FG000|Overall Study|Protocol Violation|1|||
126306937|NCT01893281|454411953|FG000|Overall Study|Withdrawal by Subject|1|||
126306938|NCT05481125|454411954|FG000|Overall Study|Adverse Event|1|||
126306939|NCT05481125|454411955|FG001|Overall Study|Adverse Event|0|||
126306940|NCT05481125|454411954|FG000|Overall Study|Lost to Follow-up|0|||
126306941|NCT05481125|454411955|FG001|Overall Study|Lost to Follow-up|1|||
126306942|NCT05481125|454411954|FG000|Overall Study|Withdrawal by Subject|0|||
126306943|NCT05481125|454411955|FG001|Overall Study|Withdrawal by Subject|1|||
126306944|NCT03615144|454411956|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
126306945|NCT03615144|454411957|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
126306946|NCT02587598|454411960|FG000|Overall Study|Death|4|||
126306947|NCT02587598|454411961|FG001|Overall Study|Death|8|||
126306948|NCT02587598|454411962|FG002|Overall Study|Death|4|||
126306949|NCT02587598|454411963|FG003|Overall Study|Death|16|||
126306950|NCT02587598|454411964|FG004|Overall Study|Death|9|||
126306951|NCT02587598|454411965|FG005|Overall Study|Death|4|||
126306952|NCT02587598|454411966|FG006|Overall Study|Death|6|||
126306953|NCT02587598|454411967|FG007|Overall Study|Death|7|||
126306954|NCT02587598|454411968|FG008|Overall Study|Death|9|||
126715316|NCT00494871|455910526|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
126715317|NCT00494871|455910527|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
126715318|NCT00494871|455910526|FG000|Follow-up (FU) Period|Adverse Event|1|||
126715319|NCT00494871|455910527|FG001|Follow-up (FU) Period|Adverse Event|1|||
126715320|NCT00494871|455910526|FG000|Follow-up (FU) Period|Death|13|||
126715321|NCT00494871|455910527|FG001|Follow-up (FU) Period|Death|12|||
126306955|NCT02587598|454411969|FG009|Overall Study|Death|1|||
126306956|NCT02587598|454411970|FG010|Overall Study|Death|3|||
126306957|NCT02587598|454411960|FG000|Overall Study|Study Terminated by the Sponsor|0|||
126306958|NCT02587598|454411961|FG001|Overall Study|Study Terminated by the Sponsor|1|||
126306959|NCT02587598|454411962|FG002|Overall Study|Study Terminated by the Sponsor|0|||
126306960|NCT02587598|454411963|FG003|Overall Study|Study Terminated by the Sponsor|3|||
126306961|NCT02587598|454411964|FG004|Overall Study|Study Terminated by the Sponsor|0|||
126306962|NCT02587598|454411965|FG005|Overall Study|Study Terminated by the Sponsor|1|||
126306963|NCT02587598|454411966|FG006|Overall Study|Study Terminated by the Sponsor|0|||
126306964|NCT02587598|454411967|FG007|Overall Study|Study Terminated by the Sponsor|0|||
126306965|NCT02587598|454411968|FG008|Overall Study|Study Terminated by the Sponsor|0|||
126770402|NCT02575807|456112469|FG000|Overall Study|Subject ineligible - medical implant|0|||
126770403|NCT02575807|456112470|FG001|Overall Study|Subject ineligible - medical implant|0|||
126770404|NCT02575807|456112471|FG002|Overall Study|Subject ineligible - medical implant|0|||
126306966|NCT02587598|454411969|FG009|Overall Study|Study Terminated by the Sponsor|1|||
126370457|NCT02255435|454653632|FG001|Overall Study|Withdrawal by Subject|0|||
126715322|NCT00494871|455910526|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
126715323|NCT00494871|455910527|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
126715324|NCT00494871|455910526|FG000|Follow-up (FU) Period|Physician Decision|0|||
126715325|NCT00494871|455910527|FG001|Follow-up (FU) Period|Physician Decision|1|||
126715326|NCT00494871|455910526|FG000|Follow-up (FU) Period|Protocol Violation|1|||
126715327|NCT00494871|455910527|FG001|Follow-up (FU) Period|Protocol Violation|0|||
126715328|NCT00494871|455910526|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
126715329|NCT00494871|455910527|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
126715330|NCT00494871|455910526|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
126715331|NCT00494871|455910527|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
126715332|NCT04543955|455910528|FG000|Overall Study|Company cancelled study|1|||
126715333|NCT04543955|455910529|FG001|Overall Study|Company cancelled study|0|||
126715334|NCT02433210|455910533|FG000|Overall Study|Physician Decision|1|||
126715335|NCT02433210|455910534|FG001|Overall Study|Physician Decision|0|||
126715336|NCT02433210|455910535|FG002|Overall Study|Physician Decision|0|||
126715337|NCT01958671|455910540|FG000|Overall Study|Adverse Event|1|||
126715338|NCT01958671|455910541|FG001|Overall Study|Adverse Event|1|||
126715339|NCT01958671|455910542|FG002|Overall Study|Adverse Event|5|||
126715340|NCT01958671|455910540|FG000|Overall Study|Death|1|||
126715341|NCT01958671|455910541|FG001|Overall Study|Death|0|||
126715342|NCT01958671|455910542|FG002|Overall Study|Death|0|||
126715343|NCT01958671|455910540|FG000|Overall Study|Excluded medication|0|||
126715344|NCT01958671|455910541|FG001|Overall Study|Excluded medication|0|||
126715345|NCT01958671|455910542|FG002|Overall Study|Excluded medication|1|||
126715346|NCT01958671|455910540|FG000|Overall Study|Hyperglycemia|0|||
126715347|NCT01958671|455910541|FG001|Overall Study|Hyperglycemia|0|||
126770405|NCT02575807|456112472|FG003|Overall Study|Subject ineligible - medical implant|1|||
126770406|NCT02575807|456112473|FG004|Overall Study|Subject ineligible - medical implant|0|||
126306967|NCT02587598|454411970|FG010|Overall Study|Study Terminated by the Sponsor|6|||
126306968|NCT02587598|454411960|FG000|Overall Study|Reason for study withdrawal not specified|0|||
126306969|NCT02587598|454411961|FG001|Overall Study|Reason for study withdrawal not specified|1|||
126370458|NCT02255435|454653633|FG002|Overall Study|Withdrawal by Subject|0|||
126370459|NCT02255435|454653634|FG003|Overall Study|Withdrawal by Subject|0|||
126370460|NCT02255435|454653635|FG004|Overall Study|Withdrawal by Subject|0|||
126370461|NCT02255435|454653636|FG005|Overall Study|Withdrawal by Subject|0|||
126370462|NCT02255435|454653637|FG006|Overall Study|Withdrawal by Subject|0|||
126370463|NCT02255435|454653638|FG007|Overall Study|Withdrawal by Subject|0|||
126370464|NCT02255435|454653639|FG008|Overall Study|Withdrawal by Subject|1|||
126370465|NCT02255435|454653640|FG009|Overall Study|Withdrawal by Subject|4|||
126370466|NCT02255435|454653631|FG000|Overall Study|Administrative reasons|0|||
126370467|NCT02255435|454653632|FG001|Overall Study|Administrative reasons|0|||
126370468|NCT02255435|454653633|FG002|Overall Study|Administrative reasons|0|||
126370469|NCT02255435|454653634|FG003|Overall Study|Administrative reasons|0|||
126370470|NCT02255435|454653635|FG004|Overall Study|Administrative reasons|0|||
126370471|NCT02255435|454653636|FG005|Overall Study|Administrative reasons|0|||
126370472|NCT02255435|454653637|FG006|Overall Study|Administrative reasons|0|||
126370473|NCT02255435|454653638|FG007|Overall Study|Administrative reasons|0|||
126370474|NCT02255435|454653639|FG008|Overall Study|Administrative reasons|0|||
126370475|NCT02255435|454653640|FG009|Overall Study|Administrative reasons|2|||
126370476|NCT00442702|454653641|FG000|Titration Period|Adverse Event|2|||
126370477|NCT00442702|454653642|FG001|Titration Period|Adverse Event|0|||
126370478|NCT00442702|454653641|FG000|Titration Period|Death|3|||
126715348|NCT01958671|455910542|FG002|Overall Study|Hyperglycemia|2|||
126715349|NCT01958671|455910540|FG000|Overall Study|Lost to Follow-up|7|||
126715350|NCT01958671|455910541|FG001|Overall Study|Lost to Follow-up|11|||
126715351|NCT01958671|455910542|FG002|Overall Study|Lost to Follow-up|7|||
126715352|NCT01958671|455910540|FG000|Overall Study|Non-compliance with study drug|1|||
126715353|NCT01958671|455910541|FG001|Overall Study|Non-compliance with study drug|1|||
126370479|NCT00442702|454653642|FG001|Titration Period|Death|2|||
126306970|NCT02587598|454411962|FG002|Overall Study|Reason for study withdrawal not specified|0|||
126306971|NCT02587598|454411963|FG003|Overall Study|Reason for study withdrawal not specified|0|||
126306972|NCT02587598|454411964|FG004|Overall Study|Reason for study withdrawal not specified|0|||
126306973|NCT02587598|454411965|FG005|Overall Study|Reason for study withdrawal not specified|0|||
126306974|NCT02587598|454411966|FG006|Overall Study|Reason for study withdrawal not specified|0|||
126306975|NCT02587598|454411967|FG007|Overall Study|Reason for study withdrawal not specified|0|||
126306976|NCT02587598|454411968|FG008|Overall Study|Reason for study withdrawal not specified|0|||
126464104|NCT03523000|455000303|FG000|Overall Study|Unsuccessful trial|2|||
126464105|NCT03523000|455000304|FG001|Overall Study|Unsuccessful trial|0|||
126464106|NCT03194490|455000330|FG000|Overall Study|Lost to Follow-up|1|||
126464107|NCT03194490|455000331|FG001|Overall Study|Lost to Follow-up|3|||
126464108|NCT03194490|455000330|FG000|Overall Study|participant developed specific neck pain|1|||
126464109|NCT03194490|455000331|FG001|Overall Study|participant developed specific neck pain|0|||
126464110|NCT01758289|455000332|FG000|Overall Study|Premature Study Termination|44|||
126464111|NCT01758289|455000332|FG000|Overall Study|Adverse Event|9|||
126464112|NCT01574079|455000333|FG000|Overall Study|Physician Decision|0|||
126464113|NCT01574079|455000334|FG001|Overall Study|Physician Decision|2|||
126464114|NCT01574079|455000333|FG000|Overall Study|Lost to Follow-up|1|||
126464115|NCT01574079|455000334|FG001|Overall Study|Lost to Follow-up|0|||
126464116|NCT01436162|455000338|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
126464117|NCT01436162|455000339|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
126464118|NCT01436162|455000340|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
126464119|NCT01436162|455000338|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
126464120|NCT01436162|455000339|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
126464121|NCT01436162|455000340|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
126464122|NCT01436162|455000338|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
126464123|NCT01436162|455000339|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
126464124|NCT01436162|455000340|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
126464125|NCT01436162|455000338|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
126464126|NCT01436162|455000339|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
126464127|NCT01436162|455000340|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
126464128|NCT01436162|455000338|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
126464129|NCT01436162|455000339|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
126464130|NCT01436162|455000340|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
126552053|NCT03881059|455315971|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
126552054|NCT03881059|455315972|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
126552055|NCT03881059|455315970|FG000|Treatment Period - Part B|Other reasons|4|||
126552056|NCT03881059|455315971|FG001|Treatment Period - Part B|Other reasons|3|||
126552057|NCT03881059|455315972|FG002|Treatment Period - Part B|Other reasons|3|||
126464131|NCT01436162|455000338|FG000|Single-blind Lead-in Phase|Other|107|||
126464132|NCT01436162|455000339|FG001|Single-blind Lead-in Phase|Other|0|||
126464133|NCT01436162|455000340|FG002|Single-blind Lead-in Phase|Other|0|||
126552058|NCT05284019|455315973|FG000|Overall Study|Study terminated|2|||
126552059|NCT05284019|455315974|FG001|Overall Study|Study terminated|2|||
126552060|NCT05284019|455315975|FG002|Overall Study|Study terminated|2|||
126552061|NCT05284019|455315976|FG003|Overall Study|Study terminated|5|||
126552062|NCT05284019|455315977|FG004|Overall Study|Study terminated|15|||
126552063|NCT05284019|455315973|FG000|Overall Study|Withdrawal by Subject|0|||
126552064|NCT05284019|455315974|FG001|Overall Study|Withdrawal by Subject|0|||
126552065|NCT05284019|455315975|FG002|Overall Study|Withdrawal by Subject|0|||
126552066|NCT05284019|455315976|FG003|Overall Study|Withdrawal by Subject|1|||
126552067|NCT05284019|455315977|FG004|Overall Study|Withdrawal by Subject|1|||
126552068|NCT05284019|455315973|FG000|Overall Study|Lost to Follow-up|1|||
126552069|NCT05284019|455315974|FG001|Overall Study|Lost to Follow-up|0|||
126552070|NCT05284019|455315975|FG002|Overall Study|Lost to Follow-up|0|||
126552071|NCT05284019|455315976|FG003|Overall Study|Lost to Follow-up|2|||
126552072|NCT05284019|455315977|FG004|Overall Study|Lost to Follow-up|1|||
126552073|NCT02065570|455315978|FG000|Induction Study|Adverse Event|5|||
126552074|NCT02065570|455315979|FG001|Induction Study|Adverse Event|12|||
126552075|NCT02065570|455315980|FG002|Induction Study|Adverse Event|0|||
126552076|NCT02065570|455315981|FG003|Induction Study|Adverse Event|0|||
126552077|NCT02065570|455315978|FG000|Induction Study|Withdrawal by Subject|2|||
126552078|NCT02065570|455315979|FG001|Induction Study|Withdrawal by Subject|3|||
126552079|NCT02065570|455315980|FG002|Induction Study|Withdrawal by Subject|0|||
126552080|NCT02065570|455315981|FG003|Induction Study|Withdrawal by Subject|0|||
126552081|NCT02065570|455315978|FG000|Induction Study|Lost to Follow-up|1|||
126552082|NCT02065570|455315979|FG001|Induction Study|Lost to Follow-up|1|||
126552083|NCT02065570|455315980|FG002|Induction Study|Lost to Follow-up|0|||
126552084|NCT02065570|455315981|FG003|Induction Study|Lost to Follow-up|0|||
126552085|NCT02065570|455315978|FG000|Induction Study|Other, Not Specified|6|||
126552086|NCT02065570|455315979|FG001|Induction Study|Other, Not Specified|5|||
126552087|NCT02065570|455315980|FG002|Induction Study|Other, Not Specified|0|||
126552088|NCT02065570|455315981|FG003|Induction Study|Other, Not Specified|0|||
126552089|NCT02065570|455315978|FG000|Maintenance Study|Adverse Event|0|||
126370480|NCT00442702|454653641|FG000|Titration Period|Insufficient Therapeutic Response|1|||
126370481|NCT00442702|454653642|FG001|Titration Period|Insufficient Therapeutic Response|0|||
126370482|NCT00442702|454653641|FG000|Titration Period|Refused Treatment|4|||
126370483|NCT00442702|454653642|FG001|Titration Period|Refused Treatment|1|||
126370484|NCT00442702|454653641|FG000|Titration Period|Failure to return|1|||
126370485|NCT00442702|454653642|FG001|Titration Period|Failure to return|0|||
126370486|NCT00442702|454653641|FG000|Titration Period|Hospitalized in another hospital|1|||
126370487|NCT00442702|454653642|FG001|Titration Period|Hospitalized in another hospital|0|||
126370488|NCT00442702|454653641|FG000|Evaluation Period|Adverse Event|1|||
126370489|NCT00442702|454653642|FG001|Evaluation Period|Adverse Event|0|||
126370490|NCT00442702|454653641|FG000|Evaluation Period|Death|1|||
126370491|NCT00442702|454653642|FG001|Evaluation Period|Death|1|||
126370492|NCT00442702|454653641|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
126370493|NCT00442702|454653642|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
126552090|NCT02065570|455315979|FG001|Maintenance Study|Adverse Event|0|||
126552091|NCT02065570|455315980|FG002|Maintenance Study|Adverse Event|8|||
126552092|NCT02065570|455315981|FG003|Maintenance Study|Adverse Event|8|||
126552093|NCT02065570|455315978|FG000|Maintenance Study|Withdrawal by Subject|0|||
126552094|NCT02065570|455315979|FG001|Maintenance Study|Withdrawal by Subject|0|||
126552095|NCT02065570|455315980|FG002|Maintenance Study|Withdrawal by Subject|1|||
126552096|NCT02065570|455315981|FG003|Maintenance Study|Withdrawal by Subject|4|||
126552097|NCT02065570|455315978|FG000|Maintenance Study|Lost to Follow-up|0|||
126552098|NCT02065570|455315979|FG001|Maintenance Study|Lost to Follow-up|0|||
126552099|NCT02065570|455315980|FG002|Maintenance Study|Lost to Follow-up|2|||
126552100|NCT02065570|455315981|FG003|Maintenance Study|Lost to Follow-up|2|||
126552101|NCT02065570|455315978|FG000|Maintenance Study|Other, Not Specified|0|||
126552102|NCT02065570|455315979|FG001|Maintenance Study|Other, Not Specified|0|||
126552103|NCT02065570|455315980|FG002|Maintenance Study|Other, Not Specified|11|||
126552104|NCT02065570|455315981|FG003|Maintenance Study|Other, Not Specified|5|||
126552105|NCT00287469|455315982|FG000|Overall Study|serious adverse event|1|||
126552106|NCT00287469|455315983|FG001|Overall Study|serious adverse event|6|||
126552107|NCT00287469|455315982|FG000|Overall Study|Adverse Event|1|||
126552108|NCT00287469|455315983|FG001|Overall Study|Adverse Event|1|||
126552109|NCT00287469|455315982|FG000|Overall Study|moved from area|144|||
126552110|NCT00287469|455315983|FG001|Overall Study|moved from area|138|||
126552111|NCT00287469|455315982|FG000|Overall Study|Lost to Follow-up|74|||
126552112|NCT00287469|455315983|FG001|Overall Study|Lost to Follow-up|69|||
126552113|NCT01266993|455315986|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
126552114|NCT01266993|455315987|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
126552115|NCT01266993|455315986|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
126552116|NCT01266993|455315987|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
126552117|NCT02293837|455315988|FG000|Overall Study|Lost to Follow-up|0|||
126552118|NCT02293837|455315989|FG001|Overall Study|Lost to Follow-up|2|||
126552119|NCT02293837|455315990|FG002|Overall Study|Lost to Follow-up|1|||
126552120|NCT02293837|455315991|FG003|Overall Study|Lost to Follow-up|0|||
126552121|NCT02293837|455315988|FG000|Overall Study|Withdrawal by Subject|2|||
126552122|NCT02293837|455315989|FG001|Overall Study|Withdrawal by Subject|1|||
126552123|NCT02293837|455315990|FG002|Overall Study|Withdrawal by Subject|2|||
126552124|NCT02293837|455315991|FG003|Overall Study|Withdrawal by Subject|1|||
126552125|NCT02293837|455315988|FG000|Overall Study|COVID-19 Related|1|||
126552126|NCT02293837|455315989|FG001|Overall Study|COVID-19 Related|1|||
126552127|NCT02293837|455315990|FG002|Overall Study|COVID-19 Related|0|||
126552128|NCT02293837|455315991|FG003|Overall Study|COVID-19 Related|0|||
126552129|NCT02293837|455315988|FG000|Overall Study|Participant ill and could not be infused|0|||
126552130|NCT02293837|455315989|FG001|Overall Study|Participant ill and could not be infused|0|||
126552131|NCT02293837|455315990|FG002|Overall Study|Participant ill and could not be infused|1|||
126552132|NCT02293837|455315991|FG003|Overall Study|Participant ill and could not be infused|0|||
126552133|NCT04779242|455315992|FG000|Overall Study|Adverse Event|1|||
126552134|NCT04779242|455315993|FG001|Overall Study|Adverse Event|1|||
126552135|NCT04779242|455315992|FG000|Overall Study|Lost to Follow-up|2|||
126552136|NCT04779242|455315993|FG001|Overall Study|Lost to Follow-up|4|||
126552137|NCT04779242|455315992|FG000|Overall Study|Withdrawal by Subject|7|||
126552138|NCT04779242|455315993|FG001|Overall Study|Withdrawal by Subject|9|||
126552139|NCT04779242|455315992|FG000|Overall Study|Death|6|||
126552140|NCT04779242|455315993|FG001|Overall Study|Death|6|||
126552141|NCT04779242|455315992|FG000|Overall Study|COVID-19 related reasons|2|||
126552142|NCT04779242|455315993|FG001|Overall Study|COVID-19 related reasons|1|||
126552143|NCT04779242|455315992|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
126552144|NCT04779242|455315993|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
126552145|NCT04779242|455315992|FG000|Overall Study|Martial Law in Ukraine|2|||
126552146|NCT04779242|455315993|FG001|Overall Study|Martial Law in Ukraine|3|||
126552147|NCT03285113|455315996|FG000|Overall Study|Unable to implant leads|2|||
126552148|NCT00849680|455315999|FG000|Overall Study|Adverse Event|0|||
126552149|NCT00849680|455316000|FG001|Overall Study|Adverse Event|0|||
126552150|NCT00849680|455316001|FG002|Overall Study|Adverse Event|0|||
126552151|NCT00849680|455316002|FG003|Overall Study|Adverse Event|0|||
126770407|NCT02575807|456112469|FG000|Overall Study|Withdrawal by Subject|0|||
126770408|NCT02575807|456112470|FG001|Overall Study|Withdrawal by Subject|0|||
126770409|NCT02575807|456112471|FG002|Overall Study|Withdrawal by Subject|1|||
126770410|NCT02575807|456112472|FG003|Overall Study|Withdrawal by Subject|1|||
126770411|NCT02575807|456112473|FG004|Overall Study|Withdrawal by Subject|2|||
126370494|NCT00442702|454653641|FG000|Evaluation Period|Refused treatment|1|||
126370495|NCT00442702|454653642|FG001|Evaluation Period|Refused treatment|1|||
126370496|NCT00442702|454653641|FG000|Evaluation Period|Renal transplant|0|||
126370497|NCT00442702|454653642|FG001|Evaluation Period|Renal transplant|1|||
126370498|NCT00442702|454653641|FG000|Evaluation Period|Failure to return|1|||
126770412|NCT03014570|456112476|FG000|Overall Study|COVID-19 Restrictions|38|||
126770413|NCT03014570|456112477|FG001|Overall Study|COVID-19 Restrictions|24|||
126770414|NCT03014570|456112476|FG000|Overall Study|Death|70|||
126770415|NCT03014570|456112477|FG001|Overall Study|Death|79|||
126770416|NCT03014570|456112476|FG000|Overall Study|Transfer from facility|11|||
126770417|NCT03014570|456112477|FG001|Overall Study|Transfer from facility|14|||
126370499|NCT00442702|454653642|FG001|Evaluation Period|Failure to return|0|||
126370500|NCT00442702|454653641|FG000|Evaluation Period|Site closure|0|||
126464134|NCT01436162|455000338|FG000|Randomized Phase|Adverse Event|1|||
126464135|NCT01436162|455000339|FG001|Randomized Phase|Adverse Event|5|||
126464136|NCT01436162|455000340|FG002|Randomized Phase|Adverse Event|6|||
126464137|NCT01436162|455000338|FG000|Randomized Phase|Protocol Violation|4|||
126464138|NCT01436162|455000339|FG001|Randomized Phase|Protocol Violation|4|||
126464139|NCT01436162|455000340|FG002|Randomized Phase|Protocol Violation|2|||
126464140|NCT01436162|455000338|FG000|Randomized Phase|Withdrawal by Subject|16|||
126715354|NCT01958671|455910542|FG002|Overall Study|Non-compliance with study drug|1|||
126715355|NCT01958671|455910540|FG000|Overall Study|Pregnancy|0|||
126715356|NCT01958671|455910541|FG001|Overall Study|Pregnancy|0|||
126715357|NCT01958671|455910542|FG002|Overall Study|Pregnancy|1|||
126715358|NCT01958671|455910540|FG000|Overall Study|Protocol Violation|0|||
126715359|NCT01958671|455910541|FG001|Overall Study|Protocol Violation|1|||
126715360|NCT01958671|455910542|FG002|Overall Study|Protocol Violation|0|||
126715361|NCT01958671|455910540|FG000|Overall Study|Study site terminated by sponsor|1|||
126715362|NCT01958671|455910541|FG001|Overall Study|Study site terminated by sponsor|0|||
126715363|NCT01958671|455910542|FG002|Overall Study|Study site terminated by sponsor|1|||
126715364|NCT01958671|455910540|FG000|Overall Study|Participant moved|0|||
126715365|NCT01958671|455910541|FG001|Overall Study|Participant moved|0|||
126715366|NCT01958671|455910542|FG002|Overall Study|Participant moved|1|||
126715367|NCT01958671|455910540|FG000|Overall Study|Withdrawal by Subject|8|||
126715368|NCT01958671|455910541|FG001|Overall Study|Withdrawal by Subject|10|||
126715369|NCT01958671|455910542|FG002|Overall Study|Withdrawal by Subject|13|||
126715370|NCT02948777|455910543|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
126715371|NCT02311478|455910544|FG000|Overall Study|Withdrawal by Subject|1|||
126715372|NCT02311478|455910544|FG000|Overall Study|Lost to Follow-up|5|||
126715373|NCT02311478|455910544|FG000|Overall Study|Failed IUD Insertion|1|||
126715374|NCT03242928|455910545|FG000|Overall Study|Adverse Event|2|||
126715375|NCT03242928|455910546|FG001|Overall Study|Adverse Event|1|||
126715376|NCT03242928|455910545|FG000|Overall Study|Lost to Follow-up|2|||
126715377|NCT03242928|455910546|FG001|Overall Study|Lost to Follow-up|0|||
126715378|NCT03242928|455910545|FG000|Overall Study|Physician Decision|0|||
126715379|NCT03242928|455910546|FG001|Overall Study|Physician Decision|1|||
126715380|NCT03242928|455910545|FG000|Overall Study|Withdrawal by Subject|5|||
126715381|NCT03242928|455910546|FG001|Overall Study|Withdrawal by Subject|3|||
126715382|NCT00390780|455910547|FG000|Overall Study|Not completed|10|||
126715383|NCT00390780|455910548|FG001|Overall Study|Not completed|4|||
126715384|NCT00390780|455910547|FG000|Overall Study|Protocol Violation|6|||
126715385|NCT00390780|455910548|FG001|Overall Study|Protocol Violation|4|||
126715386|NCT00390780|455910547|FG000|Overall Study|Lost to Follow-up|3|||
126715387|NCT00390780|455910548|FG001|Overall Study|Lost to Follow-up|6|||
126715388|NCT00390780|455910547|FG000|Overall Study|Adverse Event|2|||
126715389|NCT00390780|455910548|FG001|Overall Study|Adverse Event|3|||
126715390|NCT00390780|455910547|FG000|Overall Study|Death|1|||
126715391|NCT00390780|455910548|FG001|Overall Study|Death|3|||
126715392|NCT00390780|455910547|FG000|Overall Study|Withdrawal by Subject|1|||
126770418|NCT03014570|456112476|FG000|Overall Study|Hospitalized|5|||
126770419|NCT03014570|456112477|FG001|Overall Study|Hospitalized|3|||
126370501|NCT00442702|454653642|FG001|Evaluation Period|Site closure|1|||
126464141|NCT01436162|455000339|FG001|Randomized Phase|Withdrawal by Subject|9|||
126715393|NCT00390780|455910548|FG001|Overall Study|Withdrawal by Subject|2|||
126715394|NCT00390780|455910547|FG000|Overall Study|Inclusion criteria not satisfied|0|||
126715395|NCT00390780|455910548|FG001|Overall Study|Inclusion criteria not satisfied|2|||
126715396|NCT00390780|455910547|FG000|Overall Study|Lost to follow up and other reasons|0|||
126715397|NCT00390780|455910548|FG001|Overall Study|Lost to follow up and other reasons|1|||
126715398|NCT00390780|455910547|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
126715399|NCT00390780|455910548|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
126715400|NCT00390780|455910547|FG000|Overall Study|SAE, death|0|||
126464142|NCT01436162|455000340|FG002|Randomized Phase|Withdrawal by Subject|8|||
126370502|NCT03580044|454653643|FG000|Overall Study|Death|2|||
126370503|NCT03580044|454653644|FG001|Overall Study|Death|1|||
126370504|NCT03580044|454653643|FG000|Overall Study|Withdrawal by Subject|1|||
126370505|NCT03580044|454653644|FG001|Overall Study|Withdrawal by Subject|1|||
126370506|NCT01664624|454653645|FG000|Overall Study|Adverse Event|0|||
126370507|NCT01664624|454653646|FG001|Overall Study|Adverse Event|1|||
126464143|NCT01436162|455000338|FG000|Randomized Phase|Lost to Follow-up|17|||
126464144|NCT01436162|455000339|FG001|Randomized Phase|Lost to Follow-up|5|||
126464145|NCT01436162|455000340|FG002|Randomized Phase|Lost to Follow-up|4|||
126464146|NCT01436162|455000338|FG000|Randomized Phase|Lack of Efficacy|0|||
126464147|NCT01436162|455000339|FG001|Randomized Phase|Lack of Efficacy|1|||
126464148|NCT01436162|455000340|FG002|Randomized Phase|Lack of Efficacy|1|||
126464149|NCT01436162|455000338|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
126464150|NCT01436162|455000339|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
126464151|NCT01436162|455000340|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
126464152|NCT01436162|455000338|FG000|Randomized Phase|Other|2|||
126464153|NCT01436162|455000339|FG001|Randomized Phase|Other|5|||
126464154|NCT01436162|455000340|FG002|Randomized Phase|Other|4|||
126715401|NCT00390780|455910548|FG001|Overall Study|SAE, death|1|||
126715402|NCT00109733|455910549|FG000|Overall Study|Protocol Violation|0|||
126715403|NCT00109733|455910550|FG001|Overall Study|Protocol Violation|1|||
126715404|NCT00109733|455910549|FG000|Overall Study|Stopped taking study drug|1|||
126715405|NCT00109733|455910550|FG001|Overall Study|Stopped taking study drug|1|||
126715406|NCT00109733|455910549|FG000|Overall Study|Non-compliant|0|||
126715407|NCT00109733|455910550|FG001|Overall Study|Non-compliant|1|||
126715408|NCT00109733|455910549|FG000|Overall Study|Could not commit time for study|1|||
126715409|NCT00109733|455910550|FG001|Overall Study|Could not commit time for study|1|||
126715410|NCT02433288|455910554|FG000|Overall Study|Severe non-compliance to protocol|13|||
126715411|NCT02433288|455910555|FG001|Overall Study|Severe non-compliance to protocol|7|||
126715412|NCT02433288|455910554|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
126715413|NCT02433288|455910555|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
126715414|NCT02433288|455910554|FG000|Overall Study|Withdrawal by Subject|101|||
126715415|NCT02433288|455910555|FG001|Overall Study|Withdrawal by Subject|99|||
126715416|NCT02433288|455910554|FG000|Overall Study|Lost to Follow-up|2|||
126715417|NCT02433288|455910555|FG001|Overall Study|Lost to Follow-up|14|||
126715418|NCT02433288|455910554|FG000|Overall Study|Death|0|||
126715419|NCT02433288|455910555|FG001|Overall Study|Death|3|||
126715420|NCT00367640|455910556|FG000|Overall Study|Adverse Event|3|||
126715421|NCT00367640|455910557|FG001|Overall Study|Adverse Event|6|||
126715422|NCT00367640|455910558|FG002|Overall Study|Adverse Event|8|||
126715423|NCT00367640|455910559|FG003|Overall Study|Adverse Event|0|||
126715424|NCT00367640|455910556|FG000|Overall Study|Withdrawal by Subject|8|||
126715425|NCT00367640|455910557|FG001|Overall Study|Withdrawal by Subject|11|||
126715426|NCT00367640|455910558|FG002|Overall Study|Withdrawal by Subject|8|||
126715427|NCT00367640|455910559|FG003|Overall Study|Withdrawal by Subject|6|||
126715428|NCT00367640|455910556|FG000|Overall Study|Any other reason not above-mentioned|7|||
126715429|NCT00367640|455910557|FG001|Overall Study|Any other reason not above-mentioned|5|||
126715430|NCT00367640|455910558|FG002|Overall Study|Any other reason not above-mentioned|3|||
126715431|NCT00367640|455910559|FG003|Overall Study|Any other reason not above-mentioned|4|||
126715432|NCT00406315|455910561|FG000|Overall Study|Death|1|||
126715433|NCT00406315|455910561|FG000|Overall Study|Adverse Event|39|||
126715434|NCT00406315|455910561|FG000|Overall Study|Laboratory Abnormality|4|||
126715435|NCT00406315|455910561|FG000|Overall Study|Lack of Efficacy|13|||
126715436|NCT00406315|455910561|FG000|Overall Study|Other|33|||
126715437|NCT00406315|455910561|FG000|Overall Study|Lost to Follow-up|21|||
126715438|NCT00406315|455910561|FG000|Overall Study|Withdrawal by Subject|30|||
126715439|NCT01525849|455910564|FG000|Overall Study|Lost to Follow-up|3|||
126715440|NCT01525849|455910565|FG001|Overall Study|Lost to Follow-up|2|||
126715441|NCT01525849|455910564|FG000|Overall Study|Withdrawal by Subject|1|||
126715442|NCT01525849|455910565|FG001|Overall Study|Withdrawal by Subject|9|||
126715443|NCT01525849|455910564|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
126715444|NCT01525849|455910565|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
126464155|NCT01931202|455000344|FG000|Overall Study|Withdrawal by Subject|0|||
126464156|NCT01931202|455000345|FG001|Overall Study|Withdrawal by Subject|0|||
126464157|NCT01931202|455000346|FG002|Overall Study|Withdrawal by Subject|2|||
126715445|NCT01525849|455910564|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
126715446|NCT01525849|455910565|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
126715447|NCT00339183|455910566|FG000|Overall Study|Adverse Event|5|||
126715448|NCT00339183|455910567|FG001|Overall Study|Adverse Event|3|||
126715449|NCT00339183|455910566|FG000|Overall Study|Withdrawal by Subject|16|||
126370508|NCT01664624|454653647|FG002|Overall Study|Adverse Event|0|||
126370509|NCT01664624|454653648|FG003|Overall Study|Adverse Event|0|||
126715450|NCT00339183|455910567|FG001|Overall Study|Withdrawal by Subject|19|||
126715451|NCT00339183|455910566|FG000|Overall Study|Physician Decision|2|||
126715452|NCT00339183|455910567|FG001|Overall Study|Physician Decision|4|||
126715453|NCT00339183|455910566|FG000|Overall Study|Lost to Follow-up|17|||
126770420|NCT03014570|456112476|FG000|Overall Study|Transfer within facility|1|||
126770421|NCT03014570|456112477|FG001|Overall Study|Transfer within facility|0|||
126770422|NCT03014570|456112476|FG000|Overall Study|Site refusal|0|||
126770423|NCT03014570|456112477|FG001|Overall Study|Site refusal|11|||
126770424|NCT03332212|456112483|FG000|Overall Study|Not treated|0|||
126770425|NCT03332212|456112484|FG001|Overall Study|Not treated|1|||
126770426|NCT03332212|456112485|FG002|Overall Study|Not treated|0|||
126770427|NCT03332212|456112486|FG003|Overall Study|Not treated|0|||
126770428|NCT03332212|456112483|FG000|Overall Study|Adverse Event|0|||
126770429|NCT03332212|456112484|FG001|Overall Study|Adverse Event|0|||
126770430|NCT03332212|456112485|FG002|Overall Study|Adverse Event|0|||
126770431|NCT03332212|456112486|FG003|Overall Study|Adverse Event|1|||
126770432|NCT03332212|456112483|FG000|Overall Study|worsening of disease under study|1|||
126770433|NCT03332212|456112484|FG001|Overall Study|worsening of disease under study|1|||
126770434|NCT03332212|456112485|FG002|Overall Study|worsening of disease under study|0|||
126770435|NCT03332212|456112486|FG003|Overall Study|worsening of disease under study|0|||
126770436|NCT02058368|456112487|FG000|Overall Study|Adverse Event|15|||
126770437|NCT02058368|456112488|FG001|Overall Study|Adverse Event|20|||
126370510|NCT00335829|454653651|FG000|Overall Study|Withdrawal by Subject|1|||
126770438|NCT02058368|456112487|FG000|Overall Study|Lack of Efficacy|0|||
126770439|NCT02058368|456112488|FG001|Overall Study|Lack of Efficacy|1|||
126770440|NCT02058368|456112487|FG000|Overall Study|Protocol Violation|0|||
126770441|NCT02058368|456112488|FG001|Overall Study|Protocol Violation|4|||
126770442|NCT02058368|456112487|FG000|Overall Study|Lost to Follow-up|2|||
126770443|NCT02058368|456112488|FG001|Overall Study|Lost to Follow-up|0|||
126370511|NCT00335829|454653651|FG000|Overall Study|Lost to Follow-up|1|||
126370512|NCT00335829|454653651|FG000|Overall Study|Adverse Event|1|||
126370513|NCT04067011|454653653|FG000|Overall Study|Not Treated|8|||
126370514|NCT04067011|454653654|FG001|Overall Study|Not Treated|7|||
126370515|NCT04067011|454653655|FG002|Overall Study|Not Treated|5|||
126370516|NCT04067011|454653653|FG000|Overall Study|Adverse Event|2|||
126770444|NCT02058368|456112487|FG000|Overall Study|Physician Decision|2|||
126770445|NCT02058368|456112488|FG001|Overall Study|Physician Decision|3|||
126770446|NCT02058368|456112487|FG000|Overall Study|Withdrawal by Subject|22|||
126770447|NCT02058368|456112488|FG001|Overall Study|Withdrawal by Subject|26|||
126770448|NCT05473247|456112496|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
126770449|NCT02392559|456112497|FG000|Overall Study|Withdrawal by Subject|0|||
126770450|NCT02392559|456112498|FG001|Overall Study|Withdrawal by Subject|1|||
126770451|NCT00402779|456112499|FG000|Overall Study|Screen Failure|77|||
126770452|NCT00402779|456112500|FG001|Overall Study|Screen Failure|76|||
126770453|NCT03107715|456112501|FG000|Overall Study|did not deliver at the home hospital|4|||
126770454|NCT03107715|456112502|FG001|Overall Study|did not deliver at the home hospital|6|||
126770455|NCT03107715|456112501|FG000|Overall Study|infant stillborn|0|||
126770456|NCT03107715|456112502|FG001|Overall Study|infant stillborn|1|||
126770457|NCT02149199|456112503|FG000|Overall Study|Study specific withdrawal criteria|4|||
126770458|NCT02149199|456112504|FG001|Overall Study|Study specific withdrawal criteria|21|||
126770459|NCT02149199|456112505|FG002|Overall Study|Study specific withdrawal criteria|6|||
126770460|NCT02149199|456112503|FG000|Overall Study|Other|20|||
126770461|NCT02149199|456112504|FG001|Overall Study|Other|25|||
126770462|NCT02149199|456112505|FG002|Overall Study|Other|20|||
126770463|NCT02149199|456112503|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
126770464|NCT02149199|456112504|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
126770465|NCT02149199|456112505|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
126770466|NCT02149199|456112503|FG000|Overall Study|Withdrawal by Subject|75|||
126770467|NCT02149199|456112504|FG001|Overall Study|Withdrawal by Subject|93|||
126770468|NCT02149199|456112505|FG002|Overall Study|Withdrawal by Subject|77|||
126770469|NCT02149199|456112503|FG000|Overall Study|Protocol Violation|16|||
126770470|NCT02149199|456112504|FG001|Overall Study|Protocol Violation|13|||
126770471|NCT02149199|456112505|FG002|Overall Study|Protocol Violation|15|||
126770472|NCT02149199|456112503|FG000|Overall Study|Lost to Follow-up|3|||
126770473|NCT02149199|456112504|FG001|Overall Study|Lost to Follow-up|12|||
126770474|NCT02149199|456112505|FG002|Overall Study|Lost to Follow-up|11|||
126770475|NCT02149199|456112503|FG000|Overall Study|Death|0|||
126770476|NCT02149199|456112504|FG001|Overall Study|Death|0|||
126770477|NCT02149199|456112505|FG002|Overall Study|Death|1|||
126770478|NCT02149199|456112503|FG000|Overall Study|Adverse Event|6|||
126770479|NCT02149199|456112504|FG001|Overall Study|Adverse Event|15|||
126770480|NCT02149199|456112505|FG002|Overall Study|Adverse Event|9|||
126770481|NCT04881448|456112506|FG000|Overall Study|Study cancelled by sponsor|220|||
126770482|NCT04881448|456112506|FG000|Overall Study|Withdrawal by Subject|2|||
126770483|NCT04881448|456112506|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
126770484|NCT02662556|456112507|FG000|Overall Study|Adverse Event|4|||
126770485|NCT02662556|456112507|FG000|Overall Study|Lack of Efficacy|4|||
126770486|NCT00005879|456112512|FG000|Overall Study|Withdrawal by Subject|8|||
126770487|NCT00005879|456112513|FG001|Overall Study|Withdrawal by Subject|10|||
126770488|NCT05022121|456112515|FG000|Overall Study|Lack of Efficacy|1|||
126770489|NCT05022121|456112516|FG001|Overall Study|Lack of Efficacy|0|||
126770490|NCT05022121|456112515|FG000|Overall Study|Lost to Follow-up|0|||
126770491|NCT05022121|456112516|FG001|Overall Study|Lost to Follow-up|2|||
126770492|NCT02395536|456112523|FG000|Overall Study|Lost to Follow-up|4|||
126770493|NCT02395536|456112524|FG001|Overall Study|Lost to Follow-up|4|||
126770494|NCT02395536|456112523|FG000|Overall Study|Death|2|||
126306977|NCT02587598|454411969|FG009|Overall Study|Reason for study withdrawal not specified|0|||
126306978|NCT02587598|454411970|FG010|Overall Study|Reason for study withdrawal not specified|0|||
126306979|NCT02587598|454411960|FG000|Overall Study|Withdrawal by Subject|0|||
126770495|NCT02395536|456112524|FG001|Overall Study|Death|0|||
126770496|NCT02395536|456112523|FG000|Overall Study|Physician Decision|4|||
126306980|NCT02587598|454411961|FG001|Overall Study|Withdrawal by Subject|1|||
126306981|NCT02587598|454411962|FG002|Overall Study|Withdrawal by Subject|0|||
126306982|NCT02587598|454411963|FG003|Overall Study|Withdrawal by Subject|2|||
126306983|NCT02587598|454411964|FG004|Overall Study|Withdrawal by Subject|3|||
126306984|NCT02587598|454411965|FG005|Overall Study|Withdrawal by Subject|1|||
126306985|NCT02587598|454411966|FG006|Overall Study|Withdrawal by Subject|0|||
126306986|NCT02587598|454411967|FG007|Overall Study|Withdrawal by Subject|0|||
126306987|NCT02587598|454411968|FG008|Overall Study|Withdrawal by Subject|0|||
126306988|NCT02587598|454411969|FG009|Overall Study|Withdrawal by Subject|1|||
126306989|NCT02587598|454411970|FG010|Overall Study|Withdrawal by Subject|2|||
126306990|NCT02587598|454411960|FG000|Overall Study|Physician Decision|0|||
126306991|NCT02587598|454411961|FG001|Overall Study|Physician Decision|0|||
126306992|NCT02587598|454411962|FG002|Overall Study|Physician Decision|0|||
126306993|NCT02587598|454411963|FG003|Overall Study|Physician Decision|0|||
126306994|NCT02587598|454411964|FG004|Overall Study|Physician Decision|0|||
126306995|NCT02587598|454411965|FG005|Overall Study|Physician Decision|0|||
126306996|NCT02587598|454411966|FG006|Overall Study|Physician Decision|0|||
126306997|NCT02587598|454411967|FG007|Overall Study|Physician Decision|0|||
126306998|NCT02587598|454411968|FG008|Overall Study|Physician Decision|0|||
126306999|NCT02587598|454411969|FG009|Overall Study|Physician Decision|0|||
126307000|NCT02587598|454411970|FG010|Overall Study|Physician Decision|3|||
126307001|NCT00355147|454411975|FG000|Overall Study|Lost to Follow-up|10|||
126307002|NCT00355147|454411976|FG001|Overall Study|Lost to Follow-up|8|||
126307003|NCT00355147|454411975|FG000|Overall Study|Withdrawal by Subject|8|||
126307004|NCT00355147|454411976|FG001|Overall Study|Withdrawal by Subject|12|||
126307005|NCT02353442|454411977|FG000|Overall Study|Withdrawal by Subject|3|||
126307006|NCT02353442|454411978|FG001|Overall Study|Withdrawal by Subject|4|||
126307007|NCT06586788|454411980|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
126307008|NCT03514485|454411981|FG000|Overall Study|Lost to Follow-up|5|||
126307009|NCT03514485|454411982|FG001|Overall Study|Lost to Follow-up|3|||
126307010|NCT03514485|454411983|FG002|Overall Study|Lost to Follow-up|2|||
126307011|NCT03514485|454411984|FG003|Overall Study|Lost to Follow-up|0|||
126307012|NCT03514485|454411985|FG004|Overall Study|Lost to Follow-up|1|||
126307013|NCT03514485|454411986|FG005|Overall Study|Lost to Follow-up|4|||
126307014|NCT03514485|454411981|FG000|Overall Study|Withdrawal by Subject|0|||
126307015|NCT03514485|454411982|FG001|Overall Study|Withdrawal by Subject|1|||
126307016|NCT03514485|454411983|FG002|Overall Study|Withdrawal by Subject|3|||
126307017|NCT03514485|454411984|FG003|Overall Study|Withdrawal by Subject|1|||
126307018|NCT03514485|454411985|FG004|Overall Study|Withdrawal by Subject|2|||
126307019|NCT03514485|454411986|FG005|Overall Study|Withdrawal by Subject|1|||
126307020|NCT00791661|454411987|FG000|7 Day Wash-out|Adverse Event|0|||
126307021|NCT00791661|454411988|FG001|7 Day Wash-out|Adverse Event|0|||
126307022|NCT00791661|454411989|FG002|7 Day Wash-out|Adverse Event|1|||
126307023|NCT00791661|454411987|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
126307024|NCT00791661|454411988|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
126307025|NCT00791661|454411989|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
126307026|NCT00679289|454411990|FG000|Overall Study|Progressive disease|4|||
126307027|NCT00679289|454411991|FG001|Overall Study|Progressive disease|5|||
126307028|NCT00679289|454411992|FG002|Overall Study|Progressive disease|18|||
126307029|NCT00679289|454411990|FG000|Overall Study|Withdrawal by Subject|0|||
126307030|NCT00679289|454411991|FG001|Overall Study|Withdrawal by Subject|1|||
126307031|NCT00679289|454411992|FG002|Overall Study|Withdrawal by Subject|1|||
126307032|NCT00679289|454411990|FG000|Overall Study|Adverse Event|0|||
126307033|NCT00679289|454411991|FG001|Overall Study|Adverse Event|0|||
126307034|NCT00679289|454411992|FG002|Overall Study|Adverse Event|3|||
126307035|NCT00679289|454411990|FG000|Overall Study|Physician Decision|1|||
126307036|NCT00679289|454411991|FG001|Overall Study|Physician Decision|0|||
126307037|NCT00679289|454411992|FG002|Overall Study|Physician Decision|1|||
126307038|NCT01355575|454411994|FG000|Overall Study|Withdrawal by Subject|2|||
126307039|NCT02438826|454411996|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
126307040|NCT02438826|454411997|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
126307041|NCT02438826|454411998|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
126307042|NCT02438826|454411999|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
126370517|NCT04067011|454653654|FG001|Overall Study|Adverse Event|1|||
126370518|NCT04067011|454653655|FG002|Overall Study|Adverse Event|0|||
126770497|NCT02395536|456112524|FG001|Overall Study|Physician Decision|6|||
126770498|NCT02395536|456112523|FG000|Overall Study|Withdrawal by Subject|9|||
126770499|NCT02395536|456112524|FG001|Overall Study|Withdrawal by Subject|17|||
126370519|NCT04067011|454653653|FG000|Overall Study|Withdrawal by Subject|6|||
126370520|NCT04067011|454653654|FG001|Overall Study|Withdrawal by Subject|2|||
126370521|NCT04067011|454653655|FG002|Overall Study|Withdrawal by Subject|1|||
126370522|NCT04067011|454653653|FG000|Overall Study|Lost to Follow-up|0|||
126370523|NCT04067011|454653654|FG001|Overall Study|Lost to Follow-up|0|||
126370524|NCT04067011|454653655|FG002|Overall Study|Lost to Follow-up|1|||
126370525|NCT04067011|454653653|FG000|Overall Study|Physician Decision|1|||
126370526|NCT04067011|454653654|FG001|Overall Study|Physician Decision|1|||
126464158|NCT01931202|455000344|FG000|Overall Study|Lost to Follow-up|0|||
126770500|NCT02395536|456112523|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
126770501|NCT02395536|456112524|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
126770502|NCT02395536|456112523|FG000|Overall Study|Insurance issue|0|||
126770503|NCT02395536|456112524|FG001|Overall Study|Insurance issue|1|||
126770504|NCT00131937|456112525|FG000|Overall Study|Adverse Event|3|||
126770505|NCT00131937|456112525|FG000|Overall Study|Withdrawal by Subject|2|||
126770506|NCT00131937|456112525|FG000|Overall Study|Physician Decision|1|||
126770507|NCT00131937|456112525|FG000|Overall Study|Disease Progression|7|||
126770508|NCT00131937|456112525|FG000|Overall Study|Alternative therapy|1|||
126770509|NCT01640964|456112528|FG000|Overall Study|Lost to Follow-up|0|||
126770510|NCT01640964|456112529|FG001|Overall Study|Lost to Follow-up|0|||
126770511|NCT01640964|456112530|FG002|Overall Study|Lost to Follow-up|1|||
126770512|NCT01640964|456112528|FG000|Overall Study|Protocol Deviation|1|||
126370527|NCT04067011|454653655|FG002|Overall Study|Physician Decision|0|||
126370528|NCT04067011|454653653|FG000|Overall Study|Other Reasons|2|||
126370529|NCT04067011|454653654|FG001|Overall Study|Other Reasons|0|||
126370530|NCT04067011|454653655|FG002|Overall Study|Other Reasons|1|||
126464159|NCT01931202|455000345|FG001|Overall Study|Lost to Follow-up|5|||
126464160|NCT01931202|455000346|FG002|Overall Study|Lost to Follow-up|2|||
126464161|NCT04597918|455000349|FG000|Overall Study|Withdrawal by Subject|6|||
126464162|NCT04597918|455000349|FG000|Overall Study|Lost to Follow-up|3|||
126464163|NCT04597918|455000349|FG000|Overall Study|Death|1|||
126464164|NCT00395538|455000350|FG000|Overall Study|Did not re-consent to revised protocol|1|||
126464165|NCT00395538|455000351|FG001|Overall Study|Did not re-consent to revised protocol|10|||
126464166|NCT00395538|455000352|FG002|Overall Study|Did not re-consent to revised protocol|0|||
126464167|NCT00395538|455000350|FG000|Overall Study|FDA partial hold on PTH|0|||
126464168|NCT00395538|455000351|FG001|Overall Study|FDA partial hold on PTH|0|||
126464169|NCT00395538|455000352|FG002|Overall Study|FDA partial hold on PTH|11|||
126464170|NCT00395538|455000350|FG000|Overall Study|Failed screening|0|||
126464171|NCT00395538|455000351|FG001|Overall Study|Failed screening|0|||
126464172|NCT00395538|455000352|FG002|Overall Study|Failed screening|4|||
126464173|NCT00395538|455000350|FG000|Overall Study|Switch to Natpara|0|||
126464174|NCT00395538|455000351|FG001|Overall Study|Switch to Natpara|0|||
126464175|NCT00395538|455000352|FG002|Overall Study|Switch to Natpara|3|||
126464176|NCT00395538|455000350|FG000|Overall Study|Adverse Event|1|||
126464177|NCT00395538|455000351|FG001|Overall Study|Adverse Event|0|||
126464178|NCT00395538|455000352|FG002|Overall Study|Adverse Event|2|||
126464179|NCT00395538|455000350|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
126464180|NCT00395538|455000351|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
126464181|NCT00395538|455000352|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
126552152|NCT00849680|455316003|FG004|Overall Study|Adverse Event|0|||
126770513|NCT01640964|456112529|FG001|Overall Study|Protocol Deviation|1|||
126770514|NCT01640964|456112530|FG002|Overall Study|Protocol Deviation|2|||
126770515|NCT02038959|456114614|FG000|Overall Study|Withdrawal by Subject|6|||
126770516|NCT02038959|456114615|FG001|Overall Study|Withdrawal by Subject|8|||
126770517|NCT01788163|456114623|FG000|Overall Study|Other|53|||
126770518|NCT01788163|456114624|FG001|Overall Study|Other|0|||
126770519|NCT01788163|456114625|FG002|Overall Study|Other|0|||
126770520|NCT01788163|456114626|FG003|Overall Study|Other|0|||
126770521|NCT01788163|456114627|FG004|Overall Study|Other|0|||
126770522|NCT01788163|456114628|FG005|Overall Study|Other|7|||
126770523|NCT01788163|456114629|FG006|Overall Study|Other|1|||
126770524|NCT01788163|456114630|FG007|Overall Study|Other|48|||
126770525|NCT01788163|456114631|FG008|Overall Study|Other|15|||
126770526|NCT01788163|456114623|FG000|Overall Study|Withdrawal by Subject|2|||
126770527|NCT01788163|456114624|FG001|Overall Study|Withdrawal by Subject|0|||
126770528|NCT01788163|456114625|FG002|Overall Study|Withdrawal by Subject|0|||
126770529|NCT01788163|456114626|FG003|Overall Study|Withdrawal by Subject|0|||
126770530|NCT01788163|456114627|FG004|Overall Study|Withdrawal by Subject|0|||
126770531|NCT01788163|456114628|FG005|Overall Study|Withdrawal by Subject|0|||
126770532|NCT01788163|456114629|FG006|Overall Study|Withdrawal by Subject|0|||
126770533|NCT01788163|456114630|FG007|Overall Study|Withdrawal by Subject|0|||
126770534|NCT01788163|456114631|FG008|Overall Study|Withdrawal by Subject|1|||
126770535|NCT00545441|456114632|FG000|Overall Study|Fistula draining at 6 months|2|||
126770536|NCT00545441|456114633|FG001|Overall Study|Fistula draining at 6 months|4|||
126770537|NCT00545441|456114632|FG000|Overall Study|Lost to Follow-up|9|||
126770538|NCT00545441|456114633|FG001|Overall Study|Lost to Follow-up|5|||
126770539|NCT00545441|456114632|FG000|Overall Study|Technical failure|0|||
126770540|NCT00545441|456114633|FG001|Overall Study|Technical failure|1|||
126370531|NCT04067011|454653653|FG000|Overall Study|Missing|0|||
126370532|NCT04067011|454653654|FG001|Overall Study|Missing|2|||
126370533|NCT04067011|454653655|FG002|Overall Study|Missing|0|||
126370534|NCT05209386|454653656|FG000|Overall Study|Withdrawal by Subject|8|||
126370535|NCT05209386|454653656|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
126370536|NCT04462471|454653657|FG000|Overall Study|Adverse Event|0|||
126370537|NCT04462471|454653658|FG001|Overall Study|Adverse Event|1|||
126370538|NCT04462471|454653659|FG002|Overall Study|Adverse Event|0|||
126370539|NCT04462471|454653660|FG003|Overall Study|Adverse Event|0|||
126370540|NCT04462471|454653657|FG000|Overall Study|Disease progression|1|||
126370541|NCT04462471|454653658|FG001|Overall Study|Disease progression|0|||
126464182|NCT00395538|455000350|FG000|Overall Study|Non-compliance with study protocol|0|||
126464183|NCT00395538|455000351|FG001|Overall Study|Non-compliance with study protocol|1|||
126715454|NCT00339183|455910567|FG001|Overall Study|Lost to Follow-up|17|||
126715455|NCT00339183|455910566|FG000|Overall Study|Protocol-specified criteria|12|||
126715456|NCT00339183|455910567|FG001|Overall Study|Protocol-specified criteria|8|||
126715457|NCT00339183|455910566|FG000|Overall Study|Missing reason|3|||
126715458|NCT00339183|455910567|FG001|Overall Study|Missing reason|1|||
126715459|NCT00339183|455910566|FG000|Overall Study|Other|46|||
126715460|NCT00339183|455910567|FG001|Overall Study|Other|40|||
126715461|NCT00339183|455910566|FG000|Overall Study|Ongoing|20|||
126715462|NCT00339183|455910567|FG001|Overall Study|Ongoing|13|||
126715463|NCT02142894|455910568|FG000|Overall Study|Protocol Violation|8|||
126715464|NCT01455428|455910572|FG000|Overall Study|Protocol Violation|2|||
126715465|NCT01455428|455910573|FG001|Overall Study|Protocol Violation|1|||
126715466|NCT01455428|455910572|FG000|Overall Study|Adverse Event|6|||
126715467|NCT01455428|455910573|FG001|Overall Study|Adverse Event|2|||
126715468|NCT01455428|455910572|FG000|Overall Study|Lost to Follow-up|1|||
126715469|NCT01455428|455910573|FG001|Overall Study|Lost to Follow-up|1|||
126715470|NCT01455428|455910572|FG000|Overall Study|Withdrawal by Subject|2|||
126715471|NCT01455428|455910573|FG001|Overall Study|Withdrawal by Subject|5|||
126715472|NCT01455428|455910572|FG000|Overall Study|Did not meet entrance criteria|0|||
126715473|NCT01455428|455910573|FG001|Overall Study|Did not meet entrance criteria|2|||
126715474|NCT01455428|455910572|FG000|Overall Study|Insufficient clinical response|0|||
126715475|NCT01455428|455910573|FG001|Overall Study|Insufficient clinical response|2|||
126715476|NCT01455428|455910572|FG000|Overall Study|Did not receive treatment|1|||
126715477|NCT01455428|455910573|FG001|Overall Study|Did not receive treatment|1|||
126715478|NCT01455428|455910572|FG000|Overall Study|Other|2|||
126715479|NCT01455428|455910573|FG001|Overall Study|Other|4|||
126715480|NCT03303339|455910574|FG000|Overall Study|Death|2|||
126715481|NCT03303339|455910575|FG001|Overall Study|Death|2|||
126715482|NCT03303339|455910576|FG002|Overall Study|Death|2|||
126715483|NCT03303339|455910577|FG003|Overall Study|Death|1|||
126715484|NCT03303339|455910578|FG004|Overall Study|Death|4|||
126715485|NCT03303339|455910579|FG005|Overall Study|Death|2|||
126715486|NCT03303339|455910580|FG006|Overall Study|Death|2|||
126715487|NCT03303339|455910581|FG007|Overall Study|Death|2|||
126715488|NCT03303339|455910582|FG008|Overall Study|Death|3|||
126715489|NCT03303339|455910583|FG009|Overall Study|Death|3|||
126715490|NCT03303339|455910584|FG010|Overall Study|Death|4|||
126715491|NCT03303339|455910585|FG011|Overall Study|Death|24|||
126715492|NCT03303339|455910574|FG000|Overall Study|Study Terminated by Sponsor|0|||
126715493|NCT03303339|455910575|FG001|Overall Study|Study Terminated by Sponsor|0|||
126715494|NCT03303339|455910576|FG002|Overall Study|Study Terminated by Sponsor|0|||
126715495|NCT03303339|455910577|FG003|Overall Study|Study Terminated by Sponsor|0|||
126715496|NCT03303339|455910578|FG004|Overall Study|Study Terminated by Sponsor|0|||
126715497|NCT03303339|455910579|FG005|Overall Study|Study Terminated by Sponsor|0|||
126715498|NCT03303339|455910580|FG006|Overall Study|Study Terminated by Sponsor|0|||
126715499|NCT03303339|455910581|FG007|Overall Study|Study Terminated by Sponsor|0|||
126715500|NCT03303339|455910582|FG008|Overall Study|Study Terminated by Sponsor|1|||
126715501|NCT03303339|455910583|FG009|Overall Study|Study Terminated by Sponsor|0|||
126715502|NCT03303339|455910584|FG010|Overall Study|Study Terminated by Sponsor|1|||
126370542|NCT04462471|454653659|FG002|Overall Study|Disease progression|0|||
126370543|NCT04462471|454653660|FG003|Overall Study|Disease progression|0|||
126370544|NCT01121757|454653666|FG000|First Drug|Death|1|||
126370545|NCT01121757|454653667|FG001|First Drug|Death|0|||
126370546|NCT01121757|454653666|FG000|First Drug|Disease Progression|0|||
126370547|NCT01121757|454653667|FG001|First Drug|Disease Progression|2|||
126370548|NCT01121757|454653666|FG000|Combination|Physician Decision|0|||
126715503|NCT03303339|455910585|FG011|Overall Study|Study Terminated by Sponsor|1|||
126715504|NCT03303339|455910574|FG000|Overall Study|Withdrawal by Subject|1|||
126715505|NCT03303339|455910575|FG001|Overall Study|Withdrawal by Subject|0|||
126715506|NCT03303339|455910576|FG002|Overall Study|Withdrawal by Subject|0|||
126715507|NCT03303339|455910577|FG003|Overall Study|Withdrawal by Subject|0|||
126715508|NCT03303339|455910578|FG004|Overall Study|Withdrawal by Subject|0|||
126370549|NCT01121757|454653667|FG001|Combination|Physician Decision|1|||
126715509|NCT03303339|455910579|FG005|Overall Study|Withdrawal by Subject|1|||
126715510|NCT03303339|455910580|FG006|Overall Study|Withdrawal by Subject|1|||
126715511|NCT03303339|455910581|FG007|Overall Study|Withdrawal by Subject|0|||
126307043|NCT02438826|454411996|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
126307044|NCT02438826|454411997|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126307045|NCT02438826|454411998|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126307046|NCT02438826|454411999|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126307047|NCT02438826|454411996|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
126715512|NCT03303339|455910582|FG008|Overall Study|Withdrawal by Subject|0|||
126715513|NCT03303339|455910583|FG009|Overall Study|Withdrawal by Subject|0|||
126715514|NCT03303339|455910584|FG010|Overall Study|Withdrawal by Subject|0|||
126715515|NCT03303339|455910585|FG011|Overall Study|Withdrawal by Subject|2|||
126715516|NCT03303339|455910574|FG000|Overall Study|Physician Decision|0|||
126715517|NCT03303339|455910575|FG001|Overall Study|Physician Decision|0|||
126715518|NCT03303339|455910576|FG002|Overall Study|Physician Decision|0|||
126715519|NCT03303339|455910577|FG003|Overall Study|Physician Decision|0|||
126715520|NCT03303339|455910578|FG004|Overall Study|Physician Decision|1|||
126715521|NCT03303339|455910579|FG005|Overall Study|Physician Decision|0|||
126715522|NCT03303339|455910580|FG006|Overall Study|Physician Decision|0|||
126715523|NCT03303339|455910581|FG007|Overall Study|Physician Decision|0|||
126715524|NCT03303339|455910582|FG008|Overall Study|Physician Decision|0|||
126715525|NCT03303339|455910583|FG009|Overall Study|Physician Decision|0|||
126715526|NCT03303339|455910584|FG010|Overall Study|Physician Decision|0|||
126715527|NCT03303339|455910585|FG011|Overall Study|Physician Decision|0|||
126715528|NCT03303339|455910574|FG000|Overall Study|Safety/Non-compliance|0|||
126715529|NCT03303339|455910575|FG001|Overall Study|Safety/Non-compliance|0|||
126715530|NCT03303339|455910576|FG002|Overall Study|Safety/Non-compliance|0|||
126307048|NCT02438826|454411997|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
126307049|NCT02438826|454411998|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126307050|NCT02438826|454411999|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126307051|NCT02438826|454411996|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
126307052|NCT02438826|454411997|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
126307053|NCT02438826|454411998|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
126307054|NCT02438826|454411999|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
126307055|NCT02438826|454411996|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
126307056|NCT02438826|454411997|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
126307057|NCT02438826|454411998|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
126307058|NCT02438826|454411999|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
126307059|NCT02438826|454411996|FG000|Open-Label Treatment Phase|Adverse Event|11|||
126307060|NCT02438826|454411997|FG001|Open-Label Treatment Phase|Adverse Event|6|||
126307061|NCT02438826|454411998|FG002|Open-Label Treatment Phase|Adverse Event|0|||
126307062|NCT02438826|454411999|FG003|Open-Label Treatment Phase|Adverse Event|0|||
126307063|NCT02438826|454411996|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
126307064|NCT02438826|454411997|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
126307065|NCT02438826|454411998|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
126307066|NCT02438826|454411999|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
126307067|NCT02438826|454411996|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
126307068|NCT02438826|454411997|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
126307069|NCT02438826|454411998|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
126307070|NCT02438826|454411999|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
126307071|NCT02438826|454411996|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
126307072|NCT02438826|454411997|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
126307073|NCT02438826|454411998|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
126307074|NCT02438826|454411999|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
126307075|NCT02438826|454411996|FG000|Post-Treatment Phase|Adverse Event|3|||
126307076|NCT02438826|454411997|FG001|Post-Treatment Phase|Adverse Event|0|||
126307077|NCT02438826|454411998|FG002|Post-Treatment Phase|Adverse Event|0|||
126307078|NCT02438826|454411999|FG003|Post-Treatment Phase|Adverse Event|0|||
126307079|NCT02438826|454411996|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
126307080|NCT02438826|454411997|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
126370550|NCT01121757|454653666|FG000|Combination|Disease Progression|2|||
126715531|NCT03303339|455910577|FG003|Overall Study|Safety/Non-compliance|0|||
126715532|NCT03303339|455910578|FG004|Overall Study|Safety/Non-compliance|0|||
126715533|NCT03303339|455910579|FG005|Overall Study|Safety/Non-compliance|0|||
126715534|NCT03303339|455910580|FG006|Overall Study|Safety/Non-compliance|0|||
126715535|NCT03303339|455910581|FG007|Overall Study|Safety/Non-compliance|0|||
126307081|NCT02438826|454411998|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
126307082|NCT02438826|454411999|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
126370551|NCT01121757|454653667|FG001|Combination|Disease Progression|0|||
126307083|NCT02438826|454411996|FG000|Post-Treatment Phase|Physician Decision|1|||
126307084|NCT02438826|454411997|FG001|Post-Treatment Phase|Physician Decision|0|||
126307085|NCT02438826|454411998|FG002|Post-Treatment Phase|Physician Decision|0|||
126307086|NCT02438826|454411999|FG003|Post-Treatment Phase|Physician Decision|0|||
126307087|NCT02438826|454411996|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
126715536|NCT03303339|455910582|FG008|Overall Study|Safety/Non-compliance|0|||
126715537|NCT03303339|455910583|FG009|Overall Study|Safety/Non-compliance|0|||
126715538|NCT03303339|455910584|FG010|Overall Study|Safety/Non-compliance|0|||
126770541|NCT00545441|456114632|FG000|Overall Study|Withdrawal by Subject|1|||
126770542|NCT00545441|456114633|FG001|Overall Study|Withdrawal by Subject|1|||
126770543|NCT00545441|456114632|FG000|Overall Study|Persistence or recurrence of fistula|5|||
126770544|NCT00545441|456114633|FG001|Overall Study|Persistence or recurrence of fistula|2|||
126770545|NCT00545441|456114632|FG000|Overall Study|Patients were not treated|1|||
126770546|NCT00545441|456114633|FG001|Overall Study|Patients were not treated|3|||
126770547|NCT00265239|456114634|FG000|Overall Study|Adverse Event|2|||
126464184|NCT00395538|455000352|FG002|Overall Study|Non-compliance with study protocol|0|||
126715539|NCT03303339|455910585|FG011|Overall Study|Safety/Non-compliance|1|||
126715540|NCT02062151|455910590|FG000|Overall Study|screen failure|1|||
126715541|NCT00257192|455910593|FG000|Overall Study|Adverse Event|21|||
126715542|NCT00257192|455910594|FG001|Overall Study|Adverse Event|10|||
126715543|NCT00257192|455910593|FG000|Overall Study|Laboratory abnormality|1|||
126715544|NCT00257192|455910594|FG001|Overall Study|Laboratory abnormality|1|||
126715545|NCT00257192|455910593|FG000|Overall Study|Lost to Follow-up|3|||
126715546|NCT00257192|455910594|FG001|Overall Study|Lost to Follow-up|3|||
126715547|NCT00257192|455910593|FG000|Overall Study|Insufficient clinical response|18|||
126715548|NCT00257192|455910594|FG001|Overall Study|Insufficient clinical response|18|||
126715549|NCT00257192|455910593|FG000|Overall Study|Withdrawal by Subject|14|||
126715550|NCT00257192|455910594|FG001|Overall Study|Withdrawal by Subject|2|||
126715551|NCT00257192|455910593|FG000|Overall Study|Randomized but not treated|0|||
126715552|NCT00257192|455910594|FG001|Overall Study|Randomized but not treated|1|||
126715553|NCT00257192|455910593|FG000|Overall Study|Study terminated by sponsor|1|||
126715554|NCT00257192|455910594|FG001|Overall Study|Study terminated by sponsor|0|||
126715555|NCT00257192|455910593|FG000|Overall Study|Miscellaneous|0|||
126715556|NCT00257192|455910594|FG001|Overall Study|Miscellaneous|4|||
126715557|NCT00570739|455910595|FG000|Overall Study|Adverse Event|8|||
126715558|NCT00570739|455910596|FG001|Overall Study|Adverse Event|6|||
126715559|NCT00570739|455910597|FG002|Overall Study|Adverse Event|2|||
126715560|NCT00570739|455910598|FG003|Overall Study|Adverse Event|2|||
126715561|NCT00570739|455910595|FG000|Overall Study|Lost to Follow-up|4|||
126715562|NCT00570739|455910596|FG001|Overall Study|Lost to Follow-up|5|||
126715563|NCT00570739|455910597|FG002|Overall Study|Lost to Follow-up|4|||
126715564|NCT00570739|455910598|FG003|Overall Study|Lost to Follow-up|1|||
126715565|NCT00570739|455910595|FG000|Overall Study|Physician Decision|1|||
126715566|NCT00570739|455910596|FG001|Overall Study|Physician Decision|1|||
126715567|NCT00570739|455910597|FG002|Overall Study|Physician Decision|0|||
126715568|NCT00570739|455910598|FG003|Overall Study|Physician Decision|0|||
126715569|NCT00570739|455910595|FG000|Overall Study|Withdrawal by Subject|7|||
126715570|NCT00570739|455910596|FG001|Overall Study|Withdrawal by Subject|7|||
126715571|NCT00570739|455910597|FG002|Overall Study|Withdrawal by Subject|3|||
126715572|NCT00570739|455910598|FG003|Overall Study|Withdrawal by Subject|5|||
126715573|NCT00570739|455910595|FG000|Overall Study|Required restricted medication|0|||
126715574|NCT00570739|455910596|FG001|Overall Study|Required restricted medication|0|||
126715575|NCT00570739|455910597|FG002|Overall Study|Required restricted medication|1|||
126715576|NCT00570739|455910598|FG003|Overall Study|Required restricted medication|0|||
126715577|NCT00570739|455910595|FG000|Overall Study|Met discontinuation criteria|1|||
126715578|NCT00570739|455910596|FG001|Overall Study|Met discontinuation criteria|0|||
126715579|NCT00570739|455910597|FG002|Overall Study|Met discontinuation criteria|1|||
126715580|NCT00570739|455910598|FG003|Overall Study|Met discontinuation criteria|1|||
126715581|NCT00570739|455910595|FG000|Overall Study|Other|0|||
126715582|NCT00570739|455910596|FG001|Overall Study|Other|2|||
126715583|NCT00570739|455910597|FG002|Overall Study|Other|5|||
126715584|NCT00570739|455910598|FG003|Overall Study|Other|3|||
126715585|NCT01844700|455910604|FG000|Overall Study|Lack of Efficacy|1|||
126715586|NCT01844700|455910605|FG001|Overall Study|Lack of Efficacy|0|||
126715587|NCT01844700|455910604|FG000|Overall Study|refused medication switch|1|||
126715588|NCT01844700|455910605|FG001|Overall Study|refused medication switch|0|||
126715589|NCT01844700|455910604|FG000|Overall Study|Withdrawal by Subject|1|||
126715590|NCT01844700|455910605|FG001|Overall Study|Withdrawal by Subject|0|||
126715591|NCT01844700|455910604|FG000|Overall Study|stopped taking meds|0|||
126715592|NCT01844700|455910605|FG001|Overall Study|stopped taking meds|1|||
126715593|NCT02680847|455910606|FG000|Overall Study|Other|2|||
126715594|NCT02680847|455910607|FG001|Overall Study|Other|0|||
126715595|NCT02680847|455910608|FG002|Overall Study|Other|0|||
126715596|NCT02680847|455910606|FG000|Overall Study|No longer met eligibility criteria|2|||
126715597|NCT02680847|455910607|FG001|Overall Study|No longer met eligibility criteria|2|||
126715598|NCT02680847|455910608|FG002|Overall Study|No longer met eligibility criteria|0|||
126715599|NCT02680847|455910606|FG000|Overall Study|Unwilling to participate in study|1|||
126715600|NCT02680847|455910607|FG001|Overall Study|Unwilling to participate in study|1|||
126715601|NCT02680847|455910608|FG002|Overall Study|Unwilling to participate in study|0|||
126770548|NCT00265239|456114635|FG001|Overall Study|Adverse Event|1|||
126770549|NCT02803138|456114640|FG000|Overall Study|Failure to return|38|||
126715602|NCT02680847|455910606|FG000|Overall Study|Lack of Efficacy|0|||
126715603|NCT02680847|455910607|FG001|Overall Study|Lack of Efficacy|0|||
126715604|NCT02680847|455910608|FG002|Overall Study|Lack of Efficacy|2|||
126715605|NCT02680847|455910606|FG000|Overall Study|Adverse Event|0|||
126770550|NCT02803138|456114640|FG000|Overall Study|Insufficient virological response|2|||
126770551|NCT02803138|456114640|FG000|Overall Study|Withdrawn consent|1|||
126770552|NCT02803138|456114640|FG000|Overall Study|Death|1|||
126770553|NCT02803138|456114640|FG000|Overall Study|Other, not specified|28|||
126770554|NCT00424515|456114641|FG000|Overall Study|Progressive Disease|10|||
126770555|NCT00424515|456114642|FG001|Overall Study|Progressive Disease|11|||
126770556|NCT00424515|456114641|FG000|Overall Study|Adverse Event|0|||
126770557|NCT00424515|456114642|FG001|Overall Study|Adverse Event|1|||
126770558|NCT00424515|456114641|FG000|Overall Study|Intercurrent Illness|0|||
126770559|NCT00424515|456114642|FG001|Overall Study|Intercurrent Illness|1|||
126770560|NCT00424515|456114641|FG000|Overall Study|Withdrawal by Subject|1|||
126770561|NCT00424515|456114642|FG001|Overall Study|Withdrawal by Subject|0|||
126770562|NCT00267020|456114643|FG000|Overall Study|Adverse Event|22|||
126770563|NCT00267020|456114644|FG001|Overall Study|Adverse Event|5|||
126770564|NCT00267020|456114643|FG000|Overall Study|Death|2|||
126770565|NCT00267020|456114644|FG001|Overall Study|Death|1|||
126770566|NCT00267020|456114643|FG000|Overall Study|Withdrawal by Subject|17|||
126770567|NCT00267020|456114644|FG001|Overall Study|Withdrawal by Subject|7|||
126770568|NCT00267020|456114643|FG000|Overall Study|Physician Decision|3|||
126770569|NCT00267020|456114644|FG001|Overall Study|Physician Decision|2|||
126770570|NCT00267020|456114643|FG000|Overall Study|Disease Progression|39|||
126770571|NCT00267020|456114644|FG001|Overall Study|Disease Progression|25|||
126770572|NCT00267020|456114643|FG000|Overall Study|Unrelated Complication|1|||
126770573|NCT00267020|456114644|FG001|Overall Study|Unrelated Complication|1|||
126770574|NCT00267020|456114643|FG000|Overall Study|Sponsor Request|1|||
126770575|NCT00267020|456114644|FG001|Overall Study|Sponsor Request|0|||
126770576|NCT00267020|456114643|FG000|Overall Study|Other|1|||
126770577|NCT00267020|456114644|FG001|Overall Study|Other|2|||
126770578|NCT04071366|456114645|FG000|Part 1: Open-label (29 Days)|Death|4|||
126770579|NCT04071366|456114646|FG001|Part 1: Open-label (29 Days)|Death|2|||
126770580|NCT04071366|456114647|FG002|Part 1: Open-label (29 Days)|Death|8|||
126770581|NCT04071366|456114648|FG003|Part 1: Open-label (29 Days)|Death|0|||
126770582|NCT04071366|456114649|FG004|Part 1: Open-label (29 Days)|Death|0|||
126770583|NCT04071366|456114645|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
126770584|NCT04071366|456114646|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
126770585|NCT04071366|456114647|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
126770586|NCT04071366|456114648|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
126770587|NCT04071366|456114649|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
126770588|NCT04071366|456114645|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
126770589|NCT04071366|456114646|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
126770590|NCT04071366|456114647|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
126770591|NCT04071366|456114648|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
126770592|NCT04071366|456114649|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
126770593|NCT04071366|456114645|FG000|Part 2: Randomized (29 Days)|Death|0|||
126770594|NCT04071366|456114646|FG001|Part 2: Randomized (29 Days)|Death|0|||
126715606|NCT02680847|455910607|FG001|Overall Study|Adverse Event|0|||
126715607|NCT02680847|455910608|FG002|Overall Study|Adverse Event|1|||
126715608|NCT02375698|455910609|FG000|Overall Study|Withdrawal by Subject|0|||
126715609|NCT02375698|455910610|FG001|Overall Study|Withdrawal by Subject|2|||
126715610|NCT02375698|455910609|FG000|Overall Study|Physician Decision|2|||
126715611|NCT02375698|455910610|FG001|Overall Study|Physician Decision|0|||
126715612|NCT00803244|455910613|FG000|Overall Study|Adverse Event|1|||
126715613|NCT00803244|455910614|FG001|Overall Study|Adverse Event|2|||
126715614|NCT00803244|455910613|FG000|Overall Study|Withdrawal by Subject|2|||
126715615|NCT00803244|455910614|FG001|Overall Study|Withdrawal by Subject|3|||
126715616|NCT00803244|455910613|FG000|Overall Study|Any other reason not above-mentioned|4|||
126715617|NCT00803244|455910614|FG001|Overall Study|Any other reason not above-mentioned|10|||
126715618|NCT00616239|455910615|FG000|Overall Study|Withdrawal by Subject|2|||
126715619|NCT03241173|455910616|FG000|Overall Study|Death|3|||
126715620|NCT03241173|455910617|FG001|Overall Study|Death|2|||
126715621|NCT03241173|455910618|FG002|Overall Study|Death|4|||
126770595|NCT04071366|456114647|FG002|Part 2: Randomized (29 Days)|Death|0|||
126770596|NCT04071366|456114648|FG003|Part 2: Randomized (29 Days)|Death|2|||
126770597|NCT04071366|456114649|FG004|Part 2: Randomized (29 Days)|Death|2|||
126770598|NCT04071366|456114645|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
126770599|NCT04071366|456114646|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
126370552|NCT04251533|454653668|FG000|Overall Study|Progressive disease|33|||
126370553|NCT04251533|454653669|FG001|Overall Study|Progressive disease|29|||
126770600|NCT04071366|456114647|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
126770601|NCT04071366|456114648|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
126770602|NCT04071366|456114649|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
126770603|NCT04071366|456114645|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
126770604|NCT04071366|456114646|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
126715622|NCT03241173|455910619|FG003|Overall Study|Death|4|||
126715623|NCT03241173|455910620|FG004|Overall Study|Death|2|||
126715624|NCT03241173|455910621|FG005|Overall Study|Death|2|||
126770605|NCT04071366|456114647|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
126770606|NCT04071366|456114648|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
126770607|NCT04071366|456114649|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
126770608|NCT04071366|456114645|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
126770609|NCT04071366|456114646|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
126770610|NCT04071366|456114647|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
126770611|NCT04071366|456114648|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
126770612|NCT04071366|456114649|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
126770613|NCT04071366|456114645|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
126770614|NCT04071366|456114646|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
126770615|NCT04071366|456114647|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
126770616|NCT04071366|456114648|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
126770617|NCT04071366|456114649|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
126770618|NCT04071366|456114645|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
126770619|NCT04071366|456114646|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
126770620|NCT04071366|456114647|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
126770621|NCT04071366|456114648|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
126770622|NCT04071366|456114649|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
126770623|NCT04071366|456114645|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
126770624|NCT04071366|456114646|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
126770625|NCT04071366|456114647|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
126770626|NCT04071366|456114648|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
126770627|NCT04071366|456114649|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
126770628|NCT00021229|456114650|FG000|Overall Study|Adverse Event|10|||
126770629|NCT00021229|456114651|FG001|Overall Study|Adverse Event|5|||
126770630|NCT00021229|456114652|FG002|Overall Study|Adverse Event|2|||
126770631|NCT00021229|456114650|FG000|Overall Study|Death|0|||
126770632|NCT00021229|456114651|FG001|Overall Study|Death|1|||
126770633|NCT00021229|456114652|FG002|Overall Study|Death|0|||
126770634|NCT00021229|456114650|FG000|Overall Study|Withdrawal by Subject|7|||
126770635|NCT00021229|456114651|FG001|Overall Study|Withdrawal by Subject|7|||
126770636|NCT00021229|456114652|FG002|Overall Study|Withdrawal by Subject|1|||
126770637|NCT00021229|456114650|FG000|Overall Study|Progressive Disease|15|||
126770638|NCT00021229|456114651|FG001|Overall Study|Progressive Disease|19|||
126770639|NCT00021229|456114652|FG002|Overall Study|Progressive Disease|12|||
126770640|NCT00021229|456114650|FG000|Overall Study|Protocol Violation|1|||
126770641|NCT00021229|456114651|FG001|Overall Study|Protocol Violation|1|||
126770642|NCT00021229|456114652|FG002|Overall Study|Protocol Violation|0|||
126770643|NCT00021229|456114650|FG000|Overall Study|Physician Decision|0|||
126770644|NCT00021229|456114651|FG001|Overall Study|Physician Decision|0|||
126770645|NCT00021229|456114652|FG002|Overall Study|Physician Decision|1|||
126770646|NCT00021229|456114650|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
126770647|NCT00021229|456114651|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
126770648|NCT00021229|456114652|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
126770649|NCT02156466|456114653|FG000|Overall Study|Adverse Event|0|||
126770650|NCT02156466|456114654|FG001|Overall Study|Adverse Event|0|||
126770651|NCT02156466|456114655|FG002|Overall Study|Adverse Event|1|||
126770652|NCT02156466|456114656|FG003|Overall Study|Adverse Event|1|||
126770653|NCT02156466|456114657|FG004|Overall Study|Adverse Event|0|||
126770654|NCT02156466|456114653|FG000|Overall Study|Quantiferon Positivity|0|||
126770655|NCT02156466|456114654|FG001|Overall Study|Quantiferon Positivity|0|||
126770656|NCT02156466|456114655|FG002|Overall Study|Quantiferon Positivity|0|||
126770657|NCT02156466|456114656|FG003|Overall Study|Quantiferon Positivity|1|||
126770658|NCT02156466|456114657|FG004|Overall Study|Quantiferon Positivity|0|||
126770659|NCT02237118|456114658|FG000|Overall Study|Protocol Violation|0|||
126770660|NCT02237118|456114659|FG001|Overall Study|Protocol Violation|1|||
126770661|NCT02237118|456114658|FG000|Overall Study|consent withdrawn|1|||
126770662|NCT02237118|456114659|FG001|Overall Study|consent withdrawn|0|||
126770663|NCT00902265|456114660|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
126770664|NCT00902265|456114660|FG000|Overall Study|Adverse Event|2|||
126770665|NCT00902265|456114660|FG000|Overall Study|Lack of Efficacy|2|||
126770666|NCT00902265|456114660|FG000|Overall Study|Protocol Violation|1|||
126770667|NCT03981614|456114661|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
126770668|NCT03981614|456114662|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
126770669|NCT03981614|456114663|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
126770670|NCT04701658|456114664|FG000|Overall Study|Lost to Follow-up|6|||
126770671|NCT03387735|456114665|FG000|Overall Study|Lost to Follow-up|4|||
126770672|NCT03387735|456114666|FG001|Overall Study|Lost to Follow-up|8|||
126770673|NCT03387735|456114665|FG000|Overall Study|Death|4|||
126770674|NCT03387735|456114666|FG001|Overall Study|Death|8|||
126464185|NCT00395538|455000350|FG000|Overall Study|PTH resistance|0|||
126464186|NCT00395538|455000351|FG001|Overall Study|PTH resistance|0|||
126464187|NCT00395538|455000352|FG002|Overall Study|PTH resistance|1|||
126770675|NCT03747939|456114670|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
126464188|NCT00395538|455000350|FG000|Overall Study|Pregnancy|1|||
126464189|NCT00395538|455000351|FG001|Overall Study|Pregnancy|0|||
126464190|NCT00395538|455000352|FG002|Overall Study|Pregnancy|0|||
126464191|NCT00395538|455000350|FG000|Overall Study|Partial recovery of parathyroid function|0|||
126464192|NCT00395538|455000351|FG001|Overall Study|Partial recovery of parathyroid function|0|||
126464193|NCT00395538|455000352|FG002|Overall Study|Partial recovery of parathyroid function|1|||
126464194|NCT00395538|455000350|FG000|Overall Study|Participant elected to discontinue|0|||
126464195|NCT00395538|455000351|FG001|Overall Study|Participant elected to discontinue|0|||
126464196|NCT00395538|455000352|FG002|Overall Study|Participant elected to discontinue|1|||
126464197|NCT01074047|455000353|FG000|Treatment Phase|Adverse Event|89|||
126464198|NCT01074047|455000354|FG001|Treatment Phase|Adverse Event|66|||
126464199|NCT01074047|455000353|FG000|Treatment Phase|Disease Progression|16|||
126464200|NCT01074047|455000354|FG001|Treatment Phase|Disease Progression|21|||
126464201|NCT01074047|455000353|FG000|Treatment Phase|Withdrawal by Subject|27|||
126464202|NCT01074047|455000354|FG001|Treatment Phase|Withdrawal by Subject|48|||
126464203|NCT01074047|455000353|FG000|Treatment Phase|Death|53|||
126464204|NCT01074047|455000354|FG001|Treatment Phase|Death|58|||
126464205|NCT01074047|455000353|FG000|Treatment Phase|Lost to Follow-up|0|||
126464206|NCT01074047|455000354|FG001|Treatment Phase|Lost to Follow-up|1|||
126464207|NCT01074047|455000353|FG000|Treatment Phase|Protocol Violation|0|||
126464208|NCT01074047|455000354|FG001|Treatment Phase|Protocol Violation|1|||
126464209|NCT01074047|455000353|FG000|Treatment Phase|Miscellaneous|32|||
126464210|NCT01074047|455000354|FG001|Treatment Phase|Miscellaneous|39|||
126464211|NCT01074047|455000353|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
126464212|NCT01074047|455000354|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
126464213|NCT01074047|455000353|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
126464214|NCT01074047|455000354|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
126464215|NCT01074047|455000353|FG000|Survival Follow-Up Phase|Death|116|||
126464216|NCT01074047|455000354|FG001|Survival Follow-Up Phase|Death|124|||
126464217|NCT01074047|455000353|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
126464218|NCT01074047|455000354|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
126464219|NCT01074047|455000353|FG000|Extension Phase|Physician Decision|1|||
126464220|NCT01074047|455000354|FG001|Extension Phase|Physician Decision|0|||
126464221|NCT01074047|455000353|FG000|Extension Phase|Adverse Event|5|||
126464222|NCT01074047|455000354|FG001|Extension Phase|Adverse Event|0|||
126464223|NCT01074047|455000353|FG000|Extension Phase|Disease Progression|9|||
126464224|NCT01074047|455000354|FG001|Extension Phase|Disease Progression|0|||
126464225|NCT01074047|455000353|FG000|Extension Phase|Withdrawal by Subject|2|||
126464226|NCT01074047|455000354|FG001|Extension Phase|Withdrawal by Subject|0|||
126464227|NCT01074047|455000353|FG000|Extension Phase|Death|5|||
126464228|NCT01074047|455000354|FG001|Extension Phase|Death|0|||
126464229|NCT02294773|455001926|FG000|Overall Study|Withdrawal by Subject|0|||
126464230|NCT02294773|455001927|FG001|Overall Study|Withdrawal by Subject|2|||
126464231|NCT03052764|455001928|FG000|Double-Blind Treatment Period|Adverse Event|2|||
126464232|NCT03052764|455001929|FG001|Double-Blind Treatment Period|Adverse Event|0|||
126464233|NCT03052764|455001928|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
126464234|NCT03052764|455001929|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
126464235|NCT03052764|455001928|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
126464236|NCT03052764|455001929|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
126552153|NCT00849680|455316004|FG005|Overall Study|Adverse Event|0|||
126715625|NCT03241173|455910622|FG006|Overall Study|Death|3|||
126715626|NCT03241173|455910623|FG007|Overall Study|Death|1|||
126715627|NCT03241173|455910624|FG008|Overall Study|Death|0|||
126715628|NCT03241173|455910625|FG009|Overall Study|Death|5|||
126715629|NCT03241173|455910626|FG010|Overall Study|Death|4|||
126715630|NCT03241173|455910627|FG011|Overall Study|Death|3|||
126715631|NCT03241173|455910628|FG012|Overall Study|Death|0|||
126715632|NCT03241173|455910629|FG013|Overall Study|Death|0|||
126464237|NCT03052764|455001928|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
126464238|NCT03052764|455001929|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126464239|NCT03052764|455001928|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
126464240|NCT03052764|455001929|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
126464241|NCT05828095|455001930|FG000|Overall Study|Lost to Follow-up|1|||
126464242|NCT05828095|455001931|FG001|Overall Study|Lost to Follow-up|0|||
126464243|NCT05828095|455001930|FG000|Overall Study|Reactogenicity symptom|0|||
126464244|NCT05828095|455001931|FG001|Overall Study|Reactogenicity symptom|1|||
126464245|NCT03206073|455001932|FG000|Overall Study|Participant Noncompliance|0|||
126464246|NCT03206073|455001933|FG001|Overall Study|Participant Noncompliance|1|||
126464247|NCT03206073|455001934|FG002|Overall Study|Participant Noncompliance|0|||
126464248|NCT03206073|455001935|FG003|Overall Study|Participant Noncompliance|0|||
126464249|NCT03206073|455001932|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
126464250|NCT03206073|455001933|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
126464251|NCT03206073|455001934|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
126464252|NCT03206073|455001935|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
126715633|NCT03241173|455910630|FG014|Overall Study|Death|0|||
126715634|NCT03241173|455910616|FG000|Overall Study|Withdrawal by Subject|0|||
126715635|NCT03241173|455910617|FG001|Overall Study|Withdrawal by Subject|0|||
126715636|NCT03241173|455910618|FG002|Overall Study|Withdrawal by Subject|1|||
126715637|NCT03241173|455910619|FG003|Overall Study|Withdrawal by Subject|0|||
126715638|NCT03241173|455910620|FG004|Overall Study|Withdrawal by Subject|0|||
126715639|NCT03241173|455910621|FG005|Overall Study|Withdrawal by Subject|1|||
126715640|NCT03241173|455910622|FG006|Overall Study|Withdrawal by Subject|0|||
126715641|NCT03241173|455910623|FG007|Overall Study|Withdrawal by Subject|0|||
126715642|NCT03241173|455910624|FG008|Overall Study|Withdrawal by Subject|0|||
126715643|NCT03241173|455910625|FG009|Overall Study|Withdrawal by Subject|0|||
126715644|NCT03241173|455910626|FG010|Overall Study|Withdrawal by Subject|0|||
126715645|NCT03241173|455910627|FG011|Overall Study|Withdrawal by Subject|0|||
126715646|NCT03241173|455910628|FG012|Overall Study|Withdrawal by Subject|0|||
126715647|NCT03241173|455910629|FG013|Overall Study|Withdrawal by Subject|0|||
126715648|NCT03241173|455910630|FG014|Overall Study|Withdrawal by Subject|0|||
126715649|NCT03241173|455910616|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
126715650|NCT03241173|455910617|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
126715651|NCT03241173|455910618|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
126715652|NCT03241173|455910619|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
126715653|NCT03241173|455910620|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
126715654|NCT03241173|455910621|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
126715655|NCT03241173|455910622|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
126715656|NCT03241173|455910623|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
126715657|NCT03241173|455910624|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
126715658|NCT03241173|455910625|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
126715659|NCT03241173|455910626|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
126715660|NCT03241173|455910627|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
126715661|NCT03241173|455910628|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
126715662|NCT03241173|455910629|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
126715663|NCT03241173|455910630|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
126715664|NCT03241173|455910616|FG000|Overall Study|Lost to Follow-up|0|||
126715665|NCT03241173|455910617|FG001|Overall Study|Lost to Follow-up|0|||
126715666|NCT03241173|455910618|FG002|Overall Study|Lost to Follow-up|0|||
126715667|NCT03241173|455910619|FG003|Overall Study|Lost to Follow-up|0|||
126715668|NCT03241173|455910620|FG004|Overall Study|Lost to Follow-up|1|||
126715669|NCT03241173|455910621|FG005|Overall Study|Lost to Follow-up|0|||
126715670|NCT03241173|455910622|FG006|Overall Study|Lost to Follow-up|0|||
126715671|NCT03241173|455910623|FG007|Overall Study|Lost to Follow-up|0|||
126715672|NCT03241173|455910624|FG008|Overall Study|Lost to Follow-up|0|||
126715673|NCT03241173|455910625|FG009|Overall Study|Lost to Follow-up|1|||
126715674|NCT03241173|455910626|FG010|Overall Study|Lost to Follow-up|0|||
126715675|NCT03241173|455910627|FG011|Overall Study|Lost to Follow-up|0|||
126715676|NCT03241173|455910628|FG012|Overall Study|Lost to Follow-up|0|||
126715677|NCT03241173|455910629|FG013|Overall Study|Lost to Follow-up|0|||
126715678|NCT03241173|455910630|FG014|Overall Study|Lost to Follow-up|0|||
126715679|NCT02144220|455910632|FG000|Overall Study|technology incompatibility|9|||
126715680|NCT02144220|455910632|FG000|Overall Study|Lack of Efficacy|4|||
126715681|NCT02144220|455910632|FG000|Overall Study|Physician Decision|3|||
126715682|NCT02144220|455910632|FG000|Overall Study|Withdrawal by Subject|2|||
126715683|NCT02144220|455910632|FG000|Overall Study|Protocol Violation|1|||
126715684|NCT00053846|455910638|FG000|Overall Study|Changed mind|8|||
126715685|NCT00053846|455910639|FG001|Overall Study|Changed mind|13|||
126715686|NCT00053846|455910638|FG000|Overall Study|Became too ill|8|||
126715687|NCT00053846|455910639|FG001|Overall Study|Became too ill|7|||
126715688|NCT00053846|455910638|FG000|Overall Study|Expired|5|||
126715689|NCT00053846|455910639|FG001|Overall Study|Expired|0|||
126715690|NCT00053846|455910638|FG000|Overall Study|Became ineligible|3|||
126715691|NCT00053846|455910639|FG001|Overall Study|Became ineligible|1|||
126715692|NCT00053846|455910638|FG000|Overall Study|Did not return data|1|||
126715693|NCT00053846|455910639|FG001|Overall Study|Did not return data|2|||
126715694|NCT00053846|455910638|FG000|Overall Study|Quit due to side effects|1|||
126715695|NCT00053846|455910639|FG001|Overall Study|Quit due to side effects|3|||
126770676|NCT03747939|456114671|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
126715696|NCT00053846|455910638|FG000|Overall Study|Pills too large|0|||
126715697|NCT00053846|455910639|FG001|Overall Study|Pills too large|1|||
126770677|NCT03747939|456114672|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
126770678|NCT03747939|456114673|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
126715698|NCT01345786|455910649|FG000|Overall Study|Adverse Event|0|||
126715699|NCT01345786|455910650|FG001|Overall Study|Adverse Event|1|||
126715700|NCT01345786|455910651|FG002|Overall Study|Adverse Event|3|||
126770679|NCT03747939|456114670|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
126770680|NCT03747939|456114671|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
126307088|NCT02438826|454411997|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
126307089|NCT02438826|454411998|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
126307090|NCT02438826|454411999|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
126307091|NCT00595517|454412001|FG000|Overall Study|Adverse Event|6|||
126307092|NCT00595517|454412001|FG000|Overall Study|Withdrawal by Subject|4|||
126307093|NCT00595517|454412001|FG000|Overall Study|Protocol Violation|2|||
126307094|NCT00595517|454412001|FG000|Overall Study|Recurrence of ulcer|5|||
126307095|NCT00595517|454412001|FG000|Overall Study|usage of prohibited treatment|1|||
126307096|NCT00595517|454412001|FG000|Overall Study|No intention to attend regularly|1|||
126307097|NCT04105218|454412002|FG000|Overall Study|Withdrawal by Subject|3|||
126307098|NCT04105218|454412003|FG001|Overall Study|Withdrawal by Subject|2|||
126307099|NCT04105218|454412002|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
126307100|NCT04105218|454412003|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
126307101|NCT04105218|454412002|FG000|Overall Study|Failed screening tests|2|||
126307102|NCT04105218|454412003|FG001|Overall Study|Failed screening tests|1|||
126307103|NCT01167881|454412006|FG000|Overall Study|Adverse Event|47|||
126307104|NCT01167881|454412007|FG001|Overall Study|Adverse Event|51|||
126307105|NCT01167881|454412006|FG000|Overall Study|Lack of Efficacy|4|||
126307106|NCT01167881|454412007|FG001|Overall Study|Lack of Efficacy|7|||
126307107|NCT01167881|454412006|FG000|Overall Study|Non compliant with protocol|9|||
126307108|NCT01167881|454412007|FG001|Overall Study|Non compliant with protocol|18|||
126307109|NCT01167881|454412006|FG000|Overall Study|Lost to Follow-up|19|||
126307110|NCT01167881|454412007|FG001|Overall Study|Lost to Follow-up|20|||
126307111|NCT01167881|454412006|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
126307112|NCT01167881|454412007|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
126307113|NCT01167881|454412006|FG000|Overall Study|Not treated|4|||
126307114|NCT01167881|454412007|FG001|Overall Study|Not treated|0|||
126307115|NCT01167881|454412006|FG000|Overall Study|Other not defined above|31|||
126307116|NCT01167881|454412007|FG001|Overall Study|Other not defined above|55|||
126307117|NCT01706939|454412008|FG000|Pre Randomization|Screen Failure|1|||
126307118|NCT01706939|454412009|FG001|Pre Randomization|Screen Failure|0|||
126307119|NCT01706939|454412010|FG002|Pre Randomization|Screen Failure|0|||
126307120|NCT01706939|454412008|FG000|Pre Randomization|Ineligible for Randomization|1|||
126464253|NCT03206073|455001932|FG000|Overall Study|Death|0|||
126464254|NCT03206073|455001933|FG001|Overall Study|Death|0|||
126464255|NCT03206073|455001934|FG002|Overall Study|Death|1|||
126464256|NCT03206073|455001935|FG003|Overall Study|Death|0|||
126464257|NCT03206073|455001932|FG000|Overall Study|Taken off active treatment|0|||
126464258|NCT03206073|455001933|FG001|Overall Study|Taken off active treatment|0|||
126464259|NCT03206073|455001934|FG002|Overall Study|Taken off active treatment|3|||
126464260|NCT03206073|455001935|FG003|Overall Study|Taken off active treatment|0|||
126464261|NCT03332771|455001936|FG000|Overall Study|Adverse Event|6|||
126464262|NCT03332771|455001937|FG001|Overall Study|Adverse Event|4|||
126464263|NCT03332771|455001938|FG002|Overall Study|Adverse Event|1|||
126464264|NCT03332771|455001939|FG003|Overall Study|Adverse Event|3|||
126464265|NCT03332771|455001936|FG000|Overall Study|Poor Compliance to Protocol|0|||
126464266|NCT03332771|455001937|FG001|Overall Study|Poor Compliance to Protocol|1|||
126464267|NCT03332771|455001938|FG002|Overall Study|Poor Compliance to Protocol|0|||
126307121|NCT01706939|454412009|FG001|Pre Randomization|Ineligible for Randomization|0|||
126464268|NCT03332771|455001939|FG003|Overall Study|Poor Compliance to Protocol|1|||
126307122|NCT01706939|454412010|FG002|Pre Randomization|Ineligible for Randomization|0|||
126307123|NCT01706939|454412008|FG000|Pre Randomization|Withdrawal by Subject|1|||
126307124|NCT01706939|454412009|FG001|Pre Randomization|Withdrawal by Subject|0|||
126307125|NCT01706939|454412010|FG002|Pre Randomization|Withdrawal by Subject|0|||
126307126|NCT01706939|454412008|FG000|Randomization|Insufficient QoL survey compliance|0|||
126307127|NCT01706939|454412009|FG001|Randomization|Insufficient QoL survey compliance|1|||
126307128|NCT01706939|454412010|FG002|Randomization|Insufficient QoL survey compliance|1|||
126464269|NCT03332771|455001936|FG000|Overall Study|Lost to Follow-up|2|||
126464270|NCT03332771|455001937|FG001|Overall Study|Lost to Follow-up|2|||
126464271|NCT03332771|455001938|FG002|Overall Study|Lost to Follow-up|1|||
126464272|NCT03332771|455001939|FG003|Overall Study|Lost to Follow-up|2|||
126464273|NCT03332771|455001936|FG000|Overall Study|At the Participant's own request|20|||
126464274|NCT03332771|455001937|FG001|Overall Study|At the Participant's own request|26|||
126464275|NCT03332771|455001938|FG002|Overall Study|At the Participant's own request|14|||
126464276|NCT03332771|455001939|FG003|Overall Study|At the Participant's own request|23|||
126464277|NCT03332771|455001936|FG000|Overall Study|Reason Not Specified|6|||
126464278|NCT03332771|455001937|FG001|Overall Study|Reason Not Specified|18|||
126464279|NCT03332771|455001938|FG002|Overall Study|Reason Not Specified|16|||
126464280|NCT03332771|455001939|FG003|Overall Study|Reason Not Specified|19|||
126464281|NCT00096954|455001940|FG000|Overall Study|Adverse Event|3|||
126464282|NCT00096954|455001941|FG001|Overall Study|Adverse Event|1|||
126464283|NCT00096954|455001940|FG000|Overall Study|Withdrawal by Subject|9|||
126307129|NCT01706939|454412008|FG000|Randomization|Progression of disease|0|||
126307130|NCT01706939|454412009|FG001|Randomization|Progression of disease|2|||
126307131|NCT01706939|454412010|FG002|Randomization|Progression of disease|1|||
126307132|NCT01094301|454412021|FG000|Trial Stage|Withdrawal by Subject|1|||
126464284|NCT00096954|455001941|FG001|Overall Study|Withdrawal by Subject|8|||
126464285|NCT00096954|455001940|FG000|Overall Study|Physician Decision|1|||
126464286|NCT00096954|455001941|FG001|Overall Study|Physician Decision|1|||
126464287|NCT00096954|455001940|FG000|Overall Study|Sponsors Decision|1|||
126464288|NCT00096954|455001941|FG001|Overall Study|Sponsors Decision|1|||
126464289|NCT00096954|455001940|FG000|Overall Study|Pregnancy|1|||
126715701|NCT01345786|455910652|FG003|Overall Study|Adverse Event|1|||
126715702|NCT01345786|455910649|FG000|Overall Study|Subject withdrew consent|2|||
126715703|NCT01345786|455910650|FG001|Overall Study|Subject withdrew consent|2|||
126715704|NCT01345786|455910651|FG002|Overall Study|Subject withdrew consent|1|||
126715705|NCT01345786|455910652|FG003|Overall Study|Subject withdrew consent|0|||
126715706|NCT01345786|455910649|FG000|Overall Study|Noncompliance with protocol|1|||
126715707|NCT01345786|455910650|FG001|Overall Study|Noncompliance with protocol|0|||
126715708|NCT01345786|455910651|FG002|Overall Study|Noncompliance with protocol|1|||
126715709|NCT01345786|455910652|FG003|Overall Study|Noncompliance with protocol|0|||
126715710|NCT01345786|455910649|FG000|Overall Study|Administrative|3|||
126715711|NCT01345786|455910650|FG001|Overall Study|Administrative|5|||
126715712|NCT01345786|455910651|FG002|Overall Study|Administrative|0|||
126715713|NCT01345786|455910652|FG003|Overall Study|Administrative|0|||
126715714|NCT01345786|455910649|FG000|Overall Study|Lost to Follow-up|0|||
126715715|NCT01345786|455910650|FG001|Overall Study|Lost to Follow-up|0|||
126715716|NCT01345786|455910651|FG002|Overall Study|Lost to Follow-up|0|||
126715717|NCT01345786|455910652|FG003|Overall Study|Lost to Follow-up|2|||
126715718|NCT01929044|455910653|FG000|Overall Study|Adverse Event|1|||
126715719|NCT01929044|455910654|FG001|Overall Study|Adverse Event|0|||
126715720|NCT01929044|455910653|FG000|Overall Study|Protocol Violation|9|||
126715721|NCT01929044|455910654|FG001|Overall Study|Protocol Violation|14|||
126715722|NCT01929044|455910653|FG000|Overall Study|Not Treated|1|||
126307133|NCT01094301|454412021|FG000|Implant Stage|Adverse Event|1|||
126307134|NCT01094301|454412021|FG000|Implant Stage|Protocol Violation|1|||
126307135|NCT01094301|454412021|FG000|Implant Stage|Withdrawal by Subject|2|||
126307136|NCT01094301|454412021|FG000|Implant Stage|No return of pain|4|||
126715723|NCT01929044|455910654|FG001|Overall Study|Not Treated|3|||
126307137|NCT00586820|454412022|FG000|Overall Study|Unsuccessful PCI|1|||
126307138|NCT00586820|454412023|FG001|Overall Study|Unsuccessful PCI|0|||
126464290|NCT00096954|455001941|FG001|Overall Study|Pregnancy|1|||
126464291|NCT00096954|455001940|FG000|Overall Study|Initiation of immunotherapy|1|||
126715724|NCT02807454|455910657|FG000|Overall Study|Adverse Event|1|||
126715725|NCT02807454|455910658|FG001|Overall Study|Adverse Event|0|||
126715726|NCT02807454|455910657|FG000|Overall Study|Withdrawal by Subject|0|||
126715727|NCT02807454|455910658|FG001|Overall Study|Withdrawal by Subject|1|||
126715728|NCT02807454|455910657|FG000|Overall Study|Progressive Disease|30|||
126715729|NCT02807454|455910658|FG001|Overall Study|Progressive Disease|3|||
126715730|NCT02807454|455910657|FG000|Overall Study|Other Reasons|1|||
126715731|NCT02807454|455910658|FG001|Overall Study|Other Reasons|1|||
126715732|NCT01070784|455910659|FG000|Overall Study|Withdrawal by Subject|6|||
126715733|NCT01070784|455910660|FG001|Overall Study|Withdrawal by Subject|9|||
126715734|NCT01070784|455910659|FG000|Overall Study|Adverse Event|14|||
126715735|NCT01070784|455910660|FG001|Overall Study|Adverse Event|9|||
126715736|NCT02582749|455910661|FG000|Overall Study|Study terminated by funder|5|||
126715737|NCT02582749|455910662|FG001|Overall Study|Study terminated by funder|10|||
126715738|NCT02582749|455910661|FG000|Overall Study|Withdrawal by Subject|0|||
126715739|NCT02582749|455910662|FG001|Overall Study|Withdrawal by Subject|1|||
126715740|NCT02815397|455910663|FG000|Overall Study|Physician Decision|2|||
126715741|NCT02518620|455910664|FG000|Overall Study|Adverse Event|23|||
126715742|NCT02518620|455910665|FG001|Overall Study|Adverse Event|11|||
126715743|NCT02518620|455910664|FG000|Overall Study|Lack of Efficacy|2|||
126715744|NCT02518620|455910665|FG001|Overall Study|Lack of Efficacy|0|||
126715745|NCT02518620|455910664|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126715746|NCT02518620|455910665|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126715747|NCT02518620|455910664|FG000|Overall Study|Physician Decision|1|||
126715748|NCT02518620|455910665|FG001|Overall Study|Physician Decision|1|||
126715749|NCT02518620|455910664|FG000|Overall Study|Sponsor's Decision|0|||
126715750|NCT02518620|455910665|FG001|Overall Study|Sponsor's Decision|3|||
126715751|NCT02518620|455910664|FG000|Overall Study|Lost to Follow-up|1|||
126715752|NCT02518620|455910665|FG001|Overall Study|Lost to Follow-up|1|||
126715753|NCT02518620|455910664|FG000|Overall Study|Withdrawal by Subject|17|||
126715754|NCT02518620|455910665|FG001|Overall Study|Withdrawal by Subject|9|||
126715755|NCT02518620|455910664|FG000|Overall Study|Death|1|||
126715756|NCT02518620|455910665|FG001|Overall Study|Death|0|||
126307139|NCT03887442|454412024|FG000|Overall Study|Adverse Event|1|||
126307140|NCT03887442|454412025|FG001|Overall Study|Adverse Event|0|||
126715757|NCT02518620|455910664|FG000|Overall Study|Pregnancy Wish|3|||
126715758|NCT02518620|455910665|FG001|Overall Study|Pregnancy Wish|0|||
126715759|NCT02518620|455910664|FG000|Overall Study|Pregnancy|1|||
126715760|NCT02518620|455910665|FG001|Overall Study|Pregnancy|0|||
126715761|NCT02518620|455910664|FG000|Overall Study|Relocation|2|||
126715762|NCT02518620|455910665|FG001|Overall Study|Relocation|1|||
126715763|NCT00085540|455910666|FG000|Overall Study|Withdrawal by Subject|0|||
126715764|NCT00085540|455910667|FG001|Overall Study|Withdrawal by Subject|1|||
126770681|NCT03747939|456114672|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
126770682|NCT03747939|456114673|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
126770683|NCT03747939|456114670|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
126770684|NCT03747939|456114671|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
126770685|NCT03747939|456114672|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
126770686|NCT03747939|456114673|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
126770687|NCT03747939|456114670|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
126770688|NCT03747939|456114671|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
126770689|NCT03747939|456114672|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
126770690|NCT03747939|456114673|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
126770691|NCT03747939|456114670|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
126770692|NCT03747939|456114671|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
126770693|NCT03747939|456114672|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
126770694|NCT03747939|456114673|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
126770695|NCT03747939|456114670|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
126770696|NCT03747939|456114671|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
126770697|NCT03747939|456114672|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
126770698|NCT03747939|456114673|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
126770699|NCT03747939|456114670|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
126770700|NCT03747939|456114671|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
126770701|NCT03747939|456114672|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
126770702|NCT03747939|456114673|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
126770703|NCT03747939|456114670|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
126770704|NCT03747939|456114671|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
126770705|NCT03747939|456114672|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
126770706|NCT03747939|456114673|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
126770707|NCT03747939|456114670|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
126770708|NCT03747939|456114671|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
126770709|NCT03747939|456114672|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
126770710|NCT03747939|456114673|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
126307141|NCT00686829|454412026|FG000|Overall Study|Adverse Event|5|||
126307142|NCT00686829|454412026|FG000|Overall Study|Lack of Efficacy|6|||
126307143|NCT00686829|454412026|FG000|Overall Study|Lost to Follow-up|4|||
126307144|NCT00686829|454412026|FG000|Overall Study|Withdrawal by Subject|14|||
126307145|NCT00686829|454412026|FG000|Overall Study|Protocol Violation|3|||
126307146|NCT00686829|454412026|FG000|Overall Study|Sponsor discontinued VCV|47|||
126307147|NCT01217476|454412029|FG000|Overall Study|Adverse Event|6|||
126370554|NCT04251533|454653670|FG002|Overall Study|Progressive disease|22|||
126370555|NCT04251533|454653668|FG000|Overall Study|Death|5|||
126370556|NCT04251533|454653669|FG001|Overall Study|Death|1|||
126370557|NCT04251533|454653670|FG002|Overall Study|Death|3|||
126370558|NCT04251533|454653668|FG000|Overall Study|Physician Decision|3|||
126370559|NCT04251533|454653669|FG001|Overall Study|Physician Decision|2|||
126370560|NCT04251533|454653670|FG002|Overall Study|Physician Decision|4|||
126370561|NCT04251533|454653668|FG000|Overall Study|Participant decision|1|||
126464292|NCT00096954|455001941|FG001|Overall Study|Initiation of immunotherapy|0|||
126464293|NCT00096954|455001940|FG000|Overall Study|Non-compliance|0|||
126464294|NCT00096954|455001941|FG001|Overall Study|Non-compliance|3|||
126464295|NCT00096954|455001940|FG000|Overall Study|Lost to Follow-up|8|||
126464296|NCT00096954|455001941|FG001|Overall Study|Lost to Follow-up|5|||
126464297|NCT04478123|455001943|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
126464298|NCT04478123|455001943|FG000|Overall Study|NE|1|||
126464299|NCT03581786|455001946|FG000|Overall Study|Death|67|||
126464300|NCT03581786|455001947|FG001|Overall Study|Death|47|||
126464301|NCT03581786|455001946|FG000|Overall Study|Withdrawal by Subject|2|||
126464302|NCT03581786|455001947|FG001|Overall Study|Withdrawal by Subject|5|||
126464303|NCT03581786|455001946|FG000|Overall Study|Lost to Follow-up|7|||
126464304|NCT03581786|455001947|FG001|Overall Study|Lost to Follow-up|4|||
126370562|NCT04251533|454653669|FG001|Overall Study|Participant decision|3|||
126370563|NCT04251533|454653670|FG002|Overall Study|Participant decision|1|||
126370564|NCT04251533|454653668|FG000|Overall Study|Adverse Event|2|||
126370565|NCT04251533|454653669|FG001|Overall Study|Adverse Event|1|||
126370566|NCT04251533|454653670|FG002|Overall Study|Adverse Event|1|||
126370567|NCT05901636|454653671|FG000|Overall Study|Lost to Follow-up|0|||
126370568|NCT05901636|454653672|FG001|Overall Study|Lost to Follow-up|1|||
126370569|NCT05901636|454653673|FG002|Overall Study|Lost to Follow-up|0|||
126370570|NCT05901636|454653674|FG003|Overall Study|Lost to Follow-up|1|||
126464305|NCT03581786|455001946|FG000|Overall Study|reason other than specified above|0|||
126307148|NCT01217476|454412030|FG001|Overall Study|Adverse Event|1|||
126307149|NCT01217476|454412029|FG000|Overall Study|Physician Decision|0|||
126464306|NCT03581786|455001947|FG001|Overall Study|reason other than specified above|1|||
126464307|NCT01347307|455001950|FG000|Overall Study|Death|0|||
126370571|NCT05901636|454653675|FG004|Overall Study|Lost to Follow-up|1|||
126370572|NCT05901636|454653676|FG005|Overall Study|Lost to Follow-up|3|||
126370573|NCT05901636|454653677|FG006|Overall Study|Lost to Follow-up|1|||
126715765|NCT00085540|455910666|FG000|Overall Study|Protocol Violation|0|||
126715766|NCT00085540|455910667|FG001|Overall Study|Protocol Violation|1|||
126715767|NCT01663740|455910670|FG000|Overall Study|Lost to Follow-up|1|||
126715768|NCT01663740|455910671|FG001|Overall Study|Lost to Follow-up|4|||
126715769|NCT01663740|455910670|FG000|Overall Study|Other|9|||
126715770|NCT01663740|455910671|FG001|Overall Study|Other|2|||
126715771|NCT01663740|455910670|FG000|Overall Study|Inclusion/Exclusion not met|1|||
126715772|NCT01663740|455910671|FG001|Overall Study|Inclusion/Exclusion not met|0|||
126715773|NCT01663740|455910670|FG000|Overall Study|Death|0|||
126715774|NCT01663740|455910671|FG001|Overall Study|Death|1|||
126715775|NCT01663740|455910670|FG000|Overall Study|Withdrawal by Subject|2|||
126715776|NCT01663740|455910671|FG001|Overall Study|Withdrawal by Subject|1|||
126715777|NCT01663740|455910670|FG000|Overall Study|No end of study status|3|||
126715778|NCT01663740|455910671|FG001|Overall Study|No end of study status|0|||
126715779|NCT03607682|455910672|FG000|Overall Study|Withdrawal by Subject|1|||
126715780|NCT03607682|455910672|FG000|Overall Study|Disease progression|1|||
126715781|NCT01770353|455910673|FG000|Overall Study|Progressive disease|2|||
126715782|NCT01770353|455910674|FG001|Overall Study|Progressive disease|1|||
126715783|NCT01770353|455910673|FG000|Overall Study|Adverse Event|0|||
126715784|NCT01770353|455910674|FG001|Overall Study|Adverse Event|1|||
126715785|NCT01770353|455910673|FG000|Overall Study|Protocol Violation|1|||
126715786|NCT01770353|455910674|FG001|Overall Study|Protocol Violation|0|||
126715787|NCT01770353|455910673|FG000|Overall Study|Physician Decision|0|||
126715788|NCT01770353|455910674|FG001|Overall Study|Physician Decision|3|||
126715789|NCT01770353|455910673|FG000|Overall Study|Clinical deterioration|3|||
126715790|NCT01770353|455910674|FG001|Overall Study|Clinical deterioration|6|||
126715791|NCT01770353|455910673|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
126715792|NCT01770353|455910674|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
126715793|NCT00376688|455910675|FG000|Overall Study|Adverse Event|3|||
126715794|NCT00376688|455910675|FG000|Overall Study|Death|1|||
126715795|NCT02574312|455910676|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
126715796|NCT02574312|455910677|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
126715797|NCT04267562|455912972|FG000|Assessed for Eligibility|Screen Failure|64|||
126715798|NCT04267562|455912972|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
126715799|NCT04267562|455912972|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
126715800|NCT04267562|455912972|FG000|Assessed for Eligibility|Site closure|6|||
126715801|NCT04267562|455912972|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
126715802|NCT04267562|455912972|FG000|Assessed for Eligibility|Physician Decision|1|||
126370574|NCT05901636|454653671|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
126370575|NCT05901636|454653672|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
126370576|NCT05901636|454653673|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
126370577|NCT05901636|454653674|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
126370578|NCT05901636|454653675|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
126370579|NCT05901636|454653676|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
126370580|NCT05901636|454653677|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
126370581|NCT05901636|454653671|FG000|Overall Study|Withdrawal by Subject|1|||
126370582|NCT05901636|454653672|FG001|Overall Study|Withdrawal by Subject|1|||
126370583|NCT05901636|454653673|FG002|Overall Study|Withdrawal by Subject|0|||
126370584|NCT05901636|454653674|FG003|Overall Study|Withdrawal by Subject|0|||
126370585|NCT05901636|454653675|FG004|Overall Study|Withdrawal by Subject|1|||
126370586|NCT05901636|454653676|FG005|Overall Study|Withdrawal by Subject|1|||
126370587|NCT05901636|454653677|FG006|Overall Study|Withdrawal by Subject|0|||
126370588|NCT05901636|454653671|FG000|Overall Study|Other|0|||
126370589|NCT05901636|454653672|FG001|Overall Study|Other|0|||
126370590|NCT05901636|454653673|FG002|Overall Study|Other|1|||
126370591|NCT05901636|454653674|FG003|Overall Study|Other|1|||
126370592|NCT05901636|454653675|FG004|Overall Study|Other|0|||
126370593|NCT05901636|454653676|FG005|Overall Study|Other|0|||
126370594|NCT05901636|454653677|FG006|Overall Study|Other|0|||
126370595|NCT04583618|454653678|FG000|Overall Study|Adverse Event|0|||
126370596|NCT04583618|454653679|FG001|Overall Study|Adverse Event|0|||
126370597|NCT04583618|454653680|FG002|Overall Study|Adverse Event|1|||
126370598|NCT04583618|454653681|FG003|Overall Study|Adverse Event|0|||
126370599|NCT04583618|454653682|FG004|Overall Study|Adverse Event|0|||
126370600|NCT04583618|454653678|FG000|Overall Study|Protocol deviation|1|||
126370601|NCT04583618|454653679|FG001|Overall Study|Protocol deviation|1|||
126370602|NCT04583618|454653680|FG002|Overall Study|Protocol deviation|1|||
126370603|NCT04583618|454653681|FG003|Overall Study|Protocol deviation|0|||
126370604|NCT04583618|454653682|FG004|Overall Study|Protocol deviation|0|||
126370605|NCT04583618|454653678|FG000|Overall Study|Withdrawal by Subject|2|||
126370606|NCT04583618|454653679|FG001|Overall Study|Withdrawal by Subject|1|||
126370607|NCT04583618|454653680|FG002|Overall Study|Withdrawal by Subject|3|||
126715803|NCT04267562|455912972|FG000|Month 24|Elective hysterectomy|1|||
126715804|NCT04267562|455912972|FG000|Month 24|Lost to Follow-up|1|||
126715805|NCT04267562|455912972|FG000|Month 36|Elective hysterectomy|2|||
126370608|NCT04583618|454653681|FG003|Overall Study|Withdrawal by Subject|1|||
126370609|NCT04583618|454653682|FG004|Overall Study|Withdrawal by Subject|1|||
126715806|NCT04267562|455912972|FG000|Month 36|Lost to Follow-up|3|||
126715807|NCT02078713|455912973|FG000|Overall Study|Lost to Follow-up|49|||
126715808|NCT02078713|455912974|FG001|Overall Study|Lost to Follow-up|55|||
126715809|NCT02078713|455912975|FG002|Overall Study|Lost to Follow-up|0|||
126715810|NCT02078713|455912976|FG003|Overall Study|Lost to Follow-up|0|||
126715811|NCT02078713|455912973|FG000|Overall Study|Pregnant at baseline|3|||
126715812|NCT02078713|455912974|FG001|Overall Study|Pregnant at baseline|5|||
126715813|NCT02078713|455912975|FG002|Overall Study|Pregnant at baseline|0|||
126715814|NCT02078713|455912976|FG003|Overall Study|Pregnant at baseline|0|||
126715815|NCT02078713|455912973|FG000|Overall Study|Enrolled twice|0|||
126715816|NCT02078713|455912974|FG001|Overall Study|Enrolled twice|1|||
126715817|NCT02078713|455912975|FG002|Overall Study|Enrolled twice|0|||
126715818|NCT02078713|455912976|FG003|Overall Study|Enrolled twice|0|||
126715819|NCT00696657|455912981|FG000|Overall Study|Protocol Violation|0|||
126715820|NCT00696657|455912982|FG001|Overall Study|Protocol Violation|0|||
126715821|NCT00696657|455912983|FG002|Overall Study|Protocol Violation|0|||
126715822|NCT00696657|455912984|FG003|Overall Study|Protocol Violation|0|||
126715823|NCT00696657|455912985|FG004|Overall Study|Protocol Violation|0|||
126715824|NCT00696657|455912986|FG005|Overall Study|Protocol Violation|1|||
126715825|NCT00696657|455912987|FG006|Overall Study|Protocol Violation|0|||
126715826|NCT00696657|455912988|FG007|Overall Study|Protocol Violation|0|||
126715827|NCT00696657|455912989|FG008|Overall Study|Protocol Violation|1|||
126715828|NCT00696657|455912981|FG000|Overall Study|Lack of Efficacy|0|||
126715829|NCT00696657|455912982|FG001|Overall Study|Lack of Efficacy|1|||
126715830|NCT00696657|455912983|FG002|Overall Study|Lack of Efficacy|0|||
126715831|NCT00696657|455912984|FG003|Overall Study|Lack of Efficacy|0|||
126715832|NCT00696657|455912985|FG004|Overall Study|Lack of Efficacy|0|||
126715833|NCT00696657|455912986|FG005|Overall Study|Lack of Efficacy|0|||
126715834|NCT00696657|455912987|FG006|Overall Study|Lack of Efficacy|0|||
126715835|NCT00696657|455912988|FG007|Overall Study|Lack of Efficacy|0|||
126715836|NCT00696657|455912989|FG008|Overall Study|Lack of Efficacy|0|||
126715837|NCT00696657|455912981|FG000|Overall Study|Withdrawal criteria|1|||
126715838|NCT00696657|455912982|FG001|Overall Study|Withdrawal criteria|3|||
126715839|NCT00696657|455912983|FG002|Overall Study|Withdrawal criteria|2|||
126715840|NCT00696657|455912984|FG003|Overall Study|Withdrawal criteria|2|||
126715841|NCT00696657|455912985|FG004|Overall Study|Withdrawal criteria|0|||
126715842|NCT00696657|455912986|FG005|Overall Study|Withdrawal criteria|0|||
126715843|NCT00696657|455912987|FG006|Overall Study|Withdrawal criteria|1|||
126307150|NCT01217476|454412030|FG001|Overall Study|Physician Decision|1|||
126307151|NCT01217476|454412029|FG000|Overall Study|Withdrawal by Subject|3|||
126307152|NCT01217476|454412030|FG001|Overall Study|Withdrawal by Subject|3|||
126307153|NCT01217476|454412029|FG000|Overall Study|Surgery on the Target Limb|0|||
126307154|NCT01217476|454412030|FG001|Overall Study|Surgery on the Target Limb|2|||
126307155|NCT01217476|454412029|FG000|Overall Study|Protocol Deviation|1|||
126307156|NCT01217476|454412030|FG001|Overall Study|Protocol Deviation|0|||
126307157|NCT01217476|454412029|FG000|Overall Study|Other|2|||
126307158|NCT01217476|454412030|FG001|Overall Study|Other|0|||
126307159|NCT03033602|454412031|FG000|Overall Study|Withdrawal by Subject|11|||
126307160|NCT03033602|454412032|FG001|Overall Study|Withdrawal by Subject|21|||
126307161|NCT03033602|454412031|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
126307162|NCT03033602|454412032|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
126307163|NCT01684943|454412033|FG000|Overall Study|Inadequate Venous Access|3|||
126307164|NCT01684943|454412034|FG001|Overall Study|Inadequate Venous Access|0|||
126307165|NCT01684943|454412035|FG002|Overall Study|Inadequate Venous Access|0|||
126307166|NCT01684943|454412033|FG000|Overall Study|Principal Investigator Determination|1|||
126307167|NCT01684943|454412034|FG001|Overall Study|Principal Investigator Determination|0|||
126307168|NCT01684943|454412035|FG002|Overall Study|Principal Investigator Determination|0|||
126307169|NCT01684943|454412033|FG000|Overall Study|Excluded from Analysis|1|||
126307170|NCT01684943|454412034|FG001|Overall Study|Excluded from Analysis|1|||
126307171|NCT01684943|454412035|FG002|Overall Study|Excluded from Analysis|1|||
126307172|NCT01684943|454412033|FG000|Overall Study|Lost to Follow-up|3|||
126307173|NCT01684943|454412034|FG001|Overall Study|Lost to Follow-up|0|||
126370610|NCT04583618|454653678|FG000|Overall Study|Lost to Follow-up|0|||
126552154|NCT00849680|455316005|FG006|Overall Study|Adverse Event|2|||
126715844|NCT00696657|455912988|FG007|Overall Study|Withdrawal criteria|1|||
126715845|NCT00696657|455912989|FG008|Overall Study|Withdrawal criteria|2|||
126307174|NCT01684943|454412035|FG002|Overall Study|Lost to Follow-up|0|||
126715846|NCT00696657|455912981|FG000|Overall Study|Unclassified|0|||
126715847|NCT00696657|455912982|FG001|Overall Study|Unclassified|1|||
126715848|NCT00696657|455912983|FG002|Overall Study|Unclassified|3|||
126715849|NCT00696657|455912984|FG003|Overall Study|Unclassified|2|||
126715850|NCT00696657|455912985|FG004|Overall Study|Unclassified|4|||
126307175|NCT01684943|454412033|FG000|Overall Study|Planning Pregnancy|1|||
126307176|NCT01684943|454412034|FG001|Overall Study|Planning Pregnancy|0|||
126715851|NCT00696657|455912986|FG005|Overall Study|Unclassified|2|||
126715852|NCT00696657|455912987|FG006|Overall Study|Unclassified|0|||
126715853|NCT00696657|455912988|FG007|Overall Study|Unclassified|0|||
126715854|NCT00696657|455912989|FG008|Overall Study|Unclassified|1|||
126715855|NCT00696657|455912981|FG000|Overall Study|Adverse Event|0|||
126715856|NCT00696657|455912982|FG001|Overall Study|Adverse Event|0|||
126715857|NCT00696657|455912983|FG002|Overall Study|Adverse Event|3|||
126715858|NCT00696657|455912984|FG003|Overall Study|Adverse Event|7|||
126715859|NCT00696657|455912985|FG004|Overall Study|Adverse Event|6|||
126715860|NCT00696657|455912986|FG005|Overall Study|Adverse Event|9|||
126715861|NCT00696657|455912987|FG006|Overall Study|Adverse Event|14|||
126715862|NCT00696657|455912988|FG007|Overall Study|Adverse Event|2|||
126715863|NCT00696657|455912989|FG008|Overall Study|Adverse Event|5|||
126715864|NCT02090114|455912990|FG000|Overall Study|Withdrawal by Subject|3|||
126715865|NCT02090114|455912991|FG001|Overall Study|Withdrawal by Subject|6|||
126715866|NCT02090114|455912992|FG002|Overall Study|Withdrawal by Subject|2|||
126715867|NCT02090114|455912993|FG003|Overall Study|Withdrawal by Subject|1|||
126715868|NCT02090114|455912990|FG000|Overall Study|Physician Decision|5|||
126715869|NCT02090114|455912991|FG001|Overall Study|Physician Decision|0|||
126715870|NCT02090114|455912992|FG002|Overall Study|Physician Decision|1|||
126715871|NCT02090114|455912993|FG003|Overall Study|Physician Decision|1|||
126715872|NCT02090114|455912990|FG000|Overall Study|Adverse Event|1|||
126715873|NCT02090114|455912991|FG001|Overall Study|Adverse Event|2|||
126715874|NCT02090114|455912992|FG002|Overall Study|Adverse Event|2|||
126715875|NCT02090114|455912993|FG003|Overall Study|Adverse Event|0|||
126715876|NCT02090114|455912990|FG000|Overall Study|Progressive Disease|20|||
126715877|NCT02090114|455912991|FG001|Overall Study|Progressive Disease|21|||
126715878|NCT02090114|455912992|FG002|Overall Study|Progressive Disease|23|||
126715879|NCT02090114|455912993|FG003|Overall Study|Progressive Disease|6|||
126715880|NCT02090114|455912990|FG000|Overall Study|Death|1|||
126715881|NCT02090114|455912991|FG001|Overall Study|Death|0|||
126715882|NCT02090114|455912992|FG002|Overall Study|Death|1|||
126715883|NCT02090114|455912993|FG003|Overall Study|Death|0|||
126715884|NCT01989546|455912994|FG000|Overall Study|Clinical Progression|1|||
126715885|NCT01989546|455912994|FG000|Overall Study|Disease progression on study|8|||
126715886|NCT00059215|455912998|FG000|Overall Study|Adverse Event|5|||
126715887|NCT00059215|455912999|FG001|Overall Study|Adverse Event|5|||
126715888|NCT00059215|455913000|FG002|Overall Study|Adverse Event|9|||
126715889|NCT00059215|455913001|FG003|Overall Study|Adverse Event|9|||
126715890|NCT00059215|455912998|FG000|Overall Study|Death|0|||
126715891|NCT00059215|455912999|FG001|Overall Study|Death|0|||
126715892|NCT00059215|455913000|FG002|Overall Study|Death|3|||
126715893|NCT00059215|455913001|FG003|Overall Study|Death|0|||
126715894|NCT00059215|455912998|FG000|Overall Study|Lost to Follow-up|1|||
126715895|NCT00059215|455912999|FG001|Overall Study|Lost to Follow-up|2|||
126715896|NCT00059215|455913000|FG002|Overall Study|Lost to Follow-up|0|||
126715897|NCT00059215|455913001|FG003|Overall Study|Lost to Follow-up|0|||
126715898|NCT00059215|455912998|FG000|Overall Study|Withdrawal by Subject|4|||
126715899|NCT00059215|455912999|FG001|Overall Study|Withdrawal by Subject|4|||
126715900|NCT00059215|455913000|FG002|Overall Study|Withdrawal by Subject|1|||
126715901|NCT00059215|455913001|FG003|Overall Study|Withdrawal by Subject|3|||
126307177|NCT01684943|454412035|FG002|Overall Study|Planning Pregnancy|0|||
126307178|NCT01190410|454414377|FG000|Overall Study|Adverse Event|0|||
126307179|NCT01190410|454414378|FG001|Overall Study|Adverse Event|3|||
126307180|NCT01190410|454414377|FG000|Overall Study|Lack of Efficacy|0|||
126307181|NCT01190410|454414378|FG001|Overall Study|Lack of Efficacy|2|||
126307182|NCT01190410|454414377|FG000|Overall Study|Withdrawal by Subject|0|||
126307183|NCT01190410|454414378|FG001|Overall Study|Withdrawal by Subject|2|||
126307184|NCT01190410|454414377|FG000|Overall Study|Administrative decision|1|||
126307185|NCT01190410|454414378|FG001|Overall Study|Administrative decision|0|||
126307186|NCT01190410|454414377|FG000|Overall Study|PI discretion|0|||
126307187|NCT01190410|454414378|FG001|Overall Study|PI discretion|2|||
126307188|NCT01399047|454414379|FG000|Overall Study|Withdrawal by Subject|0|||
126307189|NCT01399047|454414380|FG001|Overall Study|Withdrawal by Subject|1|||
126307190|NCT00504725|454414386|FG000|Overall Study|Protocol Violation|1|||
126307191|NCT00504725|454414387|FG001|Overall Study|Protocol Violation|0|||
126307192|NCT00956592|454414392|FG000|Overall Study|Protocol Violation|1|||
126307193|NCT00956592|454414393|FG001|Overall Study|Protocol Violation|3|||
126307194|NCT00160706|454414395|FG000|Overall Study|Adverse Event|53|||
126307195|NCT00160706|454414395|FG000|Overall Study|Adverse Event and Other Reason|105|||
126307196|NCT00160706|454414395|FG000|Overall Study|Protocol Violation|3|||
126715902|NCT00059215|455912998|FG000|Overall Study|Protocol Violation|1|||
126715903|NCT00059215|455912999|FG001|Overall Study|Protocol Violation|0|||
126307197|NCT00160706|454414395|FG000|Overall Study|Withdrawal by Subject|41|||
126715904|NCT00059215|455913000|FG002|Overall Study|Protocol Violation|1|||
126715905|NCT00059215|455913001|FG003|Overall Study|Protocol Violation|0|||
126715906|NCT00059215|455912998|FG000|Overall Study|Protocol entry criteria not met|1|||
126307198|NCT00160706|454414395|FG000|Overall Study|Withdrawal by Subject and Other|12|||
126715907|NCT00059215|455912999|FG001|Overall Study|Protocol entry criteria not met|1|||
126715908|NCT00059215|455913000|FG002|Overall Study|Protocol entry criteria not met|0|||
126715909|NCT00059215|455913001|FG003|Overall Study|Protocol entry criteria not met|2|||
126715910|NCT00059215|455912998|FG000|Overall Study|Physician Decision|1|||
126715911|NCT00059215|455912999|FG001|Overall Study|Physician Decision|2|||
126715912|NCT00059215|455913000|FG002|Overall Study|Physician Decision|1|||
126715913|NCT00059215|455913001|FG003|Overall Study|Physician Decision|1|||
126715914|NCT04439838|455913002|FG000|Overall Study|Withdrawal by Subject|0|||
126715915|NCT04439838|455913003|FG001|Overall Study|Withdrawal by Subject|0|||
126715916|NCT04439838|455913004|FG002|Overall Study|Withdrawal by Subject|0|||
126715917|NCT04439838|455913005|FG003|Overall Study|Withdrawal by Subject|0|||
126715918|NCT04439838|455913006|FG004|Overall Study|Withdrawal by Subject|0|||
126715919|NCT04439838|455913007|FG005|Overall Study|Withdrawal by Subject|0|||
126715920|NCT04439838|455913008|FG006|Overall Study|Withdrawal by Subject|0|||
126715921|NCT04439838|455913009|FG007|Overall Study|Withdrawal by Subject|0|||
126715922|NCT04439838|455913010|FG008|Overall Study|Withdrawal by Subject|1|||
126715923|NCT04494633|455913013|FG000|Overall Study|Lost to Follow-up|5|||
126715924|NCT04494633|455913014|FG001|Overall Study|Lost to Follow-up|3|||
126715925|NCT04494633|455913013|FG000|Overall Study|Protocol Violation|1|||
126715926|NCT04494633|455913014|FG001|Overall Study|Protocol Violation|1|||
126715927|NCT00414310|455913015|FG000|Overall Study|Not treated|1|||
126715928|NCT00414310|455913016|FG001|Overall Study|Not treated|0|||
126715929|NCT01254604|455913017|FG000|Overall Study|Lost to Follow-up|1|||
126715930|NCT01254604|455913018|FG001|Overall Study|Lost to Follow-up|1|||
126715931|NCT01254604|455913017|FG000|Overall Study|Protocol Violation|2|||
126715932|NCT01254604|455913018|FG001|Overall Study|Protocol Violation|2|||
126715933|NCT01254604|455913017|FG000|Overall Study|Withdrawal by Subject|2|||
126715934|NCT01254604|455913018|FG001|Overall Study|Withdrawal by Subject|4|||
126715935|NCT01254604|455913017|FG000|Overall Study|Adverse Event|3|||
126715936|NCT01254604|455913018|FG001|Overall Study|Adverse Event|2|||
126715937|NCT03074162|455913019|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
126715938|NCT03074162|455913020|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
126715939|NCT03074162|455913021|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
126715940|NCT03074162|455913022|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
126715941|NCT03074162|455913023|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
126715942|NCT03074162|455913024|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
126715943|NCT03074162|455913019|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
126715944|NCT03074162|455913020|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
126715945|NCT03074162|455913021|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
126715946|NCT03074162|455913022|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
126715947|NCT03074162|455913023|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
126715948|NCT03074162|455913024|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
126715949|NCT03074162|455913019|FG000|Period 3|Withdrawal by Subject|1|||
126715950|NCT03074162|455913020|FG001|Period 3|Withdrawal by Subject|0|||
126715951|NCT03074162|455913021|FG002|Period 3|Withdrawal by Subject|0|||
126715952|NCT03074162|455913022|FG003|Period 3|Withdrawal by Subject|0|||
126715953|NCT03074162|455913023|FG004|Period 3|Withdrawal by Subject|1|||
126715954|NCT03074162|455913024|FG005|Period 3|Withdrawal by Subject|0|||
126715955|NCT01993329|455913025|FG000|Period 2|Adverse Event|0|||
126715956|NCT01993329|455913026|FG001|Period 2|Adverse Event|0|||
126715957|NCT01993329|455913027|FG002|Period 2|Adverse Event|0|||
126715958|NCT01993329|455913028|FG003|Period 2|Adverse Event|0|||
126715959|NCT01993329|455913029|FG004|Period 2|Adverse Event|0|||
126715960|NCT01993329|455913030|FG005|Period 2|Adverse Event|1|||
126715961|NCT01993329|455913025|FG000|Wash-out|Personal reasons|0|||
126715962|NCT01993329|455913026|FG001|Wash-out|Personal reasons|1|||
126715963|NCT01993329|455913027|FG002|Wash-out|Personal reasons|0|||
126715964|NCT01993329|455913028|FG003|Wash-out|Personal reasons|0|||
126770711|NCT03747939|456114670|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
126307199|NCT00160706|454414395|FG000|Overall Study|Physician Decision|10|||
126307200|NCT00160706|454414395|FG000|Overall Study|Physician Decision and Other|3|||
126307201|NCT00160706|454414395|FG000|Overall Study|Lost to Follow-up|4|||
126307202|NCT00160706|454414395|FG000|Overall Study|Lost to Follow-up and Other|1|||
126307203|NCT00160706|454414395|FG000|Overall Study|Lack of Efficacy|42|||
126307204|NCT00160706|454414395|FG000|Overall Study|Lack of Efficacy and Other|1|||
126307205|NCT00160706|454414395|FG000|Overall Study|Other Reason|11|||
126307206|NCT03214380|454414396|FG000|Lead-in|Adverse Event|3|||
126307207|NCT03214380|454414397|FG001|Lead-in|Adverse Event|0|||
126307208|NCT03214380|454414398|FG002|Lead-in|Adverse Event|0|||
126307209|NCT03214380|454414399|FG003|Lead-in|Adverse Event|1|||
126307210|NCT03214380|454414400|FG004|Lead-in|Adverse Event|0|||
126370611|NCT04583618|454653679|FG001|Overall Study|Lost to Follow-up|1|||
126307211|NCT03214380|454414401|FG005|Lead-in|Adverse Event|0|||
126307212|NCT03214380|454414396|FG000|Lead-in|Lost to Follow-up|4|||
126715965|NCT01993329|455913029|FG004|Wash-out|Personal reasons|0|||
126715966|NCT01993329|455913030|FG005|Wash-out|Personal reasons|0|||
126715967|NCT03041116|455913031|FG000|Double-blind|Death|0|||
126715968|NCT03041116|455913032|FG001|Double-blind|Death|2|||
126715969|NCT03041116|455913031|FG000|Double-blind|Withdrawal by Subject|0|||
126715970|NCT03041116|455913032|FG001|Double-blind|Withdrawal by Subject|4|||
126715971|NCT03041116|455913031|FG000|Open-label|Death|1|||
126307213|NCT03214380|454414397|FG001|Lead-in|Lost to Follow-up|0|||
126307214|NCT03214380|454414398|FG002|Lead-in|Lost to Follow-up|0|||
126307215|NCT03214380|454414399|FG003|Lead-in|Lost to Follow-up|1|||
126307216|NCT03214380|454414400|FG004|Lead-in|Lost to Follow-up|0|||
126307217|NCT03214380|454414401|FG005|Lead-in|Lost to Follow-up|0|||
126307218|NCT03214380|454414396|FG000|Lead-in|Eligibility Criteria|3|||
126307219|NCT03214380|454414397|FG001|Lead-in|Eligibility Criteria|0|||
126307220|NCT03214380|454414398|FG002|Lead-in|Eligibility Criteria|0|||
126307221|NCT03214380|454414399|FG003|Lead-in|Eligibility Criteria|0|||
126307222|NCT03214380|454414400|FG004|Lead-in|Eligibility Criteria|0|||
126307223|NCT03214380|454414401|FG005|Lead-in|Eligibility Criteria|0|||
126307224|NCT03214380|454414396|FG000|Lead-in|Physician Decision|6|||
126307225|NCT03214380|454414397|FG001|Lead-in|Physician Decision|0|||
126552155|NCT00849680|455316006|FG007|Overall Study|Adverse Event|0|||
126552156|NCT00849680|455315999|FG000|Overall Study|Lost to Follow-up|7|||
126552157|NCT00849680|455316000|FG001|Overall Study|Lost to Follow-up|3|||
126552158|NCT00849680|455316001|FG002|Overall Study|Lost to Follow-up|12|||
126552159|NCT00849680|455316002|FG003|Overall Study|Lost to Follow-up|11|||
126552160|NCT00849680|455316003|FG004|Overall Study|Lost to Follow-up|8|||
126552161|NCT00849680|455316004|FG005|Overall Study|Lost to Follow-up|11|||
126552162|NCT00849680|455316005|FG006|Overall Study|Lost to Follow-up|12|||
126715972|NCT03041116|455913032|FG001|Open-label|Death|0|||
126715973|NCT03041116|455913031|FG000|Open-label|Termination of the study by Sponsor|39|||
126715974|NCT03041116|455913032|FG001|Open-label|Termination of the study by Sponsor|37|||
126715975|NCT03041116|455913031|FG000|Open-label|Withdrawal by Subject|1|||
126715976|NCT03041116|455913032|FG001|Open-label|Withdrawal by Subject|0|||
126715977|NCT01675011|455913036|FG000|Overall Study|Trial terminated by Sponsor|3|||
126715978|NCT01675011|455913037|FG001|Overall Study|Trial terminated by Sponsor|1|||
126552163|NCT00849680|455316006|FG007|Overall Study|Lost to Follow-up|5|||
126552164|NCT00849680|455315999|FG000|Overall Study|Subject moved|1|||
126552165|NCT00849680|455316000|FG001|Overall Study|Subject moved|0|||
126552166|NCT00849680|455316001|FG002|Overall Study|Subject moved|3|||
126552167|NCT00849680|455316002|FG003|Overall Study|Subject moved|1|||
126552168|NCT00849680|455316003|FG004|Overall Study|Subject moved|0|||
126552169|NCT00849680|455316004|FG005|Overall Study|Subject moved|2|||
126552170|NCT00849680|455316005|FG006|Overall Study|Subject moved|2|||
126552171|NCT00849680|455316006|FG007|Overall Study|Subject moved|2|||
126715979|NCT00931892|455913040|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
126715980|NCT00931892|455913041|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
126715981|NCT01876732|455913042|FG000|Overall Study|MMA was not over 800mg/dL|75|||
126715982|NCT02531373|455913045|FG000|Overall Study|Lack of Efficacy|0|||
126715983|NCT02531373|455913046|FG001|Overall Study|Lack of Efficacy|0|||
126715984|NCT02531373|455913047|FG002|Overall Study|Lack of Efficacy|0|||
126715985|NCT02531373|455913048|FG003|Overall Study|Lack of Efficacy|0|||
126715986|NCT02531373|455913049|FG004|Overall Study|Lack of Efficacy|3|||
126715987|NCT02531373|455913050|FG005|Overall Study|Lack of Efficacy|2|||
126715988|NCT02531373|455913051|FG006|Overall Study|Lack of Efficacy|4|||
126715989|NCT02531373|455913052|FG007|Overall Study|Lack of Efficacy|8|||
126715990|NCT02531373|455913053|FG008|Overall Study|Lack of Efficacy|5|||
126715991|NCT02531373|455913045|FG000|Overall Study|Lost to Follow-up|0|||
126715992|NCT02531373|455913046|FG001|Overall Study|Lost to Follow-up|0|||
126715993|NCT02531373|455913047|FG002|Overall Study|Lost to Follow-up|0|||
126715994|NCT02531373|455913048|FG003|Overall Study|Lost to Follow-up|0|||
126715995|NCT02531373|455913049|FG004|Overall Study|Lost to Follow-up|0|||
126715996|NCT02531373|455913050|FG005|Overall Study|Lost to Follow-up|2|||
126715997|NCT02531373|455913051|FG006|Overall Study|Lost to Follow-up|2|||
126715998|NCT02531373|455913052|FG007|Overall Study|Lost to Follow-up|0|||
126715999|NCT02531373|455913053|FG008|Overall Study|Lost to Follow-up|0|||
126716000|NCT02531373|455913045|FG000|Overall Study|Physician Decision|0|||
126716001|NCT02531373|455913046|FG001|Overall Study|Physician Decision|0|||
126716002|NCT02531373|455913047|FG002|Overall Study|Physician Decision|0|||
126716003|NCT02531373|455913048|FG003|Overall Study|Physician Decision|0|||
126716004|NCT02531373|455913049|FG004|Overall Study|Physician Decision|2|||
126716005|NCT02531373|455913050|FG005|Overall Study|Physician Decision|1|||
126716006|NCT02531373|455913051|FG006|Overall Study|Physician Decision|0|||
126716007|NCT02531373|455913052|FG007|Overall Study|Physician Decision|0|||
126716008|NCT02531373|455913053|FG008|Overall Study|Physician Decision|0|||
126716009|NCT02531373|455913045|FG000|Overall Study|Protocol Violation|0|||
126716010|NCT02531373|455913046|FG001|Overall Study|Protocol Violation|0|||
126716011|NCT02531373|455913047|FG002|Overall Study|Protocol Violation|0|||
126716012|NCT02531373|455913048|FG003|Overall Study|Protocol Violation|0|||
126716013|NCT02531373|455913049|FG004|Overall Study|Protocol Violation|0|||
126716014|NCT02531373|455913050|FG005|Overall Study|Protocol Violation|1|||
126716015|NCT02531373|455913051|FG006|Overall Study|Protocol Violation|1|||
126716016|NCT02531373|455913052|FG007|Overall Study|Protocol Violation|0|||
126716017|NCT02531373|455913053|FG008|Overall Study|Protocol Violation|1|||
126716018|NCT02531373|455913045|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126716019|NCT02531373|455913046|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126716020|NCT02531373|455913047|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126716021|NCT02531373|455913048|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126307226|NCT03214380|454414398|FG002|Lead-in|Physician Decision|0|||
126307227|NCT03214380|454414399|FG003|Lead-in|Physician Decision|0|||
126307228|NCT03214380|454414400|FG004|Lead-in|Physician Decision|0|||
126307229|NCT03214380|454414401|FG005|Lead-in|Physician Decision|0|||
126307230|NCT03214380|454414396|FG000|Lead-in|Protocol Deviation|7|||
126307231|NCT03214380|454414397|FG001|Lead-in|Protocol Deviation|0|||
126307232|NCT03214380|454414398|FG002|Lead-in|Protocol Deviation|0|||
126307233|NCT03214380|454414399|FG003|Lead-in|Protocol Deviation|3|||
126307234|NCT03214380|454414400|FG004|Lead-in|Protocol Deviation|0|||
126307235|NCT03214380|454414401|FG005|Lead-in|Protocol Deviation|0|||
126307236|NCT03214380|454414396|FG000|Lead-in|Withdrawal by Subject|41|||
126307237|NCT03214380|454414397|FG001|Lead-in|Withdrawal by Subject|0|||
126307238|NCT03214380|454414398|FG002|Lead-in|Withdrawal by Subject|0|||
126307239|NCT03214380|454414399|FG003|Lead-in|Withdrawal by Subject|14|||
126307240|NCT03214380|454414400|FG004|Lead-in|Withdrawal by Subject|0|||
126307241|NCT03214380|454414401|FG005|Lead-in|Withdrawal by Subject|0|||
126307242|NCT03214380|454414396|FG000|Lead-in|Family Emergency|1|||
126307243|NCT03214380|454414397|FG001|Lead-in|Family Emergency|0|||
126307244|NCT03214380|454414398|FG002|Lead-in|Family Emergency|0|||
126307245|NCT03214380|454414399|FG003|Lead-in|Family Emergency|0|||
126307246|NCT03214380|454414400|FG004|Lead-in|Family Emergency|0|||
126307247|NCT03214380|454414401|FG005|Lead-in|Family Emergency|0|||
126307248|NCT03214380|454414396|FG000|Lead-in|Natural Disaster|9|||
126307249|NCT03214380|454414397|FG001|Lead-in|Natural Disaster|0|||
126307250|NCT03214380|454414398|FG002|Lead-in|Natural Disaster|0|||
126307251|NCT03214380|454414399|FG003|Lead-in|Natural Disaster|0|||
126307252|NCT03214380|454414400|FG004|Lead-in|Natural Disaster|0|||
126307253|NCT03214380|454414401|FG005|Lead-in|Natural Disaster|0|||
126307254|NCT03214380|454414396|FG000|Lead-in|Non Compliance|1|||
126307255|NCT03214380|454414397|FG001|Lead-in|Non Compliance|0|||
126716022|NCT02531373|455913049|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126716023|NCT02531373|455913050|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
126307256|NCT03214380|454414398|FG002|Lead-in|Non Compliance|0|||
126307257|NCT03214380|454414399|FG003|Lead-in|Non Compliance|0|||
126370612|NCT04583618|454653680|FG002|Overall Study|Lost to Follow-up|3|||
126370613|NCT04583618|454653681|FG003|Overall Study|Lost to Follow-up|1|||
126716024|NCT02531373|455913051|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
126716025|NCT02531373|455913052|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
126716026|NCT02531373|455913053|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
126716027|NCT02531373|455913045|FG000|Overall Study|Withdrawal by Subject|0|||
126716028|NCT02531373|455913046|FG001|Overall Study|Withdrawal by Subject|0|||
126716029|NCT02531373|455913047|FG002|Overall Study|Withdrawal by Subject|0|||
126716030|NCT02531373|455913048|FG003|Overall Study|Withdrawal by Subject|0|||
126716031|NCT02531373|455913049|FG004|Overall Study|Withdrawal by Subject|3|||
126716032|NCT02531373|455913050|FG005|Overall Study|Withdrawal by Subject|0|||
126716033|NCT02531373|455913051|FG006|Overall Study|Withdrawal by Subject|0|||
126716034|NCT02531373|455913052|FG007|Overall Study|Withdrawal by Subject|0|||
126716035|NCT02531373|455913053|FG008|Overall Study|Withdrawal by Subject|0|||
126716036|NCT00536731|455913054|FG000|Overall Study|Adverse Event|3|||
126716037|NCT00536731|455913055|FG001|Overall Study|Adverse Event|2|||
126716038|NCT00536731|455913056|FG002|Overall Study|Adverse Event|3|||
126716039|NCT00536731|455913054|FG000|Overall Study|Withdrawal by Subject|0|||
126716040|NCT00536731|455913055|FG001|Overall Study|Withdrawal by Subject|2|||
126716041|NCT00536731|455913056|FG002|Overall Study|Withdrawal by Subject|0|||
126716042|NCT00536731|455913054|FG000|Overall Study|Intake of prohibited conc. medication|0|||
126716043|NCT00536731|455913055|FG001|Overall Study|Intake of prohibited conc. medication|0|||
126716044|NCT00536731|455913056|FG002|Overall Study|Intake of prohibited conc. medication|1|||
126716045|NCT00536731|455913054|FG000|Overall Study|Safety reasons|0|||
126716046|NCT00536731|455913055|FG001|Overall Study|Safety reasons|0|||
126716047|NCT00536731|455913056|FG002|Overall Study|Safety reasons|1|||
126716048|NCT00536731|455913054|FG000|Overall Study|Other|1|||
126307258|NCT03214380|454414400|FG004|Lead-in|Non Compliance|0|||
126307259|NCT03214380|454414401|FG005|Lead-in|Non Compliance|0|||
126307260|NCT03214380|454414396|FG000|Lead-in|Participant Schedule|2|||
126307261|NCT03214380|454414397|FG001|Lead-in|Participant Schedule|0|||
126307262|NCT03214380|454414398|FG002|Lead-in|Participant Schedule|0|||
126307263|NCT03214380|454414399|FG003|Lead-in|Participant Schedule|0|||
126370614|NCT04583618|454653682|FG004|Overall Study|Lost to Follow-up|1|||
126370615|NCT02711202|454653683|FG000|Overall Study|Adverse Event|3|||
126370616|NCT02711202|454653684|FG001|Overall Study|Adverse Event|0|||
126370617|NCT02711202|454653683|FG000|Overall Study|graft loss|1|||
126307264|NCT03214380|454414400|FG004|Lead-in|Participant Schedule|0|||
126307265|NCT03214380|454414401|FG005|Lead-in|Participant Schedule|0|||
126307266|NCT03214380|454414396|FG000|Treatment Period|Adverse Event|0|||
126370618|NCT02711202|454653684|FG001|Overall Study|graft loss|0|||
126370619|NCT03189719|454653692|FG000|Overall Study|Death|325|||
126716049|NCT00536731|455913055|FG001|Overall Study|Other|1|||
126716050|NCT00536731|455913056|FG002|Overall Study|Other|0|||
126716051|NCT02795988|455913057|FG000|Phase 1b|Withdrawal by Subject|0|||
126716052|NCT02795988|455913058|FG001|Phase 1b|Withdrawal by Subject|1|||
126716053|NCT02795988|455913059|FG002|Phase 1b|Withdrawal by Subject|0|||
126370620|NCT03189719|454653693|FG001|Overall Study|Death|361|||
126370621|NCT03189719|454653692|FG000|Overall Study|Physician Decision|1|||
126370622|NCT03189719|454653693|FG001|Overall Study|Physician Decision|0|||
126370623|NCT03189719|454653692|FG000|Overall Study|Sponsor Decision|40|||
126370624|NCT03189719|454653693|FG001|Overall Study|Sponsor Decision|12|||
126370625|NCT03189719|454653692|FG000|Overall Study|Withdrawal by Subject|7|||
126370626|NCT03189719|454653693|FG001|Overall Study|Withdrawal by Subject|3|||
126370627|NCT03448393|454653694|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370628|NCT03448393|454653695|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370629|NCT03448393|454653696|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
126370630|NCT03448393|454653697|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370631|NCT03448393|454653698|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370632|NCT03448393|454653699|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370633|NCT03448393|454653700|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370634|NCT03448393|454653701|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
126370635|NCT03448393|454653702|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
126370636|NCT03448393|454653694|FG000|Dose Expansion|Not treated - screen failure|0|||
126370637|NCT03448393|454653695|FG001|Dose Expansion|Not treated - screen failure|0|||
126370638|NCT03448393|454653696|FG002|Dose Expansion|Not treated - screen failure|0|||
126370639|NCT03448393|454653697|FG003|Dose Expansion|Not treated - screen failure|0|||
126370640|NCT03448393|454653698|FG004|Dose Expansion|Not treated - screen failure|0|||
126370641|NCT03448393|454653699|FG005|Dose Expansion|Not treated - screen failure|0|||
126370642|NCT03448393|454653700|FG006|Dose Expansion|Not treated - screen failure|0|||
126307267|NCT03214380|454414397|FG001|Treatment Period|Adverse Event|1|||
126307268|NCT03214380|454414398|FG002|Treatment Period|Adverse Event|1|||
126307269|NCT03214380|454414399|FG003|Treatment Period|Adverse Event|0|||
126307270|NCT03214380|454414400|FG004|Treatment Period|Adverse Event|1|||
126307271|NCT03214380|454414401|FG005|Treatment Period|Adverse Event|0|||
126307272|NCT03214380|454414396|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
126307273|NCT03214380|454414397|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
126307274|NCT03214380|454414398|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
126307275|NCT03214380|454414399|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
126307276|NCT03214380|454414400|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
126307277|NCT03214380|454414401|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
126307278|NCT03214380|454414396|FG000|Treatment Period|Withdrawal by Subject|0|||
126307279|NCT03214380|454414397|FG001|Treatment Period|Withdrawal by Subject|10|||
126307280|NCT03214380|454414398|FG002|Treatment Period|Withdrawal by Subject|8|||
126307281|NCT03214380|454414399|FG003|Treatment Period|Withdrawal by Subject|0|||
126307282|NCT03214380|454414400|FG004|Treatment Period|Withdrawal by Subject|7|||
126307283|NCT03214380|454414401|FG005|Treatment Period|Withdrawal by Subject|11|||
126307284|NCT03214380|454414396|FG000|Treatment Period|Death|0|||
126307285|NCT03214380|454414397|FG001|Treatment Period|Death|1|||
126307286|NCT03214380|454414398|FG002|Treatment Period|Death|2|||
126307287|NCT03214380|454414399|FG003|Treatment Period|Death|0|||
126307288|NCT03214380|454414400|FG004|Treatment Period|Death|0|||
126307289|NCT03214380|454414401|FG005|Treatment Period|Death|0|||
126307290|NCT03214380|454414396|FG000|Treatment Period|Lost to Follow-up|0|||
126307291|NCT03214380|454414397|FG001|Treatment Period|Lost to Follow-up|6|||
126307292|NCT03214380|454414398|FG002|Treatment Period|Lost to Follow-up|3|||
126307293|NCT03214380|454414399|FG003|Treatment Period|Lost to Follow-up|0|||
126307294|NCT03214380|454414400|FG004|Treatment Period|Lost to Follow-up|0|||
126307295|NCT03214380|454414401|FG005|Treatment Period|Lost to Follow-up|0|||
126307296|NCT03214380|454414396|FG000|Treatment Period|Participant schedule|0|||
126307297|NCT03214380|454414397|FG001|Treatment Period|Participant schedule|0|||
126307298|NCT03214380|454414398|FG002|Treatment Period|Participant schedule|1|||
126307299|NCT03214380|454414399|FG003|Treatment Period|Participant schedule|0|||
126307300|NCT03214380|454414400|FG004|Treatment Period|Participant schedule|0|||
126307301|NCT03214380|454414401|FG005|Treatment Period|Participant schedule|0|||
126307302|NCT03214380|454414396|FG000|Treatment Period|Treatment Interruption|0|||
126370643|NCT03448393|454653701|FG007|Dose Expansion|Not treated - screen failure|0|||
126370644|NCT03448393|454653702|FG008|Dose Expansion|Not treated - screen failure|7|||
126370645|NCT03330847|454653703|FG000|Overall Study|Patients ongoing study|62|||
126370646|NCT03330847|454653704|FG001|Overall Study|Patients ongoing study|65|||
126370647|NCT03330847|454653705|FG002|Overall Study|Patients ongoing study|15|||
126552172|NCT00849680|455315999|FG000|Overall Study|Withdrawal by Subject|2|||
126770712|NCT03747939|456114671|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
126307303|NCT03214380|454414397|FG001|Treatment Period|Treatment Interruption|0|||
126307304|NCT03214380|454414398|FG002|Treatment Period|Treatment Interruption|1|||
126307305|NCT03214380|454414399|FG003|Treatment Period|Treatment Interruption|0|||
126307306|NCT03214380|454414400|FG004|Treatment Period|Treatment Interruption|0|||
126307307|NCT03214380|454414401|FG005|Treatment Period|Treatment Interruption|0|||
126307308|NCT01163851|454414402|FG000|Overall Study|Site Closure|0|||
126307309|NCT01163851|454414403|FG001|Overall Study|Site Closure|1|||
126370648|NCT01355627|454653706|FG000|Overall Study|Request By the Patient to Discontinue|5|||
126370649|NCT01355627|454653707|FG001|Overall Study|Request By the Patient to Discontinue|7|||
126370650|NCT01355627|454653706|FG000|Overall Study|Lost to Follow-up|8|||
126370651|NCT01355627|454653707|FG001|Overall Study|Lost to Follow-up|7|||
126370652|NCT01355627|454653706|FG000|Overall Study|Fatal Adverse Event|19|||
126370653|NCT01355627|454653707|FG001|Overall Study|Fatal Adverse Event|23|||
126370654|NCT01355627|454653706|FG000|Overall Study|Other|1|||
126370655|NCT01355627|454653707|FG001|Overall Study|Other|1|||
126370656|NCT02293551|454653710|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
126370657|NCT02293551|454653711|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
126370658|NCT02293551|454653712|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
126370659|NCT02293551|454653713|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
126552173|NCT00849680|455316000|FG001|Overall Study|Withdrawal by Subject|0|||
126552174|NCT00849680|455316001|FG002|Overall Study|Withdrawal by Subject|0|||
126370660|NCT02293551|454653714|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
126370661|NCT02293551|454653715|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
126370662|NCT02293551|454653710|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
126370663|NCT02293551|454653711|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
126370664|NCT02293551|454653712|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
126370665|NCT02293551|454653713|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
126370666|NCT02293551|454653714|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
126370667|NCT02293551|454653715|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
126370668|NCT02293551|454653710|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
126370669|NCT02293551|454653711|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
126370670|NCT02293551|454653712|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
126370671|NCT02293551|454653713|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
126370672|NCT02293551|454653714|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
126370673|NCT02293551|454653715|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
126370674|NCT04756531|454653721|FG000|Overall Study|Adverse Event|0|||
126370675|NCT04756531|454653722|FG001|Overall Study|Adverse Event|0|||
126370676|NCT04756531|454653723|FG002|Overall Study|Adverse Event|0|||
126370677|NCT04756531|454653724|FG003|Overall Study|Adverse Event|0|||
126370678|NCT04756531|454653725|FG004|Overall Study|Adverse Event|1|||
126370679|NCT04756531|454653726|FG005|Overall Study|Adverse Event|0|||
126370680|NCT04756531|454653727|FG006|Overall Study|Adverse Event|0|||
126370681|NCT04756531|454653728|FG007|Overall Study|Adverse Event|0|||
126464308|NCT01347307|455001951|FG001|Overall Study|Death|4|||
126464309|NCT01347307|455001950|FG000|Overall Study|Physician Decision|0|||
126464310|NCT01347307|455001951|FG001|Overall Study|Physician Decision|1|||
126464311|NCT04123665|455001956|FG000|Overall Study|Withdrawal by Subject|7|||
126464312|NCT04123665|455001957|FG001|Overall Study|Withdrawal by Subject|0|||
126464313|NCT04123665|455001956|FG000|Overall Study|Lost to Follow-up|1|||
126464314|NCT04123665|455001957|FG001|Overall Study|Lost to Follow-up|0|||
126464315|NCT02237911|455001958|FG000|Overall Study|Withdrawal by Subject|4|||
126464316|NCT02237911|455001959|FG001|Overall Study|Withdrawal by Subject|7|||
126464317|NCT02237911|455001960|FG002|Overall Study|Withdrawal by Subject|2|||
126464318|NCT02237911|455001958|FG000|Overall Study|Lost to Follow-up|3|||
126464319|NCT02237911|455001959|FG001|Overall Study|Lost to Follow-up|1|||
126464320|NCT02237911|455001960|FG002|Overall Study|Lost to Follow-up|1|||
126464321|NCT00053365|455001961|FG000|Overall Study|Incorrect cell type|1|||
126464322|NCT00053365|455001961|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
126464323|NCT00053365|455001961|FG000|Overall Study|Never treated|4|||
126464324|NCT00958789|455001966|FG000|Overall Study|Death|5|||
126464325|NCT00958789|455001966|FG000|Overall Study|Lost to Follow-up|14|||
126464326|NCT00958789|455001966|FG000|Overall Study|Withdrawal by Subject|17|||
126464327|NCT00958789|455001966|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
126464328|NCT00958789|455001966|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
126552175|NCT00849680|455316002|FG003|Overall Study|Withdrawal by Subject|2|||
126370682|NCT04756531|454653729|FG008|Overall Study|Adverse Event|0|||
126370683|NCT04756531|454653730|FG009|Overall Study|Adverse Event|0|||
126370684|NCT04756531|454653731|FG010|Overall Study|Adverse Event|0|||
126370685|NCT04756531|454653732|FG011|Overall Study|Adverse Event|0|||
126370686|NCT04756531|454653733|FG012|Overall Study|Adverse Event|0|||
126370687|NCT04756531|454653734|FG013|Overall Study|Adverse Event|0|||
126552176|NCT00849680|455316003|FG004|Overall Study|Withdrawal by Subject|2|||
126370688|NCT04756531|454653735|FG014|Overall Study|Adverse Event|0|||
126370689|NCT04756531|454653736|FG015|Overall Study|Adverse Event|0|||
126370690|NCT04756531|454653737|FG016|Overall Study|Adverse Event|0|||
126370691|NCT04756531|454653738|FG017|Overall Study|Adverse Event|0|||
126370692|NCT04756531|454653721|FG000|Overall Study|Withdrawal by Subject|0|||
126370693|NCT04756531|454653722|FG001|Overall Study|Withdrawal by Subject|0|||
126464329|NCT00958789|455001966|FG000|Overall Study|Subject terminated|2|||
126464330|NCT00958789|455001966|FG000|Overall Study|Revision|7|||
126464331|NCT00721123|455001968|FG000|Overall Study|Adverse Event|96|||
126464332|NCT00721123|455001968|FG000|Overall Study|Death|10|||
126464333|NCT00721123|455001968|FG000|Overall Study|Insufficient Therapeutic Response|21|||
126464334|NCT00721123|455001968|FG000|Overall Study|Protocol Violation|1|||
126716054|NCT02795988|455913060|FG003|Phase 1b|Withdrawal by Subject|0|||
126716055|NCT02795988|455913061|FG004|Phase 1b|Withdrawal by Subject|0|||
126716056|NCT02795988|455913062|FG005|Phase 1b|Withdrawal by Subject|0|||
126716057|NCT02795988|455913063|FG006|Phase 1b|Withdrawal by Subject|0|||
126716058|NCT02795988|455913057|FG000|Phase 1b|Death|1|||
126716059|NCT02795988|455913058|FG001|Phase 1b|Death|2|||
126716060|NCT02795988|455913059|FG002|Phase 1b|Death|1|||
126307310|NCT01163851|454414402|FG000|Overall Study|Enrolled but not treated|1|||
126307311|NCT01163851|454414403|FG001|Overall Study|Enrolled but not treated|0|||
126307312|NCT02028767|454414404|FG000|Treatment Period 2|Non compliant with protocol|1|||
126307313|NCT02028767|454414405|FG001|Treatment Period 2|Non compliant with protocol|0|||
126307314|NCT02028767|454414404|FG000|Treatment Period 2|Reason other than those specified above|1|||
126307315|NCT02028767|454414405|FG001|Treatment Period 2|Reason other than those specified above|0|||
126307316|NCT03192306|454414406|FG000|Overall Study|Did not treat cold sore during study|149|||
126307317|NCT03192306|454414407|FG001|Overall Study|Did not treat cold sore during study|143|||
126307318|NCT03192306|454414406|FG000|Overall Study|Withdrawal by Subject|1|||
126307319|NCT03192306|454414407|FG001|Overall Study|Withdrawal by Subject|1|||
126307320|NCT03192306|454414406|FG000|Overall Study|Lost to Follow-up|1|||
126307321|NCT03192306|454414407|FG001|Overall Study|Lost to Follow-up|0|||
126307322|NCT03192306|454414406|FG000|Overall Study|Protocol Violation|1|||
126307323|NCT03192306|454414407|FG001|Overall Study|Protocol Violation|1|||
126307324|NCT03436693|454414408|FG000|Overall Study|Adverse Event|22|||
126307325|NCT03436693|454414409|FG001|Overall Study|Adverse Event|10|||
126307326|NCT03436693|454414408|FG000|Overall Study|Physician Decision|3|||
126307327|NCT03436693|454414409|FG001|Overall Study|Physician Decision|3|||
126307328|NCT03436693|454414408|FG000|Overall Study|Withdrawal by Subject|4|||
126307329|NCT03436693|454414409|FG001|Overall Study|Withdrawal by Subject|13|||
126307330|NCT03436693|454414408|FG000|Overall Study|Progressive Disease|1|||
126307331|NCT03436693|454414409|FG001|Overall Study|Progressive Disease|1|||
126307332|NCT00654875|454414412|FG000|Overall Study|Adverse Event|5|||
126307333|NCT00654875|454414413|FG001|Overall Study|Adverse Event|5|||
126307334|NCT00654875|454414412|FG000|Overall Study|Withdrawal by Subject|4|||
126307335|NCT00654875|454414413|FG001|Overall Study|Withdrawal by Subject|4|||
126307336|NCT00654875|454414412|FG000|Overall Study|Protocol Violation|3|||
126307337|NCT00654875|454414413|FG001|Overall Study|Protocol Violation|3|||
126307338|NCT00654875|454414412|FG000|Overall Study|Lack of Efficacy|2|||
126307339|NCT00654875|454414413|FG001|Overall Study|Lack of Efficacy|2|||
126307340|NCT00654875|454414412|FG000|Overall Study|Lost to Follow-up|1|||
126307341|NCT00654875|454414413|FG001|Overall Study|Lost to Follow-up|3|||
126307342|NCT00654875|454414412|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
126307343|NCT00654875|454414413|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
126307344|NCT00654875|454414412|FG000|Overall Study|Administrative Problems|1|||
126307345|NCT00654875|454414413|FG001|Overall Study|Administrative Problems|0|||
126307346|NCT04967885|454414414|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
126307347|NCT04967885|454414415|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
126307348|NCT04967885|454414414|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
126307349|NCT04967885|454414415|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
126307350|NCT04967885|454414414|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
126307351|NCT04967885|454414415|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
126307352|NCT04967885|454414414|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
126307353|NCT04967885|454414415|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
126307354|NCT04967885|454414414|FG000|EMI-II Intervention|Lost to Follow-up|14|||
126307355|NCT04967885|454414415|FG001|EMI-II Intervention|Lost to Follow-up|10|||
126307356|NCT00886743|454414416|FG000|Overall Study|Adverse Event|3|||
126307357|NCT00886743|454414416|FG000|Overall Study|Other|1|||
126307358|NCT05217641|454414417|FG000|Overall Study|Lost to Follow-up|1|||
126307359|NCT05217641|454414418|FG001|Overall Study|Lost to Follow-up|1|||
126307360|NCT05217641|454414419|FG002|Overall Study|Lost to Follow-up|0|||
126307361|NCT05217641|454414420|FG003|Overall Study|Lost to Follow-up|1|||
126307362|NCT05217641|454414421|FG004|Overall Study|Lost to Follow-up|1|||
126307363|NCT05217641|454414422|FG005|Overall Study|Lost to Follow-up|0|||
126307364|NCT05217641|454414417|FG000|Overall Study|Withdrawal by Subject|0|||
126370694|NCT04756531|454653723|FG002|Overall Study|Withdrawal by Subject|0|||
126716061|NCT02795988|455913060|FG003|Phase 1b|Death|0|||
126370695|NCT04756531|454653724|FG003|Overall Study|Withdrawal by Subject|0|||
126370696|NCT04756531|454653725|FG004|Overall Study|Withdrawal by Subject|0|||
126716062|NCT02795988|455913061|FG004|Phase 1b|Death|0|||
126307365|NCT05217641|454414418|FG001|Overall Study|Withdrawal by Subject|0|||
126307366|NCT05217641|454414419|FG002|Overall Study|Withdrawal by Subject|0|||
126307367|NCT05217641|454414420|FG003|Overall Study|Withdrawal by Subject|3|||
126307368|NCT05217641|454414421|FG004|Overall Study|Withdrawal by Subject|1|||
126307369|NCT05217641|454414422|FG005|Overall Study|Withdrawal by Subject|0|||
126307370|NCT05217641|454414417|FG000|Overall Study|Other: participant did not specify reason|0|||
126307371|NCT05217641|454414418|FG001|Overall Study|Other: participant did not specify reason|0|||
126716063|NCT02795988|455913062|FG005|Phase 1b|Death|0|||
126716064|NCT02795988|455913063|FG006|Phase 1b|Death|0|||
126716065|NCT02795988|455913057|FG000|Phase 1b|Physician Decision|0|||
126716066|NCT02795988|455913058|FG001|Phase 1b|Physician Decision|0|||
126716067|NCT02795988|455913059|FG002|Phase 1b|Physician Decision|1|||
126716068|NCT02795988|455913060|FG003|Phase 1b|Physician Decision|0|||
126716069|NCT02795988|455913061|FG004|Phase 1b|Physician Decision|0|||
126716070|NCT02795988|455913062|FG005|Phase 1b|Physician Decision|0|||
126716071|NCT02795988|455913063|FG006|Phase 1b|Physician Decision|0|||
126716072|NCT02795988|455913057|FG000|Phase 1b|Progressive Disease|2|||
126716073|NCT02795988|455913058|FG001|Phase 1b|Progressive Disease|2|||
126716074|NCT02795988|455913059|FG002|Phase 1b|Progressive Disease|0|||
126770713|NCT03747939|456114672|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
126770714|NCT03747939|456114673|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
126770715|NCT03747939|456114670|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
126770716|NCT03747939|456114671|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
126770717|NCT03747939|456114672|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
126770718|NCT03747939|456114673|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
126770719|NCT03747939|456114670|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
126770720|NCT03747939|456114671|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
126770721|NCT03747939|456114672|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
126770722|NCT03747939|456114673|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
126770723|NCT03747939|456114670|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
126770724|NCT03747939|456114671|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
126770725|NCT03747939|456114672|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
126770726|NCT03747939|456114673|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
126770727|NCT03747939|456114670|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
126770728|NCT03747939|456114671|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
126770729|NCT03747939|456114672|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
126770730|NCT03747939|456114673|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
126770731|NCT01523301|456114674|FG000|Overall Study|Adverse Event|25|||
126770732|NCT01523301|456114675|FG001|Overall Study|Adverse Event|16|||
126770733|NCT01523301|456114674|FG000|Overall Study|Lack of Efficacy|0|||
126770734|NCT01523301|456114675|FG001|Overall Study|Lack of Efficacy|2|||
126770735|NCT01523301|456114674|FG000|Overall Study|Protocol Violation|3|||
126770736|NCT01523301|456114675|FG001|Overall Study|Protocol Violation|4|||
126770737|NCT01523301|456114674|FG000|Overall Study|Lost to Follow-up|1|||
126770738|NCT01523301|456114675|FG001|Overall Study|Lost to Follow-up|0|||
126770739|NCT01523301|456114674|FG000|Overall Study|Withdrawal by Subject|6|||
126770740|NCT01523301|456114675|FG001|Overall Study|Withdrawal by Subject|8|||
126770741|NCT01523301|456114674|FG000|Overall Study|Other Reason|0|||
126770742|NCT01523301|456114675|FG001|Overall Study|Other Reason|2|||
126770743|NCT01447628|456114678|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
126770744|NCT01447628|456114679|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
126770745|NCT01447628|456114680|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
126770746|NCT01447628|456114681|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
126307372|NCT05217641|454414419|FG002|Overall Study|Other: participant did not specify reason|0|||
126307373|NCT05217641|454414420|FG003|Overall Study|Other: participant did not specify reason|0|||
126307374|NCT05217641|454414421|FG004|Overall Study|Other: participant did not specify reason|1|||
126307375|NCT05217641|454414422|FG005|Overall Study|Other: participant did not specify reason|0|||
126307376|NCT05217641|454414417|FG000|Overall Study|Extended Follow up|1|||
126307377|NCT05217641|454414418|FG001|Overall Study|Extended Follow up|1|||
126307378|NCT05217641|454414419|FG002|Overall Study|Extended Follow up|0|||
126307379|NCT05217641|454414420|FG003|Overall Study|Extended Follow up|0|||
126307380|NCT05217641|454414421|FG004|Overall Study|Extended Follow up|1|||
126307381|NCT05217641|454414422|FG005|Overall Study|Extended Follow up|0|||
126716075|NCT02795988|455913060|FG003|Phase 1b|Progressive Disease|0|||
126716076|NCT02795988|455913061|FG004|Phase 1b|Progressive Disease|0|||
126716077|NCT02795988|455913062|FG005|Phase 1b|Progressive Disease|0|||
126716078|NCT02795988|455913063|FG006|Phase 1b|Progressive Disease|0|||
126716079|NCT02795988|455913057|FG000|Phase 2|Withdrawal by Subject|0|||
126716080|NCT02795988|455913058|FG001|Phase 2|Withdrawal by Subject|0|||
126716081|NCT02795988|455913059|FG002|Phase 2|Withdrawal by Subject|0|||
126716082|NCT02795988|455913060|FG003|Phase 2|Withdrawal by Subject|1|||
126716083|NCT02795988|455913061|FG004|Phase 2|Withdrawal by Subject|0|||
126770747|NCT00185731|456114682|FG000|Overall Study|Withdrawal by Subject|1|||
126770748|NCT00185731|456114682|FG000|Overall Study|Not Eligible|1|||
126770749|NCT03087773|456114683|FG000|Overall Study|Withdrawal by Subject|8|||
126770750|NCT03087773|456114684|FG001|Overall Study|Withdrawal by Subject|4|||
126770751|NCT03087773|456114683|FG000|Overall Study|Lost to Follow-up|12|||
126770752|NCT03087773|456114684|FG001|Overall Study|Lost to Follow-up|8|||
126770753|NCT00943384|456114689|FG000|Overall Study|Dispositioned prior to treatment|23|||
126307382|NCT00626821|454414430|FG000|Overall Study|Adverse Event|44|||
126552177|NCT00849680|455316004|FG005|Overall Study|Withdrawal by Subject|2|||
126716084|NCT02795988|455913062|FG005|Phase 2|Withdrawal by Subject|0|||
126716085|NCT02795988|455913063|FG006|Phase 2|Withdrawal by Subject|0|||
126716086|NCT02795988|455913057|FG000|Phase 2|Death|0|||
126370697|NCT04756531|454653726|FG005|Overall Study|Withdrawal by Subject|0|||
126370698|NCT04756531|454653727|FG006|Overall Study|Withdrawal by Subject|1|||
126370699|NCT04756531|454653728|FG007|Overall Study|Withdrawal by Subject|0|||
126370700|NCT04756531|454653729|FG008|Overall Study|Withdrawal by Subject|0|||
126370701|NCT04756531|454653730|FG009|Overall Study|Withdrawal by Subject|0|||
126370702|NCT04756531|454653731|FG010|Overall Study|Withdrawal by Subject|0|||
126370703|NCT04756531|454653732|FG011|Overall Study|Withdrawal by Subject|0|||
126370704|NCT04756531|454653733|FG012|Overall Study|Withdrawal by Subject|0|||
126370705|NCT04756531|454653734|FG013|Overall Study|Withdrawal by Subject|0|||
126370706|NCT04756531|454653735|FG014|Overall Study|Withdrawal by Subject|0|||
126370707|NCT04756531|454653736|FG015|Overall Study|Withdrawal by Subject|0|||
126370708|NCT04756531|454653737|FG016|Overall Study|Withdrawal by Subject|0|||
126370709|NCT04756531|454653738|FG017|Overall Study|Withdrawal by Subject|0|||
126370710|NCT05643495|454653739|FG000|Overall Study|Adverse Event|0|||
126370711|NCT05643495|454653740|FG001|Overall Study|Adverse Event|1|||
126370712|NCT05643495|454653739|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
126370713|NCT05643495|454653740|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
126370714|NCT02257528|454653741|FG000|Overall Study|Never received study treatment|1|||
126370715|NCT06272383|454653742|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
126370716|NCT06272383|454653743|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
126370717|NCT04569084|454653748|FG000|Overall Study|Adverse Event|10|||
126370718|NCT04569084|454653749|FG001|Overall Study|Adverse Event|14|||
126370719|NCT04569084|454653748|FG000|Overall Study|Death|2|||
126370720|NCT04569084|454653749|FG001|Overall Study|Death|3|||
126552178|NCT00849680|455316005|FG006|Overall Study|Withdrawal by Subject|1|||
126716087|NCT02795988|455913058|FG001|Phase 2|Death|0|||
126716088|NCT02795988|455913059|FG002|Phase 2|Death|0|||
126716089|NCT02795988|455913060|FG003|Phase 2|Death|17|||
126716090|NCT02795988|455913061|FG004|Phase 2|Death|17|||
126716091|NCT02795988|455913062|FG005|Phase 2|Death|0|||
126716092|NCT02795988|455913063|FG006|Phase 2|Death|0|||
126716093|NCT02795988|455913057|FG000|Phase 2|Other|0|||
126716094|NCT02795988|455913058|FG001|Phase 2|Other|0|||
126716095|NCT02795988|455913059|FG002|Phase 2|Other|0|||
126716096|NCT02795988|455913060|FG003|Phase 2|Other|1|||
126716097|NCT02795988|455913061|FG004|Phase 2|Other|0|||
126716098|NCT02795988|455913062|FG005|Phase 2|Other|0|||
126716099|NCT02795988|455913063|FG006|Phase 2|Other|0|||
126716100|NCT02795988|455913057|FG000|Phase 2 Extension|Death|0|||
126716101|NCT02795988|455913058|FG001|Phase 2 Extension|Death|0|||
126716102|NCT02795988|455913059|FG002|Phase 2 Extension|Death|0|||
126716103|NCT02795988|455913060|FG003|Phase 2 Extension|Death|0|||
126716104|NCT02795988|455913061|FG004|Phase 2 Extension|Death|0|||
126716105|NCT02795988|455913062|FG005|Phase 2 Extension|Death|5|||
126716106|NCT02795988|455913063|FG006|Phase 2 Extension|Death|6|||
126716107|NCT02795988|455913057|FG000|Phase 2 Extension|Other reasons|0|||
126716108|NCT02795988|455913058|FG001|Phase 2 Extension|Other reasons|0|||
126716109|NCT02795988|455913059|FG002|Phase 2 Extension|Other reasons|0|||
126716110|NCT02795988|455913060|FG003|Phase 2 Extension|Other reasons|0|||
126716111|NCT02795988|455913061|FG004|Phase 2 Extension|Other reasons|0|||
126716112|NCT02795988|455913062|FG005|Phase 2 Extension|Other reasons|2|||
126716113|NCT02795988|455913063|FG006|Phase 2 Extension|Other reasons|1|||
126716114|NCT02834403|455913064|FG000|Overall Study|Physician Decision|2|||
126716115|NCT02834403|455913065|FG001|Overall Study|Physician Decision|1|||
126716116|NCT02834403|455913066|FG002|Overall Study|Physician Decision|2|||
126716117|NCT02834403|455913067|FG003|Overall Study|Physician Decision|1|||
126716118|NCT02834403|455913068|FG004|Overall Study|Physician Decision|1|||
126716119|NCT02834403|455913069|FG005|Overall Study|Physician Decision|2|||
126716120|NCT02834403|455913070|FG006|Overall Study|Physician Decision|12|||
126716121|NCT02834403|455913064|FG000|Overall Study|Adverse Event|0|||
126716122|NCT02834403|455913065|FG001|Overall Study|Adverse Event|0|||
126716123|NCT02834403|455913066|FG002|Overall Study|Adverse Event|0|||
126370721|NCT04569084|454653748|FG000|Overall Study|Lost to Follow-up|1|||
126370722|NCT04569084|454653749|FG001|Overall Study|Lost to Follow-up|1|||
126552179|NCT00849680|455316006|FG007|Overall Study|Withdrawal by Subject|1|||
126552180|NCT00849680|455315999|FG000|Overall Study|Subject unable to comply with protocol|1|||
126716124|NCT02834403|455913067|FG003|Overall Study|Adverse Event|0|||
126716125|NCT02834403|455913068|FG004|Overall Study|Adverse Event|1|||
126716126|NCT02834403|455913069|FG005|Overall Study|Adverse Event|1|||
126716127|NCT02834403|455913070|FG006|Overall Study|Adverse Event|3|||
126716128|NCT02834403|455913064|FG000|Overall Study|Withdrawal by Subject|0|||
126716129|NCT02834403|455913065|FG001|Overall Study|Withdrawal by Subject|1|||
126716130|NCT02834403|455913066|FG002|Overall Study|Withdrawal by Subject|0|||
126716131|NCT02834403|455913067|FG003|Overall Study|Withdrawal by Subject|0|||
126716132|NCT02834403|455913068|FG004|Overall Study|Withdrawal by Subject|1|||
126716133|NCT02834403|455913069|FG005|Overall Study|Withdrawal by Subject|0|||
126716134|NCT02834403|455913070|FG006|Overall Study|Withdrawal by Subject|0|||
126716135|NCT02834403|455913064|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
126716136|NCT02834403|455913065|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
126770754|NCT00943384|456114689|FG000|Overall Study|Treated off protocol-protocol violation|5|||
126770755|NCT00943384|456114689|FG000|Overall Study|Lost to Follow-up|16|||
126770756|NCT00943384|456114689|FG000|Overall Study|Withdrawal by Subject|5|||
126770757|NCT02180659|456114690|FG000|Overall Study|Adverse Event|1|||
126770758|NCT02180659|456114691|FG001|Overall Study|Adverse Event|0|||
126770759|NCT02180659|456114690|FG000|Overall Study|Lost to Follow-up|4|||
126770760|NCT02180659|456114691|FG001|Overall Study|Lost to Follow-up|2|||
126770761|NCT02180659|456114690|FG000|Overall Study|Subject incarcerated during conduct|1|||
126770762|NCT02180659|456114691|FG001|Overall Study|Subject incarcerated during conduct|0|||
126770763|NCT02180659|456114690|FG000|Overall Study|Withdrawal by Subject|0|||
126770764|NCT02180659|456114691|FG001|Overall Study|Withdrawal by Subject|2|||
126770765|NCT02180659|456114690|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
126770766|NCT02180659|456114691|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
126770767|NCT00481871|456114694|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
126770768|NCT00481871|456114695|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
126770769|NCT00481871|456114696|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
126770770|NCT00481871|456114697|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
126770771|NCT00481871|456114698|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
126770772|NCT03151707|456114699|FG000|Overall Study|Lost to Follow-up|6|||
126770773|NCT01308762|456114700|FG000|Overall Study|Protocol Violation|0|||
126770774|NCT01308762|456114701|FG001|Overall Study|Protocol Violation|1|||
126770775|NCT01308762|456114702|FG002|Overall Study|Protocol Violation|0|||
126770776|NCT01216319|456114706|FG000|Overall Study|Lost to Follow-up|2|||
126770777|NCT01216319|456114706|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
126770778|NCT00929864|456114707|FG000|Overall Study|Death|1|||
126770779|NCT00929864|456114708|FG001|Overall Study|Death|1|||
126770780|NCT00929864|456114707|FG000|Overall Study|Adverse Event|11|||
126770781|NCT00929864|456114708|FG001|Overall Study|Adverse Event|30|||
126770782|NCT00929864|456114707|FG000|Overall Study|Lack of Efficacy|19|||
126770783|NCT00929864|456114708|FG001|Overall Study|Lack of Efficacy|16|||
126770784|NCT00929864|456114707|FG000|Overall Study|Lost to Follow-up|7|||
126770785|NCT00929864|456114708|FG001|Overall Study|Lost to Follow-up|12|||
126770786|NCT00929864|456114707|FG000|Overall Study|Withdrawal by Subject|20|||
126770787|NCT00929864|456114708|FG001|Overall Study|Withdrawal by Subject|9|||
126770788|NCT00929864|456114707|FG000|Overall Study|No longer met criteria|2|||
126770789|NCT00929864|456114708|FG001|Overall Study|No longer met criteria|1|||
126770790|NCT00929864|456114707|FG000|Overall Study|Poor or non-compliance|3|||
126770791|NCT00929864|456114708|FG001|Overall Study|Poor or non-compliance|3|||
126770792|NCT00929864|456114707|FG000|Overall Study|Pregnancy|0|||
126770793|NCT00929864|456114708|FG001|Overall Study|Pregnancy|3|||
126770794|NCT00929864|456114707|FG000|Overall Study|Administrative reason by Sponsor|1|||
126770795|NCT00929864|456114708|FG001|Overall Study|Administrative reason by Sponsor|1|||
126770796|NCT00929864|456114707|FG000|Overall Study|Non-specified|2|||
126770797|NCT00929864|456114708|FG001|Overall Study|Non-specified|7|||
126770798|NCT00390572|456114709|FG000|Overall Study|Lost to Follow-up|8|||
126770799|NCT00390572|456114710|FG001|Overall Study|Lost to Follow-up|4|||
126770800|NCT00390572|456114709|FG000|Overall Study|health condition|0|||
126770801|NCT00390572|456114710|FG001|Overall Study|health condition|1|||
126770802|NCT01345058|456114717|FG000|Overall Study|Withdrawal by Subject|1|||
126770803|NCT01345058|456114718|FG001|Overall Study|Withdrawal by Subject|0|||
126770804|NCT01345058|456114717|FG000|Overall Study|Participant Reported Increase in Events|1|||
126770805|NCT01345058|456114718|FG001|Overall Study|Participant Reported Increase in Events|0|||
126770806|NCT01345058|456114717|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
126770807|NCT01345058|456114718|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
126770808|NCT01345058|456114717|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
126770809|NCT01345058|456114718|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
126770810|NCT01345058|456114717|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
126770811|NCT01345058|456114718|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
126770812|NCT01892020|456114725|FG000|Period 1|Adverse Event|1|||
126770813|NCT01892020|456114726|FG001|Period 1|Adverse Event|1|||
126307383|NCT00626821|454414430|FG000|Overall Study|Protocol Violation|33|||
126307384|NCT00626821|454414430|FG000|Overall Study|Withdrawal by Subject|10|||
126770814|NCT01892020|456114725|FG000|Period 1|Protocol Violation|2|||
126770815|NCT01892020|456114726|FG001|Period 1|Protocol Violation|4|||
126770816|NCT01892020|456114725|FG000|Period 1|Unclassified|0|||
126770817|NCT01892020|456114726|FG001|Period 1|Unclassified|1|||
126770818|NCT01892020|456114725|FG000|Period 2|Protocol Violation|1|||
126770819|NCT01892020|456114726|FG001|Period 2|Protocol Violation|0|||
126770820|NCT03252756|456114731|FG000|Overall Study|Protocol Violation|2|||
126770821|NCT03252756|456114732|FG001|Overall Study|Protocol Violation|4|||
126770822|NCT03252756|456114731|FG000|Overall Study|COVID-19 Pandemic|1|||
126770823|NCT03252756|456114732|FG001|Overall Study|COVID-19 Pandemic|1|||
126770824|NCT03252756|456114731|FG000|Overall Study|Study Drug Expiration|0|||
126770825|NCT03252756|456114732|FG001|Overall Study|Study Drug Expiration|1|||
126770826|NCT01500434|456114735|FG000|Overall Study|Death|1|||
126770827|NCT01500434|456114735|FG000|Overall Study|Withdrawal by Subject|1|||
126770828|NCT01500434|456114735|FG000|Overall Study|Missed 12-month follow-up|5|||
126716137|NCT02834403|455913066|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
126716138|NCT02834403|455913067|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
126716139|NCT02834403|455913068|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
126716140|NCT02834403|455913069|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
126307385|NCT00626821|454414430|FG000|Overall Study|Physician Decision|9|||
126307386|NCT00626821|454414430|FG000|Overall Study|Product dysfunction|21|||
126307387|NCT00626821|454414430|FG000|Overall Study|other/unknown reason|104|||
126307388|NCT02632409|454414431|FG000|Randomized|AE unrelated to study Drug|0|||
126307389|NCT02632409|454414432|FG001|Randomized|AE unrelated to study Drug|1|||
126307390|NCT02632409|454414431|FG000|Randomized|Participant withdrew consent|2|||
126307391|NCT02632409|454414432|FG001|Randomized|Participant withdrew consent|1|||
126307392|NCT02632409|454414431|FG000|Randomized|No Longer meets study criteria|5|||
126307393|NCT02632409|454414432|FG001|Randomized|No Longer meets study criteria|0|||
126307394|NCT02632409|454414431|FG000|Randomized|other reasons|1|||
126307395|NCT02632409|454414432|FG001|Randomized|other reasons|0|||
126307396|NCT02632409|454414431|FG000|Treatment Period|Ongoing Treatment|20|||
126307397|NCT02632409|454414432|FG001|Treatment Period|Ongoing Treatment|21|||
126307398|NCT02632409|454414431|FG000|Treatment Period|Disease Recurrence|147|||
126307399|NCT02632409|454414432|FG001|Treatment Period|Disease Recurrence|90|||
126307400|NCT02632409|454414431|FG000|Treatment Period|Study Drug Toxicity|8|||
126307401|NCT02632409|454414432|FG001|Treatment Period|Study Drug Toxicity|49|||
126307402|NCT02632409|454414431|FG000|Treatment Period|Death|1|||
126307403|NCT02632409|454414432|FG001|Treatment Period|Death|0|||
126307404|NCT02632409|454414431|FG000|Treatment Period|AE unrelated to study drug|15|||
126307405|NCT02632409|454414432|FG001|Treatment Period|AE unrelated to study drug|16|||
126307406|NCT02632409|454414431|FG000|Treatment Period|Request to discontinue treatment|4|||
126307407|NCT02632409|454414432|FG001|Treatment Period|Request to discontinue treatment|19|||
126307408|NCT02632409|454414431|FG000|Treatment Period|Participant withdrew consent|7|||
126307409|NCT02632409|454414432|FG001|Treatment Period|Participant withdrew consent|5|||
126307410|NCT02632409|454414431|FG000|Treatment Period|Lost to Follow-up|0|||
126307411|NCT02632409|454414432|FG001|Treatment Period|Lost to Follow-up|1|||
126307412|NCT02632409|454414431|FG000|Treatment Period|Maximum clinical benefit|1|||
126307413|NCT02632409|454414432|FG001|Treatment Period|Maximum clinical benefit|0|||
126307414|NCT02632409|454414431|FG000|Treatment Period|No longer meets study criteria|3|||
126307415|NCT02632409|454414432|FG001|Treatment Period|No longer meets study criteria|0|||
126307416|NCT02632409|454414431|FG000|Treatment Period|Administrative Reason by sponsor|0|||
126307417|NCT02632409|454414432|FG001|Treatment Period|Administrative Reason by sponsor|1|||
126307418|NCT02632409|454414431|FG000|Treatment Period|Other Reasons|10|||
126307419|NCT02632409|454414432|FG001|Treatment Period|Other Reasons|6|||
126307420|NCT01471340|454414433|FG000|Overall Study|Death|5|||
126307421|NCT01471340|454414434|FG001|Overall Study|Death|4|||
126307422|NCT01471340|454414433|FG000|Overall Study|Lost to Follow-up|0|||
126307423|NCT01471340|454414434|FG001|Overall Study|Lost to Follow-up|1|||
126307424|NCT01471340|454414433|FG000|Overall Study|Investigational site closure|0|||
126307425|NCT01471340|454414434|FG001|Overall Study|Investigational site closure|1|||
126307426|NCT01471340|454414433|FG000|Overall Study|Invalid informed consent|1|||
126307427|NCT01471340|454414434|FG001|Overall Study|Invalid informed consent|0|||
126307428|NCT00526669|454414437|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
126307429|NCT00526669|454414438|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
126307430|NCT00526669|454414437|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
126307431|NCT00526669|454414438|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
126307432|NCT00526669|454414437|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
126307433|NCT00526669|454414438|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
126307434|NCT00526669|454414437|FG000|Combined Treatment Phase|Death|0|||
126307435|NCT00526669|454414438|FG001|Combined Treatment Phase|Death|2|||
126307436|NCT03499899|454414440|FG000|Overall Study|Adverse Event|2|||
126307437|NCT03499899|454414441|FG001|Overall Study|Adverse Event|3|||
126307438|NCT03499899|454414442|FG002|Overall Study|Adverse Event|3|||
126307439|NCT03499899|454414440|FG000|Overall Study|Death|0|||
126370723|NCT04569084|454653748|FG000|Overall Study|Physician Decision|3|||
126716141|NCT02834403|455913070|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
126716142|NCT02341014|455913071|FG000|Overall Study|Adverse Event|0|||
126716143|NCT02341014|455913072|FG001|Overall Study|Adverse Event|1|||
126307440|NCT03499899|454414441|FG001|Overall Study|Death|0|||
126307441|NCT03499899|454414442|FG002|Overall Study|Death|1|||
126307442|NCT03499899|454414440|FG000|Overall Study|Physician Decision|3|||
126307443|NCT03499899|454414441|FG001|Overall Study|Physician Decision|6|||
126307444|NCT03499899|454414442|FG002|Overall Study|Physician Decision|6|||
126307445|NCT03499899|454414440|FG000|Overall Study|Progressive disease|15|||
126307446|NCT03499899|454414441|FG001|Overall Study|Progressive disease|23|||
126307447|NCT03499899|454414442|FG002|Overall Study|Progressive disease|23|||
126307448|NCT03499899|454414440|FG000|Overall Study|Patient decision|0|||
126307449|NCT03499899|454414441|FG001|Overall Study|Patient decision|1|||
126307450|NCT03499899|454414442|FG002|Overall Study|Patient decision|1|||
126370724|NCT04569084|454653749|FG001|Overall Study|Physician Decision|3|||
126716144|NCT02341014|455913073|FG002|Overall Study|Adverse Event|0|||
126716145|NCT02341014|455913074|FG003|Overall Study|Adverse Event|0|||
126716146|NCT02341014|455913075|FG004|Overall Study|Adverse Event|2|||
126307451|NCT03499899|454414440|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
126307452|NCT03499899|454414441|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
126307453|NCT03499899|454414442|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
126307454|NCT01082211|454414444|FG000|Overall Study|Protocol Violation|4|||
126307455|NCT01082211|454414444|FG000|Overall Study|No protocol treatment received|3|||
126307456|NCT04016779|454414454|FG000|Overall Study|Adverse Event|9|||
126307457|NCT04016779|454414455|FG001|Overall Study|Adverse Event|17|||
126307458|NCT04016779|454414454|FG000|Overall Study|Lack of Efficacy|4|||
126307459|NCT04016779|454414455|FG001|Overall Study|Lack of Efficacy|1|||
126307460|NCT04016779|454414454|FG000|Overall Study|Lost to Follow-up|5|||
126307461|NCT04016779|454414455|FG001|Overall Study|Lost to Follow-up|14|||
126307462|NCT04016779|454414454|FG000|Overall Study|Physician Decision|1|||
126307463|NCT04016779|454414455|FG001|Overall Study|Physician Decision|3|||
126307464|NCT04016779|454414454|FG000|Overall Study|Withdrawal by Subject|6|||
126307465|NCT04016779|454414455|FG001|Overall Study|Withdrawal by Subject|8|||
126307466|NCT04016779|454414454|FG000|Overall Study|Non-compliance with Study Drug|2|||
126307467|NCT04016779|454414455|FG001|Overall Study|Non-compliance with Study Drug|3|||
126307468|NCT04016779|454414454|FG000|Overall Study|Other, Multiple categories|17|||
126307469|NCT04016779|454414455|FG001|Overall Study|Other, Multiple categories|17|||
126307470|NCT02295020|454414456|FG000|Overall Study|Adverse Event|0|||
126307471|NCT02295020|454414457|FG001|Overall Study|Adverse Event|1|||
126307472|NCT02295020|454414456|FG000|Overall Study|Withdrawal by Subject|3|||
126307473|NCT02295020|454414457|FG001|Overall Study|Withdrawal by Subject|2|||
126307474|NCT02394340|454414462|FG000|Overall Study|Failed drug screen test|1|||
126307475|NCT02394340|454414462|FG000|Overall Study|Adverse Event|1|||
126307476|NCT02828124|454414463|FG000|Overall Study|Disease Progression|1|||
126307477|NCT02828124|454414464|FG001|Overall Study|Disease Progression|2|||
126307478|NCT02828124|454414465|FG002|Overall Study|Disease Progression|1|||
126307479|NCT02828124|454414466|FG003|Overall Study|Disease Progression|4|||
126307480|NCT02828124|454414463|FG000|Overall Study|AE Unrelated to Study Drug|0|||
126307481|NCT02828124|454414464|FG001|Overall Study|AE Unrelated to Study Drug|0|||
126307482|NCT02828124|454414465|FG002|Overall Study|AE Unrelated to Study Drug|0|||
126307483|NCT02828124|454414466|FG003|Overall Study|AE Unrelated to Study Drug|1|||
126307484|NCT02828124|454414463|FG000|Overall Study|Subject Withdrew Consent|0|||
126307485|NCT02828124|454414464|FG001|Overall Study|Subject Withdrew Consent|0|||
126307486|NCT02828124|454414465|FG002|Overall Study|Subject Withdrew Consent|0|||
126307487|NCT02828124|454414466|FG003|Overall Study|Subject Withdrew Consent|1|||
126307488|NCT00256854|454414468|FG000|Overall Study|Withdrawal by Subject|2|||
126307489|NCT00256854|454414469|FG001|Overall Study|Withdrawal by Subject|3|||
126307490|NCT00256854|454414470|FG002|Overall Study|Withdrawal by Subject|0|||
126307491|NCT00256854|454414471|FG003|Overall Study|Withdrawal by Subject|0|||
126307492|NCT00256854|454414472|FG004|Overall Study|Withdrawal by Subject|0|||
126307493|NCT00256854|454414473|FG005|Overall Study|Withdrawal by Subject|0|||
126307494|NCT00256854|454414468|FG000|Overall Study|Lack of Efficacy|1|||
126307495|NCT00256854|454414469|FG001|Overall Study|Lack of Efficacy|0|||
126307496|NCT00256854|454414470|FG002|Overall Study|Lack of Efficacy|0|||
126307497|NCT00256854|454414471|FG003|Overall Study|Lack of Efficacy|0|||
126307498|NCT00256854|454414472|FG004|Overall Study|Lack of Efficacy|0|||
126307499|NCT00256854|454414473|FG005|Overall Study|Lack of Efficacy|0|||
126307500|NCT00256854|454414468|FG000|Overall Study|Protocol Violation|0|||
126307501|NCT00256854|454414469|FG001|Overall Study|Protocol Violation|1|||
126307502|NCT00256854|454414470|FG002|Overall Study|Protocol Violation|1|||
126307503|NCT00256854|454414471|FG003|Overall Study|Protocol Violation|1|||
126307504|NCT00256854|454414472|FG004|Overall Study|Protocol Violation|0|||
126307505|NCT00256854|454414473|FG005|Overall Study|Protocol Violation|0|||
126307506|NCT00256854|454414468|FG000|Overall Study|Adverse Event|0|||
126307507|NCT00256854|454414469|FG001|Overall Study|Adverse Event|0|||
126307508|NCT00256854|454414470|FG002|Overall Study|Adverse Event|2|||
126307509|NCT00256854|454414471|FG003|Overall Study|Adverse Event|2|||
126307510|NCT00256854|454414472|FG004|Overall Study|Adverse Event|0|||
126307511|NCT00256854|454414473|FG005|Overall Study|Adverse Event|1|||
126307512|NCT00256854|454414468|FG000|Overall Study|Not compliant with the study drug|0|||
126307513|NCT00256854|454414469|FG001|Overall Study|Not compliant with the study drug|0|||
126307514|NCT00256854|454414470|FG002|Overall Study|Not compliant with the study drug|0|||
126307515|NCT00256854|454414471|FG003|Overall Study|Not compliant with the study drug|0|||
126307516|NCT00256854|454414472|FG004|Overall Study|Not compliant with the study drug|1|||
126307517|NCT00256854|454414473|FG005|Overall Study|Not compliant with the study drug|0|||
126307518|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
126307519|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
126307520|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
126716147|NCT04705597|455913076|FG000|Overall Study|Death|16|||
126307521|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
126307522|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
126716148|NCT04705597|455913077|FG001|Overall Study|Death|9|||
126370725|NCT04569084|454653748|FG000|Overall Study|Protocol Violation|2|||
126370726|NCT04569084|454653749|FG001|Overall Study|Protocol Violation|1|||
126716149|NCT04705597|455913076|FG000|Overall Study|Lost to Follow-up|1|||
126716150|NCT04705597|455913077|FG001|Overall Study|Lost to Follow-up|0|||
126716151|NCT04705597|455913076|FG000|Overall Study|Withdrawal by Subject|1|||
126716152|NCT04705597|455913077|FG001|Overall Study|Withdrawal by Subject|2|||
126716153|NCT00273858|455913089|FG000|Overall Study|Not completed 24 month observation time|334|||
126307523|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
126307524|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
126307525|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
126307526|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
126307527|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
126307528|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Death|1|||
126307529|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Death|0|||
126307530|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
126307531|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
126307532|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
126307533|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
126307534|NCT01876784|454414474|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
126307535|NCT01876784|454414475|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
126307536|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
126307537|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
126307538|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Adverse Event|2|||
126307539|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Adverse Event|6|||
126307540|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
126307541|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
126307542|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Progressive disease|4|||
126307543|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Progressive disease|35|||
126307544|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
126307545|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
126307546|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
126307547|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
126307548|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Death|0|||
126307549|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Death|1|||
126307550|NCT01876784|454414474|FG000|Open-label Period (31 Months)|Other than specified above|9|||
126307551|NCT01876784|454414475|FG001|Open-label Period (31 Months)|Other than specified above|18|||
126307552|NCT03605862|454414476|FG000|Overall Study|Withdrawal by Subject|12|||
126307553|NCT03605862|454414477|FG001|Overall Study|Withdrawal by Subject|9|||
126307554|NCT03605862|454414476|FG000|Overall Study|Adverse Event|2|||
126307555|NCT03605862|454414477|FG001|Overall Study|Adverse Event|1|||
126307556|NCT03605862|454414476|FG000|Overall Study|Physician Decision|3|||
126307557|NCT03605862|454414477|FG001|Overall Study|Physician Decision|1|||
126307558|NCT03605862|454414476|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
126307559|NCT03605862|454414477|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
126307560|NCT00937040|454414478|FG000|Overall Study|Adverse Event|5|||
126307561|NCT00937040|454414479|FG001|Overall Study|Adverse Event|8|||
126307562|NCT00937040|454414478|FG000|Overall Study|Lost to Follow-up|12|||
126716154|NCT00273858|455913089|FG000|Overall Study|Lost to Follow-up|101|||
126716155|NCT00273858|455913089|FG000|Overall Study|Withdrawal by Subject|21|||
126716156|NCT00273858|455913089|FG000|Overall Study|Adverse Event|81|||
126716157|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
126716158|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
126716159|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
126716160|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
126307563|NCT00937040|454414479|FG001|Overall Study|Lost to Follow-up|12|||
126370727|NCT04569084|454653748|FG000|Overall Study|Withdrawal by Subject|20|||
126370728|NCT04569084|454653749|FG001|Overall Study|Withdrawal by Subject|21|||
126370729|NCT04569084|454653748|FG000|Overall Study|Study terminated by sponsor|26|||
126370730|NCT04569084|454653749|FG001|Overall Study|Study terminated by sponsor|23|||
126370731|NCT04569084|454653748|FG000|Overall Study|Other|3|||
126370732|NCT04569084|454653749|FG001|Overall Study|Other|5|||
126370733|NCT01994876|454653750|FG000|Test Period 1|Withdrawal by Subject|0|||
126370734|NCT01994876|454653751|FG001|Test Period 1|Withdrawal by Subject|1|||
126464335|NCT00721123|455001968|FG000|Overall Study|Refused Treatment|41|||
126307564|NCT00937040|454414478|FG000|Overall Study|Protocol Violation|3|||
126307565|NCT00937040|454414479|FG001|Overall Study|Protocol Violation|0|||
126370735|NCT01994876|454653750|FG000|Test Period 1|Adverse Event|0|||
126716161|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
126716162|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
126370736|NCT01994876|454653751|FG001|Test Period 1|Adverse Event|1|||
126370737|NCT01994876|454653750|FG000|Test Period 2|Adverse Event|1|||
126370738|NCT01994876|454653751|FG001|Test Period 2|Adverse Event|0|||
126370739|NCT01994876|454653750|FG000|Test Period 2|Protocol Violation|0|||
126370740|NCT01994876|454653751|FG001|Test Period 2|Protocol Violation|1|||
126370741|NCT01346176|454653752|FG000|Recruited|Protocol Violation|1|||
126370742|NCT01346176|454653753|FG001|Recruited|Protocol Violation|0|||
126370743|NCT01346176|454653754|FG002|Recruited|Protocol Violation|0|||
126370744|NCT01346176|454653752|FG000|Completed Advance Directive|Death|3|||
126370745|NCT01346176|454653753|FG001|Completed Advance Directive|Death|2|||
126370746|NCT01346176|454653754|FG002|Completed Advance Directive|Death|2|||
126370747|NCT01346176|454653752|FG000|Completed Advance Directive|Became Ineligible|3|||
126370748|NCT01346176|454653753|FG001|Completed Advance Directive|Became Ineligible|0|||
126370749|NCT01346176|454653754|FG002|Completed Advance Directive|Became Ineligible|1|||
126370750|NCT01346176|454653752|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
126370751|NCT01346176|454653753|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
126370752|NCT01346176|454653754|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
126370753|NCT01346176|454653752|FG000|Completed Satisfaction Survey|Death|3|||
126370754|NCT01346176|454653753|FG001|Completed Satisfaction Survey|Death|0|||
126370755|NCT01346176|454653754|FG002|Completed Satisfaction Survey|Death|2|||
126370756|NCT01346176|454653752|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
126370757|NCT01346176|454653753|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
126770829|NCT01966107|456114739|FG000|Overall Study|excluded from FAS|21|||
126770830|NCT01966107|456114740|FG001|Overall Study|excluded from FAS|20|||
126770831|NCT01966107|456114739|FG000|Overall Study|discontinued treatment|345|||
126770832|NCT01966107|456114740|FG001|Overall Study|discontinued treatment|372|||
126770833|NCT01966107|456114739|FG000|Overall Study|due to study closure|164|||
126770834|NCT01966107|456114740|FG001|Overall Study|due to study closure|186|||
126770835|NCT01966107|456114739|FG000|Overall Study|withdrew from the study|272|||
126770836|NCT01966107|456114740|FG001|Overall Study|withdrew from the study|303|||
126770837|NCT00532779|456114741|FG000|Overall Study|Adverse Event|122|||
126770838|NCT00532779|456114742|FG001|Overall Study|Adverse Event|112|||
126770839|NCT00532779|456114743|FG002|Overall Study|Adverse Event|56|||
126770840|NCT00532779|456114741|FG000|Overall Study|Lost to Follow-up|76|||
126370758|NCT01346176|454653754|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
126370759|NCT01400412|454653755|FG000|Overall Study|Lost to Follow-up|4|||
126370760|NCT01400412|454653756|FG001|Overall Study|Lost to Follow-up|7|||
126370761|NCT01400412|454653755|FG000|Overall Study|Withdrawal by Subject|3|||
126370762|NCT01400412|454653756|FG001|Overall Study|Withdrawal by Subject|4|||
126370763|NCT01400412|454653755|FG000|Overall Study|Unable to complete|3|||
126370764|NCT01400412|454653756|FG001|Overall Study|Unable to complete|3|||
126370765|NCT01400412|454653755|FG000|Overall Study|Never started study treatment|0|||
126370766|NCT01400412|454653756|FG001|Overall Study|Never started study treatment|3|||
126370767|NCT04043286|454655211|FG000|Overall Study|Withdrawal by Subject|2|||
126370768|NCT04043286|454655212|FG001|Overall Study|Withdrawal by Subject|2|||
126370769|NCT01323192|454655213|FG000|Overall Study|Adverse Event|6|||
126370770|NCT01323192|454655214|FG001|Overall Study|Adverse Event|1|||
126370771|NCT01323192|454655213|FG000|Overall Study|Withdrawal by Subject|3|||
126370772|NCT01323192|454655214|FG001|Overall Study|Withdrawal by Subject|1|||
126370773|NCT01323192|454655213|FG000|Overall Study|Noncompliance with study medication|0|||
126770841|NCT00532779|456114742|FG001|Overall Study|Lost to Follow-up|65|||
126770842|NCT00532779|456114743|FG002|Overall Study|Lost to Follow-up|66|||
126770843|NCT00532779|456114741|FG000|Overall Study|Withdrawal by Subject|63|||
126770844|NCT00532779|456114742|FG001|Overall Study|Withdrawal by Subject|60|||
126770845|NCT00532779|456114743|FG002|Overall Study|Withdrawal by Subject|90|||
126370774|NCT01323192|454655214|FG001|Overall Study|Noncompliance with study medication|3|||
126370775|NCT01323192|454655213|FG000|Overall Study|Nonmedical reasons|0|||
126370776|NCT01323192|454655214|FG001|Overall Study|Nonmedical reasons|1|||
126370777|NCT02296476|454655215|FG000|Overall Study|Disease Progression|6|||
126370778|NCT02296476|454655216|FG001|Overall Study|Disease Progression|4|||
126770846|NCT00532779|456114741|FG000|Overall Study|Lack of Efficacy|12|||
126370779|NCT02296476|454655217|FG002|Overall Study|Disease Progression|2|||
126552181|NCT00849680|455316000|FG001|Overall Study|Subject unable to comply with protocol|0|||
126770847|NCT00532779|456114742|FG001|Overall Study|Lack of Efficacy|12|||
126770848|NCT00532779|456114743|FG002|Overall Study|Lack of Efficacy|40|||
126770849|NCT00532779|456114741|FG000|Overall Study|Protocol Violation|5|||
126770850|NCT00532779|456114742|FG001|Overall Study|Protocol Violation|9|||
126370780|NCT03122184|454655224|FG000|Overall Study|Lost to Follow-up|4|||
126370781|NCT03122184|454655225|FG001|Overall Study|Lost to Follow-up|6|||
126370782|NCT03122184|454655224|FG000|Overall Study|Withdrawal by Subject|3|||
126370783|NCT03122184|454655225|FG001|Overall Study|Withdrawal by Subject|0|||
126370784|NCT03122184|454655224|FG000|Overall Study|Terminated due to cognitive problem|1|||
126770851|NCT00532779|456114743|FG002|Overall Study|Protocol Violation|7|||
126770852|NCT00532779|456114741|FG000|Overall Study|Pregnancy|2|||
126770853|NCT00532779|456114742|FG001|Overall Study|Pregnancy|5|||
126370785|NCT03122184|454655225|FG001|Overall Study|Terminated due to cognitive problem|0|||
126770854|NCT00532779|456114743|FG002|Overall Study|Pregnancy|3|||
126464336|NCT00721123|455001968|FG000|Overall Study|Failure to Return|9|||
126464337|NCT00721123|455001968|FG000|Overall Study|Withdrawal by Subject|5|||
126464338|NCT04177355|455001972|FG000|Overall Study|Lost to Follow-up|0|||
126464339|NCT04177355|455001973|FG001|Overall Study|Lost to Follow-up|2|||
126464340|NCT04177355|455001974|FG002|Overall Study|Lost to Follow-up|0|||
126464341|NCT04177355|455001975|FG003|Overall Study|Lost to Follow-up|1|||
126464342|NCT04177355|455001976|FG004|Overall Study|Lost to Follow-up|2|||
126464343|NCT04177355|455001977|FG005|Overall Study|Lost to Follow-up|0|||
126464344|NCT04177355|455001978|FG006|Overall Study|Lost to Follow-up|1|||
126464345|NCT04177355|455001979|FG007|Overall Study|Lost to Follow-up|0|||
126464346|NCT04177355|455001980|FG008|Overall Study|Lost to Follow-up|0|||
126464347|NCT04177355|455001981|FG009|Overall Study|Lost to Follow-up|0|||
126464348|NCT04177355|455001982|FG010|Overall Study|Lost to Follow-up|0|||
126464349|NCT04177355|455001972|FG000|Overall Study|Withdrawal by Subject|0|||
126464350|NCT04177355|455001973|FG001|Overall Study|Withdrawal by Subject|0|||
126464351|NCT04177355|455001974|FG002|Overall Study|Withdrawal by Subject|0|||
126464352|NCT04177355|455001975|FG003|Overall Study|Withdrawal by Subject|1|||
126464353|NCT04177355|455001976|FG004|Overall Study|Withdrawal by Subject|1|||
126464354|NCT04177355|455001977|FG005|Overall Study|Withdrawal by Subject|0|||
126464355|NCT04177355|455001978|FG006|Overall Study|Withdrawal by Subject|0|||
126464356|NCT04177355|455001979|FG007|Overall Study|Withdrawal by Subject|0|||
126464357|NCT04177355|455001980|FG008|Overall Study|Withdrawal by Subject|1|||
126464358|NCT04177355|455001981|FG009|Overall Study|Withdrawal by Subject|0|||
126716163|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
126716164|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
126716165|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
126716166|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
126716167|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
126716168|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
126716169|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
126716170|NCT02232516|455913090|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
126716171|NCT02232516|455913090|FG000|Survival Follow-up|Death|15|||
126716172|NCT02232516|455913090|FG000|Survival Follow-up|Withdrawal by Subject|3|||
126716173|NCT02232516|455913090|FG000|Survival Follow-up|Lost to Follow-up|1|||
126716174|NCT02232516|455913090|FG000|Survival Follow-up|Still in follow-up|5|||
126307566|NCT00937040|454414478|FG000|Overall Study|Withdrawal by Subject|13|||
126307567|NCT00937040|454414479|FG001|Overall Study|Withdrawal by Subject|7|||
126307568|NCT00937040|454414478|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
126307569|NCT00937040|454414479|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
126307570|NCT00937040|454414478|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
126307571|NCT00937040|454414479|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
126307572|NCT00492648|454414480|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
126307573|NCT00492648|454414481|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
126307574|NCT02294396|454414484|FG000|Overall Study|Adverse Event|26|||
126307575|NCT02294396|454414485|FG001|Overall Study|Adverse Event|25|||
126307576|NCT02294396|454414486|FG002|Overall Study|Adverse Event|21|||
126307577|NCT02294396|454414487|FG003|Overall Study|Adverse Event|24|||
126307578|NCT02294396|454414484|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
126307579|NCT02294396|454414485|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
126307580|NCT02294396|454414486|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
126307581|NCT02294396|454414487|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
126307582|NCT02294396|454414484|FG000|Overall Study|Withdrawal by Subject|8|||
126307583|NCT02294396|454414485|FG001|Overall Study|Withdrawal by Subject|6|||
126307584|NCT02294396|454414486|FG002|Overall Study|Withdrawal by Subject|6|||
126307585|NCT02294396|454414487|FG003|Overall Study|Withdrawal by Subject|8|||
126307586|NCT02294396|454414484|FG000|Overall Study|Lost to Follow-up|0|||
126307587|NCT02294396|454414485|FG001|Overall Study|Lost to Follow-up|0|||
126307588|NCT02294396|454414486|FG002|Overall Study|Lost to Follow-up|1|||
126307589|NCT02294396|454414487|FG003|Overall Study|Lost to Follow-up|1|||
126307590|NCT02294396|454414484|FG000|Overall Study|Protocol Deviation|3|||
126307591|NCT02294396|454414485|FG001|Overall Study|Protocol Deviation|2|||
126307592|NCT02294396|454414486|FG002|Overall Study|Protocol Deviation|2|||
126464359|NCT04177355|455001982|FG010|Overall Study|Withdrawal by Subject|0|||
126464360|NCT00397943|455001983|FG000|Overall Study|Unspecified reasons|12|||
126464361|NCT00397943|455001984|FG001|Overall Study|Unspecified reasons|9|||
126464362|NCT00397943|455001985|FG002|Overall Study|Unspecified reasons|0|||
126716175|NCT01070550|455913091|FG000|Overall Study|Adverse Event|43|||
126307593|NCT02294396|454414487|FG003|Overall Study|Protocol Deviation|1|||
126307594|NCT02294396|454414484|FG000|Overall Study|Miscellaneous|2|||
126464363|NCT00397943|455001986|FG003|Overall Study|Unspecified reasons|0|||
126307595|NCT02294396|454414485|FG001|Overall Study|Miscellaneous|0|||
126307596|NCT02294396|454414486|FG002|Overall Study|Miscellaneous|5|||
126307597|NCT02294396|454414487|FG003|Overall Study|Miscellaneous|2|||
126464364|NCT00397943|455001987|FG004|Overall Study|Unspecified reasons|0|||
126464365|NCT00433511|455001990|FG000|Step 1|Adverse Event|50|||
126716176|NCT01070550|455913092|FG001|Overall Study|Adverse Event|1|||
126370786|NCT02835690|454655226|FG000|Overall Study|Death|12|||
126370787|NCT02835690|454655227|FG001|Overall Study|Death|11|||
126370788|NCT02835690|454655228|FG002|Overall Study|Death|13|||
126370789|NCT02835690|454655226|FG000|Overall Study|Transferred to Extension Study|2|||
126370790|NCT02835690|454655227|FG001|Overall Study|Transferred to Extension Study|2|||
126370791|NCT02835690|454655228|FG002|Overall Study|Transferred to Extension Study|1|||
126370792|NCT02835690|454655226|FG000|Overall Study|Did Not Continue on Extension Study|0|||
126370793|NCT02835690|454655227|FG001|Overall Study|Did Not Continue on Extension Study|0|||
126370794|NCT02835690|454655228|FG002|Overall Study|Did Not Continue on Extension Study|1|||
126370795|NCT02835690|454655226|FG000|Overall Study|Not Treated|0|||
126370796|NCT02835690|454655227|FG001|Overall Study|Not Treated|2|||
126716177|NCT01070550|455913093|FG002|Overall Study|Adverse Event|3|||
126307598|NCT02120833|454414488|FG000|Overall Study|Adverse Event|1|||
126307599|NCT02120833|454414489|FG001|Overall Study|Adverse Event|0|||
126307600|NCT02120833|454414488|FG000|Overall Study|Withdrawal by Subject|2|||
126307601|NCT02120833|454414489|FG001|Overall Study|Withdrawal by Subject|0|||
126307602|NCT02120833|454414488|FG000|Overall Study|Lost to Follow-up|1|||
126307603|NCT02120833|454414489|FG001|Overall Study|Lost to Follow-up|1|||
126307604|NCT03502070|454414490|FG000|Overall Study|Withdrawal by Subject|1|||
126307605|NCT03502070|454414490|FG000|Overall Study|Screen Failure|1|||
126307606|NCT01435460|454414500|FG000|Overall Study|Adverse Event|2|||
126307607|NCT01435460|454414501|FG001|Overall Study|Adverse Event|1|||
126307608|NCT01435460|454414500|FG000|Overall Study|Lost to Follow-up|6|||
126307609|NCT01435460|454414501|FG001|Overall Study|Lost to Follow-up|1|||
126307610|NCT01435460|454414500|FG000|Overall Study|Withdrawal by Subject|1|||
126307611|NCT01435460|454414501|FG001|Overall Study|Withdrawal by Subject|3|||
126307612|NCT01435460|454414500|FG000|Overall Study|Protocol Violation|0|||
126307613|NCT01435460|454414501|FG001|Overall Study|Protocol Violation|1|||
126307614|NCT01435460|454414500|FG000|Overall Study|Did not meet eligibility criteria|2|||
126307615|NCT01435460|454414501|FG001|Overall Study|Did not meet eligibility criteria|0|||
126307616|NCT01046903|454414502|FG000|Overall Study|Lost to Follow-up|16|||
126307617|NCT01046903|454414502|FG000|Overall Study|Adverse Event|4|||
126307618|NCT01046903|454414502|FG000|Overall Study|Withdrawal by Subject|3|||
126307619|NCT01046903|454414502|FG000|Overall Study|Other|5|||
126307620|NCT01894100|454414505|FG000|Overall Study|Lost to Follow-up|0|||
126307621|NCT01894100|454414506|FG001|Overall Study|Lost to Follow-up|1|||
126307622|NCT01894100|454414505|FG000|Overall Study|Withdrawal by Subject|3|||
126307623|NCT01894100|454414506|FG001|Overall Study|Withdrawal by Subject|0|||
126307624|NCT02235077|454414507|FG000|Overall Study|Death|5|||
126307625|NCT02235077|454414508|FG001|Overall Study|Death|7|||
126307626|NCT02235077|454414507|FG000|Overall Study|Lost to Follow-up|5|||
126307627|NCT02235077|454414508|FG001|Overall Study|Lost to Follow-up|6|||
126307628|NCT02235077|454414507|FG000|Overall Study|Withdrawal by Subject|8|||
126307629|NCT02235077|454414508|FG001|Overall Study|Withdrawal by Subject|5|||
126307630|NCT02235077|454414507|FG000|Overall Study|Physician Decision|0|||
126370797|NCT02835690|454655228|FG002|Overall Study|Not Treated|0|||
126370798|NCT03674281|454655229|FG000|Overall Study|screen failure|2|||
126370799|NCT03674281|454655230|FG001|Overall Study|screen failure|0|||
126370800|NCT03674281|454655231|FG002|Overall Study|screen failure|0|||
126370801|NCT03674281|454655229|FG000|Overall Study|Withdrawal by Subject|1|||
126370802|NCT03674281|454655230|FG001|Overall Study|Withdrawal by Subject|3|||
126370803|NCT03674281|454655231|FG002|Overall Study|Withdrawal by Subject|3|||
126370804|NCT00710593|454655232|FG000|Overall Study|Incarceration|1|||
126370805|NCT00710593|454655233|FG001|Overall Study|Incarceration|0|||
126370806|NCT00710593|454655232|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
126370807|NCT00710593|454655233|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
126370808|NCT00710593|454655232|FG000|Overall Study|Lost to Follow-up|3|||
126370809|NCT00710593|454655233|FG001|Overall Study|Lost to Follow-up|1|||
126370810|NCT00710593|454655232|FG000|Overall Study|Moved out of area|1|||
126370811|NCT00710593|454655233|FG001|Overall Study|Moved out of area|0|||
126370812|NCT00710593|454655232|FG000|Overall Study|Failure to adhere or complete study eval|1|||
126370813|NCT00710593|454655233|FG001|Overall Study|Failure to adhere or complete study eval|1|||
126370814|NCT00710593|454655232|FG000|Overall Study|Protocol Violation|1|||
126370815|NCT00710593|454655233|FG001|Overall Study|Protocol Violation|1|||
126370816|NCT00710593|454655232|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
126370817|NCT00710593|454655233|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
126370818|NCT04490278|454655234|FG000|Overall Study|Lost to Follow-up|6|||
126370819|NCT02829996|454655237|FG000|Overall Study|Withdrawal by Subject|1|||
126370820|NCT02829996|454655238|FG001|Overall Study|Withdrawal by Subject|0|||
126370821|NCT02829996|454655239|FG002|Overall Study|Withdrawal by Subject|0|||
126370822|NCT02829996|454655240|FG003|Overall Study|Withdrawal by Subject|0|||
126370823|NCT02829996|454655241|FG004|Overall Study|Withdrawal by Subject|0|||
126464366|NCT00433511|455001991|FG001|Step 1|Adverse Event|157|||
126307631|NCT02235077|454414508|FG001|Overall Study|Physician Decision|1|||
126307632|NCT04013672|454414510|FG000|Overall Study|Withdrawal by Subject|3|||
126307633|NCT04013672|454414511|FG001|Overall Study|Withdrawal by Subject|0|||
126307634|NCT04013672|454414510|FG000|Overall Study|Death|1|||
126307635|NCT04013672|454414511|FG001|Overall Study|Death|0|||
126552182|NCT00849680|455316001|FG002|Overall Study|Subject unable to comply with protocol|0|||
126552183|NCT00849680|455316002|FG003|Overall Study|Subject unable to comply with protocol|0|||
126552184|NCT00849680|455316003|FG004|Overall Study|Subject unable to comply with protocol|0|||
126552185|NCT00849680|455316004|FG005|Overall Study|Subject unable to comply with protocol|0|||
126552186|NCT00849680|455316005|FG006|Overall Study|Subject unable to comply with protocol|0|||
126552187|NCT00849680|455316006|FG007|Overall Study|Subject unable to comply with protocol|0|||
126552188|NCT02942004|455316007|FG000|Overall Study|Withdrawal by Subject|0|||
126552189|NCT02942004|455316008|FG001|Overall Study|Withdrawal by Subject|2|||
126552190|NCT02942004|455316009|FG002|Overall Study|Withdrawal by Subject|3|||
126552191|NCT02942004|455316007|FG000|Overall Study|Lost to Follow-up|1|||
126552192|NCT02942004|455316008|FG001|Overall Study|Lost to Follow-up|1|||
126552193|NCT02942004|455316009|FG002|Overall Study|Lost to Follow-up|2|||
126552194|NCT02942004|455316007|FG000|Overall Study|Randomized but not dosed|3|||
126552195|NCT02942004|455316008|FG001|Overall Study|Randomized but not dosed|9|||
126552196|NCT02942004|455316009|FG002|Overall Study|Randomized but not dosed|4|||
126552197|NCT03382600|455316010|FG000|Overall Study|Adverse Event|3|||
126552198|NCT03382600|455316011|FG001|Overall Study|Adverse Event|3|||
126552199|NCT03382600|455316010|FG000|Overall Study|Clinical Disease Progression|2|||
126307636|NCT04013672|454414510|FG000|Overall Study|Physician Decision|5|||
126370824|NCT01441960|454655242|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
126370825|NCT01441960|454655243|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
126370826|NCT01441960|454655242|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
126370827|NCT01441960|454655243|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
126370828|NCT01441960|454655242|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
126370829|NCT01441960|454655243|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
126370830|NCT02986074|454655245|FG000|First Trial Period|Adverse Event|1|||
126370831|NCT02986074|454655246|FG001|First Trial Period|Adverse Event|0|||
126370832|NCT02986074|454655247|FG002|First Trial Period|Adverse Event|0|||
126370833|NCT02986074|454655248|FG003|First Trial Period|Adverse Event|0|||
126370834|NCT02986074|454655245|FG000|Follow up Period|system explant|0|||
126370835|NCT02986074|454655246|FG001|Follow up Period|system explant|0|||
126370836|NCT02986074|454655247|FG002|Follow up Period|system explant|1|||
126370837|NCT02986074|454655248|FG003|Follow up Period|system explant|2|||
126370838|NCT02986074|454655245|FG000|Follow up Period|Physician Decision|0|||
126370839|NCT02986074|454655246|FG001|Follow up Period|Physician Decision|0|||
126370840|NCT02986074|454655247|FG002|Follow up Period|Physician Decision|0|||
126370841|NCT02986074|454655248|FG003|Follow up Period|Physician Decision|1|||
126370842|NCT00069641|454655253|FG000|Overall Study|Death|1|||
126370843|NCT00069641|454655254|FG001|Overall Study|Death|0|||
126370844|NCT00069641|454655255|FG002|Overall Study|Death|1|||
126370845|NCT03186638|454655256|FG000|Overall Study|Withdrawal by Subject|4|||
126370846|NCT03186638|454655257|FG001|Overall Study|Withdrawal by Subject|4|||
126370847|NCT03186638|454655256|FG000|Overall Study|Withdrawn due to medical problem|3|||
126370848|NCT03186638|454655257|FG001|Overall Study|Withdrawn due to medical problem|2|||
126370849|NCT03186638|454655256|FG000|Overall Study|Lost to Follow-up|1|||
126370850|NCT03186638|454655257|FG001|Overall Study|Lost to Follow-up|0|||
126370851|NCT01263119|454655258|FG000|Period 1|Protocol Violation|2|||
126552200|NCT03382600|455316011|FG001|Overall Study|Clinical Disease Progression|4|||
126552201|NCT03382600|455316010|FG000|Overall Study|Radiological Progression|40|||
126307637|NCT04013672|454414511|FG001|Overall Study|Physician Decision|0|||
126307638|NCT00101166|454414514|FG000|Overall Study|progressive disease|10|||
126307639|NCT01868022|454414515|FG000|Overall Study|Withdrawal by Subject|0|||
126307640|NCT01868022|454414516|FG001|Overall Study|Withdrawal by Subject|0|||
126307641|NCT01868022|454414517|FG002|Overall Study|Withdrawal by Subject|1|||
126307642|NCT01868022|454414518|FG003|Overall Study|Withdrawal by Subject|1|||
126307643|NCT01868022|454414519|FG004|Overall Study|Withdrawal by Subject|0|||
126307644|NCT01868022|454414520|FG005|Overall Study|Withdrawal by Subject|0|||
126307645|NCT01868022|454414521|FG006|Overall Study|Withdrawal by Subject|0|||
126307646|NCT01868022|454414522|FG007|Overall Study|Withdrawal by Subject|1|||
126307647|NCT01868022|454414523|FG008|Overall Study|Withdrawal by Subject|0|||
126307648|NCT01868022|454414515|FG000|Overall Study|Adverse Event|0|||
126307649|NCT01868022|454414516|FG001|Overall Study|Adverse Event|0|||
126307650|NCT01868022|454414517|FG002|Overall Study|Adverse Event|0|||
126307651|NCT01868022|454414518|FG003|Overall Study|Adverse Event|0|||
126307652|NCT01868022|454414519|FG004|Overall Study|Adverse Event|2|||
126370852|NCT01263119|454655258|FG000|Period 2|Adverse Event|2|||
126370853|NCT03983421|454655259|FG000|Overall Study|Lost to Follow-up|1|||
126370854|NCT04573972|454655260|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
126552202|NCT03382600|455316011|FG001|Overall Study|Radiological Progression|31|||
126552203|NCT03382600|455316010|FG000|Overall Study|Withdrawal by Subject|0|||
126552204|NCT03382600|455316011|FG001|Overall Study|Withdrawal by Subject|1|||
126307653|NCT01868022|454414520|FG005|Overall Study|Adverse Event|0|||
126370855|NCT04573972|454655261|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
126370856|NCT05067335|454655262|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
126770855|NCT00532779|456114741|FG000|Overall Study|Death|0|||
126770856|NCT00532779|456114742|FG001|Overall Study|Death|1|||
126770857|NCT00532779|456114743|FG002|Overall Study|Death|0|||
126770858|NCT00532779|456114741|FG000|Overall Study|Drug noncompliance, moved, other|14|||
126770859|NCT00532779|456114742|FG001|Overall Study|Drug noncompliance, moved, other|23|||
126770860|NCT00532779|456114743|FG002|Overall Study|Drug noncompliance, moved, other|29|||
126770861|NCT00689273|456114744|FG000|Overall Study|Adverse Event|3|||
126770862|NCT00689273|456114745|FG001|Overall Study|Adverse Event|1|||
126770863|NCT00689273|456114744|FG000|Overall Study|Lack of Efficacy|3|||
126770864|NCT00689273|456114745|FG001|Overall Study|Lack of Efficacy|0|||
126770865|NCT00689273|456114744|FG000|Overall Study|Lost to Follow-up|0|||
126770866|NCT00689273|456114745|FG001|Overall Study|Lost to Follow-up|2|||
126770867|NCT00689273|456114744|FG000|Overall Study|Other|6|||
126770868|NCT00689273|456114745|FG001|Overall Study|Other|2|||
126770869|NCT00689273|456114744|FG000|Overall Study|Randomized but not Treated|1|||
126770870|NCT00689273|456114745|FG001|Overall Study|Randomized but not Treated|0|||
126770871|NCT01556165|456114746|FG000|Overall Study|Adverse Event|5|||
126770872|NCT01556165|456114747|FG001|Overall Study|Adverse Event|3|||
126770873|NCT01556165|456114746|FG000|Overall Study|Protocol Violation|0|||
126770874|NCT01556165|456114747|FG001|Overall Study|Protocol Violation|3|||
126770875|NCT01556165|456114746|FG000|Overall Study|Withdrawal of Consent|7|||
126770876|NCT01556165|456114747|FG001|Overall Study|Withdrawal of Consent|1|||
126770877|NCT01238172|456114748|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
126770878|NCT01238172|456114749|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
126770879|NCT01238172|456114748|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
126770880|NCT01238172|456114749|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
126770881|NCT02531698|456114750|FG000|Overall Study|Adverse Event|2|||
126770882|NCT02531698|456114751|FG001|Overall Study|Adverse Event|1|||
126770883|NCT02531698|456114750|FG000|Overall Study|Withdrawal by Subject|6|||
126770884|NCT02531698|456114751|FG001|Overall Study|Withdrawal by Subject|1|||
126770885|NCT02531698|456114750|FG000|Overall Study|Protocol Violation|2|||
126770886|NCT02531698|456114751|FG001|Overall Study|Protocol Violation|0|||
126770887|NCT02531698|456114750|FG000|Overall Study|Lost to Follow-up|1|||
126770888|NCT02531698|456114751|FG001|Overall Study|Lost to Follow-up|0|||
126770889|NCT00701558|456114752|FG000|Overall Study|Death|7|||
126770890|NCT00701558|456114752|FG000|Overall Study|Lost to Follow-up|8|||
126770891|NCT02787746|456114753|FG000|Overall Study|Adverse Event|42|||
126770892|NCT02787746|456114753|FG000|Overall Study|Withdrawal by Subject|65|||
126770893|NCT02787746|456114753|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
126770894|NCT04822701|456114756|FG000|Overall Study|Not treated|2|||
126770895|NCT04822701|456114757|FG001|Overall Study|Not treated|0|||
126770896|NCT04822701|456114756|FG000|Overall Study|Lost to Follow-up|1|||
126770897|NCT04822701|456114757|FG001|Overall Study|Lost to Follow-up|0|||
126770898|NCT04822701|456114756|FG000|Overall Study|Withdrawal by Subject|1|||
126770899|NCT04822701|456114757|FG001|Overall Study|Withdrawal by Subject|0|||
126770900|NCT02428231|456116197|FG000|Overall Study|Other|10|||
126770901|NCT02428231|456116198|FG001|Overall Study|Other|16|||
126770902|NCT02428231|456116197|FG000|Overall Study|Required Symptomatic Therapy|0|||
126552205|NCT03382600|455316010|FG000|Overall Study|Other|9|||
126552206|NCT03382600|455316011|FG001|Overall Study|Other|7|||
126552207|NCT01448044|455316012|FG000|Treatment Period|Adverse Event|4|||
126552208|NCT01448044|455316013|FG001|Treatment Period|Adverse Event|3|||
126552209|NCT01448044|455316012|FG000|Treatment Period|Lack of Efficacy|5|||
126552210|NCT01448044|455316013|FG001|Treatment Period|Lack of Efficacy|12|||
126552211|NCT01448044|455316012|FG000|Treatment Period|Subject requested discontinue study drug|1|||
126552212|NCT01448044|455316013|FG001|Treatment Period|Subject requested discontinue study drug|0|||
126552213|NCT01448044|455316012|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
126552214|NCT01448044|455316013|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
126552215|NCT01448044|455316012|FG000|Treatment Period|Participant does not meet study criteria|1|||
126552216|NCT01448044|455316013|FG001|Treatment Period|Participant does not meet study criteria|0|||
126552217|NCT01448044|455316012|FG000|Treatment Period|Lost to Follow-up|2|||
126552218|NCT01448044|455316013|FG001|Treatment Period|Lost to Follow-up|1|||
126552219|NCT01448044|455316012|FG000|Treatment Period|Other reason|2|||
126552220|NCT01448044|455316013|FG001|Treatment Period|Other reason|0|||
126552221|NCT01448044|455316012|FG000|Follow Up Period|Withdrawal by Subject|1|||
126552222|NCT01448044|455316013|FG001|Follow Up Period|Withdrawal by Subject|1|||
126552223|NCT01448044|455316012|FG000|Follow Up Period|Lost to Follow-up|6|||
126770903|NCT02428231|456116198|FG001|Overall Study|Required Symptomatic Therapy|1|||
126770904|NCT02428231|456116197|FG000|Overall Study|Adverse Event|3|||
126770905|NCT02428231|456116198|FG001|Overall Study|Adverse Event|0|||
126770906|NCT01784419|456116201|FG000|Overall Study|Adverse Event|3|||
126770907|NCT02253654|456116202|FG000|Overall Study|Withdrawal by Subject|12|||
126770908|NCT02253654|456116203|FG001|Overall Study|Withdrawal by Subject|4|||
126770909|NCT02253654|456116202|FG000|Overall Study|Decision by Sponsor|1|||
126770910|NCT02253654|456116203|FG001|Overall Study|Decision by Sponsor|1|||
126770911|NCT02253654|456116202|FG000|Overall Study|Lost to Follow-up|2|||
126770912|NCT02253654|456116203|FG001|Overall Study|Lost to Follow-up|5|||
126307654|NCT01868022|454414521|FG006|Overall Study|Adverse Event|0|||
126307655|NCT01868022|454414522|FG007|Overall Study|Adverse Event|2|||
126307656|NCT01868022|454414523|FG008|Overall Study|Adverse Event|2|||
126307657|NCT01868022|454414515|FG000|Overall Study|Physician Decision|0|||
126307658|NCT01868022|454414516|FG001|Overall Study|Physician Decision|0|||
126307659|NCT01868022|454414517|FG002|Overall Study|Physician Decision|0|||
126307660|NCT01868022|454414518|FG003|Overall Study|Physician Decision|0|||
126307661|NCT01868022|454414519|FG004|Overall Study|Physician Decision|0|||
126307662|NCT01868022|454414520|FG005|Overall Study|Physician Decision|1|||
126307663|NCT01868022|454414521|FG006|Overall Study|Physician Decision|0|||
126307664|NCT01868022|454414522|FG007|Overall Study|Physician Decision|2|||
126307665|NCT01868022|454414523|FG008|Overall Study|Physician Decision|0|||
126307666|NCT01868022|454414515|FG000|Overall Study|Study closed/terminated|0|||
126307667|NCT01868022|454414516|FG001|Overall Study|Study closed/terminated|0|||
126307668|NCT01868022|454414517|FG002|Overall Study|Study closed/terminated|0|||
126307669|NCT01868022|454414518|FG003|Overall Study|Study closed/terminated|0|||
126307670|NCT01868022|454414519|FG004|Overall Study|Study closed/terminated|0|||
126307671|NCT01868022|454414520|FG005|Overall Study|Study closed/terminated|0|||
126307672|NCT01868022|454414521|FG006|Overall Study|Study closed/terminated|0|||
126307673|NCT01868022|454414522|FG007|Overall Study|Study closed/terminated|1|||
126307674|NCT01868022|454414523|FG008|Overall Study|Study closed/terminated|0|||
126307675|NCT01868022|454414515|FG000|Overall Study|Ongoing|0|||
126307676|NCT01868022|454414516|FG001|Overall Study|Ongoing|0|||
126307677|NCT01868022|454414517|FG002|Overall Study|Ongoing|0|||
126307678|NCT01868022|454414518|FG003|Overall Study|Ongoing|0|||
126307679|NCT01868022|454414519|FG004|Overall Study|Ongoing|0|||
126307680|NCT01868022|454414520|FG005|Overall Study|Ongoing|0|||
126307681|NCT01868022|454414521|FG006|Overall Study|Ongoing|0|||
126307682|NCT01868022|454414522|FG007|Overall Study|Ongoing|3|||
126307683|NCT01868022|454414523|FG008|Overall Study|Ongoing|0|||
126307684|NCT01672710|454414524|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
126307685|NCT01672710|454414525|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
126307686|NCT01672710|454414524|FG000|3 Month Follow up|Lost to Follow-up|2|||
126307687|NCT01672710|454414525|FG001|3 Month Follow up|Lost to Follow-up|3|||
126307688|NCT01672710|454414524|FG000|3 Month Follow up|follow up due after termination date|4|||
126307689|NCT01672710|454414525|FG001|3 Month Follow up|follow up due after termination date|1|||
126307690|NCT02122887|454414526|FG000|Overall Study|Withdrawal by Subject|20|||
126716178|NCT01070550|455913094|FG003|Overall Study|Adverse Event|0|||
126716179|NCT01070550|455913095|FG004|Overall Study|Adverse Event|0|||
126716180|NCT01070550|455913096|FG005|Overall Study|Adverse Event|0|||
126716181|NCT01070550|455913091|FG000|Overall Study|Death|20|||
126716182|NCT01070550|455913092|FG001|Overall Study|Death|4|||
126716183|NCT01070550|455913093|FG002|Overall Study|Death|3|||
126716184|NCT01070550|455913094|FG003|Overall Study|Death|0|||
126716185|NCT01070550|455913095|FG004|Overall Study|Death|0|||
126716186|NCT01070550|455913096|FG005|Overall Study|Death|0|||
126716187|NCT01070550|455913091|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
126716188|NCT01070550|455913092|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
126716189|NCT01070550|455913093|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
126716190|NCT01070550|455913094|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
126716191|NCT01070550|455913095|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
126716192|NCT01070550|455913096|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
126716193|NCT01070550|455913091|FG000|Overall Study|Early termination|3|||
126716194|NCT01070550|455913092|FG001|Overall Study|Early termination|0|||
126307691|NCT02122887|454414527|FG001|Overall Study|Withdrawal by Subject|2|||
126307692|NCT04999163|454414532|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
126307693|NCT04999163|454414533|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
126307694|NCT04999163|454414532|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
126307695|NCT04999163|454414533|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
126307696|NCT04999163|454414532|FG000|Overall Study|Withdrawal by Subject|1|||
126307697|NCT04999163|454414533|FG001|Overall Study|Withdrawal by Subject|0|||
126464367|NCT00433511|455001992|FG002|Step 1|Adverse Event|153|||
126464368|NCT00433511|455001990|FG000|Step 1|Withdrawal by Subject|45|||
126464369|NCT00433511|455001991|FG001|Step 1|Withdrawal by Subject|143|||
126464370|NCT00433511|455001992|FG002|Step 1|Withdrawal by Subject|154|||
126464371|NCT00433511|455001990|FG000|Step 1|Death|3|||
126464372|NCT00433511|455001991|FG001|Step 1|Death|1|||
126464373|NCT00433511|455001992|FG002|Step 1|Death|1|||
126464374|NCT00433511|455001990|FG000|Step 1|Physician Decision|1|||
126464375|NCT00433511|455001991|FG001|Step 1|Physician Decision|4|||
126464376|NCT00433511|455001992|FG002|Step 1|Physician Decision|3|||
126464377|NCT00433511|455001990|FG000|Step 1|Never started protocol therapy|28|||
126464378|NCT00433511|455001991|FG001|Step 1|Never started protocol therapy|64|||
126464379|NCT00433511|455001992|FG002|Step 1|Never started protocol therapy|66|||
126464380|NCT00433511|455001990|FG000|Step 1|Alternative therapy|2|||
126464381|NCT00433511|455001991|FG001|Step 1|Alternative therapy|1|||
126464382|NCT00433511|455001992|FG002|Step 1|Alternative therapy|3|||
126464383|NCT00433511|455001990|FG000|Step 1|Disease progression, relapse|5|||
126464384|NCT00433511|455001991|FG001|Step 1|Disease progression, relapse|3|||
126464385|NCT00433511|455001992|FG002|Step 1|Disease progression, relapse|3|||
126464386|NCT00433511|455001990|FG000|Step 1|Other complicating disease|2|||
126464387|NCT00433511|455001991|FG001|Step 1|Other complicating disease|6|||
126464388|NCT00433511|455001992|FG002|Step 1|Other complicating disease|3|||
126716195|NCT01070550|455913093|FG002|Overall Study|Early termination|0|||
126716196|NCT01070550|455913094|FG003|Overall Study|Early termination|0|||
126716197|NCT01070550|455913095|FG004|Overall Study|Early termination|0|||
126716198|NCT01070550|455913096|FG005|Overall Study|Early termination|0|||
126716199|NCT01070550|455913091|FG000|Overall Study|Failed to return|450|||
126716200|NCT01070550|455913092|FG001|Overall Study|Failed to return|33|||
126716201|NCT01070550|455913093|FG002|Overall Study|Failed to return|144|||
126716202|NCT01070550|455913094|FG003|Overall Study|Failed to return|40|||
126716203|NCT01070550|455913095|FG004|Overall Study|Failed to return|1|||
126716204|NCT01070550|455913096|FG005|Overall Study|Failed to return|2|||
126716205|NCT01070550|455913091|FG000|Overall Study|Incomplete treatment|2|||
126716206|NCT01070550|455913092|FG001|Overall Study|Incomplete treatment|0|||
126716207|NCT01070550|455913093|FG002|Overall Study|Incomplete treatment|0|||
126716208|NCT01070550|455913094|FG003|Overall Study|Incomplete treatment|0|||
126716209|NCT01070550|455913095|FG004|Overall Study|Incomplete treatment|0|||
126716210|NCT01070550|455913096|FG005|Overall Study|Incomplete treatment|0|||
126716211|NCT01070550|455913091|FG000|Overall Study|Lab test not done|22|||
126716212|NCT01070550|455913092|FG001|Overall Study|Lab test not done|3|||
126716213|NCT01070550|455913093|FG002|Overall Study|Lab test not done|4|||
126716214|NCT01070550|455913094|FG003|Overall Study|Lab test not done|1|||
126716215|NCT01070550|455913095|FG004|Overall Study|Lab test not done|0|||
126716216|NCT01070550|455913096|FG005|Overall Study|Lab test not done|1|||
126716217|NCT01070550|455913091|FG000|Overall Study|Lack of Efficacy|65|||
126716218|NCT01070550|455913092|FG001|Overall Study|Lack of Efficacy|1|||
126716219|NCT01070550|455913093|FG002|Overall Study|Lack of Efficacy|5|||
126716220|NCT01070550|455913094|FG003|Overall Study|Lack of Efficacy|5|||
126716221|NCT01070550|455913095|FG004|Overall Study|Lack of Efficacy|0|||
126716222|NCT01070550|455913096|FG005|Overall Study|Lack of Efficacy|1|||
126716223|NCT01070550|455913091|FG000|Overall Study|Miscellaneous|12|||
126716224|NCT01070550|455913092|FG001|Overall Study|Miscellaneous|2|||
126716225|NCT01070550|455913093|FG002|Overall Study|Miscellaneous|3|||
126716226|NCT01070550|455913094|FG003|Overall Study|Miscellaneous|1|||
126716227|NCT01070550|455913095|FG004|Overall Study|Miscellaneous|0|||
126716228|NCT01070550|455913096|FG005|Overall Study|Miscellaneous|0|||
126716229|NCT01070550|455913091|FG000|Overall Study|New treatment started|3|||
126716230|NCT01070550|455913092|FG001|Overall Study|New treatment started|1|||
126716231|NCT01070550|455913093|FG002|Overall Study|New treatment started|0|||
126716232|NCT01070550|455913094|FG003|Overall Study|New treatment started|2|||
126716233|NCT01070550|455913095|FG004|Overall Study|New treatment started|0|||
126716234|NCT01070550|455913096|FG005|Overall Study|New treatment started|0|||
126716235|NCT01070550|455913091|FG000|Overall Study|Non-responders|493|||
126716236|NCT01070550|455913092|FG001|Overall Study|Non-responders|4|||
126716237|NCT01070550|455913093|FG002|Overall Study|Non-responders|21|||
126716238|NCT01070550|455913094|FG003|Overall Study|Non-responders|20|||
126716239|NCT01070550|455913095|FG004|Overall Study|Non-responders|0|||
126716240|NCT01070550|455913096|FG005|Overall Study|Non-responders|2|||
126716241|NCT01070550|455913091|FG000|Overall Study|Not categorized|33|||
126716242|NCT01070550|455913092|FG001|Overall Study|Not categorized|2|||
126716243|NCT01070550|455913093|FG002|Overall Study|Not categorized|6|||
126716244|NCT01070550|455913094|FG003|Overall Study|Not categorized|1|||
126716245|NCT01070550|455913095|FG004|Overall Study|Not categorized|0|||
126716246|NCT01070550|455913096|FG005|Overall Study|Not categorized|1|||
126716247|NCT01070550|455913091|FG000|Overall Study|Protocol Violation|15|||
126716248|NCT01070550|455913092|FG001|Overall Study|Protocol Violation|1|||
126716249|NCT01070550|455913093|FG002|Overall Study|Protocol Violation|1|||
126716250|NCT01070550|455913094|FG003|Overall Study|Protocol Violation|1|||
126770913|NCT02253654|456116202|FG000|Overall Study|Death|4|||
126770914|NCT02253654|456116203|FG001|Overall Study|Death|7|||
126464389|NCT00433511|455001990|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
126716251|NCT01070550|455913095|FG004|Overall Study|Protocol Violation|0|||
126716252|NCT01070550|455913096|FG005|Overall Study|Protocol Violation|0|||
126716253|NCT01070550|455913091|FG000|Overall Study|Relapse|44|||
126716254|NCT01070550|455913092|FG001|Overall Study|Relapse|5|||
126716255|NCT01070550|455913093|FG002|Overall Study|Relapse|14|||
126716256|NCT01070550|455913094|FG003|Overall Study|Relapse|4|||
126770915|NCT02253654|456116202|FG000|Overall Study|Did Not Receive Study Treatment|4|||
126716257|NCT01070550|455913095|FG004|Overall Study|Relapse|0|||
126716258|NCT01070550|455913096|FG005|Overall Study|Relapse|0|||
126716259|NCT01070550|455913091|FG000|Overall Study|Result not available|3|||
126716260|NCT01070550|455913092|FG001|Overall Study|Result not available|1|||
126716261|NCT01070550|455913093|FG002|Overall Study|Result not available|3|||
126716262|NCT01070550|455913094|FG003|Overall Study|Result not available|0|||
126716263|NCT01070550|455913095|FG004|Overall Study|Result not available|0|||
126716264|NCT01070550|455913096|FG005|Overall Study|Result not available|0|||
126307698|NCT03652636|454416021|FG000|Overall Study|Withdrawal by Subject|7|||
126464390|NCT00433511|455001991|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
126716265|NCT01070550|455913091|FG000|Overall Study|Screen failure|1|||
126716266|NCT01070550|455913092|FG001|Overall Study|Screen failure|0|||
126716267|NCT01070550|455913093|FG002|Overall Study|Screen failure|0|||
126716268|NCT01070550|455913094|FG003|Overall Study|Screen failure|0|||
126716269|NCT01070550|455913095|FG004|Overall Study|Screen failure|0|||
126716270|NCT01070550|455913096|FG005|Overall Study|Screen failure|0|||
126716271|NCT01070550|455913091|FG000|Overall Study|Sponsor decision|1|||
126716272|NCT01070550|455913092|FG001|Overall Study|Sponsor decision|0|||
126716273|NCT01070550|455913093|FG002|Overall Study|Sponsor decision|0|||
126716274|NCT01070550|455913094|FG003|Overall Study|Sponsor decision|0|||
126716275|NCT01070550|455913095|FG004|Overall Study|Sponsor decision|0|||
126716276|NCT01070550|455913096|FG005|Overall Study|Sponsor decision|0|||
126716277|NCT01070550|455913091|FG000|Overall Study|Treatment duration shortened|1|||
126716278|NCT01070550|455913092|FG001|Overall Study|Treatment duration shortened|0|||
126716279|NCT01070550|455913093|FG002|Overall Study|Treatment duration shortened|0|||
126716280|NCT01070550|455913094|FG003|Overall Study|Treatment duration shortened|0|||
126716281|NCT01070550|455913095|FG004|Overall Study|Treatment duration shortened|0|||
126716282|NCT01070550|455913096|FG005|Overall Study|Treatment duration shortened|0|||
126716283|NCT01070550|455913091|FG000|Overall Study|Treatment interrupted|7|||
126307699|NCT01283334|454416023|FG000|Overall Study|Withdrawal by Subject|1|||
126307700|NCT01283334|454416023|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
126307701|NCT01283334|454416023|FG000|Overall Study|Adverse Event|4|||
126307702|NCT01283334|454416023|FG000|Overall Study|Physician Decision|1|||
126464391|NCT00433511|455001992|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
126464392|NCT00433511|455001990|FG000|Step 1|Suspected recurrence|0|||
126464393|NCT00433511|455001991|FG001|Step 1|Suspected recurrence|1|||
126716284|NCT01070550|455913092|FG001|Overall Study|Treatment interrupted|0|||
126307703|NCT03233529|454416025|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
126307704|NCT03233529|454416025|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
126307705|NCT01177293|454416026|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
126307706|NCT01177293|454416027|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
126307707|NCT01905553|454416031|FG000|Period 2|Adverse Event|1|||
126307708|NCT01905553|454416032|FG001|Period 2|Adverse Event|0|||
126307709|NCT00076752|454416038|FG000|Overall Study|Death|2|||
126307710|NCT00076752|454416038|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
126307711|NCT03854370|454416039|FG000|Overall Study|samples not collected|1|||
126307712|NCT03854370|454416040|FG001|Overall Study|samples not collected|1|||
126307713|NCT03854370|454416041|FG002|Overall Study|samples not collected|1|||
126307714|NCT03854370|454416042|FG003|Overall Study|samples not collected|1|||
126307715|NCT00452673|454416043|FG000|Dose Escalation Period|Disease Progression|6|||
126307716|NCT00452673|454416044|FG001|Dose Escalation Period|Disease Progression|6|||
126307717|NCT00452673|454416045|FG002|Dose Escalation Period|Disease Progression|2|||
126307718|NCT00452673|454416046|FG003|Dose Escalation Period|Disease Progression|6|||
126307719|NCT00452673|454416047|FG004|Dose Escalation Period|Disease Progression|0|||
126307720|NCT00452673|454416043|FG000|Dose Escalation Period|study drug toxicity|1|||
126307721|NCT00452673|454416044|FG001|Dose Escalation Period|study drug toxicity|3|||
126307722|NCT00452673|454416045|FG002|Dose Escalation Period|study drug toxicity|3|||
126307723|NCT00452673|454416046|FG003|Dose Escalation Period|study drug toxicity|1|||
126307724|NCT00452673|454416047|FG004|Dose Escalation Period|study drug toxicity|0|||
126307725|NCT00452673|454416043|FG000|Dose Escalation Period|Other|0|||
126307726|NCT00452673|454416044|FG001|Dose Escalation Period|Other|0|||
126307727|NCT00452673|454416045|FG002|Dose Escalation Period|Other|1|||
126307728|NCT00452673|454416046|FG003|Dose Escalation Period|Other|0|||
126307729|NCT00452673|454416047|FG004|Dose Escalation Period|Other|0|||
126307730|NCT00452673|454416043|FG000|Dose Escalation Period|Adverse Event|0|||
126307731|NCT00452673|454416044|FG001|Dose Escalation Period|Adverse Event|0|||
126307732|NCT00452673|454416045|FG002|Dose Escalation Period|Adverse Event|0|||
126307733|NCT00452673|454416046|FG003|Dose Escalation Period|Adverse Event|1|||
126307734|NCT00452673|454416047|FG004|Dose Escalation Period|Adverse Event|0|||
126307735|NCT00452673|454416043|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
126716285|NCT01070550|455913093|FG002|Overall Study|Treatment interrupted|1|||
126716286|NCT01070550|455913094|FG003|Overall Study|Treatment interrupted|1|||
126307736|NCT00452673|454416044|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
126307737|NCT00452673|454416045|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
126307738|NCT00452673|454416046|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
126307739|NCT00452673|454416047|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
126307740|NCT00452673|454416043|FG000|Dose Expansion Period|Disease Progression|0|||
126307741|NCT00452673|454416044|FG001|Dose Expansion Period|Disease Progression|0|||
126464394|NCT00433511|455001992|FG002|Step 1|Suspected recurrence|0|||
126464395|NCT00433511|455001990|FG000|Step 1|Insurance/drug distribution issues|0|||
126716287|NCT01070550|455913095|FG004|Overall Study|Treatment interrupted|0|||
126716288|NCT01070550|455913096|FG005|Overall Study|Treatment interrupted|0|||
126716289|NCT01070550|455913091|FG000|Overall Study|Treatment not started|14|||
126370857|NCT05067335|454655263|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
126370858|NCT05067335|454655264|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
126370859|NCT05067335|454655265|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
126370860|NCT05067335|454655262|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
126370861|NCT05067335|454655263|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
126370862|NCT05067335|454655264|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
126370863|NCT05067335|454655265|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
126370864|NCT05067335|454655262|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
126370865|NCT05067335|454655263|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
126370866|NCT05067335|454655264|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
126370867|NCT05067335|454655265|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
126370868|NCT05067335|454655262|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
126370869|NCT05067335|454655263|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
126370870|NCT05067335|454655264|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
126370871|NCT05067335|454655265|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
126370872|NCT05067335|454655262|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
126370873|NCT05067335|454655263|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
126370874|NCT05067335|454655264|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
126370875|NCT05067335|454655265|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
126370876|NCT05067335|454655262|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
126370877|NCT05067335|454655263|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
126370878|NCT05067335|454655264|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
126370879|NCT05067335|454655265|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
126370880|NCT05067335|454655262|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
126370881|NCT05067335|454655263|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
126370882|NCT05067335|454655264|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
126370883|NCT05067335|454655265|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
126370884|NCT05067335|454655262|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
126370885|NCT05067335|454655263|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
126370886|NCT05067335|454655264|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
126370887|NCT05067335|454655265|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
126370888|NCT05067335|454655262|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
126370889|NCT05067335|454655263|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
126370890|NCT05067335|454655264|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
126370891|NCT05067335|454655265|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
126370892|NCT05067335|454655262|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
126370893|NCT05067335|454655263|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
126370894|NCT05067335|454655264|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
126370895|NCT05067335|454655265|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
126370896|NCT00261833|454655266|FG000|Overall Study|Death|1|||
126370897|NCT00261833|454655267|FG001|Overall Study|Death|3|||
126370898|NCT00261833|454655266|FG000|Overall Study|Adverse Event|1|||
126370899|NCT00261833|454655267|FG001|Overall Study|Adverse Event|4|||
126370900|NCT00261833|454655266|FG000|Overall Study|Withdrawal by Subject|5|||
126370901|NCT00261833|454655267|FG001|Overall Study|Withdrawal by Subject|7|||
126370902|NCT00261833|454655266|FG000|Overall Study|Protocol Violation|0|||
126370903|NCT00261833|454655267|FG001|Overall Study|Protocol Violation|1|||
126370904|NCT00261833|454655266|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
126370905|NCT00261833|454655267|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
126370906|NCT00261833|454655266|FG000|Overall Study|Lung transplantation|1|||
126370907|NCT00261833|454655267|FG001|Overall Study|Lung transplantation|1|||
126370908|NCT00261833|454655266|FG000|Overall Study|Missing reason|1|||
126370909|NCT00261833|454655267|FG001|Overall Study|Missing reason|0|||
126370910|NCT00261833|454655266|FG000|Overall Study|Not interested in being participant|0|||
126370911|NCT00261833|454655267|FG001|Overall Study|Not interested in being participant|1|||
126370912|NCT00622726|454655268|FG000|March, 2008 to August, 2010|Death|5|||
126370913|NCT00622726|454655269|FG001|March, 2008 to August, 2010|Death|2|||
126464396|NCT00433511|455001991|FG001|Step 1|Insurance/drug distribution issues|1|||
126464397|NCT00433511|455001992|FG002|Step 1|Insurance/drug distribution issues|2|||
126464398|NCT00433511|455001990|FG000|Step 1|Patient moved|0|||
126464399|NCT00433511|455001991|FG001|Step 1|Patient moved|0|||
126464400|NCT00433511|455001992|FG002|Step 1|Patient moved|1|||
126464401|NCT00433511|455001990|FG000|Step 2 (Arm D)|Adverse Event|0|||
126464402|NCT00433511|455001991|FG001|Step 2 (Arm D)|Adverse Event|0|||
126464403|NCT00433511|455001992|FG002|Step 2 (Arm D)|Adverse Event|135|||
126464404|NCT00433511|455001990|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
126464405|NCT00433511|455001991|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
126464406|NCT00433511|455001992|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
126464407|NCT00433511|455001990|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
126464408|NCT00433511|455001991|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
126464409|NCT00433511|455001992|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
126464410|NCT00433511|455001990|FG000|Step 2 (Arm D)|Physician Decision|0|||
126464411|NCT00433511|455001991|FG001|Step 2 (Arm D)|Physician Decision|0|||
126464412|NCT00433511|455001992|FG002|Step 2 (Arm D)|Physician Decision|9|||
126464413|NCT00433511|455001990|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
126464414|NCT00433511|455001991|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
126464415|NCT00433511|455001992|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
126464416|NCT00433511|455001990|FG000|Step 2 (Arm D)|Other complicating disease|0|||
126464417|NCT00433511|455001991|FG001|Step 2 (Arm D)|Other complicating disease|0|||
126464418|NCT00433511|455001992|FG002|Step 2 (Arm D)|Other complicating disease|3|||
126464419|NCT00433511|455001990|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
126464420|NCT00433511|455001991|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
126464421|NCT00433511|455001992|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
126464422|NCT00433511|455001990|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
126464423|NCT00433511|455001991|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
126464424|NCT00433511|455001992|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
126464425|NCT00433511|455001990|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
126370914|NCT00622726|454655268|FG000|August, 2010 to April, 2013|Death|1|||
126370915|NCT00622726|454655269|FG001|August, 2010 to April, 2013|Death|5|||
126370916|NCT01948427|454655270|FG000|Overall Study|Serious Adverse Event|3|||
126370917|NCT01948427|454655271|FG001|Overall Study|Serious Adverse Event|0|||
126370918|NCT01948427|454655272|FG002|Overall Study|Serious Adverse Event|0|||
126370919|NCT01948427|454655273|FG003|Overall Study|Serious Adverse Event|0|||
126370920|NCT01948427|454655274|FG004|Overall Study|Serious Adverse Event|1|||
126370921|NCT01948427|454655270|FG000|Overall Study|Investigator Request|0|||
126370922|NCT01948427|454655271|FG001|Overall Study|Investigator Request|8|||
126370923|NCT01948427|454655272|FG002|Overall Study|Investigator Request|0|||
126370924|NCT01948427|454655273|FG003|Overall Study|Investigator Request|0|||
126370925|NCT01948427|454655274|FG004|Overall Study|Investigator Request|6|||
126370926|NCT01948427|454655270|FG000|Overall Study|Lost to Follow-up|1|||
126370927|NCT01948427|454655271|FG001|Overall Study|Lost to Follow-up|0|||
126370928|NCT01948427|454655272|FG002|Overall Study|Lost to Follow-up|0|||
126370929|NCT01948427|454655273|FG003|Overall Study|Lost to Follow-up|0|||
126464426|NCT00433511|455001991|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
126464427|NCT00433511|455001992|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
126464428|NCT00433511|455001990|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
126464429|NCT00433511|455001991|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
126464430|NCT00433511|455001992|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
126464431|NCT03139604|455001993|FG000|Overall Study|Other|7|||
126464432|NCT03139604|455001994|FG001|Overall Study|Other|3|||
126464433|NCT03139604|455001993|FG000|Overall Study|Withdrawal by Subject|16|||
126464434|NCT03139604|455001994|FG001|Overall Study|Withdrawal by Subject|17|||
126464435|NCT03139604|455001993|FG000|Overall Study|Physician Decision|1|||
126464436|NCT03139604|455001994|FG001|Overall Study|Physician Decision|2|||
126464437|NCT03139604|455001993|FG000|Overall Study|Lost to Follow-up|3|||
126464438|NCT03139604|455001994|FG001|Overall Study|Lost to Follow-up|1|||
126464439|NCT03139604|455001993|FG000|Overall Study|Death|65|||
126464440|NCT03139604|455001994|FG001|Overall Study|Death|67|||
126464441|NCT03139604|455001993|FG000|Overall Study|Study Terminated by Sponsor|122|||
126464442|NCT03139604|455001994|FG001|Overall Study|Study Terminated by Sponsor|127|||
126464443|NCT03139604|455001993|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
126464444|NCT03139604|455001994|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
126464445|NCT04950608|455001995|FG000|Overall Study|Withdrawal by Subject|2|||
126464446|NCT04950608|455001995|FG000|Overall Study|Physician Decision|3|||
126464447|NCT05007717|455001996|FG000|Overall Study|Death|3|||
126464448|NCT05007717|455001997|FG001|Overall Study|Death|2|||
126464449|NCT02806973|455001999|FG000|Period 1|Withdrawal by Subject|0|||
126464450|NCT02806973|455002000|FG001|Period 1|Withdrawal by Subject|2|||
126464451|NCT02806973|455002001|FG002|Period 1|Withdrawal by Subject|1|||
126464452|NCT02806973|455002002|FG003|Period 1|Withdrawal by Subject|1|||
126464453|NCT02806973|455001999|FG000|Period 1|Adverse Event|0|||
126370930|NCT01948427|454655274|FG004|Overall Study|Lost to Follow-up|4|||
126370931|NCT01948427|454655270|FG000|Overall Study|Withdrawal by Subject|2|||
126370932|NCT01948427|454655271|FG001|Overall Study|Withdrawal by Subject|0|||
126370933|NCT01948427|454655272|FG002|Overall Study|Withdrawal by Subject|0|||
126464454|NCT02806973|455002000|FG001|Period 1|Adverse Event|0|||
126464455|NCT02806973|455002001|FG002|Period 1|Adverse Event|0|||
126464456|NCT02806973|455002002|FG003|Period 1|Adverse Event|1|||
126464457|NCT02806973|455001999|FG000|Period 3|Withdrawal by Subject|0|||
126464458|NCT02806973|455002000|FG001|Period 3|Withdrawal by Subject|0|||
126464459|NCT02806973|455002001|FG002|Period 3|Withdrawal by Subject|0|||
126370934|NCT01948427|454655273|FG003|Overall Study|Withdrawal by Subject|0|||
126370935|NCT01948427|454655274|FG004|Overall Study|Withdrawal by Subject|1|||
126370936|NCT01948427|454655270|FG000|Overall Study|Other, Not Specified|1|||
126370937|NCT01948427|454655271|FG001|Overall Study|Other, Not Specified|9|||
126370938|NCT01948427|454655272|FG002|Overall Study|Other, Not Specified|0|||
126370939|NCT01948427|454655273|FG003|Overall Study|Other, Not Specified|0|||
126370940|NCT01948427|454655274|FG004|Overall Study|Other, Not Specified|2|||
126370941|NCT00402987|454655275|FG000|Overall Study|Lack of Efficacy|0|||
126370942|NCT00402987|454655276|FG001|Overall Study|Lack of Efficacy|0|||
126370943|NCT00402987|454655277|FG002|Overall Study|Lack of Efficacy|1|||
126370944|NCT00402987|454655278|FG003|Overall Study|Lack of Efficacy|0|||
126370945|NCT05200845|454655290|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
126370946|NCT05200845|454655291|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
126370947|NCT05200845|454655292|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
126370948|NCT05200845|454655293|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
126370949|NCT05200845|454655290|FG000|Overall Study|Withdrawal by Subject|0|||
126370950|NCT05200845|454655291|FG001|Overall Study|Withdrawal by Subject|1|||
126370951|NCT05200845|454655292|FG002|Overall Study|Withdrawal by Subject|1|||
126370952|NCT05200845|454655293|FG003|Overall Study|Withdrawal by Subject|0|||
126370953|NCT02303262|454655294|FG000|Overall Study|Withdrawal by Subject|2|||
126370954|NCT04138056|454655298|FG000|Primary Study|Lost to Follow-up|3|||
126370955|NCT04138056|454655299|FG001|Primary Study|Lost to Follow-up|4|||
126370956|NCT04138056|454655300|FG002|Primary Study|Lost to Follow-up|1|||
126370957|NCT04138056|454655301|FG003|Primary Study|Lost to Follow-up|1|||
126370958|NCT04138056|454655302|FG004|Primary Study|Lost to Follow-up|4|||
126370959|NCT04138056|454655298|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
126370960|NCT04138056|454655299|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
126370961|NCT04138056|454655300|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
126370962|NCT04138056|454655301|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
126370963|NCT04138056|454655302|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
126370964|NCT04138056|454655298|FG000|Extension Study|Lost to Follow-up|1|||
126370965|NCT04138056|454655299|FG001|Extension Study|Lost to Follow-up|2|||
126370966|NCT04138056|454655300|FG002|Extension Study|Lost to Follow-up|1|||
126370967|NCT04138056|454655301|FG003|Extension Study|Lost to Follow-up|0|||
126370968|NCT04138056|454655302|FG004|Extension Study|Lost to Follow-up|1|||
126370969|NCT01215851|454655303|FG000|Treatment Period|Adverse Event|1|||
126370970|NCT01215851|454655304|FG001|Treatment Period|Adverse Event|1|||
126370971|NCT01215851|454655305|FG002|Treatment Period|Adverse Event|1|||
126370972|NCT01215851|454655306|FG003|Treatment Period|Adverse Event|3|||
126370973|NCT01215851|454655307|FG004|Treatment Period|Adverse Event|0|||
126370974|NCT01215851|454655308|FG005|Treatment Period|Adverse Event|1|||
126370975|NCT01215851|454655303|FG000|Follow up Period|Lost to Follow-up|0|||
126370976|NCT01215851|454655304|FG001|Follow up Period|Lost to Follow-up|0|||
126370977|NCT01215851|454655305|FG002|Follow up Period|Lost to Follow-up|0|||
126370978|NCT01215851|454655306|FG003|Follow up Period|Lost to Follow-up|0|||
126370979|NCT01215851|454655307|FG004|Follow up Period|Lost to Follow-up|0|||
126370980|NCT01215851|454655308|FG005|Follow up Period|Lost to Follow-up|1|||
126370981|NCT00862940|454655312|FG000|Overall Study|Adverse Event|15|||
126370982|NCT00862940|454655313|FG001|Overall Study|Adverse Event|12|||
126370983|NCT00862940|454655312|FG000|Overall Study|Lack of Efficacy|1|||
126370984|NCT00862940|454655313|FG001|Overall Study|Lack of Efficacy|3|||
126370985|NCT00862940|454655312|FG000|Overall Study|Protocol Violation|2|||
126370986|NCT00862940|454655313|FG001|Overall Study|Protocol Violation|5|||
126370987|NCT00862940|454655312|FG000|Overall Study|Withdrawal by Subject|4|||
126370988|NCT00862940|454655313|FG001|Overall Study|Withdrawal by Subject|6|||
126370989|NCT00862940|454655312|FG000|Overall Study|Non-compliance|4|||
126370990|NCT00862940|454655313|FG001|Overall Study|Non-compliance|0|||
126370991|NCT00862940|454655312|FG000|Overall Study|Lost to Follow-up|0|||
126370992|NCT00862940|454655313|FG001|Overall Study|Lost to Follow-up|1|||
126370993|NCT00862940|454655312|FG000|Overall Study|Administrative or other reason(s)|4|||
126716290|NCT01070550|455913092|FG001|Overall Study|Treatment not started|2|||
126716291|NCT01070550|455913093|FG002|Overall Study|Treatment not started|4|||
126716292|NCT01070550|455913094|FG003|Overall Study|Treatment not started|0|||
126716293|NCT01070550|455913095|FG004|Overall Study|Treatment not started|0|||
126370994|NCT00862940|454655313|FG001|Overall Study|Administrative or other reason(s)|3|||
126370995|NCT05552859|454655314|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
126370996|NCT05552859|454655315|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
126370997|NCT02581930|454655324|FG000|Overall Study|Withdrawal by Subject|1|||
126370998|NCT02581930|454655324|FG000|Overall Study|patient declined further treatment|1|||
126370999|NCT03386773|454656646|FG000|Overall Study|Lost to Follow-up|24|||
126371000|NCT03386773|454656647|FG001|Overall Study|Lost to Follow-up|33|||
126371001|NCT03386773|454656646|FG000|Overall Study|Withdrawal by Subject|3|||
126371002|NCT03386773|454656647|FG001|Overall Study|Withdrawal by Subject|2|||
126307742|NCT00452673|454416045|FG002|Dose Expansion Period|Disease Progression|0|||
126307743|NCT00452673|454416046|FG003|Dose Expansion Period|Disease Progression|0|||
126307744|NCT00452673|454416047|FG004|Dose Expansion Period|Disease Progression|19|||
126307745|NCT00452673|454416043|FG000|Dose Expansion Period|Other|0|||
126307746|NCT00452673|454416044|FG001|Dose Expansion Period|Other|0|||
126307747|NCT00452673|454416045|FG002|Dose Expansion Period|Other|0|||
126307748|NCT00452673|454416046|FG003|Dose Expansion Period|Other|0|||
126307749|NCT00452673|454416047|FG004|Dose Expansion Period|Other|2|||
126307750|NCT02656290|454416048|FG000|Overall Study|Lost to Follow-up|1|||
126307751|NCT02656290|454416048|FG000|Overall Study|Reintervention|3|||
126307752|NCT01608087|454416051|FG000|Overall Study|Lost to Follow-up|0|||
126307753|NCT01608087|454416052|FG001|Overall Study|Lost to Follow-up|1|||
126307754|NCT01608087|454416053|FG002|Overall Study|Lost to Follow-up|0|||
126307755|NCT01608087|454416051|FG000|Overall Study|Other Reason|0|||
126307756|NCT01608087|454416052|FG001|Overall Study|Other Reason|1|||
126307757|NCT01608087|454416053|FG002|Overall Study|Other Reason|0|||
126307758|NCT00348595|454416054|FG000|Overall Study|Adverse Event|5|||
126307759|NCT00348595|454416055|FG001|Overall Study|Adverse Event|8|||
126307760|NCT01942486|454416058|FG000|Overall Study|Lost to Follow-up|27|||
126307761|NCT02048826|454416059|FG000|Overall Study|Withdrawal by Subject|1|||
126307762|NCT02048826|454416060|FG001|Overall Study|Withdrawal by Subject|0|||
126307763|NCT01011465|454416061|FG000|Overall Study|Withdrawal by Subject|2|||
126307764|NCT01011465|454416062|FG001|Overall Study|Withdrawal by Subject|1|||
126307765|NCT01011465|454416063|FG002|Overall Study|Withdrawal by Subject|0|||
126307766|NCT01011465|454416064|FG003|Overall Study|Withdrawal by Subject|0|||
126307767|NCT01011465|454416065|FG004|Overall Study|Withdrawal by Subject|1|||
126307768|NCT01011465|454416066|FG005|Overall Study|Withdrawal by Subject|0|||
126307769|NCT01011465|454416067|FG006|Overall Study|Withdrawal by Subject|1|||
126307770|NCT01011465|454416068|FG007|Overall Study|Withdrawal by Subject|0|||
126307771|NCT00723008|454416070|FG000|Enrollment|Lost to Follow-up|1|||
126307772|NCT00723008|454416071|FG001|Enrollment|Lost to Follow-up|0|||
126307773|NCT00723008|454416070|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
126307774|NCT00723008|454416071|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
126307775|NCT00723008|454416070|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
126307776|NCT00723008|454416071|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
126307777|NCT00723008|454416070|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
126307778|NCT00723008|454416071|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
126307779|NCT00723008|454416070|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
126307780|NCT00723008|454416071|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
126307781|NCT00723008|454416070|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
126307782|NCT00723008|454416071|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
126307783|NCT01014988|454416074|FG000|Overall Study|Adverse Event|20|||
126307784|NCT01014988|454416075|FG001|Overall Study|Adverse Event|0|||
126307785|NCT01014988|454416076|FG002|Overall Study|Adverse Event|1|||
126307786|NCT01014988|454416077|FG003|Overall Study|Adverse Event|0|||
126307787|NCT01014988|454416078|FG004|Overall Study|Adverse Event|1|||
126307788|NCT01014988|454416079|FG005|Overall Study|Adverse Event|3|||
126307789|NCT01014988|454416074|FG000|Overall Study|Lost to Follow-up|1|||
126307790|NCT01014988|454416075|FG001|Overall Study|Lost to Follow-up|0|||
126307791|NCT01014988|454416076|FG002|Overall Study|Lost to Follow-up|1|||
126307792|NCT01014988|454416077|FG003|Overall Study|Lost to Follow-up|0|||
126307793|NCT01014988|454416078|FG004|Overall Study|Lost to Follow-up|0|||
126307794|NCT01014988|454416079|FG005|Overall Study|Lost to Follow-up|0|||
126307795|NCT01014988|454416074|FG000|Overall Study|Physician Decision|1|||
126307796|NCT01014988|454416075|FG001|Overall Study|Physician Decision|0|||
126307797|NCT01014988|454416076|FG002|Overall Study|Physician Decision|0|||
126307798|NCT01014988|454416077|FG003|Overall Study|Physician Decision|0|||
126307799|NCT01014988|454416078|FG004|Overall Study|Physician Decision|0|||
126307800|NCT01014988|454416079|FG005|Overall Study|Physician Decision|0|||
126307801|NCT01014988|454416074|FG000|Overall Study|Withdrawal by Subject|1|||
126307802|NCT01014988|454416075|FG001|Overall Study|Withdrawal by Subject|0|||
126307803|NCT01014988|454416076|FG002|Overall Study|Withdrawal by Subject|0|||
126307804|NCT01014988|454416077|FG003|Overall Study|Withdrawal by Subject|0|||
126552224|NCT01448044|455316013|FG001|Follow Up Period|Lost to Follow-up|2|||
126552225|NCT01448044|455316012|FG000|Follow Up Period|Other|5|||
126307805|NCT01014988|454416078|FG004|Overall Study|Withdrawal by Subject|0|||
126307806|NCT01014988|454416079|FG005|Overall Study|Withdrawal by Subject|0|||
126307807|NCT01683266|454416080|FG000|Overall Study|Adverse Event|5|||
126307808|NCT01683266|454416081|FG001|Overall Study|Adverse Event|4|||
126307809|NCT01683266|454416080|FG000|Overall Study|Lack of Efficacy|5|||
126307810|NCT01683266|454416081|FG001|Overall Study|Lack of Efficacy|2|||
126307811|NCT01683266|454416080|FG000|Overall Study|Protocol Violation|13|||
126307812|NCT01683266|454416081|FG001|Overall Study|Protocol Violation|6|||
126307813|NCT01683266|454416080|FG000|Overall Study|Personal Reason|17|||
126307814|NCT01683266|454416081|FG001|Overall Study|Personal Reason|25|||
126307815|NCT01683266|454416080|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
126307816|NCT01683266|454416081|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
126307817|NCT01683266|454416080|FG000|Overall Study|Lost to Follow-up|5|||
126716294|NCT01070550|455913096|FG005|Overall Study|Treatment not started|0|||
126716295|NCT01070550|455913091|FG000|Overall Study|Treatment restarted|0|||
126716296|NCT01070550|455913092|FG001|Overall Study|Treatment restarted|1|||
126716297|NCT01070550|455913093|FG002|Overall Study|Treatment restarted|0|||
126716298|NCT01070550|455913094|FG003|Overall Study|Treatment restarted|0|||
126716299|NCT01070550|455913095|FG004|Overall Study|Treatment restarted|0|||
126307818|NCT01683266|454416081|FG001|Overall Study|Lost to Follow-up|0|||
126307819|NCT01683266|454416080|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
126307820|NCT01683266|454416081|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
126307821|NCT01683266|454416080|FG000|Overall Study|Nonserious Hypoglycemia|0|||
126307822|NCT01683266|454416081|FG001|Overall Study|Nonserious Hypoglycemia|3|||
126307823|NCT01683266|454416080|FG000|Overall Study|Perceived Lack of Efficacy|1|||
126307824|NCT01683266|454416081|FG001|Overall Study|Perceived Lack of Efficacy|1|||
126307825|NCT01683266|454416080|FG000|Overall Study|Possibly Hypoglycemia|1|||
126307826|NCT01683266|454416081|FG001|Overall Study|Possibly Hypoglycemia|0|||
126307827|NCT01683266|454416080|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
126307828|NCT01683266|454416081|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
126307829|NCT01867710|454416084|FG000|Overall Study|Death|25|||
126307830|NCT01867710|454416085|FG001|Overall Study|Death|15|||
126307831|NCT01867710|454416086|FG002|Overall Study|Death|27|||
126307832|NCT01867710|454416087|FG003|Overall Study|Death|20|||
126307833|NCT01867710|454416084|FG000|Overall Study|Lost to Follow-up|3|||
126307834|NCT01867710|454416085|FG001|Overall Study|Lost to Follow-up|4|||
126307835|NCT01867710|454416086|FG002|Overall Study|Lost to Follow-up|3|||
126307836|NCT01867710|454416087|FG003|Overall Study|Lost to Follow-up|2|||
126307837|NCT01867710|454416084|FG000|Overall Study|Withdrawal of consent|2|||
126307838|NCT01867710|454416085|FG001|Overall Study|Withdrawal of consent|5|||
126307839|NCT01867710|454416086|FG002|Overall Study|Withdrawal of consent|1|||
126371003|NCT03639610|454656648|FG000|Overall Study|Adverse Event|7|||
126371004|NCT03639610|454656649|FG001|Overall Study|Adverse Event|1|||
126371005|NCT03639610|454656650|FG002|Overall Study|Adverse Event|0|||
126371006|NCT03639610|454656648|FG000|Overall Study|Physician Decision|3|||
126371007|NCT03639610|454656649|FG001|Overall Study|Physician Decision|1|||
126371008|NCT03639610|454656650|FG002|Overall Study|Physician Decision|0|||
126371009|NCT03639610|454656648|FG000|Overall Study|Disease progression|8|||
126371010|NCT03639610|454656649|FG001|Overall Study|Disease progression|5|||
126371011|NCT03639610|454656650|FG002|Overall Study|Disease progression|3|||
126371012|NCT03639610|454656648|FG000|Overall Study|Study terminated by sponsor|2|||
126371013|NCT03639610|454656649|FG001|Overall Study|Study terminated by sponsor|1|||
126371014|NCT03639610|454656650|FG002|Overall Study|Study terminated by sponsor|1|||
126371015|NCT03639610|454656648|FG000|Overall Study|Patient request to stop treatment|1|||
126371016|NCT03639610|454656649|FG001|Overall Study|Patient request to stop treatment|2|||
126371017|NCT03639610|454656650|FG002|Overall Study|Patient request to stop treatment|0|||
126371018|NCT02410772|454656655|FG000|Overall Study|Death|3|||
126371019|NCT02410772|454656656|FG001|Overall Study|Death|4|||
126371020|NCT02410772|454656657|FG002|Overall Study|Death|8|||
126371021|NCT02410772|454656655|FG000|Overall Study|Lost to Follow-up|31|||
126371022|NCT02410772|454656656|FG001|Overall Study|Lost to Follow-up|23|||
126371023|NCT02410772|454656657|FG002|Overall Study|Lost to Follow-up|22|||
126371024|NCT02410772|454656655|FG000|Overall Study|Pregnancy|8|||
126371025|NCT02410772|454656656|FG001|Overall Study|Pregnancy|4|||
126371026|NCT02410772|454656657|FG002|Overall Study|Pregnancy|5|||
126371027|NCT02410772|454656655|FG000|Overall Study|Protocol Violation|8|||
126371028|NCT02410772|454656656|FG001|Overall Study|Protocol Violation|8|||
126371029|NCT02410772|454656657|FG002|Overall Study|Protocol Violation|4|||
126371030|NCT02410772|454656655|FG000|Overall Study|Baseline Drug Resistance|49|||
126371031|NCT02410772|454656656|FG001|Overall Study|Baseline Drug Resistance|40|||
126371032|NCT02410772|454656657|FG002|Overall Study|Baseline Drug Resistance|51|||
126371033|NCT02410772|454656655|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
126371034|NCT02410772|454656656|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
126371035|NCT02410772|454656657|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
126371036|NCT02410772|454656655|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
126371037|NCT02410772|454656656|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
126371038|NCT02410772|454656657|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
126371039|NCT01517984|454656658|FG000|Overall Study|Lost to Follow-up|0|||
126371040|NCT01517984|454656659|FG001|Overall Study|Lost to Follow-up|1|||
126371041|NCT01517984|454656660|FG002|Overall Study|Lost to Follow-up|0|||
126371042|NCT01517984|454656661|FG003|Overall Study|Lost to Follow-up|0|||
126464460|NCT02806973|455002002|FG003|Period 3|Withdrawal by Subject|3|||
126464461|NCT02806973|455001999|FG000|Period 3|Adverse Event|0|||
126464462|NCT02806973|455002000|FG001|Period 3|Adverse Event|0|||
126464463|NCT02806973|455002001|FG002|Period 3|Adverse Event|1|||
126464464|NCT02806973|455002002|FG003|Period 3|Adverse Event|0|||
126464465|NCT02007512|455002008|FG000|Double Blind Treatment Period|Adverse Event|4|||
126464466|NCT02007512|455002009|FG001|Double Blind Treatment Period|Adverse Event|6|||
126464467|NCT02007512|455002010|FG002|Double Blind Treatment Period|Adverse Event|2|||
126464468|NCT02007512|455002011|FG003|Double Blind Treatment Period|Adverse Event|2|||
126307840|NCT01867710|454416087|FG003|Overall Study|Withdrawal of consent|2|||
126307841|NCT01867710|454416084|FG000|Overall Study|Study Terminated by Sponsor|9|||
126307842|NCT01867710|454416085|FG001|Overall Study|Study Terminated by Sponsor|13|||
126307843|NCT01867710|454416086|FG002|Overall Study|Study Terminated by Sponsor|8|||
126307844|NCT01867710|454416087|FG003|Overall Study|Study Terminated by Sponsor|16|||
126307845|NCT01867710|454416084|FG000|Overall Study|Biochemical progression|0|||
126307846|NCT01867710|454416085|FG001|Overall Study|Biochemical progression|1|||
126307847|NCT01867710|454416086|FG002|Overall Study|Biochemical progression|0|||
126307848|NCT01867710|454416087|FG003|Overall Study|Biochemical progression|0|||
126307849|NCT01867710|454416084|FG000|Overall Study|Clinical progression|0|||
126307850|NCT01867710|454416085|FG001|Overall Study|Clinical progression|0|||
126307851|NCT01867710|454416086|FG002|Overall Study|Clinical progression|1|||
126307852|NCT01867710|454416087|FG003|Overall Study|Clinical progression|0|||
126307853|NCT01867710|454416084|FG000|Overall Study|Disease progression|1|||
126307854|NCT01867710|454416085|FG001|Overall Study|Disease progression|0|||
126307855|NCT01867710|454416086|FG002|Overall Study|Disease progression|0|||
126307856|NCT01867710|454416087|FG003|Overall Study|Disease progression|0|||
126307857|NCT01867710|454416084|FG000|Overall Study|Patient decision|0|||
126307858|NCT01867710|454416085|FG001|Overall Study|Patient decision|0|||
126307859|NCT01867710|454416086|FG002|Overall Study|Patient decision|0|||
126307860|NCT01867710|454416087|FG003|Overall Study|Patient decision|1|||
126307861|NCT01867710|454416084|FG000|Overall Study|Patient to follow subsequent treatment|0|||
126307862|NCT01867710|454416085|FG001|Overall Study|Patient to follow subsequent treatment|1|||
126307863|NCT01867710|454416086|FG002|Overall Study|Patient to follow subsequent treatment|0|||
126307864|NCT01867710|454416087|FG003|Overall Study|Patient to follow subsequent treatment|0|||
126307865|NCT01867710|454416084|FG000|Overall Study|Progressive disease|1|||
126307866|NCT01867710|454416085|FG001|Overall Study|Progressive disease|0|||
126307867|NCT01867710|454416086|FG002|Overall Study|Progressive disease|0|||
126307868|NCT01867710|454416087|FG003|Overall Study|Progressive disease|0|||
126307869|NCT01867710|454416084|FG000|Overall Study|Protocol Violation|0|||
126307870|NCT01867710|454416085|FG001|Overall Study|Protocol Violation|0|||
126307871|NCT01867710|454416086|FG002|Overall Study|Protocol Violation|0|||
126307872|NCT01867710|454416087|FG003|Overall Study|Protocol Violation|1|||
126307873|NCT01867710|454416084|FG000|Overall Study|PSA-progression|0|||
126307874|NCT01867710|454416085|FG001|Overall Study|PSA-progression|1|||
126307875|NCT01867710|454416086|FG002|Overall Study|PSA-progression|0|||
126307876|NCT01867710|454416087|FG003|Overall Study|PSA-progression|0|||
126307877|NCT01867710|454416084|FG000|Overall Study|Study medication no longer effective|0|||
126307878|NCT01867710|454416085|FG001|Overall Study|Study medication no longer effective|1|||
126307879|NCT01867710|454416086|FG002|Overall Study|Study medication no longer effective|0|||
126307880|NCT01867710|454416087|FG003|Overall Study|Study medication no longer effective|0|||
126307881|NCT01062113|454416088|FG000|Overall Study|Adverse Event|1|||
126307882|NCT01062113|454416089|FG001|Overall Study|Adverse Event|0|||
126307883|NCT01062113|454416090|FG002|Overall Study|Adverse Event|0|||
126307884|NCT01062113|454416088|FG000|Overall Study|Lack of Efficacy|38|||
126307885|NCT01062113|454416089|FG001|Overall Study|Lack of Efficacy|22|||
126307886|NCT01062113|454416090|FG002|Overall Study|Lack of Efficacy|31|||
126307887|NCT01062113|454416088|FG000|Overall Study|Withdrawal by Subject|1|||
126307888|NCT01062113|454416089|FG001|Overall Study|Withdrawal by Subject|0|||
126307889|NCT01062113|454416090|FG002|Overall Study|Withdrawal by Subject|0|||
126307890|NCT03702010|454416093|FG000|Follow-up (30days)|Lack of Efficacy|2|||
126307891|NCT03702010|454416094|FG001|Follow-up (30days)|Lack of Efficacy|2|||
126307892|NCT02004886|454416099|FG000|Overall Study|Adverse Event|0|||
126307893|NCT02004886|454416100|FG001|Overall Study|Adverse Event|1|||
126307894|NCT02004886|454416101|FG002|Overall Study|Adverse Event|0|||
126307895|NCT02004886|454416102|FG003|Overall Study|Adverse Event|0|||
126307896|NCT02004886|454416099|FG000|Overall Study|Unable to attend future visits|1|||
126307897|NCT02004886|454416100|FG001|Overall Study|Unable to attend future visits|0|||
126307898|NCT02004886|454416101|FG002|Overall Study|Unable to attend future visits|0|||
126307899|NCT02004886|454416102|FG003|Overall Study|Unable to attend future visits|0|||
126307900|NCT05239494|454416103|FG000|Overall Study|Lost to Follow-up|1|||
126307901|NCT01194531|454416104|FG000|Overall Study|Withdrawal by Subject|1|||
126307902|NCT01194531|454416105|FG001|Overall Study|Withdrawal by Subject|0|||
126307903|NCT01194531|454416104|FG000|Overall Study|Protocol Violation|4|||
126307904|NCT01194531|454416105|FG001|Overall Study|Protocol Violation|1|||
126307905|NCT01194531|454416104|FG000|Overall Study|Physician Decision|0|||
126307906|NCT01194531|454416105|FG001|Overall Study|Physician Decision|2|||
126307907|NCT03891862|454416106|FG000|Open-label Period|Adverse Event|2|||
126371043|NCT01517984|454656658|FG000|Overall Study|Withdrawal by Subject|1|||
126552226|NCT01448044|455316013|FG001|Follow Up Period|Other|11|||
126307908|NCT03891862|454416107|FG001|Open-label Period|Adverse Event|0|||
126307909|NCT03891862|454416108|FG002|Open-label Period|Adverse Event|0|||
126307910|NCT03891862|454416106|FG000|Open-label Period|Protocol Violation|5|||
126307911|NCT03891862|454416107|FG001|Open-label Period|Protocol Violation|0|||
126307912|NCT03891862|454416108|FG002|Open-label Period|Protocol Violation|0|||
126307913|NCT03891862|454416106|FG000|Open-label Period|Withdrawal by Subject|6|||
126307914|NCT03891862|454416107|FG001|Open-label Period|Withdrawal by Subject|0|||
126464469|NCT02007512|455002008|FG000|Double Blind Treatment Period|Death|1|||
126464470|NCT02007512|455002009|FG001|Double Blind Treatment Period|Death|0|||
126464471|NCT02007512|455002010|FG002|Double Blind Treatment Period|Death|0|||
126464472|NCT02007512|455002011|FG003|Double Blind Treatment Period|Death|0|||
126464473|NCT02007512|455002008|FG000|Double Blind Treatment Period|Disease progression|51|||
126464474|NCT02007512|455002009|FG001|Double Blind Treatment Period|Disease progression|50|||
126464475|NCT02007512|455002010|FG002|Double Blind Treatment Period|Disease progression|57|||
126464476|NCT02007512|455002011|FG003|Double Blind Treatment Period|Disease progression|52|||
126464477|NCT02007512|455002008|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
126464478|NCT02007512|455002009|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
126464479|NCT02007512|455002010|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
126464480|NCT02007512|455002011|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
126464481|NCT02007512|455002008|FG000|Double Blind Treatment Period|Protocol Violation|1|||
126464482|NCT02007512|455002009|FG001|Double Blind Treatment Period|Protocol Violation|0|||
126464483|NCT02007512|455002010|FG002|Double Blind Treatment Period|Protocol Violation|0|||
126464484|NCT02007512|455002011|FG003|Double Blind Treatment Period|Protocol Violation|1|||
126464485|NCT02007512|455002008|FG000|Double Blind Treatment Period|Other|2|||
126464486|NCT02007512|455002009|FG001|Double Blind Treatment Period|Other|1|||
126464487|NCT02007512|455002010|FG002|Double Blind Treatment Period|Other|1|||
126464488|NCT02007512|455002011|FG003|Double Blind Treatment Period|Other|2|||
126464489|NCT02007512|455002008|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
126307915|NCT03891862|454416108|FG002|Open-label Period|Withdrawal by Subject|0|||
126307916|NCT03891862|454416106|FG000|Open-label Period|Death|1|||
126307917|NCT03891862|454416107|FG001|Open-label Period|Death|0|||
126307918|NCT03891862|454416108|FG002|Open-label Period|Death|0|||
126307919|NCT03891862|454416106|FG000|Open-label Period|Lost to Follow-up|2|||
126307920|NCT03891862|454416107|FG001|Open-label Period|Lost to Follow-up|0|||
126307921|NCT03891862|454416108|FG002|Open-label Period|Lost to Follow-up|0|||
126307922|NCT03891862|454416106|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
126307923|NCT03891862|454416107|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
126307924|NCT03891862|454416108|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
126307925|NCT03891862|454416106|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
126307926|NCT03891862|454416107|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
126307927|NCT03891862|454416108|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
126307928|NCT03891862|454416106|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
126307929|NCT03891862|454416107|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
126307930|NCT03891862|454416108|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
126307931|NCT03891862|454416106|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
126307932|NCT03891862|454416107|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
126307933|NCT03891862|454416108|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
126307934|NCT01053962|454416109|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
126307935|NCT01053962|454416110|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
126307936|NCT01053962|454416111|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
126307937|NCT01053962|454416112|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
126307938|NCT01053962|454416113|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
126307939|NCT01053962|454416109|FG000|Pretreatment Period|Venipuncture Failure|0|||
126307940|NCT01053962|454416110|FG001|Pretreatment Period|Venipuncture Failure|0|||
126307941|NCT01053962|454416111|FG002|Pretreatment Period|Venipuncture Failure|1|||
126307942|NCT01053962|454416112|FG003|Pretreatment Period|Venipuncture Failure|0|||
126307943|NCT01053962|454416113|FG004|Pretreatment Period|Venipuncture Failure|0|||
126307944|NCT01053962|454416109|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
126307945|NCT01053962|454416110|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
126307946|NCT01053962|454416111|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
126307947|NCT01053962|454416112|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
126307948|NCT01053962|454416113|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
126307949|NCT01053962|454416109|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
126307950|NCT01053962|454416110|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
126307951|NCT01053962|454416111|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
126307952|NCT01053962|454416112|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
126464490|NCT02007512|455002009|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
126464491|NCT02007512|455002010|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
126464492|NCT02007512|455002011|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
126464493|NCT02007512|455002008|FG000|Open Label Treatment Period|Adverse Event|1|||
126770916|NCT02253654|456116203|FG001|Overall Study|Did Not Receive Study Treatment|1|||
126307953|NCT01053962|454416113|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
126307954|NCT01053962|454416109|FG000|Treatment Period|Lack of Efficacy|0|||
126464494|NCT02007512|455002009|FG001|Open Label Treatment Period|Adverse Event|0|||
126464495|NCT02007512|455002010|FG002|Open Label Treatment Period|Adverse Event|0|||
126552227|NCT01000376|455316016|FG000|Cycle 1 Day 1|Adverse Event|1|||
126770917|NCT03456726|456116206|FG000|Overall Study|Disease Progression|6|||
126371044|NCT01517984|454656659|FG001|Overall Study|Withdrawal by Subject|8|||
126371045|NCT01517984|454656660|FG002|Overall Study|Withdrawal by Subject|4|||
126371046|NCT01517984|454656661|FG003|Overall Study|Withdrawal by Subject|1|||
126371047|NCT01517984|454656658|FG000|Overall Study|Screen Failure|4|||
126371048|NCT01517984|454656659|FG001|Overall Study|Screen Failure|0|||
126371049|NCT01517984|454656660|FG002|Overall Study|Screen Failure|0|||
126371050|NCT01517984|454656661|FG003|Overall Study|Screen Failure|0|||
126371051|NCT01517984|454656658|FG000|Overall Study|Ineligible for randomization|0|||
126371052|NCT01517984|454656659|FG001|Overall Study|Ineligible for randomization|14|||
126371053|NCT01517984|454656660|FG002|Overall Study|Ineligible for randomization|0|||
126371054|NCT01517984|454656661|FG003|Overall Study|Ineligible for randomization|0|||
126371055|NCT01645176|454656662|FG000|Overall Study|Lack of Efficacy|4|||
126371056|NCT01645176|454656662|FG000|Overall Study|did not complete final MRI|1|||
126464496|NCT02007512|455002011|FG003|Open Label Treatment Period|Adverse Event|0|||
126464497|NCT02007512|455002008|FG000|Open Label Treatment Period|Other|1|||
126464498|NCT02007512|455002009|FG001|Open Label Treatment Period|Other|1|||
126464499|NCT02007512|455002010|FG002|Open Label Treatment Period|Other|0|||
126716300|NCT01070550|455913096|FG005|Overall Study|Treatment restarted|0|||
126716301|NCT01070550|455913091|FG000|Overall Study|Treatment stopped|3|||
126716302|NCT01070550|455913092|FG001|Overall Study|Treatment stopped|0|||
126371057|NCT02234362|454656663|FG000|Overall Study|Not eligible after first screening visit|17|||
126464500|NCT02007512|455002011|FG003|Open Label Treatment Period|Other|0|||
126464501|NCT02007512|455002008|FG000|Open Label Treatment Period|Disease progression|23|||
126464502|NCT02007512|455002009|FG001|Open Label Treatment Period|Disease progression|11|||
126464503|NCT02007512|455002010|FG002|Open Label Treatment Period|Disease progression|0|||
126464504|NCT02007512|455002011|FG003|Open Label Treatment Period|Disease progression|0|||
126464505|NCT00608543|455002016|FG000|Overall Study|Adverse Event|4|||
126464506|NCT01466595|455002018|FG000|Overall Study|Withdrawal by Subject|0|||
126464507|NCT01466595|455002019|FG001|Overall Study|Withdrawal by Subject|1|||
126464508|NCT02147184|455002020|FG000|Overall Study|Lost to Follow-up|28|||
126464509|NCT02147184|455002021|FG001|Overall Study|Lost to Follow-up|15|||
126464510|NCT02147184|455002020|FG000|Overall Study|Study Burden|11|||
126464511|NCT02147184|455002021|FG001|Overall Study|Study Burden|7|||
126464512|NCT02147184|455002020|FG000|Overall Study|Pregnancy|6|||
126464513|NCT02147184|455002021|FG001|Overall Study|Pregnancy|0|||
126464514|NCT02147184|455002020|FG000|Overall Study|Moved out of state|3|||
126464515|NCT02147184|455002021|FG001|Overall Study|Moved out of state|3|||
126464516|NCT02147184|455002020|FG000|Overall Study|Physician Decision|0|||
126464517|NCT02147184|455002021|FG001|Overall Study|Physician Decision|2|||
126464518|NCT02147184|455002020|FG000|Overall Study|Other|1|||
126464519|NCT02147184|455002021|FG001|Overall Study|Other|0|||
126464520|NCT02117414|455002022|FG000|Overall Study|Death|5|||
126464521|NCT02117414|455002023|FG001|Overall Study|Death|2|||
126464522|NCT02117414|455002022|FG000|Overall Study|Withdrawal by Subject|10|||
126464523|NCT02117414|455002023|FG001|Overall Study|Withdrawal by Subject|4|||
126464524|NCT02169284|455002029|FG000|Overall Study|Physician Decision|0|||
126464525|NCT02169284|455002030|FG001|Overall Study|Physician Decision|1|||
126464526|NCT03583073|455002031|FG000|Overall Study|Lost to Follow-up|8|||
126464527|NCT03583073|455002032|FG001|Overall Study|Lost to Follow-up|12|||
126464528|NCT01367119|455002033|FG000|Overall Study|Adverse Event|1|||
126464529|NCT01367119|455002034|FG001|Overall Study|Adverse Event|0|||
126464530|NCT01367119|455002033|FG000|Overall Study|Withdrawal by Subject|1|||
126464531|NCT01367119|455002034|FG001|Overall Study|Withdrawal by Subject|1|||
126464532|NCT03180684|455002035|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
126464533|NCT03180684|455002036|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
126464534|NCT03180684|455002035|FG000|Overall Study|Physician Decision|1|||
126464535|NCT03180684|455002036|FG001|Overall Study|Physician Decision|0|||
126464536|NCT03180684|455002035|FG000|Overall Study|Lost to Follow-up|1|||
126464537|NCT03180684|455002036|FG001|Overall Study|Lost to Follow-up|0|||
126464538|NCT03180684|455002035|FG000|Overall Study|Progressive Disease|1|||
126464539|NCT03180684|455002036|FG001|Overall Study|Progressive Disease|0|||
126464540|NCT00194675|455002047|FG000|Overall Study|Lost to Follow-up|1|||
126464541|NCT00194675|455002048|FG001|Overall Study|Lost to Follow-up|1|||
126464542|NCT00194675|455002047|FG000|Overall Study|lack of interest|1|||
126371058|NCT02234362|454656663|FG000|Overall Study|Lost to Follow-up|6|||
126371059|NCT02234362|454656663|FG000|Overall Study|Withdrawal by Subject|3|||
126464543|NCT00194675|455002048|FG001|Overall Study|lack of interest|1|||
126464544|NCT00194675|455002047|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
126464545|NCT00194675|455002048|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
126464546|NCT00194675|455002047|FG000|Overall Study|Protocol Violation|1|||
126464547|NCT00194675|455002048|FG001|Overall Study|Protocol Violation|0|||
126464548|NCT00194675|455002047|FG000|Overall Study|Death|1|||
126464549|NCT00194675|455002048|FG001|Overall Study|Death|0|||
126464550|NCT01285960|455002049|FG000|Overall Study|Withdrawal by Subject|2|||
126464551|NCT01285960|455002049|FG000|Overall Study|Lost to Follow-up|2|||
126464552|NCT01285960|455002049|FG000|Overall Study|2 subjects received less 10 sonications|2|||
126464553|NCT02280473|455002052|FG000|Overall Study|Adverse Event|1|||
126716303|NCT01070550|455913093|FG002|Overall Study|Treatment stopped|0|||
126552228|NCT01000376|455316017|FG001|Cycle 1 Day 1|Adverse Event|0|||
126552229|NCT01000376|455316016|FG000|Cycle 1 Day 1|Progressive Disease|1|||
126552230|NCT01000376|455316017|FG001|Cycle 1 Day 1|Progressive Disease|0|||
126716304|NCT01070550|455913094|FG003|Overall Study|Treatment stopped|0|||
126371060|NCT00560417|454656664|FG000|Overall Study|Adverse Event|3|||
126371061|NCT00560417|454656665|FG001|Overall Study|Adverse Event|2|||
126371062|NCT00560417|454656664|FG000|Overall Study|Entry Criteria Not Met|1|||
126371063|NCT00560417|454656665|FG001|Overall Study|Entry Criteria Not Met|0|||
126371064|NCT00560417|454656664|FG000|Overall Study|Lost to Follow-up|0|||
126371065|NCT00560417|454656665|FG001|Overall Study|Lost to Follow-up|1|||
126371066|NCT00560417|454656664|FG000|Overall Study|Physician Decision|2|||
126371067|NCT00560417|454656665|FG001|Overall Study|Physician Decision|6|||
126371068|NCT00560417|454656664|FG000|Overall Study|Protocol Violation|6|||
126371069|NCT00560417|454656665|FG001|Overall Study|Protocol Violation|5|||
126371070|NCT00560417|454656664|FG000|Overall Study|Sponsor Decision|2|||
126371071|NCT00560417|454656665|FG001|Overall Study|Sponsor Decision|0|||
126371072|NCT00560417|454656664|FG000|Overall Study|Withdrawal by Subject|3|||
126371073|NCT00560417|454656665|FG001|Overall Study|Withdrawal by Subject|3|||
126371074|NCT02164864|454656668|FG000|Overall Study|Trial disease worsening|7|||
126371075|NCT02164864|454656669|FG001|Overall Study|Trial disease worsening|5|||
126371076|NCT02164864|454656670|FG002|Overall Study|Trial disease worsening|1|||
126371077|NCT02164864|454656668|FG000|Overall Study|Other pre-existing disease worsening|6|||
126371078|NCT02164864|454656669|FG001|Overall Study|Other pre-existing disease worsening|4|||
126371079|NCT02164864|454656670|FG002|Overall Study|Other pre-existing disease worsening|9|||
126371080|NCT02164864|454656668|FG000|Overall Study|Other Adverse Event (AE)|52|||
126371081|NCT02164864|454656669|FG001|Overall Study|Other Adverse Event (AE)|32|||
126371082|NCT02164864|454656670|FG002|Overall Study|Other Adverse Event (AE)|49|||
126371083|NCT02164864|454656668|FG000|Overall Study|Protocol Violation|2|||
126371084|NCT02164864|454656669|FG001|Overall Study|Protocol Violation|4|||
126371085|NCT02164864|454656670|FG002|Overall Study|Protocol Violation|1|||
126371086|NCT02164864|454656668|FG000|Overall Study|Lost to Follow-up|4|||
126371087|NCT02164864|454656669|FG001|Overall Study|Lost to Follow-up|3|||
126371088|NCT02164864|454656670|FG002|Overall Study|Lost to Follow-up|2|||
126371089|NCT02164864|454656668|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
126371090|NCT02164864|454656669|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
126371091|NCT02164864|454656670|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
126371092|NCT02164864|454656668|FG000|Overall Study|Other than stated|3|||
126371093|NCT02164864|454656669|FG001|Overall Study|Other than stated|4|||
126371094|NCT02164864|454656670|FG002|Overall Study|Other than stated|14|||
126371095|NCT02569853|454656671|FG000|Overall Study|Adverse Event|2|||
126371096|NCT02569853|454656672|FG001|Overall Study|Adverse Event|0|||
126371097|NCT02569853|454656671|FG000|Overall Study|Withdrawal by Subject|3|||
126371098|NCT02569853|454656672|FG001|Overall Study|Withdrawal by Subject|2|||
126371099|NCT02569853|454656671|FG000|Overall Study|Lost to Follow-up|3|||
126371100|NCT02569853|454656672|FG001|Overall Study|Lost to Follow-up|3|||
126371101|NCT02569853|454656671|FG000|Overall Study|Protocol Violation|1|||
126371102|NCT02569853|454656672|FG001|Overall Study|Protocol Violation|1|||
126371103|NCT02569853|454656671|FG000|Overall Study|Did not experience migraine attack|10|||
126371104|NCT02569853|454656672|FG001|Overall Study|Did not experience migraine attack|7|||
126371105|NCT02569853|454656671|FG000|Overall Study|Physician Decision|1|||
126371106|NCT02569853|454656672|FG001|Overall Study|Physician Decision|1|||
126371107|NCT02434081|454656675|FG000|Overall Study|Death (never started treatment)|2|||
126716305|NCT01070550|455913095|FG004|Overall Study|Treatment stopped|0|||
126716306|NCT01070550|455913096|FG005|Overall Study|Treatment stopped|0|||
126716307|NCT01070550|455913091|FG000|Overall Study|Treatment unavailable|1|||
126716308|NCT01070550|455913092|FG001|Overall Study|Treatment unavailable|0|||
126716309|NCT01070550|455913093|FG002|Overall Study|Treatment unavailable|0|||
126716310|NCT01070550|455913094|FG003|Overall Study|Treatment unavailable|0|||
126371108|NCT02434081|454656675|FG000|Overall Study|Death|2|||
126371109|NCT02434081|454656675|FG000|Overall Study|Progression|20|||
126371110|NCT02434081|454656675|FG000|Overall Study|Adverse Event|20|||
126552231|NCT00507026|455316018|FG000|Overall Study|Lack of Efficacy|6|||
126716311|NCT01070550|455913095|FG004|Overall Study|Treatment unavailable|0|||
126716312|NCT01070550|455913096|FG005|Overall Study|Treatment unavailable|0|||
126716313|NCT01070550|455913091|FG000|Overall Study|Treatment was stopped early|7|||
126716314|NCT01070550|455913092|FG001|Overall Study|Treatment was stopped early|0|||
126371111|NCT02434081|454656675|FG000|Overall Study|Physician Decision|2|||
126371112|NCT02434081|454656675|FG000|Overall Study|Withdrawal by Subject|1|||
126371113|NCT02434081|454656675|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
126371114|NCT00419744|454656676|FG000|Overall Study|Adverse Event|39|||
126371115|NCT00419744|454656677|FG001|Overall Study|Adverse Event|40|||
126371116|NCT00419744|454656678|FG002|Overall Study|Adverse Event|50|||
126371117|NCT00419744|454656676|FG000|Overall Study|Withdrawal by Subject|45|||
126371118|NCT00419744|454656677|FG001|Overall Study|Withdrawal by Subject|49|||
126552232|NCT00507026|455316019|FG001|Overall Study|Lack of Efficacy|4|||
126716315|NCT01070550|455913093|FG002|Overall Study|Treatment was stopped early|0|||
126716316|NCT01070550|455913094|FG003|Overall Study|Treatment was stopped early|0|||
126464554|NCT02280473|455002053|FG001|Overall Study|Adverse Event|1|||
126716317|NCT01070550|455913095|FG004|Overall Study|Treatment was stopped early|0|||
126307955|NCT01053962|454416110|FG001|Treatment Period|Lack of Efficacy|0|||
126307956|NCT01053962|454416111|FG002|Treatment Period|Lack of Efficacy|0|||
126307957|NCT01053962|454416112|FG003|Treatment Period|Lack of Efficacy|0|||
126307958|NCT01053962|454416113|FG004|Treatment Period|Lack of Efficacy|1|||
126307959|NCT01053962|454416109|FG000|Treatment Period|Adverse Event|0|||
126307960|NCT01053962|454416110|FG001|Treatment Period|Adverse Event|0|||
126307961|NCT01053962|454416111|FG002|Treatment Period|Adverse Event|0|||
126307962|NCT01053962|454416112|FG003|Treatment Period|Adverse Event|0|||
126307963|NCT01053962|454416113|FG004|Treatment Period|Adverse Event|1|||
126307964|NCT01053962|454416109|FG000|Treatment Period|Withdrawal by Subject|0|||
126307965|NCT01053962|454416110|FG001|Treatment Period|Withdrawal by Subject|0|||
126307966|NCT01053962|454416111|FG002|Treatment Period|Withdrawal by Subject|0|||
126307967|NCT01053962|454416112|FG003|Treatment Period|Withdrawal by Subject|0|||
126307968|NCT01053962|454416113|FG004|Treatment Period|Withdrawal by Subject|1|||
126307969|NCT01053962|454416109|FG000|Treatment Period|Noncompliance with protocol|1|||
126307970|NCT01053962|454416110|FG001|Treatment Period|Noncompliance with protocol|0|||
126307971|NCT01053962|454416111|FG002|Treatment Period|Noncompliance with protocol|0|||
126307972|NCT01053962|454416112|FG003|Treatment Period|Noncompliance with protocol|0|||
126307973|NCT01053962|454416113|FG004|Treatment Period|Noncompliance with protocol|0|||
126307974|NCT00638443|454416114|FG000|First Intervention|Adverse Event|2|||
126307975|NCT00638443|454416115|FG001|First Intervention|Adverse Event|1|||
126307976|NCT04603482|454416117|FG000|Overall Study|Lost to Follow-up|15|||
126307977|NCT04603482|454416118|FG001|Overall Study|Lost to Follow-up|15|||
126307978|NCT04603482|454416119|FG002|Overall Study|Lost to Follow-up|15|||
126307979|NCT01054196|454416120|FG000|Overall Study|Physician Decision|0|||
126307980|NCT01054196|454416121|FG001|Overall Study|Physician Decision|0|||
126307981|NCT01054196|454416122|FG002|Overall Study|Physician Decision|0|||
126307982|NCT01054196|454416123|FG003|Overall Study|Physician Decision|1|||
126307983|NCT01054196|454416124|FG004|Overall Study|Physician Decision|0|||
126307984|NCT01054196|454416125|FG005|Overall Study|Physician Decision|0|||
126307985|NCT01054196|454416126|FG006|Overall Study|Physician Decision|1|||
126307986|NCT02949843|454416127|FG000|Overall Study|Withdrawal by Subject|0|||
126307987|NCT02949843|454416128|FG001|Overall Study|Withdrawal by Subject|1|||
126307988|NCT02949843|454416129|FG002|Overall Study|Withdrawal by Subject|1|||
126307989|NCT02253316|454416130|FG000|Consolidation|Progression|4|||
126307990|NCT02253316|454416131|FG001|Consolidation|Progression|0|||
126307991|NCT02253316|454416132|FG002|Consolidation|Progression|0|||
126307992|NCT02253316|454416130|FG000|Consolidation|Non-Compliance|1|||
126307993|NCT02253316|454416131|FG001|Consolidation|Non-Compliance|0|||
126307994|NCT02253316|454416132|FG002|Consolidation|Non-Compliance|0|||
126307995|NCT02253316|454416130|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
126307996|NCT02253316|454416131|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
126307997|NCT02253316|454416132|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
126307998|NCT02253316|454416130|FG000|Consolidation|Secondary Malignancy|2|||
126307999|NCT02253316|454416131|FG001|Consolidation|Secondary Malignancy|0|||
126308000|NCT02253316|454416132|FG002|Consolidation|Secondary Malignancy|0|||
126308001|NCT02253316|454416130|FG000|Consolidation|Adverse Event|7|||
126308002|NCT02253316|454416131|FG001|Consolidation|Adverse Event|0|||
126308003|NCT02253316|454416132|FG002|Consolidation|Adverse Event|0|||
126308004|NCT02253316|454416130|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
126308005|NCT02253316|454416131|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
126308006|NCT02253316|454416132|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
126308007|NCT02253316|454416130|FG000|Maintenance|Physician Decision|0|||
126308008|NCT02253316|454416131|FG001|Maintenance|Physician Decision|7|||
126308009|NCT02253316|454416132|FG002|Maintenance|Physician Decision|16|||
126308010|NCT02253316|454416130|FG000|Maintenance|Non-Compliance|0|||
126308011|NCT02253316|454416131|FG001|Maintenance|Non-Compliance|1|||
126308012|NCT02253316|454416132|FG002|Maintenance|Non-Compliance|1|||
126308013|NCT02253316|454416130|FG000|Maintenance|Secondary Malignancy|0|||
126308014|NCT02253316|454416131|FG001|Maintenance|Secondary Malignancy|2|||
126308015|NCT02253316|454416132|FG002|Maintenance|Secondary Malignancy|6|||
126308016|NCT02253316|454416130|FG000|Maintenance|Adverse Event|0|||
126308017|NCT02253316|454416131|FG001|Maintenance|Adverse Event|8|||
126308018|NCT02253316|454416132|FG002|Maintenance|Adverse Event|12|||
126308019|NCT02253316|454416130|FG000|Maintenance|Still receiving active treatment|0|||
126308020|NCT02253316|454416131|FG001|Maintenance|Still receiving active treatment|5|||
126308021|NCT02253316|454416132|FG002|Maintenance|Still receiving active treatment|0|||
126716318|NCT01070550|455913096|FG005|Overall Study|Treatment was stopped early|0|||
126308022|NCT00135512|454416137|FG000|Overall Study|Adverse Event|56|||
126308023|NCT00135512|454416137|FG000|Overall Study|Lack of Efficacy|25|||
126308024|NCT00135512|454416137|FG000|Overall Study|Other|42|||
126308025|NCT04152837|454416138|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
126308026|NCT04152837|454416138|FG000|Maintenance Period|Adverse Event|1|||
126308027|NCT04152837|454416138|FG000|Maintenance Period|Withdrawal by Subject|1|||
126308028|NCT04152837|454416138|FG000|Maintenance Period|Sponsor Termination of Study|2|||
126308029|NCT01668173|454416143|FG000|Overall Study|Adverse Event|3|||
126371119|NCT00419744|454656678|FG002|Overall Study|Withdrawal by Subject|52|||
126371120|NCT00419744|454656676|FG000|Overall Study|Lost to Follow-up|8|||
126371121|NCT00419744|454656677|FG001|Overall Study|Lost to Follow-up|10|||
126371122|NCT00419744|454656678|FG002|Overall Study|Lost to Follow-up|6|||
126371123|NCT00419744|454656676|FG000|Overall Study|Protocol Violation|4|||
126371124|NCT00419744|454656677|FG001|Overall Study|Protocol Violation|7|||
126371125|NCT00419744|454656678|FG002|Overall Study|Protocol Violation|8|||
126371126|NCT00419744|454656676|FG000|Overall Study|Randomized in error|9|||
126371127|NCT00419744|454656677|FG001|Overall Study|Randomized in error|6|||
126371128|NCT00419744|454656678|FG002|Overall Study|Randomized in error|7|||
126371129|NCT00419744|454656676|FG000|Overall Study|Moving out of state|2|||
126371130|NCT00419744|454656677|FG001|Overall Study|Moving out of state|0|||
126371131|NCT00419744|454656678|FG002|Overall Study|Moving out of state|1|||
126371132|NCT00419744|454656676|FG000|Overall Study|Physician Decision|10|||
126371133|NCT00419744|454656677|FG001|Overall Study|Physician Decision|5|||
126371134|NCT00419744|454656678|FG002|Overall Study|Physician Decision|6|||
126371135|NCT00419744|454656676|FG000|Overall Study|Spirometry mouthpiece issues|0|||
126371136|NCT00419744|454656677|FG001|Overall Study|Spirometry mouthpiece issues|1|||
126371137|NCT00419744|454656678|FG002|Overall Study|Spirometry mouthpiece issues|2|||
126371138|NCT00419744|454656676|FG000|Overall Study|Incorrect medication kit dispensed|0|||
126371139|NCT00419744|454656677|FG001|Overall Study|Incorrect medication kit dispensed|0|||
126371140|NCT00419744|454656678|FG002|Overall Study|Incorrect medication kit dispensed|1|||
126371141|NCT01668004|454656679|FG000|Overall Study|Adverse Event|7|||
126371142|NCT01668004|454656679|FG000|Overall Study|Withdrawal by Subject|2|||
126371143|NCT01668004|454656679|FG000|Overall Study|Lost to Follow-up|5|||
126371144|NCT01668004|454656679|FG000|Overall Study|Lack of Efficacy|9|||
126371145|NCT01668004|454656679|FG000|Overall Study|Non-compliance with treatment|2|||
126371146|NCT02448381|454656684|FG000|Overall Study|Adverse Event|2|||
126371147|NCT02448381|454656685|FG001|Overall Study|Adverse Event|0|||
126371148|NCT02448381|454656684|FG000|Overall Study|Lost to Follow-up|16|||
126371149|NCT02448381|454656685|FG001|Overall Study|Lost to Follow-up|9|||
126371150|NCT02448381|454656684|FG000|Overall Study|Physician Decision|1|||
126371151|NCT02448381|454656685|FG001|Overall Study|Physician Decision|1|||
126371152|NCT02448381|454656684|FG000|Overall Study|Pregnancy|1|||
126371153|NCT02448381|454656685|FG001|Overall Study|Pregnancy|0|||
126371154|NCT02448381|454656684|FG000|Overall Study|Withdrawal by Subject|13|||
126371155|NCT02448381|454656685|FG001|Overall Study|Withdrawal by Subject|9|||
126371156|NCT02448381|454656684|FG000|Overall Study|Noncompliance with Study Procedures|2|||
126371157|NCT02448381|454656685|FG001|Overall Study|Noncompliance with Study Procedures|0|||
126371158|NCT02006927|454656686|FG000|Overall Study|Adverse Event|2|||
126371159|NCT02006927|454656686|FG000|Overall Study|Withdrawal by Subject|1|||
126371160|NCT02735200|454656687|FG000|Overall Study|Lost to Follow-up|0|||
126371161|NCT02735200|454656688|FG001|Overall Study|Lost to Follow-up|5|||
126371162|NCT02735200|454656687|FG000|Overall Study|Withdrawal by Subject|8|||
126371163|NCT02735200|454656688|FG001|Overall Study|Withdrawal by Subject|0|||
126371164|NCT00673920|454656689|FG000|Baseline up to Week 48|Withdrew consent|1|||
126371165|NCT00673920|454656690|FG001|Baseline up to Week 48|Withdrew consent|0|||
126371166|NCT00673920|454656691|FG002|Baseline up to Week 48|Withdrew consent|2|||
126371167|NCT00673920|454656692|FG003|Baseline up to Week 48|Withdrew consent|0|||
126371168|NCT00673920|454656693|FG004|Baseline up to Week 48|Withdrew consent|0|||
126371169|NCT00673920|454656694|FG005|Baseline up to Week 48|Withdrew consent|0|||
126464555|NCT02280473|455002052|FG000|Overall Study|Lack of Efficacy|0|||
126464556|NCT02280473|455002053|FG001|Overall Study|Lack of Efficacy|1|||
126464557|NCT02280473|455002052|FG000|Overall Study|Lost to Follow-up|0|||
126770918|NCT03456726|456116207|FG001|Overall Study|Disease Progression|1|||
126371170|NCT00673920|454656695|FG006|Baseline up to Week 48|Withdrew consent|0|||
126371171|NCT00673920|454656696|FG007|Baseline up to Week 48|Withdrew consent|0|||
126371172|NCT00673920|454656689|FG000|Baseline up to Week 48|Refused treatment|1|||
126371173|NCT00673920|454656690|FG001|Baseline up to Week 48|Refused treatment|0|||
126371174|NCT00673920|454656691|FG002|Baseline up to Week 48|Refused treatment|0|||
126371175|NCT00673920|454656692|FG003|Baseline up to Week 48|Refused treatment|0|||
126371176|NCT00673920|454656693|FG004|Baseline up to Week 48|Refused treatment|0|||
126371177|NCT00673920|454656694|FG005|Baseline up to Week 48|Refused treatment|0|||
126464558|NCT02280473|455002053|FG001|Overall Study|Lost to Follow-up|1|||
126464559|NCT01484054|455002054|FG000|Period 1|Withdrawal by Subject|0|||
126371178|NCT00673920|454656695|FG006|Baseline up to Week 48|Refused treatment|0|||
126371179|NCT00673920|454656696|FG007|Baseline up to Week 48|Refused treatment|0|||
126371180|NCT00673920|454656689|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
126371181|NCT00673920|454656690|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
126371182|NCT00673920|454656691|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
126371183|NCT00673920|454656692|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
126371184|NCT00673920|454656693|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
126371185|NCT00673920|454656694|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
126371186|NCT00673920|454656695|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
126464560|NCT01484054|455002055|FG001|Period 1|Withdrawal by Subject|1|||
126770919|NCT03456726|456116206|FG000|Overall Study|Adverse Event|4|||
126552233|NCT00507026|455316020|FG002|Overall Study|Lack of Efficacy|21|||
126552234|NCT00507026|455316018|FG000|Overall Study|Withdrawal by Subject|2|||
126552235|NCT00507026|455316019|FG001|Overall Study|Withdrawal by Subject|0|||
126552236|NCT00507026|455316020|FG002|Overall Study|Withdrawal by Subject|0|||
126552237|NCT00507026|455316018|FG000|Overall Study|Investigator Decision|1|||
126552238|NCT00507026|455316019|FG001|Overall Study|Investigator Decision|0|||
126552239|NCT00507026|455316020|FG002|Overall Study|Investigator Decision|0|||
126552240|NCT00507026|455316018|FG000|Overall Study|Adverse Event|2|||
126552241|NCT00507026|455316019|FG001|Overall Study|Adverse Event|0|||
126552242|NCT00507026|455316020|FG002|Overall Study|Adverse Event|0|||
126552243|NCT00507026|455316018|FG000|Overall Study|Protocol Violation|1|||
126552244|NCT00507026|455316019|FG001|Overall Study|Protocol Violation|0|||
126552245|NCT00507026|455316020|FG002|Overall Study|Protocol Violation|0|||
126552246|NCT00507026|455316018|FG000|Overall Study|Other|1|||
126552247|NCT00507026|455316019|FG001|Overall Study|Other|0|||
126552248|NCT00507026|455316020|FG002|Overall Study|Other|0|||
126552249|NCT00896454|455316021|FG000|Overall Study|Death|10|||
126552250|NCT00896454|455316021|FG000|Overall Study|Adverse Event|8|||
126552251|NCT00896454|455316021|FG000|Overall Study|Disease Progression|5|||
126552252|NCT00896454|455316021|FG000|Overall Study|Other|4|||
126552253|NCT00896454|455316021|FG000|Overall Study|Requirement for alternative therapy|3|||
126552254|NCT00896454|455316021|FG000|Overall Study|Ongoing in study|2|||
126552255|NCT00896454|455316021|FG000|Overall Study|Withdrawal by Subject|1|||
126552256|NCT03688711|455316024|FG000|Overall Study|Withdrawal by Subject|0|||
126552257|NCT03688711|455316025|FG001|Overall Study|Withdrawal by Subject|1|||
126552258|NCT01950273|455318290|FG000|Overall Study|Protocol Violation|1|||
126552259|NCT01950273|455318291|FG001|Overall Study|Protocol Violation|0|||
126552260|NCT01950273|455318290|FG000|Overall Study|Withdrawal by Subject|2|||
126552261|NCT01950273|455318291|FG001|Overall Study|Withdrawal by Subject|0|||
126552262|NCT01950273|455318290|FG000|Overall Study|Other not defined above|1|||
126552263|NCT01950273|455318291|FG001|Overall Study|Other not defined above|0|||
126552264|NCT01254565|455318292|FG000|Overall Study|Non-compliance to Study Procedures|0|||
126552265|NCT01254565|455318293|FG001|Overall Study|Non-compliance to Study Procedures|0|||
126552266|NCT01254565|455318294|FG002|Overall Study|Non-compliance to Study Procedures|0|||
126552267|NCT01254565|455318295|FG003|Overall Study|Non-compliance to Study Procedures|0|||
126552268|NCT01254565|455318296|FG004|Overall Study|Non-compliance to Study Procedures|1|||
126552269|NCT01254565|455318297|FG005|Overall Study|Non-compliance to Study Procedures|0|||
126552270|NCT01254565|455318292|FG000|Overall Study|Did not Receive Treatment|1|||
126552271|NCT01254565|455318293|FG001|Overall Study|Did not Receive Treatment|1|||
126552272|NCT01254565|455318294|FG002|Overall Study|Did not Receive Treatment|0|||
126552273|NCT01254565|455318295|FG003|Overall Study|Did not Receive Treatment|0|||
126552274|NCT01254565|455318296|FG004|Overall Study|Did not Receive Treatment|3|||
126552275|NCT01254565|455318297|FG005|Overall Study|Did not Receive Treatment|4|||
126552276|NCT01254565|455318292|FG000|Overall Study|Other|0|||
126552277|NCT01254565|455318293|FG001|Overall Study|Other|0|||
126552278|NCT01254565|455318294|FG002|Overall Study|Other|0|||
126552279|NCT01254565|455318295|FG003|Overall Study|Other|1|||
126552280|NCT01254565|455318296|FG004|Overall Study|Other|0|||
126552281|NCT01254565|455318297|FG005|Overall Study|Other|0|||
126552282|NCT00472186|455318298|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
126716319|NCT01070550|455913091|FG000|Overall Study|Other|5|||
126716320|NCT01070550|455913092|FG001|Overall Study|Other|0|||
126716321|NCT01070550|455913093|FG002|Overall Study|Other|0|||
126308030|NCT01668173|454416143|FG000|Overall Study|Trial suspension|4|||
126308031|NCT00746564|454416144|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
126308032|NCT01628198|454416146|FG000|Overall Study|Lost to Follow-up|7|||
126308033|NCT01628198|454416146|FG000|Overall Study|Withdrawal by Subject|10|||
126308034|NCT01628198|454416146|FG000|Overall Study|Screen failure|1|||
126308035|NCT00986921|454416155|FG000|Overall Study|Physician Decision|1|||
126308036|NCT00986921|454416156|FG001|Overall Study|Physician Decision|0|||
126308037|NCT00833482|454416157|FG000|Days 11-20|Adverse Event|0|||
126308038|NCT00833482|454416158|FG001|Days 11-20|Adverse Event|2|||
126308039|NCT00833482|454416159|FG002|Days 11-20|Adverse Event|0|||
126308040|NCT00833482|454416160|FG003|Days 11-20|Adverse Event|0|||
126308041|NCT00833482|454416161|FG004|Days 11-20|Adverse Event|0|||
126308042|NCT00833482|454416162|FG005|Days 11-20|Adverse Event|0|||
126308043|NCT00833482|454416157|FG000|Days 11-20|Withdrawal by Subject|0|||
126308044|NCT00833482|454416158|FG001|Days 11-20|Withdrawal by Subject|1|||
126308045|NCT00833482|454416159|FG002|Days 11-20|Withdrawal by Subject|0|||
126308046|NCT00833482|454416160|FG003|Days 11-20|Withdrawal by Subject|0|||
126308047|NCT00833482|454416161|FG004|Days 11-20|Withdrawal by Subject|0|||
126308048|NCT00833482|454416162|FG005|Days 11-20|Withdrawal by Subject|0|||
126308049|NCT00833482|454416157|FG000|Days 21-30|Adverse Event|0|||
126308050|NCT00833482|454416158|FG001|Days 21-30|Adverse Event|0|||
126308051|NCT00833482|454416159|FG002|Days 21-30|Adverse Event|1|||
126308052|NCT00833482|454416160|FG003|Days 21-30|Adverse Event|0|||
126308053|NCT00833482|454416161|FG004|Days 21-30|Adverse Event|0|||
126308054|NCT00833482|454416162|FG005|Days 21-30|Adverse Event|0|||
126552283|NCT00472186|455318299|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
126716322|NCT01070550|455913094|FG003|Overall Study|Other|1|||
126716323|NCT01070550|455913095|FG004|Overall Study|Other|0|||
126716324|NCT01070550|455913096|FG005|Overall Study|Other|0|||
126716325|NCT01070550|455913091|FG000|Overall Study|Withdrawal by Subject|35|||
126716326|NCT01070550|455913092|FG001|Overall Study|Withdrawal by Subject|0|||
126716327|NCT01070550|455913093|FG002|Overall Study|Withdrawal by Subject|3|||
126716328|NCT01070550|455913094|FG003|Overall Study|Withdrawal by Subject|0|||
126716329|NCT01070550|455913095|FG004|Overall Study|Withdrawal by Subject|0|||
126716330|NCT01070550|455913096|FG005|Overall Study|Withdrawal by Subject|0|||
126716331|NCT01585961|455913097|FG000|Overall Study|Death|6|||
126716332|NCT01585961|455913097|FG000|Overall Study|Physician Decision|1|||
126716333|NCT01585961|455913097|FG000|Overall Study|Decision to use non-study catheter|1|||
126716334|NCT01585961|455913097|FG000|Overall Study|Withdrawal by Subject|1|||
126716335|NCT01585961|455913097|FG000|Overall Study|Lost to Follow-up|23|||
126716336|NCT01585961|455913097|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
126371187|NCT00673920|454656696|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
126371188|NCT00673920|454656689|FG000|Baseline up to Week 48|Protocol Violation|0|||
126371189|NCT00673920|454656690|FG001|Baseline up to Week 48|Protocol Violation|0|||
126371190|NCT00673920|454656691|FG002|Baseline up to Week 48|Protocol Violation|1|||
126371191|NCT00673920|454656692|FG003|Baseline up to Week 48|Protocol Violation|0|||
126371192|NCT00673920|454656693|FG004|Baseline up to Week 48|Protocol Violation|0|||
126371193|NCT00673920|454656694|FG005|Baseline up to Week 48|Protocol Violation|0|||
126371194|NCT00673920|454656695|FG006|Baseline up to Week 48|Protocol Violation|0|||
126371195|NCT00673920|454656696|FG007|Baseline up to Week 48|Protocol Violation|0|||
126371196|NCT00673920|454656689|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371197|NCT00673920|454656690|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371198|NCT00673920|454656691|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
126371199|NCT00673920|454656692|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371200|NCT00673920|454656693|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371201|NCT00673920|454656694|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371202|NCT00673920|454656695|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371203|NCT00673920|454656696|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
126371204|NCT00673920|454656689|FG000|Baseline up to Week 48|Administrative/Other|0|||
126371205|NCT00673920|454656690|FG001|Baseline up to Week 48|Administrative/Other|1|||
126464561|NCT01610271|455002056|FG000|Overall Study|Surgery not complete|0|||
126716337|NCT01258348|455913098|FG000|Overall Study|Adverse Event|1|||
126716338|NCT01258348|455913099|FG001|Overall Study|Adverse Event|1|||
126716339|NCT01258348|455913100|FG002|Overall Study|Adverse Event|3|||
126716340|NCT01258348|455913101|FG003|Overall Study|Adverse Event|2|||
126716341|NCT01258348|455913102|FG004|Overall Study|Adverse Event|4|||
126716342|NCT01258348|455913098|FG000|Overall Study|Progressive Disease|0|||
126716343|NCT01258348|455913099|FG001|Overall Study|Progressive Disease|3|||
126716344|NCT01258348|455913100|FG002|Overall Study|Progressive Disease|0|||
126716345|NCT01258348|455913101|FG003|Overall Study|Progressive Disease|2|||
126716346|NCT01258348|455913102|FG004|Overall Study|Progressive Disease|2|||
126371206|NCT00673920|454656691|FG002|Baseline up to Week 48|Administrative/Other|2|||
126464562|NCT01610271|455002057|FG001|Overall Study|Surgery not complete|1|||
126464563|NCT01610271|455002056|FG000|Overall Study|Prosthesis not implanted|2|||
126464564|NCT01610271|455002057|FG001|Overall Study|Prosthesis not implanted|3|||
126464565|NCT00364130|455002058|FG000|Intervention Period|Lost to Follow-up|4|||
126464566|NCT00364130|455002059|FG001|Intervention Period|Lost to Follow-up|3|||
126464567|NCT00364130|455002058|FG000|Intervention Period|Pregnancy|1|||
126464568|NCT00364130|455002059|FG001|Intervention Period|Pregnancy|0|||
126464569|NCT00364130|455002058|FG000|Intervention Period|Withdrawal by Subject|4|||
126464570|NCT00364130|455002059|FG001|Intervention Period|Withdrawal by Subject|5|||
126464571|NCT00364130|455002058|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
126464572|NCT00364130|455002059|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
126464573|NCT00410202|455002060|FG000|On-Treatment|Continuing treatment|69|||
126464574|NCT00410202|455002061|FG001|On-Treatment|Continuing treatment|71|||
126464575|NCT00410202|455002062|FG002|On-Treatment|Continuing treatment|66|||
126464576|NCT00410202|455002060|FG000|On-Treatment|Adverse Event|1|||
126464577|NCT00410202|455002061|FG001|On-Treatment|Adverse Event|3|||
126464578|NCT00410202|455002062|FG002|On-Treatment|Adverse Event|2|||
126464579|NCT00410202|455002060|FG000|On-Treatment|Death|1|||
126464580|NCT00410202|455002061|FG001|On-Treatment|Death|0|||
126464581|NCT00410202|455002062|FG002|On-Treatment|Death|0|||
126464582|NCT00410202|455002060|FG000|On-Treatment|Lost to Follow-up|1|||
126371207|NCT00673920|454656692|FG003|Baseline up to Week 48|Administrative/Other|0|||
126464583|NCT00410202|455002061|FG001|On-Treatment|Lost to Follow-up|0|||
126464584|NCT00410202|455002062|FG002|On-Treatment|Lost to Follow-up|1|||
126371208|NCT00673920|454656693|FG004|Baseline up to Week 48|Administrative/Other|0|||
126464585|NCT00410202|455002060|FG000|On-Treatment|Lack of Efficacy|1|||
126716347|NCT01258348|455913098|FG000|Overall Study|Physician Decision|0|||
126716348|NCT01258348|455913099|FG001|Overall Study|Physician Decision|0|||
126716349|NCT01258348|455913100|FG002|Overall Study|Physician Decision|0|||
126716350|NCT01258348|455913101|FG003|Overall Study|Physician Decision|2|||
126308055|NCT00833482|454416157|FG000|Days 21-30|Withdrawal by Subject|0|||
126308056|NCT00833482|454416158|FG001|Days 21-30|Withdrawal by Subject|0|||
126308057|NCT00833482|454416159|FG002|Days 21-30|Withdrawal by Subject|0|||
126308058|NCT00833482|454416160|FG003|Days 21-30|Withdrawal by Subject|0|||
126308059|NCT00833482|454416161|FG004|Days 21-30|Withdrawal by Subject|1|||
126308060|NCT00833482|454416162|FG005|Days 21-30|Withdrawal by Subject|0|||
126308061|NCT02778074|454416163|FG000|Overall Study|Lost to Follow-up|7|||
126308062|NCT02778074|454416164|FG001|Overall Study|Lost to Follow-up|10|||
126308063|NCT01817582|454416165|FG000|Overall Study|Withdrawal by Subject|0|||
126308064|NCT01817582|454416166|FG001|Overall Study|Withdrawal by Subject|1|||
126308065|NCT01817582|454416167|FG002|Overall Study|Withdrawal by Subject|0|||
126308066|NCT01817582|454416165|FG000|Overall Study|Participant revealed masked treatment|1|||
126308067|NCT01817582|454416166|FG001|Overall Study|Participant revealed masked treatment|0|||
126308068|NCT01817582|454416167|FG002|Overall Study|Participant revealed masked treatment|0|||
126308069|NCT01817582|454416165|FG000|Overall Study|Randomized but exclusion criteria met|1|||
126308070|NCT01817582|454416166|FG001|Overall Study|Randomized but exclusion criteria met|0|||
126308071|NCT01817582|454416167|FG002|Overall Study|Randomized but exclusion criteria met|0|||
126308072|NCT03617770|454416170|FG000|Overall Study|Lost to Follow-up|1|||
126308073|NCT03617770|454416171|FG001|Overall Study|Lost to Follow-up|0|||
126308074|NCT00356135|454416172|FG000|Overall Study|Protocol Violation|1|||
126308075|NCT00356135|454416173|FG001|Overall Study|Protocol Violation|0|||
126308076|NCT00356135|454416174|FG002|Overall Study|Protocol Violation|0|||
126308077|NCT00356135|454416172|FG000|Overall Study|Adverse Event|1|||
126308078|NCT00356135|454416173|FG001|Overall Study|Adverse Event|0|||
126308079|NCT00356135|454416174|FG002|Overall Study|Adverse Event|0|||
126308080|NCT00356135|454416172|FG000|Overall Study|Lost to Follow-up|0|||
126308081|NCT00356135|454416173|FG001|Overall Study|Lost to Follow-up|0|||
126308082|NCT00356135|454416174|FG002|Overall Study|Lost to Follow-up|1|||
126308083|NCT00356135|454416172|FG000|Overall Study|Physician Decision|1|||
126308084|NCT00356135|454416173|FG001|Overall Study|Physician Decision|1|||
126308085|NCT00356135|454416174|FG002|Overall Study|Physician Decision|1|||
126308086|NCT00356135|454416172|FG000|Overall Study|Subject non-compliance|1|||
126308087|NCT00356135|454416173|FG001|Overall Study|Subject non-compliance|1|||
126308088|NCT00356135|454416174|FG002|Overall Study|Subject non-compliance|3|||
126308089|NCT03963232|454416175|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
126308090|NCT03963232|454416176|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
126308091|NCT03963232|454416175|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
126308092|NCT03963232|454416176|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
126308093|NCT03963232|454416175|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
126308094|NCT03963232|454416176|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
126308095|NCT03963232|454416175|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
126308096|NCT03963232|454416176|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
126308097|NCT03963232|454416175|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
126308098|NCT03963232|454416176|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
126308099|NCT03963232|454416175|FG000|Open-Label Treatment Phase|Adverse Event|1|||
126308100|NCT03963232|454416176|FG001|Open-Label Treatment Phase|Adverse Event|2|||
126308101|NCT03963232|454416175|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
126308102|NCT03963232|454416176|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
126308103|NCT03963232|454416175|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
126308104|NCT03963232|454416176|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
126308105|NCT03963232|454416175|FG000|Open-Label Treatment Phase|Pregnancy|1|||
126308106|NCT03963232|454416176|FG001|Open-Label Treatment Phase|Pregnancy|0|||
126308107|NCT03963232|454416175|FG000|Follow-up Phase|Withdrawal by Subject|7|||
126308108|NCT03963232|454416176|FG001|Follow-up Phase|Withdrawal by Subject|5|||
126308109|NCT03963232|454416175|FG000|Follow-up Phase|Protocol Violation|0|||
126308110|NCT03963232|454416176|FG001|Follow-up Phase|Protocol Violation|2|||
126308111|NCT03963232|454416175|FG000|Follow-up Phase|Adverse Event|0|||
126308112|NCT03963232|454416176|FG001|Follow-up Phase|Adverse Event|1|||
126308113|NCT03963232|454416175|FG000|Follow-up Phase|Lost to Follow-up|0|||
126308114|NCT03963232|454416176|FG001|Follow-up Phase|Lost to Follow-up|1|||
126308115|NCT03512210|454416178|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
126308116|NCT03512210|454416178|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
126308117|NCT03512210|454416178|FG000|Step 2:Post-MINMON|Death|2|||
126308118|NCT03512210|454416178|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
126464586|NCT00410202|455002061|FG001|On-Treatment|Lack of Efficacy|4|||
126464587|NCT00410202|455002062|FG002|On-Treatment|Lack of Efficacy|0|||
126464588|NCT00410202|455002060|FG000|On-Treatment|Withdrawal by Subject|2|||
126464589|NCT00410202|455002061|FG001|On-Treatment|Withdrawal by Subject|1|||
126464590|NCT00410202|455002062|FG002|On-Treatment|Withdrawal by Subject|1|||
126464591|NCT00410202|455002060|FG000|On-Treatment|Other Reason|0|||
126464592|NCT00410202|455002061|FG001|On-Treatment|Other Reason|0|||
126464593|NCT00410202|455002062|FG002|On-Treatment|Other Reason|1|||
126716351|NCT01258348|455913102|FG004|Overall Study|Physician Decision|0|||
126308119|NCT03512210|454416178|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
126308120|NCT00378508|454418629|FG000|Overall Study|Withdrawal by Subject|1|||
126464594|NCT00410202|455002060|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
126464595|NCT00410202|455002061|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
126464596|NCT00410202|455002062|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
126464597|NCT00410202|455002060|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
126464598|NCT00410202|455002061|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
126308121|NCT00378508|454418630|FG001|Overall Study|Withdrawal by Subject|3|||
126308122|NCT00378508|454418629|FG000|Overall Study|Lost to Follow-up|1|||
126308123|NCT00378508|454418630|FG001|Overall Study|Lost to Follow-up|0|||
126308124|NCT03467217|454418631|FG000|Overall Study|Trial stopped early|5|||
126308125|NCT03467217|454418632|FG001|Overall Study|Trial stopped early|2|||
126308126|NCT03467217|454418631|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
126308127|NCT03467217|454418632|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
126308128|NCT03467217|454418631|FG000|Overall Study|Lost to Follow-up|0|||
126308129|NCT03467217|454418632|FG001|Overall Study|Lost to Follow-up|2|||
126308130|NCT03991299|454418635|FG000|Overall Study|Study closed, sponsor decision|3|||
126308131|NCT03991299|454418635|FG000|Overall Study|Withdrawal by Subject|1|||
126308132|NCT04304235|454418636|FG000|Overall Study|incomplete triage data|0|||
126308133|NCT04304235|454418637|FG001|Overall Study|incomplete triage data|69|||
126308134|NCT04304235|454418638|FG002|Overall Study|incomplete triage data|0|||
126308135|NCT04304235|454418639|FG003|Overall Study|incomplete triage data|0|||
126308136|NCT04304235|454418640|FG004|Overall Study|incomplete triage data|289|||
126308137|NCT04304235|454418641|FG005|Overall Study|incomplete triage data|123|||
126308138|NCT04304235|454418642|FG006|Overall Study|incomplete triage data|65|||
126308139|NCT03728426|454418649|FG000|Overall Study|Death|3|||
126308140|NCT04429555|454418653|FG000|Overall Study|Death|0|||
126308141|NCT04429555|454418654|FG001|Overall Study|Death|2|||
126308142|NCT04429555|454418653|FG000|Overall Study|Other|2|||
126308143|NCT04429555|454418654|FG001|Overall Study|Other|0|||
126308144|NCT00231114|454418656|FG000|Randomized|Withdrawal by Subject|6|||
126308145|NCT00231114|454418657|FG001|Randomized|Withdrawal by Subject|3|||
126308146|NCT00231114|454418656|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
126308147|NCT00231114|454418657|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
126308148|NCT00231114|454418656|FG000|Post-Treatment Period|Lost to Follow-up|6|||
126308149|NCT00231114|454418657|FG001|Post-Treatment Period|Lost to Follow-up|1|||
126308150|NCT00231114|454418656|FG000|Post-Treatment Period|Physician Decision|1|||
126308151|NCT00231114|454418657|FG001|Post-Treatment Period|Physician Decision|0|||
126308152|NCT00231114|454418656|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
126308153|NCT00231114|454418657|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
126308154|NCT04470544|454418658|FG000|Overall Study|Withdrawal by Subject|4|||
126308155|NCT04470544|454418659|FG001|Overall Study|Withdrawal by Subject|6|||
126308156|NCT00712881|454418661|FG000|Overall Study|Adverse Event|3|||
126308157|NCT00712881|454418662|FG001|Overall Study|Adverse Event|3|||
126308158|NCT00712881|454418661|FG000|Overall Study|Withdrawal by Subject|1|||
126308159|NCT00712881|454418662|FG001|Overall Study|Withdrawal by Subject|1|||
126308160|NCT00712881|454418661|FG000|Overall Study|Disease Progression|2|||
126308161|NCT00712881|454418662|FG001|Overall Study|Disease Progression|1|||
126308162|NCT00712881|454418661|FG000|Overall Study|Lost to Follow-up|1|||
126308163|NCT00712881|454418662|FG001|Overall Study|Lost to Follow-up|1|||
126308164|NCT00712881|454418661|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
126308165|NCT00712881|454418662|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
126308166|NCT00712881|454418661|FG000|Overall Study|Protocol Violation|1|||
126308167|NCT00712881|454418662|FG001|Overall Study|Protocol Violation|1|||
126308168|NCT00712881|454418661|FG000|Overall Study|Randomized but not treated|1|||
126308169|NCT00712881|454418662|FG001|Overall Study|Randomized but not treated|0|||
126308170|NCT01194999|454418663|FG000|Overall Study|Lost to Follow-up|17|||
126308171|NCT05835011|454418664|FG000|Overall Study|Study Terminated by the Sponsor|1|||
126308172|NCT05835011|454418664|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
126308173|NCT04720911|454418669|FG000|Overall Study|Withdrawal by Subject|0|||
126464599|NCT00410202|455002062|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
126308174|NCT04720911|454418670|FG001|Overall Study|Withdrawal by Subject|1|||
126308175|NCT04720911|454418671|FG002|Overall Study|Withdrawal by Subject|0|||
126308176|NCT00090220|454418672|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
126308177|NCT00090220|454418673|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
126308178|NCT00090220|454418674|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126308179|NCT00090220|454418675|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126308180|NCT00090220|454418676|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126308181|NCT00090220|454418677|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126308182|NCT00090220|454418672|FG000|Base Study Vaccination Period|Adverse Event|6|||
126464600|NCT00410202|455002060|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
126308183|NCT00090220|454418673|FG001|Base Study Vaccination Period|Adverse Event|1|||
126308184|NCT00090220|454418674|FG002|Base Study Vaccination Period|Adverse Event|0|||
126308185|NCT00090220|454418675|FG003|Base Study Vaccination Period|Adverse Event|0|||
126308186|NCT00090220|454418676|FG004|Base Study Vaccination Period|Adverse Event|0|||
126308187|NCT00090220|454418677|FG005|Base Study Vaccination Period|Adverse Event|0|||
126308188|NCT00090220|454418672|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
126308189|NCT00090220|454418673|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
126308190|NCT00090220|454418674|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
126308191|NCT00090220|454418675|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
126308192|NCT00090220|454418676|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
126308193|NCT00090220|454418677|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
126308194|NCT00090220|454418672|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
126308195|NCT00090220|454418673|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
126308196|NCT00090220|454418674|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
126308197|NCT00090220|454418675|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
126308198|NCT00090220|454418676|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
126308199|NCT00090220|454418677|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
126308200|NCT00090220|454418672|FG000|Base Study Vaccination Period|Patient Moved|6|||
126308201|NCT00090220|454418673|FG001|Base Study Vaccination Period|Patient Moved|2|||
126308202|NCT00090220|454418674|FG002|Base Study Vaccination Period|Patient Moved|0|||
126308203|NCT00090220|454418675|FG003|Base Study Vaccination Period|Patient Moved|0|||
126308204|NCT00090220|454418676|FG004|Base Study Vaccination Period|Patient Moved|0|||
126308205|NCT00090220|454418677|FG005|Base Study Vaccination Period|Patient Moved|0|||
126308206|NCT00090220|454418672|FG000|Base Study Vaccination Period|Other|4|||
126308207|NCT00090220|454418673|FG001|Base Study Vaccination Period|Other|4|||
126308208|NCT00090220|454418674|FG002|Base Study Vaccination Period|Other|0|||
126308209|NCT00090220|454418675|FG003|Base Study Vaccination Period|Other|0|||
126308210|NCT00090220|454418676|FG004|Base Study Vaccination Period|Other|0|||
126308211|NCT00090220|454418677|FG005|Base Study Vaccination Period|Other|0|||
126308212|NCT00090220|454418672|FG000|Base Study Follow-up Period|Adverse Event|6|||
126308213|NCT00090220|454418673|FG001|Base Study Follow-up Period|Adverse Event|1|||
126308214|NCT00090220|454418674|FG002|Base Study Follow-up Period|Adverse Event|0|||
126308215|NCT00090220|454418675|FG003|Base Study Follow-up Period|Adverse Event|0|||
126308216|NCT00090220|454418676|FG004|Base Study Follow-up Period|Adverse Event|0|||
126308217|NCT00090220|454418677|FG005|Base Study Follow-up Period|Adverse Event|0|||
126308218|NCT00090220|454418672|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
126308219|NCT00090220|454418673|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
126308220|NCT00090220|454418674|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
126308221|NCT00090220|454418675|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
126308222|NCT00090220|454418676|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
126308223|NCT00090220|454418677|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
126308224|NCT00090220|454418672|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
126308225|NCT00090220|454418673|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
126308226|NCT00090220|454418674|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
126308227|NCT00090220|454418675|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
126308228|NCT00090220|454418676|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
126308229|NCT00090220|454418677|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
126308230|NCT00090220|454418672|FG000|Base Study Follow-up Period|Patient Moved|20|||
126308231|NCT00090220|454418673|FG001|Base Study Follow-up Period|Patient Moved|28|||
126308232|NCT00090220|454418674|FG002|Base Study Follow-up Period|Patient Moved|0|||
126308233|NCT00090220|454418675|FG003|Base Study Follow-up Period|Patient Moved|0|||
126308234|NCT00090220|454418676|FG004|Base Study Follow-up Period|Patient Moved|0|||
126308235|NCT00090220|454418677|FG005|Base Study Follow-up Period|Patient Moved|0|||
126308236|NCT00090220|454418672|FG000|Base Study Follow-up Period|Other|19|||
126308237|NCT00090220|454418673|FG001|Base Study Follow-up Period|Other|21|||
126308238|NCT00090220|454418674|FG002|Base Study Follow-up Period|Other|0|||
126308239|NCT00090220|454418675|FG003|Base Study Follow-up Period|Other|0|||
126308240|NCT00090220|454418676|FG004|Base Study Follow-up Period|Other|0|||
126308241|NCT00090220|454418677|FG005|Base Study Follow-up Period|Other|0|||
126308242|NCT00090220|454418672|FG000|Extension 1 (EXT1)|Adverse Event|0|||
126308243|NCT00090220|454418673|FG001|Extension 1 (EXT1)|Adverse Event|0|||
126308244|NCT00090220|454418674|FG002|Extension 1 (EXT1)|Adverse Event|4|||
126308245|NCT00090220|454418675|FG003|Extension 1 (EXT1)|Adverse Event|0|||
126308246|NCT00090220|454418676|FG004|Extension 1 (EXT1)|Adverse Event|0|||
126308247|NCT00090220|454418677|FG005|Extension 1 (EXT1)|Adverse Event|0|||
126464601|NCT00410202|455002061|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
126464602|NCT00410202|455002062|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
126464603|NCT00144027|455002064|FG000|Overall Study|Lost to Follow-up|1|||
126464604|NCT00144027|455002065|FG001|Overall Study|Lost to Follow-up|3|||
126464605|NCT00144027|455002064|FG000|Overall Study|Withdrawal by Subject|2|||
126716352|NCT01258348|455913098|FG000|Overall Study|Withdrawal by Subject|0|||
126716353|NCT01258348|455913099|FG001|Overall Study|Withdrawal by Subject|1|||
126308248|NCT00090220|454418672|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
126308249|NCT00090220|454418673|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
126308250|NCT00090220|454418674|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
126308251|NCT00090220|454418675|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
126308252|NCT00090220|454418676|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
126552284|NCT03354637|455318304|FG000|Double-blind Period|Protocol Violation|2|||
126552285|NCT03354637|455318305|FG001|Double-blind Period|Protocol Violation|0|||
126552286|NCT03354637|455318306|FG002|Double-blind Period|Protocol Violation|0|||
126552287|NCT03354637|455318304|FG000|Double-blind Period|Adverse Event|1|||
126552288|NCT03354637|455318305|FG001|Double-blind Period|Adverse Event|2|||
126552289|NCT03354637|455318306|FG002|Double-blind Period|Adverse Event|0|||
126552290|NCT03354637|455318304|FG000|Double-blind Period|Lost to Follow-up|3|||
126552291|NCT03354637|455318305|FG001|Double-blind Period|Lost to Follow-up|4|||
126552292|NCT03354637|455318306|FG002|Double-blind Period|Lost to Follow-up|3|||
126552293|NCT03354637|455318304|FG000|Double-blind Period|Withdrawal by Subject|10|||
126552294|NCT03354637|455318305|FG001|Double-blind Period|Withdrawal by Subject|6|||
126552295|NCT03354637|455318306|FG002|Double-blind Period|Withdrawal by Subject|4|||
126552296|NCT03354637|455318304|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
126552297|NCT03354637|455318305|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
126552298|NCT03354637|455318306|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
126552299|NCT03354637|455318304|FG000|Open Label Extension|Adverse Event|0|||
126552300|NCT03354637|455318305|FG001|Open Label Extension|Adverse Event|0|||
126552301|NCT03354637|455318306|FG002|Open Label Extension|Adverse Event|1|||
126552302|NCT03354637|455318304|FG000|Open Label Extension|Lost to Follow-up|0|||
126552303|NCT03354637|455318305|FG001|Open Label Extension|Lost to Follow-up|0|||
126552304|NCT03354637|455318306|FG002|Open Label Extension|Lost to Follow-up|2|||
126552305|NCT03354637|455318304|FG000|Open Label Extension|Withdrawal by Subject|0|||
126552306|NCT03354637|455318305|FG001|Open Label Extension|Withdrawal by Subject|0|||
126552307|NCT03354637|455318306|FG002|Open Label Extension|Withdrawal by Subject|5|||
126552308|NCT03354637|455318304|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
126552309|NCT03354637|455318305|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
126552310|NCT03354637|455318306|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
126552311|NCT03354637|455318304|FG000|Open Label Extension|Subject Noncompliance|0|||
126552312|NCT03354637|455318305|FG001|Open Label Extension|Subject Noncompliance|0|||
126552313|NCT03354637|455318306|FG002|Open Label Extension|Subject Noncompliance|1|||
126552314|NCT03354637|455318304|FG000|Open Label Extension|Lack of Efficacy|0|||
126552315|NCT03354637|455318305|FG001|Open Label Extension|Lack of Efficacy|0|||
126552316|NCT03354637|455318306|FG002|Open Label Extension|Lack of Efficacy|1|||
126552317|NCT03354637|455318304|FG000|Open Label Extension|Physician Decision|0|||
126552318|NCT03354637|455318305|FG001|Open Label Extension|Physician Decision|0|||
126552319|NCT03354637|455318306|FG002|Open Label Extension|Physician Decision|1|||
126552320|NCT02726399|455318307|FG000|Overall Study|Participant Non-Compliance|1|||
126552321|NCT02726399|455318307|FG000|Overall Study|Adverse Event|2|||
126552322|NCT02726399|455318307|FG000|Overall Study|Progression of disease|4|||
126552323|NCT04430335|455318308|FG000|Overall Study|Withdrawal by Subject|1|||
126552324|NCT02564055|455318309|FG000|Overall Study|Adverse Event|1|||
126552325|NCT02564055|455318310|FG001|Overall Study|Adverse Event|0|||
126552326|NCT02564055|455318311|FG002|Overall Study|Adverse Event|4|||
126552327|NCT02564055|455318312|FG003|Overall Study|Adverse Event|1|||
126552328|NCT02564055|455318313|FG004|Overall Study|Adverse Event|4|||
126552329|NCT02564055|455318314|FG005|Overall Study|Adverse Event|1|||
126552330|NCT02564055|455318309|FG000|Overall Study|Protocol Violation|1|||
126552331|NCT02564055|455318310|FG001|Overall Study|Protocol Violation|0|||
126552332|NCT02564055|455318311|FG002|Overall Study|Protocol Violation|0|||
126552333|NCT02564055|455318312|FG003|Overall Study|Protocol Violation|0|||
126552334|NCT02564055|455318313|FG004|Overall Study|Protocol Violation|0|||
126552335|NCT02564055|455318314|FG005|Overall Study|Protocol Violation|0|||
126552336|NCT02564055|455318309|FG000|Overall Study|Reached stopping criteria|0|||
126552337|NCT02564055|455318310|FG001|Overall Study|Reached stopping criteria|0|||
126552338|NCT02564055|455318311|FG002|Overall Study|Reached stopping criteria|0|||
126552339|NCT02564055|455318312|FG003|Overall Study|Reached stopping criteria|0|||
126552340|NCT02564055|455318313|FG004|Overall Study|Reached stopping criteria|0|||
126552341|NCT02564055|455318314|FG005|Overall Study|Reached stopping criteria|1|||
126552342|NCT02564055|455318309|FG000|Overall Study|Lost to Follow-up|0|||
126552343|NCT02564055|455318310|FG001|Overall Study|Lost to Follow-up|1|||
126716354|NCT01258348|455913100|FG002|Overall Study|Withdrawal by Subject|0|||
126716355|NCT01258348|455913101|FG003|Overall Study|Withdrawal by Subject|0|||
126716356|NCT01258348|455913102|FG004|Overall Study|Withdrawal by Subject|0|||
126308253|NCT00090220|454418677|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
126308254|NCT00090220|454418672|FG000|Extension 1 (EXT1)|Moved|0|||
126552344|NCT02564055|455318311|FG002|Overall Study|Lost to Follow-up|4|||
126552345|NCT02564055|455318312|FG003|Overall Study|Lost to Follow-up|2|||
126552346|NCT02564055|455318313|FG004|Overall Study|Lost to Follow-up|1|||
126552347|NCT02564055|455318314|FG005|Overall Study|Lost to Follow-up|0|||
126552348|NCT02564055|455318309|FG000|Overall Study|Physician Decision|0|||
126552349|NCT02564055|455318310|FG001|Overall Study|Physician Decision|0|||
126552350|NCT02564055|455318311|FG002|Overall Study|Physician Decision|1|||
126552351|NCT02564055|455318312|FG003|Overall Study|Physician Decision|0|||
126552352|NCT02564055|455318313|FG004|Overall Study|Physician Decision|0|||
126552353|NCT02564055|455318314|FG005|Overall Study|Physician Decision|0|||
126552354|NCT02564055|455318309|FG000|Overall Study|Withdrawal by Subject|4|||
126308255|NCT00090220|454418673|FG001|Extension 1 (EXT1)|Moved|0|||
126308256|NCT00090220|454418674|FG002|Extension 1 (EXT1)|Moved|2|||
126308257|NCT00090220|454418675|FG003|Extension 1 (EXT1)|Moved|1|||
126308258|NCT00090220|454418676|FG004|Extension 1 (EXT1)|Moved|0|||
126308259|NCT00090220|454418677|FG005|Extension 1 (EXT1)|Moved|0|||
126308260|NCT00090220|454418672|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
126308261|NCT00090220|454418673|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
126308262|NCT00090220|454418674|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
126308263|NCT00090220|454418675|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
126308264|NCT00090220|454418676|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
126308265|NCT00090220|454418677|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
126308266|NCT00090220|454418672|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
126371209|NCT00673920|454656694|FG005|Baseline up to Week 48|Administrative/Other|0|||
126371210|NCT00673920|454656695|FG006|Baseline up to Week 48|Administrative/Other|0|||
126371211|NCT00673920|454656696|FG007|Baseline up to Week 48|Administrative/Other|0|||
126371212|NCT00673920|454656689|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
126371213|NCT00673920|454656690|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
126371214|NCT00673920|454656691|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
126371215|NCT00673920|454656692|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
126371216|NCT00673920|454656693|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
126371217|NCT00673920|454656694|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
126371218|NCT00673920|454656695|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
126371219|NCT00673920|454656696|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
126371220|NCT00673920|454656689|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371221|NCT00673920|454656690|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371222|NCT00673920|454656691|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371223|NCT00673920|454656692|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371224|NCT00673920|454656693|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371225|NCT00673920|454656694|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371226|NCT00673920|454656695|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
126371227|NCT00673920|454656696|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
126371228|NCT00673920|454656689|FG000|Week 24 to Week 48|Failure to return|0|||
126371229|NCT00673920|454656690|FG001|Week 24 to Week 48|Failure to return|0|||
126371230|NCT00673920|454656691|FG002|Week 24 to Week 48|Failure to return|0|||
126371231|NCT00673920|454656692|FG003|Week 24 to Week 48|Failure to return|0|||
126371232|NCT00673920|454656693|FG004|Week 24 to Week 48|Failure to return|0|||
126371233|NCT00673920|454656694|FG005|Week 24 to Week 48|Failure to return|1|||
126371234|NCT00673920|454656695|FG006|Week 24 to Week 48|Failure to return|0|||
126371235|NCT00673920|454656696|FG007|Week 24 to Week 48|Failure to return|0|||
126371236|NCT00673920|454656689|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
126371237|NCT00673920|454656690|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
126371238|NCT00673920|454656691|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
126371239|NCT00673920|454656692|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
126371240|NCT00673920|454656693|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
126371241|NCT00673920|454656694|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
126371242|NCT00673920|454656695|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
126371243|NCT00673920|454656696|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
126308267|NCT00090220|454418673|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
126308268|NCT00090220|454418674|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
126308269|NCT00090220|454418675|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
126371244|NCT00673920|454656689|FG000|Week 24 to Week 48|Death|0|||
126371245|NCT00673920|454656690|FG001|Week 24 to Week 48|Death|0|||
126371246|NCT00673920|454656691|FG002|Week 24 to Week 48|Death|0|||
126371247|NCT00673920|454656692|FG003|Week 24 to Week 48|Death|0|||
126371248|NCT00673920|454656693|FG004|Week 24 to Week 48|Death|0|||
126371249|NCT00673920|454656694|FG005|Week 24 to Week 48|Death|1|||
126371250|NCT00673920|454656695|FG006|Week 24 to Week 48|Death|0|||
126464606|NCT00144027|455002065|FG001|Overall Study|Withdrawal by Subject|2|||
126464607|NCT00144027|455002064|FG000|Overall Study|did not complete baseline assessment|0|||
126464608|NCT00144027|455002065|FG001|Overall Study|did not complete baseline assessment|6|||
126464609|NCT00285207|455002066|FG000|Overall Study|Lost to Follow-up|3|||
126464610|NCT00285207|455002067|FG001|Overall Study|Lost to Follow-up|2|||
126464611|NCT00285207|455002066|FG000|Overall Study|Withdrawal by Subject|5|||
126464612|NCT00285207|455002067|FG001|Overall Study|Withdrawal by Subject|2|||
126464613|NCT00285207|455002066|FG000|Overall Study|Pregnancy|1|||
126464614|NCT00285207|455002067|FG001|Overall Study|Pregnancy|1|||
126464615|NCT00285207|455002066|FG000|Overall Study|non-compliance|0|||
126464616|NCT00285207|455002067|FG001|Overall Study|non-compliance|1|||
126464617|NCT04521777|455003825|FG000|Overall Study|Death|2|||
126464618|NCT04521777|455003825|FG000|Overall Study|Withdrawal by Subject|2|||
126308270|NCT00090220|454418676|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
126308271|NCT00090220|454418677|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
126308272|NCT00090220|454418672|FG000|Extension 1 (EXT1)|Other reason|0|||
126308273|NCT00090220|454418673|FG001|Extension 1 (EXT1)|Other reason|0|||
126770920|NCT03456726|456116207|FG001|Overall Study|Adverse Event|2|||
126770921|NCT03456726|456116206|FG000|Overall Study|Withdrawal by Subject|1|||
126770922|NCT03456726|456116207|FG001|Overall Study|Withdrawal by Subject|0|||
126308274|NCT00090220|454418674|FG002|Extension 1 (EXT1)|Other reason|2|||
126308275|NCT00090220|454418675|FG003|Extension 1 (EXT1)|Other reason|0|||
126308276|NCT00090220|454418676|FG004|Extension 1 (EXT1)|Other reason|0|||
126308277|NCT00090220|454418677|FG005|Extension 1 (EXT1)|Other reason|0|||
126308278|NCT00090220|454418672|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126308279|NCT00090220|454418673|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126308280|NCT00090220|454418674|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126308281|NCT00090220|454418675|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
126308282|NCT00090220|454418676|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
126308283|NCT00090220|454418677|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
126308284|NCT00090220|454418672|FG000|Long-term Follow-up (EXT2)|Death|0|||
126308285|NCT00090220|454418673|FG001|Long-term Follow-up (EXT2)|Death|0|||
126308286|NCT00090220|454418674|FG002|Long-term Follow-up (EXT2)|Death|0|||
126308287|NCT00090220|454418675|FG003|Long-term Follow-up (EXT2)|Death|0|||
126308288|NCT00090220|454418676|FG004|Long-term Follow-up (EXT2)|Death|1|||
126308289|NCT00090220|454418677|FG005|Long-term Follow-up (EXT2)|Death|1|||
126308290|NCT00090220|454418672|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126308291|NCT00090220|454418673|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126308292|NCT00090220|454418674|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126308293|NCT00090220|454418675|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
126308294|NCT00090220|454418676|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
126308295|NCT00090220|454418677|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
126308296|NCT00090220|454418672|FG000|Long-term Follow-up (EXT2)|Other|0|||
126308297|NCT00090220|454418673|FG001|Long-term Follow-up (EXT2)|Other|0|||
126308298|NCT00090220|454418674|FG002|Long-term Follow-up (EXT2)|Other|0|||
126308299|NCT00090220|454418675|FG003|Long-term Follow-up (EXT2)|Other|0|||
126308300|NCT00090220|454418676|FG004|Long-term Follow-up (EXT2)|Other|1|||
126308301|NCT00090220|454418677|FG005|Long-term Follow-up (EXT2)|Other|0|||
126308302|NCT00941863|454418678|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
126308303|NCT00941863|454418679|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
126308304|NCT00941863|454418680|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
126308305|NCT00941863|454418681|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
126308306|NCT00941863|454418682|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
126308307|NCT00941863|454418678|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
126308308|NCT00941863|454418679|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
126308309|NCT00941863|454418680|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
126308310|NCT00941863|454418681|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
126308311|NCT00941863|454418682|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
126308312|NCT00941863|454418678|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
126308313|NCT00941863|454418679|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
126308314|NCT00941863|454418680|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
126308315|NCT00941863|454418681|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
126308316|NCT00941863|454418682|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
126308317|NCT00941863|454418678|FG000|Until Primary Completion Date (PCD)|Death|0|||
126308318|NCT00941863|454418679|FG001|Until Primary Completion Date (PCD)|Death|0|||
126308319|NCT00941863|454418680|FG002|Until Primary Completion Date (PCD)|Death|1|||
126308320|NCT00941863|454418681|FG003|Until Primary Completion Date (PCD)|Death|2|||
126308321|NCT00941863|454418682|FG004|Until Primary Completion Date (PCD)|Death|7|||
126308322|NCT00941863|454418678|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
126308323|NCT00941863|454418679|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
126308324|NCT00941863|454418680|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
126308325|NCT00941863|454418681|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
126308326|NCT00941863|454418682|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
126371251|NCT00673920|454656696|FG007|Week 24 to Week 48|Death|0|||
126371252|NCT00673920|454656689|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
126371253|NCT00673920|454656690|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
126371254|NCT00673920|454656691|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
126371255|NCT00673920|454656692|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
126371256|NCT00673920|454656693|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
126371257|NCT00673920|454656694|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
126371258|NCT00673920|454656695|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
126371259|NCT00673920|454656696|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
126371260|NCT01164007|454656697|FG000|Overall Study|Adverse Event|5|||
126371261|NCT01164007|454656697|FG000|Overall Study|Progression of Disease|30|||
126371262|NCT01164007|454656697|FG000|Overall Study|Protocol Violation|1|||
126371263|NCT01164007|454656697|FG000|Overall Study|Withdrawal by Subject|1|||
126308327|NCT00941863|454418678|FG000|Continued After PCD|Withdrawal by Subject|0|||
126308328|NCT00941863|454418679|FG001|Continued After PCD|Withdrawal by Subject|0|||
126371264|NCT01164007|454656697|FG000|Overall Study|Medical Decision|3|||
126371265|NCT04856527|454656698|FG000|Overall Study|Unable to complete experimental task|2|||
126371266|NCT04856527|454656699|FG001|Overall Study|Unable to complete experimental task|0|||
126371267|NCT01816295|454656700|FG000|Double Blind Phase|Adverse Event|11|||
126371268|NCT01816295|454656701|FG001|Double Blind Phase|Adverse Event|8|||
126371269|NCT01816295|454656700|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
126371270|NCT01816295|454656701|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
126371271|NCT01816295|454656700|FG000|Double Blind Phase|Lost to Follow-up|3|||
126371272|NCT01816295|454656701|FG001|Double Blind Phase|Lost to Follow-up|5|||
126371273|NCT01816295|454656700|FG000|Double Blind Phase|Physician Decision|2|||
126371274|NCT01816295|454656701|FG001|Double Blind Phase|Physician Decision|2|||
126371275|NCT01816295|454656700|FG000|Double Blind Phase|Protocol Violation|17|||
126371276|NCT01816295|454656701|FG001|Double Blind Phase|Protocol Violation|11|||
126371277|NCT01816295|454656700|FG000|Double Blind Phase|Sponsor Decision|8|||
126371278|NCT01816295|454656701|FG001|Double Blind Phase|Sponsor Decision|8|||
126371279|NCT01816295|454656700|FG000|Double Blind Phase|Withdrawal by Subject|22|||
126371280|NCT01816295|454656701|FG001|Double Blind Phase|Withdrawal by Subject|20|||
126371281|NCT01816295|454656700|FG000|OLE Phase|Adverse Event|17|||
126371282|NCT01816295|454656701|FG001|OLE Phase|Adverse Event|15|||
126371283|NCT01816295|454656700|FG000|OLE Phase|Death|1|||
126371284|NCT01816295|454656701|FG001|OLE Phase|Death|0|||
126371285|NCT01816295|454656700|FG000|OLE Phase|Entry Criteria Not Met|3|||
126371286|NCT01816295|454656701|FG001|OLE Phase|Entry Criteria Not Met|5|||
126371287|NCT01816295|454656700|FG000|OLE Phase|Lost to Follow-up|5|||
126371288|NCT01816295|454656701|FG001|OLE Phase|Lost to Follow-up|5|||
126371289|NCT01816295|454656700|FG000|OLE Phase|Physician Decision|3|||
126371290|NCT01816295|454656701|FG001|OLE Phase|Physician Decision|1|||
126371291|NCT01816295|454656700|FG000|OLE Phase|Protocol Violation|4|||
126371292|NCT01816295|454656701|FG001|OLE Phase|Protocol Violation|4|||
126371293|NCT01816295|454656700|FG000|OLE Phase|Sponsor Decision|7|||
126371294|NCT01816295|454656701|FG001|OLE Phase|Sponsor Decision|9|||
126371295|NCT01816295|454656700|FG000|OLE Phase|Withdrawal by Subject|10|||
126371296|NCT01816295|454656701|FG001|OLE Phase|Withdrawal by Subject|10|||
126371297|NCT01816295|454656700|FG000|OLE Phase|Lack of Efficacy|3|||
126371298|NCT01816295|454656701|FG001|OLE Phase|Lack of Efficacy|7|||
126371299|NCT04165824|454656702|FG000|Overall Study|Adverse Event|23|||
126371300|NCT04165824|454656702|FG000|Overall Study|Physician Decision|1|||
126371301|NCT04165824|454656702|FG000|Overall Study|Withdrawal by Subject|17|||
126371302|NCT04165824|454656702|FG000|Overall Study|Other|5|||
126371303|NCT01823289|454656703|FG000|Overall Study|Lost to Follow-up|5|||
126371304|NCT01823289|454656703|FG000|Overall Study|Adverse Event|5|||
126371305|NCT01823289|454656703|FG000|Overall Study|Lack of Efficacy|1|||
126371306|NCT01823289|454656703|FG000|Overall Study|Physician Decision|9|||
126371307|NCT01823289|454656703|FG000|Overall Study|Administered contraindicated medicine|1|||
126371308|NCT01823289|454656703|FG000|Overall Study|Transaminase increased more than 3 times|1|||
126371309|NCT01823289|454656703|FG000|Overall Study|Drug affected efficacy and safety|1|||
126371310|NCT01823289|454656703|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
126371311|NCT01656161|454656713|FG000|Overall Study|Death|3|||
126371312|NCT01656161|454656713|FG000|Overall Study|Adverse Event|2|||
126371313|NCT01656161|454656713|FG000|Overall Study|Protocol Violation|1|||
126371314|NCT01656161|454656713|FG000|Overall Study|Withdrawal by Subject|1|||
126371315|NCT03510273|454656714|FG000|Overall Study|Withdrawal by Subject|2|||
126371316|NCT03510273|454656714|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
126371317|NCT03510273|454656714|FG000|Overall Study|Moved away from study area|4|||
126371318|NCT01276106|454656715|FG000|Overall Study|Adverse Event|3|||
126371319|NCT01276106|454656716|FG001|Overall Study|Adverse Event|3|||
126371320|NCT01276106|454656717|FG002|Overall Study|Adverse Event|11|||
126371321|NCT01276106|454656718|FG003|Overall Study|Adverse Event|3|||
126371322|NCT01276106|454656715|FG000|Overall Study|Withdrawal by Subject|6|||
126371323|NCT01276106|454656716|FG001|Overall Study|Withdrawal by Subject|3|||
126371324|NCT01276106|454656717|FG002|Overall Study|Withdrawal by Subject|1|||
126716357|NCT06094296|455913105|FG000|Overall Study|Progressive Disease|1|||
126371325|NCT01276106|454656718|FG003|Overall Study|Withdrawal by Subject|6|||
126716358|NCT06094296|455913106|FG001|Overall Study|Progressive Disease|0|||
126716359|NCT06094296|455913107|FG002|Overall Study|Progressive Disease|0|||
126716360|NCT06094296|455913108|FG003|Overall Study|Progressive Disease|0|||
126716361|NCT03332667|455913109|FG000|Overall Study|Adverse Event|0|||
126371326|NCT01276106|454656715|FG000|Overall Study|Lack of Efficacy|0|||
126716362|NCT03332667|455913110|FG001|Overall Study|Adverse Event|0|||
126371327|NCT01276106|454656716|FG001|Overall Study|Lack of Efficacy|1|||
126371328|NCT01276106|454656717|FG002|Overall Study|Lack of Efficacy|0|||
126371329|NCT01276106|454656718|FG003|Overall Study|Lack of Efficacy|1|||
126371330|NCT01276106|454656715|FG000|Overall Study|Lost to Follow-up|2|||
126371331|NCT01276106|454656716|FG001|Overall Study|Lost to Follow-up|1|||
126371332|NCT01276106|454656717|FG002|Overall Study|Lost to Follow-up|1|||
126371333|NCT01276106|454656718|FG003|Overall Study|Lost to Follow-up|0|||
126371334|NCT01276106|454656715|FG000|Overall Study|Physician Decision|0|||
126371335|NCT01276106|454656716|FG001|Overall Study|Physician Decision|0|||
126371336|NCT01276106|454656717|FG002|Overall Study|Physician Decision|1|||
126716363|NCT03332667|455913111|FG002|Overall Study|Adverse Event|2|||
126716364|NCT03332667|455913112|FG003|Overall Study|Adverse Event|1|||
126308329|NCT00941863|454418680|FG002|Continued After PCD|Withdrawal by Subject|0|||
126308330|NCT00941863|454418681|FG003|Continued After PCD|Withdrawal by Subject|0|||
126308331|NCT00941863|454418682|FG004|Continued After PCD|Withdrawal by Subject|1|||
126308332|NCT00941863|454418678|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
126308333|NCT00941863|454418679|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
126308334|NCT00941863|454418680|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
126308335|NCT00941863|454418681|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
126308336|NCT00941863|454418682|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
126308337|NCT00537316|454418683|FG000|Part 1|Adverse Event|7|||
126308338|NCT00537316|454418684|FG001|Part 1|Adverse Event|11|||
126308339|NCT00537316|454418685|FG002|Part 1|Adverse Event|8|||
126308340|NCT00537316|454418686|FG003|Part 1|Adverse Event|0|||
126308341|NCT00537316|454418687|FG004|Part 1|Adverse Event|0|||
126308342|NCT00537316|454418688|FG005|Part 1|Adverse Event|0|||
126308343|NCT00537316|454418689|FG006|Part 1|Adverse Event|0|||
126308344|NCT00537316|454418683|FG000|Part 1|Protocol defined clinical event|1|||
126308345|NCT00537316|454418684|FG001|Part 1|Protocol defined clinical event|0|||
126308346|NCT00537316|454418685|FG002|Part 1|Protocol defined clinical event|0|||
126308347|NCT00537316|454418686|FG003|Part 1|Protocol defined clinical event|0|||
126308348|NCT00537316|454418687|FG004|Part 1|Protocol defined clinical event|0|||
126308349|NCT00537316|454418688|FG005|Part 1|Protocol defined clinical event|0|||
126308350|NCT00537316|454418689|FG006|Part 1|Protocol defined clinical event|0|||
126308351|NCT00537316|454418683|FG000|Part 1|Lost to Follow-up|1|||
126308352|NCT00537316|454418684|FG001|Part 1|Lost to Follow-up|0|||
126308353|NCT00537316|454418685|FG002|Part 1|Lost to Follow-up|0|||
126308354|NCT00537316|454418686|FG003|Part 1|Lost to Follow-up|0|||
126308355|NCT00537316|454418687|FG004|Part 1|Lost to Follow-up|0|||
126308356|NCT00537316|454418688|FG005|Part 1|Lost to Follow-up|0|||
126308357|NCT00537316|454418689|FG006|Part 1|Lost to Follow-up|0|||
126308358|NCT00537316|454418683|FG000|Part 1|Withdrawal by Subject|3|||
126308359|NCT00537316|454418684|FG001|Part 1|Withdrawal by Subject|8|||
126308360|NCT00537316|454418685|FG002|Part 1|Withdrawal by Subject|4|||
126308361|NCT00537316|454418686|FG003|Part 1|Withdrawal by Subject|0|||
126308362|NCT00537316|454418687|FG004|Part 1|Withdrawal by Subject|0|||
126308363|NCT00537316|454418688|FG005|Part 1|Withdrawal by Subject|0|||
126308364|NCT00537316|454418689|FG006|Part 1|Withdrawal by Subject|0|||
126308365|NCT00537316|454418683|FG000|Part 1|Protocol Violation|1|||
126308366|NCT00537316|454418684|FG001|Part 1|Protocol Violation|5|||
126464619|NCT00900601|455003826|FG000|Overall Study|Physician Decision|1|||
126464620|NCT03026088|455003827|FG000|Overall Study|Study termination|20|||
126464621|NCT01869725|455003829|FG000|Overall Study|ineligible after registration|1|||
126464622|NCT01869725|455003829|FG000|Overall Study|Death|1|||
126464623|NCT01869725|455003829|FG000|Overall Study|Lost to Follow-up|2|||
126552355|NCT02564055|455318310|FG001|Overall Study|Withdrawal by Subject|4|||
126552356|NCT02564055|455318311|FG002|Overall Study|Withdrawal by Subject|3|||
126552357|NCT02564055|455318312|FG003|Overall Study|Withdrawal by Subject|3|||
126552358|NCT02564055|455318313|FG004|Overall Study|Withdrawal by Subject|10|||
126464624|NCT01143207|455003830|FG000|Overall Study|Lost to Follow-up|2|||
126464625|NCT03416374|455003843|FG000|Between Treatment Period I and II|Other|0|||
126464626|NCT03416374|455003844|FG001|Between Treatment Period I and II|Other|9|||
126464627|NCT03416374|455003843|FG000|Treatment Period II|Lack of Efficacy|3|||
126464628|NCT03416374|455003844|FG001|Treatment Period II|Lack of Efficacy|11|||
126552359|NCT02564055|455318314|FG005|Overall Study|Withdrawal by Subject|10|||
126552360|NCT04747275|455318315|FG000|Overall Study|Study terminated|0|||
126552361|NCT04747275|455318316|FG001|Overall Study|Study terminated|1|||
126552362|NCT00531011|455318320|FG000|Overall Study|Withdrawal by Subject|2|||
126552363|NCT00531011|455318321|FG001|Overall Study|Withdrawal by Subject|4|||
126552364|NCT00531011|455318320|FG000|Overall Study|Death|1|||
126552365|NCT00531011|455318321|FG001|Overall Study|Death|0|||
126552366|NCT00531011|455318320|FG000|Overall Study|Lost to Follow-up|1|||
126552367|NCT00531011|455318321|FG001|Overall Study|Lost to Follow-up|0|||
126308367|NCT00537316|454418685|FG002|Part 1|Protocol Violation|1|||
126308368|NCT00537316|454418686|FG003|Part 1|Protocol Violation|0|||
126308369|NCT00537316|454418687|FG004|Part 1|Protocol Violation|0|||
126308370|NCT00537316|454418688|FG005|Part 1|Protocol Violation|0|||
126308371|NCT00537316|454418689|FG006|Part 1|Protocol Violation|0|||
126552368|NCT00531011|455318320|FG000|Overall Study|Physician Decision|0|||
126308372|NCT00537316|454418683|FG000|Part 1|Did not meet protocol eligibility|1|||
126308373|NCT00537316|454418684|FG001|Part 1|Did not meet protocol eligibility|3|||
126464629|NCT03416374|455003843|FG000|Treatment Period II|Adverse Event|1|||
126464630|NCT03416374|455003844|FG001|Treatment Period II|Adverse Event|4|||
126552369|NCT00531011|455318321|FG001|Overall Study|Physician Decision|3|||
126308374|NCT00537316|454418685|FG002|Part 1|Did not meet protocol eligibility|2|||
126308375|NCT00537316|454418686|FG003|Part 1|Did not meet protocol eligibility|0|||
126552370|NCT03268590|455318322|FG000|Overall Study|Previously unknown exclusion criteria|1|||
126552371|NCT02139982|455318325|FG000|Overall Study|Lack of Efficacy|0|||
126308376|NCT00537316|454418687|FG004|Part 1|Did not meet protocol eligibility|0|||
126308377|NCT00537316|454418688|FG005|Part 1|Did not meet protocol eligibility|0|||
126464631|NCT03416374|455003843|FG000|Treatment Period II|Death|0|||
126308378|NCT00537316|454418689|FG006|Part 1|Did not meet protocol eligibility|0|||
126308379|NCT00537316|454418683|FG000|Part 1|Administrative|0|||
126308380|NCT00537316|454418684|FG001|Part 1|Administrative|0|||
126308381|NCT00537316|454418685|FG002|Part 1|Administrative|2|||
126308382|NCT00537316|454418686|FG003|Part 1|Administrative|0|||
126308383|NCT00537316|454418687|FG004|Part 1|Administrative|0|||
126308384|NCT00537316|454418688|FG005|Part 1|Administrative|0|||
126308385|NCT00537316|454418689|FG006|Part 1|Administrative|0|||
126308386|NCT00537316|454418683|FG000|Part 2|Never entered follow-up|0|||
126308387|NCT00537316|454418684|FG001|Part 2|Never entered follow-up|0|||
126308388|NCT00537316|454418685|FG002|Part 2|Never entered follow-up|0|||
126308389|NCT00537316|454418686|FG003|Part 2|Never entered follow-up|0|||
126308390|NCT00537316|454418687|FG004|Part 2|Never entered follow-up|0|||
126308391|NCT00537316|454418688|FG005|Part 2|Never entered follow-up|0|||
126308392|NCT00537316|454418689|FG006|Part 2|Never entered follow-up|1|||
126308393|NCT00537316|454418683|FG000|Part 2|Adverse Event|4|||
126308394|NCT00537316|454418684|FG001|Part 2|Adverse Event|0|||
126308395|NCT00537316|454418685|FG002|Part 2|Adverse Event|2|||
126308396|NCT00537316|454418686|FG003|Part 2|Adverse Event|0|||
126308397|NCT00537316|454418687|FG004|Part 2|Adverse Event|0|||
126308398|NCT00537316|454418688|FG005|Part 2|Adverse Event|0|||
126308399|NCT00537316|454418689|FG006|Part 2|Adverse Event|0|||
126308400|NCT00537316|454418683|FG000|Part 2|Lost to Follow-up|1|||
126308401|NCT00537316|454418684|FG001|Part 2|Lost to Follow-up|0|||
126308402|NCT00537316|454418685|FG002|Part 2|Lost to Follow-up|2|||
126308403|NCT00537316|454418686|FG003|Part 2|Lost to Follow-up|0|||
126308404|NCT00537316|454418687|FG004|Part 2|Lost to Follow-up|0|||
126308405|NCT00537316|454418688|FG005|Part 2|Lost to Follow-up|0|||
126308406|NCT00537316|454418689|FG006|Part 2|Lost to Follow-up|0|||
126308407|NCT00537316|454418683|FG000|Part 2|Withdrawal by Subject|5|||
126308408|NCT00537316|454418684|FG001|Part 2|Withdrawal by Subject|1|||
126308409|NCT00537316|454418685|FG002|Part 2|Withdrawal by Subject|4|||
126308410|NCT00537316|454418686|FG003|Part 2|Withdrawal by Subject|0|||
126308411|NCT00537316|454418687|FG004|Part 2|Withdrawal by Subject|0|||
126308412|NCT00537316|454418688|FG005|Part 2|Withdrawal by Subject|0|||
126308413|NCT00537316|454418689|FG006|Part 2|Withdrawal by Subject|0|||
126308414|NCT00537316|454418683|FG000|Part 2|Administrative|16|||
126308415|NCT00537316|454418684|FG001|Part 2|Administrative|8|||
126308416|NCT00537316|454418685|FG002|Part 2|Administrative|24|||
126308417|NCT00537316|454418686|FG003|Part 2|Administrative|3|||
126308418|NCT00537316|454418687|FG004|Part 2|Administrative|1|||
126308419|NCT00537316|454418688|FG005|Part 2|Administrative|4|||
126308420|NCT00537316|454418689|FG006|Part 2|Administrative|1|||
126308421|NCT05113979|454418692|FG000|Overall Study|Death|2|||
126308422|NCT05113979|454418692|FG000|Overall Study|Lost to Follow-up|1|||
126308423|NCT01137110|454418702|FG000|Overall Study|Protocol Violation|1|||
126308424|NCT01137110|454418703|FG001|Overall Study|Protocol Violation|0|||
126308425|NCT03557931|454418706|FG000|Overall Study|Adverse Event|4|||
126308426|NCT03557931|454418707|FG001|Overall Study|Adverse Event|6|||
126308427|NCT03557931|454418708|FG002|Overall Study|Adverse Event|1|||
126308428|NCT03557931|454418706|FG000|Overall Study|Lost to Follow-up|4|||
126308429|NCT03557931|454418707|FG001|Overall Study|Lost to Follow-up|4|||
126308430|NCT03557931|454418708|FG002|Overall Study|Lost to Follow-up|1|||
126308431|NCT03557931|454418706|FG000|Overall Study|Protocol Violation|1|||
126308432|NCT03557931|454418707|FG001|Overall Study|Protocol Violation|4|||
126716365|NCT03332667|455913109|FG000|Overall Study|Withdrawal by Subject|2|||
126716366|NCT03332667|455913110|FG001|Overall Study|Withdrawal by Subject|1|||
126716367|NCT03332667|455913111|FG002|Overall Study|Withdrawal by Subject|5|||
126716368|NCT03332667|455913112|FG003|Overall Study|Withdrawal by Subject|1|||
126308433|NCT03557931|454418708|FG002|Overall Study|Protocol Violation|1|||
126308434|NCT03557931|454418706|FG000|Overall Study|Withdrawal by Subject|14|||
126308435|NCT03557931|454418707|FG001|Overall Study|Withdrawal by Subject|0|||
126308436|NCT03557931|454418708|FG002|Overall Study|Withdrawal by Subject|7|||
126308437|NCT03557931|454418706|FG000|Overall Study|Miscellaneous|8|||
126308438|NCT03557931|454418707|FG001|Overall Study|Miscellaneous|5|||
126308439|NCT03557931|454418708|FG002|Overall Study|Miscellaneous|3|||
126308440|NCT02829723|454418711|FG000|Overall Study|Adverse Event|0|||
126308441|NCT02829723|454418712|FG001|Overall Study|Adverse Event|0|||
126308442|NCT02829723|454418713|FG002|Overall Study|Adverse Event|1|||
126308443|NCT02829723|454418714|FG003|Overall Study|Adverse Event|1|||
126308444|NCT02829723|454418715|FG004|Overall Study|Adverse Event|0|||
126308445|NCT02829723|454418716|FG005|Overall Study|Adverse Event|0|||
126308446|NCT02829723|454418717|FG006|Overall Study|Adverse Event|0|||
126716369|NCT03332667|455913109|FG000|Overall Study|Disease Progression or Relapse|2|||
126308447|NCT02829723|454418718|FG007|Overall Study|Adverse Event|1|||
126308448|NCT02829723|454418719|FG008|Overall Study|Adverse Event|0|||
126308449|NCT02829723|454418720|FG009|Overall Study|Adverse Event|0|||
126308450|NCT02829723|454418721|FG010|Overall Study|Adverse Event|0|||
126308451|NCT02829723|454418722|FG011|Overall Study|Adverse Event|0|||
126308452|NCT02829723|454418723|FG012|Overall Study|Adverse Event|0|||
126308453|NCT02829723|454418724|FG013|Overall Study|Adverse Event|0|||
126308454|NCT02829723|454418725|FG014|Overall Study|Adverse Event|1|||
126308455|NCT02829723|454418726|FG015|Overall Study|Adverse Event|1|||
126716370|NCT03332667|455913110|FG001|Overall Study|Disease Progression or Relapse|1|||
126716371|NCT03332667|455913111|FG002|Overall Study|Disease Progression or Relapse|3|||
126716372|NCT03332667|455913112|FG003|Overall Study|Disease Progression or Relapse|0|||
126716373|NCT03332667|455913109|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
126716374|NCT03332667|455913110|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
126716375|NCT03332667|455913111|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
126716376|NCT03332667|455913112|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
126716377|NCT03332667|455913109|FG000|Overall Study|No Treatment Received|0|||
126308456|NCT02829723|454418727|FG016|Overall Study|Adverse Event|1|||
126552372|NCT02139982|455318326|FG001|Overall Study|Lack of Efficacy|1|||
126552373|NCT02139982|455318327|FG002|Overall Study|Lack of Efficacy|0|||
126552374|NCT02139982|455318328|FG003|Overall Study|Lack of Efficacy|1|||
126552375|NCT02139982|455318329|FG004|Overall Study|Lack of Efficacy|0|||
126552376|NCT02139982|455318330|FG005|Overall Study|Lack of Efficacy|0|||
126552377|NCT02139982|455318331|FG006|Overall Study|Lack of Efficacy|0|||
126552378|NCT02139982|455318332|FG007|Overall Study|Lack of Efficacy|0|||
126552379|NCT02139982|455318333|FG008|Overall Study|Lack of Efficacy|0|||
126552380|NCT02139982|455318334|FG009|Overall Study|Lack of Efficacy|0|||
126552381|NCT04254679|455318367|FG000|Overall Study|Protocol Violation|1|||
126552382|NCT04254679|455318368|FG001|Overall Study|Protocol Violation|1|||
126552383|NCT04254679|455318367|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
126552384|NCT04254679|455318368|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
126552385|NCT02206152|455318373|FG000|Pre-Randomization|Withdrawal by Subject|2|||
126552386|NCT00478608|455318374|FG000|Overall Study|Adverse Event|1|||
126552387|NCT00478608|455318374|FG000|Overall Study|Serious Adverse Event|14|||
126552388|NCT00478608|455318374|FG000|Overall Study|Withdrawal by Subject|2|||
126552389|NCT00478608|455318374|FG000|Overall Study|Protocol Violation|3|||
126552390|NCT02080520|455318376|FG000|Overall Study|Self-reported symptoms|5|||
126552391|NCT02080520|455318377|FG001|Overall Study|Self-reported symptoms|6|||
126552392|NCT02080520|455318376|FG000|Overall Study|Unable to contact|2|||
126552393|NCT02080520|455318377|FG001|Overall Study|Unable to contact|1|||
126552394|NCT02080520|455318376|FG000|Overall Study|Initiated aspirin|2|||
126552395|NCT02080520|455318377|FG001|Overall Study|Initiated aspirin|0|||
126552396|NCT02080520|455318376|FG000|Overall Study|Atrial fibrillation|1|||
126552397|NCT02080520|455318377|FG001|Overall Study|Atrial fibrillation|1|||
126552398|NCT02080520|455318376|FG000|Overall Study|Cancer|1|||
126552399|NCT02080520|455318377|FG001|Overall Study|Cancer|2|||
126552400|NCT02080520|455318376|FG000|Overall Study|Not interested in study|1|||
126552401|NCT02080520|455318377|FG001|Overall Study|Not interested in study|3|||
126552402|NCT02080520|455318376|FG000|Overall Study|Too busy|1|||
126552403|NCT02080520|455318377|FG001|Overall Study|Too busy|1|||
126552404|NCT02080520|455318376|FG000|Overall Study|Work-related injury|1|||
126552405|NCT02080520|455318377|FG001|Overall Study|Work-related injury|0|||
126552406|NCT02080520|455318376|FG000|Overall Study|Personal reasons|0|||
126552407|NCT02080520|455318377|FG001|Overall Study|Personal reasons|3|||
126552408|NCT01394250|455318384|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
126552409|NCT01394250|455318385|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
126552410|NCT01394250|455318384|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
126552411|NCT01394250|455318385|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
126552412|NCT00432679|455318386|FG000|Overall Study|Adverse Event|2|||
126552413|NCT00432679|455318387|FG001|Overall Study|Adverse Event|1|||
126552414|NCT00432679|455318386|FG000|Overall Study|Withdrawal by Subject|3|||
126552415|NCT00432679|455318387|FG001|Overall Study|Withdrawal by Subject|2|||
126552416|NCT01177813|455318393|FG000|Overall Study|Adverse Event|8|||
126552417|NCT01177813|455318394|FG001|Overall Study|Adverse Event|2|||
126552418|NCT01177813|455318395|FG002|Overall Study|Adverse Event|4|||
126552419|NCT01177813|455318396|FG003|Overall Study|Adverse Event|6|||
126308457|NCT02829723|454418728|FG017|Overall Study|Adverse Event|2|||
126308458|NCT02829723|454418729|FG018|Overall Study|Adverse Event|1|||
126308459|NCT02829723|454418730|FG019|Overall Study|Adverse Event|1|||
126308460|NCT02829723|454418731|FG020|Overall Study|Adverse Event|3|||
126308461|NCT02829723|454418732|FG021|Overall Study|Adverse Event|0|||
126308462|NCT02829723|454418733|FG022|Overall Study|Adverse Event|0|||
126552420|NCT01177813|455318397|FG004|Overall Study|Adverse Event|3|||
126552421|NCT01177813|455318393|FG000|Overall Study|Lack of Efficacy|1|||
126308463|NCT02829723|454418734|FG023|Overall Study|Adverse Event|1|||
126552422|NCT01177813|455318394|FG001|Overall Study|Lack of Efficacy|0|||
126552423|NCT01177813|455318395|FG002|Overall Study|Lack of Efficacy|0|||
126552424|NCT01177813|455318396|FG003|Overall Study|Lack of Efficacy|0|||
126552425|NCT01177813|455318397|FG004|Overall Study|Lack of Efficacy|0|||
126552426|NCT01177813|455318393|FG000|Overall Study|Protocol Violation|3|||
126552427|NCT01177813|455318394|FG001|Overall Study|Protocol Violation|2|||
126552428|NCT01177813|455318395|FG002|Overall Study|Protocol Violation|2|||
126552429|NCT01177813|455318396|FG003|Overall Study|Protocol Violation|0|||
126552430|NCT01177813|455318397|FG004|Overall Study|Protocol Violation|1|||
126552431|NCT01177813|455318393|FG000|Overall Study|Lost to Follow-up|12|||
126552432|NCT01177813|455318394|FG001|Overall Study|Lost to Follow-up|5|||
126308464|NCT02829723|454418735|FG024|Overall Study|Adverse Event|1|||
126308465|NCT02829723|454418736|FG025|Overall Study|Adverse Event|3|||
126308466|NCT02829723|454418737|FG026|Overall Study|Adverse Event|5|||
126308467|NCT02829723|454418711|FG000|Overall Study|Death|1|||
126308468|NCT02829723|454418712|FG001|Overall Study|Death|0|||
126308469|NCT02829723|454418713|FG002|Overall Study|Death|1|||
126308470|NCT02829723|454418714|FG003|Overall Study|Death|1|||
126308471|NCT02829723|454418715|FG004|Overall Study|Death|0|||
126308472|NCT02829723|454418716|FG005|Overall Study|Death|0|||
126308473|NCT02829723|454418717|FG006|Overall Study|Death|2|||
126308474|NCT02829723|454418718|FG007|Overall Study|Death|0|||
126308475|NCT02829723|454418719|FG008|Overall Study|Death|1|||
126308476|NCT02829723|454418720|FG009|Overall Study|Death|0|||
126308477|NCT02829723|454418721|FG010|Overall Study|Death|0|||
126308478|NCT02829723|454418722|FG011|Overall Study|Death|0|||
126308479|NCT02829723|454418723|FG012|Overall Study|Death|2|||
126308480|NCT02829723|454418724|FG013|Overall Study|Death|1|||
126308481|NCT02829723|454418725|FG014|Overall Study|Death|0|||
126308482|NCT02829723|454418726|FG015|Overall Study|Death|0|||
126308483|NCT02829723|454418727|FG016|Overall Study|Death|0|||
126308484|NCT02829723|454418728|FG017|Overall Study|Death|0|||
126308485|NCT02829723|454418729|FG018|Overall Study|Death|0|||
126308486|NCT02829723|454418730|FG019|Overall Study|Death|0|||
126308487|NCT02829723|454418731|FG020|Overall Study|Death|0|||
126308488|NCT02829723|454418732|FG021|Overall Study|Death|2|||
126308489|NCT02829723|454418733|FG022|Overall Study|Death|0|||
126308490|NCT02829723|454418734|FG023|Overall Study|Death|0|||
126308491|NCT02829723|454418735|FG024|Overall Study|Death|0|||
126308492|NCT02829723|454418736|FG025|Overall Study|Death|1|||
126308493|NCT02829723|454418737|FG026|Overall Study|Death|2|||
126308494|NCT02829723|454418711|FG000|Overall Study|Physician Decision|0|||
126308495|NCT02829723|454418712|FG001|Overall Study|Physician Decision|0|||
126308496|NCT02829723|454418713|FG002|Overall Study|Physician Decision|0|||
126308497|NCT02829723|454418714|FG003|Overall Study|Physician Decision|0|||
126308498|NCT02829723|454418715|FG004|Overall Study|Physician Decision|0|||
126308499|NCT02829723|454418716|FG005|Overall Study|Physician Decision|0|||
126308500|NCT02829723|454418717|FG006|Overall Study|Physician Decision|0|||
126308501|NCT02829723|454418718|FG007|Overall Study|Physician Decision|0|||
126308502|NCT02829723|454418719|FG008|Overall Study|Physician Decision|0|||
126308503|NCT02829723|454418720|FG009|Overall Study|Physician Decision|1|||
126308504|NCT02829723|454418721|FG010|Overall Study|Physician Decision|1|||
126308505|NCT02829723|454418722|FG011|Overall Study|Physician Decision|0|||
126308506|NCT02829723|454418723|FG012|Overall Study|Physician Decision|0|||
126308507|NCT02829723|454418724|FG013|Overall Study|Physician Decision|1|||
126308508|NCT02829723|454418725|FG014|Overall Study|Physician Decision|0|||
126308509|NCT02829723|454418726|FG015|Overall Study|Physician Decision|0|||
126308510|NCT02829723|454418727|FG016|Overall Study|Physician Decision|2|||
126308511|NCT02829723|454418728|FG017|Overall Study|Physician Decision|0|||
126308512|NCT02829723|454418729|FG018|Overall Study|Physician Decision|0|||
126308513|NCT02829723|454418730|FG019|Overall Study|Physician Decision|0|||
126308514|NCT02829723|454418731|FG020|Overall Study|Physician Decision|0|||
126308515|NCT02829723|454418732|FG021|Overall Study|Physician Decision|0|||
126308516|NCT02829723|454418733|FG022|Overall Study|Physician Decision|1|||
126308517|NCT02829723|454418734|FG023|Overall Study|Physician Decision|1|||
126308518|NCT02829723|454418735|FG024|Overall Study|Physician Decision|1|||
126308519|NCT02829723|454418736|FG025|Overall Study|Physician Decision|1|||
126308520|NCT02829723|454418737|FG026|Overall Study|Physician Decision|3|||
126308521|NCT02829723|454418711|FG000|Overall Study|Progressive disease|4|||
126308522|NCT02829723|454418712|FG001|Overall Study|Progressive disease|6|||
126308523|NCT02829723|454418713|FG002|Overall Study|Progressive disease|3|||
126308524|NCT02829723|454418714|FG003|Overall Study|Progressive disease|3|||
126308525|NCT02829723|454418715|FG004|Overall Study|Progressive disease|3|||
126308526|NCT02829723|454418716|FG005|Overall Study|Progressive disease|5|||
126308527|NCT02829723|454418717|FG006|Overall Study|Progressive disease|4|||
126308528|NCT02829723|454418718|FG007|Overall Study|Progressive disease|6|||
126308529|NCT02829723|454418719|FG008|Overall Study|Progressive disease|8|||
126308530|NCT02829723|454418720|FG009|Overall Study|Progressive disease|4|||
126308531|NCT02829723|454418721|FG010|Overall Study|Progressive disease|9|||
126308532|NCT02829723|454418722|FG011|Overall Study|Progressive disease|0|||
126308533|NCT02829723|454418723|FG012|Overall Study|Progressive disease|3|||
126308534|NCT02829723|454418724|FG013|Overall Study|Progressive disease|4|||
126308535|NCT02829723|454418725|FG014|Overall Study|Progressive disease|2|||
126308536|NCT02829723|454418726|FG015|Overall Study|Progressive disease|4|||
126308537|NCT02829723|454418727|FG016|Overall Study|Progressive disease|5|||
126308538|NCT02829723|454418728|FG017|Overall Study|Progressive disease|3|||
126308539|NCT02829723|454418729|FG018|Overall Study|Progressive disease|4|||
126308540|NCT02829723|454418730|FG019|Overall Study|Progressive disease|4|||
126308541|NCT02829723|454418731|FG020|Overall Study|Progressive disease|7|||
126308542|NCT02829723|454418732|FG021|Overall Study|Progressive disease|6|||
126308543|NCT02829723|454418733|FG022|Overall Study|Progressive disease|3|||
126308544|NCT02829723|454418734|FG023|Overall Study|Progressive disease|3|||
126308545|NCT02829723|454418735|FG024|Overall Study|Progressive disease|3|||
126308546|NCT02829723|454418736|FG025|Overall Study|Progressive disease|16|||
126371337|NCT01276106|454656718|FG003|Overall Study|Physician Decision|1|||
126371338|NCT01276106|454656715|FG000|Overall Study|Protocol Violation|1|||
126371339|NCT01276106|454656716|FG001|Overall Study|Protocol Violation|1|||
126371340|NCT01276106|454656717|FG002|Overall Study|Protocol Violation|0|||
126371341|NCT01276106|454656718|FG003|Overall Study|Protocol Violation|2|||
126371342|NCT01276106|454656715|FG000|Overall Study|Insufficient therapeutic effects|0|||
126371343|NCT01276106|454656716|FG001|Overall Study|Insufficient therapeutic effects|0|||
126371344|NCT01276106|454656717|FG002|Overall Study|Insufficient therapeutic effects|2|||
126371345|NCT01276106|454656718|FG003|Overall Study|Insufficient therapeutic effects|0|||
126464632|NCT03416374|455003844|FG001|Treatment Period II|Death|1|||
126464633|NCT03416374|455003843|FG000|Treatment Period II|Other|0|||
126464634|NCT03416374|455003844|FG001|Treatment Period II|Other|2|||
126464635|NCT01052844|455003845|FG000|Overall Study|Adverse Event|0|||
126464636|NCT01052844|455003846|FG001|Overall Study|Adverse Event|1|||
126464637|NCT03463031|455003847|FG000|Overall Study|Withdrawal by Subject|4|||
126464638|NCT03463031|455003848|FG001|Overall Study|Withdrawal by Subject|2|||
126464639|NCT03463031|455003847|FG000|Overall Study|Investigator/Sponsor Decision|0|||
126464640|NCT03463031|455003848|FG001|Overall Study|Investigator/Sponsor Decision|1|||
126464641|NCT03463031|455003847|FG000|Overall Study|Lost to Follow-up|1|||
126464642|NCT03463031|455003848|FG001|Overall Study|Lost to Follow-up|1|||
126464643|NCT03463031|455003847|FG000|Overall Study|Adverse Event|4|||
126464644|NCT03463031|455003848|FG001|Overall Study|Adverse Event|1|||
126464645|NCT03463031|455003847|FG000|Overall Study|Use of prohibited medication by subject|1|||
126464646|NCT03463031|455003848|FG001|Overall Study|Use of prohibited medication by subject|0|||
126464647|NCT01933217|455003851|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
126464648|NCT01933217|455003852|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
126464649|NCT01933217|455003851|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
126464650|NCT01933217|455003852|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
126464651|NCT00057954|455003856|FG000|Overall Study|Death|1|||
126464652|NCT00057954|455003856|FG000|Overall Study|Disease progression|1|||
126464653|NCT01068652|455003861|FG000|Overall Study|Adverse Event|4|||
126464654|NCT01068652|455003862|FG001|Overall Study|Adverse Event|0|||
126464655|NCT01068652|455003861|FG000|Overall Study|Lack of Efficacy|0|||
126464656|NCT01068652|455003862|FG001|Overall Study|Lack of Efficacy|2|||
126464657|NCT01068652|455003861|FG000|Overall Study|Lost to Follow-up|2|||
126464658|NCT01068652|455003862|FG001|Overall Study|Lost to Follow-up|1|||
126464659|NCT01068652|455003861|FG000|Overall Study|Protocol Violation|3|||
126464660|NCT01068652|455003862|FG001|Overall Study|Protocol Violation|6|||
126464661|NCT01068652|455003861|FG000|Overall Study|Withdrawal criteria|1|||
126464662|NCT01068652|455003862|FG001|Overall Study|Withdrawal criteria|2|||
126464663|NCT01068652|455003861|FG000|Overall Study|Patient was not eligible|1|||
126464664|NCT01068652|455003862|FG001|Overall Study|Patient was not eligible|0|||
126464665|NCT01068652|455003861|FG000|Overall Study|Unclassified|7|||
126464666|NCT01068652|455003862|FG001|Overall Study|Unclassified|4|||
126464667|NCT00214500|455003863|FG000|Treatment Period|Adverse Event|1|||
126464668|NCT00214500|455003863|FG000|Extension Period|Withdrawal by Subject|2|||
126464669|NCT00147251|455003864|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
126464670|NCT00147251|455003865|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
126464671|NCT01629706|455003866|FG000|Phase 1 PureVision|Screen Failure|4|||
126464672|NCT01629706|455003866|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
126464673|NCT01629706|455003866|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
126464674|NCT01629706|455003866|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
126464675|NCT01629706|455003866|FG000|Phase 2 Habitual|Screen Failure|6|||
126464676|NCT01629706|455003866|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
126464677|NCT01629706|455003866|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
126464678|NCT01629706|455003866|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
126464679|NCT01629706|455003866|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
126464680|NCT02537574|455003868|FG000|Overall Study|Adverse Event|1|||
126464681|NCT02537574|455003869|FG001|Overall Study|Adverse Event|3|||
126464682|NCT02537574|455003870|FG002|Overall Study|Adverse Event|2|||
126464683|NCT02537574|455003868|FG000|Overall Study|Lost to Follow-up|40|||
126464684|NCT02537574|455003869|FG001|Overall Study|Lost to Follow-up|51|||
126464685|NCT02537574|455003870|FG002|Overall Study|Lost to Follow-up|55|||
126464686|NCT02537574|455003868|FG000|Overall Study|Noncompliance with study drug|0|||
126464687|NCT02537574|455003869|FG001|Overall Study|Noncompliance with study drug|1|||
126464688|NCT02537574|455003870|FG002|Overall Study|Noncompliance with study drug|1|||
126464689|NCT02537574|455003868|FG000|Overall Study|Physician Decision|2|||
126464690|NCT02537574|455003869|FG001|Overall Study|Physician Decision|0|||
126464691|NCT02537574|455003870|FG002|Overall Study|Physician Decision|0|||
126464692|NCT02537574|455003868|FG000|Overall Study|Protocol Violation|4|||
126464693|NCT02537574|455003869|FG001|Overall Study|Protocol Violation|2|||
126464694|NCT02537574|455003870|FG002|Overall Study|Protocol Violation|3|||
126371346|NCT04079738|454656721|FG000|Study Treatment|Death|1|||
126464695|NCT02537574|455003868|FG000|Overall Study|Withdrawal by Subject|37|||
126464696|NCT02537574|455003869|FG001|Overall Study|Withdrawal by Subject|27|||
126464697|NCT02537574|455003870|FG002|Overall Study|Withdrawal by Subject|29|||
126464698|NCT02537574|455003868|FG000|Overall Study|Lack of Efficacy|14|||
126552433|NCT01177813|455318395|FG002|Overall Study|Lost to Follow-up|6|||
126552434|NCT01177813|455318396|FG003|Overall Study|Lost to Follow-up|3|||
126308547|NCT02829723|454418737|FG026|Overall Study|Progressive disease|10|||
126308548|NCT02829723|454418711|FG000|Overall Study|Subject/guardian decision|0|||
126308549|NCT02829723|454418712|FG001|Overall Study|Subject/guardian decision|1|||
126308550|NCT02829723|454418713|FG002|Overall Study|Subject/guardian decision|0|||
126308551|NCT02829723|454418714|FG003|Overall Study|Subject/guardian decision|1|||
126308552|NCT02829723|454418715|FG004|Overall Study|Subject/guardian decision|0|||
126308553|NCT02829723|454418716|FG005|Overall Study|Subject/guardian decision|0|||
126308554|NCT02829723|454418717|FG006|Overall Study|Subject/guardian decision|0|||
126308555|NCT02829723|454418718|FG007|Overall Study|Subject/guardian decision|1|||
126308556|NCT02829723|454418719|FG008|Overall Study|Subject/guardian decision|0|||
126308557|NCT02829723|454418720|FG009|Overall Study|Subject/guardian decision|0|||
126308558|NCT02829723|454418721|FG010|Overall Study|Subject/guardian decision|0|||
126308559|NCT02829723|454418722|FG011|Overall Study|Subject/guardian decision|0|||
126308560|NCT02829723|454418723|FG012|Overall Study|Subject/guardian decision|0|||
126308561|NCT02829723|454418724|FG013|Overall Study|Subject/guardian decision|0|||
126308562|NCT02829723|454418725|FG014|Overall Study|Subject/guardian decision|1|||
126308563|NCT02829723|454418726|FG015|Overall Study|Subject/guardian decision|0|||
126308564|NCT02829723|454418727|FG016|Overall Study|Subject/guardian decision|1|||
126308565|NCT02829723|454418728|FG017|Overall Study|Subject/guardian decision|0|||
126308566|NCT02829723|454418729|FG018|Overall Study|Subject/guardian decision|1|||
126308567|NCT02829723|454418730|FG019|Overall Study|Subject/guardian decision|0|||
126308568|NCT02829723|454418731|FG020|Overall Study|Subject/guardian decision|1|||
126308569|NCT02829723|454418732|FG021|Overall Study|Subject/guardian decision|0|||
126308570|NCT02829723|454418733|FG022|Overall Study|Subject/guardian decision|0|||
126308571|NCT02829723|454418734|FG023|Overall Study|Subject/guardian decision|1|||
126308572|NCT02829723|454418735|FG024|Overall Study|Subject/guardian decision|0|||
126308573|NCT02829723|454418736|FG025|Overall Study|Subject/guardian decision|1|||
126308574|NCT02829723|454418737|FG026|Overall Study|Subject/guardian decision|1|||
126308575|NCT02829723|454418711|FG000|Overall Study|Study terminated by sponsor|0|||
126308576|NCT02829723|454418712|FG001|Overall Study|Study terminated by sponsor|0|||
126308577|NCT02829723|454418713|FG002|Overall Study|Study terminated by sponsor|0|||
126308578|NCT02829723|454418714|FG003|Overall Study|Study terminated by sponsor|0|||
126308579|NCT02829723|454418715|FG004|Overall Study|Study terminated by sponsor|0|||
126308580|NCT02829723|454418716|FG005|Overall Study|Study terminated by sponsor|0|||
126308581|NCT02829723|454418717|FG006|Overall Study|Study terminated by sponsor|0|||
126308582|NCT02829723|454418718|FG007|Overall Study|Study terminated by sponsor|0|||
126308583|NCT02829723|454418719|FG008|Overall Study|Study terminated by sponsor|0|||
126308584|NCT02829723|454418720|FG009|Overall Study|Study terminated by sponsor|0|||
126308585|NCT02829723|454418721|FG010|Overall Study|Study terminated by sponsor|0|||
126308586|NCT02829723|454418722|FG011|Overall Study|Study terminated by sponsor|0|||
126308587|NCT02829723|454418723|FG012|Overall Study|Study terminated by sponsor|0|||
126308588|NCT02829723|454418724|FG013|Overall Study|Study terminated by sponsor|0|||
126308589|NCT02829723|454418725|FG014|Overall Study|Study terminated by sponsor|0|||
126308590|NCT02829723|454418726|FG015|Overall Study|Study terminated by sponsor|0|||
126308591|NCT02829723|454418727|FG016|Overall Study|Study terminated by sponsor|0|||
126308592|NCT02829723|454418728|FG017|Overall Study|Study terminated by sponsor|0|||
126308593|NCT02829723|454418729|FG018|Overall Study|Study terminated by sponsor|0|||
126308594|NCT02829723|454418730|FG019|Overall Study|Study terminated by sponsor|0|||
126308595|NCT02829723|454418731|FG020|Overall Study|Study terminated by sponsor|0|||
126308596|NCT02829723|454418732|FG021|Overall Study|Study terminated by sponsor|1|||
126308597|NCT02829723|454418733|FG022|Overall Study|Study terminated by sponsor|0|||
126308598|NCT02829723|454418734|FG023|Overall Study|Study terminated by sponsor|0|||
126308599|NCT02829723|454418735|FG024|Overall Study|Study terminated by sponsor|0|||
126308600|NCT02829723|454418736|FG025|Overall Study|Study terminated by sponsor|0|||
126308601|NCT02829723|454418737|FG026|Overall Study|Study terminated by sponsor|0|||
126308602|NCT02989649|454418738|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
126308603|NCT02989649|454418738|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
126308604|NCT02989649|454418738|FG000|Overall Study|Lost For Observation During Study|3|||
126308605|NCT02989649|454418738|FG000|Overall Study|Reason Not Specified|13|||
126308606|NCT00330343|454418739|FG000|Overall Study|Lost to Follow-up|5|||
126308607|NCT00281632|454418740|FG000|Overall Study|Adverse Event|7|||
126308608|NCT00281632|454418740|FG000|Overall Study|Withdrawal by Subject|2|||
126308609|NCT00281632|454418740|FG000|Overall Study|Disease Progression|22|||
126308610|NCT00281632|454418740|FG000|Overall Study|Death|1|||
126308611|NCT00281632|454418740|FG000|Overall Study|Physician Decision|1|||
126308612|NCT00281632|454418740|FG000|Overall Study|Ongoing|3|||
126308613|NCT03990571|454418741|FG000|Overall Study|Withdrawal by Subject|1|||
126308614|NCT03990571|454418741|FG000|Overall Study|Insurance Issues|3|||
126308615|NCT03990571|454418741|FG000|Overall Study|Covid Restrictions|2|||
126308616|NCT04143594|454418746|FG000|Overall Study|Withdrew consent|3|||
126552435|NCT01177813|455318397|FG004|Overall Study|Lost to Follow-up|0|||
126308617|NCT04143594|454418747|FG001|Overall Study|Withdrew consent|10|||
126308618|NCT04143594|454418748|FG002|Overall Study|Withdrew consent|3|||
126552436|NCT01177813|455318393|FG000|Overall Study|Withdrawal by Subject|12|||
126371347|NCT04079738|454656722|FG001|Study Treatment|Death|0|||
126371348|NCT04079738|454656723|FG002|Study Treatment|Death|0|||
126371349|NCT04079738|454656724|FG003|Study Treatment|Death|0|||
126371350|NCT04079738|454656721|FG000|Study Treatment|Adverse Event|2|||
126371351|NCT04079738|454656722|FG001|Study Treatment|Adverse Event|0|||
126371352|NCT04079738|454656723|FG002|Study Treatment|Adverse Event|0|||
126371353|NCT04079738|454656724|FG003|Study Treatment|Adverse Event|0|||
126371354|NCT04079738|454656721|FG000|Study Treatment|withdrawal before treatment|1|||
126371355|NCT04079738|454656722|FG001|Study Treatment|withdrawal before treatment|0|||
126371356|NCT04079738|454656723|FG002|Study Treatment|withdrawal before treatment|0|||
126371357|NCT04079738|454656724|FG003|Study Treatment|withdrawal before treatment|0|||
126371358|NCT04079738|454656721|FG000|Study Treatment|symptomatic deterioration|2|||
126371359|NCT04079738|454656722|FG001|Study Treatment|symptomatic deterioration|0|||
126371360|NCT04079738|454656723|FG002|Study Treatment|symptomatic deterioration|0|||
126371361|NCT04079738|454656724|FG003|Study Treatment|symptomatic deterioration|0|||
126371362|NCT04079738|454656721|FG000|Study Treatment|Disease Progression|1|||
126371363|NCT04079738|454656722|FG001|Study Treatment|Disease Progression|0|||
126371364|NCT04079738|454656723|FG002|Study Treatment|Disease Progression|0|||
126371365|NCT04079738|454656724|FG003|Study Treatment|Disease Progression|0|||
126371366|NCT04079738|454656721|FG000|Study Treatment|withdrawal after treatment|1|||
126371367|NCT04079738|454656722|FG001|Study Treatment|withdrawal after treatment|0|||
126371368|NCT04079738|454656723|FG002|Study Treatment|withdrawal after treatment|0|||
126371369|NCT04079738|454656724|FG003|Study Treatment|withdrawal after treatment|0|||
126371370|NCT04079738|454656721|FG000|Follow up|Withdrawal by Subject|3|||
126552437|NCT01177813|455318394|FG001|Overall Study|Withdrawal by Subject|7|||
126552438|NCT01177813|455318395|FG002|Overall Study|Withdrawal by Subject|6|||
126552439|NCT01177813|455318396|FG003|Overall Study|Withdrawal by Subject|5|||
126371371|NCT04079738|454656722|FG001|Follow up|Withdrawal by Subject|0|||
126371372|NCT04079738|454656723|FG002|Follow up|Withdrawal by Subject|0|||
126371373|NCT04079738|454656724|FG003|Follow up|Withdrawal by Subject|0|||
126371374|NCT04079738|454656721|FG000|Follow up|Death|5|||
126371375|NCT04079738|454656722|FG001|Follow up|Death|0|||
126371376|NCT04079738|454656723|FG002|Follow up|Death|0|||
126552440|NCT01177813|455318397|FG004|Overall Study|Withdrawal by Subject|3|||
126552441|NCT01177813|455318393|FG000|Overall Study|Other reason not defined above|5|||
126716378|NCT03332667|455913110|FG001|Overall Study|No Treatment Received|0|||
126716379|NCT03332667|455913111|FG002|Overall Study|No Treatment Received|1|||
126716380|NCT03332667|455913112|FG003|Overall Study|No Treatment Received|0|||
126716381|NCT04964063|455913113|FG000|Overall Study|Adverse Event|4|||
126716382|NCT04964063|455913113|FG000|Overall Study|Lost to Follow-up|47|||
126716383|NCT04964063|455913113|FG000|Overall Study|Withdrawal by Subject|5|||
126371377|NCT04079738|454656724|FG003|Follow up|Death|0|||
126371378|NCT00867035|454656727|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
126371379|NCT00867035|454656728|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
126371380|NCT00867035|454656727|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
126371381|NCT00867035|454656728|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
126371382|NCT00404248|454656729|FG000|Overall Study|pts declining status|0|||
126371383|NCT00404248|454656730|FG001|Overall Study|pts declining status|1|||
126371384|NCT00404248|454656731|FG002|Overall Study|pts declining status|0|||
126371385|NCT00404248|454656732|FG003|Overall Study|pts declining status|0|||
126371386|NCT00404248|454656733|FG004|Overall Study|pts declining status|0|||
126371387|NCT00404248|454656734|FG005|Overall Study|pts declining status|0|||
126371388|NCT00404248|454656735|FG006|Overall Study|pts declining status|0|||
126464699|NCT02537574|455003869|FG001|Overall Study|Lack of Efficacy|16|||
126464700|NCT02537574|455003870|FG002|Overall Study|Lack of Efficacy|15|||
126464701|NCT02537574|455003868|FG000|Overall Study|Duplicate Patient|1|||
126464702|NCT02537574|455003869|FG001|Overall Study|Duplicate Patient|0|||
126464703|NCT02537574|455003870|FG002|Overall Study|Duplicate Patient|0|||
126464704|NCT02537574|455003868|FG000|Overall Study|Patient not Stable|0|||
126464705|NCT02537574|455003869|FG001|Overall Study|Patient not Stable|1|||
126464706|NCT02537574|455003870|FG002|Overall Study|Patient not Stable|0|||
126464707|NCT02537574|455003868|FG000|Overall Study|Incarceration|0|||
126464708|NCT02537574|455003869|FG001|Overall Study|Incarceration|1|||
126464709|NCT02537574|455003870|FG002|Overall Study|Incarceration|0|||
126464710|NCT02537574|455003868|FG000|Overall Study|Failed Naloxone Challenge|0|||
126464711|NCT02537574|455003869|FG001|Overall Study|Failed Naloxone Challenge|1|||
126464712|NCT02537574|455003870|FG002|Overall Study|Failed Naloxone Challenge|0|||
126464713|NCT02537574|455003868|FG000|Overall Study|Transportation Issues|0|||
126464714|NCT02537574|455003869|FG001|Overall Study|Transportation Issues|0|||
126464715|NCT02537574|455003870|FG002|Overall Study|Transportation Issues|1|||
126464716|NCT02537574|455003868|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
126464717|NCT02537574|455003869|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
126464718|NCT02537574|455003870|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
126464719|NCT02537574|455003868|FG000|Overall Study|Noncompliance with Protocol|0|||
126464720|NCT02537574|455003869|FG001|Overall Study|Noncompliance with Protocol|0|||
126552442|NCT01177813|455318394|FG001|Overall Study|Other reason not defined above|2|||
126552443|NCT01177813|455318395|FG002|Overall Study|Other reason not defined above|2|||
126371389|NCT00404248|454656736|FG007|Overall Study|pts declining status|0|||
126371390|NCT00404248|454656737|FG008|Overall Study|pts declining status|0|||
126371391|NCT00789555|454656738|FG000|Overall Study|Protocol Amendment|78|||
126371392|NCT00789555|454656739|FG001|Overall Study|Protocol Amendment|76|||
126371393|NCT00789555|454656740|FG002|Overall Study|Protocol Amendment|80|||
126371394|NCT00789555|454656738|FG000|Overall Study|Adverse Event|17|||
126371395|NCT00789555|454656739|FG001|Overall Study|Adverse Event|7|||
126371396|NCT00789555|454656740|FG002|Overall Study|Adverse Event|10|||
126371397|NCT00789555|454656738|FG000|Overall Study|Lost to Follow-up|9|||
126371398|NCT00789555|454656739|FG001|Overall Study|Lost to Follow-up|10|||
126371399|NCT00789555|454656740|FG002|Overall Study|Lost to Follow-up|18|||
126371400|NCT00789555|454656738|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
126371401|NCT00789555|454656739|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
126371402|NCT00789555|454656740|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
126371403|NCT00789555|454656738|FG000|Overall Study|Treatment failure|11|||
126371404|NCT00789555|454656739|FG001|Overall Study|Treatment failure|8|||
126371405|NCT00789555|454656740|FG002|Overall Study|Treatment failure|12|||
126371406|NCT00789555|454656738|FG000|Overall Study|Protocol Violation|6|||
126371407|NCT00789555|454656739|FG001|Overall Study|Protocol Violation|9|||
126371408|NCT00789555|454656740|FG002|Overall Study|Protocol Violation|13|||
126371409|NCT04646005|454656741|FG000|Overall Study|Adverse Event|1|||
126371410|NCT04646005|454656741|FG000|Overall Study|Progressive Disease|71|||
126371411|NCT04646005|454656741|FG000|Overall Study|Death|20|||
126371412|NCT04646005|454656741|FG000|Overall Study|Withdrawal by Subject|12|||
126371413|NCT04646005|454656741|FG000|Overall Study|Sponsor Request|9|||
126371414|NCT04398706|454656742|FG000|Overall Study|Adverse Event|0|||
126371415|NCT04398706|454656743|FG001|Overall Study|Adverse Event|0|||
126371416|NCT04398706|454656744|FG002|Overall Study|Adverse Event|0|||
126371417|NCT04398706|454656745|FG003|Overall Study|Adverse Event|0|||
126371418|NCT04398706|454656746|FG004|Overall Study|Adverse Event|0|||
126371419|NCT04398706|454656747|FG005|Overall Study|Adverse Event|1|||
126371420|NCT04398706|454656748|FG006|Overall Study|Adverse Event|1|||
126371421|NCT04398706|454656749|FG007|Overall Study|Adverse Event|0|||
126371422|NCT04398706|454656742|FG000|Overall Study|Lost to Follow-up|0|||
126371423|NCT04398706|454656743|FG001|Overall Study|Lost to Follow-up|1|||
126371424|NCT04398706|454656744|FG002|Overall Study|Lost to Follow-up|2|||
126371425|NCT04398706|454656745|FG003|Overall Study|Lost to Follow-up|1|||
126371426|NCT04398706|454656746|FG004|Overall Study|Lost to Follow-up|6|||
126371427|NCT04398706|454656747|FG005|Overall Study|Lost to Follow-up|3|||
126371428|NCT04398706|454656748|FG006|Overall Study|Lost to Follow-up|8|||
126371429|NCT04398706|454656749|FG007|Overall Study|Lost to Follow-up|2|||
126371430|NCT04398706|454656742|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126371431|NCT04398706|454656743|FG001|Overall Study|Withdrawal by parent/guardian|2|||
126371432|NCT04398706|454656744|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126371433|NCT04398706|454656745|FG003|Overall Study|Withdrawal by parent/guardian|2|||
126371434|NCT04398706|454656746|FG004|Overall Study|Withdrawal by parent/guardian|19|||
126371435|NCT04398706|454656747|FG005|Overall Study|Withdrawal by parent/guardian|23|||
126371436|NCT04398706|454656748|FG006|Overall Study|Withdrawal by parent/guardian|13|||
126371437|NCT04398706|454656749|FG007|Overall Study|Withdrawal by parent/guardian|11|||
126371438|NCT04398706|454656742|FG000|Overall Study|Protocol deviation|0|||
126371439|NCT04398706|454656743|FG001|Overall Study|Protocol deviation|1|||
126371440|NCT04398706|454656744|FG002|Overall Study|Protocol deviation|0|||
126371441|NCT04398706|454656745|FG003|Overall Study|Protocol deviation|0|||
126371442|NCT04398706|454656746|FG004|Overall Study|Protocol deviation|6|||
126770923|NCT03456726|456116206|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
126371443|NCT04398706|454656747|FG005|Overall Study|Protocol deviation|4|||
126464721|NCT02537574|455003870|FG002|Overall Study|Noncompliance with Protocol|1|||
126464722|NCT02663687|455003871|FG000|Overall Study|Adverse Event|1|||
126464723|NCT02663687|455003872|FG001|Overall Study|Adverse Event|0|||
126464724|NCT02663687|455003873|FG002|Overall Study|Adverse Event|0|||
126464725|NCT02663687|455003874|FG003|Overall Study|Adverse Event|0|||
126464726|NCT02663687|455003875|FG004|Overall Study|Adverse Event|0|||
126464727|NCT02663687|455003871|FG000|Overall Study|Other|1|||
126464728|NCT02663687|455003872|FG001|Overall Study|Other|0|||
126464729|NCT02663687|455003873|FG002|Overall Study|Other|1|||
126371444|NCT04398706|454656748|FG006|Overall Study|Protocol deviation|6|||
126371445|NCT04398706|454656749|FG007|Overall Study|Protocol deviation|3|||
126371446|NCT02611037|454656750|FG000|Overall Study|Withdrawal prior to treatment|2|||
126371447|NCT02611037|454656751|FG001|Overall Study|Withdrawal prior to treatment|0|||
126371448|NCT04577404|454656752|FG000|Overall Study|Adverse Event|31|||
126371449|NCT04577404|454656752|FG000|Overall Study|Death|1|||
126371450|NCT04577404|454656752|FG000|Overall Study|Lack of Efficacy|3|||
126371451|NCT04577404|454656752|FG000|Overall Study|Physician Decision|7|||
126371452|NCT04577404|454656752|FG000|Overall Study|Withdrawal by Subject|21|||
126371453|NCT04577404|454656752|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
126371454|NCT04237584|454656759|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
126464730|NCT02663687|455003874|FG003|Overall Study|Other|0|||
126464731|NCT02663687|455003875|FG004|Overall Study|Other|0|||
126552444|NCT01177813|455318396|FG003|Overall Study|Other reason not defined above|3|||
126552445|NCT01177813|455318397|FG004|Overall Study|Other reason not defined above|2|||
126770924|NCT03456726|456116207|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
126308619|NCT04143594|454418749|FG003|Overall Study|Withdrew consent|1|||
126308620|NCT04143594|454418746|FG000|Overall Study|Lost to Follow-up|3|||
126308621|NCT04143594|454418747|FG001|Overall Study|Lost to Follow-up|5|||
126308622|NCT04143594|454418748|FG002|Overall Study|Lost to Follow-up|11|||
126308623|NCT04143594|454418749|FG003|Overall Study|Lost to Follow-up|0|||
126308624|NCT04143594|454418746|FG000|Overall Study|Investigator's discretion|2|||
126308625|NCT04143594|454418747|FG001|Overall Study|Investigator's discretion|2|||
126308626|NCT04143594|454418748|FG002|Overall Study|Investigator's discretion|0|||
126308627|NCT04143594|454418749|FG003|Overall Study|Investigator's discretion|0|||
126308628|NCT04143594|454418746|FG000|Overall Study|Randomized but never treated|0|||
126308629|NCT04143594|454418747|FG001|Overall Study|Randomized but never treated|0|||
126308630|NCT04143594|454418748|FG002|Overall Study|Randomized but never treated|0|||
126308631|NCT04143594|454418749|FG003|Overall Study|Randomized but never treated|1|||
126308632|NCT04143594|454418746|FG000|Overall Study|Death|1|||
126308633|NCT04143594|454418747|FG001|Overall Study|Death|0|||
126308634|NCT04143594|454418748|FG002|Overall Study|Death|1|||
126308635|NCT04143594|454418749|FG003|Overall Study|Death|0|||
126308636|NCT04143594|454418746|FG000|Overall Study|Adverse Event|1|||
126308637|NCT04143594|454418747|FG001|Overall Study|Adverse Event|0|||
126308638|NCT04143594|454418748|FG002|Overall Study|Adverse Event|0|||
126308639|NCT04143594|454418749|FG003|Overall Study|Adverse Event|0|||
126308640|NCT04143594|454418746|FG000|Overall Study|Pregnancy|0|||
126308641|NCT04143594|454418747|FG001|Overall Study|Pregnancy|0|||
126308642|NCT04143594|454418748|FG002|Overall Study|Pregnancy|1|||
126308643|NCT04143594|454418749|FG003|Overall Study|Pregnancy|0|||
126308644|NCT04143594|454418746|FG000|Overall Study|Lack of Efficacy|1|||
126308645|NCT04143594|454418747|FG001|Overall Study|Lack of Efficacy|1|||
126308646|NCT04143594|454418748|FG002|Overall Study|Lack of Efficacy|0|||
126308647|NCT04143594|454418749|FG003|Overall Study|Lack of Efficacy|0|||
126308648|NCT00179673|454418750|FG000|Overall Study|Adverse Event|7|||
126308649|NCT00179673|454418750|FG000|Overall Study|Lack of Efficacy|15|||
126308650|NCT00179673|454418750|FG000|Overall Study|Withdrawal by Subject|3|||
126308651|NCT00179673|454418750|FG000|Overall Study|Death|4|||
126308652|NCT00179673|454418750|FG000|Overall Study|Other Observations and options|14|||
126308653|NCT00282113|454418751|FG000|Overall Study|Removed at parents request|1|||
126308654|NCT00282113|454418752|FG001|Overall Study|Removed at parents request|0|||
126308655|NCT00282113|454418753|FG002|Overall Study|Removed at parents request|0|||
126308656|NCT02107859|454418760|FG000|Overall Study|Withdrawal by Subject|14|||
126308657|NCT02107859|454418760|FG000|Overall Study|Adverse Event|3|||
126308658|NCT02107859|454418760|FG000|Overall Study|Study closure|41|||
126308659|NCT02107859|454418760|FG000|Overall Study|Other than specified|3|||
126308660|NCT01582178|454418761|FG000|Overall Study|Physician Decision|6|||
126308661|NCT01582178|454418762|FG001|Overall Study|Physician Decision|5|||
126308662|NCT04439214|454418763|FG000|Overall Study|Adverse Event|13|||
126308663|NCT04439214|454418763|FG000|Overall Study|Disease progression|16|||
126308664|NCT04439214|454418763|FG000|Overall Study|Death|1|||
126308665|NCT04439214|454418763|FG000|Overall Study|Withdrawal by Subject|2|||
126308666|NCT04439214|454418763|FG000|Overall Study|Declining health|1|||
126308667|NCT04439214|454418763|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
126308668|NCT04439214|454418763|FG000|Overall Study|Ineligible|5|||
126308669|NCT03852628|454418764|FG000|Overall Study|Lost to Follow-up|7|||
126308670|NCT03852628|454418765|FG001|Overall Study|Lost to Follow-up|6|||
126308671|NCT03852628|454418764|FG000|Overall Study|Lack of Efficacy|6|||
126308672|NCT03852628|454418765|FG001|Overall Study|Lack of Efficacy|6|||
126308673|NCT00556933|454418773|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
126308674|NCT00556933|454418774|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
126308675|NCT00556933|454418775|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
126308676|NCT00556933|454418776|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
126308677|NCT00556933|454418773|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
126308678|NCT00556933|454418774|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
126308679|NCT00556933|454418775|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
126308680|NCT00556933|454418776|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
126552446|NCT00109928|455318400|FG000|Overall Study|Adverse Event|2|||
126308681|NCT00556933|454418773|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
126308682|NCT00556933|454418774|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
126308683|NCT00556933|454418775|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
126308684|NCT00556933|454418776|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
126308685|NCT00556933|454418773|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
126308686|NCT00556933|454418774|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
126308687|NCT00556933|454418775|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
126308688|NCT00556933|454418776|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
126308689|NCT00556933|454418773|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
126371455|NCT04237584|454656760|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
126371456|NCT04237584|454656761|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
126371457|NCT04237584|454656762|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
126371458|NCT04237584|454656759|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
126371459|NCT04237584|454656760|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
126371460|NCT04237584|454656761|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
126371461|NCT04237584|454656762|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
126371462|NCT04237584|454656759|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
126371463|NCT04237584|454656760|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
126371464|NCT04237584|454656761|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
126371465|NCT04237584|454656762|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
126371466|NCT04237584|454656759|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
126371467|NCT04237584|454656760|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
126371468|NCT04237584|454656761|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
126371469|NCT04237584|454656762|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
126371470|NCT04237584|454656759|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
126371471|NCT04237584|454656760|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
126371472|NCT04237584|454656761|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
126371473|NCT04237584|454656762|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
126371474|NCT03586973|454656763|FG000|Overall Study|Death|15|||
126371475|NCT03586973|454656764|FG001|Overall Study|Death|8|||
126371476|NCT03586973|454656763|FG000|Overall Study|Site Terminated by Sponsor|3|||
126371477|NCT03586973|454656764|FG001|Overall Study|Site Terminated by Sponsor|6|||
126371478|NCT03586973|454656763|FG000|Overall Study|Withdrawal by Subject|1|||
126371479|NCT03586973|454656764|FG001|Overall Study|Withdrawal by Subject|0|||
126371480|NCT03586973|454656763|FG000|Overall Study|Lost to Follow-up|1|||
126371481|NCT03586973|454656764|FG001|Overall Study|Lost to Follow-up|0|||
126371482|NCT03423979|454656765|FG000|Overall Study|Death|1|||
126371483|NCT05239221|454656766|FG000|Overall Study|Adverse Event|0|||
126371484|NCT05239221|454656767|FG001|Overall Study|Adverse Event|0|||
126371485|NCT05239221|454656768|FG002|Overall Study|Adverse Event|0|||
126371486|NCT05239221|454656769|FG003|Overall Study|Adverse Event|0|||
126371487|NCT05239221|454656770|FG004|Overall Study|Adverse Event|0|||
126371488|NCT05239221|454656771|FG005|Overall Study|Adverse Event|0|||
126371489|NCT05239221|454656772|FG006|Overall Study|Adverse Event|1|||
126371490|NCT05239221|454656773|FG007|Overall Study|Adverse Event|0|||
126371491|NCT05239221|454656774|FG008|Overall Study|Adverse Event|0|||
126371492|NCT05239221|454656775|FG009|Overall Study|Adverse Event|0|||
126371493|NCT05239221|454656776|FG010|Overall Study|Adverse Event|1|||
126371494|NCT05239221|454656777|FG011|Overall Study|Adverse Event|1|||
126371495|NCT05239221|454656778|FG012|Overall Study|Adverse Event|0|||
126371496|NCT05239221|454656779|FG013|Overall Study|Adverse Event|0|||
126371497|NCT05239221|454656780|FG014|Overall Study|Adverse Event|0|||
126371498|NCT05239221|454656781|FG015|Overall Study|Adverse Event|0|||
126371499|NCT05239221|454656766|FG000|Overall Study|Withdrawal by Subject|0|||
126371500|NCT05239221|454656767|FG001|Overall Study|Withdrawal by Subject|0|||
126371501|NCT05239221|454656768|FG002|Overall Study|Withdrawal by Subject|0|||
126371502|NCT05239221|454656769|FG003|Overall Study|Withdrawal by Subject|0|||
126371503|NCT05239221|454656770|FG004|Overall Study|Withdrawal by Subject|0|||
126371504|NCT05239221|454656771|FG005|Overall Study|Withdrawal by Subject|0|||
126464732|NCT03595774|455003876|FG000|Overall Study|Adverse Event|1|||
126464733|NCT03595774|455003877|FG001|Overall Study|Adverse Event|0|||
126464734|NCT03595774|455003878|FG002|Overall Study|Adverse Event|1|||
126464735|NCT03595774|455003879|FG003|Overall Study|Adverse Event|0|||
126464736|NCT03595774|455003876|FG000|Overall Study|screen failure|0|||
126464737|NCT03595774|455003877|FG001|Overall Study|screen failure|1|||
126464738|NCT03595774|455003878|FG002|Overall Study|screen failure|0|||
126464739|NCT03595774|455003879|FG003|Overall Study|screen failure|1|||
126464740|NCT01151098|455003880|FG000|Overall Study|Adverse Event|82|||
126464741|NCT01151098|455003880|FG000|Overall Study|Lost to Follow-up|6|||
126464742|NCT01151098|455003880|FG000|Overall Study|Lack of Efficacy|15|||
126464743|NCT01151098|455003880|FG000|Overall Study|Protocol Violation|1|||
126770925|NCT04470622|456116208|FG000|Overall Study|Withdrawal by Subject|0|||
126770926|NCT04470622|456116209|FG001|Overall Study|Withdrawal by Subject|1|||
126770927|NCT04470622|456116208|FG000|Overall Study|Screen Failure|0|||
126770928|NCT04470622|456116209|FG001|Overall Study|Screen Failure|1|||
126371505|NCT05239221|454656772|FG006|Overall Study|Withdrawal by Subject|0|||
126371506|NCT05239221|454656773|FG007|Overall Study|Withdrawal by Subject|0|||
126371507|NCT05239221|454656774|FG008|Overall Study|Withdrawal by Subject|0|||
126371508|NCT05239221|454656775|FG009|Overall Study|Withdrawal by Subject|0|||
126371509|NCT05239221|454656776|FG010|Overall Study|Withdrawal by Subject|1|||
126464744|NCT01151098|455003880|FG000|Overall Study|Miscellaneous|13|||
126464745|NCT03343067|455003887|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
126552447|NCT00109928|455318400|FG000|Overall Study|Progression|6|||
126371510|NCT05239221|454656777|FG011|Overall Study|Withdrawal by Subject|0|||
126716384|NCT04964063|455913113|FG000|Overall Study|Baseline Tasks Expired|41|||
126716385|NCT04964063|455913113|FG000|Overall Study|Participant withdrawn in error|1|||
126716386|NCT01035606|455913114|FG000|Overall Study|change in health, job demands,family|3|||
126716387|NCT01035606|455913115|FG001|Overall Study|change in health, job demands,family|3|||
126716388|NCT01035606|455913116|FG002|Overall Study|change in health, job demands,family|4|||
126308690|NCT00556933|454418774|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
126308691|NCT00556933|454418775|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
126308692|NCT00556933|454418776|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
126308693|NCT00556933|454418773|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
126308694|NCT00556933|454418774|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
126308695|NCT00556933|454418775|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
126308696|NCT00556933|454418776|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
126308697|NCT00556933|454418773|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
126308698|NCT00556933|454418774|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
126308699|NCT00556933|454418775|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
126308700|NCT00556933|454418776|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
126308701|NCT00556933|454418773|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
126308702|NCT00556933|454418774|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
126308703|NCT00556933|454418775|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
126308704|NCT00556933|454418776|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
126308705|NCT00556933|454418773|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
126308706|NCT00556933|454418774|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
126308707|NCT00556933|454418775|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
126308708|NCT00556933|454418776|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
126308709|NCT00556933|454418773|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
126308710|NCT00556933|454418774|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
126308711|NCT00556933|454418775|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
126308712|NCT00556933|454418776|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
126308713|NCT00556933|454418773|FG000|CNI Withdrawal vs. Minimization|Death|0|||
126308714|NCT00556933|454418774|FG001|CNI Withdrawal vs. Minimization|Death|0|||
126308715|NCT00556933|454418775|FG002|CNI Withdrawal vs. Minimization|Death|0|||
126308716|NCT00556933|454418776|FG003|CNI Withdrawal vs. Minimization|Death|1|||
126308717|NCT01295827|454418777|FG000|Overall Study|Adverse Event|1|||
126308718|NCT01295827|454418778|FG001|Overall Study|Adverse Event|2|||
126308719|NCT01295827|454418779|FG002|Overall Study|Adverse Event|2|||
126308720|NCT01295827|454418780|FG003|Overall Study|Adverse Event|1|||
126308721|NCT01295827|454418781|FG004|Overall Study|Adverse Event|1|||
126308722|NCT01295827|454418782|FG005|Overall Study|Adverse Event|4|||
126308723|NCT01295827|454418783|FG006|Overall Study|Adverse Event|15|||
126308724|NCT01295827|454418784|FG007|Overall Study|Adverse Event|49|||
126308725|NCT01295827|454418785|FG008|Overall Study|Adverse Event|22|||
126308726|NCT01295827|454418786|FG009|Overall Study|Adverse Event|7|||
126308727|NCT01295827|454418787|FG010|Overall Study|Adverse Event|50|||
126308728|NCT01295827|454418788|FG011|Overall Study|Adverse Event|21|||
126308729|NCT01295827|454418789|FG012|Overall Study|Adverse Event|0|||
126308730|NCT01295827|454418790|FG013|Overall Study|Adverse Event|0|||
126308731|NCT01295827|454418791|FG014|Overall Study|Adverse Event|0|||
126308732|NCT01295827|454418777|FG000|Overall Study|Lost to Follow-up|0|||
126308733|NCT01295827|454418778|FG001|Overall Study|Lost to Follow-up|0|||
126308734|NCT01295827|454418779|FG002|Overall Study|Lost to Follow-up|3|||
126308735|NCT01295827|454418780|FG003|Overall Study|Lost to Follow-up|0|||
126308736|NCT01295827|454418781|FG004|Overall Study|Lost to Follow-up|1|||
126308737|NCT01295827|454418782|FG005|Overall Study|Lost to Follow-up|0|||
126308738|NCT01295827|454418783|FG006|Overall Study|Lost to Follow-up|4|||
126308739|NCT01295827|454418784|FG007|Overall Study|Lost to Follow-up|8|||
126308740|NCT01295827|454418785|FG008|Overall Study|Lost to Follow-up|7|||
126308741|NCT01295827|454418786|FG009|Overall Study|Lost to Follow-up|4|||
126308742|NCT01295827|454418787|FG010|Overall Study|Lost to Follow-up|7|||
126308743|NCT01295827|454418788|FG011|Overall Study|Lost to Follow-up|3|||
126308744|NCT01295827|454418789|FG012|Overall Study|Lost to Follow-up|0|||
126308745|NCT01295827|454418790|FG013|Overall Study|Lost to Follow-up|0|||
126371511|NCT05239221|454656778|FG012|Overall Study|Withdrawal by Subject|0|||
126371512|NCT05239221|454656779|FG013|Overall Study|Withdrawal by Subject|0|||
126308746|NCT01295827|454418791|FG014|Overall Study|Lost to Follow-up|0|||
126308747|NCT01295827|454418777|FG000|Overall Study|Not Reported|0|||
126371513|NCT05239221|454656780|FG014|Overall Study|Withdrawal by Subject|0|||
126371514|NCT05239221|454656781|FG015|Overall Study|Withdrawal by Subject|1|||
126308748|NCT01295827|454418778|FG001|Overall Study|Not Reported|0|||
126308749|NCT01295827|454418779|FG002|Overall Study|Not Reported|0|||
126308750|NCT01295827|454418780|FG003|Overall Study|Not Reported|1|||
126308751|NCT01295827|454418781|FG004|Overall Study|Not Reported|0|||
126371515|NCT02661672|454656782|FG000|Overall Study|Lost to Follow-up|1|||
126371516|NCT02661672|454656782|FG000|Overall Study|Death|4|||
126371517|NCT04696146|454658392|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
126371518|NCT04696146|454658393|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
126371519|NCT04696146|454658392|FG000|Overall Study|Off hours issue with product|1|||
126371520|NCT04696146|454658393|FG001|Overall Study|Off hours issue with product|0|||
126371521|NCT00529633|454658398|FG000|Overall Study|Withdrawal by Subject|1|||
126371522|NCT00529633|454658399|FG001|Overall Study|Withdrawal by Subject|1|||
126371523|NCT01576783|454658400|FG000|Overall Study|Change in Medical Care|1|||
126371524|NCT01576783|454658401|FG001|Overall Study|Change in Medical Care|0|||
126371525|NCT01576783|454658400|FG000|Overall Study|Lost to Follow-up|14|||
126371526|NCT01576783|454658401|FG001|Overall Study|Lost to Follow-up|16|||
126371527|NCT01576783|454658400|FG000|Overall Study|Withdrawal by Subject|5|||
126371528|NCT01576783|454658401|FG001|Overall Study|Withdrawal by Subject|1|||
126371529|NCT01897493|454658403|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
126371530|NCT05489328|454658404|FG000|Overall Study|Lost to Follow-up|0|||
126371531|NCT05489328|454658405|FG001|Overall Study|Lost to Follow-up|0|||
126371532|NCT05489328|454658406|FG002|Overall Study|Lost to Follow-up|1|||
126371533|NCT05489328|454658407|FG003|Overall Study|Lost to Follow-up|0|||
126371534|NCT05489328|454658408|FG004|Overall Study|Lost to Follow-up|2|||
126371535|NCT05489328|454658409|FG005|Overall Study|Lost to Follow-up|0|||
126371536|NCT05489328|454658410|FG006|Overall Study|Lost to Follow-up|0|||
126371537|NCT05489328|454658411|FG007|Overall Study|Lost to Follow-up|1|||
126371538|NCT05489328|454658412|FG008|Overall Study|Lost to Follow-up|0|||
126371539|NCT05489328|454658404|FG000|Overall Study|Withdrawal by Subject|0|||
126371540|NCT05489328|454658405|FG001|Overall Study|Withdrawal by Subject|0|||
126371541|NCT05489328|454658406|FG002|Overall Study|Withdrawal by Subject|0|||
126371542|NCT05489328|454658407|FG003|Overall Study|Withdrawal by Subject|0|||
126371543|NCT05489328|454658408|FG004|Overall Study|Withdrawal by Subject|0|||
126371544|NCT05489328|454658409|FG005|Overall Study|Withdrawal by Subject|0|||
126371545|NCT05489328|454658410|FG006|Overall Study|Withdrawal by Subject|1|||
126371546|NCT05489328|454658411|FG007|Overall Study|Withdrawal by Subject|1|||
126371547|NCT05489328|454658412|FG008|Overall Study|Withdrawal by Subject|0|||
126371548|NCT05489328|454658404|FG000|Overall Study|Other|0|||
126371549|NCT05489328|454658405|FG001|Overall Study|Other|0|||
126371550|NCT05489328|454658406|FG002|Overall Study|Other|0|||
126371551|NCT05489328|454658407|FG003|Overall Study|Other|0|||
126371552|NCT05489328|454658408|FG004|Overall Study|Other|0|||
126371553|NCT05489328|454658409|FG005|Overall Study|Other|0|||
126371554|NCT05489328|454658410|FG006|Overall Study|Other|0|||
126371555|NCT05489328|454658411|FG007|Overall Study|Other|1|||
126371556|NCT05489328|454658412|FG008|Overall Study|Other|1|||
126371557|NCT01083602|454658413|FG000|Overall Study|Adverse Event|11|||
126371558|NCT01083602|454658413|FG000|Overall Study|New Cancer Therapy|2|||
126371559|NCT01083602|454658413|FG000|Overall Study|Death|1|||
126371560|NCT01083602|454658413|FG000|Overall Study|Withdrawal by Subject|5|||
126371561|NCT01083602|454658413|FG000|Overall Study|Lack of Efficacy|36|||
126371562|NCT03698279|454658414|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126371563|NCT03698279|454658415|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126371564|NCT03698279|454658416|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126371565|NCT03698279|454658417|FG003|Overall Study|Withdrawal by parent/guardian|1|||
126371566|NCT03698279|454658418|FG004|Overall Study|Withdrawal by parent/guardian|0|||
126371567|NCT03698279|454658419|FG005|Overall Study|Withdrawal by parent/guardian|0|||
126371568|NCT03698279|454658414|FG000|Overall Study|Protocol deviation|1|||
126371569|NCT03698279|454658415|FG001|Overall Study|Protocol deviation|0|||
126371570|NCT03698279|454658416|FG002|Overall Study|Protocol deviation|1|||
126371571|NCT03698279|454658417|FG003|Overall Study|Protocol deviation|0|||
126371572|NCT03698279|454658418|FG004|Overall Study|Protocol deviation|0|||
126371573|NCT03698279|454658419|FG005|Overall Study|Protocol deviation|0|||
126371574|NCT03698279|454658414|FG000|Overall Study|Withdrawal by Subject|0|||
126371575|NCT03698279|454658415|FG001|Overall Study|Withdrawal by Subject|0|||
126371576|NCT03698279|454658416|FG002|Overall Study|Withdrawal by Subject|1|||
126371577|NCT03698279|454658417|FG003|Overall Study|Withdrawal by Subject|0|||
126371578|NCT03698279|454658418|FG004|Overall Study|Withdrawal by Subject|0|||
126552448|NCT00109928|455318400|FG000|Overall Study|Death|2|||
126716389|NCT03350750|455913117|FG000|Overall Study|Death|1|||
126371579|NCT03698279|454658419|FG005|Overall Study|Withdrawal by Subject|0|||
126371580|NCT03698279|454658414|FG000|Overall Study|Lost to Follow-up|3|||
126716390|NCT03350750|455913118|FG001|Overall Study|Death|1|||
126716391|NCT01849250|455913119|FG000|Overall Study|Withdrawal by Subject|1|||
126371581|NCT03698279|454658415|FG001|Overall Study|Lost to Follow-up|1|||
126371582|NCT03698279|454658416|FG002|Overall Study|Lost to Follow-up|4|||
126371583|NCT03698279|454658417|FG003|Overall Study|Lost to Follow-up|5|||
126371584|NCT03698279|454658418|FG004|Overall Study|Lost to Follow-up|0|||
126371585|NCT03698279|454658419|FG005|Overall Study|Lost to Follow-up|0|||
126371586|NCT01276704|454658422|FG000|Overall Study|Lost to Follow-up|2|||
126371587|NCT01276704|454658423|FG001|Overall Study|Lost to Follow-up|3|||
126371588|NCT01276704|454658422|FG000|Overall Study|Non-compliant|2|||
126371589|NCT01276704|454658423|FG001|Overall Study|Non-compliant|2|||
126552449|NCT00109928|455318400|FG000|Overall Study|not protocol specified|2|||
126371590|NCT01276704|454658422|FG000|Overall Study|Withdrawal by Subject|7|||
126308752|NCT01295827|454418782|FG005|Overall Study|Not Reported|0|||
126308753|NCT01295827|454418783|FG006|Overall Study|Not Reported|24|||
126308754|NCT01295827|454418784|FG007|Overall Study|Not Reported|58|||
126308755|NCT01295827|454418785|FG008|Overall Study|Not Reported|41|||
126308756|NCT01295827|454418786|FG009|Overall Study|Not Reported|2|||
126308757|NCT01295827|454418787|FG010|Overall Study|Not Reported|23|||
126308758|NCT01295827|454418788|FG011|Overall Study|Not Reported|13|||
126308759|NCT01295827|454418789|FG012|Overall Study|Not Reported|0|||
126308760|NCT01295827|454418790|FG013|Overall Study|Not Reported|0|||
126308761|NCT01295827|454418791|FG014|Overall Study|Not Reported|0|||
126308762|NCT01295827|454418777|FG000|Overall Study|Progressive Disease|2|||
126308763|NCT01295827|454418778|FG001|Overall Study|Progressive Disease|1|||
126308764|NCT01295827|454418779|FG002|Overall Study|Progressive Disease|5|||
126308765|NCT01295827|454418780|FG003|Overall Study|Progressive Disease|2|||
126308766|NCT01295827|454418781|FG004|Overall Study|Progressive Disease|0|||
126308767|NCT01295827|454418782|FG005|Overall Study|Progressive Disease|1|||
126308768|NCT01295827|454418783|FG006|Overall Study|Progressive Disease|87|||
126308769|NCT01295827|454418784|FG007|Overall Study|Progressive Disease|144|||
126308770|NCT01295827|454418785|FG008|Overall Study|Progressive Disease|85|||
126308771|NCT01295827|454418786|FG009|Overall Study|Progressive Disease|40|||
126308772|NCT01295827|454418787|FG010|Overall Study|Progressive Disease|175|||
126308773|NCT01295827|454418788|FG011|Overall Study|Progressive Disease|136|||
126308774|NCT01295827|454418789|FG012|Overall Study|Progressive Disease|0|||
126308775|NCT01295827|454418790|FG013|Overall Study|Progressive Disease|0|||
126308776|NCT01295827|454418791|FG014|Overall Study|Progressive Disease|0|||
126308777|NCT01295827|454418777|FG000|Overall Study|Screen Failure|0|||
126308778|NCT01295827|454418778|FG001|Overall Study|Screen Failure|0|||
126308779|NCT01295827|454418779|FG002|Overall Study|Screen Failure|0|||
126308780|NCT01295827|454418780|FG003|Overall Study|Screen Failure|0|||
126308781|NCT01295827|454418781|FG004|Overall Study|Screen Failure|0|||
126308782|NCT01295827|454418782|FG005|Overall Study|Screen Failure|0|||
126308783|NCT01295827|454418783|FG006|Overall Study|Screen Failure|2|||
126308784|NCT01295827|454418784|FG007|Overall Study|Screen Failure|2|||
126308785|NCT01295827|454418785|FG008|Overall Study|Screen Failure|2|||
126308786|NCT01295827|454418786|FG009|Overall Study|Screen Failure|0|||
126308787|NCT01295827|454418787|FG010|Overall Study|Screen Failure|1|||
126308788|NCT01295827|454418788|FG011|Overall Study|Screen Failure|0|||
126308789|NCT01295827|454418789|FG012|Overall Study|Screen Failure|0|||
126308790|NCT01295827|454418790|FG013|Overall Study|Screen Failure|0|||
126308791|NCT01295827|454418791|FG014|Overall Study|Screen Failure|0|||
126308792|NCT01295827|454418777|FG000|Overall Study|Withdrawal by Subject|1|||
126308793|NCT01295827|454418778|FG001|Overall Study|Withdrawal by Subject|0|||
126308794|NCT01295827|454418779|FG002|Overall Study|Withdrawal by Subject|2|||
126308795|NCT01295827|454418780|FG003|Overall Study|Withdrawal by Subject|0|||
126308796|NCT01295827|454418781|FG004|Overall Study|Withdrawal by Subject|0|||
126308797|NCT01295827|454418782|FG005|Overall Study|Withdrawal by Subject|1|||
126308798|NCT01295827|454418783|FG006|Overall Study|Withdrawal by Subject|13|||
126308799|NCT01295827|454418784|FG007|Overall Study|Withdrawal by Subject|35|||
126308800|NCT01295827|454418785|FG008|Overall Study|Withdrawal by Subject|11|||
126308801|NCT01295827|454418786|FG009|Overall Study|Withdrawal by Subject|2|||
126308802|NCT01295827|454418787|FG010|Overall Study|Withdrawal by Subject|18|||
126308803|NCT01295827|454418788|FG011|Overall Study|Withdrawal by Subject|13|||
126308804|NCT01295827|454418789|FG012|Overall Study|Withdrawal by Subject|0|||
126308805|NCT01295827|454418790|FG013|Overall Study|Withdrawal by Subject|0|||
126308806|NCT01295827|454418791|FG014|Overall Study|Withdrawal by Subject|0|||
126308807|NCT01295827|454418777|FG000|Overall Study|Other|0|||
126308808|NCT01295827|454418778|FG001|Overall Study|Other|0|||
126308809|NCT01295827|454418779|FG002|Overall Study|Other|0|||
126308810|NCT01295827|454418780|FG003|Overall Study|Other|0|||
126308811|NCT01295827|454418781|FG004|Overall Study|Other|0|||
126308812|NCT01295827|454418782|FG005|Overall Study|Other|0|||
126308813|NCT01295827|454418783|FG006|Overall Study|Other|1|||
126308814|NCT01295827|454418784|FG007|Overall Study|Other|1|||
126308815|NCT01295827|454418785|FG008|Overall Study|Other|1|||
126308816|NCT01295827|454418786|FG009|Overall Study|Other|0|||
126308817|NCT01295827|454418787|FG010|Overall Study|Other|2|||
126308818|NCT01295827|454418788|FG011|Overall Study|Other|0|||
126308819|NCT01295827|454418789|FG012|Overall Study|Other|0|||
126308820|NCT01295827|454418790|FG013|Overall Study|Other|0|||
126308821|NCT01295827|454418791|FG014|Overall Study|Other|0|||
126308822|NCT01743560|454418792|FG000|Overall Study|Disease progression|26|||
126308823|NCT01743560|454418792|FG000|Overall Study|Adverse Event|8|||
126308824|NCT01743560|454418792|FG000|Overall Study|Death|3|||
126308825|NCT01743560|454418792|FG000|Overall Study|Withdrawal by Subject|2|||
126308826|NCT01743560|454418792|FG000|Overall Study|Protocol Violation|1|||
126308827|NCT01743560|454418792|FG000|Overall Study|>1 dose of study drug|3|||
126371591|NCT01276704|454658423|FG001|Overall Study|Withdrawal by Subject|1|||
126308828|NCT03226769|454418793|FG000|Overall Study|Withdrawal by Subject|0|||
126308829|NCT03226769|454418794|FG001|Overall Study|Withdrawal by Subject|1|||
126308830|NCT01827267|454418795|FG000|Overall Study|Did not receive study drug|1|||
126716392|NCT01849250|455913120|FG001|Overall Study|Withdrawal by Subject|0|||
126716393|NCT01849250|455913119|FG000|Overall Study|Not Evaluable|5|||
126716394|NCT01849250|455913120|FG001|Overall Study|Not Evaluable|3|||
126716395|NCT01849250|455913119|FG000|Overall Study|Screen Failure|1|||
126716396|NCT01849250|455913120|FG001|Overall Study|Screen Failure|0|||
126308831|NCT01827267|454418796|FG001|Overall Study|Did not receive study drug|1|||
126308832|NCT01827267|454418795|FG000|Overall Study|Physician Decision|1|||
126308833|NCT01827267|454418796|FG001|Overall Study|Physician Decision|0|||
126308834|NCT01827267|454418795|FG000|Overall Study|Disease Progression|1|||
126308835|NCT01827267|454418796|FG001|Overall Study|Disease Progression|1|||
126308836|NCT01827267|454418795|FG000|Overall Study|Sponsor Discontinued Study|2|||
126308837|NCT01827267|454418796|FG001|Overall Study|Sponsor Discontinued Study|8|||
126308838|NCT01827267|454418795|FG000|Overall Study|Still on study|0|||
126308839|NCT01827267|454418796|FG001|Overall Study|Still on study|2|||
126308840|NCT02640677|454418801|FG000|Overall Study|Lost to Follow-up|1|||
126308841|NCT02640677|454418801|FG000|Overall Study|Withdrawal by Subject|1|||
126308842|NCT01516008|454418802|FG000|Overall Study|Adverse Event|0|||
126308843|NCT01516008|454418803|FG001|Overall Study|Adverse Event|2|||
126308844|NCT01516008|454418804|FG002|Overall Study|Adverse Event|7|||
126308845|NCT01516008|454418802|FG000|Overall Study|Lack of Efficacy|44|||
126308846|NCT01516008|454418803|FG001|Overall Study|Lack of Efficacy|14|||
126308847|NCT01516008|454418804|FG002|Overall Study|Lack of Efficacy|10|||
126308848|NCT01516008|454418802|FG000|Overall Study|Protocol Violation|1|||
126308849|NCT01516008|454418803|FG001|Overall Study|Protocol Violation|0|||
126308850|NCT01516008|454418804|FG002|Overall Study|Protocol Violation|0|||
126308851|NCT01516008|454418802|FG000|Overall Study|Reason not specified|0|||
126308852|NCT01516008|454418803|FG001|Overall Study|Reason not specified|0|||
126308853|NCT01516008|454418804|FG002|Overall Study|Reason not specified|1|||
126308854|NCT00813813|454418807|FG000|Overall Study|Withdrawal by Subject|1|||
126308855|NCT00813813|454418808|FG001|Overall Study|Withdrawal by Subject|1|||
126308856|NCT00813813|454418807|FG000|Overall Study|Lost to Follow-up|2|||
126308857|NCT00813813|454418808|FG001|Overall Study|Lost to Follow-up|7|||
126308858|NCT00813813|454418807|FG000|Overall Study|Other|0|||
126308859|NCT00813813|454418808|FG001|Overall Study|Other|1|||
126308860|NCT03489707|454418809|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
126308861|NCT03489707|454418810|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
126308862|NCT03489707|454418809|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
126308863|NCT03489707|454418810|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
126308864|NCT00199797|454420892|FG000|Overall Study|Progressive Disease|1|||
126308865|NCT00199797|454420892|FG000|Overall Study|Adverse Event|1|||
126308866|NCT00199797|454420892|FG000|Overall Study|Physician Decision|1|||
126308867|NCT04250350|454420897|FG000|Overall Study|Withdrawal by Subject|13|||
126308868|NCT04250350|454420897|FG000|Overall Study|Lost to Follow-up|8|||
126308869|NCT04250350|454420897|FG000|Overall Study|Adverse Event|5|||
126464746|NCT03343067|455003888|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
126464747|NCT03343067|455003889|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
126464748|NCT00116168|455003890|FG000|Overall Study|Lost to Follow-up|6|||
126464749|NCT00116168|455003891|FG001|Overall Study|Lost to Follow-up|5|||
126464750|NCT00116168|455003892|FG002|Overall Study|Lost to Follow-up|0|||
126464751|NCT00116168|455003893|FG003|Overall Study|Lost to Follow-up|0|||
126464752|NCT02788474|455003894|FG000|Double Blind Treatment Period|Not treated|1|||
126464753|NCT02788474|455003895|FG001|Double Blind Treatment Period|Not treated|0|||
126464754|NCT02788474|455003894|FG000|Double Blind Treatment Period|Patient's refusal|3|||
126464755|NCT02788474|455003895|FG001|Double Blind Treatment Period|Patient's refusal|0|||
126464756|NCT02788474|455003894|FG000|Double Blind Treatment Period|Adverse Event|6|||
126464757|NCT02788474|455003895|FG001|Double Blind Treatment Period|Adverse Event|4|||
126464758|NCT02788474|455003894|FG000|Open Label Treatment Period|Adverse Event|29|||
126464759|NCT02788474|455003895|FG001|Open Label Treatment Period|Adverse Event|9|||
126464760|NCT02788474|455003894|FG000|Open Label Treatment Period|Other than reason specified|1|||
126464761|NCT02788474|455003895|FG001|Open Label Treatment Period|Other than reason specified|0|||
126464762|NCT02788474|455003894|FG000|Open Label Treatment Period|Patient's refusal|1|||
126464763|NCT02788474|455003895|FG001|Open Label Treatment Period|Patient's refusal|3|||
126464764|NCT02788474|455003894|FG000|Open Label Treatment Period|Non-compliance|1|||
126464765|NCT02788474|455003895|FG001|Open Label Treatment Period|Non-compliance|0|||
126308870|NCT04250350|454420897|FG000|Overall Study|Lack of Efficacy|4|||
126308871|NCT04250350|454420897|FG000|Overall Study|Physician Decision|1|||
126308872|NCT04250350|454420897|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
126308873|NCT02836236|454420900|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
126308874|NCT02836236|454420901|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
126308875|NCT02836236|454420902|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
126308876|NCT02836236|454420903|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
126308877|NCT02836236|454420900|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
126716397|NCT00793819|455913124|FG000|Overall Study|Adverse Event|8|||
126716398|NCT00793819|455913125|FG001|Overall Study|Adverse Event|4|||
126464766|NCT00117286|455003897|FG000|Overall Study|Adverse Event|12|||
126464767|NCT00117286|455003898|FG001|Overall Study|Adverse Event|6|||
126464768|NCT00117286|455003897|FG000|Overall Study|Lost to Follow-up|2|||
126464769|NCT00117286|455003898|FG001|Overall Study|Lost to Follow-up|0|||
126464770|NCT00117286|455003897|FG000|Overall Study|Protocol Violation|3|||
126464771|NCT00117286|455003898|FG001|Overall Study|Protocol Violation|3|||
126464772|NCT00117286|455003897|FG000|Overall Study|Withdrawal by Subject|6|||
126464773|NCT00117286|455003898|FG001|Overall Study|Withdrawal by Subject|2|||
126464774|NCT00117286|455003897|FG000|Overall Study|Physician Decision|3|||
126464775|NCT00117286|455003898|FG001|Overall Study|Physician Decision|7|||
126464776|NCT00117286|455003897|FG000|Overall Study|Lack of Efficacy|2|||
126464777|NCT00117286|455003898|FG001|Overall Study|Lack of Efficacy|1|||
126464778|NCT00117286|455003897|FG000|Overall Study|Research site closing|0|||
126464779|NCT00117286|455003898|FG001|Overall Study|Research site closing|2|||
126464780|NCT00048061|455003899|FG000|Overall Study|Adverse Event|41|||
126464781|NCT00048061|455003900|FG001|Overall Study|Adverse Event|32|||
126464782|NCT00048061|455003901|FG002|Overall Study|Adverse Event|44|||
126464783|NCT00048061|455003902|FG003|Overall Study|Adverse Event|37|||
126464784|NCT00048061|455003899|FG000|Overall Study|Lost to Follow-up|3|||
126464785|NCT00048061|455003900|FG001|Overall Study|Lost to Follow-up|2|||
126464786|NCT00048061|455003901|FG002|Overall Study|Lost to Follow-up|4|||
126464787|NCT00048061|455003902|FG003|Overall Study|Lost to Follow-up|5|||
126464788|NCT00048061|455003899|FG000|Overall Study|Withdrawal by Subject|20|||
126464789|NCT00048061|455003900|FG001|Overall Study|Withdrawal by Subject|29|||
126464790|NCT00048061|455003901|FG002|Overall Study|Withdrawal by Subject|29|||
126464791|NCT00048061|455003902|FG003|Overall Study|Withdrawal by Subject|32|||
126464792|NCT00048061|455003899|FG000|Overall Study|Did not follow-up|5|||
126464793|NCT00048061|455003900|FG001|Overall Study|Did not follow-up|5|||
126464794|NCT00048061|455003901|FG002|Overall Study|Did not follow-up|4|||
126464795|NCT00048061|455003902|FG003|Overall Study|Did not follow-up|5|||
126464796|NCT00048061|455003899|FG000|Overall Study|Early improvement|6|||
126464797|NCT00048061|455003900|FG001|Overall Study|Early improvement|5|||
126464798|NCT00048061|455003901|FG002|Overall Study|Early improvement|3|||
126464799|NCT00048061|455003902|FG003|Overall Study|Early improvement|0|||
126464800|NCT03555435|455003903|FG000|Overall Study|Lost to Follow-up|17|||
126464801|NCT03555435|455003904|FG001|Overall Study|Lost to Follow-up|19|||
126464802|NCT03555435|455003905|FG002|Overall Study|Lost to Follow-up|8|||
126464803|NCT01323946|455003906|FG000|Overall Study|Lost to Follow-up|0|||
126464804|NCT01323946|455003907|FG001|Overall Study|Lost to Follow-up|1|||
126464805|NCT01323946|455003908|FG002|Overall Study|Lost to Follow-up|0|||
126464806|NCT01323946|455003906|FG000|Overall Study|Parents refused the last blood draw|1|||
126464807|NCT01323946|455003907|FG001|Overall Study|Parents refused the last blood draw|0|||
126464808|NCT01323946|455003908|FG002|Overall Study|Parents refused the last blood draw|0|||
126464809|NCT01323946|455003906|FG000|Overall Study|Withdrawal by Subject|2|||
126464810|NCT01323946|455003907|FG001|Overall Study|Withdrawal by Subject|2|||
126464811|NCT01323946|455003908|FG002|Overall Study|Withdrawal by Subject|0|||
126464812|NCT01272661|455003912|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
126464813|NCT01272661|455003913|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
126464814|NCT01272661|455003914|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
126464815|NCT02869438|455003915|FG000|Overall Study|Lost to Follow-up|1|||
126464816|NCT02869438|455003916|FG001|Overall Study|Lost to Follow-up|0|||
126464817|NCT02869438|455003915|FG000|Overall Study|Adverse Event|1|||
126464818|NCT02869438|455003916|FG001|Overall Study|Adverse Event|0|||
126464819|NCT02869438|455003915|FG000|Overall Study|Withdrawal by Subject|1|||
126464820|NCT02869438|455003916|FG001|Overall Study|Withdrawal by Subject|2|||
126464821|NCT01013649|455003917|FG000|First Step|Withdrawal by Subject|36|||
126464822|NCT01013649|455003918|FG001|First Step|Withdrawal by Subject|19|||
126464823|NCT01013649|455003919|FG002|First Step|Withdrawal by Subject|0|||
126464824|NCT01013649|455003920|FG003|First Step|Withdrawal by Subject|0|||
126770929|NCT04470622|456116208|FG000|Overall Study|Death|0|||
126770930|NCT04470622|456116209|FG001|Overall Study|Death|1|||
126770931|NCT00399490|456116210|FG000|Overall Study|Adverse Event|19|||
126770932|NCT00399490|456116210|FG000|Overall Study|Lack of Efficacy|31|||
126770933|NCT00399490|456116210|FG000|Overall Study|Lost to Follow-up|5|||
126770934|NCT00399490|456116210|FG000|Overall Study|Withdrawal by Subject|18|||
126464825|NCT01013649|455003917|FG000|First Step|Progression|58|||
126464826|NCT01013649|455003918|FG001|First Step|Progression|23|||
126464827|NCT01013649|455003919|FG002|First Step|Progression|0|||
126464828|NCT01013649|455003920|FG003|First Step|Progression|0|||
126464829|NCT01013649|455003917|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
126464830|NCT01013649|455003918|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
126464831|NCT01013649|455003919|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
126464832|NCT01013649|455003920|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
126464833|NCT01013649|455003917|FG000|First Step|Death|3|||
126464834|NCT01013649|455003918|FG001|First Step|Death|4|||
126464835|NCT01013649|455003919|FG002|First Step|Death|0|||
126464836|NCT01013649|455003920|FG003|First Step|Death|0|||
126464837|NCT01013649|455003917|FG000|First Step|Adverse Event|9|||
126464838|NCT01013649|455003918|FG001|First Step|Adverse Event|5|||
126371592|NCT01276704|454658422|FG000|Overall Study|Physician Decision|3|||
126371593|NCT01276704|454658423|FG001|Overall Study|Physician Decision|5|||
126371594|NCT02276040|454658424|FG000|Overall Study|Physician Decision|15|||
126371595|NCT02239926|454658425|FG000|Overall Study|Withdrawal by Subject|0|||
126371596|NCT02239926|454658426|FG001|Overall Study|Withdrawal by Subject|1|||
126371597|NCT03801525|454658427|FG000|Overall Study|Adverse Event|17|||
126371598|NCT03801525|454658428|FG001|Overall Study|Adverse Event|1|||
126371599|NCT03801525|454658429|FG002|Overall Study|Adverse Event|0|||
126371600|NCT03801525|454658427|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
126371601|NCT03801525|454658428|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
126371602|NCT03801525|454658429|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
126371603|NCT03801525|454658427|FG000|Overall Study|Death|29|||
126371604|NCT03801525|454658428|FG001|Overall Study|Death|1|||
126371605|NCT03801525|454658429|FG002|Overall Study|Death|4|||
126371606|NCT03801525|454658427|FG000|Overall Study|Disease Progression|6|||
126371607|NCT03801525|454658428|FG001|Overall Study|Disease Progression|0|||
126371608|NCT03801525|454658429|FG002|Overall Study|Disease Progression|1|||
126371609|NCT03801525|454658427|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
126371610|NCT03801525|454658428|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
126371611|NCT03801525|454658429|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
126371612|NCT03801525|454658427|FG000|Overall Study|Investigator Decision|18|||
126371613|NCT03801525|454658428|FG001|Overall Study|Investigator Decision|1|||
126371614|NCT03801525|454658429|FG002|Overall Study|Investigator Decision|0|||
126371615|NCT03801525|454658427|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
126371616|NCT03801525|454658428|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
126371617|NCT03801525|454658429|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
126371618|NCT03801525|454658427|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
126371619|NCT03801525|454658428|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
126371620|NCT03801525|454658429|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
126371621|NCT03801525|454658427|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
126371622|NCT03801525|454658428|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
126371623|NCT03801525|454658429|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
126371624|NCT03801525|454658427|FG000|Overall Study|Withdrawal of Subject Consent|38|||
126371625|NCT03801525|454658428|FG001|Overall Study|Withdrawal of Subject Consent|2|||
126371626|NCT03801525|454658429|FG002|Overall Study|Withdrawal of Subject Consent|1|||
126371627|NCT03801525|454658427|FG000|Overall Study|Reason not Specified|4|||
126371628|NCT03801525|454658428|FG001|Overall Study|Reason not Specified|0|||
126371629|NCT03801525|454658429|FG002|Overall Study|Reason not Specified|4|||
126371630|NCT04388826|454658433|FG000|Overall Study|Lost to Follow-up|3|||
126371631|NCT04388826|454658434|FG001|Overall Study|Lost to Follow-up|2|||
126371632|NCT04388826|454658433|FG000|Overall Study|Adverse Event|1|||
126371633|NCT04388826|454658434|FG001|Overall Study|Adverse Event|0|||
126371634|NCT00329420|454658435|FG000|Re-induction Phase|Lack of Efficacy|0|||
126371635|NCT00329420|454658436|FG001|Re-induction Phase|Lack of Efficacy|1|||
126371636|NCT00329420|454658437|FG002|Re-induction Phase|Lack of Efficacy|0|||
126371637|NCT00329420|454658435|FG000|Re-induction Phase|Withdrawal of Consent|0|||
126371638|NCT00329420|454658436|FG001|Re-induction Phase|Withdrawal of Consent|0|||
126371639|NCT00329420|454658437|FG002|Re-induction Phase|Withdrawal of Consent|1|||
126371640|NCT00329420|454658435|FG000|Re-induction Phase|Did not respond to re-induction|6|||
126371641|NCT00329420|454658436|FG001|Re-induction Phase|Did not respond to re-induction|5|||
126371642|NCT00329420|454658437|FG002|Re-induction Phase|Did not respond to re-induction|7|||
126371643|NCT00329420|454658435|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
126371644|NCT00329420|454658436|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
126371645|NCT00329420|454658437|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
126371646|NCT00329420|454658435|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
126371647|NCT00329420|454658436|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
126371648|NCT00329420|454658437|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
126371649|NCT00329420|454658435|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
126371650|NCT00329420|454658436|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
126371651|NCT00329420|454658437|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
126371652|NCT02862574|454658438|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126371653|NCT02862574|454658439|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126371654|NCT02862574|454658440|FG002|Double-Blind Treatment Period|Adverse Event|0|||
126371655|NCT02862574|454658438|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
126371656|NCT02862574|454658439|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
126371657|NCT02862574|454658440|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
126371658|NCT02862574|454658438|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
126371659|NCT02862574|454658439|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
126464839|NCT01013649|455003919|FG002|First Step|Adverse Event|0|||
126464840|NCT01013649|455003920|FG003|First Step|Adverse Event|0|||
126371660|NCT02862574|454658440|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
126371661|NCT00320606|454658450|FG000|Overall Study|Adverse Event|1|||
126371662|NCT00320606|454658450|FG000|Overall Study|Protocol Violation|1|||
126371663|NCT00320606|454658450|FG000|Overall Study|Withdrawal by Subject|1|||
126371664|NCT03984825|454658451|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
126371665|NCT03984825|454658451|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
126371666|NCT03984825|454658451|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
126371667|NCT00399035|454658454|FG000|Overall Study|Death|289|||
126371668|NCT00399035|454658455|FG001|Overall Study|Death|141|||
126371669|NCT00399035|454658456|FG002|Overall Study|Death|234|||
126371670|NCT00399035|454658454|FG000|Overall Study|Lost to Follow-up|2|||
126371671|NCT00399035|454658455|FG001|Overall Study|Lost to Follow-up|1|||
126371672|NCT00399035|454658456|FG002|Overall Study|Lost to Follow-up|5|||
126371673|NCT00399035|454658454|FG000|Overall Study|Withdrawal by Subject|19|||
126371674|NCT00399035|454658455|FG001|Overall Study|Withdrawal by Subject|15|||
126371675|NCT00399035|454658456|FG002|Overall Study|Withdrawal by Subject|12|||
126371676|NCT00399035|454658454|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
126371677|NCT00399035|454658455|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
126371678|NCT00399035|454658456|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
126371679|NCT00399035|454658454|FG000|Overall Study|Severe non-compliance with protocol|2|||
126371680|NCT00399035|454658455|FG001|Overall Study|Severe non-compliance with protocol|1|||
126371681|NCT00399035|454658456|FG002|Overall Study|Severe non-compliance with protocol|0|||
126371682|NCT02921256|454658465|FG000|Arm 1a v. Arm II|Adverse Event|6|||
126371683|NCT02921256|454658466|FG001|Arm 1a v. Arm II|Adverse Event|15|||
126371684|NCT02921256|454658467|FG002|Arm 1a v. Arm II|Adverse Event|0|||
126371685|NCT02921256|454658465|FG000|Arm 1a v. Arm II|Death|0|||
126371686|NCT02921256|454658466|FG001|Arm 1a v. Arm II|Death|2|||
126371687|NCT02921256|454658467|FG002|Arm 1a v. Arm II|Death|0|||
126371688|NCT02921256|454658465|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
126371689|NCT02921256|454658466|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
126371690|NCT02921256|454658467|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
126371691|NCT02921256|454658465|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
126371692|NCT02921256|454658466|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
126371693|NCT02921256|454658467|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
126371694|NCT02921256|454658465|FG000|Arm 1a v. Arm II|Physician Decision|1|||
126371695|NCT02921256|454658466|FG001|Arm 1a v. Arm II|Physician Decision|1|||
126371696|NCT02921256|454658467|FG002|Arm 1a v. Arm II|Physician Decision|0|||
126371697|NCT02921256|454658465|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
126371698|NCT02921256|454658466|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
126371699|NCT02921256|454658467|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
126371700|NCT02921256|454658465|FG000|Arm Ib v Arm III|Adverse Event|9|||
126371701|NCT02921256|454658466|FG001|Arm Ib v Arm III|Adverse Event|0|||
126371702|NCT02921256|454658467|FG002|Arm Ib v Arm III|Adverse Event|4|||
126371703|NCT02921256|454658465|FG000|Arm Ib v Arm III|Death|1|||
126371704|NCT02921256|454658466|FG001|Arm Ib v Arm III|Death|0|||
126371705|NCT02921256|454658467|FG002|Arm Ib v Arm III|Death|1|||
126371706|NCT02921256|454658465|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
126371707|NCT02921256|454658466|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
126371708|NCT02921256|454658467|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
126371709|NCT02921256|454658465|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
126371710|NCT02921256|454658466|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
126371711|NCT02921256|454658467|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
126371712|NCT02921256|454658465|FG000|Arm Ib v Arm III|Physician Decision|4|||
126371713|NCT02921256|454658466|FG001|Arm Ib v Arm III|Physician Decision|0|||
126371714|NCT02921256|454658467|FG002|Arm Ib v Arm III|Physician Decision|1|||
126371715|NCT02921256|454658465|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
126371716|NCT02921256|454658466|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
126371717|NCT02921256|454658467|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
126371718|NCT02943473|454658468|FG000|Overall Study|enrolled but not dosed|1|||
126371719|NCT02943473|454658468|FG000|Overall Study|screen failure|1|||
126770935|NCT00399490|456116210|FG000|Overall Study|Other|25|||
126371720|NCT02943473|454658468|FG000|Overall Study|Physician Decision|4|||
126371721|NCT04211363|454658469|FG000|Overall Study|Adverse Event|5|||
126371722|NCT04211363|454658470|FG001|Overall Study|Adverse Event|2|||
126371723|NCT04211363|454658469|FG000|Overall Study|Physician Decision|0|||
126371724|NCT04211363|454658470|FG001|Overall Study|Physician Decision|1|||
126371725|NCT04211363|454658469|FG000|Overall Study|Protocol Violation|1|||
126371726|NCT04211363|454658470|FG001|Overall Study|Protocol Violation|0|||
126371727|NCT04211363|454658469|FG000|Overall Study|Pregnancy|1|||
126371728|NCT04211363|454658470|FG001|Overall Study|Pregnancy|0|||
126371729|NCT04211363|454658469|FG000|Overall Study|Lost to Follow-up|12|||
126371730|NCT04211363|454658470|FG001|Overall Study|Lost to Follow-up|4|||
126371731|NCT04211363|454658469|FG000|Overall Study|Withdrawal by Subject|11|||
126371732|NCT04211363|454658470|FG001|Overall Study|Withdrawal by Subject|11|||
126371733|NCT04211363|454658469|FG000|Overall Study|Other|1|||
126371734|NCT04211363|454658470|FG001|Overall Study|Other|2|||
126371735|NCT03097289|454658471|FG000|Overall Study|Adverse Event|1|||
126371736|NCT03097289|454658471|FG000|Overall Study|Equipment failure|2|||
126552450|NCT00109928|455318400|FG000|Overall Study|not eligible|1|||
126552451|NCT01196104|455318401|FG000|Overall Study|Lost to Follow-up|1|||
126552452|NCT01196104|455318402|FG001|Overall Study|Lost to Follow-up|0|||
126371737|NCT03097289|454658471|FG000|Overall Study|Collected platelet product unusable|3|||
126371738|NCT01736917|454658472|FG000|Overall Study|Adverse Event|1|||
126371739|NCT01736917|454658472|FG000|Overall Study|Protocol Violation|10|||
126371740|NCT01911260|454658473|FG000|Supplementation Period|transference or evasion of school|7|||
126371741|NCT01911260|454658474|FG001|Supplementation Period|transference or evasion of school|9|||
126371742|NCT01911260|454658475|FG002|Supplementation Period|transference or evasion of school|7|||
126552453|NCT01196104|455318401|FG000|Overall Study|Physician Decision|0|||
126552454|NCT01196104|455318402|FG001|Overall Study|Physician Decision|1|||
126552455|NCT01196104|455318401|FG000|Overall Study|Withdrawal by Subject|3|||
126552456|NCT01196104|455318402|FG001|Overall Study|Withdrawal by Subject|3|||
126552457|NCT01196104|455318401|FG000|Overall Study|Various|0|||
126552458|NCT01196104|455318402|FG001|Overall Study|Various|1|||
126552459|NCT00610675|455318403|FG000|Overall Study|Untreated|4|||
126552460|NCT00610675|455318403|FG000|Overall Study|Adverse Event|67|||
126552461|NCT00610675|455318403|FG000|Overall Study|Insufficient Effect|31|||
126308878|NCT02836236|454420901|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
126371743|NCT01911260|454658476|FG003|Supplementation Period|transference or evasion of school|6|||
126371744|NCT01911260|454658473|FG000|Supplementation Period|Adverse Event|2|||
126371745|NCT01911260|454658474|FG001|Supplementation Period|Adverse Event|0|||
126371746|NCT01911260|454658475|FG002|Supplementation Period|Adverse Event|1|||
126371747|NCT01911260|454658476|FG003|Supplementation Period|Adverse Event|0|||
126308879|NCT02836236|454420902|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
126308880|NCT02836236|454420903|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
126308881|NCT02836236|454420900|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
126308882|NCT02836236|454420901|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
126308883|NCT02836236|454420902|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
126308884|NCT02836236|454420903|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
126308885|NCT02836236|454420900|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
126308886|NCT02836236|454420901|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
126308887|NCT02836236|454420902|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
126308888|NCT02836236|454420903|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
126308889|NCT02836236|454420900|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
126308890|NCT02836236|454420901|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
126308891|NCT02836236|454420902|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
126308892|NCT02836236|454420903|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
126308893|NCT02836236|454420900|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
126308894|NCT02836236|454420901|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
126308895|NCT02836236|454420902|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
126308896|NCT02836236|454420903|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
126308897|NCT02836236|454420900|FG000|Open-Label TAF Treatment Phase|Death|0|||
126308898|NCT02836236|454420901|FG001|Open-Label TAF Treatment Phase|Death|0|||
126308899|NCT02836236|454420902|FG002|Open-Label TAF Treatment Phase|Death|1|||
126308900|NCT02836236|454420903|FG003|Open-Label TAF Treatment Phase|Death|1|||
126308901|NCT02836236|454420900|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
126308902|NCT02836236|454420901|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
126308903|NCT02836236|454420902|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
126308904|NCT02836236|454420903|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
126371748|NCT01911260|454658473|FG000|Supplementation Period|refused to receive supplement|1|||
126371749|NCT01911260|454658474|FG001|Supplementation Period|refused to receive supplement|0|||
126371750|NCT01911260|454658475|FG002|Supplementation Period|refused to receive supplement|1|||
126371751|NCT01911260|454658476|FG003|Supplementation Period|refused to receive supplement|0|||
126371752|NCT01911260|454658473|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
126371753|NCT01911260|454658474|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
126371754|NCT01911260|454658475|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
126371755|NCT01911260|454658476|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
126371756|NCT01911260|454658473|FG000|Follow-up Period|transference or evasion of school|13|||
126371757|NCT01911260|454658474|FG001|Follow-up Period|transference or evasion of school|20|||
126371758|NCT01911260|454658475|FG002|Follow-up Period|transference or evasion of school|15|||
126371759|NCT01911260|454658476|FG003|Follow-up Period|transference or evasion of school|12|||
126371760|NCT01734902|454658479|FG000|Overall Study|Other than listed|0|||
126371761|NCT01734902|454658480|FG001|Overall Study|Other than listed|2|||
126371762|NCT01959932|454658481|FG000|Overall Study|Withdrawal by Subject|1|||
126552462|NCT00610675|455318403|FG000|Overall Study|Withdrawal by Subject|28|||
126552463|NCT00610675|455318403|FG000|Overall Study|Reasons unrelated to trial|27|||
126716399|NCT00793819|455913124|FG000|Overall Study|Lack of Efficacy|1|||
126716400|NCT00793819|455913125|FG001|Overall Study|Lack of Efficacy|1|||
126552464|NCT00610675|455318403|FG000|Overall Study|Lack of Compliance|7|||
126552465|NCT00610675|455318403|FG000|Overall Study|Lost to Follow-up|31|||
126716401|NCT00793819|455913124|FG000|Overall Study|Withdrawal by Subject|4|||
126464841|NCT01013649|455003917|FG000|First Step|Other|4|||
126464842|NCT01013649|455003918|FG001|First Step|Other|6|||
126464843|NCT01013649|455003919|FG002|First Step|Other|0|||
126464844|NCT01013649|455003920|FG003|First Step|Other|0|||
126464845|NCT01115803|455003923|FG000|Overall Study|Withdrawal by Subject|0|||
126464846|NCT01115803|455003924|FG001|Overall Study|Withdrawal by Subject|0|||
126464847|NCT01115803|455003925|FG002|Overall Study|Withdrawal by Subject|0|||
126464848|NCT01115803|455003926|FG003|Overall Study|Withdrawal by Subject|0|||
126464849|NCT01115803|455003927|FG004|Overall Study|Withdrawal by Subject|0|||
126464850|NCT01115803|455003928|FG005|Overall Study|Withdrawal by Subject|0|||
126464851|NCT01115803|455003929|FG006|Overall Study|Withdrawal by Subject|1|||
126464852|NCT01115803|455003923|FG000|Overall Study|Lost to Follow-up|0|||
126464853|NCT01115803|455003924|FG001|Overall Study|Lost to Follow-up|0|||
126464854|NCT01115803|455003925|FG002|Overall Study|Lost to Follow-up|1|||
126308905|NCT01806961|454420904|FG000|Overall Study|sponsor decision|16|||
126308906|NCT00972816|454420906|FG000|Overall Study|Adverse Event|0|||
126308907|NCT00972816|454420907|FG001|Overall Study|Adverse Event|0|||
126308908|NCT00972816|454420908|FG002|Overall Study|Adverse Event|1|||
126308909|NCT00972816|454420909|FG003|Overall Study|Adverse Event|0|||
126308910|NCT00972816|454420910|FG004|Overall Study|Adverse Event|0|||
126464855|NCT01115803|455003926|FG003|Overall Study|Lost to Follow-up|0|||
126464856|NCT01115803|455003927|FG004|Overall Study|Lost to Follow-up|0|||
126464857|NCT01115803|455003928|FG005|Overall Study|Lost to Follow-up|0|||
126464858|NCT01115803|455003929|FG006|Overall Study|Lost to Follow-up|0|||
126464859|NCT01115803|455003923|FG000|Overall Study|Progressive Disease during Cycle1|0|||
126464860|NCT01115803|455003924|FG001|Overall Study|Progressive Disease during Cycle1|0|||
126464861|NCT01115803|455003925|FG002|Overall Study|Progressive Disease during Cycle1|0|||
126464862|NCT01115803|455003926|FG003|Overall Study|Progressive Disease during Cycle1|0|||
126464863|NCT01115803|455003927|FG004|Overall Study|Progressive Disease during Cycle1|0|||
126464864|NCT01115803|455003928|FG005|Overall Study|Progressive Disease during Cycle1|0|||
126464865|NCT01115803|455003929|FG006|Overall Study|Progressive Disease during Cycle1|1|||
126716402|NCT00793819|455913125|FG001|Overall Study|Withdrawal by Subject|3|||
126716403|NCT00793819|455913124|FG000|Overall Study|Lost to Follow-up|1|||
126716404|NCT00793819|455913125|FG001|Overall Study|Lost to Follow-up|1|||
126308911|NCT00972816|454420911|FG005|Overall Study|Adverse Event|0|||
126308912|NCT00972816|454420912|FG006|Overall Study|Adverse Event|0|||
126308913|NCT00972816|454420913|FG007|Overall Study|Adverse Event|0|||
126308914|NCT00972816|454420906|FG000|Overall Study|Withdrawal by Subject|4|||
126308915|NCT00972816|454420907|FG001|Overall Study|Withdrawal by Subject|2|||
126308916|NCT00972816|454420908|FG002|Overall Study|Withdrawal by Subject|1|||
126308917|NCT00972816|454420909|FG003|Overall Study|Withdrawal by Subject|3|||
126308918|NCT00972816|454420910|FG004|Overall Study|Withdrawal by Subject|0|||
126308919|NCT00972816|454420911|FG005|Overall Study|Withdrawal by Subject|1|||
126308920|NCT00972816|454420912|FG006|Overall Study|Withdrawal by Subject|1|||
126308921|NCT00972816|454420913|FG007|Overall Study|Withdrawal by Subject|2|||
126308922|NCT00972816|454420906|FG000|Overall Study|Lost to Follow-up|11|||
126308923|NCT00972816|454420907|FG001|Overall Study|Lost to Follow-up|9|||
126308924|NCT00972816|454420908|FG002|Overall Study|Lost to Follow-up|7|||
126308925|NCT00972816|454420909|FG003|Overall Study|Lost to Follow-up|5|||
126308926|NCT00972816|454420910|FG004|Overall Study|Lost to Follow-up|11|||
126308927|NCT00972816|454420911|FG005|Overall Study|Lost to Follow-up|10|||
126308928|NCT00972816|454420912|FG006|Overall Study|Lost to Follow-up|7|||
126308929|NCT00972816|454420913|FG007|Overall Study|Lost to Follow-up|7|||
126308930|NCT00972816|454420906|FG000|Overall Study|Inappropriate enrolment|0|||
126308931|NCT00972816|454420907|FG001|Overall Study|Inappropriate enrolment|0|||
126308932|NCT00972816|454420908|FG002|Overall Study|Inappropriate enrolment|0|||
126308933|NCT00972816|454420909|FG003|Overall Study|Inappropriate enrolment|0|||
126308934|NCT00972816|454420910|FG004|Overall Study|Inappropriate enrolment|0|||
126308935|NCT00972816|454420911|FG005|Overall Study|Inappropriate enrolment|0|||
126308936|NCT00972816|454420912|FG006|Overall Study|Inappropriate enrolment|2|||
126308937|NCT00972816|454420913|FG007|Overall Study|Inappropriate enrolment|0|||
126308938|NCT00972816|454420906|FG000|Overall Study|Unable to classify|2|||
126308939|NCT00972816|454420907|FG001|Overall Study|Unable to classify|0|||
126308940|NCT00972816|454420908|FG002|Overall Study|Unable to classify|0|||
126308941|NCT00972816|454420909|FG003|Overall Study|Unable to classify|0|||
126464866|NCT03475875|455003930|FG000|Period 1|Lost to Follow-up|1|||
126464867|NCT03475875|455003931|FG001|Period 1|Lost to Follow-up|0|||
126464868|NCT03475875|455003930|FG000|Period 1|Adverse Event|2|||
126464869|NCT03475875|455003931|FG001|Period 1|Adverse Event|1|||
126464870|NCT03475875|455003930|FG000|Period 2|Adverse Event|3|||
126308942|NCT00972816|454420910|FG004|Overall Study|Unable to classify|1|||
126308943|NCT00972816|454420911|FG005|Overall Study|Unable to classify|0|||
126308944|NCT00972816|454420912|FG006|Overall Study|Unable to classify|0|||
126464871|NCT03475875|455003931|FG001|Period 2|Adverse Event|0|||
126308945|NCT00972816|454420913|FG007|Overall Study|Unable to classify|0|||
126308946|NCT05318092|454420917|FG000|Overall Study|Lost to Follow-up|3|||
126308947|NCT05318092|454420917|FG000|Overall Study|Withdrawal by Subject|1|||
126308948|NCT03917472|454420918|FG000|Overall Study|Physician Decision|4|||
126464872|NCT03475875|455003930|FG000|Period 2|Protocol Violation|0|||
126371763|NCT01959932|454658482|FG001|Overall Study|Withdrawal by Subject|0|||
126371764|NCT01959932|454658483|FG002|Overall Study|Withdrawal by Subject|0|||
126371765|NCT00060944|454658486|FG000|Overall Study|Adverse Event|12|||
126371766|NCT00060944|454658487|FG001|Overall Study|Adverse Event|10|||
126371767|NCT00060944|454658486|FG000|Overall Study|Death|2|||
126371768|NCT00060944|454658487|FG001|Overall Study|Death|3|||
126371769|NCT00060944|454658486|FG000|Overall Study|Withdrawal by Subject|18|||
126371770|NCT00060944|454658487|FG001|Overall Study|Withdrawal by Subject|5|||
126371771|NCT00060944|454658486|FG000|Overall Study|Disease Progression|93|||
126371772|NCT00060944|454658487|FG001|Overall Study|Disease Progression|94|||
126371773|NCT00060944|454658486|FG000|Overall Study|Lost to Follow-up|1|||
126371774|NCT00060944|454658487|FG001|Overall Study|Lost to Follow-up|0|||
126371775|NCT00060944|454658486|FG000|Overall Study|Subject Ineligible To Continue|2|||
126371776|NCT00060944|454658487|FG001|Overall Study|Subject Ineligible To Continue|1|||
126371777|NCT00060944|454658486|FG000|Overall Study|Treatment Switch|0|||
126371778|NCT00060944|454658487|FG001|Overall Study|Treatment Switch|13|||
126371779|NCT00060944|454658486|FG000|Overall Study|Other|2|||
126371780|NCT00060944|454658487|FG001|Overall Study|Other|4|||
126371781|NCT00060944|454658486|FG000|Overall Study|randomized but not treated|6|||
126371782|NCT00060944|454658487|FG001|Overall Study|randomized but not treated|4|||
126371783|NCT00776230|454658491|FG000|Overall Study|Lost to Follow-up|2|||
126371784|NCT00776230|454658492|FG001|Overall Study|Lost to Follow-up|1|||
126371785|NCT00776230|454658493|FG002|Overall Study|Lost to Follow-up|5|||
126371786|NCT00776230|454658491|FG000|Overall Study|Not vaccinated at Day 0|1|||
126371787|NCT00776230|454658492|FG001|Overall Study|Not vaccinated at Day 0|0|||
126371788|NCT00776230|454658493|FG002|Overall Study|Not vaccinated at Day 0|0|||
126371789|NCT00776230|454658491|FG000|Overall Study|Withdrawal by Subject|0|||
126464873|NCT03475875|455003931|FG001|Period 2|Protocol Violation|1|||
126464874|NCT02017171|455003932|FG000|Overall Study|Death|10|||
126464875|NCT02017171|455003933|FG001|Overall Study|Death|4|||
126464876|NCT02017171|455003932|FG000|Overall Study|Withdrawal by Subject|23|||
126464877|NCT02017171|455003933|FG001|Overall Study|Withdrawal by Subject|17|||
126464878|NCT02017171|455003932|FG000|Overall Study|Lost to Follow-up|21|||
126464879|NCT02017171|455003933|FG001|Overall Study|Lost to Follow-up|20|||
126464880|NCT02017171|455003932|FG000|Overall Study|ESKD|6|||
126464881|NCT02017171|455003933|FG001|Overall Study|ESKD|2|||
126464882|NCT02017171|455003932|FG000|Overall Study|Miscellaneous|2|||
126464883|NCT02017171|455003933|FG001|Overall Study|Miscellaneous|3|||
126464884|NCT03091777|455003935|FG000|Overall Study|Pregnancy|2|||
126464885|NCT03091777|455003936|FG001|Overall Study|Pregnancy|1|||
126464886|NCT03091777|455003937|FG002|Overall Study|Pregnancy|0|||
126464887|NCT03091777|455003935|FG000|Overall Study|Adverse Event|2|||
126464888|NCT03091777|455003936|FG001|Overall Study|Adverse Event|1|||
126464889|NCT03091777|455003937|FG002|Overall Study|Adverse Event|4|||
126464890|NCT03091777|455003935|FG000|Overall Study|Withdrawal by Subject|4|||
126464891|NCT03091777|455003936|FG001|Overall Study|Withdrawal by Subject|2|||
126464892|NCT03091777|455003937|FG002|Overall Study|Withdrawal by Subject|6|||
126464893|NCT03091777|455003935|FG000|Overall Study|Protocol Violation|2|||
126464894|NCT03091777|455003936|FG001|Overall Study|Protocol Violation|1|||
126464895|NCT03091777|455003937|FG002|Overall Study|Protocol Violation|1|||
126464896|NCT03091777|455003935|FG000|Overall Study|Lost to Follow-up|12|||
126464897|NCT03091777|455003936|FG001|Overall Study|Lost to Follow-up|14|||
126464898|NCT03091777|455003937|FG002|Overall Study|Lost to Follow-up|7|||
126464899|NCT03091777|455003935|FG000|Overall Study|Lack of Efficacy|0|||
126464900|NCT03091777|455003936|FG001|Overall Study|Lack of Efficacy|0|||
126464901|NCT03091777|455003937|FG002|Overall Study|Lack of Efficacy|5|||
126464902|NCT03091777|455003935|FG000|Overall Study|Noncompliance with study drug|2|||
126464903|NCT03091777|455003936|FG001|Overall Study|Noncompliance with study drug|3|||
126464904|NCT03091777|455003937|FG002|Overall Study|Noncompliance with study drug|1|||
126552466|NCT00610675|455318403|FG000|Overall Study|Other reason (not specified)|25|||
126552467|NCT01316692|455318406|FG000|Overall Study|Adverse Event|5|||
126770936|NCT02576054|456116211|FG000|Overall Study|Withdrawal by Subject|1|||
126770937|NCT01190098|456116212|FG000|Overall Study|Adverse Event|2|||
126770938|NCT01190098|456116213|FG001|Overall Study|Adverse Event|0|||
126464905|NCT03091777|455003935|FG000|Overall Study|Physician Decision|1|||
126464906|NCT03091777|455003936|FG001|Overall Study|Physician Decision|0|||
126464907|NCT03091777|455003937|FG002|Overall Study|Physician Decision|1|||
126464908|NCT03091777|455003935|FG000|Overall Study|Abnormal Laboratory Value|7|||
126770939|NCT01190098|456116212|FG000|Overall Study|Patient coomorbidity|0|||
126371790|NCT00776230|454658492|FG001|Overall Study|Withdrawal by Subject|1|||
126371791|NCT00776230|454658493|FG002|Overall Study|Withdrawal by Subject|0|||
126371792|NCT00776230|454658491|FG000|Overall Study|Subject missed Visit 4|0|||
126371793|NCT00776230|454658492|FG001|Overall Study|Subject missed Visit 4|1|||
126464909|NCT03091777|455003936|FG001|Overall Study|Abnormal Laboratory Value|11|||
126464910|NCT03091777|455003937|FG002|Overall Study|Abnormal Laboratory Value|12|||
126464911|NCT03370289|455003938|FG000|Overall Study|Screen Failure|1|||
126552468|NCT01316692|455318406|FG000|Overall Study|Disease Progression|7|||
126371794|NCT00776230|454658493|FG002|Overall Study|Subject missed Visit 4|0|||
126464912|NCT03370289|455003938|FG000|Overall Study|Sample Size Sufficient|4|||
126371795|NCT01242514|454658495|FG000|Overall Study|e.g., project closure|1042|||
126371796|NCT01242514|454658496|FG001|Overall Study|e.g., project closure|305|||
126371797|NCT01242514|454658497|FG002|Overall Study|e.g., project closure|171|||
126371798|NCT01242514|454658495|FG000|Overall Study|Subject decision|33|||
126371799|NCT01242514|454658496|FG001|Overall Study|Subject decision|8|||
126371800|NCT01242514|454658497|FG002|Overall Study|Subject decision|2|||
126371801|NCT01242514|454658495|FG000|Overall Study|Severe non-compliance to protocol|5|||
126371802|NCT01242514|454658496|FG001|Overall Study|Severe non-compliance to protocol|2|||
126371803|NCT01242514|454658497|FG002|Overall Study|Severe non-compliance to protocol|1|||
126371804|NCT01242514|454658495|FG000|Overall Study|Lack of therapeutic response|99|||
126371805|NCT01242514|454658496|FG001|Overall Study|Lack of therapeutic response|16|||
126371806|NCT01242514|454658497|FG002|Overall Study|Lack of therapeutic response|10|||
126371807|NCT01242514|454658495|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
126371808|NCT01242514|454658496|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
126371809|NCT01242514|454658497|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
126371810|NCT01242514|454658495|FG000|Overall Study|Lost to Follow-up|14|||
126371811|NCT01242514|454658496|FG001|Overall Study|Lost to Follow-up|5|||
126371812|NCT01242514|454658497|FG002|Overall Study|Lost to Follow-up|4|||
126371813|NCT01242514|454658495|FG000|Overall Study|Adverse Event|129|||
126371814|NCT01242514|454658496|FG001|Overall Study|Adverse Event|18|||
126371815|NCT01242514|454658497|FG002|Overall Study|Adverse Event|19|||
126371816|NCT03213509|454658511|FG000|Overall Study|Did not consent for verbal autopsy|4|||
126371817|NCT03213509|454658512|FG001|Overall Study|Did not consent for verbal autopsy|5|||
126371818|NCT04549454|454658515|FG000|T1 to T2|Lost to Follow-up|22|||
126371819|NCT04549454|454658516|FG001|T1 to T2|Lost to Follow-up|26|||
126371820|NCT04549454|454658515|FG000|T1 to T3|Lost to Follow-up|31|||
126371821|NCT04549454|454658516|FG001|T1 to T3|Lost to Follow-up|36|||
126371822|NCT00016354|454658517|FG000|Overall Study|Lack of Efficacy|0|||
126371823|NCT00016354|454658518|FG001|Overall Study|Lack of Efficacy|0|||
126371824|NCT00016354|454658519|FG002|Overall Study|Lack of Efficacy|0|||
126371825|NCT00016354|454658520|FG003|Overall Study|Lack of Efficacy|0|||
126371826|NCT00016354|454658521|FG004|Overall Study|Lack of Efficacy|0|||
126371827|NCT00016354|454658522|FG005|Overall Study|Lack of Efficacy|0|||
126371828|NCT00016354|454658523|FG006|Overall Study|Lack of Efficacy|0|||
126371829|NCT00016354|454658524|FG007|Overall Study|Lack of Efficacy|1|||
126371830|NCT03110562|454658525|FG000|Initial Treatment Period|Disease Progression|1|||
126371831|NCT03110562|454658526|FG001|Initial Treatment Period|Disease Progression|1|||
126371832|NCT03110562|454658527|FG002|Initial Treatment Period|Disease Progression|0|||
126371833|NCT03110562|454658528|FG003|Initial Treatment Period|Disease Progression|0|||
126371834|NCT03110562|454658525|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
126371835|NCT03110562|454658526|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
126371836|NCT03110562|454658527|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
126371837|NCT03110562|454658528|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
126371838|NCT03110562|454658525|FG000|Initial Treatment Period|Adverse Event|1|||
126371839|NCT03110562|454658526|FG001|Initial Treatment Period|Adverse Event|0|||
126371840|NCT03110562|454658527|FG002|Initial Treatment Period|Adverse Event|0|||
126371841|NCT03110562|454658528|FG003|Initial Treatment Period|Adverse Event|0|||
126371842|NCT03110562|454658525|FG000|Initial Treatment Period|Death|74|||
126371843|NCT03110562|454658526|FG001|Initial Treatment Period|Death|82|||
126371844|NCT03110562|454658527|FG002|Initial Treatment Period|Death|0|||
126464913|NCT02220998|455003939|FG000|Overall Study|Randomized but Never Treated|1|||
126464914|NCT02220998|455003940|FG001|Overall Study|Randomized but Never Treated|2|||
126464915|NCT02220998|455003939|FG000|Overall Study|Death|2|||
126464916|NCT02220998|455003940|FG001|Overall Study|Death|0|||
126464917|NCT02220998|455003939|FG000|Overall Study|Lack of Efficacy|0|||
126464918|NCT02220998|455003940|FG001|Overall Study|Lack of Efficacy|5|||
126464919|NCT02220998|455003939|FG000|Overall Study|Lost to Follow-up|4|||
126464920|NCT02220998|455003940|FG001|Overall Study|Lost to Follow-up|4|||
126464921|NCT02314143|455003941|FG000|Overall Study|Adverse Event|0|||
126464922|NCT02314143|455003942|FG001|Overall Study|Adverse Event|6|||
126464923|NCT02314143|455003943|FG002|Overall Study|Adverse Event|4|||
126464924|NCT02314143|455003941|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
126464925|NCT02314143|455003942|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
126464926|NCT02314143|455003943|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
126464927|NCT02314143|455003941|FG000|Overall Study|Physician Decision|2|||
126371845|NCT03110562|454658528|FG003|Initial Treatment Period|Death|0|||
126371846|NCT03110562|454658525|FG000|Initial Treatment Period|Lost to Follow-up|13|||
126371847|NCT03110562|454658526|FG001|Initial Treatment Period|Lost to Follow-up|8|||
126371848|NCT03110562|454658527|FG002|Initial Treatment Period|Lost to Follow-up|0|||
126371849|NCT03110562|454658528|FG003|Initial Treatment Period|Lost to Follow-up|0|||
126371850|NCT03110562|454658525|FG000|Initial Treatment Period|Protocol Deviation|1|||
126464928|NCT02314143|455003942|FG001|Overall Study|Physician Decision|1|||
126464929|NCT02314143|455003943|FG002|Overall Study|Physician Decision|0|||
126716405|NCT00446446|455913126|FG000|Overall Study|Death|10|||
126464930|NCT02314143|455003941|FG000|Overall Study|Withdrawal by Subject|1|||
126464931|NCT02314143|455003942|FG001|Overall Study|Withdrawal by Subject|0|||
126371851|NCT03110562|454658526|FG001|Initial Treatment Period|Protocol Deviation|0|||
126371852|NCT03110562|454658527|FG002|Initial Treatment Period|Protocol Deviation|0|||
126371853|NCT03110562|454658528|FG003|Initial Treatment Period|Protocol Deviation|0|||
126371854|NCT03110562|454658525|FG000|Initial Treatment Period|Physician Decision|2|||
126371855|NCT03110562|454658526|FG001|Initial Treatment Period|Physician Decision|1|||
126371856|NCT03110562|454658527|FG002|Initial Treatment Period|Physician Decision|0|||
126371857|NCT03110562|454658528|FG003|Initial Treatment Period|Physician Decision|0|||
126371858|NCT03110562|454658525|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
126371859|NCT03110562|454658526|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
126371860|NCT03110562|454658527|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
126371861|NCT03110562|454658528|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
126371862|NCT03110562|454658525|FG000|Initial Treatment Period|Other|5|||
126371863|NCT03110562|454658526|FG001|Initial Treatment Period|Other|4|||
126371864|NCT03110562|454658527|FG002|Initial Treatment Period|Other|0|||
126371865|NCT03110562|454658528|FG003|Initial Treatment Period|Other|0|||
126371866|NCT03110562|454658525|FG000|Initial Treatment Period|Randomized but never treated|0|||
126371867|NCT03110562|454658526|FG001|Initial Treatment Period|Randomized but never treated|3|||
126371868|NCT03110562|454658527|FG002|Initial Treatment Period|Randomized but never treated|0|||
126371869|NCT03110562|454658528|FG003|Initial Treatment Period|Randomized but never treated|0|||
126371870|NCT03110562|454658525|FG000|Crossover Period|Disease Progression|0|||
126371871|NCT03110562|454658526|FG001|Crossover Period|Disease Progression|0|||
126371872|NCT03110562|454658527|FG002|Crossover Period|Disease Progression|1|||
126371873|NCT03110562|454658528|FG003|Crossover Period|Disease Progression|0|||
126371874|NCT03110562|454658525|FG000|Crossover Period|Withdrawal by Subject|0|||
126371875|NCT03110562|454658526|FG001|Crossover Period|Withdrawal by Subject|0|||
126371876|NCT03110562|454658527|FG002|Crossover Period|Withdrawal by Subject|8|||
126371877|NCT03110562|454658528|FG003|Crossover Period|Withdrawal by Subject|6|||
126371878|NCT03110562|454658525|FG000|Crossover Period|Death|0|||
126371879|NCT03110562|454658526|FG001|Crossover Period|Death|0|||
126371880|NCT03110562|454658527|FG002|Crossover Period|Death|37|||
126371881|NCT03110562|454658528|FG003|Crossover Period|Death|3|||
126371882|NCT03110562|454658525|FG000|Crossover Period|Lost to Follow-up|0|||
126371883|NCT03110562|454658526|FG001|Crossover Period|Lost to Follow-up|0|||
126371884|NCT03110562|454658527|FG002|Crossover Period|Lost to Follow-up|0|||
126371885|NCT03110562|454658528|FG003|Crossover Period|Lost to Follow-up|1|||
126371886|NCT03110562|454658525|FG000|Crossover Period|Other|0|||
126371887|NCT03110562|454658526|FG001|Crossover Period|Other|0|||
126371888|NCT03110562|454658527|FG002|Crossover Period|Other|1|||
126371889|NCT03110562|454658528|FG003|Crossover Period|Other|1|||
126371890|NCT03110562|454658525|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
126371891|NCT03110562|454658526|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
126371892|NCT03110562|454658527|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
126371893|NCT03110562|454658528|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
126371894|NCT02936323|454658531|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
126371895|NCT02936323|454658532|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
126371896|NCT02936323|454658533|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
126371897|NCT02936323|454658534|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
126371898|NCT02936323|454658535|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
126371899|NCT02936323|454658536|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
126371900|NCT02936323|454658537|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
126371901|NCT02936323|454658538|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
126371902|NCT02936323|454658539|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
126371903|NCT02936323|454658540|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
126371904|NCT02936323|454658531|FG000|Phase 1 Dose Escalation|Death|2|||
126371905|NCT02936323|454658532|FG001|Phase 1 Dose Escalation|Death|1|||
126716406|NCT00446446|455913126|FG000|Overall Study|Withdrawal by Subject|6|||
126716407|NCT00446446|455913126|FG000|Overall Study|Other|4|||
126716408|NCT00446446|455913126|FG000|Overall Study|Disease Progession|2|||
126371906|NCT02936323|454658533|FG002|Phase 1 Dose Escalation|Death|3|||
126371907|NCT02936323|454658534|FG003|Phase 1 Dose Escalation|Death|1|||
126371908|NCT02936323|454658535|FG004|Phase 1 Dose Escalation|Death|2|||
126371909|NCT02936323|454658536|FG005|Phase 1 Dose Escalation|Death|3|||
126371910|NCT02936323|454658537|FG006|Phase 1 Dose Escalation|Death|3|||
126371911|NCT02936323|454658538|FG007|Phase 1 Dose Escalation|Death|0|||
126371912|NCT02936323|454658539|FG008|Phase 1 Dose Escalation|Death|0|||
126371913|NCT02936323|454658540|FG009|Phase 1 Dose Escalation|Death|0|||
126371914|NCT02936323|454658531|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371915|NCT02936323|454658532|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371916|NCT02936323|454658533|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371917|NCT02936323|454658534|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371918|NCT02936323|454658535|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126716409|NCT00446446|455913126|FG000|Overall Study|Adverse Event|1|||
126770940|NCT01190098|456116213|FG001|Overall Study|Patient coomorbidity|1|||
126308949|NCT03917472|454420919|FG001|Overall Study|Physician Decision|0|||
126308950|NCT03917472|454420918|FG000|Overall Study|Adverse Event|3|||
126308951|NCT03917472|454420919|FG001|Overall Study|Adverse Event|1|||
126308952|NCT03917472|454420918|FG000|Overall Study|Death|7|||
126308953|NCT03917472|454420919|FG001|Overall Study|Death|5|||
126308954|NCT03917472|454420918|FG000|Overall Study|Withdrawal by Subject|11|||
126308955|NCT03917472|454420919|FG001|Overall Study|Withdrawal by Subject|4|||
126308956|NCT03917472|454420918|FG000|Overall Study|Lost to Follow-up|10|||
126308957|NCT03917472|454420919|FG001|Overall Study|Lost to Follow-up|5|||
126308958|NCT04434469|454420920|FG000|Overall Study|Death|2|||
126308959|NCT04434469|454420921|FG001|Overall Study|Death|3|||
126308960|NCT04434469|454420922|FG002|Overall Study|Death|2|||
126308961|NCT04434469|454420923|FG003|Overall Study|Death|2|||
126308962|NCT04434469|454420924|FG004|Overall Study|Death|2|||
126308963|NCT04434469|454420925|FG005|Overall Study|Death|0|||
126308964|NCT04434469|454420920|FG000|Overall Study|Lost to Follow-up|0|||
126308965|NCT04434469|454420921|FG001|Overall Study|Lost to Follow-up|0|||
126308966|NCT04434469|454420922|FG002|Overall Study|Lost to Follow-up|0|||
126308967|NCT04434469|454420923|FG003|Overall Study|Lost to Follow-up|1|||
126464932|NCT02314143|455003943|FG002|Overall Study|Withdrawal by Subject|1|||
126464933|NCT00873860|455003944|FG000|Overall Study|Lost to Follow-up|1|||
126464934|NCT00873860|455003945|FG001|Overall Study|Lost to Follow-up|0|||
126464935|NCT00873860|455003946|FG002|Overall Study|Lost to Follow-up|0|||
126464936|NCT00873860|455003947|FG003|Overall Study|Lost to Follow-up|1|||
126464937|NCT00873860|455003944|FG000|Overall Study|Withdrawal by Subject|1|||
126464938|NCT00873860|455003945|FG001|Overall Study|Withdrawal by Subject|0|||
126464939|NCT00873860|455003946|FG002|Overall Study|Withdrawal by Subject|2|||
126464940|NCT00873860|455003947|FG003|Overall Study|Withdrawal by Subject|0|||
126464941|NCT00873860|455003944|FG000|Overall Study|Death|1|||
126308968|NCT04434469|454420924|FG004|Overall Study|Lost to Follow-up|1|||
126308969|NCT04434469|454420925|FG005|Overall Study|Lost to Follow-up|0|||
126308970|NCT04434469|454420920|FG000|Overall Study|Study terminated by sponsor|1|||
126308971|NCT04434469|454420921|FG001|Overall Study|Study terminated by sponsor|1|||
126308972|NCT04434469|454420922|FG002|Overall Study|Study terminated by sponsor|1|||
126308973|NCT04434469|454420923|FG003|Overall Study|Study terminated by sponsor|2|||
126308974|NCT04434469|454420924|FG004|Overall Study|Study terminated by sponsor|3|||
126308975|NCT04434469|454420925|FG005|Overall Study|Study terminated by sponsor|3|||
126308976|NCT04434469|454420920|FG000|Overall Study|Withdrawal by Subject|0|||
126308977|NCT04434469|454420921|FG001|Overall Study|Withdrawal by Subject|0|||
126308978|NCT04434469|454420922|FG002|Overall Study|Withdrawal by Subject|1|||
126308979|NCT04434469|454420923|FG003|Overall Study|Withdrawal by Subject|0|||
126308980|NCT04434469|454420924|FG004|Overall Study|Withdrawal by Subject|0|||
126308981|NCT04434469|454420925|FG005|Overall Study|Withdrawal by Subject|0|||
126308982|NCT01953601|454420929|FG000|Part 1 (Base Study)|Adverse Event|24|||
126308983|NCT01953601|454420930|FG001|Part 1 (Base Study)|Adverse Event|37|||
126308984|NCT01953601|454420931|FG002|Part 1 (Base Study)|Adverse Event|15|||
126308985|NCT01953601|454420929|FG000|Part 1 (Base Study)|Death|2|||
126464942|NCT00873860|455003945|FG001|Overall Study|Death|0|||
126464943|NCT00873860|455003946|FG002|Overall Study|Death|0|||
126464944|NCT00873860|455003947|FG003|Overall Study|Death|0|||
126464945|NCT00873860|455003944|FG000|Overall Study|Other|1|||
126464946|NCT00873860|455003945|FG001|Overall Study|Other|0|||
126464947|NCT00873860|455003946|FG002|Overall Study|Other|1|||
126464948|NCT00873860|455003947|FG003|Overall Study|Other|0|||
126464949|NCT02140775|455003950|FG000|Overall Study|Withdrawal by Subject|30|||
126464950|NCT02140775|455003951|FG001|Overall Study|Withdrawal by Subject|7|||
126464951|NCT04650854|455003954|FG000|Overall Study|Adverse Event|1|||
126464952|NCT04650854|455003955|FG001|Overall Study|Adverse Event|12|||
126464953|NCT04650854|455003956|FG002|Overall Study|Adverse Event|14|||
126464954|NCT04650854|455003954|FG000|Overall Study|Lack of Efficacy|1|||
126464955|NCT04650854|455003955|FG001|Overall Study|Lack of Efficacy|3|||
126464956|NCT04650854|455003956|FG002|Overall Study|Lack of Efficacy|6|||
126464957|NCT04650854|455003954|FG000|Overall Study|Lost to Follow-up|1|||
126464958|NCT04650854|455003955|FG001|Overall Study|Lost to Follow-up|1|||
126464959|NCT04650854|455003956|FG002|Overall Study|Lost to Follow-up|0|||
126464960|NCT04650854|455003954|FG000|Overall Study|Withdrawal by Subject|2|||
126464961|NCT04650854|455003955|FG001|Overall Study|Withdrawal by Subject|17|||
126464962|NCT04650854|455003956|FG002|Overall Study|Withdrawal by Subject|9|||
126464963|NCT04650854|455003954|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
126464964|NCT04650854|455003955|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
126464965|NCT04650854|455003956|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
126464966|NCT04650854|455003954|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
126308986|NCT01953601|454420930|FG001|Part 1 (Base Study)|Death|0|||
126308987|NCT01953601|454420931|FG002|Part 1 (Base Study)|Death|3|||
126308988|NCT01953601|454420929|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
126308989|NCT01953601|454420930|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
126308990|NCT01953601|454420931|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
126308991|NCT01953601|454420929|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
126770941|NCT01190098|456116212|FG000|Overall Study|Lack of transportation|1|||
126371919|NCT02936323|454658536|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
126371920|NCT02936323|454658537|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371921|NCT02936323|454658538|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371922|NCT02936323|454658539|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371923|NCT02936323|454658540|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
126371924|NCT02936323|454658531|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371925|NCT02936323|454658532|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371926|NCT02936323|454658533|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371927|NCT02936323|454658534|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371928|NCT02936323|454658535|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371929|NCT02936323|454658536|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371930|NCT02936323|454658537|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
126371931|NCT02936323|454658538|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
126371932|NCT02936323|454658539|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
126371933|NCT02936323|454658540|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
126371934|NCT02936323|454658531|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
126371935|NCT02936323|454658532|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
126371936|NCT02936323|454658533|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
126371937|NCT02936323|454658534|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
126371938|NCT02936323|454658535|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
126371939|NCT02936323|454658536|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
126371940|NCT02936323|454658537|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
126371941|NCT02936323|454658538|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
126371942|NCT02936323|454658539|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
126464967|NCT04650854|455003955|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
126464968|NCT04650854|455003956|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
126464969|NCT04650854|455003954|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
126464970|NCT04650854|455003955|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
126464971|NCT04650854|455003956|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
126464972|NCT04650854|455003954|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
126464973|NCT04650854|455003955|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
126464974|NCT04650854|455003956|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
126464975|NCT04650854|455003954|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
126464976|NCT04650854|455003955|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
126464977|NCT04650854|455003956|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
126464978|NCT04650854|455003954|FG000|Overall Study|Use of Rescue Medication|0|||
126464979|NCT04650854|455003955|FG001|Overall Study|Use of Rescue Medication|0|||
126464980|NCT04650854|455003956|FG002|Overall Study|Use of Rescue Medication|1|||
126464981|NCT04650854|455003954|FG000|Overall Study|Last Treatment Per Sponsor|0|||
126464982|NCT04650854|455003955|FG001|Overall Study|Last Treatment Per Sponsor|0|||
126464983|NCT04650854|455003956|FG002|Overall Study|Last Treatment Per Sponsor|2|||
126464984|NCT04650854|455003954|FG000|Overall Study|Rescue Medication|0|||
126464985|NCT04650854|455003955|FG001|Overall Study|Rescue Medication|0|||
126464986|NCT04650854|455003956|FG002|Overall Study|Rescue Medication|1|||
126464987|NCT04650854|455003954|FG000|Overall Study|Participant Want to Start a Family|0|||
126464988|NCT04650854|455003955|FG001|Overall Study|Participant Want to Start a Family|0|||
126464989|NCT04650854|455003956|FG002|Overall Study|Participant Want to Start a Family|1|||
126464990|NCT04650854|455003954|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
126464991|NCT04650854|455003955|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
126464992|NCT04650854|455003956|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
126464993|NCT04650854|455003954|FG000|Overall Study|Participant Screened For MG0020|0|||
126464994|NCT04650854|455003955|FG001|Overall Study|Participant Screened For MG0020|2|||
126464995|NCT04650854|455003956|FG002|Overall Study|Participant Screened For MG0020|3|||
126464996|NCT04650854|455003954|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
126464997|NCT04650854|455003955|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
126464998|NCT04650854|455003956|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
126464999|NCT04650854|455003954|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
126770942|NCT01190098|456116213|FG001|Overall Study|Lack of transportation|0|||
126770943|NCT01190098|456116212|FG000|Overall Study|Other|0|||
126770944|NCT01190098|456116213|FG001|Overall Study|Other|1|||
126770945|NCT02957682|456116214|FG000|Overall Study|Adverse Event|64|||
126371943|NCT02936323|454658540|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
126371944|NCT02936323|454658531|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371945|NCT02936323|454658532|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126465000|NCT04650854|455003955|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
126465001|NCT04650854|455003956|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
126465002|NCT04650854|455003954|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
126552469|NCT00983619|455318407|FG000|Overall Study|Lost to Follow-up|0|||
126308992|NCT01953601|454420930|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
126308993|NCT01953601|454420931|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
126308994|NCT01953601|454420929|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
126308995|NCT01953601|454420930|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
126308996|NCT01953601|454420931|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
126308997|NCT01953601|454420929|FG000|Part 1 (Base Study)|Physician Decision|3|||
126308998|NCT01953601|454420930|FG001|Part 1 (Base Study)|Physician Decision|7|||
126308999|NCT01953601|454420931|FG002|Part 1 (Base Study)|Physician Decision|4|||
126309000|NCT01953601|454420929|FG000|Part 1 (Base Study)|Screen failure|1|||
126309001|NCT01953601|454420930|FG001|Part 1 (Base Study)|Screen failure|0|||
126309002|NCT01953601|454420931|FG002|Part 1 (Base Study)|Screen failure|1|||
126309003|NCT01953601|454420929|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
126309004|NCT01953601|454420930|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
126309005|NCT01953601|454420931|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
126309006|NCT01953601|454420929|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
126309007|NCT01953601|454420930|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
126309008|NCT01953601|454420931|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
126309009|NCT01953601|454420929|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
126309010|NCT01953601|454420930|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
126371946|NCT02936323|454658533|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371947|NCT02936323|454658534|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371948|NCT02936323|454658535|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371949|NCT02936323|454658536|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371950|NCT02936323|454658537|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371951|NCT02936323|454658538|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
126371952|NCT02936323|454658539|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
126371953|NCT02936323|454658540|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
126371954|NCT02936323|454658531|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371955|NCT02936323|454658532|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371956|NCT02936323|454658533|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371957|NCT02936323|454658534|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371958|NCT02936323|454658535|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371959|NCT02936323|454658536|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371960|NCT02936323|454658537|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371961|NCT02936323|454658538|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371962|NCT02936323|454658539|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
126371963|NCT02936323|454658540|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
126371964|NCT02936323|454658531|FG000|Phase 2a Dose Expansion|Death|0|||
126371965|NCT02936323|454658532|FG001|Phase 2a Dose Expansion|Death|0|||
126371966|NCT02936323|454658533|FG002|Phase 2a Dose Expansion|Death|0|||
126371967|NCT02936323|454658534|FG003|Phase 2a Dose Expansion|Death|0|||
126371968|NCT02936323|454658535|FG004|Phase 2a Dose Expansion|Death|0|||
126371969|NCT02936323|454658536|FG005|Phase 2a Dose Expansion|Death|0|||
126371970|NCT02936323|454658537|FG006|Phase 2a Dose Expansion|Death|0|||
126371971|NCT02936323|454658538|FG007|Phase 2a Dose Expansion|Death|4|||
126371972|NCT02936323|454658539|FG008|Phase 2a Dose Expansion|Death|8|||
126371973|NCT02936323|454658540|FG009|Phase 2a Dose Expansion|Death|10|||
126371974|NCT05788991|454658541|FG000|Overall Study|Not treated with study medication|1|||
126371975|NCT05788991|454658542|FG001|Overall Study|Not treated with study medication|3|||
126371976|NCT05788991|454658541|FG000|Overall Study|Withdrawal by Subject|1|||
126371977|NCT05788991|454658542|FG001|Overall Study|Withdrawal by Subject|0|||
126371978|NCT05788991|454658541|FG000|Overall Study|Lack of Efficacy|0|||
126371979|NCT05788991|454658542|FG001|Overall Study|Lack of Efficacy|1|||
126371980|NCT05788991|454658541|FG000|Overall Study|Protocol Violation|1|||
126371981|NCT05788991|454658542|FG001|Overall Study|Protocol Violation|2|||
126371982|NCT05270863|454658543|FG000|Visit 2 First Intervention|Randomization error|0|||
126371983|NCT05270863|454658544|FG001|Visit 2 First Intervention|Randomization error|0|||
126552470|NCT00983619|455318408|FG001|Overall Study|Lost to Follow-up|1|||
126552471|NCT00983619|455318409|FG002|Overall Study|Lost to Follow-up|0|||
126552472|NCT00983619|455318410|FG003|Overall Study|Lost to Follow-up|0|||
126552473|NCT00983619|455318411|FG004|Overall Study|Lost to Follow-up|0|||
126552474|NCT00983619|455318412|FG005|Overall Study|Lost to Follow-up|2|||
126552475|NCT00983619|455318413|FG006|Overall Study|Lost to Follow-up|0|||
126552476|NCT00983619|455318414|FG007|Overall Study|Lost to Follow-up|0|||
126552477|NCT00983619|455318415|FG008|Overall Study|Lost to Follow-up|0|||
126552478|NCT00983619|455318416|FG009|Overall Study|Lost to Follow-up|0|||
126552479|NCT00983619|455318417|FG010|Overall Study|Lost to Follow-up|0|||
126552480|NCT00983619|455318418|FG011|Overall Study|Lost to Follow-up|2|||
126552481|NCT00983619|455318407|FG000|Overall Study|Withdrawal by Subject|2|||
126552482|NCT00983619|455318408|FG001|Overall Study|Withdrawal by Subject|1|||
126552483|NCT00983619|455318409|FG002|Overall Study|Withdrawal by Subject|1|||
126770946|NCT02957682|456116215|FG001|Overall Study|Adverse Event|67|||
126371984|NCT05270863|454658545|FG002|Visit 2 First Intervention|Randomization error|0|||
126552484|NCT00983619|455318410|FG003|Overall Study|Withdrawal by Subject|3|||
126371985|NCT05270863|454658546|FG003|Visit 2 First Intervention|Randomization error|1|||
126371986|NCT05270863|454658547|FG004|Visit 2 First Intervention|Randomization error|0|||
126371987|NCT05270863|454658548|FG005|Visit 2 First Intervention|Randomization error|0|||
126371988|NCT05270863|454658543|FG000|First Washout|Withdrawal by Subject|0|||
126371989|NCT05270863|454658544|FG001|First Washout|Withdrawal by Subject|0|||
126371990|NCT05270863|454658545|FG002|First Washout|Withdrawal by Subject|0|||
126371991|NCT05270863|454658546|FG003|First Washout|Withdrawal by Subject|0|||
126371992|NCT05270863|454658547|FG004|First Washout|Withdrawal by Subject|1|||
126371993|NCT05270863|454658548|FG005|First Washout|Withdrawal by Subject|1|||
126371994|NCT05270863|454658543|FG000|First Washout|Lost to Follow-up|0|||
126371995|NCT05270863|454658544|FG001|First Washout|Lost to Follow-up|0|||
126371996|NCT05270863|454658545|FG002|First Washout|Lost to Follow-up|0|||
126371997|NCT05270863|454658546|FG003|First Washout|Lost to Follow-up|0|||
126371998|NCT05270863|454658547|FG004|First Washout|Lost to Follow-up|0|||
126371999|NCT05270863|454658548|FG005|First Washout|Lost to Follow-up|1|||
126372000|NCT05270863|454658543|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
126372001|NCT05270863|454658544|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
126372002|NCT05270863|454658545|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
126372003|NCT05270863|454658546|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
126372004|NCT05270863|454658547|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
126372005|NCT05270863|454658548|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
126372006|NCT05270863|454658543|FG000|Second Washout|Withdrawal by Subject|1|||
126372007|NCT05270863|454658544|FG001|Second Washout|Withdrawal by Subject|1|||
126372008|NCT05270863|454658545|FG002|Second Washout|Withdrawal by Subject|0|||
126372009|NCT05270863|454658546|FG003|Second Washout|Withdrawal by Subject|0|||
126372010|NCT05270863|454658547|FG004|Second Washout|Withdrawal by Subject|0|||
126372011|NCT05270863|454658548|FG005|Second Washout|Withdrawal by Subject|0|||
126372012|NCT05270863|454658543|FG000|Second Washout|Lost to Follow-up|0|||
126372013|NCT05270863|454658544|FG001|Second Washout|Lost to Follow-up|0|||
126372014|NCT05270863|454658545|FG002|Second Washout|Lost to Follow-up|0|||
126372015|NCT05270863|454658546|FG003|Second Washout|Lost to Follow-up|1|||
126372016|NCT05270863|454658547|FG004|Second Washout|Lost to Follow-up|0|||
126372017|NCT05270863|454658548|FG005|Second Washout|Lost to Follow-up|0|||
126372018|NCT04464473|454658549|FG000|Overall Study|New piercing could not be removed for scanning|0|||
126372019|NCT04464473|454658550|FG001|Overall Study|New piercing could not be removed for scanning|0|||
126372020|NCT04464473|454658551|FG002|Overall Study|New piercing could not be removed for scanning|0|||
126372021|NCT04464473|454658552|FG003|Overall Study|New piercing could not be removed for scanning|1|||
126372022|NCT04464473|454658553|FG004|Overall Study|New piercing could not be removed for scanning|0|||
126372023|NCT04464473|454658554|FG005|Overall Study|New piercing could not be removed for scanning|0|||
126372024|NCT04464473|454658549|FG000|Overall Study|Adverse Event|0|||
126372025|NCT04464473|454658550|FG001|Overall Study|Adverse Event|0|||
126372026|NCT04464473|454658551|FG002|Overall Study|Adverse Event|0|||
126372027|NCT04464473|454658552|FG003|Overall Study|Adverse Event|1|||
126372028|NCT04464473|454658553|FG004|Overall Study|Adverse Event|0|||
126372029|NCT04464473|454658554|FG005|Overall Study|Adverse Event|0|||
126372030|NCT04464473|454658549|FG000|Overall Study|Lost to Follow-up|0|||
126372031|NCT04464473|454658550|FG001|Overall Study|Lost to Follow-up|0|||
126372032|NCT04464473|454658551|FG002|Overall Study|Lost to Follow-up|0|||
126372033|NCT04464473|454658552|FG003|Overall Study|Lost to Follow-up|1|||
126372034|NCT04464473|454658553|FG004|Overall Study|Lost to Follow-up|0|||
126372035|NCT04464473|454658554|FG005|Overall Study|Lost to Follow-up|0|||
126372036|NCT01334918|454659747|FG000|Overall Study|Did not receive study drug|6|||
126372037|NCT01334918|454659748|FG001|Overall Study|Did not receive study drug|0|||
126372038|NCT01334918|454659747|FG000|Overall Study|Adverse Event|2|||
126372039|NCT01334918|454659748|FG001|Overall Study|Adverse Event|0|||
126372040|NCT01334918|454659747|FG000|Overall Study|Withdrawal by Subject|0|||
126372041|NCT01334918|454659748|FG001|Overall Study|Withdrawal by Subject|1|||
126372042|NCT00805389|454659749|FG000|Overall Study|Adverse Event|0|||
126372043|NCT00805389|454659750|FG001|Overall Study|Adverse Event|0|||
126372044|NCT00805389|454659751|FG002|Overall Study|Adverse Event|1|||
126770947|NCT02957682|456116214|FG000|Overall Study|Poor Compliance to Protocol|30|||
126770948|NCT02957682|456116215|FG001|Overall Study|Poor Compliance to Protocol|26|||
126770949|NCT02957682|456116214|FG000|Overall Study|Physician Decision|4|||
126770950|NCT02957682|456116215|FG001|Overall Study|Physician Decision|4|||
126770951|NCT02957682|456116214|FG000|Overall Study|Study Terminated by Sponsor|4|||
126770952|NCT02957682|456116215|FG001|Overall Study|Study Terminated by Sponsor|3|||
126770953|NCT02957682|456116214|FG000|Overall Study|Subject Moved|10|||
126770954|NCT02957682|456116215|FG001|Overall Study|Subject Moved|16|||
126770955|NCT02957682|456116214|FG000|Overall Study|Withdrawal by Subject|64|||
126770956|NCT02957682|456116215|FG001|Overall Study|Withdrawal by Subject|33|||
126770957|NCT02957682|456116214|FG000|Overall Study|Related to IMP Administration|3|||
126770958|NCT02957682|456116215|FG001|Overall Study|Related to IMP Administration|6|||
126770959|NCT02957682|456116214|FG000|Overall Study|Non-disclosed|16|||
126770960|NCT02957682|456116215|FG001|Overall Study|Non-disclosed|12|||
126770961|NCT02957682|456116214|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
126465003|NCT04650854|455003955|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
126465004|NCT04650854|455003956|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
126465005|NCT04650854|455003954|FG000|Overall Study|End Of Study|0|||
126465006|NCT04650854|455003955|FG001|Overall Study|End Of Study|2|||
126465007|NCT04650854|455003956|FG002|Overall Study|End Of Study|1|||
126465008|NCT04650854|455003954|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
126465009|NCT04650854|455003955|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
126372045|NCT00805389|454659752|FG003|Overall Study|Adverse Event|2|||
126372046|NCT00805389|454659753|FG004|Overall Study|Adverse Event|0|||
126372047|NCT00805389|454659749|FG000|Overall Study|Lost to Follow-up|4|||
126372048|NCT00805389|454659750|FG001|Overall Study|Lost to Follow-up|3|||
126372049|NCT00805389|454659751|FG002|Overall Study|Lost to Follow-up|6|||
126372050|NCT00805389|454659752|FG003|Overall Study|Lost to Follow-up|10|||
126372051|NCT00805389|454659753|FG004|Overall Study|Lost to Follow-up|9|||
126372052|NCT00805389|454659749|FG000|Overall Study|Protocol Violation|0|||
126372053|NCT00805389|454659750|FG001|Overall Study|Protocol Violation|0|||
126372054|NCT00805389|454659751|FG002|Overall Study|Protocol Violation|1|||
126465010|NCT04650854|455003956|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
126770962|NCT02957682|456116215|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
126770963|NCT02499406|456116216|FG000|Overall Study|missed 3 treatment sessions|4|||
126770964|NCT04651218|456116217|FG000|Overall Study|Withdrawal by Subject|0|||
126770965|NCT04651218|456116218|FG001|Overall Study|Withdrawal by Subject|2|||
126770966|NCT00765999|456116219|FG000|Overall Study|Adverse Event|203|||
126770967|NCT00765999|456116219|FG000|Overall Study|Insufficient Therapeutic Response|100|||
126770968|NCT00765999|456116219|FG000|Overall Study|Protocol Violation|95|||
126770969|NCT00765999|456116219|FG000|Overall Study|Consent Withdrawn|202|||
126372055|NCT00805389|454659752|FG003|Overall Study|Protocol Violation|0|||
126372056|NCT00805389|454659753|FG004|Overall Study|Protocol Violation|0|||
126372057|NCT00805389|454659749|FG000|Overall Study|Withdrawal by Subject|3|||
126372058|NCT00805389|454659750|FG001|Overall Study|Withdrawal by Subject|2|||
126372059|NCT00805389|454659751|FG002|Overall Study|Withdrawal by Subject|4|||
126372060|NCT00805389|454659752|FG003|Overall Study|Withdrawal by Subject|5|||
126372061|NCT00805389|454659753|FG004|Overall Study|Withdrawal by Subject|4|||
126372062|NCT02704208|454659756|FG000|Overall Study|Lost to Follow-up|42|||
126372063|NCT02704208|454659757|FG001|Overall Study|Lost to Follow-up|37|||
126372064|NCT02724839|454659762|FG000|Overall Study|Withdrawal by Subject|1|||
126372065|NCT02724839|454659763|FG001|Overall Study|Withdrawal by Subject|1|||
126372066|NCT02724839|454659764|FG002|Overall Study|Withdrawal by Subject|0|||
126372067|NCT02724839|454659762|FG000|Overall Study|Lost to Follow-up|0|||
126372068|NCT02724839|454659763|FG001|Overall Study|Lost to Follow-up|3|||
126372069|NCT02724839|454659764|FG002|Overall Study|Lost to Follow-up|2|||
126372070|NCT02724839|454659762|FG000|Overall Study|Physician Decision|0|||
126372071|NCT02724839|454659763|FG001|Overall Study|Physician Decision|0|||
126372072|NCT02724839|454659764|FG002|Overall Study|Physician Decision|3|||
126372073|NCT01155050|454659765|FG000|Overall Study|Lost to Follow-up|15|||
126372074|NCT01155050|454659766|FG001|Overall Study|Lost to Follow-up|20|||
126372075|NCT01155050|454659767|FG002|Overall Study|Lost to Follow-up|19|||
126372076|NCT01155050|454659768|FG003|Overall Study|Lost to Follow-up|22|||
126372077|NCT05878067|454659770|FG000|Overall Study|Lost to Follow-up|2|||
126372078|NCT00949533|454659771|FG000|Overall Study|Lost to Follow-up|0|||
126770970|NCT00765999|456116219|FG000|Overall Study|Lost to Follow-up|131|||
126770971|NCT00765999|456116219|FG000|Overall Study|Study Terminated by Sponsor|2|||
126372079|NCT00949533|454659772|FG001|Overall Study|Lost to Follow-up|1|||
126372080|NCT01959529|454659773|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
126372081|NCT01959529|454659774|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
126372082|NCT01959529|454659773|FG000|Overall Study|Lost to Follow-up|4|||
126372083|NCT01959529|454659774|FG001|Overall Study|Lost to Follow-up|1|||
126372084|NCT01959529|454659773|FG000|Overall Study|Other|70|||
126372085|NCT01959529|454659774|FG001|Overall Study|Other|68|||
126372086|NCT01959529|454659773|FG000|Overall Study|Hypoglycaemia|1|||
126465011|NCT04650854|455003954|FG000|Overall Study|Participant Received Rescue Medication|0|||
126465012|NCT04650854|455003955|FG001|Overall Study|Participant Received Rescue Medication|1|||
126770972|NCT00765999|456116219|FG000|Overall Study|Other Miscellaneous Reasons|51|||
126770973|NCT00414011|456116220|FG000|Overall Study|Physician Decision|3|||
126372087|NCT01959529|454659774|FG001|Overall Study|Hypoglycaemia|1|||
126372088|NCT01959529|454659773|FG000|Overall Study|Lack of glycaemic control|1|||
126372089|NCT01959529|454659774|FG001|Overall Study|Lack of glycaemic control|1|||
126372090|NCT00557193|454659775|FG000|Induction|Adverse Event|2|||
126372091|NCT00557193|454659776|FG001|Induction|Adverse Event|0|||
126372092|NCT00557193|454659777|FG002|Induction|Adverse Event|0|||
126372093|NCT00557193|454659778|FG003|Induction|Adverse Event|0|||
126372094|NCT00557193|454659779|FG004|Induction|Adverse Event|0|||
126372095|NCT00557193|454659780|FG005|Induction|Adverse Event|0|||
126372096|NCT00557193|454659775|FG000|Induction|Death|6|||
126372097|NCT00557193|454659776|FG001|Induction|Death|0|||
126372098|NCT00557193|454659777|FG002|Induction|Death|0|||
126372099|NCT00557193|454659778|FG003|Induction|Death|0|||
126372100|NCT00557193|454659779|FG004|Induction|Death|0|||
126309011|NCT01953601|454420931|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
126309012|NCT01953601|454420929|FG000|Part 1 (Base Study)|Subject moved|2|||
126309013|NCT01953601|454420930|FG001|Part 1 (Base Study)|Subject moved|2|||
126309014|NCT01953601|454420931|FG002|Part 1 (Base Study)|Subject moved|1|||
126309015|NCT01953601|454420929|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
126309016|NCT01953601|454420930|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
126309017|NCT01953601|454420931|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
126309018|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Adverse Event|1|||
126309019|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Adverse Event|1|||
126309020|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Adverse Event|10|||
126309021|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Death|0|||
126309022|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Death|3|||
126309023|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Death|0|||
126309024|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
126309025|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
126309026|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
126309027|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
126309028|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
126309029|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
126309030|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Physician Decision|2|||
126309031|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Physician Decision|0|||
126309032|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Physician Decision|2|||
126309033|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
126309034|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
126309035|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
126309036|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
126309037|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
126309038|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
126309039|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
126309040|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
126309041|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
126309042|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Subject moved|0|||
126309043|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Subject moved|0|||
126309044|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Subject moved|1|||
126309045|NCT01953601|454420929|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
126309046|NCT01953601|454420930|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
126309047|NCT01953601|454420931|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
126309048|NCT01936181|454420950|FG000|Randomised, Double-blind|Adverse Event|27|||
126309049|NCT01936181|454420951|FG001|Randomised, Double-blind|Adverse Event|21|||
126309050|NCT01936181|454420952|FG002|Randomised, Double-blind|Adverse Event|0|||
126309051|NCT01936181|454420953|FG003|Randomised, Double-blind|Adverse Event|0|||
126309052|NCT01936181|454420950|FG000|Randomised, Double-blind|Protocol Violation|1|||
126309053|NCT01936181|454420951|FG001|Randomised, Double-blind|Protocol Violation|5|||
126309054|NCT01936181|454420952|FG002|Randomised, Double-blind|Protocol Violation|0|||
126309055|NCT01936181|454420953|FG003|Randomised, Double-blind|Protocol Violation|0|||
126309056|NCT01936181|454420950|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
126309057|NCT01936181|454420951|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
126309058|NCT01936181|454420952|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
126309059|NCT01936181|454420953|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
126309060|NCT01936181|454420950|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
126309061|NCT01936181|454420951|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
126309062|NCT01936181|454420952|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
126309063|NCT01936181|454420953|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
126309064|NCT01936181|454420950|FG000|Randomised, Double-blind|Pregnancy|0|||
126309065|NCT01936181|454420951|FG001|Randomised, Double-blind|Pregnancy|1|||
126372101|NCT00557193|454659780|FG005|Induction|Death|0|||
126309066|NCT01936181|454420952|FG002|Randomised, Double-blind|Pregnancy|0|||
126309067|NCT01936181|454420953|FG003|Randomised, Double-blind|Pregnancy|0|||
126309068|NCT01936181|454420950|FG000|Randomised, Double-blind|Physician Decision|4|||
126372102|NCT00557193|454659775|FG000|Induction|Physician Decision|3|||
126372103|NCT00557193|454659776|FG001|Induction|Physician Decision|0|||
126372104|NCT00557193|454659777|FG002|Induction|Physician Decision|0|||
126372105|NCT00557193|454659778|FG003|Induction|Physician Decision|0|||
126372106|NCT00557193|454659779|FG004|Induction|Physician Decision|0|||
126372107|NCT00557193|454659780|FG005|Induction|Physician Decision|0|||
126372108|NCT00557193|454659775|FG000|Induction|Withdrawal by Subject|1|||
126309069|NCT01936181|454420951|FG001|Randomised, Double-blind|Physician Decision|4|||
126372109|NCT00557193|454659776|FG001|Induction|Withdrawal by Subject|0|||
126372110|NCT00557193|454659777|FG002|Induction|Withdrawal by Subject|0|||
126372111|NCT00557193|454659778|FG003|Induction|Withdrawal by Subject|0|||
126309070|NCT01936181|454420952|FG002|Randomised, Double-blind|Physician Decision|0|||
126372112|NCT00557193|454659779|FG004|Induction|Withdrawal by Subject|0|||
126372113|NCT00557193|454659780|FG005|Induction|Withdrawal by Subject|0|||
126372114|NCT00557193|454659775|FG000|Induction|Refusal of Further Protocol Therapy|2|||
126372115|NCT00557193|454659776|FG001|Induction|Refusal of Further Protocol Therapy|0|||
126372116|NCT00557193|454659777|FG002|Induction|Refusal of Further Protocol Therapy|0|||
126372117|NCT00557193|454659778|FG003|Induction|Refusal of Further Protocol Therapy|0|||
126372118|NCT00557193|454659779|FG004|Induction|Refusal of Further Protocol Therapy|0|||
126372119|NCT00557193|454659780|FG005|Induction|Refusal of Further Protocol Therapy|0|||
126372120|NCT00557193|454659775|FG000|Induction|Ineligible|8|||
126372121|NCT00557193|454659776|FG001|Induction|Ineligible|0|||
126372122|NCT00557193|454659777|FG002|Induction|Ineligible|0|||
126372123|NCT00557193|454659778|FG003|Induction|Ineligible|0|||
126465013|NCT04650854|455003956|FG002|Overall Study|Participant Received Rescue Medication|0|||
126465014|NCT04650854|455003954|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
126465015|NCT04650854|455003955|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
126465016|NCT04650854|455003956|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
126465017|NCT04650854|455003954|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
126465018|NCT04650854|455003955|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
126465019|NCT04650854|455003956|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
126465020|NCT04650854|455003954|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
126465021|NCT04650854|455003955|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
126465022|NCT04650854|455003956|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
126465023|NCT04650854|455003954|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
126465024|NCT04650854|455003955|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
126465025|NCT04650854|455003956|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
126465026|NCT04650854|455003954|FG000|Overall Study|Enrollment Cup|0|||
126465027|NCT04650854|455003955|FG001|Overall Study|Enrollment Cup|0|||
126465028|NCT04650854|455003956|FG002|Overall Study|Enrollment Cup|1|||
126465029|NCT00704808|455003957|FG000|Overall Study|Discontinued prior to starting treatment|14|||
126465030|NCT00704808|455003957|FG000|Overall Study|Death|7|||
126465031|NCT00704808|455003957|FG000|Overall Study|Tumor progression|80|||
126465032|NCT00704808|455003957|FG000|Overall Study|Patient's decision|11|||
126465033|NCT00704808|455003957|FG000|Overall Study|Early therapy discontinuation|16|||
126465034|NCT00704808|455003957|FG000|Overall Study|Adverse Event|1|||
126465035|NCT00704808|455003957|FG000|Overall Study|Lost to Follow-up|1|||
126465036|NCT00704808|455003957|FG000|Overall Study|Treatment change|1|||
126465037|NCT01280955|455003963|FG000|Overall Study|Death|2|||
126465038|NCT01280955|455003963|FG000|Overall Study|Withdrawal by Subject|1|||
126465039|NCT04223232|455003964|FG000|Overall Study|Withdrawal by Subject|1|||
126465040|NCT05281601|455003965|FG000|Overall Study|Physician Decision|2|||
126465041|NCT05281601|455003966|FG001|Overall Study|Physician Decision|0|||
126465042|NCT05281601|455003965|FG000|Overall Study|Lost to Follow-up|2|||
126465043|NCT05281601|455003966|FG001|Overall Study|Lost to Follow-up|0|||
126465044|NCT05281601|455003965|FG000|Overall Study|Death|1|||
126465045|NCT05281601|455003966|FG001|Overall Study|Death|0|||
126465046|NCT05281601|455003965|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126465047|NCT05281601|455003966|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126465048|NCT00586846|455003967|FG000|Overall Study|Physician Decision|1|||
126465049|NCT00586846|455003967|FG000|Overall Study|Death|1|||
126465050|NCT00586846|455003967|FG000|Overall Study|Evaluable for Toxicity Only|4|||
126465051|NCT05063318|455003968|FG000|Overall Study|Progressive disease|2|||
126465052|NCT05063318|455003969|FG001|Overall Study|Progressive disease|0|||
126465053|NCT05063318|455003970|FG002|Overall Study|Progressive disease|3|||
126465054|NCT05063318|455003968|FG000|Overall Study|Compassionate use|1|||
126465055|NCT05063318|455003969|FG001|Overall Study|Compassionate use|3|||
126465056|NCT05063318|455003970|FG002|Overall Study|Compassionate use|3|||
126465057|NCT05063318|455003968|FG000|Overall Study|Adverse Event|0|||
126465058|NCT05063318|455003969|FG001|Overall Study|Adverse Event|1|||
126465059|NCT05063318|455003970|FG002|Overall Study|Adverse Event|0|||
126465060|NCT05063318|455003968|FG000|Overall Study|Withdrawal by Subject|0|||
126372124|NCT00557193|454659779|FG004|Induction|Ineligible|0|||
126465061|NCT05063318|455003969|FG001|Overall Study|Withdrawal by Subject|1|||
126465062|NCT05063318|455003970|FG002|Overall Study|Withdrawal by Subject|0|||
126372125|NCT00557193|454659780|FG005|Induction|Ineligible|0|||
126372126|NCT00557193|454659775|FG000|Induction|Inevaluable for post Induction|2|||
126372127|NCT00557193|454659776|FG001|Induction|Inevaluable for post Induction|0|||
126372128|NCT00557193|454659777|FG002|Induction|Inevaluable for post Induction|0|||
126372129|NCT00557193|454659778|FG003|Induction|Inevaluable for post Induction|0|||
126465063|NCT03172910|455005669|FG000|Overall Study|Adverse Event|0|||
126465064|NCT03172910|455005670|FG001|Overall Study|Adverse Event|0|||
126465065|NCT03172910|455005671|FG002|Overall Study|Adverse Event|0|||
126465066|NCT03172910|455005672|FG003|Overall Study|Adverse Event|0|||
126465067|NCT03172910|455005673|FG004|Overall Study|Adverse Event|1|||
126465068|NCT01659658|455005676|FG000|Overall Study|Withdrawal by Patient|18|||
126465069|NCT01659658|455005677|FG001|Overall Study|Withdrawal by Patient|4|||
126465070|NCT01659658|455005678|FG002|Overall Study|Withdrawal by Patient|2|||
126465071|NCT01659658|455005679|FG003|Overall Study|Withdrawal by Patient|0|||
126465072|NCT01659658|455005680|FG004|Overall Study|Withdrawal by Patient|11|||
126465073|NCT01659658|455005676|FG000|Overall Study|Study Terminated by Sponsor|9|||
126465074|NCT01659658|455005677|FG001|Overall Study|Study Terminated by Sponsor|7|||
126465075|NCT01659658|455005678|FG002|Overall Study|Study Terminated by Sponsor|0|||
126465076|NCT01659658|455005679|FG003|Overall Study|Study Terminated by Sponsor|1|||
126465077|NCT01659658|455005680|FG004|Overall Study|Study Terminated by Sponsor|4|||
126465078|NCT01659658|455005676|FG000|Overall Study|Reason not Specified|61|||
126465079|NCT01659658|455005677|FG001|Overall Study|Reason not Specified|15|||
126465080|NCT01659658|455005678|FG002|Overall Study|Reason not Specified|8|||
126465081|NCT01659658|455005679|FG003|Overall Study|Reason not Specified|1|||
126465082|NCT01659658|455005680|FG004|Overall Study|Reason not Specified|34|||
126465083|NCT01659658|455005676|FG000|Overall Study|Lost to Follow-up|2|||
126465084|NCT01659658|455005677|FG001|Overall Study|Lost to Follow-up|0|||
126465085|NCT01659658|455005678|FG002|Overall Study|Lost to Follow-up|0|||
126465086|NCT01659658|455005679|FG003|Overall Study|Lost to Follow-up|0|||
126465087|NCT01659658|455005680|FG004|Overall Study|Lost to Follow-up|0|||
126465088|NCT01927341|455005682|FG000|Phase 1b|Lost to Follow-up|1|||
126465089|NCT01927341|455005683|FG001|Phase 1b|Lost to Follow-up|0|||
126465090|NCT01927341|455005684|FG002|Phase 1b|Lost to Follow-up|0|||
126465091|NCT01927341|455005685|FG003|Phase 1b|Lost to Follow-up|0|||
126465092|NCT01927341|455005686|FG004|Phase 1b|Lost to Follow-up|0|||
126552485|NCT00983619|455318411|FG004|Overall Study|Withdrawal by Subject|1|||
126552486|NCT00983619|455318412|FG005|Overall Study|Withdrawal by Subject|23|||
126552487|NCT00983619|455318413|FG006|Overall Study|Withdrawal by Subject|0|||
126372130|NCT00557193|454659779|FG004|Induction|Inevaluable for post Induction|0|||
126372131|NCT00557193|454659780|FG005|Induction|Inevaluable for post Induction|0|||
126372132|NCT00557193|454659775|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
126372133|NCT00557193|454659776|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
126372134|NCT00557193|454659777|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
126372135|NCT00557193|454659778|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
126372136|NCT00557193|454659779|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
126372137|NCT00557193|454659780|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
126372138|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
126372139|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
126372140|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
126372141|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
126372142|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
126372143|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
126372144|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
126372145|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
126372146|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
126372147|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
126372148|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
126372149|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
126372150|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
126372151|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
126372152|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
126372153|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
126372154|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
126372155|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
126372156|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
126372157|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
126372158|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
126372159|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
126372160|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
126372161|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
126372162|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
126372163|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
126372164|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
126372165|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
126552488|NCT00983619|455318414|FG007|Overall Study|Withdrawal by Subject|0|||
126552489|NCT00983619|455318415|FG008|Overall Study|Withdrawal by Subject|0|||
126372166|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
126372167|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
126372168|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
126465093|NCT01927341|455005682|FG000|Phase 1b|Death|2|||
126465094|NCT01927341|455005683|FG001|Phase 1b|Death|0|||
126465095|NCT01927341|455005684|FG002|Phase 1b|Death|0|||
126465096|NCT01927341|455005685|FG003|Phase 1b|Death|0|||
126465097|NCT01927341|455005686|FG004|Phase 1b|Death|0|||
126465098|NCT01927341|455005682|FG000|Phase 1b|Follow-up completed|7|||
126372169|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
126372170|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
126372171|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
126372172|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
126372173|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
126372174|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
126372175|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
126372176|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
126372177|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
126372178|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
126372179|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
126372180|NCT00557193|454659775|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
126372181|NCT00557193|454659776|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
126372182|NCT00557193|454659777|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
126372183|NCT00557193|454659778|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
126372184|NCT00557193|454659779|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
126372185|NCT00557193|454659780|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
126372186|NCT00652834|454659781|FG000|Overall Study|Withdrawal by Subject|3|||
126372187|NCT00652834|454659781|FG000|Overall Study|Lost to Follow-up|2|||
126372188|NCT00976456|454659783|FG000|Overall Study|Adverse Event|17|||
126372189|NCT00976456|454659784|FG001|Overall Study|Adverse Event|22|||
126372190|NCT00976456|454659783|FG000|Overall Study|Death|7|||
126372191|NCT00976456|454659784|FG001|Overall Study|Death|9|||
126372192|NCT00976456|454659783|FG000|Overall Study|Lack of Efficacy|5|||
126372193|NCT00976456|454659784|FG001|Overall Study|Lack of Efficacy|2|||
126372194|NCT00976456|454659783|FG000|Overall Study|Withdrawal by Subject|3|||
126372195|NCT00976456|454659784|FG001|Overall Study|Withdrawal by Subject|1|||
126372196|NCT00976456|454659783|FG000|Overall Study|screening failure, unknown|11|||
126372197|NCT00976456|454659784|FG001|Overall Study|screening failure, unknown|4|||
126372198|NCT02037529|454659785|FG000|Overall Study|Withdrawal by Subject|1|||
126372199|NCT02037529|454659786|FG001|Overall Study|Withdrawal by Subject|3|||
126465099|NCT01927341|455005683|FG001|Phase 1b|Follow-up completed|0|||
126465100|NCT01927341|455005684|FG002|Phase 1b|Follow-up completed|0|||
126465101|NCT01927341|455005685|FG003|Phase 1b|Follow-up completed|0|||
126465102|NCT01927341|455005686|FG004|Phase 1b|Follow-up completed|0|||
126465103|NCT01927341|455005682|FG000|Phase 2|Lost to Follow-up|0|||
126465104|NCT01927341|455005683|FG001|Phase 2|Lost to Follow-up|1|||
126465105|NCT01927341|455005684|FG002|Phase 2|Lost to Follow-up|0|||
126465106|NCT01927341|455005685|FG003|Phase 2|Lost to Follow-up|0|||
126465107|NCT01927341|455005686|FG004|Phase 2|Lost to Follow-up|0|||
126465108|NCT01927341|455005682|FG000|Phase 2|Participant withdrew consent|0|||
126465109|NCT01927341|455005683|FG001|Phase 2|Participant withdrew consent|2|||
126465110|NCT01927341|455005684|FG002|Phase 2|Participant withdrew consent|1|||
126465111|NCT01927341|455005685|FG003|Phase 2|Participant withdrew consent|2|||
126465112|NCT01927341|455005686|FG004|Phase 2|Participant withdrew consent|3|||
126465113|NCT01927341|455005682|FG000|Phase 2|Death|0|||
126465114|NCT01927341|455005683|FG001|Phase 2|Death|4|||
126465115|NCT01927341|455005684|FG002|Phase 2|Death|0|||
126465116|NCT01927341|455005685|FG003|Phase 2|Death|3|||
126465117|NCT01927341|455005686|FG004|Phase 2|Death|2|||
126465118|NCT01927341|455005682|FG000|Phase 2|New cancer therapy|0|||
126465119|NCT01927341|455005683|FG001|Phase 2|New cancer therapy|1|||
126465120|NCT01927341|455005684|FG002|Phase 2|New cancer therapy|0|||
126465121|NCT01927341|455005685|FG003|Phase 2|New cancer therapy|4|||
126465122|NCT01927341|455005686|FG004|Phase 2|New cancer therapy|1|||
126465123|NCT01927341|455005682|FG000|Phase 2|Disease progression|0|||
126465124|NCT01927341|455005683|FG001|Phase 2|Disease progression|1|||
126465125|NCT01927341|455005684|FG002|Phase 2|Disease progression|1|||
126465126|NCT01927341|455005685|FG003|Phase 2|Disease progression|1|||
126465127|NCT01927341|455005686|FG004|Phase 2|Disease progression|0|||
126465128|NCT01927341|455005682|FG000|Phase 2|Follow-up completed|0|||
126465129|NCT01927341|455005683|FG001|Phase 2|Follow-up completed|6|||
126465130|NCT01927341|455005684|FG002|Phase 2|Follow-up completed|3|||
126465131|NCT01927341|455005685|FG003|Phase 2|Follow-up completed|5|||
126465132|NCT01927341|455005686|FG004|Phase 2|Follow-up completed|2|||
126465133|NCT01397201|455005687|FG000|Overall Study|Not treated|0|||
126552490|NCT00983619|455318416|FG009|Overall Study|Withdrawal by Subject|0|||
126465134|NCT01397201|455005688|FG001|Overall Study|Not treated|0|||
126465135|NCT01397201|455005689|FG002|Overall Study|Not treated|1|||
126465136|NCT01397201|455005690|FG003|Overall Study|Not treated|0|||
126465137|NCT01397201|455005691|FG004|Overall Study|Not treated|0|||
126465138|NCT01397201|455005687|FG000|Overall Study|Not yet defined|3|||
126465139|NCT01397201|455005688|FG001|Overall Study|Not yet defined|6|||
126465140|NCT01397201|455005689|FG002|Overall Study|Not yet defined|5|||
126465141|NCT01397201|455005690|FG003|Overall Study|Not yet defined|5|||
126372200|NCT02037529|454659785|FG000|Overall Study|Adverse Event|0|||
126372201|NCT02037529|454659786|FG001|Overall Study|Adverse Event|1|||
126372202|NCT02131766|454659787|FG000|Overall Study|Withdrawal by Subject|4|||
126372203|NCT00718315|454659788|FG000|Overall Study|Adverse Event|1|||
126372204|NCT00718315|454659789|FG001|Overall Study|Adverse Event|2|||
126372205|NCT00718315|454659790|FG002|Overall Study|Adverse Event|3|||
126372206|NCT00718315|454659788|FG000|Overall Study|Death|6|||
126372207|NCT00718315|454659789|FG001|Overall Study|Death|6|||
126372208|NCT00718315|454659790|FG002|Overall Study|Death|5|||
126372209|NCT00718315|454659788|FG000|Overall Study|Lost to Follow-up|2|||
126372210|NCT00718315|454659789|FG001|Overall Study|Lost to Follow-up|3|||
126372211|NCT00718315|454659790|FG002|Overall Study|Lost to Follow-up|4|||
126372212|NCT00718315|454659788|FG000|Overall Study|Protocol Violation|5|||
126372213|NCT00718315|454659789|FG001|Overall Study|Protocol Violation|5|||
126372214|NCT00718315|454659790|FG002|Overall Study|Protocol Violation|3|||
126372215|NCT00718315|454659788|FG000|Overall Study|Erlotinib dose decreased|4|||
126372216|NCT00718315|454659789|FG001|Overall Study|Erlotinib dose decreased|3|||
126372217|NCT00718315|454659790|FG002|Overall Study|Erlotinib dose decreased|1|||
126372218|NCT00718315|454659788|FG000|Overall Study|Use of Minocyclin|1|||
126372219|NCT00718315|454659789|FG001|Overall Study|Use of Minocyclin|1|||
126372220|NCT00718315|454659790|FG002|Overall Study|Use of Minocyclin|1|||
126372221|NCT00718315|454659788|FG000|Overall Study|Disease progression|0|||
126372222|NCT00718315|454659789|FG001|Overall Study|Disease progression|1|||
126372223|NCT00718315|454659790|FG002|Overall Study|Disease progression|1|||
126372224|NCT00718315|454659788|FG000|Overall Study|Other|0|||
126372225|NCT00718315|454659789|FG001|Overall Study|Other|0|||
126372226|NCT00718315|454659790|FG002|Overall Study|Other|1|||
126372227|NCT00718315|454659788|FG000|Overall Study|Use of ATB and Corticoids|0|||
126372228|NCT00718315|454659789|FG001|Overall Study|Use of ATB and Corticoids|1|||
126372229|NCT00718315|454659790|FG002|Overall Study|Use of ATB and Corticoids|2|||
126372230|NCT01170663|454659791|FG000|Overall Study|Lost to Follow-up|3|||
126372231|NCT01170663|454659792|FG001|Overall Study|Lost to Follow-up|9|||
126372232|NCT01170663|454659791|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
126372233|NCT01170663|454659792|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
126372234|NCT02746809|454659795|FG000|Enrollment|Inclusion Exclusion not met|9|||
126372235|NCT02746809|454659795|FG000|Enrollment|Withdrawal by Subject|1|||
126372236|NCT02746809|454659795|FG000|Enrollment|Expected Enrollment Met|2|||
126372237|NCT02746809|454659795|FG000|Procedure|Death|1|||
126372238|NCT02746809|454659795|FG000|1-Month|Death|5|||
126372239|NCT02746809|454659795|FG000|6-Month|Death|2|||
126372240|NCT02746809|454659795|FG000|6-Month|Withdrawal by Subject|1|||
126372241|NCT02746809|454659795|FG000|12-Month|Death|3|||
126372242|NCT02746809|454659795|FG000|12-Month|Withdrawal by Subject|2|||
126372243|NCT02746809|454659795|FG000|24-Month|Death|1|||
126372244|NCT02746809|454659795|FG000|24-Month|Withdrawal by Subject|1|||
126372245|NCT02746809|454659795|FG000|36-Month|Death|8|||
126372246|NCT02746809|454659795|FG000|36-Month|Withdrawal by Subject|1|||
126372247|NCT02746809|454659795|FG000|48-Month|Death|7|||
126372248|NCT02746809|454659795|FG000|48-Month|Withdrawal by Subject|1|||
126372249|NCT02746809|454659795|FG000|60-Month|Death|1|||
126372250|NCT02746809|454659795|FG000|60-Month|Lost to Follow-up|2|||
126372251|NCT00894387|454659798|FG000|Overall Study|Adverse Event|44|||
126465142|NCT01397201|455005691|FG004|Overall Study|Not yet defined|4|||
126465143|NCT01397201|455005687|FG000|Overall Study|Adverse Event|2|||
126465144|NCT01397201|455005688|FG001|Overall Study|Adverse Event|0|||
126465145|NCT01397201|455005689|FG002|Overall Study|Adverse Event|0|||
126465146|NCT01397201|455005690|FG003|Overall Study|Adverse Event|0|||
126465147|NCT01397201|455005691|FG004|Overall Study|Adverse Event|0|||
126465148|NCT00215683|455005692|FG000|Overall Study|Adverse Event|15|||
126372252|NCT00894387|454659799|FG001|Overall Study|Adverse Event|45|||
126372253|NCT00894387|454659798|FG000|Overall Study|Abnormal Laboratory values|2|||
126552491|NCT00983619|455318417|FG010|Overall Study|Withdrawal by Subject|1|||
126372254|NCT00894387|454659799|FG001|Overall Study|Abnormal Laboratory values|2|||
126372255|NCT00894387|454659798|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126372256|NCT00894387|454659799|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126372257|NCT00894387|454659798|FG000|Overall Study|Lost to Follow-up|3|||
126372258|NCT00894387|454659799|FG001|Overall Study|Lost to Follow-up|5|||
126372259|NCT00894387|454659798|FG000|Overall Study|Administrative problems|2|||
126372260|NCT00894387|454659799|FG001|Overall Study|Administrative problems|2|||
126372261|NCT00894387|454659798|FG000|Overall Study|Death|77|||
126372262|NCT00894387|454659799|FG001|Overall Study|Death|76|||
126465149|NCT00215683|455005693|FG001|Overall Study|Adverse Event|16|||
126552492|NCT00983619|455318418|FG011|Overall Study|Withdrawal by Subject|1|||
126372263|NCT00894387|454659798|FG000|Overall Study|Protocol Deviation|4|||
126465150|NCT00215683|455005694|FG002|Overall Study|Adverse Event|15|||
126372264|NCT00894387|454659799|FG001|Overall Study|Protocol Deviation|0|||
126372265|NCT00894387|454659798|FG000|Overall Study|Patient's request|25|||
126372266|NCT00894387|454659799|FG001|Overall Study|Patient's request|30|||
126372267|NCT00894387|454659798|FG000|Overall Study|Other (Missing)|5|||
126372268|NCT00894387|454659799|FG001|Overall Study|Other (Missing)|3|||
126372269|NCT00894387|454659798|FG000|Overall Study|Mis-randomized|13|||
126465151|NCT00215683|455005692|FG000|Overall Study|Lack of Efficacy|5|||
126465152|NCT00215683|455005693|FG001|Overall Study|Lack of Efficacy|1|||
126465153|NCT00215683|455005694|FG002|Overall Study|Lack of Efficacy|2|||
126465154|NCT00215683|455005692|FG000|Overall Study|Lost to Follow-up|0|||
126465155|NCT00215683|455005693|FG001|Overall Study|Lost to Follow-up|2|||
126465156|NCT00215683|455005694|FG002|Overall Study|Lost to Follow-up|1|||
126465157|NCT00215683|455005692|FG000|Overall Study|Withdrawal by Subject|9|||
126465158|NCT00215683|455005693|FG001|Overall Study|Withdrawal by Subject|4|||
126465159|NCT00215683|455005694|FG002|Overall Study|Withdrawal by Subject|13|||
126465160|NCT00215683|455005692|FG000|Overall Study|Physician Decision|0|||
126465161|NCT00215683|455005693|FG001|Overall Study|Physician Decision|0|||
126465162|NCT00215683|455005694|FG002|Overall Study|Physician Decision|1|||
126465163|NCT00215683|455005692|FG000|Overall Study|Difficult to attend visits|0|||
126465164|NCT00215683|455005693|FG001|Overall Study|Difficult to attend visits|1|||
126465165|NCT00215683|455005694|FG002|Overall Study|Difficult to attend visits|0|||
126465166|NCT00215683|455005692|FG000|Overall Study|No study drug available|0|||
126465167|NCT00215683|455005693|FG001|Overall Study|No study drug available|1|||
126465168|NCT00215683|455005694|FG002|Overall Study|No study drug available|0|||
126465169|NCT00215683|455005692|FG000|Overall Study|Intermittent therapy required|0|||
126465170|NCT00215683|455005693|FG001|Overall Study|Intermittent therapy required|1|||
126465171|NCT00215683|455005694|FG002|Overall Study|Intermittent therapy required|0|||
126465172|NCT01083485|455005695|FG000|Overall Study|Adverse Event|0|||
126465173|NCT01083485|455005696|FG001|Overall Study|Adverse Event|1|||
126465174|NCT01083485|455005695|FG000|Overall Study|Protocol Violation|1|||
126465175|NCT01083485|455005696|FG001|Overall Study|Protocol Violation|0|||
126552493|NCT00983619|455318407|FG000|Overall Study|Death|0|||
126552494|NCT00983619|455318408|FG001|Overall Study|Death|2|||
126552495|NCT00983619|455318409|FG002|Overall Study|Death|2|||
126716410|NCT00446446|455913126|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
126309071|NCT01936181|454420953|FG003|Randomised, Double-blind|Physician Decision|0|||
126309072|NCT01936181|454420950|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
126309073|NCT01936181|454420951|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
126309074|NCT01936181|454420952|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
126309075|NCT01936181|454420953|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
126309076|NCT01936181|454420950|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
126309077|NCT01936181|454420951|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
126309078|NCT01936181|454420952|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
126309079|NCT01936181|454420953|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
126309080|NCT01936181|454420950|FG000|Transition-extension|Adverse Event|3|||
126309081|NCT01936181|454420951|FG001|Transition-extension|Adverse Event|0|||
126309082|NCT01936181|454420952|FG002|Transition-extension|Adverse Event|3|||
126309083|NCT01936181|454420953|FG003|Transition-extension|Adverse Event|1|||
126309084|NCT01936181|454420950|FG000|Transition-extension|Lost to Follow-up|3|||
126309085|NCT01936181|454420951|FG001|Transition-extension|Lost to Follow-up|0|||
126309086|NCT01936181|454420952|FG002|Transition-extension|Lost to Follow-up|1|||
126309087|NCT01936181|454420953|FG003|Transition-extension|Lost to Follow-up|2|||
126309088|NCT01936181|454420950|FG000|Transition-extension|Physician Decision|2|||
126309089|NCT01936181|454420951|FG001|Transition-extension|Physician Decision|0|||
126309090|NCT01936181|454420952|FG002|Transition-extension|Physician Decision|0|||
126309091|NCT01936181|454420953|FG003|Transition-extension|Physician Decision|1|||
126309092|NCT01936181|454420950|FG000|Transition-extension|Withdrawal by Subject|7|||
126309093|NCT01936181|454420951|FG001|Transition-extension|Withdrawal by Subject|0|||
126309094|NCT01936181|454420952|FG002|Transition-extension|Withdrawal by Subject|2|||
126309095|NCT01936181|454420953|FG003|Transition-extension|Withdrawal by Subject|1|||
126309096|NCT00970632|454420954|FG000|Overall Study|Adverse Event|2|||
126309097|NCT00970632|454420955|FG001|Overall Study|Adverse Event|2|||
126309098|NCT00970632|454420956|FG002|Overall Study|Adverse Event|1|||
126309099|NCT00970632|454420954|FG000|Overall Study|Lack of Efficacy|3|||
126309100|NCT00970632|454420955|FG001|Overall Study|Lack of Efficacy|0|||
126309101|NCT00970632|454420956|FG002|Overall Study|Lack of Efficacy|0|||
126309102|NCT00970632|454420954|FG000|Overall Study|Lost to Follow-up|3|||
126309103|NCT00970632|454420955|FG001|Overall Study|Lost to Follow-up|0|||
126309104|NCT00970632|454420956|FG002|Overall Study|Lost to Follow-up|2|||
126309105|NCT00970632|454420954|FG000|Overall Study|Protocol Violation|8|||
126309106|NCT00970632|454420955|FG001|Overall Study|Protocol Violation|5|||
126309107|NCT00970632|454420956|FG002|Overall Study|Protocol Violation|8|||
126309108|NCT00970632|454420954|FG000|Overall Study|Withdrawal by Subject|7|||
126309109|NCT00970632|454420955|FG001|Overall Study|Withdrawal by Subject|6|||
126309110|NCT00970632|454420956|FG002|Overall Study|Withdrawal by Subject|4|||
126309111|NCT00970632|454420954|FG000|Overall Study|Entry criteria not met|0|||
126309112|NCT00970632|454420955|FG001|Overall Study|Entry criteria not met|2|||
126465176|NCT01083485|455005695|FG000|Overall Study|Withdrawal by Subject|5|||
126465177|NCT01083485|455005696|FG001|Overall Study|Withdrawal by Subject|2|||
126465178|NCT01083485|455005695|FG000|Overall Study|Other|1|||
126465179|NCT01083485|455005696|FG001|Overall Study|Other|0|||
126465180|NCT04493333|455005703|FG000|Overall Study|Withdrawal by Subject|1|||
126465181|NCT04493333|455005704|FG001|Overall Study|Withdrawal by Subject|1|||
126465182|NCT04493333|455005703|FG000|Overall Study|Ineligible|0|||
126465183|NCT04493333|455005704|FG001|Overall Study|Ineligible|1|||
126465184|NCT04493333|455005703|FG000|Overall Study|Noncompliance|2|||
126465185|NCT04493333|455005704|FG001|Overall Study|Noncompliance|1|||
126465186|NCT00451451|455005707|FG000|Overall Study|Adverse Event|11|||
126465187|NCT00451451|455005708|FG001|Overall Study|Adverse Event|21|||
126465188|NCT00451451|455005709|FG002|Overall Study|Adverse Event|26|||
126465189|NCT00451451|455005710|FG003|Overall Study|Adverse Event|10|||
126465190|NCT00451451|455005707|FG000|Overall Study|Lost to Follow-up|11|||
126465191|NCT00451451|455005708|FG001|Overall Study|Lost to Follow-up|9|||
126465192|NCT00451451|455005709|FG002|Overall Study|Lost to Follow-up|8|||
126465193|NCT00451451|455005710|FG003|Overall Study|Lost to Follow-up|11|||
126465194|NCT00451451|455005707|FG000|Overall Study|Consent Withdrawn|14|||
126465195|NCT00451451|455005708|FG001|Overall Study|Consent Withdrawn|9|||
126716411|NCT03648996|455913128|FG000|Overall Study|Withdrawal by Subject|0|||
126465196|NCT00451451|455005709|FG002|Overall Study|Consent Withdrawn|17|||
126465197|NCT00451451|455005710|FG003|Overall Study|Consent Withdrawn|17|||
126465198|NCT00451451|455005707|FG000|Overall Study|Investigator Decision|6|||
126465199|NCT00451451|455005708|FG001|Overall Study|Investigator Decision|2|||
126465200|NCT00451451|455005709|FG002|Overall Study|Investigator Decision|1|||
126465201|NCT00451451|455005710|FG003|Overall Study|Investigator Decision|2|||
126465202|NCT00451451|455005707|FG000|Overall Study|Subject Non-Compliance|8|||
126465203|NCT00451451|455005708|FG001|Overall Study|Subject Non-Compliance|4|||
126465204|NCT00451451|455005709|FG002|Overall Study|Subject Non-Compliance|3|||
126465205|NCT00451451|455005710|FG003|Overall Study|Subject Non-Compliance|3|||
126465206|NCT00451451|455005707|FG000|Overall Study|Death|1|||
126465207|NCT00451451|455005708|FG001|Overall Study|Death|0|||
126465208|NCT00451451|455005709|FG002|Overall Study|Death|0|||
126465209|NCT00451451|455005710|FG003|Overall Study|Death|1|||
126465210|NCT00451451|455005707|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
126465211|NCT00451451|455005708|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
126465212|NCT00451451|455005709|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
126465213|NCT00451451|455005710|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
126465214|NCT00084838|455005711|FG000|Overall Study|Death|1|||
126465215|NCT00084838|455005711|FG000|Overall Study|Adverse Event|2|||
126465216|NCT00084838|455005711|FG000|Overall Study|Withdrawal by Subject|1|||
126465217|NCT00084838|455005711|FG000|Overall Study|Progressive Disease|4|||
126465218|NCT00084838|455005711|FG000|Overall Study|Pt Non-Compliance|1|||
126465219|NCT00084838|455005711|FG000|Overall Study|Ineligible|4|||
126465220|NCT00122278|455005712|FG000|Overall Study|Lost to Follow-up|2|||
126465221|NCT00122278|455005713|FG001|Overall Study|Lost to Follow-up|0|||
126465222|NCT01865084|455005714|FG000|Double Blind Period (DB)|Adverse Event|2|||
126465223|NCT01865084|455005715|FG001|Double Blind Period (DB)|Adverse Event|2|||
126465224|NCT01865084|455005716|FG002|Double Blind Period (DB)|Adverse Event|1|||
126465225|NCT01865084|455005714|FG000|Double Blind Period (DB)|Protocol Violation|0|||
126465226|NCT01865084|455005715|FG001|Double Blind Period (DB)|Protocol Violation|0|||
126465227|NCT01865084|455005716|FG002|Double Blind Period (DB)|Protocol Violation|1|||
126465228|NCT01865084|455005714|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
126465229|NCT01865084|455005715|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
126465230|NCT01865084|455005716|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
126465231|NCT01865084|455005714|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
126465232|NCT01865084|455005715|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
126465233|NCT01865084|455005716|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
126465234|NCT01865084|455005714|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
126465235|NCT01865084|455005715|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
126465236|NCT01865084|455005716|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
126465237|NCT01865084|455005714|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
126465238|NCT01865084|455005715|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
126716412|NCT03648996|455913129|FG001|Overall Study|Withdrawal by Subject|2|||
126716413|NCT03648996|455913130|FG002|Overall Study|Withdrawal by Subject|2|||
126716414|NCT03648996|455913128|FG000|Overall Study|Physician Decision|2|||
126465239|NCT01865084|455005716|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
126465240|NCT01865084|455005714|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
126465241|NCT01865084|455005715|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
126465242|NCT01865084|455005716|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
126465243|NCT01865084|455005714|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
126465244|NCT01865084|455005715|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
126465245|NCT01865084|455005716|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
126465246|NCT01865084|455005714|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
126465247|NCT01865084|455005715|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
126465248|NCT01865084|455005716|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
126465249|NCT01994590|455005717|FG000|Overall Study|Adverse Event|1|||
126716415|NCT03648996|455913129|FG001|Overall Study|Physician Decision|0|||
126372270|NCT00894387|454659799|FG001|Overall Study|Mis-randomized|9|||
126372271|NCT00894387|454659798|FG000|Overall Study|GCP non-compliance|0|||
126372272|NCT00894387|454659799|FG001|Overall Study|GCP non-compliance|2|||
126372273|NCT01128569|454659800|FG000|Washout Period 1|Adverse Event|0|||
126372274|NCT01128569|454659801|FG001|Washout Period 1|Adverse Event|0|||
126372275|NCT01128569|454659802|FG002|Washout Period 1|Adverse Event|1|||
126372276|NCT01128569|454659803|FG003|Washout Period 1|Adverse Event|0|||
126372277|NCT01128569|454659804|FG004|Washout Period 1|Adverse Event|0|||
126372278|NCT01128569|454659805|FG005|Washout Period 1|Adverse Event|0|||
126372279|NCT01128569|454659800|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126372280|NCT01128569|454659801|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126372281|NCT01128569|454659802|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126372282|NCT01128569|454659803|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126372283|NCT01128569|454659804|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126372284|NCT01128569|454659805|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126372285|NCT02519842|454659806|FG000|Base Study: Cycle 1|Screening Failure|1|||
126372286|NCT02519842|454659807|FG001|Base Study: Cycle 1|Screening Failure|1|||
126372287|NCT02519842|454659808|FG002|Base Study: Cycle 1|Screening Failure|0|||
126372288|NCT02519842|454659806|FG000|Base Study: Cycle 1|Adverse Event|1|||
126372289|NCT02519842|454659807|FG001|Base Study: Cycle 1|Adverse Event|0|||
126372290|NCT02519842|454659808|FG002|Base Study: Cycle 1|Adverse Event|0|||
126372291|NCT02519842|454659806|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
126372292|NCT02519842|454659807|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
126372293|NCT02519842|454659808|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
126372294|NCT02519842|454659806|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
126372295|NCT02519842|454659807|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
126372296|NCT02519842|454659808|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
126372297|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
126372298|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
126372299|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
126372300|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
126372301|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
126372302|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
126372303|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126372304|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
126372305|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
126372306|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
126372307|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
126372308|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
126372309|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Death|0|||
126372310|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Death|0|||
126372311|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Death|1|||
126372312|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
126372313|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
126372314|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
126372315|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
126372316|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
126372317|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
126372318|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
126372319|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
126372320|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
126372321|NCT02519842|454659806|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
126372322|NCT02519842|454659807|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
126372323|NCT02519842|454659808|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
126372324|NCT01493414|454659814|FG000|Overall Study|Adverse Event|405|||
126372325|NCT01493414|454659814|FG000|Overall Study|Disease progression|204|||
126372326|NCT01493414|454659814|FG000|Overall Study|Death|101|||
126372327|NCT01493414|454659814|FG000|Overall Study|Physician Decision|93|||
126372328|NCT01493414|454659814|FG000|Overall Study|Withdrawal by Subject|79|||
126372329|NCT01493414|454659814|FG000|Overall Study|Protocol deviation|27|||
126372330|NCT01493414|454659814|FG000|Overall Study|Administrative problems|25|||
126372331|NCT01493414|454659814|FG000|Overall Study|Lost to Follow-up|16|||
126372332|NCT01977222|454659819|FG000|Overall Study|Withdrawal by Subject|1|||
126372333|NCT00945659|454659829|FG000|Overall Study|Lost to Follow-up|7|||
126372334|NCT00945659|454659830|FG001|Overall Study|Lost to Follow-up|20|||
126465250|NCT01994590|455005717|FG000|Overall Study|Trial Terminated|1|||
126465251|NCT03607422|455005718|FG000|Overall Study|Adverse Event|7|||
126372335|NCT00945659|454659831|FG002|Overall Study|Lost to Follow-up|17|||
126372336|NCT04562116|454659832|FG000|Overall Study|Lost to Follow-up|1|||
126372337|NCT04562116|454659832|FG000|Overall Study|Withdrawal by Subject|3|||
126372338|NCT02412670|454659835|FG000|Overall Study|Adverse Event|4|||
126372339|NCT02412670|454659836|FG001|Overall Study|Adverse Event|1|||
126465252|NCT03607422|455005719|FG001|Overall Study|Adverse Event|3|||
126465253|NCT03607422|455005720|FG002|Overall Study|Adverse Event|2|||
126465254|NCT03607422|455005721|FG003|Overall Study|Adverse Event|0|||
126465255|NCT03607422|455005722|FG004|Overall Study|Adverse Event|2|||
126465256|NCT03607422|455005723|FG005|Overall Study|Adverse Event|0|||
126465257|NCT03607422|455005718|FG000|Overall Study|Withdrawal by Subject|11|||
126465258|NCT03607422|455005719|FG001|Overall Study|Withdrawal by Subject|3|||
126465259|NCT03607422|455005720|FG002|Overall Study|Withdrawal by Subject|6|||
126465260|NCT03607422|455005721|FG003|Overall Study|Withdrawal by Subject|2|||
126465261|NCT03607422|455005722|FG004|Overall Study|Withdrawal by Subject|0|||
126465262|NCT03607422|455005723|FG005|Overall Study|Withdrawal by Subject|0|||
126465263|NCT03607422|455005718|FG000|Overall Study|Lost to Follow-up|0|||
126465264|NCT03607422|455005719|FG001|Overall Study|Lost to Follow-up|0|||
126465265|NCT03607422|455005720|FG002|Overall Study|Lost to Follow-up|1|||
126465266|NCT03607422|455005721|FG003|Overall Study|Lost to Follow-up|0|||
126465267|NCT03607422|455005722|FG004|Overall Study|Lost to Follow-up|0|||
126465268|NCT03607422|455005723|FG005|Overall Study|Lost to Follow-up|0|||
126465269|NCT03607422|455005718|FG000|Overall Study|Other|12|||
126465270|NCT03607422|455005719|FG001|Overall Study|Other|4|||
126465271|NCT03607422|455005720|FG002|Overall Study|Other|1|||
126465272|NCT03607422|455005721|FG003|Overall Study|Other|2|||
126465273|NCT03607422|455005722|FG004|Overall Study|Other|0|||
126465274|NCT03607422|455005723|FG005|Overall Study|Other|2|||
126465275|NCT03607422|455005718|FG000|Overall Study|Ongoing at Time of Analysis|8|||
126465276|NCT03607422|455005719|FG001|Overall Study|Ongoing at Time of Analysis|0|||
126465277|NCT03607422|455005720|FG002|Overall Study|Ongoing at Time of Analysis|2|||
126465278|NCT03607422|455005721|FG003|Overall Study|Ongoing at Time of Analysis|1|||
126372340|NCT02412670|454659835|FG000|Overall Study|Physician Decision|1|||
126372341|NCT02412670|454659836|FG001|Overall Study|Physician Decision|0|||
126372342|NCT02412670|454659835|FG000|Overall Study|Withdrawal by Subject|1|||
126372343|NCT02412670|454659836|FG001|Overall Study|Withdrawal by Subject|0|||
126372344|NCT02412670|454659835|FG000|Overall Study|Ineligible|1|||
126372345|NCT02412670|454659836|FG001|Overall Study|Ineligible|0|||
126372346|NCT00654732|454659839|FG000|Overall Study|Adverse Event|4|||
126372347|NCT00654732|454659840|FG001|Overall Study|Adverse Event|6|||
126372348|NCT03342560|454659841|FG000|Overall Study|Lost to Follow-up|2|||
126372349|NCT02993263|454659854|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
126372350|NCT01405196|454659855|FG000|Overall Study|Study Terminated by Sponsor|0|||
126372351|NCT01405196|454659856|FG001|Overall Study|Study Terminated by Sponsor|0|||
126372352|NCT01405196|454659857|FG002|Overall Study|Study Terminated by Sponsor|9|||
126372353|NCT01405196|454659858|FG003|Overall Study|Study Terminated by Sponsor|0|||
126372354|NCT01405196|454659855|FG000|Overall Study|Other|2|||
126372355|NCT01405196|454659856|FG001|Overall Study|Other|2|||
126372356|NCT01405196|454659857|FG002|Overall Study|Other|5|||
126372357|NCT01405196|454659858|FG003|Overall Study|Other|0|||
126372358|NCT01405196|454659855|FG000|Overall Study|Withdrawal by Subject|4|||
126465279|NCT03607422|455005722|FG004|Overall Study|Ongoing at Time of Analysis|1|||
126465280|NCT03607422|455005723|FG005|Overall Study|Ongoing at Time of Analysis|1|||
126465281|NCT03693170|455005724|FG000|Overall Study|Disease Progression|48|||
126465282|NCT03693170|455005724|FG000|Overall Study|Adverse Event|16|||
126465283|NCT03693170|455005724|FG000|Overall Study|Physician Decision|6|||
126465284|NCT03693170|455005724|FG000|Overall Study|Protocol Violation|2|||
126465285|NCT03693170|455005724|FG000|Overall Study|Death|1|||
126465286|NCT03693170|455005724|FG000|Overall Study|Non compliance with study drug|1|||
126465287|NCT03693170|455005724|FG000|Overall Study|Withdrawal by Subject|1|||
126465288|NCT01442038|455005727|FG000|Overall Study|Death|35|||
126465289|NCT01442038|455005728|FG001|Overall Study|Death|29|||
126465290|NCT01442038|455005727|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
126465291|NCT01442038|455005728|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
126552496|NCT00983619|455318410|FG003|Overall Study|Death|1|||
126372359|NCT01405196|454659856|FG001|Overall Study|Withdrawal by Subject|6|||
126372360|NCT01405196|454659857|FG002|Overall Study|Withdrawal by Subject|3|||
126372361|NCT01405196|454659858|FG003|Overall Study|Withdrawal by Subject|6|||
126372362|NCT01405196|454659855|FG000|Overall Study|Adverse Event|2|||
126372363|NCT01405196|454659856|FG001|Overall Study|Adverse Event|2|||
126372364|NCT01405196|454659857|FG002|Overall Study|Adverse Event|0|||
126372365|NCT01405196|454659858|FG003|Overall Study|Adverse Event|2|||
126372366|NCT01405196|454659855|FG000|Overall Study|Death|1|||
126465292|NCT01442038|455005727|FG000|Overall Study|Participant Withdrew Consent|137|||
126716416|NCT03648996|455913130|FG002|Overall Study|Physician Decision|0|||
126372367|NCT01405196|454659856|FG001|Overall Study|Death|0|||
126372368|NCT01405196|454659857|FG002|Overall Study|Death|3|||
126465293|NCT01442038|455005728|FG001|Overall Study|Participant Withdrew Consent|102|||
126465294|NCT01442038|455005727|FG000|Overall Study|Lost to Follow-up|37|||
126465295|NCT01442038|455005728|FG001|Overall Study|Lost to Follow-up|51|||
126465296|NCT01442038|455005727|FG000|Overall Study|Adverse Event|26|||
126465297|NCT01442038|455005728|FG001|Overall Study|Adverse Event|15|||
126465298|NCT01442038|455005727|FG000|Overall Study|Protocol Deviation|9|||
126465299|NCT01442038|455005728|FG001|Overall Study|Protocol Deviation|20|||
126465300|NCT01442038|455005727|FG000|Overall Study|Investigator's Discretion|13|||
126465301|NCT01442038|455005728|FG001|Overall Study|Investigator's Discretion|16|||
126465302|NCT01442038|455005727|FG000|Overall Study|Study Terminated By Sponsor|2|||
126465303|NCT01442038|455005728|FG001|Overall Study|Study Terminated By Sponsor|3|||
126465304|NCT00089284|455005729|FG000|Overall Study|Adverse event before starting treatment|0|||
126465305|NCT00089284|455005730|FG001|Overall Study|Adverse event before starting treatment|0|||
126465306|NCT00089284|455005731|FG002|Overall Study|Adverse event before starting treatment|0|||
126465307|NCT00089284|455005732|FG003|Overall Study|Adverse event before starting treatment|0|||
126465308|NCT00089284|455005733|FG004|Overall Study|Adverse event before starting treatment|0|||
126465309|NCT00089284|455005734|FG005|Overall Study|Adverse event before starting treatment|0|||
126465310|NCT00089284|455005735|FG006|Overall Study|Adverse event before starting treatment|1|||
126465311|NCT03228420|455005745|FG000|Overall Study|Lost to Follow-up|5|||
126465312|NCT03228420|455005746|FG001|Overall Study|Lost to Follow-up|3|||
126465313|NCT03228420|455005745|FG000|Overall Study|Withdrawal by Subject|10|||
126465314|NCT03228420|455005746|FG001|Overall Study|Withdrawal by Subject|0|||
126465315|NCT03228420|455005745|FG000|Overall Study|Adverse Event|5|||
126465316|NCT03228420|455005746|FG001|Overall Study|Adverse Event|2|||
126465317|NCT02428608|455005747|FG000|Overall Study|Pregnancy|2|||
126465318|NCT02428608|455005747|FG000|Overall Study|Lost to Follow-up|37|||
126465319|NCT02428608|455005747|FG000|Overall Study|Withdrawal by Subject|2|||
126465320|NCT02428608|455005747|FG000|Overall Study|scheduling conflicts|15|||
126465321|NCT02428608|455005747|FG000|Overall Study|moved away|10|||
126465322|NCT02428608|455005747|FG000|Overall Study|Death|1|||
126465323|NCT02428608|455005747|FG000|Overall Study|various|16|||
126552497|NCT00983619|455318411|FG004|Overall Study|Death|2|||
126465324|NCT03646643|455005750|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
126465325|NCT03646643|455005751|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
126465326|NCT03646643|455005750|FG000|Overall Study|Lost to Follow-up|0|||
126465327|NCT03646643|455005751|FG001|Overall Study|Lost to Follow-up|1|||
126465328|NCT04131556|455005752|FG000|Overall Study|Adverse Event|1|||
126465329|NCT04131556|455005752|FG000|Overall Study|Withdrawal by Subject|1|||
126465330|NCT04060862|455005753|FG000|Overall Study|Symptomatic Deterioration|1|||
126465331|NCT04060862|455005753|FG000|Overall Study|Un-specified|6|||
126465332|NCT04060862|455005753|FG000|Overall Study|Progressive disease|12|||
126465333|NCT04060862|455005753|FG000|Overall Study|Physician Decision|1|||
126465334|NCT03923738|455005758|FG000|Period 1|Adverse Event|1|||
126465335|NCT03923738|455005758|FG000|Period 1|Withdrawal by Subject|1|||
126465336|NCT03583164|455005760|FG000|Overall Study|Death in Main Phase|35|||
126465337|NCT03583164|455005760|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
126465338|NCT03583164|455005760|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
126552498|NCT00983619|455318412|FG005|Overall Study|Death|30|||
126552499|NCT00983619|455318413|FG006|Overall Study|Death|1|||
126552500|NCT00983619|455318414|FG007|Overall Study|Death|0|||
126552501|NCT00983619|455318415|FG008|Overall Study|Death|1|||
126552502|NCT00983619|455318416|FG009|Overall Study|Death|2|||
126552503|NCT00983619|455318417|FG010|Overall Study|Death|9|||
126552504|NCT00983619|455318418|FG011|Overall Study|Death|8|||
126552505|NCT00983619|455318407|FG000|Overall Study|Other|1|||
126552506|NCT00983619|455318408|FG001|Overall Study|Other|0|||
126552507|NCT00983619|455318409|FG002|Overall Study|Other|0|||
126552508|NCT00983619|455318410|FG003|Overall Study|Other|1|||
126552509|NCT00983619|455318411|FG004|Overall Study|Other|0|||
126552510|NCT00983619|455318412|FG005|Overall Study|Other|12|||
126552511|NCT00983619|455318413|FG006|Overall Study|Other|2|||
126552512|NCT00983619|455318414|FG007|Overall Study|Other|2|||
126552513|NCT00983619|455318415|FG008|Overall Study|Other|0|||
126552514|NCT00983619|455318416|FG009|Overall Study|Other|1|||
126552515|NCT00983619|455318417|FG010|Overall Study|Other|1|||
126552516|NCT00983619|455318418|FG011|Overall Study|Other|0|||
126552517|NCT03772314|455318425|FG000|Overall Study|Adverse Event|7|||
126552518|NCT03772314|455318426|FG001|Overall Study|Adverse Event|2|||
126465339|NCT03583164|455005760|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
126465340|NCT03583164|455005760|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
126465341|NCT03583164|455005760|FG000|Overall Study|Physician decision in Main Phase|1|||
126465342|NCT03583164|455005760|FG000|Overall Study|Physician decision in Extended Phase|2|||
126552519|NCT01536145|455318427|FG000|Overall Study|Progressive disease|3|||
126552520|NCT01536145|455318428|FG001|Overall Study|Progressive disease|4|||
126465343|NCT03583164|455005760|FG000|Overall Study|Death in Extended Phase|13|||
126465344|NCT03583164|455005760|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
126465345|NCT03583164|455005760|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
126465346|NCT03583164|455005760|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
126465347|NCT03583164|455005760|FG000|Overall Study|Treatment failure in Main Phase|2|||
126552521|NCT01536145|455318429|FG002|Overall Study|Progressive disease|1|||
126552522|NCT01536145|455318430|FG003|Overall Study|Progressive disease|2|||
126552523|NCT01536145|455318431|FG004|Overall Study|Progressive disease|1|||
126552524|NCT01536145|455318432|FG005|Overall Study|Progressive disease|2|||
126552525|NCT01536145|455318433|FG006|Overall Study|Progressive disease|1|||
126552526|NCT01536145|455318434|FG007|Overall Study|Progressive disease|2|||
126552527|NCT01536145|455318435|FG008|Overall Study|Progressive disease|1|||
126372369|NCT01405196|454659858|FG003|Overall Study|Death|0|||
126372370|NCT01405196|454659855|FG000|Overall Study|Lost to Follow-up|2|||
126372371|NCT01405196|454659856|FG001|Overall Study|Lost to Follow-up|2|||
126372372|NCT01405196|454659857|FG002|Overall Study|Lost to Follow-up|3|||
126372373|NCT01405196|454659858|FG003|Overall Study|Lost to Follow-up|1|||
126372374|NCT01729039|454659859|FG000|Overall Study|disqualified|2|||
126372375|NCT01729039|454659860|FG001|Overall Study|disqualified|5|||
126372376|NCT01729039|454659859|FG000|Overall Study|Withdrawal by Subject|8|||
126372377|NCT01729039|454659860|FG001|Overall Study|Withdrawal by Subject|7|||
126465348|NCT03583164|455005760|FG000|Overall Study|Treatment failure in Extended Phase|4|||
126465349|NCT03583164|455005760|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
126465350|NCT03583164|455005760|FG000|Overall Study|Other not specified reason in Main Phase|2|||
126465351|NCT00735254|455005761|FG000|Overall Study|Protocol Violation|1|||
126465352|NCT00735254|455005762|FG001|Overall Study|Protocol Violation|1|||
126465353|NCT00735254|455005763|FG002|Overall Study|Protocol Violation|1|||
126465354|NCT00735254|455005764|FG003|Overall Study|Protocol Violation|0|||
126465355|NCT00559754|455005768|FG000|Overall Study|Disease progression|1|||
126465356|NCT00559754|455005768|FG000|Overall Study|Adverse Event|5|||
126465357|NCT00559754|455005768|FG000|Overall Study|Protocol Violation|1|||
126465358|NCT00559754|455005768|FG000|Overall Study|Investigator criteria|2|||
126465359|NCT00559754|455005768|FG000|Overall Study|Withdrawal by Subject|2|||
126465360|NCT01251744|455005769|FG000|Overall Study|Lost to Follow-up|1|||
126465361|NCT01251744|455005770|FG001|Overall Study|Lost to Follow-up|0|||
126465362|NCT01243671|455005771|FG000|Overall Study|Adverse Event|3|||
126465363|NCT01243671|455005771|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
126465364|NCT01243671|455005771|FG000|Overall Study|Other|1|||
126465365|NCT00573248|455005772|FG000|Overall Study|scheduling conflicts|15|||
126465366|NCT00573248|455005773|FG001|Overall Study|scheduling conflicts|11|||
126465367|NCT04505540|455005776|FG000|Baseline|Protocol Violation|10|||
126465368|NCT04505540|455005776|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
126465369|NCT04505540|455005776|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
126465370|NCT04505540|455005776|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
126465371|NCT04505540|455005776|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
126465372|NCT04505540|455005776|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
126465373|NCT04505540|455005776|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
126465374|NCT04505540|455005776|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
126465375|NCT04505540|455005776|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
126465376|NCT04505540|455005776|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
126465377|NCT04505540|455005776|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
126465378|NCT04505540|455005776|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
126465379|NCT04505540|455005776|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
126465380|NCT05342532|455005777|FG000|Overall Study|Adverse Event|5|||
126465381|NCT05342532|455005778|FG001|Overall Study|Adverse Event|20|||
126465382|NCT05342532|455005777|FG000|Overall Study|Lost to Follow-up|10|||
126465383|NCT05342532|455005778|FG001|Overall Study|Lost to Follow-up|15|||
126465384|NCT02057393|455005781|FG000|Overall Study|Withdrawal by Subject|1|||
126465385|NCT02057393|455005781|FG000|Overall Study|Patient did not meet criteria|1|||
126465386|NCT05323656|455005782|FG000|Overall Study|Still On-Treatment|6|||
126465387|NCT05323656|455005783|FG001|Overall Study|Still On-Treatment|6|||
126465388|NCT05323656|455005782|FG000|Overall Study|Progressive Disease|15|||
126465389|NCT05323656|455005783|FG001|Overall Study|Progressive Disease|14|||
126465390|NCT05323656|455005782|FG000|Overall Study|Adverse Event|2|||
126465391|NCT05323656|455005783|FG001|Overall Study|Adverse Event|3|||
126465392|NCT05323656|455005782|FG000|Overall Study|Death|1|||
126465393|NCT05323656|455005783|FG001|Overall Study|Death|2|||
126465394|NCT05323656|455005782|FG000|Overall Study|Withdrawal by Subject|1|||
126465395|NCT05323656|455005783|FG001|Overall Study|Withdrawal by Subject|0|||
126465396|NCT05323656|455005782|FG000|Overall Study|Clinical disease progression|0|||
126465397|NCT05323656|455005783|FG001|Overall Study|Clinical disease progression|1|||
126465398|NCT05323656|455005782|FG000|Overall Study|Patient and Investigator decision|1|||
126465399|NCT05323656|455005783|FG001|Overall Study|Patient and Investigator decision|0|||
126372378|NCT00698841|454659861|FG000|Overall Study|Withdrawal by Subject|2|||
126465400|NCT05323656|455005782|FG000|Overall Study|Physician Decision|0|||
126465401|NCT05323656|455005783|FG001|Overall Study|Physician Decision|1|||
126465402|NCT02536833|455005784|FG000|Overall Study|Discontinued Before Treatment|0|||
126372379|NCT00698841|454659861|FG000|Overall Study|Adverse Event|3|||
126465403|NCT02536833|455005785|FG001|Overall Study|Discontinued Before Treatment|0|||
126465404|NCT02536833|455005786|FG002|Overall Study|Discontinued Before Treatment|1|||
126465405|NCT02536833|455005787|FG003|Overall Study|Discontinued Before Treatment|2|||
126465406|NCT02536833|455005784|FG000|Overall Study|Adverse Event|1|||
126465407|NCT02536833|455005785|FG001|Overall Study|Adverse Event|3|||
126465408|NCT02536833|455005786|FG002|Overall Study|Adverse Event|4|||
126465409|NCT02536833|455005787|FG003|Overall Study|Adverse Event|1|||
126465410|NCT02536833|455005784|FG000|Overall Study|Lost to Follow-up|2|||
126465411|NCT02536833|455005785|FG001|Overall Study|Lost to Follow-up|1|||
126465412|NCT02536833|455005786|FG002|Overall Study|Lost to Follow-up|2|||
126465413|NCT02536833|455005787|FG003|Overall Study|Lost to Follow-up|2|||
126465414|NCT02536833|455005784|FG000|Overall Study|Physician Decision|0|||
126465415|NCT02536833|455005785|FG001|Overall Study|Physician Decision|0|||
126465416|NCT02536833|455005786|FG002|Overall Study|Physician Decision|0|||
126465417|NCT02536833|455005787|FG003|Overall Study|Physician Decision|1|||
126465418|NCT02536833|455005784|FG000|Overall Study|Site Terminated by Sponsor|2|||
126465419|NCT02536833|455005785|FG001|Overall Study|Site Terminated by Sponsor|2|||
126465420|NCT02536833|455005786|FG002|Overall Study|Site Terminated by Sponsor|2|||
126465421|NCT02536833|455005787|FG003|Overall Study|Site Terminated by Sponsor|2|||
126465422|NCT02536833|455005784|FG000|Overall Study|Subject Non-Compliance|0|||
126465423|NCT02536833|455005785|FG001|Overall Study|Subject Non-Compliance|1|||
126465424|NCT02536833|455005786|FG002|Overall Study|Subject Non-Compliance|1|||
126465425|NCT02536833|455005787|FG003|Overall Study|Subject Non-Compliance|0|||
126465426|NCT02536833|455005784|FG000|Overall Study|Withdrawal by Subject|4|||
126465427|NCT02536833|455005785|FG001|Overall Study|Withdrawal by Subject|3|||
126465428|NCT02536833|455005786|FG002|Overall Study|Withdrawal by Subject|5|||
126465429|NCT02536833|455005787|FG003|Overall Study|Withdrawal by Subject|11|||
126465430|NCT02764190|455005789|FG000|Overall Study|Lost to Follow-up|17|||
126465431|NCT02764190|455005790|FG001|Overall Study|Lost to Follow-up|13|||
126465432|NCT01172275|455005795|FG000|Overall Study|Lost to Follow-up|1|||
126465433|NCT01172275|455005796|FG001|Overall Study|Lost to Follow-up|0|||
126465434|NCT01172275|455005795|FG000|Overall Study|Protocol Violation|1|||
126465435|NCT01172275|455005796|FG001|Overall Study|Protocol Violation|0|||
126465436|NCT05308290|455005801|FG000|Overall Study|Death|1|||
126465437|NCT05308290|455005802|FG001|Overall Study|Death|0|||
126465438|NCT05308290|455005801|FG000|Overall Study|Lost to Follow-up|2|||
126465439|NCT05308290|455005802|FG001|Overall Study|Lost to Follow-up|1|||
126465440|NCT05308290|455005801|FG000|Overall Study|still in study followup|0|||
126465441|NCT05308290|455005802|FG001|Overall Study|still in study followup|1|||
126465442|NCT04437368|455005803|FG000|Overall Study|Death|3|||
126465443|NCT04437368|455005804|FG001|Overall Study|Death|0|||
126465444|NCT04437368|455005805|FG002|Overall Study|Death|2|||
126465445|NCT04437368|455005803|FG000|Overall Study|Study terminated by sponsor|16|||
126465446|NCT04437368|455005804|FG001|Overall Study|Study terminated by sponsor|1|||
126465447|NCT04437368|455005805|FG002|Overall Study|Study terminated by sponsor|25|||
126465448|NCT04437368|455005803|FG000|Overall Study|Withdrawal by Subject|4|||
126465449|NCT04437368|455005804|FG001|Overall Study|Withdrawal by Subject|0|||
126465450|NCT04437368|455005805|FG002|Overall Study|Withdrawal by Subject|3|||
126465451|NCT04437368|455005803|FG000|Overall Study|Sponsor instructions|23|||
126465452|NCT04437368|455005804|FG001|Overall Study|Sponsor instructions|0|||
126465453|NCT04437368|455005805|FG002|Overall Study|Sponsor instructions|0|||
126465454|NCT01982331|455005806|FG000|Received Vaccination 2|Adverse Event|1|||
126465455|NCT01982331|455005807|FG001|Received Vaccination 2|Adverse Event|2|||
126465456|NCT01982331|455005806|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
126465457|NCT01982331|455005807|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
126465458|NCT01982331|455005806|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
126465459|NCT01982331|455005807|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
126465460|NCT02393690|455005815|FG000|Overall Study|Ineligible|0|||
126465461|NCT02393690|455005816|FG001|Overall Study|Ineligible|1|||
126465462|NCT01674634|455005817|FG000|Overall Study|Withdrawal by Subject|3|||
126465463|NCT01674634|455005817|FG000|Overall Study|Lost to Follow-up|3|||
126465464|NCT01721070|455005818|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
126465465|NCT02204007|455005819|FG000|Overall Study|Surgery Canceled|1|||
126465466|NCT02204007|455005820|FG001|Overall Study|Surgery Canceled|1|||
126465467|NCT02059005|455005821|FG000|Overall Study|Death|1|||
126465468|NCT02059005|455005822|FG001|Overall Study|Death|3|||
126465469|NCT02059005|455005821|FG000|Overall Study|Lost to Follow-up|19|||
126465470|NCT02059005|455005822|FG001|Overall Study|Lost to Follow-up|19|||
126465471|NCT02059005|455005821|FG000|Overall Study|Incarceration|0|||
126465472|NCT02059005|455005822|FG001|Overall Study|Incarceration|1|||
126465473|NCT02059005|455005821|FG000|Overall Study|Inpatient|0|||
126465474|NCT02059005|455005822|FG001|Overall Study|Inpatient|1|||
126465475|NCT02142803|455005823|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
126465476|NCT02142803|455005824|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
126465477|NCT02142803|455005825|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
126770974|NCT00414011|456116220|FG000|Overall Study|Withdrawal by Subject|2|||
126465478|NCT02142803|455005826|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
126465479|NCT02718300|455005832|FG000|Overall Study|Death|4|||
126465480|NCT02718300|455005833|FG001|Overall Study|Death|5|||
126770975|NCT02476851|456116221|FG000|Overall Study|Protocol Violation|1|||
126770976|NCT02476851|456116222|FG001|Overall Study|Protocol Violation|1|||
126770977|NCT01399125|456116223|FG000|Overall Study|Adverse Event|32|||
126770978|NCT01399125|456116224|FG001|Overall Study|Adverse Event|30|||
126770979|NCT01399125|456116223|FG000|Overall Study|Abnormal Lab values|0|||
126770980|NCT01399125|456116224|FG001|Overall Study|Abnormal Lab values|1|||
126770981|NCT01399125|456116223|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126770982|NCT01399125|456116224|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
126372380|NCT00698841|454659861|FG000|Overall Study|Disease progression|7|||
126372381|NCT00698841|454659861|FG000|Overall Study|Failure to meet eligibility criteria|2|||
126372382|NCT00698841|454659861|FG000|Overall Study|Study drug toxicity|2|||
126372383|NCT00698841|454659861|FG000|Overall Study|Other|2|||
126372384|NCT02114177|454661351|FG000|Overall Study|Lost to Follow-up|1|||
126716417|NCT00590681|455913131|FG000|Overall Study|Withdrawal by Subject|7|||
126716418|NCT00590681|455913131|FG000|Overall Study|Adverse Event|8|||
126716419|NCT00590681|455913131|FG000|Overall Study|Death|3|||
126716420|NCT00590681|455913131|FG000|Overall Study|Lost to Follow-up|1|||
126716421|NCT00590681|455913131|FG000|Overall Study|disease progression|1|||
126716422|NCT00064662|455913132|FG000|Overall Study|Death|1|||
126716423|NCT00064662|455913133|FG001|Overall Study|Death|1|||
126716424|NCT00064662|455913132|FG000|Overall Study|Lost to Follow-up|57|||
126309113|NCT00970632|454420956|FG002|Overall Study|Entry criteria not met|2|||
126309114|NCT00970632|454420954|FG000|Overall Study|Sponsor decision|1|||
126309115|NCT00970632|454420955|FG001|Overall Study|Sponsor decision|0|||
126309116|NCT00970632|454420956|FG002|Overall Study|Sponsor decision|1|||
126309117|NCT02817516|454420957|FG000|Overall Study|Other|0|||
126309118|NCT02817516|454420958|FG001|Overall Study|Other|0|||
126309119|NCT02817516|454420959|FG002|Overall Study|Other|1|||
126309120|NCT02817516|454420960|FG003|Overall Study|Other|0|||
126309121|NCT00664859|454420961|FG000|Overall Study|Adverse Event|2|||
126309122|NCT00664859|454420962|FG001|Overall Study|Adverse Event|1|||
126309123|NCT00664859|454420963|FG002|Overall Study|Adverse Event|3|||
126309124|NCT00664859|454420961|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
126309125|NCT00664859|454420962|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
126309126|NCT00664859|454420963|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
126309127|NCT00664859|454420961|FG000|Overall Study|Noncompliance with protocol|1|||
126309128|NCT00664859|454420962|FG001|Overall Study|Noncompliance with protocol|0|||
126309129|NCT00664859|454420963|FG002|Overall Study|Noncompliance with protocol|4|||
126309130|NCT00664859|454420961|FG000|Overall Study|Laboratory abnormality|2|||
126309131|NCT00664859|454420962|FG001|Overall Study|Laboratory abnormality|1|||
126309132|NCT00664859|454420963|FG002|Overall Study|Laboratory abnormality|4|||
126309133|NCT00664859|454420961|FG000|Overall Study|Withdrawal by Subject|4|||
126309134|NCT00664859|454420962|FG001|Overall Study|Withdrawal by Subject|1|||
126309135|NCT00664859|454420963|FG002|Overall Study|Withdrawal by Subject|3|||
126309136|NCT00664859|454420961|FG000|Overall Study|Lost to Follow-up|2|||
126309137|NCT00664859|454420962|FG001|Overall Study|Lost to Follow-up|2|||
126309138|NCT00664859|454420963|FG002|Overall Study|Lost to Follow-up|1|||
126309139|NCT00664859|454420961|FG000|Overall Study|Other|0|||
126309140|NCT00664859|454420962|FG001|Overall Study|Other|1|||
126309141|NCT00664859|454420963|FG002|Overall Study|Other|2|||
126309142|NCT01943851|454420964|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309143|NCT01943851|454420965|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309144|NCT01943851|454420966|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309145|NCT01943851|454420967|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
126309146|NCT01943851|454420968|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309147|NCT01943851|454420969|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309148|NCT01943851|454420970|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
126309149|NCT01943851|454420971|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
126309150|NCT01943851|454420972|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
126309151|NCT01943851|454420973|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309152|NCT01943851|454420974|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309153|NCT01943851|454420975|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309154|NCT01943851|454420976|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309155|NCT01943851|454420977|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309156|NCT01943851|454420978|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309157|NCT01943851|454420979|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126372385|NCT02114177|454661352|FG001|Overall Study|Lost to Follow-up|2|||
126372386|NCT02114177|454661351|FG000|Overall Study|Withdrawal by Subject|6|||
126372387|NCT02114177|454661352|FG001|Overall Study|Withdrawal by Subject|1|||
126372388|NCT02114177|454661351|FG000|Overall Study|Other|2|||
126309158|NCT01943851|454420980|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309159|NCT01943851|454420981|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
126309160|NCT01943851|454420964|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126372389|NCT02114177|454661352|FG001|Overall Study|Other|1|||
126372390|NCT01585025|454661353|FG000|Overall Study|Withdrawal by Subject|0|||
126372391|NCT01585025|454661354|FG001|Overall Study|Withdrawal by Subject|3|||
126372392|NCT01585025|454661355|FG002|Overall Study|Withdrawal by Subject|4|||
126372393|NCT00582907|454661356|FG000|1st Course|Withdrawal by Subject|1|||
126372394|NCT00582907|454661357|FG001|1st Course|Withdrawal by Subject|0|||
126372395|NCT00582907|454661358|FG002|1st Course|Withdrawal by Subject|0|||
126372396|NCT00582907|454661359|FG003|1st Course|Withdrawal by Subject|0|||
126372397|NCT00582907|454661356|FG000|1st Course|Lost to Follow-up|0|||
126372398|NCT00582907|454661357|FG001|1st Course|Lost to Follow-up|0|||
126372399|NCT00582907|454661358|FG002|1st Course|Lost to Follow-up|0|||
126372400|NCT00582907|454661359|FG003|1st Course|Lost to Follow-up|1|||
126552528|NCT01536145|455318436|FG009|Overall Study|Progressive disease|3|||
126552529|NCT01536145|455318437|FG010|Overall Study|Progressive disease|3|||
126552530|NCT01536145|455318427|FG000|Overall Study|Withdrawal by Subject|0|||
126552531|NCT01536145|455318428|FG001|Overall Study|Withdrawal by Subject|0|||
126552532|NCT01536145|455318429|FG002|Overall Study|Withdrawal by Subject|1|||
126552533|NCT01536145|455318430|FG003|Overall Study|Withdrawal by Subject|0|||
126552534|NCT01536145|455318431|FG004|Overall Study|Withdrawal by Subject|0|||
126552535|NCT01536145|455318432|FG005|Overall Study|Withdrawal by Subject|1|||
126552536|NCT01536145|455318433|FG006|Overall Study|Withdrawal by Subject|0|||
126552537|NCT01536145|455318434|FG007|Overall Study|Withdrawal by Subject|0|||
126552538|NCT01536145|455318435|FG008|Overall Study|Withdrawal by Subject|2|||
126552539|NCT01536145|455318436|FG009|Overall Study|Withdrawal by Subject|0|||
126552540|NCT01536145|455318437|FG010|Overall Study|Withdrawal by Subject|2|||
126552541|NCT01536145|455318427|FG000|Overall Study|Other|0|||
126552542|NCT01536145|455318428|FG001|Overall Study|Other|0|||
126552543|NCT01536145|455318429|FG002|Overall Study|Other|0|||
126552544|NCT01536145|455318430|FG003|Overall Study|Other|0|||
126552545|NCT01536145|455318431|FG004|Overall Study|Other|1|||
126716425|NCT00064662|455913133|FG001|Overall Study|Lost to Follow-up|44|||
126716426|NCT00064662|455913132|FG000|Overall Study|Withdrawal by Subject|14|||
126716427|NCT00064662|455913133|FG001|Overall Study|Withdrawal by Subject|14|||
126372401|NCT00582907|454661356|FG000|2nd Course|Lack of Efficacy|1|||
126372402|NCT00582907|454661357|FG001|2nd Course|Lack of Efficacy|0|||
126372403|NCT00582907|454661358|FG002|2nd Course|Lack of Efficacy|0|||
126372404|NCT00582907|454661359|FG003|2nd Course|Lack of Efficacy|0|||
126372405|NCT03610048|454661364|FG000|Overall Study|Study terminated by sponsor|84|||
126372406|NCT03610048|454661364|FG000|Overall Study|Adverse Event|32|||
126372407|NCT03610048|454661364|FG000|Overall Study|Withdrawal by Subject|31|||
126372408|NCT03610048|454661364|FG000|Overall Study|Lost to Follow-up|8|||
126372409|NCT03610048|454661364|FG000|Overall Study|Other|4|||
126372410|NCT03610048|454661364|FG000|Overall Study|Physician Decision|1|||
126372411|NCT03610048|454661364|FG000|Overall Study|Pregnancy|1|||
126372412|NCT01146613|454661365|FG000|Overall Study|Lost to Follow-up|3|||
126372413|NCT01146613|454661366|FG001|Overall Study|Lost to Follow-up|8|||
126372414|NCT01146613|454661365|FG000|Overall Study|Lack of Efficacy|0|||
126372415|NCT01146613|454661366|FG001|Overall Study|Lack of Efficacy|1|||
126372416|NCT01146613|454661365|FG000|Overall Study|Death|1|||
126372417|NCT01146613|454661366|FG001|Overall Study|Death|0|||
126372418|NCT01146613|454661365|FG000|Overall Study|Physician Decision|1|||
126372419|NCT01146613|454661366|FG001|Overall Study|Physician Decision|0|||
126372420|NCT01146613|454661365|FG000|Overall Study|Withdrawal by Subject|0|||
126372421|NCT01146613|454661366|FG001|Overall Study|Withdrawal by Subject|3|||
126372422|NCT01146613|454661365|FG000|Overall Study|schedule conflict|1|||
126372423|NCT01146613|454661366|FG001|Overall Study|schedule conflict|0|||
126372424|NCT01146613|454661365|FG000|Overall Study|Outpatient detox|1|||
126372425|NCT01146613|454661366|FG001|Overall Study|Outpatient detox|0|||
126372426|NCT00854360|454661373|FG000|Overall Study|Adverse Event|0|||
126372427|NCT00854360|454661374|FG001|Overall Study|Adverse Event|1|||
126372428|NCT00854360|454661375|FG002|Overall Study|Adverse Event|2|||
126372429|NCT00854360|454661376|FG003|Overall Study|Adverse Event|6|||
126372430|NCT00854360|454661373|FG000|Overall Study|Withdrawal by Subject|0|||
126372431|NCT00854360|454661374|FG001|Overall Study|Withdrawal by Subject|0|||
126372432|NCT00854360|454661375|FG002|Overall Study|Withdrawal by Subject|0|||
126372433|NCT00854360|454661376|FG003|Overall Study|Withdrawal by Subject|1|||
126372434|NCT00854360|454661373|FG000|Overall Study|Pregnancy|0|||
126372435|NCT00854360|454661374|FG001|Overall Study|Pregnancy|1|||
126372436|NCT00854360|454661375|FG002|Overall Study|Pregnancy|0|||
126372437|NCT00854360|454661376|FG003|Overall Study|Pregnancy|0|||
126372438|NCT00854360|454661373|FG000|Overall Study|Lack of Efficacy|2|||
126372439|NCT00854360|454661374|FG001|Overall Study|Lack of Efficacy|1|||
126372440|NCT00854360|454661375|FG002|Overall Study|Lack of Efficacy|0|||
126372441|NCT00854360|454661376|FG003|Overall Study|Lack of Efficacy|0|||
126372442|NCT00854360|454661373|FG000|Overall Study|Other|0|||
126372443|NCT00854360|454661374|FG001|Overall Study|Other|0|||
126372444|NCT00854360|454661375|FG002|Overall Study|Other|0|||
126372445|NCT00854360|454661376|FG003|Overall Study|Other|3|||
126372446|NCT01541371|454661377|FG000|Overall Study|Withdrawal by Subject|14|||
126372447|NCT01541371|454661377|FG000|Overall Study|Lost to Follow-up|21|||
126372448|NCT01541371|454661377|FG000|Overall Study|Adverse Event|15|||
126372449|NCT01541371|454661377|FG000|Overall Study|Lack of Efficacy|12|||
126372450|NCT01541371|454661377|FG000|Overall Study|Protocol Violation|6|||
126372451|NCT01541371|454661377|FG000|Overall Study|Study medication non-compliance|3|||
126372452|NCT01541371|454661377|FG000|Overall Study|Other|6|||
126552546|NCT01536145|455318432|FG005|Overall Study|Other|0|||
126552547|NCT01536145|455318433|FG006|Overall Study|Other|0|||
126552548|NCT01536145|455318434|FG007|Overall Study|Other|0|||
126552549|NCT01536145|455318435|FG008|Overall Study|Other|0|||
126716428|NCT00064662|455913132|FG000|Overall Study|Administratively withdrawn|2|||
126372453|NCT02441218|454661378|FG000|Overall Study|Death|503|||
126372454|NCT02441218|454661379|FG001|Overall Study|Death|553|||
126372455|NCT02441218|454661378|FG000|Overall Study|Withdrawal by Subject|73|||
126372456|NCT02441218|454661379|FG001|Overall Study|Withdrawal by Subject|58|||
126372457|NCT02441218|454661378|FG000|Overall Study|Lost to Follow-up|2|||
126372458|NCT02441218|454661379|FG001|Overall Study|Lost to Follow-up|1|||
126372459|NCT02271880|454661383|FG000|Overall Study|Premature discontinuation of study|3|||
126372460|NCT02271880|454661384|FG001|Overall Study|Premature discontinuation of study|4|||
126372461|NCT00806585|454661385|FG000|Overall Study|Study terminated by Sponsor|0|||
126372462|NCT00806585|454661386|FG001|Overall Study|Study terminated by Sponsor|0|||
126372463|NCT00806585|454661387|FG002|Overall Study|Study terminated by Sponsor|1|||
126372464|NCT00806585|454661388|FG003|Overall Study|Study terminated by Sponsor|2|||
126372465|NCT00806585|454661389|FG004|Overall Study|Study terminated by Sponsor|0|||
126372466|NCT00806585|454661385|FG000|Overall Study|Protocol Violation|3|||
126372467|NCT00806585|454661386|FG001|Overall Study|Protocol Violation|1|||
126372468|NCT00806585|454661387|FG002|Overall Study|Protocol Violation|2|||
126372469|NCT00806585|454661388|FG003|Overall Study|Protocol Violation|0|||
126372470|NCT00806585|454661389|FG004|Overall Study|Protocol Violation|0|||
126372471|NCT00806585|454661385|FG000|Overall Study|Physician Decision|0|||
126372472|NCT00806585|454661386|FG001|Overall Study|Physician Decision|2|||
126372473|NCT00806585|454661387|FG002|Overall Study|Physician Decision|3|||
126372474|NCT00806585|454661388|FG003|Overall Study|Physician Decision|0|||
126372475|NCT00806585|454661389|FG004|Overall Study|Physician Decision|1|||
126372476|NCT00806585|454661385|FG000|Overall Study|Lost to Follow-up|2|||
126372477|NCT00806585|454661386|FG001|Overall Study|Lost to Follow-up|1|||
126372478|NCT00806585|454661387|FG002|Overall Study|Lost to Follow-up|2|||
126372479|NCT00806585|454661388|FG003|Overall Study|Lost to Follow-up|2|||
126372480|NCT00806585|454661389|FG004|Overall Study|Lost to Follow-up|5|||
126372481|NCT00806585|454661385|FG000|Overall Study|Lack of Efficacy|1|||
126372482|NCT00806585|454661386|FG001|Overall Study|Lack of Efficacy|0|||
126372483|NCT00806585|454661387|FG002|Overall Study|Lack of Efficacy|0|||
126372484|NCT00806585|454661388|FG003|Overall Study|Lack of Efficacy|0|||
126372485|NCT00806585|454661389|FG004|Overall Study|Lack of Efficacy|0|||
126372486|NCT00806585|454661385|FG000|Overall Study|Adverse Event|1|||
126372487|NCT00806585|454661386|FG001|Overall Study|Adverse Event|5|||
126372488|NCT00806585|454661387|FG002|Overall Study|Adverse Event|3|||
126372489|NCT00806585|454661388|FG003|Overall Study|Adverse Event|4|||
126372490|NCT00806585|454661389|FG004|Overall Study|Adverse Event|2|||
126372491|NCT00806585|454661385|FG000|Overall Study|Withdrawal by Subject|10|||
126372492|NCT00806585|454661386|FG001|Overall Study|Withdrawal by Subject|8|||
126372493|NCT00806585|454661387|FG002|Overall Study|Withdrawal by Subject|9|||
126372494|NCT00806585|454661388|FG003|Overall Study|Withdrawal by Subject|3|||
126372495|NCT00806585|454661389|FG004|Overall Study|Withdrawal by Subject|11|||
126372496|NCT00806585|454661385|FG000|Overall Study|Completion status unknown|15|||
126372497|NCT00806585|454661386|FG001|Overall Study|Completion status unknown|14|||
126372498|NCT00806585|454661387|FG002|Overall Study|Completion status unknown|12|||
126372499|NCT00806585|454661388|FG003|Overall Study|Completion status unknown|4|||
126372500|NCT00806585|454661389|FG004|Overall Study|Completion status unknown|12|||
126372501|NCT00474903|454661390|FG000|Overall Study|Protocol Violation|1|||
126552550|NCT01536145|455318436|FG009|Overall Study|Other|3|||
126552551|NCT01536145|455318437|FG010|Overall Study|Other|2|||
126552552|NCT01536145|455318427|FG000|Overall Study|Death|0|||
126552553|NCT01536145|455318428|FG001|Overall Study|Death|0|||
126552554|NCT01536145|455318429|FG002|Overall Study|Death|0|||
126372502|NCT00474903|454661391|FG001|Overall Study|Protocol Violation|5|||
126372503|NCT00474903|454661392|FG002|Overall Study|Protocol Violation|2|||
126372504|NCT01936831|454661393|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372505|NCT01936831|454661394|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372506|NCT01936831|454661395|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372507|NCT01936831|454661396|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372508|NCT01936831|454661397|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372509|NCT01936831|454661398|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
126372510|NCT01936831|454661399|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372511|NCT01936831|454661400|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372512|NCT01936831|454661401|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
126372513|NCT03435380|454661407|FG000|Overall Study|Death|1|||
126372514|NCT03435380|454661408|FG001|Overall Study|Death|2|||
126372515|NCT03435380|454661409|FG002|Overall Study|Death|1|||
126372516|NCT03435380|454661407|FG000|Overall Study|Lost to Follow-up|12|||
126372517|NCT03435380|454661408|FG001|Overall Study|Lost to Follow-up|8|||
126372518|NCT03435380|454661409|FG002|Overall Study|Lost to Follow-up|6|||
126372519|NCT03435380|454661407|FG000|Overall Study|Physician Decision|1|||
126372520|NCT03435380|454661408|FG001|Overall Study|Physician Decision|0|||
126552555|NCT01536145|455318430|FG003|Overall Study|Death|0|||
126552556|NCT01536145|455318431|FG004|Overall Study|Death|0|||
126716429|NCT00064662|455913133|FG001|Overall Study|Administratively withdrawn|2|||
126372521|NCT03435380|454661409|FG002|Overall Study|Physician Decision|0|||
126372522|NCT03435380|454661407|FG000|Overall Study|Withdrawal by Subject|0|||
126372523|NCT03435380|454661408|FG001|Overall Study|Withdrawal by Subject|1|||
126372524|NCT03435380|454661409|FG002|Overall Study|Withdrawal by Subject|1|||
126372525|NCT03435380|454661407|FG000|Overall Study|Ineligible|0|||
126552557|NCT01536145|455318432|FG005|Overall Study|Death|0|||
126552558|NCT01536145|455318433|FG006|Overall Study|Death|1|||
126552559|NCT01536145|455318434|FG007|Overall Study|Death|0|||
126552560|NCT01536145|455318435|FG008|Overall Study|Death|0|||
126552561|NCT01536145|455318436|FG009|Overall Study|Death|0|||
126552562|NCT01536145|455318437|FG010|Overall Study|Death|0|||
126552563|NCT01536145|455318427|FG000|Overall Study|Adverse Event|0|||
126552564|NCT01536145|455318428|FG001|Overall Study|Adverse Event|0|||
126552565|NCT01536145|455318429|FG002|Overall Study|Adverse Event|0|||
126552566|NCT01536145|455318430|FG003|Overall Study|Adverse Event|0|||
126552567|NCT01536145|455318431|FG004|Overall Study|Adverse Event|0|||
126552568|NCT01536145|455318432|FG005|Overall Study|Adverse Event|0|||
126552569|NCT01536145|455318433|FG006|Overall Study|Adverse Event|0|||
126552570|NCT01536145|455318434|FG007|Overall Study|Adverse Event|2|||
126552571|NCT01536145|455318435|FG008|Overall Study|Adverse Event|0|||
126552572|NCT01536145|455318436|FG009|Overall Study|Adverse Event|0|||
126552573|NCT01536145|455318437|FG010|Overall Study|Adverse Event|3|||
126552574|NCT01284140|455318442|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
126552575|NCT01284140|455318443|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
126552576|NCT01284140|455318442|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
126552577|NCT01284140|455318443|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
126552578|NCT00579982|455318444|FG000|Overall Study|Adverse Event|4|||
126552579|NCT00579982|455318444|FG000|Overall Study|Protocol Violation|4|||
126552580|NCT00088205|455318445|FG000|Overall Study|Adverse Event|4|||
126552581|NCT00088205|455318445|FG000|Overall Study|Progressive Disease|51|||
126552582|NCT00088205|455318445|FG000|Overall Study|Physician Decision|1|||
126552583|NCT00088205|455318445|FG000|Overall Study|Death Due to Study Disease|4|||
126552584|NCT03192215|455318446|FG000|Overall Study|Death|28|||
126552585|NCT03192215|455318447|FG001|Overall Study|Death|23|||
126552586|NCT03192215|455318446|FG000|Overall Study|Lost to Follow-up|10|||
126552587|NCT03192215|455318447|FG001|Overall Study|Lost to Follow-up|15|||
126552588|NCT03192215|455318446|FG000|Overall Study|Withdrawal by Subject|49|||
126552589|NCT03192215|455318447|FG001|Overall Study|Withdrawal by Subject|48|||
126716430|NCT00504166|455913134|FG000|Overall Study|Adverse Event|1|||
126716431|NCT00504166|455913135|FG001|Overall Study|Adverse Event|4|||
126716432|NCT00504166|455913134|FG000|Overall Study|Withdrawal by Subject|3|||
126552590|NCT03192215|455318446|FG000|Overall Study|Other as reported in analysis|4|||
126552591|NCT03192215|455318447|FG001|Overall Study|Other as reported in analysis|1|||
126552592|NCT05199233|455318450|FG000|Overall Study|Lack of Efficacy|1|||
126552593|NCT02443103|455318454|FG000|Overall Study|Adverse Event|2|||
126552594|NCT02443103|455318454|FG000|Overall Study|Noncompliance|1|||
126552595|NCT01630590|455318455|FG000|Overall Study|Adverse Event|9|||
126552596|NCT01630590|455318455|FG000|Overall Study|Lack of Efficacy|37|||
126552597|NCT01630590|455318455|FG000|Overall Study|Withdrawal by Subject|4|||
126552598|NCT01630590|455318455|FG000|Overall Study|2nd primary tumor|2|||
126552599|NCT01630590|455318455|FG000|Overall Study|Automobile accident|1|||
126716433|NCT00504166|455913135|FG001|Overall Study|Withdrawal by Subject|6|||
126372526|NCT03435380|454661408|FG001|Overall Study|Ineligible|1|||
126372527|NCT03435380|454661409|FG002|Overall Study|Ineligible|1|||
126372528|NCT02115321|454661414|FG000|Overall Study|Death|1|||
126372529|NCT02115321|454661415|FG001|Overall Study|Death|0|||
126372530|NCT02493764|454661416|FG000|Overall Study|Adverse Event|2|||
126372531|NCT02493764|454661417|FG001|Overall Study|Adverse Event|2|||
126372532|NCT02493764|454661416|FG000|Overall Study|Death|44|||
126372533|NCT02493764|454661417|FG001|Overall Study|Death|58|||
126372534|NCT02493764|454661416|FG000|Overall Study|Lost to Follow-up|2|||
126372535|NCT02493764|454661417|FG001|Overall Study|Lost to Follow-up|1|||
126372536|NCT02493764|454661416|FG000|Overall Study|Protocol Violation|6|||
126372537|NCT02493764|454661417|FG001|Overall Study|Protocol Violation|7|||
126372538|NCT02493764|454661416|FG000|Overall Study|Physician Decision|1|||
126372539|NCT02493764|454661417|FG001|Overall Study|Physician Decision|1|||
126372540|NCT02493764|454661416|FG000|Overall Study|Participant moved|17|||
126372541|NCT02493764|454661417|FG001|Overall Study|Participant moved|5|||
126372542|NCT02493764|454661416|FG000|Overall Study|Withdrawal parent/guardian|0|||
126372543|NCT02493764|454661417|FG001|Overall Study|Withdrawal parent/guardian|1|||
126372544|NCT02493764|454661416|FG000|Overall Study|Withdrawal by Subject|11|||
126372545|NCT02493764|454661417|FG001|Overall Study|Withdrawal by Subject|7|||
126372546|NCT01561976|454661421|FG000|Period 1|Adverse Event|0|||
126372547|NCT01561976|454661422|FG001|Period 1|Adverse Event|0|||
126372548|NCT01561976|454661423|FG002|Period 1|Adverse Event|1|||
126372549|NCT01561976|454661424|FG003|Period 1|Adverse Event|0|||
126372550|NCT01561976|454661425|FG004|Period 1|Adverse Event|0|||
126372551|NCT01561976|454661426|FG005|Period 1|Adverse Event|0|||
126372552|NCT01561976|454661421|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
126372553|NCT01561976|454661422|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
126372554|NCT01561976|454661423|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
126372555|NCT01561976|454661424|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
126372556|NCT01561976|454661425|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
126372557|NCT01561976|454661426|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
126716434|NCT00504166|455913134|FG000|Overall Study|Physician Decision|1|||
126716435|NCT00504166|455913135|FG001|Overall Study|Physician Decision|1|||
126716436|NCT00504166|455913134|FG000|Overall Study|Lost to Follow-up|1|||
126716437|NCT00504166|455913135|FG001|Overall Study|Lost to Follow-up|3|||
126716438|NCT02229864|455913136|FG000|Overall Study|Death|2|||
126716439|NCT02229864|455913136|FG000|Overall Study|Lost to Follow-up|1|||
126716440|NCT02650284|455913137|FG000|Overall Study|Lost to Follow-up|3|||
126716441|NCT02650284|455913138|FG001|Overall Study|Lost to Follow-up|3|||
126716442|NCT02650284|455913137|FG000|Overall Study|Consent incorrectly taken|0|||
126716443|NCT02650284|455913138|FG001|Overall Study|Consent incorrectly taken|1|||
126716444|NCT01165203|455913143|FG000|Active Phase|Serious Adverse Event|1|||
126716445|NCT01165203|455913144|FG001|Active Phase|Serious Adverse Event|0|||
126372558|NCT01561976|454661421|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126372559|NCT01561976|454661422|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126372560|NCT01561976|454661423|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126372561|NCT01561976|454661424|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126372562|NCT01561976|454661425|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
126372563|NCT01561976|454661426|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
126372564|NCT01561976|454661421|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
126372565|NCT01561976|454661422|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
126372566|NCT01561976|454661423|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
126372567|NCT01561976|454661424|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
126372568|NCT01561976|454661425|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
126372569|NCT01561976|454661426|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
126372570|NCT03218917|454661427|FG000|Overall Study|Adverse Event|3|||
126372571|NCT03218917|454661428|FG001|Overall Study|Adverse Event|3|||
126372572|NCT03218917|454661429|FG002|Overall Study|Adverse Event|2|||
126372573|NCT03218917|454661427|FG000|Overall Study|Subject withdrew consent|2|||
126372574|NCT03218917|454661428|FG001|Overall Study|Subject withdrew consent|4|||
126372575|NCT03218917|454661429|FG002|Overall Study|Subject withdrew consent|10|||
126372576|NCT03218917|454661427|FG000|Overall Study|Physician Decision|0|||
126372577|NCT03218917|454661428|FG001|Overall Study|Physician Decision|1|||
126372578|NCT03218917|454661429|FG002|Overall Study|Physician Decision|1|||
126372579|NCT03218917|454661427|FG000|Overall Study|Lost to Follow-up|1|||
126372580|NCT03218917|454661428|FG001|Overall Study|Lost to Follow-up|0|||
126372581|NCT03218917|454661429|FG002|Overall Study|Lost to Follow-up|0|||
126372582|NCT03218917|454661427|FG000|Overall Study|Reason Missing|0|||
126372583|NCT03218917|454661428|FG001|Overall Study|Reason Missing|2|||
126372584|NCT03218917|454661429|FG002|Overall Study|Reason Missing|0|||
126372585|NCT03218917|454661427|FG000|Overall Study|Death|0|||
126372586|NCT03218917|454661428|FG001|Overall Study|Death|1|||
126372587|NCT03218917|454661429|FG002|Overall Study|Death|0|||
126372588|NCT03218917|454661427|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126465481|NCT02718300|455005834|FG002|Overall Study|Death|17|||
126465482|NCT02718300|455005832|FG000|Overall Study|Lost to Follow-up|1|||
126465483|NCT02718300|455005833|FG001|Overall Study|Lost to Follow-up|0|||
126465484|NCT02718300|455005834|FG002|Overall Study|Lost to Follow-up|2|||
126465485|NCT02718300|455005832|FG000|Overall Study|Physician Decision|1|||
126465486|NCT02718300|455005833|FG001|Overall Study|Physician Decision|0|||
126465487|NCT02718300|455005834|FG002|Overall Study|Physician Decision|2|||
126465488|NCT02718300|455005832|FG000|Overall Study|Study Terminated by Sponsor|6|||
126465489|NCT02718300|455005833|FG001|Overall Study|Study Terminated by Sponsor|3|||
126465490|NCT02718300|455005834|FG002|Overall Study|Study Terminated by Sponsor|4|||
126465491|NCT02718300|455005832|FG000|Overall Study|Withdrawal by Subject|0|||
126465492|NCT02718300|455005833|FG001|Overall Study|Withdrawal by Subject|4|||
126465493|NCT02718300|455005834|FG002|Overall Study|Withdrawal by Subject|3|||
126465494|NCT02718300|455005832|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
126465495|NCT02718300|455005833|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
126465496|NCT02718300|455005834|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
126465497|NCT03120624|455005835|FG000|Overall Study|Withdrawal by Subject|0|||
126465498|NCT03120624|455005836|FG001|Overall Study|Withdrawal by Subject|1|||
126465499|NCT03120624|455005837|FG002|Overall Study|Withdrawal by Subject|0|||
126716446|NCT01165203|455913143|FG000|Active Phase|Withdrawal by Subject|2|||
126716447|NCT01165203|455913144|FG001|Active Phase|Withdrawal by Subject|1|||
126716448|NCT01165203|455913143|FG000|Active Phase|Migrated/moved from study area|0|||
126372589|NCT03218917|454661428|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126372590|NCT03218917|454661429|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126465500|NCT03120624|455005838|FG003|Overall Study|Withdrawal by Subject|0|||
126465501|NCT03120624|455005839|FG004|Overall Study|Withdrawal by Subject|0|||
126465502|NCT03120624|455005840|FG005|Overall Study|Withdrawal by Subject|0|||
126465503|NCT03120624|455005841|FG006|Overall Study|Withdrawal by Subject|0|||
126465504|NCT03120624|455005842|FG007|Overall Study|Withdrawal by Subject|0|||
126716449|NCT01165203|455913144|FG001|Active Phase|Migrated/moved from study area|1|||
126716450|NCT01165203|455913143|FG000|Active Phase|Lost to Follow-up|2|||
126716451|NCT01165203|455913144|FG001|Active Phase|Lost to Follow-up|0|||
126716452|NCT01165203|455913143|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
126552600|NCT01630590|455318455|FG000|Overall Study|Maximum benefit|4|||
126552601|NCT02366936|455318456|FG000|Overall Study|Withdrawal by Subject|2|||
126552602|NCT02366936|455318456|FG000|Overall Study|Lost to Follow-up|4|||
126552603|NCT02366936|455318456|FG000|Overall Study|Physician Decision|2|||
126309161|NCT01943851|454420965|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309162|NCT01943851|454420966|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309163|NCT01943851|454420967|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309164|NCT01943851|454420968|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
126309165|NCT01943851|454420969|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309166|NCT01943851|454420970|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309167|NCT01943851|454420971|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
126309168|NCT01943851|454420972|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309169|NCT01943851|454420973|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309170|NCT01943851|454420974|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309171|NCT01943851|454420975|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309172|NCT01943851|454420976|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309173|NCT01943851|454420977|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309174|NCT01943851|454420978|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309175|NCT01943851|454420979|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309176|NCT01943851|454420980|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309177|NCT01943851|454420981|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
126309178|NCT01943851|454420964|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309179|NCT01943851|454420965|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309180|NCT01943851|454420966|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309181|NCT01943851|454420967|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309182|NCT01943851|454420968|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309183|NCT01943851|454420969|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309184|NCT01943851|454420970|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309185|NCT01943851|454420971|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309186|NCT01943851|454420972|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309187|NCT01943851|454420973|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126716453|NCT01165203|455913144|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
126716454|NCT01165203|455913143|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
126716455|NCT01165203|455913144|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
126716456|NCT01165203|455913143|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
126716457|NCT01165203|455913144|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
126309188|NCT01943851|454420974|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309189|NCT01943851|454420975|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309190|NCT01943851|454420976|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309191|NCT01943851|454420977|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
126309192|NCT01943851|454420978|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309193|NCT01943851|454420979|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309194|NCT01943851|454420980|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126309195|NCT01943851|454420981|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
126465505|NCT02247531|455007595|FG000|Overall Study|Adverse Event|3|||
126465506|NCT02247531|455007596|FG001|Overall Study|Adverse Event|4|||
126465507|NCT02247531|455007597|FG002|Overall Study|Adverse Event|9|||
126465508|NCT02247531|455007595|FG000|Overall Study|Death|8|||
126465509|NCT02247531|455007596|FG001|Overall Study|Death|9|||
126465510|NCT02247531|455007597|FG002|Overall Study|Death|5|||
126465511|NCT02247531|455007595|FG000|Overall Study|Lost to Follow-up|1|||
126465512|NCT02247531|455007596|FG001|Overall Study|Lost to Follow-up|8|||
126465513|NCT02247531|455007597|FG002|Overall Study|Lost to Follow-up|3|||
126465514|NCT02247531|455007595|FG000|Overall Study|Non-compliance|2|||
126465515|NCT02247531|455007596|FG001|Overall Study|Non-compliance|2|||
126465516|NCT02247531|455007597|FG002|Overall Study|Non-compliance|0|||
126465517|NCT02247531|455007595|FG000|Overall Study|Withdrawal by Subject|26|||
126465518|NCT02247531|455007596|FG001|Overall Study|Withdrawal by Subject|31|||
126465519|NCT02247531|455007597|FG002|Overall Study|Withdrawal by Subject|25|||
126465520|NCT02247531|455007595|FG000|Overall Study|Study Terminated by Sponsor|64|||
126716458|NCT01165203|455913143|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
126309196|NCT01943851|454420964|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126465521|NCT02247531|455007596|FG001|Overall Study|Study Terminated by Sponsor|66|||
126552604|NCT01313923|455318459|FG000|Overall Study|Physician Decision|3|||
126309197|NCT01943851|454420965|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309198|NCT01943851|454420966|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126552605|NCT03358329|455318460|FG000|Overall Study|Lost to Follow-up|2|||
126465522|NCT02247531|455007597|FG002|Overall Study|Study Terminated by Sponsor|62|||
126465523|NCT02247531|455007595|FG000|Overall Study|Physician Decision|0|||
126465524|NCT02247531|455007596|FG001|Overall Study|Physician Decision|2|||
126465525|NCT02247531|455007597|FG002|Overall Study|Physician Decision|2|||
126465526|NCT02247531|455007595|FG000|Overall Study|Unspecified Reason|2|||
126552606|NCT03358329|455318460|FG000|Overall Study|Withdrawal by Subject|2|||
126465527|NCT02247531|455007596|FG001|Overall Study|Unspecified Reason|3|||
126465528|NCT02247531|455007597|FG002|Overall Study|Unspecified Reason|4|||
126465529|NCT03875118|455007598|FG000|Overall Study|Withdrawal by Subject|4|||
126465530|NCT03875118|455007599|FG001|Overall Study|Withdrawal by Subject|4|||
126465531|NCT01298531|455007600|FG000|Overall Study|Lack of Efficacy|0|||
126465532|NCT01298531|455007601|FG001|Overall Study|Lack of Efficacy|1|||
126465533|NCT01298531|455007600|FG000|Overall Study|Lost to Follow-up|2|||
126465534|NCT01298531|455007601|FG001|Overall Study|Lost to Follow-up|0|||
126465535|NCT01298531|455007600|FG000|Overall Study|Protocol Violation|1|||
126465536|NCT01298531|455007601|FG001|Overall Study|Protocol Violation|1|||
126465537|NCT01298531|455007600|FG000|Overall Study|Adverse Event|4|||
126465538|NCT01298531|455007601|FG001|Overall Study|Adverse Event|3|||
126465539|NCT01298531|455007600|FG000|Overall Study|Does not meet entrance criteria|0|||
126465540|NCT01298531|455007601|FG001|Overall Study|Does not meet entrance criteria|1|||
126465541|NCT01298531|455007600|FG000|Overall Study|Other|2|||
126465542|NCT01298531|455007601|FG001|Overall Study|Other|1|||
126716459|NCT01165203|455913144|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
126716460|NCT01165203|455913143|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
126465543|NCT03468985|455007602|FG000|Overall Study|Adverse Event|0|||
126465544|NCT03468985|455007603|FG001|Overall Study|Adverse Event|2|||
126465545|NCT03468985|455007604|FG002|Overall Study|Adverse Event|0|||
126465546|NCT03468985|455007605|FG003|Overall Study|Adverse Event|0|||
126465547|NCT03468985|455007602|FG000|Overall Study|Withdrawal by Subject|0|||
126465548|NCT03468985|455007603|FG001|Overall Study|Withdrawal by Subject|0|||
126465549|NCT03468985|455007604|FG002|Overall Study|Withdrawal by Subject|0|||
126465550|NCT03468985|455007605|FG003|Overall Study|Withdrawal by Subject|1|||
126465551|NCT04629508|455007608|FG000|Overall Study|Adverse Event|1|||
126309199|NCT01943851|454420967|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309200|NCT01943851|454420968|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126465552|NCT04629508|455007608|FG000|Overall Study|Death|2|||
126465553|NCT04629508|455007608|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
126465554|NCT00760214|455007614|FG000|Overall Study|Adverse Event|8|||
126465555|NCT00760214|455007615|FG001|Overall Study|Adverse Event|9|||
126465556|NCT00760214|455007616|FG002|Overall Study|Adverse Event|12|||
126465557|NCT00760214|455007614|FG000|Overall Study|Protocol Violation|3|||
126465558|NCT00760214|455007615|FG001|Overall Study|Protocol Violation|0|||
126465559|NCT00760214|455007616|FG002|Overall Study|Protocol Violation|3|||
126465560|NCT00760214|455007614|FG000|Overall Study|Lost to Follow-up|0|||
126309201|NCT01943851|454420969|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309202|NCT01943851|454420970|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309203|NCT01943851|454420971|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309204|NCT01943851|454420972|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309205|NCT01943851|454420973|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309206|NCT01943851|454420974|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309207|NCT01943851|454420975|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309208|NCT01943851|454420976|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309209|NCT01943851|454420977|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309210|NCT01943851|454420978|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309211|NCT01943851|454420979|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
126309212|NCT01943851|454420980|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309213|NCT01943851|454420981|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
126309214|NCT01943851|454420964|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309215|NCT01943851|454420965|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309216|NCT01943851|454420966|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309217|NCT01943851|454420967|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309218|NCT01943851|454420968|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309219|NCT01943851|454420969|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309220|NCT01943851|454420970|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309221|NCT01943851|454420971|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309222|NCT01943851|454420972|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309223|NCT01943851|454420973|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126465561|NCT00760214|455007615|FG001|Overall Study|Lost to Follow-up|0|||
126465562|NCT00760214|455007616|FG002|Overall Study|Lost to Follow-up|1|||
126465563|NCT00760214|455007614|FG000|Overall Study|Withdrawal by Subject|12|||
126309224|NCT01943851|454420974|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126465564|NCT00760214|455007615|FG001|Overall Study|Withdrawal by Subject|14|||
126465565|NCT00760214|455007616|FG002|Overall Study|Withdrawal by Subject|13|||
126465566|NCT00760214|455007614|FG000|Overall Study|Lack of Efficacy|3|||
126465567|NCT00760214|455007615|FG001|Overall Study|Lack of Efficacy|2|||
126465568|NCT00760214|455007616|FG002|Overall Study|Lack of Efficacy|4|||
126465569|NCT00760214|455007614|FG000|Overall Study|Pregnancy|0|||
126465570|NCT00760214|455007615|FG001|Overall Study|Pregnancy|0|||
126465571|NCT00760214|455007616|FG002|Overall Study|Pregnancy|1|||
126465572|NCT00760214|455007614|FG000|Overall Study|Physician Decision|1|||
126465573|NCT00760214|455007615|FG001|Overall Study|Physician Decision|1|||
126372591|NCT01307449|454661430|FG000|Overall Study|Adverse Event|1|||
126372592|NCT01307449|454661431|FG001|Overall Study|Adverse Event|0|||
126372593|NCT01307449|454661432|FG002|Overall Study|Adverse Event|0|||
126372594|NCT01307449|454661433|FG003|Overall Study|Adverse Event|0|||
126372595|NCT01463527|454661436|FG000|Overall Study|Protocol Violation|1|||
126372596|NCT01463527|454661437|FG001|Overall Study|Protocol Violation|1|||
126372597|NCT01463527|454661436|FG000|Overall Study|Crying >20% of sedation|5|||
126372598|NCT01463527|454661437|FG001|Overall Study|Crying >20% of sedation|6|||
126372599|NCT05136170|454661438|FG000|Overall Study|Withdrawal by Subject|2|||
126372600|NCT05136170|454661439|FG001|Overall Study|Withdrawal by Subject|2|||
126372601|NCT05136170|454661438|FG000|Overall Study|Can no longer make office visits|1|||
126372602|NCT05136170|454661439|FG001|Overall Study|Can no longer make office visits|0|||
126372603|NCT01788943|454661440|FG000|Overall Study|Withdrawal by Subject|1|||
126372604|NCT01788943|454661441|FG001|Overall Study|Withdrawal by Subject|0|||
126372605|NCT01119287|454661442|FG000|Overall Study|Patient Decision, not related to AE|0|||
126372606|NCT01119287|454661443|FG001|Overall Study|Patient Decision, not related to AE|0|||
126372607|NCT01119287|454661444|FG002|Overall Study|Patient Decision, not related to AE|2|||
126372608|NCT01119287|454661445|FG003|Overall Study|Patient Decision, not related to AE|2|||
126372609|NCT01119287|454661446|FG004|Overall Study|Patient Decision, not related to AE|1|||
126372610|NCT01119287|454661447|FG005|Overall Study|Patient Decision, not related to AE|0|||
126372611|NCT04403919|454661452|FG000|Overall Study|Lost to Follow-up|0|||
126716461|NCT01165203|455913144|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
126716462|NCT01780389|455913146|FG000|Overall Study|Adverse Event|1|||
126716463|NCT02566525|455913149|FG000|Overall Study|Protocol Violation|3|||
126716464|NCT02566525|455913150|FG001|Overall Study|Protocol Violation|5|||
126716465|NCT00337467|455913151|FG000|Overall Study|Adverse Event|3|||
126716466|NCT00337467|455913151|FG000|Overall Study|Subject Withdrew Consent|2|||
126372612|NCT04403919|454661453|FG001|Overall Study|Lost to Follow-up|0|||
126372613|NCT04403919|454661454|FG002|Overall Study|Lost to Follow-up|0|||
126372614|NCT04403919|454661455|FG003|Overall Study|Lost to Follow-up|1|||
126372615|NCT01612676|454661456|FG000|Overall Study|Adverse Event|2|||
126372616|NCT01612676|454661457|FG001|Overall Study|Adverse Event|3|||
126372617|NCT01612676|454661458|FG002|Overall Study|Adverse Event|1|||
126372618|NCT01612676|454661459|FG003|Overall Study|Adverse Event|3|||
126372619|NCT01612676|454661456|FG000|Overall Study|Protocol Violation|0|||
126372620|NCT01612676|454661457|FG001|Overall Study|Protocol Violation|1|||
126372621|NCT01612676|454661458|FG002|Overall Study|Protocol Violation|0|||
126372622|NCT01612676|454661459|FG003|Overall Study|Protocol Violation|0|||
126372623|NCT01156844|454661462|FG000|Overall Study|Adverse Event|0|||
126372624|NCT01156844|454661463|FG001|Overall Study|Adverse Event|0|||
126372625|NCT01156844|454661464|FG002|Overall Study|Adverse Event|1|||
126372626|NCT01156844|454661465|FG003|Overall Study|Adverse Event|1|||
126372627|NCT01156844|454661462|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126372628|NCT01156844|454661463|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126372629|NCT01156844|454661464|FG002|Overall Study|Abnormal test procedure result(s)|2|||
126372630|NCT01156844|454661465|FG003|Overall Study|Abnormal test procedure result(s)|2|||
126372631|NCT01156844|454661462|FG000|Overall Study|Withdrawal by Subject|0|||
126372632|NCT01156844|454661463|FG001|Overall Study|Withdrawal by Subject|0|||
126372633|NCT01156844|454661464|FG002|Overall Study|Withdrawal by Subject|2|||
126372634|NCT01156844|454661465|FG003|Overall Study|Withdrawal by Subject|2|||
126372635|NCT01156844|454661462|FG000|Overall Study|Lost to Follow-up|0|||
126372636|NCT01156844|454661463|FG001|Overall Study|Lost to Follow-up|0|||
126372637|NCT01156844|454661464|FG002|Overall Study|Lost to Follow-up|1|||
126372638|NCT01156844|454661465|FG003|Overall Study|Lost to Follow-up|0|||
126372639|NCT01156844|454661462|FG000|Overall Study|Administrative problems|0|||
126372640|NCT01156844|454661463|FG001|Overall Study|Administrative problems|1|||
126372641|NCT01156844|454661464|FG002|Overall Study|Administrative problems|0|||
126372642|NCT01156844|454661465|FG003|Overall Study|Administrative problems|1|||
126372643|NCT01156844|454661462|FG000|Overall Study|Protocol deviation|2|||
126372644|NCT01156844|454661463|FG001|Overall Study|Protocol deviation|0|||
126372645|NCT01156844|454661464|FG002|Overall Study|Protocol deviation|0|||
126372646|NCT01156844|454661465|FG003|Overall Study|Protocol deviation|0|||
126372647|NCT00107276|454661469|FG000|Overall Study|Progression|46|||
126372648|NCT00107276|454661469|FG000|Overall Study|Adverse Event|6|||
126372649|NCT00107276|454661469|FG000|Overall Study|M.D. decision|2|||
126372650|NCT00107276|454661469|FG000|Overall Study|Patient refusal|1|||
126372651|NCT00107276|454661469|FG000|Overall Study|Death|1|||
126372652|NCT00107276|454661469|FG000|Overall Study|Ineligible|16|||
126372653|NCT04846231|454661470|FG000|Overall Study|Lost to Follow-up|1|||
126372654|NCT04846231|454661471|FG001|Overall Study|Lost to Follow-up|0|||
126372655|NCT04846231|454661472|FG002|Overall Study|Lost to Follow-up|0|||
126372656|NCT04846231|454661473|FG003|Overall Study|Lost to Follow-up|0|||
126716467|NCT00337467|455913151|FG000|Overall Study|Pregnancy|1|||
126716468|NCT00337467|455913151|FG000|Overall Study|Lost to Follow-up|2|||
126372657|NCT04846231|454661474|FG004|Overall Study|Lost to Follow-up|0|||
126372658|NCT04846231|454661475|FG005|Overall Study|Lost to Follow-up|0|||
126372659|NCT04846231|454661476|FG006|Overall Study|Lost to Follow-up|0|||
126372660|NCT04846231|454661477|FG007|Overall Study|Lost to Follow-up|1|||
126716469|NCT00337467|455913151|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
126716470|NCT04083222|455913152|FG000|Overall Study|Voluntary Withdrawal|0|||
126716471|NCT04083222|455913153|FG001|Overall Study|Voluntary Withdrawal|1|||
126716472|NCT04083222|455913152|FG000|Overall Study|Reason not Specified|0|||
126309225|NCT01943851|454420975|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309226|NCT01943851|454420976|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309227|NCT01943851|454420977|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309228|NCT01943851|454420978|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
126309229|NCT01943851|454420979|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
126309230|NCT01943851|454420980|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
126309231|NCT01943851|454420981|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
126309232|NCT00900757|454420982|FG000|Overall Study|screen failure|19|||
126309233|NCT00748189|454420983|FG000|Overall Study|Death|99|||
126309234|NCT00748189|454420984|FG001|Overall Study|Death|84|||
126309235|NCT00748189|454420983|FG000|Overall Study|Withdrawal by Subject|23|||
126309236|NCT00748189|454420984|FG001|Overall Study|Withdrawal by Subject|29|||
126309237|NCT00748189|454420983|FG000|Overall Study|Physician Decision|16|||
126309238|NCT00748189|454420984|FG001|Overall Study|Physician Decision|5|||
126309239|NCT00748189|454420983|FG000|Overall Study|Lost to Follow-up|8|||
126309240|NCT00748189|454420984|FG001|Overall Study|Lost to Follow-up|15|||
126309241|NCT00748189|454420983|FG000|Overall Study|Study terminated by Sponsor|70|||
126309242|NCT00748189|454420984|FG001|Overall Study|Study terminated by Sponsor|79|||
126309243|NCT03320850|454420985|FG000|Overall Study|Lost to Follow-up|0|||
126309244|NCT03320850|454420986|FG001|Overall Study|Lost to Follow-up|0|||
126309245|NCT03320850|454420987|FG002|Overall Study|Lost to Follow-up|0|||
126309246|NCT03320850|454420988|FG003|Overall Study|Lost to Follow-up|0|||
126309247|NCT03320850|454420989|FG004|Overall Study|Lost to Follow-up|1|||
126309248|NCT03320850|454420990|FG005|Overall Study|Lost to Follow-up|2|||
126309249|NCT03320850|454420991|FG006|Overall Study|Lost to Follow-up|2|||
126309250|NCT03320850|454420992|FG007|Overall Study|Lost to Follow-up|0|||
126309251|NCT03320850|454420993|FG008|Overall Study|Lost to Follow-up|6|||
126309252|NCT03320850|454420994|FG009|Overall Study|Lost to Follow-up|4|||
126309253|NCT03320850|454420985|FG000|Overall Study|Withdrawal by Subject|0|||
126309254|NCT03320850|454420986|FG001|Overall Study|Withdrawal by Subject|0|||
126309255|NCT03320850|454420987|FG002|Overall Study|Withdrawal by Subject|0|||
126309256|NCT03320850|454420988|FG003|Overall Study|Withdrawal by Subject|0|||
126309257|NCT03320850|454420989|FG004|Overall Study|Withdrawal by Subject|1|||
126309258|NCT03320850|454420990|FG005|Overall Study|Withdrawal by Subject|2|||
126309259|NCT03320850|454420991|FG006|Overall Study|Withdrawal by Subject|4|||
126309260|NCT03320850|454420992|FG007|Overall Study|Withdrawal by Subject|5|||
126309261|NCT03320850|454420993|FG008|Overall Study|Withdrawal by Subject|2|||
126372661|NCT04846231|454661470|FG000|Overall Study|Withdrawal by Subject|0|||
126372662|NCT04846231|454661471|FG001|Overall Study|Withdrawal by Subject|1|||
126372663|NCT04846231|454661472|FG002|Overall Study|Withdrawal by Subject|2|||
126372664|NCT04846231|454661473|FG003|Overall Study|Withdrawal by Subject|1|||
126372665|NCT04846231|454661474|FG004|Overall Study|Withdrawal by Subject|0|||
126372666|NCT04846231|454661475|FG005|Overall Study|Withdrawal by Subject|0|||
126372667|NCT04846231|454661476|FG006|Overall Study|Withdrawal by Subject|0|||
126372668|NCT04846231|454661477|FG007|Overall Study|Withdrawal by Subject|0|||
126372669|NCT04846231|454661470|FG000|Overall Study|Protocol Violation|0|||
126465574|NCT00760214|455007616|FG002|Overall Study|Physician Decision|1|||
126465575|NCT00760214|455007614|FG000|Overall Study|Other|3|||
126465576|NCT00760214|455007615|FG001|Overall Study|Other|4|||
126465577|NCT00760214|455007616|FG002|Overall Study|Other|6|||
126372670|NCT04846231|454661471|FG001|Overall Study|Protocol Violation|1|||
126372671|NCT04846231|454661472|FG002|Overall Study|Protocol Violation|0|||
126372672|NCT04846231|454661473|FG003|Overall Study|Protocol Violation|0|||
126372673|NCT04846231|454661474|FG004|Overall Study|Protocol Violation|0|||
126372674|NCT04846231|454661475|FG005|Overall Study|Protocol Violation|0|||
126372675|NCT04846231|454661476|FG006|Overall Study|Protocol Violation|0|||
126372676|NCT04846231|454661477|FG007|Overall Study|Protocol Violation|0|||
126372677|NCT04846231|454661470|FG000|Overall Study|Adverse Event|0|||
126372678|NCT04846231|454661471|FG001|Overall Study|Adverse Event|0|||
126372679|NCT04846231|454661472|FG002|Overall Study|Adverse Event|0|||
126372680|NCT04846231|454661473|FG003|Overall Study|Adverse Event|0|||
126372681|NCT04846231|454661474|FG004|Overall Study|Adverse Event|0|||
126372682|NCT04846231|454661475|FG005|Overall Study|Adverse Event|0|||
126372683|NCT04846231|454661476|FG006|Overall Study|Adverse Event|1|||
126372684|NCT04846231|454661477|FG007|Overall Study|Adverse Event|1|||
126372685|NCT02980107|454661478|FG000|Overall Study|Withdrawal by Subject|51|||
126309262|NCT03320850|454420994|FG009|Overall Study|Withdrawal by Subject|1|||
126309263|NCT03320850|454420985|FG000|Overall Study|Lack of Efficacy|0|||
126309264|NCT03320850|454420986|FG001|Overall Study|Lack of Efficacy|0|||
126309265|NCT03320850|454420987|FG002|Overall Study|Lack of Efficacy|0|||
126309266|NCT03320850|454420988|FG003|Overall Study|Lack of Efficacy|1|||
126309267|NCT03320850|454420989|FG004|Overall Study|Lack of Efficacy|0|||
126465578|NCT02545075|455007620|FG000|Randomization|Lost to Follow-up|0|||
126465579|NCT02545075|455007621|FG001|Randomization|Lost to Follow-up|1|||
126770983|NCT01399125|456116223|FG000|Overall Study|Withdrawal by Subject|5|||
126770984|NCT01399125|456116224|FG001|Overall Study|Withdrawal by Subject|8|||
126770985|NCT01399125|456116223|FG000|Overall Study|Lost to Follow-up|2|||
126770986|NCT01399125|456116224|FG001|Overall Study|Lost to Follow-up|3|||
126309268|NCT03320850|454420990|FG005|Overall Study|Lack of Efficacy|1|||
126309269|NCT03320850|454420991|FG006|Overall Study|Lack of Efficacy|0|||
126309270|NCT03320850|454420992|FG007|Overall Study|Lack of Efficacy|2|||
126309271|NCT03320850|454420993|FG008|Overall Study|Lack of Efficacy|0|||
126309272|NCT03320850|454420994|FG009|Overall Study|Lack of Efficacy|3|||
126309273|NCT03320850|454420985|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
126309274|NCT03320850|454420986|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
126309275|NCT03320850|454420987|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
126309276|NCT03320850|454420988|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
126309277|NCT03320850|454420989|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
126309278|NCT03320850|454420990|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
126309279|NCT03320850|454420991|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
126309280|NCT03320850|454420992|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
126309281|NCT03320850|454420993|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
126309282|NCT03320850|454420994|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
126309283|NCT03320850|454420985|FG000|Overall Study|Adverse Event|0|||
126309284|NCT03320850|454420986|FG001|Overall Study|Adverse Event|0|||
126309285|NCT03320850|454420987|FG002|Overall Study|Adverse Event|0|||
126309286|NCT03320850|454420988|FG003|Overall Study|Adverse Event|0|||
126309287|NCT03320850|454420989|FG004|Overall Study|Adverse Event|0|||
126309288|NCT03320850|454420990|FG005|Overall Study|Adverse Event|2|||
126309289|NCT03320850|454420991|FG006|Overall Study|Adverse Event|1|||
126309290|NCT03320850|454420992|FG007|Overall Study|Adverse Event|0|||
126309291|NCT03320850|454420993|FG008|Overall Study|Adverse Event|2|||
126309292|NCT03320850|454420994|FG009|Overall Study|Adverse Event|0|||
126309293|NCT03320850|454420985|FG000|Overall Study|Reason Not Specified|0|||
126309294|NCT03320850|454420986|FG001|Overall Study|Reason Not Specified|0|||
126309295|NCT03320850|454420987|FG002|Overall Study|Reason Not Specified|0|||
126309296|NCT03320850|454420988|FG003|Overall Study|Reason Not Specified|0|||
126309297|NCT03320850|454420989|FG004|Overall Study|Reason Not Specified|0|||
126309298|NCT03320850|454420990|FG005|Overall Study|Reason Not Specified|1|||
126309299|NCT03320850|454420991|FG006|Overall Study|Reason Not Specified|0|||
126309300|NCT03320850|454420992|FG007|Overall Study|Reason Not Specified|0|||
126309301|NCT03320850|454420993|FG008|Overall Study|Reason Not Specified|0|||
126309302|NCT03320850|454420994|FG009|Overall Study|Reason Not Specified|1|||
126309303|NCT00546117|454420995|FG000|Overall Study|Withdrawal by Subject|3|||
126309304|NCT00546117|454420996|FG001|Overall Study|Withdrawal by Subject|0|||
126372686|NCT02980107|454661479|FG001|Overall Study|Withdrawal by Subject|62|||
126372687|NCT01448616|454661481|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
126372688|NCT01448616|454661482|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
126372689|NCT01448616|454661483|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
126372690|NCT01448616|454661484|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
126372691|NCT01448616|454661481|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
126372692|NCT01448616|454661482|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
126372693|NCT01448616|454661483|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
126372694|NCT01448616|454661484|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
126372695|NCT01448616|454661481|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
126372696|NCT01448616|454661482|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
126372697|NCT01448616|454661483|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
126372698|NCT01448616|454661484|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
126372699|NCT01448616|454661481|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
126372700|NCT01448616|454661482|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
126372701|NCT01448616|454661483|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
126372702|NCT01448616|454661484|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
126372703|NCT01448616|454661481|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
126372704|NCT01448616|454661482|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
126372705|NCT01448616|454661483|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
126372706|NCT01448616|454661484|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
126372707|NCT00397540|454661487|FG000|Overall Study|short follow-up duration < 12 months|1|||
126770987|NCT01399125|456116223|FG000|Overall Study|Administrative Problems|7|||
126309305|NCT00546117|454420995|FG000|Overall Study|Inability to schedule follow-up visit|1|||
126309306|NCT00546117|454420996|FG001|Overall Study|Inability to schedule follow-up visit|0|||
126309307|NCT01424514|454420997|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
126309308|NCT01424514|454420998|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
126309309|NCT01424514|454420997|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
126309310|NCT01424514|454420998|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
126552607|NCT02471404|455318461|FG000|Overall Study|Adverse Event|7|||
126552608|NCT02471404|455318462|FG001|Overall Study|Adverse Event|1|||
126552609|NCT02471404|455318463|FG002|Overall Study|Adverse Event|2|||
126552610|NCT02471404|455318461|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
126552611|NCT02471404|455318462|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
126552612|NCT02471404|455318463|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
126552613|NCT02471404|455318461|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
126552614|NCT02471404|455318462|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
126552615|NCT02471404|455318463|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
126552616|NCT02471404|455318461|FG000|Overall Study|Lost to Follow-up|1|||
126552617|NCT02471404|455318462|FG001|Overall Study|Lost to Follow-up|1|||
126552618|NCT02471404|455318463|FG002|Overall Study|Lost to Follow-up|3|||
126552619|NCT02471404|455318461|FG000|Overall Study|Protocol Violation|1|||
126552620|NCT02471404|455318462|FG001|Overall Study|Protocol Violation|0|||
126552621|NCT02471404|455318463|FG002|Overall Study|Protocol Violation|0|||
126552622|NCT02471404|455318461|FG000|Overall Study|Withdrawal by Subject|8|||
126552623|NCT02471404|455318462|FG001|Overall Study|Withdrawal by Subject|4|||
126552624|NCT02471404|455318463|FG002|Overall Study|Withdrawal by Subject|5|||
126552625|NCT02471404|455318461|FG000|Overall Study|Other reasons not specified|10|||
126552626|NCT02471404|455318462|FG001|Overall Study|Other reasons not specified|7|||
126552627|NCT02471404|455318463|FG002|Overall Study|Other reasons not specified|12|||
126552628|NCT02982720|455318464|FG000|Overall Study|Adverse Event|3|||
126552629|NCT02982720|455318464|FG000|Overall Study|Death|1|||
126552630|NCT00065468|455318469|FG000|Overall Study|Death|172|||
126552631|NCT00065468|455318470|FG001|Overall Study|Death|169|||
126552632|NCT00065468|455318471|FG002|Overall Study|Death|171|||
126552633|NCT00065468|455318469|FG000|Overall Study|Withdrawal by Subject|3|||
126552634|NCT00065468|455318470|FG001|Overall Study|Withdrawal by Subject|4|||
126552635|NCT00065468|455318471|FG002|Overall Study|Withdrawal by Subject|5|||
126552636|NCT00065468|455318469|FG000|Overall Study|Lost to Follow-up|5|||
126552637|NCT00065468|455318470|FG001|Overall Study|Lost to Follow-up|3|||
126372708|NCT00397540|454661488|FG001|Overall Study|short follow-up duration < 12 months|0|||
126372709|NCT00485173|454661492|FG000|Overall Study|Death|4|||
126372710|NCT00485173|454661493|FG001|Overall Study|Death|3|||
126372711|NCT00485173|454661492|FG000|Overall Study|Lost to Follow-up|32|||
126372712|NCT00485173|454661493|FG001|Overall Study|Lost to Follow-up|61|||
126372713|NCT00746811|454661494|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
126372714|NCT00746811|454661495|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
126372715|NCT00545779|454661499|FG000|Overall Study|Violation of selection criteria at entry|8|||
126372716|NCT00545779|454661499|FG000|Overall Study|Other protocol violation|1|||
126372717|NCT00545779|454661499|FG000|Overall Study|Did not cooperate|7|||
126372718|NCT00545779|454661499|FG000|Overall Study|Withdrawal by Subject|20|||
126372719|NCT00545779|454661499|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
126372720|NCT00545779|454661499|FG000|Overall Study|Failure to return|3|||
126372721|NCT00829998|454661502|FG000|Washout|Adverse Event|0|||
126372722|NCT00829998|454661503|FG001|Washout|Adverse Event|1|||
126465580|NCT02545075|455007620|FG000|Randomization|Withdrawal by Subject|0|||
126465581|NCT02545075|455007621|FG001|Randomization|Withdrawal by Subject|6|||
126465582|NCT02545075|455007620|FG000|Treatment|Disease progression|71|||
126465583|NCT02545075|455007621|FG001|Treatment|Disease progression|32|||
126465584|NCT02545075|455007620|FG000|Treatment|Participant dicontinued study treatment|7|||
126465585|NCT02545075|455007621|FG001|Treatment|Participant dicontinued study treatment|9|||
126465586|NCT02545075|455007620|FG000|Treatment|Withdrawal by Subject|1|||
126465587|NCT02545075|455007621|FG001|Treatment|Withdrawal by Subject|0|||
126465588|NCT02545075|455007620|FG000|Treatment|Adverse event not related to study drug|1|||
126465589|NCT02545075|455007621|FG001|Treatment|Adverse event not related to study drug|0|||
126465590|NCT02545075|455007620|FG000|Treatment|Death|1|||
126465591|NCT02545075|455007621|FG001|Treatment|Death|0|||
126465592|NCT02545075|455007620|FG000|Treatment|Participant drug toxicity|1|||
126465593|NCT02545075|455007621|FG001|Treatment|Participant drug toxicity|0|||
126552638|NCT00065468|455318471|FG002|Overall Study|Lost to Follow-up|2|||
126552639|NCT00065468|455318469|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
126552640|NCT00065468|455318470|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
126552641|NCT00065468|455318471|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
126552642|NCT00065468|455318469|FG000|Overall Study|Disease progression|0|||
126552643|NCT00065468|455318470|FG001|Overall Study|Disease progression|0|||
126372723|NCT04712669|454661506|FG000|Double Blind Phase|Adverse Event|4|||
126552644|NCT00065468|455318471|FG002|Overall Study|Disease progression|1|||
126552645|NCT00065468|455318469|FG000|Overall Study|Other|14|||
126552646|NCT00065468|455318470|FG001|Overall Study|Other|24|||
126716473|NCT04083222|455913153|FG001|Overall Study|Reason not Specified|1|||
126716474|NCT03103750|455913154|FG000|Overall Study|Adverse Event|1|||
126716475|NCT03103750|455913155|FG001|Overall Study|Adverse Event|0|||
126465594|NCT02545075|455007620|FG000|Treatment|Completed treatment|40|||
126716476|NCT03103750|455913154|FG000|Overall Study|Lost to Follow-up|1|||
126716477|NCT03103750|455913155|FG001|Overall Study|Lost to Follow-up|0|||
126465595|NCT02545075|455007621|FG001|Treatment|Completed treatment|12|||
126552647|NCT00065468|455318471|FG002|Overall Study|Other|18|||
126465596|NCT00736879|455007622|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
126465597|NCT00736879|455007623|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
126716478|NCT03103750|455913154|FG000|Overall Study|PET Equipment Related|2|||
126716479|NCT03103750|455913155|FG001|Overall Study|PET Equipment Related|2|||
126465598|NCT00736879|455007624|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
126465599|NCT00736879|455007625|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
126465600|NCT00736879|455007622|FG000|Double Blind Treatment Period|Adverse Event|0|||
126465601|NCT00736879|455007623|FG001|Double Blind Treatment Period|Adverse Event|1|||
126465602|NCT00736879|455007624|FG002|Double Blind Treatment Period|Adverse Event|1|||
126465603|NCT00736879|455007625|FG003|Double Blind Treatment Period|Adverse Event|0|||
126716480|NCT02429427|455913163|FG000|Overall Study|Adverse Event|220|||
126716481|NCT02429427|455913164|FG001|Overall Study|Adverse Event|92|||
126716482|NCT02429427|455913163|FG000|Overall Study|Protocol Violation|10|||
126716483|NCT02429427|455913164|FG001|Overall Study|Protocol Violation|6|||
126309311|NCT02653170|454421001|FG000|Overall Study|Withdrawal by Subject|3|||
126309312|NCT02653170|454421002|FG001|Overall Study|Withdrawal by Subject|8|||
126309313|NCT02653170|454421003|FG002|Overall Study|Withdrawal by Subject|3|||
126309314|NCT02653170|454421001|FG000|Overall Study|withdrawn by study team|2|||
126309315|NCT02653170|454421002|FG001|Overall Study|withdrawn by study team|4|||
126309316|NCT02653170|454421003|FG002|Overall Study|withdrawn by study team|5|||
126309317|NCT02653170|454421001|FG000|Overall Study|Lost to Follow-up|12|||
126309318|NCT02653170|454421002|FG001|Overall Study|Lost to Follow-up|4|||
126309319|NCT02653170|454421003|FG002|Overall Study|Lost to Follow-up|10|||
126309320|NCT01609543|454421019|FG000|Overall Study|Disease Progression|28|||
126309321|NCT01609543|454421019|FG000|Overall Study|Adverse Event|5|||
126309322|NCT01609543|454421019|FG000|Overall Study|Withdrawal by Subject|1|||
126309323|NCT01609543|454421019|FG000|Overall Study|Protocol Violation|1|||
126309324|NCT01609543|454421019|FG000|Overall Study|Death|7|||
126309325|NCT00507819|454421020|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
126309326|NCT00507819|454421021|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
126309327|NCT03452488|454421022|FG000|Overall Study|Adverse Event|4|||
126309328|NCT03452488|454421023|FG001|Overall Study|Adverse Event|6|||
126309329|NCT03452488|454421024|FG002|Overall Study|Adverse Event|1|||
126309330|NCT03452488|454421022|FG000|Overall Study|Death|0|||
126309331|NCT03452488|454421023|FG001|Overall Study|Death|0|||
126309332|NCT03452488|454421024|FG002|Overall Study|Death|1|||
126309333|NCT03452488|454421022|FG000|Overall Study|Lost to Follow-up|1|||
126309334|NCT03452488|454421023|FG001|Overall Study|Lost to Follow-up|2|||
126309335|NCT03452488|454421024|FG002|Overall Study|Lost to Follow-up|0|||
126309336|NCT03452488|454421022|FG000|Overall Study|PI Decision|1|||
126309337|NCT03452488|454421023|FG001|Overall Study|PI Decision|0|||
126309338|NCT03452488|454421024|FG002|Overall Study|PI Decision|0|||
126309339|NCT03452488|454421022|FG000|Overall Study|Withdrew consent|4|||
126309340|NCT03452488|454421023|FG001|Overall Study|Withdrew consent|2|||
126309341|NCT03452488|454421024|FG002|Overall Study|Withdrew consent|2|||
126309342|NCT03452488|454421022|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
126309343|NCT03452488|454421023|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
126309344|NCT03452488|454421024|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
126309345|NCT03452488|454421022|FG000|Overall Study|Other|0|||
126309346|NCT03452488|454421023|FG001|Overall Study|Other|2|||
126309347|NCT03452488|454421024|FG002|Overall Study|Other|2|||
126309348|NCT03614078|454421027|FG000|Overall Study|Withdrawal by Subject|2|||
126309349|NCT03614078|454421028|FG001|Overall Study|Withdrawal by Subject|2|||
126309350|NCT03614078|454421029|FG002|Overall Study|Withdrawal by Subject|3|||
126309351|NCT03614078|454421027|FG000|Overall Study|Participant Did Not Return for Visit|0|||
126309352|NCT03614078|454421028|FG001|Overall Study|Participant Did Not Return for Visit|1|||
126309353|NCT03614078|454421029|FG002|Overall Study|Participant Did Not Return for Visit|0|||
126309354|NCT03614078|454421027|FG000|Overall Study|High Neutrophils|0|||
126309355|NCT03614078|454421028|FG001|Overall Study|High Neutrophils|0|||
126309356|NCT03614078|454421029|FG002|Overall Study|High Neutrophils|2|||
126309357|NCT03614078|454421027|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
126309358|NCT03614078|454421028|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
126309359|NCT03614078|454421029|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
126309360|NCT03614078|454421027|FG000|Overall Study|Exacerbation of Psoriasis|0|||
126309361|NCT03614078|454421028|FG001|Overall Study|Exacerbation of Psoriasis|1|||
126716484|NCT02429427|455913163|FG000|Overall Study|Lost to Follow-up|15|||
126465604|NCT00736879|455007622|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
126716485|NCT02429427|455913164|FG001|Overall Study|Lost to Follow-up|6|||
126716486|NCT02429427|455913163|FG000|Overall Study|Withdrawal by Subject|64|||
126309362|NCT03614078|454421029|FG002|Overall Study|Exacerbation of Psoriasis|0|||
126309363|NCT03614078|454421027|FG000|Overall Study|Adverse Event|0|||
126309364|NCT03614078|454421028|FG001|Overall Study|Adverse Event|2|||
126309365|NCT03614078|454421029|FG002|Overall Study|Adverse Event|0|||
126309366|NCT03614078|454421027|FG000|Overall Study|Dizziness and Rash|0|||
126309367|NCT03614078|454421028|FG001|Overall Study|Dizziness and Rash|1|||
126309368|NCT03614078|454421029|FG002|Overall Study|Dizziness and Rash|0|||
126309369|NCT02691936|454421030|FG000|Overall Study|Withdrawal by Subject|2|||
126465605|NCT00736879|455007623|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
126465606|NCT00736879|455007624|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
126465607|NCT00736879|455007625|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
126465608|NCT00736879|455007622|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
126465609|NCT00736879|455007623|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
126465610|NCT00736879|455007624|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
126465611|NCT00736879|455007625|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
126465612|NCT00736879|455007622|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
126465613|NCT00736879|455007623|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
126465614|NCT00736879|455007624|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
126465615|NCT00736879|455007625|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
126465616|NCT00736879|455007622|FG000|Double Blind Treatment Period|No longer met criteria|0|||
126465617|NCT00736879|455007623|FG001|Double Blind Treatment Period|No longer met criteria|1|||
126465618|NCT00736879|455007624|FG002|Double Blind Treatment Period|No longer met criteria|0|||
126465619|NCT00736879|455007625|FG003|Double Blind Treatment Period|No longer met criteria|0|||
126465620|NCT00736879|455007622|FG000|Double Blind Treatment Period|non-specified|0|||
126465621|NCT00736879|455007623|FG001|Double Blind Treatment Period|non-specified|1|||
126465622|NCT00736879|455007624|FG002|Double Blind Treatment Period|non-specified|0|||
126465623|NCT00736879|455007625|FG003|Double Blind Treatment Period|non-specified|0|||
126465624|NCT00736879|455007622|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
126465625|NCT00736879|455007623|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
126465626|NCT00736879|455007624|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
126465627|NCT00736879|455007625|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
126465628|NCT00736879|455007622|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
126465629|NCT00736879|455007623|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
126465630|NCT00736879|455007624|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
126465631|NCT00736879|455007625|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
126465632|NCT01810432|455007626|FG000|Washout|Protocol Violation|0|||
126465633|NCT01810432|455007627|FG001|Washout|Protocol Violation|1|||
126465634|NCT01810432|455007626|FG000|Washout|Adverse Event|1|||
126465635|NCT01810432|455007627|FG001|Washout|Adverse Event|0|||
126465636|NCT01810432|455007626|FG000|Period 2|Withdrawal by Subject|2|||
126465637|NCT01810432|455007627|FG001|Period 2|Withdrawal by Subject|1|||
126465638|NCT01810432|455007626|FG000|Period 2|Physician Decision|1|||
126465639|NCT01810432|455007627|FG001|Period 2|Physician Decision|0|||
126465640|NCT01810432|455007626|FG000|Period 2|Lost to Follow-up|1|||
126465641|NCT01810432|455007627|FG001|Period 2|Lost to Follow-up|1|||
126465642|NCT02360111|455007630|FG000|Overall Study|Death|2|||
126465643|NCT00751621|455007633|FG000|Overall Study|Adverse Event|1|||
126465644|NCT00751621|455007633|FG000|Overall Study|Withdrawal by Subject|1|||
126465645|NCT00751621|455007633|FG000|Overall Study|Subject moved to another country|1|||
126465646|NCT00751621|455007633|FG000|Overall Study|Poor adherence to asthma treatment|1|||
126465647|NCT03309046|455007636|FG000|Overall Study|Withdrawal by Subject|4|||
126465648|NCT03309046|455007637|FG001|Overall Study|Withdrawal by Subject|17|||
126465649|NCT03963401|455007638|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
126465650|NCT03963401|455007639|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
126552648|NCT01225835|455318472|FG000|Overall Study|Completed protocol|2|||
126465651|NCT03963401|455007640|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
126465652|NCT03963401|455007641|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
126465653|NCT03963401|455007642|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
126465654|NCT03963401|455007643|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
126465655|NCT03963401|455007638|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
126465656|NCT03963401|455007639|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
126465657|NCT03963401|455007640|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
126465658|NCT03963401|455007641|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
126465659|NCT03963401|455007642|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
126465660|NCT03963401|455007643|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
126465661|NCT03963401|455007638|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
126465662|NCT03963401|455007639|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
126465663|NCT03963401|455007640|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
126465664|NCT03963401|455007641|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
126465665|NCT03963401|455007642|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
126465666|NCT03963401|455007643|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
126465667|NCT03963401|455007638|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
126465668|NCT03963401|455007639|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
126465669|NCT03963401|455007640|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
126465670|NCT03963401|455007641|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
126465671|NCT03963401|455007642|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
126465672|NCT03963401|455007643|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
126552649|NCT01225835|455318473|FG001|Overall Study|Completed protocol|1|||
126372724|NCT04712669|454661507|FG001|Double Blind Phase|Adverse Event|4|||
126372725|NCT04712669|454661508|FG002|Double Blind Phase|Adverse Event|3|||
126372726|NCT04712669|454661509|FG003|Double Blind Phase|Adverse Event|0|||
126372727|NCT04712669|454661510|FG004|Double Blind Phase|Adverse Event|0|||
126372728|NCT04712669|454661511|FG005|Double Blind Phase|Adverse Event|0|||
126372729|NCT04712669|454661512|FG006|Double Blind Phase|Adverse Event|0|||
126372730|NCT04712669|454661513|FG007|Double Blind Phase|Adverse Event|0|||
126372731|NCT04712669|454661506|FG000|Double Blind Phase|Physician Decision|1|||
126372732|NCT04712669|454661507|FG001|Double Blind Phase|Physician Decision|0|||
126372733|NCT04712669|454661508|FG002|Double Blind Phase|Physician Decision|0|||
126372734|NCT04712669|454661509|FG003|Double Blind Phase|Physician Decision|0|||
126372735|NCT04712669|454661510|FG004|Double Blind Phase|Physician Decision|0|||
126372736|NCT04712669|454661511|FG005|Double Blind Phase|Physician Decision|0|||
126372737|NCT04712669|454661512|FG006|Double Blind Phase|Physician Decision|0|||
126372738|NCT04712669|454661513|FG007|Double Blind Phase|Physician Decision|0|||
126372739|NCT04712669|454661506|FG000|Double Blind Phase|Withdrawal by Subject|3|||
126372740|NCT04712669|454661507|FG001|Double Blind Phase|Withdrawal by Subject|6|||
126372741|NCT04712669|454661508|FG002|Double Blind Phase|Withdrawal by Subject|0|||
126372742|NCT04712669|454661509|FG003|Double Blind Phase|Withdrawal by Subject|0|||
126372743|NCT04712669|454661510|FG004|Double Blind Phase|Withdrawal by Subject|0|||
126372744|NCT04712669|454661511|FG005|Double Blind Phase|Withdrawal by Subject|0|||
126372745|NCT04712669|454661512|FG006|Double Blind Phase|Withdrawal by Subject|0|||
126372746|NCT04712669|454661513|FG007|Double Blind Phase|Withdrawal by Subject|0|||
126372747|NCT04712669|454661506|FG000|Double Blind Phase|Termination by Sponsor|0|||
126372748|NCT04712669|454661507|FG001|Double Blind Phase|Termination by Sponsor|0|||
126372749|NCT04712669|454661508|FG002|Double Blind Phase|Termination by Sponsor|1|||
126372750|NCT04712669|454661509|FG003|Double Blind Phase|Termination by Sponsor|0|||
126372751|NCT04712669|454661510|FG004|Double Blind Phase|Termination by Sponsor|0|||
126372752|NCT04712669|454661511|FG005|Double Blind Phase|Termination by Sponsor|0|||
126372753|NCT04712669|454661512|FG006|Double Blind Phase|Termination by Sponsor|0|||
126372754|NCT04712669|454661513|FG007|Double Blind Phase|Termination by Sponsor|0|||
126372755|NCT04712669|454661506|FG000|Open Label Phase|Adverse Event|0|||
126372756|NCT04712669|454661507|FG001|Open Label Phase|Adverse Event|0|||
126372757|NCT04712669|454661508|FG002|Open Label Phase|Adverse Event|0|||
126372758|NCT04712669|454661509|FG003|Open Label Phase|Adverse Event|1|||
126372759|NCT04712669|454661510|FG004|Open Label Phase|Adverse Event|1|||
126372760|NCT04712669|454661511|FG005|Open Label Phase|Adverse Event|3|||
126372761|NCT04712669|454661512|FG006|Open Label Phase|Adverse Event|1|||
126372762|NCT04712669|454661513|FG007|Open Label Phase|Adverse Event|2|||
126372763|NCT04712669|454661506|FG000|Open Label Phase|Death|0|||
126372764|NCT04712669|454661507|FG001|Open Label Phase|Death|0|||
126372765|NCT04712669|454661508|FG002|Open Label Phase|Death|0|||
126552650|NCT01225835|455318472|FG000|Overall Study|Did not meet hCG criterion|2|||
126716487|NCT02429427|455913164|FG001|Overall Study|Withdrawal by Subject|34|||
126716488|NCT02429427|455913163|FG000|Overall Study|Other|62|||
126716489|NCT02429427|455913164|FG001|Overall Study|Other|41|||
126372766|NCT04712669|454661509|FG003|Open Label Phase|Death|1|||
126372767|NCT04712669|454661510|FG004|Open Label Phase|Death|0|||
126372768|NCT04712669|454661511|FG005|Open Label Phase|Death|0|||
126372769|NCT04712669|454661512|FG006|Open Label Phase|Death|0|||
126372770|NCT04712669|454661513|FG007|Open Label Phase|Death|0|||
126372771|NCT04712669|454661506|FG000|Open Label Phase|Lack of Efficacy|0|||
126372772|NCT04712669|454661507|FG001|Open Label Phase|Lack of Efficacy|0|||
126372773|NCT04712669|454661508|FG002|Open Label Phase|Lack of Efficacy|0|||
126372774|NCT04712669|454661509|FG003|Open Label Phase|Lack of Efficacy|0|||
126372775|NCT04712669|454661510|FG004|Open Label Phase|Lack of Efficacy|1|||
126372776|NCT04712669|454661511|FG005|Open Label Phase|Lack of Efficacy|0|||
126372777|NCT04712669|454661512|FG006|Open Label Phase|Lack of Efficacy|0|||
126372778|NCT04712669|454661513|FG007|Open Label Phase|Lack of Efficacy|0|||
126372779|NCT04712669|454661506|FG000|Open Label Phase|Lost to Follow-up|0|||
126372780|NCT04712669|454661507|FG001|Open Label Phase|Lost to Follow-up|0|||
126372781|NCT04712669|454661508|FG002|Open Label Phase|Lost to Follow-up|0|||
126372782|NCT04712669|454661509|FG003|Open Label Phase|Lost to Follow-up|0|||
126372783|NCT04712669|454661510|FG004|Open Label Phase|Lost to Follow-up|0|||
126372784|NCT04712669|454661511|FG005|Open Label Phase|Lost to Follow-up|0|||
126372785|NCT04712669|454661512|FG006|Open Label Phase|Lost to Follow-up|1|||
126552651|NCT01225835|455318473|FG001|Overall Study|Did not meet hCG criterion|0|||
126716490|NCT00747617|455914851|FG000|Overall Study|Lost to Follow-up|3|||
126372786|NCT04712669|454661513|FG007|Open Label Phase|Lost to Follow-up|1|||
126372787|NCT04712669|454661506|FG000|Open Label Phase|Physician Decision|0|||
126372788|NCT04712669|454661507|FG001|Open Label Phase|Physician Decision|0|||
126372789|NCT04712669|454661508|FG002|Open Label Phase|Physician Decision|0|||
126372790|NCT04712669|454661509|FG003|Open Label Phase|Physician Decision|1|||
126372791|NCT04712669|454661510|FG004|Open Label Phase|Physician Decision|0|||
126372792|NCT04712669|454661511|FG005|Open Label Phase|Physician Decision|0|||
126372793|NCT04712669|454661512|FG006|Open Label Phase|Physician Decision|0|||
126372794|NCT04712669|454661513|FG007|Open Label Phase|Physician Decision|0|||
126372795|NCT04712669|454661506|FG000|Open Label Phase|Withdrawal by Subject|0|||
126372796|NCT04712669|454661507|FG001|Open Label Phase|Withdrawal by Subject|0|||
126372797|NCT04712669|454661508|FG002|Open Label Phase|Withdrawal by Subject|0|||
126372798|NCT04712669|454661509|FG003|Open Label Phase|Withdrawal by Subject|1|||
126372799|NCT04712669|454661510|FG004|Open Label Phase|Withdrawal by Subject|5|||
126372800|NCT04712669|454661511|FG005|Open Label Phase|Withdrawal by Subject|5|||
126372801|NCT04712669|454661512|FG006|Open Label Phase|Withdrawal by Subject|0|||
126372802|NCT04712669|454661513|FG007|Open Label Phase|Withdrawal by Subject|4|||
126372803|NCT04712669|454661506|FG000|Open Label Phase|Termination by Sponsor|0|||
126372804|NCT04712669|454661507|FG001|Open Label Phase|Termination by Sponsor|0|||
126372805|NCT04712669|454661508|FG002|Open Label Phase|Termination by Sponsor|0|||
126372806|NCT04712669|454661509|FG003|Open Label Phase|Termination by Sponsor|11|||
126372807|NCT04712669|454661510|FG004|Open Label Phase|Termination by Sponsor|9|||
126372808|NCT04712669|454661511|FG005|Open Label Phase|Termination by Sponsor|14|||
126372809|NCT04712669|454661512|FG006|Open Label Phase|Termination by Sponsor|0|||
126372810|NCT04712669|454661513|FG007|Open Label Phase|Termination by Sponsor|14|||
126372811|NCT03802396|454661514|FG000|Overall Study|Withdrawal by Subject|2|||
126372812|NCT03802396|454661515|FG001|Overall Study|Withdrawal by Subject|0|||
126372813|NCT03802396|454661514|FG000|Overall Study|Surgery Cancelled|1|||
126372814|NCT03802396|454661515|FG001|Overall Study|Surgery Cancelled|0|||
126372815|NCT02561962|454661519|FG000|Overall Study|Withdrawal by Subject|1|||
126372816|NCT02561962|454661520|FG001|Overall Study|Withdrawal by Subject|0|||
126372817|NCT02561962|454661521|FG002|Overall Study|Withdrawal by Subject|0|||
126372818|NCT02561962|454661522|FG003|Overall Study|Withdrawal by Subject|0|||
126372819|NCT02561962|454661523|FG004|Overall Study|Withdrawal by Subject|1|||
126372820|NCT02561962|454661524|FG005|Overall Study|Withdrawal by Subject|1|||
126372821|NCT02561962|454661525|FG006|Overall Study|Withdrawal by Subject|2|||
126372822|NCT02561962|454661526|FG007|Overall Study|Withdrawal by Subject|1|||
126372823|NCT02561962|454661527|FG008|Overall Study|Withdrawal by Subject|0|||
126372824|NCT02561962|454661519|FG000|Overall Study|Decision by sponsor|0|||
126372825|NCT02561962|454661520|FG001|Overall Study|Decision by sponsor|0|||
126372826|NCT02561962|454661521|FG002|Overall Study|Decision by sponsor|0|||
126372827|NCT02561962|454661522|FG003|Overall Study|Decision by sponsor|0|||
126372828|NCT02561962|454661523|FG004|Overall Study|Decision by sponsor|1|||
126372829|NCT02561962|454661524|FG005|Overall Study|Decision by sponsor|1|||
126372830|NCT02561962|454661525|FG006|Overall Study|Decision by sponsor|0|||
126372831|NCT02561962|454661526|FG007|Overall Study|Decision by sponsor|3|||
126372832|NCT02561962|454661527|FG008|Overall Study|Decision by sponsor|0|||
126372833|NCT02561962|454661519|FG000|Overall Study|Lost to Follow-up|0|||
126372834|NCT02561962|454661520|FG001|Overall Study|Lost to Follow-up|0|||
126372835|NCT02561962|454661521|FG002|Overall Study|Lost to Follow-up|0|||
126372836|NCT02561962|454661522|FG003|Overall Study|Lost to Follow-up|0|||
126372837|NCT02561962|454661523|FG004|Overall Study|Lost to Follow-up|0|||
126372838|NCT02561962|454661524|FG005|Overall Study|Lost to Follow-up|1|||
126372839|NCT02561962|454661525|FG006|Overall Study|Lost to Follow-up|0|||
126372840|NCT02561962|454661526|FG007|Overall Study|Lost to Follow-up|0|||
126372841|NCT02561962|454661527|FG008|Overall Study|Lost to Follow-up|0|||
126372842|NCT01150357|454661528|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
126372843|NCT01150357|454661529|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
126372844|NCT01150357|454661530|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
126372845|NCT01150357|454661528|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
126372846|NCT01150357|454661529|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
126465673|NCT03963401|455007638|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
126465674|NCT03963401|455007639|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
126465675|NCT03963401|455007640|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
126465676|NCT03963401|455007641|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
126465677|NCT03963401|455007642|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
126465678|NCT03963401|455007643|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
126465679|NCT03963401|455007638|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
126770988|NCT01399125|456116224|FG001|Overall Study|Administrative Problems|11|||
126372847|NCT01150357|454661530|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
126372848|NCT01150357|454661528|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
126372849|NCT01150357|454661529|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
126372850|NCT01150357|454661530|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
126372851|NCT01150357|454661528|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
126372852|NCT01150357|454661529|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
126372853|NCT01150357|454661530|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
126372854|NCT01150357|454661528|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
126372855|NCT01150357|454661529|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
126465680|NCT03963401|455007639|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
126465681|NCT03963401|455007640|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
126465682|NCT03963401|455007641|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
126465683|NCT03963401|455007642|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
126552652|NCT01225835|455318472|FG000|Overall Study|Adverse Event|2|||
126716491|NCT00747617|455914852|FG001|Overall Study|Lost to Follow-up|1|||
126716492|NCT01746732|455914853|FG000|Lead-In Period|Withdrawal by Subject|1|||
126716493|NCT01746732|455914854|FG001|Lead-In Period|Withdrawal by Subject|0|||
126372856|NCT01150357|454661530|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
126372857|NCT01150357|454661528|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
126372858|NCT01150357|454661529|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
126372859|NCT01150357|454661530|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
126372860|NCT01150357|454661528|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
126372861|NCT01150357|454661529|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
126372862|NCT01150357|454661530|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
126372863|NCT01819272|454663278|FG000|Overall Study|Adverse Event|1|||
126372864|NCT01819272|454663279|FG001|Overall Study|Adverse Event|0|||
126372865|NCT01819272|454663280|FG002|Overall Study|Adverse Event|0|||
126372866|NCT01819272|454663281|FG003|Overall Study|Adverse Event|2|||
126372867|NCT01819272|454663282|FG004|Overall Study|Adverse Event|0|||
126372868|NCT01819272|454663283|FG005|Overall Study|Adverse Event|0|||
126372869|NCT01819272|454663278|FG000|Overall Study|Lost to Follow-up|3|||
126372870|NCT01819272|454663279|FG001|Overall Study|Lost to Follow-up|0|||
126372871|NCT01819272|454663280|FG002|Overall Study|Lost to Follow-up|1|||
126372872|NCT01819272|454663281|FG003|Overall Study|Lost to Follow-up|0|||
126372873|NCT01819272|454663282|FG004|Overall Study|Lost to Follow-up|0|||
126372874|NCT01819272|454663283|FG005|Overall Study|Lost to Follow-up|3|||
126372875|NCT01819272|454663278|FG000|Overall Study|Protocol Violation|0|||
126372876|NCT01819272|454663279|FG001|Overall Study|Protocol Violation|0|||
126372877|NCT01819272|454663280|FG002|Overall Study|Protocol Violation|0|||
126372878|NCT01819272|454663281|FG003|Overall Study|Protocol Violation|1|||
126372879|NCT01819272|454663282|FG004|Overall Study|Protocol Violation|2|||
126372880|NCT01819272|454663283|FG005|Overall Study|Protocol Violation|3|||
126372881|NCT01819272|454663278|FG000|Overall Study|Physician Decision|0|||
126372882|NCT01819272|454663279|FG001|Overall Study|Physician Decision|1|||
126372883|NCT01819272|454663280|FG002|Overall Study|Physician Decision|0|||
126372884|NCT01819272|454663281|FG003|Overall Study|Physician Decision|0|||
126372885|NCT01819272|454663282|FG004|Overall Study|Physician Decision|0|||
126372886|NCT01819272|454663283|FG005|Overall Study|Physician Decision|0|||
126716494|NCT01746732|455914855|FG002|Lead-In Period|Withdrawal by Subject|0|||
126716495|NCT01746732|455914853|FG000|Period 1|Physician Decision|0|||
126716496|NCT01746732|455914854|FG001|Period 1|Physician Decision|1|||
126716497|NCT01746732|455914855|FG002|Period 1|Physician Decision|0|||
126770989|NCT01399125|456116223|FG000|Overall Study|Death|0|||
126770990|NCT01399125|456116224|FG001|Overall Study|Death|1|||
126770991|NCT01399125|456116223|FG000|Overall Study|Protocol Deviation|5|||
126770992|NCT01399125|456116224|FG001|Overall Study|Protocol Deviation|2|||
126770993|NCT00647426|456116227|FG000|Overall Study|Withdrawal by Subject|2|||
126770994|NCT00422058|456116232|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
126770995|NCT00422058|456116233|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
126770996|NCT00422058|456116234|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
126770997|NCT00422058|456116235|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
126770998|NCT00422058|456116236|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
126770999|NCT00422058|456116237|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
126372887|NCT01819272|454663278|FG000|Overall Study|Withdrawal of Consent|0|||
126372888|NCT01819272|454663279|FG001|Overall Study|Withdrawal of Consent|1|||
126372889|NCT01819272|454663280|FG002|Overall Study|Withdrawal of Consent|2|||
126372890|NCT01819272|454663281|FG003|Overall Study|Withdrawal of Consent|1|||
126372891|NCT01819272|454663282|FG004|Overall Study|Withdrawal of Consent|0|||
126372892|NCT01819272|454663283|FG005|Overall Study|Withdrawal of Consent|1|||
126716498|NCT01746732|455914853|FG000|Period 2|Withdrawal by Subject|0|||
126716499|NCT01746732|455914854|FG001|Period 2|Withdrawal by Subject|0|||
126716500|NCT01746732|455914855|FG002|Period 2|Withdrawal by Subject|2|||
126716501|NCT01746732|455914853|FG000|Period 2|Adverse Event|0|||
126716502|NCT01746732|455914854|FG001|Period 2|Adverse Event|0|||
126716503|NCT01746732|455914855|FG002|Period 2|Adverse Event|1|||
126716504|NCT01746732|455914853|FG000|Period 2|Lost to Follow-up|0|||
126716505|NCT01746732|455914854|FG001|Period 2|Lost to Follow-up|0|||
126716506|NCT01746732|455914855|FG002|Period 2|Lost to Follow-up|1|||
126716507|NCT02279524|455914856|FG000|Overall Study|Withdrawal by Subject|3|||
126716508|NCT02279524|455914857|FG001|Overall Study|Withdrawal by Subject|6|||
126716509|NCT02279524|455914858|FG002|Overall Study|Withdrawal by Subject|3|||
126716510|NCT02279524|455914856|FG000|Overall Study|Adverse Event|4|||
126716511|NCT02279524|455914857|FG001|Overall Study|Adverse Event|3|||
126771000|NCT00422058|456116232|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
126372893|NCT01819272|454663278|FG000|Overall Study|Loss of Glucose Control|2|||
126372894|NCT01819272|454663279|FG001|Overall Study|Loss of Glucose Control|1|||
126716512|NCT02279524|455914858|FG002|Overall Study|Adverse Event|2|||
126716513|NCT02279524|455914856|FG000|Overall Study|Lost to Follow-up|1|||
126716514|NCT02279524|455914857|FG001|Overall Study|Lost to Follow-up|1|||
126716515|NCT02279524|455914858|FG002|Overall Study|Lost to Follow-up|0|||
126716516|NCT02279524|455914856|FG000|Overall Study|Disallowed medication|1|||
126771001|NCT00422058|456116233|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
126372895|NCT01819272|454663280|FG002|Overall Study|Loss of Glucose Control|0|||
126372896|NCT01819272|454663281|FG003|Overall Study|Loss of Glucose Control|1|||
126372897|NCT01819272|454663282|FG004|Overall Study|Loss of Glucose Control|2|||
126372898|NCT01819272|454663283|FG005|Overall Study|Loss of Glucose Control|0|||
126372899|NCT00503984|454663284|FG000|Overall Study|Protocol Violation|0|||
126372900|NCT00503984|454663285|FG001|Overall Study|Protocol Violation|1|||
126372901|NCT00503984|454663286|FG002|Overall Study|Protocol Violation|0|||
126372902|NCT00503984|454663287|FG003|Overall Study|Protocol Violation|0|||
126372903|NCT00503984|454663288|FG004|Overall Study|Protocol Violation|0|||
126372904|NCT00503984|454663289|FG005|Overall Study|Protocol Violation|0|||
126372905|NCT00503984|454663284|FG000|Overall Study|Adverse Event|0|||
126372906|NCT00503984|454663285|FG001|Overall Study|Adverse Event|1|||
126372907|NCT00503984|454663286|FG002|Overall Study|Adverse Event|0|||
126372908|NCT00503984|454663287|FG003|Overall Study|Adverse Event|0|||
126372909|NCT00503984|454663288|FG004|Overall Study|Adverse Event|0|||
126372910|NCT00503984|454663289|FG005|Overall Study|Adverse Event|0|||
126372911|NCT00503984|454663284|FG000|Overall Study|Death|0|||
126372912|NCT00503984|454663285|FG001|Overall Study|Death|0|||
126372913|NCT00503984|454663286|FG002|Overall Study|Death|0|||
126372914|NCT00503984|454663287|FG003|Overall Study|Death|0|||
126372915|NCT00503984|454663288|FG004|Overall Study|Death|1|||
126372916|NCT00503984|454663289|FG005|Overall Study|Death|0|||
126372917|NCT01246960|454663292|FG000|Overall Study|Lost to Follow-up|3|||
126372918|NCT01246960|454663293|FG001|Overall Study|Lost to Follow-up|1|||
126372919|NCT01246960|454663292|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
126372920|NCT01246960|454663293|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
126372921|NCT00140140|454663298|FG000|Overall Study|Unacceptable toxicity|1|||
126372922|NCT00140140|454663299|FG001|Overall Study|Unacceptable toxicity|1|||
126372923|NCT00140140|454663300|FG002|Overall Study|Unacceptable toxicity|2|||
126372924|NCT00140140|454663298|FG000|Overall Study|Physician Decision|1|||
126372925|NCT00140140|454663299|FG001|Overall Study|Physician Decision|1|||
126372926|NCT00140140|454663300|FG002|Overall Study|Physician Decision|0|||
126372927|NCT03376516|454663301|FG000|Overall Study|Not treated|1|||
126372928|NCT03376516|454663301|FG000|Overall Study|Consent withdrawn|1|||
126372929|NCT01359956|454663302|FG000|Overall Study|Death|58|||
126372930|NCT01359956|454663303|FG001|Overall Study|Death|60|||
126372931|NCT01359956|454663304|FG002|Overall Study|Death|66|||
126372932|NCT01359956|454663305|FG003|Overall Study|Death|57|||
126372933|NCT01359956|454663302|FG000|Overall Study|Lost to Follow-up|3|||
126372934|NCT01359956|454663303|FG001|Overall Study|Lost to Follow-up|4|||
126372935|NCT01359956|454663304|FG002|Overall Study|Lost to Follow-up|1|||
126372936|NCT01359956|454663305|FG003|Overall Study|Lost to Follow-up|1|||
126372937|NCT01784029|454663306|FG000|Overall Study|Lost to Follow-up|19|||
126465684|NCT03963401|455007643|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
126465685|NCT03963401|455007638|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
126465686|NCT03963401|455007639|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
126372938|NCT01784029|454663307|FG001|Overall Study|Lost to Follow-up|20|||
126465687|NCT03963401|455007640|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
126465688|NCT03963401|455007641|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
126465689|NCT03963401|455007642|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
126465690|NCT03963401|455007643|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
126465691|NCT03963401|455007638|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
126465692|NCT03963401|455007639|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
126465693|NCT03963401|455007640|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
126465694|NCT03963401|455007641|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
126465695|NCT03963401|455007642|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
126465696|NCT03963401|455007643|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
126771002|NCT00422058|456116234|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
126771003|NCT00422058|456116235|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
126771004|NCT00422058|456116236|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
126372939|NCT01784029|454663308|FG002|Overall Study|Lost to Follow-up|22|||
126372940|NCT00639457|454663309|FG000|Overall Study|Withdrawal by Subject|2|||
126372941|NCT00639457|454663310|FG001|Overall Study|Withdrawal by Subject|3|||
126465697|NCT03963401|455007638|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
126465698|NCT03963401|455007639|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
126465699|NCT03963401|455007640|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
126552653|NCT01225835|455318473|FG001|Overall Study|Adverse Event|1|||
126552654|NCT01225835|455318472|FG000|Overall Study|Other|1|||
126552655|NCT01225835|455318473|FG001|Overall Study|Other|1|||
126372942|NCT00370292|454663311|FG000|Overall Study|Disease Progression|4|||
126372943|NCT00370292|454663311|FG000|Overall Study|Adverse Event|7|||
126372944|NCT00370292|454663311|FG000|Overall Study|Physician Decision|2|||
126552656|NCT02589392|455318474|FG000|Overall Study|Adverse Event|1|||
126372945|NCT00276419|454663312|FG000|First Intervention|Adverse Event|1|||
126372946|NCT00276419|454663313|FG001|First Intervention|Adverse Event|0|||
126372947|NCT00276419|454663312|FG000|First Intervention|Withdrawal by Subject|0|||
126372948|NCT00276419|454663313|FG001|First Intervention|Withdrawal by Subject|2|||
126552657|NCT02589392|455318475|FG001|Overall Study|Adverse Event|1|||
126552658|NCT02589392|455318474|FG000|Overall Study|Withdrawal by Subject|1|||
126552659|NCT02589392|455318475|FG001|Overall Study|Withdrawal by Subject|2|||
126552660|NCT02589392|455318474|FG000|Overall Study|Protocol Violation|1|||
126552661|NCT02589392|455318475|FG001|Overall Study|Protocol Violation|1|||
126552662|NCT02589392|455318474|FG000|Overall Study|Lost to Follow-up|2|||
126552663|NCT02589392|455318475|FG001|Overall Study|Lost to Follow-up|2|||
126552664|NCT02589392|455318474|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
126552665|NCT02589392|455318475|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
126552666|NCT02207374|455318482|FG000|Overall Study|Withdrawal by Subject|5|||
126552667|NCT02207374|455318483|FG001|Overall Study|Withdrawal by Subject|9|||
126552668|NCT02207374|455318484|FG002|Overall Study|Withdrawal by Subject|4|||
126552669|NCT02207374|455318482|FG000|Overall Study|Death|1|||
126552670|NCT02207374|455318483|FG001|Overall Study|Death|0|||
126552671|NCT02207374|455318484|FG002|Overall Study|Death|1|||
126552672|NCT02207374|455318482|FG000|Overall Study|Missing follow-up information|0|||
126552673|NCT02207374|455318483|FG001|Overall Study|Missing follow-up information|1|||
126552674|NCT02207374|455318484|FG002|Overall Study|Missing follow-up information|1|||
126552675|NCT02087150|455318485|FG000|Overall Study|Death|0|||
126552676|NCT02087150|455318486|FG001|Overall Study|Death|1|||
126552677|NCT02087150|455318487|FG002|Overall Study|Death|0|||
126552678|NCT02087150|455318485|FG000|Overall Study|Lost to Follow-up|6|||
126552679|NCT02087150|455318486|FG001|Overall Study|Lost to Follow-up|13|||
126552680|NCT02087150|455318487|FG002|Overall Study|Lost to Follow-up|7|||
126552681|NCT02087150|455318485|FG000|Overall Study|Withdrawal by Subject|2|||
126552682|NCT02087150|455318486|FG001|Overall Study|Withdrawal by Subject|5|||
126552683|NCT02087150|455318487|FG002|Overall Study|Withdrawal by Subject|3|||
126552684|NCT02087150|455318485|FG000|Overall Study|Physician Decision|0|||
126552685|NCT02087150|455318486|FG001|Overall Study|Physician Decision|1|||
126716517|NCT02279524|455914857|FG001|Overall Study|Disallowed medication|1|||
126716518|NCT02279524|455914858|FG002|Overall Study|Disallowed medication|2|||
126716519|NCT02279524|455914856|FG000|Overall Study|Bariatric surgery|1|||
126372949|NCT03545672|454663314|FG000|Overall Study|Uncertain diagnosis|2|||
126372950|NCT03545672|454663315|FG001|Overall Study|Uncertain diagnosis|1|||
126372951|NCT03545672|454663314|FG000|Overall Study|Protocol Violation|2|||
126372952|NCT03545672|454663315|FG001|Overall Study|Protocol Violation|2|||
126372953|NCT01628913|454663316|FG000|Overall Study|Adverse Event|12|||
126372954|NCT01628913|454663317|FG001|Overall Study|Adverse Event|5|||
126372955|NCT01628913|454663316|FG000|Overall Study|Disease Progression|11|||
126465700|NCT03963401|455007641|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
126465701|NCT03963401|455007642|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
126465702|NCT03963401|455007643|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
126465703|NCT03963401|455007638|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
126465704|NCT03963401|455007639|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
126465705|NCT03963401|455007640|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
126465706|NCT03963401|455007641|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
126465707|NCT03963401|455007642|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
126465708|NCT03963401|455007643|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
126465709|NCT03963401|455007638|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
126465710|NCT03963401|455007639|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
126465711|NCT03963401|455007640|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
126465712|NCT03963401|455007641|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
126465713|NCT03963401|455007642|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
126552686|NCT02087150|455318487|FG002|Overall Study|Physician Decision|0|||
126552687|NCT02087150|455318485|FG000|Overall Study|Procedure not done|1|||
126552688|NCT02087150|455318486|FG001|Overall Study|Procedure not done|13|||
126552689|NCT02087150|455318487|FG002|Overall Study|Procedure not done|0|||
126552690|NCT02087150|455318485|FG000|Overall Study|F/U not completed w/in study window|0|||
126465714|NCT03963401|455007643|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
126465715|NCT02961218|455007647|FG000|Overall Study|Lost to Follow-up|0|||
126465716|NCT02961218|455007648|FG001|Overall Study|Lost to Follow-up|2|||
126465717|NCT02961218|455007647|FG000|Overall Study|Physician Decision|0|||
126465718|NCT02961218|455007648|FG001|Overall Study|Physician Decision|2|||
126465719|NCT02961218|455007647|FG000|Overall Study|Subject/Guardian Decision|3|||
126552691|NCT02087150|455318486|FG001|Overall Study|F/U not completed w/in study window|0|||
126552692|NCT02087150|455318487|FG002|Overall Study|F/U not completed w/in study window|1|||
126372956|NCT01628913|454663317|FG001|Overall Study|Disease Progression|14|||
126465720|NCT02961218|455007648|FG001|Overall Study|Subject/Guardian Decision|1|||
126552693|NCT02087150|455318485|FG000|Overall Study|Other|1|||
126552694|NCT02087150|455318486|FG001|Overall Study|Other|0|||
126552695|NCT02087150|455318487|FG002|Overall Study|Other|0|||
126552696|NCT02087150|455318485|FG000|Overall Study|Pt moved out of town|0|||
126372957|NCT01628913|454663316|FG000|Overall Study|Protocol Violation|1|||
126716520|NCT02279524|455914857|FG001|Overall Study|Bariatric surgery|0|||
126716521|NCT02279524|455914858|FG002|Overall Study|Bariatric surgery|0|||
126716522|NCT03509207|455914859|FG000|Overall Study|Death|2|||
126716523|NCT02817555|455914860|FG000|Overall Study|Death|1|||
126716524|NCT02817555|455914861|FG001|Overall Study|Death|3|||
126716525|NCT02817555|455914860|FG000|Overall Study|moved away|1|||
126716526|NCT02817555|455914861|FG001|Overall Study|moved away|0|||
126716527|NCT02817555|455914860|FG000|Overall Study|transplant|1|||
126716528|NCT02817555|455914861|FG001|Overall Study|transplant|1|||
126716529|NCT02817555|455914860|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
126716530|NCT02817555|455914861|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
126716531|NCT00137436|455914862|FG000|Overall Study|Adverse Event|13|||
126716532|NCT00137436|455914862|FG000|Overall Study|Death|2|||
126716533|NCT00137436|455914862|FG000|Overall Study|Lack of Efficacy|17|||
126716534|NCT00137436|455914862|FG000|Overall Study|Withdrawal by Subject|6|||
126716535|NCT00137436|455914862|FG000|Overall Study|Other|5|||
126716536|NCT00165646|455914863|FG000|Overall Study|Adverse Event|1|||
126716537|NCT00165646|455914864|FG001|Overall Study|Adverse Event|1|||
126716538|NCT00165646|455914865|FG002|Overall Study|Adverse Event|1|||
126716539|NCT00165646|455914863|FG000|Overall Study|Lack of Efficacy|1|||
126716540|NCT00165646|455914864|FG001|Overall Study|Lack of Efficacy|2|||
126716541|NCT00165646|455914865|FG002|Overall Study|Lack of Efficacy|0|||
126716542|NCT00165646|455914863|FG000|Overall Study|Withdrawal by Subject|0|||
126716543|NCT00165646|455914864|FG001|Overall Study|Withdrawal by Subject|2|||
126716544|NCT00165646|455914865|FG002|Overall Study|Withdrawal by Subject|1|||
126716545|NCT00165646|455914863|FG000|Overall Study|Physician Decision|2|||
126716546|NCT00165646|455914864|FG001|Overall Study|Physician Decision|0|||
126716547|NCT00165646|455914865|FG002|Overall Study|Physician Decision|2|||
126716548|NCT00165646|455914863|FG000|Overall Study|Protocol Violation|1|||
126716549|NCT00165646|455914864|FG001|Overall Study|Protocol Violation|0|||
126716550|NCT00165646|455914865|FG002|Overall Study|Protocol Violation|0|||
126716551|NCT00912015|455914869|FG000|Overall Study|Lack of Efficacy|1|||
126716552|NCT00912015|455914870|FG001|Overall Study|Lack of Efficacy|0|||
126716553|NCT00912015|455914871|FG002|Overall Study|Lack of Efficacy|0|||
126716554|NCT00912015|455914872|FG003|Overall Study|Lack of Efficacy|0|||
126716555|NCT00912015|455914869|FG000|Overall Study|Withdrawal by Subject|8|||
126716556|NCT00912015|455914870|FG001|Overall Study|Withdrawal by Subject|8|||
126716557|NCT00912015|455914871|FG002|Overall Study|Withdrawal by Subject|3|||
126716558|NCT00912015|455914872|FG003|Overall Study|Withdrawal by Subject|0|||
126465721|NCT00591266|455007649|FG000|Overall Study|Adverse Event|2|||
126465722|NCT00591266|455007650|FG001|Overall Study|Adverse Event|2|||
126465723|NCT00591266|455007651|FG002|Overall Study|Adverse Event|3|||
126465724|NCT00591266|455007649|FG000|Overall Study|Lost to Follow-up|0|||
126465725|NCT00591266|455007650|FG001|Overall Study|Lost to Follow-up|1|||
126465726|NCT00591266|455007651|FG002|Overall Study|Lost to Follow-up|0|||
126465727|NCT00591266|455007649|FG000|Overall Study|Protocol Violation|0|||
126465728|NCT00591266|455007650|FG001|Overall Study|Protocol Violation|0|||
126465729|NCT00591266|455007651|FG002|Overall Study|Protocol Violation|1|||
126465730|NCT00591266|455007649|FG000|Overall Study|Withdrawal by Subject|6|||
126465731|NCT00591266|455007650|FG001|Overall Study|Withdrawal by Subject|2|||
126465732|NCT00591266|455007651|FG002|Overall Study|Withdrawal by Subject|5|||
126465733|NCT00591266|455007649|FG000|Overall Study|Lack of Efficacy|0|||
126465734|NCT00591266|455007650|FG001|Overall Study|Lack of Efficacy|2|||
126465735|NCT00591266|455007651|FG002|Overall Study|Lack of Efficacy|0|||
126716559|NCT00912015|455914869|FG000|Overall Study|Protocol Violation|1|||
126716560|NCT00912015|455914870|FG001|Overall Study|Protocol Violation|0|||
126716561|NCT00912015|455914871|FG002|Overall Study|Protocol Violation|0|||
126716562|NCT00912015|455914872|FG003|Overall Study|Protocol Violation|1|||
126716563|NCT00912015|455914869|FG000|Overall Study|Adverse Event|6|||
126716564|NCT00912015|455914870|FG001|Overall Study|Adverse Event|0|||
126716565|NCT00912015|455914871|FG002|Overall Study|Adverse Event|0|||
126716566|NCT00912015|455914872|FG003|Overall Study|Adverse Event|1|||
126716567|NCT01356602|455914873|FG000|Overall Study|Protocol Deviation|0|||
126716568|NCT01356602|455914874|FG001|Overall Study|Protocol Deviation|1|||
126716569|NCT01356602|455914875|FG002|Overall Study|Protocol Deviation|1|||
126716570|NCT01356602|455914873|FG000|Overall Study|Administrative Problems|1|||
126716571|NCT01356602|455914874|FG001|Overall Study|Administrative Problems|4|||
126716572|NCT01356602|455914875|FG002|Overall Study|Administrative Problems|5|||
126716573|NCT01356602|455914873|FG000|Overall Study|Lost to Follow-up|4|||
126465736|NCT00591266|455007649|FG000|Overall Study|Other|1|||
126465737|NCT00591266|455007650|FG001|Overall Study|Other|4|||
126465738|NCT00591266|455007651|FG002|Overall Study|Other|5|||
126465739|NCT03488927|455007652|FG000|Overall Study|Withdrawal by Subject|44|||
126465740|NCT03488927|455007653|FG001|Overall Study|Withdrawal by Subject|118|||
126465741|NCT03488927|455007654|FG002|Overall Study|Withdrawal by Subject|217|||
126465742|NCT00901927|455007657|FG000|Overall Study|Lack of Efficacy|1|||
126716574|NCT01356602|455914874|FG001|Overall Study|Lost to Follow-up|5|||
126716575|NCT01356602|455914875|FG002|Overall Study|Lost to Follow-up|6|||
126716576|NCT01356602|455914873|FG000|Overall Study|Withdrawal by Subject|4|||
126716577|NCT01356602|455914874|FG001|Overall Study|Withdrawal by Subject|3|||
126465743|NCT00901927|455007657|FG000|Overall Study|Protocol Violation|3|||
126465744|NCT00901927|455007657|FG000|Overall Study|Withdrawal by Subject|2|||
126465745|NCT05298306|455007658|FG000|Overall Study|Physician Decision|0|||
126465746|NCT05298306|455007659|FG001|Overall Study|Physician Decision|0|||
126465747|NCT05298306|455007660|FG002|Overall Study|Physician Decision|0|||
126465748|NCT05298306|455007661|FG003|Overall Study|Physician Decision|1|||
126465749|NCT05298306|455007662|FG004|Overall Study|Physician Decision|0|||
126465750|NCT05298306|455007663|FG005|Overall Study|Physician Decision|0|||
126465751|NCT02676466|455007669|FG000|Overall Study|Death|0|||
126465752|NCT02676466|455007670|FG001|Overall Study|Death|2|||
126465753|NCT02676466|455007671|FG002|Overall Study|Death|1|||
126465754|NCT02676466|455007672|FG003|Overall Study|Death|0|||
126465755|NCT02676466|455007673|FG004|Overall Study|Death|0|||
126465756|NCT02676466|455007674|FG005|Overall Study|Death|0|||
126465757|NCT02676466|455007675|FG006|Overall Study|Death|0|||
126465758|NCT02676466|455007676|FG007|Overall Study|Death|0|||
126465759|NCT02676466|455007669|FG000|Overall Study|Withdrawal by Subject|4|||
126465760|NCT02676466|455007670|FG001|Overall Study|Withdrawal by Subject|3|||
126465761|NCT02676466|455007671|FG002|Overall Study|Withdrawal by Subject|1|||
126465762|NCT02676466|455007672|FG003|Overall Study|Withdrawal by Subject|0|||
126465763|NCT02676466|455007673|FG004|Overall Study|Withdrawal by Subject|3|||
126465764|NCT02676466|455007674|FG005|Overall Study|Withdrawal by Subject|1|||
126465765|NCT02676466|455007675|FG006|Overall Study|Withdrawal by Subject|1|||
126465766|NCT02676466|455007676|FG007|Overall Study|Withdrawal by Subject|1|||
126465767|NCT01178073|455007680|FG000|Overall Study|Adverse Event|34|||
126465768|NCT01178073|455007681|FG001|Overall Study|Adverse Event|27|||
126465769|NCT01178073|455007682|FG002|Overall Study|Adverse Event|24|||
126465770|NCT01178073|455007680|FG000|Overall Study|Protocol Violation|1|||
126465771|NCT01178073|455007681|FG001|Overall Study|Protocol Violation|1|||
126465772|NCT01178073|455007682|FG002|Overall Study|Protocol Violation|1|||
126465773|NCT01178073|455007680|FG000|Overall Study|Lost to Follow-up|2|||
126465774|NCT01178073|455007681|FG001|Overall Study|Lost to Follow-up|0|||
126465775|NCT01178073|455007682|FG002|Overall Study|Lost to Follow-up|3|||
126465776|NCT01178073|455007680|FG000|Overall Study|Physician Decision|14|||
126552697|NCT02087150|455318486|FG001|Overall Study|Pt moved out of town|1|||
126552698|NCT02087150|455318487|FG002|Overall Study|Pt moved out of town|0|||
126552699|NCT02372058|455318489|FG000|Overall Study|Withdrawal by Subject|3|||
126771005|NCT00422058|456116237|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
126309370|NCT02691936|454421031|FG001|Overall Study|Withdrawal by Subject|5|||
126309371|NCT00834639|454421032|FG000|Second Intervention|Physician Decision|0|||
126309372|NCT00834639|454421033|FG001|Second Intervention|Physician Decision|2|||
126309373|NCT03382834|454421036|FG000|Step 1|Lost to Follow-up|0|||
126309374|NCT03382834|454421037|FG001|Step 1|Lost to Follow-up|1|||
126309375|NCT03382834|454421036|FG000|Step 2|Death|1|||
126309376|NCT03382834|454421037|FG001|Step 2|Death|0|||
126309377|NCT03382834|454421036|FG000|Step 2|Lost to Follow-up|2|||
126309378|NCT03382834|454421037|FG001|Step 2|Lost to Follow-up|2|||
126309379|NCT03382834|454421036|FG000|Step 2|Site Terminated by Sponsor|1|||
126309380|NCT03382834|454421037|FG001|Step 2|Site Terminated by Sponsor|0|||
126309381|NCT02387957|454421038|FG000|Overall Study|The study was discontinued|21|||
126309382|NCT02387957|454421039|FG001|Overall Study|The study was discontinued|21|||
126309383|NCT02387957|454421040|FG002|Overall Study|The study was discontinued|20|||
126309384|NCT00977314|454421045|FG000|Overall Study|Withdrawal by Subject|1|||
126309385|NCT00977314|454421046|FG001|Overall Study|Withdrawal by Subject|0|||
126309386|NCT00977314|454421045|FG000|Overall Study|Physician Decision|1|||
126309387|NCT00977314|454421046|FG001|Overall Study|Physician Decision|0|||
126309388|NCT01343277|454421050|FG000|Overall Study|Other|3|||
126309389|NCT01343277|454421051|FG001|Overall Study|Other|3|||
126309390|NCT01343277|454421050|FG000|Overall Study|Withdrawal by Subject|18|||
126309391|NCT01343277|454421051|FG001|Overall Study|Withdrawal by Subject|13|||
126309392|NCT01343277|454421050|FG000|Overall Study|Physician Decision|1|||
126309393|NCT01343277|454421051|FG001|Overall Study|Physician Decision|2|||
126309394|NCT01343277|454421050|FG000|Overall Study|Death|10|||
126309395|NCT01343277|454421051|FG001|Overall Study|Death|1|||
126552700|NCT00972179|455318491|FG000|Overall Study|Noncompliance|1|||
126465777|NCT01178073|455007681|FG001|Overall Study|Physician Decision|10|||
126465778|NCT01178073|455007682|FG002|Overall Study|Physician Decision|10|||
126465779|NCT01178073|455007680|FG000|Overall Study|Withdrawal by Subject|10|||
126309396|NCT01343277|454421050|FG000|Overall Study|Adverse Event|67|||
126309397|NCT01343277|454421051|FG001|Overall Study|Adverse Event|13|||
126309398|NCT01343277|454421050|FG000|Overall Study|Disease progression|270|||
126309399|NCT01343277|454421051|FG001|Overall Study|Disease progression|138|||
126309400|NCT01343277|454421050|FG000|Overall Study|Randomized not treated|6|||
126309401|NCT01343277|454421051|FG001|Overall Study|Randomized not treated|21|||
126309402|NCT01343277|454421050|FG000|Overall Study|Treatment ongoing|8|||
126465780|NCT01178073|455007681|FG001|Overall Study|Withdrawal by Subject|6|||
126465781|NCT01178073|455007682|FG002|Overall Study|Withdrawal by Subject|8|||
126465782|NCT01178073|455007680|FG000|Overall Study|Missing Completion Status|1|||
126465783|NCT01178073|455007681|FG001|Overall Study|Missing Completion Status|0|||
126465784|NCT01178073|455007682|FG002|Overall Study|Missing Completion Status|0|||
126465785|NCT03497676|455007683|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
126465786|NCT03497676|455007684|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
126465787|NCT03497676|455007685|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
126465788|NCT03497676|455007686|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
126465789|NCT03497676|455007683|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
126465790|NCT03497676|455007684|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
126465791|NCT03497676|455007685|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
126465792|NCT03497676|455007686|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
126465793|NCT03497676|455007683|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
126465794|NCT03497676|455007684|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
126465795|NCT03497676|455007685|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
126465796|NCT03497676|455007686|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
126465797|NCT03497676|455007683|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
126465798|NCT03497676|455007684|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
126465799|NCT03497676|455007685|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
126465800|NCT03497676|455007686|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
126465801|NCT03497676|455007683|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
126465802|NCT03497676|455007684|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
126465803|NCT03497676|455007685|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
126465804|NCT03497676|455007686|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
126465805|NCT03497676|455007683|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
126465806|NCT03497676|455007684|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
126465807|NCT03497676|455007685|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
126465808|NCT03497676|455007686|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
126465809|NCT03497676|455007683|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
126465810|NCT03497676|455007684|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
126465811|NCT03497676|455007685|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
126465812|NCT03497676|455007686|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
126465813|NCT03497676|455007683|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
126465814|NCT03497676|455007684|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
126465815|NCT03497676|455007685|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
126465816|NCT03497676|455007686|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
126465817|NCT01226043|455007696|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
126465818|NCT01226043|455007697|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
126465819|NCT01226043|455007698|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
126465820|NCT01226043|455007699|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
126465821|NCT01226043|455007696|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
126465822|NCT01226043|455007697|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
126465823|NCT01226043|455007698|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
126465824|NCT01226043|455007699|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
126465825|NCT01226043|455007696|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
126465826|NCT01226043|455007697|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
126465827|NCT01226043|455007698|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
126465828|NCT01226043|455007699|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
126465829|NCT01226043|455007696|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
126465830|NCT01226043|455007697|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
126465831|NCT01226043|455007698|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
126465832|NCT01226043|455007699|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
126465833|NCT01226043|455007696|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
126465834|NCT01226043|455007697|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
126465835|NCT01226043|455007698|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
126465836|NCT01226043|455007699|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
126465837|NCT01226043|455007696|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
126465838|NCT01226043|455007697|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
126465839|NCT01226043|455007698|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
126465840|NCT01226043|455007699|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
126465841|NCT01226043|455007696|FG000|6-week Re-randomization Phase|Adverse Event|0|||
126465842|NCT01226043|455007697|FG001|6-week Re-randomization Phase|Adverse Event|0|||
126465843|NCT01226043|455007698|FG002|6-week Re-randomization Phase|Adverse Event|1|||
126465844|NCT01226043|455007699|FG003|6-week Re-randomization Phase|Adverse Event|1|||
126465845|NCT01226043|455007696|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
126465846|NCT01226043|455007697|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
126465847|NCT01226043|455007698|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
126465848|NCT01226043|455007699|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
126552701|NCT00972179|455318492|FG001|Overall Study|Noncompliance|0|||
126552702|NCT00972179|455318493|FG002|Overall Study|Noncompliance|0|||
126552703|NCT00972179|455318494|FG003|Overall Study|Noncompliance|0|||
126552704|NCT00972179|455318495|FG004|Overall Study|Noncompliance|1|||
126552705|NCT00972179|455318496|FG005|Overall Study|Noncompliance|0|||
126552706|NCT00972179|455318497|FG006|Overall Study|Noncompliance|1|||
126552707|NCT00972179|455318491|FG000|Overall Study|Withdrawal by Subject|0|||
126552708|NCT00972179|455318492|FG001|Overall Study|Withdrawal by Subject|3|||
126552709|NCT00972179|455318493|FG002|Overall Study|Withdrawal by Subject|0|||
126552710|NCT00972179|455318494|FG003|Overall Study|Withdrawal by Subject|1|||
126552711|NCT00972179|455318495|FG004|Overall Study|Withdrawal by Subject|0|||
126552712|NCT00972179|455318496|FG005|Overall Study|Withdrawal by Subject|0|||
126552713|NCT00972179|455318497|FG006|Overall Study|Withdrawal by Subject|2|||
126552714|NCT00972179|455318491|FG000|Overall Study|Administrative Decision|0|||
126552715|NCT00972179|455318492|FG001|Overall Study|Administrative Decision|0|||
126552716|NCT00972179|455318493|FG002|Overall Study|Administrative Decision|0|||
126552717|NCT00972179|455318494|FG003|Overall Study|Administrative Decision|0|||
126552718|NCT00972179|455318495|FG004|Overall Study|Administrative Decision|1|||
126552719|NCT00972179|455318496|FG005|Overall Study|Administrative Decision|0|||
126552720|NCT00972179|455318497|FG006|Overall Study|Administrative Decision|0|||
126552721|NCT00972179|455318491|FG000|Overall Study|Lost to Follow-up|0|||
126552722|NCT00972179|455318492|FG001|Overall Study|Lost to Follow-up|0|||
126552723|NCT00972179|455318493|FG002|Overall Study|Lost to Follow-up|1|||
126552724|NCT00972179|455318494|FG003|Overall Study|Lost to Follow-up|0|||
126552725|NCT00972179|455318495|FG004|Overall Study|Lost to Follow-up|0|||
126552726|NCT00972179|455318496|FG005|Overall Study|Lost to Follow-up|3|||
126552727|NCT00972179|455318497|FG006|Overall Study|Lost to Follow-up|1|||
126552728|NCT02061761|455318498|FG000|Overall Study|Disease progression|2|||
126552729|NCT02061761|455318499|FG001|Overall Study|Disease progression|8|||
126552730|NCT02061761|455318500|FG002|Overall Study|Disease progression|4|||
126552731|NCT02061761|455318501|FG003|Overall Study|Disease progression|5|||
126552732|NCT02061761|455318502|FG004|Overall Study|Disease progression|9|||
126716578|NCT01356602|455914875|FG002|Overall Study|Withdrawal by Subject|7|||
126716579|NCT01356602|455914873|FG000|Overall Study|Lack of Efficacy|0|||
126716580|NCT01356602|455914874|FG001|Overall Study|Lack of Efficacy|1|||
126309403|NCT01343277|454421051|FG001|Overall Study|Treatment ongoing|2|||
126309404|NCT01343277|454421050|FG000|Overall Study|Subsequent anticancer therapy|1|||
126309405|NCT01343277|454421051|FG001|Overall Study|Subsequent anticancer therapy|0|||
126465849|NCT01226043|455007696|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
126465850|NCT01226043|455007697|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
126465851|NCT01226043|455007698|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
126465852|NCT01226043|455007699|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
126465853|NCT01226043|455007696|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
126465854|NCT01226043|455007697|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
126465855|NCT01226043|455007698|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
126465856|NCT01226043|455007699|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
126465857|NCT01226043|455007696|FG000|6-week Re-randomization Phase|Physician Decision|0|||
126465858|NCT01226043|455007697|FG001|6-week Re-randomization Phase|Physician Decision|0|||
126465859|NCT01226043|455007698|FG002|6-week Re-randomization Phase|Physician Decision|3|||
126465860|NCT01226043|455007699|FG003|6-week Re-randomization Phase|Physician Decision|2|||
126465861|NCT01226043|455007696|FG000|6-week Re-randomization Phase|completed in error|0|||
126465862|NCT01226043|455007697|FG001|6-week Re-randomization Phase|completed in error|0|||
126465863|NCT01226043|455007698|FG002|6-week Re-randomization Phase|completed in error|0|||
126465864|NCT01226043|455007699|FG003|6-week Re-randomization Phase|completed in error|1|||
126465865|NCT01226043|455007696|FG000|30-week Observational Phase|Adverse Event|0|||
126465866|NCT01226043|455007697|FG001|30-week Observational Phase|Adverse Event|0|||
126465867|NCT01226043|455007698|FG002|30-week Observational Phase|Adverse Event|1|||
126465868|NCT01226043|455007699|FG003|30-week Observational Phase|Adverse Event|1|||
126465869|NCT01226043|455007696|FG000|30-week Observational Phase|Protocol Violation|0|||
126465870|NCT01226043|455007697|FG001|30-week Observational Phase|Protocol Violation|0|||
126465871|NCT01226043|455007698|FG002|30-week Observational Phase|Protocol Violation|0|||
126465872|NCT01226043|455007699|FG003|30-week Observational Phase|Protocol Violation|1|||
126465873|NCT01226043|455007696|FG000|30-week Observational Phase|Lost to Follow-up|0|||
126465874|NCT01226043|455007697|FG001|30-week Observational Phase|Lost to Follow-up|0|||
126552733|NCT02061761|455318503|FG005|Overall Study|Disease progression|3|||
126552734|NCT02061761|455318504|FG006|Overall Study|Disease progression|1|||
126716581|NCT01356602|455914875|FG002|Overall Study|Lack of Efficacy|4|||
126465875|NCT01226043|455007698|FG002|30-week Observational Phase|Lost to Follow-up|2|||
126552735|NCT02061761|455318505|FG007|Overall Study|Disease progression|2|||
126552736|NCT02061761|455318506|FG008|Overall Study|Disease progression|28|||
126552737|NCT02061761|455318498|FG000|Overall Study|Study Drug toxicity|0|||
126552738|NCT02061761|455318499|FG001|Overall Study|Study Drug toxicity|0|||
126552739|NCT02061761|455318500|FG002|Overall Study|Study Drug toxicity|0|||
126552740|NCT02061761|455318501|FG003|Overall Study|Study Drug toxicity|0|||
126552741|NCT02061761|455318502|FG004|Overall Study|Study Drug toxicity|0|||
126309406|NCT02964208|454421059|FG000|Overall Study|Death|103|||
126716582|NCT01356602|455914873|FG000|Overall Study|Adverse Event|0|||
126309407|NCT02964208|454421059|FG000|Overall Study|Withdrawal by Subject|6|||
126309408|NCT02964208|454421059|FG000|Overall Study|Lost to Follow-up|6|||
126309409|NCT02964208|454421059|FG000|Overall Study|Unsuccessful Procedure|5|||
126309410|NCT02964208|454421059|FG000|Overall Study|Device Explant|1|||
126309411|NCT02964208|454421059|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
126309412|NCT05270395|454421075|FG000|Overall Study|Lost to Follow-up|2|||
126309413|NCT05270395|454421076|FG001|Overall Study|Lost to Follow-up|2|||
126309414|NCT05270395|454421075|FG000|Overall Study|Death|1|||
126309415|NCT05270395|454421076|FG001|Overall Study|Death|2|||
126309416|NCT05270395|454421075|FG000|Overall Study|Study Team Withdrew|1|||
126309417|NCT05270395|454421076|FG001|Overall Study|Study Team Withdrew|0|||
126309418|NCT03725761|454421077|FG000|Overall Study|still on study|1|||
126309419|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
126309420|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
126309421|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
126309422|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
126309423|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Death|0|||
126309424|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Death|0|||
126372958|NCT01628913|454663317|FG001|Overall Study|Protocol Violation|0|||
126372959|NCT01628913|454663316|FG000|Overall Study|Death|1|||
126372960|NCT01628913|454663317|FG001|Overall Study|Death|0|||
126372961|NCT01628913|454663316|FG000|Overall Study|study terminated by Sponsor|4|||
126372962|NCT01628913|454663317|FG001|Overall Study|study terminated by Sponsor|9|||
126372963|NCT01628913|454663316|FG000|Overall Study|Withdrawal by Subject|1|||
126372964|NCT01628913|454663317|FG001|Overall Study|Withdrawal by Subject|0|||
126372965|NCT01628913|454663316|FG000|Overall Study|Physician Decision|1|||
126372966|NCT01628913|454663317|FG001|Overall Study|Physician Decision|3|||
126372967|NCT04778592|454663325|FG000|Overall Study|Adverse Event|1|||
126372968|NCT04778592|454663326|FG001|Overall Study|Adverse Event|2|||
126372969|NCT04778592|454663325|FG000|Overall Study|Withdrawal by Subject|1|||
126372970|NCT04778592|454663326|FG001|Overall Study|Withdrawal by Subject|2|||
126372971|NCT01192126|454663327|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
126372972|NCT01192126|454663328|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
126372973|NCT01192126|454663327|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
126372974|NCT01192126|454663328|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
126372975|NCT04102007|454663329|FG000|Overall Study|Adverse Event|4|||
126372976|NCT04102007|454663329|FG000|Overall Study|Lost to Follow-up|3|||
126372977|NCT04102007|454663329|FG000|Overall Study|Withdrawal by Subject|12|||
126372978|NCT04102007|454663329|FG000|Overall Study|Eligibility Violation|5|||
126372979|NCT04102007|454663329|FG000|Overall Study|Lack of Efficacy|6|||
126372980|NCT04102007|454663329|FG000|Overall Study|Protocol Deviation|5|||
126372981|NCT04102007|454663329|FG000|Overall Study|Protocol Compliance|1|||
126372982|NCT04102007|454663329|FG000|Overall Study|Withdrew Treatment|2|||
126372983|NCT04102007|454663329|FG000|Overall Study|Pregnancy|1|||
126372984|NCT02660229|454663330|FG000|Overall Study|Adverse Event|2|||
126372985|NCT02660229|454663331|FG001|Overall Study|Adverse Event|0|||
126372986|NCT02660229|454663330|FG000|Overall Study|Withdrawal by Subject|0|||
126372987|NCT02660229|454663331|FG001|Overall Study|Withdrawal by Subject|1|||
126372988|NCT00892008|454663332|FG000|Overall Study|Death|5|||
126372989|NCT00892008|454663332|FG000|Overall Study|Lack of Efficacy|3|||
126372990|NCT00892008|454663332|FG000|Overall Study|Lost to Follow-up|142|||
126372991|NCT00892008|454663332|FG000|Overall Study|Other|378|||
126372992|NCT00892008|454663332|FG000|Overall Study|Adverse Event|37|||
126372993|NCT00399529|454663333|FG000|Overall Study|Off Study Prior to Treatment|2|||
126372994|NCT02133573|454663334|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
126372995|NCT02133573|454663335|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
126372996|NCT02133573|454663334|FG000|Overall Study|Child Deaths|3|||
126372997|NCT02133573|454663335|FG001|Overall Study|Child Deaths|5|||
126372998|NCT02133573|454663334|FG000|Overall Study|Child Declined Follow Ups|2|||
126372999|NCT02133573|454663335|FG001|Overall Study|Child Declined Follow Ups|1|||
126373000|NCT02133573|454663334|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
126373001|NCT02133573|454663335|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
126373002|NCT02431325|454663338|FG000|Overall Study|Adverse Event|3|||
126373003|NCT02431325|454663339|FG001|Overall Study|Adverse Event|0|||
126373004|NCT02431325|454663338|FG000|Overall Study|Lost to Follow-up|0|||
126373005|NCT02431325|454663339|FG001|Overall Study|Lost to Follow-up|1|||
126373006|NCT02431325|454663338|FG000|Overall Study|Withdrawal by Subject|1|||
126373007|NCT02431325|454663339|FG001|Overall Study|Withdrawal by Subject|2|||
126373008|NCT02431325|454663338|FG000|Overall Study|Declined to take study medication|1|||
126373009|NCT02431325|454663339|FG001|Overall Study|Declined to take study medication|0|||
126373010|NCT02431325|454663338|FG000|Overall Study|Withdrew before starting study medication|1|||
126373011|NCT02431325|454663339|FG001|Overall Study|Withdrew before starting study medication|0|||
126552742|NCT02061761|455318503|FG005|Overall Study|Study Drug toxicity|1|||
126552743|NCT02061761|455318504|FG006|Overall Study|Study Drug toxicity|0|||
126552744|NCT02061761|455318505|FG007|Overall Study|Study Drug toxicity|2|||
126552745|NCT02061761|455318506|FG008|Overall Study|Study Drug toxicity|6|||
126552746|NCT02061761|455318498|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
126552747|NCT02061761|455318499|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
126552748|NCT02061761|455318500|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
126552749|NCT02061761|455318501|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
126552750|NCT02061761|455318502|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
126552751|NCT02061761|455318503|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
126552752|NCT02061761|455318504|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
126552753|NCT02061761|455318505|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
126552754|NCT02061761|455318506|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
126552755|NCT02061761|455318498|FG000|Overall Study|Participant request to discontinue study treatment|0|||
126552756|NCT02061761|455318499|FG001|Overall Study|Participant request to discontinue study treatment|0|||
126552757|NCT02061761|455318500|FG002|Overall Study|Participant request to discontinue study treatment|2|||
126309425|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Death|1|||
126309426|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Death|0|||
126309427|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
126309428|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
126309429|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
126309430|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
126309431|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
126309432|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
126309433|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
126309434|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
126309435|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
126309436|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
126309437|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
126309438|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
126309439|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
126309440|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
126309441|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
126309442|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
126309443|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
126309444|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
126309445|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
126309446|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
126309447|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
126309448|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
126309449|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
126309450|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
126309451|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
126309452|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
126309453|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126309454|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126309455|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
126309456|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
126309457|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
126309458|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
126309459|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
126309460|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
126309461|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
126309462|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
126309463|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Other|8|||
126309464|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Other|14|||
126309465|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Other|8|||
126309466|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Other|23|||
126309467|NCT01106677|454423099|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
126309468|NCT01106677|454423100|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
126309469|NCT01106677|454423101|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
126552758|NCT02061761|455318501|FG003|Overall Study|Participant request to discontinue study treatment|2|||
126552759|NCT02061761|455318502|FG004|Overall Study|Participant request to discontinue study treatment|0|||
126552760|NCT02061761|455318503|FG005|Overall Study|Participant request to discontinue study treatment|1|||
126309470|NCT01106677|454423102|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
126771006|NCT00422058|456116232|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
126552761|NCT02061761|455318504|FG006|Overall Study|Participant request to discontinue study treatment|0|||
126552762|NCT02061761|455318505|FG007|Overall Study|Participant request to discontinue study treatment|0|||
126552763|NCT02061761|455318506|FG008|Overall Study|Participant request to discontinue study treatment|2|||
126552764|NCT02061761|455318498|FG000|Overall Study|Withdrawal by Subject|0|||
126552765|NCT02061761|455318499|FG001|Overall Study|Withdrawal by Subject|0|||
126552766|NCT02061761|455318500|FG002|Overall Study|Withdrawal by Subject|0|||
126552767|NCT02061761|455318501|FG003|Overall Study|Withdrawal by Subject|0|||
126552768|NCT02061761|455318502|FG004|Overall Study|Withdrawal by Subject|0|||
126552769|NCT02061761|455318503|FG005|Overall Study|Withdrawal by Subject|0|||
126552770|NCT02061761|455318504|FG006|Overall Study|Withdrawal by Subject|0|||
126552771|NCT02061761|455318505|FG007|Overall Study|Withdrawal by Subject|0|||
126552772|NCT02061761|455318506|FG008|Overall Study|Withdrawal by Subject|2|||
126552773|NCT02061761|455318498|FG000|Overall Study|Maximum clinical benefit|0|||
126552774|NCT02061761|455318499|FG001|Overall Study|Maximum clinical benefit|0|||
126552775|NCT02061761|455318500|FG002|Overall Study|Maximum clinical benefit|0|||
126552776|NCT02061761|455318501|FG003|Overall Study|Maximum clinical benefit|1|||
126552777|NCT02061761|455318502|FG004|Overall Study|Maximum clinical benefit|0|||
126552778|NCT02061761|455318503|FG005|Overall Study|Maximum clinical benefit|0|||
126552779|NCT02061761|455318504|FG006|Overall Study|Maximum clinical benefit|0|||
126552780|NCT02061761|455318505|FG007|Overall Study|Maximum clinical benefit|0|||
126552781|NCT02061761|455318506|FG008|Overall Study|Maximum clinical benefit|6|||
126552782|NCT02061761|455318498|FG000|Overall Study|Participant no longer meets study criteria|0|||
126552783|NCT02061761|455318499|FG001|Overall Study|Participant no longer meets study criteria|0|||
126552784|NCT02061761|455318500|FG002|Overall Study|Participant no longer meets study criteria|0|||
126552785|NCT02061761|455318501|FG003|Overall Study|Participant no longer meets study criteria|0|||
126552786|NCT02061761|455318502|FG004|Overall Study|Participant no longer meets study criteria|0|||
126552787|NCT02061761|455318503|FG005|Overall Study|Participant no longer meets study criteria|0|||
126552788|NCT02061761|455318504|FG006|Overall Study|Participant no longer meets study criteria|0|||
126552789|NCT02061761|455318505|FG007|Overall Study|Participant no longer meets study criteria|0|||
126552790|NCT02061761|455318506|FG008|Overall Study|Participant no longer meets study criteria|1|||
126552791|NCT02061761|455318498|FG000|Overall Study|Other reasons|0|||
126552792|NCT02061761|455318499|FG001|Overall Study|Other reasons|0|||
126552793|NCT02061761|455318500|FG002|Overall Study|Other reasons|0|||
126552794|NCT02061761|455318501|FG003|Overall Study|Other reasons|0|||
126552795|NCT02061761|455318502|FG004|Overall Study|Other reasons|2|||
126552796|NCT02061761|455318503|FG005|Overall Study|Other reasons|0|||
126552797|NCT02061761|455318504|FG006|Overall Study|Other reasons|0|||
126552798|NCT02061761|455318505|FG007|Overall Study|Other reasons|0|||
126552799|NCT02061761|455318506|FG008|Overall Study|Other reasons|6|||
126552800|NCT02500316|455318513|FG000|Overall Study|Adverse Event|3|||
126552801|NCT02500316|455318513|FG000|Overall Study|Lost to Follow-up|2|||
126552802|NCT02500316|455318513|FG000|Overall Study|Protocol Violation|1|||
126552803|NCT02500316|455318513|FG000|Overall Study|Withdrawal by Subject|15|||
126552804|NCT02500316|455318513|FG000|Overall Study|Final height achieved|5|||
126552805|NCT02500316|455318513|FG000|Overall Study|Due to war activity|1|||
126552806|NCT01163747|455318514|FG000|Overall Study|Adverse Event|0|||
126552807|NCT01163747|455318515|FG001|Overall Study|Adverse Event|5|||
126552808|NCT01163747|455318514|FG000|Overall Study|Insufficient Therapeutic Response|0|||
126552809|NCT01163747|455318515|FG001|Overall Study|Insufficient Therapeutic Response|1|||
126552810|NCT01163747|455318514|FG000|Overall Study|Protocol Violation|0|||
126552811|NCT01163747|455318515|FG001|Overall Study|Protocol Violation|1|||
126552812|NCT01163747|455318514|FG000|Overall Study|Refused Treatment|6|||
126552813|NCT01163747|455318515|FG001|Overall Study|Refused Treatment|4|||
126552814|NCT03681639|455320469|FG000|Overall Study|Death|4|||
126552815|NCT03681639|455320469|FG000|Overall Study|Lost to Follow-up|2|||
126771007|NCT00422058|456116233|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
126309471|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
126309472|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
126309473|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
126309474|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
126309475|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Death|0|||
126309476|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Death|0|||
126309477|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Death|0|||
126309478|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Death|1|||
126309479|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
126552816|NCT03681639|455320469|FG000|Overall Study|Withdrawal by Subject|1|||
126552817|NCT03681639|455320469|FG000|Overall Study|Adverse Event|2|||
126552818|NCT00654940|455320470|FG000|Period 1|Adverse Event|0|||
126552819|NCT00654940|455320471|FG001|Period 1|Adverse Event|1|||
126552820|NCT00654940|455320470|FG000|Period 1|Intolerable Pain Level|1|||
126552821|NCT00654940|455320471|FG001|Period 1|Intolerable Pain Level|0|||
126552822|NCT04714216|455320472|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
126552823|NCT04714216|455320472|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
126552824|NCT00581113|455320473|FG000|Overall Study|Withdrawal by Subject|0|||
126465876|NCT01226043|455007699|FG003|30-week Observational Phase|Lost to Follow-up|2|||
126465877|NCT01226043|455007696|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
126465878|NCT01226043|455007697|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
126465879|NCT01226043|455007698|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
126465880|NCT01226043|455007699|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
126465881|NCT01226043|455007696|FG000|30-week Observational Phase|Physician Decision|0|||
126465882|NCT01226043|455007697|FG001|30-week Observational Phase|Physician Decision|0|||
126465883|NCT01226043|455007698|FG002|30-week Observational Phase|Physician Decision|2|||
126465884|NCT01226043|455007699|FG003|30-week Observational Phase|Physician Decision|2|||
126465885|NCT00910988|455007700|FG000|Overall Study|Lost to Follow-up|2|||
126465886|NCT00910988|455007701|FG001|Overall Study|Lost to Follow-up|4|||
126465887|NCT00910988|455007702|FG002|Overall Study|Lost to Follow-up|3|||
126465888|NCT00910988|455007703|FG003|Overall Study|Lost to Follow-up|0|||
126465889|NCT03004443|455007704|FG000|Overall Study|Pregnancy|0|||
126465890|NCT03004443|455007705|FG001|Overall Study|Pregnancy|1|||
126465891|NCT00828854|455007706|FG000|Overall Study|Disease Progression|17|||
126465892|NCT00828854|455007706|FG000|Overall Study|Adverse Event|9|||
126465893|NCT00828854|455007706|FG000|Overall Study|Reason not Specified|1|||
126465894|NCT00191646|455007708|FG000|Overall Study|Toxicity|26|||
126465895|NCT00191646|455007709|FG001|Overall Study|Toxicity|37|||
126465896|NCT00191646|455007708|FG000|Overall Study|Disease Progression|5|||
126465897|NCT00191646|455007709|FG001|Overall Study|Disease Progression|6|||
126465898|NCT00191646|455007708|FG000|Overall Study|Physician Decision|20|||
126465899|NCT00191646|455007709|FG001|Overall Study|Physician Decision|11|||
126465900|NCT00191646|455007708|FG000|Overall Study|Withdrawal by Subject|58|||
126465901|NCT00191646|455007709|FG001|Overall Study|Withdrawal by Subject|39|||
126465902|NCT00191646|455007708|FG000|Overall Study|Protocol Violation|5|||
126465903|NCT00191646|455007709|FG001|Overall Study|Protocol Violation|7|||
126465904|NCT00191646|455007708|FG000|Overall Study|Death|6|||
126465905|NCT00191646|455007709|FG001|Overall Study|Death|8|||
126465906|NCT00191646|455007708|FG000|Overall Study|Other|33|||
126465907|NCT00191646|455007709|FG001|Overall Study|Other|34|||
126465908|NCT00191646|455007708|FG000|Overall Study|Missing Data|18|||
126465909|NCT00191646|455007709|FG001|Overall Study|Missing Data|11|||
126465910|NCT05211284|455007714|FG000|Overall Study|Study Terminated|3|||
126465911|NCT05211284|455007715|FG001|Overall Study|Study Terminated|1|||
126465912|NCT03911843|455007716|FG000|Overall Study|Adverse Event|2|||
126465913|NCT03911843|455007717|FG001|Overall Study|Adverse Event|0|||
126465914|NCT03911843|455007716|FG000|Overall Study|Protocol Violation|2|||
126465915|NCT03911843|455007717|FG001|Overall Study|Protocol Violation|0|||
126465916|NCT03911843|455007716|FG000|Overall Study|Lost to Follow-up|0|||
126465917|NCT03911843|455007717|FG001|Overall Study|Lost to Follow-up|1|||
126465918|NCT01907100|455007718|FG000|Overall Study|PD based on modified RECIST criteria|31|||
126465919|NCT01907100|455007719|FG001|Overall Study|PD based on modified RECIST criteria|32|||
126465920|NCT01907100|455007720|FG002|Overall Study|PD based on modified RECIST criteria|95|||
126465921|NCT01907100|455007721|FG003|Overall Study|PD based on modified RECIST criteria|92|||
126465922|NCT01907100|455007718|FG000|Overall Study|Withdrawal by Subject|2|||
126465923|NCT01907100|455007719|FG001|Overall Study|Withdrawal by Subject|5|||
126465924|NCT01907100|455007720|FG002|Overall Study|Withdrawal by Subject|10|||
126465925|NCT01907100|455007721|FG003|Overall Study|Withdrawal by Subject|13|||
126465926|NCT01907100|455007718|FG000|Overall Study|Protocol Violation|0|||
126716583|NCT01356602|455914874|FG001|Overall Study|Adverse Event|1|||
126716584|NCT01356602|455914875|FG002|Overall Study|Adverse Event|1|||
126716585|NCT01115569|455914876|FG000|Conversion/Titration Phase|Adverse Event|59|||
126309480|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
126309481|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
126309482|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
126309483|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
126309484|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
126309485|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
126309486|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
126309487|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
126309488|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
126465927|NCT01907100|455007719|FG001|Overall Study|Protocol Violation|0|||
126465928|NCT01907100|455007720|FG002|Overall Study|Protocol Violation|1|||
126465929|NCT01907100|455007721|FG003|Overall Study|Protocol Violation|1|||
126465930|NCT01907100|455007718|FG000|Overall Study|Lost to Follow-up|0|||
126465931|NCT01907100|455007719|FG001|Overall Study|Lost to Follow-up|0|||
126465932|NCT01907100|455007720|FG002|Overall Study|Lost to Follow-up|0|||
126465933|NCT01907100|455007721|FG003|Overall Study|Lost to Follow-up|1|||
126465934|NCT01907100|455007718|FG000|Overall Study|Not treated|2|||
126465935|NCT01907100|455007719|FG001|Overall Study|Not treated|0|||
126465936|NCT01907100|455007720|FG002|Overall Study|Not treated|1|||
126465937|NCT01907100|455007721|FG003|Overall Study|Not treated|2|||
126465938|NCT01907100|455007718|FG000|Overall Study|Other than reasons specified|1|||
126465939|NCT01907100|455007719|FG001|Overall Study|Other than reasons specified|0|||
126716586|NCT01115569|455914877|FG001|Conversion/Titration Phase|Adverse Event|0|||
126552825|NCT00581113|455320474|FG001|Overall Study|Withdrawal by Subject|1|||
126552826|NCT01818141|455320475|FG000|Overall Study|Withdrawal by Subject|2|||
126552827|NCT01818141|455320476|FG001|Overall Study|Withdrawal by Subject|0|||
126716587|NCT01115569|455914876|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
126716588|NCT01115569|455914877|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
126716589|NCT01115569|455914876|FG000|Conversion/Titration Phase|Physician Decision|5|||
126716590|NCT01115569|455914877|FG001|Conversion/Titration Phase|Physician Decision|0|||
126309489|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
126309490|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
126309491|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
126309492|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126309493|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126309494|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126309495|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126309496|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
126309497|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
126309498|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126309499|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
126309500|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
126309501|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
126309502|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
126309503|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126309504|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126309505|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
126309506|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
126309507|NCT01106677|454423099|FG000|Extension Period: Week 26 to Week 52|Other|6|||
126309508|NCT01106677|454423100|FG001|Extension Period: Week 26 to Week 52|Other|5|||
126309509|NCT01106677|454423101|FG002|Extension Period: Week 26 to Week 52|Other|8|||
126309510|NCT01106677|454423102|FG003|Extension Period: Week 26 to Week 52|Other|5|||
126309511|NCT03937908|454423103|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
126309512|NCT03937908|454423104|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
126309513|NCT03875092|454423105|FG000|Overall Study|Adverse Event|2|||
126309514|NCT03875092|454423106|FG001|Overall Study|Adverse Event|5|||
126309515|NCT03875092|454423105|FG000|Overall Study|Death|44|||
126309516|NCT03875092|454423106|FG001|Overall Study|Death|51|||
126309517|NCT03875092|454423105|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
126309518|NCT03875092|454423106|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
126309519|NCT03205761|454423107|FG000|Overall Study|Withdrawal by Subject|1|||
126309520|NCT03205761|454423107|FG000|Overall Study|Progressive Disease|10|||
126309521|NCT04420585|454423108|FG000|Overall Study|Adverse Event|1|||
126309522|NCT04420585|454423108|FG000|Overall Study|Never initiated medication|2|||
126309523|NCT02163226|454423109|FG000|Overall Study|Death|2|||
126309524|NCT02163226|454423110|FG001|Overall Study|Death|1|||
126309525|NCT02163226|454423109|FG000|Overall Study|Withdrawal by Subject|5|||
126309526|NCT02163226|454423110|FG001|Overall Study|Withdrawal by Subject|2|||
126309527|NCT02163226|454423109|FG000|Overall Study|Returned home, local radiotherapy|3|||
126309528|NCT02163226|454423110|FG001|Overall Study|Returned home, local radiotherapy|0|||
126373012|NCT02431325|454663338|FG000|Overall Study|Placebo shortage|2|||
126373013|NCT02431325|454663339|FG001|Overall Study|Placebo shortage|0|||
126373014|NCT00744861|454663340|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
126373015|NCT00744861|454663341|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
126373016|NCT00744861|454663342|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
126373017|NCT00744861|454663343|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
126373018|NCT00744861|454663340|FG000|Feasibility Stage 1|Pregnancy|0|||
126373019|NCT00744861|454663341|FG001|Feasibility Stage 1|Pregnancy|1|||
126373020|NCT00744861|454663342|FG002|Feasibility Stage 1|Pregnancy|0|||
126373021|NCT00744861|454663343|FG003|Feasibility Stage 1|Pregnancy|0|||
126373022|NCT00744861|454663340|FG000|Pivotal Stage 2|Adverse Event|0|||
126373023|NCT00744861|454663341|FG001|Pivotal Stage 2|Adverse Event|0|||
126373024|NCT00744861|454663342|FG002|Pivotal Stage 2|Adverse Event|6|||
126373025|NCT00744861|454663343|FG003|Pivotal Stage 2|Adverse Event|11|||
126373026|NCT00744861|454663340|FG000|Pivotal Stage 2|Death|0|||
126373027|NCT00744861|454663341|FG001|Pivotal Stage 2|Death|0|||
126373028|NCT00744861|454663342|FG002|Pivotal Stage 2|Death|0|||
126373029|NCT00744861|454663343|FG003|Pivotal Stage 2|Death|1|||
126373030|NCT00744861|454663340|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
126373031|NCT00744861|454663341|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
126373032|NCT00744861|454663342|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
126373033|NCT00744861|454663343|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
126373034|NCT00744861|454663340|FG000|Pivotal Stage 2|Physician Decision|0|||
126373035|NCT00744861|454663341|FG001|Pivotal Stage 2|Physician Decision|0|||
126716591|NCT01115569|455914876|FG000|Conversion/Titration Phase|Protocol Violation|68|||
126552828|NCT01818141|455320475|FG000|Overall Study|No baseline C.diff colonies|1|||
126552829|NCT01818141|455320476|FG001|Overall Study|No baseline C.diff colonies|1|||
126552830|NCT01818141|455320475|FG000|Overall Study|Lost to Follow-up|0|||
126552831|NCT01818141|455320476|FG001|Overall Study|Lost to Follow-up|2|||
126552832|NCT00619476|455320477|FG000|Overall Study|Adverse Event|12|||
126552833|NCT00619476|455320478|FG001|Overall Study|Adverse Event|6|||
126552834|NCT00619476|455320479|FG002|Overall Study|Adverse Event|12|||
126552835|NCT00619476|455320480|FG003|Overall Study|Adverse Event|16|||
126552836|NCT00619476|455320477|FG000|Overall Study|Lack of Efficacy|6|||
126552837|NCT00619476|455320478|FG001|Overall Study|Lack of Efficacy|1|||
126552838|NCT00619476|455320479|FG002|Overall Study|Lack of Efficacy|1|||
126552839|NCT00619476|455320480|FG003|Overall Study|Lack of Efficacy|4|||
126309529|NCT02163226|454423109|FG000|Overall Study|Repeat imaging showed no disease|2|||
126309530|NCT02163226|454423110|FG001|Overall Study|Repeat imaging showed no disease|0|||
126309531|NCT02163226|454423109|FG000|Overall Study|Incomplete radiotherapy|3|||
126309532|NCT02163226|454423110|FG001|Overall Study|Incomplete radiotherapy|0|||
126309533|NCT02163226|454423109|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
126309534|NCT02163226|454423110|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
126309535|NCT02163226|454423109|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
126309536|NCT02163226|454423110|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
126309537|NCT02163226|454423109|FG000|Overall Study|ineligible|0|||
126309538|NCT02163226|454423110|FG001|Overall Study|ineligible|3|||
126309539|NCT04114357|454423111|FG000|Baseline-Randomization|Adverse Event|2|||
126309540|NCT04114357|454423112|FG001|Baseline-Randomization|Adverse Event|1|||
126309541|NCT04114357|454423111|FG000|Baseline-Randomization|Lost to Follow-up|1|||
126309542|NCT04114357|454423112|FG001|Baseline-Randomization|Lost to Follow-up|1|||
126309543|NCT04114357|454423111|FG000|Cross-over|Adverse Event|0|||
126309544|NCT04114357|454423112|FG001|Cross-over|Adverse Event|1|||
126309545|NCT00477750|454423113|FG000|Overall Study|Currently Receiving Treatment|11|||
126309546|NCT00784238|454423114|FG000|Overall Study|Adverse Event|14|||
126309547|NCT00784238|454423114|FG000|Overall Study|Death|2|||
126309548|NCT00784238|454423114|FG000|Overall Study|Lack of Efficacy|33|||
126309549|NCT00784238|454423114|FG000|Overall Study|Lost to Follow-up|29|||
126373036|NCT00744861|454663342|FG002|Pivotal Stage 2|Physician Decision|3|||
126373037|NCT00744861|454663343|FG003|Pivotal Stage 2|Physician Decision|1|||
126373038|NCT00744861|454663340|FG000|Pivotal Stage 2|Protocol Violation|0|||
126373039|NCT00744861|454663341|FG001|Pivotal Stage 2|Protocol Violation|0|||
126373040|NCT00744861|454663342|FG002|Pivotal Stage 2|Protocol Violation|0|||
126373041|NCT00744861|454663343|FG003|Pivotal Stage 2|Protocol Violation|1|||
126373042|NCT00744861|454663340|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
126373043|NCT00744861|454663341|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
126373044|NCT00744861|454663342|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
126373045|NCT00744861|454663343|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
126373046|NCT00744861|454663340|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
126373047|NCT00744861|454663341|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
126373048|NCT00744861|454663342|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
126373049|NCT00744861|454663343|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
126373050|NCT01567722|454663354|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
126373051|NCT01567722|454663355|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
126373052|NCT01567722|454663356|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
126373053|NCT01567722|454663354|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
126373054|NCT01567722|454663355|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
126373055|NCT01567722|454663356|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
126373056|NCT01567722|454663354|FG000|Overall Study|Protocol closure by the OCG|2|||
126373057|NCT01567722|454663355|FG001|Overall Study|Protocol closure by the OCG|0|||
126373058|NCT01567722|454663356|FG002|Overall Study|Protocol closure by the OCG|0|||
126373059|NCT01567722|454663354|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
126373060|NCT01567722|454663355|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
126373061|NCT01567722|454663356|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
126373062|NCT00382174|454663357|FG000|Overall Study|Lost to Follow-up|1|||
126373063|NCT00382174|454663358|FG001|Overall Study|Lost to Follow-up|4|||
126373064|NCT00382174|454663359|FG002|Overall Study|Lost to Follow-up|5|||
126373065|NCT00382174|454663357|FG000|Overall Study|Adverse Event|1|||
126373066|NCT00382174|454663358|FG001|Overall Study|Adverse Event|4|||
126373067|NCT00382174|454663359|FG002|Overall Study|Adverse Event|5|||
126373068|NCT00382174|454663357|FG000|Overall Study|Withdrawal by Subject|1|||
126552840|NCT00619476|455320477|FG000|Overall Study|Protocol Violation|5|||
126309550|NCT00784238|454423114|FG000|Overall Study|Pregnancy|1|||
126309551|NCT00784238|454423114|FG000|Overall Study|Withdrawal by Subject|26|||
126309552|NCT00784238|454423114|FG000|Overall Study|Other|14|||
126309553|NCT03693612|454423115|FG000|Overall Study|Lost to Follow-up|0|||
126552841|NCT00619476|455320478|FG001|Overall Study|Protocol Violation|4|||
126552842|NCT00619476|455320479|FG002|Overall Study|Protocol Violation|4|||
126465940|NCT01907100|455007720|FG002|Overall Study|Other than reasons specified|10|||
126465941|NCT01907100|455007721|FG003|Overall Study|Other than reasons specified|6|||
126465942|NCT01907100|455007718|FG000|Overall Study|Adverse event (AE)|6|||
126465943|NCT01907100|455007719|FG001|Overall Study|Adverse event (AE)|3|||
126465944|NCT01907100|455007720|FG002|Overall Study|Adverse event (AE)|22|||
126465945|NCT01907100|455007721|FG003|Overall Study|Adverse event (AE)|23|||
126465946|NCT01907100|455007718|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
126465947|NCT01907100|455007719|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
126465948|NCT01907100|455007720|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
126465949|NCT01907100|455007721|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
126465950|NCT00739596|455007726|FG000|Overall Study|Adverse Event|12|||
126465951|NCT00739596|455007727|FG001|Overall Study|Adverse Event|6|||
126465952|NCT00739596|455007726|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
126465953|NCT00739596|455007727|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126465954|NCT00739596|455007726|FG000|Overall Study|Patient Withdrew Consent|8|||
126465955|NCT00739596|455007727|FG001|Overall Study|Patient Withdrew Consent|8|||
126465956|NCT00739596|455007726|FG000|Overall Study|Lost to Follow-up|0|||
126465957|NCT00739596|455007727|FG001|Overall Study|Lost to Follow-up|2|||
126771008|NCT00422058|456116234|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
126309554|NCT03693612|454423116|FG001|Overall Study|Lost to Follow-up|0|||
126309555|NCT03693612|454423117|FG002|Overall Study|Lost to Follow-up|0|||
126309556|NCT03693612|454423118|FG003|Overall Study|Lost to Follow-up|0|||
126309557|NCT03693612|454423119|FG004|Overall Study|Lost to Follow-up|1|||
126309558|NCT03693612|454423120|FG005|Overall Study|Lost to Follow-up|0|||
126309559|NCT03693612|454423121|FG006|Overall Study|Lost to Follow-up|0|||
126309560|NCT03693612|454423115|FG000|Overall Study|Withdrawal by Subject|0|||
126309561|NCT03693612|454423116|FG001|Overall Study|Withdrawal by Subject|0|||
126309562|NCT03693612|454423117|FG002|Overall Study|Withdrawal by Subject|1|||
126309563|NCT03693612|454423118|FG003|Overall Study|Withdrawal by Subject|0|||
126309564|NCT03693612|454423119|FG004|Overall Study|Withdrawal by Subject|2|||
126309565|NCT03693612|454423120|FG005|Overall Study|Withdrawal by Subject|0|||
126309566|NCT03693612|454423121|FG006|Overall Study|Withdrawal by Subject|0|||
126309567|NCT03693612|454423115|FG000|Overall Study|Study Terminated by Sponsor|0|||
126309568|NCT03693612|454423116|FG001|Overall Study|Study Terminated by Sponsor|1|||
126309569|NCT03693612|454423117|FG002|Overall Study|Study Terminated by Sponsor|0|||
126309570|NCT03693612|454423118|FG003|Overall Study|Study Terminated by Sponsor|0|||
126309571|NCT03693612|454423119|FG004|Overall Study|Study Terminated by Sponsor|3|||
126309572|NCT03693612|454423120|FG005|Overall Study|Study Terminated by Sponsor|0|||
126309573|NCT03693612|454423121|FG006|Overall Study|Study Terminated by Sponsor|0|||
126309574|NCT03030989|454423125|FG000|Overall Study|Fever|2|||
126309575|NCT03030989|454423126|FG001|Overall Study|Fever|2|||
126309576|NCT03030989|454423125|FG000|Overall Study|Rash|2|||
126309577|NCT03030989|454423126|FG001|Overall Study|Rash|1|||
126373069|NCT00382174|454663358|FG001|Overall Study|Withdrawal by Subject|4|||
126373070|NCT00382174|454663359|FG002|Overall Study|Withdrawal by Subject|5|||
126373071|NCT00382174|454663357|FG000|Overall Study|Non compliance|1|||
126373072|NCT00382174|454663358|FG001|Overall Study|Non compliance|0|||
126373073|NCT00382174|454663359|FG002|Overall Study|Non compliance|1|||
126373074|NCT00382174|454663357|FG000|Overall Study|Physician Decision|0|||
126373075|NCT00382174|454663358|FG001|Overall Study|Physician Decision|2|||
126373076|NCT00382174|454663359|FG002|Overall Study|Physician Decision|2|||
126373077|NCT00382174|454663357|FG000|Overall Study|Failed to meet criteria|0|||
126373078|NCT00382174|454663358|FG001|Overall Study|Failed to meet criteria|1|||
126373079|NCT00382174|454663359|FG002|Overall Study|Failed to meet criteria|1|||
126373080|NCT00382174|454663357|FG000|Overall Study|Wounds merged|0|||
126373081|NCT00382174|454663358|FG001|Overall Study|Wounds merged|2|||
126373082|NCT00382174|454663359|FG002|Overall Study|Wounds merged|2|||
126373083|NCT02170064|454663365|FG000|Overall Study|Withdrawal by Subject|5|||
126373084|NCT02170064|454663366|FG001|Overall Study|Withdrawal by Subject|1|||
126373085|NCT02170064|454663367|FG002|Overall Study|Withdrawal by Subject|1|||
126373086|NCT02170064|454663365|FG000|Overall Study|Physician Decision|1|||
126373087|NCT02170064|454663366|FG001|Overall Study|Physician Decision|1|||
126373088|NCT02170064|454663367|FG002|Overall Study|Physician Decision|0|||
126373089|NCT03323164|454663368|FG000|Overall Study|Poor quality imaging/scans|2|||
126373090|NCT03323164|454663369|FG001|Overall Study|Poor quality imaging/scans|2|||
126373091|NCT03434834|454663370|FG000|Overall Study|unable to swallow OCT probe|16|||
126373092|NCT03508050|454663378|FG000|Overall Study|Pleural adhesions|1|||
126373093|NCT03508050|454663379|FG001|Overall Study|Pleural adhesions|0|||
126373094|NCT03508050|454663378|FG000|Overall Study|Mucus plug|1|||
126373095|NCT03508050|454663379|FG001|Overall Study|Mucus plug|0|||
126373096|NCT03508050|454663378|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
126373097|NCT03508050|454663379|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
126373098|NCT03508050|454663378|FG000|Overall Study|Sustained desaturation|0|||
126373099|NCT03508050|454663379|FG001|Overall Study|Sustained desaturation|1|||
126373100|NCT03710889|454663383|FG000|Overall Study|Adverse Event|2|||
126465958|NCT00739596|455007726|FG000|Overall Study|Protocol Deviation|1|||
126465959|NCT00739596|455007727|FG001|Overall Study|Protocol Deviation|1|||
126465960|NCT00908011|455007728|FG000|Overall Study|Withdrawal by Subject|2|||
126465961|NCT00908011|455007729|FG001|Overall Study|Withdrawal by Subject|2|||
126465962|NCT00644228|455007730|FG000|Randomization & Eligibility|Ineligible|31|||
126465963|NCT00644228|455007731|FG001|Randomization & Eligibility|Ineligible|21|||
126465964|NCT00644228|455007730|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
126465965|NCT00644228|455007731|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
126465966|NCT00644228|455007730|FG000|Randomization & Eligibility|Invalid Consent|0|||
126465967|NCT00644228|455007731|FG001|Randomization & Eligibility|Invalid Consent|1|||
126465968|NCT00644228|455007730|FG000|Induction Therapy|Adverse Event|22|||
126465969|NCT00644228|455007731|FG001|Induction Therapy|Adverse Event|55|||
126465970|NCT00644228|455007730|FG000|Induction Therapy|Withdrawal by Subject|10|||
126465971|NCT00644228|455007731|FG001|Induction Therapy|Withdrawal by Subject|3|||
126465972|NCT00644228|455007730|FG000|Induction Therapy|Progression/Relapse|24|||
126465973|NCT00644228|455007731|FG001|Induction Therapy|Progression/Relapse|12|||
126465974|NCT00644228|455007730|FG000|Induction Therapy|Death|3|||
126465975|NCT00644228|455007731|FG001|Induction Therapy|Death|7|||
126465976|NCT00644228|455007730|FG000|Induction Therapy|Not Protocol-Specified|24|||
126465977|NCT00644228|455007731|FG001|Induction Therapy|Not Protocol-Specified|28|||
126465978|NCT00644228|455007730|FG000|Maintenance|Adverse Event|27|||
126465979|NCT00644228|455007731|FG001|Maintenance|Adverse Event|31|||
126465980|NCT00644228|455007730|FG000|Maintenance|Withdrawal by Subject|6|||
126465981|NCT00644228|455007731|FG001|Maintenance|Withdrawal by Subject|4|||
126465982|NCT00644228|455007730|FG000|Maintenance|Progression/Relapse|67|||
126465983|NCT00644228|455007731|FG001|Maintenance|Progression/Relapse|42|||
126465984|NCT00644228|455007730|FG000|Maintenance|Death|3|||
126465985|NCT00644228|455007731|FG001|Maintenance|Death|3|||
126465986|NCT00644228|455007730|FG000|Maintenance|Not Protocol-Specified|14|||
126465987|NCT00644228|455007731|FG001|Maintenance|Not Protocol-Specified|15|||
126465988|NCT00644228|455007730|FG000|Maintenance|On Treatment|26|||
126465989|NCT00644228|455007731|FG001|Maintenance|On Treatment|40|||
126465990|NCT00760084|455007732|FG000|Overall Study|Physician Decision|5|||
126465991|NCT00760084|455007732|FG000|Overall Study|Withdrawal by Subject|2|||
126465992|NCT00760084|455007732|FG000|Overall Study|Progressive Disease|3|||
126465993|NCT03187756|455007733|FG000|Overall Study|Termination of study|4|||
126465994|NCT02567552|455007734|FG000|Overall Study|Adverse Event|0|||
126465995|NCT02567552|455007735|FG001|Overall Study|Adverse Event|1|||
126465996|NCT03635788|455007736|FG000|Step 1|Death|1|||
126465997|NCT03635788|455007737|FG001|Step 1|Death|0|||
126465998|NCT03635788|455007738|FG002|Step 1|Death|0|||
126465999|NCT03635788|455007736|FG000|Step 1|Lost to Follow-up|31|||
126466000|NCT03635788|455007737|FG001|Step 1|Lost to Follow-up|0|||
126466001|NCT03635788|455007738|FG002|Step 1|Lost to Follow-up|0|||
126466002|NCT03635788|455007736|FG000|Step 1|Pregnancy|1|||
126466003|NCT03635788|455007737|FG001|Step 1|Pregnancy|0|||
126466004|NCT03635788|455007738|FG002|Step 1|Pregnancy|0|||
126466005|NCT03635788|455007736|FG000|Step 1|Protocol Violation|8|||
126466006|NCT03635788|455007737|FG001|Step 1|Protocol Violation|0|||
126466007|NCT03635788|455007738|FG002|Step 1|Protocol Violation|0|||
126466008|NCT03635788|455007736|FG000|Step 1|Withdrawal by Subject|13|||
126466009|NCT03635788|455007737|FG001|Step 1|Withdrawal by Subject|0|||
126466010|NCT03635788|455007738|FG002|Step 1|Withdrawal by Subject|0|||
126466011|NCT03635788|455007736|FG000|Step 1|Other reasons|12|||
126466012|NCT03635788|455007737|FG001|Step 1|Other reasons|0|||
126466013|NCT03635788|455007738|FG002|Step 1|Other reasons|0|||
126466014|NCT03635788|455007736|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
126466015|NCT03635788|455007737|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
126466016|NCT03635788|455007738|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
126466017|NCT03635788|455007736|FG000|Step 2|Lost to Follow-up|0|||
126466018|NCT03635788|455007737|FG001|Step 2|Lost to Follow-up|8|||
126466019|NCT03635788|455007738|FG002|Step 2|Lost to Follow-up|15|||
126466020|NCT03635788|455007736|FG000|Step 2|Withdrawal by Subject|0|||
126466021|NCT03635788|455007737|FG001|Step 2|Withdrawal by Subject|6|||
126466022|NCT03635788|455007738|FG002|Step 2|Withdrawal by Subject|6|||
126466023|NCT03635788|455007736|FG000|Step 2|Death|0|||
126466024|NCT03635788|455007737|FG001|Step 2|Death|2|||
126466025|NCT03635788|455007738|FG002|Step 2|Death|0|||
126466026|NCT03635788|455007736|FG000|Step 2|Incarceration|0|||
126466027|NCT03635788|455007737|FG001|Step 2|Incarceration|2|||
126466028|NCT03635788|455007738|FG002|Step 2|Incarceration|0|||
126309578|NCT03030989|454423125|FG000|Overall Study|Fatigue/Overwhelmed|1|||
126466029|NCT03635788|455007736|FG000|Step 2|Non-Compliance With Study Requirements|0|||
126466030|NCT03635788|455007737|FG001|Step 2|Non-Compliance With Study Requirements|1|||
126466031|NCT03635788|455007738|FG002|Step 2|Non-Compliance With Study Requirements|1|||
126466032|NCT03635788|455007736|FG000|Step 2|Confounding Medical Condition|0|||
126466033|NCT03635788|455007737|FG001|Step 2|Confounding Medical Condition|0|||
126466034|NCT03635788|455007738|FG002|Step 2|Confounding Medical Condition|1|||
126466035|NCT03635788|455007736|FG000|Step 2|Out Of State With No Plan To Return|0|||
126466036|NCT03635788|455007737|FG001|Step 2|Out Of State With No Plan To Return|1|||
126466037|NCT03635788|455007738|FG002|Step 2|Out Of State With No Plan To Return|0|||
126466038|NCT03635788|455007736|FG000|Step 2|Switched To Injectables|0|||
126466039|NCT03635788|455007737|FG001|Step 2|Switched To Injectables|0|||
126552843|NCT00619476|455320480|FG003|Overall Study|Protocol Violation|9|||
126552844|NCT00619476|455320477|FG000|Overall Study|Lost to Follow-up|1|||
126716592|NCT01115569|455914877|FG001|Conversion/Titration Phase|Protocol Violation|0|||
126716593|NCT01115569|455914876|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
126716594|NCT01115569|455914877|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
126716595|NCT01115569|455914876|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
126716596|NCT01115569|455914877|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
126716597|NCT01115569|455914876|FG000|Maintenance Phase|Adverse Event|0|||
126716598|NCT01115569|455914877|FG001|Maintenance Phase|Adverse Event|43|||
126309579|NCT03030989|454423126|FG001|Overall Study|Fatigue/Overwhelmed|5|||
126309580|NCT03030989|454423125|FG000|Overall Study|Positive Blood Cultures|2|||
126309581|NCT03030989|454423126|FG001|Overall Study|Positive Blood Cultures|1|||
126309582|NCT03030989|454423125|FG000|Overall Study|Line Removed|0|||
126309583|NCT03030989|454423126|FG001|Overall Study|Line Removed|2|||
126309584|NCT03030989|454423125|FG000|Overall Study|No longer interested|5|||
126309585|NCT03030989|454423126|FG001|Overall Study|No longer interested|3|||
126309586|NCT02706886|454423127|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
126309587|NCT02706886|454423128|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
126309588|NCT02706886|454423129|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
126309589|NCT02706886|454423130|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
126309590|NCT02706886|454423131|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
126309591|NCT02706886|454423132|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
126309592|NCT02706886|454423133|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
126309593|NCT02706886|454423134|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
126309594|NCT02706886|454423135|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
126309595|NCT01669174|454423142|FG000|Overall Study|Subject withdrew consent|2|||
126309596|NCT01669174|454423143|FG001|Overall Study|Subject withdrew consent|2|||
126309597|NCT01669174|454423142|FG000|Overall Study|Lost to Follow-up|1|||
126309598|NCT01669174|454423143|FG001|Overall Study|Lost to Follow-up|0|||
126309599|NCT01669174|454423142|FG000|Overall Study|Adverse Event|2|||
126309600|NCT01669174|454423143|FG001|Overall Study|Adverse Event|2|||
126309601|NCT01669174|454423142|FG000|Overall Study|Administrative problems|1|||
126309602|NCT01669174|454423143|FG001|Overall Study|Administrative problems|2|||
126309603|NCT01154296|454423146|FG000|Randomization and Intervention|Decided to decline|1|||
126309604|NCT01154296|454423147|FG001|Randomization and Intervention|Decided to decline|1|||
126309605|NCT01154296|454423146|FG000|Randomization and Intervention|Declined by staff|1|||
126309606|NCT01154296|454423147|FG001|Randomization and Intervention|Declined by staff|0|||
126309607|NCT01154296|454423146|FG000|Randomization and Intervention|Did not return|1|||
126309608|NCT01154296|454423147|FG001|Randomization and Intervention|Did not return|0|||
126309609|NCT01154296|454423146|FG000|Randomization and Intervention|Left before test|0|||
126309610|NCT01154296|454423147|FG001|Randomization and Intervention|Left before test|1|||
126309611|NCT01154296|454423146|FG000|Randomization and Intervention|Left clinic early|2|||
126309612|NCT01154296|454423147|FG001|Randomization and Intervention|Left clinic early|0|||
126309613|NCT01154296|454423146|FG000|6-month Follow-up|Lost contact|269|||
126309614|NCT01154296|454423147|FG001|6-month Follow-up|Lost contact|275|||
126309615|NCT01154296|454423146|FG000|6-month Follow-up|Incarcerated|37|||
126309616|NCT01154296|454423147|FG001|6-month Follow-up|Incarcerated|32|||
126309617|NCT01154296|454423146|FG000|6-month Follow-up|Withdrew consent|14|||
126309618|NCT01154296|454423147|FG001|6-month Follow-up|Withdrew consent|15|||
126309619|NCT01154296|454423146|FG000|6-month Follow-up|Death|3|||
126309620|NCT01154296|454423147|FG001|6-month Follow-up|Death|2|||
126309621|NCT01154296|454423146|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
126309622|NCT01154296|454423147|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
126373101|NCT03710889|454663383|FG000|Overall Study|Protocol Deviation|1|||
126373102|NCT00570713|454663384|FG000|Overall Study|Adverse Event|16|||
126373103|NCT00570713|454663385|FG001|Overall Study|Adverse Event|9|||
126373104|NCT00570713|454663384|FG000|Overall Study|Death|7|||
126373105|NCT00570713|454663385|FG001|Overall Study|Death|7|||
126373106|NCT00570713|454663384|FG000|Overall Study|Lack of Efficacy|40|||
126373107|NCT00570713|454663385|FG001|Overall Study|Lack of Efficacy|49|||
126373108|NCT00570713|454663384|FG000|Overall Study|Physician Decision|2|||
126373109|NCT00570713|454663385|FG001|Overall Study|Physician Decision|2|||
126373110|NCT00570713|454663384|FG000|Overall Study|Withdrawal by Subject|3|||
126716599|NCT01115569|455914876|FG000|Maintenance Phase|Lost to Follow-up|0|||
126309623|NCT04310397|454423148|FG000|Overall Study|Lack of Efficacy|3|||
126309624|NCT04310397|454423148|FG000|Overall Study|Withdrawal by Subject|1|||
126309625|NCT00723255|454423149|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
126309626|NCT00723255|454423149|FG000|Overall Study|Ineligible: Second primary|1|||
126309627|NCT00723255|454423149|FG000|Overall Study|Ineligible: Wrong Primary|2|||
126309628|NCT02759055|454423150|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
126309629|NCT02759055|454423151|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
126309630|NCT00614523|454423152|FG000|Overall Study|Adverse Event|4|||
126309631|NCT00614523|454423153|FG001|Overall Study|Adverse Event|20|||
126373111|NCT00570713|454663385|FG001|Overall Study|Withdrawal by Subject|3|||
126552845|NCT00619476|455320478|FG001|Overall Study|Lost to Follow-up|2|||
126466040|NCT03635788|455007738|FG002|Step 2|Switched To Injectables|1|||
126466041|NCT03635788|455007736|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
126466042|NCT03635788|455007737|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
126466043|NCT03635788|455007738|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
126466044|NCT04382755|455007739|FG000|Overall Study|Withdrawal by Subject|1|||
126466045|NCT04382755|455007740|FG001|Overall Study|Withdrawal by Subject|0|||
126466046|NCT04382755|455007739|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
126466047|NCT04382755|455007740|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
126466048|NCT04382755|455007739|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
126466049|NCT04382755|455007740|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
126466050|NCT02160782|455008880|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
126466051|NCT02160782|455008881|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
126466052|NCT02160782|455008882|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
126466053|NCT02160782|455008883|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
126466054|NCT02160782|455008884|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
126466055|NCT02160782|455008880|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
126466056|NCT02160782|455008881|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
126466057|NCT02160782|455008882|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
126466058|NCT02160782|455008883|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
126466059|NCT02160782|455008884|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
126466060|NCT02160782|455008880|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
126466061|NCT02160782|455008881|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
126466062|NCT02160782|455008882|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
126466063|NCT02160782|455008883|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
126466064|NCT02160782|455008884|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
126466065|NCT02160782|455008880|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
126466066|NCT02160782|455008881|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
126466067|NCT02160782|455008882|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
126466068|NCT02160782|455008883|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
126466069|NCT02160782|455008884|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
126466070|NCT02160782|455008880|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
126466071|NCT02160782|455008881|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
126466072|NCT02160782|455008882|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
126466073|NCT02160782|455008883|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
126466074|NCT02160782|455008884|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
126466075|NCT02160782|455008880|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
126309632|NCT00614523|454423152|FG000|Overall Study|Death|5|||
126309633|NCT00614523|454423153|FG001|Overall Study|Death|8|||
126309634|NCT00614523|454423152|FG000|Overall Study|Lack of Efficacy|9|||
126309635|NCT00614523|454423153|FG001|Overall Study|Lack of Efficacy|11|||
126309636|NCT00614523|454423152|FG000|Overall Study|Lost to Follow-up|0|||
126309637|NCT00614523|454423153|FG001|Overall Study|Lost to Follow-up|1|||
126309638|NCT00614523|454423152|FG000|Overall Study|Protocol Violation|3|||
126309639|NCT00614523|454423153|FG001|Overall Study|Protocol Violation|2|||
126309640|NCT00614523|454423152|FG000|Overall Study|Withdrawal by Subject|12|||
126309641|NCT00614523|454423153|FG001|Overall Study|Withdrawal by Subject|22|||
126309642|NCT00614523|454423152|FG000|Overall Study|Other|6|||
126309643|NCT00614523|454423153|FG001|Overall Study|Other|11|||
126309644|NCT00614523|454423152|FG000|Overall Study|Ineligibility Determined|1|||
126309645|NCT00614523|454423153|FG001|Overall Study|Ineligibility Determined|2|||
126309646|NCT00614523|454423152|FG000|Overall Study|Disease Progression|0|||
126309647|NCT00614523|454423153|FG001|Overall Study|Disease Progression|8|||
126309648|NCT00614523|454423152|FG000|Overall Study|Administrative Decision|23|||
126309649|NCT00614523|454423153|FG001|Overall Study|Administrative Decision|46|||
126309650|NCT03692325|454423167|FG000|Overall Study|Adverse Event|2|||
126309651|NCT03692325|454423167|FG000|Overall Study|Progression/Recurrence|2|||
126309652|NCT00425061|454423168|FG000|Overall Study|Adverse Event|1|||
126309653|NCT00425061|454423169|FG001|Overall Study|Adverse Event|0|||
126309654|NCT00425061|454423170|FG002|Overall Study|Adverse Event|0|||
126309655|NCT00425061|454423171|FG003|Overall Study|Adverse Event|2|||
126309656|NCT00425061|454423172|FG004|Overall Study|Adverse Event|2|||
126309657|NCT00425061|454423173|FG005|Overall Study|Adverse Event|0|||
126309658|NCT00425061|454423174|FG006|Overall Study|Adverse Event|0|||
126309659|NCT00425061|454423168|FG000|Overall Study|Lost to Follow-up|0|||
126309660|NCT00425061|454423169|FG001|Overall Study|Lost to Follow-up|1|||
126309661|NCT00425061|454423170|FG002|Overall Study|Lost to Follow-up|0|||
126309662|NCT00425061|454423171|FG003|Overall Study|Lost to Follow-up|0|||
126373112|NCT00570713|454663384|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
126373113|NCT00570713|454663385|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
126373114|NCT04881760|454663386|FG000|Overall Study|Adverse Event|0|||
126373115|NCT04881760|454663387|FG001|Overall Study|Adverse Event|1|||
126373116|NCT04881760|454663388|FG002|Overall Study|Adverse Event|1|||
126373117|NCT04881760|454663389|FG003|Overall Study|Adverse Event|0|||
126466076|NCT02160782|455008881|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
126466077|NCT02160782|455008882|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
126466078|NCT02160782|455008883|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
126466079|NCT02160782|455008884|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
126466080|NCT02160782|455008880|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
126466081|NCT02160782|455008881|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
126466082|NCT02160782|455008882|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
126466083|NCT02160782|455008883|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
126466084|NCT02160782|455008884|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
126466085|NCT00674973|455008887|FG000|Overall Study|Insufficient Therapeutic Response|77|||
126466086|NCT00674973|455008888|FG001|Overall Study|Insufficient Therapeutic Response|72|||
126466087|NCT00674973|455008887|FG000|Overall Study|Refused Treatment|1|||
126466088|NCT00674973|455008888|FG001|Overall Study|Refused Treatment|5|||
126466089|NCT00674973|455008887|FG000|Overall Study|Failure to Return|1|||
126466090|NCT00674973|455008888|FG001|Overall Study|Failure to Return|0|||
126466091|NCT00674973|455008887|FG000|Overall Study|Adverse Event|2|||
126466092|NCT00674973|455008888|FG001|Overall Study|Adverse Event|9|||
126466093|NCT00674973|455008887|FG000|Overall Study|Death|19|||
126466094|NCT00674973|455008888|FG001|Overall Study|Death|15|||
126466095|NCT00674973|455008887|FG000|Overall Study|Protocol Violation|0|||
126466096|NCT00674973|455008888|FG001|Overall Study|Protocol Violation|1|||
126466097|NCT00401531|455008891|FG000|Overall Study|Adverse Event|2|||
126466098|NCT00401531|455008892|FG001|Overall Study|Adverse Event|0|||
126466099|NCT00401531|455008891|FG000|Overall Study|Protocol Violation|3|||
126466100|NCT00401531|455008892|FG001|Overall Study|Protocol Violation|7|||
126373118|NCT04881760|454663390|FG004|Overall Study|Adverse Event|1|||
126373119|NCT04881760|454663391|FG005|Overall Study|Adverse Event|1|||
126373120|NCT04881760|454663392|FG006|Overall Study|Adverse Event|2|||
126373121|NCT04881760|454663386|FG000|Overall Study|Death|0|||
126373122|NCT04881760|454663387|FG001|Overall Study|Death|0|||
126373123|NCT04881760|454663388|FG002|Overall Study|Death|0|||
126373124|NCT04881760|454663389|FG003|Overall Study|Death|1|||
126373125|NCT04881760|454663390|FG004|Overall Study|Death|0|||
126373126|NCT04881760|454663391|FG005|Overall Study|Death|0|||
126373127|NCT04881760|454663392|FG006|Overall Study|Death|0|||
126373128|NCT04881760|454663386|FG000|Overall Study|Lost to Follow-up|5|||
126373129|NCT04881760|454663387|FG001|Overall Study|Lost to Follow-up|7|||
126373130|NCT04881760|454663388|FG002|Overall Study|Lost to Follow-up|5|||
126373131|NCT04881760|454663389|FG003|Overall Study|Lost to Follow-up|1|||
126373132|NCT04881760|454663390|FG004|Overall Study|Lost to Follow-up|2|||
126373133|NCT04881760|454663391|FG005|Overall Study|Lost to Follow-up|4|||
126373134|NCT04881760|454663392|FG006|Overall Study|Lost to Follow-up|4|||
126373135|NCT04881760|454663386|FG000|Overall Study|Withdrawal by Subject|13|||
126373136|NCT04881760|454663387|FG001|Overall Study|Withdrawal by Subject|1|||
126373137|NCT04881760|454663388|FG002|Overall Study|Withdrawal by Subject|1|||
126373138|NCT04881760|454663389|FG003|Overall Study|Withdrawal by Subject|4|||
126373139|NCT04881760|454663390|FG004|Overall Study|Withdrawal by Subject|2|||
126373140|NCT04881760|454663391|FG005|Overall Study|Withdrawal by Subject|1|||
126466101|NCT00401531|455008891|FG000|Overall Study|Lost to Follow-up|1|||
126466102|NCT00401531|455008892|FG001|Overall Study|Lost to Follow-up|1|||
126466103|NCT00401531|455008891|FG000|Overall Study|Withdrawal by Subject|3|||
126466104|NCT00401531|455008892|FG001|Overall Study|Withdrawal by Subject|2|||
126466105|NCT01801072|455008893|FG000|Overall Study|Lost to Follow-up|17|||
126466106|NCT01801072|455008894|FG001|Overall Study|Lost to Follow-up|14|||
126466107|NCT01801072|455008893|FG000|Overall Study|Physician Decision|2|||
126466108|NCT01801072|455008894|FG001|Overall Study|Physician Decision|3|||
126466109|NCT01801072|455008893|FG000|Overall Study|Withdrawal by Subject|1|||
126466110|NCT01801072|455008894|FG001|Overall Study|Withdrawal by Subject|0|||
126466111|NCT01801072|455008893|FG000|Overall Study|Protocol Violation|2|||
126466112|NCT01801072|455008894|FG001|Overall Study|Protocol Violation|0|||
126373141|NCT04881760|454663392|FG006|Overall Study|Withdrawal by Subject|2|||
126373142|NCT04881760|454663386|FG000|Overall Study|Randomized but Never Treated|0|||
126373143|NCT04881760|454663387|FG001|Overall Study|Randomized but Never Treated|0|||
126373144|NCT04881760|454663388|FG002|Overall Study|Randomized but Never Treated|0|||
126373145|NCT04881760|454663389|FG003|Overall Study|Randomized but Never Treated|1|||
126373146|NCT04881760|454663390|FG004|Overall Study|Randomized but Never Treated|0|||
126466113|NCT01801072|455008893|FG000|Overall Study|Death|7|||
126466114|NCT01801072|455008894|FG001|Overall Study|Death|8|||
126466115|NCT02423109|455008897|FG000|Lens 1|Adverse Event|1|||
126466116|NCT02423109|455008898|FG001|Lens 1|Adverse Event|0|||
126466117|NCT03956056|455008899|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
126309663|NCT00425061|454423172|FG004|Overall Study|Lost to Follow-up|0|||
126309664|NCT00425061|454423173|FG005|Overall Study|Lost to Follow-up|0|||
126309665|NCT00425061|454423174|FG006|Overall Study|Lost to Follow-up|0|||
126309666|NCT00425061|454423168|FG000|Overall Study|Protocol Violation|1|||
126309667|NCT00425061|454423169|FG001|Overall Study|Protocol Violation|0|||
126309668|NCT00425061|454423170|FG002|Overall Study|Protocol Violation|0|||
126309669|NCT00425061|454423171|FG003|Overall Study|Protocol Violation|0|||
126373147|NCT04881760|454663391|FG005|Overall Study|Randomized but Never Treated|0|||
126373148|NCT04881760|454663392|FG006|Overall Study|Randomized but Never Treated|0|||
126373149|NCT04881760|454663386|FG000|Overall Study|Inadvertent Enrollment|2|||
126373150|NCT04881760|454663387|FG001|Overall Study|Inadvertent Enrollment|0|||
126373151|NCT04881760|454663388|FG002|Overall Study|Inadvertent Enrollment|0|||
126373152|NCT04881760|454663389|FG003|Overall Study|Inadvertent Enrollment|0|||
126373153|NCT04881760|454663390|FG004|Overall Study|Inadvertent Enrollment|0|||
126373154|NCT04881760|454663391|FG005|Overall Study|Inadvertent Enrollment|0|||
126373155|NCT04881760|454663392|FG006|Overall Study|Inadvertent Enrollment|0|||
126373156|NCT04881760|454663386|FG000|Overall Study|Site Closure|0|||
126373157|NCT04881760|454663387|FG001|Overall Study|Site Closure|0|||
126373158|NCT04881760|454663388|FG002|Overall Study|Site Closure|0|||
126373159|NCT04881760|454663389|FG003|Overall Study|Site Closure|1|||
126373160|NCT04881760|454663390|FG004|Overall Study|Site Closure|0|||
126373161|NCT04881760|454663391|FG005|Overall Study|Site Closure|0|||
126373162|NCT04881760|454663392|FG006|Overall Study|Site Closure|0|||
126373163|NCT01538199|454663396|FG000|Overall Study|Lost to Follow-up|1|||
126373164|NCT01538199|454663397|FG001|Overall Study|Lost to Follow-up|2|||
126373165|NCT01538199|454663398|FG002|Overall Study|Lost to Follow-up|1|||
126373166|NCT01538199|454663399|FG003|Overall Study|Lost to Follow-up|0|||
126373167|NCT01538199|454663396|FG000|Overall Study|participant did not have time|1|||
126466118|NCT03956056|455008899|FG000|Overall Study|Lack of Efficacy|1|||
126466119|NCT03403374|455008900|FG000|Overall Study|Lost to Follow-up|1|||
126466120|NCT00085709|455008901|FG000|Overall Study|Adverse Event|8|||
126466121|NCT00085709|455008902|FG001|Overall Study|Adverse Event|0|||
126466122|NCT00085709|455008901|FG000|Overall Study|Death|8|||
126309670|NCT00425061|454423172|FG004|Overall Study|Protocol Violation|0|||
126309671|NCT00425061|454423173|FG005|Overall Study|Protocol Violation|0|||
126309672|NCT00425061|454423174|FG006|Overall Study|Protocol Violation|0|||
126309673|NCT00425061|454423168|FG000|Overall Study|Withdrawal by Subject|0|||
126309674|NCT00425061|454423169|FG001|Overall Study|Withdrawal by Subject|1|||
126309675|NCT00425061|454423170|FG002|Overall Study|Withdrawal by Subject|0|||
126309676|NCT00425061|454423171|FG003|Overall Study|Withdrawal by Subject|0|||
126309677|NCT00425061|454423172|FG004|Overall Study|Withdrawal by Subject|1|||
126309678|NCT00425061|454423173|FG005|Overall Study|Withdrawal by Subject|0|||
126309679|NCT00425061|454423174|FG006|Overall Study|Withdrawal by Subject|3|||
126309680|NCT00425061|454423168|FG000|Overall Study|Sponsor's request|0|||
126309681|NCT00425061|454423169|FG001|Overall Study|Sponsor's request|0|||
126309682|NCT00425061|454423170|FG002|Overall Study|Sponsor's request|0|||
126309683|NCT00425061|454423171|FG003|Overall Study|Sponsor's request|0|||
126309684|NCT00425061|454423172|FG004|Overall Study|Sponsor's request|19|||
126309685|NCT00425061|454423173|FG005|Overall Study|Sponsor's request|4|||
126309686|NCT00425061|454423174|FG006|Overall Study|Sponsor's request|15|||
126309687|NCT00425061|454423168|FG000|Overall Study|Physician Decision|0|||
126309688|NCT00425061|454423169|FG001|Overall Study|Physician Decision|0|||
126309689|NCT00425061|454423170|FG002|Overall Study|Physician Decision|0|||
126309690|NCT00425061|454423171|FG003|Overall Study|Physician Decision|0|||
126309691|NCT00425061|454423172|FG004|Overall Study|Physician Decision|1|||
126309692|NCT00425061|454423173|FG005|Overall Study|Physician Decision|0|||
126309693|NCT00425061|454423174|FG006|Overall Study|Physician Decision|0|||
126309694|NCT00425061|454423168|FG000|Overall Study|Other|0|||
126309695|NCT00425061|454423169|FG001|Overall Study|Other|0|||
126309696|NCT00425061|454423170|FG002|Overall Study|Other|0|||
126309697|NCT00425061|454423171|FG003|Overall Study|Other|0|||
126466123|NCT00085709|455008902|FG001|Overall Study|Death|2|||
126466124|NCT00085709|455008901|FG000|Overall Study|Refusal unrelated to adverse events|1|||
126466125|NCT00085709|455008902|FG001|Overall Study|Refusal unrelated to adverse events|2|||
126466126|NCT00085709|455008901|FG000|Overall Study|Progression|3|||
126309698|NCT00425061|454423172|FG004|Overall Study|Other|3|||
126309699|NCT00425061|454423173|FG005|Overall Study|Other|0|||
126373168|NCT01538199|454663397|FG001|Overall Study|participant did not have time|0|||
126373169|NCT01538199|454663398|FG002|Overall Study|participant did not have time|0|||
126373170|NCT01538199|454663399|FG003|Overall Study|participant did not have time|2|||
126373171|NCT01538199|454663396|FG000|Overall Study|Lack of Efficacy|0|||
126373172|NCT01538199|454663397|FG001|Overall Study|Lack of Efficacy|1|||
126373173|NCT01538199|454663398|FG002|Overall Study|Lack of Efficacy|0|||
126373174|NCT01538199|454663399|FG003|Overall Study|Lack of Efficacy|0|||
126309700|NCT00425061|454423174|FG006|Overall Study|Other|1|||
126309701|NCT02137850|454423177|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
126373175|NCT02081586|454663400|FG000|Overall Study|Lost to Follow-up|0|||
126466127|NCT00085709|455008902|FG001|Overall Study|Progression|4|||
126466128|NCT00085709|455008901|FG000|Overall Study|Not protocol specified|12|||
126716600|NCT01115569|455914877|FG001|Maintenance Phase|Lost to Follow-up|8|||
126716601|NCT01115569|455914876|FG000|Maintenance Phase|Physician Decision|0|||
126716602|NCT01115569|455914877|FG001|Maintenance Phase|Physician Decision|3|||
126716603|NCT01115569|455914876|FG000|Maintenance Phase|Protocol Violation|0|||
126716604|NCT01115569|455914877|FG001|Maintenance Phase|Protocol Violation|9|||
126716605|NCT01115569|455914876|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126716606|NCT01115569|455914877|FG001|Maintenance Phase|Withdrawal by Subject|27|||
126716607|NCT01115569|455914876|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
126716608|NCT01115569|455914877|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
126716609|NCT01115569|455914876|FG000|Maintenance Phase|Administrative|0|||
126716610|NCT01115569|455914877|FG001|Maintenance Phase|Administrative|1|||
126716611|NCT01931462|455914878|FG000|Overall Study|Withdrawal by Subject|1|||
126716612|NCT02819310|455914879|FG000|Overall Study|Withdrawal by Subject|37|||
126716613|NCT02819310|455914879|FG000|Overall Study|Lost to Follow-up|16|||
126716614|NCT02819310|455914879|FG000|Overall Study|Adverse Event|13|||
126716615|NCT02819310|455914879|FG000|Overall Study|Lack of Efficacy|5|||
126716616|NCT02819310|455914879|FG000|Overall Study|Physician Decision|8|||
126716617|NCT02819310|455914879|FG000|Overall Study|Protocol Violation|30|||
126716618|NCT05070429|455914885|FG000|Overall Study|Death|0|||
126716619|NCT05070429|455914886|FG001|Overall Study|Death|4|||
126716620|NCT05070429|455914885|FG000|Overall Study|Withdrawal by Subject|2|||
126716621|NCT05070429|455914886|FG001|Overall Study|Withdrawal by Subject|1|||
126771009|NCT00422058|456116235|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
126309702|NCT02137850|454423178|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
126309703|NCT02137850|454423179|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
126309704|NCT02137850|454423177|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
126309705|NCT02137850|454423178|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
126309706|NCT02137850|454423179|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
126309707|NCT02137850|454423177|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
126309708|NCT02137850|454423178|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
126309709|NCT02137850|454423179|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
126309710|NCT02137850|454423177|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
126309711|NCT02137850|454423178|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
126309712|NCT02137850|454423179|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
126309713|NCT02137850|454423177|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
126309714|NCT02137850|454423178|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
126309715|NCT02137850|454423179|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
126309716|NCT02137850|454423177|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
126309717|NCT02137850|454423178|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
126309718|NCT02137850|454423179|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
126309719|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
126309720|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
126309721|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
126309722|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
126309723|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
126309724|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
126309725|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
126309726|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
126309727|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
126309728|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
126309729|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
126309730|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
126309731|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Other|0|||
126309732|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Other|1|||
126309733|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Other|0|||
126309734|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
126309735|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
126309736|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
126309737|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Early site closure|0|||
126309738|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Early site closure|2|||
126309739|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Early site closure|0|||
126309740|NCT02137850|454423177|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
126309741|NCT02137850|454423178|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
126309742|NCT02137850|454423179|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
126373176|NCT02081586|454663401|FG001|Overall Study|Lost to Follow-up|1|||
126373177|NCT02081586|454663402|FG002|Overall Study|Lost to Follow-up|0|||
126716622|NCT05070429|455914885|FG000|Overall Study|Other|15|||
126716623|NCT05070429|455914886|FG001|Overall Study|Other|5|||
126716624|NCT00943319|455914887|FG000|Overall Study|Death|1|||
126716625|NCT02043301|455914888|FG000|Overall Study|Discontinued|0|||
126716626|NCT02043301|455914889|FG001|Overall Study|Discontinued|1|||
126716627|NCT02043301|455914890|FG002|Overall Study|Discontinued|0|||
126716628|NCT03097328|455914891|FG000|Overall Study|Still on Therapy|2|||
126716629|NCT03097328|455914891|FG000|Overall Study|Progressive Disease|29|||
126373178|NCT02081586|454663403|FG003|Overall Study|Lost to Follow-up|1|||
126373179|NCT02081586|454663400|FG000|Overall Study|Head injury not related to study|0|||
126373180|NCT02081586|454663401|FG001|Overall Study|Head injury not related to study|0|||
126373181|NCT02081586|454663402|FG002|Overall Study|Head injury not related to study|1|||
126373182|NCT02081586|454663403|FG003|Overall Study|Head injury not related to study|0|||
126373183|NCT01677988|454663406|FG000|Overall Study|Lack of Efficacy|2|||
126373184|NCT00659425|454663410|FG000|Overall Study|Disease progression|1|||
126373185|NCT00659425|454663411|FG001|Overall Study|Disease progression|0|||
126373186|NCT00659425|454663412|FG002|Overall Study|Disease progression|0|||
126373187|NCT00659425|454663413|FG003|Overall Study|Disease progression|1|||
126373188|NCT00659425|454663414|FG004|Overall Study|Disease progression|0|||
126373189|NCT00659425|454663415|FG005|Overall Study|Disease progression|2|||
126373190|NCT00659425|454663416|FG006|Overall Study|Disease progression|4|||
126373191|NCT00659425|454663417|FG007|Overall Study|Disease progression|3|||
126373192|NCT00659425|454663418|FG008|Overall Study|Disease progression|5|||
126373193|NCT00659425|454663419|FG009|Overall Study|Disease progression|3|||
126373194|NCT00659425|454663410|FG000|Overall Study|Death|0|||
126373195|NCT00659425|454663411|FG001|Overall Study|Death|0|||
126373196|NCT00659425|454663412|FG002|Overall Study|Death|0|||
126373197|NCT00659425|454663413|FG003|Overall Study|Death|1|||
126373198|NCT00659425|454663414|FG004|Overall Study|Death|0|||
126373199|NCT00659425|454663415|FG005|Overall Study|Death|0|||
126373200|NCT00659425|454663416|FG006|Overall Study|Death|1|||
126373201|NCT00659425|454663417|FG007|Overall Study|Death|0|||
126373202|NCT00659425|454663418|FG008|Overall Study|Death|0|||
126373203|NCT00659425|454663419|FG009|Overall Study|Death|0|||
126716630|NCT03097328|455914891|FG000|Overall Study|Adverse Event|4|||
126716631|NCT03097328|455914891|FG000|Overall Study|Withdrawal by Subject|1|||
126716632|NCT03097328|455914891|FG000|Overall Study|Physician Decision|1|||
126373204|NCT00659425|454663410|FG000|Overall Study|Adverse Event|0|||
126373205|NCT00659425|454663411|FG001|Overall Study|Adverse Event|0|||
126373206|NCT00659425|454663412|FG002|Overall Study|Adverse Event|0|||
126373207|NCT00659425|454663413|FG003|Overall Study|Adverse Event|0|||
126373208|NCT00659425|454663414|FG004|Overall Study|Adverse Event|0|||
126373209|NCT00659425|454663415|FG005|Overall Study|Adverse Event|1|||
126373210|NCT00659425|454663416|FG006|Overall Study|Adverse Event|0|||
126373211|NCT00659425|454663417|FG007|Overall Study|Adverse Event|3|||
126373212|NCT00659425|454663418|FG008|Overall Study|Adverse Event|1|||
126373213|NCT00659425|454663419|FG009|Overall Study|Adverse Event|4|||
126373214|NCT00659425|454663410|FG000|Overall Study|Investigator Discretion|0|||
126373215|NCT00659425|454663411|FG001|Overall Study|Investigator Discretion|0|||
126373216|NCT00659425|454663412|FG002|Overall Study|Investigator Discretion|0|||
126373217|NCT00659425|454663413|FG003|Overall Study|Investigator Discretion|0|||
126373218|NCT00659425|454663414|FG004|Overall Study|Investigator Discretion|0|||
126373219|NCT00659425|454663415|FG005|Overall Study|Investigator Discretion|1|||
126373220|NCT00659425|454663416|FG006|Overall Study|Investigator Discretion|0|||
126373221|NCT00659425|454663417|FG007|Overall Study|Investigator Discretion|3|||
126373222|NCT00659425|454663418|FG008|Overall Study|Investigator Discretion|0|||
126373223|NCT00659425|454663419|FG009|Overall Study|Investigator Discretion|0|||
126373224|NCT00659425|454663410|FG000|Overall Study|Other|0|||
126373225|NCT00659425|454663411|FG001|Overall Study|Other|1|||
126373226|NCT00659425|454663412|FG002|Overall Study|Other|1|||
126373227|NCT00659425|454663413|FG003|Overall Study|Other|2|||
126373228|NCT00659425|454663414|FG004|Overall Study|Other|4|||
126373229|NCT00659425|454663415|FG005|Overall Study|Other|0|||
126373230|NCT00659425|454663416|FG006|Overall Study|Other|3|||
126373231|NCT00659425|454663417|FG007|Overall Study|Other|2|||
126373232|NCT00659425|454663418|FG008|Overall Study|Other|0|||
126373233|NCT00659425|454663419|FG009|Overall Study|Other|6|||
126373234|NCT00271544|454663420|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
126373235|NCT00271544|454663420|FG000|Overall Study|Model 4196 lead not attempted|9|||
126373236|NCT00271544|454663420|FG000|Overall Study|Implant not attempted|4|||
126373237|NCT03358030|454663421|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
126373238|NCT03358030|454663422|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
126373239|NCT03358030|454663423|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
126373240|NCT03358030|454663424|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
126373241|NCT03358030|454663421|FG000|Overall Study|Ineligibility|0|||
126373242|NCT03358030|454663422|FG001|Overall Study|Ineligibility|0|||
126373243|NCT03358030|454663423|FG002|Overall Study|Ineligibility|0|||
126373244|NCT03358030|454663424|FG003|Overall Study|Ineligibility|2|||
126373245|NCT03358030|454663421|FG000|Overall Study|Voluntary Withdrawal|1|||
126373246|NCT03358030|454663422|FG001|Overall Study|Voluntary Withdrawal|1|||
126373247|NCT03358030|454663423|FG002|Overall Study|Voluntary Withdrawal|3|||
126373248|NCT03358030|454663424|FG003|Overall Study|Voluntary Withdrawal|1|||
126373249|NCT03358030|454663421|FG000|Overall Study|Other|0|||
126373250|NCT03358030|454663422|FG001|Overall Study|Other|0|||
126373251|NCT03358030|454663423|FG002|Overall Study|Other|1|||
126373252|NCT03358030|454663424|FG003|Overall Study|Other|0|||
126373253|NCT00829244|454663425|FG000|Overall Study|Adverse Event|1|||
126716633|NCT03097328|455914891|FG000|Overall Study|Patient Decision|1|||
126373254|NCT00829244|454663426|FG001|Overall Study|Adverse Event|3|||
126373255|NCT00829244|454663425|FG000|Overall Study|Protocol Violation|1|||
126373256|NCT00829244|454663426|FG001|Overall Study|Protocol Violation|0|||
126373257|NCT00829244|454663425|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
126373258|NCT00829244|454663426|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
126373259|NCT00829244|454663425|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
126373260|NCT00829244|454663426|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
126373261|NCT00829244|454663425|FG000|Overall Study|No fertilization|2|||
126373262|NCT00829244|454663426|FG001|Overall Study|No fertilization|2|||
126373263|NCT00829244|454663425|FG000|Overall Study|All embryos discarded|0|||
126373264|NCT00829244|454663426|FG001|Overall Study|All embryos discarded|3|||
126373265|NCT00829244|454663425|FG000|Overall Study|No embryo cleavage|0|||
126373266|NCT00829244|454663426|FG001|Overall Study|No embryo cleavage|2|||
126373267|NCT02604511|454663427|FG000|Overall Study|Adverse Event|3|||
126373268|NCT02604511|454663427|FG000|Overall Study|Disease Progression|4|||
126373269|NCT02604511|454663427|FG000|Overall Study|Withdrawal by Subject|3|||
126373270|NCT02604511|454663427|FG000|Overall Study|Participant ineligible|1|||
126373271|NCT02604511|454663427|FG000|Overall Study|Intercurrent illness|1|||
126373272|NCT03770286|454663428|FG000|Overall Study|Lost to Follow-up|6|||
126373273|NCT03770286|454663429|FG001|Overall Study|Lost to Follow-up|4|||
126373274|NCT03770286|454663430|FG002|Overall Study|Lost to Follow-up|3|||
126373275|NCT03770286|454663428|FG000|Overall Study|Protocol Violation|1|||
126373276|NCT03770286|454663429|FG001|Overall Study|Protocol Violation|0|||
126373277|NCT03770286|454663430|FG002|Overall Study|Protocol Violation|2|||
126373278|NCT02505425|454663431|FG000|Overall Study|Lost to Follow-up|41|||
126373279|NCT02505425|454663432|FG001|Overall Study|Lost to Follow-up|61|||
126373280|NCT02505425|454663433|FG002|Overall Study|Lost to Follow-up|31|||
126373281|NCT02505425|454663434|FG003|Overall Study|Lost to Follow-up|19|||
126373282|NCT02505425|454663431|FG000|Overall Study|Withdrawal by Subject|39|||
126373283|NCT02505425|454663432|FG001|Overall Study|Withdrawal by Subject|9|||
126373284|NCT02505425|454663433|FG002|Overall Study|Withdrawal by Subject|19|||
126373285|NCT02505425|454663434|FG003|Overall Study|Withdrawal by Subject|7|||
126373286|NCT02505425|454663431|FG000|Overall Study|Death|8|||
126373287|NCT02505425|454663432|FG001|Overall Study|Death|12|||
126373288|NCT02505425|454663433|FG002|Overall Study|Death|0|||
126373289|NCT02505425|454663434|FG003|Overall Study|Death|0|||
126373290|NCT02297412|454663435|FG000|Overall Study|Canceled|1|||
126373291|NCT02297412|454663436|FG001|Overall Study|Canceled|1|||
126373292|NCT02031302|454663437|FG000|Overall Study|Death|115|||
126373293|NCT02031302|454663438|FG001|Overall Study|Death|0|||
126373294|NCT02031302|454663437|FG000|Overall Study|Not treated with study valve system|18|||
126373295|NCT02031302|454663438|FG001|Overall Study|Not treated with study valve system|0|||
126373296|NCT02031302|454663437|FG000|Overall Study|Missed Follow Up|27|||
126373297|NCT02031302|454663438|FG001|Overall Study|Missed Follow Up|0|||
126373298|NCT02031302|454663437|FG000|Overall Study|Lost to Follow-up|4|||
126373299|NCT02031302|454663438|FG001|Overall Study|Lost to Follow-up|0|||
126373300|NCT03950856|454663439|FG000|Overall Study|Death|1|||
126373301|NCT03950856|454663440|FG001|Overall Study|Death|2|||
126373302|NCT03950856|454663441|FG002|Overall Study|Death|0|||
126373303|NCT03950856|454663442|FG003|Overall Study|Death|0|||
126373304|NCT03950856|454663439|FG000|Overall Study|Lost to Follow-up|5|||
126373305|NCT03950856|454663440|FG001|Overall Study|Lost to Follow-up|6|||
126373306|NCT03950856|454663441|FG002|Overall Study|Lost to Follow-up|8|||
126373307|NCT03950856|454663442|FG003|Overall Study|Lost to Follow-up|2|||
126373308|NCT03950856|454663439|FG000|Overall Study|Protocol Violation|2|||
126373309|NCT03950856|454663440|FG001|Overall Study|Protocol Violation|0|||
126373310|NCT03950856|454663441|FG002|Overall Study|Protocol Violation|0|||
126373311|NCT03950856|454663442|FG003|Overall Study|Protocol Violation|1|||
126373312|NCT03950856|454663439|FG000|Overall Study|Withdrawal by Subject|4|||
126373313|NCT03950856|454663440|FG001|Overall Study|Withdrawal by Subject|1|||
126373314|NCT03950856|454663441|FG002|Overall Study|Withdrawal by Subject|3|||
126373315|NCT03950856|454663442|FG003|Overall Study|Withdrawal by Subject|1|||
126373316|NCT03950856|454663439|FG000|Overall Study|Unable to phone|7|||
126373317|NCT03950856|454663440|FG001|Overall Study|Unable to phone|6|||
126373318|NCT03950856|454663441|FG002|Overall Study|Unable to phone|7|||
126373319|NCT03950856|454663442|FG003|Overall Study|Unable to phone|2|||
126373320|NCT05899829|454663443|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
126373321|NCT05899829|454663444|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
126373322|NCT05899829|454663443|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
126373323|NCT05899829|454663444|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
126373324|NCT02781558|454663448|FG000|Overall Study|Lost to Follow-up|2|||
126373325|NCT02781558|454663449|FG001|Overall Study|Lost to Follow-up|2|||
126373326|NCT02781558|454663448|FG000|Overall Study|Adverse Event|1|||
126373327|NCT02781558|454663449|FG001|Overall Study|Adverse Event|0|||
126373328|NCT01732536|454665062|FG000|Overall Study|Withdrawal by Subject|1|||
126373329|NCT01732536|454665063|FG001|Overall Study|Withdrawal by Subject|1|||
126373330|NCT01581684|454665066|FG000|Overall Study|Other reason not defined|0|||
126373331|NCT01581684|454665067|FG001|Overall Study|Other reason not defined|0|||
126716634|NCT03097328|455914891|FG000|Overall Study|Ineligible for Study Drug|1|||
126716635|NCT02653976|455914892|FG000|Overall Study|Withdrawal by Subject|5|||
126716636|NCT02653976|455914892|FG000|Overall Study|Death|4|||
126716637|NCT02023164|455914893|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
126716638|NCT02023164|455914894|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
126716639|NCT00883558|455914895|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
126309743|NCT02137850|454423177|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
126309744|NCT02137850|454423178|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
126309745|NCT02137850|454423179|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
126309746|NCT02137850|454423177|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
126309747|NCT02137850|454423178|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
126309748|NCT02137850|454423179|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
126309749|NCT02137850|454423177|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
126309750|NCT02137850|454423178|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
126309751|NCT02137850|454423179|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
126309752|NCT02137850|454423177|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
126309753|NCT02137850|454423178|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
126309754|NCT02137850|454423179|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
126309755|NCT02137850|454423177|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
126309756|NCT02137850|454423178|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
126309757|NCT02137850|454423179|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
126309758|NCT02137850|454423177|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
126309759|NCT02137850|454423178|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
126309760|NCT02137850|454423179|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
126309761|NCT02137850|454423177|FG000|Extension Phase: Prophylaxis|Other|0|||
126309762|NCT02137850|454423178|FG001|Extension Phase: Prophylaxis|Other|1|||
126309763|NCT02137850|454423179|FG002|Extension Phase: Prophylaxis|Other|0|||
126309764|NCT02137850|454423177|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
126309765|NCT02137850|454423178|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
126309766|NCT02137850|454423179|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
126309767|NCT02651155|454423180|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
126309768|NCT02651155|454423181|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
126309769|NCT02651155|454423180|FG000|Overall Study|Voluntary Withdrawal|5|||
126309770|NCT02651155|454423181|FG001|Overall Study|Voluntary Withdrawal|0|||
126309771|NCT04533412|454423182|FG000|Overall Study|Withdrawal by Subject|1|||
126309772|NCT04533412|454423183|FG001|Overall Study|Withdrawal by Subject|1|||
126309773|NCT04533412|454423182|FG000|Overall Study|Lost to Follow-up|1|||
126309774|NCT04533412|454423183|FG001|Overall Study|Lost to Follow-up|4|||
126309775|NCT00968981|454423191|FG000|Overall Study|Adverse Event|2|||
126309776|NCT00968981|454423192|FG001|Overall Study|Adverse Event|0|||
126309777|NCT00968981|454423193|FG002|Overall Study|Adverse Event|0|||
126309778|NCT00968981|454423191|FG000|Overall Study|Disease Progression|14|||
126309779|NCT00968981|454423192|FG001|Overall Study|Disease Progression|16|||
126309780|NCT00968981|454423193|FG002|Overall Study|Disease Progression|13|||
126309781|NCT00968981|454423191|FG000|Overall Study|Lost to Follow-up|0|||
126309782|NCT00968981|454423192|FG001|Overall Study|Lost to Follow-up|0|||
126309783|NCT00968981|454423193|FG002|Overall Study|Lost to Follow-up|1|||
126309784|NCT00968981|454423191|FG000|Overall Study|Physician Decision|5|||
126309785|NCT00968981|454423192|FG001|Overall Study|Physician Decision|3|||
126309786|NCT00968981|454423193|FG002|Overall Study|Physician Decision|5|||
126309787|NCT00968981|454423191|FG000|Overall Study|Withdrawal by Subject|1|||
126309788|NCT00968981|454423192|FG001|Overall Study|Withdrawal by Subject|3|||
126309789|NCT00968981|454423193|FG002|Overall Study|Withdrawal by Subject|3|||
126309790|NCT01489254|454423194|FG000|Double-blind Part|Adverse Event|7|||
126309791|NCT01489254|454423195|FG001|Double-blind Part|Adverse Event|2|||
126309792|NCT01489254|454423196|FG002|Double-blind Part|Adverse Event|2|||
126309793|NCT01489254|454423197|FG003|Double-blind Part|Adverse Event|0|||
126309794|NCT01489254|454423194|FG000|Double-blind Part|Pregnancy|1|||
126309795|NCT01489254|454423195|FG001|Double-blind Part|Pregnancy|3|||
126309796|NCT01489254|454423196|FG002|Double-blind Part|Pregnancy|0|||
126309797|NCT01489254|454423197|FG003|Double-blind Part|Pregnancy|0|||
126716640|NCT00883558|455914896|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
126309798|NCT01489254|454423194|FG000|Double-blind Part|Withdrawal by Subject|12|||
126309799|NCT01489254|454423195|FG001|Double-blind Part|Withdrawal by Subject|20|||
126309800|NCT01489254|454423196|FG002|Double-blind Part|Withdrawal by Subject|1|||
126309801|NCT01489254|454423197|FG003|Double-blind Part|Withdrawal by Subject|0|||
126309802|NCT01489254|454423194|FG000|Double-blind Part|Lost to Follow-up|1|||
126309803|NCT01489254|454423195|FG001|Double-blind Part|Lost to Follow-up|2|||
126309804|NCT01489254|454423196|FG002|Double-blind Part|Lost to Follow-up|0|||
126309805|NCT01489254|454423197|FG003|Double-blind Part|Lost to Follow-up|0|||
126309806|NCT01489254|454423194|FG000|Double-blind Part|Other reasons for not completing study|4|||
126309807|NCT01489254|454423195|FG001|Double-blind Part|Other reasons for not completing study|6|||
126552846|NCT00619476|455320479|FG002|Overall Study|Lost to Follow-up|0|||
126716641|NCT00883558|455914897|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
126373332|NCT01581684|454665068|FG002|Overall Study|Other reason not defined|0|||
126373333|NCT01581684|454665069|FG003|Overall Study|Other reason not defined|0|||
126373334|NCT01581684|454665070|FG004|Overall Study|Other reason not defined|0|||
126373335|NCT01581684|454665071|FG005|Overall Study|Other reason not defined|0|||
126373336|NCT01581684|454665072|FG006|Overall Study|Other reason not defined|0|||
126373337|NCT01581684|454665073|FG007|Overall Study|Other reason not defined|0|||
126373338|NCT01581684|454665074|FG008|Overall Study|Other reason not defined|1|||
126373339|NCT01581684|454665075|FG009|Overall Study|Other reason not defined|0|||
126373340|NCT03728933|454665076|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126373341|NCT03728933|454665077|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126373342|NCT03728933|454665078|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126373343|NCT03728933|454665076|FG000|Overall Study|Withdrawal by Subject|0|||
126373344|NCT03728933|454665077|FG001|Overall Study|Withdrawal by Subject|0|||
126373345|NCT03728933|454665078|FG002|Overall Study|Withdrawal by Subject|1|||
126373346|NCT03728933|454665076|FG000|Overall Study|Lost to Follow-up|0|||
126373347|NCT03728933|454665077|FG001|Overall Study|Lost to Follow-up|1|||
126373348|NCT03728933|454665078|FG002|Overall Study|Lost to Follow-up|0|||
126373349|NCT03728933|454665076|FG000|Overall Study|Adverse Event|1|||
126373350|NCT03728933|454665077|FG001|Overall Study|Adverse Event|0|||
126373351|NCT03728933|454665078|FG002|Overall Study|Adverse Event|0|||
126373352|NCT03235050|454665079|FG000|Overall Study|Adverse Event|0|||
126373353|NCT03235050|454665080|FG001|Overall Study|Adverse Event|0|||
126373354|NCT03235050|454665081|FG002|Overall Study|Adverse Event|1|||
126373355|NCT03235050|454665082|FG003|Overall Study|Adverse Event|4|||
126373356|NCT03235050|454665083|FG004|Overall Study|Adverse Event|1|||
126373357|NCT03235050|454665079|FG000|Overall Study|Death|0|||
126373358|NCT03235050|454665080|FG001|Overall Study|Death|0|||
126373359|NCT03235050|454665081|FG002|Overall Study|Death|0|||
126373360|NCT03235050|454665082|FG003|Overall Study|Death|2|||
126373361|NCT03235050|454665083|FG004|Overall Study|Death|1|||
126373362|NCT03235050|454665079|FG000|Overall Study|Lost to Follow-up|1|||
126373363|NCT03235050|454665080|FG001|Overall Study|Lost to Follow-up|2|||
126373364|NCT03235050|454665081|FG002|Overall Study|Lost to Follow-up|1|||
126373365|NCT03235050|454665082|FG003|Overall Study|Lost to Follow-up|2|||
126373366|NCT03235050|454665083|FG004|Overall Study|Lost to Follow-up|0|||
126373367|NCT03235050|454665079|FG000|Overall Study|Withdrawal by Subject|3|||
126373368|NCT03235050|454665080|FG001|Overall Study|Withdrawal by Subject|2|||
126373369|NCT03235050|454665081|FG002|Overall Study|Withdrawal by Subject|2|||
126373370|NCT03235050|454665082|FG003|Overall Study|Withdrawal by Subject|5|||
126373371|NCT03235050|454665083|FG004|Overall Study|Withdrawal by Subject|7|||
126466129|NCT00085709|455008902|FG001|Overall Study|Not protocol specified|22|||
126466130|NCT00085709|455008901|FG000|Overall Study|Not eligible|19|||
126466131|NCT00085709|455008902|FG001|Overall Study|Not eligible|19|||
126466132|NCT00085709|455008901|FG000|Overall Study|Withdrawal by Subject|2|||
126466133|NCT00085709|455008902|FG001|Overall Study|Withdrawal by Subject|1|||
126466134|NCT03960554|455008903|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
126466135|NCT03960554|455008904|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
126466136|NCT02310321|455008905|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
126466137|NCT02310321|455008906|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
126466138|NCT02310321|455008907|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
126466139|NCT02310321|455008905|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
126466140|NCT02310321|455008906|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
126466141|NCT02310321|455008907|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
126466142|NCT02310321|455008905|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
126466143|NCT02310321|455008906|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
126466144|NCT02310321|455008907|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
126466145|NCT02310321|455008905|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
126466146|NCT02310321|455008906|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
126466147|NCT02310321|455008907|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
126716642|NCT00883558|455914895|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
126716643|NCT00883558|455914896|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
126716644|NCT00883558|455914897|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
126716645|NCT00883558|455914895|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
126373372|NCT03235050|454665079|FG000|Overall Study|Other reasons|0|||
126373373|NCT03235050|454665080|FG001|Overall Study|Other reasons|1|||
126373374|NCT03235050|454665081|FG002|Overall Study|Other reasons|0|||
126373375|NCT03235050|454665082|FG003|Overall Study|Other reasons|1|||
126373376|NCT03235050|454665083|FG004|Overall Study|Other reasons|2|||
126373377|NCT02415556|454665084|FG000|Overall Study|Adverse Event|3|||
126373378|NCT02415556|454665085|FG001|Overall Study|Adverse Event|4|||
126373379|NCT02415556|454665086|FG002|Overall Study|Adverse Event|2|||
126373380|NCT02415556|454665087|FG003|Overall Study|Adverse Event|4|||
126373381|NCT02415556|454665084|FG000|Overall Study|Lost to Follow-up|4|||
126466148|NCT02310321|455008905|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
126466149|NCT02310321|455008906|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
126466150|NCT02310321|455008907|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
126466151|NCT02310321|455008905|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
126466152|NCT02310321|455008906|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
126466153|NCT02310321|455008907|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
126466154|NCT02310321|455008905|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
126466155|NCT02310321|455008906|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
126466156|NCT02310321|455008907|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
126466157|NCT02310321|455008905|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
126309808|NCT01489254|454423196|FG002|Double-blind Part|Other reasons for not completing study|0|||
126309809|NCT01489254|454423197|FG003|Double-blind Part|Other reasons for not completing study|0|||
126309810|NCT01489254|454423194|FG000|Open-label Extension Part|Adverse Event|0|||
126309811|NCT01489254|454423195|FG001|Open-label Extension Part|Adverse Event|0|||
126309812|NCT01489254|454423196|FG002|Open-label Extension Part|Adverse Event|0|||
126309813|NCT01489254|454423197|FG003|Open-label Extension Part|Adverse Event|10|||
126309814|NCT01489254|454423194|FG000|Open-label Extension Part|Pregnancy|0|||
126309815|NCT01489254|454423195|FG001|Open-label Extension Part|Pregnancy|0|||
126309816|NCT01489254|454423196|FG002|Open-label Extension Part|Pregnancy|0|||
126309817|NCT01489254|454423197|FG003|Open-label Extension Part|Pregnancy|3|||
126309818|NCT01489254|454423194|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
126309819|NCT01489254|454423195|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
126309820|NCT01489254|454423196|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
126309821|NCT01489254|454423197|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
126309822|NCT01489254|454423194|FG000|Open-label Extension Part|Protocol Violation|0|||
126309823|NCT01489254|454423195|FG001|Open-label Extension Part|Protocol Violation|0|||
126309824|NCT01489254|454423196|FG002|Open-label Extension Part|Protocol Violation|0|||
126309825|NCT01489254|454423197|FG003|Open-label Extension Part|Protocol Violation|1|||
126309826|NCT01489254|454423194|FG000|Open-label Extension Part|Lost to Follow-up|0|||
126309827|NCT01489254|454423195|FG001|Open-label Extension Part|Lost to Follow-up|0|||
126309828|NCT01489254|454423196|FG002|Open-label Extension Part|Lost to Follow-up|0|||
126309829|NCT01489254|454423197|FG003|Open-label Extension Part|Lost to Follow-up|9|||
126466158|NCT02310321|455008906|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
126466159|NCT02310321|455008907|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
126466160|NCT02310321|455008905|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
126466161|NCT02310321|455008906|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
126466162|NCT02310321|455008907|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
126466163|NCT02310321|455008905|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
126466164|NCT02310321|455008906|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
126466165|NCT02310321|455008907|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
126466166|NCT02310321|455008905|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
126466167|NCT02310321|455008906|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
126466168|NCT02310321|455008907|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
126466169|NCT02310321|455008905|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
126466170|NCT02310321|455008906|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
126466171|NCT02310321|455008907|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
126466172|NCT02310321|455008905|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
126466173|NCT02310321|455008906|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
126466174|NCT02310321|455008907|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
126466175|NCT02310321|455008905|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
126466176|NCT02310321|455008906|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
126466177|NCT02310321|455008907|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
126466178|NCT02310321|455008905|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
126466179|NCT02310321|455008906|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
126466180|NCT02310321|455008907|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
126466181|NCT02310321|455008905|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
126466182|NCT02310321|455008906|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
126466183|NCT02310321|455008907|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
126466184|NCT02310321|455008905|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
126466185|NCT02310321|455008906|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
126466186|NCT02310321|455008907|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
126466187|NCT02310321|455008905|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
126466188|NCT02310321|455008906|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
126466189|NCT02310321|455008907|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
126552847|NCT00619476|455320480|FG003|Overall Study|Lost to Follow-up|1|||
126309830|NCT01489254|454423194|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
126309831|NCT01489254|454423195|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
126373382|NCT02415556|454665085|FG001|Overall Study|Lost to Follow-up|5|||
126373383|NCT02415556|454665086|FG002|Overall Study|Lost to Follow-up|4|||
126373384|NCT02415556|454665087|FG003|Overall Study|Lost to Follow-up|1|||
126373385|NCT02415556|454665084|FG000|Overall Study|Withdrawal by Subject|13|||
126373386|NCT02415556|454665085|FG001|Overall Study|Withdrawal by Subject|4|||
126373387|NCT02415556|454665086|FG002|Overall Study|Withdrawal by Subject|14|||
126373388|NCT02415556|454665087|FG003|Overall Study|Withdrawal by Subject|12|||
126373389|NCT02415556|454665084|FG000|Overall Study|Physician Decision|1|||
126373390|NCT02415556|454665085|FG001|Overall Study|Physician Decision|3|||
126373391|NCT02415556|454665086|FG002|Overall Study|Physician Decision|1|||
126373392|NCT02415556|454665087|FG003|Overall Study|Physician Decision|2|||
126373393|NCT02415556|454665084|FG000|Overall Study|Censored - study completion|4|||
126373394|NCT02415556|454665085|FG001|Overall Study|Censored - study completion|5|||
126373395|NCT02415556|454665086|FG002|Overall Study|Censored - study completion|1|||
126373396|NCT02415556|454665087|FG003|Overall Study|Censored - study completion|0|||
126373397|NCT02415556|454665084|FG000|Overall Study|Family-related issues|0|||
126373398|NCT02415556|454665085|FG001|Overall Study|Family-related issues|0|||
126373399|NCT02415556|454665086|FG002|Overall Study|Family-related issues|0|||
126373400|NCT02415556|454665087|FG003|Overall Study|Family-related issues|1|||
126373401|NCT00105534|454665088|FG000|Overall Study|Adverse Event|2|||
126373402|NCT00105534|454665089|FG001|Overall Study|Adverse Event|5|||
126373403|NCT00105534|454665088|FG000|Overall Study|Protocol Violation|1|||
126373404|NCT00105534|454665089|FG001|Overall Study|Protocol Violation|4|||
126373405|NCT00105534|454665088|FG000|Overall Study|Withdrawal by Subject|6|||
126373406|NCT00105534|454665089|FG001|Overall Study|Withdrawal by Subject|6|||
126373407|NCT00105534|454665088|FG000|Overall Study|Lost to Follow-up|5|||
126373408|NCT00105534|454665089|FG001|Overall Study|Lost to Follow-up|1|||
126373409|NCT00105534|454665088|FG000|Overall Study|Lack of Efficacy|7|||
126373410|NCT00105534|454665089|FG001|Overall Study|Lack of Efficacy|15|||
126373411|NCT00105534|454665088|FG000|Overall Study|Treatment unmasked|1|||
126373412|NCT00105534|454665089|FG001|Overall Study|Treatment unmasked|0|||
126373413|NCT00105534|454665088|FG000|Overall Study|Other Reason|0|||
126373414|NCT00105534|454665089|FG001|Overall Study|Other Reason|2|||
126373415|NCT01621178|454665090|FG000|Overall Study|Adverse Event|5|||
126373416|NCT01621178|454665091|FG001|Overall Study|Adverse Event|2|||
126373417|NCT01621178|454665092|FG002|Overall Study|Adverse Event|8|||
126373418|NCT01621178|454665090|FG000|Overall Study|Death|6|||
126373419|NCT01621178|454665091|FG001|Overall Study|Death|7|||
126373420|NCT01621178|454665092|FG002|Overall Study|Death|2|||
126373421|NCT01621178|454665090|FG000|Overall Study|Lost to Follow-up|1|||
126373422|NCT01621178|454665091|FG001|Overall Study|Lost to Follow-up|2|||
126373423|NCT01621178|454665092|FG002|Overall Study|Lost to Follow-up|1|||
126373424|NCT01621178|454665090|FG000|Overall Study|Withdrawal by Subject|14|||
126373425|NCT01621178|454665091|FG001|Overall Study|Withdrawal by Subject|17|||
126373426|NCT01621178|454665092|FG002|Overall Study|Withdrawal by Subject|18|||
126373427|NCT01621178|454665090|FG000|Overall Study|Physician Decision|5|||
126373428|NCT01621178|454665091|FG001|Overall Study|Physician Decision|2|||
126373429|NCT01621178|454665092|FG002|Overall Study|Physician Decision|7|||
126373430|NCT02935192|454665093|FG000|Overall Study|Withdrawal by Subject|8|||
126373431|NCT02935192|454665094|FG001|Overall Study|Withdrawal by Subject|4|||
126373432|NCT02896257|454665095|FG000|Providers|Without eligible patients|21|||
126373433|NCT02896257|454665096|FG001|Providers|Without eligible patients|28|||
126373434|NCT02896257|454665095|FG000|Patients|PFT entry criteria not met|43|||
126373435|NCT02896257|454665096|FG001|Patients|PFT entry criteria not met|50|||
126373436|NCT02896257|454665095|FG000|Patients|No capacity to review|8|||
126373437|NCT02896257|454665096|FG001|Patients|No capacity to review|11|||
126373438|NCT02896257|454665095|FG000|Patients|Appointment rescheduled/cancelled|5|||
126373439|NCT02896257|454665096|FG001|Patients|Appointment rescheduled/cancelled|7|||
126373440|NCT02896257|454665095|FG000|Patients|PCP not assigned a clinic|4|||
126373441|NCT02896257|454665096|FG001|Patients|PCP not assigned a clinic|0|||
126373442|NCT02896257|454665095|FG000|Patients|No history of COPD|0|||
126716646|NCT00883558|455914896|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
126716647|NCT00883558|455914897|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
126373443|NCT02896257|454665096|FG001|Patients|No history of COPD|1|||
126373444|NCT02896257|454665095|FG000|Patients|Deceased between review and index date|0|||
126373445|NCT02896257|454665096|FG001|Patients|Deceased between review and index date|1|||
126373446|NCT02896257|454665095|FG000|Patients|No ICS Rx upon review|1|||
126373447|NCT02896257|454665096|FG001|Patients|No ICS Rx upon review|1|||
126373448|NCT02896257|454665095|FG000|Patients|Protocol Violation|2|||
126373449|NCT02896257|454665096|FG001|Patients|Protocol Violation|1|||
126373450|NCT02896257|454665095|FG000|Patients|Hospice care|0|||
126373451|NCT02896257|454665096|FG001|Patients|Hospice care|1|||
126373452|NCT02465931|454665097|FG000|Overall Study|Lost to Follow-up|9|||
126373453|NCT02465931|454665098|FG001|Overall Study|Lost to Follow-up|11|||
126373454|NCT02465931|454665097|FG000|Overall Study|Protocol Violation|1|||
126373455|NCT02465931|454665098|FG001|Overall Study|Protocol Violation|0|||
126373456|NCT02465931|454665097|FG000|Overall Study|Withdrawal by Subject|1|||
126373457|NCT02465931|454665098|FG001|Overall Study|Withdrawal by Subject|0|||
126309832|NCT01489254|454423196|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
126309833|NCT01489254|454423197|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
126309834|NCT01254318|454423198|FG000|Overall Study|Lost to Follow-up|5|||
126309835|NCT01254318|454423198|FG000|Overall Study|Death|47|||
126309836|NCT00782184|454423205|FG000|Overall Study|Adverse Event|1|||
126309837|NCT00782184|454423206|FG001|Overall Study|Adverse Event|2|||
126309838|NCT00782184|454423205|FG000|Overall Study|Protocol Violation|0|||
126309839|NCT00782184|454423206|FG001|Overall Study|Protocol Violation|1|||
126309840|NCT00782184|454423205|FG000|Overall Study|Withdrawal by Subject|3|||
126309841|NCT00782184|454423206|FG001|Overall Study|Withdrawal by Subject|2|||
126309842|NCT01878084|454423208|FG000|Overall Study|Physician Decision|2|||
126309843|NCT00749684|454423209|FG000|Overall Study|Death|1|||
126309844|NCT00749684|454423209|FG000|Overall Study|Adverse Event|27|||
126309845|NCT00749684|454423209|FG000|Overall Study|Participant's Wish|10|||
126309846|NCT00749684|454423209|FG000|Overall Study|Not Documented|1|||
126309847|NCT00749684|454423209|FG000|Overall Study|Progressive Desease|31|||
126309848|NCT00749684|454423209|FG000|Overall Study|Therapy according to protocol + AE|2|||
126309849|NCT00749684|454423209|FG000|Overall Study|AE+discontinuation on participants wish|1|||
126309850|NCT00749684|454423209|FG000|Overall Study|Missing|9|||
126309851|NCT02892422|454423211|FG000|Overall Study|Enrolled not treated|4|||
126309852|NCT02892422|454423211|FG000|Overall Study|Adverse Event|38|||
126309853|NCT02892422|454423211|FG000|Overall Study|Lack of Efficacy|32|||
126309854|NCT02892422|454423211|FG000|Overall Study|Non-compliance with study drug|11|||
126309855|NCT02892422|454423211|FG000|Overall Study|Protocol Violation|4|||
126309856|NCT02892422|454423211|FG000|Overall Study|Withdrawal by Subject|56|||
126309857|NCT02892422|454423211|FG000|Overall Study|Lost to Follow-up|5|||
126309858|NCT02892422|454423211|FG000|Overall Study|sponsor information 16159A results|21|||
126309859|NCT02892422|454423211|FG000|Overall Study|withdrawal of consent|13|||
126309860|NCT02892422|454423211|FG000|Overall Study|exclusion criteria met|3|||
126309861|NCT02892422|454423211|FG000|Overall Study|moving elsewhere|4|||
126309862|NCT02892422|454423211|FG000|Overall Study|non-compliance|10|||
126309863|NCT02892422|454423211|FG000|Overall Study|patient legally incapable|1|||
126309864|NCT02892422|454423211|FG000|Overall Study|patient decision|7|||
126309865|NCT02892422|454423211|FG000|Overall Study|Investigator decision|1|||
126309866|NCT01023256|454423212|FG000|Overall Study|Protocol Violation|2|||
126309867|NCT01023256|454423213|FG001|Overall Study|Protocol Violation|3|||
126309868|NCT01023256|454423214|FG002|Overall Study|Protocol Violation|0|||
126309869|NCT01023256|454423215|FG003|Overall Study|Protocol Violation|0|||
126309870|NCT01023256|454423212|FG000|Overall Study|Randomized but not treated|1|||
126309871|NCT01023256|454423213|FG001|Overall Study|Randomized but not treated|0|||
126309872|NCT01023256|454423214|FG002|Overall Study|Randomized but not treated|1|||
126309873|NCT01023256|454423215|FG003|Overall Study|Randomized but not treated|0|||
126309874|NCT01023256|454423212|FG000|Overall Study|Other|1|||
126309875|NCT01023256|454423213|FG001|Overall Study|Other|0|||
126309876|NCT01023256|454423214|FG002|Overall Study|Other|0|||
126309877|NCT01023256|454423215|FG003|Overall Study|Other|2|||
126309878|NCT01023256|454423212|FG000|Overall Study|Adverse Event|0|||
126309879|NCT01023256|454423213|FG001|Overall Study|Adverse Event|0|||
126309880|NCT01023256|454423214|FG002|Overall Study|Adverse Event|0|||
126309881|NCT01023256|454423215|FG003|Overall Study|Adverse Event|1|||
126309882|NCT01023256|454423212|FG000|Overall Study|Withdrawal by Subject|0|||
126309883|NCT01023256|454423213|FG001|Overall Study|Withdrawal by Subject|0|||
126309884|NCT01023256|454423214|FG002|Overall Study|Withdrawal by Subject|0|||
126309885|NCT01023256|454423215|FG003|Overall Study|Withdrawal by Subject|2|||
126309886|NCT03155178|454423216|FG000|Overall Study|Did not meet treatment day baseline|7|||
126309887|NCT03155178|454423217|FG001|Overall Study|Did not meet treatment day baseline|7|||
126309888|NCT03155178|454423218|FG002|Overall Study|Did not meet treatment day baseline|7|||
126309889|NCT03155178|454423219|FG003|Overall Study|Did not meet treatment day baseline|7|||
126309890|NCT03089697|454423220|FG000|Overall Study|Adverse Event|1|||
126309891|NCT03089697|454423221|FG001|Overall Study|Adverse Event|2|||
126309892|NCT03089697|454423220|FG000|Overall Study|Withdrawal by Subject|1|||
126309893|NCT03089697|454423221|FG001|Overall Study|Withdrawal by Subject|0|||
126716648|NCT00883558|455914895|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
126309894|NCT03613649|454423222|FG000|Second Treatment|Lost to Follow-up|0|||
126309895|NCT03613649|454423223|FG001|Second Treatment|Lost to Follow-up|0|||
126309896|NCT03613649|454423224|FG002|Second Treatment|Lost to Follow-up|1|||
126309897|NCT03613649|454423225|FG003|Second Treatment|Lost to Follow-up|0|||
126309898|NCT03613649|454423226|FG004|Second Treatment|Lost to Follow-up|0|||
126309899|NCT03613649|454423227|FG005|Second Treatment|Lost to Follow-up|0|||
126309900|NCT03613649|454423228|FG006|Second Treatment|Lost to Follow-up|0|||
126309901|NCT03613649|454423229|FG007|Second Treatment|Lost to Follow-up|0|||
126716649|NCT00883558|455914896|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
126716650|NCT00883558|455914897|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
126716651|NCT00883558|455914895|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
126716652|NCT00883558|455914896|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
126716653|NCT00883558|455914897|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
126552848|NCT00619476|455320477|FG000|Overall Study|Investigator Discretion|2|||
126552849|NCT00619476|455320478|FG001|Overall Study|Investigator Discretion|2|||
126552850|NCT00619476|455320479|FG002|Overall Study|Investigator Discretion|2|||
126552851|NCT00619476|455320480|FG003|Overall Study|Investigator Discretion|0|||
126552852|NCT00619476|455320477|FG000|Overall Study|Withdrawal by Subject|5|||
126552853|NCT00619476|455320478|FG001|Overall Study|Withdrawal by Subject|7|||
126552854|NCT00619476|455320479|FG002|Overall Study|Withdrawal by Subject|5|||
126552855|NCT00619476|455320480|FG003|Overall Study|Withdrawal by Subject|4|||
126552856|NCT01811563|455320484|FG000|Overall Study|Lost to Follow-up|5|||
126552857|NCT01811563|455320485|FG001|Overall Study|Lost to Follow-up|2|||
126552858|NCT01811563|455320484|FG000|Overall Study|Incorrect Randomization procedure|0|||
126552859|NCT01811563|455320485|FG001|Overall Study|Incorrect Randomization procedure|1|||
126552860|NCT01327547|455320486|FG000|Overall Study|Adverse Event|4|||
126716654|NCT02436577|455914898|FG000|Overall Study|Protocol Deviation|0|||
126309902|NCT03613649|454423230|FG008|Second Treatment|Lost to Follow-up|0|||
126309903|NCT03613649|454423231|FG009|Second Treatment|Lost to Follow-up|0|||
126309904|NCT03613649|454423232|FG010|Second Treatment|Lost to Follow-up|0|||
126309905|NCT03613649|454423233|FG011|Second Treatment|Lost to Follow-up|0|||
126309906|NCT03613649|454423222|FG000|Second Treatment|Withdrawal by Subject|0|||
126309907|NCT03613649|454423223|FG001|Second Treatment|Withdrawal by Subject|0|||
126309908|NCT03613649|454423224|FG002|Second Treatment|Withdrawal by Subject|0|||
126309909|NCT03613649|454423225|FG003|Second Treatment|Withdrawal by Subject|0|||
126309910|NCT03613649|454423226|FG004|Second Treatment|Withdrawal by Subject|1|||
126309911|NCT03613649|454423227|FG005|Second Treatment|Withdrawal by Subject|0|||
126309912|NCT03613649|454423228|FG006|Second Treatment|Withdrawal by Subject|0|||
126309913|NCT03613649|454423229|FG007|Second Treatment|Withdrawal by Subject|0|||
126309914|NCT03613649|454423230|FG008|Second Treatment|Withdrawal by Subject|0|||
126309915|NCT03613649|454423231|FG009|Second Treatment|Withdrawal by Subject|0|||
126309916|NCT03613649|454423232|FG010|Second Treatment|Withdrawal by Subject|0|||
126309917|NCT03613649|454423233|FG011|Second Treatment|Withdrawal by Subject|0|||
126309918|NCT03613649|454423222|FG000|Third Treatment|Lost to Follow-up|0|||
126309919|NCT03613649|454423223|FG001|Third Treatment|Lost to Follow-up|0|||
126309920|NCT03613649|454423224|FG002|Third Treatment|Lost to Follow-up|0|||
126309921|NCT03613649|454423225|FG003|Third Treatment|Lost to Follow-up|0|||
126309922|NCT03613649|454423226|FG004|Third Treatment|Lost to Follow-up|1|||
126309923|NCT03613649|454423227|FG005|Third Treatment|Lost to Follow-up|0|||
126309924|NCT03613649|454423228|FG006|Third Treatment|Lost to Follow-up|0|||
126309925|NCT03613649|454423229|FG007|Third Treatment|Lost to Follow-up|0|||
126309926|NCT03613649|454423230|FG008|Third Treatment|Lost to Follow-up|0|||
126309927|NCT03613649|454423231|FG009|Third Treatment|Lost to Follow-up|0|||
126309928|NCT03613649|454423232|FG010|Third Treatment|Lost to Follow-up|0|||
126309929|NCT03613649|454423233|FG011|Third Treatment|Lost to Follow-up|1|||
126309930|NCT03613649|454423222|FG000|Third Treatment|Protocol Violation|0|||
126309931|NCT03613649|454423223|FG001|Third Treatment|Protocol Violation|0|||
126309932|NCT03613649|454423224|FG002|Third Treatment|Protocol Violation|0|||
126309933|NCT03613649|454423225|FG003|Third Treatment|Protocol Violation|0|||
126309934|NCT03613649|454423226|FG004|Third Treatment|Protocol Violation|0|||
126309935|NCT03613649|454423227|FG005|Third Treatment|Protocol Violation|0|||
126309936|NCT03613649|454423228|FG006|Third Treatment|Protocol Violation|1|||
126309937|NCT03613649|454423229|FG007|Third Treatment|Protocol Violation|0|||
126309938|NCT03613649|454423230|FG008|Third Treatment|Protocol Violation|0|||
126309939|NCT03613649|454423231|FG009|Third Treatment|Protocol Violation|0|||
126309940|NCT03613649|454423232|FG010|Third Treatment|Protocol Violation|0|||
126309941|NCT03613649|454423233|FG011|Third Treatment|Protocol Violation|1|||
126309942|NCT03613649|454423222|FG000|Fourth Treatment|Protocol Violation|1|||
126309943|NCT03613649|454423223|FG001|Fourth Treatment|Protocol Violation|0|||
126309944|NCT03613649|454423224|FG002|Fourth Treatment|Protocol Violation|0|||
126309945|NCT03613649|454423225|FG003|Fourth Treatment|Protocol Violation|0|||
126309946|NCT03613649|454423226|FG004|Fourth Treatment|Protocol Violation|1|||
126309947|NCT03613649|454423227|FG005|Fourth Treatment|Protocol Violation|0|||
126309948|NCT03613649|454423228|FG006|Fourth Treatment|Protocol Violation|0|||
126716655|NCT02436577|455914899|FG001|Overall Study|Protocol Deviation|1|||
126309949|NCT03613649|454423229|FG007|Fourth Treatment|Protocol Violation|0|||
126552861|NCT01327547|455320487|FG001|Overall Study|Adverse Event|1|||
126309950|NCT03613649|454423230|FG008|Fourth Treatment|Protocol Violation|0|||
126309951|NCT03613649|454423231|FG009|Fourth Treatment|Protocol Violation|0|||
126309952|NCT03613649|454423232|FG010|Fourth Treatment|Protocol Violation|0|||
126309953|NCT03613649|454423233|FG011|Fourth Treatment|Protocol Violation|0|||
126309954|NCT03613649|454423222|FG000|Fourth Treatment|Physician Decision|0|||
126552862|NCT01327547|455320486|FG000|Overall Study|Death|1|||
126552863|NCT01327547|455320487|FG001|Overall Study|Death|2|||
126309955|NCT03613649|454423223|FG001|Fourth Treatment|Physician Decision|0|||
126309956|NCT03613649|454423224|FG002|Fourth Treatment|Physician Decision|0|||
126309957|NCT03613649|454423225|FG003|Fourth Treatment|Physician Decision|0|||
126309958|NCT03613649|454423226|FG004|Fourth Treatment|Physician Decision|0|||
126309959|NCT03613649|454423227|FG005|Fourth Treatment|Physician Decision|0|||
126716656|NCT02436577|455914900|FG002|Overall Study|Protocol Deviation|0|||
126552864|NCT01327547|455320486|FG000|Overall Study|Lost to Follow-up|6|||
126552865|NCT01327547|455320487|FG001|Overall Study|Lost to Follow-up|6|||
126552866|NCT01327547|455320486|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
126552867|NCT01327547|455320487|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
126552868|NCT01327547|455320486|FG000|Overall Study|Withdrawal by Subject|3|||
126552869|NCT01327547|455320487|FG001|Overall Study|Withdrawal by Subject|7|||
126552870|NCT01327547|455320486|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
126552871|NCT01327547|455320487|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
126552872|NCT01327547|455320486|FG000|Overall Study|Protocol Violation|1|||
126552873|NCT01327547|455320487|FG001|Overall Study|Protocol Violation|0|||
126552874|NCT01327547|455320486|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
126552875|NCT01327547|455320487|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
126552876|NCT01327547|455320486|FG000|Overall Study|Required prohibited medication|2|||
126552877|NCT01327547|455320487|FG001|Overall Study|Required prohibited medication|0|||
126716657|NCT02436577|455914901|FG003|Overall Study|Protocol Deviation|0|||
126716658|NCT02436577|455914902|FG004|Overall Study|Protocol Deviation|0|||
126716659|NCT02436577|455914903|FG005|Overall Study|Protocol Deviation|0|||
126309960|NCT03613649|454423228|FG006|Fourth Treatment|Physician Decision|1|||
126309961|NCT03613649|454423229|FG007|Fourth Treatment|Physician Decision|0|||
126309962|NCT03613649|454423230|FG008|Fourth Treatment|Physician Decision|0|||
126309963|NCT03613649|454423231|FG009|Fourth Treatment|Physician Decision|0|||
126309964|NCT03613649|454423232|FG010|Fourth Treatment|Physician Decision|0|||
126309965|NCT03613649|454423233|FG011|Fourth Treatment|Physician Decision|0|||
126309966|NCT00675428|454423234|FG000|Overall Study|Disease Progression|2|||
126309967|NCT00675428|454423235|FG001|Overall Study|Disease Progression|2|||
126309968|NCT00675428|454423234|FG000|Overall Study|No Disease Response After Cycle 6|0|||
126309969|NCT00675428|454423235|FG001|Overall Study|No Disease Response After Cycle 6|1|||
126309970|NCT00675428|454423234|FG000|Overall Study|Physician Decision|1|||
126309971|NCT00675428|454423235|FG001|Overall Study|Physician Decision|0|||
126309972|NCT00319592|454423236|FG000|Overall Study|Protocol Violation|1|||
126309973|NCT00319592|454423237|FG001|Overall Study|Protocol Violation|0|||
126309974|NCT00319592|454423236|FG000|Overall Study|Physician Decision|0|||
126309975|NCT00319592|454423237|FG001|Overall Study|Physician Decision|1|||
126309976|NCT01500187|454423240|FG000|Overall Study|Lost to Follow-up|6|||
126309977|NCT01500187|454423241|FG001|Overall Study|Lost to Follow-up|0|||
126309978|NCT01992653|454423244|FG000|Overall Study|Death|0|||
126309979|NCT01992653|454423245|FG001|Overall Study|Death|0|||
126309980|NCT01992653|454423246|FG002|Overall Study|Death|1|||
126309981|NCT01992653|454423247|FG003|Overall Study|Death|0|||
126309982|NCT01992653|454423248|FG004|Overall Study|Death|1|||
126309983|NCT01992653|454423249|FG005|Overall Study|Death|0|||
126309984|NCT01992653|454423250|FG006|Overall Study|Death|4|||
126309985|NCT01992653|454423251|FG007|Overall Study|Death|2|||
126309986|NCT01992653|454423244|FG000|Overall Study|Lost to Follow-up|0|||
126309987|NCT01992653|454423245|FG001|Overall Study|Lost to Follow-up|0|||
126309988|NCT01992653|454423246|FG002|Overall Study|Lost to Follow-up|0|||
126309989|NCT01992653|454423247|FG003|Overall Study|Lost to Follow-up|0|||
126309990|NCT01992653|454423248|FG004|Overall Study|Lost to Follow-up|0|||
126309991|NCT01992653|454423249|FG005|Overall Study|Lost to Follow-up|0|||
126309992|NCT01992653|454423250|FG006|Overall Study|Lost to Follow-up|0|||
126309993|NCT01992653|454423251|FG007|Overall Study|Lost to Follow-up|1|||
126309994|NCT01992653|454423244|FG000|Overall Study|Study Completed|0|||
126309995|NCT01992653|454423245|FG001|Overall Study|Study Completed|0|||
126309996|NCT01992653|454423246|FG002|Overall Study|Study Completed|0|||
126309997|NCT01992653|454423247|FG003|Overall Study|Study Completed|0|||
126309998|NCT01992653|454423248|FG004|Overall Study|Study Completed|0|||
126309999|NCT01992653|454423249|FG005|Overall Study|Study Completed|0|||
126310000|NCT01992653|454423250|FG006|Overall Study|Study Completed|0|||
126310001|NCT01992653|454423251|FG007|Overall Study|Study Completed|1|||
126310002|NCT01992653|454423244|FG000|Overall Study|Disease Progression|0|||
126310003|NCT01992653|454423245|FG001|Overall Study|Disease Progression|0|||
126310004|NCT01992653|454423246|FG002|Overall Study|Disease Progression|0|||
126310005|NCT01992653|454423247|FG003|Overall Study|Disease Progression|0|||
126310006|NCT01992653|454423248|FG004|Overall Study|Disease Progression|0|||
126716660|NCT03703375|455914904|FG000|Randomization Period|Withdrawal by Subject|0|||
126310007|NCT01992653|454423249|FG005|Overall Study|Disease Progression|0|||
126310008|NCT01992653|454423250|FG006|Overall Study|Disease Progression|4|||
126310009|NCT01992653|454423251|FG007|Overall Study|Disease Progression|0|||
126310010|NCT04553471|454423252|FG000|Overall Study|Did not start treatment on protocol|3|||
126310011|NCT04553471|454423252|FG000|Overall Study|Death|1|||
126310012|NCT00940823|454423253|FG000|Overall Study|Death|8|||
126310013|NCT00940823|454423254|FG001|Overall Study|Death|12|||
126310014|NCT00940823|454423253|FG000|Overall Study|Lost to Follow-up|27|||
126310015|NCT00940823|454423254|FG001|Overall Study|Lost to Follow-up|20|||
126310016|NCT02572076|454423257|FG000|Overall Study|Protocol Violation|1|||
126310017|NCT01397786|454425185|FG000|Phase A|Lost to Follow-up|0|||
126310018|NCT01397786|454425186|FG001|Phase A|Lost to Follow-up|0|||
126310019|NCT01397786|454425187|FG002|Phase A|Lost to Follow-up|6|||
126310020|NCT01397786|454425185|FG000|Phase A|Adverse Event|0|||
126373458|NCT00492557|454665099|FG000|Overall Study|Subject request|12|||
126373459|NCT00492557|454665100|FG001|Overall Study|Subject request|11|||
126373460|NCT00492557|454665099|FG000|Overall Study|Protocol Violation|7|||
126373461|NCT00492557|454665100|FG001|Overall Study|Protocol Violation|8|||
126373462|NCT00492557|454665099|FG000|Overall Study|Other|2|||
126373463|NCT00492557|454665100|FG001|Overall Study|Other|2|||
126373464|NCT00492557|454665099|FG000|Overall Study|Death|1|||
126373465|NCT00492557|454665100|FG001|Overall Study|Death|1|||
126373466|NCT00492557|454665099|FG000|Overall Study|Adverse Event|1|||
126373467|NCT00492557|454665100|FG001|Overall Study|Adverse Event|0|||
126466190|NCT02310321|455008905|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
126466191|NCT02310321|455008906|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
126466192|NCT02310321|455008907|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
126466193|NCT02310321|455008905|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
126466194|NCT02310321|455008906|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
126466195|NCT02310321|455008907|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
126466196|NCT02310321|455008905|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
126466197|NCT02310321|455008906|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
126466198|NCT02310321|455008907|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
126466199|NCT02310321|455008905|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
126466200|NCT02310321|455008906|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
126466201|NCT02310321|455008907|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
126466202|NCT02310321|455008905|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
126466203|NCT02310321|455008906|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
126466204|NCT02310321|455008907|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
126466205|NCT01698905|455008908|FG000|Overall Study|Adverse Event|4|||
126466206|NCT01698905|455008908|FG000|Overall Study|Physician Decision|2|||
126466207|NCT01698905|455008908|FG000|Overall Study|Pregnancy|1|||
126466208|NCT01698905|455008908|FG000|Overall Study|Protocol Violation|1|||
126466209|NCT01698905|455008908|FG000|Overall Study|Subject/guardian decision|2|||
126466210|NCT01698905|455008908|FG000|Overall Study|Death|1|||
126466211|NCT02325791|455008911|FG000|Overall Study|Adverse Event|0|||
126466212|NCT02325791|455008912|FG001|Overall Study|Adverse Event|1|||
126466213|NCT02325791|455008913|FG002|Overall Study|Adverse Event|1|||
126466214|NCT02325791|455008914|FG003|Overall Study|Adverse Event|0|||
126466215|NCT02325791|455008911|FG000|Overall Study|Death|0|||
126466216|NCT02325791|455008912|FG001|Overall Study|Death|3|||
126466217|NCT02325791|455008913|FG002|Overall Study|Death|0|||
126466218|NCT02325791|455008914|FG003|Overall Study|Death|1|||
126466219|NCT02325791|455008911|FG000|Overall Study|Lost to Follow-up|0|||
126466220|NCT02325791|455008912|FG001|Overall Study|Lost to Follow-up|15|||
126466221|NCT02325791|455008913|FG002|Overall Study|Lost to Follow-up|14|||
126466222|NCT02325791|455008914|FG003|Overall Study|Lost to Follow-up|9|||
126466223|NCT02325791|455008911|FG000|Overall Study|Physician Decision|0|||
126466224|NCT02325791|455008912|FG001|Overall Study|Physician Decision|1|||
126466225|NCT02325791|455008913|FG002|Overall Study|Physician Decision|1|||
126466226|NCT02325791|455008914|FG003|Overall Study|Physician Decision|0|||
126466227|NCT02325791|455008911|FG000|Overall Study|Protocol Violation|0|||
126466228|NCT02325791|455008912|FG001|Overall Study|Protocol Violation|0|||
126466229|NCT02325791|455008913|FG002|Overall Study|Protocol Violation|1|||
126466230|NCT02325791|455008914|FG003|Overall Study|Protocol Violation|0|||
126466231|NCT02325791|455008911|FG000|Overall Study|Withdrawal by Subject|0|||
126466232|NCT02325791|455008912|FG001|Overall Study|Withdrawal by Subject|5|||
126466233|NCT02325791|455008913|FG002|Overall Study|Withdrawal by Subject|8|||
126466234|NCT02325791|455008914|FG003|Overall Study|Withdrawal by Subject|16|||
126466235|NCT03953183|455008915|FG000|Overall Study|Physician Decision|0|||
126466236|NCT03953183|455008916|FG001|Overall Study|Physician Decision|1|||
126466237|NCT03953183|455008915|FG000|Overall Study|Withdrawal by Subject|0|||
126466238|NCT03953183|455008916|FG001|Overall Study|Withdrawal by Subject|1|||
126466239|NCT00764504|455008917|FG000|Overall Study|Death|12|||
126466240|NCT00764504|455008918|FG001|Overall Study|Death|6|||
126466241|NCT00764504|455008919|FG002|Overall Study|Death|13|||
126466242|NCT00764504|455008917|FG000|Overall Study|Revision of Device|12|||
126466243|NCT00764504|455008918|FG001|Overall Study|Revision of Device|23|||
126771010|NCT00422058|456116236|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
126771011|NCT00422058|456116237|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
126466244|NCT00764504|455008919|FG002|Overall Study|Revision of Device|14|||
126373468|NCT00492557|454665099|FG000|Overall Study|Failed to return|1|||
126373469|NCT00492557|454665100|FG001|Overall Study|Failed to return|0|||
126466245|NCT00764504|455008917|FG000|Overall Study|Physician Decision|1|||
126466246|NCT00764504|455008918|FG001|Overall Study|Physician Decision|0|||
126466247|NCT00764504|455008919|FG002|Overall Study|Physician Decision|0|||
126466248|NCT00764504|455008917|FG000|Overall Study|Withdrawal by Subject|1|||
126466249|NCT00764504|455008918|FG001|Overall Study|Withdrawal by Subject|7|||
126466250|NCT00764504|455008919|FG002|Overall Study|Withdrawal by Subject|4|||
126466251|NCT00764504|455008917|FG000|Overall Study|Lost to Follow-up|40|||
126771012|NCT00422058|456116232|FG000|Double-Blind, Week 0-20|Other|11|||
126373470|NCT00492557|454665099|FG000|Overall Study|Lost to Follow-up|0|||
126373471|NCT00492557|454665100|FG001|Overall Study|Lost to Follow-up|1|||
126373472|NCT01493089|454665104|FG000|Overall Study|Protocol Violation|2|||
126373473|NCT01493089|454665105|FG001|Overall Study|Protocol Violation|2|||
126373474|NCT01493089|454665104|FG000|Overall Study|Withdrawal by Subject|1|||
126373475|NCT01493089|454665105|FG001|Overall Study|Withdrawal by Subject|0|||
126373476|NCT01493089|454665104|FG000|Overall Study|Physician Decision|0|||
126373477|NCT01493089|454665105|FG001|Overall Study|Physician Decision|1|||
126373478|NCT00329030|454665106|FG000|Overall Study|Withdrawal by Subject|1|||
126373479|NCT00329030|454665107|FG001|Overall Study|Withdrawal by Subject|3|||
126373480|NCT00329030|454665106|FG000|Overall Study|Progressive Disease|6|||
126373481|NCT00329030|454665107|FG001|Overall Study|Progressive Disease|2|||
126373482|NCT00329030|454665106|FG000|Overall Study|Ineligible Pathology|1|||
126373483|NCT00329030|454665107|FG001|Overall Study|Ineligible Pathology|1|||
126373484|NCT00325143|454665108|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
126373485|NCT00325143|454665108|FG000|Overall Study|Migrated/moved from study area|1|||
126373486|NCT00325143|454665108|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
126373487|NCT00325143|454665108|FG000|Overall Study|Withdrawal by Subject|8|||
126373488|NCT01008618|454665109|FG000|Period 1 (Titration Period)|Physician Decision|2|||
126373489|NCT01008618|454665110|FG001|Period 1 (Titration Period)|Physician Decision|0|||
126373490|NCT01008618|454665111|FG002|Period 1 (Titration Period)|Physician Decision|0|||
126373491|NCT01008618|454665109|FG000|Period 1 (Titration Period)|Adverse Event|33|||
126373492|NCT01008618|454665110|FG001|Period 1 (Titration Period)|Adverse Event|0|||
126373493|NCT01008618|454665111|FG002|Period 1 (Titration Period)|Adverse Event|0|||
126310021|NCT01397786|454425186|FG001|Phase A|Adverse Event|0|||
126310022|NCT01397786|454425187|FG002|Phase A|Adverse Event|8|||
126310023|NCT01397786|454425185|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
126310024|NCT01397786|454425186|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
126310025|NCT01397786|454425187|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
126310026|NCT01397786|454425185|FG000|Phase A|Physician Decision|0|||
126310027|NCT01397786|454425186|FG001|Phase A|Physician Decision|0|||
126310028|NCT01397786|454425187|FG002|Phase A|Physician Decision|1|||
126310029|NCT01397786|454425185|FG000|Phase A|Withdrawal by Subject|0|||
126310030|NCT01397786|454425186|FG001|Phase A|Withdrawal by Subject|0|||
126310031|NCT01397786|454425187|FG002|Phase A|Withdrawal by Subject|5|||
126310032|NCT01397786|454425185|FG000|Phase A|Lack of Efficacy|0|||
126310033|NCT01397786|454425186|FG001|Phase A|Lack of Efficacy|0|||
126310034|NCT01397786|454425187|FG002|Phase A|Lack of Efficacy|1|||
126310035|NCT01397786|454425185|FG000|Phase B|Lost to Follow-up|22|||
126310036|NCT01397786|454425186|FG001|Phase B|Lost to Follow-up|12|||
126310037|NCT01397786|454425187|FG002|Phase B|Lost to Follow-up|22|||
126310038|NCT01397786|454425185|FG000|Phase B|Adverse Event|109|||
126310039|NCT01397786|454425186|FG001|Phase B|Adverse Event|23|||
126310040|NCT01397786|454425187|FG002|Phase B|Adverse Event|27|||
126310041|NCT01397786|454425185|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
126310042|NCT01397786|454425186|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
126310043|NCT01397786|454425187|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
126310044|NCT01397786|454425185|FG000|Phase B|Physician Decision|9|||
126310045|NCT01397786|454425186|FG001|Phase B|Physician Decision|1|||
126310046|NCT01397786|454425187|FG002|Phase B|Physician Decision|3|||
126310047|NCT01397786|454425185|FG000|Phase B|Withdrawal by Subject|102|||
126310048|NCT01397786|454425186|FG001|Phase B|Withdrawal by Subject|45|||
126310049|NCT01397786|454425187|FG002|Phase B|Withdrawal by Subject|30|||
126310050|NCT01397786|454425185|FG000|Phase B|Protocol Deviation|1|||
126373494|NCT01008618|454665109|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
126373495|NCT01008618|454665110|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
126373496|NCT01008618|454665111|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
126716661|NCT03703375|455914905|FG001|Randomization Period|Withdrawal by Subject|0|||
126716662|NCT03703375|455914906|FG002|Randomization Period|Withdrawal by Subject|0|||
126716663|NCT03703375|455914907|FG003|Randomization Period|Withdrawal by Subject|1|||
126716664|NCT03703375|455914904|FG000|Randomization Period|Completed safety run-in treatment|7|||
126310051|NCT01397786|454425186|FG001|Phase B|Protocol Deviation|2|||
126310052|NCT01397786|454425187|FG002|Phase B|Protocol Deviation|4|||
126373497|NCT01008618|454665109|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
126466252|NCT00764504|455008918|FG001|Overall Study|Lost to Follow-up|34|||
126310053|NCT01397786|454425185|FG000|Phase B|Lack of Efficacy|22|||
126310054|NCT01397786|454425186|FG001|Phase B|Lack of Efficacy|7|||
126310055|NCT01397786|454425187|FG002|Phase B|Lack of Efficacy|14|||
126310056|NCT00784550|454425188|FG000|Overall Study|Adverse Event|12|||
126310057|NCT00784550|454425189|FG001|Overall Study|Adverse Event|10|||
126466253|NCT00764504|455008919|FG002|Overall Study|Lost to Follow-up|72|||
126466254|NCT01465191|455008920|FG000|Overall Study|Protocol Violation|6|||
126466255|NCT01465191|455008921|FG001|Overall Study|Protocol Violation|3|||
126466256|NCT01465191|455008922|FG002|Overall Study|Protocol Violation|3|||
126466257|NCT01465191|455008920|FG000|Overall Study|Lost to Follow-up|3|||
126466258|NCT01465191|455008921|FG001|Overall Study|Lost to Follow-up|6|||
126466259|NCT01465191|455008922|FG002|Overall Study|Lost to Follow-up|4|||
126310058|NCT00784550|454425188|FG000|Overall Study|Lack of Efficacy|0|||
126310059|NCT00784550|454425189|FG001|Overall Study|Lack of Efficacy|1|||
126373498|NCT01008618|454665110|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
126373499|NCT01008618|454665111|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
126373500|NCT01008618|454665109|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
126373501|NCT01008618|454665110|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
126373502|NCT01008618|454665111|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
126373503|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
126373504|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
126373505|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
126373506|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
126373507|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
126373508|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
126373509|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
126373510|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
126373511|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
126373512|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
126373513|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
126373514|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
126373515|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
126373516|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
126373517|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
126373518|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
126373519|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
126373520|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
126373521|NCT01008618|454665109|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
126373522|NCT01008618|454665110|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
126373523|NCT01008618|454665111|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
126373524|NCT01627691|454665112|FG000|Overall Study|Death|11|||
126373525|NCT01627691|454665112|FG000|Overall Study|Lost to Follow-up|3|||
126373526|NCT01627691|454665112|FG000|Overall Study|Withdrawal by Subject|1|||
126373527|NCT01627691|454665112|FG000|Overall Study|Missed the visit|3|||
126373528|NCT00181844|454665113|FG000|Signed Consent|Withdrawal by Subject|5|||
126373529|NCT00181844|454665113|FG000|Signed Consent|Did not meet entrance criteria|7|||
126373530|NCT00181844|454665113|FG000|Exposed to Study Medication|Adverse Event|10|||
126373531|NCT00181844|454665113|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
126373532|NCT00181844|454665113|FG000|Exposed to Study Medication|Non-compliance|2|||
126373533|NCT00181844|454665113|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
126373534|NCT00181844|454665113|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
126373535|NCT04661033|454665114|FG000|Overall Study|Adverse Event|0|||
126373536|NCT04661033|454665115|FG001|Overall Study|Adverse Event|0|||
126373537|NCT04661033|454665116|FG002|Overall Study|Adverse Event|1|||
126373538|NCT04661033|454665117|FG003|Overall Study|Adverse Event|0|||
126373539|NCT04661033|454665114|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
126373540|NCT04661033|454665115|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
126373541|NCT04661033|454665116|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
126373542|NCT04661033|454665117|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
126373543|NCT04661033|454665114|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
126373544|NCT04661033|454665115|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
126373545|NCT04661033|454665116|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
126373546|NCT04661033|454665117|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
126373547|NCT04661033|454665114|FG000|Overall Study|Early discontinuation as per PI|1|||
126373548|NCT04661033|454665115|FG001|Overall Study|Early discontinuation as per PI|0|||
126373549|NCT04661033|454665116|FG002|Overall Study|Early discontinuation as per PI|0|||
126373550|NCT04661033|454665117|FG003|Overall Study|Early discontinuation as per PI|0|||
126373551|NCT00565409|454665120|FG000|Period 1 Open Label|Adverse Event|17|||
126373552|NCT00565409|454665121|FG001|Period 1 Open Label|Adverse Event|0|||
126373553|NCT00565409|454665122|FG002|Period 1 Open Label|Adverse Event|0|||
126373554|NCT00565409|454665123|FG003|Period 1 Open Label|Adverse Event|0|||
126466260|NCT04010539|455008923|FG000|Overall Study|Withdrawal by Subject|4|||
126466261|NCT04010539|455008924|FG001|Overall Study|Withdrawal by Subject|1|||
126373555|NCT00565409|454665120|FG000|Period 1 Open Label|Death|2|||
126373556|NCT00565409|454665121|FG001|Period 1 Open Label|Death|0|||
126373557|NCT00565409|454665122|FG002|Period 1 Open Label|Death|0|||
126373558|NCT00565409|454665123|FG003|Period 1 Open Label|Death|0|||
126373559|NCT00565409|454665120|FG000|Period 1 Open Label|Lost to Follow-up|1|||
126373560|NCT00565409|454665121|FG001|Period 1 Open Label|Lost to Follow-up|0|||
126373561|NCT00565409|454665122|FG002|Period 1 Open Label|Lost to Follow-up|0|||
126373562|NCT00565409|454665123|FG003|Period 1 Open Label|Lost to Follow-up|0|||
126466262|NCT04010539|455008923|FG000|Overall Study|Physician Decision|0|||
126466263|NCT04010539|455008924|FG001|Overall Study|Physician Decision|2|||
126466264|NCT04010539|455008923|FG000|Overall Study|Lost to Follow-up|10|||
126466265|NCT04010539|455008924|FG001|Overall Study|Lost to Follow-up|14|||
126466266|NCT04010539|455008923|FG000|Overall Study|Adverse Event|3|||
126466267|NCT04010539|455008924|FG001|Overall Study|Adverse Event|0|||
126466268|NCT04010539|455008923|FG000|Overall Study|Participant Did Not Receive IP|0|||
126466269|NCT04010539|455008924|FG001|Overall Study|Participant Did Not Receive IP|1|||
126466270|NCT04010539|455008923|FG000|Overall Study|Protocol Deviation|0|||
126466271|NCT04010539|455008924|FG001|Overall Study|Protocol Deviation|1|||
126466272|NCT04010539|455008923|FG000|Overall Study|Randomized in Error/ Mistake|2|||
126466273|NCT04010539|455008924|FG001|Overall Study|Randomized in Error/ Mistake|0|||
126466274|NCT04010539|455008923|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
126466275|NCT04010539|455008924|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
126466276|NCT00249288|455008925|FG000|Overall Study|Lost to Follow-up|3|||
126466277|NCT00249288|455008926|FG001|Overall Study|Lost to Follow-up|3|||
126466278|NCT00249288|455008925|FG000|Overall Study|Withdrawal by Subject|2|||
126466279|NCT00249288|455008926|FG001|Overall Study|Withdrawal by Subject|2|||
126466280|NCT03059446|455008927|FG000|Overall Study|Adverse Event|11|||
126466281|NCT03059446|455008927|FG000|Overall Study|Withdrawal of Consent|16|||
126310060|NCT00784550|454425188|FG000|Overall Study|Protocol Violation|10|||
126310061|NCT00784550|454425189|FG001|Overall Study|Protocol Violation|10|||
126310062|NCT00784550|454425188|FG000|Overall Study|Lost to Follow-up|8|||
126310063|NCT00784550|454425189|FG001|Overall Study|Lost to Follow-up|5|||
126310064|NCT00784550|454425188|FG000|Overall Study|Physician Decision|2|||
126310065|NCT00784550|454425189|FG001|Overall Study|Physician Decision|3|||
126310066|NCT00784550|454425188|FG000|Overall Study|Withdrawal by Subject|4|||
126310067|NCT00784550|454425189|FG001|Overall Study|Withdrawal by Subject|13|||
126310068|NCT00688701|454425190|FG000|Overall Study|Adverse Event|1|||
126310069|NCT00688701|454425191|FG001|Overall Study|Adverse Event|0|||
126310070|NCT00688701|454425192|FG002|Overall Study|Adverse Event|5|||
126310071|NCT00688701|454425193|FG003|Overall Study|Adverse Event|3|||
126310072|NCT00688701|454425190|FG000|Overall Study|Lack of Efficacy|0|||
126310073|NCT00688701|454425191|FG001|Overall Study|Lack of Efficacy|1|||
126310074|NCT00688701|454425192|FG002|Overall Study|Lack of Efficacy|0|||
126310075|NCT00688701|454425193|FG003|Overall Study|Lack of Efficacy|0|||
126310076|NCT00688701|454425190|FG000|Overall Study|Withdrawal by Subject|3|||
126310077|NCT00688701|454425191|FG001|Overall Study|Withdrawal by Subject|3|||
126310078|NCT00688701|454425192|FG002|Overall Study|Withdrawal by Subject|4|||
126310079|NCT00688701|454425193|FG003|Overall Study|Withdrawal by Subject|8|||
126310080|NCT00688701|454425190|FG000|Overall Study|Poor compliance to protocol|0|||
126310081|NCT00688701|454425191|FG001|Overall Study|Poor compliance to protocol|1|||
126310082|NCT00688701|454425192|FG002|Overall Study|Poor compliance to protocol|1|||
126310083|NCT00688701|454425193|FG003|Overall Study|Poor compliance to protocol|0|||
126310084|NCT03558152|454425201|FG000|Overall Study|Adverse Event|0|||
126310085|NCT03558152|454425202|FG001|Overall Study|Adverse Event|0|||
126310086|NCT03558152|454425203|FG002|Overall Study|Adverse Event|1|||
126310087|NCT03558152|454425204|FG003|Overall Study|Adverse Event|1|||
126310088|NCT03558152|454425205|FG004|Overall Study|Adverse Event|2|||
126310089|NCT03558152|454425206|FG005|Overall Study|Adverse Event|1|||
126466282|NCT03059446|455008927|FG000|Overall Study|Lost to Follow-up|3|||
126466283|NCT03059446|455008927|FG000|Overall Study|Protocol Violation|1|||
126466284|NCT03059446|455008927|FG000|Overall Study|Study Terminated by Sponsor|131|||
126466285|NCT03059446|455008927|FG000|Overall Study|Reason not Specified|5|||
126466286|NCT02273739|455008928|FG000|Overall Study|Progression of Disease|3|||
126466287|NCT02273739|455008929|FG001|Overall Study|Progression of Disease|4|||
126466288|NCT02273739|455008930|FG002|Overall Study|Progression of Disease|5|||
126466289|NCT02273739|455008931|FG003|Overall Study|Progression of Disease|2|||
126466290|NCT02273739|455008928|FG000|Overall Study|Death|0|||
126466291|NCT02273739|455008929|FG001|Overall Study|Death|0|||
126466292|NCT02273739|455008930|FG002|Overall Study|Death|0|||
126466293|NCT02273739|455008931|FG003|Overall Study|Death|2|||
126716665|NCT03703375|455914905|FG001|Randomization Period|Completed safety run-in treatment|0|||
126716666|NCT03703375|455914906|FG002|Randomization Period|Completed safety run-in treatment|0|||
126716667|NCT03703375|455914907|FG003|Randomization Period|Completed safety run-in treatment|0|||
126310090|NCT03558152|454425207|FG006|Overall Study|Adverse Event|1|||
126466294|NCT02273739|455008928|FG000|Overall Study|Adverse Event|0|||
126466295|NCT02273739|455008929|FG001|Overall Study|Adverse Event|0|||
126466296|NCT02273739|455008930|FG002|Overall Study|Adverse Event|0|||
126466297|NCT02273739|455008931|FG003|Overall Study|Adverse Event|1|||
126716668|NCT03703375|455914904|FG000|Treatment Period|Other Reasons|0|||
126716669|NCT03703375|455914905|FG001|Treatment Period|Other Reasons|1|||
126310091|NCT03558152|454425208|FG007|Overall Study|Adverse Event|0|||
126310092|NCT03558152|454425201|FG000|Overall Study|Death|0|||
126310093|NCT03558152|454425202|FG001|Overall Study|Death|0|||
126310094|NCT03558152|454425203|FG002|Overall Study|Death|0|||
126310095|NCT03558152|454425204|FG003|Overall Study|Death|0|||
126310096|NCT03558152|454425205|FG004|Overall Study|Death|1|||
126310097|NCT03558152|454425206|FG005|Overall Study|Death|0|||
126310098|NCT03558152|454425207|FG006|Overall Study|Death|0|||
126466298|NCT02273739|455008928|FG000|Overall Study|Withdrawal by Subject|0|||
126466299|NCT02273739|455008929|FG001|Overall Study|Withdrawal by Subject|0|||
126373563|NCT00565409|454665120|FG000|Period 1 Open Label|Other|21|||
126373564|NCT00565409|454665121|FG001|Period 1 Open Label|Other|0|||
126373565|NCT00565409|454665122|FG002|Period 1 Open Label|Other|0|||
126373566|NCT00565409|454665123|FG003|Period 1 Open Label|Other|0|||
126373567|NCT00565409|454665120|FG000|Period 1 Open Label|Protocol Violation|14|||
126373568|NCT00565409|454665121|FG001|Period 1 Open Label|Protocol Violation|0|||
126373569|NCT00565409|454665122|FG002|Period 1 Open Label|Protocol Violation|0|||
126373570|NCT00565409|454665123|FG003|Period 1 Open Label|Protocol Violation|0|||
126373571|NCT00565409|454665120|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
126373572|NCT00565409|454665121|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
126373573|NCT00565409|454665122|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
126373574|NCT00565409|454665123|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
126373575|NCT00565409|454665120|FG000|Period 1 Open Label|no conclusion of participation record|1|||
126373576|NCT00565409|454665121|FG001|Period 1 Open Label|no conclusion of participation record|0|||
126373577|NCT00565409|454665122|FG002|Period 1 Open Label|no conclusion of participation record|0|||
126373578|NCT00565409|454665123|FG003|Period 1 Open Label|no conclusion of participation record|0|||
126373579|NCT00565409|454665120|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
126373580|NCT00565409|454665121|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
126373581|NCT00565409|454665122|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
126373582|NCT00565409|454665123|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
126373583|NCT00565409|454665120|FG000|Period 2 Double-Blind|Adverse Event|0|||
126373584|NCT00565409|454665121|FG001|Period 2 Double-Blind|Adverse Event|7|||
126373585|NCT00565409|454665122|FG002|Period 2 Double-Blind|Adverse Event|4|||
126373586|NCT00565409|454665123|FG003|Period 2 Double-Blind|Adverse Event|5|||
126373587|NCT00565409|454665120|FG000|Period 2 Double-Blind|Death|0|||
126373588|NCT00565409|454665121|FG001|Period 2 Double-Blind|Death|2|||
126373589|NCT00565409|454665122|FG002|Period 2 Double-Blind|Death|0|||
126373590|NCT00565409|454665123|FG003|Period 2 Double-Blind|Death|0|||
126552878|NCT01327547|455320486|FG000|Overall Study|Non-compliance with study procedures|1|||
126552879|NCT01327547|455320487|FG001|Overall Study|Non-compliance with study procedures|0|||
126552880|NCT01327547|455320486|FG000|Overall Study|By investigator in subject's interest|0|||
126552881|NCT01327547|455320487|FG001|Overall Study|By investigator in subject's interest|1|||
126552882|NCT00329719|455320488|FG000|Overall Study|Lost to Follow-up|0|||
126552883|NCT00329719|455320489|FG001|Overall Study|Lost to Follow-up|0|||
126552884|NCT00329719|455320490|FG002|Overall Study|Lost to Follow-up|0|||
126552885|NCT00329719|455320491|FG003|Overall Study|Lost to Follow-up|1|||
126552886|NCT01995357|455320494|FG000|Period 5|Lack of Efficacy|1|||
126552887|NCT01995357|455320495|FG001|Period 5|Lack of Efficacy|0|||
126552888|NCT01995357|455320496|FG002|Period 5|Lack of Efficacy|0|||
126552889|NCT01995357|455320497|FG003|Period 5|Lack of Efficacy|0|||
126552890|NCT01995357|455320498|FG004|Period 5|Lack of Efficacy|0|||
126552891|NCT01995357|455320499|FG005|Period 5|Lack of Efficacy|0|||
126552892|NCT01995357|455320494|FG000|Period 5|Adverse Event|1|||
126552893|NCT01995357|455320495|FG001|Period 5|Adverse Event|0|||
126552894|NCT01995357|455320496|FG002|Period 5|Adverse Event|1|||
126552895|NCT01995357|455320497|FG003|Period 5|Adverse Event|0|||
126552896|NCT01995357|455320498|FG004|Period 5|Adverse Event|0|||
126552897|NCT01995357|455320499|FG005|Period 5|Adverse Event|0|||
126552898|NCT02462083|455320500|FG000|Overall Study|Sponsor request|39|||
126310099|NCT03558152|454425208|FG007|Overall Study|Death|0|||
126310100|NCT03558152|454425201|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
126310101|NCT03558152|454425202|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310102|NCT03558152|454425203|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310103|NCT03558152|454425204|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310104|NCT03558152|454425205|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310105|NCT03558152|454425206|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310106|NCT03558152|454425207|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310107|NCT03558152|454425208|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
126310108|NCT03558152|454425201|FG000|Overall Study|Miscalculation in mmcs|0|||
126310109|NCT03558152|454425202|FG001|Overall Study|Miscalculation in mmcs|0|||
126310110|NCT03558152|454425203|FG002|Overall Study|Miscalculation in mmcs|0|||
126373591|NCT00565409|454665120|FG000|Period 2 Double-Blind|Protocol Violation|0|||
126552899|NCT02462083|455320500|FG000|Overall Study|Withdrawal by Subject|87|||
126552900|NCT02462083|455320500|FG000|Overall Study|Lost to Follow-up|41|||
126373592|NCT00565409|454665121|FG001|Period 2 Double-Blind|Protocol Violation|4|||
126552901|NCT02462083|455320500|FG000|Overall Study|Lack of Efficacy|151|||
126552902|NCT02462083|455320500|FG000|Overall Study|Pregnancy|1|||
126373593|NCT00565409|454665122|FG002|Period 2 Double-Blind|Protocol Violation|6|||
126373594|NCT00565409|454665123|FG003|Period 2 Double-Blind|Protocol Violation|2|||
126373595|NCT00565409|454665120|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
126373596|NCT00565409|454665121|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
126552903|NCT02462083|455320500|FG000|Overall Study|Protocol Violation|6|||
126552904|NCT02462083|455320500|FG000|Overall Study|Adverse Event|33|||
126552905|NCT02462083|455320500|FG000|Overall Study|Worsening condition|16|||
126552906|NCT02462083|455320500|FG000|Overall Study|Other than specified|45|||
126310111|NCT03558152|454425204|FG003|Overall Study|Miscalculation in mmcs|0|||
126310112|NCT03558152|454425205|FG004|Overall Study|Miscalculation in mmcs|0|||
126310113|NCT03558152|454425206|FG005|Overall Study|Miscalculation in mmcs|0|||
126310114|NCT03558152|454425207|FG006|Overall Study|Miscalculation in mmcs|1|||
126310115|NCT03558152|454425208|FG007|Overall Study|Miscalculation in mmcs|0|||
126310116|NCT03558152|454425201|FG000|Overall Study|Mistake in calculation|0|||
126310117|NCT03558152|454425202|FG001|Overall Study|Mistake in calculation|0|||
126310118|NCT03558152|454425203|FG002|Overall Study|Mistake in calculation|0|||
126310119|NCT03558152|454425204|FG003|Overall Study|Mistake in calculation|1|||
126310120|NCT03558152|454425205|FG004|Overall Study|Mistake in calculation|0|||
126310121|NCT03558152|454425206|FG005|Overall Study|Mistake in calculation|0|||
126310122|NCT03558152|454425207|FG006|Overall Study|Mistake in calculation|0|||
126310123|NCT03558152|454425208|FG007|Overall Study|Mistake in calculation|0|||
126310124|NCT03558152|454425201|FG000|Overall Study|Mistake in evaluation of disease status|0|||
126310125|NCT03558152|454425202|FG001|Overall Study|Mistake in evaluation of disease status|0|||
126310126|NCT03558152|454425203|FG002|Overall Study|Mistake in evaluation of disease status|0|||
126310127|NCT03558152|454425204|FG003|Overall Study|Mistake in evaluation of disease status|0|||
126310128|NCT03558152|454425205|FG004|Overall Study|Mistake in evaluation of disease status|0|||
126310129|NCT03558152|454425206|FG005|Overall Study|Mistake in evaluation of disease status|0|||
126310130|NCT03558152|454425207|FG006|Overall Study|Mistake in evaluation of disease status|0|||
126310131|NCT03558152|454425208|FG007|Overall Study|Mistake in evaluation of disease status|1|||
126310132|NCT03558152|454425201|FG000|Overall Study|Physician Decision|0|||
126310133|NCT03558152|454425202|FG001|Overall Study|Physician Decision|0|||
126310134|NCT03558152|454425203|FG002|Overall Study|Physician Decision|0|||
126310135|NCT03558152|454425204|FG003|Overall Study|Physician Decision|0|||
126310136|NCT03558152|454425205|FG004|Overall Study|Physician Decision|0|||
126310137|NCT03558152|454425206|FG005|Overall Study|Physician Decision|0|||
126310138|NCT03558152|454425207|FG006|Overall Study|Physician Decision|1|||
126310139|NCT03558152|454425208|FG007|Overall Study|Physician Decision|0|||
126310140|NCT03558152|454425201|FG000|Overall Study|Withdrawal by Subject|2|||
126310141|NCT03558152|454425202|FG001|Overall Study|Withdrawal by Subject|3|||
126310142|NCT03558152|454425203|FG002|Overall Study|Withdrawal by Subject|2|||
126310143|NCT03558152|454425204|FG003|Overall Study|Withdrawal by Subject|1|||
126310144|NCT03558152|454425205|FG004|Overall Study|Withdrawal by Subject|1|||
126310145|NCT03558152|454425206|FG005|Overall Study|Withdrawal by Subject|1|||
126310146|NCT03558152|454425207|FG006|Overall Study|Withdrawal by Subject|3|||
126310147|NCT03558152|454425208|FG007|Overall Study|Withdrawal by Subject|2|||
126310148|NCT03558152|454425201|FG000|Overall Study|Lack of Efficacy|11|||
126310149|NCT03558152|454425202|FG001|Overall Study|Lack of Efficacy|11|||
126310150|NCT03558152|454425203|FG002|Overall Study|Lack of Efficacy|10|||
126310151|NCT03558152|454425204|FG003|Overall Study|Lack of Efficacy|11|||
126310152|NCT03558152|454425205|FG004|Overall Study|Lack of Efficacy|14|||
126310153|NCT03558152|454425206|FG005|Overall Study|Lack of Efficacy|12|||
126310154|NCT03558152|454425207|FG006|Overall Study|Lack of Efficacy|14|||
126310155|NCT03558152|454425208|FG007|Overall Study|Lack of Efficacy|13|||
126466300|NCT02273739|455008930|FG002|Overall Study|Withdrawal by Subject|2|||
126466301|NCT02273739|455008931|FG003|Overall Study|Withdrawal by Subject|1|||
126310156|NCT03558152|454425201|FG000|Overall Study|Protocol Violation|1|||
126310157|NCT03558152|454425202|FG001|Overall Study|Protocol Violation|1|||
126310158|NCT03558152|454425203|FG002|Overall Study|Protocol Violation|0|||
126310159|NCT03558152|454425204|FG003|Overall Study|Protocol Violation|1|||
126310160|NCT03558152|454425205|FG004|Overall Study|Protocol Violation|1|||
126310161|NCT03558152|454425206|FG005|Overall Study|Protocol Violation|0|||
126310162|NCT03558152|454425207|FG006|Overall Study|Protocol Violation|2|||
126310163|NCT03558152|454425208|FG007|Overall Study|Protocol Violation|0|||
126310164|NCT00601172|454425209|FG000|Overall Study|Adverse Event|43|||
126310165|NCT00601172|454425210|FG001|Overall Study|Adverse Event|32|||
126310166|NCT00601172|454425209|FG000|Overall Study|Lack of Efficacy|11|||
126310167|NCT00601172|454425210|FG001|Overall Study|Lack of Efficacy|12|||
126310168|NCT00601172|454425209|FG000|Overall Study|Protocol Violation|2|||
126310169|NCT00601172|454425210|FG001|Overall Study|Protocol Violation|5|||
126310170|NCT00601172|454425209|FG000|Overall Study|Lost to Follow-up|4|||
126310171|NCT00601172|454425210|FG001|Overall Study|Lost to Follow-up|3|||
126310172|NCT00601172|454425209|FG000|Overall Study|Physician Decision|27|||
126310173|NCT00601172|454425210|FG001|Overall Study|Physician Decision|28|||
126310174|NCT00601172|454425209|FG000|Overall Study|Withdrawal by Subject|35|||
126310175|NCT00601172|454425210|FG001|Overall Study|Withdrawal by Subject|27|||
126310176|NCT00601172|454425209|FG000|Overall Study|Did not meet continuation criteria|19|||
126310177|NCT00601172|454425210|FG001|Overall Study|Did not meet continuation criteria|20|||
126310178|NCT01300338|454425213|FG000|Overall Study|Lost to Follow-up|5|||
126310179|NCT01300338|454425214|FG001|Overall Study|Lost to Follow-up|0|||
126310180|NCT02461524|454425215|FG000|Overall Study|Death|16|||
126310181|NCT02461524|454425215|FG000|Overall Study|Withdrawal by Subject|4|||
126310182|NCT02461524|454425215|FG000|Overall Study|Device Explanted|5|||
126310183|NCT02461524|454425215|FG000|Overall Study|Missed Visit|6|||
126310184|NCT04481191|454425226|FG000|Overall Study|Withdrawn by parent/guardian|15|||
126310185|NCT04481191|454425227|FG001|Overall Study|Withdrawn by parent/guardian|10|||
126373597|NCT00565409|454665122|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
126373598|NCT00565409|454665123|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
126373599|NCT00565409|454665120|FG000|Period 2 Double-Blind|Other|0|||
126373600|NCT00565409|454665121|FG001|Period 2 Double-Blind|Other|4|||
126373601|NCT00565409|454665122|FG002|Period 2 Double-Blind|Other|5|||
126373602|NCT00565409|454665123|FG003|Period 2 Double-Blind|Other|9|||
126373603|NCT00565409|454665120|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
126373604|NCT00565409|454665121|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
126373605|NCT00565409|454665122|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
126373606|NCT00565409|454665123|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
126373607|NCT04064905|454665141|FG000|Overall Study|Lost to Follow-up|0|||
126373608|NCT04064905|454665142|FG001|Overall Study|Lost to Follow-up|3|||
126373609|NCT04064905|454665143|FG002|Overall Study|Lost to Follow-up|1|||
126373610|NCT04064905|454665144|FG003|Overall Study|Lost to Follow-up|4|||
126373611|NCT04064905|454665145|FG004|Overall Study|Lost to Follow-up|2|||
126373612|NCT02257684|454665146|FG000|Overall Study|Adverse Event|2|||
126373613|NCT02257684|454665146|FG000|Overall Study|Lack of Efficacy|1|||
126373614|NCT02257684|454665146|FG000|Overall Study|Sponsor's Decision|1|||
126373615|NCT01570387|454665147|FG000|Overall Study|Adverse Event|1|||
126716670|NCT03703375|455914906|FG002|Treatment Period|Other Reasons|0|||
126716671|NCT03703375|455914907|FG003|Treatment Period|Other Reasons|3|||
126716672|NCT03703375|455914904|FG000|Treatment Period|Consent Withdrawal|0|||
126716673|NCT03703375|455914905|FG001|Treatment Period|Consent Withdrawal|0|||
126716674|NCT03703375|455914906|FG002|Treatment Period|Consent Withdrawal|0|||
126373616|NCT01570387|454665148|FG001|Overall Study|Adverse Event|0|||
126373617|NCT01570387|454665149|FG002|Overall Study|Adverse Event|0|||
126373618|NCT01570387|454665150|FG003|Overall Study|Adverse Event|0|||
126373619|NCT01570387|454665147|FG000|Overall Study|Death|0|||
126373620|NCT01570387|454665148|FG001|Overall Study|Death|0|||
126373621|NCT01570387|454665149|FG002|Overall Study|Death|0|||
126373622|NCT01570387|454665150|FG003|Overall Study|Death|1|||
126373623|NCT01570387|454665147|FG000|Overall Study|Withdrawal by Subject|0|||
126373624|NCT01570387|454665148|FG001|Overall Study|Withdrawal by Subject|0|||
126373625|NCT01570387|454665149|FG002|Overall Study|Withdrawal by Subject|0|||
126373626|NCT01570387|454665150|FG003|Overall Study|Withdrawal by Subject|1|||
126373627|NCT01987557|454665151|FG000|Overall Study|Protocol Violation|1|||
126373628|NCT01987557|454665152|FG001|Overall Study|Protocol Violation|0|||
126716675|NCT03703375|455914907|FG003|Treatment Period|Consent Withdrawal|1|||
126373629|NCT01987557|454665153|FG002|Overall Study|Protocol Violation|1|||
126373630|NCT01987557|454665151|FG000|Overall Study|Withdrawal by Subject|2|||
126373631|NCT01987557|454665152|FG001|Overall Study|Withdrawal by Subject|1|||
126373632|NCT01987557|454665153|FG002|Overall Study|Withdrawal by Subject|2|||
126373633|NCT01987557|454665151|FG000|Overall Study|Adverse Event|0|||
126373634|NCT01987557|454665152|FG001|Overall Study|Adverse Event|2|||
126373635|NCT01987557|454665153|FG002|Overall Study|Adverse Event|0|||
126373636|NCT00431964|454665154|FG000|Overall Study|Adverse Event|1|||
126373637|NCT00431964|454665155|FG001|Overall Study|Adverse Event|0|||
126373638|NCT00431964|454665154|FG000|Overall Study|Lost to Follow-up|1|||
126373639|NCT00431964|454665155|FG001|Overall Study|Lost to Follow-up|2|||
126373640|NCT00431964|454665154|FG000|Overall Study|Physician Decision|2|||
126373641|NCT00431964|454665155|FG001|Overall Study|Physician Decision|2|||
126373642|NCT00431964|454665154|FG000|Overall Study|Withdrawal by Subject|2|||
126373643|NCT00431964|454665155|FG001|Overall Study|Withdrawal by Subject|1|||
126716676|NCT03703375|455914904|FG000|Treatment Period|Death|1|||
126373644|NCT00431964|454665154|FG000|Overall Study|Parental Consent Withdrawn|0|||
126373645|NCT00431964|454665155|FG001|Overall Study|Parental Consent Withdrawn|2|||
126716677|NCT03703375|455914905|FG001|Treatment Period|Death|0|||
126716678|NCT03703375|455914906|FG002|Treatment Period|Death|1|||
126716679|NCT03703375|455914907|FG003|Treatment Period|Death|2|||
126716680|NCT03703375|455914904|FG000|Treatment Period|Toxicity of Study Treatment|2|||
126716681|NCT03703375|455914905|FG001|Treatment Period|Toxicity of Study Treatment|0|||
126716682|NCT03703375|455914906|FG002|Treatment Period|Toxicity of Study Treatment|4|||
126771013|NCT00422058|456116233|FG001|Double-Blind, Week 0-20|Other|3|||
126771014|NCT00422058|456116234|FG002|Double-Blind, Week 0-20|Other|8|||
126373646|NCT00431964|454665154|FG000|Overall Study|Due to Unstable Health|0|||
126373647|NCT00431964|454665155|FG001|Overall Study|Due to Unstable Health|1|||
126373648|NCT01657305|454665157|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
126373649|NCT01657305|454665157|FG000|Overall Study|Withdrawal by Subject|4|||
126373650|NCT01657305|454665157|FG000|Overall Study|Adverse Event|1|||
126373651|NCT01657305|454665157|FG000|Overall Study|Lost to Follow-up|1|||
126373652|NCT01657305|454665157|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
126373653|NCT04103450|454665158|FG000|Overall Study|Adverse Event|4|||
126373654|NCT04103450|454665159|FG001|Overall Study|Adverse Event|2|||
126373655|NCT04103450|454665158|FG000|Overall Study|Lack of Efficacy|3|||
126373656|NCT04103450|454665159|FG001|Overall Study|Lack of Efficacy|0|||
126373657|NCT04103450|454665158|FG000|Overall Study|Withdrawal by Subject|5|||
126466302|NCT02273739|455008928|FG000|Overall Study|Physician Decision|0|||
126716683|NCT03703375|455914907|FG003|Treatment Period|Toxicity of Study Treatment|1|||
126310186|NCT02487771|454425228|FG000|Overall Study|Lost to Follow-up|2|||
126310187|NCT02487771|454425229|FG001|Overall Study|Lost to Follow-up|3|||
126310188|NCT02487771|454425228|FG000|Overall Study|Moved out of area|5|||
126310189|NCT02487771|454425229|FG001|Overall Study|Moved out of area|6|||
126310190|NCT02487771|454425228|FG000|Overall Study|Withdrawal by Subject|3|||
126310191|NCT02487771|454425229|FG001|Overall Study|Withdrawal by Subject|5|||
126310192|NCT02002533|454425230|FG000|Overall Study|Withdrawal by Subject|6|||
126310193|NCT02002533|454425231|FG001|Overall Study|Withdrawal by Subject|13|||
126310194|NCT02002533|454425230|FG000|Overall Study|Protocol Violation|0|||
126310195|NCT02002533|454425231|FG001|Overall Study|Protocol Violation|1|||
126310196|NCT02002533|454425230|FG000|Overall Study|Adverse Event|0|||
126310197|NCT02002533|454425231|FG001|Overall Study|Adverse Event|3|||
126310198|NCT02002533|454425230|FG000|Overall Study|Lost to Follow-up|0|||
126310199|NCT02002533|454425231|FG001|Overall Study|Lost to Follow-up|1|||
126310200|NCT04984278|454425236|FG000|Period 1|Withdrawal by Subject|1|||
126310201|NCT04984278|454425237|FG001|Period 1|Withdrawal by Subject|0|||
126310202|NCT04984278|454425236|FG000|Period 1|Other|0|||
126310203|NCT04984278|454425237|FG001|Period 1|Other|1|||
126310204|NCT04984278|454425236|FG000|Period 2|Adverse Event|1|||
126310205|NCT04984278|454425237|FG001|Period 2|Adverse Event|0|||
126310206|NCT04984278|454425236|FG000|Period 2|Other|0|||
126310207|NCT04984278|454425237|FG001|Period 2|Other|1|||
126310208|NCT01482065|454425238|FG000|Overall Study|Withdrawal by Subject|0|||
126310209|NCT01482065|454425239|FG001|Overall Study|Withdrawal by Subject|1|||
126310210|NCT01895270|454425240|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
126310211|NCT01895270|454425241|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
126310212|NCT01895270|454425240|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
126310213|NCT01895270|454425241|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
126310214|NCT01895270|454425240|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
126310215|NCT01895270|454425241|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
126310216|NCT01895270|454425240|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
126310217|NCT01895270|454425241|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
126310218|NCT01895270|454425240|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
126310219|NCT01895270|454425241|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
126310220|NCT01895270|454425240|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
126310221|NCT01895270|454425241|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
126310222|NCT01895270|454425240|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
126310223|NCT01895270|454425241|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
126310224|NCT00976820|454425242|FG000|Overall Study|Lost to Follow-up|5|||
126310225|NCT00976820|454425243|FG001|Overall Study|Lost to Follow-up|16|||
126310226|NCT00976820|454425244|FG002|Overall Study|Lost to Follow-up|2|||
126310227|NCT00976820|454425245|FG003|Overall Study|Lost to Follow-up|3|||
126310228|NCT00976820|454425242|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
126310229|NCT00976820|454425243|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
126310230|NCT00976820|454425244|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
126310231|NCT00976820|454425245|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
126310232|NCT00976820|454425242|FG000|Overall Study|Withdrawal by Subject|2|||
126310233|NCT00976820|454425243|FG001|Overall Study|Withdrawal by Subject|4|||
126310234|NCT00976820|454425244|FG002|Overall Study|Withdrawal by Subject|1|||
126310235|NCT00976820|454425245|FG003|Overall Study|Withdrawal by Subject|4|||
126310236|NCT03261674|454425251|FG000|Overall Study|Lost to Follow-up|6|||
126310237|NCT03261674|454425252|FG001|Overall Study|Lost to Follow-up|7|||
126310238|NCT03261674|454425251|FG000|Overall Study|Protocol Violation|1|||
126310239|NCT03261674|454425252|FG001|Overall Study|Protocol Violation|4|||
126310240|NCT03261674|454425251|FG000|Overall Study|Withdrawal by Subject|1|||
126310241|NCT03261674|454425252|FG001|Overall Study|Withdrawal by Subject|4|||
126310242|NCT03261674|454425251|FG000|Overall Study|Physician Decision|1|||
126310243|NCT03261674|454425252|FG001|Overall Study|Physician Decision|0|||
126310244|NCT00623935|454425257|FG000|Overall Study|Death|1|||
126310245|NCT00623935|454425257|FG000|Overall Study|Patient Declined Transplant|1|||
126310246|NCT00747474|454425260|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310247|NCT00747474|454425261|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310248|NCT00747474|454425262|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310249|NCT00747474|454425263|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126373658|NCT04103450|454665159|FG001|Overall Study|Withdrawal by Subject|3|||
126373659|NCT04103450|454665158|FG000|Overall Study|Lost to Follow-up|1|||
126373660|NCT04103450|454665159|FG001|Overall Study|Lost to Follow-up|2|||
126373661|NCT04103450|454665158|FG000|Overall Study|Physician Decision|1|||
126373662|NCT04103450|454665159|FG001|Overall Study|Physician Decision|2|||
126373663|NCT04103450|454665158|FG000|Overall Study|Protocol Violation|1|||
126373664|NCT04103450|454665159|FG001|Overall Study|Protocol Violation|0|||
126373665|NCT04103450|454665158|FG000|Overall Study|Other|1|||
126310250|NCT00747474|454425264|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126373666|NCT04103450|454665159|FG001|Overall Study|Other|1|||
126373667|NCT01696643|454665169|FG000|Overall Study|Adverse Event|15|||
126373668|NCT01696643|454665170|FG001|Overall Study|Adverse Event|7|||
126373669|NCT01696643|454665169|FG000|Overall Study|Death|1|||
126373670|NCT01696643|454665170|FG001|Overall Study|Death|2|||
126373671|NCT01696643|454665169|FG000|Overall Study|Lack of Efficacy|3|||
126373672|NCT01696643|454665170|FG001|Overall Study|Lack of Efficacy|0|||
126373673|NCT01696643|454665169|FG000|Overall Study|Lost to Follow-up|67|||
126373674|NCT01696643|454665170|FG001|Overall Study|Lost to Follow-up|67|||
126373675|NCT01696643|454665169|FG000|Overall Study|Physician Decision|3|||
126373676|NCT01696643|454665170|FG001|Overall Study|Physician Decision|2|||
126373677|NCT01696643|454665169|FG000|Overall Study|Pregnancy|0|||
126373678|NCT01696643|454665170|FG001|Overall Study|Pregnancy|1|||
126373679|NCT01696643|454665169|FG000|Overall Study|Protocol Violation|7|||
126373680|NCT01696643|454665170|FG001|Overall Study|Protocol Violation|7|||
126373681|NCT01696643|454665169|FG000|Overall Study|Study Terminated by Sponsor|286|||
126373682|NCT01696643|454665170|FG001|Overall Study|Study Terminated by Sponsor|294|||
126373683|NCT01696643|454665169|FG000|Overall Study|Withdrawal by Subject|142|||
126373684|NCT01696643|454665170|FG001|Overall Study|Withdrawal by Subject|149|||
126373685|NCT01696643|454665169|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
126373686|NCT01696643|454665170|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
126373687|NCT01696643|454665169|FG000|Overall Study|Site Error|2|||
126373688|NCT01696643|454665170|FG001|Overall Study|Site Error|1|||
126373689|NCT01696643|454665169|FG000|Overall Study|Participant Incarcerated|0|||
126373690|NCT01696643|454665170|FG001|Overall Study|Participant Incarcerated|1|||
126373691|NCT01696643|454665169|FG000|Overall Study|Medical Monitor Decision|0|||
126373692|NCT01696643|454665170|FG001|Overall Study|Medical Monitor Decision|2|||
126373693|NCT01696643|454665169|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
126373694|NCT01696643|454665170|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
126373695|NCT00518180|454665171|FG000|Overall Study|Withdrawal by Subject|29|||
126373696|NCT00518180|454665172|FG001|Overall Study|Withdrawal by Subject|30|||
126373697|NCT00518180|454665173|FG002|Overall Study|Withdrawal by Subject|42|||
126373698|NCT00518180|454665171|FG000|Overall Study|Lost to Follow-up|30|||
126373699|NCT00518180|454665172|FG001|Overall Study|Lost to Follow-up|28|||
126373700|NCT00518180|454665173|FG002|Overall Study|Lost to Follow-up|34|||
126373701|NCT00518180|454665171|FG000|Overall Study|Administrative reason|0|||
126373702|NCT00518180|454665172|FG001|Overall Study|Administrative reason|2|||
126373703|NCT00518180|454665173|FG002|Overall Study|Administrative reason|2|||
126373704|NCT00518180|454665171|FG000|Overall Study|Protocol Violation|5|||
126373705|NCT00518180|454665172|FG001|Overall Study|Protocol Violation|7|||
126373706|NCT00518180|454665173|FG002|Overall Study|Protocol Violation|4|||
126373707|NCT00518180|454665171|FG000|Overall Study|Unable to classify|0|||
126373708|NCT00518180|454665172|FG001|Overall Study|Unable to classify|2|||
126373709|NCT00518180|454665173|FG002|Overall Study|Unable to classify|0|||
126373710|NCT00518180|454665171|FG000|Overall Study|Adverse Event|1|||
126373711|NCT00518180|454665172|FG001|Overall Study|Adverse Event|0|||
126373712|NCT00518180|454665173|FG002|Overall Study|Adverse Event|0|||
126373713|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
126373714|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
126373715|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
126373716|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Death|0|||
126373717|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Death|0|||
126373718|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Death|1|||
126466303|NCT02273739|455008929|FG001|Overall Study|Physician Decision|0|||
126466304|NCT02273739|455008930|FG002|Overall Study|Physician Decision|0|||
126466305|NCT02273739|455008931|FG003|Overall Study|Physician Decision|1|||
126466306|NCT04795622|455008932|FG000|Overall Study|Adverse Event|1|||
126466307|NCT04795622|455008933|FG001|Overall Study|Adverse Event|0|||
126466308|NCT04795622|455008932|FG000|Overall Study|Withdrawal by Subject|3|||
126466309|NCT04795622|455008933|FG001|Overall Study|Withdrawal by Subject|3|||
126466310|NCT04795622|455008932|FG000|Overall Study|Protocol Violation|0|||
126466311|NCT04795622|455008933|FG001|Overall Study|Protocol Violation|2|||
126466312|NCT04795622|455008932|FG000|Overall Study|Lost to Follow-up|2|||
126466313|NCT04795622|455008933|FG001|Overall Study|Lost to Follow-up|3|||
126466314|NCT04795622|455008932|FG000|Overall Study|Other|7|||
126466315|NCT04795622|455008933|FG001|Overall Study|Other|8|||
126716684|NCT03703375|455914904|FG000|Treatment Period|Progression|32|||
126373719|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
126373720|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
126373721|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
126373722|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
126373723|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
126373724|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
126373725|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
126373726|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
126373727|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
126466316|NCT00089674|455008934|FG000|Overall Study|Physician Decision|4|||
126466317|NCT00089674|455008935|FG001|Overall Study|Physician Decision|2|||
126373728|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Graft loss|0|||
126373729|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Graft loss|0|||
126373730|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Graft loss|7|||
126373731|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
126373732|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
126373733|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
126373734|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
126373735|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
126373736|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
126373737|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
126373738|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
126373739|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
126373740|NCT00956293|454665177|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
126373741|NCT00956293|454665178|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
126373742|NCT00956293|454665179|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
126373743|NCT00956293|454665177|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
126373744|NCT00956293|454665178|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
126373745|NCT00956293|454665179|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
126373746|NCT00956293|454665177|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
126373747|NCT00956293|454665178|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
126373748|NCT00956293|454665179|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
126373749|NCT00956293|454665177|FG000|Main Period (Randomization)|Adverse Event|0|||
126373750|NCT00956293|454665178|FG001|Main Period (Randomization)|Adverse Event|15|||
126373751|NCT00956293|454665179|FG002|Main Period (Randomization)|Adverse Event|0|||
126373752|NCT00956293|454665177|FG000|Follow-up Period|Follow-up period was terminated.|20|||
126373753|NCT00956293|454665178|FG001|Follow-up Period|Follow-up period was terminated.|32|||
126373754|NCT00956293|454665179|FG002|Follow-up Period|Follow-up period was terminated.|0|||
126373755|NCT02536664|454665180|FG000|Overall Study|Inadequate completion of documentation|2|||
126373756|NCT02536664|454665181|FG001|Overall Study|Inadequate completion of documentation|4|||
126373757|NCT02536664|454665180|FG000|Overall Study|Progression|13|||
126373758|NCT02536664|454665181|FG001|Overall Study|Progression|18|||
126373759|NCT02536664|454665180|FG000|Overall Study|Death due to lymphoma|2|||
126373760|NCT02536664|454665181|FG001|Overall Study|Death due to lymphoma|1|||
126373761|NCT02536664|454665180|FG000|Overall Study|Death due to other reason|3|||
126373762|NCT02536664|454665181|FG001|Overall Study|Death due to other reason|2|||
126373763|NCT02536664|454665180|FG000|Overall Study|Intolerability|8|||
126373764|NCT02536664|454665181|FG001|Overall Study|Intolerability|6|||
126373765|NCT02536664|454665180|FG000|Overall Study|Withdrawal by Subject|8|||
126373766|NCT02536664|454665181|FG001|Overall Study|Withdrawal by Subject|5|||
126373767|NCT02536664|454665180|FG000|Overall Study|Other|18|||
126373768|NCT02536664|454665181|FG001|Overall Study|Other|24|||
126373769|NCT02536664|454665180|FG000|Overall Study|Missing|53|||
126373770|NCT02536664|454665181|FG001|Overall Study|Missing|20|||
126373771|NCT03383666|454665182|FG000|Overall Study|Withdrawal by Subject|2|||
126373772|NCT03383666|454665182|FG000|Overall Study|Lost to Follow-up|2|||
126373773|NCT03961308|454665189|FG000|Overall Study|Withdrawal by Subject|1|||
126373774|NCT03961308|454665190|FG001|Overall Study|Withdrawal by Subject|0|||
126373775|NCT03961308|454665189|FG000|Overall Study|Other|1|||
126373776|NCT03961308|454665190|FG001|Overall Study|Other|0|||
126373777|NCT03961308|454665189|FG000|Overall Study|Lost to Follow-up|0|||
126373778|NCT03961308|454665190|FG001|Overall Study|Lost to Follow-up|1|||
126373779|NCT03961308|454665189|FG000|Overall Study|Adverse Event|0|||
126373780|NCT03961308|454665190|FG001|Overall Study|Adverse Event|1|||
126373781|NCT01174563|454665197|FG000|Overall Study|Progressive Disease|45|||
126466318|NCT00089674|455008934|FG000|Overall Study|Adverse Event|23|||
126466319|NCT00089674|455008935|FG001|Overall Study|Adverse Event|29|||
126466320|NCT00089674|455008934|FG000|Overall Study|Withdrawal by Subject|143|||
126466321|NCT00089674|455008935|FG001|Overall Study|Withdrawal by Subject|127|||
126466322|NCT00089674|455008934|FG000|Overall Study|Death|43|||
126466323|NCT00089674|455008935|FG001|Overall Study|Death|43|||
126466324|NCT00089674|455008934|FG000|Overall Study|Disease progression|21|||
126466325|NCT00089674|455008935|FG001|Overall Study|Disease progression|23|||
126466326|NCT00089674|455008934|FG000|Overall Study|Ineligibility determined|8|||
126373782|NCT01174563|454665197|FG000|Overall Study|Death|5|||
126373783|NCT01174563|454665197|FG000|Overall Study|Investigator's Discretion|5|||
126373784|NCT01174563|454665197|FG000|Overall Study|Participant Withdrew Consent|3|||
126373785|NCT01174563|454665197|FG000|Overall Study|Rash Adverse Event|1|||
126373786|NCT01174563|454665197|FG000|Overall Study|Sponsor's decision|1|||
126373787|NCT03402841|454665198|FG000|Overall Study|Withdrawal by Subject|3|||
126373788|NCT03402841|454665198|FG000|Overall Study|Lost to Follow-up|2|||
126373789|NCT03402841|454665198|FG000|Overall Study|Death|146|||
126373790|NCT01542788|454665203|FG000|Overall Study|Randomized but Not Treated|2|||
126373791|NCT01542788|454665204|FG001|Overall Study|Randomized but Not Treated|0|||
126373792|NCT01542788|454665203|FG000|Overall Study|Lack of Efficacy|41|||
126466327|NCT00089674|455008935|FG001|Overall Study|Ineligibility determined|10|||
126466328|NCT00089674|455008934|FG000|Overall Study|Lost to Follow-up|21|||
126466329|NCT00089674|455008935|FG001|Overall Study|Lost to Follow-up|17|||
126310251|NCT00747474|454425265|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310252|NCT00747474|454425266|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310253|NCT00747474|454425267|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
126310254|NCT00747474|454425268|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310255|NCT00747474|454425269|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310256|NCT00747474|454425270|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310257|NCT00747474|454425271|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
126310258|NCT04507256|454425272|FG000|Overall Study|Withdrawal by Subject|1|||
126310259|NCT04507256|454425273|FG001|Overall Study|Withdrawal by Subject|0|||
126310260|NCT04507256|454425274|FG002|Overall Study|Withdrawal by Subject|0|||
126310261|NCT04507256|454425275|FG003|Overall Study|Withdrawal by Subject|1|||
126310262|NCT04507256|454425276|FG004|Overall Study|Withdrawal by Subject|0|||
126310263|NCT04507256|454425277|FG005|Overall Study|Withdrawal by Subject|0|||
126310264|NCT00631410|454425278|FG000|Overall Study|Adverse Event|1|||
126310265|NCT00631410|454425279|FG001|Overall Study|Adverse Event|3|||
126310266|NCT00631410|454425278|FG000|Overall Study|Objective Progression or Relapse|4|||
126310267|NCT00631410|454425279|FG001|Overall Study|Objective Progression or Relapse|3|||
126310268|NCT00631410|454425278|FG000|Overall Study|Surgery|1|||
126310269|NCT00631410|454425279|FG001|Overall Study|Surgery|0|||
126310270|NCT00890084|454425280|FG000|Overall Study|Adverse Event|16|||
126310271|NCT00890084|454425280|FG000|Overall Study|Lost to Follow-up|126|||
126310272|NCT01647516|454425285|FG000|Induction Period (IP)|Physician Decision|2|||
126310273|NCT01647516|454425286|FG001|Induction Period (IP)|Physician Decision|0|||
126310274|NCT01647516|454425287|FG002|Induction Period (IP)|Physician Decision|0|||
126310275|NCT01647516|454425288|FG003|Induction Period (IP)|Physician Decision|0|||
126310276|NCT01647516|454425289|FG004|Induction Period (IP)|Physician Decision|0|||
126310277|NCT01647516|454425290|FG005|Induction Period (IP)|Physician Decision|0|||
126310278|NCT01647516|454425285|FG000|Induction Period (IP)|Adverse Event|1|||
126310279|NCT01647516|454425286|FG001|Induction Period (IP)|Adverse Event|2|||
126310280|NCT01647516|454425287|FG002|Induction Period (IP)|Adverse Event|0|||
126310281|NCT01647516|454425288|FG003|Induction Period (IP)|Adverse Event|0|||
126310282|NCT01647516|454425289|FG004|Induction Period (IP)|Adverse Event|0|||
126310283|NCT01647516|454425290|FG005|Induction Period (IP)|Adverse Event|0|||
126310284|NCT01647516|454425285|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
126310285|NCT01647516|454425286|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
126310286|NCT01647516|454425287|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
126310287|NCT01647516|454425288|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
126310288|NCT01647516|454425289|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
126310289|NCT01647516|454425290|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
126310290|NCT01647516|454425285|FG000|Induction Period (IP)|Participant Choice|0|||
126310291|NCT01647516|454425286|FG001|Induction Period (IP)|Participant Choice|0|||
126310292|NCT01647516|454425287|FG002|Induction Period (IP)|Participant Choice|1|||
126310293|NCT01647516|454425288|FG003|Induction Period (IP)|Participant Choice|0|||
126310294|NCT01647516|454425289|FG004|Induction Period (IP)|Participant Choice|0|||
126310295|NCT01647516|454425290|FG005|Induction Period (IP)|Participant Choice|0|||
126310296|NCT01647516|454425285|FG000|Induction Period (IP)|Lack of Efficacy|1|||
126310297|NCT01647516|454425286|FG001|Induction Period (IP)|Lack of Efficacy|0|||
126310298|NCT01647516|454425287|FG002|Induction Period (IP)|Lack of Efficacy|0|||
126466330|NCT00089674|455008934|FG000|Overall Study|Noncompliance|7|||
126466331|NCT00089674|455008935|FG001|Overall Study|Noncompliance|3|||
126310299|NCT01647516|454425288|FG003|Induction Period (IP)|Lack of Efficacy|0|||
126310300|NCT01647516|454425289|FG004|Induction Period (IP)|Lack of Efficacy|0|||
126310301|NCT01647516|454425290|FG005|Induction Period (IP)|Lack of Efficacy|0|||
126310302|NCT01647516|454425285|FG000|Induction Period (IP)|No study drug received|1|||
126310303|NCT01647516|454425286|FG001|Induction Period (IP)|No study drug received|1|||
126310304|NCT01647516|454425287|FG002|Induction Period (IP)|No study drug received|0|||
126310305|NCT01647516|454425288|FG003|Induction Period (IP)|No study drug received|0|||
126310306|NCT01647516|454425289|FG004|Induction Period (IP)|No study drug received|0|||
126466332|NCT00089674|455008934|FG000|Overall Study|Other|5|||
126466333|NCT00089674|455008935|FG001|Overall Study|Other|9|||
126466334|NCT00089674|455008934|FG000|Overall Study|Requirement for alternative therapy|14|||
126466335|NCT00089674|455008935|FG001|Overall Study|Requirement for alternative therapy|4|||
126310307|NCT01647516|454425290|FG005|Induction Period (IP)|No study drug received|0|||
126310308|NCT01647516|454425285|FG000|Maintenance Period (MP)|Adverse Event|2|||
126310309|NCT01647516|454425286|FG001|Maintenance Period (MP)|Adverse Event|1|||
126310310|NCT01647516|454425287|FG002|Maintenance Period (MP)|Adverse Event|0|||
126310311|NCT01647516|454425288|FG003|Maintenance Period (MP)|Adverse Event|0|||
126310312|NCT01647516|454425289|FG004|Maintenance Period (MP)|Adverse Event|0|||
126310313|NCT01647516|454425290|FG005|Maintenance Period (MP)|Adverse Event|0|||
126310314|NCT01647516|454425285|FG000|Maintenance Period (MP)|Non-compliance|1|||
126466336|NCT00880165|455008938|FG000|Overall Study|Withdrawal by Subject|27|||
126466337|NCT00880165|455008939|FG001|Overall Study|Withdrawal by Subject|23|||
126373793|NCT01542788|454665204|FG001|Overall Study|Lack of Efficacy|71|||
126373794|NCT01542788|454665203|FG000|Overall Study|Lost to Follow-up|5|||
126373795|NCT01542788|454665204|FG001|Overall Study|Lost to Follow-up|0|||
126373796|NCT01542788|454665203|FG000|Overall Study|Death|3|||
126373797|NCT01542788|454665204|FG001|Overall Study|Death|0|||
126373798|NCT01542788|454665203|FG000|Overall Study|Protocol Violation|2|||
126373799|NCT01542788|454665204|FG001|Overall Study|Protocol Violation|0|||
126373800|NCT01542788|454665203|FG000|Overall Study|Physician Decision|1|||
126373801|NCT01542788|454665204|FG001|Overall Study|Physician Decision|0|||
126373802|NCT01542788|454665203|FG000|Overall Study|Withdrawal by Subject|1|||
126373803|NCT01542788|454665204|FG001|Overall Study|Withdrawal by Subject|0|||
126373804|NCT01280968|454665205|FG000|Overall Study|Lost to Follow-up|8|||
126373805|NCT01280968|454665206|FG001|Overall Study|Lost to Follow-up|2|||
126373806|NCT01280968|454665205|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
126373807|NCT01280968|454665206|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
126373808|NCT01280968|454665205|FG000|Overall Study|Commuting Problems|2|||
126373809|NCT01280968|454665206|FG001|Overall Study|Commuting Problems|0|||
126373810|NCT01280968|454665205|FG000|Overall Study|Anxiety|2|||
126373811|NCT01280968|454665206|FG001|Overall Study|Anxiety|0|||
126373812|NCT01280968|454665205|FG000|Overall Study|Adverse Event|1|||
126373813|NCT01280968|454665206|FG001|Overall Study|Adverse Event|0|||
126373814|NCT01280968|454665205|FG000|Overall Study|Scheduling Conflicts|1|||
126373815|NCT01280968|454665206|FG001|Overall Study|Scheduling Conflicts|1|||
126373816|NCT01280968|454665205|FG000|Overall Study|Pre-existing Neurological Condition|1|||
126373817|NCT01280968|454665206|FG001|Overall Study|Pre-existing Neurological Condition|0|||
126373818|NCT01280968|454665205|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
126373819|NCT01280968|454665206|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
126373820|NCT04704193|454665207|FG000|Overall Study|Withdrawal by Subject|1|||
126373821|NCT00542178|454665208|FG000|Overall Study|did not complete year 4 follow-up|75|||
126373822|NCT00542178|454665209|FG001|Overall Study|did not complete year 4 follow-up|80|||
126373823|NCT00542178|454665210|FG002|Overall Study|did not complete year 4 follow-up|74|||
126373824|NCT00542178|454665211|FG003|Overall Study|did not complete year 4 follow-up|62|||
126373825|NCT00542178|454665212|FG004|Overall Study|did not complete year 4 follow-up|64|||
126373826|NCT00542178|454665213|FG005|Overall Study|did not complete year 4 follow-up|89|||
126373827|NCT00542178|454665214|FG006|Overall Study|did not complete year 4 follow-up|87|||
126373828|NCT00542178|454665215|FG007|Overall Study|did not complete year 4 follow-up|85|||
126373829|NCT03984188|454665221|FG000|Overall Study|Death|2|||
126373830|NCT03984188|454665222|FG001|Overall Study|Death|4|||
126373831|NCT03984188|454665221|FG000|Overall Study|Physician Decision|0|||
126373832|NCT03984188|454665222|FG001|Overall Study|Physician Decision|2|||
126373833|NCT03984188|454665221|FG000|Overall Study|Lost to Follow-up|3|||
126373834|NCT03984188|454665222|FG001|Overall Study|Lost to Follow-up|2|||
126373835|NCT03984188|454665221|FG000|Overall Study|Withdrawal by Subject|6|||
126373836|NCT03984188|454665222|FG001|Overall Study|Withdrawal by Subject|0|||
126373837|NCT01978145|454666823|FG000|Treatment Period 1|Adverse Event|1|||
126373838|NCT01978145|454666824|FG001|Treatment Period 1|Adverse Event|9|||
126373839|NCT01978145|454666823|FG000|Treatment Period 1|Physician Decision|1|||
126373840|NCT01978145|454666824|FG001|Treatment Period 1|Physician Decision|0|||
126373841|NCT01978145|454666823|FG000|Treatment Period 1|Withdrawal by Subject|5|||
126373842|NCT01978145|454666824|FG001|Treatment Period 1|Withdrawal by Subject|4|||
126373843|NCT01978145|454666823|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
126373844|NCT01978145|454666824|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
126373845|NCT01978145|454666823|FG000|Washout Period 1|Adverse Event|0|||
126373846|NCT01978145|454666824|FG001|Washout Period 1|Adverse Event|1|||
126373847|NCT01978145|454666823|FG000|Washout Period 1|Withdrawal by Subject|1|||
126373848|NCT01978145|454666824|FG001|Washout Period 1|Withdrawal by Subject|1|||
126373849|NCT01978145|454666823|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
126373850|NCT01978145|454666824|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
126373851|NCT01978145|454666823|FG000|Treatment Period 2|Adverse Event|3|||
126373852|NCT01978145|454666824|FG001|Treatment Period 2|Adverse Event|3|||
126373853|NCT01978145|454666823|FG000|Treatment Period 2|Protocol Violation|0|||
126373854|NCT01978145|454666824|FG001|Treatment Period 2|Protocol Violation|1|||
126373855|NCT01978145|454666823|FG000|Treatment Period 2|Lost to Follow-up|1|||
126373856|NCT01978145|454666824|FG001|Treatment Period 2|Lost to Follow-up|1|||
126373857|NCT01978145|454666823|FG000|Treatment Period 2|Withdrawal by Subject|7|||
126373858|NCT01978145|454666824|FG001|Treatment Period 2|Withdrawal by Subject|4|||
126373859|NCT01978145|454666823|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
126373860|NCT01978145|454666824|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
126373861|NCT01173679|454666825|FG000|Overall Study|Death|1|||
126373862|NCT01250054|454666826|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
126373863|NCT01250054|454666827|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
126373864|NCT02777086|454666828|FG000|Overall Study|Lost to Follow-up|96|||
126373865|NCT02777086|454666829|FG001|Overall Study|Lost to Follow-up|99|||
126373866|NCT01133665|454666834|FG000|Overall Study|Physician Decision|2|||
126373867|NCT02122380|454666835|FG000|First Intervention (30 Days)|Adverse Event|1|||
126466338|NCT00880165|455008938|FG000|Overall Study|Not diagnosed with OSA|14|||
126466339|NCT00880165|455008939|FG001|Overall Study|Not diagnosed with OSA|8|||
126466340|NCT00880165|455008938|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
126466341|NCT00880165|455008939|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
126466342|NCT00880165|455008938|FG000|Overall Study|Lost to follow|9|||
126466343|NCT00880165|455008939|FG001|Overall Study|Lost to follow|15|||
126466344|NCT00667602|455008940|FG000|Overall Study|Withdrawal by Subject|4|||
126466345|NCT00667602|455008941|FG001|Overall Study|Withdrawal by Subject|9|||
126466346|NCT00667602|455008942|FG002|Overall Study|Withdrawal by Subject|10|||
126466347|NCT00667602|455008940|FG000|Overall Study|Lost to Follow-up|4|||
126466348|NCT00667602|455008941|FG001|Overall Study|Lost to Follow-up|5|||
126466349|NCT00667602|455008942|FG002|Overall Study|Lost to Follow-up|6|||
126466350|NCT00667602|455008940|FG000|Overall Study|Administrative reason|0|||
126466351|NCT00667602|455008941|FG001|Overall Study|Administrative reason|0|||
126466352|NCT00667602|455008942|FG002|Overall Study|Administrative reason|2|||
126466353|NCT00667602|455008940|FG000|Overall Study|Protocol Violation|0|||
126466354|NCT00667602|455008941|FG001|Overall Study|Protocol Violation|1|||
126466355|NCT00667602|455008942|FG002|Overall Study|Protocol Violation|0|||
126466356|NCT00973349|455008947|FG000|Overall Study|Adverse Event|0|||
126466357|NCT00973349|455008948|FG001|Overall Study|Adverse Event|0|||
126466358|NCT00973349|455008949|FG002|Overall Study|Adverse Event|0|||
126466359|NCT00973349|455008950|FG003|Overall Study|Adverse Event|0|||
126466360|NCT00973349|455008951|FG004|Overall Study|Adverse Event|1|||
126466361|NCT00973349|455008952|FG005|Overall Study|Adverse Event|0|||
126466362|NCT00973349|455008953|FG006|Overall Study|Adverse Event|0|||
126466363|NCT00973349|455008954|FG007|Overall Study|Adverse Event|0|||
126466364|NCT00973349|455008955|FG008|Overall Study|Adverse Event|1|||
126466365|NCT00973349|455008956|FG009|Overall Study|Adverse Event|0|||
126466366|NCT00973349|455008957|FG010|Overall Study|Adverse Event|0|||
126466367|NCT00973349|455008958|FG011|Overall Study|Adverse Event|0|||
126466368|NCT00973349|455008959|FG012|Overall Study|Adverse Event|0|||
126466369|NCT00973349|455008960|FG013|Overall Study|Adverse Event|0|||
126466370|NCT00973349|455008961|FG014|Overall Study|Adverse Event|1|||
126466371|NCT00973349|455008962|FG015|Overall Study|Adverse Event|0|||
126466372|NCT00973349|455008947|FG000|Overall Study|Withdrawal by Subject|1|||
126466373|NCT00973349|455008948|FG001|Overall Study|Withdrawal by Subject|2|||
126466374|NCT00973349|455008949|FG002|Overall Study|Withdrawal by Subject|2|||
126466375|NCT00973349|455008950|FG003|Overall Study|Withdrawal by Subject|3|||
126466376|NCT00973349|455008951|FG004|Overall Study|Withdrawal by Subject|2|||
126466377|NCT00973349|455008952|FG005|Overall Study|Withdrawal by Subject|0|||
126466378|NCT00973349|455008953|FG006|Overall Study|Withdrawal by Subject|2|||
126466379|NCT00973349|455008954|FG007|Overall Study|Withdrawal by Subject|2|||
126466380|NCT00973349|455008955|FG008|Overall Study|Withdrawal by Subject|0|||
126466381|NCT00973349|455008956|FG009|Overall Study|Withdrawal by Subject|2|||
126466382|NCT00973349|455008957|FG010|Overall Study|Withdrawal by Subject|0|||
126771015|NCT00422058|456116235|FG003|Double-Blind, Week 0-20|Other|8|||
126771016|NCT00422058|456116236|FG004|Double-Blind, Week 0-20|Other|4|||
126771017|NCT00422058|456116237|FG005|Double-Blind, Week 0-20|Other|10|||
126310315|NCT01647516|454425286|FG001|Maintenance Period (MP)|Non-compliance|0|||
126310316|NCT01647516|454425287|FG002|Maintenance Period (MP)|Non-compliance|0|||
126310317|NCT01647516|454425288|FG003|Maintenance Period (MP)|Non-compliance|0|||
126310318|NCT01647516|454425289|FG004|Maintenance Period (MP)|Non-compliance|0|||
126310319|NCT01647516|454425290|FG005|Maintenance Period (MP)|Non-compliance|0|||
126310320|NCT01647516|454425285|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
126310321|NCT01647516|454425286|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
126310322|NCT01647516|454425287|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
126310323|NCT01647516|454425288|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
126310324|NCT01647516|454425289|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
126310325|NCT01647516|454425290|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
126310326|NCT01647516|454425285|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
126310327|NCT01647516|454425286|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
126310328|NCT01647516|454425287|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
126310329|NCT01647516|454425288|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
126310330|NCT01647516|454425289|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
126310331|NCT01647516|454425290|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
126310332|NCT01647516|454425285|FG000|Open-Label Period|Adverse Event|0|||
126310333|NCT01647516|454425286|FG001|Open-Label Period|Adverse Event|0|||
126310334|NCT01647516|454425287|FG002|Open-Label Period|Adverse Event|0|||
126310335|NCT01647516|454425288|FG003|Open-Label Period|Adverse Event|5|||
126466383|NCT00973349|455008958|FG011|Overall Study|Withdrawal by Subject|1|||
126466384|NCT00973349|455008959|FG012|Overall Study|Withdrawal by Subject|0|||
126466385|NCT00973349|455008960|FG013|Overall Study|Withdrawal by Subject|0|||
126466386|NCT00973349|455008961|FG014|Overall Study|Withdrawal by Subject|0|||
126466387|NCT00973349|455008962|FG015|Overall Study|Withdrawal by Subject|0|||
126310336|NCT01647516|454425289|FG004|Open-Label Period|Adverse Event|6|||
126466388|NCT00973349|455008947|FG000|Overall Study|Lost to Follow-up|3|||
126466389|NCT00973349|455008948|FG001|Overall Study|Lost to Follow-up|1|||
126310337|NCT01647516|454425290|FG005|Open-Label Period|Adverse Event|3|||
126310338|NCT01647516|454425285|FG000|Open-Label Period|Pregnancy|0|||
126310339|NCT01647516|454425286|FG001|Open-Label Period|Pregnancy|0|||
126310340|NCT01647516|454425287|FG002|Open-Label Period|Pregnancy|0|||
126310341|NCT01647516|454425288|FG003|Open-Label Period|Pregnancy|0|||
126310342|NCT01647516|454425289|FG004|Open-Label Period|Pregnancy|0|||
126310343|NCT01647516|454425290|FG005|Open-Label Period|Pregnancy|1|||
126310344|NCT01647516|454425285|FG000|Open-Label Period|Non-compliance|0|||
126310345|NCT01647516|454425286|FG001|Open-Label Period|Non-compliance|0|||
126310346|NCT01647516|454425287|FG002|Open-Label Period|Non-compliance|0|||
126310347|NCT01647516|454425288|FG003|Open-Label Period|Non-compliance|1|||
126771018|NCT00422058|456116232|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
126771019|NCT00422058|456116233|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
126771020|NCT00422058|456116234|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
126771021|NCT00422058|456116235|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
126771022|NCT00422058|456116236|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
126310348|NCT01647516|454425289|FG004|Open-Label Period|Non-compliance|0|||
126310349|NCT01647516|454425290|FG005|Open-Label Period|Non-compliance|1|||
126310350|NCT01647516|454425285|FG000|Open-Label Period|Physician Decision|0|||
126310351|NCT01647516|454425286|FG001|Open-Label Period|Physician Decision|0|||
126310352|NCT01647516|454425287|FG002|Open-Label Period|Physician Decision|0|||
126310353|NCT01647516|454425288|FG003|Open-Label Period|Physician Decision|1|||
126310354|NCT01647516|454425289|FG004|Open-Label Period|Physician Decision|1|||
126310355|NCT01647516|454425290|FG005|Open-Label Period|Physician Decision|0|||
126310356|NCT01647516|454425285|FG000|Open-Label Period|Withdrawal by Subject|0|||
126310357|NCT01647516|454425286|FG001|Open-Label Period|Withdrawal by Subject|0|||
126310358|NCT01647516|454425287|FG002|Open-Label Period|Withdrawal by Subject|0|||
126310359|NCT01647516|454425288|FG003|Open-Label Period|Withdrawal by Subject|9|||
126310360|NCT01647516|454425289|FG004|Open-Label Period|Withdrawal by Subject|11|||
126310361|NCT01647516|454425290|FG005|Open-Label Period|Withdrawal by Subject|6|||
126310362|NCT01647516|454425285|FG000|Open-Label Period|Lost to Follow-up|0|||
126310363|NCT01647516|454425286|FG001|Open-Label Period|Lost to Follow-up|0|||
126310364|NCT01647516|454425287|FG002|Open-Label Period|Lost to Follow-up|0|||
126310365|NCT01647516|454425288|FG003|Open-Label Period|Lost to Follow-up|1|||
126310366|NCT01647516|454425289|FG004|Open-Label Period|Lost to Follow-up|0|||
126310367|NCT01647516|454425290|FG005|Open-Label Period|Lost to Follow-up|1|||
126310368|NCT01647516|454425285|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
126310369|NCT01647516|454425286|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
126310370|NCT01647516|454425287|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
126310371|NCT01647516|454425288|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
126310372|NCT01647516|454425289|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
126310373|NCT01647516|454425290|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
126373868|NCT02122380|454666836|FG001|First Intervention (30 Days)|Adverse Event|0|||
126373869|NCT02122380|454666835|FG000|First Intervention (30 Days)|Physician Decision|0|||
126373870|NCT02122380|454666836|FG001|First Intervention (30 Days)|Physician Decision|1|||
126373871|NCT02122380|454666835|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
126373872|NCT02122380|454666836|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
126373873|NCT02122380|454666835|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
126373874|NCT02122380|454666836|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
126771023|NCT00422058|456116237|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
126771024|NCT00422058|456116232|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
126771025|NCT00422058|456116233|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
126771026|NCT00422058|456116234|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
126771027|NCT00422058|456116235|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
126771028|NCT00422058|456116236|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
126771029|NCT00422058|456116237|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
126771030|NCT00422058|456116232|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
126771031|NCT00422058|456116233|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
126771032|NCT00422058|456116234|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
126771033|NCT00422058|456116235|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
126310374|NCT01647516|454425285|FG000|Open-Label Period|Lack of Efficacy|0|||
126310375|NCT01647516|454425286|FG001|Open-Label Period|Lack of Efficacy|0|||
126310376|NCT01647516|454425287|FG002|Open-Label Period|Lack of Efficacy|0|||
126310377|NCT01647516|454425288|FG003|Open-Label Period|Lack of Efficacy|7|||
126310378|NCT01647516|454425289|FG004|Open-Label Period|Lack of Efficacy|9|||
126310379|NCT01647516|454425290|FG005|Open-Label Period|Lack of Efficacy|10|||
126310380|NCT01647516|454425285|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
126310381|NCT01647516|454425286|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
126373875|NCT02122380|454666835|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
126373876|NCT02122380|454666836|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
126310382|NCT01647516|454425287|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
126310383|NCT01647516|454425288|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
126310384|NCT01647516|454425289|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
126310385|NCT01647516|454425290|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
126310386|NCT01647516|454425285|FG000|Open-Label Period|No completion / discontinuation visit|0|||
126310387|NCT01647516|454425286|FG001|Open-Label Period|No completion / discontinuation visit|0|||
126466390|NCT00973349|455008949|FG002|Overall Study|Lost to Follow-up|2|||
126466391|NCT00973349|455008950|FG003|Overall Study|Lost to Follow-up|2|||
126466392|NCT00973349|455008951|FG004|Overall Study|Lost to Follow-up|1|||
126466393|NCT00973349|455008952|FG005|Overall Study|Lost to Follow-up|3|||
126466394|NCT00973349|455008953|FG006|Overall Study|Lost to Follow-up|0|||
126466395|NCT00973349|455008954|FG007|Overall Study|Lost to Follow-up|1|||
126466396|NCT00973349|455008955|FG008|Overall Study|Lost to Follow-up|2|||
126310388|NCT01647516|454425287|FG002|Open-Label Period|No completion / discontinuation visit|0|||
126310389|NCT01647516|454425288|FG003|Open-Label Period|No completion / discontinuation visit|0|||
126310390|NCT01647516|454425289|FG004|Open-Label Period|No completion / discontinuation visit|2|||
126310391|NCT01647516|454425290|FG005|Open-Label Period|No completion / discontinuation visit|1|||
126466397|NCT00973349|455008956|FG009|Overall Study|Lost to Follow-up|1|||
126466398|NCT00973349|455008957|FG010|Overall Study|Lost to Follow-up|0|||
126466399|NCT00973349|455008958|FG011|Overall Study|Lost to Follow-up|1|||
126716685|NCT03703375|455914905|FG001|Treatment Period|Progression|1|||
126716686|NCT03703375|455914906|FG002|Treatment Period|Progression|7|||
126466400|NCT00973349|455008959|FG012|Overall Study|Lost to Follow-up|0|||
126466401|NCT00973349|455008960|FG013|Overall Study|Lost to Follow-up|0|||
126466402|NCT00973349|455008961|FG014|Overall Study|Lost to Follow-up|0|||
126466403|NCT00973349|455008962|FG015|Overall Study|Lost to Follow-up|1|||
126466404|NCT00973349|455008947|FG000|Overall Study|Inappropriate enrolment|0|||
126466405|NCT00973349|455008948|FG001|Overall Study|Inappropriate enrolment|0|||
126466406|NCT00973349|455008949|FG002|Overall Study|Inappropriate enrolment|1|||
126466407|NCT00973349|455008950|FG003|Overall Study|Inappropriate enrolment|0|||
126466408|NCT00973349|455008951|FG004|Overall Study|Inappropriate enrolment|0|||
126466409|NCT00973349|455008952|FG005|Overall Study|Inappropriate enrolment|0|||
126466410|NCT00973349|455008953|FG006|Overall Study|Inappropriate enrolment|0|||
126466411|NCT00973349|455008954|FG007|Overall Study|Inappropriate enrolment|0|||
126716687|NCT03703375|455914907|FG003|Treatment Period|Progression|11|||
126716688|NCT03703375|455914904|FG000|Treatment Period|Completed treatment|7|||
126716689|NCT03703375|455914905|FG001|Treatment Period|Completed treatment|2|||
126716690|NCT03703375|455914906|FG002|Treatment Period|Completed treatment|0|||
126716691|NCT03703375|455914907|FG003|Treatment Period|Completed treatment|0|||
126310392|NCT02980341|454425291|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
126310393|NCT02980341|454425292|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
126310394|NCT02980341|454425293|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
126310395|NCT02980341|454425294|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
126310396|NCT02980341|454425295|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
126310397|NCT02980341|454425296|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
126310398|NCT02980341|454425297|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
126310399|NCT02980341|454425298|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
126310400|NCT02980341|454425299|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
126310401|NCT02980341|454425300|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
126310402|NCT02980341|454425301|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
126310403|NCT02980341|454425291|FG000|Dose Escalation|Clinical progression|0|||
126310404|NCT02980341|454425292|FG001|Dose Escalation|Clinical progression|0|||
126310405|NCT02980341|454425293|FG002|Dose Escalation|Clinical progression|2|||
126310406|NCT02980341|454425294|FG003|Dose Escalation|Clinical progression|1|||
126310407|NCT02980341|454425295|FG004|Dose Escalation|Clinical progression|0|||
126310408|NCT02980341|454425296|FG005|Dose Escalation|Clinical progression|0|||
126310409|NCT02980341|454425297|FG006|Dose Escalation|Clinical progression|0|||
126310410|NCT02980341|454425298|FG007|Dose Escalation|Clinical progression|0|||
126310411|NCT02980341|454425299|FG008|Dose Escalation|Clinical progression|0|||
126310412|NCT02980341|454425300|FG009|Dose Escalation|Clinical progression|0|||
126310413|NCT02980341|454425301|FG010|Dose Escalation|Clinical progression|0|||
126466412|NCT00973349|455008955|FG008|Overall Study|Inappropriate enrolment|0|||
126466413|NCT00973349|455008956|FG009|Overall Study|Inappropriate enrolment|2|||
126466414|NCT00973349|455008957|FG010|Overall Study|Inappropriate enrolment|0|||
126466415|NCT00973349|455008958|FG011|Overall Study|Inappropriate enrolment|0|||
126466416|NCT00973349|455008959|FG012|Overall Study|Inappropriate enrolment|1|||
126466417|NCT00973349|455008960|FG013|Overall Study|Inappropriate enrolment|0|||
126466418|NCT00973349|455008961|FG014|Overall Study|Inappropriate enrolment|1|||
126466419|NCT00973349|455008962|FG015|Overall Study|Inappropriate enrolment|1|||
126466420|NCT00973349|455008947|FG000|Overall Study|Protocol Violation|0|||
126466421|NCT00973349|455008948|FG001|Overall Study|Protocol Violation|0|||
126716692|NCT01781429|455914910|FG000|Overall Study|Death|0|||
126310414|NCT02980341|454425291|FG000|Dose Escalation|Adverse Event|0|||
126466422|NCT00973349|455008949|FG002|Overall Study|Protocol Violation|0|||
126373877|NCT00272792|454666837|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
126373878|NCT00272792|454666838|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
126373879|NCT00272792|454666837|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
126373880|NCT00272792|454666838|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
126373881|NCT00272792|454666837|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
126373882|NCT00272792|454666838|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
126373883|NCT00272792|454666837|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
126373884|NCT00272792|454666838|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
126373885|NCT02921789|454666839|FG000|Overall Study|Adverse Event|0|||
126373886|NCT02921789|454666840|FG001|Overall Study|Adverse Event|1|||
126373887|NCT02921789|454666839|FG000|Overall Study|Lost to Follow-up|1|||
126373888|NCT02921789|454666840|FG001|Overall Study|Lost to Follow-up|0|||
126373889|NCT02921789|454666839|FG000|Overall Study|Protocol Deviation|2|||
126373890|NCT02921789|454666840|FG001|Overall Study|Protocol Deviation|0|||
126373891|NCT02921789|454666839|FG000|Overall Study|Withdrawal by Subject|2|||
126373892|NCT02921789|454666840|FG001|Overall Study|Withdrawal by Subject|1|||
126373893|NCT02921789|454666839|FG000|Overall Study|Miscellaneous|3|||
126373894|NCT02921789|454666840|FG001|Overall Study|Miscellaneous|2|||
126373895|NCT04099277|454666841|FG000|Overall Study|Physician Decision|1|||
126373896|NCT04099277|454666841|FG000|Overall Study|Withdrawal by Subject|1|||
126373897|NCT00598650|454666844|FG000|Overall Study|Withdrawal by Subject|3|||
126373898|NCT00598650|454666844|FG000|Overall Study|Adverse Event|18|||
126373899|NCT00598650|454666844|FG000|Overall Study|No treatment for 3 weeks|1|||
126373900|NCT00598650|454666844|FG000|Overall Study|Not eligible|1|||
126373901|NCT00598650|454666844|FG000|Overall Study|Prohibited Concomitant Medication|2|||
126373902|NCT00598650|454666844|FG000|Overall Study|Physician Decision|2|||
126373903|NCT03423602|454666845|FG000|Overall Study|Death|1|||
126373904|NCT03423602|454666845|FG000|Overall Study|Lost to Follow-up|6|||
126373905|NCT03423602|454666845|FG000|Overall Study|Protocol Violation|1|||
126373906|NCT03423602|454666845|FG000|Overall Study|Withdrawal by Subject|4|||
126373907|NCT03423121|454666846|FG000|Overall Study|Lost to Follow-up|2|||
126373908|NCT03423121|454666847|FG001|Overall Study|Lost to Follow-up|6|||
126373909|NCT03423121|454666846|FG000|Overall Study|Adverse Event|1|||
126373910|NCT03423121|454666847|FG001|Overall Study|Adverse Event|0|||
126373911|NCT00560508|454666848|FG000|12 Week Double-blind Period|Adverse Event|3|||
126373912|NCT00560508|454666849|FG001|12 Week Double-blind Period|Adverse Event|2|||
126373913|NCT00560508|454666848|FG000|12 Week Double-blind Period|Protocol Violation|1|||
126373914|NCT00560508|454666849|FG001|12 Week Double-blind Period|Protocol Violation|0|||
126373915|NCT00560508|454666848|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
126373916|NCT00560508|454666849|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
126373917|NCT00560508|454666848|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
126373918|NCT00560508|454666849|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
126373919|NCT00560508|454666848|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
126373920|NCT00560508|454666849|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
126373921|NCT00560508|454666848|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
126373922|NCT00560508|454666849|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
126373923|NCT00560508|454666848|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
126373924|NCT00560508|454666849|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
126373925|NCT01354223|454666850|FG000|Overall Study|Withdrawal by Subject|3|||
126373926|NCT01354223|454666851|FG001|Overall Study|Withdrawal by Subject|1|||
126373927|NCT00948688|454666859|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
126373928|NCT00948688|454666860|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
126716693|NCT01781429|455914911|FG001|Overall Study|Death|0|||
126373929|NCT00948688|454666859|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
126373930|NCT00948688|454666860|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
126373931|NCT00948688|454666859|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
126373932|NCT00948688|454666860|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
126373933|NCT02852967|454666861|FG000|Overall Study|Adverse Event|3|||
126373934|NCT02852967|454666862|FG001|Overall Study|Adverse Event|1|||
126373935|NCT02852967|454666863|FG002|Overall Study|Adverse Event|0|||
126373936|NCT02852967|454666864|FG003|Overall Study|Adverse Event|1|||
126373937|NCT02852967|454666865|FG004|Overall Study|Adverse Event|0|||
126373938|NCT02852967|454666861|FG000|Overall Study|Death|1|||
126373939|NCT02852967|454666862|FG001|Overall Study|Death|0|||
126373940|NCT02852967|454666863|FG002|Overall Study|Death|0|||
126373941|NCT02852967|454666864|FG003|Overall Study|Death|0|||
126373942|NCT02852967|454666865|FG004|Overall Study|Death|0|||
126373943|NCT02852967|454666861|FG000|Overall Study|Lost to Follow-up|1|||
126373944|NCT02852967|454666862|FG001|Overall Study|Lost to Follow-up|2|||
126373945|NCT02852967|454666863|FG002|Overall Study|Lost to Follow-up|3|||
126373946|NCT02852967|454666864|FG003|Overall Study|Lost to Follow-up|4|||
126373947|NCT02852967|454666865|FG004|Overall Study|Lost to Follow-up|4|||
126373948|NCT02852967|454666861|FG000|Overall Study|Withdrawal by Subject|6|||
126373949|NCT02852967|454666862|FG001|Overall Study|Withdrawal by Subject|12|||
126373950|NCT02852967|454666863|FG002|Overall Study|Withdrawal by Subject|7|||
126716694|NCT01781429|455914912|FG002|Overall Study|Death|0|||
126716695|NCT01781429|455914913|FG003|Overall Study|Death|0|||
126310415|NCT02980341|454425292|FG001|Dose Escalation|Adverse Event|0|||
126310416|NCT02980341|454425293|FG002|Dose Escalation|Adverse Event|1|||
126310417|NCT02980341|454425294|FG003|Dose Escalation|Adverse Event|2|||
126310418|NCT02980341|454425295|FG004|Dose Escalation|Adverse Event|2|||
126310419|NCT02980341|454425296|FG005|Dose Escalation|Adverse Event|0|||
126310420|NCT02980341|454425297|FG006|Dose Escalation|Adverse Event|0|||
126310421|NCT02980341|454425298|FG007|Dose Escalation|Adverse Event|0|||
126310422|NCT02980341|454425299|FG008|Dose Escalation|Adverse Event|0|||
126373951|NCT02852967|454666864|FG003|Overall Study|Withdrawal by Subject|10|||
126373952|NCT02852967|454666865|FG004|Overall Study|Withdrawal by Subject|10|||
126373953|NCT02852967|454666861|FG000|Overall Study|SAE|0|||
126373954|NCT02852967|454666862|FG001|Overall Study|SAE|0|||
126373955|NCT02852967|454666863|FG002|Overall Study|SAE|0|||
126373956|NCT02852967|454666864|FG003|Overall Study|SAE|3|||
126373957|NCT02852967|454666865|FG004|Overall Study|SAE|0|||
126373958|NCT02852967|454666861|FG000|Overall Study|Elevated Liver Enzymes|2|||
126373959|NCT02852967|454666862|FG001|Overall Study|Elevated Liver Enzymes|0|||
126373960|NCT02852967|454666863|FG002|Overall Study|Elevated Liver Enzymes|0|||
126373961|NCT02852967|454666864|FG003|Overall Study|Elevated Liver Enzymes|2|||
126373962|NCT02852967|454666865|FG004|Overall Study|Elevated Liver Enzymes|2|||
126373963|NCT02852967|454666861|FG000|Overall Study|Physician Decision|0|||
126373964|NCT02852967|454666862|FG001|Overall Study|Physician Decision|0|||
126373965|NCT02852967|454666863|FG002|Overall Study|Physician Decision|0|||
126373966|NCT02852967|454666864|FG003|Overall Study|Physician Decision|1|||
126373967|NCT02852967|454666865|FG004|Overall Study|Physician Decision|0|||
126373968|NCT02852967|454666861|FG000|Overall Study|Lack of Efficacy|0|||
126373969|NCT02852967|454666862|FG001|Overall Study|Lack of Efficacy|1|||
126373970|NCT02852967|454666863|FG002|Overall Study|Lack of Efficacy|0|||
126373971|NCT02852967|454666864|FG003|Overall Study|Lack of Efficacy|0|||
126373972|NCT02852967|454666865|FG004|Overall Study|Lack of Efficacy|0|||
126373973|NCT02852967|454666861|FG000|Overall Study|Non-compliance|0|||
126373974|NCT02852967|454666862|FG001|Overall Study|Non-compliance|0|||
126373975|NCT02852967|454666863|FG002|Overall Study|Non-compliance|1|||
126373976|NCT02852967|454666864|FG003|Overall Study|Non-compliance|1|||
126373977|NCT02852967|454666865|FG004|Overall Study|Non-compliance|0|||
126373978|NCT02852967|454666861|FG000|Overall Study|Dispensing Drug Violation|0|||
126373979|NCT02852967|454666862|FG001|Overall Study|Dispensing Drug Violation|0|||
126373980|NCT02852967|454666863|FG002|Overall Study|Dispensing Drug Violation|1|||
126373981|NCT02852967|454666864|FG003|Overall Study|Dispensing Drug Violation|0|||
126373982|NCT02852967|454666865|FG004|Overall Study|Dispensing Drug Violation|0|||
126373983|NCT02852967|454666861|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
126373984|NCT02852967|454666862|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
126373985|NCT02852967|454666863|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
126373986|NCT02852967|454666864|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
126373987|NCT02852967|454666865|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
126373988|NCT01693367|454666866|FG000|Overall Study|Withdrawal by Subject|1|||
126466423|NCT00973349|455008950|FG003|Overall Study|Protocol Violation|0|||
126466424|NCT00973349|455008951|FG004|Overall Study|Protocol Violation|0|||
126466425|NCT00973349|455008952|FG005|Overall Study|Protocol Violation|0|||
126466426|NCT00973349|455008953|FG006|Overall Study|Protocol Violation|0|||
126466427|NCT00973349|455008954|FG007|Overall Study|Protocol Violation|0|||
126466428|NCT00973349|455008955|FG008|Overall Study|Protocol Violation|1|||
126466429|NCT00973349|455008956|FG009|Overall Study|Protocol Violation|0|||
126466430|NCT00973349|455008957|FG010|Overall Study|Protocol Violation|0|||
126466431|NCT00973349|455008958|FG011|Overall Study|Protocol Violation|0|||
126466432|NCT00973349|455008959|FG012|Overall Study|Protocol Violation|0|||
126466433|NCT00973349|455008960|FG013|Overall Study|Protocol Violation|0|||
126466434|NCT00973349|455008961|FG014|Overall Study|Protocol Violation|0|||
126466435|NCT00973349|455008962|FG015|Overall Study|Protocol Violation|0|||
126552907|NCT02291289|455320501|FG000|Induction Treatment|Withdrawal by Subject|0|||
126373989|NCT01693367|454666867|FG001|Overall Study|Withdrawal by Subject|1|||
126373990|NCT01693367|454666866|FG000|Overall Study|Physician Decision|0|||
126373991|NCT01693367|454666867|FG001|Overall Study|Physician Decision|1|||
126373992|NCT02136914|454666868|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
126373993|NCT02136914|454666869|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
126373994|NCT02136914|454666868|FG000|Overall Study|Withdrawal by Subject|3|||
126466436|NCT00973349|455008947|FG000|Overall Study|Unable to classify|0|||
126466437|NCT00973349|455008948|FG001|Overall Study|Unable to classify|0|||
126466438|NCT00973349|455008949|FG002|Overall Study|Unable to classify|0|||
126466439|NCT00973349|455008950|FG003|Overall Study|Unable to classify|0|||
126310423|NCT02980341|454425300|FG009|Dose Escalation|Adverse Event|0|||
126310424|NCT02980341|454425301|FG010|Dose Escalation|Adverse Event|0|||
126310425|NCT02980341|454425291|FG000|Dose Escalation|Withdrawal by Subject|0|||
126310426|NCT02980341|454425292|FG001|Dose Escalation|Withdrawal by Subject|0|||
126466440|NCT00973349|455008951|FG004|Overall Study|Unable to classify|1|||
126466441|NCT00973349|455008952|FG005|Overall Study|Unable to classify|1|||
126466442|NCT00973349|455008953|FG006|Overall Study|Unable to classify|0|||
126716696|NCT01781429|455914914|FG004|Overall Study|Death|0|||
126771034|NCT00422058|456116236|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
126310427|NCT02980341|454425293|FG002|Dose Escalation|Withdrawal by Subject|1|||
126310428|NCT02980341|454425294|FG003|Dose Escalation|Withdrawal by Subject|0|||
126310429|NCT02980341|454425295|FG004|Dose Escalation|Withdrawal by Subject|0|||
126310430|NCT02980341|454425296|FG005|Dose Escalation|Withdrawal by Subject|0|||
126310431|NCT02980341|454425297|FG006|Dose Escalation|Withdrawal by Subject|0|||
126310432|NCT02980341|454425298|FG007|Dose Escalation|Withdrawal by Subject|0|||
126310433|NCT02980341|454425299|FG008|Dose Escalation|Withdrawal by Subject|0|||
126310434|NCT02980341|454425300|FG009|Dose Escalation|Withdrawal by Subject|0|||
126310435|NCT02980341|454425301|FG010|Dose Escalation|Withdrawal by Subject|0|||
126310436|NCT02980341|454425291|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310437|NCT02980341|454425292|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310438|NCT02980341|454425293|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310439|NCT02980341|454425294|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
126310440|NCT02980341|454425295|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310441|NCT02980341|454425296|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310442|NCT02980341|454425297|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310443|NCT02980341|454425298|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310444|NCT02980341|454425299|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310445|NCT02980341|454425300|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310446|NCT02980341|454425301|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
126310447|NCT02980341|454425291|FG000|Dose Escalation|Due to investigator's decision|0|||
126310448|NCT02980341|454425292|FG001|Dose Escalation|Due to investigator's decision|0|||
126310449|NCT02980341|454425293|FG002|Dose Escalation|Due to investigator's decision|0|||
126310450|NCT02980341|454425294|FG003|Dose Escalation|Due to investigator's decision|0|||
126310451|NCT02980341|454425295|FG004|Dose Escalation|Due to investigator's decision|1|||
126310452|NCT02980341|454425296|FG005|Dose Escalation|Due to investigator's decision|0|||
126310453|NCT02980341|454425297|FG006|Dose Escalation|Due to investigator's decision|0|||
126310454|NCT02980341|454425298|FG007|Dose Escalation|Due to investigator's decision|0|||
126310455|NCT02980341|454425299|FG008|Dose Escalation|Due to investigator's decision|0|||
126310456|NCT02980341|454425300|FG009|Dose Escalation|Due to investigator's decision|0|||
126310457|NCT02980341|454425301|FG010|Dose Escalation|Due to investigator's decision|0|||
126310458|NCT02980341|454425291|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310459|NCT02980341|454425292|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310460|NCT02980341|454425293|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310461|NCT02980341|454425294|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310462|NCT02980341|454425295|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310463|NCT02980341|454425296|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
126310464|NCT02980341|454425297|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
126310465|NCT02980341|454425298|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310466|NCT02980341|454425299|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310467|NCT02980341|454425300|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310468|NCT02980341|454425301|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
126310469|NCT02980341|454425291|FG000|Dose Finding|Adverse Event|0|||
126310470|NCT02980341|454425292|FG001|Dose Finding|Adverse Event|0|||
126310471|NCT02980341|454425293|FG002|Dose Finding|Adverse Event|0|||
126310472|NCT02980341|454425294|FG003|Dose Finding|Adverse Event|0|||
126310473|NCT02980341|454425295|FG004|Dose Finding|Adverse Event|0|||
126310474|NCT02980341|454425296|FG005|Dose Finding|Adverse Event|3|||
126310475|NCT02980341|454425297|FG006|Dose Finding|Adverse Event|0|||
126310476|NCT02980341|454425298|FG007|Dose Finding|Adverse Event|0|||
126310477|NCT02980341|454425299|FG008|Dose Finding|Adverse Event|0|||
126310478|NCT02980341|454425300|FG009|Dose Finding|Adverse Event|0|||
126310479|NCT02980341|454425301|FG010|Dose Finding|Adverse Event|0|||
126310480|NCT02980341|454425291|FG000|Dose Finding|Withdrawal by Subject|0|||
126310481|NCT02980341|454425292|FG001|Dose Finding|Withdrawal by Subject|0|||
126310482|NCT02980341|454425293|FG002|Dose Finding|Withdrawal by Subject|0|||
126310483|NCT02980341|454425294|FG003|Dose Finding|Withdrawal by Subject|0|||
126310484|NCT02980341|454425295|FG004|Dose Finding|Withdrawal by Subject|0|||
126310485|NCT02980341|454425296|FG005|Dose Finding|Withdrawal by Subject|1|||
126310486|NCT02980341|454425297|FG006|Dose Finding|Withdrawal by Subject|1|||
126310487|NCT02980341|454425298|FG007|Dose Finding|Withdrawal by Subject|0|||
126310488|NCT02980341|454425299|FG008|Dose Finding|Withdrawal by Subject|0|||
126310489|NCT02980341|454425300|FG009|Dose Finding|Withdrawal by Subject|0|||
126310490|NCT02980341|454425301|FG010|Dose Finding|Withdrawal by Subject|0|||
126310491|NCT02980341|454425291|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126771035|NCT00422058|456116237|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
126771036|NCT00422058|456116232|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
126310492|NCT02980341|454425292|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126310493|NCT02980341|454425293|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126310494|NCT02980341|454425294|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126310495|NCT02980341|454425295|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126310496|NCT02980341|454425296|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126310497|NCT02980341|454425297|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
126310498|NCT02980341|454425298|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
126310499|NCT02980341|454425299|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
126310500|NCT02980341|454425300|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
126310501|NCT02980341|454425301|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
126310502|NCT02980341|454425291|FG000|Dose Expansion|Clinical progression|0|||
126310503|NCT02980341|454425292|FG001|Dose Expansion|Clinical progression|0|||
126310504|NCT02980341|454425293|FG002|Dose Expansion|Clinical progression|0|||
126310505|NCT02980341|454425294|FG003|Dose Expansion|Clinical progression|0|||
126310506|NCT02980341|454425295|FG004|Dose Expansion|Clinical progression|0|||
126310507|NCT02980341|454425296|FG005|Dose Expansion|Clinical progression|0|||
126310508|NCT02980341|454425297|FG006|Dose Expansion|Clinical progression|0|||
126310509|NCT02980341|454425298|FG007|Dose Expansion|Clinical progression|4|||
126310510|NCT02980341|454425299|FG008|Dose Expansion|Clinical progression|3|||
126310511|NCT02980341|454425300|FG009|Dose Expansion|Clinical progression|1|||
126310512|NCT02980341|454425301|FG010|Dose Expansion|Clinical progression|4|||
126310513|NCT02980341|454425291|FG000|Dose Expansion|Adverse Event|0|||
126310514|NCT02980341|454425292|FG001|Dose Expansion|Adverse Event|0|||
126310515|NCT02980341|454425293|FG002|Dose Expansion|Adverse Event|0|||
126310516|NCT02980341|454425294|FG003|Dose Expansion|Adverse Event|0|||
126310517|NCT02980341|454425295|FG004|Dose Expansion|Adverse Event|0|||
126310518|NCT02980341|454425296|FG005|Dose Expansion|Adverse Event|0|||
126310519|NCT02980341|454425297|FG006|Dose Expansion|Adverse Event|0|||
126310520|NCT02980341|454425298|FG007|Dose Expansion|Adverse Event|3|||
126310521|NCT02980341|454425299|FG008|Dose Expansion|Adverse Event|0|||
126310522|NCT02980341|454425300|FG009|Dose Expansion|Adverse Event|1|||
126310523|NCT02980341|454425301|FG010|Dose Expansion|Adverse Event|3|||
126310524|NCT02980341|454425291|FG000|Dose Expansion|Death|0|||
126310525|NCT02980341|454425292|FG001|Dose Expansion|Death|0|||
126310526|NCT02980341|454425293|FG002|Dose Expansion|Death|0|||
126310527|NCT02980341|454425294|FG003|Dose Expansion|Death|0|||
126310528|NCT02980341|454425295|FG004|Dose Expansion|Death|0|||
126310529|NCT02980341|454425296|FG005|Dose Expansion|Death|0|||
126310530|NCT02980341|454425297|FG006|Dose Expansion|Death|0|||
126310531|NCT02980341|454425298|FG007|Dose Expansion|Death|0|||
126310532|NCT02980341|454425299|FG008|Dose Expansion|Death|2|||
126310533|NCT02980341|454425300|FG009|Dose Expansion|Death|1|||
126310534|NCT02980341|454425301|FG010|Dose Expansion|Death|0|||
126310535|NCT02980341|454425291|FG000|Dose Expansion|Withdrawal by Subject|0|||
126310536|NCT02980341|454425292|FG001|Dose Expansion|Withdrawal by Subject|0|||
126373995|NCT02136914|454666869|FG001|Overall Study|Withdrawal by Subject|10|||
126373996|NCT02136914|454666868|FG000|Overall Study|Subject Unwilling to Proceed|7|||
126373997|NCT02136914|454666869|FG001|Overall Study|Subject Unwilling to Proceed|2|||
126373998|NCT02136914|454666868|FG000|Overall Study|Lost to Follow-up|1|||
126373999|NCT02136914|454666869|FG001|Overall Study|Lost to Follow-up|1|||
126374000|NCT02136914|454666868|FG000|Overall Study|Did Not Receive Study Drug|2|||
126374001|NCT02136914|454666869|FG001|Overall Study|Did Not Receive Study Drug|0|||
126374002|NCT02136914|454666868|FG000|Overall Study|Lack of Efficacy|1|||
126374003|NCT02136914|454666869|FG001|Overall Study|Lack of Efficacy|0|||
126374004|NCT02136914|454666868|FG000|Overall Study|Death|0|||
126374005|NCT02136914|454666869|FG001|Overall Study|Death|1|||
126374006|NCT03012334|454666872|FG000|Period 1|Withdrawal by Subject|0|||
126374007|NCT03012334|454666873|FG001|Period 1|Withdrawal by Subject|0|||
126374008|NCT03012334|454666874|FG002|Period 1|Withdrawal by Subject|0|||
126374009|NCT03012334|454666875|FG003|Period 1|Withdrawal by Subject|0|||
126374010|NCT03012334|454666876|FG004|Period 1|Withdrawal by Subject|0|||
126374011|NCT03012334|454666877|FG005|Period 1|Withdrawal by Subject|0|||
126374012|NCT03012334|454666878|FG006|Period 1|Withdrawal by Subject|0|||
126374013|NCT03012334|454666879|FG007|Period 1|Withdrawal by Subject|0|||
126374014|NCT03012334|454666880|FG008|Period 1|Withdrawal by Subject|0|||
126374015|NCT03012334|454666881|FG009|Period 1|Withdrawal by Subject|1|||
126374016|NCT03012334|454666872|FG000|Period 2|Withdrawal by Subject|0|||
126374017|NCT03012334|454666873|FG001|Period 2|Withdrawal by Subject|1|||
126374018|NCT03012334|454666874|FG002|Period 2|Withdrawal by Subject|0|||
126374019|NCT03012334|454666875|FG003|Period 2|Withdrawal by Subject|0|||
126374020|NCT03012334|454666876|FG004|Period 2|Withdrawal by Subject|0|||
126374021|NCT03012334|454666877|FG005|Period 2|Withdrawal by Subject|0|||
126374022|NCT03012334|454666878|FG006|Period 2|Withdrawal by Subject|0|||
126374023|NCT03012334|454666879|FG007|Period 2|Withdrawal by Subject|0|||
126374024|NCT03012334|454666880|FG008|Period 2|Withdrawal by Subject|0|||
126374025|NCT03012334|454666881|FG009|Period 2|Withdrawal by Subject|0|||
126374026|NCT03012334|454666872|FG000|Period 2|Protocol Violation|0|||
126374027|NCT03012334|454666873|FG001|Period 2|Protocol Violation|0|||
126374028|NCT03012334|454666874|FG002|Period 2|Protocol Violation|1|||
126310537|NCT02980341|454425293|FG002|Dose Expansion|Withdrawal by Subject|0|||
126374029|NCT03012334|454666875|FG003|Period 2|Protocol Violation|0|||
126374030|NCT03012334|454666876|FG004|Period 2|Protocol Violation|0|||
126716697|NCT01781429|455914915|FG005|Overall Study|Death|0|||
126310538|NCT02980341|454425294|FG003|Dose Expansion|Withdrawal by Subject|0|||
126310539|NCT02980341|454425295|FG004|Dose Expansion|Withdrawal by Subject|0|||
126310540|NCT02980341|454425296|FG005|Dose Expansion|Withdrawal by Subject|0|||
126310541|NCT02980341|454425297|FG006|Dose Expansion|Withdrawal by Subject|0|||
126310542|NCT02980341|454425298|FG007|Dose Expansion|Withdrawal by Subject|2|||
126310543|NCT02980341|454425299|FG008|Dose Expansion|Withdrawal by Subject|0|||
126310544|NCT02980341|454425300|FG009|Dose Expansion|Withdrawal by Subject|1|||
126310545|NCT02980341|454425301|FG010|Dose Expansion|Withdrawal by Subject|0|||
126310546|NCT02980341|454425291|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310547|NCT02980341|454425292|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310548|NCT02980341|454425293|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310549|NCT02980341|454425294|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310550|NCT02980341|454425295|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310551|NCT02980341|454425296|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310552|NCT02980341|454425297|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310553|NCT02980341|454425298|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
126310554|NCT02980341|454425299|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310555|NCT02980341|454425300|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310556|NCT02980341|454425301|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
126310557|NCT02980341|454425291|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310558|NCT02980341|454425292|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310559|NCT02980341|454425293|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310560|NCT02980341|454425294|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310561|NCT02980341|454425295|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310562|NCT02980341|454425296|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310563|NCT02980341|454425297|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310564|NCT02980341|454425298|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310565|NCT02980341|454425299|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
126310566|NCT02980341|454425300|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310567|NCT02980341|454425301|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
126310568|NCT02980341|454425291|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310569|NCT02980341|454425292|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310570|NCT02980341|454425293|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310571|NCT02980341|454425294|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310572|NCT02980341|454425295|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310573|NCT02980341|454425296|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310574|NCT02980341|454425297|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310575|NCT02980341|454425298|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310576|NCT02980341|454425299|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
126310577|NCT02980341|454425300|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310578|NCT02980341|454425301|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
126310579|NCT02980341|454425291|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310580|NCT02980341|454425292|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310581|NCT02980341|454425293|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310582|NCT02980341|454425294|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126374031|NCT03012334|454666877|FG005|Period 2|Protocol Violation|0|||
126374032|NCT03012334|454666878|FG006|Period 2|Protocol Violation|0|||
126374033|NCT03012334|454666879|FG007|Period 2|Protocol Violation|1|||
126374034|NCT03012334|454666880|FG008|Period 2|Protocol Violation|0|||
126374035|NCT03012334|454666881|FG009|Period 2|Protocol Violation|0|||
126374036|NCT03012334|454666872|FG000|Period 4|Non-Compliance|0|||
126374037|NCT03012334|454666873|FG001|Period 4|Non-Compliance|0|||
126374038|NCT03012334|454666874|FG002|Period 4|Non-Compliance|0|||
126374039|NCT03012334|454666875|FG003|Period 4|Non-Compliance|0|||
126374040|NCT03012334|454666876|FG004|Period 4|Non-Compliance|0|||
126374041|NCT03012334|454666877|FG005|Period 4|Non-Compliance|0|||
126374042|NCT03012334|454666878|FG006|Period 4|Non-Compliance|1|||
126374043|NCT03012334|454666879|FG007|Period 4|Non-Compliance|0|||
126374044|NCT03012334|454666880|FG008|Period 4|Non-Compliance|0|||
126374045|NCT03012334|454666881|FG009|Period 4|Non-Compliance|0|||
126374046|NCT03012334|454666872|FG000|Period 4|Adverse Event|0|||
126466443|NCT00973349|455008954|FG007|Overall Study|Unable to classify|0|||
126466444|NCT00973349|455008955|FG008|Overall Study|Unable to classify|0|||
126466445|NCT00973349|455008956|FG009|Overall Study|Unable to classify|1|||
126466446|NCT00973349|455008957|FG010|Overall Study|Unable to classify|0|||
126466447|NCT00973349|455008958|FG011|Overall Study|Unable to classify|0|||
126466448|NCT00973349|455008959|FG012|Overall Study|Unable to classify|0|||
126466449|NCT00973349|455008960|FG013|Overall Study|Unable to classify|0|||
126466450|NCT00973349|455008961|FG014|Overall Study|Unable to classify|0|||
126466451|NCT00973349|455008962|FG015|Overall Study|Unable to classify|0|||
126466452|NCT02301988|455008963|FG000|Overall Study|Withdrawal by Subject|2|||
126466453|NCT02301988|455008964|FG001|Overall Study|Withdrawal by Subject|1|||
126466454|NCT02301988|455008963|FG000|Overall Study|Physician Decision|2|||
126466455|NCT02301988|455008964|FG001|Overall Study|Physician Decision|2|||
126466456|NCT02301988|455008963|FG000|Overall Study|Unknown Reason|1|||
126466457|NCT02301988|455008964|FG001|Overall Study|Unknown Reason|3|||
126466458|NCT02301988|455008963|FG000|Overall Study|Lack of Efficacy|3|||
126466459|NCT02301988|455008964|FG001|Overall Study|Lack of Efficacy|2|||
126466460|NCT02301988|455008963|FG000|Overall Study|Death|1|||
126466461|NCT02301988|455008964|FG001|Overall Study|Death|0|||
126466462|NCT02301988|455008963|FG000|Overall Study|Adverse Event|1|||
126310583|NCT02980341|454425295|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310584|NCT02980341|454425296|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310585|NCT02980341|454425297|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310586|NCT02980341|454425298|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310587|NCT02980341|454425299|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310588|NCT02980341|454425300|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
126310589|NCT02980341|454425301|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
126310590|NCT03193801|454425306|FG000|Overall Study|Physician Decision|2|||
126310591|NCT03193801|454425306|FG000|Overall Study|Withdrawal by Subject|1|||
126310592|NCT04964544|454425309|FG000|Overall Study|Screen failure or other uncategorised|10|||
126310593|NCT04964544|454425309|FG000|Overall Study|Physician Decision|4|||
126310594|NCT04964544|454425309|FG000|Overall Study|Lost to Follow-up|9|||
126310595|NCT04964544|454425309|FG000|Overall Study|Withdrawal by Subject|18|||
126310596|NCT04964544|454425309|FG000|Overall Study|Death|1|||
126310597|NCT01613222|454425310|FG000|Overall Study|Physician Decision|1|||
126310598|NCT01613222|454425310|FG000|Overall Study|Unable to place arterial line|1|||
126310599|NCT01613222|454425310|FG000|Overall Study|Reused disposable sensors|10|||
126310600|NCT04323306|454425311|FG000|Overall Study|Physician Decision|1|||
126310601|NCT04323306|454425312|FG001|Overall Study|Physician Decision|0|||
126310602|NCT04323306|454425313|FG002|Overall Study|Physician Decision|0|||
126310603|NCT04323306|454425314|FG003|Overall Study|Physician Decision|0|||
126310604|NCT04323306|454425315|FG004|Overall Study|Physician Decision|0|||
126310605|NCT04323306|454425316|FG005|Overall Study|Physician Decision|0|||
126310606|NCT04323306|454425317|FG006|Overall Study|Physician Decision|0|||
126310607|NCT04323306|454425318|FG007|Overall Study|Physician Decision|0|||
126310608|NCT04323306|454425319|FG008|Overall Study|Physician Decision|0|||
126310609|NCT04323306|454425311|FG000|Overall Study|Withdrawal by Subject|0|||
126310610|NCT04323306|454425312|FG001|Overall Study|Withdrawal by Subject|0|||
126310611|NCT04323306|454425313|FG002|Overall Study|Withdrawal by Subject|0|||
126310612|NCT04323306|454425314|FG003|Overall Study|Withdrawal by Subject|0|||
126310613|NCT04323306|454425315|FG004|Overall Study|Withdrawal by Subject|0|||
126310614|NCT04323306|454425316|FG005|Overall Study|Withdrawal by Subject|1|||
126310615|NCT04323306|454425317|FG006|Overall Study|Withdrawal by Subject|3|||
126310616|NCT04323306|454425318|FG007|Overall Study|Withdrawal by Subject|0|||
126310617|NCT04323306|454425319|FG008|Overall Study|Withdrawal by Subject|1|||
126310618|NCT00089778|454425320|FG000|Overall Study|Protocol Violation|0|||
126310619|NCT00089778|454425321|FG001|Overall Study|Protocol Violation|0|||
126310620|NCT00089778|454425322|FG002|Overall Study|Protocol Violation|1|||
126310621|NCT01154088|454425323|FG000|Overall Study|Lost to Follow-up|4|||
126310622|NCT01154088|454425324|FG001|Overall Study|Lost to Follow-up|6|||
126310623|NCT01154088|454425325|FG002|Overall Study|Lost to Follow-up|7|||
126310624|NCT00750139|454425329|FG000|Overall Study|Adverse Event|1|||
126310625|NCT00750139|454425330|FG001|Overall Study|Adverse Event|2|||
126310626|NCT00750139|454425331|FG002|Overall Study|Adverse Event|0|||
126310627|NCT00750139|454425332|FG003|Overall Study|Adverse Event|1|||
126310628|NCT00750139|454425329|FG000|Overall Study|Lost to Follow-up|17|||
126310629|NCT00750139|454425330|FG001|Overall Study|Lost to Follow-up|12|||
126310630|NCT00750139|454425331|FG002|Overall Study|Lost to Follow-up|15|||
126310631|NCT00750139|454425332|FG003|Overall Study|Lost to Follow-up|6|||
126466463|NCT02301988|455008964|FG001|Overall Study|Adverse Event|1|||
126466464|NCT02750943|455008965|FG000|Overall Study|Lost to Follow-up|1|||
126466465|NCT02750943|455008966|FG001|Overall Study|Lost to Follow-up|2|||
126466466|NCT02750943|455008965|FG000|Overall Study|Withdrawal by Subject|5|||
126310632|NCT00750139|454425329|FG000|Overall Study|Withdrawal by Subject|3|||
126310633|NCT00750139|454425330|FG001|Overall Study|Withdrawal by Subject|2|||
126466467|NCT02750943|455008966|FG001|Overall Study|Withdrawal by Subject|7|||
126466468|NCT00171054|455008967|FG000|Overall Study|Protocol Violation|1|||
126374047|NCT03012334|454666873|FG001|Period 4|Adverse Event|0|||
126374048|NCT03012334|454666874|FG002|Period 4|Adverse Event|0|||
126374049|NCT03012334|454666875|FG003|Period 4|Adverse Event|0|||
126374050|NCT03012334|454666876|FG004|Period 4|Adverse Event|0|||
126374051|NCT03012334|454666877|FG005|Period 4|Adverse Event|0|||
126374052|NCT03012334|454666878|FG006|Period 4|Adverse Event|0|||
126374053|NCT03012334|454666879|FG007|Period 4|Adverse Event|0|||
126374054|NCT03012334|454666880|FG008|Period 4|Adverse Event|1|||
126374055|NCT03012334|454666881|FG009|Period 4|Adverse Event|0|||
126374056|NCT01870869|454666882|FG000|Overall Study|Implanted with nonstudy device|1|||
126374057|NCT01870869|454666883|FG001|Overall Study|Implanted with nonstudy device|3|||
126374058|NCT01870869|454666884|FG002|Overall Study|Implanted with nonstudy device|14|||
126374059|NCT01870869|454666885|FG003|Overall Study|Implanted with nonstudy device|4|||
126374060|NCT01870869|454666882|FG000|Overall Study|Death|0|||
126374061|NCT01870869|454666883|FG001|Overall Study|Death|0|||
126374062|NCT01870869|454666884|FG002|Overall Study|Death|7|||
126374063|NCT01870869|454666885|FG003|Overall Study|Death|1|||
126374064|NCT01870869|454666882|FG000|Overall Study|Subject choice|6|||
126374065|NCT01870869|454666883|FG001|Overall Study|Subject choice|2|||
126374066|NCT01870869|454666884|FG002|Overall Study|Subject choice|22|||
126374067|NCT01870869|454666885|FG003|Overall Study|Subject choice|8|||
126374068|NCT01870869|454666882|FG000|Overall Study|Lost to Follow-up|10|||
126374069|NCT01870869|454666883|FG001|Overall Study|Lost to Follow-up|2|||
126374070|NCT01870869|454666884|FG002|Overall Study|Lost to Follow-up|25|||
126374071|NCT01870869|454666885|FG003|Overall Study|Lost to Follow-up|3|||
126374072|NCT01870869|454666882|FG000|Overall Study|Reason not Specified|1|||
126374073|NCT01870869|454666883|FG001|Overall Study|Reason not Specified|2|||
126374074|NCT01870869|454666884|FG002|Overall Study|Reason not Specified|20|||
126374075|NCT01870869|454666885|FG003|Overall Study|Reason not Specified|4|||
126374076|NCT01870869|454666882|FG000|Overall Study|Not evaluable|10|||
126374077|NCT01870869|454666883|FG001|Overall Study|Not evaluable|5|||
126374078|NCT01870869|454666884|FG002|Overall Study|Not evaluable|42|||
126374079|NCT01870869|454666885|FG003|Overall Study|Not evaluable|10|||
126374080|NCT02286895|454666886|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
126374081|NCT02286895|454666887|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
126374082|NCT02286895|454666886|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
126374083|NCT02286895|454666887|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
126374084|NCT02286895|454666886|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
126374085|NCT02286895|454666887|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
126374086|NCT01073293|454666888|FG000|Overall Study|Lost to Follow-up|0|||
126374087|NCT01073293|454666889|FG001|Overall Study|Lost to Follow-up|1|||
126374088|NCT01073293|454666888|FG000|Overall Study|Withdrawal by Subject|5|||
126374089|NCT01073293|454666889|FG001|Overall Study|Withdrawal by Subject|10|||
126374090|NCT03036852|454666890|FG000|Overall Study|Death|2|||
126374091|NCT03036852|454666890|FG000|Overall Study|Lack of Efficacy|2|||
126374092|NCT03036852|454666890|FG000|Overall Study|Adverse Event|1|||
126374093|NCT03036852|454666890|FG000|Overall Study|Lost to Follow-up|1|||
126374094|NCT00002766|454666893|FG000|Overall Study|Withdrawal by Subject|0|||
126374095|NCT00002766|454666894|FG001|Overall Study|Withdrawal by Subject|1|||
126374096|NCT00002766|454666893|FG000|Overall Study|Patient Not Treated|1|||
126374097|NCT00002766|454666894|FG001|Overall Study|Patient Not Treated|2|||
126374098|NCT00002766|454666893|FG000|Overall Study|Adverse Event|1|||
126374099|NCT00002766|454666894|FG001|Overall Study|Adverse Event|1|||
126374100|NCT00002766|454666893|FG000|Overall Study|Protocol Violation|1|||
126374101|NCT00002766|454666894|FG001|Overall Study|Protocol Violation|0|||
126374102|NCT00077974|454666897|FG000|Overall Study|Adverse Event|22|||
126374103|NCT00077974|454666897|FG000|Overall Study|Protocol Violation|1|||
126374104|NCT00077974|454666897|FG000|Overall Study|Withdrawal by Subject|3|||
126374105|NCT00077974|454666897|FG000|Overall Study|Lack of Efficacy|76|||
126374106|NCT00077974|454666897|FG000|Overall Study|Decision of Sponsor|2|||
126374107|NCT00256126|454666898|FG000|Overall Study|Adverse Event|1|||
126374108|NCT00256126|454666899|FG001|Overall Study|Adverse Event|0|||
126374109|NCT00256126|454666898|FG000|Overall Study|Other|1|||
126374110|NCT00256126|454666899|FG001|Overall Study|Other|2|||
126374111|NCT02949011|454666908|FG000|Overall Study|Adverse Event|6|||
126374112|NCT02949011|454666909|FG001|Overall Study|Adverse Event|7|||
126374113|NCT02949011|454666910|FG002|Overall Study|Adverse Event|3|||
126374114|NCT02949011|454666908|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
126374115|NCT02949011|454666909|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
126466469|NCT00171054|455008968|FG001|Overall Study|Protocol Violation|2|||
126466470|NCT00171054|455008967|FG000|Overall Study|Patient withdrew consent|1|||
126374116|NCT02949011|454666910|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
126374117|NCT02949011|454666908|FG000|Overall Study|Protocol Deviation|5|||
126374118|NCT02949011|454666909|FG001|Overall Study|Protocol Deviation|3|||
126374119|NCT02949011|454666910|FG002|Overall Study|Protocol Deviation|3|||
126374120|NCT02949011|454666908|FG000|Overall Study|Lack of Efficacy|0|||
126374121|NCT02949011|454666909|FG001|Overall Study|Lack of Efficacy|2|||
126374122|NCT02949011|454666910|FG002|Overall Study|Lack of Efficacy|0|||
126374123|NCT02949011|454666908|FG000|Overall Study|Withdrawal by Subject|13|||
126374124|NCT02949011|454666909|FG001|Overall Study|Withdrawal by Subject|13|||
126374125|NCT02949011|454666910|FG002|Overall Study|Withdrawal by Subject|21|||
126374126|NCT02949011|454666908|FG000|Overall Study|Lost to Follow-up|7|||
126374127|NCT02949011|454666909|FG001|Overall Study|Lost to Follow-up|5|||
126374128|NCT02949011|454666910|FG002|Overall Study|Lost to Follow-up|5|||
126374129|NCT02949011|454666908|FG000|Overall Study|Death|0|||
126374130|NCT02949011|454666909|FG001|Overall Study|Death|0|||
126374131|NCT02949011|454666910|FG002|Overall Study|Death|1|||
126374132|NCT02949011|454666908|FG000|Overall Study|Miscellaneous|2|||
126374133|NCT02949011|454666909|FG001|Overall Study|Miscellaneous|4|||
126374134|NCT02949011|454666910|FG002|Overall Study|Miscellaneous|6|||
126374135|NCT00163189|454666911|FG000|Overall Study|Other|6|||
126374136|NCT00163189|454666911|FG000|Overall Study|Lost to Follow-up|1|||
126374137|NCT00163189|454666911|FG000|Overall Study|Protocol Violation|2|||
126374138|NCT00163189|454666911|FG000|Overall Study|Death|3|||
126466471|NCT00171054|455008968|FG001|Overall Study|Patient withdrew consent|0|||
126466472|NCT00171054|455008967|FG000|Overall Study|Lost to Follow-up|0|||
126466473|NCT00171054|455008968|FG001|Overall Study|Lost to Follow-up|1|||
126466474|NCT00171054|455008967|FG000|Overall Study|Adverse Event|8|||
126466475|NCT00171054|455008968|FG001|Overall Study|Adverse Event|8|||
126466476|NCT00171054|455008967|FG000|Overall Study|Condition no longer required study drug|0|||
126466477|NCT00171054|455008968|FG001|Overall Study|Condition no longer required study drug|1|||
126466478|NCT04669535|455008972|FG000|Overall Study|Death|1|||
126466479|NCT04669535|455008973|FG001|Overall Study|Death|1|||
126466480|NCT04669535|455008974|FG002|Overall Study|Death|0|||
126466481|NCT04669535|455008975|FG003|Overall Study|Death|0|||
126466482|NCT02452697|455008976|FG000|Overall Study|Physician Decision|4|||
126466483|NCT02452697|455008977|FG001|Overall Study|Physician Decision|4|||
126466484|NCT02452697|455008978|FG002|Overall Study|Physician Decision|3|||
126466485|NCT02452697|455008979|FG003|Overall Study|Physician Decision|2|||
126466486|NCT02452697|455008976|FG000|Overall Study|Withdrawal by Subject|1|||
126466487|NCT02452697|455008977|FG001|Overall Study|Withdrawal by Subject|0|||
126466488|NCT02452697|455008978|FG002|Overall Study|Withdrawal by Subject|0|||
126466489|NCT02452697|455008979|FG003|Overall Study|Withdrawal by Subject|0|||
126466490|NCT02452697|455008976|FG000|Overall Study|still in follow-up|2|||
126466491|NCT02452697|455008977|FG001|Overall Study|still in follow-up|2|||
126466492|NCT02452697|455008978|FG002|Overall Study|still in follow-up|1|||
126466493|NCT02452697|455008979|FG003|Overall Study|still in follow-up|3|||
126466494|NCT03552965|455008981|FG000|Overall Study|Death|1|||
126466495|NCT03552965|455008982|FG001|Overall Study|Death|1|||
126552908|NCT02291289|455320502|FG001|Induction Treatment|Withdrawal by Subject|0|||
126552909|NCT02291289|455320503|FG002|Induction Treatment|Withdrawal by Subject|0|||
126310634|NCT00750139|454425331|FG002|Overall Study|Withdrawal by Subject|6|||
126310635|NCT00750139|454425332|FG003|Overall Study|Withdrawal by Subject|2|||
126310636|NCT00750139|454425329|FG000|Overall Study|Physician Decision|1|||
126310637|NCT00750139|454425330|FG001|Overall Study|Physician Decision|1|||
126310638|NCT00750139|454425331|FG002|Overall Study|Physician Decision|0|||
126310639|NCT00750139|454425332|FG003|Overall Study|Physician Decision|0|||
126310640|NCT00750139|454425329|FG000|Overall Study|Non-compliance|1|||
126310641|NCT00750139|454425330|FG001|Overall Study|Non-compliance|0|||
126310642|NCT00750139|454425331|FG002|Overall Study|Non-compliance|1|||
126310643|NCT00750139|454425332|FG003|Overall Study|Non-compliance|3|||
126310644|NCT00750139|454425329|FG000|Overall Study|Termination by sponsor|4|||
126310645|NCT00750139|454425330|FG001|Overall Study|Termination by sponsor|0|||
126310646|NCT00750139|454425331|FG002|Overall Study|Termination by sponsor|0|||
126310647|NCT00750139|454425332|FG003|Overall Study|Termination by sponsor|1|||
126310648|NCT00750139|454425329|FG000|Overall Study|Non-specific|62|||
126310649|NCT00750139|454425330|FG001|Overall Study|Non-specific|42|||
126310650|NCT00750139|454425331|FG002|Overall Study|Non-specific|79|||
126310651|NCT00750139|454425332|FG003|Overall Study|Non-specific|33|||
126310652|NCT02537431|454425333|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
126310653|NCT03395184|454425341|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
126310654|NCT03395184|454425342|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
126310655|NCT03395184|454425343|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
126466496|NCT03552965|455008981|FG000|Overall Study|Lost to Follow-up|1|||
126466497|NCT03552965|455008982|FG001|Overall Study|Lost to Follow-up|1|||
126466498|NCT03552965|455008981|FG000|Overall Study|Physician Decision|1|||
126466499|NCT03552965|455008982|FG001|Overall Study|Physician Decision|1|||
126552910|NCT02291289|455320504|FG003|Induction Treatment|Withdrawal by Subject|24|||
126552911|NCT02291289|455320505|FG004|Induction Treatment|Withdrawal by Subject|0|||
126310656|NCT03395184|454425344|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
126310657|NCT03395184|454425345|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
126310658|NCT03395184|454425346|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
126310659|NCT03395184|454425347|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
126374139|NCT00163189|454666911|FG000|Overall Study|Adverse Event|6|||
126374140|NCT00163189|454666911|FG000|Overall Study|Lack of Efficacy|7|||
126374141|NCT00163189|454666911|FG000|Overall Study|Study terminated by sponsor|11|||
126374142|NCT00163189|454666911|FG000|Overall Study|Withdrawal by Subject|11|||
126466500|NCT03552965|455008981|FG000|Overall Study|Withdrawal by Subject|0|||
126466501|NCT03552965|455008982|FG001|Overall Study|Withdrawal by Subject|2|||
126466502|NCT03552965|455008981|FG000|Overall Study|Continuation not in patient best interest|1|||
126466503|NCT03552965|455008982|FG001|Overall Study|Continuation not in patient best interest|0|||
126466504|NCT03552965|455008981|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
126466505|NCT03552965|455008982|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
126466506|NCT02477696|455008983|FG000|Overall Study|Death|89|||
126466507|NCT02477696|455008984|FG001|Overall Study|Death|106|||
126466508|NCT02477696|455008983|FG000|Overall Study|Lost to Follow-up|7|||
126466509|NCT02477696|455008984|FG001|Overall Study|Lost to Follow-up|5|||
126466510|NCT02477696|455008983|FG000|Overall Study|Withdrawal by Subject|37|||
126466511|NCT02477696|455008984|FG001|Overall Study|Withdrawal by Subject|34|||
126716698|NCT01781429|455914916|FG006|Overall Study|Death|0|||
126716699|NCT01781429|455914917|FG007|Overall Study|Death|0|||
126716700|NCT01781429|455914918|FG008|Overall Study|Death|0|||
126310660|NCT03395184|454425341|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
126310661|NCT03395184|454425342|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
126310662|NCT03395184|454425343|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
126310663|NCT03395184|454425344|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
126310664|NCT03395184|454425345|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
126310665|NCT03395184|454425346|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
126310666|NCT03395184|454425347|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
126310667|NCT03395184|454425341|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
126310668|NCT03395184|454425342|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
126310669|NCT03395184|454425343|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
126310670|NCT03395184|454425344|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
126310671|NCT03395184|454425345|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
126310672|NCT03395184|454425346|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
126310673|NCT03395184|454425347|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
126310674|NCT03395184|454425341|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
126310675|NCT03395184|454425342|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
126310676|NCT03395184|454425343|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
126310677|NCT03395184|454425344|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
126310678|NCT03395184|454425345|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
126310679|NCT03395184|454425346|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
126310680|NCT03395184|454425347|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
126310681|NCT03395184|454425341|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
126310682|NCT03395184|454425342|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126310683|NCT03395184|454425343|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
126310684|NCT03395184|454425344|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126310685|NCT03395184|454425345|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126310686|NCT03395184|454425346|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126310687|NCT03395184|454425347|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126310688|NCT03395184|454425341|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
126310689|NCT03395184|454425342|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
126310690|NCT03395184|454425343|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
126310691|NCT03395184|454425344|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
126310692|NCT03395184|454425345|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
126310693|NCT03395184|454425346|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
126310694|NCT03395184|454425347|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
126310695|NCT03395184|454425341|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
126310696|NCT03395184|454425342|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
126310697|NCT03395184|454425343|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
126310698|NCT03395184|454425344|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
126310699|NCT03395184|454425345|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
126310700|NCT03395184|454425346|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
126310701|NCT03395184|454425347|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
126310702|NCT03395184|454425341|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
126310703|NCT03395184|454425342|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
126716701|NCT01781429|455914919|FG009|Overall Study|Death|1|||
126716702|NCT01781429|455914920|FG010|Overall Study|Death|0|||
126716703|NCT01781429|455914921|FG011|Overall Study|Death|0|||
126716704|NCT01781429|455914922|FG012|Overall Study|Death|1|||
126310704|NCT03395184|454425343|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
126310705|NCT03395184|454425344|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
126310706|NCT03395184|454425345|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
126466512|NCT02477696|455008983|FG000|Overall Study|Physician Decision|7|||
126466513|NCT02477696|455008984|FG001|Overall Study|Physician Decision|9|||
126466514|NCT02477696|455008983|FG000|Overall Study|Study terminated by sponsor|103|||
126466515|NCT02477696|455008984|FG001|Overall Study|Study terminated by sponsor|99|||
126716705|NCT01781429|455914923|FG013|Overall Study|Death|0|||
126716706|NCT01781429|455914924|FG014|Overall Study|Death|1|||
126716707|NCT01781429|455914925|FG015|Overall Study|Death|0|||
126466516|NCT02477696|455008983|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
126310707|NCT03395184|454425346|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
126310708|NCT03395184|454425347|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
126310709|NCT03395184|454425341|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
126310710|NCT03395184|454425342|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
126466517|NCT02477696|455008984|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
126466518|NCT02477696|455008983|FG000|Overall Study|Missing/Unknown|2|||
126466519|NCT02477696|455008984|FG001|Overall Study|Missing/Unknown|0|||
126466520|NCT05419908|455008986|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
126466521|NCT05419908|455008987|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
126466522|NCT05419908|455008986|FG000|Overall Study|Serious Adverse Event|0|||
126466523|NCT05419908|455008987|FG001|Overall Study|Serious Adverse Event|2|||
126466524|NCT05419908|455008986|FG000|Overall Study|Withdrawal by Subject|2|||
126466525|NCT05419908|455008987|FG001|Overall Study|Withdrawal by Subject|0|||
126466526|NCT05419908|455008986|FG000|Overall Study|Miscellaneous|1|||
126466527|NCT05419908|455008987|FG001|Overall Study|Miscellaneous|1|||
126466528|NCT05098938|455008991|FG000|Overall Study|Adverse Event|4|||
126466529|NCT05098938|455008992|FG001|Overall Study|Adverse Event|3|||
126466530|NCT05098938|455008991|FG000|Overall Study|inclusion/exclusion criteria change|11|||
126466531|NCT05098938|455008992|FG001|Overall Study|inclusion/exclusion criteria change|5|||
126466532|NCT05098938|455008991|FG000|Overall Study|lack of compliance|26|||
126466533|NCT05098938|455008992|FG001|Overall Study|lack of compliance|19|||
126466534|NCT05098938|455008991|FG000|Overall Study|Lost to Follow-up|37|||
126466535|NCT05098938|455008992|FG001|Overall Study|Lost to Follow-up|40|||
126466536|NCT05098938|455008991|FG000|Overall Study|Lost in treatment period|17|||
126466537|NCT05098938|455008992|FG001|Overall Study|Lost in treatment period|13|||
126466538|NCT05098938|455008991|FG000|Overall Study|Met an exclusion criterion|0|||
126466539|NCT05098938|455008992|FG001|Overall Study|Met an exclusion criterion|3|||
126466540|NCT05098938|455008991|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
126466541|NCT05098938|455008992|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
126466542|NCT05098938|455008991|FG000|Overall Study|Physician Decision|25|||
126466543|NCT05098938|455008992|FG001|Overall Study|Physician Decision|32|||
126466544|NCT05098938|455008991|FG000|Overall Study|Run in failure in treatment phase|1|||
126466545|NCT05098938|455008992|FG001|Overall Study|Run in failure in treatment phase|1|||
126466546|NCT05098938|455008991|FG000|Overall Study|Withdrawal by Subject|0|||
126466547|NCT05098938|455008992|FG001|Overall Study|Withdrawal by Subject|3|||
126466548|NCT05098938|455008991|FG000|Overall Study|Run-in Failure in early study|505|||
126466549|NCT05098938|455008992|FG001|Overall Study|Run-in Failure in early study|514|||
126466550|NCT05098938|455008991|FG000|Overall Study|IMP delivery missed|1|||
126552912|NCT02291289|455320506|FG005|Induction Treatment|Withdrawal by Subject|0|||
126552913|NCT02291289|455320507|FG006|Induction Treatment|Withdrawal by Subject|0|||
126552914|NCT02291289|455320508|FG007|Induction Treatment|Withdrawal by Subject|0|||
126552915|NCT02291289|455320509|FG008|Induction Treatment|Withdrawal by Subject|0|||
126310711|NCT03395184|454425343|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
126310712|NCT03395184|454425344|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
126310713|NCT03395184|454425345|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
126310714|NCT03395184|454425346|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
126310715|NCT03395184|454425347|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
126310716|NCT03395184|454425341|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
126310717|NCT03395184|454425342|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
126310718|NCT03395184|454425343|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
126310719|NCT03395184|454425344|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
126310720|NCT03395184|454425345|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
126310721|NCT03395184|454425346|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
126310722|NCT03395184|454425347|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
126310723|NCT03395184|454425341|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
126310724|NCT03395184|454425342|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
126310725|NCT03395184|454425343|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
126310726|NCT03395184|454425344|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
126466551|NCT05098938|455008992|FG001|Overall Study|IMP delivery missed|5|||
126466552|NCT05098938|455008991|FG000|Overall Study|6 months visit was missed|2|||
126466553|NCT05098938|455008992|FG001|Overall Study|6 months visit was missed|0|||
126466554|NCT05098938|455008991|FG000|Overall Study|fit for use was not completed within window|3|||
126552916|NCT02291289|455320510|FG009|Induction Treatment|Withdrawal by Subject|18|||
126310727|NCT03395184|454425345|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
126466555|NCT05098938|455008992|FG001|Overall Study|fit for use was not completed within window|0|||
126466556|NCT05098938|455008991|FG000|Overall Study|V2 visit was not completed within window|0|||
126466557|NCT05098938|455008992|FG001|Overall Study|V2 visit was not completed within window|1|||
126466558|NCT05098938|455008991|FG000|Overall Study|exclusionary medication use|1|||
126552917|NCT02291289|455320511|FG010|Induction Treatment|Withdrawal by Subject|0|||
126552918|NCT02291289|455320512|FG011|Induction Treatment|Withdrawal by Subject|0|||
126771037|NCT00422058|456116233|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
126310728|NCT03395184|454425346|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
126310729|NCT03395184|454425347|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
126310730|NCT03395184|454425341|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
126310731|NCT03395184|454425342|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
126310732|NCT03395184|454425343|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
126310733|NCT03395184|454425344|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
126310734|NCT03395184|454425345|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
126310735|NCT03395184|454425346|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
126310736|NCT03395184|454425347|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
126310737|NCT01741792|454427443|FG000|Overall Study|Death|6|||
126466559|NCT05098938|455008992|FG001|Overall Study|exclusionary medication use|2|||
126310738|NCT01741792|454427444|FG001|Overall Study|Death|1|||
126310739|NCT01741792|454427445|FG002|Overall Study|Death|12|||
126310740|NCT03696108|454427446|FG000|Overall Study|Physician Decision|1|||
126310741|NCT03696108|454427447|FG001|Overall Study|Physician Decision|0|||
126310742|NCT03696108|454427446|FG000|Overall Study|Withdrawal by Subject|3|||
126310743|NCT03696108|454427447|FG001|Overall Study|Withdrawal by Subject|6|||
126310744|NCT02833844|454427451|FG000|Double-Blind Period|Withdrawal by Subject|2|||
126310745|NCT02833844|454427452|FG001|Double-Blind Period|Withdrawal by Subject|3|||
126310746|NCT02833844|454427451|FG000|Double-Blind Period|Protocol Violation|0|||
126310747|NCT02833844|454427452|FG001|Double-Blind Period|Protocol Violation|4|||
126310748|NCT02833844|454427451|FG000|Open-Label Period|Death|0|||
126310749|NCT02833844|454427452|FG001|Open-Label Period|Death|2|||
126310750|NCT02833844|454427451|FG000|Open-Label Period|Lost to Follow-up|1|||
126310751|NCT02833844|454427452|FG001|Open-Label Period|Lost to Follow-up|0|||
126310752|NCT02833844|454427451|FG000|Open-Label Period|Withdrawal by Subject|1|||
126310753|NCT02833844|454427452|FG001|Open-Label Period|Withdrawal by Subject|0|||
126310754|NCT01899742|454427453|FG000|Overall Study|Adverse Event|5|||
126310755|NCT01899742|454427454|FG001|Overall Study|Adverse Event|4|||
126310756|NCT01899742|454427453|FG000|Overall Study|Lack of Efficacy|1|||
126310757|NCT01899742|454427454|FG001|Overall Study|Lack of Efficacy|5|||
126310758|NCT01899742|454427453|FG000|Overall Study|Protocol Violation|2|||
126310759|NCT01899742|454427454|FG001|Overall Study|Protocol Violation|2|||
126310760|NCT01899742|454427453|FG000|Overall Study|Withdrawal by Subject|9|||
126310761|NCT01899742|454427454|FG001|Overall Study|Withdrawal by Subject|5|||
126310762|NCT02662764|454427455|FG000|Overall Study|Adverse Event|6|||
126310763|NCT02662764|454427455|FG000|Overall Study|Lack of Efficacy|8|||
126310764|NCT02662764|454427455|FG000|Overall Study|Protocol Violation|1|||
126310765|NCT02662764|454427455|FG000|Overall Study|Withdrawal by Subject|5|||
126310766|NCT02662764|454427455|FG000|Overall Study|Device failure|4|||
126310767|NCT02662764|454427455|FG000|Overall Study|Patient changed treatment|1|||
126310768|NCT02662764|454427455|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
126310769|NCT05129137|454427458|FG000|Second Period|Adverse Event|1|||
126310770|NCT05129137|454427459|FG001|Second Period|Adverse Event|0|||
126310771|NCT05129137|454427460|FG002|Second Period|Adverse Event|0|||
126310772|NCT05129137|454427461|FG003|Second Period|Adverse Event|0|||
126310773|NCT05129137|454427458|FG000|Second Period|Protocol Violation|0|||
126310774|NCT05129137|454427459|FG001|Second Period|Protocol Violation|0|||
126310775|NCT05129137|454427460|FG002|Second Period|Protocol Violation|0|||
126310776|NCT05129137|454427461|FG003|Second Period|Protocol Violation|1|||
126310777|NCT05129137|454427458|FG000|Third Period|Protocol Violation|0|||
126310778|NCT05129137|454427459|FG001|Third Period|Protocol Violation|0|||
126310779|NCT05129137|454427460|FG002|Third Period|Protocol Violation|0|||
126310780|NCT05129137|454427461|FG003|Third Period|Protocol Violation|1|||
126310781|NCT05129137|454427458|FG000|Forth Period|Protocol Violation|0|||
126310782|NCT05129137|454427459|FG001|Forth Period|Protocol Violation|1|||
126310783|NCT05129137|454427460|FG002|Forth Period|Protocol Violation|0|||
126310784|NCT05129137|454427461|FG003|Forth Period|Protocol Violation|0|||
126310785|NCT05129137|454427458|FG000|Forth Period|Withdrawal by Subject|0|||
126310786|NCT05129137|454427459|FG001|Forth Period|Withdrawal by Subject|0|||
126310787|NCT05129137|454427460|FG002|Forth Period|Withdrawal by Subject|1|||
126310788|NCT05129137|454427461|FG003|Forth Period|Withdrawal by Subject|0|||
126310789|NCT01104246|454427462|FG000|Overall Study|Withdrawal by Subject|1|||
126310790|NCT01104246|454427462|FG000|Overall Study|did not meet inclusion criteria|4|||
126310791|NCT05178641|454427473|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
126310792|NCT05178641|454427474|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
126310793|NCT05178641|454427473|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
126310794|NCT05178641|454427474|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
126310795|NCT01869699|454427475|FG000|Overall Study|Withdrawal by Subject|1|||
126310796|NCT01869699|454427476|FG001|Overall Study|Withdrawal by Subject|0|||
126310797|NCT01475851|454427477|FG000|Overall Study|Protocol defined stopping criteria|1|||
126310798|NCT01475851|454427478|FG001|Overall Study|Protocol defined stopping criteria|0|||
126310799|NCT01867294|454427481|FG000|Overall Study|Withdrawal by Subject|1|||
126466560|NCT05098938|455008991|FG000|Overall Study|change in medication|1|||
126466561|NCT05098938|455008992|FG001|Overall Study|change in medication|0|||
126466562|NCT05098938|455008991|FG000|Overall Study|treatment failure|2|||
126466563|NCT05098938|455008992|FG001|Overall Study|treatment failure|1|||
126466564|NCT01104701|455010381|FG000|Overall Study|Withdrawal by Subject|0|||
126466565|NCT01104701|455010382|FG001|Overall Study|Withdrawal by Subject|1|||
126466566|NCT01104701|455010383|FG002|Overall Study|Withdrawal by Subject|2|||
126466567|NCT01104701|455010384|FG003|Overall Study|Withdrawal by Subject|1|||
126466568|NCT01104701|455010381|FG000|Overall Study|Adverse Event|0|||
126466569|NCT01104701|455010382|FG001|Overall Study|Adverse Event|0|||
126466570|NCT01104701|455010383|FG002|Overall Study|Adverse Event|0|||
126466571|NCT01104701|455010384|FG003|Overall Study|Adverse Event|1|||
126466572|NCT01104701|455010381|FG000|Overall Study|Physician Decision|0|||
126466573|NCT01104701|455010382|FG001|Overall Study|Physician Decision|2|||
126466574|NCT01104701|455010383|FG002|Overall Study|Physician Decision|0|||
126466575|NCT01104701|455010384|FG003|Overall Study|Physician Decision|0|||
126466576|NCT03437512|455010385|FG000|Randomized|Withdrawal by Subject|0|||
126466577|NCT03437512|455010386|FG001|Randomized|Withdrawal by Subject|2|||
126466578|NCT03437512|455010385|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
126466579|NCT03437512|455010386|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
126466580|NCT01002482|455010387|FG000|Overall Study|Withdrawal by Subject|14|||
126466581|NCT01002482|455010388|FG001|Overall Study|Withdrawal by Subject|21|||
126466582|NCT01002482|455010387|FG000|Overall Study|Included twice|1|||
126466583|NCT01002482|455010388|FG001|Overall Study|Included twice|0|||
126466584|NCT05036369|455010392|FG000|Overall Study|Run In non compliance|1|||
126466585|NCT05036369|455010393|FG001|Overall Study|Run In non compliance|2|||
126466586|NCT05036369|455010392|FG000|Overall Study|Change in eligibility criteria|0|||
126466587|NCT05036369|455010393|FG001|Overall Study|Change in eligibility criteria|1|||
126466588|NCT03906461|455010396|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
126466589|NCT03906461|455010396|FG000|Completed 12-month Follow-up|Missed Visit|6|||
126466590|NCT00510874|455010397|FG000|Overall Study|Withdrawal by Subject|1|||
126466591|NCT00510874|455010398|FG001|Overall Study|Withdrawal by Subject|1|||
126310800|NCT01867294|454427482|FG001|Overall Study|Withdrawal by Subject|1|||
126310801|NCT01867294|454427483|FG002|Overall Study|Withdrawal by Subject|0|||
126310802|NCT01867294|454427484|FG003|Overall Study|Withdrawal by Subject|0|||
126310803|NCT02447497|454427485|FG000|Overall Study|Did not meet treatment day baseline.|6|||
126310804|NCT02447497|454427486|FG001|Overall Study|Did not meet treatment day baseline.|5|||
126310805|NCT02447497|454427487|FG002|Overall Study|Did not meet treatment day baseline.|2|||
126310806|NCT02447497|454427488|FG003|Overall Study|Did not meet treatment day baseline.|2|||
126310807|NCT02447497|454427485|FG000|Overall Study|Dressing was compromised|0|||
126310808|NCT02447497|454427486|FG001|Overall Study|Dressing was compromised|1|||
126310809|NCT02447497|454427487|FG002|Overall Study|Dressing was compromised|0|||
126310810|NCT02447497|454427488|FG003|Overall Study|Dressing was compromised|0|||
126310811|NCT02017912|454427489|FG000|Overall Study|Withdrawal by Subject|2|||
126310812|NCT02017912|454427490|FG001|Overall Study|Withdrawal by Subject|1|||
126310813|NCT02017912|454427489|FG000|Overall Study|miscellaneous|1|||
126310814|NCT02017912|454427490|FG001|Overall Study|miscellaneous|1|||
126310815|NCT01322035|454427491|FG000|Overall Study|Lost to Follow-up|8|||
126310816|NCT01322035|454427492|FG001|Overall Study|Lost to Follow-up|3|||
126310817|NCT00732758|454427493|FG000|Overall Study|Lost to Follow-up|8|||
126466592|NCT00510874|455010399|FG002|Overall Study|Withdrawal by Subject|0|||
126466593|NCT00510874|455010400|FG003|Overall Study|Withdrawal by Subject|0|||
126466594|NCT00510874|455010401|FG004|Overall Study|Withdrawal by Subject|3|||
126466595|NCT00510874|455010402|FG005|Overall Study|Withdrawal by Subject|0|||
126466596|NCT00510874|455010403|FG006|Overall Study|Withdrawal by Subject|0|||
126466597|NCT00510874|455010397|FG000|Overall Study|Lost to Follow-up|2|||
126466598|NCT00510874|455010398|FG001|Overall Study|Lost to Follow-up|3|||
126466599|NCT00510874|455010399|FG002|Overall Study|Lost to Follow-up|1|||
126466600|NCT00510874|455010400|FG003|Overall Study|Lost to Follow-up|3|||
126466601|NCT00510874|455010401|FG004|Overall Study|Lost to Follow-up|4|||
126466602|NCT00510874|455010402|FG005|Overall Study|Lost to Follow-up|0|||
126466603|NCT00510874|455010403|FG006|Overall Study|Lost to Follow-up|1|||
126466604|NCT00426231|455010406|FG000|Overall Study|Withdrawal by Subject|9|||
126466605|NCT00426231|455010407|FG001|Overall Study|Withdrawal by Subject|12|||
126310818|NCT00732758|454427494|FG001|Overall Study|Lost to Follow-up|16|||
126310819|NCT04240457|454427497|FG000|Overall Study|Lost to Follow-up|5|||
126310820|NCT04240457|454427498|FG001|Overall Study|Lost to Follow-up|1|||
126310821|NCT01508130|454427502|FG000|Overall Study|Adverse Event|81|||
126466606|NCT01795638|455010408|FG000|Overall Study|Death|0|||
126466607|NCT01795638|455010409|FG001|Overall Study|Death|3|||
126466608|NCT01795638|455010408|FG000|Overall Study|transferred to quaternary hospital|2|||
126466609|NCT01795638|455010409|FG001|Overall Study|transferred to quaternary hospital|3|||
126466610|NCT01795638|455010408|FG000|Overall Study|Protocol Violation|3|||
126466611|NCT01795638|455010409|FG001|Overall Study|Protocol Violation|0|||
126466612|NCT01795638|455010408|FG000|Overall Study|discharged from hospital|7|||
126466613|NCT01795638|455010409|FG001|Overall Study|discharged from hospital|5|||
126552919|NCT02291289|455320513|FG012|Induction Treatment|Withdrawal by Subject|0|||
126552920|NCT02291289|455320501|FG000|Induction Treatment|Adverse Event|0|||
126552921|NCT02291289|455320502|FG001|Induction Treatment|Adverse Event|0|||
126552922|NCT02291289|455320503|FG002|Induction Treatment|Adverse Event|0|||
126552923|NCT02291289|455320504|FG003|Induction Treatment|Adverse Event|3|||
126552924|NCT02291289|455320505|FG004|Induction Treatment|Adverse Event|0|||
126552925|NCT02291289|455320506|FG005|Induction Treatment|Adverse Event|0|||
126716708|NCT01781429|455914910|FG000|Overall Study|Withdrawal by Subject|0|||
126310822|NCT01508130|454427503|FG001|Overall Study|Adverse Event|28|||
126310823|NCT01508130|454427502|FG000|Overall Study|Death|3|||
126310824|NCT01508130|454427503|FG001|Overall Study|Death|1|||
126310825|NCT01508130|454427502|FG000|Overall Study|Protocol Violation|2|||
126310826|NCT01508130|454427503|FG001|Overall Study|Protocol Violation|0|||
126310827|NCT01508130|454427502|FG000|Overall Study|Lost to Follow-up|25|||
126310828|NCT01508130|454427503|FG001|Overall Study|Lost to Follow-up|2|||
126310829|NCT01508130|454427502|FG000|Overall Study|Withdrawal by Subject|3|||
126310830|NCT01508130|454427503|FG001|Overall Study|Withdrawal by Subject|3|||
126310831|NCT01508130|454427502|FG000|Overall Study|Subject's substantial non-compliance|25|||
126374143|NCT00163189|454666911|FG000|Overall Study|Did not meet continuation criterion|16|||
126374144|NCT00506142|454666912|FG000|Overall Study|Adverse Event|8|||
126374145|NCT00506142|454666913|FG001|Overall Study|Adverse Event|7|||
126374146|NCT00506142|454666912|FG000|Overall Study|Lack of Efficacy|21|||
126374147|NCT00506142|454666913|FG001|Overall Study|Lack of Efficacy|7|||
126374148|NCT00506142|454666912|FG000|Overall Study|Withdrawal by Subject|4|||
126374149|NCT00506142|454666913|FG001|Overall Study|Withdrawal by Subject|5|||
126374150|NCT00506142|454666912|FG000|Overall Study|Physician Decision|1|||
126374151|NCT00506142|454666913|FG001|Overall Study|Physician Decision|0|||
126374152|NCT00506142|454666912|FG000|Overall Study|New health condition|1|||
126374153|NCT00506142|454666913|FG001|Overall Study|New health condition|0|||
126374154|NCT02154061|454666914|FG000|Overall Study|Pregnancy|1|||
126374155|NCT02154061|454666915|FG001|Overall Study|Pregnancy|0|||
126374156|NCT02154061|454666914|FG000|Overall Study|enrolled but not vaccinated|1|||
126374157|NCT02154061|454666915|FG001|Overall Study|enrolled but not vaccinated|0|||
126374158|NCT00454116|454666916|FG000|Overall Study|Adverse Event|5|||
126374159|NCT00454116|454666917|FG001|Overall Study|Adverse Event|11|||
126374160|NCT00454116|454666918|FG002|Overall Study|Adverse Event|9|||
126374161|NCT00454116|454666916|FG000|Overall Study|Condition under investigation worsened|17|||
126374162|NCT00454116|454666917|FG001|Overall Study|Condition under investigation worsened|13|||
126374163|NCT00454116|454666918|FG002|Overall Study|Condition under investigation worsened|18|||
126374164|NCT00454116|454666916|FG000|Overall Study|Withdrawal by Subject|3|||
126374165|NCT00454116|454666917|FG001|Overall Study|Withdrawal by Subject|3|||
126374166|NCT00454116|454666918|FG002|Overall Study|Withdrawal by Subject|1|||
126374167|NCT00454116|454666916|FG000|Overall Study|Other|2|||
126374168|NCT00454116|454666917|FG001|Overall Study|Other|2|||
126374169|NCT00454116|454666918|FG002|Overall Study|Other|0|||
126374170|NCT01917318|454666921|FG000|First Treatment|Withdrawal by Subject|0|||
126374171|NCT01917318|454666922|FG001|First Treatment|Withdrawal by Subject|1|||
126374172|NCT00742625|454666923|FG000|Remission Induction|Progression|6|||
126374173|NCT00742625|454666923|FG000|Remission Induction|Failed induction|8|||
126374174|NCT00742625|454666923|FG000|Remission Induction|Adverse Event|3|||
126374175|NCT00742625|454666923|FG000|Remission Induction|Death|10|||
126374176|NCT00742625|454666923|FG000|Remission Induction|Refusal|5|||
126374177|NCT00742625|454666923|FG000|Remission Induction|Non protocol treatment|17|||
126374178|NCT00742625|454666923|FG000|Remission Induction|Other, not specified|5|||
126374179|NCT00742625|454666923|FG000|Consolidation|Progression|5|||
126374180|NCT00742625|454666923|FG000|Consolidation|Adverse Event|1|||
126374181|NCT00742625|454666923|FG000|Consolidation|Death|1|||
126374182|NCT00742625|454666923|FG000|Consolidation|Refused|1|||
126374183|NCT00742625|454666923|FG000|Consolidation|Non protocol therapy|13|||
126374184|NCT03338400|454666924|FG000|Overall Study|Lost to Follow-up|1|||
126374185|NCT03338400|454666925|FG001|Overall Study|Lost to Follow-up|2|||
126374186|NCT01865487|454666928|FG000|Overall Study|Lost to Follow-up|0|||
126374187|NCT01865487|454666929|FG001|Overall Study|Lost to Follow-up|0|||
126716709|NCT01781429|455914911|FG001|Overall Study|Withdrawal by Subject|0|||
126716710|NCT01781429|455914912|FG002|Overall Study|Withdrawal by Subject|0|||
126716711|NCT01781429|455914913|FG003|Overall Study|Withdrawal by Subject|0|||
126374188|NCT01865487|454666930|FG002|Overall Study|Lost to Follow-up|0|||
126374189|NCT01865487|454666931|FG003|Overall Study|Lost to Follow-up|1|||
126374190|NCT01865487|454666932|FG004|Overall Study|Lost to Follow-up|0|||
126374191|NCT01865487|454666933|FG005|Overall Study|Lost to Follow-up|0|||
126374192|NCT01865487|454666934|FG006|Overall Study|Lost to Follow-up|1|||
126374193|NCT01865487|454666935|FG007|Overall Study|Lost to Follow-up|0|||
126374194|NCT01865487|454666936|FG008|Overall Study|Lost to Follow-up|0|||
126374195|NCT01865487|454666937|FG009|Overall Study|Lost to Follow-up|0|||
126374196|NCT01865487|454666928|FG000|Overall Study|Withdrawal by Subject|0|||
126374197|NCT01865487|454666929|FG001|Overall Study|Withdrawal by Subject|0|||
126374198|NCT01865487|454666930|FG002|Overall Study|Withdrawal by Subject|0|||
126374199|NCT01865487|454666931|FG003|Overall Study|Withdrawal by Subject|0|||
126716712|NCT01781429|455914914|FG004|Overall Study|Withdrawal by Subject|0|||
126374200|NCT01865487|454666932|FG004|Overall Study|Withdrawal by Subject|1|||
126374201|NCT01865487|454666933|FG005|Overall Study|Withdrawal by Subject|0|||
126374202|NCT01865487|454666934|FG006|Overall Study|Withdrawal by Subject|0|||
126374203|NCT01865487|454666935|FG007|Overall Study|Withdrawal by Subject|0|||
126374204|NCT01865487|454666936|FG008|Overall Study|Withdrawal by Subject|0|||
126374205|NCT01865487|454666937|FG009|Overall Study|Withdrawal by Subject|0|||
126374206|NCT01213082|454666941|FG000|Overall Study|Lost to Follow-up|6|||
126374207|NCT01213082|454666942|FG001|Overall Study|Lost to Follow-up|7|||
126374208|NCT01213082|454666943|FG002|Overall Study|Lost to Follow-up|4|||
126374209|NCT01213082|454666941|FG000|Overall Study|Physician Decision|0|||
126374210|NCT01213082|454666942|FG001|Overall Study|Physician Decision|0|||
126374211|NCT01213082|454666943|FG002|Overall Study|Physician Decision|1|||
126374212|NCT03848416|454666946|FG000|Overall Study|Withdrawal by Subject|1|||
126374213|NCT03848416|454666947|FG001|Overall Study|Withdrawal by Subject|0|||
126374214|NCT03848416|454666948|FG002|Overall Study|Withdrawal by Subject|0|||
126374215|NCT03848416|454666946|FG000|Overall Study|Death|0|||
126374216|NCT03848416|454666947|FG001|Overall Study|Death|0|||
126374217|NCT03848416|454666948|FG002|Overall Study|Death|1|||
126374218|NCT01908140|454666949|FG000|Overall Study|Other or Progressive Disease|5|||
126374219|NCT01908140|454666950|FG001|Overall Study|Other or Progressive Disease|12|||
126374220|NCT01908140|454666949|FG000|Overall Study|Lack of Efficacy|7|||
126374221|NCT01908140|454666950|FG001|Overall Study|Lack of Efficacy|5|||
126374222|NCT01908140|454666949|FG000|Overall Study|Withdrawal by Subject|23|||
126374223|NCT01908140|454666950|FG001|Overall Study|Withdrawal by Subject|24|||
126374224|NCT01908140|454666949|FG000|Overall Study|Lost to Follow-up|1|||
126374225|NCT01908140|454666950|FG001|Overall Study|Lost to Follow-up|6|||
126374226|NCT01908140|454666949|FG000|Overall Study|Protocol Violation|8|||
126374227|NCT01908140|454666950|FG001|Overall Study|Protocol Violation|9|||
126374228|NCT01908140|454666949|FG000|Overall Study|Adverse Event|22|||
126374229|NCT01908140|454666950|FG001|Overall Study|Adverse Event|23|||
126374230|NCT02639390|454666951|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
126374231|NCT02639390|454666952|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
126374232|NCT01436110|454666953|FG000|Overall Study|Lack of Efficacy|23|||
126374233|NCT01436110|454666954|FG001|Overall Study|Lack of Efficacy|14|||
126374234|NCT01436110|454666955|FG002|Overall Study|Lack of Efficacy|9|||
126374235|NCT01436110|454666953|FG000|Overall Study|Withdrawal by Subject|6|||
126374236|NCT01436110|454666954|FG001|Overall Study|Withdrawal by Subject|8|||
126374237|NCT01436110|454666955|FG002|Overall Study|Withdrawal by Subject|4|||
126374238|NCT01436110|454666953|FG000|Overall Study|Adverse Event|2|||
126374239|NCT01436110|454666954|FG001|Overall Study|Adverse Event|1|||
126374240|NCT01436110|454666955|FG002|Overall Study|Adverse Event|2|||
126374241|NCT01436110|454666953|FG000|Overall Study|Physician Decision|3|||
126374242|NCT01436110|454666954|FG001|Overall Study|Physician Decision|1|||
126374243|NCT01436110|454666955|FG002|Overall Study|Physician Decision|1|||
126374244|NCT01436110|454666953|FG000|Overall Study|Lost to Follow-up|1|||
126374245|NCT01436110|454666954|FG001|Overall Study|Lost to Follow-up|1|||
126374246|NCT01436110|454666955|FG002|Overall Study|Lost to Follow-up|3|||
126374247|NCT01436110|454666953|FG000|Overall Study|Protocol Violation|3|||
126374248|NCT01436110|454666954|FG001|Overall Study|Protocol Violation|1|||
126374249|NCT01436110|454666955|FG002|Overall Study|Protocol Violation|1|||
126374250|NCT01436110|454666953|FG000|Overall Study|Did Not Receive Trial Medication|1|||
126374251|NCT01436110|454666954|FG001|Overall Study|Did Not Receive Trial Medication|0|||
126374252|NCT01436110|454666955|FG002|Overall Study|Did Not Receive Trial Medication|3|||
126374253|NCT01088503|454666957|FG000|Overall Study|Withdrawal by Subject|118|||
126466614|NCT01795638|455010408|FG000|Overall Study|Withdrawal by Subject|1|||
126466615|NCT01795638|455010409|FG001|Overall Study|Withdrawal by Subject|0|||
126466616|NCT02360995|455010410|FG000|Overall Study|Lost to Follow-up|2|||
126466617|NCT02360995|455010411|FG001|Overall Study|Lost to Follow-up|0|||
126466618|NCT02360995|455010412|FG002|Overall Study|Lost to Follow-up|2|||
126552926|NCT02291289|455320507|FG006|Induction Treatment|Adverse Event|0|||
126374254|NCT01088503|454666958|FG001|Overall Study|Withdrawal by Subject|327|||
126374255|NCT01088503|454666959|FG002|Overall Study|Withdrawal by Subject|10|||
126374256|NCT01088503|454666957|FG000|Overall Study|Death|64|||
126374257|NCT01088503|454666958|FG001|Overall Study|Death|358|||
126374258|NCT01088503|454666959|FG002|Overall Study|Death|7|||
126374259|NCT01531998|454666960|FG000|Overall Study|Withdrawal by Subject|3|||
126374260|NCT00186628|454666965|FG000|Overall Study|Death|2|||
126374261|NCT00186628|454666965|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
126374262|NCT02927795|454666966|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
126374263|NCT02927795|454666966|FG000|Overall Study|Not Treated|4|||
126374264|NCT01076010|454666967|FG000|Overall Study|Death|15|||
126374265|NCT01076010|454666968|FG001|Overall Study|Death|1|||
126374266|NCT01076010|454666969|FG002|Overall Study|Death|0|||
126374267|NCT01076010|454666967|FG000|Overall Study|Adverse Event|7|||
126374268|NCT01076010|454666968|FG001|Overall Study|Adverse Event|2|||
126374269|NCT01076010|454666969|FG002|Overall Study|Adverse Event|0|||
126374270|NCT01076010|454666967|FG000|Overall Study|Progressive disease|90|||
126374271|NCT01076010|454666968|FG001|Overall Study|Progressive disease|30|||
126374272|NCT01076010|454666969|FG002|Overall Study|Progressive disease|1|||
126716713|NCT01781429|455914915|FG005|Overall Study|Withdrawal by Subject|0|||
126716714|NCT01781429|455914916|FG006|Overall Study|Withdrawal by Subject|0|||
126716715|NCT01781429|455914917|FG007|Overall Study|Withdrawal by Subject|0|||
126716716|NCT01781429|455914918|FG008|Overall Study|Withdrawal by Subject|1|||
126716717|NCT01781429|455914919|FG009|Overall Study|Withdrawal by Subject|3|||
126466619|NCT02360995|455010410|FG000|Overall Study|Withdrawal by Subject|0|||
126466620|NCT02360995|455010411|FG001|Overall Study|Withdrawal by Subject|1|||
126466621|NCT02360995|455010412|FG002|Overall Study|Withdrawal by Subject|0|||
126466622|NCT02611960|455010413|FG000|Overall Study|Adverse Event|7|||
126466623|NCT02611960|455010414|FG001|Overall Study|Adverse Event|8|||
126466624|NCT02611960|455010413|FG000|Overall Study|Death|98|||
126466625|NCT02611960|455010414|FG001|Overall Study|Death|92|||
126466626|NCT02611960|455010413|FG000|Overall Study|Withdrawal by Subject|1|||
126466627|NCT02611960|455010414|FG001|Overall Study|Withdrawal by Subject|5|||
126466628|NCT02611960|455010413|FG000|Overall Study|Sponsor Decision|11|||
126466629|NCT02611960|455010414|FG001|Overall Study|Sponsor Decision|11|||
126466630|NCT02395666|455010415|FG000|Overall Study|Physician Decision|3|||
126466631|NCT02395666|455010416|FG001|Overall Study|Physician Decision|0|||
126466632|NCT02395666|455010415|FG000|Overall Study|Lost to Follow-up|1|||
126466633|NCT02395666|455010416|FG001|Overall Study|Lost to Follow-up|0|||
126466634|NCT02395666|455010415|FG000|Overall Study|Withdrawal by Subject|2|||
126466635|NCT02395666|455010416|FG001|Overall Study|Withdrawal by Subject|1|||
126466636|NCT00293215|455010417|FG000|Overall Study|Progressive disease|3|||
126466637|NCT00293215|455010418|FG001|Overall Study|Progressive disease|1|||
126466638|NCT00293215|455010417|FG000|Overall Study|Adverse Event|2|||
126466639|NCT00293215|455010418|FG001|Overall Study|Adverse Event|2|||
126466640|NCT01409434|455010419|FG000|Overall Study|Protocol Violation|4|||
126466641|NCT01229371|455010422|FG000|Overall Study|Withdrawal by Subject|0|||
126466642|NCT01229371|455010423|FG001|Overall Study|Withdrawal by Subject|1|||
126466643|NCT01229371|455010424|FG002|Overall Study|Withdrawal by Subject|0|||
126466644|NCT01229371|455010425|FG003|Overall Study|Withdrawal by Subject|0|||
126466645|NCT02213042|455010426|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
126466646|NCT02213042|455010427|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
126310832|NCT01508130|454427503|FG001|Overall Study|Subject's substantial non-compliance|9|||
126310833|NCT01508130|454427502|FG000|Overall Study|Insufficient therapeutic response|74|||
126716718|NCT01781429|455914920|FG010|Overall Study|Withdrawal by Subject|1|||
126716719|NCT01781429|455914921|FG011|Overall Study|Withdrawal by Subject|1|||
126771038|NCT00422058|456116234|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
126771039|NCT00422058|456116235|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
126310834|NCT01508130|454427503|FG001|Overall Study|Insufficient therapeutic response|23|||
126310835|NCT01508130|454427502|FG000|Overall Study|Administrative|14|||
126310836|NCT01508130|454427503|FG001|Overall Study|Administrative|3|||
126310837|NCT01680159|454427504|FG000|Screening Period|Not meet criteria for dose-up period|7|||
126310838|NCT01680159|454427504|FG000|Increased Dose Period|Adverse Event|6|||
126310839|NCT01680159|454427504|FG000|Increased Dose Period|Withdrawal by Subject|2|||
126310840|NCT01252563|454427507|FG000|Overall Study|Contract Deviation|41|||
126310841|NCT01252563|454427507|FG000|Overall Study|Centralized Registration Deviation|30|||
126310842|NCT01252563|454427507|FG000|Overall Study|Lost to Follow-up|161|||
126310843|NCT01252563|454427507|FG000|Overall Study|No visit after first day of treatment|194|||
126310844|NCT01252563|454427507|FG000|Overall Study|No drug administration|6|||
126310845|NCT01880086|454427508|FG000|Overall Study|Lost to Follow-up|1|||
126310846|NCT01880086|454427509|FG001|Overall Study|Lost to Follow-up|1|||
126310847|NCT03429244|454427510|FG000|Overall Study|Withdrawal by Subject|2|||
126310848|NCT03429244|454427511|FG001|Overall Study|Withdrawal by Subject|1|||
126310849|NCT03429244|454427512|FG002|Overall Study|Withdrawal by Subject|1|||
126310850|NCT03403751|454427515|FG000|Overall Study|Death|5|||
126310851|NCT03403751|454427516|FG001|Overall Study|Death|6|||
126310852|NCT03403751|454427515|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
126310853|NCT03403751|454427516|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
126310854|NCT01820572|454427517|FG000|Randomization|Not Treated|2|||
126310855|NCT01820572|454427518|FG001|Randomization|Not Treated|1|||
126310856|NCT01820572|454427517|FG000|Treatment Period|Adverse Event|12|||
126310857|NCT01820572|454427518|FG001|Treatment Period|Adverse Event|7|||
126310858|NCT01820572|454427517|FG000|Treatment Period|Death|3|||
126716720|NCT01781429|455914922|FG012|Overall Study|Withdrawal by Subject|5|||
126310859|NCT01820572|454427518|FG001|Treatment Period|Death|3|||
126310860|NCT01820572|454427517|FG000|Treatment Period|Lack of Efficacy|1|||
126310861|NCT01820572|454427518|FG001|Treatment Period|Lack of Efficacy|0|||
126310862|NCT01820572|454427517|FG000|Treatment Period|poor/non compliance|0|||
126310863|NCT01820572|454427518|FG001|Treatment Period|poor/non compliance|3|||
126552927|NCT02291289|455320508|FG007|Induction Treatment|Adverse Event|0|||
126310864|NCT01820572|454427517|FG000|Treatment Period|request to discontinue|6|||
126466647|NCT02213042|455010428|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
126466648|NCT02213042|455010426|FG000|Overall Study|Adverse Event|2|||
126466649|NCT02213042|455010427|FG001|Overall Study|Adverse Event|1|||
126716721|NCT01781429|455914923|FG013|Overall Study|Withdrawal by Subject|2|||
126310865|NCT01820572|454427518|FG001|Treatment Period|request to discontinue|11|||
126310866|NCT01820572|454427517|FG000|Treatment Period|No longer meets study criteria|3|||
126310867|NCT01820572|454427518|FG001|Treatment Period|No longer meets study criteria|10|||
126310868|NCT01820572|454427517|FG000|Treatment Period|withdrew consent|1|||
126310869|NCT01820572|454427518|FG001|Treatment Period|withdrew consent|2|||
126310870|NCT00658775|454427522|FG000|Overall Study|Adverse Event|4|||
126466650|NCT02213042|455010428|FG002|Overall Study|Adverse Event|0|||
126466651|NCT02213042|455010426|FG000|Overall Study|Withdrawal by Subject|0|||
126466652|NCT02213042|455010427|FG001|Overall Study|Withdrawal by Subject|1|||
126466653|NCT02213042|455010428|FG002|Overall Study|Withdrawal by Subject|1|||
126466654|NCT02213042|455010426|FG000|Overall Study|Protocol Violation|1|||
126466655|NCT02213042|455010427|FG001|Overall Study|Protocol Violation|0|||
126466656|NCT02213042|455010428|FG002|Overall Study|Protocol Violation|0|||
126466657|NCT02213042|455010426|FG000|Overall Study|Investigator discretion|0|||
126466658|NCT02213042|455010427|FG001|Overall Study|Investigator discretion|0|||
126466659|NCT02213042|455010428|FG002|Overall Study|Investigator discretion|1|||
126466660|NCT04622735|455010429|FG000|Overall Study|Lost to Follow-up|1|||
126466661|NCT04622735|455010430|FG001|Overall Study|Lost to Follow-up|2|||
126466662|NCT04622735|455010431|FG002|Overall Study|Lost to Follow-up|1|||
126466663|NCT04622735|455010429|FG000|Overall Study|Adverse Event|0|||
126466664|NCT04622735|455010430|FG001|Overall Study|Adverse Event|0|||
126466665|NCT04622735|455010431|FG002|Overall Study|Adverse Event|1|||
126466666|NCT04622735|455010429|FG000|Overall Study|Protocol Violation|1|||
126466667|NCT04622735|455010430|FG001|Overall Study|Protocol Violation|0|||
126466668|NCT04622735|455010431|FG002|Overall Study|Protocol Violation|0|||
126466669|NCT05314478|455010432|FG000|Overall Study|Physician Decision|1|||
126466670|NCT04073368|455010433|FG000|Overall Study|Adverse Event|2|||
126466671|NCT04073368|455010434|FG001|Overall Study|Adverse Event|0|||
126466672|NCT04073368|455010435|FG002|Overall Study|Adverse Event|1|||
126466673|NCT04073368|455010436|FG003|Overall Study|Adverse Event|1|||
126466674|NCT04073368|455010433|FG000|Overall Study|Withdrawal by Subject|2|||
126466675|NCT04073368|455010434|FG001|Overall Study|Withdrawal by Subject|2|||
126466676|NCT04073368|455010435|FG002|Overall Study|Withdrawal by Subject|1|||
126466677|NCT04073368|455010436|FG003|Overall Study|Withdrawal by Subject|1|||
126466678|NCT04073368|455010433|FG000|Overall Study|Lost to Follow-up|1|||
126716722|NCT01781429|455914924|FG014|Overall Study|Withdrawal by Subject|3|||
126716723|NCT01781429|455914925|FG015|Overall Study|Withdrawal by Subject|0|||
126716724|NCT01781429|455914910|FG000|Overall Study|Disease Progression|1|||
126310871|NCT00658775|454427523|FG001|Overall Study|Adverse Event|6|||
126310872|NCT00658775|454427522|FG000|Overall Study|Lost to Follow-up|17|||
126310873|NCT00658775|454427523|FG001|Overall Study|Lost to Follow-up|18|||
126310874|NCT00658775|454427522|FG000|Overall Study|Withdrawal by Subject|6|||
126310875|NCT00658775|454427523|FG001|Overall Study|Withdrawal by Subject|4|||
126310876|NCT00658775|454427522|FG000|Overall Study|Withdrawal of consent|8|||
126310877|NCT00658775|454427523|FG001|Overall Study|Withdrawal of consent|7|||
126310878|NCT00658775|454427522|FG000|Overall Study|Other|7|||
126310879|NCT00658775|454427523|FG001|Overall Study|Other|8|||
126310880|NCT00387010|454427524|FG000|Dose Titration Period|Adverse Event|12|||
126310881|NCT00387010|454427524|FG000|Dose Titration Period|Lack of Efficacy|5|||
126310882|NCT00387010|454427524|FG000|Dose Titration Period|Withdrawal by Subject|3|||
126310883|NCT00387010|454427524|FG000|Dose Titration Period|Protocol Violation|1|||
126310884|NCT00387010|454427524|FG000|Dose Titration Period|Lost to Follow-up|2|||
126310885|NCT00387010|454427524|FG000|Dose Titration Period|Noncompliance with study medication|8|||
126310886|NCT00387010|454427524|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
126310887|NCT00387010|454427524|FG000|Treatment Period|Adverse Event|4|||
126310888|NCT00387010|454427524|FG000|Treatment Period|Withdrawal by Subject|1|||
126310889|NCT00387010|454427524|FG000|Treatment Period|Noncompliance with study medication|2|||
126310890|NCT00387010|454427524|FG000|Treatment Period|Noncompliance with study procedures|3|||
126310891|NCT00387010|454427524|FG000|Treatment Period|Participant reported study drug stolen|1|||
126310892|NCT01931956|454427527|FG000|Overall Study|Death|42|||
126466679|NCT04073368|455010434|FG001|Overall Study|Lost to Follow-up|1|||
126466680|NCT04073368|455010435|FG002|Overall Study|Lost to Follow-up|1|||
126466681|NCT04073368|455010436|FG003|Overall Study|Lost to Follow-up|0|||
126466682|NCT04073368|455010433|FG000|Overall Study|Protocol Violation|0|||
126466683|NCT04073368|455010434|FG001|Overall Study|Protocol Violation|1|||
126466684|NCT04073368|455010435|FG002|Overall Study|Protocol Violation|0|||
126466685|NCT04073368|455010436|FG003|Overall Study|Protocol Violation|0|||
126466686|NCT04073368|455010433|FG000|Overall Study|Subject noncompliance|7|||
126466687|NCT04073368|455010434|FG001|Overall Study|Subject noncompliance|4|||
126466688|NCT04073368|455010435|FG002|Overall Study|Subject noncompliance|0|||
126466689|NCT04073368|455010436|FG003|Overall Study|Subject noncompliance|0|||
126466690|NCT02923427|455010437|FG000|Overall Study|convert to laparatomy|2|||
126466691|NCT02923427|455010438|FG001|Overall Study|convert to laparatomy|2|||
126466692|NCT02923427|455010437|FG000|Overall Study|destaturation|1|||
126466693|NCT02923427|455010438|FG001|Overall Study|destaturation|0|||
126466694|NCT02923427|455010437|FG000|Overall Study|can not replace LMA|1|||
126466695|NCT02923427|455010438|FG001|Overall Study|can not replace LMA|0|||
126716725|NCT01781429|455914911|FG001|Overall Study|Disease Progression|0|||
126466696|NCT01325623|455010439|FG000|Overall Study|Withdrawal by Subject|3|||
126466697|NCT01229397|455010440|FG000|Overall Study|Withdrawal by Subject|3|||
126466698|NCT01229397|455010441|FG001|Overall Study|Withdrawal by Subject|3|||
126466699|NCT01229397|455010440|FG000|Overall Study|Lost to Follow-up|7|||
126466700|NCT01229397|455010441|FG001|Overall Study|Lost to Follow-up|6|||
126466701|NCT01229397|455010440|FG000|Overall Study|Migrated/moved from study area|1|||
126466702|NCT01229397|455010441|FG001|Overall Study|Migrated/moved from study area|0|||
126466703|NCT00950911|455010443|FG000|Overall Study|Adverse Event|0|||
126466704|NCT00950911|455010444|FG001|Overall Study|Adverse Event|2|||
126466705|NCT00950911|455010443|FG000|Overall Study|Death|4|||
126466706|NCT00950911|455010444|FG001|Overall Study|Death|6|||
126466707|NCT00950911|455010443|FG000|Overall Study|Disease progression|2|||
126466708|NCT00950911|455010444|FG001|Overall Study|Disease progression|2|||
126466709|NCT00950911|455010443|FG000|Overall Study|Consent withdrawn|1|||
126374273|NCT01076010|454666967|FG000|Overall Study|Lack of Efficacy|4|||
126374274|NCT01076010|454666968|FG001|Overall Study|Lack of Efficacy|0|||
126374275|NCT01076010|454666969|FG002|Overall Study|Lack of Efficacy|0|||
126374276|NCT01076010|454666967|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
126374277|NCT01076010|454666968|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
126374278|NCT01076010|454666969|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
126374279|NCT01076010|454666967|FG000|Overall Study|Significant Surgical Procedure|0|||
126374280|NCT01076010|454666968|FG001|Overall Study|Significant Surgical Procedure|1|||
126374281|NCT01076010|454666969|FG002|Overall Study|Significant Surgical Procedure|0|||
126374282|NCT01076010|454666967|FG000|Overall Study|Protocol Violation|0|||
126374283|NCT01076010|454666968|FG001|Overall Study|Protocol Violation|1|||
126374284|NCT01076010|454666969|FG002|Overall Study|Protocol Violation|0|||
126374285|NCT01076010|454666967|FG000|Overall Study|Noncompliance|1|||
126374286|NCT01076010|454666968|FG001|Overall Study|Noncompliance|1|||
126374287|NCT01076010|454666969|FG002|Overall Study|Noncompliance|0|||
126374288|NCT01076010|454666967|FG000|Overall Study|Withdrawal by Subject|3|||
126374289|NCT01076010|454666968|FG001|Overall Study|Withdrawal by Subject|0|||
126374290|NCT01076010|454666969|FG002|Overall Study|Withdrawal by Subject|1|||
126374291|NCT01076010|454666967|FG000|Overall Study|Other|5|||
126374292|NCT01076010|454666968|FG001|Overall Study|Other|2|||
126374293|NCT01076010|454666969|FG002|Overall Study|Other|0|||
126374294|NCT03440008|454666972|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
126374295|NCT03440008|454666973|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
126374296|NCT03440008|454666972|FG000|Overall Study|Withdrawal by Subject|1|||
126374297|NCT03440008|454666973|FG001|Overall Study|Withdrawal by Subject|0|||
126374298|NCT03498716|454666979|FG000|Overall Study|Withdrawal by Subject|88|||
126374299|NCT03498716|454666980|FG001|Overall Study|Withdrawal by Subject|73|||
126374300|NCT03498716|454666979|FG000|Overall Study|Study Terminated By Sponsor|933|||
126374301|NCT03498716|454666980|FG001|Overall Study|Study Terminated By Sponsor|927|||
126374302|NCT03498716|454666979|FG000|Overall Study|Lost to Follow-up|15|||
126374303|NCT03498716|454666980|FG001|Overall Study|Lost to Follow-up|26|||
126374304|NCT03498716|454666979|FG000|Overall Study|Disease Relapse|0|||
126374305|NCT03498716|454666980|FG001|Overall Study|Disease Relapse|1|||
126466710|NCT00950911|455010444|FG001|Overall Study|Consent withdrawn|3|||
126466711|NCT00950911|455010443|FG000|Overall Study|Administrative decision|3|||
126466712|NCT00950911|455010444|FG001|Overall Study|Administrative decision|1|||
126466713|NCT00950911|455010443|FG000|Overall Study|Ineligibility determined|1|||
126466714|NCT00950911|455010444|FG001|Overall Study|Ineligibility determined|0|||
126374306|NCT03498716|454666979|FG000|Overall Study|Death|58|||
126374307|NCT03498716|454666980|FG001|Overall Study|Death|72|||
126374308|NCT03498716|454666979|FG000|Overall Study|Physician Decision|4|||
126466715|NCT00950911|455010443|FG000|Overall Study|Noncompliance|1|||
126466716|NCT00950911|455010444|FG001|Overall Study|Noncompliance|0|||
126466717|NCT00950911|455010443|FG000|Overall Study|Poor performance status|0|||
126716726|NCT01781429|455914912|FG002|Overall Study|Disease Progression|1|||
126716727|NCT01781429|455914913|FG003|Overall Study|Disease Progression|1|||
126466718|NCT00950911|455010444|FG001|Overall Study|Poor performance status|1|||
126466719|NCT02476422|455010447|FG000|Overall Study|Subject/guardian decision|0|||
126466720|NCT02476422|455010448|FG001|Overall Study|Subject/guardian decision|1|||
126466721|NCT01134315|455010453|FG000|Overall Study|Adverse Event|1|||
126716728|NCT01781429|455914914|FG004|Overall Study|Disease Progression|1|||
126466722|NCT01134315|455010454|FG001|Overall Study|Adverse Event|2|||
126466723|NCT01134315|455010453|FG000|Overall Study|Other Reason|8|||
126374309|NCT03498716|454666980|FG001|Overall Study|Physician Decision|2|||
126374310|NCT00760552|454666984|FG000|Overall Study|Death|2|||
126374311|NCT00760552|454666985|FG001|Overall Study|Death|0|||
126374312|NCT00760552|454666984|FG000|Overall Study|Lost to Follow-up|11|||
126374313|NCT00760552|454666985|FG001|Overall Study|Lost to Follow-up|10|||
126374314|NCT02216526|454666986|FG000|Overall Study|Adverse Event|1|||
126374315|NCT02216526|454666987|FG001|Overall Study|Adverse Event|1|||
126374316|NCT02216526|454666988|FG002|Overall Study|Adverse Event|0|||
126374317|NCT02216526|454666986|FG000|Overall Study|Death|0|||
126374318|NCT02216526|454666987|FG001|Overall Study|Death|1|||
126716729|NCT01781429|455914915|FG005|Overall Study|Disease Progression|4|||
126716730|NCT01781429|455914916|FG006|Overall Study|Disease Progression|7|||
126716731|NCT01781429|455914917|FG007|Overall Study|Disease Progression|4|||
126716732|NCT01781429|455914918|FG008|Overall Study|Disease Progression|6|||
126310893|NCT01931956|454427528|FG001|Overall Study|Death|7|||
126310894|NCT01931956|454427529|FG002|Overall Study|Death|379|||
126310895|NCT01931956|454427530|FG003|Overall Study|Death|96|||
126310896|NCT01931956|454427527|FG000|Overall Study|Withdrawal by Subject|5|||
126310897|NCT01931956|454427528|FG001|Overall Study|Withdrawal by Subject|0|||
126310898|NCT01931956|454427529|FG002|Overall Study|Withdrawal by Subject|70|||
126310899|NCT01931956|454427530|FG003|Overall Study|Withdrawal by Subject|30|||
126310900|NCT01931956|454427527|FG000|Overall Study|Lost to Follow-up|2|||
126310901|NCT01931956|454427528|FG001|Overall Study|Lost to Follow-up|0|||
126310902|NCT01931956|454427529|FG002|Overall Study|Lost to Follow-up|11|||
126310903|NCT01931956|454427530|FG003|Overall Study|Lost to Follow-up|7|||
126310904|NCT01931956|454427527|FG000|Overall Study|Expected|2|||
126310905|NCT01931956|454427528|FG001|Overall Study|Expected|0|||
126310906|NCT01931956|454427529|FG002|Overall Study|Expected|6|||
126310907|NCT01931956|454427530|FG003|Overall Study|Expected|0|||
126310908|NCT01931956|454427527|FG000|Overall Study|Not due|0|||
126310909|NCT01931956|454427528|FG001|Overall Study|Not due|0|||
126310910|NCT01931956|454427529|FG002|Overall Study|Not due|21|||
126310911|NCT01931956|454427530|FG003|Overall Study|Not due|0|||
126310912|NCT02847494|454427531|FG000|Overall Study|Lost to Follow-up|8|||
126310913|NCT02847494|454427532|FG001|Overall Study|Lost to Follow-up|5|||
126310914|NCT02841280|454427535|FG000|Overall Study|Adverse Event|2|||
126310915|NCT02841280|454427536|FG001|Overall Study|Adverse Event|1|||
126310916|NCT02841280|454427535|FG000|Overall Study|Death|1|||
126310917|NCT02841280|454427536|FG001|Overall Study|Death|0|||
126310918|NCT02841280|454427535|FG000|Overall Study|Lost to Follow-up|2|||
126310919|NCT02841280|454427536|FG001|Overall Study|Lost to Follow-up|2|||
126310920|NCT02841280|454427535|FG000|Overall Study|Withdrawal by Subject|7|||
126310921|NCT02841280|454427536|FG001|Overall Study|Withdrawal by Subject|3|||
126310922|NCT02841280|454427535|FG000|Overall Study|Stop Point: BP above threshold|2|||
126310923|NCT02841280|454427536|FG001|Overall Study|Stop Point: BP above threshold|0|||
126310924|NCT02727777|454427537|FG000|Overall Study|Screen Failure|2|||
126310925|NCT02727777|454427538|FG001|Overall Study|Screen Failure|0|||
126310926|NCT02727777|454427539|FG002|Overall Study|Screen Failure|0|||
126310927|NCT02727777|454427537|FG000|Overall Study|Progressive disease|2|||
126310928|NCT02727777|454427538|FG001|Overall Study|Progressive disease|0|||
126310929|NCT02727777|454427539|FG002|Overall Study|Progressive disease|0|||
126310930|NCT01738503|454427540|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
126310931|NCT01738503|454427541|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
126310932|NCT01738503|454427542|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
126310933|NCT01738503|454427543|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
126310934|NCT01738503|454427544|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
126310935|NCT01738503|454427545|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
126310936|NCT01738503|454427546|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
126310937|NCT01738503|454427540|FG000|Treatment Period|Adverse Event|0|||
126310938|NCT01738503|454427541|FG001|Treatment Period|Adverse Event|1|||
126310939|NCT01738503|454427542|FG002|Treatment Period|Adverse Event|0|||
126310940|NCT01738503|454427543|FG003|Treatment Period|Adverse Event|1|||
126310941|NCT01738503|454427544|FG004|Treatment Period|Adverse Event|2|||
126310942|NCT01738503|454427545|FG005|Treatment Period|Adverse Event|2|||
126310943|NCT01738503|454427546|FG006|Treatment Period|Adverse Event|2|||
126310944|NCT01738503|454427540|FG000|Treatment Period|Lost to Follow-up|0|||
126310945|NCT01738503|454427541|FG001|Treatment Period|Lost to Follow-up|0|||
126310946|NCT01738503|454427542|FG002|Treatment Period|Lost to Follow-up|3|||
126310947|NCT01738503|454427543|FG003|Treatment Period|Lost to Follow-up|4|||
126310948|NCT01738503|454427544|FG004|Treatment Period|Lost to Follow-up|1|||
126310949|NCT01738503|454427545|FG005|Treatment Period|Lost to Follow-up|1|||
126552928|NCT02291289|455320509|FG008|Induction Treatment|Adverse Event|0|||
126310950|NCT01738503|454427546|FG006|Treatment Period|Lost to Follow-up|5|||
126310951|NCT01738503|454427540|FG000|Treatment Period|Withdrawal by Subject|0|||
126310952|NCT01738503|454427541|FG001|Treatment Period|Withdrawal by Subject|1|||
126310953|NCT01738503|454427542|FG002|Treatment Period|Withdrawal by Subject|0|||
126310954|NCT01738503|454427543|FG003|Treatment Period|Withdrawal by Subject|1|||
126310955|NCT01738503|454427544|FG004|Treatment Period|Withdrawal by Subject|1|||
126716733|NCT01781429|455914919|FG009|Overall Study|Disease Progression|15|||
126310956|NCT01738503|454427545|FG005|Treatment Period|Withdrawal by Subject|1|||
126310957|NCT01738503|454427546|FG006|Treatment Period|Withdrawal by Subject|1|||
126310958|NCT01738503|454427540|FG000|Treatment Period|Protocol Violation|0|||
126310959|NCT01738503|454427541|FG001|Treatment Period|Protocol Violation|3|||
126310960|NCT01738503|454427542|FG002|Treatment Period|Protocol Violation|1|||
126310961|NCT01738503|454427543|FG003|Treatment Period|Protocol Violation|0|||
126310962|NCT01738503|454427544|FG004|Treatment Period|Protocol Violation|4|||
126310963|NCT01738503|454427545|FG005|Treatment Period|Protocol Violation|2|||
126310964|NCT01738503|454427546|FG006|Treatment Period|Protocol Violation|0|||
126310965|NCT01738503|454427540|FG000|Treatment Period|Other|0|||
126771040|NCT00422058|456116236|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
126310966|NCT01738503|454427541|FG001|Treatment Period|Other|0|||
126310967|NCT01738503|454427542|FG002|Treatment Period|Other|1|||
126310968|NCT01738503|454427543|FG003|Treatment Period|Other|0|||
126310969|NCT01738503|454427544|FG004|Treatment Period|Other|0|||
126310970|NCT01738503|454427545|FG005|Treatment Period|Other|0|||
126310971|NCT01738503|454427546|FG006|Treatment Period|Other|0|||
126310972|NCT01738503|454427540|FG000|PET Imaging Sub-study|Adverse Event|0|||
126310973|NCT01738503|454427541|FG001|PET Imaging Sub-study|Adverse Event|0|||
126310974|NCT01738503|454427542|FG002|PET Imaging Sub-study|Adverse Event|0|||
126310975|NCT01738503|454427543|FG003|PET Imaging Sub-study|Adverse Event|0|||
126310976|NCT01738503|454427544|FG004|PET Imaging Sub-study|Adverse Event|0|||
126310977|NCT01738503|454427545|FG005|PET Imaging Sub-study|Adverse Event|1|||
126310978|NCT01738503|454427546|FG006|PET Imaging Sub-study|Adverse Event|0|||
126310979|NCT01738503|454427540|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
126310980|NCT01738503|454427541|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
126310981|NCT01738503|454427542|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
126310982|NCT01738503|454427543|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
126310983|NCT01738503|454427544|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
126310984|NCT01738503|454427545|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
126310985|NCT01738503|454427546|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
126310986|NCT01758731|454427547|FG000|Overall Study|Physician Decision|1|||
126310987|NCT01340027|454427548|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
126310988|NCT01340027|454427549|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
126310989|NCT01340027|454427550|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
126310990|NCT01340027|454427551|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
126310991|NCT01340027|454427552|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
126310992|NCT01340027|454427553|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
126310993|NCT01340027|454427554|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
126310994|NCT01340027|454427555|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
126310995|NCT01340027|454427556|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
126310996|NCT01340027|454427557|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
126310997|NCT01340027|454427558|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
126310998|NCT01340027|454427559|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
126310999|NCT01340027|454427548|FG000|Overall Study|Adverse Event|0|||
126311000|NCT01340027|454427549|FG001|Overall Study|Adverse Event|1|||
126311001|NCT01340027|454427550|FG002|Overall Study|Adverse Event|2|||
126311002|NCT01340027|454427551|FG003|Overall Study|Adverse Event|0|||
126311003|NCT01340027|454427552|FG004|Overall Study|Adverse Event|1|||
126311004|NCT01340027|454427553|FG005|Overall Study|Adverse Event|2|||
126311005|NCT01340027|454427554|FG006|Overall Study|Adverse Event|2|||
126311006|NCT01340027|454427555|FG007|Overall Study|Adverse Event|1|||
126311007|NCT01340027|454427556|FG008|Overall Study|Adverse Event|4|||
126311008|NCT01340027|454427557|FG009|Overall Study|Adverse Event|1|||
126311009|NCT01340027|454427558|FG010|Overall Study|Adverse Event|1|||
126311010|NCT01340027|454427559|FG011|Overall Study|Adverse Event|3|||
126311011|NCT01340027|454427548|FG000|Overall Study|Lack of Efficacy|0|||
126311012|NCT01340027|454427549|FG001|Overall Study|Lack of Efficacy|0|||
126311013|NCT01340027|454427550|FG002|Overall Study|Lack of Efficacy|0|||
126311014|NCT01340027|454427551|FG003|Overall Study|Lack of Efficacy|0|||
126311015|NCT01340027|454427552|FG004|Overall Study|Lack of Efficacy|0|||
126311016|NCT01340027|454427553|FG005|Overall Study|Lack of Efficacy|0|||
126311017|NCT01340027|454427554|FG006|Overall Study|Lack of Efficacy|1|||
126311018|NCT01340027|454427555|FG007|Overall Study|Lack of Efficacy|1|||
126311019|NCT01340027|454427556|FG008|Overall Study|Lack of Efficacy|1|||
126311020|NCT01340027|454427557|FG009|Overall Study|Lack of Efficacy|0|||
126311021|NCT01340027|454427558|FG010|Overall Study|Lack of Efficacy|0|||
126311022|NCT01340027|454427559|FG011|Overall Study|Lack of Efficacy|0|||
126311023|NCT01340027|454427548|FG000|Overall Study|Lost to Follow-up|0|||
126311024|NCT01340027|454427549|FG001|Overall Study|Lost to Follow-up|1|||
126311025|NCT01340027|454427550|FG002|Overall Study|Lost to Follow-up|0|||
126311026|NCT01340027|454427551|FG003|Overall Study|Lost to Follow-up|0|||
126311027|NCT01340027|454427552|FG004|Overall Study|Lost to Follow-up|0|||
126311028|NCT01340027|454427553|FG005|Overall Study|Lost to Follow-up|0|||
126311029|NCT01340027|454427554|FG006|Overall Study|Lost to Follow-up|1|||
126311030|NCT01340027|454427555|FG007|Overall Study|Lost to Follow-up|0|||
126311031|NCT01340027|454427556|FG008|Overall Study|Lost to Follow-up|0|||
126311032|NCT01340027|454427557|FG009|Overall Study|Lost to Follow-up|1|||
126311033|NCT01340027|454427558|FG010|Overall Study|Lost to Follow-up|0|||
126311034|NCT01340027|454427559|FG011|Overall Study|Lost to Follow-up|0|||
126311035|NCT01340027|454427548|FG000|Overall Study|Protocol Violation|1|||
126311036|NCT01340027|454427549|FG001|Overall Study|Protocol Violation|2|||
126311037|NCT01340027|454427550|FG002|Overall Study|Protocol Violation|0|||
126311038|NCT01340027|454427551|FG003|Overall Study|Protocol Violation|0|||
126311039|NCT01340027|454427552|FG004|Overall Study|Protocol Violation|6|||
126311040|NCT01340027|454427553|FG005|Overall Study|Protocol Violation|0|||
126311041|NCT01340027|454427554|FG006|Overall Study|Protocol Violation|0|||
126311042|NCT01340027|454427555|FG007|Overall Study|Protocol Violation|1|||
126311043|NCT01340027|454427556|FG008|Overall Study|Protocol Violation|2|||
126311044|NCT01340027|454427557|FG009|Overall Study|Protocol Violation|2|||
126311045|NCT01340027|454427558|FG010|Overall Study|Protocol Violation|0|||
126311046|NCT01340027|454427559|FG011|Overall Study|Protocol Violation|0|||
126311047|NCT01340027|454427548|FG000|Overall Study|Withdrawal by Subject|4|||
126311048|NCT01340027|454427549|FG001|Overall Study|Withdrawal by Subject|3|||
126311049|NCT01340027|454427550|FG002|Overall Study|Withdrawal by Subject|1|||
126311050|NCT01340027|454427551|FG003|Overall Study|Withdrawal by Subject|3|||
126311051|NCT01340027|454427552|FG004|Overall Study|Withdrawal by Subject|3|||
126311052|NCT01340027|454427553|FG005|Overall Study|Withdrawal by Subject|2|||
126311053|NCT01340027|454427554|FG006|Overall Study|Withdrawal by Subject|3|||
126311054|NCT01340027|454427555|FG007|Overall Study|Withdrawal by Subject|4|||
126311055|NCT01340027|454427556|FG008|Overall Study|Withdrawal by Subject|1|||
126374319|NCT02216526|454666988|FG002|Overall Study|Death|3|||
126374320|NCT02216526|454666986|FG000|Overall Study|Protocol Violation|2|||
126374321|NCT02216526|454666987|FG001|Overall Study|Protocol Violation|0|||
126374322|NCT02216526|454666988|FG002|Overall Study|Protocol Violation|2|||
126374323|NCT02216526|454666986|FG000|Overall Study|Hospitalization|2|||
126374324|NCT02216526|454666987|FG001|Overall Study|Hospitalization|1|||
126374325|NCT02216526|454666988|FG002|Overall Study|Hospitalization|3|||
126374326|NCT02271529|454666996|FG000|Overall Study|Withdrawal by Subject|1|||
126374327|NCT03507127|454666997|FG000|Overall Study|Withdrawal by Subject|1|||
126374328|NCT03507127|454666998|FG001|Overall Study|Withdrawal by Subject|0|||
126374329|NCT03507127|454666997|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
126374330|NCT03507127|454666998|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
126374331|NCT01492426|454669010|FG000|Treatment|Death|0|||
126374332|NCT01492426|454669011|FG001|Treatment|Death|1|||
126374333|NCT01492426|454669010|FG000|Treatment|Other|1|||
126311056|NCT01340027|454427557|FG009|Overall Study|Withdrawal by Subject|2|||
126311057|NCT01340027|454427558|FG010|Overall Study|Withdrawal by Subject|0|||
126311058|NCT01340027|454427559|FG011|Overall Study|Withdrawal by Subject|1|||
126374334|NCT01492426|454669011|FG001|Treatment|Other|0|||
126374335|NCT01492426|454669010|FG000|Treatment|Adverse Event|25|||
126374336|NCT01492426|454669011|FG001|Treatment|Adverse Event|25|||
126374337|NCT01492426|454669010|FG000|Treatment|Lack of Efficacy|38|||
126374338|NCT01492426|454669011|FG001|Treatment|Lack of Efficacy|5|||
126374339|NCT01492426|454669010|FG000|Treatment|Participant withdrew consent|1|||
126374340|NCT01492426|454669011|FG001|Treatment|Participant withdrew consent|2|||
126374341|NCT01492426|454669010|FG000|Treatment|Poor compliance/noncompliance|1|||
126374342|NCT01492426|454669011|FG001|Treatment|Poor compliance/noncompliance|0|||
126374343|NCT01492426|454669010|FG000|Treatment|Subject requested discontinue study drug|7|||
126374344|NCT01492426|454669011|FG001|Treatment|Subject requested discontinue study drug|3|||
126374345|NCT01492426|454669010|FG000|Treatment|Lost to Follow-up|9|||
126374346|NCT01492426|454669011|FG001|Treatment|Lost to Follow-up|4|||
126374347|NCT01492426|454669010|FG000|Treatment|Participant does not meet study criteria|1|||
126374348|NCT01492426|454669011|FG001|Treatment|Participant does not meet study criteria|0|||
126374349|NCT01492426|454669010|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
126374350|NCT01492426|454669011|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
126374351|NCT01492426|454669010|FG000|Follow-Up|Death|1|||
126374352|NCT01492426|454669011|FG001|Follow-Up|Death|0|||
126374353|NCT01492426|454669010|FG000|Follow-Up|Other|4|||
126374354|NCT01492426|454669011|FG001|Follow-Up|Other|2|||
126374355|NCT01492426|454669010|FG000|Follow-Up|Participant Withdrew Consent|6|||
126374356|NCT01492426|454669011|FG001|Follow-Up|Participant Withdrew Consent|1|||
126374357|NCT01492426|454669010|FG000|Follow-Up|Lost to Follow-up|12|||
126374358|NCT01492426|454669011|FG001|Follow-Up|Lost to Follow-up|6|||
126374359|NCT00322049|454669012|FG000|Overall Study|Moved out of area|0|||
126374360|NCT00322049|454669013|FG001|Overall Study|Moved out of area|0|||
126374361|NCT00322049|454669014|FG002|Overall Study|Moved out of area|0|||
126374362|NCT00322049|454669015|FG003|Overall Study|Moved out of area|1|||
126374363|NCT00322049|454669012|FG000|Overall Study|Infected with Dengue during study|0|||
126374364|NCT00322049|454669013|FG001|Overall Study|Infected with Dengue during study|1|||
126374365|NCT00322049|454669014|FG002|Overall Study|Infected with Dengue during study|0|||
126374366|NCT00322049|454669015|FG003|Overall Study|Infected with Dengue during study|0|||
126374367|NCT02026011|454669016|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
126374368|NCT02026011|454669017|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
126374369|NCT02026011|454669016|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
126374370|NCT02026011|454669017|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
126374371|NCT02026011|454669016|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
126374372|NCT02026011|454669017|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
126374373|NCT02026011|454669016|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
126374374|NCT02026011|454669017|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
126374375|NCT01770743|454669018|FG000|Overall Study|Adverse Event|1|||
126552929|NCT02291289|455320510|FG009|Induction Treatment|Adverse Event|1|||
126311059|NCT01340027|454427548|FG000|Overall Study|Miscellaneous|0|||
126311060|NCT01340027|454427549|FG001|Overall Study|Miscellaneous|0|||
126311061|NCT01340027|454427550|FG002|Overall Study|Miscellaneous|0|||
126311062|NCT01340027|454427551|FG003|Overall Study|Miscellaneous|1|||
126311063|NCT01340027|454427552|FG004|Overall Study|Miscellaneous|0|||
126311064|NCT01340027|454427553|FG005|Overall Study|Miscellaneous|0|||
126311065|NCT01340027|454427554|FG006|Overall Study|Miscellaneous|0|||
126311066|NCT01340027|454427555|FG007|Overall Study|Miscellaneous|0|||
126311067|NCT01340027|454427556|FG008|Overall Study|Miscellaneous|0|||
126311068|NCT01340027|454427557|FG009|Overall Study|Miscellaneous|0|||
126311069|NCT01340027|454427558|FG010|Overall Study|Miscellaneous|1|||
126311070|NCT01340027|454427559|FG011|Overall Study|Miscellaneous|0|||
126311071|NCT03005327|454427560|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
126311072|NCT03005327|454427561|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
126311073|NCT03005327|454427562|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
126311074|NCT03005327|454427563|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
126311075|NCT03005327|454427560|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126311076|NCT03005327|454427561|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
126311077|NCT03005327|454427562|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126311078|NCT03005327|454427563|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126311079|NCT04687072|454427564|FG000|Overall Study|Adverse Event|2|||
126311080|NCT04687072|454427565|FG001|Overall Study|Adverse Event|0|||
126311081|NCT04687072|454427564|FG000|Overall Study|Death|1|||
126311082|NCT04687072|454427565|FG001|Overall Study|Death|0|||
126311083|NCT04687072|454427564|FG000|Overall Study|Lack of Efficacy|2|||
126311084|NCT04687072|454427565|FG001|Overall Study|Lack of Efficacy|1|||
126311085|NCT04687072|454427564|FG000|Overall Study|Physician Decision|1|||
126311086|NCT04687072|454427565|FG001|Overall Study|Physician Decision|0|||
126311087|NCT04687072|454427564|FG000|Overall Study|Pregnancy|1|||
126311088|NCT04687072|454427565|FG001|Overall Study|Pregnancy|0|||
126311089|NCT04687072|454427564|FG000|Overall Study|Requires Prohibited Medication|2|||
126311090|NCT04687072|454427565|FG001|Overall Study|Requires Prohibited Medication|0|||
126311091|NCT04687072|454427564|FG000|Overall Study|Withdrawal of Consent|11|||
126311092|NCT04687072|454427565|FG001|Overall Study|Withdrawal of Consent|6|||
126311093|NCT04687072|454427564|FG000|Overall Study|Miscellaneous|4|||
126311094|NCT04687072|454427565|FG001|Overall Study|Miscellaneous|1|||
126311095|NCT00915876|454427566|FG000|Overall Study|Adverse Event|0|||
126311096|NCT00915876|454427567|FG001|Overall Study|Adverse Event|1|||
126311097|NCT02496091|454427572|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
126311098|NCT02272842|454427573|FG000|Overall Study|Lost to Follow-up|8|||
126311099|NCT02272842|454427574|FG001|Overall Study|Lost to Follow-up|8|||
126311100|NCT02272842|454427573|FG000|Overall Study|Withdrawal by Subject|8|||
126311101|NCT02272842|454427574|FG001|Overall Study|Withdrawal by Subject|2|||
126311102|NCT05033262|454427575|FG000|Overall Study|Lost to Follow-up|1|||
126311103|NCT05033262|454427576|FG001|Overall Study|Lost to Follow-up|0|||
126311104|NCT05033262|454427577|FG002|Overall Study|Lost to Follow-up|0|||
126311105|NCT05033262|454427578|FG003|Overall Study|Lost to Follow-up|1|||
126311106|NCT01493284|454427581|FG000|Overall Study|Death|29|||
126311107|NCT01493284|454427581|FG000|Overall Study|Withdrawal by Subject|32|||
126311108|NCT00519428|454427582|FG000|Overall Study|Adverse Event|5|||
126311109|NCT00519428|454427583|FG001|Overall Study|Adverse Event|2|||
126311110|NCT00519428|454427584|FG002|Overall Study|Adverse Event|10|||
126311111|NCT00519428|454427582|FG000|Overall Study|Lost to Follow-up|7|||
126311112|NCT00519428|454427583|FG001|Overall Study|Lost to Follow-up|7|||
126311113|NCT00519428|454427584|FG002|Overall Study|Lost to Follow-up|6|||
126311114|NCT00519428|454427582|FG000|Overall Study|Withdrawal by Subject|8|||
126311115|NCT00519428|454427583|FG001|Overall Study|Withdrawal by Subject|3|||
126311116|NCT00519428|454427584|FG002|Overall Study|Withdrawal by Subject|7|||
126311117|NCT00519428|454427582|FG000|Overall Study|unstated|1|||
126311118|NCT00519428|454427583|FG001|Overall Study|unstated|3|||
126311119|NCT00519428|454427584|FG002|Overall Study|unstated|2|||
126311120|NCT00325156|454427585|FG000|Overall Study|Protocol Violation|8|||
126311121|NCT00325156|454427585|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
126374376|NCT01770743|454669019|FG001|Overall Study|Adverse Event|0|||
126374377|NCT01770743|454669020|FG002|Overall Study|Adverse Event|0|||
126374378|NCT01770743|454669021|FG003|Overall Study|Adverse Event|0|||
126374379|NCT01770743|454669022|FG004|Overall Study|Adverse Event|0|||
126374380|NCT01770743|454669018|FG000|Overall Study|Withdrawal by Subject|0|||
126374381|NCT01770743|454669019|FG001|Overall Study|Withdrawal by Subject|0|||
126374382|NCT01770743|454669020|FG002|Overall Study|Withdrawal by Subject|1|||
126374383|NCT01770743|454669021|FG003|Overall Study|Withdrawal by Subject|1|||
126374384|NCT01770743|454669022|FG004|Overall Study|Withdrawal by Subject|1|||
126374385|NCT01770743|454669018|FG000|Overall Study|Lost to Follow-up|0|||
126374386|NCT01770743|454669019|FG001|Overall Study|Lost to Follow-up|2|||
126374387|NCT01770743|454669020|FG002|Overall Study|Lost to Follow-up|0|||
126374388|NCT01770743|454669021|FG003|Overall Study|Lost to Follow-up|0|||
126374389|NCT01770743|454669022|FG004|Overall Study|Lost to Follow-up|1|||
126716734|NCT01781429|455914920|FG010|Overall Study|Disease Progression|15|||
126716735|NCT01781429|455914921|FG011|Overall Study|Disease Progression|15|||
126716736|NCT01781429|455914922|FG012|Overall Study|Disease Progression|15|||
126716737|NCT01781429|455914923|FG013|Overall Study|Disease Progression|4|||
126716738|NCT01781429|455914924|FG014|Overall Study|Disease Progression|11|||
126716739|NCT01781429|455914925|FG015|Overall Study|Disease Progression|0|||
126716740|NCT01781429|455914910|FG000|Overall Study|Unacceptable Toxicity|0|||
126716741|NCT01781429|455914911|FG001|Overall Study|Unacceptable Toxicity|0|||
126311122|NCT00325156|454427585|FG000|Overall Study|Migrated/moved from study area|12|||
126311123|NCT00325156|454427585|FG000|Overall Study|Adverse event, non-fatal|3|||
126311124|NCT00325156|454427585|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
126311125|NCT00325156|454427585|FG000|Overall Study|Other|1|||
126311126|NCT00325156|454427585|FG000|Overall Study|Withdrawal by Subject|31|||
126311127|NCT03626363|454427588|FG000|Overall Study|Protocol Violation|4|||
126311128|NCT03626363|454427589|FG001|Overall Study|Protocol Violation|0|||
126311129|NCT03626363|454427588|FG000|Overall Study|Lost to Follow-up|5|||
126311130|NCT03626363|454427589|FG001|Overall Study|Lost to Follow-up|7|||
126311131|NCT00533702|454427590|FG000|Overall Study|Withdrawal by Subject|3|||
126311132|NCT00533702|454427591|FG001|Overall Study|Withdrawal by Subject|1|||
126311133|NCT00533702|454427590|FG000|Overall Study|Found ineligible after randomization|2|||
126311134|NCT00533702|454427591|FG001|Overall Study|Found ineligible after randomization|1|||
126311135|NCT03053063|454427594|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
126311136|NCT03053063|454427595|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
126311137|NCT03053063|454427596|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
126311138|NCT03053063|454427597|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
126311139|NCT03053063|454427594|FG000|Randomized Phase|Withdrew consent|8|||
126311140|NCT03053063|454427595|FG001|Randomized Phase|Withdrew consent|11|||
126311141|NCT03053063|454427596|FG002|Randomized Phase|Withdrew consent|5|||
126311142|NCT03053063|454427597|FG003|Randomized Phase|Withdrew consent|0|||
126311143|NCT03053063|454427594|FG000|Randomized Phase|Investigator's Discretion|8|||
126311144|NCT03053063|454427595|FG001|Randomized Phase|Investigator's Discretion|6|||
126311145|NCT03053063|454427596|FG002|Randomized Phase|Investigator's Discretion|2|||
126311146|NCT03053063|454427597|FG003|Randomized Phase|Investigator's Discretion|0|||
126311147|NCT03053063|454427594|FG000|Randomized Phase|Lost to Follow-up|3|||
126311148|NCT03053063|454427595|FG001|Randomized Phase|Lost to Follow-up|5|||
126311149|NCT03053063|454427596|FG002|Randomized Phase|Lost to Follow-up|1|||
126311150|NCT03053063|454427597|FG003|Randomized Phase|Lost to Follow-up|0|||
126311151|NCT03053063|454427594|FG000|Randomized Phase|Adverse Event|0|||
126311152|NCT03053063|454427595|FG001|Randomized Phase|Adverse Event|1|||
126311153|NCT03053063|454427596|FG002|Randomized Phase|Adverse Event|0|||
126311154|NCT03053063|454427597|FG003|Randomized Phase|Adverse Event|0|||
126311155|NCT03053063|454427594|FG000|Randomized Phase|Randomized but Never Treated|1|||
126311156|NCT03053063|454427595|FG001|Randomized Phase|Randomized but Never Treated|3|||
126311157|NCT03053063|454427596|FG002|Randomized Phase|Randomized but Never Treated|2|||
126311158|NCT03053063|454427597|FG003|Randomized Phase|Randomized but Never Treated|0|||
126311159|NCT03053063|454427594|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
126311160|NCT03053063|454427595|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
126311161|NCT03053063|454427596|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
126311162|NCT03053063|454427597|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
126311163|NCT03053063|454427594|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
126311164|NCT03053063|454427595|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
126311165|NCT03053063|454427596|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
126311166|NCT03053063|454427597|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
126311167|NCT03053063|454427594|FG000|Open-Label Phase|Death|0|||
126311168|NCT03053063|454427595|FG001|Open-Label Phase|Death|0|||
126311169|NCT03053063|454427596|FG002|Open-Label Phase|Death|0|||
126311170|NCT03053063|454427597|FG003|Open-Label Phase|Death|2|||
126311171|NCT03053063|454427594|FG000|Open-Label Phase|Investigator's discretion|0|||
126311172|NCT03053063|454427595|FG001|Open-Label Phase|Investigator's discretion|0|||
126311173|NCT03053063|454427596|FG002|Open-Label Phase|Investigator's discretion|0|||
126311174|NCT03053063|454427597|FG003|Open-Label Phase|Investigator's discretion|2|||
126311175|NCT02600845|454427598|FG000|Overall Study|Reason Not Specified|3|||
126311176|NCT02600845|454427598|FG000|Overall Study|Non-compliance with Study Procedures|10|||
126311177|NCT02600845|454427598|FG000|Overall Study|Consent Withdrawal|5|||
126374390|NCT01770743|454669018|FG000|Overall Study|Sponsor Terminated Subject|1|||
126374391|NCT01770743|454669019|FG001|Overall Study|Sponsor Terminated Subject|0|||
126374392|NCT01770743|454669020|FG002|Overall Study|Sponsor Terminated Subject|0|||
126374393|NCT01770743|454669021|FG003|Overall Study|Sponsor Terminated Subject|1|||
126374394|NCT01770743|454669022|FG004|Overall Study|Sponsor Terminated Subject|0|||
126374395|NCT01770743|454669018|FG000|Overall Study|Moving Out of State|0|||
126374396|NCT01770743|454669019|FG001|Overall Study|Moving Out of State|1|||
126374397|NCT01770743|454669020|FG002|Overall Study|Moving Out of State|0|||
126374398|NCT01770743|454669021|FG003|Overall Study|Moving Out of State|0|||
126374399|NCT01770743|454669022|FG004|Overall Study|Moving Out of State|0|||
126374400|NCT00529243|454669023|FG000|Overall Study|Adverse Event|1|||
126374401|NCT00529243|454669023|FG000|Overall Study|Death|1|||
126374402|NCT00529243|454669023|FG000|Overall Study|Relocated|1|||
126374403|NCT00698828|454669028|FG000|Overall Study|Adverse Event|3|||
126374404|NCT00698828|454669029|FG001|Overall Study|Adverse Event|4|||
126374405|NCT00698828|454669030|FG002|Overall Study|Adverse Event|4|||
126374406|NCT00698828|454669028|FG000|Overall Study|Death|0|||
126374407|NCT00698828|454669029|FG001|Overall Study|Death|0|||
126374408|NCT00698828|454669030|FG002|Overall Study|Death|1|||
126374409|NCT00698828|454669028|FG000|Overall Study|Exacerbation of COPD|1|||
126374410|NCT00698828|454669029|FG001|Overall Study|Exacerbation of COPD|3|||
126374411|NCT00698828|454669030|FG002|Overall Study|Exacerbation of COPD|0|||
126374412|NCT00698828|454669028|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
126374413|NCT00698828|454669029|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
126374414|NCT00698828|454669030|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
126374415|NCT00698828|454669028|FG000|Overall Study|Investigator/Sponsor decision|1|||
126374416|NCT00698828|454669029|FG001|Overall Study|Investigator/Sponsor decision|0|||
126374417|NCT00698828|454669030|FG002|Overall Study|Investigator/Sponsor decision|2|||
126374418|NCT00698828|454669028|FG000|Overall Study|Lost to Follow-up|1|||
126374419|NCT00698828|454669029|FG001|Overall Study|Lost to Follow-up|1|||
126374420|NCT00698828|454669030|FG002|Overall Study|Lost to Follow-up|0|||
126374421|NCT00698828|454669028|FG000|Overall Study|Withdrew consent|0|||
126374422|NCT00698828|454669029|FG001|Overall Study|Withdrew consent|7|||
126374423|NCT00698828|454669030|FG002|Overall Study|Withdrew consent|4|||
126374424|NCT00698828|454669028|FG000|Overall Study|Withdrew consent (not treated)|2|||
126374425|NCT00698828|454669029|FG001|Overall Study|Withdrew consent (not treated)|0|||
126374426|NCT00698828|454669030|FG002|Overall Study|Withdrew consent (not treated)|0|||
126374427|NCT02013609|454669031|FG000|Overall Study|Withdrawal by Subject|9|||
126374428|NCT02013609|454669031|FG000|Overall Study|Lost to Follow-up|3|||
126374429|NCT02013609|454669031|FG000|Overall Study|Adverse Event|3|||
126374430|NCT02013609|454669031|FG000|Overall Study|Met Withdrawal Criteria|3|||
126374431|NCT00856609|454669032|FG000|Overall Study|Adverse Event|1|||
126374432|NCT00856609|454669033|FG001|Overall Study|Adverse Event|0|||
126374433|NCT00783432|454669034|FG000|Overall Study|Adverse Event|22|||
126374434|NCT00783432|454669035|FG001|Overall Study|Adverse Event|17|||
126374435|NCT00783432|454669034|FG000|Overall Study|Lack of Efficacy|20|||
126374436|NCT00783432|454669035|FG001|Overall Study|Lack of Efficacy|21|||
126374437|NCT00783432|454669034|FG000|Overall Study|Lost to Follow-up|11|||
126374438|NCT00783432|454669035|FG001|Overall Study|Lost to Follow-up|6|||
126374439|NCT00783432|454669034|FG000|Overall Study|Withdrawal by Subject|23|||
126374440|NCT00783432|454669035|FG001|Overall Study|Withdrawal by Subject|20|||
126374441|NCT00783432|454669034|FG000|Overall Study|subject moved|3|||
126374442|NCT00783432|454669035|FG001|Overall Study|subject moved|5|||
126374443|NCT00783432|454669034|FG000|Overall Study|Protocol Violation|6|||
126374444|NCT00783432|454669035|FG001|Overall Study|Protocol Violation|9|||
126374445|NCT03273907|454669036|FG000|Overall Study|Death|1|||
126374446|NCT03273907|454669036|FG000|Overall Study|Lost to Follow-up|4|||
126374447|NCT03273907|454669036|FG000|Overall Study|Withdrawal by Subject|2|||
126374448|NCT03273907|454669036|FG000|Overall Study|COVID 19|2|||
126374449|NCT00110214|454669037|FG000|Overall Study|Never started treatment|21|||
126374450|NCT00110214|454669038|FG001|Overall Study|Never started treatment|20|||
126374451|NCT00110214|454669037|FG000|Overall Study|Disease progression or death|260|||
126374452|NCT00110214|454669038|FG001|Overall Study|Disease progression or death|151|||
126374453|NCT00110214|454669037|FG000|Overall Study|Adverse Event|115|||
126374454|NCT00110214|454669038|FG001|Overall Study|Adverse Event|192|||
126374455|NCT00110214|454669037|FG000|Overall Study|Refused further treatment|52|||
126374456|NCT00110214|454669038|FG001|Overall Study|Refused further treatment|65|||
126374457|NCT00110214|454669037|FG000|Overall Study|Other (not specified)|61|||
126374458|NCT00110214|454669038|FG001|Overall Study|Other (not specified)|75|||
126374459|NCT02581891|454669039|FG000|Overall Study|Adverse Event|4|||
126374460|NCT02581891|454669040|FG001|Overall Study|Adverse Event|6|||
126374461|NCT02581891|454669039|FG000|Overall Study|Death|3|||
126374462|NCT02581891|454669040|FG001|Overall Study|Death|4|||
126374463|NCT02581891|454669039|FG000|Overall Study|Lost to Follow-up|1|||
126374464|NCT02581891|454669040|FG001|Overall Study|Lost to Follow-up|2|||
126374465|NCT02581891|454669039|FG000|Overall Study|Physician Decision|0|||
126374466|NCT02581891|454669040|FG001|Overall Study|Physician Decision|1|||
126374467|NCT02581891|454669039|FG000|Overall Study|Withdrawal by Subject|4|||
126374468|NCT02581891|454669040|FG001|Overall Study|Withdrawal by Subject|5|||
126374469|NCT02581891|454669039|FG000|Overall Study|Other Reasons|3|||
126374470|NCT02581891|454669040|FG001|Overall Study|Other Reasons|1|||
126374471|NCT02581891|454669039|FG000|Overall Study|Discontinued during followup|1|||
126374472|NCT02581891|454669040|FG001|Overall Study|Discontinued during followup|0|||
126374473|NCT05518461|454669045|FG000|Overall Study|Lost to Follow-up|25|||
126374474|NCT03179761|454669046|FG000|Overall Study|Death|2|||
126374475|NCT03179761|454669047|FG001|Overall Study|Death|5|||
126374476|NCT03179761|454669046|FG000|Overall Study|Lost to Follow-up|2|||
126374477|NCT03179761|454669047|FG001|Overall Study|Lost to Follow-up|2|||
126374478|NCT03179761|454669046|FG000|Overall Study|Protocol Violation|1|||
126374479|NCT03179761|454669047|FG001|Overall Study|Protocol Violation|0|||
126771041|NCT00422058|456116237|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
126374480|NCT03179761|454669046|FG000|Overall Study|Withdrawal by Subject|1|||
126374481|NCT03179761|454669047|FG001|Overall Study|Withdrawal by Subject|4|||
126374482|NCT03179761|454669046|FG000|Overall Study|Investigator Request|0|||
126374483|NCT03179761|454669047|FG001|Overall Study|Investigator Request|2|||
126374484|NCT00448448|454669049|FG000|Overall Study|Withdrawal by Subject|13|||
126374485|NCT00448448|454669050|FG001|Overall Study|Withdrawal by Subject|2|||
126374486|NCT00448448|454669049|FG000|Overall Study|On protocol when study ended|83|||
126374487|NCT00448448|454669050|FG001|Overall Study|On protocol when study ended|36|||
126374488|NCT00448448|454669049|FG000|Overall Study|Lost to Follow-up|2|||
126374489|NCT00448448|454669050|FG001|Overall Study|Lost to Follow-up|1|||
126374490|NCT00448448|454669049|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
126374491|NCT00448448|454669050|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
126374492|NCT00448448|454669049|FG000|Overall Study|Signed consent lost|0|||
126374493|NCT00448448|454669050|FG001|Overall Study|Signed consent lost|1|||
126374494|NCT02284191|454669051|FG000|Overall Study|Withdrawal by Subject|1|||
126374495|NCT02284191|454669052|FG001|Overall Study|Withdrawal by Subject|3|||
126374496|NCT02284191|454669051|FG000|Overall Study|Lost to Follow-up|1|||
126374497|NCT02284191|454669052|FG001|Overall Study|Lost to Follow-up|0|||
126374498|NCT01188967|454669053|FG000|Overall Study|Withdrawal by Subject|1|||
126374499|NCT01188967|454669054|FG001|Overall Study|Withdrawal by Subject|1|||
126374500|NCT01188967|454669053|FG000|Overall Study|Physician Decision|1|||
126374501|NCT01188967|454669054|FG001|Overall Study|Physician Decision|1|||
126374502|NCT01188967|454669053|FG000|Overall Study|Lost to Follow-up|3|||
126374503|NCT01188967|454669054|FG001|Overall Study|Lost to Follow-up|2|||
126374504|NCT01832727|454669059|FG000|Overall Study|Adverse Event|4|||
126374505|NCT01832727|454669060|FG001|Overall Study|Adverse Event|6|||
126374506|NCT01832727|454669061|FG002|Overall Study|Adverse Event|1|||
126374507|NCT01832727|454669062|FG003|Overall Study|Adverse Event|0|||
126374508|NCT01832727|454669063|FG004|Overall Study|Adverse Event|1|||
126374509|NCT01832727|454669064|FG005|Overall Study|Adverse Event|1|||
126374510|NCT01832727|454669065|FG006|Overall Study|Adverse Event|2|||
126374511|NCT01832727|454669066|FG007|Overall Study|Adverse Event|1|||
126374512|NCT01832727|454669067|FG008|Overall Study|Adverse Event|9|||
126374513|NCT01832727|454669059|FG000|Overall Study|Disease progression|3|||
126374514|NCT01832727|454669060|FG001|Overall Study|Disease progression|0|||
126374515|NCT01832727|454669061|FG002|Overall Study|Disease progression|2|||
126374516|NCT01832727|454669062|FG003|Overall Study|Disease progression|1|||
126374517|NCT01832727|454669063|FG004|Overall Study|Disease progression|3|||
126374518|NCT01832727|454669064|FG005|Overall Study|Disease progression|3|||
126374519|NCT01832727|454669065|FG006|Overall Study|Disease progression|6|||
126374520|NCT01832727|454669066|FG007|Overall Study|Disease progression|2|||
126374521|NCT01832727|454669067|FG008|Overall Study|Disease progression|7|||
126374522|NCT01832727|454669059|FG000|Overall Study|Lost to Follow-up|0|||
126374523|NCT01832727|454669060|FG001|Overall Study|Lost to Follow-up|0|||
126374524|NCT01832727|454669061|FG002|Overall Study|Lost to Follow-up|0|||
126374525|NCT01832727|454669062|FG003|Overall Study|Lost to Follow-up|1|||
126374526|NCT01832727|454669063|FG004|Overall Study|Lost to Follow-up|0|||
126374527|NCT01832727|454669064|FG005|Overall Study|Lost to Follow-up|0|||
126374528|NCT01832727|454669065|FG006|Overall Study|Lost to Follow-up|0|||
126374529|NCT01832727|454669066|FG007|Overall Study|Lost to Follow-up|0|||
126374530|NCT01832727|454669067|FG008|Overall Study|Lost to Follow-up|0|||
126374531|NCT01832727|454669059|FG000|Overall Study|Physician Decision|1|||
126374532|NCT01832727|454669060|FG001|Overall Study|Physician Decision|0|||
126374533|NCT01832727|454669061|FG002|Overall Study|Physician Decision|0|||
126374534|NCT01832727|454669062|FG003|Overall Study|Physician Decision|1|||
126374535|NCT01832727|454669063|FG004|Overall Study|Physician Decision|0|||
126374536|NCT01832727|454669064|FG005|Overall Study|Physician Decision|1|||
126374537|NCT01832727|454669065|FG006|Overall Study|Physician Decision|0|||
126374538|NCT01832727|454669066|FG007|Overall Study|Physician Decision|0|||
126374539|NCT01832727|454669067|FG008|Overall Study|Physician Decision|0|||
126374540|NCT01832727|454669059|FG000|Overall Study|Withdrawal by Subject|1|||
126374541|NCT01832727|454669060|FG001|Overall Study|Withdrawal by Subject|1|||
126374542|NCT01832727|454669061|FG002|Overall Study|Withdrawal by Subject|0|||
126374543|NCT01832727|454669062|FG003|Overall Study|Withdrawal by Subject|1|||
126374544|NCT01832727|454669063|FG004|Overall Study|Withdrawal by Subject|0|||
126374545|NCT01832727|454669064|FG005|Overall Study|Withdrawal by Subject|1|||
126374546|NCT01832727|454669065|FG006|Overall Study|Withdrawal by Subject|0|||
126771042|NCT00422058|456116232|FG000|Open-Label Extension, Week 20-104|Other|13|||
126374547|NCT01832727|454669066|FG007|Overall Study|Withdrawal by Subject|2|||
126374548|NCT01832727|454669067|FG008|Overall Study|Withdrawal by Subject|1|||
126374549|NCT01832727|454669059|FG000|Overall Study|Study terminated by sponsor|0|||
126374550|NCT01832727|454669060|FG001|Overall Study|Study terminated by sponsor|0|||
126374551|NCT01832727|454669061|FG002|Overall Study|Study terminated by sponsor|0|||
126374552|NCT01832727|454669062|FG003|Overall Study|Study terminated by sponsor|0|||
126374553|NCT01832727|454669063|FG004|Overall Study|Study terminated by sponsor|0|||
126374554|NCT01832727|454669064|FG005|Overall Study|Study terminated by sponsor|0|||
126374555|NCT01832727|454669065|FG006|Overall Study|Study terminated by sponsor|0|||
126374556|NCT01832727|454669066|FG007|Overall Study|Study terminated by sponsor|1|||
126374557|NCT01832727|454669067|FG008|Overall Study|Study terminated by sponsor|1|||
126374558|NCT04436744|454669074|FG000|Overall Study|Adverse Event|1|||
126374559|NCT04436744|454669075|FG001|Overall Study|Adverse Event|1|||
126374560|NCT04436744|454669074|FG000|Overall Study|Death|1|||
126374561|NCT04436744|454669075|FG001|Overall Study|Death|0|||
126374562|NCT04436744|454669074|FG000|Overall Study|Lost to Follow-up|0|||
126374563|NCT04436744|454669075|FG001|Overall Study|Lost to Follow-up|2|||
126374564|NCT04436744|454669074|FG000|Overall Study|Physician Decision|0|||
126374565|NCT04436744|454669075|FG001|Overall Study|Physician Decision|1|||
126374566|NCT04436744|454669074|FG000|Overall Study|Progressive Disease|0|||
126374567|NCT04436744|454669075|FG001|Overall Study|Progressive Disease|4|||
126374568|NCT04436744|454669074|FG000|Overall Study|Protocol Deviation|1|||
126374569|NCT04436744|454669075|FG001|Overall Study|Protocol Deviation|1|||
126374570|NCT04436744|454669074|FG000|Overall Study|Withdrawal by Subject|1|||
126374571|NCT04436744|454669075|FG001|Overall Study|Withdrawal by Subject|2|||
126374572|NCT01133847|454669076|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
126374573|NCT01133847|454669077|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
126374574|NCT01133847|454669078|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
126374575|NCT01133847|454669076|FG000|Follow-Up Phase|Lost to Follow-up|1|||
126374576|NCT01133847|454669077|FG001|Follow-Up Phase|Lost to Follow-up|3|||
126374577|NCT01133847|454669078|FG002|Follow-Up Phase|Lost to Follow-up|7|||
126374578|NCT01463033|454669079|FG000|Overall Study|Lost to Follow-up|4|||
126374579|NCT01463033|454669080|FG001|Overall Study|Lost to Follow-up|4|||
126374580|NCT01463033|454669079|FG000|Overall Study|Death|3|||
126374581|NCT01463033|454669080|FG001|Overall Study|Death|2|||
126374582|NCT00967616|454669081|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
126374583|NCT00967616|454669082|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
126374584|NCT00967616|454669081|FG000|Overall Study|Death|0|||
126374585|NCT00967616|454669082|FG001|Overall Study|Death|3|||
126374586|NCT00967616|454669081|FG000|Overall Study|Withdrawal by Subject|8|||
126374587|NCT00967616|454669082|FG001|Overall Study|Withdrawal by Subject|4|||
126374588|NCT00967616|454669081|FG000|Overall Study|Progressive Disease|31|||
126374589|NCT00967616|454669082|FG001|Overall Study|Progressive Disease|18|||
126374590|NCT00967616|454669081|FG000|Overall Study|Other|8|||
126374591|NCT00967616|454669082|FG001|Overall Study|Other|8|||
126374592|NCT00967616|454669081|FG000|Overall Study|Protocol Violation|1|||
126374593|NCT00967616|454669082|FG001|Overall Study|Protocol Violation|0|||
126374594|NCT01368614|454669083|FG000|Screening Period|Screen Failure|58|||
126374595|NCT01368614|454669084|FG001|Screening Period|Screen Failure|0|||
126374596|NCT01368614|454669085|FG002|Screening Period|Screen Failure|0|||
126374597|NCT01368614|454669086|FG003|Screening Period|Screen Failure|0|||
126374598|NCT01368614|454669083|FG000|Study Period|Withdrawal by Subject|0|||
126374599|NCT01368614|454669084|FG001|Study Period|Withdrawal by Subject|1|||
126374600|NCT01368614|454669085|FG002|Study Period|Withdrawal by Subject|1|||
126374601|NCT01368614|454669086|FG003|Study Period|Withdrawal by Subject|3|||
126374602|NCT01368614|454669083|FG000|Study Period|Lost to Follow-up|0|||
126374603|NCT01368614|454669084|FG001|Study Period|Lost to Follow-up|0|||
126374604|NCT01368614|454669085|FG002|Study Period|Lost to Follow-up|1|||
126374605|NCT01368614|454669086|FG003|Study Period|Lost to Follow-up|0|||
126374606|NCT02951780|454669087|FG000|Period 1|Adverse Event|0|||
126374607|NCT02951780|454669088|FG001|Period 1|Adverse Event|0|||
126374608|NCT02951780|454669089|FG002|Period 1|Adverse Event|0|||
126374609|NCT02951780|454669090|FG003|Period 1|Adverse Event|1|||
126374610|NCT02951780|454669091|FG004|Period 1|Adverse Event|0|||
126374611|NCT02951780|454669092|FG005|Period 1|Adverse Event|0|||
126374612|NCT02951780|454669093|FG006|Period 1|Adverse Event|0|||
126374613|NCT02951780|454669094|FG007|Period 1|Adverse Event|0|||
126374614|NCT02951780|454669095|FG008|Period 1|Adverse Event|0|||
126374615|NCT02951780|454669087|FG000|Period 1|Scheduling Conflicts|0|||
126466724|NCT01134315|455010454|FG001|Overall Study|Other Reason|17|||
126466725|NCT02694523|455010455|FG000|Part A|Adverse Event|7|||
126466726|NCT02694523|455010456|FG001|Part A|Adverse Event|3|||
126466727|NCT02694523|455010457|FG002|Part A|Adverse Event|0|||
126374616|NCT02951780|454669088|FG001|Period 1|Scheduling Conflicts|0|||
126374617|NCT02951780|454669089|FG002|Period 1|Scheduling Conflicts|0|||
126374618|NCT02951780|454669090|FG003|Period 1|Scheduling Conflicts|0|||
126374619|NCT02951780|454669091|FG004|Period 1|Scheduling Conflicts|0|||
126374620|NCT02951780|454669092|FG005|Period 1|Scheduling Conflicts|0|||
126374621|NCT02951780|454669093|FG006|Period 1|Scheduling Conflicts|0|||
126374622|NCT02951780|454669094|FG007|Period 1|Scheduling Conflicts|1|||
126374623|NCT02951780|454669095|FG008|Period 1|Scheduling Conflicts|0|||
126374624|NCT02951780|454669087|FG000|Period 2|Scheduling Conflicts|0|||
126374625|NCT02951780|454669088|FG001|Period 2|Scheduling Conflicts|0|||
126374626|NCT02951780|454669089|FG002|Period 2|Scheduling Conflicts|0|||
126374627|NCT02951780|454669090|FG003|Period 2|Scheduling Conflicts|0|||
126466728|NCT02694523|455010458|FG003|Part A|Adverse Event|0|||
126716742|NCT01781429|455914912|FG002|Overall Study|Unacceptable Toxicity|0|||
126374628|NCT02951780|454669091|FG004|Period 2|Scheduling Conflicts|0|||
126374629|NCT02951780|454669092|FG005|Period 2|Scheduling Conflicts|0|||
126466729|NCT02694523|455010459|FG004|Part A|Adverse Event|0|||
126374630|NCT02951780|454669093|FG006|Period 2|Scheduling Conflicts|0|||
126374631|NCT02951780|454669094|FG007|Period 2|Scheduling Conflicts|1|||
126374632|NCT02951780|454669095|FG008|Period 2|Scheduling Conflicts|0|||
126374633|NCT01374425|454669096|FG000|Overall Study|Radiographic Disease Progression|86|||
126374634|NCT01374425|454669097|FG001|Overall Study|Radiographic Disease Progression|81|||
126374635|NCT01374425|454669096|FG000|Overall Study|Clinical Disease Progression|9|||
126374636|NCT01374425|454669097|FG001|Overall Study|Clinical Disease Progression|6|||
126466730|NCT02694523|455010460|FG005|Part A|Adverse Event|0|||
126466731|NCT02694523|455010461|FG006|Part A|Adverse Event|0|||
126374637|NCT01374425|454669096|FG000|Overall Study|Adverse Event|29|||
126374638|NCT01374425|454669097|FG001|Overall Study|Adverse Event|18|||
126374639|NCT01374425|454669096|FG000|Overall Study|Death (Progression of Disease)|1|||
126374640|NCT01374425|454669097|FG001|Overall Study|Death (Progression of Disease)|0|||
126374641|NCT01374425|454669096|FG000|Overall Study|Death (Adverse Event)|2|||
126374642|NCT01374425|454669097|FG001|Overall Study|Death (Adverse Event)|4|||
126374643|NCT01374425|454669096|FG000|Overall Study|Withdrawal by Subject|6|||
126374644|NCT01374425|454669097|FG001|Overall Study|Withdrawal by Subject|7|||
126374645|NCT01374425|454669096|FG000|Overall Study|Refused Treatment|10|||
126374646|NCT01374425|454669097|FG001|Overall Study|Refused Treatment|24|||
126374647|NCT01374425|454669096|FG000|Overall Study|Protocol Violation|2|||
126374648|NCT01374425|454669097|FG001|Overall Study|Protocol Violation|3|||
126374649|NCT01374425|454669096|FG000|Overall Study|Sponsor Decision|0|||
126374650|NCT01374425|454669097|FG001|Overall Study|Sponsor Decision|1|||
126374651|NCT01374425|454669096|FG000|Overall Study|Lost to Follow-up|2|||
126374652|NCT01374425|454669097|FG001|Overall Study|Lost to Follow-up|1|||
126374653|NCT01374425|454669096|FG000|Overall Study|Other|41|||
126374654|NCT01374425|454669097|FG001|Overall Study|Other|43|||
126374655|NCT02359903|454669098|FG000|Overall Study|Adverse Event|0|||
126374656|NCT02359903|454669099|FG001|Overall Study|Adverse Event|2|||
126374657|NCT00546481|454669100|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
126374658|NCT00546481|454669101|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
126374659|NCT00546481|454669102|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
126374660|NCT00546481|454669100|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
126374661|NCT00546481|454669101|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
126374662|NCT00546481|454669102|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
126374663|NCT00546481|454669100|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
126374664|NCT00546481|454669101|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
126374665|NCT00546481|454669102|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
126374666|NCT00546481|454669100|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
126374667|NCT00546481|454669101|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
126374668|NCT00546481|454669102|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
126466732|NCT02694523|455010455|FG000|Part A|Protocol Violation|1|||
126466733|NCT02694523|455010456|FG001|Part A|Protocol Violation|0|||
126466734|NCT02694523|455010457|FG002|Part A|Protocol Violation|0|||
126374669|NCT00546481|454669100|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
126374670|NCT00546481|454669101|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
126374671|NCT00546481|454669102|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
126374672|NCT00546481|454669100|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
126374673|NCT00546481|454669101|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
126374674|NCT00546481|454669102|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
126374675|NCT00546481|454669100|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
126374676|NCT00546481|454669101|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
126374677|NCT00546481|454669102|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
126374678|NCT00546481|454669100|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
126374679|NCT00546481|454669101|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
126374680|NCT00546481|454669102|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
126374681|NCT00546481|454669100|FG000|Maintenance Phase (CERA)|Other Reason|0|||
126716743|NCT01781429|455914913|FG003|Overall Study|Unacceptable Toxicity|0|||
126374682|NCT00546481|454669101|FG001|Maintenance Phase (CERA)|Other Reason|0|||
126374683|NCT00546481|454669102|FG002|Maintenance Phase (CERA)|Other Reason|1|||
126466735|NCT02694523|455010458|FG003|Part A|Protocol Violation|0|||
126466736|NCT02694523|455010459|FG004|Part A|Protocol Violation|0|||
126466737|NCT02694523|455010460|FG005|Part A|Protocol Violation|0|||
126374684|NCT01240863|454669105|FG000|Open-label Titration Period|Adverse Event|47|||
126374685|NCT01240863|454669106|FG001|Open-label Titration Period|Adverse Event|0|||
126374686|NCT01240863|454669107|FG002|Open-label Titration Period|Adverse Event|0|||
126374687|NCT01240863|454669105|FG000|Open-label Titration Period|Lack of Efficacy|19|||
126374688|NCT01240863|454669106|FG001|Open-label Titration Period|Lack of Efficacy|0|||
126374689|NCT01240863|454669107|FG002|Open-label Titration Period|Lack of Efficacy|0|||
126374690|NCT01240863|454669105|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
126374691|NCT01240863|454669106|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
126374692|NCT01240863|454669107|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
126466738|NCT02694523|455010461|FG006|Part A|Protocol Violation|0|||
126374693|NCT01240863|454669105|FG000|Open-label Titration Period|Protocol Violation|7|||
126374694|NCT01240863|454669106|FG001|Open-label Titration Period|Protocol Violation|0|||
126374695|NCT01240863|454669107|FG002|Open-label Titration Period|Protocol Violation|0|||
126374696|NCT01240863|454669105|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
126374697|NCT01240863|454669106|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
126374698|NCT01240863|454669107|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
126374699|NCT01240863|454669105|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
126374700|NCT01240863|454669106|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
126374701|NCT01240863|454669107|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
126374702|NCT01240863|454669105|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
126374703|NCT01240863|454669106|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
126374704|NCT01240863|454669107|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
126374705|NCT01240863|454669105|FG000|Open-label Titration Period|Other|7|||
126374706|NCT01240863|454669106|FG001|Open-label Titration Period|Other|0|||
126374707|NCT01240863|454669107|FG002|Open-label Titration Period|Other|0|||
126374708|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
126374709|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
126374710|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
126374711|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
126374712|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
126466739|NCT02694523|455010455|FG000|Part A|Lost to Follow-up|1|||
126466740|NCT02694523|455010456|FG001|Part A|Lost to Follow-up|2|||
126466741|NCT02694523|455010457|FG002|Part A|Lost to Follow-up|0|||
126552930|NCT02291289|455320511|FG010|Induction Treatment|Adverse Event|0|||
126552931|NCT02291289|455320512|FG011|Induction Treatment|Adverse Event|0|||
126552932|NCT02291289|455320513|FG012|Induction Treatment|Adverse Event|0|||
126552933|NCT02291289|455320501|FG000|Induction Treatment|Death|25|||
126552934|NCT02291289|455320502|FG001|Induction Treatment|Death|0|||
126374713|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
126374714|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
126374715|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
126374716|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
126374717|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
126374718|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
126466742|NCT02694523|455010458|FG003|Part A|Lost to Follow-up|0|||
126466743|NCT02694523|455010459|FG004|Part A|Lost to Follow-up|0|||
126466744|NCT02694523|455010460|FG005|Part A|Lost to Follow-up|0|||
126466745|NCT02694523|455010461|FG006|Part A|Lost to Follow-up|0|||
126466746|NCT02694523|455010455|FG000|Part A|Withdrawal by Subject|3|||
126466747|NCT02694523|455010456|FG001|Part A|Withdrawal by Subject|1|||
126466748|NCT02694523|455010457|FG002|Part A|Withdrawal by Subject|0|||
126552935|NCT02291289|455320503|FG002|Induction Treatment|Death|0|||
126552936|NCT02291289|455320504|FG003|Induction Treatment|Death|111|||
126552937|NCT02291289|455320505|FG004|Induction Treatment|Death|0|||
126552938|NCT02291289|455320506|FG005|Induction Treatment|Death|0|||
126552939|NCT02291289|455320507|FG006|Induction Treatment|Death|1|||
126552940|NCT02291289|455320508|FG007|Induction Treatment|Death|0|||
126552941|NCT02291289|455320509|FG008|Induction Treatment|Death|0|||
126552942|NCT02291289|455320510|FG009|Induction Treatment|Death|82|||
126552943|NCT02291289|455320511|FG010|Induction Treatment|Death|0|||
126771043|NCT00422058|456116233|FG001|Open-Label Extension, Week 20-104|Other|14|||
126771044|NCT00422058|456116234|FG002|Open-Label Extension, Week 20-104|Other|6|||
126771045|NCT00422058|456116235|FG003|Open-Label Extension, Week 20-104|Other|13|||
126771046|NCT00422058|456116236|FG004|Open-Label Extension, Week 20-104|Other|16|||
126771047|NCT00422058|456116237|FG005|Open-Label Extension, Week 20-104|Other|18|||
126771048|NCT01346501|456116238|FG000|Overall Study|Initiated Other Biological Agents|3|||
126771049|NCT01346501|456116239|FG001|Overall Study|Initiated Other Biological Agents|1|||
126771050|NCT01346501|456116238|FG000|Overall Study|Other|8|||
126771051|NCT01346501|456116239|FG001|Overall Study|Other|12|||
126771052|NCT00038467|456116240|FG000|Overall Study|Adverse Event|170|||
126771053|NCT00038467|456116241|FG001|Overall Study|Adverse Event|145|||
126771054|NCT00038467|456116240|FG000|Overall Study|Withdrawal by Subject|150|||
126771055|NCT00038467|456116241|FG001|Overall Study|Withdrawal by Subject|107|||
126771056|NCT00038467|456116240|FG000|Overall Study|Protocol Violation|19|||
126771057|NCT00038467|456116241|FG001|Overall Study|Protocol Violation|22|||
126771058|NCT00038467|456116240|FG000|Overall Study|Death|22|||
126771059|NCT00038467|456116241|FG001|Overall Study|Death|16|||
126771060|NCT00038467|456116240|FG000|Overall Study|Lost to Follow-up|15|||
126771061|NCT00038467|456116241|FG001|Overall Study|Lost to Follow-up|10|||
126771062|NCT00038467|456116240|FG000|Overall Study|Recurrence|109|||
126771063|NCT00038467|456116241|FG001|Overall Study|Recurrence|179|||
126552944|NCT02291289|455320512|FG011|Induction Treatment|Death|0|||
126552945|NCT02291289|455320513|FG012|Induction Treatment|Death|0|||
126552946|NCT02291289|455320501|FG000|Induction Treatment|Lost to Follow-up|1|||
126552947|NCT02291289|455320502|FG001|Induction Treatment|Lost to Follow-up|0|||
126771064|NCT00038467|456116240|FG000|Overall Study|Randomized, but not treated|31|||
126552948|NCT02291289|455320503|FG002|Induction Treatment|Lost to Follow-up|0|||
126552949|NCT02291289|455320504|FG003|Induction Treatment|Lost to Follow-up|12|||
126552950|NCT02291289|455320505|FG004|Induction Treatment|Lost to Follow-up|0|||
126552951|NCT02291289|455320506|FG005|Induction Treatment|Lost to Follow-up|0|||
126552952|NCT02291289|455320507|FG006|Induction Treatment|Lost to Follow-up|0|||
126552953|NCT02291289|455320508|FG007|Induction Treatment|Lost to Follow-up|0|||
126374719|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
126374720|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
126374721|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
126374722|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
126374723|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
126374724|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
126374725|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
126374726|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
126374727|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
126374728|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
126374729|NCT01240863|454669105|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
126374730|NCT01240863|454669106|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
126374731|NCT01240863|454669107|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
126374732|NCT03783780|454669112|FG000|Overall Study|Withdrawn prior to completion|1|||
126374733|NCT03768427|454669113|FG000|Overall Study|Death|0|||
126374734|NCT03768427|454669114|FG001|Overall Study|Death|0|||
126374735|NCT03768427|454669115|FG002|Overall Study|Death|1|||
126374736|NCT03768427|454669116|FG003|Overall Study|Death|0|||
126374737|NCT03768427|454669113|FG000|Overall Study|Lost to Follow-up|2|||
126374738|NCT03768427|454669114|FG001|Overall Study|Lost to Follow-up|0|||
126374739|NCT03768427|454669115|FG002|Overall Study|Lost to Follow-up|0|||
126374740|NCT03768427|454669116|FG003|Overall Study|Lost to Follow-up|0|||
126374741|NCT03768427|454669113|FG000|Overall Study|Physician Decision|3|||
126374742|NCT03768427|454669114|FG001|Overall Study|Physician Decision|2|||
126374743|NCT03768427|454669115|FG002|Overall Study|Physician Decision|4|||
126374744|NCT03768427|454669116|FG003|Overall Study|Physician Decision|4|||
126374745|NCT03768427|454669113|FG000|Overall Study|Withdrawal by Subject|7|||
126374746|NCT03768427|454669114|FG001|Overall Study|Withdrawal by Subject|2|||
126374747|NCT03768427|454669115|FG002|Overall Study|Withdrawal by Subject|6|||
126374748|NCT03768427|454669116|FG003|Overall Study|Withdrawal by Subject|7|||
126374749|NCT00776789|454669117|FG000|Overall Study|Consent refusal|2|||
126374750|NCT00776789|454669118|FG001|Overall Study|Consent refusal|2|||
126374751|NCT00776789|454669117|FG000|Overall Study|Poor quality video|1|||
126374752|NCT00776789|454669118|FG001|Overall Study|Poor quality video|1|||
126374753|NCT02629861|454669124|FG000|Overall Study|Adverse Event|7|||
126374754|NCT02629861|454669125|FG001|Overall Study|Adverse Event|5|||
126374755|NCT02629861|454669126|FG002|Overall Study|Adverse Event|4|||
126374756|NCT02629861|454669124|FG000|Overall Study|Withdrawal by Subject|5|||
126374757|NCT02629861|454669125|FG001|Overall Study|Withdrawal by Subject|8|||
126374758|NCT02629861|454669126|FG002|Overall Study|Withdrawal by Subject|13|||
126374759|NCT02629861|454669124|FG000|Overall Study|Protocol Violation|2|||
126374760|NCT02629861|454669125|FG001|Overall Study|Protocol Violation|3|||
126374761|NCT02629861|454669126|FG002|Overall Study|Protocol Violation|7|||
126374762|NCT02629861|454669124|FG000|Overall Study|Lost to Follow-up|12|||
126374763|NCT02629861|454669125|FG001|Overall Study|Lost to Follow-up|9|||
126374764|NCT02629861|454669126|FG002|Overall Study|Lost to Follow-up|4|||
126374765|NCT02629861|454669124|FG000|Overall Study|Other|1|||
126374766|NCT02629861|454669125|FG001|Overall Study|Other|1|||
126374767|NCT02629861|454669126|FG002|Overall Study|Other|0|||
126374768|NCT02629861|454669124|FG000|Overall Study|Pregnancy|2|||
126374769|NCT02629861|454669125|FG001|Overall Study|Pregnancy|1|||
126374770|NCT02629861|454669126|FG002|Overall Study|Pregnancy|0|||
126374771|NCT00907621|454669130|FG000|Overall Study|Lost to Follow-up|6|||
126374772|NCT00907621|454669131|FG001|Overall Study|Lost to Follow-up|3|||
126374773|NCT00907621|454669130|FG000|Overall Study|intercurrent febrile illness|1|||
126374774|NCT00907621|454669131|FG001|Overall Study|intercurrent febrile illness|1|||
126374775|NCT00902330|454669134|FG000|Overall Study|Too overwhelmed by treatment|2|||
126374776|NCT00902330|454669135|FG001|Overall Study|Too overwhelmed by treatment|5|||
126552954|NCT02291289|455320509|FG008|Induction Treatment|Lost to Follow-up|0|||
126374777|NCT00902330|454669134|FG000|Overall Study|Adverse Event|1|||
126374778|NCT00902330|454669135|FG001|Overall Study|Adverse Event|0|||
126374779|NCT00902330|454669134|FG000|Overall Study|No post baseline data|1|||
126374780|NCT00902330|454669135|FG001|Overall Study|No post baseline data|0|||
126374781|NCT00165789|454669136|FG000|Overall Study|Adverse Event|0|||
126374782|NCT00165789|454669137|FG001|Overall Study|Adverse Event|3|||
126374783|NCT00165789|454669138|FG002|Overall Study|Adverse Event|0|||
126374784|NCT00165789|454669139|FG003|Overall Study|Adverse Event|12|||
126374785|NCT00165789|454669136|FG000|Overall Study|Withdrawal by Subject|0|||
126552955|NCT02291289|455320510|FG009|Induction Treatment|Lost to Follow-up|9|||
126374786|NCT00165789|454669137|FG001|Overall Study|Withdrawal by Subject|1|||
126374787|NCT00165789|454669138|FG002|Overall Study|Withdrawal by Subject|1|||
126374788|NCT00165789|454669139|FG003|Overall Study|Withdrawal by Subject|2|||
126374789|NCT01816048|454669140|FG000|Overall Study|Adverse Event|1|||
126374790|NCT01816048|454669140|FG000|Overall Study|Death|1|||
126374791|NCT01816048|454669140|FG000|Overall Study|Withdrawal by Subject|1|||
126374792|NCT01816048|454669140|FG000|Overall Study|Disease Progression|3|||
126374793|NCT04290624|454669141|FG000|Overall Study|Adverse Event|1|||
126374794|NCT04290624|454669142|FG001|Overall Study|Adverse Event|0|||
126374795|NCT00656370|454669147|FG000|Overall Study|Screen Failures|7|||
126374796|NCT00656370|454669147|FG000|Overall Study|Alternates|3|||
126374797|NCT01816984|454669148|FG000|Overall Study|declining health status|1|||
126374798|NCT01342094|454669151|FG000|Overall Study|Adverse Event|5|||
126374799|NCT01342094|454669152|FG001|Overall Study|Adverse Event|0|||
126374800|NCT01342094|454669151|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
126374801|NCT01342094|454669152|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
126374802|NCT01342094|454669151|FG000|Overall Study|Withdrawal by Subject|0|||
126374803|NCT01342094|454669152|FG001|Overall Study|Withdrawal by Subject|2|||
126374804|NCT02121509|454669153|FG000|Washout Period (35 Days)|Adverse Event|1|||
126374805|NCT02121509|454669154|FG001|Washout Period (35 Days)|Adverse Event|1|||
126374806|NCT02121509|454669155|FG002|Washout Period (35 Days)|Adverse Event|0|||
126374807|NCT02121509|454669156|FG003|Washout Period (35 Days)|Adverse Event|0|||
126374808|NCT02121509|454669153|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
126374809|NCT02121509|454669154|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
126374810|NCT02121509|454669155|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
126374811|NCT02121509|454669156|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
126374812|NCT02121509|454669153|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
126374813|NCT02121509|454669154|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
126374814|NCT02121509|454669155|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
126374815|NCT02121509|454669156|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
126374816|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
126374817|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
126374818|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
126374819|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
126374820|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
126374821|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
126374822|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
126374823|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
126374824|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
126374825|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
126374826|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
126374827|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
126374828|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
126374829|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
126374830|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
126374831|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
126374832|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
126374833|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
126374834|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
126374835|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
126374836|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
126374837|NCT04021290|454669163|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
126374838|NCT04021290|454669164|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
126374839|NCT04021290|454669165|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
126374840|NCT04021290|454669163|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
126374841|NCT04021290|454669164|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
126374842|NCT04021290|454669165|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
126374843|NCT04021290|454669163|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
126374844|NCT04021290|454669164|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
126374845|NCT04021290|454669165|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
126374846|NCT04021290|454669163|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
126374847|NCT04021290|454669164|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
126374848|NCT04021290|454669165|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
126374849|NCT04021290|454669163|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
126374850|NCT04021290|454669164|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
126374851|NCT04021290|454669165|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
126374852|NCT00636181|454669166|FG000|Overall Study|Withdrawal by Subject|8|||
126374853|NCT00636181|454669167|FG001|Overall Study|Withdrawal by Subject|6|||
126374854|NCT00636181|454669168|FG002|Overall Study|Withdrawal by Subject|10|||
126466749|NCT02694523|455010458|FG003|Part A|Withdrawal by Subject|0|||
126466750|NCT02694523|455010459|FG004|Part A|Withdrawal by Subject|0|||
126466751|NCT02694523|455010460|FG005|Part A|Withdrawal by Subject|0|||
126466752|NCT02694523|455010461|FG006|Part A|Withdrawal by Subject|0|||
126466753|NCT02694523|455010455|FG000|Part A|Other|1|||
126466754|NCT02694523|455010456|FG001|Part A|Other|1|||
126466755|NCT02694523|455010457|FG002|Part A|Other|0|||
126466756|NCT02694523|455010458|FG003|Part A|Other|0|||
126466757|NCT02694523|455010459|FG004|Part A|Other|0|||
126466758|NCT02694523|455010460|FG005|Part A|Other|0|||
126466759|NCT02694523|455010461|FG006|Part A|Other|0|||
126466760|NCT02694523|455010455|FG000|Part B|Adverse Event|0|||
126466761|NCT02694523|455010456|FG001|Part B|Adverse Event|0|||
126716744|NCT01781429|455914914|FG004|Overall Study|Unacceptable Toxicity|0|||
126466762|NCT02694523|455010457|FG002|Part B|Adverse Event|7|||
126466763|NCT02694523|455010458|FG003|Part B|Adverse Event|1|||
126466764|NCT02694523|455010459|FG004|Part B|Adverse Event|1|||
126466765|NCT02694523|455010460|FG005|Part B|Adverse Event|2|||
126466766|NCT02694523|455010461|FG006|Part B|Adverse Event|0|||
126466767|NCT02694523|455010455|FG000|Part B|Protocol Violation|0|||
126466768|NCT02694523|455010456|FG001|Part B|Protocol Violation|0|||
126466769|NCT02694523|455010457|FG002|Part B|Protocol Violation|1|||
126466770|NCT02694523|455010458|FG003|Part B|Protocol Violation|0|||
126466771|NCT02694523|455010459|FG004|Part B|Protocol Violation|0|||
126466772|NCT02694523|455010460|FG005|Part B|Protocol Violation|0|||
126466773|NCT02694523|455010461|FG006|Part B|Protocol Violation|0|||
126466774|NCT02694523|455010455|FG000|Part B|Lost to Follow-up|0|||
126466775|NCT02694523|455010456|FG001|Part B|Lost to Follow-up|0|||
126466776|NCT02694523|455010457|FG002|Part B|Lost to Follow-up|2|||
126466777|NCT02694523|455010458|FG003|Part B|Lost to Follow-up|3|||
126466778|NCT02694523|455010459|FG004|Part B|Lost to Follow-up|2|||
126466779|NCT02694523|455010460|FG005|Part B|Lost to Follow-up|0|||
126466780|NCT02694523|455010461|FG006|Part B|Lost to Follow-up|1|||
126466781|NCT02694523|455010455|FG000|Part B|Withdrawal by Subject|0|||
126466782|NCT02694523|455010456|FG001|Part B|Withdrawal by Subject|0|||
126552956|NCT02291289|455320511|FG010|Induction Treatment|Lost to Follow-up|0|||
126552957|NCT02291289|455320512|FG011|Induction Treatment|Lost to Follow-up|0|||
126552958|NCT02291289|455320513|FG012|Induction Treatment|Lost to Follow-up|0|||
126552959|NCT02291289|455320501|FG000|Induction Treatment|Non-Compliance|0|||
126552960|NCT02291289|455320502|FG001|Induction Treatment|Non-Compliance|0|||
126552961|NCT02291289|455320503|FG002|Induction Treatment|Non-Compliance|0|||
126552962|NCT02291289|455320504|FG003|Induction Treatment|Non-Compliance|1|||
126552963|NCT02291289|455320505|FG004|Induction Treatment|Non-Compliance|0|||
126552964|NCT02291289|455320506|FG005|Induction Treatment|Non-Compliance|0|||
126552965|NCT02291289|455320507|FG006|Induction Treatment|Non-Compliance|0|||
126716745|NCT01781429|455914915|FG005|Overall Study|Unacceptable Toxicity|0|||
126716746|NCT01781429|455914916|FG006|Overall Study|Unacceptable Toxicity|0|||
126716747|NCT01781429|455914917|FG007|Overall Study|Unacceptable Toxicity|0|||
126716748|NCT01781429|455914918|FG008|Overall Study|Unacceptable Toxicity|0|||
126374855|NCT03069716|454669171|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
126374856|NCT03069716|454669172|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
126374857|NCT03069716|454669173|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
126374858|NCT03069716|454669171|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
126374859|NCT03069716|454669172|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
126374860|NCT03069716|454669173|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
126374861|NCT03069716|454669171|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
126374862|NCT03069716|454669172|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
126374863|NCT03069716|454669173|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
126374864|NCT03069716|454669171|FG000|Randomized Treatment|Withdrawal by Subject|0|||
126374865|NCT03069716|454669172|FG001|Randomized Treatment|Withdrawal by Subject|2|||
126374866|NCT03069716|454669173|FG002|Randomized Treatment|Withdrawal by Subject|0|||
126374867|NCT05076045|454669179|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
126374868|NCT05076045|454669180|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
126374869|NCT03391882|454669181|FG000|Study Overall|Adverse Event|3|||
126374870|NCT03391882|454669182|FG001|Study Overall|Adverse Event|6|||
126374871|NCT03391882|454669183|FG002|Study Overall|Adverse Event|1|||
126374872|NCT03391882|454669184|FG003|Study Overall|Adverse Event|1|||
126466783|NCT02694523|455010457|FG002|Part B|Withdrawal by Subject|9|||
126552966|NCT02291289|455320508|FG007|Induction Treatment|Non-Compliance|0|||
126552967|NCT02291289|455320509|FG008|Induction Treatment|Non-Compliance|0|||
126466784|NCT02694523|455010458|FG003|Part B|Withdrawal by Subject|0|||
126466785|NCT02694523|455010459|FG004|Part B|Withdrawal by Subject|1|||
126466786|NCT02694523|455010460|FG005|Part B|Withdrawal by Subject|3|||
126466787|NCT02694523|455010461|FG006|Part B|Withdrawal by Subject|0|||
126466788|NCT02694523|455010455|FG000|Part B|Other|0|||
126466789|NCT02694523|455010456|FG001|Part B|Other|0|||
126466790|NCT02694523|455010457|FG002|Part B|Other|1|||
126466791|NCT02694523|455010458|FG003|Part B|Other|0|||
126466792|NCT02694523|455010459|FG004|Part B|Other|0|||
126466793|NCT02694523|455010460|FG005|Part B|Other|0|||
126466794|NCT02694523|455010461|FG006|Part B|Other|1|||
126716749|NCT01781429|455914919|FG009|Overall Study|Unacceptable Toxicity|0|||
126716750|NCT01781429|455914920|FG010|Overall Study|Unacceptable Toxicity|0|||
126716751|NCT01781429|455914921|FG011|Overall Study|Unacceptable Toxicity|2|||
126716752|NCT01781429|455914922|FG012|Overall Study|Unacceptable Toxicity|0|||
126716753|NCT01781429|455914923|FG013|Overall Study|Unacceptable Toxicity|0|||
126374873|NCT03391882|454669185|FG004|Study Overall|Adverse Event|3|||
126374874|NCT03391882|454669186|FG005|Study Overall|Adverse Event|1|||
126374875|NCT03391882|454669181|FG000|Study Overall|Lack of Efficacy|13|||
126374876|NCT03391882|454669182|FG001|Study Overall|Lack of Efficacy|9|||
126374877|NCT03391882|454669183|FG002|Study Overall|Lack of Efficacy|0|||
126374878|NCT03391882|454669184|FG003|Study Overall|Lack of Efficacy|0|||
126374879|NCT03391882|454669185|FG004|Study Overall|Lack of Efficacy|0|||
126374880|NCT03391882|454669186|FG005|Study Overall|Lack of Efficacy|0|||
126374881|NCT03391882|454669181|FG000|Study Overall|Withdrawal by Subject|3|||
126374882|NCT03391882|454669182|FG001|Study Overall|Withdrawal by Subject|3|||
126374883|NCT03391882|454669183|FG002|Study Overall|Withdrawal by Subject|2|||
126374884|NCT03391882|454669184|FG003|Study Overall|Withdrawal by Subject|2|||
126374885|NCT03391882|454669185|FG004|Study Overall|Withdrawal by Subject|1|||
126374886|NCT03391882|454669186|FG005|Study Overall|Withdrawal by Subject|3|||
126374887|NCT03391882|454669181|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
126374888|NCT03391882|454669182|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
126374889|NCT03391882|454669183|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
126374890|NCT03391882|454669184|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
126374891|NCT03391882|454669185|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
126374892|NCT03391882|454669186|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
126374893|NCT03391882|454669181|FG000|Study Overall|Protocol Violation|1|||
126374894|NCT03391882|454669182|FG001|Study Overall|Protocol Violation|0|||
126374895|NCT03391882|454669183|FG002|Study Overall|Protocol Violation|0|||
126374896|NCT03391882|454669184|FG003|Study Overall|Protocol Violation|0|||
126374897|NCT03391882|454669185|FG004|Study Overall|Protocol Violation|0|||
126374898|NCT03391882|454669186|FG005|Study Overall|Protocol Violation|0|||
126374899|NCT03391882|454669181|FG000|Part A - Titration Phase|Adverse Event|3|||
126374900|NCT03391882|454669182|FG001|Part A - Titration Phase|Adverse Event|6|||
126374901|NCT03391882|454669183|FG002|Part A - Titration Phase|Adverse Event|0|||
126374902|NCT03391882|454669184|FG003|Part A - Titration Phase|Adverse Event|0|||
126374903|NCT03391882|454669185|FG004|Part A - Titration Phase|Adverse Event|0|||
126374904|NCT03391882|454669186|FG005|Part A - Titration Phase|Adverse Event|0|||
126374905|NCT03391882|454669181|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
126374906|NCT03391882|454669182|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
126374907|NCT03391882|454669183|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
126374908|NCT03391882|454669184|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
126374909|NCT03391882|454669185|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
126374910|NCT03391882|454669186|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
126374911|NCT03391882|454669181|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
126374912|NCT03391882|454669182|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
126374913|NCT03391882|454669183|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
126374914|NCT03391882|454669184|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
126374915|NCT03391882|454669185|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
126374916|NCT03391882|454669186|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
126374917|NCT03391882|454669181|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
126374918|NCT03391882|454669182|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
126374919|NCT03391882|454669183|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
126374920|NCT03391882|454669184|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
126374921|NCT03391882|454669185|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
126374922|NCT03391882|454669186|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
126374923|NCT03391882|454669181|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
126374924|NCT03391882|454669182|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
126374925|NCT03391882|454669183|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
126374926|NCT03391882|454669184|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
126374927|NCT03391882|454669185|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
126374928|NCT03391882|454669186|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
126374929|NCT03391882|454669181|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
126374930|NCT03391882|454669182|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
126374931|NCT03391882|454669183|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
126374932|NCT03391882|454669184|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
126374933|NCT03391882|454669185|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
126374934|NCT03391882|454669186|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
126374935|NCT03391882|454669181|FG000|Part B - Treatment Phase|Adverse Event|0|||
126374936|NCT03391882|454669182|FG001|Part B - Treatment Phase|Adverse Event|0|||
126466795|NCT05896748|455010463|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
126374937|NCT03391882|454669183|FG002|Part B - Treatment Phase|Adverse Event|1|||
126374938|NCT03391882|454669184|FG003|Part B - Treatment Phase|Adverse Event|1|||
126374939|NCT03391882|454669185|FG004|Part B - Treatment Phase|Adverse Event|3|||
126716754|NCT01781429|455914924|FG014|Overall Study|Unacceptable Toxicity|0|||
126716755|NCT01781429|455914925|FG015|Overall Study|Unacceptable Toxicity|0|||
126374940|NCT03391882|454669186|FG005|Part B - Treatment Phase|Adverse Event|1|||
126374941|NCT03391882|454669181|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
126374942|NCT03391882|454669182|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
126374943|NCT03391882|454669183|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
126374944|NCT03391882|454669184|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
126374945|NCT03391882|454669185|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
126374946|NCT03391882|454669186|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
126466796|NCT05896748|455010463|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
126466797|NCT05896748|455010463|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
126466798|NCT05896748|455010463|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
126466799|NCT05896748|455010463|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
126466800|NCT01298193|455010464|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
126466801|NCT01298193|455010464|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
126466802|NCT01298193|455010464|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
126466803|NCT01298193|455010464|FG000|Efficacy Phase (Second Cycle)|Death|1|||
126466804|NCT01070043|455010465|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
126466805|NCT01070043|455010466|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
126466806|NCT01070043|455010467|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
126466807|NCT01070043|455010465|FG000|Double-Blind Treatment|Adverse Event|0|||
126466808|NCT01070043|455010466|FG001|Double-Blind Treatment|Adverse Event|0|||
126466809|NCT01070043|455010467|FG002|Double-Blind Treatment|Adverse Event|2|||
126466810|NCT00473746|455010469|FG000|Period 1 (Phase 1)|Adverse Event|1|||
126466811|NCT00473746|455010470|FG001|Period 1 (Phase 1)|Adverse Event|0|||
126466812|NCT00473746|455010471|FG002|Period 1 (Phase 1)|Adverse Event|0|||
126466813|NCT00473746|455010472|FG003|Period 1 (Phase 1)|Adverse Event|0|||
126466814|NCT00473746|455010473|FG004|Period 1 (Phase 1)|Adverse Event|0|||
126466815|NCT00473746|455010469|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
126466816|NCT00473746|455010470|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
126466817|NCT00473746|455010471|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
126466818|NCT00473746|455010472|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
126466819|NCT00473746|455010473|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
126466820|NCT00473746|455010469|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
126466821|NCT00473746|455010470|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
126466822|NCT00473746|455010471|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
126466823|NCT00473746|455010472|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
126466824|NCT00473746|455010473|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
126466825|NCT00473746|455010469|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
126466826|NCT00473746|455010470|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
126466827|NCT00473746|455010471|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
126466828|NCT00473746|455010472|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
126466829|NCT00473746|455010473|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
126466830|NCT00473746|455010469|FG000|Period 1 (Phase 1)|Reason not specified|0|||
126552968|NCT02291289|455320510|FG009|Induction Treatment|Non-Compliance|1|||
126374947|NCT03913130|454669187|FG000|Overall Study|Sponsor Decision|1|||
126374948|NCT01085214|454669190|FG000|Overall Study|Alternate treatment required|1|||
126374949|NCT01634152|454669191|FG000|Overall Study|Adverse Event|2|||
126374950|NCT01634152|454669192|FG001|Overall Study|Adverse Event|0|||
126374951|NCT01634152|454669193|FG002|Overall Study|Adverse Event|2|||
126374952|NCT01634152|454669191|FG000|Overall Study|Consent withdrawn not due to AE|1|||
126374953|NCT01634152|454669192|FG001|Overall Study|Consent withdrawn not due to AE|0|||
126374954|NCT01634152|454669193|FG002|Overall Study|Consent withdrawn not due to AE|1|||
126374955|NCT01634152|454669191|FG000|Overall Study|Not treated|0|||
126374956|NCT01634152|454669192|FG001|Overall Study|Not treated|1|||
126374957|NCT01634152|454669193|FG002|Overall Study|Not treated|0|||
126374958|NCT01634152|454669191|FG000|Overall Study|Other reason not defined above|1|||
126374959|NCT01634152|454669192|FG001|Overall Study|Other reason not defined above|0|||
126374960|NCT01634152|454669193|FG002|Overall Study|Other reason not defined above|1|||
126374961|NCT01985022|454669210|FG000|Overall Study|Lost to Follow-up|0|||
126374962|NCT01985022|454669211|FG001|Overall Study|Lost to Follow-up|1|||
126374963|NCT01985022|454669210|FG000|Overall Study|Protocol Violation|0|||
126374964|NCT01985022|454669211|FG001|Overall Study|Protocol Violation|1|||
126374965|NCT01985022|454669210|FG000|Overall Study|Withdrawal by Subject|4|||
126466831|NCT00473746|455010470|FG001|Period 1 (Phase 1)|Reason not specified|1|||
126552969|NCT02291289|455320511|FG010|Induction Treatment|Non-Compliance|0|||
126552970|NCT02291289|455320512|FG011|Induction Treatment|Non-Compliance|0|||
126552971|NCT02291289|455320513|FG012|Induction Treatment|Non-Compliance|0|||
126552972|NCT02291289|455320501|FG000|Induction Treatment|Reason Not Specified|0|||
126552973|NCT02291289|455320502|FG001|Induction Treatment|Reason Not Specified|0|||
126466832|NCT00473746|455010471|FG002|Period 1 (Phase 1)|Reason not specified|0|||
126466833|NCT00473746|455010472|FG003|Period 1 (Phase 1)|Reason not specified|0|||
126552974|NCT02291289|455320503|FG002|Induction Treatment|Reason Not Specified|0|||
126374966|NCT01985022|454669211|FG001|Overall Study|Withdrawal by Subject|1|||
126374967|NCT01152437|454669212|FG000|Overall Study|Other Adverse Event|8|||
126374968|NCT01152437|454669213|FG001|Overall Study|Other Adverse Event|1|||
126374969|NCT01152437|454669214|FG002|Overall Study|Other Adverse Event|7|||
126374970|NCT01152437|454669212|FG000|Overall Study|Not treated|0|||
126374971|NCT01152437|454669213|FG001|Overall Study|Not treated|1|||
126374972|NCT01152437|454669214|FG002|Overall Study|Not treated|2|||
126374973|NCT01152437|454669212|FG000|Overall Study|Progressive disease|27|||
126374974|NCT01152437|454669213|FG001|Overall Study|Progressive disease|13|||
126374975|NCT01152437|454669214|FG002|Overall Study|Progressive disease|32|||
126374976|NCT01152437|454669212|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
126374977|NCT01152437|454669213|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
126374978|NCT01152437|454669214|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
126374979|NCT00279214|454669215|FG000|Overall Study|Physician Decision|3|||
126374980|NCT00279214|454669216|FG001|Overall Study|Physician Decision|2|||
126374981|NCT01214837|454669217|FG000|Overall Study|Death|0|||
126374982|NCT01214837|454669218|FG001|Overall Study|Death|0|||
126374983|NCT01214837|454669219|FG002|Overall Study|Death|1|||
126374984|NCT01214837|454669217|FG000|Overall Study|Adverse Event|1|||
126374985|NCT01214837|454669218|FG001|Overall Study|Adverse Event|2|||
126374986|NCT01214837|454669219|FG002|Overall Study|Adverse Event|1|||
126374987|NCT01214837|454669217|FG000|Overall Study|Withdrawal by Subject|27|||
126374988|NCT01214837|454669218|FG001|Overall Study|Withdrawal by Subject|36|||
126374989|NCT01214837|454669219|FG002|Overall Study|Withdrawal by Subject|28|||
126374990|NCT01214837|454669217|FG000|Overall Study|Lost to Follow-up|20|||
126374991|NCT01214837|454669218|FG001|Overall Study|Lost to Follow-up|15|||
126374992|NCT01214837|454669219|FG002|Overall Study|Lost to Follow-up|21|||
126374993|NCT01214837|454669217|FG000|Overall Study|Inappropriate Enrolment|0|||
126374994|NCT01214837|454669218|FG001|Overall Study|Inappropriate Enrolment|1|||
126374995|NCT01214837|454669219|FG002|Overall Study|Inappropriate Enrolment|2|||
126374996|NCT01214837|454669217|FG000|Overall Study|Administrative Reason|2|||
126374997|NCT01214837|454669218|FG001|Overall Study|Administrative Reason|6|||
126374998|NCT01214837|454669219|FG002|Overall Study|Administrative Reason|4|||
126374999|NCT01214837|454669217|FG000|Overall Study|Protocol Violation|3|||
126375000|NCT01214837|454669218|FG001|Overall Study|Protocol Violation|1|||
126375001|NCT01214837|454669219|FG002|Overall Study|Protocol Violation|5|||
126375002|NCT01214837|454669217|FG000|Overall Study|Unable to Classify|1|||
126375003|NCT01214837|454669218|FG001|Overall Study|Unable to Classify|3|||
126375004|NCT01214837|454669219|FG002|Overall Study|Unable to Classify|0|||
126375005|NCT00457626|454669220|FG000|Overall Study|Adverse Event|3|||
126466834|NCT00473746|455010473|FG004|Period 1 (Phase 1)|Reason not specified|0|||
126466835|NCT00473746|455010469|FG000|Period 2 (Phase 2)|Adverse Event|0|||
126466836|NCT00473746|455010470|FG001|Period 2 (Phase 2)|Adverse Event|0|||
126466837|NCT00473746|455010471|FG002|Period 2 (Phase 2)|Adverse Event|0|||
126466838|NCT00473746|455010472|FG003|Period 2 (Phase 2)|Adverse Event|0|||
126466839|NCT00473746|455010473|FG004|Period 2 (Phase 2)|Adverse Event|3|||
126466840|NCT00473746|455010469|FG000|Period 2 (Phase 2)|Death|0|||
126466841|NCT00473746|455010470|FG001|Period 2 (Phase 2)|Death|0|||
126466842|NCT00473746|455010471|FG002|Period 2 (Phase 2)|Death|0|||
126466843|NCT00473746|455010472|FG003|Period 2 (Phase 2)|Death|0|||
126466844|NCT00473746|455010473|FG004|Period 2 (Phase 2)|Death|1|||
126466845|NCT00473746|455010469|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
126466846|NCT00473746|455010470|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
126466847|NCT00473746|455010471|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
126466848|NCT00473746|455010472|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
126466849|NCT00473746|455010473|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
126466850|NCT00473746|455010469|FG000|Period 2 (Phase 2)|Reason not specified|0|||
126466851|NCT00473746|455010470|FG001|Period 2 (Phase 2)|Reason not specified|0|||
126716756|NCT01781429|455914910|FG000|Overall Study|Patient Condition Changed|0|||
126716757|NCT01781429|455914911|FG001|Overall Study|Patient Condition Changed|0|||
126716758|NCT01781429|455914912|FG002|Overall Study|Patient Condition Changed|0|||
126716759|NCT01781429|455914913|FG003|Overall Study|Patient Condition Changed|0|||
126375006|NCT00457626|454669220|FG000|Overall Study|Administrative Problems|2|||
126375007|NCT00457626|454669220|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
126716760|NCT01781429|455914914|FG004|Overall Study|Patient Condition Changed|0|||
126716761|NCT01781429|455914915|FG005|Overall Study|Patient Condition Changed|0|||
126716762|NCT01781429|455914916|FG006|Overall Study|Patient Condition Changed|0|||
126716763|NCT01781429|455914917|FG007|Overall Study|Patient Condition Changed|0|||
126375008|NCT03549338|454671240|FG000|Overall Study|Progressive Disease|1|||
126375009|NCT03549338|454671241|FG001|Overall Study|Progressive Disease|0|||
126375010|NCT03549338|454671242|FG002|Overall Study|Progressive Disease|0|||
126375011|NCT03549338|454671240|FG000|Overall Study|Clinical Progression|0|||
126375012|NCT03549338|454671241|FG001|Overall Study|Clinical Progression|1|||
126375013|NCT03549338|454671242|FG002|Overall Study|Clinical Progression|0|||
126375014|NCT00652743|454671243|FG000|Months 12-18|Lost to Follow-up|1|||
126375015|NCT00652743|454671244|FG001|Months 12-18|Lost to Follow-up|2|||
126375016|NCT00652743|454671245|FG002|Months 12-18|Lost to Follow-up|7|||
126466852|NCT00473746|455010471|FG002|Period 2 (Phase 2)|Reason not specified|0|||
126375017|NCT00652743|454671243|FG000|Months 24-30|Other|5|||
126466853|NCT00473746|455010472|FG003|Period 2 (Phase 2)|Reason not specified|0|||
126466854|NCT00473746|455010473|FG004|Period 2 (Phase 2)|Reason not specified|3|||
126466855|NCT00667420|455010474|FG000|Overall Study|Adverse Event|2|||
126466856|NCT00667420|455010474|FG000|Overall Study|Lack of Efficacy|5|||
126466857|NCT00667420|455010474|FG000|Overall Study|Physician Decision|1|||
126466858|NCT00667420|455010474|FG000|Overall Study|Withdrawal by Subject|2|||
126466859|NCT01528215|455010478|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
126466860|NCT01528215|455010479|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
126466861|NCT01528215|455010478|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
126466862|NCT01528215|455010479|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
126466863|NCT01528215|455010478|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
126466864|NCT01528215|455010479|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
126466865|NCT01528215|455010478|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
126466866|NCT01528215|455010479|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
126552975|NCT02291289|455320504|FG003|Induction Treatment|Reason Not Specified|4|||
126552976|NCT02291289|455320505|FG004|Induction Treatment|Reason Not Specified|0|||
126375018|NCT00652743|454671244|FG001|Months 24-30|Other|1|||
126375019|NCT00652743|454671245|FG002|Months 24-30|Other|11|||
126375020|NCT00652743|454671243|FG000|Months 36-42|Serious Adverse Events|0|||
126375021|NCT00652743|454671244|FG001|Months 36-42|Serious Adverse Events|1|||
126375022|NCT00652743|454671245|FG002|Months 36-42|Serious Adverse Events|1|||
126375023|NCT00652743|454671243|FG000|Months 36-42|Withdrawal by Subject|1|||
126375024|NCT00652743|454671244|FG001|Months 36-42|Withdrawal by Subject|1|||
126375025|NCT00652743|454671245|FG002|Months 36-42|Withdrawal by Subject|0|||
126375026|NCT00652743|454671243|FG000|Months 36-42|Lost to Follow-up|0|||
126375027|NCT00652743|454671244|FG001|Months 36-42|Lost to Follow-up|1|||
126375028|NCT00652743|454671245|FG002|Months 36-42|Lost to Follow-up|0|||
126375029|NCT00652743|454671243|FG000|Months 36-42|Migrated/moved from study area|1|||
126375030|NCT00652743|454671244|FG001|Months 36-42|Migrated/moved from study area|0|||
126375031|NCT00652743|454671245|FG002|Months 36-42|Migrated/moved from study area|0|||
126375032|NCT00652743|454671243|FG000|Months 36-42|Other|4|||
126375033|NCT00652743|454671244|FG001|Months 36-42|Other|2|||
126375034|NCT00652743|454671245|FG002|Months 36-42|Other|8|||
126375035|NCT00269113|454671246|FG000|Overall Study|Adverse Event|14|||
126375036|NCT00269113|454671247|FG001|Overall Study|Adverse Event|7|||
126375037|NCT00269113|454671246|FG000|Overall Study|Lack of Efficacy|35|||
126375038|NCT00269113|454671247|FG001|Overall Study|Lack of Efficacy|18|||
126375039|NCT00269113|454671246|FG000|Overall Study|Early Improvement|2|||
126375040|NCT00269113|454671247|FG001|Overall Study|Early Improvement|0|||
126375041|NCT00269113|454671246|FG000|Overall Study|Withdrawal by Subject|0|||
126375042|NCT00269113|454671247|FG001|Overall Study|Withdrawal by Subject|2|||
126375043|NCT00269113|454671246|FG000|Overall Study|Death|6|||
126375044|NCT00269113|454671247|FG001|Overall Study|Death|2|||
126375045|NCT00269113|454671246|FG000|Overall Study|Lost to Follow-up|2|||
126375046|NCT00269113|454671247|FG001|Overall Study|Lost to Follow-up|1|||
126375047|NCT00269113|454671246|FG000|Overall Study|Protocol Violation|15|||
126375048|NCT00269113|454671247|FG001|Overall Study|Protocol Violation|5|||
126375049|NCT00269113|454671246|FG000|Overall Study|Other|0|||
126375050|NCT00269113|454671247|FG001|Overall Study|Other|2|||
126375051|NCT00755807|454671250|FG000|Acute Phase|Adverse Event|16|||
126375052|NCT00755807|454671251|FG001|Acute Phase|Adverse Event|5|||
126375053|NCT00755807|454671250|FG000|Acute Phase|Protocol Violation|1|||
126375054|NCT00755807|454671251|FG001|Acute Phase|Protocol Violation|3|||
126375055|NCT00755807|454671250|FG000|Acute Phase|Withdrawal by Subject|1|||
126375056|NCT00755807|454671251|FG001|Acute Phase|Withdrawal by Subject|2|||
126375057|NCT00755807|454671250|FG000|Acute Phase|Lack of Efficacy|0|||
126375058|NCT00755807|454671251|FG001|Acute Phase|Lack of Efficacy|1|||
126375059|NCT00755807|454671250|FG000|Acute Phase|Physician Decision|0|||
126375060|NCT00755807|454671251|FG001|Acute Phase|Physician Decision|1|||
126375061|NCT00755807|454671250|FG000|Open-label Extension Phase|Adverse Event|7|||
126375062|NCT00755807|454671251|FG001|Open-label Extension Phase|Adverse Event|7|||
126375063|NCT00755807|454671250|FG000|Open-label Extension Phase|Protocol Violation|5|||
126375064|NCT00755807|454671251|FG001|Open-label Extension Phase|Protocol Violation|2|||
126375065|NCT00755807|454671250|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
126375066|NCT00755807|454671251|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
126466867|NCT01462227|455010480|FG000|Second Assignment|Lost to Follow-up|1|||
126466868|NCT01462227|455010481|FG001|Second Assignment|Lost to Follow-up|0|||
126552977|NCT02291289|455320506|FG005|Induction Treatment|Reason Not Specified|0|||
126552978|NCT02291289|455320507|FG006|Induction Treatment|Reason Not Specified|0|||
126375067|NCT00755807|454671250|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
126375068|NCT00755807|454671251|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
126375069|NCT00755807|454671250|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
126375070|NCT00755807|454671251|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
126552979|NCT02291289|455320508|FG007|Induction Treatment|Reason Not Specified|0|||
126552980|NCT02291289|455320509|FG008|Induction Treatment|Reason Not Specified|0|||
126375071|NCT00755807|454671250|FG000|Open-label Extension Phase|Sponsor Decision|0|||
126375072|NCT00755807|454671251|FG001|Open-label Extension Phase|Sponsor Decision|1|||
126375073|NCT05111145|454671256|FG000|Overall Study|Commercial drug is available for participant|76|||
126716764|NCT01781429|455914918|FG008|Overall Study|Patient Condition Changed|0|||
126716765|NCT01781429|455914919|FG009|Overall Study|Patient Condition Changed|4|||
126716766|NCT01781429|455914920|FG010|Overall Study|Patient Condition Changed|0|||
126716767|NCT01781429|455914921|FG011|Overall Study|Patient Condition Changed|1|||
126716768|NCT01781429|455914922|FG012|Overall Study|Patient Condition Changed|0|||
126716769|NCT01781429|455914923|FG013|Overall Study|Patient Condition Changed|1|||
126716770|NCT01781429|455914924|FG014|Overall Study|Patient Condition Changed|0|||
126716771|NCT01781429|455914925|FG015|Overall Study|Patient Condition Changed|0|||
126716772|NCT01781429|455914910|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
126716773|NCT01781429|455914911|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
126716774|NCT01781429|455914912|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
126716775|NCT01781429|455914913|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
126375074|NCT05111145|454671256|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
126375075|NCT02336815|454671257|FG000|Overall Study|Disease Progression|45|||
126375076|NCT02336815|454671258|FG001|Overall Study|Disease Progression|70|||
126375077|NCT02336815|454671257|FG000|Overall Study|Adverse Event|18|||
126375078|NCT02336815|454671258|FG001|Overall Study|Adverse Event|39|||
126375079|NCT02336815|454671257|FG000|Overall Study|Physician Decision|11|||
126375080|NCT02336815|454671258|FG001|Overall Study|Physician Decision|4|||
126375081|NCT02336815|454671257|FG000|Overall Study|Withdrawal by Subject|3|||
126375082|NCT02336815|454671258|FG001|Overall Study|Withdrawal by Subject|2|||
126375083|NCT02336815|454671257|FG000|Overall Study|Lost to Follow-up|1|||
126375084|NCT02336815|454671258|FG001|Overall Study|Lost to Follow-up|3|||
126375085|NCT02336815|454671257|FG000|Overall Study|Other|1|||
126375086|NCT02336815|454671258|FG001|Overall Study|Other|5|||
126375087|NCT00952705|454671259|FG000|Overall Study|Lost to Follow-up|24|||
126375088|NCT00952705|454671260|FG001|Overall Study|Lost to Follow-up|8|||
126375089|NCT00952705|454671261|FG002|Overall Study|Lost to Follow-up|9|||
126375090|NCT00952705|454671259|FG000|Overall Study|Withdrawal by Subject|2|||
126375091|NCT00952705|454671260|FG001|Overall Study|Withdrawal by Subject|1|||
126375092|NCT00952705|454671261|FG002|Overall Study|Withdrawal by Subject|1|||
126375093|NCT00952705|454671259|FG000|Overall Study|Death|2|||
126375094|NCT00952705|454671260|FG001|Overall Study|Death|0|||
126375095|NCT00952705|454671261|FG002|Overall Study|Death|0|||
126375096|NCT00952705|454671259|FG000|Overall Study|Incarcerated post dose|5|||
126375097|NCT00952705|454671260|FG001|Overall Study|Incarcerated post dose|0|||
126375098|NCT00952705|454671261|FG002|Overall Study|Incarcerated post dose|0|||
126375099|NCT00952705|454671259|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
126375100|NCT00952705|454671260|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
126375101|NCT00952705|454671261|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
126375102|NCT03759600|454671263|FG000|Overall Study|Adverse Event|2|||
126375103|NCT03759600|454671263|FG000|Overall Study|Progressive Disease|15|||
126375104|NCT03759600|454671263|FG000|Overall Study|Site Terminated by Sponsor|3|||
126375105|NCT05173974|454671264|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
126375106|NCT05173974|454671265|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
126375107|NCT05173974|454671266|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
126375108|NCT05173974|454671267|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
126375109|NCT05173974|454671264|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
126375110|NCT05173974|454671265|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
126375111|NCT05173974|454671266|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
126375112|NCT05173974|454671267|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
126375113|NCT03257358|454671269|FG000|Overall Study|Adverse Event|25|||
126375114|NCT03257358|454671270|FG001|Overall Study|Adverse Event|12|||
126375115|NCT03257358|454671269|FG000|Overall Study|Lack of Efficacy|1|||
126375116|NCT03257358|454671270|FG001|Overall Study|Lack of Efficacy|1|||
126375117|NCT03257358|454671269|FG000|Overall Study|Lost to Follow-up|12|||
126375118|NCT03257358|454671270|FG001|Overall Study|Lost to Follow-up|4|||
126375119|NCT03257358|454671269|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
126375120|NCT03257358|454671270|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
126375121|NCT03257358|454671269|FG000|Overall Study|Physician Decision|2|||
126375122|NCT03257358|454671270|FG001|Overall Study|Physician Decision|2|||
126375123|NCT03257358|454671269|FG000|Overall Study|Protocol Violation|5|||
126375124|NCT03257358|454671270|FG001|Overall Study|Protocol Violation|3|||
126375125|NCT03257358|454671269|FG000|Overall Study|Technical problems|4|||
126771065|NCT00038467|456116241|FG001|Overall Study|Randomized, but not treated|35|||
126375126|NCT03257358|454671270|FG001|Overall Study|Technical problems|1|||
126375127|NCT03257358|454671269|FG000|Overall Study|Withdrawal by Subject|8|||
126375128|NCT03257358|454671270|FG001|Overall Study|Withdrawal by Subject|3|||
126375129|NCT03257358|454671269|FG000|Overall Study|Withdrawal of informed consent|9|||
126375130|NCT03257358|454671270|FG001|Overall Study|Withdrawal of informed consent|5|||
126375131|NCT03257358|454671269|FG000|Overall Study|New therapy for study indication|1|||
126716776|NCT01781429|455914914|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
126771066|NCT00038467|456116240|FG000|Overall Study|Other|26|||
126716777|NCT01781429|455914915|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
126771067|NCT00038467|456116241|FG001|Overall Study|Other|28|||
126375132|NCT03257358|454671270|FG001|Overall Study|New therapy for study indication|0|||
126375133|NCT03257358|454671269|FG000|Overall Study|No longer requires treatment|0|||
126375134|NCT03257358|454671270|FG001|Overall Study|No longer requires treatment|1|||
126375135|NCT03289143|454671271|FG000|Overall Study|Caregiver Unavailability|1|||
126375136|NCT03289143|454671272|FG001|Overall Study|Caregiver Unavailability|1|||
126375137|NCT03289143|454671273|FG002|Overall Study|Caregiver Unavailability|0|||
126375138|NCT03289143|454671274|FG003|Overall Study|Caregiver Unavailability|0|||
126375139|NCT03289143|454671271|FG000|Overall Study|Research Department Closure|0|||
126375140|NCT03289143|454671272|FG001|Overall Study|Research Department Closure|0|||
126375141|NCT03289143|454671273|FG002|Overall Study|Research Department Closure|1|||
126375142|NCT03289143|454671274|FG003|Overall Study|Research Department Closure|0|||
126375143|NCT03289143|454671271|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
126375144|NCT03289143|454671272|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
126375145|NCT03289143|454671273|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
126375146|NCT03289143|454671274|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
126375147|NCT03289143|454671271|FG000|Overall Study|Medical Monitor Decision|1|||
126375148|NCT03289143|454671272|FG001|Overall Study|Medical Monitor Decision|0|||
126375149|NCT03289143|454671273|FG002|Overall Study|Medical Monitor Decision|0|||
126375150|NCT03289143|454671274|FG003|Overall Study|Medical Monitor Decision|0|||
126375151|NCT03289143|454671271|FG000|Overall Study|Participant Non-Compliance|0|||
126375152|NCT03289143|454671272|FG001|Overall Study|Participant Non-Compliance|0|||
126375153|NCT03289143|454671273|FG002|Overall Study|Participant Non-Compliance|1|||
126375154|NCT03289143|454671274|FG003|Overall Study|Participant Non-Compliance|0|||
126375155|NCT03289143|454671271|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
126375156|NCT03289143|454671272|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
126375157|NCT03289143|454671273|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
126375158|NCT03289143|454671274|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
126375159|NCT03289143|454671271|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
126375160|NCT03289143|454671272|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
126375161|NCT03289143|454671273|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
126375162|NCT03289143|454671274|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
126375163|NCT03289143|454671271|FG000|Overall Study|Caregiver Passed Away|1|||
126375164|NCT03289143|454671272|FG001|Overall Study|Caregiver Passed Away|0|||
126375165|NCT03289143|454671273|FG002|Overall Study|Caregiver Passed Away|0|||
126375166|NCT03289143|454671274|FG003|Overall Study|Caregiver Passed Away|0|||
126375167|NCT03289143|454671271|FG000|Overall Study|Physician Decision|0|||
126375168|NCT03289143|454671272|FG001|Overall Study|Physician Decision|2|||
126375169|NCT03289143|454671273|FG002|Overall Study|Physician Decision|2|||
126375170|NCT03289143|454671274|FG003|Overall Study|Physician Decision|2|||
126375171|NCT03289143|454671271|FG000|Overall Study|Protocol Deviation|2|||
126375172|NCT03289143|454671272|FG001|Overall Study|Protocol Deviation|1|||
126375173|NCT03289143|454671273|FG002|Overall Study|Protocol Deviation|3|||
126375174|NCT03289143|454671274|FG003|Overall Study|Protocol Deviation|1|||
126375175|NCT03289143|454671271|FG000|Overall Study|Study Terminated By Sponsor|101|||
126375176|NCT03289143|454671272|FG001|Overall Study|Study Terminated By Sponsor|75|||
126375177|NCT03289143|454671273|FG002|Overall Study|Study Terminated By Sponsor|100|||
126375178|NCT03289143|454671274|FG003|Overall Study|Study Terminated By Sponsor|69|||
126375179|NCT03289143|454671271|FG000|Overall Study|Withdrawal by Subject|14|||
126375180|NCT03289143|454671272|FG001|Overall Study|Withdrawal by Subject|6|||
126375181|NCT03289143|454671273|FG002|Overall Study|Withdrawal by Subject|14|||
126375182|NCT03289143|454671274|FG003|Overall Study|Withdrawal by Subject|12|||
126375183|NCT03289143|454671271|FG000|Overall Study|Adverse Event|10|||
126375184|NCT03289143|454671272|FG001|Overall Study|Adverse Event|7|||
126375185|NCT03289143|454671273|FG002|Overall Study|Adverse Event|6|||
126375186|NCT03289143|454671274|FG003|Overall Study|Adverse Event|5|||
126375187|NCT03289143|454671271|FG000|Overall Study|Death|2|||
126375188|NCT03289143|454671272|FG001|Overall Study|Death|0|||
126375189|NCT03289143|454671273|FG002|Overall Study|Death|2|||
126375190|NCT03289143|454671274|FG003|Overall Study|Death|1|||
126375191|NCT03289143|454671271|FG000|Overall Study|Lost to Follow-up|2|||
126375192|NCT03289143|454671272|FG001|Overall Study|Lost to Follow-up|1|||
126375193|NCT03289143|454671273|FG002|Overall Study|Lost to Follow-up|1|||
126375194|NCT03289143|454671274|FG003|Overall Study|Lost to Follow-up|0|||
126375195|NCT03289143|454671271|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
126771068|NCT01988493|456116242|FG000|Overall Study|Randomized but not treated|0|||
126375196|NCT03289143|454671272|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
126375197|NCT03289143|454671273|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
126375198|NCT03289143|454671274|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
126375199|NCT03289143|454671271|FG000|Overall Study|Withdrawal by Caregiver|0|||
126375200|NCT03289143|454671272|FG001|Overall Study|Withdrawal by Caregiver|1|||
126375201|NCT03289143|454671273|FG002|Overall Study|Withdrawal by Caregiver|0|||
126375202|NCT03289143|454671274|FG003|Overall Study|Withdrawal by Caregiver|0|||
126375203|NCT03289143|454671271|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
126375204|NCT03289143|454671272|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
126375205|NCT03289143|454671273|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
126375206|NCT03289143|454671274|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
126375207|NCT03289143|454671271|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
126375208|NCT03289143|454671272|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
126375209|NCT03289143|454671273|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
126375210|NCT03289143|454671274|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
126375211|NCT00730756|454671275|FG000|Overall Study|Adverse Event|2|||
126375212|NCT00730756|454671276|FG001|Overall Study|Adverse Event|0|||
126375213|NCT00730756|454671275|FG000|Overall Study|Lack of Efficacy|1|||
126375214|NCT00730756|454671276|FG001|Overall Study|Lack of Efficacy|1|||
126375215|NCT00730756|454671275|FG000|Overall Study|Protocol Deviation|1|||
126375216|NCT00730756|454671276|FG001|Overall Study|Protocol Deviation|2|||
126375217|NCT00730756|454671275|FG000|Overall Study|Lost to Follow-up|0|||
126375218|NCT00730756|454671276|FG001|Overall Study|Lost to Follow-up|1|||
126375219|NCT00730756|454671275|FG000|Overall Study|Withdrew Consent|0|||
126375220|NCT00730756|454671276|FG001|Overall Study|Withdrew Consent|1|||
126375221|NCT00305877|454671277|FG000|Overall Study|Lack of Efficacy|6|||
126375222|NCT00305877|454671278|FG001|Overall Study|Lack of Efficacy|9|||
126375223|NCT00305877|454671277|FG000|Overall Study|Adverse Event|9|||
126375224|NCT00305877|454671278|FG001|Overall Study|Adverse Event|14|||
126375225|NCT00305877|454671277|FG000|Overall Study|Death|0|||
126375226|NCT00305877|454671278|FG001|Overall Study|Death|1|||
126375227|NCT00305877|454671277|FG000|Overall Study|Withdrawal by Subject|4|||
126375228|NCT00305877|454671278|FG001|Overall Study|Withdrawal by Subject|2|||
126375229|NCT00305877|454671277|FG000|Overall Study|Physician Decision|1|||
126375230|NCT00305877|454671278|FG001|Overall Study|Physician Decision|1|||
126375231|NCT00305877|454671277|FG000|Overall Study|Never start treatment|2|||
126375232|NCT00305877|454671278|FG001|Overall Study|Never start treatment|5|||
126375233|NCT00305877|454671277|FG000|Overall Study|Ineligible|2|||
126375234|NCT00305877|454671278|FG001|Overall Study|Ineligible|1|||
126375235|NCT00305877|454671277|FG000|Overall Study|Transportation issue with daily RT|0|||
126375236|NCT00305877|454671278|FG001|Overall Study|Transportation issue with daily RT|1|||
126375237|NCT01126190|454671279|FG000|Double-Blind Phase|Death|0|||
126375238|NCT01126190|454671280|FG001|Double-Blind Phase|Death|1|||
126375239|NCT01126190|454671281|FG002|Double-Blind Phase|Death|0|||
126466869|NCT01462227|455010482|FG002|Second Assignment|Lost to Follow-up|0|||
126466870|NCT01462227|455010483|FG003|Second Assignment|Lost to Follow-up|0|||
126466871|NCT01462227|455010480|FG000|Second Assignment|Protocol Violation|0|||
126466872|NCT01462227|455010481|FG001|Second Assignment|Protocol Violation|1|||
126466873|NCT01462227|455010482|FG002|Second Assignment|Protocol Violation|1|||
126466874|NCT01462227|455010483|FG003|Second Assignment|Protocol Violation|0|||
126466875|NCT03538431|455010489|FG000|Overall Study|Physician Decision|0|||
126466876|NCT03538431|455010490|FG001|Overall Study|Physician Decision|1|||
126466877|NCT03538431|455010489|FG000|Overall Study|Withdrawal by Subject|1|||
126466878|NCT03538431|455010490|FG001|Overall Study|Withdrawal by Subject|0|||
126466879|NCT00620464|455010491|FG000|Overall Study|Adverse Event|15|||
126466880|NCT00620464|455010492|FG001|Overall Study|Adverse Event|17|||
126771069|NCT01988493|456116243|FG001|Overall Study|Randomized but not treated|0|||
126771070|NCT01988493|456116244|FG002|Overall Study|Randomized but not treated|0|||
126375240|NCT01126190|454671279|FG000|Double-Blind Phase|Adverse Event|1|||
126375241|NCT01126190|454671280|FG001|Double-Blind Phase|Adverse Event|2|||
126375242|NCT01126190|454671281|FG002|Double-Blind Phase|Adverse Event|0|||
126375243|NCT01126190|454671279|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
126375244|NCT01126190|454671280|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
126375245|NCT01126190|454671281|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
126375246|NCT01126190|454671279|FG000|Double-Blind Phase|Request of Investigator|1|||
126375247|NCT01126190|454671280|FG001|Double-Blind Phase|Request of Investigator|0|||
126375248|NCT01126190|454671281|FG002|Double-Blind Phase|Request of Investigator|0|||
126375249|NCT01126190|454671279|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
126375250|NCT01126190|454671280|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
126375251|NCT01126190|454671281|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
126375252|NCT01126190|454671279|FG000|Double-Blind Phase|Non-compliance|1|||
126375253|NCT01126190|454671280|FG001|Double-Blind Phase|Non-compliance|0|||
126375254|NCT01126190|454671281|FG002|Double-Blind Phase|Non-compliance|0|||
126375255|NCT01126190|454671279|FG000|Double-Blind Phase|Lost to Follow-up|1|||
126375256|NCT01126190|454671280|FG001|Double-Blind Phase|Lost to Follow-up|3|||
126375257|NCT01126190|454671281|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126375258|NCT01126190|454671279|FG000|Open-Label Phase|Death|0|||
126375259|NCT01126190|454671280|FG001|Open-Label Phase|Death|0|||
126375260|NCT01126190|454671281|FG002|Open-Label Phase|Death|1|||
126771071|NCT01988493|456116245|FG003|Overall Study|Randomized but not treated|0|||
126375261|NCT01126190|454671279|FG000|Open-Label Phase|Adverse Event|0|||
126375262|NCT01126190|454671280|FG001|Open-Label Phase|Adverse Event|0|||
126466881|NCT00620464|455010491|FG000|Overall Study|Lost to Follow-up|1|||
126466882|NCT00620464|455010492|FG001|Overall Study|Lost to Follow-up|1|||
126466883|NCT00620464|455010491|FG000|Overall Study|Planning Pregnancy|1|||
126375263|NCT01126190|454671281|FG002|Open-Label Phase|Adverse Event|4|||
126375264|NCT01126190|454671279|FG000|Open-Label Phase|Withdrawal by Subject|0|||
126375265|NCT01126190|454671280|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126375266|NCT01126190|454671281|FG002|Open-Label Phase|Withdrawal by Subject|6|||
126375267|NCT00524121|454671284|FG000|Overall Study|Disease progression|6|||
126375268|NCT00524121|454671284|FG000|Overall Study|Adverse Event|4|||
126375269|NCT00524121|454671284|FG000|Overall Study|Patient refused|2|||
126375270|NCT00524121|454671284|FG000|Overall Study|Other|1|||
126375271|NCT00524121|454671284|FG000|Overall Study|Death|1|||
126375272|NCT00524121|454671284|FG000|Overall Study|Not treated (became ineligible)|4|||
126375273|NCT00524121|454671284|FG000|Overall Study|Not treated (changed mind)|1|||
126375274|NCT01114737|454671285|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
126375275|NCT01114737|454671286|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
126375276|NCT01114737|454671285|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
126375277|NCT01114737|454671286|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
126375278|NCT01114737|454671285|FG000|Randomized Treatment Period|Pregnancy|1|||
126375279|NCT01114737|454671286|FG001|Randomized Treatment Period|Pregnancy|0|||
126375280|NCT01114737|454671285|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
126375281|NCT01114737|454671286|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
126375282|NCT01114737|454671285|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
126375283|NCT01114737|454671286|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
126375284|NCT01114737|454671285|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
126375285|NCT01114737|454671286|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
126375286|NCT01446874|454671287|FG000|Overall Study|Not eligible|1|||
126375287|NCT01446874|454671288|FG001|Overall Study|Not eligible|0|||
126375288|NCT01446874|454671289|FG002|Overall Study|Not eligible|0|||
126375289|NCT01446874|454671287|FG000|Overall Study|No surgery/No qualifying surgery|1|||
126375290|NCT01446874|454671288|FG001|Overall Study|No surgery/No qualifying surgery|0|||
126375291|NCT01446874|454671289|FG002|Overall Study|No surgery/No qualifying surgery|12|||
126375292|NCT01446874|454671287|FG000|Overall Study|Non-compliance|0|||
126375293|NCT01446874|454671288|FG001|Overall Study|Non-compliance|4|||
126375294|NCT01446874|454671289|FG002|Overall Study|Non-compliance|0|||
126375295|NCT01446874|454671287|FG000|Overall Study|Antibiotics for pre-op infection|0|||
126375296|NCT01446874|454671288|FG001|Overall Study|Antibiotics for pre-op infection|0|||
126375297|NCT01446874|454671289|FG002|Overall Study|Antibiotics for pre-op infection|2|||
126375298|NCT01446874|454671287|FG000|Overall Study|Withdrawal by Subject|0|||
126375299|NCT01446874|454671288|FG001|Overall Study|Withdrawal by Subject|0|||
126375300|NCT01446874|454671289|FG002|Overall Study|Withdrawal by Subject|4|||
126375301|NCT00457392|454671290|FG000|Overall Study|Objective Progression or Relapse|229|||
126375302|NCT00457392|454671291|FG001|Overall Study|Objective Progression or Relapse|296|||
126375303|NCT00457392|454671290|FG000|Overall Study|Death|106|||
126375304|NCT00457392|454671291|FG001|Overall Study|Death|106|||
126375305|NCT00457392|454671290|FG000|Overall Study|Adverse Event|84|||
126375306|NCT00457392|454671291|FG001|Overall Study|Adverse Event|41|||
126375307|NCT00457392|454671290|FG000|Overall Study|Global Deterioration of Health Status|22|||
126375308|NCT00457392|454671291|FG001|Overall Study|Global Deterioration of Health Status|8|||
126375309|NCT00457392|454671290|FG000|Overall Study|Withdrawal by Subject|14|||
126375310|NCT00457392|454671291|FG001|Overall Study|Withdrawal by Subject|8|||
126375311|NCT00457392|454671290|FG000|Overall Study|Lost to Follow-up|6|||
126466884|NCT00620464|455010492|FG001|Overall Study|Planning Pregnancy|4|||
126466885|NCT00620464|455010491|FG000|Overall Study|Personal|2|||
126466886|NCT00620464|455010492|FG001|Overall Study|Personal|2|||
126466887|NCT00620464|455010491|FG000|Overall Study|Used prohibited medication|1|||
126466888|NCT00620464|455010492|FG001|Overall Study|Used prohibited medication|0|||
126466889|NCT00586066|455010493|FG000|Overall Study|Lost to Follow-up|6|||
126466890|NCT00586066|455010494|FG001|Overall Study|Lost to Follow-up|3|||
126466891|NCT00586066|455010493|FG000|Overall Study|Lack of Efficacy|5|||
126466892|NCT00586066|455010494|FG001|Overall Study|Lack of Efficacy|3|||
126466893|NCT00586066|455010493|FG000|Overall Study|Adverse Event|2|||
126466894|NCT00586066|455010494|FG001|Overall Study|Adverse Event|2|||
126375312|NCT00457392|454671291|FG001|Overall Study|Lost to Follow-up|7|||
126375313|NCT00457392|454671290|FG000|Overall Study|Protocol Violation|4|||
126375314|NCT00457392|454671291|FG001|Overall Study|Protocol Violation|3|||
126375315|NCT00457392|454671290|FG000|Overall Study|Other|7|||
126375316|NCT00457392|454671291|FG001|Overall Study|Other|4|||
126375317|NCT00457392|454671290|FG000|Overall Study|Study Terminated by Sponsor|1|||
126375318|NCT00457392|454671291|FG001|Overall Study|Study Terminated by Sponsor|4|||
126375319|NCT00457392|454671290|FG000|Overall Study|Randomized, Not Treated|7|||
126375320|NCT00457392|454671291|FG001|Overall Study|Randomized, Not Treated|3|||
126375321|NCT01135992|454671292|FG000|Overall Study|Adverse Event|1|||
126466895|NCT00586066|455010493|FG000|Overall Study|Physician Decision|1|||
126466896|NCT00586066|455010494|FG001|Overall Study|Physician Decision|0|||
126466897|NCT00586066|455010493|FG000|Overall Study|Withdrawal of consent|4|||
126375322|NCT01135992|454671292|FG000|Overall Study|Lack of Efficacy|1|||
126375323|NCT01135992|454671292|FG000|Overall Study|Protocol Violation|2|||
126375324|NCT01135992|454671292|FG000|Overall Study|Withdrawal criteria|10|||
126375325|NCT01135992|454671292|FG000|Overall Study|Unclassified|7|||
126771072|NCT01988493|456116246|FG004|Overall Study|Randomized but not treated|1|||
126375326|NCT01977898|454671293|FG000|Overall Study|Non functioning catheter|1|||
126375327|NCT01977898|454671294|FG001|Overall Study|Non functioning catheter|1|||
126375328|NCT01466491|454671296|FG000|Overall Study|Protocol Violation|0|||
126375329|NCT01466491|454671297|FG001|Overall Study|Protocol Violation|3|||
126375330|NCT01466491|454671298|FG002|Overall Study|Protocol Violation|2|||
126375331|NCT01466491|454671299|FG003|Overall Study|Protocol Violation|0|||
126375332|NCT01466491|454671296|FG000|Overall Study|Missing Data|0|||
126375333|NCT01466491|454671297|FG001|Overall Study|Missing Data|0|||
126375334|NCT01466491|454671298|FG002|Overall Study|Missing Data|1|||
126375335|NCT01466491|454671299|FG003|Overall Study|Missing Data|0|||
126375336|NCT02727322|454671300|FG000|Overall Study|Withdrawal by Subject|1|||
126375337|NCT02727322|454671301|FG001|Overall Study|Withdrawal by Subject|1|||
126375338|NCT02727322|454671300|FG000|Overall Study|Protocol Violation|1|||
126375339|NCT02727322|454671301|FG001|Overall Study|Protocol Violation|0|||
126375340|NCT00355030|454671308|FG000|Study Period 1 Treatment|Adverse Event|1|||
126375341|NCT00355030|454671309|FG001|Study Period 1 Treatment|Adverse Event|1|||
126375342|NCT00355030|454671308|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
126375343|NCT00355030|454671309|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
126375344|NCT00355030|454671308|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
126375345|NCT00355030|454671309|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
126375346|NCT00355030|454671308|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
126375347|NCT00355030|454671309|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
126375348|NCT00355030|454671308|FG000|Study Period 1 Treatment|Physician Decision|0|||
126375349|NCT00355030|454671309|FG001|Study Period 1 Treatment|Physician Decision|1|||
126375350|NCT00355030|454671308|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
126375351|NCT00355030|454671309|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
126375352|NCT00355030|454671308|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
126375353|NCT00355030|454671309|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
126375354|NCT00355030|454671308|FG000|Study Period 1 Treatment|Other|2|||
126375355|NCT00355030|454671309|FG001|Study Period 1 Treatment|Other|6|||
126375356|NCT00355030|454671308|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
126375357|NCT00355030|454671309|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
126375358|NCT00355030|454671308|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
126375359|NCT00355030|454671309|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
126375360|NCT01123148|454671310|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
126375361|NCT01123148|454671310|FG000|Overall Study|Didn't meet milestone criteria|1|||
126375362|NCT01049373|454671311|FG000|Overall Study|Protocol Violation|9|||
126375363|NCT01049373|454671312|FG001|Overall Study|Protocol Violation|9|||
126375364|NCT01049373|454671311|FG000|Overall Study|Withdrawal by Subject|8|||
126375365|NCT01049373|454671312|FG001|Overall Study|Withdrawal by Subject|5|||
126375366|NCT01049373|454671311|FG000|Overall Study|Adverse Event|3|||
126375367|NCT01049373|454671312|FG001|Overall Study|Adverse Event|3|||
126375368|NCT01049373|454671311|FG000|Overall Study|Lost to Follow-up|9|||
126375369|NCT01049373|454671312|FG001|Overall Study|Lost to Follow-up|4|||
126375370|NCT01049373|454671311|FG000|Overall Study|no evaluable study values|9|||
126375371|NCT01049373|454671312|FG001|Overall Study|no evaluable study values|21|||
126375372|NCT01049373|454671311|FG000|Overall Study|Other|1|||
126375373|NCT01049373|454671312|FG001|Overall Study|Other|1|||
126375374|NCT01049373|454671311|FG000|Overall Study|Non-cooperation|0|||
126375375|NCT01049373|454671312|FG001|Overall Study|Non-cooperation|1|||
126375376|NCT00339040|454671313|FG000|Stage I|Not able to attend clinic|1|||
126375377|NCT00339040|454671314|FG001|Stage I|Not able to attend clinic|0|||
126375378|NCT00339040|454671313|FG000|Stage I|Protocol Violation|1|||
126375379|NCT00339040|454671314|FG001|Stage I|Protocol Violation|1|||
126375380|NCT00339040|454671313|FG000|Stage II|Lost to Follow-up|3|||
126375381|NCT00339040|454671314|FG001|Stage II|Lost to Follow-up|0|||
126375382|NCT00339040|454671313|FG000|Stage II|Withdrawal by Subject|1|||
126375383|NCT00339040|454671314|FG001|Stage II|Withdrawal by Subject|2|||
126375384|NCT00339040|454671313|FG000|Stage II|Protocol Violation|3|||
126375385|NCT00339040|454671314|FG001|Stage II|Protocol Violation|0|||
126375386|NCT00339040|454671313|FG000|Stage II|Not able to attend clinic|1|||
126375387|NCT00339040|454671314|FG001|Stage II|Not able to attend clinic|0|||
126375388|NCT00339040|454671313|FG000|Stage II|Site closing|2|||
126375389|NCT00339040|454671314|FG001|Stage II|Site closing|0|||
126375390|NCT00812955|454671319|FG000|Overall Study|Adverse Event|7|||
126375391|NCT00812955|454671320|FG001|Overall Study|Adverse Event|6|||
126375392|NCT00812955|454671321|FG002|Overall Study|Adverse Event|3|||
126375393|NCT00812955|454671322|FG003|Overall Study|Adverse Event|4|||
126375394|NCT00812955|454671319|FG000|Overall Study|Lost to Follow-up|2|||
126375395|NCT00812955|454671320|FG001|Overall Study|Lost to Follow-up|1|||
126375396|NCT00812955|454671321|FG002|Overall Study|Lost to Follow-up|1|||
126771073|NCT00627458|456116247|FG000|Overall Study|Migrated from study area|1|||
126375397|NCT00812955|454671322|FG003|Overall Study|Lost to Follow-up|2|||
126375398|NCT00812955|454671319|FG000|Overall Study|Withdrawal by Subject|1|||
126375399|NCT00812955|454671320|FG001|Overall Study|Withdrawal by Subject|0|||
126375400|NCT00812955|454671321|FG002|Overall Study|Withdrawal by Subject|1|||
126466898|NCT00586066|455010494|FG001|Overall Study|Withdrawal of consent|2|||
126466899|NCT00467610|455010497|FG000|Overall Study|Withdrawal by Subject|1|||
126466900|NCT04263454|455010498|FG000|Overall Study|Adverse Event|0|||
126466901|NCT04263454|455010499|FG001|Overall Study|Adverse Event|2|||
126466902|NCT04263454|455010498|FG000|Overall Study|Physician Decision|3|||
126466903|NCT04263454|455010499|FG001|Overall Study|Physician Decision|5|||
126466904|NCT04263454|455010498|FG000|Overall Study|Poor Data Quality|0|||
126466905|NCT04263454|455010499|FG001|Overall Study|Poor Data Quality|1|||
126466906|NCT00986479|455010500|FG000|Period 1|Improved mood|1|||
126466907|NCT00986479|455010501|FG001|Period 1|Improved mood|0|||
126466908|NCT00986479|455010500|FG000|Period 1|Administrative reasons|1|||
126466909|NCT00986479|455010501|FG001|Period 1|Administrative reasons|0|||
126466910|NCT00915356|455010504|FG000|Overall Study|Withdrawal by Subject|1|||
126466911|NCT00915356|455010505|FG001|Overall Study|Withdrawal by Subject|0|||
126466912|NCT00915356|455010506|FG002|Overall Study|Withdrawal by Subject|0|||
126466913|NCT00915356|455010507|FG003|Overall Study|Withdrawal by Subject|0|||
126552981|NCT02291289|455320510|FG009|Induction Treatment|Reason Not Specified|7|||
126552982|NCT02291289|455320511|FG010|Induction Treatment|Reason Not Specified|0|||
126552983|NCT02291289|455320512|FG011|Induction Treatment|Reason Not Specified|0|||
126552984|NCT02291289|455320513|FG012|Induction Treatment|Reason Not Specified|0|||
126375401|NCT00812955|454671322|FG003|Overall Study|Withdrawal by Subject|2|||
126375402|NCT00812955|454671319|FG000|Overall Study|randomized in error|0|||
126375403|NCT00812955|454671320|FG001|Overall Study|randomized in error|0|||
126375404|NCT00812955|454671321|FG002|Overall Study|randomized in error|1|||
126375405|NCT00812955|454671322|FG003|Overall Study|randomized in error|0|||
126375406|NCT02391311|454671323|FG000|Overall Study|Lost to Follow-up|2|||
126375407|NCT02391311|454671324|FG001|Overall Study|Lost to Follow-up|1|||
126375408|NCT02391311|454671323|FG000|Overall Study|deemed ineligible after baseline|1|||
126375409|NCT02391311|454671324|FG001|Overall Study|deemed ineligible after baseline|1|||
126375410|NCT01815424|454671327|FG000|Week 0 to 16|Adverse Event|1|||
126375411|NCT01815424|454671328|FG001|Week 0 to 16|Adverse Event|3|||
126375412|NCT01815424|454671329|FG002|Week 0 to 16|Adverse Event|3|||
126375413|NCT01815424|454671330|FG003|Week 0 to 16|Adverse Event|0|||
126375414|NCT01815424|454671331|FG004|Week 0 to 16|Adverse Event|0|||
126375415|NCT01815424|454671327|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
126375416|NCT01815424|454671328|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
126375417|NCT01815424|454671329|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
126375418|NCT01815424|454671330|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
126375419|NCT01815424|454671331|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
126375420|NCT01815424|454671327|FG000|Week 0 to 16|Lost to Follow-up|0|||
126375421|NCT01815424|454671328|FG001|Week 0 to 16|Lost to Follow-up|1|||
126375422|NCT01815424|454671329|FG002|Week 0 to 16|Lost to Follow-up|0|||
126375423|NCT01815424|454671330|FG003|Week 0 to 16|Lost to Follow-up|0|||
126375424|NCT01815424|454671331|FG004|Week 0 to 16|Lost to Follow-up|0|||
126375425|NCT01815424|454671327|FG000|Week 0 to 16|Withdrawal by Subject|0|||
126375426|NCT01815424|454671328|FG001|Week 0 to 16|Withdrawal by Subject|0|||
126375427|NCT01815424|454671329|FG002|Week 0 to 16|Withdrawal by Subject|1|||
126375428|NCT01815424|454671330|FG003|Week 0 to 16|Withdrawal by Subject|0|||
126375429|NCT01815424|454671331|FG004|Week 0 to 16|Withdrawal by Subject|0|||
126375430|NCT01815424|454671327|FG000|Week 0 to 16|Other|1|||
126375431|NCT01815424|454671328|FG001|Week 0 to 16|Other|0|||
126375432|NCT01815424|454671329|FG002|Week 0 to 16|Other|3|||
126375433|NCT01815424|454671330|FG003|Week 0 to 16|Other|0|||
126375434|NCT01815424|454671331|FG004|Week 0 to 16|Other|0|||
126375435|NCT01815424|454671327|FG000|Week 0 to 16|Protocol Violation|1|||
126375436|NCT01815424|454671328|FG001|Week 0 to 16|Protocol Violation|0|||
126375437|NCT01815424|454671329|FG002|Week 0 to 16|Protocol Violation|0|||
126375438|NCT01815424|454671330|FG003|Week 0 to 16|Protocol Violation|0|||
126375439|NCT01815424|454671331|FG004|Week 0 to 16|Protocol Violation|0|||
126375440|NCT01815424|454671327|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
126375441|NCT01815424|454671328|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
126375442|NCT01815424|454671329|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
126375443|NCT01815424|454671330|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
126375444|NCT01815424|454671331|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
126375445|NCT01815424|454671327|FG000|Week 16 to 52|Other|0|||
126375446|NCT01815424|454671328|FG001|Week 16 to 52|Other|1|||
126375447|NCT01815424|454671329|FG002|Week 16 to 52|Other|0|||
126375448|NCT01815424|454671330|FG003|Week 16 to 52|Other|0|||
126375449|NCT01815424|454671331|FG004|Week 16 to 52|Other|0|||
126375450|NCT01815424|454671327|FG000|Week 16 to 52|Adverse Event|0|||
126375451|NCT01815424|454671328|FG001|Week 16 to 52|Adverse Event|0|||
126466914|NCT00915356|455010508|FG004|Overall Study|Withdrawal by Subject|0|||
126466915|NCT02001181|455010511|FG000|Overall Study|Adverse Event|0|||
126375452|NCT01815424|454671329|FG002|Week 16 to 52|Adverse Event|0|||
126375453|NCT01815424|454671330|FG003|Week 16 to 52|Adverse Event|0|||
126466916|NCT02001181|455010512|FG001|Overall Study|Adverse Event|2|||
126375454|NCT01815424|454671331|FG004|Week 16 to 52|Adverse Event|1|||
126375455|NCT01815424|454671327|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
126466917|NCT02001181|455010511|FG000|Overall Study|Lost to Follow-up|1|||
126466918|NCT02001181|455010512|FG001|Overall Study|Lost to Follow-up|0|||
126466919|NCT02001181|455010511|FG000|Overall Study|Withdrawal by Subject|0|||
126466920|NCT02001181|455010512|FG001|Overall Study|Withdrawal by Subject|1|||
126466921|NCT00292318|455010514|FG000|Overall Study|Study terminated by officials|2|||
126375456|NCT01815424|454671328|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
126375457|NCT01815424|454671329|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
126375458|NCT01815424|454671330|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
126375459|NCT01815424|454671331|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
126375460|NCT01815424|454671327|FG000|Week 16 to 52|Lost to Follow-up|0|||
126375461|NCT01815424|454671328|FG001|Week 16 to 52|Lost to Follow-up|2|||
126375462|NCT01815424|454671329|FG002|Week 16 to 52|Lost to Follow-up|0|||
126375463|NCT01815424|454671330|FG003|Week 16 to 52|Lost to Follow-up|2|||
126375464|NCT01815424|454671331|FG004|Week 16 to 52|Lost to Follow-up|1|||
126375465|NCT01815424|454671327|FG000|Week 16 to 52|Withdrawal by Subject|1|||
126375466|NCT01815424|454671328|FG001|Week 16 to 52|Withdrawal by Subject|2|||
126375467|NCT01815424|454671329|FG002|Week 16 to 52|Withdrawal by Subject|0|||
126375468|NCT01815424|454671330|FG003|Week 16 to 52|Withdrawal by Subject|0|||
126375469|NCT01815424|454671331|FG004|Week 16 to 52|Withdrawal by Subject|0|||
126375470|NCT01309204|454671332|FG000|Overall Study|Adverse Event|48|||
126375471|NCT01309204|454671333|FG001|Overall Study|Adverse Event|58|||
126375472|NCT01309204|454671332|FG000|Overall Study|Lost to Follow-up|2|||
126375473|NCT01309204|454671333|FG001|Overall Study|Lost to Follow-up|2|||
126375474|NCT01309204|454671332|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
126375475|NCT01309204|454671333|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
126375476|NCT01309204|454671332|FG000|Overall Study|Inadequate control of IOP|4|||
126375477|NCT01309204|454671333|FG001|Overall Study|Inadequate control of IOP|4|||
126375478|NCT01309204|454671332|FG000|Overall Study|Other|4|||
126375479|NCT01309204|454671333|FG001|Overall Study|Other|1|||
126375480|NCT03046446|454671334|FG000|Overall Study|Lack of Efficacy|7|||
126375481|NCT03046446|454671334|FG000|Overall Study|Adverse Event|6|||
126375482|NCT03046446|454671334|FG000|Overall Study|Lost to Follow-up|3|||
126375483|NCT03046446|454671334|FG000|Overall Study|Withdrawal by Subject|14|||
126375484|NCT03046446|454671334|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
126375485|NCT03046446|454671334|FG000|Overall Study|Disease Progression (see caveats)|25|||
126375486|NCT03046446|454671334|FG000|Overall Study|Non OA related knee surgery|1|||
126375487|NCT02808897|454671335|FG000|Overall Study|Lost to Follow-up|9|||
126375488|NCT02808897|454671336|FG001|Overall Study|Lost to Follow-up|11|||
126375489|NCT00925002|454671337|FG000|Overall Study|Other|1|||
126375490|NCT00925002|454671338|FG001|Overall Study|Other|4|||
126375491|NCT00925002|454671339|FG002|Overall Study|Other|0|||
126375492|NCT00925002|454671337|FG000|Overall Study|Death|1|||
126375493|NCT00925002|454671338|FG001|Overall Study|Death|1|||
126375494|NCT00925002|454671339|FG002|Overall Study|Death|5|||
126375495|NCT00925002|454671337|FG000|Overall Study|Adverse Event|3|||
126375496|NCT00925002|454671338|FG001|Overall Study|Adverse Event|1|||
126375497|NCT00925002|454671339|FG002|Overall Study|Adverse Event|2|||
126375498|NCT00925002|454671337|FG000|Overall Study|Participant withdrew consent|1|||
126375499|NCT00925002|454671338|FG001|Overall Study|Participant withdrew consent|3|||
126375500|NCT00925002|454671339|FG002|Overall Study|Participant withdrew consent|3|||
126375501|NCT01496287|454671340|FG000|Overall Study|Lost to Follow-up|1|||
126375502|NCT01496287|454671340|FG000|Overall Study|Incomplete anesthesia|5|||
126375503|NCT00305448|454671341|FG000|Overall Study|Protocol Violation|0|||
126375504|NCT00305448|454671342|FG001|Overall Study|Protocol Violation|1|||
126375505|NCT00305448|454671343|FG002|Overall Study|Protocol Violation|0|||
126375506|NCT00305448|454671341|FG000|Overall Study|Withdrawal by Subject|2|||
126466922|NCT00292318|455010515|FG001|Overall Study|Study terminated by officials|1|||
126466923|NCT00771316|455010516|FG000|Overall Study|Adverse Event|0|||
126466924|NCT00771316|455010517|FG001|Overall Study|Adverse Event|1|||
126466925|NCT00771316|455010516|FG000|Overall Study|Patient withdrew consent|1|||
126466926|NCT00771316|455010517|FG001|Overall Study|Patient withdrew consent|0|||
126466927|NCT00771316|455010516|FG000|Overall Study|Discontinued due to early termination|1|||
126466928|NCT00771316|455010517|FG001|Overall Study|Discontinued due to early termination|0|||
126466929|NCT02027376|455010518|FG000|Overall Study|Death|1|||
126771074|NCT00627458|456116248|FG001|Overall Study|Migrated from study area|0|||
126771075|NCT00627458|456116249|FG002|Overall Study|Migrated from study area|1|||
126375507|NCT00305448|454671342|FG001|Overall Study|Withdrawal by Subject|0|||
126375508|NCT00305448|454671343|FG002|Overall Study|Withdrawal by Subject|1|||
126375509|NCT00305448|454671341|FG000|Overall Study|Adverse Event|1|||
126375510|NCT00305448|454671342|FG001|Overall Study|Adverse Event|0|||
126375511|NCT00305448|454671343|FG002|Overall Study|Adverse Event|1|||
126375512|NCT00305448|454671341|FG000|Overall Study|Disease Progression|27|||
126375513|NCT00305448|454671342|FG001|Overall Study|Disease Progression|31|||
126375514|NCT00305448|454671343|FG002|Overall Study|Disease Progression|28|||
126375515|NCT00305448|454671341|FG000|Overall Study|Subjective Disease Progression|1|||
126375516|NCT00305448|454671342|FG001|Overall Study|Subjective Disease Progression|2|||
126375517|NCT00305448|454671343|FG002|Overall Study|Subjective Disease Progression|2|||
126375518|NCT00305448|454671341|FG000|Overall Study|Tumor Marker Elevation|0|||
126466930|NCT02027376|455010519|FG001|Overall Study|Death|0|||
126466931|NCT02027376|455010520|FG002|Overall Study|Death|0|||
126466932|NCT01278160|455010526|FG000|Overall Study|Adverse Event|1|||
126466933|NCT01278160|455010527|FG001|Overall Study|Adverse Event|1|||
126466934|NCT01278160|455010526|FG000|Overall Study|Lost to Follow-up|0|||
126466935|NCT01278160|455010527|FG001|Overall Study|Lost to Follow-up|1|||
126466936|NCT01278160|455010526|FG000|Overall Study|Withdrawal by Subject|3|||
126466937|NCT01278160|455010527|FG001|Overall Study|Withdrawal by Subject|2|||
126466938|NCT01278160|455010526|FG000|Overall Study|Unclassified|1|||
126466939|NCT01278160|455010527|FG001|Overall Study|Unclassified|2|||
126466940|NCT02819518|455010531|FG000|Overall Study|Death|9|||
126466941|NCT02819518|455010532|FG001|Overall Study|Death|12|||
126466942|NCT02819518|455010533|FG002|Overall Study|Death|9|||
126466943|NCT02819518|455010534|FG003|Overall Study|Death|475|||
126466944|NCT02819518|455010535|FG004|Overall Study|Death|244|||
126466945|NCT02819518|455010531|FG000|Overall Study|Withdrawal by Subject|0|||
126466946|NCT02819518|455010532|FG001|Overall Study|Withdrawal by Subject|0|||
126466947|NCT02819518|455010533|FG002|Overall Study|Withdrawal by Subject|0|||
126466948|NCT02819518|455010534|FG003|Overall Study|Withdrawal by Subject|25|||
126466949|NCT02819518|455010535|FG004|Overall Study|Withdrawal by Subject|8|||
126466950|NCT02819518|455010531|FG000|Overall Study|Lost to Follow-up|0|||
126466951|NCT02819518|455010532|FG001|Overall Study|Lost to Follow-up|0|||
126466952|NCT02819518|455010533|FG002|Overall Study|Lost to Follow-up|0|||
126466953|NCT02819518|455010534|FG003|Overall Study|Lost to Follow-up|0|||
126466954|NCT02819518|455010535|FG004|Overall Study|Lost to Follow-up|1|||
126466955|NCT02819518|455010531|FG000|Overall Study|Sponsor Decision|1|||
126466956|NCT02819518|455010532|FG001|Overall Study|Sponsor Decision|1|||
126466957|NCT02819518|455010533|FG002|Overall Study|Sponsor Decision|0|||
126466958|NCT02819518|455010534|FG003|Overall Study|Sponsor Decision|34|||
126466959|NCT02819518|455010535|FG004|Overall Study|Sponsor Decision|17|||
126466960|NCT02819518|455010531|FG000|Overall Study|Transferred to extension study|1|||
126466961|NCT02819518|455010532|FG001|Overall Study|Transferred to extension study|1|||
126466962|NCT02819518|455010533|FG002|Overall Study|Transferred to extension study|1|||
126466963|NCT02819518|455010534|FG003|Overall Study|Transferred to extension study|32|||
126466964|NCT02819518|455010535|FG004|Overall Study|Transferred to extension study|11|||
126466965|NCT01505647|455010536|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
126466966|NCT01505647|455010537|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
126466967|NCT01505647|455010536|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
126466968|NCT01505647|455010537|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
126466969|NCT01505647|455010536|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
126466970|NCT01505647|455010537|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
126466971|NCT01505647|455010536|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
126466972|NCT01505647|455010537|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
126466973|NCT01505647|455010536|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
126771076|NCT00627458|456116247|FG000|Overall Study|Withdrawal by Subject|2|||
126771077|NCT00627458|456116248|FG001|Overall Study|Withdrawal by Subject|6|||
126771078|NCT00627458|456116249|FG002|Overall Study|Withdrawal by Subject|5|||
126375519|NCT00305448|454671342|FG001|Overall Study|Tumor Marker Elevation|0|||
126375520|NCT00305448|454671343|FG002|Overall Study|Tumor Marker Elevation|1|||
126375521|NCT00328172|454671344|FG000|Overall Study|Adverse Event|3|||
126375522|NCT00328172|454671345|FG001|Overall Study|Adverse Event|2|||
126375523|NCT00328172|454671346|FG002|Overall Study|Adverse Event|1|||
126375524|NCT00328172|454671347|FG003|Overall Study|Adverse Event|2|||
126375525|NCT00328172|454671348|FG004|Overall Study|Adverse Event|1|||
126375526|NCT00328172|454671344|FG000|Overall Study|Protocol Violation|0|||
126375527|NCT00328172|454671345|FG001|Overall Study|Protocol Violation|1|||
126375528|NCT00328172|454671346|FG002|Overall Study|Protocol Violation|1|||
126375529|NCT00328172|454671347|FG003|Overall Study|Protocol Violation|0|||
126375530|NCT00328172|454671348|FG004|Overall Study|Protocol Violation|0|||
126375531|NCT00328172|454671344|FG000|Overall Study|Lost to Follow-up|1|||
126375532|NCT00328172|454671345|FG001|Overall Study|Lost to Follow-up|1|||
126375533|NCT00328172|454671346|FG002|Overall Study|Lost to Follow-up|2|||
126375534|NCT00328172|454671347|FG003|Overall Study|Lost to Follow-up|1|||
126375535|NCT00328172|454671348|FG004|Overall Study|Lost to Follow-up|1|||
126375536|NCT00328172|454671344|FG000|Overall Study|Withdrawal by Subject|1|||
126375537|NCT00328172|454671345|FG001|Overall Study|Withdrawal by Subject|1|||
126375538|NCT00328172|454671346|FG002|Overall Study|Withdrawal by Subject|1|||
126466974|NCT01505647|455010537|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
126466975|NCT04755283|455010538|FG000|Overall Study|Withdrawal by Subject|14|||
126466976|NCT04755283|455010539|FG001|Overall Study|Withdrawal by Subject|3|||
126771079|NCT00627458|456116247|FG000|Overall Study|Lost to Follow-up|1|||
126375539|NCT00328172|454671347|FG003|Overall Study|Withdrawal by Subject|6|||
126375540|NCT00328172|454671348|FG004|Overall Study|Withdrawal by Subject|0|||
126375541|NCT00328172|454671344|FG000|Overall Study|Lack of Efficacy|14|||
126466977|NCT04755283|455010540|FG002|Overall Study|Withdrawal by Subject|6|||
126466978|NCT04755283|455010538|FG000|Overall Study|Lost to Follow-up|0|||
126466979|NCT04755283|455010539|FG001|Overall Study|Lost to Follow-up|0|||
126466980|NCT04755283|455010540|FG002|Overall Study|Lost to Follow-up|1|||
126375542|NCT00328172|454671345|FG001|Overall Study|Lack of Efficacy|9|||
126375543|NCT00328172|454671346|FG002|Overall Study|Lack of Efficacy|4|||
126375544|NCT00328172|454671347|FG003|Overall Study|Lack of Efficacy|4|||
126375545|NCT00328172|454671348|FG004|Overall Study|Lack of Efficacy|3|||
126375546|NCT00328172|454671344|FG000|Overall Study|Other reason (not specified)|3|||
126375547|NCT00328172|454671345|FG001|Overall Study|Other reason (not specified)|0|||
126375548|NCT00328172|454671346|FG002|Overall Study|Other reason (not specified)|1|||
126375549|NCT00328172|454671347|FG003|Overall Study|Other reason (not specified)|0|||
126375550|NCT00328172|454671348|FG004|Overall Study|Other reason (not specified)|0|||
126375551|NCT00558636|454671353|FG000|Treatment|Adverse Event|9|||
126375552|NCT00558636|454671354|FG001|Treatment|Adverse Event|2|||
126375553|NCT00558636|454671353|FG000|Treatment|Withdrawal by Subject|2|||
126375554|NCT00558636|454671354|FG001|Treatment|Withdrawal by Subject|0|||
126375555|NCT00558636|454671353|FG000|Treatment|Premature termination of the study|35|||
126375556|NCT00558636|454671354|FG001|Treatment|Premature termination of the study|37|||
126375557|NCT00558636|454671353|FG000|Treatment|Disease progression|1|||
126375558|NCT00558636|454671354|FG001|Treatment|Disease progression|5|||
126375559|NCT00558636|454671353|FG000|Follow-up|Premature termination of the study|12|||
126375560|NCT00558636|454671354|FG001|Follow-up|Premature termination of the study|7|||
126375561|NCT01990742|454671355|FG000|Overall Study|Withdrawal by facility|407|||
126375562|NCT01990742|454671356|FG001|Overall Study|Withdrawal by facility|1083|||
126375563|NCT01990742|454671355|FG000|Overall Study|Facility closed|0|||
126375564|NCT01990742|454671356|FG001|Overall Study|Facility closed|270|||
126375565|NCT03443687|454671357|FG000|Overall Study|Lost to Follow-up|3|||
126375566|NCT03443687|454671358|FG001|Overall Study|Lost to Follow-up|5|||
126375567|NCT03443687|454671357|FG000|Overall Study|Withdrawal by Subject|1|||
126375568|NCT03443687|454671358|FG001|Overall Study|Withdrawal by Subject|0|||
126375569|NCT03443687|454671357|FG000|Overall Study|Discontinued intervention|1|||
126375570|NCT03443687|454671358|FG001|Overall Study|Discontinued intervention|1|||
126375571|NCT04108273|454671359|FG000|Overall Study|COVID Pandemic|1|||
126375572|NCT04108273|454671360|FG001|Overall Study|COVID Pandemic|0|||
126375573|NCT02897115|454671364|FG000|Overall Study|Early termination of study by sponsor|11|||
126375574|NCT02897115|454671365|FG001|Overall Study|Early termination of study by sponsor|8|||
126375575|NCT00487981|454671366|FG000|Overall Study|Hypothyroidism diagnosis|1|||
126375576|NCT02808429|454671371|FG000|Overall Study|Lost to Follow-up|1|||
126375577|NCT02808429|454671372|FG001|Overall Study|Lost to Follow-up|0|||
126375578|NCT02808429|454671373|FG002|Overall Study|Lost to Follow-up|0|||
126375579|NCT02808429|454671371|FG000|Overall Study|Protocol Violation|0|||
126375580|NCT02808429|454671372|FG001|Overall Study|Protocol Violation|1|||
126375581|NCT02808429|454671373|FG002|Overall Study|Protocol Violation|0|||
126375582|NCT02808429|454671371|FG000|Overall Study|Premature study termination by sponsor|2|||
126375583|NCT02808429|454671372|FG001|Overall Study|Premature study termination by sponsor|0|||
126375584|NCT02808429|454671373|FG002|Overall Study|Premature study termination by sponsor|1|||
126375585|NCT02808429|454671371|FG000|Overall Study|Relocation|0|||
126375586|NCT02808429|454671372|FG001|Overall Study|Relocation|0|||
126375587|NCT02808429|454671373|FG002|Overall Study|Relocation|1|||
126375588|NCT03886493|454671378|FG000|Overall Study|Adverse Event|1|||
126375589|NCT04828707|454671379|FG000|Overall Study|Lost to Follow-up|3|||
126375590|NCT04828707|454671380|FG001|Overall Study|Lost to Follow-up|2|||
126375591|NCT04828707|454671379|FG000|Overall Study|Withdrawal by Subject|2|||
126375592|NCT04828707|454671380|FG001|Overall Study|Withdrawal by Subject|1|||
126375593|NCT03139448|454671381|FG000|Overall Study|Lack of Efficacy|6|||
126375594|NCT03139448|454671382|FG001|Overall Study|Lack of Efficacy|7|||
126375595|NCT03139448|454671381|FG000|Overall Study|Location of procedure changed|2|||
126375596|NCT03139448|454671382|FG001|Overall Study|Location of procedure changed|8|||
126375597|NCT03139448|454671381|FG000|Overall Study|Withdrawal by Subject|3|||
126375598|NCT03139448|454671382|FG001|Overall Study|Withdrawal by Subject|6|||
126375599|NCT03139448|454671381|FG000|Overall Study|Screen fail|1|||
126375600|NCT03139448|454671382|FG001|Overall Study|Screen fail|3|||
126375601|NCT03139448|454671381|FG000|Overall Study|Physician Decision|0|||
126375602|NCT03139448|454671382|FG001|Overall Study|Physician Decision|2|||
126375603|NCT00523978|454671383|FG000|Overall Study|Withdrawal by Subject|3|||
126375604|NCT00523978|454671384|FG001|Overall Study|Withdrawal by Subject|7|||
126375605|NCT00523978|454671383|FG000|Overall Study|Screen Failures|5|||
126375606|NCT00523978|454671384|FG001|Overall Study|Screen Failures|1|||
126375607|NCT00523978|454671383|FG000|Overall Study|Death|1|||
126375608|NCT00523978|454671384|FG001|Overall Study|Death|0|||
126375609|NCT00696878|454671385|FG000|Overall Study|Adverse Event|8|||
126375610|NCT00696878|454671385|FG000|Overall Study|Withdrawal by Subject|87|||
126375611|NCT00696878|454671385|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
126375612|NCT00696878|454671385|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
126375613|NCT00696878|454671385|FG000|Overall Study|Trial stopped|32|||
126375614|NCT00696878|454671385|FG000|Overall Study|Other reason (not specified)|55|||
126375615|NCT02712788|454671386|FG000|Overall Study|Physician Decision|1|||
126375616|NCT02712788|454671387|FG001|Overall Study|Physician Decision|0|||
126375617|NCT02712788|454671386|FG000|Overall Study|Protocol Violation|1|||
126375618|NCT02712788|454671387|FG001|Overall Study|Protocol Violation|0|||
126552985|NCT02291289|455320501|FG000|Induction Treatment|Physician Decision|0|||
126552986|NCT02291289|455320502|FG001|Induction Treatment|Physician Decision|0|||
126552987|NCT02291289|455320503|FG002|Induction Treatment|Physician Decision|0|||
126552988|NCT02291289|455320504|FG003|Induction Treatment|Physician Decision|3|||
126375619|NCT01880957|454671388|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
126375620|NCT01880957|454671389|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
126375621|NCT01880957|454671388|FG000|Overall Study|Lost to Follow-up|11|||
126375622|NCT01880957|454671389|FG001|Overall Study|Lost to Follow-up|0|||
126375623|NCT01880957|454671388|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
126375624|NCT01880957|454671389|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
126375625|NCT00940602|454671390|FG000|Overall Study|Administrative problems|1|||
126375626|NCT00940602|454671391|FG001|Overall Study|Administrative problems|1|||
126375627|NCT00940602|454671390|FG000|Overall Study|Patient/guardian decision|13|||
126375628|NCT00940602|454671391|FG001|Overall Study|Patient/guardian decision|28|||
126375629|NCT00940602|454671390|FG000|Overall Study|Physician Decision|8|||
126375630|NCT00940602|454671391|FG001|Overall Study|Physician Decision|5|||
126375631|NCT00940602|454671390|FG000|Overall Study|Pregnancy|1|||
126375632|NCT00940602|454671391|FG001|Overall Study|Pregnancy|0|||
126375633|NCT00940602|454671390|FG000|Overall Study|Protocol Deviation (untreated)|1|||
126375634|NCT00940602|454671391|FG001|Overall Study|Protocol Deviation (untreated)|0|||
126375635|NCT00940602|454671390|FG000|Overall Study|Disease progression|8|||
126375636|NCT00940602|454671391|FG001|Overall Study|Disease progression|2|||
126375637|NCT00940602|454671390|FG000|Overall Study|Death|38|||
126375638|NCT00940602|454671391|FG001|Overall Study|Death|19|||
126375639|NCT00940602|454671390|FG000|Overall Study|Lost to Follow-up|3|||
126375640|NCT00940602|454671391|FG001|Overall Study|Lost to Follow-up|1|||
126375641|NCT00940602|454671390|FG000|Overall Study|Patient withdrew consent|26|||
126375642|NCT00940602|454671391|FG001|Overall Study|Patient withdrew consent|13|||
126375643|NCT00940602|454671390|FG000|Overall Study|Adverse Event|7|||
126375644|NCT00940602|454671391|FG001|Overall Study|Adverse Event|2|||
126375645|NCT00940602|454671390|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
126375646|NCT00940602|454671391|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
126375647|NCT00575666|454671394|FG000|Overall Study|Withdrawal by Subject|3|||
126375648|NCT00575666|454671395|FG001|Overall Study|Withdrawal by Subject|2|||
126375649|NCT00575666|454671394|FG000|Overall Study|Physician Decision|1|||
126375650|NCT00575666|454671395|FG001|Overall Study|Physician Decision|1|||
126375651|NCT00508482|454671396|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
126375652|NCT00508482|454671397|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
126375653|NCT00508482|454671398|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
126375654|NCT00508482|454671396|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
126375655|NCT00508482|454671397|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
126375656|NCT00508482|454671398|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
126375657|NCT00508482|454671396|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
126375658|NCT00508482|454671397|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
126375659|NCT00508482|454671398|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
126375660|NCT02289469|454671399|FG000|Overall Study|Unable to match a control|6|||
126375661|NCT02289469|454671400|FG001|Overall Study|Unable to match a control|0|||
126375662|NCT02750930|454671404|FG000|Overall Study|Study closed/terminated|8|||
126375663|NCT01944020|454672951|FG000|Overall Study|Withdrawal by Subject|5|||
126375664|NCT01944020|454672952|FG001|Overall Study|Withdrawal by Subject|0|||
126375665|NCT00811954|454672958|FG000|Overall Study|Death|10|||
126375666|NCT00811954|454672959|FG001|Overall Study|Death|6|||
126375667|NCT00811954|454672960|FG002|Overall Study|Death|13|||
126375668|NCT00811954|454672958|FG000|Overall Study|Lost to Follow-up|29|||
126375669|NCT00811954|454672959|FG001|Overall Study|Lost to Follow-up|23|||
126375670|NCT00811954|454672960|FG002|Overall Study|Lost to Follow-up|34|||
126375671|NCT00811954|454672958|FG000|Overall Study|Not able to get to clinic|28|||
126375672|NCT00811954|454672959|FG001|Overall Study|Not able to get to clinic|35|||
126375673|NCT00811954|454672960|FG002|Overall Study|Not able to get to clinic|30|||
126375674|NCT00811954|454672958|FG000|Overall Study|Not willing to adhere to requirements|12|||
126375675|NCT00811954|454672959|FG001|Overall Study|Not willing to adhere to requirements|2|||
126375676|NCT00811954|454672960|FG002|Overall Study|Not willing to adhere to requirements|16|||
126375677|NCT00811954|454672958|FG000|Overall Study|Withdraw consent prior study completion|4|||
126375678|NCT00811954|454672959|FG001|Overall Study|Withdraw consent prior study completion|6|||
126375679|NCT00811954|454672960|FG002|Overall Study|Withdraw consent prior study completion|5|||
126375680|NCT00811954|454672958|FG000|Overall Study|Site Closure|4|||
126375681|NCT00811954|454672959|FG001|Overall Study|Site Closure|0|||
126375682|NCT00811954|454672960|FG002|Overall Study|Site Closure|1|||
126375683|NCT00811954|454672958|FG000|Overall Study|Severe Debilitation|2|||
126375684|NCT00811954|454672959|FG001|Overall Study|Severe Debilitation|0|||
126375685|NCT00811954|454672960|FG002|Overall Study|Severe Debilitation|1|||
126375686|NCT00811954|454672958|FG000|Overall Study|Complete Protocol: No follow-up|0|||
126375687|NCT00811954|454672959|FG001|Overall Study|Complete Protocol: No follow-up|0|||
126716778|NCT01781429|455914916|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
126716779|NCT01781429|455914917|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
126716780|NCT01781429|455914918|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
126716781|NCT01781429|455914919|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
126375688|NCT00811954|454672960|FG002|Overall Study|Complete Protocol: No follow-up|1|||
126375689|NCT01016067|454672961|FG000|Overall Study|Lost to Follow-up|1|||
126375690|NCT01016067|454672962|FG001|Overall Study|Lost to Follow-up|2|||
126375691|NCT01016067|454672961|FG000|Overall Study|Physician Decision|1|||
126375692|NCT01016067|454672962|FG001|Overall Study|Physician Decision|1|||
126375693|NCT01016067|454672961|FG000|Overall Study|Withdrew due to Relocation|0|||
126375694|NCT01016067|454672962|FG001|Overall Study|Withdrew due to Relocation|1|||
126375695|NCT01534481|454672969|FG000|Overall Study|Lost to Follow-up|29|||
126375696|NCT01534481|454672970|FG001|Overall Study|Lost to Follow-up|24|||
126375697|NCT01534481|454672969|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
126375698|NCT01534481|454672970|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
126466981|NCT04755283|455010538|FG000|Overall Study|Death|31|||
126375699|NCT01130337|454672971|FG000|Overall Study|Withdrawal by Subject|3|||
126375700|NCT01130337|454672971|FG000|Overall Study|Principal investigator decision|1|||
126375701|NCT01130337|454672971|FG000|Overall Study|Death|1|||
126375702|NCT01130337|454672971|FG000|Overall Study|Disease progression|1|||
126375703|NCT01130337|454672971|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
126375704|NCT01130337|454672971|FG000|Overall Study|Surgical resection (R2)|1|||
126375705|NCT05525910|454672972|FG000|Period 4|Per sponsor due to study timelines|0|||
126375706|NCT05525910|454672973|FG001|Period 4|Per sponsor due to study timelines|0|||
126375707|NCT05525910|454672974|FG002|Period 4|Per sponsor due to study timelines|1|||
126375708|NCT05525910|454672975|FG003|Period 4|Per sponsor due to study timelines|1|||
126375709|NCT05525910|454672976|FG004|Period 4|Per sponsor due to study timelines|1|||
126375710|NCT00658541|454672977|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
126375711|NCT00658541|454672978|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126375712|NCT00658541|454672977|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
126375713|NCT00658541|454672978|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126375714|NCT01063348|454672979|FG000|Overall Study|Lost to Follow-up|3|||
126375715|NCT01063348|454672980|FG001|Overall Study|Lost to Follow-up|10|||
126375716|NCT03326063|454672981|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
126375717|NCT03326063|454672982|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
126375718|NCT02750514|454672983|FG000|Track 1|Disease progression|20|||
126375719|NCT02750514|454672984|FG001|Track 1|Disease progression|1|||
126375720|NCT02750514|454672985|FG002|Track 1|Disease progression|0|||
126375721|NCT02750514|454672986|FG003|Track 1|Disease progression|1|||
126375722|NCT02750514|454672987|FG004|Track 1|Disease progression|0|||
126375723|NCT02750514|454672983|FG000|Track 1|Adverse event unrelated to study drug|1|||
126375724|NCT02750514|454672984|FG001|Track 1|Adverse event unrelated to study drug|0|||
126375725|NCT02750514|454672985|FG002|Track 1|Adverse event unrelated to study drug|0|||
126375726|NCT02750514|454672986|FG003|Track 1|Adverse event unrelated to study drug|0|||
126375727|NCT02750514|454672987|FG004|Track 1|Adverse event unrelated to study drug|0|||
126375728|NCT02750514|454672983|FG000|Track 1|Study drug toxicity|4|||
126375729|NCT02750514|454672984|FG001|Track 1|Study drug toxicity|1|||
126375730|NCT02750514|454672985|FG002|Track 1|Study drug toxicity|0|||
126375731|NCT02750514|454672986|FG003|Track 1|Study drug toxicity|1|||
126375732|NCT02750514|454672987|FG004|Track 1|Study drug toxicity|0|||
126375733|NCT02750514|454672983|FG000|Track 1|Participant request to discontinue|1|||
126375734|NCT02750514|454672984|FG001|Track 1|Participant request to discontinue|0|||
126375735|NCT02750514|454672985|FG002|Track 1|Participant request to discontinue|0|||
126375736|NCT02750514|454672986|FG003|Track 1|Participant request to discontinue|0|||
126375737|NCT02750514|454672987|FG004|Track 1|Participant request to discontinue|0|||
126375738|NCT02750514|454672983|FG000|Track 1|Other reasons|1|||
126716782|NCT01781429|455914920|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
126375739|NCT02750514|454672984|FG001|Track 1|Other reasons|0|||
126375740|NCT02750514|454672985|FG002|Track 1|Other reasons|0|||
126375741|NCT02750514|454672986|FG003|Track 1|Other reasons|0|||
126716783|NCT01781429|455914921|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
126716784|NCT01781429|455914922|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
126716785|NCT01781429|455914923|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
126716786|NCT01781429|455914924|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
126716787|NCT01781429|455914925|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
126375742|NCT02750514|454672987|FG004|Track 1|Other reasons|0|||
126375743|NCT02750514|454672983|FG000|Track 2|Disease progression|4|||
126375744|NCT02750514|454672984|FG001|Track 2|Disease progression|5|||
126375745|NCT02750514|454672985|FG002|Track 2|Disease progression|2|||
126375746|NCT02750514|454672986|FG003|Track 2|Disease progression|5|||
126375747|NCT02750514|454672987|FG004|Track 2|Disease progression|0|||
126375748|NCT02750514|454672983|FG000|Track 2|Adverse event unrelated to study drug|1|||
126375749|NCT02750514|454672984|FG001|Track 2|Adverse event unrelated to study drug|0|||
126375750|NCT02750514|454672985|FG002|Track 2|Adverse event unrelated to study drug|0|||
126375751|NCT02750514|454672986|FG003|Track 2|Adverse event unrelated to study drug|0|||
126716788|NCT01781429|455914910|FG000|Overall Study|Enrolled, but not treated|0|||
126375752|NCT02750514|454672987|FG004|Track 2|Adverse event unrelated to study drug|0|||
126375753|NCT02750514|454672983|FG000|Track 2|Study drug toxicity|1|||
126375754|NCT02750514|454672984|FG001|Track 2|Study drug toxicity|2|||
126375755|NCT02750514|454672985|FG002|Track 2|Study drug toxicity|0|||
126375756|NCT02750514|454672986|FG003|Track 2|Study drug toxicity|2|||
126375757|NCT02750514|454672987|FG004|Track 2|Study drug toxicity|0|||
126375758|NCT02750514|454672983|FG000|Track 2|Participant withdrew consent|0|||
126375759|NCT02750514|454672984|FG001|Track 2|Participant withdrew consent|1|||
126375760|NCT02750514|454672985|FG002|Track 2|Participant withdrew consent|0|||
126375761|NCT02750514|454672986|FG003|Track 2|Participant withdrew consent|0|||
126375762|NCT02750514|454672987|FG004|Track 2|Participant withdrew consent|0|||
126375763|NCT02750514|454672983|FG000|Track 3|Disease progression|0|||
126375764|NCT02750514|454672984|FG001|Track 3|Disease progression|24|||
126375765|NCT02750514|454672985|FG002|Track 3|Disease progression|13|||
126375766|NCT02750514|454672986|FG003|Track 3|Disease progression|14|||
126375767|NCT02750514|454672987|FG004|Track 3|Disease progression|0|||
126375768|NCT02750514|454672983|FG000|Track 3|Adverse event unrelated to study drug|0|||
126375769|NCT02750514|454672984|FG001|Track 3|Adverse event unrelated to study drug|1|||
126375770|NCT02750514|454672985|FG002|Track 3|Adverse event unrelated to study drug|1|||
126375771|NCT02750514|454672986|FG003|Track 3|Adverse event unrelated to study drug|1|||
126375772|NCT02750514|454672987|FG004|Track 3|Adverse event unrelated to study drug|0|||
126375773|NCT02750514|454672983|FG000|Track 3|Study drug toxicity|0|||
126375774|NCT02750514|454672984|FG001|Track 3|Study drug toxicity|3|||
126375775|NCT02750514|454672985|FG002|Track 3|Study drug toxicity|0|||
126375776|NCT02750514|454672986|FG003|Track 3|Study drug toxicity|1|||
126375777|NCT02750514|454672987|FG004|Track 3|Study drug toxicity|0|||
126375778|NCT02750514|454672983|FG000|Track 3|Participant request to discontinue|0|||
126375779|NCT02750514|454672984|FG001|Track 3|Participant request to discontinue|2|||
126375780|NCT02750514|454672985|FG002|Track 3|Participant request to discontinue|0|||
126375781|NCT02750514|454672986|FG003|Track 3|Participant request to discontinue|0|||
126375782|NCT02750514|454672987|FG004|Track 3|Participant request to discontinue|0|||
126375783|NCT02750514|454672983|FG000|Track 3|Participant withdrew consent|0|||
126375784|NCT02750514|454672984|FG001|Track 3|Participant withdrew consent|3|||
126375785|NCT02750514|454672985|FG002|Track 3|Participant withdrew consent|1|||
126375786|NCT02750514|454672986|FG003|Track 3|Participant withdrew consent|0|||
126375787|NCT02750514|454672987|FG004|Track 3|Participant withdrew consent|0|||
126375788|NCT02750514|454672983|FG000|Track 3|Other reasons|0|||
126375789|NCT02750514|454672984|FG001|Track 3|Other reasons|3|||
126375790|NCT02750514|454672985|FG002|Track 3|Other reasons|0|||
126375791|NCT02750514|454672986|FG003|Track 3|Other reasons|0|||
126375792|NCT02750514|454672987|FG004|Track 3|Other reasons|0|||
126375793|NCT02750514|454672983|FG000|Track 4|Study drug toxicity|0|||
126375794|NCT02750514|454672984|FG001|Track 4|Study drug toxicity|6|||
126375795|NCT02750514|454672985|FG002|Track 4|Study drug toxicity|0|||
126375796|NCT02750514|454672986|FG003|Track 4|Study drug toxicity|5|||
126375797|NCT02750514|454672987|FG004|Track 4|Study drug toxicity|0|||
126375798|NCT02750514|454672983|FG000|Track 4|Participant request to discontinue|0|||
126375799|NCT02750514|454672984|FG001|Track 4|Participant request to discontinue|1|||
126375800|NCT02750514|454672985|FG002|Track 4|Participant request to discontinue|0|||
126375801|NCT02750514|454672986|FG003|Track 4|Participant request to discontinue|1|||
126375802|NCT02750514|454672987|FG004|Track 4|Participant request to discontinue|0|||
126375803|NCT02750514|454672983|FG000|Track 4|Participant withdrew consent|0|||
126375804|NCT02750514|454672984|FG001|Track 4|Participant withdrew consent|1|||
126375805|NCT02750514|454672985|FG002|Track 4|Participant withdrew consent|0|||
126375806|NCT02750514|454672986|FG003|Track 4|Participant withdrew consent|0|||
126375807|NCT02750514|454672987|FG004|Track 4|Participant withdrew consent|0|||
126375808|NCT02750514|454672983|FG000|Track 4|Other reasons|0|||
126375809|NCT02750514|454672984|FG001|Track 4|Other reasons|5|||
126375810|NCT02750514|454672985|FG002|Track 4|Other reasons|0|||
126375811|NCT02750514|454672986|FG003|Track 4|Other reasons|3|||
126375812|NCT02750514|454672987|FG004|Track 4|Other reasons|0|||
126375813|NCT02750514|454672983|FG000|Track 4|Disease progression|0|||
126375814|NCT02750514|454672984|FG001|Track 4|Disease progression|33|||
126375815|NCT02750514|454672985|FG002|Track 4|Disease progression|0|||
126375816|NCT02750514|454672986|FG003|Track 4|Disease progression|32|||
126375817|NCT02750514|454672987|FG004|Track 4|Disease progression|0|||
126375818|NCT02750514|454672983|FG000|Track 4|Adverse event unrelated to study drug|0|||
126375819|NCT02750514|454672984|FG001|Track 4|Adverse event unrelated to study drug|5|||
126375820|NCT02750514|454672985|FG002|Track 4|Adverse event unrelated to study drug|0|||
126375821|NCT02750514|454672986|FG003|Track 4|Adverse event unrelated to study drug|0|||
126375822|NCT02750514|454672987|FG004|Track 4|Adverse event unrelated to study drug|0|||
126375823|NCT02750514|454672983|FG000|Track 4|Death|0|||
126375824|NCT02750514|454672984|FG001|Track 4|Death|0|||
126375825|NCT02750514|454672985|FG002|Track 4|Death|0|||
126375826|NCT02750514|454672986|FG003|Track 4|Death|1|||
126375827|NCT02750514|454672987|FG004|Track 4|Death|0|||
126375828|NCT02750514|454672983|FG000|Track 5|Disease progression|0|||
126375829|NCT02750514|454672984|FG001|Track 5|Disease progression|0|||
126375830|NCT02750514|454672985|FG002|Track 5|Disease progression|0|||
126375831|NCT02750514|454672986|FG003|Track 5|Disease progression|0|||
126375832|NCT02750514|454672987|FG004|Track 5|Disease progression|34|||
126375833|NCT02750514|454672983|FG000|Track 5|Adverse event unrelated to study drug|0|||
126375834|NCT02750514|454672984|FG001|Track 5|Adverse event unrelated to study drug|0|||
126375835|NCT02750514|454672985|FG002|Track 5|Adverse event unrelated to study drug|0|||
126375836|NCT02750514|454672986|FG003|Track 5|Adverse event unrelated to study drug|0|||
126375837|NCT02750514|454672987|FG004|Track 5|Adverse event unrelated to study drug|2|||
126375838|NCT02750514|454672983|FG000|Track 5|Study drug toxicity|0|||
126375839|NCT02750514|454672984|FG001|Track 5|Study drug toxicity|0|||
126375840|NCT02750514|454672985|FG002|Track 5|Study drug toxicity|0|||
126375841|NCT02750514|454672986|FG003|Track 5|Study drug toxicity|0|||
126375842|NCT02750514|454672987|FG004|Track 5|Study drug toxicity|2|||
126375843|NCT02750514|454672983|FG000|Track 5|Participant request to discontinue|0|||
126375844|NCT02750514|454672984|FG001|Track 5|Participant request to discontinue|0|||
126375845|NCT02750514|454672985|FG002|Track 5|Participant request to discontinue|0|||
126375846|NCT02750514|454672986|FG003|Track 5|Participant request to discontinue|0|||
126375847|NCT02750514|454672987|FG004|Track 5|Participant request to discontinue|3|||
126375848|NCT02750514|454672983|FG000|Track 5|Other reasons|0|||
126375849|NCT02750514|454672984|FG001|Track 5|Other reasons|0|||
126375850|NCT02750514|454672985|FG002|Track 5|Other reasons|0|||
126375851|NCT02750514|454672986|FG003|Track 5|Other reasons|0|||
126375852|NCT02750514|454672987|FG004|Track 5|Other reasons|2|||
126375853|NCT02553629|454672988|FG000|Overall Study|Logistic reasons|3|||
126375854|NCT02553629|454672989|FG001|Overall Study|Logistic reasons|6|||
126375855|NCT01812057|454672990|FG000|Overall Study|Protocol Violation|1|||
126375856|NCT01812057|454672991|FG001|Overall Study|Protocol Violation|0|||
126375857|NCT01812057|454672990|FG000|Overall Study|Physician Decision|1|||
126375858|NCT01812057|454672991|FG001|Overall Study|Physician Decision|0|||
126375859|NCT01882465|454672994|FG000|Period 1|Lens Discomfort|0|||
126375860|NCT01882465|454672995|FG001|Period 1|Lens Discomfort|0|||
126375861|NCT01882465|454672996|FG002|Period 1|Lens Discomfort|0|||
126375862|NCT01882465|454672997|FG003|Period 1|Lens Discomfort|1|||
126375863|NCT01882465|454672998|FG004|Period 1|Lens Discomfort|0|||
126375864|NCT01882465|454672999|FG005|Period 1|Lens Discomfort|0|||
126375865|NCT01882465|454673000|FG006|Period 1|Lens Discomfort|0|||
126375866|NCT01882465|454672994|FG000|Period 1|Withdrawal by Subject|0|||
126375867|NCT01882465|454672995|FG001|Period 1|Withdrawal by Subject|0|||
126375868|NCT01882465|454672996|FG002|Period 1|Withdrawal by Subject|0|||
126375869|NCT01882465|454672997|FG003|Period 1|Withdrawal by Subject|0|||
126375870|NCT01882465|454672998|FG004|Period 1|Withdrawal by Subject|0|||
126375871|NCT01882465|454672999|FG005|Period 1|Withdrawal by Subject|0|||
126375872|NCT01882465|454673000|FG006|Period 1|Withdrawal by Subject|1|||
126375873|NCT01882465|454672994|FG000|Period 2|Protocol Violation|0|||
126375874|NCT01882465|454672995|FG001|Period 2|Protocol Violation|0|||
126375875|NCT01882465|454672996|FG002|Period 2|Protocol Violation|0|||
126375876|NCT01882465|454672997|FG003|Period 2|Protocol Violation|0|||
126375877|NCT01882465|454672998|FG004|Period 2|Protocol Violation|1|||
126375878|NCT01882465|454672999|FG005|Period 2|Protocol Violation|0|||
126375879|NCT01882465|454673000|FG006|Period 2|Protocol Violation|0|||
126375880|NCT02259114|454673005|FG000|Overall Study|Progressive Disease|14|||
126375881|NCT02259114|454673006|FG001|Overall Study|Progressive Disease|2|||
126375882|NCT02259114|454673007|FG002|Overall Study|Progressive Disease|10|||
126375883|NCT02259114|454673008|FG003|Overall Study|Progressive Disease|2|||
126375884|NCT02259114|454673009|FG004|Overall Study|Progressive Disease|5|||
126375885|NCT02259114|454673005|FG000|Overall Study|Adverse Event|2|||
126375886|NCT02259114|454673006|FG001|Overall Study|Adverse Event|1|||
126375887|NCT02259114|454673007|FG002|Overall Study|Adverse Event|0|||
126375888|NCT02259114|454673008|FG003|Overall Study|Adverse Event|0|||
126375889|NCT02259114|454673009|FG004|Overall Study|Adverse Event|1|||
126375890|NCT02259114|454673005|FG000|Overall Study|Death|3|||
126375891|NCT02259114|454673006|FG001|Overall Study|Death|0|||
126375892|NCT02259114|454673007|FG002|Overall Study|Death|1|||
126375893|NCT02259114|454673008|FG003|Overall Study|Death|0|||
126375894|NCT02259114|454673009|FG004|Overall Study|Death|0|||
126375895|NCT02259114|454673005|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
126375896|NCT02259114|454673006|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
126375897|NCT02259114|454673007|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
126375898|NCT02259114|454673008|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
126375899|NCT02259114|454673009|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
126375900|NCT02259114|454673005|FG000|Overall Study|Withdrawal by Subject|0|||
126375901|NCT02259114|454673006|FG001|Overall Study|Withdrawal by Subject|0|||
126375902|NCT02259114|454673007|FG002|Overall Study|Withdrawal by Subject|1|||
126375903|NCT02259114|454673008|FG003|Overall Study|Withdrawal by Subject|1|||
126375904|NCT02259114|454673009|FG004|Overall Study|Withdrawal by Subject|0|||
126375905|NCT02259114|454673005|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
126375906|NCT02259114|454673006|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
126375907|NCT02259114|454673007|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
126375908|NCT02259114|454673008|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
126375909|NCT02259114|454673009|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
126375910|NCT02259114|454673005|FG000|Overall Study|Not Treated|1|||
126375911|NCT02259114|454673006|FG001|Overall Study|Not Treated|0|||
126375912|NCT02259114|454673007|FG002|Overall Study|Not Treated|0|||
126375913|NCT02259114|454673008|FG003|Overall Study|Not Treated|0|||
126375914|NCT02259114|454673009|FG004|Overall Study|Not Treated|0|||
126375915|NCT03937479|454673010|FG000|Overall Study|Adverse Event|2|||
126375916|NCT03937479|454673011|FG001|Overall Study|Adverse Event|3|||
126375917|NCT03937479|454673012|FG002|Overall Study|Adverse Event|0|||
126375918|NCT03937479|454673013|FG003|Overall Study|Adverse Event|0|||
126375919|NCT03937479|454673014|FG004|Overall Study|Adverse Event|1|||
126375920|NCT03937479|454673010|FG000|Overall Study|Withdrawal by Subject|3|||
126375921|NCT03937479|454673011|FG001|Overall Study|Withdrawal by Subject|5|||
126375922|NCT03937479|454673012|FG002|Overall Study|Withdrawal by Subject|2|||
126375923|NCT03937479|454673013|FG003|Overall Study|Withdrawal by Subject|2|||
126375924|NCT03937479|454673014|FG004|Overall Study|Withdrawal by Subject|1|||
126375925|NCT03937479|454673010|FG000|Overall Study|Protocol Violation|5|||
126375926|NCT03937479|454673011|FG001|Overall Study|Protocol Violation|6|||
126375927|NCT03937479|454673012|FG002|Overall Study|Protocol Violation|4|||
126375928|NCT03937479|454673013|FG003|Overall Study|Protocol Violation|3|||
126375929|NCT03937479|454673014|FG004|Overall Study|Protocol Violation|2|||
126375930|NCT03937479|454673010|FG000|Overall Study|Lost to Follow-up|0|||
126375931|NCT03937479|454673011|FG001|Overall Study|Lost to Follow-up|1|||
126466982|NCT04755283|455010539|FG001|Overall Study|Death|36|||
126466983|NCT04755283|455010540|FG002|Overall Study|Death|34|||
126466984|NCT01828320|455010541|FG000|Overall Study|Lost to Follow-up|1|||
126466985|NCT01828320|455010542|FG001|Overall Study|Lost to Follow-up|3|||
126466986|NCT01828320|455010541|FG000|Overall Study|Withdrawal by Subject|7|||
126466987|NCT01828320|455010542|FG001|Overall Study|Withdrawal by Subject|2|||
126466988|NCT05108922|455011691|FG000|Overall Study|Adverse Event|2|||
126466989|NCT05108922|455011692|FG001|Overall Study|Adverse Event|3|||
126466990|NCT05108922|455011691|FG000|Overall Study|Lost to Follow-up|2|||
126466991|NCT05108922|455011692|FG001|Overall Study|Lost to Follow-up|1|||
126466992|NCT05108922|455011691|FG000|Overall Study|Inadvertent enrollment|0|||
126466993|NCT05108922|455011692|FG001|Overall Study|Inadvertent enrollment|1|||
126466994|NCT05108922|455011691|FG000|Overall Study|Physician Decision|2|||
126466995|NCT05108922|455011692|FG001|Overall Study|Physician Decision|3|||
126466996|NCT05108922|455011691|FG000|Overall Study|Protocol deviation|1|||
126466997|NCT05108922|455011692|FG001|Overall Study|Protocol deviation|0|||
126466998|NCT05108922|455011691|FG000|Overall Study|Screen failure|1|||
126466999|NCT05108922|455011692|FG001|Overall Study|Screen failure|0|||
126552989|NCT02291289|455320505|FG004|Induction Treatment|Physician Decision|0|||
126552990|NCT02291289|455320506|FG005|Induction Treatment|Physician Decision|0|||
126375932|NCT03937479|454673012|FG002|Overall Study|Lost to Follow-up|0|||
126375933|NCT03937479|454673013|FG003|Overall Study|Lost to Follow-up|1|||
126375934|NCT03937479|454673014|FG004|Overall Study|Lost to Follow-up|0|||
126375935|NCT03937479|454673010|FG000|Overall Study|Physician Decision|0|||
126375936|NCT03937479|454673011|FG001|Overall Study|Physician Decision|0|||
126375937|NCT03937479|454673012|FG002|Overall Study|Physician Decision|1|||
126375938|NCT03937479|454673013|FG003|Overall Study|Physician Decision|0|||
126375939|NCT03937479|454673014|FG004|Overall Study|Physician Decision|1|||
126375940|NCT01378117|454673017|FG000|Overall Study|withdrawal|2|||
126375941|NCT01378117|454673018|FG001|Overall Study|withdrawal|1|||
126375942|NCT01378117|454673019|FG002|Overall Study|withdrawal|2|||
126375943|NCT01378117|454673017|FG000|Overall Study|discharged before med given|2|||
126375944|NCT01378117|454673018|FG001|Overall Study|discharged before med given|0|||
126375945|NCT01378117|454673019|FG002|Overall Study|discharged before med given|1|||
126467000|NCT05108922|455011691|FG000|Overall Study|Withdrawal by Subject|11|||
126467001|NCT05108922|455011692|FG001|Overall Study|Withdrawal by Subject|8|||
126552991|NCT02291289|455320507|FG006|Induction Treatment|Physician Decision|0|||
126552992|NCT02291289|455320508|FG007|Induction Treatment|Physician Decision|0|||
126552993|NCT02291289|455320509|FG008|Induction Treatment|Physician Decision|0|||
126375946|NCT01854528|454673021|FG000|Overall Study|Adverse Event|0|||
126375947|NCT01854528|454673022|FG001|Overall Study|Adverse Event|4|||
126375948|NCT01854528|454673021|FG000|Overall Study|Withdrawal by Subject|0|||
126375949|NCT01854528|454673022|FG001|Overall Study|Withdrawal by Subject|2|||
126467002|NCT00422097|455011693|FG000|Dose Level 2|Still on treatment|0|||
126552994|NCT02291289|455320510|FG009|Induction Treatment|Physician Decision|1|||
126375950|NCT01854528|454673021|FG000|Overall Study|Virologic Failure|0|||
126375951|NCT01854528|454673022|FG001|Overall Study|Virologic Failure|9|||
126467003|NCT00422097|455011694|FG001|Dose Level 2|Still on treatment|1|||
126375952|NCT02961244|454673023|FG000|Overall Study|Protocol Violation|0|||
126375953|NCT02961244|454673024|FG001|Overall Study|Protocol Violation|1|||
126375954|NCT02961244|454673023|FG000|Overall Study|Withdrawal by Subject|1|||
126375955|NCT02961244|454673024|FG001|Overall Study|Withdrawal by Subject|2|||
126375956|NCT02961244|454673023|FG000|Overall Study|Surgery plan change after study approval|0|||
126375957|NCT02961244|454673024|FG001|Overall Study|Surgery plan change after study approval|2|||
126467004|NCT00422097|455011695|FG002|Dose Level 2|Still on treatment|0|||
126467005|NCT00422097|455011696|FG003|Dose Level 2|Still on treatment|0|||
126467006|NCT00422097|455011697|FG004|Dose Level 2|Still on treatment|0|||
126467007|NCT00422097|455011698|FG005|Dose Level 2|Still on treatment|0|||
126467008|NCT00422097|455011699|FG006|Dose Level 2|Still on treatment|0|||
126467009|NCT00422097|455011700|FG007|Dose Level 2|Still on treatment|0|||
126467010|NCT05061966|455011711|FG000|Overall Study|Lost to Follow-up|13|||
126467011|NCT05061966|455011712|FG001|Overall Study|Lost to Follow-up|13|||
126467012|NCT02180165|455011718|FG000|Overall Study|Not Treated|0|||
126467013|NCT02180165|455011719|FG001|Overall Study|Not Treated|0|||
126467014|NCT02180165|455011720|FG002|Overall Study|Not Treated|1|||
126467015|NCT02180165|455011721|FG003|Overall Study|Not Treated|0|||
126467016|NCT02180165|455011718|FG000|Overall Study|Adverse Event|7|||
126467017|NCT02180165|455011719|FG001|Overall Study|Adverse Event|0|||
126467018|NCT02180165|455011720|FG002|Overall Study|Adverse Event|18|||
126467019|NCT02180165|455011721|FG003|Overall Study|Adverse Event|3|||
126467020|NCT02180165|455011718|FG000|Overall Study|Lack of Efficacy|0|||
126467021|NCT02180165|455011719|FG001|Overall Study|Lack of Efficacy|1|||
126467022|NCT02180165|455011720|FG002|Overall Study|Lack of Efficacy|3|||
126467023|NCT02180165|455011721|FG003|Overall Study|Lack of Efficacy|2|||
126467024|NCT02180165|455011718|FG000|Overall Study|Physician Decision|1|||
126467025|NCT02180165|455011719|FG001|Overall Study|Physician Decision|0|||
126467026|NCT02180165|455011720|FG002|Overall Study|Physician Decision|5|||
126467027|NCT02180165|455011721|FG003|Overall Study|Physician Decision|0|||
126467028|NCT02180165|455011718|FG000|Overall Study|Withdrawal by Subject|3|||
126467029|NCT02180165|455011719|FG001|Overall Study|Withdrawal by Subject|0|||
126467030|NCT02180165|455011720|FG002|Overall Study|Withdrawal by Subject|2|||
126467031|NCT02180165|455011721|FG003|Overall Study|Withdrawal by Subject|1|||
126467032|NCT03875768|455011722|FG000|Overall Study|Lost to Follow-up|16|||
126467033|NCT03875768|455011723|FG001|Overall Study|Lost to Follow-up|13|||
126467034|NCT03875768|455011722|FG000|Overall Study|Withdrawal by Subject|10|||
126467035|NCT03875768|455011723|FG001|Overall Study|Withdrawal by Subject|21|||
126467036|NCT03875768|455011722|FG000|Overall Study|Did not complete assessment|21|||
126467037|NCT03875768|455011723|FG001|Overall Study|Did not complete assessment|12|||
126467038|NCT03875768|455011722|FG000|Overall Study|Became ineligible|1|||
126375958|NCT02961244|454673023|FG000|Overall Study|Lost to Follow-up|0|||
126375959|NCT02961244|454673024|FG001|Overall Study|Lost to Follow-up|2|||
126375960|NCT02961244|454673023|FG000|Overall Study|İnadequate data|0|||
126375961|NCT02961244|454673024|FG001|Overall Study|İnadequate data|2|||
126375962|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
126375963|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
126375964|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
126375965|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
126375966|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
126375967|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
126375968|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
126375969|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
126375970|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
126375971|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
126375972|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
126375973|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
126375974|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
126375975|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
126375976|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
126375977|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
126375978|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
126375979|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
126375980|NCT03789292|454673025|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
126375981|NCT03789292|454673026|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
126375982|NCT03789292|454673027|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
126375983|NCT03789292|454673025|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
126375984|NCT03789292|454673026|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
126375985|NCT03789292|454673027|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
126467039|NCT03875768|455011723|FG001|Overall Study|Became ineligible|0|||
126467040|NCT00737438|455011726|FG000|Overall Study|Withdrawal by Subject|2|||
126467041|NCT00737438|455011726|FG000|Overall Study|Patient ineligible|1|||
126467042|NCT02791594|455011727|FG000|Overall Study|Physician Decision|2|||
126467043|NCT04950166|455011730|FG000|Overall Study|Withdrawal by Subject|1|||
126467044|NCT00857415|455011731|FG000|Overall Study|Image acquisition failure|2|||
126467045|NCT00857415|455011732|FG001|Overall Study|Image acquisition failure|0|||
126467046|NCT00857415|455011731|FG000|Overall Study|Invalid image or not imaged|3|||
126467047|NCT00857415|455011732|FG001|Overall Study|Invalid image or not imaged|0|||
126467048|NCT00857415|455011731|FG000|Overall Study|Subject still living at end of study|110|||
126467049|NCT00857415|455011732|FG001|Overall Study|Subject still living at end of study|0|||
126467050|NCT00857415|455011731|FG000|Overall Study|Deceased with no autopsy|2|||
126771080|NCT00627458|456116248|FG001|Overall Study|Lost to Follow-up|1|||
126771081|NCT00627458|456116249|FG002|Overall Study|Lost to Follow-up|0|||
126375986|NCT03789292|454673025|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
126375987|NCT03789292|454673026|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
126375988|NCT03789292|454673027|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
126375989|NCT03789292|454673025|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
126375990|NCT03789292|454673026|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
126375991|NCT03789292|454673027|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
126375992|NCT03789292|454673025|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
126375993|NCT03789292|454673026|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
126375994|NCT03789292|454673027|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
126375995|NCT03789292|454673025|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
126375996|NCT03789292|454673026|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
126375997|NCT03789292|454673027|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
126375998|NCT03789292|454673025|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
126375999|NCT03789292|454673026|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
126376000|NCT03789292|454673027|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
126376001|NCT01904721|454673029|FG000|Overall Study|Other Reasons|0|||
126376002|NCT01904721|454673030|FG001|Overall Study|Other Reasons|0|||
126376003|NCT01904721|454673031|FG002|Overall Study|Other Reasons|1|||
126376004|NCT01904721|454673032|FG003|Overall Study|Other Reasons|1|||
126376005|NCT01904721|454673033|FG004|Overall Study|Other Reasons|2|||
126376006|NCT01904721|454673034|FG005|Overall Study|Other Reasons|2|||
126376007|NCT01904721|454673035|FG006|Overall Study|Other Reasons|2|||
126376008|NCT01904721|454673029|FG000|Overall Study|Personal Reasons|0|||
126376009|NCT01904721|454673030|FG001|Overall Study|Personal Reasons|0|||
126376010|NCT01904721|454673031|FG002|Overall Study|Personal Reasons|0|||
126376011|NCT01904721|454673032|FG003|Overall Study|Personal Reasons|0|||
126376012|NCT01904721|454673033|FG004|Overall Study|Personal Reasons|2|||
126376013|NCT01904721|454673034|FG005|Overall Study|Personal Reasons|3|||
126376014|NCT01904721|454673035|FG006|Overall Study|Personal Reasons|3|||
126376015|NCT01904721|454673029|FG000|Overall Study|Lost to Follow-up|0|||
126376016|NCT01904721|454673030|FG001|Overall Study|Lost to Follow-up|0|||
126376017|NCT01904721|454673031|FG002|Overall Study|Lost to Follow-up|0|||
126376018|NCT01904721|454673032|FG003|Overall Study|Lost to Follow-up|0|||
126376019|NCT01904721|454673033|FG004|Overall Study|Lost to Follow-up|1|||
126376020|NCT01904721|454673034|FG005|Overall Study|Lost to Follow-up|3|||
126376021|NCT01904721|454673035|FG006|Overall Study|Lost to Follow-up|1|||
126376022|NCT01904721|454673029|FG000|Overall Study|Lack of Efficacy|0|||
126376023|NCT01904721|454673030|FG001|Overall Study|Lack of Efficacy|0|||
126376024|NCT01904721|454673031|FG002|Overall Study|Lack of Efficacy|0|||
126376025|NCT01904721|454673032|FG003|Overall Study|Lack of Efficacy|0|||
126376026|NCT01904721|454673033|FG004|Overall Study|Lack of Efficacy|0|||
126376027|NCT01904721|454673034|FG005|Overall Study|Lack of Efficacy|0|||
126376028|NCT01904721|454673035|FG006|Overall Study|Lack of Efficacy|1|||
126376029|NCT01904721|454673029|FG000|Overall Study|Adverse Event|0|||
126376030|NCT01904721|454673030|FG001|Overall Study|Adverse Event|0|||
126376031|NCT01904721|454673031|FG002|Overall Study|Adverse Event|0|||
126376032|NCT01904721|454673032|FG003|Overall Study|Adverse Event|0|||
126376033|NCT01904721|454673033|FG004|Overall Study|Adverse Event|3|||
126376034|NCT01904721|454673034|FG005|Overall Study|Adverse Event|1|||
126376035|NCT01904721|454673035|FG006|Overall Study|Adverse Event|0|||
126376036|NCT01082614|454673036|FG000|Overall Study|Adverse Event|1|||
126376037|NCT01082614|454673037|FG001|Overall Study|Adverse Event|4|||
126376038|NCT01082614|454673036|FG000|Overall Study|Equipment Malfunction|0|||
126376039|NCT01082614|454673037|FG001|Overall Study|Equipment Malfunction|1|||
126376040|NCT01082614|454673036|FG000|Overall Study|Physician Decision|2|||
126376041|NCT01082614|454673037|FG001|Overall Study|Physician Decision|0|||
126376042|NCT00811720|454673041|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
126376043|NCT00811720|454673042|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
126376044|NCT00811720|454673041|FG000|All Treated Patients|Adverse Event|20|||
126376045|NCT00811720|454673042|FG001|All Treated Patients|Adverse Event|62|||
126771082|NCT02617446|456116253|FG000|Overall Study|Withdrawal by Subject|0|||
126376046|NCT00811720|454673041|FG000|All Treated Patients|Lack of Efficacy|22|||
126376047|NCT00811720|454673042|FG001|All Treated Patients|Lack of Efficacy|18|||
126376048|NCT00811720|454673041|FG000|All Treated Patients|Non-compliance|0|||
126376049|NCT00811720|454673042|FG001|All Treated Patients|Non-compliance|14|||
126376050|NCT00811720|454673041|FG000|All Treated Patients|Protocol Violation|9|||
126376051|NCT00811720|454673042|FG001|All Treated Patients|Protocol Violation|16|||
126376052|NCT00811720|454673041|FG000|All Treated Patients|Withdrawal by Subject|28|||
126376053|NCT00811720|454673042|FG001|All Treated Patients|Withdrawal by Subject|34|||
126376054|NCT00811720|454673041|FG000|All Treated Patients|Lost to Follow-up|10|||
126376055|NCT00811720|454673042|FG001|All Treated Patients|Lost to Follow-up|16|||
126771083|NCT02617446|456116254|FG001|Overall Study|Withdrawal by Subject|2|||
126376056|NCT00811720|454673041|FG000|All Treated Patients|Other Reason|7|||
126376057|NCT00811720|454673042|FG001|All Treated Patients|Other Reason|4|||
126376058|NCT01077063|454673043|FG000|Overall Study|Adverse Event|3|||
126376059|NCT01077063|454673044|FG001|Overall Study|Adverse Event|0|||
126376060|NCT01077063|454673043|FG000|Overall Study|Death|1|||
126376061|NCT01077063|454673044|FG001|Overall Study|Death|1|||
126376062|NCT01077063|454673043|FG000|Overall Study|Withdrawal by Subject|0|||
126376063|NCT01077063|454673044|FG001|Overall Study|Withdrawal by Subject|2|||
126376064|NCT03894891|454673045|FG000|Overall Study|Withdrawal by Subject|1|||
126376065|NCT03894891|454673045|FG000|Overall Study|Completed protocol treatment per protocol|5|||
126376066|NCT00553631|454673046|FG000|Overall Study|Withdrawal by Subject|0|||
126376067|NCT00553631|454673047|FG001|Overall Study|Withdrawal by Subject|1|||
126376068|NCT00553631|454673046|FG000|Overall Study|Lost to Follow-up|1|||
126376069|NCT00553631|454673047|FG001|Overall Study|Lost to Follow-up|0|||
126376070|NCT02761642|454673048|FG000|Overall Study|Did not Receive Study Treatment|3|||
126376071|NCT02761642|454673048|FG000|Overall Study|Adverse Event|13|||
126376072|NCT02761642|454673048|FG000|Overall Study|Withdrawal by Subject|2|||
126376073|NCT02761642|454673048|FG000|Overall Study|Non-compliant|7|||
126376074|NCT02761642|454673048|FG000|Overall Study|Death|3|||
126376075|NCT02761642|454673048|FG000|Overall Study|Lack of Efficacy|20|||
126376076|NCT02761642|454673048|FG000|Overall Study|Physician Decision|1|||
126376077|NCT02761642|454673048|FG000|Overall Study|Reason Unspecified|21|||
126376078|NCT00950651|454673049|FG000|Overall Study|Adverse Event|17|||
126376079|NCT00950651|454673050|FG001|Overall Study|Adverse Event|20|||
126376080|NCT00950651|454673049|FG000|Overall Study|Death|1|||
126376081|NCT00950651|454673050|FG001|Overall Study|Death|0|||
126376082|NCT00950651|454673049|FG000|Overall Study|Lack of Efficacy|2|||
126376083|NCT00950651|454673050|FG001|Overall Study|Lack of Efficacy|2|||
126376084|NCT00950651|454673049|FG000|Overall Study|Protocol Violation|3|||
126376085|NCT00950651|454673050|FG001|Overall Study|Protocol Violation|4|||
126376086|NCT00950651|454673049|FG000|Overall Study|Withdrawal by Subject|8|||
126376087|NCT00950651|454673050|FG001|Overall Study|Withdrawal by Subject|9|||
126376088|NCT02850978|454673055|FG000|Overall Study|Uncollectable CRF|27|||
126376089|NCT02850978|454673055|FG000|Overall Study|No visit since the first visit|35|||
126376090|NCT02850978|454673055|FG000|Overall Study|Adverse Event|81|||
126376091|NCT02850978|454673055|FG000|Overall Study|Lack of Efficacy|40|||
126376092|NCT02850978|454673055|FG000|Overall Study|Improvement in condition|34|||
126376093|NCT02850978|454673055|FG000|Overall Study|Lost to Follow-up|121|||
126376094|NCT02850978|454673055|FG000|Overall Study|Reason not listed|88|||
126376095|NCT03188263|454673058|FG000|Overall Study|Withdrawal by Subject|3|||
126376096|NCT03188263|454673059|FG001|Overall Study|Withdrawal by Subject|0|||
126376097|NCT03188263|454673058|FG000|Overall Study|Physician Decision|1|||
126467051|NCT00857415|455011732|FG001|Overall Study|Deceased with no autopsy|0|||
126467052|NCT01130103|455011735|FG000|Randomized Treatment|Adverse Event|1|||
126467053|NCT01130103|455011736|FG001|Randomized Treatment|Adverse Event|1|||
126467054|NCT01130103|455011735|FG000|Randomized Treatment|Lost to Follow-up|1|||
126467055|NCT01130103|455011736|FG001|Randomized Treatment|Lost to Follow-up|0|||
126467056|NCT01130103|455011735|FG000|Randomized Treatment|Protocol Violation|3|||
126467057|NCT01130103|455011736|FG001|Randomized Treatment|Protocol Violation|2|||
126467058|NCT01130103|455011735|FG000|Randomized Treatment|Withdrawal by Subject|1|||
126467059|NCT01130103|455011736|FG001|Randomized Treatment|Withdrawal by Subject|2|||
126467060|NCT01130103|455011735|FG000|Maintenance Treatment|Lack of Efficacy|0|||
126467061|NCT01130103|455011736|FG001|Maintenance Treatment|Lack of Efficacy|1|||
126467062|NCT01130103|455011735|FG000|Maintenance Treatment|Lost to Follow-up|1|||
126467063|NCT01130103|455011736|FG001|Maintenance Treatment|Lost to Follow-up|1|||
126467064|NCT01130103|455011735|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
126467065|NCT01130103|455011736|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
126467066|NCT04508140|455011737|FG000|Overall Study|Adverse Event|2|||
126467067|NCT04508140|455011738|FG001|Overall Study|Adverse Event|2|||
126467068|NCT04508140|455011737|FG000|Overall Study|Withdrawal by Subject|0|||
126467069|NCT04508140|455011738|FG001|Overall Study|Withdrawal by Subject|2|||
126467070|NCT04508140|455011737|FG000|Overall Study|progressive disease|9|||
126467071|NCT04508140|455011738|FG001|Overall Study|progressive disease|3|||
126467072|NCT01199731|455011739|FG000|Overall Study|Adverse Event|0|||
126467073|NCT01199731|455011740|FG001|Overall Study|Adverse Event|1|||
126467074|NCT01199731|455011741|FG002|Overall Study|Adverse Event|0|||
126467075|NCT01199731|455011739|FG000|Overall Study|Study closed/terminated|7|||
126467076|NCT01199731|455011740|FG001|Overall Study|Study closed/terminated|9|||
126376098|NCT03188263|454673059|FG001|Overall Study|Physician Decision|0|||
126376099|NCT01030822|454673060|FG000|Overall Study|Moved/migrated from study area|6|||
126376100|NCT01030822|454673061|FG001|Overall Study|Moved/migrated from study area|7|||
126376101|NCT01030822|454673062|FG002|Overall Study|Moved/migrated from study area|3|||
126376102|NCT01030822|454673060|FG000|Overall Study|Withdrawal by Subject|16|||
126376103|NCT01030822|454673061|FG001|Overall Study|Withdrawal by Subject|13|||
126376104|NCT01030822|454673062|FG002|Overall Study|Withdrawal by Subject|16|||
126376105|NCT01030822|454673060|FG000|Overall Study|Lost to Follow-up|9|||
126376106|NCT01030822|454673061|FG001|Overall Study|Lost to Follow-up|4|||
126376107|NCT01030822|454673062|FG002|Overall Study|Lost to Follow-up|7|||
126376108|NCT00539240|454673063|FG000|Overall Study|Withdrawal by Subject|0|||
126376109|NCT00539240|454673064|FG001|Overall Study|Withdrawal by Subject|2|||
126376110|NCT00539240|454673065|FG002|Overall Study|Withdrawal by Subject|0|||
126376111|NCT00539240|454673063|FG000|Overall Study|Protocol Violation|1|||
126376112|NCT00539240|454673064|FG001|Overall Study|Protocol Violation|1|||
126376113|NCT00539240|454673065|FG002|Overall Study|Protocol Violation|4|||
126376114|NCT00539240|454673063|FG000|Overall Study|Lost to Follow-up|2|||
126376115|NCT00539240|454673064|FG001|Overall Study|Lost to Follow-up|3|||
126376116|NCT00539240|454673065|FG002|Overall Study|Lost to Follow-up|1|||
126376117|NCT00539240|454673063|FG000|Overall Study|Adverse Event|3|||
126376118|NCT00539240|454673064|FG001|Overall Study|Adverse Event|1|||
126376119|NCT00539240|454673065|FG002|Overall Study|Adverse Event|10|||
126376120|NCT01055613|454673066|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
126376121|NCT01055613|454673067|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126376122|NCT01055613|454673066|FG000|Overall Study|Unacceptable lens fit|1|||
126376123|NCT01055613|454673067|FG001|Overall Study|Unacceptable lens fit|0|||
126376124|NCT01055613|454673066|FG000|Overall Study|Discomfort|2|||
126376125|NCT01055613|454673067|FG001|Overall Study|Discomfort|1|||
126376126|NCT01055613|454673066|FG000|Overall Study|Lost to Follow-up|1|||
126376127|NCT01055613|454673067|FG001|Overall Study|Lost to Follow-up|1|||
126376128|NCT01055613|454673066|FG000|Overall Study|Protocol Violation|1|||
126376129|NCT01055613|454673067|FG001|Overall Study|Protocol Violation|1|||
126376130|NCT01055613|454673066|FG000|Overall Study|Subject Disinterest|1|||
126376131|NCT01055613|454673067|FG001|Overall Study|Subject Disinterest|1|||
126376132|NCT02765399|454673068|FG000|Overall Study|Nausea|1|||
126376133|NCT02765399|454673069|FG001|Overall Study|Nausea|0|||
126376134|NCT01182298|454673076|FG000|Overall Study|Lack of Efficacy|4|||
126376135|NCT01182298|454673076|FG000|Overall Study|Withdrawal by Subject|2|||
126376136|NCT04540367|454673090|FG000|Overall Study|Withdrawal by Subject|0|||
126376137|NCT04540367|454673091|FG001|Overall Study|Withdrawal by Subject|0|||
126376138|NCT04540367|454673092|FG002|Overall Study|Withdrawal by Subject|0|||
126376139|NCT04540367|454673093|FG003|Overall Study|Withdrawal by Subject|2|||
126376140|NCT04540367|454673090|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
126376141|NCT04540367|454673091|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
126376142|NCT04540367|454673092|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
126376143|NCT04540367|454673093|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
126376144|NCT04540367|454673090|FG000|Overall Study|Adverse Event|0|||
126376145|NCT04540367|454673091|FG001|Overall Study|Adverse Event|0|||
126376146|NCT04540367|454673092|FG002|Overall Study|Adverse Event|1|||
126376147|NCT04540367|454673093|FG003|Overall Study|Adverse Event|1|||
126376148|NCT03958331|454673095|FG000|Overall Study|Withdrawal by Subject|3|||
126376149|NCT03958331|454673096|FG001|Overall Study|Withdrawal by Subject|1|||
126376150|NCT03958331|454673097|FG002|Overall Study|Withdrawal by Subject|5|||
126376151|NCT03958331|454673095|FG000|Overall Study|Weaned from medicine|2|||
126376152|NCT03958331|454673096|FG001|Overall Study|Weaned from medicine|0|||
126376153|NCT03958331|454673097|FG002|Overall Study|Weaned from medicine|0|||
126376154|NCT03958331|454673095|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
126376155|NCT03958331|454673096|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
126376156|NCT03958331|454673097|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
126376157|NCT04422431|454673100|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
126376158|NCT04422431|454673100|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
126376159|NCT04422431|454673100|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
126376160|NCT04422431|454673100|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
126376161|NCT04422431|454673100|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
126376162|NCT04422431|454673100|FG000|Extension Period (48 Weeks)|Other than specified|2|||
126376163|NCT02317627|454673103|FG000|Overall Study|Withdrawal by Subject|0|||
126376164|NCT02317627|454673104|FG001|Overall Study|Withdrawal by Subject|1|||
126376165|NCT02317627|454673105|FG002|Overall Study|Withdrawal by Subject|1|||
126376166|NCT02317627|454673103|FG000|Overall Study|Lost to Follow-up|2|||
126376167|NCT02317627|454673104|FG001|Overall Study|Lost to Follow-up|0|||
126376168|NCT02317627|454673105|FG002|Overall Study|Lost to Follow-up|0|||
126376169|NCT02317627|454673103|FG000|Overall Study|Stopped by Investigator|0|||
126376170|NCT02317627|454673104|FG001|Overall Study|Stopped by Investigator|1|||
126376171|NCT02317627|454673105|FG002|Overall Study|Stopped by Investigator|0|||
126376172|NCT02317627|454673103|FG000|Overall Study|Adverse Event|0|||
126376173|NCT02317627|454673104|FG001|Overall Study|Adverse Event|2|||
126376174|NCT02317627|454673105|FG002|Overall Study|Adverse Event|3|||
126376175|NCT02317627|454673103|FG000|Overall Study|Non-compliance with study drug|0|||
126376176|NCT02317627|454673104|FG001|Overall Study|Non-compliance with study drug|1|||
126376177|NCT02317627|454673105|FG002|Overall Study|Non-compliance with study drug|0|||
126376178|NCT01088906|454673107|FG000|Overall Study|Inclusion error|1|||
126376179|NCT01088906|454673107|FG000|Overall Study|Did not receive study treatment|3|||
126376180|NCT01088906|454673107|FG000|Overall Study|Missing data|1|||
126376181|NCT00027560|454673108|FG000|Overall Study|Withdrawal by Subject|1|||
126716789|NCT01781429|455914911|FG001|Overall Study|Enrolled, but not treated|0|||
126376182|NCT03384875|454673109|FG000|Overall Study|Death|1|||
126376183|NCT03384875|454673110|FG001|Overall Study|Death|1|||
126376184|NCT03384875|454673111|FG002|Overall Study|Death|0|||
126376185|NCT03384875|454673109|FG000|Overall Study|Reason not provided|1|||
126376186|NCT03384875|454673110|FG001|Overall Study|Reason not provided|0|||
126376187|NCT03384875|454673111|FG002|Overall Study|Reason not provided|0|||
126376188|NCT02735421|454674529|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
126376189|NCT02735421|454674529|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
126376190|NCT02735421|454674529|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
126376191|NCT02735421|454674529|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
126376192|NCT02735421|454674529|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
126376193|NCT02735421|454674529|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
126376194|NCT02735421|454674529|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
126376195|NCT00939107|454674530|FG000|Overall Study|Lost to Follow-up|14|||
126376196|NCT00939107|454674531|FG001|Overall Study|Lost to Follow-up|12|||
126376197|NCT05010070|454674532|FG000|Overall Study|Lost to Follow-up|1|||
126376198|NCT05010070|454674532|FG000|Overall Study|Withdrawal by Subject|1|||
126376199|NCT01772550|454674544|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
126376200|NCT01772550|454674545|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
126376201|NCT01772550|454674546|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
126376202|NCT01772550|454674544|FG000|Overall Study|Adverse Event|0|||
126376203|NCT01772550|454674545|FG001|Overall Study|Adverse Event|0|||
126376204|NCT01772550|454674546|FG002|Overall Study|Adverse Event|1|||
126376205|NCT03374358|454674549|FG000|Overall Study|Withdrawal by Subject|0|||
126376206|NCT03374358|454674550|FG001|Overall Study|Withdrawal by Subject|2|||
126376207|NCT03183063|454674551|FG000|Overall Study|Withdrawal by Subject|2|||
126376208|NCT03183063|454674552|FG001|Overall Study|Withdrawal by Subject|0|||
126716790|NCT01781429|455914912|FG002|Overall Study|Enrolled, but not treated|0|||
126376209|NCT03183063|454674553|FG002|Overall Study|Withdrawal by Subject|0|||
126376210|NCT03183063|454674551|FG000|Overall Study|Physician Decision|3|||
126376211|NCT03183063|454674552|FG001|Overall Study|Physician Decision|4|||
126552995|NCT02291289|455320511|FG010|Induction Treatment|Physician Decision|0|||
126376212|NCT03183063|454674553|FG002|Overall Study|Physician Decision|4|||
126376213|NCT01127633|454674554|FG000|Overall Study|Adverse Event|74|||
126376214|NCT01127633|454674555|FG001|Overall Study|Adverse Event|73|||
126376215|NCT01127633|454674554|FG000|Overall Study|Death|40|||
126376216|NCT01127633|454674555|FG001|Overall Study|Death|43|||
126376217|NCT01127633|454674554|FG000|Overall Study|Lost to Follow-up|4|||
126376218|NCT01127633|454674555|FG001|Overall Study|Lost to Follow-up|0|||
126376219|NCT01127633|454674554|FG000|Overall Study|Parent/Caregiver Decision|246|||
126376220|NCT01127633|454674555|FG001|Overall Study|Parent/Caregiver Decision|228|||
126376221|NCT01127633|454674554|FG000|Overall Study|Physician Decision|60|||
126376222|NCT01127633|454674555|FG001|Overall Study|Physician Decision|45|||
126376223|NCT01127633|454674554|FG000|Overall Study|Withdrawal by Subject|57|||
126376224|NCT01127633|454674555|FG001|Overall Study|Withdrawal by Subject|72|||
126376225|NCT01127633|454674554|FG000|Overall Study|Sponsor Decision|163|||
126376226|NCT01127633|454674555|FG001|Overall Study|Sponsor Decision|195|||
126376227|NCT01127633|454674554|FG000|Overall Study|Protocol Violation|8|||
126376228|NCT01127633|454674555|FG001|Overall Study|Protocol Violation|16|||
126376229|NCT01127633|454674554|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
126376230|NCT01127633|454674555|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
126376231|NCT01127633|454674554|FG000|Overall Study|Not treated|1|||
126376232|NCT01127633|454674555|FG001|Overall Study|Not treated|0|||
126376233|NCT00688467|454674557|FG000|Treatment Period 1|Adverse Event|2|||
126376234|NCT00688467|454674558|FG001|Treatment Period 1|Adverse Event|1|||
126376235|NCT00688467|454674557|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
126376236|NCT00688467|454674558|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
126376237|NCT00688467|454674557|FG000|Treatment Period 2|Protocol Violation|0|||
126376238|NCT00688467|454674558|FG001|Treatment Period 2|Protocol Violation|1|||
126376239|NCT00688467|454674557|FG000|Treatment Period 2|Adverse Event|0|||
126376240|NCT00688467|454674558|FG001|Treatment Period 2|Adverse Event|1|||
126376241|NCT00690794|454674561|FG000|Overall Study|Adverse Event|12|||
126376242|NCT00690794|454674562|FG001|Overall Study|Adverse Event|10|||
126376243|NCT00690794|454674561|FG000|Overall Study|Lost to Follow-up|1|||
126716791|NCT01781429|455914913|FG003|Overall Study|Enrolled, but not treated|0|||
126376244|NCT00690794|454674562|FG001|Overall Study|Lost to Follow-up|4|||
126376245|NCT00690794|454674561|FG000|Overall Study|Withdrawal by Subject|0|||
126376246|NCT00690794|454674562|FG001|Overall Study|Withdrawal by Subject|9|||
126552996|NCT02291289|455320512|FG011|Induction Treatment|Physician Decision|0|||
126376247|NCT00690794|454674561|FG000|Overall Study|Protocol Violation|6|||
126376248|NCT00690794|454674562|FG001|Overall Study|Protocol Violation|7|||
126376249|NCT00690794|454674561|FG000|Overall Study|Noncompliance|1|||
126376250|NCT00690794|454674562|FG001|Overall Study|Noncompliance|2|||
126376251|NCT00690794|454674561|FG000|Overall Study|Other not specified|1|||
126376252|NCT00690794|454674562|FG001|Overall Study|Other not specified|3|||
126716792|NCT01781429|455914914|FG004|Overall Study|Enrolled, but not treated|0|||
126376253|NCT01823107|454674563|FG000|Overall Study|Withdrawal by Subject|1|||
126467077|NCT01199731|455011741|FG002|Overall Study|Study closed/terminated|7|||
126467078|NCT01199731|455011739|FG000|Overall Study|Lost to Follow-up|0|||
126467079|NCT01199731|455011740|FG001|Overall Study|Lost to Follow-up|0|||
126716793|NCT01781429|455914915|FG005|Overall Study|Enrolled, but not treated|0|||
126716794|NCT01781429|455914916|FG006|Overall Study|Enrolled, but not treated|0|||
126376254|NCT01343888|454674564|FG000|Overall Study|Adverse Event|12|||
126376255|NCT01343888|454674565|FG001|Overall Study|Adverse Event|22|||
126376256|NCT01343888|454674566|FG002|Overall Study|Adverse Event|5|||
126376257|NCT01343888|454674564|FG000|Overall Study|Lack of Efficacy|9|||
126376258|NCT01343888|454674565|FG001|Overall Study|Lack of Efficacy|9|||
126376259|NCT01343888|454674566|FG002|Overall Study|Lack of Efficacy|13|||
126376260|NCT01343888|454674564|FG000|Overall Study|Lost to Follow-up|0|||
126376261|NCT01343888|454674565|FG001|Overall Study|Lost to Follow-up|2|||
126376262|NCT01343888|454674566|FG002|Overall Study|Lost to Follow-up|1|||
126376263|NCT01343888|454674564|FG000|Overall Study|Protocol Violation|0|||
126376264|NCT01343888|454674565|FG001|Overall Study|Protocol Violation|2|||
126376265|NCT01343888|454674566|FG002|Overall Study|Protocol Violation|0|||
126376266|NCT01343888|454674564|FG000|Overall Study|Withdrawal by Subject|4|||
126376267|NCT01343888|454674565|FG001|Overall Study|Withdrawal by Subject|4|||
126376268|NCT01343888|454674566|FG002|Overall Study|Withdrawal by Subject|2|||
126376269|NCT01343888|454674564|FG000|Overall Study|other than stated above|0|||
126376270|NCT01343888|454674565|FG001|Overall Study|other than stated above|0|||
126376271|NCT01343888|454674566|FG002|Overall Study|other than stated above|1|||
126376272|NCT00800735|454674569|FG000|Overall Study|Administrative/Other|2|||
126376273|NCT00800735|454674569|FG000|Overall Study|Insufficient Therapeutic Response|2|||
126376274|NCT00800735|454674569|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
126376275|NCT00800735|454674569|FG000|Overall Study|Withdrew Consent|3|||
126376276|NCT02805790|454674570|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
126376277|NCT02805790|454674571|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
126376278|NCT04460183|454674572|FG000|Overall Study|Lost to Follow-up|3|||
126376279|NCT04460183|454674573|FG001|Overall Study|Lost to Follow-up|1|||
126376280|NCT04460183|454674572|FG000|Overall Study|Withdrawal by Subject|1|||
126376281|NCT04460183|454674573|FG001|Overall Study|Withdrawal by Subject|0|||
126376282|NCT00856323|454674574|FG000|Overall Study|Withdrawal by Subject|2|||
126376283|NCT01847092|454674575|FG000|Overall Study|Adverse Event|12|||
126376284|NCT01847092|454674576|FG001|Overall Study|Adverse Event|3|||
126376285|NCT01847092|454674575|FG000|Overall Study|Withdrawal by Subject|5|||
126376286|NCT01847092|454674576|FG001|Overall Study|Withdrawal by Subject|5|||
126376287|NCT01847092|454674575|FG000|Overall Study|Protocol Specified|8|||
126376288|NCT01847092|454674576|FG001|Overall Study|Protocol Specified|0|||
126376289|NCT01847092|454674575|FG000|Overall Study|Physician Decision|1|||
126376290|NCT01847092|454674576|FG001|Overall Study|Physician Decision|1|||
126376291|NCT01847092|454674575|FG000|Overall Study|Protocol Violation|0|||
126376292|NCT01847092|454674576|FG001|Overall Study|Protocol Violation|2|||
126376293|NCT00825994|454674577|FG000|Overall Study|Withdrawal by Subject|2|||
126376294|NCT00825994|454674577|FG000|Overall Study|Lost to Follow-up|1|||
126376295|NCT00825994|454674577|FG000|Overall Study|Protocol Violation|1|||
126376296|NCT00825994|454674577|FG000|Overall Study|Placebo Responder at V2|1|||
126376297|NCT01331681|454674578|FG000|Overall Study|Adverse Event|10|||
126376298|NCT01331681|454674579|FG001|Overall Study|Adverse Event|13|||
126376299|NCT01331681|454674580|FG002|Overall Study|Adverse Event|10|||
126376300|NCT01331681|454674578|FG000|Overall Study|Death|6|||
126376301|NCT01331681|454674579|FG001|Overall Study|Death|6|||
126376302|NCT01331681|454674580|FG002|Overall Study|Death|2|||
126376303|NCT01331681|454674578|FG000|Overall Study|Lack of Efficacy|0|||
126376304|NCT01331681|454674579|FG001|Overall Study|Lack of Efficacy|1|||
126376305|NCT01331681|454674580|FG002|Overall Study|Lack of Efficacy|0|||
126376306|NCT01331681|454674578|FG000|Overall Study|Withdrawal by Subject|12|||
126376307|NCT01331681|454674579|FG001|Overall Study|Withdrawal by Subject|8|||
126376308|NCT01331681|454674580|FG002|Overall Study|Withdrawal by Subject|15|||
126467080|NCT01199731|455011741|FG002|Overall Study|Lost to Follow-up|2|||
126467081|NCT01199731|455011739|FG000|Overall Study|Physician Decision|0|||
126376309|NCT01331681|454674578|FG000|Overall Study|Protocol Violation|1|||
126376310|NCT01331681|454674579|FG001|Overall Study|Protocol Violation|1|||
126467082|NCT01199731|455011740|FG001|Overall Study|Physician Decision|1|||
126467083|NCT01199731|455011741|FG002|Overall Study|Physician Decision|1|||
126376311|NCT01331681|454674580|FG002|Overall Study|Protocol Violation|0|||
126376312|NCT01331681|454674578|FG000|Overall Study|Lost to Follow-up|2|||
126376313|NCT01331681|454674579|FG001|Overall Study|Lost to Follow-up|4|||
126376314|NCT01331681|454674580|FG002|Overall Study|Lost to Follow-up|1|||
126376315|NCT01331681|454674578|FG000|Overall Study|Physician Decision|2|||
126376316|NCT01331681|454674579|FG001|Overall Study|Physician Decision|0|||
126376317|NCT01331681|454674580|FG002|Overall Study|Physician Decision|4|||
126376318|NCT01331681|454674578|FG000|Overall Study|Therapeutic procedure required|1|||
126376319|NCT01331681|454674579|FG001|Overall Study|Therapeutic procedure required|0|||
126376320|NCT01331681|454674580|FG002|Overall Study|Therapeutic procedure required|0|||
126467084|NCT01199731|455011739|FG000|Overall Study|Withdrawal by Subject|2|||
126467085|NCT01199731|455011740|FG001|Overall Study|Withdrawal by Subject|0|||
126467086|NCT01199731|455011741|FG002|Overall Study|Withdrawal by Subject|0|||
126467087|NCT01822678|455011742|FG000|Overall Study|Withdrawal by Subject|5|||
126467088|NCT01822678|455011743|FG001|Overall Study|Withdrawal by Subject|4|||
126467089|NCT01822678|455011744|FG002|Overall Study|Withdrawal by Subject|4|||
126467090|NCT01822678|455011742|FG000|Overall Study|Adverse Event|4|||
126467091|NCT01822678|455011743|FG001|Overall Study|Adverse Event|3|||
126467092|NCT01822678|455011744|FG002|Overall Study|Adverse Event|1|||
126467093|NCT01822678|455011742|FG000|Overall Study|Lack of Efficacy|3|||
126467094|NCT01822678|455011743|FG001|Overall Study|Lack of Efficacy|6|||
126467095|NCT01822678|455011744|FG002|Overall Study|Lack of Efficacy|5|||
126467096|NCT01822678|455011742|FG000|Overall Study|Lost to Follow-up|0|||
126467097|NCT01822678|455011743|FG001|Overall Study|Lost to Follow-up|2|||
126467098|NCT01822678|455011744|FG002|Overall Study|Lost to Follow-up|1|||
126467099|NCT00943124|455011748|FG000|Period 1|Withdrawal by Subject|1|||
126467100|NCT00943124|455011749|FG001|Period 1|Withdrawal by Subject|1|||
126467101|NCT00943124|455011748|FG000|Period 1|Did Not Follow Study Procedures|1|||
126467102|NCT00943124|455011749|FG001|Period 1|Did Not Follow Study Procedures|0|||
126467103|NCT00943124|455011748|FG000|Period 1|Personal Reasons|0|||
126467104|NCT00943124|455011749|FG001|Period 1|Personal Reasons|1|||
126467105|NCT02992132|455011750|FG000|Overall Study|Adverse Event|4|||
126467106|NCT02992132|455011751|FG001|Overall Study|Adverse Event|1|||
126467107|NCT02992132|455011752|FG002|Overall Study|Adverse Event|3|||
126467108|NCT02992132|455011750|FG000|Overall Study|Lack of Efficacy|2|||
126467109|NCT02992132|455011751|FG001|Overall Study|Lack of Efficacy|0|||
126467110|NCT02992132|455011752|FG002|Overall Study|Lack of Efficacy|0|||
126467111|NCT02992132|455011750|FG000|Overall Study|Non-compliance with study drug|2|||
126467112|NCT02992132|455011751|FG001|Overall Study|Non-compliance with study drug|0|||
126467113|NCT02992132|455011752|FG002|Overall Study|Non-compliance with study drug|0|||
126467114|NCT02992132|455011750|FG000|Overall Study|Progressive disease|1|||
126467115|NCT02992132|455011751|FG001|Overall Study|Progressive disease|0|||
126467116|NCT02992132|455011752|FG002|Overall Study|Progressive disease|0|||
126467117|NCT02992132|455011750|FG000|Overall Study|Protocol Violation|2|||
126467118|NCT02992132|455011751|FG001|Overall Study|Protocol Violation|2|||
126467119|NCT02992132|455011752|FG002|Overall Study|Protocol Violation|0|||
126467120|NCT02992132|455011750|FG000|Overall Study|Caregiver withdrew consent|2|||
126467121|NCT02992132|455011751|FG001|Overall Study|Caregiver withdrew consent|3|||
126467122|NCT02992132|455011752|FG002|Overall Study|Caregiver withdrew consent|2|||
126467123|NCT02992132|455011750|FG000|Overall Study|Withdrawal by Subject|0|||
126467124|NCT02992132|455011751|FG001|Overall Study|Withdrawal by Subject|2|||
126552997|NCT02291289|455320513|FG012|Induction Treatment|Physician Decision|0|||
126376321|NCT01331681|454674578|FG000|Overall Study|Sponsor decision|1|||
126376322|NCT01331681|454674579|FG001|Overall Study|Sponsor decision|1|||
126376323|NCT01331681|454674580|FG002|Overall Study|Sponsor decision|0|||
126376324|NCT01331681|454674578|FG000|Overall Study|Switching to other therapy|0|||
126376325|NCT01331681|454674579|FG001|Overall Study|Switching to other therapy|0|||
126376326|NCT01331681|454674580|FG002|Overall Study|Switching to other therapy|1|||
126376327|NCT01331681|454674578|FG000|Overall Study|Not Received Study Treatment|0|||
126376328|NCT01331681|454674579|FG001|Overall Study|Not Received Study Treatment|0|||
126376329|NCT01331681|454674580|FG002|Overall Study|Not Received Study Treatment|2|||
126376330|NCT01876381|454674582|FG000|Overall Study|Lack of Efficacy|5|||
126376331|NCT01876381|454674582|FG000|Overall Study|Physician Decision|1|||
126376332|NCT01876381|454674582|FG000|Overall Study|Withdrawal by Subject|1|||
126376333|NCT00461708|454674583|FG000|Overall Study|Adverse Event|17|||
126376334|NCT00461708|454674584|FG001|Overall Study|Adverse Event|7|||
126376335|NCT00461708|454674583|FG000|Overall Study|Lack of Efficacy|68|||
126376336|NCT00461708|454674584|FG001|Overall Study|Lack of Efficacy|20|||
126376337|NCT00461708|454674583|FG000|Overall Study|Physician Decision|10|||
126376338|NCT00461708|454674584|FG001|Overall Study|Physician Decision|4|||
126376339|NCT00461708|454674583|FG000|Overall Study|Withdrawal by Subject|8|||
126376340|NCT00461708|454674584|FG001|Overall Study|Withdrawal by Subject|2|||
126376341|NCT00461708|454674583|FG000|Overall Study|Other|4|||
126376342|NCT00461708|454674584|FG001|Overall Study|Other|4|||
126376343|NCT00461708|454674583|FG000|Overall Study|Death|8|||
126376344|NCT00461708|454674584|FG001|Overall Study|Death|1|||
126467125|NCT02992132|455011752|FG002|Overall Study|Withdrawal by Subject|1|||
126467126|NCT02992132|455011750|FG000|Overall Study|Physician Decision|0|||
126467127|NCT02992132|455011751|FG001|Overall Study|Physician Decision|0|||
126376345|NCT02394561|454674585|FG000|CORE Phase|Adverse Event|7|||
126376346|NCT02394561|454674586|FG001|CORE Phase|Adverse Event|9|||
126376347|NCT02394561|454674585|FG000|CORE Phase|Death|0|||
126376348|NCT02394561|454674586|FG001|CORE Phase|Death|1|||
126467128|NCT02992132|455011752|FG002|Overall Study|Physician Decision|1|||
126467129|NCT00381381|455011760|FG000|Overall Study|Adverse Event|3|||
126467130|NCT00381381|455011760|FG000|Overall Study|Lost to Follow-up|52|||
126467131|NCT00381381|455011760|FG000|Overall Study|Withdrawal by Subject|9|||
126376349|NCT02394561|454674585|FG000|CORE Phase|Pregnancy|1|||
126467132|NCT01916967|455011761|FG000|Overall Study|Adverse Event|0|||
126467133|NCT01916967|455011762|FG001|Overall Study|Adverse Event|0|||
126716795|NCT01781429|455914917|FG007|Overall Study|Enrolled, but not treated|0|||
126376350|NCT02394561|454674586|FG001|CORE Phase|Pregnancy|0|||
126376351|NCT02394561|454674585|FG000|CORE Phase|Lost to Follow-up|1|||
126376352|NCT02394561|454674586|FG001|CORE Phase|Lost to Follow-up|0|||
126376353|NCT02394561|454674585|FG000|CORE Phase|Physician Decision|1|||
126376354|NCT02394561|454674586|FG001|CORE Phase|Physician Decision|1|||
126376355|NCT02394561|454674585|FG000|CORE Phase|Withdrawal by Subject|2|||
126376356|NCT02394561|454674586|FG001|CORE Phase|Withdrawal by Subject|2|||
126376357|NCT02394561|454674585|FG000|CORE Phase|Lack of Efficacy|1|||
126376358|NCT02394561|454674586|FG001|CORE Phase|Lack of Efficacy|6|||
126376359|NCT02394561|454674585|FG000|Extension Phase|Adverse Event|6|||
126376360|NCT02394561|454674586|FG001|Extension Phase|Adverse Event|1|||
126376361|NCT02394561|454674585|FG000|Extension Phase|Death|0|||
126376362|NCT02394561|454674586|FG001|Extension Phase|Death|1|||
126376363|NCT02394561|454674585|FG000|Extension Phase|Protocol Violation|1|||
126376364|NCT02394561|454674586|FG001|Extension Phase|Protocol Violation|0|||
126376365|NCT02394561|454674585|FG000|Extension Phase|Lost to Follow-up|1|||
126376366|NCT02394561|454674586|FG001|Extension Phase|Lost to Follow-up|0|||
126376367|NCT02394561|454674585|FG000|Extension Phase|Physician Decision|0|||
126376368|NCT02394561|454674586|FG001|Extension Phase|Physician Decision|2|||
126376369|NCT02394561|454674585|FG000|Extension Phase|Withdrawal by Subject|0|||
126376370|NCT02394561|454674586|FG001|Extension Phase|Withdrawal by Subject|5|||
126376371|NCT02394561|454674585|FG000|Extension Phase|Lack of Efficacy|3|||
126376372|NCT02394561|454674586|FG001|Extension Phase|Lack of Efficacy|3|||
126376373|NCT00501644|454674587|FG000|Overall Study|Adverse Event|4|||
126376374|NCT00501644|454674587|FG000|Overall Study|Withdrawal by Subject|1|||
126376375|NCT02803203|454674588|FG000|Overall Study|Adverse Event|4|||
126376376|NCT02803203|454674588|FG000|Overall Study|Death|4|||
126376377|NCT02803203|454674588|FG000|Overall Study|Progressive disease|29|||
126376378|NCT02803203|454674588|FG000|Overall Study|Withdrawal by Subject|8|||
126376379|NCT02803203|454674588|FG000|Overall Study|Complete resection of target disease|2|||
126376380|NCT02803203|454674588|FG000|Overall Study|Switched to commercial Osi|1|||
126376381|NCT02803203|454674588|FG000|Overall Study|Participant moved away|1|||
126376382|NCT04577781|454674589|FG000|Overall Study|Adverse Event|2|||
126376383|NCT04577781|454674590|FG001|Overall Study|Adverse Event|2|||
126376384|NCT04577781|454674589|FG000|Overall Study|Physician Decision|1|||
126376385|NCT04577781|454674590|FG001|Overall Study|Physician Decision|0|||
126376386|NCT01957865|454674591|FG000|Overall Study|Found HIV negative|0|||
126376387|NCT01957865|454674592|FG001|Overall Study|Found HIV negative|0|||
126376388|NCT01957865|454674593|FG002|Overall Study|Found HIV negative|1|||
126376389|NCT01957865|454674591|FG000|Overall Study|Lost to Follow-up|0|||
126376390|NCT01957865|454674592|FG001|Overall Study|Lost to Follow-up|2|||
126376391|NCT01957865|454674593|FG002|Overall Study|Lost to Follow-up|2|||
126376392|NCT01644643|454674601|FG000|Overall Study|Death|1|||
126376393|NCT01644643|454674602|FG001|Overall Study|Death|0|||
126716796|NCT01781429|455914918|FG008|Overall Study|Enrolled, but not treated|0|||
126716797|NCT01781429|455914919|FG009|Overall Study|Enrolled, but not treated|0|||
126376394|NCT01644643|454674603|FG002|Overall Study|Death|3|||
126376395|NCT01644643|454674604|FG003|Overall Study|Death|3|||
126376396|NCT01644643|454674601|FG000|Overall Study|Lost to Follow-up|0|||
126376397|NCT01644643|454674602|FG001|Overall Study|Lost to Follow-up|0|||
126376398|NCT01644643|454674603|FG002|Overall Study|Lost to Follow-up|0|||
126376399|NCT01644643|454674604|FG003|Overall Study|Lost to Follow-up|4|||
126376400|NCT01644643|454674601|FG000|Overall Study|Withdrawal by Subject|1|||
126376401|NCT01644643|454674602|FG001|Overall Study|Withdrawal by Subject|0|||
126376402|NCT01644643|454674603|FG002|Overall Study|Withdrawal by Subject|2|||
126376403|NCT01644643|454674604|FG003|Overall Study|Withdrawal by Subject|1|||
126376404|NCT01644643|454674601|FG000|Overall Study|Other Eligibility criteria|0|||
126376405|NCT01644643|454674602|FG001|Overall Study|Other Eligibility criteria|0|||
126376406|NCT01644643|454674603|FG002|Overall Study|Other Eligibility criteria|0|||
126376407|NCT01644643|454674604|FG003|Overall Study|Other Eligibility criteria|2|||
126376408|NCT02756403|454674605|FG000|Overall Study|Unable to swallow medication|0|||
126376409|NCT02756403|454674606|FG001|Overall Study|Unable to swallow medication|1|||
126376410|NCT02756403|454674607|FG002|Overall Study|Unable to swallow medication|1|||
126376411|NCT02756403|454674608|FG003|Overall Study|Unable to swallow medication|1|||
126376412|NCT02756403|454674605|FG000|Overall Study|Did not complete Procedure|0|||
126376413|NCT02756403|454674606|FG001|Overall Study|Did not complete Procedure|1|||
126376414|NCT02756403|454674607|FG002|Overall Study|Did not complete Procedure|0|||
126376415|NCT02756403|454674608|FG003|Overall Study|Did not complete Procedure|0|||
126376416|NCT02756403|454674605|FG000|Overall Study|Changed Mind About Procedure|0|||
126376417|NCT02756403|454674606|FG001|Overall Study|Changed Mind About Procedure|0|||
126376418|NCT02756403|454674607|FG002|Overall Study|Changed Mind About Procedure|1|||
126376419|NCT02756403|454674608|FG003|Overall Study|Changed Mind About Procedure|0|||
126376420|NCT02756403|454674605|FG000|Overall Study|Protocol Violation|0|||
126376421|NCT02756403|454674606|FG001|Overall Study|Protocol Violation|1|||
126376422|NCT02756403|454674607|FG002|Overall Study|Protocol Violation|0|||
126376423|NCT02756403|454674608|FG003|Overall Study|Protocol Violation|1|||
126716798|NCT01781429|455914920|FG010|Overall Study|Enrolled, but not treated|1|||
126467134|NCT01916967|455011763|FG002|Overall Study|Adverse Event|2|||
126467135|NCT01916967|455011761|FG000|Overall Study|Lack of Efficacy|0|||
126467136|NCT01916967|455011762|FG001|Overall Study|Lack of Efficacy|0|||
126467137|NCT01916967|455011763|FG002|Overall Study|Lack of Efficacy|6|||
126467138|NCT01916967|455011761|FG000|Overall Study|Physician Decision|0|||
126467139|NCT01916967|455011762|FG001|Overall Study|Physician Decision|0|||
126467140|NCT01916967|455011763|FG002|Overall Study|Physician Decision|1|||
126467141|NCT01916967|455011761|FG000|Overall Study|Protocol Violation|0|||
126467142|NCT01916967|455011762|FG001|Overall Study|Protocol Violation|1|||
126467143|NCT01916967|455011763|FG002|Overall Study|Protocol Violation|0|||
126467144|NCT01437878|455011768|FG000|Overall Study|Withdrawal by Subject|1|||
126467145|NCT01437878|455011769|FG001|Overall Study|Withdrawal by Subject|0|||
126467146|NCT01369615|455011772|FG000|Overall Study|Withdrawal by Subject|0|||
126467147|NCT01369615|455011773|FG001|Overall Study|Withdrawal by Subject|1|||
126467148|NCT01369615|455011772|FG000|Overall Study|Lost to Follow-up|0|||
126467149|NCT01369615|455011773|FG001|Overall Study|Lost to Follow-up|1|||
126467150|NCT03911154|455011774|FG000|Overall Study|Withdrawal by Subject|1|||
126467151|NCT02035475|455011775|FG000|Overall Study|Withdrawal by Subject|4|||
126467152|NCT02035475|455011775|FG000|Overall Study|Physician Decision|1|||
126467153|NCT02035475|455011775|FG000|Overall Study|Equipment Error|1|||
126376424|NCT00114127|454674610|FG000|Overall Study|Adverse Event|2|||
126376425|NCT00114127|454674611|FG001|Overall Study|Adverse Event|1|||
126376426|NCT00114127|454674610|FG000|Overall Study|Lost to Follow-up|1|||
126376427|NCT00114127|454674611|FG001|Overall Study|Lost to Follow-up|0|||
126376428|NCT00114127|454674610|FG000|Overall Study|Withdrawal by Subject|1|||
126376429|NCT00114127|454674611|FG001|Overall Study|Withdrawal by Subject|3|||
126376430|NCT00699413|454674612|FG000|Overall Study|Withdrawal by Subject|0|||
126376431|NCT00699413|454674613|FG001|Overall Study|Withdrawal by Subject|2|||
126376432|NCT00699413|454674612|FG000|Overall Study|Study terminated by sponsor|4|||
126376433|NCT00699413|454674613|FG001|Overall Study|Study terminated by sponsor|2|||
126376434|NCT00881894|454674614|FG000|Overall Study|Consent withdrawn|0|||
126376435|NCT00881894|454674615|FG001|Overall Study|Consent withdrawn|1|||
126376436|NCT00881894|454674614|FG000|Overall Study|Other reasons for premature termination|1|||
126376437|NCT00881894|454674615|FG001|Overall Study|Other reasons for premature termination|2|||
126376438|NCT00421148|454674616|FG000|Overall Study|Lost to Follow-up|0|||
126376439|NCT00421148|454674617|FG001|Overall Study|Lost to Follow-up|0|||
126376440|NCT00421148|454674618|FG002|Overall Study|Lost to Follow-up|0|||
126376441|NCT00421148|454674619|FG003|Overall Study|Lost to Follow-up|0|||
126376442|NCT00421148|454674620|FG004|Overall Study|Lost to Follow-up|0|||
126376443|NCT00421148|454674621|FG005|Overall Study|Lost to Follow-up|0|||
126376444|NCT00421148|454674622|FG006|Overall Study|Lost to Follow-up|0|||
126376445|NCT00421148|454674623|FG007|Overall Study|Lost to Follow-up|0|||
126376446|NCT00421148|454674624|FG008|Overall Study|Lost to Follow-up|0|||
126376447|NCT00421148|454674625|FG009|Overall Study|Lost to Follow-up|0|||
126376448|NCT00421148|454674626|FG010|Overall Study|Lost to Follow-up|0|||
126376449|NCT00421148|454674627|FG011|Overall Study|Lost to Follow-up|0|||
126376450|NCT00421148|454674628|FG012|Overall Study|Lost to Follow-up|0|||
126376451|NCT00421148|454674629|FG013|Overall Study|Lost to Follow-up|0|||
126376452|NCT00421148|454674630|FG014|Overall Study|Lost to Follow-up|0|||
126376453|NCT00421148|454674631|FG015|Overall Study|Lost to Follow-up|0|||
126376454|NCT00421148|454674632|FG016|Overall Study|Lost to Follow-up|0|||
126376455|NCT00421148|454674633|FG017|Overall Study|Lost to Follow-up|1|||
126467154|NCT01231347|455011776|FG000|Overall Study|Full Consent withdrawn|19|||
126467155|NCT01231347|455011777|FG001|Overall Study|Full Consent withdrawn|19|||
126467156|NCT01231347|455011778|FG002|Overall Study|Full Consent withdrawn|11|||
126467157|NCT01231347|455011776|FG000|Overall Study|Lost to Follow-up|4|||
126467158|NCT01231347|455011777|FG001|Overall Study|Lost to Follow-up|2|||
126467159|NCT01231347|455011778|FG002|Overall Study|Lost to Follow-up|2|||
126376456|NCT00421148|454674634|FG018|Overall Study|Lost to Follow-up|0|||
126376457|NCT00421148|454674635|FG019|Overall Study|Lost to Follow-up|0|||
126376458|NCT00421148|454674616|FG000|Overall Study|Withdrawal by Subject|0|||
126376459|NCT00421148|454674617|FG001|Overall Study|Withdrawal by Subject|0|||
126376460|NCT00421148|454674618|FG002|Overall Study|Withdrawal by Subject|0|||
126467160|NCT01231347|455011776|FG000|Overall Study|Death|202|||
126467161|NCT01231347|455011777|FG001|Overall Study|Death|210|||
126467162|NCT01231347|455011778|FG002|Overall Study|Death|101|||
126552998|NCT02291289|455320501|FG000|Induction Treatment|Protocol Violation|0|||
126376461|NCT00421148|454674619|FG003|Overall Study|Withdrawal by Subject|0|||
126376462|NCT00421148|454674620|FG004|Overall Study|Withdrawal by Subject|0|||
126376463|NCT00421148|454674621|FG005|Overall Study|Withdrawal by Subject|0|||
126376464|NCT00421148|454674622|FG006|Overall Study|Withdrawal by Subject|0|||
126376465|NCT00421148|454674623|FG007|Overall Study|Withdrawal by Subject|0|||
126376466|NCT00421148|454674624|FG008|Overall Study|Withdrawal by Subject|0|||
126467163|NCT01231347|455011776|FG000|Overall Study|other event|7|||
126467164|NCT01231347|455011777|FG001|Overall Study|other event|9|||
126467165|NCT01231347|455011778|FG002|Overall Study|other event|3|||
126467166|NCT02322021|455011779|FG000|Core Phase|Adverse Event|1|||
126467167|NCT02322021|455011780|FG001|Core Phase|Adverse Event|3|||
126467168|NCT02322021|455011781|FG002|Core Phase|Adverse Event|4|||
126376467|NCT00421148|454674625|FG009|Overall Study|Withdrawal by Subject|0|||
126376468|NCT00421148|454674626|FG010|Overall Study|Withdrawal by Subject|0|||
126376469|NCT00421148|454674627|FG011|Overall Study|Withdrawal by Subject|0|||
126376470|NCT00421148|454674628|FG012|Overall Study|Withdrawal by Subject|0|||
126376471|NCT00421148|454674629|FG013|Overall Study|Withdrawal by Subject|0|||
126376472|NCT00421148|454674630|FG014|Overall Study|Withdrawal by Subject|0|||
126376473|NCT00421148|454674631|FG015|Overall Study|Withdrawal by Subject|0|||
126376474|NCT00421148|454674632|FG016|Overall Study|Withdrawal by Subject|0|||
126376475|NCT00421148|454674633|FG017|Overall Study|Withdrawal by Subject|1|||
126376476|NCT00421148|454674634|FG018|Overall Study|Withdrawal by Subject|0|||
126376477|NCT00421148|454674635|FG019|Overall Study|Withdrawal by Subject|0|||
126376478|NCT00421148|454674616|FG000|Overall Study|Protocol Violation|0|||
126376479|NCT00421148|454674617|FG001|Overall Study|Protocol Violation|0|||
126376480|NCT00421148|454674618|FG002|Overall Study|Protocol Violation|0|||
126376481|NCT00421148|454674619|FG003|Overall Study|Protocol Violation|0|||
126376482|NCT00421148|454674620|FG004|Overall Study|Protocol Violation|0|||
126376483|NCT00421148|454674621|FG005|Overall Study|Protocol Violation|1|||
126376484|NCT00421148|454674622|FG006|Overall Study|Protocol Violation|0|||
126376485|NCT00421148|454674623|FG007|Overall Study|Protocol Violation|0|||
126376486|NCT00421148|454674624|FG008|Overall Study|Protocol Violation|0|||
126376487|NCT00421148|454674625|FG009|Overall Study|Protocol Violation|0|||
126376488|NCT00421148|454674626|FG010|Overall Study|Protocol Violation|0|||
126376489|NCT00421148|454674627|FG011|Overall Study|Protocol Violation|0|||
126376490|NCT00421148|454674628|FG012|Overall Study|Protocol Violation|0|||
126376491|NCT00421148|454674629|FG013|Overall Study|Protocol Violation|0|||
126376492|NCT00421148|454674630|FG014|Overall Study|Protocol Violation|0|||
126376493|NCT00421148|454674631|FG015|Overall Study|Protocol Violation|0|||
126376494|NCT00421148|454674632|FG016|Overall Study|Protocol Violation|0|||
126376495|NCT00421148|454674633|FG017|Overall Study|Protocol Violation|0|||
126376496|NCT00421148|454674634|FG018|Overall Study|Protocol Violation|1|||
126376497|NCT00421148|454674635|FG019|Overall Study|Protocol Violation|0|||
126376498|NCT00469833|454674637|FG000|Overall Study|No IV access|2|||
126376499|NCT01253369|454674638|FG000|Overall Study|Adverse Event|4|||
126376500|NCT01253369|454674638|FG000|Overall Study|Withdrawal by Subject|2|||
126376501|NCT01253369|454674638|FG000|Overall Study|Death|1|||
126376502|NCT01253369|454674638|FG000|Overall Study|Progressive disease|23|||
126376503|NCT01253369|454674638|FG000|Overall Study|Not Evaluable|3|||
126376504|NCT03289533|454674639|FG000|Overall Study|Death|12|||
126376505|NCT03289533|454674639|FG000|Overall Study|Terminated from study by sponsor|10|||
126376506|NCT04016714|454674640|FG000|Overall Study|Death|1|||
126376507|NCT04016714|454674641|FG001|Overall Study|Death|0|||
126376508|NCT04016714|454674640|FG000|Overall Study|Lost to Follow-up|3|||
126376509|NCT04016714|454674641|FG001|Overall Study|Lost to Follow-up|1|||
126376510|NCT04016714|454674640|FG000|Overall Study|Physician Decision|3|||
126376511|NCT04016714|454674641|FG001|Overall Study|Physician Decision|3|||
126716799|NCT01781429|455914921|FG011|Overall Study|Enrolled, but not treated|0|||
126716800|NCT01781429|455914922|FG012|Overall Study|Enrolled, but not treated|0|||
126716801|NCT01781429|455914923|FG013|Overall Study|Enrolled, but not treated|0|||
126716802|NCT01781429|455914924|FG014|Overall Study|Enrolled, but not treated|0|||
126716803|NCT01781429|455914925|FG015|Overall Study|Enrolled, but not treated|0|||
126376512|NCT04016714|454674640|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
126376513|NCT04016714|454674641|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
126376514|NCT01822665|454674648|FG000|Overall Study|Adverse Event|3|||
126376515|NCT01822665|454674648|FG000|Overall Study|Other Reason|5|||
126376516|NCT00959907|454674650|FG000|Overall Study|Protocol Violation|0|||
126376517|NCT00959907|454674651|FG001|Overall Study|Protocol Violation|1|||
126376518|NCT00959907|454674650|FG000|Overall Study|Adverse Event|1|||
126376519|NCT00959907|454674651|FG001|Overall Study|Adverse Event|0|||
126467169|NCT02322021|455011782|FG003|Core Phase|Adverse Event|2|||
126467170|NCT02322021|455011783|FG004|Core Phase|Adverse Event|0|||
126716804|NCT02678741|455914926|FG000|Overall Study|Death|4|||
126467171|NCT02322021|455011779|FG000|Core Phase|Participant Choice|4|||
126716805|NCT02678741|455914926|FG000|Overall Study|Withdrawal by Subject|1|||
126716806|NCT02678741|455914926|FG000|Overall Study|ineligible|3|||
126376520|NCT00959907|454674650|FG000|Overall Study|Withdrawal by Subject|2|||
126376521|NCT00959907|454674651|FG001|Overall Study|Withdrawal by Subject|0|||
126376522|NCT01171677|454674653|FG000|Overall Study|Withdrawal by Subject|0|||
126376523|NCT01171677|454674654|FG001|Overall Study|Withdrawal by Subject|3|||
126376524|NCT01171677|454674653|FG000|Overall Study|Adverse Event|1|||
126376525|NCT01171677|454674654|FG001|Overall Study|Adverse Event|0|||
126376526|NCT01171677|454674653|FG000|Overall Study|completed <70% IntenSati classes|5|||
126376527|NCT01171677|454674654|FG001|Overall Study|completed <70% IntenSati classes|0|||
126376528|NCT01847443|454674655|FG000|Study Period 1|Withdrawal by Subject|0|||
126376529|NCT01847443|454674656|FG001|Study Period 1|Withdrawal by Subject|1|||
126716807|NCT02678741|455914926|FG000|Overall Study|Not RECIST Measurable|2|||
126467172|NCT02322021|455011780|FG001|Core Phase|Participant Choice|5|||
126376530|NCT01847443|454674657|FG002|Study Period 1|Withdrawal by Subject|0|||
126376531|NCT01847443|454674658|FG003|Study Period 1|Withdrawal by Subject|0|||
126467173|NCT02322021|455011781|FG002|Core Phase|Participant Choice|4|||
126376532|NCT01847443|454674655|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
126376533|NCT01847443|454674656|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
126376534|NCT01847443|454674657|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
126376535|NCT01847443|454674658|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
126376536|NCT01847443|454674655|FG000|Washout Period Before Study Period 2|Other reason|1|||
126376537|NCT01847443|454674656|FG001|Washout Period Before Study Period 2|Other reason|0|||
126376538|NCT01847443|454674657|FG002|Washout Period Before Study Period 2|Other reason|0|||
126376539|NCT01847443|454674658|FG003|Washout Period Before Study Period 2|Other reason|0|||
126376540|NCT01847443|454674655|FG000|Washout Period Before Study Period 3|Other reason|1|||
126376541|NCT01847443|454674656|FG001|Washout Period Before Study Period 3|Other reason|0|||
126376542|NCT01847443|454674657|FG002|Washout Period Before Study Period 3|Other reason|0|||
126376543|NCT01847443|454674658|FG003|Washout Period Before Study Period 3|Other reason|0|||
126376544|NCT01847443|454674655|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
126376545|NCT01847443|454674656|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
126376546|NCT01847443|454674657|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
126376547|NCT01847443|454674658|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
126376548|NCT01847443|454674655|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
126376549|NCT01847443|454674656|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
126376550|NCT01847443|454674657|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
126376551|NCT01847443|454674658|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
126376552|NCT03571971|454674659|FG000|Overall Study|Lost to Follow-up|2|||
126376553|NCT03571971|454674660|FG001|Overall Study|Lost to Follow-up|2|||
126376554|NCT03571971|454674659|FG000|Overall Study|Protocol Violation|2|||
126376555|NCT03571971|454674660|FG001|Overall Study|Protocol Violation|3|||
126376556|NCT03571971|454674659|FG000|Overall Study|Withdrawal by Subject|2|||
126376557|NCT03571971|454674660|FG001|Overall Study|Withdrawal by Subject|0|||
126376558|NCT03571971|454674659|FG000|Overall Study|Incomplete primary outcome data|2|||
126376559|NCT03571971|454674660|FG001|Overall Study|Incomplete primary outcome data|0|||
126376560|NCT04046939|454674670|FG000|Primary Assessment Period|Adverse Event|1|||
126376561|NCT04046939|454674671|FG001|Primary Assessment Period|Adverse Event|0|||
126376562|NCT04046939|454674672|FG002|Primary Assessment Period|Adverse Event|0|||
126376563|NCT04046939|454674673|FG003|Primary Assessment Period|Adverse Event|0|||
126376564|NCT04046939|454674670|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
126376565|NCT04046939|454674671|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
126376566|NCT04046939|454674672|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
126376567|NCT04046939|454674673|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
126376568|NCT04046939|454674670|FG000|Primary Assessment Period|Physician Decision|0|||
126376569|NCT04046939|454674671|FG001|Primary Assessment Period|Physician Decision|0|||
126376570|NCT04046939|454674672|FG002|Primary Assessment Period|Physician Decision|1|||
126376571|NCT04046939|454674673|FG003|Primary Assessment Period|Physician Decision|0|||
126376572|NCT04046939|454674670|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
126376573|NCT04046939|454674671|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
126376574|NCT04046939|454674672|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
126376575|NCT04046939|454674673|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
126376576|NCT00403130|454674674|FG000|2 Years From Start of Treatment|Not Eligible|3|||
126376577|NCT00403130|454674674|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
126376578|NCT00403130|454674674|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
126376579|NCT00403130|454674674|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
126376580|NCT00806260|454674675|FG000|Period 1 (1 Day)|Adverse Event|0|||
126376581|NCT00806260|454674676|FG001|Period 1 (1 Day)|Adverse Event|0|||
126376582|NCT00806260|454674677|FG002|Period 1 (1 Day)|Adverse Event|0|||
126376583|NCT00806260|454674678|FG003|Period 1 (1 Day)|Adverse Event|0|||
126376584|NCT00806260|454674679|FG004|Period 1 (1 Day)|Adverse Event|3|||
126376585|NCT00806260|454674680|FG005|Period 1 (1 Day)|Adverse Event|0|||
126376586|NCT00806260|454674675|FG000|Period 2|Adverse Event|0|||
126376587|NCT00806260|454674676|FG001|Period 2|Adverse Event|0|||
126376588|NCT00806260|454674677|FG002|Period 2|Adverse Event|0|||
126376589|NCT00806260|454674678|FG003|Period 2|Adverse Event|1|||
126376590|NCT00806260|454674679|FG004|Period 2|Adverse Event|0|||
126376591|NCT00806260|454674680|FG005|Period 2|Adverse Event|0|||
126376592|NCT00806260|454674675|FG000|Period 2|Protocol Violation|1|||
126376593|NCT00806260|454674676|FG001|Period 2|Protocol Violation|0|||
126376594|NCT00806260|454674677|FG002|Period 2|Protocol Violation|1|||
126376595|NCT00806260|454674678|FG003|Period 2|Protocol Violation|0|||
126376596|NCT00806260|454674679|FG004|Period 2|Protocol Violation|0|||
126376597|NCT00806260|454674680|FG005|Period 2|Protocol Violation|0|||
126376598|NCT00806260|454674675|FG000|Period 2|Need to take concomitant medication|1|||
126376599|NCT00806260|454674676|FG001|Period 2|Need to take concomitant medication|0|||
126376600|NCT00806260|454674677|FG002|Period 2|Need to take concomitant medication|0|||
126376601|NCT00806260|454674678|FG003|Period 2|Need to take concomitant medication|0|||
126376602|NCT00806260|454674679|FG004|Period 2|Need to take concomitant medication|0|||
126376603|NCT00806260|454674680|FG005|Period 2|Need to take concomitant medication|0|||
126376604|NCT00806260|454674675|FG000|Period 2|sponsor request|0|||
126376605|NCT00806260|454674676|FG001|Period 2|sponsor request|0|||
126467174|NCT02322021|455011782|FG003|Core Phase|Participant Choice|2|||
126467175|NCT02322021|455011783|FG004|Core Phase|Participant Choice|0|||
126467176|NCT02322021|455011779|FG000|Core Phase|Lost to Follow-up|0|||
126467177|NCT02322021|455011780|FG001|Core Phase|Lost to Follow-up|0|||
126467178|NCT02322021|455011781|FG002|Core Phase|Lost to Follow-up|0|||
126467179|NCT02322021|455011782|FG003|Core Phase|Lost to Follow-up|1|||
126467180|NCT02322021|455011783|FG004|Core Phase|Lost to Follow-up|0|||
126467181|NCT02322021|455011779|FG000|Core Phase|Other|0|||
126467182|NCT02322021|455011780|FG001|Core Phase|Other|0|||
126376606|NCT00806260|454674677|FG002|Period 2|sponsor request|1|||
126376607|NCT00806260|454674678|FG003|Period 2|sponsor request|1|||
126467183|NCT02322021|455011781|FG002|Core Phase|Other|1|||
126467184|NCT02322021|455011782|FG003|Core Phase|Other|0|||
126467185|NCT02322021|455011783|FG004|Core Phase|Other|0|||
126467186|NCT02322021|455011779|FG000|Extension Phase|Adverse Event|0|||
126467187|NCT02322021|455011780|FG001|Extension Phase|Adverse Event|0|||
126467188|NCT02322021|455011781|FG002|Extension Phase|Adverse Event|0|||
126467189|NCT02322021|455011782|FG003|Extension Phase|Adverse Event|0|||
126467190|NCT02322021|455011783|FG004|Extension Phase|Adverse Event|3|||
126467191|NCT02322021|455011779|FG000|Extension Phase|Participant Choice|0|||
126467192|NCT02322021|455011780|FG001|Extension Phase|Participant Choice|0|||
126467193|NCT02322021|455011781|FG002|Extension Phase|Participant Choice|0|||
126467194|NCT02322021|455011782|FG003|Extension Phase|Participant Choice|0|||
126467195|NCT02322021|455011783|FG004|Extension Phase|Participant Choice|6|||
126467196|NCT02322021|455011779|FG000|Extension Phase|Other|0|||
126467197|NCT02322021|455011780|FG001|Extension Phase|Other|0|||
126467198|NCT02322021|455011781|FG002|Extension Phase|Other|0|||
126467199|NCT02322021|455011782|FG003|Extension Phase|Other|0|||
126467200|NCT02322021|455011783|FG004|Extension Phase|Other|3|||
126467201|NCT02322021|455011779|FG000|Extension Phase|Lost to Follow-up|0|||
126467202|NCT02322021|455011780|FG001|Extension Phase|Lost to Follow-up|0|||
126467203|NCT02322021|455011781|FG002|Extension Phase|Lost to Follow-up|0|||
126716808|NCT02678741|455914926|FG000|Overall Study|Lack of Efficacy|10|||
126716809|NCT00903032|455914927|FG000|Overall Study|Withdrawal by Subject|5|||
126716810|NCT00903032|455914928|FG001|Overall Study|Withdrawal by Subject|3|||
126716811|NCT00903032|455914927|FG000|Overall Study|Lost to Follow-up|2|||
126376608|NCT00806260|454674679|FG004|Period 2|sponsor request|0|||
126376609|NCT00806260|454674680|FG005|Period 2|sponsor request|0|||
126376610|NCT00806260|454674675|FG000|Period 3|Protocol Violation|0|||
126376611|NCT00806260|454674676|FG001|Period 3|Protocol Violation|1|||
126376612|NCT00806260|454674677|FG002|Period 3|Protocol Violation|1|||
126376613|NCT00806260|454674678|FG003|Period 3|Protocol Violation|0|||
126376614|NCT00806260|454674679|FG004|Period 3|Protocol Violation|0|||
126376615|NCT00806260|454674680|FG005|Period 3|Protocol Violation|0|||
126376616|NCT00806260|454674675|FG000|Period 3|Pregnancy|1|||
126376617|NCT00806260|454674676|FG001|Period 3|Pregnancy|0|||
126376618|NCT00806260|454674677|FG002|Period 3|Pregnancy|0|||
126376619|NCT00806260|454674678|FG003|Period 3|Pregnancy|0|||
126376620|NCT00806260|454674679|FG004|Period 3|Pregnancy|0|||
126376621|NCT00806260|454674680|FG005|Period 3|Pregnancy|0|||
126376622|NCT03559270|454674681|FG000|Overall Study|Adverse Event|6|||
126467204|NCT02322021|455011782|FG003|Extension Phase|Lost to Follow-up|0|||
126716812|NCT00903032|455914928|FG001|Overall Study|Lost to Follow-up|2|||
126716813|NCT01675531|455914940|FG000|Overall Study|Adverse Event|9|||
126376623|NCT03559270|454674682|FG001|Overall Study|Adverse Event|5|||
126467205|NCT02322021|455011783|FG004|Extension Phase|Lost to Follow-up|1|||
126716814|NCT01675531|455914940|FG000|Overall Study|Withdrawal by Subject|7|||
126376624|NCT03559270|454674683|FG002|Overall Study|Adverse Event|3|||
126467206|NCT02322021|455011779|FG000|Extension Phase|Study terminated by sponsor|0|||
126467207|NCT02322021|455011780|FG001|Extension Phase|Study terminated by sponsor|0|||
126467208|NCT02322021|455011781|FG002|Extension Phase|Study terminated by sponsor|0|||
126467209|NCT02322021|455011782|FG003|Extension Phase|Study terminated by sponsor|0|||
126467210|NCT02322021|455011783|FG004|Extension Phase|Study terminated by sponsor|28|||
126467211|NCT01702571|455011784|FG000|Overall Study|Death|1067|||
126467212|NCT01702571|455011785|FG001|Overall Study|Death|76|||
126467213|NCT01702571|455011784|FG000|Overall Study|Lost to Follow-up|144|||
126467214|NCT01702571|455011785|FG001|Overall Study|Lost to Follow-up|10|||
126467215|NCT01702571|455011784|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
126467216|NCT01702571|455011785|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
126467217|NCT01702571|455011784|FG000|Overall Study|Investigator Decision|5|||
126467218|NCT01702571|455011785|FG001|Overall Study|Investigator Decision|0|||
126716815|NCT01675531|455914940|FG000|Overall Study|Lack of Efficacy|1|||
126467219|NCT01702571|455011784|FG000|Overall Study|Not Classifiable|1|||
126467220|NCT01702571|455011785|FG001|Overall Study|Not Classifiable|0|||
126467221|NCT01702571|455011784|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
126467222|NCT01702571|455011785|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
126376625|NCT03559270|454674684|FG003|Overall Study|Adverse Event|0|||
126376626|NCT03559270|454674681|FG000|Overall Study|Lack of Efficacy|34|||
126467223|NCT01702571|455011784|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
126376627|NCT03559270|454674682|FG001|Overall Study|Lack of Efficacy|52|||
126376628|NCT03559270|454674683|FG002|Overall Study|Lack of Efficacy|37|||
126376629|NCT03559270|454674684|FG003|Overall Study|Lack of Efficacy|2|||
126376630|NCT03559270|454674681|FG000|Overall Study|Death|0|||
126376631|NCT03559270|454674682|FG001|Overall Study|Death|2|||
126376632|NCT03559270|454674683|FG002|Overall Study|Death|0|||
126376633|NCT03559270|454674684|FG003|Overall Study|Death|0|||
126376634|NCT03559270|454674681|FG000|Overall Study|Lost to Follow-up|16|||
126376635|NCT03559270|454674682|FG001|Overall Study|Lost to Follow-up|4|||
126376636|NCT03559270|454674683|FG002|Overall Study|Lost to Follow-up|12|||
126376637|NCT03559270|454674684|FG003|Overall Study|Lost to Follow-up|3|||
126376638|NCT03559270|454674681|FG000|Overall Study|Sponsor Decision|38|||
126376639|NCT03559270|454674682|FG001|Overall Study|Sponsor Decision|31|||
126376640|NCT03559270|454674683|FG002|Overall Study|Sponsor Decision|35|||
126376641|NCT03559270|454674684|FG003|Overall Study|Sponsor Decision|18|||
126376642|NCT03559270|454674681|FG000|Overall Study|Withdrawal by Subject|19|||
126376643|NCT03559270|454674682|FG001|Overall Study|Withdrawal by Subject|21|||
126376644|NCT03559270|454674683|FG002|Overall Study|Withdrawal by Subject|18|||
126376645|NCT03559270|454674684|FG003|Overall Study|Withdrawal by Subject|7|||
126376646|NCT03559270|454674681|FG000|Overall Study|Physician Decision|3|||
126376647|NCT03559270|454674682|FG001|Overall Study|Physician Decision|2|||
126376648|NCT03559270|454674683|FG002|Overall Study|Physician Decision|1|||
126376649|NCT03559270|454674684|FG003|Overall Study|Physician Decision|0|||
126376650|NCT03559270|454674681|FG000|Overall Study|Pregnancy|0|||
126376651|NCT03559270|454674682|FG001|Overall Study|Pregnancy|1|||
126376652|NCT03559270|454674683|FG002|Overall Study|Pregnancy|0|||
126376653|NCT03559270|454674684|FG003|Overall Study|Pregnancy|0|||
126376654|NCT03559270|454674681|FG000|Overall Study|Protocol Violation|1|||
126376655|NCT03559270|454674682|FG001|Overall Study|Protocol Violation|0|||
126376656|NCT03559270|454674683|FG002|Overall Study|Protocol Violation|2|||
126376657|NCT03559270|454674684|FG003|Overall Study|Protocol Violation|0|||
126376658|NCT03247829|454676621|FG000|Overall Study|Death|3|||
126376659|NCT03247829|454676622|FG001|Overall Study|Death|4|||
126376660|NCT03247829|454676621|FG000|Overall Study|Enter Hospice Care|1|||
126376661|NCT03247829|454676622|FG001|Overall Study|Enter Hospice Care|0|||
126376662|NCT03247829|454676621|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
126376663|NCT03247829|454676622|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
126376664|NCT03247829|454676621|FG000|Overall Study|LVAD Explant|1|||
126376665|NCT03247829|454676622|FG001|Overall Study|LVAD Explant|1|||
126376666|NCT03247829|454676621|FG000|Overall Study|Transplant|1|||
126376667|NCT03247829|454676622|FG001|Overall Study|Transplant|1|||
126376668|NCT01783444|454676623|FG000|Treatment Phase|Adverse Event|9|||
126376669|NCT01783444|454676624|FG001|Treatment Phase|Adverse Event|20|||
126376670|NCT01783444|454676625|FG002|Treatment Phase|Adverse Event|19|||
126376671|NCT01783444|454676623|FG000|Treatment Phase|Disease Progression|76|||
126376672|NCT01783444|454676624|FG001|Treatment Phase|Disease Progression|66|||
126376673|NCT01783444|454676625|FG002|Treatment Phase|Disease Progression|64|||
126376674|NCT01783444|454676623|FG000|Treatment Phase|Death|2|||
126376675|NCT01783444|454676624|FG001|Treatment Phase|Death|2|||
126376676|NCT01783444|454676625|FG002|Treatment Phase|Death|2|||
126376677|NCT01783444|454676623|FG000|Treatment Phase|Protocol Violation|1|||
126376678|NCT01783444|454676624|FG001|Treatment Phase|Protocol Violation|1|||
126376679|NCT01783444|454676625|FG002|Treatment Phase|Protocol Violation|2|||
126376680|NCT01783444|454676623|FG000|Treatment Phase|Withdrawal by Subject|6|||
126376681|NCT01783444|454676624|FG001|Treatment Phase|Withdrawal by Subject|8|||
126376682|NCT01783444|454676625|FG002|Treatment Phase|Withdrawal by Subject|9|||
126376683|NCT01783444|454676623|FG000|Treatment Phase|Administrative problems|2|||
126376684|NCT01783444|454676624|FG001|Treatment Phase|Administrative problems|0|||
126376685|NCT01783444|454676625|FG002|Treatment Phase|Administrative problems|1|||
126376686|NCT01783444|454676623|FG000|Treatment Phase|Physician Decision|8|||
126376687|NCT01783444|454676624|FG001|Treatment Phase|Physician Decision|6|||
126376688|NCT01783444|454676625|FG002|Treatment Phase|Physician Decision|5|||
126376689|NCT01783444|454676623|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
126376690|NCT01783444|454676624|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
126376691|NCT01783444|454676625|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
126376692|NCT01783444|454676623|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
126376693|NCT01783444|454676624|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
126376694|NCT01783444|454676625|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
126376695|NCT01783444|454676623|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
126376696|NCT01783444|454676624|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
126376697|NCT01783444|454676625|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
126376698|NCT01783444|454676623|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
126376699|NCT01783444|454676624|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
126376700|NCT01783444|454676625|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
126376701|NCT01783444|454676623|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
126376702|NCT01783444|454676624|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
126716816|NCT01675531|455914940|FG000|Overall Study|Protocol Violation|8|||
126376703|NCT01783444|454676625|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
126376704|NCT01783444|454676623|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
126376705|NCT01783444|454676624|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
126376706|NCT01783444|454676625|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
126376707|NCT00427011|454676634|FG000|Overall Study|Adverse Event|10|||
126376708|NCT00427011|454676634|FG000|Overall Study|Withdrawal by Subject|1|||
126376709|NCT00427011|454676634|FG000|Overall Study|Lack of Efficacy|2|||
126376710|NCT00427011|454676634|FG000|Overall Study|Other|12|||
126376711|NCT01047007|454676635|FG000|Overall Study|Adverse Event|0|||
126376712|NCT01047007|454676636|FG001|Overall Study|Adverse Event|2|||
126376713|NCT01047007|454676637|FG002|Overall Study|Adverse Event|1|||
126376714|NCT01047007|454676638|FG003|Overall Study|Adverse Event|0|||
126376715|NCT01047007|454676635|FG000|Overall Study|Progressive Disease|2|||
126376716|NCT01047007|454676636|FG001|Overall Study|Progressive Disease|4|||
126376717|NCT01047007|454676637|FG002|Overall Study|Progressive Disease|1|||
126376718|NCT01047007|454676638|FG003|Overall Study|Progressive Disease|0|||
126376719|NCT04776161|454676639|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
126376720|NCT04776161|454676640|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
126376721|NCT04776161|454676641|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
126376722|NCT04776161|454676639|FG000|Overall Study|Withdrawal by Subject|1|||
126376723|NCT04776161|454676640|FG001|Overall Study|Withdrawal by Subject|0|||
126376724|NCT04776161|454676641|FG002|Overall Study|Withdrawal by Subject|1|||
126376725|NCT04776161|454676639|FG000|Overall Study|Adverse Event|0|||
126376726|NCT04776161|454676640|FG001|Overall Study|Adverse Event|1|||
126376727|NCT04776161|454676641|FG002|Overall Study|Adverse Event|1|||
126376728|NCT01334554|454676642|FG000|Overall Study|Adverse Event|4|||
126376729|NCT01334554|454676643|FG001|Overall Study|Adverse Event|2|||
126376730|NCT02393859|454676645|FG000|Overall Study|Decision by Sponsor|2|||
126376731|NCT02393859|454676646|FG001|Overall Study|Decision by Sponsor|4|||
126376732|NCT02393859|454676645|FG000|Overall Study|Withdrawal by Subject|11|||
126376733|NCT02393859|454676646|FG001|Overall Study|Withdrawal by Subject|6|||
126376734|NCT02393859|454676645|FG000|Overall Study|Death|27|||
126376735|NCT02393859|454676646|FG001|Overall Study|Death|10|||
126376736|NCT02393859|454676645|FG000|Overall Study|Lost to Follow-up|1|||
126376737|NCT02393859|454676646|FG001|Overall Study|Lost to Follow-up|1|||
126376738|NCT00954447|454676647|FG000|Overall Study|Adverse Event|33|||
126376739|NCT00954447|454676648|FG001|Overall Study|Adverse Event|25|||
126376740|NCT00954447|454676647|FG000|Overall Study|Lack of Efficacy|17|||
126376741|NCT00954447|454676648|FG001|Overall Study|Lack of Efficacy|3|||
126376742|NCT00954447|454676647|FG000|Overall Study|Protocol Violation|5|||
126376743|NCT00954447|454676648|FG001|Overall Study|Protocol Violation|7|||
126376744|NCT00954447|454676647|FG000|Overall Study|Lost to Follow-up|8|||
126376745|NCT00954447|454676648|FG001|Overall Study|Lost to Follow-up|14|||
126376746|NCT00954447|454676647|FG000|Overall Study|Withdrawal by Subject|26|||
126376747|NCT00954447|454676648|FG001|Overall Study|Withdrawal by Subject|21|||
126376748|NCT00954447|454676647|FG000|Overall Study|Other|21|||
126376749|NCT00954447|454676648|FG001|Overall Study|Other|18|||
126376750|NCT04592341|454676649|FG000|Overall Study|Physician Decision|5|||
126376751|NCT04592341|454676649|FG000|Overall Study|Study Terminated by Sponsor|5|||
126376752|NCT04592341|454676649|FG000|Overall Study|Withdrawal by Subject|53|||
126376753|NCT04592341|454676649|FG000|Overall Study|Lost to Follow-up|3|||
126376754|NCT04592341|454676649|FG000|Overall Study|Death|1|||
126376755|NCT04592341|454676649|FG000|Overall Study|Adverse Event|5|||
126376756|NCT04592341|454676649|FG000|Overall Study|other|4|||
126376757|NCT00692003|454676650|FG000|Overall Study|Sponsor Decision|5|||
126376758|NCT00692003|454676651|FG001|Overall Study|Sponsor Decision|1|||
126376759|NCT01248793|454676652|FG000|Overall Study|Lost to Follow-up|0|||
126376760|NCT01248793|454676653|FG001|Overall Study|Lost to Follow-up|1|||
126376761|NCT01248793|454676652|FG000|Overall Study|Adverse Event|1|||
126376762|NCT01248793|454676653|FG001|Overall Study|Adverse Event|1|||
126376763|NCT01248793|454676652|FG000|Overall Study|Protocol Violation|0|||
126376764|NCT01248793|454676653|FG001|Overall Study|Protocol Violation|1|||
126376765|NCT01248793|454676652|FG000|Overall Study|Withdrawal by Subject|3|||
126376766|NCT01248793|454676653|FG001|Overall Study|Withdrawal by Subject|3|||
126376767|NCT00517699|454676654|FG000|Overall Study|Withdrawal by Subject|1|||
126376768|NCT00517699|454676654|FG000|Overall Study|Lack of Efficacy|1|||
126376769|NCT00517699|454676654|FG000|Overall Study|Administrative error|1|||
126376770|NCT00517699|454676654|FG000|Overall Study|Study terminated by Sponsor|2|||
126376771|NCT02332187|454676657|FG000|Overall Study|Withdrawal by Subject|2|||
126376772|NCT02332187|454676658|FG001|Overall Study|Withdrawal by Subject|2|||
126376773|NCT02332187|454676657|FG000|Overall Study|Adverse Event|0|||
126376774|NCT02332187|454676658|FG001|Overall Study|Adverse Event|1|||
126376775|NCT01840943|454676659|FG000|Overall Study|Withdrawal by Subject|5|||
126376776|NCT01840943|454676660|FG001|Overall Study|Withdrawal by Subject|6|||
126376777|NCT01840943|454676659|FG000|Overall Study|Physician Decision|4|||
126376778|NCT01840943|454676660|FG001|Overall Study|Physician Decision|2|||
126376779|NCT01840943|454676659|FG000|Overall Study|Lost to Follow-up|4|||
126376780|NCT01840943|454676660|FG001|Overall Study|Lost to Follow-up|4|||
126376781|NCT02580877|454676663|FG000|Overall Study|Withdrawal by Subject|1|||
126376782|NCT02580877|454676664|FG001|Overall Study|Withdrawal by Subject|3|||
126376783|NCT02580877|454676663|FG000|Overall Study|Adverse Event|0|||
126376784|NCT02580877|454676664|FG001|Overall Study|Adverse Event|1|||
126376785|NCT00980148|454676665|FG000|Overall Study|Discharged from facility|89|||
126376786|NCT00980148|454676666|FG001|Overall Study|Discharged from facility|96|||
126376787|NCT00980148|454676665|FG000|Overall Study|Received other antichlamydia treatment|20|||
126376788|NCT00980148|454676666|FG001|Overall Study|Received other antichlamydia treatment|14|||
126376789|NCT00980148|454676665|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
126376790|NCT00980148|454676666|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
126376791|NCT00980148|454676665|FG000|Overall Study|Various other reasons|8|||
126376792|NCT00980148|454676666|FG001|Overall Study|Various other reasons|9|||
126376793|NCT00551031|454676667|FG000|Overall Study|Adverse Event|0|||
126376794|NCT00551031|454676668|FG001|Overall Study|Adverse Event|1|||
126376795|NCT00551031|454676669|FG002|Overall Study|Adverse Event|0|||
126376796|NCT00551031|454676670|FG003|Overall Study|Adverse Event|0|||
126376797|NCT00551031|454676671|FG004|Overall Study|Adverse Event|0|||
126376798|NCT00551031|454676667|FG000|Overall Study|Protocol Violation|1|||
126376799|NCT00551031|454676668|FG001|Overall Study|Protocol Violation|1|||
126376800|NCT00551031|454676669|FG002|Overall Study|Protocol Violation|0|||
126376801|NCT00551031|454676670|FG003|Overall Study|Protocol Violation|0|||
126376802|NCT00551031|454676671|FG004|Overall Study|Protocol Violation|0|||
126376803|NCT00551031|454676667|FG000|Overall Study|Lost to Follow-up|0|||
126376804|NCT00551031|454676668|FG001|Overall Study|Lost to Follow-up|1|||
126376805|NCT00551031|454676669|FG002|Overall Study|Lost to Follow-up|0|||
126376806|NCT00551031|454676670|FG003|Overall Study|Lost to Follow-up|1|||
126376807|NCT00551031|454676671|FG004|Overall Study|Lost to Follow-up|1|||
126376808|NCT00551031|454676667|FG000|Overall Study|Withdrawal by Subject|0|||
126376809|NCT00551031|454676668|FG001|Overall Study|Withdrawal by Subject|4|||
126376810|NCT00551031|454676669|FG002|Overall Study|Withdrawal by Subject|1|||
126376811|NCT00551031|454676670|FG003|Overall Study|Withdrawal by Subject|2|||
126376812|NCT00551031|454676671|FG004|Overall Study|Withdrawal by Subject|0|||
126376813|NCT00551031|454676667|FG000|Overall Study|Serious Adverse Event|0|||
126376814|NCT00551031|454676668|FG001|Overall Study|Serious Adverse Event|2|||
126376815|NCT00551031|454676669|FG002|Overall Study|Serious Adverse Event|1|||
126376816|NCT00551031|454676670|FG003|Overall Study|Serious Adverse Event|0|||
126376817|NCT00551031|454676671|FG004|Overall Study|Serious Adverse Event|0|||
126376818|NCT00551031|454676667|FG000|Overall Study|Did not receive vaccine|1|||
126376819|NCT00551031|454676668|FG001|Overall Study|Did not receive vaccine|2|||
126376820|NCT00551031|454676669|FG002|Overall Study|Did not receive vaccine|0|||
126376821|NCT00551031|454676670|FG003|Overall Study|Did not receive vaccine|0|||
126376822|NCT00551031|454676671|FG004|Overall Study|Did not receive vaccine|0|||
126376823|NCT02903823|454676672|FG000|Overall Study|Physician Decision|5|||
126376824|NCT02903823|454676672|FG000|Overall Study|Could not advance catheter|1|||
126376825|NCT02903823|454676672|FG000|Overall Study|Catheter dislodgement|1|||
126376826|NCT01747915|454676673|FG000|Overall Study|Other|1|||
126376827|NCT01747915|454676674|FG001|Overall Study|Other|1|||
126376828|NCT01747915|454676675|FG002|Overall Study|Other|1|||
126376829|NCT01747915|454676673|FG000|Overall Study|Adverse Event|8|||
126376830|NCT01747915|454676674|FG001|Overall Study|Adverse Event|5|||
126376831|NCT01747915|454676675|FG002|Overall Study|Adverse Event|2|||
126376832|NCT01747915|454676673|FG000|Overall Study|Death|0|||
126376833|NCT01747915|454676674|FG001|Overall Study|Death|0|||
126467224|NCT01702571|455011785|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
126467225|NCT01702571|455011784|FG000|Overall Study|Progressive Disease|3|||
126467226|NCT01702571|455011785|FG001|Overall Study|Progressive Disease|0|||
126467227|NCT01702571|455011784|FG000|Overall Study|Protocol Violation|2|||
126467228|NCT01702571|455011785|FG001|Overall Study|Protocol Violation|0|||
126467229|NCT01702571|455011784|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
126376834|NCT01747915|454676675|FG002|Overall Study|Death|1|||
126376835|NCT01747915|454676673|FG000|Overall Study|Lack of Efficacy|0|||
126467230|NCT01702571|455011785|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
126376836|NCT01747915|454676674|FG001|Overall Study|Lack of Efficacy|1|||
126376837|NCT01747915|454676675|FG002|Overall Study|Lack of Efficacy|0|||
126376838|NCT01747915|454676673|FG000|Overall Study|Lost to Follow-up|1|||
126376839|NCT01747915|454676674|FG001|Overall Study|Lost to Follow-up|0|||
126376840|NCT01747915|454676675|FG002|Overall Study|Lost to Follow-up|0|||
126467231|NCT01702571|455011784|FG000|Overall Study|Termination By Sponsor|4|||
126467232|NCT01702571|455011785|FG001|Overall Study|Termination By Sponsor|0|||
126376841|NCT01747915|454676673|FG000|Overall Study|Withdrawal by Subject|4|||
126467233|NCT01702571|455011784|FG000|Overall Study|Withdrawal by Subject|177|||
126467234|NCT01702571|455011785|FG001|Overall Study|Withdrawal by Subject|29|||
126716817|NCT00623467|455914941|FG000|Overall Study|Lost to Follow-up|1|||
126716818|NCT00623467|455914941|FG000|Overall Study|Protocol Violation|4|||
126376842|NCT01747915|454676674|FG001|Overall Study|Withdrawal by Subject|4|||
126376843|NCT01747915|454676675|FG002|Overall Study|Withdrawal by Subject|1|||
126376844|NCT01747915|454676673|FG000|Overall Study|Protocol Violation|1|||
126376845|NCT01747915|454676674|FG001|Overall Study|Protocol Violation|0|||
126376846|NCT01747915|454676675|FG002|Overall Study|Protocol Violation|0|||
126376847|NCT01747915|454676673|FG000|Overall Study|Pregnancy|0|||
126376848|NCT01747915|454676674|FG001|Overall Study|Pregnancy|0|||
126376849|NCT01747915|454676675|FG002|Overall Study|Pregnancy|1|||
126376850|NCT03341637|454676676|FG000|Overall Study|Lost to Follow-up|1|||
126376851|NCT03341637|454676677|FG001|Overall Study|Lost to Follow-up|0|||
126376852|NCT03341637|454676676|FG000|Overall Study|Withdrawal by Subject|3|||
126376853|NCT03341637|454676677|FG001|Overall Study|Withdrawal by Subject|3|||
126376854|NCT03341637|454676676|FG000|Overall Study|Reason not Specified|1|||
126376855|NCT03341637|454676677|FG001|Overall Study|Reason not Specified|1|||
126376856|NCT00887159|454676678|FG000|Overall Study|Disease progression|6|||
126376857|NCT00887159|454676679|FG001|Overall Study|Disease progression|39|||
126376858|NCT00887159|454676680|FG002|Overall Study|Disease progression|33|||
126376859|NCT00887159|454676678|FG000|Overall Study|Adverse Event|3|||
126376860|NCT00887159|454676679|FG001|Overall Study|Adverse Event|4|||
126376861|NCT00887159|454676680|FG002|Overall Study|Adverse Event|17|||
126376862|NCT00887159|454676678|FG000|Overall Study|Death|2|||
126376863|NCT00887159|454676679|FG001|Overall Study|Death|2|||
126376864|NCT00887159|454676680|FG002|Overall Study|Death|0|||
126376865|NCT00887159|454676678|FG000|Overall Study|Withdrawal by Subject|4|||
126376866|NCT00887159|454676679|FG001|Overall Study|Withdrawal by Subject|4|||
126376867|NCT00887159|454676680|FG002|Overall Study|Withdrawal by Subject|2|||
126376868|NCT00887159|454676678|FG000|Overall Study|Alternative therapy|2|||
126376869|NCT00887159|454676679|FG001|Overall Study|Alternative therapy|0|||
126376870|NCT00887159|454676680|FG002|Overall Study|Alternative therapy|0|||
126376871|NCT00887159|454676678|FG000|Overall Study|Physician Decision|1|||
126376872|NCT00887159|454676679|FG001|Overall Study|Physician Decision|1|||
126376873|NCT00887159|454676680|FG002|Overall Study|Physician Decision|0|||
126376874|NCT00887159|454676678|FG000|Overall Study|Sympomatic deterioration|1|||
126376875|NCT00887159|454676679|FG001|Overall Study|Sympomatic deterioration|0|||
126376876|NCT00887159|454676680|FG002|Overall Study|Sympomatic deterioration|0|||
126376877|NCT00887159|454676678|FG000|Overall Study|Treatment delayed|1|||
126552999|NCT02291289|455320502|FG001|Induction Treatment|Protocol Violation|0|||
126553000|NCT02291289|455320503|FG002|Induction Treatment|Protocol Violation|0|||
126553001|NCT02291289|455320504|FG003|Induction Treatment|Protocol Violation|3|||
126553002|NCT02291289|455320505|FG004|Induction Treatment|Protocol Violation|0|||
126553003|NCT02291289|455320506|FG005|Induction Treatment|Protocol Violation|0|||
126553004|NCT02291289|455320507|FG006|Induction Treatment|Protocol Violation|0|||
126553005|NCT02291289|455320508|FG007|Induction Treatment|Protocol Violation|0|||
126553006|NCT02291289|455320509|FG008|Induction Treatment|Protocol Violation|0|||
126553007|NCT02291289|455320510|FG009|Induction Treatment|Protocol Violation|2|||
126553008|NCT02291289|455320511|FG010|Induction Treatment|Protocol Violation|0|||
126553009|NCT02291289|455320512|FG011|Induction Treatment|Protocol Violation|0|||
126553010|NCT02291289|455320513|FG012|Induction Treatment|Protocol Violation|0|||
126553011|NCT02291289|455320501|FG000|Induction Treatment|Missing|4|||
126553012|NCT02291289|455320502|FG001|Induction Treatment|Missing|0|||
126553013|NCT02291289|455320503|FG002|Induction Treatment|Missing|0|||
126553014|NCT02291289|455320504|FG003|Induction Treatment|Missing|14|||
126553015|NCT02291289|455320505|FG004|Induction Treatment|Missing|0|||
126553016|NCT02291289|455320506|FG005|Induction Treatment|Missing|0|||
126553017|NCT02291289|455320507|FG006|Induction Treatment|Missing|0|||
126553018|NCT02291289|455320508|FG007|Induction Treatment|Missing|0|||
126553019|NCT02291289|455320509|FG008|Induction Treatment|Missing|0|||
126553020|NCT02291289|455320510|FG009|Induction Treatment|Missing|54|||
126553021|NCT02291289|455320511|FG010|Induction Treatment|Missing|0|||
126553022|NCT02291289|455320512|FG011|Induction Treatment|Missing|0|||
126553023|NCT02291289|455320513|FG012|Induction Treatment|Missing|0|||
126553024|NCT02291289|455320501|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
126553025|NCT02291289|455320502|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
126376878|NCT00887159|454676679|FG001|Overall Study|Treatment delayed|1|||
126376879|NCT00887159|454676680|FG002|Overall Study|Treatment delayed|0|||
126376880|NCT00887159|454676678|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
126376881|NCT00887159|454676679|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
126376882|NCT00887159|454676680|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
126553026|NCT02291289|455320503|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
126553027|NCT02291289|455320504|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
126553028|NCT02291289|455320505|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
126771084|NCT02617446|456116255|FG002|Overall Study|Withdrawal by Subject|0|||
126771085|NCT02617446|456116253|FG000|Overall Study|Adverse Event|1|||
126376883|NCT00887159|454676678|FG000|Overall Study|Received more tx instead of observation|1|||
126376884|NCT00887159|454676679|FG001|Overall Study|Received more tx instead of observation|0|||
126376885|NCT00887159|454676680|FG002|Overall Study|Received more tx instead of observation|0|||
126376886|NCT00887159|454676678|FG000|Overall Study|Ineligible|5|||
126553029|NCT02291289|455320506|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
126553030|NCT02291289|455320507|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
126376887|NCT00887159|454676679|FG001|Overall Study|Ineligible|1|||
126376888|NCT00887159|454676680|FG002|Overall Study|Ineligible|0|||
126376889|NCT00887159|454676678|FG000|Overall Study|Never started assigned therapy|3|||
126376890|NCT00887159|454676679|FG001|Overall Study|Never started assigned therapy|3|||
126376891|NCT00887159|454676680|FG002|Overall Study|Never started assigned therapy|4|||
126376892|NCT03500211|454676685|FG000|Overall Study|Withdrawal by Subject|1|||
126376893|NCT03500211|454676686|FG001|Overall Study|Withdrawal by Subject|1|||
126376894|NCT01119443|454676692|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
126376895|NCT01119443|454676693|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
126376896|NCT02078752|454676696|FG000|Overall Study|Death|0|||
126376897|NCT02078752|454676697|FG001|Overall Study|Death|3|||
126376898|NCT02078752|454676698|FG002|Overall Study|Death|0|||
126376899|NCT02078752|454676699|FG003|Overall Study|Death|0|||
126376900|NCT02078752|454676700|FG004|Overall Study|Death|0|||
126376901|NCT02078752|454676701|FG005|Overall Study|Death|1|||
126376902|NCT02078752|454676702|FG006|Overall Study|Death|0|||
126376903|NCT02078752|454676703|FG007|Overall Study|Death|1|||
126376904|NCT02078752|454676704|FG008|Overall Study|Death|0|||
126376905|NCT02078752|454676705|FG009|Overall Study|Death|4|||
126376906|NCT02078752|454676696|FG000|Overall Study|Lost to Follow-up|1|||
126376907|NCT02078752|454676697|FG001|Overall Study|Lost to Follow-up|0|||
126716819|NCT00623467|455914941|FG000|Overall Study|Withdrawal by Subject|2|||
126716820|NCT01809262|455914950|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
126376908|NCT02078752|454676698|FG002|Overall Study|Lost to Follow-up|0|||
126376909|NCT02078752|454676699|FG003|Overall Study|Lost to Follow-up|1|||
126376910|NCT02078752|454676700|FG004|Overall Study|Lost to Follow-up|0|||
126376911|NCT02078752|454676701|FG005|Overall Study|Lost to Follow-up|0|||
126376912|NCT02078752|454676702|FG006|Overall Study|Lost to Follow-up|0|||
126376913|NCT02078752|454676703|FG007|Overall Study|Lost to Follow-up|0|||
126376914|NCT02078752|454676704|FG008|Overall Study|Lost to Follow-up|0|||
126376915|NCT02078752|454676705|FG009|Overall Study|Lost to Follow-up|0|||
126376916|NCT02078752|454676696|FG000|Overall Study|Withdrawal by Subject|1|||
126376917|NCT02078752|454676697|FG001|Overall Study|Withdrawal by Subject|1|||
126376918|NCT02078752|454676698|FG002|Overall Study|Withdrawal by Subject|1|||
126376919|NCT02078752|454676699|FG003|Overall Study|Withdrawal by Subject|1|||
126376920|NCT02078752|454676700|FG004|Overall Study|Withdrawal by Subject|0|||
126376921|NCT02078752|454676701|FG005|Overall Study|Withdrawal by Subject|3|||
126376922|NCT02078752|454676702|FG006|Overall Study|Withdrawal by Subject|2|||
126376923|NCT02078752|454676703|FG007|Overall Study|Withdrawal by Subject|1|||
126376924|NCT02078752|454676704|FG008|Overall Study|Withdrawal by Subject|0|||
126376925|NCT02078752|454676705|FG009|Overall Study|Withdrawal by Subject|1|||
126376926|NCT02078752|454676696|FG000|Overall Study|Other|0|||
126376927|NCT02078752|454676697|FG001|Overall Study|Other|3|||
126376928|NCT02078752|454676698|FG002|Overall Study|Other|0|||
126376929|NCT02078752|454676699|FG003|Overall Study|Other|0|||
126376930|NCT02078752|454676700|FG004|Overall Study|Other|1|||
126376931|NCT02078752|454676701|FG005|Overall Study|Other|0|||
126376932|NCT02078752|454676702|FG006|Overall Study|Other|0|||
126376933|NCT02078752|454676703|FG007|Overall Study|Other|1|||
126376934|NCT02078752|454676704|FG008|Overall Study|Other|0|||
126467235|NCT02047227|455011786|FG000|Overall Study|Adverse Event|2|||
126467236|NCT02047227|455011787|FG001|Overall Study|Adverse Event|4|||
126467237|NCT02047227|455011786|FG000|Overall Study|Lost to Follow-up|0|||
126467238|NCT02047227|455011787|FG001|Overall Study|Lost to Follow-up|3|||
126467239|NCT02047227|455011786|FG000|Overall Study|Protocol Violation|1|||
126716821|NCT01809262|455914951|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
126376935|NCT02078752|454676705|FG009|Overall Study|Other|0|||
126467240|NCT02047227|455011787|FG001|Overall Study|Protocol Violation|0|||
126716822|NCT01809262|455914952|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
126716823|NCT01809262|455914953|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
126376936|NCT02078752|454676696|FG000|Overall Study|Study terminated by sponsor|0|||
126376937|NCT02078752|454676697|FG001|Overall Study|Study terminated by sponsor|0|||
126376938|NCT02078752|454676698|FG002|Overall Study|Study terminated by sponsor|0|||
126376939|NCT02078752|454676699|FG003|Overall Study|Study terminated by sponsor|0|||
126376940|NCT02078752|454676700|FG004|Overall Study|Study terminated by sponsor|0|||
126376941|NCT02078752|454676701|FG005|Overall Study|Study terminated by sponsor|0|||
126376942|NCT02078752|454676702|FG006|Overall Study|Study terminated by sponsor|0|||
126553031|NCT02291289|455320508|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
126553032|NCT02291289|455320509|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
126716824|NCT01809262|455914954|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
126376943|NCT02078752|454676703|FG007|Overall Study|Study terminated by sponsor|0|||
126376944|NCT02078752|454676704|FG008|Overall Study|Study terminated by sponsor|0|||
126467241|NCT02047227|455011786|FG000|Overall Study|Spontaneous pregnancy|1|||
126467242|NCT02047227|455011787|FG001|Overall Study|Spontaneous pregnancy|0|||
126553033|NCT02291289|455320510|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
126716825|NCT01809262|455914955|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
126376945|NCT02078752|454676705|FG009|Overall Study|Study terminated by sponsor|5|||
126376946|NCT00775268|454676706|FG000|Baseline|Drug not synthesize dose|1|||
126376947|NCT00775268|454676707|FG001|Baseline|Drug not synthesize dose|0|||
126376948|NCT00775268|454676706|FG000|Baseline|Not treated-ineligible per CT|0|||
126376949|NCT00775268|454676707|FG001|Baseline|Not treated-ineligible per CT|1|||
126376950|NCT00775268|454676706|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
126376951|NCT00775268|454676707|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
126376952|NCT00775268|454676706|FG000|After Completion|Participant missed scan appointment|1|||
126376953|NCT00775268|454676707|FG001|After Completion|Participant missed scan appointment|0|||
126376954|NCT03604497|454676708|FG000|Overall Study|Protocol Violation|52|||
126376955|NCT01194245|454676710|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
126376956|NCT01194245|454676711|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
126376957|NCT01194245|454676712|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
126376958|NCT01194245|454676713|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
126376959|NCT01194245|454676714|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
126376960|NCT01194245|454676710|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
126376961|NCT01194245|454676711|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
126376962|NCT01194245|454676712|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
126376963|NCT01194245|454676713|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
126376964|NCT01194245|454676714|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
126376965|NCT01194245|454676710|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
126376966|NCT01194245|454676711|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
126376967|NCT01194245|454676712|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
126376968|NCT01194245|454676713|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
126376969|NCT01194245|454676714|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
126376970|NCT01194245|454676710|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
126376971|NCT01194245|454676711|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
126376972|NCT01194245|454676712|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
126376973|NCT01194245|454676713|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
126376974|NCT01194245|454676714|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
126376975|NCT01194245|454676710|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126376976|NCT01194245|454676711|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126376977|NCT01194245|454676712|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126376978|NCT01194245|454676713|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126376979|NCT01194245|454676714|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
126376980|NCT01194245|454676710|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126376981|NCT01194245|454676711|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126376982|NCT01194245|454676712|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
126376983|NCT01194245|454676713|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
126376984|NCT01194245|454676714|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
126376985|NCT00269087|454676715|FG000|Overall Study|Adverse Event|20|||
126376986|NCT00269087|454676715|FG000|Overall Study|Withdrawal by Subject|1|||
126376987|NCT00269087|454676715|FG000|Overall Study|Exacerbation of COPD|13|||
126376988|NCT00041470|454676719|FG000|Overall Study|Loss of Funding|38|||
126376989|NCT02230189|454676726|FG000|Overall Study|Withdrawal by Subject|3|||
126376990|NCT02230189|454676727|FG001|Overall Study|Withdrawal by Subject|0|||
126376991|NCT02230189|454676728|FG002|Overall Study|Withdrawal by Subject|1|||
126376992|NCT02230189|454676726|FG000|Overall Study|Lost to Follow-up|1|||
126376993|NCT02230189|454676727|FG001|Overall Study|Lost to Follow-up|0|||
126376994|NCT02230189|454676728|FG002|Overall Study|Lost to Follow-up|0|||
126376995|NCT02230189|454676726|FG000|Overall Study|Physician Decision|1|||
126376996|NCT02230189|454676727|FG001|Overall Study|Physician Decision|0|||
126376997|NCT02230189|454676728|FG002|Overall Study|Physician Decision|0|||
126376998|NCT01193101|454676732|FG000|Overall Study|Adverse Event|0|||
126376999|NCT01193101|454676733|FG001|Overall Study|Adverse Event|1|||
126377000|NCT01193101|454676734|FG002|Overall Study|Adverse Event|1|||
126377001|NCT01193101|454676735|FG003|Overall Study|Adverse Event|3|||
126377002|NCT01193101|454676732|FG000|Overall Study|Lack of Efficacy|3|||
126377003|NCT01193101|454676733|FG001|Overall Study|Lack of Efficacy|1|||
126377004|NCT01193101|454676734|FG002|Overall Study|Lack of Efficacy|0|||
126377005|NCT01193101|454676735|FG003|Overall Study|Lack of Efficacy|8|||
126377006|NCT01193101|454676732|FG000|Overall Study|Withdrawal by Subject|2|||
126377007|NCT01193101|454676733|FG001|Overall Study|Withdrawal by Subject|4|||
126377008|NCT01193101|454676734|FG002|Overall Study|Withdrawal by Subject|1|||
126377009|NCT01193101|454676735|FG003|Overall Study|Withdrawal by Subject|1|||
126377010|NCT01193101|454676732|FG000|Overall Study|Administrative problems|0|||
126377011|NCT01193101|454676733|FG001|Overall Study|Administrative problems|0|||
126467243|NCT02047227|455011786|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
126377012|NCT01193101|454676734|FG002|Overall Study|Administrative problems|1|||
126377013|NCT01193101|454676735|FG003|Overall Study|Administrative problems|0|||
126377014|NCT01193101|454676732|FG000|Overall Study|Abnormal test procedure results|0|||
126377015|NCT01193101|454676733|FG001|Overall Study|Abnormal test procedure results|1|||
126467244|NCT02047227|455011787|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
126467245|NCT02047227|455011786|FG000|Overall Study|No oocytes retrieved|21|||
126467246|NCT02047227|455011787|FG001|Overall Study|No oocytes retrieved|20|||
126467247|NCT02047227|455011786|FG000|Overall Study|No fertilization|61|||
126467248|NCT02047227|455011787|FG001|Overall Study|No fertilization|51|||
126377016|NCT01193101|454676734|FG002|Overall Study|Abnormal test procedure results|0|||
126377017|NCT01193101|454676735|FG003|Overall Study|Abnormal test procedure results|0|||
126377018|NCT02347085|454676738|FG000|Overall Study|Adverse Event|2|||
126377019|NCT02347085|454676738|FG000|Overall Study|Lack of Efficacy|1|||
126377020|NCT02347085|454676738|FG000|Overall Study|Withdrawal by Subject|4|||
126377021|NCT02347085|454676738|FG000|Overall Study|Lost to Follow-up|1|||
126377022|NCT02347085|454676738|FG000|Overall Study|Protocol Criteria|2|||
126377023|NCT02834819|454676739|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
126377024|NCT02834819|454676740|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
126377025|NCT00800982|454676743|FG000|Overall Study|Lost to Follow-up|1|||
126377026|NCT00800982|454676744|FG001|Overall Study|Lost to Follow-up|2|||
126377027|NCT00800982|454676743|FG000|Overall Study|Withdrawal by Subject|0|||
126377028|NCT00800982|454676744|FG001|Overall Study|Withdrawal by Subject|1|||
126377029|NCT00800982|454676743|FG000|Overall Study|Patient moved out of state|1|||
126377030|NCT00800982|454676744|FG001|Overall Study|Patient moved out of state|0|||
126377031|NCT01824290|454676745|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
126377032|NCT01824290|454676746|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
126377033|NCT01824290|454676747|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
126377034|NCT01824290|454676748|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
126377035|NCT01824290|454676745|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
126377036|NCT01824290|454676746|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
126377037|NCT01824290|454676747|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
126377038|NCT01824290|454676748|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
126377039|NCT01824290|454676745|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
126377040|NCT01824290|454676746|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
126377041|NCT01824290|454676747|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
126377042|NCT01824290|454676748|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
126377043|NCT01824290|454676745|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
126377044|NCT01824290|454676746|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
126377045|NCT01824290|454676747|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
126377046|NCT01824290|454676748|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
126377047|NCT01824290|454676745|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
126377048|NCT01824290|454676746|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
126377049|NCT01824290|454676747|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
126377050|NCT01824290|454676748|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
126377051|NCT01824290|454676745|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
126377052|NCT01824290|454676746|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
126377053|NCT01824290|454676747|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
126377054|NCT01824290|454676748|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
126377055|NCT00527618|454676749|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
126377056|NCT00527618|454676750|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
126377057|NCT00527618|454676749|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
126377058|NCT00527618|454676750|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
126377059|NCT00527618|454676749|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
126377060|NCT00527618|454676750|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
126377061|NCT00527618|454676749|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
126377062|NCT00527618|454676750|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
126377063|NCT00527618|454676749|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
126377064|NCT00527618|454676750|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
126377065|NCT00527618|454676749|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
126377066|NCT00527618|454676750|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
126377067|NCT00363311|454676761|FG000|Overall Study|Adverse Event|6|||
126377068|NCT00363311|454676762|FG001|Overall Study|Adverse Event|4|||
126377069|NCT00363311|454676761|FG000|Overall Study|Lost to Follow-up|3|||
126377070|NCT00363311|454676762|FG001|Overall Study|Lost to Follow-up|0|||
126377071|NCT00363311|454676761|FG000|Overall Study|Protocol Violation|1|||
126377072|NCT00363311|454676762|FG001|Overall Study|Protocol Violation|2|||
126377073|NCT00363311|454676761|FG000|Overall Study|Withdrawal by Subject|12|||
126377074|NCT00363311|454676762|FG001|Overall Study|Withdrawal by Subject|6|||
126377075|NCT00363311|454676761|FG000|Overall Study|Physician Decision|1|||
126377076|NCT00363311|454676762|FG001|Overall Study|Physician Decision|1|||
126377077|NCT00363311|454676761|FG000|Overall Study|Sponsor Terminated Study|2|||
126377078|NCT00363311|454676762|FG001|Overall Study|Sponsor Terminated Study|2|||
126377079|NCT00363311|454676761|FG000|Overall Study|Disease Progression|46|||
126377080|NCT00363311|454676762|FG001|Overall Study|Disease Progression|26|||
126377081|NCT00363311|454676761|FG000|Overall Study|Non-Compliance|1|||
126377082|NCT00363311|454676762|FG001|Overall Study|Non-Compliance|1|||
126377083|NCT00363311|454676761|FG000|Overall Study|Participant Refused Biopsy|1|||
126377084|NCT00363311|454676762|FG001|Overall Study|Participant Refused Biopsy|0|||
126377085|NCT00363311|454676761|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
126771086|NCT02617446|456116254|FG001|Overall Study|Adverse Event|0|||
126377086|NCT00363311|454676762|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
126377087|NCT00363311|454676761|FG000|Overall Study|Participant Opted for Treatment|1|||
126377088|NCT00363311|454676762|FG001|Overall Study|Participant Opted for Treatment|0|||
126377089|NCT00363311|454676761|FG000|Overall Study|Participant Moved to Another Country|1|||
126377090|NCT00363311|454676762|FG001|Overall Study|Participant Moved to Another Country|0|||
126377091|NCT00363311|454676761|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
126377092|NCT00363311|454676762|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
126377093|NCT00363311|454676761|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
126377094|NCT00363311|454676762|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
126377095|NCT00363311|454676761|FG000|Overall Study|Participant Moved to Louisiana|0|||
126377096|NCT00363311|454676762|FG001|Overall Study|Participant Moved to Louisiana|1|||
126377097|NCT00120627|454676765|FG000|Overall Study|Withdrawal by Subject|5|||
126377098|NCT00120627|454676766|FG001|Overall Study|Withdrawal by Subject|5|||
126377099|NCT01508910|454676767|FG000|Treatment|Death|2|||
126377100|NCT01508910|454676768|FG001|Treatment|Death|3|||
126377101|NCT01508910|454676769|FG002|Treatment|Death|2|||
126377102|NCT01508910|454676770|FG003|Treatment|Death|0|||
126377103|NCT01508910|454676767|FG000|Treatment|Lost to Follow-up|0|||
126377104|NCT01508910|454676768|FG001|Treatment|Lost to Follow-up|0|||
126377105|NCT01508910|454676769|FG002|Treatment|Lost to Follow-up|2|||
126377106|NCT01508910|454676770|FG003|Treatment|Lost to Follow-up|1|||
126377107|NCT01508910|454676767|FG000|Treatment|Withdrawal by Subject|0|||
126377108|NCT01508910|454676768|FG001|Treatment|Withdrawal by Subject|1|||
126377109|NCT01508910|454676769|FG002|Treatment|Withdrawal by Subject|6|||
126377110|NCT01508910|454676770|FG003|Treatment|Withdrawal by Subject|1|||
126377111|NCT01508910|454676767|FG000|Treatment|Sponsor Decision|0|||
126377112|NCT01508910|454676768|FG001|Treatment|Sponsor Decision|0|||
126377113|NCT01508910|454676769|FG002|Treatment|Sponsor Decision|0|||
126377114|NCT01508910|454676770|FG003|Treatment|Sponsor Decision|1|||
126377115|NCT01595529|454676771|FG000|Overall Study|Adverse Event|2|||
126377116|NCT01595529|454676772|FG001|Overall Study|Adverse Event|0|||
126377117|NCT01595529|454676771|FG000|Overall Study|Subject Non-Compliant|2|||
126377118|NCT01595529|454676772|FG001|Overall Study|Subject Non-Compliant|0|||
126377119|NCT01595529|454676771|FG000|Overall Study|Lost to Follow-up|8|||
126377120|NCT01595529|454676772|FG001|Overall Study|Lost to Follow-up|14|||
126377121|NCT01595529|454676771|FG000|Overall Study|Protocol Violation|1|||
126377122|NCT01595529|454676772|FG001|Overall Study|Protocol Violation|2|||
126377123|NCT01595529|454676771|FG000|Overall Study|Physician Decision|1|||
126377124|NCT01595529|454676772|FG001|Overall Study|Physician Decision|0|||
126377125|NCT01595529|454676771|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
126377126|NCT01595529|454676772|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
126377127|NCT01595529|454676771|FG000|Overall Study|Administrative Decision|1|||
126377128|NCT01595529|454676772|FG001|Overall Study|Administrative Decision|0|||
126377129|NCT01595529|454676771|FG000|Overall Study|Entry Failure/Screening Failure|6|||
126377130|NCT01595529|454676772|FG001|Overall Study|Entry Failure/Screening Failure|1|||
126377131|NCT00730886|454676773|FG000|Overall Study|Lost to Follow-up|1|||
126377132|NCT00730886|454676774|FG001|Overall Study|Lost to Follow-up|0|||
126377133|NCT00730886|454676773|FG000|Overall Study|Physician Decision|1|||
126377134|NCT00730886|454676774|FG001|Overall Study|Physician Decision|0|||
126377135|NCT01991483|454676775|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
126377136|NCT01991483|454676776|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
126377137|NCT01991483|454676777|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
126377138|NCT01991483|454676778|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
126377139|NCT01991483|454676775|FG000|Dose Level 600 mg|Physician Decision|0|||
126377140|NCT01991483|454676776|FG001|Dose Level 600 mg|Physician Decision|0|||
126377141|NCT01991483|454676777|FG002|Dose Level 600 mg|Physician Decision|1|||
126377142|NCT01991483|454676778|FG003|Dose Level 600 mg|Physician Decision|0|||
126377143|NCT01991483|454676775|FG000|Dose Level 1000 mg|Protocol Violation|0|||
126377144|NCT01991483|454676776|FG001|Dose Level 1000 mg|Protocol Violation|0|||
126377145|NCT01991483|454676777|FG002|Dose Level 1000 mg|Protocol Violation|0|||
126377146|NCT01991483|454676778|FG003|Dose Level 1000 mg|Protocol Violation|1|||
126377147|NCT01932788|454676785|FG000|Overall Study|Protocol Violation|18|||
126377148|NCT01932788|454676786|FG001|Overall Study|Protocol Violation|0|||
126377149|NCT01932788|454676785|FG000|Overall Study|Lost to Follow-up|18|||
126377150|NCT01932788|454676786|FG001|Overall Study|Lost to Follow-up|46|||
126377151|NCT01932788|454676785|FG000|Overall Study|Lack of Efficacy|2|||
126377152|NCT01932788|454676786|FG001|Overall Study|Lack of Efficacy|0|||
126377153|NCT01932788|454676785|FG000|Overall Study|Withdrawal by Subject|0|||
126377154|NCT01932788|454676786|FG001|Overall Study|Withdrawal by Subject|5|||
126377155|NCT04819113|454676787|FG000|Overall Study|Withdrawal by parent/guardian|3|||
126377156|NCT04819113|454676787|FG000|Overall Study|Lost to Follow-up|1|||
126377157|NCT04819113|454676787|FG000|Overall Study|Withdrawn before vaccination|2|||
126377158|NCT04067492|454676788|FG000|Overall Study|Lost to Follow-up|0|||
126377159|NCT04067492|454676789|FG001|Overall Study|Lost to Follow-up|0|||
126377160|NCT04067492|454676790|FG002|Overall Study|Lost to Follow-up|0|||
126377161|NCT04067492|454676791|FG003|Overall Study|Lost to Follow-up|0|||
126716826|NCT01809262|455914956|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
126716827|NCT01809262|455914957|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
126716828|NCT01809262|455914958|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
126716829|NCT01809262|455914959|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
126377162|NCT04067492|454676792|FG004|Overall Study|Lost to Follow-up|0|||
126377163|NCT04067492|454676793|FG005|Overall Study|Lost to Follow-up|1|||
126377164|NCT04067492|454676788|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
126377165|NCT04067492|454676789|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
126377166|NCT04067492|454676790|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
126377167|NCT04067492|454676791|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
126377168|NCT04067492|454676792|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
126377169|NCT04067492|454676793|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
126377170|NCT04067492|454676788|FG000|Overall Study|COVID-19 epidemiological situation|0|||
126377171|NCT04067492|454676789|FG001|Overall Study|COVID-19 epidemiological situation|0|||
126377172|NCT04067492|454676790|FG002|Overall Study|COVID-19 epidemiological situation|0|||
126377173|NCT04067492|454676791|FG003|Overall Study|COVID-19 epidemiological situation|1|||
126377174|NCT04067492|454676792|FG004|Overall Study|COVID-19 epidemiological situation|0|||
126377175|NCT04067492|454676793|FG005|Overall Study|COVID-19 epidemiological situation|0|||
126377176|NCT00833027|454676794|FG000|Overall Study|Adverse Event|33|||
126377177|NCT00833027|454676794|FG000|Overall Study|Death|1|||
126377178|NCT00833027|454676794|FG000|Overall Study|Lack of Efficacy|12|||
126377179|NCT00833027|454676794|FG000|Overall Study|Lost to Follow-up|24|||
126377180|NCT00833027|454676794|FG000|Overall Study|Protocol Violation|115|||
126377181|NCT00833027|454676794|FG000|Overall Study|Withdrawal by Subject|16|||
126377182|NCT00833027|454676794|FG000|Overall Study|Missing|10|||
126377183|NCT02806414|454676801|FG000|Overall Study|Lost to Follow-up|2|||
126377184|NCT03092479|454676804|FG000|Overall Study|Lost to Follow-up|3|||
126377185|NCT03092479|454676805|FG001|Overall Study|Lost to Follow-up|2|||
126377186|NCT03092479|454676804|FG000|Overall Study|Withdrawal by Subject|4|||
126377187|NCT03092479|454676805|FG001|Overall Study|Withdrawal by Subject|0|||
126377188|NCT00937495|454678389|FG000|Overall Study|Protocol Violation|2|||
126377189|NCT00441272|454678390|FG000|Overall Study|Study terminated prior to enrollment|25|||
126377190|NCT00441272|454678391|FG001|Overall Study|Study terminated prior to enrollment|25|||
126377191|NCT01856322|454678392|FG000|Overall Study|off study due to lack of accrual|0|||
126377192|NCT01856322|454678393|FG001|Overall Study|off study due to lack of accrual|0|||
126377193|NCT01856322|454678394|FG002|Overall Study|off study due to lack of accrual|3|||
126377194|NCT00443703|454678395|FG000|Overall Study|Never Treated|3|||
126377195|NCT00443703|454678396|FG001|Overall Study|Never Treated|1|||
126377196|NCT00443703|454678395|FG000|Overall Study|Adverse Event|7|||
126377197|NCT00443703|454678396|FG001|Overall Study|Adverse Event|3|||
126377198|NCT00443703|454678395|FG000|Overall Study|Lack of Efficacy|3|||
126377199|NCT00443703|454678396|FG001|Overall Study|Lack of Efficacy|1|||
126377200|NCT00443703|454678395|FG000|Overall Study|Lost to Follow-up|0|||
126377201|NCT00443703|454678396|FG001|Overall Study|Lost to Follow-up|4|||
126377202|NCT00443703|454678395|FG000|Overall Study|Physician Decision|4|||
126377203|NCT00443703|454678396|FG001|Overall Study|Physician Decision|2|||
126377204|NCT00443703|454678395|FG000|Overall Study|Protocol Violation|1|||
126377205|NCT00443703|454678396|FG001|Overall Study|Protocol Violation|1|||
126377206|NCT00443703|454678395|FG000|Overall Study|Withdrawal by Subject|9|||
126377207|NCT00443703|454678396|FG001|Overall Study|Withdrawal by Subject|6|||
126377208|NCT00443703|454678395|FG000|Overall Study|Progressive Disease|1|||
126377209|NCT00443703|454678396|FG001|Overall Study|Progressive Disease|0|||
126377210|NCT00661830|454678400|FG000|Overall Study|Death|37|||
126377211|NCT00661830|454678401|FG001|Overall Study|Death|33|||
126377212|NCT00661830|454678400|FG000|Overall Study|Lost to Follow-up|1|||
126377213|NCT00661830|454678401|FG001|Overall Study|Lost to Follow-up|3|||
126377214|NCT00661830|454678400|FG000|Overall Study|Withdrawal by Subject|1|||
126377215|NCT00661830|454678401|FG001|Overall Study|Withdrawal by Subject|1|||
126377216|NCT00661830|454678400|FG000|Overall Study|Other reason|1|||
126716830|NCT01809262|455914950|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126716831|NCT01809262|455914951|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
126377217|NCT00661830|454678401|FG001|Overall Study|Other reason|5|||
126377218|NCT01669902|454678402|FG000|Overall Study|Adverse Event|11|||
126716832|NCT01809262|455914952|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126377219|NCT01669902|454678402|FG000|Overall Study|Lack of Efficacy|10|||
126377220|NCT01669902|454678402|FG000|Overall Study|Other|8|||
126377221|NCT01535287|454678403|FG000|Overall Study|drug not prepared in time|5|||
126377222|NCT01535287|454678404|FG001|Overall Study|drug not prepared in time|6|||
126377223|NCT02364037|454678413|FG000|Overall Study|Withdrawal by Subject|7|||
126377224|NCT02364037|454678414|FG001|Overall Study|Withdrawal by Subject|4|||
126377225|NCT02364037|454678413|FG000|Overall Study|Lost to Follow-up|37|||
126716833|NCT01809262|455914953|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126716834|NCT01809262|455914954|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126377226|NCT02364037|454678414|FG001|Overall Study|Lost to Follow-up|49|||
126377227|NCT04567524|454678415|FG000|Overall Study|Adverse Event|1|||
126467249|NCT02047227|455011786|FG000|Overall Study|Intention to freeze all embryos|1|||
126467250|NCT02047227|455011787|FG001|Overall Study|Intention to freeze all embryos|0|||
126467251|NCT02047227|455011786|FG000|Overall Study|All embryos discarded|12|||
126467252|NCT02047227|455011787|FG001|Overall Study|All embryos discarded|11|||
126467253|NCT02047227|455011786|FG000|Overall Study|Other|10|||
126467254|NCT02047227|455011787|FG001|Overall Study|Other|9|||
126467255|NCT01977937|455011794|FG000|Overall Study|Withdrawal by Subject|2|||
126467256|NCT01977937|455011795|FG001|Overall Study|Withdrawal by Subject|1|||
126377228|NCT04567524|454678416|FG001|Overall Study|Adverse Event|1|||
126377229|NCT04567524|454678417|FG002|Overall Study|Adverse Event|0|||
126377230|NCT04567524|454678418|FG003|Overall Study|Adverse Event|0|||
126377231|NCT04567524|454678415|FG000|Overall Study|Withdrawal by Subject|2|||
126377232|NCT04567524|454678416|FG001|Overall Study|Withdrawal by Subject|0|||
126377233|NCT04567524|454678417|FG002|Overall Study|Withdrawal by Subject|0|||
126377234|NCT04567524|454678418|FG003|Overall Study|Withdrawal by Subject|1|||
126377235|NCT01639469|454678421|FG000|Overall Study|Death|4|||
126377236|NCT01639469|454678422|FG001|Overall Study|Death|2|||
126377237|NCT01639469|454678421|FG000|Overall Study|Lost to Follow-up|1|||
126377238|NCT01639469|454678422|FG001|Overall Study|Lost to Follow-up|1|||
126377239|NCT00420381|454678423|FG000|Overall Study|Protocol Violation|1|||
126377240|NCT00616642|454678433|FG000|Overall Study|Withdrawal by Subject|0|||
126377241|NCT00616642|454678434|FG001|Overall Study|Withdrawal by Subject|1|||
126377242|NCT00589797|454678441|FG000|Overall Study|Death|1|||
126377243|NCT00589797|454678442|FG001|Overall Study|Death|0|||
126377244|NCT00589797|454678441|FG000|Overall Study|Lost to Follow-up|12|||
126377245|NCT00589797|454678442|FG001|Overall Study|Lost to Follow-up|9|||
126377246|NCT00589797|454678441|FG000|Overall Study|Physician Decision|8|||
126377247|NCT00589797|454678442|FG001|Overall Study|Physician Decision|3|||
126377248|NCT00589797|454678441|FG000|Overall Study|Withdrawal by Subject|6|||
126377249|NCT00589797|454678442|FG001|Overall Study|Withdrawal by Subject|5|||
126377250|NCT00589797|454678441|FG000|Overall Study|Non-Randomized Training Subjects|46|||
126377251|NCT00589797|454678442|FG001|Overall Study|Non-Randomized Training Subjects|6|||
126377252|NCT01881009|454678443|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
126377253|NCT01881009|454678444|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
126377254|NCT02141672|454678445|FG000|Overall Study|Adverse Event|0|||
126377255|NCT02141672|454678446|FG001|Overall Study|Adverse Event|1|||
126377256|NCT02141672|454678447|FG002|Overall Study|Adverse Event|0|||
126377257|NCT02141672|454678445|FG000|Overall Study|Death|10|||
126377258|NCT02141672|454678446|FG001|Overall Study|Death|2|||
126377259|NCT02141672|454678447|FG002|Overall Study|Death|1|||
126377260|NCT02141672|454678445|FG000|Overall Study|Lack of Efficacy|0|||
126467257|NCT01977937|455011794|FG000|Overall Study|Adverse Event|1|||
126467258|NCT01977937|455011795|FG001|Overall Study|Adverse Event|0|||
126467259|NCT01977937|455011794|FG000|Overall Study|Physician Decision|0|||
126467260|NCT01977937|455011795|FG001|Overall Study|Physician Decision|1|||
126467261|NCT00406718|455011797|FG000|Overall Study|Withdrawal by Subject|2|||
126467262|NCT00406718|455011798|FG001|Overall Study|Withdrawal by Subject|9|||
126467263|NCT00406718|455011799|FG002|Overall Study|Withdrawal by Subject|4|||
126377261|NCT02141672|454678446|FG001|Overall Study|Lack of Efficacy|0|||
126377262|NCT02141672|454678447|FG002|Overall Study|Lack of Efficacy|2|||
126377263|NCT02141672|454678445|FG000|Overall Study|Lost to Follow-up|1|||
126377264|NCT02141672|454678446|FG001|Overall Study|Lost to Follow-up|1|||
126377265|NCT02141672|454678447|FG002|Overall Study|Lost to Follow-up|3|||
126377266|NCT02141672|454678445|FG000|Overall Study|Physician Decision|1|||
126377267|NCT02141672|454678446|FG001|Overall Study|Physician Decision|2|||
126377268|NCT02141672|454678447|FG002|Overall Study|Physician Decision|5|||
126377269|NCT02141672|454678445|FG000|Overall Study|Protocol Violation|0|||
126377270|NCT02141672|454678446|FG001|Overall Study|Protocol Violation|0|||
126467264|NCT00406718|455011797|FG000|Overall Study|Lost to Follow-up|2|||
126467265|NCT00406718|455011798|FG001|Overall Study|Lost to Follow-up|5|||
126467266|NCT00406718|455011799|FG002|Overall Study|Lost to Follow-up|4|||
126553034|NCT02291289|455320511|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
126377271|NCT02141672|454678447|FG002|Overall Study|Protocol Violation|1|||
126377272|NCT02141672|454678445|FG000|Overall Study|Withdrawal by Subject|3|||
126377273|NCT02141672|454678446|FG001|Overall Study|Withdrawal by Subject|2|||
126377274|NCT02141672|454678447|FG002|Overall Study|Withdrawal by Subject|5|||
126377275|NCT02141672|454678445|FG000|Overall Study|refused to follow-up|1|||
126467267|NCT02898116|455011802|FG000|Overall Study|Adverse Event|1|||
126467268|NCT02898116|455011802|FG000|Overall Study|Progressive disease|1|||
126467269|NCT05597020|455011803|FG000|Washout|Forbidden medication|2|||
126467270|NCT05597020|455011804|FG001|Washout|Forbidden medication|0|||
126377276|NCT02141672|454678446|FG001|Overall Study|refused to follow-up|0|||
126377277|NCT02141672|454678447|FG002|Overall Study|refused to follow-up|1|||
126377278|NCT00332696|454678455|FG000|Overall Study|Death|24|||
126377279|NCT00332696|454678456|FG001|Overall Study|Death|14|||
126377280|NCT00332696|454678455|FG000|Overall Study|Insufficient therapeutic effect|4|||
126377281|NCT00332696|454678456|FG001|Overall Study|Insufficient therapeutic effect|11|||
126377282|NCT00332696|454678455|FG000|Overall Study|Adverse Event|1|||
126377283|NCT00332696|454678456|FG001|Overall Study|Adverse Event|2|||
126716835|NCT01809262|455914955|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126716836|NCT01809262|455914956|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126716837|NCT01809262|455914957|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126716838|NCT01809262|455914958|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126716839|NCT01809262|455914959|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
126716840|NCT02064439|455914961|FG000|Overall Study|Adverse Event|51|||
126716841|NCT02064439|455914962|FG001|Overall Study|Adverse Event|47|||
126716842|NCT02064439|455914963|FG002|Overall Study|Adverse Event|46|||
126716843|NCT02064439|455914961|FG000|Overall Study|Death|0|||
126716844|NCT02064439|455914962|FG001|Overall Study|Death|2|||
126716845|NCT02064439|455914963|FG002|Overall Study|Death|3|||
126716846|NCT02064439|455914961|FG000|Overall Study|Withdrawal by Subject|29|||
126716847|NCT02064439|455914962|FG001|Overall Study|Withdrawal by Subject|18|||
126716848|NCT02064439|455914963|FG002|Overall Study|Withdrawal by Subject|26|||
126716849|NCT02064439|455914961|FG000|Overall Study|Protocol Violation|3|||
126716850|NCT02064439|455914962|FG001|Overall Study|Protocol Violation|5|||
126716851|NCT02064439|455914963|FG002|Overall Study|Protocol Violation|3|||
126716852|NCT02064439|455914961|FG000|Overall Study|Lost to Follow-up|1|||
126716853|NCT02064439|455914962|FG001|Overall Study|Lost to Follow-up|3|||
126716854|NCT02064439|455914963|FG002|Overall Study|Lost to Follow-up|4|||
126716855|NCT02064439|455914961|FG000|Overall Study|Non-compliance with study medication|21|||
126716856|NCT02064439|455914962|FG001|Overall Study|Non-compliance with study medication|19|||
126716857|NCT02064439|455914963|FG002|Overall Study|Non-compliance with study medication|23|||
126716858|NCT02064439|455914961|FG000|Overall Study|Physician Decision|0|||
126377284|NCT00332696|454678455|FG000|Overall Study|Condition does not justify treatment|0|||
126377285|NCT00332696|454678456|FG001|Overall Study|Condition does not justify treatment|2|||
126377286|NCT00332696|454678455|FG000|Overall Study|Lost to Follow-up|0|||
126377287|NCT00332696|454678456|FG001|Overall Study|Lost to Follow-up|1|||
126377288|NCT00332696|454678455|FG000|Overall Study|Withdrawal by Subject|1|||
126377289|NCT00332696|454678456|FG001|Overall Study|Withdrawal by Subject|0|||
126377290|NCT01061385|454678458|FG000|Overall Study|Lost to Follow-up|1|||
126377291|NCT01061385|454678459|FG001|Overall Study|Lost to Follow-up|0|||
126377292|NCT01061385|454678458|FG000|Overall Study|subject decision not related to AE|0|||
126377293|NCT01061385|454678459|FG001|Overall Study|subject decision not related to AE|1|||
126377294|NCT00533429|454678460|FG000|Overall Study|Adverse Event|3|||
126377295|NCT00533429|454678461|FG001|Overall Study|Adverse Event|1|||
126377296|NCT00533429|454678460|FG000|Overall Study|Death|1|||
126377297|NCT00533429|454678461|FG001|Overall Study|Death|0|||
126377298|NCT00533429|454678460|FG000|Overall Study|Withdrawal by Subject|2|||
126377299|NCT00533429|454678461|FG001|Overall Study|Withdrawal by Subject|0|||
126377300|NCT00533429|454678460|FG000|Overall Study|Progressive Disease|12|||
126377301|NCT00533429|454678461|FG001|Overall Study|Progressive Disease|13|||
126377302|NCT00533429|454678460|FG000|Overall Study|Symptomatic deterioration|1|||
126377303|NCT00533429|454678461|FG001|Overall Study|Symptomatic deterioration|2|||
126377304|NCT01464879|454678462|FG000|Overall Study|Physician Decision|1|||
126377305|NCT01464879|454678462|FG000|Overall Study|Non-compliance|1|||
126377306|NCT00244621|454678463|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126377307|NCT00244621|454678464|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
126377308|NCT00244621|454678465|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
126377309|NCT00244621|454678463|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
126377310|NCT00244621|454678464|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
126377311|NCT00244621|454678465|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126377312|NCT00244621|454678463|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
126377313|NCT00244621|454678464|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
126377314|NCT00244621|454678465|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
126377315|NCT00244621|454678463|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
126377316|NCT00244621|454678464|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
126377317|NCT00244621|454678465|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
126377318|NCT00244621|454678463|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
126377319|NCT00244621|454678464|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
126377320|NCT00244621|454678465|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
126377321|NCT00244621|454678463|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
126377322|NCT00244621|454678464|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
126377323|NCT00244621|454678465|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
126377324|NCT00244621|454678463|FG000|Open-label Treatment Period|Adverse Event|0|||
126377325|NCT00244621|454678464|FG001|Open-label Treatment Period|Adverse Event|0|||
126377326|NCT00244621|454678465|FG002|Open-label Treatment Period|Adverse Event|1|||
126716859|NCT02064439|455914962|FG001|Overall Study|Physician Decision|1|||
126716860|NCT02064439|455914963|FG002|Overall Study|Physician Decision|1|||
126771087|NCT02617446|456116255|FG002|Overall Study|Adverse Event|5|||
126377327|NCT00244621|454678463|FG000|Open-label Treatment Period|Moved abroad|0|||
126377328|NCT00244621|454678464|FG001|Open-label Treatment Period|Moved abroad|0|||
126716861|NCT02064439|455914961|FG000|Overall Study|Logistical difficulties|6|||
126716862|NCT02064439|455914962|FG001|Overall Study|Logistical difficulties|5|||
126716863|NCT02064439|455914963|FG002|Overall Study|Logistical difficulties|2|||
126377329|NCT00244621|454678465|FG002|Open-label Treatment Period|Moved abroad|1|||
126377330|NCT00648037|454678469|FG000|Overall Study|Not Treated|1|||
126377331|NCT00648037|454678469|FG000|Overall Study|Withdrawal by Subject|1|||
126377332|NCT00648037|454678469|FG000|Overall Study|Adverse Event|11|||
126377333|NCT00648037|454678469|FG000|Overall Study|Relapse|2|||
126377334|NCT00648037|454678469|FG000|Overall Study|Other|1|||
126377335|NCT02967679|454678470|FG000|Overall Study|Adverse Event|1|||
126377336|NCT00003631|454678473|FG000|Overall Study|Patient not treated|1|||
126377337|NCT00003631|454678474|FG001|Overall Study|Patient not treated|0|||
126377338|NCT00003631|454678475|FG002|Overall Study|Patient not treated|1|||
126377339|NCT00003631|454678473|FG000|Overall Study|Protocol Violation|1|||
126377340|NCT00003631|454678474|FG001|Overall Study|Protocol Violation|0|||
126377341|NCT00003631|454678475|FG002|Overall Study|Protocol Violation|0|||
126377342|NCT00003631|454678473|FG000|Overall Study|Adverse Event|1|||
126377343|NCT00003631|454678474|FG001|Overall Study|Adverse Event|1|||
126377344|NCT00003631|454678475|FG002|Overall Study|Adverse Event|5|||
126377345|NCT00003631|454678473|FG000|Overall Study|Death|0|||
126377346|NCT00003631|454678474|FG001|Overall Study|Death|0|||
126377347|NCT00003631|454678475|FG002|Overall Study|Death|1|||
126377348|NCT00003631|454678473|FG000|Overall Study|Evaluable for toxicity only|0|||
126377349|NCT00003631|454678474|FG001|Overall Study|Evaluable for toxicity only|0|||
126377350|NCT00003631|454678475|FG002|Overall Study|Evaluable for toxicity only|2|||
126377351|NCT00600067|454678476|FG000|Overall Study|Adverse Event|0|||
126377352|NCT00600067|454678477|FG001|Overall Study|Adverse Event|1|||
126377353|NCT00600067|454678476|FG000|Overall Study|Lost to Follow-up|2|||
126377354|NCT00600067|454678477|FG001|Overall Study|Lost to Follow-up|3|||
126377355|NCT00600067|454678476|FG000|Overall Study|protocol non-compliance|0|||
126377356|NCT00600067|454678477|FG001|Overall Study|protocol non-compliance|3|||
126377357|NCT00600067|454678476|FG000|Overall Study|Lack of Efficacy|1|||
126377358|NCT00600067|454678477|FG001|Overall Study|Lack of Efficacy|0|||
126377359|NCT04339413|454678478|FG000|Overall Study|Reason Not Specified|2|||
126377360|NCT04339413|454678479|FG001|Overall Study|Reason Not Specified|7|||
126377361|NCT04339413|454678478|FG000|Overall Study|Study Terminated by Sponsor|30|||
126377362|NCT04339413|454678479|FG001|Overall Study|Study Terminated by Sponsor|33|||
126377363|NCT04339413|454678478|FG000|Overall Study|Progressive Disease|9|||
126377364|NCT04339413|454678479|FG001|Overall Study|Progressive Disease|6|||
126377365|NCT04339413|454678478|FG000|Overall Study|Withdrawal by Subject|9|||
126377366|NCT04339413|454678479|FG001|Overall Study|Withdrawal by Subject|10|||
126377367|NCT04339413|454678478|FG000|Overall Study|Physician Decision|3|||
126377368|NCT04339413|454678479|FG001|Overall Study|Physician Decision|1|||
126377369|NCT04339413|454678478|FG000|Overall Study|Death|2|||
126377370|NCT04339413|454678479|FG001|Overall Study|Death|0|||
126377371|NCT04339413|454678478|FG000|Overall Study|Adverse Event|3|||
126377372|NCT04339413|454678479|FG001|Overall Study|Adverse Event|0|||
126377373|NCT00251693|454678485|FG000|Overall Study|Adverse Event|17|||
126377374|NCT00251693|454678486|FG001|Overall Study|Adverse Event|9|||
126377375|NCT00251693|454678487|FG002|Overall Study|Adverse Event|9|||
126377376|NCT00251693|454678485|FG000|Overall Study|Protocol Violation|2|||
126377377|NCT00251693|454678486|FG001|Overall Study|Protocol Violation|0|||
126377378|NCT00251693|454678487|FG002|Overall Study|Protocol Violation|2|||
126377379|NCT00251693|454678485|FG000|Overall Study|Lost to Follow-up|12|||
126377380|NCT00251693|454678486|FG001|Overall Study|Lost to Follow-up|7|||
126377381|NCT00251693|454678487|FG002|Overall Study|Lost to Follow-up|8|||
126377382|NCT00251693|454678485|FG000|Overall Study|Withdrawal by Subject|11|||
126377383|NCT00251693|454678486|FG001|Overall Study|Withdrawal by Subject|17|||
126377384|NCT00251693|454678487|FG002|Overall Study|Withdrawal by Subject|14|||
126377385|NCT00251693|454678485|FG000|Overall Study|Lack of Efficacy|0|||
126377386|NCT00251693|454678486|FG001|Overall Study|Lack of Efficacy|1|||
126377387|NCT00251693|454678487|FG002|Overall Study|Lack of Efficacy|0|||
126467271|NCT05597020|455011803|FG000|Treatment Period II|Advice from primary care physician|1|||
126771088|NCT02617446|456116253|FG000|Overall Study|Lost to Follow-up|3|||
126377388|NCT00251693|454678485|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
126377389|NCT00251693|454678486|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
126467272|NCT05597020|455011804|FG001|Treatment Period II|Advice from primary care physician|0|||
126377390|NCT00251693|454678487|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
126377391|NCT00251693|454678485|FG000|Overall Study|Noncompliant|0|||
126377392|NCT00251693|454678486|FG001|Overall Study|Noncompliant|0|||
126377393|NCT00251693|454678487|FG002|Overall Study|Noncompliant|2|||
126377394|NCT00251693|454678485|FG000|Overall Study|Possible Barrett's esophagus|3|||
126377395|NCT00251693|454678486|FG001|Overall Study|Possible Barrett's esophagus|5|||
126377396|NCT00251693|454678487|FG002|Overall Study|Possible Barrett's esophagus|2|||
126377397|NCT00251693|454678485|FG000|Overall Study|Subject request/subject unavailable|1|||
126377398|NCT00251693|454678486|FG001|Overall Study|Subject request/subject unavailable|2|||
126377399|NCT00251693|454678487|FG002|Overall Study|Subject request/subject unavailable|0|||
126377400|NCT00251693|454678485|FG000|Overall Study|Abnormal laboratory findings|0|||
126467273|NCT05597020|455011803|FG000|Treatment Period II|Subject lost investigational product|1|||
126771089|NCT02617446|456116254|FG001|Overall Study|Lost to Follow-up|0|||
126377401|NCT00251693|454678486|FG001|Overall Study|Abnormal laboratory findings|0|||
126771090|NCT02617446|456116255|FG002|Overall Study|Lost to Follow-up|0|||
126771091|NCT02617446|456116253|FG000|Overall Study|Death|0|||
126771092|NCT02617446|456116254|FG001|Overall Study|Death|0|||
126771093|NCT02617446|456116255|FG002|Overall Study|Death|2|||
126771094|NCT00530088|456116256|FG000|Overall Study|Disease Progression|4|||
126771095|NCT00530088|456116256|FG000|Overall Study|Physician Decision|4|||
126771096|NCT00530088|456116256|FG000|Overall Study|Other Not Specified|2|||
126771097|NCT00902278|456116257|FG000|Overall Study|Physician Decision|1|||
126771098|NCT00902278|456116258|FG001|Overall Study|Physician Decision|0|||
126771099|NCT00902278|456116259|FG002|Overall Study|Physician Decision|2|||
126771100|NCT00902278|456116260|FG003|Overall Study|Physician Decision|0|||
126771101|NCT00902278|456116261|FG004|Overall Study|Physician Decision|1|||
126771102|NCT00902278|456116257|FG000|Overall Study|Lost to Follow-up|3|||
126771103|NCT00902278|456116258|FG001|Overall Study|Lost to Follow-up|2|||
126771104|NCT00902278|456116259|FG002|Overall Study|Lost to Follow-up|3|||
126771105|NCT00902278|456116260|FG003|Overall Study|Lost to Follow-up|0|||
126771106|NCT00902278|456116261|FG004|Overall Study|Lost to Follow-up|1|||
126771107|NCT02362646|456116262|FG000|Overall Study|Death|15|||
126771108|NCT02362646|456116263|FG001|Overall Study|Death|8|||
126377402|NCT00251693|454678487|FG002|Overall Study|Abnormal laboratory findings|1|||
126377403|NCT00401843|454678488|FG000|Overall Study|Achieved Complete Response|1|||
126377404|NCT00401843|454678489|FG001|Overall Study|Achieved Complete Response|5|||
126377405|NCT00401843|454678490|FG002|Overall Study|Achieved Complete Response|11|||
126377406|NCT00401843|454678488|FG000|Overall Study|Adverse Event|7|||
126377407|NCT00401843|454678489|FG001|Overall Study|Adverse Event|26|||
126377408|NCT00401843|454678490|FG002|Overall Study|Adverse Event|27|||
126377409|NCT00401843|454678488|FG000|Overall Study|Death|0|||
126377410|NCT00401843|454678489|FG001|Overall Study|Death|8|||
126377411|NCT00401843|454678490|FG002|Overall Study|Death|10|||
126377412|NCT00401843|454678488|FG000|Overall Study|Disease progression|10|||
126377413|NCT00401843|454678489|FG001|Overall Study|Disease progression|60|||
126377414|NCT00401843|454678490|FG002|Overall Study|Disease progression|49|||
126377415|NCT00401843|454678488|FG000|Overall Study|End of Study|1|||
126377416|NCT00401843|454678489|FG001|Overall Study|End of Study|1|||
126377417|NCT00401843|454678490|FG002|Overall Study|End of Study|2|||
126377418|NCT00401843|454678488|FG000|Overall Study|Lost to Follow-up|0|||
126377419|NCT00401843|454678489|FG001|Overall Study|Lost to Follow-up|0|||
126377420|NCT00401843|454678490|FG002|Overall Study|Lost to Follow-up|2|||
126377421|NCT00401843|454678488|FG000|Overall Study|Other Unspecified|0|||
126377422|NCT00401843|454678489|FG001|Overall Study|Other Unspecified|3|||
126377423|NCT00401843|454678490|FG002|Overall Study|Other Unspecified|5|||
126377424|NCT00401843|454678488|FG000|Overall Study|Physician Decision|0|||
126377425|NCT00401843|454678489|FG001|Overall Study|Physician Decision|16|||
126377426|NCT00401843|454678490|FG002|Overall Study|Physician Decision|10|||
126377427|NCT00401843|454678488|FG000|Overall Study|Protocol Violation|0|||
126377428|NCT00401843|454678489|FG001|Overall Study|Protocol Violation|0|||
126377429|NCT00401843|454678490|FG002|Overall Study|Protocol Violation|1|||
126377430|NCT00401843|454678488|FG000|Overall Study|Withdrawal by Subject|1|||
126377431|NCT00401843|454678489|FG001|Overall Study|Withdrawal by Subject|5|||
126377432|NCT00401843|454678490|FG002|Overall Study|Withdrawal by Subject|5|||
126377433|NCT00401843|454678488|FG000|Overall Study|Withdrawal of consent to study agent|1|||
126377434|NCT00401843|454678489|FG001|Overall Study|Withdrawal of consent to study agent|15|||
126377435|NCT00401843|454678490|FG002|Overall Study|Withdrawal of consent to study agent|17|||
126377436|NCT00401843|454678488|FG000|Overall Study|Randomized but not Treated|0|||
126467274|NCT05597020|455011804|FG001|Treatment Period II|Subject lost investigational product|0|||
126467275|NCT05597020|455011803|FG000|Treatment Period II|Private reasons|0|||
126467276|NCT05597020|455011804|FG001|Treatment Period II|Private reasons|1|||
126467277|NCT05169567|455011805|FG000|Overall Study|On study treatment|116|||
126467278|NCT05169567|455011806|FG001|Overall Study|On study treatment|128|||
126467279|NCT05169567|455011805|FG000|Overall Study|Lost to Follow-up|1|||
126467280|NCT05169567|455011806|FG001|Overall Study|Lost to Follow-up|0|||
126467281|NCT05169567|455011805|FG000|Overall Study|Withdrawal by Subject|25|||
126467282|NCT05169567|455011806|FG001|Overall Study|Withdrawal by Subject|21|||
126377437|NCT00401843|454678489|FG001|Overall Study|Randomized but not Treated|2|||
126377438|NCT00401843|454678490|FG002|Overall Study|Randomized but not Treated|3|||
126377439|NCT00401843|454678488|FG000|Overall Study|Received incorrect treatment|0|||
126377440|NCT00401843|454678489|FG001|Overall Study|Received incorrect treatment|3|||
126377441|NCT00401843|454678490|FG002|Overall Study|Received incorrect treatment|0|||
126377442|NCT02103062|454678491|FG000|Overall Study|Adverse Event|1|||
126377443|NCT02103062|454678492|FG001|Overall Study|Adverse Event|2|||
126467283|NCT01015131|455011807|FG000|Overall Study|Physician Decision|1|||
126771109|NCT02362646|456116262|FG000|Overall Study|Withdrawal by Subject|2|||
126771110|NCT02362646|456116263|FG001|Overall Study|Withdrawal by Subject|2|||
126771111|NCT02362646|456116262|FG000|Overall Study|received transplant|21|||
126377444|NCT02103062|454678491|FG000|Overall Study|Progressive Disease|17|||
126377445|NCT02103062|454678492|FG001|Overall Study|Progressive Disease|20|||
126771112|NCT02362646|456116263|FG001|Overall Study|received transplant|14|||
126377446|NCT02103062|454678491|FG000|Overall Study|Death|0|||
126771113|NCT00865306|456116264|FG000|Controlled Trial|Lost to Follow-up|1|||
126377447|NCT02103062|454678492|FG001|Overall Study|Death|1|||
126377448|NCT02030821|454678494|FG000|Overall Study|Physician Decision|2|||
126377449|NCT02030821|454678495|FG001|Overall Study|Physician Decision|2|||
126377450|NCT02030821|454678496|FG002|Overall Study|Physician Decision|5|||
126377451|NCT02030821|454678497|FG003|Overall Study|Physician Decision|2|||
126377452|NCT03192137|454678498|FG000|Overall Study|Adverse Event|10|||
126377453|NCT03192137|454678499|FG001|Overall Study|Adverse Event|11|||
126377454|NCT03192137|454678498|FG000|Overall Study|Physician Decision|1|||
126377455|NCT03192137|454678499|FG001|Overall Study|Physician Decision|0|||
126377456|NCT03192137|454678498|FG000|Overall Study|Lack of Efficacy|20|||
126377457|NCT03192137|454678499|FG001|Overall Study|Lack of Efficacy|37|||
126377458|NCT03192137|454678498|FG000|Overall Study|Withdrawal by Subject|3|||
126377459|NCT03192137|454678499|FG001|Overall Study|Withdrawal by Subject|3|||
126377460|NCT03192137|454678498|FG000|Overall Study|Protocol Violation|4|||
126377461|NCT03192137|454678499|FG001|Overall Study|Protocol Violation|3|||
126377462|NCT03192137|454678498|FG000|Overall Study|Surgery Cancelled|4|||
126377463|NCT03192137|454678499|FG001|Overall Study|Surgery Cancelled|1|||
126377464|NCT03192137|454678498|FG000|Overall Study|Other - Various Administrative Reasons|8|||
126377465|NCT03192137|454678499|FG001|Overall Study|Other - Various Administrative Reasons|3|||
126377466|NCT00657267|454678502|FG000|Overall Study|Progressive disease|45|||
126377467|NCT00657267|454678502|FG000|Overall Study|Adverse Event|9|||
126377468|NCT02737501|454678506|FG000|Randomized Phase|Died|41|||
126377469|NCT02737501|454678507|FG001|Randomized Phase|Died|29|||
126377470|NCT02737501|454678508|FG002|Randomized Phase|Died|0|||
126377471|NCT02737501|454678506|FG000|Randomized Phase|Withdrawal by Subject|16|||
126377472|NCT02737501|454678507|FG001|Randomized Phase|Withdrawal by Subject|6|||
126377473|NCT02737501|454678508|FG002|Randomized Phase|Withdrawal by Subject|0|||
126377474|NCT02737501|454678506|FG000|Randomized Phase|Lost to Follow-up|0|||
126377475|NCT02737501|454678507|FG001|Randomized Phase|Lost to Follow-up|1|||
126377476|NCT02737501|454678508|FG002|Randomized Phase|Lost to Follow-up|0|||
126377477|NCT02737501|454678506|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
126377478|NCT02737501|454678507|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
126377479|NCT02737501|454678508|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
126377480|NCT02737501|454678506|FG000|Randomized Phase|Reason not Specified|1|||
126377481|NCT02737501|454678507|FG001|Randomized Phase|Reason not Specified|1|||
126377482|NCT02737501|454678508|FG002|Randomized Phase|Reason not Specified|0|||
126377483|NCT02737501|454678506|FG000|Randomized Phase|Never Treated|1|||
126377484|NCT02737501|454678507|FG001|Randomized Phase|Never Treated|1|||
126377485|NCT02737501|454678508|FG002|Randomized Phase|Never Treated|0|||
126377486|NCT02737501|454678506|FG000|Crossover Phase|Died|0|||
126377487|NCT02737501|454678507|FG001|Crossover Phase|Died|0|||
126377488|NCT02737501|454678508|FG002|Crossover Phase|Died|22|||
126377489|NCT02737501|454678506|FG000|Crossover Phase|Withdrew Consent|0|||
126377490|NCT02737501|454678507|FG001|Crossover Phase|Withdrew Consent|0|||
126377491|NCT02737501|454678508|FG002|Crossover Phase|Withdrew Consent|9|||
126716864|NCT02064439|455914961|FG000|Overall Study|Efficacy outcome reached|18|||
126716865|NCT02064439|455914962|FG001|Overall Study|Efficacy outcome reached|16|||
126716866|NCT02064439|455914963|FG002|Overall Study|Efficacy outcome reached|57|||
126716867|NCT02064439|455914961|FG000|Overall Study|Safety outcome reached|12|||
126716868|NCT02064439|455914962|FG001|Overall Study|Safety outcome reached|20|||
126716869|NCT02064439|455914963|FG002|Overall Study|Safety outcome reached|10|||
126716870|NCT02064439|455914961|FG000|Overall Study|Other|2|||
126716871|NCT02064439|455914962|FG001|Overall Study|Other|2|||
126716872|NCT02064439|455914963|FG002|Overall Study|Other|7|||
126716873|NCT01120093|455914968|FG000|Treatment Period 1|Adverse Event|0|||
126716874|NCT01120093|455914969|FG001|Treatment Period 1|Adverse Event|0|||
126716875|NCT01120093|455914970|FG002|Treatment Period 1|Adverse Event|1|||
126716876|NCT01120093|455914971|FG003|Treatment Period 1|Adverse Event|0|||
126716877|NCT01120093|455914972|FG004|Treatment Period 1|Adverse Event|1|||
126716878|NCT01120093|455914968|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126377492|NCT02737501|454678506|FG000|Crossover Phase|Physician Decision|0|||
126377493|NCT02737501|454678507|FG001|Crossover Phase|Physician Decision|0|||
126377494|NCT02737501|454678508|FG002|Crossover Phase|Physician Decision|1|||
126377495|NCT02737501|454678506|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
126377496|NCT02737501|454678507|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
126377497|NCT02737501|454678508|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
126377498|NCT01261975|454678509|FG000|Overall Study|Surgical complication|1|||
126377499|NCT00716274|454678510|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
126377500|NCT00716274|454678511|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
126377501|NCT00716274|454678512|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
126377502|NCT00716274|454678513|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
126377503|NCT00716274|454678514|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
126377504|NCT00716274|454678515|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
126377505|NCT00716274|454678510|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
126377506|NCT00716274|454678511|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
126377507|NCT00716274|454678512|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
126716879|NCT01120093|455914969|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126377508|NCT00716274|454678513|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
126377509|NCT00716274|454678514|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
126377510|NCT00716274|454678515|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
126377511|NCT00716274|454678510|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
126377512|NCT00716274|454678511|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
126377513|NCT00716274|454678512|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
126377514|NCT00716274|454678513|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
126377515|NCT00716274|454678514|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
126377516|NCT00716274|454678515|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
126377517|NCT00716274|454678510|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
126377518|NCT00716274|454678511|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
126377519|NCT00716274|454678512|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
126377520|NCT00716274|454678513|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
126377521|NCT00716274|454678514|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
126377522|NCT00716274|454678515|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
126377523|NCT00716274|454678510|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
126377524|NCT00716274|454678511|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
126377525|NCT00716274|454678512|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
126377526|NCT00716274|454678513|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
126377527|NCT00716274|454678514|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
126377528|NCT00716274|454678515|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
126377529|NCT00716274|454678510|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
126377530|NCT00716274|454678511|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
126377531|NCT00716274|454678512|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
126377532|NCT00716274|454678513|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
126377533|NCT00716274|454678514|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
126377534|NCT00716274|454678515|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
126377535|NCT00716274|454678510|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
126377536|NCT00716274|454678511|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
126377537|NCT00716274|454678512|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
126377538|NCT00716274|454678513|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
126377539|NCT00716274|454678514|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
126377540|NCT00716274|454678515|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
126377541|NCT00716274|454678510|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
126377542|NCT00716274|454678511|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
126377543|NCT00716274|454678512|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
126377544|NCT00716274|454678513|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
126377545|NCT00716274|454678514|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
126377546|NCT00716274|454678515|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
126377547|NCT00716274|454678510|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
126377548|NCT00716274|454678511|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
126377549|NCT00716274|454678512|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
126377550|NCT00716274|454678513|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
126377551|NCT00716274|454678514|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
126377552|NCT00716274|454678515|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
126377553|NCT00716274|454678510|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
126377554|NCT00716274|454678511|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
126377555|NCT00716274|454678512|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
126467284|NCT01015131|455011807|FG000|Overall Study|Protocol Violation|1|||
126467285|NCT01015131|455011807|FG000|Overall Study|Withdrawal by Subject|2|||
126467286|NCT01015131|455011807|FG000|Overall Study|Other Protocol Specified Criteria|4|||
126467287|NCT05430022|455011808|FG000|Overall Study|Withdrawal by Subject|4|||
126467288|NCT05430022|455011809|FG001|Overall Study|Withdrawal by Subject|4|||
126467289|NCT02445391|455011820|FG000|Overall Study|No active protocol treatment|3|||
126467290|NCT02445391|455011821|FG001|Overall Study|No active protocol treatment|0|||
126467291|NCT02445391|455011822|FG002|Overall Study|No active protocol treatment|0|||
126467292|NCT02445391|455011820|FG000|Overall Study|Adverse Event|0|||
126467293|NCT02445391|455011821|FG001|Overall Study|Adverse Event|21|||
126467294|NCT02445391|455011822|FG002|Overall Study|Adverse Event|12|||
126771114|NCT00865306|456116265|FG001|Controlled Trial|Lost to Follow-up|1|||
126377556|NCT00716274|454678513|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
126467295|NCT02445391|455011820|FG000|Overall Study|Alternative therapy|0|||
126467296|NCT02445391|455011821|FG001|Overall Study|Alternative therapy|0|||
126467297|NCT02445391|455011822|FG002|Overall Study|Alternative therapy|1|||
126377557|NCT00716274|454678514|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
126771115|NCT00865306|456116264|FG000|Controlled Trial|Difficulty commuting|2|||
126377558|NCT00716274|454678515|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
126377559|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Death|2|||
126377560|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
126377561|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
126377562|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Physician Decision|1|||
126467298|NCT02445391|455011820|FG000|Overall Study|Disease progression|0|||
126467299|NCT02445391|455011821|FG001|Overall Study|Disease progression|7|||
126467300|NCT02445391|455011822|FG002|Overall Study|Disease progression|22|||
126467301|NCT02445391|455011820|FG000|Overall Study|Complicating disease|0|||
126467302|NCT02445391|455011821|FG001|Overall Study|Complicating disease|2|||
126467303|NCT02445391|455011822|FG002|Overall Study|Complicating disease|1|||
126771116|NCT00865306|456116265|FG001|Controlled Trial|Difficulty commuting|0|||
126771117|NCT00865306|456116264|FG000|Controlled Trial|Improved btw baseline and first session|1|||
126771118|NCT00865306|456116265|FG001|Controlled Trial|Improved btw baseline and first session|0|||
126771119|NCT00865306|456116264|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
126771120|NCT00865306|456116265|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
126771121|NCT00865306|456116264|FG000|Controlled Trial|Withdrawal by Subject|0|||
126771122|NCT00865306|456116265|FG001|Controlled Trial|Withdrawal by Subject|1|||
126771123|NCT02181842|456116268|FG000|Overall Study|Case Report Forms Uncollected|2|||
126771124|NCT01652872|456116269|FG000|Overall Study|Death|36|||
126771125|NCT01652872|456116270|FG001|Overall Study|Death|39|||
126771126|NCT01652872|456116269|FG000|Overall Study|Lost to Follow-up|28|||
126377563|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
126377564|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
126377565|NCT00786422|454678518|FG000|Rivaroxaban Treatment|Adverse Event|2|||
126377566|NCT00786422|454678518|FG000|Follow-up Period|Death|1|||
126377567|NCT00786422|454678518|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
126377568|NCT00543985|454678521|FG000|Overall Study|Withdrawal by Subject|4|||
126377569|NCT02015039|454678522|FG000|Overall Study|Not eligible|0|||
126377570|NCT02015039|454678523|FG001|Overall Study|Not eligible|1|||
126377571|NCT04570384|454678524|FG000|Overall Study|Adverse Event|2|||
126377572|NCT04570384|454678525|FG001|Overall Study|Adverse Event|1|||
126377573|NCT04570384|454678524|FG000|Overall Study|Death|2|||
126377574|NCT04570384|454678525|FG001|Overall Study|Death|5|||
126377575|NCT04570384|454678524|FG000|Overall Study|Lost to Follow-up|1|||
126377576|NCT04570384|454678525|FG001|Overall Study|Lost to Follow-up|0|||
126377577|NCT04570384|454678524|FG000|Overall Study|Other|1|||
126377578|NCT04570384|454678525|FG001|Overall Study|Other|0|||
126377579|NCT04570384|454678524|FG000|Overall Study|Protocol Violation|0|||
126377580|NCT04570384|454678525|FG001|Overall Study|Protocol Violation|1|||
126377581|NCT04570384|454678524|FG000|Overall Study|Sponsor Decision|1|||
126377582|NCT04570384|454678525|FG001|Overall Study|Sponsor Decision|0|||
126377583|NCT04570384|454678524|FG000|Overall Study|Withdrawal by Subject|4|||
126377584|NCT04570384|454678525|FG001|Overall Study|Withdrawal by Subject|2|||
126377585|NCT01673126|454678526|FG000|Overall Study|change of diagnosis|4|||
126377586|NCT01673126|454678527|FG001|Overall Study|change of diagnosis|3|||
126377587|NCT00237042|454678528|FG000|Treatment|Became ineligible post-randomization|0|||
126377588|NCT00237042|454678529|FG001|Treatment|Became ineligible post-randomization|1|||
126377589|NCT00237042|454678530|FG002|Treatment|Became ineligible post-randomization|16|||
126377590|NCT00237042|454678528|FG000|Treatment|Moved out of state|1|||
126377591|NCT00237042|454678529|FG001|Treatment|Moved out of state|1|||
126377592|NCT00237042|454678530|FG002|Treatment|Moved out of state|1|||
126716880|NCT01120093|455914970|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126716881|NCT01120093|455914971|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126716882|NCT01120093|455914972|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126716883|NCT01120093|455914968|FG000|Treatment Period 2|Adverse Event|0|||
126716884|NCT01120093|455914969|FG001|Treatment Period 2|Adverse Event|0|||
126716885|NCT01120093|455914970|FG002|Treatment Period 2|Adverse Event|0|||
126716886|NCT01120093|455914971|FG003|Treatment Period 2|Adverse Event|1|||
126716887|NCT01120093|455914972|FG004|Treatment Period 2|Adverse Event|0|||
126716888|NCT01120093|455914968|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126716889|NCT01120093|455914969|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126377593|NCT00237042|454678528|FG000|Treatment|Completed no treatment|5|||
126377594|NCT00237042|454678529|FG001|Treatment|Completed no treatment|5|||
126467304|NCT02445391|455011820|FG000|Overall Study|Withdrawal by Subject|0|||
126467305|NCT02445391|455011821|FG001|Overall Study|Withdrawal by Subject|4|||
126467306|NCT02445391|455011822|FG002|Overall Study|Withdrawal by Subject|9|||
126467307|NCT02445391|455011820|FG000|Overall Study|Financial issue|0|||
126467308|NCT02445391|455011821|FG001|Overall Study|Financial issue|0|||
126467309|NCT02445391|455011822|FG002|Overall Study|Financial issue|2|||
126467310|NCT02445391|455011820|FG000|Overall Study|Still on treatment|0|||
126716890|NCT01120093|455914970|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126716891|NCT01120093|455914971|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126771127|NCT01652872|456116270|FG001|Overall Study|Lost to Follow-up|23|||
126377595|NCT00237042|454678530|FG002|Treatment|Completed no treatment|21|||
126377596|NCT00237042|454678528|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
126716892|NCT01120093|455914972|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126716893|NCT01120093|455914968|FG000|Treatment Period 3|Lack of Efficacy|0|||
126771128|NCT01652872|456116269|FG000|Overall Study|Decision by sponsor|5|||
126377597|NCT00237042|454678529|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
126467311|NCT02445391|455011821|FG001|Overall Study|Still on treatment|7|||
126771129|NCT01652872|456116270|FG001|Overall Study|Decision by sponsor|7|||
126377598|NCT00237042|454678530|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
126377599|NCT00237042|454678528|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
126377600|NCT00237042|454678529|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
126377601|NCT00237042|454678530|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
126377602|NCT01897532|454678537|FG000|Discontinuation From Treatment|Not Treated|7|||
126377603|NCT01897532|454678538|FG001|Discontinuation From Treatment|Not Treated|5|||
126377604|NCT01897532|454678537|FG000|Discontinuation From Treatment|Other reason than specified|196|||
126377605|NCT01897532|454678538|FG001|Discontinuation From Treatment|Other reason than specified|176|||
126377606|NCT01897532|454678537|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
126377607|NCT01897532|454678538|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
126377608|NCT01897532|454678537|FG000|Discontinuation From Treatment|Non compliance|24|||
126377609|NCT01897532|454678538|FG001|Discontinuation From Treatment|Non compliance|15|||
126377610|NCT01897532|454678537|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
126377611|NCT01897532|454678538|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
126377612|NCT01897532|454678537|FG000|Discontinuation From Trial|Not Treated|7|||
126377613|NCT01897532|454678538|FG001|Discontinuation From Trial|Not Treated|5|||
126377614|NCT01897532|454678537|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
126377615|NCT01897532|454678538|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
126377616|NCT03132467|454678539|FG000|Overall Study|Adverse Event|2|||
126377617|NCT03132467|454678539|FG000|Overall Study|Withdrawal by Subject|2|||
126377618|NCT00038948|454678540|FG000|Overall Study|Adverse Event|131|||
126377619|NCT00038948|454678541|FG001|Overall Study|Adverse Event|43|||
126377620|NCT00038948|454678540|FG000|Overall Study|Lost to Follow-up|4|||
126377621|NCT00038948|454678541|FG001|Overall Study|Lost to Follow-up|4|||
126377622|NCT00038948|454678540|FG000|Overall Study|Nonmedical event|5|||
126377623|NCT00038948|454678541|FG001|Overall Study|Nonmedical event|7|||
126377624|NCT00038948|454678540|FG000|Overall Study|Withdrawal by Subject|23|||
126377625|NCT00038948|454678541|FG001|Overall Study|Withdrawal by Subject|10|||
126377626|NCT00038948|454678540|FG000|Overall Study|Protocol Violation|3|||
126377627|NCT00038948|454678541|FG001|Overall Study|Protocol Violation|7|||
126377628|NCT00038948|454678540|FG000|Overall Study|Lack of Efficacy|3|||
126377629|NCT00038948|454678541|FG001|Overall Study|Lack of Efficacy|6|||
126377630|NCT01404234|454678544|FG000|Overall Study|Withdrawal by Subject|2|||
126377631|NCT02670473|454678545|FG000|Overall Study|Withdrawal by Subject|1|||
126377632|NCT05223673|454678546|FG000|Overall Study|Protocol Violation|1|||
126377633|NCT05223673|454678546|FG000|Overall Study|Study termination|6|||
126377634|NCT04472650|454680258|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
126377635|NCT04472650|454680259|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
126377636|NCT00288015|454680264|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
126377637|NCT00288015|454680264|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
126377638|NCT00288015|454680264|FG000|First Response Assessment|Withdrawal by Subject|1|||
126377639|NCT00288015|454680264|FG000|First Response Assessment|Death|1|||
126377640|NCT00288015|454680264|FG000|First Response Assessment|Physician Decision|2|||
126377641|NCT00288015|454680264|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
126377642|NCT00288015|454680264|FG000|Follow up for Survival x 2 Years|Death|13|||
126377643|NCT00288015|454680264|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
126377644|NCT00288015|454680264|FG000|Follow up for Survival x 2 Years|Other|9|||
126377645|NCT01333722|454680265|FG000|Overall Study|Lack of Efficacy|0|||
126377646|NCT01333722|454680266|FG001|Overall Study|Lack of Efficacy|2|||
126467312|NCT02445391|455011822|FG002|Overall Study|Still on treatment|16|||
126467313|NCT02445391|455011820|FG000|Overall Study|Not start protocol therapy|0|||
126467314|NCT02445391|455011821|FG001|Overall Study|Not start protocol therapy|12|||
126716894|NCT01120093|455914969|FG001|Treatment Period 3|Lack of Efficacy|0|||
126716895|NCT01120093|455914970|FG002|Treatment Period 3|Lack of Efficacy|0|||
126716896|NCT01120093|455914971|FG003|Treatment Period 3|Lack of Efficacy|1|||
126716897|NCT01120093|455914972|FG004|Treatment Period 3|Lack of Efficacy|0|||
126716898|NCT01120093|455914968|FG000|Treatment Period 3|Adverse Event|0|||
126467315|NCT02445391|455011822|FG002|Overall Study|Not start protocol therapy|9|||
126467316|NCT05069259|455011826|FG000|Overall Study|Withdrawal by Subject|1|||
126467317|NCT05069259|455011826|FG000|Overall Study|Sponsor decision|1|||
126467318|NCT03148275|455011827|FG000|Overall Study|Death|6|||
126467319|NCT03148275|455011827|FG000|Overall Study|Adverse Event|3|||
126467320|NCT03148275|455011827|FG000|Overall Study|Liver transplant|2|||
126467321|NCT03148275|455011827|FG000|Overall Study|Patient decision|5|||
126716899|NCT01120093|455914969|FG001|Treatment Period 3|Adverse Event|0|||
126377647|NCT01333722|454680265|FG000|Overall Study|Withdrawal by Subject|0|||
126377648|NCT01333722|454680266|FG001|Overall Study|Withdrawal by Subject|1|||
126377649|NCT00488514|454680267|FG000|Overall Study|Adverse Event|41|||
126467322|NCT03148275|455011827|FG000|Overall Study|transition to commercial drug|1|||
126467323|NCT03148275|455011827|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
126467324|NCT00492050|455011828|FG000|Overall Study|Adverse Event|1|||
126377650|NCT00488514|454680267|FG000|Overall Study|Lost to Follow-up|44|||
126377651|NCT00488514|454680267|FG000|Overall Study|Protocol Violation|32|||
126377652|NCT00488514|454680267|FG000|Overall Study|Withdrawal by Subject|106|||
126553035|NCT02291289|455320512|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
126553036|NCT02291289|455320513|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
126553037|NCT02291289|455320501|FG000|Maintenance Treatment Phase|Death|0|||
126553038|NCT02291289|455320502|FG001|Maintenance Treatment Phase|Death|29|||
126716900|NCT01120093|455914970|FG002|Treatment Period 3|Adverse Event|0|||
126716901|NCT01120093|455914971|FG003|Treatment Period 3|Adverse Event|0|||
126716902|NCT01120093|455914972|FG004|Treatment Period 3|Adverse Event|1|||
126716903|NCT01120093|455914968|FG000|Treatment Period 3|Withdrawal by Subject|0|||
126716904|NCT01120093|455914969|FG001|Treatment Period 3|Withdrawal by Subject|0|||
126467325|NCT00492050|455011828|FG000|Overall Study|Lack of Efficacy|1|||
126467326|NCT00492050|455011828|FG000|Overall Study|Withdrawal by Subject|3|||
126467327|NCT00492050|455011828|FG000|Overall Study|Unable to collect SCT|2|||
126467328|NCT00492050|455011828|FG000|Overall Study|Progressive Disease|2|||
126467329|NCT01897714|455013305|FG000|Phase I (Dose Escalation)|Disease progression|3|||
126467330|NCT01897714|455013306|FG001|Phase I (Dose Escalation)|Disease progression|5|||
126467331|NCT01897714|455013307|FG002|Phase I (Dose Escalation)|Disease progression|1|||
126467332|NCT01897714|455013308|FG003|Phase I (Dose Escalation)|Disease progression|3|||
126467333|NCT01897714|455013309|FG004|Phase I (Dose Escalation)|Disease progression|0|||
126467334|NCT01897714|455013310|FG005|Phase I (Dose Escalation)|Disease progression|0|||
126467335|NCT01897714|455013305|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
126467336|NCT01897714|455013306|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
126467337|NCT01897714|455013307|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
126467338|NCT01897714|455013308|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
126467339|NCT01897714|455013309|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
126467340|NCT01897714|455013310|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
126467341|NCT01897714|455013305|FG000|Phase I (Dose Escalation)|Other|0|||
126467342|NCT01897714|455013306|FG001|Phase I (Dose Escalation)|Other|1|||
126467343|NCT01897714|455013307|FG002|Phase I (Dose Escalation)|Other|0|||
126467344|NCT01897714|455013308|FG003|Phase I (Dose Escalation)|Other|0|||
126467345|NCT01897714|455013309|FG004|Phase I (Dose Escalation)|Other|0|||
126467346|NCT01897714|455013310|FG005|Phase I (Dose Escalation)|Other|0|||
126467347|NCT01897714|455013305|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
126467348|NCT01897714|455013306|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
126467349|NCT01897714|455013307|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
126467350|NCT01897714|455013308|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
126467351|NCT01897714|455013309|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
126467352|NCT01897714|455013310|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
126467353|NCT01897714|455013305|FG000|Phase II (MTD)|Lost to Follow-up|0|||
126467354|NCT01897714|455013306|FG001|Phase II (MTD)|Lost to Follow-up|0|||
126467355|NCT01897714|455013307|FG002|Phase II (MTD)|Lost to Follow-up|0|||
126467356|NCT01897714|455013308|FG003|Phase II (MTD)|Lost to Follow-up|0|||
126467357|NCT01897714|455013309|FG004|Phase II (MTD)|Lost to Follow-up|1|||
126467358|NCT01897714|455013310|FG005|Phase II (MTD)|Lost to Follow-up|0|||
126467359|NCT01897714|455013305|FG000|Phase II (MTD)|Death|0|||
126467360|NCT01897714|455013306|FG001|Phase II (MTD)|Death|0|||
126467361|NCT01897714|455013307|FG002|Phase II (MTD)|Death|0|||
126467362|NCT01897714|455013308|FG003|Phase II (MTD)|Death|0|||
126467363|NCT01897714|455013309|FG004|Phase II (MTD)|Death|25|||
126467364|NCT01897714|455013310|FG005|Phase II (MTD)|Death|10|||
126553039|NCT02291289|455320503|FG002|Maintenance Treatment Phase|Death|16|||
126716905|NCT01120093|455914970|FG002|Treatment Period 3|Withdrawal by Subject|1|||
126716906|NCT01120093|455914971|FG003|Treatment Period 3|Withdrawal by Subject|0|||
126716907|NCT01120093|455914972|FG004|Treatment Period 3|Withdrawal by Subject|0|||
126377653|NCT00488514|454680267|FG000|Overall Study|Lack of Efficacy|28|||
126377654|NCT00488514|454680267|FG000|Overall Study|Did not meet criteria for treatment|30|||
126377655|NCT00488514|454680267|FG000|Overall Study|Postive drug screen|1|||
126377656|NCT00488514|454680267|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
126377657|NCT00488514|454680267|FG000|Overall Study|Investigator decision|1|||
126377658|NCT00488514|454680267|FG000|Overall Study|Participant had too few migraines|5|||
126377659|NCT00488514|454680267|FG000|Overall Study|Increase in number of migraines|2|||
126377660|NCT00488514|454680267|FG000|Overall Study|Increased use of concomitant medication|1|||
126377661|NCT01475721|454680270|FG000|Overall Study|Death|3|||
126377662|NCT01475721|454680271|FG001|Overall Study|Death|6|||
126377663|NCT01475721|454680270|FG000|Overall Study|Withdrawal by Subject|8|||
126377664|NCT01475721|454680271|FG001|Overall Study|Withdrawal by Subject|8|||
126377665|NCT00803738|454680272|FG000|Overall Study|Adverse Event|3|||
126377666|NCT00803738|454680273|FG001|Overall Study|Adverse Event|5|||
126377667|NCT00803738|454680272|FG000|Overall Study|Lost to Follow-up|4|||
126377668|NCT00803738|454680273|FG001|Overall Study|Lost to Follow-up|4|||
126377669|NCT00803738|454680272|FG000|Overall Study|Protocol Violation|18|||
126377670|NCT00803738|454680273|FG001|Overall Study|Protocol Violation|10|||
126377671|NCT00803738|454680272|FG000|Overall Study|Withdrawal by Subject|1|||
126467365|NCT01897714|455013305|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
126467366|NCT01897714|455013306|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
126467367|NCT01897714|455013307|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
126553040|NCT02291289|455320504|FG003|Maintenance Treatment Phase|Death|0|||
126377672|NCT00803738|454680273|FG001|Overall Study|Withdrawal by Subject|4|||
126377673|NCT00803738|454680272|FG000|Overall Study|Lack of Efficacy|10|||
126377674|NCT00803738|454680273|FG001|Overall Study|Lack of Efficacy|16|||
126377675|NCT00803738|454680272|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
126377676|NCT00803738|454680273|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
126377677|NCT00803738|454680272|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
126377678|NCT00803738|454680273|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
126377679|NCT00387088|454680276|FG000|Overall Study|Adverse Event|143|||
126377680|NCT00387088|454680277|FG001|Overall Study|Adverse Event|156|||
126377681|NCT00387088|454680276|FG000|Overall Study|Protocol Violation|47|||
126377682|NCT00387088|454680277|FG001|Overall Study|Protocol Violation|35|||
126377683|NCT00387088|454680276|FG000|Overall Study|Withdrawal by Subject|20|||
126377684|NCT00387088|454680277|FG001|Overall Study|Withdrawal by Subject|35|||
126377685|NCT00387088|454680276|FG000|Overall Study|Lack of Efficacy|28|||
126377686|NCT00387088|454680277|FG001|Overall Study|Lack of Efficacy|67|||
126377687|NCT00387088|454680276|FG000|Overall Study|Lost to Follow-up|22|||
126377688|NCT00387088|454680277|FG001|Overall Study|Lost to Follow-up|28|||
126377689|NCT00387088|454680276|FG000|Overall Study|Other|58|||
126377690|NCT00387088|454680277|FG001|Overall Study|Other|52|||
126377691|NCT02848092|454680280|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
126377692|NCT02848092|454680281|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
126377693|NCT02848092|454680280|FG000|1-month Post-training Follow-up|Adverse Event|2|||
126377694|NCT02848092|454680281|FG001|1-month Post-training Follow-up|Adverse Event|1|||
126377695|NCT02848092|454680280|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
126377696|NCT02848092|454680281|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
126377697|NCT02848092|454680280|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
126377698|NCT02848092|454680281|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
126377699|NCT02848092|454680280|FG000|1-month Post-training Follow-up|fatigue|0|||
126377700|NCT02848092|454680281|FG001|1-month Post-training Follow-up|fatigue|1|||
126377701|NCT02848092|454680280|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
126377702|NCT02848092|454680281|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
126377703|NCT02848092|454680280|FG000|6-month Post-training Follow-up|Adverse Event|1|||
126377704|NCT02848092|454680281|FG001|6-month Post-training Follow-up|Adverse Event|1|||
126467368|NCT01897714|455013308|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
126467369|NCT01897714|455013309|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
126467370|NCT01897714|455013310|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
126467371|NCT01897714|455013305|FG000|Phase II (MTD)|Other|0|||
126467372|NCT01897714|455013306|FG001|Phase II (MTD)|Other|0|||
126467373|NCT01897714|455013307|FG002|Phase II (MTD)|Other|0|||
126467374|NCT01897714|455013308|FG003|Phase II (MTD)|Other|0|||
126467375|NCT01897714|455013309|FG004|Phase II (MTD)|Other|3|||
126467376|NCT01897714|455013310|FG005|Phase II (MTD)|Other|0|||
126467377|NCT00423722|455013311|FG000|Overall Study|Death|4|||
126467378|NCT00423722|455013312|FG001|Overall Study|Death|4|||
126467379|NCT00423722|455013311|FG000|Overall Study|Declined to participate|2|||
126467380|NCT00423722|455013312|FG001|Overall Study|Declined to participate|3|||
126467381|NCT00423722|455013311|FG000|Overall Study|Unable to complete questionnaires|4|||
126467382|NCT00423722|455013312|FG001|Overall Study|Unable to complete questionnaires|4|||
126467383|NCT00423722|455013311|FG000|Overall Study|Withdrawal by Subject|4|||
126467384|NCT00423722|455013312|FG001|Overall Study|Withdrawal by Subject|2|||
126467385|NCT00518687|455013314|FG000|Overall Study|Adverse Event|201|||
126467386|NCT00518687|455013315|FG001|Overall Study|Adverse Event|177|||
126467387|NCT00518687|455013314|FG000|Overall Study|Lost to Follow-up|144|||
126467388|NCT00518687|455013315|FG001|Overall Study|Lost to Follow-up|155|||
126467389|NCT00518687|455013314|FG000|Overall Study|Physician Decision|42|||
126467390|NCT00518687|455013315|FG001|Overall Study|Physician Decision|48|||
126467391|NCT00518687|455013314|FG000|Overall Study|Progressive disease|2|||
126467392|NCT00518687|455013315|FG001|Overall Study|Progressive disease|2|||
126467393|NCT00518687|455013314|FG000|Overall Study|Protocol Violation|8|||
126467394|NCT00518687|455013315|FG001|Overall Study|Protocol Violation|10|||
126467395|NCT00518687|455013314|FG000|Overall Study|Study terminated by sponsor|930|||
126467396|NCT00518687|455013315|FG001|Overall Study|Study terminated by sponsor|918|||
126467397|NCT00518687|455013314|FG000|Overall Study|Withdrawal by Subject|110|||
126467398|NCT00518687|455013315|FG001|Overall Study|Withdrawal by Subject|110|||
126467399|NCT01846104|455013320|FG000|Overall Study|Withdrawal by Subject|1|||
126467400|NCT00851630|455013324|FG000|Overall Study|Death|2|||
126467401|NCT00851630|455013325|FG001|Overall Study|Death|1|||
126467402|NCT00851630|455013324|FG000|Overall Study|Clinical failure|0|||
126467403|NCT00851630|455013325|FG001|Overall Study|Clinical failure|1|||
126377705|NCT02848092|454680280|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
126467404|NCT02349061|455013327|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
126467405|NCT02349061|455013328|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
126467406|NCT02349061|455013329|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
126377706|NCT02848092|454680281|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
126467407|NCT02349061|455013327|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
126467408|NCT02349061|455013328|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
126377707|NCT02848092|454680280|FG000|6-month Post-training Follow-up|frustrated with task|1|||
126377708|NCT02848092|454680281|FG001|6-month Post-training Follow-up|frustrated with task|0|||
126377709|NCT02848092|454680280|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
126377710|NCT02848092|454680281|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
126377711|NCT02848092|454680280|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
126377712|NCT02848092|454680281|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
126377713|NCT02329743|454680285|FG000|Overall Study|Adverse Event|1|||
126377714|NCT02329743|454680286|FG001|Overall Study|Adverse Event|1|||
126377715|NCT02329743|454680287|FG002|Overall Study|Adverse Event|3|||
126377716|NCT02329743|454680285|FG000|Overall Study|Lost to Follow-up|1|||
126377717|NCT02329743|454680286|FG001|Overall Study|Lost to Follow-up|0|||
126377718|NCT02329743|454680287|FG002|Overall Study|Lost to Follow-up|1|||
126377719|NCT02329743|454680285|FG000|Overall Study|Withdrawal by Subject|4|||
126377720|NCT02329743|454680286|FG001|Overall Study|Withdrawal by Subject|4|||
126377721|NCT02329743|454680287|FG002|Overall Study|Withdrawal by Subject|1|||
126377722|NCT02329743|454680285|FG000|Overall Study|Other|0|||
126377723|NCT02329743|454680286|FG001|Overall Study|Other|2|||
126377724|NCT02329743|454680287|FG002|Overall Study|Other|3|||
126377725|NCT01428219|454680299|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
126377726|NCT00592631|454680302|FG000|Overall Study|Lost to Follow-up|0|||
126377727|NCT00592631|454680303|FG001|Overall Study|Lost to Follow-up|2|||
126377728|NCT03745768|454680305|FG000|Overall Study|discontinued study|2|||
126377729|NCT03745768|454680306|FG001|Overall Study|discontinued study|0|||
126377730|NCT00443118|454680307|FG000|Overall Study|unknown primary outcome|3|||
126377731|NCT00443118|454680308|FG001|Overall Study|unknown primary outcome|1|||
126377732|NCT00443118|454680309|FG002|Overall Study|unknown primary outcome|0|||
126377733|NCT00443118|454680307|FG000|Overall Study|Withdrawal by Subject|1|||
126377734|NCT00443118|454680308|FG001|Overall Study|Withdrawal by Subject|0|||
126377735|NCT00443118|454680309|FG002|Overall Study|Withdrawal by Subject|0|||
126377736|NCT01023217|454680313|FG000|Overall Study|Withdrawal by Subject|1|||
126377737|NCT01023217|454680314|FG001|Overall Study|Withdrawal by Subject|0|||
126377738|NCT01106157|454680315|FG000|Overall Study|Withdrawal by Subject|1|||
126377739|NCT01106157|454680316|FG001|Overall Study|Withdrawal by Subject|0|||
126377740|NCT01673646|454680320|FG000|Overall Study|Adverse Event|2|||
126377741|NCT01673646|454680321|FG001|Overall Study|Adverse Event|1|||
126467409|NCT02349061|455013329|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
126467410|NCT02349061|455013327|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
126467411|NCT02349061|455013328|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
126467412|NCT02349061|455013329|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
126467413|NCT02349061|455013327|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
126467414|NCT02349061|455013328|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
126467415|NCT02349061|455013329|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
126467416|NCT02349061|455013327|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
126467417|NCT02349061|455013328|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
126467418|NCT02349061|455013329|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
126467419|NCT02349061|455013327|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
126467420|NCT02349061|455013328|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
126467421|NCT02349061|455013329|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
126467422|NCT02349061|455013327|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
126467423|NCT02349061|455013328|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
126467424|NCT02349061|455013329|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
126467425|NCT02349061|455013327|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
126467426|NCT02349061|455013328|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
126467427|NCT02349061|455013329|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
126467428|NCT02349061|455013327|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
126467429|NCT02349061|455013328|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
126467430|NCT02349061|455013329|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
126467431|NCT02349061|455013327|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
126467432|NCT02349061|455013328|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
126467433|NCT02349061|455013329|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
126467434|NCT02349061|455013327|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
126467435|NCT02349061|455013328|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
126377742|NCT01673646|454680322|FG002|Overall Study|Adverse Event|1|||
126377743|NCT01673646|454680320|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126377744|NCT01673646|454680321|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126377745|NCT01673646|454680322|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126377746|NCT01673646|454680320|FG000|Overall Study|Condition no longer requires study drug|0|||
126377747|NCT01673646|454680321|FG001|Overall Study|Condition no longer requires study drug|1|||
126377748|NCT01673646|454680322|FG002|Overall Study|Condition no longer requires study drug|0|||
126467436|NCT02349061|455013329|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
126467437|NCT02349061|455013327|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
126467438|NCT02349061|455013328|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
126377749|NCT01673646|454680320|FG000|Overall Study|Withdrawal by Subject|0|||
126377750|NCT01673646|454680321|FG001|Overall Study|Withdrawal by Subject|2|||
126377751|NCT01673646|454680322|FG002|Overall Study|Withdrawal by Subject|2|||
126377752|NCT01673646|454680320|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
126377753|NCT01673646|454680321|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
126377754|NCT01673646|454680322|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
126377755|NCT02651116|454680323|FG000|Overall Study|Adverse Event|0|||
126377756|NCT02651116|454680324|FG001|Overall Study|Adverse Event|1|||
126377757|NCT02651116|454680323|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
126377758|NCT02651116|454680324|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
126377759|NCT02457247|454680325|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
126377760|NCT02457247|454680326|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
126377761|NCT02457247|454680327|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
126377762|NCT02457247|454680328|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
126377763|NCT02457247|454680325|FG000|Period 1|Significant Protocol Deviation|1|||
126377764|NCT02457247|454680326|FG001|Period 1|Significant Protocol Deviation|1|||
126377765|NCT02457247|454680327|FG002|Period 1|Significant Protocol Deviation|0|||
126377766|NCT02457247|454680328|FG003|Period 1|Significant Protocol Deviation|0|||
126377767|NCT02457247|454680325|FG000|Period 1|Voluntary Withdrawal|1|||
126377768|NCT02457247|454680326|FG001|Period 1|Voluntary Withdrawal|0|||
126377769|NCT02457247|454680327|FG002|Period 1|Voluntary Withdrawal|0|||
126377770|NCT02457247|454680328|FG003|Period 1|Voluntary Withdrawal|0|||
126377771|NCT02457247|454680325|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
126377772|NCT02457247|454680326|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
126377773|NCT02457247|454680327|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
126377774|NCT02457247|454680328|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
126377775|NCT02457247|454680325|FG000|Period 2|Significant Protocol Deviation|1|||
126377776|NCT02457247|454680326|FG001|Period 2|Significant Protocol Deviation|0|||
126377777|NCT02457247|454680327|FG002|Period 2|Significant Protocol Deviation|0|||
126377778|NCT02457247|454680328|FG003|Period 2|Significant Protocol Deviation|0|||
126377779|NCT02457247|454680325|FG000|Period 2|Lost to Follow-up|0|||
126377780|NCT02457247|454680326|FG001|Period 2|Lost to Follow-up|1|||
126377781|NCT02457247|454680327|FG002|Period 2|Lost to Follow-up|0|||
126377782|NCT02457247|454680328|FG003|Period 2|Lost to Follow-up|0|||
126377783|NCT02457247|454680325|FG000|Period 2|Voluntary Withdrawal|1|||
126377784|NCT02457247|454680326|FG001|Period 2|Voluntary Withdrawal|1|||
126377785|NCT02457247|454680327|FG002|Period 2|Voluntary Withdrawal|0|||
126377786|NCT02457247|454680328|FG003|Period 2|Voluntary Withdrawal|0|||
126377787|NCT01492088|454680329|FG000|Overall Study|Withdrawal by Patient|0|||
126377788|NCT01492088|454680330|FG001|Overall Study|Withdrawal by Patient|2|||
126377789|NCT01492088|454680331|FG002|Overall Study|Withdrawal by Patient|0|||
126377790|NCT01492088|454680329|FG000|Overall Study|Death|1|||
126377791|NCT01492088|454680330|FG001|Overall Study|Death|6|||
126377792|NCT01492088|454680331|FG002|Overall Study|Death|2|||
126377793|NCT01492088|454680329|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
126377794|NCT01492088|454680330|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
126377795|NCT01492088|454680331|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
126377796|NCT01492088|454680329|FG000|Overall Study|Alive at Last Follow-up|0|||
126377797|NCT01492088|454680330|FG001|Overall Study|Alive at Last Follow-up|6|||
126377798|NCT01492088|454680331|FG002|Overall Study|Alive at Last Follow-up|11|||
126377799|NCT03824392|454680332|FG000|Overall Study|Adverse Event|1|||
126377800|NCT03824392|454680333|FG001|Overall Study|Adverse Event|0|||
126467439|NCT02349061|455013329|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
126467440|NCT02349061|455013327|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
126467441|NCT02349061|455013328|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
126467442|NCT02349061|455013329|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
126467443|NCT00398411|455013330|FG000|Overall Study|Death|0|||
126467444|NCT00398411|455013331|FG001|Overall Study|Death|1|||
126467445|NCT02095223|455013332|FG000|Overall Study|Withdrawal by Subject|1|||
126377801|NCT03824392|454680334|FG002|Overall Study|Adverse Event|0|||
126467446|NCT02095223|455013333|FG001|Overall Study|Withdrawal by Subject|0|||
126467447|NCT01397162|455013334|FG000|Overall Study|Adverse Event|4|||
126467448|NCT01397162|455013335|FG001|Overall Study|Adverse Event|0|||
126467449|NCT01397162|455013336|FG002|Overall Study|Adverse Event|0|||
126467450|NCT01397162|455013337|FG003|Overall Study|Adverse Event|0|||
126771130|NCT01652872|456116269|FG000|Overall Study|Withdrawal by Subject|76|||
126377802|NCT03824392|454680335|FG003|Overall Study|Adverse Event|0|||
126377803|NCT03824392|454680332|FG000|Overall Study|Investigator Decision|0|||
126377804|NCT03824392|454680333|FG001|Overall Study|Investigator Decision|1|||
126377805|NCT03824392|454680334|FG002|Overall Study|Investigator Decision|0|||
126377806|NCT03824392|454680335|FG003|Overall Study|Investigator Decision|0|||
126377807|NCT03824392|454680332|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
126377808|NCT03824392|454680333|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
126467451|NCT01397162|455013338|FG004|Overall Study|Adverse Event|0|||
126467452|NCT01397162|455013334|FG000|Overall Study|Not yet defined|3|||
126377809|NCT03824392|454680334|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
126377810|NCT03824392|454680335|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
126377811|NCT00127855|454680336|FG000|Primary Vaccination Course|Adverse Event|0|||
126377812|NCT00127855|454680337|FG001|Primary Vaccination Course|Adverse Event|0|||
126377813|NCT00127855|454680338|FG002|Primary Vaccination Course|Adverse Event|1|||
126377814|NCT00127855|454680339|FG003|Primary Vaccination Course|Adverse Event|0|||
126377815|NCT00127855|454680340|FG004|Primary Vaccination Course|Adverse Event|0|||
126377816|NCT00127855|454680336|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
126377817|NCT00127855|454680337|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
126377818|NCT00127855|454680338|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
126377819|NCT00127855|454680339|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
126377820|NCT00127855|454680340|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
126377821|NCT00127855|454680336|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
126377822|NCT00127855|454680337|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
126377823|NCT00127855|454680338|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
126377824|NCT00127855|454680339|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
126377825|NCT00127855|454680340|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
126377826|NCT00127855|454680336|FG000|Primary Vaccination Course|Other|0|||
126377827|NCT00127855|454680337|FG001|Primary Vaccination Course|Other|0|||
126377828|NCT00127855|454680338|FG002|Primary Vaccination Course|Other|0|||
126377829|NCT00127855|454680339|FG003|Primary Vaccination Course|Other|0|||
126377830|NCT00127855|454680340|FG004|Primary Vaccination Course|Other|1|||
126377831|NCT02343302|454680341|FG000|Overall Study|Physician Decision|1|||
126377832|NCT02343302|454680342|FG001|Overall Study|Physician Decision|1|||
126377833|NCT01887717|454680343|FG000|Overall Study|Withdrawal by Subject|1|||
126377834|NCT01887717|454680344|FG001|Overall Study|Withdrawal by Subject|7|||
126377835|NCT01887717|454680343|FG000|Overall Study|Physician Decision|0|||
126377836|NCT01887717|454680344|FG001|Overall Study|Physician Decision|2|||
126377837|NCT01887717|454680343|FG000|Overall Study|Administrative reasons|5|||
126377838|NCT01887717|454680344|FG001|Overall Study|Administrative reasons|2|||
126377839|NCT02655887|454680345|FG000|Overall Study|Lost to Follow-up|3|||
126377840|NCT02655887|454680345|FG000|Overall Study|Death|4|||
126377841|NCT02655887|454680345|FG000|Overall Study|Withdrawal by Subject|3|||
126377842|NCT02655887|454680345|FG000|Overall Study|Missed 12-month follow-up visit|4|||
126377843|NCT03637491|454680346|FG000|Overall Study|Death|9|||
126377844|NCT03637491|454680347|FG001|Overall Study|Death|9|||
126377845|NCT03637491|454680348|FG002|Overall Study|Death|5|||
126377846|NCT03637491|454680349|FG003|Overall Study|Death|3|||
126377847|NCT03637491|454680346|FG000|Overall Study|Lost to Follow-up|0|||
126377848|NCT03637491|454680347|FG001|Overall Study|Lost to Follow-up|1|||
126377849|NCT03637491|454680348|FG002|Overall Study|Lost to Follow-up|0|||
126377850|NCT03637491|454680349|FG003|Overall Study|Lost to Follow-up|1|||
126377851|NCT03637491|454680346|FG000|Overall Study|Study Terminated By Sponsor|0|||
126377852|NCT03637491|454680347|FG001|Overall Study|Study Terminated By Sponsor|2|||
126377853|NCT03637491|454680348|FG002|Overall Study|Study Terminated By Sponsor|1|||
126377854|NCT03637491|454680349|FG003|Overall Study|Study Terminated By Sponsor|0|||
126377855|NCT03637491|454680346|FG000|Overall Study|Withdrawal by Subject|1|||
126377856|NCT03637491|454680347|FG001|Overall Study|Withdrawal by Subject|0|||
126377857|NCT03637491|454680348|FG002|Overall Study|Withdrawal by Subject|1|||
126377858|NCT03637491|454680349|FG003|Overall Study|Withdrawal by Subject|2|||
126377859|NCT00532844|454680351|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
126377860|NCT00532844|454680352|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
126377861|NCT00532844|454680351|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
126377862|NCT00532844|454680352|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
126377863|NCT00532844|454680351|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
126377864|NCT00532844|454680352|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
126377865|NCT00532844|454680351|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
126377866|NCT00532844|454680352|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
126377867|NCT00532844|454680351|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
126377868|NCT00532844|454680352|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
126377869|NCT04389866|454680354|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
126377870|NCT04389866|454680355|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
126467453|NCT01397162|455013335|FG001|Overall Study|Not yet defined|4|||
126467454|NCT01397162|455013336|FG002|Overall Study|Not yet defined|3|||
126467455|NCT01397162|455013337|FG003|Overall Study|Not yet defined|5|||
126377871|NCT03465722|454680359|FG000|Overall Study|Withdrawal by Subject|21|||
126377872|NCT03465722|454680360|FG001|Overall Study|Withdrawal by Subject|14|||
126377873|NCT03465722|454680359|FG000|Overall Study|Death|89|||
126377874|NCT03465722|454680360|FG001|Overall Study|Death|87|||
126377875|NCT03465722|454680359|FG000|Overall Study|Lost to Follow-up|5|||
126377876|NCT03465722|454680360|FG001|Overall Study|Lost to Follow-up|3|||
126467456|NCT01397162|455013338|FG004|Overall Study|Not yet defined|3|||
126467457|NCT02339285|455013339|FG000|Overall Study|Withdrawal by Subject|0|||
126467458|NCT02339285|455013340|FG001|Overall Study|Withdrawal by Subject|1|||
126553041|NCT02291289|455320505|FG004|Maintenance Treatment Phase|Death|188|||
126553042|NCT02291289|455320506|FG005|Maintenance Treatment Phase|Death|107|||
126553043|NCT02291289|455320507|FG006|Maintenance Treatment Phase|Death|0|||
126553044|NCT02291289|455320508|FG007|Maintenance Treatment Phase|Death|1|||
126553045|NCT02291289|455320509|FG008|Maintenance Treatment Phase|Death|1|||
126553046|NCT02291289|455320510|FG009|Maintenance Treatment Phase|Death|0|||
126553047|NCT02291289|455320511|FG010|Maintenance Treatment Phase|Death|46|||
126553048|NCT02291289|455320512|FG011|Maintenance Treatment Phase|Death|19|||
126553049|NCT02291289|455320513|FG012|Maintenance Treatment Phase|Death|0|||
126553050|NCT02291289|455320501|FG000|Maintenance Treatment Phase|Adverse Event|0|||
126553051|NCT02291289|455320502|FG001|Maintenance Treatment Phase|Adverse Event|0|||
126553052|NCT02291289|455320503|FG002|Maintenance Treatment Phase|Adverse Event|0|||
126553053|NCT02291289|455320504|FG003|Maintenance Treatment Phase|Adverse Event|0|||
126553054|NCT02291289|455320505|FG004|Maintenance Treatment Phase|Adverse Event|1|||
126553055|NCT02291289|455320506|FG005|Maintenance Treatment Phase|Adverse Event|1|||
126553056|NCT02291289|455320507|FG006|Maintenance Treatment Phase|Adverse Event|0|||
126553057|NCT02291289|455320508|FG007|Maintenance Treatment Phase|Adverse Event|0|||
126553058|NCT02291289|455320509|FG008|Maintenance Treatment Phase|Adverse Event|0|||
126553059|NCT02291289|455320510|FG009|Maintenance Treatment Phase|Adverse Event|0|||
126553060|NCT02291289|455320511|FG010|Maintenance Treatment Phase|Adverse Event|0|||
126553061|NCT02291289|455320512|FG011|Maintenance Treatment Phase|Adverse Event|0|||
126553062|NCT02291289|455320513|FG012|Maintenance Treatment Phase|Adverse Event|0|||
126553063|NCT02291289|455320501|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
126553064|NCT02291289|455320502|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
126553065|NCT02291289|455320503|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
126553066|NCT02291289|455320504|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
126553067|NCT02291289|455320505|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
126553068|NCT02291289|455320506|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
126553069|NCT02291289|455320507|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
126553070|NCT02291289|455320508|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
126553071|NCT02291289|455320509|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
126553072|NCT02291289|455320510|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
126553073|NCT02291289|455320511|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
126553074|NCT02291289|455320512|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
126553075|NCT02291289|455320513|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
126553076|NCT02291289|455320501|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
126553077|NCT02291289|455320502|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
126553078|NCT02291289|455320503|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
126553079|NCT02291289|455320504|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
126553080|NCT02291289|455320505|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
126553081|NCT02291289|455320506|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
126553082|NCT02291289|455320507|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
126553083|NCT02291289|455320508|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
126553084|NCT02291289|455320509|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
126553085|NCT02291289|455320510|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
126553086|NCT02291289|455320511|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
126553087|NCT02291289|455320512|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
126553088|NCT02291289|455320513|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
126553089|NCT02291289|455320501|FG000|Maintenance Treatment Phase|Physician Decision|0|||
126553090|NCT02291289|455320502|FG001|Maintenance Treatment Phase|Physician Decision|2|||
126553091|NCT02291289|455320503|FG002|Maintenance Treatment Phase|Physician Decision|0|||
126553092|NCT02291289|455320504|FG003|Maintenance Treatment Phase|Physician Decision|0|||
126553093|NCT02291289|455320505|FG004|Maintenance Treatment Phase|Physician Decision|3|||
126553094|NCT02291289|455320506|FG005|Maintenance Treatment Phase|Physician Decision|0|||
126553095|NCT02291289|455320507|FG006|Maintenance Treatment Phase|Physician Decision|0|||
126553096|NCT02291289|455320508|FG007|Maintenance Treatment Phase|Physician Decision|0|||
126553097|NCT02291289|455320509|FG008|Maintenance Treatment Phase|Physician Decision|0|||
126553098|NCT02291289|455320510|FG009|Maintenance Treatment Phase|Physician Decision|0|||
126553099|NCT02291289|455320511|FG010|Maintenance Treatment Phase|Physician Decision|1|||
126553100|NCT02291289|455320512|FG011|Maintenance Treatment Phase|Physician Decision|3|||
126553101|NCT02291289|455320513|FG012|Maintenance Treatment Phase|Physician Decision|0|||
126553102|NCT02291289|455320501|FG000|Maintenance Treatment Phase|Not Treated|0|||
126553103|NCT02291289|455320502|FG001|Maintenance Treatment Phase|Not Treated|0|||
126553104|NCT02291289|455320503|FG002|Maintenance Treatment Phase|Not Treated|2|||
126553105|NCT02291289|455320504|FG003|Maintenance Treatment Phase|Not Treated|0|||
126553106|NCT02291289|455320505|FG004|Maintenance Treatment Phase|Not Treated|0|||
126553107|NCT02291289|455320506|FG005|Maintenance Treatment Phase|Not Treated|0|||
126553108|NCT02291289|455320507|FG006|Maintenance Treatment Phase|Not Treated|0|||
126553109|NCT02291289|455320508|FG007|Maintenance Treatment Phase|Not Treated|0|||
126553110|NCT02291289|455320509|FG008|Maintenance Treatment Phase|Not Treated|0|||
126553111|NCT02291289|455320510|FG009|Maintenance Treatment Phase|Not Treated|0|||
126553112|NCT02291289|455320511|FG010|Maintenance Treatment Phase|Not Treated|0|||
126553113|NCT02291289|455320512|FG011|Maintenance Treatment Phase|Not Treated|0|||
126716908|NCT01120093|455914968|FG000|Treatment Period 4|Adverse Event|1|||
126716909|NCT01120093|455914969|FG001|Treatment Period 4|Adverse Event|0|||
126716910|NCT01120093|455914970|FG002|Treatment Period 4|Adverse Event|0|||
126716911|NCT01120093|455914971|FG003|Treatment Period 4|Adverse Event|0|||
126716912|NCT01120093|455914972|FG004|Treatment Period 4|Adverse Event|0|||
126716913|NCT01120093|455914968|FG000|Treatment Period 5|Adverse Event|0|||
126716914|NCT01120093|455914969|FG001|Treatment Period 5|Adverse Event|1|||
126377877|NCT03465722|454680359|FG000|Overall Study|Administrative/Other|33|||
126377878|NCT03465722|454680360|FG001|Overall Study|Administrative/Other|32|||
126377879|NCT03465722|454680359|FG000|Overall Study|Not treated|1|||
126377880|NCT03465722|454680360|FG001|Overall Study|Not treated|2|||
126377881|NCT03465722|454680359|FG000|Overall Study|Sponsor decision|91|||
126377882|NCT03465722|454680360|FG001|Overall Study|Sponsor decision|98|||
126377883|NCT01490918|454680361|FG000|Overall Study|Lost to Follow-up|2|||
126377884|NCT01490918|454680362|FG001|Overall Study|Lost to Follow-up|1|||
126377885|NCT01490918|454680363|FG002|Overall Study|Lost to Follow-up|0|||
126377886|NCT01490918|454680361|FG000|Overall Study|Withdrawal by Subject|7|||
126377887|NCT01490918|454680362|FG001|Overall Study|Withdrawal by Subject|8|||
126377888|NCT01490918|454680363|FG002|Overall Study|Withdrawal by Subject|3|||
126377889|NCT01490918|454680361|FG000|Overall Study|Adverse Event|0|||
126377890|NCT01490918|454680362|FG001|Overall Study|Adverse Event|0|||
126377891|NCT01490918|454680363|FG002|Overall Study|Adverse Event|1|||
126377892|NCT01490918|454680361|FG000|Overall Study|other cause|4|||
126377893|NCT01490918|454680362|FG001|Overall Study|other cause|5|||
126377894|NCT01490918|454680363|FG002|Overall Study|other cause|8|||
126377895|NCT04940130|454680369|FG000|Overall Study|Travel|1|||
126377896|NCT04940130|454680370|FG001|Overall Study|Travel|0|||
126377897|NCT04940130|454680371|FG002|Overall Study|Travel|2|||
126377898|NCT04940130|454680369|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
126377899|NCT04940130|454680370|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
126377900|NCT04940130|454680371|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
126377901|NCT04940130|454680369|FG000|Overall Study|Adverse Event|0|||
126377902|NCT04940130|454680370|FG001|Overall Study|Adverse Event|0|||
126377903|NCT04940130|454680371|FG002|Overall Study|Adverse Event|2|||
126377904|NCT04940130|454680369|FG000|Overall Study|Disease progression/treatment failure|0|||
126377905|NCT04940130|454680370|FG001|Overall Study|Disease progression/treatment failure|0|||
126377906|NCT04940130|454680371|FG002|Overall Study|Disease progression/treatment failure|1|||
126377907|NCT04940130|454680369|FG000|Overall Study|Participant refusal|0|||
126377908|NCT04940130|454680370|FG001|Overall Study|Participant refusal|0|||
126377909|NCT04940130|454680371|FG002|Overall Study|Participant refusal|1|||
126377910|NCT02240121|454680374|FG000|Overall Study|Protocol Violation|1|||
126377911|NCT02240121|454680375|FG001|Overall Study|Protocol Violation|2|||
126377912|NCT02240121|454680374|FG000|Overall Study|Physician Decision|0|||
126377913|NCT02240121|454680375|FG001|Overall Study|Physician Decision|1|||
126377914|NCT02240121|454680374|FG000|Overall Study|Change in protocol interpretation|1|||
126377915|NCT02240121|454680375|FG001|Overall Study|Change in protocol interpretation|0|||
126377916|NCT02240121|454680374|FG000|Overall Study|Lack of Efficacy|2|||
126377917|NCT02240121|454680375|FG001|Overall Study|Lack of Efficacy|3|||
126377918|NCT02240121|454680374|FG000|Overall Study|Site closed|1|||
126377919|NCT02240121|454680375|FG001|Overall Study|Site closed|1|||
126377920|NCT02240121|454680374|FG000|Overall Study|Pregnancy|1|||
126377921|NCT02240121|454680375|FG001|Overall Study|Pregnancy|0|||
126377922|NCT02240121|454680374|FG000|Overall Study|Adverse Event|2|||
126377923|NCT02240121|454680375|FG001|Overall Study|Adverse Event|4|||
126377924|NCT02240121|454680374|FG000|Overall Study|Withdrawal by Subject|6|||
126377925|NCT02240121|454680375|FG001|Overall Study|Withdrawal by Subject|2|||
126377926|NCT02240121|454680374|FG000|Overall Study|Lost to Follow-up|3|||
126377927|NCT02240121|454680375|FG001|Overall Study|Lost to Follow-up|4|||
126377928|NCT02240121|454680374|FG000|Overall Study|Other than specified|1|||
126377929|NCT02240121|454680375|FG001|Overall Study|Other than specified|3|||
126377930|NCT01925768|454680378|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
126377931|NCT01925768|454680379|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126377932|NCT01925768|454680378|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
126377933|NCT01925768|454680379|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
126377934|NCT01925768|454680378|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
126716915|NCT01120093|455914970|FG002|Treatment Period 5|Adverse Event|0|||
126716916|NCT01120093|455914971|FG003|Treatment Period 5|Adverse Event|1|||
126377935|NCT01925768|454680379|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
126377936|NCT01925768|454680378|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
126377937|NCT01925768|454680379|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
126377938|NCT01925768|454680378|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
126377939|NCT01925768|454680379|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
126377940|NCT01925768|454680378|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
126377941|NCT01925768|454680379|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
126377942|NCT01925768|454680378|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
126377943|NCT01925768|454680379|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
126467459|NCT02339285|455013341|FG002|Overall Study|Withdrawal by Subject|1|||
126467460|NCT02339285|455013339|FG000|Overall Study|Lost to Follow-up|1|||
126467461|NCT02339285|455013340|FG001|Overall Study|Lost to Follow-up|1|||
126467462|NCT02339285|455013341|FG002|Overall Study|Lost to Follow-up|1|||
126467463|NCT02339285|455013339|FG000|Overall Study|Protocol Deviation|0|||
126467464|NCT02339285|455013340|FG001|Overall Study|Protocol Deviation|1|||
126467465|NCT02339285|455013341|FG002|Overall Study|Protocol Deviation|0|||
126467466|NCT00282412|455013344|FG000|Overall Study|Death|2|||
126467467|NCT01507298|455013345|FG000|Overall Study|Protocol Violation|0|||
126467468|NCT01507298|455013346|FG001|Overall Study|Protocol Violation|6|||
126467469|NCT00537238|455013347|FG000|Overall Study|Death|1|||
126467470|NCT00537238|455013348|FG001|Overall Study|Death|2|||
126467471|NCT00537238|455013347|FG000|Overall Study|Adverse Event|31|||
126467472|NCT00537238|455013348|FG001|Overall Study|Adverse Event|22|||
126467473|NCT00537238|455013347|FG000|Overall Study|Lack of Efficacy|20|||
126467474|NCT00537238|455013348|FG001|Overall Study|Lack of Efficacy|21|||
126467475|NCT00537238|455013347|FG000|Overall Study|Lost to Follow-up|12|||
126467476|NCT00537238|455013348|FG001|Overall Study|Lost to Follow-up|8|||
126467477|NCT00537238|455013347|FG000|Overall Study|Withdrawal by Subject|51|||
126467478|NCT00537238|455013348|FG001|Overall Study|Withdrawal by Subject|47|||
126467479|NCT00537238|455013347|FG000|Overall Study|Protocol Violation|15|||
126467480|NCT00537238|455013348|FG001|Overall Study|Protocol Violation|19|||
126716917|NCT01120093|455914972|FG004|Treatment Period 5|Adverse Event|0|||
126716918|NCT03649321|455914975|FG000|Overall Study|Withdrawal by Subject|1|||
126716919|NCT03649321|455914976|FG001|Overall Study|Withdrawal by Subject|0|||
126716920|NCT03649321|455914975|FG000|Overall Study|Death|1|||
126716921|NCT03649321|455914976|FG001|Overall Study|Death|0|||
126716922|NCT01702363|455914977|FG000|Overall Study|Adverse Event|14|||
126377944|NCT01925768|454680378|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
126377945|NCT01925768|454680379|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
126377946|NCT01925768|454680378|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
126377947|NCT01925768|454680379|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
126377948|NCT01925768|454680378|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
126377949|NCT01925768|454680379|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
126377950|NCT01925768|454680378|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
126377951|NCT01925768|454680379|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
126377952|NCT02779777|454680382|FG000|Overall Study|Disease Progression|1|||
126377953|NCT02779777|454680383|FG001|Overall Study|Disease Progression|0|||
126377954|NCT02779777|454680384|FG002|Overall Study|Disease Progression|0|||
126377955|NCT02779777|454680382|FG000|Overall Study|Adverse Event|3|||
126377956|NCT02779777|454680383|FG001|Overall Study|Adverse Event|1|||
126377957|NCT02779777|454680384|FG002|Overall Study|Adverse Event|0|||
126377958|NCT02779777|454680382|FG000|Overall Study|Physician Decision|9|||
126377959|NCT02779777|454680383|FG001|Overall Study|Physician Decision|0|||
126377960|NCT02779777|454680384|FG002|Overall Study|Physician Decision|1|||
126377961|NCT02779777|454680382|FG000|Overall Study|Withdrawal by Subject|1|||
126377962|NCT02779777|454680383|FG001|Overall Study|Withdrawal by Subject|0|||
126377963|NCT02779777|454680384|FG002|Overall Study|Withdrawal by Subject|0|||
126377964|NCT04571060|454680385|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
126377965|NCT04571060|454680386|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
126377966|NCT04571060|454680385|FG000|Overall Study|Never treated migraine|47|||
126377967|NCT04571060|454680386|FG001|Overall Study|Never treated migraine|36|||
126377968|NCT04571060|454680385|FG000|Overall Study|Protocol Violation|4|||
126377969|NCT04571060|454680386|FG001|Overall Study|Protocol Violation|2|||
126467481|NCT00537238|455013347|FG000|Overall Study|Does not meet entrance criteria|0|||
126467482|NCT00537238|455013348|FG001|Overall Study|Does not meet entrance criteria|2|||
126467483|NCT00537238|455013347|FG000|Overall Study|Other|44|||
126467484|NCT00537238|455013348|FG001|Overall Study|Other|52|||
126553114|NCT02291289|455320513|FG012|Maintenance Treatment Phase|Not Treated|0|||
126716923|NCT01702363|455914977|FG000|Overall Study|Lack of Efficacy|4|||
126716924|NCT01702363|455914977|FG000|Overall Study|Withdrawal by Subject|2|||
126716925|NCT02184143|455914984|FG000|Overall Study|Withdrawal by Subject|4|||
126716926|NCT02184143|455914985|FG001|Overall Study|Withdrawal by Subject|4|||
126716927|NCT02184143|455914984|FG000|Overall Study|Lost to Follow-up|5|||
126377970|NCT04571060|454680385|FG000|Overall Study|Withdrawal by Subject|6|||
126377971|NCT04571060|454680386|FG001|Overall Study|Withdrawal by Subject|2|||
126377972|NCT04571060|454680385|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
126467485|NCT03061097|455013351|FG000|Overall Study|Withdrawal by Subject|0|||
126377973|NCT04571060|454680386|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
126377974|NCT00087698|454680392|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
126467486|NCT03061097|455013352|FG001|Overall Study|Withdrawal by Subject|3|||
126467487|NCT03911713|455013353|FG000|Overall Study|Lost to Follow-up|0|||
126467488|NCT03911713|455013354|FG001|Overall Study|Lost to Follow-up|2|||
126467489|NCT03911713|455013355|FG002|Overall Study|Lost to Follow-up|0|||
126467490|NCT03911713|455013356|FG003|Overall Study|Lost to Follow-up|0|||
126467491|NCT03911713|455013357|FG004|Overall Study|Lost to Follow-up|0|||
126377975|NCT00087698|454680392|FG000|Overall Study|Death from Other Causes|3|||
126377976|NCT00087698|454680392|FG000|Overall Study|Adverse Event|4|||
126467492|NCT03911713|455013353|FG000|Overall Study|Other|0|||
126467493|NCT03911713|455013354|FG001|Overall Study|Other|0|||
126467494|NCT03911713|455013355|FG002|Overall Study|Other|0|||
126467495|NCT03911713|455013356|FG003|Overall Study|Other|1|||
126467496|NCT03911713|455013357|FG004|Overall Study|Other|0|||
126467497|NCT03911713|455013353|FG000|Overall Study|Randomized, Never Dosed|1|||
126467498|NCT03911713|455013354|FG001|Overall Study|Randomized, Never Dosed|0|||
126467499|NCT03911713|455013355|FG002|Overall Study|Randomized, Never Dosed|0|||
126467500|NCT03911713|455013356|FG003|Overall Study|Randomized, Never Dosed|1|||
126467501|NCT03911713|455013357|FG004|Overall Study|Randomized, Never Dosed|0|||
126467502|NCT02437513|455013358|FG000|Overall Study|Withdrawal by Subject|2|||
126467503|NCT01845818|455013359|FG000|Overall Study|Withdrawal by Subject|0|||
126467504|NCT01845818|455013360|FG001|Overall Study|Withdrawal by Subject|1|||
126467505|NCT01845818|455013359|FG000|Overall Study|Lost to Follow-up|7|||
126467506|NCT01845818|455013360|FG001|Overall Study|Lost to Follow-up|5|||
126467507|NCT01845818|455013359|FG000|Overall Study|Administrative Reasons|3|||
126467508|NCT01845818|455013360|FG001|Overall Study|Administrative Reasons|1|||
126467509|NCT01845818|455013359|FG000|Overall Study|Serious Adverse Event|1|||
126467510|NCT01845818|455013360|FG001|Overall Study|Serious Adverse Event|1|||
126467511|NCT01845818|455013359|FG000|Overall Study|Other|25|||
126467512|NCT01845818|455013360|FG001|Overall Study|Other|8|||
126467513|NCT01845818|455013359|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
126467514|NCT01845818|455013360|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
126467515|NCT01845818|455013359|FG000|Overall Study|No Follow-Up Data Available|4|||
126467516|NCT01845818|455013360|FG001|Overall Study|No Follow-Up Data Available|1|||
126377977|NCT00087698|454680392|FG000|Overall Study|Withdrawal by Subject|4|||
126377978|NCT00087698|454680392|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
126377979|NCT00087698|454680392|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
126377980|NCT00087698|454680392|FG000|Overall Study|Clinical Relapse|1|||
126377981|NCT00087698|454680392|FG000|Overall Study|Death from Study Disease|2|||
126377982|NCT00087698|454680392|FG000|Overall Study|Death from Study Drug Toxicity|2|||
126377983|NCT00087698|454680392|FG000|Overall Study|Protocol Violation|1|||
126377984|NCT01900665|454680409|FG000|Placebo Controlled Period|Death|9|||
126377985|NCT01900665|454680410|FG001|Placebo Controlled Period|Death|16|||
126377986|NCT01900665|454680409|FG000|Placebo Controlled Period|Adverse Event|48|||
126377987|NCT01900665|454680410|FG001|Placebo Controlled Period|Adverse Event|39|||
126377988|NCT01900665|454680409|FG000|Placebo Controlled Period|Protocol Violation|1|||
126377989|NCT01900665|454680410|FG001|Placebo Controlled Period|Protocol Violation|7|||
126377990|NCT01900665|454680409|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
126377991|NCT01900665|454680410|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
126377992|NCT01900665|454680409|FG000|Placebo Controlled Period|Physician Decision|11|||
126377993|NCT01900665|454680410|FG001|Placebo Controlled Period|Physician Decision|7|||
126377994|NCT01900665|454680409|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
126377995|NCT01900665|454680410|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
126377996|NCT01900665|454680409|FG000|Placebo Controlled Period|Caregiver Decision|33|||
126377997|NCT01900665|454680410|FG001|Placebo Controlled Period|Caregiver Decision|41|||
126377998|NCT01900665|454680409|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
126377999|NCT01900665|454680410|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
126378000|NCT01900665|454680409|FG000|Open Label Period|Adverse Event|16|||
126378001|NCT01900665|454680410|FG001|Open Label Period|Adverse Event|20|||
126378002|NCT01900665|454680409|FG000|Open Label Period|Death|5|||
126378003|NCT01900665|454680410|FG001|Open Label Period|Death|6|||
126378004|NCT01900665|454680409|FG000|Open Label Period|Lost to Follow-up|1|||
126378005|NCT01900665|454680410|FG001|Open Label Period|Lost to Follow-up|1|||
126378006|NCT01900665|454680409|FG000|Open Label Period|Parent/Caregiver Decision|33|||
126378007|NCT01900665|454680410|FG001|Open Label Period|Parent/Caregiver Decision|34|||
126378008|NCT01900665|454680409|FG000|Open Label Period|Physician Decision|4|||
126467517|NCT00736957|455013361|FG000|Overall Study|Adverse Event|43|||
126467518|NCT00736957|455013361|FG000|Overall Study|Withdrawal by Subject|49|||
126771131|NCT01652872|456116270|FG001|Overall Study|Withdrawal by Subject|84|||
126378009|NCT01900665|454680410|FG001|Open Label Period|Physician Decision|4|||
126378010|NCT01900665|454680409|FG000|Open Label Period|Protocol Violation|0|||
126378011|NCT01900665|454680410|FG001|Open Label Period|Protocol Violation|1|||
126467519|NCT00736957|455013361|FG000|Overall Study|violation of eligibility criteria|2|||
126467520|NCT00736957|455013361|FG000|Overall Study|did not attend hospital appointments|1|||
126467521|NCT00736957|455013361|FG000|Overall Study|not eligible for Treatment Period I|22|||
126467522|NCT00736957|455013361|FG000|Overall Study|Physician Decision|5|||
126467523|NCT01051466|455013363|FG000|Overall Study|Adverse Event|1|||
126467524|NCT01051466|455013364|FG001|Overall Study|Adverse Event|0|||
126378012|NCT01900665|454680409|FG000|Open Label Period|Sponsor Decision|802|||
126378013|NCT01900665|454680410|FG001|Open Label Period|Sponsor Decision|765|||
126378014|NCT01900665|454680409|FG000|Open Label Period|Withdrawal by Subject|20|||
126378015|NCT01900665|454680410|FG001|Open Label Period|Withdrawal by Subject|28|||
126771132|NCT04529096|456116271|FG000|Overall Study|Adverse Event|6|||
126467525|NCT01051466|455013363|FG000|Overall Study|Lost to Follow-up|1|||
126467526|NCT01051466|455013364|FG001|Overall Study|Lost to Follow-up|1|||
126467527|NCT01051466|455013363|FG000|Overall Study|Withdrawal by Subject|5|||
126467528|NCT01051466|455013364|FG001|Overall Study|Withdrawal by Subject|1|||
126467529|NCT01051466|455013363|FG000|Overall Study|Entry Criteria Not Met|0|||
126378016|NCT04749745|454680412|FG000|Overall Study|Withdrawal by Subject|1|||
126378017|NCT04749745|454680413|FG001|Overall Study|Withdrawal by Subject|0|||
126378018|NCT03816176|454680418|FG000|Overall Study|Miscellaneous|5|||
126378019|NCT03816176|454680418|FG000|Overall Study|Lack of Efficacy|4|||
126378020|NCT03816176|454680418|FG000|Overall Study|Adverse Event|3|||
126378021|NCT02477527|454681476|FG000|Overall Study|Lost to Follow-up|2|||
126378022|NCT02477527|454681476|FG000|Overall Study|Withdrawal by Subject|1|||
126378023|NCT02477527|454681476|FG000|Overall Study|Screen Failure|3|||
126378024|NCT02383862|454681479|FG000|3 Month Follow up|Lost to Follow-up|23|||
126378025|NCT02383862|454681480|FG001|3 Month Follow up|Lost to Follow-up|21|||
126378026|NCT01833494|454681481|FG000|Overall Study|Adverse Event|24|||
126378027|NCT01833494|454681481|FG000|Overall Study|Physician Decision|6|||
126378028|NCT01833494|454681481|FG000|Overall Study|Withdrawal by Subject|6|||
126378029|NCT01833494|454681481|FG000|Overall Study|Decrease in serum phosphorus|4|||
126378030|NCT01833494|454681481|FG000|Overall Study|Decrease in serum calcium|4|||
126378031|NCT01833494|454681481|FG000|Overall Study|Increase in serum ferritin|1|||
126378032|NCT01694433|454681482|FG000|Overall Study|Adverse Event|7|||
126378033|NCT01694433|454681483|FG001|Overall Study|Adverse Event|0|||
126378034|NCT01694433|454681482|FG000|Overall Study|Physician Decision|1|||
126378035|NCT01694433|454681483|FG001|Overall Study|Physician Decision|0|||
126378036|NCT01694433|454681482|FG000|Overall Study|Withdrawal by Subject|3|||
126378037|NCT01694433|454681483|FG001|Overall Study|Withdrawal by Subject|4|||
126378038|NCT00374595|454681486|FG000|Overall Study|Death|23|||
126378039|NCT00374595|454681486|FG000|Overall Study|Withdrawal by Subject|39|||
126378040|NCT00374595|454681486|FG000|Overall Study|Lost to Follow-up|3|||
126378041|NCT00374595|454681486|FG000|Overall Study|too much time commitment|1|||
126378042|NCT00374595|454681486|FG000|Overall Study|transfer care to other clinical site|1|||
126378043|NCT00374595|454681486|FG000|Overall Study|relocation|3|||
126378044|NCT01664247|454681487|FG000|Overall Study|Adverse Event|5|||
126378045|NCT01664247|454681488|FG001|Overall Study|Adverse Event|3|||
126378046|NCT01664247|454681487|FG000|Overall Study|Protocol Violation|3|||
126378047|NCT01664247|454681488|FG001|Overall Study|Protocol Violation|5|||
126378048|NCT01664247|454681487|FG000|Overall Study|Withdrawal Criteria|1|||
126378049|NCT01664247|454681488|FG001|Overall Study|Withdrawal Criteria|4|||
126378050|NCT01664247|454681487|FG000|Overall Study|Unclassified|5|||
126378051|NCT01664247|454681488|FG001|Overall Study|Unclassified|29|||
126378052|NCT03064074|454681493|FG000|Overall Study|Physician Decision|0|||
126378053|NCT03064074|454681494|FG001|Overall Study|Physician Decision|0|||
126378054|NCT03064074|454681495|FG002|Overall Study|Physician Decision|0|||
126378055|NCT03064074|454681496|FG003|Overall Study|Physician Decision|1|||
126378056|NCT01118780|454681501|FG000|Overall Study|Adverse Event|15|||
126378057|NCT01118780|454681502|FG001|Overall Study|Adverse Event|15|||
126378058|NCT01118780|454681501|FG000|Overall Study|Death|1|||
126378059|NCT01118780|454681502|FG001|Overall Study|Death|0|||
126378060|NCT01118780|454681501|FG000|Overall Study|Lack of Efficacy|2|||
126378061|NCT01118780|454681502|FG001|Overall Study|Lack of Efficacy|6|||
126378062|NCT01118780|454681501|FG000|Overall Study|Physician Decision|2|||
126378063|NCT01118780|454681502|FG001|Overall Study|Physician Decision|0|||
126378064|NCT01118780|454681501|FG000|Overall Study|Protocol Violation|3|||
126378065|NCT01118780|454681502|FG001|Overall Study|Protocol Violation|6|||
126378066|NCT01118780|454681501|FG000|Overall Study|Withdrawal by Subject|13|||
126378067|NCT01118780|454681502|FG001|Overall Study|Withdrawal by Subject|8|||
126378068|NCT03962855|454681513|FG000|Overall Study|Death|0|||
126378069|NCT03962855|454681514|FG001|Overall Study|Death|1|||
126378070|NCT03962855|454681513|FG000|Overall Study|Lost to Follow-up|0|||
126378071|NCT03962855|454681514|FG001|Overall Study|Lost to Follow-up|1|||
126378072|NCT03962855|454681513|FG000|Overall Study|Adverse Event|0|||
126378073|NCT03962855|454681514|FG001|Overall Study|Adverse Event|1|||
126378074|NCT03962855|454681513|FG000|Overall Study|Physician Decision|0|||
126378075|NCT03962855|454681514|FG001|Overall Study|Physician Decision|2|||
126378076|NCT02379052|454681515|FG000|Overall Study|Protocol Violation|0|||
126378077|NCT02379052|454681516|FG001|Overall Study|Protocol Violation|1|||
126378078|NCT02379052|454681515|FG000|Overall Study|Adverse Event|0|||
126378079|NCT02379052|454681516|FG001|Overall Study|Adverse Event|1|||
126378080|NCT02379052|454681515|FG000|Overall Study|Physician Decision|1|||
126467530|NCT01051466|455013364|FG001|Overall Study|Entry Criteria Not Met|3|||
126378081|NCT02379052|454681516|FG001|Overall Study|Physician Decision|1|||
126378082|NCT02379052|454681515|FG000|Overall Study|Withdrawal by Subject|2|||
126378083|NCT02379052|454681516|FG001|Overall Study|Withdrawal by Subject|0|||
126378084|NCT02379052|454681515|FG000|Overall Study|Lost to Follow-up|2|||
126378085|NCT02379052|454681516|FG001|Overall Study|Lost to Follow-up|1|||
126378086|NCT02379052|454681515|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
126378087|NCT02379052|454681516|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
126378088|NCT02379052|454681515|FG000|Overall Study|Subject was Incarcerated|0|||
126378089|NCT02379052|454681516|FG001|Overall Study|Subject was Incarcerated|1|||
126378090|NCT00846846|454681519|FG000|Overall Study|Death|56|||
126378091|NCT00846846|454681519|FG000|Overall Study|Withdrawal by Subject|19|||
126378092|NCT04419467|454681520|FG000|Overall Study|Not treated with IP|0|||
126378093|NCT04419467|454681521|FG001|Overall Study|Not treated with IP|0|||
126378094|NCT04419467|454681522|FG002|Overall Study|Not treated with IP|2|||
126378095|NCT04419467|454681520|FG000|Overall Study|Adverse Event|0|||
126378096|NCT04419467|454681521|FG001|Overall Study|Adverse Event|2|||
126378097|NCT04419467|454681522|FG002|Overall Study|Adverse Event|0|||
126378098|NCT04419467|454681520|FG000|Overall Study|Death|1|||
126378099|NCT04419467|454681521|FG001|Overall Study|Death|0|||
126378100|NCT04419467|454681522|FG002|Overall Study|Death|0|||
126378101|NCT04419467|454681520|FG000|Overall Study|Lost to Follow-up|0|||
126378102|NCT04419467|454681521|FG001|Overall Study|Lost to Follow-up|1|||
126378103|NCT04419467|454681522|FG002|Overall Study|Lost to Follow-up|2|||
126378104|NCT04419467|454681520|FG000|Overall Study|Withdrawal by Subject|0|||
126378105|NCT04419467|454681521|FG001|Overall Study|Withdrawal by Subject|0|||
126378106|NCT04419467|454681522|FG002|Overall Study|Withdrawal by Subject|4|||
126378107|NCT04419467|454681520|FG000|Overall Study|Pandemic related|0|||
126378108|NCT04419467|454681521|FG001|Overall Study|Pandemic related|0|||
126378109|NCT04419467|454681522|FG002|Overall Study|Pandemic related|1|||
126378110|NCT04419467|454681520|FG000|Overall Study|Reason not known|1|||
126378111|NCT04419467|454681521|FG001|Overall Study|Reason not known|0|||
126378112|NCT04419467|454681522|FG002|Overall Study|Reason not known|0|||
126378113|NCT00442416|454681527|FG000|Overall Study|Adverse Event|4|||
126378114|NCT00442416|454681528|FG001|Overall Study|Adverse Event|1|||
126467531|NCT01051466|455013363|FG000|Overall Study|Physician Decision|1|||
126467532|NCT01051466|455013364|FG001|Overall Study|Physician Decision|0|||
126467533|NCT00145600|455013368|FG000|Overall Study|Death|1|||
126467534|NCT00145600|455013369|FG001|Overall Study|Death|2|||
126467535|NCT00145600|455013370|FG002|Overall Study|Death|2|||
126467536|NCT00145600|455013371|FG003|Overall Study|Death|6|||
126553115|NCT02291289|455320501|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
126553116|NCT02291289|455320502|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
126553117|NCT02291289|455320503|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
126553118|NCT02291289|455320504|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
126553119|NCT02291289|455320505|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
126553120|NCT02291289|455320506|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
126553121|NCT02291289|455320507|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
126553122|NCT02291289|455320508|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
126553123|NCT02291289|455320509|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
126553124|NCT02291289|455320510|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
126553125|NCT02291289|455320511|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
126553126|NCT02291289|455320512|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
126553127|NCT02291289|455320513|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
126553128|NCT02291289|455320501|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
126553129|NCT02291289|455320502|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
126553130|NCT02291289|455320503|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
126553131|NCT02291289|455320504|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
126553132|NCT02291289|455320505|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
126553133|NCT02291289|455320506|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
126553134|NCT02291289|455320507|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
126553135|NCT02291289|455320508|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
126553136|NCT02291289|455320509|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
126378115|NCT00442416|454681527|FG000|Overall Study|Death|1|||
126378116|NCT00442416|454681528|FG001|Overall Study|Death|0|||
126467537|NCT00145600|455013368|FG000|Overall Study|Ineligible|3|||
126467538|NCT00145600|455013369|FG001|Overall Study|Ineligible|0|||
126467539|NCT00145600|455013370|FG002|Overall Study|Ineligible|1|||
126553137|NCT02291289|455320510|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
126553138|NCT02291289|455320511|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
126378117|NCT00442416|454681527|FG000|Overall Study|Lack of Efficacy|2|||
126378118|NCT00442416|454681528|FG001|Overall Study|Lack of Efficacy|0|||
126378119|NCT00442416|454681527|FG000|Overall Study|Protocol Violation|2|||
126378120|NCT00442416|454681528|FG001|Overall Study|Protocol Violation|3|||
126378121|NCT00442416|454681527|FG000|Overall Study|Withdrew consent|1|||
126378122|NCT00442416|454681528|FG001|Overall Study|Withdrew consent|2|||
126378123|NCT00442416|454681527|FG000|Overall Study|Administrative/Other|27|||
126378124|NCT00442416|454681528|FG001|Overall Study|Administrative/Other|33|||
126378125|NCT01284959|454681531|FG000|Overall Study|Withdrawal by Subject|1|||
126467540|NCT00145600|455013371|FG003|Overall Study|Ineligible|5|||
126467541|NCT00145600|455013368|FG000|Overall Study|Lost to Follow-up|2|||
126467542|NCT00145600|455013369|FG001|Overall Study|Lost to Follow-up|6|||
126378126|NCT01284959|454681532|FG001|Overall Study|Withdrawal by Subject|0|||
126378127|NCT01284959|454681533|FG002|Overall Study|Withdrawal by Subject|0|||
126378128|NCT01284959|454681531|FG000|Overall Study|Adverse Event|0|||
126467543|NCT00145600|455013370|FG002|Overall Study|Lost to Follow-up|2|||
126467544|NCT00145600|455013371|FG003|Overall Study|Lost to Follow-up|4|||
126467545|NCT00145600|455013368|FG000|Overall Study|Noncompliance|1|||
126467546|NCT00145600|455013369|FG001|Overall Study|Noncompliance|0|||
126467547|NCT00145600|455013370|FG002|Overall Study|Noncompliance|0|||
126467548|NCT00145600|455013371|FG003|Overall Study|Noncompliance|0|||
126467549|NCT00145600|455013368|FG000|Overall Study|Withdrawal by Subject|1|||
126467550|NCT00145600|455013369|FG001|Overall Study|Withdrawal by Subject|2|||
126467551|NCT00145600|455013370|FG002|Overall Study|Withdrawal by Subject|0|||
126467552|NCT00145600|455013371|FG003|Overall Study|Withdrawal by Subject|1|||
126467553|NCT00761579|455013376|FG000|Overall Study|Adverse Event|10|||
126467554|NCT00761579|455013376|FG000|Overall Study|Death|2|||
126467555|NCT00761579|455013376|FG000|Overall Study|Lack of Efficacy|21|||
126467556|NCT00761579|455013376|FG000|Overall Study|Lost to Follow-up|16|||
126467557|NCT00761579|455013376|FG000|Overall Study|Pregnancy|1|||
126467558|NCT00761579|455013376|FG000|Overall Study|Withdrawal by Subject|34|||
126716928|NCT02184143|455914985|FG001|Overall Study|Lost to Follow-up|3|||
126716929|NCT02184143|455914984|FG000|Overall Study|Death|1|||
126716930|NCT02184143|455914985|FG001|Overall Study|Death|0|||
126716931|NCT00321984|455914986|FG000|Overall Study|Adverse Event|9|||
126716932|NCT00321984|455914987|FG001|Overall Study|Adverse Event|6|||
126716933|NCT00321984|455914988|FG002|Overall Study|Adverse Event|8|||
126716934|NCT00321984|455914986|FG000|Overall Study|Protocol Violation|0|||
126716935|NCT00321984|455914987|FG001|Overall Study|Protocol Violation|1|||
126378129|NCT01284959|454681532|FG001|Overall Study|Adverse Event|0|||
126378130|NCT01284959|454681533|FG002|Overall Study|Adverse Event|1|||
126378131|NCT00003869|454681535|FG000|Overall Study|Adverse Event|14|||
126378132|NCT00003869|454681536|FG001|Overall Study|Adverse Event|3|||
126378133|NCT00003869|454681535|FG000|Overall Study|Withdrawal by Subject|21|||
126378134|NCT00003869|454681536|FG001|Overall Study|Withdrawal by Subject|3|||
126378135|NCT00003869|454681535|FG000|Overall Study|Death|1|||
126378136|NCT00003869|454681536|FG001|Overall Study|Death|2|||
126378137|NCT00003869|454681535|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
126378138|NCT00003869|454681536|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
126378139|NCT03364231|454681537|FG000|Overall Study|Adverse Event|1|||
126378140|NCT03364231|454681538|FG001|Overall Study|Adverse Event|4|||
126378141|NCT03364231|454681537|FG000|Overall Study|Death|1|||
126378142|NCT03364231|454681538|FG001|Overall Study|Death|0|||
126378143|NCT03364231|454681537|FG000|Overall Study|Investigator Decision|2|||
126378144|NCT03364231|454681538|FG001|Overall Study|Investigator Decision|2|||
126378145|NCT03364231|454681537|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
126378146|NCT03364231|454681538|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
126378147|NCT03364231|454681537|FG000|Overall Study|Withdrawal of Subject Consent|1|||
126378148|NCT03364231|454681538|FG001|Overall Study|Withdrawal of Subject Consent|0|||
126378149|NCT03364231|454681537|FG000|Overall Study|Reason Not Specified|1|||
126378150|NCT03364231|454681538|FG001|Overall Study|Reason Not Specified|0|||
126378151|NCT03364231|454681537|FG000|Overall Study|Disease Progression|0|||
126378152|NCT03364231|454681538|FG001|Overall Study|Disease Progression|6|||
126378153|NCT04068922|454681539|FG000|Overall Study|Lost to Follow-up|5|||
126378154|NCT04068922|454681539|FG000|Overall Study|Withdrawal by Subject|7|||
126378155|NCT04068922|454681539|FG000|Overall Study|Adverse Event|1|||
126378156|NCT01070979|454681547|FG000|Overall Study|Adverse Event|2|||
126378157|NCT01070979|454681548|FG001|Overall Study|Adverse Event|3|||
126378158|NCT01070979|454681549|FG002|Overall Study|Adverse Event|3|||
126378159|NCT01070979|454681547|FG000|Overall Study|Lost to Follow-up|2|||
126378160|NCT01070979|454681548|FG001|Overall Study|Lost to Follow-up|1|||
126378161|NCT01070979|454681549|FG002|Overall Study|Lost to Follow-up|1|||
126378162|NCT01070979|454681547|FG000|Overall Study|Protocol Violation|0|||
126378163|NCT01070979|454681548|FG001|Overall Study|Protocol Violation|2|||
126378164|NCT01070979|454681549|FG002|Overall Study|Protocol Violation|6|||
126378165|NCT01070979|454681547|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
126378166|NCT01070979|454681548|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
126378167|NCT01070979|454681549|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
126378168|NCT01070979|454681547|FG000|Overall Study|Withdrawal by Subject|3|||
126378169|NCT01070979|454681548|FG001|Overall Study|Withdrawal by Subject|1|||
126378170|NCT01070979|454681549|FG002|Overall Study|Withdrawal by Subject|1|||
126378171|NCT01070979|454681547|FG000|Overall Study|No study drug taken|0|||
126716936|NCT00321984|455914988|FG002|Overall Study|Protocol Violation|1|||
126378172|NCT01070979|454681548|FG001|Overall Study|No study drug taken|1|||
126378173|NCT01070979|454681549|FG002|Overall Study|No study drug taken|0|||
126378174|NCT00142792|454681550|FG000|Overall Study|Death|0|||
126467559|NCT00761579|455013376|FG000|Overall Study|Lack of compliance|2|||
126467560|NCT00761579|455013376|FG000|Overall Study|Protocol deviation|1|||
126467561|NCT00761579|455013376|FG000|Overall Study|Drug overdose|1|||
126467562|NCT00761579|455013376|FG000|Overall Study|Aggravation of depression|1|||
126467563|NCT00761579|455013376|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
126716937|NCT00321984|455914986|FG000|Overall Study|Lost to Follow-up|2|||
126378175|NCT00142792|454681551|FG001|Overall Study|Death|0|||
126467564|NCT00761579|455013376|FG000|Overall Study|Lost survey form|1|||
126716938|NCT00321984|455914987|FG001|Overall Study|Lost to Follow-up|4|||
126716939|NCT00321984|455914988|FG002|Overall Study|Lost to Follow-up|2|||
126716940|NCT00321984|455914986|FG000|Overall Study|Withdrawal by Subject|8|||
126716941|NCT00321984|455914987|FG001|Overall Study|Withdrawal by Subject|6|||
126716942|NCT00321984|455914988|FG002|Overall Study|Withdrawal by Subject|5|||
126716943|NCT00321984|455914986|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
126716944|NCT00321984|455914987|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
126716945|NCT00321984|455914988|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
126716946|NCT00321984|455914986|FG000|Overall Study|Lack of Efficacy|3|||
126716947|NCT00321984|455914987|FG001|Overall Study|Lack of Efficacy|1|||
126716948|NCT00321984|455914988|FG002|Overall Study|Lack of Efficacy|3|||
126716949|NCT00321984|455914986|FG000|Overall Study|Noncompliant|0|||
126716950|NCT00321984|455914987|FG001|Overall Study|Noncompliant|0|||
126716951|NCT00321984|455914988|FG002|Overall Study|Noncompliant|2|||
126716952|NCT00321984|455914986|FG000|Overall Study|Pregnancy|0|||
126716953|NCT00321984|455914987|FG001|Overall Study|Pregnancy|1|||
126716954|NCT00321984|455914988|FG002|Overall Study|Pregnancy|0|||
126716955|NCT00321984|455914986|FG000|Overall Study|Per Subject Request|1|||
126716956|NCT00321984|455914987|FG001|Overall Study|Per Subject Request|0|||
126378176|NCT00142792|454681552|FG002|Overall Study|Death|1|||
126378177|NCT00142792|454681550|FG000|Overall Study|Withdrawal by Subject|3|||
126378178|NCT00142792|454681551|FG001|Overall Study|Withdrawal by Subject|2|||
126378179|NCT00142792|454681552|FG002|Overall Study|Withdrawal by Subject|3|||
126378180|NCT00142792|454681550|FG000|Overall Study|Lost to Follow-up|8|||
126378181|NCT00142792|454681551|FG001|Overall Study|Lost to Follow-up|11|||
126378182|NCT00142792|454681552|FG002|Overall Study|Lost to Follow-up|7|||
126378183|NCT00142792|454681550|FG000|Overall Study|No category|1|||
126378184|NCT00142792|454681551|FG001|Overall Study|No category|2|||
126378185|NCT00142792|454681552|FG002|Overall Study|No category|1|||
126378186|NCT00444106|454681555|FG000|Overall Study|Lost to Follow-up|2|||
126378187|NCT00444106|454681556|FG001|Overall Study|Lost to Follow-up|1|||
126378188|NCT00444106|454681557|FG002|Overall Study|Lost to Follow-up|0|||
126378189|NCT00444106|454681555|FG000|Overall Study|Abnormal Test Procedure Results|0|||
126378190|NCT00444106|454681556|FG001|Overall Study|Abnormal Test Procedure Results|0|||
126378191|NCT00444106|454681557|FG002|Overall Study|Abnormal Test Procedure Results|1|||
126378192|NCT04749914|454681558|FG000|Period 1|Adverse Event|1|||
126378193|NCT04749914|454681559|FG001|Period 1|Adverse Event|0|||
126378194|NCT04749914|454681560|FG002|Period 1|Adverse Event|0|||
126378195|NCT04749914|454681561|FG003|Period 1|Adverse Event|0|||
126378196|NCT04749914|454681558|FG000|Period 1|Withdrawal by Subject|1|||
126378197|NCT04749914|454681559|FG001|Period 1|Withdrawal by Subject|0|||
126378198|NCT04749914|454681560|FG002|Period 1|Withdrawal by Subject|1|||
126378199|NCT04749914|454681561|FG003|Period 1|Withdrawal by Subject|0|||
126378200|NCT01913327|454681564|FG000|Overall Study|Withdrawal by Subject|0|||
126378201|NCT01913327|454681565|FG001|Overall Study|Withdrawal by Subject|1|||
126378202|NCT01074931|454681570|FG000|Overall Study|Economic reasons|1|||
126378203|NCT01074931|454681570|FG000|Overall Study|Death|5|||
126378204|NCT00953706|454681571|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
126378205|NCT00953706|454681572|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
126378206|NCT00953706|454681573|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
126378207|NCT00953706|454681574|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
126378208|NCT00953706|454681571|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
126378209|NCT00953706|454681572|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
126378210|NCT00953706|454681573|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
126378211|NCT00953706|454681574|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
126378212|NCT00953706|454681571|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
126378213|NCT00953706|454681572|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
126378214|NCT00953706|454681573|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
126378215|NCT00953706|454681574|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
126378216|NCT00953706|454681571|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
126378217|NCT00953706|454681572|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
126378218|NCT00953706|454681573|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
126378219|NCT00953706|454681574|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
126378220|NCT00953706|454681571|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
126378221|NCT00953706|454681572|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
126378222|NCT00953706|454681573|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
126378223|NCT00953706|454681574|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
126378224|NCT00953706|454681571|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
126467565|NCT00761579|455013376|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
126716957|NCT00321984|455914988|FG002|Overall Study|Per Subject Request|0|||
126716958|NCT00321984|455914986|FG000|Overall Study|Per Investigator Request|1|||
126716959|NCT00321984|455914987|FG001|Overall Study|Per Investigator Request|0|||
126771133|NCT04529096|456116272|FG001|Overall Study|Adverse Event|1|||
126378225|NCT00953706|454681572|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
126378226|NCT00953706|454681573|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
126378227|NCT00953706|454681574|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
126378228|NCT00953706|454681571|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
126378229|NCT00953706|454681572|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
126378230|NCT00953706|454681573|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
126378231|NCT00953706|454681574|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
126378232|NCT00953706|454681571|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
126378233|NCT00953706|454681572|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
126378234|NCT00953706|454681573|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
126378235|NCT00953706|454681574|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
126378236|NCT00953706|454681571|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
126378237|NCT00953706|454681572|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
126378238|NCT00953706|454681573|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
126378239|NCT00953706|454681574|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
126378240|NCT00953706|454681571|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
126378241|NCT00953706|454681572|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
126378242|NCT00953706|454681573|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
126378243|NCT00953706|454681574|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
126378244|NCT00953706|454681571|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
126378245|NCT00953706|454681572|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
126378246|NCT00953706|454681573|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
126378247|NCT00953706|454681574|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
126378248|NCT02137070|454681576|FG000|Overall Study|Adverse Event|12|||
126378249|NCT02137070|454681577|FG001|Overall Study|Adverse Event|3|||
126378250|NCT02137070|454681576|FG000|Overall Study|Death|2|||
126378251|NCT02137070|454681577|FG001|Overall Study|Death|0|||
126378252|NCT02137070|454681576|FG000|Overall Study|Lost to Follow-up|24|||
126378253|NCT02137070|454681577|FG001|Overall Study|Lost to Follow-up|9|||
126378254|NCT02137070|454681576|FG000|Overall Study|Physician Decision|0|||
126378255|NCT02137070|454681577|FG001|Overall Study|Physician Decision|1|||
126378256|NCT02137070|454681576|FG000|Overall Study|Protocol Violation|18|||
126378257|NCT02137070|454681577|FG001|Overall Study|Protocol Violation|4|||
126378258|NCT02137070|454681576|FG000|Overall Study|Withdrawal by Subject|18|||
126378259|NCT02137070|454681577|FG001|Overall Study|Withdrawal by Subject|1|||
126378260|NCT02112656|454681578|FG000|Overall Study|Death|78|||
126378261|NCT02112656|454681579|FG001|Overall Study|Death|82|||
126378262|NCT02112656|454681578|FG000|Overall Study|Withdrawal by Subject|9|||
126378263|NCT02112656|454681579|FG001|Overall Study|Withdrawal by Subject|11|||
126378264|NCT02112656|454681578|FG000|Overall Study|Lost to Follow-up|2|||
126378265|NCT02112656|454681579|FG001|Overall Study|Lost to Follow-up|4|||
126378266|NCT02112656|454681578|FG000|Overall Study|Noncompliance|1|||
126378267|NCT02112656|454681579|FG001|Overall Study|Noncompliance|2|||
126378268|NCT03761056|454681580|FG000|Overall Study|Death|8|||
126467566|NCT02600351|455013377|FG000|Overall Study|Lack of Efficacy|3|||
126467567|NCT02600351|455013378|FG001|Overall Study|Lack of Efficacy|0|||
126467568|NCT02600351|455013379|FG002|Overall Study|Lack of Efficacy|5|||
126467569|NCT02600351|455013380|FG003|Overall Study|Lack of Efficacy|2|||
126467570|NCT02600351|455013377|FG000|Overall Study|Lost to Follow-up|1|||
126467571|NCT02600351|455013378|FG001|Overall Study|Lost to Follow-up|0|||
126467572|NCT02600351|455013379|FG002|Overall Study|Lost to Follow-up|0|||
126467573|NCT02600351|455013380|FG003|Overall Study|Lost to Follow-up|0|||
126467574|NCT02600351|455013377|FG000|Overall Study|Randomized but Not Treated|1|||
126467575|NCT02600351|455013378|FG001|Overall Study|Randomized but Not Treated|0|||
126716960|NCT00321984|455914988|FG002|Overall Study|Per Investigator Request|0|||
126716961|NCT00321984|455914986|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
126716962|NCT00321984|455914987|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
126716963|NCT00321984|455914988|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
126716964|NCT02985450|455914992|FG000|Overall Study|Lost to Follow-up|7|||
126716965|NCT00431847|455914995|FG000|Overall Study|completion of less than two study visits|6|||
126716966|NCT00431847|455914996|FG001|Overall Study|completion of less than two study visits|3|||
126716967|NCT00431847|455914997|FG002|Overall Study|completion of less than two study visits|4|||
126716968|NCT00431847|455914998|FG003|Overall Study|completion of less than two study visits|14|||
126716969|NCT00431847|455914999|FG004|Overall Study|completion of less than two study visits|0|||
126378269|NCT03761056|454681580|FG000|Overall Study|Enrolled but never treated|2|||
126378270|NCT03761056|454681580|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
126467576|NCT02600351|455013379|FG002|Overall Study|Randomized but Not Treated|1|||
126467577|NCT02600351|455013380|FG003|Overall Study|Randomized but Not Treated|3|||
126467578|NCT04087213|455013381|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
126467579|NCT04087213|455013381|FG000|In-Facility Introduction|Adverse Event|1|||
126378271|NCT03761056|454681580|FG000|Overall Study|Investigator decision|1|||
126378272|NCT03965403|454681585|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
126378273|NCT00552071|454682945|FG000|Overall Study|Adverse Event|1|||
126378274|NCT00552071|454682946|FG001|Overall Study|Adverse Event|0|||
126378275|NCT00552071|454682945|FG000|Overall Study|Lack of Efficacy|1|||
126378276|NCT00552071|454682946|FG001|Overall Study|Lack of Efficacy|0|||
126378277|NCT00552071|454682945|FG000|Overall Study|Physician Decision|1|||
126378278|NCT00552071|454682946|FG001|Overall Study|Physician Decision|0|||
126378279|NCT00552071|454682945|FG000|Overall Study|Pregnancy|1|||
126378280|NCT00552071|454682946|FG001|Overall Study|Pregnancy|0|||
126378281|NCT00552071|454682945|FG000|Overall Study|Death|0|||
126378282|NCT00552071|454682946|FG001|Overall Study|Death|1|||
126378283|NCT00552071|454682945|FG000|Overall Study|Withdrawal by Subject|0|||
126378284|NCT00552071|454682946|FG001|Overall Study|Withdrawal by Subject|1|||
126378285|NCT01979614|454682947|FG000|Overall Study|Adverse Event|1|||
126378286|NCT01979614|454682948|FG001|Overall Study|Adverse Event|1|||
126378287|NCT00756275|454682949|FG000|Overall Study|Lost to Follow-up|25|||
126378288|NCT00756275|454682950|FG001|Overall Study|Lost to Follow-up|21|||
126378289|NCT00756275|454682949|FG000|Overall Study|Withdrawal by Subject|4|||
126378290|NCT00756275|454682950|FG001|Overall Study|Withdrawal by Subject|7|||
126378291|NCT00938912|454682951|FG000|Overall Study|Withdrawal by Subject|28|||
126378292|NCT00938912|454682951|FG000|Overall Study|Lost to Follow-up|4|||
126378293|NCT00938912|454682951|FG000|Overall Study|Lack of Efficacy|43|||
126378294|NCT00938912|454682951|FG000|Overall Study|Adverse event, non-fatal|24|||
126378295|NCT00938912|454682951|FG000|Overall Study|Adverse event, fatal|1|||
126378296|NCT00938912|454682951|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
126378297|NCT00938912|454682951|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
126378298|NCT00938912|454682951|FG000|Overall Study|Participant needed prohibit medication|1|||
126378299|NCT00938912|454682951|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
126378300|NCT00938912|454682951|FG000|Overall Study|Did not meet Eligibility criteria|1|||
126378301|NCT00938912|454682951|FG000|Overall Study|Participant relocated not related to AE|1|||
126378302|NCT00938912|454682951|FG000|Overall Study|Participant moved to another city|1|||
126378303|NCT00938912|454682951|FG000|Overall Study|Participant experienced break through seizures|1|||
126378304|NCT00938912|454682951|FG000|Overall Study|No longer wished to participate in the study|1|||
126378305|NCT00938912|454682951|FG000|Overall Study|Protocol Deviation|2|||
126378306|NCT00456755|454682954|FG000|Overall Study|Lost to Follow-up|2|||
126378307|NCT00456755|454682955|FG001|Overall Study|Lost to Follow-up|1|||
126378308|NCT06164691|454682956|FG000|Overall Study|Withdrawal by Subject|2|||
126378309|NCT06164691|454682957|FG001|Overall Study|Withdrawal by Subject|0|||
126378310|NCT06164691|454682958|FG002|Overall Study|Withdrawal by Subject|0|||
126378311|NCT03432494|454682977|FG000|Overall Study|Death|1|||
126378312|NCT03432494|454682977|FG000|Overall Study|Noncompliance|1|||
126378313|NCT00856635|454682978|FG000|Overall Study|Lost to Follow-up|2|||
126378314|NCT00856635|454682979|FG001|Overall Study|Lost to Follow-up|5|||
126378315|NCT00856635|454682978|FG000|Overall Study|Pregnancy|1|||
126378316|NCT00856635|454682979|FG001|Overall Study|Pregnancy|0|||
126378317|NCT00856635|454682978|FG000|Overall Study|Withdrawal by Subject|3|||
126378318|NCT00856635|454682979|FG001|Overall Study|Withdrawal by Subject|1|||
126378319|NCT00856635|454682978|FG000|Overall Study|Serious Adverse Event|1|||
126378320|NCT00856635|454682979|FG001|Overall Study|Serious Adverse Event|0|||
126378321|NCT00856635|454682978|FG000|Overall Study|Other|1|||
126378322|NCT00856635|454682979|FG001|Overall Study|Other|0|||
126378323|NCT00856635|454682978|FG000|Overall Study|Discontinued at Randomization|2|||
126378324|NCT00856635|454682979|FG001|Overall Study|Discontinued at Randomization|2|||
126378325|NCT01244035|454682980|FG000|Part 1: Period 1|Adverse Event|0|||
126378326|NCT01244035|454682981|FG001|Part 1: Period 1|Adverse Event|0|||
126716970|NCT00431847|455914995|FG000|Overall Study|Protocol Violation|0|||
126716971|NCT00431847|455914996|FG001|Overall Study|Protocol Violation|0|||
126716972|NCT00431847|455914997|FG002|Overall Study|Protocol Violation|0|||
126716973|NCT00431847|455914998|FG003|Overall Study|Protocol Violation|0|||
126716974|NCT00431847|455914999|FG004|Overall Study|Protocol Violation|1|||
126378327|NCT01244035|454682982|FG002|Part 1: Period 1|Adverse Event|0|||
126378328|NCT01244035|454682983|FG003|Part 1: Period 1|Adverse Event|0|||
126378329|NCT01244035|454682984|FG004|Part 1: Period 1|Adverse Event|0|||
126378330|NCT01244035|454682985|FG005|Part 1: Period 1|Adverse Event|1|||
126378331|NCT01244035|454682980|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
126378332|NCT01244035|454682981|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
126378333|NCT01244035|454682982|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
126378334|NCT01244035|454682983|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
126378335|NCT01244035|454682984|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
126378336|NCT01244035|454682985|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
126378337|NCT01244035|454682980|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
126378338|NCT01244035|454682981|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
126378339|NCT01244035|454682982|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
126378340|NCT01244035|454682983|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
126378341|NCT01244035|454682984|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
126716975|NCT01469013|455915000|FG000|Part A (Treatment Period)|Adverse Event|1|||
126716976|NCT01469013|455915001|FG001|Part A (Treatment Period)|Adverse Event|0|||
126716977|NCT01469013|455915002|FG002|Part A (Treatment Period)|Adverse Event|0|||
126716978|NCT01469013|455915003|FG003|Part A (Treatment Period)|Adverse Event|0|||
126716979|NCT01469013|455915004|FG004|Part A (Treatment Period)|Adverse Event|1|||
126716980|NCT01469013|455915005|FG005|Part A (Treatment Period)|Adverse Event|0|||
126716981|NCT01469013|455915006|FG006|Part A (Treatment Period)|Adverse Event|0|||
126716982|NCT01469013|455915007|FG007|Part A (Treatment Period)|Adverse Event|0|||
126716983|NCT01469013|455915008|FG008|Part A (Treatment Period)|Adverse Event|0|||
126716984|NCT01469013|455915009|FG009|Part A (Treatment Period)|Adverse Event|0|||
126716985|NCT01469013|455915010|FG010|Part A (Treatment Period)|Adverse Event|0|||
126716986|NCT01469013|455915011|FG011|Part A (Treatment Period)|Adverse Event|0|||
126716987|NCT01469013|455915012|FG012|Part A (Treatment Period)|Adverse Event|0|||
126716988|NCT01469013|455915000|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
126716989|NCT01469013|455915001|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
126716990|NCT01469013|455915002|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
126716991|NCT01469013|455915003|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
126716992|NCT01469013|455915004|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
126716993|NCT01469013|455915005|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
126716994|NCT01469013|455915006|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
126716995|NCT01469013|455915007|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
126716996|NCT01469013|455915008|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
126716997|NCT01469013|455915009|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
126716998|NCT01469013|455915010|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
126716999|NCT01469013|455915011|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
126717000|NCT01469013|455915012|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
126717001|NCT01469013|455915000|FG000|Part B (Extension Period)|Adverse Event|0|||
126717002|NCT01469013|455915001|FG001|Part B (Extension Period)|Adverse Event|0|||
126717003|NCT01469013|455915002|FG002|Part B (Extension Period)|Adverse Event|0|||
126717004|NCT01469013|455915003|FG003|Part B (Extension Period)|Adverse Event|0|||
126378342|NCT01244035|454682985|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
126378343|NCT01244035|454682980|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
126378344|NCT01244035|454682981|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
126378345|NCT01244035|454682982|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
126378346|NCT01244035|454682983|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
126378347|NCT01244035|454682984|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
126378348|NCT01244035|454682985|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
126378349|NCT01244035|454682980|FG000|Part 1: Period 3|Adverse Event|0|||
126378350|NCT01244035|454682981|FG001|Part 1: Period 3|Adverse Event|0|||
126378351|NCT01244035|454682982|FG002|Part 1: Period 3|Adverse Event|0|||
126378352|NCT01244035|454682983|FG003|Part 1: Period 3|Adverse Event|0|||
126378353|NCT01244035|454682984|FG004|Part 1: Period 3|Adverse Event|0|||
126378354|NCT01244035|454682985|FG005|Part 1: Period 3|Adverse Event|1|||
126378355|NCT01244035|454682980|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
126378356|NCT01244035|454682981|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
126378357|NCT01244035|454682982|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
126378358|NCT01244035|454682983|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
126378359|NCT01244035|454682984|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
126378360|NCT01244035|454682985|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
126378361|NCT01244035|454682980|FG000|Part 1: Period 3|Protocol Deviation|0|||
126378362|NCT01244035|454682981|FG001|Part 1: Period 3|Protocol Deviation|1|||
126378363|NCT01244035|454682982|FG002|Part 1: Period 3|Protocol Deviation|0|||
126378364|NCT01244035|454682983|FG003|Part 1: Period 3|Protocol Deviation|0|||
126378365|NCT01244035|454682984|FG004|Part 1: Period 3|Protocol Deviation|0|||
126378366|NCT01244035|454682985|FG005|Part 1: Period 3|Protocol Deviation|0|||
126378367|NCT01696773|454682986|FG000|Days 15-27, Washout|Adverse Event|1|||
126378368|NCT01696773|454682987|FG001|Days 15-27, Washout|Adverse Event|0|||
126378369|NCT02370368|454682990|FG000|Overall Study|Adverse Event|1|||
126378370|NCT02370368|454682991|FG001|Overall Study|Adverse Event|2|||
126378371|NCT02370368|454682990|FG000|Overall Study|Withdrawal by Subject|5|||
126378372|NCT02370368|454682991|FG001|Overall Study|Withdrawal by Subject|4|||
126378373|NCT00347932|454682994|FG000|Overall Study|Adverse Event|4|||
126378374|NCT00347932|454682995|FG001|Overall Study|Adverse Event|5|||
126378375|NCT00347932|454682994|FG000|Overall Study|Lack of Efficacy|3|||
126378376|NCT00347932|454682995|FG001|Overall Study|Lack of Efficacy|14|||
126378377|NCT00347932|454682994|FG000|Overall Study|Lost to Follow-up|10|||
126378378|NCT00347932|454682995|FG001|Overall Study|Lost to Follow-up|9|||
126378379|NCT00347932|454682994|FG000|Overall Study|Withdrawal by Subject|10|||
126378380|NCT00347932|454682995|FG001|Overall Study|Withdrawal by Subject|16|||
126717005|NCT01469013|455915004|FG004|Part B (Extension Period)|Adverse Event|0|||
126378381|NCT00347932|454682994|FG000|Overall Study|Did not meet inclusion criteria|4|||
126378382|NCT00347932|454682995|FG001|Overall Study|Did not meet inclusion criteria|8|||
126378383|NCT04512001|454682996|FG000|Week 0 to Week 24|Adverse Event|14|||
126378384|NCT04512001|454682997|FG001|Week 0 to Week 24|Adverse Event|10|||
126378385|NCT04512001|454682998|FG002|Week 0 to Week 24|Adverse Event|0|||
126378386|NCT04512001|454682999|FG003|Week 0 to Week 24|Adverse Event|0|||
126378387|NCT04512001|454683000|FG004|Week 0 to Week 24|Adverse Event|0|||
126378388|NCT04512001|454682996|FG000|Week 0 to Week 24|Death|0|||
126378389|NCT04512001|454682997|FG001|Week 0 to Week 24|Death|2|||
126378390|NCT04512001|454682998|FG002|Week 0 to Week 24|Death|0|||
126378391|NCT04512001|454682999|FG003|Week 0 to Week 24|Death|0|||
126378392|NCT04512001|454683000|FG004|Week 0 to Week 24|Death|0|||
126378393|NCT04512001|454682996|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
126378394|NCT04512001|454682997|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
126378395|NCT04512001|454682998|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
126378396|NCT04512001|454682999|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
126378397|NCT04512001|454683000|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
126378398|NCT04512001|454682996|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
126378399|NCT04512001|454682997|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
126378400|NCT04512001|454682998|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
126378401|NCT04512001|454682999|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
126378402|NCT04512001|454683000|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
126378403|NCT04512001|454682996|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
126378404|NCT04512001|454682997|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
126378405|NCT04512001|454682998|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
126378406|NCT04512001|454682999|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
126378407|NCT04512001|454683000|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
126378408|NCT04512001|454682996|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
126378409|NCT04512001|454682997|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
126378410|NCT04512001|454682998|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
126378411|NCT04512001|454682999|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
126378412|NCT04512001|454683000|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
126378413|NCT04512001|454682996|FG000|Week 24 to Week 63|Adverse Event|0|||
126378414|NCT04512001|454682997|FG001|Week 24 to Week 63|Adverse Event|0|||
126378415|NCT04512001|454682998|FG002|Week 24 to Week 63|Adverse Event|13|||
126378416|NCT04512001|454682999|FG003|Week 24 to Week 63|Adverse Event|8|||
126378417|NCT04512001|454683000|FG004|Week 24 to Week 63|Adverse Event|6|||
126378418|NCT04512001|454682996|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
126467580|NCT04087213|455013381|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
126467581|NCT04087213|455013381|FG000|Assisted Evaluable Period|Personal reasons|3|||
126467582|NCT04087213|455013381|FG000|Transition Period B|Renal Transplantation|1|||
126717006|NCT01469013|455915005|FG005|Part B (Extension Period)|Adverse Event|2|||
126717007|NCT01469013|455915006|FG006|Part B (Extension Period)|Adverse Event|5|||
126717008|NCT01469013|455915007|FG007|Part B (Extension Period)|Adverse Event|5|||
126717009|NCT01469013|455915008|FG008|Part B (Extension Period)|Adverse Event|3|||
126717010|NCT01469013|455915009|FG009|Part B (Extension Period)|Adverse Event|3|||
126717011|NCT01469013|455915010|FG010|Part B (Extension Period)|Adverse Event|1|||
126717012|NCT01469013|455915011|FG011|Part B (Extension Period)|Adverse Event|6|||
126717013|NCT01469013|455915012|FG012|Part B (Extension Period)|Adverse Event|3|||
126717014|NCT01469013|455915000|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
126717015|NCT01469013|455915001|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
126717016|NCT01469013|455915002|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
126717017|NCT01469013|455915003|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
126717018|NCT01469013|455915004|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
126717019|NCT01469013|455915005|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
126717020|NCT01469013|455915006|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
126717021|NCT01469013|455915007|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
126717022|NCT01469013|455915008|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
126717023|NCT01469013|455915009|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
126717024|NCT01469013|455915010|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
126717025|NCT01469013|455915011|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
126717026|NCT01469013|455915012|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
126717027|NCT00002663|455915013|FG000|Overall Study|Death|4|||
126717028|NCT00002663|455915014|FG001|Overall Study|Death|1|||
126717029|NCT00002663|455915015|FG002|Overall Study|Death|1|||
126717030|NCT00002663|455915016|FG003|Overall Study|Death|0|||
126717031|NCT00002663|455915017|FG004|Overall Study|Death|0|||
126467583|NCT02556203|455013388|FG000|Overall Study|Withdrawal by Subject|21|||
126467584|NCT02556203|455013389|FG001|Overall Study|Withdrawal by Subject|21|||
126717032|NCT00002663|455915018|FG005|Overall Study|Death|13|||
126717033|NCT00002663|455915019|FG006|Overall Study|Death|0|||
126717034|NCT00002663|455915020|FG007|Overall Study|Death|1|||
126771134|NCT04529096|456116271|FG000|Overall Study|Lack of Efficacy|1|||
126378419|NCT04512001|454682997|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
126378420|NCT04512001|454682998|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
126378421|NCT04512001|454682999|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
126378422|NCT04512001|454683000|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
126378423|NCT04512001|454682996|FG000|Week 24 to Week 63|Death|0|||
126717035|NCT00002663|455915021|FG008|Overall Study|Death|1|||
126378424|NCT04512001|454682997|FG001|Week 24 to Week 63|Death|0|||
126378425|NCT04512001|454682998|FG002|Week 24 to Week 63|Death|0|||
126378426|NCT04512001|454682999|FG003|Week 24 to Week 63|Death|1|||
126378427|NCT04512001|454683000|FG004|Week 24 to Week 63|Death|1|||
126378428|NCT04512001|454682996|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
126378429|NCT04512001|454682997|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
126378430|NCT04512001|454682998|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
126378431|NCT04512001|454682999|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
126378432|NCT04512001|454683000|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
126378433|NCT04512001|454682996|FG000|Week 24 to Week 63|Miscellaneous|0|||
126378434|NCT04512001|454682997|FG001|Week 24 to Week 63|Miscellaneous|0|||
126378435|NCT04512001|454682998|FG002|Week 24 to Week 63|Miscellaneous|3|||
126378436|NCT04512001|454682999|FG003|Week 24 to Week 63|Miscellaneous|2|||
126378437|NCT04512001|454683000|FG004|Week 24 to Week 63|Miscellaneous|1|||
126378438|NCT03389308|454683003|FG000|Overall Study|Withdrawal by Subject|5|||
126378439|NCT03389308|454683003|FG000|Overall Study|Lost to Follow-up|3|||
126378440|NCT03389308|454683003|FG000|Overall Study|Adverse Event|2|||
126378441|NCT03389308|454683003|FG000|Overall Study|Sponsor Request|2|||
126378442|NCT03198767|454683004|FG000|Overall Study|Protocol Violation|0|||
126378443|NCT03198767|454683005|FG001|Overall Study|Protocol Violation|0|||
126378444|NCT03198767|454683006|FG002|Overall Study|Protocol Violation|0|||
126378445|NCT03198767|454683007|FG003|Overall Study|Protocol Violation|6|||
126378446|NCT03198767|454683008|FG004|Overall Study|Protocol Violation|0|||
126378447|NCT03198767|454683009|FG005|Overall Study|Protocol Violation|0|||
126378448|NCT03198767|454683010|FG006|Overall Study|Protocol Violation|0|||
126378449|NCT00570323|454683011|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
126378450|NCT00570323|454683012|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
126378451|NCT00570323|454683011|FG000|Started Treatment After Randomization|Protocol Violation|1|||
126378452|NCT00570323|454683012|FG001|Started Treatment After Randomization|Protocol Violation|0|||
126378453|NCT00570323|454683011|FG000|Started Treatment After Randomization|Physician Decision|1|||
126378454|NCT00570323|454683012|FG001|Started Treatment After Randomization|Physician Decision|0|||
126378455|NCT00570323|454683011|FG000|Complete Study After Start|Lost to Follow-up|0|||
126378456|NCT00570323|454683012|FG001|Complete Study After Start|Lost to Follow-up|1|||
126378457|NCT00570323|454683011|FG000|Complete Study After Start|Withdrawal by Subject|2|||
126378458|NCT00570323|454683012|FG001|Complete Study After Start|Withdrawal by Subject|0|||
126378459|NCT00570323|454683011|FG000|Complete Study After Start|Physician Decision|1|||
126378460|NCT00570323|454683012|FG001|Complete Study After Start|Physician Decision|0|||
126378461|NCT04232943|454683013|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
126378462|NCT04232943|454683014|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
126378463|NCT04232943|454683015|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
126378464|NCT04232943|454683013|FG000|Overall Study|Withdrawal by Subject|1|||
126378465|NCT04232943|454683014|FG001|Overall Study|Withdrawal by Subject|1|||
126378466|NCT04232943|454683015|FG002|Overall Study|Withdrawal by Subject|0|||
126378467|NCT03896477|454683018|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
126378468|NCT03896477|454683019|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
126378469|NCT03896477|454683020|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
126378470|NCT03896477|454683018|FG000|Overall Study|Parent Requested Withdrawal|8|||
126378471|NCT03896477|454683019|FG001|Overall Study|Parent Requested Withdrawal|12|||
126378472|NCT03896477|454683020|FG002|Overall Study|Parent Requested Withdrawal|9|||
126378473|NCT03896477|454683018|FG000|Overall Study|Adverse Event|0|||
126378474|NCT03896477|454683019|FG001|Overall Study|Adverse Event|0|||
126378475|NCT03896477|454683020|FG002|Overall Study|Adverse Event|1|||
126378476|NCT03896477|454683018|FG000|Overall Study|Death|1|||
126378477|NCT03896477|454683019|FG001|Overall Study|Death|0|||
126378478|NCT03896477|454683020|FG002|Overall Study|Death|0|||
126378479|NCT03896477|454683018|FG000|Overall Study|Other|5|||
126378480|NCT03896477|454683019|FG001|Overall Study|Other|6|||
126378481|NCT03896477|454683020|FG002|Overall Study|Other|7|||
126378482|NCT03896477|454683018|FG000|Overall Study|Lost to Follow-up|2|||
126378483|NCT03896477|454683019|FG001|Overall Study|Lost to Follow-up|1|||
126378484|NCT03896477|454683020|FG002|Overall Study|Lost to Follow-up|1|||
126378485|NCT01791517|454683021|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
126378486|NCT01791517|454683022|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
126378487|NCT01791517|454683023|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
126378488|NCT01791517|454683024|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
126378489|NCT01791517|454683025|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
126378490|NCT01791517|454683026|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
126378491|NCT01791517|454683027|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
126378492|NCT01791517|454683028|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
126378493|NCT01791517|454683029|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
126378494|NCT01791517|454683030|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
126467585|NCT02556203|455013388|FG000|Overall Study|Lost to Follow-up|5|||
126467586|NCT02556203|455013389|FG001|Overall Study|Lost to Follow-up|5|||
126467587|NCT02556203|455013388|FG000|Overall Study|Adverse Event|1|||
126378495|NCT01791517|454683031|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
126467588|NCT02556203|455013389|FG001|Overall Study|Adverse Event|0|||
126553139|NCT02291289|455320512|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
126553140|NCT02291289|455320513|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
126553141|NCT02291289|455320501|FG000|Early Disease Progression|Death|0|||
126553142|NCT02291289|455320502|FG001|Early Disease Progression|Death|0|||
126553143|NCT02291289|455320503|FG002|Early Disease Progression|Death|0|||
126553144|NCT02291289|455320504|FG003|Early Disease Progression|Death|0|||
126553145|NCT02291289|455320505|FG004|Early Disease Progression|Death|0|||
126553146|NCT02291289|455320506|FG005|Early Disease Progression|Death|0|||
126553147|NCT02291289|455320507|FG006|Early Disease Progression|Death|0|||
126553148|NCT02291289|455320508|FG007|Early Disease Progression|Death|0|||
126553149|NCT02291289|455320509|FG008|Early Disease Progression|Death|0|||
126553150|NCT02291289|455320510|FG009|Early Disease Progression|Death|0|||
126553151|NCT02291289|455320511|FG010|Early Disease Progression|Death|0|||
126553152|NCT02291289|455320512|FG011|Early Disease Progression|Death|0|||
126553153|NCT02291289|455320513|FG012|Early Disease Progression|Death|10|||
126553154|NCT02291289|455320501|FG000|Early Disease Progression|Lost to Follow-up|0|||
126553155|NCT02291289|455320502|FG001|Early Disease Progression|Lost to Follow-up|0|||
126553156|NCT02291289|455320503|FG002|Early Disease Progression|Lost to Follow-up|0|||
126553157|NCT02291289|455320504|FG003|Early Disease Progression|Lost to Follow-up|0|||
126553158|NCT02291289|455320505|FG004|Early Disease Progression|Lost to Follow-up|0|||
126553159|NCT02291289|455320506|FG005|Early Disease Progression|Lost to Follow-up|0|||
126553160|NCT02291289|455320507|FG006|Early Disease Progression|Lost to Follow-up|0|||
126553161|NCT02291289|455320508|FG007|Early Disease Progression|Lost to Follow-up|0|||
126553162|NCT02291289|455320509|FG008|Early Disease Progression|Lost to Follow-up|0|||
126553163|NCT02291289|455320510|FG009|Early Disease Progression|Lost to Follow-up|0|||
126553164|NCT02291289|455320511|FG010|Early Disease Progression|Lost to Follow-up|0|||
126553165|NCT02291289|455320512|FG011|Early Disease Progression|Lost to Follow-up|0|||
126553166|NCT02291289|455320513|FG012|Early Disease Progression|Lost to Follow-up|1|||
126553167|NCT01642186|455320516|FG000|Overall Study|Death|0|||
126553168|NCT01642186|455320517|FG001|Overall Study|Death|2|||
126553169|NCT01642186|455320518|FG002|Overall Study|Death|2|||
126553170|NCT01642186|455320516|FG000|Overall Study|Lost to Follow-up|0|||
126378496|NCT01791517|454683032|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
126378497|NCT01791517|454683021|FG000|Phase I: Period 1|Adverse Event|0|||
126378498|NCT01791517|454683022|FG001|Phase I: Period 1|Adverse Event|0|||
126378499|NCT01791517|454683023|FG002|Phase I: Period 1|Adverse Event|1|||
126378500|NCT01791517|454683024|FG003|Phase I: Period 1|Adverse Event|1|||
126378501|NCT01791517|454683025|FG004|Phase I: Period 1|Adverse Event|0|||
126378502|NCT01791517|454683026|FG005|Phase I: Period 1|Adverse Event|0|||
126378503|NCT01791517|454683027|FG006|Phase I: Period 1|Adverse Event|0|||
126378504|NCT01791517|454683028|FG007|Phase I: Period 1|Adverse Event|0|||
126378505|NCT01791517|454683029|FG008|Phase I: Period 1|Adverse Event|0|||
126378506|NCT01791517|454683030|FG009|Phase I: Period 1|Adverse Event|0|||
126378507|NCT01791517|454683031|FG010|Phase I: Period 1|Adverse Event|0|||
126378508|NCT01791517|454683032|FG011|Phase I: Period 1|Adverse Event|0|||
126378509|NCT01791517|454683021|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
126378510|NCT01791517|454683022|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378511|NCT01791517|454683023|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378512|NCT01791517|454683024|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378513|NCT01791517|454683025|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378514|NCT01791517|454683026|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378515|NCT01791517|454683027|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378516|NCT01791517|454683028|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378517|NCT01791517|454683029|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378518|NCT01791517|454683030|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378519|NCT01791517|454683031|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378520|NCT01791517|454683032|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
126378521|NCT01791517|454683021|FG000|Phase I: Period 1|Protocol Violation|0|||
126378522|NCT01791517|454683022|FG001|Phase I: Period 1|Protocol Violation|1|||
126378523|NCT01791517|454683023|FG002|Phase I: Period 1|Protocol Violation|0|||
126378524|NCT01791517|454683024|FG003|Phase I: Period 1|Protocol Violation|0|||
126378525|NCT01791517|454683025|FG004|Phase I: Period 1|Protocol Violation|0|||
126378526|NCT01791517|454683026|FG005|Phase I: Period 1|Protocol Violation|0|||
126553171|NCT01642186|455320517|FG001|Overall Study|Lost to Follow-up|0|||
126553172|NCT01642186|455320518|FG002|Overall Study|Lost to Follow-up|1|||
126378527|NCT01791517|454683027|FG006|Phase I: Period 1|Protocol Violation|0|||
126378528|NCT01791517|454683028|FG007|Phase I: Period 1|Protocol Violation|0|||
126378529|NCT01791517|454683029|FG008|Phase I: Period 1|Protocol Violation|0|||
126378530|NCT01791517|454683030|FG009|Phase I: Period 1|Protocol Violation|0|||
126378531|NCT01791517|454683031|FG010|Phase I: Period 1|Protocol Violation|0|||
126553173|NCT01668147|455320519|FG000|Overall Study|Withdrawal by Subject|6|||
126553174|NCT00590980|455320525|FG000|Overall Study|Did not meet all inclusion criteria|10|||
126553175|NCT00506285|455320527|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
126378532|NCT01791517|454683032|FG011|Phase I: Period 1|Protocol Violation|0|||
126553176|NCT00506285|455320528|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
126717036|NCT00002663|455915022|FG009|Overall Study|Death|1|||
126467589|NCT04587271|455013390|FG000|Overall Study|Lost to Follow-up|2|||
126467590|NCT04587271|455013391|FG001|Overall Study|Lost to Follow-up|2|||
126467591|NCT04587271|455013392|FG002|Overall Study|Lost to Follow-up|0|||
126467592|NCT04587271|455013393|FG003|Overall Study|Lost to Follow-up|2|||
126467593|NCT04587271|455013394|FG004|Overall Study|Lost to Follow-up|2|||
126467594|NCT04587271|455013395|FG005|Overall Study|Lost to Follow-up|0|||
126467595|NCT04587271|455013390|FG000|Overall Study|Caregiver brought child to visits|0|||
126553177|NCT00506285|455320527|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
126553178|NCT00506285|455320528|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
126553179|NCT00506285|455320527|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
126553180|NCT00506285|455320528|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
126553181|NCT00506285|455320527|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
126553182|NCT00506285|455320528|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
126553183|NCT00506285|455320527|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
126553184|NCT00506285|455320528|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
126553185|NCT01089556|455320529|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
126553186|NCT01089556|455320530|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
126553187|NCT01089556|455320531|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
126553188|NCT01089556|455320532|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
126553189|NCT01089556|455320533|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
126553190|NCT01089556|455320534|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
126553191|NCT01089556|455320529|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
126553192|NCT01089556|455320530|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
126717037|NCT00002663|455915013|FG000|Overall Study|Lost to Follow-up|3|||
126717038|NCT00002663|455915014|FG001|Overall Study|Lost to Follow-up|0|||
126717039|NCT00002663|455915015|FG002|Overall Study|Lost to Follow-up|0|||
126717040|NCT00002663|455915016|FG003|Overall Study|Lost to Follow-up|1|||
126717041|NCT00002663|455915017|FG004|Overall Study|Lost to Follow-up|0|||
126717042|NCT00002663|455915018|FG005|Overall Study|Lost to Follow-up|1|||
126717043|NCT00002663|455915019|FG006|Overall Study|Lost to Follow-up|0|||
126717044|NCT00002663|455915020|FG007|Overall Study|Lost to Follow-up|0|||
126717045|NCT00002663|455915021|FG008|Overall Study|Lost to Follow-up|0|||
126717046|NCT00002663|455915022|FG009|Overall Study|Lost to Follow-up|0|||
126717047|NCT00002663|455915013|FG000|Overall Study|Other|0|||
126717048|NCT00002663|455915014|FG001|Overall Study|Other|1|||
126717049|NCT00002663|455915015|FG002|Overall Study|Other|0|||
126717050|NCT00002663|455915016|FG003|Overall Study|Other|0|||
126717051|NCT00002663|455915017|FG004|Overall Study|Other|0|||
126717052|NCT00002663|455915018|FG005|Overall Study|Other|1|||
126717053|NCT00002663|455915019|FG006|Overall Study|Other|1|||
126717054|NCT00002663|455915020|FG007|Overall Study|Other|0|||
126717055|NCT00002663|455915021|FG008|Overall Study|Other|0|||
126717056|NCT00002663|455915022|FG009|Overall Study|Other|0|||
126553193|NCT01089556|455320531|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
126553194|NCT01089556|455320532|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
126717057|NCT00002663|455915013|FG000|Overall Study|Physician Decision|0|||
126717058|NCT00002663|455915014|FG001|Overall Study|Physician Decision|0|||
126378533|NCT01791517|454683021|FG000|Phase I: Period 1|Lost to Follow-up|0|||
126378534|NCT01791517|454683022|FG001|Phase I: Period 1|Lost to Follow-up|0|||
126378535|NCT01791517|454683023|FG002|Phase I: Period 1|Lost to Follow-up|0|||
126378536|NCT01791517|454683024|FG003|Phase I: Period 1|Lost to Follow-up|1|||
126378537|NCT01791517|454683025|FG004|Phase I: Period 1|Lost to Follow-up|0|||
126378538|NCT01791517|454683026|FG005|Phase I: Period 1|Lost to Follow-up|0|||
126378539|NCT01791517|454683027|FG006|Phase I: Period 1|Lost to Follow-up|1|||
126378540|NCT01791517|454683028|FG007|Phase I: Period 1|Lost to Follow-up|0|||
126378541|NCT01791517|454683029|FG008|Phase I: Period 1|Lost to Follow-up|1|||
126378542|NCT01791517|454683030|FG009|Phase I: Period 1|Lost to Follow-up|1|||
126378543|NCT01791517|454683031|FG010|Phase I: Period 1|Lost to Follow-up|0|||
126378544|NCT01791517|454683032|FG011|Phase I: Period 1|Lost to Follow-up|0|||
126378545|NCT01791517|454683021|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378546|NCT01791517|454683022|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378547|NCT01791517|454683023|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378548|NCT01791517|454683024|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378549|NCT01791517|454683025|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378550|NCT01791517|454683026|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378551|NCT01791517|454683027|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378552|NCT01791517|454683028|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378553|NCT01791517|454683029|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378554|NCT01791517|454683030|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378555|NCT01791517|454683031|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
126378556|NCT01791517|454683032|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
126378557|NCT01791517|454683021|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
126467596|NCT04587271|455013391|FG001|Overall Study|Caregiver brought child to visits|0|||
126717059|NCT00002663|455915015|FG002|Overall Study|Physician Decision|0|||
126717060|NCT00002663|455915016|FG003|Overall Study|Physician Decision|0|||
126467597|NCT04587271|455013392|FG002|Overall Study|Caregiver brought child to visits|0|||
126378558|NCT01791517|454683022|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378559|NCT01791517|454683023|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378560|NCT01791517|454683024|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378561|NCT01791517|454683025|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378562|NCT01791517|454683026|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378563|NCT01791517|454683027|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378564|NCT01791517|454683028|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378565|NCT01791517|454683029|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378566|NCT01791517|454683030|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378567|NCT01791517|454683031|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378568|NCT01791517|454683032|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
126378569|NCT01791517|454683021|FG000|Phase I: Period 2|Protocol Violation|0|||
126378570|NCT01791517|454683022|FG001|Phase I: Period 2|Protocol Violation|0|||
126378571|NCT01791517|454683023|FG002|Phase I: Period 2|Protocol Violation|0|||
126378572|NCT01791517|454683024|FG003|Phase I: Period 2|Protocol Violation|1|||
126378573|NCT01791517|454683025|FG004|Phase I: Period 2|Protocol Violation|0|||
126378574|NCT01791517|454683026|FG005|Phase I: Period 2|Protocol Violation|0|||
126378575|NCT01791517|454683027|FG006|Phase I: Period 2|Protocol Violation|0|||
126378576|NCT01791517|454683028|FG007|Phase I: Period 2|Protocol Violation|0|||
126378577|NCT01791517|454683029|FG008|Phase I: Period 2|Protocol Violation|0|||
126378578|NCT01791517|454683030|FG009|Phase I: Period 2|Protocol Violation|0|||
126378579|NCT01791517|454683031|FG010|Phase I: Period 2|Protocol Violation|0|||
126378580|NCT01791517|454683032|FG011|Phase I: Period 2|Protocol Violation|0|||
126378581|NCT01791517|454683021|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
126378582|NCT01791517|454683022|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
126378583|NCT01791517|454683023|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
126378584|NCT01791517|454683024|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
126378585|NCT01791517|454683025|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
126378586|NCT01791517|454683026|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
126378587|NCT01791517|454683027|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
126378588|NCT01791517|454683028|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
126378589|NCT01791517|454683029|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
126378590|NCT01791517|454683030|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
126378591|NCT01791517|454683031|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
126378592|NCT01791517|454683032|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
126378593|NCT01791517|454683021|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378594|NCT01791517|454683022|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378595|NCT01791517|454683023|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378596|NCT01791517|454683024|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378597|NCT01791517|454683025|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378598|NCT01791517|454683026|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378599|NCT01791517|454683027|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378600|NCT01791517|454683028|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378601|NCT01791517|454683029|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378602|NCT01791517|454683030|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378603|NCT01791517|454683031|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
126378604|NCT01791517|454683032|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
126378605|NCT01791517|454683021|FG000|Phase I: Period 2|Lens Discomfort|0|||
126378606|NCT01791517|454683022|FG001|Phase I: Period 2|Lens Discomfort|0|||
126378607|NCT01791517|454683023|FG002|Phase I: Period 2|Lens Discomfort|0|||
126378608|NCT01791517|454683024|FG003|Phase I: Period 2|Lens Discomfort|0|||
126378609|NCT01791517|454683025|FG004|Phase I: Period 2|Lens Discomfort|0|||
126378610|NCT01791517|454683026|FG005|Phase I: Period 2|Lens Discomfort|1|||
126378611|NCT01791517|454683027|FG006|Phase I: Period 2|Lens Discomfort|0|||
126378612|NCT01791517|454683028|FG007|Phase I: Period 2|Lens Discomfort|0|||
126378613|NCT01791517|454683029|FG008|Phase I: Period 2|Lens Discomfort|0|||
126378614|NCT01791517|454683030|FG009|Phase I: Period 2|Lens Discomfort|0|||
126378615|NCT01791517|454683031|FG010|Phase I: Period 2|Lens Discomfort|0|||
126378616|NCT01791517|454683032|FG011|Phase I: Period 2|Lens Discomfort|0|||
126378617|NCT01791517|454683021|FG000|Phase I: Period 2|Lost to Follow-up|0|||
126378618|NCT01791517|454683022|FG001|Phase I: Period 2|Lost to Follow-up|3|||
126378619|NCT01791517|454683023|FG002|Phase I: Period 2|Lost to Follow-up|2|||
126378620|NCT01791517|454683024|FG003|Phase I: Period 2|Lost to Follow-up|0|||
126378621|NCT01791517|454683025|FG004|Phase I: Period 2|Lost to Follow-up|0|||
126378622|NCT01791517|454683026|FG005|Phase I: Period 2|Lost to Follow-up|0|||
126378623|NCT01791517|454683027|FG006|Phase I: Period 2|Lost to Follow-up|0|||
126378624|NCT01791517|454683028|FG007|Phase I: Period 2|Lost to Follow-up|0|||
126378625|NCT01791517|454683029|FG008|Phase I: Period 2|Lost to Follow-up|0|||
126378626|NCT01791517|454683030|FG009|Phase I: Period 2|Lost to Follow-up|0|||
126378627|NCT01791517|454683031|FG010|Phase I: Period 2|Lost to Follow-up|0|||
126378628|NCT01791517|454683032|FG011|Phase I: Period 2|Lost to Follow-up|0|||
126378629|NCT01791517|454683021|FG000|Phase I: Period 3|Lens Discomfort|0|||
126378630|NCT01791517|454683022|FG001|Phase I: Period 3|Lens Discomfort|0|||
126378631|NCT01791517|454683023|FG002|Phase I: Period 3|Lens Discomfort|0|||
126378632|NCT01791517|454683024|FG003|Phase I: Period 3|Lens Discomfort|0|||
126378633|NCT01791517|454683025|FG004|Phase I: Period 3|Lens Discomfort|0|||
126467598|NCT04587271|455013393|FG003|Overall Study|Caregiver brought child to visits|1|||
126467599|NCT04587271|455013394|FG004|Overall Study|Caregiver brought child to visits|0|||
126467600|NCT04587271|455013395|FG005|Overall Study|Caregiver brought child to visits|0|||
126467601|NCT01925274|455013400|FG000|Overall Study|Death|1|||
126467602|NCT01925274|455013401|FG001|Overall Study|Death|0|||
126467603|NCT01925274|455013402|FG002|Overall Study|Death|0|||
126467604|NCT01925274|455013400|FG000|Overall Study|Lost to Follow-up|0|||
126467605|NCT01925274|455013401|FG001|Overall Study|Lost to Follow-up|1|||
126467606|NCT01925274|455013402|FG002|Overall Study|Lost to Follow-up|0|||
126467607|NCT01925274|455013400|FG000|Overall Study|Withdrawal by Subject|1|||
126467608|NCT01925274|455013401|FG001|Overall Study|Withdrawal by Subject|2|||
126467609|NCT01925274|455013402|FG002|Overall Study|Withdrawal by Subject|0|||
126467610|NCT01925274|455013400|FG000|Overall Study|Study terminated by sponsor|4|||
126467611|NCT01925274|455013401|FG001|Overall Study|Study terminated by sponsor|0|||
126467612|NCT01925274|455013402|FG002|Overall Study|Study terminated by sponsor|0|||
126467613|NCT01925274|455013400|FG000|Overall Study|Protocol amendment|1|||
126467614|NCT01925274|455013401|FG001|Overall Study|Protocol amendment|3|||
126467615|NCT01925274|455013402|FG002|Overall Study|Protocol amendment|6|||
126467616|NCT01031381|455013405|FG000|Overall Study|Physician Decision|3|||
126467617|NCT01031381|455013405|FG000|Overall Study|Withdrawal by Subject|6|||
126467618|NCT00723398|455013406|FG000|Overall Study|Withdrawal by Subject|2|||
126378634|NCT01791517|454683026|FG005|Phase I: Period 3|Lens Discomfort|0|||
126378635|NCT01791517|454683027|FG006|Phase I: Period 3|Lens Discomfort|0|||
126378636|NCT01791517|454683028|FG007|Phase I: Period 3|Lens Discomfort|0|||
126378637|NCT01791517|454683029|FG008|Phase I: Period 3|Lens Discomfort|0|||
126378638|NCT01791517|454683030|FG009|Phase I: Period 3|Lens Discomfort|0|||
126378639|NCT01791517|454683031|FG010|Phase I: Period 3|Lens Discomfort|0|||
126378640|NCT01791517|454683032|FG011|Phase I: Period 3|Lens Discomfort|1|||
126378641|NCT01791517|454683021|FG000|Phase I: Period 3|Lost to Follow-up|0|||
126378642|NCT01791517|454683022|FG001|Phase I: Period 3|Lost to Follow-up|1|||
126378643|NCT01791517|454683023|FG002|Phase I: Period 3|Lost to Follow-up|0|||
126378644|NCT01791517|454683024|FG003|Phase I: Period 3|Lost to Follow-up|0|||
126378645|NCT01791517|454683025|FG004|Phase I: Period 3|Lost to Follow-up|1|||
126378646|NCT01791517|454683026|FG005|Phase I: Period 3|Lost to Follow-up|0|||
126378647|NCT01791517|454683027|FG006|Phase I: Period 3|Lost to Follow-up|0|||
126378648|NCT01791517|454683028|FG007|Phase I: Period 3|Lost to Follow-up|0|||
126378649|NCT01791517|454683029|FG008|Phase I: Period 3|Lost to Follow-up|0|||
126378650|NCT01791517|454683030|FG009|Phase I: Period 3|Lost to Follow-up|0|||
126378651|NCT01791517|454683031|FG010|Phase I: Period 3|Lost to Follow-up|0|||
126378652|NCT01791517|454683032|FG011|Phase I: Period 3|Lost to Follow-up|0|||
126378653|NCT01791517|454683021|FG000|Phase I: Period 3|Adverse Event|0|||
126378654|NCT01791517|454683022|FG001|Phase I: Period 3|Adverse Event|0|||
126378655|NCT01791517|454683023|FG002|Phase I: Period 3|Adverse Event|0|||
126378656|NCT01791517|454683024|FG003|Phase I: Period 3|Adverse Event|1|||
126378657|NCT01791517|454683025|FG004|Phase I: Period 3|Adverse Event|0|||
126378658|NCT01791517|454683026|FG005|Phase I: Period 3|Adverse Event|0|||
126378659|NCT01791517|454683027|FG006|Phase I: Period 3|Adverse Event|0|||
126378660|NCT01791517|454683028|FG007|Phase I: Period 3|Adverse Event|0|||
126378661|NCT01791517|454683029|FG008|Phase I: Period 3|Adverse Event|0|||
126378662|NCT01791517|454683030|FG009|Phase I: Period 3|Adverse Event|0|||
126378663|NCT01791517|454683031|FG010|Phase I: Period 3|Adverse Event|0|||
126378664|NCT01791517|454683032|FG011|Phase I: Period 3|Adverse Event|0|||
126378665|NCT01791517|454683021|FG000|Phase II|Lost to Follow-up|1|||
126378666|NCT01791517|454683022|FG001|Phase II|Lost to Follow-up|0|||
126378667|NCT01791517|454683023|FG002|Phase II|Lost to Follow-up|1|||
126378668|NCT01791517|454683024|FG003|Phase II|Lost to Follow-up|0|||
126378669|NCT01791517|454683025|FG004|Phase II|Lost to Follow-up|1|||
126378670|NCT01791517|454683026|FG005|Phase II|Lost to Follow-up|2|||
126378671|NCT01791517|454683027|FG006|Phase II|Lost to Follow-up|0|||
126378672|NCT01791517|454683028|FG007|Phase II|Lost to Follow-up|1|||
126378673|NCT01791517|454683029|FG008|Phase II|Lost to Follow-up|1|||
126467619|NCT00723398|455013407|FG001|Overall Study|Withdrawal by Subject|6|||
126467620|NCT00723398|455013408|FG002|Overall Study|Withdrawal by Subject|4|||
126467621|NCT00723398|455013409|FG003|Overall Study|Withdrawal by Subject|4|||
126378674|NCT01791517|454683030|FG009|Phase II|Lost to Follow-up|1|||
126378675|NCT01791517|454683031|FG010|Phase II|Lost to Follow-up|0|||
126378676|NCT01791517|454683032|FG011|Phase II|Lost to Follow-up|0|||
126378677|NCT01791517|454683021|FG000|Phase II|Withdrawal by Subject|1|||
126378678|NCT01791517|454683022|FG001|Phase II|Withdrawal by Subject|0|||
126378679|NCT01791517|454683023|FG002|Phase II|Withdrawal by Subject|0|||
126378680|NCT01791517|454683024|FG003|Phase II|Withdrawal by Subject|0|||
126378681|NCT01791517|454683025|FG004|Phase II|Withdrawal by Subject|0|||
126378682|NCT01791517|454683026|FG005|Phase II|Withdrawal by Subject|2|||
126378683|NCT01791517|454683027|FG006|Phase II|Withdrawal by Subject|0|||
126378684|NCT01791517|454683028|FG007|Phase II|Withdrawal by Subject|1|||
126467622|NCT00723398|455013410|FG004|Overall Study|Withdrawal by Subject|4|||
126467623|NCT00723398|455013406|FG000|Overall Study|Protocol Violation|2|||
126467624|NCT00723398|455013407|FG001|Overall Study|Protocol Violation|1|||
126467625|NCT00723398|455013408|FG002|Overall Study|Protocol Violation|5|||
126378685|NCT01791517|454683029|FG008|Phase II|Withdrawal by Subject|0|||
126378686|NCT01791517|454683030|FG009|Phase II|Withdrawal by Subject|0|||
126378687|NCT01791517|454683031|FG010|Phase II|Withdrawal by Subject|1|||
126378688|NCT01791517|454683032|FG011|Phase II|Withdrawal by Subject|0|||
126378689|NCT01791517|454683021|FG000|Phase II|Lack of Efficacy|0|||
126378690|NCT01791517|454683022|FG001|Phase II|Lack of Efficacy|0|||
126378691|NCT01791517|454683023|FG002|Phase II|Lack of Efficacy|0|||
126378692|NCT01791517|454683024|FG003|Phase II|Lack of Efficacy|0|||
126378693|NCT01791517|454683025|FG004|Phase II|Lack of Efficacy|1|||
126378694|NCT01791517|454683026|FG005|Phase II|Lack of Efficacy|0|||
126378695|NCT01791517|454683027|FG006|Phase II|Lack of Efficacy|0|||
126378696|NCT01791517|454683028|FG007|Phase II|Lack of Efficacy|0|||
126378697|NCT01791517|454683029|FG008|Phase II|Lack of Efficacy|0|||
126378698|NCT01791517|454683030|FG009|Phase II|Lack of Efficacy|0|||
126378699|NCT01791517|454683031|FG010|Phase II|Lack of Efficacy|0|||
126378700|NCT01791517|454683032|FG011|Phase II|Lack of Efficacy|0|||
126378701|NCT01791517|454683021|FG000|Phase II|Adverse Event|0|||
126378702|NCT01791517|454683022|FG001|Phase II|Adverse Event|0|||
126378703|NCT01791517|454683023|FG002|Phase II|Adverse Event|0|||
126378704|NCT01791517|454683024|FG003|Phase II|Adverse Event|0|||
126378705|NCT01791517|454683025|FG004|Phase II|Adverse Event|0|||
126378706|NCT01791517|454683026|FG005|Phase II|Adverse Event|0|||
126378707|NCT01791517|454683027|FG006|Phase II|Adverse Event|2|||
126378708|NCT01791517|454683028|FG007|Phase II|Adverse Event|1|||
126378709|NCT01791517|454683029|FG008|Phase II|Adverse Event|0|||
126378710|NCT01791517|454683030|FG009|Phase II|Adverse Event|1|||
126378711|NCT01791517|454683031|FG010|Phase II|Adverse Event|0|||
126378712|NCT01791517|454683032|FG011|Phase II|Adverse Event|0|||
126378713|NCT01791517|454683021|FG000|Phase II|Lens Handling Difficulties|0|||
126378714|NCT01791517|454683022|FG001|Phase II|Lens Handling Difficulties|0|||
126378715|NCT01791517|454683023|FG002|Phase II|Lens Handling Difficulties|0|||
126378716|NCT01791517|454683024|FG003|Phase II|Lens Handling Difficulties|0|||
126378717|NCT01791517|454683025|FG004|Phase II|Lens Handling Difficulties|0|||
126378718|NCT01791517|454683026|FG005|Phase II|Lens Handling Difficulties|0|||
126378719|NCT01791517|454683027|FG006|Phase II|Lens Handling Difficulties|0|||
126378720|NCT01791517|454683028|FG007|Phase II|Lens Handling Difficulties|0|||
126378721|NCT01791517|454683029|FG008|Phase II|Lens Handling Difficulties|1|||
126378722|NCT01791517|454683030|FG009|Phase II|Lens Handling Difficulties|0|||
126378723|NCT01791517|454683031|FG010|Phase II|Lens Handling Difficulties|0|||
126378724|NCT01791517|454683032|FG011|Phase II|Lens Handling Difficulties|0|||
126378725|NCT01791517|454683021|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
126378726|NCT01791517|454683022|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
126378727|NCT01791517|454683023|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
126378728|NCT01791517|454683024|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
126467626|NCT00723398|455013409|FG003|Overall Study|Protocol Violation|0|||
126467627|NCT00723398|455013410|FG004|Overall Study|Protocol Violation|0|||
126467628|NCT00723398|455013406|FG000|Overall Study|Physician Decision|2|||
126467629|NCT00723398|455013407|FG001|Overall Study|Physician Decision|2|||
126467630|NCT00723398|455013408|FG002|Overall Study|Physician Decision|5|||
126467631|NCT00723398|455013409|FG003|Overall Study|Physician Decision|0|||
126467632|NCT00723398|455013410|FG004|Overall Study|Physician Decision|1|||
126467633|NCT00723398|455013406|FG000|Overall Study|Adverse Event|0|||
126467634|NCT00723398|455013407|FG001|Overall Study|Adverse Event|5|||
126467635|NCT00723398|455013408|FG002|Overall Study|Adverse Event|3|||
126467636|NCT00723398|455013409|FG003|Overall Study|Adverse Event|1|||
126467637|NCT00723398|455013410|FG004|Overall Study|Adverse Event|4|||
126467638|NCT00723398|455013406|FG000|Overall Study|Lost to Follow-up|0|||
126467639|NCT00723398|455013407|FG001|Overall Study|Lost to Follow-up|1|||
126467640|NCT00723398|455013408|FG002|Overall Study|Lost to Follow-up|0|||
126467641|NCT00723398|455013409|FG003|Overall Study|Lost to Follow-up|0|||
126467642|NCT00723398|455013410|FG004|Overall Study|Lost to Follow-up|0|||
126467643|NCT00777205|455013413|FG000|Overall Study|Lost to Follow-up|25|||
126467644|NCT00777205|455013414|FG001|Overall Study|Lost to Follow-up|9|||
126467645|NCT00777205|455013413|FG000|Overall Study|Withdrawal by Subject|6|||
126467646|NCT00777205|455013414|FG001|Overall Study|Withdrawal by Subject|4|||
126467647|NCT00777205|455013413|FG000|Overall Study|Death|0|||
126467648|NCT00777205|455013414|FG001|Overall Study|Death|2|||
126378729|NCT01791517|454683025|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
126467649|NCT00777205|455013413|FG000|Overall Study|Protocol Violation|0|||
126378730|NCT01791517|454683026|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
126378731|NCT01791517|454683027|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
126378732|NCT01791517|454683028|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
126378733|NCT01791517|454683029|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
126378734|NCT01791517|454683030|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
126467650|NCT00777205|455013414|FG001|Overall Study|Protocol Violation|56|||
126467651|NCT01578330|455013417|FG000|Overall Study|Adverse Event|2|||
126467652|NCT01578330|455013417|FG000|Overall Study|Protocol Violation|5|||
126717061|NCT00002663|455915017|FG004|Overall Study|Physician Decision|1|||
126378735|NCT01791517|454683031|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
126378736|NCT01791517|454683032|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
126467653|NCT01676727|455013418|FG000|Overall Study|Death|18|||
126378737|NCT01791517|454683021|FG000|Phase II|Pre-Existing Ocular Issue|0|||
126378738|NCT01791517|454683022|FG001|Phase II|Pre-Existing Ocular Issue|0|||
126378739|NCT01791517|454683023|FG002|Phase II|Pre-Existing Ocular Issue|0|||
126378740|NCT01791517|454683024|FG003|Phase II|Pre-Existing Ocular Issue|0|||
126378741|NCT01791517|454683025|FG004|Phase II|Pre-Existing Ocular Issue|0|||
126378742|NCT01791517|454683026|FG005|Phase II|Pre-Existing Ocular Issue|0|||
126378743|NCT01791517|454683027|FG006|Phase II|Pre-Existing Ocular Issue|0|||
126378744|NCT01791517|454683028|FG007|Phase II|Pre-Existing Ocular Issue|0|||
126378745|NCT01791517|454683029|FG008|Phase II|Pre-Existing Ocular Issue|0|||
126378746|NCT01791517|454683030|FG009|Phase II|Pre-Existing Ocular Issue|0|||
126378747|NCT01791517|454683031|FG010|Phase II|Pre-Existing Ocular Issue|0|||
126378748|NCT01791517|454683032|FG011|Phase II|Pre-Existing Ocular Issue|1|||
126378749|NCT04011735|454683033|FG000|Overall Study|Withdrawal by Subject|1|||
126378750|NCT04011735|454683034|FG001|Overall Study|Withdrawal by Subject|0|||
126553195|NCT01089556|455320533|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
126378751|NCT04011735|454683035|FG002|Overall Study|Withdrawal by Subject|1|||
126378752|NCT04011735|454683033|FG000|Overall Study|Met exclusion criteria after study entry|0|||
126378753|NCT04011735|454683034|FG001|Overall Study|Met exclusion criteria after study entry|1|||
126378754|NCT04011735|454683035|FG002|Overall Study|Met exclusion criteria after study entry|0|||
126378755|NCT02298868|454683036|FG000|Overall Study|Adverse Event|1|||
126378756|NCT02298868|454683036|FG000|Overall Study|Death|1|||
126378757|NCT02298868|454683036|FG000|Overall Study|Patient underwent transplant|1|||
126378758|NCT01000506|454683037|FG000|Overall Study|Adverse Event|6|||
126378759|NCT01000506|454683038|FG001|Overall Study|Adverse Event|5|||
126378760|NCT01000506|454683039|FG002|Overall Study|Adverse Event|8|||
126378761|NCT01000506|454683040|FG003|Overall Study|Adverse Event|9|||
126378762|NCT01000506|454683037|FG000|Overall Study|Lack of Efficacy|8|||
126378763|NCT01000506|454683038|FG001|Overall Study|Lack of Efficacy|6|||
126378764|NCT01000506|454683039|FG002|Overall Study|Lack of Efficacy|4|||
126378765|NCT01000506|454683040|FG003|Overall Study|Lack of Efficacy|4|||
126378766|NCT01000506|454683037|FG000|Overall Study|Protocol Violation|1|||
126378767|NCT01000506|454683038|FG001|Overall Study|Protocol Violation|1|||
126378768|NCT01000506|454683039|FG002|Overall Study|Protocol Violation|0|||
126378769|NCT01000506|454683040|FG003|Overall Study|Protocol Violation|0|||
126378770|NCT01000506|454683037|FG000|Overall Study|Lost to Follow-up|1|||
126378771|NCT01000506|454683038|FG001|Overall Study|Lost to Follow-up|1|||
126378772|NCT01000506|454683039|FG002|Overall Study|Lost to Follow-up|4|||
126378773|NCT01000506|454683040|FG003|Overall Study|Lost to Follow-up|0|||
126378774|NCT01000506|454683037|FG000|Overall Study|Physician Decision|1|||
126378775|NCT01000506|454683038|FG001|Overall Study|Physician Decision|3|||
126378776|NCT01000506|454683039|FG002|Overall Study|Physician Decision|3|||
126378777|NCT01000506|454683040|FG003|Overall Study|Physician Decision|3|||
126378778|NCT01000506|454683037|FG000|Overall Study|Withdrawal by Subject|11|||
126378779|NCT01000506|454683038|FG001|Overall Study|Withdrawal by Subject|8|||
126378780|NCT01000506|454683039|FG002|Overall Study|Withdrawal by Subject|2|||
126378781|NCT01000506|454683040|FG003|Overall Study|Withdrawal by Subject|7|||
126378782|NCT00739310|454683041|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
126378783|NCT00739310|454683041|FG000|Overall Study|Withdrawal by Subject|1|||
126378784|NCT00739310|454683041|FG000|Overall Study|Lost to Follow-up|2|||
126378785|NCT01071954|454683042|FG000|Overall Study|Noncompliance|4|||
126378786|NCT01071954|454683042|FG000|Overall Study|Adverse Event|1|||
126378787|NCT01071954|454683042|FG000|Overall Study|Withdrawal by Subject|11|||
126378788|NCT01071954|454683042|FG000|Overall Study|Requirement for Alternative Therapy|5|||
126378789|NCT01071954|454683042|FG000|Overall Study|Administrative Decision|5|||
126378790|NCT01071954|454683042|FG000|Overall Study|Protocol Specified Criteria|1|||
126378791|NCT00590967|454683043|FG000|Overall Study|Withdrawal by Subject|1|||
126378792|NCT00590967|454683044|FG001|Overall Study|Withdrawal by Subject|1|||
126378793|NCT00590967|454683043|FG000|Overall Study|Ineligible|1|||
126378794|NCT00590967|454683044|FG001|Overall Study|Ineligible|0|||
126378795|NCT00590967|454683043|FG000|Overall Study|Poor performance status|0|||
126378796|NCT00590967|454683044|FG001|Overall Study|Poor performance status|1|||
126378797|NCT00590967|454683043|FG000|Overall Study|Non-compliant|0|||
126378798|NCT00590967|454683044|FG001|Overall Study|Non-compliant|2|||
126378799|NCT00590967|454683043|FG000|Overall Study|Did not sign consent form|0|||
126378800|NCT00590967|454683044|FG001|Overall Study|Did not sign consent form|1|||
126378801|NCT00590967|454683043|FG000|Overall Study|Did not receive chemo per protocol|1|||
126378802|NCT00590967|454683044|FG001|Overall Study|Did not receive chemo per protocol|0|||
126378803|NCT01847755|454683045|FG000|Overall Study|Adverse Event|2|||
126378804|NCT01847755|454683045|FG000|Overall Study|Withdrawal by Subject|2|||
126378805|NCT01847755|454683045|FG000|Overall Study|Physician Decision|1|||
126378806|NCT00920556|454683046|FG000|Overall Study|Adverse Event|16|||
126553196|NCT01089556|455320534|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
126378807|NCT00920556|454683046|FG000|Overall Study|Physician Decision|7|||
126378808|NCT00920556|454683046|FG000|Overall Study|Withdrawal by Subject|1|||
126378809|NCT04245709|454683047|FG000|Overall Study|Adverse Event|13|||
126378810|NCT04245709|454683047|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
126378811|NCT02185534|454683049|FG000|First Period|Withdrawal by Subject|0|||
126378812|NCT02185534|454683050|FG001|First Period|Withdrawal by Subject|0|||
126378813|NCT02185534|454683051|FG002|First Period|Withdrawal by Subject|0|||
126378814|NCT02185534|454683052|FG003|First Period|Withdrawal by Subject|1|||
126378815|NCT02185534|454683053|FG004|First Period|Withdrawal by Subject|0|||
126378816|NCT02185534|454683054|FG005|First Period|Withdrawal by Subject|0|||
126378817|NCT02185534|454683049|FG000|First Washout Period|Withdrawal by Subject|1|||
126378818|NCT02185534|454683050|FG001|First Washout Period|Withdrawal by Subject|0|||
126378819|NCT02185534|454683051|FG002|First Washout Period|Withdrawal by Subject|0|||
126378820|NCT02185534|454683052|FG003|First Washout Period|Withdrawal by Subject|0|||
126378821|NCT02185534|454683053|FG004|First Washout Period|Withdrawal by Subject|1|||
126378822|NCT02185534|454683054|FG005|First Washout Period|Withdrawal by Subject|0|||
126378823|NCT02185534|454683049|FG000|First Washout Period|Protocol Violation|0|||
126378824|NCT02185534|454683050|FG001|First Washout Period|Protocol Violation|0|||
126378825|NCT02185534|454683051|FG002|First Washout Period|Protocol Violation|0|||
126378826|NCT02185534|454683052|FG003|First Washout Period|Protocol Violation|0|||
126378827|NCT02185534|454683053|FG004|First Washout Period|Protocol Violation|0|||
126378828|NCT02185534|454683054|FG005|First Washout Period|Protocol Violation|1|||
126378829|NCT02041299|454683055|FG000|Overall Study|Adverse Event|9|||
126378830|NCT02041299|454683056|FG001|Overall Study|Adverse Event|3|||
126378831|NCT02041299|454683055|FG000|Overall Study|Lost to Follow-up|4|||
126378832|NCT02041299|454683056|FG001|Overall Study|Lost to Follow-up|1|||
126378833|NCT02041299|454683055|FG000|Overall Study|Physician Decision|1|||
126378834|NCT02041299|454683056|FG001|Overall Study|Physician Decision|1|||
126378835|NCT02041299|454683055|FG000|Overall Study|Withdrawal by Subject|13|||
126378836|NCT02041299|454683056|FG001|Overall Study|Withdrawal by Subject|7|||
126378837|NCT02041299|454683055|FG000|Overall Study|Protocol Violation|11|||
126378838|NCT02041299|454683056|FG001|Overall Study|Protocol Violation|4|||
126378839|NCT02041299|454683055|FG000|Overall Study|Termination of the study|7|||
126378840|NCT02041299|454683056|FG001|Overall Study|Termination of the study|3|||
126378841|NCT02041299|454683055|FG000|Overall Study|Required bone marrow transplant|0|||
126378842|NCT02041299|454683056|FG001|Overall Study|Required bone marrow transplant|1|||
126378843|NCT02041299|454683055|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
126378844|NCT02041299|454683056|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
126378845|NCT02389465|454683057|FG000|Overall Study|Lost to Follow-up|1|||
126378846|NCT02389465|454683058|FG001|Overall Study|Lost to Follow-up|3|||
126378847|NCT02389465|454683059|FG002|Overall Study|Lost to Follow-up|3|||
126378848|NCT02389465|454683060|FG003|Overall Study|Lost to Follow-up|0|||
126378849|NCT02389465|454683057|FG000|Overall Study|Physician Decision|0|||
126378850|NCT02389465|454683058|FG001|Overall Study|Physician Decision|0|||
126378851|NCT02389465|454683059|FG002|Overall Study|Physician Decision|0|||
126378852|NCT02389465|454683060|FG003|Overall Study|Physician Decision|1|||
126378853|NCT02389465|454683057|FG000|Overall Study|Withdrawal by Subject|0|||
126378854|NCT02389465|454683058|FG001|Overall Study|Withdrawal by Subject|1|||
126378855|NCT02389465|454683059|FG002|Overall Study|Withdrawal by Subject|2|||
126378856|NCT02389465|454683060|FG003|Overall Study|Withdrawal by Subject|2|||
126378857|NCT04179305|454683064|FG000|Overall Study|Death|1|||
126378858|NCT04179305|454683065|FG001|Overall Study|Death|1|||
126378859|NCT04179305|454683066|FG002|Overall Study|Death|0|||
126378860|NCT04179305|454683067|FG003|Overall Study|Death|0|||
126378861|NCT04179305|454683064|FG000|Overall Study|Lost to Follow-up|1|||
126378862|NCT04179305|454683065|FG001|Overall Study|Lost to Follow-up|1|||
126378863|NCT04179305|454683066|FG002|Overall Study|Lost to Follow-up|0|||
126378864|NCT04179305|454683067|FG003|Overall Study|Lost to Follow-up|0|||
126378865|NCT04179305|454683064|FG000|Overall Study|Withdrawal by Subject|0|||
126378866|NCT04179305|454683065|FG001|Overall Study|Withdrawal by Subject|1|||
126717062|NCT00002663|455915018|FG005|Overall Study|Physician Decision|0|||
126378867|NCT04179305|454683066|FG002|Overall Study|Withdrawal by Subject|0|||
126717063|NCT00002663|455915019|FG006|Overall Study|Physician Decision|0|||
126717064|NCT00002663|455915020|FG007|Overall Study|Physician Decision|0|||
126378868|NCT04179305|454683067|FG003|Overall Study|Withdrawal by Subject|0|||
126378869|NCT04179305|454683064|FG000|Overall Study|Did not have scan|1|||
126378870|NCT04179305|454683065|FG001|Overall Study|Did not have scan|0|||
126717065|NCT00002663|455915021|FG008|Overall Study|Physician Decision|1|||
126717066|NCT00002663|455915022|FG009|Overall Study|Physician Decision|1|||
126378871|NCT04179305|454683066|FG002|Overall Study|Did not have scan|0|||
126378872|NCT04179305|454683067|FG003|Overall Study|Did not have scan|0|||
126378873|NCT04179305|454683064|FG000|Overall Study|In hospice care|3|||
126378874|NCT04179305|454683065|FG001|Overall Study|In hospice care|0|||
126378875|NCT04179305|454683066|FG002|Overall Study|In hospice care|0|||
126378876|NCT04179305|454683067|FG003|Overall Study|In hospice care|0|||
126378877|NCT00503425|454683070|FG000|Overall Study|Participant files lost|6|||
126378878|NCT00503425|454683070|FG000|Overall Study|Adverse Event|5|||
126378879|NCT00503425|454683070|FG000|Overall Study|Lack of Efficacy|25|||
126378880|NCT00503425|454683070|FG000|Overall Study|Withdrawal by Subject|8|||
126378881|NCT00503425|454683070|FG000|Overall Study|Lost to Follow-up|3|||
126378882|NCT00503425|454683070|FG000|Overall Study|Death|3|||
126378883|NCT00503425|454683070|FG000|Overall Study|Missing Data/Unknown|4|||
126717067|NCT00002663|455915013|FG000|Overall Study|Adverse Event|0|||
126378884|NCT00326599|454683071|FG000|Overall Study|Withdrawal by Subject|1|||
126378885|NCT00326599|454683072|FG001|Overall Study|Withdrawal by Subject|0|||
126378886|NCT00326599|454683073|FG002|Overall Study|Withdrawal by Subject|5|||
126378887|NCT00326599|454683074|FG003|Overall Study|Withdrawal by Subject|2|||
126378888|NCT00326599|454683071|FG000|Overall Study|Adverse Event|1|||
126378889|NCT00326599|454683072|FG001|Overall Study|Adverse Event|0|||
126378890|NCT00326599|454683073|FG002|Overall Study|Adverse Event|32|||
126378891|NCT00326599|454683074|FG003|Overall Study|Adverse Event|3|||
126378892|NCT00326599|454683071|FG000|Overall Study|Disease Progression|3|||
126378893|NCT00326599|454683072|FG001|Overall Study|Disease Progression|1|||
126378894|NCT00326599|454683073|FG002|Overall Study|Disease Progression|13|||
126378895|NCT00326599|454683074|FG003|Overall Study|Disease Progression|11|||
126378896|NCT00326599|454683071|FG000|Overall Study|Alternate Treatment|1|||
126378897|NCT00326599|454683072|FG001|Overall Study|Alternate Treatment|0|||
126378898|NCT00326599|454683073|FG002|Overall Study|Alternate Treatment|0|||
126378899|NCT00326599|454683074|FG003|Overall Study|Alternate Treatment|0|||
126378900|NCT00326599|454683071|FG000|Overall Study|Death|0|||
126378901|NCT00326599|454683072|FG001|Overall Study|Death|0|||
126378902|NCT00326599|454683073|FG002|Overall Study|Death|1|||
126378903|NCT00326599|454683074|FG003|Overall Study|Death|2|||
126378904|NCT00326599|454683071|FG000|Overall Study|Other Unspecified Reason|0|||
126378905|NCT00326599|454683072|FG001|Overall Study|Other Unspecified Reason|0|||
126378906|NCT00326599|454683073|FG002|Overall Study|Other Unspecified Reason|2|||
126378907|NCT00326599|454683074|FG003|Overall Study|Other Unspecified Reason|1|||
126378908|NCT00437268|454683075|FG000|Overall Study|Adverse Event|1|||
126378909|NCT00437268|454683076|FG001|Overall Study|Adverse Event|1|||
126378910|NCT00437268|454683075|FG000|Overall Study|Withdrawal by Subject|2|||
126378911|NCT00437268|454683076|FG001|Overall Study|Withdrawal by Subject|2|||
126378912|NCT00437268|454683075|FG000|Overall Study|Progressive disease|9|||
126378913|NCT00437268|454683076|FG001|Overall Study|Progressive disease|9|||
126378914|NCT00437268|454683075|FG000|Overall Study|Physician Decision|1|||
126378915|NCT00437268|454683076|FG001|Overall Study|Physician Decision|0|||
126378916|NCT00437268|454683075|FG000|Overall Study|Death|0|||
126378917|NCT00437268|454683076|FG001|Overall Study|Death|1|||
126378918|NCT00444925|454683077|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
126378919|NCT00444925|454683078|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
126378920|NCT00444925|454683079|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
126378921|NCT00444925|454683077|FG000|Double-blind Treatment Period|Death|2|||
126378922|NCT00444925|454683078|FG001|Double-blind Treatment Period|Death|0|||
126378923|NCT00444925|454683079|FG002|Double-blind Treatment Period|Death|0|||
126378924|NCT00444925|454683077|FG000|Double-blind Treatment Period|Adverse Event|6|||
126378925|NCT00444925|454683078|FG001|Double-blind Treatment Period|Adverse Event|28|||
126378926|NCT00444925|454683079|FG002|Double-blind Treatment Period|Adverse Event|44|||
126378927|NCT00444925|454683077|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
126378928|NCT00444925|454683078|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
126378929|NCT00444925|454683079|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
126378930|NCT00444925|454683077|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
126378931|NCT00444925|454683078|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
126378932|NCT00444925|454683079|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
126378933|NCT00444925|454683077|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
126378934|NCT00444925|454683078|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
126378935|NCT00444925|454683079|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
126378936|NCT00444925|454683077|FG000|Double-blind Treatment Period|Other|7|||
126378937|NCT00444925|454683078|FG001|Double-blind Treatment Period|Other|7|||
126378938|NCT00444925|454683079|FG002|Double-blind Treatment Period|Other|12|||
126378939|NCT03484429|454683083|FG000|Overall Study|Withdrawal by Subject|1|||
126467654|NCT01676727|455013418|FG000|Overall Study|Withdrawal by Subject|6|||
126467655|NCT01676727|455013418|FG000|Overall Study|Screening failure|5|||
126467656|NCT01676727|455013418|FG000|Overall Study|Not willing to attend 1-year visit|2|||
126467657|NCT01676727|455013418|FG000|Overall Study|Valve explanted|1|||
126467658|NCT03053271|455013421|FG000|Overall Study|Did not meet randomization criteria|3|||
126467659|NCT03053271|455013421|FG000|Overall Study|Withdrawal by Subject|1|||
126467660|NCT00580970|455013422|FG000|Pre-treatment|Non-compliance|1|||
126378940|NCT03484429|454683084|FG001|Overall Study|Withdrawal by Subject|0|||
126378941|NCT03484429|454683083|FG000|Overall Study|Adverse Event|2|||
126378942|NCT03484429|454683084|FG001|Overall Study|Adverse Event|0|||
126378943|NCT00943761|454683085|FG000|Overall Study|Lost to Follow-up|2|||
126467661|NCT00580970|455013422|FG000|Treatment (Lovastatin)|Non-compliance|6|||
126378944|NCT00943761|454683086|FG001|Overall Study|Lost to Follow-up|0|||
126378945|NCT00943761|454683085|FG000|Overall Study|Withdrawal by Subject|2|||
126378946|NCT00943761|454683086|FG001|Overall Study|Withdrawal by Subject|1|||
126378947|NCT00714948|454683087|FG000|Overall Study|Adverse Event|2|||
126378948|NCT01342926|454683090|FG000|Overall Study|Adverse Event|5|||
126467662|NCT00580970|455013422|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
126553197|NCT01089556|455320529|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
126717068|NCT00002663|455915014|FG001|Overall Study|Adverse Event|0|||
126467663|NCT00580970|455013422|FG000|Treatment (Lovastatin)|Physician Decision|4|||
126467664|NCT00580970|455013422|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
126378949|NCT01342926|454683091|FG001|Overall Study|Adverse Event|8|||
126378950|NCT01342926|454683092|FG002|Overall Study|Adverse Event|10|||
126378951|NCT01342926|454683093|FG003|Overall Study|Adverse Event|7|||
126378952|NCT01342926|454683090|FG000|Overall Study|Lost to Follow-up|0|||
126378953|NCT01342926|454683091|FG001|Overall Study|Lost to Follow-up|1|||
126378954|NCT01342926|454683092|FG002|Overall Study|Lost to Follow-up|1|||
126378955|NCT01342926|454683093|FG003|Overall Study|Lost to Follow-up|0|||
126378956|NCT01342926|454683090|FG000|Overall Study|Investigator Discretion|2|||
126378957|NCT01342926|454683091|FG001|Overall Study|Investigator Discretion|2|||
126378958|NCT01342926|454683092|FG002|Overall Study|Investigator Discretion|0|||
126378959|NCT01342926|454683093|FG003|Overall Study|Investigator Discretion|0|||
126378960|NCT01342926|454683090|FG000|Overall Study|Withdrawal by Subject|2|||
126378961|NCT01342926|454683091|FG001|Overall Study|Withdrawal by Subject|4|||
126378962|NCT01342926|454683092|FG002|Overall Study|Withdrawal by Subject|3|||
126378963|NCT01342926|454683093|FG003|Overall Study|Withdrawal by Subject|5|||
126378964|NCT03382912|454683094|FG000|Overall Study|Physician Decision|0|||
126378965|NCT03382912|454683095|FG001|Overall Study|Physician Decision|1|||
126378966|NCT03382912|454683094|FG000|Overall Study|Sponsor Decision|6|||
126378967|NCT03382912|454683095|FG001|Overall Study|Sponsor Decision|6|||
126378968|NCT03382912|454683094|FG000|Overall Study|Withdrawal by Subject|0|||
126378969|NCT03382912|454683095|FG001|Overall Study|Withdrawal by Subject|5|||
126378970|NCT05588440|454683096|FG000|Overall Study|Sponsor Decision|2|||
126378971|NCT05588440|454683097|FG001|Overall Study|Sponsor Decision|0|||
126378972|NCT05588440|454683098|FG002|Overall Study|Sponsor Decision|1|||
126378973|NCT05588440|454683096|FG000|Overall Study|Death|1|||
126378974|NCT05588440|454683097|FG001|Overall Study|Death|1|||
126378975|NCT05588440|454683098|FG002|Overall Study|Death|1|||
126378976|NCT05588440|454683096|FG000|Overall Study|Screen Fail|0|||
126378977|NCT05588440|454683097|FG001|Overall Study|Screen Fail|1|||
126378978|NCT05588440|454683098|FG002|Overall Study|Screen Fail|1|||
126378979|NCT05588440|454683096|FG000|Overall Study|Withdrawal by Subject|0|||
126378980|NCT05588440|454683097|FG001|Overall Study|Withdrawal by Subject|0|||
126378981|NCT05588440|454683098|FG002|Overall Study|Withdrawal by Subject|1|||
126378982|NCT05653700|454683099|FG000|Overall Study|Non Responders|9|||
126378983|NCT05653700|454683100|FG001|Overall Study|Non Responders|0|||
126378984|NCT02573948|454683103|FG000|Longitudinal Cohort|Death|9|||
126378985|NCT02573948|454683103|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
126378986|NCT02573948|454683103|FG000|Longitudinal Cohort|Incarcerated|25|||
126378987|NCT00707993|454683104|FG000|Overall Study|Adverse Event|16|||
126378988|NCT00707993|454683105|FG001|Overall Study|Adverse Event|20|||
126378989|NCT00707993|454683104|FG000|Overall Study|Protocol Violation|4|||
126378990|NCT00707993|454683105|FG001|Overall Study|Protocol Violation|7|||
126378991|NCT00707993|454683104|FG000|Overall Study|Lost to Follow-up|0|||
126378992|NCT00707993|454683105|FG001|Overall Study|Lost to Follow-up|4|||
126378993|NCT00707993|454683104|FG000|Overall Study|Withdrawal by Subject|12|||
126378994|NCT00707993|454683105|FG001|Overall Study|Withdrawal by Subject|16|||
126378995|NCT00707993|454683104|FG000|Overall Study|Hyperglycemic Rescue|55|||
126378996|NCT00707993|454683105|FG001|Overall Study|Hyperglycemic Rescue|47|||
126378997|NCT00707993|454683104|FG000|Overall Study|Other|2|||
126378998|NCT00707993|454683105|FG001|Overall Study|Other|0|||
126378999|NCT05414175|454683110|FG000|Overall Study|Withdrawal by Subject|1|||
126379000|NCT05414175|454683110|FG000|Overall Study|Other Reasons|1|||
126379001|NCT00532129|454684949|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
126379002|NCT00532129|454684949|FG000|Treatment Period|Physician Decision|15|||
126379003|NCT00532129|454684949|FG000|Treatment Period|Disease progression|3|||
126379004|NCT00532129|454684949|FG000|Treatment Period|Protocol Violation|1|||
126467665|NCT00580970|455013422|FG000|Treatment (Lovastatin)|Death|1|||
126379005|NCT00532129|454684949|FG000|Treatment Period|Other|5|||
126379006|NCT00532129|454684949|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
126379007|NCT00532129|454684949|FG000|Follow-up Period|Disease progression|57|||
126379008|NCT00532129|454684949|FG000|Follow-up Period|Lost to Follow-up|1|||
126379009|NCT00532129|454684949|FG000|Follow-up Period|Other|6|||
126379010|NCT02237001|454684950|FG000|Overall Study|Lost to Follow-up|2|||
126467666|NCT01086423|455013423|FG000|Overall Study|Protocol Violation|0|||
126467667|NCT01086423|455013424|FG001|Overall Study|Protocol Violation|0|||
126379011|NCT02237001|454684950|FG000|Overall Study|Withdrawal by Subject|1|||
126379012|NCT02237001|454684950|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
126379013|NCT02237001|454684950|FG000|Overall Study|Re-operation|4|||
126379014|NCT02237001|454684950|FG000|Overall Study|Incarceration|1|||
126379015|NCT00342628|454684951|FG000|Overall Study|Withdrawal by Subject|19|||
126379016|NCT00342628|454684952|FG001|Overall Study|Withdrawal by Subject|19|||
126379017|NCT00342628|454684953|FG002|Overall Study|Withdrawal by Subject|18|||
126379018|NCT00342628|454684951|FG000|Overall Study|Death|1|||
126379019|NCT00342628|454684952|FG001|Overall Study|Death|1|||
126379020|NCT00342628|454684953|FG002|Overall Study|Death|0|||
126379021|NCT00342628|454684951|FG000|Overall Study|moved residence|0|||
126379022|NCT00342628|454684952|FG001|Overall Study|moved residence|1|||
126379023|NCT00342628|454684953|FG002|Overall Study|moved residence|1|||
126379024|NCT03427814|454684954|FG000|Overall Study|Withdrawal by Subject|4|||
126379025|NCT03427814|454684955|FG001|Overall Study|Withdrawal by Subject|4|||
126379026|NCT03427814|454684954|FG000|Overall Study|Lost to Follow-up|0|||
126379027|NCT03427814|454684955|FG001|Overall Study|Lost to Follow-up|2|||
126379028|NCT03427814|454684954|FG000|Overall Study|Death|42|||
126379029|NCT03427814|454684955|FG001|Overall Study|Death|31|||
126379030|NCT03427814|454684954|FG000|Overall Study|Sponsor's Decision|1|||
126379031|NCT03427814|454684955|FG001|Overall Study|Sponsor's Decision|0|||
126379032|NCT03427814|454684954|FG000|Overall Study|Investigator's Decision|1|||
126379033|NCT03427814|454684955|FG001|Overall Study|Investigator's Decision|2|||
126379034|NCT03427814|454684954|FG000|Overall Study|Disease progression|1|||
126379035|NCT03427814|454684955|FG001|Overall Study|Disease progression|0|||
126379036|NCT03427814|454684954|FG000|Overall Study|Treatment Completed|0|||
126379037|NCT03427814|454684955|FG001|Overall Study|Treatment Completed|1|||
126379038|NCT03427814|454684954|FG000|Overall Study|Sponsor's Decision to End study|21|||
126379039|NCT03427814|454684955|FG001|Overall Study|Sponsor's Decision to End study|25|||
126379040|NCT03427814|454684954|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
126379041|NCT03427814|454684955|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
126379042|NCT03145064|454684956|FG000|Overall Study|Death|24|||
126379043|NCT03145064|454684956|FG000|Overall Study|Lost to Follow-up|3|||
126379044|NCT03145064|454684956|FG000|Overall Study|Withdrawal by Subject|6|||
126379045|NCT03145064|454684956|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
126379046|NCT03145064|454684956|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
126379047|NCT03846427|454684957|FG000|Overall Study|Death|13|||
126379048|NCT03846427|454684957|FG000|Overall Study|Withdrawal by Subject|3|||
126379049|NCT03846427|454684957|FG000|Overall Study|Physician Decision|1|||
126379050|NCT01693250|454684958|FG000|Overall Study|Lost to Follow-up|2|||
126379051|NCT01693250|454684959|FG001|Overall Study|Lost to Follow-up|2|||
126379052|NCT00628446|454684960|FG000|Overall Study|Lost to Follow-up|3|||
126379053|NCT00628446|454684960|FG000|Overall Study|Withdrawal by Subject|1|||
126379054|NCT00628446|454684960|FG000|Overall Study|Protocol Violation|3|||
126379055|NCT01396187|454684961|FG000|Overall Study|Adverse Event|0|||
126379056|NCT01396187|454684962|FG001|Overall Study|Adverse Event|1|||
126379057|NCT01396187|454684963|FG002|Overall Study|Adverse Event|0|||
126379058|NCT01396187|454684964|FG003|Overall Study|Adverse Event|0|||
126379059|NCT01396187|454684965|FG004|Overall Study|Adverse Event|0|||
126379060|NCT01396187|454684961|FG000|Overall Study|Withdrawal by Subject|0|||
126379061|NCT01396187|454684962|FG001|Overall Study|Withdrawal by Subject|1|||
126379062|NCT01396187|454684963|FG002|Overall Study|Withdrawal by Subject|1|||
126379063|NCT01396187|454684964|FG003|Overall Study|Withdrawal by Subject|0|||
126379064|NCT01396187|454684965|FG004|Overall Study|Withdrawal by Subject|0|||
126379065|NCT01396187|454684961|FG000|Overall Study|Other|1|||
126379066|NCT01396187|454684962|FG001|Overall Study|Other|1|||
126379067|NCT01396187|454684963|FG002|Overall Study|Other|0|||
126379068|NCT01396187|454684964|FG003|Overall Study|Other|0|||
126379069|NCT01396187|454684965|FG004|Overall Study|Other|1|||
126379070|NCT04971967|454684969|FG000|Overall Study|Lost to Follow-up|6|||
126379071|NCT04971967|454684970|FG001|Overall Study|Lost to Follow-up|7|||
126379072|NCT00682929|454684973|FG000|Overall Study|Adverse Event|4|||
126379073|NCT00682929|454684974|FG001|Overall Study|Adverse Event|1|||
126379074|NCT00682929|454684975|FG002|Overall Study|Adverse Event|1|||
126379075|NCT00682929|454684973|FG000|Overall Study|Withdrawal by Subject|1|||
126379076|NCT00682929|454684974|FG001|Overall Study|Withdrawal by Subject|2|||
126379077|NCT00682929|454684975|FG002|Overall Study|Withdrawal by Subject|1|||
126379078|NCT00682929|454684973|FG000|Overall Study|dosing compliance < 80%|0|||
126379079|NCT00682929|454684974|FG001|Overall Study|dosing compliance < 80%|2|||
126379080|NCT00682929|454684975|FG002|Overall Study|dosing compliance < 80%|0|||
126379081|NCT00682929|454684973|FG000|Overall Study|lag in DEA renewal|1|||
126379082|NCT00682929|454684974|FG001|Overall Study|lag in DEA renewal|0|||
126379083|NCT00682929|454684975|FG002|Overall Study|lag in DEA renewal|0|||
126771135|NCT04529096|456116272|FG001|Overall Study|Lack of Efficacy|0|||
126379084|NCT01462929|454684976|FG000|Overall Study|Adverse Event|3|||
126379085|NCT01462929|454684977|FG001|Overall Study|Adverse Event|3|||
126379086|NCT01462929|454684978|FG002|Overall Study|Adverse Event|4|||
126379087|NCT01462929|454684976|FG000|Overall Study|Withdrawal by Subject|2|||
126379088|NCT01462929|454684977|FG001|Overall Study|Withdrawal by Subject|1|||
126379089|NCT01462929|454684978|FG002|Overall Study|Withdrawal by Subject|0|||
126379090|NCT01462929|454684976|FG000|Overall Study|Lack of Efficacy|0|||
126379091|NCT01462929|454684977|FG001|Overall Study|Lack of Efficacy|0|||
126379092|NCT01462929|454684978|FG002|Overall Study|Lack of Efficacy|1|||
126379093|NCT03333928|454684980|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
126379094|NCT03333928|454684981|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
126379095|NCT03333928|454684982|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
126379096|NCT03333928|454684980|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
126379097|NCT03333928|454684981|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
126467668|NCT01086423|455013425|FG002|Overall Study|Protocol Violation|1|||
126379098|NCT03333928|454684982|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
126379099|NCT03333928|454684980|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
126379100|NCT03333928|454684981|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
126379101|NCT03333928|454684982|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
126379102|NCT03333928|454684980|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
126379103|NCT03333928|454684981|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
126379104|NCT03333928|454684982|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
126379105|NCT03333928|454684980|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
126379106|NCT03333928|454684981|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
126379107|NCT03333928|454684982|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
126379108|NCT03333928|454684980|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
126379109|NCT03333928|454684981|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
126379110|NCT03333928|454684982|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
126379111|NCT03333928|454684980|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
126379112|NCT03333928|454684981|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
126379113|NCT03333928|454684982|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
126379114|NCT03333928|454684980|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
126379115|NCT03333928|454684981|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
126379116|NCT03333928|454684982|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
126379117|NCT04072835|454684983|FG000|Overall Study|Overall trial ended|603|||
126379118|NCT04072835|454684983|FG000|Overall Study|Ablation|97|||
126379119|NCT04072835|454684983|FG000|Overall Study|Withdrawal of consent|66|||
126379120|NCT04072835|454684983|FG000|Overall Study|Physician Decision|50|||
126379121|NCT04072835|454684983|FG000|Overall Study|Lost to Follow-up|39|||
126379122|NCT04072835|454684983|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
126379123|NCT04072835|454684983|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
126379124|NCT04072835|454684983|FG000|Overall Study|Adverse Event|25|||
126379125|NCT04072835|454684983|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
126379126|NCT04072835|454684983|FG000|Overall Study|Death|11|||
126379127|NCT04072835|454684983|FG000|Overall Study|Participant felt the drug did not work|8|||
126379128|NCT04072835|454684983|FG000|Overall Study|Participant tolerability|5|||
126379129|NCT04072835|454684983|FG000|Overall Study|Missing|5|||
126379130|NCT04072835|454684983|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
126379131|NCT04072835|454684983|FG000|Overall Study|Pregnancy|3|||
126379132|NCT04723355|454684984|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
126379133|NCT04723355|454684984|FG000|Overall Study|Errors in the informed consent form|2|||
126379134|NCT00841776|454684987|FG000|Overall Study|Lack of Efficacy|0|||
126379135|NCT00841776|454684988|FG001|Overall Study|Lack of Efficacy|1|||
126379136|NCT00841776|454684987|FG000|Overall Study|Lost to Follow-up|2|||
126379137|NCT00841776|454684988|FG001|Overall Study|Lost to Follow-up|1|||
126379138|NCT00841776|454684987|FG000|Overall Study|Withdrawal by Subject|0|||
126379139|NCT00841776|454684988|FG001|Overall Study|Withdrawal by Subject|1|||
126379140|NCT01306643|454684990|FG000|Overall Study|Adverse Event|5|||
126379141|NCT01306643|454684990|FG000|Overall Study|Disease Progression|7|||
126379142|NCT01306643|454684990|FG000|Overall Study|Other: Change in Eligibility Status|1|||
126379143|NCT02071771|454684991|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
126379144|NCT02071771|454684992|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
126379145|NCT02071771|454684991|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
126379146|NCT02071771|454684992|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
126379147|NCT02479880|454684996|FG000|Overall Study|Study Terminated by Sponsor|13|||
126379148|NCT02479880|454684997|FG001|Overall Study|Study Terminated by Sponsor|12|||
126379149|NCT02479880|454684996|FG000|Overall Study|Pregnancy|0|||
126379150|NCT02479880|454684997|FG001|Overall Study|Pregnancy|1|||
126379151|NCT00355368|454684998|FG000|Overall Study|Protocol Violation|8|||
126379152|NCT00355368|454684999|FG001|Overall Study|Protocol Violation|7|||
126379153|NCT00355368|454684998|FG000|Overall Study|cardiac arrest prior to intubation|2|||
126379154|NCT00355368|454684999|FG001|Overall Study|cardiac arrest prior to intubation|2|||
126379155|NCT01349673|454685000|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
126379156|NCT01349673|454685000|FG000|Overall Study|No Longer Qualified For Study|1|||
126379157|NCT01349673|454685000|FG000|Overall Study|Site Closure|10|||
126379158|NCT01349673|454685000|FG000|Overall Study|Withdrawal by Subject|21|||
126379159|NCT01349673|454685000|FG000|Overall Study|Lost to Follow-up|6|||
126379160|NCT01349673|454685000|FG000|Overall Study|Adverse Event|17|||
126379161|NCT01349673|454685000|FG000|Overall Study|Study Terminated By Sponsor|50|||
126379162|NCT01349673|454685000|FG000|Overall Study|Lack of Efficacy|8|||
126379163|NCT03688919|454685003|FG000|Overall Study|Lost to Follow-up|2|||
126379164|NCT03688919|454685004|FG001|Overall Study|Lost to Follow-up|1|||
126467669|NCT01086423|455013423|FG000|Overall Study|Migrated/moved from study area|2|||
126379165|NCT03688919|454685003|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
126379166|NCT03688919|454685004|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
126379167|NCT00506779|454685008|FG000|Overall Study|Withdrawal by Subject|1|||
126379168|NCT00506779|454685009|FG001|Overall Study|Withdrawal by Subject|0|||
126379169|NCT00506779|454685010|FG002|Overall Study|Withdrawal by Subject|1|||
126379170|NCT00506779|454685011|FG003|Overall Study|Withdrawal by Subject|0|||
126379171|NCT00506779|454685008|FG000|Overall Study|Adverse Event|0|||
126379172|NCT00506779|454685009|FG001|Overall Study|Adverse Event|1|||
126379173|NCT00506779|454685010|FG002|Overall Study|Adverse Event|1|||
126379174|NCT00506779|454685011|FG003|Overall Study|Adverse Event|1|||
126379175|NCT02639247|454685012|FG000|Overall Study|Lost to Follow-up|2|||
126379176|NCT02639247|454685013|FG001|Overall Study|Lost to Follow-up|1|||
126379177|NCT02639247|454685012|FG000|Overall Study|Death|2|||
126379178|NCT02639247|454685013|FG001|Overall Study|Death|0|||
126379179|NCT02639247|454685012|FG000|Overall Study|Withdrew Consent|0|||
126379180|NCT02639247|454685013|FG001|Overall Study|Withdrew Consent|1|||
126379181|NCT02639247|454685012|FG000|Overall Study|Protocol Violation|1|||
126379182|NCT02639247|454685013|FG001|Overall Study|Protocol Violation|0|||
126379183|NCT03462758|454685014|FG000|Overall Study|Chose no or other method of contraception|20|||
126379184|NCT03462758|454685015|FG001|Overall Study|Chose no or other method of contraception|23|||
126379185|NCT03462758|454685014|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
126379186|NCT03462758|454685015|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
126379187|NCT03462758|454685014|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
126379188|NCT03462758|454685015|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
126379189|NCT03462758|454685014|FG000|Overall Study|Medical contraindication|2|||
126379190|NCT03462758|454685015|FG001|Overall Study|Medical contraindication|2|||
126379191|NCT03462758|454685014|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
126379192|NCT03462758|454685015|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
126379193|NCT02820844|454685016|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
126379194|NCT02820844|454685017|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
126379195|NCT02820844|454685018|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
126379196|NCT02820844|454685019|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
126379197|NCT02820844|454685020|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
126379198|NCT02820844|454685021|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
126379199|NCT02820844|454685016|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
126379200|NCT02820844|454685017|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
126379201|NCT02820844|454685018|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
126379202|NCT02820844|454685019|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
126379203|NCT02820844|454685020|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
126379204|NCT02820844|454685021|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
126379205|NCT02820844|454685016|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
126379206|NCT02820844|454685017|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
126379207|NCT02820844|454685018|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
126379208|NCT02820844|454685019|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
126379209|NCT02820844|454685020|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
126379210|NCT02820844|454685021|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
126379211|NCT02820844|454685016|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
126379212|NCT02820844|454685017|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
126379213|NCT02820844|454685018|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
126379214|NCT02820844|454685019|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
126379215|NCT02820844|454685020|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
126379216|NCT02820844|454685021|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
126379217|NCT02820844|454685016|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
126379218|NCT02820844|454685017|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
126379219|NCT02820844|454685018|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
126379220|NCT02820844|454685019|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
126379221|NCT02820844|454685020|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
126379222|NCT02820844|454685021|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
126379223|NCT02820844|454685016|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
126379224|NCT02820844|454685017|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
126379225|NCT02820844|454685018|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
126467670|NCT01086423|455013424|FG001|Overall Study|Migrated/moved from study area|0|||
126467671|NCT01086423|455013425|FG002|Overall Study|Migrated/moved from study area|4|||
126467672|NCT01086423|455013423|FG000|Overall Study|Adverse event, fatal|1|||
126467673|NCT01086423|455013424|FG001|Overall Study|Adverse event, fatal|1|||
126379226|NCT02820844|454685019|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
126379227|NCT02820844|454685020|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
126379228|NCT02820844|454685021|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
126379229|NCT02820844|454685016|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
126379230|NCT02820844|454685017|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
126467674|NCT01086423|455013425|FG002|Overall Study|Adverse event, fatal|0|||
126467675|NCT01086423|455013423|FG000|Overall Study|Adverse event, non-fatal|2|||
126379231|NCT02820844|454685018|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
126379232|NCT02820844|454685019|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
126379233|NCT02820844|454685020|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
126379234|NCT02820844|454685021|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
126379235|NCT02820844|454685016|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379236|NCT02820844|454685017|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379237|NCT02820844|454685018|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
126379238|NCT02820844|454685019|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
126379239|NCT02820844|454685020|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379240|NCT02820844|454685021|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379241|NCT02820844|454685016|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
126379242|NCT02820844|454685017|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
126379243|NCT02820844|454685018|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
126379244|NCT02820844|454685019|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
126379245|NCT02820844|454685020|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
126379246|NCT02820844|454685021|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
126379247|NCT02820844|454685016|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379248|NCT02820844|454685017|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379249|NCT02820844|454685018|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379250|NCT02820844|454685019|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379251|NCT02820844|454685020|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
126379252|NCT02820844|454685021|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
126379253|NCT02266147|454685022|FG000|PART 1: Dose Escalation|Physician Decision|0|||
126379254|NCT02266147|454685023|FG001|PART 1: Dose Escalation|Physician Decision|0|||
126379255|NCT02266147|454685024|FG002|PART 1: Dose Escalation|Physician Decision|1|||
126379256|NCT02266147|454685025|FG003|PART 1: Dose Escalation|Physician Decision|0|||
126379257|NCT02266147|454685022|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
126379258|NCT02266147|454685023|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
126379259|NCT02266147|454685024|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
126379260|NCT02266147|454685025|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
126379261|NCT02266147|454685022|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
126379262|NCT02266147|454685023|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
126379263|NCT02266147|454685024|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
126379264|NCT02266147|454685025|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
126379265|NCT02266147|454685022|FG000|PART 1: Dose Escalation|Other|1|||
126379266|NCT02266147|454685023|FG001|PART 1: Dose Escalation|Other|1|||
126379267|NCT02266147|454685024|FG002|PART 1: Dose Escalation|Other|0|||
126379268|NCT02266147|454685025|FG003|PART 1: Dose Escalation|Other|0|||
126379269|NCT02266147|454685022|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
126379270|NCT02266147|454685023|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
126379271|NCT02266147|454685024|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
126379272|NCT02266147|454685025|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
126379273|NCT02266147|454685022|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
126379274|NCT02266147|454685023|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
126379275|NCT02266147|454685024|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
126379276|NCT02266147|454685025|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
126379277|NCT00413660|454685028|FG000|Up To Week 12|Adverse Event|1|||
126379278|NCT00413660|454685029|FG001|Up To Week 12|Adverse Event|3|||
126379279|NCT00413660|454685030|FG002|Up To Week 12|Adverse Event|1|||
126379280|NCT00413660|454685031|FG003|Up To Week 12|Adverse Event|4|||
126379281|NCT00413660|454685032|FG004|Up To Week 12|Adverse Event|6|||
126379282|NCT00413660|454685033|FG005|Up To Week 12|Adverse Event|4|||
126379283|NCT00413660|454685034|FG006|Up To Week 12|Adverse Event|1|||
126379284|NCT00413660|454685035|FG007|Up To Week 12|Adverse Event|0|||
126379285|NCT00413660|454685036|FG008|Up To Week 12|Adverse Event|0|||
126379286|NCT00413660|454685037|FG009|Up To Week 12|Adverse Event|0|||
126379287|NCT00413660|454685038|FG010|Up To Week 12|Adverse Event|0|||
126379288|NCT00413660|454685028|FG000|Up To Week 12|Lack of Efficacy|2|||
126379289|NCT00413660|454685029|FG001|Up To Week 12|Lack of Efficacy|0|||
126379290|NCT00413660|454685030|FG002|Up To Week 12|Lack of Efficacy|0|||
126379291|NCT00413660|454685031|FG003|Up To Week 12|Lack of Efficacy|0|||
126379292|NCT00413660|454685032|FG004|Up To Week 12|Lack of Efficacy|0|||
126379293|NCT00413660|454685033|FG005|Up To Week 12|Lack of Efficacy|0|||
126379294|NCT00413660|454685034|FG006|Up To Week 12|Lack of Efficacy|5|||
126379295|NCT00413660|454685035|FG007|Up To Week 12|Lack of Efficacy|0|||
126379296|NCT00413660|454685036|FG008|Up To Week 12|Lack of Efficacy|0|||
126379297|NCT00413660|454685037|FG009|Up To Week 12|Lack of Efficacy|0|||
126379298|NCT00413660|454685038|FG010|Up To Week 12|Lack of Efficacy|0|||
126379299|NCT00413660|454685028|FG000|Up To Week 12|Lost to Follow-up|0|||
126467676|NCT01086423|455013424|FG001|Overall Study|Adverse event, non-fatal|1|||
126379300|NCT00413660|454685029|FG001|Up To Week 12|Lost to Follow-up|1|||
126379301|NCT00413660|454685030|FG002|Up To Week 12|Lost to Follow-up|0|||
126379302|NCT00413660|454685031|FG003|Up To Week 12|Lost to Follow-up|0|||
126379303|NCT00413660|454685032|FG004|Up To Week 12|Lost to Follow-up|1|||
126379304|NCT00413660|454685033|FG005|Up To Week 12|Lost to Follow-up|0|||
126379305|NCT00413660|454685034|FG006|Up To Week 12|Lost to Follow-up|0|||
126379306|NCT00413660|454685035|FG007|Up To Week 12|Lost to Follow-up|0|||
126379307|NCT00413660|454685036|FG008|Up To Week 12|Lost to Follow-up|0|||
126379308|NCT00413660|454685037|FG009|Up To Week 12|Lost to Follow-up|0|||
126379309|NCT00413660|454685038|FG010|Up To Week 12|Lost to Follow-up|0|||
126379310|NCT00413660|454685028|FG000|Up To Week 12|Withdrawal by Subject|0|||
126379311|NCT00413660|454685029|FG001|Up To Week 12|Withdrawal by Subject|2|||
126379312|NCT00413660|454685030|FG002|Up To Week 12|Withdrawal by Subject|0|||
126379313|NCT00413660|454685031|FG003|Up To Week 12|Withdrawal by Subject|2|||
126379314|NCT00413660|454685032|FG004|Up To Week 12|Withdrawal by Subject|0|||
126379315|NCT00413660|454685033|FG005|Up To Week 12|Withdrawal by Subject|2|||
126379316|NCT00413660|454685034|FG006|Up To Week 12|Withdrawal by Subject|2|||
126379317|NCT00413660|454685035|FG007|Up To Week 12|Withdrawal by Subject|0|||
126379318|NCT00413660|454685036|FG008|Up To Week 12|Withdrawal by Subject|0|||
126379319|NCT00413660|454685037|FG009|Up To Week 12|Withdrawal by Subject|0|||
126379320|NCT00413660|454685038|FG010|Up To Week 12|Withdrawal by Subject|0|||
126379321|NCT00413660|454685028|FG000|Up To Week 12|Randomized, Not Treated|1|||
126379322|NCT00413660|454685029|FG001|Up To Week 12|Randomized, Not Treated|0|||
126379323|NCT00413660|454685030|FG002|Up To Week 12|Randomized, Not Treated|0|||
126379324|NCT00413660|454685031|FG003|Up To Week 12|Randomized, Not Treated|1|||
126379325|NCT00413660|454685032|FG004|Up To Week 12|Randomized, Not Treated|0|||
126379326|NCT00413660|454685033|FG005|Up To Week 12|Randomized, Not Treated|0|||
126379327|NCT00413660|454685034|FG006|Up To Week 12|Randomized, Not Treated|0|||
126379328|NCT00413660|454685035|FG007|Up To Week 12|Randomized, Not Treated|0|||
126379329|NCT00413660|454685036|FG008|Up To Week 12|Randomized, Not Treated|0|||
126379330|NCT00413660|454685037|FG009|Up To Week 12|Randomized, Not Treated|0|||
126379331|NCT00413660|454685038|FG010|Up To Week 12|Randomized, Not Treated|0|||
126379332|NCT00413660|454685028|FG000|Up To Week 12|Other|3|||
126379333|NCT00413660|454685029|FG001|Up To Week 12|Other|1|||
126379334|NCT00413660|454685030|FG002|Up To Week 12|Other|6|||
126379335|NCT00413660|454685031|FG003|Up To Week 12|Other|1|||
126379336|NCT00413660|454685032|FG004|Up To Week 12|Other|2|||
126379337|NCT00413660|454685033|FG005|Up To Week 12|Other|4|||
126379338|NCT00413660|454685034|FG006|Up To Week 12|Other|3|||
126379339|NCT00413660|454685035|FG007|Up To Week 12|Other|0|||
126379340|NCT00413660|454685036|FG008|Up To Week 12|Other|0|||
126379341|NCT00413660|454685037|FG009|Up To Week 12|Other|0|||
126379342|NCT00413660|454685038|FG010|Up To Week 12|Other|0|||
126379343|NCT00413660|454685028|FG000|Post Week 12|Adverse Event|2|||
126379344|NCT00413660|454685029|FG001|Post Week 12|Adverse Event|0|||
126379345|NCT00413660|454685030|FG002|Post Week 12|Adverse Event|2|||
126379346|NCT00413660|454685031|FG003|Post Week 12|Adverse Event|1|||
126379347|NCT00413660|454685032|FG004|Post Week 12|Adverse Event|4|||
126379348|NCT00413660|454685033|FG005|Post Week 12|Adverse Event|2|||
126379349|NCT00413660|454685034|FG006|Post Week 12|Adverse Event|2|||
126379350|NCT00413660|454685035|FG007|Post Week 12|Adverse Event|0|||
126379351|NCT00413660|454685036|FG008|Post Week 12|Adverse Event|0|||
126379352|NCT00413660|454685037|FG009|Post Week 12|Adverse Event|0|||
126379353|NCT00413660|454685038|FG010|Post Week 12|Adverse Event|0|||
126379354|NCT00413660|454685028|FG000|Post Week 12|Lack of Efficacy|0|||
126379355|NCT00413660|454685029|FG001|Post Week 12|Lack of Efficacy|0|||
126379356|NCT00413660|454685030|FG002|Post Week 12|Lack of Efficacy|1|||
126379357|NCT00413660|454685031|FG003|Post Week 12|Lack of Efficacy|0|||
126379358|NCT00413660|454685032|FG004|Post Week 12|Lack of Efficacy|0|||
126379359|NCT00413660|454685033|FG005|Post Week 12|Lack of Efficacy|0|||
126379360|NCT00413660|454685034|FG006|Post Week 12|Lack of Efficacy|0|||
126379361|NCT00413660|454685035|FG007|Post Week 12|Lack of Efficacy|0|||
126379362|NCT00413660|454685036|FG008|Post Week 12|Lack of Efficacy|0|||
126379363|NCT00413660|454685037|FG009|Post Week 12|Lack of Efficacy|1|||
126379364|NCT00413660|454685038|FG010|Post Week 12|Lack of Efficacy|0|||
126379365|NCT00413660|454685028|FG000|Post Week 12|Lost to Follow-up|0|||
126379366|NCT00413660|454685029|FG001|Post Week 12|Lost to Follow-up|1|||
126379367|NCT00413660|454685030|FG002|Post Week 12|Lost to Follow-up|1|||
126379368|NCT00413660|454685031|FG003|Post Week 12|Lost to Follow-up|0|||
126379369|NCT00413660|454685032|FG004|Post Week 12|Lost to Follow-up|0|||
126379370|NCT00413660|454685033|FG005|Post Week 12|Lost to Follow-up|0|||
126379371|NCT00413660|454685034|FG006|Post Week 12|Lost to Follow-up|0|||
126379372|NCT00413660|454685035|FG007|Post Week 12|Lost to Follow-up|0|||
126379373|NCT00413660|454685036|FG008|Post Week 12|Lost to Follow-up|0|||
126379374|NCT00413660|454685037|FG009|Post Week 12|Lost to Follow-up|0|||
126379375|NCT00413660|454685038|FG010|Post Week 12|Lost to Follow-up|0|||
126379376|NCT00413660|454685028|FG000|Post Week 12|Withdrawal by Subject|0|||
126379377|NCT00413660|454685029|FG001|Post Week 12|Withdrawal by Subject|1|||
126379378|NCT00413660|454685030|FG002|Post Week 12|Withdrawal by Subject|1|||
126379379|NCT00413660|454685031|FG003|Post Week 12|Withdrawal by Subject|0|||
126379380|NCT00413660|454685032|FG004|Post Week 12|Withdrawal by Subject|1|||
126467677|NCT01086423|455013425|FG002|Overall Study|Adverse event, non-fatal|0|||
126467678|NCT01086423|455013423|FG000|Overall Study|Withdrawal by Subject|5|||
126467679|NCT01086423|455013424|FG001|Overall Study|Withdrawal by Subject|1|||
126467680|NCT01086423|455013425|FG002|Overall Study|Withdrawal by Subject|3|||
126379381|NCT00413660|454685033|FG005|Post Week 12|Withdrawal by Subject|0|||
126379382|NCT00413660|454685034|FG006|Post Week 12|Withdrawal by Subject|0|||
126379383|NCT00413660|454685035|FG007|Post Week 12|Withdrawal by Subject|0|||
126379384|NCT00413660|454685036|FG008|Post Week 12|Withdrawal by Subject|0|||
126379385|NCT00413660|454685037|FG009|Post Week 12|Withdrawal by Subject|0|||
126379386|NCT00413660|454685038|FG010|Post Week 12|Withdrawal by Subject|1|||
126379387|NCT00413660|454685028|FG000|Post Week 12|Other|1|||
126379388|NCT00413660|454685029|FG001|Post Week 12|Other|2|||
126379389|NCT00413660|454685030|FG002|Post Week 12|Other|3|||
126379390|NCT00413660|454685031|FG003|Post Week 12|Other|0|||
126379391|NCT00413660|454685032|FG004|Post Week 12|Other|1|||
126379392|NCT00413660|454685033|FG005|Post Week 12|Other|1|||
126379393|NCT00413660|454685034|FG006|Post Week 12|Other|1|||
126379394|NCT00413660|454685035|FG007|Post Week 12|Other|0|||
126379395|NCT00413660|454685036|FG008|Post Week 12|Other|0|||
126379396|NCT00413660|454685037|FG009|Post Week 12|Other|0|||
126379397|NCT00413660|454685038|FG010|Post Week 12|Other|0|||
126379398|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
126379399|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
126379400|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
126379401|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
126379402|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
126379403|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
126379404|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
126379405|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
126379406|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
126379407|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
126379408|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
126379409|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
126379410|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
126379411|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
126379412|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
126379413|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
126379414|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
126379415|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
126379416|NCT02831855|454685039|FG000|Open Label Phase (24 Weeks)|Other|4|||
126379417|NCT02831855|454685040|FG001|Open Label Phase (24 Weeks)|Other|0|||
126379418|NCT02831855|454685041|FG002|Open Label Phase (24 Weeks)|Other|0|||
126379419|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
126379420|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
126379421|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
126379422|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Death|0|||
126379423|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Death|0|||
126379424|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Death|2|||
126379425|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
126379426|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
126379427|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
126379428|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
126379429|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
126379430|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
126379431|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
126379432|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
126379433|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
126379434|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Other|0|||
126379435|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Other|2|||
126379436|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Other|5|||
126379437|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
126379438|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
126379439|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
126379440|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
126467681|NCT01086423|455013423|FG000|Overall Study|Lost to Follow-up|0|||
126467682|NCT01086423|455013424|FG001|Overall Study|Lost to Follow-up|0|||
126379441|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
126379442|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
126379443|NCT02831855|454685039|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
126467683|NCT01086423|455013425|FG002|Overall Study|Lost to Follow-up|1|||
126467684|NCT03114488|455013426|FG000|Time Period 2|Withdrawal by Subject|1|||
126467685|NCT03114488|455013427|FG001|Time Period 2|Withdrawal by Subject|3|||
126467686|NCT04137224|455013429|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
126467687|NCT04137224|455013430|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
126467688|NCT04137224|455013429|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
126467689|NCT04137224|455013430|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
126467690|NCT04137224|455013429|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
126467691|NCT04137224|455013430|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
126467692|NCT01225887|455013431|FG000|Overall Study|Ineligible:required test not done|2|||
126467693|NCT01225887|455013431|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
126467694|NCT01225887|455013431|FG000|Overall Study|Ineligible:inadequate pathology|2|||
126467695|NCT01669928|455013432|FG000|First Intervention|Withdrawal by Subject|3|||
126467696|NCT01669928|455013433|FG001|First Intervention|Withdrawal by Subject|5|||
126467697|NCT00679055|455013436|FG000|Overall Study|Adverse Event|0|||
126467698|NCT00679055|455013437|FG001|Overall Study|Adverse Event|1|||
126467699|NCT00679055|455013436|FG000|Overall Study|Other|0|||
126467700|NCT00679055|455013437|FG001|Overall Study|Other|3|||
126467701|NCT00679055|455013436|FG000|Overall Study|Study Terminated|2|||
126467702|NCT00679055|455013437|FG001|Overall Study|Study Terminated|1|||
126467703|NCT00925990|455013438|FG000|Overall Study|Adverse Event|1|||
126467704|NCT00925990|455013439|FG001|Overall Study|Adverse Event|3|||
126467705|NCT00925990|455013438|FG000|Overall Study|Withdrawal by Subject|2|||
126467706|NCT00925990|455013439|FG001|Overall Study|Withdrawal by Subject|2|||
126467707|NCT00925990|455013438|FG000|Overall Study|Lost to Follow-up|1|||
126467708|NCT00925990|455013439|FG001|Overall Study|Lost to Follow-up|3|||
126467709|NCT00925990|455013438|FG000|Overall Study|Physician Decision|1|||
126467710|NCT00925990|455013439|FG001|Overall Study|Physician Decision|1|||
126467711|NCT00925990|455013438|FG000|Overall Study|moved out of state, missed medication|0|||
126467712|NCT00925990|455013439|FG001|Overall Study|moved out of state, missed medication|2|||
126467713|NCT01008150|455013445|FG000|Overall Study|did not receive study drug|1|||
126467714|NCT01008150|455013446|FG001|Overall Study|did not receive study drug|1|||
126467715|NCT01008150|455013447|FG002|Overall Study|did not receive study drug|1|||
126467716|NCT01008150|455013448|FG003|Overall Study|did not receive study drug|0|||
126467717|NCT01912963|455013459|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
126467718|NCT01912963|455013460|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
126467719|NCT01912963|455013461|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
126467720|NCT01912963|455013459|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
126467721|NCT01912963|455013460|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
126467722|NCT01912963|455013461|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
126467723|NCT01912963|455013459|FG000|Overall Study|Adverse Event|0|||
126467724|NCT01912963|455013460|FG001|Overall Study|Adverse Event|1|||
126467725|NCT01912963|455013461|FG002|Overall Study|Adverse Event|1|||
126379444|NCT02831855|454685040|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
126379445|NCT02831855|454685041|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
126379446|NCT01722994|454685042|FG000|Overall Study|Missing data|25|||
126379447|NCT01722994|454685043|FG001|Overall Study|Missing data|17|||
126379448|NCT01803880|454685047|FG000|Overall Study|Adverse Event|1|||
126379449|NCT01803880|454685048|FG001|Overall Study|Adverse Event|0|||
126379450|NCT01803880|454685049|FG002|Overall Study|Adverse Event|0|||
126379451|NCT01803880|454685047|FG000|Overall Study|Withdrawal by Subject|1|||
126379452|NCT01803880|454685048|FG001|Overall Study|Withdrawal by Subject|1|||
126379453|NCT01803880|454685049|FG002|Overall Study|Withdrawal by Subject|4|||
126379454|NCT01803880|454685047|FG000|Overall Study|Physician Decision|0|||
126379455|NCT01803880|454685048|FG001|Overall Study|Physician Decision|0|||
126379456|NCT01803880|454685049|FG002|Overall Study|Physician Decision|1|||
126379457|NCT01803880|454685047|FG000|Overall Study|Unable to return for follow-up visits|0|||
126379458|NCT01803880|454685048|FG001|Overall Study|Unable to return for follow-up visits|1|||
126379459|NCT01803880|454685049|FG002|Overall Study|Unable to return for follow-up visits|2|||
126379460|NCT01803880|454685047|FG000|Overall Study|Lost to Follow-up|1|||
126379461|NCT01803880|454685048|FG001|Overall Study|Lost to Follow-up|2|||
126467726|NCT01912963|455013459|FG000|Overall Study|Withdrawal by Subject|0|||
126467727|NCT01912963|455013460|FG001|Overall Study|Withdrawal by Subject|1|||
126467728|NCT01912963|455013461|FG002|Overall Study|Withdrawal by Subject|0|||
126467729|NCT01912963|455013459|FG000|Overall Study|Sought treatment locally|0|||
126467730|NCT01912963|455013460|FG001|Overall Study|Sought treatment locally|1|||
126467731|NCT01912963|455013461|FG002|Overall Study|Sought treatment locally|0|||
126467732|NCT03112590|455013466|FG000|Overall Study|Adverse Event|0|||
126379462|NCT01803880|454685049|FG002|Overall Study|Lost to Follow-up|3|||
126379463|NCT01803880|454685047|FG000|Overall Study|Protocol Violation|1|||
126379464|NCT01803880|454685048|FG001|Overall Study|Protocol Violation|0|||
126379465|NCT01803880|454685049|FG002|Overall Study|Protocol Violation|0|||
126467733|NCT03112590|455013467|FG001|Overall Study|Adverse Event|1|||
126467734|NCT03112590|455013468|FG002|Overall Study|Adverse Event|0|||
126467735|NCT00843726|455013469|FG000|Overall Study|Death|1|||
126467736|NCT00843726|455013470|FG001|Overall Study|Death|0|||
126467737|NCT00843726|455013469|FG000|Overall Study|Withdrawal by Subject|0|||
126467738|NCT00843726|455013470|FG001|Overall Study|Withdrawal by Subject|1|||
126379466|NCT01803880|454685047|FG000|Overall Study|Early study termination|0|||
126379467|NCT01803880|454685048|FG001|Overall Study|Early study termination|6|||
126379468|NCT01803880|454685049|FG002|Overall Study|Early study termination|5|||
126379469|NCT01803880|454685047|FG000|Overall Study|Incomplete data entry by sites|2|||
126379470|NCT01803880|454685048|FG001|Overall Study|Incomplete data entry by sites|0|||
126379471|NCT01803880|454685049|FG002|Overall Study|Incomplete data entry by sites|0|||
126467739|NCT00891462|455015057|FG000|Overall Study|Withdrawal by Subject|9|||
126467740|NCT00891462|455015058|FG001|Overall Study|Withdrawal by Subject|6|||
126467741|NCT00891462|455015059|FG002|Overall Study|Withdrawal by Subject|7|||
126467742|NCT00891462|455015057|FG000|Overall Study|Adverse Event|7|||
126467743|NCT00891462|455015058|FG001|Overall Study|Adverse Event|8|||
126467744|NCT00891462|455015059|FG002|Overall Study|Adverse Event|7|||
126467745|NCT00891462|455015057|FG000|Overall Study|Lack of Efficacy|10|||
126467746|NCT00891462|455015058|FG001|Overall Study|Lack of Efficacy|5|||
126467747|NCT00891462|455015059|FG002|Overall Study|Lack of Efficacy|1|||
126467748|NCT00891462|455015057|FG000|Overall Study|COPD exacerbation|7|||
126467749|NCT00891462|455015058|FG001|Overall Study|COPD exacerbation|4|||
126467750|NCT00891462|455015059|FG002|Overall Study|COPD exacerbation|1|||
126467751|NCT00891462|455015057|FG000|Overall Study|Other Reason|2|||
126467752|NCT00891462|455015058|FG001|Overall Study|Other Reason|5|||
126467753|NCT00891462|455015059|FG002|Overall Study|Other Reason|3|||
126467754|NCT00891462|455015057|FG000|Overall Study|Protocol Violation|2|||
126379472|NCT02954887|454685050|FG000|Overall Study|Withdrawal by Subject|3|||
126379473|NCT02954887|454685050|FG000|Overall Study|Lack of Efficacy|3|||
126379474|NCT02954887|454685050|FG000|Overall Study|Other|1|||
126379475|NCT01459666|454685052|FG000|Overall Study|PI left institution|5|||
126379476|NCT01459666|454685053|FG001|Overall Study|PI left institution|4|||
126379477|NCT01152788|454685055|FG000|Overall Study|Withdrawal by Subject|0|||
126379478|NCT01152788|454685056|FG001|Overall Study|Withdrawal by Subject|3|||
126379479|NCT01152788|454685055|FG000|Overall Study|No treatment|0|||
126379480|NCT01152788|454685056|FG001|Overall Study|No treatment|1|||
126379481|NCT00889707|454685061|FG000|Overall Study|Adverse Event|1|||
126379482|NCT00889707|454685062|FG001|Overall Study|Adverse Event|0|||
126379483|NCT00889707|454685061|FG000|Overall Study|Withdrawal by Subject|4|||
126379484|NCT00889707|454685062|FG001|Overall Study|Withdrawal by Subject|3|||
126379485|NCT00889707|454685061|FG000|Overall Study|Lost to Follow-up|0|||
126379486|NCT00889707|454685062|FG001|Overall Study|Lost to Follow-up|2|||
126379487|NCT00889707|454685061|FG000|Overall Study|Lack of Efficacy|2|||
126379488|NCT00889707|454685062|FG001|Overall Study|Lack of Efficacy|5|||
126379489|NCT03542266|454685066|FG000|Treatment Phase|Withdrawal by Subject|1|||
126379490|NCT03542266|454685066|FG000|Treatment Phase|Adverse Event|1|||
126379491|NCT03542266|454685066|FG000|Treatment Phase|PD|1|||
126379492|NCT02268383|454685071|FG000|Overall Study|Death|12|||
126379493|NCT02268383|454685071|FG000|Overall Study|Lost to Follow-up|2|||
126379494|NCT02268383|454685071|FG000|Overall Study|Withdrawal by Subject|9|||
126379495|NCT02268383|454685071|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
126379496|NCT02268383|454685071|FG000|Overall Study|Protocol deviation|3|||
126379497|NCT02268383|454685071|FG000|Overall Study|Sponsor decision|22|||
126379498|NCT02268383|454685071|FG000|Overall Study|Not reported|12|||
126379499|NCT02708680|454685072|FG000|Overall Study|Withdrawal by Subject|4|||
126379500|NCT02708680|454685073|FG001|Overall Study|Withdrawal by Subject|12|||
126379501|NCT02708680|454685074|FG002|Overall Study|Withdrawal by Subject|12|||
126379502|NCT02708680|454685072|FG000|Overall Study|Death|4|||
126379503|NCT02708680|454685073|FG001|Overall Study|Death|19|||
126379504|NCT02708680|454685074|FG002|Overall Study|Death|21|||
126379505|NCT02708680|454685072|FG000|Overall Study|Lost to Follow-up|0|||
126379506|NCT02708680|454685073|FG001|Overall Study|Lost to Follow-up|3|||
126379507|NCT02708680|454685074|FG002|Overall Study|Lost to Follow-up|3|||
126379508|NCT02708680|454685072|FG000|Overall Study|Study Terminated By Sponsor|0|||
126379509|NCT02708680|454685073|FG001|Overall Study|Study Terminated By Sponsor|5|||
126379510|NCT02708680|454685074|FG002|Overall Study|Study Terminated By Sponsor|4|||
126379511|NCT02708680|454685072|FG000|Overall Study|Other than Specified|0|||
126467755|NCT00891462|455015058|FG001|Overall Study|Protocol Violation|1|||
126467756|NCT00891462|455015059|FG002|Overall Study|Protocol Violation|3|||
126467757|NCT00891462|455015057|FG000|Overall Study|Inclusion/exclusion criteria|0|||
126467758|NCT00891462|455015058|FG001|Overall Study|Inclusion/exclusion criteria|2|||
126379512|NCT02708680|454685073|FG001|Overall Study|Other than Specified|0|||
126379513|NCT02708680|454685074|FG002|Overall Study|Other than Specified|1|||
126379514|NCT02708680|454685072|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
126379515|NCT02708680|454685073|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
126379516|NCT02708680|454685074|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
126467759|NCT00891462|455015059|FG002|Overall Study|Inclusion/exclusion criteria|2|||
126379517|NCT04162470|454685075|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
126379518|NCT01544348|454685082|FG000|Overall Study|Lost to Follow-up|1|||
126379519|NCT01544348|454685083|FG001|Overall Study|Lost to Follow-up|0|||
126467760|NCT00891462|455015057|FG000|Overall Study|Lost to Follow-up|0|||
126467761|NCT00891462|455015058|FG001|Overall Study|Lost to Follow-up|2|||
126467762|NCT00891462|455015059|FG002|Overall Study|Lost to Follow-up|0|||
126379520|NCT01544348|454685084|FG002|Overall Study|Lost to Follow-up|0|||
126379521|NCT01544348|454685085|FG003|Overall Study|Lost to Follow-up|0|||
126379522|NCT01544348|454685086|FG004|Overall Study|Lost to Follow-up|0|||
126379523|NCT01544348|454685087|FG005|Overall Study|Lost to Follow-up|0|||
126379524|NCT01544348|454685088|FG006|Overall Study|Lost to Follow-up|1|||
126379525|NCT01544348|454685089|FG007|Overall Study|Lost to Follow-up|0|||
126379526|NCT01544348|454685082|FG000|Overall Study|Withdrawal by Subject|1|||
126379527|NCT01544348|454685083|FG001|Overall Study|Withdrawal by Subject|0|||
126379528|NCT01544348|454685084|FG002|Overall Study|Withdrawal by Subject|0|||
126379529|NCT01544348|454685085|FG003|Overall Study|Withdrawal by Subject|0|||
126379530|NCT01544348|454685086|FG004|Overall Study|Withdrawal by Subject|1|||
126379531|NCT01544348|454685087|FG005|Overall Study|Withdrawal by Subject|2|||
126379532|NCT01544348|454685088|FG006|Overall Study|Withdrawal by Subject|1|||
126379533|NCT01544348|454685089|FG007|Overall Study|Withdrawal by Subject|0|||
126379534|NCT01544348|454685082|FG000|Overall Study|Physician Decision|0|||
126379535|NCT01544348|454685083|FG001|Overall Study|Physician Decision|0|||
126379536|NCT01544348|454685084|FG002|Overall Study|Physician Decision|0|||
126379537|NCT01544348|454685085|FG003|Overall Study|Physician Decision|0|||
126379538|NCT01544348|454685086|FG004|Overall Study|Physician Decision|0|||
126379539|NCT01544348|454685087|FG005|Overall Study|Physician Decision|1|||
126379540|NCT01544348|454685088|FG006|Overall Study|Physician Decision|0|||
126379541|NCT01544348|454685089|FG007|Overall Study|Physician Decision|0|||
126379542|NCT01445847|454685090|FG000|Overall Study|Protocol Violation|13|||
126379543|NCT01445847|454685091|FG001|Overall Study|Protocol Violation|14|||
126379544|NCT01445847|454685090|FG000|Overall Study|Missed Data|1|||
126379545|NCT01445847|454685091|FG001|Overall Study|Missed Data|0|||
126379546|NCT04790279|454686984|FG000|Overall Study|Did not meet medication start criteria|27|||
126379547|NCT04790279|454686985|FG001|Overall Study|Did not meet medication start criteria|15|||
126379548|NCT04790279|454686984|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
126379549|NCT04790279|454686985|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
126379550|NCT04790279|454686984|FG000|Overall Study|Protocol Violation|8|||
126379551|NCT04790279|454686985|FG001|Overall Study|Protocol Violation|3|||
126379552|NCT04790279|454686984|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
126379553|NCT04790279|454686985|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
126379554|NCT00810277|454686998|FG000|Overall Study|Adverse Event|1|||
126379555|NCT00678288|454687005|FG000|Overall Study|Adverse Event|0|||
126379556|NCT00678288|454687006|FG001|Overall Study|Adverse Event|2|||
126379557|NCT00678288|454687005|FG000|Overall Study|Withdrawal by Subject|1|||
126379558|NCT00678288|454687006|FG001|Overall Study|Withdrawal by Subject|1|||
126379559|NCT00678288|454687005|FG000|Overall Study|Study terminated by the sponsor|2|||
126379560|NCT00678288|454687006|FG001|Overall Study|Study terminated by the sponsor|0|||
126379561|NCT00678288|454687005|FG000|Overall Study|Not compliant with study medication|0|||
126379562|NCT00678288|454687006|FG001|Overall Study|Not compliant with study medication|1|||
126379563|NCT00678288|454687005|FG000|Overall Study|Switch to commercial drug|0|||
126379564|NCT00678288|454687006|FG001|Overall Study|Switch to commercial drug|1|||
126379565|NCT00678288|454687005|FG000|Overall Study|Reason not reported|1|||
126379566|NCT00678288|454687006|FG001|Overall Study|Reason not reported|0|||
126379567|NCT00678288|454687005|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
126379568|NCT00678288|454687006|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
126379569|NCT02549989|454687007|FG000|Overall Study|Adverse Event|4|||
126379570|NCT02549989|454687007|FG000|Overall Study|Death|1|||
126379571|NCT02549989|454687007|FG000|Overall Study|Lack of Efficacy|19|||
126379572|NCT02549989|454687007|FG000|Overall Study|Withdrawal by Subject|3|||
126379573|NCT00972023|454687008|FG000|Overall Study|Withdrawal by Subject|1|||
126467763|NCT00257608|455015065|FG000|Chemotherapy Phase|Adverse Event|138|||
126467764|NCT00257608|455015066|FG001|Chemotherapy Phase|Adverse Event|0|||
126467765|NCT00257608|455015067|FG002|Chemotherapy Phase|Adverse Event|0|||
126467766|NCT00257608|455015065|FG000|Chemotherapy Phase|Disease progression|139|||
126467767|NCT00257608|455015066|FG001|Chemotherapy Phase|Disease progression|0|||
126467768|NCT00257608|455015067|FG002|Chemotherapy Phase|Disease progression|0|||
126467769|NCT00257608|455015065|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
126467770|NCT00257608|455015066|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
126467771|NCT00257608|455015067|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
126467772|NCT00257608|455015065|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
126467773|NCT00257608|455015066|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
126467774|NCT00257608|455015067|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
126467775|NCT00257608|455015065|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
126379574|NCT02628444|454687009|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
126379575|NCT02628444|454687010|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379576|NCT02628444|454687011|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379577|NCT02628444|454687012|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126467776|NCT00257608|455015066|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
126717069|NCT00002663|455915015|FG002|Overall Study|Adverse Event|0|||
126553198|NCT01089556|455320530|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
126553199|NCT01089556|455320531|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
126553200|NCT01089556|455320532|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
126379578|NCT02628444|454687013|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379579|NCT02628444|454687014|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379580|NCT02628444|454687015|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379581|NCT02628444|454687016|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379582|NCT02628444|454687017|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
126379583|NCT02628444|454687009|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379584|NCT02628444|454687010|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
126379585|NCT02628444|454687011|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
126379586|NCT02628444|454687012|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379587|NCT02628444|454687013|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379588|NCT02628444|454687014|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379589|NCT02628444|454687015|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379590|NCT02628444|454687016|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379591|NCT02628444|454687017|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
126379592|NCT02628444|454687009|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
126379593|NCT02628444|454687010|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
126379594|NCT02628444|454687011|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
126379595|NCT02628444|454687012|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379596|NCT02628444|454687013|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379597|NCT02628444|454687014|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379598|NCT02628444|454687015|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379599|NCT02628444|454687016|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379600|NCT02628444|454687017|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379601|NCT02628444|454687009|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
126379602|NCT02628444|454687010|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
126379603|NCT02628444|454687011|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
126379604|NCT02628444|454687012|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
126379605|NCT02628444|454687013|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
126379606|NCT02628444|454687014|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
126379607|NCT02628444|454687015|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
126379608|NCT02628444|454687016|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
126379609|NCT02628444|454687017|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
126379610|NCT02628444|454687009|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
126379611|NCT02628444|454687010|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
126379612|NCT02628444|454687011|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
126379613|NCT02628444|454687012|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
126379614|NCT02628444|454687013|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
126379615|NCT02628444|454687014|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
126379616|NCT02628444|454687015|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
126379617|NCT02628444|454687016|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
126379618|NCT02628444|454687017|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
126379619|NCT02628444|454687009|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379620|NCT02628444|454687010|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379621|NCT02628444|454687011|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379622|NCT02628444|454687012|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
126379623|NCT02628444|454687013|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379624|NCT02628444|454687014|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379625|NCT02628444|454687015|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379626|NCT02628444|454687016|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379627|NCT02628444|454687017|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
126379628|NCT02628444|454687009|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
126379629|NCT02628444|454687010|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
126379630|NCT02628444|454687011|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
126379631|NCT02628444|454687012|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
126379632|NCT02628444|454687013|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
126379633|NCT02628444|454687014|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
126553201|NCT01089556|455320533|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
126717070|NCT00002663|455915016|FG003|Overall Study|Adverse Event|1|||
126379634|NCT02628444|454687015|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
126379635|NCT02628444|454687016|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
126379636|NCT02628444|454687017|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
126379637|NCT02628444|454687009|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379638|NCT02628444|454687010|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379639|NCT02628444|454687011|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
126379640|NCT02628444|454687012|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
126379641|NCT02628444|454687013|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
126379642|NCT02628444|454687014|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
126379643|NCT02628444|454687015|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
126379644|NCT02628444|454687016|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
126379645|NCT02628444|454687017|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
126379646|NCT02628444|454687009|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
126379647|NCT02628444|454687010|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
126379648|NCT02628444|454687011|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
126379649|NCT02628444|454687012|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
126379650|NCT02628444|454687013|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
126379651|NCT02628444|454687014|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
126379652|NCT02628444|454687015|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
126379653|NCT02628444|454687016|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
126379654|NCT02628444|454687017|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
126379655|NCT02628444|454687009|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
126379656|NCT02628444|454687010|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
126379657|NCT02628444|454687011|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
126379658|NCT02628444|454687012|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
126379659|NCT02628444|454687013|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
126379660|NCT02628444|454687014|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
126379661|NCT02628444|454687015|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
126379662|NCT02628444|454687016|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
126379663|NCT02628444|454687017|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
126379664|NCT00784368|454687020|FG000|Overall Study|Physician Decision|0|||
126379665|NCT00784368|454687021|FG001|Overall Study|Physician Decision|0|||
126379666|NCT00784368|454687022|FG002|Overall Study|Physician Decision|6|||
126379667|NCT00784368|454687020|FG000|Overall Study|Lack of Efficacy|2|||
126379668|NCT00784368|454687021|FG001|Overall Study|Lack of Efficacy|0|||
126379669|NCT00784368|454687022|FG002|Overall Study|Lack of Efficacy|1|||
126379670|NCT00784368|454687020|FG000|Overall Study|Adverse Event|6|||
126379671|NCT00784368|454687021|FG001|Overall Study|Adverse Event|9|||
126379672|NCT00784368|454687022|FG002|Overall Study|Adverse Event|2|||
126379673|NCT00784368|454687020|FG000|Overall Study|Diagnosis of fever|0|||
126379674|NCT00784368|454687021|FG001|Overall Study|Diagnosis of fever|0|||
126379675|NCT00784368|454687022|FG002|Overall Study|Diagnosis of fever|1|||
126379676|NCT00784368|454687020|FG000|Overall Study|Worsening of complications|0|||
126379677|NCT00784368|454687021|FG001|Overall Study|Worsening of complications|0|||
126379678|NCT00784368|454687022|FG002|Overall Study|Worsening of complications|1|||
126379679|NCT00784368|454687020|FG000|Overall Study|Worsening of symptoms|0|||
126379680|NCT00784368|454687021|FG001|Overall Study|Worsening of symptoms|1|||
126379681|NCT00784368|454687022|FG002|Overall Study|Worsening of symptoms|0|||
126379682|NCT00784368|454687020|FG000|Overall Study|Withdrawal of informed consent|0|||
126379683|NCT00784368|454687021|FG001|Overall Study|Withdrawal of informed consent|1|||
126379684|NCT00784368|454687022|FG002|Overall Study|Withdrawal of informed consent|0|||
126379685|NCT02079909|454687023|FG000|Overall Study|Adverse Event|23|||
126379686|NCT02079909|454687024|FG001|Overall Study|Adverse Event|23|||
126379687|NCT02079909|454687025|FG002|Overall Study|Adverse Event|7|||
126379688|NCT02079909|454687023|FG000|Overall Study|Withdrawal by Subject|9|||
126379689|NCT02079909|454687024|FG001|Overall Study|Withdrawal by Subject|17|||
126379690|NCT02079909|454687025|FG002|Overall Study|Withdrawal by Subject|4|||
126379691|NCT02079909|454687023|FG000|Overall Study|Lost to Follow-up|2|||
126379692|NCT02079909|454687024|FG001|Overall Study|Lost to Follow-up|3|||
126379693|NCT02079909|454687025|FG002|Overall Study|Lost to Follow-up|1|||
126379694|NCT02079909|454687023|FG000|Overall Study|Death|2|||
126379695|NCT02079909|454687024|FG001|Overall Study|Death|2|||
126379696|NCT02079909|454687025|FG002|Overall Study|Death|0|||
126379697|NCT02079909|454687023|FG000|Overall Study|Lack of Efficacy|0|||
126379698|NCT02079909|454687024|FG001|Overall Study|Lack of Efficacy|0|||
126379699|NCT02079909|454687025|FG002|Overall Study|Lack of Efficacy|1|||
126379700|NCT02079909|454687023|FG000|Overall Study|Protocol Violation|0|||
126379701|NCT02079909|454687024|FG001|Overall Study|Protocol Violation|1|||
126379702|NCT02079909|454687025|FG002|Overall Study|Protocol Violation|1|||
126379703|NCT02079909|454687023|FG000|Overall Study|Physician Decision|0|||
126379704|NCT02079909|454687024|FG001|Overall Study|Physician Decision|1|||
126379705|NCT02079909|454687025|FG002|Overall Study|Physician Decision|1|||
126379706|NCT02079909|454687023|FG000|Overall Study|Relocation etc.|2|||
126379707|NCT02079909|454687024|FG001|Overall Study|Relocation etc.|2|||
126379708|NCT02079909|454687025|FG002|Overall Study|Relocation etc.|3|||
126379709|NCT00720356|454687030|FG000|Registration to Study|Determined to have methylated MGMT|67|||
126379710|NCT00720356|454687030|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
126379711|NCT00720356|454687030|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
126379712|NCT00720356|454687030|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
126379713|NCT00720356|454687030|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
126379714|NCT00720356|454687030|FG000|Follow up Until Death|Withdrawal by Subject|1|||
126379715|NCT00720356|454687030|FG000|Follow up Until Death|Alive at last data collection|4|||
126379716|NCT01713582|454687033|FG000|Overall Study|Disease progression|3|||
126379717|NCT01713582|454687034|FG001|Overall Study|Disease progression|3|||
126379718|NCT01713582|454687035|FG002|Overall Study|Disease progression|3|||
126379719|NCT01713582|454687036|FG003|Overall Study|Disease progression|2|||
126379720|NCT01713582|454687037|FG004|Overall Study|Disease progression|3|||
126379721|NCT01713582|454687038|FG005|Overall Study|Disease progression|3|||
126379722|NCT01713582|454687039|FG006|Overall Study|Disease progression|3|||
126379723|NCT01713582|454687040|FG007|Overall Study|Disease progression|3|||
126379724|NCT01713582|454687041|FG008|Overall Study|Disease progression|3|||
126379725|NCT01713582|454687042|FG009|Overall Study|Disease progression|11|||
126379726|NCT01713582|454687043|FG010|Overall Study|Disease progression|10|||
126379727|NCT01713582|454687044|FG011|Overall Study|Disease progression|5|||
126379728|NCT01713582|454687045|FG012|Overall Study|Disease progression|3|||
126379729|NCT01713582|454687046|FG013|Overall Study|Disease progression|3|||
126379730|NCT01713582|454687047|FG014|Overall Study|Disease progression|6|||
126379731|NCT01713582|454687048|FG015|Overall Study|Disease progression|6|||
126379732|NCT01713582|454687049|FG016|Overall Study|Disease progression|5|||
126379733|NCT01713582|454687050|FG017|Overall Study|Disease progression|2|||
126379734|NCT01713582|454687051|FG018|Overall Study|Disease progression|3|||
126379735|NCT01713582|454687052|FG019|Overall Study|Disease progression|5|||
126379736|NCT01713582|454687053|FG020|Overall Study|Disease progression|15|||
126379737|NCT01713582|454687033|FG000|Overall Study|Death|0|||
126379738|NCT01713582|454687034|FG001|Overall Study|Death|0|||
126379739|NCT01713582|454687035|FG002|Overall Study|Death|0|||
126379740|NCT01713582|454687036|FG003|Overall Study|Death|1|||
126379741|NCT01713582|454687037|FG004|Overall Study|Death|1|||
126379742|NCT01713582|454687038|FG005|Overall Study|Death|3|||
126379743|NCT01713582|454687039|FG006|Overall Study|Death|3|||
126379744|NCT01713582|454687040|FG007|Overall Study|Death|2|||
126379745|NCT01713582|454687041|FG008|Overall Study|Death|3|||
126379746|NCT01713582|454687042|FG009|Overall Study|Death|4|||
126379747|NCT01713582|454687043|FG010|Overall Study|Death|3|||
126379748|NCT01713582|454687044|FG011|Overall Study|Death|0|||
126379749|NCT01713582|454687045|FG012|Overall Study|Death|0|||
126379750|NCT01713582|454687046|FG013|Overall Study|Death|0|||
126379751|NCT01713582|454687047|FG014|Overall Study|Death|0|||
126379752|NCT01713582|454687048|FG015|Overall Study|Death|0|||
126379753|NCT01713582|454687049|FG016|Overall Study|Death|0|||
126379754|NCT01713582|454687050|FG017|Overall Study|Death|0|||
126379755|NCT01713582|454687051|FG018|Overall Study|Death|0|||
126379756|NCT01713582|454687052|FG019|Overall Study|Death|0|||
126379757|NCT01713582|454687053|FG020|Overall Study|Death|0|||
126379758|NCT01713582|454687033|FG000|Overall Study|Adverse event-related|0|||
126379759|NCT01713582|454687034|FG001|Overall Study|Adverse event-related|0|||
126379760|NCT01713582|454687035|FG002|Overall Study|Adverse event-related|0|||
126379761|NCT01713582|454687036|FG003|Overall Study|Adverse event-related|0|||
126379762|NCT01713582|454687037|FG004|Overall Study|Adverse event-related|0|||
126379763|NCT01713582|454687038|FG005|Overall Study|Adverse event-related|0|||
126379764|NCT01713582|454687039|FG006|Overall Study|Adverse event-related|0|||
126467777|NCT00257608|455015067|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
126467778|NCT00257608|455015065|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
126467779|NCT00257608|455015066|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
126771136|NCT04529096|456116271|FG000|Overall Study|Lost to Follow-up|1|||
126379765|NCT01713582|454687040|FG007|Overall Study|Adverse event-related|0|||
126379766|NCT01713582|454687041|FG008|Overall Study|Adverse event-related|0|||
126379767|NCT01713582|454687042|FG009|Overall Study|Adverse event-related|1|||
126379768|NCT01713582|454687043|FG010|Overall Study|Adverse event-related|1|||
126379769|NCT01713582|454687044|FG011|Overall Study|Adverse event-related|0|||
126379770|NCT01713582|454687045|FG012|Overall Study|Adverse event-related|0|||
126379771|NCT01713582|454687046|FG013|Overall Study|Adverse event-related|0|||
126379772|NCT01713582|454687047|FG014|Overall Study|Adverse event-related|0|||
126379773|NCT01713582|454687048|FG015|Overall Study|Adverse event-related|0|||
126379774|NCT01713582|454687049|FG016|Overall Study|Adverse event-related|0|||
126379775|NCT01713582|454687050|FG017|Overall Study|Adverse event-related|0|||
126379776|NCT01713582|454687051|FG018|Overall Study|Adverse event-related|1|||
126379777|NCT01713582|454687052|FG019|Overall Study|Adverse event-related|0|||
126379778|NCT01713582|454687053|FG020|Overall Study|Adverse event-related|0|||
126467780|NCT00257608|455015067|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
126467781|NCT00257608|455015065|FG000|Chemotherapy Phase|Physician Decision|28|||
126467782|NCT00257608|455015066|FG001|Chemotherapy Phase|Physician Decision|0|||
126467783|NCT00257608|455015067|FG002|Chemotherapy Phase|Physician Decision|0|||
126467784|NCT00257608|455015065|FG000|Post Chemotherapy Phase|Adverse Event|0|||
126467785|NCT00257608|455015066|FG001|Post Chemotherapy Phase|Adverse Event|34|||
126467786|NCT00257608|455015067|FG002|Post Chemotherapy Phase|Adverse Event|38|||
126467787|NCT00257608|455015065|FG000|Post Chemotherapy Phase|Disease progression|0|||
126467788|NCT00257608|455015066|FG001|Post Chemotherapy Phase|Disease progression|204|||
126467789|NCT00257608|455015067|FG002|Post Chemotherapy Phase|Disease progression|168|||
126467790|NCT00257608|455015065|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
126467791|NCT00257608|455015066|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
126467792|NCT00257608|455015067|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
126467793|NCT00257608|455015065|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
126467794|NCT00257608|455015066|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
126467795|NCT00257608|455015067|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
126467796|NCT00257608|455015065|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
126467797|NCT00257608|455015066|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
126467798|NCT00257608|455015067|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
126467799|NCT00257608|455015065|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
126467800|NCT00257608|455015066|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
126467801|NCT00257608|455015067|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
126467802|NCT00257608|455015065|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
126467803|NCT00257608|455015066|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
126467804|NCT00257608|455015067|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
126467805|NCT00257608|455015065|FG000|Post Chemotherapy Phase|Physician Decision|0|||
126467806|NCT00257608|455015066|FG001|Post Chemotherapy Phase|Physician Decision|8|||
126467807|NCT00257608|455015067|FG002|Post Chemotherapy Phase|Physician Decision|11|||
126467808|NCT00257608|455015065|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
126467809|NCT00257608|455015066|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
126467810|NCT00257608|455015067|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
126467811|NCT00257608|455015065|FG000|Post Chemotherapy Phase|Not treated|0|||
126467812|NCT00257608|455015066|FG001|Post Chemotherapy Phase|Not treated|4|||
126467813|NCT00257608|455015067|FG002|Post Chemotherapy Phase|Not treated|7|||
126467814|NCT02171065|455015068|FG000|Overall Study|Withdrawal by Subject|1|||
126467815|NCT02171065|455015069|FG001|Overall Study|Withdrawal by Subject|0|||
126467816|NCT02171065|455015070|FG002|Overall Study|Withdrawal by Subject|0|||
126553202|NCT01089556|455320534|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
126553203|NCT01089556|455320529|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
126379779|NCT01713582|454687033|FG000|Overall Study|Adverse event-unrelated|0|||
126379780|NCT01713582|454687034|FG001|Overall Study|Adverse event-unrelated|0|||
126379781|NCT01713582|454687035|FG002|Overall Study|Adverse event-unrelated|0|||
126379782|NCT01713582|454687036|FG003|Overall Study|Adverse event-unrelated|0|||
126379783|NCT01713582|454687037|FG004|Overall Study|Adverse event-unrelated|0|||
126379784|NCT01713582|454687038|FG005|Overall Study|Adverse event-unrelated|1|||
126379785|NCT01713582|454687039|FG006|Overall Study|Adverse event-unrelated|1|||
126379786|NCT01713582|454687040|FG007|Overall Study|Adverse event-unrelated|1|||
126379787|NCT01713582|454687041|FG008|Overall Study|Adverse event-unrelated|0|||
126379788|NCT01713582|454687042|FG009|Overall Study|Adverse event-unrelated|0|||
126379789|NCT01713582|454687043|FG010|Overall Study|Adverse event-unrelated|0|||
126379790|NCT01713582|454687044|FG011|Overall Study|Adverse event-unrelated|0|||
126379791|NCT01713582|454687045|FG012|Overall Study|Adverse event-unrelated|0|||
126379792|NCT01713582|454687046|FG013|Overall Study|Adverse event-unrelated|1|||
126379793|NCT01713582|454687047|FG014|Overall Study|Adverse event-unrelated|1|||
126379794|NCT01713582|454687048|FG015|Overall Study|Adverse event-unrelated|0|||
126379795|NCT01713582|454687049|FG016|Overall Study|Adverse event-unrelated|0|||
126379796|NCT01713582|454687050|FG017|Overall Study|Adverse event-unrelated|0|||
126379797|NCT01713582|454687051|FG018|Overall Study|Adverse event-unrelated|0|||
126379798|NCT01713582|454687052|FG019|Overall Study|Adverse event-unrelated|0|||
126379799|NCT01713582|454687053|FG020|Overall Study|Adverse event-unrelated|0|||
126379800|NCT01713582|454687033|FG000|Overall Study|Withdrawal of consent|0|||
126379801|NCT01713582|454687034|FG001|Overall Study|Withdrawal of consent|0|||
126379802|NCT01713582|454687035|FG002|Overall Study|Withdrawal of consent|1|||
126379803|NCT01713582|454687036|FG003|Overall Study|Withdrawal of consent|0|||
126379804|NCT01713582|454687037|FG004|Overall Study|Withdrawal of consent|0|||
126467817|NCT02171065|455015068|FG000|Overall Study|Lost to Follow-up|0|||
126467818|NCT02171065|455015069|FG001|Overall Study|Lost to Follow-up|0|||
126467819|NCT02171065|455015070|FG002|Overall Study|Lost to Follow-up|1|||
126553204|NCT01089556|455320530|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
126379805|NCT01713582|454687038|FG005|Overall Study|Withdrawal of consent|1|||
126379806|NCT01713582|454687039|FG006|Overall Study|Withdrawal of consent|0|||
126379807|NCT01713582|454687040|FG007|Overall Study|Withdrawal of consent|0|||
126553205|NCT01089556|455320531|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
126553206|NCT01089556|455320532|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
126553207|NCT01089556|455320533|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
126553208|NCT01089556|455320534|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
126553209|NCT01089556|455320529|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
126553210|NCT01089556|455320530|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
126553211|NCT01089556|455320531|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
126717071|NCT00002663|455915017|FG004|Overall Study|Adverse Event|0|||
126717072|NCT00002663|455915018|FG005|Overall Study|Adverse Event|0|||
126717073|NCT00002663|455915019|FG006|Overall Study|Adverse Event|0|||
126553212|NCT01089556|455320532|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
126553213|NCT01089556|455320533|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
126553214|NCT01089556|455320534|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
126553215|NCT01089556|455320529|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
126553216|NCT01089556|455320530|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
126553217|NCT01089556|455320531|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
126553218|NCT01089556|455320532|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
126553219|NCT01089556|455320533|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
126553220|NCT01089556|455320534|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
126553221|NCT01089556|455320529|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
126553222|NCT01089556|455320530|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
126553223|NCT01089556|455320531|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
126553224|NCT01089556|455320532|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
126553225|NCT01089556|455320533|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
126553226|NCT01089556|455320534|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
126553227|NCT01089556|455320529|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
126553228|NCT01089556|455320530|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
126553229|NCT01089556|455320531|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
126553230|NCT01089556|455320532|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
126553231|NCT01089556|455320533|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
126553232|NCT01089556|455320534|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
126553233|NCT01089556|455320529|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
126553234|NCT01089556|455320530|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
126553235|NCT01089556|455320531|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
126553236|NCT01089556|455320532|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
126553237|NCT01089556|455320533|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
126553238|NCT01089556|455320534|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
126553239|NCT01089556|455320529|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
126553240|NCT01089556|455320530|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
126553241|NCT01089556|455320531|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
126553242|NCT01089556|455320532|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
126553243|NCT01089556|455320533|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
126553244|NCT01089556|455320534|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
126553245|NCT01089556|455320529|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
126553246|NCT01089556|455320530|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
126553247|NCT01089556|455320531|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
126553248|NCT01089556|455320532|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
126553249|NCT01089556|455320533|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
126553250|NCT01089556|455320534|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
126717074|NCT00002663|455915020|FG007|Overall Study|Adverse Event|1|||
126379808|NCT01713582|454687041|FG008|Overall Study|Withdrawal of consent|0|||
126379809|NCT01713582|454687042|FG009|Overall Study|Withdrawal of consent|1|||
126379810|NCT01713582|454687043|FG010|Overall Study|Withdrawal of consent|0|||
126379811|NCT01713582|454687044|FG011|Overall Study|Withdrawal of consent|0|||
126379812|NCT01713582|454687045|FG012|Overall Study|Withdrawal of consent|0|||
126379813|NCT01713582|454687046|FG013|Overall Study|Withdrawal of consent|0|||
126379814|NCT01713582|454687047|FG014|Overall Study|Withdrawal of consent|0|||
126379815|NCT01713582|454687048|FG015|Overall Study|Withdrawal of consent|0|||
126379816|NCT01713582|454687049|FG016|Overall Study|Withdrawal of consent|0|||
126379817|NCT01713582|454687050|FG017|Overall Study|Withdrawal of consent|0|||
126379818|NCT01713582|454687051|FG018|Overall Study|Withdrawal of consent|1|||
126379819|NCT01713582|454687052|FG019|Overall Study|Withdrawal of consent|0|||
126379820|NCT01713582|454687053|FG020|Overall Study|Withdrawal of consent|0|||
126379821|NCT01713582|454687033|FG000|Overall Study|Lack of Efficacy|0|||
126379822|NCT01713582|454687034|FG001|Overall Study|Lack of Efficacy|0|||
126379823|NCT01713582|454687035|FG002|Overall Study|Lack of Efficacy|0|||
126379824|NCT01713582|454687036|FG003|Overall Study|Lack of Efficacy|0|||
126379825|NCT01713582|454687037|FG004|Overall Study|Lack of Efficacy|0|||
126553251|NCT01089556|455320529|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
126553252|NCT01089556|455320530|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
126379826|NCT01713582|454687038|FG005|Overall Study|Lack of Efficacy|0|||
126379827|NCT01713582|454687039|FG006|Overall Study|Lack of Efficacy|0|||
126379828|NCT01713582|454687040|FG007|Overall Study|Lack of Efficacy|0|||
126379829|NCT01713582|454687041|FG008|Overall Study|Lack of Efficacy|0|||
126379830|NCT01713582|454687042|FG009|Overall Study|Lack of Efficacy|1|||
126379831|NCT01713582|454687043|FG010|Overall Study|Lack of Efficacy|2|||
126379832|NCT01713582|454687044|FG011|Overall Study|Lack of Efficacy|0|||
126379833|NCT01713582|454687045|FG012|Overall Study|Lack of Efficacy|0|||
126379834|NCT01713582|454687046|FG013|Overall Study|Lack of Efficacy|0|||
126379835|NCT01713582|454687047|FG014|Overall Study|Lack of Efficacy|0|||
126379836|NCT01713582|454687048|FG015|Overall Study|Lack of Efficacy|0|||
126379837|NCT01713582|454687049|FG016|Overall Study|Lack of Efficacy|0|||
126379838|NCT01713582|454687050|FG017|Overall Study|Lack of Efficacy|0|||
126379839|NCT01713582|454687051|FG018|Overall Study|Lack of Efficacy|0|||
126379840|NCT01713582|454687052|FG019|Overall Study|Lack of Efficacy|0|||
126379841|NCT01713582|454687053|FG020|Overall Study|Lack of Efficacy|0|||
126379842|NCT01713582|454687033|FG000|Overall Study|Withdrawal by Subject|0|||
126379843|NCT01713582|454687034|FG001|Overall Study|Withdrawal by Subject|0|||
126379844|NCT01713582|454687035|FG002|Overall Study|Withdrawal by Subject|0|||
126379845|NCT01713582|454687036|FG003|Overall Study|Withdrawal by Subject|0|||
126379846|NCT01713582|454687037|FG004|Overall Study|Withdrawal by Subject|0|||
126379847|NCT01713582|454687038|FG005|Overall Study|Withdrawal by Subject|0|||
126379848|NCT01713582|454687039|FG006|Overall Study|Withdrawal by Subject|0|||
126379849|NCT01713582|454687040|FG007|Overall Study|Withdrawal by Subject|0|||
126379850|NCT01713582|454687041|FG008|Overall Study|Withdrawal by Subject|0|||
126379851|NCT01713582|454687042|FG009|Overall Study|Withdrawal by Subject|0|||
126379852|NCT01713582|454687043|FG010|Overall Study|Withdrawal by Subject|0|||
126379853|NCT01713582|454687044|FG011|Overall Study|Withdrawal by Subject|0|||
126379854|NCT01713582|454687045|FG012|Overall Study|Withdrawal by Subject|0|||
126379855|NCT01713582|454687046|FG013|Overall Study|Withdrawal by Subject|0|||
126379856|NCT01713582|454687047|FG014|Overall Study|Withdrawal by Subject|0|||
126379857|NCT01713582|454687048|FG015|Overall Study|Withdrawal by Subject|0|||
126379858|NCT01713582|454687049|FG016|Overall Study|Withdrawal by Subject|0|||
126379859|NCT01713582|454687050|FG017|Overall Study|Withdrawal by Subject|1|||
126379860|NCT01713582|454687051|FG018|Overall Study|Withdrawal by Subject|0|||
126379861|NCT01713582|454687052|FG019|Overall Study|Withdrawal by Subject|0|||
126379862|NCT01713582|454687053|FG020|Overall Study|Withdrawal by Subject|0|||
126379863|NCT01713582|454687033|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
126379864|NCT01713582|454687034|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
126379865|NCT01713582|454687035|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
126379866|NCT01713582|454687036|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
126379867|NCT01713582|454687037|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
126379868|NCT01713582|454687038|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
126379869|NCT01713582|454687039|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
126379870|NCT01713582|454687040|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
126379871|NCT01713582|454687041|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
126379872|NCT01713582|454687042|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
126379873|NCT01713582|454687043|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
126379874|NCT01713582|454687044|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
126379875|NCT01713582|454687045|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
126379876|NCT01713582|454687046|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
126379877|NCT01713582|454687047|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
126379878|NCT01713582|454687048|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
126379879|NCT01713582|454687049|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
126379880|NCT01713582|454687050|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
126379881|NCT01713582|454687051|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
126379882|NCT01713582|454687052|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
126379883|NCT01713582|454687053|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
126379884|NCT01713582|454687033|FG000|Overall Study|Disease progression and adverse event|0|||
126379885|NCT01713582|454687034|FG001|Overall Study|Disease progression and adverse event|0|||
126379886|NCT01713582|454687035|FG002|Overall Study|Disease progression and adverse event|0|||
126379887|NCT01713582|454687036|FG003|Overall Study|Disease progression and adverse event|0|||
126379888|NCT01713582|454687037|FG004|Overall Study|Disease progression and adverse event|0|||
126379889|NCT01713582|454687038|FG005|Overall Study|Disease progression and adverse event|0|||
126379890|NCT01713582|454687039|FG006|Overall Study|Disease progression and adverse event|0|||
126379891|NCT01713582|454687040|FG007|Overall Study|Disease progression and adverse event|0|||
126379892|NCT01713582|454687041|FG008|Overall Study|Disease progression and adverse event|0|||
126379893|NCT01713582|454687042|FG009|Overall Study|Disease progression and adverse event|0|||
126379894|NCT01713582|454687043|FG010|Overall Study|Disease progression and adverse event|0|||
126379895|NCT01713582|454687044|FG011|Overall Study|Disease progression and adverse event|0|||
126379896|NCT01713582|454687045|FG012|Overall Study|Disease progression and adverse event|0|||
126379897|NCT01713582|454687046|FG013|Overall Study|Disease progression and adverse event|0|||
126379898|NCT01713582|454687047|FG014|Overall Study|Disease progression and adverse event|0|||
126379899|NCT01713582|454687048|FG015|Overall Study|Disease progression and adverse event|0|||
126379900|NCT01713582|454687049|FG016|Overall Study|Disease progression and adverse event|1|||
126379901|NCT01713582|454687050|FG017|Overall Study|Disease progression and adverse event|0|||
126379902|NCT01713582|454687051|FG018|Overall Study|Disease progression and adverse event|0|||
126379903|NCT01713582|454687052|FG019|Overall Study|Disease progression and adverse event|0|||
126379904|NCT01713582|454687053|FG020|Overall Study|Disease progression and adverse event|0|||
126379905|NCT04551898|454687056|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
126379906|NCT04551898|454687057|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
126379907|NCT04551898|454687058|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
126379908|NCT04551898|454687059|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
126379909|NCT04551898|454687056|FG000|Overall Study|Withdrawal by Subject|5|||
126379910|NCT04551898|454687057|FG001|Overall Study|Withdrawal by Subject|1|||
126467820|NCT01920555|455015073|FG000|Overall Study|Physician Decision|1|||
126467821|NCT01920555|455015074|FG001|Overall Study|Physician Decision|2|||
126467822|NCT01920555|455015075|FG002|Overall Study|Physician Decision|1|||
126467823|NCT01920555|455015076|FG003|Overall Study|Physician Decision|2|||
126467824|NCT01920555|455015077|FG004|Overall Study|Physician Decision|0|||
126467825|NCT01920555|455015073|FG000|Overall Study|Lack of Efficacy|2|||
126467826|NCT01920555|455015074|FG001|Overall Study|Lack of Efficacy|0|||
126379911|NCT04551898|454687058|FG002|Overall Study|Withdrawal by Subject|2|||
126379912|NCT04551898|454687059|FG003|Overall Study|Withdrawal by Subject|2|||
126379913|NCT04551898|454687056|FG000|Overall Study|Lost to Follow-up|2|||
126379914|NCT04551898|454687057|FG001|Overall Study|Lost to Follow-up|1|||
126379915|NCT04551898|454687058|FG002|Overall Study|Lost to Follow-up|2|||
126379916|NCT04551898|454687059|FG003|Overall Study|Lost to Follow-up|2|||
126379917|NCT04551898|454687056|FG000|Overall Study|Death|1|||
126379918|NCT04551898|454687057|FG001|Overall Study|Death|0|||
126379919|NCT04551898|454687058|FG002|Overall Study|Death|0|||
126379920|NCT04551898|454687059|FG003|Overall Study|Death|0|||
126379921|NCT04551898|454687056|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
126379922|NCT04551898|454687057|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
126379923|NCT04551898|454687058|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
126379924|NCT04551898|454687059|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
126379925|NCT01898286|454687062|FG000|Overall Study|Withdrawal by Subject|1|||
126379926|NCT01898286|454687062|FG000|Overall Study|Protocol Violation|1|||
126379927|NCT01898286|454687062|FG000|Overall Study|Lost to Follow-up|1|||
126379928|NCT02257242|454687063|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
126379929|NCT02257242|454687064|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379930|NCT02257242|454687065|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379931|NCT02257242|454687066|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379932|NCT02257242|454687067|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379933|NCT02257242|454687068|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379934|NCT02257242|454687069|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379935|NCT02257242|454687070|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379936|NCT02257242|454687071|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
126379937|NCT01650831|454687077|FG000|Overall Study|Screen failure|1|||
126379938|NCT01048242|454687080|FG000|Overall Study|See study flow chart|4|||
126379939|NCT01048242|454687081|FG001|Overall Study|See study flow chart|2|||
126379940|NCT02964273|454687082|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
126379941|NCT02964273|454687083|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
126379942|NCT02964273|454687084|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
126379943|NCT02964273|454687085|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
126379944|NCT02964273|454687082|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
126379945|NCT02964273|454687083|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
126379946|NCT02964273|454687084|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
126379947|NCT02964273|454687085|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
126379948|NCT02964273|454687082|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
126379949|NCT02964273|454687083|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
126379950|NCT02964273|454687084|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
126379951|NCT02964273|454687085|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
126379952|NCT02964273|454687082|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
126379953|NCT02964273|454687083|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
126467827|NCT01920555|455015075|FG002|Overall Study|Lack of Efficacy|0|||
126379954|NCT02964273|454687084|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
126379955|NCT02964273|454687085|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
126379956|NCT02964273|454687082|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
126379957|NCT02964273|454687083|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
126379958|NCT02964273|454687084|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
126379959|NCT02964273|454687085|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
126379960|NCT02964273|454687082|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
126379961|NCT02964273|454687083|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
126379962|NCT02964273|454687084|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
126379963|NCT02964273|454687085|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
126379964|NCT01453036|454687087|FG000|Overall Study|Lost to Follow-up|26|||
126379965|NCT01453036|454687088|FG001|Overall Study|Lost to Follow-up|115|||
126379966|NCT01453036|454687089|FG002|Overall Study|Lost to Follow-up|31|||
126379967|NCT00559104|454687090|FG000|Overall Study|Lack of Efficacy|9|||
126379968|NCT00559104|454687091|FG001|Overall Study|Lack of Efficacy|0|||
126379969|NCT01336712|454687092|FG000|Overall Study|Death|2|||
126379970|NCT01336712|454687092|FG000|Overall Study|Lack of Efficacy|1|||
126379971|NCT00620373|454687094|FG000|Overall Study|Unverified cancer status|33|||
126379972|NCT00399568|454687095|FG000|Overall Study|Adverse Event|1|||
126379973|NCT00399568|454687096|FG001|Overall Study|Adverse Event|2|||
126379974|NCT00399568|454687095|FG000|Overall Study|Withdrawal by Subject|7|||
126379975|NCT00399568|454687096|FG001|Overall Study|Withdrawal by Subject|3|||
126379976|NCT00399568|454687095|FG000|Overall Study|Protocol non-compliance|2|||
126379977|NCT00399568|454687096|FG001|Overall Study|Protocol non-compliance|2|||
126379978|NCT00399568|454687095|FG000|Overall Study|Lost to Follow-up|2|||
126379979|NCT00399568|454687096|FG001|Overall Study|Lost to Follow-up|2|||
126379980|NCT03073525|454687097|FG000|Overall Study|Withdrawal by Subject|0|||
126379981|NCT03073525|454687098|FG001|Overall Study|Withdrawal by Subject|0|||
126379982|NCT03073525|454687099|FG002|Overall Study|Withdrawal by Subject|3|||
126379983|NCT01273038|454687100|FG000|Second Intervention (14 Days)|Adverse Event|0|||
126379984|NCT01273038|454687101|FG001|Second Intervention (14 Days)|Adverse Event|1|||
126379985|NCT01273038|454687100|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
126379986|NCT01273038|454687101|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
126379987|NCT03692403|454687102|FG000|Overall Study|Withdrawal by Subject|1|||
126379988|NCT03692403|454687103|FG001|Overall Study|Withdrawal by Subject|0|||
126379989|NCT03692403|454687104|FG002|Overall Study|Withdrawal by Subject|1|||
126379990|NCT03692403|454687105|FG003|Overall Study|Withdrawal by Subject|0|||
126379991|NCT03692403|454687102|FG000|Overall Study|Adverse Event|0|||
126379992|NCT03692403|454687103|FG001|Overall Study|Adverse Event|0|||
126379993|NCT03692403|454687104|FG002|Overall Study|Adverse Event|0|||
126379994|NCT03692403|454687105|FG003|Overall Study|Adverse Event|1|||
126379995|NCT03692403|454687102|FG000|Overall Study|Pregnancy|0|||
126379996|NCT03692403|454687103|FG001|Overall Study|Pregnancy|1|||
126379997|NCT03692403|454687104|FG002|Overall Study|Pregnancy|0|||
126379998|NCT03692403|454687105|FG003|Overall Study|Pregnancy|0|||
126379999|NCT03692403|454687102|FG000|Overall Study|Other|0|||
126380000|NCT03692403|454687103|FG001|Overall Study|Other|0|||
126380001|NCT03692403|454687104|FG002|Overall Study|Other|1|||
126380002|NCT03692403|454687105|FG003|Overall Study|Other|0|||
126380003|NCT02776683|454687106|FG000|Pre-switch Period|Protocol Violation|1|||
126380004|NCT02776683|454687107|FG001|Pre-switch Period|Protocol Violation|0|||
126380005|NCT02776683|454687106|FG000|Pre-switch Period|Adverse Event|21|||
126467828|NCT01920555|455015076|FG003|Overall Study|Lack of Efficacy|0|||
126380006|NCT02776683|454687107|FG001|Pre-switch Period|Adverse Event|0|||
126380007|NCT02776683|454687106|FG000|Pre-switch Period|Withdrawal by Subject|9|||
126380008|NCT02776683|454687107|FG001|Pre-switch Period|Withdrawal by Subject|0|||
126467829|NCT01920555|455015077|FG004|Overall Study|Lack of Efficacy|0|||
126467830|NCT01920555|455015073|FG000|Overall Study|Travel Difficulties|1|||
126467831|NCT01920555|455015074|FG001|Overall Study|Travel Difficulties|1|||
126380009|NCT02776683|454687106|FG000|Pre-switch Period|Physician Decision|7|||
126380010|NCT02776683|454687107|FG001|Pre-switch Period|Physician Decision|0|||
126380011|NCT02776683|454687106|FG000|Pre-switch Period|Progressive disease|39|||
126380012|NCT02776683|454687107|FG001|Pre-switch Period|Progressive disease|0|||
126467832|NCT01920555|455015075|FG002|Overall Study|Travel Difficulties|0|||
126467833|NCT01920555|455015076|FG003|Overall Study|Travel Difficulties|0|||
126380013|NCT02776683|454687106|FG000|Pre-switch Period|Other than listed|3|||
126380014|NCT02776683|454687107|FG001|Pre-switch Period|Other than listed|0|||
126380015|NCT02776683|454687106|FG000|Post-switch Period|Adverse Event|0|||
126380016|NCT02776683|454687107|FG001|Post-switch Period|Adverse Event|3|||
126380017|NCT02776683|454687106|FG000|Post-switch Period|Withdrawal by Subject|0|||
126380018|NCT02776683|454687107|FG001|Post-switch Period|Withdrawal by Subject|2|||
126380019|NCT02776683|454687106|FG000|Post-switch Period|Physician Decision|0|||
126380020|NCT02776683|454687107|FG001|Post-switch Period|Physician Decision|3|||
126380021|NCT02776683|454687106|FG000|Post-switch Period|Progressive disease|0|||
126380022|NCT02776683|454687107|FG001|Post-switch Period|Progressive disease|20|||
126380023|NCT02776683|454687106|FG000|Post-switch Period|Other than listed|0|||
126380024|NCT02776683|454687107|FG001|Post-switch Period|Other than listed|15|||
126380025|NCT01891396|454687110|FG000|Overall Study|Withdrawal by Subject|4|||
126380026|NCT01891396|454687111|FG001|Overall Study|Withdrawal by Subject|4|||
126380027|NCT01891396|454687112|FG002|Overall Study|Withdrawal by Subject|3|||
126380028|NCT01891396|454687110|FG000|Overall Study|Lost to Follow-up|0|||
126380029|NCT01891396|454687111|FG001|Overall Study|Lost to Follow-up|1|||
126380030|NCT01891396|454687112|FG002|Overall Study|Lost to Follow-up|0|||
126380031|NCT00400517|454687114|FG000|Overall Study|Withdrawal by Subject|1|||
126380032|NCT00400517|454687114|FG000|Overall Study|Physician Decision|1|||
126380033|NCT01881789|454687118|FG000|Overall Study|Withdrawal by Subject|0|||
126380034|NCT01881789|454687119|FG001|Overall Study|Withdrawal by Subject|2|||
126380035|NCT01881789|454687120|FG002|Overall Study|Withdrawal by Subject|1|||
126380036|NCT01881789|454687121|FG003|Overall Study|Withdrawal by Subject|0|||
126380037|NCT01881789|454687122|FG004|Overall Study|Withdrawal by Subject|1|||
126380038|NCT01881789|454687123|FG005|Overall Study|Withdrawal by Subject|1|||
126380039|NCT01881789|454687118|FG000|Overall Study|Study Terminated by Sponsor|0|||
126380040|NCT01881789|454687119|FG001|Overall Study|Study Terminated by Sponsor|0|||
126380041|NCT01881789|454687120|FG002|Overall Study|Study Terminated by Sponsor|0|||
126380042|NCT01881789|454687121|FG003|Overall Study|Study Terminated by Sponsor|0|||
126380043|NCT01881789|454687122|FG004|Overall Study|Study Terminated by Sponsor|0|||
126380044|NCT01881789|454687123|FG005|Overall Study|Study Terminated by Sponsor|1|||
126380045|NCT01881789|454687118|FG000|Overall Study|Other|3|||
126380046|NCT01881789|454687119|FG001|Overall Study|Other|5|||
126380047|NCT01881789|454687120|FG002|Overall Study|Other|2|||
126467834|NCT01920555|455015077|FG004|Overall Study|Travel Difficulties|1|||
126467835|NCT01920555|455015073|FG000|Overall Study|Lost to Follow-up|0|||
126467836|NCT01920555|455015074|FG001|Overall Study|Lost to Follow-up|1|||
126467837|NCT01920555|455015075|FG002|Overall Study|Lost to Follow-up|0|||
126467838|NCT01920555|455015076|FG003|Overall Study|Lost to Follow-up|1|||
126467839|NCT01920555|455015077|FG004|Overall Study|Lost to Follow-up|0|||
126380048|NCT01881789|454687121|FG003|Overall Study|Other|3|||
126380049|NCT01881789|454687122|FG004|Overall Study|Other|1|||
126380050|NCT01881789|454687123|FG005|Overall Study|Other|1|||
126380051|NCT01282866|454687126|FG000|Overall Study|Adverse Event|1|||
126380052|NCT01299389|454687127|FG000|Double-blind|Adverse Event|45|||
126380053|NCT01299389|454687128|FG001|Double-blind|Adverse Event|27|||
126380054|NCT01299389|454687129|FG002|Double-blind|Adverse Event|0|||
126380055|NCT01299389|454687130|FG003|Double-blind|Adverse Event|0|||
126380056|NCT01299389|454687127|FG000|Double-blind|Lack of Efficacy|45|||
126380057|NCT01299389|454687128|FG001|Double-blind|Lack of Efficacy|21|||
126380058|NCT01299389|454687129|FG002|Double-blind|Lack of Efficacy|0|||
126380059|NCT01299389|454687130|FG003|Double-blind|Lack of Efficacy|0|||
126380060|NCT01299389|454687127|FG000|Double-blind|Lost to Follow-up|2|||
126380061|NCT01299389|454687128|FG001|Double-blind|Lost to Follow-up|1|||
126380062|NCT01299389|454687129|FG002|Double-blind|Lost to Follow-up|0|||
126380063|NCT01299389|454687130|FG003|Double-blind|Lost to Follow-up|0|||
126380064|NCT01299389|454687127|FG000|Double-blind|Withdrawal by Subject|16|||
126380065|NCT01299389|454687128|FG001|Double-blind|Withdrawal by Subject|13|||
126380066|NCT01299389|454687129|FG002|Double-blind|Withdrawal by Subject|0|||
126380067|NCT01299389|454687130|FG003|Double-blind|Withdrawal by Subject|0|||
126380068|NCT01299389|454687127|FG000|Double-blind|Other|1|||
126380069|NCT01299389|454687128|FG001|Double-blind|Other|1|||
126380070|NCT01299389|454687129|FG002|Double-blind|Other|0|||
126380071|NCT01299389|454687130|FG003|Double-blind|Other|0|||
126380072|NCT01299389|454687127|FG000|Double-blind|"fail to meet study population criteria"|0|||
126380073|NCT01299389|454687128|FG001|Double-blind|"fail to meet study population criteria"|1|||
126380074|NCT01299389|454687129|FG002|Double-blind|"fail to meet study population criteria"|0|||
126380075|NCT01299389|454687130|FG003|Double-blind|"fail to meet study population criteria"|0|||
126380076|NCT01299389|454687127|FG000|Post-observational|Other|0|||
126380077|NCT01299389|454687128|FG001|Post-observational|Other|0|||
126380078|NCT01299389|454687129|FG002|Post-observational|Other|12|||
126380079|NCT01299389|454687130|FG003|Post-observational|Other|6|||
126380080|NCT01151020|454687131|FG000|Overall Study|Death|25|||
126380081|NCT01151020|454687131|FG000|Overall Study|Conversion to open repair|1|||
126467840|NCT00697073|455015078|FG000|Overall Study|Withdrawal by Subject|2|||
126467841|NCT00697073|455015078|FG000|Overall Study|Pregnancy|1|||
126467842|NCT00697073|455015078|FG000|Overall Study|non compliance and other|6|||
126467843|NCT03265665|455015081|FG000|24-week Data Collection|Withdrawal by Subject|2|||
126380082|NCT01151020|454687131|FG000|Overall Study|Lost to Follow-up|4|||
126380083|NCT01151020|454687131|FG000|Overall Study|Withdrawal by Subject|22|||
126380084|NCT01151020|454687131|FG000|Overall Study|Patients did not receive the device|2|||
126380085|NCT01635998|454687132|FG000|Overall Study|Death|1|||
126380086|NCT01635998|454687133|FG001|Overall Study|Death|1|||
126467844|NCT03265665|455015082|FG001|24-week Data Collection|Withdrawal by Subject|2|||
126467845|NCT03265665|455015081|FG000|24-week Data Collection|Lost to Follow-up|4|||
126380087|NCT01635998|454687132|FG000|Overall Study|Lost to Follow-up|2|||
126380088|NCT01635998|454687133|FG001|Overall Study|Lost to Follow-up|1|||
126380089|NCT01635998|454687132|FG000|Overall Study|Withdrawal by Subject|1|||
126380090|NCT01635998|454687133|FG001|Overall Study|Withdrawal by Subject|5|||
126380091|NCT01220401|454687134|FG000|Overall Study|Withdrawal by Subject|2|||
126380092|NCT01220401|454687134|FG000|Overall Study|Protocol Violation|1|||
126380093|NCT01964378|454687135|FG000|Overall Study|Disc. due to death before first dosing|0|||
126380094|NCT01964378|454687136|FG001|Overall Study|Disc. due to death before first dosing|1|||
126380095|NCT01964378|454687135|FG000|Overall Study|Disc. due to AE before first dosing|1|||
126380096|NCT01964378|454687136|FG001|Overall Study|Disc. due to AE before first dosing|0|||
126380097|NCT01964378|454687135|FG000|Overall Study|Death|3|||
126380098|NCT01964378|454687136|FG001|Overall Study|Death|2|||
126380099|NCT01964378|454687135|FG000|Overall Study|Adverse Event|12|||
126380100|NCT01964378|454687136|FG001|Overall Study|Adverse Event|5|||
126380101|NCT01964378|454687135|FG000|Overall Study|Lack of Efficacy|0|||
126380102|NCT01964378|454687136|FG001|Overall Study|Lack of Efficacy|1|||
126380103|NCT01964378|454687135|FG000|Overall Study|Protocol Violation|0|||
126380104|NCT01964378|454687136|FG001|Overall Study|Protocol Violation|1|||
126380105|NCT01964378|454687135|FG000|Overall Study|Lost to Follow-up|0|||
126380106|NCT01964378|454687136|FG001|Overall Study|Lost to Follow-up|1|||
126380107|NCT01964378|454687135|FG000|Overall Study|Withdrawal by Subject|7|||
126380108|NCT01964378|454687136|FG001|Overall Study|Withdrawal by Subject|5|||
126380109|NCT01964378|454687135|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
126380110|NCT01964378|454687136|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
126380111|NCT01964378|454687135|FG000|Overall Study|Other|1|||
126380112|NCT01964378|454687136|FG001|Overall Study|Other|2|||
126380113|NCT01162473|454687141|FG000|Overall Study|Adverse Event|2|||
126380114|NCT01162473|454687142|FG001|Overall Study|Adverse Event|1|||
126380115|NCT01162473|454687141|FG000|Overall Study|Withdrawal by Subject|0|||
126380116|NCT01162473|454687142|FG001|Overall Study|Withdrawal by Subject|4|||
126380117|NCT01392573|454687151|FG000|Overall Study|Adverse Event|1|||
126380118|NCT01392573|454687152|FG001|Overall Study|Adverse Event|3|||
126380119|NCT01392573|454687151|FG000|Overall Study|Lack of Efficacy|1|||
126380120|NCT01392573|454687152|FG001|Overall Study|Lack of Efficacy|2|||
126380121|NCT01392573|454687151|FG000|Overall Study|Protocol Violation|0|||
126380122|NCT01392573|454687152|FG001|Overall Study|Protocol Violation|2|||
126380123|NCT01392573|454687151|FG000|Overall Study|Withdrawal Criteria|13|||
126380124|NCT01392573|454687152|FG001|Overall Study|Withdrawal Criteria|15|||
126380125|NCT01392573|454687151|FG000|Overall Study|Site closure|8|||
126380126|NCT01392573|454687152|FG001|Overall Study|Site closure|7|||
126380127|NCT01392573|454687151|FG000|Overall Study|Unclassified|9|||
126380128|NCT01392573|454687152|FG001|Overall Study|Unclassified|6|||
126380129|NCT03008070|454687153|FG000|Overall Study|Adverse Event|3|||
126380130|NCT03008070|454687154|FG001|Overall Study|Adverse Event|3|||
126380131|NCT03008070|454687155|FG002|Overall Study|Adverse Event|3|||
126380132|NCT03008070|454687153|FG000|Overall Study|Lost to Follow-up|1|||
126380133|NCT03008070|454687154|FG001|Overall Study|Lost to Follow-up|1|||
126380134|NCT03008070|454687155|FG002|Overall Study|Lost to Follow-up|0|||
126380135|NCT03008070|454687153|FG000|Overall Study|Non compliance|0|||
126380136|NCT03008070|454687154|FG001|Overall Study|Non compliance|1|||
126380137|NCT03008070|454687155|FG002|Overall Study|Non compliance|1|||
126380138|NCT03008070|454687153|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
126380139|NCT03008070|454687154|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
126380140|NCT03008070|454687155|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
126380141|NCT03008070|454687153|FG000|Overall Study|Withdrawal by Subject|2|||
126380142|NCT03008070|454687154|FG001|Overall Study|Withdrawal by Subject|0|||
126380143|NCT03008070|454687155|FG002|Overall Study|Withdrawal by Subject|1|||
126380144|NCT03008070|454687153|FG000|Overall Study|Use of prohibited drug|0|||
126380145|NCT03008070|454687154|FG001|Overall Study|Use of prohibited drug|0|||
126380146|NCT03008070|454687155|FG002|Overall Study|Use of prohibited drug|2|||
126380147|NCT04409834|454687158|FG000|Overall Study|Death|55|||
126380148|NCT04409834|454687159|FG001|Overall Study|Death|62|||
126380149|NCT01365455|454687160|FG000|Induction Period|Adverse Event|5|||
126380150|NCT01365455|454687161|FG001|Induction Period|Adverse Event|3|||
126380151|NCT01365455|454687162|FG002|Induction Period|Adverse Event|4|||
126380152|NCT01365455|454687163|FG003|Induction Period|Adverse Event|0|||
126380153|NCT01365455|454687164|FG004|Induction Period|Adverse Event|0|||
126380154|NCT01365455|454687160|FG000|Induction Period|Lack of Efficacy|1|||
126380155|NCT01365455|454687161|FG001|Induction Period|Lack of Efficacy|1|||
126380156|NCT01365455|454687162|FG002|Induction Period|Lack of Efficacy|0|||
126380157|NCT01365455|454687163|FG003|Induction Period|Lack of Efficacy|0|||
126380158|NCT01365455|454687164|FG004|Induction Period|Lack of Efficacy|0|||
126380159|NCT01365455|454687160|FG000|Induction Period|Pregnancy|0|||
126380160|NCT01365455|454687161|FG001|Induction Period|Pregnancy|1|||
126380161|NCT01365455|454687162|FG002|Induction Period|Pregnancy|0|||
126380162|NCT01365455|454687163|FG003|Induction Period|Pregnancy|0|||
126380163|NCT01365455|454687164|FG004|Induction Period|Pregnancy|0|||
126380164|NCT01365455|454687160|FG000|Induction Period|Protocol deviation|0|||
126380165|NCT01365455|454687161|FG001|Induction Period|Protocol deviation|1|||
126380166|NCT01365455|454687162|FG002|Induction Period|Protocol deviation|1|||
126380167|NCT01365455|454687163|FG003|Induction Period|Protocol deviation|0|||
126380168|NCT01365455|454687164|FG004|Induction Period|Protocol deviation|0|||
126380169|NCT01365455|454687160|FG000|Induction Period|Subject/guardian decision|9|||
126380170|NCT01365455|454687161|FG001|Induction Period|Subject/guardian decision|1|||
126380171|NCT01365455|454687162|FG002|Induction Period|Subject/guardian decision|8|||
126380172|NCT01365455|454687163|FG003|Induction Period|Subject/guardian decision|0|||
126380173|NCT01365455|454687164|FG004|Induction Period|Subject/guardian decision|0|||
126380174|NCT01365455|454687160|FG000|Induction Period|Lost to Follow-up|0|||
126380175|NCT01365455|454687161|FG001|Induction Period|Lost to Follow-up|0|||
126380176|NCT01365455|454687162|FG002|Induction Period|Lost to Follow-up|3|||
126380177|NCT01365455|454687163|FG003|Induction Period|Lost to Follow-up|0|||
126380178|NCT01365455|454687164|FG004|Induction Period|Lost to Follow-up|0|||
126380179|NCT01365455|454687160|FG000|Maintenance Period|Adverse Event|12|||
126380180|NCT01365455|454687161|FG001|Maintenance Period|Adverse Event|5|||
126380181|NCT01365455|454687162|FG002|Maintenance Period|Adverse Event|1|||
126380182|NCT01365455|454687163|FG003|Maintenance Period|Adverse Event|2|||
126380183|NCT01365455|454687164|FG004|Maintenance Period|Adverse Event|4|||
126380184|NCT01365455|454687160|FG000|Maintenance Period|Lack of Efficacy|10|||
126380185|NCT01365455|454687161|FG001|Maintenance Period|Lack of Efficacy|2|||
126380186|NCT01365455|454687162|FG002|Maintenance Period|Lack of Efficacy|0|||
126380187|NCT01365455|454687163|FG003|Maintenance Period|Lack of Efficacy|2|||
126380188|NCT01365455|454687164|FG004|Maintenance Period|Lack of Efficacy|2|||
126380189|NCT01365455|454687160|FG000|Maintenance Period|Lost to Follow-up|2|||
126380190|NCT01365455|454687161|FG001|Maintenance Period|Lost to Follow-up|4|||
126380191|NCT01365455|454687162|FG002|Maintenance Period|Lost to Follow-up|0|||
126380192|NCT01365455|454687163|FG003|Maintenance Period|Lost to Follow-up|0|||
126380193|NCT01365455|454687164|FG004|Maintenance Period|Lost to Follow-up|3|||
126380194|NCT01365455|454687160|FG000|Maintenance Period|Non-compliance with study treatment|0|||
126380195|NCT01365455|454687161|FG001|Maintenance Period|Non-compliance with study treatment|0|||
126380196|NCT01365455|454687162|FG002|Maintenance Period|Non-compliance with study treatment|0|||
126380197|NCT01365455|454687163|FG003|Maintenance Period|Non-compliance with study treatment|1|||
126380198|NCT01365455|454687164|FG004|Maintenance Period|Non-compliance with study treatment|0|||
126380199|NCT01365455|454687160|FG000|Maintenance Period|Physician Decision|0|||
126380200|NCT01365455|454687161|FG001|Maintenance Period|Physician Decision|1|||
126380201|NCT01365455|454687162|FG002|Maintenance Period|Physician Decision|0|||
126380202|NCT01365455|454687163|FG003|Maintenance Period|Physician Decision|0|||
126380203|NCT01365455|454687164|FG004|Maintenance Period|Physician Decision|1|||
126380204|NCT01365455|454687160|FG000|Maintenance Period|Pregnancy|0|||
126380205|NCT01365455|454687161|FG001|Maintenance Period|Pregnancy|4|||
126380206|NCT01365455|454687162|FG002|Maintenance Period|Pregnancy|0|||
126380207|NCT01365455|454687163|FG003|Maintenance Period|Pregnancy|0|||
126380208|NCT01365455|454687164|FG004|Maintenance Period|Pregnancy|2|||
126380209|NCT01365455|454687160|FG000|Maintenance Period|Protocol deviation|1|||
126380210|NCT01365455|454687161|FG001|Maintenance Period|Protocol deviation|1|||
126380211|NCT01365455|454687162|FG002|Maintenance Period|Protocol deviation|0|||
126380212|NCT01365455|454687163|FG003|Maintenance Period|Protocol deviation|0|||
126380213|NCT01365455|454687164|FG004|Maintenance Period|Protocol deviation|0|||
126380214|NCT01365455|454687160|FG000|Maintenance Period|Subject/guardian decision|4|||
126380215|NCT01365455|454687161|FG001|Maintenance Period|Subject/guardian decision|6|||
126380216|NCT01365455|454687162|FG002|Maintenance Period|Subject/guardian decision|2|||
126380217|NCT01365455|454687163|FG003|Maintenance Period|Subject/guardian decision|4|||
126380218|NCT01365455|454687164|FG004|Maintenance Period|Subject/guardian decision|1|||
126380219|NCT00928187|454687165|FG000|Overall Study|Death|1|||
126380220|NCT00928187|454687166|FG001|Overall Study|Death|2|||
126380221|NCT00928187|454687167|FG002|Overall Study|Death|3|||
126380222|NCT00928187|454687165|FG000|Overall Study|Lost to Follow-up|1|||
126380223|NCT00928187|454687166|FG001|Overall Study|Lost to Follow-up|2|||
126380224|NCT00928187|454687167|FG002|Overall Study|Lost to Follow-up|1|||
126380225|NCT00928187|454687165|FG000|Overall Study|Withdrawal by Subject|0|||
126380226|NCT00928187|454687166|FG001|Overall Study|Withdrawal by Subject|1|||
126380227|NCT00928187|454687167|FG002|Overall Study|Withdrawal by Subject|1|||
126380228|NCT00928187|454687165|FG000|Overall Study|Protocol Violation|0|||
126380229|NCT00928187|454687166|FG001|Overall Study|Protocol Violation|1|||
126380230|NCT00928187|454687167|FG002|Overall Study|Protocol Violation|0|||
126380231|NCT01976299|454688828|FG000|Overall Study|Withdrawal by Subject|3|||
126717075|NCT00002663|455915021|FG008|Overall Study|Adverse Event|0|||
126717076|NCT00002663|455915022|FG009|Overall Study|Adverse Event|0|||
126380232|NCT01976299|454688829|FG001|Overall Study|Withdrawal by Subject|1|||
126380233|NCT01976299|454688828|FG000|Overall Study|Death|4|||
126380234|NCT01976299|454688829|FG001|Overall Study|Death|2|||
126380235|NCT01976299|454688828|FG000|Overall Study|Lost to Follow-up|7|||
126380236|NCT01976299|454688829|FG001|Overall Study|Lost to Follow-up|1|||
126380237|NCT01976299|454688828|FG000|Overall Study|See clarification above in comments|9|||
126380238|NCT01976299|454688829|FG001|Overall Study|See clarification above in comments|2|||
126380239|NCT00540592|454688832|FG000|Overall Study|Adverse Event|0|||
126380240|NCT00540592|454688833|FG001|Overall Study|Adverse Event|1|||
126380241|NCT00540592|454688834|FG002|Overall Study|Adverse Event|0|||
126380242|NCT00540592|454688835|FG003|Overall Study|Adverse Event|0|||
126380243|NCT00540592|454688836|FG004|Overall Study|Adverse Event|1|||
126380244|NCT00540592|454688837|FG005|Overall Study|Adverse Event|0|||
126380245|NCT00540592|454688838|FG006|Overall Study|Adverse Event|0|||
126380246|NCT00540592|454688839|FG007|Overall Study|Adverse Event|1|||
126380247|NCT00540592|454688840|FG008|Overall Study|Adverse Event|1|||
126380248|NCT00540592|454688841|FG009|Overall Study|Adverse Event|2|||
126380249|NCT00540592|454688832|FG000|Overall Study|Lost to Follow-up|2|||
126380250|NCT00540592|454688833|FG001|Overall Study|Lost to Follow-up|0|||
126380251|NCT00540592|454688834|FG002|Overall Study|Lost to Follow-up|0|||
126380252|NCT00540592|454688835|FG003|Overall Study|Lost to Follow-up|0|||
126380253|NCT00540592|454688836|FG004|Overall Study|Lost to Follow-up|0|||
126380254|NCT00540592|454688837|FG005|Overall Study|Lost to Follow-up|0|||
126380255|NCT00540592|454688838|FG006|Overall Study|Lost to Follow-up|0|||
126380256|NCT00540592|454688839|FG007|Overall Study|Lost to Follow-up|0|||
126380257|NCT00540592|454688840|FG008|Overall Study|Lost to Follow-up|0|||
126380258|NCT00540592|454688841|FG009|Overall Study|Lost to Follow-up|0|||
126380259|NCT00540592|454688832|FG000|Overall Study|Withdrawal by Subject|0|||
126380260|NCT00540592|454688833|FG001|Overall Study|Withdrawal by Subject|0|||
126380261|NCT00540592|454688834|FG002|Overall Study|Withdrawal by Subject|1|||
126380262|NCT00540592|454688835|FG003|Overall Study|Withdrawal by Subject|1|||
126380263|NCT00540592|454688836|FG004|Overall Study|Withdrawal by Subject|0|||
126380264|NCT00540592|454688837|FG005|Overall Study|Withdrawal by Subject|0|||
126380265|NCT00540592|454688838|FG006|Overall Study|Withdrawal by Subject|0|||
126380266|NCT00540592|454688839|FG007|Overall Study|Withdrawal by Subject|0|||
126380267|NCT00540592|454688840|FG008|Overall Study|Withdrawal by Subject|0|||
126380268|NCT00540592|454688841|FG009|Overall Study|Withdrawal by Subject|0|||
126380269|NCT01456130|454688842|FG000|Overall Study|Adverse Event|4|||
126380270|NCT01456130|454688842|FG000|Overall Study|Voluntary Withdrawal|1|||
126380271|NCT01456130|454688842|FG000|Overall Study|Lack of Efficacy|4|||
126380272|NCT01456130|454688842|FG000|Overall Study|Other|1|||
126380273|NCT02688192|454688847|FG000|Overall Study|Lost to Follow-up|11|||
126380274|NCT02688192|454688848|FG001|Overall Study|Lost to Follow-up|5|||
126380275|NCT02688192|454688847|FG000|Overall Study|Physician Decision|1|||
126380276|NCT02688192|454688848|FG001|Overall Study|Physician Decision|0|||
126380277|NCT05384834|454688849|FG000|Overall Study|Lost to Follow-up|43|||
126380278|NCT05384834|454688849|FG000|Overall Study|Withdrawal by Subject|5|||
126380279|NCT02948582|454688850|FG000|Washout Period 1|Adverse Event|0|||
126380280|NCT02948582|454688851|FG001|Washout Period 1|Adverse Event|2|||
126380281|NCT02948582|454688852|FG002|Washout Period 1|Adverse Event|0|||
126380282|NCT02948582|454688853|FG003|Washout Period 1|Adverse Event|0|||
126380283|NCT02948582|454688854|FG004|Washout Period 1|Adverse Event|0|||
126380284|NCT02948582|454688855|FG005|Washout Period 1|Adverse Event|0|||
126380285|NCT02948582|454688850|FG000|Washout Period 1|Protocol Violation|0|||
126380286|NCT02948582|454688851|FG001|Washout Period 1|Protocol Violation|0|||
126380287|NCT02948582|454688852|FG002|Washout Period 1|Protocol Violation|0|||
126380288|NCT02948582|454688853|FG003|Washout Period 1|Protocol Violation|0|||
126380289|NCT02948582|454688854|FG004|Washout Period 1|Protocol Violation|0|||
126380290|NCT02948582|454688855|FG005|Washout Period 1|Protocol Violation|1|||
126380291|NCT02948582|454688850|FG000|Washout Period 2|Adverse Event|0|||
126380292|NCT02948582|454688851|FG001|Washout Period 2|Adverse Event|1|||
126380293|NCT02948582|454688852|FG002|Washout Period 2|Adverse Event|0|||
126380294|NCT02948582|454688853|FG003|Washout Period 2|Adverse Event|0|||
126380295|NCT02948582|454688854|FG004|Washout Period 2|Adverse Event|0|||
126380296|NCT02948582|454688855|FG005|Washout Period 2|Adverse Event|0|||
126380297|NCT02948582|454688850|FG000|Washout Period 2|personal reasons|0|||
126380298|NCT02948582|454688851|FG001|Washout Period 2|personal reasons|0|||
126380299|NCT02948582|454688852|FG002|Washout Period 2|personal reasons|0|||
126380300|NCT02948582|454688853|FG003|Washout Period 2|personal reasons|1|||
126380301|NCT02948582|454688854|FG004|Washout Period 2|personal reasons|0|||
126380302|NCT02948582|454688855|FG005|Washout Period 2|personal reasons|0|||
126380303|NCT02948582|454688850|FG000|Washout Period 4|Adverse Event|1|||
126380304|NCT02948582|454688851|FG001|Washout Period 4|Adverse Event|0|||
126467846|NCT03265665|455015082|FG001|24-week Data Collection|Lost to Follow-up|5|||
126467847|NCT03265665|455015081|FG000|36-week Data Collection|Lost to Follow-up|6|||
126380305|NCT02948582|454688852|FG002|Washout Period 4|Adverse Event|1|||
126380306|NCT02948582|454688853|FG003|Washout Period 4|Adverse Event|0|||
126380307|NCT02948582|454688854|FG004|Washout Period 4|Adverse Event|0|||
126380308|NCT02948582|454688855|FG005|Washout Period 4|Adverse Event|0|||
126380309|NCT03386435|454688870|FG000|Overall Study|Protocol Violation|5|||
126380310|NCT03386435|454688871|FG001|Overall Study|Protocol Violation|7|||
126380311|NCT00625586|454688872|FG000|Overall Study|Adverse Event|1|||
126380312|NCT00625586|454688872|FG000|Overall Study|Progressive disease|1|||
126467848|NCT03265665|455015082|FG001|36-week Data Collection|Lost to Follow-up|8|||
126380313|NCT00124072|454688875|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
126380314|NCT00124072|454688876|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
126380315|NCT00124072|454688877|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
126380316|NCT00124072|454688878|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
126380317|NCT00124072|454688875|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
126467849|NCT01614600|455015083|FG000|Overall Study|Unacceptable fit|1|||
126380318|NCT00124072|454688876|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
126380319|NCT00124072|454688877|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
126380320|NCT00124072|454688878|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
126380321|NCT00124072|454688875|FG000|Overall Study|Death|499|||
126380322|NCT00124072|454688876|FG001|Overall Study|Death|484|||
126380323|NCT00124072|454688877|FG002|Overall Study|Death|471|||
126380324|NCT00124072|454688878|FG003|Overall Study|Death|480|||
126380325|NCT02534883|454688879|FG000|Overall Study|Early Termination|8|||
126380326|NCT02534883|454688880|FG001|Overall Study|Early Termination|3|||
126380327|NCT03328832|454688881|FG000|Overall Study|Lost to Follow-up|0|||
126380328|NCT03328832|454688882|FG001|Overall Study|Lost to Follow-up|1|||
126380329|NCT00886769|454688883|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
126380330|NCT00886769|454688884|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
126380331|NCT00778336|454688885|FG000|Index Procedure-Discharge|Death|6|||
126380332|NCT00778336|454688886|FG001|Index Procedure-Discharge|Death|3|||
126380333|NCT00778336|454688887|FG002|Index Procedure-Discharge|Death|2|||
126380334|NCT00778336|454688888|FG003|Index Procedure-Discharge|Death|0|||
126380335|NCT00778336|454688885|FG000|3 Month Follow Up|Lost to Follow-up|15|||
126380336|NCT00778336|454688886|FG001|3 Month Follow Up|Lost to Follow-up|20|||
126380337|NCT00778336|454688887|FG002|3 Month Follow Up|Lost to Follow-up|3|||
126380338|NCT00778336|454688888|FG003|3 Month Follow Up|Lost to Follow-up|0|||
126380339|NCT00778336|454688885|FG000|3 Month Follow Up|Death|8|||
126380340|NCT00778336|454688886|FG001|3 Month Follow Up|Death|3|||
126380341|NCT00778336|454688887|FG002|3 Month Follow Up|Death|2|||
126380342|NCT00778336|454688888|FG003|3 Month Follow Up|Death|0|||
126380343|NCT00414076|454688891|FG000|Overall Study|Progression|1|||
126380344|NCT00414076|454688892|FG001|Overall Study|Progression|2|||
126380345|NCT00414076|454688891|FG000|Overall Study|Withdrawal by Subject|1|||
126380346|NCT00414076|454688892|FG001|Overall Study|Withdrawal by Subject|3|||
126380347|NCT00414076|454688891|FG000|Overall Study|Adverse Event|1|||
126380348|NCT00414076|454688892|FG001|Overall Study|Adverse Event|0|||
126380349|NCT00049257|454688893|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
126380350|NCT00049257|454688893|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
126380351|NCT00049257|454688893|FG000|Carboplatin, Paclitaxel|Death|2|||
126380352|NCT00049257|454688893|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
126380353|NCT04721158|454688894|FG000|Overall Study|Lost to Follow-up|4|||
126380354|NCT04721158|454688894|FG000|Overall Study|Device did not connect|1|||
126380355|NCT04872569|454688895|FG000|Overall Study|Withdrawal by Subject|2|||
126380356|NCT02382991|454688896|FG000|Overall Study|Adverse Event|1|||
126380357|NCT02382991|454688897|FG001|Overall Study|Adverse Event|2|||
126380358|NCT02382991|454688896|FG000|Overall Study|Lost to Follow-up|1|||
126380359|NCT02382991|454688897|FG001|Overall Study|Lost to Follow-up|0|||
126380360|NCT02382991|454688896|FG000|Overall Study|Withdrawal by Subject|0|||
126380361|NCT02382991|454688897|FG001|Overall Study|Withdrawal by Subject|1|||
126380362|NCT04466384|454688898|FG000|First Phase|Protocol Violation|1|||
126380363|NCT04466384|454688899|FG001|First Phase|Protocol Violation|0|||
126380364|NCT04466384|454688898|FG000|First Phase|Missing data|1|||
126380365|NCT04466384|454688899|FG001|First Phase|Missing data|0|||
126380366|NCT04466384|454688898|FG000|Cross Over Phase|Physician Decision|1|||
126380367|NCT04466384|454688899|FG001|Cross Over Phase|Physician Decision|0|||
126380368|NCT04466384|454688898|FG000|Cross Over Phase|Withdrawal by Subject|0|||
126380369|NCT04466384|454688899|FG001|Cross Over Phase|Withdrawal by Subject|1|||
126380370|NCT03666988|454688900|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
126380371|NCT03666988|454688901|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
126380372|NCT03666988|454688902|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
126380373|NCT03666988|454688903|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
126380374|NCT03666988|454688904|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
126380375|NCT03666988|454688905|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
126380376|NCT03666988|454688900|FG000|Part 1 (Up to 28 Months)|Other|0|||
126380377|NCT03666988|454688901|FG001|Part 1 (Up to 28 Months)|Other|1|||
126380378|NCT03666988|454688902|FG002|Part 1 (Up to 28 Months)|Other|1|||
126380379|NCT03666988|454688903|FG003|Part 1 (Up to 28 Months)|Other|0|||
126380380|NCT03666988|454688904|FG004|Part 1 (Up to 28 Months)|Other|0|||
126380381|NCT03666988|454688905|FG005|Part 1 (Up to 28 Months)|Other|0|||
126380382|NCT03666988|454688900|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
126717077|NCT01603641|455915025|FG000|Overall Study|Did not Receive Treatment|3|||
126380383|NCT03666988|454688901|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
126380384|NCT03666988|454688902|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
126380385|NCT03666988|454688903|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
126380386|NCT03666988|454688904|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
126380387|NCT03666988|454688905|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
126380388|NCT03666988|454688900|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
126380389|NCT03666988|454688901|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
126380390|NCT03666988|454688902|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
126380391|NCT03666988|454688903|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
126380392|NCT03666988|454688904|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
126380393|NCT03666988|454688905|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
126467850|NCT01614600|455015083|FG000|Overall Study|Discomfort|1|||
126467851|NCT01614600|455015083|FG000|Overall Study|Unable to remove lens at the end of day|1|||
126467852|NCT01614600|455015083|FG000|Overall Study|Protocol deviation|1|||
126467853|NCT01193660|455015086|FG000|Overall Study|Withdrawal by Subject|2|||
126467854|NCT01193660|455015087|FG001|Overall Study|Withdrawal by Subject|3|||
126467855|NCT01193660|455015088|FG002|Overall Study|Withdrawal by Subject|1|||
126467856|NCT01193660|455015086|FG000|Overall Study|Death|1|||
126380394|NCT03666988|454688900|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
126380395|NCT03666988|454688901|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
126380396|NCT03666988|454688902|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
126380397|NCT03666988|454688903|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
126380398|NCT03666988|454688904|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
126380399|NCT03666988|454688905|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
126380400|NCT03554018|454688908|FG000|Overall Study|Lost to Follow-up|3|||
126380401|NCT03554018|454688909|FG001|Overall Study|Lost to Follow-up|7|||
126380402|NCT02891226|454688912|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
126380403|NCT02891226|454688913|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
126380404|NCT02891226|454688914|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
126380405|NCT02891226|454688915|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380406|NCT02891226|454688916|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380407|NCT02891226|454688917|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380408|NCT02891226|454688918|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380409|NCT02891226|454688919|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380410|NCT02891226|454688920|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380411|NCT02891226|454688921|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380412|NCT02891226|454688922|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380413|NCT02891226|454688923|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380414|NCT02891226|454688924|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380415|NCT02891226|454688925|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380416|NCT02891226|454688926|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380417|NCT02891226|454688927|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
126380418|NCT02891226|454688912|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
126380419|NCT02891226|454688913|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
126380420|NCT02891226|454688914|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380421|NCT02891226|454688915|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380422|NCT02891226|454688916|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380423|NCT02891226|454688917|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380424|NCT02891226|454688918|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380425|NCT02891226|454688919|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380426|NCT02891226|454688920|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380427|NCT02891226|454688921|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380428|NCT02891226|454688922|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380429|NCT02891226|454688923|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380430|NCT02891226|454688924|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380431|NCT02891226|454688925|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380432|NCT02891226|454688926|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380433|NCT02891226|454688927|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
126380434|NCT02891226|454688912|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380435|NCT02891226|454688913|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380436|NCT02891226|454688914|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380437|NCT02891226|454688915|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
126380438|NCT02891226|454688916|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380439|NCT02891226|454688917|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380440|NCT02891226|454688918|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380441|NCT02891226|454688919|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380442|NCT02891226|454688920|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380443|NCT02891226|454688921|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380444|NCT02891226|454688922|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380445|NCT02891226|454688923|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380446|NCT02891226|454688924|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380447|NCT02891226|454688925|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380448|NCT02891226|454688926|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380449|NCT02891226|454688927|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
126380450|NCT02891226|454688912|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380451|NCT02891226|454688913|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380452|NCT02891226|454688914|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
126380453|NCT02891226|454688915|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126717078|NCT01603641|455915025|FG000|Overall Study|Adverse Event|1|||
126380454|NCT02891226|454688916|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126467857|NCT01193660|455015087|FG001|Overall Study|Death|0|||
126380455|NCT02891226|454688917|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380456|NCT02891226|454688918|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380457|NCT02891226|454688919|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380458|NCT02891226|454688920|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380459|NCT02891226|454688921|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380460|NCT02891226|454688922|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380461|NCT02891226|454688923|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380462|NCT02891226|454688924|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380463|NCT02891226|454688925|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380464|NCT02891226|454688926|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380465|NCT02891226|454688927|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
126380466|NCT02891226|454688912|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380467|NCT02891226|454688913|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380468|NCT02891226|454688914|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380469|NCT02891226|454688915|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
126380470|NCT02891226|454688916|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380471|NCT02891226|454688917|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380472|NCT02891226|454688918|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380473|NCT02891226|454688919|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380474|NCT02891226|454688920|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380475|NCT02891226|454688921|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380476|NCT02891226|454688922|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380477|NCT02891226|454688923|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380478|NCT02891226|454688924|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380479|NCT02891226|454688925|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380480|NCT02891226|454688926|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380481|NCT02891226|454688927|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
126380482|NCT02891226|454688912|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380483|NCT02891226|454688913|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380484|NCT02891226|454688914|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380485|NCT02891226|454688915|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
126380486|NCT02891226|454688916|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380487|NCT02891226|454688917|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380488|NCT02891226|454688918|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380489|NCT02891226|454688919|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380490|NCT02891226|454688920|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380491|NCT02891226|454688921|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126771137|NCT04529096|456116272|FG001|Overall Study|Lost to Follow-up|1|||
126771138|NCT04529096|456116271|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126771139|NCT04529096|456116272|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126771140|NCT04529096|456116271|FG000|Overall Study|Physician Decision|1|||
126380492|NCT02891226|454688922|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380493|NCT02891226|454688923|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380494|NCT02891226|454688924|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380495|NCT02891226|454688925|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380496|NCT02891226|454688926|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380497|NCT02891226|454688927|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
126380498|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380499|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380500|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380501|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380502|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380503|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380504|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
126380505|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
126380506|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
126380507|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
126380508|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380509|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380510|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380511|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380512|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380513|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
126380514|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380515|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380516|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380517|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380518|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380519|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
126380520|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380521|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380522|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380523|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
126380524|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380525|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126771141|NCT04529096|456116272|FG001|Overall Study|Physician Decision|3|||
126553253|NCT01089556|455320531|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
126553254|NCT01089556|455320532|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
126553255|NCT01089556|455320533|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
126553256|NCT01089556|455320534|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
126553257|NCT01089556|455320529|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
126553258|NCT01089556|455320530|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
126553259|NCT01089556|455320531|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
126553260|NCT01089556|455320532|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
126553261|NCT01089556|455320533|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
126553262|NCT01089556|455320534|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
126553263|NCT01089556|455320529|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
126553264|NCT01089556|455320530|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
126380526|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380527|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126553265|NCT01089556|455320531|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
126553266|NCT01089556|455320532|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
126553267|NCT01089556|455320533|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
126553268|NCT01089556|455320534|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
126553269|NCT01089556|455320529|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
126553270|NCT01089556|455320530|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
126553271|NCT01089556|455320531|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
126553272|NCT01089556|455320532|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
126553273|NCT01089556|455320533|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
126553274|NCT01089556|455320534|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
126553275|NCT01238575|455320535|FG000|Overall Study|Lack of Efficacy|2|||
126553276|NCT01238575|455320536|FG001|Overall Study|Lack of Efficacy|4|||
126553277|NCT01238575|455320535|FG000|Overall Study|Adverse Event|2|||
126553278|NCT01238575|455320536|FG001|Overall Study|Adverse Event|0|||
126553279|NCT00262743|455320538|FG000|Overall Study|Adverse Event|0|||
126553280|NCT00262743|455320539|FG001|Overall Study|Adverse Event|9|||
126553281|NCT00262743|455320538|FG000|Overall Study|Disease progression|0|||
126553282|NCT00262743|455320539|FG001|Overall Study|Disease progression|3|||
126380528|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380529|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
126380530|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380531|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380532|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380533|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380534|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380535|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126553283|NCT01591460|455320556|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
126553284|NCT01591460|455320556|FG000|Overall Study|Futility Rule (Week 12)|7|||
126553285|NCT01591460|455320556|FG000|Overall Study|Futility Rule (Week 24)|3|||
126553286|NCT01591460|455320556|FG000|Overall Study|Rebound or Breakthrough|3|||
126553287|NCT01591460|455320556|FG000|Overall Study|Treatment Discontinued by Error|1|||
126553288|NCT01591460|455320556|FG000|Overall Study|Lost to Follow-up|1|||
126553289|NCT01591460|455320556|FG000|Overall Study|Noncompliance|1|||
126380536|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
126380537|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
126380538|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
126380539|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
126380540|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380541|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380542|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380543|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380544|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380545|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
126380546|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380547|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126553290|NCT01591460|455320556|FG000|Overall Study|Participant Refusal|3|||
126553291|NCT01591460|455320556|FG000|Overall Study|Withdrawal by Subject|1|||
126553292|NCT01591460|455320556|FG000|Overall Study|Protocol Violation|1|||
126380548|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126553293|NCT03230864|455320557|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
126380549|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380550|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
126380551|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126553294|NCT03230864|455320558|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
126553295|NCT03230864|455320559|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
126553296|NCT03230864|455320560|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
126380552|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380553|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380554|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380555|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380556|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380557|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380558|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380559|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380560|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380561|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
126380562|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380563|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380564|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380565|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380566|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380567|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380568|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
126380569|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380570|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380571|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380572|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380573|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380574|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380575|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380576|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380577|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
126380578|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380579|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380580|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380581|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380582|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380583|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380584|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380585|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
126380586|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
126380587|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
126380588|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380589|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380590|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380591|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380592|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380593|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
126380594|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126467858|NCT01193660|455015088|FG002|Overall Study|Death|0|||
126467859|NCT01193660|455015086|FG000|Overall Study|Physician Decision|1|||
126467860|NCT01193660|455015087|FG001|Overall Study|Physician Decision|0|||
126467861|NCT01193660|455015088|FG002|Overall Study|Physician Decision|1|||
126467862|NCT03347188|455015089|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
126467863|NCT03347188|455015090|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
126467864|NCT03347188|455015089|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
126467865|NCT03347188|455015090|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
126467866|NCT03347188|455015089|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
126467867|NCT03347188|455015090|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
126467868|NCT03347188|455015089|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
126467869|NCT03347188|455015090|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
126467870|NCT03347188|455015089|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
126467871|NCT03347188|455015090|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
126467872|NCT03347188|455015089|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
126467873|NCT03347188|455015090|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
126467874|NCT03347188|455015089|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
126467875|NCT03347188|455015090|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
126467876|NCT03347188|455015089|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
126467877|NCT03347188|455015090|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
126467878|NCT02186873|455015091|FG000|Overall Study|Adverse Event|1|||
126467879|NCT02186873|455015092|FG001|Overall Study|Adverse Event|3|||
126717079|NCT01603641|455915025|FG000|Overall Study|Lack of Efficacy|1|||
126380595|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380596|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380597|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380598|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380599|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380600|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380601|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
126380602|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380603|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380604|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380605|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380606|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380607|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380608|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380609|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
126380610|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380611|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380612|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380613|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380614|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380615|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380616|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380617|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380618|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
126380619|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380620|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380621|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380622|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380623|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380624|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380625|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
126380626|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380627|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380628|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380629|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380630|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380631|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380632|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380633|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380634|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380635|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
126380636|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380637|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380638|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380639|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380640|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380641|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
126380642|NCT02891226|454688912|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380643|NCT02891226|454688913|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380644|NCT02891226|454688914|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380645|NCT02891226|454688915|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380646|NCT02891226|454688916|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380647|NCT02891226|454688917|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380648|NCT02891226|454688918|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380649|NCT02891226|454688919|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380650|NCT02891226|454688920|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380651|NCT02891226|454688921|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
126380652|NCT02891226|454688922|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380653|NCT02891226|454688923|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380654|NCT02891226|454688924|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126467880|NCT02186873|455015091|FG000|Overall Study|Lack of Efficacy|0|||
126717080|NCT01603641|455915025|FG000|Overall Study|Lost to Follow-up|6|||
126717081|NCT01603641|455915025|FG000|Overall Study|Personal Reasons|18|||
126717082|NCT01603641|455915025|FG000|Overall Study|Other Miscellaneous Reasons|6|||
126717083|NCT03161678|455915026|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
126717084|NCT03161678|455915027|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
126717085|NCT03161678|455915028|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
126717086|NCT03161678|455915029|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
126717087|NCT03161678|455915030|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
126717088|NCT03161678|455915031|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
126717089|NCT03161678|455915026|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
126717090|NCT03161678|455915027|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
126771142|NCT04529096|456116271|FG000|Overall Study|Withdrawal by Subject|5|||
126771143|NCT04529096|456116272|FG001|Overall Study|Withdrawal by Subject|0|||
126771144|NCT03454672|456116284|FG000|Overall Study|Adverse Event|1|||
126380655|NCT02891226|454688925|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380656|NCT02891226|454688926|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380657|NCT02891226|454688927|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
126380658|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380659|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380660|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380661|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380662|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380663|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380664|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380665|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380666|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380667|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380668|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
126771145|NCT03454672|456116285|FG001|Overall Study|Adverse Event|1|||
126380669|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380670|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380671|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380672|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380673|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
126380674|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380675|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380676|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380677|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380678|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380679|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380680|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380681|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380682|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380683|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380684|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
126380685|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380686|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126771146|NCT03454672|456116284|FG000|Overall Study|Lost to Follow-up|1|||
126771147|NCT03454672|456116285|FG001|Overall Study|Lost to Follow-up|3|||
126380687|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380688|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380689|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
126380690|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380691|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380692|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380693|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380694|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380695|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380696|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380697|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380698|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380699|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380700|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
126380701|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380702|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380703|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380704|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380705|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
126380706|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380707|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380708|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380709|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380710|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380711|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380712|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380713|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380714|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380715|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380716|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
126380717|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380718|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380719|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380720|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380721|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
126380722|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380723|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380724|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380725|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380726|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380727|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380728|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380729|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380730|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380731|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380732|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
126380733|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380734|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380735|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380736|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380737|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
126380738|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380739|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380740|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380741|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126467881|NCT02186873|455015092|FG001|Overall Study|Lack of Efficacy|1|||
126467882|NCT02186873|455015091|FG000|Overall Study|Lost to Follow-up|1|||
126467883|NCT02186873|455015092|FG001|Overall Study|Lost to Follow-up|2|||
126467884|NCT02186873|455015091|FG000|Overall Study|Withdrawal by Subject|7|||
126467885|NCT02186873|455015092|FG001|Overall Study|Withdrawal by Subject|2|||
126467886|NCT00195273|455015093|FG000|Overall Study|Adverse Event|9|||
126467887|NCT00195273|455015094|FG001|Overall Study|Adverse Event|9|||
126467888|NCT00195273|455015093|FG000|Overall Study|Protocol deviation|0|||
126467889|NCT00195273|455015094|FG001|Overall Study|Protocol deviation|1|||
126467890|NCT00195273|455015093|FG000|Overall Study|Lack of Efficacy|3|||
126467891|NCT00195273|455015094|FG001|Overall Study|Lack of Efficacy|1|||
126467892|NCT00195273|455015093|FG000|Overall Study|Procedural complications|9|||
126467893|NCT00195273|455015094|FG001|Overall Study|Procedural complications|3|||
126467894|NCT01680965|455015095|FG000|Overall Study|Death|0|||
126467895|NCT01680965|455015096|FG001|Overall Study|Death|0|||
126717091|NCT03161678|455915028|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
126717092|NCT03161678|455915029|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
126717093|NCT03161678|455915030|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
126380742|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380743|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380744|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380745|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380746|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380747|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380748|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
126380749|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126467896|NCT01680965|455015097|FG002|Overall Study|Death|0|||
126467897|NCT01680965|455015098|FG003|Overall Study|Death|6|||
126467898|NCT00595465|455015099|FG000|Overall Study|Adverse Event|4|||
126467899|NCT00595465|455015100|FG001|Overall Study|Adverse Event|3|||
126717094|NCT03161678|455915031|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
126717095|NCT03161678|455915026|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
126467900|NCT00595465|455015101|FG002|Overall Study|Adverse Event|3|||
126467901|NCT00595465|455015099|FG000|Overall Study|Pregnancy|0|||
126717096|NCT03161678|455915027|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
126467902|NCT00595465|455015100|FG001|Overall Study|Pregnancy|0|||
126467903|NCT00595465|455015101|FG002|Overall Study|Pregnancy|1|||
126380750|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380751|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380752|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380753|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
126380754|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380755|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380756|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380757|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380758|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380759|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380760|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380761|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380762|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380763|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380764|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
126380765|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380766|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380767|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380768|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380769|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
126380770|NCT02891226|454688912|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380771|NCT02891226|454688913|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380772|NCT02891226|454688914|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380773|NCT02891226|454688915|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380774|NCT02891226|454688916|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380775|NCT02891226|454688917|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380776|NCT02891226|454688918|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380777|NCT02891226|454688919|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380778|NCT02891226|454688920|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380779|NCT02891226|454688921|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380780|NCT02891226|454688922|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
126380781|NCT02891226|454688923|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380782|NCT02891226|454688924|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380783|NCT02891226|454688925|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380784|NCT02891226|454688926|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380785|NCT02891226|454688927|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
126380786|NCT02891226|454688912|FG000|Follow-up Period|Withdrawal by Subject|0|||
126380787|NCT02891226|454688913|FG001|Follow-up Period|Withdrawal by Subject|0|||
126380788|NCT02891226|454688914|FG002|Follow-up Period|Withdrawal by Subject|0|||
126380789|NCT02891226|454688915|FG003|Follow-up Period|Withdrawal by Subject|0|||
126380790|NCT02891226|454688916|FG004|Follow-up Period|Withdrawal by Subject|0|||
126380791|NCT02891226|454688917|FG005|Follow-up Period|Withdrawal by Subject|0|||
126380792|NCT02891226|454688918|FG006|Follow-up Period|Withdrawal by Subject|0|||
126380793|NCT02891226|454688919|FG007|Follow-up Period|Withdrawal by Subject|0|||
126380794|NCT02891226|454688920|FG008|Follow-up Period|Withdrawal by Subject|0|||
126380795|NCT02891226|454688921|FG009|Follow-up Period|Withdrawal by Subject|0|||
126380796|NCT02891226|454688922|FG010|Follow-up Period|Withdrawal by Subject|0|||
126380797|NCT02891226|454688923|FG011|Follow-up Period|Withdrawal by Subject|1|||
126553297|NCT03230864|455320557|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
126553298|NCT03230864|455320558|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
126553299|NCT03230864|455320559|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
126553300|NCT03230864|455320560|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
126717097|NCT03161678|455915028|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
126380798|NCT02891226|454688924|FG012|Follow-up Period|Withdrawal by Subject|0|||
126380799|NCT02891226|454688925|FG013|Follow-up Period|Withdrawal by Subject|0|||
126380800|NCT02891226|454688926|FG014|Follow-up Period|Withdrawal by Subject|1|||
126380801|NCT02891226|454688927|FG015|Follow-up Period|Withdrawal by Subject|1|||
126380802|NCT01928433|454688928|FG000|Overall Study|Adverse Event|5|||
126380803|NCT01928433|454688929|FG001|Overall Study|Adverse Event|2|||
126380804|NCT01928433|454688930|FG002|Overall Study|Adverse Event|5|||
126380805|NCT01928433|454688928|FG000|Overall Study|Protocol Violation|0|||
126380806|NCT01928433|454688929|FG001|Overall Study|Protocol Violation|0|||
126380807|NCT01928433|454688930|FG002|Overall Study|Protocol Violation|2|||
126380808|NCT01928433|454688928|FG000|Overall Study|Lack of Efficacy|5|||
126380809|NCT01928433|454688929|FG001|Overall Study|Lack of Efficacy|4|||
126380810|NCT01928433|454688930|FG002|Overall Study|Lack of Efficacy|4|||
126380811|NCT01928433|454688928|FG000|Overall Study|Withdrawal by Subject|0|||
126380812|NCT01928433|454688929|FG001|Overall Study|Withdrawal by Subject|4|||
126380813|NCT01928433|454688930|FG002|Overall Study|Withdrawal by Subject|0|||
126380814|NCT01928433|454688928|FG000|Overall Study|Negative screening urine culture|7|||
126380815|NCT01928433|454688929|FG001|Overall Study|Negative screening urine culture|6|||
126380816|NCT01928433|454688930|FG002|Overall Study|Negative screening urine culture|10|||
126380817|NCT01928433|454688928|FG000|Overall Study|Lost to Follow-up|0|||
126380818|NCT01928433|454688929|FG001|Overall Study|Lost to Follow-up|2|||
126380819|NCT01928433|454688930|FG002|Overall Study|Lost to Follow-up|3|||
126380820|NCT01928433|454688928|FG000|Overall Study|Other reasons|3|||
126380821|NCT01928433|454688929|FG001|Overall Study|Other reasons|3|||
126380822|NCT01928433|454688930|FG002|Overall Study|Other reasons|4|||
126380823|NCT00145626|454688931|FG000|Overall Study|Did not have NK infusions|2|||
126380824|NCT00145626|454688931|FG000|Overall Study|Turned 2 years old before treatment|1|||
126380825|NCT00145626|454688931|FG000|Overall Study|Death|1|||
126380826|NCT00145626|454688931|FG000|Overall Study|Withdrawal by Subject|1|||
126380827|NCT00436436|454688932|FG000|Overall Study|Progression|4|||
126380828|NCT00436436|454688932|FG000|Overall Study|Adverse Event|2|||
126380829|NCT00436436|454688932|FG000|Overall Study|Death|6|||
126380830|NCT03654274|454688937|FG000|Overall Study|Adverse Event|19|||
126380831|NCT03654274|454688938|FG001|Overall Study|Adverse Event|23|||
126380832|NCT03654274|454688939|FG002|Overall Study|Adverse Event|24|||
126380833|NCT03654274|454688937|FG000|Overall Study|Protocol Deviation|0|||
126380834|NCT03654274|454688938|FG001|Overall Study|Protocol Deviation|2|||
126380835|NCT03654274|454688939|FG002|Overall Study|Protocol Deviation|0|||
126380836|NCT03654274|454688937|FG000|Overall Study|Lost to Follow-up|8|||
126380837|NCT03654274|454688938|FG001|Overall Study|Lost to Follow-up|6|||
126380838|NCT03654274|454688939|FG002|Overall Study|Lost to Follow-up|5|||
126380839|NCT03654274|454688937|FG000|Overall Study|Withdrawal by Subject|46|||
126380840|NCT03654274|454688938|FG001|Overall Study|Withdrawal by Subject|25|||
126380841|NCT03654274|454688939|FG002|Overall Study|Withdrawal by Subject|33|||
126380842|NCT03654274|454688937|FG000|Overall Study|Lack of Efficacy|4|||
126380843|NCT03654274|454688938|FG001|Overall Study|Lack of Efficacy|5|||
126380844|NCT03654274|454688939|FG002|Overall Study|Lack of Efficacy|7|||
126380845|NCT03654274|454688937|FG000|Overall Study|Pregnancy|2|||
126380846|NCT03654274|454688938|FG001|Overall Study|Pregnancy|2|||
126380847|NCT03654274|454688939|FG002|Overall Study|Pregnancy|1|||
126380848|NCT03654274|454688937|FG000|Overall Study|Other|27|||
126380849|NCT03654274|454688938|FG001|Overall Study|Other|29|||
126380850|NCT03654274|454688939|FG002|Overall Study|Other|32|||
126380851|NCT03654274|454688937|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
126380852|NCT03654274|454688938|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
126380853|NCT03654274|454688939|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
126380854|NCT01102491|454688942|FG000|Overall Study|Protocol Violation|11|||
126380855|NCT01102491|454688943|FG001|Overall Study|Protocol Violation|12|||
126380856|NCT05005273|454688944|FG000|Overall Study|Study Terminated|1|||
126380857|NCT05005273|454688945|FG001|Overall Study|Study Terminated|0|||
126380858|NCT02151786|454688946|FG000|Overall Study|Unavailability of Case Report Form|26|||
126380859|NCT02151786|454688946|FG000|Overall Study|Outside the Contract Period|1|||
126380860|NCT02151786|454688946|FG000|Overall Study|Randomized, not Treated|1|||
126380861|NCT02151786|454688946|FG000|Overall Study|Unavailability of Information|8|||
126380862|NCT03533660|454688947|FG000|Overall Study|Withdrawal by Subject|2|||
126467904|NCT00595465|455015099|FG000|Overall Study|Protocol Violation|2|||
126467905|NCT00595465|455015100|FG001|Overall Study|Protocol Violation|1|||
126467906|NCT00595465|455015101|FG002|Overall Study|Protocol Violation|0|||
126467907|NCT00595465|455015099|FG000|Overall Study|Lost to Follow-up|0|||
126380863|NCT03533660|454688948|FG001|Overall Study|Withdrawal by Subject|2|||
126380864|NCT03533660|454688947|FG000|Overall Study|Death|2|||
126380865|NCT03533660|454688948|FG001|Overall Study|Death|4|||
126380866|NCT03533660|454688947|FG000|Overall Study|Adverse Event|0|||
126380867|NCT03533660|454688948|FG001|Overall Study|Adverse Event|2|||
126380868|NCT00996658|454688949|FG000|Overall Study|Adverse Event|2|||
126467908|NCT00595465|455015100|FG001|Overall Study|Lost to Follow-up|0|||
126467909|NCT00595465|455015101|FG002|Overall Study|Lost to Follow-up|2|||
126380869|NCT00996658|454688950|FG001|Overall Study|Adverse Event|5|||
126380870|NCT00996658|454688949|FG000|Overall Study|Protocol Violation|0|||
126380871|NCT00996658|454688950|FG001|Overall Study|Protocol Violation|1|||
126380872|NCT00996658|454688949|FG000|Overall Study|Lost to Follow-up|2|||
126380873|NCT00996658|454688950|FG001|Overall Study|Lost to Follow-up|5|||
126380874|NCT00996658|454688949|FG000|Overall Study|Non-compliance issues|3|||
126380875|NCT00996658|454688950|FG001|Overall Study|Non-compliance issues|3|||
126380876|NCT00996658|454688949|FG000|Overall Study|Other|9|||
126380877|NCT00996658|454688950|FG001|Overall Study|Other|7|||
126380878|NCT03154476|454688959|FG000|Overall Study|Lost to Follow-up|4|||
126380879|NCT03154476|454688960|FG001|Overall Study|Lost to Follow-up|4|||
126467910|NCT00595465|455015099|FG000|Overall Study|administrative reason|0|||
126467911|NCT00595465|455015100|FG001|Overall Study|administrative reason|0|||
126380880|NCT02685826|454688961|FG000|Overall Study|Adverse Event|2|||
126380881|NCT02685826|454688962|FG001|Overall Study|Adverse Event|0|||
126380882|NCT02685826|454688963|FG002|Overall Study|Adverse Event|1|||
126380883|NCT02685826|454688961|FG000|Overall Study|Progressive Disease|2|||
126380884|NCT02685826|454688962|FG001|Overall Study|Progressive Disease|1|||
126380885|NCT02685826|454688963|FG002|Overall Study|Progressive Disease|0|||
126380886|NCT02685826|454688961|FG000|Overall Study|Withdrawal by Subject|2|||
126380887|NCT02685826|454688962|FG001|Overall Study|Withdrawal by Subject|0|||
126380888|NCT02685826|454688963|FG002|Overall Study|Withdrawal by Subject|0|||
126380889|NCT02685826|454688961|FG000|Overall Study|Full Clinical Hold by FDA|19|||
126380890|NCT02685826|454688962|FG001|Overall Study|Full Clinical Hold by FDA|9|||
126380891|NCT02685826|454688963|FG002|Overall Study|Full Clinical Hold by FDA|20|||
126380892|NCT00200967|454688966|FG000|First Treatment Period|Withdrawal by Subject|5|||
126380893|NCT00200967|454688967|FG001|First Treatment Period|Withdrawal by Subject|1|||
126380894|NCT00200967|454688966|FG000|First Treatment Period|Pregnancy|1|||
126380895|NCT00200967|454688967|FG001|First Treatment Period|Pregnancy|0|||
126380896|NCT00200967|454688966|FG000|Wash-out Period|Lost to Follow-up|0|||
126380897|NCT00200967|454688967|FG001|Wash-out Period|Lost to Follow-up|1|||
126380898|NCT00200967|454688966|FG000|Second Treatment Period|Withdrawal by Subject|1|||
126380899|NCT00200967|454688967|FG001|Second Treatment Period|Withdrawal by Subject|2|||
126380900|NCT00200967|454688966|FG000|Run-out Period|Lost to Follow-up|1|||
126380901|NCT00200967|454688967|FG001|Run-out Period|Lost to Follow-up|0|||
126380902|NCT01444430|454688970|FG000|Overall Study|Withdrawal by Subject|53|||
126380903|NCT01444430|454688971|FG001|Overall Study|Withdrawal by Subject|72|||
126380904|NCT01444430|454688970|FG000|Overall Study|Death|6|||
126380905|NCT01444430|454688971|FG001|Overall Study|Death|8|||
126380906|NCT01444430|454688970|FG000|Overall Study|Lost to Follow-up|2|||
126380907|NCT01444430|454688971|FG001|Overall Study|Lost to Follow-up|0|||
126380908|NCT01444430|454688970|FG000|Overall Study|CRF termination module not completed.|0|||
126380909|NCT01444430|454688971|FG001|Overall Study|CRF termination module not completed.|1|||
126380910|NCT02297815|454690351|FG000|Overall Study|Lost to Follow-up|236|||
126380911|NCT02297815|454690352|FG001|Overall Study|Lost to Follow-up|140|||
126380912|NCT00662831|454690353|FG000|Overall Study|Death|4|||
126380913|NCT00662831|454690354|FG001|Overall Study|Death|1|||
126380914|NCT00662831|454690353|FG000|Overall Study|Lack of Efficacy|6|||
126380915|NCT00662831|454690354|FG001|Overall Study|Lack of Efficacy|6|||
126380916|NCT00662831|454690353|FG000|Overall Study|Lost to Follow-up|1|||
126380917|NCT00662831|454690354|FG001|Overall Study|Lost to Follow-up|0|||
126380918|NCT00662831|454690353|FG000|Overall Study|Withdrawal by Subject|2|||
126380919|NCT00662831|454690354|FG001|Overall Study|Withdrawal by Subject|1|||
126380920|NCT00662831|454690353|FG000|Overall Study|Other|62|||
126380921|NCT00662831|454690354|FG001|Overall Study|Other|31|||
126380922|NCT00662831|454690353|FG000|Overall Study|Protocol Violation|8|||
126380923|NCT00662831|454690354|FG001|Overall Study|Protocol Violation|4|||
126380924|NCT00662831|454690353|FG000|Overall Study|Adverse Event|23|||
126380925|NCT00662831|454690354|FG001|Overall Study|Adverse Event|16|||
126380926|NCT01061723|454690356|FG000|Overall Study|Adverse Event|0|||
126380927|NCT01061723|454690357|FG001|Overall Study|Adverse Event|2|||
126380928|NCT01061723|454690358|FG002|Overall Study|Adverse Event|5|||
126380929|NCT01061723|454690359|FG003|Overall Study|Adverse Event|5|||
126380930|NCT01061723|454690360|FG004|Overall Study|Adverse Event|2|||
126467912|NCT00595465|455015101|FG002|Overall Study|administrative reason|1|||
126467913|NCT02595970|455015102|FG000|Overall Study|Withdrawal by Subject|2|||
126467914|NCT02595970|455015102|FG000|Overall Study|Physician Decision|2|||
126467915|NCT02595970|455015102|FG000|Overall Study|Protocol Violation|4|||
126467916|NCT02595970|455015102|FG000|Overall Study|Adverse Event|5|||
126467917|NCT02595970|455015102|FG000|Overall Study|Lack of Efficacy|7|||
126380931|NCT01061723|454690361|FG005|Overall Study|Adverse Event|6|||
126380932|NCT01061723|454690356|FG000|Overall Study|Lack of Efficacy|2|||
126467918|NCT00107783|455015105|FG000|Overall Study|Adverse Event|0|||
126467919|NCT00107783|455015106|FG001|Overall Study|Adverse Event|2|||
126467920|NCT00107783|455015105|FG000|Overall Study|Death|0|||
126380933|NCT01061723|454690357|FG001|Overall Study|Lack of Efficacy|3|||
126380934|NCT01061723|454690358|FG002|Overall Study|Lack of Efficacy|4|||
126380935|NCT01061723|454690359|FG003|Overall Study|Lack of Efficacy|2|||
126380936|NCT01061723|454690360|FG004|Overall Study|Lack of Efficacy|1|||
126380937|NCT01061723|454690361|FG005|Overall Study|Lack of Efficacy|1|||
126380938|NCT01061723|454690356|FG000|Overall Study|Randomized but not treated|0|||
126380939|NCT01061723|454690357|FG001|Overall Study|Randomized but not treated|0|||
126467921|NCT00107783|455015106|FG001|Overall Study|Death|1|||
126467922|NCT00107783|455015105|FG000|Overall Study|Withdrawal by Subject|2|||
126380940|NCT01061723|454690358|FG002|Overall Study|Randomized but not treated|0|||
126380941|NCT01061723|454690359|FG003|Overall Study|Randomized but not treated|0|||
126380942|NCT01061723|454690360|FG004|Overall Study|Randomized but not treated|0|||
126380943|NCT01061723|454690361|FG005|Overall Study|Randomized but not treated|1|||
126380944|NCT01061723|454690356|FG000|Overall Study|Other than specified above|2|||
126380945|NCT01061723|454690357|FG001|Overall Study|Other than specified above|1|||
126380946|NCT01061723|454690358|FG002|Overall Study|Other than specified above|1|||
126380947|NCT01061723|454690359|FG003|Overall Study|Other than specified above|1|||
126380948|NCT01061723|454690360|FG004|Overall Study|Other than specified above|0|||
126380949|NCT01061723|454690361|FG005|Overall Study|Other than specified above|1|||
126380950|NCT00566982|454690362|FG000|Overall Study|Adverse Event|6|||
126380951|NCT00566982|454690363|FG001|Overall Study|Adverse Event|48|||
126380952|NCT00566982|454690362|FG000|Overall Study|Withdrawal by Subject|1|||
126380953|NCT00566982|454690363|FG001|Overall Study|Withdrawal by Subject|14|||
126380954|NCT00566982|454690362|FG000|Overall Study|Protocol Violation|1|||
126380955|NCT00566982|454690363|FG001|Overall Study|Protocol Violation|4|||
126380956|NCT00566982|454690362|FG000|Overall Study|Lost to Follow-up|0|||
126380957|NCT00566982|454690363|FG001|Overall Study|Lost to Follow-up|1|||
126380958|NCT00566982|454690362|FG000|Overall Study|Other-family problems & doctor's request|0|||
126380959|NCT00566982|454690363|FG001|Overall Study|Other-family problems & doctor's request|2|||
126380960|NCT04245449|454690367|FG000|Overall Study|COVID shutdown|7|||
126380961|NCT02197572|454690372|FG000|Overall Study|Progressive Disease|28|||
126380962|NCT02197572|454690372|FG000|Overall Study|Withdrawal by Subject|9|||
126380963|NCT02197572|454690372|FG000|Overall Study|Adverse Event|3|||
126380964|NCT02197572|454690372|FG000|Overall Study|Reason Not Specified|4|||
126380965|NCT01147393|454690373|FG000|Dose Level 1|Dose limiting Toxicity|2|||
126380966|NCT01147393|454690373|FG000|Dose Level -1|Dose Limited Toxicity|1|||
126380967|NCT01408277|454690377|FG000|Overall Study|Adverse Event|3|||
126380968|NCT01408277|454690378|FG001|Overall Study|Adverse Event|4|||
126380969|NCT01408277|454690377|FG000|Overall Study|Lost to Follow-up|1|||
126380970|NCT01408277|454690378|FG001|Overall Study|Lost to Follow-up|0|||
126380971|NCT01408277|454690377|FG000|Overall Study|Withdrawal by Subject|2|||
126380972|NCT01408277|454690378|FG001|Overall Study|Withdrawal by Subject|0|||
126380973|NCT01408277|454690377|FG000|Overall Study|Protocol Violation|2|||
126380974|NCT01408277|454690378|FG001|Overall Study|Protocol Violation|0|||
126380975|NCT03801928|454690381|FG000|Overall Study|Adverse Event|1|||
126380976|NCT03801928|454690382|FG001|Overall Study|Adverse Event|0|||
126380977|NCT03801928|454690383|FG002|Overall Study|Adverse Event|1|||
126380978|NCT03801928|454690384|FG003|Overall Study|Adverse Event|2|||
126380979|NCT03801928|454690385|FG004|Overall Study|Adverse Event|0|||
126380980|NCT03801928|454690386|FG005|Overall Study|Adverse Event|2|||
126380981|NCT03801928|454690381|FG000|Overall Study|Lack of Efficacy|0|||
126380982|NCT03801928|454690382|FG001|Overall Study|Lack of Efficacy|0|||
126380983|NCT03801928|454690383|FG002|Overall Study|Lack of Efficacy|1|||
126380984|NCT03801928|454690384|FG003|Overall Study|Lack of Efficacy|0|||
126380985|NCT03801928|454690385|FG004|Overall Study|Lack of Efficacy|0|||
126380986|NCT03801928|454690386|FG005|Overall Study|Lack of Efficacy|0|||
126380987|NCT03801928|454690381|FG000|Overall Study|Lost to Follow-up|5|||
126380988|NCT03801928|454690382|FG001|Overall Study|Lost to Follow-up|1|||
126380989|NCT03801928|454690383|FG002|Overall Study|Lost to Follow-up|1|||
126380990|NCT03801928|454690384|FG003|Overall Study|Lost to Follow-up|4|||
126380991|NCT03801928|454690385|FG004|Overall Study|Lost to Follow-up|4|||
126380992|NCT03801928|454690386|FG005|Overall Study|Lost to Follow-up|2|||
126380993|NCT03801928|454690381|FG000|Overall Study|Withdrawal by Subject|0|||
126380994|NCT03801928|454690382|FG001|Overall Study|Withdrawal by Subject|0|||
126380995|NCT03801928|454690383|FG002|Overall Study|Withdrawal by Subject|2|||
126380996|NCT03801928|454690384|FG003|Overall Study|Withdrawal by Subject|1|||
126380997|NCT03801928|454690385|FG004|Overall Study|Withdrawal by Subject|0|||
126380998|NCT03801928|454690386|FG005|Overall Study|Withdrawal by Subject|0|||
126380999|NCT03801928|454690381|FG000|Overall Study|Other|0|||
126381000|NCT03801928|454690382|FG001|Overall Study|Other|2|||
126381001|NCT03801928|454690383|FG002|Overall Study|Other|0|||
126381002|NCT03801928|454690384|FG003|Overall Study|Other|1|||
126381003|NCT03801928|454690385|FG004|Overall Study|Other|0|||
126381004|NCT03801928|454690386|FG005|Overall Study|Other|1|||
126381005|NCT04263766|454690387|FG000|Overall Study|Withdrawal by Subject|6|||
126381006|NCT04263766|454690388|FG001|Overall Study|Withdrawal by Subject|4|||
126381007|NCT04263766|454690387|FG000|Overall Study|Lack of Efficacy|1|||
126381008|NCT04263766|454690388|FG001|Overall Study|Lack of Efficacy|3|||
126381009|NCT00573391|454690390|FG000|Overall Study|study stopped|2|||
126381010|NCT00573391|454690391|FG001|Overall Study|study stopped|2|||
126381011|NCT00573391|454690390|FG000|Overall Study|Death|1|||
126467923|NCT00107783|455015106|FG001|Overall Study|Withdrawal by Subject|0|||
126467924|NCT00107783|455015105|FG000|Overall Study|Second hip replacement|1|||
126381012|NCT00573391|454690391|FG001|Overall Study|Death|0|||
126381013|NCT03369665|454690392|FG000|Overall Study|Adverse Event|3|||
126381014|NCT03369665|454690392|FG000|Overall Study|Lost to Follow-up|7|||
126381015|NCT03369665|454690392|FG000|Overall Study|Withdrawal by Subject|15|||
126381016|NCT03369665|454690392|FG000|Overall Study|Progression Disease|2|||
126381017|NCT03369665|454690392|FG000|Overall Study|Not classified|3|||
126381018|NCT02553928|454690393|FG000|Overall Study|Adverse Event|2|||
126381019|NCT02553928|454690394|FG001|Overall Study|Adverse Event|1|||
126381020|NCT02553928|454690393|FG000|Overall Study|Lost to Follow-up|0|||
126381021|NCT02553928|454690394|FG001|Overall Study|Lost to Follow-up|1|||
126381022|NCT02553928|454690393|FG000|Overall Study|Administrative reason(s)|0|||
126381023|NCT02553928|454690394|FG001|Overall Study|Administrative reason(s)|1|||
126467925|NCT00107783|455015106|FG001|Overall Study|Second hip replacement|1|||
126467926|NCT01886716|455015107|FG000|Week 1|Lost to Follow-up|0|||
126381024|NCT03230318|454690395|FG000|Overall Study|Radiographic disease progression|72|||
126381025|NCT03230318|454690396|FG001|Overall Study|Radiographic disease progression|19|||
126381026|NCT03230318|454690395|FG000|Overall Study|Clinical progression|17|||
126381027|NCT03230318|454690396|FG001|Overall Study|Clinical progression|7|||
126381028|NCT03230318|454690395|FG000|Overall Study|Adverse Event|5|||
126381029|NCT03230318|454690396|FG001|Overall Study|Adverse Event|3|||
126381030|NCT03230318|454690395|FG000|Overall Study|Physician Decision|2|||
126381031|NCT03230318|454690396|FG001|Overall Study|Physician Decision|3|||
126381032|NCT03230318|454690395|FG000|Overall Study|Death|3|||
126381033|NCT03230318|454690396|FG001|Overall Study|Death|2|||
126381034|NCT03230318|454690395|FG000|Overall Study|Lost to Follow-up|1|||
126381035|NCT03230318|454690396|FG001|Overall Study|Lost to Follow-up|0|||
126381036|NCT03230318|454690395|FG000|Overall Study|Withdrawal by Subject|1|||
126381037|NCT03230318|454690396|FG001|Overall Study|Withdrawal by Subject|3|||
126381038|NCT03230318|454690395|FG000|Overall Study|Other|3|||
126381039|NCT03230318|454690396|FG001|Overall Study|Other|7|||
126381040|NCT00075764|454690403|FG000|Overall Study|Adverse Event|5|||
126381041|NCT00075764|454690404|FG001|Overall Study|Adverse Event|12|||
126381042|NCT00075764|454690403|FG000|Overall Study|Death|4|||
126381043|NCT00075764|454690404|FG001|Overall Study|Death|8|||
126381044|NCT00075764|454690403|FG000|Overall Study|Withdrawal by Subject|28|||
126381045|NCT00075764|454690404|FG001|Overall Study|Withdrawal by Subject|18|||
126381046|NCT00075764|454690403|FG000|Overall Study|Progression|269|||
126381047|NCT00075764|454690404|FG001|Overall Study|Progression|274|||
126381048|NCT00075764|454690403|FG000|Overall Study|Still on treatment|8|||
126381049|NCT00075764|454690404|FG001|Overall Study|Still on treatment|15|||
126381050|NCT00075764|454690403|FG000|Overall Study|Delinquent|4|||
126381051|NCT00075764|454690404|FG001|Overall Study|Delinquent|2|||
126381052|NCT00075764|454690403|FG000|Overall Study|Not protocol specified|27|||
126381053|NCT00075764|454690404|FG001|Overall Study|Not protocol specified|19|||
126381054|NCT00075764|454690403|FG000|Overall Study|Under review|0|||
126381055|NCT00075764|454690404|FG001|Overall Study|Under review|1|||
126381056|NCT02817594|454690405|FG000|Overall Study|Withdrawal by Subject|1|||
126381057|NCT02817594|454690405|FG000|Overall Study|Other|1|||
126381058|NCT02817594|454690405|FG000|Overall Study|Did Not Receive Treatment|1|||
126381059|NCT02010593|454690406|FG000|Overall Study|Lost to Follow-up|1|||
126381060|NCT02010593|454690407|FG001|Overall Study|Lost to Follow-up|0|||
126467927|NCT01886716|455015108|FG001|Week 1|Lost to Follow-up|0|||
126467928|NCT01886716|455015109|FG002|Week 1|Lost to Follow-up|2|||
126467929|NCT01886716|455015110|FG003|Week 1|Lost to Follow-up|2|||
126467930|NCT01886716|455015107|FG000|Week 2|Lost to Follow-up|3|||
126467931|NCT01886716|455015108|FG001|Week 2|Lost to Follow-up|2|||
126467932|NCT01886716|455015109|FG002|Week 2|Lost to Follow-up|1|||
126467933|NCT01886716|455015110|FG003|Week 2|Lost to Follow-up|3|||
126467934|NCT01886716|455015107|FG000|Week 3|Lost to Follow-up|1|||
126467935|NCT01886716|455015108|FG001|Week 3|Lost to Follow-up|1|||
126467936|NCT01886716|455015109|FG002|Week 3|Lost to Follow-up|0|||
126467937|NCT01886716|455015110|FG003|Week 3|Lost to Follow-up|1|||
126467938|NCT04879225|455015111|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
126467939|NCT04879225|455015111|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
126467940|NCT02572388|455015114|FG000|Overall Study|Withdrawal by Subject|1|||
126467941|NCT02572388|455015115|FG001|Overall Study|Withdrawal by Subject|1|||
126467942|NCT02572388|455015116|FG002|Overall Study|Withdrawal by Subject|2|||
126467943|NCT02572388|455015117|FG003|Overall Study|Withdrawal by Subject|2|||
126467944|NCT00810108|455015120|FG000|Overall Study|Withdrawal by Subject|1|||
126467945|NCT00810108|455015121|FG001|Overall Study|Withdrawal by Subject|0|||
126467946|NCT02231918|455015123|FG000|Overall Study|Withdrawal by Subject|0|||
126467947|NCT02231918|455015124|FG001|Overall Study|Withdrawal by Subject|1|||
126467948|NCT02231918|455015125|FG002|Overall Study|Withdrawal by Subject|0|||
126381061|NCT02010593|454690406|FG000|Overall Study|Physician Decision|1|||
126381062|NCT02010593|454690407|FG001|Overall Study|Physician Decision|0|||
126381063|NCT02010593|454690406|FG000|Overall Study|Unable to adhere to visit schedule|0|||
126381064|NCT02010593|454690407|FG001|Overall Study|Unable to adhere to visit schedule|2|||
126467949|NCT02231918|455015123|FG000|Overall Study|Adverse Event|0|||
126381065|NCT01773967|454690408|FG000|Overall Study|Lost to Follow-up|15|||
126381066|NCT01773967|454690409|FG001|Overall Study|Lost to Follow-up|13|||
126381067|NCT01135459|454690410|FG000|Overall Study|Adverse Event|8|||
126381068|NCT01135459|454690411|FG001|Overall Study|Adverse Event|10|||
126381069|NCT01135459|454690410|FG000|Overall Study|Lack of Efficacy|3|||
126381070|NCT01135459|454690411|FG001|Overall Study|Lack of Efficacy|1|||
126381071|NCT01135459|454690410|FG000|Overall Study|Withdrawal by Subject|2|||
126381072|NCT01135459|454690411|FG001|Overall Study|Withdrawal by Subject|3|||
126381073|NCT01135459|454690410|FG000|Overall Study|Protocol Violation|5|||
126381074|NCT01135459|454690411|FG001|Overall Study|Protocol Violation|3|||
126381075|NCT01135459|454690410|FG000|Overall Study|Lost to Follow-up|2|||
126467950|NCT02231918|455015124|FG001|Overall Study|Adverse Event|0|||
126467951|NCT02231918|455015125|FG002|Overall Study|Adverse Event|1|||
126467952|NCT00331864|455015131|FG000|Overall Study|Adverse Event|30|||
126467953|NCT00331864|455015132|FG001|Overall Study|Adverse Event|1|||
126467954|NCT00331864|455015131|FG000|Overall Study|Lack of Efficacy|4|||
126381076|NCT01135459|454690411|FG001|Overall Study|Lost to Follow-up|1|||
126381077|NCT01135459|454690410|FG000|Overall Study|Non-compliance to study procedures|0|||
126381078|NCT01135459|454690411|FG001|Overall Study|Non-compliance to study procedures|1|||
126381079|NCT01135459|454690410|FG000|Overall Study|Other than specified|1|||
126381080|NCT01135459|454690411|FG001|Overall Study|Other than specified|1|||
126381081|NCT01766037|454690412|FG000|Overall Study|Adverse Event|1|||
126381082|NCT01766037|454690413|FG001|Overall Study|Adverse Event|0|||
126381083|NCT01766037|454690412|FG000|Overall Study|Lack of Efficacy|1|||
126381084|NCT01766037|454690413|FG001|Overall Study|Lack of Efficacy|0|||
126381085|NCT01766037|454690412|FG000|Overall Study|Lost to Follow-up|0|||
126381086|NCT01766037|454690413|FG001|Overall Study|Lost to Follow-up|10|||
126381087|NCT01766037|454690412|FG000|Overall Study|Physician Decision|0|||
126381088|NCT01766037|454690413|FG001|Overall Study|Physician Decision|1|||
126381089|NCT01766037|454690412|FG000|Overall Study|Withdrawal by Subject|18|||
126381090|NCT01766037|454690413|FG001|Overall Study|Withdrawal by Subject|16|||
126381091|NCT01766037|454690412|FG000|Overall Study|Moved from area|5|||
126381092|NCT01766037|454690413|FG001|Overall Study|Moved from area|0|||
126381093|NCT01766037|454690412|FG000|Overall Study|medical - unrelated|1|||
126381094|NCT01766037|454690413|FG001|Overall Study|medical - unrelated|2|||
126381095|NCT01766037|454690412|FG000|Overall Study|nausea / discomfort|3|||
126381096|NCT01766037|454690413|FG001|Overall Study|nausea / discomfort|0|||
126381097|NCT02413996|454690414|FG000|Overall Study|not comfortable with the intervention|9|||
126381098|NCT02413996|454690415|FG001|Overall Study|not comfortable with the intervention|2|||
126381099|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
126381100|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
126381101|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
126381102|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
126381103|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
126381104|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
126381105|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
126381106|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
126381107|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
126381108|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
126381109|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
126381110|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
126381111|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
126381112|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
126381113|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
126381114|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
126381115|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
126381116|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
126381117|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
126381118|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
126381119|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
126381120|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
126381121|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
126381122|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
126381123|NCT01672879|454690417|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
126381124|NCT01672879|454690418|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
126381125|NCT01672879|454690419|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
126381126|NCT01672879|454690417|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
126381127|NCT01672879|454690418|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
126717098|NCT03161678|455915029|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
126381128|NCT01672879|454690419|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
126381129|NCT01672879|454690417|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
126381130|NCT01672879|454690418|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
126381131|NCT01672879|454690419|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
126381132|NCT01672879|454690417|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
126381133|NCT01672879|454690418|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
126381134|NCT01672879|454690419|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
126381135|NCT01672879|454690417|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
126381136|NCT01672879|454690418|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
126381137|NCT01672879|454690419|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
126381138|NCT01871545|454690420|FG000|Overall Study|Death|2|||
126381139|NCT01871545|454690421|FG001|Overall Study|Death|0|||
126381140|NCT01871545|454690420|FG000|Overall Study|Lack of Efficacy|11|||
126381141|NCT01871545|454690421|FG001|Overall Study|Lack of Efficacy|2|||
126381142|NCT01871545|454690420|FG000|Overall Study|Physician Decision|4|||
126381143|NCT01871545|454690421|FG001|Overall Study|Physician Decision|0|||
126381144|NCT01871545|454690420|FG000|Overall Study|Withdrawal by Subject|0|||
126381145|NCT01871545|454690421|FG001|Overall Study|Withdrawal by Subject|1|||
126381146|NCT04834726|454690424|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
126381147|NCT04834726|454690425|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
126381148|NCT04834726|454690426|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
126381149|NCT04834726|454690427|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
126381150|NCT04834726|454690428|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
126381151|NCT04834726|454690429|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
126381152|NCT04834726|454690430|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
126381153|NCT04834726|454690431|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
126381154|NCT04834726|454690432|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
126381155|NCT03810014|454690436|FG000|Overall Study|Pregnancy|2|||
126381156|NCT03810014|454690437|FG001|Overall Study|Pregnancy|2|||
126381157|NCT03810014|454690438|FG002|Overall Study|Pregnancy|0|||
126381158|NCT03810014|454690439|FG003|Overall Study|Pregnancy|2|||
126381159|NCT03606486|454690440|FG000|Overall Study|Unable to collect sample|5|||
126381160|NCT01853462|454690441|FG000|Overall Study|Withdrawal by Subject|1|||
126381161|NCT01853462|454690442|FG001|Overall Study|Withdrawal by Subject|1|||
126381162|NCT02148263|454690443|FG000|Overall Study|Withdrawal by Subject|3|||
126381163|NCT02148263|454690444|FG001|Overall Study|Withdrawal by Subject|2|||
126381164|NCT00132301|454690445|FG000|Overall Study|Death|7|||
126381165|NCT00132301|454690446|FG001|Overall Study|Death|6|||
126381166|NCT00132301|454690445|FG000|Overall Study|Withdrawal by Subject|5|||
126467955|NCT00331864|455015132|FG001|Overall Study|Lack of Efficacy|0|||
126467956|NCT00331864|455015131|FG000|Overall Study|Protocol Violation|3|||
126467957|NCT00331864|455015132|FG001|Overall Study|Protocol Violation|0|||
126467958|NCT00331864|455015131|FG000|Overall Study|Withdrawal by Subject|10|||
126467959|NCT00331864|455015132|FG001|Overall Study|Withdrawal by Subject|0|||
126467960|NCT00331864|455015131|FG000|Overall Study|Lost to Follow-up|4|||
126467961|NCT00331864|455015132|FG001|Overall Study|Lost to Follow-up|3|||
126467962|NCT00331864|455015131|FG000|Overall Study|Administrative Problems|1|||
126467963|NCT00331864|455015132|FG001|Overall Study|Administrative Problems|0|||
126467964|NCT00331864|455015131|FG000|Overall Study|Death|6|||
126467965|NCT00331864|455015132|FG001|Overall Study|Death|0|||
126467966|NCT00137631|455015133|FG000|Overall Study|Lost to Follow-up|37|||
126467967|NCT00137631|455015134|FG001|Overall Study|Lost to Follow-up|41|||
126467968|NCT01092507|455015135|FG000|Overall Study|Withdrawal by Subject|2|||
126467969|NCT01092507|455015136|FG001|Overall Study|Withdrawal by Subject|0|||
126467970|NCT02486302|455015138|FG000|Overall Study|Discontinued prematurely|410|||
126467971|NCT02486302|455015138|FG000|Overall Study|Documentation not completed|255|||
126467972|NCT02486302|455015138|FG000|Overall Study|Excluded due to legal reasons|8|||
126467973|NCT02486302|455015138|FG000|Overall Study|Not treated|3|||
126467974|NCT01871142|455015139|FG000|Overall Study|Adverse Event|1|||
126467975|NCT01539642|455015145|FG000|Overall Study|Lack of Efficacy|20|||
126467976|NCT01539642|455015146|FG001|Overall Study|Lack of Efficacy|18|||
126467977|NCT01539642|455015145|FG000|Overall Study|Patient ready for early discharge|8|||
126467978|NCT01539642|455015146|FG001|Overall Study|Patient ready for early discharge|7|||
126467979|NCT01539642|455015145|FG000|Overall Study|Adverse Event|6|||
126467980|NCT01539642|455015146|FG001|Overall Study|Adverse Event|4|||
126467981|NCT01539642|455015145|FG000|Overall Study|Withdrawal by Subject|2|||
126467982|NCT01539642|455015146|FG001|Overall Study|Withdrawal by Subject|2|||
126467983|NCT03611010|455015147|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
126467984|NCT03611010|455015148|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
126467985|NCT03611010|455015149|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
126467986|NCT03611010|455015150|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
126467987|NCT00598702|455015151|FG000|Overall Study|Other|0|||
126467988|NCT00598702|455015152|FG001|Overall Study|Other|2|||
126467989|NCT00598702|455015153|FG002|Overall Study|Other|0|||
126553301|NCT03230864|455320557|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
126553302|NCT03230864|455320558|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
126717099|NCT03161678|455915030|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
126717100|NCT03161678|455915031|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
126717101|NCT03161678|455915026|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
126717102|NCT03161678|455915027|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
126717103|NCT03161678|455915028|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
126381167|NCT00132301|454690446|FG001|Overall Study|Withdrawal by Subject|2|||
126381168|NCT00132301|454690445|FG000|Overall Study|Physician Decision|1|||
126381169|NCT00132301|454690446|FG001|Overall Study|Physician Decision|1|||
126381170|NCT00132301|454690445|FG000|Overall Study|Lost to Follow-up|5|||
126381171|NCT00132301|454690446|FG001|Overall Study|Lost to Follow-up|3|||
126381172|NCT00132301|454690445|FG000|Overall Study|Other|1|||
126467990|NCT00598702|455015154|FG003|Overall Study|Other|0|||
126467991|NCT00598702|455015155|FG004|Overall Study|Other|0|||
126467992|NCT00598702|455015156|FG005|Overall Study|Other|1|||
126467993|NCT00598702|455015157|FG006|Overall Study|Other|0|||
126467994|NCT00598702|455015158|FG007|Overall Study|Other|0|||
126467995|NCT00598702|455015151|FG000|Overall Study|Early discharge from hospital|0|||
126381173|NCT00132301|454690446|FG001|Overall Study|Other|1|||
126381174|NCT00132301|454690445|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
126381175|NCT00132301|454690446|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
126381176|NCT02012218|454690447|FG000|Overall Study|Withdrawal by Subject|1|||
126381177|NCT02012218|454690448|FG001|Overall Study|Withdrawal by Subject|0|||
126381178|NCT02012218|454690449|FG002|Overall Study|Withdrawal by Subject|1|||
126381179|NCT02012218|454690450|FG003|Overall Study|Withdrawal by Subject|1|||
126381180|NCT02012218|454690451|FG004|Overall Study|Withdrawal by Subject|1|||
126381181|NCT02012218|454690447|FG000|Overall Study|Adverse Event|1|||
126381182|NCT02012218|454690448|FG001|Overall Study|Adverse Event|0|||
126381183|NCT02012218|454690449|FG002|Overall Study|Adverse Event|0|||
126381184|NCT02012218|454690450|FG003|Overall Study|Adverse Event|1|||
126381185|NCT02012218|454690451|FG004|Overall Study|Adverse Event|0|||
126381186|NCT02012218|454690447|FG000|Overall Study|Lost to Follow-up|0|||
126381187|NCT02012218|454690448|FG001|Overall Study|Lost to Follow-up|1|||
126381188|NCT02012218|454690449|FG002|Overall Study|Lost to Follow-up|1|||
126381189|NCT02012218|454690450|FG003|Overall Study|Lost to Follow-up|0|||
126381190|NCT02012218|454690451|FG004|Overall Study|Lost to Follow-up|0|||
126381191|NCT02012218|454690447|FG000|Overall Study|Protocol Specified|1|||
126381192|NCT02012218|454690448|FG001|Overall Study|Protocol Specified|0|||
126381193|NCT02012218|454690449|FG002|Overall Study|Protocol Specified|0|||
126381194|NCT02012218|454690450|FG003|Overall Study|Protocol Specified|0|||
126381195|NCT02012218|454690451|FG004|Overall Study|Protocol Specified|0|||
126381196|NCT02012218|454690447|FG000|Overall Study|Protocol Deviation|1|||
126381197|NCT02012218|454690448|FG001|Overall Study|Protocol Deviation|0|||
126381198|NCT02012218|454690449|FG002|Overall Study|Protocol Deviation|0|||
126381199|NCT02012218|454690450|FG003|Overall Study|Protocol Deviation|0|||
126381200|NCT02012218|454690451|FG004|Overall Study|Protocol Deviation|0|||
126381201|NCT02720523|454690457|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
126381202|NCT02720523|454690458|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
126381203|NCT02720523|454690459|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
126381204|NCT02720523|454690460|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
126381205|NCT02720523|454690461|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
126381206|NCT02720523|454690462|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
126381207|NCT02720523|454690463|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
126381208|NCT02720523|454690457|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
126381209|NCT02720523|454690458|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126381210|NCT02720523|454690459|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126381211|NCT02720523|454690460|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126381212|NCT02720523|454690461|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126381213|NCT02720523|454690462|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126381214|NCT02720523|454690463|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
126381215|NCT02720523|454690457|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
126381216|NCT02720523|454690458|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
126381217|NCT02720523|454690459|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
126381218|NCT02720523|454690460|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
126381219|NCT02720523|454690461|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
126381220|NCT02720523|454690462|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
126381221|NCT02720523|454690463|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
126381222|NCT02720523|454690457|FG000|Period 1: Placebo-controlled Period|Other|0|||
126381223|NCT02720523|454690458|FG001|Period 1: Placebo-controlled Period|Other|0|||
126381224|NCT02720523|454690459|FG002|Period 1: Placebo-controlled Period|Other|1|||
126381225|NCT02720523|454690460|FG003|Period 1: Placebo-controlled Period|Other|1|||
126381226|NCT02720523|454690461|FG004|Period 1: Placebo-controlled Period|Other|0|||
126381227|NCT02720523|454690462|FG005|Period 1: Placebo-controlled Period|Other|0|||
126381228|NCT02720523|454690463|FG006|Period 1: Placebo-controlled Period|Other|0|||
126381229|NCT02720523|454690457|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
126381230|NCT02720523|454690458|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
126381231|NCT02720523|454690459|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
126381232|NCT02720523|454690460|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
126381233|NCT02720523|454690461|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
126381234|NCT02720523|454690462|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
126381235|NCT02720523|454690463|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
126381236|NCT02720523|454690457|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
126381237|NCT02720523|454690458|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
126381238|NCT02720523|454690459|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
126381239|NCT02720523|454690460|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
126381240|NCT02720523|454690461|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
126381241|NCT02720523|454690462|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
126381242|NCT02720523|454690463|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
126381243|NCT02720523|454690457|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
126381244|NCT02720523|454690458|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
126381245|NCT02720523|454690459|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
126381246|NCT02720523|454690460|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
126381247|NCT02720523|454690461|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
126381248|NCT02720523|454690462|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
126381249|NCT02720523|454690463|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
126381250|NCT02720523|454690457|FG000|Period 2: Long-term Extension Period|Other|0|||
126381251|NCT02720523|454690458|FG001|Period 2: Long-term Extension Period|Other|0|||
126381252|NCT02720523|454690459|FG002|Period 2: Long-term Extension Period|Other|0|||
126381253|NCT02720523|454690460|FG003|Period 2: Long-term Extension Period|Other|0|||
126381254|NCT02720523|454690461|FG004|Period 2: Long-term Extension Period|Other|2|||
126381255|NCT02720523|454690462|FG005|Period 2: Long-term Extension Period|Other|0|||
126381256|NCT02720523|454690463|FG006|Period 2: Long-term Extension Period|Other|3|||
126467996|NCT00598702|455015152|FG001|Overall Study|Early discharge from hospital|0|||
126467997|NCT00598702|455015153|FG002|Overall Study|Early discharge from hospital|2|||
126467998|NCT00598702|455015154|FG003|Overall Study|Early discharge from hospital|5|||
126467999|NCT00598702|455015155|FG004|Overall Study|Early discharge from hospital|0|||
126468000|NCT00598702|455015156|FG005|Overall Study|Early discharge from hospital|10|||
126468001|NCT00598702|455015157|FG006|Overall Study|Early discharge from hospital|1|||
126468002|NCT00598702|455015158|FG007|Overall Study|Early discharge from hospital|0|||
126468003|NCT00598702|455015151|FG000|Overall Study|Adverse Event|0|||
126468004|NCT00598702|455015152|FG001|Overall Study|Adverse Event|0|||
126468005|NCT00598702|455015153|FG002|Overall Study|Adverse Event|0|||
126468006|NCT00598702|455015154|FG003|Overall Study|Adverse Event|1|||
126468007|NCT00598702|455015155|FG004|Overall Study|Adverse Event|0|||
126468008|NCT00598702|455015156|FG005|Overall Study|Adverse Event|0|||
126468009|NCT00598702|455015157|FG006|Overall Study|Adverse Event|0|||
126468010|NCT00598702|455015158|FG007|Overall Study|Adverse Event|0|||
126468011|NCT00598702|455015151|FG000|Overall Study|Withdrawal by Subject|0|||
126468012|NCT00598702|455015152|FG001|Overall Study|Withdrawal by Subject|0|||
126468013|NCT00598702|455015153|FG002|Overall Study|Withdrawal by Subject|0|||
126468014|NCT00598702|455015154|FG003|Overall Study|Withdrawal by Subject|1|||
126468015|NCT00598702|455015155|FG004|Overall Study|Withdrawal by Subject|1|||
126468016|NCT00598702|455015156|FG005|Overall Study|Withdrawal by Subject|0|||
126468017|NCT00598702|455015157|FG006|Overall Study|Withdrawal by Subject|0|||
126468018|NCT00598702|455015158|FG007|Overall Study|Withdrawal by Subject|0|||
126468019|NCT00598702|455015151|FG000|Overall Study|Physician Decision|0|||
126468020|NCT00598702|455015152|FG001|Overall Study|Physician Decision|0|||
126468021|NCT00598702|455015153|FG002|Overall Study|Physician Decision|0|||
126468022|NCT00598702|455015154|FG003|Overall Study|Physician Decision|0|||
126468023|NCT00598702|455015155|FG004|Overall Study|Physician Decision|1|||
126468024|NCT00598702|455015156|FG005|Overall Study|Physician Decision|0|||
126468025|NCT00598702|455015157|FG006|Overall Study|Physician Decision|0|||
126468026|NCT00598702|455015158|FG007|Overall Study|Physician Decision|0|||
126468027|NCT00598702|455015151|FG000|Overall Study|Dose limiting toxicity|0|||
126468028|NCT00598702|455015152|FG001|Overall Study|Dose limiting toxicity|0|||
126468029|NCT00598702|455015153|FG002|Overall Study|Dose limiting toxicity|0|||
126468030|NCT00598702|455015154|FG003|Overall Study|Dose limiting toxicity|1|||
126468031|NCT00598702|455015155|FG004|Overall Study|Dose limiting toxicity|1|||
126468032|NCT00598702|455015156|FG005|Overall Study|Dose limiting toxicity|1|||
126468033|NCT00598702|455015157|FG006|Overall Study|Dose limiting toxicity|0|||
126468034|NCT00598702|455015158|FG007|Overall Study|Dose limiting toxicity|0|||
126468035|NCT01859143|455015161|FG000|Overall Study|Lost to Follow-up|2|||
126468036|NCT01859143|455015162|FG001|Overall Study|Lost to Follow-up|0|||
126468037|NCT02413372|455015166|FG000|Treatment|Lost to Follow-up|0|||
126468038|NCT02413372|455015167|FG001|Treatment|Lost to Follow-up|2|||
126468039|NCT02413372|455015168|FG002|Treatment|Lost to Follow-up|1|||
126468040|NCT02413372|455015166|FG000|Treatment|Withdrawal by Subject|1|||
126468041|NCT02413372|455015167|FG001|Treatment|Withdrawal by Subject|0|||
126468042|NCT02413372|455015168|FG002|Treatment|Withdrawal by Subject|0|||
126381257|NCT03929913|454690467|FG000|Overall Study|Death|4|||
126381258|NCT03929913|454690467|FG000|Overall Study|Lost to Follow-up|1|||
126468043|NCT02413372|455015166|FG000|Follow-up|Lost to Follow-up|1|||
126468044|NCT02413372|455015167|FG001|Follow-up|Lost to Follow-up|1|||
126468045|NCT02413372|455015168|FG002|Follow-up|Lost to Follow-up|0|||
126468046|NCT02413372|455015166|FG000|Follow-up|Subject Withdrew Consent|1|||
126468047|NCT02413372|455015167|FG001|Follow-up|Subject Withdrew Consent|0|||
126468048|NCT02413372|455015168|FG002|Follow-up|Subject Withdrew Consent|1|||
126468049|NCT02413372|455015166|FG000|Follow-up|Subject unable to return for visit|0|||
126468050|NCT02413372|455015167|FG001|Follow-up|Subject unable to return for visit|0|||
126468051|NCT02413372|455015168|FG002|Follow-up|Subject unable to return for visit|1|||
126468052|NCT02943460|455015169|FG000|Blinded Study Phase|Adverse Event|3|||
126468053|NCT02943460|455015170|FG001|Blinded Study Phase|Adverse Event|0|||
126468054|NCT02943460|455015171|FG002|Blinded Study Phase|Adverse Event|0|||
126468055|NCT02943460|455015169|FG000|Blinded Study Phase|Withdrew Consent|0|||
126468056|NCT02943460|455015170|FG001|Blinded Study Phase|Withdrew Consent|1|||
126468057|NCT02943460|455015171|FG002|Blinded Study Phase|Withdrew Consent|0|||
126468058|NCT02943460|455015169|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
126468059|NCT02943460|455015170|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
126468060|NCT02943460|455015171|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
126468061|NCT02943460|455015169|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
126468062|NCT02943460|455015170|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
126468063|NCT02943460|455015171|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
126468064|NCT02943460|455015169|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
126468065|NCT02943460|455015170|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
126468066|NCT02943460|455015171|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
126468067|NCT01368432|455015174|FG000|Overall Study|Lost to Follow-up|0|||
126468068|NCT01368432|455015175|FG001|Overall Study|Lost to Follow-up|1|||
126381259|NCT03929913|454690467|FG000|Overall Study|Failed Procedure|2|||
126381260|NCT01154452|454690468|FG000|Phase Ib|Not Treated|1|||
126381261|NCT01154452|454690469|FG001|Phase Ib|Not Treated|0|||
126381262|NCT01154452|454690470|FG002|Phase Ib|Not Treated|0|||
126381263|NCT01154452|454690471|FG003|Phase Ib|Not Treated|0|||
126381264|NCT01154452|454690468|FG000|Phase Ib|Adverse Event|2|||
126381265|NCT01154452|454690469|FG001|Phase Ib|Adverse Event|1|||
126381266|NCT01154452|454690470|FG002|Phase Ib|Adverse Event|0|||
126381267|NCT01154452|454690471|FG003|Phase Ib|Adverse Event|0|||
126381268|NCT01154452|454690468|FG000|Phase II|Withdrawal by Subject|0|||
126381269|NCT01154452|454690469|FG001|Phase II|Withdrawal by Subject|0|||
126381270|NCT01154452|454690470|FG002|Phase II|Withdrawal by Subject|1|||
126381271|NCT01154452|454690471|FG003|Phase II|Withdrawal by Subject|2|||
126381272|NCT01154452|454690468|FG000|Phase II|Adverse Event|0|||
126381273|NCT01154452|454690469|FG001|Phase II|Adverse Event|0|||
126381274|NCT01154452|454690470|FG002|Phase II|Adverse Event|4|||
126381275|NCT01154452|454690471|FG003|Phase II|Adverse Event|4|||
126381276|NCT03381287|454690472|FG000|Overall Study|Withdrawal by Subject|0|||
126381277|NCT03381287|454690473|FG001|Overall Study|Withdrawal by Subject|1|||
126381278|NCT03381287|454690474|FG002|Overall Study|Withdrawal by Subject|0|||
126381279|NCT03381287|454690475|FG003|Overall Study|Withdrawal by Subject|0|||
126381280|NCT03381287|454690472|FG000|Overall Study|Adverse Event|0|||
126381281|NCT03381287|454690473|FG001|Overall Study|Adverse Event|0|||
126381282|NCT03381287|454690474|FG002|Overall Study|Adverse Event|0|||
126381283|NCT03381287|454690475|FG003|Overall Study|Adverse Event|1|||
126381284|NCT03381287|454690472|FG000|Overall Study|Physician Decision|0|||
126381285|NCT03381287|454690473|FG001|Overall Study|Physician Decision|0|||
126381286|NCT03381287|454690474|FG002|Overall Study|Physician Decision|0|||
126381287|NCT03381287|454690475|FG003|Overall Study|Physician Decision|1|||
126381288|NCT01265992|454690478|FG000|Overall Study|Lost to Follow-up|1|||
126381289|NCT01265992|454690478|FG000|Overall Study|Withdrawal by Subject|1|||
126381290|NCT01265992|454690478|FG000|Overall Study|Adverse Event|1|||
126381291|NCT01265992|454690478|FG000|Overall Study|Administrative reasons|2|||
126381292|NCT01265992|454690478|FG000|Overall Study|Stopped treatment|3|||
126381293|NCT01265992|454690478|FG000|Overall Study|Did not receive treatment|1|||
126381294|NCT01837680|454690479|FG000|Overall Study|Lost to Follow-up|2|||
126381295|NCT01837680|454690480|FG001|Overall Study|Lost to Follow-up|2|||
126381296|NCT01837680|454690479|FG000|Overall Study|lack of insurance|0|||
126381297|NCT01837680|454690480|FG001|Overall Study|lack of insurance|2|||
126381298|NCT01837680|454690479|FG000|Overall Study|allergic reaction|6|||
126381299|NCT01837680|454690480|FG001|Overall Study|allergic reaction|0|||
126381300|NCT01837680|454690479|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
126381301|NCT01837680|454690480|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
126381302|NCT00473889|454691784|FG000|Overall Study|Did not receive study medication|1|||
126381303|NCT00473889|454691785|FG001|Overall Study|Did not receive study medication|4|||
126381304|NCT00473889|454691784|FG000|Overall Study|Adverse Event|30|||
126381305|NCT00473889|454691785|FG001|Overall Study|Adverse Event|17|||
126381306|NCT00473889|454691784|FG000|Overall Study|Protocol Violation|4|||
126381307|NCT00473889|454691785|FG001|Overall Study|Protocol Violation|2|||
126381308|NCT00473889|454691784|FG000|Overall Study|Lack of Efficacy|28|||
126468069|NCT00437320|455015176|FG000|Overall Study|Participant request|2|||
126468070|NCT00437320|455015177|FG001|Overall Study|Participant request|1|||
126468071|NCT00437320|455015178|FG002|Overall Study|Participant request|4|||
126381309|NCT00473889|454691785|FG001|Overall Study|Lack of Efficacy|29|||
126381310|NCT00473889|454691784|FG000|Overall Study|Lost to Follow-up|2|||
126381311|NCT00473889|454691785|FG001|Overall Study|Lost to Follow-up|1|||
126381312|NCT00473889|454691784|FG000|Overall Study|Physician Decision|10|||
126468072|NCT03845543|455015182|FG000|Overall Study|Death|25|||
126381313|NCT00473889|454691785|FG001|Overall Study|Physician Decision|5|||
126381314|NCT00473889|454691784|FG000|Overall Study|Trial Terminated|3|||
126381315|NCT00473889|454691785|FG001|Overall Study|Trial Terminated|6|||
126381316|NCT00473889|454691784|FG000|Overall Study|Withdrawal by Subject|5|||
126381317|NCT00473889|454691785|FG001|Overall Study|Withdrawal by Subject|0|||
126381318|NCT02840253|454691786|FG000|Overall Study|Unsuccessful block|4|||
126381319|NCT03783962|454691787|FG000|Overall Study|Lost to Follow-up|3|||
126381320|NCT03783962|454691788|FG001|Overall Study|Lost to Follow-up|6|||
126381321|NCT03783962|454691787|FG000|Overall Study|Protocol Violation|0|||
126381322|NCT03783962|454691788|FG001|Overall Study|Protocol Violation|1|||
126381323|NCT03458325|454691789|FG000|Overall Study|Withdrawal by Subject|1|||
126381324|NCT01724216|454691798|FG000|Overall Study|Scan was not completed|1|||
126381325|NCT00175916|454691799|FG000|Overall Study|Death|19|||
126381326|NCT00175916|454691799|FG000|Overall Study|Adverse Event|81|||
126381327|NCT00175916|454691799|FG000|Overall Study|Lack of Efficacy|354|||
126381328|NCT00175916|454691799|FG000|Overall Study|Lost to Follow-up|17|||
126381329|NCT00175916|454691799|FG000|Overall Study|Subject Choice|98|||
126381330|NCT00175916|454691799|FG000|Overall Study|Lack of compliance|8|||
126381331|NCT00175916|454691799|FG000|Overall Study|Patient cannot record seizures|1|||
126381332|NCT00175916|454691799|FG000|Overall Study|Sponsor decision|17|||
126381333|NCT00175916|454691799|FG000|Overall Study|Vigabatrin intake|1|||
126381334|NCT00175916|454691799|FG000|Overall Study|Suicidal behaviour|1|||
126381335|NCT00175916|454691799|FG000|Overall Study|Withdrawal by Subject|1|||
126381336|NCT00175916|454691799|FG000|Overall Study|Seizure - free|4|||
126381337|NCT00175916|454691799|FG000|Overall Study|Administrative reason|1|||
126381338|NCT00175916|454691799|FG000|Overall Study|Pregnancy|1|||
126381339|NCT00175916|454691799|FG000|Overall Study|Patient's request|2|||
126381340|NCT00175916|454691799|FG000|Overall Study|Treating physiciant's choice|1|||
126381341|NCT00175916|454691799|FG000|Overall Study|Moved overseas|1|||
126381342|NCT00175916|454691799|FG000|Overall Study|Loss of job and economic burden|1|||
126381343|NCT00175916|454691799|FG000|Overall Study|Site was closed|9|||
126381344|NCT00175916|454691799|FG000|Overall Study|Patient went to prison|1|||
126717104|NCT03161678|455915029|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
126771148|NCT03454672|456116284|FG000|Overall Study|painful|1|||
126381345|NCT00564733|454691800|FG000|Overall Study|Withdrawal by Subject|4|||
126381346|NCT00564733|454691800|FG000|Overall Study|Ineligible|5|||
126381347|NCT01014767|454691801|FG000|Overall Study|PI left institution, data unavailable|12|||
126381348|NCT01014767|454691802|FG001|Overall Study|PI left institution, data unavailable|1|||
126381349|NCT01014767|454691803|FG002|Overall Study|PI left institution, data unavailable|4|||
126381350|NCT01014767|454691804|FG003|Overall Study|PI left institution, data unavailable|1|||
126381351|NCT00310375|454691809|FG000|Primary Reporting Phase|Adverse Event|28|||
126381352|NCT00310375|454691810|FG001|Primary Reporting Phase|Adverse Event|22|||
126381353|NCT00310375|454691811|FG002|Primary Reporting Phase|Adverse Event|0|||
126381354|NCT00310375|454691809|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
126381355|NCT00310375|454691810|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
126381356|NCT00310375|454691811|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
126381357|NCT00310375|454691809|FG000|Primary Reporting Phase|Pregnancy|2|||
126381358|NCT00310375|454691810|FG001|Primary Reporting Phase|Pregnancy|2|||
126381359|NCT00310375|454691811|FG002|Primary Reporting Phase|Pregnancy|0|||
126381360|NCT00310375|454691809|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
126381361|NCT00310375|454691810|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
126381362|NCT00310375|454691811|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
126381363|NCT00310375|454691809|FG000|Primary Reporting Phase|Protocol Violation|8|||
126381364|NCT00310375|454691810|FG001|Primary Reporting Phase|Protocol Violation|5|||
126381365|NCT00310375|454691811|FG002|Primary Reporting Phase|Protocol Violation|0|||
126381366|NCT00310375|454691809|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
126381367|NCT00310375|454691810|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
126381368|NCT00310375|454691811|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
126381369|NCT00310375|454691809|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
126381370|NCT00310375|454691810|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
126381371|NCT00310375|454691811|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
126381372|NCT00310375|454691809|FG000|Primary Reporting Phase|Physician Decision|5|||
126381373|NCT00310375|454691810|FG001|Primary Reporting Phase|Physician Decision|3|||
126381374|NCT00310375|454691811|FG002|Primary Reporting Phase|Physician Decision|0|||
126381375|NCT00310375|454691809|FG000|Primary Reporting Phase|Request of the sponsor|2|||
126381376|NCT00310375|454691810|FG001|Primary Reporting Phase|Request of the sponsor|2|||
126381377|NCT00310375|454691811|FG002|Primary Reporting Phase|Request of the sponsor|0|||
126381378|NCT00310375|454691809|FG000|Primary Reporting Phase|Failed to return|1|||
126381379|NCT00310375|454691810|FG001|Primary Reporting Phase|Failed to return|3|||
126381380|NCT00310375|454691811|FG002|Primary Reporting Phase|Failed to return|0|||
126381381|NCT00310375|454691809|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
126381382|NCT00310375|454691810|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
126381383|NCT00310375|454691811|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
126381384|NCT00310375|454691809|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
126381385|NCT00310375|454691810|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
126381386|NCT00310375|454691811|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
126381387|NCT00310375|454691809|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
126381388|NCT00310375|454691810|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
126381389|NCT00310375|454691811|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
126381390|NCT00310375|454691809|FG000|Primary Reporting Phase|Site closure|3|||
126381391|NCT00310375|454691810|FG001|Primary Reporting Phase|Site closure|0|||
126381392|NCT00310375|454691811|FG002|Primary Reporting Phase|Site closure|0|||
126717105|NCT03161678|455915030|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
126381393|NCT00310375|454691809|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
126381394|NCT00310375|454691810|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
126381395|NCT00310375|454691811|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
126381396|NCT00310375|454691809|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
126381397|NCT00310375|454691810|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
126381398|NCT00310375|454691811|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
126381399|NCT00310375|454691809|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
126717106|NCT03161678|455915031|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
126717107|NCT00739297|455915032|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
126717108|NCT00739297|455915033|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
126717109|NCT00739297|455915034|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
126717110|NCT00739297|455915035|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
126717111|NCT00739297|455915036|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
126717112|NCT00739297|455915037|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
126717113|NCT00739297|455915038|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
126717114|NCT00739297|455915032|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
126717115|NCT00739297|455915033|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
126717116|NCT00739297|455915034|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
126717117|NCT00739297|455915035|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
126717118|NCT00739297|455915036|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
126717119|NCT00739297|455915037|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
126717120|NCT00739297|455915038|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
126717121|NCT01757704|455915039|FG000|Overall Study|Protocol Violation|1|||
126717122|NCT01757704|455915040|FG001|Overall Study|Protocol Violation|3|||
126717123|NCT02749721|455915046|FG000|Screening|Withdrawal by Subject|1|||
126717124|NCT02749721|455915046|FG000|Screening|Lost to Follow-up|2|||
126717125|NCT02749721|455915046|FG000|Screening|Protocol Violation|3|||
126717126|NCT02749721|455915046|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
126717127|NCT02749721|455915046|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
126717128|NCT02137772|455915047|FG000|Overall Study|Adverse Event|6|||
126717129|NCT02137772|455915048|FG001|Overall Study|Adverse Event|3|||
126717130|NCT02137772|455915047|FG000|Overall Study|Death|71|||
126717131|NCT02137772|455915048|FG001|Overall Study|Death|44|||
126717132|NCT02137772|455915047|FG000|Overall Study|Lost to Follow-up|8|||
126717133|NCT02137772|455915048|FG001|Overall Study|Lost to Follow-up|4|||
126717134|NCT02137772|455915047|FG000|Overall Study|Physician Decision|15|||
126717135|NCT02137772|455915048|FG001|Overall Study|Physician Decision|5|||
126717136|NCT02137772|455915047|FG000|Overall Study|Withdrawal by Subject|28|||
126717137|NCT02137772|455915048|FG001|Overall Study|Withdrawal by Subject|17|||
126717138|NCT02137772|455915047|FG000|Overall Study|Non-compliance with study drug|1|||
126717139|NCT02137772|455915048|FG001|Overall Study|Non-compliance with study drug|0|||
126717140|NCT02137772|455915047|FG000|Overall Study|Not treated|3|||
126717141|NCT02137772|455915048|FG001|Overall Study|Not treated|2|||
126717142|NCT02691247|455915049|FG000|Overall Study|Withdrawal by Subject|1|||
126717143|NCT02691247|455915050|FG001|Overall Study|Withdrawal by Subject|2|||
126717144|NCT02691247|455915051|FG002|Overall Study|Withdrawal by Subject|2|||
126717145|NCT02691247|455915049|FG000|Overall Study|Lost to Follow-up|2|||
126717146|NCT02691247|455915050|FG001|Overall Study|Lost to Follow-up|0|||
126717147|NCT02691247|455915051|FG002|Overall Study|Lost to Follow-up|1|||
126717148|NCT02084134|455915056|FG000|Overall Study|Protocol Violation|4|||
126717149|NCT02084134|455915057|FG001|Overall Study|Protocol Violation|2|||
126717150|NCT02084134|455915056|FG000|Overall Study|Death|0|||
126717151|NCT02084134|455915057|FG001|Overall Study|Death|1|||
126717152|NCT01095250|455915062|FG000|Overall Study|administrative reasons|8|||
126717153|NCT01095250|455915063|FG001|Overall Study|administrative reasons|10|||
126717154|NCT01095250|455915064|FG002|Overall Study|administrative reasons|7|||
126717155|NCT01095250|455915065|FG003|Overall Study|administrative reasons|5|||
126717156|NCT01095250|455915062|FG000|Overall Study|Withdrawal by Subject|0|||
126717157|NCT01095250|455915063|FG001|Overall Study|Withdrawal by Subject|0|||
126717158|NCT01095250|455915064|FG002|Overall Study|Withdrawal by Subject|1|||
126717159|NCT01095250|455915065|FG003|Overall Study|Withdrawal by Subject|0|||
126717160|NCT04598165|455915066|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
126717161|NCT04598165|455915067|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
126717162|NCT04598165|455915066|FG000|Completed 6-week Follow-up|Death|2|||
126717163|NCT04598165|455915067|FG001|Completed 6-week Follow-up|Death|1|||
126717164|NCT04598165|455915066|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
126717165|NCT04598165|455915067|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
126717166|NCT04598165|455915066|FG000|Completed 6-week Follow-up|Ineligible|4|||
126717167|NCT04598165|455915067|FG001|Completed 6-week Follow-up|Ineligible|3|||
126717168|NCT04598165|455915066|FG000|Completed 6-week Follow-up|Partner refusal|0|||
126717169|NCT04598165|455915067|FG001|Completed 6-week Follow-up|Partner refusal|1|||
126717170|NCT04598165|455915066|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
126717171|NCT04598165|455915067|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
126717172|NCT01323673|455915068|FG000|Overall Study|Adverse Event|0|||
126717173|NCT01323673|455915069|FG001|Overall Study|Adverse Event|1|||
126717174|NCT01323673|455915068|FG000|Overall Study|Lost to Follow-up|0|||
126717175|NCT01323673|455915069|FG001|Overall Study|Lost to Follow-up|1|||
126717176|NCT01323673|455915068|FG000|Overall Study|Protocol Violation|1|||
126717177|NCT01323673|455915069|FG001|Overall Study|Protocol Violation|0|||
126717178|NCT01323673|455915068|FG000|Overall Study|Withdrawal by Subject|2|||
126717179|NCT01323673|455915069|FG001|Overall Study|Withdrawal by Subject|3|||
126717180|NCT00426751|455915070|FG000|Overall Study|Adverse Event|8|||
126717181|NCT00426751|455915071|FG001|Overall Study|Adverse Event|1|||
126717182|NCT00426751|455915070|FG000|Overall Study|Lost to Follow-up|7|||
126717183|NCT00426751|455915071|FG001|Overall Study|Lost to Follow-up|6|||
126717184|NCT00426751|455915070|FG000|Overall Study|Consent Withdrawn|0|||
126717185|NCT00426751|455915071|FG001|Overall Study|Consent Withdrawn|1|||
126553303|NCT03230864|455320559|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
126717186|NCT00426751|455915070|FG000|Overall Study|Other Reasons|7|||
126717187|NCT00426751|455915071|FG001|Overall Study|Other Reasons|12|||
126717188|NCT02488759|455915075|FG000|Overall Study|Disease progression|73|||
126717189|NCT02488759|455915076|FG001|Overall Study|Disease progression|111|||
126717190|NCT02488759|455915077|FG002|Overall Study|Disease progression|62|||
126381400|NCT00310375|454691810|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
126381401|NCT00310375|454691811|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
126381402|NCT00310375|454691809|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
126381403|NCT00310375|454691810|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
126381404|NCT00310375|454691811|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
126381405|NCT00131352|454691812|FG000|Initial Treatment Period|Adverse Event|1|||
126381406|NCT00131352|454691813|FG001|Initial Treatment Period|Adverse Event|3|||
126381407|NCT00131352|454691812|FG000|Initial Treatment Period|Non-compliant|1|||
126381408|NCT00131352|454691813|FG001|Initial Treatment Period|Non-compliant|2|||
126381409|NCT00131352|454691812|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
126381410|NCT00131352|454691813|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
126381411|NCT00131352|454691812|FG000|Initial Treatment Period|Lack of Efficacy|6|||
126381412|NCT00131352|454691813|FG001|Initial Treatment Period|Lack of Efficacy|4|||
126381413|NCT00131352|454691812|FG000|Initial Treatment Period|Other|0|||
126381414|NCT00131352|454691813|FG001|Initial Treatment Period|Other|2|||
126381415|NCT00131352|454691812|FG000|Repeat Treatment Period|Adverse Event|1|||
126381416|NCT00131352|454691813|FG001|Repeat Treatment Period|Adverse Event|0|||
126381417|NCT00131352|454691812|FG000|Repeat Treatment Period|Other|1|||
126381418|NCT00131352|454691813|FG001|Repeat Treatment Period|Other|0|||
126381419|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
126381420|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
126381421|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381422|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381423|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381424|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381425|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381426|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381427|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381428|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
126381429|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
126381430|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
126381431|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381432|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381433|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381434|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381435|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381436|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381437|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381438|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
126381439|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
126381440|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126717191|NCT02488759|455915078|FG003|Overall Study|Disease progression|7|||
126717192|NCT02488759|455915079|FG004|Overall Study|Disease progression|4|||
126717193|NCT02488759|455915080|FG005|Overall Study|Disease progression|2|||
126717194|NCT02488759|455915075|FG000|Overall Study|Study drug toxicity|11|||
126717195|NCT02488759|455915076|FG001|Overall Study|Study drug toxicity|33|||
126717196|NCT02488759|455915077|FG002|Overall Study|Study drug toxicity|31|||
126717197|NCT02488759|455915078|FG003|Overall Study|Study drug toxicity|0|||
126717198|NCT02488759|455915079|FG004|Overall Study|Study drug toxicity|0|||
126717199|NCT02488759|455915080|FG005|Overall Study|Study drug toxicity|2|||
126717200|NCT02488759|455915075|FG000|Overall Study|Adverse event unrelated to study drug|9|||
126381441|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381442|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381443|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381444|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381445|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381446|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381447|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381448|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
126381449|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
126381450|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
126381451|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381452|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381453|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381454|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381455|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381456|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381457|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381458|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
126381459|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381460|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
126381461|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381462|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381463|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381464|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381465|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381466|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381467|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381468|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
126381469|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
126381470|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
126381471|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381472|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381473|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381474|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381475|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381476|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381477|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381478|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
126381479|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
126381480|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
126717201|NCT02488759|455915076|FG001|Overall Study|Adverse event unrelated to study drug|11|||
126717202|NCT02488759|455915077|FG002|Overall Study|Adverse event unrelated to study drug|7|||
126717203|NCT02488759|455915078|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126717204|NCT02488759|455915079|FG004|Overall Study|Adverse event unrelated to study drug|1|||
126717205|NCT02488759|455915080|FG005|Overall Study|Adverse event unrelated to study drug|0|||
126717206|NCT02488759|455915075|FG000|Overall Study|Participant request to discontinue study treatment|6|||
126717207|NCT02488759|455915076|FG001|Overall Study|Participant request to discontinue study treatment|8|||
126717208|NCT02488759|455915077|FG002|Overall Study|Participant request to discontinue study treatment|4|||
126717209|NCT02488759|455915078|FG003|Overall Study|Participant request to discontinue study treatment|0|||
126717210|NCT02488759|455915079|FG004|Overall Study|Participant request to discontinue study treatment|0|||
126717211|NCT02488759|455915080|FG005|Overall Study|Participant request to discontinue study treatment|0|||
126717212|NCT02488759|455915075|FG000|Overall Study|Withdrawal by Subject|4|||
126717213|NCT02488759|455915076|FG001|Overall Study|Withdrawal by Subject|0|||
126717214|NCT02488759|455915077|FG002|Overall Study|Withdrawal by Subject|3|||
126717215|NCT02488759|455915078|FG003|Overall Study|Withdrawal by Subject|0|||
126717216|NCT02488759|455915079|FG004|Overall Study|Withdrawal by Subject|0|||
126717217|NCT02488759|455915080|FG005|Overall Study|Withdrawal by Subject|2|||
126717218|NCT02488759|455915075|FG000|Overall Study|Lost to Follow-up|0|||
126717219|NCT02488759|455915076|FG001|Overall Study|Lost to Follow-up|0|||
126717220|NCT02488759|455915077|FG002|Overall Study|Lost to Follow-up|2|||
126717221|NCT02488759|455915078|FG003|Overall Study|Lost to Follow-up|0|||
126717222|NCT02488759|455915079|FG004|Overall Study|Lost to Follow-up|0|||
126717223|NCT02488759|455915080|FG005|Overall Study|Lost to Follow-up|0|||
126717224|NCT02488759|455915075|FG000|Overall Study|Maximum clinical benefit|3|||
126717225|NCT02488759|455915076|FG001|Overall Study|Maximum clinical benefit|0|||
126381481|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126717226|NCT02488759|455915077|FG002|Overall Study|Maximum clinical benefit|1|||
126717227|NCT02488759|455915078|FG003|Overall Study|Maximum clinical benefit|0|||
126381482|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381483|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381484|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381485|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381486|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381487|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381488|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
126381489|NCT01194219|454691814|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
126381490|NCT01194219|454691815|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
126381491|NCT01194219|454691816|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381492|NCT01194219|454691817|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381493|NCT01194219|454691818|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381494|NCT01194219|454691819|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381495|NCT01194219|454691820|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381496|NCT01194219|454691821|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381497|NCT01194219|454691822|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381498|NCT01194219|454691823|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
126381499|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381500|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381501|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
126381502|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
126381503|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381504|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381505|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381506|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381507|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381508|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
126381509|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381510|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381511|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
126381512|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
126381513|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381514|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381515|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381516|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381517|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381518|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
126381519|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381520|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381521|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
126381522|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
126381523|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381524|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381525|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381526|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381527|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381528|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
126381529|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381530|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381531|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
126381532|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
126381533|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381534|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381535|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381536|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381537|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381538|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
126381539|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381540|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381541|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
126381542|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381543|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381544|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381545|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381546|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381547|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126381548|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
126771149|NCT03454672|456116285|FG001|Overall Study|painful|2|||
126381549|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381550|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381551|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381552|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
126381553|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381554|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381555|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381556|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381557|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381558|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
126381559|NCT01194219|454691814|FG000|Maintenance Phase Weeks16-32|Other|0|||
126381560|NCT01194219|454691815|FG001|Maintenance Phase Weeks16-32|Other|0|||
126381561|NCT01194219|454691816|FG002|Maintenance Phase Weeks16-32|Other|2|||
126381562|NCT01194219|454691817|FG003|Maintenance Phase Weeks16-32|Other|1|||
126381563|NCT01194219|454691818|FG004|Maintenance Phase Weeks16-32|Other|0|||
126381564|NCT01194219|454691819|FG005|Maintenance Phase Weeks16-32|Other|0|||
126381565|NCT01194219|454691820|FG006|Maintenance Phase Weeks16-32|Other|0|||
126381566|NCT01194219|454691821|FG007|Maintenance Phase Weeks16-32|Other|0|||
126381567|NCT01194219|454691822|FG008|Maintenance Phase Weeks16-32|Other|0|||
126381568|NCT01194219|454691823|FG009|Maintenance Phase Weeks16-32|Other|0|||
126381569|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381570|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381571|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381572|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381573|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381574|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
126381575|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
126381576|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
126381577|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381578|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
126381579|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
126381580|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
126381581|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
126381582|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
126381583|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
126381584|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
126381585|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
126381586|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
126381587|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
126381588|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
126381589|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381590|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381591|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381592|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381593|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
126381594|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126468073|NCT03845543|455015182|FG000|Overall Study|Withdrawal by Subject|2|||
126468074|NCT03845543|455015182|FG000|Overall Study|Lost to Follow-up|12|||
126468075|NCT03845543|455015182|FG000|Overall Study|Adverse Event|17|||
126468076|NCT01400815|455015183|FG000|Overall Study|Adverse Event|3|||
126468077|NCT01400815|455015184|FG001|Overall Study|Adverse Event|0|||
126468078|NCT01400815|455015183|FG000|Overall Study|Death|0|||
126468079|NCT01400815|455015184|FG001|Overall Study|Death|1|||
126468080|NCT01400815|455015183|FG000|Overall Study|Lost to Follow-up|18|||
126468081|NCT01400815|455015184|FG001|Overall Study|Lost to Follow-up|11|||
126468082|NCT01400815|455015183|FG000|Overall Study|Protocol Violation|0|||
126468083|NCT01400815|455015184|FG001|Overall Study|Protocol Violation|1|||
126468084|NCT01400815|455015183|FG000|Overall Study|Physician Decision|1|||
126468085|NCT01400815|455015184|FG001|Overall Study|Physician Decision|0|||
126468086|NCT01400815|455015183|FG000|Overall Study|Withdrawal by Subject|15|||
126468087|NCT01400815|455015184|FG001|Overall Study|Withdrawal by Subject|8|||
126468088|NCT01400815|455015183|FG000|Overall Study|Subject in jail|1|||
126468089|NCT01400815|455015184|FG001|Overall Study|Subject in jail|0|||
126468090|NCT00568685|455015189|FG000|Overall Study|Adverse Event|2|||
126468091|NCT00568685|455015190|FG001|Overall Study|Adverse Event|3|||
126468092|NCT00568685|455015191|FG002|Overall Study|Adverse Event|3|||
126468093|NCT00568685|455015189|FG000|Overall Study|Withdrawal by Subject|7|||
126468094|NCT00568685|455015190|FG001|Overall Study|Withdrawal by Subject|2|||
126468095|NCT00568685|455015191|FG002|Overall Study|Withdrawal by Subject|2|||
126468096|NCT00568685|455015189|FG000|Overall Study|Protocol Violation|1|||
126468097|NCT00568685|455015190|FG001|Overall Study|Protocol Violation|0|||
126717228|NCT02488759|455915079|FG004|Overall Study|Maximum clinical benefit|0|||
126717229|NCT02488759|455915080|FG005|Overall Study|Maximum clinical benefit|0|||
126717230|NCT02488759|455915075|FG000|Overall Study|Other reasons|7|||
126717231|NCT02488759|455915076|FG001|Overall Study|Other reasons|32|||
126717232|NCT02488759|455915077|FG002|Overall Study|Other reasons|23|||
126717233|NCT02488759|455915078|FG003|Overall Study|Other reasons|1|||
126717234|NCT02488759|455915079|FG004|Overall Study|Other reasons|1|||
126717235|NCT02488759|455915080|FG005|Overall Study|Other reasons|1|||
126717236|NCT01432262|455916159|FG000|Overall Study|Withdrawal by Subject|2|||
126717237|NCT01432262|455916160|FG001|Overall Study|Withdrawal by Subject|1|||
126381595|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
126381596|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381597|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381598|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
126381599|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381600|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381601|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381602|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381603|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
126381604|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381605|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
126381606|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
126381607|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381608|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
126381609|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381610|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381611|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381612|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381613|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
126381614|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
126381615|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
126381616|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381617|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381618|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
126381619|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381620|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381621|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381622|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381623|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381624|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381625|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381626|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
126381627|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381628|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
126381629|NCT01194219|454691814|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381630|NCT01194219|454691815|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381631|NCT01194219|454691816|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381632|NCT01194219|454691817|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381633|NCT01194219|454691818|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381634|NCT01194219|454691819|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381635|NCT01194219|454691820|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
126381636|NCT01194219|454691821|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381637|NCT01194219|454691822|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381638|NCT01194219|454691823|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
126381639|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381640|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381641|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381642|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381643|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381644|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381645|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381646|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
126381647|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
126381648|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
126468098|NCT00568685|455015191|FG002|Overall Study|Protocol Violation|0|||
126717238|NCT04657016|455916161|FG000|Overall Study|Adverse Event|2|||
126717239|NCT04657016|455916162|FG001|Overall Study|Adverse Event|4|||
126381649|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381650|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381651|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381652|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381653|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381654|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381655|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381656|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
126381657|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
126381658|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
126381659|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381660|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381661|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381662|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381663|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381664|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381665|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381666|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
126381667|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
126381668|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
126381669|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381670|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381671|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381672|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381673|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381674|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381675|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381676|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
126381677|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
126381678|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
126381679|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
126381680|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
126381681|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
126381682|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
126381683|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
126381684|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
126381685|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
126381686|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
126381687|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
126381688|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
126381689|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381690|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381691|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381692|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381693|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381694|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381695|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381696|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
126381697|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
126381698|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
126381699|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381700|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381701|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126717240|NCT04657016|455916161|FG000|Overall Study|Death|1|||
126717241|NCT04657016|455916162|FG001|Overall Study|Death|1|||
126717242|NCT04657016|455916161|FG000|Overall Study|Lost to Follow-up|24|||
126717243|NCT04657016|455916162|FG001|Overall Study|Lost to Follow-up|12|||
126717244|NCT04657016|455916161|FG000|Overall Study|Physician Decision|1|||
126381702|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381703|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381704|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126717245|NCT04657016|455916162|FG001|Overall Study|Physician Decision|2|||
126717246|NCT04657016|455916161|FG000|Overall Study|Pregnancy|2|||
126717247|NCT04657016|455916162|FG001|Overall Study|Pregnancy|2|||
126717248|NCT04657016|455916161|FG000|Overall Study|Protocol Deviation|1|||
126717249|NCT04657016|455916162|FG001|Overall Study|Protocol Deviation|0|||
126717250|NCT04657016|455916161|FG000|Overall Study|Withdrawal by Subject|28|||
126717251|NCT04657016|455916162|FG001|Overall Study|Withdrawal by Subject|14|||
126717252|NCT04657016|455916161|FG000|Overall Study|Other - as reported by the investigator|6|||
126381705|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381706|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381707|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
126381708|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
126381709|NCT01194219|454691814|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381710|NCT01194219|454691815|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381711|NCT01194219|454691816|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381712|NCT01194219|454691817|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381713|NCT01194219|454691818|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381714|NCT01194219|454691819|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381715|NCT01194219|454691820|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381716|NCT01194219|454691821|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
126381717|NCT01194219|454691822|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
126381718|NCT01194219|454691823|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
126381719|NCT00292045|454691826|FG000|Core Study (Through Week 13)|Adverse Event|1|||
126381720|NCT00292045|454691826|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
126381721|NCT04474197|454691827|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
126381722|NCT04474197|454691828|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
126381723|NCT04474197|454691829|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
126381724|NCT04474197|454691830|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
126381725|NCT02443337|454691831|FG000|Overall Study|Adverse Event|0|||
126381726|NCT02443337|454691832|FG001|Overall Study|Adverse Event|1|||
126381727|NCT02443337|454691831|FG000|Overall Study|Clinical Progressive Disease|3|||
126381728|NCT02443337|454691832|FG001|Overall Study|Clinical Progressive Disease|0|||
126381729|NCT02443337|454691831|FG000|Overall Study|Withdrawal by Subject|2|||
126381730|NCT02443337|454691832|FG001|Overall Study|Withdrawal by Subject|1|||
126381731|NCT00635349|454691834|FG000|Overall Study|Other|8|||
126381732|NCT00635349|454691835|FG001|Overall Study|Other|6|||
126381733|NCT00635349|454691834|FG000|Overall Study|Protocol Violation|18|||
126381734|NCT00635349|454691835|FG001|Overall Study|Protocol Violation|22|||
126381735|NCT00635349|454691834|FG000|Overall Study|Withdrawal by Subject|3|||
126381736|NCT00635349|454691835|FG001|Overall Study|Withdrawal by Subject|8|||
126381737|NCT00635349|454691834|FG000|Overall Study|Lost to Follow-up|4|||
126381738|NCT00635349|454691835|FG001|Overall Study|Lost to Follow-up|3|||
126381739|NCT00635349|454691834|FG000|Overall Study|Adverse Event|11|||
126381740|NCT00635349|454691835|FG001|Overall Study|Adverse Event|9|||
126381741|NCT04860869|454691840|FG000|Overall Study|Withdrawal by Subject|1|||
126381742|NCT04860869|454691841|FG001|Overall Study|Withdrawal by Subject|0|||
126381743|NCT03951766|454691842|FG000|Treatment Phase|Lost to Follow-up|1|||
126381744|NCT03951766|454691842|FG000|Follow-up Phase|Lost to Follow-up|10|||
126381745|NCT00049322|454691845|FG000|Overall Study|disease burden|0|||
126381746|NCT00049322|454691846|FG001|Overall Study|disease burden|3|||
126381747|NCT00049322|454691845|FG000|Overall Study|Adverse Event|1|||
126381748|NCT00049322|454691846|FG001|Overall Study|Adverse Event|0|||
126381749|NCT00049322|454691845|FG000|Overall Study|refused angio|0|||
126381750|NCT00049322|454691846|FG001|Overall Study|refused angio|3|||
126381751|NCT03943290|454691849|FG000|Overall Study|Sponsor Terminated Study|6|||
126381752|NCT03943290|454691850|FG001|Overall Study|Sponsor Terminated Study|1|||
126381753|NCT03943290|454691851|FG002|Overall Study|Sponsor Terminated Study|11|||
126381754|NCT03943290|454691852|FG003|Overall Study|Sponsor Terminated Study|6|||
126381755|NCT03943290|454691853|FG004|Overall Study|Sponsor Terminated Study|7|||
126381756|NCT03943290|454691854|FG005|Overall Study|Sponsor Terminated Study|6|||
126381757|NCT03943290|454691855|FG006|Overall Study|Sponsor Terminated Study|6|||
126381758|NCT03943290|454691856|FG007|Overall Study|Sponsor Terminated Study|7|||
126381759|NCT03943290|454691857|FG008|Overall Study|Sponsor Terminated Study|8|||
126381760|NCT03943290|454691849|FG000|Overall Study|Lost to Follow-up|1|||
126381761|NCT03943290|454691850|FG001|Overall Study|Lost to Follow-up|0|||
126381762|NCT03943290|454691851|FG002|Overall Study|Lost to Follow-up|1|||
126381763|NCT03943290|454691852|FG003|Overall Study|Lost to Follow-up|0|||
126381764|NCT03943290|454691853|FG004|Overall Study|Lost to Follow-up|0|||
126381765|NCT03943290|454691854|FG005|Overall Study|Lost to Follow-up|0|||
126381766|NCT03943290|454691855|FG006|Overall Study|Lost to Follow-up|0|||
126381767|NCT03943290|454691856|FG007|Overall Study|Lost to Follow-up|1|||
126381768|NCT03943290|454691857|FG008|Overall Study|Lost to Follow-up|0|||
126381769|NCT03943290|454691849|FG000|Overall Study|Withdrawal by Subject|0|||
126381770|NCT03943290|454691850|FG001|Overall Study|Withdrawal by Subject|0|||
126381771|NCT03943290|454691851|FG002|Overall Study|Withdrawal by Subject|1|||
126381772|NCT03943290|454691852|FG003|Overall Study|Withdrawal by Subject|0|||
126381773|NCT03943290|454691853|FG004|Overall Study|Withdrawal by Subject|0|||
126381774|NCT03943290|454691854|FG005|Overall Study|Withdrawal by Subject|0|||
126381775|NCT03943290|454691855|FG006|Overall Study|Withdrawal by Subject|0|||
126381776|NCT03943290|454691856|FG007|Overall Study|Withdrawal by Subject|0|||
126381777|NCT03943290|454691857|FG008|Overall Study|Withdrawal by Subject|0|||
126381778|NCT00295646|454691858|FG000|Overall Study|Protocol Violation|18|||
126381779|NCT00295646|454691859|FG001|Overall Study|Protocol Violation|20|||
126381780|NCT00295646|454691860|FG002|Overall Study|Protocol Violation|20|||
126381781|NCT00295646|454691861|FG003|Overall Study|Protocol Violation|18|||
126381782|NCT00295646|454691858|FG000|Overall Study|Withdrawal by Subject|8|||
126381783|NCT00295646|454691859|FG001|Overall Study|Withdrawal by Subject|9|||
126381784|NCT00295646|454691860|FG002|Overall Study|Withdrawal by Subject|11|||
126381785|NCT00295646|454691861|FG003|Overall Study|Withdrawal by Subject|14|||
126381786|NCT00295646|454691858|FG000|Overall Study|Lost to Follow-up|0|||
126381787|NCT00295646|454691859|FG001|Overall Study|Lost to Follow-up|5|||
126381788|NCT00295646|454691860|FG002|Overall Study|Lost to Follow-up|1|||
126381789|NCT00295646|454691861|FG003|Overall Study|Lost to Follow-up|5|||
126381790|NCT00295646|454691858|FG000|Overall Study|Death|9|||
126381791|NCT00295646|454691859|FG001|Overall Study|Death|7|||
126381792|NCT00295646|454691860|FG002|Overall Study|Death|18|||
126381793|NCT00295646|454691861|FG003|Overall Study|Death|8|||
126381794|NCT02441101|454691872|FG000|Overall Study|Withdrawal by Subject|1|||
126381795|NCT02441101|454691873|FG001|Overall Study|Withdrawal by Subject|0|||
126381796|NCT02441101|454691872|FG000|Overall Study|Lost to Follow-up|1|||
126381797|NCT02441101|454691873|FG001|Overall Study|Lost to Follow-up|0|||
126381798|NCT02441101|454691872|FG000|Overall Study|PI relocated and study terminated|1|||
126381799|NCT02441101|454691873|FG001|Overall Study|PI relocated and study terminated|0|||
126381800|NCT00955474|454691874|FG000|Overall Study|Physician Decision|7|||
126381801|NCT00955474|454691875|FG001|Overall Study|Physician Decision|5|||
126381802|NCT01737762|454691878|FG000|Overall Study|Adverse Event|2|||
126381803|NCT01737762|454691879|FG001|Overall Study|Adverse Event|2|||
126381804|NCT01737762|454691878|FG000|Overall Study|Lost to Follow-up|1|||
126381805|NCT01737762|454691879|FG001|Overall Study|Lost to Follow-up|0|||
126381806|NCT01737762|454691878|FG000|Overall Study|Withdrawal by Subject|2|||
126381807|NCT01737762|454691879|FG001|Overall Study|Withdrawal by Subject|2|||
126381808|NCT01737762|454691878|FG000|Overall Study|Progressive disease|1|||
126381809|NCT01737762|454691879|FG001|Overall Study|Progressive disease|2|||
126381810|NCT01737762|454691878|FG000|Overall Study|Physician Decision|1|||
126381811|NCT01737762|454691879|FG001|Overall Study|Physician Decision|1|||
126381812|NCT01737762|454691878|FG000|Overall Study|Moved from area|2|||
126381813|NCT01737762|454691879|FG001|Overall Study|Moved from area|1|||
126381814|NCT01737762|454691878|FG000|Overall Study|Trial termination|11|||
126381815|NCT01737762|454691879|FG001|Overall Study|Trial termination|9|||
126381816|NCT03083665|454691881|FG000|Double-Blind Period|Adverse Event|5|||
126381817|NCT03083665|454691882|FG001|Double-Blind Period|Adverse Event|4|||
126381818|NCT03083665|454691883|FG002|Double-Blind Period|Adverse Event|5|||
126381819|NCT03083665|454691884|FG003|Double-Blind Period|Adverse Event|0|||
126381820|NCT03083665|454691885|FG004|Double-Blind Period|Adverse Event|0|||
126381821|NCT03083665|454691886|FG005|Double-Blind Period|Adverse Event|0|||
126381822|NCT03083665|454691881|FG000|Double-Blind Period|Lack of Efficacy|0|||
126381823|NCT03083665|454691882|FG001|Double-Blind Period|Lack of Efficacy|0|||
126381824|NCT03083665|454691883|FG002|Double-Blind Period|Lack of Efficacy|1|||
126381825|NCT03083665|454691884|FG003|Double-Blind Period|Lack of Efficacy|0|||
126381826|NCT03083665|454691885|FG004|Double-Blind Period|Lack of Efficacy|0|||
126381827|NCT03083665|454691886|FG005|Double-Blind Period|Lack of Efficacy|0|||
126381828|NCT03083665|454691881|FG000|Double-Blind Period|Protocol Violation|1|||
126381829|NCT03083665|454691882|FG001|Double-Blind Period|Protocol Violation|0|||
126381830|NCT03083665|454691883|FG002|Double-Blind Period|Protocol Violation|1|||
126381831|NCT03083665|454691884|FG003|Double-Blind Period|Protocol Violation|0|||
126381832|NCT03083665|454691885|FG004|Double-Blind Period|Protocol Violation|0|||
126381833|NCT03083665|454691886|FG005|Double-Blind Period|Protocol Violation|0|||
126381834|NCT03083665|454691881|FG000|Double-Blind Period|Lost to Follow-up|1|||
126381835|NCT03083665|454691882|FG001|Double-Blind Period|Lost to Follow-up|0|||
126381836|NCT03083665|454691883|FG002|Double-Blind Period|Lost to Follow-up|1|||
126381837|NCT03083665|454691884|FG003|Double-Blind Period|Lost to Follow-up|0|||
126381838|NCT03083665|454691885|FG004|Double-Blind Period|Lost to Follow-up|0|||
126381839|NCT03083665|454691886|FG005|Double-Blind Period|Lost to Follow-up|0|||
126381840|NCT03083665|454691881|FG000|Double-Blind Period|Withdrawal by Subject|3|||
126381841|NCT03083665|454691882|FG001|Double-Blind Period|Withdrawal by Subject|0|||
126381842|NCT03083665|454691883|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126468099|NCT01147172|455015192|FG000|Overall Study|Withdrawal by Subject|2|||
126468100|NCT01147172|455015192|FG000|Overall Study|Lost to Follow-up|2|||
126468101|NCT02787551|455015193|FG000|Core Period: 26 Weeks|Adverse Event|10|||
126381843|NCT03083665|454691884|FG003|Double-Blind Period|Withdrawal by Subject|0|||
126381844|NCT03083665|454691885|FG004|Double-Blind Period|Withdrawal by Subject|0|||
126468102|NCT02787551|455015194|FG001|Core Period: 26 Weeks|Adverse Event|0|||
126381845|NCT03083665|454691886|FG005|Double-Blind Period|Withdrawal by Subject|0|||
126381846|NCT03083665|454691881|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
126381847|NCT03083665|454691882|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
126381848|NCT03083665|454691883|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
126381849|NCT03083665|454691884|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
126381850|NCT03083665|454691885|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
126381851|NCT03083665|454691886|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
126381852|NCT03083665|454691881|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
126381853|NCT03083665|454691882|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
126381854|NCT03083665|454691883|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
126381855|NCT03083665|454691884|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
126381856|NCT03083665|454691885|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
126381857|NCT03083665|454691886|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
126381858|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
126381859|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
126381860|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
126381861|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
126381862|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
126381863|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
126381864|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
126381865|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
126381866|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
126381867|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
126381868|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
126381869|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
126381870|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
126381871|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
126381872|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
126381873|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
126381874|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
126381875|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
126381876|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
126381877|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
126381878|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
126381879|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
126381880|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
126381881|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
126381882|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
126381883|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
126381884|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
126381885|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
126381886|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
126381887|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
126381888|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
126381889|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
126381890|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
126381891|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
126381892|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
126381893|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
126381894|NCT03083665|454691881|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
126381895|NCT03083665|454691882|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
126381896|NCT03083665|454691883|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
126381897|NCT03083665|454691884|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
126381898|NCT03083665|454691885|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
126381899|NCT03083665|454691886|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
126381900|NCT01467466|454691887|FG000|Overall Study|Withdrawal by Subject|15|||
126381901|NCT01467466|454691888|FG001|Overall Study|Withdrawal by Subject|18|||
126381902|NCT01467466|454691889|FG002|Overall Study|Withdrawal by Subject|13|||
126381903|NCT01467466|454691890|FG003|Overall Study|Withdrawal by Subject|11|||
126381904|NCT01467466|454691887|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
126381905|NCT01467466|454691888|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
126381906|NCT01467466|454691889|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
126381907|NCT01467466|454691890|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
126381908|NCT01467466|454691887|FG000|Overall Study|Procedure Cancelled|46|||
126381909|NCT01467466|454691888|FG001|Overall Study|Procedure Cancelled|45|||
126381910|NCT01467466|454691889|FG002|Overall Study|Procedure Cancelled|25|||
126381911|NCT01467466|454691890|FG003|Overall Study|Procedure Cancelled|29|||
126381912|NCT01467466|454691887|FG000|Overall Study|No Endpoint Blood Draw|38|||
126468103|NCT02787551|455015193|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
126468104|NCT02787551|455015194|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
126468105|NCT02787551|455015193|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
126381913|NCT01467466|454691888|FG001|Overall Study|No Endpoint Blood Draw|32|||
126381914|NCT01467466|454691889|FG002|Overall Study|No Endpoint Blood Draw|51|||
126381915|NCT01467466|454691890|FG003|Overall Study|No Endpoint Blood Draw|43|||
126381916|NCT01144416|454691897|FG000|Intervention Period|Adverse Event|5|||
126381917|NCT01144416|454691898|FG001|Intervention Period|Adverse Event|6|||
126381918|NCT01144416|454691897|FG000|Intervention Period|Insufficient ovarian response|11|||
126381919|NCT01144416|454691898|FG001|Intervention Period|Insufficient ovarian response|17|||
126381920|NCT01144416|454691897|FG000|Intervention Period|Risk of OHSS|0|||
126381921|NCT01144416|454691898|FG001|Intervention Period|Risk of OHSS|1|||
126381922|NCT01144416|454691897|FG000|Intervention Period|Too high ovarian response|4|||
126381923|NCT01144416|454691898|FG001|Intervention Period|Too high ovarian response|2|||
126381924|NCT01144416|454691897|FG000|Intervention Period|No/too few/bad oocytes|7|||
126381925|NCT01144416|454691898|FG001|Intervention Period|No/too few/bad oocytes|5|||
126381926|NCT01144416|454691897|FG000|Intervention Period|No or abnormal fertilization|25|||
126381927|NCT01144416|454691898|FG001|Intervention Period|No or abnormal fertilization|10|||
126381928|NCT01144416|454691897|FG000|Intervention Period|No/too few/bad quality embryos|3|||
126381929|NCT01144416|454691898|FG001|Intervention Period|No/too few/bad quality embryos|3|||
126381930|NCT01144416|454691897|FG000|Intervention Period|Other|7|||
126381931|NCT01144416|454691898|FG001|Intervention Period|Other|5|||
126381932|NCT01445613|454691903|FG000|30-day Follow-up|Withdrawal by Subject|6|||
126381933|NCT01445613|454691903|FG000|30-day Follow-up|Physician Decision|3|||
126381934|NCT01445613|454691903|FG000|30-day Follow-up|Missed visit|23|||
126381935|NCT01445613|454691903|FG000|30-day Follow-up|Death|3|||
126381936|NCT01445613|454691903|FG000|1-year Follow-up|Withdrawal by Subject|12|||
126381937|NCT01445613|454691903|FG000|1-year Follow-up|Missed visit|29|||
126381938|NCT01445613|454691903|FG000|1-year Follow-up|Lost to Follow-up|2|||
126381939|NCT01445613|454691903|FG000|1-year Follow-up|Death|30|||
126381940|NCT01445613|454691903|FG000|1-year Follow-up|Physician Decision|2|||
126381941|NCT01445613|454691903|FG000|1-year Follow-up|Received a non-study stent|2|||
126381942|NCT02131662|454691910|FG000|Overall Study|Protocol Violation|1|||
126381943|NCT02131662|454691911|FG001|Overall Study|Protocol Violation|0|||
126381944|NCT02131662|454691912|FG002|Overall Study|Protocol Violation|0|||
126381945|NCT02131662|454691913|FG003|Overall Study|Protocol Violation|0|||
126381946|NCT02131662|454691914|FG004|Overall Study|Protocol Violation|0|||
126381947|NCT02131662|454691910|FG000|Overall Study|Other|2|||
126717253|NCT04657016|455916162|FG001|Overall Study|Other - as reported by the investigator|0|||
126717254|NCT01755195|455916163|FG000|Overall Study|Participant noncompliance|2|||
126717255|NCT01755195|455916163|FG000|Overall Study|Switched to alternative treatment|4|||
126717256|NCT01755195|455916163|FG000|Overall Study|Withdrawal by Subject|1|||
126717257|NCT01755195|455916163|FG000|Overall Study|Participant refused to start treatment|1|||
126717258|NCT01755195|455916163|FG000|Overall Study|Participant has been consented for another trial|1|||
126717259|NCT01755195|455916163|FG000|Overall Study|Refused further treatment|3|||
126717260|NCT01755195|455916163|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
126717261|NCT03470922|455916164|FG000|Overall Study|Death|107|||
126717262|NCT03470922|455916165|FG001|Overall Study|Death|118|||
126717263|NCT03470922|455916164|FG000|Overall Study|Lost to Follow-up|5|||
126717264|NCT03470922|455916165|FG001|Overall Study|Lost to Follow-up|5|||
126717265|NCT03470922|455916164|FG000|Overall Study|Participant Withdrew Consent|4|||
126717266|NCT03470922|455916165|FG001|Overall Study|Participant Withdrew Consent|9|||
126717267|NCT03470922|455916164|FG000|Overall Study|Other reasons|1|||
126717268|NCT03470922|455916165|FG001|Overall Study|Other reasons|0|||
126717269|NCT03470922|455916164|FG000|Overall Study|Not reported|1|||
126717270|NCT03470922|455916165|FG001|Overall Study|Not reported|0|||
126717271|NCT02340819|455916166|FG000|Overall Study|Adverse Event|1|||
126717272|NCT02340819|455916166|FG000|Overall Study|Withdrawal by Subject|2|||
126717273|NCT02340819|455916166|FG000|Overall Study|Discontinued with other reason|1|||
126717274|NCT02361762|455916167|FG000|Overall Study|Withdrawal by Subject|0|||
126717275|NCT02361762|455916168|FG001|Overall Study|Withdrawal by Subject|1|||
126381948|NCT02131662|454691911|FG001|Overall Study|Other|4|||
126381949|NCT02131662|454691912|FG002|Overall Study|Other|3|||
126381950|NCT02131662|454691913|FG003|Overall Study|Other|3|||
126381951|NCT02131662|454691914|FG004|Overall Study|Other|4|||
126381952|NCT02131662|454691910|FG000|Overall Study|Adverse Event|0|||
126381953|NCT02131662|454691911|FG001|Overall Study|Adverse Event|1|||
126381954|NCT02131662|454691912|FG002|Overall Study|Adverse Event|1|||
126381955|NCT02131662|454691913|FG003|Overall Study|Adverse Event|1|||
126381956|NCT02131662|454691914|FG004|Overall Study|Adverse Event|3|||
126381957|NCT02131662|454691910|FG000|Overall Study|Pregnancy|0|||
126381958|NCT02131662|454691911|FG001|Overall Study|Pregnancy|1|||
126381959|NCT02131662|454691912|FG002|Overall Study|Pregnancy|0|||
126381960|NCT02131662|454691913|FG003|Overall Study|Pregnancy|1|||
126717276|NCT02361762|455916167|FG000|Overall Study|Lost to Follow-up|0|||
126717277|NCT02361762|455916168|FG001|Overall Study|Lost to Follow-up|1|||
126717278|NCT00028002|455916169|FG000|Overall Study|Withdrawal by Subject|3|||
126381961|NCT02131662|454691914|FG004|Overall Study|Pregnancy|0|||
126381962|NCT02131662|454691910|FG000|Overall Study|Wish for pregnancy|0|||
126468106|NCT02787551|455015194|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
126717279|NCT00028002|455916169|FG000|Overall Study|Ineligible|8|||
126381963|NCT02131662|454691911|FG001|Overall Study|Wish for pregnancy|0|||
126381964|NCT02131662|454691912|FG002|Overall Study|Wish for pregnancy|0|||
126381965|NCT02131662|454691913|FG003|Overall Study|Wish for pregnancy|0|||
126381966|NCT02131662|454691914|FG004|Overall Study|Wish for pregnancy|1|||
126381967|NCT02131662|454691910|FG000|Overall Study|Lack of Efficacy|1|||
126381968|NCT02131662|454691911|FG001|Overall Study|Lack of Efficacy|0|||
126381969|NCT02131662|454691912|FG002|Overall Study|Lack of Efficacy|0|||
126381970|NCT02131662|454691913|FG003|Overall Study|Lack of Efficacy|0|||
126381971|NCT02131662|454691914|FG004|Overall Study|Lack of Efficacy|1|||
126381972|NCT02131662|454691910|FG000|Overall Study|Withdrawal by Subject|1|||
126381973|NCT02131662|454691911|FG001|Overall Study|Withdrawal by Subject|5|||
126381974|NCT02131662|454691912|FG002|Overall Study|Withdrawal by Subject|1|||
126381975|NCT02131662|454691913|FG003|Overall Study|Withdrawal by Subject|5|||
126381976|NCT02131662|454691914|FG004|Overall Study|Withdrawal by Subject|6|||
126381977|NCT02131662|454691910|FG000|Overall Study|Lost to Follow-up|1|||
126381978|NCT02131662|454691911|FG001|Overall Study|Lost to Follow-up|3|||
126381979|NCT02131662|454691912|FG002|Overall Study|Lost to Follow-up|0|||
126381980|NCT02131662|454691913|FG003|Overall Study|Lost to Follow-up|9|||
126381981|NCT02131662|454691914|FG004|Overall Study|Lost to Follow-up|0|||
126381982|NCT02131662|454691910|FG000|Overall Study|Not treated|2|||
126381983|NCT02131662|454691911|FG001|Overall Study|Not treated|0|||
126381984|NCT02131662|454691912|FG002|Overall Study|Not treated|2|||
126381985|NCT02131662|454691913|FG003|Overall Study|Not treated|2|||
126381986|NCT02131662|454691914|FG004|Overall Study|Not treated|3|||
126381987|NCT01402869|454691915|FG000|Overall Study|Required Tooth Extraction|0|||
126381988|NCT01402869|454691916|FG001|Overall Study|Required Tooth Extraction|0|||
126381989|NCT01402869|454691917|FG002|Overall Study|Required Tooth Extraction|1|||
126381990|NCT01740687|454691918|FG000|Overall Study|Lost to Follow-up|11|||
126381991|NCT01740687|454691918|FG000|Overall Study|Withdrawal by Subject|2|||
126381992|NCT01740687|454691918|FG000|Overall Study|other reason|22|||
126381993|NCT01740687|454691918|FG000|Overall Study|treatment not received|2|||
126381994|NCT00104728|454691920|FG000|Overall Study|screen failures|19|||
126381995|NCT01963767|454691921|FG000|Overall Study|Withdrawal by Subject|4|||
126381996|NCT01963767|454691922|FG001|Overall Study|Withdrawal by Subject|2|||
126381997|NCT01963767|454691921|FG000|Overall Study|Adverse Event|2|||
126381998|NCT01963767|454691922|FG001|Overall Study|Adverse Event|0|||
126381999|NCT03960684|454691923|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
126382000|NCT03941483|454691927|FG000|Overall Study|Miscellaneous|2|||
126382001|NCT03941483|454691928|FG001|Overall Study|Miscellaneous|3|||
126382002|NCT03941483|454691929|FG002|Overall Study|Miscellaneous|0|||
126382003|NCT03941483|454691927|FG000|Overall Study|Study Terminated by Sponsor|1|||
126382004|NCT03941483|454691928|FG001|Overall Study|Study Terminated by Sponsor|0|||
126382005|NCT03941483|454691929|FG002|Overall Study|Study Terminated by Sponsor|0|||
126382006|NCT03941483|454691927|FG000|Overall Study|Withdrawal by Subject|1|||
126382007|NCT03941483|454691928|FG001|Overall Study|Withdrawal by Subject|4|||
126382008|NCT03941483|454691929|FG002|Overall Study|Withdrawal by Subject|1|||
126382009|NCT03941483|454691927|FG000|Overall Study|Lost to Follow-up|2|||
126382010|NCT03941483|454691928|FG001|Overall Study|Lost to Follow-up|1|||
126382011|NCT03941483|454691929|FG002|Overall Study|Lost to Follow-up|8|||
126382012|NCT03941483|454691927|FG000|Overall Study|Death|3|||
126382013|NCT03941483|454691928|FG001|Overall Study|Death|2|||
126717280|NCT01793051|455916170|FG000|Overall Study|Withdrawal by Subject|6|||
126717281|NCT01793051|455916171|FG001|Overall Study|Withdrawal by Subject|4|||
126717282|NCT01793051|455916170|FG000|Overall Study|Adverse Event|0|||
126382014|NCT03941483|454691929|FG002|Overall Study|Death|6|||
126382015|NCT01082081|454691930|FG000|Overall Study|Lost to Follow-up|0|||
126717283|NCT01793051|455916171|FG001|Overall Study|Adverse Event|2|||
126717284|NCT01793051|455916170|FG000|Overall Study|Too ill to continue|1|||
126717285|NCT01793051|455916171|FG001|Overall Study|Too ill to continue|0|||
126717286|NCT01793051|455916170|FG000|Overall Study|Switched chemo|1|||
126717287|NCT01793051|455916171|FG001|Overall Study|Switched chemo|1|||
126717288|NCT01793051|455916170|FG000|Overall Study|Lack of compliance|1|||
126382016|NCT01082081|454691931|FG001|Overall Study|Lost to Follow-up|0|||
126382017|NCT01082081|454691932|FG002|Overall Study|Lost to Follow-up|1|||
126382018|NCT01082081|454691930|FG000|Overall Study|Withdrawal by Subject|0|||
126382019|NCT01082081|454691931|FG001|Overall Study|Withdrawal by Subject|0|||
126382020|NCT01082081|454691932|FG002|Overall Study|Withdrawal by Subject|1|||
126382021|NCT01082081|454691930|FG000|Overall Study|Other Reason|0|||
126382022|NCT01082081|454691931|FG001|Overall Study|Other Reason|1|||
126382023|NCT01082081|454691932|FG002|Overall Study|Other Reason|0|||
126382024|NCT00670930|454691935|FG000|Overall Study|Adminstrative Problem|0|||
126717289|NCT01793051|455916171|FG001|Overall Study|Lack of compliance|0|||
126771150|NCT03454672|456116284|FG000|Overall Study|Non-compliance|2|||
126382025|NCT00670930|454691936|FG001|Overall Study|Adminstrative Problem|1|||
126382026|NCT00670930|454691935|FG000|Overall Study|Lost to Follow-up|1|||
126382027|NCT00670930|454691936|FG001|Overall Study|Lost to Follow-up|0|||
126382028|NCT03493451|454693476|FG000|Overall Study|Death|11|||
126717290|NCT01793051|455916170|FG000|Overall Study|Requested to be removed from the study|1|||
126382029|NCT03493451|454693477|FG001|Overall Study|Death|26|||
126382030|NCT03493451|454693478|FG002|Overall Study|Death|3|||
126382031|NCT03493451|454693476|FG000|Overall Study|Lost to Follow-up|1|||
126382032|NCT03493451|454693477|FG001|Overall Study|Lost to Follow-up|4|||
126382033|NCT03493451|454693478|FG002|Overall Study|Lost to Follow-up|1|||
126382034|NCT03493451|454693476|FG000|Overall Study|Withdrawal by Subject|1|||
126382035|NCT03493451|454693477|FG001|Overall Study|Withdrawal by Subject|1|||
126382036|NCT03493451|454693478|FG002|Overall Study|Withdrawal by Subject|2|||
126382037|NCT03493451|454693476|FG000|Overall Study|Progressive Disease|1|||
126382038|NCT03493451|454693477|FG001|Overall Study|Progressive Disease|0|||
126382039|NCT03493451|454693478|FG002|Overall Study|Progressive Disease|0|||
126382040|NCT03493451|454693476|FG000|Overall Study|Transferred to long term extension study|8|||
126382041|NCT03493451|454693477|FG001|Overall Study|Transferred to long term extension study|13|||
126382042|NCT03493451|454693478|FG002|Overall Study|Transferred to long term extension study|5|||
126382043|NCT00600106|454693484|FG000|Overall Study|Withdrawal by Subject|1|||
126382044|NCT00600106|454693485|FG001|Overall Study|Withdrawal by Subject|1|||
126382045|NCT03015363|454693488|FG000|Overall Study|Physician Decision|14|||
126382046|NCT03015363|454693488|FG000|Overall Study|Withdrawal by Subject|3|||
126382047|NCT01947283|454693491|FG000|Overall Study|Death|1|||
126382048|NCT01947283|454693492|FG001|Overall Study|Death|1|||
126382049|NCT01947283|454693493|FG002|Overall Study|Death|1|||
126382050|NCT01947283|454693494|FG003|Overall Study|Death|0|||
126382051|NCT01947283|454693495|FG004|Overall Study|Death|0|||
126382052|NCT01947283|454693496|FG005|Overall Study|Death|0|||
126382053|NCT01947283|454693497|FG006|Overall Study|Death|0|||
126382054|NCT01947283|454693491|FG000|Overall Study|Lost to Follow-up|4|||
126382055|NCT01947283|454693492|FG001|Overall Study|Lost to Follow-up|6|||
126382056|NCT01947283|454693493|FG002|Overall Study|Lost to Follow-up|5|||
126382057|NCT01947283|454693494|FG003|Overall Study|Lost to Follow-up|5|||
126382058|NCT01947283|454693495|FG004|Overall Study|Lost to Follow-up|0|||
126382059|NCT01947283|454693496|FG005|Overall Study|Lost to Follow-up|2|||
126382060|NCT01947283|454693497|FG006|Overall Study|Lost to Follow-up|5|||
126382061|NCT01947283|454693491|FG000|Overall Study|Withdrawal by Subject|10|||
126382062|NCT01947283|454693492|FG001|Overall Study|Withdrawal by Subject|8|||
126382063|NCT01947283|454693493|FG002|Overall Study|Withdrawal by Subject|4|||
126382064|NCT01947283|454693494|FG003|Overall Study|Withdrawal by Subject|1|||
126382065|NCT01947283|454693495|FG004|Overall Study|Withdrawal by Subject|0|||
126382066|NCT01947283|454693496|FG005|Overall Study|Withdrawal by Subject|0|||
126382067|NCT01947283|454693497|FG006|Overall Study|Withdrawal by Subject|2|||
126382068|NCT01947283|454693491|FG000|Overall Study|No Clinical Recording|12|||
126717291|NCT01793051|455916171|FG001|Overall Study|Requested to be removed from the study|1|||
126717292|NCT04467164|455916175|FG000|Washout (1 Week)|Lost to Follow-up|2|||
126717293|NCT04467164|455916176|FG001|Washout (1 Week)|Lost to Follow-up|0|||
126717294|NCT03276936|455916179|FG000|Overall Study|Adverse Event|4|||
126717295|NCT03276936|455916180|FG001|Overall Study|Adverse Event|2|||
126717296|NCT03276936|455916179|FG000|Overall Study|Lost to Follow-up|16|||
126717297|NCT03276936|455916180|FG001|Overall Study|Lost to Follow-up|13|||
126717298|NCT03276936|455916179|FG000|Overall Study|Withdrawal by Subject|30|||
126717299|NCT03276936|455916180|FG001|Overall Study|Withdrawal by Subject|20|||
126717300|NCT03276936|455916179|FG000|Overall Study|Not mentioned|6|||
126717301|NCT03276936|455916180|FG001|Overall Study|Not mentioned|3|||
126717302|NCT01798134|455916181|FG000|Overall Study|Lost to Follow-up|1|||
126717303|NCT01798134|455916181|FG000|Overall Study|Withdrawal by Subject|3|||
126717304|NCT01798134|455916181|FG000|Overall Study|Death|2|||
126717305|NCT01798134|455916181|FG000|Overall Study|Adverse Event|3|||
126717306|NCT01798134|455916181|FG000|Overall Study|Physician Decision|3|||
126717307|NCT01798134|455916181|FG000|Overall Study|Liver transplant/surgery|4|||
126717308|NCT00625365|455916182|FG000|Overall Study|Withdrawal by Subject|1|||
126717309|NCT00625365|455916182|FG000|Overall Study|No IV access|5|||
126717310|NCT00625365|455916182|FG000|Overall Study|VSD|1|||
126717311|NCT01703286|455916184|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
126717312|NCT01703286|455916185|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
126717313|NCT01703286|455916186|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
126717314|NCT01703286|455916187|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
126717315|NCT01703286|455916188|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
126382069|NCT01947283|454693492|FG001|Overall Study|No Clinical Recording|6|||
126382070|NCT01947283|454693493|FG002|Overall Study|No Clinical Recording|8|||
126382071|NCT01947283|454693494|FG003|Overall Study|No Clinical Recording|10|||
126382072|NCT01947283|454693495|FG004|Overall Study|No Clinical Recording|0|||
126382073|NCT01947283|454693496|FG005|Overall Study|No Clinical Recording|0|||
126382074|NCT01947283|454693497|FG006|Overall Study|No Clinical Recording|0|||
126382075|NCT01947283|454693491|FG000|Overall Study|Non-coding Clinical Recording language|0|||
126382076|NCT01947283|454693492|FG001|Overall Study|Non-coding Clinical Recording language|0|||
126382077|NCT01947283|454693493|FG002|Overall Study|Non-coding Clinical Recording language|0|||
126382078|NCT01947283|454693494|FG003|Overall Study|Non-coding Clinical Recording language|1|||
126382079|NCT01947283|454693495|FG004|Overall Study|Non-coding Clinical Recording language|0|||
126717316|NCT01703286|455916189|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
126717317|NCT01703286|455916184|FG000|Period 2 Including Washout|Adverse Event|0|||
126717318|NCT01703286|455916185|FG001|Period 2 Including Washout|Adverse Event|0|||
126382080|NCT01947283|454693496|FG005|Overall Study|Non-coding Clinical Recording language|0|||
126382081|NCT01947283|454693497|FG006|Overall Study|Non-coding Clinical Recording language|0|||
126382082|NCT01947283|454693491|FG000|Overall Study|Missing Follow-up Assessment|2|||
126382083|NCT01947283|454693492|FG001|Overall Study|Missing Follow-up Assessment|2|||
126382084|NCT01947283|454693493|FG002|Overall Study|Missing Follow-up Assessment|3|||
126382085|NCT01947283|454693494|FG003|Overall Study|Missing Follow-up Assessment|0|||
126382086|NCT01947283|454693495|FG004|Overall Study|Missing Follow-up Assessment|0|||
126382087|NCT01947283|454693496|FG005|Overall Study|Missing Follow-up Assessment|2|||
126382088|NCT01947283|454693497|FG006|Overall Study|Missing Follow-up Assessment|0|||
126382089|NCT01947283|454693491|FG000|Overall Study|No patients were enrolled in study|0|||
126382090|NCT01947283|454693492|FG001|Overall Study|No patients were enrolled in study|0|||
126382091|NCT01947283|454693493|FG002|Overall Study|No patients were enrolled in study|0|||
126382092|NCT01947283|454693494|FG003|Overall Study|No patients were enrolled in study|0|||
126382093|NCT01947283|454693495|FG004|Overall Study|No patients were enrolled in study|0|||
126382094|NCT01947283|454693496|FG005|Overall Study|No patients were enrolled in study|3|||
126382095|NCT01947283|454693497|FG006|Overall Study|No patients were enrolled in study|1|||
126382096|NCT00460655|454693498|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
126382097|NCT00460655|454693499|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126382098|NCT00460655|454693500|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126382099|NCT00460655|454693501|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126382100|NCT00460655|454693498|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
126382101|NCT00460655|454693499|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126382102|NCT00460655|454693500|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126382103|NCT00460655|454693501|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126382104|NCT00460655|454693498|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
126382105|NCT00460655|454693499|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
126382106|NCT00460655|454693500|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
126382107|NCT00460655|454693501|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
126382108|NCT00460655|454693498|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126382109|NCT00460655|454693499|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126382110|NCT00460655|454693500|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
126382111|NCT00460655|454693501|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
126382112|NCT00460655|454693498|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126382113|NCT00460655|454693499|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126382114|NCT00460655|454693500|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
126382115|NCT00460655|454693501|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
126382116|NCT00460655|454693498|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
126382117|NCT00460655|454693499|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
126382118|NCT00460655|454693500|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
126382119|NCT00460655|454693501|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
126382120|NCT00833469|454693502|FG000|Overall Study|Withdrawal by Subject|1|||
126382121|NCT00833469|454693502|FG000|Overall Study|Lost to Follow-up|1|||
126382122|NCT01665911|454693503|FG000|Overall Study|Protocol Violation|4|||
126382123|NCT01665911|454693503|FG000|Overall Study|Withdrawal by Subject|1|||
126382124|NCT01665911|454693503|FG000|Overall Study|Adverse Event|1|||
126382125|NCT00735553|454693504|FG000|Overall Study|Study prematurely terminated|77|||
126382126|NCT03650413|454693505|FG000|Overall Study|Adverse Event|1|||
126382127|NCT03650413|454693505|FG000|Overall Study|Lack of Efficacy|17|||
126382128|NCT03650413|454693505|FG000|Overall Study|Other|9|||
126382129|NCT03650413|454693505|FG000|Overall Study|Physician Decision|2|||
126382130|NCT03650413|454693505|FG000|Overall Study|Study Terminated By Sponsor|16|||
126382131|NCT03650413|454693505|FG000|Overall Study|Withdrawal by Subject|16|||
126382132|NCT03654040|454693506|FG000|Overall Study|Death|1|||
126382133|NCT03654040|454693507|FG001|Overall Study|Death|0|||
126382134|NCT03654040|454693506|FG000|Overall Study|Withdrawal by Subject|1|||
126382135|NCT03654040|454693507|FG001|Overall Study|Withdrawal by Subject|0|||
126382136|NCT03654040|454693506|FG000|Overall Study|Study terminated by sponsor|8|||
126382137|NCT03654040|454693507|FG001|Overall Study|Study terminated by sponsor|2|||
126382138|NCT03654040|454693506|FG000|Overall Study|Failure to initiate study therapy|2|||
126553304|NCT03230864|455320560|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
126553305|NCT03230864|455320557|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
126717319|NCT01703286|455916186|FG002|Period 2 Including Washout|Adverse Event|0|||
126717320|NCT01703286|455916187|FG003|Period 2 Including Washout|Adverse Event|1|||
126382139|NCT03654040|454693507|FG001|Overall Study|Failure to initiate study therapy|0|||
126382140|NCT03654040|454693506|FG000|Overall Study|Transplanted at another center|2|||
126382141|NCT03654040|454693507|FG001|Overall Study|Transplanted at another center|0|||
126382142|NCT03654040|454693506|FG000|Overall Study|Failure to meet eligibility criteria|14|||
126382143|NCT03654040|454693507|FG001|Overall Study|Failure to meet eligibility criteria|2|||
126553306|NCT03230864|455320558|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
126717321|NCT01703286|455916188|FG004|Period 2 Including Washout|Adverse Event|0|||
126717322|NCT01703286|455916189|FG005|Period 2 Including Washout|Adverse Event|0|||
126382144|NCT03654040|454693506|FG000|Overall Study|No longer transplant candidate|1|||
126382145|NCT03654040|454693507|FG001|Overall Study|No longer transplant candidate|0|||
126382146|NCT03654040|454693506|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
126382147|NCT03654040|454693507|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
126382148|NCT03654040|454693506|FG000|Overall Study|Recipient ineligible|0|||
126382149|NCT03654040|454693507|FG001|Overall Study|Recipient ineligible|2|||
126382150|NCT03654040|454693506|FG000|Overall Study|Received deceased liver|0|||
126382151|NCT03654040|454693507|FG001|Overall Study|Received deceased liver|1|||
126382152|NCT01484496|454693511|FG000|Period 1|Protocol Violation|3|||
126382153|NCT01484496|454693512|FG001|Period 1|Protocol Violation|4|||
126382154|NCT01484496|454693513|FG002|Period 1|Protocol Violation|0|||
126382155|NCT01484496|454693514|FG003|Period 1|Protocol Violation|0|||
126382156|NCT01484496|454693511|FG000|Period 1|Physician Decision|5|||
126382157|NCT01484496|454693512|FG001|Period 1|Physician Decision|1|||
126382158|NCT01484496|454693513|FG002|Period 1|Physician Decision|0|||
126382159|NCT01484496|454693514|FG003|Period 1|Physician Decision|0|||
126382160|NCT01484496|454693511|FG000|Period 1|Lack of Efficacy|10|||
126382161|NCT01484496|454693512|FG001|Period 1|Lack of Efficacy|15|||
126382162|NCT01484496|454693513|FG002|Period 1|Lack of Efficacy|0|||
126382163|NCT01484496|454693514|FG003|Period 1|Lack of Efficacy|0|||
126382164|NCT01484496|454693511|FG000|Period 1|Adverse Event|25|||
126382165|NCT01484496|454693512|FG001|Period 1|Adverse Event|40|||
126382166|NCT01484496|454693513|FG002|Period 1|Adverse Event|0|||
126382167|NCT01484496|454693514|FG003|Period 1|Adverse Event|0|||
126382168|NCT01484496|454693511|FG000|Period 1|Withdrawal by Subject|15|||
126382169|NCT01484496|454693512|FG001|Period 1|Withdrawal by Subject|12|||
126382170|NCT01484496|454693513|FG002|Period 1|Withdrawal by Subject|0|||
126382171|NCT01484496|454693514|FG003|Period 1|Withdrawal by Subject|0|||
126382172|NCT01484496|454693511|FG000|Period 1|Lost to Follow-up|2|||
126382173|NCT01484496|454693512|FG001|Period 1|Lost to Follow-up|6|||
126382174|NCT01484496|454693513|FG002|Period 1|Lost to Follow-up|0|||
126382175|NCT01484496|454693514|FG003|Period 1|Lost to Follow-up|0|||
126553307|NCT03230864|455320559|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
126553308|NCT03230864|455320560|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
126553309|NCT03230864|455320557|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
126553310|NCT03230864|455320558|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
126553311|NCT03230864|455320559|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
126553312|NCT03230864|455320560|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
126382176|NCT01484496|454693511|FG000|Period 1|Positive Pregnancy|1|||
126382177|NCT01484496|454693512|FG001|Period 1|Positive Pregnancy|6|||
126382178|NCT01484496|454693513|FG002|Period 1|Positive Pregnancy|0|||
126382179|NCT01484496|454693514|FG003|Period 1|Positive Pregnancy|0|||
126382180|NCT01484496|454693511|FG000|Period 1|Treatment Failure|3|||
126382181|NCT01484496|454693512|FG001|Period 1|Treatment Failure|6|||
126382182|NCT01484496|454693513|FG002|Period 1|Treatment Failure|0|||
126382183|NCT01484496|454693514|FG003|Period 1|Treatment Failure|0|||
126382184|NCT01484496|454693511|FG000|Period 1|Lack of Compliance|2|||
126382185|NCT01484496|454693512|FG001|Period 1|Lack of Compliance|1|||
126382186|NCT01484496|454693513|FG002|Period 1|Lack of Compliance|0|||
126382187|NCT01484496|454693514|FG003|Period 1|Lack of Compliance|0|||
126382188|NCT01484496|454693511|FG000|Period 1|Unable to Visit Site|0|||
126382189|NCT01484496|454693512|FG001|Period 1|Unable to Visit Site|2|||
126382190|NCT01484496|454693513|FG002|Period 1|Unable to Visit Site|0|||
126382191|NCT01484496|454693514|FG003|Period 1|Unable to Visit Site|0|||
126382192|NCT01484496|454693511|FG000|Period 2|Lack of Efficacy|0|||
126382193|NCT01484496|454693512|FG001|Period 2|Lack of Efficacy|0|||
126382194|NCT01484496|454693513|FG002|Period 2|Lack of Efficacy|1|||
126382195|NCT01484496|454693514|FG003|Period 2|Lack of Efficacy|3|||
126382196|NCT01484496|454693511|FG000|Period 2|Adverse Event|0|||
126382197|NCT01484496|454693512|FG001|Period 2|Adverse Event|0|||
126382198|NCT01484496|454693513|FG002|Period 2|Adverse Event|5|||
126382199|NCT01484496|454693514|FG003|Period 2|Adverse Event|13|||
126382200|NCT01484496|454693511|FG000|Period 2|Other|0|||
126382201|NCT01484496|454693512|FG001|Period 2|Other|0|||
126382202|NCT01484496|454693513|FG002|Period 2|Other|9|||
126382203|NCT01484496|454693514|FG003|Period 2|Other|6|||
126382204|NCT01645735|454693515|FG000|Overall Study|Physician Decision|2|||
126382205|NCT01645735|454693516|FG001|Overall Study|Physician Decision|0|||
126382206|NCT01645735|454693515|FG000|Overall Study|Withdrawal by Subject|1|||
126553313|NCT03230864|455320557|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
126717323|NCT01984346|455916190|FG000|Overall Study|Physician Decision|4|||
126382207|NCT01645735|454693516|FG001|Overall Study|Withdrawal by Subject|0|||
126382208|NCT01645735|454693515|FG000|Overall Study|Protocol Violation|1|||
126382209|NCT01645735|454693516|FG001|Overall Study|Protocol Violation|0|||
126382210|NCT01645735|454693515|FG000|Overall Study|Adverse Event|0|||
126382211|NCT01645735|454693516|FG001|Overall Study|Adverse Event|1|||
126382212|NCT01206140|454693517|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
126382213|NCT01206140|454693518|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
126382214|NCT00211172|454693519|FG000|Overall Study|Died or lost health plan eligibility|39|||
126382215|NCT00211172|454693520|FG001|Overall Study|Died or lost health plan eligibility|32|||
126382216|NCT00770562|454693526|FG000|Overall Study|Did not take treatment|1|||
126382217|NCT00770562|454693527|FG001|Overall Study|Did not take treatment|1|||
126382218|NCT01643408|454693528|FG000|Overall Study|Adverse Event|12|||
126382219|NCT01643408|454693528|FG000|Overall Study|Other|2|||
126382220|NCT02236572|454693529|FG000|Overall Study|Withdrawal by Subject|1|||
126382221|NCT02236572|454693529|FG000|Overall Study|Protocol Violation|1|||
126382222|NCT02236572|454693529|FG000|Overall Study|Lost to Follow-up|1|||
126382223|NCT01057693|454693530|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
126382224|NCT01057693|454693531|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
126382225|NCT01057693|454693532|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
126382226|NCT01057693|454693530|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
126382227|NCT01057693|454693531|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
126382228|NCT01057693|454693532|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
126382229|NCT01057693|454693530|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
126382230|NCT01057693|454693531|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
126382231|NCT01057693|454693532|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
126382232|NCT01057693|454693530|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
126382233|NCT01057693|454693531|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
126382234|NCT01057693|454693532|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
126382235|NCT01057693|454693530|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
126382236|NCT01057693|454693531|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
126382237|NCT01057693|454693532|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
126382238|NCT01057693|454693530|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
126382239|NCT01057693|454693531|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
126382240|NCT01057693|454693532|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
126382241|NCT01057693|454693530|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
126382242|NCT01057693|454693531|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
126382243|NCT01057693|454693532|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
126382244|NCT01057693|454693530|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
126382245|NCT01057693|454693531|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
126382246|NCT01057693|454693532|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
126382247|NCT01057693|454693530|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
126382248|NCT01057693|454693531|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
126382249|NCT01057693|454693532|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
126382250|NCT01057693|454693530|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
126382251|NCT01057693|454693531|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
126382252|NCT01057693|454693532|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
126382253|NCT01057693|454693530|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
126382254|NCT01057693|454693531|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
126382255|NCT01057693|454693532|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
126382256|NCT01057693|454693530|FG000|Between Single-Blind and Double-Blind|Other|6|||
126382257|NCT01057693|454693531|FG001|Between Single-Blind and Double-Blind|Other|0|||
126382258|NCT01057693|454693532|FG002|Between Single-Blind and Double-Blind|Other|0|||
126382259|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
126382260|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
126382261|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
126382262|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
126717324|NCT01984346|455916191|FG001|Overall Study|Physician Decision|2|||
126717325|NCT01984346|455916190|FG000|Overall Study|Withdrawal by Subject|2|||
126717326|NCT01984346|455916191|FG001|Overall Study|Withdrawal by Subject|2|||
126717327|NCT01984346|455916190|FG000|Overall Study|Enrollment Closed|8|||
126717328|NCT01984346|455916191|FG001|Overall Study|Enrollment Closed|1|||
126717329|NCT01984346|455916190|FG000|Overall Study|Insurance Coverage|1|||
126717330|NCT01984346|455916191|FG001|Overall Study|Insurance Coverage|0|||
126717331|NCT01984346|455916190|FG000|Overall Study|Intra-operative Exclusion|2|||
126717332|NCT01984346|455916191|FG001|Overall Study|Intra-operative Exclusion|0|||
126717333|NCT01234402|455916193|FG000|Overall Study|Lost to Follow-up|0|||
126717334|NCT01234402|455916194|FG001|Overall Study|Lost to Follow-up|1|||
126717335|NCT01234402|455916195|FG002|Overall Study|Lost to Follow-up|3|||
126717336|NCT01234402|455916193|FG000|Overall Study|Withdrawal by Subject|1|||
126382263|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
126382264|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
126468107|NCT02787551|455015193|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
126382265|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
126382266|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
126468108|NCT02787551|455015194|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
126717337|NCT01234402|455916194|FG001|Overall Study|Withdrawal by Subject|3|||
126717338|NCT01234402|455916195|FG002|Overall Study|Withdrawal by Subject|4|||
126717339|NCT01234402|455916193|FG000|Overall Study|Never treated: Death|0|||
126382267|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
126382268|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
126382269|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
126382270|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
126382271|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
126382272|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
126382273|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
126382274|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
126382275|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
126382276|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
126382277|NCT01057693|454693530|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
126382278|NCT01057693|454693531|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
126382279|NCT01057693|454693532|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
126382280|NCT00709319|454693534|FG000|Overall Study|Death|4|||
126382281|NCT00709319|454693534|FG000|Overall Study|Withdrawal by Subject|2|||
126382282|NCT00579553|454693535|FG000|Overall Study|Lost to Follow-up|16|||
126382283|NCT00579553|454693536|FG001|Overall Study|Lost to Follow-up|13|||
126382284|NCT00363142|454693539|FG000|Overall Study|Adverse Event|2|||
126382285|NCT00363142|454693540|FG001|Overall Study|Adverse Event|0|||
126382286|NCT00363142|454693539|FG000|Overall Study|Lack of Efficacy|0|||
126382287|NCT00363142|454693540|FG001|Overall Study|Lack of Efficacy|1|||
126382288|NCT00363142|454693539|FG000|Overall Study|Lost to Follow-up|1|||
126382289|NCT00363142|454693540|FG001|Overall Study|Lost to Follow-up|0|||
126382290|NCT00363142|454693539|FG000|Overall Study|Non-compliance|1|||
126382291|NCT00363142|454693540|FG001|Overall Study|Non-compliance|1|||
126382292|NCT00363142|454693539|FG000|Overall Study|Withdrawal by Subject|3|||
126382293|NCT00363142|454693540|FG001|Overall Study|Withdrawal by Subject|1|||
126382294|NCT01541865|454693541|FG000|Overall Study|Lost to Follow-up|11|||
126382295|NCT01541865|454693541|FG000|Overall Study|Withdrawal by Subject|9|||
126382296|NCT01541865|454693541|FG000|Overall Study|Adverse Event|1|||
126382297|NCT01541865|454693541|FG000|Overall Study|Protocol Violation|1|||
126382298|NCT03072043|454693544|FG000|Overall Study|Death|0|||
126468109|NCT02787551|455015193|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
126468110|NCT02787551|455015194|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
126468111|NCT02787551|455015193|FG000|Core Period: 26 Weeks|Other than specified|3|||
126468112|NCT02787551|455015194|FG001|Core Period: 26 Weeks|Other than specified|1|||
126468113|NCT02787551|455015193|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
126468114|NCT02787551|455015194|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
126468115|NCT02787551|455015193|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
126468116|NCT02787551|455015194|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
126468117|NCT02787551|455015193|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
126468118|NCT02787551|455015194|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
126468119|NCT01638819|455015195|FG000|Overall Study|Lost to Follow-up|1|||
126468120|NCT01638819|455015196|FG001|Overall Study|Lost to Follow-up|0|||
126468121|NCT00237185|455015197|FG000|Core|Adverse Event|3|||
126468122|NCT00237185|455015198|FG001|Core|Adverse Event|4|||
126468123|NCT00237185|455015197|FG000|Core|Abnormal laboratory value|0|||
126468124|NCT00237185|455015198|FG001|Core|Abnormal laboratory value|4|||
126468125|NCT00237185|455015197|FG000|Core|Abnormal test procedure results|1|||
126468126|NCT00237185|455015198|FG001|Core|Abnormal test procedure results|0|||
126468127|NCT00237185|455015197|FG000|Core|Lack of Efficacy|30|||
126468128|NCT00237185|455015198|FG001|Core|Lack of Efficacy|23|||
126468129|NCT00237185|455015197|FG000|Core|Protocol Violation|1|||
126468130|NCT00237185|455015198|FG001|Core|Protocol Violation|1|||
126468131|NCT00237185|455015197|FG000|Core|Withdrawal by Subject|4|||
126468132|NCT00237185|455015198|FG001|Core|Withdrawal by Subject|4|||
126468133|NCT00237185|455015197|FG000|Core|Administrative problems|0|||
126468134|NCT00237185|455015198|FG001|Core|Administrative problems|1|||
126468135|NCT00237185|455015197|FG000|Core|Death|4|||
126468136|NCT00237185|455015198|FG001|Core|Death|0|||
126468137|NCT00237185|455015197|FG000|Core|Determined ineligible post randomization|1|||
126771151|NCT03454672|456116285|FG001|Overall Study|Non-compliance|4|||
126771152|NCT03454672|456116284|FG000|Overall Study|personal reasons|3|||
126771153|NCT03454672|456116285|FG001|Overall Study|personal reasons|2|||
126771154|NCT03454672|456116284|FG000|Overall Study|Withdrawal by Subject|1|||
126382299|NCT03072043|454693545|FG001|Overall Study|Death|0|||
126468138|NCT00237185|455015198|FG001|Core|Determined ineligible post randomization|0|||
126468139|NCT00237185|455015197|FG000|Extension|Adverse Event|1|||
126468140|NCT00237185|455015198|FG001|Extension|Adverse Event|0|||
126468141|NCT00237185|455015197|FG000|Extension|Abnormal laboratory value|0|||
126468142|NCT00237185|455015198|FG001|Extension|Abnormal laboratory value|1|||
126382300|NCT03072043|454693546|FG002|Overall Study|Death|3|||
126382301|NCT03072043|454693544|FG000|Overall Study|Adverse Event|0|||
126382302|NCT03072043|454693545|FG001|Overall Study|Adverse Event|0|||
126382303|NCT03072043|454693546|FG002|Overall Study|Adverse Event|2|||
126468143|NCT00237185|455015197|FG000|Extension|Lack of Efficacy|9|||
126468144|NCT00237185|455015198|FG001|Extension|Lack of Efficacy|14|||
126468145|NCT00237185|455015197|FG000|Extension|Condition no longer required study drug|0|||
126468146|NCT00237185|455015198|FG001|Extension|Condition no longer required study drug|1|||
126468147|NCT00237185|455015197|FG000|Extension|Withdrawal by Subject|3|||
126468148|NCT00237185|455015198|FG001|Extension|Withdrawal by Subject|2|||
126468149|NCT00237185|455015197|FG000|Extension|Lost to Follow-up|1|||
126468150|NCT00237185|455015198|FG001|Extension|Lost to Follow-up|0|||
126468151|NCT00237185|455015197|FG000|Extension|Administrative problems|1|||
126468152|NCT00237185|455015198|FG001|Extension|Administrative problems|0|||
126468153|NCT00237185|455015197|FG000|Extension|Death|1|||
126468154|NCT00237185|455015198|FG001|Extension|Death|1|||
126468155|NCT05156073|455015199|FG000|Overall Study|Patient canceled appointment with PCP|1|||
126468156|NCT02891161|455015210|FG000|Study Treatment|Disease Progression|2|||
126468157|NCT02891161|455015211|FG001|Study Treatment|Disease Progression|4|||
126468158|NCT02891161|455015210|FG000|Study Treatment|AE/Side Effects/Complications|1|||
126468159|NCT02891161|455015211|FG001|Study Treatment|AE/Side Effects/Complications|5|||
126468160|NCT02891161|455015210|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
126468161|NCT02891161|455015211|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
126468162|NCT02891161|455015210|FG000|Follow up|Death|4|||
126468163|NCT02891161|455015211|FG001|Follow up|Death|8|||
126468164|NCT02891161|455015210|FG000|Follow up|Refused to Follow up|0|||
126468165|NCT02891161|455015211|FG001|Follow up|Refused to Follow up|2|||
126468166|NCT02891161|455015210|FG000|Follow up|Symptomatic deterioration|0|||
126468167|NCT02891161|455015211|FG001|Follow up|Symptomatic deterioration|1|||
126468168|NCT02891161|455015210|FG000|Follow up|Study terminated|0|||
126468169|NCT02891161|455015211|FG001|Follow up|Study terminated|6|||
126468170|NCT02734433|455015213|FG000|Overall Study|Disease progression|1|||
126468171|NCT02734433|455015214|FG001|Overall Study|Disease progression|5|||
126553314|NCT03230864|455320558|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
126553315|NCT03230864|455320559|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
126553316|NCT03230864|455320560|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
126553317|NCT03230864|455320557|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
126553318|NCT03230864|455320558|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
126553319|NCT03230864|455320559|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
126553320|NCT03230864|455320560|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
126382304|NCT03072043|454693544|FG000|Overall Study|Withdrawal by Subject|0|||
126382305|NCT03072043|454693545|FG001|Overall Study|Withdrawal by Subject|0|||
126382306|NCT03072043|454693546|FG002|Overall Study|Withdrawal by Subject|4|||
126382307|NCT01340664|454693547|FG000|Overall Study|Adverse Event|0|||
126382308|NCT01340664|454693548|FG001|Overall Study|Adverse Event|1|||
126382309|NCT01340664|454693549|FG002|Overall Study|Adverse Event|7|||
126382310|NCT01340664|454693547|FG000|Overall Study|Lost to Follow-up|2|||
126382311|NCT01340664|454693548|FG001|Overall Study|Lost to Follow-up|0|||
126382312|NCT01340664|454693549|FG002|Overall Study|Lost to Follow-up|2|||
126382313|NCT01340664|454693547|FG000|Overall Study|Withdrawal by Subject|2|||
126382314|NCT01340664|454693548|FG001|Overall Study|Withdrawal by Subject|4|||
126382315|NCT01340664|454693549|FG002|Overall Study|Withdrawal by Subject|0|||
126382316|NCT01340664|454693547|FG000|Overall Study|Glycemic withdrawal criteria|2|||
126382317|NCT01340664|454693548|FG001|Overall Study|Glycemic withdrawal criteria|0|||
126382318|NCT01340664|454693549|FG002|Overall Study|Glycemic withdrawal criteria|0|||
126382319|NCT01340664|454693547|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
126382320|NCT01340664|454693548|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
126382321|NCT01340664|454693549|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
126382322|NCT01340664|454693547|FG000|Overall Study|Other|1|||
126382323|NCT01340664|454693548|FG001|Overall Study|Other|2|||
126382324|NCT01340664|454693549|FG002|Overall Study|Other|2|||
126382325|NCT02997865|454693551|FG000|Overall Study|Death|2|||
126382326|NCT02997865|454693552|FG001|Overall Study|Death|1|||
126382327|NCT02997865|454693551|FG000|Overall Study|Lost to Follow-up|6|||
126382328|NCT02997865|454693552|FG001|Overall Study|Lost to Follow-up|3|||
126382329|NCT02997865|454693551|FG000|Overall Study|Withdrawal by Subject|5|||
126382330|NCT02997865|454693552|FG001|Overall Study|Withdrawal by Subject|0|||
126382331|NCT01926444|454693553|FG000|Overall Study|Colonoscopy not performed|0|||
126382332|NCT01926444|454693554|FG001|Overall Study|Colonoscopy not performed|0|||
126382333|NCT01926444|454693555|FG002|Overall Study|Colonoscopy not performed|4|||
126382334|NCT01926444|454693556|FG003|Overall Study|Colonoscopy not performed|2|||
126382335|NCT02528942|454693557|FG000|Overall Study|Did not meet imaging criteria|9|||
126382336|NCT02528942|454693557|FG000|Overall Study|Lost to Follow-up|25|||
126382337|NCT00881530|454693558|FG000|Overall Study|Adverse Event|5|||
126468172|NCT02734433|455015213|FG000|Overall Study|Clinical progression|0|||
126468173|NCT02734433|455015214|FG001|Overall Study|Clinical progression|1|||
126468174|NCT02734433|455015213|FG000|Overall Study|Withdrawal by Subject|1|||
126468175|NCT02734433|455015214|FG001|Overall Study|Withdrawal by Subject|2|||
126382338|NCT00881530|454693559|FG001|Overall Study|Adverse Event|1|||
126382339|NCT00881530|454693560|FG002|Overall Study|Adverse Event|1|||
126382340|NCT00881530|454693561|FG003|Overall Study|Adverse Event|4|||
126382341|NCT00881530|454693562|FG004|Overall Study|Adverse Event|10|||
126382342|NCT00881530|454693563|FG005|Overall Study|Adverse Event|2|||
126382343|NCT00881530|454693558|FG000|Overall Study|Lack of Efficacy|1|||
126382344|NCT00881530|454693559|FG001|Overall Study|Lack of Efficacy|0|||
126382345|NCT00881530|454693560|FG002|Overall Study|Lack of Efficacy|0|||
126382346|NCT00881530|454693561|FG003|Overall Study|Lack of Efficacy|0|||
126382347|NCT00881530|454693562|FG004|Overall Study|Lack of Efficacy|1|||
126382348|NCT00881530|454693563|FG005|Overall Study|Lack of Efficacy|1|||
126382349|NCT00881530|454693558|FG000|Overall Study|Not compliant with the protocol|0|||
126382350|NCT00881530|454693559|FG001|Overall Study|Not compliant with the protocol|0|||
126382351|NCT00881530|454693560|FG002|Overall Study|Not compliant with the protocol|0|||
126382352|NCT00881530|454693561|FG003|Overall Study|Not compliant with the protocol|0|||
126382353|NCT00881530|454693562|FG004|Overall Study|Not compliant with the protocol|2|||
126382354|NCT00881530|454693563|FG005|Overall Study|Not compliant with the protocol|0|||
126382355|NCT00881530|454693558|FG000|Overall Study|Lost to Follow-up|0|||
126382356|NCT00881530|454693559|FG001|Overall Study|Lost to Follow-up|1|||
126382357|NCT00881530|454693560|FG002|Overall Study|Lost to Follow-up|1|||
126382358|NCT00881530|454693561|FG003|Overall Study|Lost to Follow-up|3|||
126382359|NCT00881530|454693562|FG004|Overall Study|Lost to Follow-up|1|||
126382360|NCT00881530|454693563|FG005|Overall Study|Lost to Follow-up|0|||
126382361|NCT00881530|454693558|FG000|Overall Study|Refused to continue medication|7|||
126382362|NCT00881530|454693559|FG001|Overall Study|Refused to continue medication|2|||
126382363|NCT00881530|454693560|FG002|Overall Study|Refused to continue medication|1|||
126382364|NCT00881530|454693561|FG003|Overall Study|Refused to continue medication|2|||
126382365|NCT00881530|454693562|FG004|Overall Study|Refused to continue medication|0|||
126382366|NCT00881530|454693563|FG005|Overall Study|Refused to continue medication|0|||
126382367|NCT00881530|454693558|FG000|Overall Study|Other reason not defined above|1|||
126382368|NCT00881530|454693559|FG001|Overall Study|Other reason not defined above|1|||
126382369|NCT00881530|454693560|FG002|Overall Study|Other reason not defined above|2|||
126382370|NCT00881530|454693561|FG003|Overall Study|Other reason not defined above|0|||
126382371|NCT00881530|454693562|FG004|Overall Study|Other reason not defined above|0|||
126382372|NCT00881530|454693563|FG005|Overall Study|Other reason not defined above|2|||
126382373|NCT01509846|454693564|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
126468176|NCT05521906|455015221|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
126468177|NCT05521906|455015222|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
126468178|NCT00560885|455015223|FG000|Overall Study|Death|7|||
126468179|NCT00560885|455015223|FG000|Overall Study|Withdrawal by Subject|1|||
126468180|NCT02887859|455015224|FG000|Overall Study|Ongoing|6|||
126468181|NCT02887859|455015224|FG000|Overall Study|Adverse Event|7|||
126468182|NCT02887859|455015224|FG000|Overall Study|Death|1|||
126468183|NCT02887859|455015224|FG000|Overall Study|Physician Decision|1|||
126468184|NCT03803683|455015225|FG000|Overall Study|Lost to Follow-up|41|||
126468185|NCT03803683|455015226|FG001|Overall Study|Lost to Follow-up|18|||
126468186|NCT03803683|455015227|FG002|Overall Study|Lost to Follow-up|12|||
126468187|NCT03803683|455015225|FG000|Overall Study|Withdrawal by Subject|9|||
126468188|NCT03803683|455015226|FG001|Overall Study|Withdrawal by Subject|1|||
126468189|NCT03803683|455015227|FG002|Overall Study|Withdrawal by Subject|4|||
126717340|NCT01234402|455916194|FG001|Overall Study|Never treated: Death|0|||
126382374|NCT01509846|454693565|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
126382375|NCT01509846|454693566|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
126382376|NCT01509846|454693567|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
126382377|NCT01509846|454693568|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
126382378|NCT01509846|454693564|FG000|Received Vaccination 2|Illness|0|||
126382379|NCT01509846|454693565|FG001|Received Vaccination 2|Illness|0|||
126382380|NCT01509846|454693566|FG002|Received Vaccination 2|Illness|0|||
126382381|NCT01509846|454693567|FG003|Received Vaccination 2|Illness|0|||
126382382|NCT01509846|454693568|FG004|Received Vaccination 2|Illness|1|||
126382383|NCT01509846|454693564|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
126382384|NCT01509846|454693565|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
126382385|NCT01509846|454693566|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
126382386|NCT01509846|454693567|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
126382387|NCT01509846|454693568|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
126382388|NCT01509846|454693564|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
126382389|NCT01509846|454693565|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
126717341|NCT01234402|455916195|FG002|Overall Study|Never treated: Death|1|||
126382390|NCT01509846|454693566|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
126382391|NCT01509846|454693567|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
126382392|NCT01509846|454693568|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
126468190|NCT02063880|455017536|FG000|Overall Study|Death|21|||
126468191|NCT02063880|455017537|FG001|Overall Study|Death|18|||
126468192|NCT02063880|455017536|FG000|Overall Study|Lost to Follow-up|7|||
126468193|NCT02063880|455017537|FG001|Overall Study|Lost to Follow-up|7|||
126717342|NCT01234402|455916193|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
126382393|NCT01509846|454693564|FG000|Received Vaccination 3|Pregnancy|0|||
126382394|NCT01509846|454693565|FG001|Received Vaccination 3|Pregnancy|0|||
126382395|NCT01509846|454693566|FG002|Received Vaccination 3|Pregnancy|0|||
126382396|NCT01509846|454693567|FG003|Received Vaccination 3|Pregnancy|1|||
126382397|NCT01509846|454693568|FG004|Received Vaccination 3|Pregnancy|0|||
126382398|NCT01509846|454693564|FG000|Received Vaccination 3|Lost to Follow-up|0|||
126382399|NCT01509846|454693565|FG001|Received Vaccination 3|Lost to Follow-up|0|||
126382400|NCT01509846|454693566|FG002|Received Vaccination 3|Lost to Follow-up|1|||
126382401|NCT01509846|454693567|FG003|Received Vaccination 3|Lost to Follow-up|0|||
126382402|NCT01509846|454693568|FG004|Received Vaccination 3|Lost to Follow-up|0|||
126382403|NCT01637584|454693569|FG000|Overall Study|Withdrawal by Subject|1|||
126382404|NCT01637584|454693570|FG001|Overall Study|Withdrawal by Subject|3|||
126382405|NCT02484443|454693571|FG000|Overall Study|Lack of Efficacy|28|||
126382406|NCT02484443|454693571|FG000|Overall Study|Physician Decision|2|||
126382407|NCT02484443|454693571|FG000|Overall Study|Ineligible|2|||
126382408|NCT02969915|454693572|FG000|Overall Study|Death|104|||
126382409|NCT02969915|454693573|FG001|Overall Study|Death|125|||
126382410|NCT02969915|454693572|FG000|Overall Study|Lost to Follow-up|108|||
126382411|NCT02969915|454693573|FG001|Overall Study|Lost to Follow-up|112|||
126382412|NCT02969915|454693572|FG000|Overall Study|Censored due to COVID-19|481|||
126382413|NCT02969915|454693573|FG001|Overall Study|Censored due to COVID-19|471|||
126382414|NCT03799952|454693574|FG000|Overall Study|Program was too easy, discontinued|1|||
126382415|NCT03799952|454693575|FG001|Overall Study|Program was too easy, discontinued|0|||
126382416|NCT03799952|454693574|FG000|Overall Study|Lost to Follow-up|0|||
126382417|NCT03799952|454693575|FG001|Overall Study|Lost to Follow-up|2|||
126382418|NCT01393899|454693576|FG000|Overall Study|Study terminated by sponsor|1|||
126382419|NCT01393899|454693577|FG001|Overall Study|Study terminated by sponsor|0|||
126382420|NCT01393899|454693578|FG002|Overall Study|Study terminated by sponsor|1|||
126382421|NCT01393899|454693576|FG000|Overall Study|Other|1|||
126382422|NCT01393899|454693577|FG001|Overall Study|Other|0|||
126382423|NCT01393899|454693578|FG002|Overall Study|Other|0|||
126382424|NCT01393899|454693576|FG000|Overall Study|Withdrawal by Subject|2|||
126382425|NCT01393899|454693577|FG001|Overall Study|Withdrawal by Subject|2|||
126382426|NCT01393899|454693578|FG002|Overall Study|Withdrawal by Subject|1|||
126382427|NCT01393899|454693576|FG000|Overall Study|Lost to Follow-up|0|||
126382428|NCT01393899|454693577|FG001|Overall Study|Lost to Follow-up|0|||
126382429|NCT01393899|454693578|FG002|Overall Study|Lost to Follow-up|1|||
126382430|NCT01393899|454693576|FG000|Overall Study|Does not meet entrance criteria|1|||
126382431|NCT01393899|454693577|FG001|Overall Study|Does not meet entrance criteria|0|||
126382432|NCT01393899|454693578|FG002|Overall Study|Does not meet entrance criteria|1|||
126382433|NCT01393899|454693576|FG000|Overall Study|Lack of Efficacy|26|||
126382434|NCT01393899|454693577|FG001|Overall Study|Lack of Efficacy|21|||
126382435|NCT01393899|454693578|FG002|Overall Study|Lack of Efficacy|16|||
126382436|NCT01393899|454693576|FG000|Overall Study|Adverse Event|1|||
126382437|NCT01393899|454693577|FG001|Overall Study|Adverse Event|5|||
126382438|NCT01393899|454693578|FG002|Overall Study|Adverse Event|3|||
126382439|NCT02503085|454693579|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
126382440|NCT02503085|454693580|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
126382441|NCT02503085|454693581|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
126382442|NCT02503085|454693582|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
126382443|NCT02595866|454693583|FG000|Overall Study|Adverse Event|2|||
126382444|NCT02595866|454693584|FG001|Overall Study|Adverse Event|5|||
126382445|NCT02595866|454693583|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
126382446|NCT02595866|454693584|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
126382447|NCT02595866|454693583|FG000|Overall Study|Death|0|||
126382448|NCT02595866|454693584|FG001|Overall Study|Death|1|||
126771155|NCT03454672|456116285|FG001|Overall Study|Withdrawal by Subject|0|||
126771156|NCT03985293|456116287|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
126382449|NCT02595866|454693583|FG000|Overall Study|Incarceration|1|||
126382450|NCT02595866|454693584|FG001|Overall Study|Incarceration|0|||
126382451|NCT02595866|454693583|FG000|Overall Study|Lack of Efficacy|17|||
126382452|NCT02595866|454693584|FG001|Overall Study|Lack of Efficacy|7|||
126382453|NCT02595866|454693583|FG000|Overall Study|Physician Decision|4|||
126382454|NCT02595866|454693584|FG001|Overall Study|Physician Decision|3|||
126382455|NCT02595866|454693583|FG000|Overall Study|Switched to Alternative Treatment|1|||
126382456|NCT02595866|454693584|FG001|Overall Study|Switched to Alternative Treatment|0|||
126382457|NCT02595866|454693583|FG000|Overall Study|Study Terminated|0|||
126382458|NCT02595866|454693584|FG001|Overall Study|Study Terminated|4|||
126382459|NCT02595866|454693583|FG000|Overall Study|Withdrawal by Subject|6|||
126382460|NCT02595866|454693584|FG001|Overall Study|Withdrawal by Subject|1|||
126382461|NCT02520388|454693585|FG000|Overall Study|Physician Decision|1|||
126382462|NCT02520388|454693586|FG001|Overall Study|Physician Decision|0|||
126382463|NCT02520388|454693585|FG000|Overall Study|Subject or parent/guardian request|0|||
126382464|NCT02520388|454693586|FG001|Overall Study|Subject or parent/guardian request|6|||
126382465|NCT02520388|454693585|FG000|Overall Study|Adverse Event|1|||
126382466|NCT02520388|454693586|FG001|Overall Study|Adverse Event|4|||
126771157|NCT03985293|456116288|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
126382467|NCT02520388|454693585|FG000|Overall Study|Lost to Follow-up|3|||
126771158|NCT03985293|456116289|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
126771159|NCT03985293|456116290|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
126468194|NCT02063880|455017536|FG000|Overall Study|Ineligible|0|||
126468195|NCT02063880|455017537|FG001|Overall Study|Ineligible|2|||
126468196|NCT02106910|455017538|FG000|Overall Study|Lost to Follow-up|1|||
126468197|NCT02106910|455017539|FG001|Overall Study|Lost to Follow-up|1|||
126468198|NCT00567593|455017540|FG000|Overall Study|Adverse Event|1|||
126468199|NCT00567593|455017540|FG000|Overall Study|Physician Decision|1|||
126468200|NCT01675427|455017543|FG000|Overall Study|Withdrawal by Subject|7|||
126468201|NCT01675427|455017543|FG000|Overall Study|Participant Refused Sample Collection|18|||
126468202|NCT01675427|455017543|FG000|Overall Study|Sample not Collected by Mistake|2|||
126468203|NCT01675427|455017543|FG000|Overall Study|Lost to Follow-up|5|||
126468204|NCT01675427|455017543|FG000|Overall Study|Other|2|||
126468205|NCT00700570|455017544|FG000|Overall Study|Adverse Event|2|||
126468206|NCT00700570|455017545|FG001|Overall Study|Adverse Event|6|||
126468207|NCT00700570|455017544|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
126468208|NCT00700570|455017545|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
126468209|NCT00700570|455017544|FG000|Overall Study|Disease Progression|8|||
126468210|NCT00700570|455017545|FG001|Overall Study|Disease Progression|11|||
126468211|NCT00700570|455017544|FG000|Overall Study|Withdrawal by Subject|1|||
126468212|NCT00700570|455017545|FG001|Overall Study|Withdrawal by Subject|6|||
126468213|NCT00611533|455017546|FG000|First Intervention (6 Weeks)|Never started study|0|||
126468214|NCT00611533|455017547|FG001|First Intervention (6 Weeks)|Never started study|1|||
126468215|NCT00611533|455017546|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
126468216|NCT00611533|455017547|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
126468217|NCT00611533|455017546|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
126468218|NCT00611533|455017547|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
126468219|NCT05246397|455017550|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
126468220|NCT04327674|455017556|FG000|Overall Study|Protocol Violation|19|||
126468221|NCT01461980|455017557|FG000|Overall Study|Other|9|||
126468222|NCT01461980|455017558|FG001|Overall Study|Other|8|||
126468223|NCT01461980|455017559|FG002|Overall Study|Other|6|||
126468224|NCT01461980|455017557|FG000|Overall Study|Medication error|7|||
126468225|NCT01461980|455017558|FG001|Overall Study|Medication error|5|||
126468226|NCT01461980|455017559|FG002|Overall Study|Medication error|6|||
126468227|NCT01461980|455017557|FG000|Overall Study|Adverse Event|12|||
126468228|NCT01461980|455017558|FG001|Overall Study|Adverse Event|5|||
126468229|NCT01461980|455017559|FG002|Overall Study|Adverse Event|6|||
126468230|NCT01461980|455017557|FG000|Overall Study|Protocol Violation|12|||
126468231|NCT01461980|455017558|FG001|Overall Study|Protocol Violation|19|||
126468232|NCT01461980|455017559|FG002|Overall Study|Protocol Violation|16|||
126468233|NCT01461980|455017557|FG000|Overall Study|No longer meets eligibility criteria|18|||
126468234|NCT01461980|455017558|FG001|Overall Study|No longer meets eligibility criteria|9|||
126468235|NCT01461980|455017559|FG002|Overall Study|No longer meets eligibility criteria|19|||
126468236|NCT01461980|455017557|FG000|Overall Study|Lost to Follow-up|52|||
126468237|NCT01461980|455017558|FG001|Overall Study|Lost to Follow-up|53|||
126468238|NCT01461980|455017559|FG002|Overall Study|Lost to Follow-up|51|||
126468239|NCT01461980|455017557|FG000|Overall Study|No longer willing to participate|52|||
126468240|NCT01461980|455017558|FG001|Overall Study|No longer willing to participate|38|||
126468241|NCT01461980|455017559|FG002|Overall Study|No longer willing to participate|54|||
126468242|NCT01461980|455017557|FG000|Overall Study|Randomized but not vaccinated|4|||
126468243|NCT01461980|455017558|FG001|Overall Study|Randomized but not vaccinated|8|||
126468244|NCT01461980|455017559|FG002|Overall Study|Randomized but not vaccinated|7|||
126468245|NCT00122109|455017560|FG000|Overall Study|Did not meet criteria|6|||
126468246|NCT00122109|455017561|FG001|Overall Study|Did not meet criteria|7|||
126468247|NCT00809354|455017567|FG000|Overall Study|Adverse Event|32|||
126468248|NCT00809354|455017568|FG001|Overall Study|Adverse Event|45|||
126468249|NCT00809354|455017569|FG002|Overall Study|Adverse Event|37|||
126468250|NCT00809354|455017570|FG003|Overall Study|Adverse Event|53|||
126468251|NCT00809354|455017571|FG004|Overall Study|Adverse Event|26|||
126468252|NCT00809354|455017572|FG005|Overall Study|Adverse Event|33|||
126468253|NCT00809354|455017573|FG006|Overall Study|Adverse Event|44|||
126468254|NCT00809354|455017574|FG007|Overall Study|Adverse Event|40|||
126468255|NCT00809354|455017575|FG008|Overall Study|Adverse Event|46|||
126468256|NCT00809354|455017576|FG009|Overall Study|Adverse Event|26|||
126468257|NCT00809354|455017567|FG000|Overall Study|Lack of Efficacy|23|||
126468258|NCT00809354|455017568|FG001|Overall Study|Lack of Efficacy|23|||
126468259|NCT00809354|455017569|FG002|Overall Study|Lack of Efficacy|22|||
126468260|NCT00809354|455017570|FG003|Overall Study|Lack of Efficacy|15|||
126468261|NCT00809354|455017571|FG004|Overall Study|Lack of Efficacy|40|||
126468262|NCT00809354|455017572|FG005|Overall Study|Lack of Efficacy|19|||
126468263|NCT00809354|455017573|FG006|Overall Study|Lack of Efficacy|21|||
126468264|NCT00809354|455017574|FG007|Overall Study|Lack of Efficacy|15|||
126468265|NCT00809354|455017575|FG008|Overall Study|Lack of Efficacy|18|||
126468266|NCT00809354|455017576|FG009|Overall Study|Lack of Efficacy|38|||
126468267|NCT00809354|455017567|FG000|Overall Study|Lost to Follow-up|10|||
126468268|NCT00809354|455017568|FG001|Overall Study|Lost to Follow-up|11|||
126382468|NCT02520388|454693586|FG001|Overall Study|Lost to Follow-up|2|||
126382469|NCT02520388|454693585|FG000|Overall Study|Other (reason not defined)|4|||
126382470|NCT02520388|454693586|FG001|Overall Study|Other (reason not defined)|4|||
126382471|NCT01232127|454693587|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
126382472|NCT01232127|454693588|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
126382473|NCT01232127|454693589|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
126382474|NCT03035864|454693595|FG000|Treatment Period|Adverse Event|1|||
126382475|NCT03035864|454693596|FG001|Treatment Period|Adverse Event|0|||
126382476|NCT03035864|454693595|FG000|Treatment Period|Other|3|||
126382477|NCT03035864|454693596|FG001|Treatment Period|Other|1|||
126382478|NCT03035864|454693595|FG000|Follow-up Period|Adverse Event|1|||
126382479|NCT03035864|454693596|FG001|Follow-up Period|Adverse Event|0|||
126382480|NCT03035864|454693595|FG000|Follow-up Period|Lost to Follow-up|6|||
126382481|NCT03035864|454693596|FG001|Follow-up Period|Lost to Follow-up|2|||
126382482|NCT03035864|454693595|FG000|Follow-up Period|Physician Decision|1|||
126382483|NCT03035864|454693596|FG001|Follow-up Period|Physician Decision|0|||
126382484|NCT03035864|454693595|FG000|Follow-up Period|Other|3|||
126382485|NCT03035864|454693596|FG001|Follow-up Period|Other|2|||
126382486|NCT02375373|454693597|FG000|Overall Study|Withdrawal by Subject|11|||
126382487|NCT01890265|454693598|FG000|Overall Study|Other (Unspecified reason)|0|||
126382488|NCT01890265|454693599|FG001|Overall Study|Other (Unspecified reason)|1|||
126382489|NCT01890265|454693600|FG002|Overall Study|Other (Unspecified reason)|0|||
126382490|NCT01890265|454693601|FG003|Overall Study|Other (Unspecified reason)|0|||
126382491|NCT01890265|454693602|FG004|Overall Study|Other (Unspecified reason)|0|||
126382492|NCT01890265|454693603|FG005|Overall Study|Other (Unspecified reason)|0|||
126382493|NCT01890265|454693598|FG000|Overall Study|Progressive disease|6|||
126382494|NCT01890265|454693599|FG001|Overall Study|Progressive disease|6|||
126382495|NCT01890265|454693600|FG002|Overall Study|Progressive disease|0|||
126382496|NCT01890265|454693601|FG003|Overall Study|Progressive disease|0|||
126382497|NCT01890265|454693602|FG004|Overall Study|Progressive disease|0|||
126382498|NCT01890265|454693603|FG005|Overall Study|Progressive disease|0|||
126382499|NCT01890265|454693598|FG000|Overall Study|Adverse Event|2|||
126382500|NCT01890265|454693599|FG001|Overall Study|Adverse Event|1|||
126382501|NCT01890265|454693600|FG002|Overall Study|Adverse Event|0|||
126382502|NCT01890265|454693601|FG003|Overall Study|Adverse Event|0|||
126382503|NCT01890265|454693602|FG004|Overall Study|Adverse Event|0|||
126382504|NCT01890265|454693603|FG005|Overall Study|Adverse Event|0|||
126382505|NCT01890265|454693598|FG000|Overall Study|Death|2|||
126382506|NCT01890265|454693599|FG001|Overall Study|Death|3|||
126382507|NCT01890265|454693600|FG002|Overall Study|Death|1|||
126382508|NCT01890265|454693601|FG003|Overall Study|Death|0|||
126382509|NCT01890265|454693602|FG004|Overall Study|Death|0|||
126382510|NCT01890265|454693603|FG005|Overall Study|Death|0|||
126382511|NCT01890265|454693598|FG000|Overall Study|Withdrawal by Subject|0|||
126382512|NCT01890265|454693599|FG001|Overall Study|Withdrawal by Subject|2|||
126382513|NCT01890265|454693600|FG002|Overall Study|Withdrawal by Subject|3|||
126382514|NCT01890265|454693601|FG003|Overall Study|Withdrawal by Subject|0|||
126382515|NCT01890265|454693602|FG004|Overall Study|Withdrawal by Subject|2|||
126382516|NCT01890265|454693603|FG005|Overall Study|Withdrawal by Subject|0|||
126382517|NCT00809926|454693604|FG000|Overall Study|Adverse Event|18|||
126382518|NCT00809926|454693605|FG001|Overall Study|Adverse Event|10|||
126382519|NCT00809926|454693604|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
126382520|NCT00809926|454693605|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126382521|NCT00809926|454693604|FG000|Overall Study|Patient withdrew consent|8|||
126382522|NCT00809926|454693605|FG001|Overall Study|Patient withdrew consent|6|||
126382523|NCT00809926|454693604|FG000|Overall Study|Lost to Follow-up|2|||
126382524|NCT00809926|454693605|FG001|Overall Study|Lost to Follow-up|1|||
126382525|NCT00809926|454693604|FG000|Overall Study|Administrative Problems|0|||
126382526|NCT00809926|454693605|FG001|Overall Study|Administrative Problems|1|||
126382527|NCT00809926|454693604|FG000|Overall Study|Protocol deviation|0|||
126382528|NCT00809926|454693605|FG001|Overall Study|Protocol deviation|2|||
126382529|NCT00642707|454693610|FG000|Overall Study|Adverse Event|0|||
126382530|NCT00642707|454693611|FG001|Overall Study|Adverse Event|0|||
126382531|NCT00642707|454693612|FG002|Overall Study|Adverse Event|0|||
126382532|NCT00642707|454693613|FG003|Overall Study|Adverse Event|2|||
126382533|NCT00642707|454693610|FG000|Overall Study|Withdrawal by Subject|1|||
126717343|NCT01234402|455916194|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
126382534|NCT00642707|454693611|FG001|Overall Study|Withdrawal by Subject|0|||
126382535|NCT00642707|454693612|FG002|Overall Study|Withdrawal by Subject|0|||
126382536|NCT00642707|454693613|FG003|Overall Study|Withdrawal by Subject|0|||
126717344|NCT01234402|455916195|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
126717345|NCT01234402|455916193|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
126382537|NCT00130039|454693614|FG000|Overall Study|Withdrawal by Subject|15|||
126382538|NCT00130039|454693615|FG001|Overall Study|Withdrawal by Subject|11|||
126382539|NCT00130039|454693614|FG000|Overall Study|Lost to Follow-up|3|||
126382540|NCT00130039|454693615|FG001|Overall Study|Lost to Follow-up|1|||
126382541|NCT00130039|454693614|FG000|Overall Study|Adverse Event|4|||
126382542|NCT00130039|454693615|FG001|Overall Study|Adverse Event|2|||
126553321|NCT03230864|455320557|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
126553322|NCT03230864|455320558|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
126553323|NCT03230864|455320559|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
126553324|NCT03230864|455320560|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
126553325|NCT03230864|455320557|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
126553326|NCT03230864|455320558|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
126553327|NCT03230864|455320559|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
126553328|NCT03230864|455320560|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
126553329|NCT03230864|455320557|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
126553330|NCT03230864|455320558|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
126553331|NCT03230864|455320559|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
126553332|NCT03230864|455320560|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
126553333|NCT01744496|455320567|FG000|Titration Period|Adverse Event|2|||
126553334|NCT01744496|455320568|FG001|Titration Period|Adverse Event|1|||
126553335|NCT01744496|455320567|FG000|Titration Period|Personal reasons|0|||
126553336|NCT01744496|455320568|FG001|Titration Period|Personal reasons|1|||
126553337|NCT01744496|455320567|FG000|Maintenance Period|Adverse Event|1|||
126553338|NCT01744496|455320568|FG001|Maintenance Period|Adverse Event|3|||
126553339|NCT01744496|455320567|FG000|Maintenance Period|Protocol Violation|1|||
126553340|NCT01744496|455320568|FG001|Maintenance Period|Protocol Violation|0|||
126717346|NCT01234402|455916194|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
126717347|NCT01234402|455916195|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
126717348|NCT02389816|455916198|FG000|Overall Study|Randomized but Not Treated|1|||
126553341|NCT01744496|455320567|FG000|Maintenance Period|Withdrawal by Subject|1|||
126553342|NCT01744496|455320568|FG001|Maintenance Period|Withdrawal by Subject|1|||
126553343|NCT01744496|455320567|FG000|Maintenance Period|Subject left town|1|||
126553344|NCT01744496|455320568|FG001|Maintenance Period|Subject left town|0|||
126553345|NCT01567163|455320569|FG000|Overall Study|Progressive Disease|2|||
126553346|NCT01567163|455320569|FG000|Overall Study|Lost to Follow-up|2|||
126553347|NCT01406717|455320577|FG000|Overall Study|Subject non-compliance|4|||
126553348|NCT01406717|455320578|FG001|Overall Study|Subject non-compliance|3|||
126717349|NCT02389816|455916199|FG001|Overall Study|Randomized but Not Treated|0|||
126382543|NCT00130039|454693614|FG000|Overall Study|Physician Decision|3|||
126382544|NCT00130039|454693615|FG001|Overall Study|Physician Decision|0|||
126382545|NCT00130039|454693614|FG000|Overall Study|clinical events without follow up MRI|5|||
126382546|NCT00130039|454693615|FG001|Overall Study|clinical events without follow up MRI|4|||
126382547|NCT00100802|454693619|FG000|Overall Study|Adverse Event|9|||
126382548|NCT00100802|454693619|FG000|Overall Study|Death|1|||
126382549|NCT00100802|454693619|FG000|Overall Study|Lack of Efficacy|47|||
126382550|NCT00100802|454693619|FG000|Overall Study|Physician Decision|5|||
126382551|NCT00100802|454693619|FG000|Overall Study|Protocol Violation|1|||
126382552|NCT00100802|454693619|FG000|Overall Study|Withdrawal by Subject|5|||
126382553|NCT00100802|454693619|FG000|Overall Study|Ineligible|12|||
126382554|NCT02709720|454693620|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
126382555|NCT02709720|454693620|FG000|Overall Study|Protocol Violation|1|||
126382556|NCT02709720|454693620|FG000|Overall Study|Not take study medication|1|||
126382557|NCT01198574|454693650|FG000|Overall Study|Resigned from schools|4|||
126382558|NCT01198574|454693651|FG001|Overall Study|Resigned from schools|1|||
126382559|NCT01198574|454693652|FG002|Overall Study|Resigned from schools|1|||
126382560|NCT01198574|454693653|FG003|Overall Study|Resigned from schools|4|||
126382561|NCT00325130|454693654|FG000|Overall Study|Lost to Follow-up|6|||
126382562|NCT00325130|454693655|FG001|Overall Study|Lost to Follow-up|14|||
126382563|NCT00325130|454693654|FG000|Overall Study|Withdrawal by Subject|12|||
126382564|NCT00325130|454693655|FG001|Overall Study|Withdrawal by Subject|14|||
126382565|NCT00325130|454693654|FG000|Overall Study|Protocol Deviation|0|||
126717350|NCT02389816|455916200|FG002|Overall Study|Randomized but Not Treated|0|||
126382566|NCT00325130|454693655|FG001|Overall Study|Protocol Deviation|1|||
126382567|NCT00325130|454693654|FG000|Overall Study|Moved|0|||
126382568|NCT00325130|454693655|FG001|Overall Study|Moved|1|||
126382569|NCT00325130|454693654|FG000|Overall Study|Patient Discontinued for Other|1|||
126382570|NCT00325130|454693655|FG001|Overall Study|Patient Discontinued for Other|0|||
126553349|NCT01406717|455320577|FG000|Overall Study|Protocol Violation|5|||
126717351|NCT02389816|455916198|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
126717352|NCT02389816|455916199|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
126382571|NCT00326001|454693656|FG000|Overall Study|Adverse Event|4|||
126553350|NCT01406717|455320578|FG001|Overall Study|Protocol Violation|1|||
126382572|NCT00326001|454693657|FG001|Overall Study|Adverse Event|5|||
126382573|NCT00326001|454693656|FG000|Overall Study|Physician Decision|3|||
126382574|NCT00326001|454693657|FG001|Overall Study|Physician Decision|3|||
126553351|NCT01406717|455320577|FG000|Overall Study|Lost to Follow-up|14|||
126553352|NCT01406717|455320578|FG001|Overall Study|Lost to Follow-up|8|||
126553353|NCT01406717|455320577|FG000|Overall Study|Withdrawal by Subject|19|||
126553354|NCT01406717|455320578|FG001|Overall Study|Withdrawal by Subject|15|||
126553355|NCT01406717|455320577|FG000|Overall Study|Adverse Event|1|||
126553356|NCT01406717|455320578|FG001|Overall Study|Adverse Event|2|||
126717353|NCT02389816|455916200|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
126717354|NCT02389816|455916198|FG000|Overall Study|Major Protocol Deviation|1|||
126717355|NCT02389816|455916199|FG001|Overall Study|Major Protocol Deviation|0|||
126382575|NCT01042158|454693658|FG000|Overall Study|Physician Decision|1|||
126382576|NCT03640325|454694923|FG000|Overall Study|Withdrawal by Subject|4|||
126382577|NCT03640325|454694924|FG001|Overall Study|Withdrawal by Subject|1|||
126382578|NCT03640325|454694925|FG002|Overall Study|Withdrawal by Subject|0|||
126382579|NCT03640325|454694923|FG000|Overall Study|Lost to Follow-up|4|||
126382580|NCT03640325|454694924|FG001|Overall Study|Lost to Follow-up|5|||
126382581|NCT03640325|454694925|FG002|Overall Study|Lost to Follow-up|21|||
126382582|NCT03640325|454694923|FG000|Overall Study|Death|5|||
126382583|NCT03640325|454694924|FG001|Overall Study|Death|5|||
126382584|NCT03640325|454694925|FG002|Overall Study|Death|0|||
126382585|NCT01133756|454694929|FG000|Overall Study|Adverse Event|1|||
126382586|NCT01133756|454694930|FG001|Overall Study|Adverse Event|2|||
126382587|NCT01133756|454694931|FG002|Overall Study|Adverse Event|1|||
126382588|NCT01133756|454694929|FG000|Overall Study|Investigator Decision|1|||
126382589|NCT01133756|454694930|FG001|Overall Study|Investigator Decision|0|||
126382590|NCT01133756|454694931|FG002|Overall Study|Investigator Decision|0|||
126382591|NCT01133756|454694929|FG000|Overall Study|Withdrawal by Subject|0|||
126382592|NCT01133756|454694930|FG001|Overall Study|Withdrawal by Subject|1|||
126382593|NCT01133756|454694931|FG002|Overall Study|Withdrawal by Subject|0|||
126382594|NCT01133756|454694929|FG000|Overall Study|Progression of Disease|0|||
126382595|NCT01133756|454694930|FG001|Overall Study|Progression of Disease|0|||
126382596|NCT01133756|454694931|FG002|Overall Study|Progression of Disease|1|||
126382597|NCT01566149|454694932|FG000|Overall Study|Adverse Event|0|||
126382598|NCT01566149|454694933|FG001|Overall Study|Adverse Event|1|||
126382599|NCT01566149|454694932|FG000|Overall Study|Non-compliance with study medication|2|||
126382600|NCT01566149|454694933|FG001|Overall Study|Non-compliance with study medication|0|||
126382601|NCT01566149|454694932|FG000|Overall Study|Protocol Violation|0|||
126382602|NCT01566149|454694933|FG001|Overall Study|Protocol Violation|1|||
126382603|NCT01566149|454694932|FG000|Overall Study|Withdrawal by Subject|1|||
126382604|NCT01566149|454694933|FG001|Overall Study|Withdrawal by Subject|0|||
126382605|NCT03276728|454694936|FG000|Overall Study|Lost to Follow-up|0|||
126382606|NCT03276728|454694937|FG001|Overall Study|Lost to Follow-up|0|||
126382607|NCT03276728|454694938|FG002|Overall Study|Lost to Follow-up|2|||
126382608|NCT03276728|454694939|FG003|Overall Study|Lost to Follow-up|2|||
126382609|NCT03276728|454694940|FG004|Overall Study|Lost to Follow-up|0|||
126382610|NCT03276728|454694941|FG005|Overall Study|Lost to Follow-up|0|||
126382611|NCT03276728|454694942|FG006|Overall Study|Lost to Follow-up|0|||
126382612|NCT03276728|454694943|FG007|Overall Study|Lost to Follow-up|0|||
126382613|NCT03276728|454694936|FG000|Overall Study|Withdrawal by Subject|0|||
126382614|NCT03276728|454694937|FG001|Overall Study|Withdrawal by Subject|0|||
126382615|NCT03276728|454694938|FG002|Overall Study|Withdrawal by Subject|0|||
126382616|NCT03276728|454694939|FG003|Overall Study|Withdrawal by Subject|3|||
126382617|NCT03276728|454694940|FG004|Overall Study|Withdrawal by Subject|0|||
126382618|NCT03276728|454694941|FG005|Overall Study|Withdrawal by Subject|0|||
126382619|NCT03276728|454694942|FG006|Overall Study|Withdrawal by Subject|0|||
126382620|NCT03276728|454694943|FG007|Overall Study|Withdrawal by Subject|0|||
126382621|NCT03276728|454694936|FG000|Overall Study|Decision by sponsor|0|||
126382622|NCT03276728|454694937|FG001|Overall Study|Decision by sponsor|0|||
126382623|NCT03276728|454694938|FG002|Overall Study|Decision by sponsor|0|||
126382624|NCT03276728|454694939|FG003|Overall Study|Decision by sponsor|0|||
126382625|NCT03276728|454694940|FG004|Overall Study|Decision by sponsor|1|||
126382626|NCT03276728|454694941|FG005|Overall Study|Decision by sponsor|0|||
126382627|NCT03276728|454694942|FG006|Overall Study|Decision by sponsor|2|||
126382628|NCT03276728|454694943|FG007|Overall Study|Decision by sponsor|1|||
126382629|NCT03941873|454694950|FG000|Overall Study|Death|0|||
126382630|NCT03941873|454694951|FG001|Overall Study|Death|12|||
126382631|NCT03941873|454694952|FG002|Overall Study|Death|2|||
126382632|NCT03941873|454694953|FG003|Overall Study|Death|53|||
126382633|NCT03941873|454694950|FG000|Overall Study|Withdrawal by Subject|1|||
126382634|NCT03941873|454694951|FG001|Overall Study|Withdrawal by Subject|1|||
126382635|NCT03941873|454694952|FG002|Overall Study|Withdrawal by Subject|0|||
126382636|NCT03941873|454694953|FG003|Overall Study|Withdrawal by Subject|5|||
126382637|NCT03941873|454694950|FG000|Overall Study|Lost to Follow-up|1|||
126382638|NCT03941873|454694951|FG001|Overall Study|Lost to Follow-up|2|||
126382639|NCT03941873|454694952|FG002|Overall Study|Lost to Follow-up|0|||
126382640|NCT03941873|454694953|FG003|Overall Study|Lost to Follow-up|0|||
126382641|NCT03941873|454694950|FG000|Overall Study|Sponsor Decision|0|||
126382642|NCT03941873|454694951|FG001|Overall Study|Sponsor Decision|6|||
126382643|NCT03941873|454694952|FG002|Overall Study|Sponsor Decision|0|||
126382644|NCT03941873|454694953|FG003|Overall Study|Sponsor Decision|15|||
126382645|NCT02982772|454694954|FG000|Intervention|Lost to Follow-up|19|||
126382646|NCT02982772|454694955|FG001|Intervention|Lost to Follow-up|13|||
126382647|NCT02982772|454694954|FG000|1M Follow-Up|Lost to Follow-up|21|||
126468269|NCT00809354|455017569|FG002|Overall Study|Lost to Follow-up|8|||
126382648|NCT02982772|454694955|FG001|1M Follow-Up|Lost to Follow-up|18|||
126382649|NCT02982772|454694954|FG000|3M Follow-Up|Lost to Follow-up|17|||
126382650|NCT02982772|454694955|FG001|3M Follow-Up|Lost to Follow-up|11|||
126382651|NCT02982772|454694954|FG000|6M Follow-Up|Lost to Follow-up|11|||
126382652|NCT02982772|454694955|FG001|6M Follow-Up|Lost to Follow-up|9|||
126382653|NCT02982772|454694954|FG000|12M Follow-Up|Lost to Follow-up|11|||
126382654|NCT02982772|454694955|FG001|12M Follow-Up|Lost to Follow-up|5|||
126382655|NCT01234480|454694956|FG000|Overall Study|Pregnancy|88|||
126382656|NCT01234480|454694956|FG000|Overall Study|>36/Normal History|50|||
126382657|NCT01234480|454694956|FG000|Overall Study|Age|3|||
126382658|NCT01234480|454694956|FG000|Overall Study|HPV Vaccine History|28|||
126382659|NCT01234480|454694956|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
126382660|NCT01234480|454694956|FG000|Overall Study|Hysterectomy|2|||
126382661|NCT01234480|454694956|FG000|Overall Study|Hysterectomy post enrollment|1|||
126382662|NCT01234480|454694956|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
126382663|NCT01234480|454694956|FG000|Overall Study|Informed Consent Form Violation|30|||
126382664|NCT01234480|454694956|FG000|Overall Study|Incorrect Visit|3|||
126382665|NCT01234480|454694956|FG000|Overall Study|No Florida Lab License|20|||
126382666|NCT01234480|454694956|FG000|Overall Study|Out of Window|42|||
126382667|NCT01234480|454694956|FG000|Overall Study|Sample Processing/Storage|92|||
126382668|NCT01234480|454694956|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
126382669|NCT01234480|454694956|FG000|Overall Study|Site/Subject non-compliance|44|||
126382670|NCT01234480|454694956|FG000|Overall Study|Missing Sample|9|||
126382671|NCT01238991|454694959|FG000|Overall Study|Adverse Event|1|||
126382672|NCT01238991|454694960|FG001|Overall Study|Adverse Event|0|||
126382673|NCT01238991|454694961|FG002|Overall Study|Adverse Event|3|||
126382674|NCT01238991|454694962|FG003|Overall Study|Adverse Event|1|||
126382675|NCT01238991|454694963|FG004|Overall Study|Adverse Event|1|||
126382676|NCT01238991|454694964|FG005|Overall Study|Adverse Event|0|||
126382677|NCT01238991|454694965|FG006|Overall Study|Adverse Event|1|||
126382678|NCT01238991|454694966|FG007|Overall Study|Adverse Event|1|||
126382679|NCT01238991|454694967|FG008|Overall Study|Adverse Event|0|||
126382680|NCT01238991|454694968|FG009|Overall Study|Adverse Event|0|||
126382681|NCT01238991|454694959|FG000|Overall Study|Death|0|||
126382682|NCT01238991|454694960|FG001|Overall Study|Death|0|||
126382683|NCT01238991|454694961|FG002|Overall Study|Death|0|||
126382684|NCT01238991|454694962|FG003|Overall Study|Death|1|||
126382685|NCT01238991|454694963|FG004|Overall Study|Death|0|||
126382686|NCT01238991|454694964|FG005|Overall Study|Death|0|||
126382687|NCT01238991|454694965|FG006|Overall Study|Death|0|||
126382688|NCT01238991|454694966|FG007|Overall Study|Death|0|||
126382689|NCT01238991|454694967|FG008|Overall Study|Death|0|||
126382690|NCT01238991|454694968|FG009|Overall Study|Death|0|||
126382691|NCT01238991|454694959|FG000|Overall Study|Lack of Efficacy|0|||
126382692|NCT01238991|454694960|FG001|Overall Study|Lack of Efficacy|0|||
126382693|NCT01238991|454694961|FG002|Overall Study|Lack of Efficacy|1|||
126382694|NCT01238991|454694962|FG003|Overall Study|Lack of Efficacy|0|||
126382695|NCT01238991|454694963|FG004|Overall Study|Lack of Efficacy|0|||
126382696|NCT01238991|454694964|FG005|Overall Study|Lack of Efficacy|0|||
126382697|NCT01238991|454694965|FG006|Overall Study|Lack of Efficacy|0|||
126382698|NCT01238991|454694966|FG007|Overall Study|Lack of Efficacy|0|||
126382699|NCT01238991|454694967|FG008|Overall Study|Lack of Efficacy|1|||
126382700|NCT01238991|454694968|FG009|Overall Study|Lack of Efficacy|0|||
126382701|NCT01238991|454694959|FG000|Overall Study|Withdrawal by Subject|0|||
126382702|NCT01238991|454694960|FG001|Overall Study|Withdrawal by Subject|0|||
126382703|NCT01238991|454694961|FG002|Overall Study|Withdrawal by Subject|1|||
126382704|NCT01238991|454694962|FG003|Overall Study|Withdrawal by Subject|0|||
126382705|NCT01238991|454694963|FG004|Overall Study|Withdrawal by Subject|0|||
126382706|NCT01238991|454694964|FG005|Overall Study|Withdrawal by Subject|0|||
126382707|NCT01238991|454694965|FG006|Overall Study|Withdrawal by Subject|0|||
126382708|NCT01238991|454694966|FG007|Overall Study|Withdrawal by Subject|0|||
126382709|NCT01238991|454694967|FG008|Overall Study|Withdrawal by Subject|0|||
126382710|NCT01238991|454694968|FG009|Overall Study|Withdrawal by Subject|0|||
126382711|NCT01238991|454694959|FG000|Overall Study|Study Terminated by Sponsor|0|||
126382712|NCT01238991|454694960|FG001|Overall Study|Study Terminated by Sponsor|0|||
126717356|NCT02389816|455916200|FG002|Overall Study|Major Protocol Deviation|0|||
126382713|NCT01238991|454694961|FG002|Overall Study|Study Terminated by Sponsor|0|||
126382714|NCT01238991|454694962|FG003|Overall Study|Study Terminated by Sponsor|0|||
126382715|NCT01238991|454694963|FG004|Overall Study|Study Terminated by Sponsor|1|||
126382716|NCT01238991|454694964|FG005|Overall Study|Study Terminated by Sponsor|0|||
126382717|NCT01238991|454694965|FG006|Overall Study|Study Terminated by Sponsor|7|||
126382718|NCT01238991|454694966|FG007|Overall Study|Study Terminated by Sponsor|4|||
126382719|NCT01238991|454694967|FG008|Overall Study|Study Terminated by Sponsor|2|||
126382720|NCT01238991|454694968|FG009|Overall Study|Study Terminated by Sponsor|2|||
126382721|NCT01238991|454694959|FG000|Overall Study|Caregiver's request|0|||
126382722|NCT01238991|454694960|FG001|Overall Study|Caregiver's request|0|||
126382723|NCT01238991|454694961|FG002|Overall Study|Caregiver's request|0|||
126382724|NCT01238991|454694962|FG003|Overall Study|Caregiver's request|0|||
126382725|NCT01238991|454694963|FG004|Overall Study|Caregiver's request|0|||
126382726|NCT01238991|454694964|FG005|Overall Study|Caregiver's request|0|||
126382727|NCT01238991|454694965|FG006|Overall Study|Caregiver's request|0|||
126382728|NCT01238991|454694966|FG007|Overall Study|Caregiver's request|0|||
126382729|NCT01238991|454694967|FG008|Overall Study|Caregiver's request|1|||
126382730|NCT01238991|454694968|FG009|Overall Study|Caregiver's request|0|||
126382731|NCT01238991|454694959|FG000|Overall Study|Admission to a nursing home|1|||
126382732|NCT01238991|454694960|FG001|Overall Study|Admission to a nursing home|0|||
126382733|NCT01238991|454694961|FG002|Overall Study|Admission to a nursing home|1|||
126382734|NCT01238991|454694962|FG003|Overall Study|Admission to a nursing home|0|||
126382735|NCT01238991|454694963|FG004|Overall Study|Admission to a nursing home|0|||
126382736|NCT01238991|454694964|FG005|Overall Study|Admission to a nursing home|0|||
126382737|NCT01238991|454694965|FG006|Overall Study|Admission to a nursing home|0|||
126382738|NCT01238991|454694966|FG007|Overall Study|Admission to a nursing home|0|||
126382739|NCT01238991|454694967|FG008|Overall Study|Admission to a nursing home|0|||
126382740|NCT01238991|454694968|FG009|Overall Study|Admission to a nursing home|0|||
126382741|NCT03370419|454694969|FG000|Overall Study|Lost to Follow-up|16|||
126382742|NCT01897727|454694974|FG000|Overall Study|Exclusion: central sleep apnea|0|||
126382743|NCT01897727|454694975|FG001|Overall Study|Exclusion: central sleep apnea|1|||
126382744|NCT00078806|454694976|FG000|Part 1A|Adverse Event|2|||
126382745|NCT00078806|454694977|FG001|Part 1A|Adverse Event|0|||
126382746|NCT00078806|454694978|FG002|Part 1A|Adverse Event|0|||
126382747|NCT00078806|454694979|FG003|Part 1A|Adverse Event|0|||
126382748|NCT00078806|454694976|FG000|Part 1A|Lack of Efficacy|7|||
126382749|NCT00078806|454694977|FG001|Part 1A|Lack of Efficacy|0|||
126382750|NCT00078806|454694978|FG002|Part 1A|Lack of Efficacy|0|||
126382751|NCT00078806|454694979|FG003|Part 1A|Lack of Efficacy|0|||
126382752|NCT00078806|454694976|FG000|Part 1A|Other|1|||
126382753|NCT00078806|454694977|FG001|Part 1A|Other|0|||
126382754|NCT00078806|454694978|FG002|Part 1A|Other|0|||
126382755|NCT00078806|454694979|FG003|Part 1A|Other|0|||
126382756|NCT00078806|454694976|FG000|Part 1B|Adverse Event|1|||
126382757|NCT00078806|454694977|FG001|Part 1B|Adverse Event|0|||
126382758|NCT00078806|454694978|FG002|Part 1B|Adverse Event|0|||
126382759|NCT00078806|454694979|FG003|Part 1B|Adverse Event|0|||
126382760|NCT00078806|454694976|FG000|Part 1B|Lack of Efficacy|7|||
126382761|NCT00078806|454694977|FG001|Part 1B|Lack of Efficacy|0|||
126382762|NCT00078806|454694978|FG002|Part 1B|Lack of Efficacy|0|||
126382763|NCT00078806|454694979|FG003|Part 1B|Lack of Efficacy|0|||
126382764|NCT00078806|454694976|FG000|Part 2|Adverse Event|0|||
126382765|NCT00078806|454694977|FG001|Part 2|Adverse Event|1|||
126382766|NCT00078806|454694978|FG002|Part 2|Adverse Event|0|||
126382767|NCT00078806|454694979|FG003|Part 2|Adverse Event|0|||
126382768|NCT01734785|454694980|FG000|Open-Label Period|Adverse Event|0|||
126382769|NCT01734785|454694981|FG001|Open-Label Period|Adverse Event|0|||
126382770|NCT01734785|454694982|FG002|Open-Label Period|Adverse Event|0|||
126382771|NCT01734785|454694983|FG003|Open-Label Period|Adverse Event|9|||
126382772|NCT01734785|454694980|FG000|Open-Label Period|Lack of Efficacy|0|||
126382773|NCT01734785|454694981|FG001|Open-Label Period|Lack of Efficacy|0|||
126382774|NCT01734785|454694982|FG002|Open-Label Period|Lack of Efficacy|0|||
126382775|NCT01734785|454694983|FG003|Open-Label Period|Lack of Efficacy|1|||
126382776|NCT01734785|454694980|FG000|Open-Label Period|Protocol Violation|0|||
126382777|NCT01734785|454694981|FG001|Open-Label Period|Protocol Violation|0|||
126382778|NCT01734785|454694982|FG002|Open-Label Period|Protocol Violation|0|||
126382779|NCT01734785|454694983|FG003|Open-Label Period|Protocol Violation|13|||
126382780|NCT01734785|454694980|FG000|Open-Label Period|Lost to Follow-up|0|||
126382781|NCT01734785|454694981|FG001|Open-Label Period|Lost to Follow-up|0|||
126382782|NCT01734785|454694982|FG002|Open-Label Period|Lost to Follow-up|0|||
126382783|NCT01734785|454694983|FG003|Open-Label Period|Lost to Follow-up|14|||
126382784|NCT01734785|454694980|FG000|Open-Label Period|Withdrawal by Subject|0|||
126382785|NCT01734785|454694981|FG001|Open-Label Period|Withdrawal by Subject|0|||
126382786|NCT01734785|454694982|FG002|Open-Label Period|Withdrawal by Subject|0|||
126382787|NCT01734785|454694983|FG003|Open-Label Period|Withdrawal by Subject|12|||
126382788|NCT01734785|454694980|FG000|Open-Label Period|Other Reasons|0|||
126382789|NCT01734785|454694981|FG001|Open-Label Period|Other Reasons|0|||
126382790|NCT01734785|454694982|FG002|Open-Label Period|Other Reasons|0|||
126382791|NCT01734785|454694983|FG003|Open-Label Period|Other Reasons|224|||
126382792|NCT01734785|454694980|FG000|Double-Blind Period|Adverse Event|0|||
126382793|NCT01734785|454694981|FG001|Double-Blind Period|Adverse Event|3|||
126382794|NCT01734785|454694982|FG002|Double-Blind Period|Adverse Event|2|||
126382795|NCT01734785|454694983|FG003|Double-Blind Period|Adverse Event|0|||
126382796|NCT01734785|454694980|FG000|Double-Blind Period|Lack of Efficacy|0|||
126382797|NCT01734785|454694981|FG001|Double-Blind Period|Lack of Efficacy|1|||
126382798|NCT01734785|454694982|FG002|Double-Blind Period|Lack of Efficacy|0|||
126382799|NCT01734785|454694983|FG003|Double-Blind Period|Lack of Efficacy|0|||
126382800|NCT01734785|454694980|FG000|Double-Blind Period|Protocol Violation|0|||
126468270|NCT00809354|455017570|FG003|Overall Study|Lost to Follow-up|13|||
126382801|NCT01734785|454694981|FG001|Double-Blind Period|Protocol Violation|1|||
126382802|NCT01734785|454694982|FG002|Double-Blind Period|Protocol Violation|1|||
126382803|NCT01734785|454694983|FG003|Double-Blind Period|Protocol Violation|0|||
126382804|NCT01734785|454694980|FG000|Double-Blind Period|Lost to Follow-up|2|||
126382805|NCT01734785|454694981|FG001|Double-Blind Period|Lost to Follow-up|4|||
126382806|NCT01734785|454694982|FG002|Double-Blind Period|Lost to Follow-up|2|||
126382807|NCT01734785|454694983|FG003|Double-Blind Period|Lost to Follow-up|0|||
126382808|NCT01734785|454694980|FG000|Double-Blind Period|Withdrawal by Subject|2|||
126382809|NCT01734785|454694981|FG001|Double-Blind Period|Withdrawal by Subject|0|||
126382810|NCT01734785|454694982|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126382811|NCT01734785|454694983|FG003|Double-Blind Period|Withdrawal by Subject|0|||
126382812|NCT01734785|454694980|FG000|Double-Blind Period|Not treated|1|||
126382813|NCT01734785|454694981|FG001|Double-Blind Period|Not treated|0|||
126382814|NCT01734785|454694982|FG002|Double-Blind Period|Not treated|0|||
126382815|NCT01734785|454694983|FG003|Double-Blind Period|Not treated|0|||
126382816|NCT02013778|454694986|FG000|Overall Study|Death|4|||
126382817|NCT02013778|454694986|FG000|Overall Study|Withdrawal by Subject|1|||
126382818|NCT02013778|454694986|FG000|Overall Study|Physician Decision|1|||
126382819|NCT02013778|454694986|FG000|Overall Study|Adverse Event|1|||
126382820|NCT00293813|454694987|FG000|Overall Study|Physician Decision|0|||
126382821|NCT00293813|454694988|FG001|Overall Study|Physician Decision|1|||
126382822|NCT00293813|454694989|FG002|Overall Study|Physician Decision|0|||
126382823|NCT00293813|454694987|FG000|Overall Study|Adverse Event|3|||
126382824|NCT00293813|454694988|FG001|Overall Study|Adverse Event|1|||
126382825|NCT00293813|454694989|FG002|Overall Study|Adverse Event|1|||
126382826|NCT00293813|454694987|FG000|Overall Study|Withdrawal by Subject|7|||
126382827|NCT00293813|454694988|FG001|Overall Study|Withdrawal by Subject|4|||
126382828|NCT00293813|454694989|FG002|Overall Study|Withdrawal by Subject|4|||
126382829|NCT00293813|454694987|FG000|Overall Study|Lost to Follow-up|3|||
126382830|NCT00293813|454694988|FG001|Overall Study|Lost to Follow-up|2|||
126382831|NCT00293813|454694989|FG002|Overall Study|Lost to Follow-up|3|||
126382832|NCT00293813|454694987|FG000|Overall Study|Noncompliance|0|||
126382833|NCT00293813|454694988|FG001|Overall Study|Noncompliance|1|||
126382834|NCT00293813|454694989|FG002|Overall Study|Noncompliance|0|||
126382835|NCT01521923|454694992|FG000|Overall Study|AE, serious fatal|1|||
126382836|NCT01521923|454694993|FG001|Overall Study|AE, serious fatal|0|||
126382837|NCT01521923|454694994|FG002|Overall Study|AE, serious fatal|0|||
126382838|NCT01521923|454694995|FG003|Overall Study|AE, serious fatal|0|||
126382839|NCT01521923|454694992|FG000|Overall Study|SAE, non-fatal|0|||
126382840|NCT01521923|454694993|FG001|Overall Study|SAE, non-fatal|2|||
126382841|NCT01521923|454694994|FG002|Overall Study|SAE, non-fatal|2|||
126382842|NCT01521923|454694995|FG003|Overall Study|SAE, non-fatal|0|||
126382843|NCT01521923|454694992|FG000|Overall Study|AE, non-serious, non-fatal|1|||
126382844|NCT01521923|454694993|FG001|Overall Study|AE, non-serious, non-fatal|3|||
126382845|NCT01521923|454694994|FG002|Overall Study|AE, non-serious, non-fatal|6|||
126382846|NCT01521923|454694995|FG003|Overall Study|AE, non-serious, non-fatal|2|||
126382847|NCT01521923|454694992|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
126382848|NCT01521923|454694993|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
126382849|NCT01521923|454694994|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
126382850|NCT01521923|454694995|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
126382851|NCT01521923|454694992|FG000|Overall Study|Lack of Efficacy|1|||
126382852|NCT01521923|454694993|FG001|Overall Study|Lack of Efficacy|1|||
126382853|NCT01521923|454694994|FG002|Overall Study|Lack of Efficacy|0|||
126382854|NCT01521923|454694995|FG003|Overall Study|Lack of Efficacy|0|||
126382855|NCT01521923|454694992|FG000|Overall Study|Protocol Violation|0|||
126382856|NCT01521923|454694993|FG001|Overall Study|Protocol Violation|0|||
126382857|NCT01521923|454694994|FG002|Overall Study|Protocol Violation|1|||
126382858|NCT01521923|454694995|FG003|Overall Study|Protocol Violation|0|||
126382859|NCT01521923|454694992|FG000|Overall Study|Lost to Follow-up|1|||
126382860|NCT01521923|454694993|FG001|Overall Study|Lost to Follow-up|0|||
126382861|NCT01521923|454694994|FG002|Overall Study|Lost to Follow-up|2|||
126382862|NCT01521923|454694995|FG003|Overall Study|Lost to Follow-up|1|||
126382863|NCT01521923|454694992|FG000|Overall Study|Withdrawal by Subject|1|||
126382864|NCT01521923|454694993|FG001|Overall Study|Withdrawal by Subject|1|||
126382865|NCT01521923|454694994|FG002|Overall Study|Withdrawal by Subject|1|||
126382866|NCT01521923|454694995|FG003|Overall Study|Withdrawal by Subject|2|||
126382867|NCT01521923|454694992|FG000|Overall Study|Other|2|||
126382868|NCT01521923|454694993|FG001|Overall Study|Other|1|||
126382869|NCT01521923|454694994|FG002|Overall Study|Other|3|||
126382870|NCT01521923|454694995|FG003|Overall Study|Other|6|||
126382871|NCT01521923|454694992|FG000|Overall Study|AE, captured in Period 1|0|||
126382872|NCT01521923|454694993|FG001|Overall Study|AE, captured in Period 1|1|||
126382873|NCT01521923|454694994|FG002|Overall Study|AE, captured in Period 1|0|||
126382874|NCT01521923|454694995|FG003|Overall Study|AE, captured in Period 1|1|||
126382875|NCT01465386|454694999|FG000|Overall Study|Lack of Efficacy|3|||
126382876|NCT01465386|454694999|FG000|Overall Study|Adverse Event|1|||
126382877|NCT01279044|454695000|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
126382878|NCT01279044|454695001|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
126382879|NCT01279044|454695002|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
126382880|NCT01279044|454695000|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
126382881|NCT01279044|454695001|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
126382882|NCT01279044|454695002|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
126382883|NCT01279044|454695000|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
126382884|NCT01279044|454695001|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
126382885|NCT01279044|454695002|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
126382886|NCT01582009|454695003|FG000|Overall Study|Withdrawal by Subject|1|||
126382887|NCT01582009|454695003|FG000|Overall Study|Physician Decision|1|||
126382888|NCT03592771|454695008|FG000|Overall Study|Adverse Event|2|||
126382889|NCT03592771|454695009|FG001|Overall Study|Adverse Event|0|||
126382890|NCT03592771|454695010|FG002|Overall Study|Adverse Event|1|||
126382891|NCT03592771|454695008|FG000|Overall Study|Death|0|||
126382892|NCT03592771|454695009|FG001|Overall Study|Death|1|||
126382893|NCT03592771|454695010|FG002|Overall Study|Death|1|||
126382894|NCT03592771|454695008|FG000|Overall Study|Lost to Follow-up|5|||
126382895|NCT03592771|454695009|FG001|Overall Study|Lost to Follow-up|11|||
126382896|NCT03592771|454695010|FG002|Overall Study|Lost to Follow-up|15|||
126382897|NCT03592771|454695008|FG000|Overall Study|Withdrawal by Subject|0|||
126382898|NCT03592771|454695009|FG001|Overall Study|Withdrawal by Subject|2|||
126382899|NCT03592771|454695010|FG002|Overall Study|Withdrawal by Subject|0|||
126382900|NCT04830215|454695011|FG000|Overall Study|Adverse Event|6|||
126382901|NCT04830215|454695011|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
126382902|NCT04830215|454695011|FG000|Overall Study|Withdrawal by Subject|3|||
126382903|NCT04830215|454695011|FG000|Overall Study|Protocol Deviation|1|||
126382904|NCT00988052|454695015|FG000|Overall Study|Missing|1|||
126382905|NCT00988052|454695016|FG001|Overall Study|Missing|0|||
126382906|NCT00988052|454695015|FG000|Overall Study|Teva requested subject withdrawal|3|||
126382907|NCT00988052|454695016|FG001|Overall Study|Teva requested subject withdrawal|1|||
126382908|NCT00988052|454695015|FG000|Overall Study|Death|1|||
126382909|NCT00988052|454695016|FG001|Overall Study|Death|3|||
126382910|NCT00988052|454695015|FG000|Overall Study|Protocol Violation|6|||
126382911|NCT00988052|454695016|FG001|Overall Study|Protocol Violation|5|||
126382912|NCT00988052|454695015|FG000|Overall Study|Pregnancy|6|||
126382913|NCT00988052|454695016|FG001|Overall Study|Pregnancy|6|||
126382914|NCT00988052|454695015|FG000|Overall Study|Lack of Efficacy|8|||
126382915|NCT00988052|454695016|FG001|Overall Study|Lack of Efficacy|7|||
126382916|NCT00988052|454695015|FG000|Overall Study|Lost to Follow-up|6|||
126382917|NCT00988052|454695016|FG001|Overall Study|Lost to Follow-up|11|||
126382918|NCT00988052|454695015|FG000|Overall Study|Physician Decision|27|||
126382919|NCT00988052|454695016|FG001|Overall Study|Physician Decision|28|||
126382920|NCT00988052|454695015|FG000|Overall Study|Adverse Event|35|||
126382921|NCT00988052|454695016|FG001|Overall Study|Adverse Event|28|||
126382922|NCT00988052|454695015|FG000|Overall Study|Withdrawal by Subject|90|||
126382923|NCT00988052|454695016|FG001|Overall Study|Withdrawal by Subject|91|||
126382924|NCT00988052|454695015|FG000|Overall Study|Study terminated by sponsor|240|||
126382925|NCT00988052|454695016|FG001|Overall Study|Study terminated by sponsor|236|||
126382926|NCT03782064|454695017|FG000|Overall Study|Lack of Efficacy|2|||
126382927|NCT03782064|454695017|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
126382928|NCT02446769|454695018|FG000|Screening Period|Screen Failure|11|||
126382929|NCT02446769|454695019|FG001|Screening Period|Screen Failure|0|||
126382930|NCT02446769|454695020|FG002|Screening Period|Screen Failure|0|||
126382931|NCT02446769|454695018|FG000|Study Period|Randomized in Error|0|||
126382932|NCT02446769|454695019|FG001|Study Period|Randomized in Error|2|||
126382933|NCT02446769|454695020|FG002|Study Period|Randomized in Error|0|||
126382934|NCT00645840|454695021|FG000|Overall Study|Protocol Violation|3|||
126382935|NCT03994211|454695022|FG000|Core Phase|Adverse Event|0|||
126382936|NCT03994211|454695023|FG001|Core Phase|Adverse Event|1|||
126382937|NCT03994211|454695024|FG002|Core Phase|Adverse Event|0|||
126382938|NCT03994211|454695022|FG000|Extension Phase|Adverse Event|0|||
126382939|NCT03994211|454695023|FG001|Extension Phase|Adverse Event|0|||
126382940|NCT03994211|454695024|FG002|Extension Phase|Adverse Event|1|||
126382941|NCT03994211|454695022|FG000|Extension Phase|Physician Decision|0|||
126382942|NCT03994211|454695023|FG001|Extension Phase|Physician Decision|0|||
126382943|NCT03994211|454695024|FG002|Extension Phase|Physician Decision|1|||
126382944|NCT03994211|454695022|FG000|Extension Phase|Progressive Disease|0|||
126382945|NCT03994211|454695023|FG001|Extension Phase|Progressive Disease|0|||
126382946|NCT03994211|454695024|FG002|Extension Phase|Progressive Disease|20|||
126382947|NCT03994211|454695022|FG000|Extension Phase|Withdrawal by Subject|0|||
126382948|NCT03994211|454695023|FG001|Extension Phase|Withdrawal by Subject|0|||
126382949|NCT03994211|454695024|FG002|Extension Phase|Withdrawal by Subject|2|||
126382950|NCT00271856|454695030|FG000|Overall Study|Withdrawal by Subject|1|||
126382951|NCT00271856|454695031|FG001|Overall Study|Withdrawal by Subject|7|||
126717357|NCT02389816|455916198|FG000|Overall Study|Lost to Follow-up|1|||
126382952|NCT00271856|454695030|FG000|Overall Study|Lost to Follow-up|10|||
126382953|NCT00271856|454695031|FG001|Overall Study|Lost to Follow-up|11|||
126382954|NCT04599803|454695032|FG000|Overall Study|Withdrawal by Subject|5|||
126382955|NCT04599803|454695032|FG000|Overall Study|Lost to Follow-up|26|||
126382956|NCT04677543|454695033|FG000|Overall Study|Withdrawal by Subject|4|||
126382957|NCT04677543|454695034|FG001|Overall Study|Withdrawal by Subject|1|||
126382958|NCT04677543|454695033|FG000|Overall Study|Physician Decision|0|||
126382959|NCT04677543|454695034|FG001|Overall Study|Physician Decision|1|||
126382960|NCT04677543|454695033|FG000|Overall Study|Adverse Event|0|||
126382961|NCT04677543|454695034|FG001|Overall Study|Adverse Event|1|||
126468271|NCT00809354|455017571|FG004|Overall Study|Lost to Follow-up|6|||
126468272|NCT00809354|455017572|FG005|Overall Study|Lost to Follow-up|2|||
126468273|NCT00809354|455017573|FG006|Overall Study|Lost to Follow-up|0|||
126468274|NCT00809354|455017574|FG007|Overall Study|Lost to Follow-up|5|||
126468275|NCT00809354|455017575|FG008|Overall Study|Lost to Follow-up|4|||
126717358|NCT02389816|455916199|FG001|Overall Study|Lost to Follow-up|0|||
126717359|NCT02389816|455916200|FG002|Overall Study|Lost to Follow-up|0|||
126382962|NCT00995436|454695039|FG000|Overall Study|Withdrawal by Subject|2|||
126382963|NCT00995436|454695040|FG001|Overall Study|Withdrawal by Subject|5|||
126382964|NCT00995436|454695041|FG002|Overall Study|Withdrawal by Subject|0|||
126382965|NCT00771927|454695043|FG000|Overall Study|Adverse Event|100|||
126382966|NCT00771927|454695044|FG001|Overall Study|Adverse Event|105|||
126382967|NCT00771927|454695043|FG000|Overall Study|Lack of Efficacy|70|||
126382968|NCT00771927|454695044|FG001|Overall Study|Lack of Efficacy|42|||
126382969|NCT00771927|454695043|FG000|Overall Study|Lost to Follow-up|46|||
126382970|NCT00771927|454695044|FG001|Overall Study|Lost to Follow-up|46|||
126382971|NCT00771927|454695043|FG000|Overall Study|Withdrawal by Subject|16|||
126382972|NCT00771927|454695044|FG001|Overall Study|Withdrawal by Subject|17|||
126382973|NCT00771927|454695043|FG000|Overall Study|Other reason|23|||
126382974|NCT00771927|454695044|FG001|Overall Study|Other reason|27|||
126382975|NCT02063984|454695045|FG000|Overall Study|Lost to Follow-up|6|||
126382976|NCT02063984|454695046|FG001|Overall Study|Lost to Follow-up|5|||
126382977|NCT00577707|454695050|FG000|Overall Study|Withdrawal by Subject|3|||
126382978|NCT03299244|454695051|FG000|Overall Study|Withdrawal by Subject|34|||
126382979|NCT03299244|454695052|FG001|Overall Study|Withdrawal by Subject|29|||
126382980|NCT03299244|454695051|FG000|Overall Study|Decision by Sponsor|4|||
126382981|NCT03299244|454695052|FG001|Overall Study|Decision by Sponsor|5|||
126382982|NCT03299244|454695051|FG000|Overall Study|Death|9|||
126382983|NCT03299244|454695052|FG001|Overall Study|Death|4|||
126382984|NCT01603043|454695053|FG000|Overall Study|Study Futility|7|||
126382985|NCT01603043|454695054|FG001|Overall Study|Study Futility|3|||
126382986|NCT02712996|454695056|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
126382987|NCT02712996|454695057|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
126382988|NCT01016132|454695058|FG000|Overall Study|Discomfort|1|||
126382989|NCT01451749|454695061|FG000|Overall Study|Protocol Violation|14|||
126382990|NCT01451749|454695062|FG001|Overall Study|Protocol Violation|7|||
126382991|NCT01451749|454695061|FG000|Overall Study|Lost to Follow-up|15|||
126382992|NCT01451749|454695062|FG001|Overall Study|Lost to Follow-up|5|||
126382993|NCT01451749|454695061|FG000|Overall Study|Meet the exclusion criteria,and|1|||
126382994|NCT01451749|454695062|FG001|Overall Study|Meet the exclusion criteria,and|1|||
126382995|NCT01451749|454695061|FG000|Overall Study|Adverse Event|2|||
126382996|NCT01451749|454695062|FG001|Overall Study|Adverse Event|0|||
126382997|NCT01451749|454695061|FG000|Overall Study|Withdrawal by Subject|0|||
126382998|NCT01451749|454695062|FG001|Overall Study|Withdrawal by Subject|1|||
126382999|NCT02454530|454695068|FG000|Overall Study|Other|8|||
126383000|NCT02454530|454695069|FG001|Overall Study|Other|13|||
126383001|NCT02454530|454695068|FG000|Overall Study|Missing information|56|||
126383002|NCT02454530|454695069|FG001|Overall Study|Missing information|69|||
126383003|NCT02454530|454695068|FG000|Overall Study|Death|2|||
126383004|NCT02454530|454695069|FG001|Overall Study|Death|41|||
126383005|NCT02454530|454695068|FG000|Overall Study|Lost to Follow-up|4|||
126383006|NCT02454530|454695069|FG001|Overall Study|Lost to Follow-up|4|||
126383007|NCT03265145|454695070|FG000|Overall Study|Protocol Violation|2|||
126383008|NCT03265145|454695071|FG001|Overall Study|Protocol Violation|0|||
126383009|NCT03265145|454695070|FG000|Overall Study|Adverse Event|1|||
126383010|NCT03265145|454695071|FG001|Overall Study|Adverse Event|0|||
126383011|NCT03265145|454695070|FG000|Overall Study|Withdrawal by Subject|23|||
126383012|NCT03265145|454695071|FG001|Overall Study|Withdrawal by Subject|19|||
126383013|NCT03265145|454695070|FG000|Overall Study|Death|12|||
126383014|NCT03265145|454695071|FG001|Overall Study|Death|12|||
126383015|NCT03265145|454695070|FG000|Overall Study|Lost to Follow-up|13|||
126383016|NCT03265145|454695071|FG001|Overall Study|Lost to Follow-up|9|||
126383017|NCT03265145|454695070|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
126468276|NCT00809354|455017576|FG009|Overall Study|Lost to Follow-up|0|||
126468277|NCT00809354|455017567|FG000|Overall Study|Protocol Violation|7|||
126717360|NCT02389816|455916198|FG000|Overall Study|Withdrawal of Consent|6|||
126383018|NCT03265145|454695071|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
126383019|NCT03265145|454695070|FG000|Overall Study|Switched back to previous medication|1|||
126383020|NCT03265145|454695071|FG001|Overall Study|Switched back to previous medication|0|||
126383021|NCT03265145|454695070|FG000|Overall Study|Did not want to take medication|1|||
126383022|NCT03265145|454695071|FG001|Overall Study|Did not want to take medication|0|||
126383023|NCT03265145|454695070|FG000|Overall Study|Subject could not afford medication|0|||
126383024|NCT03265145|454695071|FG001|Overall Study|Subject could not afford medication|1|||
126383025|NCT03265145|454695070|FG000|Overall Study|Site closed|2|||
126383026|NCT03265145|454695071|FG001|Overall Study|Site closed|3|||
126383027|NCT03265145|454695070|FG000|Overall Study|Incorrectly randomized|16|||
126383028|NCT03265145|454695071|FG001|Overall Study|Incorrectly randomized|6|||
126383029|NCT03265145|454695070|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
126383030|NCT03265145|454695071|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
126383031|NCT03265145|454695070|FG000|Overall Study|Physician Decision|0|||
126383032|NCT03265145|454695071|FG001|Overall Study|Physician Decision|3|||
126383033|NCT03265145|454695070|FG000|Overall Study|Subject transferred to another facility|0|||
126383034|NCT03265145|454695071|FG001|Overall Study|Subject transferred to another facility|1|||
126383035|NCT03159468|454695072|FG000|Overall Study|Withdrawal by Subject|0|||
126383036|NCT03159468|454695073|FG001|Overall Study|Withdrawal by Subject|0|||
126383037|NCT03159468|454695074|FG002|Overall Study|Withdrawal by Subject|3|||
126383038|NCT03159468|454695075|FG003|Overall Study|Withdrawal by Subject|0|||
126383039|NCT03159468|454695076|FG004|Overall Study|Withdrawal by Subject|0|||
126383040|NCT03159468|454695077|FG005|Overall Study|Withdrawal by Subject|0|||
126383041|NCT03280303|454696756|FG000|Overall Study|Death|505|||
126383042|NCT03280303|454696756|FG000|Overall Study|Study terminated by sponsor|383|||
126383043|NCT03280303|454696756|FG000|Overall Study|Other|148|||
126383044|NCT03280303|454696756|FG000|Overall Study|No longer willing to participate in study|101|||
126383045|NCT03280303|454696756|FG000|Overall Study|Lost to follow up|39|||
126383046|NCT03280303|454696756|FG000|Overall Study|Adverse Event|20|||
126383047|NCT02974140|454696763|FG000|Overall Study|Adverse Event|2|||
126383048|NCT02974140|454696763|FG000|Overall Study|Lost to Follow-up|1|||
126383049|NCT02974140|454696763|FG000|Overall Study|Study Terminated by Sponsor|36|||
126383050|NCT00617084|454696764|FG000|Overall Study|Withdrawal by Subject|5|||
126383051|NCT00617084|454696765|FG001|Overall Study|Withdrawal by Subject|7|||
126383052|NCT00617084|454696764|FG000|Overall Study|Missed 12 Months visit|16|||
126383053|NCT00617084|454696765|FG001|Overall Study|Missed 12 Months visit|19|||
126383054|NCT02222688|454696769|FG000|Overall Study|Withdrawal by Subject|0|||
126383055|NCT02222688|454696770|FG001|Overall Study|Withdrawal by Subject|0|||
126383056|NCT02222688|454696771|FG002|Overall Study|Withdrawal by Subject|0|||
126383057|NCT02222688|454696772|FG003|Overall Study|Withdrawal by Subject|2|||
126383058|NCT02222688|454696773|FG004|Overall Study|Withdrawal by Subject|1|||
126383059|NCT02222688|454696774|FG005|Overall Study|Withdrawal by Subject|0|||
126383060|NCT02222688|454696775|FG006|Overall Study|Withdrawal by Subject|1|||
126383061|NCT02222688|454696769|FG000|Overall Study|Disease progression|1|||
126383062|NCT02222688|454696770|FG001|Overall Study|Disease progression|0|||
126383063|NCT02222688|454696771|FG002|Overall Study|Disease progression|0|||
126383064|NCT02222688|454696772|FG003|Overall Study|Disease progression|0|||
126383065|NCT02222688|454696773|FG004|Overall Study|Disease progression|0|||
126383066|NCT02222688|454696774|FG005|Overall Study|Disease progression|0|||
126383067|NCT02222688|454696775|FG006|Overall Study|Disease progression|0|||
126383068|NCT02522429|454696784|FG000|Overall Study|Lost to Follow-up|8|||
126383069|NCT02522429|454696784|FG000|Overall Study|Adverse Event|2|||
126383070|NCT02522429|454696784|FG000|Overall Study|Death|1|||
126383071|NCT02522429|454696784|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
126383072|NCT00500357|454696788|FG000|Overall Study|Death|1|||
126383073|NCT00161616|454696789|FG000|Overall Study|Withdrawal by Subject|6|||
126383074|NCT00161616|454696790|FG001|Overall Study|Withdrawal by Subject|5|||
126383075|NCT00161616|454696789|FG000|Overall Study|Physician Decision|1|||
126383076|NCT00161616|454696790|FG001|Overall Study|Physician Decision|0|||
126383077|NCT00161616|454696789|FG000|Overall Study|Death|1|||
126383078|NCT00161616|454696790|FG001|Overall Study|Death|1|||
126383079|NCT00161616|454696789|FG000|Overall Study|Lost to Follow-up|17|||
126383080|NCT00161616|454696790|FG001|Overall Study|Lost to Follow-up|13|||
126383081|NCT00161616|454696789|FG000|Overall Study|Protocol deviation|1|||
126383082|NCT00161616|454696790|FG001|Overall Study|Protocol deviation|0|||
126383083|NCT00854724|454696791|FG000|First Intervention|Withdrawal by Subject|1|||
126383084|NCT00854724|454696792|FG001|First Intervention|Withdrawal by Subject|1|||
126383085|NCT00854724|454696791|FG000|Washout|Protocol Violation|1|||
126383086|NCT00854724|454696792|FG001|Washout|Protocol Violation|0|||
126383087|NCT00854724|454696791|FG000|Washout|Withdrawal by Subject|0|||
126383088|NCT00854724|454696792|FG001|Washout|Withdrawal by Subject|1|||
126383089|NCT00854724|454696791|FG000|Second Intervention|Protocol Violation|1|||
126383090|NCT00854724|454696792|FG001|Second Intervention|Protocol Violation|0|||
126383091|NCT00854724|454696791|FG000|Second Intervention|Physician Decision|0|||
126383092|NCT00854724|454696792|FG001|Second Intervention|Physician Decision|1|||
126383093|NCT00861757|454696794|FG000|Overall Study|Adverse Event|1|||
126383094|NCT00861757|454696795|FG001|Overall Study|Adverse Event|5|||
126383095|NCT00861757|454696796|FG002|Overall Study|Adverse Event|7|||
126383096|NCT00861757|454696797|FG003|Overall Study|Adverse Event|2|||
126383097|NCT00861757|454696794|FG000|Overall Study|Entry Criteria Not Met|1|||
126383098|NCT00861757|454696795|FG001|Overall Study|Entry Criteria Not Met|2|||
126383099|NCT00861757|454696796|FG002|Overall Study|Entry Criteria Not Met|1|||
126383100|NCT00861757|454696797|FG003|Overall Study|Entry Criteria Not Met|1|||
126383101|NCT00861757|454696794|FG000|Overall Study|Lack of Efficacy|3|||
126383102|NCT00861757|454696795|FG001|Overall Study|Lack of Efficacy|1|||
126383103|NCT00861757|454696796|FG002|Overall Study|Lack of Efficacy|0|||
126383104|NCT00861757|454696797|FG003|Overall Study|Lack of Efficacy|1|||
126383105|NCT00861757|454696794|FG000|Overall Study|Lost to Follow-up|1|||
126383106|NCT00861757|454696795|FG001|Overall Study|Lost to Follow-up|0|||
126383107|NCT00861757|454696796|FG002|Overall Study|Lost to Follow-up|1|||
126383108|NCT00861757|454696797|FG003|Overall Study|Lost to Follow-up|1|||
126383109|NCT00861757|454696794|FG000|Overall Study|Physician Decision|0|||
126383110|NCT00861757|454696795|FG001|Overall Study|Physician Decision|0|||
126383111|NCT00861757|454696796|FG002|Overall Study|Physician Decision|0|||
126383112|NCT00861757|454696797|FG003|Overall Study|Physician Decision|1|||
126383113|NCT00861757|454696794|FG000|Overall Study|Protocol Violation|2|||
126383114|NCT00861757|454696795|FG001|Overall Study|Protocol Violation|2|||
126383115|NCT00861757|454696796|FG002|Overall Study|Protocol Violation|4|||
126383116|NCT00861757|454696797|FG003|Overall Study|Protocol Violation|1|||
126383117|NCT00861757|454696794|FG000|Overall Study|Withdrawal by Subject|1|||
126383118|NCT00861757|454696795|FG001|Overall Study|Withdrawal by Subject|5|||
126383119|NCT00861757|454696796|FG002|Overall Study|Withdrawal by Subject|5|||
126383120|NCT00861757|454696797|FG003|Overall Study|Withdrawal by Subject|2|||
126383121|NCT02140970|454696800|FG000|Overall Study|Lost to Follow-up|1|||
126383122|NCT02140970|454696801|FG001|Overall Study|Lost to Follow-up|2|||
126383123|NCT02140970|454696800|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
126383124|NCT02140970|454696801|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
126383125|NCT02140970|454696800|FG000|Overall Study|Did not meet inclusion criteria|0|||
126383126|NCT02140970|454696801|FG001|Overall Study|Did not meet inclusion criteria|1|||
126383127|NCT02705105|454696802|FG000|Treatment|Objective Disease Progression|1|||
126383128|NCT02705105|454696803|FG001|Treatment|Objective Disease Progression|50|||
126383129|NCT02705105|454696802|FG000|Treatment|Withdrawal by Subject|3|||
126383130|NCT02705105|454696803|FG001|Treatment|Withdrawal by Subject|5|||
126383131|NCT02705105|454696802|FG000|Treatment|Adverse Event|0|||
126383132|NCT02705105|454696803|FG001|Treatment|Adverse Event|17|||
126383133|NCT02705105|454696802|FG000|Treatment|Clinical Disease Progression|0|||
126383134|NCT02705105|454696803|FG001|Treatment|Clinical Disease Progression|32|||
126383135|NCT02705105|454696802|FG000|Treatment|Physician Decision|0|||
126383136|NCT02705105|454696803|FG001|Treatment|Physician Decision|3|||
126383137|NCT02705105|454696802|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
126383138|NCT02705105|454696803|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
126383139|NCT02705105|454696802|FG000|Follow-Up|Death|3|||
126383140|NCT02705105|454696803|FG001|Follow-Up|Death|68|||
126383141|NCT02705105|454696802|FG000|Follow-Up|Withdrawal by Subject|1|||
126383142|NCT02705105|454696803|FG001|Follow-Up|Withdrawal by Subject|14|||
126383143|NCT02705105|454696802|FG000|Follow-Up|Study Terminated|0|||
126383144|NCT02705105|454696803|FG001|Follow-Up|Study Terminated|26|||
126383145|NCT02705105|454696802|FG000|Follow-Up|Discontinued per Amendment 3|0|||
126383146|NCT02705105|454696803|FG001|Follow-Up|Discontinued per Amendment 3|2|||
126383147|NCT01709110|454696806|FG000|Overall Study|Adverse Event|56|||
126383148|NCT01709110|454696807|FG001|Overall Study|Adverse Event|48|||
126383149|NCT01709110|454696806|FG000|Overall Study|Death|14|||
126383150|NCT01709110|454696807|FG001|Overall Study|Death|6|||
126383151|NCT01709110|454696806|FG000|Overall Study|Lost to Follow-up|7|||
126383152|NCT01709110|454696807|FG001|Overall Study|Lost to Follow-up|5|||
126383153|NCT01709110|454696806|FG000|Overall Study|Protocol Violation|4|||
126383154|NCT01709110|454696807|FG001|Overall Study|Protocol Violation|6|||
126383155|NCT01709110|454696806|FG000|Overall Study|Withdrawal by Subject|96|||
126383156|NCT01709110|454696807|FG001|Overall Study|Withdrawal by Subject|89|||
126383157|NCT01709110|454696806|FG000|Overall Study|Physician Decision|4|||
126383158|NCT01709110|454696807|FG001|Overall Study|Physician Decision|10|||
126383159|NCT01709110|454696806|FG000|Overall Study|Sponsor Decision|2|||
126383160|NCT01709110|454696807|FG001|Overall Study|Sponsor Decision|2|||
126383161|NCT01709110|454696806|FG000|Overall Study|Lack of Efficacy|1|||
126383162|NCT01709110|454696807|FG001|Overall Study|Lack of Efficacy|1|||
126383163|NCT01709110|454696806|FG000|Overall Study|Caregiver Decision|1|||
126383164|NCT01709110|454696807|FG001|Overall Study|Caregiver Decision|1|||
126717361|NCT02389816|455916199|FG001|Overall Study|Withdrawal of Consent|4|||
126717362|NCT02389816|455916200|FG002|Overall Study|Withdrawal of Consent|4|||
126383165|NCT03332173|454696808|FG000|Overall Study|Death|7|||
126383166|NCT03332173|454696808|FG000|Overall Study|Withdrawal by Subject|6|||
126383167|NCT03332173|454696808|FG000|Overall Study|Lost to Follow-up|2|||
126717363|NCT02389816|455916198|FG000|Overall Study|Lack of Efficacy|1|||
126383168|NCT03332173|454696808|FG000|Overall Study|Transferred to long-term extension study|29|||
126383169|NCT02168101|454696809|FG000|Overall Study|Death|2|||
126383170|NCT02168101|454696810|FG001|Overall Study|Death|2|||
126383171|NCT02168101|454696811|FG002|Overall Study|Death|1|||
126383172|NCT00910910|454696812|FG000|Overall Study|Adverse Event|63|||
126383173|NCT00910910|454696813|FG001|Overall Study|Adverse Event|35|||
126383174|NCT00910910|454696812|FG000|Overall Study|PD without histologic change|27|||
126383175|NCT00910910|454696813|FG001|Overall Study|PD without histologic change|23|||
126383176|NCT00910910|454696812|FG000|Overall Study|PD with histologic change|0|||
126383177|NCT00910910|454696813|FG001|Overall Study|PD with histologic change|2|||
126717364|NCT02389816|455916199|FG001|Overall Study|Lack of Efficacy|0|||
126383178|NCT00910910|454696812|FG000|Overall Study|Withdrawal by Subject|7|||
126383179|NCT00910910|454696813|FG001|Overall Study|Withdrawal by Subject|5|||
126383180|NCT00910910|454696812|FG000|Overall Study|Lost to Follow-up|2|||
126383181|NCT00910910|454696813|FG001|Overall Study|Lost to Follow-up|2|||
126383182|NCT00910910|454696812|FG000|Overall Study|Death|9|||
126383183|NCT00910910|454696813|FG001|Overall Study|Death|3|||
126383184|NCT00910910|454696812|FG000|Overall Study|Protocol Violation|2|||
126383185|NCT00910910|454696813|FG001|Overall Study|Protocol Violation|2|||
126383186|NCT00910910|454696812|FG000|Overall Study|Completed 13 cycles of treatment|0|||
126383187|NCT00910910|454696813|FG001|Overall Study|Completed 13 cycles of treatment|118|||
126383188|NCT00910910|454696812|FG000|Overall Study|Other|114|||
126383189|NCT00910910|454696813|FG001|Overall Study|Other|32|||
126383190|NCT00910910|454696812|FG000|Overall Study|Untreated before cycle 1|1|||
126383191|NCT00910910|454696813|FG001|Overall Study|Untreated before cycle 1|2|||
126383192|NCT01973231|454696814|FG000|Overall Study|Protocol Violation|1|||
126383193|NCT01973231|454696815|FG001|Overall Study|Protocol Violation|1|||
126383194|NCT01973231|454696814|FG000|Overall Study|Lost to Follow-up|1|||
126383195|NCT01973231|454696815|FG001|Overall Study|Lost to Follow-up|1|||
126383196|NCT01973231|454696814|FG000|Overall Study|unclassified|2|||
126383197|NCT01973231|454696815|FG001|Overall Study|unclassified|1|||
126383198|NCT01973231|454696814|FG000|Overall Study|Withdrawal by Subject|7|||
126383199|NCT01973231|454696815|FG001|Overall Study|Withdrawal by Subject|9|||
126383200|NCT01485796|454696818|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
126383201|NCT01485796|454696818|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
126383202|NCT01485796|454696818|FG000|Period 2: Epoch 2|Adverse Event|3|||
126383203|NCT01485796|454696818|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
126383204|NCT01485796|454696818|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
126383205|NCT01485796|454696818|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
126383206|NCT01485796|454696818|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
126383207|NCT01485796|454696818|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
126383208|NCT01775553|454696825|FG000|Overall Study|Adverse Event|1|||
126383209|NCT01775553|454696825|FG000|Overall Study|Disease Progression|12|||
126383210|NCT01523743|454696826|FG000|Period 1|Adverse Event|1|||
126383211|NCT01523743|454696827|FG001|Period 1|Adverse Event|0|||
126383212|NCT01523743|454696826|FG000|Period 1|Withdrawal by Subject|6|||
126383213|NCT01523743|454696827|FG001|Period 1|Withdrawal by Subject|2|||
126383214|NCT01523743|454696826|FG000|Period 1|Lost to Follow-up|1|||
126383215|NCT01523743|454696827|FG001|Period 1|Lost to Follow-up|0|||
126383216|NCT01523743|454696826|FG000|Period 1|Lack of Efficacy|1|||
126468278|NCT00809354|455017568|FG001|Overall Study|Protocol Violation|14|||
126468279|NCT00809354|455017569|FG002|Overall Study|Protocol Violation|14|||
126468280|NCT00809354|455017570|FG003|Overall Study|Protocol Violation|12|||
126468281|NCT00809354|455017571|FG004|Overall Study|Protocol Violation|14|||
126468282|NCT00809354|455017572|FG005|Overall Study|Protocol Violation|6|||
126468283|NCT00809354|455017573|FG006|Overall Study|Protocol Violation|4|||
126468284|NCT00809354|455017574|FG007|Overall Study|Protocol Violation|6|||
126468285|NCT00809354|455017575|FG008|Overall Study|Protocol Violation|9|||
126468286|NCT00809354|455017576|FG009|Overall Study|Protocol Violation|3|||
126468287|NCT00809354|455017567|FG000|Overall Study|Withdrawal by Subject|32|||
126468288|NCT00809354|455017568|FG001|Overall Study|Withdrawal by Subject|27|||
126468289|NCT00809354|455017569|FG002|Overall Study|Withdrawal by Subject|31|||
126468290|NCT00809354|455017570|FG003|Overall Study|Withdrawal by Subject|33|||
126468291|NCT00809354|455017571|FG004|Overall Study|Withdrawal by Subject|34|||
126468292|NCT00809354|455017572|FG005|Overall Study|Withdrawal by Subject|29|||
126468293|NCT00809354|455017573|FG006|Overall Study|Withdrawal by Subject|27|||
126468294|NCT00809354|455017574|FG007|Overall Study|Withdrawal by Subject|19|||
126468295|NCT00809354|455017575|FG008|Overall Study|Withdrawal by Subject|18|||
126468296|NCT00809354|455017576|FG009|Overall Study|Withdrawal by Subject|20|||
126468297|NCT00809354|455017567|FG000|Overall Study|Other|10|||
126468298|NCT00809354|455017568|FG001|Overall Study|Other|2|||
126468299|NCT00809354|455017569|FG002|Overall Study|Other|7|||
126468300|NCT00809354|455017570|FG003|Overall Study|Other|10|||
126383217|NCT01523743|454696827|FG001|Period 1|Lack of Efficacy|0|||
126383218|NCT01523743|454696826|FG000|Period 1|Felt unable to empty bladder|1|||
126383219|NCT01523743|454696827|FG001|Period 1|Felt unable to empty bladder|0|||
126383220|NCT01523743|454696826|FG000|Period 2|Withdrawal by Subject|0|||
126468301|NCT00809354|455017571|FG004|Overall Study|Other|5|||
126468302|NCT00809354|455017572|FG005|Overall Study|Other|3|||
126468303|NCT00809354|455017573|FG006|Overall Study|Other|2|||
126468304|NCT00809354|455017574|FG007|Overall Study|Other|3|||
126468305|NCT00809354|455017575|FG008|Overall Study|Other|4|||
126553357|NCT01406717|455320577|FG000|Overall Study|Lack of Efficacy|0|||
126383221|NCT01523743|454696827|FG001|Period 2|Withdrawal by Subject|2|||
126383222|NCT01523743|454696826|FG000|Period 2|Adverse Event|1|||
126383223|NCT01523743|454696827|FG001|Period 2|Adverse Event|0|||
126383224|NCT02569476|454696828|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
126383225|NCT02569476|454696828|FG000|Overall Study|Death|33|||
126383226|NCT02569476|454696828|FG000|Overall Study|Withdrawal by Subject|9|||
126383227|NCT02569476|454696828|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
126383228|NCT02569476|454696828|FG000|Overall Study|Palliative care|1|||
126468306|NCT00809354|455017576|FG009|Overall Study|Other|3|||
126553358|NCT01406717|455320578|FG001|Overall Study|Lack of Efficacy|1|||
126771160|NCT03985293|456116291|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
126771161|NCT03985293|456116292|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
126771162|NCT03985293|456116287|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
126383229|NCT02569476|454696828|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
126383230|NCT02569476|454696828|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
126383231|NCT01434654|454696829|FG000|Overall Study|Withdrawal by Subject|1|||
126383232|NCT01434654|454696830|FG001|Overall Study|Withdrawal by Subject|0|||
126383233|NCT01434654|454696829|FG000|Overall Study|Lost to Follow-up|1|||
126383234|NCT01434654|454696830|FG001|Overall Study|Lost to Follow-up|0|||
126383235|NCT00703963|454696833|FG000|Overall Study|Withdrawal by Subject|7|||
126383236|NCT00703963|454696834|FG001|Overall Study|Withdrawal by Subject|13|||
126383237|NCT00703963|454696833|FG000|Overall Study|Physician Decision|0|||
126383238|NCT00703963|454696834|FG001|Overall Study|Physician Decision|1|||
126383239|NCT00402324|454696837|FG000|Overall Study|Lost to Follow-up|11|||
126383240|NCT00402324|454696838|FG001|Overall Study|Lost to Follow-up|11|||
126383241|NCT00402324|454696837|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
126383242|NCT00402324|454696838|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
126383243|NCT00402324|454696837|FG000|Overall Study|Protocol Violation|8|||
126383244|NCT00402324|454696838|FG001|Overall Study|Protocol Violation|7|||
126383245|NCT00402324|454696837|FG000|Overall Study|Withdrawal by Subject|5|||
126383246|NCT00402324|454696838|FG001|Overall Study|Withdrawal by Subject|2|||
126383247|NCT00402324|454696837|FG000|Overall Study|Physician Decision|2|||
126383248|NCT00402324|454696838|FG001|Overall Study|Physician Decision|4|||
126383249|NCT00402324|454696837|FG000|Overall Study|Sponsor Decision|4|||
126383250|NCT00402324|454696838|FG001|Overall Study|Sponsor Decision|5|||
126383251|NCT00402324|454696837|FG000|Overall Study|Lack of Efficacy|1|||
126383252|NCT00402324|454696838|FG001|Overall Study|Lack of Efficacy|4|||
126383253|NCT00402324|454696837|FG000|Overall Study|Adverse Event|6|||
126383254|NCT00402324|454696838|FG001|Overall Study|Adverse Event|4|||
126383255|NCT00402324|454696837|FG000|Overall Study|Death|1|||
126383256|NCT00402324|454696838|FG001|Overall Study|Death|0|||
126383257|NCT01277822|454696839|FG000|Overall Study|Adverse Event|2|||
126383258|NCT01277822|454696840|FG001|Overall Study|Adverse Event|1|||
126383259|NCT01277822|454696839|FG000|Overall Study|Withdrawal by Subject|6|||
126383260|NCT01277822|454696840|FG001|Overall Study|Withdrawal by Subject|7|||
126383261|NCT01277822|454696839|FG000|Overall Study|Physician Decision|1|||
126383262|NCT01277822|454696840|FG001|Overall Study|Physician Decision|1|||
126383263|NCT01277822|454696839|FG000|Overall Study|Protocol Violation|1|||
126383264|NCT01277822|454696840|FG001|Overall Study|Protocol Violation|0|||
126383265|NCT01277822|454696839|FG000|Overall Study|Lost to Follow-up|2|||
126383266|NCT01277822|454696840|FG001|Overall Study|Lost to Follow-up|1|||
126383267|NCT01277822|454696839|FG000|Overall Study|Contraindicated medication used|2|||
126383268|NCT01277822|454696840|FG001|Overall Study|Contraindicated medication used|1|||
126383269|NCT01277822|454696839|FG000|Overall Study|Participant moved|1|||
126383270|NCT01277822|454696840|FG001|Overall Study|Participant moved|0|||
126383271|NCT02625220|454696841|FG000|Overall Study|Adverse Event|2|||
126383272|NCT02625220|454696841|FG000|Overall Study|Lost to Follow-up|2|||
126383273|NCT02625220|454696841|FG000|Overall Study|Protocol Violation|1|||
126383274|NCT02625220|454696841|FG000|Overall Study|Study discontinued at site|2|||
126383275|NCT02923531|454696842|FG000|Overall Study|Adverse Event|4|||
126383276|NCT02923531|454696842|FG000|Overall Study|Clinical Deterioration|1|||
126383277|NCT02923531|454696842|FG000|Overall Study|Disease Progression|3|||
126383278|NCT02923531|454696842|FG000|Overall Study|Study Termination|1|||
126383279|NCT00997984|454696843|FG000|Overall Study|Adverse Event|1|||
126383280|NCT00997984|454696844|FG001|Overall Study|Adverse Event|8|||
126383281|NCT00997984|454696845|FG002|Overall Study|Adverse Event|8|||
126383282|NCT00997984|454696843|FG000|Overall Study|Protocol Violation|1|||
126383283|NCT00997984|454696844|FG001|Overall Study|Protocol Violation|3|||
126383284|NCT00997984|454696845|FG002|Overall Study|Protocol Violation|0|||
126383285|NCT00997984|454696843|FG000|Overall Study|Withdrawal by Subject|6|||
126383286|NCT00997984|454696844|FG001|Overall Study|Withdrawal by Subject|9|||
126383287|NCT00997984|454696845|FG002|Overall Study|Withdrawal by Subject|5|||
126383288|NCT00997984|454696843|FG000|Overall Study|Lost to Follow-up|8|||
126383289|NCT00997984|454696844|FG001|Overall Study|Lost to Follow-up|5|||
126383290|NCT00997984|454696845|FG002|Overall Study|Lost to Follow-up|4|||
126383291|NCT00997984|454696843|FG000|Overall Study|Lack of Efficacy|20|||
126383292|NCT00997984|454696844|FG001|Overall Study|Lack of Efficacy|6|||
126383293|NCT00997984|454696845|FG002|Overall Study|Lack of Efficacy|3|||
126383294|NCT00997984|454696843|FG000|Overall Study|Met exclusion criteria|1|||
126383295|NCT00997984|454696844|FG001|Overall Study|Met exclusion criteria|0|||
126383296|NCT00997984|454696845|FG002|Overall Study|Met exclusion criteria|0|||
126383297|NCT00997984|454696843|FG000|Overall Study|non-compliance|0|||
126383298|NCT00997984|454696844|FG001|Overall Study|non-compliance|2|||
126383299|NCT00997984|454696845|FG002|Overall Study|non-compliance|3|||
126383300|NCT00997984|454696843|FG000|Overall Study|Wrong medication dispensed|0|||
126383301|NCT00997984|454696844|FG001|Overall Study|Wrong medication dispensed|1|||
126383302|NCT00997984|454696845|FG002|Overall Study|Wrong medication dispensed|0|||
126383303|NCT00997984|454696843|FG000|Overall Study|Suicidal ideation|0|||
126383304|NCT00997984|454696844|FG001|Overall Study|Suicidal ideation|0|||
126383305|NCT00997984|454696845|FG002|Overall Study|Suicidal ideation|1|||
126383306|NCT00997984|454696843|FG000|Overall Study|Work schedule|0|||
126383307|NCT00997984|454696844|FG001|Overall Study|Work schedule|0|||
126383308|NCT00997984|454696845|FG002|Overall Study|Work schedule|2|||
126383309|NCT01140867|454696846|FG000|Overall Study|Adverse Event|22|||
126383310|NCT01140867|454696846|FG000|Overall Study|Lack of Efficacy|3|||
126383311|NCT01140867|454696846|FG000|Overall Study|Lost to Follow-up|2|||
126383312|NCT01140867|454696846|FG000|Overall Study|Withdrawal by Subject|1|||
126383313|NCT01140867|454696846|FG000|Overall Study|Protocol Violation|1|||
126383314|NCT01140867|454696846|FG000|Overall Study|Uncooperative patient|2|||
126383315|NCT01140867|454696846|FG000|Overall Study|Medication Noncompliance|2|||
126383316|NCT01119066|454696848|FG000|Overall Study|Withdrawal by Subject|4|||
126383317|NCT01119066|454696849|FG001|Overall Study|Withdrawal by Subject|6|||
126383318|NCT01119066|454696850|FG002|Overall Study|Withdrawal by Subject|0|||
126383319|NCT01119066|454696851|FG003|Overall Study|Withdrawal by Subject|0|||
126383320|NCT01119066|454696848|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
126383321|NCT01119066|454696849|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
126383322|NCT01119066|454696850|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
126383323|NCT01119066|454696851|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
126383324|NCT01119066|454696848|FG000|Overall Study|Relapse identified before transplant|1|||
126383325|NCT01119066|454696849|FG001|Overall Study|Relapse identified before transplant|0|||
126383326|NCT01119066|454696850|FG002|Overall Study|Relapse identified before transplant|0|||
126383327|NCT01119066|454696851|FG003|Overall Study|Relapse identified before transplant|0|||
126383328|NCT01119066|454696848|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
126383329|NCT01119066|454696849|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
126383330|NCT01119066|454696850|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
126383331|NCT01119066|454696851|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
126383332|NCT01119066|454696848|FG000|Overall Study|Relapse identified before transplant|0|||
126383333|NCT01119066|454696849|FG001|Overall Study|Relapse identified before transplant|4|||
126383334|NCT01119066|454696850|FG002|Overall Study|Relapse identified before transplant|0|||
126383335|NCT01119066|454696851|FG003|Overall Study|Relapse identified before transplant|0|||
126383336|NCT02366923|454696852|FG000|Overall Study|Withdrawal by Subject|1|||
126383337|NCT02366923|454696852|FG000|Overall Study|Positive Slit Lamp Findings|2|||
126383338|NCT02366923|454696852|FG000|Overall Study|High Astigmatism|3|||
126383339|NCT03902392|454696853|FG000|Overall Study|Lost to Follow-up|7|||
126383340|NCT03902392|454696854|FG001|Overall Study|Lost to Follow-up|7|||
126383341|NCT01437111|454696855|FG000|Overall Study|Adverse Event|2|||
126383342|NCT01437111|454696855|FG000|Overall Study|Withdrawal by Subject|4|||
126383343|NCT01437111|454696855|FG000|Overall Study|Not reported|5|||
126383344|NCT01437111|454696855|FG000|Overall Study|Physician Decision|1|||
126383345|NCT01437111|454696855|FG000|Overall Study|Lost to Follow-up|5|||
126383346|NCT01437111|454696855|FG000|Overall Study|Protocol Violation|1|||
126383347|NCT03711370|454696856|FG000|Overall Study|Lost to Follow-up|16|||
126383348|NCT03711370|454696857|FG001|Overall Study|Lost to Follow-up|10|||
126383349|NCT03711370|454696856|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
126383350|NCT03711370|454696857|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
126383351|NCT00407602|454696858|FG000|Overall Study|Death - unrelated to device|1|||
126383352|NCT00407602|454696858|FG000|Overall Study|Device explanted|5|||
126383353|NCT00407602|454696858|FG000|Overall Study|Withdrawal by Subject|1|||
126383354|NCT00431444|454696861|FG000|Overall Study|Protocol Violation|1|||
126383355|NCT00431444|454696862|FG001|Overall Study|Protocol Violation|4|||
126383356|NCT00431444|454696861|FG000|Overall Study|Adverse Event|2|||
126383357|NCT00431444|454696862|FG001|Overall Study|Adverse Event|1|||
126383358|NCT00431444|454696861|FG000|Overall Study|Withdrawal by Subject|1|||
126383359|NCT00431444|454696862|FG001|Overall Study|Withdrawal by Subject|1|||
126383360|NCT00431444|454696861|FG000|Overall Study|Lost to Follow-up|1|||
126468307|NCT00809354|455017567|FG000|Overall Study|Study terminated by sponsor|138|||
126468308|NCT00809354|455017568|FG001|Overall Study|Study terminated by sponsor|134|||
126468309|NCT00809354|455017569|FG002|Overall Study|Study terminated by sponsor|129|||
126468310|NCT00809354|455017570|FG003|Overall Study|Study terminated by sponsor|120|||
126383361|NCT00431444|454696862|FG001|Overall Study|Lost to Follow-up|0|||
126383362|NCT00431444|454696861|FG000|Overall Study|Administrative Problems|0|||
126383363|NCT00431444|454696862|FG001|Overall Study|Administrative Problems|1|||
126383364|NCT02517398|454696877|FG000|Overall Study|Death|2|||
126383365|NCT02517398|454696878|FG001|Overall Study|Death|3|||
126383366|NCT02517398|454696879|FG002|Overall Study|Death|4|||
126383367|NCT02517398|454696880|FG003|Overall Study|Death|2|||
126383368|NCT02517398|454696881|FG004|Overall Study|Death|3|||
126383369|NCT02517398|454696882|FG005|Overall Study|Death|8|||
126383370|NCT02517398|454696883|FG006|Overall Study|Death|3|||
126383371|NCT02517398|454696884|FG007|Overall Study|Death|2|||
126383372|NCT02517398|454696885|FG008|Overall Study|Death|6|||
126383373|NCT02517398|454696886|FG009|Overall Study|Death|24|||
126383374|NCT02517398|454696887|FG010|Overall Study|Death|53|||
126383375|NCT02517398|454696888|FG011|Overall Study|Death|25|||
126383376|NCT02517398|454696889|FG012|Overall Study|Death|73|||
126383377|NCT02517398|454696890|FG013|Overall Study|Death|29|||
126383378|NCT02517398|454696891|FG014|Overall Study|Death|26|||
126383379|NCT02517398|454696892|FG015|Overall Study|Death|23|||
126383380|NCT02517398|454696893|FG016|Overall Study|Death|26|||
126383381|NCT02517398|454696894|FG017|Overall Study|Death|25|||
126383382|NCT02517398|454696895|FG018|Overall Study|Death|22|||
126383383|NCT02517398|454696896|FG019|Overall Study|Death|7|||
126383384|NCT02517398|454696897|FG020|Overall Study|Death|26|||
126383385|NCT02517398|454696898|FG021|Overall Study|Death|30|||
126383386|NCT02517398|454696899|FG022|Overall Study|Death|20|||
126383387|NCT02517398|454696877|FG000|Overall Study|Other|0|||
126383388|NCT02517398|454696878|FG001|Overall Study|Other|0|||
126383389|NCT02517398|454696879|FG002|Overall Study|Other|0|||
126383390|NCT02517398|454696880|FG003|Overall Study|Other|1|||
126383391|NCT02517398|454696881|FG004|Overall Study|Other|0|||
126383392|NCT02517398|454696882|FG005|Overall Study|Other|0|||
126383393|NCT02517398|454696883|FG006|Overall Study|Other|0|||
126383394|NCT02517398|454696884|FG007|Overall Study|Other|0|||
126383395|NCT02517398|454696885|FG008|Overall Study|Other|0|||
126383396|NCT02517398|454696886|FG009|Overall Study|Other|1|||
126383397|NCT02517398|454696887|FG010|Overall Study|Other|0|||
126383398|NCT02517398|454696888|FG011|Overall Study|Other|0|||
126383399|NCT02517398|454696889|FG012|Overall Study|Other|0|||
126383400|NCT02517398|454696890|FG013|Overall Study|Other|1|||
126383401|NCT02517398|454696891|FG014|Overall Study|Other|0|||
126383402|NCT02517398|454696892|FG015|Overall Study|Other|1|||
126383403|NCT02517398|454696893|FG016|Overall Study|Other|1|||
126383404|NCT02517398|454696894|FG017|Overall Study|Other|0|||
126383405|NCT02517398|454696895|FG018|Overall Study|Other|0|||
126383406|NCT02517398|454696896|FG019|Overall Study|Other|1|||
126383407|NCT02517398|454696897|FG020|Overall Study|Other|0|||
126383408|NCT02517398|454696898|FG021|Overall Study|Other|0|||
126383409|NCT02517398|454696899|FG022|Overall Study|Other|0|||
126383410|NCT02517398|454696877|FG000|Overall Study|Lost to Follow-up|0|||
126383411|NCT02517398|454696878|FG001|Overall Study|Lost to Follow-up|0|||
126383412|NCT02517398|454696879|FG002|Overall Study|Lost to Follow-up|0|||
126383413|NCT02517398|454696880|FG003|Overall Study|Lost to Follow-up|0|||
126383414|NCT02517398|454696881|FG004|Overall Study|Lost to Follow-up|0|||
126383415|NCT02517398|454696882|FG005|Overall Study|Lost to Follow-up|0|||
126383416|NCT02517398|454696883|FG006|Overall Study|Lost to Follow-up|0|||
126383417|NCT02517398|454696884|FG007|Overall Study|Lost to Follow-up|0|||
126383418|NCT02517398|454696885|FG008|Overall Study|Lost to Follow-up|0|||
126383419|NCT02517398|454696886|FG009|Overall Study|Lost to Follow-up|1|||
126383420|NCT02517398|454696887|FG010|Overall Study|Lost to Follow-up|0|||
126383421|NCT02517398|454696888|FG011|Overall Study|Lost to Follow-up|2|||
126383422|NCT02517398|454696889|FG012|Overall Study|Lost to Follow-up|2|||
126383423|NCT02517398|454696890|FG013|Overall Study|Lost to Follow-up|0|||
126468311|NCT00809354|455017571|FG004|Overall Study|Study terminated by sponsor|126|||
126468312|NCT00809354|455017572|FG005|Overall Study|Study terminated by sponsor|133|||
126468313|NCT00809354|455017573|FG006|Overall Study|Study terminated by sponsor|124|||
126468314|NCT00809354|455017574|FG007|Overall Study|Study terminated by sponsor|148|||
126468315|NCT00809354|455017575|FG008|Overall Study|Study terminated by sponsor|127|||
126468316|NCT00809354|455017576|FG009|Overall Study|Study terminated by sponsor|135|||
126468317|NCT00809354|455017567|FG000|Overall Study|Withdrawn due to pregnancy|0|||
126553359|NCT01406717|455320577|FG000|Overall Study|Non-completion of visit activity|0|||
126717365|NCT02389816|455916200|FG002|Overall Study|Lack of Efficacy|0|||
126717366|NCT02389816|455916198|FG000|Overall Study|Non Compliance with Study Drug|1|||
126717367|NCT02389816|455916199|FG001|Overall Study|Non Compliance with Study Drug|1|||
126717368|NCT02389816|455916200|FG002|Overall Study|Non Compliance with Study Drug|1|||
126717369|NCT02389816|455916198|FG000|Overall Study|Reason not Specified|0|||
126717370|NCT02389816|455916199|FG001|Overall Study|Reason not Specified|2|||
126383424|NCT02517398|454696891|FG014|Overall Study|Lost to Follow-up|1|||
126383425|NCT02517398|454696892|FG015|Overall Study|Lost to Follow-up|1|||
126383426|NCT02517398|454696893|FG016|Overall Study|Lost to Follow-up|0|||
126383427|NCT02517398|454696894|FG017|Overall Study|Lost to Follow-up|3|||
126383428|NCT02517398|454696895|FG018|Overall Study|Lost to Follow-up|1|||
126383429|NCT02517398|454696896|FG019|Overall Study|Lost to Follow-up|0|||
126383430|NCT02517398|454696897|FG020|Overall Study|Lost to Follow-up|1|||
126468318|NCT00809354|455017568|FG001|Overall Study|Withdrawn due to pregnancy|1|||
126468319|NCT00809354|455017569|FG002|Overall Study|Withdrawn due to pregnancy|0|||
126383431|NCT02517398|454696898|FG021|Overall Study|Lost to Follow-up|0|||
126383432|NCT02517398|454696899|FG022|Overall Study|Lost to Follow-up|2|||
126383433|NCT02517398|454696877|FG000|Overall Study|Withdrew Consent|0|||
126383434|NCT02517398|454696878|FG001|Overall Study|Withdrew Consent|0|||
126383435|NCT02517398|454696879|FG002|Overall Study|Withdrew Consent|0|||
126383436|NCT02517398|454696880|FG003|Overall Study|Withdrew Consent|0|||
126383437|NCT02517398|454696881|FG004|Overall Study|Withdrew Consent|0|||
126383438|NCT02517398|454696882|FG005|Overall Study|Withdrew Consent|0|||
126383439|NCT02517398|454696883|FG006|Overall Study|Withdrew Consent|1|||
126383440|NCT02517398|454696884|FG007|Overall Study|Withdrew Consent|0|||
126383441|NCT02517398|454696885|FG008|Overall Study|Withdrew Consent|0|||
126383442|NCT02517398|454696886|FG009|Overall Study|Withdrew Consent|2|||
126383443|NCT02517398|454696887|FG010|Overall Study|Withdrew Consent|7|||
126383444|NCT02517398|454696888|FG011|Overall Study|Withdrew Consent|1|||
126383445|NCT02517398|454696889|FG012|Overall Study|Withdrew Consent|5|||
126383446|NCT02517398|454696890|FG013|Overall Study|Withdrew Consent|4|||
126383447|NCT02517398|454696891|FG014|Overall Study|Withdrew Consent|2|||
126383448|NCT02517398|454696892|FG015|Overall Study|Withdrew Consent|5|||
126383449|NCT02517398|454696893|FG016|Overall Study|Withdrew Consent|4|||
126383450|NCT02517398|454696894|FG017|Overall Study|Withdrew Consent|2|||
126383451|NCT02517398|454696895|FG018|Overall Study|Withdrew Consent|3|||
126383452|NCT02517398|454696896|FG019|Overall Study|Withdrew Consent|2|||
126383453|NCT02517398|454696897|FG020|Overall Study|Withdrew Consent|9|||
126383454|NCT02517398|454696898|FG021|Overall Study|Withdrew Consent|3|||
126383455|NCT02517398|454696899|FG022|Overall Study|Withdrew Consent|1|||
126383456|NCT00005947|454696900|FG000|Overall Study|Death|54|||
126383457|NCT00005947|454696901|FG001|Overall Study|Death|40|||
126383458|NCT00005947|454696900|FG000|Overall Study|Patient Refused to Continue|2|||
126383459|NCT00005947|454696901|FG001|Overall Study|Patient Refused to Continue|1|||
126383460|NCT00005947|454696900|FG000|Overall Study|Site Closure|1|||
126383461|NCT00005947|454696901|FG001|Overall Study|Site Closure|0|||
126383462|NCT00556439|454696917|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
126383463|NCT00556439|454696918|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
126383464|NCT00556439|454696919|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
126383465|NCT00556439|454696920|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
126383466|NCT00556439|454696917|FG000|Study Entry to Week 12|Physician Decision|1|||
126383467|NCT00556439|454696918|FG001|Study Entry to Week 12|Physician Decision|0|||
126383468|NCT00556439|454696919|FG002|Study Entry to Week 12|Physician Decision|0|||
126383469|NCT00556439|454696920|FG003|Study Entry to Week 12|Physician Decision|0|||
126383470|NCT00556439|454696917|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
126383471|NCT00556439|454696918|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
126383472|NCT00556439|454696919|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
126383473|NCT00556439|454696920|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
126383474|NCT00556439|454696917|FG000|Study Entry to Week 12|Recurrent infection|1|||
126383475|NCT00556439|454696918|FG001|Study Entry to Week 12|Recurrent infection|0|||
126383476|NCT00556439|454696919|FG002|Study Entry to Week 12|Recurrent infection|0|||
126383477|NCT00556439|454696920|FG003|Study Entry to Week 12|Recurrent infection|0|||
126383478|NCT00556439|454696917|FG000|Study Entry to Week 12|Malignancy|0|||
126383479|NCT00556439|454696918|FG001|Study Entry to Week 12|Malignancy|0|||
126383480|NCT00556439|454696919|FG002|Study Entry to Week 12|Malignancy|1|||
126383481|NCT00556439|454696920|FG003|Study Entry to Week 12|Malignancy|0|||
126383482|NCT00556439|454696917|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
126383483|NCT00556439|454696918|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
126383484|NCT00556439|454696919|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
126383485|NCT00556439|454696920|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
126383486|NCT00556439|454696917|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
126383487|NCT00556439|454696918|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
126383488|NCT00556439|454696919|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
126383489|NCT00556439|454696920|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
126383490|NCT00556439|454696917|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
126383491|NCT00556439|454696918|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
126383492|NCT00556439|454696919|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
126383493|NCT00556439|454696920|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
126383494|NCT00556439|454696917|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
126383495|NCT00556439|454696918|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
126383496|NCT00556439|454696919|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
126383497|NCT00556439|454696920|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
126383498|NCT02100423|454696921|FG000|Overall Study|Death|1|||
126383499|NCT02100423|454696921|FG000|Overall Study|Withdrawal by Subject|3|||
126468320|NCT00809354|455017570|FG003|Overall Study|Withdrawn due to pregnancy|0|||
126383500|NCT02100423|454696921|FG000|Overall Study|Adverse Event|1|||
126383501|NCT02100423|454696921|FG000|Overall Study|Physician Decision|1|||
126383502|NCT02931838|454696922|FG000|Overall Study|Reason not provided by investigator|1|||
126383503|NCT02931838|454696923|FG001|Overall Study|Reason not provided by investigator|0|||
126383504|NCT02931838|454696924|FG002|Overall Study|Reason not provided by investigator|1|||
126468321|NCT00809354|455017571|FG004|Overall Study|Withdrawn due to pregnancy|0|||
126468322|NCT00809354|455017572|FG005|Overall Study|Withdrawn due to pregnancy|0|||
126468323|NCT00809354|455017573|FG006|Overall Study|Withdrawn due to pregnancy|0|||
126383505|NCT02931838|454696925|FG003|Overall Study|Reason not provided by investigator|0|||
126383506|NCT02931838|454696926|FG004|Overall Study|Reason not provided by investigator|0|||
126383507|NCT02931838|454696927|FG005|Overall Study|Reason not provided by investigator|0|||
126468324|NCT00809354|455017574|FG007|Overall Study|Withdrawn due to pregnancy|0|||
126468325|NCT00809354|455017575|FG008|Overall Study|Withdrawn due to pregnancy|0|||
126383508|NCT02931838|454696922|FG000|Overall Study|Poor/non-compliance|0|||
126383509|NCT02931838|454696923|FG001|Overall Study|Poor/non-compliance|0|||
126383510|NCT02931838|454696924|FG002|Overall Study|Poor/non-compliance|1|||
126383511|NCT02931838|454696925|FG003|Overall Study|Poor/non-compliance|0|||
126383512|NCT02931838|454696926|FG004|Overall Study|Poor/non-compliance|0|||
126383513|NCT02931838|454696927|FG005|Overall Study|Poor/non-compliance|0|||
126383514|NCT02931838|454696922|FG000|Overall Study|Lack of Efficacy|5|||
126383515|NCT02931838|454696923|FG001|Overall Study|Lack of Efficacy|4|||
126383516|NCT02931838|454696924|FG002|Overall Study|Lack of Efficacy|0|||
126383517|NCT02931838|454696925|FG003|Overall Study|Lack of Efficacy|0|||
126383518|NCT02931838|454696926|FG004|Overall Study|Lack of Efficacy|0|||
126383519|NCT02931838|454696927|FG005|Overall Study|Lack of Efficacy|1|||
126383520|NCT02931838|454696922|FG000|Overall Study|Lost to Follow-up|1|||
126383521|NCT02931838|454696923|FG001|Overall Study|Lost to Follow-up|0|||
126383522|NCT02931838|454696924|FG002|Overall Study|Lost to Follow-up|1|||
126383523|NCT02931838|454696925|FG003|Overall Study|Lost to Follow-up|1|||
126383524|NCT02931838|454696926|FG004|Overall Study|Lost to Follow-up|2|||
126383525|NCT02931838|454696927|FG005|Overall Study|Lost to Follow-up|0|||
126383526|NCT02931838|454696922|FG000|Overall Study|Subject request to discontinue treatment|4|||
126383527|NCT02931838|454696923|FG001|Overall Study|Subject request to discontinue treatment|3|||
126383528|NCT02931838|454696924|FG002|Overall Study|Subject request to discontinue treatment|3|||
126383529|NCT02931838|454696925|FG003|Overall Study|Subject request to discontinue treatment|0|||
126383530|NCT02931838|454696926|FG004|Overall Study|Subject request to discontinue treatment|1|||
126383531|NCT02931838|454696927|FG005|Overall Study|Subject request to discontinue treatment|0|||
126383532|NCT02931838|454696922|FG000|Overall Study|Withdrawal by Subject|1|||
126383533|NCT02931838|454696923|FG001|Overall Study|Withdrawal by Subject|2|||
126383534|NCT02931838|454696924|FG002|Overall Study|Withdrawal by Subject|0|||
126383535|NCT02931838|454696925|FG003|Overall Study|Withdrawal by Subject|1|||
126383536|NCT02931838|454696926|FG004|Overall Study|Withdrawal by Subject|0|||
126383537|NCT02931838|454696927|FG005|Overall Study|Withdrawal by Subject|0|||
126383538|NCT02931838|454696922|FG000|Overall Study|Adverse Event|2|||
126383539|NCT02931838|454696923|FG001|Overall Study|Adverse Event|1|||
126383540|NCT02931838|454696924|FG002|Overall Study|Adverse Event|2|||
126383541|NCT02931838|454696925|FG003|Overall Study|Adverse Event|1|||
126383542|NCT02931838|454696926|FG004|Overall Study|Adverse Event|3|||
126383543|NCT02931838|454696927|FG005|Overall Study|Adverse Event|1|||
126383544|NCT02701764|454696928|FG000|Overall Study|Lost to Follow-up|0|||
126383545|NCT02701764|454696929|FG001|Overall Study|Lost to Follow-up|1|||
126383546|NCT02949024|454696932|FG000|Overall Study|Withdrawal by Subject|0|||
126383547|NCT02949024|454696933|FG001|Overall Study|Withdrawal by Subject|1|||
126383548|NCT01027650|454696934|FG000|Overall Study|Personal Reasons|0|||
126383549|NCT01027650|454696935|FG001|Overall Study|Personal Reasons|0|||
126383550|NCT01027650|454696936|FG002|Overall Study|Personal Reasons|0|||
126383551|NCT01027650|454696937|FG003|Overall Study|Personal Reasons|0|||
126383552|NCT01027650|454696938|FG004|Overall Study|Personal Reasons|2|||
126383553|NCT01027650|454696939|FG005|Overall Study|Personal Reasons|1|||
126383554|NCT01027650|454696940|FG006|Overall Study|Personal Reasons|0|||
126383555|NCT01027650|454696941|FG007|Overall Study|Personal Reasons|0|||
126383556|NCT01027650|454696934|FG000|Overall Study|Lost to Follow-up|0|||
126383557|NCT01027650|454696935|FG001|Overall Study|Lost to Follow-up|0|||
126383558|NCT01027650|454696936|FG002|Overall Study|Lost to Follow-up|0|||
126383559|NCT01027650|454696937|FG003|Overall Study|Lost to Follow-up|0|||
126383560|NCT01027650|454696938|FG004|Overall Study|Lost to Follow-up|0|||
126383561|NCT01027650|454696939|FG005|Overall Study|Lost to Follow-up|0|||
126383562|NCT01027650|454696940|FG006|Overall Study|Lost to Follow-up|1|||
126383563|NCT01027650|454696941|FG007|Overall Study|Lost to Follow-up|0|||
126383564|NCT01027650|454696934|FG000|Overall Study|Lack of Efficacy|0|||
126383565|NCT01027650|454696935|FG001|Overall Study|Lack of Efficacy|0|||
126383566|NCT01027650|454696936|FG002|Overall Study|Lack of Efficacy|0|||
126383567|NCT01027650|454696937|FG003|Overall Study|Lack of Efficacy|0|||
126383568|NCT01027650|454696938|FG004|Overall Study|Lack of Efficacy|0|||
126383569|NCT01027650|454696939|FG005|Overall Study|Lack of Efficacy|1|||
126383570|NCT01027650|454696940|FG006|Overall Study|Lack of Efficacy|0|||
126383571|NCT01027650|454696941|FG007|Overall Study|Lack of Efficacy|0|||
126553360|NCT01406717|455320578|FG001|Overall Study|Non-completion of visit activity|1|||
126717371|NCT02389816|455916200|FG002|Overall Study|Reason not Specified|0|||
126383572|NCT00912782|454696942|FG000|Overall Study|Death|2|||
126383573|NCT00912782|454696943|FG001|Overall Study|Death|1|||
126383574|NCT00912782|454696942|FG000|Overall Study|Lost to Follow-up|0|||
126383575|NCT00912782|454696943|FG001|Overall Study|Lost to Follow-up|1|||
126383576|NCT00912782|454696942|FG000|Overall Study|Did not receive vascular access type|1|||
126383577|NCT00912782|454696943|FG001|Overall Study|Did not receive vascular access type|2|||
126383578|NCT00912782|454696942|FG000|Overall Study|Relocated before study completion|0|||
126383579|NCT00912782|454696943|FG001|Overall Study|Relocated before study completion|1|||
126383580|NCT00283803|454698786|FG000|Overall Study|Physician Decision|9|||
126383581|NCT00283803|454698786|FG000|Overall Study|Withdrawal by Subject|4|||
126383582|NCT01127607|454698787|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
126383583|NCT01127607|454698788|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
126383584|NCT01127607|454698787|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
126383585|NCT01127607|454698788|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
126383586|NCT02220855|454698789|FG000|Overall Study|Adverse Event|8|||
126383587|NCT02220855|454698789|FG000|Overall Study|Disease Progression|5|||
126383588|NCT02220855|454698789|FG000|Overall Study|Withdrawal by Subject|1|||
126383589|NCT03419897|454698790|FG000|Overall Study|Death|180|||
126383590|NCT03419897|454698790|FG000|Overall Study|Lost to Follow-up|1|||
126383591|NCT03419897|454698790|FG000|Overall Study|Withdrawal by Subject|6|||
126383592|NCT03419897|454698790|FG000|Overall Study|Sponsor Decision|61|||
126383593|NCT03419897|454698790|FG000|Overall Study|Physician Decision|1|||
126383594|NCT00958360|454698798|FG000|Overall Study|Withdrawal by Subject|3|||
126383595|NCT00958360|454698799|FG001|Overall Study|Withdrawal by Subject|1|||
126383596|NCT00958360|454698798|FG000|Overall Study|Death|6|||
126383597|NCT00958360|454698799|FG001|Overall Study|Death|7|||
126383598|NCT00958360|454698798|FG000|Overall Study|Physician Decision|2|||
126383599|NCT00958360|454698799|FG001|Overall Study|Physician Decision|1|||
126383600|NCT00958360|454698798|FG000|Overall Study|Lost to Follow-up|0|||
126383601|NCT00958360|454698799|FG001|Overall Study|Lost to Follow-up|1|||
126383602|NCT02719691|454698800|FG000|Overall Study|Physician Decision|0|||
126383603|NCT02719691|454698801|FG001|Overall Study|Physician Decision|0|||
126383604|NCT02719691|454698802|FG002|Overall Study|Physician Decision|1|||
126383605|NCT02719691|454698803|FG003|Overall Study|Physician Decision|0|||
126383606|NCT02719691|454698804|FG004|Overall Study|Physician Decision|0|||
126383607|NCT02719691|454698805|FG005|Overall Study|Physician Decision|0|||
126383608|NCT02719691|454698806|FG006|Overall Study|Physician Decision|0|||
126383609|NCT02719691|454698800|FG000|Overall Study|Withdrawal by Subject|0|||
126383610|NCT02719691|454698801|FG001|Overall Study|Withdrawal by Subject|0|||
126383611|NCT02719691|454698802|FG002|Overall Study|Withdrawal by Subject|0|||
126383612|NCT02719691|454698803|FG003|Overall Study|Withdrawal by Subject|0|||
126383613|NCT02719691|454698804|FG004|Overall Study|Withdrawal by Subject|0|||
126383614|NCT02719691|454698805|FG005|Overall Study|Withdrawal by Subject|1|||
126383615|NCT02719691|454698806|FG006|Overall Study|Withdrawal by Subject|0|||
126383616|NCT00336284|454698807|FG000|Overall Study|Death|52|||
126383617|NCT00336284|454698808|FG001|Overall Study|Death|26|||
126383618|NCT00336284|454698807|FG000|Overall Study|Lost to Follow-up|82|||
126383619|NCT00336284|454698808|FG001|Overall Study|Lost to Follow-up|61|||
126383620|NCT00336284|454698807|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
126383621|NCT00336284|454698808|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
126383622|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
126383623|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
126383624|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
126383625|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
126383626|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
126383627|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
126383628|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
126383629|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
126383630|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
126383631|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
126383632|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
126383633|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
126383634|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
126383635|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
126383636|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
126383637|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
126383638|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
126383639|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
126383640|NCT03308968|454698813|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
126553361|NCT03257995|455320579|FG000|Overall Study|Adverse Event|0|||
126383641|NCT03308968|454698814|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
126383642|NCT03308968|454698815|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
126383643|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
126383644|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
126383645|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
126383646|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
126383647|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
126383648|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
126383649|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
126383650|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
126383651|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
126383652|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
126383653|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
126383654|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
126553362|NCT03257995|455320580|FG001|Overall Study|Adverse Event|1|||
126553363|NCT03257995|455320581|FG002|Overall Study|Adverse Event|0|||
126717372|NCT02417233|455916201|FG000|Overall Study|Death|4|||
126383655|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
126383656|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
126383657|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
126383658|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
126383659|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
126383660|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
126383661|NCT03308968|454698813|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
126383662|NCT03308968|454698814|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
126383663|NCT03308968|454698815|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
126383664|NCT01961297|454698821|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
126383665|NCT01961297|454698822|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
126383666|NCT02141633|454698823|FG000|Overall Study|Physician Decision|1|||
126383667|NCT02141633|454698824|FG001|Overall Study|Physician Decision|0|||
126383668|NCT02482298|454698825|FG000|Overall Study|Withdrawal by Subject|2|||
126383669|NCT02482298|454698826|FG001|Overall Study|Withdrawal by Subject|1|||
126383670|NCT02482298|454698827|FG002|Overall Study|Withdrawal by Subject|2|||
126383671|NCT02482298|454698825|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
126383672|NCT02482298|454698826|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
126383673|NCT02482298|454698827|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
126383674|NCT02482298|454698825|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
126383675|NCT02482298|454698826|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
126383676|NCT02482298|454698827|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
126383677|NCT02482298|454698825|FG000|Overall Study|Lost to Follow-up|0|||
126383678|NCT02482298|454698826|FG001|Overall Study|Lost to Follow-up|1|||
126383679|NCT02482298|454698827|FG002|Overall Study|Lost to Follow-up|0|||
126383680|NCT01188551|454698832|FG000|Overall Study|Pharmacy issues|1|||
126383681|NCT01188551|454698833|FG001|Overall Study|Pharmacy issues|0|||
126383682|NCT01188551|454698834|FG002|Overall Study|Pharmacy issues|0|||
126383683|NCT01188551|454698835|FG003|Overall Study|Pharmacy issues|0|||
126383684|NCT03782259|454698838|FG000|Overall Study|Lost to Follow-up|1|||
126383685|NCT03782259|454698839|FG001|Overall Study|Lost to Follow-up|1|||
126383686|NCT03782259|454698838|FG000|Overall Study|Moved out of state|0|||
126383687|NCT03782259|454698839|FG001|Overall Study|Moved out of state|2|||
126383688|NCT03782259|454698838|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
126383689|NCT03782259|454698839|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
126383690|NCT03782259|454698838|FG000|Overall Study|Subject discontinued intervention|1|||
126383691|NCT03782259|454698839|FG001|Overall Study|Subject discontinued intervention|0|||
126383692|NCT00603941|454698840|FG000|Overall Study|Disease progression|6|||
126383693|NCT00603941|454698841|FG001|Overall Study|Disease progression|7|||
126383694|NCT00603941|454698842|FG002|Overall Study|Disease progression|1|||
126383695|NCT00603941|454698840|FG000|Overall Study|Adverse Event|1|||
126383696|NCT00603941|454698841|FG001|Overall Study|Adverse Event|0|||
126383697|NCT00603941|454698842|FG002|Overall Study|Adverse Event|1|||
126383698|NCT00603941|454698840|FG000|Overall Study|Physician Decision|0|||
126383699|NCT00603941|454698841|FG001|Overall Study|Physician Decision|1|||
126383700|NCT00603941|454698842|FG002|Overall Study|Physician Decision|0|||
126383701|NCT00603941|454698840|FG000|Overall Study|Withdrawal by Subject|0|||
126383702|NCT00603941|454698841|FG001|Overall Study|Withdrawal by Subject|2|||
126383703|NCT00603941|454698842|FG002|Overall Study|Withdrawal by Subject|0|||
126383704|NCT05069597|454698843|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
126383705|NCT05069597|454698844|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
126383706|NCT05507567|454698845|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
126383707|NCT05507567|454698846|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
126383708|NCT05507567|454698847|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
126383709|NCT05507567|454698845|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
126383710|NCT05507567|454698846|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
126383711|NCT05507567|454698847|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
126383712|NCT05507567|454698845|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
126383713|NCT05507567|454698846|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
126383714|NCT05507567|454698847|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
126383715|NCT05507567|454698845|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
126383716|NCT05507567|454698846|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
126468326|NCT00809354|455017576|FG009|Overall Study|Withdrawn due to pregnancy|0|||
126468327|NCT00809354|455017567|FG000|Overall Study|Randomized but not Treated|3|||
126468328|NCT00809354|455017568|FG001|Overall Study|Randomized but not Treated|1|||
126468329|NCT00809354|455017569|FG002|Overall Study|Randomized but not Treated|6|||
126468330|NCT00809354|455017570|FG003|Overall Study|Randomized but not Treated|0|||
126468331|NCT00809354|455017571|FG004|Overall Study|Randomized but not Treated|5|||
126468332|NCT00809354|455017572|FG005|Overall Study|Randomized but not Treated|0|||
126468333|NCT00809354|455017573|FG006|Overall Study|Randomized but not Treated|1|||
126383717|NCT05507567|454698847|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
126383718|NCT00375427|454698848|FG000|Overall Study|Adverse Event|21|||
126383719|NCT00375427|454698849|FG001|Overall Study|Adverse Event|27|||
126383720|NCT00375427|454698848|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126383721|NCT00375427|454698849|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126383722|NCT00375427|454698848|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126383723|NCT00375427|454698849|FG001|Overall Study|Abnormal laboratory value(s)|2|||
126383724|NCT00375427|454698848|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126383725|NCT00375427|454698849|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
126383726|NCT00375427|454698848|FG000|Overall Study|Patient no longer requires study drug|3|||
126383727|NCT00375427|454698849|FG001|Overall Study|Patient no longer requires study drug|7|||
126383728|NCT00375427|454698848|FG000|Overall Study|Protocol Violation|10|||
126383729|NCT00375427|454698849|FG001|Overall Study|Protocol Violation|8|||
126383730|NCT00375427|454698848|FG000|Overall Study|Withdrawal by Subject|9|||
126383731|NCT00375427|454698849|FG001|Overall Study|Withdrawal by Subject|13|||
126383732|NCT00375427|454698848|FG000|Overall Study|Lost to Follow-up|1|||
126383733|NCT00375427|454698849|FG001|Overall Study|Lost to Follow-up|1|||
126383734|NCT00375427|454698848|FG000|Overall Study|Administrative reasons|0|||
126383735|NCT00375427|454698849|FG001|Overall Study|Administrative reasons|1|||
126383736|NCT00375427|454698848|FG000|Overall Study|Death|11|||
126383737|NCT00375427|454698849|FG001|Overall Study|Death|10|||
126383738|NCT00606411|454698853|FG000|Overall Study|Adverse Event|1|||
126383739|NCT00606411|454698854|FG001|Overall Study|Adverse Event|2|||
126383740|NCT00606411|454698853|FG000|Overall Study|Lack of Adherence|1|||
126383741|NCT00606411|454698854|FG001|Overall Study|Lack of Adherence|1|||
126383742|NCT00606411|454698853|FG000|Overall Study|Lack of Efficacy|1|||
126383743|NCT00606411|454698854|FG001|Overall Study|Lack of Efficacy|1|||
126383744|NCT00606411|454698853|FG000|Overall Study|Withdrawal by Subject|2|||
126383745|NCT00606411|454698854|FG001|Overall Study|Withdrawal by Subject|0|||
126383746|NCT00606411|454698853|FG000|Overall Study|Lost to Follow-up|1|||
126383747|NCT00606411|454698854|FG001|Overall Study|Lost to Follow-up|2|||
126383748|NCT00606411|454698853|FG000|Overall Study|Move out of state|0|||
126383749|NCT00606411|454698854|FG001|Overall Study|Move out of state|1|||
126383750|NCT03726658|454698855|FG000|Overall Study|Lost to Follow-up|0|||
126383751|NCT03726658|454698856|FG001|Overall Study|Lost to Follow-up|0|||
126383752|NCT03726658|454698857|FG002|Overall Study|Lost to Follow-up|2|||
126383753|NCT03726658|454698858|FG003|Overall Study|Lost to Follow-up|0|||
126383754|NCT03726658|454698859|FG004|Overall Study|Lost to Follow-up|0|||
126383755|NCT03726658|454698860|FG005|Overall Study|Lost to Follow-up|1|||
126383756|NCT03726658|454698861|FG006|Overall Study|Lost to Follow-up|1|||
126383757|NCT03726658|454698855|FG000|Overall Study|Withdrawal by Subject|1|||
126383758|NCT03726658|454698856|FG001|Overall Study|Withdrawal by Subject|0|||
126383759|NCT03726658|454698857|FG002|Overall Study|Withdrawal by Subject|0|||
126383760|NCT03726658|454698858|FG003|Overall Study|Withdrawal by Subject|0|||
126383761|NCT03726658|454698859|FG004|Overall Study|Withdrawal by Subject|6|||
126383762|NCT03726658|454698860|FG005|Overall Study|Withdrawal by Subject|4|||
126383763|NCT03726658|454698861|FG006|Overall Study|Withdrawal by Subject|2|||
126717373|NCT02417233|455916202|FG001|Overall Study|Death|10|||
126717374|NCT02417233|455916203|FG002|Overall Study|Death|14|||
126717375|NCT02417233|455916201|FG000|Overall Study|Lost to Follow-up|27|||
126717376|NCT02417233|455916202|FG001|Overall Study|Lost to Follow-up|39|||
126717377|NCT02417233|455916203|FG002|Overall Study|Lost to Follow-up|34|||
126717378|NCT02417233|455916201|FG000|Overall Study|Protocol Violation|2|||
126717379|NCT02417233|455916202|FG001|Overall Study|Protocol Violation|0|||
126717380|NCT02417233|455916203|FG002|Overall Study|Protocol Violation|2|||
126717381|NCT02417233|455916201|FG000|Overall Study|Withdrawal by Subject|2|||
126717382|NCT02417233|455916202|FG001|Overall Study|Withdrawal by Subject|1|||
126717383|NCT02417233|455916203|FG002|Overall Study|Withdrawal by Subject|8|||
126771163|NCT03985293|456116288|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
126383764|NCT03726658|454698855|FG000|Overall Study|Pregnancy|0|||
126383765|NCT03726658|454698856|FG001|Overall Study|Pregnancy|0|||
126383766|NCT03726658|454698857|FG002|Overall Study|Pregnancy|0|||
126383767|NCT03726658|454698858|FG003|Overall Study|Pregnancy|0|||
126383768|NCT03726658|454698859|FG004|Overall Study|Pregnancy|0|||
126383769|NCT03726658|454698860|FG005|Overall Study|Pregnancy|0|||
126553364|NCT03257995|455320582|FG003|Overall Study|Adverse Event|0|||
126717384|NCT02417233|455916201|FG000|Overall Study|Relocation out of study area|1|||
126771164|NCT03985293|456116289|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
126383770|NCT03726658|454698861|FG006|Overall Study|Pregnancy|1|||
126383771|NCT03726658|454698855|FG000|Overall Study|Not Reported|0|||
126383772|NCT03726658|454698856|FG001|Overall Study|Not Reported|0|||
126383773|NCT03726658|454698857|FG002|Overall Study|Not Reported|0|||
126383774|NCT03726658|454698858|FG003|Overall Study|Not Reported|0|||
126771165|NCT03985293|456116290|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
126383775|NCT03726658|454698859|FG004|Overall Study|Not Reported|0|||
126383776|NCT03726658|454698860|FG005|Overall Study|Not Reported|0|||
126383777|NCT03726658|454698861|FG006|Overall Study|Not Reported|1|||
126383778|NCT00412958|454698862|FG000|Overall Study|Withdrawal by Subject|3|||
126383779|NCT00412958|454698863|FG001|Overall Study|Withdrawal by Subject|0|||
126383780|NCT00412958|454698864|FG002|Overall Study|Withdrawal by Subject|0|||
126383781|NCT00412958|454698865|FG003|Overall Study|Withdrawal by Subject|1|||
126383782|NCT00412958|454698862|FG000|Overall Study|Adverse Event|0|||
126383783|NCT00412958|454698863|FG001|Overall Study|Adverse Event|1|||
126383784|NCT00412958|454698864|FG002|Overall Study|Adverse Event|0|||
126383785|NCT00412958|454698865|FG003|Overall Study|Adverse Event|0|||
126383786|NCT00412958|454698862|FG000|Overall Study|Lost to Follow-up|0|||
126383787|NCT00412958|454698863|FG001|Overall Study|Lost to Follow-up|1|||
126383788|NCT00412958|454698864|FG002|Overall Study|Lost to Follow-up|0|||
126383789|NCT00412958|454698865|FG003|Overall Study|Lost to Follow-up|0|||
126383790|NCT00412958|454698862|FG000|Overall Study|Death|0|||
126383791|NCT00412958|454698863|FG001|Overall Study|Death|1|||
126383792|NCT00412958|454698864|FG002|Overall Study|Death|0|||
126383793|NCT00412958|454698865|FG003|Overall Study|Death|0|||
126383794|NCT00412958|454698862|FG000|Overall Study|Transport issue|0|||
126383795|NCT00412958|454698863|FG001|Overall Study|Transport issue|1|||
126383796|NCT00412958|454698864|FG002|Overall Study|Transport issue|0|||
126383797|NCT00412958|454698865|FG003|Overall Study|Transport issue|0|||
126383798|NCT01318135|454698866|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
126383799|NCT01318135|454698867|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383800|NCT01318135|454698868|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383801|NCT01318135|454698869|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383802|NCT01318135|454698870|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383803|NCT01318135|454698871|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383804|NCT01318135|454698872|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383805|NCT01318135|454698873|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126383806|NCT01318135|454698866|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
126383807|NCT01318135|454698867|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383808|NCT01318135|454698868|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383809|NCT01318135|454698869|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383810|NCT01318135|454698870|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383811|NCT01318135|454698871|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383812|NCT01318135|454698872|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383813|NCT01318135|454698873|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
126383814|NCT01318135|454698866|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
126383815|NCT01318135|454698867|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
126383816|NCT01318135|454698868|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
126383817|NCT01318135|454698869|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
126383818|NCT01318135|454698870|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
126383819|NCT01318135|454698871|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
126383820|NCT01318135|454698872|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
126383821|NCT01318135|454698873|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
126383822|NCT01318135|454698866|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
126383823|NCT01318135|454698867|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
126383824|NCT01318135|454698868|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
126383825|NCT01318135|454698869|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
126383826|NCT01318135|454698870|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
126383827|NCT01318135|454698871|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
126383828|NCT01318135|454698872|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
126383829|NCT01318135|454698873|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
126383830|NCT01318135|454698866|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126383831|NCT01318135|454698867|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126383832|NCT01318135|454698868|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126383833|NCT01318135|454698869|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126383834|NCT01318135|454698870|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126383835|NCT01318135|454698871|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126383836|NCT01318135|454698872|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126383837|NCT01318135|454698873|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126383838|NCT01318135|454698866|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
126383839|NCT01318135|454698867|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
126383840|NCT01318135|454698868|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
126383841|NCT01318135|454698869|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
126383842|NCT01318135|454698870|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
126383843|NCT01318135|454698871|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
126383844|NCT01318135|454698872|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
126383845|NCT01318135|454698873|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
126383846|NCT01318135|454698866|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383847|NCT01318135|454698867|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383848|NCT01318135|454698868|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383849|NCT01318135|454698869|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383850|NCT01318135|454698870|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383851|NCT01318135|454698871|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383852|NCT01318135|454698872|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
126383853|NCT01318135|454698873|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
126383854|NCT00090779|454698874|FG000|Step 1|Withdrawal by Subject|4|||
126383855|NCT00090779|454698875|FG001|Step 1|Withdrawal by Subject|2|||
126383856|NCT00090779|454698874|FG000|Step 1|Lost to Follow-up|3|||
126383857|NCT00090779|454698875|FG001|Step 1|Lost to Follow-up|2|||
126383858|NCT00090779|454698874|FG000|Step 1|Death|0|||
126383859|NCT00090779|454698875|FG001|Step 1|Death|2|||
126383860|NCT00090779|454698874|FG000|Step 1|Physician Decision|1|||
126383861|NCT00090779|454698875|FG001|Step 1|Physician Decision|0|||
126383862|NCT00090779|454698874|FG000|Step 1|Pregnancy|1|||
126383863|NCT00090779|454698875|FG001|Step 1|Pregnancy|0|||
126383864|NCT00090779|454698874|FG000|Step 1|Non-compliance to study requirements|0|||
126383865|NCT00090779|454698875|FG001|Step 1|Non-compliance to study requirements|1|||
126383866|NCT00090779|454698874|FG000|Step 1|Subject relocated|2|||
126383867|NCT00090779|454698875|FG001|Step 1|Subject relocated|8|||
126383868|NCT00090779|454698874|FG000|Step 2|Off study per study closure|6|||
126383869|NCT00090779|454698875|FG001|Step 2|Off study per study closure|16|||
126383870|NCT00090779|454698874|FG000|Step 2|Subject relocated|0|||
126383871|NCT00090779|454698875|FG001|Step 2|Subject relocated|1|||
126383872|NCT00090779|454698874|FG000|Step 2|Non-compliance to study requirements|0|||
126383873|NCT00090779|454698875|FG001|Step 2|Non-compliance to study requirements|1|||
126383874|NCT00090779|454698874|FG000|Step 3|Initiation of ART and off extended study|3|||
126383875|NCT00090779|454698875|FG001|Step 3|Initiation of ART and off extended study|2|||
126383876|NCT00090779|454698874|FG000|Step 3|Off extended study due to study closure|4|||
126383877|NCT00090779|454698875|FG001|Step 3|Off extended study due to study closure|3|||
126383878|NCT03012828|454698884|FG000|Overall Study|Lost to Follow-up|1|||
126383879|NCT03012828|454698885|FG001|Overall Study|Lost to Follow-up|0|||
126383880|NCT03012828|454698886|FG002|Overall Study|Lost to Follow-up|1|||
126383881|NCT03012828|454698887|FG003|Overall Study|Lost to Follow-up|0|||
126383882|NCT03012828|454698888|FG004|Overall Study|Lost to Follow-up|1|||
126383883|NCT03012828|454698889|FG005|Overall Study|Lost to Follow-up|0|||
126383884|NCT03012828|454698884|FG000|Overall Study|Withdrawal by Subject|0|||
126383885|NCT03012828|454698885|FG001|Overall Study|Withdrawal by Subject|0|||
126383886|NCT03012828|454698886|FG002|Overall Study|Withdrawal by Subject|1|||
126383887|NCT03012828|454698887|FG003|Overall Study|Withdrawal by Subject|0|||
126383888|NCT03012828|454698888|FG004|Overall Study|Withdrawal by Subject|0|||
126383889|NCT03012828|454698889|FG005|Overall Study|Withdrawal by Subject|1|||
126383890|NCT03012828|454698884|FG000|Overall Study|Non-compliance with protocol|0|||
126383891|NCT03012828|454698885|FG001|Overall Study|Non-compliance with protocol|0|||
126383892|NCT03012828|454698886|FG002|Overall Study|Non-compliance with protocol|0|||
126383893|NCT03012828|454698887|FG003|Overall Study|Non-compliance with protocol|0|||
126383894|NCT03012828|454698888|FG004|Overall Study|Non-compliance with protocol|1|||
126383895|NCT03012828|454698889|FG005|Overall Study|Non-compliance with protocol|0|||
126383896|NCT03012828|454698884|FG000|Overall Study|Delay to last visit would delay DBL|0|||
126383897|NCT03012828|454698885|FG001|Overall Study|Delay to last visit would delay DBL|0|||
126383898|NCT03012828|454698886|FG002|Overall Study|Delay to last visit would delay DBL|0|||
126383899|NCT03012828|454698887|FG003|Overall Study|Delay to last visit would delay DBL|0|||
126383900|NCT03012828|454698888|FG004|Overall Study|Delay to last visit would delay DBL|0|||
126383901|NCT03012828|454698889|FG005|Overall Study|Delay to last visit would delay DBL|1|||
126383902|NCT04396795|454698894|FG000|Month 1|Lost to Follow-up|2|||
126383903|NCT04396795|454698895|FG001|Month 1|Lost to Follow-up|3|||
126383904|NCT04396795|454698894|FG000|Month 3|Lost to Follow-up|1|||
126468334|NCT00809354|455017574|FG007|Overall Study|Randomized but not Treated|1|||
126468335|NCT00809354|455017575|FG008|Overall Study|Randomized but not Treated|2|||
126468336|NCT00809354|455017576|FG009|Overall Study|Randomized but not Treated|1|||
126468337|NCT00809354|455017567|FG000|Overall Study|Death|0|||
126383905|NCT04396795|454698895|FG001|Month 3|Lost to Follow-up|3|||
126383906|NCT04396795|454698894|FG000|Month 6|Lost to Follow-up|3|||
126383907|NCT04396795|454698895|FG001|Month 6|Lost to Follow-up|3|||
126383908|NCT03472495|454698899|FG000|Overall Study|Treatment no longer indicated|1|||
126383909|NCT03472495|454698900|FG001|Overall Study|Treatment no longer indicated|2|||
126383910|NCT03472495|454698899|FG000|Overall Study|Physician Decision|0|||
126383911|NCT03472495|454698900|FG001|Overall Study|Physician Decision|2|||
126383912|NCT01107392|454698901|FG000|Overall Study|Adverse Event|2|||
126468338|NCT00809354|455017568|FG001|Overall Study|Death|0|||
126468339|NCT00809354|455017569|FG002|Overall Study|Death|0|||
126468340|NCT00809354|455017570|FG003|Overall Study|Death|0|||
126383913|NCT01107392|454698902|FG001|Overall Study|Adverse Event|0|||
126383914|NCT01107392|454698901|FG000|Overall Study|Personal Reasons|2|||
126383915|NCT01107392|454698902|FG001|Overall Study|Personal Reasons|3|||
126468341|NCT00809354|455017571|FG004|Overall Study|Death|0|||
126468342|NCT00809354|455017572|FG005|Overall Study|Death|0|||
126383916|NCT01107392|454698901|FG000|Overall Study|Administrative decision|1|||
126383917|NCT01107392|454698902|FG001|Overall Study|Administrative decision|0|||
126383918|NCT02998671|454698906|FG000|Period 1|Study Terminated By Sponsor|2|||
126383919|NCT02998671|454698907|FG001|Period 1|Study Terminated By Sponsor|1|||
126383920|NCT02998671|454698908|FG002|Period 1|Study Terminated By Sponsor|0|||
126383921|NCT02998671|454698909|FG003|Period 1|Study Terminated By Sponsor|0|||
126383922|NCT02998671|454698910|FG004|Period 1|Study Terminated By Sponsor|1|||
126383923|NCT02998671|454698906|FG000|Period 1|Withdrawal by Subject|1|||
126383924|NCT02998671|454698907|FG001|Period 1|Withdrawal by Subject|2|||
126383925|NCT02998671|454698908|FG002|Period 1|Withdrawal by Subject|0|||
126383926|NCT02998671|454698909|FG003|Period 1|Withdrawal by Subject|0|||
126383927|NCT02998671|454698910|FG004|Period 1|Withdrawal by Subject|2|||
126468343|NCT00809354|455017573|FG006|Overall Study|Death|0|||
126717385|NCT02417233|455916202|FG001|Overall Study|Relocation out of study area|0|||
126717386|NCT02417233|455916203|FG002|Overall Study|Relocation out of study area|1|||
126717387|NCT02417233|455916201|FG000|Overall Study|Mentally unstable|0|||
126383928|NCT02998671|454698906|FG000|Period 1|Pregnancy|1|||
126383929|NCT02998671|454698907|FG001|Period 1|Pregnancy|0|||
126383930|NCT02998671|454698908|FG002|Period 1|Pregnancy|0|||
126383931|NCT02998671|454698909|FG003|Period 1|Pregnancy|0|||
126383932|NCT02998671|454698910|FG004|Period 1|Pregnancy|0|||
126383933|NCT02998671|454698906|FG000|Period 1|Adverse Event|0|||
126383934|NCT02998671|454698907|FG001|Period 1|Adverse Event|0|||
126383935|NCT02998671|454698908|FG002|Period 1|Adverse Event|0|||
126383936|NCT02998671|454698909|FG003|Period 1|Adverse Event|0|||
126383937|NCT02998671|454698910|FG004|Period 1|Adverse Event|1|||
126383938|NCT02998671|454698906|FG000|Period 2|Adverse Event|0|||
126383939|NCT02998671|454698907|FG001|Period 2|Adverse Event|1|||
126383940|NCT02998671|454698908|FG002|Period 2|Adverse Event|0|||
126383941|NCT02998671|454698909|FG003|Period 2|Adverse Event|0|||
126383942|NCT02998671|454698910|FG004|Period 2|Adverse Event|0|||
126383943|NCT02998671|454698906|FG000|Period 2|Study Terminated By Sponsor|3|||
126383944|NCT02998671|454698907|FG001|Period 2|Study Terminated By Sponsor|5|||
126383945|NCT02998671|454698908|FG002|Period 2|Study Terminated By Sponsor|1|||
126383946|NCT02998671|454698909|FG003|Period 2|Study Terminated By Sponsor|3|||
126383947|NCT02998671|454698910|FG004|Period 2|Study Terminated By Sponsor|0|||
126383948|NCT02998671|454698906|FG000|Period 2|Withdrawal by Subject|0|||
126383949|NCT02998671|454698907|FG001|Period 2|Withdrawal by Subject|1|||
126383950|NCT02998671|454698908|FG002|Period 2|Withdrawal by Subject|0|||
126383951|NCT02998671|454698909|FG003|Period 2|Withdrawal by Subject|0|||
126383952|NCT02998671|454698910|FG004|Period 2|Withdrawal by Subject|0|||
126383953|NCT02998671|454698906|FG000|Period 2|Lost to Follow-up|0|||
126383954|NCT02998671|454698907|FG001|Period 2|Lost to Follow-up|0|||
126383955|NCT02998671|454698908|FG002|Period 2|Lost to Follow-up|0|||
126383956|NCT02998671|454698909|FG003|Period 2|Lost to Follow-up|1|||
126383957|NCT02998671|454698910|FG004|Period 2|Lost to Follow-up|0|||
126383958|NCT02038946|454698912|FG000|Overall Study|Death|5|||
126383959|NCT02038946|454698912|FG000|Overall Study|Withdrawal by Subject|3|||
126383960|NCT02038946|454698912|FG000|Overall Study|Lost to Follow-up|2|||
126383961|NCT02038946|454698912|FG000|Overall Study|Other reasons|2|||
126383962|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
126383963|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
126383964|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
126383965|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
126383966|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
126383967|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
126383968|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
126383969|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
126383970|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
126383971|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
126383972|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
126383973|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
126383974|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
126383975|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
126383976|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
126383977|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
126383978|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
126383979|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
126383980|NCT03162796|454698914|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
126383981|NCT03162796|454698915|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
126383982|NCT03162796|454698916|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
126383983|NCT03162796|454698914|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
126383984|NCT03162796|454698915|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
126383985|NCT03162796|454698916|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
126383986|NCT03162796|454698914|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
126383987|NCT03162796|454698915|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
126383988|NCT03162796|454698916|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
126383989|NCT03162796|454698914|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
126383990|NCT03162796|454698915|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
126383991|NCT03162796|454698916|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
126383992|NCT03162796|454698914|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
126383993|NCT03162796|454698915|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
126383994|NCT03162796|454698916|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
126383995|NCT02623205|454698917|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
126383996|NCT02623205|454698918|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
126383997|NCT02473471|454698919|FG000|Overall Study|poor oral hygiene|2|||
126383998|NCT02473471|454698919|FG000|Overall Study|Lost to Follow-up|1|||
126383999|NCT02342288|454698922|FG000|Overall Study|no protocol anesthesiologist available|3|||
126384000|NCT02342288|454698923|FG001|Overall Study|no protocol anesthesiologist available|2|||
126384001|NCT02342288|454698922|FG000|Overall Study|anesthesia leak in system|1|||
126384002|NCT02342288|454698923|FG001|Overall Study|anesthesia leak in system|0|||
126384003|NCT02342288|454698922|FG000|Overall Study|Withdrawal by Subject|1|||
126384004|NCT02342288|454698923|FG001|Overall Study|Withdrawal by Subject|0|||
126384005|NCT02342288|454698922|FG000|Overall Study|coordinator contaminated with blood|0|||
126384006|NCT02342288|454698923|FG001|Overall Study|coordinator contaminated with blood|1|||
126384007|NCT02342288|454698922|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
126384008|NCT02342288|454698923|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
126384009|NCT02342288|454698922|FG000|Overall Study|coordinator not available|0|||
126384010|NCT02342288|454698923|FG001|Overall Study|coordinator not available|2|||
126384011|NCT03082677|454698924|FG000|Overall Study|Not Treated|2|||
126384012|NCT01916824|454698929|FG000|Overall Study|Lost to Follow-up|3|||
126384013|NCT01916824|454698930|FG001|Overall Study|Lost to Follow-up|6|||
126384014|NCT01916824|454698929|FG000|Overall Study|Physician Decision|2|||
126384015|NCT01916824|454698930|FG001|Overall Study|Physician Decision|0|||
126384016|NCT01916824|454698929|FG000|Overall Study|Withdrawal by Subject|2|||
126384017|NCT01916824|454698930|FG001|Overall Study|Withdrawal by Subject|3|||
126384018|NCT02455336|454698936|FG000|Overall Study|Withdrawal by Subject|0|||
126384019|NCT02455336|454698937|FG001|Overall Study|Withdrawal by Subject|2|||
126384020|NCT02455336|454698936|FG000|Overall Study|Adverse Event|3|||
126384021|NCT02455336|454698937|FG001|Overall Study|Adverse Event|0|||
126384022|NCT02455336|454698936|FG000|Overall Study|Non-responder to treatment|2|||
126384023|NCT02455336|454698937|FG001|Overall Study|Non-responder to treatment|0|||
126384024|NCT02467192|454698938|FG000|Overall Study|Death|1|||
126384025|NCT02467192|454698938|FG000|Overall Study|revealed to have pneumonia before|2|||
126384026|NCT02195700|454698947|FG000|Overall Study|Protocol Violation|0|||
126384027|NCT02195700|454698948|FG001|Overall Study|Protocol Violation|2|||
126384028|NCT02195700|454698947|FG000|Overall Study|Noncompliance|1|||
126384029|NCT02195700|454698948|FG001|Overall Study|Noncompliance|0|||
126384030|NCT02195700|454698947|FG000|Overall Study|Adverse Event|1|||
126384031|NCT02195700|454698948|FG001|Overall Study|Adverse Event|2|||
126384032|NCT02195700|454698947|FG000|Overall Study|Withdrawal by Subject|3|||
126384033|NCT02195700|454698948|FG001|Overall Study|Withdrawal by Subject|2|||
126384034|NCT02195700|454698947|FG000|Overall Study|Lost to Follow-up|1|||
126384035|NCT02195700|454698948|FG001|Overall Study|Lost to Follow-up|1|||
126384036|NCT03110029|454698949|FG000|Overall Study|Withdrawal by Subject|1|||
126384037|NCT03110029|454698950|FG001|Overall Study|Withdrawal by Subject|1|||
126384038|NCT02524145|454698952|FG000|Overall Study|Withdrawal by Subject|2|||
126384039|NCT02524145|454698953|FG001|Overall Study|Withdrawal by Subject|2|||
126384040|NCT02524145|454698954|FG002|Overall Study|Withdrawal by Subject|3|||
126384041|NCT03107052|454700546|FG000|Overall Study|Adverse Event|6|||
126384042|NCT03107052|454700547|FG001|Overall Study|Adverse Event|1|||
126384043|NCT03107052|454700548|FG002|Overall Study|Adverse Event|2|||
126384044|NCT03107052|454700546|FG000|Overall Study|Withdrawal by Subject|9|||
126384045|NCT03107052|454700547|FG001|Overall Study|Withdrawal by Subject|5|||
126384046|NCT03107052|454700548|FG002|Overall Study|Withdrawal by Subject|8|||
126384047|NCT03107052|454700546|FG000|Overall Study|Protocol Violation|6|||
126384048|NCT03107052|454700547|FG001|Overall Study|Protocol Violation|0|||
126384049|NCT03107052|454700548|FG002|Overall Study|Protocol Violation|3|||
126384050|NCT03107052|454700546|FG000|Overall Study|Lost to Follow-up|4|||
126384051|NCT03107052|454700547|FG001|Overall Study|Lost to Follow-up|0|||
126384052|NCT03107052|454700548|FG002|Overall Study|Lost to Follow-up|1|||
126384053|NCT03107052|454700546|FG000|Overall Study|Lack of Efficacy|23|||
126384054|NCT03107052|454700547|FG001|Overall Study|Lack of Efficacy|7|||
126384055|NCT03107052|454700548|FG002|Overall Study|Lack of Efficacy|4|||
126384056|NCT03107052|454700546|FG000|Overall Study|Other than specified|4|||
126384057|NCT03107052|454700547|FG001|Overall Study|Other than specified|2|||
126384058|NCT03107052|454700548|FG002|Overall Study|Other than specified|0|||
126384059|NCT03107052|454700546|FG000|Overall Study|Study terminated due to futility|67|||
126384060|NCT03107052|454700547|FG001|Overall Study|Study terminated due to futility|31|||
126384061|NCT03107052|454700548|FG002|Overall Study|Study terminated due to futility|23|||
126384062|NCT02263326|454700549|FG000|Overall Study|Lost to Follow-up|1|||
126384063|NCT02263326|454700550|FG001|Overall Study|Lost to Follow-up|1|||
126384064|NCT02397915|454700551|FG000|Period 1|Protocol Violation|0|||
126384065|NCT02397915|454700552|FG001|Period 1|Protocol Violation|1|||
126384066|NCT02397915|454700553|FG002|Period 1|Protocol Violation|0|||
126384067|NCT02397915|454700554|FG003|Period 1|Protocol Violation|0|||
126384068|NCT02397915|454700551|FG000|Period 1|Physician Decision|1|||
126384069|NCT02397915|454700552|FG001|Period 1|Physician Decision|0|||
126384070|NCT02397915|454700553|FG002|Period 1|Physician Decision|0|||
126384071|NCT02397915|454700554|FG003|Period 1|Physician Decision|0|||
126384072|NCT00933608|454700555|FG000|Overall Study|Adverse Event|4|||
126384073|NCT00933608|454700556|FG001|Overall Study|Adverse Event|2|||
126384074|NCT00933608|454700555|FG000|Overall Study|Physician Decision|1|||
126384075|NCT00933608|454700556|FG001|Overall Study|Physician Decision|0|||
126384076|NCT00391053|454700559|FG000|Overall Study|Serious Adverse Events|1|||
126384077|NCT00391053|454700560|FG001|Overall Study|Serious Adverse Events|0|||
126384078|NCT00391053|454700561|FG002|Overall Study|Serious Adverse Events|1|||
126384079|NCT00391053|454700562|FG003|Overall Study|Serious Adverse Events|4|||
126384080|NCT00391053|454700559|FG000|Overall Study|Protocol Violation|2|||
126384081|NCT00391053|454700560|FG001|Overall Study|Protocol Violation|0|||
126384082|NCT00391053|454700561|FG002|Overall Study|Protocol Violation|0|||
126384083|NCT00391053|454700562|FG003|Overall Study|Protocol Violation|0|||
126384084|NCT00391053|454700559|FG000|Overall Study|Lost to Follow-up|1|||
126384085|NCT00391053|454700560|FG001|Overall Study|Lost to Follow-up|0|||
126384086|NCT00391053|454700561|FG002|Overall Study|Lost to Follow-up|0|||
126384087|NCT00391053|454700562|FG003|Overall Study|Lost to Follow-up|5|||
126384088|NCT00391053|454700559|FG000|Overall Study|Withdrawal by Subject|5|||
126384089|NCT00391053|454700560|FG001|Overall Study|Withdrawal by Subject|1|||
126384090|NCT00391053|454700561|FG002|Overall Study|Withdrawal by Subject|1|||
126384091|NCT00391053|454700562|FG003|Overall Study|Withdrawal by Subject|1|||
126384092|NCT04908384|454700563|FG000|Overall Study|Lost to Follow-up|4|||
126384093|NCT04908384|454700564|FG001|Overall Study|Lost to Follow-up|4|||
126384094|NCT04908384|454700565|FG002|Overall Study|Lost to Follow-up|0|||
126384095|NCT04908384|454700566|FG003|Overall Study|Lost to Follow-up|0|||
126384096|NCT05002985|454700567|FG000|Overall Study|Withdrawal by Subject|1|||
126384097|NCT01642901|454700571|FG000|12-month Follow-up|Withdrawal by Subject|1|||
126384098|NCT01642901|454700572|FG001|12-month Follow-up|Withdrawal by Subject|0|||
126384099|NCT02943070|454700574|FG000|Overall Study|Physician Decision|1|||
126384100|NCT02943070|454700574|FG000|Overall Study|Adverse Event|2|||
126384101|NCT02943070|454700574|FG000|Overall Study|Death|2|||
126384102|NCT02943070|454700574|FG000|Overall Study|Withdrawal by Subject|3|||
126384103|NCT02943070|454700574|FG000|Overall Study|Lost to Follow-up|4|||
126384104|NCT02943070|454700574|FG000|Overall Study|Retreatment or TURP|13|||
126384105|NCT02943070|454700574|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
126384106|NCT04123093|454700579|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
126384107|NCT04123093|454700580|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
126384108|NCT04123093|454700579|FG000|Phase 2|Physician Decision|0|||
126384109|NCT04123093|454700580|FG001|Phase 2|Physician Decision|1|||
126384110|NCT04123093|454700579|FG000|Phase 2|Withdrawal by Subject|0|||
126384111|NCT04123093|454700580|FG001|Phase 2|Withdrawal by Subject|1|||
126384112|NCT04556591|454700581|FG000|Overall Study|Lost to Follow-up|1|||
126384113|NCT04556591|454700582|FG001|Overall Study|Lost to Follow-up|0|||
126384114|NCT04556591|454700581|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
126384115|NCT04556591|454700582|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
126384116|NCT04551963|454700583|FG000|Overall Study|Physician Decision|1|||
126384117|NCT04551963|454700584|FG001|Overall Study|Physician Decision|1|||
126384118|NCT04551963|454700583|FG000|Overall Study|Death|1|||
126384119|NCT04551963|454700584|FG001|Overall Study|Death|0|||
126384120|NCT03379259|454700585|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
126384121|NCT03379259|454700586|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
126384122|NCT03379259|454700587|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
126384123|NCT03379259|454700588|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
126384124|NCT03379259|454700589|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
126384125|NCT03379259|454700590|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
126384126|NCT03379259|454700585|FG000|Overall Study|Death|0|||
126771166|NCT03985293|456116291|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
126384127|NCT03379259|454700586|FG001|Overall Study|Death|1|||
126384128|NCT03379259|454700587|FG002|Overall Study|Death|2|||
126384129|NCT03379259|454700588|FG003|Overall Study|Death|1|||
126384130|NCT03379259|454700589|FG004|Overall Study|Death|4|||
126384131|NCT03379259|454700590|FG005|Overall Study|Death|2|||
126771167|NCT03985293|456116292|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
126384132|NCT03379259|454700585|FG000|Overall Study|Withdrawal by Subject|0|||
126384133|NCT03379259|454700586|FG001|Overall Study|Withdrawal by Subject|0|||
126384134|NCT03379259|454700587|FG002|Overall Study|Withdrawal by Subject|1|||
126384135|NCT03379259|454700588|FG003|Overall Study|Withdrawal by Subject|0|||
126468344|NCT00809354|455017574|FG007|Overall Study|Death|1|||
126384136|NCT03379259|454700589|FG004|Overall Study|Withdrawal by Subject|2|||
126384137|NCT03379259|454700590|FG005|Overall Study|Withdrawal by Subject|0|||
126384138|NCT03379259|454700585|FG000|Overall Study|Study terminated by sponsor|0|||
126384139|NCT03379259|454700586|FG001|Overall Study|Study terminated by sponsor|0|||
126384140|NCT03379259|454700587|FG002|Overall Study|Study terminated by sponsor|0|||
126384141|NCT03379259|454700588|FG003|Overall Study|Study terminated by sponsor|1|||
126384142|NCT03379259|454700589|FG004|Overall Study|Study terminated by sponsor|1|||
126384143|NCT03379259|454700590|FG005|Overall Study|Study terminated by sponsor|4|||
126384144|NCT03379259|454700585|FG000|Overall Study|Disease progression|0|||
126384145|NCT03379259|454700586|FG001|Overall Study|Disease progression|0|||
126384146|NCT03379259|454700587|FG002|Overall Study|Disease progression|0|||
126384147|NCT03379259|454700588|FG003|Overall Study|Disease progression|1|||
126384148|NCT03379259|454700589|FG004|Overall Study|Disease progression|0|||
126384149|NCT03379259|454700590|FG005|Overall Study|Disease progression|1|||
126384150|NCT03379259|454700585|FG000|Overall Study|Lost to Follow-up|0|||
126384151|NCT03379259|454700586|FG001|Overall Study|Lost to Follow-up|0|||
126384152|NCT03379259|454700587|FG002|Overall Study|Lost to Follow-up|0|||
126384153|NCT03379259|454700588|FG003|Overall Study|Lost to Follow-up|0|||
126384154|NCT03379259|454700589|FG004|Overall Study|Lost to Follow-up|1|||
126384155|NCT03379259|454700590|FG005|Overall Study|Lost to Follow-up|0|||
126384156|NCT03379259|454700585|FG000|Overall Study|Deteriorating condition|0|||
126384157|NCT03379259|454700586|FG001|Overall Study|Deteriorating condition|0|||
126384158|NCT03379259|454700587|FG002|Overall Study|Deteriorating condition|0|||
126384159|NCT03379259|454700588|FG003|Overall Study|Deteriorating condition|0|||
126384160|NCT03379259|454700589|FG004|Overall Study|Deteriorating condition|1|||
126384161|NCT03379259|454700590|FG005|Overall Study|Deteriorating condition|0|||
126384162|NCT00700622|454700592|FG000|Overall Study|Adverse Event|4|||
126384163|NCT00700622|454700593|FG001|Overall Study|Adverse Event|0|||
126384164|NCT00700622|454700592|FG000|Overall Study|Lost to Follow-up|0|||
126384165|NCT00700622|454700593|FG001|Overall Study|Lost to Follow-up|1|||
126384166|NCT00700622|454700592|FG000|Overall Study|Physician Decision|2|||
126384167|NCT00700622|454700593|FG001|Overall Study|Physician Decision|1|||
126384168|NCT00700622|454700592|FG000|Overall Study|Protocol Violation|0|||
126384169|NCT00700622|454700593|FG001|Overall Study|Protocol Violation|1|||
126384170|NCT00700622|454700592|FG000|Overall Study|Withdrawal by Subject|4|||
126384171|NCT00700622|454700593|FG001|Overall Study|Withdrawal by Subject|1|||
126384172|NCT00700622|454700592|FG000|Overall Study|Other|3|||
126384173|NCT00700622|454700593|FG001|Overall Study|Other|1|||
126384174|NCT02526212|454700597|FG000|Overall Study|Incarceration|1|||
126384175|NCT02526212|454700598|FG001|Overall Study|Incarceration|0|||
126384176|NCT02526212|454700597|FG000|Overall Study|Lost to Follow-up|1|||
126384177|NCT02526212|454700598|FG001|Overall Study|Lost to Follow-up|0|||
126384178|NCT02526212|454700597|FG000|Overall Study|Death|0|||
126384179|NCT02526212|454700598|FG001|Overall Study|Death|1|||
126384180|NCT01390298|454700599|FG000|Overall Study|Death|1|||
126384181|NCT01390298|454700599|FG000|Overall Study|long term ICU admission|1|||
126384182|NCT01390298|454700599|FG000|Overall Study|Withdrawal by Subject|14|||
126384183|NCT01390298|454700599|FG000|Overall Study|Lost to Follow-up|7|||
126384184|NCT01390298|454700599|FG000|Overall Study|Surgery cancelled|1|||
126384185|NCT00040742|454700606|FG000|Overall Study|Death|0|||
126384186|NCT00040742|454700607|FG001|Overall Study|Death|0|||
126384187|NCT00040742|454700608|FG002|Overall Study|Death|1|||
126384188|NCT00040742|454700609|FG003|Overall Study|Death|0|||
126384189|NCT00040742|454700606|FG000|Overall Study|Adverse Event|15|||
126384190|NCT00040742|454700607|FG001|Overall Study|Adverse Event|16|||
126384191|NCT00040742|454700608|FG002|Overall Study|Adverse Event|21|||
126468345|NCT00809354|455017575|FG008|Overall Study|Death|0|||
126468346|NCT00809354|455017576|FG009|Overall Study|Death|0|||
126468347|NCT00267189|455017577|FG000|Overall Study|Patient withdrew consent|1|||
126771168|NCT03985293|456116287|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
126771169|NCT03985293|456116288|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
126771170|NCT03985293|456116289|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
126771171|NCT03985293|456116290|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
126771172|NCT03985293|456116291|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
126384192|NCT00040742|454700609|FG003|Overall Study|Adverse Event|9|||
126384193|NCT00040742|454700606|FG000|Overall Study|Withdrawal by Subject|7|||
126384194|NCT00040742|454700607|FG001|Overall Study|Withdrawal by Subject|15|||
126384195|NCT00040742|454700608|FG002|Overall Study|Withdrawal by Subject|10|||
126384196|NCT00040742|454700609|FG003|Overall Study|Withdrawal by Subject|13|||
126384197|NCT00040742|454700606|FG000|Overall Study|Chemotoxicity|4|||
126384198|NCT00040742|454700607|FG001|Overall Study|Chemotoxicity|3|||
126384199|NCT00040742|454700608|FG002|Overall Study|Chemotoxicity|5|||
126384200|NCT00040742|454700609|FG003|Overall Study|Chemotoxicity|2|||
126384201|NCT00040742|454700606|FG000|Overall Study|Incomplete Forms|6|||
126384202|NCT00040742|454700607|FG001|Overall Study|Incomplete Forms|10|||
126384203|NCT00040742|454700608|FG002|Overall Study|Incomplete Forms|4|||
126384204|NCT00040742|454700609|FG003|Overall Study|Incomplete Forms|5|||
126384205|NCT00040742|454700606|FG000|Overall Study|Other medical|7|||
126384206|NCT00040742|454700607|FG001|Overall Study|Other medical|5|||
126468348|NCT00267189|455017578|FG001|Overall Study|Patient withdrew consent|1|||
126468349|NCT00267189|455017577|FG000|Overall Study|Death|1|||
126468350|NCT00267189|455017578|FG001|Overall Study|Death|0|||
126468351|NCT00267189|455017577|FG000|Overall Study|Missing|3|||
126468352|NCT00267189|455017578|FG001|Overall Study|Missing|0|||
126468353|NCT00100178|455017579|FG000|Overall Study|Lost to Follow-up|0|||
126468354|NCT00100178|455017580|FG001|Overall Study|Lost to Follow-up|6|||
126468355|NCT00100178|455017581|FG002|Overall Study|Lost to Follow-up|5|||
126468356|NCT00100178|455017579|FG000|Overall Study|Adverse Event|2|||
126468357|NCT00100178|455017580|FG001|Overall Study|Adverse Event|2|||
126468358|NCT00100178|455017581|FG002|Overall Study|Adverse Event|1|||
126468359|NCT00100178|455017579|FG000|Overall Study|Withdrawal by Subject|1|||
126468360|NCT00100178|455017580|FG001|Overall Study|Withdrawal by Subject|1|||
126468361|NCT00100178|455017581|FG002|Overall Study|Withdrawal by Subject|1|||
126468362|NCT00100178|455017579|FG000|Overall Study|Physician Decision|6|||
126468363|NCT00100178|455017580|FG001|Overall Study|Physician Decision|1|||
126468364|NCT00100178|455017581|FG002|Overall Study|Physician Decision|3|||
126468365|NCT03257371|455017582|FG000|Overall Study|Lost to Follow-up|1|||
126468366|NCT02477839|455017585|FG000|Overall Study|Adverse Event|0|||
126468367|NCT02477839|455017586|FG001|Overall Study|Adverse Event|1|||
126468368|NCT02477839|455017585|FG000|Overall Study|Protocol Violation|0|||
126468369|NCT02477839|455017586|FG001|Overall Study|Protocol Violation|2|||
126468370|NCT02477839|455017585|FG000|Overall Study|Withdrawal by Subject|3|||
126468371|NCT02477839|455017586|FG001|Overall Study|Withdrawal by Subject|3|||
126468372|NCT02477839|455017585|FG000|Overall Study|Participant had PGS during V6|0|||
126468373|NCT02477839|455017586|FG001|Overall Study|Participant had PGS during V6|1|||
126468374|NCT02477839|455017585|FG000|Overall Study|Parents decided to stop medication|0|||
126468375|NCT02477839|455017586|FG001|Overall Study|Parents decided to stop medication|1|||
126468376|NCT02477839|455017585|FG000|Overall Study|Lack of tolerability|0|||
126384207|NCT00040742|454700608|FG002|Overall Study|Other medical|5|||
126384208|NCT00040742|454700609|FG003|Overall Study|Other medical|5|||
126384209|NCT03520920|454700612|FG000|Overall Study|Death|13|||
126384210|NCT03520920|454700613|FG001|Overall Study|Death|1|||
126384211|NCT03520920|454700614|FG002|Overall Study|Death|0|||
126384212|NCT03520920|454700612|FG000|Overall Study|Withdrawal by Subject|2|||
126384213|NCT03520920|454700613|FG001|Overall Study|Withdrawal by Subject|1|||
126384214|NCT03520920|454700614|FG002|Overall Study|Withdrawal by Subject|0|||
126384215|NCT03520920|454700612|FG000|Overall Study|Study Terminated by the Sponsor|5|||
126384216|NCT03520920|454700613|FG001|Overall Study|Study Terminated by the Sponsor|14|||
126384217|NCT03520920|454700614|FG002|Overall Study|Study Terminated by the Sponsor|5|||
126384218|NCT00405392|454700615|FG000|Overall Study|Adverse Event|15|||
126384219|NCT00405392|454700616|FG001|Overall Study|Adverse Event|14|||
126384220|NCT00405392|454700615|FG000|Overall Study|Did not meet Eligibility criteria|7|||
126384221|NCT00405392|454700616|FG001|Overall Study|Did not meet Eligibility criteria|2|||
126384222|NCT00405392|454700615|FG000|Overall Study|Withdrawal by Subject|4|||
126384223|NCT00405392|454700616|FG001|Overall Study|Withdrawal by Subject|3|||
126384224|NCT00405392|454700615|FG000|Overall Study|Lost to Follow-up|1|||
126384225|NCT00405392|454700616|FG001|Overall Study|Lost to Follow-up|2|||
126384226|NCT00405392|454700615|FG000|Overall Study|Data missing|2|||
126384227|NCT00405392|454700616|FG001|Overall Study|Data missing|0|||
126771173|NCT03985293|456116292|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
126771174|NCT03985293|456116287|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
126771175|NCT03985293|456116288|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
126771176|NCT03985293|456116289|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
126771177|NCT03985293|456116290|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
126771178|NCT03985293|456116291|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
126771179|NCT03985293|456116292|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
126384228|NCT00405392|454700615|FG000|Overall Study|Non-compliance|0|||
126384229|NCT00405392|454700616|FG001|Overall Study|Non-compliance|1|||
126384230|NCT00405392|454700615|FG000|Overall Study|Other|1|||
126384231|NCT00405392|454700616|FG001|Overall Study|Other|5|||
126384232|NCT01703091|454700627|FG000|Overall Study|Adverse Event|5|||
126384233|NCT01703091|454700628|FG001|Overall Study|Adverse Event|3|||
126384234|NCT01703091|454700627|FG000|Overall Study|Physician Decision|2|||
126384235|NCT01703091|454700628|FG001|Overall Study|Physician Decision|1|||
126384236|NCT01703091|454700627|FG000|Overall Study|Withdrawal by Subject|1|||
126384237|NCT01703091|454700628|FG001|Overall Study|Withdrawal by Subject|0|||
126468377|NCT02477839|455017586|FG001|Overall Study|Lack of tolerability|1|||
126384238|NCT01703091|454700627|FG000|Overall Study|Sponsor Decision|1|||
126384239|NCT01703091|454700628|FG001|Overall Study|Sponsor Decision|0|||
126384240|NCT02550288|454700632|FG000|Overall Study|Adverse Event|0|||
126384241|NCT02550288|454700633|FG001|Overall Study|Adverse Event|1|||
126384242|NCT02550288|454700634|FG002|Overall Study|Adverse Event|0|||
126468378|NCT02477839|455017585|FG000|Overall Study|Exclusion criterion|0|||
126468379|NCT02477839|455017586|FG001|Overall Study|Exclusion criterion|1|||
126771180|NCT03985293|456116287|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
126771181|NCT03985293|456116288|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
126384243|NCT02550288|454700635|FG003|Overall Study|Adverse Event|0|||
126384244|NCT02550288|454700636|FG004|Overall Study|Adverse Event|0|||
126468380|NCT01439568|455017593|FG000|Overall Study|Lost to Follow-up|1|||
126384245|NCT02550288|454700632|FG000|Overall Study|Physician Decision|0|||
126384246|NCT02550288|454700633|FG001|Overall Study|Physician Decision|0|||
126384247|NCT02550288|454700634|FG002|Overall Study|Physician Decision|0|||
126384248|NCT02550288|454700635|FG003|Overall Study|Physician Decision|1|||
126384249|NCT02550288|454700636|FG004|Overall Study|Physician Decision|0|||
126384250|NCT02550288|454700632|FG000|Overall Study|Protocol Violation|2|||
126384251|NCT02550288|454700633|FG001|Overall Study|Protocol Violation|2|||
126384252|NCT02550288|454700634|FG002|Overall Study|Protocol Violation|1|||
126384253|NCT02550288|454700635|FG003|Overall Study|Protocol Violation|0|||
126384254|NCT02550288|454700636|FG004|Overall Study|Protocol Violation|3|||
126384255|NCT02550288|454700632|FG000|Overall Study|Participant moved|0|||
126384256|NCT02550288|454700633|FG001|Overall Study|Participant moved|0|||
126384257|NCT02550288|454700634|FG002|Overall Study|Participant moved|0|||
126384258|NCT02550288|454700635|FG003|Overall Study|Participant moved|1|||
126384259|NCT02550288|454700636|FG004|Overall Study|Participant moved|0|||
126384260|NCT02550288|454700632|FG000|Overall Study|Withdrawal by Subject|0|||
126384261|NCT02550288|454700633|FG001|Overall Study|Withdrawal by Subject|0|||
126384262|NCT02550288|454700634|FG002|Overall Study|Withdrawal by Subject|0|||
126384263|NCT02550288|454700635|FG003|Overall Study|Withdrawal by Subject|1|||
126384264|NCT02550288|454700636|FG004|Overall Study|Withdrawal by Subject|0|||
126384265|NCT02819297|454700637|FG000|Overall Study|Withdrawal by Subject|25|||
126384266|NCT02819297|454700638|FG001|Overall Study|Withdrawal by Subject|13|||
126384267|NCT02819297|454700637|FG000|Overall Study|Lost to Follow-up|12|||
126384268|NCT02819297|454700638|FG001|Overall Study|Lost to Follow-up|14|||
126384269|NCT02819297|454700637|FG000|Overall Study|Adverse Event|12|||
126384270|NCT02819297|454700638|FG001|Overall Study|Adverse Event|10|||
126384271|NCT02819297|454700637|FG000|Overall Study|Physician Decision|5|||
126384272|NCT02819297|454700638|FG001|Overall Study|Physician Decision|5|||
126384273|NCT02819297|454700637|FG000|Overall Study|Lack of Efficacy|5|||
126384274|NCT02819297|454700638|FG001|Overall Study|Lack of Efficacy|8|||
126384275|NCT02819297|454700637|FG000|Overall Study|Protocol Violation|1|||
126384276|NCT02819297|454700638|FG001|Overall Study|Protocol Violation|2|||
126384277|NCT01071252|454700640|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
126384278|NCT01071252|454700641|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
126384279|NCT01071252|454700642|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
126384280|NCT01071252|454700643|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
126384281|NCT01071252|454700644|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
126384282|NCT01071252|454700640|FG000|Overall Study|Withdrawal by Subject|8|||
126384283|NCT01071252|454700641|FG001|Overall Study|Withdrawal by Subject|2|||
126384284|NCT01071252|454700642|FG002|Overall Study|Withdrawal by Subject|1|||
126384285|NCT01071252|454700643|FG003|Overall Study|Withdrawal by Subject|2|||
126384286|NCT01071252|454700644|FG004|Overall Study|Withdrawal by Subject|3|||
126384287|NCT01071252|454700640|FG000|Overall Study|administrative problems|1|||
126384288|NCT01071252|454700641|FG001|Overall Study|administrative problems|1|||
126384289|NCT01071252|454700642|FG002|Overall Study|administrative problems|0|||
126384290|NCT01071252|454700643|FG003|Overall Study|administrative problems|2|||
126384291|NCT01071252|454700644|FG004|Overall Study|administrative problems|1|||
126384292|NCT01071252|454700640|FG000|Overall Study|Lost to Follow-up|1|||
126384293|NCT01071252|454700641|FG001|Overall Study|Lost to Follow-up|0|||
126384294|NCT01071252|454700642|FG002|Overall Study|Lost to Follow-up|1|||
126384295|NCT01071252|454700643|FG003|Overall Study|Lost to Follow-up|2|||
126384296|NCT01071252|454700644|FG004|Overall Study|Lost to Follow-up|0|||
126384297|NCT01071252|454700640|FG000|Overall Study|Adverse Event|1|||
126384298|NCT01071252|454700641|FG001|Overall Study|Adverse Event|1|||
126384299|NCT01071252|454700642|FG002|Overall Study|Adverse Event|0|||
126384300|NCT01071252|454700643|FG003|Overall Study|Adverse Event|1|||
126384301|NCT01071252|454700644|FG004|Overall Study|Adverse Event|0|||
126384302|NCT01071252|454700640|FG000|Overall Study|Death|0|||
126384303|NCT01071252|454700641|FG001|Overall Study|Death|0|||
126384304|NCT01071252|454700642|FG002|Overall Study|Death|0|||
126384305|NCT01071252|454700643|FG003|Overall Study|Death|0|||
126384306|NCT01071252|454700644|FG004|Overall Study|Death|1|||
126384307|NCT01945996|454700645|FG000|Overall Study|Lost to Follow-up|3|||
126384308|NCT01945996|454700646|FG001|Overall Study|Lost to Follow-up|5|||
126384309|NCT03928418|454700647|FG000|Overall Study|Lost to Follow-up|5|||
126384310|NCT03928418|454700648|FG001|Overall Study|Lost to Follow-up|3|||
126384311|NCT03928418|454700649|FG002|Overall Study|Lost to Follow-up|5|||
126384312|NCT03928418|454700647|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
126717388|NCT02417233|455916202|FG001|Overall Study|Mentally unstable|1|||
126384313|NCT03928418|454700648|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
126384314|NCT03928418|454700649|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
126384315|NCT00763256|454700650|FG000|Overall Study|Didn't return for appointments|7|||
126384316|NCT00763256|454700651|FG001|Overall Study|Didn't return for appointments|10|||
126468381|NCT01439568|455017594|FG001|Overall Study|Lost to Follow-up|0|||
126384317|NCT02544750|454700652|FG000|Overall Study|Physician Decision|3|||
126384318|NCT02544750|454700653|FG001|Overall Study|Physician Decision|1|||
126384319|NCT02544750|454700652|FG000|Overall Study|Other reasons|69|||
126553365|NCT03257995|455320583|FG004|Overall Study|Adverse Event|0|||
126553366|NCT03257995|455320584|FG005|Overall Study|Adverse Event|0|||
126553367|NCT03257995|455320579|FG000|Overall Study|Protocol deviation|0|||
126553368|NCT03257995|455320580|FG001|Overall Study|Protocol deviation|0|||
126553369|NCT03257995|455320581|FG002|Overall Study|Protocol deviation|0|||
126717389|NCT02417233|455916203|FG002|Overall Study|Mentally unstable|0|||
126717390|NCT01293032|455916204|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
126717391|NCT01293032|455916205|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
126717392|NCT01293032|455916206|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
126717393|NCT01293032|455916207|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
126717394|NCT01293032|455916204|FG000|Treatment|Adverse Event|0|||
126717395|NCT01293032|455916205|FG001|Treatment|Adverse Event|0|||
126717396|NCT01293032|455916206|FG002|Treatment|Adverse Event|1|||
126717397|NCT01293032|455916207|FG003|Treatment|Adverse Event|1|||
126717398|NCT01293032|455916204|FG000|Treatment|Withdrawal by Subject|2|||
126717399|NCT01293032|455916205|FG001|Treatment|Withdrawal by Subject|4|||
126717400|NCT01293032|455916206|FG002|Treatment|Withdrawal by Subject|0|||
126717401|NCT01293032|455916207|FG003|Treatment|Withdrawal by Subject|0|||
126717402|NCT01293032|455916204|FG000|Treatment|Disease Progression, relapse|0|||
126717403|NCT01293032|455916205|FG001|Treatment|Disease Progression, relapse|1|||
126717404|NCT01293032|455916206|FG002|Treatment|Disease Progression, relapse|0|||
126717405|NCT01293032|455916207|FG003|Treatment|Disease Progression, relapse|0|||
126717406|NCT01594476|455916208|FG000|Overall Study|Protocol Violation|1|||
126717407|NCT01594476|455916209|FG001|Overall Study|Protocol Violation|3|||
126717408|NCT02890329|455916214|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
126717409|NCT02890329|455916215|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
126717410|NCT02890329|455916216|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
126717411|NCT02890329|455916217|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
126717412|NCT02890329|455916218|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
126717413|NCT02890329|455916219|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
126717414|NCT02890329|455916214|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
126717415|NCT02890329|455916215|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
126717416|NCT02890329|455916216|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
126717417|NCT02890329|455916217|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
126717418|NCT02890329|455916218|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
126717419|NCT02890329|455916219|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
126717420|NCT02890329|455916214|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
126717421|NCT02890329|455916215|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
126771182|NCT03985293|456116289|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
126384320|NCT02544750|454700653|FG001|Overall Study|Other reasons|39|||
126384321|NCT02544750|454700652|FG000|Overall Study|Met withdrawal criteria|2|||
126384322|NCT02544750|454700653|FG001|Overall Study|Met withdrawal criteria|2|||
126384323|NCT02544750|454700652|FG000|Overall Study|Transition To Commercial Product|1|||
126384324|NCT02544750|454700653|FG001|Overall Study|Transition To Commercial Product|0|||
126384325|NCT02544750|454700652|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
126384326|NCT02544750|454700653|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
126384327|NCT02544750|454700652|FG000|Overall Study|Adverse Event|8|||
126384328|NCT02544750|454700653|FG001|Overall Study|Adverse Event|10|||
126384329|NCT02544750|454700652|FG000|Overall Study|Withdrawal by Subject|10|||
126384330|NCT02544750|454700653|FG001|Overall Study|Withdrawal by Subject|4|||
126384331|NCT02544750|454700652|FG000|Overall Study|Lost to Follow-up|1|||
126384332|NCT02544750|454700653|FG001|Overall Study|Lost to Follow-up|0|||
126384333|NCT00244725|454700656|FG000|Overall Study|Lost to Follow-up|3|||
126384334|NCT00244725|454700657|FG001|Overall Study|Lost to Follow-up|4|||
126384335|NCT00244725|454700658|FG002|Overall Study|Lost to Follow-up|9|||
126384336|NCT00244725|454700659|FG003|Overall Study|Lost to Follow-up|2|||
126384337|NCT00244725|454700656|FG000|Overall Study|Withdrawal by Subject|9|||
126384338|NCT00244725|454700657|FG001|Overall Study|Withdrawal by Subject|7|||
126384339|NCT00244725|454700658|FG002|Overall Study|Withdrawal by Subject|7|||
126384340|NCT00244725|454700659|FG003|Overall Study|Withdrawal by Subject|8|||
126553370|NCT03257995|455320582|FG003|Overall Study|Protocol deviation|0|||
126553371|NCT03257995|455320583|FG004|Overall Study|Protocol deviation|0|||
126553372|NCT03257995|455320584|FG005|Overall Study|Protocol deviation|2|||
126717422|NCT02890329|455916216|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
126717423|NCT02890329|455916217|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
126717424|NCT02890329|455916218|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
126771183|NCT03985293|456116290|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
126553373|NCT01556763|455320589|FG000|Overall Study|Withdrawal by Subject|0|||
126384341|NCT00244725|454700656|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
126384342|NCT00244725|454700657|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
126384343|NCT00244725|454700658|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
126384344|NCT00244725|454700659|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
126384345|NCT00244725|454700656|FG000|Overall Study|Physician Decision|3|||
126384346|NCT00244725|454700657|FG001|Overall Study|Physician Decision|0|||
126384347|NCT00244725|454700658|FG002|Overall Study|Physician Decision|1|||
126384348|NCT00244725|454700659|FG003|Overall Study|Physician Decision|2|||
126384349|NCT00244725|454700656|FG000|Overall Study|Adverse Events|3|||
126384350|NCT00244725|454700657|FG001|Overall Study|Adverse Events|1|||
126384351|NCT00244725|454700658|FG002|Overall Study|Adverse Events|4|||
126384352|NCT00244725|454700659|FG003|Overall Study|Adverse Events|4|||
126384353|NCT00244725|454700656|FG000|Overall Study|Withdrwal by participant|1|||
126384354|NCT00244725|454700657|FG001|Overall Study|Withdrwal by participant|0|||
126384355|NCT00244725|454700658|FG002|Overall Study|Withdrwal by participant|0|||
126384356|NCT00244725|454700659|FG003|Overall Study|Withdrwal by participant|1|||
126384357|NCT00244725|454700656|FG000|Overall Study|Liver function test abnormality|2|||
126384358|NCT00244725|454700657|FG001|Overall Study|Liver function test abnormality|0|||
126384359|NCT00244725|454700658|FG002|Overall Study|Liver function test abnormality|0|||
126384360|NCT00244725|454700659|FG003|Overall Study|Liver function test abnormality|1|||
126384361|NCT00244725|454700656|FG000|Overall Study|Sponsor withdrew the participant|1|||
126384362|NCT00244725|454700657|FG001|Overall Study|Sponsor withdrew the participant|0|||
126717425|NCT02890329|455916219|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
126717426|NCT02890329|455916214|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
126384363|NCT00244725|454700658|FG002|Overall Study|Sponsor withdrew the participant|0|||
126384364|NCT00244725|454700659|FG003|Overall Study|Sponsor withdrew the participant|1|||
126384365|NCT00244725|454700656|FG000|Overall Study|Mediciation Error|0|||
126384366|NCT00244725|454700657|FG001|Overall Study|Mediciation Error|1|||
126384367|NCT00244725|454700658|FG002|Overall Study|Mediciation Error|0|||
126384368|NCT00244725|454700659|FG003|Overall Study|Mediciation Error|0|||
126384369|NCT00244725|454700656|FG000|Overall Study|Rehab Refused to allow participantion|0|||
126384370|NCT00244725|454700657|FG001|Overall Study|Rehab Refused to allow participantion|1|||
126384371|NCT00244725|454700658|FG002|Overall Study|Rehab Refused to allow participantion|0|||
126384372|NCT00244725|454700659|FG003|Overall Study|Rehab Refused to allow participantion|0|||
126384373|NCT00244725|454700656|FG000|Overall Study|Headache|0|||
126384374|NCT00244725|454700657|FG001|Overall Study|Headache|1|||
126384375|NCT00244725|454700658|FG002|Overall Study|Headache|0|||
126384376|NCT00244725|454700659|FG003|Overall Study|Headache|0|||
126384377|NCT00244725|454700656|FG000|Overall Study|Received prohibited medication|0|||
126384378|NCT00244725|454700657|FG001|Overall Study|Received prohibited medication|1|||
126384379|NCT00244725|454700658|FG002|Overall Study|Received prohibited medication|0|||
126384380|NCT00244725|454700659|FG003|Overall Study|Received prohibited medication|1|||
126384381|NCT00244725|454700656|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
126384382|NCT00244725|454700657|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
126384383|NCT00244725|454700658|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
126384384|NCT00244725|454700659|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
126384385|NCT00244725|454700656|FG000|Overall Study|Administrative reason|0|||
126384386|NCT00244725|454700657|FG001|Overall Study|Administrative reason|0|||
126384387|NCT00244725|454700658|FG002|Overall Study|Administrative reason|1|||
126384388|NCT00244725|454700659|FG003|Overall Study|Administrative reason|0|||
126384389|NCT00244725|454700656|FG000|Overall Study|Vomit|0|||
126384390|NCT00244725|454700657|FG001|Overall Study|Vomit|0|||
126384391|NCT00244725|454700658|FG002|Overall Study|Vomit|1|||
126384392|NCT00244725|454700659|FG003|Overall Study|Vomit|0|||
126384393|NCT00244725|454700656|FG000|Overall Study|Failed to follow-up|0|||
126384394|NCT00244725|454700657|FG001|Overall Study|Failed to follow-up|0|||
126384395|NCT00244725|454700658|FG002|Overall Study|Failed to follow-up|1|||
126384396|NCT00244725|454700659|FG003|Overall Study|Failed to follow-up|1|||
126384397|NCT02131311|454700660|FG000|Overall Study|Adverse Event|2|||
126384398|NCT02131311|454700660|FG000|Overall Study|Protocol Violation|1|||
126384399|NCT02131311|454700660|FG000|Overall Study|Lost to Follow-up|1|||
126384400|NCT00255723|454700662|FG000|Overall Study|Adverse Event|1|||
126384401|NCT00255723|454700663|FG001|Overall Study|Adverse Event|1|||
126384402|NCT00255723|454700662|FG000|Overall Study|Death|0|||
126384403|NCT00255723|454700663|FG001|Overall Study|Death|1|||
126384404|NCT00255723|454700662|FG000|Overall Study|Response Data Not Available|1|||
126384405|NCT00255723|454700663|FG001|Overall Study|Response Data Not Available|0|||
126384406|NCT01169701|454700668|FG000|Overall Study|Lost to Follow-up|1|||
126384407|NCT01169701|454700669|FG001|Overall Study|Lost to Follow-up|1|||
126384408|NCT01169701|454700668|FG000|Overall Study|Withdrawal by Subject|1|||
126384409|NCT01169701|454700669|FG001|Overall Study|Withdrawal by Subject|3|||
126384410|NCT01169701|454700668|FG000|Overall Study|Adverse Event|1|||
126384411|NCT01169701|454700669|FG001|Overall Study|Adverse Event|2|||
126384412|NCT01169701|454700668|FG000|Overall Study|Exclusion criteria|2|||
126384413|NCT01169701|454700669|FG001|Overall Study|Exclusion criteria|0|||
126384414|NCT01169701|454700668|FG000|Overall Study|Death|0|||
126384415|NCT01169701|454700669|FG001|Overall Study|Death|1|||
126384416|NCT01169701|454700668|FG000|Overall Study|Administrative problems|0|||
126384417|NCT01169701|454700669|FG001|Overall Study|Administrative problems|1|||
126717427|NCT02890329|455916215|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
126717428|NCT02890329|455916216|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
126717429|NCT02890329|455916217|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
126717430|NCT02890329|455916218|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
126717431|NCT02890329|455916219|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
126717432|NCT00443430|455916220|FG000|Overall Study|Lack of Efficacy|3|||
126717433|NCT00443430|455916221|FG001|Overall Study|Lack of Efficacy|3|||
126384418|NCT01169701|454700668|FG000|Overall Study|Serious adverse event|0|||
126384419|NCT01169701|454700669|FG001|Overall Study|Serious adverse event|1|||
126384420|NCT01169701|454700668|FG000|Overall Study|Sponsor decision|0|||
126384421|NCT01169701|454700669|FG001|Overall Study|Sponsor decision|1|||
126384422|NCT00553436|454700670|FG000|Overall Study|Conversion to another procedure|1|||
126384423|NCT01814046|454700671|FG000|Drug Administration|Death due to complications of RSV|1|||
126384424|NCT01814046|454700672|FG001|Drug Administration|Death due to complications of RSV|0|||
126384425|NCT01814046|454700673|FG002|Drug Administration|Death due to complications of RSV|0|||
126384426|NCT03146663|454700676|FG000|Overall Study|Did not receive study treatment|1|||
126384427|NCT03146663|454700677|FG001|Overall Study|Did not receive study treatment|1|||
126384428|NCT03089047|454700678|FG000|Overall Study|Lost to Follow-up|1|||
126384429|NCT03089047|454700679|FG001|Overall Study|Lost to Follow-up|0|||
126384430|NCT03599518|454700680|FG000|Overall Study|Clinical progression|0|||
126384431|NCT03599518|454700681|FG001|Overall Study|Clinical progression|0|||
126384432|NCT03599518|454700682|FG002|Overall Study|Clinical progression|0|||
126384433|NCT03599518|454700683|FG003|Overall Study|Clinical progression|0|||
126384434|NCT03599518|454700684|FG004|Overall Study|Clinical progression|1|||
126384435|NCT03599518|454700680|FG000|Overall Study|Adverse Event|0|||
126384436|NCT03599518|454700681|FG001|Overall Study|Adverse Event|0|||
126384437|NCT03599518|454700682|FG002|Overall Study|Adverse Event|0|||
126384438|NCT03599518|454700683|FG003|Overall Study|Adverse Event|0|||
126384439|NCT03599518|454700684|FG004|Overall Study|Adverse Event|1|||
126384440|NCT03599518|454700680|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
126384441|NCT03599518|454700681|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
126384442|NCT03599518|454700682|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
126384443|NCT03599518|454700683|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
126384444|NCT03599518|454700684|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
126384445|NCT03599518|454700680|FG000|Overall Study|Participant withdrawal from study treatment|0|||
126384446|NCT03599518|454700681|FG001|Overall Study|Participant withdrawal from study treatment|0|||
126384447|NCT03599518|454700682|FG002|Overall Study|Participant withdrawal from study treatment|1|||
126384448|NCT03599518|454700683|FG003|Overall Study|Participant withdrawal from study treatment|0|||
126384449|NCT03599518|454700684|FG004|Overall Study|Participant withdrawal from study treatment|0|||
126384450|NCT00429182|454700687|FG000|Overall Study|Not evaluable, Disease Progression|2|||
126384451|NCT00429182|454700687|FG000|Overall Study|Not eligible|5|||
126384452|NCT02311881|454700698|FG000|Overall Study|Did not meet the study criteria|2|||
126384453|NCT02311881|454700699|FG001|Overall Study|Did not meet the study criteria|2|||
126384454|NCT02311881|454700700|FG002|Overall Study|Did not meet the study criteria|0|||
126384455|NCT02311881|454700698|FG000|Overall Study|Adverse Event|7|||
126384456|NCT02311881|454700699|FG001|Overall Study|Adverse Event|15|||
126384457|NCT02311881|454700700|FG002|Overall Study|Adverse Event|8|||
126384458|NCT02311881|454700698|FG000|Overall Study|Lost to Follow-up|3|||
126384459|NCT02311881|454700699|FG001|Overall Study|Lost to Follow-up|3|||
126384460|NCT02311881|454700700|FG002|Overall Study|Lost to Follow-up|2|||
126384461|NCT02311881|454700698|FG000|Overall Study|Protocol Violation|1|||
126384462|NCT02311881|454700699|FG001|Overall Study|Protocol Violation|2|||
126384463|NCT02311881|454700700|FG002|Overall Study|Protocol Violation|3|||
126384464|NCT02311881|454700698|FG000|Overall Study|Withdrawal of consent|14|||
126384465|NCT02311881|454700699|FG001|Overall Study|Withdrawal of consent|16|||
126384466|NCT02311881|454700700|FG002|Overall Study|Withdrawal of consent|17|||
126384467|NCT02311881|454700698|FG000|Overall Study|Other|0|||
126384468|NCT02311881|454700699|FG001|Overall Study|Other|0|||
126384469|NCT02311881|454700700|FG002|Overall Study|Other|1|||
126384470|NCT02311881|454700698|FG000|Overall Study|Lack of Efficacy|1|||
126384471|NCT02311881|454700699|FG001|Overall Study|Lack of Efficacy|2|||
126384472|NCT02311881|454700700|FG002|Overall Study|Lack of Efficacy|0|||
126384473|NCT02311881|454700698|FG000|Overall Study|Subject has border line pregnancy test|1|||
126384474|NCT02311881|454700699|FG001|Overall Study|Subject has border line pregnancy test|0|||
126384475|NCT02311881|454700700|FG002|Overall Study|Subject has border line pregnancy test|0|||
126384476|NCT02311881|454700698|FG000|Overall Study|Withdrawal by Subject|3|||
126384477|NCT02311881|454700699|FG001|Overall Study|Withdrawal by Subject|1|||
126384478|NCT02311881|454700700|FG002|Overall Study|Withdrawal by Subject|4|||
126384479|NCT02311881|454700698|FG000|Overall Study|Sponsor Decision|1|||
126384480|NCT02311881|454700699|FG001|Overall Study|Sponsor Decision|1|||
126384481|NCT02311881|454700700|FG002|Overall Study|Sponsor Decision|1|||
126384482|NCT02311881|454700698|FG000|Overall Study|Protocol Deviation|1|||
126384483|NCT02311881|454700699|FG001|Overall Study|Protocol Deviation|0|||
126384484|NCT02311881|454700700|FG002|Overall Study|Protocol Deviation|0|||
126384485|NCT02311881|454700698|FG000|Overall Study|Non-Compliance|1|||
126384486|NCT02311881|454700699|FG001|Overall Study|Non-Compliance|0|||
126384487|NCT02311881|454700700|FG002|Overall Study|Non-Compliance|2|||
126384488|NCT02311881|454700698|FG000|Overall Study|Physician Decision|0|||
126384489|NCT02311881|454700699|FG001|Overall Study|Physician Decision|0|||
126384490|NCT02311881|454700700|FG002|Overall Study|Physician Decision|1|||
126384491|NCT02311881|454700698|FG000|Overall Study|Medical Monitor Discretion|0|||
126384492|NCT02311881|454700699|FG001|Overall Study|Medical Monitor Discretion|0|||
126384493|NCT02311881|454700700|FG002|Overall Study|Medical Monitor Discretion|1|||
126384494|NCT02311881|454700698|FG000|Overall Study|Participant taking another medication|0|||
126384495|NCT02311881|454700699|FG001|Overall Study|Participant taking another medication|0|||
126384496|NCT02311881|454700700|FG002|Overall Study|Participant taking another medication|1|||
126384497|NCT02311881|454700698|FG000|Overall Study|Serious Adverse Event|0|||
126384498|NCT02311881|454700699|FG001|Overall Study|Serious Adverse Event|1|||
126384499|NCT02311881|454700700|FG002|Overall Study|Serious Adverse Event|0|||
126384500|NCT00819156|454700701|FG000|Overall Study|Adverse Event|1|||
126384501|NCT00819156|454700702|FG001|Overall Study|Adverse Event|4|||
126384502|NCT00819156|454700703|FG002|Overall Study|Adverse Event|2|||
126384503|NCT00819156|454700704|FG003|Overall Study|Adverse Event|1|||
126384504|NCT00819156|454700705|FG004|Overall Study|Adverse Event|2|||
126384505|NCT00819156|454700706|FG005|Overall Study|Adverse Event|3|||
126384506|NCT00819156|454700701|FG000|Overall Study|Withdrawal by Subject|0|||
126384507|NCT00819156|454700702|FG001|Overall Study|Withdrawal by Subject|3|||
126384508|NCT00819156|454700703|FG002|Overall Study|Withdrawal by Subject|2|||
126384509|NCT00819156|454700704|FG003|Overall Study|Withdrawal by Subject|0|||
126384510|NCT00819156|454700705|FG004|Overall Study|Withdrawal by Subject|1|||
126384511|NCT00819156|454700706|FG005|Overall Study|Withdrawal by Subject|0|||
126384512|NCT00819156|454700701|FG000|Overall Study|Protocol Violation|1|||
126384513|NCT00819156|454700702|FG001|Overall Study|Protocol Violation|0|||
126384514|NCT00819156|454700703|FG002|Overall Study|Protocol Violation|1|||
126384515|NCT00819156|454700704|FG003|Overall Study|Protocol Violation|0|||
126384516|NCT00819156|454700705|FG004|Overall Study|Protocol Violation|0|||
126384517|NCT00819156|454700706|FG005|Overall Study|Protocol Violation|1|||
126384518|NCT00819156|454700701|FG000|Overall Study|Lost to Follow-up|0|||
126384519|NCT00819156|454700702|FG001|Overall Study|Lost to Follow-up|1|||
126384520|NCT00819156|454700703|FG002|Overall Study|Lost to Follow-up|0|||
126384521|NCT00819156|454700704|FG003|Overall Study|Lost to Follow-up|0|||
126384522|NCT00819156|454700705|FG004|Overall Study|Lost to Follow-up|0|||
126384523|NCT00819156|454700706|FG005|Overall Study|Lost to Follow-up|2|||
126384524|NCT00819156|454700701|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
126384525|NCT00819156|454700702|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
126384526|NCT00819156|454700703|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
126384527|NCT00819156|454700704|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
126384528|NCT00819156|454700705|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
126384529|NCT00819156|454700706|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
126384530|NCT00819156|454700701|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
126384531|NCT00819156|454700702|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
126384532|NCT00819156|454700703|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
126384533|NCT00819156|454700704|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
126384534|NCT00819156|454700705|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
126384535|NCT00819156|454700706|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
126384536|NCT00819156|454700701|FG000|Overall Study|Prostate-specific antigen progression|0|||
126384537|NCT00819156|454700702|FG001|Overall Study|Prostate-specific antigen progression|0|||
126384538|NCT00819156|454700703|FG002|Overall Study|Prostate-specific antigen progression|0|||
126384539|NCT00819156|454700704|FG003|Overall Study|Prostate-specific antigen progression|0|||
126384540|NCT00819156|454700705|FG004|Overall Study|Prostate-specific antigen progression|1|||
126384541|NCT00819156|454700706|FG005|Overall Study|Prostate-specific antigen progression|0|||
126384542|NCT00790582|454700707|FG000|Overall Study|Death|14|||
126384543|NCT00790582|454700708|FG001|Overall Study|Death|32|||
126384544|NCT00790582|454700707|FG000|Overall Study|Physician Decision|7|||
126384545|NCT00790582|454700708|FG001|Overall Study|Physician Decision|1|||
126384546|NCT00790582|454700707|FG000|Overall Study|Lost to Follow-up|3|||
126384547|NCT00790582|454700708|FG001|Overall Study|Lost to Follow-up|3|||
126384548|NCT00790582|454700707|FG000|Overall Study|Withdrawal by Subject|7|||
126384549|NCT00790582|454700708|FG001|Overall Study|Withdrawal by Subject|51|||
126384550|NCT01575808|454700711|FG000|Overall Study|Death|2|||
126384551|NCT01575808|454700712|FG001|Overall Study|Death|0|||
126384552|NCT01575808|454700711|FG000|Overall Study|Withdrawal by Subject|1|||
126384553|NCT01575808|454700712|FG001|Overall Study|Withdrawal by Subject|0|||
126384554|NCT05823974|454703052|FG000|Overall Study|Lost to Follow-up|0|||
126384555|NCT05823974|454703053|FG001|Overall Study|Lost to Follow-up|3|||
126384556|NCT05823974|454703054|FG002|Overall Study|Lost to Follow-up|1|||
126384557|NCT05823974|454703055|FG003|Overall Study|Lost to Follow-up|0|||
126384558|NCT05823974|454703056|FG004|Overall Study|Lost to Follow-up|1|||
126384559|NCT05823974|454703057|FG005|Overall Study|Lost to Follow-up|0|||
126384560|NCT05823974|454703058|FG006|Overall Study|Lost to Follow-up|1|||
126384561|NCT05823974|454703059|FG007|Overall Study|Lost to Follow-up|0|||
126384562|NCT05823974|454703060|FG008|Overall Study|Lost to Follow-up|0|||
126384563|NCT05823974|454703061|FG009|Overall Study|Lost to Follow-up|1|||
126384564|NCT05823974|454703062|FG010|Overall Study|Lost to Follow-up|1|||
126384565|NCT05823974|454703063|FG011|Overall Study|Lost to Follow-up|0|||
126384566|NCT05823974|454703064|FG012|Overall Study|Lost to Follow-up|1|||
126384567|NCT05823974|454703065|FG013|Overall Study|Lost to Follow-up|2|||
126384568|NCT05823974|454703066|FG014|Overall Study|Lost to Follow-up|1|||
126384569|NCT05823974|454703067|FG015|Overall Study|Lost to Follow-up|1|||
126384570|NCT05823974|454703068|FG016|Overall Study|Lost to Follow-up|1|||
126384571|NCT05823974|454703069|FG017|Overall Study|Lost to Follow-up|0|||
126384572|NCT05823974|454703070|FG018|Overall Study|Lost to Follow-up|0|||
126384573|NCT05823974|454703071|FG019|Overall Study|Lost to Follow-up|2|||
126384574|NCT05823974|454703072|FG020|Overall Study|Lost to Follow-up|0|||
126384575|NCT05823974|454703052|FG000|Overall Study|Physician Decision|0|||
126384576|NCT05823974|454703053|FG001|Overall Study|Physician Decision|0|||
126384577|NCT05823974|454703054|FG002|Overall Study|Physician Decision|0|||
126384578|NCT05823974|454703055|FG003|Overall Study|Physician Decision|0|||
126384579|NCT05823974|454703056|FG004|Overall Study|Physician Decision|0|||
126384580|NCT05823974|454703057|FG005|Overall Study|Physician Decision|0|||
126384581|NCT05823974|454703058|FG006|Overall Study|Physician Decision|0|||
126384582|NCT05823974|454703059|FG007|Overall Study|Physician Decision|0|||
126384583|NCT05823974|454703060|FG008|Overall Study|Physician Decision|0|||
126384584|NCT05823974|454703061|FG009|Overall Study|Physician Decision|0|||
126384585|NCT05823974|454703062|FG010|Overall Study|Physician Decision|0|||
126384586|NCT05823974|454703063|FG011|Overall Study|Physician Decision|0|||
126384587|NCT05823974|454703064|FG012|Overall Study|Physician Decision|0|||
126384588|NCT05823974|454703065|FG013|Overall Study|Physician Decision|0|||
126384589|NCT05823974|454703066|FG014|Overall Study|Physician Decision|0|||
126384590|NCT05823974|454703067|FG015|Overall Study|Physician Decision|1|||
126384591|NCT05823974|454703068|FG016|Overall Study|Physician Decision|0|||
126384592|NCT05823974|454703069|FG017|Overall Study|Physician Decision|1|||
126384593|NCT05823974|454703070|FG018|Overall Study|Physician Decision|1|||
126384594|NCT05823974|454703071|FG019|Overall Study|Physician Decision|0|||
126384595|NCT05823974|454703072|FG020|Overall Study|Physician Decision|0|||
126384596|NCT05823974|454703052|FG000|Overall Study|Withdrawal by Subject|1|||
126384597|NCT05823974|454703053|FG001|Overall Study|Withdrawal by Subject|1|||
126384598|NCT05823974|454703054|FG002|Overall Study|Withdrawal by Subject|2|||
126384599|NCT05823974|454703055|FG003|Overall Study|Withdrawal by Subject|0|||
126384600|NCT05823974|454703056|FG004|Overall Study|Withdrawal by Subject|2|||
126384601|NCT05823974|454703057|FG005|Overall Study|Withdrawal by Subject|3|||
126384602|NCT05823974|454703058|FG006|Overall Study|Withdrawal by Subject|1|||
126384603|NCT05823974|454703059|FG007|Overall Study|Withdrawal by Subject|1|||
126384604|NCT05823974|454703060|FG008|Overall Study|Withdrawal by Subject|2|||
126384605|NCT05823974|454703061|FG009|Overall Study|Withdrawal by Subject|1|||
126384606|NCT05823974|454703062|FG010|Overall Study|Withdrawal by Subject|1|||
126384607|NCT05823974|454703063|FG011|Overall Study|Withdrawal by Subject|0|||
126384608|NCT05823974|454703064|FG012|Overall Study|Withdrawal by Subject|0|||
126384609|NCT05823974|454703065|FG013|Overall Study|Withdrawal by Subject|1|||
126384610|NCT05823974|454703066|FG014|Overall Study|Withdrawal by Subject|1|||
126384611|NCT05823974|454703067|FG015|Overall Study|Withdrawal by Subject|3|||
126384612|NCT05823974|454703068|FG016|Overall Study|Withdrawal by Subject|0|||
126384613|NCT05823974|454703069|FG017|Overall Study|Withdrawal by Subject|2|||
126384614|NCT05823974|454703070|FG018|Overall Study|Withdrawal by Subject|2|||
126384615|NCT05823974|454703071|FG019|Overall Study|Withdrawal by Subject|0|||
126384616|NCT05823974|454703072|FG020|Overall Study|Withdrawal by Subject|1|||
126384617|NCT05823974|454703052|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384618|NCT05823974|454703053|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384619|NCT05823974|454703054|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126384620|NCT05823974|454703055|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384621|NCT05823974|454703056|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384622|NCT05823974|454703057|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384623|NCT05823974|454703058|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384624|NCT05823974|454703059|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384625|NCT05823974|454703060|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384626|NCT05823974|454703061|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384627|NCT05823974|454703062|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384628|NCT05823974|454703063|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384629|NCT05823974|454703064|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384630|NCT05823974|454703065|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384631|NCT05823974|454703066|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126384632|NCT05823974|454703067|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384633|NCT05823974|454703068|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384634|NCT05823974|454703069|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384635|NCT05823974|454703070|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126771184|NCT03985293|456116291|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
126384636|NCT05823974|454703071|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384637|NCT05823974|454703072|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126384638|NCT05823974|454703052|FG000|Overall Study|Other|0|||
126384639|NCT05823974|454703053|FG001|Overall Study|Other|1|||
126384640|NCT05823974|454703054|FG002|Overall Study|Other|1|||
126384641|NCT05823974|454703055|FG003|Overall Study|Other|1|||
126384642|NCT05823974|454703056|FG004|Overall Study|Other|0|||
126384643|NCT05823974|454703057|FG005|Overall Study|Other|1|||
126384644|NCT05823974|454703058|FG006|Overall Study|Other|1|||
126384645|NCT05823974|454703059|FG007|Overall Study|Other|1|||
126384646|NCT05823974|454703060|FG008|Overall Study|Other|1|||
126384647|NCT05823974|454703061|FG009|Overall Study|Other|0|||
126384648|NCT05823974|454703062|FG010|Overall Study|Other|0|||
126384649|NCT05823974|454703063|FG011|Overall Study|Other|0|||
126384650|NCT05823974|454703064|FG012|Overall Study|Other|2|||
126384651|NCT05823974|454703065|FG013|Overall Study|Other|1|||
126384652|NCT05823974|454703066|FG014|Overall Study|Other|0|||
126384653|NCT05823974|454703067|FG015|Overall Study|Other|1|||
126384654|NCT05823974|454703068|FG016|Overall Study|Other|0|||
126384655|NCT05823974|454703069|FG017|Overall Study|Other|0|||
126384656|NCT05823974|454703070|FG018|Overall Study|Other|0|||
126384657|NCT05823974|454703071|FG019|Overall Study|Other|0|||
126384658|NCT05823974|454703072|FG020|Overall Study|Other|0|||
126384659|NCT00316706|454703073|FG000|Overall Study|Lost to Follow-up|38|||
126384660|NCT00316706|454703074|FG001|Overall Study|Lost to Follow-up|48|||
126384661|NCT03292874|454703078|FG000|Overall Study|Due to pandemic|5|||
126384662|NCT00485758|454703086|FG000|Overall Study|Adverse Event|102|||
126384663|NCT00485758|454703087|FG001|Overall Study|Adverse Event|31|||
126384664|NCT00485758|454703086|FG000|Overall Study|Death|0|||
126384665|NCT00485758|454703087|FG001|Overall Study|Death|1|||
126384666|NCT00485758|454703086|FG000|Overall Study|Lost to Follow-up|5|||
126384667|NCT00485758|454703087|FG001|Overall Study|Lost to Follow-up|1|||
126384668|NCT00485758|454703086|FG000|Overall Study|Physician Decision|3|||
126384669|NCT00485758|454703087|FG001|Overall Study|Physician Decision|3|||
126384670|NCT00485758|454703086|FG000|Overall Study|Protocol Violation|11|||
126384671|NCT00485758|454703087|FG001|Overall Study|Protocol Violation|2|||
126384672|NCT00485758|454703086|FG000|Overall Study|Withdrawal by Subject|32|||
126384673|NCT00485758|454703087|FG001|Overall Study|Withdrawal by Subject|27|||
126384674|NCT00485758|454703086|FG000|Overall Study|Study Terminated by Sponsor|3|||
126384675|NCT00485758|454703087|FG001|Overall Study|Study Terminated by Sponsor|0|||
126384676|NCT00654745|454703088|FG000|Overall Study|Adverse Event|12|||
126384677|NCT00654745|454703088|FG000|Overall Study|Lost to Follow-up|7|||
126384678|NCT00654745|454703088|FG000|Overall Study|Protocol Violation|11|||
126384679|NCT00654745|454703088|FG000|Overall Study|Withdrawal by Subject|10|||
126384680|NCT00654745|454703088|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
126384681|NCT01995526|454703089|FG000|Overall Study|Physician Decision|1|||
126384682|NCT00383331|454703090|FG000|Overall Study|Protocol Violation|0|||
126384683|NCT00383331|454703091|FG001|Overall Study|Protocol Violation|1|||
126384684|NCT02229825|454703099|FG000|Overall Study|Personal Reasons|0|||
126384685|NCT02229825|454703100|FG001|Overall Study|Personal Reasons|1|||
126384686|NCT02229825|454703099|FG000|Overall Study|Refused continuing medication|7|||
126384687|NCT02229825|454703100|FG001|Overall Study|Refused continuing medication|6|||
126384688|NCT02229825|454703099|FG000|Overall Study|Lost to Follow-up|1|||
126384689|NCT02229825|454703100|FG001|Overall Study|Lost to Follow-up|2|||
126384690|NCT02229825|454703099|FG000|Overall Study|Protocol Violation|1|||
126384691|NCT02229825|454703100|FG001|Overall Study|Protocol Violation|1|||
126384692|NCT02229825|454703099|FG000|Overall Study|Lack of Efficacy|4|||
126384693|NCT02229825|454703100|FG001|Overall Study|Lack of Efficacy|10|||
126384694|NCT02229825|454703099|FG000|Overall Study|Adverse Event|11|||
126384695|NCT02229825|454703100|FG001|Overall Study|Adverse Event|9|||
126384696|NCT02229825|454703099|FG000|Overall Study|Not treated|0|||
126384697|NCT02229825|454703100|FG001|Overall Study|Not treated|1|||
126717434|NCT00443430|455916220|FG000|Overall Study|Adverse Event|1|||
126384698|NCT01532921|454703105|FG000|Overall Study|Death|3|||
126384699|NCT01532921|454703105|FG000|Overall Study|Withdrawal by Subject|2|||
126384700|NCT01532921|454703105|FG000|Overall Study|Lost to Follow-up|3|||
126384701|NCT01532921|454703105|FG000|Overall Study|Physician Decision|7|||
126717435|NCT00443430|455916221|FG001|Overall Study|Adverse Event|1|||
126717436|NCT00933335|455916222|FG000|Overall Study|Lost to Follow-up|1|||
126717437|NCT00933335|455916223|FG001|Overall Study|Lost to Follow-up|3|||
126717438|NCT00933335|455916222|FG000|Overall Study|Withdrawal by Subject|0|||
126717439|NCT00933335|455916223|FG001|Overall Study|Withdrawal by Subject|1|||
126717440|NCT00933335|455916222|FG000|Overall Study|Progressive Disease|0|||
126384702|NCT01532921|454703105|FG000|Overall Study|Device was explanted during procedure|1|||
126384703|NCT00070109|454703106|FG000|Overall Study|Death|1|||
126384704|NCT00070109|454703107|FG001|Overall Study|Death|1|||
126384705|NCT00070109|454703108|FG002|Overall Study|Death|0|||
126384706|NCT00070109|454703109|FG003|Overall Study|Death|0|||
126384707|NCT00070109|454703110|FG004|Overall Study|Death|1|||
126717441|NCT00933335|455916223|FG001|Overall Study|Progressive Disease|11|||
126771185|NCT03985293|456116292|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
126384708|NCT00070109|454703106|FG000|Overall Study|Lack of Efficacy|6|||
126384709|NCT00070109|454703107|FG001|Overall Study|Lack of Efficacy|4|||
126384710|NCT00070109|454703108|FG002|Overall Study|Lack of Efficacy|5|||
126384711|NCT00070109|454703109|FG003|Overall Study|Lack of Efficacy|15|||
126384712|NCT00070109|454703110|FG004|Overall Study|Lack of Efficacy|5|||
126384713|NCT00070109|454703106|FG000|Overall Study|Physician Decision|1|||
126384714|NCT00070109|454703107|FG001|Overall Study|Physician Decision|0|||
126384715|NCT00070109|454703108|FG002|Overall Study|Physician Decision|0|||
126384716|NCT00070109|454703109|FG003|Overall Study|Physician Decision|0|||
126384717|NCT00070109|454703110|FG004|Overall Study|Physician Decision|0|||
126384718|NCT00070109|454703106|FG000|Overall Study|Withdrawal by Subject|0|||
126384719|NCT00070109|454703107|FG001|Overall Study|Withdrawal by Subject|1|||
126384720|NCT00070109|454703108|FG002|Overall Study|Withdrawal by Subject|1|||
126384721|NCT00070109|454703109|FG003|Overall Study|Withdrawal by Subject|0|||
126384722|NCT00070109|454703110|FG004|Overall Study|Withdrawal by Subject|0|||
126384723|NCT00070109|454703106|FG000|Overall Study|Adverse Event|0|||
126384724|NCT00070109|454703107|FG001|Overall Study|Adverse Event|0|||
126384725|NCT00070109|454703108|FG002|Overall Study|Adverse Event|2|||
126384726|NCT00070109|454703109|FG003|Overall Study|Adverse Event|4|||
126384727|NCT00070109|454703110|FG004|Overall Study|Adverse Event|2|||
126384728|NCT00070109|454703106|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
126384729|NCT00070109|454703107|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
126384730|NCT00070109|454703108|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
126384731|NCT00070109|454703109|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
126384732|NCT00070109|454703110|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
126384733|NCT00624468|454703116|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
126384734|NCT00624468|454703117|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
126384735|NCT00624468|454703118|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
126384736|NCT00624468|454703119|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
126384737|NCT00624468|454703116|FG000|Double-blind Period|Withdrew Prematurely|1|||
126384738|NCT00624468|454703117|FG001|Double-blind Period|Withdrew Prematurely|1|||
126384739|NCT00624468|454703118|FG002|Double-blind Period|Withdrew Prematurely|0|||
126384740|NCT00624468|454703119|FG003|Double-blind Period|Withdrew Prematurely|0|||
126384741|NCT00624468|454703116|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
126384742|NCT00624468|454703117|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
126384743|NCT00624468|454703118|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
126384744|NCT00624468|454703119|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
126384745|NCT00624468|454703116|FG000|Safety Follow-up (SFU) Period|Other|0|||
126384746|NCT00624468|454703117|FG001|Safety Follow-up (SFU) Period|Other|0|||
126384747|NCT00624468|454703118|FG002|Safety Follow-up (SFU) Period|Other|1|||
126384748|NCT00624468|454703119|FG003|Safety Follow-up (SFU) Period|Other|1|||
126384749|NCT01524224|454703122|FG000|Overall Study|Progressive Disease|1|||
126384750|NCT01524224|454703123|FG001|Overall Study|Progressive Disease|0|||
126384751|NCT01524224|454703124|FG002|Overall Study|Progressive Disease|2|||
126384752|NCT01524224|454703125|FG003|Overall Study|Progressive Disease|1|||
126384753|NCT01524224|454703126|FG004|Overall Study|Progressive Disease|2|||
126384754|NCT01524224|454703127|FG005|Overall Study|Progressive Disease|1|||
126384755|NCT01524224|454703128|FG006|Overall Study|Progressive Disease|1|||
126384756|NCT01524224|454703129|FG007|Overall Study|Progressive Disease|5|||
126717442|NCT00933335|455916222|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
126384757|NCT01524224|454703122|FG000|Overall Study|Withdrawal by Subject|2|||
126384758|NCT01524224|454703123|FG001|Overall Study|Withdrawal by Subject|0|||
126384759|NCT01524224|454703124|FG002|Overall Study|Withdrawal by Subject|0|||
126384760|NCT01524224|454703125|FG003|Overall Study|Withdrawal by Subject|0|||
126384761|NCT01524224|454703126|FG004|Overall Study|Withdrawal by Subject|0|||
126717443|NCT00933335|455916223|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
126717444|NCT00933335|455916222|FG000|Overall Study|Co-morbid Illness|1|||
126717445|NCT00933335|455916223|FG001|Overall Study|Co-morbid Illness|0|||
126717446|NCT05468086|455916228|FG000|Overall Study|Withdrawal by Subject|3|||
126384762|NCT01524224|454703127|FG005|Overall Study|Withdrawal by Subject|0|||
126384763|NCT01524224|454703128|FG006|Overall Study|Withdrawal by Subject|2|||
126384764|NCT01524224|454703129|FG007|Overall Study|Withdrawal by Subject|0|||
126717447|NCT05468086|455916228|FG000|Overall Study|Subject was found ineligible after consent|1|||
126717448|NCT00374907|455916229|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
126717449|NCT00374907|455916230|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
126384765|NCT01524224|454703122|FG000|Overall Study|Adverse Event|0|||
126384766|NCT01524224|454703123|FG001|Overall Study|Adverse Event|1|||
126384767|NCT01524224|454703124|FG002|Overall Study|Adverse Event|0|||
126384768|NCT01524224|454703125|FG003|Overall Study|Adverse Event|0|||
126384769|NCT01524224|454703126|FG004|Overall Study|Adverse Event|0|||
126384770|NCT01524224|454703127|FG005|Overall Study|Adverse Event|1|||
126384771|NCT01524224|454703128|FG006|Overall Study|Adverse Event|0|||
126384772|NCT01524224|454703129|FG007|Overall Study|Adverse Event|0|||
126717450|NCT00374907|455916229|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
126384773|NCT01524224|454703122|FG000|Overall Study|Physician Decision|0|||
126384774|NCT01524224|454703123|FG001|Overall Study|Physician Decision|0|||
126384775|NCT01524224|454703124|FG002|Overall Study|Physician Decision|0|||
126384776|NCT01524224|454703125|FG003|Overall Study|Physician Decision|1|||
126384777|NCT01524224|454703126|FG004|Overall Study|Physician Decision|1|||
126384778|NCT01524224|454703127|FG005|Overall Study|Physician Decision|0|||
126384779|NCT01524224|454703128|FG006|Overall Study|Physician Decision|0|||
126384780|NCT01524224|454703129|FG007|Overall Study|Physician Decision|1|||
126384781|NCT01524224|454703122|FG000|Overall Study|Sponsor Decision|0|||
126384782|NCT01524224|454703123|FG001|Overall Study|Sponsor Decision|0|||
126384783|NCT01524224|454703124|FG002|Overall Study|Sponsor Decision|0|||
126384784|NCT01524224|454703125|FG003|Overall Study|Sponsor Decision|0|||
126384785|NCT01524224|454703126|FG004|Overall Study|Sponsor Decision|1|||
126384786|NCT01524224|454703127|FG005|Overall Study|Sponsor Decision|0|||
126384787|NCT01524224|454703128|FG006|Overall Study|Sponsor Decision|0|||
126384788|NCT01524224|454703129|FG007|Overall Study|Sponsor Decision|0|||
126384789|NCT00803361|454703131|FG000|Overall Study|Adverse Event|13|||
126384790|NCT00803361|454703132|FG001|Overall Study|Adverse Event|3|||
126384791|NCT00803361|454703131|FG000|Overall Study|Lack of Efficacy|4|||
126717451|NCT00374907|455916230|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
126717452|NCT00374907|455916229|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
126717453|NCT00374907|455916230|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
126717454|NCT00374907|455916229|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
126717455|NCT00374907|455916230|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
126717456|NCT00374907|455916229|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
126717457|NCT00374907|455916230|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
126717458|NCT01108809|455916231|FG000|Overall Study|Adverse Event|3|||
126717459|NCT01108809|455916231|FG000|Overall Study|Lost to Follow-up|1|||
126717460|NCT00783705|455916235|FG000|Overall Study|Adverse Event|2|||
126717461|NCT00783705|455916236|FG001|Overall Study|Adverse Event|0|||
126717462|NCT00783705|455916235|FG000|Overall Study|Withdrawal by Subject|3|||
126717463|NCT00783705|455916236|FG001|Overall Study|Withdrawal by Subject|2|||
126717464|NCT00783705|455916235|FG000|Overall Study|Lost to Follow-up|1|||
126717465|NCT00783705|455916236|FG001|Overall Study|Lost to Follow-up|3|||
126717466|NCT02379923|455916238|FG000|Overall Study|Death|5|||
126717467|NCT01200511|455916239|FG000|Overall Study|Lost to Follow-up|3|||
126717468|NCT01200511|455916239|FG000|Overall Study|Withdrawal by Subject|1|||
126717469|NCT01200511|455916239|FG000|Overall Study|Adverse Event|1|||
126717470|NCT04229446|455916240|FG000|Overall Study|Death|12|||
126717471|NCT04229446|455916241|FG001|Overall Study|Death|10|||
126717472|NCT04229446|455916240|FG000|Overall Study|Lost to Follow-up|5|||
126717473|NCT04229446|455916241|FG001|Overall Study|Lost to Follow-up|8|||
126717474|NCT03596177|455916242|FG000|Single Blind Period|Withdrawal by Subject|1|||
126717475|NCT03596177|455916243|FG001|Single Blind Period|Withdrawal by Subject|1|||
126717476|NCT03596177|455916242|FG000|Single Blind Period|Other|1|||
126717477|NCT03596177|455916243|FG001|Single Blind Period|Other|0|||
126384792|NCT00803361|454703132|FG001|Overall Study|Lack of Efficacy|13|||
126384793|NCT00803361|454703131|FG000|Overall Study|Lost to Follow-up|1|||
126384794|NCT00803361|454703132|FG001|Overall Study|Lost to Follow-up|2|||
126384795|NCT00803361|454703131|FG000|Overall Study|Physician Decision|1|||
126384796|NCT00803361|454703132|FG001|Overall Study|Physician Decision|0|||
126384797|NCT00803361|454703131|FG000|Overall Study|Protocol Violation|2|||
126384798|NCT00803361|454703132|FG001|Overall Study|Protocol Violation|4|||
126384799|NCT00803361|454703131|FG000|Overall Study|Withdrawal by Subject|5|||
126384800|NCT00803361|454703132|FG001|Overall Study|Withdrawal by Subject|6|||
126384801|NCT02858440|454703133|FG000|Overall Study|Lost to Follow-up|3|||
126717478|NCT03596177|455916242|FG000|Double Blind Period|Withdrawal by Subject|0|||
126771186|NCT03985293|456116287|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
126771187|NCT03985293|456116288|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
126384802|NCT02858440|454703133|FG000|Overall Study|Protocol Violation|2|||
126384803|NCT02858440|454703133|FG000|Overall Study|Consent withdrawal|3|||
126384804|NCT02858440|454703133|FG000|Overall Study|Migrated/moved from study area|4|||
126384805|NCT01670279|454703134|FG000|Overall Study|Adverse Event|0|||
126384806|NCT01670279|454703135|FG001|Overall Study|Adverse Event|1|||
126384807|NCT01670279|454703136|FG002|Overall Study|Adverse Event|0|||
126384808|NCT01670279|454703137|FG003|Overall Study|Adverse Event|0|||
126384809|NCT01670279|454703134|FG000|Overall Study|Physician Decision|0|||
126384810|NCT01670279|454703135|FG001|Overall Study|Physician Decision|1|||
126717479|NCT03596177|455916243|FG001|Double Blind Period|Withdrawal by Subject|1|||
126717480|NCT03596177|455916242|FG000|Double Blind Period|Other|0|||
126717481|NCT03596177|455916243|FG001|Double Blind Period|Other|4|||
126384811|NCT01670279|454703136|FG002|Overall Study|Physician Decision|0|||
126384812|NCT01670279|454703137|FG003|Overall Study|Physician Decision|0|||
126384813|NCT01670279|454703134|FG000|Overall Study|Participant met withdrawal criteria|0|||
126384814|NCT01670279|454703135|FG001|Overall Study|Participant met withdrawal criteria|0|||
126717482|NCT03596177|455916242|FG000|Double Blind Period|Death during safety follow-up|0|||
126717483|NCT03596177|455916243|FG001|Double Blind Period|Death during safety follow-up|1|||
126717484|NCT00968253|455916244|FG000|Overall Study|Death|0|||
126384815|NCT01670279|454703136|FG002|Overall Study|Participant met withdrawal criteria|0|||
126384816|NCT01670279|454703137|FG003|Overall Study|Participant met withdrawal criteria|1|||
126384817|NCT01901614|454703138|FG000|Overall Study|Adverse Event|0|||
126384818|NCT01901614|454703139|FG001|Overall Study|Adverse Event|1|||
126384819|NCT01901614|454703138|FG000|Overall Study|Lost to Follow-up|1|||
126384820|NCT01901614|454703139|FG001|Overall Study|Lost to Follow-up|0|||
126384821|NCT01901614|454703138|FG000|Overall Study|Screen Fail|1|||
126384822|NCT01901614|454703139|FG001|Overall Study|Screen Fail|0|||
126384823|NCT01823198|454703140|FG000|Overall Study|Physician Decision|0|||
126384824|NCT01823198|454703141|FG001|Overall Study|Physician Decision|1|||
126384825|NCT01823198|454703142|FG002|Overall Study|Physician Decision|0|||
126384826|NCT01823198|454703143|FG003|Overall Study|Physician Decision|0|||
126384827|NCT01823198|454703144|FG004|Overall Study|Physician Decision|0|||
126384828|NCT01823198|454703145|FG005|Overall Study|Physician Decision|3|||
126384829|NCT01823198|454703146|FG006|Overall Study|Physician Decision|3|||
126384830|NCT02674464|454703147|FG000|Overall Study|Death|10|||
126384831|NCT02674464|454703148|FG001|Overall Study|Death|21|||
126384832|NCT02674464|454703147|FG000|Overall Study|Withdrawal by Subject|24|||
126384833|NCT02674464|454703148|FG001|Overall Study|Withdrawal by Subject|44|||
126384834|NCT02674464|454703147|FG000|Overall Study|Lost to Follow-up|97|||
126384835|NCT02674464|454703148|FG001|Overall Study|Lost to Follow-up|92|||
126384836|NCT02674464|454703147|FG000|Overall Study|Outside survey window|6|||
126384837|NCT02674464|454703148|FG001|Overall Study|Outside survey window|3|||
126384838|NCT00783835|454703149|FG000|Overall Study|Adverse Event|3|||
126384839|NCT00783835|454703149|FG000|Overall Study|Medical Criteria|1|||
126384840|NCT00783835|454703149|FG000|Overall Study|Withdrawal by Subject|2|||
126384841|NCT00783835|454703149|FG000|Overall Study|Lost to Follow-up|1|||
126384842|NCT00783835|454703149|FG000|Overall Study|Participant not Adherent|3|||
126384843|NCT01262638|454703150|FG000|Overall Study|Adverse Event|3|||
126384844|NCT01262638|454703151|FG001|Overall Study|Adverse Event|4|||
126384845|NCT01262638|454703152|FG002|Overall Study|Adverse Event|3|||
126384846|NCT01262638|454703153|FG003|Overall Study|Adverse Event|4|||
126384847|NCT01262638|454703150|FG000|Overall Study|Protocol Violation|1|||
126384848|NCT01262638|454703151|FG001|Overall Study|Protocol Violation|0|||
126384849|NCT01262638|454703152|FG002|Overall Study|Protocol Violation|0|||
126384850|NCT01262638|454703153|FG003|Overall Study|Protocol Violation|1|||
126384851|NCT01262638|454703150|FG000|Overall Study|Withdrawal by Subject|2|||
126384852|NCT01262638|454703151|FG001|Overall Study|Withdrawal by Subject|1|||
126384853|NCT01262638|454703152|FG002|Overall Study|Withdrawal by Subject|0|||
126384854|NCT01262638|454703153|FG003|Overall Study|Withdrawal by Subject|1|||
126384855|NCT01262638|454703150|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
126384856|NCT01262638|454703151|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
126384857|NCT01262638|454703152|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
126384858|NCT01262638|454703153|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
126384859|NCT01262638|454703150|FG000|Overall Study|Lost to Follow-up|1|||
126384860|NCT01262638|454703151|FG001|Overall Study|Lost to Follow-up|1|||
126384861|NCT01262638|454703152|FG002|Overall Study|Lost to Follow-up|1|||
126384862|NCT01262638|454703153|FG003|Overall Study|Lost to Follow-up|1|||
126384863|NCT01262638|454703150|FG000|Overall Study|Participant Went Out of Town|0|||
126384864|NCT01262638|454703151|FG001|Overall Study|Participant Went Out of Town|0|||
126384865|NCT01262638|454703152|FG002|Overall Study|Participant Went Out of Town|1|||
126384866|NCT01262638|454703153|FG003|Overall Study|Participant Went Out of Town|0|||
126384867|NCT02243371|454703158|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
126384868|NCT02243371|454703159|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
126384869|NCT02243371|454703158|FG000|Overall Study|Death (unrelated)|2|||
126384870|NCT02243371|454703159|FG001|Overall Study|Death (unrelated)|4|||
126384871|NCT02243371|454703158|FG000|Overall Study|Adverse Event (unrelated)|0|||
126384872|NCT02243371|454703159|FG001|Overall Study|Adverse Event (unrelated)|1|||
126384873|NCT02243371|454703158|FG000|Overall Study|Lack of Clinical Benefit|0|||
126384874|NCT02243371|454703159|FG001|Overall Study|Lack of Clinical Benefit|1|||
126384875|NCT02243371|454703158|FG000|Overall Study|Withdrawal by Subject|0|||
126384876|NCT02243371|454703159|FG001|Overall Study|Withdrawal by Subject|2|||
126384877|NCT01369199|454703160|FG000|Overall Study|Withdrawal by Subject|1|||
126384878|NCT01369199|454703160|FG000|Overall Study|Lost to Follow-up|2|||
126384879|NCT01066104|454703161|FG000|Overall Study|Adverse Event|1|||
126384880|NCT01066104|454703162|FG001|Overall Study|Adverse Event|1|||
126384881|NCT01066104|454703161|FG000|Overall Study|Protocol Violation|1|||
126384882|NCT01066104|454703162|FG001|Overall Study|Protocol Violation|0|||
126384883|NCT02091362|454703170|FG000|Period 1|Protocol Violation|1|||
126384884|NCT02091362|454703171|FG001|Period 1|Protocol Violation|0|||
126384885|NCT02091362|454703170|FG000|Period 1|Withdrawal by Subject|2|||
126384886|NCT02091362|454703171|FG001|Period 1|Withdrawal by Subject|3|||
126384887|NCT02091362|454703170|FG000|Period 1|Lost to Follow-up|0|||
126384888|NCT02091362|454703171|FG001|Period 1|Lost to Follow-up|1|||
126384889|NCT02091362|454703170|FG000|Period 1|Adverse Event|2|||
126384890|NCT02091362|454703171|FG001|Period 1|Adverse Event|0|||
126384891|NCT02091362|454703170|FG000|Wash-out|Lost to Follow-up|1|||
126384892|NCT02091362|454703171|FG001|Wash-out|Lost to Follow-up|1|||
126384893|NCT02091362|454703170|FG000|Wash-out|Withdrawal by Subject|0|||
126384894|NCT02091362|454703171|FG001|Wash-out|Withdrawal by Subject|2|||
126384895|NCT02091362|454703170|FG000|Period 2|Adverse Event|1|||
126384896|NCT02091362|454703171|FG001|Period 2|Adverse Event|0|||
126384897|NCT02091362|454703170|FG000|Period 2|Lost to Follow-up|0|||
126384898|NCT02091362|454703171|FG001|Period 2|Lost to Follow-up|1|||
126384899|NCT02091362|454703170|FG000|Period 2|Withdrawal by Subject|1|||
126384900|NCT02091362|454703171|FG001|Period 2|Withdrawal by Subject|1|||
126384901|NCT00470262|454703172|FG000|Overall Study|Withdrawal by Subject|2|||
126384902|NCT00470262|454703173|FG001|Overall Study|Withdrawal by Subject|0|||
126384903|NCT03900728|454703174|FG000|Overall Study|No text responses|0|||
126384904|NCT03900728|454703175|FG001|Overall Study|No text responses|0|||
126384905|NCT03900728|454703176|FG002|Overall Study|No text responses|4|||
126384906|NCT03248167|454703185|FG000|Overall Study|Withdrawal by Subject|2|||
126384907|NCT03248167|454703186|FG001|Overall Study|Withdrawal by Subject|2|||
126384908|NCT03248167|454703185|FG000|Overall Study|Physician Decision|0|||
126384909|NCT03248167|454703186|FG001|Overall Study|Physician Decision|1|||
126384910|NCT03248167|454703185|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
126384911|NCT03248167|454703186|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
126384912|NCT03248167|454703185|FG000|Overall Study|Lost to Follow-up|1|||
126384913|NCT03248167|454703186|FG001|Overall Study|Lost to Follow-up|0|||
126384914|NCT02122146|454703187|FG000|Part 1: Dose Escalation|Death|0|||
126384915|NCT02122146|454703188|FG001|Part 1: Dose Escalation|Death|1|||
126384916|NCT02122146|454703189|FG002|Part 1: Dose Escalation|Death|1|||
126384917|NCT02122146|454703190|FG003|Part 1: Dose Escalation|Death|0|||
126384918|NCT02122146|454703191|FG004|Part 1: Dose Escalation|Death|0|||
126384919|NCT02122146|454703192|FG005|Part 1: Dose Escalation|Death|0|||
126553374|NCT01556763|455320590|FG001|Overall Study|Withdrawal by Subject|1|||
126553375|NCT01556763|455320591|FG002|Overall Study|Withdrawal by Subject|0|||
126553376|NCT02258464|455320592|FG000|Overall Study|Progressive disease (PD)|9|||
126553377|NCT02258464|455320593|FG001|Overall Study|Progressive disease (PD)|17|||
126553378|NCT02258464|455320592|FG000|Overall Study|Study drug never administered|1|||
126553379|NCT02258464|455320593|FG001|Overall Study|Study drug never administered|1|||
126553380|NCT02258464|455320592|FG000|Overall Study|AE not related to clinical PD|1|||
126553381|NCT02258464|455320593|FG001|Overall Study|AE not related to clinical PD|3|||
126384920|NCT02122146|454703193|FG006|Part 1: Dose Escalation|Death|0|||
126384921|NCT02122146|454703194|FG007|Part 1: Dose Escalation|Death|0|||
126384922|NCT02122146|454703187|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
126384923|NCT02122146|454703188|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
126384924|NCT02122146|454703189|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
126384925|NCT02122146|454703190|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
126384926|NCT02122146|454703191|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
126384927|NCT02122146|454703192|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
126384928|NCT02122146|454703193|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
126384929|NCT02122146|454703194|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
126384930|NCT02122146|454703187|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384931|NCT02122146|454703188|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384932|NCT02122146|454703189|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384933|NCT02122146|454703190|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
126384934|NCT02122146|454703191|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384935|NCT02122146|454703192|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384936|NCT02122146|454703193|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384937|NCT02122146|454703194|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126384938|NCT02122146|454703187|FG000|Part 1: Dose Escalation|Other|1|||
126384939|NCT02122146|454703188|FG001|Part 1: Dose Escalation|Other|0|||
126384940|NCT02122146|454703189|FG002|Part 1: Dose Escalation|Other|0|||
126384941|NCT02122146|454703190|FG003|Part 1: Dose Escalation|Other|0|||
126384942|NCT02122146|454703191|FG004|Part 1: Dose Escalation|Other|0|||
126384943|NCT02122146|454703192|FG005|Part 1: Dose Escalation|Other|1|||
126384944|NCT02122146|454703193|FG006|Part 1: Dose Escalation|Other|1|||
126384945|NCT02122146|454703194|FG007|Part 1: Dose Escalation|Other|2|||
126384946|NCT03835481|454703195|FG000|Double-blind Period|Other not stated below|0|||
126384947|NCT03835481|454703196|FG001|Double-blind Period|Other not stated below|0|||
126384948|NCT03835481|454703197|FG002|Double-blind Period|Other not stated below|0|||
126384949|NCT03835481|454703198|FG003|Double-blind Period|Other not stated below|1|||
126384950|NCT03835481|454703199|FG004|Double-blind Period|Other not stated below|1|||
126384951|NCT03835481|454703195|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
126384952|NCT03835481|454703196|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
126384953|NCT03835481|454703197|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
126771188|NCT03985293|456116289|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
126384954|NCT03835481|454703198|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
126384955|NCT03835481|454703199|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
126384956|NCT03835481|454703195|FG000|Double-blind Period|Withdrawal by Subject|0|||
126553382|NCT02258464|455320592|FG000|Overall Study|Withdrawal by Subject|5|||
126553383|NCT02258464|455320593|FG001|Overall Study|Withdrawal by Subject|4|||
126384957|NCT03835481|454703196|FG001|Double-blind Period|Withdrawal by Subject|0|||
126384958|NCT03835481|454703197|FG002|Double-blind Period|Withdrawal by Subject|1|||
126384959|NCT03835481|454703198|FG003|Double-blind Period|Withdrawal by Subject|0|||
126384960|NCT03835481|454703199|FG004|Double-blind Period|Withdrawal by Subject|5|||
126384961|NCT03835481|454703195|FG000|Double-blind Period|Lost to Follow-up|0|||
126384962|NCT03835481|454703196|FG001|Double-blind Period|Lost to Follow-up|0|||
126384963|NCT03835481|454703197|FG002|Double-blind Period|Lost to Follow-up|0|||
126384964|NCT03835481|454703198|FG003|Double-blind Period|Lost to Follow-up|1|||
126384965|NCT03835481|454703199|FG004|Double-blind Period|Lost to Follow-up|0|||
126384966|NCT03835481|454703195|FG000|Double-blind Period|Protocol Violation|0|||
126384967|NCT03835481|454703196|FG001|Double-blind Period|Protocol Violation|2|||
126384968|NCT03835481|454703197|FG002|Double-blind Period|Protocol Violation|0|||
126384969|NCT03835481|454703198|FG003|Double-blind Period|Protocol Violation|1|||
126384970|NCT03835481|454703199|FG004|Double-blind Period|Protocol Violation|0|||
126384971|NCT03835481|454703195|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
126384972|NCT03835481|454703196|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
126384973|NCT03835481|454703197|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
126384974|NCT03835481|454703198|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
126384975|NCT03835481|454703199|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
126384976|NCT03835481|454703195|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
126384977|NCT03835481|454703196|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
126384978|NCT03835481|454703197|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
126384979|NCT03835481|454703198|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
126384980|NCT03835481|454703199|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
126384981|NCT03835481|454703195|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
126384982|NCT03835481|454703196|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
126384983|NCT03835481|454703197|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
126384984|NCT03835481|454703198|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
126384985|NCT03835481|454703199|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
126384986|NCT03835481|454703195|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
126384987|NCT03835481|454703196|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
126384988|NCT03835481|454703197|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
126384989|NCT03835481|454703198|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
126384990|NCT03835481|454703199|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
126384991|NCT03835481|454703195|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
126384992|NCT03835481|454703196|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
126384993|NCT03835481|454703197|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
126384994|NCT03835481|454703198|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
126384995|NCT03835481|454703199|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
126384996|NCT03835481|454703195|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
126384997|NCT03835481|454703196|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
126384998|NCT03835481|454703197|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
126384999|NCT03835481|454703198|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
126385000|NCT03835481|454703199|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
126385001|NCT00191945|454703201|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
126385002|NCT00191945|454703202|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
126385003|NCT00191945|454703201|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
126385004|NCT00191945|454703202|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
126385005|NCT00191945|454703201|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
126385006|NCT00191945|454703202|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
126385007|NCT00191945|454703201|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
126385008|NCT00191945|454703202|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
126385009|NCT02725476|454703203|FG000|Overall Study|Physician Decision|2|||
126385010|NCT02725476|454703204|FG001|Overall Study|Physician Decision|0|||
126385011|NCT02725476|454703203|FG000|Overall Study|Adverse Event|1|||
126385012|NCT02725476|454703204|FG001|Overall Study|Adverse Event|1|||
126385013|NCT04188834|454703215|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
126385014|NCT01030952|454703216|FG000|Overall Study|Protocol Violation|0|||
126385015|NCT01030952|454703217|FG001|Overall Study|Protocol Violation|1|||
126385016|NCT01030952|454703216|FG000|Overall Study|Informed consent withdrawal|1|||
126385017|NCT01030952|454703217|FG001|Overall Study|Informed consent withdrawal|0|||
126385018|NCT01030952|454703216|FG000|Overall Study|Lost to Follow-up|0|||
126385019|NCT01030952|454703217|FG001|Overall Study|Lost to Follow-up|1|||
126385020|NCT01030952|454703216|FG000|Overall Study|Unexplained|1|||
126385021|NCT01030952|454703217|FG001|Overall Study|Unexplained|1|||
126385022|NCT00391430|454703218|FG000|Overall Study|Withdrawal by Subject|3|||
126385023|NCT00391430|454703219|FG001|Overall Study|Withdrawal by Subject|0|||
126385024|NCT00391430|454703220|FG002|Overall Study|Withdrawal by Subject|12|||
126385025|NCT00958347|454703224|FG000|Overall Study|Death|43|||
126385026|NCT00958347|454703224|FG000|Overall Study|Withdrawal by Subject|23|||
126771189|NCT03985293|456116290|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
126771190|NCT03985293|456116291|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
126771191|NCT03985293|456116292|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
126771192|NCT03985293|456116287|FG000|FOLLOW-UP|Lost to Follow-up|0|||
126771193|NCT03985293|456116288|FG001|FOLLOW-UP|Lost to Follow-up|0|||
126385027|NCT00958347|454703224|FG000|Overall Study|Lost to Follow-up|15|||
126385028|NCT00958347|454703224|FG000|Overall Study|revision/removal|10|||
126385029|NCT00958347|454703224|FG000|Overall Study|study termination|135|||
126385030|NCT02470585|454703232|FG000|Overall Study|Death|224|||
126385031|NCT02470585|454703233|FG001|Overall Study|Death|227|||
126385032|NCT02470585|454703234|FG002|Overall Study|Death|199|||
126385033|NCT02470585|454703232|FG000|Overall Study|Withdrew consent|21|||
126385034|NCT02470585|454703233|FG001|Overall Study|Withdrew consent|22|||
126385035|NCT02470585|454703234|FG002|Overall Study|Withdrew consent|31|||
126385036|NCT02470585|454703232|FG000|Overall Study|Lost to Follow-up|8|||
126385037|NCT02470585|454703233|FG001|Overall Study|Lost to Follow-up|15|||
126385038|NCT02470585|454703234|FG002|Overall Study|Lost to Follow-up|13|||
126385039|NCT02470585|454703232|FG000|Overall Study|Sponsor discontinued study|117|||
126385040|NCT02470585|454703233|FG001|Overall Study|Sponsor discontinued study|110|||
126385041|NCT02470585|454703234|FG002|Overall Study|Sponsor discontinued study|122|||
126385042|NCT02470585|454703232|FG000|Overall Study|Other, not specified|5|||
126385043|NCT02470585|454703233|FG001|Overall Study|Other, not specified|7|||
126385044|NCT02470585|454703234|FG002|Overall Study|Other, not specified|14|||
126385045|NCT02470585|454703232|FG000|Overall Study|Missing due to site non-compliance|0|||
126385046|NCT02470585|454703233|FG001|Overall Study|Missing due to site non-compliance|2|||
126385047|NCT02470585|454703234|FG002|Overall Study|Missing due to site non-compliance|3|||
126385048|NCT03497039|454703235|FG000|Overall Study|Withdrawal by Subject|1|||
126385049|NCT03497039|454703236|FG001|Overall Study|Withdrawal by Subject|0|||
126385050|NCT03497039|454703235|FG000|Overall Study|Protocol Violation|0|||
126385051|NCT03497039|454703236|FG001|Overall Study|Protocol Violation|1|||
126385052|NCT00465972|454703239|FG000|Overall Study|Withdrawal by Subject|2|||
126385053|NCT00465972|454703240|FG001|Overall Study|Withdrawal by Subject|1|||
126385054|NCT03292640|454703242|FG000|Overall Study|Withdrawal by Subject|17|||
126385055|NCT03292640|454703243|FG001|Overall Study|Withdrawal by Subject|16|||
126385056|NCT03292640|454703242|FG000|Overall Study|Adverse Event|20|||
126385057|NCT03292640|454703243|FG001|Overall Study|Adverse Event|2|||
126385058|NCT03292640|454703242|FG000|Overall Study|Lost to Follow-up|24|||
126385059|NCT03292640|454703243|FG001|Overall Study|Lost to Follow-up|24|||
126385060|NCT02218697|454703244|FG000|Overall Study|Adverse Event|0|||
126385061|NCT02218697|454703245|FG001|Overall Study|Adverse Event|2|||
126385062|NCT02218697|454703244|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
126385063|NCT02218697|454703245|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
126385064|NCT02218697|454703244|FG000|Overall Study|Withdrawal by Subject|2|||
126385065|NCT02218697|454703245|FG001|Overall Study|Withdrawal by Subject|3|||
126385066|NCT03306433|454703248|FG000|Overall Study|Lost to Follow-up|3|||
126385067|NCT03306433|454703248|FG000|Overall Study|Patient did not have teeth extracted|1|||
126385068|NCT03306433|454703248|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
126385069|NCT00294671|454704857|FG000|Overall Study|Lack of Efficacy|11|||
126385070|NCT00294671|454704858|FG001|Overall Study|Lack of Efficacy|23|||
126385071|NCT00294671|454704857|FG000|Overall Study|Liver transplant|7|||
126385072|NCT00294671|454704858|FG001|Overall Study|Liver transplant|9|||
126385073|NCT00294671|454704857|FG000|Overall Study|Drug related adverse event (AE)|4|||
126385074|NCT00294671|454704858|FG001|Overall Study|Drug related adverse event (AE)|2|||
126385075|NCT00294671|454704857|FG000|Overall Study|Non-drug related AE|3|||
126385076|NCT00294671|454704858|FG001|Overall Study|Non-drug related AE|2|||
126385077|NCT00294671|454704857|FG000|Overall Study|Lost to Follow-up|1|||
126385078|NCT00294671|454704858|FG001|Overall Study|Lost to Follow-up|3|||
126385079|NCT00294671|454704857|FG000|Overall Study|Non-compliance|1|||
126385080|NCT00294671|454704858|FG001|Overall Study|Non-compliance|0|||
126385081|NCT00294671|454704857|FG000|Overall Study|Death|0|||
126385082|NCT00294671|454704858|FG001|Overall Study|Death|1|||
126385083|NCT01893411|454704862|FG000|Overall Study|Protocol Violation|1|||
126385084|NCT01893411|454704863|FG001|Overall Study|Protocol Violation|0|||
126385085|NCT01893411|454704864|FG002|Overall Study|Protocol Violation|0|||
126385086|NCT01893411|454704862|FG000|Overall Study|Physician Decision|1|||
126468382|NCT01439568|455017593|FG000|Overall Study|Withdrawal by Subject|2|||
126468383|NCT01439568|455017594|FG001|Overall Study|Withdrawal by Subject|2|||
126468384|NCT03198078|455017597|FG000|Overall Study|Adverse Event|0|||
126468385|NCT03198078|455017598|FG001|Overall Study|Adverse Event|1|||
126468386|NCT03198078|455017599|FG002|Overall Study|Adverse Event|2|||
126385087|NCT01893411|454704863|FG001|Overall Study|Physician Decision|1|||
126385088|NCT01893411|454704864|FG002|Overall Study|Physician Decision|2|||
126385089|NCT01893411|454704862|FG000|Overall Study|Lack of Efficacy|2|||
126385090|NCT01893411|454704863|FG001|Overall Study|Lack of Efficacy|1|||
126468387|NCT03198078|455017597|FG000|Overall Study|Lack of Efficacy|0|||
126468388|NCT03198078|455017598|FG001|Overall Study|Lack of Efficacy|0|||
126771194|NCT03985293|456116289|FG002|FOLLOW-UP|Lost to Follow-up|1|||
126385091|NCT01893411|454704864|FG002|Overall Study|Lack of Efficacy|0|||
126385092|NCT01893411|454704862|FG000|Overall Study|Other|3|||
126385093|NCT01893411|454704863|FG001|Overall Study|Other|1|||
126385094|NCT01893411|454704864|FG002|Overall Study|Other|3|||
126385095|NCT01893411|454704862|FG000|Overall Study|Adverse Event|1|||
126385096|NCT01893411|454704863|FG001|Overall Study|Adverse Event|0|||
126385097|NCT01893411|454704864|FG002|Overall Study|Adverse Event|0|||
126385098|NCT01893411|454704862|FG000|Overall Study|Withdrawal by Subject|7|||
126385099|NCT01893411|454704863|FG001|Overall Study|Withdrawal by Subject|4|||
126385100|NCT01893411|454704864|FG002|Overall Study|Withdrawal by Subject|3|||
126385101|NCT01893411|454704862|FG000|Overall Study|Lost to Follow-up|2|||
126385102|NCT01893411|454704863|FG001|Overall Study|Lost to Follow-up|0|||
126385103|NCT01893411|454704864|FG002|Overall Study|Lost to Follow-up|1|||
126385104|NCT02403817|454704867|FG000|Overall Study|Withdrawal by Subject|5|||
126385105|NCT02403817|454704868|FG001|Overall Study|Withdrawal by Subject|0|||
126385106|NCT03053440|454704869|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
126385107|NCT03053440|454704870|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
126385108|NCT03053440|454704869|FG000|Overall Study|Death|18|||
126385109|NCT03053440|454704870|FG001|Overall Study|Death|14|||
126385110|NCT03053440|454704869|FG000|Overall Study|Withdrawal by Subject|9|||
126385111|NCT03053440|454704870|FG001|Overall Study|Withdrawal by Subject|8|||
126385112|NCT03053440|454704869|FG000|Overall Study|Lost to Follow-up|1|||
126385113|NCT03053440|454704870|FG001|Overall Study|Lost to Follow-up|0|||
126385114|NCT03053440|454704869|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
126385115|NCT03053440|454704870|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
126385116|NCT03053440|454704869|FG000|Overall Study|Physician Decision|2|||
126385117|NCT03053440|454704870|FG001|Overall Study|Physician Decision|1|||
126385118|NCT03053440|454704869|FG000|Overall Study|Participant Randomized but died before dosing|1|||
126385119|NCT03053440|454704870|FG001|Overall Study|Participant Randomized but died before dosing|0|||
126385120|NCT00430989|454704871|FG000|Overall Study|Lost to Follow-up|2|||
126385121|NCT00430989|454704872|FG001|Overall Study|Lost to Follow-up|3|||
126385122|NCT00430989|454704871|FG000|Overall Study|Withdrawal by Subject|15|||
126385123|NCT00430989|454704872|FG001|Overall Study|Withdrawal by Subject|14|||
126385124|NCT00430989|454704871|FG000|Overall Study|Protocol Violation|30|||
126385125|NCT00430989|454704872|FG001|Overall Study|Protocol Violation|37|||
126385126|NCT00430989|454704871|FG000|Overall Study|Not eligible|13|||
126385127|NCT00430989|454704872|FG001|Overall Study|Not eligible|6|||
126385128|NCT01701362|454704873|FG000|Overall Study|Adverse events not related to study drug|1|||
126385129|NCT01701362|454704874|FG001|Overall Study|Adverse events not related to study drug|6|||
126385130|NCT01701362|454704873|FG000|Overall Study|Adverse events related to study drug|12|||
126385131|NCT01701362|454704874|FG001|Overall Study|Adverse events related to study drug|10|||
126385132|NCT01701362|454704873|FG000|Overall Study|Protocol Violation|5|||
126385133|NCT01701362|454704874|FG001|Overall Study|Protocol Violation|3|||
126385134|NCT01701362|454704873|FG000|Overall Study|No longer willing to participate|8|||
126385135|NCT01701362|454704874|FG001|Overall Study|No longer willing to participate|14|||
126385136|NCT01701362|454704873|FG000|Overall Study|Lost to Follow-up|6|||
126385137|NCT01701362|454704874|FG001|Overall Study|Lost to Follow-up|9|||
126385138|NCT01701362|454704873|FG000|Overall Study|Insufficient clinical response|6|||
126385139|NCT01701362|454704874|FG001|Overall Study|Insufficient clinical response|6|||
126385140|NCT01701362|454704873|FG000|Overall Study|Death|0|||
126385141|NCT01701362|454704874|FG001|Overall Study|Death|1|||
126385142|NCT01701362|454704873|FG000|Overall Study|Randomized but not treated|1|||
126385143|NCT01701362|454704874|FG001|Overall Study|Randomized but not treated|2|||
126385144|NCT01701362|454704873|FG000|Overall Study|Reasons other than those mentioned above|3|||
126385145|NCT01701362|454704874|FG001|Overall Study|Reasons other than those mentioned above|5|||
126385146|NCT00570778|454704875|FG000|Overall Study|Protocol deviation|2|||
126385147|NCT00570778|454704876|FG001|Overall Study|Protocol deviation|1|||
126385148|NCT00570778|454704877|FG002|Overall Study|Protocol deviation|2|||
126385149|NCT00570778|454704878|FG003|Overall Study|Protocol deviation|2|||
126385150|NCT00570778|454704875|FG000|Overall Study|Adverse Event|0|||
126385151|NCT00570778|454704876|FG001|Overall Study|Adverse Event|1|||
126385152|NCT00570778|454704877|FG002|Overall Study|Adverse Event|4|||
126385153|NCT00570778|454704878|FG003|Overall Study|Adverse Event|1|||
126385154|NCT00570778|454704875|FG000|Overall Study|Subject withdrew consent|0|||
126385155|NCT00570778|454704876|FG001|Overall Study|Subject withdrew consent|1|||
126385156|NCT00570778|454704877|FG002|Overall Study|Subject withdrew consent|0|||
126385157|NCT00570778|454704878|FG003|Overall Study|Subject withdrew consent|1|||
126385158|NCT00570778|454704875|FG000|Overall Study|Abnormal test procedure|1|||
126385159|NCT00570778|454704876|FG001|Overall Study|Abnormal test procedure|0|||
126385160|NCT00570778|454704877|FG002|Overall Study|Abnormal test procedure|0|||
126385161|NCT00570778|454704878|FG003|Overall Study|Abnormal test procedure|0|||
126385162|NCT00570778|454704875|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126385163|NCT00570778|454704876|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126385164|NCT00570778|454704877|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126385165|NCT00570778|454704878|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
126385166|NCT00570778|454704875|FG000|Overall Study|Lost to Follow-up|0|||
126385167|NCT00570778|454704876|FG001|Overall Study|Lost to Follow-up|0|||
126385168|NCT00570778|454704877|FG002|Overall Study|Lost to Follow-up|1|||
126385169|NCT00570778|454704878|FG003|Overall Study|Lost to Follow-up|0|||
126385170|NCT00570778|454704875|FG000|Overall Study|Subject no longer requires study drug|0|||
126385171|NCT00570778|454704876|FG001|Overall Study|Subject no longer requires study drug|1|||
126385172|NCT00570778|454704877|FG002|Overall Study|Subject no longer requires study drug|0|||
126385173|NCT00570778|454704878|FG003|Overall Study|Subject no longer requires study drug|0|||
126385174|NCT02120781|454704883|FG000|Overall Study|Physician Decision|2|||
126385175|NCT02120781|454704884|FG001|Overall Study|Physician Decision|0|||
126385176|NCT02120781|454704883|FG000|Overall Study|Completion not documented|2|||
126385177|NCT02120781|454704884|FG001|Overall Study|Completion not documented|1|||
126385178|NCT00984165|454704885|FG000|Overall Study|Death on study|2|||
126385179|NCT00984165|454704886|FG001|Overall Study|Death on study|0|||
126385180|NCT00984165|454704887|FG002|Overall Study|Death on study|0|||
126385181|NCT00984165|454704888|FG003|Overall Study|Death on study|0|||
126385182|NCT00984165|454704885|FG000|Overall Study|Disease progression on study|5|||
126385183|NCT00984165|454704886|FG001|Overall Study|Disease progression on study|1|||
126385184|NCT00984165|454704887|FG002|Overall Study|Disease progression on study|0|||
126385185|NCT00984165|454704888|FG003|Overall Study|Disease progression on study|0|||
126385186|NCT00984165|454704885|FG000|Overall Study|Death of recipient|0|||
126385187|NCT00984165|454704886|FG001|Overall Study|Death of recipient|0|||
126385188|NCT00984165|454704887|FG002|Overall Study|Death of recipient|0|||
126385189|NCT00984165|454704888|FG003|Overall Study|Death of recipient|1|||
126385190|NCT00984165|454704885|FG000|Overall Study|New protocol|0|||
126385191|NCT00984165|454704886|FG001|Overall Study|New protocol|0|||
126385192|NCT00984165|454704887|FG002|Overall Study|New protocol|0|||
126385193|NCT00984165|454704888|FG003|Overall Study|New protocol|1|||
126717485|NCT00968253|455916245|FG001|Overall Study|Death|0|||
126385194|NCT00984165|454704885|FG000|Overall Study|P+/donor pair removed from protocol|0|||
126385195|NCT00984165|454704886|FG001|Overall Study|P+/donor pair removed from protocol|0|||
126717486|NCT00968253|455916246|FG002|Overall Study|Death|2|||
126717487|NCT00968253|455916244|FG000|Overall Study|Withdrawal by Subject|0|||
126385196|NCT00984165|454704887|FG002|Overall Study|P+/donor pair removed from protocol|0|||
126385197|NCT00984165|454704888|FG003|Overall Study|P+/donor pair removed from protocol|1|||
126385198|NCT00984165|454704885|FG000|Overall Study|removed with a pair recipient|0|||
126385199|NCT00984165|454704886|FG001|Overall Study|removed with a pair recipient|0|||
126385200|NCT00984165|454704887|FG002|Overall Study|removed with a pair recipient|0|||
126385201|NCT00984165|454704888|FG003|Overall Study|removed with a pair recipient|1|||
126385202|NCT00466947|454704889|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
126385203|NCT00466947|454704890|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
126385204|NCT00466947|454704889|FG000|Study End Analysis Period|Adverse Event|35|||
126385205|NCT00466947|454704890|FG001|Study End Analysis Period|Adverse Event|43|||
126385206|NCT00466947|454704889|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
126385207|NCT00466947|454704890|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
126385208|NCT00466947|454704889|FG000|Study End Analysis Period|Physician Decision|29|||
126385209|NCT00466947|454704890|FG001|Study End Analysis Period|Physician Decision|29|||
126385210|NCT00466947|454704889|FG000|Study End Analysis Period|Protocol Violation|9|||
126385211|NCT00466947|454704890|FG001|Study End Analysis Period|Protocol Violation|17|||
126385212|NCT00466947|454704889|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
126385213|NCT00466947|454704890|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
126385214|NCT00466947|454704889|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
126385215|NCT00466947|454704890|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
126385216|NCT00466947|454704889|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
126385217|NCT00466947|454704890|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
126385218|NCT00466947|454704889|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
126385219|NCT00466947|454704890|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
126385220|NCT03850093|454704891|FG000|Overall Study|Withdrawal by Subject|1|||
126385221|NCT03850093|454704892|FG001|Overall Study|Withdrawal by Subject|0|||
126385222|NCT03850093|454704893|FG002|Overall Study|Withdrawal by Subject|2|||
126385223|NCT03226249|454704894|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
126385224|NCT03226249|454704894|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
126385225|NCT03226249|454704894|FG000|Survival Follow-up|Patients still in follow-up.|30|||
126385226|NCT02096952|454704895|FG000|Overall Study|Adverse Event|1|||
126468389|NCT03198078|455017599|FG002|Overall Study|Lack of Efficacy|3|||
126468390|NCT03198078|455017597|FG000|Overall Study|Lost to Follow-up|1|||
126385227|NCT00066222|454704896|FG000|Overall Study|No protocol treatment received|1|||
126385228|NCT02684617|454704897|FG000|Overall Study|Adverse Event|1|||
126385229|NCT02684617|454704898|FG001|Overall Study|Adverse Event|0|||
126385230|NCT02684617|454704899|FG002|Overall Study|Adverse Event|1|||
126385231|NCT02684617|454704897|FG000|Overall Study|Death|8|||
126385232|NCT02684617|454704898|FG001|Overall Study|Death|16|||
126468391|NCT03198078|455017598|FG001|Overall Study|Lost to Follow-up|0|||
126717488|NCT00968253|455916245|FG001|Overall Study|Withdrawal by Subject|0|||
126385233|NCT02684617|454704899|FG002|Overall Study|Death|28|||
126385234|NCT02684617|454704897|FG000|Overall Study|Withdrawal by Subject|2|||
126385235|NCT02684617|454704898|FG001|Overall Study|Withdrawal by Subject|0|||
126385236|NCT02684617|454704899|FG002|Overall Study|Withdrawal by Subject|4|||
126385237|NCT02684617|454704897|FG000|Overall Study|Screen Failure|1|||
126385238|NCT02684617|454704898|FG001|Overall Study|Screen Failure|0|||
126385239|NCT02684617|454704899|FG002|Overall Study|Screen Failure|2|||
126385240|NCT02684617|454704897|FG000|Overall Study|Study Terminated by Sponsor|6|||
126385241|NCT02684617|454704898|FG001|Overall Study|Study Terminated by Sponsor|1|||
126385242|NCT02684617|454704899|FG002|Overall Study|Study Terminated by Sponsor|5|||
126385243|NCT00615719|454704910|FG000|Overall Study|Physician Decision|5|||
126385244|NCT04482439|454704915|FG000|Overall Study|Lost to Follow-up|1|||
126385245|NCT04482439|454704915|FG000|Overall Study|Unrelated illness|1|||
126385246|NCT02318368|454704916|FG000|Overall Study|Withdrawal by Subject|2|||
126385247|NCT02318368|454704917|FG001|Overall Study|Withdrawal by Subject|0|||
126385248|NCT02318368|454704916|FG000|Overall Study|Study terminated by the sponsor|5|||
126385249|NCT02318368|454704917|FG001|Overall Study|Study terminated by the sponsor|2|||
126385250|NCT02318368|454704916|FG000|Overall Study|Death|0|||
126385251|NCT02318368|454704917|FG001|Overall Study|Death|1|||
126385252|NCT02201329|454704918|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
126385253|NCT02201329|454704918|FG000|Overall Study|Withdrawal by Subject|2|||
126385254|NCT03629223|454704919|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
126385255|NCT03629223|454704920|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
126385256|NCT03629223|454704921|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
126385257|NCT03629223|454704922|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
126385258|NCT03629223|454704923|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
126385259|NCT03629223|454704924|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
126385260|NCT03629223|454704919|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
126385261|NCT03629223|454704920|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
126385262|NCT03629223|454704921|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
126385263|NCT03629223|454704922|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
126385264|NCT03629223|454704923|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
126385265|NCT03629223|454704924|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
126385266|NCT03629223|454704919|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
126385267|NCT03629223|454704920|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
126385268|NCT03629223|454704921|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
126385269|NCT03629223|454704922|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
126385270|NCT03629223|454704923|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
126385271|NCT03629223|454704924|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
126385272|NCT03629223|454704919|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
126385273|NCT03629223|454704920|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
126385274|NCT03629223|454704921|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
126385275|NCT03629223|454704922|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
126385276|NCT03629223|454704923|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
126385277|NCT03629223|454704924|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
126385278|NCT03629223|454704919|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
126385279|NCT03629223|454704920|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
126385280|NCT03629223|454704921|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
126385281|NCT03629223|454704922|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
126385282|NCT03629223|454704923|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
126385283|NCT03629223|454704924|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
126385284|NCT01534351|454704925|FG000|Overall Study|Study Terminated Early|1|||
126385285|NCT01534351|454704926|FG001|Overall Study|Study Terminated Early|0|||
126385286|NCT01534351|454704927|FG002|Overall Study|Study Terminated Early|0|||
126385287|NCT02702609|454704928|FG000|Overall Study|Lost to Follow-up|8|||
126385288|NCT02702609|454704929|FG001|Overall Study|Lost to Follow-up|4|||
126385289|NCT02702609|454704928|FG000|Overall Study|Physician Decision|1|||
126385290|NCT02702609|454704929|FG001|Overall Study|Physician Decision|0|||
126385291|NCT04660552|454704931|FG000|Overall Study|Withdrawal by Subject|3|||
126385292|NCT04660552|454704932|FG001|Overall Study|Withdrawal by Subject|1|||
126385293|NCT00690430|454704933|FG000|Core Phase|Abnormal Laboratory value|0|||
126385294|NCT00690430|454704934|FG001|Core Phase|Abnormal Laboratory value|1|||
126385295|NCT00690430|454704935|FG002|Core Phase|Abnormal Laboratory value|0|||
126385296|NCT00690430|454704933|FG000|Core Phase|Adverse Event|5|||
126385297|NCT00690430|454704934|FG001|Core Phase|Adverse Event|1|||
126385298|NCT00690430|454704935|FG002|Core Phase|Adverse Event|0|||
126385299|NCT00690430|454704933|FG000|Core Phase|Death|0|||
126385300|NCT00690430|454704934|FG001|Core Phase|Death|2|||
126385301|NCT00690430|454704935|FG002|Core Phase|Death|0|||
126385302|NCT00690430|454704933|FG000|Core Phase|Protocol Violation|1|||
126385303|NCT00690430|454704934|FG001|Core Phase|Protocol Violation|0|||
126385304|NCT00690430|454704935|FG002|Core Phase|Protocol Violation|0|||
126385305|NCT00690430|454704933|FG000|Core Phase|Withdrawal by Subject|3|||
126385306|NCT00690430|454704934|FG001|Core Phase|Withdrawal by Subject|3|||
126385307|NCT00690430|454704935|FG002|Core Phase|Withdrawal by Subject|0|||
126385308|NCT00690430|454704933|FG000|Core Phase|Subject no longer requires study drug|1|||
126385309|NCT00690430|454704934|FG001|Core Phase|Subject no longer requires study drug|0|||
126385310|NCT00690430|454704935|FG002|Core Phase|Subject no longer requires study drug|0|||
126385311|NCT00690430|454704933|FG000|Core Phase|Lack of Efficacy|8|||
126385312|NCT00690430|454704934|FG001|Core Phase|Lack of Efficacy|10|||
126385313|NCT00690430|454704935|FG002|Core Phase|Lack of Efficacy|0|||
126385314|NCT00690430|454704933|FG000|Core Phase|Administrative Problems|0|||
126385315|NCT00690430|454704934|FG001|Core Phase|Administrative Problems|1|||
126385316|NCT00690430|454704935|FG002|Core Phase|Administrative Problems|0|||
126385317|NCT00690430|454704933|FG000|Core Phase|Early Termination|0|||
126385318|NCT00690430|454704934|FG001|Core Phase|Early Termination|5|||
126385319|NCT00690430|454704935|FG002|Core Phase|Early Termination|0|||
126385320|NCT00690430|454704933|FG000|Extension Phase|Lack of Efficacy|3|||
126385321|NCT00690430|454704934|FG001|Extension Phase|Lack of Efficacy|1|||
126385322|NCT00690430|454704935|FG002|Extension Phase|Lack of Efficacy|4|||
126385323|NCT00690430|454704933|FG000|Extension Phase|Abnormal Lab Values|1|||
126385324|NCT00690430|454704934|FG001|Extension Phase|Abnormal Lab Values|0|||
126385325|NCT00690430|454704935|FG002|Extension Phase|Abnormal Lab Values|0|||
126385326|NCT00690430|454704933|FG000|Extension Phase|Abnormal test procedure results|1|||
126385327|NCT00690430|454704934|FG001|Extension Phase|Abnormal test procedure results|0|||
126385328|NCT00690430|454704935|FG002|Extension Phase|Abnormal test procedure results|0|||
126385329|NCT00690430|454704933|FG000|Extension Phase|Administrative Problems|0|||
126385330|NCT00690430|454704934|FG001|Extension Phase|Administrative Problems|1|||
126385331|NCT00690430|454704935|FG002|Extension Phase|Administrative Problems|1|||
126385332|NCT00690430|454704933|FG000|Extension Phase|Adverse Event|2|||
126385333|NCT00690430|454704934|FG001|Extension Phase|Adverse Event|1|||
126385334|NCT00690430|454704935|FG002|Extension Phase|Adverse Event|2|||
126385335|NCT00690430|454704933|FG000|Extension Phase|Death|1|||
126385336|NCT00690430|454704934|FG001|Extension Phase|Death|1|||
126385337|NCT00690430|454704935|FG002|Extension Phase|Death|1|||
126385338|NCT00690430|454704933|FG000|Extension Phase|Withdrawal by Subject|0|||
126385339|NCT00690430|454704934|FG001|Extension Phase|Withdrawal by Subject|0|||
126385340|NCT00690430|454704935|FG002|Extension Phase|Withdrawal by Subject|2|||
126385341|NCT00690430|454704933|FG000|Extension Phase|Early Termination|10|||
126385342|NCT00690430|454704934|FG001|Extension Phase|Early Termination|1|||
126385343|NCT00690430|454704935|FG002|Extension Phase|Early Termination|3|||
126385344|NCT02125838|454704938|FG000|Overall Study|Lost to Follow-up|4|||
126385345|NCT02125838|454704939|FG001|Overall Study|Lost to Follow-up|4|||
126385346|NCT00787839|454704940|FG000|Overall Study|Failure to have the OGTT was most common|404|||
126385347|NCT00335738|454704943|FG000|Overall Study|Physician Decision|6|||
126385348|NCT00335738|454704944|FG001|Overall Study|Physician Decision|0|||
126385349|NCT00335738|454704943|FG000|Overall Study|Withdrawal by Subject|2|||
126385350|NCT00335738|454704944|FG001|Overall Study|Withdrawal by Subject|0|||
126385351|NCT00335738|454704943|FG000|Overall Study|Ineligible|3|||
126385352|NCT00335738|454704944|FG001|Overall Study|Ineligible|4|||
126385353|NCT01970241|454704951|FG000|Overall Study|Withdrawal by Subject|2|||
126385354|NCT01970241|454704952|FG001|Overall Study|Withdrawal by Subject|0|||
126385355|NCT01970241|454704951|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
126385356|NCT01970241|454704952|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
126385357|NCT00992056|454704955|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
126385358|NCT00992056|454704956|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
126385359|NCT00992056|454704955|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
126385360|NCT00992056|454704956|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
126385361|NCT00564902|454704959|FG000|Overall Study|Withdrawal by Subject|0|||
126385362|NCT00564902|454704960|FG001|Overall Study|Withdrawal by Subject|3|||
126385363|NCT00564902|454704961|FG002|Overall Study|Withdrawal by Subject|4|||
126385364|NCT00564902|454704959|FG000|Overall Study|Death|1|||
126385365|NCT00564902|454704960|FG001|Overall Study|Death|1|||
126385366|NCT00564902|454704961|FG002|Overall Study|Death|0|||
126385367|NCT00375505|454704964|FG000|Overall Study|Adverse Event|1|||
126385368|NCT00375505|454704965|FG001|Overall Study|Adverse Event|2|||
126385369|NCT02146131|454704966|FG000|Overall Study|Physician Decision|61|||
126385370|NCT02146131|454704967|FG001|Overall Study|Physician Decision|56|||
126385371|NCT02567799|454704968|FG000|Concurrent Chemoradiotherapy|Death|1|||
126553384|NCT02258464|455320592|FG000|Overall Study|AE related to clinical PD|1|||
126553385|NCT02258464|455320593|FG001|Overall Study|AE related to clinical PD|0|||
126385372|NCT02567799|454704969|FG001|Concurrent Chemoradiotherapy|Death|0|||
126385373|NCT02567799|454704970|FG002|Concurrent Chemoradiotherapy|Death|0|||
126385374|NCT02567799|454704968|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
126385375|NCT02567799|454704969|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
126385376|NCT02567799|454704970|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
126385377|NCT02567799|454704968|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
126385378|NCT02567799|454704969|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
126717489|NCT00968253|455916246|FG002|Overall Study|Withdrawal by Subject|1|||
126385379|NCT02567799|454704970|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
126717490|NCT00968253|455916244|FG000|Overall Study|Disease Progression|0|||
126553386|NCT02337478|455320594|FG000|Overall Study|Lack of Efficacy|5|||
126553387|NCT04170296|455320595|FG000|Overall Study|Adverse Event|1|||
126553388|NCT04170296|455320596|FG001|Overall Study|Adverse Event|0|||
126553389|NCT04170296|455320595|FG000|Overall Study|Withdrawal by Subject|3|||
126553390|NCT04170296|455320596|FG001|Overall Study|Withdrawal by Subject|2|||
126553391|NCT04170296|455320595|FG000|Overall Study|Lost to Follow-up|4|||
126553392|NCT04170296|455320596|FG001|Overall Study|Lost to Follow-up|2|||
126553393|NCT00932646|455320597|FG000|Overall Study|Adverse Event|2|||
126553394|NCT00932646|455320598|FG001|Overall Study|Adverse Event|1|||
126553395|NCT00932646|455320599|FG002|Overall Study|Adverse Event|1|||
126553396|NCT00932646|455320600|FG003|Overall Study|Adverse Event|1|||
126553397|NCT00932646|455320597|FG000|Overall Study|Lost to Follow-up|2|||
126553398|NCT00932646|455320598|FG001|Overall Study|Lost to Follow-up|1|||
126553399|NCT00932646|455320599|FG002|Overall Study|Lost to Follow-up|0|||
126553400|NCT00932646|455320600|FG003|Overall Study|Lost to Follow-up|0|||
126553401|NCT00932646|455320597|FG000|Overall Study|Withdrawal by Subject|1|||
126553402|NCT00932646|455320598|FG001|Overall Study|Withdrawal by Subject|1|||
126553403|NCT00932646|455320599|FG002|Overall Study|Withdrawal by Subject|3|||
126553404|NCT00932646|455320600|FG003|Overall Study|Withdrawal by Subject|0|||
126553405|NCT00653263|455320601|FG000|Overall Study|Withdrawal by Subject|1|||
126553406|NCT00653263|455320601|FG000|Overall Study|Physician Decision|1|||
126553407|NCT02285595|455320606|FG000|Overall Study|Lost to Follow-up|14|||
126553408|NCT02285595|455320606|FG000|Overall Study|Withdrawal by Subject|1|||
126553409|NCT00195715|455320607|FG000|Overall Study|Adverse Event|122|||
126553410|NCT00195715|455320607|FG000|Overall Study|Withdrawal by Subject|58|||
126553411|NCT00195715|455320607|FG000|Overall Study|Lost to Follow-up|27|||
126553412|NCT00195715|455320607|FG000|Overall Study|Protocol Violation|13|||
126553413|NCT00195715|455320607|FG000|Overall Study|Lack of Efficacy|93|||
126553414|NCT00195715|455320607|FG000|Overall Study|Pregnancy|14|||
126553415|NCT00195715|455320607|FG000|Overall Study|Investigative site closure|8|||
126553416|NCT00195715|455320607|FG000|Overall Study|Subject moved/relocated|7|||
126553417|NCT00195715|455320607|FG000|Overall Study|Subject non-compliance|6|||
126553418|NCT00195715|455320607|FG000|Overall Study|Subject started commercial Humira|5|||
126553419|NCT00195715|455320607|FG000|Overall Study|Subject choice|3|||
126553420|NCT00195715|455320607|FG000|Overall Study|Loss of response/no improvement|3|||
126553421|NCT00195715|455320607|FG000|Overall Study|Sponsor stopped study|1|||
126553422|NCT00195715|455320607|FG000|Overall Study|Administrative reasons|2|||
126553423|NCT00195715|455320607|FG000|Overall Study|Investigator's decision|2|||
126553424|NCT00195715|455320607|FG000|Overall Study|Subject wants to get pregnant|4|||
126553425|NCT00195715|455320607|FG000|Overall Study|Use of prohibited medication|2|||
126553426|NCT00195715|455320607|FG000|Overall Study|Planned surgery|2|||
126553427|NCT00195715|455320607|FG000|Overall Study|Increased infection rate|1|||
126553428|NCT00195715|455320607|FG000|Overall Study|Ineligible|1|||
126553429|NCT00195715|455320607|FG000|Overall Study|Colonic stricture|1|||
126553430|NCT00195715|455320607|FG000|Overall Study|Sponsor discontinued trial|1|||
126553431|NCT00195715|455320607|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
126553432|NCT00845871|455320611|FG000|Assessment Period|Adverse Event|2|||
126553433|NCT00845871|455320611|FG000|Assessment Period|Abnormal laboratory values|1|||
126553434|NCT00845871|455320611|FG000|Assessment Period|Abnormal test procedure results|1|||
126553435|NCT00845871|455320611|FG000|Assessment Period|Patient withdrew consent|3|||
126553436|NCT00064025|455320620|FG000|Overall Study|Ineligible|4|||
126553437|NCT00064025|455320620|FG000|Overall Study|Inevaluable|3|||
126553438|NCT02468934|455320623|FG000|Overall Study|Withdrawal by Subject|4|||
126553439|NCT02468934|455320623|FG000|Overall Study|Screen Failure|3|||
126553440|NCT01370603|455320624|FG000|Period 1|Adverse Event|5|||
126553441|NCT01370603|455320625|FG001|Period 1|Adverse Event|3|||
126717491|NCT00968253|455916245|FG001|Overall Study|Disease Progression|3|||
126717492|NCT00968253|455916246|FG002|Overall Study|Disease Progression|3|||
126385380|NCT02567799|454704968|FG000|Follow-up|Death|1|||
126717493|NCT00968253|455916244|FG000|Overall Study|Adverse Event|0|||
126717494|NCT00968253|455916245|FG001|Overall Study|Adverse Event|0|||
126385381|NCT02567799|454704969|FG001|Follow-up|Death|0|||
126385382|NCT02567799|454704970|FG002|Follow-up|Death|1|||
126385383|NCT02567799|454704968|FG000|Follow-up|Progressive Disease|1|||
126385384|NCT02567799|454704969|FG001|Follow-up|Progressive Disease|1|||
126553442|NCT01370603|455320624|FG000|Period 1|Lost to Follow-up|2|||
126553443|NCT01370603|455320625|FG001|Period 1|Lost to Follow-up|0|||
126553444|NCT01370603|455320624|FG000|Period 1|Protocol Violation|2|||
126385385|NCT02567799|454704970|FG002|Follow-up|Progressive Disease|3|||
126385386|NCT00349349|454704972|FG000|Overall Study|Adverse Event|5|||
126553445|NCT01370603|455320625|FG001|Period 1|Protocol Violation|2|||
126553446|NCT01370603|455320624|FG000|Period 1|Withdrawal by Subject|5|||
126553447|NCT01370603|455320625|FG001|Period 1|Withdrawal by Subject|5|||
126553448|NCT01370603|455320624|FG000|Crossover Washout|Adverse Event|2|||
126553449|NCT01370603|455320625|FG001|Crossover Washout|Adverse Event|1|||
126553450|NCT01370603|455320624|FG000|Crossover Washout|Lost to Follow-up|2|||
126553451|NCT01370603|455320625|FG001|Crossover Washout|Lost to Follow-up|0|||
126553452|NCT01370603|455320624|FG000|Crossover Washout|Protocol Violation|1|||
126717495|NCT00968253|455916246|FG002|Overall Study|Adverse Event|1|||
126553453|NCT01370603|455320625|FG001|Crossover Washout|Protocol Violation|0|||
126553454|NCT01370603|455320624|FG000|Crossover Washout|Withdrawal by Subject|4|||
126553455|NCT01370603|455320625|FG001|Crossover Washout|Withdrawal by Subject|1|||
126553456|NCT01370603|455320624|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
126553457|NCT01370603|455320625|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
126553458|NCT01370603|455320624|FG000|Period 2|Adverse Event|1|||
126553459|NCT01370603|455320625|FG001|Period 2|Adverse Event|4|||
126553460|NCT01370603|455320624|FG000|Period 2|Lost to Follow-up|1|||
126553461|NCT01370603|455320625|FG001|Period 2|Lost to Follow-up|0|||
126553462|NCT01370603|455320624|FG000|Period 2|Withdrawal by Subject|1|||
126553463|NCT01370603|455320625|FG001|Period 2|Withdrawal by Subject|0|||
126553464|NCT02218489|455320632|FG000|Overall Study|Withdrawal by Subject|4|||
126553465|NCT02218489|455320633|FG001|Overall Study|Withdrawal by Subject|3|||
126553466|NCT02218489|455320632|FG000|Overall Study|Lost to Follow-up|1|||
126553467|NCT02218489|455320633|FG001|Overall Study|Lost to Follow-up|0|||
126553468|NCT02404493|455320634|FG000|Overall Study|Adverse Event|1|||
126553469|NCT02404493|455320635|FG001|Overall Study|Adverse Event|1|||
126553470|NCT04039503|455320636|FG000|Overall Study|Adverse Event|3|||
126553471|NCT04039503|455320637|FG001|Overall Study|Adverse Event|0|||
126553472|NCT04039503|455320638|FG002|Overall Study|Adverse Event|2|||
126553473|NCT04039503|455320639|FG003|Overall Study|Adverse Event|0|||
126553474|NCT04039503|455320636|FG000|Overall Study|Lost to Follow-up|0|||
126553475|NCT04039503|455320637|FG001|Overall Study|Lost to Follow-up|0|||
126553476|NCT04039503|455320638|FG002|Overall Study|Lost to Follow-up|1|||
126553477|NCT04039503|455320639|FG003|Overall Study|Lost to Follow-up|0|||
126553478|NCT04039503|455320636|FG000|Overall Study|Protocol Violation|0|||
126553479|NCT04039503|455320637|FG001|Overall Study|Protocol Violation|1|||
126553480|NCT04039503|455320638|FG002|Overall Study|Protocol Violation|2|||
126553481|NCT04039503|455320639|FG003|Overall Study|Protocol Violation|1|||
126553482|NCT04039503|455320636|FG000|Overall Study|Withdrawal by Subject|4|||
126553483|NCT04039503|455320637|FG001|Overall Study|Withdrawal by Subject|3|||
126553484|NCT04039503|455320638|FG002|Overall Study|Withdrawal by Subject|5|||
126553485|NCT04039503|455320639|FG003|Overall Study|Withdrawal by Subject|2|||
126717496|NCT04400318|455917553|FG000|Overall Study|Adverse Event|1|||
126553486|NCT03204695|455322507|FG000|Overall Study|Death|1|||
126553487|NCT03204695|455322507|FG000|Overall Study|Participant was treated with another device|1|||
126553488|NCT03204695|455322507|FG000|Overall Study|Physician Decision|2|||
126553489|NCT04834362|455322508|FG000|Overall Study|Death|1|||
126553490|NCT04834362|455322509|FG001|Overall Study|Death|2|||
126553491|NCT01349829|455322512|FG000|Overall Study|Lost to Follow-up|4|||
126553492|NCT01349829|455322513|FG001|Overall Study|Lost to Follow-up|8|||
126553493|NCT01349829|455322512|FG000|Overall Study|Consent withdrawal|3|||
126553494|NCT01349829|455322513|FG001|Overall Study|Consent withdrawal|8|||
126553495|NCT01349829|455322512|FG000|Overall Study|Migrated/moved|2|||
126553496|NCT01349829|455322513|FG001|Overall Study|Migrated/moved|7|||
126553497|NCT02555371|455322514|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
126553498|NCT02555371|455322515|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
126553499|NCT02555371|455322516|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
126553500|NCT02555371|455322517|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
126553501|NCT02555371|455322518|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
126553502|NCT02555371|455322514|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
126553503|NCT02555371|455322515|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
126553504|NCT02555371|455322516|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
126553505|NCT02555371|455322517|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
126553506|NCT02555371|455322518|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
126553507|NCT02555371|455322514|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
126553508|NCT02555371|455322515|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
126553509|NCT02555371|455322516|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
126553510|NCT02555371|455322517|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
126553511|NCT02555371|455322518|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
126553512|NCT02555371|455322514|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
126553513|NCT02555371|455322515|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
126717497|NCT04400318|455917554|FG001|Overall Study|Adverse Event|0|||
126717498|NCT04400318|455917553|FG000|Overall Study|Withdrawal by Subject|1|||
126385387|NCT00349349|454704973|FG001|Overall Study|Adverse Event|6|||
126385388|NCT00349349|454704974|FG002|Overall Study|Adverse Event|2|||
126385389|NCT00349349|454704972|FG000|Overall Study|Withdrawal by Subject|5|||
126717499|NCT04400318|455917554|FG001|Overall Study|Withdrawal by Subject|1|||
126553514|NCT02555371|455322516|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
126553515|NCT02555371|455322517|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
126717500|NCT04400318|455917553|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
126553516|NCT02555371|455322518|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
126553517|NCT02555371|455322514|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
126717501|NCT04400318|455917554|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
126717502|NCT01096446|455917555|FG000|Overall Study|Death|1|||
126717503|NCT01096446|455917556|FG001|Overall Study|Death|0|||
126717504|NCT01096446|455917555|FG000|Overall Study|Protocol Violation|2|||
126717505|NCT01096446|455917556|FG001|Overall Study|Protocol Violation|0|||
126385390|NCT00349349|454704973|FG001|Overall Study|Withdrawal by Subject|2|||
126385391|NCT00349349|454704974|FG002|Overall Study|Withdrawal by Subject|1|||
126385392|NCT00349349|454704972|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
126385393|NCT00349349|454704973|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
126385394|NCT00349349|454704974|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
126385395|NCT00349349|454704972|FG000|Overall Study|Death|13|||
126385396|NCT00349349|454704973|FG001|Overall Study|Death|10|||
126385397|NCT00349349|454704974|FG002|Overall Study|Death|1|||
126385398|NCT00349349|454704972|FG000|Overall Study|Other Treatment Selected|2|||
126385399|NCT00349349|454704973|FG001|Overall Study|Other Treatment Selected|0|||
126385400|NCT00349349|454704974|FG002|Overall Study|Other Treatment Selected|0|||
126385401|NCT00349349|454704972|FG000|Overall Study|Participant Reduced General Condition|0|||
126385402|NCT00349349|454704973|FG001|Overall Study|Participant Reduced General Condition|1|||
126385403|NCT00349349|454704974|FG002|Overall Study|Participant Reduced General Condition|0|||
126385404|NCT00349349|454704972|FG000|Overall Study|Physician Decision|1|||
126385405|NCT00349349|454704973|FG001|Overall Study|Physician Decision|2|||
126385406|NCT00349349|454704974|FG002|Overall Study|Physician Decision|1|||
126385407|NCT00349349|454704972|FG000|Overall Study|No Response|0|||
126385408|NCT00349349|454704973|FG001|Overall Study|No Response|3|||
126468392|NCT03198078|455017599|FG002|Overall Study|Lost to Follow-up|0|||
126468393|NCT03198078|455017597|FG000|Overall Study|Pregnancy|0|||
126468394|NCT03198078|455017598|FG001|Overall Study|Pregnancy|1|||
126468395|NCT03198078|455017599|FG002|Overall Study|Pregnancy|0|||
126468396|NCT03198078|455017597|FG000|Overall Study|Withdrawal by Subject|1|||
126468397|NCT03198078|455017598|FG001|Overall Study|Withdrawal by Subject|0|||
126468398|NCT03198078|455017599|FG002|Overall Study|Withdrawal by Subject|2|||
126468399|NCT03198078|455017597|FG000|Overall Study|Withdrawal by Caregiver|1|||
126468400|NCT03198078|455017598|FG001|Overall Study|Withdrawal by Caregiver|3|||
126468401|NCT03198078|455017599|FG002|Overall Study|Withdrawal by Caregiver|5|||
126468402|NCT02607930|455017600|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
126468403|NCT02607930|455017601|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
126468404|NCT02607930|455017602|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
126468405|NCT02607930|455017603|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
126468406|NCT02607930|455017600|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
126468407|NCT02607930|455017601|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
126468408|NCT02607930|455017602|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
126468409|NCT02607930|455017603|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
126468410|NCT02607930|455017600|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
126468411|NCT02607930|455017601|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
126468412|NCT02607930|455017602|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
126468413|NCT02607930|455017603|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
126468414|NCT02607930|455017600|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
126468415|NCT02607930|455017601|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
126468416|NCT02607930|455017602|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
126468417|NCT02607930|455017603|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
126468418|NCT02607930|455017600|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
126468419|NCT02607930|455017601|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
126468420|NCT02607930|455017602|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
126468421|NCT02607930|455017603|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
126468422|NCT02607930|455017600|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
126468423|NCT02607930|455017601|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
126468424|NCT02607930|455017602|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
126468425|NCT02607930|455017603|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
126468426|NCT02607930|455017600|FG000|Double-Blinded Treatment Phase|Death|2|||
126468427|NCT02607930|455017601|FG001|Double-Blinded Treatment Phase|Death|1|||
126468428|NCT02607930|455017602|FG002|Double-Blinded Treatment Phase|Death|0|||
126468429|NCT02607930|455017603|FG003|Double-Blinded Treatment Phase|Death|0|||
126468430|NCT02607930|455017600|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
126468431|NCT02607930|455017601|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
126468432|NCT02607930|455017602|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
126468433|NCT02607930|455017603|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
126468434|NCT02607930|455017600|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
126468435|NCT02607930|455017601|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
126468436|NCT02607930|455017602|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
126468437|NCT02607930|455017603|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
126468438|NCT02607930|455017600|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
126468439|NCT02607930|455017601|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
126717506|NCT01043185|455917557|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
126385409|NCT00349349|454704974|FG002|Overall Study|No Response|0|||
126385410|NCT00349349|454704972|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
126385411|NCT00349349|454704973|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
126385412|NCT00349349|454704974|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
126385413|NCT00861692|454704975|FG000|Overall Study|Death|6|||
126385414|NCT05111002|454704980|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
126385415|NCT05111002|454704981|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
126385416|NCT05111002|454704980|FG000|Secondary Outcome|Lost to Follow-up|1|||
126385417|NCT05111002|454704981|FG001|Secondary Outcome|Lost to Follow-up|0|||
126385418|NCT04380753|454704982|FG000|Overall Study|Participants continuing study|4|||
126385419|NCT04380753|454704982|FG000|Overall Study|Death|2|||
126385420|NCT04776720|454704985|FG000|Overall Study|COVID Related|4|||
126385421|NCT04776720|454704986|FG001|Overall Study|COVID Related|2|||
126385422|NCT04776720|454704985|FG000|Overall Study|Adverse Event|2|||
126385423|NCT04776720|454704986|FG001|Overall Study|Adverse Event|0|||
126385424|NCT04776720|454704985|FG000|Overall Study|Serious Adverse Event|0|||
126385425|NCT04776720|454704986|FG001|Overall Study|Serious Adverse Event|1|||
126385426|NCT04776720|454704985|FG000|Overall Study|Too Busy|3|||
126385427|NCT04776720|454704986|FG001|Overall Study|Too Busy|1|||
126385428|NCT04776720|454704985|FG000|Overall Study|Lost to Follow-up|1|||
126385429|NCT04776720|454704986|FG001|Overall Study|Lost to Follow-up|2|||
126385430|NCT04776720|454704985|FG000|Overall Study|Family|2|||
126385431|NCT04776720|454704986|FG001|Overall Study|Family|2|||
126385432|NCT04776720|454704985|FG000|Overall Study|No remote technology access|0|||
126385433|NCT04776720|454704986|FG001|Overall Study|No remote technology access|1|||
126385434|NCT04776720|454704985|FG000|Overall Study|Withdrawal by Subject|1|||
126385435|NCT04776720|454704986|FG001|Overall Study|Withdrawal by Subject|0|||
126385436|NCT04776720|454704985|FG000|Overall Study|Cannot tolerate intervention|1|||
126385437|NCT04776720|454704986|FG001|Overall Study|Cannot tolerate intervention|0|||
126385438|NCT04776720|454704985|FG000|Overall Study|Incomplete outcome data|6|||
126385439|NCT04776720|454704986|FG001|Overall Study|Incomplete outcome data|1|||
126385440|NCT00972517|454704987|FG000|Overall Study|Adverse Event|0|||
126385441|NCT00972517|454704988|FG001|Overall Study|Adverse Event|0|||
126385442|NCT00972517|454704989|FG002|Overall Study|Adverse Event|0|||
126385443|NCT00972517|454704990|FG003|Overall Study|Adverse Event|1|||
126385444|NCT00972517|454704991|FG004|Overall Study|Adverse Event|0|||
126385445|NCT00972517|454704992|FG005|Overall Study|Adverse Event|0|||
126385446|NCT00972517|454704987|FG000|Overall Study|Withdrawal by Subject|0|||
126385447|NCT00972517|454704988|FG001|Overall Study|Withdrawal by Subject|1|||
126385448|NCT00972517|454704989|FG002|Overall Study|Withdrawal by Subject|0|||
126385449|NCT00972517|454704990|FG003|Overall Study|Withdrawal by Subject|2|||
126385450|NCT00972517|454704991|FG004|Overall Study|Withdrawal by Subject|1|||
126385451|NCT00972517|454704992|FG005|Overall Study|Withdrawal by Subject|0|||
126385452|NCT00984594|454704993|FG000|Overall Study|Lost to Follow-up|1|||
126385453|NCT00984594|454704994|FG001|Overall Study|Lost to Follow-up|0|||
126385454|NCT00984594|454704993|FG000|Overall Study|Withdrawal by Subject|0|||
126385455|NCT00984594|454704994|FG001|Overall Study|Withdrawal by Subject|1|||
126385456|NCT00803595|454704995|FG000|Overall Study|Adverse Event|3|||
126385457|NCT00803595|454704996|FG001|Overall Study|Adverse Event|4|||
126385458|NCT00803595|454704997|FG002|Overall Study|Adverse Event|1|||
126385459|NCT00803595|454704995|FG000|Overall Study|Protocol Violation|7|||
126385460|NCT00803595|454704996|FG001|Overall Study|Protocol Violation|2|||
126385461|NCT00803595|454704997|FG002|Overall Study|Protocol Violation|12|||
126385462|NCT00803595|454704995|FG000|Overall Study|Withdrawal by Subject|5|||
126385463|NCT00803595|454704996|FG001|Overall Study|Withdrawal by Subject|2|||
126385464|NCT00803595|454704997|FG002|Overall Study|Withdrawal by Subject|3|||
126385465|NCT00851890|454704998|FG000|Overall Study|Lost to Follow-up|0|||
126385466|NCT00851890|454704999|FG001|Overall Study|Lost to Follow-up|1|||
126385467|NCT00851890|454705000|FG002|Overall Study|Lost to Follow-up|0|||
126385468|NCT00851890|454705001|FG003|Overall Study|Lost to Follow-up|1|||
126385469|NCT03135431|454705002|FG000|Overall Study|Study Surgeon not available|2|||
126385470|NCT03135431|454705003|FG001|Overall Study|Study Surgeon not available|0|||
126771195|NCT03985293|456116290|FG003|FOLLOW-UP|Lost to Follow-up|0|||
126468440|NCT02607930|455017602|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
126771196|NCT03985293|456116291|FG004|FOLLOW-UP|Lost to Follow-up|0|||
126385471|NCT02709577|454705004|FG000|Overall Study|non-accommodating anatomy|0|||
126385472|NCT02709577|454705005|FG001|Overall Study|non-accommodating anatomy|1|||
126385473|NCT02709577|454705006|FG002|Overall Study|non-accommodating anatomy|0|||
126385474|NCT02709577|454705007|FG003|Overall Study|non-accommodating anatomy|0|||
126385475|NCT02709577|454705004|FG000|Overall Study|procedural complication|0|||
126385476|NCT02709577|454705005|FG001|Overall Study|procedural complication|1|||
126385477|NCT02709577|454705006|FG002|Overall Study|procedural complication|0|||
126385478|NCT02709577|454705007|FG003|Overall Study|procedural complication|0|||
126385479|NCT02709577|454705004|FG000|Overall Study|Withdrawal by Subject|2|||
126385480|NCT02709577|454705005|FG001|Overall Study|Withdrawal by Subject|3|||
126385481|NCT02709577|454705006|FG002|Overall Study|Withdrawal by Subject|2|||
126385482|NCT02709577|454705007|FG003|Overall Study|Withdrawal by Subject|0|||
126385483|NCT00375674|454705008|FG000|Overall Study|Other|26|||
126385484|NCT00375674|454705009|FG001|Overall Study|Other|18|||
126385485|NCT00375674|454705008|FG000|Overall Study|Death|67|||
126385486|NCT00375674|454705009|FG001|Overall Study|Death|76|||
126385487|NCT00375674|454705008|FG000|Overall Study|Participants refused further follow-up|31|||
126385488|NCT00375674|454705009|FG001|Overall Study|Participants refused further follow-up|30|||
126385489|NCT00375674|454705008|FG000|Overall Study|Lost to Follow-up|17|||
126385490|NCT00375674|454705009|FG001|Overall Study|Lost to Follow-up|15|||
126385491|NCT00375674|454705008|FG000|Overall Study|Enrolled but not treated|3|||
126385492|NCT00375674|454705009|FG001|Overall Study|Enrolled but not treated|2|||
126385493|NCT03744910|454707461|FG000|Overall Study|Withdrew Consent|1|||
126385494|NCT03744910|454707462|FG001|Overall Study|Withdrew Consent|8|||
126385495|NCT03744910|454707461|FG000|Overall Study|Physician Decision|5|||
126385496|NCT03744910|454707462|FG001|Overall Study|Physician Decision|4|||
126385497|NCT03744910|454707461|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
126553518|NCT02555371|455322515|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
126553519|NCT02555371|455322516|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
126553520|NCT02555371|455322517|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
126553521|NCT02555371|455322518|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
126385498|NCT03744910|454707462|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
126385499|NCT03744910|454707461|FG000|Overall Study|Lost to Follow-up|0|||
126385500|NCT03744910|454707462|FG001|Overall Study|Lost to Follow-up|1|||
126553522|NCT02555371|455322514|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
126553523|NCT02555371|455322515|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
126553524|NCT02555371|455322516|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
126717507|NCT01043185|455917558|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
126771197|NCT03985293|456116292|FG005|FOLLOW-UP|Lost to Follow-up|0|||
126385501|NCT03744910|454707461|FG000|Overall Study|Other-unspecified|4|||
126385502|NCT03744910|454707462|FG001|Overall Study|Other-unspecified|1|||
126385503|NCT00064259|454707463|FG000|Overall Study|Adverse Event|1|||
126385504|NCT00064259|454707464|FG001|Overall Study|Adverse Event|0|||
126385505|NCT00064259|454707465|FG002|Overall Study|Adverse Event|0|||
126385506|NCT00064259|454707466|FG003|Overall Study|Adverse Event|1|||
126385507|NCT01132651|454707469|FG000|Overall Study|Lost to Follow-up|1|||
126385508|NCT01132651|454707470|FG001|Overall Study|Lost to Follow-up|1|||
126385509|NCT00948857|454707471|FG000|Overall Study|Lost to Follow-up|1|||
126385510|NCT00948857|454707472|FG001|Overall Study|Lost to Follow-up|0|||
126385511|NCT03430843|454707475|FG000|Overall Study|Death|233|||
126385512|NCT03430843|454707476|FG001|Overall Study|Death|233|||
126385513|NCT03430843|454707475|FG000|Overall Study|Sponsor Decision|17|||
126385514|NCT03430843|454707476|FG001|Overall Study|Sponsor Decision|6|||
126385515|NCT03430843|454707475|FG000|Overall Study|Withdrawal by Subject|5|||
126385516|NCT03430843|454707476|FG001|Overall Study|Withdrawal by Subject|14|||
126385517|NCT03430843|454707475|FG000|Overall Study|Lost to Follow-up|1|||
126385518|NCT03430843|454707476|FG001|Overall Study|Lost to Follow-up|3|||
126385519|NCT03037476|454707485|FG000|Overall Study|Lost to Follow-up|63|||
126385520|NCT03037476|454707486|FG001|Overall Study|Lost to Follow-up|46|||
126385521|NCT01498692|454707489|FG000|Overall Study|Death|4|||
126385522|NCT01498692|454707489|FG000|Overall Study|Withdrawal by Subject|1|||
126385523|NCT01498692|454707489|FG000|Overall Study|Missed 12-month visit|3|||
126385524|NCT00590122|454707490|FG000|Overall Study|swallowed oral dissolving dose|1|||
126385525|NCT00590122|454707491|FG001|Overall Study|swallowed oral dissolving dose|0|||
126385526|NCT03050450|454707492|FG000|Overall Study|Physician Decision|1|||
126385527|NCT03050450|454707493|FG001|Overall Study|Physician Decision|0|||
126385528|NCT03050450|454707494|FG002|Overall Study|Physician Decision|0|||
126385529|NCT03050450|454707495|FG003|Overall Study|Physician Decision|0|||
126385530|NCT03050450|454707496|FG004|Overall Study|Physician Decision|0|||
126385531|NCT00711594|454707497|FG000|Overall Study|Progressive disease|2|||
126385532|NCT00711594|454707498|FG001|Overall Study|Progressive disease|2|||
126385533|NCT00711594|454707499|FG002|Overall Study|Progressive disease|6|||
126385534|NCT00711594|454707500|FG003|Overall Study|Progressive disease|44|||
126385535|NCT00711594|454707497|FG000|Overall Study|Other Adverse Event|1|||
126385536|NCT00711594|454707498|FG001|Overall Study|Other Adverse Event|0|||
126385537|NCT00711594|454707499|FG002|Overall Study|Other Adverse Event|0|||
126385538|NCT00711594|454707500|FG003|Overall Study|Other Adverse Event|16|||
126385539|NCT00711594|454707497|FG000|Overall Study|Withdrawal by Subject|0|||
126385540|NCT00711594|454707498|FG001|Overall Study|Withdrawal by Subject|1|||
126385541|NCT00711594|454707499|FG002|Overall Study|Withdrawal by Subject|0|||
126385542|NCT00711594|454707500|FG003|Overall Study|Withdrawal by Subject|2|||
126385543|NCT00443872|454707501|FG000|Overall Study|Protocol Violation|7|||
126385544|NCT00443872|454707501|FG000|Overall Study|Lost to Follow-up|2|||
126385545|NCT00443872|454707501|FG000|Overall Study|Adverse Event|8|||
126385546|NCT00135330|454707502|FG000|Overall Study|Adverse Event|2|||
126385547|NCT00135330|454707503|FG001|Overall Study|Adverse Event|5|||
126385548|NCT00135330|454707504|FG002|Overall Study|Adverse Event|1|||
126385549|NCT00135330|454707502|FG000|Overall Study|Lost to Follow-up|0|||
126385550|NCT00135330|454707503|FG001|Overall Study|Lost to Follow-up|2|||
126385551|NCT00135330|454707504|FG002|Overall Study|Lost to Follow-up|3|||
126553525|NCT02555371|455322517|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
126553526|NCT02555371|455322518|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
126553527|NCT02555371|455322514|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
126553528|NCT02555371|455322515|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
126553529|NCT02555371|455322516|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
126553530|NCT02555371|455322517|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
126553531|NCT02555371|455322518|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
126553532|NCT02555371|455322514|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
126553533|NCT02555371|455322515|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
126553534|NCT02555371|455322516|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
126553535|NCT02555371|455322517|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
126553536|NCT02555371|455322518|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
126553537|NCT02555371|455322514|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
126553538|NCT02555371|455322515|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
126553539|NCT02555371|455322516|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
126553540|NCT02555371|455322517|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
126553541|NCT02555371|455322518|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
126553542|NCT02555371|455322514|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
126553543|NCT02555371|455322515|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
126553544|NCT02555371|455322516|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
126553545|NCT02555371|455322517|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
126553546|NCT02555371|455322518|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
126553547|NCT02555371|455322514|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
126553548|NCT02555371|455322515|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
126553549|NCT02555371|455322516|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
126553550|NCT02555371|455322517|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
126553551|NCT02555371|455322518|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
126553552|NCT02555371|455322514|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
126553553|NCT02555371|455322515|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
126553554|NCT02555371|455322516|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
126385552|NCT00135330|454707502|FG000|Overall Study|Physician Decision|1|||
126385553|NCT00135330|454707503|FG001|Overall Study|Physician Decision|1|||
126553555|NCT02555371|455322517|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
126553556|NCT02555371|455322518|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
126553557|NCT02555371|455322514|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
126553558|NCT02555371|455322515|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
126553559|NCT02555371|455322516|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
126553560|NCT02555371|455322517|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
126553561|NCT02555371|455322518|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
126553562|NCT02555371|455322514|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
126717508|NCT01043185|455917559|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
126717509|NCT01043185|455917560|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
126717510|NCT01043185|455917561|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
126385554|NCT00135330|454707504|FG002|Overall Study|Physician Decision|0|||
126385555|NCT00135330|454707502|FG000|Overall Study|Protocol Violation|4|||
126385556|NCT00135330|454707503|FG001|Overall Study|Protocol Violation|3|||
126385557|NCT00135330|454707504|FG002|Overall Study|Protocol Violation|3|||
126385558|NCT00135330|454707502|FG000|Overall Study|Patient Decision|5|||
126385559|NCT00135330|454707503|FG001|Overall Study|Patient Decision|1|||
126385560|NCT00135330|454707504|FG002|Overall Study|Patient Decision|4|||
126385561|NCT00135330|454707502|FG000|Overall Study|Sponsor Decision|0|||
126385562|NCT00135330|454707503|FG001|Overall Study|Sponsor Decision|1|||
126385563|NCT00135330|454707504|FG002|Overall Study|Sponsor Decision|0|||
126385564|NCT00104416|454707508|FG000|Double-Blind Phase|Adverse Event|2|||
126385565|NCT00104416|454707509|FG001|Double-Blind Phase|Adverse Event|1|||
126385566|NCT00104416|454707510|FG002|Double-Blind Phase|Adverse Event|0|||
126385567|NCT00104416|454707511|FG003|Double-Blind Phase|Adverse Event|0|||
126385568|NCT00104416|454707512|FG004|Double-Blind Phase|Adverse Event|0|||
126385569|NCT00104416|454707508|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126717511|NCT01043185|455917562|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
126717512|NCT01043185|455917563|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
126717513|NCT01043185|455917564|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
126385570|NCT00104416|454707509|FG001|Double-Blind Phase|Lost to Follow-up|1|||
126385571|NCT00104416|454707510|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126385572|NCT00104416|454707511|FG003|Double-Blind Phase|Lost to Follow-up|0|||
126385573|NCT00104416|454707512|FG004|Double-Blind Phase|Lost to Follow-up|0|||
126385574|NCT00104416|454707508|FG000|Double-Blind Phase|Protocol Violation|0|||
126385575|NCT00104416|454707509|FG001|Double-Blind Phase|Protocol Violation|1|||
126385576|NCT00104416|454707510|FG002|Double-Blind Phase|Protocol Violation|0|||
126385577|NCT00104416|454707511|FG003|Double-Blind Phase|Protocol Violation|0|||
126385578|NCT00104416|454707512|FG004|Double-Blind Phase|Protocol Violation|0|||
126385579|NCT00104416|454707508|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
126385580|NCT00104416|454707509|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
126385581|NCT00104416|454707510|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
126385582|NCT00104416|454707511|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
126385583|NCT00104416|454707512|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
126385584|NCT00104416|454707508|FG000|Double-Blind Phase|Pregnancy|1|||
126385585|NCT00104416|454707509|FG001|Double-Blind Phase|Pregnancy|0|||
126385586|NCT00104416|454707510|FG002|Double-Blind Phase|Pregnancy|0|||
126385587|NCT00104416|454707511|FG003|Double-Blind Phase|Pregnancy|0|||
126385588|NCT00104416|454707512|FG004|Double-Blind Phase|Pregnancy|0|||
126385589|NCT00104416|454707508|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
126385590|NCT00104416|454707509|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
126385591|NCT00104416|454707510|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
126385592|NCT00104416|454707511|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
126385593|NCT00104416|454707512|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
126385594|NCT00104416|454707508|FG000|Continuation Phase|Adverse Event|0|||
126385595|NCT00104416|454707509|FG001|Continuation Phase|Adverse Event|0|||
126385596|NCT00104416|454707510|FG002|Continuation Phase|Adverse Event|2|||
126385597|NCT00104416|454707511|FG003|Continuation Phase|Adverse Event|0|||
126385598|NCT00104416|454707512|FG004|Continuation Phase|Adverse Event|2|||
126385599|NCT00104416|454707508|FG000|Continuation Phase|Lost to Follow-up|0|||
126385600|NCT00104416|454707509|FG001|Continuation Phase|Lost to Follow-up|0|||
126385601|NCT00104416|454707510|FG002|Continuation Phase|Lost to Follow-up|1|||
126385602|NCT00104416|454707511|FG003|Continuation Phase|Lost to Follow-up|0|||
126385603|NCT00104416|454707512|FG004|Continuation Phase|Lost to Follow-up|1|||
126385604|NCT00104416|454707508|FG000|Continuation Phase|Withdrawal by Subject|0|||
126385605|NCT00104416|454707509|FG001|Continuation Phase|Withdrawal by Subject|0|||
126385606|NCT00104416|454707510|FG002|Continuation Phase|Withdrawal by Subject|2|||
126385607|NCT00104416|454707511|FG003|Continuation Phase|Withdrawal by Subject|1|||
126385608|NCT00104416|454707512|FG004|Continuation Phase|Withdrawal by Subject|1|||
126385609|NCT00104416|454707508|FG000|Continuation Phase|Pregnancy|0|||
126385610|NCT00104416|454707509|FG001|Continuation Phase|Pregnancy|0|||
126385611|NCT00104416|454707510|FG002|Continuation Phase|Pregnancy|1|||
126385612|NCT00104416|454707511|FG003|Continuation Phase|Pregnancy|1|||
126385613|NCT00104416|454707512|FG004|Continuation Phase|Pregnancy|0|||
126385614|NCT00104416|454707508|FG000|Continuation Phase|Non-compliance|0|||
126385615|NCT00104416|454707509|FG001|Continuation Phase|Non-compliance|0|||
126385616|NCT00104416|454707510|FG002|Continuation Phase|Non-compliance|0|||
126385617|NCT00104416|454707511|FG003|Continuation Phase|Non-compliance|0|||
126385618|NCT00104416|454707512|FG004|Continuation Phase|Non-compliance|1|||
126385619|NCT01309997|454707513|FG000|Overall Study|Adverse Event|1|||
126385620|NCT01309997|454707514|FG001|Overall Study|Adverse Event|0|||
126385621|NCT01309997|454707513|FG000|Overall Study|Death|1|||
126385622|NCT01309997|454707514|FG001|Overall Study|Death|3|||
126385623|NCT01309997|454707513|FG000|Overall Study|Lack of Efficacy|2|||
126385624|NCT01309997|454707514|FG001|Overall Study|Lack of Efficacy|2|||
126385625|NCT01309997|454707513|FG000|Overall Study|Withdrawal by Subject|1|||
126385626|NCT01309997|454707514|FG001|Overall Study|Withdrawal by Subject|1|||
126385627|NCT03462641|454707515|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
126385628|NCT03462641|454707516|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
126385629|NCT03462641|454707515|FG000|Visit 2|Withdrawal by Subject|0|||
126385630|NCT03462641|454707516|FG001|Visit 2|Withdrawal by Subject|1|||
126385631|NCT00372619|454707517|FG000|Overall Study|Ineligible|0|||
126385632|NCT00372619|454707518|FG001|Overall Study|Ineligible|0|||
126385633|NCT00372619|454707519|FG002|Overall Study|Ineligible|0|||
126385634|NCT00372619|454707520|FG003|Overall Study|Ineligible|0|||
126385635|NCT00372619|454707521|FG004|Overall Study|Ineligible|0|||
126385636|NCT00372619|454707522|FG005|Overall Study|Ineligible|2|||
126385637|NCT00372619|454707523|FG006|Overall Study|Ineligible|0|||
126385638|NCT00372619|454707517|FG000|Overall Study|Inevaluable|0|||
126385639|NCT00372619|454707518|FG001|Overall Study|Inevaluable|0|||
126385640|NCT00372619|454707519|FG002|Overall Study|Inevaluable|0|||
126385641|NCT00372619|454707520|FG003|Overall Study|Inevaluable|0|||
126385642|NCT00372619|454707521|FG004|Overall Study|Inevaluable|0|||
126553563|NCT02555371|455322515|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
126553564|NCT02555371|455322516|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
126385643|NCT00372619|454707522|FG005|Overall Study|Inevaluable|1|||
126385644|NCT00372619|454707523|FG006|Overall Study|Inevaluable|0|||
126385645|NCT03748706|454707528|FG000|Overall Study|Lost to Follow-up|1|||
126385646|NCT03517371|454707531|FG000|Overall Study|Adverse Event|8|||
126385647|NCT03517371|454707532|FG001|Overall Study|Adverse Event|9|||
126385648|NCT03517371|454707531|FG000|Overall Study|Lost to Follow-up|1|||
126385649|NCT03517371|454707532|FG001|Overall Study|Lost to Follow-up|2|||
126385650|NCT03517371|454707531|FG000|Overall Study|Withdrawal by Subject|4|||
126385651|NCT03517371|454707532|FG001|Overall Study|Withdrawal by Subject|4|||
126385652|NCT03517371|454707531|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
126385653|NCT03517371|454707532|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
126385654|NCT03517371|454707531|FG000|Overall Study|COVID restrictions|2|||
126385655|NCT03517371|454707532|FG001|Overall Study|COVID restrictions|0|||
126385656|NCT03517371|454707531|FG000|Overall Study|Receiving DBS Surgery|0|||
126385657|NCT03517371|454707532|FG001|Overall Study|Receiving DBS Surgery|1|||
126553565|NCT02555371|455322517|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
126553566|NCT02555371|455322518|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
126553567|NCT03095599|455322519|FG000|Overall Study|Withdrawal by Subject|1|||
126553568|NCT03095599|455322520|FG001|Overall Study|Withdrawal by Subject|0|||
126553569|NCT03095599|455322519|FG000|Overall Study|Lost to Follow-up|1|||
126717514|NCT01043185|455917565|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
126717515|NCT01043185|455917566|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
126717516|NCT01104558|455917567|FG000|Overall Study|Protocol Violation|6|||
126717517|NCT01104558|455917567|FG000|Overall Study|Missing of primary efficacy assessment|10|||
126717518|NCT01104558|455917567|FG000|Overall Study|Missing of genetic analysis results|1|||
126717519|NCT03395197|455917570|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
126385658|NCT05420961|454707533|FG000|Overall Study|Withdrawal by Subject|2|||
126385659|NCT05420961|454707534|FG001|Overall Study|Withdrawal by Subject|1|||
126385660|NCT05420961|454707535|FG002|Overall Study|Withdrawal by Subject|1|||
126385661|NCT05420961|454707536|FG003|Overall Study|Withdrawal by Subject|0|||
126385662|NCT05420961|454707537|FG004|Overall Study|Withdrawal by Subject|0|||
126385663|NCT05420961|454707533|FG000|Overall Study|Lost to Follow-up|0|||
126385664|NCT05420961|454707534|FG001|Overall Study|Lost to Follow-up|0|||
126385665|NCT05420961|454707535|FG002|Overall Study|Lost to Follow-up|1|||
126385666|NCT05420961|454707536|FG003|Overall Study|Lost to Follow-up|0|||
126385667|NCT05420961|454707537|FG004|Overall Study|Lost to Follow-up|0|||
126385668|NCT05420961|454707533|FG000|Overall Study|Randomized by mistake without study treatment|0|||
126385669|NCT05420961|454707534|FG001|Overall Study|Randomized by mistake without study treatment|0|||
126385670|NCT05420961|454707535|FG002|Overall Study|Randomized by mistake without study treatment|1|||
126385671|NCT05420961|454707536|FG003|Overall Study|Randomized by mistake without study treatment|0|||
126385672|NCT05420961|454707537|FG004|Overall Study|Randomized by mistake without study treatment|1|||
126385673|NCT04283656|454707538|FG000|Overall Study|Adverse Event|1|||
126385674|NCT04283656|454707539|FG001|Overall Study|Adverse Event|0|||
126385675|NCT04283656|454707538|FG000|Overall Study|Lost to Follow-up|0|||
126385676|NCT04283656|454707539|FG001|Overall Study|Lost to Follow-up|1|||
126385677|NCT00935493|454707542|FG000|Overall Study|Lost to Follow-up|1|||
126385678|NCT00935493|454707543|FG001|Overall Study|Lost to Follow-up|1|||
126385679|NCT00935493|454707544|FG002|Overall Study|Lost to Follow-up|1|||
126385680|NCT00935493|454707542|FG000|Overall Study|Treatment Discontinued|0|||
126385681|NCT00935493|454707543|FG001|Overall Study|Treatment Discontinued|1|||
126385682|NCT00935493|454707544|FG002|Overall Study|Treatment Discontinued|0|||
126385683|NCT01555073|454707545|FG000|Overall Study|Lost to Follow-up|1|||
126385684|NCT01555073|454707546|FG001|Overall Study|Lost to Follow-up|2|||
126385685|NCT01555073|454707547|FG002|Overall Study|Lost to Follow-up|0|||
126385686|NCT01555073|454707548|FG003|Overall Study|Lost to Follow-up|5|||
126385687|NCT03490292|454707549|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
126385688|NCT03490292|454707550|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
126385689|NCT03490292|454707549|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
126385690|NCT03490292|454707550|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
126385691|NCT03490292|454707549|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
126385692|NCT03490292|454707550|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
126385693|NCT03490292|454707549|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
126385694|NCT03490292|454707550|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
126385695|NCT03490292|454707549|FG000|1 Year Follow Up Post Last Dose|Death|1|||
126385696|NCT03490292|454707550|FG001|1 Year Follow Up Post Last Dose|Death|1|||
126385697|NCT02565147|454707553|FG000|Overall Study|Withdrawal by Subject|5|||
126385698|NCT02565147|454707554|FG001|Overall Study|Withdrawal by Subject|1|||
126385699|NCT02565147|454707553|FG000|Overall Study|Lost to Follow-up|0|||
126385700|NCT02565147|454707554|FG001|Overall Study|Lost to Follow-up|1|||
126385701|NCT02565147|454707553|FG000|Overall Study|Death|1|||
126385702|NCT02565147|454707554|FG001|Overall Study|Death|1|||
126385703|NCT01001767|454707557|FG000|Overall Study|no baseline study performed|1|||
126385704|NCT01001767|454707558|FG001|Overall Study|no baseline study performed|0|||
126385705|NCT01001767|454707557|FG000|Overall Study|Protocol Violation|1|||
126385706|NCT01001767|454707558|FG001|Overall Study|Protocol Violation|0|||
126385707|NCT01001767|454707557|FG000|Overall Study|Lost to Follow-up|1|||
126385708|NCT01001767|454707558|FG001|Overall Study|Lost to Follow-up|0|||
126385709|NCT01001767|454707557|FG000|Overall Study|Physician Decision|1|||
126385710|NCT01001767|454707558|FG001|Overall Study|Physician Decision|0|||
126385711|NCT03098433|454707559|FG000|Overall Study|Withdrawal by Subject|10|||
126385712|NCT01667133|454707560|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
126385713|NCT01667133|454707561|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
126385714|NCT01667133|454707562|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
126385715|NCT01667133|454707563|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
126385716|NCT01667133|454707564|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
126385717|NCT01667133|454707565|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
126385718|NCT01667133|454707566|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
126385719|NCT01667133|454707567|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
126385720|NCT01667133|454707568|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
126385721|NCT01667133|454707569|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
126385722|NCT01667133|454707570|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
126385723|NCT01667133|454707571|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
126385724|NCT01667133|454707560|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385725|NCT01667133|454707561|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126553570|NCT03095599|455322520|FG001|Overall Study|Lost to Follow-up|0|||
126553571|NCT03095599|455322519|FG000|Overall Study|Withdrawal prior to vaccination|1|||
126553572|NCT03095599|455322520|FG001|Overall Study|Withdrawal prior to vaccination|0|||
126553573|NCT00513019|455322522|FG000|Overall Study|Adverse Event|1|||
126553574|NCT00513019|455322523|FG001|Overall Study|Adverse Event|0|||
126553575|NCT00513019|455322522|FG000|Overall Study|Withdrawal by Subject|4|||
126553576|NCT00513019|455322523|FG001|Overall Study|Withdrawal by Subject|5|||
126553577|NCT00742885|455322526|FG000|Overall Study|Lost to Follow-up|1|||
126553578|NCT00742885|455322527|FG001|Overall Study|Lost to Follow-up|0|||
126553579|NCT04781647|455322528|FG000|Overall Study|Study terminated by Sponsor|11|||
126553580|NCT04781647|455322529|FG001|Overall Study|Study terminated by Sponsor|9|||
126553581|NCT04781647|455322530|FG002|Overall Study|Study terminated by Sponsor|9|||
126553582|NCT04781647|455322528|FG000|Overall Study|Withdrawal by Subject|1|||
126553583|NCT04781647|455322529|FG001|Overall Study|Withdrawal by Subject|2|||
126553584|NCT04781647|455322530|FG002|Overall Study|Withdrawal by Subject|0|||
126717520|NCT03395197|455917571|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
126385726|NCT01667133|454707562|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
126385727|NCT01667133|454707563|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385728|NCT01667133|454707564|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385729|NCT01667133|454707565|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385730|NCT01667133|454707566|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385731|NCT01667133|454707567|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385732|NCT01667133|454707568|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385733|NCT01667133|454707569|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385734|NCT01667133|454707570|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385735|NCT01667133|454707571|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
126385736|NCT01667133|454707560|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
126385737|NCT01667133|454707561|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
126385738|NCT01667133|454707562|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
126385739|NCT01667133|454707563|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
126385740|NCT01667133|454707564|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
126385741|NCT01667133|454707565|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
126385742|NCT01667133|454707566|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
126385743|NCT01667133|454707567|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
126385744|NCT01667133|454707568|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
126385745|NCT01667133|454707569|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
126385746|NCT01667133|454707570|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
126385747|NCT01667133|454707571|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
126385748|NCT01667133|454707560|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385749|NCT01667133|454707561|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385750|NCT01667133|454707562|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385751|NCT01667133|454707563|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
126385752|NCT01667133|454707564|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385753|NCT01667133|454707565|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385754|NCT01667133|454707566|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126553585|NCT04781647|455322528|FG000|Overall Study|Adverse Event|0|||
126717521|NCT03395197|455917572|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
126717522|NCT03395197|455917573|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
126385755|NCT01667133|454707567|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385756|NCT01667133|454707568|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385757|NCT01667133|454707569|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385758|NCT01667133|454707570|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385759|NCT01667133|454707571|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
126385760|NCT01667133|454707560|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
126385761|NCT01667133|454707561|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
126385762|NCT01667133|454707562|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
126385763|NCT01667133|454707563|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
126385764|NCT01667133|454707564|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
126385765|NCT01667133|454707565|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
126385766|NCT01667133|454707566|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
126385767|NCT01667133|454707567|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
126385768|NCT01667133|454707568|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
126553586|NCT04781647|455322529|FG001|Overall Study|Adverse Event|1|||
126553587|NCT04781647|455322530|FG002|Overall Study|Adverse Event|1|||
126717523|NCT03395197|455917574|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
126771198|NCT00858234|456117701|FG000|Overall Study|Adverse Event|6|||
126385769|NCT01667133|454707569|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
126385770|NCT01667133|454707570|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
126385771|NCT01667133|454707571|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
126385772|NCT01667133|454707560|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385773|NCT01667133|454707561|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385774|NCT01667133|454707562|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385775|NCT01667133|454707563|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385776|NCT01667133|454707564|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385777|NCT01667133|454707565|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385778|NCT01667133|454707566|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385779|NCT01667133|454707567|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385780|NCT01667133|454707568|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385781|NCT01667133|454707569|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
126385782|NCT01667133|454707570|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385783|NCT01667133|454707571|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
126385784|NCT01667133|454707560|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
126385785|NCT01667133|454707561|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
126385786|NCT01667133|454707562|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
126385787|NCT01667133|454707563|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
126385788|NCT01667133|454707564|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
126385789|NCT01667133|454707565|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
126385790|NCT01667133|454707566|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
126385791|NCT01667133|454707567|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
126385792|NCT01667133|454707568|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
126385793|NCT01667133|454707569|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
126385794|NCT01667133|454707570|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
126385795|NCT01667133|454707571|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
126385796|NCT01667133|454707560|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385797|NCT01667133|454707561|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385798|NCT01667133|454707562|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385799|NCT01667133|454707563|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385800|NCT01667133|454707564|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385801|NCT01667133|454707565|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385802|NCT01667133|454707566|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385803|NCT01667133|454707567|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385804|NCT01667133|454707568|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385805|NCT01667133|454707569|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
126385806|NCT01667133|454707570|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385807|NCT01667133|454707571|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
126385808|NCT01667133|454707560|FG000|Phase 2: Dose-expansion|Death|0|||
126385809|NCT01667133|454707561|FG001|Phase 2: Dose-expansion|Death|0|||
126385810|NCT01667133|454707562|FG002|Phase 2: Dose-expansion|Death|0|||
126385811|NCT01667133|454707563|FG003|Phase 2: Dose-expansion|Death|0|||
126385812|NCT01667133|454707564|FG004|Phase 2: Dose-expansion|Death|0|||
126385813|NCT01667133|454707565|FG005|Phase 2: Dose-expansion|Death|0|||
126385814|NCT01667133|454707566|FG006|Phase 2: Dose-expansion|Death|0|||
126385815|NCT01667133|454707567|FG007|Phase 2: Dose-expansion|Death|0|||
126385816|NCT01667133|454707568|FG008|Phase 2: Dose-expansion|Death|0|||
126385817|NCT01667133|454707569|FG009|Phase 2: Dose-expansion|Death|1|||
126385818|NCT01667133|454707570|FG010|Phase 2: Dose-expansion|Death|0|||
126385819|NCT01667133|454707571|FG011|Phase 2: Dose-expansion|Death|0|||
126385820|NCT01667133|454707560|FG000|Phase 2: Dose-expansion|Other|0|||
126385821|NCT01667133|454707561|FG001|Phase 2: Dose-expansion|Other|0|||
126385822|NCT01667133|454707562|FG002|Phase 2: Dose-expansion|Other|0|||
126385823|NCT01667133|454707563|FG003|Phase 2: Dose-expansion|Other|0|||
126385824|NCT01667133|454707564|FG004|Phase 2: Dose-expansion|Other|0|||
126385825|NCT01667133|454707565|FG005|Phase 2: Dose-expansion|Other|0|||
126385826|NCT01667133|454707566|FG006|Phase 2: Dose-expansion|Other|0|||
126385827|NCT01667133|454707567|FG007|Phase 2: Dose-expansion|Other|0|||
126385828|NCT01667133|454707568|FG008|Phase 2: Dose-expansion|Other|0|||
126385829|NCT01667133|454707569|FG009|Phase 2: Dose-expansion|Other|0|||
126385830|NCT01667133|454707570|FG010|Phase 2: Dose-expansion|Other|0|||
126385831|NCT01667133|454707571|FG011|Phase 2: Dose-expansion|Other|1|||
126385832|NCT01104545|454707575|FG000|Overall Study|Adverse Event|0|||
126385833|NCT01104545|454707576|FG001|Overall Study|Adverse Event|1|||
126385834|NCT01104545|454707577|FG002|Overall Study|Adverse Event|2|||
126385835|NCT02676895|454707579|FG000|Overall Study|Administrative reason|1|||
126385836|NCT02676895|454707580|FG001|Overall Study|Administrative reason|0|||
126385837|NCT02676895|454707581|FG002|Overall Study|Administrative reason|0|||
126385838|NCT02676895|454707579|FG000|Overall Study|Protocol Violation|1|||
126385839|NCT02676895|454707580|FG001|Overall Study|Protocol Violation|0|||
126385840|NCT02676895|454707581|FG002|Overall Study|Protocol Violation|0|||
126385841|NCT02676895|454707579|FG000|Overall Study|Adverse Event|0|||
126385842|NCT02676895|454707580|FG001|Overall Study|Adverse Event|3|||
126385843|NCT02676895|454707581|FG002|Overall Study|Adverse Event|1|||
126385844|NCT02676895|454707579|FG000|Overall Study|Lost to Follow-up|0|||
126385845|NCT02676895|454707580|FG001|Overall Study|Lost to Follow-up|0|||
126385846|NCT02676895|454707581|FG002|Overall Study|Lost to Follow-up|1|||
126385847|NCT02676895|454707579|FG000|Overall Study|Withdrawal by Subject|0|||
126385848|NCT02676895|454707580|FG001|Overall Study|Withdrawal by Subject|0|||
126385849|NCT02676895|454707581|FG002|Overall Study|Withdrawal by Subject|1|||
126385850|NCT00289289|454707582|FG000|Overall Study|Withdrawal by Subject|5|||
126385851|NCT00289289|454707583|FG001|Overall Study|Withdrawal by Subject|3|||
126385852|NCT00289289|454707584|FG002|Overall Study|Withdrawal by Subject|15|||
126385853|NCT00289289|454707582|FG000|Overall Study|Lost to Follow-up|1|||
126385854|NCT00289289|454707583|FG001|Overall Study|Lost to Follow-up|0|||
126385855|NCT00289289|454707584|FG002|Overall Study|Lost to Follow-up|1|||
126385856|NCT00289289|454707582|FG000|Overall Study|Death|4|||
126385857|NCT00289289|454707583|FG001|Overall Study|Death|2|||
126385858|NCT00289289|454707584|FG002|Overall Study|Death|5|||
126385859|NCT00289289|454707582|FG000|Overall Study|No implant attempted|0|||
126385860|NCT00289289|454707583|FG001|Overall Study|No implant attempted|0|||
126385861|NCT00289289|454707584|FG002|Overall Study|No implant attempted|1|||
126385862|NCT00289289|454707582|FG000|Overall Study|Physician Decision|1|||
126385863|NCT00289289|454707583|FG001|Overall Study|Physician Decision|0|||
126385864|NCT00289289|454707584|FG002|Overall Study|Physician Decision|6|||
126385865|NCT00289289|454707582|FG000|Overall Study|Non-study device implanted|2|||
126385866|NCT00289289|454707583|FG001|Overall Study|Non-study device implanted|1|||
126385867|NCT00289289|454707584|FG002|Overall Study|Non-study device implanted|3|||
126385868|NCT00289289|454707582|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
126385869|NCT00289289|454707583|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
126385870|NCT00289289|454707584|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
126385871|NCT00289289|454707582|FG000|Overall Study|Other Exit Reason|6|||
126385872|NCT00289289|454707583|FG001|Overall Study|Other Exit Reason|4|||
126385873|NCT00289289|454707584|FG002|Overall Study|Other Exit Reason|12|||
126385874|NCT03028129|454707592|FG000|Overall Study|Adverse Event|13|||
126385875|NCT03028129|454707593|FG001|Overall Study|Adverse Event|2|||
126385876|NCT03028129|454707592|FG000|Overall Study|Lost to Follow-up|50|||
126385877|NCT03028129|454707593|FG001|Overall Study|Lost to Follow-up|38|||
126385878|NCT03028129|454707592|FG000|Overall Study|Physician Decision|0|||
126385879|NCT03028129|454707593|FG001|Overall Study|Physician Decision|1|||
126385880|NCT03028129|454707592|FG000|Overall Study|Protocol Violation|1|||
126385881|NCT03028129|454707593|FG001|Overall Study|Protocol Violation|1|||
126385882|NCT03028129|454707592|FG000|Overall Study|Withdrawal by Subject|62|||
126385883|NCT03028129|454707593|FG001|Overall Study|Withdrawal by Subject|45|||
126385884|NCT03583359|454707603|FG000|Overall Study|Withdrawal by Subject|15|||
126385885|NCT03583359|454707604|FG001|Overall Study|Withdrawal by Subject|6|||
126385886|NCT03583359|454707603|FG000|Overall Study|Lost to Follow-up|12|||
126385887|NCT03583359|454707604|FG001|Overall Study|Lost to Follow-up|3|||
126385888|NCT03583359|454707603|FG000|Overall Study|Adverse Event|0|||
126385889|NCT03583359|454707604|FG001|Overall Study|Adverse Event|1|||
126385890|NCT03583359|454707603|FG000|Overall Study|Protocol Violation|0|||
126385891|NCT03583359|454707604|FG001|Overall Study|Protocol Violation|1|||
126385892|NCT03583359|454707603|FG000|Overall Study|Other|2|||
126385893|NCT03583359|454707604|FG001|Overall Study|Other|1|||
126385894|NCT01831466|454707605|FG000|Overall Study|Protocol Violation|1|||
126385895|NCT01831466|454707606|FG001|Overall Study|Protocol Violation|1|||
126385896|NCT01831466|454707607|FG002|Overall Study|Protocol Violation|2|||
126717524|NCT03395197|455917575|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
126717525|NCT03395197|455917570|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
126717526|NCT03395197|455917571|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
126717527|NCT03395197|455917572|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
126717528|NCT03395197|455917573|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
126717529|NCT03395197|455917574|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
126771199|NCT00858234|456117701|FG000|Overall Study|Progressive disease|2|||
126385897|NCT01831466|454707608|FG003|Overall Study|Protocol Violation|0|||
126385898|NCT01831466|454707609|FG004|Overall Study|Protocol Violation|0|||
126385899|NCT01831466|454707610|FG005|Overall Study|Protocol Violation|1|||
126385900|NCT01831466|454707611|FG006|Overall Study|Protocol Violation|0|||
126385901|NCT01831466|454707612|FG007|Overall Study|Protocol Violation|0|||
126385902|NCT01831466|454707613|FG008|Overall Study|Protocol Violation|0|||
126385903|NCT01831466|454707614|FG009|Overall Study|Protocol Violation|0|||
126385904|NCT01831466|454707615|FG010|Overall Study|Protocol Violation|0|||
126385905|NCT01831466|454707616|FG011|Overall Study|Protocol Violation|0|||
126385906|NCT01831466|454707605|FG000|Overall Study|Other|2|||
126385907|NCT01831466|454707606|FG001|Overall Study|Other|3|||
126385908|NCT01831466|454707607|FG002|Overall Study|Other|2|||
126385909|NCT01831466|454707608|FG003|Overall Study|Other|2|||
126385910|NCT01831466|454707609|FG004|Overall Study|Other|2|||
126385911|NCT01831466|454707610|FG005|Overall Study|Other|1|||
126385912|NCT01831466|454707611|FG006|Overall Study|Other|0|||
126385913|NCT01831466|454707612|FG007|Overall Study|Other|0|||
126385914|NCT01831466|454707613|FG008|Overall Study|Other|0|||
126385915|NCT01831466|454707614|FG009|Overall Study|Other|0|||
126385916|NCT01831466|454707615|FG010|Overall Study|Other|0|||
126385917|NCT01831466|454707616|FG011|Overall Study|Other|0|||
126385918|NCT01831466|454707605|FG000|Overall Study|Non-compliance with study treatment|2|||
126385919|NCT01831466|454707606|FG001|Overall Study|Non-compliance with study treatment|1|||
126385920|NCT01831466|454707607|FG002|Overall Study|Non-compliance with study treatment|1|||
126385921|NCT01831466|454707608|FG003|Overall Study|Non-compliance with study treatment|0|||
126385922|NCT01831466|454707609|FG004|Overall Study|Non-compliance with study treatment|0|||
126385923|NCT01831466|454707610|FG005|Overall Study|Non-compliance with study treatment|1|||
126385924|NCT01831466|454707611|FG006|Overall Study|Non-compliance with study treatment|0|||
126385925|NCT01831466|454707612|FG007|Overall Study|Non-compliance with study treatment|0|||
126385926|NCT01831466|454707613|FG008|Overall Study|Non-compliance with study treatment|0|||
126385927|NCT01831466|454707614|FG009|Overall Study|Non-compliance with study treatment|0|||
126385928|NCT01831466|454707615|FG010|Overall Study|Non-compliance with study treatment|0|||
126385929|NCT01831466|454707616|FG011|Overall Study|Non-compliance with study treatment|0|||
126385930|NCT01831466|454707605|FG000|Overall Study|Death|0|||
126385931|NCT01831466|454707606|FG001|Overall Study|Death|1|||
126385932|NCT01831466|454707607|FG002|Overall Study|Death|0|||
126385933|NCT01831466|454707608|FG003|Overall Study|Death|0|||
126385934|NCT01831466|454707609|FG004|Overall Study|Death|0|||
126385935|NCT01831466|454707610|FG005|Overall Study|Death|0|||
126385936|NCT01831466|454707611|FG006|Overall Study|Death|0|||
126385937|NCT01831466|454707612|FG007|Overall Study|Death|0|||
126385938|NCT01831466|454707613|FG008|Overall Study|Death|0|||
126385939|NCT01831466|454707614|FG009|Overall Study|Death|0|||
126385940|NCT01831466|454707615|FG010|Overall Study|Death|0|||
126385941|NCT01831466|454707616|FG011|Overall Study|Death|0|||
126385942|NCT01831466|454707605|FG000|Overall Study|Withdrawal by Subject|6|||
126385943|NCT01831466|454707606|FG001|Overall Study|Withdrawal by Subject|3|||
126385944|NCT01831466|454707607|FG002|Overall Study|Withdrawal by Subject|3|||
126385945|NCT01831466|454707608|FG003|Overall Study|Withdrawal by Subject|3|||
126385946|NCT01831466|454707609|FG004|Overall Study|Withdrawal by Subject|3|||
126385947|NCT01831466|454707610|FG005|Overall Study|Withdrawal by Subject|5|||
126385948|NCT01831466|454707611|FG006|Overall Study|Withdrawal by Subject|0|||
126385949|NCT01831466|454707612|FG007|Overall Study|Withdrawal by Subject|0|||
126385950|NCT01831466|454707613|FG008|Overall Study|Withdrawal by Subject|0|||
126385951|NCT01831466|454707614|FG009|Overall Study|Withdrawal by Subject|1|||
126385952|NCT01831466|454707615|FG010|Overall Study|Withdrawal by Subject|0|||
126385953|NCT01831466|454707616|FG011|Overall Study|Withdrawal by Subject|1|||
126385954|NCT01831466|454707605|FG000|Overall Study|Lost to Follow-up|0|||
126385955|NCT01831466|454707606|FG001|Overall Study|Lost to Follow-up|1|||
126385956|NCT01831466|454707607|FG002|Overall Study|Lost to Follow-up|4|||
126385957|NCT01831466|454707608|FG003|Overall Study|Lost to Follow-up|2|||
126385958|NCT01831466|454707609|FG004|Overall Study|Lost to Follow-up|0|||
126385959|NCT01831466|454707610|FG005|Overall Study|Lost to Follow-up|3|||
126385960|NCT01831466|454707611|FG006|Overall Study|Lost to Follow-up|0|||
126385961|NCT01831466|454707612|FG007|Overall Study|Lost to Follow-up|0|||
126385962|NCT01831466|454707613|FG008|Overall Study|Lost to Follow-up|0|||
126385963|NCT01831466|454707614|FG009|Overall Study|Lost to Follow-up|1|||
126385964|NCT01831466|454707615|FG010|Overall Study|Lost to Follow-up|0|||
126385965|NCT01831466|454707616|FG011|Overall Study|Lost to Follow-up|1|||
126385966|NCT01831466|454707605|FG000|Overall Study|Lack of Efficacy|5|||
126385967|NCT01831466|454707606|FG001|Overall Study|Lack of Efficacy|8|||
126385968|NCT01831466|454707607|FG002|Overall Study|Lack of Efficacy|7|||
126385969|NCT01831466|454707608|FG003|Overall Study|Lack of Efficacy|6|||
126385970|NCT01831466|454707609|FG004|Overall Study|Lack of Efficacy|9|||
126385971|NCT01831466|454707610|FG005|Overall Study|Lack of Efficacy|8|||
126385972|NCT01831466|454707611|FG006|Overall Study|Lack of Efficacy|1|||
126385973|NCT01831466|454707612|FG007|Overall Study|Lack of Efficacy|1|||
126385974|NCT01831466|454707613|FG008|Overall Study|Lack of Efficacy|2|||
126553588|NCT04781647|455322528|FG000|Overall Study|Protocol Violation|1|||
126717530|NCT03395197|455917575|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
126553589|NCT04781647|455322529|FG001|Overall Study|Protocol Violation|0|||
126717531|NCT03395197|455917570|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
126385975|NCT01831466|454707614|FG009|Overall Study|Lack of Efficacy|2|||
126385976|NCT01831466|454707615|FG010|Overall Study|Lack of Efficacy|2|||
126385977|NCT01831466|454707616|FG011|Overall Study|Lack of Efficacy|0|||
126553590|NCT04781647|455322530|FG002|Overall Study|Protocol Violation|0|||
126553591|NCT04781647|455322528|FG000|Overall Study|Pregnancy|0|||
126385978|NCT01831466|454707605|FG000|Overall Study|Adverse Event|0|||
126385979|NCT01831466|454707606|FG001|Overall Study|Adverse Event|0|||
126385980|NCT01831466|454707607|FG002|Overall Study|Adverse Event|4|||
126385981|NCT01831466|454707608|FG003|Overall Study|Adverse Event|6|||
126385982|NCT01831466|454707609|FG004|Overall Study|Adverse Event|3|||
126385983|NCT01831466|454707610|FG005|Overall Study|Adverse Event|7|||
126385984|NCT01831466|454707611|FG006|Overall Study|Adverse Event|0|||
126385985|NCT01831466|454707612|FG007|Overall Study|Adverse Event|1|||
126385986|NCT01831466|454707613|FG008|Overall Study|Adverse Event|1|||
126385987|NCT01831466|454707614|FG009|Overall Study|Adverse Event|1|||
126553592|NCT04781647|455322529|FG001|Overall Study|Pregnancy|0|||
126385988|NCT01831466|454707615|FG010|Overall Study|Adverse Event|0|||
126385989|NCT01831466|454707616|FG011|Overall Study|Adverse Event|2|||
126385990|NCT05356910|454707617|FG000|Overall Study|Lost to Follow-up|10|||
126385991|NCT05356910|454707618|FG001|Overall Study|Lost to Follow-up|19|||
126385992|NCT05356910|454707619|FG002|Overall Study|Lost to Follow-up|0|||
126385993|NCT05356910|454707620|FG003|Overall Study|Lost to Follow-up|0|||
126385994|NCT05356910|454707617|FG000|Overall Study|Withdrawal by Subject|4|||
126385995|NCT05356910|454707618|FG001|Overall Study|Withdrawal by Subject|2|||
126385996|NCT05356910|454707619|FG002|Overall Study|Withdrawal by Subject|0|||
126385997|NCT05356910|454707620|FG003|Overall Study|Withdrawal by Subject|0|||
126385998|NCT03122145|454707621|FG000|Overall Study|Concurrent respiratory disease|3|||
126385999|NCT03122145|454707622|FG001|Overall Study|Concurrent respiratory disease|0|||
126386000|NCT01597908|454707623|FG000|Randomized Phase|Death|217|||
126386001|NCT01597908|454707624|FG001|Randomized Phase|Death|238|||
126386002|NCT01597908|454707625|FG002|Randomized Phase|Death|0|||
126386003|NCT01597908|454707623|FG000|Randomized Phase|Sponsor Decision|93|||
126386004|NCT01597908|454707624|FG001|Randomized Phase|Sponsor Decision|39|||
126386005|NCT01597908|454707625|FG002|Randomized Phase|Sponsor Decision|0|||
126386006|NCT01597908|454707623|FG000|Randomized Phase|Lost to Follow-up|9|||
126386007|NCT01597908|454707624|FG001|Randomized Phase|Lost to Follow-up|16|||
126386008|NCT01597908|454707625|FG002|Randomized Phase|Lost to Follow-up|0|||
126386009|NCT01597908|454707623|FG000|Randomized Phase|Physician Decision|6|||
126386010|NCT01597908|454707624|FG001|Randomized Phase|Physician Decision|3|||
126386011|NCT01597908|454707625|FG002|Randomized Phase|Physician Decision|0|||
126386012|NCT01597908|454707623|FG000|Randomized Phase|Withdrawal by Subject|26|||
126386013|NCT01597908|454707624|FG001|Randomized Phase|Withdrawal by Subject|22|||
126386014|NCT01597908|454707625|FG002|Randomized Phase|Withdrawal by Subject|0|||
126386015|NCT01597908|454707623|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
126386016|NCT01597908|454707624|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
126386017|NCT01597908|454707625|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
126386018|NCT01597908|454707623|FG000|Crossover Phase|Death|0|||
126386019|NCT01597908|454707624|FG001|Crossover Phase|Death|0|||
126386020|NCT01597908|454707625|FG002|Crossover Phase|Death|11|||
126386021|NCT01597908|454707623|FG000|Crossover Phase|Withdrawal by Subject|0|||
126386022|NCT01597908|454707624|FG001|Crossover Phase|Withdrawal by Subject|0|||
126386023|NCT01597908|454707625|FG002|Crossover Phase|Withdrawal by Subject|3|||
126386024|NCT01597908|454707623|FG000|Crossover Phase|Sponsor Decision|0|||
126717532|NCT03395197|455917571|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
126717533|NCT03395197|455917572|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
126386025|NCT01597908|454707624|FG001|Crossover Phase|Sponsor Decision|0|||
126386026|NCT01597908|454707625|FG002|Crossover Phase|Sponsor Decision|20|||
126386027|NCT00837161|454707628|FG000|Overall Study|refused hysterectomy|2|||
126386028|NCT01659996|454707631|FG000|Overall Study|Protocol Violation|3|||
126386029|NCT01659996|454707632|FG001|Overall Study|Protocol Violation|3|||
126386030|NCT01659996|454707633|FG002|Overall Study|Protocol Violation|3|||
126386031|NCT01659996|454707631|FG000|Overall Study|Lost to Follow-up|1|||
126386032|NCT01659996|454707632|FG001|Overall Study|Lost to Follow-up|3|||
126386033|NCT01659996|454707633|FG002|Overall Study|Lost to Follow-up|2|||
126386034|NCT01659996|454707631|FG000|Overall Study|Adverse Event|0|||
126386035|NCT01659996|454707632|FG001|Overall Study|Adverse Event|0|||
126386036|NCT01659996|454707633|FG002|Overall Study|Adverse Event|1|||
126386037|NCT01659996|454707631|FG000|Overall Study|Withdrawal by Subject|4|||
126386038|NCT01659996|454707632|FG001|Overall Study|Withdrawal by Subject|1|||
126386039|NCT01659996|454707633|FG002|Overall Study|Withdrawal by Subject|5|||
126717534|NCT03395197|455917573|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
126717535|NCT03395197|455917574|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
126386040|NCT01059864|454707640|FG000|Open-Label Run-In Phase|Adverse Event|7|||
126468441|NCT02607930|455017603|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
126468442|NCT02607930|455017600|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
126468443|NCT02607930|455017601|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
126468444|NCT02607930|455017602|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
126468445|NCT02607930|455017603|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
126468446|NCT02607930|455017600|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
126468447|NCT02607930|455017601|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
126553593|NCT04781647|455322530|FG002|Overall Study|Pregnancy|1|||
126386041|NCT01059864|454707641|FG001|Open-Label Run-In Phase|Adverse Event|0|||
126386042|NCT01059864|454707642|FG002|Open-Label Run-In Phase|Adverse Event|0|||
126386043|NCT01059864|454707640|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
126386044|NCT01059864|454707641|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
126386045|NCT01059864|454707642|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
126386046|NCT01059864|454707640|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
126386047|NCT01059864|454707641|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
126386048|NCT01059864|454707642|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
126386049|NCT01059864|454707640|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
126386050|NCT01059864|454707641|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
126386051|NCT01059864|454707642|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
126386052|NCT01059864|454707640|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
126386053|NCT01059864|454707641|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
126386054|NCT01059864|454707642|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
126386055|NCT01059864|454707640|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
126386056|NCT01059864|454707641|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
126386057|NCT01059864|454707642|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
126386058|NCT00451958|454707643|FG000|CS21A (NCT00451958)|Adverse Event|21|||
126386059|NCT00451958|454707644|FG001|CS21A (NCT00451958)|Adverse Event|34|||
126386060|NCT00451958|454707645|FG002|CS21A (NCT00451958)|Adverse Event|14|||
126386061|NCT00451958|454707646|FG003|CS21A (NCT00451958)|Adverse Event|17|||
126386062|NCT00451958|454707647|FG004|CS21A (NCT00451958)|Adverse Event|0|||
126386063|NCT00451958|454707643|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
126386064|NCT00451958|454707644|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
126386065|NCT00451958|454707645|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
126386066|NCT00451958|454707646|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
126386067|NCT00451958|454707647|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
126386068|NCT00451958|454707643|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
126386069|NCT00451958|454707644|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
126386070|NCT00451958|454707645|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
126386071|NCT00451958|454707646|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
126386072|NCT00451958|454707647|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
126386073|NCT00451958|454707643|FG000|CS21A (NCT00451958)|Physician Decision|2|||
126386074|NCT00451958|454707644|FG001|CS21A (NCT00451958)|Physician Decision|4|||
126386075|NCT00451958|454707645|FG002|CS21A (NCT00451958)|Physician Decision|4|||
126386076|NCT00451958|454707646|FG003|CS21A (NCT00451958)|Physician Decision|4|||
126386077|NCT00451958|454707647|FG004|CS21A (NCT00451958)|Physician Decision|0|||
126386078|NCT00451958|454707643|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
126386079|NCT00451958|454707644|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
126386080|NCT00451958|454707645|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
126386081|NCT00451958|454707646|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
126386082|NCT00451958|454707647|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
126386083|NCT00451958|454707643|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
126386084|NCT00451958|454707644|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
126386085|NCT00451958|454707645|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
126386086|NCT00451958|454707646|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
126386087|NCT00451958|454707647|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
126386088|NCT03281629|454707656|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
126386089|NCT03281629|454707657|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
126386090|NCT03281629|454707656|FG000|Overall Study|Death|0|||
126386091|NCT03281629|454707657|FG001|Overall Study|Death|1|||
126386092|NCT03281629|454707656|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
126386093|NCT03281629|454707657|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
126386094|NCT02175277|454707659|FG000|Overall Study|Protocol-specified Criteria|1|||
126386095|NCT01905943|454709275|FG000|Overall Study|Withdrawal of consent|90|||
126386096|NCT01905943|454709275|FG000|Overall Study|Lost to Follow-up|16|||
126386097|NCT01905943|454709275|FG000|Overall Study|Investigator discretion|7|||
126386098|NCT01905943|454709275|FG000|Overall Study|Death|186|||
126386099|NCT01905943|454709275|FG000|Overall Study|Adverse Event|3|||
126386100|NCT01905943|454709275|FG000|Overall Study|Other|12|||
126386101|NCT02574078|454709276|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386102|NCT02574078|454709277|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386103|NCT02574078|454709278|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386104|NCT02574078|454709279|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386105|NCT02574078|454709280|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386106|NCT02574078|454709281|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126717536|NCT03395197|455917575|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
126717537|NCT03395197|455917570|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
126717538|NCT03395197|455917571|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
126717539|NCT03395197|455917572|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
126717540|NCT03395197|455917573|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
126386107|NCT02574078|454709282|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
126468448|NCT02607930|455017602|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
126386108|NCT02574078|454709283|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386109|NCT02574078|454709284|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126386110|NCT02574078|454709285|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386111|NCT02574078|454709286|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386112|NCT02574078|454709287|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126386113|NCT02574078|454709288|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126553594|NCT04781647|455322528|FG000|Overall Study|Virology rebounded|1|||
126553595|NCT04781647|455322529|FG001|Overall Study|Virology rebounded|0|||
126553596|NCT04781647|455322530|FG002|Overall Study|Virology rebounded|0|||
126553597|NCT01755689|455322531|FG000|Overall Study|Withdrawal by Subject|1|||
126386114|NCT02574078|454709276|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
126386115|NCT02574078|454709277|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
126386116|NCT02574078|454709278|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
126386117|NCT02574078|454709279|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
126386118|NCT02574078|454709280|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
126386119|NCT02574078|454709281|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
126386120|NCT02574078|454709282|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
126386121|NCT02574078|454709283|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
126386122|NCT02574078|454709284|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
126386123|NCT02574078|454709285|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
126386124|NCT02574078|454709286|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
126386125|NCT02574078|454709287|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
126386126|NCT02574078|454709288|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
126386127|NCT02574078|454709276|FG000|Pre-Treatment Period|Other reasons|0|||
126386128|NCT02574078|454709277|FG001|Pre-Treatment Period|Other reasons|0|||
126386129|NCT02574078|454709278|FG002|Pre-Treatment Period|Other reasons|0|||
126386130|NCT02574078|454709279|FG003|Pre-Treatment Period|Other reasons|0|||
126386131|NCT02574078|454709280|FG004|Pre-Treatment Period|Other reasons|0|||
126386132|NCT02574078|454709281|FG005|Pre-Treatment Period|Other reasons|0|||
126386133|NCT02574078|454709282|FG006|Pre-Treatment Period|Other reasons|2|||
126386134|NCT02574078|454709283|FG007|Pre-Treatment Period|Other reasons|0|||
126386135|NCT02574078|454709284|FG008|Pre-Treatment Period|Other reasons|0|||
126386136|NCT02574078|454709285|FG009|Pre-Treatment Period|Other reasons|0|||
126386137|NCT02574078|454709286|FG010|Pre-Treatment Period|Other reasons|2|||
126386138|NCT02574078|454709287|FG011|Pre-Treatment Period|Other reasons|0|||
126386139|NCT02574078|454709288|FG012|Pre-Treatment Period|Other reasons|0|||
126386140|NCT02574078|454709276|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
126386141|NCT02574078|454709277|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
126386142|NCT02574078|454709278|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
126386143|NCT02574078|454709279|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
126386144|NCT02574078|454709280|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
126386145|NCT02574078|454709281|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
126386146|NCT02574078|454709282|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
126386147|NCT02574078|454709283|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
126386148|NCT02574078|454709284|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
126386149|NCT02574078|454709285|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
126386150|NCT02574078|454709286|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
126386151|NCT02574078|454709287|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
126386152|NCT02574078|454709288|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
126386153|NCT02574078|454709276|FG000|Treatment Period|Disease progression|6|||
126386154|NCT02574078|454709277|FG001|Treatment Period|Disease progression|4|||
126386155|NCT02574078|454709278|FG002|Treatment Period|Disease progression|7|||
126386156|NCT02574078|454709279|FG003|Treatment Period|Disease progression|18|||
126386157|NCT02574078|454709280|FG004|Treatment Period|Disease progression|16|||
126386158|NCT02574078|454709281|FG005|Treatment Period|Disease progression|26|||
126386159|NCT02574078|454709282|FG006|Treatment Period|Disease progression|5|||
126386160|NCT02574078|454709283|FG007|Treatment Period|Disease progression|9|||
126386161|NCT02574078|454709284|FG008|Treatment Period|Disease progression|8|||
126386162|NCT02574078|454709285|FG009|Treatment Period|Disease progression|5|||
126386163|NCT02574078|454709286|FG010|Treatment Period|Disease progression|20|||
126386164|NCT02574078|454709287|FG011|Treatment Period|Disease progression|29|||
126386165|NCT02574078|454709288|FG012|Treatment Period|Disease progression|2|||
126386166|NCT02574078|454709276|FG000|Treatment Period|Study drug toxicity|1|||
126386167|NCT02574078|454709277|FG001|Treatment Period|Study drug toxicity|1|||
126386168|NCT02574078|454709278|FG002|Treatment Period|Study drug toxicity|0|||
126386169|NCT02574078|454709279|FG003|Treatment Period|Study drug toxicity|5|||
126386170|NCT02574078|454709280|FG004|Treatment Period|Study drug toxicity|3|||
126386171|NCT02574078|454709281|FG005|Treatment Period|Study drug toxicity|1|||
126386172|NCT02574078|454709282|FG006|Treatment Period|Study drug toxicity|2|||
126386173|NCT02574078|454709283|FG007|Treatment Period|Study drug toxicity|0|||
126386174|NCT02574078|454709284|FG008|Treatment Period|Study drug toxicity|2|||
126386175|NCT02574078|454709285|FG009|Treatment Period|Study drug toxicity|1|||
126386176|NCT02574078|454709286|FG010|Treatment Period|Study drug toxicity|16|||
126386177|NCT02574078|454709287|FG011|Treatment Period|Study drug toxicity|2|||
126386178|NCT02574078|454709288|FG012|Treatment Period|Study drug toxicity|4|||
126386179|NCT02574078|454709276|FG000|Treatment Period|Death|2|||
126386180|NCT02574078|454709277|FG001|Treatment Period|Death|0|||
126386181|NCT02574078|454709278|FG002|Treatment Period|Death|0|||
126386182|NCT02574078|454709279|FG003|Treatment Period|Death|0|||
126386183|NCT02574078|454709280|FG004|Treatment Period|Death|1|||
126553598|NCT01755689|455322532|FG001|Overall Study|Withdrawal by Subject|3|||
126386184|NCT02574078|454709281|FG005|Treatment Period|Death|1|||
126386185|NCT02574078|454709282|FG006|Treatment Period|Death|1|||
126386186|NCT02574078|454709283|FG007|Treatment Period|Death|1|||
126386187|NCT02574078|454709284|FG008|Treatment Period|Death|7|||
126386188|NCT02574078|454709285|FG009|Treatment Period|Death|1|||
126386189|NCT02574078|454709286|FG010|Treatment Period|Death|0|||
126386190|NCT02574078|454709287|FG011|Treatment Period|Death|2|||
126386191|NCT02574078|454709288|FG012|Treatment Period|Death|1|||
126386192|NCT02574078|454709276|FG000|Treatment Period|Adverse event unrelated to drug|0|||
126386193|NCT02574078|454709277|FG001|Treatment Period|Adverse event unrelated to drug|0|||
126386194|NCT02574078|454709278|FG002|Treatment Period|Adverse event unrelated to drug|1|||
126386195|NCT02574078|454709279|FG003|Treatment Period|Adverse event unrelated to drug|0|||
126386196|NCT02574078|454709280|FG004|Treatment Period|Adverse event unrelated to drug|2|||
126386197|NCT02574078|454709281|FG005|Treatment Period|Adverse event unrelated to drug|3|||
126386198|NCT02574078|454709282|FG006|Treatment Period|Adverse event unrelated to drug|0|||
126386199|NCT02574078|454709283|FG007|Treatment Period|Adverse event unrelated to drug|0|||
126386200|NCT02574078|454709284|FG008|Treatment Period|Adverse event unrelated to drug|1|||
126386201|NCT02574078|454709285|FG009|Treatment Period|Adverse event unrelated to drug|2|||
126386202|NCT02574078|454709286|FG010|Treatment Period|Adverse event unrelated to drug|4|||
126386203|NCT02574078|454709287|FG011|Treatment Period|Adverse event unrelated to drug|1|||
126386204|NCT02574078|454709288|FG012|Treatment Period|Adverse event unrelated to drug|0|||
126386205|NCT02574078|454709276|FG000|Treatment Period|Administrative reason by Sponsor|0|||
126386206|NCT02574078|454709277|FG001|Treatment Period|Administrative reason by Sponsor|1|||
126386207|NCT02574078|454709278|FG002|Treatment Period|Administrative reason by Sponsor|0|||
126386208|NCT02574078|454709279|FG003|Treatment Period|Administrative reason by Sponsor|0|||
126386209|NCT02574078|454709280|FG004|Treatment Period|Administrative reason by Sponsor|0|||
126386210|NCT02574078|454709281|FG005|Treatment Period|Administrative reason by Sponsor|0|||
126386211|NCT02574078|454709282|FG006|Treatment Period|Administrative reason by Sponsor|1|||
126386212|NCT02574078|454709283|FG007|Treatment Period|Administrative reason by Sponsor|0|||
126386213|NCT02574078|454709284|FG008|Treatment Period|Administrative reason by Sponsor|0|||
126386214|NCT02574078|454709285|FG009|Treatment Period|Administrative reason by Sponsor|0|||
126386215|NCT02574078|454709286|FG010|Treatment Period|Administrative reason by Sponsor|0|||
126386216|NCT02574078|454709287|FG011|Treatment Period|Administrative reason by Sponsor|0|||
126386217|NCT02574078|454709288|FG012|Treatment Period|Administrative reason by Sponsor|3|||
126386218|NCT02574078|454709276|FG000|Treatment Period|Other reasons|1|||
126386219|NCT02574078|454709277|FG001|Treatment Period|Other reasons|0|||
126386220|NCT02574078|454709278|FG002|Treatment Period|Other reasons|1|||
126386221|NCT02574078|454709279|FG003|Treatment Period|Other reasons|3|||
126386222|NCT02574078|454709280|FG004|Treatment Period|Other reasons|3|||
126386223|NCT02574078|454709281|FG005|Treatment Period|Other reasons|1|||
126386224|NCT02574078|454709282|FG006|Treatment Period|Other reasons|2|||
126386225|NCT02574078|454709283|FG007|Treatment Period|Other reasons|1|||
126386226|NCT02574078|454709284|FG008|Treatment Period|Other reasons|3|||
126386227|NCT02574078|454709285|FG009|Treatment Period|Other reasons|1|||
126386228|NCT02574078|454709286|FG010|Treatment Period|Other reasons|1|||
126386229|NCT02574078|454709287|FG011|Treatment Period|Other reasons|3|||
126386230|NCT02574078|454709288|FG012|Treatment Period|Other reasons|1|||
126386231|NCT02574078|454709276|FG000|Treatment Period|Participant request to stop drug|0|||
126386232|NCT02574078|454709277|FG001|Treatment Period|Participant request to stop drug|0|||
126386233|NCT02574078|454709278|FG002|Treatment Period|Participant request to stop drug|0|||
126386234|NCT02574078|454709279|FG003|Treatment Period|Participant request to stop drug|2|||
126386235|NCT02574078|454709280|FG004|Treatment Period|Participant request to stop drug|4|||
126386236|NCT02574078|454709281|FG005|Treatment Period|Participant request to stop drug|0|||
126386237|NCT02574078|454709282|FG006|Treatment Period|Participant request to stop drug|1|||
126386238|NCT02574078|454709283|FG007|Treatment Period|Participant request to stop drug|0|||
126386239|NCT02574078|454709284|FG008|Treatment Period|Participant request to stop drug|3|||
126386240|NCT02574078|454709285|FG009|Treatment Period|Participant request to stop drug|2|||
126386241|NCT02574078|454709286|FG010|Treatment Period|Participant request to stop drug|2|||
126386242|NCT02574078|454709287|FG011|Treatment Period|Participant request to stop drug|4|||
126386243|NCT02574078|454709288|FG012|Treatment Period|Participant request to stop drug|1|||
126386244|NCT02574078|454709276|FG000|Treatment Period|Participant withdrew consent|0|||
126386245|NCT02574078|454709277|FG001|Treatment Period|Participant withdrew consent|0|||
126717541|NCT03395197|455917574|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
126386246|NCT02574078|454709278|FG002|Treatment Period|Participant withdrew consent|0|||
126386247|NCT02574078|454709279|FG003|Treatment Period|Participant withdrew consent|0|||
126386248|NCT02574078|454709280|FG004|Treatment Period|Participant withdrew consent|1|||
126386249|NCT02574078|454709281|FG005|Treatment Period|Participant withdrew consent|1|||
126386250|NCT02574078|454709282|FG006|Treatment Period|Participant withdrew consent|0|||
126386251|NCT02574078|454709283|FG007|Treatment Period|Participant withdrew consent|1|||
126386252|NCT02574078|454709284|FG008|Treatment Period|Participant withdrew consent|0|||
126386253|NCT02574078|454709285|FG009|Treatment Period|Participant withdrew consent|2|||
126386254|NCT02574078|454709286|FG010|Treatment Period|Participant withdrew consent|1|||
126386255|NCT02574078|454709287|FG011|Treatment Period|Participant withdrew consent|4|||
126553599|NCT01755689|455322533|FG002|Overall Study|Withdrawal by Subject|2|||
126553600|NCT01755689|455322534|FG003|Overall Study|Withdrawal by Subject|1|||
126553601|NCT01755689|455322535|FG004|Overall Study|Withdrawal by Subject|1|||
126553602|NCT01755689|455322531|FG000|Overall Study|Migrated/moved from study area|0|||
126553603|NCT01755689|455322532|FG001|Overall Study|Migrated/moved from study area|1|||
126553604|NCT01755689|455322533|FG002|Overall Study|Migrated/moved from study area|1|||
126553605|NCT01755689|455322534|FG003|Overall Study|Migrated/moved from study area|1|||
126553606|NCT01755689|455322535|FG004|Overall Study|Migrated/moved from study area|1|||
126553607|NCT01755689|455322531|FG000|Overall Study|Lost to Follow-up|1|||
126553608|NCT01755689|455322532|FG001|Overall Study|Lost to Follow-up|0|||
126553609|NCT01755689|455322533|FG002|Overall Study|Lost to Follow-up|1|||
126553610|NCT01755689|455322534|FG003|Overall Study|Lost to Follow-up|0|||
126553611|NCT01755689|455322535|FG004|Overall Study|Lost to Follow-up|2|||
126553612|NCT01755689|455322531|FG000|Overall Study|Pregnancy|1|||
126553613|NCT01755689|455322532|FG001|Overall Study|Pregnancy|1|||
126553614|NCT01755689|455322533|FG002|Overall Study|Pregnancy|2|||
126553615|NCT01755689|455322534|FG003|Overall Study|Pregnancy|4|||
126553616|NCT01755689|455322535|FG004|Overall Study|Pregnancy|2|||
126553617|NCT02955277|455322536|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
126386256|NCT02574078|454709288|FG012|Treatment Period|Participant withdrew consent|1|||
126386257|NCT02574078|454709276|FG000|Treatment Period|Participant no longer meets criteria|0|||
126386258|NCT02574078|454709277|FG001|Treatment Period|Participant no longer meets criteria|0|||
126386259|NCT02574078|454709278|FG002|Treatment Period|Participant no longer meets criteria|0|||
126386260|NCT02574078|454709279|FG003|Treatment Period|Participant no longer meets criteria|0|||
126386261|NCT02574078|454709280|FG004|Treatment Period|Participant no longer meets criteria|1|||
126386262|NCT02574078|454709281|FG005|Treatment Period|Participant no longer meets criteria|0|||
126386263|NCT02574078|454709282|FG006|Treatment Period|Participant no longer meets criteria|0|||
126386264|NCT02574078|454709283|FG007|Treatment Period|Participant no longer meets criteria|0|||
126386265|NCT02574078|454709284|FG008|Treatment Period|Participant no longer meets criteria|0|||
126386266|NCT02574078|454709285|FG009|Treatment Period|Participant no longer meets criteria|1|||
126386267|NCT02574078|454709286|FG010|Treatment Period|Participant no longer meets criteria|1|||
126386268|NCT02574078|454709287|FG011|Treatment Period|Participant no longer meets criteria|1|||
126386269|NCT02574078|454709288|FG012|Treatment Period|Participant no longer meets criteria|0|||
126386270|NCT02574078|454709276|FG000|Treatment Period|Lost to Follow-up|0|||
126553618|NCT02955277|455322537|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
126553619|NCT02955277|455322536|FG000|Post to Follow-up|Lost to Follow-up|8|||
126386271|NCT02574078|454709277|FG001|Treatment Period|Lost to Follow-up|0|||
126386272|NCT02574078|454709278|FG002|Treatment Period|Lost to Follow-up|0|||
126386273|NCT02574078|454709279|FG003|Treatment Period|Lost to Follow-up|0|||
126386274|NCT02574078|454709280|FG004|Treatment Period|Lost to Follow-up|0|||
126386275|NCT02574078|454709281|FG005|Treatment Period|Lost to Follow-up|0|||
126386276|NCT02574078|454709282|FG006|Treatment Period|Lost to Follow-up|0|||
126386277|NCT02574078|454709283|FG007|Treatment Period|Lost to Follow-up|0|||
126386278|NCT02574078|454709284|FG008|Treatment Period|Lost to Follow-up|0|||
126386279|NCT02574078|454709285|FG009|Treatment Period|Lost to Follow-up|1|||
126386280|NCT02574078|454709286|FG010|Treatment Period|Lost to Follow-up|0|||
126386281|NCT02574078|454709287|FG011|Treatment Period|Lost to Follow-up|1|||
126386282|NCT02574078|454709288|FG012|Treatment Period|Lost to Follow-up|0|||
126386283|NCT02574078|454709276|FG000|Treatment Period|Maximum clinical benefit|0|||
126386284|NCT02574078|454709277|FG001|Treatment Period|Maximum clinical benefit|0|||
126386285|NCT02574078|454709278|FG002|Treatment Period|Maximum clinical benefit|0|||
126386286|NCT02574078|454709279|FG003|Treatment Period|Maximum clinical benefit|0|||
126386287|NCT02574078|454709280|FG004|Treatment Period|Maximum clinical benefit|0|||
126386288|NCT02574078|454709281|FG005|Treatment Period|Maximum clinical benefit|0|||
126386289|NCT02574078|454709282|FG006|Treatment Period|Maximum clinical benefit|0|||
126386290|NCT02574078|454709283|FG007|Treatment Period|Maximum clinical benefit|0|||
126386291|NCT02574078|454709284|FG008|Treatment Period|Maximum clinical benefit|0|||
126386292|NCT02574078|454709285|FG009|Treatment Period|Maximum clinical benefit|1|||
126386293|NCT02574078|454709286|FG010|Treatment Period|Maximum clinical benefit|0|||
126386294|NCT02574078|454709287|FG011|Treatment Period|Maximum clinical benefit|0|||
126386295|NCT02574078|454709288|FG012|Treatment Period|Maximum clinical benefit|0|||
126386296|NCT00301262|454709292|FG000|Double Blind Phase (DB)|Adverse Event|1|||
126553620|NCT02955277|455322537|FG001|Post to Follow-up|Lost to Follow-up|11|||
126553621|NCT01809210|455322544|FG000|Overall Study|Withdrawal by Subject|0|||
126553622|NCT01809210|455322545|FG001|Overall Study|Withdrawal by Subject|0|||
126553623|NCT01809210|455322546|FG002|Overall Study|Withdrawal by Subject|1|||
126553624|NCT01809210|455322547|FG003|Overall Study|Withdrawal by Subject|1|||
126553625|NCT01809210|455322548|FG004|Overall Study|Withdrawal by Subject|1|||
126553626|NCT01809210|455322549|FG005|Overall Study|Withdrawal by Subject|0|||
126386297|NCT00301262|454709293|FG001|Double Blind Phase (DB)|Adverse Event|0|||
126386298|NCT00301262|454709292|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
126386299|NCT00301262|454709293|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
126386300|NCT00301262|454709292|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
126386301|NCT00301262|454709293|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
126386302|NCT00301262|454709292|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
126386303|NCT00301262|454709293|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
126386304|NCT00301262|454709292|FG000|Double Blind Phase (DB)|Other|1|||
126386305|NCT00301262|454709293|FG001|Double Blind Phase (DB)|Other|4|||
126386306|NCT00301262|454709292|FG000|Open Label Phase (OL)|Adverse Event|1|||
126386307|NCT00301262|454709293|FG001|Open Label Phase (OL)|Adverse Event|0|||
126386308|NCT00301262|454709292|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
126386309|NCT00301262|454709293|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
126386310|NCT00301262|454709292|FG000|Open Label Phase (OL)|Other|2|||
126386311|NCT00301262|454709293|FG001|Open Label Phase (OL)|Other|0|||
126386312|NCT00368745|454709294|FG000|Double-blind Treatment Period|Adverse Event|6|||
126386313|NCT00368745|454709295|FG001|Double-blind Treatment Period|Adverse Event|6|||
126386314|NCT00368745|454709294|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
126386315|NCT00368745|454709295|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
126386316|NCT00368745|454709294|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
126386317|NCT00368745|454709295|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
126386318|NCT00368745|454709294|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
126386319|NCT00368745|454709295|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
126386320|NCT00368745|454709294|FG000|Double-blind Treatment Period|Other|7|||
126386321|NCT00368745|454709295|FG001|Double-blind Treatment Period|Other|6|||
126386322|NCT01208324|454709296|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
126386323|NCT01208324|454709297|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
126386324|NCT01208324|454709298|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
126386325|NCT01208324|454709299|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
126386326|NCT02707965|454709300|FG000|Overall Study|Withdrawal by Subject|0|||
126386327|NCT02707965|454709301|FG001|Overall Study|Withdrawal by Subject|0|||
126386328|NCT02707965|454709302|FG002|Overall Study|Withdrawal by Subject|1|||
126386329|NCT02707965|454709303|FG003|Overall Study|Withdrawal by Subject|0|||
126386330|NCT02707965|454709304|FG004|Overall Study|Withdrawal by Subject|0|||
126386331|NCT02707965|454709305|FG005|Overall Study|Withdrawal by Subject|0|||
126386332|NCT02707965|454709306|FG006|Overall Study|Withdrawal by Subject|0|||
126386333|NCT02707965|454709307|FG007|Overall Study|Withdrawal by Subject|2|||
126386334|NCT02707965|454709308|FG008|Overall Study|Withdrawal by Subject|0|||
126386335|NCT02707965|454709309|FG009|Overall Study|Withdrawal by Subject|0|||
126386336|NCT02707965|454709310|FG010|Overall Study|Withdrawal by Subject|0|||
126386337|NCT02707965|454709311|FG011|Overall Study|Withdrawal by Subject|0|||
126386338|NCT02707965|454709312|FG012|Overall Study|Withdrawal by Subject|0|||
126386339|NCT02707965|454709313|FG013|Overall Study|Withdrawal by Subject|0|||
126386340|NCT02707965|454709314|FG014|Overall Study|Withdrawal by Subject|0|||
126386341|NCT02707965|454709315|FG015|Overall Study|Withdrawal by Subject|0|||
126386342|NCT02707965|454709300|FG000|Overall Study|PI decisions|0|||
126386343|NCT02707965|454709301|FG001|Overall Study|PI decisions|0|||
126386344|NCT02707965|454709302|FG002|Overall Study|PI decisions|0|||
126386345|NCT02707965|454709303|FG003|Overall Study|PI decisions|0|||
126386346|NCT02707965|454709304|FG004|Overall Study|PI decisions|0|||
126386347|NCT02707965|454709305|FG005|Overall Study|PI decisions|0|||
126386348|NCT02707965|454709306|FG006|Overall Study|PI decisions|0|||
126386349|NCT02707965|454709307|FG007|Overall Study|PI decisions|0|||
126386350|NCT02707965|454709308|FG008|Overall Study|PI decisions|0|||
126386351|NCT02707965|454709309|FG009|Overall Study|PI decisions|0|||
126386352|NCT02707965|454709310|FG010|Overall Study|PI decisions|0|||
126386353|NCT02707965|454709311|FG011|Overall Study|PI decisions|0|||
126386354|NCT02707965|454709312|FG012|Overall Study|PI decisions|0|||
126386355|NCT02707965|454709313|FG013|Overall Study|PI decisions|0|||
126386356|NCT02707965|454709314|FG014|Overall Study|PI decisions|2|||
126386357|NCT02707965|454709315|FG015|Overall Study|PI decisions|0|||
126386358|NCT02707965|454709300|FG000|Overall Study|Protocol deviation|1|||
126386359|NCT02707965|454709301|FG001|Overall Study|Protocol deviation|1|||
126386360|NCT02707965|454709302|FG002|Overall Study|Protocol deviation|0|||
126386361|NCT02707965|454709303|FG003|Overall Study|Protocol deviation|0|||
126386362|NCT02707965|454709304|FG004|Overall Study|Protocol deviation|0|||
126386363|NCT02707965|454709305|FG005|Overall Study|Protocol deviation|0|||
126386364|NCT02707965|454709306|FG006|Overall Study|Protocol deviation|0|||
126386365|NCT02707965|454709307|FG007|Overall Study|Protocol deviation|1|||
126386366|NCT02707965|454709308|FG008|Overall Study|Protocol deviation|0|||
126386367|NCT02707965|454709309|FG009|Overall Study|Protocol deviation|0|||
126386368|NCT02707965|454709310|FG010|Overall Study|Protocol deviation|0|||
126386369|NCT02707965|454709311|FG011|Overall Study|Protocol deviation|0|||
126386370|NCT02707965|454709312|FG012|Overall Study|Protocol deviation|0|||
126386371|NCT02707965|454709313|FG013|Overall Study|Protocol deviation|0|||
126386372|NCT02707965|454709314|FG014|Overall Study|Protocol deviation|0|||
126386373|NCT02707965|454709315|FG015|Overall Study|Protocol deviation|0|||
126386374|NCT00748618|454709317|FG000|Overall Study|Adverse Event|1|||
126386375|NCT00748618|454709318|FG001|Overall Study|Adverse Event|0|||
126386376|NCT02854436|454709319|FG000|Overall Study|Adverse Event|1|||
126386377|NCT02854436|454709319|FG000|Overall Study|Death|208|||
126386378|NCT02854436|454709319|FG000|Overall Study|Lost to Follow-up|5|||
126553627|NCT01809210|455322550|FG006|Overall Study|Withdrawal by Subject|4|||
126553628|NCT01809210|455322544|FG000|Overall Study|Death|1|||
126553629|NCT01809210|455322545|FG001|Overall Study|Death|1|||
126553630|NCT01809210|455322546|FG002|Overall Study|Death|2|||
126553631|NCT01809210|455322547|FG003|Overall Study|Death|0|||
126553632|NCT01809210|455322548|FG004|Overall Study|Death|1|||
126553633|NCT01809210|455322549|FG005|Overall Study|Death|3|||
126553634|NCT01809210|455322550|FG006|Overall Study|Death|1|||
126553635|NCT03699124|455322551|FG000|Overall Study|Adverse Event|6|||
126553636|NCT03699124|455322552|FG001|Overall Study|Adverse Event|5|||
126553637|NCT03699124|455322553|FG002|Overall Study|Adverse Event|2|||
126553638|NCT03699124|455322551|FG000|Overall Study|Death|0|||
126553639|NCT03699124|455322552|FG001|Overall Study|Death|2|||
126553640|NCT03699124|455322553|FG002|Overall Study|Death|0|||
126553641|NCT03699124|455322551|FG000|Overall Study|Lost to Follow-up|20|||
126553642|NCT03699124|455322552|FG001|Overall Study|Lost to Follow-up|16|||
126553643|NCT03699124|455322553|FG002|Overall Study|Lost to Follow-up|15|||
126553644|NCT03699124|455322551|FG000|Overall Study|Protocol Violation|1|||
126553645|NCT03699124|455322552|FG001|Overall Study|Protocol Violation|0|||
126553646|NCT03699124|455322553|FG002|Overall Study|Protocol Violation|0|||
126553647|NCT03699124|455322551|FG000|Overall Study|Withdrawal by Subject|13|||
126553648|NCT03699124|455322552|FG001|Overall Study|Withdrawal by Subject|14|||
126553649|NCT03699124|455322553|FG002|Overall Study|Withdrawal by Subject|13|||
126553650|NCT03699124|455322551|FG000|Overall Study|Other reasons|5|||
126553651|NCT03699124|455322552|FG001|Overall Study|Other reasons|3|||
126553652|NCT03699124|455322553|FG002|Overall Study|Other reasons|10|||
126553653|NCT01118962|455322554|FG000|Overall Study|Adverse Event|2|||
126553654|NCT01118962|455322554|FG000|Overall Study|Lack of Efficacy|1|||
126553655|NCT01118962|455322554|FG000|Overall Study|Protocol Violation|1|||
126553656|NCT01118962|455322554|FG000|Overall Study|Withdrawal by Subject|4|||
126553657|NCT01118962|455322554|FG000|Overall Study|Pregnancy|1|||
126553658|NCT01118962|455322554|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
126553659|NCT03405662|455322560|FG000|Overall Study|COVID-19 restriction|1|||
126553660|NCT03405662|455322561|FG001|Overall Study|COVID-19 restriction|0|||
126553661|NCT03405662|455322560|FG000|Overall Study|unblinding|0|||
126553662|NCT03405662|455322561|FG001|Overall Study|unblinding|1|||
126553663|NCT03405662|455322560|FG000|Overall Study|placement in memory care facility|0|||
126553664|NCT03405662|455322561|FG001|Overall Study|placement in memory care facility|2|||
126553665|NCT01686932|455322565|FG000|Period 1|Adverse Event|1|||
126553666|NCT01686932|455322566|FG001|Period 1|Adverse Event|1|||
126553667|NCT01364727|455322567|FG000|Overall Study|Not Eligible|2|||
126553668|NCT04716881|455322568|FG000|Overall Study|Adverse Event|1|||
126553669|NCT04716881|455322568|FG000|Overall Study|Lost to Follow-up|1|||
126553670|NCT01558674|455322571|FG000|Part 1|Study Terminated by Sponsor|10|||
126553671|NCT01558674|455322572|FG001|Part 1|Study Terminated by Sponsor|0|||
126553672|NCT01558674|455322571|FG000|Part 1|Withdrawal by Subject|1|||
126553673|NCT01558674|455322572|FG001|Part 1|Withdrawal by Subject|0|||
126553674|NCT04147260|455322573|FG000|Overall Study|Adverse Event|1|||
126553675|NCT04147260|455322574|FG001|Overall Study|Adverse Event|0|||
126553676|NCT04147260|455322575|FG002|Overall Study|Adverse Event|1|||
126553677|NCT04147260|455322576|FG003|Overall Study|Adverse Event|2|||
126553678|NCT04147260|455322577|FG004|Overall Study|Adverse Event|0|||
126553679|NCT04147260|455322573|FG000|Overall Study|Withdrawal by Subject|0|||
126553680|NCT04147260|455322574|FG001|Overall Study|Withdrawal by Subject|0|||
126717542|NCT03395197|455917575|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
126386379|NCT02854436|454709319|FG000|Overall Study|Withdrawal by Subject|24|||
126386380|NCT02854436|454709319|FG000|Overall Study|Other|45|||
126386381|NCT02854436|454709319|FG000|Overall Study|Physician Decision|6|||
126386382|NCT01977729|454709320|FG000|Overall Study|Study terminated|1|||
126386383|NCT01268046|454709321|FG000|Overall Study|Withdrawal by Subject|1|||
126386384|NCT01268046|454709322|FG001|Overall Study|Withdrawal by Subject|0|||
126553681|NCT04147260|455322575|FG002|Overall Study|Withdrawal by Subject|1|||
126717543|NCT03395197|455917570|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
126553682|NCT04147260|455322576|FG003|Overall Study|Withdrawal by Subject|1|||
126717544|NCT03395197|455917571|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
126553683|NCT04147260|455322577|FG004|Overall Study|Withdrawal by Subject|0|||
126553684|NCT01555021|455322578|FG000|Overall Study|Lost to Follow-up|1|||
126553685|NCT01555021|455322579|FG001|Overall Study|Lost to Follow-up|2|||
126717545|NCT03395197|455917572|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
126553686|NCT00750893|455322586|FG000|Overall Study|Adverse Event|5|||
126717546|NCT03395197|455917573|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
126553687|NCT00750893|455322586|FG000|Overall Study|Withdrawal by Subject|10|||
126553688|NCT00750893|455322586|FG000|Overall Study|Lost to Follow-up|510|||
126386385|NCT01268046|454709323|FG002|Overall Study|Withdrawal by Subject|0|||
126386386|NCT01268046|454709324|FG003|Overall Study|Withdrawal by Subject|1|||
126553689|NCT00750893|455322586|FG000|Overall Study|Other|17|||
126553690|NCT01734850|455322587|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
126553691|NCT01734850|455322588|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
126386387|NCT01268046|454709321|FG000|Overall Study|Lost to Follow-up|0|||
126386388|NCT01268046|454709322|FG001|Overall Study|Lost to Follow-up|0|||
126386389|NCT01268046|454709323|FG002|Overall Study|Lost to Follow-up|1|||
126386390|NCT01268046|454709324|FG003|Overall Study|Lost to Follow-up|0|||
126386391|NCT00224120|454709325|FG000|Overall Study|Adverse Event|10|||
126386392|NCT00224120|454709326|FG001|Overall Study|Adverse Event|4|||
126386393|NCT00224120|454709325|FG000|Overall Study|Protocol Violation|1|||
126386394|NCT00224120|454709326|FG001|Overall Study|Protocol Violation|0|||
126386395|NCT00224120|454709325|FG000|Overall Study|Withdrawal by Subject|5|||
126386396|NCT00224120|454709326|FG001|Overall Study|Withdrawal by Subject|10|||
126386397|NCT00224120|454709325|FG000|Overall Study|Lack of Efficacy|0|||
126386398|NCT00224120|454709326|FG001|Overall Study|Lack of Efficacy|2|||
126386399|NCT00224120|454709325|FG000|Overall Study|Lost to Follow-up|2|||
126386400|NCT00224120|454709326|FG001|Overall Study|Lost to Follow-up|3|||
126386401|NCT00224120|454709325|FG000|Overall Study|Other|4|||
126386402|NCT00224120|454709326|FG001|Overall Study|Other|5|||
126386403|NCT00282087|454709327|FG000|Overall Study|Death|1|||
126386404|NCT00338286|454709335|FG000|Overall Study|Withdrawal by Subject|50|||
126386405|NCT00338286|454709336|FG001|Overall Study|Withdrawal by Subject|54|||
126386406|NCT00338286|454709335|FG000|Overall Study|Lost to Follow-up|80|||
126386407|NCT00338286|454709336|FG001|Overall Study|Lost to Follow-up|66|||
126386408|NCT00338286|454709335|FG000|Overall Study|Other|103|||
126386409|NCT00338286|454709336|FG001|Overall Study|Other|93|||
126386410|NCT03248531|454709337|FG000|Overall Study|Adverse Event|0|||
126386411|NCT03248531|454709338|FG001|Overall Study|Adverse Event|0|||
126386412|NCT03248531|454709339|FG002|Overall Study|Adverse Event|1|||
126386413|NCT03248531|454709337|FG000|Overall Study|Lost to Follow-up|1|||
126386414|NCT03248531|454709338|FG001|Overall Study|Lost to Follow-up|0|||
126386415|NCT03248531|454709339|FG002|Overall Study|Lost to Follow-up|5|||
126386416|NCT03248531|454709337|FG000|Overall Study|Withdrawal by Subject|3|||
126386417|NCT03248531|454709338|FG001|Overall Study|Withdrawal by Subject|3|||
126386418|NCT03248531|454709339|FG002|Overall Study|Withdrawal by Subject|2|||
126386419|NCT03248531|454709337|FG000|Overall Study|Sponsor Request|0|||
126386420|NCT03248531|454709338|FG001|Overall Study|Sponsor Request|2|||
126386421|NCT03248531|454709339|FG002|Overall Study|Sponsor Request|0|||
126386422|NCT04075513|454709340|FG000|Overall Study|Withdrawal by Subject|2|||
126386423|NCT04075513|454709341|FG001|Overall Study|Withdrawal by Subject|2|||
126386424|NCT04075513|454709340|FG000|Overall Study|Lack of Efficacy|1|||
126386425|NCT04075513|454709341|FG001|Overall Study|Lack of Efficacy|0|||
126386426|NCT04075513|454709340|FG000|Overall Study|Lost to Follow-up|4|||
126386427|NCT04075513|454709341|FG001|Overall Study|Lost to Follow-up|2|||
126386428|NCT04075513|454709340|FG000|Overall Study|Switch to insulin pump|1|||
126386429|NCT04075513|454709341|FG001|Overall Study|Switch to insulin pump|0|||
126386430|NCT01035463|454709342|FG000|Overall Study|Adverse Event|0|||
126386431|NCT01035463|454709343|FG001|Overall Study|Adverse Event|0|||
126386432|NCT01035463|454709344|FG002|Overall Study|Adverse Event|4|||
126386433|NCT01035463|454709345|FG003|Overall Study|Adverse Event|1|||
126386434|NCT01035463|454709346|FG004|Overall Study|Adverse Event|5|||
126386435|NCT01035463|454709347|FG005|Overall Study|Adverse Event|7|||
126386436|NCT01035463|454709342|FG000|Overall Study|Withdrawal by Subject|0|||
126386437|NCT01035463|454709343|FG001|Overall Study|Withdrawal by Subject|2|||
126386438|NCT01035463|454709344|FG002|Overall Study|Withdrawal by Subject|1|||
126386439|NCT01035463|454709345|FG003|Overall Study|Withdrawal by Subject|0|||
126386440|NCT01035463|454709346|FG004|Overall Study|Withdrawal by Subject|1|||
126386441|NCT01035463|454709347|FG005|Overall Study|Withdrawal by Subject|4|||
126386442|NCT01035463|454709342|FG000|Overall Study|Disease progression|0|||
126386443|NCT01035463|454709343|FG001|Overall Study|Disease progression|0|||
126386444|NCT01035463|454709344|FG002|Overall Study|Disease progression|0|||
126386445|NCT01035463|454709345|FG003|Overall Study|Disease progression|0|||
126386446|NCT01035463|454709346|FG004|Overall Study|Disease progression|0|||
126553692|NCT01734850|455322589|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
126386447|NCT01035463|454709347|FG005|Overall Study|Disease progression|3|||
126553693|NCT01734850|455322587|FG000|Overall Study|Not infused due to manufacturing failure|0|||
126553694|NCT01734850|455322588|FG001|Overall Study|Not infused due to manufacturing failure|0|||
126386448|NCT01035463|454709342|FG000|Overall Study|Other Malignancy|0|||
126386449|NCT01035463|454709343|FG001|Overall Study|Other Malignancy|0|||
126386450|NCT01035463|454709344|FG002|Overall Study|Other Malignancy|0|||
126386451|NCT01035463|454709345|FG003|Overall Study|Other Malignancy|0|||
126386452|NCT01035463|454709346|FG004|Overall Study|Other Malignancy|0|||
126386453|NCT01035463|454709347|FG005|Overall Study|Other Malignancy|2|||
126386454|NCT01035463|454709342|FG000|Overall Study|Other|0|||
126386455|NCT01035463|454709343|FG001|Overall Study|Other|0|||
126386456|NCT01035463|454709344|FG002|Overall Study|Other|0|||
126386457|NCT01035463|454709345|FG003|Overall Study|Other|1|||
126386458|NCT01035463|454709346|FG004|Overall Study|Other|0|||
126386459|NCT01035463|454709347|FG005|Overall Study|Other|2|||
126386460|NCT04153981|454709355|FG000|Overall Study|Death|1|||
126386461|NCT04153981|454709355|FG000|Overall Study|Withdrawal by Subject|24|||
126386462|NCT04153981|454709355|FG000|Overall Study|Lost to Follow-up|1|||
126386463|NCT04153981|454709355|FG000|Overall Study|Physician Decision|1|||
126386464|NCT04153981|454709355|FG000|Overall Study|Due to Unavailable Glucometer|1|||
126386465|NCT04153981|454709355|FG000|Overall Study|Covid 19|52|||
126386466|NCT04153981|454709355|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
126386467|NCT04153981|454709355|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
126386468|NCT01355679|454709356|FG000|Overall Study|benign tumor types found at biopsy|2|||
126386469|NCT00964002|454709357|FG000|Overall Study|Protocol Violation|8|||
126386470|NCT00904670|454709360|FG000|Open Label Phase|Withdrawal by Subject|2|||
126386471|NCT00904670|454709361|FG001|Open Label Phase|Withdrawal by Subject|0|||
126386472|NCT00904670|454709360|FG000|Open Label Phase|Adverse Event|2|||
126386473|NCT00904670|454709361|FG001|Open Label Phase|Adverse Event|0|||
126386474|NCT00904670|454709360|FG000|Open Label Phase|Lack of Efficacy|1|||
126386475|NCT00904670|454709361|FG001|Open Label Phase|Lack of Efficacy|0|||
126386476|NCT00904670|454709360|FG000|Open Label Phase|Lost to Follow-up|1|||
126386477|NCT00904670|454709361|FG001|Open Label Phase|Lost to Follow-up|0|||
126386478|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
126386479|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
126386480|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
126386481|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
126386482|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Death|58|||
126386483|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Death|65|||
126386484|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Adverse Event|28|||
126386485|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Adverse Event|40|||
126386486|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Disease Progression|22|||
126386487|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Disease Progression|35|||
126386488|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Other|25|||
126386489|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Other|33|||
126386490|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
126386491|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
126386492|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Noncompliance|8|||
126386493|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Noncompliance|8|||
126386494|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
126386495|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
126386496|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
126386497|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
126386498|NCT00286091|454709362|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
126386499|NCT00286091|454709363|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
126386500|NCT00286091|454709362|FG000|Open-label Treatment Phase|Physician Decision|24|||
126386501|NCT00286091|454709363|FG001|Open-label Treatment Phase|Physician Decision|21|||
126386502|NCT00286091|454709362|FG000|Open-label Treatment Phase|Adverse Event|5|||
126386503|NCT00286091|454709363|FG001|Open-label Treatment Phase|Adverse Event|16|||
126386504|NCT00286091|454709362|FG000|Open-label Treatment Phase|Other|11|||
126386505|NCT00286091|454709363|FG001|Open-label Treatment Phase|Other|11|||
126386506|NCT00286091|454709362|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
126386507|NCT00286091|454709363|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
126386508|NCT00286091|454709362|FG000|Open-label Treatment Phase|Death|10|||
126386509|NCT00286091|454709363|FG001|Open-label Treatment Phase|Death|7|||
126386510|NCT00286091|454709362|FG000|Open-label Treatment Phase|Disease Progression|9|||
126386511|NCT00286091|454709363|FG001|Open-label Treatment Phase|Disease Progression|3|||
126386512|NCT00286091|454709362|FG000|Open-label Treatment Phase|Noncompliance|3|||
126386513|NCT00286091|454709363|FG001|Open-label Treatment Phase|Noncompliance|1|||
126386514|NCT00286091|454709362|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
126386515|NCT00286091|454709363|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
126386516|NCT00286091|454709362|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
126386517|NCT00286091|454709363|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
126386518|NCT00286091|454709362|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
126386519|NCT00286091|454709363|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
126386520|NCT03423238|454709364|FG000|Overall Study|Lost to Follow-up|1|||
126386521|NCT03423238|454709365|FG001|Overall Study|Lost to Follow-up|0|||
126386522|NCT03423238|454709364|FG000|Overall Study|Withdrawal by Subject|1|||
126771200|NCT00858234|456117701|FG000|Overall Study|Status unknown|1|||
126771201|NCT01678924|456117702|FG000|Overall Study|Adverse Event|1|||
126386523|NCT03423238|454709365|FG001|Overall Study|Withdrawal by Subject|0|||
126386524|NCT02036580|454709366|FG000|Overall Study|Withdrawal by Subject|0|||
126386525|NCT02036580|454709367|FG001|Overall Study|Withdrawal by Subject|1|||
126386526|NCT02036580|454709368|FG002|Overall Study|Withdrawal by Subject|0|||
126386527|NCT02036580|454709366|FG000|Overall Study|Adverse Event|1|||
126386528|NCT02036580|454709367|FG001|Overall Study|Adverse Event|0|||
126386529|NCT02036580|454709368|FG002|Overall Study|Adverse Event|0|||
126386530|NCT02584452|454709369|FG000|Overall Study|Physician Decision|1|||
126386531|NCT02584452|454709370|FG001|Overall Study|Physician Decision|1|||
126386532|NCT02584452|454709369|FG000|Overall Study|Lost to Follow-up|1|||
126771202|NCT01678924|456117703|FG001|Overall Study|Adverse Event|1|||
126771203|NCT01678924|456117704|FG002|Overall Study|Adverse Event|0|||
126386533|NCT02584452|454709370|FG001|Overall Study|Lost to Follow-up|1|||
126386534|NCT00923351|454709371|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
126386535|NCT00923351|454709372|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
126386536|NCT00923351|454709373|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
126386537|NCT01536561|454709374|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
126386538|NCT01536561|454709374|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
126386539|NCT01536561|454709374|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
126386540|NCT01536561|454709374|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
126386541|NCT01536561|454709374|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
126386542|NCT01536561|454709374|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
126386543|NCT01221753|454709375|FG000|Overall Study|Adverse Event|1|||
126386544|NCT04552288|454709379|FG000|Overall Study|Death|3|||
126386545|NCT04552288|454709379|FG000|Overall Study|Lost to Follow-up|6|||
126386546|NCT04552288|454709379|FG000|Overall Study|Physician Decision|3|||
126386547|NCT04552288|454709379|FG000|Overall Study|Protocol Violation|9|||
126386548|NCT04552288|454709379|FG000|Overall Study|Withdrawal by Subject|6|||
126386549|NCT04552288|454709379|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
126386550|NCT05285644|454709380|FG000|Overall Study|Adverse Event|3|||
126386551|NCT05285644|454709381|FG001|Overall Study|Adverse Event|3|||
126386552|NCT05285644|454709380|FG000|Overall Study|Withdrawal of Consent|2|||
126386553|NCT05285644|454709381|FG001|Overall Study|Withdrawal of Consent|5|||
126386554|NCT05285644|454709380|FG000|Overall Study|Noncompliance|0|||
126386555|NCT05285644|454709381|FG001|Overall Study|Noncompliance|4|||
126386556|NCT05285644|454709380|FG000|Overall Study|Lost to Follow-up|4|||
126386557|NCT05285644|454709381|FG001|Overall Study|Lost to Follow-up|6|||
126386558|NCT05285644|454709380|FG000|Overall Study|Disallowed Concurrent Medication|1|||
126386559|NCT05285644|454709381|FG001|Overall Study|Disallowed Concurrent Medication|1|||
126386560|NCT05285644|454709380|FG000|Overall Study|Investigator Decision|2|||
126386561|NCT05285644|454709381|FG001|Overall Study|Investigator Decision|0|||
126386562|NCT05285644|454709380|FG000|Overall Study|Protocol Deviation|1|||
126386563|NCT05285644|454709381|FG001|Overall Study|Protocol Deviation|0|||
126386564|NCT05285644|454709380|FG000|Overall Study|As specified in the Clinical Study Report|7|||
126386565|NCT05285644|454709381|FG001|Overall Study|As specified in the Clinical Study Report|3|||
126386566|NCT04532294|454709382|FG000|Overall Study|Withdrawal by Subject|0|||
126386567|NCT04532294|454709383|FG001|Overall Study|Withdrawal by Subject|0|||
126386568|NCT04532294|454709384|FG002|Overall Study|Withdrawal by Subject|1|||
126386569|NCT04532294|454709382|FG000|Overall Study|Participants Not Dosed|0|||
126386570|NCT04532294|454709383|FG001|Overall Study|Participants Not Dosed|0|||
126386571|NCT04532294|454709384|FG002|Overall Study|Participants Not Dosed|2|||
126386572|NCT04295759|454709385|FG000|Overall Study|Lack of Efficacy|9|||
126386573|NCT04295759|454709385|FG000|Overall Study|Death|1|||
126386574|NCT04295759|454709385|FG000|Overall Study|Withdrawal by Subject|2|||
126386575|NCT04295759|454709385|FG000|Overall Study|Deemed ineligible|1|||
126386576|NCT01696981|454709386|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
126386577|NCT01696981|454709387|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
126386578|NCT01696981|454709386|FG000|Overall Study|Died Before Randomization|3|||
126386579|NCT01696981|454709387|FG001|Overall Study|Died Before Randomization|8|||
126386580|NCT01696981|454709386|FG000|Overall Study|Died Before ASU (Control)|278|||
126386581|NCT01696981|454709387|FG001|Overall Study|Died Before ASU (Control)|0|||
126386582|NCT01696981|454709386|FG000|Overall Study|Refused ASU (Control)|920|||
126386583|NCT01696981|454709387|FG001|Overall Study|Refused ASU (Control)|0|||
126386584|NCT01696981|454709386|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
126386585|NCT01696981|454709387|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
126386586|NCT02798315|454709388|FG000|Overall Study|Failure to return|1|||
126386587|NCT03335150|454709390|FG000|Overall Study|Withdrawal by Subject|10|||
126386588|NCT03335150|454709391|FG001|Overall Study|Withdrawal by Subject|4|||
126386589|NCT03335150|454709390|FG000|Overall Study|Adverse Event|0|||
126386590|NCT03335150|454709391|FG001|Overall Study|Adverse Event|1|||
126386591|NCT02097719|454709392|FG000|Overall Study|Subject Withdrew Consent|1|||
126386592|NCT02097719|454709393|FG001|Overall Study|Subject Withdrew Consent|0|||
126386593|NCT02097719|454709392|FG000|Overall Study|Lost to Follow-up|0|||
126386594|NCT02097719|454709393|FG001|Overall Study|Lost to Follow-up|1|||
126386595|NCT02097719|454709392|FG000|Overall Study|Adverse Event|2|||
126386596|NCT02097719|454709393|FG001|Overall Study|Adverse Event|0|||
126386597|NCT03028415|454709394|FG000|Overall Study|Lost to Follow-up|6|||
126386598|NCT03028415|454709395|FG001|Overall Study|Lost to Follow-up|3|||
126386599|NCT03028415|454709394|FG000|Overall Study|Withdrawal by Subject|1|||
126386600|NCT03028415|454709395|FG001|Overall Study|Withdrawal by Subject|0|||
126386601|NCT03028415|454709394|FG000|Overall Study|Discontinued due to COVID-19|1|||
126386602|NCT03028415|454709395|FG001|Overall Study|Discontinued due to COVID-19|0|||
126386603|NCT02907216|454709396|FG000|Overall Study|No benefit to be obtained by continuing|0|||
126386604|NCT02907216|454709397|FG001|Overall Study|No benefit to be obtained by continuing|1|||
126386605|NCT02907216|454709396|FG000|Overall Study|Withdrawal by Subject|1|||
126386606|NCT02907216|454709397|FG001|Overall Study|Withdrawal by Subject|0|||
126386607|NCT01854775|454709398|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
126386608|NCT01854775|454709399|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
126386609|NCT01854775|454709400|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
126386610|NCT01854775|454709398|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
126386611|NCT01854775|454709399|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
126386612|NCT01854775|454709400|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
126386613|NCT01854775|454709398|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
126386614|NCT01854775|454709399|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
126386615|NCT01854775|454709400|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
126386616|NCT01854775|454709398|FG000|Extension Phase|Pregnancy|3|||
126386617|NCT01854775|454709399|FG001|Extension Phase|Pregnancy|0|||
126386618|NCT01854775|454709400|FG002|Extension Phase|Pregnancy|0|||
126386619|NCT01854775|454709398|FG000|Extension Phase|Investigator's Discretion|1|||
126386620|NCT01854775|454709399|FG001|Extension Phase|Investigator's Discretion|0|||
126386621|NCT01854775|454709400|FG002|Extension Phase|Investigator's Discretion|0|||
126386622|NCT01854775|454709398|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
126386623|NCT01854775|454709399|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
126386624|NCT01854775|454709400|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
126386625|NCT01854775|454709398|FG000|Extension Phase|Lost to Follow-up|2|||
126386626|NCT01854775|454709399|FG001|Extension Phase|Lost to Follow-up|0|||
126386627|NCT01854775|454709400|FG002|Extension Phase|Lost to Follow-up|0|||
126386628|NCT01854775|454709398|FG000|Extension Phase|Still on Study|32|||
126386629|NCT01854775|454709399|FG001|Extension Phase|Still on Study|47|||
126386630|NCT01854775|454709400|FG002|Extension Phase|Still on Study|18|||
126386631|NCT04601532|454709403|FG000|Overall Study|Lost to Follow-up|1|||
126386632|NCT04601532|454709404|FG001|Overall Study|Lost to Follow-up|2|||
126386633|NCT04601532|454709403|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
126386634|NCT04601532|454709404|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
126386635|NCT00281099|454709405|FG000|Overall Study|Death|46|||
126386636|NCT00281099|454709406|FG001|Overall Study|Death|57|||
126386637|NCT00281099|454709405|FG000|Overall Study|Lost to Follow-up|10|||
126386638|NCT00281099|454709406|FG001|Overall Study|Lost to Follow-up|19|||
126386639|NCT00281099|454709405|FG000|Overall Study|Withdrawal by Subject|65|||
126386640|NCT00281099|454709406|FG001|Overall Study|Withdrawal by Subject|70|||
126386641|NCT00281099|454709405|FG000|Overall Study|Physician Decision|79|||
126386642|NCT00281099|454709406|FG001|Overall Study|Physician Decision|72|||
126386643|NCT00281099|454709405|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
126386644|NCT00281099|454709406|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
126386645|NCT04621240|454709407|FG000|Overall Study|Withdrawal by Subject|36|||
126386646|NCT03108521|454709408|FG000|Overall Study|Lost to Follow-up|3|||
126386647|NCT03108521|454709409|FG001|Overall Study|Lost to Follow-up|0|||
126386648|NCT03108521|454709408|FG000|Overall Study|Lack of Efficacy|2|||
126386649|NCT03108521|454709409|FG001|Overall Study|Lack of Efficacy|0|||
126386650|NCT03108521|454709408|FG000|Overall Study|Physician Decision|4|||
126386651|NCT03108521|454709409|FG001|Overall Study|Physician Decision|0|||
126386652|NCT03108521|454709408|FG000|Overall Study|Adverse Event|3|||
126386653|NCT03108521|454709409|FG001|Overall Study|Adverse Event|0|||
126386654|NCT06899737|454709410|FG000|Overall Study|Lost to Follow-up|19|||
126386655|NCT06899737|454709411|FG001|Overall Study|Lost to Follow-up|7|||
126386656|NCT01945216|454711297|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
126386657|NCT01945216|454711297|FG000|Overall Study|Protocol Violation|42|||
126386658|NCT01945216|454711297|FG000|Overall Study|CRF not assured by investigators|5|||
126386659|NCT03062280|454711301|FG000|Overall Study|Adverse Event|1|||
126386660|NCT03062280|454711301|FG000|Overall Study|Death|1|||
126386661|NCT03062280|454711301|FG000|Overall Study|Fertility Treatment|2|||
126386662|NCT03062280|454711301|FG000|Overall Study|Physician Decision|2|||
126386663|NCT03062280|454711301|FG000|Overall Study|Pregnancy|5|||
126386664|NCT03062280|454711301|FG000|Overall Study|Withdrawal by Subject|11|||
126386665|NCT04299308|454711302|FG000|Overall Study|Withdrawal by Subject|1|||
126386666|NCT04299308|454711303|FG001|Overall Study|Withdrawal by Subject|0|||
126386667|NCT04299308|454711302|FG000|Overall Study|issue with PET image (1)|1|||
126386668|NCT04299308|454711303|FG001|Overall Study|issue with PET image (1)|0|||
126386669|NCT05258890|454711304|FG000|Overall Study|Patient withdrawal|6|||
126386670|NCT05258890|454711305|FG001|Overall Study|Patient withdrawal|7|||
126386671|NCT05258890|454711304|FG000|Overall Study|Patient lost to follow-up|10|||
126386672|NCT05258890|454711305|FG001|Overall Study|Patient lost to follow-up|3|||
126386673|NCT05258890|454711304|FG000|Overall Study|Social network member withdrawal|1|||
126386674|NCT05258890|454711305|FG001|Overall Study|Social network member withdrawal|0|||
126386675|NCT05258890|454711304|FG000|Overall Study|Social network member lost to follow-up|5|||
126386676|NCT05258890|454711305|FG001|Overall Study|Social network member lost to follow-up|0|||
126386677|NCT05959447|454711308|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
126386678|NCT05959447|454711309|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
126386679|NCT05959447|454711308|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
126386680|NCT05959447|454711309|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
126386681|NCT05959447|454711308|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
126386682|NCT05959447|454711309|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
126386683|NCT05959447|454711308|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
126386684|NCT05959447|454711309|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
126386685|NCT00249808|454711315|FG000|Overall Study|Other|27|||
126386686|NCT00249808|454711315|FG000|Overall Study|Protocol Violation|3|||
126386687|NCT00249808|454711315|FG000|Overall Study|Lost to Follow-up|8|||
126386688|NCT00249808|454711315|FG000|Overall Study|Adverse Event|81|||
126386689|NCT00249808|454711315|FG000|Overall Study|Lack of Efficacy|52|||
126386690|NCT00249808|454711315|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
126386691|NCT02789345|454711316|FG000|Overall Study|Adverse Event|0|||
126386692|NCT02789345|454711317|FG001|Overall Study|Adverse Event|0|||
126386693|NCT02789345|454711318|FG002|Overall Study|Adverse Event|1|||
126386694|NCT02789345|454711316|FG000|Overall Study|Death|0|||
126386695|NCT02789345|454711317|FG001|Overall Study|Death|0|||
126386696|NCT02789345|454711318|FG002|Overall Study|Death|1|||
126386697|NCT02789345|454711316|FG000|Overall Study|Physician Decision|2|||
126386698|NCT02789345|454711317|FG001|Overall Study|Physician Decision|0|||
126386699|NCT02789345|454711318|FG002|Overall Study|Physician Decision|1|||
126386700|NCT02789345|454711316|FG000|Overall Study|Progressive Disease|1|||
126386701|NCT02789345|454711317|FG001|Overall Study|Progressive Disease|3|||
126386702|NCT02789345|454711318|FG002|Overall Study|Progressive Disease|14|||
126386703|NCT01804049|454711319|FG000|Overall Study|Adverse Event|2|||
126386704|NCT01804049|454711320|FG001|Overall Study|Adverse Event|10|||
126386705|NCT01804049|454711319|FG000|Overall Study|Lost to Follow-up|2|||
126386706|NCT01804049|454711320|FG001|Overall Study|Lost to Follow-up|1|||
126386707|NCT01804049|454711319|FG000|Overall Study|Decreased interest/personal|4|||
126386708|NCT01804049|454711320|FG001|Overall Study|Decreased interest/personal|5|||
126386709|NCT01804049|454711319|FG000|Overall Study|Other health concerns|2|||
126386710|NCT01804049|454711320|FG001|Overall Study|Other health concerns|7|||
126386711|NCT01804049|454711319|FG000|Overall Study|Moved out of area|0|||
126386712|NCT01804049|454711320|FG001|Overall Study|Moved out of area|7|||
126386713|NCT01804049|454711319|FG000|Overall Study|other MD recommended|1|||
126386714|NCT01804049|454711320|FG001|Overall Study|other MD recommended|1|||
126386715|NCT01804049|454711319|FG000|Overall Study|Enrollment in dual studies|0|||
126386716|NCT01804049|454711320|FG001|Overall Study|Enrollment in dual studies|1|||
126386717|NCT01147250|454711321|FG000|Overall Study|Lost to Follow-up|14|||
126386718|NCT01147250|454711322|FG001|Overall Study|Lost to Follow-up|11|||
126386719|NCT01147250|454711321|FG000|Overall Study|Withdrawal by Subject|83|||
126386720|NCT01147250|454711322|FG001|Overall Study|Withdrawal by Subject|88|||
126386721|NCT01147250|454711321|FG000|Overall Study|Site termination by sponsor|13|||
126386722|NCT01147250|454711322|FG001|Overall Study|Site termination by sponsor|5|||
126386723|NCT01147250|454711321|FG000|Overall Study|Other than specified|0|||
126386724|NCT01147250|454711322|FG001|Overall Study|Other than specified|1|||
126386725|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
126386726|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
126386727|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
126386728|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
126386729|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
126386730|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
126386731|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
126386732|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
126386733|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126386734|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126386735|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126386736|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126386737|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
126386738|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
126386739|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126386740|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126386741|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126386742|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126717547|NCT03395197|455917574|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
126717548|NCT03395197|455917575|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
126386743|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
126717549|NCT03395197|455917570|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
126386744|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
126386745|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
126717550|NCT03395197|455917571|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
126386746|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
126386747|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
126386748|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
126386749|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126717551|NCT03395197|455917572|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
126717552|NCT03395197|455917573|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
126717553|NCT03395197|455917574|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
126717554|NCT03395197|455917575|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
126717555|NCT03395197|455917570|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
126717556|NCT03395197|455917571|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
126717557|NCT03395197|455917572|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
126717558|NCT03395197|455917573|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
126717559|NCT03395197|455917574|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
126386750|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
126717560|NCT03395197|455917575|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
126386751|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126386752|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126386753|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126386754|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126386755|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
126386756|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
126386757|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
126386758|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
126386759|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
126386760|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
126386761|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
126386762|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
126386763|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
126386764|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
126386765|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
126386766|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
126386767|NCT03985943|454711325|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
126386768|NCT03985943|454711326|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
126386769|NCT03985943|454711327|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
126386770|NCT03985943|454711328|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
126386771|NCT03985943|454711329|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
126386772|NCT03985943|454711330|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
126386773|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126717561|NCT03395197|455917570|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
126717562|NCT03395197|455917571|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
126717563|NCT03395197|455917572|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
126717564|NCT03395197|455917573|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
126717565|NCT03395197|455917574|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
126771204|NCT01678924|456117705|FG003|Overall Study|Adverse Event|1|||
126771205|NCT01678924|456117702|FG000|Overall Study|Lack of Efficacy|7|||
126771206|NCT01678924|456117703|FG001|Overall Study|Lack of Efficacy|2|||
126771207|NCT01678924|456117704|FG002|Overall Study|Lack of Efficacy|0|||
126386774|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126386775|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
126386776|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
126386777|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
126386778|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
126386779|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126386780|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126386781|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
126386782|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
126386783|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
126386784|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
126386785|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
126386786|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
126386787|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
126386788|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
126386789|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
126386790|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
126386791|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126386792|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126771208|NCT01678924|456117705|FG003|Overall Study|Lack of Efficacy|5|||
126386793|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126386794|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
126386795|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
126386796|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
126386797|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
126386798|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
126386799|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
126386800|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
126386801|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
126386802|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
126386803|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
126386804|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
126386805|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
126386806|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
126386807|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
126386808|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
126386809|NCT03985943|454711325|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
126386810|NCT03985943|454711326|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
126386811|NCT03985943|454711327|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
126386812|NCT03985943|454711328|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
126386813|NCT03985943|454711329|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
126386814|NCT03985943|454711330|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
126386815|NCT00022763|454711334|FG000|Overall Study|Adverse Event|1|||
126386816|NCT00022763|454711335|FG001|Overall Study|Adverse Event|2|||
126386817|NCT00022763|454711334|FG000|Overall Study|Injection Site Reactions|0|||
126386818|NCT00022763|454711335|FG001|Overall Study|Injection Site Reactions|2|||
126386819|NCT00022763|454711334|FG000|Overall Study|Death|0|||
126386820|NCT00022763|454711335|FG001|Overall Study|Death|1|||
126386821|NCT00022763|454711334|FG000|Overall Study|Lost to Follow-up|0|||
126386822|NCT00022763|454711335|FG001|Overall Study|Lost to Follow-up|3|||
126386823|NCT00022763|454711334|FG000|Overall Study|Withdrawal by Subject|4|||
126386824|NCT00022763|454711335|FG001|Overall Study|Withdrawal by Subject|7|||
126386825|NCT00022763|454711334|FG000|Overall Study|Insufficient Therapy|1|||
126386826|NCT00022763|454711335|FG001|Overall Study|Insufficient Therapy|0|||
126386827|NCT00022763|454711334|FG000|Overall Study|Admin|3|||
126386828|NCT00022763|454711335|FG001|Overall Study|Admin|2|||
126386829|NCT00716482|454711336|FG000|Overall Study|Lost to Follow-up|6|||
126386830|NCT00716482|454711336|FG000|Overall Study|Inadequate acquisition or analysis|50|||
126386831|NCT00716482|454711336|FG000|Overall Study|no pathology obtained|10|||
126386832|NCT00716482|454711336|FG000|Overall Study|technical/machine error|28|||
126386833|NCT00716482|454711336|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
126386834|NCT01092780|454711337|FG000|Washout Period 1|Adverse Event|0|||
126717566|NCT03395197|455917575|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
126717567|NCT03395197|455917570|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
126717568|NCT03395197|455917571|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
126717569|NCT03395197|455917572|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
126386835|NCT01092780|454711338|FG001|Washout Period 1|Adverse Event|1|||
126386836|NCT01092780|454711339|FG002|Washout Period 1|Adverse Event|0|||
126386837|NCT01092780|454711340|FG003|Washout Period 1|Adverse Event|0|||
126386838|NCT01092780|454711337|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
126386839|NCT01092780|454711338|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
126386840|NCT01092780|454711339|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
126386841|NCT01092780|454711340|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
126386842|NCT01092780|454711337|FG000|Washout Period 2|Adverse Event|0|||
126386843|NCT01092780|454711338|FG001|Washout Period 2|Adverse Event|1|||
126717570|NCT03395197|455917573|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
126717571|NCT03395197|455917574|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
126717572|NCT03395197|455917575|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
126386844|NCT01092780|454711339|FG002|Washout Period 2|Adverse Event|1|||
126386845|NCT01092780|454711340|FG003|Washout Period 2|Adverse Event|0|||
126386846|NCT01864148|454711341|FG000|Overall Study|Other|2|||
126386847|NCT01864148|454711342|FG001|Overall Study|Other|1|||
126386848|NCT01864148|454711343|FG002|Overall Study|Other|1|||
126386849|NCT01864148|454711344|FG003|Overall Study|Other|3|||
126386850|NCT01864148|454711345|FG004|Overall Study|Other|1|||
126386851|NCT01864148|454711341|FG000|Overall Study|Death|0|||
126386852|NCT01864148|454711342|FG001|Overall Study|Death|0|||
126386853|NCT01864148|454711343|FG002|Overall Study|Death|0|||
126386854|NCT01864148|454711344|FG003|Overall Study|Death|1|||
126386855|NCT01864148|454711345|FG004|Overall Study|Death|0|||
126386856|NCT01864148|454711341|FG000|Overall Study|Investigator Decision|5|||
126386857|NCT01864148|454711342|FG001|Overall Study|Investigator Decision|0|||
126386858|NCT01864148|454711343|FG002|Overall Study|Investigator Decision|0|||
126386859|NCT01864148|454711344|FG003|Overall Study|Investigator Decision|4|||
126386860|NCT01864148|454711345|FG004|Overall Study|Investigator Decision|6|||
126386861|NCT01864148|454711341|FG000|Overall Study|Withdrawal by Subject|9|||
126386862|NCT01864148|454711342|FG001|Overall Study|Withdrawal by Subject|2|||
126386863|NCT01864148|454711343|FG002|Overall Study|Withdrawal by Subject|6|||
126386864|NCT01864148|454711344|FG003|Overall Study|Withdrawal by Subject|8|||
126386865|NCT01864148|454711345|FG004|Overall Study|Withdrawal by Subject|8|||
126386866|NCT01864148|454711341|FG000|Overall Study|Lost to Follow-up|0|||
126386867|NCT01864148|454711342|FG001|Overall Study|Lost to Follow-up|0|||
126386868|NCT01864148|454711343|FG002|Overall Study|Lost to Follow-up|0|||
126386869|NCT01864148|454711344|FG003|Overall Study|Lost to Follow-up|2|||
126386870|NCT01864148|454711345|FG004|Overall Study|Lost to Follow-up|1|||
126386871|NCT01864148|454711341|FG000|Overall Study|Adverse Event|4|||
126386872|NCT01864148|454711342|FG001|Overall Study|Adverse Event|2|||
126386873|NCT01864148|454711343|FG002|Overall Study|Adverse Event|4|||
126386874|NCT01864148|454711344|FG003|Overall Study|Adverse Event|7|||
126386875|NCT01864148|454711345|FG004|Overall Study|Adverse Event|7|||
126386876|NCT01864148|454711341|FG000|Overall Study|Not Dosed|0|||
126386877|NCT01864148|454711342|FG001|Overall Study|Not Dosed|0|||
126386878|NCT01864148|454711343|FG002|Overall Study|Not Dosed|0|||
126386879|NCT01864148|454711344|FG003|Overall Study|Not Dosed|1|||
126386880|NCT01864148|454711345|FG004|Overall Study|Not Dosed|0|||
126386881|NCT02936869|454711354|FG000|Overall Study|Lost to Follow-up|1|||
126386882|NCT02936869|454711355|FG001|Overall Study|Lost to Follow-up|3|||
126386883|NCT02936869|454711354|FG000|Overall Study|Death|0|||
126386884|NCT02936869|454711355|FG001|Overall Study|Death|1|||
126386885|NCT02936869|454711354|FG000|Overall Study|Legal Case|0|||
126386886|NCT02936869|454711355|FG001|Overall Study|Legal Case|1|||
126386887|NCT02936869|454711354|FG000|Overall Study|Protocol Violation|1|||
126386888|NCT02936869|454711355|FG001|Overall Study|Protocol Violation|0|||
126386889|NCT04004221|454711356|FG000|Overall Study|Death|89|||
126386890|NCT04004221|454711356|FG000|Overall Study|Withdrawal by Subject|5|||
126386891|NCT04004221|454711356|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
126386892|NCT04004221|454711356|FG000|Overall Study|Sponsor Decision|9|||
126386893|NCT04004221|454711356|FG000|Overall Study|Participant refused to enter LTE|1|||
126386894|NCT00506454|454711357|FG000|Overall Study|Withdrawal by Subject|1|||
126386895|NCT00506454|454711358|FG001|Overall Study|Withdrawal by Subject|1|||
126386896|NCT00851552|454711359|FG000|Overall Study|Death|2|||
126386897|NCT00851552|454711359|FG000|Overall Study|Adverse Event|1|||
126386898|NCT00851552|454711359|FG000|Overall Study|Disease Progression|4|||
126386899|NCT02689206|454711360|FG000|Overall Study|Adverse Event|0|||
126386900|NCT02689206|454711361|FG001|Overall Study|Adverse Event|0|||
126386901|NCT02689206|454711362|FG002|Overall Study|Adverse Event|1|||
126717573|NCT03395197|455917570|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
126717574|NCT03395197|455917571|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
126717575|NCT03395197|455917572|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
126717576|NCT03395197|455917573|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
126717577|NCT03395197|455917574|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
126717578|NCT03395197|455917575|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
126717579|NCT03395197|455917570|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
126717580|NCT03395197|455917571|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
126717581|NCT03395197|455917572|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
126717582|NCT03395197|455917573|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
126717583|NCT03395197|455917574|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
126386902|NCT02689206|454711363|FG003|Overall Study|Adverse Event|0|||
126386903|NCT02689206|454711364|FG004|Overall Study|Adverse Event|2|||
126386904|NCT02689206|454711360|FG000|Overall Study|Protocol Violation|1|||
126386905|NCT02689206|454711361|FG001|Overall Study|Protocol Violation|0|||
126386906|NCT02689206|454711362|FG002|Overall Study|Protocol Violation|0|||
126386907|NCT02689206|454711363|FG003|Overall Study|Protocol Violation|1|||
126386908|NCT02689206|454711364|FG004|Overall Study|Protocol Violation|2|||
126386909|NCT02689206|454711360|FG000|Overall Study|Other: Reached stopping criteria|0|||
126468449|NCT02607930|455017603|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
126468450|NCT02607930|455017600|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
126468451|NCT02607930|455017601|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
126468452|NCT02607930|455017602|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
126468453|NCT02607930|455017603|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
126386910|NCT02689206|454711361|FG001|Overall Study|Other: Reached stopping criteria|1|||
126386911|NCT02689206|454711362|FG002|Overall Study|Other: Reached stopping criteria|2|||
126386912|NCT02689206|454711363|FG003|Overall Study|Other: Reached stopping criteria|3|||
126386913|NCT02689206|454711364|FG004|Overall Study|Other: Reached stopping criteria|4|||
126386914|NCT02689206|454711360|FG000|Overall Study|Physician Decision|1|||
126468454|NCT02607930|455017600|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
126468455|NCT02607930|455017601|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
126468456|NCT02607930|455017602|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
126553695|NCT01734850|455322589|FG002|Overall Study|Not infused due to manufacturing failure|1|||
126553696|NCT02204293|455322593|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
126553697|NCT02204293|455322594|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
126553698|NCT02204293|455322595|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
126553699|NCT02204293|455322596|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
126553700|NCT02204293|455322597|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
126553701|NCT02204293|455322598|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
126553702|NCT02204293|455322593|FG000|Core Study Part I|Adverse Event|1|||
126717584|NCT03395197|455917575|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
126717585|NCT03395197|455917570|FG000|Analysis for DDR-Deficient Participants|Death|0|||
126717586|NCT03395197|455917571|FG001|Analysis for DDR-Deficient Participants|Death|0|||
126717587|NCT03395197|455917572|FG002|Analysis for DDR-Deficient Participants|Death|0|||
126717588|NCT03395197|455917573|FG003|Analysis for DDR-Deficient Participants|Death|0|||
126717589|NCT03395197|455917574|FG004|Analysis for DDR-Deficient Participants|Death|1|||
126717590|NCT03395197|455917575|FG005|Analysis for DDR-Deficient Participants|Death|4|||
126717591|NCT03395197|455917570|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
126717592|NCT03395197|455917571|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
126717593|NCT03395197|455917572|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
126717594|NCT03395197|455917573|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
126717595|NCT03395197|455917574|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
126771209|NCT01678924|456117702|FG000|Overall Study|Lost to Follow-up|0|||
126386915|NCT02689206|454711361|FG001|Overall Study|Physician Decision|0|||
126386916|NCT02689206|454711362|FG002|Overall Study|Physician Decision|0|||
126386917|NCT02689206|454711363|FG003|Overall Study|Physician Decision|0|||
126386918|NCT02689206|454711364|FG004|Overall Study|Physician Decision|0|||
126386919|NCT02689206|454711360|FG000|Overall Study|Withdrawal by Subject|1|||
126386920|NCT02689206|454711361|FG001|Overall Study|Withdrawal by Subject|0|||
126386921|NCT02689206|454711362|FG002|Overall Study|Withdrawal by Subject|1|||
126386922|NCT02689206|454711363|FG003|Overall Study|Withdrawal by Subject|0|||
126386923|NCT02689206|454711364|FG004|Overall Study|Withdrawal by Subject|0|||
126386924|NCT01558596|454711367|FG000|Overall Study|Withdrawal by Subject|1|||
126386925|NCT01558596|454711368|FG001|Overall Study|Withdrawal by Subject|0|||
126386926|NCT01558596|454711367|FG000|Overall Study|surgery elsewhere or cancelled|1|||
126386927|NCT01558596|454711368|FG001|Overall Study|surgery elsewhere or cancelled|1|||
126386928|NCT01558596|454711367|FG000|Overall Study|Protocol Violation|1|||
126386929|NCT01558596|454711368|FG001|Overall Study|Protocol Violation|0|||
126386930|NCT01479764|454711370|FG000|Randomized|Adverse Event|1|||
126386931|NCT01479764|454711371|FG001|Randomized|Adverse Event|1|||
126386932|NCT01479764|454711370|FG000|Randomized|Withdrawal by Subject|1|||
126386933|NCT01479764|454711371|FG001|Randomized|Withdrawal by Subject|0|||
126386934|NCT01479764|454711370|FG000|Treated|Lost to Follow-up|0|||
126386935|NCT01479764|454711371|FG001|Treated|Lost to Follow-up|2|||
126386936|NCT00902850|454711373|FG000|Overall Study|Physician Decision|2|||
126386937|NCT00902850|454711374|FG001|Overall Study|Physician Decision|2|||
126386938|NCT00260832|454711375|FG000|Overall Study|Adverse Event|26|||
126386939|NCT00260832|454711376|FG001|Overall Study|Adverse Event|19|||
126386940|NCT00260832|454711375|FG000|Overall Study|Progression|116|||
126386941|NCT00260832|454711376|FG001|Overall Study|Progression|96|||
126386942|NCT00260832|454711375|FG000|Overall Study|Withdrawal by Subject|15|||
126386943|NCT00260832|454711376|FG001|Overall Study|Withdrawal by Subject|17|||
126386944|NCT00260832|454711375|FG000|Overall Study|Physician Decision|15|||
126386945|NCT00260832|454711376|FG001|Overall Study|Physician Decision|9|||
126386946|NCT00260832|454711375|FG000|Overall Study|Death|43|||
126386947|NCT00260832|454711376|FG001|Overall Study|Death|62|||
126386948|NCT00260832|454711375|FG000|Overall Study|Other|10|||
126386949|NCT00260832|454711376|FG001|Overall Study|Other|7|||
126386950|NCT00260832|454711375|FG000|Overall Study|Protocol Violation|3|||
126386951|NCT00260832|454711376|FG001|Overall Study|Protocol Violation|1|||
126386952|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
126386953|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
126386954|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
126386955|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126386956|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126553703|NCT02204293|455322594|FG001|Core Study Part I|Adverse Event|0|||
126386957|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126386958|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126386959|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
126386960|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126386961|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126386962|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126386963|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126386964|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126386965|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
126717596|NCT03395197|455917575|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
126717597|NCT03395197|455917570|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
126717598|NCT03395197|455917571|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
126717599|NCT03395197|455917572|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
126717600|NCT03395197|455917573|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
126386966|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
126386967|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
126386968|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
126386969|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126386970|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126386971|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126386972|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126386973|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
126717601|NCT03395197|455917574|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
126386974|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
126386975|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126386976|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126386977|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126386978|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126386979|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126386980|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
126386981|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
126386982|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
126386983|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
126386984|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
126386985|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
126386986|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
126386987|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126386988|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
126386989|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126386990|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126386991|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126386992|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126386993|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126386994|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
126386995|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
126386996|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
126386997|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126386998|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126386999|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126387000|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126387001|NCT03745638|454711377|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
126387002|NCT03745638|454711378|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
126387003|NCT03745638|454711379|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
126387004|NCT03745638|454711380|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
126387005|NCT03745638|454711381|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
126387006|NCT03745638|454711382|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
126387007|NCT03745638|454711383|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
126387008|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126387009|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126387010|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126387011|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126387012|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126387013|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
126387014|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
126387015|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126387016|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126387017|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126387018|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
126387019|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126387020|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
126387021|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
126387022|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126387023|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126387024|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126387025|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
126387026|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
126387027|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
126387028|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
126387029|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126387030|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126387031|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126387032|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126387033|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
126387034|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
126387035|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126387036|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126387037|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126387038|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126387039|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126387040|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126387041|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
126387042|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126387043|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126387044|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126387045|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126387046|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
126387047|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
126387048|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
126387049|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
126387050|NCT03745638|454711377|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
126387051|NCT03745638|454711378|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
126387052|NCT03745638|454711379|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
126717602|NCT03395197|455917575|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
126717603|NCT03395197|455917570|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
126717604|NCT03395197|455917571|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
126717605|NCT03395197|455917572|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
126717606|NCT03395197|455917573|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
126387053|NCT03745638|454711380|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
126387054|NCT03745638|454711381|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
126387055|NCT03745638|454711382|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
126387056|NCT03745638|454711383|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
126387057|NCT04470050|454711386|FG000|Double-blind Treatment Phase|Adverse Event|0|||
126387058|NCT04470050|454711387|FG001|Double-blind Treatment Phase|Adverse Event|0|||
126387059|NCT04470050|454711388|FG002|Double-blind Treatment Phase|Adverse Event|0|||
126387060|NCT04470050|454711389|FG003|Double-blind Treatment Phase|Adverse Event|1|||
126387061|NCT04470050|454711390|FG004|Double-blind Treatment Phase|Adverse Event|0|||
126387062|NCT04470050|454711391|FG005|Double-blind Treatment Phase|Adverse Event|0|||
126387063|NCT04470050|454711392|FG006|Double-blind Treatment Phase|Adverse Event|0|||
126387064|NCT04470050|454711386|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
126387065|NCT04470050|454711387|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
126387066|NCT04470050|454711388|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
126387067|NCT04470050|454711389|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
126387068|NCT04470050|454711390|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
126387069|NCT04470050|454711391|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
126387070|NCT04470050|454711392|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
126387071|NCT04470050|454711386|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
126387072|NCT04470050|454711387|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
126387073|NCT04470050|454711388|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
126387074|NCT04470050|454711389|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
126387075|NCT04470050|454711390|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
126387076|NCT04470050|454711391|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
126387077|NCT04470050|454711392|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
126387078|NCT03585764|454711395|FG000|Overall Study|Death|3|||
126387079|NCT03585764|454711396|FG001|Overall Study|Death|2|||
126387080|NCT03585764|454711397|FG002|Overall Study|Death|3|||
126387081|NCT03585764|454711398|FG003|Overall Study|Death|0|||
126387082|NCT03585764|454711395|FG000|Overall Study|Lost to Follow-up|0|||
126387083|NCT03585764|454711396|FG001|Overall Study|Lost to Follow-up|1|||
126387084|NCT03585764|454711397|FG002|Overall Study|Lost to Follow-up|0|||
126387085|NCT03585764|454711398|FG003|Overall Study|Lost to Follow-up|0|||
126387086|NCT03585764|454711395|FG000|Overall Study|Physician Decision|0|||
126387087|NCT03585764|454711396|FG001|Overall Study|Physician Decision|0|||
126387088|NCT03585764|454711397|FG002|Overall Study|Physician Decision|2|||
126387089|NCT03585764|454711398|FG003|Overall Study|Physician Decision|0|||
126387090|NCT03640507|454711399|FG000|Overall Study|Withdrawal by Subject|0|||
126387091|NCT03640507|454711400|FG001|Overall Study|Withdrawal by Subject|0|||
126387092|NCT03640507|454711401|FG002|Overall Study|Withdrawal by Subject|1|||
126387093|NCT03604172|454711402|FG000|Overall Study|Lost to Follow-up|1|||
126387094|NCT03604172|454711403|FG001|Overall Study|Lost to Follow-up|2|||
126387095|NCT01270880|454711407|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
126387096|NCT00976716|454711408|FG000|Overall Study|Adverse Event|1|||
126387097|NCT04222699|454711409|FG000|Overall Study|Lost to Follow-up|2|||
126387098|NCT01606176|454711410|FG000|Overall Study|Adverse Event|2|||
126387099|NCT01606176|454711411|FG001|Overall Study|Adverse Event|3|||
126387100|NCT01606176|454711410|FG000|Overall Study|Disease progression|1|||
126387101|NCT01606176|454711411|FG001|Overall Study|Disease progression|0|||
126387102|NCT01606176|454711410|FG000|Overall Study|Withdrawal by Subject|1|||
126387103|NCT01606176|454711411|FG001|Overall Study|Withdrawal by Subject|0|||
126387104|NCT01832493|454711412|FG000|Overall Study|Physician Decision|2|||
126387105|NCT01832493|454711412|FG000|Overall Study|Protocol Violation|4|||
126387106|NCT01832493|454711412|FG000|Overall Study|Unable to place LV lead|2|||
126387107|NCT02993822|454711413|FG000|Overall Study|Lack of Efficacy|1|||
126387108|NCT02993822|454711414|FG001|Overall Study|Lack of Efficacy|1|||
126387109|NCT02993822|454711415|FG002|Overall Study|Lack of Efficacy|0|||
126387110|NCT02993822|454711416|FG003|Overall Study|Lack of Efficacy|0|||
126387111|NCT02993822|454711413|FG000|Overall Study|Protocol Violation|1|||
126387112|NCT02993822|454711414|FG001|Overall Study|Protocol Violation|0|||
126387113|NCT02993822|454711415|FG002|Overall Study|Protocol Violation|0|||
126387114|NCT02993822|454711416|FG003|Overall Study|Protocol Violation|0|||
126387115|NCT02993822|454711413|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
126387116|NCT02993822|454711414|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
126387117|NCT02993822|454711415|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
126387118|NCT02993822|454711416|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
126387119|NCT02993822|454711413|FG000|Overall Study|Adverse Event|3|||
126387120|NCT02993822|454711414|FG001|Overall Study|Adverse Event|1|||
126387121|NCT02993822|454711415|FG002|Overall Study|Adverse Event|7|||
126387122|NCT02993822|454711416|FG003|Overall Study|Adverse Event|0|||
126387123|NCT02993822|454711413|FG000|Overall Study|Withdrawal by Subject|4|||
126387124|NCT02993822|454711414|FG001|Overall Study|Withdrawal by Subject|2|||
126387125|NCT02993822|454711415|FG002|Overall Study|Withdrawal by Subject|2|||
126387126|NCT02993822|454711416|FG003|Overall Study|Withdrawal by Subject|3|||
126387127|NCT02993822|454711413|FG000|Overall Study|Lost to Follow-up|1|||
126387128|NCT02993822|454711414|FG001|Overall Study|Lost to Follow-up|0|||
126387129|NCT02993822|454711415|FG002|Overall Study|Lost to Follow-up|1|||
126387130|NCT02993822|454711416|FG003|Overall Study|Lost to Follow-up|0|||
126387131|NCT01732510|454711417|FG000|Overall Study|Adverse Event|0|||
126387132|NCT01732510|454711418|FG001|Overall Study|Adverse Event|1|||
126387133|NCT01732510|454711419|FG002|Overall Study|Adverse Event|1|||
126387134|NCT01732510|454711420|FG003|Overall Study|Adverse Event|0|||
126387135|NCT01732510|454711421|FG004|Overall Study|Adverse Event|0|||
126387136|NCT01732510|454711422|FG005|Overall Study|Adverse Event|0|||
126387137|NCT01732510|454711423|FG006|Overall Study|Adverse Event|1|||
126387138|NCT01732510|454711417|FG000|Overall Study|Protocol Violation|0|||
126387139|NCT01732510|454711418|FG001|Overall Study|Protocol Violation|0|||
126387140|NCT01732510|454711419|FG002|Overall Study|Protocol Violation|0|||
126387141|NCT01732510|454711420|FG003|Overall Study|Protocol Violation|1|||
126553704|NCT02204293|455322595|FG002|Core Study Part I|Adverse Event|0|||
126553705|NCT02204293|455322596|FG003|Core Study Part I|Adverse Event|0|||
126387142|NCT01732510|454711421|FG004|Overall Study|Protocol Violation|0|||
126387143|NCT01732510|454711422|FG005|Overall Study|Protocol Violation|0|||
126387144|NCT01732510|454711423|FG006|Overall Study|Protocol Violation|0|||
126387145|NCT01732510|454711417|FG000|Overall Study|Withdrawal by Subject|1|||
126387146|NCT01732510|454711418|FG001|Overall Study|Withdrawal by Subject|3|||
126387147|NCT01732510|454711419|FG002|Overall Study|Withdrawal by Subject|2|||
126387148|NCT01732510|454711420|FG003|Overall Study|Withdrawal by Subject|1|||
126387149|NCT01732510|454711421|FG004|Overall Study|Withdrawal by Subject|5|||
126387150|NCT01732510|454711422|FG005|Overall Study|Withdrawal by Subject|0|||
126387151|NCT01732510|454711423|FG006|Overall Study|Withdrawal by Subject|1|||
126387152|NCT01732510|454711417|FG000|Overall Study|Lost to Follow-up|0|||
126387153|NCT01732510|454711418|FG001|Overall Study|Lost to Follow-up|0|||
126387154|NCT01732510|454711419|FG002|Overall Study|Lost to Follow-up|1|||
126387155|NCT01732510|454711420|FG003|Overall Study|Lost to Follow-up|1|||
126387156|NCT01732510|454711421|FG004|Overall Study|Lost to Follow-up|0|||
126387157|NCT01732510|454711422|FG005|Overall Study|Lost to Follow-up|1|||
126387158|NCT01732510|454711423|FG006|Overall Study|Lost to Follow-up|0|||
126387159|NCT01732510|454711417|FG000|Overall Study|Physician Decision|0|||
126387160|NCT01732510|454711418|FG001|Overall Study|Physician Decision|1|||
126387161|NCT01732510|454711419|FG002|Overall Study|Physician Decision|0|||
126387162|NCT01732510|454711420|FG003|Overall Study|Physician Decision|0|||
126387163|NCT01732510|454711421|FG004|Overall Study|Physician Decision|0|||
126387164|NCT01732510|454711422|FG005|Overall Study|Physician Decision|0|||
126387165|NCT01732510|454711423|FG006|Overall Study|Physician Decision|0|||
126387166|NCT01732510|454711417|FG000|Overall Study|Pregnancy|0|||
126387167|NCT01732510|454711418|FG001|Overall Study|Pregnancy|0|||
126387168|NCT01732510|454711419|FG002|Overall Study|Pregnancy|0|||
126387169|NCT01732510|454711420|FG003|Overall Study|Pregnancy|1|||
126387170|NCT01732510|454711421|FG004|Overall Study|Pregnancy|0|||
126387171|NCT01732510|454711422|FG005|Overall Study|Pregnancy|0|||
126387172|NCT01732510|454711423|FG006|Overall Study|Pregnancy|0|||
126387173|NCT01732510|454711417|FG000|Overall Study|Study Terminated By Sponsor|0|||
126387174|NCT01732510|454711418|FG001|Overall Study|Study Terminated By Sponsor|0|||
126387175|NCT01732510|454711419|FG002|Overall Study|Study Terminated By Sponsor|0|||
126387176|NCT01732510|454711420|FG003|Overall Study|Study Terminated By Sponsor|1|||
126387177|NCT01732510|454711421|FG004|Overall Study|Study Terminated By Sponsor|0|||
126387178|NCT01732510|454711422|FG005|Overall Study|Study Terminated By Sponsor|12|||
126387179|NCT01732510|454711423|FG006|Overall Study|Study Terminated By Sponsor|6|||
126387180|NCT00313144|454711424|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
126387181|NCT00313144|454711424|FG000|Overall Study|Death|7|||
126387182|NCT00313144|454711424|FG000|Overall Study|Lost to Follow-up|5|||
126387183|NCT00313144|454711424|FG000|Overall Study|Withdrawal by Subject|4|||
126387184|NCT00313144|454711424|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
126387185|NCT00313144|454711424|FG000|Overall Study|Physician Decision|4|||
126387186|NCT00313144|454711424|FG000|Overall Study|Adverse event - transient|5|||
126387187|NCT00313144|454711424|FG000|Overall Study|Liver transplant|1|||
126387188|NCT00313144|454711424|FG000|Overall Study|Insurance (homecare provider) change|1|||
126387189|NCT00313144|454711424|FG000|Overall Study|Change to different product|1|||
126387190|NCT00313144|454711424|FG000|Overall Study|Due to termination of the study|66|||
126387191|NCT01939977|454711426|FG000|Overall Study|Adverse Event|4|||
126387192|NCT01939977|454711427|FG001|Overall Study|Adverse Event|3|||
126387193|NCT01939977|454711426|FG000|Overall Study|Lack of Efficacy|3|||
126387194|NCT01939977|454711427|FG001|Overall Study|Lack of Efficacy|0|||
126387195|NCT01939977|454711426|FG000|Overall Study|Physician Decision|1|||
126387196|NCT01939977|454711427|FG001|Overall Study|Physician Decision|1|||
126387197|NCT01939977|454711426|FG000|Overall Study|Withdrawal by Subject|0|||
126387198|NCT01939977|454711427|FG001|Overall Study|Withdrawal by Subject|2|||
126387199|NCT01939977|454711426|FG000|Overall Study|Did not meet inclusion criteria|1|||
126387200|NCT01939977|454711427|FG001|Overall Study|Did not meet inclusion criteria|0|||
126387201|NCT01939977|454711426|FG000|Overall Study|Did not receive study medication|0|||
126387202|NCT01939977|454711427|FG001|Overall Study|Did not receive study medication|1|||
126387203|NCT01262560|454711431|FG000|Overall Study|Protocol Violation|0|||
126387204|NCT01262560|454711432|FG001|Overall Study|Protocol Violation|1|||
126387205|NCT01262560|454711433|FG002|Overall Study|Protocol Violation|2|||
126387206|NCT03213938|454711434|FG000|Overall Study|Lost to Follow-up|4|||
126387207|NCT03213938|454711435|FG001|Overall Study|Lost to Follow-up|3|||
126387208|NCT03213938|454711434|FG000|Overall Study|Lack of Efficacy|1|||
126387209|NCT03213938|454711435|FG001|Overall Study|Lack of Efficacy|0|||
126387210|NCT03213938|454711434|FG000|Overall Study|Decline to participate|5|||
126387211|NCT03213938|454711435|FG001|Overall Study|Decline to participate|4|||
126387212|NCT03213938|454711434|FG000|Overall Study|Without reason|4|||
126387213|NCT03213938|454711435|FG001|Overall Study|Without reason|5|||
126387214|NCT04238481|454711436|FG000|Overall Study|Miscellaneous|0|||
126387215|NCT04238481|454711437|FG001|Overall Study|Miscellaneous|1|||
126387216|NCT04238481|454711438|FG002|Overall Study|Miscellaneous|0|||
126387217|NCT04238481|454711439|FG003|Overall Study|Miscellaneous|0|||
126387218|NCT00673231|454711440|FG000|Overall Study|Withdrawal by Subject|14|||
126387219|NCT00673231|454711441|FG001|Overall Study|Withdrawal by Subject|10|||
126387220|NCT00673231|454711442|FG002|Overall Study|Withdrawal by Subject|8|||
126387221|NCT00673231|454711443|FG003|Overall Study|Withdrawal by Subject|6|||
126387222|NCT00673231|454711440|FG000|Overall Study|Adverse Event|6|||
126387223|NCT00673231|454711441|FG001|Overall Study|Adverse Event|5|||
126387224|NCT00673231|454711442|FG002|Overall Study|Adverse Event|9|||
126717607|NCT03395197|455917574|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
126387225|NCT00673231|454711443|FG003|Overall Study|Adverse Event|6|||
126387226|NCT00673231|454711440|FG000|Overall Study|Lost to Follow-up|1|||
126387227|NCT00673231|454711441|FG001|Overall Study|Lost to Follow-up|2|||
126387228|NCT00673231|454711442|FG002|Overall Study|Lost to Follow-up|1|||
126387229|NCT00673231|454711443|FG003|Overall Study|Lost to Follow-up|2|||
126387230|NCT00673231|454711440|FG000|Overall Study|Death|0|||
126387231|NCT00673231|454711441|FG001|Overall Study|Death|0|||
126387232|NCT00673231|454711442|FG002|Overall Study|Death|1|||
126387233|NCT00673231|454711443|FG003|Overall Study|Death|0|||
126387234|NCT00673231|454711440|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
126387235|NCT00673231|454711441|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
126387236|NCT00673231|454711442|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
126553706|NCT02204293|455322597|FG004|Core Study Part I|Adverse Event|0|||
126553707|NCT02204293|455322598|FG005|Core Study Part I|Adverse Event|0|||
126553708|NCT02204293|455322593|FG000|Core Study Part I|Physician Decision|0|||
126553709|NCT02204293|455322594|FG001|Core Study Part I|Physician Decision|3|||
126553710|NCT02204293|455322595|FG002|Core Study Part I|Physician Decision|0|||
126553711|NCT02204293|455322596|FG003|Core Study Part I|Physician Decision|0|||
126553712|NCT02204293|455322597|FG004|Core Study Part I|Physician Decision|0|||
126553713|NCT02204293|455322598|FG005|Core Study Part I|Physician Decision|0|||
126553714|NCT02204293|455322593|FG000|LTE Phase|Study Suspended|0|||
126553715|NCT02204293|455322594|FG001|LTE Phase|Study Suspended|0|||
126553716|NCT02204293|455322595|FG002|LTE Phase|Study Suspended|0|||
126553717|NCT02204293|455322596|FG003|LTE Phase|Study Suspended|0|||
126553718|NCT02204293|455322597|FG004|LTE Phase|Study Suspended|0|||
126553719|NCT02204293|455322598|FG005|LTE Phase|Study Suspended|7|||
126553720|NCT02420327|455322599|FG000|Overall Study|Adverse Event|7|||
126553721|NCT02420327|455322599|FG000|Overall Study|Pregnancy|1|||
126553722|NCT02420327|455322599|FG000|Overall Study|Withdrawal by Subject|6|||
126553723|NCT02420327|455322599|FG000|Overall Study|Lost to Follow-up|1|||
126553724|NCT02420327|455322599|FG000|Overall Study|Protocol Violation|1|||
126553725|NCT00393094|455322601|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
126553726|NCT00393094|455322601|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
126553727|NCT02019602|455322602|FG000|Screening Period|Ineligibility|4|||
126553728|NCT02019602|455322603|FG001|Screening Period|Ineligibility|0|||
126387237|NCT00673231|454711443|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
126387238|NCT03594747|454711444|FG000|Overall Study|Death|78|||
126387239|NCT03594747|454711445|FG001|Overall Study|Death|86|||
126387240|NCT03594747|454711446|FG002|Overall Study|Death|87|||
126553729|NCT02019602|455322602|FG000|Screening Period|Adverse Event|1|||
126553730|NCT02019602|455322603|FG001|Screening Period|Adverse Event|0|||
126553731|NCT00322374|455322604|FG000|Starting Dose|Physician Decision|2|||
126717608|NCT03395197|455917575|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
126387241|NCT03594747|454711444|FG000|Overall Study|Withdrawal by Subject|5|||
126387242|NCT03594747|454711445|FG001|Overall Study|Withdrawal by Subject|2|||
126387243|NCT03594747|454711446|FG002|Overall Study|Withdrawal by Subject|11|||
126387244|NCT03594747|454711444|FG000|Overall Study|Lost to Follow-up|4|||
126387245|NCT03594747|454711445|FG001|Overall Study|Lost to Follow-up|1|||
126387246|NCT03594747|454711446|FG002|Overall Study|Lost to Follow-up|1|||
126387247|NCT03594747|454711444|FG000|Overall Study|Physician Decision|0|||
126387248|NCT03594747|454711445|FG001|Overall Study|Physician Decision|1|||
126387249|NCT03594747|454711446|FG002|Overall Study|Physician Decision|0|||
126387250|NCT03594747|454711444|FG000|Overall Study|Sponsor decision|23|||
126387251|NCT03594747|454711445|FG001|Overall Study|Sponsor decision|17|||
126387252|NCT03594747|454711446|FG002|Overall Study|Sponsor decision|16|||
126387253|NCT03594747|454711444|FG000|Overall Study|Did not meet inclusion criteria|0|||
126387254|NCT03594747|454711445|FG001|Overall Study|Did not meet inclusion criteria|0|||
126387255|NCT03594747|454711446|FG002|Overall Study|Did not meet inclusion criteria|1|||
126387256|NCT03594747|454711444|FG000|Overall Study|Transfer to long term extension study|10|||
126387257|NCT03594747|454711445|FG001|Overall Study|Transfer to long term extension study|12|||
126387258|NCT03594747|454711446|FG002|Overall Study|Transfer to long term extension study|5|||
126387259|NCT02095873|454711449|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
126387260|NCT02095873|454711450|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
126387261|NCT02095873|454711449|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
126387262|NCT02095873|454711450|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
126387263|NCT02095873|454711449|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
126387264|NCT02095873|454711450|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
126387265|NCT00792740|454711451|FG000|Overall Study|Disease Worsening|3|||
126387266|NCT00792740|454711452|FG001|Overall Study|Disease Worsening|2|||
126387267|NCT00792740|454711451|FG000|Overall Study|Personal Reason|1|||
126387268|NCT00792740|454711452|FG001|Overall Study|Personal Reason|0|||
126387269|NCT00792740|454711451|FG000|Overall Study|Adverse Event|1|||
126387270|NCT00792740|454711452|FG001|Overall Study|Adverse Event|3|||
126387271|NCT00792740|454711451|FG000|Overall Study|Patient's withdrawal of consent|0|||
126387272|NCT00792740|454711452|FG001|Overall Study|Patient's withdrawal of consent|1|||
126387273|NCT00792740|454711451|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
126553732|NCT00322374|455322605|FG001|Starting Dose|Physician Decision|0|||
126553733|NCT00322374|455322606|FG002|Starting Dose|Physician Decision|0|||
126553734|NCT00322374|455322607|FG003|Starting Dose|Physician Decision|0|||
126717609|NCT03395197|455917570|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
126387274|NCT00792740|454711452|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
126387275|NCT00792740|454711451|FG000|Overall Study|Other reasons|0|||
126387276|NCT00792740|454711452|FG001|Overall Study|Other reasons|1|||
126553735|NCT00322374|455322604|FG000|Starting Dose|Study Drug Toxicity|4|||
126553736|NCT00322374|455322605|FG001|Starting Dose|Study Drug Toxicity|0|||
126387277|NCT01063062|454711453|FG000|Overall Study|Patient withdrew consent|0|||
126387278|NCT01063062|454711454|FG001|Overall Study|Patient withdrew consent|1|||
126717610|NCT03395197|455917571|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
126553737|NCT00322374|455322606|FG002|Starting Dose|Study Drug Toxicity|0|||
126553738|NCT00322374|455322607|FG003|Starting Dose|Study Drug Toxicity|0|||
126553739|NCT00322374|455322604|FG000|First Escalation|Documented Disease Progression|0|||
126553740|NCT00322374|455322605|FG001|First Escalation|Documented Disease Progression|6|||
126553741|NCT00322374|455322606|FG002|First Escalation|Documented Disease Progression|0|||
126553742|NCT00322374|455322607|FG003|First Escalation|Documented Disease Progression|0|||
126553743|NCT00322374|455322604|FG000|First Escalation|Physician Decision|0|||
126553744|NCT00322374|455322605|FG001|First Escalation|Physician Decision|12|||
126553745|NCT00322374|455322606|FG002|First Escalation|Physician Decision|0|||
126553746|NCT00322374|455322607|FG003|First Escalation|Physician Decision|0|||
126553747|NCT00322374|455322604|FG000|First Escalation|Study Drug Toxicity|0|||
126553748|NCT00322374|455322605|FG001|First Escalation|Study Drug Toxicity|11|||
126553749|NCT00322374|455322606|FG002|First Escalation|Study Drug Toxicity|0|||
126553750|NCT00322374|455322607|FG003|First Escalation|Study Drug Toxicity|0|||
126553751|NCT00322374|455322604|FG000|First Escalation|Participant Request|0|||
126553752|NCT00322374|455322605|FG001|First Escalation|Participant Request|1|||
126553753|NCT00322374|455322606|FG002|First Escalation|Participant Request|0|||
126553754|NCT00322374|455322607|FG003|First Escalation|Participant Request|0|||
126553755|NCT00322374|455322604|FG000|Second Escalation|Physician Decision|0|||
126553756|NCT00322374|455322605|FG001|Second Escalation|Physician Decision|0|||
126553757|NCT00322374|455322606|FG002|Second Escalation|Physician Decision|5|||
126553758|NCT00322374|455322607|FG003|Second Escalation|Physician Decision|0|||
126553759|NCT00322374|455322604|FG000|Second Escalation|Study Drug Toxicity|0|||
126553760|NCT00322374|455322605|FG001|Second Escalation|Study Drug Toxicity|0|||
126553761|NCT00322374|455322606|FG002|Second Escalation|Study Drug Toxicity|1|||
126553762|NCT00322374|455322607|FG003|Second Escalation|Study Drug Toxicity|0|||
126553763|NCT02788006|455322610|FG000|Overall Study|Patient not treated|1|||
126553764|NCT03050398|455322611|FG000|Overall Study|Study terminated by sponsor|8|||
126553765|NCT00598481|455322612|FG000|Treatment|Physician Decision|1|||
126553766|NCT03523871|455322613|FG000|Overall Study|Death|1|||
126553767|NCT01994720|455322614|FG000|Overall Study|Withdrawal by Subject|46|||
126553768|NCT01994720|455322615|FG001|Overall Study|Withdrawal by Subject|56|||
126553769|NCT01991197|455322616|FG000|Overall Study|Lost to Follow-up|1|||
126553770|NCT01991197|455322617|FG001|Overall Study|Lost to Follow-up|1|||
126553771|NCT01991197|455322616|FG000|Overall Study|Physician Decision|0|||
126553772|NCT01991197|455322617|FG001|Overall Study|Physician Decision|2|||
126553773|NCT01991197|455322616|FG000|Overall Study|Withdrawal by Subject|2|||
126553774|NCT01991197|455322617|FG001|Overall Study|Withdrawal by Subject|0|||
126553775|NCT04285229|455322621|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126553776|NCT04285229|455322622|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126553777|NCT04285229|455322623|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126553778|NCT04285229|455322624|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126553779|NCT04285229|455322625|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126553780|NCT04285229|455322626|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126553781|NCT04285229|455322621|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
126553782|NCT04285229|455322622|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
126553783|NCT04285229|455322623|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
126553784|NCT04285229|455322624|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
126553785|NCT04285229|455322625|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
126553786|NCT04285229|455322626|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
126553787|NCT04285229|455322621|FG000|Extended Treatment Period|Adverse Event|0|||
126553788|NCT04285229|455322622|FG001|Extended Treatment Period|Adverse Event|0|||
126553789|NCT04285229|455322623|FG002|Extended Treatment Period|Adverse Event|0|||
126553790|NCT04285229|455322624|FG003|Extended Treatment Period|Adverse Event|1|||
126553791|NCT04285229|455322625|FG004|Extended Treatment Period|Adverse Event|0|||
126553792|NCT04285229|455322626|FG005|Extended Treatment Period|Adverse Event|0|||
126553793|NCT04285229|455322621|FG000|Extended Treatment Period|Physician Decision|0|||
126553794|NCT04285229|455322622|FG001|Extended Treatment Period|Physician Decision|0|||
126553795|NCT04285229|455322623|FG002|Extended Treatment Period|Physician Decision|1|||
126553796|NCT04285229|455322624|FG003|Extended Treatment Period|Physician Decision|0|||
126553797|NCT04285229|455322625|FG004|Extended Treatment Period|Physician Decision|0|||
126553798|NCT04285229|455322626|FG005|Extended Treatment Period|Physician Decision|0|||
126553799|NCT04285229|455322621|FG000|Follow-up Period|Adverse Event|0|||
126553800|NCT04285229|455322622|FG001|Follow-up Period|Adverse Event|0|||
126553801|NCT04285229|455322623|FG002|Follow-up Period|Adverse Event|0|||
126553802|NCT04285229|455322624|FG003|Follow-up Period|Adverse Event|0|||
126553803|NCT04285229|455322625|FG004|Follow-up Period|Adverse Event|1|||
126553804|NCT04285229|455322626|FG005|Follow-up Period|Adverse Event|4|||
126553805|NCT04285229|455322621|FG000|Follow-up Period|Withdrawal by Subject|0|||
126553806|NCT04285229|455322622|FG001|Follow-up Period|Withdrawal by Subject|0|||
126553807|NCT04285229|455322623|FG002|Follow-up Period|Withdrawal by Subject|0|||
126387279|NCT01063062|454711453|FG000|Overall Study|Adverse Event|2|||
126553808|NCT04285229|455322624|FG003|Follow-up Period|Withdrawal by Subject|0|||
126717611|NCT03395197|455917572|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
126387280|NCT01063062|454711454|FG001|Overall Study|Adverse Event|4|||
126387281|NCT01063062|454711453|FG000|Overall Study|Protocol Violation|5|||
126387282|NCT01063062|454711454|FG001|Overall Study|Protocol Violation|4|||
126387283|NCT01063062|454711453|FG000|Overall Study|Investigator's request|1|||
126387284|NCT01063062|454711454|FG001|Overall Study|Investigator's request|0|||
126387285|NCT01063062|454711453|FG000|Overall Study|Lost to Follow-up|0|||
126387286|NCT01063062|454711454|FG001|Overall Study|Lost to Follow-up|2|||
126387287|NCT01063062|454711453|FG000|Overall Study|Miscellaneous reason|0|||
126387288|NCT01063062|454711454|FG001|Overall Study|Miscellaneous reason|1|||
126387289|NCT02485639|454711459|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
126387290|NCT02485639|454711459|FG000|Overall Study|Early termination|4|||
126387291|NCT02485639|454711459|FG000|Overall Study|Withdrawal by Subject|4|||
126387292|NCT02015481|454711460|FG000|Overall Study|Death|1|||
126387293|NCT02597452|454711461|FG000|Overall Study|testing incomplete|30|||
126387294|NCT02566785|454711468|FG000|Overall Study|Lost to Follow-up|0|||
126387295|NCT02566785|454711469|FG001|Overall Study|Lost to Follow-up|2|||
126387296|NCT02566785|454711468|FG000|Overall Study|Worsening condition|1|||
126387297|NCT02566785|454711469|FG001|Overall Study|Worsening condition|1|||
126387298|NCT02147197|454711470|FG000|Overall Study|Adverse Event|1|||
126387299|NCT02147197|454711471|FG001|Overall Study|Adverse Event|0|||
126387300|NCT02147197|454711472|FG002|Overall Study|Adverse Event|0|||
126387301|NCT02147197|454711470|FG000|Overall Study|Withdrawal of Consent|4|||
126387302|NCT02147197|454711471|FG001|Overall Study|Withdrawal of Consent|3|||
126387303|NCT02147197|454711472|FG002|Overall Study|Withdrawal of Consent|2|||
126387304|NCT02147197|454711470|FG000|Overall Study|Lost to Follow-up|2|||
126387305|NCT02147197|454711471|FG001|Overall Study|Lost to Follow-up|3|||
126387306|NCT02147197|454711472|FG002|Overall Study|Lost to Follow-up|1|||
126387307|NCT02147197|454711470|FG000|Overall Study|Protocol Violation|1|||
126387308|NCT02147197|454711471|FG001|Overall Study|Protocol Violation|0|||
126387309|NCT02147197|454711472|FG002|Overall Study|Protocol Violation|3|||
126387310|NCT02147197|454711470|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126387311|NCT02147197|454711471|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126387312|NCT02147197|454711472|FG002|Overall Study|Other Miscellaneous Reasons|3|||
126387313|NCT02744612|454713621|FG000|Overall Study|Withdrawal by Subject|0|||
126387314|NCT02744612|454713622|FG001|Overall Study|Withdrawal by Subject|2|||
126387315|NCT02712983|454713624|FG000|Treatment Phase|Adverse Event|3|||
126387316|NCT02712983|454713625|FG001|Treatment Phase|Adverse Event|1|||
126387317|NCT02712983|454713626|FG002|Treatment Phase|Adverse Event|1|||
126387318|NCT02712983|454713627|FG003|Treatment Phase|Adverse Event|4|||
126387319|NCT02712983|454713628|FG004|Treatment Phase|Adverse Event|3|||
126387320|NCT02712983|454713629|FG005|Treatment Phase|Adverse Event|0|||
126387321|NCT02712983|454713630|FG006|Treatment Phase|Adverse Event|6|||
126387322|NCT02712983|454713631|FG007|Treatment Phase|Adverse Event|6|||
126387323|NCT02712983|454713632|FG008|Treatment Phase|Adverse Event|1|||
126387324|NCT02712983|454713624|FG000|Treatment Phase|Protocol Deviation|0|||
126387325|NCT02712983|454713625|FG001|Treatment Phase|Protocol Deviation|0|||
126387326|NCT02712983|454713626|FG002|Treatment Phase|Protocol Deviation|0|||
126387327|NCT02712983|454713627|FG003|Treatment Phase|Protocol Deviation|2|||
126387328|NCT02712983|454713628|FG004|Treatment Phase|Protocol Deviation|0|||
126387329|NCT02712983|454713629|FG005|Treatment Phase|Protocol Deviation|0|||
126387330|NCT02712983|454713630|FG006|Treatment Phase|Protocol Deviation|1|||
126387331|NCT02712983|454713631|FG007|Treatment Phase|Protocol Deviation|0|||
126387332|NCT02712983|454713632|FG008|Treatment Phase|Protocol Deviation|0|||
126387333|NCT02712983|454713624|FG000|Treatment Phase|Technical Problems|0|||
126387334|NCT02712983|454713625|FG001|Treatment Phase|Technical Problems|0|||
126387335|NCT02712983|454713626|FG002|Treatment Phase|Technical Problems|0|||
126387336|NCT02712983|454713627|FG003|Treatment Phase|Technical Problems|0|||
126387337|NCT02712983|454713628|FG004|Treatment Phase|Technical Problems|0|||
126387338|NCT02712983|454713629|FG005|Treatment Phase|Technical Problems|0|||
126387339|NCT02712983|454713630|FG006|Treatment Phase|Technical Problems|1|||
126387340|NCT02712983|454713631|FG007|Treatment Phase|Technical Problems|0|||
126387341|NCT02712983|454713632|FG008|Treatment Phase|Technical Problems|0|||
126387342|NCT02712983|454713624|FG000|Treatment Phase|Physician Decision|0|||
126387343|NCT02712983|454713625|FG001|Treatment Phase|Physician Decision|0|||
126387344|NCT02712983|454713626|FG002|Treatment Phase|Physician Decision|0|||
126387345|NCT02712983|454713627|FG003|Treatment Phase|Physician Decision|0|||
126387346|NCT02712983|454713628|FG004|Treatment Phase|Physician Decision|0|||
126387347|NCT02712983|454713629|FG005|Treatment Phase|Physician Decision|0|||
126387348|NCT02712983|454713630|FG006|Treatment Phase|Physician Decision|0|||
126387349|NCT02712983|454713631|FG007|Treatment Phase|Physician Decision|1|||
126387350|NCT02712983|454713632|FG008|Treatment Phase|Physician Decision|1|||
126387351|NCT02712983|454713624|FG000|Treatment Phase|Subject Decision|2|||
126387352|NCT02712983|454713625|FG001|Treatment Phase|Subject Decision|0|||
126387353|NCT02712983|454713626|FG002|Treatment Phase|Subject Decision|0|||
126387354|NCT02712983|454713627|FG003|Treatment Phase|Subject Decision|2|||
126387355|NCT02712983|454713628|FG004|Treatment Phase|Subject Decision|1|||
126387356|NCT02712983|454713629|FG005|Treatment Phase|Subject Decision|0|||
126717612|NCT03395197|455917573|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
126717613|NCT03395197|455917574|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
126717614|NCT03395197|455917575|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
126387357|NCT02712983|454713630|FG006|Treatment Phase|Subject Decision|1|||
126387358|NCT02712983|454713631|FG007|Treatment Phase|Subject Decision|2|||
126387359|NCT02712983|454713632|FG008|Treatment Phase|Subject Decision|0|||
126387360|NCT02712983|454713624|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126387361|NCT02712983|454713625|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
126387362|NCT02712983|454713626|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126387363|NCT02712983|454713627|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126387364|NCT02712983|454713628|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126387365|NCT02712983|454713629|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126387366|NCT02712983|454713630|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
126387367|NCT02712983|454713631|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
126387368|NCT02712983|454713632|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
126387369|NCT02712983|454713624|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387370|NCT02712983|454713625|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387371|NCT02712983|454713626|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387372|NCT02712983|454713627|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
126387373|NCT02712983|454713628|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387374|NCT02712983|454713629|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387375|NCT02712983|454713630|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387376|NCT02712983|454713631|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387377|NCT02712983|454713632|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
126387378|NCT02712983|454713624|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
126387379|NCT02712983|454713625|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
126387380|NCT02712983|454713626|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
126387381|NCT02712983|454713627|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
126387382|NCT02712983|454713628|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
126387383|NCT02712983|454713629|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
126387384|NCT02712983|454713630|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
126387385|NCT02712983|454713631|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
126387386|NCT02712983|454713632|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
126387387|NCT02954406|454713633|FG000|Overall Study|Adverse Event|0|||
126387388|NCT02954406|454713634|FG001|Overall Study|Adverse Event|1|||
126387389|NCT02954406|454713635|FG002|Overall Study|Adverse Event|0|||
126387390|NCT02954406|454713636|FG003|Overall Study|Adverse Event|0|||
126387391|NCT02954406|454713637|FG004|Overall Study|Adverse Event|1|||
126387392|NCT02954406|454713638|FG005|Overall Study|Adverse Event|0|||
126387393|NCT02954406|454713639|FG006|Overall Study|Adverse Event|0|||
126387394|NCT02954406|454713640|FG007|Overall Study|Adverse Event|0|||
126387395|NCT02954406|454713641|FG008|Overall Study|Adverse Event|1|||
126387396|NCT02954406|454713642|FG009|Overall Study|Adverse Event|1|||
126387397|NCT02954406|454713643|FG010|Overall Study|Adverse Event|0|||
126387398|NCT02954406|454713633|FG000|Overall Study|Progressive Disease|3|||
126387399|NCT02954406|454713634|FG001|Overall Study|Progressive Disease|4|||
126387400|NCT02954406|454713635|FG002|Overall Study|Progressive Disease|3|||
126387401|NCT02954406|454713636|FG003|Overall Study|Progressive Disease|4|||
126387402|NCT02954406|454713637|FG004|Overall Study|Progressive Disease|3|||
126387403|NCT02954406|454713638|FG005|Overall Study|Progressive Disease|3|||
126387404|NCT02954406|454713639|FG006|Overall Study|Progressive Disease|2|||
126387405|NCT02954406|454713640|FG007|Overall Study|Progressive Disease|2|||
126387406|NCT02954406|454713641|FG008|Overall Study|Progressive Disease|1|||
126387407|NCT02954406|454713642|FG009|Overall Study|Progressive Disease|1|||
126387408|NCT02954406|454713643|FG010|Overall Study|Progressive Disease|0|||
126387409|NCT02954406|454713633|FG000|Overall Study|Symptomatic Deterioration|0|||
126387410|NCT02954406|454713634|FG001|Overall Study|Symptomatic Deterioration|1|||
126387411|NCT02954406|454713635|FG002|Overall Study|Symptomatic Deterioration|0|||
126387412|NCT02954406|454713636|FG003|Overall Study|Symptomatic Deterioration|0|||
126387413|NCT02954406|454713637|FG004|Overall Study|Symptomatic Deterioration|0|||
126387414|NCT02954406|454713638|FG005|Overall Study|Symptomatic Deterioration|0|||
126717615|NCT03395197|455917570|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
126717616|NCT03395197|455917571|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
126717617|NCT03395197|455917572|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
126717618|NCT03395197|455917573|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
126771210|NCT01678924|456117703|FG001|Overall Study|Lost to Follow-up|4|||
126387415|NCT02954406|454713639|FG006|Overall Study|Symptomatic Deterioration|0|||
126387416|NCT02954406|454713640|FG007|Overall Study|Symptomatic Deterioration|0|||
126387417|NCT02954406|454713641|FG008|Overall Study|Symptomatic Deterioration|0|||
126387418|NCT02954406|454713642|FG009|Overall Study|Symptomatic Deterioration|0|||
126387419|NCT02954406|454713643|FG010|Overall Study|Symptomatic Deterioration|0|||
126387420|NCT02954406|454713633|FG000|Overall Study|Death|0|||
126387421|NCT02954406|454713634|FG001|Overall Study|Death|0|||
126387422|NCT02954406|454713635|FG002|Overall Study|Death|0|||
126387423|NCT02954406|454713636|FG003|Overall Study|Death|0|||
126387424|NCT02954406|454713637|FG004|Overall Study|Death|1|||
126387425|NCT02954406|454713638|FG005|Overall Study|Death|0|||
126387426|NCT02954406|454713639|FG006|Overall Study|Death|0|||
126387427|NCT02954406|454713640|FG007|Overall Study|Death|0|||
126387428|NCT02954406|454713641|FG008|Overall Study|Death|1|||
126387429|NCT02954406|454713642|FG009|Overall Study|Death|1|||
126387430|NCT02954406|454713643|FG010|Overall Study|Death|0|||
126387431|NCT02954406|454713633|FG000|Overall Study|Reason Not Specified|0|||
126387432|NCT02954406|454713634|FG001|Overall Study|Reason Not Specified|0|||
126387433|NCT02954406|454713635|FG002|Overall Study|Reason Not Specified|3|||
126387434|NCT02954406|454713636|FG003|Overall Study|Reason Not Specified|2|||
126387435|NCT02954406|454713637|FG004|Overall Study|Reason Not Specified|2|||
126387436|NCT02954406|454713638|FG005|Overall Study|Reason Not Specified|0|||
126553809|NCT04285229|455322625|FG004|Follow-up Period|Withdrawal by Subject|0|||
126553810|NCT04285229|455322626|FG005|Follow-up Period|Withdrawal by Subject|5|||
126553811|NCT04285229|455322621|FG000|Follow-up Period|Covid-19|0|||
126553812|NCT04285229|455322622|FG001|Follow-up Period|Covid-19|0|||
126553813|NCT04285229|455322623|FG002|Follow-up Period|Covid-19|0|||
126553814|NCT04285229|455322624|FG003|Follow-up Period|Covid-19|0|||
126553815|NCT04285229|455322625|FG004|Follow-up Period|Covid-19|0|||
126553816|NCT04285229|455322626|FG005|Follow-up Period|Covid-19|2|||
126553817|NCT04285229|455322621|FG000|Follow-up Period|Physician Decision|0|||
126553818|NCT04285229|455322622|FG001|Follow-up Period|Physician Decision|0|||
126553819|NCT04285229|455322623|FG002|Follow-up Period|Physician Decision|0|||
126387437|NCT02954406|454713639|FG006|Overall Study|Reason Not Specified|1|||
126387438|NCT02954406|454713640|FG007|Overall Study|Reason Not Specified|0|||
126387439|NCT02954406|454713641|FG008|Overall Study|Reason Not Specified|1|||
126387440|NCT02954406|454713642|FG009|Overall Study|Reason Not Specified|0|||
126387441|NCT02954406|454713643|FG010|Overall Study|Reason Not Specified|0|||
126387442|NCT05360966|454713644|FG000|Overall Study|Adverse Event|5|||
126387443|NCT05360966|454713645|FG001|Overall Study|Adverse Event|5|||
126387444|NCT05360966|454713644|FG000|Overall Study|Withdrawal of Consent|5|||
126387445|NCT05360966|454713645|FG001|Overall Study|Withdrawal of Consent|3|||
126387446|NCT05360966|454713644|FG000|Overall Study|Noncompliance|2|||
126387447|NCT05360966|454713645|FG001|Overall Study|Noncompliance|1|||
126387448|NCT05360966|454713644|FG000|Overall Study|Lost to Follow-up|2|||
126387449|NCT05360966|454713645|FG001|Overall Study|Lost to Follow-up|3|||
126387450|NCT05360966|454713644|FG000|Overall Study|Protocol Deviation|2|||
126387451|NCT05360966|454713645|FG001|Overall Study|Protocol Deviation|1|||
126387452|NCT05360966|454713644|FG000|Overall Study|As specified in the Clinical Study Report|1|||
126553820|NCT04285229|455322624|FG003|Follow-up Period|Physician Decision|0|||
126553821|NCT04285229|455322625|FG004|Follow-up Period|Physician Decision|0|||
126553822|NCT04285229|455322626|FG005|Follow-up Period|Physician Decision|1|||
126553823|NCT02397460|455322627|FG000|Treatment Period 2|Adverse Event|0|||
126553824|NCT02397460|455322628|FG001|Treatment Period 2|Adverse Event|0|||
126553825|NCT02397460|455322629|FG002|Treatment Period 2|Adverse Event|0|||
126553826|NCT02397460|455322630|FG003|Treatment Period 2|Adverse Event|0|||
126553827|NCT02397460|455322631|FG004|Treatment Period 2|Adverse Event|0|||
126553828|NCT02397460|455322632|FG005|Treatment Period 2|Adverse Event|0|||
126387453|NCT05360966|454713645|FG001|Overall Study|As specified in the Clinical Study Report|3|||
126387454|NCT05396014|454713646|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
126387455|NCT05396014|454713647|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387456|NCT05396014|454713648|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387457|NCT05396014|454713649|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387458|NCT05396014|454713650|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387459|NCT05396014|454713651|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387460|NCT05396014|454713652|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387461|NCT05396014|454713653|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387462|NCT05396014|454713654|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387463|NCT05396014|454713655|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387464|NCT05396014|454713656|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387465|NCT05396014|454713657|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387466|NCT05396014|454713658|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387467|NCT05396014|454713659|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
126717619|NCT03395197|455917574|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
126553829|NCT02397460|455322633|FG006|Treatment Period 2|Adverse Event|0|||
126553830|NCT02397460|455322634|FG007|Treatment Period 2|Adverse Event|1|||
126553831|NCT02397460|455322627|FG000|Treatment Period 4|Adverse Event|0|||
126553832|NCT02397460|455322628|FG001|Treatment Period 4|Adverse Event|1|||
126553833|NCT02397460|455322629|FG002|Treatment Period 4|Adverse Event|0|||
126717620|NCT03395197|455917575|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
126387468|NCT05396014|454713660|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126553834|NCT02397460|455322630|FG003|Treatment Period 4|Adverse Event|0|||
126387469|NCT05396014|454713661|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387470|NCT05396014|454713662|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387471|NCT05396014|454713663|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387472|NCT05396014|454713664|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387473|NCT05396014|454713665|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387474|NCT05396014|454713666|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387475|NCT05396014|454713667|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387476|NCT05396014|454713668|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387477|NCT05396014|454713669|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387478|NCT05396014|454713670|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387479|NCT05396014|454713671|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387480|NCT05396014|454713672|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
126387481|NCT05396014|454713673|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387482|NCT05396014|454713674|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387483|NCT05396014|454713675|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387484|NCT05396014|454713676|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387485|NCT05396014|454713677|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126717621|NCT03395197|455917570|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
126717622|NCT03395197|455917571|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
126717623|NCT03395197|455917572|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
126717624|NCT03395197|455917573|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
126717625|NCT03395197|455917574|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
126717626|NCT03395197|455917575|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
126717627|NCT03395197|455917570|FG000|Analysis for DDR-Deficient Participants|Other|0|||
126717628|NCT03395197|455917571|FG001|Analysis for DDR-Deficient Participants|Other|0|||
126717629|NCT03395197|455917572|FG002|Analysis for DDR-Deficient Participants|Other|0|||
126717630|NCT03395197|455917573|FG003|Analysis for DDR-Deficient Participants|Other|0|||
126771211|NCT01678924|456117704|FG002|Overall Study|Lost to Follow-up|0|||
126387486|NCT05396014|454713678|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387487|NCT05396014|454713679|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387488|NCT05396014|454713680|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387489|NCT05396014|454713681|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387490|NCT05396014|454713682|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387491|NCT05396014|454713683|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387492|NCT05396014|454713684|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387493|NCT05396014|454713685|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
126387494|NCT05396014|454713686|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387495|NCT05396014|454713687|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387496|NCT05396014|454713688|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
126387497|NCT05396014|454713646|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
126387498|NCT05396014|454713647|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126553835|NCT02397460|455322631|FG004|Treatment Period 4|Adverse Event|0|||
126553836|NCT02397460|455322632|FG005|Treatment Period 4|Adverse Event|0|||
126387499|NCT05396014|454713648|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387500|NCT05396014|454713649|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387501|NCT05396014|454713650|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387502|NCT05396014|454713651|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387503|NCT05396014|454713652|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387504|NCT05396014|454713653|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387505|NCT05396014|454713654|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387506|NCT05396014|454713655|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387507|NCT05396014|454713656|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387508|NCT05396014|454713657|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387509|NCT05396014|454713658|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387510|NCT05396014|454713659|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
126387511|NCT05396014|454713660|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387512|NCT05396014|454713661|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387513|NCT05396014|454713662|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387514|NCT05396014|454713663|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387515|NCT05396014|454713664|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387516|NCT05396014|454713665|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387517|NCT05396014|454713666|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126553837|NCT02397460|455322633|FG006|Treatment Period 4|Adverse Event|0|||
126717631|NCT03395197|455917574|FG004|Analysis for DDR-Deficient Participants|Other|3|||
126771212|NCT01678924|456117705|FG003|Overall Study|Lost to Follow-up|2|||
126771213|NCT01678924|456117702|FG000|Overall Study|Personal Reasons|2|||
126553838|NCT02397460|455322634|FG007|Treatment Period 4|Adverse Event|0|||
126553839|NCT02397460|455322627|FG000|Treatment Period 4|Physician Decision|0|||
126553840|NCT02397460|455322628|FG001|Treatment Period 4|Physician Decision|0|||
126553841|NCT02397460|455322629|FG002|Treatment Period 4|Physician Decision|0|||
126553842|NCT02397460|455322630|FG003|Treatment Period 4|Physician Decision|0|||
126553843|NCT02397460|455322631|FG004|Treatment Period 4|Physician Decision|1|||
126553844|NCT02397460|455322632|FG005|Treatment Period 4|Physician Decision|0|||
126553845|NCT02397460|455322633|FG006|Treatment Period 4|Physician Decision|0|||
126553846|NCT02397460|455322634|FG007|Treatment Period 4|Physician Decision|0|||
126553847|NCT02584855|455322637|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
126553848|NCT02584855|455322638|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
126553849|NCT02584855|455322639|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
126553850|NCT02584855|455322640|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
126553851|NCT02584855|455322641|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
126553852|NCT02584855|455322642|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
126553853|NCT02584855|455322637|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
126553854|NCT02584855|455322638|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
126553855|NCT02584855|455322639|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
126553856|NCT02584855|455322640|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
126553857|NCT02584855|455322641|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
126553858|NCT02584855|455322642|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
126553859|NCT02584855|455322637|FG000|Open-Label Treatment Period|Adverse Event|14|||
126553860|NCT02584855|455322638|FG001|Open-Label Treatment Period|Adverse Event|0|||
126387518|NCT05396014|454713667|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387519|NCT05396014|454713668|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387520|NCT05396014|454713669|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387521|NCT05396014|454713670|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387522|NCT05396014|454713671|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387523|NCT05396014|454713672|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
126387524|NCT05396014|454713673|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387525|NCT05396014|454713674|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387526|NCT05396014|454713675|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387527|NCT05396014|454713676|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387528|NCT05396014|454713677|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387529|NCT05396014|454713678|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387530|NCT05396014|454713679|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387531|NCT05396014|454713680|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387532|NCT05396014|454713681|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387533|NCT05396014|454713682|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387534|NCT05396014|454713683|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387535|NCT05396014|454713684|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387536|NCT05396014|454713685|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
126387537|NCT05396014|454713686|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126553861|NCT02584855|455322639|FG002|Open-Label Treatment Period|Adverse Event|0|||
126553862|NCT02584855|455322640|FG003|Open-Label Treatment Period|Adverse Event|0|||
126553863|NCT02584855|455322641|FG004|Open-Label Treatment Period|Adverse Event|0|||
126553864|NCT02584855|455322642|FG005|Open-Label Treatment Period|Adverse Event|0|||
126553865|NCT02584855|455322637|FG000|Open-Label Treatment Period|Death|2|||
126553866|NCT02584855|455322638|FG001|Open-Label Treatment Period|Death|0|||
126553867|NCT02584855|455322639|FG002|Open-Label Treatment Period|Death|0|||
126553868|NCT02584855|455322640|FG003|Open-Label Treatment Period|Death|0|||
126553869|NCT02584855|455322641|FG004|Open-Label Treatment Period|Death|0|||
126553870|NCT02584855|455322642|FG005|Open-Label Treatment Period|Death|0|||
126553871|NCT02584855|455322637|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
126553872|NCT02584855|455322638|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
126553873|NCT02584855|455322639|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
126553874|NCT02584855|455322640|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
126553875|NCT02584855|455322641|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
126717632|NCT03395197|455917575|FG005|Analysis for DDR-Deficient Participants|Other|3|||
126717633|NCT03395197|455917570|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
126717634|NCT03395197|455917571|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
126717635|NCT03395197|455917572|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
126717636|NCT03395197|455917573|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
126717637|NCT03395197|455917574|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
126553876|NCT02584855|455322642|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
126553877|NCT02584855|455322637|FG000|Open-Label Treatment Period|Protocol Violation|1|||
126553878|NCT02584855|455322638|FG001|Open-Label Treatment Period|Protocol Violation|0|||
126553879|NCT02584855|455322639|FG002|Open-Label Treatment Period|Protocol Violation|0|||
126717638|NCT03395197|455917575|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
126717639|NCT01605071|455917576|FG000|Overall Study|Withdrawal by Subject|3|||
126771214|NCT01678924|456117703|FG001|Overall Study|Personal Reasons|2|||
126553880|NCT02584855|455322640|FG003|Open-Label Treatment Period|Protocol Violation|0|||
126553881|NCT02584855|455322641|FG004|Open-Label Treatment Period|Protocol Violation|0|||
126553882|NCT02584855|455322642|FG005|Open-Label Treatment Period|Protocol Violation|0|||
126553883|NCT02584855|455322637|FG000|Open-Label Treatment Period|No PI Available|2|||
126553884|NCT02584855|455322638|FG001|Open-Label Treatment Period|No PI Available|0|||
126553885|NCT02584855|455322639|FG002|Open-Label Treatment Period|No PI Available|0|||
126553886|NCT02584855|455322640|FG003|Open-Label Treatment Period|No PI Available|0|||
126553887|NCT02584855|455322641|FG004|Open-Label Treatment Period|No PI Available|0|||
126553888|NCT02584855|455322642|FG005|Open-Label Treatment Period|No PI Available|0|||
126553889|NCT02584855|455322637|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
126553890|NCT02584855|455322638|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
126553891|NCT02584855|455322639|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
126553892|NCT02584855|455322640|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
126553893|NCT02584855|455322641|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
126553894|NCT02584855|455322642|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
126553895|NCT02584855|455322637|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
126553896|NCT02584855|455322638|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
126553897|NCT02584855|455322639|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
126553898|NCT02584855|455322640|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
126553899|NCT02584855|455322641|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
126553900|NCT02584855|455322642|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
126553901|NCT02584855|455322637|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
126553902|NCT02584855|455322638|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
126553903|NCT02584855|455322639|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
126553904|NCT02584855|455322640|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
126553905|NCT02584855|455322641|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
126553906|NCT02584855|455322642|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
126553907|NCT02584855|455322637|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
126553908|NCT02584855|455322638|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
126553909|NCT02584855|455322639|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
126553910|NCT02584855|455322640|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
126553911|NCT02584855|455322641|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
126553912|NCT02584855|455322642|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
126553913|NCT02584855|455322637|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
126553914|NCT02584855|455322638|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
126553915|NCT02584855|455322639|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
126553916|NCT02584855|455322640|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
126553917|NCT02584855|455322641|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
126553918|NCT02584855|455322642|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
126553919|NCT02584855|455322637|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
126553920|NCT02584855|455322638|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
126553921|NCT02584855|455322639|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
126553922|NCT02584855|455322640|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
126553923|NCT02584855|455322641|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
126553924|NCT02584855|455322642|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
126553925|NCT02584855|455322637|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
126553926|NCT02584855|455322638|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
126553927|NCT02584855|455322639|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
126553928|NCT02584855|455322640|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
126553929|NCT02584855|455322641|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
126553930|NCT02584855|455322642|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
126553931|NCT02138747|455322643|FG000|Treatment Period 1|Adverse Event|10|||
126553932|NCT02138747|455322644|FG001|Treatment Period 1|Adverse Event|14|||
126553933|NCT02138747|455322645|FG002|Treatment Period 1|Adverse Event|2|||
126553934|NCT02138747|455322646|FG003|Treatment Period 1|Adverse Event|1|||
126553935|NCT02138747|455322643|FG000|Treatment Period 1|Lost to Follow-up|0|||
126553936|NCT02138747|455322644|FG001|Treatment Period 1|Lost to Follow-up|1|||
126553937|NCT02138747|455322645|FG002|Treatment Period 1|Lost to Follow-up|1|||
126553938|NCT02138747|455322646|FG003|Treatment Period 1|Lost to Follow-up|0|||
126553939|NCT02138747|455322643|FG000|Treatment Period 1|Protocol Violation|0|||
126553940|NCT02138747|455322644|FG001|Treatment Period 1|Protocol Violation|2|||
126553941|NCT02138747|455322645|FG002|Treatment Period 1|Protocol Violation|0|||
126553942|NCT02138747|455322646|FG003|Treatment Period 1|Protocol Violation|0|||
126553943|NCT02138747|455322643|FG000|Treatment Period 1|Withdrawal by Subject|8|||
126553944|NCT02138747|455322644|FG001|Treatment Period 1|Withdrawal by Subject|4|||
126553945|NCT02138747|455322645|FG002|Treatment Period 1|Withdrawal by Subject|1|||
126553946|NCT02138747|455322646|FG003|Treatment Period 1|Withdrawal by Subject|3|||
126553947|NCT02138747|455322643|FG000|Treatment Period 1|Other - Miscellaneous|2|||
126553948|NCT02138747|455322644|FG001|Treatment Period 1|Other - Miscellaneous|4|||
126387538|NCT05396014|454713687|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387539|NCT05396014|454713688|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
126387540|NCT05396014|454713646|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
126387541|NCT05396014|454713647|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387542|NCT05396014|454713648|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387543|NCT05396014|454713649|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387544|NCT05396014|454713650|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387545|NCT05396014|454713651|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387546|NCT05396014|454713652|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387547|NCT05396014|454713653|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387548|NCT05396014|454713654|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387549|NCT05396014|454713655|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387550|NCT05396014|454713656|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387551|NCT05396014|454713657|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387552|NCT05396014|454713658|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387553|NCT05396014|454713659|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
126387554|NCT05396014|454713660|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387555|NCT05396014|454713661|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387556|NCT05396014|454713662|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387557|NCT05396014|454713663|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387558|NCT05396014|454713664|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387559|NCT05396014|454713665|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387560|NCT05396014|454713666|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387561|NCT05396014|454713667|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387562|NCT05396014|454713668|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387563|NCT05396014|454713669|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387564|NCT05396014|454713670|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387565|NCT05396014|454713671|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387566|NCT05396014|454713672|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
126387567|NCT05396014|454713673|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387568|NCT05396014|454713674|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387569|NCT05396014|454713675|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387570|NCT05396014|454713676|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387571|NCT05396014|454713677|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387572|NCT05396014|454713678|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387573|NCT05396014|454713679|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387574|NCT05396014|454713680|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387575|NCT05396014|454713681|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387576|NCT05396014|454713682|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387577|NCT05396014|454713683|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387578|NCT05396014|454713684|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387579|NCT05396014|454713685|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
126387580|NCT05396014|454713686|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387581|NCT05396014|454713687|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387582|NCT05396014|454713688|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
126387583|NCT05396014|454713646|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387584|NCT05396014|454713647|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387585|NCT05396014|454713648|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387586|NCT05396014|454713649|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387587|NCT05396014|454713650|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387588|NCT05396014|454713651|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387589|NCT05396014|454713652|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387590|NCT05396014|454713653|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387591|NCT05396014|454713654|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387592|NCT05396014|454713655|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387593|NCT05396014|454713656|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387594|NCT05396014|454713657|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387595|NCT05396014|454713658|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387596|NCT05396014|454713659|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387597|NCT05396014|454713660|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387598|NCT05396014|454713661|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387599|NCT05396014|454713662|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387600|NCT05396014|454713663|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387601|NCT05396014|454713664|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387602|NCT05396014|454713665|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387603|NCT05396014|454713666|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387604|NCT05396014|454713667|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387605|NCT05396014|454713668|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387606|NCT05396014|454713669|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387607|NCT05396014|454713670|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387608|NCT05396014|454713671|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387609|NCT05396014|454713672|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
126387610|NCT05396014|454713673|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387611|NCT05396014|454713674|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126717640|NCT01605071|455917577|FG001|Overall Study|Withdrawal by Subject|2|||
126717641|NCT00392171|455917578|FG000|Overall Study|Did not meet inclusion criteria|4|||
126717642|NCT00392171|455917578|FG000|Overall Study|Disease progression|101|||
126717643|NCT01881620|455917585|FG000|Overall Study|Protocol Violation|4|||
126387612|NCT05396014|454713675|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387613|NCT05396014|454713676|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387614|NCT05396014|454713677|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387615|NCT05396014|454713678|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387616|NCT05396014|454713679|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387617|NCT05396014|454713680|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387618|NCT05396014|454713681|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387619|NCT05396014|454713682|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387620|NCT05396014|454713683|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387621|NCT05396014|454713684|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387622|NCT05396014|454713685|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
126387623|NCT05396014|454713686|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387624|NCT05396014|454713687|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387625|NCT05396014|454713688|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
126387626|NCT05396014|454713646|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387627|NCT05396014|454713647|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387628|NCT05396014|454713648|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387629|NCT05396014|454713649|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387630|NCT05396014|454713650|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126553949|NCT02138747|455322645|FG002|Treatment Period 1|Other - Miscellaneous|0|||
126553950|NCT02138747|455322646|FG003|Treatment Period 1|Other - Miscellaneous|0|||
126553951|NCT02138747|455322643|FG000|Treatment Period 2|Adverse Event|6|||
126553952|NCT02138747|455322644|FG001|Treatment Period 2|Adverse Event|3|||
126553953|NCT02138747|455322645|FG002|Treatment Period 2|Adverse Event|1|||
126553954|NCT02138747|455322646|FG003|Treatment Period 2|Adverse Event|1|||
126553955|NCT02138747|455322643|FG000|Treatment Period 2|Lost to Follow-up|2|||
126553956|NCT02138747|455322644|FG001|Treatment Period 2|Lost to Follow-up|0|||
126553957|NCT02138747|455322645|FG002|Treatment Period 2|Lost to Follow-up|0|||
126387631|NCT05396014|454713651|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387632|NCT05396014|454713652|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387633|NCT05396014|454713653|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387634|NCT05396014|454713654|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387635|NCT05396014|454713655|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387636|NCT05396014|454713656|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387637|NCT05396014|454713657|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387638|NCT05396014|454713658|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387639|NCT05396014|454713659|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387640|NCT05396014|454713660|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387641|NCT05396014|454713661|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387642|NCT05396014|454713662|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387643|NCT05396014|454713663|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387644|NCT05396014|454713664|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387645|NCT05396014|454713665|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387646|NCT05396014|454713666|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387647|NCT05396014|454713667|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387648|NCT05396014|454713668|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387649|NCT05396014|454713669|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387650|NCT05396014|454713670|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387651|NCT05396014|454713671|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387652|NCT05396014|454713672|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
126553958|NCT02138747|455322646|FG003|Treatment Period 2|Lost to Follow-up|0|||
126553959|NCT02138747|455322643|FG000|Treatment Period 2|Protocol Violation|1|||
126553960|NCT02138747|455322644|FG001|Treatment Period 2|Protocol Violation|0|||
126387653|NCT05396014|454713673|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387654|NCT05396014|454713674|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126553961|NCT02138747|455322645|FG002|Treatment Period 2|Protocol Violation|0|||
126553962|NCT02138747|455322646|FG003|Treatment Period 2|Protocol Violation|0|||
126717644|NCT01808118|455917586|FG000|Period 1|Adverse Event|15|||
126717645|NCT01808118|455917587|FG001|Period 1|Adverse Event|0|||
126387655|NCT05396014|454713675|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387656|NCT05396014|454713676|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387657|NCT05396014|454713677|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387658|NCT05396014|454713678|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387659|NCT05396014|454713679|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387660|NCT05396014|454713680|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387661|NCT05396014|454713681|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387662|NCT05396014|454713682|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387663|NCT05396014|454713683|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387664|NCT05396014|454713684|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387665|NCT05396014|454713685|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387666|NCT05396014|454713686|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387667|NCT05396014|454713687|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387668|NCT05396014|454713688|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
126387669|NCT05396014|454713646|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387670|NCT05396014|454713647|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387671|NCT05396014|454713648|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387672|NCT05396014|454713649|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387673|NCT05396014|454713650|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387674|NCT05396014|454713651|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387675|NCT05396014|454713652|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387676|NCT05396014|454713653|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387677|NCT05396014|454713654|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387678|NCT05396014|454713655|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387679|NCT05396014|454713656|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387680|NCT05396014|454713657|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387681|NCT05396014|454713658|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387682|NCT05396014|454713659|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
126387683|NCT05396014|454713660|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387684|NCT05396014|454713661|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387685|NCT05396014|454713662|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387686|NCT05396014|454713663|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387687|NCT05396014|454713664|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387688|NCT05396014|454713665|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387689|NCT05396014|454713666|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387690|NCT05396014|454713667|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387691|NCT05396014|454713668|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387692|NCT05396014|454713669|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387693|NCT05396014|454713670|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387694|NCT05396014|454713671|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387695|NCT05396014|454713672|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387696|NCT05396014|454713673|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387697|NCT05396014|454713674|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387698|NCT05396014|454713675|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387699|NCT05396014|454713676|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387700|NCT05396014|454713677|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387701|NCT05396014|454713678|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387702|NCT05396014|454713679|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387703|NCT05396014|454713680|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387704|NCT05396014|454713681|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387705|NCT05396014|454713682|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387706|NCT05396014|454713683|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387707|NCT05396014|454713684|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387708|NCT05396014|454713685|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387709|NCT05396014|454713686|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387710|NCT05396014|454713687|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387711|NCT05396014|454713688|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
126387712|NCT05396014|454713646|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
126387713|NCT05396014|454713647|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387714|NCT05396014|454713648|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387715|NCT05396014|454713649|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387716|NCT05396014|454713650|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387717|NCT05396014|454713651|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126717646|NCT01808118|455917588|FG002|Period 1|Adverse Event|0|||
126717647|NCT01808118|455917586|FG000|Period 1|Withdrew consent|24|||
126717648|NCT01808118|455917587|FG001|Period 1|Withdrew consent|0|||
126717649|NCT01808118|455917588|FG002|Period 1|Withdrew consent|0|||
126717650|NCT01808118|455917586|FG000|Period 1|Lost to Follow-up|9|||
126717651|NCT01808118|455917587|FG001|Period 1|Lost to Follow-up|0|||
126387718|NCT05396014|454713652|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387719|NCT05396014|454713653|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387720|NCT05396014|454713654|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387721|NCT05396014|454713655|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387722|NCT05396014|454713656|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387723|NCT05396014|454713657|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387724|NCT05396014|454713658|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387725|NCT05396014|454713659|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
126387726|NCT05396014|454713660|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387727|NCT05396014|454713661|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387728|NCT05396014|454713662|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387729|NCT05396014|454713663|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387730|NCT05396014|454713664|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387731|NCT05396014|454713665|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387732|NCT05396014|454713666|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387733|NCT05396014|454713667|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387734|NCT05396014|454713668|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387735|NCT05396014|454713669|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387736|NCT05396014|454713670|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387737|NCT05396014|454713671|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387738|NCT05396014|454713672|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387739|NCT05396014|454713673|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387740|NCT05396014|454713674|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387741|NCT05396014|454713675|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387742|NCT05396014|454713676|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387743|NCT05396014|454713677|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387744|NCT05396014|454713678|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387745|NCT05396014|454713679|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387746|NCT05396014|454713680|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387747|NCT05396014|454713681|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387748|NCT05396014|454713682|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387749|NCT05396014|454713683|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387750|NCT05396014|454713684|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387751|NCT05396014|454713685|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
126387752|NCT05396014|454713686|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387753|NCT05396014|454713687|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387754|NCT05396014|454713688|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
126387755|NCT05396014|454713646|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
126387756|NCT05396014|454713647|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387757|NCT05396014|454713648|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387758|NCT05396014|454713649|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387759|NCT05396014|454713650|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387760|NCT05396014|454713651|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387761|NCT05396014|454713652|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387762|NCT05396014|454713653|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387763|NCT05396014|454713654|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387764|NCT05396014|454713655|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387765|NCT05396014|454713656|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387766|NCT05396014|454713657|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387767|NCT05396014|454713658|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387768|NCT05396014|454713659|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387769|NCT05396014|454713660|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387770|NCT05396014|454713661|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387771|NCT05396014|454713662|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387772|NCT05396014|454713663|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387773|NCT05396014|454713664|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387774|NCT05396014|454713665|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387775|NCT05396014|454713666|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126717652|NCT01808118|455917588|FG002|Period 1|Lost to Follow-up|0|||
126717653|NCT01808118|455917586|FG000|Period 1|Did not meet criteria for remission|303|||
126717654|NCT01808118|455917587|FG001|Period 1|Did not meet criteria for remission|0|||
126387776|NCT05396014|454713667|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387777|NCT05396014|454713668|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387778|NCT05396014|454713669|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387779|NCT05396014|454713670|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387780|NCT05396014|454713671|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387781|NCT05396014|454713672|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
126387782|NCT05396014|454713673|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387783|NCT05396014|454713674|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387784|NCT05396014|454713675|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387785|NCT05396014|454713676|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387786|NCT05396014|454713677|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387787|NCT05396014|454713678|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387788|NCT05396014|454713679|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387789|NCT05396014|454713680|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387790|NCT05396014|454713681|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387791|NCT05396014|454713682|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387792|NCT05396014|454713683|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387793|NCT05396014|454713684|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387794|NCT05396014|454713685|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387795|NCT05396014|454713686|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387796|NCT05396014|454713687|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387797|NCT05396014|454713688|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
126387798|NCT05396014|454713646|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387799|NCT05396014|454713647|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387800|NCT05396014|454713648|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387801|NCT05396014|454713649|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387802|NCT05396014|454713650|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387803|NCT05396014|454713651|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387804|NCT05396014|454713652|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387805|NCT05396014|454713653|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387806|NCT05396014|454713654|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387807|NCT05396014|454713655|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387808|NCT05396014|454713656|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387809|NCT05396014|454713657|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387810|NCT05396014|454713658|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387811|NCT05396014|454713659|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
126387812|NCT05396014|454713660|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387813|NCT05396014|454713661|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387814|NCT05396014|454713662|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387815|NCT05396014|454713663|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387816|NCT05396014|454713664|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387817|NCT05396014|454713665|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387818|NCT05396014|454713666|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387819|NCT05396014|454713667|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387820|NCT05396014|454713668|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387821|NCT05396014|454713669|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387822|NCT05396014|454713670|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387823|NCT05396014|454713671|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387824|NCT05396014|454713672|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387825|NCT05396014|454713673|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387826|NCT05396014|454713674|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387827|NCT05396014|454713675|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387828|NCT05396014|454713676|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387829|NCT05396014|454713677|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387830|NCT05396014|454713678|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387831|NCT05396014|454713679|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387832|NCT05396014|454713680|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387833|NCT05396014|454713681|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387834|NCT05396014|454713682|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387835|NCT05396014|454713683|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387836|NCT05396014|454713684|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387837|NCT05396014|454713685|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387838|NCT05396014|454713686|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387839|NCT05396014|454713687|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126771215|NCT01678924|456117704|FG002|Overall Study|Personal Reasons|2|||
126771216|NCT01678924|456117705|FG003|Overall Study|Personal Reasons|7|||
126387840|NCT05396014|454713688|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
126387841|NCT05396014|454713646|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387842|NCT05396014|454713647|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387843|NCT05396014|454713648|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387844|NCT05396014|454713649|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
126387845|NCT05396014|454713650|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387846|NCT05396014|454713651|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387847|NCT05396014|454713652|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387848|NCT05396014|454713653|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387849|NCT05396014|454713654|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
126387850|NCT05396014|454713655|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387851|NCT05396014|454713656|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387852|NCT05396014|454713657|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387853|NCT05396014|454713658|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387854|NCT05396014|454713659|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387855|NCT05396014|454713660|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387856|NCT05396014|454713661|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387857|NCT05396014|454713662|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387858|NCT05396014|454713663|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387859|NCT05396014|454713664|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387860|NCT05396014|454713665|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387861|NCT05396014|454713666|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387862|NCT05396014|454713667|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387863|NCT05396014|454713668|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387864|NCT05396014|454713669|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387865|NCT05396014|454713670|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387866|NCT05396014|454713671|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
126387867|NCT05396014|454713672|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387868|NCT05396014|454713673|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387869|NCT05396014|454713674|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387870|NCT05396014|454713675|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387871|NCT05396014|454713676|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387872|NCT05396014|454713677|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387873|NCT05396014|454713678|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387874|NCT05396014|454713679|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387875|NCT05396014|454713680|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387876|NCT05396014|454713681|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387877|NCT05396014|454713682|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387878|NCT05396014|454713683|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387879|NCT05396014|454713684|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387880|NCT05396014|454713685|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
126387881|NCT05396014|454713686|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
126387882|NCT05396014|454713687|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
126387883|NCT05396014|454713688|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
126387884|NCT05396014|454713646|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387885|NCT05396014|454713647|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387886|NCT05396014|454713648|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387887|NCT05396014|454713649|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387888|NCT05396014|454713650|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387889|NCT05396014|454713651|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387890|NCT05396014|454713652|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387891|NCT05396014|454713653|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387892|NCT05396014|454713654|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
126387893|NCT05396014|454713655|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387894|NCT05396014|454713656|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387895|NCT05396014|454713657|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387896|NCT05396014|454713658|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387897|NCT05396014|454713659|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387898|NCT05396014|454713660|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387899|NCT05396014|454713661|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387900|NCT05396014|454713662|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387901|NCT05396014|454713663|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387902|NCT05396014|454713664|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387903|NCT05396014|454713665|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387904|NCT05396014|454713666|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387905|NCT05396014|454713667|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387906|NCT05396014|454713668|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
126387907|NCT05396014|454713669|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387908|NCT05396014|454713670|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387909|NCT05396014|454713671|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387910|NCT05396014|454713672|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387911|NCT05396014|454713673|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387912|NCT05396014|454713674|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387913|NCT05396014|454713675|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387914|NCT05396014|454713676|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387915|NCT05396014|454713677|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387916|NCT05396014|454713678|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387917|NCT05396014|454713679|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387918|NCT05396014|454713680|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387919|NCT05396014|454713681|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
126387920|NCT05396014|454713682|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387921|NCT05396014|454713683|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387922|NCT05396014|454713684|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387923|NCT05396014|454713685|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
126387924|NCT05396014|454713686|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387925|NCT05396014|454713687|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
126387926|NCT05396014|454713688|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
126387927|NCT05396014|454713646|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387928|NCT05396014|454713647|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387929|NCT05396014|454713648|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387930|NCT05396014|454713649|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387931|NCT05396014|454713650|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387932|NCT05396014|454713651|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387933|NCT05396014|454713652|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387934|NCT05396014|454713653|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387935|NCT05396014|454713654|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387936|NCT05396014|454713655|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387937|NCT05396014|454713656|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387938|NCT05396014|454713657|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387939|NCT05396014|454713658|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387940|NCT05396014|454713659|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
126387941|NCT05396014|454713660|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387942|NCT05396014|454713661|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387943|NCT05396014|454713662|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387944|NCT05396014|454713663|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387945|NCT05396014|454713664|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387946|NCT05396014|454713665|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387947|NCT05396014|454713666|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387948|NCT05396014|454713667|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387949|NCT05396014|454713668|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387950|NCT05396014|454713669|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387951|NCT05396014|454713670|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387952|NCT05396014|454713671|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126717655|NCT01808118|455917588|FG002|Period 1|Did not meet criteria for remission|0|||
126717656|NCT01808118|455917586|FG000|Period 1|Enrolled in error|7|||
126717657|NCT01808118|455917587|FG001|Period 1|Enrolled in error|0|||
126717658|NCT01808118|455917588|FG002|Period 1|Enrolled in error|0|||
126717659|NCT01808118|455917586|FG000|Period 1|Did not meet inclusion criteria|3|||
126717660|NCT01808118|455917587|FG001|Period 1|Did not meet inclusion criteria|0|||
126387953|NCT05396014|454713672|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
126387954|NCT05396014|454713673|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387955|NCT05396014|454713674|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387956|NCT05396014|454713675|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387957|NCT05396014|454713676|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387958|NCT05396014|454713677|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387959|NCT05396014|454713678|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387960|NCT05396014|454713679|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387961|NCT05396014|454713680|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
126387962|NCT05396014|454713681|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387963|NCT05396014|454713682|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126717661|NCT01808118|455917588|FG002|Period 1|Did not meet inclusion criteria|0|||
126717662|NCT01808118|455917586|FG000|Period 1|Non-conformance with inclusion criteria|3|||
126717663|NCT01808118|455917587|FG001|Period 1|Non-conformance with inclusion criteria|0|||
126717664|NCT01808118|455917588|FG002|Period 1|Non-conformance with inclusion criteria|0|||
126387964|NCT05396014|454713683|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387965|NCT05396014|454713684|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387966|NCT05396014|454713685|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387967|NCT05396014|454713686|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387968|NCT05396014|454713687|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
126387969|NCT05396014|454713688|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
126387970|NCT05396014|454713646|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387971|NCT05396014|454713647|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387972|NCT05396014|454713648|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387973|NCT05396014|454713649|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387974|NCT05396014|454713650|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387975|NCT05396014|454713651|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387976|NCT05396014|454713652|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387977|NCT05396014|454713653|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387978|NCT05396014|454713654|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387979|NCT05396014|454713655|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387980|NCT05396014|454713656|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387981|NCT05396014|454713657|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387982|NCT05396014|454713658|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387983|NCT05396014|454713659|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387984|NCT05396014|454713660|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387985|NCT05396014|454713661|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387986|NCT05396014|454713662|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387987|NCT05396014|454713663|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387988|NCT05396014|454713664|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387989|NCT05396014|454713665|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387990|NCT05396014|454713666|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387991|NCT05396014|454713667|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387992|NCT05396014|454713668|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387993|NCT05396014|454713669|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387994|NCT05396014|454713670|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387995|NCT05396014|454713671|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387996|NCT05396014|454713672|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
126387997|NCT05396014|454713673|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387998|NCT05396014|454713674|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126387999|NCT05396014|454713675|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388000|NCT05396014|454713676|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388001|NCT05396014|454713677|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388002|NCT05396014|454713678|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388003|NCT05396014|454713679|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388004|NCT05396014|454713680|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388005|NCT05396014|454713681|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388006|NCT05396014|454713682|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388007|NCT05396014|454713683|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388008|NCT05396014|454713684|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388009|NCT05396014|454713685|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388010|NCT05396014|454713686|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388011|NCT05396014|454713687|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388012|NCT05396014|454713688|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
126388013|NCT03522246|454713696|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
126388014|NCT03522246|454713697|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
126388015|NCT03522246|454713698|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
126388016|NCT03522246|454713699|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
126388017|NCT03522246|454713700|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
126388018|NCT04683029|454713701|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
126388019|NCT04683029|454713702|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
126388020|NCT04683029|454713703|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
126388021|NCT04683029|454713704|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
126388022|NCT04683029|454713701|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
126388023|NCT04683029|454713702|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
126388024|NCT04683029|454713703|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
126388025|NCT04683029|454713704|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
126388026|NCT04683029|454713701|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
126388027|NCT04683029|454713702|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
126388028|NCT04683029|454713703|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
126717665|NCT01808118|455917586|FG000|Period 1|Investigator decision: site closure|2|||
126388029|NCT04683029|454713704|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
126388030|NCT04493424|454713706|FG000|Overall Study|Termination of the trial by the sponsor|89|||
126388031|NCT04493424|454713706|FG000|Overall Study|Withdrawal by Subject|9|||
126388032|NCT04493424|454713706|FG000|Overall Study|Lost to Follow-up|2|||
126388033|NCT04493424|454713706|FG000|Overall Study|Lack of Efficacy|3|||
126388034|NCT04493424|454713706|FG000|Overall Study|Adverse Event|5|||
126388035|NCT00814580|454713707|FG000|Overall Study|Adverse Event|6|||
126388036|NCT00814580|454713708|FG001|Overall Study|Adverse Event|15|||
126388037|NCT00814580|454713707|FG000|Overall Study|Lack of Efficacy|18|||
126388038|NCT00814580|454713708|FG001|Overall Study|Lack of Efficacy|25|||
126388039|NCT00814580|454713707|FG000|Overall Study|Protocol Violation|2|||
126388040|NCT00814580|454713708|FG001|Overall Study|Protocol Violation|0|||
126388041|NCT00814580|454713707|FG000|Overall Study|Withdrawal by Subject|2|||
126388042|NCT00814580|454713708|FG001|Overall Study|Withdrawal by Subject|2|||
126388043|NCT00814580|454713707|FG000|Overall Study|Other|1|||
126388044|NCT00814580|454713708|FG001|Overall Study|Other|3|||
126388045|NCT00814580|454713707|FG000|Overall Study|Did Not Take Drug|2|||
126388046|NCT00814580|454713708|FG001|Overall Study|Did Not Take Drug|2|||
126388047|NCT02482428|454713709|FG000|Overall Study|Lost to Follow-up|4|||
126388048|NCT02482428|454713710|FG001|Overall Study|Lost to Follow-up|9|||
126388049|NCT02482428|454713711|FG002|Overall Study|Lost to Follow-up|1|||
126388050|NCT02482428|454713712|FG003|Overall Study|Lost to Follow-up|2|||
126388051|NCT02482428|454713713|FG004|Overall Study|Lost to Follow-up|4|||
126388052|NCT02482428|454713709|FG000|Overall Study|Physician Decision|0|||
126388053|NCT02482428|454713710|FG001|Overall Study|Physician Decision|0|||
126388054|NCT02482428|454713711|FG002|Overall Study|Physician Decision|0|||
126388055|NCT02482428|454713712|FG003|Overall Study|Physician Decision|0|||
126388056|NCT02482428|454713713|FG004|Overall Study|Physician Decision|1|||
126388057|NCT02482428|454713709|FG000|Overall Study|protocol deviation|1|||
126388058|NCT02482428|454713710|FG001|Overall Study|protocol deviation|1|||
126388059|NCT02482428|454713711|FG002|Overall Study|protocol deviation|0|||
126388060|NCT02482428|454713712|FG003|Overall Study|protocol deviation|0|||
126388061|NCT02482428|454713713|FG004|Overall Study|protocol deviation|0|||
126388062|NCT02482428|454713709|FG000|Overall Study|subject/guardian decision|4|||
126388063|NCT02482428|454713710|FG001|Overall Study|subject/guardian decision|2|||
126388064|NCT02482428|454713711|FG002|Overall Study|subject/guardian decision|0|||
126388065|NCT02482428|454713712|FG003|Overall Study|subject/guardian decision|0|||
126388066|NCT02482428|454713713|FG004|Overall Study|subject/guardian decision|2|||
126388067|NCT00516893|454713714|FG000|Overall Study|Lost to Follow-up|4|||
126388068|NCT00516893|454713714|FG000|Overall Study|Adverse Event|3|||
126388069|NCT00516893|454713714|FG000|Overall Study|Withdrawal by Subject|2|||
126388070|NCT00516893|454713714|FG000|Overall Study|Noncompliance|2|||
126388071|NCT00516893|454713714|FG000|Overall Study|Death|1|||
126388072|NCT00516893|454713714|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
126388073|NCT00516893|454713714|FG000|Overall Study|Relocated|1|||
126388074|NCT00516893|454713714|FG000|Overall Study|Pregnancy|1|||
126388075|NCT00516893|454713714|FG000|Overall Study|Received Medication From Another Study|1|||
126388076|NCT05924165|454713720|FG000|Overall Study|Physician Decision|2|||
126388077|NCT05924165|454713721|FG001|Overall Study|Physician Decision|3|||
126388078|NCT04075292|454713722|FG000|Overall Study|Withdrawal by Subject|1|||
126388079|NCT04075292|454713723|FG001|Overall Study|Withdrawal by Subject|9|||
126388080|NCT04075292|454713722|FG000|Overall Study|Death|2|||
126388081|NCT04075292|454713723|FG001|Overall Study|Death|5|||
126388082|NCT04075292|454713722|FG000|Overall Study|Remained on study at time of DCO|74|||
126388083|NCT04075292|454713723|FG001|Overall Study|Remained on study at time of DCO|64|||
126388084|NCT04308239|454713724|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
126388085|NCT04308239|454713725|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
126388086|NCT04308239|454713724|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
126388087|NCT04308239|454713725|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
126388088|NCT04308239|454713724|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
126388089|NCT04308239|454713725|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
126388090|NCT04308239|454713724|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
126388091|NCT04308239|454713725|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
126388092|NCT00459875|454713728|FG000|Overall Study|Ineligible participant|1|||
126388093|NCT00459875|454713728|FG000|Overall Study|Adverse Event|2|||
126717666|NCT01808118|455917587|FG001|Period 1|Investigator decision: site closure|0|||
126717667|NCT01808118|455917588|FG002|Period 1|Investigator decision: site closure|0|||
126717668|NCT01808118|455917586|FG000|Period 1|Non-compliance per sponsor|1|||
126717669|NCT01808118|455917587|FG001|Period 1|Non-compliance per sponsor|0|||
126717670|NCT01808118|455917588|FG002|Period 1|Non-compliance per sponsor|0|||
126717671|NCT01808118|455917586|FG000|Period 1|Lack of Efficacy|1|||
126717672|NCT01808118|455917587|FG001|Period 1|Lack of Efficacy|0|||
126717673|NCT01808118|455917588|FG002|Period 1|Lack of Efficacy|0|||
126717674|NCT01808118|455917586|FG000|Period 2|Adverse Event|0|||
126388094|NCT01436656|454713729|FG000|Dose Escalation|Death|1|||
126388095|NCT01436656|454713730|FG001|Dose Escalation|Death|3|||
126553963|NCT02138747|455322643|FG000|Treatment Period 2|Withdrawal by Subject|5|||
126553964|NCT02138747|455322644|FG001|Treatment Period 2|Withdrawal by Subject|4|||
126717675|NCT01808118|455917587|FG001|Period 2|Adverse Event|4|||
126388096|NCT01436656|454713731|FG002|Dose Escalation|Death|1|||
126388097|NCT01436656|454713732|FG003|Dose Escalation|Death|0|||
126388098|NCT01436656|454713733|FG004|Dose Escalation|Death|2|||
126388099|NCT01436656|454713734|FG005|Dose Escalation|Death|1|||
126388100|NCT01436656|454713735|FG006|Dose Escalation|Death|1|||
126388101|NCT01436656|454713736|FG007|Dose Escalation|Death|1|||
126388102|NCT01436656|454713737|FG008|Dose Escalation|Death|1|||
126388103|NCT01436656|454713738|FG009|Dose Escalation|Death|0|||
126388104|NCT01436656|454713739|FG010|Dose Escalation|Death|0|||
126388105|NCT01436656|454713740|FG011|Dose Escalation|Death|0|||
126388106|NCT01436656|454713741|FG012|Dose Escalation|Death|0|||
126388107|NCT01436656|454713742|FG013|Dose Escalation|Death|0|||
126388108|NCT01436656|454713743|FG014|Dose Escalation|Death|0|||
126388109|NCT01436656|454713744|FG015|Dose Escalation|Death|0|||
126388110|NCT01436656|454713745|FG016|Dose Escalation|Death|0|||
126388111|NCT01436656|454713746|FG017|Dose Escalation|Death|0|||
126388112|NCT01436656|454713729|FG000|Dose Escalation|Protocol Violation|0|||
126388113|NCT01436656|454713730|FG001|Dose Escalation|Protocol Violation|0|||
126388114|NCT01436656|454713731|FG002|Dose Escalation|Protocol Violation|0|||
126388115|NCT01436656|454713732|FG003|Dose Escalation|Protocol Violation|0|||
126388116|NCT01436656|454713733|FG004|Dose Escalation|Protocol Violation|0|||
126388117|NCT01436656|454713734|FG005|Dose Escalation|Protocol Violation|1|||
126388118|NCT01436656|454713735|FG006|Dose Escalation|Protocol Violation|0|||
126388119|NCT01436656|454713736|FG007|Dose Escalation|Protocol Violation|0|||
126388120|NCT01436656|454713737|FG008|Dose Escalation|Protocol Violation|0|||
126388121|NCT01436656|454713738|FG009|Dose Escalation|Protocol Violation|0|||
126388122|NCT01436656|454713739|FG010|Dose Escalation|Protocol Violation|0|||
126388123|NCT01436656|454713740|FG011|Dose Escalation|Protocol Violation|0|||
126388124|NCT01436656|454713741|FG012|Dose Escalation|Protocol Violation|0|||
126388125|NCT01436656|454713742|FG013|Dose Escalation|Protocol Violation|0|||
126388126|NCT01436656|454713743|FG014|Dose Escalation|Protocol Violation|0|||
126388127|NCT01436656|454713744|FG015|Dose Escalation|Protocol Violation|0|||
126388128|NCT01436656|454713745|FG016|Dose Escalation|Protocol Violation|0|||
126388129|NCT01436656|454713746|FG017|Dose Escalation|Protocol Violation|0|||
126388130|NCT01436656|454713729|FG000|Dose Escalation|Withdrawal by Subject|0|||
126388131|NCT01436656|454713730|FG001|Dose Escalation|Withdrawal by Subject|0|||
126388132|NCT01436656|454713731|FG002|Dose Escalation|Withdrawal by Subject|0|||
126388133|NCT01436656|454713732|FG003|Dose Escalation|Withdrawal by Subject|0|||
126388134|NCT01436656|454713733|FG004|Dose Escalation|Withdrawal by Subject|1|||
126388135|NCT01436656|454713734|FG005|Dose Escalation|Withdrawal by Subject|0|||
126388136|NCT01436656|454713735|FG006|Dose Escalation|Withdrawal by Subject|0|||
126388137|NCT01436656|454713736|FG007|Dose Escalation|Withdrawal by Subject|2|||
126388138|NCT01436656|454713737|FG008|Dose Escalation|Withdrawal by Subject|0|||
126388139|NCT01436656|454713738|FG009|Dose Escalation|Withdrawal by Subject|1|||
126388140|NCT01436656|454713739|FG010|Dose Escalation|Withdrawal by Subject|1|||
126388141|NCT01436656|454713740|FG011|Dose Escalation|Withdrawal by Subject|0|||
126388142|NCT01436656|454713741|FG012|Dose Escalation|Withdrawal by Subject|0|||
126388143|NCT01436656|454713742|FG013|Dose Escalation|Withdrawal by Subject|0|||
126388144|NCT01436656|454713743|FG014|Dose Escalation|Withdrawal by Subject|0|||
126388145|NCT01436656|454713744|FG015|Dose Escalation|Withdrawal by Subject|0|||
126388146|NCT01436656|454713745|FG016|Dose Escalation|Withdrawal by Subject|0|||
126388147|NCT01436656|454713746|FG017|Dose Escalation|Withdrawal by Subject|0|||
126388148|NCT01436656|454713729|FG000|Dose Escalation|Administrative problems|0|||
126388149|NCT01436656|454713730|FG001|Dose Escalation|Administrative problems|1|||
126388150|NCT01436656|454713731|FG002|Dose Escalation|Administrative problems|0|||
126388151|NCT01436656|454713732|FG003|Dose Escalation|Administrative problems|0|||
126388152|NCT01436656|454713733|FG004|Dose Escalation|Administrative problems|0|||
126388153|NCT01436656|454713734|FG005|Dose Escalation|Administrative problems|0|||
126388154|NCT01436656|454713735|FG006|Dose Escalation|Administrative problems|0|||
126388155|NCT01436656|454713736|FG007|Dose Escalation|Administrative problems|0|||
126388156|NCT01436656|454713737|FG008|Dose Escalation|Administrative problems|0|||
126388157|NCT01436656|454713738|FG009|Dose Escalation|Administrative problems|0|||
126388158|NCT01436656|454713739|FG010|Dose Escalation|Administrative problems|0|||
126388159|NCT01436656|454713740|FG011|Dose Escalation|Administrative problems|0|||
126388160|NCT01436656|454713741|FG012|Dose Escalation|Administrative problems|0|||
126388161|NCT01436656|454713742|FG013|Dose Escalation|Administrative problems|0|||
126553965|NCT02138747|455322645|FG002|Treatment Period 2|Withdrawal by Subject|1|||
126553966|NCT02138747|455322646|FG003|Treatment Period 2|Withdrawal by Subject|2|||
126717676|NCT01808118|455917588|FG002|Period 2|Adverse Event|0|||
126388162|NCT01436656|454713743|FG014|Dose Escalation|Administrative problems|0|||
126388163|NCT01436656|454713744|FG015|Dose Escalation|Administrative problems|0|||
126388164|NCT01436656|454713745|FG016|Dose Escalation|Administrative problems|0|||
126388165|NCT01436656|454713746|FG017|Dose Escalation|Administrative problems|0|||
126388166|NCT01436656|454713729|FG000|Dose Escalation|Lost to Follow-up|1|||
126388167|NCT01436656|454713730|FG001|Dose Escalation|Lost to Follow-up|0|||
126388168|NCT01436656|454713731|FG002|Dose Escalation|Lost to Follow-up|0|||
126388169|NCT01436656|454713732|FG003|Dose Escalation|Lost to Follow-up|0|||
126388170|NCT01436656|454713733|FG004|Dose Escalation|Lost to Follow-up|1|||
126717677|NCT01808118|455917586|FG000|Period 2|Withdrew consent|0|||
126717678|NCT01808118|455917587|FG001|Period 2|Withdrew consent|7|||
126717679|NCT01808118|455917588|FG002|Period 2|Withdrew consent|6|||
126717680|NCT01808118|455917586|FG000|Period 2|Lost to Follow-up|0|||
126717681|NCT01808118|455917587|FG001|Period 2|Lost to Follow-up|0|||
126717682|NCT01808118|455917588|FG002|Period 2|Lost to Follow-up|2|||
126717683|NCT01808118|455917586|FG000|Period 2|Investigator no longer conducting trials|0|||
126717684|NCT01808118|455917587|FG001|Period 2|Investigator no longer conducting trials|1|||
126717685|NCT01808118|455917588|FG002|Period 2|Investigator no longer conducting trials|0|||
126717686|NCT01808118|455917586|FG000|Period 2|Switched to other therapy|0|||
126717687|NCT01808118|455917587|FG001|Period 2|Switched to other therapy|1|||
126717688|NCT01808118|455917588|FG002|Period 2|Switched to other therapy|0|||
126717689|NCT02750813|455917594|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
126717690|NCT02750813|455917595|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
126717691|NCT02750813|455917594|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
126717692|NCT02750813|455917595|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
126717693|NCT00615290|455917596|FG000|Overall Study|Adverse Event|2|||
126717694|NCT00615290|455917596|FG000|Overall Study|Lost to Follow-up|3|||
126717695|NCT00615290|455917596|FG000|Overall Study|Withdrawal by Subject|1|||
126717696|NCT00615290|455917596|FG000|Overall Study|Other|2|||
126717697|NCT01252134|455917597|FG000|Period 1, 8 Hours|Personal Reasons|0|||
126717698|NCT01252134|455917598|FG001|Period 1, 8 Hours|Personal Reasons|1|||
126717699|NCT01252134|455917599|FG002|Period 1, 8 Hours|Personal Reasons|1|||
126717700|NCT01252134|455917600|FG003|Period 1, 8 Hours|Personal Reasons|0|||
126717701|NCT01252134|455917601|FG004|Period 1, 8 Hours|Personal Reasons|0|||
126717702|NCT01252134|455917602|FG005|Period 1, 8 Hours|Personal Reasons|0|||
126717703|NCT03650452|455917603|FG000|Overall Study|Physician Decision|1|||
126717704|NCT03650452|455917604|FG001|Overall Study|Physician Decision|0|||
126388171|NCT01436656|454713734|FG005|Dose Escalation|Lost to Follow-up|0|||
126388172|NCT01436656|454713735|FG006|Dose Escalation|Lost to Follow-up|0|||
126388173|NCT01436656|454713736|FG007|Dose Escalation|Lost to Follow-up|0|||
126388174|NCT01436656|454713737|FG008|Dose Escalation|Lost to Follow-up|0|||
126388175|NCT01436656|454713738|FG009|Dose Escalation|Lost to Follow-up|0|||
126388176|NCT01436656|454713739|FG010|Dose Escalation|Lost to Follow-up|0|||
126388177|NCT01436656|454713740|FG011|Dose Escalation|Lost to Follow-up|0|||
126388178|NCT01436656|454713741|FG012|Dose Escalation|Lost to Follow-up|0|||
126388179|NCT01436656|454713742|FG013|Dose Escalation|Lost to Follow-up|0|||
126388180|NCT01436656|454713743|FG014|Dose Escalation|Lost to Follow-up|0|||
126388181|NCT01436656|454713744|FG015|Dose Escalation|Lost to Follow-up|0|||
126388182|NCT01436656|454713745|FG016|Dose Escalation|Lost to Follow-up|0|||
126388183|NCT01436656|454713746|FG017|Dose Escalation|Lost to Follow-up|0|||
126388184|NCT01436656|454713729|FG000|Dose Escalation|New anti-cancer therapy|1|||
126388185|NCT01436656|454713730|FG001|Dose Escalation|New anti-cancer therapy|0|||
126388186|NCT01436656|454713731|FG002|Dose Escalation|New anti-cancer therapy|0|||
126388187|NCT01436656|454713732|FG003|Dose Escalation|New anti-cancer therapy|0|||
126388188|NCT01436656|454713733|FG004|Dose Escalation|New anti-cancer therapy|0|||
126388189|NCT01436656|454713734|FG005|Dose Escalation|New anti-cancer therapy|0|||
126388190|NCT01436656|454713735|FG006|Dose Escalation|New anti-cancer therapy|0|||
126388191|NCT01436656|454713736|FG007|Dose Escalation|New anti-cancer therapy|0|||
126388192|NCT01436656|454713737|FG008|Dose Escalation|New anti-cancer therapy|1|||
126388193|NCT01436656|454713738|FG009|Dose Escalation|New anti-cancer therapy|1|||
126388194|NCT01436656|454713739|FG010|Dose Escalation|New anti-cancer therapy|0|||
126388195|NCT01436656|454713740|FG011|Dose Escalation|New anti-cancer therapy|0|||
126388196|NCT01436656|454713741|FG012|Dose Escalation|New anti-cancer therapy|0|||
126388197|NCT01436656|454713742|FG013|Dose Escalation|New anti-cancer therapy|0|||
126388198|NCT01436656|454713743|FG014|Dose Escalation|New anti-cancer therapy|0|||
126388199|NCT01436656|454713744|FG015|Dose Escalation|New anti-cancer therapy|0|||
126388200|NCT01436656|454713745|FG016|Dose Escalation|New anti-cancer therapy|0|||
126388201|NCT01436656|454713746|FG017|Dose Escalation|New anti-cancer therapy|0|||
126717705|NCT03650452|455917603|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
126388202|NCT01436656|454713729|FG000|Dose Expansion|Adverse Event|0|||
126388203|NCT01436656|454713730|FG001|Dose Expansion|Adverse Event|0|||
126717706|NCT03650452|455917604|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126388204|NCT01436656|454713731|FG002|Dose Expansion|Adverse Event|0|||
126388205|NCT01436656|454713732|FG003|Dose Expansion|Adverse Event|0|||
126388206|NCT01436656|454713733|FG004|Dose Expansion|Adverse Event|0|||
126717707|NCT03650452|455917603|FG000|Overall Study|Adverse Event|3|||
126717708|NCT03650452|455917604|FG001|Overall Study|Adverse Event|4|||
126717709|NCT03650452|455917603|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
126388207|NCT01436656|454713734|FG005|Dose Expansion|Adverse Event|0|||
126388208|NCT01436656|454713735|FG006|Dose Expansion|Adverse Event|0|||
126388209|NCT01436656|454713736|FG007|Dose Expansion|Adverse Event|0|||
126388210|NCT01436656|454713737|FG008|Dose Expansion|Adverse Event|0|||
126388211|NCT01436656|454713738|FG009|Dose Expansion|Adverse Event|0|||
126388212|NCT01436656|454713739|FG010|Dose Expansion|Adverse Event|0|||
126388213|NCT01436656|454713740|FG011|Dose Expansion|Adverse Event|1|||
126388214|NCT01436656|454713741|FG012|Dose Expansion|Adverse Event|0|||
126388215|NCT01436656|454713742|FG013|Dose Expansion|Adverse Event|0|||
126388216|NCT01436656|454713743|FG014|Dose Expansion|Adverse Event|0|||
126388217|NCT01436656|454713744|FG015|Dose Expansion|Adverse Event|0|||
126388218|NCT01436656|454713745|FG016|Dose Expansion|Adverse Event|0|||
126388219|NCT01436656|454713746|FG017|Dose Expansion|Adverse Event|0|||
126388220|NCT01436656|454713729|FG000|Dose Expansion|Withdrawal by Subject|0|||
126388221|NCT01436656|454713730|FG001|Dose Expansion|Withdrawal by Subject|0|||
126388222|NCT01436656|454713731|FG002|Dose Expansion|Withdrawal by Subject|0|||
126388223|NCT01436656|454713732|FG003|Dose Expansion|Withdrawal by Subject|0|||
126388224|NCT01436656|454713733|FG004|Dose Expansion|Withdrawal by Subject|0|||
126388225|NCT01436656|454713734|FG005|Dose Expansion|Withdrawal by Subject|0|||
126388226|NCT01436656|454713735|FG006|Dose Expansion|Withdrawal by Subject|0|||
126388227|NCT01436656|454713736|FG007|Dose Expansion|Withdrawal by Subject|0|||
126388228|NCT01436656|454713737|FG008|Dose Expansion|Withdrawal by Subject|0|||
126388229|NCT01436656|454713738|FG009|Dose Expansion|Withdrawal by Subject|0|||
126388230|NCT01436656|454713739|FG010|Dose Expansion|Withdrawal by Subject|0|||
126388231|NCT01436656|454713740|FG011|Dose Expansion|Withdrawal by Subject|1|||
126388232|NCT01436656|454713741|FG012|Dose Expansion|Withdrawal by Subject|3|||
126388233|NCT01436656|454713742|FG013|Dose Expansion|Withdrawal by Subject|1|||
126388234|NCT01436656|454713743|FG014|Dose Expansion|Withdrawal by Subject|2|||
126388235|NCT01436656|454713744|FG015|Dose Expansion|Withdrawal by Subject|0|||
126388236|NCT01436656|454713745|FG016|Dose Expansion|Withdrawal by Subject|1|||
126388237|NCT01436656|454713746|FG017|Dose Expansion|Withdrawal by Subject|1|||
126388238|NCT01436656|454713729|FG000|Dose Expansion|Death|0|||
126388239|NCT01436656|454713730|FG001|Dose Expansion|Death|0|||
126388240|NCT01436656|454713731|FG002|Dose Expansion|Death|0|||
126388241|NCT01436656|454713732|FG003|Dose Expansion|Death|0|||
126388242|NCT01436656|454713733|FG004|Dose Expansion|Death|0|||
126388243|NCT01436656|454713734|FG005|Dose Expansion|Death|0|||
126388244|NCT01436656|454713735|FG006|Dose Expansion|Death|0|||
126388245|NCT01436656|454713736|FG007|Dose Expansion|Death|0|||
126388246|NCT01436656|454713737|FG008|Dose Expansion|Death|0|||
126388247|NCT01436656|454713738|FG009|Dose Expansion|Death|0|||
126388248|NCT01436656|454713739|FG010|Dose Expansion|Death|0|||
126388249|NCT01436656|454713740|FG011|Dose Expansion|Death|0|||
126388250|NCT01436656|454713741|FG012|Dose Expansion|Death|1|||
126388251|NCT01436656|454713742|FG013|Dose Expansion|Death|0|||
126388252|NCT01436656|454713743|FG014|Dose Expansion|Death|3|||
126388253|NCT01436656|454713744|FG015|Dose Expansion|Death|0|||
126388254|NCT01436656|454713745|FG016|Dose Expansion|Death|3|||
126388255|NCT01436656|454713746|FG017|Dose Expansion|Death|3|||
126388256|NCT01436656|454713729|FG000|Dose Expansion|Lost to Follow-up|0|||
126388257|NCT01436656|454713730|FG001|Dose Expansion|Lost to Follow-up|0|||
126388258|NCT01436656|454713731|FG002|Dose Expansion|Lost to Follow-up|0|||
126388259|NCT01436656|454713732|FG003|Dose Expansion|Lost to Follow-up|0|||
126388260|NCT01436656|454713733|FG004|Dose Expansion|Lost to Follow-up|0|||
126553967|NCT02138747|455322643|FG000|Treatment Period 2|Other - Miscellaneous|3|||
126553968|NCT02138747|455322644|FG001|Treatment Period 2|Other - Miscellaneous|0|||
126553969|NCT02138747|455322645|FG002|Treatment Period 2|Other - Miscellaneous|0|||
126553970|NCT02138747|455322646|FG003|Treatment Period 2|Other - Miscellaneous|0|||
126388261|NCT01436656|454713734|FG005|Dose Expansion|Lost to Follow-up|0|||
126388262|NCT01436656|454713735|FG006|Dose Expansion|Lost to Follow-up|0|||
126388263|NCT01436656|454713736|FG007|Dose Expansion|Lost to Follow-up|0|||
126388264|NCT01436656|454713737|FG008|Dose Expansion|Lost to Follow-up|0|||
126388265|NCT01436656|454713738|FG009|Dose Expansion|Lost to Follow-up|0|||
126388266|NCT01436656|454713739|FG010|Dose Expansion|Lost to Follow-up|0|||
126388267|NCT01436656|454713740|FG011|Dose Expansion|Lost to Follow-up|0|||
126388268|NCT01436656|454713741|FG012|Dose Expansion|Lost to Follow-up|0|||
126388269|NCT01436656|454713742|FG013|Dose Expansion|Lost to Follow-up|0|||
126388270|NCT01436656|454713743|FG014|Dose Expansion|Lost to Follow-up|0|||
126717710|NCT03650452|455917604|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
126717711|NCT02273050|455917605|FG000|Overall Study|Adverse Event|4|||
126388271|NCT01436656|454713744|FG015|Dose Expansion|Lost to Follow-up|0|||
126388272|NCT01436656|454713745|FG016|Dose Expansion|Lost to Follow-up|0|||
126388273|NCT01436656|454713746|FG017|Dose Expansion|Lost to Follow-up|3|||
126388274|NCT01436656|454713729|FG000|Dose Expansion|Disease progression|0|||
126388275|NCT01436656|454713730|FG001|Dose Expansion|Disease progression|0|||
126388276|NCT01436656|454713731|FG002|Dose Expansion|Disease progression|0|||
126388277|NCT01436656|454713732|FG003|Dose Expansion|Disease progression|0|||
126388278|NCT01436656|454713733|FG004|Dose Expansion|Disease progression|0|||
126388279|NCT01436656|454713734|FG005|Dose Expansion|Disease progression|0|||
126388280|NCT01436656|454713735|FG006|Dose Expansion|Disease progression|0|||
126388281|NCT01436656|454713736|FG007|Dose Expansion|Disease progression|0|||
126388282|NCT01436656|454713737|FG008|Dose Expansion|Disease progression|0|||
126388283|NCT01436656|454713738|FG009|Dose Expansion|Disease progression|0|||
126553971|NCT00776100|455322652|FG000|Overall Study|Disease Progression|1|||
126553972|NCT00776100|455322653|FG001|Overall Study|Disease Progression|0|||
126771217|NCT01678924|456117702|FG000|Overall Study|Withdrawal by Subject|0|||
126388284|NCT01436656|454713739|FG010|Dose Expansion|Disease progression|0|||
126388285|NCT01436656|454713740|FG011|Dose Expansion|Disease progression|3|||
126388286|NCT01436656|454713741|FG012|Dose Expansion|Disease progression|1|||
126388287|NCT01436656|454713742|FG013|Dose Expansion|Disease progression|0|||
126388288|NCT01436656|454713743|FG014|Dose Expansion|Disease progression|1|||
126388289|NCT01436656|454713744|FG015|Dose Expansion|Disease progression|0|||
126388290|NCT01436656|454713745|FG016|Dose Expansion|Disease progression|0|||
126388291|NCT01436656|454713746|FG017|Dose Expansion|Disease progression|1|||
126388292|NCT01436656|454713729|FG000|Dose Expansion|New cancer therapy|0|||
126388293|NCT01436656|454713730|FG001|Dose Expansion|New cancer therapy|0|||
126388294|NCT01436656|454713731|FG002|Dose Expansion|New cancer therapy|0|||
126388295|NCT01436656|454713732|FG003|Dose Expansion|New cancer therapy|0|||
126388296|NCT01436656|454713733|FG004|Dose Expansion|New cancer therapy|0|||
126388297|NCT01436656|454713734|FG005|Dose Expansion|New cancer therapy|0|||
126388298|NCT01436656|454713735|FG006|Dose Expansion|New cancer therapy|0|||
126388299|NCT01436656|454713736|FG007|Dose Expansion|New cancer therapy|0|||
126388300|NCT01436656|454713737|FG008|Dose Expansion|New cancer therapy|0|||
126388301|NCT01436656|454713738|FG009|Dose Expansion|New cancer therapy|0|||
126388302|NCT01436656|454713739|FG010|Dose Expansion|New cancer therapy|0|||
126388303|NCT01436656|454713740|FG011|Dose Expansion|New cancer therapy|1|||
126388304|NCT01436656|454713741|FG012|Dose Expansion|New cancer therapy|1|||
126388305|NCT01436656|454713742|FG013|Dose Expansion|New cancer therapy|0|||
126388306|NCT01436656|454713743|FG014|Dose Expansion|New cancer therapy|2|||
126388307|NCT01436656|454713744|FG015|Dose Expansion|New cancer therapy|0|||
126388308|NCT01436656|454713745|FG016|Dose Expansion|New cancer therapy|0|||
126388309|NCT01436656|454713746|FG017|Dose Expansion|New cancer therapy|0|||
126388310|NCT04729972|454713747|FG000|Overall Study|Adverse Event|1|||
126388311|NCT00576628|454713749|FG000|Overall Study|Adverse Event|11|||
126388312|NCT00576628|454713749|FG000|Overall Study|Death|2|||
126388313|NCT00576628|454713749|FG000|Overall Study|Failure to return|1|||
126388314|NCT00576628|454713749|FG000|Overall Study|Refused Treatment|8|||
126388315|NCT00576628|454713749|FG000|Overall Study|Pregnancy|1|||
126388316|NCT00576628|454713749|FG000|Overall Study|RBC transfusion|1|||
126388317|NCT00576628|454713749|FG000|Overall Study|Progression of Kidney Disease|1|||
126388318|NCT00576628|454713749|FG000|Overall Study|Progression of Renal Failure|1|||
126388319|NCT00576628|454713749|FG000|Overall Study|The patient move into other town|1|||
126388320|NCT00576628|454713749|FG000|Overall Study|Transplantation|1|||
126388321|NCT00576628|454713749|FG000|Overall Study|Dialysis|15|||
126388322|NCT03206970|454713750|FG000|Overall Study|Death|21|||
126388323|NCT03206970|454713750|FG000|Overall Study|Withdrawal by Subject|13|||
126388324|NCT03206970|454713750|FG000|Overall Study|Lost to Follow-up|3|||
126388325|NCT03206970|454713750|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
126388326|NCT02516982|454713753|FG000|Overall Study|Called in to antenatal appointment|32|||
126388327|NCT02516982|454713754|FG001|Overall Study|Called in to antenatal appointment|35|||
126388328|NCT02516982|454713755|FG002|Overall Study|Called in to antenatal appointment|0|||
126388329|NCT02516982|454713756|FG003|Overall Study|Called in to antenatal appointment|0|||
126388330|NCT02516982|454713753|FG000|Overall Study|Withdrawal by Subject|0|||
126388331|NCT02516982|454713754|FG001|Overall Study|Withdrawal by Subject|0|||
126388332|NCT02516982|454713755|FG002|Overall Study|Withdrawal by Subject|1|||
126388333|NCT02516982|454713756|FG003|Overall Study|Withdrawal by Subject|2|||
126388334|NCT02516982|454713753|FG000|Overall Study|Protocol Violation|0|||
126388335|NCT02516982|454713754|FG001|Overall Study|Protocol Violation|0|||
126388336|NCT02516982|454713755|FG002|Overall Study|Protocol Violation|1|||
126388337|NCT02516982|454713756|FG003|Overall Study|Protocol Violation|1|||
126388338|NCT02516982|454713753|FG000|Overall Study|Did not install the app|0|||
126388339|NCT02516982|454713754|FG001|Overall Study|Did not install the app|0|||
126388340|NCT02516982|454713755|FG002|Overall Study|Did not install the app|46|||
126388341|NCT02516982|454713756|FG003|Overall Study|Did not install the app|47|||
126388342|NCT00962741|454713758|FG000|Overall Study|Failed to return|3|||
126388343|NCT00962741|454713758|FG000|Overall Study|Lost to Follow-up|2|||
126388344|NCT00962741|454713758|FG000|Overall Study|Withdrawal by Subject|1|||
126388345|NCT00962741|454713758|FG000|Overall Study|Lack of Efficacy|1|||
126388346|NCT00962741|454713758|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
126388347|NCT01814878|454713761|FG000|Overall Study|Adverse Event|16|||
126388348|NCT01814878|454713762|FG001|Overall Study|Adverse Event|5|||
126388349|NCT01814878|454713761|FG000|Overall Study|Withdrawal by Subject|20|||
126388350|NCT01814878|454713762|FG001|Overall Study|Withdrawal by Subject|16|||
126388351|NCT01814878|454713761|FG000|Overall Study|Protocol Violation|5|||
126388352|NCT01814878|454713762|FG001|Overall Study|Protocol Violation|5|||
126388353|NCT01814878|454713761|FG000|Overall Study|Physician Decision|3|||
126553973|NCT03567993|455322656|FG000|Overall Study|Lost to Follow-up|4|||
126771218|NCT01678924|456117703|FG001|Overall Study|Withdrawal by Subject|3|||
126388354|NCT01814878|454713762|FG001|Overall Study|Physician Decision|1|||
126388355|NCT01814878|454713761|FG000|Overall Study|Screening failure (drop-out)|0|||
126388356|NCT01814878|454713762|FG001|Overall Study|Screening failure (drop-out)|3|||
126388357|NCT01814878|454713761|FG000|Overall Study|Other|2|||
126388358|NCT01814878|454713762|FG001|Overall Study|Other|0|||
126388359|NCT03645421|454713763|FG000|Overall Study|Adverse Event|0|||
126388360|NCT03645421|454713764|FG001|Overall Study|Adverse Event|0|||
126388361|NCT03645421|454713765|FG002|Overall Study|Adverse Event|4|||
126388362|NCT03645421|454713766|FG003|Overall Study|Adverse Event|1|||
126388363|NCT03645421|454713763|FG000|Overall Study|Withdrawal by patient|0|||
126388364|NCT03645421|454713764|FG001|Overall Study|Withdrawal by patient|0|||
126388365|NCT03645421|454713765|FG002|Overall Study|Withdrawal by patient|0|||
126388366|NCT03645421|454713766|FG003|Overall Study|Withdrawal by patient|3|||
126388367|NCT03645421|454713763|FG000|Overall Study|Study specific withdrawal criteria|0|||
126388368|NCT03645421|454713764|FG001|Overall Study|Study specific withdrawal criteria|0|||
126388369|NCT03645421|454713765|FG002|Overall Study|Study specific withdrawal criteria|1|||
126388370|NCT03645421|454713766|FG003|Overall Study|Study specific withdrawal criteria|0|||
126388371|NCT02253433|454713770|FG000|Overall Study|Unable to Contact|9|||
126553974|NCT03567993|455322657|FG001|Overall Study|Lost to Follow-up|2|||
126553975|NCT03567993|455322656|FG000|Overall Study|Death|1|||
126553976|NCT03567993|455322657|FG001|Overall Study|Death|1|||
126553977|NCT03567993|455322656|FG000|Overall Study|Withdrawal by Subject|1|||
126553978|NCT03567993|455322657|FG001|Overall Study|Withdrawal by Subject|0|||
126553979|NCT04793464|455322658|FG000|Overall Study|Lost to Follow-up|458|||
126553980|NCT04793464|455322659|FG001|Overall Study|Lost to Follow-up|168|||
126553981|NCT04793464|455322660|FG002|Overall Study|Lost to Follow-up|5|||
126553982|NCT04793464|455322658|FG000|Overall Study|Withdrawal by Subject|43|||
126553983|NCT04793464|455322659|FG001|Overall Study|Withdrawal by Subject|15|||
126553984|NCT04793464|455322660|FG002|Overall Study|Withdrawal by Subject|0|||
126553985|NCT00641186|455322663|FG000|Overall Study|Adverse Event|3|||
126553986|NCT05221749|455322664|FG000|Overall Study|Lost to Follow-up|2|||
126553987|NCT05221749|455322665|FG001|Overall Study|Lost to Follow-up|3|||
126553988|NCT02388074|455322666|FG000|Overall Study|Lost in Transit|2|||
126553989|NCT02388074|455322666|FG000|Overall Study|Sample Not Returned|1|||
126553990|NCT00003458|455322669|FG000|Overall Study|Not evaluable|4|||
126553991|NCT02133924|455322670|FG000|Overall Study|Death|38|||
126553992|NCT02133924|455322670|FG000|Overall Study|Physician Decision|1|||
126553993|NCT02133924|455322670|FG000|Overall Study|Withdrawal by Subject|3|||
126553994|NCT01254890|455322671|FG000|Overall Study|Ineligible|0|||
126553995|NCT01254890|455322672|FG001|Overall Study|Ineligible|3|||
126553996|NCT01254890|455322671|FG000|Overall Study|Withdrawal by Subject|1|||
126553997|NCT01254890|455322672|FG001|Overall Study|Withdrawal by Subject|2|||
126553998|NCT01254890|455322671|FG000|Overall Study|Disease Progression|0|||
126388372|NCT02253433|454713771|FG001|Overall Study|Unable to Contact|16|||
126388373|NCT02253433|454713770|FG000|Overall Study|Death|1|||
126388374|NCT02253433|454713771|FG001|Overall Study|Death|1|||
126388375|NCT02253433|454713770|FG000|Overall Study|No Longer Interested|3|||
126388376|NCT02253433|454713771|FG001|Overall Study|No Longer Interested|15|||
126388377|NCT02253433|454713770|FG000|Overall Study|Out of Study Area|2|||
126388378|NCT02253433|454713771|FG001|Overall Study|Out of Study Area|7|||
126388379|NCT02253433|454713770|FG000|Overall Study|Uncomfortable with home visitors|0|||
126388380|NCT02253433|454713771|FG001|Overall Study|Uncomfortable with home visitors|3|||
126388381|NCT02253433|454713770|FG000|Overall Study|Unstable Housing/Homeless|0|||
126388382|NCT02253433|454713771|FG001|Overall Study|Unstable Housing/Homeless|7|||
126388383|NCT02253433|454713770|FG000|Overall Study|Too Busy|0|||
126388384|NCT02253433|454713771|FG001|Overall Study|Too Busy|4|||
126388385|NCT02253433|454713770|FG000|Overall Study|Medical or Other Concerns|1|||
126388386|NCT02253433|454713771|FG001|Overall Study|Medical or Other Concerns|2|||
126388387|NCT00759876|454713779|FG000|Overall Study|Sponsor terminated study early|36|||
126388388|NCT02836717|454713780|FG000|Test Phase|Lack of Efficacy|14|||
126388389|NCT02836717|454713781|FG001|Test Phase|Lack of Efficacy|8|||
126388390|NCT02836717|454713782|FG002|Test Phase|Lack of Efficacy|0|||
126388391|NCT02836717|454713780|FG000|Study Phase|Adverse Event|2|||
126388392|NCT02836717|454713781|FG001|Study Phase|Adverse Event|0|||
126388393|NCT02836717|454713782|FG002|Study Phase|Adverse Event|0|||
126553999|NCT01254890|455322672|FG001|Overall Study|Disease Progression|5|||
126554000|NCT04157686|455322677|FG000|Overall Study|Adverse Event|1|||
126554001|NCT04157686|455322678|FG001|Overall Study|Adverse Event|0|||
126554002|NCT04157686|455322679|FG002|Overall Study|Adverse Event|1|||
126554003|NCT04157686|455322680|FG003|Overall Study|Adverse Event|0|||
126554004|NCT04157686|455322681|FG004|Overall Study|Adverse Event|1|||
126554005|NCT04157686|455322682|FG005|Overall Study|Adverse Event|0|||
126554006|NCT04157686|455322683|FG006|Overall Study|Adverse Event|0|||
126388394|NCT02836717|454713780|FG000|Study Phase|Lack of Efficacy|8|||
126388395|NCT02836717|454713781|FG001|Study Phase|Lack of Efficacy|6|||
126388396|NCT02836717|454713782|FG002|Study Phase|Lack of Efficacy|1|||
126388397|NCT02836717|454713780|FG000|Study Phase|Withdrawal by Subject|1|||
126388398|NCT02836717|454713781|FG001|Study Phase|Withdrawal by Subject|0|||
126388399|NCT02836717|454713782|FG002|Study Phase|Withdrawal by Subject|0|||
126388400|NCT02836717|454713780|FG000|Study Phase|Death|1|||
126388401|NCT02836717|454713781|FG001|Study Phase|Death|0|||
126388402|NCT02836717|454713782|FG002|Study Phase|Death|0|||
126554007|NCT04157686|455322684|FG007|Overall Study|Adverse Event|0|||
126554008|NCT04157686|455322677|FG000|Overall Study|Pregnancy|0|||
126388403|NCT02836717|454713780|FG000|Study Phase|abdominal surgeries|2|||
126388404|NCT02836717|454713781|FG001|Study Phase|abdominal surgeries|1|||
126388405|NCT02836717|454713782|FG002|Study Phase|abdominal surgeries|0|||
126388406|NCT03636893|454713783|FG000|Overall Study|Death|0|||
126388407|NCT03636893|454713784|FG001|Overall Study|Death|1|||
126388408|NCT03636893|454713783|FG000|Overall Study|Protocol Violation|0|||
126388409|NCT03636893|454713784|FG001|Overall Study|Protocol Violation|3|||
126388410|NCT03636893|454713783|FG000|Overall Study|Withdrawal by Subject|1|||
126388411|NCT03636893|454713784|FG001|Overall Study|Withdrawal by Subject|2|||
126388412|NCT03636893|454713783|FG000|Overall Study|Refusal to surgery|4|||
126388413|NCT03636893|454713784|FG001|Overall Study|Refusal to surgery|3|||
126388414|NCT03636893|454713783|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
126388415|NCT03636893|454713784|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
126388416|NCT03636893|454713783|FG000|Overall Study|Adverse Event|1|||
126388417|NCT03636893|454713784|FG001|Overall Study|Adverse Event|1|||
126388418|NCT00438360|454713785|FG000|Overall Study|Adverse Event|6|||
126388419|NCT00438360|454713786|FG001|Overall Study|Adverse Event|1|||
126388420|NCT00438360|454713785|FG000|Overall Study|Lack of Efficacy|42|||
126388421|NCT00438360|454713786|FG001|Overall Study|Lack of Efficacy|27|||
126388422|NCT00438360|454713785|FG000|Overall Study|Other|24|||
126388423|NCT00438360|454713786|FG001|Overall Study|Other|15|||
126388424|NCT04560816|454713788|FG000|Overall Study|Withdrawal by Subject|1|||
126388425|NCT04560816|454713789|FG001|Overall Study|Withdrawal by Subject|1|||
126388426|NCT04560816|454713790|FG002|Overall Study|Withdrawal by Subject|1|||
126388427|NCT04560816|454713791|FG003|Overall Study|Withdrawal by Subject|0|||
126388428|NCT04560816|454713792|FG004|Overall Study|Withdrawal by Subject|3|||
126388429|NCT04560816|454713793|FG005|Overall Study|Withdrawal by Subject|0|||
126388430|NCT04560816|454713788|FG000|Overall Study|Lost to Follow-up|1|||
126388431|NCT04560816|454713789|FG001|Overall Study|Lost to Follow-up|0|||
126388432|NCT04560816|454713790|FG002|Overall Study|Lost to Follow-up|0|||
126388433|NCT04560816|454713791|FG003|Overall Study|Lost to Follow-up|0|||
126388434|NCT04560816|454713792|FG004|Overall Study|Lost to Follow-up|0|||
126388435|NCT04560816|454713793|FG005|Overall Study|Lost to Follow-up|0|||
126388436|NCT04560816|454713788|FG000|Overall Study|Protocol Violation|1|||
126388437|NCT04560816|454713789|FG001|Overall Study|Protocol Violation|0|||
126388438|NCT04560816|454713790|FG002|Overall Study|Protocol Violation|0|||
126388439|NCT04560816|454713791|FG003|Overall Study|Protocol Violation|0|||
126388440|NCT04560816|454713792|FG004|Overall Study|Protocol Violation|0|||
126388441|NCT04560816|454713793|FG005|Overall Study|Protocol Violation|0|||
126388442|NCT02277691|454713794|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
126388443|NCT02277691|454713794|FG000|Overall Study|Voluntary Withdrawal|7|||
126388444|NCT02277691|454713794|FG000|Overall Study|Lack of Efficacy|5|||
126388445|NCT02277691|454713794|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
126388446|NCT03818607|454713795|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
126388447|NCT03818607|454713796|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
126388448|NCT03818607|454713795|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
126388449|NCT03818607|454713796|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
126388450|NCT03818607|454713795|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
126388451|NCT03818607|454713796|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
126388452|NCT05059301|454713798|FG000|Overall Study|Adverse Event|0|||
126388453|NCT05059301|454713799|FG001|Overall Study|Adverse Event|2|||
126388454|NCT05059301|454713800|FG002|Overall Study|Adverse Event|2|||
126388455|NCT05059301|454713798|FG000|Overall Study|Lost to Follow-up|2|||
126388456|NCT05059301|454713799|FG001|Overall Study|Lost to Follow-up|3|||
126388457|NCT05059301|454713800|FG002|Overall Study|Lost to Follow-up|3|||
126388458|NCT01164891|454713801|FG000|Overall Study|Disease Progression|5|||
126388459|NCT01164891|454713801|FG000|Overall Study|Adverse Event|1|||
126388460|NCT00441142|454713802|FG000|Overall Study|Adverse Event|2|||
126388461|NCT00441142|454713803|FG001|Overall Study|Adverse Event|3|||
126388462|NCT00441142|454713804|FG002|Overall Study|Adverse Event|3|||
126388463|NCT00441142|454713805|FG003|Overall Study|Adverse Event|22|||
126388464|NCT00441142|454713802|FG000|Overall Study|Lack of Efficacy|3|||
126388465|NCT00441142|454713803|FG001|Overall Study|Lack of Efficacy|3|||
126388466|NCT00441142|454713804|FG002|Overall Study|Lack of Efficacy|17|||
126388467|NCT00441142|454713805|FG003|Overall Study|Lack of Efficacy|32|||
126388468|NCT00441142|454713802|FG000|Overall Study|Withdrawal by Subject|0|||
126388469|NCT00441142|454713803|FG001|Overall Study|Withdrawal by Subject|0|||
126388470|NCT00441142|454713804|FG002|Overall Study|Withdrawal by Subject|2|||
126388471|NCT00441142|454713805|FG003|Overall Study|Withdrawal by Subject|10|||
126388472|NCT00441142|454713802|FG000|Overall Study|Patient still receiving active study tx|1|||
126388473|NCT00441142|454713803|FG001|Overall Study|Patient still receiving active study tx|0|||
126388474|NCT00441142|454713804|FG002|Overall Study|Patient still receiving active study tx|0|||
126388475|NCT00441142|454713805|FG003|Overall Study|Patient still receiving active study tx|2|||
126388476|NCT00441142|454713802|FG000|Overall Study|Physician Decision|0|||
126388477|NCT00441142|454713803|FG001|Overall Study|Physician Decision|1|||
126388478|NCT00441142|454713804|FG002|Overall Study|Physician Decision|0|||
126388479|NCT00441142|454713805|FG003|Overall Study|Physician Decision|1|||
126388480|NCT00441142|454713802|FG000|Overall Study|Death|0|||
126717712|NCT02273050|455917606|FG001|Overall Study|Adverse Event|3|||
126388481|NCT00441142|454713803|FG001|Overall Study|Death|0|||
126388482|NCT00441142|454713804|FG002|Overall Study|Death|0|||
126388483|NCT00441142|454713805|FG003|Overall Study|Death|1|||
126388484|NCT04952597|454713806|FG000|Overall Study|Death|12|||
126388485|NCT04952597|454713807|FG001|Overall Study|Death|13|||
126388486|NCT04952597|454713808|FG002|Overall Study|Death|14|||
126388487|NCT04952597|454713806|FG000|Overall Study|Withdrawal by Subject|1|||
126388488|NCT04952597|454713807|FG001|Overall Study|Withdrawal by Subject|0|||
126388489|NCT04952597|454713808|FG002|Overall Study|Withdrawal by Subject|3|||
126388490|NCT04952597|454713806|FG000|Overall Study|Lost to Follow-up|0|||
126388491|NCT04952597|454713807|FG001|Overall Study|Lost to Follow-up|1|||
126388492|NCT04952597|454713808|FG002|Overall Study|Lost to Follow-up|1|||
126388493|NCT05730335|454713809|FG000|Overall Study|Lost to Follow-up|8|||
126388494|NCT05730335|454713809|FG000|Overall Study|Withdrawal by Subject|6|||
126388495|NCT03249909|454713814|FG000|Overall Study|Withdrawal by Subject|3|||
126388496|NCT03249909|454713815|FG001|Overall Study|Withdrawal by Subject|0|||
126388497|NCT03249909|454713816|FG002|Overall Study|Withdrawal by Subject|0|||
126388498|NCT03249909|454713814|FG000|Overall Study|Adverse Event|3|||
126388499|NCT03249909|454713815|FG001|Overall Study|Adverse Event|0|||
126388500|NCT03249909|454713816|FG002|Overall Study|Adverse Event|0|||
126388501|NCT03249909|454713814|FG000|Overall Study|Lost to Follow-up|0|||
126388502|NCT03249909|454713815|FG001|Overall Study|Lost to Follow-up|1|||
126388503|NCT03249909|454713816|FG002|Overall Study|Lost to Follow-up|0|||
126388504|NCT05286658|454713820|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
126388505|NCT05286658|454713820|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
126388506|NCT05411822|454713821|FG000|Overall Study|Withdrawal by Subject|2|||
126388507|NCT05411822|454713822|FG001|Overall Study|Withdrawal by Subject|1|||
126388508|NCT01814397|454713825|FG000|Overall Study|Adverse Event|7|||
126388509|NCT01814397|454713825|FG000|Overall Study|Withdrawal by Subject|7|||
126388510|NCT02952313|454713835|FG000|Primary Endpoint|Lost to Follow-up|4|||
126388511|NCT02952313|454713835|FG000|Primary Endpoint|Withdrawal by Subject|1|||
126388512|NCT02952313|454713835|FG000|Primary Endpoint|Lack of Efficacy|1|||
126388513|NCT02952313|454713835|FG000|Primary Endpoint|Missed visit|1|||
126388514|NCT02952313|454713835|FG000|Long-term Follow-up|Lost to Follow-up|12|||
126388515|NCT02952313|454713835|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
126388516|NCT02952313|454713835|FG000|Long-term Follow-up|Lack of Efficacy|6|||
126388517|NCT02952313|454713835|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
126388518|NCT02952313|454713835|FG000|Long-term Follow-up|Physician Decision|1|||
126388519|NCT02952313|454713835|FG000|Long-term Follow-up|Death|1|||
126388520|NCT03206918|454713846|FG000|Overall Study|Death|11|||
126388521|NCT03206918|454713846|FG000|Overall Study|Withdrawal by Subject|5|||
126388522|NCT03206918|454713846|FG000|Overall Study|Study terminated by sponsor|12|||
126388523|NCT03206918|454713846|FG000|Overall Study|Lost to Follow-up|3|||
126388524|NCT03206918|454713846|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
126388525|NCT03823287|454713847|FG000|Overall Study|Withdrawal by Subject|25|||
126388526|NCT03823287|454713848|FG001|Overall Study|Withdrawal by Subject|17|||
126388527|NCT03823287|454713847|FG000|Overall Study|Death|13|||
126388528|NCT03823287|454713848|FG001|Overall Study|Death|7|||
126388529|NCT03823287|454713847|FG000|Overall Study|Lost to Follow-up|7|||
126388530|NCT03823287|454713848|FG001|Overall Study|Lost to Follow-up|8|||
126388531|NCT03823287|454713847|FG000|Overall Study|Adverse Event|6|||
126388532|NCT03823287|454713848|FG001|Overall Study|Adverse Event|8|||
126388533|NCT03823287|454713847|FG000|Overall Study|Physician Decision|5|||
126388534|NCT03823287|454713848|FG001|Overall Study|Physician Decision|2|||
126388535|NCT03823287|454713847|FG000|Overall Study|Lack of Efficacy|2|||
126388536|NCT03823287|454713848|FG001|Overall Study|Lack of Efficacy|0|||
126388537|NCT03823287|454713847|FG000|Overall Study|Other|2|||
126717713|NCT02273050|455917607|FG002|Overall Study|Adverse Event|3|||
126717714|NCT02273050|455917605|FG000|Overall Study|Death|0|||
126717715|NCT02273050|455917606|FG001|Overall Study|Death|0|||
126717716|NCT02273050|455917607|FG002|Overall Study|Death|1|||
126388538|NCT03823287|454713848|FG001|Overall Study|Other|4|||
126388539|NCT01170273|454713850|FG000|Overall Study|Lost to Follow-up|6|||
126388540|NCT01170273|454713851|FG001|Overall Study|Lost to Follow-up|8|||
126388541|NCT01170273|454713850|FG000|Overall Study|Protocol Violation|1|||
126388542|NCT01170273|454713851|FG001|Overall Study|Protocol Violation|0|||
126388543|NCT01170273|454713850|FG000|Overall Study|Death|1|||
126388544|NCT01170273|454713851|FG001|Overall Study|Death|0|||
126388545|NCT01170273|454713850|FG000|Overall Study|Adverse Event|0|||
126388546|NCT01170273|454713851|FG001|Overall Study|Adverse Event|1|||
126388547|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
126388548|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
126388549|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
126388550|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
126388551|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
126717717|NCT02273050|455917605|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
126717718|NCT02273050|455917606|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
126717719|NCT02273050|455917607|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
126717720|NCT02273050|455917605|FG000|Overall Study|Lack of Efficacy|0|||
126717721|NCT02273050|455917606|FG001|Overall Study|Lack of Efficacy|1|||
126717722|NCT02273050|455917607|FG002|Overall Study|Lack of Efficacy|1|||
126717723|NCT02273050|455917605|FG000|Overall Study|Withdrawal by Subject|17|||
126717724|NCT02273050|455917606|FG001|Overall Study|Withdrawal by Subject|14|||
126717725|NCT02273050|455917607|FG002|Overall Study|Withdrawal by Subject|16|||
126717726|NCT02273050|455917605|FG000|Overall Study|Lost to Follow-up|0|||
126717727|NCT02273050|455917606|FG001|Overall Study|Lost to Follow-up|2|||
126717728|NCT02273050|455917607|FG002|Overall Study|Lost to Follow-up|3|||
126717729|NCT02273050|455917605|FG000|Overall Study|Protocol Violation|3|||
126717730|NCT02273050|455917606|FG001|Overall Study|Protocol Violation|1|||
126717731|NCT02273050|455917607|FG002|Overall Study|Protocol Violation|4|||
126717732|NCT02297438|455917608|FG000|Overall Study|Death|79|||
126717733|NCT02297438|455917609|FG001|Overall Study|Death|86|||
126717734|NCT02297438|455917608|FG000|Overall Study|Lost to Follow-up|9|||
126717735|NCT02297438|455917609|FG001|Overall Study|Lost to Follow-up|7|||
126717736|NCT02297438|455917608|FG000|Overall Study|Withdrawal by Subject|7|||
126717737|NCT02297438|455917609|FG001|Overall Study|Withdrawal by Subject|0|||
126717738|NCT02297438|455917608|FG000|Overall Study|Other|9|||
126717739|NCT02297438|455917609|FG001|Overall Study|Other|5|||
126717740|NCT02297438|455917608|FG000|Overall Study|Ongoing|65|||
126717741|NCT02297438|455917609|FG001|Overall Study|Ongoing|73|||
126717742|NCT02042404|455917610|FG000|Overall Study|Death|1|||
126717743|NCT02042404|455917611|FG001|Overall Study|Death|0|||
126717744|NCT02042404|455917610|FG000|Overall Study|Unrelated Adverse Event|3|||
126717745|NCT02042404|455917611|FG001|Overall Study|Unrelated Adverse Event|0|||
126388552|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
126388553|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
126388554|NCT01673854|454713852|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
126388555|NCT01673854|454713852|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
126388556|NCT01673854|454713852|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
126388557|NCT01673854|454713852|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
126388558|NCT01673854|454713852|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
126388559|NCT00334737|454713853|FG000|Hospital Phase|Death|1|||
126388560|NCT00334737|454713854|FG001|Hospital Phase|Death|2|||
126388561|NCT00334737|454713855|FG002|Hospital Phase|Death|3|||
126388562|NCT00334737|454713853|FG000|Hospital Phase|Withdrawal by Subject|0|||
126388563|NCT00334737|454713854|FG001|Hospital Phase|Withdrawal by Subject|0|||
126388564|NCT00334737|454713855|FG002|Hospital Phase|Withdrawal by Subject|1|||
126388565|NCT00334737|454713853|FG000|Hospital Phase|Did not receive study drug|1|||
126388566|NCT00334737|454713854|FG001|Hospital Phase|Did not receive study drug|0|||
126388567|NCT00334737|454713855|FG002|Hospital Phase|Did not receive study drug|0|||
126388568|NCT00334737|454713853|FG000|Follow up Phase|Lost to Follow-up|5|||
126388569|NCT00334737|454713854|FG001|Follow up Phase|Lost to Follow-up|3|||
126388570|NCT00334737|454713855|FG002|Follow up Phase|Lost to Follow-up|6|||
126388571|NCT00583752|454713856|FG000|Overall Study|Lost to Follow-up|5|||
126388572|NCT00583752|454713857|FG001|Overall Study|Lost to Follow-up|5|||
126717746|NCT02042404|455917610|FG000|Overall Study|Inability to meet time requirements|1|||
126717747|NCT02042404|455917611|FG001|Overall Study|Inability to meet time requirements|0|||
126717748|NCT05058664|455917618|FG000|Overall Study|No follow-up data provided|4|||
126717749|NCT05058664|455917619|FG001|Overall Study|No follow-up data provided|0|||
126717750|NCT05058664|455917620|FG002|Overall Study|No follow-up data provided|2|||
126717751|NCT05058664|455917618|FG000|Overall Study|Withdrawal by Subject|0|||
126717752|NCT05058664|455917619|FG001|Overall Study|Withdrawal by Subject|0|||
126717753|NCT05058664|455917620|FG002|Overall Study|Withdrawal by Subject|1|||
126717754|NCT00972244|455917621|FG000|Overall Study|Incorrect Enrolment|1|||
126717755|NCT00972244|455917622|FG001|Overall Study|Incorrect Enrolment|0|||
126717756|NCT00972244|455917623|FG002|Overall Study|Incorrect Enrolment|0|||
126717757|NCT00972244|455917624|FG003|Overall Study|Incorrect Enrolment|0|||
126717758|NCT00972244|455917625|FG004|Overall Study|Incorrect Enrolment|0|||
126717759|NCT00972244|455917621|FG000|Overall Study|Adverse Event|0|||
126388573|NCT02316353|454713858|FG000|Overall Study|Pregnancy|1|||
126388574|NCT02316353|454713859|FG001|Overall Study|Pregnancy|3|||
126717760|NCT00972244|455917622|FG001|Overall Study|Adverse Event|1|||
126717761|NCT00972244|455917623|FG002|Overall Study|Adverse Event|1|||
126717762|NCT00972244|455917624|FG003|Overall Study|Adverse Event|0|||
126717763|NCT00972244|455917625|FG004|Overall Study|Adverse Event|0|||
126717764|NCT00972244|455917621|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
126717765|NCT00972244|455917622|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
126717766|NCT00972244|455917623|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
126388575|NCT02316353|454713858|FG000|Overall Study|Adverse Event|1|||
126388576|NCT02316353|454713859|FG001|Overall Study|Adverse Event|3|||
126388577|NCT02316353|454713858|FG000|Overall Study|Withdrawal by Subject|6|||
126388578|NCT02316353|454713859|FG001|Overall Study|Withdrawal by Subject|2|||
126717767|NCT00972244|455917624|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
126388579|NCT00782171|454715329|FG000|Overall Study|Lost to Follow-up|2|||
126388580|NCT00782171|454715330|FG001|Overall Study|Lost to Follow-up|2|||
126388581|NCT00782171|454715329|FG000|Overall Study|Withdrawal by Subject|2|||
126388582|NCT00782171|454715330|FG001|Overall Study|Withdrawal by Subject|1|||
126388583|NCT00782171|454715329|FG000|Overall Study|complications|3|||
126388584|NCT00782171|454715330|FG001|Overall Study|complications|1|||
126388585|NCT00782171|454715329|FG000|Overall Study|others|7|||
126388586|NCT00782171|454715330|FG001|Overall Study|others|9|||
126388587|NCT00782171|454715329|FG000|Overall Study|not eligible|8|||
126388588|NCT00782171|454715330|FG001|Overall Study|not eligible|6|||
126388589|NCT05935878|454715331|FG000|Overall Study|Death|1|||
126388590|NCT05935878|454715332|FG001|Overall Study|Death|2|||
126388591|NCT05935878|454715331|FG000|Overall Study|Withdrawal by Subject|5|||
126388592|NCT05935878|454715332|FG001|Overall Study|Withdrawal by Subject|5|||
126388593|NCT05935878|454715331|FG000|Overall Study|Revision of implant|1|||
126388594|NCT05935878|454715332|FG001|Overall Study|Revision of implant|1|||
126388595|NCT05935878|454715331|FG000|Overall Study|Mobile bearing dislocation|0|||
126388596|NCT05935878|454715332|FG001|Overall Study|Mobile bearing dislocation|1|||
126388597|NCT01443364|454715339|FG000|Overall Study|Lack of Efficacy|14|||
126388598|NCT01443364|454715339|FG000|Overall Study|Lost to Follow-up|3|||
126388599|NCT01443364|454715339|FG000|Overall Study|Withdrawal by Subject|5|||
126388600|NCT01443364|454715339|FG000|Overall Study|Other Reason|4|||
126388601|NCT01443364|454715339|FG000|Overall Study|SAE, non-fatal|6|||
126388602|NCT01443364|454715339|FG000|Overall Study|AE, non-serious non-fatal|8|||
126388603|NCT01443364|454715339|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126388604|NCT00559845|454715340|FG000|Overall Study|Withdrew Consent|1|||
126388605|NCT00559845|454715340|FG000|Overall Study|Disease Progression|1|||
126388606|NCT00559845|454715340|FG000|Overall Study|Adverse Event|3|||
126388607|NCT00559845|454715340|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
126388608|NCT00559845|454715340|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
126388609|NCT01406938|454715343|FG000|Induction Period|Subject/guardian decision|6|||
126388610|NCT01406938|454715344|FG001|Induction Period|Subject/guardian decision|8|||
126388611|NCT01406938|454715345|FG002|Induction Period|Subject/guardian decision|0|||
126388612|NCT01406938|454715346|FG003|Induction Period|Subject/guardian decision|0|||
126388613|NCT01406938|454715347|FG004|Induction Period|Subject/guardian decision|0|||
126388614|NCT01406938|454715348|FG005|Induction Period|Subject/guardian decision|0|||
126388615|NCT01406938|454715343|FG000|Induction Period|Protocol deviation|1|||
126388616|NCT01406938|454715344|FG001|Induction Period|Protocol deviation|0|||
126388617|NCT01406938|454715345|FG002|Induction Period|Protocol deviation|0|||
126388618|NCT01406938|454715346|FG003|Induction Period|Protocol deviation|0|||
126388619|NCT01406938|454715347|FG004|Induction Period|Protocol deviation|0|||
126388620|NCT01406938|454715348|FG005|Induction Period|Protocol deviation|0|||
126388621|NCT01406938|454715343|FG000|Induction Period|Adverse Event|8|||
126388622|NCT01406938|454715344|FG001|Induction Period|Adverse Event|9|||
126388623|NCT01406938|454715345|FG002|Induction Period|Adverse Event|0|||
126388624|NCT01406938|454715346|FG003|Induction Period|Adverse Event|0|||
126388625|NCT01406938|454715347|FG004|Induction Period|Adverse Event|0|||
126388626|NCT01406938|454715348|FG005|Induction Period|Adverse Event|0|||
126388627|NCT01406938|454715343|FG000|Induction Period|Lack of Efficacy|1|||
126388628|NCT01406938|454715344|FG001|Induction Period|Lack of Efficacy|0|||
126388629|NCT01406938|454715345|FG002|Induction Period|Lack of Efficacy|0|||
126388630|NCT01406938|454715346|FG003|Induction Period|Lack of Efficacy|0|||
126388631|NCT01406938|454715347|FG004|Induction Period|Lack of Efficacy|0|||
126388632|NCT01406938|454715348|FG005|Induction Period|Lack of Efficacy|0|||
126388633|NCT01406938|454715343|FG000|Induction Period|Lost to Follow-up|2|||
126388634|NCT01406938|454715344|FG001|Induction Period|Lost to Follow-up|3|||
126388635|NCT01406938|454715345|FG002|Induction Period|Lost to Follow-up|0|||
126388636|NCT01406938|454715346|FG003|Induction Period|Lost to Follow-up|0|||
126388637|NCT01406938|454715347|FG004|Induction Period|Lost to Follow-up|0|||
126388638|NCT01406938|454715348|FG005|Induction Period|Lost to Follow-up|0|||
126388639|NCT01406938|454715343|FG000|Maintenance Period|Adverse Event|0|||
126388640|NCT01406938|454715344|FG001|Maintenance Period|Adverse Event|0|||
126717768|NCT00972244|455917625|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
126717769|NCT00972244|455917621|FG000|Overall Study|Withdrawal by Subject|1|||
126717770|NCT00972244|455917622|FG001|Overall Study|Withdrawal by Subject|2|||
126388641|NCT01406938|454715345|FG002|Maintenance Period|Adverse Event|2|||
126388642|NCT01406938|454715346|FG003|Maintenance Period|Adverse Event|8|||
126388643|NCT01406938|454715347|FG004|Maintenance Period|Adverse Event|4|||
126388644|NCT01406938|454715348|FG005|Maintenance Period|Adverse Event|2|||
126388645|NCT01406938|454715343|FG000|Maintenance Period|Death|0|||
126388646|NCT01406938|454715344|FG001|Maintenance Period|Death|0|||
126388647|NCT01406938|454715345|FG002|Maintenance Period|Death|0|||
126388648|NCT01406938|454715346|FG003|Maintenance Period|Death|0|||
126388649|NCT01406938|454715347|FG004|Maintenance Period|Death|1|||
126388650|NCT01406938|454715348|FG005|Maintenance Period|Death|0|||
126388651|NCT01406938|454715343|FG000|Maintenance Period|Subject/guardian decision|0|||
126388652|NCT01406938|454715344|FG001|Maintenance Period|Subject/guardian decision|0|||
126388653|NCT01406938|454715345|FG002|Maintenance Period|Subject/guardian decision|11|||
126388654|NCT01406938|454715346|FG003|Maintenance Period|Subject/guardian decision|7|||
126388655|NCT01406938|454715347|FG004|Maintenance Period|Subject/guardian decision|10|||
126388656|NCT01406938|454715348|FG005|Maintenance Period|Subject/guardian decision|7|||
126388657|NCT01406938|454715343|FG000|Maintenance Period|Protocol Violation|0|||
126388658|NCT01406938|454715344|FG001|Maintenance Period|Protocol Violation|0|||
126388659|NCT01406938|454715345|FG002|Maintenance Period|Protocol Violation|2|||
126388660|NCT01406938|454715346|FG003|Maintenance Period|Protocol Violation|2|||
126388661|NCT01406938|454715347|FG004|Maintenance Period|Protocol Violation|2|||
126388662|NCT01406938|454715348|FG005|Maintenance Period|Protocol Violation|2|||
126388663|NCT01406938|454715343|FG000|Maintenance Period|Pregnancy|0|||
126388664|NCT01406938|454715344|FG001|Maintenance Period|Pregnancy|0|||
126388665|NCT01406938|454715345|FG002|Maintenance Period|Pregnancy|0|||
126388666|NCT01406938|454715346|FG003|Maintenance Period|Pregnancy|0|||
126388667|NCT01406938|454715347|FG004|Maintenance Period|Pregnancy|1|||
126388668|NCT01406938|454715348|FG005|Maintenance Period|Pregnancy|0|||
126388669|NCT01406938|454715343|FG000|Maintenance Period|Lost to Follow-up|0|||
126388670|NCT01406938|454715344|FG001|Maintenance Period|Lost to Follow-up|0|||
126388671|NCT01406938|454715345|FG002|Maintenance Period|Lost to Follow-up|0|||
126388672|NCT01406938|454715346|FG003|Maintenance Period|Lost to Follow-up|0|||
126388673|NCT01406938|454715347|FG004|Maintenance Period|Lost to Follow-up|4|||
126388674|NCT01406938|454715348|FG005|Maintenance Period|Lost to Follow-up|0|||
126388675|NCT01406938|454715343|FG000|Maintenance Period|Lack of Efficacy|0|||
126388676|NCT01406938|454715344|FG001|Maintenance Period|Lack of Efficacy|0|||
126388677|NCT01406938|454715345|FG002|Maintenance Period|Lack of Efficacy|2|||
126388678|NCT01406938|454715346|FG003|Maintenance Period|Lack of Efficacy|1|||
126388679|NCT01406938|454715347|FG004|Maintenance Period|Lack of Efficacy|3|||
126388680|NCT01406938|454715348|FG005|Maintenance Period|Lack of Efficacy|5|||
126388681|NCT01406938|454715343|FG000|Follow up|Lack of Efficacy|3|||
126388682|NCT01406938|454715344|FG001|Follow up|Lack of Efficacy|2|||
126388683|NCT01406938|454715345|FG002|Follow up|Lack of Efficacy|1|||
126388684|NCT01406938|454715346|FG003|Follow up|Lack of Efficacy|0|||
126388685|NCT01406938|454715347|FG004|Follow up|Lack of Efficacy|0|||
126388686|NCT01406938|454715348|FG005|Follow up|Lack of Efficacy|0|||
126388687|NCT01406938|454715343|FG000|Follow up|Patient/guardian decision|4|||
126388688|NCT01406938|454715344|FG001|Follow up|Patient/guardian decision|2|||
126388689|NCT01406938|454715345|FG002|Follow up|Patient/guardian decision|4|||
126388690|NCT01406938|454715346|FG003|Follow up|Patient/guardian decision|2|||
126388691|NCT01406938|454715347|FG004|Follow up|Patient/guardian decision|4|||
126388692|NCT01406938|454715348|FG005|Follow up|Patient/guardian decision|1|||
126388693|NCT01406938|454715343|FG000|Follow up|Protocol Violation|0|||
126388694|NCT01406938|454715344|FG001|Follow up|Protocol Violation|0|||
126388695|NCT01406938|454715345|FG002|Follow up|Protocol Violation|1|||
126388696|NCT01406938|454715346|FG003|Follow up|Protocol Violation|0|||
126388697|NCT01406938|454715347|FG004|Follow up|Protocol Violation|0|||
126388698|NCT01406938|454715348|FG005|Follow up|Protocol Violation|0|||
126388699|NCT01406938|454715343|FG000|Follow up|Physician Decision|0|||
126388700|NCT01406938|454715344|FG001|Follow up|Physician Decision|0|||
126388701|NCT01406938|454715345|FG002|Follow up|Physician Decision|2|||
126388702|NCT01406938|454715346|FG003|Follow up|Physician Decision|0|||
126388703|NCT01406938|454715347|FG004|Follow up|Physician Decision|3|||
126388704|NCT01406938|454715348|FG005|Follow up|Physician Decision|1|||
126388705|NCT01406938|454715343|FG000|Follow up|Lost to Follow-up|1|||
126388706|NCT01406938|454715344|FG001|Follow up|Lost to Follow-up|1|||
126388707|NCT01406938|454715345|FG002|Follow up|Lost to Follow-up|0|||
126388708|NCT01406938|454715346|FG003|Follow up|Lost to Follow-up|1|||
126388709|NCT01406938|454715347|FG004|Follow up|Lost to Follow-up|2|||
126388710|NCT01406938|454715348|FG005|Follow up|Lost to Follow-up|1|||
126388711|NCT00878254|454715350|FG000|Overall Study|Physician Decision|1|||
126717771|NCT00972244|455917623|FG002|Overall Study|Withdrawal by Subject|1|||
126717772|NCT00972244|455917624|FG003|Overall Study|Withdrawal by Subject|0|||
126717773|NCT00972244|455917625|FG004|Overall Study|Withdrawal by Subject|1|||
126717774|NCT00972244|455917621|FG000|Overall Study|Safety|0|||
126388712|NCT00878254|454715350|FG000|Overall Study|Death|1|||
126717775|NCT00972244|455917622|FG001|Overall Study|Safety|0|||
126388713|NCT00878254|454715350|FG000|Overall Study|Withdrawal by Subject|1|||
126388714|NCT03367403|454715353|FG000|Overall Study|Adverse Event|20|||
126388715|NCT03367403|454715354|FG001|Overall Study|Adverse Event|6|||
126388716|NCT03367403|454715355|FG002|Overall Study|Adverse Event|2|||
126388717|NCT03367403|454715353|FG000|Overall Study|Withdrawal by Subject|12|||
126388718|NCT03367403|454715354|FG001|Overall Study|Withdrawal by Subject|13|||
126388719|NCT03367403|454715355|FG002|Overall Study|Withdrawal by Subject|1|||
126388720|NCT03367403|454715353|FG000|Overall Study|Death|1|||
126717776|NCT00972244|455917623|FG002|Overall Study|Safety|0|||
126388721|NCT03367403|454715354|FG001|Overall Study|Death|2|||
126388722|NCT03367403|454715355|FG002|Overall Study|Death|0|||
126388723|NCT03367403|454715353|FG000|Overall Study|Physician Decision|0|||
126717777|NCT00972244|455917624|FG003|Overall Study|Safety|0|||
126717778|NCT00972244|455917625|FG004|Overall Study|Safety|1|||
126388724|NCT03367403|454715354|FG001|Overall Study|Physician Decision|1|||
126388725|NCT03367403|454715355|FG002|Overall Study|Physician Decision|0|||
126388726|NCT03367403|454715353|FG000|Overall Study|Protocol Violation|1|||
126388727|NCT03367403|454715354|FG001|Overall Study|Protocol Violation|1|||
126388728|NCT03367403|454715355|FG002|Overall Study|Protocol Violation|0|||
126388729|NCT03367403|454715353|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
126388730|NCT03367403|454715354|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
126388731|NCT03367403|454715355|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
126388732|NCT03367403|454715353|FG000|Overall Study|COVID-19|3|||
126388733|NCT03367403|454715354|FG001|Overall Study|COVID-19|6|||
126388734|NCT03367403|454715355|FG002|Overall Study|COVID-19|0|||
126388735|NCT03367403|454715353|FG000|Overall Study|Abuse of Alcohol Intake|0|||
126388736|NCT03367403|454715354|FG001|Overall Study|Abuse of Alcohol Intake|1|||
126388737|NCT03367403|454715355|FG002|Overall Study|Abuse of Alcohol Intake|0|||
126388738|NCT03367403|454715353|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
126388739|NCT03367403|454715354|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
126388740|NCT03367403|454715355|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
126388741|NCT00194077|454715356|FG000|Overall Study|Lack of Efficacy|22|||
126388742|NCT00194077|454715357|FG001|Overall Study|Lack of Efficacy|29|||
126388743|NCT00194077|454715356|FG000|Overall Study|Study nonadherence|1|||
126388744|NCT00194077|454715357|FG001|Overall Study|Study nonadherence|0|||
126388745|NCT00194077|454715356|FG000|Overall Study|Withdrawal by Subject|1|||
126388746|NCT00194077|454715357|FG001|Overall Study|Withdrawal by Subject|1|||
126388747|NCT03470194|454715360|FG000|Overall Study|Lost to Follow-up|11|||
126388748|NCT03470194|454715361|FG001|Overall Study|Lost to Follow-up|17|||
126388749|NCT03286543|454715362|FG000|Consented|Screen failure before randomization|2|||
126388750|NCT03286543|454715363|FG001|Consented|Screen failure before randomization|0|||
126388751|NCT03286543|454715364|FG002|Consented|Screen failure before randomization|0|||
126388752|NCT03286543|454715362|FG000|Consented|Screen failure before enrollment|4|||
126388753|NCT03286543|454715363|FG001|Consented|Screen failure before enrollment|0|||
126388754|NCT03286543|454715364|FG002|Consented|Screen failure before enrollment|0|||
126388755|NCT03286543|454715362|FG000|Consented|TKA cancelled after enrollment|1|||
126388756|NCT03286543|454715363|FG001|Consented|TKA cancelled after enrollment|0|||
126388757|NCT03286543|454715364|FG002|Consented|TKA cancelled after enrollment|0|||
126388758|NCT03286543|454715362|FG000|Consented|Withdrawn from study|12|||
126388759|NCT03286543|454715363|FG001|Consented|Withdrawn from study|0|||
126388760|NCT03286543|454715364|FG002|Consented|Withdrawn from study|0|||
126388761|NCT03286543|454715362|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
126388762|NCT03286543|454715363|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
126388763|NCT03286543|454715364|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
126388764|NCT03286543|454715362|FG000|Study Enrollment|Withdrawn from study|0|||
126388765|NCT03286543|454715363|FG001|Study Enrollment|Withdrawn from study|6|||
126388766|NCT03286543|454715364|FG002|Study Enrollment|Withdrawn from study|6|||
126388767|NCT00758069|454715365|FG000|Overall Study|Lack of Efficacy|0|||
126388768|NCT00758069|454715366|FG001|Overall Study|Lack of Efficacy|0|||
126388769|NCT00758069|454715367|FG002|Overall Study|Lack of Efficacy|1|||
126388770|NCT00758069|454715365|FG000|Overall Study|Incorrect Study Drug|1|||
126388771|NCT00758069|454715366|FG001|Overall Study|Incorrect Study Drug|0|||
126388772|NCT00758069|454715367|FG002|Overall Study|Incorrect Study Drug|0|||
126388773|NCT00588237|454715368|FG000|Overall Study|Evaluable for toxicity only|3|||
126388774|NCT00588237|454715368|FG000|Overall Study|Patien not treated|1|||
126388775|NCT04908865|454715372|FG000|Overall Study|Adverse Event|2|||
126388776|NCT04908865|454715372|FG000|Overall Study|Lack of Efficacy|5|||
126388777|NCT04908865|454715372|FG000|Overall Study|Lost to Follow-up|1|||
126388778|NCT00606034|454715377|FG000|Overall Study|incarceration|1|||
126388779|NCT02027311|454715378|FG000|Overall Study|Protocol Violation|3|||
126388780|NCT02027311|454715379|FG001|Overall Study|Protocol Violation|2|||
126388781|NCT02466425|454715382|FG000|Overall Study|Adverse Event|3|||
126388782|NCT02466425|454715383|FG001|Overall Study|Adverse Event|11|||
126388783|NCT02466425|454715382|FG000|Overall Study|Lack of Efficacy|4|||
126388784|NCT02466425|454715383|FG001|Overall Study|Lack of Efficacy|1|||
126388785|NCT02466425|454715382|FG000|Overall Study|Lost to Follow-up|3|||
126388786|NCT02466425|454715383|FG001|Overall Study|Lost to Follow-up|0|||
126388787|NCT02466425|454715382|FG000|Overall Study|Protocol Violation|1|||
126388788|NCT02466425|454715383|FG001|Overall Study|Protocol Violation|0|||
126388789|NCT02466425|454715382|FG000|Overall Study|Withdrawal by Subject|0|||
126388790|NCT02466425|454715383|FG001|Overall Study|Withdrawal by Subject|1|||
126388791|NCT02466425|454715382|FG000|Overall Study|Other|1|||
126388792|NCT02466425|454715383|FG001|Overall Study|Other|3|||
126388793|NCT02466425|454715382|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126388794|NCT02466425|454715383|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126388795|NCT01721486|454715388|FG000|Overall Study|Protocol Violation|1|||
126388796|NCT01721486|454715389|FG001|Overall Study|Protocol Violation|0|||
126388797|NCT01721486|454715388|FG000|Overall Study|Physician Decision|0|||
126388798|NCT01721486|454715389|FG001|Overall Study|Physician Decision|1|||
126388799|NCT00582712|454715390|FG000|Overall Study|Adverse Event|1|||
126388800|NCT00582712|454715390|FG000|Overall Study|Lack of Efficacy|1|||
126388801|NCT00582712|454715390|FG000|Overall Study|Withdrawal by Subject|1|||
126388802|NCT00582712|454715390|FG000|Overall Study|Complicating disease requiring treatment|1|||
126388803|NCT05141175|454715391|FG000|Overall Study|Withdrawal by Subject|1|||
126388804|NCT01901289|454715393|FG000|Overall Study|Death|32|||
126388805|NCT01901289|454715393|FG000|Overall Study|Lost to Follow-up|16|||
126388806|NCT01901289|454715393|FG000|Overall Study|Withdrawal by Subject|35|||
126388807|NCT01901289|454715393|FG000|Overall Study|Other type of endpoint met|2|||
126388808|NCT01813058|454715394|FG000|Overall Study|Withdrawal by Subject|5|||
126388809|NCT01813058|454715395|FG001|Overall Study|Withdrawal by Subject|4|||
126388810|NCT00182078|454715397|FG000|Overall Study|Withdrawal by Subject|1|||
126388811|NCT00182078|454715398|FG001|Overall Study|Withdrawal by Subject|0|||
126388812|NCT00395486|454715399|FG000|Overall Study|Adverse Event|1|||
126388813|NCT00395486|454715400|FG001|Overall Study|Adverse Event|2|||
126388814|NCT00395486|454715399|FG000|Overall Study|Withdrawal by Subject|5|||
126388815|NCT00395486|454715400|FG001|Overall Study|Withdrawal by Subject|2|||
126388816|NCT00395486|454715399|FG000|Overall Study|Lost to Follow-up|0|||
126388817|NCT00395486|454715400|FG001|Overall Study|Lost to Follow-up|1|||
126388818|NCT01076205|454715401|FG000|Overall Study|Adverse Drug Reaction|299|||
126388819|NCT01076205|454715401|FG000|Overall Study|Lack of Effectiveness|1423|||
126388820|NCT01076205|454715401|FG000|Overall Study|Other Reason|1075|||
126388821|NCT01076205|454715401|FG000|Overall Study|Unknown Reason|71|||
126388822|NCT01076205|454715401|FG000|Overall Study|Lost to Follow-up|3151|||
126388823|NCT04731298|454715408|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
126388824|NCT04731298|454715409|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
126388825|NCT02443116|454715414|FG000|Part 1|Adverse Event|2|||
126388826|NCT02443116|454715415|FG001|Part 1|Adverse Event|3|||
126388827|NCT02443116|454715416|FG002|Part 1|Adverse Event|0|||
126388828|NCT02443116|454715417|FG003|Part 1|Adverse Event|0|||
126388829|NCT02443116|454715418|FG004|Part 1|Adverse Event|0|||
126388830|NCT02443116|454715419|FG005|Part 1|Adverse Event|0|||
126388831|NCT02443116|454715420|FG006|Part 1|Adverse Event|0|||
126388832|NCT02443116|454715421|FG007|Part 1|Adverse Event|0|||
126388833|NCT02443116|454715422|FG008|Part 1|Adverse Event|0|||
126388834|NCT02443116|454715414|FG000|Part 1|Withdrew informed consent|0|||
126388835|NCT02443116|454715415|FG001|Part 1|Withdrew informed consent|1|||
126388836|NCT02443116|454715416|FG002|Part 1|Withdrew informed consent|0|||
126388837|NCT02443116|454715417|FG003|Part 1|Withdrew informed consent|0|||
126388838|NCT02443116|454715418|FG004|Part 1|Withdrew informed consent|0|||
126388839|NCT02443116|454715419|FG005|Part 1|Withdrew informed consent|0|||
126388840|NCT02443116|454715420|FG006|Part 1|Withdrew informed consent|0|||
126388841|NCT02443116|454715421|FG007|Part 1|Withdrew informed consent|0|||
126388842|NCT02443116|454715422|FG008|Part 1|Withdrew informed consent|0|||
126388843|NCT02443116|454715414|FG000|Part 1|Lost to Follow-up|0|||
126388844|NCT02443116|454715415|FG001|Part 1|Lost to Follow-up|0|||
126388845|NCT02443116|454715416|FG002|Part 1|Lost to Follow-up|2|||
126388846|NCT02443116|454715417|FG003|Part 1|Lost to Follow-up|0|||
126388847|NCT02443116|454715418|FG004|Part 1|Lost to Follow-up|0|||
126388848|NCT02443116|454715419|FG005|Part 1|Lost to Follow-up|0|||
126388849|NCT02443116|454715420|FG006|Part 1|Lost to Follow-up|0|||
126388850|NCT02443116|454715421|FG007|Part 1|Lost to Follow-up|0|||
126388851|NCT02443116|454715422|FG008|Part 1|Lost to Follow-up|0|||
126388852|NCT02443116|454715414|FG000|Part 1|Participant moved out of state|0|||
126388853|NCT02443116|454715415|FG001|Part 1|Participant moved out of state|0|||
126388854|NCT02443116|454715416|FG002|Part 1|Participant moved out of state|1|||
126388855|NCT02443116|454715417|FG003|Part 1|Participant moved out of state|0|||
126388856|NCT02443116|454715418|FG004|Part 1|Participant moved out of state|0|||
126388857|NCT02443116|454715419|FG005|Part 1|Participant moved out of state|0|||
126388858|NCT02443116|454715420|FG006|Part 1|Participant moved out of state|0|||
126388859|NCT02443116|454715421|FG007|Part 1|Participant moved out of state|0|||
126388860|NCT02443116|454715422|FG008|Part 1|Participant moved out of state|0|||
126388861|NCT02443116|454715414|FG000|Part 1|Participant enrolled in another clinical trial|0|||
126388862|NCT02443116|454715415|FG001|Part 1|Participant enrolled in another clinical trial|0|||
126388863|NCT02443116|454715416|FG002|Part 1|Participant enrolled in another clinical trial|1|||
126388864|NCT02443116|454715417|FG003|Part 1|Participant enrolled in another clinical trial|0|||
126388865|NCT02443116|454715418|FG004|Part 1|Participant enrolled in another clinical trial|0|||
126388866|NCT02443116|454715419|FG005|Part 1|Participant enrolled in another clinical trial|0|||
126388867|NCT02443116|454715420|FG006|Part 1|Participant enrolled in another clinical trial|0|||
126388868|NCT02443116|454715421|FG007|Part 1|Participant enrolled in another clinical trial|0|||
126388869|NCT02443116|454715422|FG008|Part 1|Participant enrolled in another clinical trial|0|||
126388870|NCT02443116|454715414|FG000|Part 2|Adverse Event|0|||
126388871|NCT02443116|454715415|FG001|Part 2|Adverse Event|0|||
126388872|NCT02443116|454715416|FG002|Part 2|Adverse Event|0|||
126388873|NCT02443116|454715417|FG003|Part 2|Adverse Event|0|||
126388874|NCT02443116|454715418|FG004|Part 2|Adverse Event|1|||
126388875|NCT02443116|454715419|FG005|Part 2|Adverse Event|1|||
126388876|NCT02443116|454715420|FG006|Part 2|Adverse Event|2|||
126388877|NCT02443116|454715421|FG007|Part 2|Adverse Event|0|||
126388878|NCT02443116|454715422|FG008|Part 2|Adverse Event|0|||
126388879|NCT02443116|454715414|FG000|Part 2|Withdrew informed consent|0|||
126388880|NCT02443116|454715415|FG001|Part 2|Withdrew informed consent|0|||
126388881|NCT02443116|454715416|FG002|Part 2|Withdrew informed consent|0|||
126388882|NCT02443116|454715417|FG003|Part 2|Withdrew informed consent|0|||
126388883|NCT02443116|454715418|FG004|Part 2|Withdrew informed consent|0|||
126388884|NCT02443116|454715419|FG005|Part 2|Withdrew informed consent|1|||
126388885|NCT02443116|454715420|FG006|Part 2|Withdrew informed consent|1|||
126388886|NCT02443116|454715421|FG007|Part 2|Withdrew informed consent|0|||
126388887|NCT02443116|454715422|FG008|Part 2|Withdrew informed consent|0|||
126388888|NCT02443116|454715414|FG000|Part 2|Inability to comply with protocol|0|||
126388889|NCT02443116|454715415|FG001|Part 2|Inability to comply with protocol|0|||
126388890|NCT02443116|454715416|FG002|Part 2|Inability to comply with protocol|0|||
126388891|NCT02443116|454715417|FG003|Part 2|Inability to comply with protocol|1|||
126388892|NCT02443116|454715418|FG004|Part 2|Inability to comply with protocol|0|||
126388893|NCT02443116|454715419|FG005|Part 2|Inability to comply with protocol|0|||
126388894|NCT02443116|454715420|FG006|Part 2|Inability to comply with protocol|0|||
126388895|NCT02443116|454715421|FG007|Part 2|Inability to comply with protocol|0|||
126388896|NCT02443116|454715422|FG008|Part 2|Inability to comply with protocol|0|||
126388897|NCT02443116|454715414|FG000|Part 2|Lost to Follow-up|0|||
126388898|NCT02443116|454715415|FG001|Part 2|Lost to Follow-up|0|||
126388899|NCT02443116|454715416|FG002|Part 2|Lost to Follow-up|0|||
126388900|NCT02443116|454715417|FG003|Part 2|Lost to Follow-up|1|||
126388901|NCT02443116|454715418|FG004|Part 2|Lost to Follow-up|0|||
126388902|NCT02443116|454715419|FG005|Part 2|Lost to Follow-up|0|||
126388903|NCT02443116|454715420|FG006|Part 2|Lost to Follow-up|0|||
126388904|NCT02443116|454715421|FG007|Part 2|Lost to Follow-up|0|||
126388905|NCT02443116|454715422|FG008|Part 2|Lost to Follow-up|0|||
126388906|NCT02443116|454715414|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388907|NCT02443116|454715415|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388908|NCT02443116|454715416|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388909|NCT02443116|454715417|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388910|NCT02443116|454715418|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388911|NCT02443116|454715419|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
126388912|NCT02443116|454715420|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388913|NCT02443116|454715421|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388914|NCT02443116|454715422|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
126388915|NCT02443116|454715414|FG000|Part 3|Adverse Event|0|||
126388916|NCT02443116|454715415|FG001|Part 3|Adverse Event|0|||
126388917|NCT02443116|454715416|FG002|Part 3|Adverse Event|0|||
126388918|NCT02443116|454715417|FG003|Part 3|Adverse Event|0|||
126388919|NCT02443116|454715418|FG004|Part 3|Adverse Event|0|||
126388920|NCT02443116|454715419|FG005|Part 3|Adverse Event|0|||
126388921|NCT02443116|454715420|FG006|Part 3|Adverse Event|0|||
126388922|NCT02443116|454715421|FG007|Part 3|Adverse Event|0|||
126388923|NCT02443116|454715422|FG008|Part 3|Adverse Event|1|||
126388924|NCT02443116|454715414|FG000|Part 3|Withdrew informed consent|0|||
126388925|NCT02443116|454715415|FG001|Part 3|Withdrew informed consent|0|||
126388926|NCT02443116|454715416|FG002|Part 3|Withdrew informed consent|0|||
126388927|NCT02443116|454715417|FG003|Part 3|Withdrew informed consent|0|||
126388928|NCT02443116|454715418|FG004|Part 3|Withdrew informed consent|0|||
126388929|NCT02443116|454715419|FG005|Part 3|Withdrew informed consent|0|||
126388930|NCT02443116|454715420|FG006|Part 3|Withdrew informed consent|0|||
126388931|NCT02443116|454715421|FG007|Part 3|Withdrew informed consent|3|||
126388932|NCT02443116|454715422|FG008|Part 3|Withdrew informed consent|2|||
126388933|NCT02443116|454715414|FG000|Part 3|Lost to Follow-up|0|||
126388934|NCT02443116|454715415|FG001|Part 3|Lost to Follow-up|0|||
126388935|NCT02443116|454715416|FG002|Part 3|Lost to Follow-up|0|||
126388936|NCT02443116|454715417|FG003|Part 3|Lost to Follow-up|0|||
126388937|NCT02443116|454715418|FG004|Part 3|Lost to Follow-up|0|||
126388938|NCT02443116|454715419|FG005|Part 3|Lost to Follow-up|0|||
126717779|NCT00972244|455917621|FG000|Overall Study|Death|1|||
126388939|NCT02443116|454715420|FG006|Part 3|Lost to Follow-up|0|||
126717780|NCT00972244|455917622|FG001|Overall Study|Death|0|||
126388940|NCT02443116|454715421|FG007|Part 3|Lost to Follow-up|1|||
126388941|NCT02443116|454715422|FG008|Part 3|Lost to Follow-up|2|||
126388942|NCT01932372|454715423|FG000|Overall Study|Not meeting eligibility criteria|33|||
126388943|NCT01932372|454715424|FG001|Overall Study|Not meeting eligibility criteria|179|||
126388944|NCT01917929|454715425|FG000|Overall Study|Death|8|||
126388945|NCT01917929|454715425|FG000|Overall Study|Lost to Follow-up|19|||
126388946|NCT01917929|454715425|FG000|Overall Study|Withdrawal by Subject|33|||
126388947|NCT01917929|454715425|FG000|Overall Study|Adverse Event|6|||
126388948|NCT01917929|454715425|FG000|Overall Study|Investigative Site Terminated|35|||
126388949|NCT01917929|454715425|FG000|Overall Study|Censored because study device not implanted|6|||
126388950|NCT01917929|454715425|FG000|Overall Study|Censored because surgery not performed|3|||
126554009|NCT04157686|455322678|FG001|Overall Study|Pregnancy|1|||
126717781|NCT00972244|455917623|FG002|Overall Study|Death|0|||
126717782|NCT00972244|455917624|FG003|Overall Study|Death|0|||
126717783|NCT00972244|455917625|FG004|Overall Study|Death|0|||
126717784|NCT00972244|455917621|FG000|Overall Study|Various|0|||
126388951|NCT01917929|454715425|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
126388952|NCT01917929|454715425|FG000|Overall Study|Sponsor terminated study|175|||
126388953|NCT02059499|454715434|FG000|Upto Week 20|Lost to Follow-up|2|||
126388954|NCT02059499|454715435|FG001|Upto Week 20|Lost to Follow-up|6|||
126388955|NCT02059499|454715436|FG002|Upto Week 20|Lost to Follow-up|0|||
126388956|NCT02059499|454715434|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
126388957|NCT02059499|454715435|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
126388958|NCT02059499|454715436|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
126388959|NCT02059499|454715434|FG000|Upto Week 20|Withdrawal by Subject|1|||
126388960|NCT02059499|454715435|FG001|Upto Week 20|Withdrawal by Subject|1|||
126388961|NCT02059499|454715436|FG002|Upto Week 20|Withdrawal by Subject|0|||
126388962|NCT02059499|454715434|FG000|Upto Week 20|No treatment per protocol criteria|0|||
126388963|NCT02059499|454715435|FG001|Upto Week 20|No treatment per protocol criteria|0|||
126388964|NCT02059499|454715436|FG002|Upto Week 20|No treatment per protocol criteria|5|||
126388965|NCT02059499|454715434|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
126388966|NCT02059499|454715435|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
126388967|NCT02059499|454715436|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
126388968|NCT02059499|454715434|FG000|Post-week 20|Lost to Follow-up|0|||
126388969|NCT02059499|454715435|FG001|Post-week 20|Lost to Follow-up|2|||
126388970|NCT02059499|454715436|FG002|Post-week 20|Lost to Follow-up|0|||
126388971|NCT02059499|454715434|FG000|Post-week 20|Withdrawal by Subject|0|||
126388972|NCT02059499|454715435|FG001|Post-week 20|Withdrawal by Subject|1|||
126388973|NCT02059499|454715436|FG002|Post-week 20|Withdrawal by Subject|0|||
126388974|NCT02059499|454715434|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
126388975|NCT02059499|454715435|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
126388976|NCT02059499|454715436|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
126388977|NCT00703846|454715437|FG000|Overall Study|Adverse Event|8|||
126388978|NCT00703846|454715437|FG000|Overall Study|Lost to Follow-up|55|||
126388979|NCT00703846|454715437|FG000|Overall Study|Lack of Efficacy|15|||
126388980|NCT00703846|454715437|FG000|Overall Study|Noncompliance with Study Treatment|2|||
126388981|NCT00703846|454715437|FG000|Overall Study|Withdrawal by Subject|40|||
126388982|NCT00703846|454715437|FG000|Overall Study|Death|1|||
126388983|NCT00703846|454715437|FG000|Overall Study|Other|14|||
126388984|NCT00703846|454715437|FG000|Overall Study|Did Not Receive Study Drug|2|||
126388985|NCT01700959|454715442|FG000|Overall Study|Adverse Event|0|||
126388986|NCT01700959|454715443|FG001|Overall Study|Adverse Event|1|||
126388987|NCT01700959|454715444|FG002|Overall Study|Adverse Event|1|||
126388988|NCT01700959|454715445|FG003|Overall Study|Adverse Event|2|||
126388989|NCT01700959|454715446|FG004|Overall Study|Adverse Event|0|||
126388990|NCT01700959|454715447|FG005|Overall Study|Adverse Event|2|||
126388991|NCT01700959|454715442|FG000|Overall Study|Withdrawal by Subject|15|||
126388992|NCT01700959|454715443|FG001|Overall Study|Withdrawal by Subject|9|||
126388993|NCT01700959|454715444|FG002|Overall Study|Withdrawal by Subject|12|||
126388994|NCT01700959|454715445|FG003|Overall Study|Withdrawal by Subject|11|||
126388995|NCT01700959|454715446|FG004|Overall Study|Withdrawal by Subject|8|||
126388996|NCT01700959|454715447|FG005|Overall Study|Withdrawal by Subject|12|||
126388997|NCT01700959|454715442|FG000|Overall Study|Ineligible|2|||
126388998|NCT01700959|454715443|FG001|Overall Study|Ineligible|1|||
126388999|NCT01700959|454715444|FG002|Overall Study|Ineligible|2|||
126389000|NCT01700959|454715445|FG003|Overall Study|Ineligible|0|||
126389001|NCT01700959|454715446|FG004|Overall Study|Ineligible|0|||
126389002|NCT01700959|454715447|FG005|Overall Study|Ineligible|1|||
126389003|NCT01700959|454715442|FG000|Overall Study|Noncompliant|9|||
126389004|NCT01700959|454715443|FG001|Overall Study|Noncompliant|9|||
126389005|NCT01700959|454715444|FG002|Overall Study|Noncompliant|17|||
126389006|NCT01700959|454715445|FG003|Overall Study|Noncompliant|18|||
126389007|NCT01700959|454715446|FG004|Overall Study|Noncompliant|15|||
126389008|NCT01700959|454715447|FG005|Overall Study|Noncompliant|9|||
126389009|NCT01700959|454715442|FG000|Overall Study|Side effects|1|||
126389010|NCT01700959|454715443|FG001|Overall Study|Side effects|4|||
126389011|NCT01700959|454715444|FG002|Overall Study|Side effects|8|||
126389012|NCT01700959|454715445|FG003|Overall Study|Side effects|4|||
126389013|NCT01700959|454715446|FG004|Overall Study|Side effects|4|||
126389014|NCT01700959|454715447|FG005|Overall Study|Side effects|1|||
126389015|NCT00830375|454715448|FG000|Overall Study|Lost to Follow-up|1|||
126389016|NCT02582814|454717356|FG000|Overall Study|Study-specific withdrawal criteria|1|||
126389017|NCT02582814|454717357|FG001|Overall Study|Study-specific withdrawal criteria|0|||
126389018|NCT02582814|454717356|FG000|Overall Study|Withdrawal by Subject|4|||
126389019|NCT02582814|454717357|FG001|Overall Study|Withdrawal by Subject|3|||
126389020|NCT02582814|454717356|FG000|Overall Study|Adverse Event|4|||
126389021|NCT02582814|454717357|FG001|Overall Study|Adverse Event|4|||
126389022|NCT03530995|454717358|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
126389023|NCT03530995|454717359|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
126717785|NCT00972244|455917622|FG001|Overall Study|Various|0|||
126389024|NCT03530995|454717358|FG000|Part 1 Period 3|Protocol Violation|1|||
126389025|NCT03530995|454717359|FG001|Part 1 Period 3|Protocol Violation|0|||
126389026|NCT03530995|454717358|FG000|Part 1 Period 4|Physician Decision|1|||
126389027|NCT03530995|454717359|FG001|Part 1 Period 4|Physician Decision|0|||
126389028|NCT03530995|454717358|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
126389029|NCT03530995|454717359|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
126389030|NCT01986231|454717363|FG000|Overall Study|Adverse Event|1|||
126389031|NCT00623233|454717364|FG000|Overall Study|Adverse Event|10|||
126389032|NCT00623233|454717364|FG000|Overall Study|Physician Decision|10|||
126389033|NCT00623233|454717364|FG000|Overall Study|Lost to Follow-up|1|||
126389034|NCT00623233|454717364|FG000|Overall Study|Withdrawal by Subject|3|||
126389035|NCT01751906|454717365|FG000|Overall Study|Lost to Follow-up|151|||
126389036|NCT01751906|454717366|FG001|Overall Study|Lost to Follow-up|68|||
126389037|NCT01751906|454717365|FG000|Overall Study|Withdrawal by Subject|22|||
126389038|NCT01751906|454717366|FG001|Overall Study|Withdrawal by Subject|18|||
126389039|NCT01751906|454717365|FG000|Overall Study|Physician Decision|5|||
126389040|NCT01751906|454717366|FG001|Overall Study|Physician Decision|2|||
126389041|NCT01751906|454717365|FG000|Overall Study|Death|84|||
126389042|NCT01751906|454717366|FG001|Overall Study|Death|43|||
126389043|NCT01751906|454717365|FG000|Overall Study|Denied on premises for follow-up by law|1|||
126389044|NCT01751906|454717366|FG001|Overall Study|Denied on premises for follow-up by law|0|||
126389045|NCT01110330|454717367|FG000|Overall Study|Adverse Event|0|||
126389046|NCT01110330|454717368|FG001|Overall Study|Adverse Event|4|||
126389047|NCT01110330|454717369|FG002|Overall Study|Adverse Event|3|||
126389048|NCT01110330|454717367|FG000|Overall Study|Lack of Efficacy|3|||
126389049|NCT01110330|454717368|FG001|Overall Study|Lack of Efficacy|1|||
126389050|NCT01110330|454717369|FG002|Overall Study|Lack of Efficacy|1|||
126389051|NCT01110330|454717367|FG000|Overall Study|Lost to Follow-up|9|||
126389052|NCT01110330|454717368|FG001|Overall Study|Lost to Follow-up|10|||
126389053|NCT01110330|454717369|FG002|Overall Study|Lost to Follow-up|15|||
126389054|NCT01110330|454717367|FG000|Overall Study|Physician Decision|0|||
126389055|NCT01110330|454717368|FG001|Overall Study|Physician Decision|1|||
126389056|NCT01110330|454717369|FG002|Overall Study|Physician Decision|0|||
126389057|NCT01110330|454717367|FG000|Overall Study|Protocol Violation|2|||
126389058|NCT01110330|454717368|FG001|Overall Study|Protocol Violation|0|||
126389059|NCT01110330|454717369|FG002|Overall Study|Protocol Violation|4|||
126389060|NCT01110330|454717367|FG000|Overall Study|Withdrawal by Subject|0|||
126389061|NCT01110330|454717368|FG001|Overall Study|Withdrawal by Subject|6|||
126389062|NCT01110330|454717369|FG002|Overall Study|Withdrawal by Subject|2|||
126389063|NCT01110330|454717367|FG000|Overall Study|Other|1|||
126389064|NCT01110330|454717368|FG001|Overall Study|Other|1|||
126389065|NCT01110330|454717369|FG002|Overall Study|Other|1|||
126389066|NCT02557100|454717370|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
126389067|NCT02557100|454717371|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
126389068|NCT02557100|454717372|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
126389069|NCT02557100|454717370|FG000|Single Blind Treatment Period|Death|0|||
126389070|NCT02557100|454717371|FG001|Single Blind Treatment Period|Death|1|||
126389071|NCT02557100|454717372|FG002|Single Blind Treatment Period|Death|0|||
126389072|NCT02557100|454717370|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
126389073|NCT02557100|454717371|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
126389074|NCT02557100|454717372|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
126389075|NCT02557100|454717370|FG000|Single Blind Treatment Period|Adverse Event|0|||
126389076|NCT02557100|454717371|FG001|Single Blind Treatment Period|Adverse Event|1|||
126389077|NCT02557100|454717372|FG002|Single Blind Treatment Period|Adverse Event|0|||
126389078|NCT02557100|454717370|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
126389079|NCT02557100|454717371|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
126389080|NCT02557100|454717372|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
126389081|NCT02557100|454717370|FG000|Cumulative Abatacept Period|Other Reasons|0|||
126389082|NCT02557100|454717371|FG001|Cumulative Abatacept Period|Other Reasons|0|||
126389083|NCT02557100|454717372|FG002|Cumulative Abatacept Period|Other Reasons|1|||
126389084|NCT02557100|454717370|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
126389085|NCT02557100|454717371|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
126389086|NCT02557100|454717372|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
126389087|NCT02557100|454717370|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
126389088|NCT02557100|454717371|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
126389089|NCT02557100|454717372|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
126389090|NCT02150057|454717380|FG000|Overall Study|Lost to Follow-up|6|||
126389091|NCT02150057|454717381|FG001|Overall Study|Lost to Follow-up|4|||
126389092|NCT00489424|454717382|FG000|Overall Study|Adverse Event|3|||
126389093|NCT00489424|454717383|FG001|Overall Study|Adverse Event|3|||
126389094|NCT00489424|454717384|FG002|Overall Study|Adverse Event|4|||
126389095|NCT00489424|454717382|FG000|Overall Study|Lack of Efficacy|1|||
126389096|NCT00489424|454717383|FG001|Overall Study|Lack of Efficacy|0|||
126389097|NCT00489424|454717384|FG002|Overall Study|Lack of Efficacy|0|||
126389098|NCT00489424|454717382|FG000|Overall Study|Administrative problems|0|||
126389099|NCT00489424|454717383|FG001|Overall Study|Administrative problems|2|||
126554010|NCT04157686|455322679|FG002|Overall Study|Pregnancy|3|||
126554011|NCT04157686|455322680|FG003|Overall Study|Pregnancy|0|||
126554012|NCT04157686|455322681|FG004|Overall Study|Pregnancy|0|||
126554013|NCT04157686|455322682|FG005|Overall Study|Pregnancy|0|||
126554014|NCT04157686|455322683|FG006|Overall Study|Pregnancy|3|||
126554015|NCT04157686|455322684|FG007|Overall Study|Pregnancy|0|||
126554016|NCT04157686|455322677|FG000|Overall Study|Lost to Follow-up|1|||
126554017|NCT04157686|455322678|FG001|Overall Study|Lost to Follow-up|2|||
126554018|NCT04157686|455322679|FG002|Overall Study|Lost to Follow-up|8|||
126554019|NCT04157686|455322680|FG003|Overall Study|Lost to Follow-up|6|||
126554020|NCT04157686|455322681|FG004|Overall Study|Lost to Follow-up|6|||
126554021|NCT04157686|455322682|FG005|Overall Study|Lost to Follow-up|3|||
126554022|NCT04157686|455322683|FG006|Overall Study|Lost to Follow-up|7|||
126554023|NCT04157686|455322684|FG007|Overall Study|Lost to Follow-up|9|||
126554024|NCT04157686|455322677|FG000|Overall Study|Lack of Efficacy|0|||
126554025|NCT04157686|455322678|FG001|Overall Study|Lack of Efficacy|0|||
126554026|NCT04157686|455322679|FG002|Overall Study|Lack of Efficacy|0|||
126554027|NCT04157686|455322680|FG003|Overall Study|Lack of Efficacy|0|||
126554028|NCT04157686|455322681|FG004|Overall Study|Lack of Efficacy|0|||
126554029|NCT04157686|455322682|FG005|Overall Study|Lack of Efficacy|2|||
126554030|NCT04157686|455322683|FG006|Overall Study|Lack of Efficacy|0|||
126554031|NCT04157686|455322684|FG007|Overall Study|Lack of Efficacy|1|||
126554032|NCT04157686|455322677|FG000|Overall Study|Withdrawal by Subject|10|||
126554033|NCT04157686|455322678|FG001|Overall Study|Withdrawal by Subject|10|||
126554034|NCT04157686|455322679|FG002|Overall Study|Withdrawal by Subject|12|||
126554035|NCT04157686|455322680|FG003|Overall Study|Withdrawal by Subject|20|||
126554036|NCT04157686|455322681|FG004|Overall Study|Withdrawal by Subject|12|||
126554037|NCT04157686|455322682|FG005|Overall Study|Withdrawal by Subject|11|||
126554038|NCT04157686|455322683|FG006|Overall Study|Withdrawal by Subject|18|||
126554039|NCT04157686|455322684|FG007|Overall Study|Withdrawal by Subject|24|||
126554040|NCT04157686|455322677|FG000|Overall Study|Physician Decision|0|||
126554041|NCT04157686|455322678|FG001|Overall Study|Physician Decision|0|||
126554042|NCT04157686|455322679|FG002|Overall Study|Physician Decision|1|||
126554043|NCT04157686|455322680|FG003|Overall Study|Physician Decision|0|||
126554044|NCT04157686|455322681|FG004|Overall Study|Physician Decision|1|||
126554045|NCT04157686|455322682|FG005|Overall Study|Physician Decision|0|||
126554046|NCT04157686|455322683|FG006|Overall Study|Physician Decision|3|||
126554047|NCT04157686|455322684|FG007|Overall Study|Physician Decision|0|||
126554048|NCT04157686|455322677|FG000|Overall Study|Death|0|||
126554049|NCT04157686|455322678|FG001|Overall Study|Death|0|||
126554050|NCT04157686|455322679|FG002|Overall Study|Death|0|||
126554051|NCT04157686|455322680|FG003|Overall Study|Death|2|||
126554052|NCT04157686|455322681|FG004|Overall Study|Death|0|||
126389100|NCT00489424|454717384|FG002|Overall Study|Administrative problems|1|||
126389101|NCT00394251|454717385|FG000|Overall Study|Adverse Event|7|||
126389102|NCT00394251|454717386|FG001|Overall Study|Adverse Event|5|||
126389103|NCT00394251|454717385|FG000|Overall Study|Unacceptable Toxicity|20|||
126389104|NCT00394251|454717386|FG001|Overall Study|Unacceptable Toxicity|18|||
126389105|NCT00394251|454717385|FG000|Overall Study|Physician Decision|1|||
126389106|NCT00394251|454717386|FG001|Overall Study|Physician Decision|1|||
126389107|NCT00394251|454717385|FG000|Overall Study|Protocol Violation|0|||
126389108|NCT00394251|454717386|FG001|Overall Study|Protocol Violation|1|||
126389109|NCT00394251|454717385|FG000|Overall Study|Withdrawal by Subject|7|||
126389110|NCT00394251|454717386|FG001|Overall Study|Withdrawal by Subject|11|||
126389111|NCT00394251|454717385|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
126554053|NCT04157686|455322682|FG005|Overall Study|Death|0|||
126554054|NCT04157686|455322683|FG006|Overall Study|Death|0|||
126554055|NCT04157686|455322684|FG007|Overall Study|Death|0|||
126717786|NCT00972244|455917623|FG002|Overall Study|Various|0|||
126717787|NCT00972244|455917624|FG003|Overall Study|Various|0|||
126717788|NCT00972244|455917625|FG004|Overall Study|Various|2|||
126717789|NCT01597557|455917626|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
126717790|NCT01597557|455917627|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
126717791|NCT02561000|455917630|FG000|Overall Study|Withdrawal by Subject|2|||
126554056|NCT04157686|455322677|FG000|Overall Study|Protocol Violation|0|||
126554057|NCT04157686|455322678|FG001|Overall Study|Protocol Violation|0|||
126554058|NCT04157686|455322679|FG002|Overall Study|Protocol Violation|0|||
126554059|NCT04157686|455322680|FG003|Overall Study|Protocol Violation|0|||
126554060|NCT04157686|455322681|FG004|Overall Study|Protocol Violation|1|||
126554061|NCT04157686|455322682|FG005|Overall Study|Protocol Violation|0|||
126554062|NCT04157686|455322683|FG006|Overall Study|Protocol Violation|0|||
126554063|NCT04157686|455322684|FG007|Overall Study|Protocol Violation|0|||
126554064|NCT04157686|455322677|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
126554065|NCT04157686|455322678|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
126554066|NCT04157686|455322679|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
126717792|NCT02561000|455917631|FG001|Overall Study|Withdrawal by Subject|3|||
126717793|NCT02561000|455917632|FG002|Overall Study|Withdrawal by Subject|0|||
126554067|NCT04157686|455322680|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
126554068|NCT04157686|455322681|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
126554069|NCT04157686|455322682|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
126389112|NCT00394251|454717386|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
126389113|NCT01558115|454717387|FG000|Overall Study|Withdrawal by Subject|3|||
126389114|NCT01558115|454717387|FG000|Overall Study|Study closed due to poor enrollment|4|||
126389115|NCT01696994|454717388|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
126389116|NCT01696994|454717389|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
126389117|NCT01696994|454717388|FG000|Overall Study|Died Before Randomization|1|||
126389118|NCT01696994|454717389|FG001|Overall Study|Died Before Randomization|2|||
126389119|NCT01696994|454717388|FG000|Overall Study|Died Before ASU (Control)|73|||
126389120|NCT01696994|454717389|FG001|Overall Study|Died Before ASU (Control)|0|||
126389121|NCT01696994|454717388|FG000|Overall Study|No Ovaries at Baseline|4807|||
126389122|NCT01696994|454717389|FG001|Overall Study|No Ovaries at Baseline|4851|||
126389123|NCT01696994|454717388|FG000|Overall Study|Refused ASU (Control)|311|||
126389124|NCT01696994|454717389|FG001|Overall Study|Refused ASU (Control)|0|||
126389125|NCT01696994|454717388|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
126389126|NCT01696994|454717389|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
126389127|NCT04644276|454717390|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
126389128|NCT04644276|454717391|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
126389129|NCT04644276|454717392|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
126389130|NCT00705250|454717393|FG000|Overall Study|Withdrawal by Subject|1|||
126389131|NCT00705250|454717393|FG000|Overall Study|Patient died in car accident|1|||
126389132|NCT01576146|454717394|FG000|Extension Period 1|Adverse Event|2|||
126389133|NCT01576146|454717394|FG000|Extension Period 1|Death|2|||
126389134|NCT01576146|454717394|FG000|Extension Period 1|Physician Decision|2|||
126389135|NCT01576146|454717394|FG000|Extension Period 1|Withdrawal by Subject|1|||
126389136|NCT01576146|454717394|FG000|Extension Period 1|Lost to Follow-up|1|||
126389137|NCT01576146|454717394|FG000|Extension Period 1|Parathyroidectomy|1|||
126389138|NCT01576146|454717394|FG000|Extension Period 1|Renal Transplant|1|||
126389139|NCT01576146|454717394|FG000|Extension Period 2|Sponsor Decision|13|||
126389140|NCT01576146|454717394|FG000|Extension Period 2|Death|1|||
126389141|NCT01576146|454717394|FG000|Extension Period 2|Adverse Event|1|||
126389142|NCT01576146|454717394|FG000|Extension Period 2|Renal Transplant|1|||
126389143|NCT01576146|454717394|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
126389144|NCT01951586|454717401|FG000|Overall Study|Death|61|||
126389145|NCT01951586|454717402|FG001|Overall Study|Death|120|||
126389146|NCT01951586|454717401|FG000|Overall Study|Withdrawal by Subject|8|||
126389147|NCT01951586|454717402|FG001|Overall Study|Withdrawal by Subject|17|||
126389148|NCT01951586|454717401|FG000|Overall Study|Lost to Follow-up|0|||
126389149|NCT01951586|454717402|FG001|Overall Study|Lost to Follow-up|1|||
126389150|NCT01951586|454717401|FG000|Overall Study|Sponsor Decision|9|||
126389151|NCT01951586|454717402|FG001|Overall Study|Sponsor Decision|10|||
126389152|NCT01667224|454717405|FG000|Overall Study|Withdrawal by Subject|3|||
126389153|NCT01667224|454717406|FG001|Overall Study|Withdrawal by Subject|1|||
126389154|NCT01667224|454717405|FG000|Overall Study|Protocol Violation|1|||
126717794|NCT02561000|455917630|FG000|Overall Study|Adverse Event|0|||
126717795|NCT02561000|455917631|FG001|Overall Study|Adverse Event|1|||
126389155|NCT01667224|454717406|FG001|Overall Study|Protocol Violation|1|||
126389156|NCT04995419|454717411|FG000|Overall Study|Withdrawal by Subject|3|||
126389157|NCT04995419|454717411|FG000|Overall Study|Progressive Disease|19|||
126389158|NCT04995419|454717411|FG000|Overall Study|Adverse Event|2|||
126389159|NCT04995419|454717411|FG000|Overall Study|Ongoing|16|||
126389160|NCT01822899|454717412|FG000|Overall Study|Adverse Event|6|||
126389161|NCT01822899|454717413|FG001|Overall Study|Adverse Event|5|||
126389162|NCT01822899|454717412|FG000|Overall Study|Lack of Efficacy|6|||
126389163|NCT01822899|454717413|FG001|Overall Study|Lack of Efficacy|3|||
126389164|NCT01822899|454717412|FG000|Overall Study|Protocol Violation|6|||
126389165|NCT01822899|454717413|FG001|Overall Study|Protocol Violation|3|||
126389166|NCT01822899|454717412|FG000|Overall Study|Lost to Follow-up|1|||
126389167|NCT01822899|454717413|FG001|Overall Study|Lost to Follow-up|0|||
126389168|NCT01822899|454717412|FG000|Overall Study|Withdrawal by Subject|5|||
126389169|NCT01822899|454717413|FG001|Overall Study|Withdrawal by Subject|7|||
126389170|NCT05332392|454717414|FG000|Overall Study|Did not meet inclusion criteria|25|||
126389171|NCT05332392|454717414|FG000|Overall Study|Principal Investigator's decision|17|||
126389172|NCT05332392|454717414|FG000|Overall Study|Adverse Event|1|||
126389173|NCT05332392|454717414|FG000|Overall Study|Subject's decision|1|||
126389174|NCT02752633|454717416|FG000|Overall Study|Withdrawal by Subject|1|||
126389175|NCT02846389|454717417|FG000|Overall Study|Withdrawal by Subject|1|||
126389176|NCT02846389|454717418|FG001|Overall Study|Withdrawal by Subject|1|||
126389177|NCT00853242|454717420|FG000|Overall Study|Adverse Event|0|||
126389178|NCT00853242|454717421|FG001|Overall Study|Adverse Event|1|||
126389179|NCT00853242|454717422|FG002|Overall Study|Adverse Event|1|||
126389180|NCT00853242|454717423|FG003|Overall Study|Adverse Event|0|||
126389181|NCT00853242|454717424|FG004|Overall Study|Adverse Event|3|||
126389182|NCT00853242|454717425|FG005|Overall Study|Adverse Event|1|||
126389183|NCT00853242|454717426|FG006|Overall Study|Adverse Event|1|||
126717796|NCT02561000|455917632|FG002|Overall Study|Adverse Event|0|||
126717797|NCT03952468|455917633|FG000|Overall Study|Death|0|||
126389184|NCT00853242|454717420|FG000|Overall Study|Noncompliant|0|||
126389185|NCT00853242|454717421|FG001|Overall Study|Noncompliant|0|||
126389186|NCT00853242|454717422|FG002|Overall Study|Noncompliant|0|||
126389187|NCT00853242|454717423|FG003|Overall Study|Noncompliant|0|||
126389188|NCT00853242|454717424|FG004|Overall Study|Noncompliant|1|||
126389189|NCT00853242|454717425|FG005|Overall Study|Noncompliant|0|||
126389190|NCT00853242|454717426|FG006|Overall Study|Noncompliant|0|||
126389191|NCT00853242|454717420|FG000|Overall Study|Withdrawal by Subject|1|||
126389192|NCT00853242|454717421|FG001|Overall Study|Withdrawal by Subject|2|||
126389193|NCT00853242|454717422|FG002|Overall Study|Withdrawal by Subject|0|||
126389194|NCT00853242|454717423|FG003|Overall Study|Withdrawal by Subject|4|||
126554070|NCT04157686|455322683|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
126554071|NCT04157686|455322684|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
126554072|NCT01216293|455322685|FG000|Main Study|Adverse Event|1|||
126554073|NCT01216293|455322686|FG001|Main Study|Adverse Event|4|||
126554074|NCT01216293|455322687|FG002|Main Study|Adverse Event|2|||
126554075|NCT01216293|455322685|FG000|Main Study|Major Protocol Deviation|1|||
126554076|NCT01216293|455322686|FG001|Main Study|Major Protocol Deviation|0|||
126389195|NCT00853242|454717424|FG004|Overall Study|Withdrawal by Subject|0|||
126389196|NCT00853242|454717425|FG005|Overall Study|Withdrawal by Subject|0|||
126389197|NCT00853242|454717426|FG006|Overall Study|Withdrawal by Subject|2|||
126389198|NCT00853242|454717420|FG000|Overall Study|Other|2|||
126389199|NCT00853242|454717421|FG001|Overall Study|Other|0|||
126389200|NCT00853242|454717422|FG002|Overall Study|Other|2|||
126389201|NCT00853242|454717423|FG003|Overall Study|Other|0|||
126389202|NCT00853242|454717424|FG004|Overall Study|Other|0|||
126389203|NCT00853242|454717425|FG005|Overall Study|Other|1|||
126389204|NCT00853242|454717426|FG006|Overall Study|Other|2|||
126389205|NCT01265563|454717427|FG000|Overall Study|Withdrawal by Subject|0|||
126554077|NCT01216293|455322687|FG002|Main Study|Major Protocol Deviation|1|||
126554078|NCT01216293|455322685|FG000|Main Study|Lost to Follow-up|3|||
126389206|NCT01265563|454717428|FG001|Overall Study|Withdrawal by Subject|1|||
126389207|NCT01265563|454717429|FG002|Overall Study|Withdrawal by Subject|1|||
126554079|NCT01216293|455322686|FG001|Main Study|Lost to Follow-up|1|||
126554080|NCT01216293|455322687|FG002|Main Study|Lost to Follow-up|0|||
126554081|NCT01216293|455322685|FG000|Main Study|Voluntary Withdrawal|2|||
126554082|NCT01216293|455322686|FG001|Main Study|Voluntary Withdrawal|2|||
126554083|NCT01216293|455322687|FG002|Main Study|Voluntary Withdrawal|2|||
126554084|NCT01216293|455322685|FG000|Main Study|Other Reason Not Specified|0|||
126554085|NCT01216293|455322686|FG001|Main Study|Other Reason Not Specified|1|||
126554086|NCT01216293|455322687|FG002|Main Study|Other Reason Not Specified|1|||
126554087|NCT01216293|455322685|FG000|Main Study|Randomized, Not Treated|1|||
126554088|NCT01216293|455322686|FG001|Main Study|Randomized, Not Treated|0|||
126554089|NCT01216293|455322687|FG002|Main Study|Randomized, Not Treated|0|||
126554090|NCT01216293|455322685|FG000|Calcium Absorption Substudy|Adverse Event|0|||
126554091|NCT01216293|455322686|FG001|Calcium Absorption Substudy|Adverse Event|2|||
126554092|NCT01216293|455322687|FG002|Calcium Absorption Substudy|Adverse Event|0|||
126554093|NCT01216293|455322685|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
126554094|NCT01216293|455322686|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
126554095|NCT01216293|455322687|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
126554096|NCT01216293|455322685|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
126554097|NCT01216293|455322686|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
126554098|NCT01216293|455322687|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
126554099|NCT01671748|455322688|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
126554100|NCT01671748|455322689|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
126554101|NCT01671748|455322688|FG000|4 Week run-in Phase|Adverse Event|1|||
126554102|NCT01671748|455322689|FG001|4 Week run-in Phase|Adverse Event|0|||
126554103|NCT01671748|455322688|FG000|4 Week run-in Phase|Not eligible|9|||
126554104|NCT01671748|455322689|FG001|4 Week run-in Phase|Not eligible|0|||
126554105|NCT02169830|455323999|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
126389208|NCT01265563|454717430|FG003|Overall Study|Withdrawal by Subject|0|||
126554106|NCT02169830|455324000|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
126717798|NCT03952468|455917634|FG001|Overall Study|Death|1|||
126389209|NCT01265563|454717431|FG004|Overall Study|Withdrawal by Subject|2|||
126389210|NCT02141399|454717436|FG000|Overall Study|Adverse Event|158|||
126389211|NCT02141399|454717436|FG000|Overall Study|Lack of Efficacy|62|||
126389212|NCT02141399|454717436|FG000|Overall Study|Lost to Follow-up|151|||
126389213|NCT02141399|454717436|FG000|Overall Study|Non-compliance with study drug|18|||
126389214|NCT02141399|454717436|FG000|Overall Study|Other|45|||
126554107|NCT02169830|455324001|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
126554108|NCT02169830|455323999|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
126554109|NCT02169830|455324000|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
126554110|NCT02169830|455324001|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
126389215|NCT02141399|454717436|FG000|Overall Study|Physician Decision|17|||
126554111|NCT02169830|455323999|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
126717799|NCT03952468|455917633|FG000|Overall Study|Adverse Event|0|||
126389216|NCT02141399|454717436|FG000|Overall Study|Pregnancy|3|||
126389217|NCT02141399|454717436|FG000|Overall Study|Protocol Violation|38|||
126389218|NCT02141399|454717436|FG000|Overall Study|Withdrawal by Subject|238|||
126389219|NCT02141399|454717436|FG000|Overall Study|Failure to meet eligibility criteria|14|||
126389220|NCT01296711|454717437|FG000|Overall Study|Adverse Event|3|||
126389221|NCT01296711|454717438|FG001|Overall Study|Adverse Event|1|||
126389222|NCT01296711|454717439|FG002|Overall Study|Adverse Event|4|||
126389223|NCT01296711|454717440|FG003|Overall Study|Adverse Event|3|||
126389224|NCT01296711|454717441|FG004|Overall Study|Adverse Event|1|||
126389225|NCT01296711|454717442|FG005|Overall Study|Adverse Event|6|||
126389226|NCT01296711|454717443|FG006|Overall Study|Adverse Event|11|||
126389227|NCT01296711|454717444|FG007|Overall Study|Adverse Event|3|||
126389228|NCT01296711|454717437|FG000|Overall Study|Lack of Efficacy|1|||
126389229|NCT01296711|454717438|FG001|Overall Study|Lack of Efficacy|4|||
126389230|NCT01296711|454717439|FG002|Overall Study|Lack of Efficacy|1|||
126389231|NCT01296711|454717440|FG003|Overall Study|Lack of Efficacy|1|||
126389232|NCT01296711|454717441|FG004|Overall Study|Lack of Efficacy|1|||
126389233|NCT01296711|454717442|FG005|Overall Study|Lack of Efficacy|0|||
126389234|NCT01296711|454717443|FG006|Overall Study|Lack of Efficacy|2|||
126389235|NCT01296711|454717444|FG007|Overall Study|Lack of Efficacy|3|||
126389236|NCT01296711|454717437|FG000|Overall Study|Lost to Follow-up|0|||
126389237|NCT01296711|454717438|FG001|Overall Study|Lost to Follow-up|0|||
126389238|NCT01296711|454717439|FG002|Overall Study|Lost to Follow-up|1|||
126389239|NCT01296711|454717440|FG003|Overall Study|Lost to Follow-up|1|||
126389240|NCT01296711|454717441|FG004|Overall Study|Lost to Follow-up|2|||
126389241|NCT01296711|454717442|FG005|Overall Study|Lost to Follow-up|0|||
126389242|NCT01296711|454717443|FG006|Overall Study|Lost to Follow-up|4|||
126389243|NCT01296711|454717444|FG007|Overall Study|Lost to Follow-up|2|||
126389244|NCT01296711|454717437|FG000|Overall Study|Protocol Violation|0|||
126389245|NCT01296711|454717438|FG001|Overall Study|Protocol Violation|0|||
126389246|NCT01296711|454717439|FG002|Overall Study|Protocol Violation|0|||
126389247|NCT01296711|454717440|FG003|Overall Study|Protocol Violation|1|||
126389248|NCT01296711|454717441|FG004|Overall Study|Protocol Violation|1|||
126389249|NCT01296711|454717442|FG005|Overall Study|Protocol Violation|0|||
126389250|NCT01296711|454717443|FG006|Overall Study|Protocol Violation|0|||
126389251|NCT01296711|454717444|FG007|Overall Study|Protocol Violation|0|||
126389252|NCT01296711|454717437|FG000|Overall Study|Withdrawal by Subject|4|||
126389253|NCT01296711|454717438|FG001|Overall Study|Withdrawal by Subject|2|||
126389254|NCT01296711|454717439|FG002|Overall Study|Withdrawal by Subject|2|||
126389255|NCT01296711|454717440|FG003|Overall Study|Withdrawal by Subject|1|||
126389256|NCT01296711|454717441|FG004|Overall Study|Withdrawal by Subject|1|||
126389257|NCT01296711|454717442|FG005|Overall Study|Withdrawal by Subject|1|||
126389258|NCT01296711|454717443|FG006|Overall Study|Withdrawal by Subject|2|||
126389259|NCT01296711|454717444|FG007|Overall Study|Withdrawal by Subject|1|||
126389260|NCT01296711|454717437|FG000|Overall Study|Study termination|8|||
126389261|NCT01296711|454717438|FG001|Overall Study|Study termination|1|||
126389262|NCT01296711|454717439|FG002|Overall Study|Study termination|5|||
126389263|NCT01296711|454717440|FG003|Overall Study|Study termination|4|||
126389264|NCT01296711|454717441|FG004|Overall Study|Study termination|4|||
126389265|NCT01296711|454717442|FG005|Overall Study|Study termination|4|||
126389266|NCT01296711|454717443|FG006|Overall Study|Study termination|8|||
126389267|NCT01296711|454717444|FG007|Overall Study|Study termination|10|||
126389268|NCT01296711|454717437|FG000|Overall Study|Continued elevated liver enzymes|0|||
126389269|NCT01296711|454717438|FG001|Overall Study|Continued elevated liver enzymes|0|||
126389270|NCT01296711|454717439|FG002|Overall Study|Continued elevated liver enzymes|0|||
126389271|NCT01296711|454717440|FG003|Overall Study|Continued elevated liver enzymes|1|||
126389272|NCT01296711|454717441|FG004|Overall Study|Continued elevated liver enzymes|0|||
126389273|NCT01296711|454717442|FG005|Overall Study|Continued elevated liver enzymes|0|||
126389274|NCT01296711|454717443|FG006|Overall Study|Continued elevated liver enzymes|0|||
126389275|NCT01296711|454717444|FG007|Overall Study|Continued elevated liver enzymes|0|||
126389276|NCT01296711|454717437|FG000|Overall Study|Methotrexate discontinued|0|||
126389277|NCT01296711|454717438|FG001|Overall Study|Methotrexate discontinued|0|||
126389278|NCT01296711|454717439|FG002|Overall Study|Methotrexate discontinued|0|||
126389279|NCT01296711|454717440|FG003|Overall Study|Methotrexate discontinued|1|||
126389280|NCT01296711|454717441|FG004|Overall Study|Methotrexate discontinued|0|||
126389281|NCT01296711|454717442|FG005|Overall Study|Methotrexate discontinued|0|||
126389282|NCT01296711|454717443|FG006|Overall Study|Methotrexate discontinued|0|||
126389283|NCT01296711|454717444|FG007|Overall Study|Methotrexate discontinued|0|||
126389284|NCT01296711|454717437|FG000|Overall Study|Investigator discretion|0|||
126389285|NCT01296711|454717438|FG001|Overall Study|Investigator discretion|0|||
126389286|NCT01296711|454717439|FG002|Overall Study|Investigator discretion|0|||
126389287|NCT01296711|454717440|FG003|Overall Study|Investigator discretion|0|||
126389288|NCT01296711|454717441|FG004|Overall Study|Investigator discretion|0|||
126389289|NCT01296711|454717442|FG005|Overall Study|Investigator discretion|0|||
126389290|NCT01296711|454717443|FG006|Overall Study|Investigator discretion|1|||
126389291|NCT01296711|454717444|FG007|Overall Study|Investigator discretion|0|||
126389292|NCT01296711|454717437|FG000|Overall Study|Other|0|||
126389293|NCT01296711|454717438|FG001|Overall Study|Other|0|||
126389294|NCT01296711|454717439|FG002|Overall Study|Other|0|||
126554112|NCT02169830|455324000|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
126554113|NCT02169830|455324001|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
126554114|NCT02169830|455323999|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
126554115|NCT02169830|455324000|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
126554116|NCT02169830|455324001|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
126554117|NCT02169830|455323999|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
126554118|NCT02169830|455324000|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
126554119|NCT02169830|455324001|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
126554120|NCT03615482|455324002|FG000|Overall Study|Death|1|||
126554121|NCT03615482|455324003|FG001|Overall Study|Death|0|||
126554122|NCT03615482|455324002|FG000|Overall Study|Lost to Follow-up|7|||
126554123|NCT03615482|455324003|FG001|Overall Study|Lost to Follow-up|7|||
126554124|NCT03615482|455324002|FG000|Overall Study|Physician Decision|2|||
126554125|NCT03615482|455324003|FG001|Overall Study|Physician Decision|3|||
126554126|NCT03615482|455324002|FG000|Overall Study|Withdrawal by Subject|7|||
126554127|NCT03615482|455324003|FG001|Overall Study|Withdrawal by Subject|7|||
126554128|NCT01500226|455324006|FG000|Overall Study|Adverse Event|31|||
126554129|NCT01500226|455324007|FG001|Overall Study|Adverse Event|38|||
126554130|NCT01500226|455324006|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
126554131|NCT01500226|455324007|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
126554132|NCT01500226|455324006|FG000|Overall Study|Withdrawal by Subject|93|||
126554133|NCT01500226|455324007|FG001|Overall Study|Withdrawal by Subject|96|||
126554134|NCT01500226|455324006|FG000|Overall Study|Death|12|||
126554135|NCT01500226|455324007|FG001|Overall Study|Death|4|||
126554136|NCT01500226|455324006|FG000|Overall Study|Disease Progression|16|||
126554137|NCT01500226|455324007|FG001|Overall Study|Disease Progression|14|||
126554138|NCT01500226|455324006|FG000|Overall Study|Protocol Violation|53|||
126554139|NCT01500226|455324007|FG001|Overall Study|Protocol Violation|39|||
126554140|NCT01500226|455324006|FG000|Overall Study|Physician Decision|17|||
126554141|NCT01500226|455324007|FG001|Overall Study|Physician Decision|15|||
126554142|NCT01500226|455324006|FG000|Overall Study|Lack of Efficacy|14|||
126554143|NCT01500226|455324007|FG001|Overall Study|Lack of Efficacy|30|||
126554144|NCT01500226|455324006|FG000|Overall Study|Lost to Follow-up|9|||
126554145|NCT01500226|455324007|FG001|Overall Study|Lost to Follow-up|5|||
126554146|NCT01500226|455324006|FG000|Overall Study|Other Reasons|19|||
126717800|NCT03952468|455917634|FG001|Overall Study|Adverse Event|1|||
126717801|NCT03952468|455917633|FG000|Overall Study|Physician Decision|1|||
126717802|NCT03952468|455917634|FG001|Overall Study|Physician Decision|0|||
126717803|NCT03952468|455917633|FG000|Overall Study|Lost to Follow-up|3|||
126717804|NCT03952468|455917634|FG001|Overall Study|Lost to Follow-up|4|||
126717805|NCT03952468|455917633|FG000|Overall Study|Withdrawal by Subject|2|||
126717806|NCT03952468|455917634|FG001|Overall Study|Withdrawal by Subject|1|||
126717807|NCT05761444|455917636|FG000|Overall Study|Protocol Violation|2|||
126717808|NCT05761444|455917637|FG001|Overall Study|Protocol Violation|1|||
126717809|NCT05761444|455917636|FG000|Overall Study|Adverse Event|2|||
126389295|NCT01296711|454717440|FG003|Overall Study|Other|0|||
126389296|NCT01296711|454717441|FG004|Overall Study|Other|0|||
126389297|NCT01296711|454717442|FG005|Overall Study|Other|0|||
126389298|NCT01296711|454717443|FG006|Overall Study|Other|1|||
126389299|NCT01296711|454717444|FG007|Overall Study|Other|0|||
126389300|NCT01296711|454717437|FG000|Overall Study|Required restricted steroid injections|0|||
126389301|NCT01296711|454717438|FG001|Overall Study|Required restricted steroid injections|0|||
126389302|NCT01296711|454717439|FG002|Overall Study|Required restricted steroid injections|0|||
126389303|NCT01296711|454717440|FG003|Overall Study|Required restricted steroid injections|0|||
126389304|NCT01296711|454717441|FG004|Overall Study|Required restricted steroid injections|0|||
126389305|NCT01296711|454717442|FG005|Overall Study|Required restricted steroid injections|0|||
126389306|NCT01296711|454717443|FG006|Overall Study|Required restricted steroid injections|1|||
126389307|NCT01296711|454717444|FG007|Overall Study|Required restricted steroid injections|0|||
126389308|NCT01296711|454717437|FG000|Overall Study|Ongoing missed appointments|0|||
126389309|NCT01296711|454717438|FG001|Overall Study|Ongoing missed appointments|0|||
126389310|NCT01296711|454717439|FG002|Overall Study|Ongoing missed appointments|0|||
126389311|NCT01296711|454717440|FG003|Overall Study|Ongoing missed appointments|0|||
126717810|NCT05761444|455917637|FG001|Overall Study|Adverse Event|2|||
126771219|NCT01678924|456117704|FG002|Overall Study|Withdrawal by Subject|0|||
126389312|NCT01296711|454717441|FG004|Overall Study|Ongoing missed appointments|0|||
126389313|NCT01296711|454717442|FG005|Overall Study|Ongoing missed appointments|0|||
126554147|NCT01500226|455324007|FG001|Overall Study|Other Reasons|16|||
126554148|NCT02018861|455324014|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
126554149|NCT02018861|455324015|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
126554150|NCT02018861|455324016|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
126554151|NCT02018861|455324017|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
126554152|NCT02018861|455324018|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
126554153|NCT02018861|455324019|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
126554154|NCT02018861|455324020|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
126717811|NCT05761444|455917636|FG000|Overall Study|Withdrawal by Subject|3|||
126771220|NCT01678924|456117705|FG003|Overall Study|Withdrawal by Subject|2|||
126389314|NCT01296711|454717443|FG006|Overall Study|Ongoing missed appointments|1|||
126389315|NCT01296711|454717444|FG007|Overall Study|Ongoing missed appointments|0|||
126389316|NCT01296711|454717437|FG000|Overall Study|Failure to comply with visits|0|||
126389317|NCT01296711|454717438|FG001|Overall Study|Failure to comply with visits|0|||
126389318|NCT01296711|454717439|FG002|Overall Study|Failure to comply with visits|0|||
126389319|NCT01296711|454717440|FG003|Overall Study|Failure to comply with visits|0|||
126389320|NCT01296711|454717441|FG004|Overall Study|Failure to comply with visits|0|||
126389321|NCT01296711|454717442|FG005|Overall Study|Failure to comply with visits|0|||
126389322|NCT01296711|454717443|FG006|Overall Study|Failure to comply with visits|0|||
126389323|NCT01296711|454717444|FG007|Overall Study|Failure to comply with visits|1|||
126389324|NCT01296711|454717437|FG000|Overall Study|Patient decision due to transport|0|||
126389325|NCT01296711|454717438|FG001|Overall Study|Patient decision due to transport|0|||
126389326|NCT01296711|454717439|FG002|Overall Study|Patient decision due to transport|0|||
126389327|NCT01296711|454717440|FG003|Overall Study|Patient decision due to transport|0|||
126389328|NCT01296711|454717441|FG004|Overall Study|Patient decision due to transport|0|||
126389329|NCT01296711|454717442|FG005|Overall Study|Patient decision due to transport|0|||
126389330|NCT01296711|454717443|FG006|Overall Study|Patient decision due to transport|0|||
126389331|NCT01296711|454717444|FG007|Overall Study|Patient decision due to transport|1|||
126389332|NCT01126268|454717445|FG000|Overall Study|Adverse Event|1|||
126389333|NCT04026009|454717446|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126389334|NCT04026009|454717447|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126389335|NCT04026009|454717448|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
126389336|NCT04026009|454717449|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
126389337|NCT04026009|454717450|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
126389338|NCT04026009|454717446|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
126389339|NCT04026009|454717447|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
126389340|NCT04026009|454717448|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
126389341|NCT04026009|454717449|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
126389342|NCT04026009|454717450|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
126389343|NCT01988662|454717451|FG000|Overall Study|Subject/guardian decision|1|||
126389344|NCT01988662|454717452|FG001|Overall Study|Subject/guardian decision|1|||
126389345|NCT01988662|454717451|FG000|Overall Study|Adverse Event|3|||
126389346|NCT01988662|454717452|FG001|Overall Study|Adverse Event|1|||
126389347|NCT00842153|454717456|FG000|Overall Study|Adverse Event|0|||
126389348|NCT00842153|454717457|FG001|Overall Study|Adverse Event|1|||
126389349|NCT00842153|454717456|FG000|Overall Study|Lost to Follow-up|1|||
126389350|NCT00842153|454717457|FG001|Overall Study|Lost to Follow-up|2|||
126389351|NCT00002540|454717458|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
126389352|NCT00002540|454717459|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
126389353|NCT00002540|454717458|FG000|Overall Study|Died Before Randomization|2|||
126389354|NCT00002540|454717459|FG001|Overall Study|Died Before Randomization|6|||
126389355|NCT00002540|454717458|FG000|Overall Study|Died Before ASU (Control)|202|||
126389356|NCT00002540|454717459|FG001|Overall Study|Died Before ASU (Control)|0|||
126389357|NCT00002540|454717458|FG000|Overall Study|Refused ASU (Control)|597|||
126389358|NCT00002540|454717459|FG001|Overall Study|Refused ASU (Control)|0|||
126389359|NCT00002540|454717458|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
126389360|NCT00002540|454717459|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
126389361|NCT01345929|454717460|FG000|Overall Study|Withdrawal by Subject|9|||
126389362|NCT01345929|454717461|FG001|Overall Study|Withdrawal by Subject|8|||
126389363|NCT01345929|454717460|FG000|Overall Study|Lost to Follow-up|9|||
126389364|NCT01345929|454717461|FG001|Overall Study|Lost to Follow-up|9|||
126389365|NCT01345929|454717460|FG000|Overall Study|Adverse Event|0|||
126389366|NCT01345929|454717461|FG001|Overall Study|Adverse Event|1|||
126389367|NCT01345929|454717460|FG000|Overall Study|Didn't meet eligibility criteria|2|||
126389368|NCT01345929|454717461|FG001|Overall Study|Didn't meet eligibility criteria|0|||
126389369|NCT01345929|454717460|FG000|Overall Study|40,000 CFU/ML|1|||
126389370|NCT01345929|454717461|FG001|Overall Study|40,000 CFU/ML|0|||
126389371|NCT01345929|454717460|FG000|Overall Study|Patient withdrawal|0|||
126389372|NCT01345929|454717461|FG001|Overall Study|Patient withdrawal|1|||
126389373|NCT02151903|454717462|FG000|Overall Study|Withdrawal by Subject|1|||
126389374|NCT02151903|454717463|FG001|Overall Study|Withdrawal by Subject|0|||
126389375|NCT02151903|454717462|FG000|Overall Study|Progressive disease|2|||
126389376|NCT02151903|454717463|FG001|Overall Study|Progressive disease|1|||
126389377|NCT01500252|454717466|FG000|Overall Study|Death|4|||
126389378|NCT01500252|454717467|FG001|Overall Study|Death|2|||
126389379|NCT01500252|454717466|FG000|Overall Study|Lost to Follow-up|5|||
126389380|NCT01500252|454717467|FG001|Overall Study|Lost to Follow-up|4|||
126389381|NCT05319600|454717468|FG000|Overall Study|Withdrawal by Subject|1|||
126389382|NCT05319600|454717469|FG001|Overall Study|Withdrawal by Subject|0|||
126389383|NCT05319600|454717468|FG000|Overall Study|Lost to Follow-up|0|||
126389384|NCT05319600|454717469|FG001|Overall Study|Lost to Follow-up|4|||
126389385|NCT03768089|454717473|FG000|Part A|Lost to Follow-up|0|||
126389386|NCT03768089|454717474|FG001|Part A|Lost to Follow-up|0|||
126389387|NCT03768089|454717475|FG002|Part A|Lost to Follow-up|0|||
126389388|NCT03768089|454717476|FG003|Part A|Lost to Follow-up|0|||
126389389|NCT03768089|454717477|FG004|Part A|Lost to Follow-up|1|||
126389390|NCT03768089|454717478|FG005|Part A|Lost to Follow-up|0|||
126389391|NCT03768089|454717479|FG006|Part A|Lost to Follow-up|0|||
126389392|NCT03768089|454717480|FG007|Part A|Lost to Follow-up|0|||
126389393|NCT03768089|454717481|FG008|Part A|Lost to Follow-up|0|||
126389394|NCT03768089|454717482|FG009|Part A|Lost to Follow-up|0|||
126389395|NCT03768089|454717483|FG010|Part A|Lost to Follow-up|0|||
126389396|NCT03768089|454717484|FG011|Part A|Lost to Follow-up|0|||
126389397|NCT03768089|454717485|FG012|Part A|Lost to Follow-up|0|||
126389398|NCT03768089|454717486|FG013|Part A|Lost to Follow-up|0|||
126389399|NCT03768089|454717487|FG014|Part A|Lost to Follow-up|0|||
126389400|NCT03768089|454717488|FG015|Part A|Lost to Follow-up|0|||
126389401|NCT03768089|454717489|FG016|Part A|Lost to Follow-up|0|||
126389402|NCT03768089|454717490|FG017|Part A|Lost to Follow-up|0|||
126389403|NCT03768089|454717473|FG000|Part C|Randomized, Never Dosed|0|||
126389404|NCT03768089|454717474|FG001|Part C|Randomized, Never Dosed|0|||
126389405|NCT03768089|454717475|FG002|Part C|Randomized, Never Dosed|0|||
126389406|NCT03768089|454717476|FG003|Part C|Randomized, Never Dosed|0|||
126389407|NCT03768089|454717477|FG004|Part C|Randomized, Never Dosed|0|||
126389408|NCT03768089|454717478|FG005|Part C|Randomized, Never Dosed|0|||
126389409|NCT03768089|454717479|FG006|Part C|Randomized, Never Dosed|0|||
126389410|NCT03768089|454717480|FG007|Part C|Randomized, Never Dosed|0|||
126389411|NCT03768089|454717481|FG008|Part C|Randomized, Never Dosed|0|||
126389412|NCT03768089|454717482|FG009|Part C|Randomized, Never Dosed|0|||
126389413|NCT03768089|454717483|FG010|Part C|Randomized, Never Dosed|0|||
126389414|NCT03768089|454717484|FG011|Part C|Randomized, Never Dosed|0|||
126389415|NCT03768089|454717485|FG012|Part C|Randomized, Never Dosed|0|||
126389416|NCT03768089|454717486|FG013|Part C|Randomized, Never Dosed|0|||
126389417|NCT03768089|454717487|FG014|Part C|Randomized, Never Dosed|1|||
126389418|NCT03768089|454717488|FG015|Part C|Randomized, Never Dosed|0|||
126389419|NCT03768089|454717489|FG016|Part C|Randomized, Never Dosed|0|||
126389420|NCT03768089|454717490|FG017|Part C|Randomized, Never Dosed|0|||
126389421|NCT02120300|454717493|FG000|Overall Study|Enrolled but Never Treated|2|||
126389422|NCT02120300|454717494|FG001|Overall Study|Enrolled but Never Treated|0|||
126389423|NCT02120300|454717495|FG002|Overall Study|Enrolled but Never Treated|0|||
126389424|NCT02120300|454717496|FG003|Overall Study|Enrolled but Never Treated|0|||
126389425|NCT02120300|454717493|FG000|Overall Study|Lack of Efficacy|0|||
126389426|NCT02120300|454717494|FG001|Overall Study|Lack of Efficacy|0|||
126389427|NCT02120300|454717495|FG002|Overall Study|Lack of Efficacy|0|||
126389428|NCT02120300|454717496|FG003|Overall Study|Lack of Efficacy|1|||
126389429|NCT02120300|454717493|FG000|Overall Study|Lost to Follow-up|1|||
126389430|NCT02120300|454717494|FG001|Overall Study|Lost to Follow-up|0|||
126389431|NCT02120300|454717495|FG002|Overall Study|Lost to Follow-up|0|||
126389432|NCT02120300|454717496|FG003|Overall Study|Lost to Follow-up|0|||
126389433|NCT00361231|454717500|FG000|Overall Study|Physician Decision|3|||
126389434|NCT00361231|454717500|FG000|Overall Study|Symptomatic deterioration|5|||
126389435|NCT00361231|454717500|FG000|Overall Study|Radiographic disease progression|16|||
126389436|NCT00361231|454717500|FG000|Overall Study|Withdrawal by Subject|4|||
126389437|NCT00361231|454717500|FG000|Overall Study|Adverse Event|6|||
126389438|NCT01208961|454717503|FG000|High-Fat Period III|Protocol Violation|1|||
126389439|NCT01208961|454717504|FG001|High-Fat Period III|Protocol Violation|0|||
126389440|NCT02241733|454717507|FG000|Overall Study|Lost to Follow-up|9|||
126389441|NCT02241733|454717508|FG001|Overall Study|Lost to Follow-up|4|||
126389442|NCT02241733|454717507|FG000|Overall Study|Physician Decision|6|||
126389443|NCT02241733|454717508|FG001|Overall Study|Physician Decision|2|||
126389444|NCT02241733|454717507|FG000|Overall Study|Withdrawal by Subject|0|||
126389445|NCT02241733|454717508|FG001|Overall Study|Withdrawal by Subject|2|||
126389446|NCT02241733|454717507|FG000|Overall Study|Death|0|||
126389447|NCT02241733|454717508|FG001|Overall Study|Death|2|||
126389448|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
126389449|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
126389450|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
126389451|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
126389452|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
126389453|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
126389454|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
126389455|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
126389456|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
126389457|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
126389458|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
126389459|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
126389460|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
126389461|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
126389462|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
126389463|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
126554155|NCT02018861|455324021|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
126554156|NCT02018861|455324022|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
126554157|NCT02018861|455324023|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
126554158|NCT02018861|455324014|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
126554159|NCT02018861|455324015|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
126554160|NCT02018861|455324016|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
126554161|NCT02018861|455324017|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
126554162|NCT02018861|455324018|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
126554163|NCT02018861|455324019|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
126554164|NCT02018861|455324020|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
126554165|NCT02018861|455324021|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
126554166|NCT02018861|455324022|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
126554167|NCT02018861|455324023|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
126554168|NCT02018861|455324014|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
126554169|NCT02018861|455324015|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
126554170|NCT02018861|455324016|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
126717812|NCT05761444|455917637|FG001|Overall Study|Withdrawal by Subject|2|||
126717813|NCT05761444|455917636|FG000|Overall Study|Other|1|||
126717814|NCT05761444|455917637|FG001|Overall Study|Other|0|||
126717815|NCT04716933|455917638|FG000|Overall Study|Sponsor Decision|36|||
126389464|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
126389465|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
126389466|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
126389467|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
126389468|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
126389469|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
126389470|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
126389471|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
126389472|NCT01866111|454717509|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
126389473|NCT01866111|454717510|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
126389474|NCT01866111|454717511|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
126389475|NCT01866111|454717512|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
126389476|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
126389477|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
126389478|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
126389479|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
126389480|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
126389481|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
126389482|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
126389483|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
126389484|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
126389485|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
126389486|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
126389487|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
126389488|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
126389489|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
126389490|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
126389491|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
126389492|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Death|1|||
126389493|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Death|1|||
126389494|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Death|3|||
126389495|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Death|2|||
126389496|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
126389497|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
126389498|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
126389499|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
126389500|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
126389501|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
126389502|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
126389503|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
126554171|NCT02018861|455324017|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
126717816|NCT04716933|455917639|FG001|Overall Study|Sponsor Decision|33|||
126717817|NCT04716933|455917638|FG000|Overall Study|Death|65|||
126389504|NCT01866111|454717509|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
126389505|NCT01866111|454717510|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
126389506|NCT01866111|454717511|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
126389507|NCT01866111|454717512|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
126389508|NCT04576455|454717514|FG000|Overall Study|Ongoing in the Study|48|||
126389509|NCT04576455|454717515|FG001|Overall Study|Ongoing in the Study|58|||
126389510|NCT04576455|454717514|FG000|Overall Study|Death|83|||
126389511|NCT04576455|454717515|FG001|Overall Study|Death|77|||
126389512|NCT04576455|454717514|FG000|Overall Study|Lost to Follow-up|4|||
126389513|NCT04576455|454717515|FG001|Overall Study|Lost to Follow-up|5|||
126389514|NCT04576455|454717514|FG000|Overall Study|Withdrawal by Subject|16|||
126389515|NCT04576455|454717515|FG001|Overall Study|Withdrawal by Subject|12|||
126389516|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
126389517|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126389518|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126389519|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126389520|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126389521|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
126389522|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
126389523|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
126389524|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126389525|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126389526|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126389527|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
126554172|NCT02018861|455324018|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
126554173|NCT02018861|455324019|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
126389528|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
126389529|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
126389530|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
126389531|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
126389532|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
126389533|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
126389534|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
126389535|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
126389536|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126389537|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126389538|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126389539|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
126389540|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
126389541|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
126389542|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
126389543|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
126389544|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
126389545|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
126389546|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
126389547|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
126389548|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
126389549|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
126389550|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
126389551|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
126389552|NCT03989349|454717516|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
126389553|NCT03989349|454717517|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
126389554|NCT03989349|454717518|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
126389555|NCT03989349|454717519|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
126389556|NCT03989349|454717520|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
126389557|NCT03989349|454717521|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
126389558|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126389559|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126389560|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
126389561|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
126717818|NCT04716933|455917639|FG001|Overall Study|Death|67|||
126717819|NCT01106534|455917642|FG000|Overall Study|Withdrawal by Subject|18|||
126717820|NCT01106534|455917642|FG000|Overall Study|Lost to Follow-up|2|||
126717821|NCT01106534|455917642|FG000|Overall Study|Death|16|||
126717822|NCT01106534|455917642|FG000|Overall Study|Physician Decision|1|||
126717823|NCT04488822|455917643|FG000|Overall Study|Adverse Event|8|||
126717824|NCT04488822|455917643|FG000|Overall Study|Withdrawal by Subject|1|||
126771221|NCT01678924|456117702|FG000|Overall Study|Unable to attend scheduled visits|0|||
126771222|NCT01678924|456117703|FG001|Overall Study|Unable to attend scheduled visits|0|||
126771223|NCT01678924|456117704|FG002|Overall Study|Unable to attend scheduled visits|0|||
126771224|NCT01678924|456117705|FG003|Overall Study|Unable to attend scheduled visits|1|||
126389562|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
126389563|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
126389564|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126389565|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126389566|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
126389567|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
126389568|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
126389569|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
126389570|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
126389571|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
126389572|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
126389573|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
126389574|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
126389575|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
126389576|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126389577|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126389578|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
126389579|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126389580|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
126389581|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126389582|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
126389583|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
126389584|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
126389585|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
126389586|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
126389587|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
126389588|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
126389589|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
126389590|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
126389591|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
126389592|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
126389593|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
126389594|NCT03989349|454717516|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
126389595|NCT03989349|454717517|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
126389596|NCT03989349|454717518|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
126389597|NCT03989349|454717519|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
126389598|NCT03989349|454717520|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
126389599|NCT03989349|454717521|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
126389600|NCT01352221|454717522|FG000|Double-blind Phase|Adverse Event|6|||
126389601|NCT01352221|454717523|FG001|Double-blind Phase|Adverse Event|4|||
126389602|NCT01352221|454717524|FG002|Double-blind Phase|Adverse Event|0|||
126389603|NCT01352221|454717525|FG003|Double-blind Phase|Adverse Event|0|||
126389604|NCT01352221|454717522|FG000|Double-blind Phase|Withdrawal by Subject|3|||
126389605|NCT01352221|454717523|FG001|Double-blind Phase|Withdrawal by Subject|5|||
126389606|NCT01352221|454717524|FG002|Double-blind Phase|Withdrawal by Subject|0|||
126389607|NCT01352221|454717525|FG003|Double-blind Phase|Withdrawal by Subject|0|||
126389608|NCT01352221|454717522|FG000|Double-blind Phase|Lost to Follow-up|0|||
126389609|NCT01352221|454717523|FG001|Double-blind Phase|Lost to Follow-up|1|||
126389610|NCT01352221|454717524|FG002|Double-blind Phase|Lost to Follow-up|0|||
126389611|NCT01352221|454717525|FG003|Double-blind Phase|Lost to Follow-up|0|||
126389612|NCT01352221|454717522|FG000|Double-blind Phase|Protocol Violation|0|||
126389613|NCT01352221|454717523|FG001|Double-blind Phase|Protocol Violation|1|||
126389614|NCT01352221|454717524|FG002|Double-blind Phase|Protocol Violation|0|||
126389615|NCT01352221|454717525|FG003|Double-blind Phase|Protocol Violation|0|||
126389616|NCT01352221|454717522|FG000|Open-label Phase|Physician Decision|0|||
126389617|NCT01352221|454717523|FG001|Open-label Phase|Physician Decision|0|||
126389618|NCT01352221|454717524|FG002|Open-label Phase|Physician Decision|2|||
126389619|NCT01352221|454717525|FG003|Open-label Phase|Physician Decision|1|||
126389620|NCT01352221|454717522|FG000|Open-label Phase|Pregnancy|0|||
126389621|NCT01352221|454717523|FG001|Open-label Phase|Pregnancy|0|||
126389622|NCT01352221|454717524|FG002|Open-label Phase|Pregnancy|1|||
126389623|NCT01352221|454717525|FG003|Open-label Phase|Pregnancy|0|||
126389624|NCT01352221|454717522|FG000|Open-label Phase|Adverse Event|0|||
126389625|NCT01352221|454717523|FG001|Open-label Phase|Adverse Event|0|||
126389626|NCT01352221|454717524|FG002|Open-label Phase|Adverse Event|8|||
126771225|NCT00640614|456117709|FG000|Overall Study|Lost to Follow-up|1|||
126771226|NCT00640614|456117710|FG001|Overall Study|Lost to Follow-up|0|||
126771227|NCT00529802|456117711|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
126771228|NCT00529802|456117711|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
126771229|NCT00529802|456117711|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
126771230|NCT00529802|456117711|FG000|Evaluable for Primary Endpoint|Death|1|||
126771231|NCT00529802|456117711|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
126771232|NCT00529802|456117711|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
126389627|NCT01352221|454717525|FG003|Open-label Phase|Adverse Event|4|||
126389628|NCT01352221|454717522|FG000|Open-label Phase|Withdrawal by Subject|0|||
126389629|NCT01352221|454717523|FG001|Open-label Phase|Withdrawal by Subject|0|||
126389630|NCT01352221|454717524|FG002|Open-label Phase|Withdrawal by Subject|1|||
126389631|NCT01352221|454717525|FG003|Open-label Phase|Withdrawal by Subject|6|||
126389632|NCT01352221|454717522|FG000|Open-label Phase|Worsening of IBD|0|||
126389633|NCT01352221|454717523|FG001|Open-label Phase|Worsening of IBD|0|||
126389634|NCT01352221|454717524|FG002|Open-label Phase|Worsening of IBD|1|||
126389635|NCT01352221|454717525|FG003|Open-label Phase|Worsening of IBD|0|||
126389636|NCT02016716|454717526|FG000|Overall Study|Withdrawal by Subject|5|||
126389637|NCT02016716|454717527|FG001|Overall Study|Withdrawal by Subject|5|||
126389638|NCT02016716|454717528|FG002|Overall Study|Withdrawal by Subject|5|||
126389639|NCT02016716|454717526|FG000|Overall Study|Protocol-specified Criteria|0|||
126389640|NCT02016716|454717527|FG001|Overall Study|Protocol-specified Criteria|1|||
126389641|NCT02016716|454717528|FG002|Overall Study|Protocol-specified Criteria|0|||
126771233|NCT00529802|456117711|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
126389642|NCT02016716|454717526|FG000|Overall Study|Lost to Follow-up|1|||
126389643|NCT02016716|454717527|FG001|Overall Study|Lost to Follow-up|2|||
126389644|NCT02016716|454717528|FG002|Overall Study|Lost to Follow-up|1|||
126389645|NCT02248649|454717529|FG000|Overall Study|Death|7|||
126389646|NCT02248649|454717530|FG001|Overall Study|Death|11|||
126389647|NCT02248649|454717529|FG000|Overall Study|Lost to Follow-up|14|||
126389648|NCT02248649|454717530|FG001|Overall Study|Lost to Follow-up|10|||
126389649|NCT01439971|454717531|FG000|Overall Study|Required number in cohort dosed|0|||
126389650|NCT01439971|454717532|FG001|Overall Study|Required number in cohort dosed|1|||
126389651|NCT01439971|454717533|FG002|Overall Study|Required number in cohort dosed|2|||
126389652|NCT01439971|454717534|FG003|Overall Study|Required number in cohort dosed|0|||
126389653|NCT01439971|454717535|FG004|Overall Study|Required number in cohort dosed|1|||
126389654|NCT02628600|454717539|FG000|Overall Study|Death|2|||
126389655|NCT02628600|454717540|FG001|Overall Study|Death|1|||
126389656|NCT02628600|454717539|FG000|Overall Study|Adverse Event|3|||
126389657|NCT02628600|454717540|FG001|Overall Study|Adverse Event|20|||
126389658|NCT02628600|454717539|FG000|Overall Study|Protocol Violation|0|||
126389659|NCT02628600|454717540|FG001|Overall Study|Protocol Violation|1|||
126389660|NCT02628600|454717539|FG000|Overall Study|Lack of Efficacy|2|||
126389661|NCT02628600|454717540|FG001|Overall Study|Lack of Efficacy|0|||
126389662|NCT02628600|454717539|FG000|Overall Study|Withdrawal by Subject|13|||
126389663|NCT02628600|454717540|FG001|Overall Study|Withdrawal by Subject|8|||
126389664|NCT02628600|454717539|FG000|Overall Study|Lost to Follow-up|1|||
126389665|NCT02628600|454717540|FG001|Overall Study|Lost to Follow-up|0|||
126389666|NCT02628600|454717539|FG000|Overall Study|Physician Decision|2|||
126389667|NCT02628600|454717540|FG001|Overall Study|Physician Decision|2|||
126389668|NCT02628600|454717539|FG000|Overall Study|Other not specified|1|||
126389669|NCT02628600|454717540|FG001|Overall Study|Other not specified|0|||
126389670|NCT01221623|454717545|FG000|Overall Study|Withdrawal by Subject|19|||
126389671|NCT01221623|454717546|FG001|Overall Study|Withdrawal by Subject|8|||
126389672|NCT01221623|454717545|FG000|Overall Study|Lost to Follow-up|7|||
126389673|NCT01221623|454717546|FG001|Overall Study|Lost to Follow-up|1|||
126389674|NCT01221623|454717545|FG000|Overall Study|Adverse Event|6|||
126389675|NCT01221623|454717546|FG001|Overall Study|Adverse Event|3|||
126389676|NCT01221623|454717545|FG000|Overall Study|Death|1|||
126389677|NCT01221623|454717546|FG001|Overall Study|Death|0|||
126389678|NCT01221623|454717545|FG000|Overall Study|Other|5|||
126389679|NCT01221623|454717546|FG001|Overall Study|Other|2|||
126389680|NCT00661726|454717547|FG000|Overall Study|Adverse Event|1|||
126389681|NCT00875485|454720473|FG000|Challenge Dose Epoch|Pregnancy|1|||
126389682|NCT00875485|454720474|FG001|Challenge Dose Epoch|Pregnancy|0|||
126389683|NCT01271010|454720475|FG000|Overall Study|Reason not specified|11|||
126389684|NCT01271010|454720475|FG000|Overall Study|Start of new CLL therapy|1|||
126389685|NCT01271010|454720475|FG000|Overall Study|Protocol Violation|1|||
126389686|NCT01271010|454720475|FG000|Overall Study|Death|2|||
126389687|NCT01271010|454720475|FG000|Overall Study|Progression and relapse of disease|1|||
126389688|NCT01271010|454720475|FG000|Overall Study|Withdrawal by Subject|18|||
126389689|NCT01271010|454720475|FG000|Overall Study|Disease progression|27|||
126771234|NCT01336608|456117712|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
126389690|NCT01631747|454720476|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
126389691|NCT01631747|454720477|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
126389692|NCT01631747|454720476|FG000|Live Birth|Pregnancy Termination|1|||
126389693|NCT01631747|454720477|FG001|Live Birth|Pregnancy Termination|0|||
126389694|NCT01631747|454720476|FG000|Live Birth|MIscarriage|2|||
126389695|NCT01631747|454720477|FG001|Live Birth|MIscarriage|0|||
126389696|NCT01631747|454720476|FG000|Live Birth|Stillbirth|1|||
126389697|NCT01631747|454720477|FG001|Live Birth|Stillbirth|1|||
126389698|NCT01631747|454720476|FG000|One Year Infant Outcomes|Patient Refused|13|||
126389699|NCT01631747|454720477|FG001|One Year Infant Outcomes|Patient Refused|9|||
126389700|NCT02908685|454720478|FG000|Part 1 OLE|Withdrawal by Subject|0|||
126389701|NCT02908685|454720479|FG001|Part 1 OLE|Withdrawal by Subject|0|||
126389702|NCT02908685|454720480|FG002|Part 1 OLE|Withdrawal by Subject|0|||
126389703|NCT02908685|454720481|FG003|Part 1 OLE|Withdrawal by Subject|0|||
126389704|NCT02908685|454720482|FG004|Part 1 OLE|Withdrawal by Subject|0|||
126389705|NCT02908685|454720483|FG005|Part 1 OLE|Withdrawal by Subject|0|||
126389706|NCT02908685|454720484|FG006|Part 1 OLE|Withdrawal by Subject|0|||
126389707|NCT02908685|454720485|FG007|Part 1 OLE|Withdrawal by Subject|0|||
126389708|NCT02908685|454720486|FG008|Part 1 OLE|Withdrawal by Subject|0|||
126389709|NCT02908685|454720487|FG009|Part 1 OLE|Withdrawal by Subject|0|||
126389710|NCT02908685|454720488|FG010|Part 1 OLE|Withdrawal by Subject|2|||
126389711|NCT02908685|454720489|FG011|Part 1 OLE|Withdrawal by Subject|1|||
126389712|NCT02908685|454720490|FG012|Part 1 OLE|Withdrawal by Subject|0|||
126389713|NCT02908685|454720491|FG013|Part 1 OLE|Withdrawal by Subject|0|||
126389714|NCT02908685|454720478|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389715|NCT02908685|454720479|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389716|NCT02908685|454720480|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389717|NCT02908685|454720481|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389718|NCT02908685|454720482|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389719|NCT02908685|454720483|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389720|NCT02908685|454720484|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389721|NCT02908685|454720485|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389722|NCT02908685|454720486|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389723|NCT02908685|454720487|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389724|NCT02908685|454720488|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389725|NCT02908685|454720489|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
126389726|NCT02908685|454720490|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
126389727|NCT02908685|454720491|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
126389728|NCT02908685|454720478|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389729|NCT02908685|454720479|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389730|NCT02908685|454720480|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389731|NCT02908685|454720481|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389732|NCT02908685|454720482|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389733|NCT02908685|454720483|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389734|NCT02908685|454720484|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389735|NCT02908685|454720485|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389736|NCT02908685|454720486|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389737|NCT02908685|454720487|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389738|NCT02908685|454720488|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389739|NCT02908685|454720489|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389740|NCT02908685|454720490|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
126389741|NCT02908685|454720491|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
126389742|NCT02908685|454720478|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389743|NCT02908685|454720479|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389744|NCT02908685|454720480|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389745|NCT02908685|454720481|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389746|NCT02908685|454720482|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389747|NCT02908685|454720483|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389748|NCT02908685|454720484|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389749|NCT02908685|454720485|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389750|NCT02908685|454720486|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389751|NCT02908685|454720487|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389752|NCT02908685|454720488|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389753|NCT02908685|454720489|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389754|NCT02908685|454720490|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
126389755|NCT02908685|454720491|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
126389756|NCT02908685|454720478|FG000|Part 2 OLE: > Month 24|Death|0|||
126389757|NCT02908685|454720479|FG001|Part 2 OLE: > Month 24|Death|0|||
126389758|NCT02908685|454720480|FG002|Part 2 OLE: > Month 24|Death|0|||
126717825|NCT03838367|455917644|FG000|Overall Study|Early termination of study|3|||
126389759|NCT02908685|454720481|FG003|Part 2 OLE: > Month 24|Death|0|||
126389760|NCT02908685|454720482|FG004|Part 2 OLE: > Month 24|Death|0|||
126389761|NCT02908685|454720483|FG005|Part 2 OLE: > Month 24|Death|0|||
126389762|NCT02908685|454720484|FG006|Part 2 OLE: > Month 24|Death|0|||
126389763|NCT02908685|454720485|FG007|Part 2 OLE: > Month 24|Death|0|||
126389764|NCT02908685|454720486|FG008|Part 2 OLE: > Month 24|Death|0|||
126389765|NCT02908685|454720487|FG009|Part 2 OLE: > Month 24|Death|0|||
126389766|NCT02908685|454720488|FG010|Part 2 OLE: > Month 24|Death|0|||
126389767|NCT02908685|454720489|FG011|Part 2 OLE: > Month 24|Death|0|||
126389768|NCT02908685|454720490|FG012|Part 2 OLE: > Month 24|Death|1|||
126389769|NCT02908685|454720491|FG013|Part 2 OLE: > Month 24|Death|0|||
126389770|NCT02908685|454720478|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
126389771|NCT02908685|454720479|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
126389772|NCT02908685|454720480|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
126389773|NCT02908685|454720481|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
126389774|NCT02908685|454720482|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
126389775|NCT02908685|454720483|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
126389776|NCT02908685|454720484|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
126389777|NCT02908685|454720485|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
126389778|NCT02908685|454720486|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
126389779|NCT02908685|454720487|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
126389780|NCT02908685|454720488|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
126389781|NCT02908685|454720489|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
126389782|NCT02908685|454720490|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
126389783|NCT02908685|454720491|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
126389784|NCT02908685|454720478|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389785|NCT02908685|454720479|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389786|NCT02908685|454720480|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389787|NCT02908685|454720481|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389788|NCT02908685|454720482|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389789|NCT02908685|454720483|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389790|NCT02908685|454720484|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389791|NCT02908685|454720485|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389792|NCT02908685|454720486|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389793|NCT02908685|454720487|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389794|NCT02908685|454720488|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389795|NCT02908685|454720489|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
126389796|NCT02908685|454720490|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
126389797|NCT02908685|454720491|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
126389798|NCT02370537|454720494|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
126389799|NCT02370537|454720495|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
126389800|NCT02370537|454720496|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
126389801|NCT02370537|454720494|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
126389802|NCT02370537|454720495|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
126389803|NCT02370537|454720496|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
126389804|NCT02370537|454720494|FG000|Part B|Not randomised to receive treatment|1|||
126389805|NCT02370537|454720495|FG001|Part B|Not randomised to receive treatment|2|||
126389806|NCT02370537|454720496|FG002|Part B|Not randomised to receive treatment|259|||
126389807|NCT02370537|454720494|FG000|Part B|Withdrawal by Subject|0|||
126389808|NCT02370537|454720495|FG001|Part B|Withdrawal by Subject|1|||
126389809|NCT02370537|454720496|FG002|Part B|Withdrawal by Subject|0|||
126389810|NCT01691014|454720497|FG000|Overall Study|Premature Termination|1|||
126389811|NCT01691014|454720498|FG001|Overall Study|Premature Termination|6|||
126389812|NCT01691014|454720499|FG002|Overall Study|Premature Termination|0|||
126389813|NCT01691014|454720500|FG003|Overall Study|Premature Termination|3|||
126389814|NCT01691014|454720497|FG000|Overall Study|Other|0|||
126389815|NCT01691014|454720498|FG001|Overall Study|Other|0|||
126389816|NCT01691014|454720499|FG002|Overall Study|Other|2|||
126389817|NCT01691014|454720500|FG003|Overall Study|Other|0|||
126389818|NCT01691014|454720497|FG000|Overall Study|Withdrawal by Subject|0|||
126389819|NCT01691014|454720498|FG001|Overall Study|Withdrawal by Subject|1|||
126389820|NCT01691014|454720499|FG002|Overall Study|Withdrawal by Subject|1|||
126389821|NCT01691014|454720500|FG003|Overall Study|Withdrawal by Subject|1|||
126389822|NCT01691014|454720497|FG000|Overall Study|Adverse Event|0|||
126389823|NCT01691014|454720498|FG001|Overall Study|Adverse Event|5|||
126389824|NCT01691014|454720499|FG002|Overall Study|Adverse Event|1|||
126389825|NCT01691014|454720500|FG003|Overall Study|Adverse Event|1|||
126389826|NCT01691014|454720497|FG000|Overall Study|Lack of Efficacy|2|||
126389827|NCT01691014|454720498|FG001|Overall Study|Lack of Efficacy|3|||
126389828|NCT01691014|454720499|FG002|Overall Study|Lack of Efficacy|7|||
126389829|NCT01691014|454720500|FG003|Overall Study|Lack of Efficacy|0|||
126389830|NCT03100539|454720507|FG000|Overall Study|Lost to Follow-up|60|||
126389831|NCT03100539|454720508|FG001|Overall Study|Lost to Follow-up|54|||
126389832|NCT03100539|454720509|FG002|Overall Study|Lost to Follow-up|17|||
126389833|NCT03100539|454720507|FG000|Overall Study|Uncollected|8|||
126389834|NCT03100539|454720508|FG001|Overall Study|Uncollected|8|||
126389835|NCT03100539|454720509|FG002|Overall Study|Uncollected|0|||
126717826|NCT03838367|455917645|FG001|Overall Study|Early termination of study|4|||
126389836|NCT03100539|454720507|FG000|Overall Study|Ally Health|0|||
126389837|NCT03100539|454720508|FG001|Overall Study|Ally Health|0|||
126389838|NCT03100539|454720509|FG002|Overall Study|Ally Health|3|||
126389839|NCT03100539|454720507|FG000|Overall Study|Disinterest|0|||
126389840|NCT03100539|454720508|FG001|Overall Study|Disinterest|0|||
126389841|NCT03100539|454720509|FG002|Overall Study|Disinterest|22|||
126389842|NCT03100539|454720507|FG000|Overall Study|Veteran Health|0|||
126389843|NCT03100539|454720508|FG001|Overall Study|Veteran Health|0|||
126389844|NCT03100539|454720509|FG002|Overall Study|Veteran Health|8|||
126389845|NCT03100539|454720507|FG000|Overall Study|Moved|0|||
126389846|NCT03100539|454720508|FG001|Overall Study|Moved|0|||
126389847|NCT03100539|454720509|FG002|Overall Study|Moved|1|||
126389848|NCT03100539|454720507|FG000|Overall Study|Scheduling Conflicts|0|||
126389849|NCT03100539|454720508|FG001|Overall Study|Scheduling Conflicts|0|||
126389850|NCT03100539|454720509|FG002|Overall Study|Scheduling Conflicts|12|||
126389851|NCT05897242|454720510|FG000|Overall Study|Lost to Follow-up|6|||
126389852|NCT05897242|454720511|FG001|Overall Study|Lost to Follow-up|1|||
126389853|NCT05897242|454720510|FG000|Overall Study|Incomplete|1|||
126389854|NCT05897242|454720511|FG001|Overall Study|Incomplete|0|||
126389855|NCT05897242|454720510|FG000|Overall Study|Withdrawal by Subject|1|||
126389856|NCT05897242|454720511|FG001|Overall Study|Withdrawal by Subject|0|||
126389857|NCT00809835|454720512|FG000|Overall Study|Lost to Follow-up|7|||
126389858|NCT00809835|454720513|FG001|Overall Study|Lost to Follow-up|6|||
126554174|NCT02018861|455324020|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
126389859|NCT00809835|454720514|FG002|Overall Study|Lost to Follow-up|10|||
126389860|NCT00809835|454720515|FG003|Overall Study|Lost to Follow-up|2|||
126389861|NCT00809835|454720512|FG000|Overall Study|Withdrawal by Subject|1|||
126389862|NCT00809835|454720513|FG001|Overall Study|Withdrawal by Subject|1|||
126389863|NCT00809835|454720514|FG002|Overall Study|Withdrawal by Subject|1|||
126389864|NCT00809835|454720515|FG003|Overall Study|Withdrawal by Subject|0|||
126389865|NCT00066703|454720516|FG000|Overall Study|Adverse Event|80|||
126389866|NCT00066703|454720517|FG001|Overall Study|Adverse Event|111|||
126389867|NCT00066703|454720516|FG000|Overall Study|Death|3|||
126389868|NCT00066703|454720517|FG001|Overall Study|Death|0|||
126389869|NCT00066703|454720516|FG000|Overall Study|Lack of Efficacy|114|||
126389870|NCT00066703|454720517|FG001|Overall Study|Lack of Efficacy|69|||
126389871|NCT00066703|454720516|FG000|Overall Study|Lost to Follow-up|31|||
126389872|NCT00066703|454720517|FG001|Overall Study|Lost to Follow-up|28|||
126389873|NCT00066703|454720516|FG000|Overall Study|Withdrawal by Subject|38|||
126389874|NCT00066703|454720517|FG001|Overall Study|Withdrawal by Subject|63|||
126389875|NCT00066703|454720516|FG000|Overall Study|Treatment ongoing|346|||
126389876|NCT00066703|454720517|FG001|Overall Study|Treatment ongoing|311|||
126389877|NCT01696968|454720518|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
126389878|NCT01696968|454720519|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
126389879|NCT01696968|454720518|FG000|Overall Study|Died Before Randomization|3|||
126389880|NCT01696968|454720519|FG001|Overall Study|Died Before Randomization|8|||
126389881|NCT01696968|454720518|FG000|Overall Study|Died Before ASU (Control)|278|||
126389882|NCT01696968|454720519|FG001|Overall Study|Died Before ASU (Control)|0|||
126389883|NCT01696968|454720518|FG000|Overall Study|Refused ASU (Control)|920|||
126389884|NCT01696968|454720519|FG001|Overall Study|Refused ASU (Control)|0|||
126389885|NCT01696968|454720518|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
126389886|NCT01696968|454720519|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
126389887|NCT05659719|454720520|FG000|Overall Study|At sponsor's request|0|||
126389888|NCT05659719|454720521|FG001|Overall Study|At sponsor's request|0|||
126389889|NCT05659719|454720522|FG002|Overall Study|At sponsor's request|0|||
126389890|NCT05659719|454720523|FG003|Overall Study|At sponsor's request|95|||
126389891|NCT05659719|454720520|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
126389892|NCT05659719|454720521|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
126389893|NCT05659719|454720522|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
126389894|NCT05659719|454720523|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
126389895|NCT05659719|454720520|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
126389896|NCT05659719|454720521|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
126389897|NCT05659719|454720522|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
126389898|NCT05659719|454720523|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
126389899|NCT05659719|454720520|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
126389900|NCT05659719|454720521|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
126389901|NCT05659719|454720522|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
126389902|NCT05659719|454720523|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
126389903|NCT05659719|454720520|FG000|Overall Study|Lost to Follow-up|0|||
126389904|NCT05659719|454720521|FG001|Overall Study|Lost to Follow-up|0|||
126389905|NCT05659719|454720522|FG002|Overall Study|Lost to Follow-up|0|||
126389906|NCT05659719|454720523|FG003|Overall Study|Lost to Follow-up|2|||
126389907|NCT05659719|454720520|FG000|Overall Study|Moved to another observational study|0|||
126389908|NCT05659719|454720521|FG001|Overall Study|Moved to another observational study|0|||
126717827|NCT03838367|455917646|FG002|Overall Study|Early termination of study|3|||
126717828|NCT03838367|455917647|FG003|Overall Study|Early termination of study|0|||
126389909|NCT05659719|454720522|FG002|Overall Study|Moved to another observational study|0|||
126389910|NCT05659719|454720523|FG003|Overall Study|Moved to another observational study|1|||
126389911|NCT05659719|454720520|FG000|Overall Study|The child was enrolled in an interventional study|0|||
126717829|NCT03406104|455917648|FG000|Overall Study|Lost to Follow-up|2|||
126717830|NCT03406104|455917648|FG000|Overall Study|Withdrawal by Subject|2|||
126717831|NCT03406104|455917648|FG000|Overall Study|due to Covid patient did not want to travel|1|||
126717832|NCT03406104|455917648|FG000|Overall Study|Death|2|||
126717833|NCT02499146|455917657|FG000|Overall Study|Lost to Follow-up|1|||
126717834|NCT02499146|455917657|FG000|Overall Study|Withdrawal by Subject|1|||
126717835|NCT02499146|455917657|FG000|Overall Study|Other|2|||
126717836|NCT02499146|455917657|FG000|Overall Study|Ongoing at date of cut-off|9|||
126717837|NCT02499146|455917657|FG000|Overall Study|Began other treatment/therapy|13|||
126717838|NCT05692154|455917658|FG000|Overall Study|Adverse Event|0|||
126717839|NCT05692154|455917659|FG001|Overall Study|Adverse Event|1|||
126717840|NCT01879618|455917660|FG000|Overall Study|Does not meet entrance criteria|1|||
126717841|NCT01879618|455917660|FG000|Overall Study|Withdrawal by Subject|1|||
126717842|NCT01879618|455917660|FG000|Overall Study|Surgery;changed schedule; not available|8|||
126717843|NCT01879618|455917660|FG000|Overall Study|Protocol Violation|6|||
126717844|NCT01879618|455917660|FG000|Overall Study|Adverse Event|5|||
126717845|NCT01519245|455917661|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
126717846|NCT01519245|455917662|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
126717847|NCT02275026|455917663|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
126717848|NCT02275026|455917663|FG000|Overall Study|Withdrawal by Subject|4|||
126717849|NCT02275026|455917663|FG000|Overall Study|Ineligible due to medical history|13|||
126717850|NCT02275026|455917663|FG000|Overall Study|MRI malfunction precluded testing|1|||
126717851|NCT02275026|455917663|FG000|Overall Study|Ineligible after MRI findings|1|||
126717852|NCT02275026|455917663|FG000|Overall Study|Lost to Follow-up|2|||
126717853|NCT02275026|455917663|FG000|Overall Study|Scanner failure|1|||
126717854|NCT00001262|455917666|FG000|Overall Study|Death|10|||
126717855|NCT00001262|455917667|FG001|Overall Study|Death|11|||
126717856|NCT00001262|455917668|FG002|Overall Study|Death|0|||
126717857|NCT00001262|455917666|FG000|Overall Study|Withdrawal by Subject|0|||
126717858|NCT00001262|455917667|FG001|Overall Study|Withdrawal by Subject|3|||
126717859|NCT00001262|455917668|FG002|Overall Study|Withdrawal by Subject|0|||
126717860|NCT01954121|455917669|FG000|Overall Study|Lack of Efficacy|94|||
126717861|NCT01954121|455917670|FG001|Overall Study|Lack of Efficacy|41|||
126717862|NCT01954121|455917669|FG000|Overall Study|Protocol Violation|0|||
126717863|NCT01954121|455917670|FG001|Overall Study|Protocol Violation|2|||
126717864|NCT01954121|455917669|FG000|Overall Study|Lost to Follow-up|5|||
126717865|NCT01954121|455917670|FG001|Overall Study|Lost to Follow-up|6|||
126717866|NCT01954121|455917669|FG000|Overall Study|Withdrawal by Subject|18|||
126389912|NCT05659719|454720521|FG001|Overall Study|The child was enrolled in an interventional study|0|||
126389913|NCT05659719|454720522|FG002|Overall Study|The child was enrolled in an interventional study|0|||
126389914|NCT05659719|454720523|FG003|Overall Study|The child was enrolled in an interventional study|55|||
126389915|NCT05659719|454720520|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
126389916|NCT05659719|454720521|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
126389917|NCT05659719|454720522|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
126389918|NCT05659719|454720523|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
126389919|NCT05659719|454720520|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
126468457|NCT02607930|455017603|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
126468458|NCT02607930|455017600|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
126468459|NCT02607930|455017601|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
126468460|NCT02607930|455017602|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
126468461|NCT02607930|455017603|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
126468462|NCT02607930|455017600|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
126468463|NCT02607930|455017601|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
126468464|NCT02607930|455017602|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
126468465|NCT02607930|455017603|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
126468466|NCT00566501|455017604|FG000|Overall Study|Adverse Event|68|||
126468467|NCT00566501|455017605|FG001|Overall Study|Adverse Event|59|||
126468468|NCT00566501|455017604|FG000|Overall Study|Medication Non-compliance|5|||
126468469|NCT00566501|455017605|FG001|Overall Study|Medication Non-compliance|0|||
126468470|NCT00566501|455017604|FG000|Overall Study|Protocol Violation|2|||
126468471|NCT00566501|455017605|FG001|Overall Study|Protocol Violation|2|||
126468472|NCT00566501|455017604|FG000|Overall Study|Request of Investigator or Sponsor|6|||
126468473|NCT00566501|455017605|FG001|Overall Study|Request of Investigator or Sponsor|7|||
126468474|NCT00566501|455017604|FG000|Overall Study|Withdrawal by Subject|33|||
126468475|NCT00566501|455017605|FG001|Overall Study|Withdrawal by Subject|30|||
126468476|NCT00566501|455017604|FG000|Overall Study|Lack of Efficacy|8|||
126554175|NCT02018861|455324021|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
126554176|NCT02018861|455324022|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
126554177|NCT02018861|455324023|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
126554178|NCT02018861|455324014|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
126554179|NCT02018861|455324015|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
126554180|NCT02018861|455324016|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
126554181|NCT02018861|455324017|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
126554182|NCT02018861|455324018|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
126554183|NCT02018861|455324019|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
126554184|NCT02018861|455324020|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
126554185|NCT02018861|455324021|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
126554186|NCT02018861|455324022|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
126554187|NCT02018861|455324023|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
126554188|NCT02018861|455324014|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
126554189|NCT02018861|455324015|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
126554190|NCT02018861|455324016|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
126554191|NCT02018861|455324017|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
126554192|NCT02018861|455324018|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
126554193|NCT02018861|455324019|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
126554194|NCT02018861|455324020|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
126554195|NCT02018861|455324021|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
126554196|NCT02018861|455324022|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
126554197|NCT02018861|455324023|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
126554198|NCT02018861|455324014|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
126554199|NCT02018861|455324015|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
126554200|NCT02018861|455324016|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
126554201|NCT02018861|455324017|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
126554202|NCT02018861|455324018|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
126554203|NCT02018861|455324019|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
126554204|NCT02018861|455324020|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
126554205|NCT02018861|455324021|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
126554206|NCT02018861|455324022|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
126554207|NCT02018861|455324023|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
126554208|NCT02018861|455324014|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
126554209|NCT02018861|455324015|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
126717867|NCT01954121|455917670|FG001|Overall Study|Withdrawal by Subject|12|||
126717868|NCT01954121|455917669|FG000|Overall Study|Pregnancy|1|||
126717869|NCT01954121|455917670|FG001|Overall Study|Pregnancy|1|||
126717870|NCT01954121|455917669|FG000|Overall Study|AE, serious fatal|1|||
126717871|NCT01954121|455917670|FG001|Overall Study|AE, serious fatal|0|||
126717872|NCT01954121|455917669|FG000|Overall Study|AE, non-serious non-fatal|5|||
126717873|NCT01954121|455917670|FG001|Overall Study|AE, non-serious non-fatal|22|||
126717874|NCT01954121|455917669|FG000|Overall Study|SAE, non-fatal|1|||
126717875|NCT01954121|455917670|FG001|Overall Study|SAE, non-fatal|4|||
126717876|NCT01954121|455917669|FG000|Overall Study|Non-compliant with study procedures|1|||
126717877|NCT01954121|455917670|FG001|Overall Study|Non-compliant with study procedures|0|||
126717878|NCT01954121|455917669|FG000|Overall Study|Non-compliant patient|1|||
126717879|NCT01954121|455917670|FG001|Overall Study|Non-compliant patient|1|||
126717880|NCT01954121|455917669|FG000|Overall Study|Subject did not follow instructions|0|||
126717881|NCT01954121|455917670|FG001|Overall Study|Subject did not follow instructions|2|||
126389920|NCT05659719|454720521|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
126389921|NCT05659719|454720522|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
126717882|NCT03844633|455917671|FG000|1 Week FU|Lost to Follow-up|0|||
126717883|NCT03844633|455917672|FG001|1 Week FU|Lost to Follow-up|1|||
126717884|NCT03844633|455917673|FG002|1 Week FU|Lost to Follow-up|4|||
126389922|NCT05659719|454720523|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
126389923|NCT01681186|454720524|FG000|Washout Period From Second Intervention|Adverse Event|0|||
126389924|NCT01681186|454720525|FG001|Washout Period From Second Intervention|Adverse Event|0|||
126389925|NCT01681186|454720526|FG002|Washout Period From Second Intervention|Adverse Event|0|||
126389926|NCT01681186|454720527|FG003|Washout Period From Second Intervention|Adverse Event|0|||
126389927|NCT01681186|454720528|FG004|Washout Period From Second Intervention|Adverse Event|0|||
126389928|NCT01681186|454720529|FG005|Washout Period From Second Intervention|Adverse Event|0|||
126389929|NCT01681186|454720530|FG006|Washout Period From Second Intervention|Adverse Event|1|||
126554210|NCT02018861|455324016|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
126717885|NCT03844633|455917671|FG000|12-month Follow-up|Lost to Follow-up|7|||
126771235|NCT01336608|456117713|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126389930|NCT01681186|454720531|FG007|Washout Period From Second Intervention|Adverse Event|0|||
126389931|NCT01681186|454720524|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
126389932|NCT01681186|454720525|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
126389933|NCT01681186|454720526|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
126389934|NCT01681186|454720527|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
126389935|NCT01681186|454720528|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
126389936|NCT01681186|454720529|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
126389937|NCT01681186|454720530|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
126389938|NCT01681186|454720531|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
126389939|NCT01681186|454720524|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389940|NCT01681186|454720525|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389941|NCT01681186|454720526|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389942|NCT01681186|454720527|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389943|NCT01681186|454720528|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389944|NCT01681186|454720529|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389945|NCT01681186|454720530|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
126389946|NCT01681186|454720531|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
126389947|NCT01681186|454720524|FG000|Fourth Intervention|Protocol Violation|0|||
126389948|NCT01681186|454720525|FG001|Fourth Intervention|Protocol Violation|0|||
126389949|NCT01681186|454720526|FG002|Fourth Intervention|Protocol Violation|0|||
126389950|NCT01681186|454720527|FG003|Fourth Intervention|Protocol Violation|0|||
126389951|NCT01681186|454720528|FG004|Fourth Intervention|Protocol Violation|0|||
126389952|NCT01681186|454720529|FG005|Fourth Intervention|Protocol Violation|0|||
126389953|NCT01681186|454720530|FG006|Fourth Intervention|Protocol Violation|0|||
126389954|NCT01681186|454720531|FG007|Fourth Intervention|Protocol Violation|1|||
126389955|NCT05160415|454720532|FG000|Overall Study|Withdrawal by Subject|3|||
126389956|NCT04848220|454720533|FG000|Overall Study|Unable to proceed to study procedure|0|||
126389957|NCT04848220|454720534|FG001|Overall Study|Unable to proceed to study procedure|1|||
126389958|NCT04848220|454720535|FG002|Overall Study|Unable to proceed to study procedure|0|||
126389959|NCT04848220|454720533|FG000|Overall Study|Fractional flow not significant|0|||
126389960|NCT04848220|454720534|FG001|Overall Study|Fractional flow not significant|1|||
126389961|NCT04848220|454720535|FG002|Overall Study|Fractional flow not significant|0|||
126389962|NCT02923830|454720536|FG000|Overall Study|Physician Decision|13|||
126389963|NCT02923830|454720537|FG001|Overall Study|Physician Decision|15|||
126389964|NCT00510718|454720548|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
126389965|NCT00510718|454720549|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
126389966|NCT00510718|454720548|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
126771236|NCT01336608|456117714|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126771237|NCT01336608|456117715|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126771238|NCT01336608|456117712|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
126771239|NCT01336608|456117713|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126771240|NCT01336608|456117714|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126389967|NCT00510718|454720549|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
126389968|NCT00510718|454720548|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
126389969|NCT00510718|454720549|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
126389970|NCT00510718|454720548|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
126389971|NCT00510718|454720549|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
126389972|NCT00510718|454720548|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
126389973|NCT00510718|454720549|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
126389974|NCT00510718|454720548|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
126389975|NCT00510718|454720549|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
126389976|NCT05791565|454720552|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
126389977|NCT05791565|454720553|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
126389978|NCT02388165|454720554|FG000|Overall Study|Study terminated by sponsor|5|||
126389979|NCT02388165|454720555|FG001|Overall Study|Study terminated by sponsor|5|||
126389980|NCT02388165|454720554|FG000|Overall Study|Other|11|||
126389981|NCT02388165|454720555|FG001|Overall Study|Other|13|||
126389982|NCT02388165|454720554|FG000|Overall Study|No longer meet eligibility criteria|40|||
126389983|NCT02388165|454720555|FG001|Overall Study|No longer meet eligibility criteria|43|||
126389984|NCT02388165|454720554|FG000|Overall Study|Withdrawal of consent|31|||
126389985|NCT02388165|454720555|FG001|Overall Study|Withdrawal of consent|32|||
126389986|NCT02388165|454720554|FG000|Overall Study|Lost to Follow-up|19|||
126389987|NCT02388165|454720555|FG001|Overall Study|Lost to Follow-up|20|||
126389988|NCT02388165|454720554|FG000|Overall Study|Death|13|||
126389989|NCT02388165|454720555|FG001|Overall Study|Death|10|||
126389990|NCT02388165|454720554|FG000|Overall Study|Adverse Event|3|||
126389991|NCT02388165|454720555|FG001|Overall Study|Adverse Event|5|||
126389992|NCT02388165|454720554|FG000|Overall Study|Did not meet entrance criteria|5|||
126389993|NCT02388165|454720555|FG001|Overall Study|Did not meet entrance criteria|2|||
126554211|NCT02018861|455324017|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
126554212|NCT02018861|455324018|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
126554213|NCT02018861|455324019|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
126554214|NCT02018861|455324020|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
126554215|NCT02018861|455324021|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
126554216|NCT02018861|455324022|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
126554217|NCT02018861|455324023|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
126554218|NCT02018861|455324014|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
126389994|NCT00880269|454720556|FG000|Overall Study|Protocol Violation|1|||
126389995|NCT00880269|454720557|FG001|Overall Study|Protocol Violation|0|||
126389996|NCT00880269|454720556|FG000|Overall Study|Disease Progression|13|||
126389997|NCT00880269|454720557|FG001|Overall Study|Disease Progression|11|||
126389998|NCT00880269|454720556|FG000|Overall Study|New Cancer Therapy|1|||
126389999|NCT00880269|454720557|FG001|Overall Study|New Cancer Therapy|0|||
126390000|NCT00880269|454720556|FG000|Overall Study|Death|4|||
126390001|NCT00880269|454720557|FG001|Overall Study|Death|2|||
126390002|NCT00880269|454720556|FG000|Overall Study|Lost to Follow-up|0|||
126390003|NCT00880269|454720557|FG001|Overall Study|Lost to Follow-up|1|||
126390004|NCT00880269|454720556|FG000|Overall Study|Withdrawal by Subject|3|||
126390005|NCT00880269|454720557|FG001|Overall Study|Withdrawal by Subject|4|||
126390006|NCT00880269|454720556|FG000|Overall Study|Adverse Event|10|||
126390007|NCT00880269|454720557|FG001|Overall Study|Adverse Event|9|||
126390008|NCT00316225|454720564|FG000|Overall Study|Adverse Event|2|||
126390009|NCT00316225|454720564|FG000|Overall Study|Physician Decision|3|||
126390010|NCT00316225|454720564|FG000|Overall Study|Progressive Disease|15|||
126390011|NCT00316225|454720564|FG000|Overall Study|Withdrawal by Subject|3|||
126390012|NCT00316225|454720564|FG000|Overall Study|Death|2|||
126390013|NCT01811485|454720565|FG000|Overall Study|Adverse Event|1|||
126390014|NCT01811485|454720566|FG001|Overall Study|Adverse Event|3|||
126390015|NCT01811485|454720567|FG002|Overall Study|Adverse Event|2|||
126390016|NCT01811485|454720565|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126390017|NCT01811485|454720566|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126390018|NCT01811485|454720567|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
126390019|NCT01811485|454720565|FG000|Overall Study|Administrative problems|1|||
126390020|NCT01811485|454720566|FG001|Overall Study|Administrative problems|0|||
126390021|NCT01811485|454720567|FG002|Overall Study|Administrative problems|0|||
126390022|NCT01811485|454720565|FG000|Overall Study|Protocol Deviation|0|||
126390023|NCT01811485|454720566|FG001|Overall Study|Protocol Deviation|1|||
126390024|NCT01811485|454720567|FG002|Overall Study|Protocol Deviation|0|||
126390025|NCT01545934|454720568|FG000|Overall Study|Withdrawal by Subject|4|||
126554219|NCT02018861|455324015|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
126554220|NCT02018861|455324016|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
126554221|NCT02018861|455324017|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
126390026|NCT01545934|454720569|FG001|Overall Study|Withdrawal by Subject|3|||
126390027|NCT01545934|454720568|FG000|Overall Study|Lost to Follow-up|1|||
126390028|NCT01545934|454720569|FG001|Overall Study|Lost to Follow-up|0|||
126390029|NCT03654404|454720570|FG000|Overall Study|Death|1|||
126390030|NCT03654404|454720570|FG000|Overall Study|Lost to Follow-up|2|||
126390031|NCT03654404|454720570|FG000|Overall Study|Withdrawal by Subject|5|||
126390032|NCT02003638|454720573|FG000|Overall Study|Withdrawal by Subject|1|||
126390033|NCT02003638|454720574|FG001|Overall Study|Withdrawal by Subject|0|||
126390034|NCT06004895|454720580|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
126390035|NCT06004895|454720580|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
126390036|NCT02314156|454720582|FG000|Overall Study|Adverse Event|1|||
126390037|NCT02314156|454720583|FG001|Overall Study|Adverse Event|0|||
126390038|NCT02314156|454720582|FG000|Overall Study|Withdrawal by Subject|1|||
126390039|NCT02314156|454720583|FG001|Overall Study|Withdrawal by Subject|0|||
126390040|NCT03497975|454720587|FG000|Overall Study|Withdrew Consent|34|||
126390041|NCT03497975|454720588|FG001|Overall Study|Withdrew Consent|35|||
126390042|NCT03497975|454720587|FG000|Overall Study|Lost to Follow-up|7|||
126390043|NCT03497975|454720588|FG001|Overall Study|Lost to Follow-up|7|||
126390044|NCT03497975|454720587|FG000|Overall Study|Physician Decision|4|||
126390045|NCT03497975|454720588|FG001|Overall Study|Physician Decision|5|||
126390046|NCT03497975|454720587|FG000|Overall Study|Discontinued|42|||
126390047|NCT03497975|454720588|FG001|Overall Study|Discontinued|39|||
126390048|NCT03497975|454720587|FG000|Overall Study|Reason Not Specified|15|||
126390049|NCT03497975|454720588|FG001|Overall Study|Reason Not Specified|14|||
126390050|NCT01257230|454720589|FG000|Overall Study|Not Treated|0|||
126390051|NCT01257230|454720590|FG001|Overall Study|Not Treated|0|||
126390052|NCT01257230|454720591|FG002|Overall Study|Not Treated|1|||
126390053|NCT01257230|454720589|FG000|Overall Study|Adverse Event|2|||
126390054|NCT01257230|454720590|FG001|Overall Study|Adverse Event|0|||
126390055|NCT01257230|454720591|FG002|Overall Study|Adverse Event|0|||
126390056|NCT01257230|454720589|FG000|Overall Study|Lack of Efficacy|0|||
126390057|NCT01257230|454720590|FG001|Overall Study|Lack of Efficacy|1|||
126390058|NCT01257230|454720591|FG002|Overall Study|Lack of Efficacy|0|||
126390059|NCT01257230|454720589|FG000|Overall Study|Protocol Violation|3|||
126390060|NCT01257230|454720590|FG001|Overall Study|Protocol Violation|0|||
126390061|NCT01257230|454720591|FG002|Overall Study|Protocol Violation|1|||
126390062|NCT01257230|454720589|FG000|Overall Study|Withdrawal by Subject|0|||
126390063|NCT01257230|454720590|FG001|Overall Study|Withdrawal by Subject|4|||
126390064|NCT01257230|454720591|FG002|Overall Study|Withdrawal by Subject|1|||
126390065|NCT01257230|454720589|FG000|Overall Study|Other reason not defined above|1|||
126390066|NCT01257230|454720590|FG001|Overall Study|Other reason not defined above|5|||
126390067|NCT01257230|454720591|FG002|Overall Study|Other reason not defined above|3|||
126390068|NCT01205061|454720594|FG000|Overall Study|Adverse Event|4|||
126390069|NCT01205061|454720594|FG000|Overall Study|Withdrawal by Subject|11|||
126390070|NCT01205061|454720594|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
126390071|NCT01205061|454720594|FG000|Overall Study|Lost to Follow-up|9|||
126390072|NCT01205061|454720594|FG000|Overall Study|Other|1|||
126390073|NCT00765037|454720595|FG000|Overall Study|Lost to Follow-up|5|||
126390074|NCT00765037|454720595|FG000|Overall Study|Adverse Event|1|||
126390075|NCT03070171|454720600|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
126390076|NCT03070171|454720601|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
126390077|NCT03070171|454720600|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
126390078|NCT03070171|454720601|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
126390079|NCT01471028|454720605|FG000|VTI-208|Adverse Event|39|||
126390080|NCT01471028|454720606|FG001|VTI-208|Adverse Event|41|||
126390081|NCT01471028|454720605|FG000|VTI-208|Withdrawal by Subject|0|||
126390082|NCT01471028|454720606|FG001|VTI-208|Withdrawal by Subject|2|||
126390083|NCT01471028|454720605|FG000|VTI-208|Lost to Follow-up|1|||
126390084|NCT01471028|454720606|FG001|VTI-208|Lost to Follow-up|1|||
126390085|NCT01471028|454720605|FG000|VTI-208E|Death|7|||
126390086|NCT01471028|454720606|FG001|VTI-208E|Death|10|||
126390087|NCT01471028|454720605|FG000|VTI-208E|Withdrawal by Subject|1|||
126390088|NCT01471028|454720606|FG001|VTI-208E|Withdrawal by Subject|0|||
126390089|NCT01471028|454720605|FG000|VTI-208E|Lost to Follow-up|0|||
126390090|NCT01471028|454720606|FG001|VTI-208E|Lost to Follow-up|2|||
126390091|NCT00610857|454720608|FG000|Overall Study|Not evaluable for response|2|||
126390092|NCT04826094|454720609|FG000|Overall Study|Lost to Follow-up|2|||
126390093|NCT04826094|454720610|FG001|Overall Study|Lost to Follow-up|1|||
126390094|NCT04826094|454720611|FG002|Overall Study|Lost to Follow-up|0|||
126390095|NCT04826094|454720612|FG003|Overall Study|Lost to Follow-up|0|||
126390096|NCT04826094|454720613|FG004|Overall Study|Lost to Follow-up|1|||
126390097|NCT04826094|454720614|FG005|Overall Study|Lost to Follow-up|3|||
126390098|NCT04826094|454720615|FG006|Overall Study|Lost to Follow-up|1|||
126390099|NCT04826094|454720616|FG007|Overall Study|Lost to Follow-up|1|||
126390100|NCT04826094|454720609|FG000|Overall Study|Participant withdrew consent|1|||
126390101|NCT04826094|454720610|FG001|Overall Study|Participant withdrew consent|0|||
126390102|NCT04826094|454720611|FG002|Overall Study|Participant withdrew consent|0|||
126390103|NCT04826094|454720612|FG003|Overall Study|Participant withdrew consent|1|||
126390104|NCT04826094|454720613|FG004|Overall Study|Participant withdrew consent|1|||
126390105|NCT04826094|454720614|FG005|Overall Study|Participant withdrew consent|1|||
126390106|NCT04826094|454720615|FG006|Overall Study|Participant withdrew consent|0|||
126390107|NCT04826094|454720616|FG007|Overall Study|Participant withdrew consent|1|||
126390108|NCT04826094|454720609|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
126390109|NCT04826094|454720610|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
126390110|NCT04826094|454720611|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
126390111|NCT04826094|454720612|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
126390112|NCT04826094|454720613|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
126390113|NCT04826094|454720614|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
126390114|NCT04826094|454720615|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
126390115|NCT04826094|454720616|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
126390116|NCT04826094|454720609|FG000|Overall Study|Withdrawn by Investigator|0|||
126390117|NCT04826094|454720610|FG001|Overall Study|Withdrawn by Investigator|0|||
126390118|NCT04826094|454720611|FG002|Overall Study|Withdrawn by Investigator|0|||
126390119|NCT04826094|454720612|FG003|Overall Study|Withdrawn by Investigator|0|||
126390120|NCT04826094|454720613|FG004|Overall Study|Withdrawn by Investigator|0|||
126390121|NCT04826094|454720614|FG005|Overall Study|Withdrawn by Investigator|1|||
126390122|NCT04826094|454720615|FG006|Overall Study|Withdrawn by Investigator|0|||
126390123|NCT04826094|454720616|FG007|Overall Study|Withdrawn by Investigator|1|||
126390124|NCT04826094|454720609|FG000|Overall Study|Other: Moved from area|1|||
126390125|NCT04826094|454720610|FG001|Overall Study|Other: Moved from area|1|||
126390126|NCT04826094|454720611|FG002|Overall Study|Other: Moved from area|1|||
126390127|NCT04826094|454720612|FG003|Overall Study|Other: Moved from area|0|||
126390128|NCT04826094|454720613|FG004|Overall Study|Other: Moved from area|0|||
126390129|NCT04826094|454720614|FG005|Overall Study|Other: Moved from area|0|||
126390130|NCT04826094|454720615|FG006|Overall Study|Other: Moved from area|0|||
126390131|NCT04826094|454720616|FG007|Overall Study|Other: Moved from area|0|||
126390132|NCT04826094|454720609|FG000|Overall Study|Other: Declined|0|||
126390133|NCT04826094|454720610|FG001|Overall Study|Other: Declined|0|||
126717886|NCT03844633|455917672|FG001|12-month Follow-up|Lost to Follow-up|5|||
126390134|NCT04826094|454720611|FG002|Overall Study|Other: Declined|0|||
126390135|NCT04826094|454720612|FG003|Overall Study|Other: Declined|0|||
126390136|NCT04826094|454720613|FG004|Overall Study|Other: Declined|1|||
126390137|NCT04826094|454720614|FG005|Overall Study|Other: Declined|0|||
126390138|NCT04826094|454720615|FG006|Overall Study|Other: Declined|0|||
126390139|NCT04826094|454720616|FG007|Overall Study|Other: Declined|0|||
126390140|NCT04826094|454720609|FG000|Overall Study|Other: Vaccine not administered|0|||
126390141|NCT04826094|454720610|FG001|Overall Study|Other: Vaccine not administered|0|||
126390142|NCT04826094|454720611|FG002|Overall Study|Other: Vaccine not administered|1|||
126390143|NCT04826094|454720612|FG003|Overall Study|Other: Vaccine not administered|0|||
126717887|NCT03844633|455917673|FG002|12-month Follow-up|Lost to Follow-up|8|||
126717888|NCT02504892|455917680|FG000|Overall Study|Adverse event-pneumonitis|2|||
126717889|NCT01413178|455917681|FG000|Overall Study|Toxicity|1|||
126717890|NCT01413178|455917682|FG001|Overall Study|Toxicity|0|||
126771241|NCT01336608|456117715|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126717891|NCT01413178|455917681|FG000|Overall Study|Ineligible|0|||
126717892|NCT01413178|455917682|FG001|Overall Study|Ineligible|2|||
126717893|NCT00576693|455917683|FG000|Overall Study|Lost to Follow-up|7|||
126717894|NCT00576693|455917684|FG001|Overall Study|Lost to Follow-up|11|||
126717895|NCT00576693|455917683|FG000|Overall Study|Withdrawal by Subject|3|||
126717896|NCT00576693|455917684|FG001|Overall Study|Withdrawal by Subject|13|||
126717897|NCT00804193|455917685|FG000|Overall Study|Lack of baseline fungus|32|||
126717898|NCT00804193|455917686|FG001|Overall Study|Lack of baseline fungus|31|||
126717899|NCT00804193|455917687|FG002|Overall Study|Lack of baseline fungus|19|||
126717900|NCT00804193|455917685|FG000|Overall Study|Adverse Event|0|||
126717901|NCT00804193|455917686|FG001|Overall Study|Adverse Event|0|||
126717902|NCT00804193|455917687|FG002|Overall Study|Adverse Event|2|||
126717903|NCT00804193|455917685|FG000|Overall Study|Lack of Efficacy|1|||
126717904|NCT00804193|455917686|FG001|Overall Study|Lack of Efficacy|1|||
126717905|NCT00804193|455917687|FG002|Overall Study|Lack of Efficacy|3|||
126717906|NCT00804193|455917685|FG000|Overall Study|Protocol Violation|0|||
126717907|NCT00804193|455917686|FG001|Overall Study|Protocol Violation|8|||
126717908|NCT00804193|455917687|FG002|Overall Study|Protocol Violation|2|||
126717909|NCT00804193|455917685|FG000|Overall Study|Lost to Follow-up|3|||
126717910|NCT00804193|455917686|FG001|Overall Study|Lost to Follow-up|3|||
126717911|NCT00804193|455917687|FG002|Overall Study|Lost to Follow-up|4|||
126717912|NCT00804193|455917685|FG000|Overall Study|Withdrawal by Subject|3|||
126717913|NCT00804193|455917686|FG001|Overall Study|Withdrawal by Subject|1|||
126717914|NCT00804193|455917687|FG002|Overall Study|Withdrawal by Subject|2|||
126717915|NCT00705224|455917688|FG000|Overall Study|Adverse Event|1|||
126717916|NCT00705224|455917688|FG000|Overall Study|Lack of Efficacy|2|||
126717917|NCT00705224|455917688|FG000|Overall Study|Withdrawal by Subject|3|||
126717918|NCT00705224|455917688|FG000|Overall Study|Lost to Follow-up|5|||
126717919|NCT01987986|455917689|FG000|Overall Study|Lost to Follow-up|1|||
126717920|NCT01987986|455917690|FG001|Overall Study|Lost to Follow-up|0|||
126717921|NCT01987986|455917691|FG002|Overall Study|Lost to Follow-up|0|||
126717922|NCT01987986|455917692|FG003|Overall Study|Lost to Follow-up|0|||
126717923|NCT01987986|455917689|FG000|Overall Study|Adverse Event|1|||
126390144|NCT04826094|454720613|FG004|Overall Study|Other: Vaccine not administered|0|||
126390145|NCT04826094|454720614|FG005|Overall Study|Other: Vaccine not administered|1|||
126390146|NCT04826094|454720615|FG006|Overall Study|Other: Vaccine not administered|1|||
126390147|NCT04826094|454720616|FG007|Overall Study|Other: Vaccine not administered|3|||
126390148|NCT05312697|454720617|FG000|Overall Study|Sponsor Terminated Trial|2|||
126390149|NCT04445519|454720618|FG000|Overall Study|Due to adaptive design|3|||
126390150|NCT04445519|454720619|FG001|Overall Study|Due to adaptive design|0|||
126717924|NCT01987986|455917690|FG001|Overall Study|Adverse Event|0|||
126771242|NCT01336608|456117712|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
126390151|NCT04445519|454720620|FG002|Overall Study|Due to adaptive design|0|||
126390152|NCT04445519|454720618|FG000|Overall Study|Lost to Follow-up|0|||
126390153|NCT04445519|454720619|FG001|Overall Study|Lost to Follow-up|1|||
126390154|NCT04445519|454720620|FG002|Overall Study|Lost to Follow-up|4|||
126390155|NCT04445519|454720618|FG000|Overall Study|Sponsor or IRB Decision|0|||
126390156|NCT04445519|454720619|FG001|Overall Study|Sponsor or IRB Decision|1|||
126390157|NCT04445519|454720620|FG002|Overall Study|Sponsor or IRB Decision|2|||
126390158|NCT04445519|454720618|FG000|Overall Study|Withdrawal by Subject|0|||
126390159|NCT04445519|454720619|FG001|Overall Study|Withdrawal by Subject|3|||
126717925|NCT01987986|455917691|FG002|Overall Study|Adverse Event|2|||
126771243|NCT01336608|456117713|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
126390160|NCT04445519|454720620|FG002|Overall Study|Withdrawal by Subject|3|||
126390161|NCT04445519|454720618|FG000|Overall Study|Adverse Event|0|||
126717926|NCT01987986|455917692|FG003|Overall Study|Adverse Event|0|||
126717927|NCT01617434|455917693|FG000|Overall Study|Adverse Event|12|||
126717928|NCT01617434|455917694|FG001|Overall Study|Adverse Event|3|||
126717929|NCT01617434|455917693|FG000|Overall Study|Protocol Violation|8|||
126717930|NCT01617434|455917694|FG001|Overall Study|Protocol Violation|7|||
126717931|NCT01617434|455917693|FG000|Overall Study|Withdrawal Criteria|12|||
126717932|NCT01617434|455917694|FG001|Overall Study|Withdrawal Criteria|37|||
126390162|NCT04445519|454720619|FG001|Overall Study|Adverse Event|8|||
126390163|NCT04445519|454720620|FG002|Overall Study|Adverse Event|6|||
126390164|NCT04445519|454720618|FG000|Overall Study|Other Reason|0|||
126390165|NCT04445519|454720619|FG001|Overall Study|Other Reason|1|||
126390166|NCT04445519|454720620|FG002|Overall Study|Other Reason|1|||
126390167|NCT04445519|454720618|FG000|Overall Study|Protocol Violation|0|||
126390168|NCT04445519|454720619|FG001|Overall Study|Protocol Violation|0|||
126390169|NCT04445519|454720620|FG002|Overall Study|Protocol Violation|1|||
126390170|NCT00177294|454720627|FG000|Overall Study|Withdrawal by Subject|7|||
126390171|NCT00177294|454720628|FG001|Overall Study|Withdrawal by Subject|5|||
126390172|NCT04154605|454720629|FG000|Overall Study|Procedure Canceled|1|||
126390173|NCT04154605|454720630|FG001|Overall Study|Procedure Canceled|1|||
126390174|NCT04154605|454720629|FG000|Overall Study|Missed follow up|1|||
126390175|NCT04154605|454720630|FG001|Overall Study|Missed follow up|1|||
126390176|NCT04154605|454720629|FG000|Overall Study|Withdrawal by Subject|1|||
126390177|NCT04154605|454720630|FG001|Overall Study|Withdrawal by Subject|0|||
126390178|NCT00700882|454720631|FG000|Overall Study|Never received treatment|6|||
126390179|NCT00700882|454720631|FG000|Overall Study|Ineligible|2|||
126390180|NCT00700882|454720631|FG000|Overall Study|No KIT mutation|51|||
126390181|NCT04154293|454720635|FG000|Overall Study|Withdrawal by Subject|2|||
126390182|NCT04154293|454720636|FG001|Overall Study|Withdrawal by Subject|3|||
126390183|NCT04154293|454720637|FG002|Overall Study|Withdrawal by Subject|1|||
126390184|NCT04154293|454720635|FG000|Overall Study|Physician Decision|0|||
126390185|NCT04154293|454720636|FG001|Overall Study|Physician Decision|0|||
126390186|NCT04154293|454720637|FG002|Overall Study|Physician Decision|1|||
126390187|NCT03403361|454720638|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
126390188|NCT02152371|454720640|FG000|Overall Study|Adverse Event|6|||
126390189|NCT02152371|454720641|FG001|Overall Study|Adverse Event|2|||
126390190|NCT02152371|454720640|FG000|Overall Study|Withdrawal by Subject|3|||
126390191|NCT02152371|454720641|FG001|Overall Study|Withdrawal by Subject|7|||
126390192|NCT02152371|454720640|FG000|Overall Study|Protocol Violation|2|||
126390193|NCT02152371|454720641|FG001|Overall Study|Protocol Violation|3|||
126390194|NCT02152371|454720640|FG000|Overall Study|Lost to Follow-up|1|||
126390195|NCT02152371|454720641|FG001|Overall Study|Lost to Follow-up|0|||
126390196|NCT02152371|454720640|FG000|Overall Study|Lack of Efficacy|0|||
126390197|NCT02152371|454720641|FG001|Overall Study|Lack of Efficacy|1|||
126390198|NCT02152371|454720640|FG000|Overall Study|Physician Decision|0|||
126390199|NCT02152371|454720641|FG001|Overall Study|Physician Decision|2|||
126390200|NCT02152371|454720640|FG000|Overall Study|Reason Not Given|0|||
126390201|NCT02152371|454720641|FG001|Overall Study|Reason Not Given|1|||
126390202|NCT06359028|454720646|FG000|Overall Study|Adverse Event|1|||
126390203|NCT06359028|454720647|FG001|Overall Study|Adverse Event|0|||
126390204|NCT06359028|454720646|FG000|Overall Study|Withdrawal by Subject|1|||
126390205|NCT06359028|454720647|FG001|Overall Study|Withdrawal by Subject|0|||
126390206|NCT04382586|454720648|FG000|Overall Study|Death|3|||
126390207|NCT04382586|454720649|FG001|Overall Study|Death|4|||
126390208|NCT04382586|454720648|FG000|Overall Study|Lost to Follow-up|11|||
126390209|NCT04382586|454720649|FG001|Overall Study|Lost to Follow-up|8|||
126390210|NCT04382586|454720648|FG000|Overall Study|Withdrawal by Subject|3|||
126390211|NCT04382586|454720649|FG001|Overall Study|Withdrawal by Subject|1|||
126390212|NCT04382586|454720648|FG000|Overall Study|Physician Decision|0|||
126390213|NCT04382586|454720649|FG001|Overall Study|Physician Decision|3|||
126390214|NCT00107900|454720654|FG000|Overall Study|Adverse Event|3|||
126390215|NCT00107900|454720655|FG001|Overall Study|Adverse Event|2|||
126390216|NCT00107900|454720656|FG002|Overall Study|Adverse Event|10|||
126390217|NCT00107900|454720657|FG003|Overall Study|Adverse Event|3|||
126390218|NCT00107900|454720658|FG004|Overall Study|Adverse Event|5|||
126390219|NCT00107900|454720659|FG005|Overall Study|Adverse Event|3|||
126390220|NCT00107900|454720654|FG000|Overall Study|Death|0|||
126390221|NCT00107900|454720655|FG001|Overall Study|Death|0|||
126390222|NCT00107900|454720656|FG002|Overall Study|Death|0|||
126390223|NCT00107900|454720657|FG003|Overall Study|Death|0|||
126390224|NCT00107900|454720658|FG004|Overall Study|Death|1|||
126390225|NCT00107900|454720659|FG005|Overall Study|Death|0|||
126390226|NCT00107900|454720654|FG000|Overall Study|Lost to Follow-up|4|||
126390227|NCT00107900|454720655|FG001|Overall Study|Lost to Follow-up|1|||
126390228|NCT00107900|454720656|FG002|Overall Study|Lost to Follow-up|3|||
126390229|NCT00107900|454720657|FG003|Overall Study|Lost to Follow-up|2|||
126390230|NCT00107900|454720658|FG004|Overall Study|Lost to Follow-up|5|||
126390231|NCT00107900|454720659|FG005|Overall Study|Lost to Follow-up|5|||
126390232|NCT00107900|454720654|FG000|Overall Study|Protocol Violation|1|||
126390233|NCT00107900|454720655|FG001|Overall Study|Protocol Violation|0|||
126390234|NCT00107900|454720656|FG002|Overall Study|Protocol Violation|5|||
126390235|NCT00107900|454720657|FG003|Overall Study|Protocol Violation|5|||
126390236|NCT00107900|454720658|FG004|Overall Study|Protocol Violation|7|||
126390237|NCT00107900|454720659|FG005|Overall Study|Protocol Violation|0|||
126390238|NCT00107900|454720654|FG000|Overall Study|Withdrawal by Subject|1|||
126390239|NCT00107900|454720655|FG001|Overall Study|Withdrawal by Subject|0|||
126390240|NCT00107900|454720656|FG002|Overall Study|Withdrawal by Subject|5|||
126390241|NCT00107900|454720657|FG003|Overall Study|Withdrawal by Subject|0|||
126390242|NCT00107900|454720658|FG004|Overall Study|Withdrawal by Subject|1|||
126390243|NCT00107900|454720659|FG005|Overall Study|Withdrawal by Subject|1|||
126390244|NCT00107900|454720654|FG000|Overall Study|Administrative Reasons|1|||
126390245|NCT00107900|454720655|FG001|Overall Study|Administrative Reasons|0|||
126390246|NCT00107900|454720656|FG002|Overall Study|Administrative Reasons|2|||
126390247|NCT00107900|454720657|FG003|Overall Study|Administrative Reasons|2|||
126390248|NCT00107900|454720658|FG004|Overall Study|Administrative Reasons|2|||
126390249|NCT00107900|454720659|FG005|Overall Study|Administrative Reasons|0|||
126390250|NCT02109432|454722469|FG000|Overall Study|Withdrawal by Subject|1|||
126390251|NCT02920528|454722470|FG000|Overall Study|Incomplete Data|1|||
126390252|NCT02920528|454722471|FG001|Overall Study|Incomplete Data|1|||
126390253|NCT02920528|454722472|FG002|Overall Study|Incomplete Data|1|||
126390254|NCT02920528|454722470|FG000|Overall Study|Adverse Event|0|||
126390255|NCT02920528|454722471|FG001|Overall Study|Adverse Event|0|||
126390256|NCT02920528|454722472|FG002|Overall Study|Adverse Event|3|||
126390257|NCT02920528|454722470|FG000|Overall Study|Did not meet inclusion criteria|2|||
126390258|NCT02920528|454722471|FG001|Overall Study|Did not meet inclusion criteria|0|||
126390259|NCT02920528|454722472|FG002|Overall Study|Did not meet inclusion criteria|1|||
126390260|NCT03215758|454722484|FG000|Overall Study|Technical Problems|1|||
126390261|NCT03215758|454722485|FG001|Overall Study|Technical Problems|0|||
126390262|NCT03215758|454722484|FG000|Overall Study|Protocol deviation|0|||
126390263|NCT03215758|454722485|FG001|Overall Study|Protocol deviation|1|||
126390264|NCT03215758|454722484|FG000|Overall Study|Physician Decision|0|||
126390265|NCT03215758|454722485|FG001|Overall Study|Physician Decision|1|||
126390266|NCT03215758|454722484|FG000|Overall Study|Death|0|||
126390267|NCT03215758|454722485|FG001|Overall Study|Death|1|||
126390268|NCT03215758|454722484|FG000|Overall Study|Adverse Event|1|||
126390269|NCT03215758|454722485|FG001|Overall Study|Adverse Event|2|||
126390270|NCT03215758|454722484|FG000|Overall Study|Subject/Guardian Decision|3|||
126390271|NCT03215758|454722485|FG001|Overall Study|Subject/Guardian Decision|3|||
126390272|NCT04115748|454722486|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
126390273|NCT04115748|454722487|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
126390274|NCT04115748|454722488|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
126390275|NCT04115748|454722489|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
126390276|NCT04115748|454722490|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
126390277|NCT04115748|454722491|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
126390278|NCT04115748|454722492|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
126390279|NCT04115748|454722493|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
126390280|NCT04115748|454722494|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
126390281|NCT04115748|454722495|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
126390282|NCT04115748|454722486|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390283|NCT04115748|454722487|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390284|NCT04115748|454722488|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390285|NCT04115748|454722489|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
126390286|NCT04115748|454722490|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390287|NCT04115748|454722491|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390288|NCT04115748|454722492|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390289|NCT04115748|454722493|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390290|NCT04115748|454722494|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390291|NCT04115748|454722495|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
126390292|NCT04115748|454722486|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
126390293|NCT04115748|454722487|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
126390294|NCT04115748|454722488|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
126390295|NCT04115748|454722489|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
126390296|NCT04115748|454722490|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
126390297|NCT04115748|454722491|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
126390298|NCT04115748|454722492|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
126390299|NCT04115748|454722493|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
126390300|NCT04115748|454722494|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
126390301|NCT04115748|454722495|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
126390302|NCT04115748|454722486|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390303|NCT04115748|454722487|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390304|NCT04115748|454722488|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390305|NCT04115748|454722489|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390306|NCT04115748|454722490|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390307|NCT04115748|454722491|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390308|NCT04115748|454722492|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390309|NCT04115748|454722493|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390310|NCT04115748|454722494|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
126390311|NCT04115748|454722495|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
126390312|NCT00713349|454722496|FG000|Overall Study|Protocol Violation|1|||
126717933|NCT01617434|455917693|FG000|Overall Study|Unclassified|3|||
126390313|NCT03764631|454722497|FG000|Overall Study|Personal Reasons|3|||
126390314|NCT03764631|454722498|FG001|Overall Study|Personal Reasons|2|||
126390315|NCT03764631|454722497|FG000|Overall Study|Switching Therapy|3|||
126390316|NCT03764631|454722498|FG001|Overall Study|Switching Therapy|3|||
126390317|NCT03764631|454722497|FG000|Overall Study|Adverse Event|0|||
126390318|NCT03764631|454722498|FG001|Overall Study|Adverse Event|1|||
126390319|NCT03764631|454722497|FG000|Overall Study|Lost to Follow-up|33|||
126390320|NCT03764631|454722498|FG001|Overall Study|Lost to Follow-up|41|||
126390321|NCT03764631|454722497|FG000|Overall Study|No data as study site was closed|2|||
126390322|NCT03764631|454722498|FG001|Overall Study|No data as study site was closed|6|||
126390323|NCT01200407|454722499|FG000|Overall Study|Lost to Follow-up|56|||
126390324|NCT01200407|454722499|FG000|Overall Study|Adverse Event|3|||
126390325|NCT01200407|454722499|FG000|Overall Study|Withdrawal by Subject|4|||
126390326|NCT01200407|454722499|FG000|Overall Study|Other|19|||
126390327|NCT03299881|454722500|FG000|Overall Study|Study Termination|17|||
126390328|NCT03299881|454722501|FG001|Overall Study|Study Termination|13|||
126390329|NCT01549886|454722504|FG000|Overall Study|Sponsor's decision|2|||
126390330|NCT01549886|454722505|FG001|Overall Study|Sponsor's decision|3|||
126390331|NCT00473668|454722506|FG000|Overall Study|Withdrawal by Subject|0|||
126390332|NCT00473668|454722507|FG001|Overall Study|Withdrawal by Subject|2|||
126390333|NCT00473668|454722508|FG002|Overall Study|Withdrawal by Subject|0|||
126390334|NCT00473668|454722506|FG000|Overall Study|Migrated/moved from study area|3|||
126390335|NCT00473668|454722507|FG001|Overall Study|Migrated/moved from study area|2|||
126390336|NCT00473668|454722508|FG002|Overall Study|Migrated/moved from study area|0|||
126390337|NCT00473668|454722506|FG000|Overall Study|Lost to Follow-up|0|||
126390338|NCT00473668|454722507|FG001|Overall Study|Lost to Follow-up|4|||
126390339|NCT00473668|454722508|FG002|Overall Study|Lost to Follow-up|6|||
126390340|NCT00473668|454722506|FG000|Overall Study|Other|2|||
126390341|NCT00473668|454722507|FG001|Overall Study|Other|3|||
126390342|NCT00473668|454722508|FG002|Overall Study|Other|4|||
126390343|NCT03195660|454722509|FG000|Overall Study|The study was terminated|2|||
126390344|NCT05260073|454722511|FG000|Overall Study|Physician Decision|1|||
126390345|NCT05260073|454722511|FG000|Overall Study|Withdrawal by Subject|6|||
126390346|NCT05260073|454722511|FG000|Overall Study|Lost to Follow-up|14|||
126390347|NCT03458910|454722512|FG000|Overall Study|Withdrawal by Subject|7|||
126390348|NCT03458910|454722513|FG001|Overall Study|Withdrawal by Subject|8|||
126390349|NCT03458910|454722514|FG002|Overall Study|Withdrawal by Subject|6|||
126390350|NCT03458910|454722515|FG003|Overall Study|Withdrawal by Subject|4|||
126390351|NCT03458910|454722512|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
126390352|NCT03458910|454722513|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
126390353|NCT03458910|454722514|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
126390354|NCT03458910|454722515|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
126390355|NCT04484649|454722516|FG000|Overall Study|Lost to Follow-up|2|||
126390356|NCT04484649|454722517|FG001|Overall Study|Lost to Follow-up|1|||
126390357|NCT04484649|454722516|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
126390358|NCT04484649|454722517|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
126390359|NCT01450696|454722518|FG000|Overall Study|Never Treated|1|||
126390360|NCT01450696|454722519|FG001|Overall Study|Never Treated|1|||
126390361|NCT01450696|454722518|FG000|Overall Study|Death|77|||
126390362|NCT01450696|454722519|FG001|Overall Study|Death|84|||
126390363|NCT01450696|454722518|FG000|Overall Study|Lost to Follow-up|3|||
126390364|NCT01450696|454722519|FG001|Overall Study|Lost to Follow-up|3|||
126390365|NCT01450696|454722518|FG000|Overall Study|Non-Compliance|1|||
126390366|NCT01450696|454722519|FG001|Overall Study|Non-Compliance|0|||
126390367|NCT01450696|454722518|FG000|Overall Study|Withdrawal by Subject|13|||
126390368|NCT01450696|454722519|FG001|Overall Study|Withdrawal by Subject|2|||
126390369|NCT01450696|454722518|FG000|Overall Study|Study Terminated by Sponsor|53|||
126390370|NCT01450696|454722519|FG001|Overall Study|Study Terminated by Sponsor|58|||
126390371|NCT02249091|454722522|FG000|Overall Study|Lack of Efficacy|8|||
126390372|NCT02249091|454722523|FG001|Overall Study|Lack of Efficacy|3|||
126390373|NCT02249091|454722522|FG000|Overall Study|Physician Decision|4|||
126390374|NCT02249091|454722523|FG001|Overall Study|Physician Decision|1|||
126390375|NCT02249091|454722522|FG000|Overall Study|Withdrawal by Subject|2|||
126390376|NCT02249091|454722523|FG001|Overall Study|Withdrawal by Subject|2|||
126390377|NCT02249091|454722522|FG000|Overall Study|Death|3|||
126390378|NCT02249091|454722523|FG001|Overall Study|Death|4|||
126390379|NCT02249091|454722522|FG000|Overall Study|Adverse Event|1|||
126390380|NCT02249091|454722523|FG001|Overall Study|Adverse Event|0|||
126390381|NCT02249091|454722522|FG000|Overall Study|Stable disease with following SCT|0|||
126390382|NCT02249091|454722523|FG001|Overall Study|Stable disease with following SCT|1|||
126390383|NCT02249091|454722522|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
126554222|NCT02018861|455324018|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
126717934|NCT01617434|455917694|FG001|Overall Study|Unclassified|4|||
126390384|NCT02249091|454722523|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
126390385|NCT02249091|454722522|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
126390386|NCT02249091|454722523|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
126390387|NCT02249091|454722522|FG000|Overall Study|Refractory AML|1|||
126390388|NCT02249091|454722523|FG001|Overall Study|Refractory AML|1|||
126390389|NCT00433966|454722524|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
126390390|NCT00433966|454722525|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
126390391|NCT00433966|454722526|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
126390392|NCT00433966|454722527|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
126390393|NCT00433966|454722524|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
126390394|NCT00433966|454722525|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
126390395|NCT00433966|454722526|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
126390396|NCT00433966|454722527|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
126390397|NCT00433966|454722524|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
126390398|NCT00433966|454722525|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
126390399|NCT00433966|454722526|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
126390400|NCT00433966|454722527|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
126390401|NCT00433966|454722524|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
126390402|NCT00433966|454722525|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
126390403|NCT00433966|454722526|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
126390404|NCT00433966|454722527|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
126390405|NCT00433966|454722524|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
126390406|NCT00433966|454722525|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
126390407|NCT00433966|454722526|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
126390408|NCT00433966|454722527|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
126390409|NCT02570152|454722528|FG000|Overall Study|Protocol Violation|2|||
126390410|NCT02570152|454722528|FG000|Overall Study|Migrated/moved from study area|13|||
126390411|NCT02957747|454722529|FG000|Overall Study|Withdrawal by Subject|0|||
126554223|NCT02018861|455324019|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
126554224|NCT02018861|455324020|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
126554225|NCT02018861|455324021|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
126554226|NCT02018861|455324022|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
126554227|NCT02018861|455324023|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
126554228|NCT02018861|455324014|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
126554229|NCT02018861|455324015|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
126554230|NCT02018861|455324016|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
126554231|NCT02018861|455324017|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
126554232|NCT02018861|455324018|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
126554233|NCT02018861|455324019|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
126554234|NCT02018861|455324020|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
126554235|NCT02018861|455324021|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
126554236|NCT02018861|455324022|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
126554237|NCT02018861|455324023|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
126554238|NCT02018861|455324014|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
126554239|NCT02018861|455324015|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
126554240|NCT02018861|455324016|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
126554241|NCT02018861|455324017|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
126554242|NCT02018861|455324018|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
126554243|NCT02018861|455324019|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
126554244|NCT02018861|455324020|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
126554245|NCT02018861|455324021|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
126554246|NCT02018861|455324022|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
126554247|NCT02018861|455324023|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
126554248|NCT02018861|455324014|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
126717935|NCT03283163|455917695|FG000|Overall Study|Lost to Follow-up|1|||
126717936|NCT03283163|455917695|FG000|Overall Study|other life commitments|6|||
126390412|NCT02957747|454722530|FG001|Overall Study|Withdrawal by Subject|3|||
126390413|NCT02957747|454722529|FG000|Overall Study|Lost to Follow-up|10|||
126390414|NCT02957747|454722530|FG001|Overall Study|Lost to Follow-up|5|||
126390415|NCT00632827|454722531|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
126390416|NCT00632827|454722531|FG000|Overall Study|Death|2|||
126390417|NCT00632827|454722531|FG000|Overall Study|Adverse Event|5|||
126390418|NCT00632827|454722531|FG000|Overall Study|Lost to Follow-up|1|||
126390419|NCT01177553|454722534|FG000|Overall Study|babies not yet 6 months of age|1|||
126390420|NCT01177553|454722535|FG001|Overall Study|babies not yet 6 months of age|0|||
126390421|NCT03931382|454722536|FG000|Overall Study|Equipment malfunction|2|||
126717937|NCT03283163|455917695|FG000|Overall Study|COVID-19 institution wide halting|1|||
126756522|NCT02719028|456059453|FG002|Overall Study|Use of prohibited medication|1|||
126717938|NCT03283163|455917695|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
126717939|NCT03283163|455917695|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
126717940|NCT00237796|455917696|FG000|Overall Study|Baseline and one other ILSS required|10|||
126717941|NCT00237796|455917697|FG001|Overall Study|Baseline and one other ILSS required|5|||
126717942|NCT04238663|455917698|FG000|Overall Study|Lost to Follow-up|0|||
126717943|NCT04238663|455917699|FG001|Overall Study|Lost to Follow-up|1|||
126717944|NCT04238663|455917700|FG002|Overall Study|Lost to Follow-up|0|||
126717945|NCT03141086|455917701|FG000|Overall Study|Study Terminated By Sponsor|1|||
126717946|NCT03141086|455917702|FG001|Overall Study|Study Terminated By Sponsor|1|||
126717947|NCT03141086|455917701|FG000|Overall Study|Withdrawal by Subject|0|||
126717948|NCT03141086|455917702|FG001|Overall Study|Withdrawal by Subject|1|||
126717949|NCT03141086|455917701|FG000|Overall Study|Protocol Violation|0|||
126717950|NCT03141086|455917702|FG001|Overall Study|Protocol Violation|1|||
126390422|NCT03931382|454722537|FG001|Overall Study|Equipment malfunction|0|||
126390423|NCT03931382|454722538|FG002|Overall Study|Equipment malfunction|2|||
126390424|NCT03931382|454722536|FG000|Overall Study|Withdrawal by Subject|0|||
126390425|NCT03931382|454722537|FG001|Overall Study|Withdrawal by Subject|1|||
126390426|NCT03931382|454722538|FG002|Overall Study|Withdrawal by Subject|0|||
126390427|NCT00778375|454722544|FG000|Overall Study|Ineligible|3|||
126390428|NCT04590404|454722547|FG000|Overall Study|Death|16|||
126390429|NCT04590404|454722548|FG001|Overall Study|Death|17|||
126390430|NCT04590404|454722547|FG000|Overall Study|Withdrawal by Subject|7|||
126390431|NCT04590404|454722548|FG001|Overall Study|Withdrawal by Subject|2|||
126390432|NCT01581021|454722553|FG000|Overall Study|Lost to Follow-up|4|||
126390433|NCT01581021|454722554|FG001|Overall Study|Lost to Follow-up|6|||
126390434|NCT01581021|454722553|FG000|Overall Study|More than 2 hooks in thoracic|3|||
126390435|NCT01581021|454722554|FG001|Overall Study|More than 2 hooks in thoracic|0|||
126390436|NCT01581021|454722553|FG000|Overall Study|Neuromuscular|2|||
126390437|NCT01581021|454722554|FG001|Overall Study|Neuromuscular|1|||
126390438|NCT01581021|454722553|FG000|Overall Study|Not Randomized|1|||
126390439|NCT01581021|454722554|FG001|Overall Study|Not Randomized|2|||
126390440|NCT01581021|454722553|FG000|Overall Study|Lenke 6 Classification|0|||
126390441|NCT01581021|454722554|FG001|Overall Study|Lenke 6 Classification|1|||
126390442|NCT01581021|454722553|FG000|Overall Study|Lack of Efficacy|0|||
126390443|NCT01581021|454722554|FG001|Overall Study|Lack of Efficacy|1|||
126390444|NCT00675441|454722555|FG000|Overall Study|Withdrawal by Subject|2|||
126390445|NCT00675441|454722555|FG000|Overall Study|Death|1|||
126390446|NCT00054327|454722558|FG000|Overall Study|Engraftment failure|1|||
126390447|NCT00054327|454722559|FG001|Overall Study|Engraftment failure|0|||
126390448|NCT00054327|454722560|FG002|Overall Study|Engraftment failure|0|||
126390449|NCT00054327|454722561|FG003|Overall Study|Engraftment failure|0|||
126390450|NCT00054327|454722562|FG004|Overall Study|Engraftment failure|0|||
126390451|NCT00054327|454722563|FG005|Overall Study|Engraftment failure|0|||
126390452|NCT05596734|454722573|FG000|Substudy A|Withdrawal by Subject|1|||
126390453|NCT05596734|454722574|FG001|Substudy A|Withdrawal by Subject|0|||
126390454|NCT05596734|454722575|FG002|Substudy A|Withdrawal by Subject|0|||
126390455|NCT05596734|454722576|FG003|Substudy A|Withdrawal by Subject|0|||
126390456|NCT05596734|454722577|FG004|Substudy A|Withdrawal by Subject|0|||
126390457|NCT05596734|454722578|FG005|Substudy A|Withdrawal by Subject|0|||
126390458|NCT05596734|454722579|FG006|Substudy A|Withdrawal by Subject|1|||
126390459|NCT05596734|454722580|FG007|Substudy A|Withdrawal by Subject|0|||
126390460|NCT05596734|454722581|FG008|Substudy A|Withdrawal by Subject|0|||
126390461|NCT05596734|454722582|FG009|Substudy A|Withdrawal by Subject|0|||
126390462|NCT05596734|454722583|FG010|Substudy A|Withdrawal by Subject|0|||
126390463|NCT05596734|454722584|FG011|Substudy A|Withdrawal by Subject|0|||
126390464|NCT05596734|454722585|FG012|Substudy A|Withdrawal by Subject|0|||
126390465|NCT05596734|454722586|FG013|Substudy A|Withdrawal by Subject|0|||
126390466|NCT05596734|454722587|FG014|Substudy A|Withdrawal by Subject|0|||
126390467|NCT05596734|454722588|FG015|Substudy A|Withdrawal by Subject|0|||
126717951|NCT03141086|455917701|FG000|Overall Study|Adverse Event|0|||
126717952|NCT03141086|455917702|FG001|Overall Study|Adverse Event|2|||
126717953|NCT03860844|455917703|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
126717954|NCT03860844|455917704|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
126390468|NCT05596734|454722589|FG016|Substudy A|Withdrawal by Subject|0|||
126390469|NCT05596734|454722590|FG017|Substudy A|Withdrawal by Subject|0|||
126390470|NCT05596734|454722591|FG018|Substudy A|Withdrawal by Subject|0|||
126390471|NCT05596734|454722592|FG019|Substudy A|Withdrawal by Subject|0|||
126390472|NCT05596734|454722593|FG020|Substudy A|Withdrawal by Subject|0|||
126390473|NCT05596734|454722594|FG021|Substudy A|Withdrawal by Subject|0|||
126390474|NCT05596734|454722595|FG022|Substudy A|Withdrawal by Subject|0|||
126390475|NCT05596734|454722596|FG023|Substudy A|Withdrawal by Subject|0|||
126390476|NCT05596734|454722573|FG000|Substudy A|Lost to Follow-up|1|||
126390477|NCT05596734|454722574|FG001|Substudy A|Lost to Follow-up|0|||
126717955|NCT03860844|455917705|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
126717956|NCT03860844|455917703|FG000|Overall Study|Progressive disease|5|||
126390478|NCT05596734|454722575|FG002|Substudy A|Lost to Follow-up|1|||
126390479|NCT05596734|454722576|FG003|Substudy A|Lost to Follow-up|0|||
126390480|NCT05596734|454722577|FG004|Substudy A|Lost to Follow-up|0|||
126390481|NCT05596734|454722578|FG005|Substudy A|Lost to Follow-up|0|||
126390482|NCT05596734|454722579|FG006|Substudy A|Lost to Follow-up|0|||
126390483|NCT05596734|454722580|FG007|Substudy A|Lost to Follow-up|0|||
126390484|NCT05596734|454722581|FG008|Substudy A|Lost to Follow-up|0|||
126390485|NCT05596734|454722582|FG009|Substudy A|Lost to Follow-up|0|||
126390486|NCT05596734|454722583|FG010|Substudy A|Lost to Follow-up|0|||
126390487|NCT05596734|454722584|FG011|Substudy A|Lost to Follow-up|0|||
126390488|NCT05596734|454722585|FG012|Substudy A|Lost to Follow-up|0|||
126390489|NCT05596734|454722586|FG013|Substudy A|Lost to Follow-up|0|||
126390490|NCT05596734|454722587|FG014|Substudy A|Lost to Follow-up|0|||
126390491|NCT05596734|454722588|FG015|Substudy A|Lost to Follow-up|0|||
126390492|NCT05596734|454722589|FG016|Substudy A|Lost to Follow-up|0|||
126390493|NCT05596734|454722590|FG017|Substudy A|Lost to Follow-up|0|||
126390494|NCT05596734|454722591|FG018|Substudy A|Lost to Follow-up|0|||
126390495|NCT05596734|454722592|FG019|Substudy A|Lost to Follow-up|0|||
126390496|NCT05596734|454722593|FG020|Substudy A|Lost to Follow-up|0|||
126390497|NCT05596734|454722594|FG021|Substudy A|Lost to Follow-up|0|||
126390498|NCT05596734|454722595|FG022|Substudy A|Lost to Follow-up|0|||
126390499|NCT05596734|454722596|FG023|Substudy A|Lost to Follow-up|0|||
126390500|NCT05596734|454722573|FG000|Substudy B|Withdrawal by Subject|0|||
126390501|NCT05596734|454722574|FG001|Substudy B|Withdrawal by Subject|0|||
126390502|NCT05596734|454722575|FG002|Substudy B|Withdrawal by Subject|0|||
126390503|NCT05596734|454722576|FG003|Substudy B|Withdrawal by Subject|0|||
126390504|NCT05596734|454722577|FG004|Substudy B|Withdrawal by Subject|0|||
126390505|NCT05596734|454722578|FG005|Substudy B|Withdrawal by Subject|0|||
126390506|NCT05596734|454722579|FG006|Substudy B|Withdrawal by Subject|0|||
126390507|NCT05596734|454722580|FG007|Substudy B|Withdrawal by Subject|0|||
126390508|NCT05596734|454722581|FG008|Substudy B|Withdrawal by Subject|0|||
126390509|NCT05596734|454722582|FG009|Substudy B|Withdrawal by Subject|0|||
126390510|NCT05596734|454722583|FG010|Substudy B|Withdrawal by Subject|0|||
126390511|NCT05596734|454722584|FG011|Substudy B|Withdrawal by Subject|0|||
126390512|NCT05596734|454722585|FG012|Substudy B|Withdrawal by Subject|1|||
126390513|NCT05596734|454722586|FG013|Substudy B|Withdrawal by Subject|0|||
126390514|NCT05596734|454722587|FG014|Substudy B|Withdrawal by Subject|1|||
126390515|NCT05596734|454722588|FG015|Substudy B|Withdrawal by Subject|2|||
126390516|NCT05596734|454722589|FG016|Substudy B|Withdrawal by Subject|2|||
126390517|NCT05596734|454722590|FG017|Substudy B|Withdrawal by Subject|1|||
126390518|NCT05596734|454722591|FG018|Substudy B|Withdrawal by Subject|2|||
126390519|NCT05596734|454722592|FG019|Substudy B|Withdrawal by Subject|0|||
126390520|NCT05596734|454722593|FG020|Substudy B|Withdrawal by Subject|0|||
126390521|NCT05596734|454722594|FG021|Substudy B|Withdrawal by Subject|0|||
126390522|NCT05596734|454722595|FG022|Substudy B|Withdrawal by Subject|0|||
126390523|NCT05596734|454722596|FG023|Substudy B|Withdrawal by Subject|1|||
126390524|NCT05596734|454722573|FG000|Substudy B|Physician Decision|0|||
126390525|NCT05596734|454722574|FG001|Substudy B|Physician Decision|0|||
126390526|NCT05596734|454722575|FG002|Substudy B|Physician Decision|0|||
126390527|NCT05596734|454722576|FG003|Substudy B|Physician Decision|0|||
126390528|NCT05596734|454722577|FG004|Substudy B|Physician Decision|0|||
126390529|NCT05596734|454722578|FG005|Substudy B|Physician Decision|0|||
126390530|NCT05596734|454722579|FG006|Substudy B|Physician Decision|0|||
126390531|NCT05596734|454722580|FG007|Substudy B|Physician Decision|0|||
126554249|NCT02018861|455324015|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
126554250|NCT02018861|455324016|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
126554251|NCT02018861|455324017|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
126390532|NCT05596734|454722581|FG008|Substudy B|Physician Decision|0|||
126390533|NCT05596734|454722582|FG009|Substudy B|Physician Decision|0|||
126390534|NCT05596734|454722583|FG010|Substudy B|Physician Decision|0|||
126390535|NCT05596734|454722584|FG011|Substudy B|Physician Decision|0|||
126390536|NCT05596734|454722585|FG012|Substudy B|Physician Decision|0|||
126390537|NCT05596734|454722586|FG013|Substudy B|Physician Decision|0|||
126390538|NCT05596734|454722587|FG014|Substudy B|Physician Decision|0|||
126390539|NCT05596734|454722588|FG015|Substudy B|Physician Decision|1|||
126390540|NCT05596734|454722589|FG016|Substudy B|Physician Decision|0|||
126390541|NCT05596734|454722590|FG017|Substudy B|Physician Decision|0|||
126390542|NCT05596734|454722591|FG018|Substudy B|Physician Decision|0|||
126390543|NCT05596734|454722592|FG019|Substudy B|Physician Decision|0|||
126390544|NCT05596734|454722593|FG020|Substudy B|Physician Decision|0|||
126771244|NCT01336608|456117714|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
126390545|NCT05596734|454722594|FG021|Substudy B|Physician Decision|0|||
126390546|NCT05596734|454722595|FG022|Substudy B|Physician Decision|0|||
126554252|NCT02018861|455324018|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
126390547|NCT05596734|454722596|FG023|Substudy B|Physician Decision|0|||
126390548|NCT05596734|454722573|FG000|Substudy B|Lost to Follow-up|0|||
126390549|NCT05596734|454722574|FG001|Substudy B|Lost to Follow-up|0|||
126390550|NCT05596734|454722575|FG002|Substudy B|Lost to Follow-up|0|||
126390551|NCT05596734|454722576|FG003|Substudy B|Lost to Follow-up|0|||
126390552|NCT05596734|454722577|FG004|Substudy B|Lost to Follow-up|0|||
126390553|NCT05596734|454722578|FG005|Substudy B|Lost to Follow-up|0|||
126390554|NCT05596734|454722579|FG006|Substudy B|Lost to Follow-up|0|||
126390555|NCT05596734|454722580|FG007|Substudy B|Lost to Follow-up|0|||
126390556|NCT05596734|454722581|FG008|Substudy B|Lost to Follow-up|0|||
126390557|NCT05596734|454722582|FG009|Substudy B|Lost to Follow-up|0|||
126390558|NCT05596734|454722583|FG010|Substudy B|Lost to Follow-up|0|||
126390559|NCT05596734|454722584|FG011|Substudy B|Lost to Follow-up|0|||
126390560|NCT05596734|454722585|FG012|Substudy B|Lost to Follow-up|1|||
126390561|NCT05596734|454722586|FG013|Substudy B|Lost to Follow-up|0|||
126390562|NCT05596734|454722587|FG014|Substudy B|Lost to Follow-up|1|||
126390563|NCT05596734|454722588|FG015|Substudy B|Lost to Follow-up|1|||
126390564|NCT05596734|454722589|FG016|Substudy B|Lost to Follow-up|0|||
126390565|NCT05596734|454722590|FG017|Substudy B|Lost to Follow-up|0|||
126390566|NCT05596734|454722591|FG018|Substudy B|Lost to Follow-up|0|||
126390567|NCT05596734|454722592|FG019|Substudy B|Lost to Follow-up|0|||
126390568|NCT05596734|454722593|FG020|Substudy B|Lost to Follow-up|0|||
126390569|NCT05596734|454722594|FG021|Substudy B|Lost to Follow-up|0|||
126390570|NCT05596734|454722595|FG022|Substudy B|Lost to Follow-up|0|||
126390571|NCT05596734|454722596|FG023|Substudy B|Lost to Follow-up|0|||
126390572|NCT04113018|454722597|FG000|Overall Study|Death|2|||
126390573|NCT04113018|454722597|FG000|Overall Study|Lost to Follow-up|1|||
126390574|NCT04113018|454722597|FG000|Overall Study|Still On Study (on study treatment)|24|||
126390575|NCT04113018|454722597|FG000|Overall Study|Still On Study (in follow up)|12|||
126390576|NCT06099223|454722598|FG000|Overall Study|Preoperative surveys missed|0|||
126390577|NCT06099223|454722599|FG001|Overall Study|Preoperative surveys missed|1|||
126390578|NCT00079391|454722600|FG000|Overall Study|Withdrawal by Subject|1|||
126390579|NCT01802580|454722603|FG000|Overall Study|Physician Decision|1|||
126390580|NCT01802580|454722604|FG001|Overall Study|Physician Decision|0|||
126390581|NCT01802580|454722603|FG000|Overall Study|Protocol Violation|2|||
126390582|NCT01802580|454722604|FG001|Overall Study|Protocol Violation|0|||
126390583|NCT01802580|454722603|FG000|Overall Study|Withdrawal by Subject|5|||
126390584|NCT01802580|454722604|FG001|Overall Study|Withdrawal by Subject|6|||
126390585|NCT01802580|454722603|FG000|Overall Study|Other|1|||
126390586|NCT01802580|454722604|FG001|Overall Study|Other|3|||
126390587|NCT01802580|454722603|FG000|Overall Study|Lack of Efficacy|0|||
126390588|NCT01802580|454722604|FG001|Overall Study|Lack of Efficacy|2|||
126390589|NCT02791516|454722607|FG000|Overall Study|Withdrawal by Subject|1|||
126390590|NCT02791516|454722608|FG001|Overall Study|Withdrawal by Subject|1|||
126390591|NCT00211757|454722611|FG000|Overall Study|Withdrawal by Subject|1|||
126390592|NCT00211757|454722612|FG001|Overall Study|Withdrawal by Subject|1|||
126390593|NCT00211757|454722611|FG000|Overall Study|Lack of Efficacy|0|||
126390594|NCT00211757|454722612|FG001|Overall Study|Lack of Efficacy|1|||
126390595|NCT03479541|454722613|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
126390596|NCT03479541|454722614|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
126390597|NCT03479541|454722615|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
126390598|NCT03479541|454722616|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
126390599|NCT03479541|454722613|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
126390600|NCT03479541|454722614|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
126390601|NCT03479541|454722615|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
126390602|NCT03479541|454722616|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
126390603|NCT03479541|454722613|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
126390604|NCT03479541|454722614|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
126390605|NCT03479541|454722615|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
126390606|NCT03479541|454722616|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
126390607|NCT03479541|454722613|FG000|Home Monitoring|Lost to Follow-up|0|||
126390608|NCT03479541|454722614|FG001|Home Monitoring|Lost to Follow-up|0|||
126771245|NCT01336608|456117715|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
126771246|NCT01336608|456117712|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
126771247|NCT01336608|456117713|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
126771248|NCT01336608|456117714|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
126771249|NCT01336608|456117715|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
126771250|NCT01336608|456117712|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
126771251|NCT01336608|456117713|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126771252|NCT01336608|456117714|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126771253|NCT01336608|456117715|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126771254|NCT01336608|456117712|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
126771255|NCT01336608|456117713|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
126771256|NCT01336608|456117714|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
126390609|NCT03479541|454722615|FG002|Home Monitoring|Lost to Follow-up|8|||
126390610|NCT03479541|454722616|FG003|Home Monitoring|Lost to Follow-up|12|||
126390611|NCT03479541|454722613|FG000|Home Monitoring|Withdrawal by Subject|0|||
126390612|NCT03479541|454722614|FG001|Home Monitoring|Withdrawal by Subject|0|||
126390613|NCT03479541|454722615|FG002|Home Monitoring|Withdrawal by Subject|17|||
126390614|NCT03479541|454722616|FG003|Home Monitoring|Withdrawal by Subject|30|||
126390615|NCT03479541|454722613|FG000|Home Monitoring|Early Termination - PI Decision|0|||
126390616|NCT03479541|454722614|FG001|Home Monitoring|Early Termination - PI Decision|0|||
126390617|NCT03479541|454722615|FG002|Home Monitoring|Early Termination - PI Decision|4|||
126390618|NCT03479541|454722616|FG003|Home Monitoring|Early Termination - PI Decision|6|||
126390619|NCT02644096|454722617|FG000|Overall Study|Withdrawal by Subject|28|||
126390620|NCT02644096|454722618|FG001|Overall Study|Withdrawal by Subject|25|||
126390621|NCT02461290|454722619|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
126390622|NCT02461290|454722619|FG000|Overall Study|Lost to Follow-up|3|||
126390623|NCT00526656|454722620|FG000|Overall Study|Death|1|||
126390624|NCT00526656|454722620|FG000|Overall Study|Refused surgery|1|||
126390625|NCT01456195|454724375|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
126390626|NCT01456195|454724376|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
126390627|NCT01456195|454724377|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
126390628|NCT01456195|454724375|FG000|Overall Study|Lost to Follow-up|3|||
126390629|NCT01456195|454724376|FG001|Overall Study|Lost to Follow-up|1|||
126390630|NCT01456195|454724377|FG002|Overall Study|Lost to Follow-up|3|||
126390631|NCT01456195|454724375|FG000|Overall Study|Voluntary Withdrawal|5|||
126390632|NCT01456195|454724376|FG001|Overall Study|Voluntary Withdrawal|3|||
126390633|NCT01456195|454724377|FG002|Overall Study|Voluntary Withdrawal|7|||
126390634|NCT01456195|454724375|FG000|Overall Study|Lack of Efficacy|0|||
126554253|NCT02018861|455324019|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
126554254|NCT02018861|455324020|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
126554255|NCT02018861|455324021|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
126554256|NCT02018861|455324022|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
126554257|NCT02018861|455324023|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
126554258|NCT02018861|455324014|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
126554259|NCT02018861|455324015|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
126554260|NCT02018861|455324016|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
126554261|NCT02018861|455324017|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
126554262|NCT02018861|455324018|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
126554263|NCT02018861|455324019|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
126554264|NCT02018861|455324020|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
126554265|NCT02018861|455324021|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
126554266|NCT02018861|455324022|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
126554267|NCT02018861|455324023|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
126554268|NCT02018861|455324014|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126554269|NCT02018861|455324015|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126554270|NCT02018861|455324016|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126554271|NCT02018861|455324017|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126554272|NCT02018861|455324018|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126554273|NCT02018861|455324019|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126554274|NCT02018861|455324020|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126554275|NCT02018861|455324021|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126554276|NCT02018861|455324022|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
126554277|NCT02018861|455324023|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
126554278|NCT00504348|455324024|FG000|Overall Study|Adverse Event|3|||
126554279|NCT00504348|455324024|FG000|Overall Study|Lack of Efficacy|4|||
126554280|NCT00504348|455324024|FG000|Overall Study|Physician Decision|1|||
126554281|NCT01474512|455324028|FG000|Induction Period|Adverse Event|6|||
126554282|NCT01474512|455324029|FG001|Induction Period|Adverse Event|10|||
126554283|NCT01474512|455324030|FG002|Induction Period|Adverse Event|10|||
126554284|NCT01474512|455324031|FG003|Induction Period|Adverse Event|0|||
126554285|NCT01474512|455324032|FG004|Induction Period|Adverse Event|0|||
126554286|NCT01474512|455324033|FG005|Induction Period|Adverse Event|0|||
126390635|NCT01456195|454724376|FG001|Overall Study|Lack of Efficacy|1|||
126390636|NCT01456195|454724377|FG002|Overall Study|Lack of Efficacy|0|||
126390637|NCT01456195|454724375|FG000|Overall Study|Other Reasons|2|||
126390638|NCT01456195|454724376|FG001|Overall Study|Other Reasons|1|||
126390639|NCT01456195|454724377|FG002|Overall Study|Other Reasons|3|||
126390640|NCT02547038|454724378|FG000|Overall Study|Lost to Follow-up|3|||
126390641|NCT02547038|454724379|FG001|Overall Study|Lost to Follow-up|2|||
126390642|NCT01340625|454724380|FG000|First Intervention|Adverse Event|1|||
126390643|NCT01340625|454724381|FG001|First Intervention|Adverse Event|0|||
126390644|NCT01340625|454724380|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
126390645|NCT01340625|454724381|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
126390646|NCT00734604|454724388|FG000|Overall Study|Adverse Event|0|||
126390647|NCT00734604|454724389|FG001|Overall Study|Adverse Event|2|||
126554287|NCT01474512|455324034|FG006|Induction Period|Adverse Event|0|||
126554288|NCT01474512|455324035|FG007|Induction Period|Adverse Event|0|||
126554289|NCT01474512|455324036|FG008|Induction Period|Adverse Event|0|||
126554290|NCT01474512|455324037|FG009|Induction Period|Adverse Event|0|||
126554291|NCT01474512|455324038|FG010|Induction Period|Adverse Event|0|||
126554292|NCT01474512|455324039|FG011|Induction Period|Adverse Event|0|||
126390648|NCT00734604|454724390|FG002|Overall Study|Adverse Event|0|||
126390649|NCT00734604|454724391|FG003|Overall Study|Adverse Event|2|||
126390650|NCT00734604|454724392|FG004|Overall Study|Adverse Event|1|||
126390651|NCT00734604|454724393|FG005|Overall Study|Adverse Event|1|||
126390652|NCT00734604|454724388|FG000|Overall Study|Serious Adverse Event|1|||
126390653|NCT00734604|454724389|FG001|Overall Study|Serious Adverse Event|0|||
126390654|NCT00734604|454724390|FG002|Overall Study|Serious Adverse Event|1|||
126390655|NCT00734604|454724391|FG003|Overall Study|Serious Adverse Event|2|||
126390656|NCT00734604|454724392|FG004|Overall Study|Serious Adverse Event|0|||
126390657|NCT00734604|454724393|FG005|Overall Study|Serious Adverse Event|1|||
126390658|NCT00734604|454724388|FG000|Overall Study|Lost to Follow-up|1|||
126390659|NCT00734604|454724389|FG001|Overall Study|Lost to Follow-up|2|||
126390660|NCT00734604|454724390|FG002|Overall Study|Lost to Follow-up|2|||
126390661|NCT00734604|454724391|FG003|Overall Study|Lost to Follow-up|4|||
126390662|NCT00734604|454724392|FG004|Overall Study|Lost to Follow-up|2|||
126390663|NCT00734604|454724393|FG005|Overall Study|Lost to Follow-up|3|||
126390664|NCT00734604|454724388|FG000|Overall Study|Physician Decision|0|||
126390665|NCT00734604|454724389|FG001|Overall Study|Physician Decision|1|||
126390666|NCT00734604|454724390|FG002|Overall Study|Physician Decision|1|||
126390667|NCT00734604|454724391|FG003|Overall Study|Physician Decision|0|||
126390668|NCT00734604|454724392|FG004|Overall Study|Physician Decision|0|||
126390669|NCT00734604|454724393|FG005|Overall Study|Physician Decision|0|||
126390670|NCT00734604|454724388|FG000|Overall Study|Protocol Violation|0|||
126390671|NCT00734604|454724389|FG001|Overall Study|Protocol Violation|2|||
126390672|NCT00734604|454724390|FG002|Overall Study|Protocol Violation|0|||
126390673|NCT00734604|454724391|FG003|Overall Study|Protocol Violation|0|||
126390674|NCT00734604|454724392|FG004|Overall Study|Protocol Violation|1|||
126390675|NCT00734604|454724393|FG005|Overall Study|Protocol Violation|0|||
126390676|NCT00734604|454724388|FG000|Overall Study|Sponsor Decision|1|||
126390677|NCT00734604|454724389|FG001|Overall Study|Sponsor Decision|2|||
126390678|NCT00734604|454724390|FG002|Overall Study|Sponsor Decision|1|||
126390679|NCT00734604|454724391|FG003|Overall Study|Sponsor Decision|0|||
126390680|NCT00734604|454724392|FG004|Overall Study|Sponsor Decision|2|||
126390681|NCT00734604|454724393|FG005|Overall Study|Sponsor Decision|0|||
126390682|NCT00734604|454724388|FG000|Overall Study|Withdrawal by Subject|0|||
126390683|NCT00734604|454724389|FG001|Overall Study|Withdrawal by Subject|2|||
126390684|NCT00734604|454724390|FG002|Overall Study|Withdrawal by Subject|0|||
126390685|NCT00734604|454724391|FG003|Overall Study|Withdrawal by Subject|1|||
126390686|NCT00734604|454724392|FG004|Overall Study|Withdrawal by Subject|2|||
126390687|NCT00734604|454724393|FG005|Overall Study|Withdrawal by Subject|1|||
126390688|NCT00734604|454724388|FG000|Overall Study|Lack of Efficacy|0|||
126390689|NCT00734604|454724389|FG001|Overall Study|Lack of Efficacy|1|||
126390690|NCT00734604|454724390|FG002|Overall Study|Lack of Efficacy|1|||
126390691|NCT00734604|454724391|FG003|Overall Study|Lack of Efficacy|0|||
126390692|NCT00734604|454724392|FG004|Overall Study|Lack of Efficacy|0|||
126390693|NCT00734604|454724393|FG005|Overall Study|Lack of Efficacy|0|||
126390694|NCT02589665|454724394|FG000|Induction Period|Did not receive drug|0|||
126390695|NCT02589665|454724395|FG001|Induction Period|Did not receive drug|0|||
126390696|NCT02589665|454724396|FG002|Induction Period|Did not receive drug|0|||
126390697|NCT02589665|454724397|FG003|Induction Period|Did not receive drug|1|||
126390698|NCT02589665|454724398|FG004|Induction Period|Did not receive drug|0|||
126390699|NCT02589665|454724399|FG005|Induction Period|Did not receive drug|0|||
126390700|NCT02589665|454724400|FG006|Induction Period|Did not receive drug|0|||
126390701|NCT02589665|454724401|FG007|Induction Period|Did not receive drug|0|||
126390702|NCT02589665|454724402|FG008|Induction Period|Did not receive drug|0|||
126390703|NCT02589665|454724403|FG009|Induction Period|Did not receive drug|0|||
126390704|NCT02589665|454724394|FG000|Induction Period|Adverse Event|3|||
126390705|NCT02589665|454724395|FG001|Induction Period|Adverse Event|0|||
126390706|NCT02589665|454724396|FG002|Induction Period|Adverse Event|2|||
126390707|NCT02589665|454724397|FG003|Induction Period|Adverse Event|2|||
126390708|NCT02589665|454724398|FG004|Induction Period|Adverse Event|0|||
126390709|NCT02589665|454724399|FG005|Induction Period|Adverse Event|0|||
126390710|NCT02589665|454724400|FG006|Induction Period|Adverse Event|0|||
126390711|NCT02589665|454724401|FG007|Induction Period|Adverse Event|0|||
126390712|NCT02589665|454724402|FG008|Induction Period|Adverse Event|0|||
126390713|NCT02589665|454724403|FG009|Induction Period|Adverse Event|0|||
126390714|NCT02589665|454724394|FG000|Induction Period|Withdrawal by Subject|0|||
126390715|NCT02589665|454724395|FG001|Induction Period|Withdrawal by Subject|1|||
126390716|NCT02589665|454724396|FG002|Induction Period|Withdrawal by Subject|0|||
126390717|NCT02589665|454724397|FG003|Induction Period|Withdrawal by Subject|1|||
126390718|NCT02589665|454724398|FG004|Induction Period|Withdrawal by Subject|0|||
126390719|NCT02589665|454724399|FG005|Induction Period|Withdrawal by Subject|0|||
126390720|NCT02589665|454724400|FG006|Induction Period|Withdrawal by Subject|0|||
126390721|NCT02589665|454724401|FG007|Induction Period|Withdrawal by Subject|0|||
126390722|NCT02589665|454724402|FG008|Induction Period|Withdrawal by Subject|0|||
126390723|NCT02589665|454724403|FG009|Induction Period|Withdrawal by Subject|0|||
126390724|NCT02589665|454724394|FG000|Induction Period|Protocol Violation|0|||
126390725|NCT02589665|454724395|FG001|Induction Period|Protocol Violation|1|||
126390726|NCT02589665|454724396|FG002|Induction Period|Protocol Violation|0|||
126390727|NCT02589665|454724397|FG003|Induction Period|Protocol Violation|0|||
126390728|NCT02589665|454724398|FG004|Induction Period|Protocol Violation|0|||
126390729|NCT02589665|454724399|FG005|Induction Period|Protocol Violation|0|||
126390730|NCT02589665|454724400|FG006|Induction Period|Protocol Violation|0|||
126390731|NCT02589665|454724401|FG007|Induction Period|Protocol Violation|0|||
126390732|NCT02589665|454724402|FG008|Induction Period|Protocol Violation|0|||
126390733|NCT02589665|454724403|FG009|Induction Period|Protocol Violation|0|||
126390734|NCT02589665|454724394|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390735|NCT02589665|454724395|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390736|NCT02589665|454724396|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390737|NCT02589665|454724397|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390738|NCT02589665|454724398|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
126390739|NCT02589665|454724399|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
126390740|NCT02589665|454724400|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
126390741|NCT02589665|454724401|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390742|NCT02589665|454724402|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390743|NCT02589665|454724403|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390744|NCT02589665|454724394|FG000|Maintenance Period|Withdrawal by Subject|0|||
126390745|NCT02589665|454724395|FG001|Maintenance Period|Withdrawal by Subject|0|||
126390746|NCT02589665|454724396|FG002|Maintenance Period|Withdrawal by Subject|0|||
126390747|NCT02589665|454724397|FG003|Maintenance Period|Withdrawal by Subject|0|||
126390748|NCT02589665|454724398|FG004|Maintenance Period|Withdrawal by Subject|4|||
126390749|NCT02589665|454724399|FG005|Maintenance Period|Withdrawal by Subject|2|||
126390750|NCT02589665|454724400|FG006|Maintenance Period|Withdrawal by Subject|4|||
126390751|NCT02589665|454724401|FG007|Maintenance Period|Withdrawal by Subject|0|||
126390752|NCT02589665|454724402|FG008|Maintenance Period|Withdrawal by Subject|0|||
126390753|NCT02589665|454724403|FG009|Maintenance Period|Withdrawal by Subject|0|||
126390754|NCT02589665|454724394|FG000|Maintenance Period|Lack of Efficacy|0|||
126390755|NCT02589665|454724395|FG001|Maintenance Period|Lack of Efficacy|0|||
126390756|NCT02589665|454724396|FG002|Maintenance Period|Lack of Efficacy|0|||
126390757|NCT02589665|454724397|FG003|Maintenance Period|Lack of Efficacy|0|||
126390758|NCT02589665|454724398|FG004|Maintenance Period|Lack of Efficacy|2|||
126390759|NCT02589665|454724399|FG005|Maintenance Period|Lack of Efficacy|1|||
126390760|NCT02589665|454724400|FG006|Maintenance Period|Lack of Efficacy|0|||
126390761|NCT02589665|454724401|FG007|Maintenance Period|Lack of Efficacy|0|||
126390762|NCT02589665|454724402|FG008|Maintenance Period|Lack of Efficacy|0|||
126390763|NCT02589665|454724403|FG009|Maintenance Period|Lack of Efficacy|0|||
126390764|NCT02589665|454724394|FG000|Maintenance Period|Adverse Event|0|||
126390765|NCT02589665|454724395|FG001|Maintenance Period|Adverse Event|0|||
126390766|NCT02589665|454724396|FG002|Maintenance Period|Adverse Event|0|||
126390767|NCT02589665|454724397|FG003|Maintenance Period|Adverse Event|0|||
126390768|NCT02589665|454724398|FG004|Maintenance Period|Adverse Event|0|||
126390769|NCT02589665|454724399|FG005|Maintenance Period|Adverse Event|0|||
126390770|NCT02589665|454724400|FG006|Maintenance Period|Adverse Event|2|||
126390771|NCT02589665|454724401|FG007|Maintenance Period|Adverse Event|0|||
126390772|NCT02589665|454724402|FG008|Maintenance Period|Adverse Event|0|||
126390773|NCT02589665|454724403|FG009|Maintenance Period|Adverse Event|0|||
126390774|NCT02589665|454724394|FG000|Maintenance Period|Lost to Follow-up|0|||
126390775|NCT02589665|454724395|FG001|Maintenance Period|Lost to Follow-up|0|||
126390776|NCT02589665|454724396|FG002|Maintenance Period|Lost to Follow-up|0|||
126390777|NCT02589665|454724397|FG003|Maintenance Period|Lost to Follow-up|0|||
126390778|NCT02589665|454724398|FG004|Maintenance Period|Lost to Follow-up|0|||
126390779|NCT02589665|454724399|FG005|Maintenance Period|Lost to Follow-up|1|||
126390780|NCT02589665|454724400|FG006|Maintenance Period|Lost to Follow-up|0|||
126390781|NCT02589665|454724401|FG007|Maintenance Period|Lost to Follow-up|0|||
126390782|NCT02589665|454724402|FG008|Maintenance Period|Lost to Follow-up|0|||
126390783|NCT02589665|454724403|FG009|Maintenance Period|Lost to Follow-up|0|||
126390784|NCT02589665|454724394|FG000|Maintenance Period|Physician Decision|0|||
126390785|NCT02589665|454724395|FG001|Maintenance Period|Physician Decision|0|||
126390786|NCT02589665|454724396|FG002|Maintenance Period|Physician Decision|0|||
126390787|NCT02589665|454724397|FG003|Maintenance Period|Physician Decision|0|||
126390788|NCT02589665|454724398|FG004|Maintenance Period|Physician Decision|0|||
126390789|NCT02589665|454724399|FG005|Maintenance Period|Physician Decision|1|||
126390790|NCT02589665|454724400|FG006|Maintenance Period|Physician Decision|0|||
126390791|NCT02589665|454724401|FG007|Maintenance Period|Physician Decision|0|||
126390792|NCT02589665|454724402|FG008|Maintenance Period|Physician Decision|0|||
126390793|NCT02589665|454724403|FG009|Maintenance Period|Physician Decision|0|||
126390794|NCT02589665|454724394|FG000|Maintenance Period|Reason Not Collected|0|||
126390795|NCT02589665|454724395|FG001|Maintenance Period|Reason Not Collected|0|||
126390796|NCT02589665|454724396|FG002|Maintenance Period|Reason Not Collected|0|||
126390797|NCT02589665|454724397|FG003|Maintenance Period|Reason Not Collected|0|||
126390798|NCT02589665|454724398|FG004|Maintenance Period|Reason Not Collected|0|||
126390799|NCT02589665|454724399|FG005|Maintenance Period|Reason Not Collected|1|||
126390800|NCT02589665|454724400|FG006|Maintenance Period|Reason Not Collected|1|||
126390801|NCT02589665|454724401|FG007|Maintenance Period|Reason Not Collected|0|||
126554293|NCT01474512|455324040|FG012|Induction Period|Adverse Event|0|||
126717957|NCT03860844|455917704|FG001|Overall Study|Progressive disease|3|||
126717958|NCT03860844|455917705|FG002|Overall Study|Progressive disease|4|||
126717959|NCT03860844|455917703|FG000|Overall Study|Other, Not related to COVID-19|0|||
126717960|NCT03860844|455917704|FG001|Overall Study|Other, Not related to COVID-19|1|||
126717961|NCT03860844|455917705|FG002|Overall Study|Other, Not related to COVID-19|0|||
126717962|NCT01678807|455917706|FG000|Overall Study|Adverse Event|4|||
126717963|NCT01678807|455917707|FG001|Overall Study|Adverse Event|4|||
126717964|NCT01678807|455917708|FG002|Overall Study|Adverse Event|0|||
126717965|NCT01678807|455917706|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
126717966|NCT01678807|455917707|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
126717967|NCT01678807|455917708|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
126717968|NCT00370149|455917709|FG000|Overall Study|Physician Decision|16|||
126717969|NCT00370149|455917710|FG001|Overall Study|Physician Decision|16|||
126717970|NCT00370149|455917709|FG000|Overall Study|Protocol Violation|1|||
126717971|NCT00370149|455917710|FG001|Overall Study|Protocol Violation|0|||
126717972|NCT00370149|455917709|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
126717973|NCT00370149|455917710|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
126717974|NCT00370149|455917709|FG000|Overall Study|Pre-existing infection|0|||
126717975|NCT00370149|455917710|FG001|Overall Study|Pre-existing infection|1|||
126717976|NCT00370149|455917709|FG000|Overall Study|Antibiotic coated dressing placed|0|||
126717977|NCT00370149|455917710|FG001|Overall Study|Antibiotic coated dressing placed|1|||
126717978|NCT00719732|455917711|FG000|Overall Study|Lost to Follow-up|20|||
126717979|NCT00719732|455917711|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
126717980|NCT00719732|455917711|FG000|Overall Study|Illness not associated with device|1|||
126717981|NCT03625986|455919413|FG000|Randomization Period|Lost to Follow-up|7|||
126717982|NCT03625986|455919414|FG001|Randomization Period|Lost to Follow-up|12|||
126390802|NCT02589665|454724402|FG008|Maintenance Period|Reason Not Collected|0|||
126390803|NCT02589665|454724403|FG009|Maintenance Period|Reason Not Collected|0|||
126390804|NCT02589665|454724394|FG000|Induction Extension Period|Adverse Event|0|||
126390805|NCT02589665|454724395|FG001|Induction Extension Period|Adverse Event|0|||
126390806|NCT02589665|454724396|FG002|Induction Extension Period|Adverse Event|0|||
126717983|NCT03625986|455919413|FG000|Randomization Period|Withdrawal by Subject|10|||
126717984|NCT03625986|455919414|FG001|Randomization Period|Withdrawal by Subject|6|||
126717985|NCT04920084|455919416|FG000|Overall Study|Adverse Event|1|||
126717986|NCT04920084|455919416|FG000|Overall Study|Lost to Follow-up|2|||
126717987|NCT04920084|455919416|FG000|Overall Study|Withdrawal by Subject|2|||
126717988|NCT00620321|455919417|FG000|Overall Study|Adverse Event|1|||
126717989|NCT00620321|455919418|FG001|Overall Study|Adverse Event|1|||
126717990|NCT00620321|455919417|FG000|Overall Study|Death|1|||
126717991|NCT00620321|455919418|FG001|Overall Study|Death|1|||
126717992|NCT00620321|455919417|FG000|Overall Study|Physician Decision|0|||
126717993|NCT00620321|455919418|FG001|Overall Study|Physician Decision|7|||
126717994|NCT00620321|455919417|FG000|Overall Study|Progressive Disease|5|||
126717995|NCT00620321|455919418|FG001|Overall Study|Progressive Disease|5|||
126717996|NCT00620321|455919417|FG000|Overall Study|Sponsor Decision|0|||
126717997|NCT00620321|455919418|FG001|Overall Study|Sponsor Decision|1|||
126717998|NCT00620321|455919417|FG000|Overall Study|Withdrawal by Subject|1|||
126717999|NCT00620321|455919418|FG001|Overall Study|Withdrawal by Subject|1|||
126390807|NCT02589665|454724397|FG003|Induction Extension Period|Adverse Event|0|||
126718000|NCT04191967|455919419|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
126718001|NCT04191967|455919419|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
126718002|NCT01431144|455919420|FG000|Overall Study|Implant mobility and removal|2|||
126718003|NCT01431144|455919421|FG001|Overall Study|Implant mobility and removal|0|||
126718004|NCT02410902|455919430|FG000|Overall Study|Adverse Event|2|||
126718005|NCT02410902|455919431|FG001|Overall Study|Adverse Event|3|||
126718006|NCT02410902|455919430|FG000|Overall Study|Lost to Follow-up|4|||
126718007|NCT02410902|455919431|FG001|Overall Study|Lost to Follow-up|1|||
126718008|NCT02410902|455919430|FG000|Overall Study|Protocol Violation|1|||
126718009|NCT02410902|455919431|FG001|Overall Study|Protocol Violation|4|||
126718010|NCT02410902|455919430|FG000|Overall Study|Withdrawal by Subject|6|||
126771257|NCT01336608|456117715|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
126771258|NCT01336608|456117712|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126771259|NCT01336608|456117713|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
126771260|NCT01336608|456117714|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126390808|NCT02589665|454724398|FG004|Induction Extension Period|Adverse Event|0|||
126390809|NCT02589665|454724399|FG005|Induction Extension Period|Adverse Event|0|||
126390810|NCT02589665|454724400|FG006|Induction Extension Period|Adverse Event|0|||
126390811|NCT02589665|454724401|FG007|Induction Extension Period|Adverse Event|0|||
126390812|NCT02589665|454724402|FG008|Induction Extension Period|Adverse Event|4|||
126718011|NCT02410902|455919431|FG001|Overall Study|Withdrawal by Subject|8|||
126718012|NCT02410902|455919430|FG000|Overall Study|Non-Compliance|8|||
126718013|NCT02410902|455919431|FG001|Overall Study|Non-Compliance|2|||
126718014|NCT00953043|455919432|FG000|Overall Study|Withdrawal by Subject|4|||
126468477|NCT00566501|455017605|FG001|Overall Study|Lack of Efficacy|3|||
126390813|NCT02589665|454724403|FG009|Induction Extension Period|Adverse Event|0|||
126390814|NCT02589665|454724394|FG000|Induction Extension Period|Lack of Efficacy|0|||
126390815|NCT02589665|454724395|FG001|Induction Extension Period|Lack of Efficacy|0|||
126390816|NCT02589665|454724396|FG002|Induction Extension Period|Lack of Efficacy|0|||
126390817|NCT02589665|454724397|FG003|Induction Extension Period|Lack of Efficacy|0|||
126390818|NCT02589665|454724398|FG004|Induction Extension Period|Lack of Efficacy|0|||
126390819|NCT02589665|454724399|FG005|Induction Extension Period|Lack of Efficacy|0|||
126390820|NCT02589665|454724400|FG006|Induction Extension Period|Lack of Efficacy|0|||
126390821|NCT02589665|454724401|FG007|Induction Extension Period|Lack of Efficacy|0|||
126390822|NCT02589665|454724402|FG008|Induction Extension Period|Lack of Efficacy|3|||
126390823|NCT02589665|454724403|FG009|Induction Extension Period|Lack of Efficacy|0|||
126390824|NCT02589665|454724394|FG000|Induction Extension Period|Withdrawal by Subject|0|||
126390825|NCT02589665|454724395|FG001|Induction Extension Period|Withdrawal by Subject|0|||
126390826|NCT02589665|454724396|FG002|Induction Extension Period|Withdrawal by Subject|0|||
126390827|NCT02589665|454724397|FG003|Induction Extension Period|Withdrawal by Subject|0|||
126390828|NCT02589665|454724398|FG004|Induction Extension Period|Withdrawal by Subject|0|||
126390829|NCT02589665|454724399|FG005|Induction Extension Period|Withdrawal by Subject|0|||
126390830|NCT02589665|454724400|FG006|Induction Extension Period|Withdrawal by Subject|0|||
126390831|NCT02589665|454724401|FG007|Induction Extension Period|Withdrawal by Subject|2|||
126390832|NCT02589665|454724402|FG008|Induction Extension Period|Withdrawal by Subject|3|||
126390833|NCT02589665|454724403|FG009|Induction Extension Period|Withdrawal by Subject|0|||
126390834|NCT02589665|454724394|FG000|Induction Extension Period|Physician Decision|0|||
126390835|NCT02589665|454724395|FG001|Induction Extension Period|Physician Decision|0|||
126390836|NCT02589665|454724396|FG002|Induction Extension Period|Physician Decision|0|||
126390837|NCT02589665|454724397|FG003|Induction Extension Period|Physician Decision|0|||
126390838|NCT02589665|454724398|FG004|Induction Extension Period|Physician Decision|0|||
126390839|NCT02589665|454724399|FG005|Induction Extension Period|Physician Decision|0|||
126390840|NCT02589665|454724400|FG006|Induction Extension Period|Physician Decision|0|||
126390841|NCT02589665|454724401|FG007|Induction Extension Period|Physician Decision|0|||
126390842|NCT02589665|454724402|FG008|Induction Extension Period|Physician Decision|1|||
126390843|NCT02589665|454724403|FG009|Induction Extension Period|Physician Decision|0|||
126390844|NCT02589665|454724394|FG000|Induction Extension Period|Reason Not Collected|0|||
126390845|NCT02589665|454724395|FG001|Induction Extension Period|Reason Not Collected|0|||
126390846|NCT02589665|454724396|FG002|Induction Extension Period|Reason Not Collected|0|||
126390847|NCT02589665|454724397|FG003|Induction Extension Period|Reason Not Collected|0|||
126390848|NCT02589665|454724398|FG004|Induction Extension Period|Reason Not Collected|0|||
126390849|NCT02589665|454724399|FG005|Induction Extension Period|Reason Not Collected|0|||
126390850|NCT02589665|454724400|FG006|Induction Extension Period|Reason Not Collected|0|||
126390851|NCT02589665|454724401|FG007|Induction Extension Period|Reason Not Collected|0|||
126554294|NCT01474512|455324041|FG013|Induction Period|Adverse Event|0|||
126554295|NCT01474512|455324042|FG014|Induction Period|Adverse Event|0|||
126554296|NCT01474512|455324043|FG015|Induction Period|Adverse Event|0|||
126554297|NCT01474512|455324044|FG016|Induction Period|Adverse Event|0|||
126554298|NCT01474512|455324045|FG017|Induction Period|Adverse Event|0|||
126554299|NCT01474512|455324028|FG000|Induction Period|Lack of Efficacy|7|||
126554300|NCT01474512|455324029|FG001|Induction Period|Lack of Efficacy|1|||
126554301|NCT01474512|455324030|FG002|Induction Period|Lack of Efficacy|0|||
126554302|NCT01474512|455324031|FG003|Induction Period|Lack of Efficacy|0|||
126554303|NCT01474512|455324032|FG004|Induction Period|Lack of Efficacy|0|||
126390852|NCT02589665|454724402|FG008|Induction Extension Period|Reason Not Collected|1|||
126390853|NCT02589665|454724403|FG009|Induction Extension Period|Reason Not Collected|0|||
126390854|NCT02589665|454724394|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126554304|NCT01474512|455324033|FG005|Induction Period|Lack of Efficacy|0|||
126554305|NCT01474512|455324034|FG006|Induction Period|Lack of Efficacy|0|||
126554306|NCT01474512|455324035|FG007|Induction Period|Lack of Efficacy|0|||
126554307|NCT01474512|455324036|FG008|Induction Period|Lack of Efficacy|0|||
126554308|NCT01474512|455324037|FG009|Induction Period|Lack of Efficacy|0|||
126554309|NCT01474512|455324038|FG010|Induction Period|Lack of Efficacy|0|||
126554310|NCT01474512|455324039|FG011|Induction Period|Lack of Efficacy|0|||
126390855|NCT02589665|454724395|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390856|NCT02589665|454724396|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390857|NCT02589665|454724397|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126554311|NCT01474512|455324040|FG012|Induction Period|Lack of Efficacy|0|||
126554312|NCT01474512|455324041|FG013|Induction Period|Lack of Efficacy|0|||
126390858|NCT02589665|454724398|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126554313|NCT01474512|455324042|FG014|Induction Period|Lack of Efficacy|0|||
126390859|NCT02589665|454724399|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390860|NCT02589665|454724400|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126554314|NCT01474512|455324043|FG015|Induction Period|Lack of Efficacy|0|||
126554315|NCT01474512|455324044|FG016|Induction Period|Lack of Efficacy|0|||
126554316|NCT01474512|455324045|FG017|Induction Period|Lack of Efficacy|0|||
126554317|NCT01474512|455324028|FG000|Induction Period|Withdrawal by Subject|6|||
126390861|NCT02589665|454724401|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126390862|NCT02589665|454724402|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
126718015|NCT00953043|455919433|FG001|Overall Study|Withdrawal by Subject|0|||
126718016|NCT00953043|455919432|FG000|Overall Study|Physician Decision|0|||
126718017|NCT00953043|455919433|FG001|Overall Study|Physician Decision|2|||
126390863|NCT02589665|454724403|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
126390864|NCT02589665|454724394|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
126390865|NCT02589665|454724395|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
126390866|NCT02589665|454724396|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
126390867|NCT02589665|454724397|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
126390868|NCT02589665|454724398|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
126390869|NCT02589665|454724399|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
126390870|NCT02589665|454724400|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
126390871|NCT02589665|454724401|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
126390872|NCT02589665|454724402|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
126390873|NCT02589665|454724403|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
126390874|NCT02589665|454724394|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
126390875|NCT02589665|454724395|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
126390876|NCT02589665|454724396|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
126390877|NCT02589665|454724397|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
126390878|NCT02589665|454724398|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
126390879|NCT02589665|454724399|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
126390880|NCT02589665|454724400|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
126390881|NCT02589665|454724401|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
126390882|NCT02589665|454724402|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
126390883|NCT02589665|454724403|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
126390884|NCT02589665|454724394|FG000|Maintenance Extension Period|Adverse Event|0|||
126390885|NCT02589665|454724395|FG001|Maintenance Extension Period|Adverse Event|0|||
126390886|NCT02589665|454724396|FG002|Maintenance Extension Period|Adverse Event|0|||
126390887|NCT02589665|454724397|FG003|Maintenance Extension Period|Adverse Event|0|||
126390888|NCT02589665|454724398|FG004|Maintenance Extension Period|Adverse Event|0|||
126390889|NCT02589665|454724399|FG005|Maintenance Extension Period|Adverse Event|0|||
126390890|NCT02589665|454724400|FG006|Maintenance Extension Period|Adverse Event|0|||
126390891|NCT02589665|454724401|FG007|Maintenance Extension Period|Adverse Event|0|||
126390892|NCT02589665|454724402|FG008|Maintenance Extension Period|Adverse Event|0|||
126390893|NCT02589665|454724403|FG009|Maintenance Extension Period|Adverse Event|2|||
126390894|NCT02589665|454724394|FG000|Maintenance Extension Period|Non-responder|0|||
126390895|NCT02589665|454724395|FG001|Maintenance Extension Period|Non-responder|0|||
126390896|NCT02589665|454724396|FG002|Maintenance Extension Period|Non-responder|0|||
126390897|NCT02589665|454724397|FG003|Maintenance Extension Period|Non-responder|0|||
126390898|NCT02589665|454724398|FG004|Maintenance Extension Period|Non-responder|0|||
126390899|NCT02589665|454724399|FG005|Maintenance Extension Period|Non-responder|0|||
126390900|NCT02589665|454724400|FG006|Maintenance Extension Period|Non-responder|0|||
126390901|NCT02589665|454724401|FG007|Maintenance Extension Period|Non-responder|0|||
126390902|NCT02589665|454724402|FG008|Maintenance Extension Period|Non-responder|0|||
126390903|NCT02589665|454724403|FG009|Maintenance Extension Period|Non-responder|1|||
126390904|NCT00978380|454724404|FG000|Overall Study|Protocol Violation|2|||
126390905|NCT00978380|454724404|FG000|Overall Study|Withdrawal criteria|9|||
126390906|NCT00978380|454724404|FG000|Overall Study|Unclassified|8|||
126390907|NCT00327015|454724405|FG000|Overall Study|Lack of Efficacy|18|||
126390908|NCT00327015|454724406|FG001|Overall Study|Lack of Efficacy|18|||
126390909|NCT00327015|454724407|FG002|Overall Study|Lack of Efficacy|35|||
126390910|NCT00327015|454724408|FG003|Overall Study|Lack of Efficacy|29|||
126390911|NCT00327015|454724405|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
126390912|NCT00327015|454724406|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
126390913|NCT00327015|454724407|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
126390914|NCT00327015|454724408|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
126390915|NCT00327015|454724405|FG000|Overall Study|Lost to Follow-up|22|||
126390916|NCT00327015|454724406|FG001|Overall Study|Lost to Follow-up|23|||
126390917|NCT00327015|454724407|FG002|Overall Study|Lost to Follow-up|29|||
126390918|NCT00327015|454724408|FG003|Overall Study|Lost to Follow-up|22|||
126390919|NCT00327015|454724405|FG000|Overall Study|Adverse Event|14|||
126390920|NCT00327015|454724406|FG001|Overall Study|Adverse Event|10|||
126390921|NCT00327015|454724407|FG002|Overall Study|Adverse Event|14|||
126390922|NCT00327015|454724408|FG003|Overall Study|Adverse Event|14|||
126390923|NCT00327015|454724405|FG000|Overall Study|Subject no longer meets study criteria|4|||
126390924|NCT00327015|454724406|FG001|Overall Study|Subject no longer meets study criteria|2|||
126390925|NCT00327015|454724407|FG002|Overall Study|Subject no longer meets study criteria|8|||
126390926|NCT00327015|454724408|FG003|Overall Study|Subject no longer meets study criteria|7|||
126390927|NCT00327015|454724405|FG000|Overall Study|Poor/Noncompliance|11|||
126718018|NCT00701727|455919435|FG000|First Treatment Period|Adverse Event|0|||
126390928|NCT00327015|454724406|FG001|Overall Study|Poor/Noncompliance|8|||
126390929|NCT00327015|454724407|FG002|Overall Study|Poor/Noncompliance|4|||
126390930|NCT00327015|454724408|FG003|Overall Study|Poor/Noncompliance|5|||
126390931|NCT00327015|454724405|FG000|Overall Study|Physician Decision|0|||
126390932|NCT00327015|454724406|FG001|Overall Study|Physician Decision|1|||
126390933|NCT00327015|454724407|FG002|Overall Study|Physician Decision|3|||
126390934|NCT00327015|454724408|FG003|Overall Study|Physician Decision|2|||
126390935|NCT00327015|454724405|FG000|Overall Study|Death|1|||
126390936|NCT00327015|454724406|FG001|Overall Study|Death|2|||
126390937|NCT00327015|454724407|FG002|Overall Study|Death|2|||
126390938|NCT00327015|454724408|FG003|Overall Study|Death|3|||
126390939|NCT00327015|454724405|FG000|Overall Study|Pregnancy|0|||
126390940|NCT00327015|454724406|FG001|Overall Study|Pregnancy|2|||
126390941|NCT00327015|454724407|FG002|Overall Study|Pregnancy|1|||
126390942|NCT00327015|454724408|FG003|Overall Study|Pregnancy|1|||
126390943|NCT00327015|454724405|FG000|Overall Study|Administrative Reason by Sponsor|1|||
126390944|NCT00327015|454724406|FG001|Overall Study|Administrative Reason by Sponsor|2|||
126390945|NCT00327015|454724407|FG002|Overall Study|Administrative Reason by Sponsor|2|||
126390946|NCT00327015|454724408|FG003|Overall Study|Administrative Reason by Sponsor|1|||
126390947|NCT01519791|454724409|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
126390948|NCT01519791|454724410|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
126390949|NCT01519791|454724409|FG000|Overall Study|Protocol Violation|6|||
126390950|NCT01519791|454724410|FG001|Overall Study|Protocol Violation|19|||
126390951|NCT01519791|454724409|FG000|Overall Study|Other Reason|87|||
126390952|NCT01519791|454724410|FG001|Overall Study|Other Reason|222|||
126390953|NCT01519791|454724409|FG000|Overall Study|subjects randomized in error|2|||
126390954|NCT01519791|454724410|FG001|Overall Study|subjects randomized in error|0|||
126390955|NCT01519791|454724409|FG000|Overall Study|Lack of Efficacy|16|||
126390956|NCT01519791|454724410|FG001|Overall Study|Lack of Efficacy|20|||
126390957|NCT01519791|454724409|FG000|Overall Study|SAE, non-fatal|6|||
126390958|NCT01519791|454724410|FG001|Overall Study|SAE, non-fatal|22|||
126390959|NCT01519791|454724409|FG000|Overall Study|AE, serious fatal|0|||
126390960|NCT01519791|454724410|FG001|Overall Study|AE, serious fatal|1|||
126554318|NCT01474512|455324029|FG001|Induction Period|Withdrawal by Subject|6|||
126554319|NCT01474512|455324030|FG002|Induction Period|Withdrawal by Subject|5|||
126390961|NCT01519791|454724409|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
126390962|NCT01519791|454724410|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
126390963|NCT01519791|454724409|FG000|Overall Study|AE, non-serious non-fatal|12|||
126390964|NCT01519791|454724410|FG001|Overall Study|AE, non-serious non-fatal|31|||
126390965|NCT01519791|454724409|FG000|Overall Study|Withdrawal by Subject|15|||
126390966|NCT01519791|454724410|FG001|Overall Study|Withdrawal by Subject|37|||
126390967|NCT01519791|454724409|FG000|Overall Study|Lost to Follow-up|6|||
126390968|NCT01519791|454724410|FG001|Overall Study|Lost to Follow-up|14|||
126390969|NCT00837265|454724411|FG000|Pilot Phase|Withdrawal by Subject|0|||
126390970|NCT00837265|454724412|FG001|Pilot Phase|Withdrawal by Subject|2|||
126390971|NCT00837265|454724413|FG002|Pilot Phase|Withdrawal by Subject|3|||
126390972|NCT00837265|454724414|FG003|Pilot Phase|Withdrawal by Subject|2|||
126390973|NCT00837265|454724415|FG004|Pilot Phase|Withdrawal by Subject|0|||
126390974|NCT00837265|454724416|FG005|Pilot Phase|Withdrawal by Subject|0|||
126390975|NCT00837265|454724417|FG006|Pilot Phase|Withdrawal by Subject|0|||
126390976|NCT00837265|454724411|FG000|Pilot Phase|Decision of the investigator|2|||
126390977|NCT00837265|454724412|FG001|Pilot Phase|Decision of the investigator|1|||
126390978|NCT00837265|454724413|FG002|Pilot Phase|Decision of the investigator|0|||
126390979|NCT00837265|454724414|FG003|Pilot Phase|Decision of the investigator|0|||
126390980|NCT00837265|454724415|FG004|Pilot Phase|Decision of the investigator|0|||
126390981|NCT00837265|454724416|FG005|Pilot Phase|Decision of the investigator|0|||
126390982|NCT00837265|454724417|FG006|Pilot Phase|Decision of the investigator|0|||
126390983|NCT00837265|454724411|FG000|Pilot Phase|Adverse Event|1|||
126390984|NCT00837265|454724412|FG001|Pilot Phase|Adverse Event|0|||
126390985|NCT00837265|454724413|FG002|Pilot Phase|Adverse Event|0|||
126390986|NCT00837265|454724414|FG003|Pilot Phase|Adverse Event|0|||
126390987|NCT00837265|454724415|FG004|Pilot Phase|Adverse Event|0|||
126390988|NCT00837265|454724416|FG005|Pilot Phase|Adverse Event|0|||
126390989|NCT00837265|454724417|FG006|Pilot Phase|Adverse Event|0|||
126390990|NCT00837265|454724411|FG000|Pilot Phase|Disease progression|0|||
126390991|NCT00837265|454724412|FG001|Pilot Phase|Disease progression|0|||
126390992|NCT00837265|454724413|FG002|Pilot Phase|Disease progression|0|||
126390993|NCT00837265|454724414|FG003|Pilot Phase|Disease progression|1|||
126390994|NCT00837265|454724415|FG004|Pilot Phase|Disease progression|0|||
126390995|NCT00837265|454724416|FG005|Pilot Phase|Disease progression|0|||
126390996|NCT00837265|454724417|FG006|Pilot Phase|Disease progression|0|||
126390997|NCT00837265|454724411|FG000|Pilot Phase|Participant left the city|0|||
126390998|NCT00837265|454724412|FG001|Pilot Phase|Participant left the city|0|||
126390999|NCT00837265|454724413|FG002|Pilot Phase|Participant left the city|0|||
126391000|NCT00837265|454724414|FG003|Pilot Phase|Participant left the city|1|||
126391001|NCT00837265|454724415|FG004|Pilot Phase|Participant left the city|0|||
126391002|NCT00837265|454724416|FG005|Pilot Phase|Participant left the city|0|||
126391003|NCT00837265|454724417|FG006|Pilot Phase|Participant left the city|0|||
126391004|NCT00837265|454724411|FG000|Main Phase|Withdrawal by Subject|0|||
126391005|NCT00837265|454724412|FG001|Main Phase|Withdrawal by Subject|0|||
126391006|NCT00837265|454724413|FG002|Main Phase|Withdrawal by Subject|0|||
126391007|NCT00837265|454724414|FG003|Main Phase|Withdrawal by Subject|0|||
126391008|NCT00837265|454724415|FG004|Main Phase|Withdrawal by Subject|4|||
126391009|NCT00837265|454724416|FG005|Main Phase|Withdrawal by Subject|2|||
126391010|NCT00837265|454724417|FG006|Main Phase|Withdrawal by Subject|1|||
126391011|NCT00837265|454724411|FG000|Main Phase|Decision of the investigator|0|||
126391012|NCT00837265|454724412|FG001|Main Phase|Decision of the investigator|0|||
126391013|NCT00837265|454724413|FG002|Main Phase|Decision of the investigator|0|||
126391014|NCT00837265|454724414|FG003|Main Phase|Decision of the investigator|0|||
126391015|NCT00837265|454724415|FG004|Main Phase|Decision of the investigator|0|||
126391016|NCT00837265|454724416|FG005|Main Phase|Decision of the investigator|2|||
126391017|NCT00837265|454724417|FG006|Main Phase|Decision of the investigator|1|||
126554320|NCT01474512|455324031|FG003|Induction Period|Withdrawal by Subject|0|||
126554321|NCT01474512|455324032|FG004|Induction Period|Withdrawal by Subject|0|||
126554322|NCT01474512|455324033|FG005|Induction Period|Withdrawal by Subject|0|||
126554323|NCT01474512|455324034|FG006|Induction Period|Withdrawal by Subject|0|||
126554324|NCT01474512|455324035|FG007|Induction Period|Withdrawal by Subject|0|||
126554325|NCT01474512|455324036|FG008|Induction Period|Withdrawal by Subject|0|||
126554326|NCT01474512|455324037|FG009|Induction Period|Withdrawal by Subject|0|||
126554327|NCT01474512|455324038|FG010|Induction Period|Withdrawal by Subject|0|||
126554328|NCT01474512|455324039|FG011|Induction Period|Withdrawal by Subject|0|||
126554329|NCT01474512|455324040|FG012|Induction Period|Withdrawal by Subject|0|||
126554330|NCT01474512|455324041|FG013|Induction Period|Withdrawal by Subject|0|||
126554331|NCT01474512|455324042|FG014|Induction Period|Withdrawal by Subject|0|||
126554332|NCT01474512|455324043|FG015|Induction Period|Withdrawal by Subject|0|||
126554333|NCT01474512|455324044|FG016|Induction Period|Withdrawal by Subject|0|||
126554334|NCT01474512|455324045|FG017|Induction Period|Withdrawal by Subject|0|||
126554335|NCT01474512|455324028|FG000|Induction Period|Protocol Violation|3|||
126554336|NCT01474512|455324029|FG001|Induction Period|Protocol Violation|6|||
126554337|NCT01474512|455324030|FG002|Induction Period|Protocol Violation|0|||
126554338|NCT01474512|455324031|FG003|Induction Period|Protocol Violation|0|||
126554339|NCT01474512|455324032|FG004|Induction Period|Protocol Violation|0|||
126554340|NCT01474512|455324033|FG005|Induction Period|Protocol Violation|0|||
126554341|NCT01474512|455324034|FG006|Induction Period|Protocol Violation|0|||
126554342|NCT01474512|455324035|FG007|Induction Period|Protocol Violation|0|||
126554343|NCT01474512|455324036|FG008|Induction Period|Protocol Violation|0|||
126554344|NCT01474512|455324037|FG009|Induction Period|Protocol Violation|0|||
126554345|NCT01474512|455324038|FG010|Induction Period|Protocol Violation|0|||
126554346|NCT01474512|455324039|FG011|Induction Period|Protocol Violation|0|||
126554347|NCT01474512|455324040|FG012|Induction Period|Protocol Violation|0|||
126554348|NCT01474512|455324041|FG013|Induction Period|Protocol Violation|0|||
126554349|NCT01474512|455324042|FG014|Induction Period|Protocol Violation|0|||
126554350|NCT01474512|455324043|FG015|Induction Period|Protocol Violation|0|||
126554351|NCT01474512|455324044|FG016|Induction Period|Protocol Violation|0|||
126554352|NCT01474512|455324045|FG017|Induction Period|Protocol Violation|0|||
126554353|NCT01474512|455324028|FG000|Induction Period|Sponsor Decision|1|||
126554354|NCT01474512|455324029|FG001|Induction Period|Sponsor Decision|1|||
126554355|NCT01474512|455324030|FG002|Induction Period|Sponsor Decision|1|||
126554356|NCT01474512|455324031|FG003|Induction Period|Sponsor Decision|0|||
126554357|NCT01474512|455324032|FG004|Induction Period|Sponsor Decision|0|||
126554358|NCT01474512|455324033|FG005|Induction Period|Sponsor Decision|0|||
126554359|NCT01474512|455324034|FG006|Induction Period|Sponsor Decision|0|||
126554360|NCT01474512|455324035|FG007|Induction Period|Sponsor Decision|0|||
126554361|NCT01474512|455324036|FG008|Induction Period|Sponsor Decision|0|||
126554362|NCT01474512|455324037|FG009|Induction Period|Sponsor Decision|0|||
126554363|NCT01474512|455324038|FG010|Induction Period|Sponsor Decision|0|||
126554364|NCT01474512|455324039|FG011|Induction Period|Sponsor Decision|0|||
126554365|NCT01474512|455324040|FG012|Induction Period|Sponsor Decision|0|||
126554366|NCT01474512|455324041|FG013|Induction Period|Sponsor Decision|0|||
126554367|NCT01474512|455324042|FG014|Induction Period|Sponsor Decision|0|||
126554368|NCT01474512|455324043|FG015|Induction Period|Sponsor Decision|0|||
126554369|NCT01474512|455324044|FG016|Induction Period|Sponsor Decision|0|||
126554370|NCT01474512|455324045|FG017|Induction Period|Sponsor Decision|0|||
126718019|NCT00701727|455919436|FG001|First Treatment Period|Adverse Event|0|||
126554371|NCT01474512|455324028|FG000|Induction Period|Lost to Follow-up|1|||
126554372|NCT01474512|455324029|FG001|Induction Period|Lost to Follow-up|0|||
126554373|NCT01474512|455324030|FG002|Induction Period|Lost to Follow-up|2|||
126554374|NCT01474512|455324031|FG003|Induction Period|Lost to Follow-up|0|||
126391018|NCT00837265|454724411|FG000|Main Phase|Adverse Event|0|||
126554375|NCT01474512|455324032|FG004|Induction Period|Lost to Follow-up|0|||
126554376|NCT01474512|455324033|FG005|Induction Period|Lost to Follow-up|0|||
126391019|NCT00837265|454724412|FG001|Main Phase|Adverse Event|0|||
126391020|NCT00837265|454724413|FG002|Main Phase|Adverse Event|0|||
126391021|NCT00837265|454724414|FG003|Main Phase|Adverse Event|0|||
126391022|NCT00837265|454724415|FG004|Main Phase|Adverse Event|0|||
126554377|NCT01474512|455324034|FG006|Induction Period|Lost to Follow-up|0|||
126718020|NCT00701727|455919435|FG000|First Treatment Period|Withdrawal by Subject|1|||
126391023|NCT00837265|454724416|FG005|Main Phase|Adverse Event|1|||
126391024|NCT00837265|454724417|FG006|Main Phase|Adverse Event|0|||
126391025|NCT00837265|454724411|FG000|Main Phase|Death|0|||
126391026|NCT00837265|454724412|FG001|Main Phase|Death|0|||
126391027|NCT00837265|454724413|FG002|Main Phase|Death|0|||
126391028|NCT00837265|454724414|FG003|Main Phase|Death|0|||
126391029|NCT00837265|454724415|FG004|Main Phase|Death|2|||
126391030|NCT00837265|454724416|FG005|Main Phase|Death|0|||
126391031|NCT00837265|454724417|FG006|Main Phase|Death|1|||
126391032|NCT00837265|454724411|FG000|Main Phase|Lost to Follow-up|0|||
126391033|NCT00837265|454724412|FG001|Main Phase|Lost to Follow-up|0|||
126391034|NCT00837265|454724413|FG002|Main Phase|Lost to Follow-up|0|||
126391035|NCT00837265|454724414|FG003|Main Phase|Lost to Follow-up|0|||
126391036|NCT00837265|454724415|FG004|Main Phase|Lost to Follow-up|1|||
126391037|NCT00837265|454724416|FG005|Main Phase|Lost to Follow-up|0|||
126391038|NCT00837265|454724417|FG006|Main Phase|Lost to Follow-up|0|||
126391039|NCT00837265|454724411|FG000|Main Phase|Principal investigator resignation|0|||
126391040|NCT00837265|454724412|FG001|Main Phase|Principal investigator resignation|0|||
126391041|NCT00837265|454724413|FG002|Main Phase|Principal investigator resignation|0|||
126391042|NCT00837265|454724414|FG003|Main Phase|Principal investigator resignation|0|||
126391043|NCT00837265|454724415|FG004|Main Phase|Principal investigator resignation|2|||
126391044|NCT00837265|454724416|FG005|Main Phase|Principal investigator resignation|0|||
126391045|NCT00837265|454724417|FG006|Main Phase|Principal investigator resignation|0|||
126391046|NCT00837265|454724411|FG000|Main Phase|Participant's personal reason|0|||
126391047|NCT00837265|454724412|FG001|Main Phase|Participant's personal reason|0|||
126391048|NCT00837265|454724413|FG002|Main Phase|Participant's personal reason|0|||
126391049|NCT00837265|454724414|FG003|Main Phase|Participant's personal reason|0|||
126391050|NCT00837265|454724415|FG004|Main Phase|Participant's personal reason|1|||
126391051|NCT00837265|454724416|FG005|Main Phase|Participant's personal reason|0|||
126391052|NCT00837265|454724417|FG006|Main Phase|Participant's personal reason|0|||
126391053|NCT01289353|454724418|FG000|Overall Study|Lost to Follow-up|2|||
126391054|NCT02226562|454724419|FG000|Overall Study|Lost to Follow-up|0|||
126391055|NCT02226562|454724420|FG001|Overall Study|Lost to Follow-up|1|||
126391056|NCT01474772|454724422|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
126391057|NCT01474772|454724423|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
126391058|NCT01474772|454724422|FG000|Period 1|AE not Related to Study Drug|1|||
126391059|NCT01474772|454724423|FG001|Period 1|AE not Related to Study Drug|0|||
126391060|NCT01474772|454724422|FG000|Period 1|Withdrawal by Subject|3|||
126391061|NCT01474772|454724423|FG001|Period 1|Withdrawal by Subject|1|||
126391062|NCT01474772|454724422|FG000|Period 1|Lost to Follow-up|1|||
126391063|NCT01474772|454724423|FG001|Period 1|Lost to Follow-up|0|||
126391064|NCT01474772|454724422|FG000|Period 1|Reason not Specified|1|||
126391065|NCT01474772|454724423|FG001|Period 1|Reason not Specified|1|||
126391066|NCT01474772|454724422|FG000|Washout|AE not Related to Study Drug|2|||
126391067|NCT01474772|454724423|FG001|Washout|AE not Related to Study Drug|0|||
126391068|NCT01474772|454724422|FG000|Washout|Withdrawal by Subject|1|||
126391069|NCT01474772|454724423|FG001|Washout|Withdrawal by Subject|0|||
126391070|NCT01474772|454724422|FG000|Washout|Lost to Follow-up|0|||
126391071|NCT01474772|454724423|FG001|Washout|Lost to Follow-up|1|||
126391072|NCT01474772|454724422|FG000|Washout|Reason not Specified|0|||
126391073|NCT01474772|454724423|FG001|Washout|Reason not Specified|1|||
126391074|NCT01474772|454724422|FG000|Period 2|Death|0|||
126391075|NCT01474772|454724423|FG001|Period 2|Death|1|||
126391076|NCT01474772|454724422|FG000|Period 2|AE Related to Study Drug|0|||
126391077|NCT01474772|454724423|FG001|Period 2|AE Related to Study Drug|1|||
126391078|NCT01474772|454724422|FG000|Period 2|AE not Related to Study Drug|4|||
126391079|NCT01474772|454724423|FG001|Period 2|AE not Related to Study Drug|1|||
126391080|NCT01474772|454724422|FG000|Period 2|Lack of Efficacy|1|||
126391081|NCT01474772|454724423|FG001|Period 2|Lack of Efficacy|0|||
126391082|NCT01474772|454724422|FG000|Period 2|Withdrawal by Subject|3|||
126391083|NCT01474772|454724423|FG001|Period 2|Withdrawal by Subject|4|||
126391084|NCT01474772|454724422|FG000|Period 2|Lost to Follow-up|1|||
126391085|NCT01474772|454724423|FG001|Period 2|Lost to Follow-up|1|||
126391086|NCT01474772|454724422|FG000|Period 2|Reason not Specified|0|||
126391087|NCT01474772|454724423|FG001|Period 2|Reason not Specified|2|||
126391088|NCT01474772|454724422|FG000|Follow-up|AE not Related to Study Drug|0|||
126391089|NCT01474772|454724423|FG001|Follow-up|AE not Related to Study Drug|1|||
126391090|NCT00223808|454724424|FG000|Overall Study|<5 hrs therapy before discharge|3|||
126391091|NCT00223808|454724425|FG001|Overall Study|<5 hrs therapy before discharge|5|||
126391092|NCT00223808|454724426|FG002|Overall Study|<5 hrs therapy before discharge|5|||
126391093|NCT00967694|454724429|FG000|Overall Study|Withdrawal by Subject|6|||
126391094|NCT02321319|454724430|FG000|Overall Study|Product discontinued|5|||
126391095|NCT00152477|454724431|FG000|Chemotherapy Period|Adverse Event|9|||
126391096|NCT00152477|454724432|FG001|Chemotherapy Period|Adverse Event|4|||
126391097|NCT00152477|454724433|FG002|Chemotherapy Period|Adverse Event|5|||
126391098|NCT00152477|454724431|FG000|Chemotherapy Period|Death|1|||
126391099|NCT00152477|454724432|FG001|Chemotherapy Period|Death|3|||
126391100|NCT00152477|454724433|FG002|Chemotherapy Period|Death|3|||
126391101|NCT00152477|454724431|FG000|Chemotherapy Period|Lack of Efficacy|4|||
126391102|NCT00152477|454724432|FG001|Chemotherapy Period|Lack of Efficacy|5|||
126554378|NCT01474512|455324035|FG007|Induction Period|Lost to Follow-up|0|||
126554379|NCT01474512|455324036|FG008|Induction Period|Lost to Follow-up|0|||
126554380|NCT01474512|455324037|FG009|Induction Period|Lost to Follow-up|0|||
126554381|NCT01474512|455324038|FG010|Induction Period|Lost to Follow-up|0|||
126554382|NCT01474512|455324039|FG011|Induction Period|Lost to Follow-up|0|||
126554383|NCT01474512|455324040|FG012|Induction Period|Lost to Follow-up|0|||
126554384|NCT01474512|455324041|FG013|Induction Period|Lost to Follow-up|0|||
126554385|NCT01474512|455324042|FG014|Induction Period|Lost to Follow-up|0|||
126554386|NCT01474512|455324043|FG015|Induction Period|Lost to Follow-up|0|||
126554387|NCT01474512|455324044|FG016|Induction Period|Lost to Follow-up|0|||
126554388|NCT01474512|455324045|FG017|Induction Period|Lost to Follow-up|0|||
126554389|NCT01474512|455324028|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554390|NCT01474512|455324029|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554391|NCT01474512|455324030|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554392|NCT01474512|455324031|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
126554393|NCT01474512|455324032|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
126554394|NCT01474512|455324033|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
126554395|NCT01474512|455324034|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
126554396|NCT01474512|455324035|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554397|NCT01474512|455324036|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554398|NCT01474512|455324037|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554399|NCT01474512|455324038|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554400|NCT01474512|455324039|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554401|NCT01474512|455324040|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554402|NCT01474512|455324041|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554403|NCT01474512|455324042|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554404|NCT01474512|455324043|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554405|NCT01474512|455324044|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554406|NCT01474512|455324045|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
126554407|NCT01474512|455324028|FG000|Maintenance Period|Adverse Event|0|||
126554408|NCT01474512|455324029|FG001|Maintenance Period|Adverse Event|0|||
126554409|NCT01474512|455324030|FG002|Maintenance Period|Adverse Event|0|||
126554410|NCT01474512|455324031|FG003|Maintenance Period|Adverse Event|4|||
126554411|NCT01474512|455324032|FG004|Maintenance Period|Adverse Event|2|||
126554412|NCT01474512|455324033|FG005|Maintenance Period|Adverse Event|7|||
126554413|NCT01474512|455324034|FG006|Maintenance Period|Adverse Event|0|||
126554414|NCT01474512|455324035|FG007|Maintenance Period|Adverse Event|19|||
126554415|NCT01474512|455324036|FG008|Maintenance Period|Adverse Event|1|||
126468478|NCT00566501|455017604|FG000|Overall Study|Other|25|||
126468479|NCT00566501|455017605|FG001|Overall Study|Other|21|||
126468480|NCT00057876|455017606|FG000|Overall Study|Adverse Event|8|||
126468481|NCT00057876|455017607|FG001|Overall Study|Adverse Event|8|||
126468482|NCT00057876|455017606|FG000|Overall Study|Death|2|||
126468483|NCT00057876|455017607|FG001|Overall Study|Death|1|||
126468484|NCT00057876|455017606|FG000|Overall Study|Withdrawal by Subject|5|||
126468485|NCT00057876|455017607|FG001|Overall Study|Withdrawal by Subject|6|||
126468486|NCT00057876|455017606|FG000|Overall Study|Lack of Efficacy|10|||
126468487|NCT00057876|455017607|FG001|Overall Study|Lack of Efficacy|8|||
126468488|NCT00057876|455017606|FG000|Overall Study|Ineligible|1|||
126468489|NCT00057876|455017607|FG001|Overall Study|Ineligible|2|||
126468490|NCT00057876|455017606|FG000|Overall Study|other reason|2|||
126468491|NCT00057876|455017607|FG001|Overall Study|other reason|2|||
126468492|NCT00057876|455017606|FG000|Overall Study|other complicating disease|1|||
126468493|NCT00057876|455017607|FG001|Overall Study|other complicating disease|0|||
126468494|NCT01938573|455017608|FG000|Overall Study|Lack of Efficacy|1|||
126468495|NCT01938573|455017609|FG001|Overall Study|Lack of Efficacy|0|||
126468496|NCT01938573|455017608|FG000|Overall Study|Operation at other hospital|1|||
126468497|NCT01938573|455017609|FG001|Overall Study|Operation at other hospital|0|||
126468498|NCT01649804|455017616|FG000|Overall Study|Administrative/Other|8|||
126554416|NCT01474512|455324037|FG009|Maintenance Period|Adverse Event|3|||
126554417|NCT01474512|455324038|FG010|Maintenance Period|Adverse Event|0|||
126554418|NCT01474512|455324039|FG011|Maintenance Period|Adverse Event|0|||
126554419|NCT01474512|455324040|FG012|Maintenance Period|Adverse Event|0|||
126468499|NCT01123850|455017623|FG000|Overall Study|Slow enrollment|45|||
126468500|NCT02456103|455017624|FG000|Overall Study|Study Closure|207|||
126554420|NCT01474512|455324041|FG013|Maintenance Period|Adverse Event|0|||
126554421|NCT01474512|455324042|FG014|Maintenance Period|Adverse Event|0|||
126554422|NCT01474512|455324043|FG015|Maintenance Period|Adverse Event|0|||
126554423|NCT01474512|455324044|FG016|Maintenance Period|Adverse Event|0|||
126468501|NCT02456103|455017624|FG000|Overall Study|Physician Decision|1|||
126468502|NCT02456103|455017624|FG000|Overall Study|Required prohibited medications|5|||
126554424|NCT01474512|455324045|FG017|Maintenance Period|Adverse Event|0|||
126554425|NCT01474512|455324028|FG000|Maintenance Period|Withdrawal by Subject|0|||
126468503|NCT02456103|455017624|FG000|Overall Study|Protocol Violation|1|||
126468504|NCT02456103|455017624|FG000|Overall Study|Adverse Event|5|||
126468505|NCT02456103|455017624|FG000|Overall Study|Abnormal Laboratory Value|2|||
126468506|NCT02456103|455017624|FG000|Overall Study|Lost to Follow-up|1|||
126554426|NCT01474512|455324029|FG001|Maintenance Period|Withdrawal by Subject|0|||
126391103|NCT00152477|454724433|FG002|Chemotherapy Period|Lack of Efficacy|6|||
126391104|NCT00152477|454724431|FG000|Chemotherapy Period|Lost to Follow-up|1|||
126391105|NCT00152477|454724432|FG001|Chemotherapy Period|Lost to Follow-up|0|||
126391106|NCT00152477|454724433|FG002|Chemotherapy Period|Lost to Follow-up|1|||
126391107|NCT00152477|454724431|FG000|Chemotherapy Period|Protocol Violation|1|||
126391108|NCT00152477|454724432|FG001|Chemotherapy Period|Protocol Violation|1|||
126391109|NCT00152477|454724433|FG002|Chemotherapy Period|Protocol Violation|0|||
126391110|NCT00152477|454724431|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
126391111|NCT00152477|454724432|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
126391112|NCT00152477|454724433|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
126391113|NCT00152477|454724431|FG000|Chemotherapy Period|Progression of Disease|6|||
126391114|NCT00152477|454724432|FG001|Chemotherapy Period|Progression of Disease|8|||
126391115|NCT00152477|454724433|FG002|Chemotherapy Period|Progression of Disease|4|||
126391116|NCT00152477|454724431|FG000|Chemotherapy Period|Investigator decision|0|||
126391117|NCT00152477|454724432|FG001|Chemotherapy Period|Investigator decision|0|||
126391118|NCT00152477|454724433|FG002|Chemotherapy Period|Investigator decision|1|||
126391119|NCT00152477|454724431|FG000|Chemotherapy Period|Patient condition worsened|1|||
126391120|NCT00152477|454724432|FG001|Chemotherapy Period|Patient condition worsened|0|||
126391121|NCT00152477|454724433|FG002|Chemotherapy Period|Patient condition worsened|0|||
126391122|NCT00152477|454724431|FG000|Monotherapy Period|Adverse Event|1|||
126391123|NCT00152477|454724432|FG001|Monotherapy Period|Adverse Event|0|||
126391124|NCT00152477|454724433|FG002|Monotherapy Period|Adverse Event|5|||
126391125|NCT00152477|454724431|FG000|Monotherapy Period|Death|2|||
126391126|NCT00152477|454724432|FG001|Monotherapy Period|Death|0|||
126391127|NCT00152477|454724433|FG002|Monotherapy Period|Death|1|||
126391128|NCT00152477|454724431|FG000|Monotherapy Period|Lack of Efficacy|7|||
126391129|NCT00152477|454724432|FG001|Monotherapy Period|Lack of Efficacy|16|||
126391130|NCT00152477|454724433|FG002|Monotherapy Period|Lack of Efficacy|10|||
126391131|NCT00152477|454724431|FG000|Monotherapy Period|Protocol Violation|0|||
126391132|NCT00152477|454724432|FG001|Monotherapy Period|Protocol Violation|1|||
126391133|NCT00152477|454724433|FG002|Monotherapy Period|Protocol Violation|0|||
126391134|NCT00152477|454724431|FG000|Monotherapy Period|Withdrawal by Subject|0|||
126391135|NCT00152477|454724432|FG001|Monotherapy Period|Withdrawal by Subject|0|||
126391136|NCT00152477|454724433|FG002|Monotherapy Period|Withdrawal by Subject|4|||
126391137|NCT00152477|454724431|FG000|Monotherapy Period|Progression of Disease|5|||
126391138|NCT00152477|454724432|FG001|Monotherapy Period|Progression of Disease|11|||
126391139|NCT00152477|454724433|FG002|Monotherapy Period|Progression of Disease|12|||
126391140|NCT00152477|454724431|FG000|Monotherapy Period|Patient decision|0|||
126391141|NCT00152477|454724432|FG001|Monotherapy Period|Patient decision|1|||
126391142|NCT00152477|454724433|FG002|Monotherapy Period|Patient decision|1|||
126391143|NCT00152477|454724431|FG000|Monotherapy Period|Study personel decision|0|||
126391144|NCT00152477|454724432|FG001|Monotherapy Period|Study personel decision|0|||
126391145|NCT00152477|454724433|FG002|Monotherapy Period|Study personel decision|1|||
126391146|NCT00923975|454724434|FG000|Overall Study|Did not meet inclusion criteria|1|||
126391147|NCT01005316|454724435|FG000|Overall Study|Adverse Event|0|||
126391148|NCT01005316|454724436|FG001|Overall Study|Adverse Event|0|||
126391149|NCT01005316|454724437|FG002|Overall Study|Adverse Event|0|||
126391150|NCT01005316|454724438|FG003|Overall Study|Adverse Event|1|||
126391151|NCT01005316|454724435|FG000|Overall Study|Death|20|||
126391152|NCT01005316|454724436|FG001|Overall Study|Death|5|||
126391153|NCT01005316|454724437|FG002|Overall Study|Death|1|||
126391154|NCT01005316|454724438|FG003|Overall Study|Death|15|||
126391155|NCT01005316|454724435|FG000|Overall Study|Study Termination|5|||
126468507|NCT02456103|455017624|FG000|Overall Study|Withdrawal by Subject|24|||
126468508|NCT02083081|455017625|FG000|Overall Study|Lost to Follow-up|31|||
126468509|NCT02083081|455017626|FG001|Overall Study|Lost to Follow-up|9|||
126468510|NCT02448810|455017627|FG000|Overall Study|Adverse Event|0|||
126468511|NCT02448810|455017628|FG001|Overall Study|Adverse Event|0|||
126391156|NCT01005316|454724436|FG001|Overall Study|Study Termination|63|||
126391157|NCT01005316|454724437|FG002|Overall Study|Study Termination|9|||
126391158|NCT01005316|454724438|FG003|Overall Study|Study Termination|85|||
126391159|NCT01005316|454724435|FG000|Overall Study|Lost to Follow-up|1|||
126391160|NCT01005316|454724436|FG001|Overall Study|Lost to Follow-up|3|||
126391161|NCT01005316|454724437|FG002|Overall Study|Lost to Follow-up|0|||
126468512|NCT02448810|455017629|FG002|Overall Study|Adverse Event|1|||
126391162|NCT01005316|454724438|FG003|Overall Study|Lost to Follow-up|2|||
126391163|NCT01005316|454724435|FG000|Overall Study|Physician Decision|6|||
126391164|NCT01005316|454724436|FG001|Overall Study|Physician Decision|0|||
126391165|NCT01005316|454724437|FG002|Overall Study|Physician Decision|0|||
126391166|NCT01005316|454724438|FG003|Overall Study|Physician Decision|0|||
126391167|NCT01005316|454724435|FG000|Overall Study|Sponsor Decision|6|||
126391168|NCT01005316|454724436|FG001|Overall Study|Sponsor Decision|3|||
126391169|NCT01005316|454724437|FG002|Overall Study|Sponsor Decision|0|||
126391170|NCT01005316|454724438|FG003|Overall Study|Sponsor Decision|0|||
126391171|NCT01005316|454724435|FG000|Overall Study|Withdrawal by Subject|1|||
126391172|NCT01005316|454724436|FG001|Overall Study|Withdrawal by Subject|1|||
126468513|NCT02448810|455017630|FG003|Overall Study|Adverse Event|0|||
126468514|NCT02448810|455017631|FG004|Overall Study|Adverse Event|0|||
126771261|NCT01336608|456117715|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126391173|NCT01005316|454724437|FG002|Overall Study|Withdrawal by Subject|0|||
126391174|NCT01005316|454724438|FG003|Overall Study|Withdrawal by Subject|2|||
126391175|NCT01005316|454724435|FG000|Overall Study|Consented to Another Study|2|||
126771262|NCT01336608|456117712|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
126771263|NCT01336608|456117713|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
126771264|NCT01336608|456117714|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
126771265|NCT01336608|456117715|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
126771266|NCT01336608|456117712|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
126771267|NCT01336608|456117713|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
126771268|NCT01336608|456117714|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
126771269|NCT01336608|456117715|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
126771270|NCT01336608|456117712|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
126771271|NCT01336608|456117713|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
126771272|NCT01336608|456117714|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
126771273|NCT01336608|456117715|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
126771274|NCT01336608|456117712|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126391176|NCT01005316|454724436|FG001|Overall Study|Consented to Another Study|0|||
126391177|NCT01005316|454724437|FG002|Overall Study|Consented to Another Study|0|||
126391178|NCT01005316|454724438|FG003|Overall Study|Consented to Another Study|0|||
126391179|NCT01005316|454724435|FG000|Overall Study|Delisted|8|||
126391180|NCT01005316|454724436|FG001|Overall Study|Delisted|0|||
126391181|NCT01005316|454724437|FG002|Overall Study|Delisted|0|||
126391182|NCT01005316|454724438|FG003|Overall Study|Delisted|0|||
126391183|NCT01005316|454724435|FG000|Overall Study|Transferred Care|1|||
126391184|NCT01005316|454724436|FG001|Overall Study|Transferred Care|0|||
126391185|NCT01005316|454724437|FG002|Overall Study|Transferred Care|1|||
126391186|NCT01005316|454724438|FG003|Overall Study|Transferred Care|3|||
126391187|NCT01005316|454724435|FG000|Overall Study|Retransplanted|0|||
126391188|NCT01005316|454724436|FG001|Overall Study|Retransplanted|1|||
126391189|NCT01005316|454724437|FG002|Overall Study|Retransplanted|0|||
126391190|NCT01005316|454724438|FG003|Overall Study|Retransplanted|0|||
126391191|NCT00960011|454724439|FG000|Overall Study|Death|5|||
126391192|NCT00960011|454724440|FG001|Overall Study|Death|0|||
126391193|NCT00960011|454724439|FG000|Overall Study|Lost to Follow-up|6|||
126391194|NCT00960011|454724440|FG001|Overall Study|Lost to Follow-up|2|||
126468515|NCT02448810|455017632|FG005|Overall Study|Adverse Event|0|||
126468516|NCT02448810|455017633|FG006|Overall Study|Adverse Event|0|||
126391195|NCT00758264|454724441|FG000|Active Phase|Withdrawal by Subject|0|||
126468517|NCT02448810|455017634|FG007|Overall Study|Adverse Event|0|||
126468518|NCT02448810|455017627|FG000|Overall Study|Withdrawal by Subject|0|||
126468519|NCT02448810|455017628|FG001|Overall Study|Withdrawal by Subject|0|||
126468520|NCT02448810|455017629|FG002|Overall Study|Withdrawal by Subject|1|||
126468521|NCT02448810|455017630|FG003|Overall Study|Withdrawal by Subject|0|||
126468522|NCT02448810|455017631|FG004|Overall Study|Withdrawal by Subject|3|||
126468523|NCT02448810|455017632|FG005|Overall Study|Withdrawal by Subject|5|||
126468524|NCT02448810|455017633|FG006|Overall Study|Withdrawal by Subject|0|||
126468525|NCT02448810|455017634|FG007|Overall Study|Withdrawal by Subject|2|||
126468526|NCT02448810|455017627|FG000|Overall Study|Other (study terminated by sponsor)|0|||
126468527|NCT02448810|455017628|FG001|Overall Study|Other (study terminated by sponsor)|0|||
126468528|NCT02448810|455017629|FG002|Overall Study|Other (study terminated by sponsor)|0|||
126468529|NCT02448810|455017630|FG003|Overall Study|Other (study terminated by sponsor)|0|||
126468530|NCT02448810|455017631|FG004|Overall Study|Other (study terminated by sponsor)|4|||
126554427|NCT01474512|455324030|FG002|Maintenance Period|Withdrawal by Subject|0|||
126554428|NCT01474512|455324031|FG003|Maintenance Period|Withdrawal by Subject|6|||
126554429|NCT01474512|455324032|FG004|Maintenance Period|Withdrawal by Subject|2|||
126554430|NCT01474512|455324033|FG005|Maintenance Period|Withdrawal by Subject|3|||
126718021|NCT00701727|455919436|FG001|First Treatment Period|Withdrawal by Subject|0|||
126718022|NCT00701727|455919435|FG000|First Treatment Period|sponsor decision|0|||
126718023|NCT00701727|455919436|FG001|First Treatment Period|sponsor decision|1|||
126718024|NCT00701727|455919435|FG000|First Treatment Period|Lost to Follow-up|0|||
126718025|NCT00701727|455919436|FG001|First Treatment Period|Lost to Follow-up|1|||
126718026|NCT00701727|455919435|FG000|Second Treatment Period|Withdrawal by Subject|2|||
126718027|NCT00701727|455919436|FG001|Second Treatment Period|Withdrawal by Subject|0|||
126718028|NCT05113953|455919439|FG000|Overall Study|Adverse Event|5|||
126718029|NCT05113953|455919440|FG001|Overall Study|Adverse Event|0|||
126718030|NCT05113953|455919441|FG002|Overall Study|Adverse Event|3|||
126718031|NCT05113953|455919439|FG000|Overall Study|Lost to Follow-up|3|||
126718032|NCT05113953|455919440|FG001|Overall Study|Lost to Follow-up|4|||
126391196|NCT00758264|454724442|FG001|Active Phase|Withdrawal by Subject|0|||
126391197|NCT00758264|454724443|FG002|Active Phase|Withdrawal by Subject|1|||
126391198|NCT00758264|454724441|FG000|Active Phase|Lost to Follow-up|1|||
126391199|NCT00758264|454724442|FG001|Active Phase|Lost to Follow-up|0|||
126718033|NCT05113953|455919441|FG002|Overall Study|Lost to Follow-up|2|||
126718034|NCT05113953|455919439|FG000|Overall Study|Non-compliance with Study Drug|1|||
126718035|NCT05113953|455919440|FG001|Overall Study|Non-compliance with Study Drug|0|||
126718036|NCT05113953|455919441|FG002|Overall Study|Non-compliance with Study Drug|0|||
126718037|NCT05113953|455919439|FG000|Overall Study|Withdrawal by Subject|2|||
126718038|NCT05113953|455919440|FG001|Overall Study|Withdrawal by Subject|6|||
126718039|NCT05113953|455919441|FG002|Overall Study|Withdrawal by Subject|4|||
126718040|NCT05113953|455919439|FG000|Overall Study|Reason not Specified|2|||
126718041|NCT05113953|455919440|FG001|Overall Study|Reason not Specified|0|||
126718042|NCT05113953|455919441|FG002|Overall Study|Reason not Specified|0|||
126718043|NCT00523341|455919442|FG000|Overall Study|Withdrawal by Subject|399|||
126718044|NCT00523341|455919443|FG001|Overall Study|Withdrawal by Subject|427|||
126718045|NCT00523341|455919442|FG000|Overall Study|Other|181|||
126718046|NCT00523341|455919443|FG001|Overall Study|Other|198|||
126718047|NCT00523341|455919442|FG000|Overall Study|Adverse Event|122|||
126718048|NCT00523341|455919443|FG001|Overall Study|Adverse Event|155|||
126718049|NCT00523341|455919442|FG000|Overall Study|Death|101|||
126718050|NCT00523341|455919443|FG001|Overall Study|Death|110|||
126718051|NCT00523341|455919442|FG000|Overall Study|Lost to Follow-up|73|||
126718052|NCT00523341|455919443|FG001|Overall Study|Lost to Follow-up|61|||
126718053|NCT00523341|455919442|FG000|Overall Study|Non-compliance|20|||
126391200|NCT00758264|454724443|FG002|Active Phase|Lost to Follow-up|0|||
126391201|NCT00758264|454724441|FG000|Active Phase|Other|0|||
126391202|NCT00758264|454724442|FG001|Active Phase|Other|0|||
126391203|NCT00758264|454724443|FG002|Active Phase|Other|4|||
126391204|NCT01626118|454724449|FG000|Overall Study|Lack of Efficacy|1|||
126391205|NCT01626118|454724450|FG001|Overall Study|Lack of Efficacy|0|||
126391206|NCT01626118|454724451|FG002|Overall Study|Lack of Efficacy|1|||
126391207|NCT01626118|454724452|FG003|Overall Study|Lack of Efficacy|3|||
126718054|NCT00523341|455919443|FG001|Overall Study|Non-compliance|13|||
126718055|NCT00523341|455919442|FG000|Overall Study|Physician Decision|14|||
126718056|NCT00523341|455919443|FG001|Overall Study|Physician Decision|13|||
126718057|NCT00523341|455919442|FG000|Overall Study|Requirement for Alternative Therapy|4|||
126718058|NCT00523341|455919443|FG001|Overall Study|Requirement for Alternative Therapy|14|||
126718059|NCT00523341|455919442|FG000|Overall Study|Protocol Deviation|6|||
126718060|NCT00523341|455919443|FG001|Overall Study|Protocol Deviation|5|||
126718061|NCT00523341|455919442|FG000|Overall Study|Ineligibility Determined|3|||
126718062|NCT00523341|455919443|FG001|Overall Study|Ineligibility Determined|4|||
126718063|NCT00523341|455919442|FG000|Overall Study|Disease Progression|1|||
126718064|NCT00523341|455919443|FG001|Overall Study|Disease Progression|0|||
126718065|NCT05137041|455919444|FG000|Overall Study|Lost to Follow-up|1|||
126718066|NCT05137041|455919445|FG001|Overall Study|Lost to Follow-up|1|||
126718067|NCT05137041|455919444|FG000|Overall Study|Withdrawal by Subject|0|||
126718068|NCT05137041|455919445|FG001|Overall Study|Withdrawal by Subject|2|||
126718069|NCT05137041|455919444|FG000|Overall Study|Reason not Specified|0|||
126718070|NCT05137041|455919445|FG001|Overall Study|Reason not Specified|1|||
126718071|NCT02626819|455919446|FG000|Overall Study|Lost to Follow-up|3|||
126718072|NCT02626819|455919447|FG001|Overall Study|Lost to Follow-up|2|||
126718073|NCT02626819|455919446|FG000|Overall Study|Withdrawal by Subject|1|||
126718074|NCT02626819|455919447|FG001|Overall Study|Withdrawal by Subject|0|||
126391208|NCT01626118|454724449|FG000|Overall Study|Lost to Follow-up|1|||
126468531|NCT02448810|455017632|FG005|Overall Study|Other (study terminated by sponsor)|2|||
126468532|NCT02448810|455017633|FG006|Overall Study|Other (study terminated by sponsor)|2|||
126468533|NCT02448810|455017634|FG007|Overall Study|Other (study terminated by sponsor)|1|||
126468534|NCT02448810|455017627|FG000|Overall Study|Death|1|||
126468535|NCT02448810|455017628|FG001|Overall Study|Death|0|||
126468536|NCT02448810|455017629|FG002|Overall Study|Death|1|||
126468537|NCT02448810|455017630|FG003|Overall Study|Death|0|||
126468538|NCT02448810|455017631|FG004|Overall Study|Death|1|||
126468539|NCT02448810|455017632|FG005|Overall Study|Death|0|||
126468540|NCT02448810|455017633|FG006|Overall Study|Death|0|||
126468541|NCT02448810|455017634|FG007|Overall Study|Death|0|||
126468542|NCT02448810|455017627|FG000|Overall Study|Other (Progressive disease)|2|||
126468543|NCT02448810|455017628|FG001|Overall Study|Other (Progressive disease)|2|||
126468544|NCT02448810|455017629|FG002|Overall Study|Other (Progressive disease)|0|||
126468545|NCT02448810|455017630|FG003|Overall Study|Other (Progressive disease)|3|||
126468546|NCT02448810|455017631|FG004|Overall Study|Other (Progressive disease)|23|||
126468547|NCT02448810|455017632|FG005|Overall Study|Other (Progressive disease)|9|||
126468548|NCT02448810|455017633|FG006|Overall Study|Other (Progressive disease)|14|||
126468549|NCT02448810|455017634|FG007|Overall Study|Other (Progressive disease)|5|||
126718075|NCT02626819|455919446|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
126468550|NCT02448810|455017627|FG000|Overall Study|Lost to Follow-up|0|||
126468551|NCT02448810|455017628|FG001|Overall Study|Lost to Follow-up|1|||
126718076|NCT02626819|455919447|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
126718077|NCT00502307|455919450|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
126391209|NCT01626118|454724450|FG001|Overall Study|Lost to Follow-up|0|||
126391210|NCT01626118|454724451|FG002|Overall Study|Lost to Follow-up|0|||
126468552|NCT02448810|455017629|FG002|Overall Study|Lost to Follow-up|0|||
126468553|NCT02448810|455017630|FG003|Overall Study|Lost to Follow-up|0|||
126391211|NCT01626118|454724452|FG003|Overall Study|Lost to Follow-up|0|||
126391212|NCT01626118|454724449|FG000|Overall Study|Adverse Event|0|||
126391213|NCT01626118|454724450|FG001|Overall Study|Adverse Event|1|||
126391214|NCT01626118|454724451|FG002|Overall Study|Adverse Event|1|||
126391215|NCT01626118|454724452|FG003|Overall Study|Adverse Event|0|||
126391216|NCT01626118|454724449|FG000|Overall Study|Investigator Decision|0|||
126391217|NCT01626118|454724450|FG001|Overall Study|Investigator Decision|1|||
126391218|NCT01626118|454724451|FG002|Overall Study|Investigator Decision|0|||
126391219|NCT01626118|454724452|FG003|Overall Study|Investigator Decision|0|||
126391220|NCT00888329|454724453|FG000|Overall Study|Physician Decision|6|||
126391221|NCT00888329|454724454|FG001|Overall Study|Physician Decision|9|||
126391222|NCT00939029|454724455|FG000|Overall Study|Withdrawal by Subject|3|||
126391223|NCT00939029|454724456|FG001|Overall Study|Withdrawal by Subject|7|||
126391224|NCT00939029|454724455|FG000|Overall Study|Lost to Follow-up|3|||
126391225|NCT00939029|454724456|FG001|Overall Study|Lost to Follow-up|4|||
126391226|NCT00939029|454724455|FG000|Overall Study|Adverse Event|0|||
126391227|NCT00939029|454724456|FG001|Overall Study|Adverse Event|1|||
126391228|NCT06003777|454724457|FG000|Period 1|Adverse Event|0|||
126391229|NCT06003777|454724458|FG001|Period 1|Adverse Event|0|||
126391230|NCT06003777|454724459|FG002|Period 1|Adverse Event|1|||
126391231|NCT06003777|454724460|FG003|Period 1|Adverse Event|0|||
126391232|NCT06003777|454724461|FG004|Period 1|Adverse Event|0|||
126391233|NCT06003777|454724462|FG005|Period 1|Adverse Event|0|||
126391234|NCT06003777|454724463|FG006|Period 1|Adverse Event|0|||
126391235|NCT06003777|454724464|FG007|Period 1|Adverse Event|0|||
126391236|NCT06003777|454724465|FG008|Period 1|Adverse Event|0|||
126391237|NCT06003777|454724466|FG009|Period 1|Adverse Event|0|||
126391238|NCT06003777|454724467|FG010|Period 1|Adverse Event|0|||
126391239|NCT06003777|454724468|FG011|Period 1|Adverse Event|0|||
126391240|NCT06003777|454724457|FG000|Period 1|Withdrawal by Subject|0|||
126391241|NCT06003777|454724458|FG001|Period 1|Withdrawal by Subject|0|||
126391242|NCT06003777|454724459|FG002|Period 1|Withdrawal by Subject|0|||
126391243|NCT06003777|454724460|FG003|Period 1|Withdrawal by Subject|0|||
126391244|NCT06003777|454724461|FG004|Period 1|Withdrawal by Subject|1|||
126718078|NCT00502307|455919451|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
126718079|NCT00502307|455919452|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
126718080|NCT00502307|455919450|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
126718081|NCT00502307|455919451|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
126718082|NCT00502307|455919452|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
126718083|NCT00502307|455919450|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
126718084|NCT00502307|455919451|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
126718085|NCT00502307|455919452|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
126718086|NCT00502307|455919450|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
126718087|NCT00502307|455919451|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
126718088|NCT00502307|455919452|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
126718089|NCT00502307|455919450|FG000|Maintenance Period|Progressive disease|80|||
126718090|NCT00502307|455919451|FG001|Maintenance Period|Progressive disease|0|||
126718091|NCT00502307|455919452|FG002|Maintenance Period|Progressive disease|0|||
126718092|NCT00502307|455919450|FG000|Maintenance Period|Discontinued due to other reasons|68|||
126718093|NCT00502307|455919451|FG001|Maintenance Period|Discontinued due to other reasons|0|||
126718094|NCT00502307|455919452|FG002|Maintenance Period|Discontinued due to other reasons|0|||
126718095|NCT04907539|455919453|FG000|Overall Study|Consent withdrawn|1|||
126718096|NCT04907539|455919454|FG001|Overall Study|Consent withdrawn|0|||
126718097|NCT04907539|455919453|FG000|Overall Study|Death|14|||
126718098|NCT04907539|455919454|FG001|Overall Study|Death|3|||
126718099|NCT00051558|455919455|FG000|Overall Study|Adverse Event|30|||
126718100|NCT00051558|455919456|FG001|Overall Study|Adverse Event|18|||
126718101|NCT00051558|455919455|FG000|Overall Study|Withdrawal by Subject|29|||
126718102|NCT00051558|455919456|FG001|Overall Study|Withdrawal by Subject|42|||
126718103|NCT00051558|455919455|FG000|Overall Study|Death|9|||
126718104|NCT00051558|455919456|FG001|Overall Study|Death|15|||
126718105|NCT00051558|455919455|FG000|Overall Study|Lost to Follow-up|4|||
126718106|NCT00051558|455919456|FG001|Overall Study|Lost to Follow-up|13|||
126718107|NCT00051558|455919455|FG000|Overall Study|Protocol Violation|3|||
126718108|NCT00051558|455919456|FG001|Overall Study|Protocol Violation|4|||
126718109|NCT00051558|455919455|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
126718110|NCT00051558|455919456|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
126718111|NCT00051558|455919455|FG000|Overall Study|Sponsor Decision|6|||
126391245|NCT06003777|454724462|FG005|Period 1|Withdrawal by Subject|0|||
126391246|NCT06003777|454724463|FG006|Period 1|Withdrawal by Subject|0|||
126391247|NCT06003777|454724464|FG007|Period 1|Withdrawal by Subject|0|||
126391248|NCT06003777|454724465|FG008|Period 1|Withdrawal by Subject|0|||
126391249|NCT06003777|454724466|FG009|Period 1|Withdrawal by Subject|0|||
126391250|NCT06003777|454724467|FG010|Period 1|Withdrawal by Subject|0|||
126391251|NCT06003777|454724468|FG011|Period 1|Withdrawal by Subject|0|||
126391252|NCT06003777|454724457|FG000|Period 2|Withdrawal by Subject|0|||
126391253|NCT06003777|454724458|FG001|Period 2|Withdrawal by Subject|0|||
126718112|NCT00051558|455919456|FG001|Overall Study|Sponsor Decision|1|||
126391254|NCT06003777|454724459|FG002|Period 2|Withdrawal by Subject|0|||
126391255|NCT06003777|454724460|FG003|Period 2|Withdrawal by Subject|0|||
126391256|NCT06003777|454724461|FG004|Period 2|Withdrawal by Subject|0|||
126391257|NCT06003777|454724462|FG005|Period 2|Withdrawal by Subject|0|||
126718113|NCT00051558|455919455|FG000|Overall Study|Other|2|||
126718114|NCT00051558|455919456|FG001|Overall Study|Other|1|||
126718115|NCT00051558|455919455|FG000|Overall Study|Significant Lab Value|2|||
126718116|NCT00051558|455919456|FG001|Overall Study|Significant Lab Value|0|||
126718117|NCT00051558|455919455|FG000|Overall Study|Physician Decision|5|||
126718118|NCT00051558|455919456|FG001|Overall Study|Physician Decision|0|||
126718119|NCT01701583|455919462|FG000|Overall Study|Withdrawal by Subject|2|||
126718120|NCT01701583|455919463|FG001|Overall Study|Withdrawal by Subject|0|||
126718121|NCT01441440|455919464|FG000|Overall Study|Death|1|||
126718122|NCT01441440|455919465|FG001|Overall Study|Death|0|||
126718123|NCT01441440|455919466|FG002|Overall Study|Death|1|||
126718124|NCT01441440|455919464|FG000|Overall Study|Adverse Event|2|||
126718125|NCT01441440|455919465|FG001|Overall Study|Adverse Event|9|||
126718126|NCT01441440|455919466|FG002|Overall Study|Adverse Event|9|||
126718127|NCT01441440|455919464|FG000|Overall Study|Lost to Follow-up|0|||
126718128|NCT01441440|455919465|FG001|Overall Study|Lost to Follow-up|2|||
126718129|NCT01441440|455919466|FG002|Overall Study|Lost to Follow-up|1|||
126718130|NCT01441440|455919464|FG000|Overall Study|Withdrawal by Subject|11|||
126718131|NCT01441440|455919465|FG001|Overall Study|Withdrawal by Subject|9|||
126718132|NCT01441440|455919466|FG002|Overall Study|Withdrawal by Subject|9|||
126718133|NCT01441440|455919464|FG000|Overall Study|Pregnancy|1|||
126718134|NCT01441440|455919465|FG001|Overall Study|Pregnancy|0|||
126718135|NCT01441440|455919466|FG002|Overall Study|Pregnancy|0|||
126718136|NCT01441440|455919464|FG000|Overall Study|Lack of Efficacy|1|||
126718137|NCT01441440|455919465|FG001|Overall Study|Lack of Efficacy|0|||
126718138|NCT01441440|455919466|FG002|Overall Study|Lack of Efficacy|1|||
126718139|NCT01441440|455919464|FG000|Overall Study|Moving|0|||
126718140|NCT01441440|455919465|FG001|Overall Study|Moving|1|||
126718141|NCT01441440|455919466|FG002|Overall Study|Moving|1|||
126718142|NCT01441440|455919464|FG000|Overall Study|Work-related matter|0|||
126718143|NCT01441440|455919465|FG001|Overall Study|Work-related matter|1|||
126718144|NCT01441440|455919466|FG002|Overall Study|Work-related matter|0|||
126718145|NCT01441440|455919464|FG000|Overall Study|Difficllty in keeping the schedule|1|||
126718146|NCT01441440|455919465|FG001|Overall Study|Difficllty in keeping the schedule|1|||
126718147|NCT01441440|455919466|FG002|Overall Study|Difficllty in keeping the schedule|0|||
126718148|NCT02245568|455919469|FG000|Overall Study|Study terminated by Sponsor|346|||
126718149|NCT02245568|455919469|FG000|Overall Study|Adverse Event|144|||
126718150|NCT02245568|455919469|FG000|Overall Study|Lack of Efficacy|98|||
126718151|NCT02245568|455919469|FG000|Overall Study|Withdrawal by Caregiver|85|||
126718152|NCT02245568|455919469|FG000|Overall Study|Withdrawal by Subject|77|||
126718153|NCT02245568|455919469|FG000|Overall Study|Withdrawal by Legal Representative|31|||
126718154|NCT02245568|455919469|FG000|Overall Study|Missing (Site closure)|16|||
126718155|NCT02245568|455919469|FG000|Overall Study|Physician Decision|14|||
126718156|NCT02245568|455919469|FG000|Overall Study|Non-compliance with study drug|11|||
126718157|NCT02245568|455919469|FG000|Overall Study|Death|9|||
126718158|NCT02245568|455919469|FG000|Overall Study|Blue staining|6|||
126718159|NCT02245568|455919469|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
126718160|NCT02245568|455919469|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
126718161|NCT02245568|455919469|FG000|Overall Study|Lost to Follow-up|5|||
126718162|NCT00366548|455919470|FG000|Infant Series|Adverse Event|1|||
126718163|NCT00366548|455919471|FG001|Infant Series|Adverse Event|3|||
126718164|NCT00366548|455919470|FG000|Infant Series|Protocol Violation|0|||
126718165|NCT00366548|455919471|FG001|Infant Series|Protocol Violation|1|||
126718166|NCT00366548|455919470|FG000|Infant Series|Withdrawal by Subject|3|||
126718167|NCT00366548|455919471|FG001|Infant Series|Withdrawal by Subject|1|||
126718168|NCT00366548|455919470|FG000|After Infant Series|Withdrawal by Subject|3|||
126718169|NCT00366548|455919471|FG001|After Infant Series|Withdrawal by Subject|1|||
126718170|NCT00366548|455919470|FG000|After Infant Series|Adverse Event|2|||
126718171|NCT00366548|455919471|FG001|After Infant Series|Adverse Event|0|||
126718172|NCT00366548|455919470|FG000|After Infant Series|Lost to Follow-up|1|||
126718173|NCT00366548|455919471|FG001|After Infant Series|Lost to Follow-up|0|||
126718174|NCT02849990|455919472|FG000|Overall Study|Adverse Event|1|||
126718175|NCT02849990|455919472|FG000|Overall Study|Withdrawal by Subject|1|||
126718176|NCT01051986|455919474|FG000|Overall Study|Death|1|||
126718177|NCT01051986|455919475|FG001|Overall Study|Death|0|||
126718178|NCT01051986|455919474|FG000|Overall Study|Withdrawal by Subject|2|||
126718179|NCT01051986|455919475|FG001|Overall Study|Withdrawal by Subject|1|||
126718180|NCT01051986|455919474|FG000|Overall Study|Protocol Violation|2|||
126718181|NCT01051986|455919475|FG001|Overall Study|Protocol Violation|3|||
126718182|NCT02044159|455919477|FG000|Overall Study|Consent declined (deferred consent)|2|||
126718183|NCT02044159|455919478|FG001|Overall Study|Consent declined (deferred consent)|4|||
126718184|NCT02044159|455919477|FG000|Overall Study|No longer eligible, drug not given|1|||
126718185|NCT02044159|455919478|FG001|Overall Study|No longer eligible, drug not given|0|||
126718186|NCT02044159|455919477|FG000|Overall Study|Nurse declined to give study drug|1|||
126718187|NCT02044159|455919478|FG001|Overall Study|Nurse declined to give study drug|0|||
126718188|NCT01111539|455919480|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
126718189|NCT01111539|455919481|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126718190|NCT01111539|455919482|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126718191|NCT01111539|455919483|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126718192|NCT01111539|455919484|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
126718193|NCT01111539|455919480|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
126718194|NCT01111539|455919481|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126718195|NCT01111539|455919482|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126718196|NCT01111539|455919483|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126718197|NCT01111539|455919484|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
126718198|NCT01111539|455919480|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
126718199|NCT01111539|455919481|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126718200|NCT01111539|455919482|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126718201|NCT01111539|455919483|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126718202|NCT01111539|455919484|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
126718203|NCT01111539|455919480|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
126718204|NCT01111539|455919481|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
126718205|NCT01111539|455919482|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
126718206|NCT01111539|455919483|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
126718207|NCT01111539|455919484|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
126718208|NCT01111539|455919480|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
126718209|NCT01111539|455919481|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
126718210|NCT01111539|455919482|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
126718211|NCT01111539|455919483|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
126718212|NCT01111539|455919484|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
126718213|NCT01111539|455919480|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
126718214|NCT01111539|455919481|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126718215|NCT01111539|455919482|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126718216|NCT01111539|455919483|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126718217|NCT01111539|455919484|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
126718218|NCT01111539|455919480|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
126718219|NCT01111539|455919481|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
126718220|NCT01111539|455919482|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
126718221|NCT01111539|455919483|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
126718222|NCT01111539|455919484|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
126718223|NCT01111539|455919480|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126718224|NCT01111539|455919481|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126718225|NCT01111539|455919482|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
126718226|NCT01111539|455919483|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
126718227|NCT01111539|455919484|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
126718228|NCT01111539|455919480|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126718229|NCT01111539|455919481|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126718230|NCT01111539|455919482|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
126718231|NCT01111539|455919483|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
126718232|NCT01111539|455919484|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
126718233|NCT01111539|455919480|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
126718234|NCT01111539|455919481|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
126718235|NCT01111539|455919482|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
126718236|NCT01111539|455919483|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
126718237|NCT01111539|455919484|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
126718238|NCT01111539|455919480|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
126718239|NCT01111539|455919481|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
126718240|NCT01111539|455919482|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
126718241|NCT01111539|455919483|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
126718242|NCT01111539|455919484|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
126718243|NCT01111539|455919480|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
126718244|NCT01111539|455919481|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
126718245|NCT01111539|455919482|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
126718246|NCT01111539|455919483|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
126718247|NCT01111539|455919484|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
126718248|NCT01111539|455919480|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
126718249|NCT01111539|455919481|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
126718250|NCT01111539|455919482|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
126718251|NCT01111539|455919483|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
126718252|NCT01111539|455919484|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
126718253|NCT01111539|455919480|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126718254|NCT01111539|455919481|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126718255|NCT01111539|455919482|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126718256|NCT01111539|455919483|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
126718257|NCT01111539|455919484|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
126718258|NCT01795898|455919485|FG000|Overall Study|Adverse Event|27|||
126554431|NCT01474512|455324034|FG006|Maintenance Period|Withdrawal by Subject|1|||
126554432|NCT01474512|455324035|FG007|Maintenance Period|Withdrawal by Subject|6|||
126554433|NCT01474512|455324036|FG008|Maintenance Period|Withdrawal by Subject|3|||
126554434|NCT01474512|455324037|FG009|Maintenance Period|Withdrawal by Subject|1|||
126554435|NCT01474512|455324038|FG010|Maintenance Period|Withdrawal by Subject|0|||
126554436|NCT01474512|455324039|FG011|Maintenance Period|Withdrawal by Subject|0|||
126554437|NCT01474512|455324040|FG012|Maintenance Period|Withdrawal by Subject|0|||
126554438|NCT01474512|455324041|FG013|Maintenance Period|Withdrawal by Subject|0|||
126554439|NCT01474512|455324042|FG014|Maintenance Period|Withdrawal by Subject|0|||
126554440|NCT01474512|455324043|FG015|Maintenance Period|Withdrawal by Subject|0|||
126554441|NCT01474512|455324044|FG016|Maintenance Period|Withdrawal by Subject|0|||
126554442|NCT01474512|455324045|FG017|Maintenance Period|Withdrawal by Subject|0|||
126554443|NCT01474512|455324028|FG000|Maintenance Period|Lost to Follow-up|0|||
126554444|NCT01474512|455324029|FG001|Maintenance Period|Lost to Follow-up|0|||
126554445|NCT01474512|455324030|FG002|Maintenance Period|Lost to Follow-up|0|||
126554446|NCT01474512|455324031|FG003|Maintenance Period|Lost to Follow-up|3|||
126554447|NCT01474512|455324032|FG004|Maintenance Period|Lost to Follow-up|3|||
126554448|NCT01474512|455324033|FG005|Maintenance Period|Lost to Follow-up|0|||
126554449|NCT01474512|455324034|FG006|Maintenance Period|Lost to Follow-up|0|||
126554450|NCT01474512|455324035|FG007|Maintenance Period|Lost to Follow-up|2|||
126554451|NCT01474512|455324036|FG008|Maintenance Period|Lost to Follow-up|1|||
126554452|NCT01474512|455324037|FG009|Maintenance Period|Lost to Follow-up|1|||
126718259|NCT01795898|455919485|FG000|Overall Study|Lost to Follow-up|20|||
126718260|NCT01795898|455919485|FG000|Overall Study|Withdrawal of consent|6|||
126718261|NCT01795898|455919485|FG000|Overall Study|Diagnosed with metastasis|1|||
126718262|NCT01795898|455919485|FG000|Overall Study|No pain|1|||
126718263|NCT01795898|455919485|FG000|Overall Study|Death|1|||
126718264|NCT01795898|455919485|FG000|Overall Study|Withdrew consent & had adverse events|3|||
126718265|NCT01795898|455919485|FG000|Overall Study|Physician Decision|1|||
126718266|NCT03628417|455919486|FG000|Overall Study|Death|1|||
126718267|NCT03628417|455919487|FG001|Overall Study|Death|1|||
126718268|NCT03539458|455919488|FG000|Overall Study|Death|1|||
126718269|NCT00718419|455919489|FG000|Overall Study|Adverse Event|2|||
126718270|NCT00718419|455919490|FG001|Overall Study|Adverse Event|1|||
126718271|NCT00718419|455919489|FG000|Overall Study|Physician Decision|1|||
126718272|NCT00718419|455919490|FG001|Overall Study|Physician Decision|6|||
126718273|NCT00718419|455919489|FG000|Overall Study|Sponsor decision|0|||
126718274|NCT00718419|455919490|FG001|Overall Study|Sponsor decision|1|||
126718275|NCT00718419|455919489|FG000|Overall Study|Withdrawal by Subject|0|||
126718276|NCT00718419|455919490|FG001|Overall Study|Withdrawal by Subject|5|||
126718277|NCT00718419|455919489|FG000|Overall Study|Progressive Disease|7|||
126718278|NCT00718419|455919490|FG001|Overall Study|Progressive Disease|25|||
126718279|NCT00718419|455919489|FG000|Overall Study|Death Due to Progressive Disease|2|||
126718280|NCT00718419|455919490|FG001|Overall Study|Death Due to Progressive Disease|0|||
126718281|NCT00718419|455919489|FG000|Overall Study|Death Due to Study Drug Related|0|||
126718282|NCT00718419|455919490|FG001|Overall Study|Death Due to Study Drug Related|1|||
126718283|NCT00718419|455919489|FG000|Overall Study|Death Due to Adverse Events|1|||
126718284|NCT00718419|455919490|FG001|Overall Study|Death Due to Adverse Events|0|||
126718285|NCT00726323|455919493|FG000|Overall Study|Withdrawal by Subject|3|||
126718286|NCT00726323|455919494|FG001|Overall Study|Withdrawal by Subject|1|||
126718287|NCT00726323|455919493|FG000|Overall Study|Physician Decision|1|||
126718288|NCT00726323|455919494|FG001|Overall Study|Physician Decision|0|||
126718289|NCT00726323|455919493|FG000|Overall Study|Progressive disease|23|||
126718290|NCT00726323|455919494|FG001|Overall Study|Progressive disease|16|||
126718291|NCT00726323|455919493|FG000|Overall Study|Clinical progression|0|||
126554453|NCT01474512|455324038|FG010|Maintenance Period|Lost to Follow-up|0|||
126718292|NCT00726323|455919494|FG001|Overall Study|Clinical progression|3|||
126718293|NCT00726323|455919493|FG000|Overall Study|Adverse Event|9|||
126718294|NCT00726323|455919494|FG001|Overall Study|Adverse Event|9|||
126554454|NCT01474512|455324039|FG011|Maintenance Period|Lost to Follow-up|0|||
126554455|NCT01474512|455324040|FG012|Maintenance Period|Lost to Follow-up|0|||
126554456|NCT01474512|455324041|FG013|Maintenance Period|Lost to Follow-up|0|||
126554457|NCT01474512|455324042|FG014|Maintenance Period|Lost to Follow-up|0|||
126718295|NCT00726323|455919493|FG000|Overall Study|Death|1|||
126718296|NCT00726323|455919494|FG001|Overall Study|Death|0|||
126554458|NCT01474512|455324043|FG015|Maintenance Period|Lost to Follow-up|0|||
126554459|NCT01474512|455324044|FG016|Maintenance Period|Lost to Follow-up|0|||
126718297|NCT00726323|455919493|FG000|Overall Study|Participant wished to discontinue|0|||
126771275|NCT01336608|456117713|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
126771276|NCT01336608|456117714|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126771277|NCT01336608|456117715|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126771278|NCT01336608|456117712|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
126771279|NCT01336608|456117713|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
126771280|NCT01336608|456117714|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
126771281|NCT01336608|456117715|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
126771282|NCT01336608|456117712|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126771283|NCT01336608|456117713|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
126771284|NCT01336608|456117714|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
126771285|NCT01336608|456117715|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
126771286|NCT00080288|456117716|FG000|Overall Study|Adverse Event|7|||
126771287|NCT00080288|456117717|FG001|Overall Study|Adverse Event|4|||
126771288|NCT00080288|456117716|FG000|Overall Study|Lost to Follow-up|3|||
126771289|NCT00080288|456117717|FG001|Overall Study|Lost to Follow-up|5|||
126771290|NCT00080288|456117716|FG000|Overall Study|Physician Decision|6|||
126771291|NCT00080288|456117717|FG001|Overall Study|Physician Decision|2|||
126771292|NCT00080288|456117716|FG000|Overall Study|Withdrawal by Subject|3|||
126771293|NCT00080288|456117717|FG001|Overall Study|Withdrawal by Subject|16|||
126771294|NCT00080288|456117716|FG000|Overall Study|Miscellaneous|11|||
126771295|NCT00080288|456117717|FG001|Overall Study|Miscellaneous|11|||
126771296|NCT03044431|456117718|FG000|Overall Study|Lost to Follow-up|59|||
126771297|NCT02328547|456117719|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
126468554|NCT02448810|455017631|FG004|Overall Study|Lost to Follow-up|0|||
126468555|NCT02448810|455017632|FG005|Overall Study|Lost to Follow-up|0|||
126468556|NCT02448810|455017633|FG006|Overall Study|Lost to Follow-up|0|||
126468557|NCT02448810|455017634|FG007|Overall Study|Lost to Follow-up|0|||
126468558|NCT02448810|455017627|FG000|Overall Study|Other (unspecified)|0|||
126468559|NCT02448810|455017628|FG001|Overall Study|Other (unspecified)|0|||
126468560|NCT02448810|455017629|FG002|Overall Study|Other (unspecified)|0|||
126468561|NCT02448810|455017630|FG003|Overall Study|Other (unspecified)|0|||
126468562|NCT02448810|455017631|FG004|Overall Study|Other (unspecified)|0|||
126468563|NCT02448810|455017632|FG005|Overall Study|Other (unspecified)|0|||
126771298|NCT02328547|456117720|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
126391258|NCT06003777|454724463|FG006|Period 2|Withdrawal by Subject|0|||
126391259|NCT06003777|454724464|FG007|Period 2|Withdrawal by Subject|0|||
126391260|NCT06003777|454724465|FG008|Period 2|Withdrawal by Subject|1|||
126468564|NCT02448810|455017633|FG006|Overall Study|Other (unspecified)|2|||
126468565|NCT02448810|455017634|FG007|Overall Study|Other (unspecified)|0|||
126468566|NCT00470847|455017639|FG000|Overall Study|Pt still receiving treatment|1|||
126468567|NCT02038452|455017647|FG000|Overall Study|Withdrawal by Subject|7|||
126468568|NCT02038452|455017648|FG001|Overall Study|Withdrawal by Subject|9|||
126468569|NCT02038452|455017647|FG000|Overall Study|Lost to Follow-up|31|||
126468570|NCT02038452|455017648|FG001|Overall Study|Lost to Follow-up|28|||
126468571|NCT03139279|455017651|FG000|Overall Study|Physician Decision|2|||
126468572|NCT03139279|455017652|FG001|Overall Study|Physician Decision|0|||
126468573|NCT03139279|455017651|FG000|Overall Study|Protocol Violation|5|||
126468574|NCT03139279|455017652|FG001|Overall Study|Protocol Violation|4|||
126468575|NCT03139279|455017651|FG000|Overall Study|Withdrawal by Subject|0|||
126468576|NCT03139279|455017652|FG001|Overall Study|Withdrawal by Subject|2|||
126468577|NCT01090973|455017653|FG000|Overall Study|Disease progression|1|||
126468578|NCT01626495|455017656|FG000|Overall Study|Adverse Event|3|||
126468579|NCT01626495|455017656|FG000|Overall Study|Disease progression|27|||
126468580|NCT01626495|455017656|FG000|Overall Study|Withdrawal by Subject|1|||
126468581|NCT01626495|455017656|FG000|Overall Study|Administrative problem|1|||
126554460|NCT01474512|455324045|FG017|Maintenance Period|Lost to Follow-up|0|||
126771299|NCT02328547|456117719|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
126771300|NCT02328547|456117720|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
126771301|NCT00344305|456117724|FG000|Overall Study|Lost to Follow-up|2|||
126391261|NCT06003777|454724466|FG009|Period 2|Withdrawal by Subject|0|||
126391262|NCT06003777|454724467|FG010|Period 2|Withdrawal by Subject|0|||
126391263|NCT06003777|454724468|FG011|Period 2|Withdrawal by Subject|0|||
126771302|NCT00344305|456117725|FG001|Overall Study|Lost to Follow-up|0|||
126391264|NCT06003777|454724457|FG000|Period 3|Adverse Event|0|||
126468582|NCT01626495|455017656|FG000|Overall Study|Death|2|||
126468583|NCT01626495|455017656|FG000|Overall Study|Physician Decision|1|||
126468584|NCT01626495|455017656|FG000|Overall Study|New cancer therapy|16|||
126468585|NCT01626495|455017656|FG000|Overall Study|Manufacturing failure|1|||
126468586|NCT01934972|455017657|FG000|Overall Study|Withdrawal by Subject|9|||
126554461|NCT01474512|455324028|FG000|Maintenance Period|Death|0|||
126771303|NCT00344305|456117724|FG000|Overall Study|Participant was not contacted in window|0|||
126391265|NCT06003777|454724458|FG001|Period 3|Adverse Event|0|||
126468587|NCT01934972|455017658|FG001|Overall Study|Withdrawal by Subject|6|||
126468588|NCT03131453|455017659|FG000|Overall Study|Study terminated by Sponsor|424|||
126468589|NCT03131453|455017660|FG001|Overall Study|Study terminated by Sponsor|222|||
126554462|NCT01474512|455324029|FG001|Maintenance Period|Death|0|||
126771304|NCT00344305|456117725|FG001|Overall Study|Participant was not contacted in window|1|||
126771305|NCT01726335|456117732|FG000|Overall Study|Lost to Follow-up|2|||
126771306|NCT01726335|456117732|FG000|Overall Study|Withdrawal by Subject|15|||
126771307|NCT01726335|456117732|FG000|Overall Study|Adverse Event|4|||
126391266|NCT06003777|454724459|FG002|Period 3|Adverse Event|0|||
126391267|NCT06003777|454724460|FG003|Period 3|Adverse Event|0|||
126391268|NCT06003777|454724461|FG004|Period 3|Adverse Event|0|||
126391269|NCT06003777|454724462|FG005|Period 3|Adverse Event|0|||
126468590|NCT03131453|455017661|FG002|Overall Study|Study terminated by Sponsor|438|||
126468591|NCT03131453|455017659|FG000|Overall Study|Withdrawal by Subject|18|||
126468592|NCT03131453|455017660|FG001|Overall Study|Withdrawal by Subject|7|||
126468593|NCT03131453|455017661|FG002|Overall Study|Withdrawal by Subject|13|||
126468594|NCT03131453|455017659|FG000|Overall Study|Adverse Event|10|||
126468595|NCT03131453|455017660|FG001|Overall Study|Adverse Event|3|||
126468596|NCT03131453|455017661|FG002|Overall Study|Adverse Event|3|||
126468597|NCT03131453|455017659|FG000|Overall Study|Lost to Follow-up|1|||
126468598|NCT03131453|455017660|FG001|Overall Study|Lost to Follow-up|0|||
126718298|NCT00726323|455919494|FG001|Overall Study|Participant wished to discontinue|1|||
126718299|NCT00726323|455919493|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
126718300|NCT00726323|455919494|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
126718301|NCT00972478|455919503|FG000|Overall Study|Adverse Event|3|||
126718302|NCT00972478|455919504|FG001|Overall Study|Adverse Event|16|||
126718303|NCT00972478|455919503|FG000|Overall Study|Withdrawal by Subject|1|||
126718304|NCT00972478|455919504|FG001|Overall Study|Withdrawal by Subject|8|||
126718305|NCT00972478|455919503|FG000|Overall Study|Progression/Relapse|0|||
126718306|NCT00972478|455919504|FG001|Overall Study|Progression/Relapse|2|||
126718307|NCT00972478|455919503|FG000|Overall Study|Death|0|||
126718308|NCT00972478|455919504|FG001|Overall Study|Death|2|||
126718309|NCT00972478|455919503|FG000|Overall Study|Not protocol specified|1|||
126718310|NCT00972478|455919504|FG001|Overall Study|Not protocol specified|1|||
126718311|NCT00972478|455919503|FG000|Overall Study|Ineligible|1|||
126718312|NCT00972478|455919504|FG001|Overall Study|Ineligible|7|||
126718313|NCT00972478|455919503|FG000|Overall Study|Not start protocol treatment|1|||
126718314|NCT00972478|455919504|FG001|Overall Study|Not start protocol treatment|2|||
126718315|NCT01522976|455919505|FG000|Overall Study|Ineligible|4|||
126718316|NCT01522976|455919506|FG001|Overall Study|Ineligible|0|||
126718317|NCT01522976|455919507|FG002|Overall Study|Ineligible|1|||
126718318|NCT01522976|455919505|FG000|Overall Study|Death|7|||
126718319|NCT01522976|455919506|FG001|Overall Study|Death|6|||
126718320|NCT01522976|455919507|FG002|Overall Study|Death|2|||
126718321|NCT01522976|455919505|FG000|Overall Study|Still on treatment|9|||
126718322|NCT01522976|455919506|FG001|Overall Study|Still on treatment|9|||
126718323|NCT01522976|455919507|FG002|Overall Study|Still on treatment|6|||
126718324|NCT01522976|455919505|FG000|Overall Study|Disease progression|28|||
126718325|NCT01522976|455919506|FG001|Overall Study|Disease progression|30|||
126718326|NCT01522976|455919507|FG002|Overall Study|Disease progression|25|||
126718327|NCT01522976|455919505|FG000|Overall Study|Adverse Event|17|||
126718328|NCT01522976|455919506|FG001|Overall Study|Adverse Event|7|||
126718329|NCT01522976|455919507|FG002|Overall Study|Adverse Event|18|||
126718330|NCT01522976|455919505|FG000|Overall Study|Refusal unrelated to adverse event|10|||
126391270|NCT06003777|454724463|FG006|Period 3|Adverse Event|1|||
126391271|NCT06003777|454724464|FG007|Period 3|Adverse Event|0|||
126391272|NCT06003777|454724465|FG008|Period 3|Adverse Event|0|||
126391273|NCT06003777|454724466|FG009|Period 3|Adverse Event|0|||
126391274|NCT06003777|454724467|FG010|Period 3|Adverse Event|0|||
126391275|NCT06003777|454724468|FG011|Period 3|Adverse Event|0|||
126391276|NCT06003777|454724457|FG000|Period 4|No longer met eligibility criteria|0|||
126391277|NCT06003777|454724458|FG001|Period 4|No longer met eligibility criteria|0|||
126391278|NCT06003777|454724459|FG002|Period 4|No longer met eligibility criteria|1|||
126391279|NCT06003777|454724460|FG003|Period 4|No longer met eligibility criteria|0|||
126391280|NCT06003777|454724461|FG004|Period 4|No longer met eligibility criteria|0|||
126391281|NCT06003777|454724462|FG005|Period 4|No longer met eligibility criteria|0|||
126391282|NCT06003777|454724463|FG006|Period 4|No longer met eligibility criteria|0|||
126391283|NCT06003777|454724464|FG007|Period 4|No longer met eligibility criteria|0|||
126468599|NCT03131453|455017661|FG002|Overall Study|Lost to Follow-up|1|||
126554463|NCT01474512|455324030|FG002|Maintenance Period|Death|0|||
126718331|NCT01522976|455919506|FG001|Overall Study|Refusal unrelated to adverse event|13|||
126718332|NCT01522976|455919507|FG002|Overall Study|Refusal unrelated to adverse event|14|||
126718333|NCT01522976|455919505|FG000|Overall Study|Not protocol specified|22|||
126718334|NCT01522976|455919506|FG001|Overall Study|Not protocol specified|27|||
126771308|NCT01726335|456117732|FG000|Overall Study|Lost to Follow-up|2|||
126391284|NCT06003777|454724465|FG008|Period 4|No longer met eligibility criteria|0|||
126391285|NCT06003777|454724466|FG009|Period 4|No longer met eligibility criteria|0|||
126391286|NCT06003777|454724467|FG010|Period 4|No longer met eligibility criteria|0|||
126391287|NCT06003777|454724468|FG011|Period 4|No longer met eligibility criteria|0|||
126391288|NCT06003777|454724457|FG000|Period 4|Withdrawal by Subject|0|||
126391289|NCT06003777|454724458|FG001|Period 4|Withdrawal by Subject|1|||
126554464|NCT01474512|455324031|FG003|Maintenance Period|Death|0|||
126554465|NCT01474512|455324032|FG004|Maintenance Period|Death|0|||
126554466|NCT01474512|455324033|FG005|Maintenance Period|Death|2|||
126554467|NCT01474512|455324034|FG006|Maintenance Period|Death|0|||
126554468|NCT01474512|455324035|FG007|Maintenance Period|Death|0|||
126554469|NCT01474512|455324036|FG008|Maintenance Period|Death|0|||
126554470|NCT01474512|455324037|FG009|Maintenance Period|Death|0|||
126554471|NCT01474512|455324038|FG010|Maintenance Period|Death|0|||
126554472|NCT01474512|455324039|FG011|Maintenance Period|Death|0|||
126554473|NCT01474512|455324040|FG012|Maintenance Period|Death|0|||
126554474|NCT01474512|455324041|FG013|Maintenance Period|Death|0|||
126554475|NCT01474512|455324042|FG014|Maintenance Period|Death|0|||
126554476|NCT01474512|455324043|FG015|Maintenance Period|Death|0|||
126554477|NCT01474512|455324044|FG016|Maintenance Period|Death|0|||
126554478|NCT01474512|455324045|FG017|Maintenance Period|Death|0|||
126554479|NCT01474512|455324028|FG000|Maintenance Period|Physician Decision|0|||
126554480|NCT01474512|455324029|FG001|Maintenance Period|Physician Decision|0|||
126391290|NCT06003777|454724459|FG002|Period 4|Withdrawal by Subject|0|||
126391291|NCT06003777|454724460|FG003|Period 4|Withdrawal by Subject|0|||
126391292|NCT06003777|454724461|FG004|Period 4|Withdrawal by Subject|0|||
126391293|NCT06003777|454724462|FG005|Period 4|Withdrawal by Subject|0|||
126391294|NCT06003777|454724463|FG006|Period 4|Withdrawal by Subject|0|||
126391295|NCT06003777|454724464|FG007|Period 4|Withdrawal by Subject|0|||
126391296|NCT06003777|454724465|FG008|Period 4|Withdrawal by Subject|0|||
126391297|NCT06003777|454724466|FG009|Period 4|Withdrawal by Subject|0|||
126391298|NCT06003777|454724467|FG010|Period 4|Withdrawal by Subject|0|||
126391299|NCT06003777|454724468|FG011|Period 4|Withdrawal by Subject|0|||
126391300|NCT01106651|454724469|FG000|Overall Study|Adverse Event|17|||
126391301|NCT01106651|454724470|FG001|Overall Study|Adverse Event|9|||
126391302|NCT01106651|454724471|FG002|Overall Study|Adverse Event|23|||
126391303|NCT01106651|454724469|FG000|Overall Study|Lost to Follow-up|8|||
126391304|NCT01106651|454724470|FG001|Overall Study|Lost to Follow-up|2|||
126391305|NCT01106651|454724471|FG002|Overall Study|Lost to Follow-up|6|||
126391306|NCT01106651|454724469|FG000|Overall Study|Physician Decision|4|||
126391307|NCT01106651|454724470|FG001|Overall Study|Physician Decision|3|||
126391308|NCT01106651|454724471|FG002|Overall Study|Physician Decision|1|||
126391309|NCT01106651|454724469|FG000|Overall Study|Protocol Violation|1|||
126391310|NCT01106651|454724470|FG001|Overall Study|Protocol Violation|2|||
126391311|NCT01106651|454724471|FG002|Overall Study|Protocol Violation|1|||
126391312|NCT01106651|454724469|FG000|Overall Study|Withdrawal by Subject|14|||
126391313|NCT01106651|454724470|FG001|Overall Study|Withdrawal by Subject|7|||
126391314|NCT01106651|454724471|FG002|Overall Study|Withdrawal by Subject|4|||
126391315|NCT01106651|454724469|FG000|Overall Study|Noncompliance with study drug|1|||
126391316|NCT01106651|454724470|FG001|Overall Study|Noncompliance with study drug|0|||
126391317|NCT01106651|454724471|FG002|Overall Study|Noncompliance with study drug|2|||
126391318|NCT01106651|454724469|FG000|Overall Study|Other|34|||
126391319|NCT01106651|454724470|FG001|Overall Study|Other|31|||
126391320|NCT01106651|454724471|FG002|Overall Study|Other|21|||
126391321|NCT01106651|454724469|FG000|Overall Study|Death|0|||
126391322|NCT01106651|454724470|FG001|Overall Study|Death|3|||
126391323|NCT01106651|454724471|FG002|Overall Study|Death|0|||
126391324|NCT00613327|454724475|FG000|Overall Study|Adverse Event|38|||
126391325|NCT00613327|454724475|FG000|Overall Study|Lost to Follow-up|8|||
126391326|NCT00613327|454724475|FG000|Overall Study|Withdrawal by Subject|6|||
126391327|NCT00613327|454724475|FG000|Overall Study|Protocol Violation|2|||
126554481|NCT01474512|455324030|FG002|Maintenance Period|Physician Decision|0|||
126554482|NCT01474512|455324031|FG003|Maintenance Period|Physician Decision|0|||
126554483|NCT01474512|455324032|FG004|Maintenance Period|Physician Decision|0|||
126554484|NCT01474512|455324033|FG005|Maintenance Period|Physician Decision|1|||
126554485|NCT01474512|455324034|FG006|Maintenance Period|Physician Decision|0|||
126554486|NCT01474512|455324035|FG007|Maintenance Period|Physician Decision|2|||
126554487|NCT01474512|455324036|FG008|Maintenance Period|Physician Decision|0|||
126554488|NCT01474512|455324037|FG009|Maintenance Period|Physician Decision|0|||
126391328|NCT00613327|454724475|FG000|Overall Study|Other|47|||
126391329|NCT00344318|454724476|FG000|Overall Study|Adverse Event|0|||
126391330|NCT00344318|454724477|FG001|Overall Study|Adverse Event|3|||
126391331|NCT00344318|454724478|FG002|Overall Study|Adverse Event|0|||
126391332|NCT00344318|454724479|FG003|Overall Study|Adverse Event|1|||
126391333|NCT00344318|454724476|FG000|Overall Study|Withdrawal by Subject|2|||
126391334|NCT00344318|454724477|FG001|Overall Study|Withdrawal by Subject|2|||
126391335|NCT00344318|454724478|FG002|Overall Study|Withdrawal by Subject|0|||
126391336|NCT00344318|454724479|FG003|Overall Study|Withdrawal by Subject|2|||
126391337|NCT00344318|454724476|FG000|Overall Study|Lost to Follow-up|2|||
126391338|NCT00344318|454724477|FG001|Overall Study|Lost to Follow-up|0|||
126391339|NCT00344318|454724478|FG002|Overall Study|Lost to Follow-up|1|||
126391340|NCT00344318|454724479|FG003|Overall Study|Lost to Follow-up|0|||
126391341|NCT03832322|454724482|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
126554489|NCT01474512|455324038|FG010|Maintenance Period|Physician Decision|0|||
126554490|NCT01474512|455324039|FG011|Maintenance Period|Physician Decision|0|||
126554491|NCT01474512|455324040|FG012|Maintenance Period|Physician Decision|0|||
126554492|NCT01474512|455324041|FG013|Maintenance Period|Physician Decision|0|||
126468600|NCT03131453|455017659|FG000|Overall Study|Physician Decision|1|||
126468601|NCT03131453|455017660|FG001|Overall Study|Physician Decision|0|||
126468602|NCT03131453|455017661|FG002|Overall Study|Physician Decision|1|||
126468603|NCT03131453|455017659|FG000|Overall Study|Non-compliance with study treatment|1|||
126468604|NCT03131453|455017660|FG001|Overall Study|Non-compliance with study treatment|0|||
126468605|NCT03131453|455017661|FG002|Overall Study|Non-compliance with study treatment|0|||
126468606|NCT03131453|455017659|FG000|Overall Study|Technical problems|1|||
126468607|NCT03131453|455017660|FG001|Overall Study|Technical problems|0|||
126468608|NCT03131453|455017661|FG002|Overall Study|Technical problems|0|||
126468609|NCT03131453|455017659|FG000|Overall Study|Protocol deviation|0|||
126468610|NCT03131453|455017660|FG001|Overall Study|Protocol deviation|1|||
126468611|NCT03131453|455017661|FG002|Overall Study|Protocol deviation|0|||
126554493|NCT01474512|455324042|FG014|Maintenance Period|Physician Decision|0|||
126554494|NCT01474512|455324043|FG015|Maintenance Period|Physician Decision|0|||
126718335|NCT01522976|455919507|FG002|Overall Study|Not protocol specified|27|||
126718336|NCT04075266|455919508|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
126718337|NCT04075266|455919509|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
126718338|NCT04075266|455919508|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
126718339|NCT04075266|455919509|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
126718340|NCT05132569|455919510|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
126718341|NCT05132569|455919511|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
126718342|NCT05132569|455919510|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
126718343|NCT05132569|455919511|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
126718344|NCT05132569|455919510|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
126718345|NCT05132569|455919511|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
126718346|NCT04102098|455919512|FG000|Main Study Period|Ongoing in study|302|||
126718347|NCT04102098|455919513|FG001|Main Study Period|Ongoing in study|291|||
126718348|NCT04102098|455919512|FG000|Main Study Period|Death|20|||
126718349|NCT04102098|455919513|FG001|Main Study Period|Death|27|||
126718350|NCT04102098|455919512|FG000|Main Study Period|Lost to Follow-up|1|||
126718351|NCT04102098|455919513|FG001|Main Study Period|Lost to Follow-up|1|||
126718352|NCT04102098|455919512|FG000|Main Study Period|Physician Decision|0|||
126718353|NCT04102098|455919513|FG001|Main Study Period|Physician Decision|1|||
126718354|NCT04102098|455919512|FG000|Main Study Period|Withdrawal by Subject|11|||
126718355|NCT04102098|455919513|FG001|Main Study Period|Withdrawal by Subject|14|||
126718356|NCT04102098|455919512|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
126718357|NCT04102098|455919513|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
126718358|NCT04102098|455919512|FG000|Crossover: AS Who Crossed Over|Death|11|||
126718359|NCT04102098|455919513|FG001|Crossover: AS Who Crossed Over|Death|0|||
126718360|NCT04102098|455919512|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
126718361|NCT04102098|455919513|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
126718362|NCT04742907|455919514|FG000|Overall Study|Adverse Event|1|||
126718363|NCT04742907|455919515|FG001|Overall Study|Adverse Event|0|||
126718364|NCT04742907|455919516|FG002|Overall Study|Adverse Event|1|||
126718365|NCT04742907|455919514|FG000|Overall Study|Lost to Follow-up|3|||
126718366|NCT04742907|455919515|FG001|Overall Study|Lost to Follow-up|3|||
126718367|NCT04742907|455919516|FG002|Overall Study|Lost to Follow-up|2|||
126718368|NCT04742907|455919514|FG000|Overall Study|Physician Decision|0|||
126718369|NCT04742907|455919515|FG001|Overall Study|Physician Decision|1|||
126718370|NCT04742907|455919516|FG002|Overall Study|Physician Decision|0|||
126718371|NCT04742907|455919514|FG000|Overall Study|Protocol Violation|1|||
126718372|NCT04742907|455919515|FG001|Overall Study|Protocol Violation|1|||
126718373|NCT04742907|455919516|FG002|Overall Study|Protocol Violation|1|||
126718374|NCT04742907|455919514|FG000|Overall Study|Withdrawal by Subject|5|||
126718375|NCT04742907|455919515|FG001|Overall Study|Withdrawal by Subject|6|||
126718376|NCT04742907|455919516|FG002|Overall Study|Withdrawal by Subject|4|||
126718377|NCT04742907|455919514|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
126718378|NCT04742907|455919515|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
126718379|NCT04742907|455919516|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
126718380|NCT04742907|455919514|FG000|Overall Study|Did Not Receive the Study Drug|2|||
126718381|NCT04742907|455919515|FG001|Overall Study|Did Not Receive the Study Drug|4|||
126718382|NCT04742907|455919516|FG002|Overall Study|Did Not Receive the Study Drug|4|||
126718383|NCT02280291|455919517|FG000|Overall Study|Lost to Follow-up|2|||
126718384|NCT02280291|455919518|FG001|Overall Study|Lost to Follow-up|1|||
126718385|NCT02280291|455919519|FG002|Overall Study|Lost to Follow-up|3|||
126718386|NCT02280291|455919520|FG003|Overall Study|Lost to Follow-up|8|||
126718387|NCT02280291|455919517|FG000|Overall Study|Protocol Violation|1|||
126718388|NCT02280291|455919518|FG001|Overall Study|Protocol Violation|0|||
126718389|NCT02280291|455919519|FG002|Overall Study|Protocol Violation|0|||
126718390|NCT02280291|455919520|FG003|Overall Study|Protocol Violation|0|||
126718391|NCT02280291|455919517|FG000|Overall Study|Other|1|||
126468612|NCT03643159|455017664|FG000|Overall Study|Adverse Event|1|||
126468613|NCT03643159|455017664|FG000|Overall Study|Withdrawal by Subject|1|||
126468614|NCT03438383|455017665|FG000|Overall Study|Protocol Violation|9|||
126468615|NCT03438383|455017666|FG001|Overall Study|Protocol Violation|3|||
126391342|NCT03832322|454724483|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
126391343|NCT01923363|454724484|FG000|Overall Study|Protocol Violation|1|||
126391344|NCT00290771|454724487|FG000|Overall Study|Disease progression|95|||
126391345|NCT00290771|454724488|FG001|Overall Study|Disease progression|73|||
126391346|NCT00290771|454724487|FG000|Overall Study|Death|11|||
126391347|NCT00290771|454724488|FG001|Overall Study|Death|10|||
126391348|NCT00290771|454724487|FG000|Overall Study|Adverse Event|12|||
126391349|NCT00290771|454724488|FG001|Overall Study|Adverse Event|6|||
126391350|NCT00290771|454724487|FG000|Overall Study|Withdrawal by Subject|5|||
126391351|NCT00290771|454724488|FG001|Overall Study|Withdrawal by Subject|6|||
126718392|NCT02280291|455919518|FG001|Overall Study|Other|1|||
126718393|NCT02280291|455919519|FG002|Overall Study|Other|0|||
126718394|NCT02280291|455919520|FG003|Overall Study|Other|0|||
126718395|NCT03508622|455919521|FG000|Overall Study|Protocol Violation|1|||
126718396|NCT03508622|455919522|FG001|Overall Study|Protocol Violation|0|||
126718397|NCT03508622|455919521|FG000|Overall Study|Withdrawal by Subject|1|||
126718398|NCT03508622|455919522|FG001|Overall Study|Withdrawal by Subject|0|||
126718399|NCT03508622|455919521|FG000|Overall Study|Lost to Follow-up|16|||
126718400|NCT03508622|455919522|FG001|Overall Study|Lost to Follow-up|0|||
126718401|NCT03508622|455919521|FG000|Overall Study|Incomplete data|0|||
126718402|NCT03508622|455919522|FG001|Overall Study|Incomplete data|24|||
126718403|NCT00210158|455919524|FG000|Overall Study|Protocol Violation|0|||
126718404|NCT00210158|455919525|FG001|Overall Study|Protocol Violation|2|||
126718405|NCT03196505|455919527|FG000|Overall Study|Physician Decision|26|||
126718406|NCT03196505|455919528|FG001|Overall Study|Physician Decision|26|||
126718407|NCT01005719|455919529|FG000|Period 1|Adverse Event|0|||
126718408|NCT01005719|455919530|FG001|Period 1|Adverse Event|0|||
126718409|NCT01005719|455919531|FG002|Period 1|Adverse Event|0|||
126718410|NCT01005719|455919532|FG003|Period 1|Adverse Event|1|||
126718411|NCT01005719|455919533|FG004|Period 1|Adverse Event|0|||
126718412|NCT01005719|455919534|FG005|Period 1|Adverse Event|0|||
126718413|NCT01005719|455919529|FG000|Period 1|Delay in completing study procedures|0|||
126718414|NCT01005719|455919530|FG001|Period 1|Delay in completing study procedures|0|||
126718415|NCT01005719|455919531|FG002|Period 1|Delay in completing study procedures|0|||
126718416|NCT01005719|455919532|FG003|Period 1|Delay in completing study procedures|0|||
126718417|NCT01005719|455919533|FG004|Period 1|Delay in completing study procedures|0|||
126718418|NCT01005719|455919534|FG005|Period 1|Delay in completing study procedures|1|||
126718419|NCT01005719|455919529|FG000|Period 2|Adverse Event|0|||
126718420|NCT01005719|455919530|FG001|Period 2|Adverse Event|0|||
126718421|NCT01005719|455919531|FG002|Period 2|Adverse Event|0|||
126718422|NCT01005719|455919532|FG003|Period 2|Adverse Event|0|||
126718423|NCT01005719|455919533|FG004|Period 2|Adverse Event|1|||
126718424|NCT01005719|455919534|FG005|Period 2|Adverse Event|1|||
126718425|NCT04430738|455919536|FG000|Phase 1: Dose Escalation|Death|1|||
126718426|NCT04430738|455919537|FG001|Phase 1: Dose Escalation|Death|4|||
126718427|NCT04430738|455919538|FG002|Phase 1: Dose Escalation|Death|4|||
126718428|NCT04430738|455919539|FG003|Phase 1: Dose Escalation|Death|1|||
126718429|NCT04430738|455919540|FG004|Phase 1: Dose Escalation|Death|6|||
126718430|NCT04430738|455919541|FG005|Phase 1: Dose Escalation|Death|0|||
126718431|NCT04430738|455919536|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
126718432|NCT04430738|455919537|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
126718433|NCT04430738|455919538|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
126718434|NCT04430738|455919539|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
126718435|NCT04430738|455919540|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
126718436|NCT04430738|455919541|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
126718437|NCT04430738|455919536|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
126718438|NCT04430738|455919537|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
126718439|NCT04430738|455919538|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
126718440|NCT04430738|455919539|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
126718441|NCT04430738|455919540|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
126718442|NCT04430738|455919541|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
126718443|NCT04430738|455919536|FG000|Phase 1: Dose Escalation|Other|1|||
126391352|NCT00290771|454724487|FG000|Overall Study|Administrative problems|2|||
126718444|NCT04430738|455919537|FG001|Phase 1: Dose Escalation|Other|0|||
126718445|NCT04430738|455919538|FG002|Phase 1: Dose Escalation|Other|0|||
126718446|NCT04430738|455919539|FG003|Phase 1: Dose Escalation|Other|0|||
126718447|NCT04430738|455919540|FG004|Phase 1: Dose Escalation|Other|0|||
126718448|NCT04430738|455919541|FG005|Phase 1: Dose Escalation|Other|0|||
126718449|NCT04430738|455919536|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
126771309|NCT01726335|456117732|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
126391353|NCT00290771|454724488|FG001|Overall Study|Administrative problems|1|||
126391354|NCT00290771|454724487|FG000|Overall Study|Protocol Violation|2|||
126718450|NCT04430738|455919537|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
126771310|NCT01796860|456117738|FG000|Overall Study|Withdrawal by Subject|3|||
126391355|NCT00290771|454724488|FG001|Overall Study|Protocol Violation|0|||
126391356|NCT00290771|454724487|FG000|Overall Study|Lost to Follow-up|0|||
126771311|NCT02703454|456117746|FG000|Overall Study|Not treated|1|||
126771312|NCT02703454|456117747|FG001|Overall Study|Not treated|3|||
126771313|NCT02703454|456117746|FG000|Overall Study|Withdrawal by Subject|4|||
126771314|NCT02703454|456117747|FG001|Overall Study|Withdrawal by Subject|3|||
126771315|NCT02703454|456117746|FG000|Overall Study|Lost to Follow-up|1|||
126771316|NCT02703454|456117747|FG001|Overall Study|Lost to Follow-up|2|||
126771317|NCT02703454|456117746|FG000|Overall Study|Study discontinuation|5|||
126771318|NCT02703454|456117747|FG001|Overall Study|Study discontinuation|8|||
126771319|NCT00791154|456117748|FG000|Overall Study|Noncompliance|0|||
126771320|NCT00791154|456117749|FG001|Overall Study|Noncompliance|1|||
126771321|NCT00791154|456117750|FG002|Overall Study|Noncompliance|0|||
126771322|NCT00791154|456117751|FG003|Overall Study|Noncompliance|0|||
126771323|NCT00791154|456117752|FG004|Overall Study|Noncompliance|1|||
126771324|NCT00791154|456117753|FG005|Overall Study|Noncompliance|1|||
126771325|NCT00791154|456117754|FG006|Overall Study|Noncompliance|1|||
126771326|NCT00791154|456117748|FG000|Overall Study|Adverse Event|0|||
126771327|NCT00791154|456117749|FG001|Overall Study|Adverse Event|0|||
126771328|NCT00791154|456117750|FG002|Overall Study|Adverse Event|0|||
126771329|NCT00791154|456117751|FG003|Overall Study|Adverse Event|0|||
126771330|NCT00791154|456117752|FG004|Overall Study|Adverse Event|2|||
126771331|NCT00791154|456117753|FG005|Overall Study|Adverse Event|0|||
126771332|NCT00791154|456117754|FG006|Overall Study|Adverse Event|1|||
126771333|NCT00791154|456117748|FG000|Overall Study|Full Consent withdrawn|1|||
126771334|NCT00791154|456117749|FG001|Overall Study|Full Consent withdrawn|3|||
126771335|NCT00791154|456117750|FG002|Overall Study|Full Consent withdrawn|0|||
126771336|NCT00791154|456117751|FG003|Overall Study|Full Consent withdrawn|0|||
126771337|NCT00791154|456117752|FG004|Overall Study|Full Consent withdrawn|1|||
126771338|NCT00791154|456117753|FG005|Overall Study|Full Consent withdrawn|3|||
126771339|NCT00791154|456117754|FG006|Overall Study|Full Consent withdrawn|1|||
126771340|NCT00791154|456117748|FG000|Overall Study|Lost to Follow-up|0|||
126771341|NCT00791154|456117749|FG001|Overall Study|Lost to Follow-up|0|||
126771342|NCT00791154|456117750|FG002|Overall Study|Lost to Follow-up|0|||
126771343|NCT00791154|456117751|FG003|Overall Study|Lost to Follow-up|1|||
126771344|NCT00791154|456117752|FG004|Overall Study|Lost to Follow-up|2|||
126771345|NCT00791154|456117753|FG005|Overall Study|Lost to Follow-up|0|||
126771346|NCT00791154|456117754|FG006|Overall Study|Lost to Follow-up|4|||
126771347|NCT00791154|456117748|FG000|Overall Study|Death|5|||
126771348|NCT00791154|456117749|FG001|Overall Study|Death|4|||
126771349|NCT00791154|456117750|FG002|Overall Study|Death|4|||
126771350|NCT00791154|456117751|FG003|Overall Study|Death|7|||
126771351|NCT00791154|456117752|FG004|Overall Study|Death|54|||
126771352|NCT00791154|456117753|FG005|Overall Study|Death|54|||
126771353|NCT00791154|456117754|FG006|Overall Study|Death|52|||
126771354|NCT00791154|456117748|FG000|Overall Study|Other event|0|||
126771355|NCT00791154|456117749|FG001|Overall Study|Other event|0|||
126771356|NCT00791154|456117750|FG002|Overall Study|Other event|2|||
126771357|NCT00791154|456117751|FG003|Overall Study|Other event|0|||
126771358|NCT00791154|456117752|FG004|Overall Study|Other event|2|||
126771359|NCT00791154|456117753|FG005|Overall Study|Other event|4|||
126771360|NCT00791154|456117754|FG006|Overall Study|Other event|2|||
126391357|NCT00290771|454724488|FG001|Overall Study|Lost to Follow-up|1|||
126391358|NCT00244933|454724491|FG000|Overall Study|Not response evaluable|2|||
126391359|NCT02487654|454724494|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
126391360|NCT02487654|454724495|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
126391361|NCT02487654|454724494|FG000|Overall Study|Withdrawal by Subject|3|||
126391362|NCT02487654|454724495|FG001|Overall Study|Withdrawal by Subject|7|||
126391363|NCT02247011|454724496|FG000|Overall Study|Poor quality of radiological results|125|||
126391364|NCT00656058|454724497|FG000|Overall Study|Withdrawal by Subject|2|||
126391365|NCT00656058|454724497|FG000|Overall Study|Withdrawal by Subject|4|||
126391366|NCT03718884|454724498|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
126391367|NCT03718884|454724499|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
126391368|NCT03718884|454724498|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
126391369|NCT03718884|454724499|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
126391370|NCT04700540|454724500|FG000|Overall Study|Withdrawal by Subject|12|||
126391371|NCT04700540|454724501|FG001|Overall Study|Withdrawal by Subject|8|||
126468616|NCT02766465|455017667|FG000|Overall Study|Withdrawal by Subject|0|||
126468617|NCT02766465|455017668|FG001|Overall Study|Withdrawal by Subject|10|||
126468618|NCT02435069|455017669|FG000|Dose Response - First Intervention|Adverse Event|0|||
126771361|NCT02284373|456117755|FG000|Overall Study|Withdrawal by Subject|0|||
126771362|NCT02284373|456117756|FG001|Overall Study|Withdrawal by Subject|1|||
126771363|NCT02284373|456117757|FG002|Overall Study|Withdrawal by Subject|0|||
126771364|NCT02284373|456117755|FG000|Overall Study|Other|0|||
126771365|NCT02284373|456117756|FG001|Overall Study|Other|1|||
126391372|NCT04700540|454724500|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
126771366|NCT02284373|456117757|FG002|Overall Study|Other|0|||
126771367|NCT02284373|456117755|FG000|Overall Study|Lost to Follow-up|0|||
126771368|NCT02284373|456117756|FG001|Overall Study|Lost to Follow-up|1|||
126771369|NCT02284373|456117757|FG002|Overall Study|Lost to Follow-up|0|||
126771370|NCT02626182|456117758|FG000|Overall Study|Adverse Event|2|||
126771371|NCT02626182|456117759|FG001|Overall Study|Adverse Event|0|||
126771372|NCT03578276|456117760|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
126771373|NCT03578276|456117761|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
126771374|NCT00981409|456117762|FG000|Overall Study|Adverse Event|4|||
126771375|NCT00981409|456117763|FG001|Overall Study|Adverse Event|0|||
126771376|NCT00981409|456117762|FG000|Overall Study|Protocol Violation|0|||
126771377|NCT00981409|456117763|FG001|Overall Study|Protocol Violation|1|||
126771378|NCT00981409|456117762|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
126771379|NCT00981409|456117763|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
126468619|NCT02435069|455017670|FG001|Dose Response - First Intervention|Adverse Event|1|||
126718451|NCT04430738|455919538|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
126718452|NCT04430738|455919539|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
126718453|NCT04430738|455919540|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
126718454|NCT04430738|455919541|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
126718455|NCT04430738|455919536|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
126718456|NCT04430738|455919537|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
126718457|NCT04430738|455919538|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
126718458|NCT04430738|455919539|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
126718459|NCT04430738|455919540|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
126718460|NCT04430738|455919541|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
126718461|NCT05590793|455919542|FG000|Overall Study|Withdrawal by Subject|6|||
126718462|NCT05590793|455919542|FG000|Overall Study|Physician Decision|1|||
126718463|NCT05187013|455919543|FG000|Overall Study|Withdrawal by Subject|1|||
126718464|NCT05187013|455919544|FG001|Overall Study|Withdrawal by Subject|1|||
126718465|NCT05187013|455919545|FG002|Overall Study|Withdrawal by Subject|0|||
126718466|NCT05187013|455919543|FG000|Overall Study|Death|0|||
126718467|NCT05187013|455919544|FG001|Overall Study|Death|1|||
126718468|NCT05187013|455919545|FG002|Overall Study|Death|0|||
126718469|NCT05187013|455919543|FG000|Overall Study|Lost to Follow-up|20|||
126718470|NCT05187013|455919544|FG001|Overall Study|Lost to Follow-up|17|||
126718471|NCT05187013|455919545|FG002|Overall Study|Lost to Follow-up|0|||
126718472|NCT05187013|455919543|FG000|Overall Study|Ongoing Participants|3|||
126718473|NCT05187013|455919544|FG001|Overall Study|Ongoing Participants|5|||
126718474|NCT05187013|455919545|FG002|Overall Study|Ongoing Participants|0|||
126718475|NCT03015610|455919555|FG000|Overall Study|Lost to Follow-up|1|||
126718476|NCT03015610|455919556|FG001|Overall Study|Lost to Follow-up|5|||
126718477|NCT00938327|455919563|FG000|Overall Study|Adverse Event|2|||
126718478|NCT00938327|455919563|FG000|Overall Study|Protocol Violation|1|||
126718479|NCT00938327|455919563|FG000|Overall Study|Withdrawal by Subject|4|||
126718480|NCT00938327|455919563|FG000|Overall Study|Lost to Follow-up|37|||
126718481|NCT00938327|455919563|FG000|Overall Study|2nd dose received outside of the study|7|||
126718482|NCT00938327|455919563|FG000|Overall Study|Vaccine not received as out of stock|9|||
126718483|NCT02552355|455919564|FG000|Overall Study|Adverse Event|0|||
126718484|NCT02552355|455919565|FG001|Overall Study|Adverse Event|2|||
126718485|NCT02552355|455919566|FG002|Overall Study|Adverse Event|2|||
126718486|NCT02552355|455919567|FG003|Overall Study|Adverse Event|0|||
126718487|NCT02552355|455919564|FG000|Overall Study|Withdrawal by Subject|0|||
126718488|NCT02552355|455919565|FG001|Overall Study|Withdrawal by Subject|0|||
126718489|NCT02552355|455919566|FG002|Overall Study|Withdrawal by Subject|0|||
126718490|NCT02552355|455919567|FG003|Overall Study|Withdrawal by Subject|1|||
126718491|NCT00878072|455919568|FG000|Overall Study|Withdrew consent|2|||
126718492|NCT02588248|455919571|FG000|Overall Study|Physician Decision|4|||
126718493|NCT02588248|455919572|FG001|Overall Study|Physician Decision|3|||
126468620|NCT02435069|455017671|FG002|Dose Response - First Intervention|Adverse Event|1|||
126468621|NCT02435069|455017672|FG003|Dose Response - First Intervention|Adverse Event|0|||
126468622|NCT02435069|455017673|FG004|Dose Response - First Intervention|Adverse Event|0|||
126468623|NCT02435069|455017669|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
126468624|NCT02435069|455017670|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
126468625|NCT02435069|455017671|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
126468626|NCT02435069|455017672|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
126468627|NCT02435069|455017673|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
126718494|NCT04072146|455919573|FG000|Overall Study|Adverse Event|0|||
126718495|NCT04072146|455919574|FG001|Overall Study|Adverse Event|1|||
126718496|NCT01193348|455919578|FG000|Screening Period|Screen Failure|5|||
126718497|NCT01193348|455919578|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
126468628|NCT01528033|455017674|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
126718498|NCT01193348|455919578|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
126718499|NCT01193348|455919578|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
126718500|NCT01193348|455919578|FG000|Extension Treatment Period|Physician Decision|1|||
126718501|NCT01193348|455919578|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
126771380|NCT03869684|456117770|FG000|Overall Study|Adverse Event|0|||
126771381|NCT03869684|456117771|FG001|Overall Study|Adverse Event|3|||
126554495|NCT01474512|455324044|FG016|Maintenance Period|Physician Decision|0|||
126718502|NCT04070378|455919579|FG000|Overall Study|Withdrawal by Subject|2|||
126391373|NCT04700540|454724501|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
126391374|NCT03515551|454724502|FG000|Overall Study|Death|4|||
126391375|NCT03515551|454724503|FG001|Overall Study|Death|1|||
126391376|NCT03515551|454724504|FG002|Overall Study|Death|2|||
126391377|NCT03515551|454724505|FG003|Overall Study|Death|2|||
126391378|NCT03515551|454724506|FG004|Overall Study|Death|2|||
126391379|NCT03515551|454724507|FG005|Overall Study|Death|4|||
126391380|NCT03515551|454724508|FG006|Overall Study|Death|1|||
126391381|NCT03515551|454724502|FG000|Overall Study|Lost to Follow-up|0|||
126391382|NCT03515551|454724503|FG001|Overall Study|Lost to Follow-up|0|||
126391383|NCT03515551|454724504|FG002|Overall Study|Lost to Follow-up|1|||
126391384|NCT03515551|454724505|FG003|Overall Study|Lost to Follow-up|0|||
126391385|NCT03515551|454724506|FG004|Overall Study|Lost to Follow-up|0|||
126391386|NCT03515551|454724507|FG005|Overall Study|Lost to Follow-up|0|||
126391387|NCT03515551|454724508|FG006|Overall Study|Lost to Follow-up|0|||
126391388|NCT03515551|454724502|FG000|Overall Study|Withdrawal by Subject|0|||
126391389|NCT03515551|454724503|FG001|Overall Study|Withdrawal by Subject|1|||
126391390|NCT03515551|454724504|FG002|Overall Study|Withdrawal by Subject|0|||
126391391|NCT03515551|454724505|FG003|Overall Study|Withdrawal by Subject|0|||
126391392|NCT03515551|454724506|FG004|Overall Study|Withdrawal by Subject|0|||
126391393|NCT03515551|454724507|FG005|Overall Study|Withdrawal by Subject|0|||
126391394|NCT03515551|454724508|FG006|Overall Study|Withdrawal by Subject|1|||
126391395|NCT03515551|454724502|FG000|Overall Study|Study ended by sponsor|0|||
126391396|NCT03515551|454724503|FG001|Overall Study|Study ended by sponsor|0|||
126391397|NCT03515551|454724504|FG002|Overall Study|Study ended by sponsor|2|||
126391398|NCT03515551|454724505|FG003|Overall Study|Study ended by sponsor|1|||
126391399|NCT03515551|454724506|FG004|Overall Study|Study ended by sponsor|3|||
126391400|NCT03515551|454724507|FG005|Overall Study|Study ended by sponsor|0|||
126391401|NCT03515551|454724508|FG006|Overall Study|Study ended by sponsor|3|||
126391402|NCT03515551|454724502|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
126391403|NCT03515551|454724503|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
126391404|NCT03515551|454724504|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
126391405|NCT03515551|454724505|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
126391406|NCT03515551|454724506|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
126391407|NCT03515551|454724507|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
126391408|NCT03515551|454724508|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
126391409|NCT00920387|454724515|FG000|Stage 1|Adverse Event|1|||
126391410|NCT00920387|454724516|FG001|Stage 1|Adverse Event|0|||
126391411|NCT00920387|454724517|FG002|Stage 1|Adverse Event|0|||
126391412|NCT02265536|454724528|FG000|Overall Study|Adverse Event|1|||
126391413|NCT02265536|454724529|FG001|Overall Study|Adverse Event|0|||
126391414|NCT02265536|454724530|FG002|Overall Study|Adverse Event|0|||
126391415|NCT02265536|454724531|FG003|Overall Study|Adverse Event|0|||
126391416|NCT02265536|454724532|FG004|Overall Study|Adverse Event|1|||
126391417|NCT02265536|454724533|FG005|Overall Study|Adverse Event|0|||
126391418|NCT02265536|454724528|FG000|Overall Study|Physician Decision|0|||
126391419|NCT02265536|454724529|FG001|Overall Study|Physician Decision|0|||
126391420|NCT02265536|454724530|FG002|Overall Study|Physician Decision|0|||
126391421|NCT02265536|454724531|FG003|Overall Study|Physician Decision|0|||
126391422|NCT02265536|454724532|FG004|Overall Study|Physician Decision|2|||
126391423|NCT02265536|454724533|FG005|Overall Study|Physician Decision|0|||
126391424|NCT02265536|454724528|FG000|Overall Study|Withdrawal by Subject|0|||
126391425|NCT02265536|454724529|FG001|Overall Study|Withdrawal by Subject|3|||
126391426|NCT02265536|454724530|FG002|Overall Study|Withdrawal by Subject|0|||
126391427|NCT02265536|454724531|FG003|Overall Study|Withdrawal by Subject|0|||
126391428|NCT02265536|454724532|FG004|Overall Study|Withdrawal by Subject|0|||
126391429|NCT02265536|454724533|FG005|Overall Study|Withdrawal by Subject|0|||
126391430|NCT03268954|454724534|FG000|Overall Study|Ongoing|23|||
126391431|NCT03268954|454724535|FG001|Overall Study|Ongoing|31|||
126391432|NCT03268954|454724534|FG000|Overall Study|Adverse Event|53|||
126391433|NCT03268954|454724535|FG001|Overall Study|Adverse Event|62|||
126391434|NCT03268954|454724534|FG000|Overall Study|Withdrawal by Subject|25|||
126391435|NCT03268954|454724535|FG001|Overall Study|Withdrawal by Subject|16|||
126391436|NCT03268954|454724534|FG000|Overall Study|Progressive Disease|61|||
126391437|NCT03268954|454724535|FG001|Overall Study|Progressive Disease|48|||
126391438|NCT03268954|454724534|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
126391439|NCT03268954|454724535|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
126391440|NCT03268954|454724534|FG000|Overall Study|Reason not Specified|40|||
126391441|NCT03268954|454724535|FG001|Overall Study|Reason not Specified|40|||
126391442|NCT03802630|454724536|FG000|Overall Study|Study terminated by sponsor|130|||
126391443|NCT03802630|454724537|FG001|Overall Study|Study terminated by sponsor|134|||
126391444|NCT03802630|454724536|FG000|Overall Study|Subject decision|16|||
126391445|NCT03802630|454724537|FG001|Overall Study|Subject decision|9|||
126391446|NCT03802630|454724536|FG000|Overall Study|Adverse Event|3|||
126391447|NCT03802630|454724537|FG001|Overall Study|Adverse Event|1|||
126391448|NCT03802630|454724536|FG000|Overall Study|Lost to Follow-up|2|||
126391449|NCT03802630|454724537|FG001|Overall Study|Lost to Follow-up|2|||
126391450|NCT03802630|454724536|FG000|Overall Study|Physician Decision|2|||
126391451|NCT03802630|454724537|FG001|Overall Study|Physician Decision|0|||
126391452|NCT03802630|454724536|FG000|Overall Study|Death|0|||
126391453|NCT03802630|454724537|FG001|Overall Study|Death|2|||
126391454|NCT05005013|454724538|FG000|Overall Study|Withdrawal by Subject|5|||
126391455|NCT05005013|454724539|FG001|Overall Study|Withdrawal by Subject|1|||
126391456|NCT05005013|454724538|FG000|Overall Study|Lost to Follow-up|3|||
126391457|NCT05005013|454724539|FG001|Overall Study|Lost to Follow-up|1|||
126391458|NCT05005013|454724538|FG000|Overall Study|Ineligibility|1|||
126391459|NCT05005013|454724539|FG001|Overall Study|Ineligibility|1|||
126391460|NCT04210245|454724540|FG000|Overall Study|Adverse Event|0|||
126391461|NCT04210245|454724541|FG001|Overall Study|Adverse Event|3|||
126391462|NCT04210245|454724542|FG002|Overall Study|Adverse Event|6|||
126391463|NCT04210245|454724543|FG003|Overall Study|Adverse Event|0|||
126391464|NCT04210245|454724540|FG000|Overall Study|Withdrawal by Subject|0|||
126391465|NCT04210245|454724541|FG001|Overall Study|Withdrawal by Subject|1|||
126391466|NCT04210245|454724542|FG002|Overall Study|Withdrawal by Subject|4|||
126391467|NCT04210245|454724543|FG003|Overall Study|Withdrawal by Subject|4|||
126391468|NCT04210245|454724540|FG000|Overall Study|Lost to Follow-up|0|||
126391469|NCT04210245|454724541|FG001|Overall Study|Lost to Follow-up|1|||
126391470|NCT04210245|454724542|FG002|Overall Study|Lost to Follow-up|1|||
126391471|NCT04210245|454724543|FG003|Overall Study|Lost to Follow-up|1|||
126391472|NCT04210245|454724540|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
126391473|NCT04210245|454724541|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
126468629|NCT01528033|455017675|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
126468630|NCT01528033|455017674|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
126468631|NCT01528033|455017675|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
126468632|NCT01528033|455017674|FG000|Primary Endpoint Assessment ITT|Death|2|||
126468633|NCT01528033|455017675|FG001|Primary Endpoint Assessment ITT|Death|2|||
126468634|NCT01528033|455017674|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
126468635|NCT01528033|455017675|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
126468636|NCT01528033|455017674|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
126391474|NCT04210245|454724542|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
126391475|NCT04210245|454724543|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
126391476|NCT04091581|454724544|FG000|Overall Study|Lost to Follow-up|0|||
126391477|NCT04091581|454724545|FG001|Overall Study|Lost to Follow-up|1|||
126391478|NCT03724981|454726245|FG000|First Device|Protocol Violation|1|||
126391479|NCT03724981|454726246|FG001|First Device|Protocol Violation|1|||
126391480|NCT04439539|454726250|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
126391481|NCT04439539|454726251|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
126391482|NCT04439539|454726252|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
126391483|NCT04439539|454726250|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
126391484|NCT04439539|454726251|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
126391485|NCT04439539|454726252|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
126391486|NCT04439539|454726250|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
126391487|NCT04439539|454726251|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
126391488|NCT04439539|454726252|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
126391489|NCT03596047|454726253|FG000|Overall Study|Withdrawal by Subject|7|||
126391490|NCT03596047|454726254|FG001|Overall Study|Withdrawal by Subject|4|||
126391491|NCT03596047|454726253|FG000|Overall Study|Lost to Follow-up|0|||
126391492|NCT03596047|454726254|FG001|Overall Study|Lost to Follow-up|2|||
126391493|NCT03727646|454726255|FG000|Overall Study|Adverse Event|1|||
126391494|NCT03727646|454726256|FG001|Overall Study|Adverse Event|0|||
126391495|NCT02290691|454726259|FG000|Overall Study|Noncompliance|0|||
126391496|NCT02290691|454726260|FG001|Overall Study|Noncompliance|1|||
126391497|NCT02290691|454726259|FG000|Overall Study|Withdrawal by Subject|1|||
126391498|NCT02290691|454726260|FG001|Overall Study|Withdrawal by Subject|1|||
126391499|NCT02290691|454726259|FG000|Overall Study|Lost to Follow-up|7|||
126391500|NCT02290691|454726260|FG001|Overall Study|Lost to Follow-up|7|||
126391501|NCT01843673|454726262|FG000|Overall Study|Lack of Efficacy|2|||
126391502|NCT01843673|454726262|FG000|Overall Study|Withdrawal by Subject|4|||
126391503|NCT01328535|454726266|FG000|Overall Study|Ineligible|1|||
126391504|NCT04417218|454726267|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
126391505|NCT04417218|454726268|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
126391506|NCT00873041|454726271|FG000|Core Study|Adverse Event|2|||
126391507|NCT00873041|454726272|FG001|Core Study|Adverse Event|3|||
126391508|NCT00873041|454726273|FG002|Core Study|Adverse Event|1|||
126391509|NCT00873041|454726271|FG000|Core Study|Withdrawal by Subject|1|||
126391510|NCT00873041|454726272|FG001|Core Study|Withdrawal by Subject|2|||
126468637|NCT01528033|455017675|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
126468638|NCT01528033|455017674|FG000|Follow Up|No data available|46|||
126391511|NCT00873041|454726273|FG002|Core Study|Withdrawal by Subject|2|||
126391512|NCT00873041|454726271|FG000|Core Study|Lost to Follow-up|3|||
126391513|NCT00873041|454726272|FG001|Core Study|Lost to Follow-up|1|||
126391514|NCT00873041|454726273|FG002|Core Study|Lost to Follow-up|0|||
126391515|NCT00873041|454726271|FG000|Core Study|Abnormal laboratory value|0|||
126391516|NCT00873041|454726272|FG001|Core Study|Abnormal laboratory value|0|||
126391517|NCT00873041|454726273|FG002|Core Study|Abnormal laboratory value|1|||
126391518|NCT00873041|454726271|FG000|Core Study|Protocol deviation|1|||
126391519|NCT00873041|454726272|FG001|Core Study|Protocol deviation|0|||
126391520|NCT00873041|454726273|FG002|Core Study|Protocol deviation|1|||
126718503|NCT04070378|455919579|FG000|Overall Study|Screen Failure|6|||
126718504|NCT04070378|455919579|FG000|Overall Study|Physician Decision|1|||
126718505|NCT04070378|455919579|FG000|Overall Study|Adverse Event|1|||
126718506|NCT03259334|455919580|FG000|Overall Study|Adverse Event|3|||
126718507|NCT03259334|455919581|FG001|Overall Study|Adverse Event|8|||
126718508|NCT03259334|455919582|FG002|Overall Study|Adverse Event|5|||
126718509|NCT03259334|455919580|FG000|Overall Study|Withdrawal by Subject|4|||
126468639|NCT01528033|455017675|FG001|Follow Up|No data available|44|||
126468640|NCT02520661|455017676|FG000|Overall Study|Lost to Follow-up|7|||
126468641|NCT02520661|455017677|FG001|Overall Study|Lost to Follow-up|3|||
126468642|NCT02520661|455017676|FG000|Overall Study|Admitted from ED|49|||
126718510|NCT03259334|455919581|FG001|Overall Study|Withdrawal by Subject|2|||
126718511|NCT03259334|455919582|FG002|Overall Study|Withdrawal by Subject|4|||
126718512|NCT03259334|455919580|FG000|Overall Study|Physician Decision|1|||
126718513|NCT03259334|455919581|FG001|Overall Study|Physician Decision|0|||
126718514|NCT03259334|455919582|FG002|Overall Study|Physician Decision|0|||
126718515|NCT03259334|455919580|FG000|Overall Study|Lost to Follow-up|0|||
126718516|NCT03259334|455919581|FG001|Overall Study|Lost to Follow-up|2|||
126718517|NCT03259334|455919582|FG002|Overall Study|Lost to Follow-up|1|||
126718518|NCT03259334|455919580|FG000|Overall Study|Protocol Deviation|0|||
126718519|NCT03259334|455919581|FG001|Overall Study|Protocol Deviation|3|||
126718520|NCT03259334|455919582|FG002|Overall Study|Protocol Deviation|2|||
126718521|NCT03259334|455919580|FG000|Overall Study|Lack of Efficacy|2|||
126718522|NCT03259334|455919581|FG001|Overall Study|Lack of Efficacy|0|||
126718523|NCT03259334|455919582|FG002|Overall Study|Lack of Efficacy|1|||
126718524|NCT03259334|455919580|FG000|Overall Study|Randomized but never treated|0|||
126718525|NCT03259334|455919581|FG001|Overall Study|Randomized but never treated|2|||
126718526|NCT03259334|455919582|FG002|Overall Study|Randomized but never treated|0|||
126718527|NCT05306873|455920513|FG000|Stage 2|Study stopped|1|||
126718528|NCT05306873|455920514|FG001|Stage 2|Study stopped|1|||
126391521|NCT00873041|454726271|FG000|Extension Study|Adverse Event|1|||
126718529|NCT05306873|455920515|FG002|Stage 2|Study stopped|0|||
126718530|NCT05306873|455920516|FG003|Stage 2|Study stopped|0|||
126718531|NCT05306873|455920513|FG000|Stage 2|Stage 2 Treatment Failure|2|||
126718532|NCT05306873|455920514|FG001|Stage 2|Stage 2 Treatment Failure|3|||
126718533|NCT05306873|455920515|FG002|Stage 2|Stage 2 Treatment Failure|0|||
126718534|NCT05306873|455920516|FG003|Stage 2|Stage 2 Treatment Failure|0|||
126718535|NCT05306873|455920513|FG000|Stage 2|Logistical issues due to participant moving|1|||
126718536|NCT05306873|455920514|FG001|Stage 2|Logistical issues due to participant moving|0|||
126718537|NCT05306873|455920515|FG002|Stage 2|Logistical issues due to participant moving|0|||
126718538|NCT05306873|455920516|FG003|Stage 2|Logistical issues due to participant moving|0|||
126718539|NCT05306873|455920513|FG000|Stage 3|Stage 3 Treatment Failure|0|||
126718540|NCT05306873|455920514|FG001|Stage 3|Stage 3 Treatment Failure|0|||
126718541|NCT05306873|455920515|FG002|Stage 3|Stage 3 Treatment Failure|0|||
126391522|NCT00873041|454726272|FG001|Extension Study|Adverse Event|0|||
126391523|NCT00873041|454726273|FG002|Extension Study|Adverse Event|1|||
126391524|NCT00873041|454726271|FG000|Extension Study|Administrative reasons|0|||
126391525|NCT00873041|454726272|FG001|Extension Study|Administrative reasons|0|||
126391526|NCT00873041|454726273|FG002|Extension Study|Administrative reasons|1|||
126391527|NCT01734395|454726276|FG000|Overall Study|Other|65|||
126391528|NCT01734395|454726276|FG000|Overall Study|Lost to Follow-up|287|||
126391529|NCT01734395|454726276|FG000|Overall Study|Lack of Efficacy|5|||
126468643|NCT02520661|455017677|FG001|Overall Study|Admitted from ED|48|||
126468644|NCT02520661|455017676|FG000|Overall Study|ED greater than 24 hours|29|||
126468645|NCT02520661|455017677|FG001|Overall Study|ED greater than 24 hours|38|||
126468646|NCT02520661|455017676|FG000|Overall Study|other ineligibility|14|||
126468647|NCT02520661|455017677|FG001|Overall Study|other ineligibility|22|||
126468648|NCT02520661|455017676|FG000|Overall Study|Withdrawal by Subject|7|||
126718542|NCT05306873|455920516|FG003|Stage 3|Stage 3 Treatment Failure|1|||
126718543|NCT05306873|455920513|FG000|Stage 3|Study Stopped|0|||
126391530|NCT01734395|454726276|FG000|Overall Study|Adverse Event|40|||
126391531|NCT01734395|454726276|FG000|Overall Study|Withdrawal by Subject|10|||
126391532|NCT01734395|454726276|FG000|Overall Study|Missing the reasons for not completed|3|||
126468649|NCT02520661|455017677|FG001|Overall Study|Withdrawal by Subject|16|||
126391533|NCT01032291|454726277|FG000|Safety Lead-in|Adverse Event|1|||
126391534|NCT01032291|454726278|FG001|Safety Lead-in|Adverse Event|0|||
126718544|NCT05306873|455920514|FG001|Stage 3|Study Stopped|0|||
126718545|NCT05306873|455920515|FG002|Stage 3|Study Stopped|1|||
126718546|NCT05306873|455920516|FG003|Stage 3|Study Stopped|0|||
126391535|NCT01032291|454726279|FG002|Safety Lead-in|Adverse Event|0|||
126391536|NCT01032291|454726277|FG000|Safety Lead-in|Death|1|||
126391537|NCT01032291|454726278|FG001|Safety Lead-in|Death|0|||
126391538|NCT01032291|454726279|FG002|Safety Lead-in|Death|0|||
126391539|NCT01032291|454726277|FG000|Proof of Concept|Adverse Event|0|||
126391540|NCT01032291|454726278|FG001|Proof of Concept|Adverse Event|5|||
126391541|NCT01032291|454726279|FG002|Proof of Concept|Adverse Event|1|||
126391542|NCT01032291|454726277|FG000|Proof of Concept|Death|0|||
126391543|NCT01032291|454726278|FG001|Proof of Concept|Death|1|||
126391544|NCT01032291|454726279|FG002|Proof of Concept|Death|2|||
126391545|NCT01032291|454726277|FG000|Proof of Concept|Lack of Efficacy|0|||
126391546|NCT01032291|454726278|FG001|Proof of Concept|Lack of Efficacy|1|||
126391547|NCT01032291|454726279|FG002|Proof of Concept|Lack of Efficacy|0|||
126391548|NCT01032291|454726277|FG000|Proof of Concept|Never Received Study Drug|0|||
126391549|NCT01032291|454726278|FG001|Proof of Concept|Never Received Study Drug|1|||
126391550|NCT01032291|454726279|FG002|Proof of Concept|Never Received Study Drug|0|||
126391551|NCT00313313|454726280|FG000|Overall Study|Lack of Efficacy|14|||
126391552|NCT00313313|454726281|FG001|Overall Study|Lack of Efficacy|9|||
126391553|NCT00313313|454726282|FG002|Overall Study|Lack of Efficacy|20|||
126391554|NCT00313313|454726280|FG000|Overall Study|Withdrawal of consent by subject|18|||
126391555|NCT00313313|454726281|FG001|Overall Study|Withdrawal of consent by subject|17|||
126391556|NCT00313313|454726282|FG002|Overall Study|Withdrawal of consent by subject|31|||
126391557|NCT00313313|454726280|FG000|Overall Study|Lost to Follow-up|10|||
126391558|NCT00313313|454726281|FG001|Overall Study|Lost to Follow-up|7|||
126391559|NCT00313313|454726282|FG002|Overall Study|Lost to Follow-up|9|||
126391560|NCT00313313|454726280|FG000|Overall Study|Adverse Event|15|||
126391561|NCT00313313|454726281|FG001|Overall Study|Adverse Event|16|||
126391562|NCT00313313|454726282|FG002|Overall Study|Adverse Event|12|||
126391563|NCT00313313|454726280|FG000|Overall Study|Physician Decision|2|||
126391564|NCT00313313|454726281|FG001|Overall Study|Physician Decision|6|||
126391565|NCT00313313|454726282|FG002|Overall Study|Physician Decision|4|||
126391566|NCT00313313|454726280|FG000|Overall Study|Poor/Noncompliance|3|||
126391567|NCT00313313|454726281|FG001|Overall Study|Poor/Noncompliance|6|||
126391568|NCT00313313|454726282|FG002|Overall Study|Poor/Noncompliance|2|||
126391569|NCT00313313|454726280|FG000|Overall Study|Pregnancy|1|||
126391570|NCT00313313|454726281|FG001|Overall Study|Pregnancy|2|||
126391571|NCT00313313|454726282|FG002|Overall Study|Pregnancy|0|||
126391572|NCT00313313|454726280|FG000|Overall Study|Death|0|||
126391573|NCT00313313|454726281|FG001|Overall Study|Death|0|||
126391574|NCT00313313|454726282|FG002|Overall Study|Death|2|||
126391575|NCT00313313|454726280|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
126391576|NCT00313313|454726281|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
126391577|NCT00313313|454726282|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
126391578|NCT03425006|454726285|FG000|Overall Study|Withdrawal by Subject|1|||
126391579|NCT03425006|454726285|FG000|Overall Study|Physician Decision|1|||
126391580|NCT03425006|454726285|FG000|Overall Study|Death|1|||
126391581|NCT02300558|454726288|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
126391582|NCT02300558|454726288|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
126391583|NCT02300558|454726288|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
126391584|NCT02300558|454726288|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
126391585|NCT00695955|454726289|FG000|Cohort 1|Adverse Event|26|||
126391586|NCT00695955|454726289|FG000|Cohort 1|Protocol Violation|2|||
126391587|NCT00695955|454726289|FG000|Cohort 1|Lost to Follow-up|30|||
126391588|NCT00695955|454726289|FG000|Cohort 1|Withdrawal by Subject|25|||
126391589|NCT00695955|454726289|FG000|Cohort 1|Lack of Efficacy|3|||
126391590|NCT00695955|454726289|FG000|Cohort 1|Other|16|||
126391591|NCT00695955|454726289|FG000|Cohort 2|Adverse Event|24|||
126391592|NCT00695955|454726289|FG000|Cohort 2|Protocol Violation|5|||
126391593|NCT00695955|454726289|FG000|Cohort 2|Lost to Follow-up|38|||
126391594|NCT00695955|454726289|FG000|Cohort 2|Withdrawal by Subject|28|||
126391595|NCT00695955|454726289|FG000|Cohort 2|Lack of Efficacy|4|||
126391596|NCT00695955|454726289|FG000|Cohort 2|Other|5|||
126391597|NCT03888235|454726292|FG000|Overall Study|Lost to Follow-up|1|||
126391598|NCT03888235|454726293|FG001|Overall Study|Lost to Follow-up|1|||
126391599|NCT03888235|454726294|FG002|Overall Study|Lost to Follow-up|0|||
126391600|NCT01054560|454726295|FG000|Overall Study|Death|10|||
126391601|NCT01054560|454726296|FG001|Overall Study|Death|21|||
126391602|NCT01054560|454726295|FG000|Overall Study|Lost to Follow-up|2|||
126391603|NCT01054560|454726296|FG001|Overall Study|Lost to Follow-up|5|||
126391604|NCT01054560|454726295|FG000|Overall Study|Withdrawal by Subject|0|||
126468650|NCT04399837|455017680|FG000|Overall Study|Other than listed|0|||
126468651|NCT04399837|455017681|FG001|Overall Study|Other than listed|2|||
126468652|NCT04399837|455017682|FG002|Overall Study|Other than listed|2|||
126391605|NCT01054560|454726296|FG001|Overall Study|Withdrawal by Subject|2|||
126391606|NCT01054560|454726295|FG000|Overall Study|Physician Decision|1|||
126391607|NCT01054560|454726296|FG001|Overall Study|Physician Decision|0|||
126391608|NCT01421303|454726297|FG000|Overall Study|Lost to Follow-up|13|||
126391609|NCT01421303|454726297|FG000|Overall Study|Non compliance with study procedure|1|||
126391610|NCT01421303|454726297|FG000|Overall Study|Other|7|||
126391611|NCT01421303|454726297|FG000|Overall Study|Withdrawal by Subject|1|||
126771382|NCT03869684|456117772|FG002|Overall Study|Adverse Event|1|||
126771383|NCT03869684|456117770|FG000|Overall Study|Withdrawal by Subject|1|||
126771384|NCT03869684|456117771|FG001|Overall Study|Withdrawal by Subject|0|||
126771385|NCT03869684|456117772|FG002|Overall Study|Withdrawal by Subject|0|||
126771386|NCT03869684|456117770|FG000|Overall Study|Lost to Follow-up|1|||
126771387|NCT03869684|456117771|FG001|Overall Study|Lost to Follow-up|0|||
126771388|NCT03869684|456117772|FG002|Overall Study|Lost to Follow-up|0|||
126771389|NCT03869684|456117770|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
126771390|NCT03869684|456117771|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
126771391|NCT03869684|456117772|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
126771392|NCT00078312|456117773|FG000|Overall Study|Adverse Event|43|||
126771393|NCT00078312|456117773|FG000|Overall Study|Lack of Efficacy|15|||
126771394|NCT00078312|456117773|FG000|Overall Study|Lost to Follow-up|41|||
126771395|NCT00078312|456117773|FG000|Overall Study|Physician Decision|9|||
126771396|NCT00078312|456117773|FG000|Overall Study|Protocol Violation|3|||
126771397|NCT00078312|456117773|FG000|Overall Study|Withdrawal by Subject|33|||
126771398|NCT00078312|456117773|FG000|Overall Study|Miscellaneous|33|||
126771399|NCT04840901|456117774|FG000|Overall Study|Lost to Follow-up|3|||
126771400|NCT04840901|456117775|FG001|Overall Study|Lost to Follow-up|1|||
126771401|NCT04840901|456117774|FG000|Overall Study|Moved|1|||
126771402|NCT04840901|456117775|FG001|Overall Study|Moved|0|||
126771403|NCT04840901|456117774|FG000|Overall Study|Unable to comply with study schedule|0|||
126771404|NCT04840901|456117775|FG001|Overall Study|Unable to comply with study schedule|1|||
126771405|NCT04840901|456117774|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
126771406|NCT04840901|456117775|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
126771407|NCT05354206|456117776|FG000|Overall Study|Withdrawal by Subject|1|||
126771408|NCT05354206|456117777|FG001|Overall Study|Withdrawal by Subject|0|||
126771409|NCT04285983|456117778|FG000|Overall Study|Protocol Violation|6|||
126771410|NCT04936334|456117779|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
126771411|NCT00110084|456117785|FG000|Overall Study|Adverse Event|9|||
126771412|NCT00110084|456117785|FG000|Overall Study|Death|1|||
126771413|NCT00110084|456117785|FG000|Overall Study|Patient Refusal|10|||
126771414|NCT00110084|456117785|FG000|Overall Study|Alternate Therapy|5|||
126771415|NCT00110084|456117785|FG000|Overall Study|Intercurrent Illness|1|||
126771416|NCT00110084|456117785|FG000|Overall Study|Other|2|||
126771417|NCT00103259|456117786|FG000|Overall Study|Death|3|||
126771418|NCT00103259|456117787|FG001|Overall Study|Death|2|||
126771419|NCT00103259|456117786|FG000|Overall Study|Withdrawal by Subject|2|||
126771420|NCT00103259|456117787|FG001|Overall Study|Withdrawal by Subject|3|||
126771421|NCT00103259|456117786|FG000|Overall Study|alternative therapy|1|||
126771422|NCT00103259|456117787|FG001|Overall Study|alternative therapy|0|||
126771423|NCT00103259|456117786|FG000|Overall Study|other (reasons were not specified)|2|||
126771424|NCT00103259|456117787|FG001|Overall Study|other (reasons were not specified)|1|||
126771425|NCT00103259|456117786|FG000|Overall Study|ineligible/no protocol therapy|4|||
126771426|NCT00103259|456117787|FG001|Overall Study|ineligible/no protocol therapy|6|||
126771427|NCT03224234|456117792|FG000|Main Study|Lost to Follow-up|5|||
126771428|NCT03224234|456117793|FG001|Main Study|Lost to Follow-up|5|||
126771429|NCT02866695|456117794|FG000|Overall Study|Adverse Event|1|||
126771430|NCT02866695|456117794|FG000|Overall Study|Lost to Follow-up|1|||
126771431|NCT05016765|456117795|FG000|Overall Study|Lost to Follow-up|4|||
126771432|NCT04101721|456117799|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
126771433|NCT04101721|456117800|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
126771434|NCT04101721|456117799|FG000|Overall Study|Death|0|||
126771435|NCT04101721|456117800|FG001|Overall Study|Death|1|||
126771436|NCT04101721|456117799|FG000|Overall Study|Lost to Follow-up|0|||
126771437|NCT04101721|456117800|FG001|Overall Study|Lost to Follow-up|3|||
126771438|NCT02564952|456117801|FG000|Overall Study|Adverse Event|6|||
126771439|NCT02564952|456117801|FG000|Overall Study|Lost to Follow-up|1|||
126771440|NCT02564952|456117801|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
126771441|NCT02564952|456117801|FG000|Overall Study|Withdrawal by Subject|1|||
126391612|NCT00712725|454726299|FG000|Overall Study|Adverse Event|1|||
126391613|NCT00712725|454726300|FG001|Overall Study|Adverse Event|0|||
126391614|NCT00712725|454726301|FG002|Overall Study|Adverse Event|0|||
126391615|NCT00712725|454726302|FG003|Overall Study|Adverse Event|1|||
126391616|NCT00712725|454726303|FG004|Overall Study|Adverse Event|0|||
126391617|NCT00712725|454726304|FG005|Overall Study|Adverse Event|0|||
126391618|NCT00712725|454726305|FG006|Overall Study|Adverse Event|0|||
126391619|NCT00712725|454726306|FG007|Overall Study|Adverse Event|0|||
126391620|NCT00712725|454726299|FG000|Overall Study|Lost to Follow-up|3|||
126391621|NCT00712725|454726300|FG001|Overall Study|Lost to Follow-up|2|||
126771442|NCT02564952|456117801|FG000|Overall Study|Low Efficacy|1|||
126771443|NCT02564952|456117801|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
126771444|NCT02610842|456117802|FG000|Overall Study|Lost to Follow-up|5|||
126391622|NCT00712725|454726301|FG002|Overall Study|Lost to Follow-up|1|||
126771445|NCT00756652|456117803|FG000|Original Phase|Withdrawal by Subject|864|||
126391623|NCT00712725|454726302|FG003|Overall Study|Lost to Follow-up|1|||
126391624|NCT00712725|454726303|FG004|Overall Study|Lost to Follow-up|2|||
126718547|NCT01725152|455920517|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
126718548|NCT01725152|455920518|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
126718549|NCT01725152|455920517|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
126718550|NCT01725152|455920518|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
126718551|NCT01725152|455920517|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
126718552|NCT01725152|455920518|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
126718553|NCT01725152|455920517|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
126718554|NCT01725152|455920518|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
126718555|NCT00372190|455920519|FG000|Overall Study|Lost to Follow-up|3|||
126718556|NCT00372190|455920520|FG001|Overall Study|Lost to Follow-up|1|||
126718557|NCT03521154|455920524|FG000|Overall Study|Ongoing study at data cut-off|111|||
126718558|NCT03521154|455920525|FG001|Overall Study|Ongoing study at data cut-off|52|||
126718559|NCT01554956|455920528|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
126718560|NCT01554956|455920529|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
126718561|NCT01554956|455920530|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
126718562|NCT01554956|455920528|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
126718563|NCT01554956|455920529|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
126718564|NCT01554956|455920530|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
126718565|NCT01554956|455920528|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
126718566|NCT01554956|455920529|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
126718567|NCT01554956|455920530|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
126718568|NCT00365716|455920531|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
126718569|NCT00365716|455920532|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
126718570|NCT00365716|455920533|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
126718571|NCT00365716|455920534|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
126718572|NCT00365716|455920535|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
126718573|NCT00365716|455920536|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
126718574|NCT00365716|455920537|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
126718575|NCT00365716|455920531|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
126718576|NCT00365716|455920532|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
126718577|NCT00365716|455920533|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
126718578|NCT00365716|455920534|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
126718579|NCT00365716|455920535|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
126718580|NCT00365716|455920536|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
126718581|NCT00365716|455920537|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
126718582|NCT00365716|455920531|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
126391625|NCT00712725|454726304|FG005|Overall Study|Lost to Follow-up|2|||
126391626|NCT00712725|454726305|FG006|Overall Study|Lost to Follow-up|3|||
126391627|NCT00712725|454726306|FG007|Overall Study|Lost to Follow-up|1|||
126391628|NCT00712725|454726299|FG000|Overall Study|Physician Decision|2|||
126391629|NCT00712725|454726300|FG001|Overall Study|Physician Decision|0|||
126391630|NCT00712725|454726301|FG002|Overall Study|Physician Decision|0|||
126391631|NCT00712725|454726302|FG003|Overall Study|Physician Decision|0|||
126391632|NCT00712725|454726303|FG004|Overall Study|Physician Decision|1|||
126391633|NCT00712725|454726304|FG005|Overall Study|Physician Decision|0|||
126391634|NCT00712725|454726305|FG006|Overall Study|Physician Decision|2|||
126391635|NCT00712725|454726306|FG007|Overall Study|Physician Decision|0|||
126391636|NCT00712725|454726299|FG000|Overall Study|Pregnancy|0|||
126391637|NCT00712725|454726300|FG001|Overall Study|Pregnancy|1|||
126391638|NCT00712725|454726301|FG002|Overall Study|Pregnancy|0|||
126391639|NCT00712725|454726302|FG003|Overall Study|Pregnancy|0|||
126391640|NCT00712725|454726303|FG004|Overall Study|Pregnancy|1|||
126391641|NCT00712725|454726304|FG005|Overall Study|Pregnancy|0|||
126391642|NCT00712725|454726305|FG006|Overall Study|Pregnancy|2|||
126391643|NCT00712725|454726306|FG007|Overall Study|Pregnancy|0|||
126391644|NCT00712725|454726299|FG000|Overall Study|Protocol Violation|2|||
126391645|NCT00712725|454726300|FG001|Overall Study|Protocol Violation|0|||
126391646|NCT00712725|454726301|FG002|Overall Study|Protocol Violation|1|||
126391647|NCT00712725|454726302|FG003|Overall Study|Protocol Violation|3|||
126391648|NCT00712725|454726303|FG004|Overall Study|Protocol Violation|2|||
126718583|NCT00365716|455920532|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
126718584|NCT00365716|455920533|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
126718585|NCT00365716|455920534|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
126718586|NCT00365716|455920535|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
126391649|NCT00712725|454726304|FG005|Overall Study|Protocol Violation|0|||
126391650|NCT00712725|454726305|FG006|Overall Study|Protocol Violation|1|||
126391651|NCT00712725|454726306|FG007|Overall Study|Protocol Violation|1|||
126391652|NCT00712725|454726299|FG000|Overall Study|Withdrawal by Subject|2|||
126391653|NCT00712725|454726300|FG001|Overall Study|Withdrawal by Subject|1|||
126391654|NCT00712725|454726301|FG002|Overall Study|Withdrawal by Subject|1|||
126391655|NCT00712725|454726302|FG003|Overall Study|Withdrawal by Subject|2|||
126468653|NCT04399837|455017683|FG003|Overall Study|Other than listed|3|||
126468654|NCT04399837|455017680|FG000|Overall Study|Withdrawal by Subject|1|||
126468655|NCT04399837|455017681|FG001|Overall Study|Withdrawal by Subject|2|||
126468656|NCT04399837|455017682|FG002|Overall Study|Withdrawal by Subject|1|||
126468657|NCT04399837|455017683|FG003|Overall Study|Withdrawal by Subject|1|||
126468658|NCT02628769|455017685|FG000|First Intervention|Adverse Event|1|||
126468659|NCT02628769|455017686|FG001|First Intervention|Adverse Event|0|||
126468660|NCT02628769|455017685|FG000|First Intervention|Withdrawal by Subject|0|||
126468661|NCT02628769|455017686|FG001|First Intervention|Withdrawal by Subject|1|||
126468662|NCT02628769|455017685|FG000|Second Intervention|Adverse Event|2|||
126468663|NCT02628769|455017686|FG001|Second Intervention|Adverse Event|0|||
126554496|NCT01474512|455324045|FG017|Maintenance Period|Physician Decision|0|||
126554497|NCT01474512|455324028|FG000|Maintenance Period|Clinical Relapse|0|||
126718587|NCT00365716|455920536|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
126718588|NCT00365716|455920537|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
126718589|NCT00365716|455920531|FG000|Base Study (Day 1 to Month 7)|Other|0|||
126718590|NCT00365716|455920532|FG001|Base Study (Day 1 to Month 7)|Other|1|||
126718591|NCT00365716|455920533|FG002|Base Study (Day 1 to Month 7)|Other|0|||
126718592|NCT00365716|455920534|FG003|Base Study (Day 1 to Month 7)|Other|0|||
126718593|NCT00365716|455920535|FG004|Base Study (Day 1 to Month 7)|Other|0|||
126391656|NCT00712725|454726303|FG004|Overall Study|Withdrawal by Subject|1|||
126391657|NCT00712725|454726304|FG005|Overall Study|Withdrawal by Subject|1|||
126391658|NCT00712725|454726305|FG006|Overall Study|Withdrawal by Subject|1|||
126391659|NCT00712725|454726306|FG007|Overall Study|Withdrawal by Subject|2|||
126391660|NCT00712725|454726299|FG000|Overall Study|Lack of Qualifying Event|16|||
126391661|NCT00712725|454726300|FG001|Overall Study|Lack of Qualifying Event|2|||
126391662|NCT00712725|454726301|FG002|Overall Study|Lack of Qualifying Event|6|||
126391663|NCT00712725|454726302|FG003|Overall Study|Lack of Qualifying Event|8|||
126391664|NCT00712725|454726303|FG004|Overall Study|Lack of Qualifying Event|11|||
126391665|NCT00712725|454726304|FG005|Overall Study|Lack of Qualifying Event|13|||
126391666|NCT00712725|454726305|FG006|Overall Study|Lack of Qualifying Event|11|||
126468664|NCT02628769|455017685|FG000|Second Intervention|Physician Decision|0|||
126468665|NCT02628769|455017686|FG001|Second Intervention|Physician Decision|1|||
126554498|NCT01474512|455324029|FG001|Maintenance Period|Clinical Relapse|0|||
126718594|NCT00365716|455920536|FG005|Base Study (Day 1 to Month 7)|Other|0|||
126718595|NCT00365716|455920537|FG006|Base Study (Day 1 to Month 7)|Other|0|||
126718596|NCT00365716|455920531|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
126391667|NCT00712725|454726306|FG007|Overall Study|Lack of Qualifying Event|6|||
126391668|NCT00712725|454726299|FG000|Overall Study|Protocol Specified Criteria|3|||
126391669|NCT00712725|454726300|FG001|Overall Study|Protocol Specified Criteria|0|||
126391670|NCT00712725|454726301|FG002|Overall Study|Protocol Specified Criteria|1|||
126391671|NCT00712725|454726302|FG003|Overall Study|Protocol Specified Criteria|2|||
126391672|NCT00712725|454726303|FG004|Overall Study|Protocol Specified Criteria|1|||
126391673|NCT00712725|454726304|FG005|Overall Study|Protocol Specified Criteria|0|||
126391674|NCT00712725|454726305|FG006|Overall Study|Protocol Specified Criteria|2|||
126391675|NCT00712725|454726306|FG007|Overall Study|Protocol Specified Criteria|1|||
126391676|NCT03466099|454726307|FG000|Overall Study|Adverse Event|1|||
126391677|NCT03466099|454726308|FG001|Overall Study|Adverse Event|1|||
126391678|NCT03466099|454726309|FG002|Overall Study|Adverse Event|1|||
126391679|NCT03466099|454726307|FG000|Overall Study|Withdrawal by Subject|2|||
126391680|NCT03466099|454726308|FG001|Overall Study|Withdrawal by Subject|3|||
126391681|NCT03466099|454726309|FG002|Overall Study|Withdrawal by Subject|1|||
126391682|NCT03466099|454726307|FG000|Overall Study|Use of rescue medication|8|||
126391683|NCT03466099|454726308|FG001|Overall Study|Use of rescue medication|9|||
126391684|NCT03466099|454726309|FG002|Overall Study|Use of rescue medication|13|||
126468666|NCT02024555|455017687|FG000|Overall Study|Lost to Follow-up|1|||
126468667|NCT02024555|455017688|FG001|Overall Study|Lost to Follow-up|1|||
126468668|NCT02024555|455017687|FG000|Overall Study|Withdrawal by Subject|5|||
126468669|NCT02024555|455017688|FG001|Overall Study|Withdrawal by Subject|1|||
126554499|NCT01474512|455324030|FG002|Maintenance Period|Clinical Relapse|0|||
126554500|NCT01474512|455324031|FG003|Maintenance Period|Clinical Relapse|1|||
126718597|NCT00365716|455920532|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
126718598|NCT00365716|455920533|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
126718599|NCT00365716|455920534|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
126718600|NCT00365716|455920535|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
126718601|NCT00365716|455920536|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
126718602|NCT00365716|455920537|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
126718603|NCT00365716|455920531|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
126391685|NCT03466099|454726307|FG000|Overall Study|Rescued without meeting criteria|4|||
126391686|NCT03466099|454726308|FG001|Overall Study|Rescued without meeting criteria|1|||
126391687|NCT03466099|454726309|FG002|Overall Study|Rescued without meeting criteria|1|||
126391688|NCT03466099|454726307|FG000|Overall Study|Subject compliance|2|||
126391689|NCT03466099|454726308|FG001|Overall Study|Subject compliance|0|||
126391690|NCT03466099|454726309|FG002|Overall Study|Subject compliance|0|||
126391691|NCT03466099|454726307|FG000|Overall Study|Worsening disease|0|||
126554501|NCT01474512|455324032|FG004|Maintenance Period|Clinical Relapse|0|||
126771446|NCT00756652|456117804|FG001|Original Phase|Withdrawal by Subject|23|||
126771447|NCT00756652|456117803|FG000|Original Phase|Lost to Follow-up|601|||
126771448|NCT00756652|456117804|FG001|Original Phase|Lost to Follow-up|0|||
126771449|NCT00756652|456117803|FG000|Original Phase|Other Discontinuation|797|||
126771450|NCT00756652|456117804|FG001|Original Phase|Other Discontinuation|5|||
126771451|NCT00756652|456117803|FG000|Original Phase|Participant Noncompliance|18622|||
126771452|NCT00756652|456117804|FG001|Original Phase|Participant Noncompliance|424|||
126771453|NCT00756652|456117803|FG000|Original Phase|Unknown Discontinuation Reason|2|||
126771454|NCT00756652|456117804|FG001|Original Phase|Unknown Discontinuation Reason|0|||
126771455|NCT00756652|456117803|FG000|Original Phase|Participants without data|3259|||
126771456|NCT00756652|456117804|FG001|Original Phase|Participants without data|466|||
126391692|NCT03466099|454726308|FG001|Overall Study|Worsening disease|0|||
126391693|NCT03466099|454726309|FG002|Overall Study|Worsening disease|1|||
126771457|NCT00756652|456117803|FG000|Original Phase|Death|168|||
126771458|NCT00756652|456117804|FG001|Original Phase|Death|1|||
126771459|NCT00756652|456117803|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
126771460|NCT00756652|456117804|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
126771461|NCT00756652|456117803|FG000|Re-Op Phase|Withdrawal by Subject|62|||
126771462|NCT00756652|456117804|FG001|Re-Op Phase|Withdrawal by Subject|0|||
126771463|NCT00756652|456117803|FG000|Re-Op Phase|Death|6|||
126771464|NCT00756652|456117804|FG001|Re-Op Phase|Death|0|||
126771465|NCT00756652|456117803|FG000|Re-Op Phase|Lost to Follow-up|340|||
126771466|NCT00756652|456117804|FG001|Re-Op Phase|Lost to Follow-up|0|||
126771467|NCT00756652|456117803|FG000|Re-Op Phase|Site Closed|2454|||
126771468|NCT00756652|456117804|FG001|Re-Op Phase|Site Closed|0|||
126771469|NCT00756652|456117803|FG000|Re-Op Phase|Withdrawn after explant|14|||
126771470|NCT00756652|456117804|FG001|Re-Op Phase|Withdrawn after explant|0|||
126771471|NCT04736576|456117805|FG000|Overall Study|Progressive disease|3|||
126771472|NCT04736576|456117806|FG001|Overall Study|Progressive disease|1|||
126771473|NCT04736576|456117805|FG000|Overall Study|Death|1|||
126771474|NCT04736576|456117806|FG001|Overall Study|Death|0|||
126771475|NCT01850108|456117807|FG000|Overall Study|Lost to Follow-up|4|||
126771476|NCT01850108|456117807|FG000|Overall Study|Not eligible|1|||
126771477|NCT01850108|456117807|FG000|Overall Study|Failed engraftment|2|||
126771478|NCT01850108|456117807|FG000|Overall Study|Physician Decision|1|||
126771479|NCT04330482|456117812|FG000|Overall Study|Lost to Follow-up|2|||
126771480|NCT04330482|456117813|FG001|Overall Study|Lost to Follow-up|1|||
126771481|NCT04330482|456117812|FG000|Overall Study|Withdrawal by Subject|0|||
126771482|NCT04330482|456117813|FG001|Overall Study|Withdrawal by Subject|3|||
126771483|NCT05144477|456117815|FG000|Overall Study|Withdrawal by Subject|1|||
126771484|NCT05144477|456117816|FG001|Overall Study|Withdrawal by Subject|1|||
126771485|NCT03273712|456117817|FG000|Overall Study|Death|5|||
126771486|NCT03273712|456117817|FG000|Overall Study|Adverse Event|1|||
126771487|NCT03273712|456117817|FG000|Overall Study|Disease Progression|1|||
126771488|NCT01289990|456117820|FG000|Overall Study|Death|0|||
126771489|NCT01289990|456117821|FG001|Overall Study|Death|0|||
126771490|NCT01289990|456117822|FG002|Overall Study|Death|0|||
126771491|NCT01289990|456117823|FG003|Overall Study|Death|1|||
126771492|NCT01289990|456117824|FG004|Overall Study|Death|2|||
126391694|NCT00616018|454726314|FG000|Overall Study|Protocol Violation|3|||
126771493|NCT01289990|456117825|FG005|Overall Study|Death|1|||
126771494|NCT01289990|456117826|FG006|Overall Study|Death|0|||
126771495|NCT01289990|456117827|FG007|Overall Study|Death|0|||
126771496|NCT01289990|456117828|FG008|Overall Study|Death|0|||
126771497|NCT01289990|456117829|FG009|Overall Study|Death|0|||
126771498|NCT01289990|456117830|FG010|Overall Study|Death|0|||
126771499|NCT01289990|456117831|FG011|Overall Study|Death|1|||
126391695|NCT00404755|454726316|FG000|Phase I (Bupropion)|Adverse Event|3|||
126391696|NCT00404755|454726316|FG000|Phase I (Bupropion)|Other|1|||
126771500|NCT01289990|456117832|FG012|Overall Study|Death|0|||
126771501|NCT01289990|456117820|FG000|Overall Study|Lost to Follow-up|3|||
126771502|NCT01289990|456117821|FG001|Overall Study|Lost to Follow-up|2|||
126771503|NCT01289990|456117822|FG002|Overall Study|Lost to Follow-up|5|||
126391697|NCT00404755|454726316|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
126391698|NCT00350870|454726317|FG000|Overall Study|Withdrawal by Subject|21|||
126391699|NCT00350870|454726318|FG001|Overall Study|Withdrawal by Subject|17|||
126391700|NCT00350870|454726319|FG002|Overall Study|Withdrawal by Subject|15|||
126391701|NCT00350870|454726320|FG003|Overall Study|Withdrawal by Subject|14|||
126391702|NCT00350870|454726317|FG000|Overall Study|Physician Decision|1|||
126391703|NCT00350870|454726318|FG001|Overall Study|Physician Decision|0|||
126468670|NCT03805646|455017690|FG000|Overall Study|Death|40|||
126391704|NCT00350870|454726319|FG002|Overall Study|Physician Decision|1|||
126771504|NCT01289990|456117823|FG003|Overall Study|Lost to Follow-up|5|||
126468671|NCT03805646|455017691|FG001|Overall Study|Death|49|||
126771505|NCT01289990|456117824|FG004|Overall Study|Lost to Follow-up|3|||
126771506|NCT01289990|456117825|FG005|Overall Study|Lost to Follow-up|4|||
126771507|NCT01289990|456117826|FG006|Overall Study|Lost to Follow-up|2|||
126771508|NCT01289990|456117827|FG007|Overall Study|Lost to Follow-up|2|||
126771509|NCT01289990|456117828|FG008|Overall Study|Lost to Follow-up|1|||
126771510|NCT01289990|456117829|FG009|Overall Study|Lost to Follow-up|4|||
126771511|NCT01289990|456117830|FG010|Overall Study|Lost to Follow-up|2|||
126391705|NCT00350870|454726320|FG003|Overall Study|Physician Decision|1|||
126718604|NCT00365716|455920532|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
126718605|NCT00365716|455920533|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
126718606|NCT00365716|455920534|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
126718607|NCT00365716|455920535|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
126718608|NCT00365716|455920536|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
126718609|NCT00365716|455920537|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
126718610|NCT00365716|455920531|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
126718611|NCT00365716|455920532|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
126718612|NCT00365716|455920533|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
126718613|NCT00365716|455920534|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
126718614|NCT00365716|455920535|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
126718615|NCT00365716|455920536|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
126718616|NCT00365716|455920537|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
126718617|NCT00365716|455920531|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
126718618|NCT00365716|455920532|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
126718619|NCT00365716|455920533|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
126718620|NCT00365716|455920534|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
126718621|NCT00365716|455920535|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
126718622|NCT00365716|455920536|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
126718623|NCT00365716|455920537|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
126718624|NCT00365716|455920531|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
126718625|NCT00365716|455920532|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
126718626|NCT00365716|455920533|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
126718627|NCT00365716|455920534|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
126718628|NCT00365716|455920535|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
126718629|NCT00365716|455920536|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
126718630|NCT00365716|455920537|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
126718631|NCT00365716|455920531|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
126718632|NCT00365716|455920532|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
126718633|NCT00365716|455920533|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
126718634|NCT00365716|455920534|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
126718635|NCT00365716|455920535|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
126718636|NCT00365716|455920536|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
126718637|NCT00365716|455920537|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
126718638|NCT00365716|455920531|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
126718639|NCT00365716|455920532|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
126718640|NCT00365716|455920533|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
126718641|NCT00365716|455920534|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
126718642|NCT00365716|455920535|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
126718643|NCT00365716|455920536|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
126718644|NCT00365716|455920537|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
126718645|NCT00365716|455920531|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
126718646|NCT00365716|455920532|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
126718647|NCT00365716|455920533|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
126718648|NCT00365716|455920534|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
126718649|NCT00365716|455920535|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
126718650|NCT00365716|455920536|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
126718651|NCT00365716|455920537|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
126718652|NCT00365716|455920531|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
126718653|NCT00365716|455920532|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
126718654|NCT00365716|455920533|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
126718655|NCT00365716|455920534|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
126718656|NCT00365716|455920535|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
126718657|NCT00365716|455920536|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
126718658|NCT00365716|455920537|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
126718659|NCT00365716|455920531|FG000|Extension 1|Lost to Follow-up|0|||
126718660|NCT00365716|455920532|FG001|Extension 1|Lost to Follow-up|0|||
126718661|NCT00365716|455920533|FG002|Extension 1|Lost to Follow-up|0|||
126391706|NCT03194568|454726321|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
126718662|NCT00365716|455920534|FG003|Extension 1|Lost to Follow-up|0|||
126718663|NCT00365716|455920535|FG004|Extension 1|Lost to Follow-up|0|||
126718664|NCT00365716|455920536|FG005|Extension 1|Lost to Follow-up|1|||
126718665|NCT00365716|455920537|FG006|Extension 1|Lost to Follow-up|0|||
126718666|NCT00365716|455920531|FG000|Extension 1|Other|0|||
126718667|NCT00365716|455920532|FG001|Extension 1|Other|0|||
126718668|NCT00365716|455920533|FG002|Extension 1|Other|0|||
126718669|NCT00365716|455920534|FG003|Extension 1|Other|0|||
126718670|NCT00365716|455920535|FG004|Extension 1|Other|0|||
126468672|NCT03805646|455017690|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
126468673|NCT03805646|455017691|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
126468674|NCT02203071|455018823|FG000|Overall Study|Lost to Follow-up|3|||
126468675|NCT02203071|455018824|FG001|Overall Study|Lost to Follow-up|1|||
126468676|NCT03894046|455018825|FG000|Overall Study|Protocol Violation|1|||
126468677|NCT03894046|455018826|FG001|Overall Study|Protocol Violation|0|||
126468678|NCT03894046|455018827|FG002|Overall Study|Protocol Violation|0|||
126468679|NCT03894046|455018825|FG000|Overall Study|Adverse Event|0|||
126468680|NCT03894046|455018826|FG001|Overall Study|Adverse Event|1|||
126468681|NCT03894046|455018827|FG002|Overall Study|Adverse Event|0|||
126718671|NCT00365716|455920536|FG005|Extension 1|Other|9|||
126718672|NCT00365716|455920537|FG006|Extension 1|Other|0|||
126718673|NCT00365716|455920531|FG000|Extension 1|Moved|0|||
126718674|NCT00365716|455920532|FG001|Extension 1|Moved|0|||
126718675|NCT00365716|455920533|FG002|Extension 1|Moved|0|||
126718676|NCT00365716|455920534|FG003|Extension 1|Moved|0|||
126718677|NCT00365716|455920535|FG004|Extension 1|Moved|0|||
126718678|NCT00365716|455920536|FG005|Extension 1|Moved|4|||
126718679|NCT00365716|455920537|FG006|Extension 1|Moved|0|||
126718680|NCT00365716|455920531|FG000|Extension 1|Withdrawal by Subject|0|||
126718681|NCT00365716|455920532|FG001|Extension 1|Withdrawal by Subject|0|||
126718682|NCT00365716|455920533|FG002|Extension 1|Withdrawal by Subject|0|||
126718683|NCT00365716|455920534|FG003|Extension 1|Withdrawal by Subject|0|||
126718684|NCT00365716|455920535|FG004|Extension 1|Withdrawal by Subject|0|||
126718685|NCT00365716|455920536|FG005|Extension 1|Withdrawal by Subject|3|||
126718686|NCT00365716|455920537|FG006|Extension 1|Withdrawal by Subject|0|||
126718687|NCT00365716|455920531|FG000|Extension 1|Pregnancy|0|||
126718688|NCT00365716|455920532|FG001|Extension 1|Pregnancy|0|||
126718689|NCT00365716|455920533|FG002|Extension 1|Pregnancy|0|||
126718690|NCT00365716|455920534|FG003|Extension 1|Pregnancy|0|||
126718691|NCT00365716|455920535|FG004|Extension 1|Pregnancy|0|||
126718692|NCT00365716|455920536|FG005|Extension 1|Pregnancy|4|||
126718693|NCT00365716|455920537|FG006|Extension 1|Pregnancy|0|||
126718694|NCT00365716|455920531|FG000|Extension 1|Protocol Violation|0|||
126718695|NCT00365716|455920532|FG001|Extension 1|Protocol Violation|0|||
126718696|NCT00365716|455920533|FG002|Extension 1|Protocol Violation|0|||
126718697|NCT00365716|455920534|FG003|Extension 1|Protocol Violation|0|||
126718698|NCT00365716|455920535|FG004|Extension 1|Protocol Violation|0|||
126718699|NCT00365716|455920536|FG005|Extension 1|Protocol Violation|1|||
126718700|NCT00365716|455920537|FG006|Extension 1|Protocol Violation|0|||
126718701|NCT00365716|455920531|FG000|Extension 2|Lost to Follow-up|0|||
126718702|NCT00365716|455920532|FG001|Extension 2|Lost to Follow-up|0|||
126718703|NCT00365716|455920533|FG002|Extension 2|Lost to Follow-up|0|||
126718704|NCT00365716|455920534|FG003|Extension 2|Lost to Follow-up|0|||
126718705|NCT00365716|455920535|FG004|Extension 2|Lost to Follow-up|0|||
126718706|NCT00365716|455920536|FG005|Extension 2|Lost to Follow-up|0|||
126718707|NCT00365716|455920537|FG006|Extension 2|Lost to Follow-up|2|||
126391707|NCT05248997|454726322|FG000|Overall Study|Lost to Follow-up|1|||
126391708|NCT05248997|454726323|FG001|Overall Study|Lost to Follow-up|1|||
126391709|NCT05248997|454726322|FG000|Overall Study|Randomized but not treated|32|||
126391710|NCT05248997|454726323|FG001|Overall Study|Randomized but not treated|25|||
126391711|NCT01453205|454726324|FG000|Overall Study|Lost to Follow-up|3|||
126391712|NCT01453205|454726325|FG001|Overall Study|Lost to Follow-up|0|||
126391713|NCT01453205|454726326|FG002|Overall Study|Lost to Follow-up|1|||
126391714|NCT01453205|454726324|FG000|Overall Study|Withdrawal by Subject|8|||
126391715|NCT01453205|454726325|FG001|Overall Study|Withdrawal by Subject|3|||
126391716|NCT01453205|454726326|FG002|Overall Study|Withdrawal by Subject|0|||
126391717|NCT01453205|454726324|FG000|Overall Study|Death|24|||
126391718|NCT01453205|454726325|FG001|Overall Study|Death|22|||
126391719|NCT01453205|454726326|FG002|Overall Study|Death|18|||
126391720|NCT01453205|454726324|FG000|Overall Study|Other|45|||
126391721|NCT01453205|454726325|FG001|Overall Study|Other|27|||
126391722|NCT01453205|454726326|FG002|Overall Study|Other|35|||
126391723|NCT02602275|454726331|FG000|Day 1|Physician Decision|0|||
126391724|NCT02602275|454726332|FG001|Day 1|Physician Decision|1|||
126391725|NCT04262882|454726333|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
126391726|NCT04262882|454726334|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
126391727|NCT04262882|454726333|FG000|Overall Study|Lost to Follow-up|1|||
126391728|NCT04262882|454726334|FG001|Overall Study|Lost to Follow-up|0|||
126391729|NCT01301066|454726335|FG000|Overall Study|Lost to Follow-up|5|||
126391730|NCT01301066|454726336|FG001|Overall Study|Lost to Follow-up|11|||
126468682|NCT03894046|455018825|FG000|Overall Study|Withdrawal by Subject|2|||
126468683|NCT03894046|455018826|FG001|Overall Study|Withdrawal by Subject|3|||
126718708|NCT00365716|455920531|FG000|Extension 2|Other|0|||
126718709|NCT00365716|455920532|FG001|Extension 2|Other|0|||
126718710|NCT00365716|455920533|FG002|Extension 2|Other|0|||
126718711|NCT00365716|455920534|FG003|Extension 2|Other|0|||
126718712|NCT00365716|455920535|FG004|Extension 2|Other|0|||
126718713|NCT00365716|455920536|FG005|Extension 2|Other|0|||
126718714|NCT00365716|455920537|FG006|Extension 2|Other|3|||
126718715|NCT00365716|455920531|FG000|Extension 2|Withdrawal by Subject|0|||
126468684|NCT03894046|455018827|FG002|Overall Study|Withdrawal by Subject|1|||
126468685|NCT03894046|455018825|FG000|Overall Study|Death|15|||
126468686|NCT03894046|455018826|FG001|Overall Study|Death|21|||
126468687|NCT03894046|455018827|FG002|Overall Study|Death|4|||
126468688|NCT03894046|455018825|FG000|Overall Study|No growth of ABC|2|||
126468689|NCT03894046|455018826|FG001|Overall Study|No growth of ABC|1|||
126468690|NCT03894046|455018827|FG002|Overall Study|No growth of ABC|0|||
126468691|NCT03894046|455018825|FG000|Overall Study|Physician Decision|1|||
126718716|NCT00365716|455920532|FG001|Extension 2|Withdrawal by Subject|0|||
126718717|NCT00365716|455920533|FG002|Extension 2|Withdrawal by Subject|0|||
126718718|NCT00365716|455920534|FG003|Extension 2|Withdrawal by Subject|0|||
126718719|NCT00365716|455920535|FG004|Extension 2|Withdrawal by Subject|0|||
126718720|NCT00365716|455920536|FG005|Extension 2|Withdrawal by Subject|0|||
126718721|NCT00365716|455920537|FG006|Extension 2|Withdrawal by Subject|5|||
126718722|NCT06150573|455920538|FG000|Overall Study|Did not meet study criteria|1|||
126718723|NCT06150573|455920539|FG001|Overall Study|Did not meet study criteria|0|||
126718724|NCT06150573|455920538|FG000|Overall Study|Adverse Event|1|||
126718725|NCT06150573|455920539|FG001|Overall Study|Adverse Event|0|||
126718726|NCT06150573|455920538|FG000|Overall Study|Lost to Follow-up|0|||
126718727|NCT06150573|455920539|FG001|Overall Study|Lost to Follow-up|1|||
126718728|NCT06150573|455920538|FG000|Overall Study|Protocol Violation|0|||
126718729|NCT06150573|455920539|FG001|Overall Study|Protocol Violation|1|||
126718730|NCT06150573|455920538|FG000|Overall Study|Withdrawal by Subject|2|||
126718731|NCT06150573|455920539|FG001|Overall Study|Withdrawal by Subject|0|||
126718732|NCT00069095|455920540|FG000|Primary Treatment Phase|Ongoing|0|||
126718733|NCT00069095|455920541|FG001|Primary Treatment Phase|Ongoing|0|||
126771512|NCT01289990|456117831|FG011|Overall Study|Lost to Follow-up|1|||
126391731|NCT01301066|454726335|FG000|Overall Study|Protocol Violation|8|||
126391732|NCT01301066|454726336|FG001|Overall Study|Protocol Violation|7|||
126391733|NCT01301066|454726335|FG000|Overall Study|Withdrawal by Subject|4|||
126391734|NCT01301066|454726336|FG001|Overall Study|Withdrawal by Subject|9|||
126391735|NCT01301066|454726335|FG000|Overall Study|Adverse Event|6|||
126391736|NCT01301066|454726336|FG001|Overall Study|Adverse Event|6|||
126391737|NCT01301066|454726335|FG000|Overall Study|Sponsor Decision|2|||
126391738|NCT01301066|454726336|FG001|Overall Study|Sponsor Decision|1|||
126391739|NCT01301066|454726335|FG000|Overall Study|Physician Decision|0|||
126391740|NCT01301066|454726336|FG001|Overall Study|Physician Decision|1|||
126391741|NCT01301066|454726335|FG000|Overall Study|Other|2|||
126391742|NCT01301066|454726336|FG001|Overall Study|Other|0|||
126391743|NCT01108731|454726343|FG000|Overall Study|Withdrawal by Subject|1|||
126391744|NCT01108731|454726344|FG001|Overall Study|Withdrawal by Subject|1|||
126391745|NCT01108731|454726343|FG000|Overall Study|Adverse Event|3|||
126391746|NCT01108731|454726344|FG001|Overall Study|Adverse Event|3|||
126391747|NCT01892722|454726345|FG000|Overall Study|Protocol deviation|0|||
126391748|NCT01892722|454726346|FG001|Overall Study|Protocol deviation|1|||
126391749|NCT01892722|454726345|FG000|Overall Study|Administrative problems|0|||
126391750|NCT01892722|454726346|FG001|Overall Study|Administrative problems|1|||
126391751|NCT01892722|454726345|FG000|Overall Study|Patient/guardian decision|0|||
126391752|NCT01892722|454726346|FG001|Overall Study|Patient/guardian decision|2|||
126391753|NCT01892722|454726345|FG000|Overall Study|Physician Decision|1|||
126391754|NCT01892722|454726346|FG001|Overall Study|Physician Decision|2|||
126391755|NCT01892722|454726345|FG000|Overall Study|Adverse Event|3|||
126391756|NCT01892722|454726346|FG001|Overall Study|Adverse Event|2|||
126391757|NCT01892722|454726345|FG000|Overall Study|Lack of Efficacy|0|||
126391758|NCT01892722|454726346|FG001|Overall Study|Lack of Efficacy|7|||
126391759|NCT01892722|454726345|FG000|Overall Study|Withdrawal by Subject|3|||
126391760|NCT01892722|454726346|FG001|Overall Study|Withdrawal by Subject|5|||
126391761|NCT01252186|454726347|FG000|Overall Study|Adverse Event|9|||
126391762|NCT01252186|454726348|FG001|Overall Study|Adverse Event|6|||
126391763|NCT01252186|454726349|FG002|Overall Study|Adverse Event|8|||
126391764|NCT01252186|454726347|FG000|Overall Study|Withdrawal by Subject|2|||
126391765|NCT01252186|454726348|FG001|Overall Study|Withdrawal by Subject|5|||
126391766|NCT01252186|454726349|FG002|Overall Study|Withdrawal by Subject|2|||
126391767|NCT01252186|454726347|FG000|Overall Study|Physician Decision|0|||
126391768|NCT01252186|454726348|FG001|Overall Study|Physician Decision|0|||
126391769|NCT01252186|454726349|FG002|Overall Study|Physician Decision|1|||
126391770|NCT01252186|454726347|FG000|Overall Study|Non-compliance|0|||
126391771|NCT01252186|454726348|FG001|Overall Study|Non-compliance|3|||
126391772|NCT01252186|454726349|FG002|Overall Study|Non-compliance|4|||
126391773|NCT01252186|454726347|FG000|Overall Study|Protocol Violation|0|||
126391774|NCT01252186|454726348|FG001|Overall Study|Protocol Violation|0|||
126391775|NCT01252186|454726349|FG002|Overall Study|Protocol Violation|1|||
126391776|NCT01252186|454726347|FG000|Overall Study|Pregnancy|2|||
126468692|NCT03894046|455018826|FG001|Overall Study|Physician Decision|1|||
126391777|NCT01252186|454726348|FG001|Overall Study|Pregnancy|2|||
126391778|NCT01252186|454726349|FG002|Overall Study|Pregnancy|0|||
126391779|NCT01252186|454726347|FG000|Overall Study|Sponsor Request|2|||
126468693|NCT03894046|455018827|FG002|Overall Study|Physician Decision|1|||
126718734|NCT00069095|455920542|FG002|Primary Treatment Phase|Ongoing|5|||
126718735|NCT00069095|455920543|FG003|Primary Treatment Phase|Ongoing|7|||
126771513|NCT01289990|456117832|FG012|Overall Study|Lost to Follow-up|2|||
126771514|NCT01289990|456117820|FG000|Overall Study|Withdrawal by Subject|15|||
126771515|NCT01289990|456117821|FG001|Overall Study|Withdrawal by Subject|14|||
126771516|NCT01289990|456117822|FG002|Overall Study|Withdrawal by Subject|12|||
126771517|NCT01289990|456117823|FG003|Overall Study|Withdrawal by Subject|13|||
126771518|NCT01289990|456117824|FG004|Overall Study|Withdrawal by Subject|8|||
126771519|NCT01289990|456117825|FG005|Overall Study|Withdrawal by Subject|7|||
126771520|NCT01289990|456117826|FG006|Overall Study|Withdrawal by Subject|13|||
126771521|NCT01289990|456117827|FG007|Overall Study|Withdrawal by Subject|9|||
126771522|NCT01289990|456117828|FG008|Overall Study|Withdrawal by Subject|12|||
126771523|NCT01289990|456117829|FG009|Overall Study|Withdrawal by Subject|13|||
126771524|NCT01289990|456117830|FG010|Overall Study|Withdrawal by Subject|11|||
126771525|NCT01289990|456117831|FG011|Overall Study|Withdrawal by Subject|13|||
126771526|NCT01289990|456117832|FG012|Overall Study|Withdrawal by Subject|16|||
126771527|NCT01289990|456117820|FG000|Overall Study|discontinued in preceding trial|18|||
126771528|NCT01289990|456117821|FG001|Overall Study|discontinued in preceding trial|20|||
126771529|NCT01289990|456117822|FG002|Overall Study|discontinued in preceding trial|41|||
126771530|NCT01289990|456117823|FG003|Overall Study|discontinued in preceding trial|17|||
126771531|NCT01289990|456117824|FG004|Overall Study|discontinued in preceding trial|11|||
126771532|NCT01289990|456117825|FG005|Overall Study|discontinued in preceding trial|12|||
126771533|NCT01289990|456117826|FG006|Overall Study|discontinued in preceding trial|18|||
126771534|NCT01289990|456117827|FG007|Overall Study|discontinued in preceding trial|8|||
126771535|NCT01289990|456117828|FG008|Overall Study|discontinued in preceding trial|17|||
126771536|NCT01289990|456117829|FG009|Overall Study|discontinued in preceding trial|21|||
126771537|NCT01289990|456117830|FG010|Overall Study|discontinued in preceding trial|17|||
126771538|NCT01289990|456117831|FG011|Overall Study|discontinued in preceding trial|17|||
126391780|NCT01252186|454726348|FG001|Overall Study|Sponsor Request|1|||
126391781|NCT01252186|454726349|FG002|Overall Study|Sponsor Request|0|||
126391782|NCT01252186|454726347|FG000|Overall Study|Lost to Follow-up|10|||
126391783|NCT01252186|454726348|FG001|Overall Study|Lost to Follow-up|10|||
126391784|NCT01252186|454726349|FG002|Overall Study|Lost to Follow-up|11|||
126391785|NCT01252186|454726347|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
126391786|NCT01252186|454726348|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
126391787|NCT01252186|454726349|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
126391788|NCT04283994|454726356|FG000|Overall Study|Death|11|||
126391789|NCT04283994|454726357|FG001|Overall Study|Death|20|||
126391790|NCT04283994|454726358|FG002|Overall Study|Death|11|||
126391791|NCT04283994|454726359|FG003|Overall Study|Death|0|||
126391792|NCT04283994|454726360|FG004|Overall Study|Death|0|||
126391793|NCT04283994|454726361|FG005|Overall Study|Death|0|||
126391794|NCT04283994|454726362|FG006|Overall Study|Death|0|||
126391795|NCT04283994|454726356|FG000|Overall Study|Withdrawal by Subject|16|||
126391796|NCT04283994|454726357|FG001|Overall Study|Withdrawal by Subject|4|||
126391797|NCT04283994|454726358|FG002|Overall Study|Withdrawal by Subject|6|||
126391798|NCT04283994|454726359|FG003|Overall Study|Withdrawal by Subject|1|||
126391799|NCT04283994|454726360|FG004|Overall Study|Withdrawal by Subject|0|||
126391800|NCT04283994|454726361|FG005|Overall Study|Withdrawal by Subject|1|||
126391801|NCT04283994|454726362|FG006|Overall Study|Withdrawal by Subject|0|||
126391802|NCT03763656|454726363|FG000|Overall Study|Physician Decision|1|||
126391803|NCT03763656|454726363|FG000|Overall Study|Protocol Violation|1|||
126391804|NCT03763656|454726363|FG000|Overall Study|Withdrawal by Subject|7|||
126391805|NCT00487942|454726364|FG000|Overall Study|Adverse Event|1|||
126391806|NCT00487942|454726365|FG001|Overall Study|Adverse Event|1|||
126391807|NCT00487942|454726366|FG002|Overall Study|Adverse Event|1|||
126391808|NCT00487942|454726367|FG003|Overall Study|Adverse Event|1|||
126391809|NCT00487942|454726364|FG000|Overall Study|Lost to Follow-up|1|||
126391810|NCT00487942|454726365|FG001|Overall Study|Lost to Follow-up|0|||
126468694|NCT03894046|455018825|FG000|Overall Study|Prohibited concomitant medication|1|||
126468695|NCT03894046|455018826|FG001|Overall Study|Prohibited concomitant medication|0|||
126468696|NCT03894046|455018827|FG002|Overall Study|Prohibited concomitant medication|0|||
126468697|NCT03894046|455018825|FG000|Overall Study|Transferred to other arm/group|1|||
126468698|NCT03894046|455018826|FG001|Overall Study|Transferred to other arm/group|1|||
126468699|NCT03894046|455018827|FG002|Overall Study|Transferred to other arm/group|0|||
126468700|NCT02367131|455018828|FG000|Overall Study|Adverse Event|64|||
126468701|NCT02367131|455018828|FG000|Overall Study|No visit since the first visit|3|||
126468702|NCT02367131|455018828|FG000|Overall Study|Request by patient|53|||
126468703|NCT02367131|455018828|FG000|Overall Study|Improvement/remission|2|||
126468704|NCT02367131|455018828|FG000|Overall Study|No change/progressive disease|78|||
126554502|NCT01474512|455324033|FG005|Maintenance Period|Clinical Relapse|0|||
126391811|NCT00487942|454726366|FG002|Overall Study|Lost to Follow-up|0|||
126391812|NCT00487942|454726367|FG003|Overall Study|Lost to Follow-up|1|||
126391813|NCT00487942|454726364|FG000|Overall Study|Protocol Violation|1|||
126391814|NCT00487942|454726365|FG001|Overall Study|Protocol Violation|1|||
126391815|NCT00487942|454726366|FG002|Overall Study|Protocol Violation|0|||
126391816|NCT00487942|454726367|FG003|Overall Study|Protocol Violation|0|||
126391817|NCT00487942|454726364|FG000|Overall Study|Withdrawal by Subject|0|||
126771539|NCT01289990|456117832|FG012|Overall Study|discontinued in preceding trial|24|||
126771540|NCT01289990|456117820|FG000|Overall Study|did not continue in extension|41|||
126771541|NCT01289990|456117821|FG001|Overall Study|did not continue in extension|45|||
126554503|NCT01474512|455324034|FG006|Maintenance Period|Clinical Relapse|0|||
126554504|NCT01474512|455324035|FG007|Maintenance Period|Clinical Relapse|0|||
126554505|NCT01474512|455324036|FG008|Maintenance Period|Clinical Relapse|0|||
126554506|NCT01474512|455324037|FG009|Maintenance Period|Clinical Relapse|0|||
126771542|NCT01289990|456117822|FG002|Overall Study|did not continue in extension|51|||
126391818|NCT00487942|454726365|FG001|Overall Study|Withdrawal by Subject|1|||
126391819|NCT00487942|454726366|FG002|Overall Study|Withdrawal by Subject|2|||
126391820|NCT00487942|454726367|FG003|Overall Study|Withdrawal by Subject|0|||
126391821|NCT00322452|454726368|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126391822|NCT00322452|454726369|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126391823|NCT00322452|454726368|FG000|Overall Study|Lost to Follow-up|5|||
126391824|NCT00322452|454726369|FG001|Overall Study|Lost to Follow-up|2|||
126391825|NCT00322452|454726368|FG000|Overall Study|Withdrawal by Subject|19|||
126391826|NCT00322452|454726369|FG001|Overall Study|Withdrawal by Subject|46|||
126391827|NCT00322452|454726368|FG000|Overall Study|Death|223|||
126391828|NCT00322452|454726369|FG001|Overall Study|Death|227|||
126391829|NCT00197145|454727756|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
126391830|NCT00197145|454727757|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
126391831|NCT00197145|454727756|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
126391832|NCT00197145|454727757|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
126391833|NCT00197145|454727756|FG000|Period 1: Randomized Treatment Phase|Other|2|||
126391834|NCT00197145|454727757|FG001|Period 1: Randomized Treatment Phase|Other|2|||
126391835|NCT00197145|454727756|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
126391836|NCT00197145|454727757|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
126391837|NCT00197145|454727756|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
126391838|NCT00197145|454727757|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
126391839|NCT00197145|454727756|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
126391840|NCT00197145|454727757|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
126391841|NCT00197145|454727756|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
126391842|NCT00197145|454727757|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
126391843|NCT00197145|454727756|FG000|Period 2 : Open Label Phase|Other|1|||
126391844|NCT00197145|454727757|FG001|Period 2 : Open Label Phase|Other|0|||
126391845|NCT03372551|454727764|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
126391846|NCT03372551|454727765|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
126391847|NCT03285958|454727770|FG000|Overall Study|Lost to Follow-up|1|||
126391848|NCT03285958|454727771|FG001|Overall Study|Lost to Follow-up|1|||
126391849|NCT03285958|454727770|FG000|Overall Study|Withdrawal by Subject|1|||
126391850|NCT03285958|454727771|FG001|Overall Study|Withdrawal by Subject|0|||
126391851|NCT03285958|454727770|FG000|Overall Study|Not able to attend required orientation|3|||
126391852|NCT03285958|454727771|FG001|Overall Study|Not able to attend required orientation|0|||
126391853|NCT02578680|454727772|FG000|Overall Study|Death|329|||
126391854|NCT02578680|454727773|FG001|Overall Study|Death|181|||
126391855|NCT02578680|454727772|FG000|Overall Study|Lost to Follow-up|3|||
126391856|NCT02578680|454727773|FG001|Overall Study|Lost to Follow-up|1|||
126391857|NCT02578680|454727772|FG000|Overall Study|Physician Decision|0|||
126391858|NCT02578680|454727773|FG001|Overall Study|Physician Decision|1|||
126391859|NCT02578680|454727772|FG000|Overall Study|Protocol Violation|1|||
126391860|NCT02578680|454727773|FG001|Overall Study|Protocol Violation|1|||
126391861|NCT02578680|454727772|FG000|Overall Study|Sponsor Decision|64|||
126391862|NCT02578680|454727773|FG001|Overall Study|Sponsor Decision|13|||
126391863|NCT02578680|454727772|FG000|Overall Study|Withdrawal by Subject|13|||
126391864|NCT02578680|454727773|FG001|Overall Study|Withdrawal by Subject|9|||
126391865|NCT03116828|454727774|FG000|Overall Study|Adverse Event|1|||
126391866|NCT03116828|454727775|FG001|Overall Study|Adverse Event|10|||
126391867|NCT03116828|454727774|FG000|Overall Study|Withdrawal by Subject|4|||
126391868|NCT03116828|454727775|FG001|Overall Study|Withdrawal by Subject|8|||
126391869|NCT03116828|454727774|FG000|Overall Study|OTHER|3|||
126391870|NCT03116828|454727775|FG001|Overall Study|OTHER|3|||
126391871|NCT00176488|454727777|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
126391872|NCT00591149|454727793|FG000|Overall Study|Adverse Event|4|||
126391873|NCT00591149|454727793|FG000|Overall Study|Withdrawal by Subject|1|||
126391874|NCT00470093|454727794|FG000|Overall Study|Adverse Event|2|||
126391875|NCT00664560|454727795|FG000|Overall Study|Adverse Event|19|||
126391876|NCT00664560|454727796|FG001|Overall Study|Adverse Event|16|||
126391877|NCT00664560|454727797|FG002|Overall Study|Adverse Event|7|||
126391878|NCT00664560|454727795|FG000|Overall Study|Withdrawal by Subject|9|||
126391879|NCT00664560|454727796|FG001|Overall Study|Withdrawal by Subject|13|||
126391880|NCT00664560|454727797|FG002|Overall Study|Withdrawal by Subject|7|||
126391881|NCT00664560|454727795|FG000|Overall Study|Lost to Follow-up|0|||
126554507|NCT01474512|455324038|FG010|Maintenance Period|Clinical Relapse|0|||
126554508|NCT01474512|455324039|FG011|Maintenance Period|Clinical Relapse|0|||
126718736|NCT00069095|455920544|FG004|Primary Treatment Phase|Ongoing|7|||
126718737|NCT00069095|455920545|FG005|Primary Treatment Phase|Ongoing|4|||
126718738|NCT00069095|455920540|FG000|Primary Treatment Phase|Admin/Other|29|||
126718739|NCT00069095|455920541|FG001|Primary Treatment Phase|Admin/Other|38|||
126718740|NCT00069095|455920542|FG002|Primary Treatment Phase|Admin/Other|31|||
126718741|NCT00069095|455920543|FG003|Primary Treatment Phase|Admin/Other|45|||
126718742|NCT00069095|455920544|FG004|Primary Treatment Phase|Admin/Other|48|||
126718743|NCT00069095|455920545|FG005|Primary Treatment Phase|Admin/Other|42|||
126718744|NCT00069095|455920540|FG000|Primary Treatment Phase|Adverse Event|99|||
126718745|NCT00069095|455920541|FG001|Primary Treatment Phase|Adverse Event|92|||
126718746|NCT00069095|455920542|FG002|Primary Treatment Phase|Adverse Event|71|||
126718747|NCT00069095|455920543|FG003|Primary Treatment Phase|Adverse Event|72|||
126718748|NCT00069095|455920544|FG004|Primary Treatment Phase|Adverse Event|109|||
126718749|NCT00069095|455920545|FG005|Primary Treatment Phase|Adverse Event|101|||
126718750|NCT00069095|455920540|FG000|Primary Treatment Phase|Death|14|||
126718751|NCT00069095|455920541|FG001|Primary Treatment Phase|Death|8|||
126718752|NCT00069095|455920542|FG002|Primary Treatment Phase|Death|2|||
126718753|NCT00069095|455920543|FG003|Primary Treatment Phase|Death|5|||
126718754|NCT00069095|455920544|FG004|Primary Treatment Phase|Death|8|||
126718755|NCT00069095|455920545|FG005|Primary Treatment Phase|Death|8|||
126718756|NCT00069095|455920540|FG000|Primary Treatment Phase|Failure to return|5|||
126718757|NCT00069095|455920541|FG001|Primary Treatment Phase|Failure to return|5|||
126718758|NCT00069095|455920542|FG002|Primary Treatment Phase|Failure to return|0|||
126718759|NCT00069095|455920543|FG003|Primary Treatment Phase|Failure to return|0|||
126718760|NCT00069095|455920544|FG004|Primary Treatment Phase|Failure to return|0|||
126718761|NCT00069095|455920545|FG005|Primary Treatment Phase|Failure to return|2|||
126718762|NCT00069095|455920540|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
126718763|NCT00069095|455920541|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
126718764|NCT00069095|455920542|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
126391882|NCT00664560|454727796|FG001|Overall Study|Lost to Follow-up|2|||
126391883|NCT00664560|454727797|FG002|Overall Study|Lost to Follow-up|0|||
126391884|NCT00664560|454727795|FG000|Overall Study|Other|11|||
126391885|NCT00664560|454727796|FG001|Overall Study|Other|4|||
126391886|NCT00664560|454727797|FG002|Overall Study|Other|5|||
126391887|NCT02456636|454727798|FG000|Overall Study|Death|0|||
126391888|NCT02456636|454727799|FG001|Overall Study|Death|3|||
126391889|NCT02456636|454727800|FG002|Overall Study|Death|0|||
126391890|NCT02456636|454727798|FG000|Overall Study|Pregnancy|1|||
126391891|NCT02456636|454727799|FG001|Overall Study|Pregnancy|3|||
126391892|NCT02456636|454727800|FG002|Overall Study|Pregnancy|5|||
126391893|NCT02456636|454727798|FG000|Overall Study|Physician Decision|4|||
126391894|NCT02456636|454727799|FG001|Overall Study|Physician Decision|5|||
126391895|NCT02456636|454727800|FG002|Overall Study|Physician Decision|4|||
126391896|NCT02456636|454727798|FG000|Overall Study|Withdrawal by Subject|13|||
126391897|NCT02456636|454727799|FG001|Overall Study|Withdrawal by Subject|14|||
126391898|NCT02456636|454727800|FG002|Overall Study|Withdrawal by Subject|16|||
126391899|NCT02456636|454727798|FG000|Overall Study|Lost to Follow-up|50|||
126391900|NCT02456636|454727799|FG001|Overall Study|Lost to Follow-up|44|||
126391901|NCT02456636|454727800|FG002|Overall Study|Lost to Follow-up|50|||
126391902|NCT03350035|454727801|FG000|Overall Study|Lack of Efficacy|2|||
126391903|NCT03350035|454727802|FG001|Overall Study|Lack of Efficacy|0|||
126391904|NCT03350035|454727803|FG002|Overall Study|Lack of Efficacy|0|||
126391905|NCT03350035|454727801|FG000|Overall Study|Subject discharged to hospice|0|||
126391906|NCT03350035|454727802|FG001|Overall Study|Subject discharged to hospice|0|||
126391907|NCT03350035|454727803|FG002|Overall Study|Subject discharged to hospice|1|||
126391908|NCT03576066|454727804|FG000|Overall Study|Noncompliance with study drug|0|||
126391909|NCT03576066|454727805|FG001|Overall Study|Noncompliance with study drug|1|||
126391910|NCT00006164|454727806|FG000|Overall Study|Withdrew or lost to follow-up|70|||
126391911|NCT00006164|454727807|FG001|Overall Study|Withdrew or lost to follow-up|81|||
126391912|NCT00633074|454727810|FG000|Overall Study|Adverse Event|1|||
126391913|NCT00633074|454727811|FG001|Overall Study|Adverse Event|0|||
126391914|NCT00365105|454727812|FG000|Overall Study|Protocol Violation|5|||
126391915|NCT00365105|454727813|FG001|Overall Study|Protocol Violation|8|||
126391916|NCT00608023|454727814|FG000|Overall Study|Withdrawal by Subject|8|||
126391917|NCT00608023|454727815|FG001|Overall Study|Withdrawal by Subject|10|||
126391918|NCT00608023|454727816|FG002|Overall Study|Withdrawal by Subject|7|||
126391919|NCT00608023|454727814|FG000|Overall Study|Adverse Event|1|||
126391920|NCT00608023|454727815|FG001|Overall Study|Adverse Event|4|||
126391921|NCT00608023|454727816|FG002|Overall Study|Adverse Event|5|||
126391922|NCT00608023|454727814|FG000|Overall Study|Lost to Follow-up|2|||
126391923|NCT00608023|454727815|FG001|Overall Study|Lost to Follow-up|2|||
126391924|NCT00608023|454727816|FG002|Overall Study|Lost to Follow-up|1|||
126391925|NCT00608023|454727814|FG000|Overall Study|Protocol Violation|1|||
126391926|NCT00608023|454727815|FG001|Overall Study|Protocol Violation|3|||
126554509|NCT01474512|455324040|FG012|Maintenance Period|Clinical Relapse|0|||
126718765|NCT00069095|455920543|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
126718766|NCT00069095|455920544|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
126554510|NCT01474512|455324041|FG013|Maintenance Period|Clinical Relapse|0|||
126554511|NCT01474512|455324042|FG014|Maintenance Period|Clinical Relapse|0|||
126554512|NCT01474512|455324043|FG015|Maintenance Period|Clinical Relapse|0|||
126554513|NCT01474512|455324044|FG016|Maintenance Period|Clinical Relapse|0|||
126554514|NCT01474512|455324045|FG017|Maintenance Period|Clinical Relapse|0|||
126554515|NCT01474512|455324028|FG000|Maintenance Period|Lack of Efficacy|0|||
126554516|NCT01474512|455324029|FG001|Maintenance Period|Lack of Efficacy|0|||
126554517|NCT01474512|455324030|FG002|Maintenance Period|Lack of Efficacy|0|||
126554518|NCT01474512|455324031|FG003|Maintenance Period|Lack of Efficacy|1|||
126554519|NCT01474512|455324032|FG004|Maintenance Period|Lack of Efficacy|0|||
126554520|NCT01474512|455324033|FG005|Maintenance Period|Lack of Efficacy|0|||
126554521|NCT01474512|455324034|FG006|Maintenance Period|Lack of Efficacy|0|||
126554522|NCT01474512|455324035|FG007|Maintenance Period|Lack of Efficacy|11|||
126554523|NCT01474512|455324036|FG008|Maintenance Period|Lack of Efficacy|11|||
126554524|NCT01474512|455324037|FG009|Maintenance Period|Lack of Efficacy|12|||
126554525|NCT01474512|455324038|FG010|Maintenance Period|Lack of Efficacy|0|||
126554526|NCT01474512|455324039|FG011|Maintenance Period|Lack of Efficacy|0|||
126554527|NCT01474512|455324040|FG012|Maintenance Period|Lack of Efficacy|0|||
126554528|NCT01474512|455324041|FG013|Maintenance Period|Lack of Efficacy|0|||
126554529|NCT01474512|455324042|FG014|Maintenance Period|Lack of Efficacy|0|||
126554530|NCT01474512|455324043|FG015|Maintenance Period|Lack of Efficacy|0|||
126554531|NCT01474512|455324044|FG016|Maintenance Period|Lack of Efficacy|0|||
126554532|NCT01474512|455324045|FG017|Maintenance Period|Lack of Efficacy|0|||
126554533|NCT01474512|455324028|FG000|Maintenance Period|Protocol Violation|0|||
126554534|NCT01474512|455324029|FG001|Maintenance Period|Protocol Violation|0|||
126554535|NCT01474512|455324030|FG002|Maintenance Period|Protocol Violation|0|||
126554536|NCT01474512|455324031|FG003|Maintenance Period|Protocol Violation|1|||
126554537|NCT01474512|455324032|FG004|Maintenance Period|Protocol Violation|0|||
126554538|NCT01474512|455324033|FG005|Maintenance Period|Protocol Violation|0|||
126554539|NCT01474512|455324034|FG006|Maintenance Period|Protocol Violation|0|||
126554540|NCT01474512|455324035|FG007|Maintenance Period|Protocol Violation|1|||
126554541|NCT01474512|455324036|FG008|Maintenance Period|Protocol Violation|0|||
126554542|NCT01474512|455324037|FG009|Maintenance Period|Protocol Violation|1|||
126554543|NCT01474512|455324038|FG010|Maintenance Period|Protocol Violation|0|||
126554544|NCT01474512|455324039|FG011|Maintenance Period|Protocol Violation|0|||
126554545|NCT01474512|455324040|FG012|Maintenance Period|Protocol Violation|0|||
126554546|NCT01474512|455324041|FG013|Maintenance Period|Protocol Violation|0|||
126554547|NCT01474512|455324042|FG014|Maintenance Period|Protocol Violation|0|||
126554548|NCT01474512|455324043|FG015|Maintenance Period|Protocol Violation|0|||
126554549|NCT01474512|455324044|FG016|Maintenance Period|Protocol Violation|0|||
126554550|NCT01474512|455324045|FG017|Maintenance Period|Protocol Violation|0|||
126554551|NCT01474512|455324028|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
126554552|NCT01474512|455324029|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
126554553|NCT01474512|455324030|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
126554554|NCT01474512|455324031|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
126554555|NCT01474512|455324032|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
126554556|NCT01474512|455324033|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
126554557|NCT01474512|455324034|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
126554558|NCT01474512|455324035|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
126554559|NCT01474512|455324036|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
126554560|NCT01474512|455324037|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
126554561|NCT01474512|455324038|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
126554562|NCT01474512|455324039|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
126554563|NCT01474512|455324040|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
126554564|NCT01474512|455324041|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
126554565|NCT01474512|455324042|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
126554566|NCT01474512|455324043|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
126554567|NCT01474512|455324044|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
126554568|NCT01474512|455324045|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
126718767|NCT00069095|455920545|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
126718768|NCT00069095|455920540|FG000|Primary Treatment Phase|Refused treatment|15|||
126391927|NCT00608023|454727816|FG002|Overall Study|Protocol Violation|1|||
126391928|NCT00608023|454727814|FG000|Overall Study|Unknown reason|0|||
126391929|NCT00608023|454727815|FG001|Overall Study|Unknown reason|3|||
126391930|NCT00608023|454727816|FG002|Overall Study|Unknown reason|0|||
126554569|NCT01474512|455324028|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
126554570|NCT01474512|455324029|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
126554571|NCT01474512|455324030|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
126554572|NCT01474512|455324031|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
126554573|NCT01474512|455324032|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
126554574|NCT01474512|455324033|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
126554575|NCT01474512|455324034|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
126718769|NCT00069095|455920541|FG001|Primary Treatment Phase|Refused treatment|26|||
126718770|NCT00069095|455920542|FG002|Primary Treatment Phase|Refused treatment|17|||
126718771|NCT00069095|455920543|FG003|Primary Treatment Phase|Refused treatment|31|||
126718772|NCT00069095|455920544|FG004|Primary Treatment Phase|Refused treatment|24|||
126718773|NCT00069095|455920545|FG005|Primary Treatment Phase|Refused treatment|27|||
126718774|NCT00069095|455920540|FG000|Primary Treatment Phase|Withdrew|2|||
126468705|NCT02367131|455018828|FG000|Overall Study|Other than stated above|20|||
126468706|NCT02367131|455018828|FG000|Overall Study|Not treated|2|||
126391931|NCT06422364|454727817|FG000|Overall Study|Withdrawn due to study closure|0|||
126391932|NCT06422364|454727818|FG001|Overall Study|Withdrawn due to study closure|2|||
126391933|NCT01681069|454727820|FG000|Overall Study|Withdrawal by Subject|4|||
126468707|NCT01973569|455018829|FG000|Overall Study|Adverse Event|9|||
126468708|NCT01973569|455018830|FG001|Overall Study|Adverse Event|2|||
126468709|NCT01973569|455018831|FG002|Overall Study|Adverse Event|4|||
126468710|NCT01973569|455018829|FG000|Overall Study|Protocol Violation|2|||
126468711|NCT01973569|455018830|FG001|Overall Study|Protocol Violation|1|||
126468712|NCT01973569|455018831|FG002|Overall Study|Protocol Violation|3|||
126468713|NCT01973569|455018829|FG000|Overall Study|Withdrawal by Subject|7|||
126468714|NCT01973569|455018830|FG001|Overall Study|Withdrawal by Subject|5|||
126468715|NCT01973569|455018831|FG002|Overall Study|Withdrawal by Subject|2|||
126468716|NCT01973569|455018829|FG000|Overall Study|Invasive dental treatment|3|||
126468717|NCT01973569|455018830|FG001|Overall Study|Invasive dental treatment|5|||
126468718|NCT01973569|455018831|FG002|Overall Study|Invasive dental treatment|6|||
126468719|NCT01973569|455018829|FG000|Overall Study|Prohibited concomitant d|1|||
126468720|NCT01973569|455018830|FG001|Overall Study|Prohibited concomitant d|5|||
126468721|NCT01973569|455018831|FG002|Overall Study|Prohibited concomitant d|0|||
126468722|NCT01973569|455018829|FG000|Overall Study|Disease progression|0|||
126468723|NCT01973569|455018830|FG001|Overall Study|Disease progression|3|||
126468724|NCT01973569|455018831|FG002|Overall Study|Disease progression|0|||
126468725|NCT01973569|455018829|FG000|Overall Study|Other|1|||
126468726|NCT01973569|455018830|FG001|Overall Study|Other|1|||
126468727|NCT01973569|455018831|FG002|Overall Study|Other|0|||
126468728|NCT01973569|455018829|FG000|Overall Study|Did not receive study drug|6|||
126468729|NCT01973569|455018830|FG001|Overall Study|Did not receive study drug|3|||
126468730|NCT01973569|455018831|FG002|Overall Study|Did not receive study drug|3|||
126468731|NCT03711266|455018835|FG000|Overall Study|Lost to Follow-up|10|||
126468732|NCT01646073|455018836|FG000|Period A (12 Weeks)|Adverse Event|0|||
126718775|NCT00069095|455920541|FG001|Primary Treatment Phase|Withdrew|3|||
126391934|NCT01681069|454727821|FG001|Overall Study|Withdrawal by Subject|5|||
126391935|NCT01681069|454727820|FG000|Overall Study|Protocol Violation|1|||
126391936|NCT01681069|454727821|FG001|Overall Study|Protocol Violation|1|||
126391937|NCT01681069|454727820|FG000|Overall Study|Adverse Event|0|||
126391938|NCT01681069|454727821|FG001|Overall Study|Adverse Event|1|||
126391939|NCT01463696|454727822|FG000|Overall Study|Adverse Event|0|||
126391940|NCT01463696|454727823|FG001|Overall Study|Adverse Event|1|||
126391941|NCT01463696|454727824|FG002|Overall Study|Adverse Event|0|||
126391942|NCT01463696|454727825|FG003|Overall Study|Adverse Event|2|||
126391943|NCT01463696|454727826|FG004|Overall Study|Adverse Event|0|||
126391944|NCT01463696|454727827|FG005|Overall Study|Adverse Event|1|||
126391945|NCT01463696|454727828|FG006|Overall Study|Adverse Event|3|||
126391946|NCT01463696|454727829|FG007|Overall Study|Adverse Event|2|||
126391947|NCT01463696|454727822|FG000|Overall Study|Lost to Follow-up|0|||
126391948|NCT01463696|454727823|FG001|Overall Study|Lost to Follow-up|0|||
126391949|NCT01463696|454727824|FG002|Overall Study|Lost to Follow-up|1|||
126391950|NCT01463696|454727825|FG003|Overall Study|Lost to Follow-up|0|||
126391951|NCT01463696|454727826|FG004|Overall Study|Lost to Follow-up|0|||
126391952|NCT01463696|454727827|FG005|Overall Study|Lost to Follow-up|0|||
126391953|NCT01463696|454727828|FG006|Overall Study|Lost to Follow-up|0|||
126391954|NCT01463696|454727829|FG007|Overall Study|Lost to Follow-up|0|||
126391955|NCT01463696|454727822|FG000|Overall Study|Progressive Disease|0|||
126391956|NCT01463696|454727823|FG001|Overall Study|Progressive Disease|1|||
126391957|NCT01463696|454727824|FG002|Overall Study|Progressive Disease|0|||
126391958|NCT01463696|454727825|FG003|Overall Study|Progressive Disease|1|||
126391959|NCT01463696|454727826|FG004|Overall Study|Progressive Disease|0|||
126468733|NCT01646073|455018837|FG001|Period A (12 Weeks)|Adverse Event|2|||
126718776|NCT00069095|455920542|FG002|Primary Treatment Phase|Withdrew|8|||
126771543|NCT01289990|456117823|FG003|Overall Study|did not continue in extension|51|||
126391960|NCT01463696|454727827|FG005|Overall Study|Progressive Disease|1|||
126468734|NCT01646073|455018836|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
126468735|NCT01646073|455018837|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
126391961|NCT01463696|454727828|FG006|Overall Study|Progressive Disease|4|||
126391962|NCT01463696|454727829|FG007|Overall Study|Progressive Disease|2|||
126391963|NCT01463696|454727822|FG000|Overall Study|Withdrawal by Subject|0|||
126468736|NCT01646073|455018836|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
126391964|NCT01463696|454727823|FG001|Overall Study|Withdrawal by Subject|0|||
126468737|NCT01646073|455018837|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
126468738|NCT01646073|455018836|FG000|Period A (12 Weeks)|Protocol Violation|0|||
126468739|NCT01646073|455018837|FG001|Period A (12 Weeks)|Protocol Violation|1|||
126718777|NCT00069095|455920543|FG003|Primary Treatment Phase|Withdrew|2|||
126391965|NCT01463696|454727824|FG002|Overall Study|Withdrawal by Subject|0|||
126391966|NCT01463696|454727825|FG003|Overall Study|Withdrawal by Subject|1|||
126391967|NCT01463696|454727826|FG004|Overall Study|Withdrawal by Subject|1|||
126391968|NCT01463696|454727827|FG005|Overall Study|Withdrawal by Subject|1|||
126391969|NCT01463696|454727828|FG006|Overall Study|Withdrawal by Subject|2|||
126391970|NCT01463696|454727829|FG007|Overall Study|Withdrawal by Subject|0|||
126391971|NCT01463696|454727822|FG000|Overall Study|Not Treated|0|||
126391972|NCT01463696|454727823|FG001|Overall Study|Not Treated|0|||
126391973|NCT01463696|454727824|FG002|Overall Study|Not Treated|0|||
126391974|NCT01463696|454727825|FG003|Overall Study|Not Treated|0|||
126391975|NCT01463696|454727826|FG004|Overall Study|Not Treated|0|||
126391976|NCT01463696|454727827|FG005|Overall Study|Not Treated|0|||
126391977|NCT01463696|454727828|FG006|Overall Study|Not Treated|1|||
126391978|NCT01463696|454727829|FG007|Overall Study|Not Treated|0|||
126468740|NCT01646073|455018836|FG000|Period A (12 Weeks)|Other|0|||
126468741|NCT01646073|455018837|FG001|Period A (12 Weeks)|Other|1|||
126468742|NCT01646073|455018836|FG000|Period B (12 Weeks)|Adverse Event|0|||
126468743|NCT01646073|455018837|FG001|Period B (12 Weeks)|Adverse Event|7|||
126468744|NCT01646073|455018836|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
126468745|NCT01646073|455018837|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
126468746|NCT01646073|455018836|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
126468747|NCT01646073|455018837|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
126468748|NCT02028871|455018841|FG000|Overall Study|Positive urine drug screen|1|||
126468749|NCT02028871|455018842|FG001|Overall Study|Positive urine drug screen|1|||
126391979|NCT03883165|454727831|FG000|Overall Study|Withdrawal by Subject|4|||
126391980|NCT03883165|454727832|FG001|Overall Study|Withdrawal by Subject|3|||
126391981|NCT00245050|454727836|FG000|Overall Study|Adverse Event|3|||
126391982|NCT00245050|454727837|FG001|Overall Study|Adverse Event|2|||
126391983|NCT00425698|454727838|FG000|Overall Study|Adverse Event|3|||
126391984|NCT00425698|454727839|FG001|Overall Study|Adverse Event|1|||
126391985|NCT00425698|454727838|FG000|Overall Study|Withdrawal by Subject|0|||
126391986|NCT00425698|454727839|FG001|Overall Study|Withdrawal by Subject|1|||
126391987|NCT03275246|454727846|FG000|Overall Study|Protocol Violation|5|||
126391988|NCT03275246|454727846|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
126391989|NCT03905265|454727849|FG000|Overall Study|Withdrawal by Subject|1|||
126391990|NCT03905265|454727850|FG001|Overall Study|Withdrawal by Subject|1|||
126391991|NCT03905265|454727851|FG002|Overall Study|Withdrawal by Subject|0|||
126391992|NCT03905265|454727852|FG003|Overall Study|Withdrawal by Subject|0|||
126391993|NCT02516098|454727853|FG000|Period 1|Protocol Violation|1|||
126391994|NCT02516098|454727854|FG001|Period 1|Protocol Violation|0|||
126391995|NCT02516098|454727853|FG000|Washout After Period 1|Adverse Event|0|||
126391996|NCT02516098|454727854|FG001|Washout After Period 1|Adverse Event|1|||
126391997|NCT02516098|454727853|FG000|Period 2|Withdrawal by Subject|0|||
126391998|NCT02516098|454727854|FG001|Period 2|Withdrawal by Subject|1|||
126391999|NCT01973387|454727855|FG000|Overall Study|Adverse Event|14|||
126392000|NCT01973387|454727856|FG001|Overall Study|Adverse Event|4|||
126392001|NCT01973387|454727855|FG000|Overall Study|Withdrawal by Subject|7|||
126392002|NCT01973387|454727856|FG001|Overall Study|Withdrawal by Subject|4|||
126392003|NCT01973387|454727855|FG000|Overall Study|Study terminated by sponsor|63|||
126392004|NCT01973387|454727856|FG001|Overall Study|Study terminated by sponsor|0|||
126392005|NCT01973387|454727855|FG000|Overall Study|Progressive disease or relapse|16|||
126392006|NCT01973387|454727856|FG001|Overall Study|Progressive disease or relapse|5|||
126392007|NCT01973387|454727855|FG000|Overall Study|Death|4|||
126392008|NCT01973387|454727856|FG001|Overall Study|Death|3|||
126392009|NCT01973387|454727855|FG000|Overall Study|Randomized, not treated|2|||
126392010|NCT01973387|454727856|FG001|Overall Study|Randomized, not treated|2|||
126392011|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
126392012|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
126392013|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
126392014|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
126392015|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
126392016|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
126392017|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
126468750|NCT02028871|455018841|FG000|Overall Study|Withdrawal by Subject|1|||
126468751|NCT02028871|455018842|FG001|Overall Study|Withdrawal by Subject|2|||
126468752|NCT02028871|455018841|FG000|Overall Study|IV placement difficulty|1|||
126468753|NCT02028871|455018842|FG001|Overall Study|IV placement difficulty|0|||
126392018|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
126392019|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
126392020|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
126392021|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
126392022|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
126392023|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
126392024|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
126392025|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
126392026|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
126392027|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
126392028|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392029|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392030|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392031|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392032|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392033|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392034|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392035|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392036|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392037|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392038|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392039|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392040|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126392041|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
126392042|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
126392043|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
126392044|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
126392045|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
126392046|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
126392047|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
126392048|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
126392049|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
126392050|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
126392051|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
126392052|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
126392053|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
126392054|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
126392055|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
126392056|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
126392057|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
126392058|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
126392059|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
126392060|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
126392061|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
126392062|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
126392063|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
126392064|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
126392065|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
126392066|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
126392067|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
126392068|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
126392069|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
126392070|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
126392071|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
126392072|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
126392073|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
126392074|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
126392075|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392076|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392077|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392078|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392079|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392080|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392081|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392082|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392083|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392084|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392085|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126392086|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
126392087|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
126392088|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
126392089|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
126392090|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392091|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392092|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392093|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392094|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392095|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392096|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392097|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392098|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392099|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392100|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
126392101|NCT03831191|454727859|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392102|NCT03831191|454727860|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392103|NCT03831191|454727861|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392104|NCT03831191|454727862|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
126392105|NCT03831191|454727863|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392106|NCT03831191|454727864|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392107|NCT03831191|454727865|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392108|NCT03831191|454727866|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392109|NCT03831191|454727867|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392110|NCT03831191|454727868|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392111|NCT03831191|454727869|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392112|NCT03831191|454727870|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392113|NCT03831191|454727871|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392114|NCT03831191|454727872|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392115|NCT03831191|454727873|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
126392116|NCT03831191|454727859|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
126392117|NCT03831191|454727860|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
126392118|NCT03831191|454727861|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
126392119|NCT03831191|454727862|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
126392120|NCT03831191|454727863|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
126392121|NCT03831191|454727864|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
126392122|NCT03831191|454727865|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
126392123|NCT03831191|454727866|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
126392124|NCT03831191|454727867|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
126392125|NCT03831191|454727868|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
126392126|NCT03831191|454727869|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
126392127|NCT03831191|454727870|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
126392128|NCT03831191|454727871|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
126392129|NCT03831191|454727872|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
126392130|NCT03831191|454727873|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
126392131|NCT03831191|454727859|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392132|NCT03831191|454727860|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392133|NCT03831191|454727861|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392134|NCT03831191|454727862|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392135|NCT03831191|454727863|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392136|NCT03831191|454727864|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392137|NCT03831191|454727865|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392138|NCT03831191|454727866|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392139|NCT03831191|454727867|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392140|NCT03831191|454727868|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392141|NCT03831191|454727869|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392142|NCT03831191|454727870|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392143|NCT03831191|454727871|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392144|NCT03831191|454727872|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126392145|NCT03831191|454727873|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
126392146|NCT03831191|454727859|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392147|NCT03831191|454727860|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392148|NCT03831191|454727861|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392149|NCT03831191|454727862|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392150|NCT03831191|454727863|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392151|NCT03831191|454727864|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126468754|NCT02028871|455018841|FG000|Overall Study|Current Illness|1|||
126468755|NCT02028871|455018842|FG001|Overall Study|Current Illness|0|||
126468756|NCT01691898|455018843|FG000|Overall Study|Death|34|||
126718778|NCT00069095|455920544|FG004|Primary Treatment Phase|Withdrew|4|||
126392152|NCT03831191|454727865|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392153|NCT03831191|454727866|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392154|NCT03831191|454727867|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126468757|NCT01691898|455018844|FG001|Overall Study|Death|32|||
126468758|NCT01691898|455018845|FG002|Overall Study|Death|6|||
126468759|NCT01691898|455018846|FG003|Overall Study|Death|3|||
126718779|NCT00069095|455920545|FG005|Primary Treatment Phase|Withdrew|9|||
126718780|NCT00069095|455920540|FG000|Primary Treatment Phase|Other Violation|0|||
126718781|NCT00069095|455920541|FG001|Primary Treatment Phase|Other Violation|1|||
126392155|NCT03831191|454727868|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126468760|NCT01691898|455018847|FG004|Overall Study|Death|8|||
126392156|NCT03831191|454727869|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392157|NCT03831191|454727870|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392158|NCT03831191|454727871|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392159|NCT03831191|454727872|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126392160|NCT03831191|454727873|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
126392161|NCT01562314|454727874|FG000|Overall Study|Adverse Event|10|||
126392162|NCT01562314|454727875|FG001|Overall Study|Adverse Event|5|||
126392163|NCT01562314|454727874|FG000|Overall Study|Met Withdrawal Criteria|3|||
126392164|NCT01562314|454727875|FG001|Overall Study|Met Withdrawal Criteria|2|||
126392165|NCT01562314|454727874|FG000|Overall Study|Withdrawal by Subject|0|||
126392166|NCT01562314|454727875|FG001|Overall Study|Withdrawal by Subject|1|||
126392167|NCT03655054|454727876|FG000|Overall Study|Lost to Follow-up|1|||
126392168|NCT02256384|454727885|FG000|Overall Study|Withdrawal by Subject|12|||
126392169|NCT02256384|454727885|FG000|Overall Study|Equipment not capturing data|2|||
126392170|NCT03703817|454727898|FG000|Overall Study|Not meeting eligibility criteria|7|||
126392171|NCT03703817|454727899|FG001|Overall Study|Not meeting eligibility criteria|4|||
126392172|NCT00349921|454727900|FG000|First Spinal Injection|Physician Decision|1|||
126392173|NCT00349921|454727901|FG001|First Spinal Injection|Physician Decision|0|||
126392174|NCT00349921|454727902|FG002|First Spinal Injection|Physician Decision|0|||
126392175|NCT00349921|454727903|FG003|First Spinal Injection|Physician Decision|0|||
126392176|NCT00349921|454727900|FG000|First Spinal Injection|Adverse Event|0|||
126392177|NCT00349921|454727901|FG001|First Spinal Injection|Adverse Event|0|||
126392178|NCT00349921|454727902|FG002|First Spinal Injection|Adverse Event|1|||
126392179|NCT00349921|454727903|FG003|First Spinal Injection|Adverse Event|0|||
126392180|NCT00157196|454727904|FG000|Overall Study|Ongoing at data cut-off|9|||
126392181|NCT02524275|454727905|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
126392182|NCT00778258|454727906|FG000|Overall Study|Adverse Event|1|||
126392183|NCT00778258|454727907|FG001|Overall Study|Adverse Event|0|||
126392184|NCT00778258|454727908|FG002|Overall Study|Adverse Event|0|||
126392185|NCT00778258|454727909|FG003|Overall Study|Adverse Event|0|||
126392186|NCT00778258|454727910|FG004|Overall Study|Adverse Event|0|||
126392187|NCT00778258|454727911|FG005|Overall Study|Adverse Event|1|||
126392188|NCT00778258|454727912|FG006|Overall Study|Adverse Event|0|||
126392189|NCT00778258|454727913|FG007|Overall Study|Adverse Event|0|||
126392190|NCT00778258|454727914|FG008|Overall Study|Adverse Event|0|||
126392191|NCT00778258|454727906|FG000|Overall Study|Lost to Follow-up|0|||
126392192|NCT00778258|454727907|FG001|Overall Study|Lost to Follow-up|0|||
126392193|NCT00778258|454727908|FG002|Overall Study|Lost to Follow-up|2|||
126392194|NCT00778258|454727909|FG003|Overall Study|Lost to Follow-up|0|||
126392195|NCT00778258|454727910|FG004|Overall Study|Lost to Follow-up|0|||
126392196|NCT00778258|454727911|FG005|Overall Study|Lost to Follow-up|3|||
126392197|NCT00778258|454727912|FG006|Overall Study|Lost to Follow-up|2|||
126468761|NCT01691898|455018848|FG005|Overall Study|Death|31|||
126468762|NCT01691898|455018843|FG000|Overall Study|Adverse Event|0|||
126468763|NCT01691898|455018844|FG001|Overall Study|Adverse Event|1|||
126468764|NCT01691898|455018845|FG002|Overall Study|Adverse Event|0|||
126468765|NCT01691898|455018846|FG003|Overall Study|Adverse Event|1|||
126468766|NCT01691898|455018847|FG004|Overall Study|Adverse Event|1|||
126468767|NCT01691898|455018848|FG005|Overall Study|Adverse Event|0|||
126468768|NCT01691898|455018843|FG000|Overall Study|Progression of Disease|1|||
126468769|NCT01691898|455018844|FG001|Overall Study|Progression of Disease|2|||
126468770|NCT01691898|455018845|FG002|Overall Study|Progression of Disease|1|||
126468771|NCT01691898|455018846|FG003|Overall Study|Progression of Disease|0|||
126468772|NCT01691898|455018847|FG004|Overall Study|Progression of Disease|0|||
126468773|NCT01691898|455018848|FG005|Overall Study|Progression of Disease|1|||
126468774|NCT01691898|455018843|FG000|Overall Study|Lost to Follow-up|3|||
126468775|NCT01691898|455018844|FG001|Overall Study|Lost to Follow-up|1|||
126468776|NCT01691898|455018845|FG002|Overall Study|Lost to Follow-up|0|||
126468777|NCT01691898|455018846|FG003|Overall Study|Lost to Follow-up|0|||
126468778|NCT01691898|455018847|FG004|Overall Study|Lost to Follow-up|1|||
126468779|NCT01691898|455018848|FG005|Overall Study|Lost to Follow-up|0|||
126468780|NCT01691898|455018843|FG000|Overall Study|Withdrawal by Subject|9|||
126468781|NCT01691898|455018844|FG001|Overall Study|Withdrawal by Subject|8|||
126554576|NCT01474512|455324035|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
126554577|NCT01474512|455324036|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
126554578|NCT01474512|455324037|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
126392198|NCT00778258|454727913|FG007|Overall Study|Lost to Follow-up|2|||
126392199|NCT00778258|454727914|FG008|Overall Study|Lost to Follow-up|0|||
126392200|NCT00778258|454727906|FG000|Overall Study|Withdrawal by Subject|6|||
126468782|NCT01691898|455018845|FG002|Overall Study|Withdrawal by Subject|2|||
126468783|NCT01691898|455018846|FG003|Overall Study|Withdrawal by Subject|1|||
126468784|NCT01691898|455018847|FG004|Overall Study|Withdrawal by Subject|3|||
126468785|NCT01691898|455018848|FG005|Overall Study|Withdrawal by Subject|3|||
126468786|NCT01691898|455018843|FG000|Overall Study|Non-Compliance|0|||
126468787|NCT01691898|455018844|FG001|Overall Study|Non-Compliance|0|||
126392201|NCT00778258|454727907|FG001|Overall Study|Withdrawal by Subject|2|||
126392202|NCT00778258|454727908|FG002|Overall Study|Withdrawal by Subject|8|||
126392203|NCT00778258|454727909|FG003|Overall Study|Withdrawal by Subject|2|||
126392204|NCT00778258|454727910|FG004|Overall Study|Withdrawal by Subject|0|||
126392205|NCT00778258|454727911|FG005|Overall Study|Withdrawal by Subject|6|||
126392206|NCT00778258|454727912|FG006|Overall Study|Withdrawal by Subject|12|||
126392207|NCT00778258|454727913|FG007|Overall Study|Withdrawal by Subject|12|||
126392208|NCT00778258|454727914|FG008|Overall Study|Withdrawal by Subject|4|||
126392209|NCT00778258|454727906|FG000|Overall Study|New Contraindication|0|||
126392210|NCT00778258|454727907|FG001|Overall Study|New Contraindication|0|||
126392211|NCT00778258|454727908|FG002|Overall Study|New Contraindication|0|||
126554579|NCT01474512|455324038|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
126554580|NCT01474512|455324039|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
126554581|NCT01474512|455324040|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
126554582|NCT01474512|455324041|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
126392212|NCT00778258|454727909|FG003|Overall Study|New Contraindication|0|||
126392213|NCT00778258|454727910|FG004|Overall Study|New Contraindication|0|||
126392214|NCT00778258|454727911|FG005|Overall Study|New Contraindication|0|||
126392215|NCT00778258|454727912|FG006|Overall Study|New Contraindication|0|||
126392216|NCT00778258|454727913|FG007|Overall Study|New Contraindication|1|||
126392217|NCT00778258|454727914|FG008|Overall Study|New Contraindication|0|||
126392218|NCT00778258|454727906|FG000|Overall Study|Non-compliance|0|||
126392219|NCT00778258|454727907|FG001|Overall Study|Non-compliance|0|||
126392220|NCT00778258|454727908|FG002|Overall Study|Non-compliance|0|||
126392221|NCT00778258|454727909|FG003|Overall Study|Non-compliance|1|||
126392222|NCT00778258|454727910|FG004|Overall Study|Non-compliance|0|||
126392223|NCT00778258|454727911|FG005|Overall Study|Non-compliance|0|||
126392224|NCT00778258|454727912|FG006|Overall Study|Non-compliance|0|||
126392225|NCT00778258|454727913|FG007|Overall Study|Non-compliance|0|||
126392226|NCT00778258|454727914|FG008|Overall Study|Non-compliance|0|||
126392227|NCT00778258|454727906|FG000|Overall Study|Other|0|||
126392228|NCT00778258|454727907|FG001|Overall Study|Other|0|||
126392229|NCT00778258|454727908|FG002|Overall Study|Other|0|||
126392230|NCT00778258|454727909|FG003|Overall Study|Other|0|||
126392231|NCT00778258|454727910|FG004|Overall Study|Other|0|||
126392232|NCT00778258|454727911|FG005|Overall Study|Other|0|||
126392233|NCT00778258|454727912|FG006|Overall Study|Other|1|||
126392234|NCT00778258|454727913|FG007|Overall Study|Other|0|||
126392235|NCT00778258|454727914|FG008|Overall Study|Other|0|||
126392236|NCT00780143|454727923|FG000|Overall Study|Progressive disease|1|||
126392237|NCT00780143|454727923|FG000|Overall Study|Toxicity|1|||
126392238|NCT00780143|454727923|FG000|Overall Study|Adverse Event|1|||
126392239|NCT00082368|454727926|FG000|Overall Study|Not treated-pt had poor IV access|1|||
126392240|NCT01331837|454727929|FG000|Overall Study|Death|30|||
126392241|NCT01331837|454727930|FG001|Overall Study|Death|34|||
126392242|NCT01331837|454727929|FG000|Overall Study|Lost to Follow-up|3|||
126392243|NCT01331837|454727930|FG001|Overall Study|Lost to Follow-up|1|||
126392244|NCT01331837|454727929|FG000|Overall Study|Info not recorded|10|||
126392245|NCT01331837|454727930|FG001|Overall Study|Info not recorded|16|||
126392246|NCT01331837|454727929|FG000|Overall Study|Withdrawal by Subject|13|||
126392247|NCT01331837|454727930|FG001|Overall Study|Withdrawal by Subject|16|||
126392248|NCT01380535|454729904|FG000|Overall Study|Adverse Event|3|||
126392249|NCT01380535|454729905|FG001|Overall Study|Adverse Event|3|||
126392250|NCT01380535|454729904|FG000|Overall Study|Death|3|||
126392251|NCT01380535|454729905|FG001|Overall Study|Death|0|||
126392252|NCT01380535|454729904|FG000|Overall Study|Study site closed|0|||
126392253|NCT01380535|454729905|FG001|Overall Study|Study site closed|5|||
126392254|NCT01380535|454729904|FG000|Overall Study|Withdrawal by Subject|1|||
126392255|NCT01380535|454729905|FG001|Overall Study|Withdrawal by Subject|2|||
126392256|NCT01380535|454729904|FG000|Overall Study|Protocol Violation|0|||
126392257|NCT01380535|454729905|FG001|Overall Study|Protocol Violation|2|||
126392258|NCT01380535|454729904|FG000|Overall Study|Lack of Efficacy|0|||
126392259|NCT01380535|454729905|FG001|Overall Study|Lack of Efficacy|3|||
126392260|NCT00882583|454729906|FG000|Overall Study|Physician Decision|1|||
126392261|NCT00882583|454729907|FG001|Overall Study|Physician Decision|0|||
126392262|NCT00882583|454729906|FG000|Overall Study|Adverse Event|0|||
126392263|NCT00882583|454729907|FG001|Overall Study|Adverse Event|1|||
126392264|NCT04753658|454729908|FG000|Overall Study|Progressive disease|7|||
126392265|NCT04753658|454729908|FG000|Overall Study|Other|7|||
126392266|NCT04753658|454729908|FG000|Overall Study|Adverse Event|1|||
126392267|NCT00218634|454729909|FG000|Overall Study|Lost to Follow-up|8|||
126392268|NCT00218634|454729910|FG001|Overall Study|Lost to Follow-up|15|||
126392269|NCT05243745|454729911|FG000|Overall Study|Withdrawal by Subject|0|||
126392270|NCT05243745|454729912|FG001|Overall Study|Withdrawal by Subject|0|||
126392271|NCT05243745|454729913|FG002|Overall Study|Withdrawal by Subject|0|||
126392272|NCT05243745|454729914|FG003|Overall Study|Withdrawal by Subject|1|||
126392273|NCT05243745|454729911|FG000|Overall Study|Unable to Attend Visit 6|0|||
126392274|NCT05243745|454729912|FG001|Overall Study|Unable to Attend Visit 6|0|||
126392275|NCT05243745|454729913|FG002|Overall Study|Unable to Attend Visit 6|1|||
126392276|NCT05243745|454729914|FG003|Overall Study|Unable to Attend Visit 6|0|||
126468788|NCT01691898|455018845|FG002|Overall Study|Non-Compliance|0|||
126468789|NCT01691898|455018846|FG003|Overall Study|Non-Compliance|0|||
126468790|NCT01691898|455018847|FG004|Overall Study|Non-Compliance|1|||
126468791|NCT01691898|455018848|FG005|Overall Study|Non-Compliance|0|||
126468792|NCT02808650|455018855|FG000|Overall Study|Death|0|||
126468793|NCT02808650|455018856|FG001|Overall Study|Death|0|||
126468794|NCT02808650|455018857|FG002|Overall Study|Death|0|||
126468795|NCT02808650|455018858|FG003|Overall Study|Death|0|||
126468796|NCT02808650|455018859|FG004|Overall Study|Death|1|||
126468797|NCT02808650|455018855|FG000|Overall Study|Lack of Efficacy|5|||
126468798|NCT02808650|455018856|FG001|Overall Study|Lack of Efficacy|5|||
126468799|NCT02808650|455018857|FG002|Overall Study|Lack of Efficacy|6|||
126468800|NCT02808650|455018858|FG003|Overall Study|Lack of Efficacy|5|||
126468801|NCT02808650|455018859|FG004|Overall Study|Lack of Efficacy|4|||
126468802|NCT02808650|455018855|FG000|Overall Study|Physician Decision|1|||
126468803|NCT02808650|455018856|FG001|Overall Study|Physician Decision|1|||
126718782|NCT00069095|455920542|FG002|Primary Treatment Phase|Other Violation|1|||
126718783|NCT00069095|455920543|FG003|Primary Treatment Phase|Other Violation|1|||
126718784|NCT00069095|455920544|FG004|Primary Treatment Phase|Other Violation|0|||
126718785|NCT00069095|455920545|FG005|Primary Treatment Phase|Other Violation|1|||
126718786|NCT00069095|455920540|FG000|Primary Treatment Phase|Violation criteria|0|||
126718787|NCT00069095|455920541|FG001|Primary Treatment Phase|Violation criteria|2|||
126718788|NCT00069095|455920542|FG002|Primary Treatment Phase|Violation criteria|4|||
126718789|NCT00069095|455920543|FG003|Primary Treatment Phase|Violation criteria|3|||
126718790|NCT00069095|455920544|FG004|Primary Treatment Phase|Violation criteria|1|||
126718791|NCT00069095|455920545|FG005|Primary Treatment Phase|Violation criteria|5|||
126771544|NCT01289990|456117824|FG004|Overall Study|did not continue in extension|48|||
126771545|NCT01289990|456117825|FG005|Overall Study|did not continue in extension|50|||
126468804|NCT02808650|455018857|FG002|Overall Study|Physician Decision|0|||
126468805|NCT02808650|455018858|FG003|Overall Study|Physician Decision|0|||
126468806|NCT02808650|455018859|FG004|Overall Study|Physician Decision|0|||
126468807|NCT02808650|455018855|FG000|Overall Study|Withdrawal by Subject|0|||
126468808|NCT02808650|455018856|FG001|Overall Study|Withdrawal by Subject|0|||
126468809|NCT02808650|455018857|FG002|Overall Study|Withdrawal by Subject|0|||
126468810|NCT02808650|455018858|FG003|Overall Study|Withdrawal by Subject|1|||
126468811|NCT02808650|455018859|FG004|Overall Study|Withdrawal by Subject|1|||
126468812|NCT03799211|455018860|FG000|Overall Study|Lost to Follow-up|2|||
126468813|NCT03799211|455018861|FG001|Overall Study|Lost to Follow-up|13|||
126468814|NCT03799211|455018860|FG000|Overall Study|Withdrawal by Subject|2|||
126468815|NCT03799211|455018861|FG001|Overall Study|Withdrawal by Subject|0|||
126468816|NCT00764491|455018862|FG000|Overall Study|Lost to Follow-up|35|||
126771546|NCT01289990|456117826|FG006|Overall Study|did not continue in extension|54|||
126771547|NCT01289990|456117827|FG007|Overall Study|did not continue in extension|36|||
126771548|NCT01289990|456117828|FG008|Overall Study|did not continue in extension|44|||
126771549|NCT01289990|456117829|FG009|Overall Study|did not continue in extension|48|||
126771550|NCT01289990|456117830|FG010|Overall Study|did not continue in extension|45|||
126771551|NCT01289990|456117831|FG011|Overall Study|did not continue in extension|34|||
126771552|NCT01289990|456117832|FG012|Overall Study|did not continue in extension|56|||
126771553|NCT01289990|456117820|FG000|Overall Study|Not treated|0|||
126771554|NCT01289990|456117821|FG001|Overall Study|Not treated|0|||
126771555|NCT01289990|456117822|FG002|Overall Study|Not treated|0|||
126771556|NCT01289990|456117823|FG003|Overall Study|Not treated|0|||
126771557|NCT01289990|456117824|FG004|Overall Study|Not treated|0|||
126771558|NCT01289990|456117825|FG005|Overall Study|Not treated|0|||
126771559|NCT01289990|456117826|FG006|Overall Study|Not treated|1|||
126771560|NCT01289990|456117827|FG007|Overall Study|Not treated|0|||
126771561|NCT01289990|456117828|FG008|Overall Study|Not treated|1|||
126771562|NCT01289990|456117829|FG009|Overall Study|Not treated|0|||
126771563|NCT01289990|456117830|FG010|Overall Study|Not treated|1|||
126771564|NCT01289990|456117831|FG011|Overall Study|Not treated|2|||
126771565|NCT01289990|456117832|FG012|Overall Study|Not treated|0|||
126771566|NCT01488071|456117833|FG000|Overall Study|Adverse Event|15|||
126468817|NCT00764491|455018863|FG001|Overall Study|Lost to Follow-up|17|||
126468818|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
126468819|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
126468820|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|Death|1|||
126718792|NCT00069095|455920540|FG000|Post-study Treatment Phase|Missing reason|1|||
126718793|NCT00069095|455920541|FG001|Post-study Treatment Phase|Missing reason|3|||
126771567|NCT01488071|456117834|FG001|Overall Study|Adverse Event|23|||
126771568|NCT01488071|456117833|FG000|Overall Study|Lack of Efficacy|11|||
126771569|NCT01488071|456117834|FG001|Overall Study|Lack of Efficacy|17|||
126468821|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|Death|0|||
126468822|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
126468823|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
126468824|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
126718794|NCT00069095|455920542|FG002|Post-study Treatment Phase|Missing reason|12|||
126771570|NCT01488071|456117833|FG000|Overall Study|Non-compliance with study drug|2|||
126392277|NCT03842969|454729925|FG000|Overall Study|Participant declined follow-up visit|0|||
126392278|NCT03842969|454729926|FG001|Overall Study|Participant declined follow-up visit|1|||
126392279|NCT03842969|454729927|FG002|Overall Study|Participant declined follow-up visit|0|||
126392280|NCT03842969|454729925|FG000|Overall Study|Sponsor's decision|12|||
126392281|NCT03842969|454729926|FG001|Overall Study|Sponsor's decision|99|||
126392282|NCT03842969|454729927|FG002|Overall Study|Sponsor's decision|61|||
126392283|NCT03842969|454729925|FG000|Overall Study|Pregnancy|0|||
126392284|NCT03842969|454729926|FG001|Overall Study|Pregnancy|0|||
126392285|NCT03842969|454729927|FG002|Overall Study|Pregnancy|1|||
126392286|NCT03842969|454729925|FG000|Overall Study|Death|1|||
126392287|NCT03842969|454729926|FG001|Overall Study|Death|0|||
126392288|NCT03842969|454729927|FG002|Overall Study|Death|1|||
126392289|NCT03842969|454729925|FG000|Overall Study|Withdrawal by Subject|3|||
126392290|NCT03842969|454729926|FG001|Overall Study|Withdrawal by Subject|30|||
126392291|NCT03842969|454729927|FG002|Overall Study|Withdrawal by Subject|18|||
126392292|NCT03842969|454729925|FG000|Overall Study|Protocol Violation|1|||
126392293|NCT03842969|454729926|FG001|Overall Study|Protocol Violation|1|||
126392294|NCT03842969|454729927|FG002|Overall Study|Protocol Violation|0|||
126392295|NCT03842969|454729925|FG000|Overall Study|Physician Decision|0|||
126392296|NCT03842969|454729926|FG001|Overall Study|Physician Decision|3|||
126392297|NCT03842969|454729927|FG002|Overall Study|Physician Decision|0|||
126392298|NCT03842969|454729925|FG000|Overall Study|Lost to Follow-up|0|||
126392299|NCT03842969|454729926|FG001|Overall Study|Lost to Follow-up|2|||
126392300|NCT03842969|454729927|FG002|Overall Study|Lost to Follow-up|0|||
126392301|NCT03842969|454729925|FG000|Overall Study|Adverse Event|0|||
126392302|NCT03842969|454729926|FG001|Overall Study|Adverse Event|2|||
126392303|NCT03842969|454729927|FG002|Overall Study|Adverse Event|0|||
126392304|NCT01044745|454729928|FG000|Overall Study|Ineiligible|2|||
126392305|NCT01159171|454729930|FG000|Overall Study|Adverse Event|11|||
126392306|NCT01159171|454729930|FG000|Overall Study|Progression of Disease|28|||
126392307|NCT01159171|454729930|FG000|Overall Study|Protocol Violation|1|||
126392308|NCT01159171|454729930|FG000|Overall Study|Need for Surgery|5|||
126392309|NCT01159171|454729930|FG000|Overall Study|Medical Decision|4|||
126392310|NCT01159171|454729930|FG000|Overall Study|Death|1|||
126392311|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Adverse Event|76|||
126392312|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Adverse Event|0|||
126392313|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Adverse Event|0|||
126392314|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Death|3|||
126392315|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Death|0|||
126392316|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Death|0|||
126392317|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
126392318|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
126392319|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
126392320|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Physician Decision|9|||
126392321|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Physician Decision|0|||
126392322|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Physician Decision|0|||
126392323|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
126392324|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
126392325|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
126392326|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Disease progression|45|||
126392327|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Disease progression|0|||
126392328|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Disease progression|0|||
126392329|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
126392330|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
126392331|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
126392332|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
126468825|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
126468826|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
126468827|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
126468828|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
126468829|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
126468830|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
126468831|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
126392333|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
126392334|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
126468832|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
126392335|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
126392336|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
126392337|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
126392338|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
126392339|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
126392340|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
126392341|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
126392342|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
126392343|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
126392344|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
126392345|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
126392346|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
126392347|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
126392348|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
126392349|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
126392350|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
126392351|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
126392352|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
126392353|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
126392354|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
126392355|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
126392356|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Promotor request|1|||
126392357|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Promotor request|0|||
126392358|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Promotor request|0|||
126392359|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
126392360|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
126392361|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
126392362|NCT01461928|454729931|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
126392363|NCT01461928|454729932|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
126392364|NCT01461928|454729933|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
126392365|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Death|3|||
126392366|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Death|0|||
126392367|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Death|0|||
126392368|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
126392369|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
126392370|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
126392371|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
126392372|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
126392373|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
126392374|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Diseases progression|91|||
126392375|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Diseases progression|0|||
126392376|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Diseases progression|0|||
126392377|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Adverse Event|70|||
126392378|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Adverse Event|0|||
126392379|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Adverse Event|0|||
126392380|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Physician Decision|9|||
126392381|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Physician Decision|0|||
126392382|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Physician Decision|0|||
126392383|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
126392384|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
126392385|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
126392386|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
126468833|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
126468834|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
126468835|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
126468836|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
126468837|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
126468838|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
126468839|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
126468840|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
126468841|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
126718795|NCT00069095|455920543|FG003|Post-study Treatment Phase|Missing reason|8|||
126392387|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
126392388|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
126392389|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
126392390|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
126392391|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
126392392|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Not compliant|1|||
126392393|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Not compliant|0|||
126392394|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Not compliant|0|||
126392395|NCT01461928|454729931|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
126392396|NCT01461928|454729932|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
126392397|NCT01461928|454729933|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
126392398|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Adverse Event|0|||
126392399|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Adverse Event|2|||
126392400|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Adverse Event|0|||
126392401|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Death|0|||
126392402|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Death|10|||
126392403|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Death|8|||
126392404|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Physician Decision|0|||
126392405|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Physician Decision|0|||
126392406|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Physician Decision|4|||
126392407|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
126392408|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
126392409|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
126392410|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Moved to another town|0|||
126392411|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Moved to another town|1|||
126392412|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Moved to another town|0|||
126392413|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Disease progression|0|||
126392414|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Disease progression|0|||
126392415|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Disease progression|3|||
126392416|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
126392417|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
126392418|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
126392419|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
126392420|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
126392421|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
126392422|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
126392423|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
126392424|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
126392425|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
126392426|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
126392427|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
126392428|NCT01461928|454729931|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
126392429|NCT01461928|454729932|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
126392430|NCT01461928|454729933|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
126392431|NCT01892436|454729936|FG000|Overall Study|Withdrawal by Subject|8|||
126392432|NCT01892436|454729937|FG001|Overall Study|Withdrawal by Subject|15|||
126392433|NCT01892436|454729938|FG002|Overall Study|Withdrawal by Subject|4|||
126392434|NCT01892436|454729939|FG003|Overall Study|Withdrawal by Subject|4|||
126392435|NCT01892436|454729936|FG000|Overall Study|Death|1|||
126392436|NCT01892436|454729937|FG001|Overall Study|Death|1|||
126392437|NCT01892436|454729938|FG002|Overall Study|Death|0|||
126392438|NCT01892436|454729939|FG003|Overall Study|Death|0|||
126392439|NCT01892436|454729936|FG000|Overall Study|Physician Decision|2|||
126392440|NCT01892436|454729937|FG001|Overall Study|Physician Decision|1|||
126392441|NCT01892436|454729938|FG002|Overall Study|Physician Decision|0|||
126392442|NCT01892436|454729939|FG003|Overall Study|Physician Decision|1|||
126392443|NCT01892436|454729936|FG000|Overall Study|Pregnancy|0|||
126392444|NCT01892436|454729937|FG001|Overall Study|Pregnancy|2|||
126392445|NCT01892436|454729938|FG002|Overall Study|Pregnancy|1|||
126392446|NCT01892436|454729939|FG003|Overall Study|Pregnancy|0|||
126392447|NCT01892436|454729936|FG000|Overall Study|Technical problems|2|||
126392448|NCT01892436|454729937|FG001|Overall Study|Technical problems|1|||
126771571|NCT01488071|456117834|FG001|Overall Study|Non-compliance with study drug|0|||
126392449|NCT01892436|454729938|FG002|Overall Study|Technical problems|1|||
126392450|NCT01892436|454729939|FG003|Overall Study|Technical problems|1|||
126392451|NCT01892436|454729936|FG000|Overall Study|Lack of Efficacy|1|||
126392452|NCT01892436|454729937|FG001|Overall Study|Lack of Efficacy|2|||
126392453|NCT01892436|454729938|FG002|Overall Study|Lack of Efficacy|2|||
126392454|NCT01892436|454729939|FG003|Overall Study|Lack of Efficacy|2|||
126392455|NCT01892436|454729936|FG000|Overall Study|Lost to Follow-up|1|||
126392456|NCT01892436|454729937|FG001|Overall Study|Lost to Follow-up|1|||
126392457|NCT01892436|454729938|FG002|Overall Study|Lost to Follow-up|1|||
126392458|NCT01892436|454729939|FG003|Overall Study|Lost to Follow-up|3|||
126392459|NCT01892436|454729936|FG000|Overall Study|non-compliance with treatment|1|||
126771572|NCT01488071|456117833|FG000|Overall Study|Protocol Violation|5|||
126392460|NCT01892436|454729937|FG001|Overall Study|non-compliance with treatment|0|||
126392461|NCT01892436|454729938|FG002|Overall Study|non-compliance with treatment|0|||
126392462|NCT01892436|454729939|FG003|Overall Study|non-compliance with treatment|0|||
126392463|NCT01892436|454729936|FG000|Overall Study|Adverse Event|7|||
126392464|NCT01892436|454729937|FG001|Overall Study|Adverse Event|6|||
126392465|NCT01892436|454729938|FG002|Overall Study|Adverse Event|2|||
126392466|NCT01892436|454729939|FG003|Overall Study|Adverse Event|3|||
126392467|NCT00733291|454729947|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
126468842|NCT02927262|455018870|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
126468843|NCT02927262|455018871|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
126468844|NCT02927262|455018870|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
126718796|NCT00069095|455920544|FG004|Post-study Treatment Phase|Missing reason|18|||
126718797|NCT00069095|455920545|FG005|Post-study Treatment Phase|Missing reason|17|||
126718798|NCT00069095|455920540|FG000|Post-study Treatment Phase|Adverse Event|2|||
126718799|NCT00069095|455920541|FG001|Post-study Treatment Phase|Adverse Event|3|||
126718800|NCT00069095|455920542|FG002|Post-study Treatment Phase|Adverse Event|1|||
126718801|NCT00069095|455920543|FG003|Post-study Treatment Phase|Adverse Event|0|||
126392468|NCT00733291|454729948|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
126392469|NCT00733291|454729949|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
126392470|NCT00733291|454729950|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
126392471|NCT02242435|454729955|FG000|Overall Study|Lost to Follow-up|3|||
126392472|NCT02242435|454729956|FG001|Overall Study|Lost to Follow-up|4|||
126392473|NCT02242435|454729955|FG000|Overall Study|Adverse Event|3|||
126392474|NCT02242435|454729956|FG001|Overall Study|Adverse Event|2|||
126392475|NCT02242435|454729955|FG000|Overall Study|Withdrawal by Subject|13|||
126392476|NCT02242435|454729956|FG001|Overall Study|Withdrawal by Subject|8|||
126392477|NCT02242435|454729955|FG000|Overall Study|Death|0|||
126392478|NCT02242435|454729956|FG001|Overall Study|Death|1|||
126392479|NCT02242435|454729955|FG000|Overall Study|Protocol Violation|1|||
126392480|NCT02242435|454729956|FG001|Overall Study|Protocol Violation|0|||
126392481|NCT02242435|454729955|FG000|Overall Study|Physician Decision|0|||
126392482|NCT02242435|454729956|FG001|Overall Study|Physician Decision|1|||
126392483|NCT03895086|454729958|FG000|Overall Study|Early termination study|1|||
126392484|NCT03895086|454729959|FG001|Overall Study|Early termination study|0|||
126392485|NCT01089413|454729963|FG000|Overall Study|Lost to Follow-up|1|||
126392486|NCT01089413|454729963|FG000|Overall Study|Progressive Disease|93|||
126392487|NCT01089413|454729963|FG000|Overall Study|Participant Withdrew Consent|1|||
126392488|NCT01089413|454729963|FG000|Overall Study|Unacceptable Toxicity|12|||
126392489|NCT01089413|454729963|FG000|Overall Study|Death|10|||
126392490|NCT01089413|454729963|FG000|Overall Study|Metastasectomy|13|||
126392491|NCT01089413|454729963|FG000|Overall Study|Other|71|||
126392492|NCT00420004|454729974|FG000|Overall Study|Adverse Event|4|||
126392493|NCT00420004|454729975|FG001|Overall Study|Adverse Event|1|||
126392494|NCT00420004|454729976|FG002|Overall Study|Adverse Event|1|||
126392495|NCT00420004|454729974|FG000|Overall Study|Lack of Efficacy|5|||
126392496|NCT00420004|454729975|FG001|Overall Study|Lack of Efficacy|4|||
126392497|NCT00420004|454729976|FG002|Overall Study|Lack of Efficacy|1|||
126392498|NCT00420004|454729974|FG000|Overall Study|Lost to Follow-up|31|||
126392499|NCT00420004|454729975|FG001|Overall Study|Lost to Follow-up|12|||
126392500|NCT00420004|454729976|FG002|Overall Study|Lost to Follow-up|10|||
126392501|NCT00420004|454729974|FG000|Overall Study|Entry Criteria Not Met|0|||
126392502|NCT00420004|454729975|FG001|Overall Study|Entry Criteria Not Met|1|||
126392503|NCT00420004|454729976|FG002|Overall Study|Entry Criteria Not Met|0|||
126392504|NCT00420004|454729974|FG000|Overall Study|Physician Decision|14|||
126392505|NCT00420004|454729975|FG001|Overall Study|Physician Decision|4|||
126392506|NCT00420004|454729976|FG002|Overall Study|Physician Decision|2|||
126392507|NCT00420004|454729974|FG000|Overall Study|Protocol Violation|5|||
126392508|NCT00420004|454729975|FG001|Overall Study|Protocol Violation|4|||
126392509|NCT00420004|454729976|FG002|Overall Study|Protocol Violation|3|||
126392510|NCT00420004|454729974|FG000|Overall Study|Withdrawal by Subject|67|||
126392511|NCT00420004|454729975|FG001|Overall Study|Withdrawal by Subject|42|||
126392512|NCT00420004|454729976|FG002|Overall Study|Withdrawal by Subject|14|||
126392513|NCT00420004|454729974|FG000|Overall Study|Sponsor Decision|3|||
126392514|NCT00420004|454729975|FG001|Overall Study|Sponsor Decision|3|||
126392515|NCT00420004|454729976|FG002|Overall Study|Sponsor Decision|1|||
126392516|NCT02379221|454729977|FG000|Overall Study|Lost to Follow-up|1|||
126392517|NCT01610557|454729978|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
126392518|NCT01610557|454729979|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
126392519|NCT01610557|454729980|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
126392520|NCT01610557|454729981|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
126392521|NCT01610557|454729982|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
126392522|NCT01610557|454729978|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
126392523|NCT01610557|454729979|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
126392524|NCT01610557|454729980|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
126392525|NCT01610557|454729981|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
126392526|NCT01610557|454729982|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
126718802|NCT00069095|455920544|FG004|Post-study Treatment Phase|Adverse Event|5|||
126718803|NCT00069095|455920545|FG005|Post-study Treatment Phase|Adverse Event|1|||
126392527|NCT00519376|454729983|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392528|NCT00519376|454729984|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392529|NCT00519376|454729985|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126718804|NCT00069095|455920540|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
126392530|NCT00519376|454729986|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392531|NCT00519376|454729987|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392532|NCT00519376|454729988|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392533|NCT00519376|454729989|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392534|NCT00519376|454729990|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392535|NCT00519376|454729991|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392536|NCT00519376|454729992|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392537|NCT00519376|454729993|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392538|NCT00519376|454729994|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392539|NCT00519376|454729995|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
126392540|NCT00519376|454729996|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392541|NCT00519376|454729997|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392542|NCT00519376|454729998|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
126392543|NCT00519376|454729983|FG000|Treatment Period 4|Lost to Follow-up|0|||
126392544|NCT00519376|454729984|FG001|Treatment Period 4|Lost to Follow-up|0|||
126392545|NCT00519376|454729985|FG002|Treatment Period 4|Lost to Follow-up|1|||
126392546|NCT00519376|454729986|FG003|Treatment Period 4|Lost to Follow-up|0|||
126392547|NCT00519376|454729987|FG004|Treatment Period 4|Lost to Follow-up|0|||
126392548|NCT00519376|454729988|FG005|Treatment Period 4|Lost to Follow-up|0|||
126392549|NCT00519376|454729989|FG006|Treatment Period 4|Lost to Follow-up|0|||
126392550|NCT00519376|454729990|FG007|Treatment Period 4|Lost to Follow-up|0|||
126392551|NCT00519376|454729991|FG008|Treatment Period 4|Lost to Follow-up|0|||
126468845|NCT02927262|455018871|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
126468846|NCT02927262|455018870|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
126468847|NCT02927262|455018871|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
126468848|NCT02927262|455018870|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
126468849|NCT02927262|455018871|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
126468850|NCT00923936|455018872|FG000|Overall Study|progressive disease on study|2|||
126468851|NCT00923936|455018873|FG001|Overall Study|progressive disease on study|1|||
126468852|NCT00923936|455018872|FG000|Overall Study|Adverse Event|2|||
126468853|NCT00923936|455018873|FG001|Overall Study|Adverse Event|1|||
126468854|NCT00923936|455018872|FG000|Overall Study|Lost to follow up|2|||
126468855|NCT00923936|455018873|FG001|Overall Study|Lost to follow up|0|||
126468856|NCT00923936|455018872|FG000|Overall Study|Continuing in follow up period|2|||
126468857|NCT00923936|455018873|FG001|Overall Study|Continuing in follow up period|1|||
126468858|NCT01697358|455018874|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
126718805|NCT00069095|455920541|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
126718806|NCT00069095|455920542|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
126718807|NCT00069095|455920543|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
126718808|NCT00069095|455920544|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
126718809|NCT00069095|455920545|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
126718810|NCT00069095|455920540|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
126718811|NCT00069095|455920541|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
126718812|NCT00069095|455920542|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
126718813|NCT00069095|455920543|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
126718814|NCT00069095|455920544|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
126468859|NCT01697358|455018875|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
126468860|NCT01697358|455018874|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
126468861|NCT01697358|455018875|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
126468862|NCT01697358|455018874|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
126468863|NCT01697358|455018875|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
126468864|NCT01697358|455018874|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
126468865|NCT01697358|455018875|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
126468866|NCT01697358|455018874|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
126468867|NCT01697358|455018875|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
126468868|NCT01697358|455018874|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
126718815|NCT00069095|455920545|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
126392552|NCT00519376|454729992|FG009|Treatment Period 4|Lost to Follow-up|0|||
126392553|NCT00519376|454729993|FG010|Treatment Period 4|Lost to Follow-up|0|||
126468869|NCT01697358|455018875|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
126468870|NCT01697358|455018874|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
126468871|NCT01697358|455018875|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
126718816|NCT00069095|455920540|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
126392554|NCT00519376|454729994|FG011|Treatment Period 4|Lost to Follow-up|0|||
126392555|NCT00519376|454729995|FG012|Treatment Period 4|Lost to Follow-up|0|||
126392556|NCT00519376|454729996|FG013|Treatment Period 4|Lost to Follow-up|0|||
126392557|NCT00519376|454729997|FG014|Treatment Period 4|Lost to Follow-up|0|||
126392558|NCT00519376|454729998|FG015|Treatment Period 4|Lost to Follow-up|0|||
126392559|NCT02039219|454730001|FG000|Treatment|Withdrawal by Subject|1|||
126392560|NCT02039219|454730002|FG001|Treatment|Withdrawal by Subject|0|||
126392561|NCT02039219|454730001|FG000|Treatment|Adverse Event|0|||
126392562|NCT02039219|454730002|FG001|Treatment|Adverse Event|1|||
126392563|NCT02039219|454730001|FG000|Treatment|Physician Decision|1|||
126392564|NCT02039219|454730002|FG001|Treatment|Physician Decision|0|||
126392565|NCT02039219|454730001|FG000|Treatment|Lost to Follow-up|0|||
126392566|NCT02039219|454730002|FG001|Treatment|Lost to Follow-up|1|||
126392567|NCT02039219|454730001|FG000|Treatment|Protocol Violation|1|||
126392568|NCT02039219|454730002|FG001|Treatment|Protocol Violation|0|||
126392569|NCT02039219|454730001|FG000|Treatment|Death|1|||
126392570|NCT02039219|454730002|FG001|Treatment|Death|0|||
126392571|NCT02039219|454730001|FG000|Follow up|Adverse Event|0|||
126392572|NCT02039219|454730002|FG001|Follow up|Adverse Event|1|||
126392573|NCT02974855|454730003|FG000|Overall Study|Adverse Event|0|||
126392574|NCT02974855|454730004|FG001|Overall Study|Adverse Event|1|||
126392575|NCT02974855|454730005|FG002|Overall Study|Adverse Event|0|||
126392576|NCT02974855|454730006|FG003|Overall Study|Adverse Event|1|||
126392577|NCT00129701|454730007|FG000|Overall Study|Withdrawal by Subject|33|||
126392578|NCT02750345|454730008|FG000|Intervention 1|Adverse Event|0|||
126392579|NCT02750345|454730009|FG001|Intervention 1|Adverse Event|0|||
126392580|NCT02750345|454730010|FG002|Intervention 1|Adverse Event|0|||
126392581|NCT02750345|454730011|FG003|Intervention 1|Adverse Event|0|||
126392582|NCT02750345|454730012|FG004|Intervention 1|Adverse Event|1|||
126392583|NCT02750345|454730013|FG005|Intervention 1|Adverse Event|0|||
126392584|NCT02650128|454730014|FG000|Overall Study|Death|2|||
126392585|NCT01801436|454730035|FG000|Overall Study|Withdrawal by Subject|3|||
126392586|NCT01801436|454730035|FG000|Overall Study|Adverse Event|2|||
126392587|NCT01801436|454730035|FG000|Overall Study|Progressive disease|4|||
126392588|NCT01126437|454730040|FG000|Overall Study|Not treated|11|||
126392589|NCT01126437|454730041|FG001|Overall Study|Not treated|18|||
126392590|NCT01126437|454730042|FG002|Overall Study|Not treated|19|||
126392591|NCT01126437|454730040|FG000|Overall Study|Sites with data irregularities/fraud|6|||
126392592|NCT01126437|454730041|FG001|Overall Study|Sites with data irregularities/fraud|6|||
126392593|NCT01126437|454730042|FG002|Overall Study|Sites with data irregularities/fraud|7|||
126392594|NCT01126437|454730040|FG000|Overall Study|Adverse Event|602|||
126392595|NCT01126437|454730041|FG001|Overall Study|Adverse Event|606|||
126392596|NCT01126437|454730042|FG002|Overall Study|Adverse Event|635|||
126392597|NCT01126437|454730040|FG000|Overall Study|Lack of Efficacy|65|||
126392598|NCT01126437|454730041|FG001|Overall Study|Lack of Efficacy|60|||
126392599|NCT01126437|454730042|FG002|Overall Study|Lack of Efficacy|59|||
126392600|NCT01126437|454730040|FG000|Overall Study|Protocol Violation|64|||
126392601|NCT01126437|454730041|FG001|Overall Study|Protocol Violation|66|||
126392602|NCT01126437|454730042|FG002|Overall Study|Protocol Violation|41|||
126392603|NCT01126437|454730040|FG000|Overall Study|Lost to Follow-up|52|||
126392604|NCT01126437|454730041|FG001|Overall Study|Lost to Follow-up|63|||
126392605|NCT01126437|454730042|FG002|Overall Study|Lost to Follow-up|55|||
126392606|NCT01126437|454730040|FG000|Overall Study|Withdrawal by Subject|331|||
126392607|NCT01126437|454730041|FG001|Overall Study|Withdrawal by Subject|335|||
126392608|NCT01126437|454730042|FG002|Overall Study|Withdrawal by Subject|319|||
126392609|NCT01126437|454730040|FG000|Overall Study|Other reason not specified|210|||
126392610|NCT01126437|454730041|FG001|Overall Study|Other reason not specified|176|||
126392611|NCT01126437|454730042|FG002|Overall Study|Other reason not specified|178|||
126392612|NCT01846663|454730053|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
126392613|NCT01846663|454730054|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
126392614|NCT01846663|454730053|FG000|Overall Study|Withdrawal by Subject|1|||
126392615|NCT01846663|454730054|FG001|Overall Study|Withdrawal by Subject|0|||
126392616|NCT01846663|454730053|FG000|Overall Study|Adverse Event|1|||
126392617|NCT01846663|454730054|FG001|Overall Study|Adverse Event|2|||
126392618|NCT02851797|454730060|FG000|Overall Study|Withdrawal by Subject|4|||
126392619|NCT02851797|454730061|FG001|Overall Study|Withdrawal by Subject|2|||
126392620|NCT02851797|454730060|FG000|Overall Study|Adverse Event|3|||
126392621|NCT02851797|454730061|FG001|Overall Study|Adverse Event|0|||
126392622|NCT00813865|454730062|FG000|Overall Study|Failure to Respond|3|||
126392623|NCT00813865|454730062|FG000|Overall Study|Lost to Follow-up|3|||
126392624|NCT00813865|454730062|FG000|Overall Study|Withdrawal by Subject|1|||
126392625|NCT04295681|454730063|FG000|Overall Study|Eligibility error|1|||
126392626|NCT04295681|454730064|FG001|Overall Study|Eligibility error|3|||
126392627|NCT02135029|454730073|FG000|Overall Study|Adverse Event|2|||
126392628|NCT02135029|454730074|FG001|Overall Study|Adverse Event|2|||
126392629|NCT02135029|454730075|FG002|Overall Study|Adverse Event|2|||
126392630|NCT02135029|454730073|FG000|Overall Study|Lost to Follow-up|0|||
126392631|NCT02135029|454730074|FG001|Overall Study|Lost to Follow-up|1|||
126392632|NCT02135029|454730075|FG002|Overall Study|Lost to Follow-up|0|||
126392633|NCT02135029|454730073|FG000|Overall Study|Withdrawal by Subject|2|||
126392634|NCT02135029|454730074|FG001|Overall Study|Withdrawal by Subject|0|||
126392635|NCT02135029|454730075|FG002|Overall Study|Withdrawal by Subject|1|||
126392636|NCT02135029|454730073|FG000|Overall Study|Other|0|||
126392637|NCT02135029|454730074|FG001|Overall Study|Other|1|||
126392638|NCT02135029|454730075|FG002|Overall Study|Other|0|||
126392639|NCT02135029|454730073|FG000|Overall Study|Death|0|||
126392640|NCT02135029|454730074|FG001|Overall Study|Death|1|||
126392641|NCT02135029|454730075|FG002|Overall Study|Death|0|||
126392642|NCT03525600|454730076|FG000|Overall Study|Adverse Event|9|||
126392643|NCT03525600|454730077|FG001|Overall Study|Adverse Event|6|||
126392644|NCT03525600|454730078|FG002|Overall Study|Adverse Event|5|||
126392645|NCT03525600|454730079|FG003|Overall Study|Adverse Event|3|||
126392646|NCT03525600|454730076|FG000|Overall Study|Lost to Follow-up|2|||
126392647|NCT03525600|454730077|FG001|Overall Study|Lost to Follow-up|4|||
126392648|NCT03525600|454730078|FG002|Overall Study|Lost to Follow-up|4|||
126392649|NCT03525600|454730079|FG003|Overall Study|Lost to Follow-up|0|||
126392650|NCT03525600|454730076|FG000|Overall Study|Physician Decision|1|||
126392651|NCT03525600|454730077|FG001|Overall Study|Physician Decision|0|||
126392652|NCT03525600|454730078|FG002|Overall Study|Physician Decision|2|||
126392653|NCT03525600|454730079|FG003|Overall Study|Physician Decision|0|||
126392654|NCT03525600|454730076|FG000|Overall Study|Consent withdrawal|36|||
126392655|NCT03525600|454730077|FG001|Overall Study|Consent withdrawal|20|||
126392656|NCT03525600|454730078|FG002|Overall Study|Consent withdrawal|6|||
126392657|NCT03525600|454730079|FG003|Overall Study|Consent withdrawal|13|||
126392658|NCT03525600|454730076|FG000|Overall Study|Death|7|||
126392659|NCT03525600|454730077|FG001|Overall Study|Death|6|||
126392660|NCT03525600|454730078|FG002|Overall Study|Death|4|||
126392661|NCT03525600|454730079|FG003|Overall Study|Death|3|||
126392662|NCT03525600|454730076|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
126392663|NCT03525600|454730077|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
126392664|NCT03525600|454730078|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
126392665|NCT03525600|454730079|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
126392666|NCT03525600|454730076|FG000|Overall Study|Other|0|||
126392667|NCT03525600|454730077|FG001|Overall Study|Other|1|||
126392668|NCT03525600|454730078|FG002|Overall Study|Other|0|||
126392669|NCT03525600|454730079|FG003|Overall Study|Other|0|||
126392670|NCT03255967|454730082|FG000|Overall Study|Adverse Event|26|||
126392671|NCT03255967|454730083|FG001|Overall Study|Adverse Event|30|||
126392672|NCT03255967|454730082|FG000|Overall Study|Withdrawal by Subject|6|||
126392673|NCT03255967|454730083|FG001|Overall Study|Withdrawal by Subject|6|||
126392674|NCT03255967|454730082|FG000|Overall Study|Schedule conflict|6|||
126392675|NCT03255967|454730083|FG001|Overall Study|Schedule conflict|4|||
126392676|NCT03255967|454730082|FG000|Overall Study|POA did not sign consent form|2|||
126392677|NCT03255967|454730083|FG001|Overall Study|POA did not sign consent form|0|||
126392678|NCT01202188|454730084|FG000|Overall Study|Protocol deviation|14|||
126392679|NCT01202188|454730085|FG001|Overall Study|Protocol deviation|8|||
126392680|NCT01202188|454730086|FG002|Overall Study|Protocol deviation|12|||
126392681|NCT01202188|454730087|FG003|Overall Study|Protocol deviation|10|||
126392682|NCT01202188|454730088|FG004|Overall Study|Protocol deviation|11|||
126392683|NCT01202188|454730084|FG000|Overall Study|Subject withdrew consent|12|||
126392684|NCT01202188|454730085|FG001|Overall Study|Subject withdrew consent|13|||
126392685|NCT01202188|454730086|FG002|Overall Study|Subject withdrew consent|22|||
126392686|NCT01202188|454730087|FG003|Overall Study|Subject withdrew consent|11|||
126392687|NCT01202188|454730088|FG004|Overall Study|Subject withdrew consent|13|||
126392688|NCT01202188|454730084|FG000|Overall Study|Adverse Event|5|||
126392689|NCT01202188|454730085|FG001|Overall Study|Adverse Event|23|||
126392690|NCT01202188|454730086|FG002|Overall Study|Adverse Event|13|||
126392691|NCT01202188|454730087|FG003|Overall Study|Adverse Event|10|||
126392692|NCT01202188|454730088|FG004|Overall Study|Adverse Event|10|||
126392693|NCT01202188|454730084|FG000|Overall Study|Administrative problems|3|||
126392694|NCT01202188|454730085|FG001|Overall Study|Administrative problems|2|||
126392695|NCT01202188|454730086|FG002|Overall Study|Administrative problems|1|||
126392696|NCT01202188|454730087|FG003|Overall Study|Administrative problems|1|||
126392697|NCT01202188|454730088|FG004|Overall Study|Administrative problems|2|||
126392698|NCT01202188|454730084|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126392699|NCT01202188|454730085|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
126392700|NCT01202188|454730086|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126392701|NCT01202188|454730087|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
126392702|NCT01202188|454730088|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
126392703|NCT01202188|454730084|FG000|Overall Study|Lost to Follow-up|1|||
126392704|NCT01202188|454730085|FG001|Overall Study|Lost to Follow-up|1|||
126392705|NCT01202188|454730086|FG002|Overall Study|Lost to Follow-up|0|||
126392706|NCT01202188|454730087|FG003|Overall Study|Lost to Follow-up|4|||
126392707|NCT01202188|454730088|FG004|Overall Study|Lost to Follow-up|1|||
126392708|NCT01202188|454730084|FG000|Overall Study|Death|1|||
126392709|NCT01202188|454730085|FG001|Overall Study|Death|1|||
126392710|NCT01202188|454730086|FG002|Overall Study|Death|1|||
126392711|NCT01202188|454730087|FG003|Overall Study|Death|1|||
126392712|NCT01202188|454730088|FG004|Overall Study|Death|0|||
126392713|NCT01202188|454730084|FG000|Overall Study|Abnormal test procedure result (s)|0|||
126392714|NCT01202188|454730085|FG001|Overall Study|Abnormal test procedure result (s)|0|||
126392715|NCT01202188|454730086|FG002|Overall Study|Abnormal test procedure result (s)|2|||
126771573|NCT01488071|456117834|FG001|Overall Study|Protocol Violation|7|||
126771574|NCT01488071|456117833|FG000|Overall Study|Withdrawal of Consent|14|||
126392716|NCT01202188|454730087|FG003|Overall Study|Abnormal test procedure result (s)|0|||
126392717|NCT01202188|454730088|FG004|Overall Study|Abnormal test procedure result (s)|0|||
126392718|NCT02438384|454730090|FG000|Overall Study|Lost to Follow-up|8|||
126392719|NCT02438384|454730091|FG001|Overall Study|Lost to Follow-up|6|||
126392720|NCT02438384|454730092|FG002|Overall Study|Lost to Follow-up|4|||
126392721|NCT03319953|454730093|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
126392722|NCT03319953|454730094|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
126392723|NCT03319953|454730095|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
126392724|NCT03319953|454730096|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
126392725|NCT03319953|454730093|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
126392726|NCT03319953|454730094|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
126392727|NCT03319953|454730095|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
126392728|NCT03319953|454730096|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
126392729|NCT01795495|454730097|FG000|Overall Study|Protocol Violation|1|||
126392730|NCT01795495|454730098|FG001|Overall Study|Protocol Violation|0|||
126392731|NCT01795495|454730099|FG002|Overall Study|Protocol Violation|1|||
126392732|NCT01795495|454730097|FG000|Overall Study|Physician Decision|0|||
126392733|NCT01795495|454730098|FG001|Overall Study|Physician Decision|0|||
126392734|NCT01795495|454730099|FG002|Overall Study|Physician Decision|1|||
126392735|NCT03315793|454730100|FG000|Overall Study|Adverse Event|4|||
126392736|NCT03315793|454730101|FG001|Overall Study|Adverse Event|2|||
126392737|NCT03315793|454730100|FG000|Overall Study|Protocol Deviation|1|||
126392738|NCT03315793|454730101|FG001|Overall Study|Protocol Deviation|0|||
126392739|NCT03315793|454730100|FG000|Overall Study|Difficult for regular visit|0|||
126392740|NCT03315793|454730101|FG001|Overall Study|Difficult for regular visit|1|||
126392741|NCT02640625|454732059|FG000|Overall Study|Adverse Event|1|||
126392742|NCT00511433|454732060|FG000|Overall Study|Adverse Event|5|||
126392743|NCT00511433|454732061|FG001|Overall Study|Adverse Event|0|||
126392744|NCT00511433|454732060|FG000|Overall Study|Other Reason|1|||
126392745|NCT00511433|454732061|FG001|Overall Study|Other Reason|1|||
126392746|NCT01740089|454732062|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
126392747|NCT01740089|454732063|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
126392748|NCT01740089|454732064|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
126392749|NCT01740089|454732062|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
126392750|NCT01740089|454732063|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
126392751|NCT01740089|454732064|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
126468872|NCT01697358|455018874|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
126468873|NCT01697358|455018875|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
126468874|NCT01697358|455018874|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
126468875|NCT01697358|455018875|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
126468876|NCT01697358|455018874|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
126718817|NCT00069095|455920541|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
126718818|NCT00069095|455920542|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
126718819|NCT00069095|455920543|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
126718820|NCT00069095|455920544|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
126718821|NCT00069095|455920545|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
126718822|NCT00069095|455920540|FG000|Post-study Treatment Phase|Participant had complete response|1|||
126718823|NCT00069095|455920541|FG001|Post-study Treatment Phase|Participant had complete response|1|||
126771575|NCT01488071|456117834|FG001|Overall Study|Withdrawal of Consent|12|||
126771576|NCT01488071|456117833|FG000|Overall Study|Lost to Follow-up|1|||
126771577|NCT01488071|456117834|FG001|Overall Study|Lost to Follow-up|0|||
126468877|NCT01697358|455018875|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
126468878|NCT01460368|455018876|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
126468879|NCT01460368|455018877|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
126468880|NCT01460368|455018878|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
126468881|NCT01460368|455018879|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
126468882|NCT01460368|455018880|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
126468883|NCT01460368|455018881|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
126468884|NCT01460368|455018882|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
126468885|NCT01460368|455018876|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
126468886|NCT01460368|455018877|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
126468887|NCT01460368|455018878|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
126392752|NCT01740089|454732062|FG000|After 12 Weeks|Lack of Efficacy|3|||
126392753|NCT01740089|454732063|FG001|After 12 Weeks|Lack of Efficacy|1|||
126392754|NCT01740089|454732064|FG002|After 12 Weeks|Lack of Efficacy|4|||
126392755|NCT01740089|454732062|FG000|After 12 Weeks|Adverse Event|2|||
126392756|NCT01740089|454732063|FG001|After 12 Weeks|Adverse Event|0|||
126392757|NCT01740089|454732064|FG002|After 12 Weeks|Adverse Event|5|||
126554583|NCT01474512|455324042|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
126392758|NCT01740089|454732062|FG000|After 12 Weeks|Protocol Violation|1|||
126392759|NCT01740089|454732063|FG001|After 12 Weeks|Protocol Violation|1|||
126392760|NCT01740089|454732064|FG002|After 12 Weeks|Protocol Violation|1|||
126718824|NCT00069095|455920542|FG002|Post-study Treatment Phase|Participant had complete response|0|||
126718825|NCT00069095|455920543|FG003|Post-study Treatment Phase|Participant had complete response|0|||
126718826|NCT00069095|455920544|FG004|Post-study Treatment Phase|Participant had complete response|0|||
126392761|NCT01740089|454732062|FG000|After 12 Weeks|Withdrawal by Subject|1|||
126392762|NCT01740089|454732063|FG001|After 12 Weeks|Withdrawal by Subject|1|||
126392763|NCT01740089|454732064|FG002|After 12 Weeks|Withdrawal by Subject|1|||
126392764|NCT00790868|454732065|FG000|Overall Study|Withdrawal by Subject|4|||
126392765|NCT00790868|454732066|FG001|Overall Study|Withdrawal by Subject|5|||
126392766|NCT00790868|454732065|FG000|Overall Study|Lost to Follow-up|2|||
126392767|NCT00790868|454732066|FG001|Overall Study|Lost to Follow-up|12|||
126392768|NCT02013206|454732067|FG000|Overall Study|Progressive disease (PD)|14|||
126392769|NCT02013206|454732068|FG001|Overall Study|Progressive disease (PD)|17|||
126392770|NCT02013206|454732067|FG000|Overall Study|Symptomatic deterioration|3|||
126392771|NCT02013206|454732068|FG001|Overall Study|Symptomatic deterioration|1|||
126392772|NCT02013206|454732067|FG000|Overall Study|Adverse Event|1|||
126392773|NCT02013206|454732068|FG001|Overall Study|Adverse Event|0|||
126392774|NCT02013206|454732067|FG000|Overall Study|Patient refusal|2|||
126392775|NCT02013206|454732068|FG001|Overall Study|Patient refusal|0|||
126392776|NCT02013206|454732067|FG000|Overall Study|Patient non-compliance|1|||
126392777|NCT02013206|454732068|FG001|Overall Study|Patient non-compliance|0|||
126392778|NCT02013206|454732067|FG000|Overall Study|Death|1|||
126392779|NCT02013206|454732068|FG001|Overall Study|Death|2|||
126392780|NCT02013206|454732067|FG000|Overall Study|Other reasons off treatment|5|||
126392781|NCT02013206|454732068|FG001|Overall Study|Other reasons off treatment|2|||
126392782|NCT02791191|454732069|FG000|Overall Study|Adverse Event|2|||
126392783|NCT02791191|454732070|FG001|Overall Study|Adverse Event|4|||
126392784|NCT02791191|454732071|FG002|Overall Study|Adverse Event|5|||
126392785|NCT02791191|454732069|FG000|Overall Study|Lack of Efficacy|0|||
126392786|NCT02791191|454732070|FG001|Overall Study|Lack of Efficacy|1|||
126392787|NCT02791191|454732071|FG002|Overall Study|Lack of Efficacy|0|||
126392788|NCT02791191|454732069|FG000|Overall Study|Study Drug Non-Compliance|0|||
126392789|NCT02791191|454732070|FG001|Overall Study|Study Drug Non-Compliance|2|||
126392790|NCT02791191|454732071|FG002|Overall Study|Study Drug Non-Compliance|0|||
126392791|NCT02791191|454732069|FG000|Overall Study|Site Closed by Sponsor|1|||
126392792|NCT02791191|454732070|FG001|Overall Study|Site Closed by Sponsor|1|||
126392793|NCT02791191|454732071|FG002|Overall Study|Site Closed by Sponsor|3|||
126392794|NCT02791191|454732069|FG000|Overall Study|Progressive Disease|1|||
126392795|NCT02791191|454732070|FG001|Overall Study|Progressive Disease|0|||
126392796|NCT02791191|454732071|FG002|Overall Study|Progressive Disease|0|||
126392797|NCT02791191|454732069|FG000|Overall Study|Study Terminated by Sponsor|29|||
126392798|NCT02791191|454732070|FG001|Overall Study|Study Terminated by Sponsor|101|||
126392799|NCT02791191|454732071|FG002|Overall Study|Study Terminated by Sponsor|109|||
126392800|NCT02791191|454732069|FG000|Overall Study|Withdrawal by Subject|3|||
126392801|NCT02791191|454732070|FG001|Overall Study|Withdrawal by Subject|1|||
126392802|NCT02791191|454732071|FG002|Overall Study|Withdrawal by Subject|3|||
126392803|NCT02791191|454732069|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
126392804|NCT02791191|454732070|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
126392805|NCT02791191|454732071|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
126392806|NCT01952665|454732072|FG000|Overall Study|Physician Decision|3|||
126392807|NCT01952665|454732073|FG001|Overall Study|Physician Decision|2|||
126392808|NCT01952665|454732072|FG000|Overall Study|Lost to Follow-up|1|||
126392809|NCT01952665|454732073|FG001|Overall Study|Lost to Follow-up|2|||
126392810|NCT01952665|454732072|FG000|Overall Study|Adverse Event|2|||
126392811|NCT01952665|454732073|FG001|Overall Study|Adverse Event|1|||
126392812|NCT01952665|454732072|FG000|Overall Study|Protocol Violation|0|||
126392813|NCT01952665|454732073|FG001|Overall Study|Protocol Violation|1|||
126392814|NCT01537081|454732074|FG000|Overall Study|Adverse Event|5|||
126392815|NCT01537081|454732075|FG001|Overall Study|Adverse Event|2|||
126392816|NCT01537081|454732076|FG002|Overall Study|Adverse Event|2|||
126392817|NCT01537081|454732074|FG000|Overall Study|Lack of Efficacy|2|||
126392818|NCT01537081|454732075|FG001|Overall Study|Lack of Efficacy|1|||
126392819|NCT01537081|454732076|FG002|Overall Study|Lack of Efficacy|0|||
126392820|NCT01537081|454732074|FG000|Overall Study|Lost to Follow-up|17|||
126392821|NCT01537081|454732075|FG001|Overall Study|Lost to Follow-up|15|||
126392822|NCT01537081|454732076|FG002|Overall Study|Lost to Follow-up|9|||
126718827|NCT00069095|455920545|FG005|Post-study Treatment Phase|Participant had complete response|0|||
126718828|NCT00069095|455920540|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
126392823|NCT01537081|454732074|FG000|Overall Study|Protocol Violation|3|||
126392824|NCT01537081|454732075|FG001|Overall Study|Protocol Violation|2|||
126392825|NCT01537081|454732076|FG002|Overall Study|Protocol Violation|2|||
126392826|NCT01537081|454732074|FG000|Overall Study|Withdrawal by Subject|6|||
126392827|NCT01537081|454732075|FG001|Overall Study|Withdrawal by Subject|11|||
126392828|NCT01537081|454732076|FG002|Overall Study|Withdrawal by Subject|3|||
126392829|NCT01537081|454732074|FG000|Overall Study|Physician Decision|5|||
126392830|NCT01537081|454732075|FG001|Overall Study|Physician Decision|6|||
126392831|NCT01537081|454732076|FG002|Overall Study|Physician Decision|0|||
126771578|NCT01488071|456117833|FG000|Overall Study|Administrative or Other Reason(s)|5|||
126392832|NCT01537081|454732074|FG000|Overall Study|Sponsor decision|0|||
126468888|NCT01460368|455018879|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
126468889|NCT01460368|455018880|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
126468890|NCT01460368|455018881|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
126468891|NCT01460368|455018882|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
126468892|NCT01460368|455018876|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
126468893|NCT01460368|455018877|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
126468894|NCT01460368|455018878|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
126468895|NCT01460368|455018879|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
126468896|NCT01460368|455018880|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
126468897|NCT01460368|455018881|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
126468898|NCT01460368|455018882|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
126468899|NCT01460368|455018876|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
126468900|NCT01460368|455018877|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
126468901|NCT01460368|455018878|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
126468902|NCT01460368|455018879|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
126468903|NCT01460368|455018880|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
126468904|NCT01460368|455018881|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
126468905|NCT01460368|455018882|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
126468906|NCT01460368|455018876|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
126468907|NCT01460368|455018877|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
126468908|NCT01460368|455018878|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
126468909|NCT01460368|455018879|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
126468910|NCT01460368|455018880|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
126468911|NCT01460368|455018881|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
126468912|NCT01460368|455018882|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
126468913|NCT00299182|455018892|FG000|Overall Study|Withdrawal by Subject|0|||
126468914|NCT00299182|455018893|FG001|Overall Study|Withdrawal by Subject|0|||
126468915|NCT00299182|455018894|FG002|Overall Study|Withdrawal by Subject|1|||
126771579|NCT01488071|456117834|FG001|Overall Study|Administrative or Other Reason(s)|4|||
126392833|NCT01537081|454732075|FG001|Overall Study|Sponsor decision|1|||
126392834|NCT01537081|454732076|FG002|Overall Study|Sponsor decision|0|||
126392835|NCT01537081|454732074|FG000|Overall Study|Assigned but never dosed|1|||
126392836|NCT01537081|454732075|FG001|Overall Study|Assigned but never dosed|0|||
126392837|NCT01537081|454732076|FG002|Overall Study|Assigned but never dosed|0|||
126392838|NCT01463111|454732079|FG000|Overall Study|Withdrawal by Subject|2|||
126392839|NCT01463111|454732079|FG000|Overall Study|Lost to Follow-up|5|||
126392840|NCT01463111|454732079|FG000|Overall Study|Physician Decision|2|||
126392841|NCT02596958|454732082|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
126392842|NCT02596958|454732082|FG000|Overall Study|Cancer Progression|441|||
126392843|NCT02596958|454732082|FG000|Overall Study|Death From Cancer|112|||
126392844|NCT02596958|454732082|FG000|Overall Study|Death From Other Cause|33|||
126392845|NCT02596958|454732082|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
126392846|NCT02596958|454732082|FG000|Overall Study|Administrative Reasons/Other|231|||
126392847|NCT02596958|454732082|FG000|Overall Study|Lost to Follow-up|33|||
126392848|NCT02596958|454732082|FG000|Overall Study|Missing|32|||
126392849|NCT02596958|454732082|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
126392850|NCT01559259|454732083|FG000|Overall Study|Withdrawal by Subject|0|||
126392851|NCT01559259|454732084|FG001|Overall Study|Withdrawal by Subject|0|||
126392852|NCT01559259|454732085|FG002|Overall Study|Withdrawal by Subject|0|||
126392853|NCT01559259|454732086|FG003|Overall Study|Withdrawal by Subject|1|||
126392854|NCT01559259|454732087|FG004|Overall Study|Withdrawal by Subject|0|||
126392855|NCT01559259|454732083|FG000|Overall Study|Adverse Event|0|||
126392856|NCT01559259|454732084|FG001|Overall Study|Adverse Event|1|||
126392857|NCT01559259|454732085|FG002|Overall Study|Adverse Event|1|||
126392858|NCT01559259|454732086|FG003|Overall Study|Adverse Event|0|||
126392859|NCT01559259|454732087|FG004|Overall Study|Adverse Event|0|||
126392860|NCT05425732|454732088|FG000|Overall Study|Death|4|||
126392861|NCT05425732|454732089|FG001|Overall Study|Death|2|||
126392862|NCT05425732|454732090|FG002|Overall Study|Death|0|||
126392863|NCT05425732|454732091|FG003|Overall Study|Death|0|||
126392864|NCT05425732|454732088|FG000|Overall Study|Lost to Follow-up|10|||
126392865|NCT05425732|454732089|FG001|Overall Study|Lost to Follow-up|15|||
126392866|NCT05425732|454732090|FG002|Overall Study|Lost to Follow-up|5|||
126392867|NCT05425732|454732091|FG003|Overall Study|Lost to Follow-up|3|||
126468916|NCT00299182|455018895|FG003|Overall Study|Withdrawal by Subject|0|||
126468917|NCT00299182|455018896|FG004|Overall Study|Withdrawal by Subject|1|||
126771580|NCT02587325|456117835|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
126392868|NCT05425732|454732088|FG000|Overall Study|Physician Decision|0|||
126392869|NCT05425732|454732089|FG001|Overall Study|Physician Decision|2|||
126392870|NCT05425732|454732090|FG002|Overall Study|Physician Decision|0|||
126392871|NCT05425732|454732091|FG003|Overall Study|Physician Decision|0|||
126392872|NCT05425732|454732088|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126392873|NCT05425732|454732089|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
126392874|NCT05425732|454732090|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126392875|NCT05425732|454732091|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126392876|NCT05425732|454732088|FG000|Overall Study|Withdrawal by Subject|4|||
126392877|NCT05425732|454732089|FG001|Overall Study|Withdrawal by Subject|8|||
126392878|NCT05425732|454732090|FG002|Overall Study|Withdrawal by Subject|1|||
126392879|NCT05425732|454732091|FG003|Overall Study|Withdrawal by Subject|1|||
126392880|NCT05425732|454732088|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
126392881|NCT05425732|454732089|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
126392882|NCT05425732|454732090|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
126392883|NCT05425732|454732091|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
126392884|NCT00306293|454732093|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
126392885|NCT00306293|454732094|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
126392886|NCT00306293|454732093|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
126392887|NCT00306293|454732094|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
126392888|NCT00306293|454732093|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
126392889|NCT00306293|454732094|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
126392890|NCT00306293|454732093|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
126392891|NCT00306293|454732094|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
126392892|NCT00306293|454732093|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
126392893|NCT00306293|454732094|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
126392894|NCT00306293|454732093|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
126392895|NCT00306293|454732094|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
126392896|NCT00306293|454732093|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
126392897|NCT00306293|454732094|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
126392898|NCT00306293|454732093|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
126392899|NCT00306293|454732094|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
126392900|NCT00185380|454732095|FG000|Overall Study|Adverse Event|41|||
126392901|NCT00185380|454732096|FG001|Overall Study|Adverse Event|43|||
126392902|NCT00185380|454732097|FG002|Overall Study|Adverse Event|48|||
126392903|NCT00185380|454732095|FG000|Overall Study|Lost to Follow-up|0|||
126392904|NCT00185380|454732096|FG001|Overall Study|Lost to Follow-up|4|||
126392905|NCT00185380|454732097|FG002|Overall Study|Lost to Follow-up|3|||
126392906|NCT00185380|454732095|FG000|Overall Study|Pregnancy|1|||
126392907|NCT00185380|454732096|FG001|Overall Study|Pregnancy|4|||
126392908|NCT00185380|454732097|FG002|Overall Study|Pregnancy|0|||
126392909|NCT00185380|454732095|FG000|Overall Study|Protocol Violation|2|||
126392910|NCT00185380|454732096|FG001|Overall Study|Protocol Violation|2|||
126392911|NCT00185380|454732097|FG002|Overall Study|Protocol Violation|1|||
126392912|NCT00185380|454732095|FG000|Overall Study|Withdrawal by Subject|1|||
126392913|NCT00185380|454732096|FG001|Overall Study|Withdrawal by Subject|2|||
126392914|NCT00185380|454732097|FG002|Overall Study|Withdrawal by Subject|0|||
126392915|NCT00185380|454732095|FG000|Overall Study|Failed insertion|1|||
126392916|NCT00185380|454732096|FG001|Overall Study|Failed insertion|1|||
126392917|NCT00185380|454732097|FG002|Overall Study|Failed insertion|2|||
126392918|NCT00185380|454732095|FG000|Overall Study|Planned pregnancy|9|||
126392919|NCT00185380|454732096|FG001|Overall Study|Planned pregnancy|12|||
126392920|NCT00185380|454732097|FG002|Overall Study|Planned pregnancy|12|||
126392921|NCT00185380|454732095|FG000|Overall Study|No need for contraception|3|||
126392922|NCT00185380|454732096|FG001|Overall Study|No need for contraception|3|||
126392923|NCT00185380|454732097|FG002|Overall Study|No need for contraception|3|||
126392924|NCT00185380|454732095|FG000|Overall Study|Could not attend visits|2|||
126392925|NCT00185380|454732096|FG001|Overall Study|Could not attend visits|0|||
126392926|NCT00185380|454732097|FG002|Overall Study|Could not attend visits|4|||
126392927|NCT00185380|454732095|FG000|Overall Study|personal reason|6|||
126392928|NCT00185380|454732096|FG001|Overall Study|personal reason|1|||
126392929|NCT00185380|454732097|FG002|Overall Study|personal reason|1|||
126392930|NCT02199314|454732100|FG000|Overall Study|Withdrawal by Subject|6|||
126392931|NCT02199314|454732100|FG000|Overall Study|Physician Decision|10|||
126392932|NCT04187144|454732101|FG000|Overall Study|Lost to Follow-up|12|||
126392933|NCT04187144|454732102|FG001|Overall Study|Lost to Follow-up|11|||
126392934|NCT04187144|454732101|FG000|Overall Study|Withdrawal by Subject|20|||
126392935|NCT04187144|454732102|FG001|Overall Study|Withdrawal by Subject|18|||
126392936|NCT04187144|454732101|FG000|Overall Study|Adverse Event|19|||
126392937|NCT04187144|454732102|FG001|Overall Study|Adverse Event|4|||
126468918|NCT00299182|455018897|FG005|Overall Study|Withdrawal by Subject|2|||
126392938|NCT04187144|454732101|FG000|Overall Study|Physician Decision|5|||
126392939|NCT04187144|454732102|FG001|Overall Study|Physician Decision|3|||
126468919|NCT00299182|455018898|FG006|Overall Study|Withdrawal by Subject|0|||
126392940|NCT04187144|454732101|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
126468920|NCT00299182|455018892|FG000|Overall Study|Chemotherapy Changed|0|||
126718829|NCT00069095|455920541|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
126718830|NCT00069095|455920542|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
126718831|NCT00069095|455920543|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
126718832|NCT00069095|455920544|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
126718833|NCT00069095|455920545|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
126718834|NCT00069095|455920540|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
126392941|NCT04187144|454732102|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
126392942|NCT04187144|454732101|FG000|Overall Study|Protocol Deviation|1|||
126392943|NCT04187144|454732102|FG001|Overall Study|Protocol Deviation|4|||
126392944|NCT02650804|454732103|FG000|Overall Study|Adverse Event|3|||
126392945|NCT02650804|454732104|FG001|Overall Study|Adverse Event|2|||
126392946|NCT02650804|454732103|FG000|Overall Study|Death|1|||
126392947|NCT02650804|454732104|FG001|Overall Study|Death|2|||
126392948|NCT02650804|454732103|FG000|Overall Study|Progressive Disease|7|||
126392949|NCT02650804|454732104|FG001|Overall Study|Progressive Disease|10|||
126392950|NCT02650804|454732103|FG000|Overall Study|Physician Decision|0|||
126392951|NCT02650804|454732104|FG001|Overall Study|Physician Decision|2|||
126392952|NCT02650804|454732103|FG000|Overall Study|Withdrawal by Subject|1|||
126392953|NCT02650804|454732104|FG001|Overall Study|Withdrawal by Subject|4|||
126392954|NCT02650804|454732103|FG000|Overall Study|Symptomatic deterioration|5|||
126392955|NCT02650804|454732104|FG001|Overall Study|Symptomatic deterioration|7|||
126392956|NCT02650804|454732103|FG000|Overall Study|Protocol Violation|0|||
126392957|NCT02650804|454732104|FG001|Overall Study|Protocol Violation|1|||
126392958|NCT02759107|454732105|FG000|Overall Study|Adverse Event|0|||
126392959|NCT02759107|454732106|FG001|Overall Study|Adverse Event|0|||
126392960|NCT02759107|454732107|FG002|Overall Study|Adverse Event|0|||
126392961|NCT02759107|454732108|FG003|Overall Study|Adverse Event|0|||
126392962|NCT02759107|454732109|FG004|Overall Study|Adverse Event|0|||
126392963|NCT02759107|454732110|FG005|Overall Study|Adverse Event|0|||
126392964|NCT02759107|454732111|FG006|Overall Study|Adverse Event|0|||
126392965|NCT02759107|454732112|FG007|Overall Study|Adverse Event|0|||
126392966|NCT02759107|454732113|FG008|Overall Study|Adverse Event|0|||
126392967|NCT02759107|454732114|FG009|Overall Study|Adverse Event|0|||
126392968|NCT02759107|454732115|FG010|Overall Study|Adverse Event|0|||
126392969|NCT02759107|454732116|FG011|Overall Study|Adverse Event|0|||
126392970|NCT02759107|454732117|FG012|Overall Study|Adverse Event|2|||
126392971|NCT02759107|454732118|FG013|Overall Study|Adverse Event|0|||
126392972|NCT02759107|454732119|FG014|Overall Study|Adverse Event|0|||
126392973|NCT02759107|454732120|FG015|Overall Study|Adverse Event|1|||
126392974|NCT02759107|454732121|FG016|Overall Study|Adverse Event|0|||
126392975|NCT02759107|454732122|FG017|Overall Study|Adverse Event|2|||
126392976|NCT02759107|454732105|FG000|Overall Study|Scheduling Conflict|0|||
126392977|NCT02759107|454732106|FG001|Overall Study|Scheduling Conflict|0|||
126392978|NCT02759107|454732107|FG002|Overall Study|Scheduling Conflict|0|||
126392979|NCT02759107|454732108|FG003|Overall Study|Scheduling Conflict|0|||
126392980|NCT02759107|454732109|FG004|Overall Study|Scheduling Conflict|0|||
126392981|NCT02759107|454732110|FG005|Overall Study|Scheduling Conflict|0|||
126392982|NCT02759107|454732111|FG006|Overall Study|Scheduling Conflict|0|||
126392983|NCT02759107|454732112|FG007|Overall Study|Scheduling Conflict|0|||
126392984|NCT02759107|454732113|FG008|Overall Study|Scheduling Conflict|0|||
126392985|NCT02759107|454732114|FG009|Overall Study|Scheduling Conflict|1|||
126392986|NCT02759107|454732115|FG010|Overall Study|Scheduling Conflict|0|||
126392987|NCT02759107|454732116|FG011|Overall Study|Scheduling Conflict|0|||
126392988|NCT02759107|454732117|FG012|Overall Study|Scheduling Conflict|0|||
126392989|NCT02759107|454732118|FG013|Overall Study|Scheduling Conflict|0|||
126392990|NCT02759107|454732119|FG014|Overall Study|Scheduling Conflict|0|||
126392991|NCT02759107|454732120|FG015|Overall Study|Scheduling Conflict|0|||
126392992|NCT02759107|454732121|FG016|Overall Study|Scheduling Conflict|0|||
126392993|NCT02759107|454732122|FG017|Overall Study|Scheduling Conflict|0|||
126392994|NCT02513485|454732126|FG000|Overall Study|Adverse Event|1|||
126392995|NCT02513485|454732127|FG001|Overall Study|Adverse Event|0|||
126392996|NCT02526524|454732128|FG000|Overall Study|Withdrawal by Subject|3|||
126392997|NCT02526524|454732129|FG001|Overall Study|Withdrawal by Subject|3|||
126392998|NCT02526524|454732130|FG002|Overall Study|Withdrawal by Subject|6|||
126392999|NCT02526524|454732131|FG003|Overall Study|Withdrawal by Subject|1|||
126468921|NCT00299182|455018893|FG001|Overall Study|Chemotherapy Changed|0|||
126468922|NCT00299182|455018894|FG002|Overall Study|Chemotherapy Changed|1|||
126468923|NCT00299182|455018895|FG003|Overall Study|Chemotherapy Changed|0|||
126393000|NCT02526524|454732132|FG004|Overall Study|Withdrawal by Subject|9|||
126393001|NCT02526524|454732133|FG005|Overall Study|Withdrawal by Subject|5|||
126393002|NCT02526524|454732128|FG000|Overall Study|Adverse Event|3|||
126393003|NCT02526524|454732129|FG001|Overall Study|Adverse Event|2|||
126393004|NCT02526524|454732130|FG002|Overall Study|Adverse Event|4|||
126393005|NCT02526524|454732131|FG003|Overall Study|Adverse Event|2|||
126393006|NCT02526524|454732132|FG004|Overall Study|Adverse Event|6|||
126393007|NCT02526524|454732133|FG005|Overall Study|Adverse Event|8|||
126393008|NCT02526524|454732128|FG000|Overall Study|Lost to Follow-up|2|||
126393009|NCT02526524|454732129|FG001|Overall Study|Lost to Follow-up|3|||
126393010|NCT02526524|454732130|FG002|Overall Study|Lost to Follow-up|8|||
126393011|NCT02526524|454732131|FG003|Overall Study|Lost to Follow-up|1|||
126393012|NCT02526524|454732132|FG004|Overall Study|Lost to Follow-up|2|||
126393013|NCT02526524|454732133|FG005|Overall Study|Lost to Follow-up|5|||
126393014|NCT02526524|454732128|FG000|Overall Study|Protocol Violation|3|||
126393015|NCT02526524|454732129|FG001|Overall Study|Protocol Violation|1|||
126393016|NCT02526524|454732130|FG002|Overall Study|Protocol Violation|5|||
126393017|NCT02526524|454732131|FG003|Overall Study|Protocol Violation|3|||
126393018|NCT02526524|454732132|FG004|Overall Study|Protocol Violation|4|||
126393019|NCT02526524|454732133|FG005|Overall Study|Protocol Violation|3|||
126393020|NCT02526524|454732128|FG000|Overall Study|Loss of Glucose Control|0|||
126393021|NCT02526524|454732129|FG001|Overall Study|Loss of Glucose Control|0|||
126393022|NCT02526524|454732130|FG002|Overall Study|Loss of Glucose Control|3|||
126393023|NCT02526524|454732131|FG003|Overall Study|Loss of Glucose Control|0|||
126393024|NCT02526524|454732132|FG004|Overall Study|Loss of Glucose Control|2|||
126393025|NCT02526524|454732133|FG005|Overall Study|Loss of Glucose Control|0|||
126393026|NCT02526524|454732128|FG000|Overall Study|Physician Decision|0|||
126393027|NCT02526524|454732129|FG001|Overall Study|Physician Decision|0|||
126393028|NCT02526524|454732130|FG002|Overall Study|Physician Decision|0|||
126393029|NCT02526524|454732131|FG003|Overall Study|Physician Decision|0|||
126393030|NCT02526524|454732132|FG004|Overall Study|Physician Decision|1|||
126393031|NCT02526524|454732133|FG005|Overall Study|Physician Decision|0|||
126393032|NCT02526524|454732128|FG000|Overall Study|Sponsor Decision|1|||
126393033|NCT02526524|454732129|FG001|Overall Study|Sponsor Decision|0|||
126393034|NCT02526524|454732130|FG002|Overall Study|Sponsor Decision|0|||
126393035|NCT02526524|454732131|FG003|Overall Study|Sponsor Decision|0|||
126393036|NCT02526524|454732132|FG004|Overall Study|Sponsor Decision|0|||
126393037|NCT02526524|454732133|FG005|Overall Study|Sponsor Decision|0|||
126393038|NCT05312632|454732138|FG000|Overall Study|Adverse Event|12|||
126393039|NCT05312632|454732138|FG000|Overall Study|Withdrawal by Subject|10|||
126393040|NCT05312632|454732138|FG000|Overall Study|Lack of Efficacy|4|||
126393041|NCT05312632|454732138|FG000|Overall Study|Non-compliance with study procedures|9|||
126393042|NCT05312632|454732138|FG000|Overall Study|Other|4|||
126393043|NCT02019108|454732139|FG000|Overall Study|Lost to Follow-up|5|||
126393044|NCT02019108|454732140|FG001|Overall Study|Lost to Follow-up|7|||
126393045|NCT04569136|454732146|FG000|Overall Study|Lost to Follow-up|2|||
126393046|NCT04569136|454732147|FG001|Overall Study|Lost to Follow-up|0|||
126393047|NCT04569136|454732148|FG002|Overall Study|Lost to Follow-up|1|||
126393048|NCT01466660|454732153|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
126393049|NCT01466660|454732154|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
126393050|NCT01466660|454732153|FG000|Overall Study|Worsening of underlying cancer disease|5|||
126393051|NCT01466660|454732154|FG001|Overall Study|Worsening of underlying cancer disease|2|||
126393052|NCT01466660|454732153|FG000|Overall Study|Other adverse event|19|||
126393053|NCT01466660|454732154|FG001|Overall Study|Other adverse event|18|||
126393054|NCT01466660|454732153|FG000|Overall Study|Protocol Violation|2|||
126393055|NCT01466660|454732154|FG001|Overall Study|Protocol Violation|1|||
126393056|NCT01466660|454732153|FG000|Overall Study|Refused continuation of trial medication|4|||
126393057|NCT01466660|454732154|FG001|Overall Study|Refused continuation of trial medication|3|||
126393058|NCT01466660|454732153|FG000|Overall Study|Other reason not defined above|10|||
126393059|NCT01466660|454732154|FG001|Overall Study|Other reason not defined above|8|||
126393060|NCT00191724|454732155|FG000|Overall Study|Adverse Event|0|||
126393061|NCT00191724|454732156|FG001|Overall Study|Adverse Event|0|||
126393062|NCT00191724|454732157|FG002|Overall Study|Adverse Event|1|||
126393063|NCT00191724|454732158|FG003|Overall Study|Adverse Event|0|||
126393064|NCT00191724|454732159|FG004|Overall Study|Adverse Event|0|||
126393065|NCT00191724|454732155|FG000|Overall Study|Lost to Follow-up|1|||
126393066|NCT00191724|454732156|FG001|Overall Study|Lost to Follow-up|1|||
126393067|NCT00191724|454732157|FG002|Overall Study|Lost to Follow-up|0|||
126393068|NCT00191724|454732158|FG003|Overall Study|Lost to Follow-up|2|||
126393069|NCT00191724|454732159|FG004|Overall Study|Lost to Follow-up|3|||
126393070|NCT00191724|454732155|FG000|Overall Study|Withdrawal by Subject|0|||
126468924|NCT00299182|455018896|FG004|Overall Study|Chemotherapy Changed|1|||
126468925|NCT00299182|455018897|FG005|Overall Study|Chemotherapy Changed|0|||
126468926|NCT00299182|455018898|FG006|Overall Study|Chemotherapy Changed|1|||
126393071|NCT00191724|454732156|FG001|Overall Study|Withdrawal by Subject|0|||
126393072|NCT00191724|454732157|FG002|Overall Study|Withdrawal by Subject|0|||
126393073|NCT00191724|454732158|FG003|Overall Study|Withdrawal by Subject|1|||
126393074|NCT00191724|454732159|FG004|Overall Study|Withdrawal by Subject|0|||
126393075|NCT02301546|454732160|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
126393076|NCT02301546|454732161|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
126393077|NCT02301546|454732160|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
126393078|NCT02301546|454732161|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
126393079|NCT02301546|454732160|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
126393080|NCT02301546|454732161|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
126393081|NCT02301546|454732160|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
126393082|NCT02301546|454732161|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
126393083|NCT02301546|454732160|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
126393084|NCT02301546|454732161|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
126393085|NCT02301546|454732160|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
126393086|NCT02301546|454732161|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
126393087|NCT02301546|454732160|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
126393088|NCT02301546|454732161|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
126393089|NCT02447250|454732164|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
126393090|NCT02447250|454732164|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
126393091|NCT02447250|454732164|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
126393092|NCT01885208|454732167|FG000|Overall Study|Unclassified|32|||
126393093|NCT01885208|454732168|FG001|Overall Study|Unclassified|38|||
126393094|NCT03224507|454732174|FG000|Overall Study|Death|3|||
126393095|NCT03224507|454732175|FG001|Overall Study|Death|0|||
126393096|NCT03224507|454732174|FG000|Overall Study|Lack of Efficacy|6|||
126393097|NCT03224507|454732175|FG001|Overall Study|Lack of Efficacy|0|||
126393098|NCT03224507|454732174|FG000|Overall Study|Withdrawal by Subject|6|||
126393099|NCT03224507|454732175|FG001|Overall Study|Withdrawal by Subject|0|||
126393100|NCT01498575|454732176|FG000|Overall Sample|Withdrawal by Subject|60|||
126393101|NCT01498575|454732177|FG001|Overall Sample|Withdrawal by Subject|14|||
126393102|NCT01498575|454732176|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
126393103|NCT01498575|454732177|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
126393104|NCT01498575|454732176|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
126393105|NCT01498575|454732177|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
126393106|NCT01972308|454732179|FG000|Overall Study|Withdrawal by Subject|0|||
126393107|NCT01972308|454732180|FG001|Overall Study|Withdrawal by Subject|1|||
126393108|NCT01972308|454732179|FG000|Overall Study|Lost to Follow-up|4|||
126393109|NCT01972308|454732180|FG001|Overall Study|Lost to Follow-up|6|||
126393110|NCT01972308|454732179|FG000|Overall Study|Death|4|||
126393111|NCT01972308|454732180|FG001|Overall Study|Death|1|||
126393112|NCT00543803|454732181|FG000|Overall Study|Adverse Event|14|||
126393113|NCT00543803|454732181|FG000|Overall Study|Lack of Efficacy|22|||
126393114|NCT00543803|454732181|FG000|Overall Study|Lost to Follow-up|20|||
126393115|NCT00543803|454732181|FG000|Overall Study|Other|86|||
126393116|NCT05129449|454732195|FG000|Overall Study|Protocol Violation|1|||
126393117|NCT02839720|454732198|FG000|Overall Study|Adverse Event|2|||
126393118|NCT02839720|454732198|FG000|Overall Study|Non-compliance|2|||
126393119|NCT02839720|454732198|FG000|Overall Study|Intercurrent Illness|1|||
126393120|NCT02839720|454732198|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
126393121|NCT00503581|454732199|FG000|Overall Study|Study closed|3|||
126393122|NCT00503581|454732200|FG001|Overall Study|Study closed|4|||
126393123|NCT00503581|454732201|FG002|Overall Study|Study closed|2|||
126393124|NCT06107803|454732207|FG000|Overall Study|Adverse Event|1|||
126393125|NCT06107803|454732207|FG000|Overall Study|Withdrawal by Subject|2|||
126393126|NCT06107803|454732207|FG000|Overall Study|Protocol Violation|1|||
126393127|NCT02378298|454732209|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
126393128|NCT02378298|454732210|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
126393129|NCT02378298|454732211|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
126393130|NCT02378298|454732209|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
126393131|NCT02378298|454732210|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
126393132|NCT02378298|454732211|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
126393133|NCT02378298|454732209|FG000|Surveillance (19-68 Weeks)|Death|1|||
126718835|NCT00069095|455920541|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
126718836|NCT00069095|455920542|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
126393134|NCT02378298|454732210|FG001|Surveillance (19-68 Weeks)|Death|0|||
126393135|NCT02378298|454732211|FG002|Surveillance (19-68 Weeks)|Death|0|||
126393136|NCT04730635|454732212|FG000|Overall Study|Lost to Follow-up|1|||
126393137|NCT04730635|454732213|FG001|Overall Study|Lost to Follow-up|0|||
126393138|NCT04730635|454732212|FG000|Overall Study|Withdrawal by Subject|0|||
126393139|NCT04730635|454732213|FG001|Overall Study|Withdrawal by Subject|1|||
126393140|NCT04934800|454732214|FG000|Overall Study|Other|1|||
126393141|NCT04934800|454732214|FG000|Overall Study|Withdrawal by Subject|5|||
126718837|NCT00069095|455920543|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
126393142|NCT04934800|454732214|FG000|Overall Study|Lack of Efficacy|1|||
126393143|NCT04934800|454732214|FG000|Overall Study|Adverse Event|9|||
126393144|NCT04934800|454732214|FG000|Overall Study|Lost to Follow-up|5|||
126393145|NCT04934800|454732214|FG000|Overall Study|Enrolled but not treated|1|||
126393146|NCT00516906|454732215|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
126393147|NCT00516906|454732216|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
126393148|NCT01974206|454732219|FG000|Overall Study|Did Not Take Study Drug|0|||
126468927|NCT00299182|455018892|FG000|Overall Study|Adverse Event|0|||
126393149|NCT01974206|454732220|FG001|Overall Study|Did Not Take Study Drug|1|||
126393150|NCT01974206|454732219|FG000|Overall Study|Physician Decision|1|||
126393151|NCT01974206|454732220|FG001|Overall Study|Physician Decision|0|||
126393152|NCT01974206|454732219|FG000|Overall Study|Withdrawal by Subject|3|||
126393153|NCT01974206|454732220|FG001|Overall Study|Withdrawal by Subject|0|||
126393154|NCT01974206|454732219|FG000|Overall Study|Lost to Follow-up|1|||
126393155|NCT01974206|454732220|FG001|Overall Study|Lost to Follow-up|0|||
126393156|NCT01974206|454732219|FG000|Overall Study|Death|1|||
126393157|NCT01974206|454732220|FG001|Overall Study|Death|0|||
126393158|NCT03219034|454732228|FG000|Overall Study|Lost to Follow-up|9|||
126393159|NCT03219034|454732229|FG001|Overall Study|Lost to Follow-up|13|||
126393160|NCT03219034|454732228|FG000|Overall Study|Additional dental work needed|1|||
126393161|NCT03219034|454732229|FG001|Overall Study|Additional dental work needed|0|||
126393162|NCT03219034|454732228|FG000|Overall Study|UPPP Surgery|1|||
126393163|NCT03219034|454732229|FG001|Overall Study|UPPP Surgery|0|||
126393164|NCT03219034|454732228|FG000|Overall Study|Dental sensitivity|0|||
126393165|NCT03219034|454732229|FG001|Overall Study|Dental sensitivity|1|||
126393166|NCT03219034|454732228|FG000|Overall Study|Death in family|0|||
126393167|NCT03219034|454732229|FG001|Overall Study|Death in family|1|||
126393168|NCT02438683|454732230|FG000|Overall Study|Adverse Event|1|||
126393169|NCT02438683|454732231|FG001|Overall Study|Adverse Event|0|||
126393170|NCT02438683|454732232|FG002|Overall Study|Adverse Event|0|||
126393171|NCT02438683|454732233|FG003|Overall Study|Adverse Event|0|||
126393172|NCT02438683|454732234|FG004|Overall Study|Adverse Event|0|||
126393173|NCT02438683|454732235|FG005|Overall Study|Adverse Event|0|||
126393174|NCT04669262|454732241|FG000|Overall Study|Withdrawal by Subject|0|||
126393175|NCT04669262|454732242|FG001|Overall Study|Withdrawal by Subject|0|||
126393176|NCT04669262|454732243|FG002|Overall Study|Withdrawal by Subject|0|||
126393177|NCT04669262|454732244|FG003|Overall Study|Withdrawal by Subject|1|||
126393178|NCT04669262|454732241|FG000|Overall Study|Randomized but Not Treated|0|||
126393179|NCT04669262|454732242|FG001|Overall Study|Randomized but Not Treated|1|||
126393180|NCT04669262|454732243|FG002|Overall Study|Randomized but Not Treated|0|||
126393181|NCT04669262|454732244|FG003|Overall Study|Randomized but Not Treated|0|||
126393182|NCT01638013|454732245|FG000|Overall Study|Adverse Event|36|||
126393183|NCT01638013|454732246|FG001|Overall Study|Adverse Event|29|||
126393184|NCT01638013|454732247|FG002|Overall Study|Adverse Event|48|||
126393185|NCT01638013|454732245|FG000|Overall Study|Lack of Efficacy|39|||
126393186|NCT01638013|454732246|FG001|Overall Study|Lack of Efficacy|11|||
126393187|NCT01638013|454732247|FG002|Overall Study|Lack of Efficacy|14|||
126393188|NCT01638013|454732245|FG000|Overall Study|Protocol Violation|10|||
126393189|NCT01638013|454732246|FG001|Overall Study|Protocol Violation|7|||
126393190|NCT01638013|454732247|FG002|Overall Study|Protocol Violation|11|||
126393191|NCT01638013|454732245|FG000|Overall Study|Met discontinuation criteria|4|||
126393192|NCT01638013|454732246|FG001|Overall Study|Met discontinuation criteria|0|||
126393193|NCT01638013|454732247|FG002|Overall Study|Met discontinuation criteria|7|||
126393194|NCT01638013|454732245|FG000|Overall Study|Subject Lost to Follow up|1|||
126393195|NCT01638013|454732246|FG001|Overall Study|Subject Lost to Follow up|0|||
126393196|NCT01638013|454732247|FG002|Overall Study|Subject Lost to Follow up|1|||
126393197|NCT01638013|454732245|FG000|Overall Study|Miscellaneous|25|||
126393198|NCT01638013|454732246|FG001|Overall Study|Miscellaneous|19|||
126393199|NCT01638013|454732247|FG002|Overall Study|Miscellaneous|23|||
126393200|NCT01638013|454732245|FG000|Overall Study|Withdrawal of Consent|16|||
126393201|NCT01638013|454732246|FG001|Overall Study|Withdrawal of Consent|12|||
126393202|NCT01638013|454732247|FG002|Overall Study|Withdrawal of Consent|16|||
126393203|NCT01638013|454732245|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
126393204|NCT01638013|454732246|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
126393205|NCT01638013|454732247|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
126393206|NCT05463744|454732248|FG000|Treatment Period|Withdrawal by Subject|19|||
126393207|NCT05463744|454732249|FG001|Treatment Period|Withdrawal by Subject|16|||
126393208|NCT05463744|454732248|FG000|Treatment Period|Adverse Event|4|||
126393209|NCT05463744|454732249|FG001|Treatment Period|Adverse Event|4|||
126393210|NCT05463744|454732248|FG000|Treatment Period|Pregnancy|0|||
126393211|NCT05463744|454732249|FG001|Treatment Period|Pregnancy|3|||
126393212|NCT05463744|454732248|FG000|Treatment Period|Lost to Follow-up|1|||
126393213|NCT05463744|454732249|FG001|Treatment Period|Lost to Follow-up|3|||
126393214|NCT05463744|454732248|FG000|Treatment Period|Inadvertent enrollment|2|||
126393215|NCT05463744|454732249|FG001|Treatment Period|Inadvertent enrollment|1|||
126393216|NCT05463744|454732248|FG000|Treatment Period|Death|0|||
126393217|NCT05463744|454732249|FG001|Treatment Period|Death|1|||
126393218|NCT05463744|454732248|FG000|Treatment Period|Non-compliance with Study Drug|1|||
126393219|NCT05463744|454732249|FG001|Treatment Period|Non-compliance with Study Drug|0|||
126393220|NCT05463744|454732248|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
126393221|NCT05463744|454732249|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
126393222|NCT05463744|454732248|FG000|Treatment Period|Physician Decision|0|||
126393223|NCT05463744|454732249|FG001|Treatment Period|Physician Decision|1|||
126393224|NCT05463744|454732248|FG000|Follow-Up Period|Withdrawal by Subject|3|||
126393225|NCT05463744|454732249|FG001|Follow-Up Period|Withdrawal by Subject|1|||
126393226|NCT05463744|454732248|FG000|Follow-Up Period|Lost to Follow-up|1|||
126393227|NCT05463744|454732249|FG001|Follow-Up Period|Lost to Follow-up|1|||
126554584|NCT01474512|455324043|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
126554585|NCT01474512|455324044|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
126554586|NCT01474512|455324045|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
126554587|NCT01474512|455324028|FG000|Long-Term Extension Period|Adverse Event|0|||
126554588|NCT01474512|455324029|FG001|Long-Term Extension Period|Adverse Event|0|||
126554589|NCT01474512|455324030|FG002|Long-Term Extension Period|Adverse Event|0|||
126554590|NCT01474512|455324031|FG003|Long-Term Extension Period|Adverse Event|0|||
126554591|NCT01474512|455324032|FG004|Long-Term Extension Period|Adverse Event|0|||
126554592|NCT01474512|455324033|FG005|Long-Term Extension Period|Adverse Event|0|||
126554593|NCT01474512|455324034|FG006|Long-Term Extension Period|Adverse Event|0|||
126554594|NCT01474512|455324035|FG007|Long-Term Extension Period|Adverse Event|0|||
126554595|NCT01474512|455324036|FG008|Long-Term Extension Period|Adverse Event|0|||
126554596|NCT01474512|455324037|FG009|Long-Term Extension Period|Adverse Event|0|||
126554597|NCT01474512|455324038|FG010|Long-Term Extension Period|Adverse Event|0|||
126554598|NCT01474512|455324039|FG011|Long-Term Extension Period|Adverse Event|1|||
126554599|NCT01474512|455324040|FG012|Long-Term Extension Period|Adverse Event|57|||
126554600|NCT01474512|455324041|FG013|Long-Term Extension Period|Adverse Event|58|||
126554601|NCT01474512|455324042|FG014|Long-Term Extension Period|Adverse Event|0|||
126554602|NCT01474512|455324043|FG015|Long-Term Extension Period|Adverse Event|0|||
126554603|NCT01474512|455324044|FG016|Long-Term Extension Period|Adverse Event|0|||
126554604|NCT01474512|455324045|FG017|Long-Term Extension Period|Adverse Event|0|||
126554605|NCT01474512|455324028|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
126554606|NCT01474512|455324029|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
126554607|NCT01474512|455324030|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
126554608|NCT01474512|455324031|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
126554609|NCT01474512|455324032|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
126554610|NCT01474512|455324033|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
126554611|NCT01474512|455324034|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
126393228|NCT01579565|454734029|FG000|Randomized|Adverse Event|1|||
126393229|NCT01579565|454734030|FG001|Randomized|Adverse Event|3|||
126393230|NCT01579565|454734029|FG000|Randomized|Withdrawal by Subject|3|||
126393231|NCT01579565|454734030|FG001|Randomized|Withdrawal by Subject|0|||
126393232|NCT01579565|454734029|FG000|Randomized|inadequate preoperative pupil dilation|0|||
126393233|NCT01579565|454734030|FG001|Randomized|inadequate preoperative pupil dilation|1|||
126393234|NCT01579565|454734029|FG000|Randomized|prohibited preoperative eating|1|||
126393235|NCT01579565|454734030|FG001|Randomized|prohibited preoperative eating|0|||
126393236|NCT01579565|454734029|FG000|Randomized|prohibited preoperative medication|0|||
126393237|NCT01579565|454734030|FG001|Randomized|prohibited preoperative medication|1|||
126393238|NCT01579565|454734029|FG000|Treated|Physician Decision|0|||
126393239|NCT01579565|454734030|FG001|Treated|Physician Decision|1|||
126393240|NCT01579565|454734029|FG000|Treated|Lost to Follow-up|2|||
126393241|NCT01579565|454734030|FG001|Treated|Lost to Follow-up|1|||
126393242|NCT01579565|454734029|FG000|Treated|declined to return for final visit|0|||
126393243|NCT01579565|454734030|FG001|Treated|declined to return for final visit|1|||
126393244|NCT02867813|454734031|FG000|Overall Study|Withdrawal by Subject|57|||
126393245|NCT02867813|454734032|FG001|Overall Study|Withdrawal by Subject|56|||
126393246|NCT02867813|454734031|FG000|Overall Study|Decision by Sponsor|7|||
126393247|NCT02867813|454734032|FG001|Overall Study|Decision by Sponsor|7|||
126393248|NCT02867813|454734031|FG000|Overall Study|Lost to Follow-up|91|||
126393249|NCT02867813|454734032|FG001|Overall Study|Lost to Follow-up|78|||
126393250|NCT02867813|454734031|FG000|Overall Study|Missing|2|||
126393251|NCT02867813|454734032|FG001|Overall Study|Missing|1|||
126393252|NCT02867813|454734031|FG000|Overall Study|Death|294|||
126393253|NCT02867813|454734032|FG001|Overall Study|Death|268|||
126393254|NCT01448824|454734033|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393255|NCT01448824|454734034|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393256|NCT01448824|454734035|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393257|NCT01448824|454734036|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393258|NCT01448824|454734037|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393259|NCT01448824|454734038|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393260|NCT01448824|454734039|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
126554612|NCT01474512|455324035|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
126554613|NCT01474512|455324036|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
126718838|NCT00069095|455920544|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
126718839|NCT00069095|455920545|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
126393261|NCT01448824|454734040|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
126393262|NCT01448824|454734033|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
126393263|NCT01448824|454734034|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
126554614|NCT01474512|455324037|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
126718840|NCT00069095|455920540|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
126393264|NCT01448824|454734035|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
126393265|NCT01448824|454734036|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
126468928|NCT00299182|455018893|FG001|Overall Study|Adverse Event|0|||
126468929|NCT00299182|455018894|FG002|Overall Study|Adverse Event|0|||
126468930|NCT00299182|455018895|FG003|Overall Study|Adverse Event|0|||
126468931|NCT00299182|455018896|FG004|Overall Study|Adverse Event|0|||
126468932|NCT00299182|455018897|FG005|Overall Study|Adverse Event|1|||
126468933|NCT00299182|455018898|FG006|Overall Study|Adverse Event|0|||
126468934|NCT00299182|455018892|FG000|Overall Study|Not Eligible|0|||
126468935|NCT00299182|455018893|FG001|Overall Study|Not Eligible|0|||
126468936|NCT00299182|455018894|FG002|Overall Study|Not Eligible|0|||
126468937|NCT00299182|455018895|FG003|Overall Study|Not Eligible|0|||
126468938|NCT00299182|455018896|FG004|Overall Study|Not Eligible|1|||
126468939|NCT00299182|455018897|FG005|Overall Study|Not Eligible|0|||
126468940|NCT00299182|455018898|FG006|Overall Study|Not Eligible|0|||
126393266|NCT01448824|454734037|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
126393267|NCT01448824|454734038|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
126393268|NCT01448824|454734039|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
126393269|NCT01448824|454734040|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
126393270|NCT01448824|454734033|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393271|NCT01448824|454734034|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393272|NCT01448824|454734035|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393273|NCT01448824|454734036|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393274|NCT01448824|454734037|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393275|NCT01448824|454734038|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
126393276|NCT01448824|454734039|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393277|NCT01448824|454734040|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
126393278|NCT01448824|454734033|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
126393279|NCT01448824|454734034|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
126393280|NCT01448824|454734035|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
126393281|NCT01448824|454734036|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
126393282|NCT01448824|454734037|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
126393283|NCT01448824|454734038|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
126393284|NCT01448824|454734039|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
126393285|NCT01448824|454734040|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
126393286|NCT01448824|454734033|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393287|NCT01448824|454734034|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393288|NCT01448824|454734035|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393289|NCT01448824|454734036|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393290|NCT01448824|454734037|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393291|NCT01448824|454734038|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393292|NCT01448824|454734039|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
126393293|NCT01448824|454734040|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
126393294|NCT01448824|454734033|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393295|NCT01448824|454734034|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393296|NCT01448824|454734035|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393297|NCT01448824|454734036|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393298|NCT01448824|454734037|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393299|NCT01448824|454734038|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393300|NCT01448824|454734039|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
126393301|NCT01448824|454734040|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
126393302|NCT01448824|454734033|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393303|NCT01448824|454734034|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393304|NCT01448824|454734035|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393305|NCT01448824|454734036|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126468941|NCT02770170|455018903|FG000|Overall Study|Withdrawal by Subject|0|||
126468942|NCT02770170|455018904|FG001|Overall Study|Withdrawal by Subject|0|||
126468943|NCT02770170|455018905|FG002|Overall Study|Withdrawal by Subject|0|||
126468944|NCT02770170|455018906|FG003|Overall Study|Withdrawal by Subject|2|||
126468945|NCT02770170|455018903|FG000|Overall Study|due to pregnancy|1|||
126468946|NCT02770170|455018904|FG001|Overall Study|due to pregnancy|0|||
126393306|NCT01448824|454734037|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393307|NCT01448824|454734038|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393308|NCT01448824|454734039|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
126393309|NCT01448824|454734040|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
126393310|NCT01448824|454734033|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126468947|NCT02770170|455018905|FG002|Overall Study|due to pregnancy|0|||
126468948|NCT02770170|455018906|FG003|Overall Study|due to pregnancy|0|||
126468949|NCT02770170|455018903|FG000|Overall Study|Lack of Efficacy|2|||
126468950|NCT02770170|455018904|FG001|Overall Study|Lack of Efficacy|0|||
126468951|NCT02770170|455018905|FG002|Overall Study|Lack of Efficacy|0|||
126468952|NCT02770170|455018906|FG003|Overall Study|Lack of Efficacy|1|||
126393311|NCT01448824|454734034|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393312|NCT01448824|454734035|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393313|NCT01448824|454734036|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393314|NCT01448824|454734037|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393315|NCT01448824|454734038|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393316|NCT01448824|454734039|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
126393317|NCT01448824|454734040|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
126393318|NCT01995669|454734052|FG000|Overall Study|Progression|2|||
126393319|NCT01995669|454734053|FG001|Overall Study|Progression|1|||
126393320|NCT01995669|454734054|FG002|Overall Study|Progression|1|||
126393321|NCT01995669|454734055|FG003|Overall Study|Progression|13|||
126393322|NCT01995669|454734052|FG000|Overall Study|Adverse Event|0|||
126393323|NCT01995669|454734053|FG001|Overall Study|Adverse Event|0|||
126393324|NCT01995669|454734054|FG002|Overall Study|Adverse Event|0|||
126393325|NCT01995669|454734055|FG003|Overall Study|Adverse Event|3|||
126393326|NCT01995669|454734052|FG000|Overall Study|Death|0|||
126393327|NCT01995669|454734053|FG001|Overall Study|Death|0|||
126393328|NCT01995669|454734054|FG002|Overall Study|Death|0|||
126393329|NCT01995669|454734055|FG003|Overall Study|Death|6|||
126393330|NCT01995669|454734052|FG000|Overall Study|Withdrawal by Subject|0|||
126718841|NCT00069095|455920541|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
126718842|NCT00069095|455920542|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
126718843|NCT00069095|455920543|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
126393331|NCT01995669|454734053|FG001|Overall Study|Withdrawal by Subject|0|||
126393332|NCT01995669|454734054|FG002|Overall Study|Withdrawal by Subject|0|||
126393333|NCT01995669|454734055|FG003|Overall Study|Withdrawal by Subject|6|||
126393334|NCT01995669|454734052|FG000|Overall Study|Insurance Expired|0|||
126393335|NCT01995669|454734053|FG001|Overall Study|Insurance Expired|0|||
126393336|NCT01995669|454734054|FG002|Overall Study|Insurance Expired|0|||
126393337|NCT01995669|454734055|FG003|Overall Study|Insurance Expired|1|||
126393338|NCT02998203|454734056|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
126393339|NCT02998203|454734057|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
126393340|NCT02998203|454734056|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
126393341|NCT02998203|454734057|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
126393342|NCT04085458|454734058|FG000|Overall Study|Other|1|||
126393343|NCT04085458|454734058|FG000|Overall Study|Withdrawal by Subject|2|||
126393344|NCT04085458|454734058|FG000|Overall Study|Adverse Event|2|||
126393345|NCT03632993|454734059|FG000|Overall Study|Withdrawal by Subject|1|||
126468953|NCT02770170|455018903|FG000|Overall Study|Adverse Event|4|||
126468954|NCT02770170|455018904|FG001|Overall Study|Adverse Event|3|||
126468955|NCT02770170|455018905|FG002|Overall Study|Adverse Event|5|||
126468956|NCT02770170|455018906|FG003|Overall Study|Adverse Event|3|||
126468957|NCT02770170|455018903|FG000|Overall Study|due to disease worsening|0|||
126468958|NCT02770170|455018904|FG001|Overall Study|due to disease worsening|0|||
126468959|NCT02770170|455018905|FG002|Overall Study|due to disease worsening|0|||
126468960|NCT02770170|455018906|FG003|Overall Study|due to disease worsening|1|||
126468961|NCT00445978|455018907|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
126468962|NCT00445978|455018907|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
126468963|NCT00445978|455018907|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
126468964|NCT00445978|455018907|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
126468965|NCT00445978|455018907|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
126468966|NCT00445978|455018907|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
126468967|NCT00445978|455018907|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
126468968|NCT00445978|455018907|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
126468969|NCT00445978|455018907|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
126468970|NCT01822496|455018910|FG000|Overall Study|Protocol Violation|2|||
126468971|NCT01822496|455018911|FG001|Overall Study|Protocol Violation|2|||
126468972|NCT01822496|455018912|FG002|Overall Study|Protocol Violation|0|||
126468973|NCT01822496|455018913|FG003|Overall Study|Protocol Violation|1|||
126468974|NCT01822496|455018910|FG000|Overall Study|Withdrawal by Subject|0|||
126468975|NCT01822496|455018911|FG001|Overall Study|Withdrawal by Subject|0|||
126468976|NCT01822496|455018912|FG002|Overall Study|Withdrawal by Subject|0|||
126468977|NCT01822496|455018913|FG003|Overall Study|Withdrawal by Subject|3|||
126468978|NCT00304239|455018914|FG000|Overall Study|Protocol Deviations/Violations|15|||
126468979|NCT00304239|455018915|FG001|Overall Study|Protocol Deviations/Violations|0|||
126468980|NCT00304239|455018914|FG000|Overall Study|Adverse Event|2|||
126468981|NCT00304239|455018915|FG001|Overall Study|Adverse Event|0|||
126468982|NCT02979197|455018916|FG000|Overall Study|Adverse Event|4|||
126393346|NCT03632993|454734060|FG001|Overall Study|Withdrawal by Subject|0|||
126393347|NCT03632993|454734061|FG002|Overall Study|Withdrawal by Subject|0|||
126393348|NCT03632993|454734062|FG003|Overall Study|Withdrawal by Subject|0|||
126468983|NCT02979197|455018917|FG001|Overall Study|Adverse Event|2|||
126468984|NCT02979197|455018918|FG002|Overall Study|Adverse Event|0|||
126468985|NCT02979197|455018916|FG000|Overall Study|Protocol Violation|0|||
126468986|NCT02979197|455018917|FG001|Overall Study|Protocol Violation|1|||
126393349|NCT03632993|454734063|FG004|Overall Study|Withdrawal by Subject|0|||
126393350|NCT03632993|454734064|FG005|Overall Study|Withdrawal by Subject|0|||
126393351|NCT03632993|454734065|FG006|Overall Study|Withdrawal by Subject|0|||
126393352|NCT03632993|454734066|FG007|Overall Study|Withdrawal by Subject|0|||
126393353|NCT03632993|454734067|FG008|Overall Study|Withdrawal by Subject|0|||
126393354|NCT03632993|454734068|FG009|Overall Study|Withdrawal by Subject|1|||
126393355|NCT03632993|454734059|FG000|Overall Study|Protocol Non-compliance|0|||
126393356|NCT03632993|454734060|FG001|Overall Study|Protocol Non-compliance|1|||
126393357|NCT03632993|454734061|FG002|Overall Study|Protocol Non-compliance|0|||
126393358|NCT03632993|454734062|FG003|Overall Study|Protocol Non-compliance|0|||
126393359|NCT03632993|454734063|FG004|Overall Study|Protocol Non-compliance|0|||
126393360|NCT03632993|454734064|FG005|Overall Study|Protocol Non-compliance|0|||
126393361|NCT03632993|454734065|FG006|Overall Study|Protocol Non-compliance|0|||
126393362|NCT03632993|454734066|FG007|Overall Study|Protocol Non-compliance|0|||
126393363|NCT03632993|454734067|FG008|Overall Study|Protocol Non-compliance|0|||
126393364|NCT03632993|454734068|FG009|Overall Study|Protocol Non-compliance|0|||
126393365|NCT03632993|454734059|FG000|Overall Study|Lost to Follow-up|0|||
126393366|NCT03632993|454734060|FG001|Overall Study|Lost to Follow-up|0|||
126468987|NCT02979197|455018918|FG002|Overall Study|Protocol Violation|0|||
126468988|NCT02979197|455018916|FG000|Overall Study|Subject unable to commit to study dates|0|||
126468989|NCT02979197|455018917|FG001|Overall Study|Subject unable to commit to study dates|1|||
126468990|NCT02979197|455018918|FG002|Overall Study|Subject unable to commit to study dates|0|||
126468991|NCT01898208|455018921|FG000|Overall Study|Positive blood culture|17|||
126468992|NCT01898208|455018922|FG001|Overall Study|Positive blood culture|23|||
126468993|NCT01898208|455018923|FG002|Overall Study|Positive blood culture|15|||
126468994|NCT01898208|455018921|FG000|Overall Study|Death/comfort care within 24 hours|10|||
126468995|NCT01898208|455018922|FG001|Overall Study|Death/comfort care within 24 hours|9|||
126468996|NCT01898208|455018923|FG002|Overall Study|Death/comfort care within 24 hours|8|||
126468997|NCT01898208|455018921|FG000|Overall Study|Negative Gram Stain|6|||
126468998|NCT01898208|455018922|FG001|Overall Study|Negative Gram Stain|9|||
126468999|NCT01898208|455018923|FG002|Overall Study|Negative Gram Stain|6|||
126469000|NCT01898208|455018921|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
126469001|NCT01898208|455018922|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
126469002|NCT01898208|455018923|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
126469003|NCT01898208|455018921|FG000|Overall Study|System/Technical Error|1|||
126469004|NCT01898208|455018922|FG001|Overall Study|System/Technical Error|2|||
126469005|NCT01898208|455018923|FG002|Overall Study|System/Technical Error|3|||
126469006|NCT01898208|455018921|FG000|Overall Study|Lost to Follow-up|3|||
126469007|NCT01898208|455018922|FG001|Overall Study|Lost to Follow-up|1|||
126469008|NCT01898208|455018923|FG002|Overall Study|Lost to Follow-up|1|||
126469009|NCT01631812|455018924|FG000|Overall Study|Adverse Event|25|||
126469010|NCT01631812|455018924|FG000|Overall Study|Lack of Efficacy|5|||
126469011|NCT01631812|455018924|FG000|Overall Study|Withdrawal by Subject|4|||
126469012|NCT01631812|455018924|FG000|Overall Study|Physician Decision|3|||
126469013|NCT02436681|455018927|FG000|Overall Study|Lost to Follow-up|10|||
126469014|NCT02436681|455018927|FG000|Overall Study|Withdrawal by Subject|2|||
126469015|NCT02436681|455018927|FG000|Overall Study|Death|2|||
126469016|NCT02030938|455018930|FG000|Overall Study|Lost to Follow-up|4|||
126469017|NCT02030938|455018930|FG000|Overall Study|Withdrawal by Subject|1|||
126469018|NCT03954132|455018932|FG000|Overall Study|Adverse Event|2|||
126469019|NCT03954132|455018933|FG001|Overall Study|Adverse Event|0|||
126469020|NCT03954132|455018932|FG000|Overall Study|Patient's wish|5|||
126469021|NCT03954132|455018933|FG001|Overall Study|Patient's wish|0|||
126469022|NCT03954132|455018932|FG000|Overall Study|Lost to Follow-up|10|||
126469023|NCT03954132|455018933|FG001|Overall Study|Lost to Follow-up|0|||
126469024|NCT03954132|455018932|FG000|Overall Study|Screening failure|0|||
126469025|NCT03954132|455018933|FG001|Overall Study|Screening failure|1|||
126718844|NCT00069095|455920544|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
126393367|NCT03632993|454734061|FG002|Overall Study|Lost to Follow-up|0|||
126393368|NCT03632993|454734062|FG003|Overall Study|Lost to Follow-up|0|||
126393369|NCT03632993|454734063|FG004|Overall Study|Lost to Follow-up|0|||
126393370|NCT03632993|454734064|FG005|Overall Study|Lost to Follow-up|1|||
126393371|NCT03632993|454734065|FG006|Overall Study|Lost to Follow-up|0|||
126469026|NCT03954132|455018932|FG000|Overall Study|No registration after Visit 1|5|||
126469027|NCT03954132|455018933|FG001|Overall Study|No registration after Visit 1|2|||
126469028|NCT03954132|455018932|FG000|Overall Study|Other reason than listed|2|||
126469029|NCT03954132|455018933|FG001|Overall Study|Other reason than listed|2|||
126469030|NCT03954132|455018932|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
126469031|NCT03954132|455018933|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
126469032|NCT03954132|455018932|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
126393372|NCT03632993|454734066|FG007|Overall Study|Lost to Follow-up|1|||
126469033|NCT03954132|455018933|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
126469034|NCT00072176|455018934|FG000|Overall Study|Withdrawal by Subject|1|||
126469035|NCT00072176|455018935|FG001|Overall Study|Withdrawal by Subject|0|||
126554615|NCT01474512|455324038|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
126393373|NCT03632993|454734067|FG008|Overall Study|Lost to Follow-up|0|||
126393374|NCT03632993|454734068|FG009|Overall Study|Lost to Follow-up|0|||
126393375|NCT03632993|454734059|FG000|Overall Study|Adverse Event|0|||
126393376|NCT03632993|454734060|FG001|Overall Study|Adverse Event|0|||
126393377|NCT03632993|454734061|FG002|Overall Study|Adverse Event|0|||
126393378|NCT03632993|454734062|FG003|Overall Study|Adverse Event|0|||
126393379|NCT03632993|454734063|FG004|Overall Study|Adverse Event|0|||
126393380|NCT03632993|454734064|FG005|Overall Study|Adverse Event|1|||
126393381|NCT03632993|454734065|FG006|Overall Study|Adverse Event|0|||
126393382|NCT03632993|454734066|FG007|Overall Study|Adverse Event|1|||
126393383|NCT03632993|454734067|FG008|Overall Study|Adverse Event|0|||
126393384|NCT03632993|454734068|FG009|Overall Study|Adverse Event|0|||
126393385|NCT02743949|454734069|FG000|Overall Study|Adverse Event|0|||
126393386|NCT02743949|454734070|FG001|Overall Study|Adverse Event|0|||
126393387|NCT02743949|454734071|FG002|Overall Study|Adverse Event|2|||
126393388|NCT02743949|454734069|FG000|Overall Study|Significant Protocol Deviation|2|||
126393389|NCT02743949|454734070|FG001|Overall Study|Significant Protocol Deviation|0|||
126393390|NCT02743949|454734071|FG002|Overall Study|Significant Protocol Deviation|1|||
126393391|NCT02743949|454734069|FG000|Overall Study|Voluntary Withdrawal|2|||
126393392|NCT02743949|454734070|FG001|Overall Study|Voluntary Withdrawal|1|||
126393393|NCT02743949|454734071|FG002|Overall Study|Voluntary Withdrawal|0|||
126393394|NCT03389555|454734072|FG000|Overall Study|Protocol Violation|1|||
126393395|NCT03389555|454734073|FG001|Overall Study|Protocol Violation|3|||
126393396|NCT03389555|454734072|FG000|Overall Study|Death|1|||
126393397|NCT03389555|454734073|FG001|Overall Study|Death|0|||
126393398|NCT00920218|454734074|FG000|Overall Study|Serious Adverse Event|2|||
126393399|NCT00920218|454734075|FG001|Overall Study|Serious Adverse Event|0|||
126393400|NCT00920218|454734076|FG002|Overall Study|Serious Adverse Event|2|||
126393401|NCT00920218|454734077|FG003|Overall Study|Serious Adverse Event|1|||
126393402|NCT00920218|454734074|FG000|Overall Study|Withdrawal by Subject|0|||
126393403|NCT00920218|454734075|FG001|Overall Study|Withdrawal by Subject|3|||
126393404|NCT00920218|454734076|FG002|Overall Study|Withdrawal by Subject|2|||
126393405|NCT00920218|454734077|FG003|Overall Study|Withdrawal by Subject|0|||
126393406|NCT00920218|454734074|FG000|Overall Study|Migrated/moved from study area|0|||
126393407|NCT00920218|454734075|FG001|Overall Study|Migrated/moved from study area|0|||
126393408|NCT00920218|454734076|FG002|Overall Study|Migrated/moved from study area|1|||
126393409|NCT00920218|454734077|FG003|Overall Study|Migrated/moved from study area|0|||
126393410|NCT00920218|454734074|FG000|Overall Study|Lost to Follow-up|0|||
126393411|NCT00920218|454734075|FG001|Overall Study|Lost to Follow-up|1|||
126393412|NCT00920218|454734076|FG002|Overall Study|Lost to Follow-up|0|||
126393413|NCT00920218|454734077|FG003|Overall Study|Lost to Follow-up|3|||
126393414|NCT00920218|454734074|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
126393415|NCT00920218|454734075|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
126393416|NCT00920218|454734076|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
126393417|NCT00920218|454734077|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
126393418|NCT00920218|454734074|FG000|Overall Study|Other|0|||
126393419|NCT00920218|454734075|FG001|Overall Study|Other|0|||
126393420|NCT00920218|454734076|FG002|Overall Study|Other|1|||
126469036|NCT00072176|455018934|FG000|Overall Study|Protocol Violation|0|||
126469037|NCT00072176|455018935|FG001|Overall Study|Protocol Violation|1|||
126469038|NCT00932737|455018946|FG000|Overall Study|Not treated in second episode|1|||
126469039|NCT00932737|455018947|FG001|Overall Study|Not treated in second episode|0|||
126469040|NCT00932737|455018946|FG000|Overall Study|Adverse Event|0|||
126469041|NCT00932737|455018947|FG001|Overall Study|Adverse Event|1|||
126469042|NCT02719327|455018951|FG000|Overall Study|Withdrawal by Subject|11|||
126469043|NCT02719327|455018952|FG001|Overall Study|Withdrawal by Subject|8|||
126469044|NCT03350620|455018953|FG000|Stage 2|Adverse Event|0|||
126469045|NCT03350620|455018954|FG001|Stage 2|Adverse Event|1|||
126469046|NCT03350620|455018955|FG002|Stage 2|Adverse Event|1|||
126718845|NCT00069095|455920545|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
126393421|NCT00920218|454734077|FG003|Overall Study|Other|0|||
126393422|NCT01007435|454734078|FG000|Overall Study|Adverse Event|16|||
126393423|NCT01007435|454734079|FG001|Overall Study|Adverse Event|25|||
126393424|NCT01007435|454734080|FG002|Overall Study|Adverse Event|47|||
126393425|NCT01007435|454734081|FG003|Overall Study|Adverse Event|31|||
126393426|NCT01007435|454734078|FG000|Overall Study|Death|2|||
126393427|NCT01007435|454734079|FG001|Overall Study|Death|4|||
126469047|NCT03350620|455018953|FG000|Stage 2|Lack of Efficacy|0|||
126393428|NCT01007435|454734080|FG002|Overall Study|Death|2|||
126393429|NCT01007435|454734081|FG003|Overall Study|Death|1|||
126393430|NCT01007435|454734078|FG000|Overall Study|Insufficient Therapeutic Response|21|||
126393431|NCT01007435|454734079|FG001|Overall Study|Insufficient Therapeutic Response|7|||
126393432|NCT01007435|454734080|FG002|Overall Study|Insufficient Therapeutic Response|2|||
126393433|NCT01007435|454734081|FG003|Overall Study|Insufficient Therapeutic Response|9|||
126393434|NCT01007435|454734078|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
126393435|NCT01007435|454734079|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
126469048|NCT03350620|455018954|FG001|Stage 2|Lack of Efficacy|2|||
126393436|NCT01007435|454734080|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
126393437|NCT01007435|454734081|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
126393438|NCT01007435|454734078|FG000|Overall Study|Other Protocol Violation|2|||
126393439|NCT01007435|454734079|FG001|Overall Study|Other Protocol Violation|0|||
126393440|NCT01007435|454734080|FG002|Overall Study|Other Protocol Violation|1|||
126393441|NCT01007435|454734081|FG003|Overall Study|Other Protocol Violation|0|||
126393442|NCT01007435|454734078|FG000|Overall Study|Refused Treatment|13|||
126393443|NCT01007435|454734079|FG001|Overall Study|Refused Treatment|13|||
126393444|NCT01007435|454734080|FG002|Overall Study|Refused Treatment|5|||
126393445|NCT01007435|454734081|FG003|Overall Study|Refused Treatment|8|||
126393446|NCT01007435|454734078|FG000|Overall Study|Failure to Return|5|||
126393447|NCT01007435|454734079|FG001|Overall Study|Failure to Return|4|||
126393448|NCT01007435|454734080|FG002|Overall Study|Failure to Return|3|||
126393449|NCT01007435|454734081|FG003|Overall Study|Failure to Return|6|||
126393450|NCT01007435|454734078|FG000|Overall Study|Reason not Specified|1|||
126393451|NCT01007435|454734079|FG001|Overall Study|Reason not Specified|1|||
126393452|NCT01007435|454734080|FG002|Overall Study|Reason not Specified|2|||
126393453|NCT01007435|454734081|FG003|Overall Study|Reason not Specified|1|||
126393454|NCT01345591|454734084|FG000|Overall Study|Lost to Follow-up|1|||
126393455|NCT00847665|454734091|FG000|Overall Study|Withdrawal by Subject|1|||
126393456|NCT00847665|454734092|FG001|Overall Study|Withdrawal by Subject|0|||
126393457|NCT00624585|454734093|FG000|Overall Study|Death|3|||
126393458|NCT00624585|454734093|FG000|Overall Study|Disease Progression|6|||
126393459|NCT00624585|454734093|FG000|Overall Study|Adverse Event|3|||
126393460|NCT00676520|454734095|FG000|Overall Study|Withdrawal by Subject|163|||
126393461|NCT00676520|454734095|FG000|Overall Study|Lost to Follow-up|162|||
126393462|NCT00676520|454734095|FG000|Overall Study|Death|159|||
126393463|NCT00676520|454734095|FG000|Overall Study|Physician Decision|20|||
126393464|NCT00676520|454734095|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
126393465|NCT00676520|454734095|FG000|Overall Study|Other Reason|18|||
126393466|NCT01425359|454734096|FG000|Overall Study|Randomized but Not Treated|2|||
126393467|NCT01425359|454734097|FG001|Overall Study|Randomized but Not Treated|3|||
126393468|NCT01425359|454734096|FG000|Overall Study|Adverse Event|9|||
126393469|NCT01425359|454734097|FG001|Overall Study|Adverse Event|8|||
126393470|NCT01425359|454734096|FG000|Overall Study|Revascularization|0|||
126393471|NCT01425359|454734097|FG001|Overall Study|Revascularization|1|||
126393472|NCT01425359|454734096|FG000|Overall Study|Death|0|||
126393473|NCT01425359|454734097|FG001|Overall Study|Death|1|||
126393474|NCT01425359|454734096|FG000|Overall Study|Unsatisfactory Response|1|||
126393475|NCT01425359|454734097|FG001|Overall Study|Unsatisfactory Response|0|||
126393476|NCT01425359|454734096|FG000|Overall Study|Protocol Violation|1|||
126393477|NCT01425359|454734097|FG001|Overall Study|Protocol Violation|2|||
126393478|NCT01425359|454734096|FG000|Overall Study|Subject Withdrew Consent|1|||
126393479|NCT01425359|454734097|FG001|Overall Study|Subject Withdrew Consent|2|||
126393480|NCT01425359|454734096|FG000|Overall Study|Investigator's Discretion|2|||
126393481|NCT01425359|454734097|FG001|Overall Study|Investigator's Discretion|0|||
126393482|NCT01425359|454734096|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
126393483|NCT01425359|454734097|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
126393484|NCT03172325|454734098|FG000|Overall Study|Adverse Event|2|||
126393485|NCT03172325|454734099|FG001|Overall Study|Adverse Event|3|||
126393486|NCT03172325|454734098|FG000|Overall Study|Positive PPD|1|||
126393487|NCT03172325|454734099|FG001|Overall Study|Positive PPD|0|||
126393488|NCT03172325|454734098|FG000|Overall Study|Poor Compliance|1|||
126393489|NCT03172325|454734099|FG001|Overall Study|Poor Compliance|1|||
126393490|NCT03305419|454734104|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393491|NCT03305419|454734105|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
126393492|NCT03305419|454734106|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393493|NCT03305419|454734107|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393494|NCT03305419|454734108|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393495|NCT03305419|454734109|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393496|NCT03305419|454734110|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393497|NCT03305419|454734111|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
126393498|NCT03305419|454734104|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
126393499|NCT03305419|454734105|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126393500|NCT03305419|454734106|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126718846|NCT00069095|455920540|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
126393501|NCT03305419|454734107|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126393502|NCT03305419|454734108|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126718847|NCT00069095|455920541|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
126393503|NCT03305419|454734109|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126393504|NCT03305419|454734110|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126393505|NCT03305419|454734111|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
126469049|NCT03350620|455018955|FG002|Stage 2|Lack of Efficacy|0|||
126469050|NCT03350620|455018953|FG000|Stage 2|Lost to Follow-up|1|||
126393506|NCT03305419|454734104|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
126393507|NCT03305419|454734105|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393508|NCT03305419|454734106|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393509|NCT03305419|454734107|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393510|NCT03305419|454734108|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393511|NCT03305419|454734109|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393512|NCT03305419|454734110|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393513|NCT03305419|454734111|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
126393514|NCT03305419|454734104|FG000|Part B (14 Days)|Adverse Event|0|||
126393515|NCT03305419|454734105|FG001|Part B (14 Days)|Adverse Event|0|||
126393516|NCT03305419|454734106|FG002|Part B (14 Days)|Adverse Event|0|||
126393517|NCT03305419|454734107|FG003|Part B (14 Days)|Adverse Event|0|||
126393518|NCT03305419|454734108|FG004|Part B (14 Days)|Adverse Event|1|||
126393519|NCT03305419|454734109|FG005|Part B (14 Days)|Adverse Event|2|||
126393520|NCT03305419|454734110|FG006|Part B (14 Days)|Adverse Event|4|||
126393521|NCT03305419|454734111|FG007|Part B (14 Days)|Adverse Event|0|||
126393522|NCT03305419|454734104|FG000|Part B (14 Days)|Physician Decision|0|||
126393523|NCT03305419|454734105|FG001|Part B (14 Days)|Physician Decision|0|||
126393524|NCT03305419|454734106|FG002|Part B (14 Days)|Physician Decision|0|||
126393525|NCT03305419|454734107|FG003|Part B (14 Days)|Physician Decision|0|||
126393526|NCT03305419|454734108|FG004|Part B (14 Days)|Physician Decision|2|||
126393527|NCT03305419|454734109|FG005|Part B (14 Days)|Physician Decision|8|||
126393528|NCT03305419|454734110|FG006|Part B (14 Days)|Physician Decision|1|||
126393529|NCT03305419|454734111|FG007|Part B (14 Days)|Physician Decision|0|||
126393530|NCT00075946|454734112|FG000|Overall Study|Path ineligible: undetermined histology|0|||
126393531|NCT00075946|454734113|FG001|Overall Study|Path ineligible: undetermined histology|0|||
126393532|NCT00075946|454734114|FG002|Overall Study|Path ineligible: undetermined histology|0|||
126393533|NCT00075946|454734115|FG003|Overall Study|Path ineligible: undetermined histology|0|||
126393534|NCT00075946|454734116|FG004|Overall Study|Path ineligible: undetermined histology|6|||
126393535|NCT00075946|454734112|FG000|Overall Study|Did not achieve response after induction|0|||
126393536|NCT00075946|454734113|FG001|Overall Study|Did not achieve response after induction|0|||
126393537|NCT00075946|454734114|FG002|Overall Study|Did not achieve response after induction|0|||
126393538|NCT00075946|454734115|FG003|Overall Study|Did not achieve response after induction|0|||
126469051|NCT03350620|455018954|FG001|Stage 2|Lost to Follow-up|2|||
126469052|NCT03350620|455018955|FG002|Stage 2|Lost to Follow-up|2|||
126469053|NCT03350620|455018953|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
126469054|NCT03350620|455018954|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
126469055|NCT03350620|455018955|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
126469056|NCT01066000|455018958|FG000|Overall Study|Protocol Violation|4|||
126469057|NCT01066000|455018958|FG000|Overall Study|Death|3|||
126469058|NCT01066000|455018958|FG000|Overall Study|Withdrawal by Subject|1|||
126469059|NCT01066000|455018958|FG000|Overall Study|Adverse Event|1|||
126469060|NCT05268055|455018959|FG000|Overall Study|Lost to Follow-up|68|||
126469061|NCT05268055|455018960|FG001|Overall Study|Lost to Follow-up|68|||
126469062|NCT05268055|455018959|FG000|Overall Study|Withdrawal by Subject|12|||
126469063|NCT05268055|455018960|FG001|Overall Study|Withdrawal by Subject|8|||
126469064|NCT01554397|455018961|FG000|Overall Study|Withdrawal by Subject|1|||
126469065|NCT01554397|455018962|FG001|Overall Study|Withdrawal by Subject|0|||
126469066|NCT01554397|455018961|FG000|Overall Study|Ineligible|7|||
126469067|NCT01554397|455018962|FG001|Overall Study|Ineligible|0|||
126469068|NCT01854658|455020865|FG000|Overall Study|Protocol Violation|6|||
126469069|NCT01854658|455020866|FG001|Overall Study|Protocol Violation|2|||
126469070|NCT01854658|455020867|FG002|Overall Study|Protocol Violation|2|||
126469071|NCT01854658|455020868|FG003|Overall Study|Protocol Violation|1|||
126469072|NCT01854658|455020865|FG000|Overall Study|Physician Decision|7|||
126393539|NCT00075946|454734116|FG004|Overall Study|Did not achieve response after induction|182|||
126393540|NCT00075946|454734112|FG000|Overall Study|Incorrectly randomized (no response)|5|||
126393541|NCT00075946|454734113|FG001|Overall Study|Incorrectly randomized (no response)|5|||
126393542|NCT00075946|454734114|FG002|Overall Study|Incorrectly randomized (no response)|5|||
126469073|NCT01854658|455020866|FG001|Overall Study|Physician Decision|5|||
126469074|NCT01854658|455020867|FG002|Overall Study|Physician Decision|2|||
126469075|NCT01854658|455020868|FG003|Overall Study|Physician Decision|4|||
126469076|NCT01854658|455020865|FG000|Overall Study|Lost to Follow-up|8|||
126469077|NCT01854658|455020866|FG001|Overall Study|Lost to Follow-up|9|||
126469078|NCT01854658|455020867|FG002|Overall Study|Lost to Follow-up|8|||
126469079|NCT01854658|455020868|FG003|Overall Study|Lost to Follow-up|4|||
126469080|NCT01854658|455020865|FG000|Overall Study|Withdrawal by Subject|28|||
126469081|NCT01854658|455020866|FG001|Overall Study|Withdrawal by Subject|21|||
126469082|NCT01854658|455020867|FG002|Overall Study|Withdrawal by Subject|29|||
126469083|NCT01854658|455020868|FG003|Overall Study|Withdrawal by Subject|15|||
126469084|NCT01854658|455020865|FG000|Overall Study|Protocol-specified criteria|15|||
126469085|NCT01854658|455020866|FG001|Overall Study|Protocol-specified criteria|15|||
126393543|NCT00075946|454734115|FG003|Overall Study|Incorrectly randomized (no response)|1|||
126393544|NCT00075946|454734116|FG004|Overall Study|Incorrectly randomized (no response)|0|||
126393545|NCT00075946|454734112|FG000|Overall Study|Adverse Event|2|||
126393546|NCT00075946|454734113|FG001|Overall Study|Adverse Event|10|||
126393547|NCT00075946|454734114|FG002|Overall Study|Adverse Event|0|||
126393548|NCT00075946|454734115|FG003|Overall Study|Adverse Event|2|||
126393549|NCT00075946|454734116|FG004|Overall Study|Adverse Event|0|||
126393550|NCT00075946|454734112|FG000|Overall Study|Death|0|||
126393551|NCT00075946|454734113|FG001|Overall Study|Death|1|||
126393552|NCT00075946|454734114|FG002|Overall Study|Death|0|||
126393553|NCT00075946|454734115|FG003|Overall Study|Death|0|||
126393554|NCT00075946|454734116|FG004|Overall Study|Death|0|||
126393555|NCT00075946|454734112|FG000|Overall Study|Withdrawal by Subject|23|||
126393556|NCT00075946|454734113|FG001|Overall Study|Withdrawal by Subject|58|||
126393557|NCT00075946|454734114|FG002|Overall Study|Withdrawal by Subject|4|||
126393558|NCT00075946|454734115|FG003|Overall Study|Withdrawal by Subject|9|||
126393559|NCT00075946|454734116|FG004|Overall Study|Withdrawal by Subject|0|||
126393560|NCT00075946|454734112|FG000|Overall Study|Alternative therapy|16|||
126393561|NCT00075946|454734113|FG001|Overall Study|Alternative therapy|2|||
126393562|NCT00075946|454734114|FG002|Overall Study|Alternative therapy|5|||
126393563|NCT00075946|454734115|FG003|Overall Study|Alternative therapy|0|||
126393564|NCT00075946|454734116|FG004|Overall Study|Alternative therapy|0|||
126393565|NCT00075946|454734112|FG000|Overall Study|Other complicating disease|7|||
126393566|NCT00075946|454734113|FG001|Overall Study|Other complicating disease|13|||
126393567|NCT00075946|454734114|FG002|Overall Study|Other complicating disease|1|||
126393568|NCT00075946|454734115|FG003|Overall Study|Other complicating disease|4|||
126393569|NCT00075946|454734116|FG004|Overall Study|Other complicating disease|0|||
126393570|NCT00075946|454734112|FG000|Overall Study|No response to retreatment|23|||
126393571|NCT00075946|454734113|FG001|Overall Study|No response to retreatment|0|||
126393572|NCT00075946|454734114|FG002|Overall Study|No response to retreatment|2|||
126393573|NCT00075946|454734115|FG003|Overall Study|No response to retreatment|0|||
126393574|NCT00075946|454734116|FG004|Overall Study|No response to retreatment|0|||
126393575|NCT00075946|454734112|FG000|Overall Study|Time to progression less than 6 months|15|||
126393576|NCT00075946|454734113|FG001|Overall Study|Time to progression less than 6 months|30|||
126393577|NCT00075946|454734114|FG002|Overall Study|Time to progression less than 6 months|8|||
126469086|NCT01854658|455020867|FG002|Overall Study|Protocol-specified criteria|10|||
126469087|NCT01854658|455020868|FG003|Overall Study|Protocol-specified criteria|7|||
126469088|NCT01854658|455020865|FG000|Overall Study|Lack of Efficacy|3|||
126469089|NCT01854658|455020866|FG001|Overall Study|Lack of Efficacy|8|||
126469090|NCT01854658|455020867|FG002|Overall Study|Lack of Efficacy|4|||
126469091|NCT01854658|455020868|FG003|Overall Study|Lack of Efficacy|7|||
126469092|NCT01854658|455020865|FG000|Overall Study|Adverse Event|21|||
126469093|NCT01854658|455020866|FG001|Overall Study|Adverse Event|14|||
126469094|NCT01854658|455020867|FG002|Overall Study|Adverse Event|23|||
126469095|NCT01854658|455020868|FG003|Overall Study|Adverse Event|19|||
126469096|NCT01854658|455020865|FG000|Overall Study|Administrative reasons|5|||
126469097|NCT01854658|455020866|FG001|Overall Study|Administrative reasons|1|||
126469098|NCT01854658|455020867|FG002|Overall Study|Administrative reasons|2|||
126469099|NCT01854658|455020868|FG003|Overall Study|Administrative reasons|2|||
126469100|NCT01858376|455020869|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
126469101|NCT02436304|455020884|FG000|Overall Study|Lost to Follow-up|0|||
126469102|NCT02436304|455020885|FG001|Overall Study|Lost to Follow-up|1|||
126469103|NCT02436304|455020886|FG002|Overall Study|Lost to Follow-up|0|||
126469104|NCT02436304|455020884|FG000|Overall Study|Withdrawal by Subject|0|||
126469105|NCT02436304|455020885|FG001|Overall Study|Withdrawal by Subject|1|||
126469106|NCT02436304|455020886|FG002|Overall Study|Withdrawal by Subject|0|||
126469107|NCT02436304|455020884|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
126469108|NCT02436304|455020885|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
126469109|NCT02436304|455020886|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
126469110|NCT03793556|455020887|FG000|Overall Study|Withdrawal by Subject|12|||
126469111|NCT03793556|455020888|FG001|Overall Study|Withdrawal by Subject|1|||
126469112|NCT03793556|455020887|FG000|Overall Study|Lost to Follow-up|1|||
126469113|NCT03793556|455020888|FG001|Overall Study|Lost to Follow-up|1|||
126469114|NCT04416633|455020889|FG000|Overall Study|Death|1|||
126469115|NCT04416633|455020889|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
126718848|NCT00069095|455920542|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
126469116|NCT04416633|455020889|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
126469117|NCT04416633|455020889|FG000|Overall Study|Adverse Event|6|||
126469118|NCT04416633|455020889|FG000|Overall Study|Withdrawal by Subject|6|||
126393578|NCT00075946|454734115|FG003|Overall Study|Time to progression less than 6 months|3|||
126393579|NCT00075946|454734116|FG004|Overall Study|Time to progression less than 6 months|0|||
126393580|NCT00075946|454734112|FG000|Overall Study|Other|57|||
126393581|NCT00075946|454734113|FG001|Overall Study|Other|32|||
126393582|NCT00075946|454734114|FG002|Overall Study|Other|3|||
126393583|NCT00075946|454734115|FG003|Overall Study|Other|11|||
126469119|NCT04612790|455020890|FG000|DB Period (Up to 36 Weeks)|Death|1|||
126393584|NCT00075946|454734116|FG004|Overall Study|Other|0|||
126393585|NCT00889603|454734119|FG000|Overall Study|Adverse Event|7|||
126393586|NCT00889603|454734119|FG000|Overall Study|Death|3|||
126393587|NCT00889603|454734119|FG000|Overall Study|Lost to Follow-up|19|||
126393588|NCT00889603|454734119|FG000|Overall Study|No longer willing to participant in stud|4|||
126393589|NCT00889603|454734119|FG000|Overall Study|Other|4|||
126393590|NCT01229254|454734120|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
126393591|NCT01229254|454734121|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
126393592|NCT01229254|454734122|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
126393593|NCT01229254|454734120|FG000|Overall Study|Adverse Event|4|||
126393594|NCT01229254|454734121|FG001|Overall Study|Adverse Event|5|||
126393595|NCT01229254|454734122|FG002|Overall Study|Adverse Event|3|||
126393596|NCT01229254|454734120|FG000|Overall Study|Lost to Follow-up|3|||
126393597|NCT01229254|454734121|FG001|Overall Study|Lost to Follow-up|0|||
126718849|NCT00069095|455920543|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
126393598|NCT01229254|454734122|FG002|Overall Study|Lost to Follow-up|1|||
126393599|NCT01229254|454734120|FG000|Overall Study|Physician Decision|0|||
126393600|NCT01229254|454734121|FG001|Overall Study|Physician Decision|3|||
126393601|NCT01229254|454734122|FG002|Overall Study|Physician Decision|0|||
126393602|NCT01229254|454734120|FG000|Overall Study|Protocol Violation|4|||
126393603|NCT01229254|454734121|FG001|Overall Study|Protocol Violation|6|||
126393604|NCT01229254|454734122|FG002|Overall Study|Protocol Violation|5|||
126393605|NCT01229254|454734120|FG000|Overall Study|Withdrawal by Subject|1|||
126393606|NCT01229254|454734121|FG001|Overall Study|Withdrawal by Subject|0|||
126393607|NCT01229254|454734122|FG002|Overall Study|Withdrawal by Subject|1|||
126393608|NCT01229254|454734120|FG000|Overall Study|Non-compliance with Study Drug|0|||
126393609|NCT01229254|454734121|FG001|Overall Study|Non-compliance with Study Drug|1|||
126393610|NCT01229254|454734122|FG002|Overall Study|Non-compliance with Study Drug|1|||
126393611|NCT02231892|454734123|FG000|Overall Study|Lost to Follow-up|1|||
126393612|NCT02231892|454734124|FG001|Overall Study|Lost to Follow-up|0|||
126393613|NCT02231892|454734125|FG002|Overall Study|Lost to Follow-up|3|||
126393614|NCT02231892|454734123|FG000|Overall Study|Withdrawal by Subject|4|||
126393615|NCT02231892|454734124|FG001|Overall Study|Withdrawal by Subject|3|||
126393616|NCT02231892|454734125|FG002|Overall Study|Withdrawal by Subject|15|||
126393617|NCT02231892|454734123|FG000|Overall Study|Physician Decision|0|||
126393618|NCT02231892|454734124|FG001|Overall Study|Physician Decision|2|||
126393619|NCT02231892|454734125|FG002|Overall Study|Physician Decision|4|||
126393620|NCT02231892|454734123|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
126393621|NCT02231892|454734124|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
126393622|NCT02231892|454734125|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
126393623|NCT02231892|454734123|FG000|Overall Study|Participant motor threshold was >83%|0|||
126393624|NCT02231892|454734124|FG001|Overall Study|Participant motor threshold was >83%|0|||
126469120|NCT04612790|455020891|FG001|DB Period (Up to 36 Weeks)|Death|1|||
126469121|NCT04612790|455020892|FG002|DB Period (Up to 36 Weeks)|Death|0|||
126469122|NCT04612790|455020893|FG003|DB Period (Up to 36 Weeks)|Death|0|||
126469123|NCT04612790|455020890|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
126469124|NCT04612790|455020891|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
126469125|NCT04612790|455020892|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
126469126|NCT04612790|455020893|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
126469127|NCT04612790|455020890|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
126469128|NCT04612790|455020891|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
126469129|NCT04612790|455020892|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
126469130|NCT04612790|455020893|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
126469131|NCT04612790|455020890|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
126469132|NCT04612790|455020891|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
126469133|NCT04612790|455020892|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
126469134|NCT04612790|455020893|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
126469135|NCT04612790|455020890|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
126469136|NCT04612790|455020891|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
126469137|NCT04612790|455020892|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
126469138|NCT04612790|455020893|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
126469139|NCT04612790|455020890|FG000|DB Period (Up to 36 Weeks)|Other|1|||
126469140|NCT04612790|455020891|FG001|DB Period (Up to 36 Weeks)|Other|0|||
126469141|NCT04612790|455020892|FG002|DB Period (Up to 36 Weeks)|Other|0|||
126469142|NCT04612790|455020893|FG003|DB Period (Up to 36 Weeks)|Other|0|||
126469143|NCT04612790|455020890|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
126469144|NCT04612790|455020891|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
126393625|NCT02231892|454734125|FG002|Overall Study|Participant motor threshold was >83%|9|||
126469145|NCT04612790|455020892|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
126469146|NCT04612790|455020893|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
126718850|NCT00069095|455920544|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
126718851|NCT00069095|455920545|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
126393626|NCT02231892|454734123|FG000|Overall Study|Could not find motor threshold|2|||
126393627|NCT02231892|454734124|FG001|Overall Study|Could not find motor threshold|0|||
126393628|NCT02231892|454734125|FG002|Overall Study|Could not find motor threshold|1|||
126393629|NCT02231892|454734123|FG000|Overall Study|Could not find reliable motor hotspot|0|||
126393630|NCT02231892|454734124|FG001|Overall Study|Could not find reliable motor hotspot|0|||
126393631|NCT02231892|454734125|FG002|Overall Study|Could not find reliable motor hotspot|1|||
126393632|NCT01694121|454734128|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
126393633|NCT01694121|454734129|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
126393634|NCT02680041|454734130|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
126393635|NCT02680041|454734130|FG000|Overall Study|Lost to Follow-up|2|||
126393636|NCT00521599|454734131|FG000|Overall Study|Adverse Event|5|||
126393637|NCT00521599|454734132|FG001|Overall Study|Adverse Event|7|||
126393638|NCT00521599|454734133|FG002|Overall Study|Adverse Event|6|||
126393639|NCT00521599|454734131|FG000|Overall Study|Treatment Failure|8|||
126393640|NCT00521599|454734132|FG001|Overall Study|Treatment Failure|9|||
126393641|NCT00521599|454734133|FG002|Overall Study|Treatment Failure|22|||
126393642|NCT00521599|454734131|FG000|Overall Study|Lost to Follow-up|2|||
126393643|NCT00521599|454734132|FG001|Overall Study|Lost to Follow-up|1|||
126393644|NCT00521599|454734133|FG002|Overall Study|Lost to Follow-up|2|||
126393645|NCT00521599|454734131|FG000|Overall Study|Withdrawal by Subject|3|||
126393646|NCT00521599|454734132|FG001|Overall Study|Withdrawal by Subject|5|||
126393647|NCT00521599|454734133|FG002|Overall Study|Withdrawal by Subject|1|||
126393648|NCT00521599|454734131|FG000|Overall Study|Withdrawal by subject treatment related|3|||
126393649|NCT00521599|454734132|FG001|Overall Study|Withdrawal by subject treatment related|1|||
126393650|NCT00521599|454734133|FG002|Overall Study|Withdrawal by subject treatment related|2|||
126393651|NCT00521599|454734131|FG000|Overall Study|Protocol Violation|2|||
126393652|NCT00521599|454734132|FG001|Overall Study|Protocol Violation|4|||
126393653|NCT00521599|454734133|FG002|Overall Study|Protocol Violation|2|||
126393654|NCT00521599|454734131|FG000|Overall Study|Did not meet protocol eligibility|2|||
126393655|NCT00521599|454734132|FG001|Overall Study|Did not meet protocol eligibility|2|||
126393656|NCT00521599|454734133|FG002|Overall Study|Did not meet protocol eligibility|1|||
126393657|NCT02186652|454734134|FG000|Overall Study|Lost to Follow-up|2|||
126393658|NCT02186652|454734135|FG001|Overall Study|Lost to Follow-up|0|||
126393659|NCT00744978|454734136|FG000|Period 1|Lost to Follow-up|1|||
126393660|NCT00744978|454734137|FG001|Period 1|Lost to Follow-up|0|||
126393661|NCT00744978|454734136|FG000|Period 1|Withdrawal by Subject|0|||
126393662|NCT00744978|454734137|FG001|Period 1|Withdrawal by Subject|2|||
126393663|NCT00744978|454734136|FG000|Period 1|Other|0|||
126393664|NCT00744978|454734137|FG001|Period 1|Other|2|||
126393665|NCT00744978|454734136|FG000|Period 1|Adverse Event|4|||
126718852|NCT00069095|455920540|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
126718853|NCT00069095|455920541|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
126718854|NCT00069095|455920542|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
126718855|NCT00069095|455920543|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
126718856|NCT00069095|455920544|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
126718857|NCT00069095|455920545|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
126718858|NCT00069095|455920540|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
126718859|NCT00069095|455920541|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
126718860|NCT00069095|455920542|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
126718861|NCT00069095|455920543|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
126718862|NCT00069095|455920544|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
126718863|NCT00069095|455920545|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
126718864|NCT00069095|455920540|FG000|Post-study Treatment Phase|Surgery|0|||
126718865|NCT00069095|455920541|FG001|Post-study Treatment Phase|Surgery|0|||
126718866|NCT00069095|455920542|FG002|Post-study Treatment Phase|Surgery|0|||
126718867|NCT00069095|455920543|FG003|Post-study Treatment Phase|Surgery|1|||
126718868|NCT00069095|455920544|FG004|Post-study Treatment Phase|Surgery|1|||
126718869|NCT00069095|455920545|FG005|Post-study Treatment Phase|Surgery|0|||
126718870|NCT00069095|455920540|FG000|Post-study Treatment Phase|Death|0|||
126771581|NCT02587325|456117836|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
126393666|NCT00744978|454734137|FG001|Period 1|Adverse Event|0|||
126393667|NCT00744978|454734136|FG000|Period 1|Randomized but not Treated|1|||
126393668|NCT00744978|454734137|FG001|Period 1|Randomized but not Treated|1|||
126393669|NCT00744978|454734136|FG000|Period 2|Adverse Event|0|||
126393670|NCT00744978|454734137|FG001|Period 2|Adverse Event|1|||
126393671|NCT00866047|454734141|FG000|Treatment Period|Progressive disease|13|||
126393672|NCT00866047|454734141|FG000|Treatment Period|Adverse Event|16|||
126393673|NCT00866047|454734141|FG000|Treatment Period|Physician Decision|14|||
126393674|NCT00866047|454734141|FG000|Treatment Period|Withdrawal by Subject|5|||
126393675|NCT00866047|454734141|FG000|Follow-up Period|Lost to Follow-up|5|||
126718871|NCT00069095|455920541|FG001|Post-study Treatment Phase|Death|0|||
126718872|NCT00069095|455920542|FG002|Post-study Treatment Phase|Death|0|||
126393676|NCT02928029|454734142|FG000|Overall Study|Withdrawal by Subject|0|||
126393677|NCT02928029|454734143|FG001|Overall Study|Withdrawal by Subject|1|||
126393678|NCT02928029|454734142|FG000|Overall Study|Radiological progression|1|||
126718873|NCT00069095|455920543|FG003|Post-study Treatment Phase|Death|0|||
126718874|NCT00069095|455920544|FG004|Post-study Treatment Phase|Death|1|||
126718875|NCT00069095|455920545|FG005|Post-study Treatment Phase|Death|0|||
126718876|NCT00069095|455920540|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
126718877|NCT00069095|455920541|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
126718878|NCT00069095|455920542|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
126718879|NCT00069095|455920543|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
126718880|NCT00069095|455920544|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
126718881|NCT00069095|455920545|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
126718882|NCT00069095|455920540|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
126718883|NCT00069095|455920541|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
126718884|NCT00069095|455920542|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
126718885|NCT00069095|455920543|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
126718886|NCT00069095|455920544|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
126718887|NCT00069095|455920545|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
126718888|NCT00069095|455920540|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
126718889|NCT00069095|455920541|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
126718890|NCT00069095|455920542|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
126718891|NCT00069095|455920543|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
126718892|NCT00069095|455920544|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
126718893|NCT00069095|455920545|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
126718894|NCT00069095|455920540|FG000|Post-study Treatment Phase|Investigator decision|0|||
126718895|NCT00069095|455920541|FG001|Post-study Treatment Phase|Investigator decision|0|||
126718896|NCT00069095|455920542|FG002|Post-study Treatment Phase|Investigator decision|0|||
126718897|NCT00069095|455920543|FG003|Post-study Treatment Phase|Investigator decision|0|||
126718898|NCT00069095|455920544|FG004|Post-study Treatment Phase|Investigator decision|0|||
126718899|NCT00069095|455920545|FG005|Post-study Treatment Phase|Investigator decision|1|||
126718900|NCT00069095|455920540|FG000|Follow-up Phase|Death|174|||
126718901|NCT00069095|455920541|FG001|Follow-up Phase|Death|206|||
126718902|NCT00069095|455920542|FG002|Follow-up Phase|Death|120|||
126718903|NCT00069095|455920543|FG003|Follow-up Phase|Death|112|||
126718904|NCT00069095|455920544|FG004|Follow-up Phase|Death|92|||
126718905|NCT00069095|455920545|FG005|Follow-up Phase|Death|101|||
126718906|NCT00913978|455920546|FG000|Overall Study|Surgeon choice|1|||
126718907|NCT00913978|455920547|FG001|Overall Study|Surgeon choice|3|||
126718908|NCT05100199|455920551|FG000|Overall Study|Lost to Follow-up|5|||
126718909|NCT05100199|455920552|FG001|Overall Study|Lost to Follow-up|8|||
126718910|NCT05100199|455920553|FG002|Overall Study|Lost to Follow-up|3|||
126718911|NCT05100199|455920554|FG003|Overall Study|Lost to Follow-up|6|||
126718912|NCT05100199|455920551|FG000|Overall Study|Withdrawal by Subject|3|||
126718913|NCT05100199|455920552|FG001|Overall Study|Withdrawal by Subject|3|||
126393679|NCT02928029|454734143|FG001|Overall Study|Radiological progression|0|||
126393680|NCT02928029|454734142|FG000|Overall Study|Clinical progression|1|||
126393681|NCT02928029|454734143|FG001|Overall Study|Clinical progression|2|||
126393682|NCT02928029|454734142|FG000|Overall Study|AE not related to clinical progression|1|||
126393683|NCT02928029|454734143|FG001|Overall Study|AE not related to clinical progression|1|||
126393684|NCT00515294|454734144|FG000|Overall Study|Lost to Follow-up|3|||
126393685|NCT00515294|454734145|FG001|Overall Study|Lost to Follow-up|2|||
126393686|NCT00515294|454734146|FG002|Overall Study|Lost to Follow-up|3|||
126393687|NCT00515294|454734147|FG003|Overall Study|Lost to Follow-up|1|||
126393688|NCT00515294|454734144|FG000|Overall Study|Driver simulator problems|1|||
126393689|NCT00515294|454734145|FG001|Overall Study|Driver simulator problems|1|||
126393690|NCT00515294|454734146|FG002|Overall Study|Driver simulator problems|1|||
126393691|NCT00515294|454734147|FG003|Overall Study|Driver simulator problems|3|||
126393692|NCT00515294|454734144|FG000|Overall Study|Caffeine amount inaccurate|5|||
126393693|NCT00515294|454734145|FG001|Overall Study|Caffeine amount inaccurate|0|||
126393694|NCT00515294|454734146|FG002|Overall Study|Caffeine amount inaccurate|7|||
126718914|NCT05100199|455920553|FG002|Overall Study|Withdrawal by Subject|9|||
126718915|NCT05100199|455920554|FG003|Overall Study|Withdrawal by Subject|7|||
126718916|NCT05100199|455920551|FG000|Overall Study|Other|0|||
126718917|NCT05100199|455920552|FG001|Overall Study|Other|0|||
126771582|NCT02587325|456117837|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
126771583|NCT02587325|456117838|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
126393695|NCT00515294|454734147|FG003|Overall Study|Caffeine amount inaccurate|0|||
126393696|NCT02778555|454734148|FG000|Overall Study|Withdrawal by Subject|55|||
126718918|NCT05100199|455920553|FG002|Overall Study|Other|1|||
126718919|NCT05100199|455920554|FG003|Overall Study|Other|1|||
126718920|NCT00830037|455920555|FG000|Overall Study|Withdrawal by Subject|2|||
126718921|NCT00830037|455920556|FG001|Overall Study|Withdrawal by Subject|3|||
126718922|NCT00830037|455920555|FG000|Overall Study|Lost to Follow-up|1|||
126718923|NCT00830037|455920556|FG001|Overall Study|Lost to Follow-up|2|||
126718924|NCT00830037|455920555|FG000|Overall Study|Active when terminated by DSMB|15|||
126718925|NCT00830037|455920556|FG001|Overall Study|Active when terminated by DSMB|14|||
126393697|NCT02778555|454734149|FG001|Overall Study|Withdrawal by Subject|32|||
126393698|NCT02778555|454734150|FG002|Overall Study|Withdrawal by Subject|107|||
126718926|NCT00752609|455920557|FG000|Overall Study|Adverse Event|2|||
126718927|NCT00752609|455920558|FG001|Overall Study|Adverse Event|2|||
126718928|NCT00752609|455920557|FG000|Overall Study|Withdrawal by Subject|3|||
126393699|NCT04659174|454734155|FG000|Overall Study|Sponsor decision to discontinue study|0|||
126393700|NCT04659174|454734156|FG001|Overall Study|Sponsor decision to discontinue study|2|||
126393701|NCT04659174|454734155|FG000|Overall Study|Lost to Follow-up|9|||
126393702|NCT04659174|454734156|FG001|Overall Study|Lost to Follow-up|11|||
126393703|NCT04659174|454734155|FG000|Overall Study|Adverse Event|8|||
126393704|NCT04659174|454734156|FG001|Overall Study|Adverse Event|5|||
126393705|NCT04659174|454734155|FG000|Overall Study|Withdrawal by Subject|17|||
126393706|NCT04659174|454734156|FG001|Overall Study|Withdrawal by Subject|33|||
126393707|NCT04659174|454734155|FG000|Overall Study|Progressive disease|0|||
126393708|NCT04659174|454734156|FG001|Overall Study|Progressive disease|2|||
126393709|NCT04659174|454734155|FG000|Overall Study|Other reasons|0|||
126393710|NCT04659174|454734156|FG001|Overall Study|Other reasons|2|||
126393711|NCT04659174|454734155|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
126393712|NCT04659174|454734156|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
126393713|NCT04659174|454734155|FG000|Overall Study|Alcohol or illegal drug use|0|||
126393714|NCT04659174|454734156|FG001|Overall Study|Alcohol or illegal drug use|3|||
126393715|NCT04659174|454734155|FG000|Overall Study|Violation of entry criteria|1|||
126393716|NCT04659174|454734156|FG001|Overall Study|Violation of entry criteria|0|||
126393717|NCT04659174|454734155|FG000|Overall Study|Death|0|||
126393718|NCT04659174|454734156|FG001|Overall Study|Death|1|||
126393719|NCT01818258|454734163|FG000|Overall Study|Death|3|||
126393720|NCT01818258|454734164|FG001|Overall Study|Death|0|||
126393721|NCT01818258|454734163|FG000|Overall Study|Withdrawal by Subject|0|||
126393722|NCT01818258|454734164|FG001|Overall Study|Withdrawal by Subject|1|||
126718929|NCT00752609|455920558|FG001|Overall Study|Withdrawal by Subject|0|||
126718930|NCT00752609|455920557|FG000|Overall Study|Physician Decision|1|||
126718931|NCT00752609|455920558|FG001|Overall Study|Physician Decision|0|||
126718932|NCT00752609|455920557|FG000|Overall Study|Death|1|||
126718933|NCT00752609|455920558|FG001|Overall Study|Death|0|||
126393723|NCT01818258|454734163|FG000|Overall Study|Lost to Follow-up|0|||
126393724|NCT01818258|454734164|FG001|Overall Study|Lost to Follow-up|1|||
126393725|NCT01818258|454734163|FG000|Overall Study|Unable to Travel to Clinic|0|||
126393726|NCT01818258|454734164|FG001|Overall Study|Unable to Travel to Clinic|1|||
126393727|NCT02099344|454734165|FG000|Overall Study|Physician Decision|1|||
126393728|NCT02099344|454734166|FG001|Overall Study|Physician Decision|0|||
126393729|NCT01639339|454734172|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
126393730|NCT01639339|454734173|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
126393731|NCT01639339|454734172|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
126393732|NCT01639339|454734173|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
126393733|NCT01639339|454734172|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
126393734|NCT01639339|454734173|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
126393735|NCT01639339|454734172|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
126393736|NCT01639339|454734173|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
126393737|NCT01639339|454734172|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
126393738|NCT01639339|454734173|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
126393739|NCT01639339|454734172|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
126393740|NCT01639339|454734173|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
126393741|NCT01639339|454734172|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
126393742|NCT01639339|454734173|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
126718934|NCT00752609|455920557|FG000|Overall Study|Met exclusion criteria|1|||
126393743|NCT01639339|454734172|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
126393744|NCT01639339|454734173|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
126393745|NCT01639339|454734172|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
126393746|NCT01639339|454734173|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
126393747|NCT01639339|454734172|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
126393748|NCT01639339|454734173|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
126393749|NCT02649218|454734174|FG000|Overall Study|Adverse Event|8|||
126393750|NCT02649218|454734174|FG000|Overall Study|Lack of Efficacy|8|||
126393751|NCT02649218|454734174|FG000|Overall Study|Pregnancy|3|||
126393752|NCT02649218|454734174|FG000|Overall Study|Protocol Violation|3|||
126393753|NCT02649218|454734174|FG000|Overall Study|Physician Decision|1|||
126393754|NCT02649218|454734174|FG000|Overall Study|Withdrawal by Subject|2|||
126393755|NCT03022097|454734176|FG000|Overall Study|Adverse Event|3|||
126718935|NCT00752609|455920558|FG001|Overall Study|Met exclusion criteria|0|||
126718936|NCT00752609|455920557|FG000|Overall Study|Received Aranesp in error|1|||
126393756|NCT03022097|454734177|FG001|Overall Study|Adverse Event|4|||
126393757|NCT03022097|454734178|FG002|Overall Study|Adverse Event|1|||
126393758|NCT03022097|454734179|FG003|Overall Study|Adverse Event|3|||
126718937|NCT00752609|455920558|FG001|Overall Study|Received Aranesp in error|0|||
126718938|NCT05114590|455920559|FG000|Overall Study|Adverse Event|1|||
126718939|NCT05114590|455920559|FG000|Overall Study|Investigator decision|1|||
126718940|NCT05114590|455920559|FG000|Overall Study|Lost to Follow-up|5|||
126718941|NCT05114590|455920559|FG000|Overall Study|Withdrawal by Subject|5|||
126393759|NCT03022097|454734176|FG000|Overall Study|Progressive Disease|2|||
126393760|NCT03022097|454734177|FG001|Overall Study|Progressive Disease|0|||
126393761|NCT03022097|454734178|FG002|Overall Study|Progressive Disease|5|||
126393762|NCT03022097|454734179|FG003|Overall Study|Progressive Disease|2|||
126393763|NCT03022097|454734176|FG000|Overall Study|Lack of Efficacy|0|||
126393764|NCT03022097|454734177|FG001|Overall Study|Lack of Efficacy|0|||
126393765|NCT03022097|454734178|FG002|Overall Study|Lack of Efficacy|3|||
126393766|NCT03022097|454734179|FG003|Overall Study|Lack of Efficacy|3|||
126393767|NCT03022097|454734176|FG000|Overall Study|Protocol Violation|1|||
126393768|NCT03022097|454734177|FG001|Overall Study|Protocol Violation|0|||
126393769|NCT03022097|454734178|FG002|Overall Study|Protocol Violation|1|||
126393770|NCT03022097|454734179|FG003|Overall Study|Protocol Violation|0|||
126393771|NCT03022097|454734176|FG000|Overall Study|Withdrawal by Subject|11|||
126393772|NCT03022097|454734177|FG001|Overall Study|Withdrawal by Subject|13|||
126393773|NCT03022097|454734178|FG002|Overall Study|Withdrawal by Subject|15|||
126393774|NCT03022097|454734179|FG003|Overall Study|Withdrawal by Subject|21|||
126393775|NCT03022097|454734176|FG000|Overall Study|Lost to Follow-up|0|||
126393776|NCT03022097|454734177|FG001|Overall Study|Lost to Follow-up|0|||
126393777|NCT03022097|454734178|FG002|Overall Study|Lost to Follow-up|1|||
126393778|NCT03022097|454734179|FG003|Overall Study|Lost to Follow-up|1|||
126393779|NCT03022097|454734176|FG000|Overall Study|Other|4|||
126393780|NCT03022097|454734177|FG001|Overall Study|Other|1|||
126393781|NCT03022097|454734178|FG002|Overall Study|Other|6|||
126393782|NCT03022097|454734179|FG003|Overall Study|Other|4|||
126393783|NCT03022097|454734176|FG000|Overall Study|Due to COVID-19 pandemic|0|||
126393784|NCT03022097|454734177|FG001|Overall Study|Due to COVID-19 pandemic|1|||
126393785|NCT03022097|454734178|FG002|Overall Study|Due to COVID-19 pandemic|0|||
126393786|NCT03022097|454734179|FG003|Overall Study|Due to COVID-19 pandemic|0|||
126393787|NCT01451931|454734182|FG000|Overall Study|Lost to Follow-up|17|||
126393788|NCT01451931|454734183|FG001|Overall Study|Lost to Follow-up|36|||
126393789|NCT01451931|454734184|FG002|Overall Study|Lost to Follow-up|21|||
126393790|NCT01451931|454734182|FG000|Overall Study|Withdrawal by Subject|16|||
126393791|NCT01451931|454734183|FG001|Overall Study|Withdrawal by Subject|22|||
126393792|NCT01451931|454734184|FG002|Overall Study|Withdrawal by Subject|22|||
126393793|NCT01349322|454734185|FG000|Overall Study|Protocol Violation|45|||
126393794|NCT01349322|454734186|FG001|Overall Study|Protocol Violation|47|||
126393795|NCT04470908|454734191|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
126393796|NCT02118766|454734192|FG000|Overall Study|Adverse Event|7|||
126393797|NCT02118766|454734193|FG001|Overall Study|Adverse Event|2|||
126393798|NCT02118766|454734192|FG000|Overall Study|Withdrawal by Subject|3|||
126393799|NCT02118766|454734193|FG001|Overall Study|Withdrawal by Subject|6|||
126393800|NCT02118766|454734192|FG000|Overall Study|Lost to Follow-up|5|||
126393801|NCT02118766|454734193|FG001|Overall Study|Lost to Follow-up|4|||
126393802|NCT02118766|454734192|FG000|Overall Study|Withdrawal by parent/guardian|12|||
126393803|NCT02118766|454734193|FG001|Overall Study|Withdrawal by parent/guardian|18|||
126393804|NCT02118766|454734192|FG000|Overall Study|Other|3|||
126393805|NCT02118766|454734193|FG001|Overall Study|Other|1|||
126393806|NCT01846299|454734196|FG000|Overall Study|Physician Decision|4|||
126393807|NCT01846299|454734197|FG001|Overall Study|Physician Decision|2|||
126393808|NCT01846299|454734196|FG000|Overall Study|Protocol deviation|1|||
126393809|NCT01846299|454734197|FG001|Overall Study|Protocol deviation|0|||
126393810|NCT01846299|454734196|FG000|Overall Study|Death|1|||
126393811|NCT01846299|454734197|FG001|Overall Study|Death|2|||
126393812|NCT01846299|454734196|FG000|Overall Study|Lost to Follow-up|3|||
126393813|NCT01846299|454734197|FG001|Overall Study|Lost to Follow-up|0|||
126393814|NCT01846299|454734196|FG000|Overall Study|Withdrawal by Subject|1|||
126393815|NCT01846299|454734197|FG001|Overall Study|Withdrawal by Subject|6|||
126469147|NCT04612790|455020890|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
126469148|NCT04612790|455020891|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
126469149|NCT04612790|455020892|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
126718942|NCT05114590|455920559|FG000|Overall Study|Other|2|||
126718943|NCT00358917|455920562|FG000|Overall Study|Adverse Event|14|||
126393816|NCT01846299|454734196|FG000|Overall Study|Adverse Event|2|||
126393817|NCT01846299|454734197|FG001|Overall Study|Adverse Event|0|||
126393818|NCT00496483|454736401|FG000|Overall Study|Not dosed|9|||
126393819|NCT00496483|454736401|FG000|Overall Study|Adverse Event|2|||
126393820|NCT00496483|454736401|FG000|Overall Study|Lack of Efficacy|1|||
126393821|NCT03095027|454736404|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
126393822|NCT03095027|454736405|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
126393823|NCT02264665|454736406|FG000|Overall Study|Other|0|||
126393824|NCT02264665|454736407|FG001|Overall Study|Other|0|||
126393825|NCT02264665|454736408|FG002|Overall Study|Other|3|||
126393826|NCT02264665|454736409|FG003|Overall Study|Other|0|||
126393827|NCT02264665|454736410|FG004|Overall Study|Other|0|||
126393828|NCT02264665|454736411|FG005|Overall Study|Other|0|||
126718944|NCT00358917|455920563|FG001|Overall Study|Adverse Event|21|||
126393829|NCT02264665|454736412|FG006|Overall Study|Other|0|||
126393830|NCT02264665|454736406|FG000|Overall Study|Death|9|||
126393831|NCT02264665|454736407|FG001|Overall Study|Death|8|||
126393832|NCT02264665|454736408|FG002|Overall Study|Death|13|||
126393833|NCT02264665|454736409|FG003|Overall Study|Death|5|||
126393834|NCT02264665|454736410|FG004|Overall Study|Death|0|||
126393835|NCT02264665|454736411|FG005|Overall Study|Death|0|||
126393836|NCT02264665|454736412|FG006|Overall Study|Death|1|||
126393837|NCT02264665|454736406|FG000|Overall Study|Lost to Follow-up|1|||
126393838|NCT02264665|454736407|FG001|Overall Study|Lost to Follow-up|0|||
126393839|NCT02264665|454736408|FG002|Overall Study|Lost to Follow-up|2|||
126393840|NCT02264665|454736409|FG003|Overall Study|Lost to Follow-up|1|||
126393841|NCT02264665|454736410|FG004|Overall Study|Lost to Follow-up|0|||
126393842|NCT02264665|454736411|FG005|Overall Study|Lost to Follow-up|0|||
126393843|NCT02264665|454736412|FG006|Overall Study|Lost to Follow-up|0|||
126393844|NCT02264665|454736406|FG000|Overall Study|Participant decision|0|||
126393845|NCT02264665|454736407|FG001|Overall Study|Participant decision|0|||
126393846|NCT02264665|454736408|FG002|Overall Study|Participant decision|0|||
126393847|NCT02264665|454736409|FG003|Overall Study|Participant decision|1|||
126393848|NCT02264665|454736410|FG004|Overall Study|Participant decision|0|||
126393849|NCT02264665|454736411|FG005|Overall Study|Participant decision|0|||
126393850|NCT02264665|454736412|FG006|Overall Study|Participant decision|0|||
126393851|NCT02264665|454736406|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
126393852|NCT02264665|454736407|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
126393853|NCT02264665|454736408|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
126393854|NCT02264665|454736409|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
126393855|NCT02264665|454736410|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
126393856|NCT02264665|454736411|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
126393857|NCT02264665|454736412|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
126393858|NCT02264665|454736406|FG000|Overall Study|Data Missing|0|||
126393859|NCT02264665|454736407|FG001|Overall Study|Data Missing|0|||
126393860|NCT02264665|454736408|FG002|Overall Study|Data Missing|1|||
126393861|NCT02264665|454736409|FG003|Overall Study|Data Missing|0|||
126393862|NCT02264665|454736410|FG004|Overall Study|Data Missing|0|||
126393863|NCT02264665|454736411|FG005|Overall Study|Data Missing|0|||
126393864|NCT02264665|454736412|FG006|Overall Study|Data Missing|0|||
126393865|NCT01962987|454736413|FG000|Overall Study|Adverse Event|4|||
126393866|NCT01962987|454736414|FG001|Overall Study|Adverse Event|4|||
126393867|NCT01962987|454736415|FG002|Overall Study|Adverse Event|0|||
126393868|NCT01962987|454736413|FG000|Overall Study|Lost to Follow-up|0|||
126393869|NCT01962987|454736414|FG001|Overall Study|Lost to Follow-up|0|||
126393870|NCT01962987|454736415|FG002|Overall Study|Lost to Follow-up|1|||
126393871|NCT01962987|454736413|FG000|Overall Study|Non compliance with dosing requirements|4|||
126393872|NCT01962987|454736414|FG001|Overall Study|Non compliance with dosing requirements|2|||
126393873|NCT01962987|454736415|FG002|Overall Study|Non compliance with dosing requirements|0|||
126393874|NCT01962987|454736413|FG000|Overall Study|Miscellaneous|1|||
126393875|NCT01962987|454736414|FG001|Overall Study|Miscellaneous|9|||
126393876|NCT01962987|454736415|FG002|Overall Study|Miscellaneous|2|||
126393877|NCT01962987|454736413|FG000|Overall Study|Restricted medication|5|||
126393878|NCT01962987|454736414|FG001|Overall Study|Restricted medication|1|||
126469150|NCT04612790|455020893|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
126469151|NCT04612790|455020890|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
126469152|NCT04612790|455020891|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
126469153|NCT04612790|455020892|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
126469154|NCT04612790|455020893|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
126469155|NCT04612790|455020890|FG000|OLE Period (Up to 1 Year)|Other|0|||
126469156|NCT04612790|455020891|FG001|OLE Period (Up to 1 Year)|Other|0|||
126469157|NCT04612790|455020892|FG002|OLE Period (Up to 1 Year)|Other|0|||
126469158|NCT04612790|455020893|FG003|OLE Period (Up to 1 Year)|Other|1|||
126469159|NCT00785928|455020894|FG000|Treatment Phase|Adverse Event|1|||
126469160|NCT00785928|455020895|FG001|Treatment Phase|Adverse Event|1|||
126718945|NCT00358917|455920562|FG000|Overall Study|Withdrawal by Subject|5|||
126393879|NCT01962987|454736415|FG002|Overall Study|Restricted medication|1|||
126393880|NCT01962987|454736413|FG000|Overall Study|Serious Adverse Event|1|||
126393881|NCT01962987|454736414|FG001|Overall Study|Serious Adverse Event|0|||
126393882|NCT01962987|454736415|FG002|Overall Study|Serious Adverse Event|0|||
126393883|NCT01962987|454736413|FG000|Overall Study|Withdrawal by Subject|11|||
126393884|NCT01962987|454736414|FG001|Overall Study|Withdrawal by Subject|10|||
126393885|NCT01962987|454736415|FG002|Overall Study|Withdrawal by Subject|6|||
126393886|NCT01962987|454736413|FG000|Overall Study|Randomized in Error|4|||
126469161|NCT00785928|455020896|FG002|Treatment Phase|Adverse Event|2|||
126469162|NCT00785928|455020897|FG003|Treatment Phase|Adverse Event|0|||
126469163|NCT00785928|455020898|FG004|Treatment Phase|Adverse Event|0|||
126393887|NCT01962987|454736414|FG001|Overall Study|Randomized in Error|2|||
126393888|NCT01962987|454736415|FG002|Overall Study|Randomized in Error|2|||
126393889|NCT00789581|454736421|FG000|AC Therapy|Adverse Event|2|||
126393890|NCT00789581|454736422|FG001|AC Therapy|Adverse Event|3|||
126393891|NCT00789581|454736421|FG000|AC Therapy|Withdrawal by Subject|4|||
126393892|NCT00789581|454736422|FG001|AC Therapy|Withdrawal by Subject|7|||
126393893|NCT00789581|454736421|FG000|AC Therapy|Disease recurrence|3|||
126393894|NCT00789581|454736422|FG001|AC Therapy|Disease recurrence|1|||
126393895|NCT00789581|454736421|FG000|AC Therapy|Intercurrent Illness|1|||
126393896|NCT00789581|454736422|FG001|AC Therapy|Intercurrent Illness|0|||
126393897|NCT00789581|454736421|FG000|AC Therapy|Never Treated|1|||
126393898|NCT00789581|454736422|FG001|AC Therapy|Never Treated|4|||
126393899|NCT00789581|454736421|FG000|AC Therapy|Other|0|||
126393900|NCT00789581|454736422|FG001|AC Therapy|Other|2|||
126393901|NCT00789581|454736421|FG000|Adjuvant Therapy|Never treated|2|||
126393902|NCT00789581|454736422|FG001|Adjuvant Therapy|Never treated|2|||
126393903|NCT00789581|454736421|FG000|Adjuvant Therapy|Adverse Event|20|||
126393904|NCT00789581|454736422|FG001|Adjuvant Therapy|Adverse Event|44|||
126393905|NCT00789581|454736421|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
126393906|NCT00789581|454736422|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
126393907|NCT00789581|454736421|FG000|Adjuvant Therapy|Disease recurrence|2|||
126393908|NCT00789581|454736422|FG001|Adjuvant Therapy|Disease recurrence|1|||
126393909|NCT00789581|454736421|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
126393910|NCT00789581|454736422|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
126393911|NCT00789581|454736421|FG000|Adjuvant Therapy|Protocol Violation|1|||
126393912|NCT00789581|454736422|FG001|Adjuvant Therapy|Protocol Violation|1|||
126393913|NCT00789581|454736421|FG000|Adjuvant Therapy|Other|0|||
126393914|NCT00789581|454736422|FG001|Adjuvant Therapy|Other|1|||
126393915|NCT04021524|454736423|FG000|Overall Study|Change in surgical intervention|0|||
126393916|NCT04021524|454736424|FG001|Overall Study|Change in surgical intervention|1|||
126393917|NCT05275010|454736425|FG000|Overall Study|Reason Not Specified|4|||
126393918|NCT05275010|454736426|FG001|Overall Study|Reason Not Specified|1|||
126393919|NCT05275010|454736425|FG000|Overall Study|Withdrawal by Subject|1|||
126393920|NCT05275010|454736426|FG001|Overall Study|Withdrawal by Subject|0|||
126393921|NCT05275010|454736425|FG000|Overall Study|Lost to Follow-up|0|||
126393922|NCT05275010|454736426|FG001|Overall Study|Lost to Follow-up|1|||
126393923|NCT00730041|454736427|FG000|Overall Study|Lost to Follow-up|0|||
126393924|NCT00730041|454736428|FG001|Overall Study|Lost to Follow-up|2|||
126393925|NCT05526781|454736429|FG000|Overall Study|Lost to Follow-up|1|||
126393926|NCT03327220|454736430|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
126393927|NCT03327220|454736431|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
126393928|NCT03327220|454736430|FG000|Overall Study|Investigator Decision|2|||
126393929|NCT03327220|454736431|FG001|Overall Study|Investigator Decision|0|||
126393930|NCT03327220|454736430|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
126393931|NCT03327220|454736431|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
126393932|NCT03327220|454736430|FG000|Overall Study|Fungal infection|1|||
126393933|NCT03327220|454736431|FG001|Overall Study|Fungal infection|0|||
126393934|NCT03327220|454736430|FG000|Overall Study|Discharged to Rehabilitation|0|||
126393935|NCT03327220|454736431|FG001|Overall Study|Discharged to Rehabilitation|1|||
126393936|NCT03327220|454736430|FG000|Overall Study|Missing|1|||
126393937|NCT03327220|454736431|FG001|Overall Study|Missing|0|||
126393938|NCT00523705|454736434|FG000|Overall Study|No time for study.|0|||
126393939|NCT00523705|454736435|FG001|Overall Study|No time for study.|1|||
126393940|NCT00368836|454736436|FG000|Phase II|Screen Failure|1|||
126393941|NCT00368836|454736436|FG000|Phase II|Withdrawal by Subject|1|||
126393942|NCT00368836|454736436|FG000|Phase II|unable to collect blood and/or breath|17|||
126393943|NCT00368836|454736436|FG000|Phase II|Protocol Violation|2|||
126393944|NCT02442310|454736437|FG000|Overall Study|Adverse Event|2|||
126393945|NCT02442310|454736437|FG000|Overall Study|Withdrawal by Subject|1|||
126393946|NCT03176472|454736438|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
126393947|NCT03176472|454736439|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
126393948|NCT03176472|454736438|FG000|Double Blind Treatment Period|Adverse Event|0|||
126393949|NCT03176472|454736439|FG001|Double Blind Treatment Period|Adverse Event|5|||
126393950|NCT03176472|454736438|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
126393951|NCT03176472|454736439|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
126393952|NCT03176472|454736438|FG000|Double Blind Treatment Period|Physician Decision|0|||
126718946|NCT00358917|455920563|FG001|Overall Study|Withdrawal by Subject|7|||
126718947|NCT00358917|455920562|FG000|Overall Study|Lost to Follow-up|20|||
126393953|NCT03176472|454736439|FG001|Double Blind Treatment Period|Physician Decision|1|||
126393954|NCT03176472|454736438|FG000|Double Blind Treatment Period|Protocol Violation|1|||
126393955|NCT03176472|454736439|FG001|Double Blind Treatment Period|Protocol Violation|0|||
126393956|NCT03176472|454736438|FG000|Double Blind Treatment Period|Not Provided|1|||
126393957|NCT03176472|454736439|FG001|Double Blind Treatment Period|Not Provided|0|||
126393958|NCT03176472|454736438|FG000|Open Label Extension|Withdrawal by Subject|3|||
126393959|NCT03176472|454736439|FG001|Open Label Extension|Withdrawal by Subject|4|||
126393960|NCT03176472|454736438|FG000|Open Label Extension|Adverse Event|2|||
126393961|NCT03176472|454736439|FG001|Open Label Extension|Adverse Event|4|||
126469164|NCT00785928|455020899|FG005|Treatment Phase|Adverse Event|0|||
126718948|NCT00358917|455920563|FG001|Overall Study|Lost to Follow-up|17|||
126718949|NCT00358917|455920562|FG000|Overall Study|Noncompliance|12|||
126393962|NCT03176472|454736438|FG000|Open Label Extension|Lost to Follow-up|1|||
126393963|NCT03176472|454736439|FG001|Open Label Extension|Lost to Follow-up|2|||
126393964|NCT03176472|454736438|FG000|Open Label Extension|Protocol Violation|0|||
126393965|NCT03176472|454736439|FG001|Open Label Extension|Protocol Violation|1|||
126393966|NCT03176472|454736438|FG000|Open Label Extension|Not Provided|2|||
126393967|NCT03176472|454736439|FG001|Open Label Extension|Not Provided|1|||
126393968|NCT03077438|454736440|FG000|Overall Study|Protocol Violation|3|||
126393969|NCT03077438|454736441|FG001|Overall Study|Protocol Violation|5|||
126393970|NCT03077438|454736440|FG000|Overall Study|Withdrawal by Subject|3|||
126393971|NCT03077438|454736441|FG001|Overall Study|Withdrawal by Subject|6|||
126393972|NCT03077438|454736440|FG000|Overall Study|Lost to Follow-up|6|||
126393973|NCT03077438|454736441|FG001|Overall Study|Lost to Follow-up|3|||
126393974|NCT01190475|454736442|FG000|Overall Study|Withdrawal by Subject|0|||
126393975|NCT01190475|454736443|FG001|Overall Study|Withdrawal by Subject|0|||
126393976|NCT01190475|454736444|FG002|Overall Study|Withdrawal by Subject|1|||
126393977|NCT04154345|454736447|FG000|Overall Study|Covid-19 pandemic|4|||
126393978|NCT03622112|454736460|FG000|Overall Study|Withdrawal by Subject|6|||
126393979|NCT03622112|454736461|FG001|Overall Study|Withdrawal by Subject|2|||
126393980|NCT03622112|454736462|FG002|Overall Study|Withdrawal by Subject|4|||
126393981|NCT03622112|454736463|FG003|Overall Study|Withdrawal by Subject|2|||
126393982|NCT03622112|454736464|FG004|Overall Study|Withdrawal by Subject|1|||
126393983|NCT03622112|454736465|FG005|Overall Study|Withdrawal by Subject|2|||
126393984|NCT03622112|454736466|FG006|Overall Study|Withdrawal by Subject|2|||
126393985|NCT03622112|454736460|FG000|Overall Study|Death|0|||
126393986|NCT03622112|454736461|FG001|Overall Study|Death|0|||
126393987|NCT03622112|454736462|FG002|Overall Study|Death|0|||
126393988|NCT03622112|454736463|FG003|Overall Study|Death|1|||
126393989|NCT03622112|454736464|FG004|Overall Study|Death|0|||
126393990|NCT03622112|454736465|FG005|Overall Study|Death|0|||
126393991|NCT03622112|454736466|FG006|Overall Study|Death|0|||
126393992|NCT03622112|454736460|FG000|Overall Study|Lost to Follow-up|1|||
126393993|NCT03622112|454736461|FG001|Overall Study|Lost to Follow-up|1|||
126393994|NCT03622112|454736462|FG002|Overall Study|Lost to Follow-up|0|||
126393995|NCT03622112|454736463|FG003|Overall Study|Lost to Follow-up|0|||
126393996|NCT03622112|454736464|FG004|Overall Study|Lost to Follow-up|0|||
126393997|NCT03622112|454736465|FG005|Overall Study|Lost to Follow-up|0|||
126393998|NCT03622112|454736466|FG006|Overall Study|Lost to Follow-up|0|||
126393999|NCT03622112|454736460|FG000|Overall Study|Study-specific withdrawal criteria|10|||
126394000|NCT03622112|454736461|FG001|Overall Study|Study-specific withdrawal criteria|8|||
126394001|NCT03622112|454736462|FG002|Overall Study|Study-specific withdrawal criteria|7|||
126394002|NCT03622112|454736463|FG003|Overall Study|Study-specific withdrawal criteria|6|||
126394003|NCT03622112|454736464|FG004|Overall Study|Study-specific withdrawal criteria|4|||
126394004|NCT03622112|454736465|FG005|Overall Study|Study-specific withdrawal criteria|18|||
126394005|NCT03622112|454736466|FG006|Overall Study|Study-specific withdrawal criteria|4|||
126394006|NCT03622112|454736460|FG000|Overall Study|Protocol Violation|2|||
126394007|NCT03622112|454736461|FG001|Overall Study|Protocol Violation|0|||
126394008|NCT03622112|454736462|FG002|Overall Study|Protocol Violation|1|||
126394009|NCT03622112|454736463|FG003|Overall Study|Protocol Violation|1|||
126394010|NCT03622112|454736464|FG004|Overall Study|Protocol Violation|0|||
126394011|NCT03622112|454736465|FG005|Overall Study|Protocol Violation|0|||
126394012|NCT03622112|454736466|FG006|Overall Study|Protocol Violation|0|||
126394013|NCT03622112|454736460|FG000|Overall Study|Adverse Event|6|||
126394014|NCT03622112|454736461|FG001|Overall Study|Adverse Event|8|||
126394015|NCT03622112|454736462|FG002|Overall Study|Adverse Event|4|||
126394016|NCT03622112|454736463|FG003|Overall Study|Adverse Event|11|||
126394017|NCT03622112|454736464|FG004|Overall Study|Adverse Event|4|||
126394018|NCT03622112|454736465|FG005|Overall Study|Adverse Event|20|||
126394019|NCT03622112|454736466|FG006|Overall Study|Adverse Event|2|||
126394020|NCT03622112|454736460|FG000|Overall Study|Reason not specified|0|||
126394021|NCT03622112|454736461|FG001|Overall Study|Reason not specified|1|||
126394022|NCT03622112|454736462|FG002|Overall Study|Reason not specified|0|||
126394023|NCT03622112|454736463|FG003|Overall Study|Reason not specified|1|||
126394024|NCT03622112|454736464|FG004|Overall Study|Reason not specified|1|||
126394025|NCT03622112|454736465|FG005|Overall Study|Reason not specified|2|||
126394026|NCT03622112|454736466|FG006|Overall Study|Reason not specified|1|||
126394027|NCT03773133|454736467|FG000|Overall Study|Screen Failure|8|||
126394028|NCT01610713|454736468|FG000|Overall Study|Adverse Event|3|||
126394029|NCT01610713|454736469|FG001|Overall Study|Adverse Event|0|||
126394030|NCT01610713|454736468|FG000|Overall Study|Lack of Efficacy|1|||
126394031|NCT01610713|454736469|FG001|Overall Study|Lack of Efficacy|0|||
126394032|NCT01610713|454736468|FG000|Overall Study|low mood and poor motivation|1|||
126394033|NCT01610713|454736469|FG001|Overall Study|low mood and poor motivation|0|||
126394034|NCT01610713|454736468|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
126394035|NCT01610713|454736469|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
126394036|NCT01610713|454736468|FG000|Overall Study|Lost to Follow-up|0|||
126394037|NCT01610713|454736469|FG001|Overall Study|Lost to Follow-up|1|||
126394038|NCT03943550|454736473|FG000|Overall Study|Adverse Event|0|||
126394039|NCT03943550|454736474|FG001|Overall Study|Adverse Event|0|||
126394040|NCT03943550|454736475|FG002|Overall Study|Adverse Event|1|||
126394041|NCT03943550|454736473|FG000|Overall Study|Lost to Follow-up|0|||
126394042|NCT03943550|454736474|FG001|Overall Study|Lost to Follow-up|0|||
126394043|NCT03943550|454736475|FG002|Overall Study|Lost to Follow-up|1|||
126394044|NCT03943550|454736473|FG000|Overall Study|Progressive Disease|0|||
126394045|NCT03943550|454736474|FG001|Overall Study|Progressive Disease|0|||
126394046|NCT03943550|454736475|FG002|Overall Study|Progressive Disease|2|||
126394047|NCT03943550|454736473|FG000|Overall Study|Participant Moved Out of the Country|0|||
126394048|NCT03943550|454736474|FG001|Overall Study|Participant Moved Out of the Country|1|||
126394049|NCT03943550|454736475|FG002|Overall Study|Participant Moved Out of the Country|0|||
126394050|NCT03359785|454736476|FG000|Overall Study|Protocol Violation|0|||
126394051|NCT03359785|454736477|FG001|Overall Study|Protocol Violation|1|||
126394052|NCT03359785|454736478|FG002|Overall Study|Protocol Violation|0|||
126394053|NCT03359785|454736479|FG003|Overall Study|Protocol Violation|0|||
126394054|NCT03359785|454736476|FG000|Overall Study|Early study termination due to study pause|0|||
126394055|NCT03359785|454736477|FG001|Overall Study|Early study termination due to study pause|0|||
126394056|NCT03359785|454736478|FG002|Overall Study|Early study termination due to study pause|2|||
126394057|NCT03359785|454736479|FG003|Overall Study|Early study termination due to study pause|0|||
126394058|NCT03359785|454736476|FG000|Overall Study|Withdrawal by Subject|2|||
126394059|NCT03359785|454736477|FG001|Overall Study|Withdrawal by Subject|2|||
126394060|NCT03359785|454736478|FG002|Overall Study|Withdrawal by Subject|0|||
126394061|NCT03359785|454736479|FG003|Overall Study|Withdrawal by Subject|0|||
126394062|NCT01895543|454736480|FG000|Overall Study|Withdrawal by Subject|43|||
126394063|NCT01895543|454736480|FG000|Overall Study|Lost to Follow-up|25|||
126394064|NCT01895543|454736480|FG000|Overall Study|Adverse Event|28|||
126394065|NCT01895543|454736480|FG000|Overall Study|Subject's substantial non-compliance|6|||
126394066|NCT01895543|454736480|FG000|Overall Study|Protocol Violation|1|||
126394067|NCT01895543|454736480|FG000|Overall Study|Physician Decision|2|||
126394068|NCT01895543|454736480|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
126394069|NCT03650803|454736484|FG000|Overall Study|Lost to Follow-up|6|||
126394070|NCT02901054|454736487|FG000|Overall Study|Physician Decision|1|||
126394071|NCT02901054|454736487|FG000|Overall Study|Withdrawal by Subject|3|||
126394072|NCT01534260|454736488|FG000|Overall Study|Adverse Event|1|||
126394073|NCT01534260|454736489|FG001|Overall Study|Adverse Event|8|||
126394074|NCT01534260|454736488|FG000|Overall Study|Death|2|||
126394075|NCT01534260|454736489|FG001|Overall Study|Death|0|||
126394076|NCT01534260|454736488|FG000|Overall Study|Lack of Efficacy|1|||
126394077|NCT01534260|454736489|FG001|Overall Study|Lack of Efficacy|1|||
126394078|NCT01534260|454736488|FG000|Overall Study|Withdrawal by Subject|1|||
126394079|NCT01534260|454736489|FG001|Overall Study|Withdrawal by Subject|3|||
126394080|NCT01534260|454736488|FG000|Overall Study|Disease Progression|8|||
126394081|NCT01534260|454736489|FG001|Overall Study|Disease Progression|6|||
126394082|NCT01534260|454736488|FG000|Overall Study|Physician Decision|3|||
126394083|NCT01534260|454736489|FG001|Overall Study|Physician Decision|1|||
126394084|NCT01534260|454736488|FG000|Overall Study|No treatment, per protocol|0|||
126394085|NCT01534260|454736489|FG001|Overall Study|No treatment, per protocol|1|||
126394086|NCT05145322|454736493|FG000|Overall Study|Lost to Follow-up|4|||
126394087|NCT05145322|454736494|FG001|Overall Study|Lost to Follow-up|5|||
126394088|NCT04376684|454736495|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
126394089|NCT04376684|454736496|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
126394090|NCT04376684|454736497|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
126394091|NCT04376684|454736498|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
126394092|NCT04376684|454736495|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
126394093|NCT04376684|454736496|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
126394094|NCT04376684|454736497|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
126394095|NCT04376684|454736498|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
126394096|NCT04376684|454736495|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
126469165|NCT00785928|455020900|FG006|Treatment Phase|Adverse Event|2|||
126718950|NCT00358917|455920563|FG001|Overall Study|Noncompliance|11|||
126718951|NCT00358917|455920562|FG000|Overall Study|Death|2|||
126469166|NCT00785928|455020894|FG000|Treatment Phase|Inadequate Response|0|||
126718952|NCT00358917|455920563|FG001|Overall Study|Death|3|||
126718953|NCT00358917|455920562|FG000|Overall Study|Virologic failure|11|||
126469167|NCT00785928|455020895|FG001|Treatment Phase|Inadequate Response|1|||
126469168|NCT00785928|455020896|FG002|Treatment Phase|Inadequate Response|0|||
126469169|NCT00785928|455020897|FG003|Treatment Phase|Inadequate Response|0|||
126718954|NCT00358917|455920563|FG001|Overall Study|Virologic failure|8|||
126394097|NCT04376684|454736496|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
126394098|NCT04376684|454736497|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
126394099|NCT04376684|454736498|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
126394100|NCT04376684|454736495|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
126394101|NCT04376684|454736496|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
126394102|NCT04376684|454736497|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
126394103|NCT04376684|454736498|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
126394104|NCT04376684|454736495|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
126718955|NCT00358917|455920562|FG000|Overall Study|Unable to Continue Participation|2|||
126394105|NCT04376684|454736496|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
126394106|NCT04376684|454736497|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
126394107|NCT04376684|454736498|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
126394108|NCT04376684|454736495|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
126394109|NCT04376684|454736496|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
126394110|NCT04376684|454736497|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
126394111|NCT04376684|454736498|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
126394112|NCT04376684|454736495|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
126394113|NCT04376684|454736496|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
126394114|NCT04376684|454736497|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
126394115|NCT04376684|454736498|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
126394116|NCT02979093|454736502|FG000|First Scan Session|Scanning data problems|1|||
126394117|NCT02979093|454736503|FG001|First Scan Session|Scanning data problems|2|||
126394118|NCT02979093|454736504|FG002|First Scan Session|Scanning data problems|2|||
126394119|NCT02979093|454736505|FG003|First Scan Session|Scanning data problems|0|||
126394120|NCT02979093|454736502|FG000|Second Scan Session|Scanning data problems|3|||
126394121|NCT02979093|454736503|FG001|Second Scan Session|Scanning data problems|0|||
126394122|NCT02979093|454736504|FG002|Second Scan Session|Scanning data problems|1|||
126394123|NCT02979093|454736505|FG003|Second Scan Session|Scanning data problems|3|||
126394124|NCT03099174|454736506|FG000|Overall Study|Withdrawal by Subject|0|||
126394125|NCT03099174|454736507|FG001|Overall Study|Withdrawal by Subject|0|||
126394126|NCT03099174|454736508|FG002|Overall Study|Withdrawal by Subject|1|||
126394127|NCT03099174|454736509|FG003|Overall Study|Withdrawal by Subject|0|||
126394128|NCT03099174|454736510|FG004|Overall Study|Withdrawal by Subject|2|||
126394129|NCT03099174|454736511|FG005|Overall Study|Withdrawal by Subject|2|||
126394130|NCT03099174|454736512|FG006|Overall Study|Withdrawal by Subject|1|||
126394131|NCT03099174|454736513|FG007|Overall Study|Withdrawal by Subject|4|||
126394132|NCT03099174|454736506|FG000|Overall Study|Adverse Event|0|||
126394133|NCT03099174|454736507|FG001|Overall Study|Adverse Event|1|||
126394134|NCT03099174|454736508|FG002|Overall Study|Adverse Event|1|||
126394135|NCT03099174|454736509|FG003|Overall Study|Adverse Event|2|||
126394136|NCT03099174|454736510|FG004|Overall Study|Adverse Event|5|||
126394137|NCT03099174|454736511|FG005|Overall Study|Adverse Event|3|||
126394138|NCT03099174|454736512|FG006|Overall Study|Adverse Event|6|||
126394139|NCT03099174|454736513|FG007|Overall Study|Adverse Event|4|||
126394140|NCT03099174|454736506|FG000|Overall Study|Other than listed|6|||
126394141|NCT03099174|454736507|FG001|Overall Study|Other than listed|6|||
126394142|NCT03099174|454736508|FG002|Overall Study|Other than listed|5|||
126394143|NCT03099174|454736509|FG003|Overall Study|Other than listed|6|||
126394144|NCT03099174|454736510|FG004|Overall Study|Other than listed|19|||
126394145|NCT03099174|454736511|FG005|Overall Study|Other than listed|10|||
126394146|NCT03099174|454736512|FG006|Overall Study|Other than listed|26|||
126394147|NCT03099174|454736513|FG007|Overall Study|Other than listed|23|||
126718956|NCT00358917|455920563|FG001|Overall Study|Unable to Continue Participation|2|||
126718957|NCT01379534|455920568|FG000|Treatment Phase|Withdrawal by Subject|2|||
126718958|NCT01379534|455920569|FG001|Treatment Phase|Withdrawal by Subject|2|||
126394148|NCT04173260|454736514|FG000|Overall Study|Early termination|4|||
126394149|NCT01096368|454736515|FG000|Overall Study|Death|0|||
126394150|NCT01096368|454736516|FG001|Overall Study|Death|1|||
126394151|NCT01096368|454736517|FG002|Overall Study|Death|0|||
126394152|NCT01096368|454736518|FG003|Overall Study|Death|0|||
126394153|NCT01096368|454736519|FG004|Overall Study|Death|0|||
126394154|NCT01096368|454736515|FG000|Overall Study|Physician Decision|0|||
126394155|NCT01096368|454736516|FG001|Overall Study|Physician Decision|13|||
126394156|NCT01096368|454736517|FG002|Overall Study|Physician Decision|2|||
126394157|NCT01096368|454736518|FG003|Overall Study|Physician Decision|4|||
126394158|NCT01096368|454736519|FG004|Overall Study|Physician Decision|6|||
126394159|NCT01096368|454736515|FG000|Overall Study|Withdrawal by Subject|0|||
126394160|NCT01096368|454736516|FG001|Overall Study|Withdrawal by Subject|52|||
126394161|NCT01096368|454736517|FG002|Overall Study|Withdrawal by Subject|0|||
126394162|NCT01096368|454736518|FG003|Overall Study|Withdrawal by Subject|10|||
126394163|NCT01096368|454736519|FG004|Overall Study|Withdrawal by Subject|14|||
126394164|NCT01096368|454736515|FG000|Overall Study|Ineligible|0|||
126394165|NCT01096368|454736516|FG001|Overall Study|Ineligible|3|||
126394166|NCT01096368|454736517|FG002|Overall Study|Ineligible|2|||
126394167|NCT01096368|454736518|FG003|Overall Study|Ineligible|0|||
126394168|NCT01096368|454736519|FG004|Overall Study|Ineligible|25|||
126394169|NCT01096368|454736515|FG000|Overall Study|Did not start treatment|0|||
126394170|NCT01096368|454736516|FG001|Overall Study|Did not start treatment|4|||
126394171|NCT01096368|454736517|FG002|Overall Study|Did not start treatment|4|||
126718959|NCT01379534|455920568|FG000|Treatment Phase|Progressive disease|13|||
126394172|NCT01096368|454736518|FG003|Overall Study|Did not start treatment|0|||
126394173|NCT01096368|454736519|FG004|Overall Study|Did not start treatment|0|||
126394174|NCT01096368|454736515|FG000|Overall Study|Progressive disease|0|||
126394175|NCT01096368|454736516|FG001|Overall Study|Progressive disease|6|||
126394176|NCT01096368|454736517|FG002|Overall Study|Progressive disease|0|||
126394177|NCT01096368|454736518|FG003|Overall Study|Progressive disease|10|||
126394178|NCT01096368|454736519|FG004|Overall Study|Progressive disease|3|||
126394179|NCT01096368|454736515|FG000|Overall Study|Other|0|||
126394180|NCT01096368|454736516|FG001|Overall Study|Other|0|||
126394181|NCT01096368|454736517|FG002|Overall Study|Other|1|||
126394182|NCT01096368|454736518|FG003|Overall Study|Other|0|||
126394183|NCT01096368|454736519|FG004|Overall Study|Other|0|||
126394184|NCT01096368|454736515|FG000|Overall Study|Treated with institutional review|0|||
126394185|NCT01096368|454736516|FG001|Overall Study|Treated with institutional review|0|||
126394186|NCT01096368|454736517|FG002|Overall Study|Treated with institutional review|0|||
126394187|NCT01096368|454736518|FG003|Overall Study|Treated with institutional review|0|||
126394188|NCT01096368|454736519|FG004|Overall Study|Treated with institutional review|1|||
126394189|NCT03070223|454736520|FG000|Overall Study|Lost to Follow-up|34|||
126394190|NCT03070223|454736521|FG001|Overall Study|Lost to Follow-up|27|||
126394191|NCT03070223|454736520|FG000|Overall Study|Withdrawal by Subject|12|||
126394192|NCT03070223|454736521|FG001|Overall Study|Withdrawal by Subject|22|||
126394193|NCT03070223|454736520|FG000|Overall Study|Protocol Violation|0|||
126394194|NCT03070223|454736521|FG001|Overall Study|Protocol Violation|1|||
126394195|NCT02308163|454736522|FG000|Overall Study|Not fulfill eligible criteria|1|||
126394196|NCT02308163|454736523|FG001|Overall Study|Not fulfill eligible criteria|2|||
126394197|NCT02308163|454736524|FG002|Overall Study|Not fulfill eligible criteria|0|||
126394198|NCT02308163|454736525|FG003|Overall Study|Not fulfill eligible criteria|1|||
126394199|NCT02308163|454736526|FG004|Overall Study|Not fulfill eligible criteria|1|||
126394200|NCT02308163|454736522|FG000|Overall Study|Adverse Event|9|||
126394201|NCT02308163|454736523|FG001|Overall Study|Adverse Event|5|||
126394202|NCT02308163|454736524|FG002|Overall Study|Adverse Event|2|||
126394203|NCT02308163|454736525|FG003|Overall Study|Adverse Event|2|||
126394204|NCT02308163|454736526|FG004|Overall Study|Adverse Event|11|||
126394205|NCT02308163|454736522|FG000|Overall Study|Lack of Efficacy|11|||
126394206|NCT02308163|454736523|FG001|Overall Study|Lack of Efficacy|3|||
126394207|NCT02308163|454736524|FG002|Overall Study|Lack of Efficacy|8|||
126394208|NCT02308163|454736525|FG003|Overall Study|Lack of Efficacy|4|||
126394209|NCT02308163|454736526|FG004|Overall Study|Lack of Efficacy|6|||
126394210|NCT02308163|454736522|FG000|Overall Study|Withdrawal of consent|2|||
126394211|NCT02308163|454736523|FG001|Overall Study|Withdrawal of consent|3|||
126394212|NCT02308163|454736524|FG002|Overall Study|Withdrawal of consent|0|||
126394213|NCT02308163|454736525|FG003|Overall Study|Withdrawal of consent|2|||
126394214|NCT02308163|454736526|FG004|Overall Study|Withdrawal of consent|6|||
126394215|NCT02308163|454736522|FG000|Overall Study|Protocol Violation|3|||
126394216|NCT02308163|454736523|FG001|Overall Study|Protocol Violation|3|||
126394217|NCT02308163|454736524|FG002|Overall Study|Protocol Violation|3|||
126394218|NCT02308163|454736525|FG003|Overall Study|Protocol Violation|2|||
126394219|NCT02308163|454736526|FG004|Overall Study|Protocol Violation|5|||
126394220|NCT02308163|454736522|FG000|Overall Study|Lab data met discontinuation criteria|3|||
126394221|NCT02308163|454736523|FG001|Overall Study|Lab data met discontinuation criteria|0|||
126469170|NCT00785928|455020898|FG004|Treatment Phase|Inadequate Response|0|||
126469171|NCT00785928|455020899|FG005|Treatment Phase|Inadequate Response|0|||
126469172|NCT00785928|455020900|FG006|Treatment Phase|Inadequate Response|0|||
126394222|NCT02308163|454736524|FG002|Overall Study|Lab data met discontinuation criteria|0|||
126394223|NCT02308163|454736525|FG003|Overall Study|Lab data met discontinuation criteria|2|||
126394224|NCT02308163|454736526|FG004|Overall Study|Lab data met discontinuation criteria|0|||
126394225|NCT02308163|454736522|FG000|Overall Study|Miscellaneous|2|||
126394226|NCT02308163|454736523|FG001|Overall Study|Miscellaneous|2|||
126394227|NCT02308163|454736524|FG002|Overall Study|Miscellaneous|1|||
126394228|NCT02308163|454736525|FG003|Overall Study|Miscellaneous|0|||
126394229|NCT02308163|454736526|FG004|Overall Study|Miscellaneous|5|||
126394230|NCT03941964|454736529|FG000|Overall Study|Adverse Event|1|||
126394231|NCT03941964|454736530|FG001|Overall Study|Adverse Event|8|||
126394232|NCT03941964|454736529|FG000|Overall Study|Progressive disease|7|||
126394233|NCT03941964|454736530|FG001|Overall Study|Progressive disease|3|||
126394234|NCT03941964|454736529|FG000|Overall Study|Lack of Efficacy|0|||
126394235|NCT03941964|454736530|FG001|Overall Study|Lack of Efficacy|1|||
126394236|NCT03941964|454736529|FG000|Overall Study|Death|3|||
126394237|NCT03941964|454736530|FG001|Overall Study|Death|1|||
126394238|NCT03941964|454736529|FG000|Overall Study|Withdrew consent|1|||
126394239|NCT03941964|454736530|FG001|Overall Study|Withdrew consent|3|||
126394240|NCT03941964|454736529|FG000|Overall Study|Physician Decision|9|||
126394241|NCT03941964|454736530|FG001|Overall Study|Physician Decision|2|||
126394242|NCT03941964|454736529|FG000|Overall Study|Other, not specified|2|||
126394243|NCT03941964|454736530|FG001|Overall Study|Other, not specified|1|||
126394244|NCT02136680|454736535|FG000|Overall Study|No Longer Interested|1|||
126469173|NCT00785928|455020894|FG000|Treatment Phase|Lack of Efficacy|0|||
126469174|NCT00785928|455020895|FG001|Treatment Phase|Lack of Efficacy|1|||
126394245|NCT02136680|454736536|FG001|Overall Study|No Longer Interested|1|||
126394246|NCT02136680|454736535|FG000|Overall Study|No longer receiving care at clinic|3|||
126394247|NCT02136680|454736536|FG001|Overall Study|No longer receiving care at clinic|5|||
126394248|NCT02136680|454736535|FG000|Overall Study|Moved away|5|||
126394249|NCT02136680|454736536|FG001|Overall Study|Moved away|4|||
126394250|NCT02136680|454736535|FG000|Overall Study|Unable to schedule|17|||
126394251|NCT02136680|454736536|FG001|Overall Study|Unable to schedule|16|||
126394252|NCT02136680|454736535|FG000|Overall Study|Study ended before interview due|6|||
126394253|NCT02136680|454736536|FG001|Overall Study|Study ended before interview due|3|||
126394254|NCT05151445|454736537|FG000|Overall Study|Withdrawal by Subject|3|||
126394255|NCT02298179|454736538|FG000|Overall Study|Lost to Follow-up|0|||
126394256|NCT02298179|454736539|FG001|Overall Study|Lost to Follow-up|0|||
126394257|NCT02298179|454736540|FG002|Overall Study|Lost to Follow-up|1|||
126394258|NCT02298179|454736541|FG003|Overall Study|Lost to Follow-up|0|||
126394259|NCT02298179|454736542|FG004|Overall Study|Lost to Follow-up|0|||
126394260|NCT02298179|454736543|FG005|Overall Study|Lost to Follow-up|0|||
126394261|NCT02298179|454736544|FG006|Overall Study|Lost to Follow-up|0|||
126394262|NCT02298179|454736545|FG007|Overall Study|Lost to Follow-up|1|||
126394263|NCT02298179|454736546|FG008|Overall Study|Lost to Follow-up|0|||
126394264|NCT02298179|454736547|FG009|Overall Study|Lost to Follow-up|0|||
126394265|NCT02298179|454736548|FG010|Overall Study|Lost to Follow-up|0|||
126394266|NCT02298179|454736549|FG011|Overall Study|Lost to Follow-up|0|||
126394267|NCT03559517|454736552|FG000|Overall Study|Withdrawal by Subject|1|||
126394268|NCT03559517|454736553|FG001|Overall Study|Withdrawal by Subject|0|||
126394269|NCT03559517|454736554|FG002|Overall Study|Withdrawal by Subject|0|||
126394270|NCT01457014|454736555|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
126394271|NCT01457014|454736556|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
126394272|NCT01457014|454736557|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
126394273|NCT01457014|454736558|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
126394274|NCT01457014|454736555|FG000|First Night|Withdrawal by Subject|3|||
126394275|NCT01457014|454736556|FG001|First Night|Withdrawal by Subject|0|||
126394276|NCT01457014|454736557|FG002|First Night|Withdrawal by Subject|0|||
126394277|NCT01457014|454736558|FG003|First Night|Withdrawal by Subject|0|||
126394278|NCT01357161|454736559|FG000|Part 1 (Open Label Run-in)|Death|5|||
126394279|NCT01357161|454736560|FG001|Part 1 (Open Label Run-in)|Death|0|||
126469175|NCT00785928|455020896|FG002|Treatment Phase|Lack of Efficacy|1|||
126469176|NCT00785928|455020897|FG003|Treatment Phase|Lack of Efficacy|0|||
126469177|NCT00785928|455020898|FG004|Treatment Phase|Lack of Efficacy|0|||
126469178|NCT00785928|455020899|FG005|Treatment Phase|Lack of Efficacy|0|||
126469179|NCT00785928|455020900|FG006|Treatment Phase|Lack of Efficacy|0|||
126469180|NCT00785928|455020894|FG000|Treatment Phase|Physician Decision|0|||
126469181|NCT00785928|455020895|FG001|Treatment Phase|Physician Decision|0|||
126469182|NCT00785928|455020896|FG002|Treatment Phase|Physician Decision|0|||
126469183|NCT00785928|455020897|FG003|Treatment Phase|Physician Decision|0|||
126394280|NCT01357161|454736561|FG002|Part 1 (Open Label Run-in)|Death|0|||
126394281|NCT01357161|454736559|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
126394282|NCT01357161|454736560|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
126394283|NCT01357161|454736561|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
126394284|NCT01357161|454736559|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
126394285|NCT01357161|454736560|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
126394286|NCT01357161|454736561|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
126394287|NCT01357161|454736559|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
126394288|NCT01357161|454736560|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
126394289|NCT01357161|454736561|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
126394290|NCT01357161|454736559|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
126394291|NCT01357161|454736560|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
126394292|NCT01357161|454736561|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
126394293|NCT01357161|454736559|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
126394294|NCT01357161|454736560|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
126394295|NCT01357161|454736561|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
126394296|NCT01357161|454736559|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
126394297|NCT01357161|454736560|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
126394298|NCT01357161|454736561|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
126394299|NCT01357161|454736559|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
126394300|NCT01357161|454736560|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
126394301|NCT01357161|454736561|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
126394302|NCT01357161|454736559|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
126394303|NCT01357161|454736560|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
126394304|NCT01357161|454736561|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
126394305|NCT01357161|454736559|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
126394306|NCT01357161|454736560|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
126718960|NCT01379534|455920569|FG001|Treatment Phase|Progressive disease|22|||
126394307|NCT01357161|454736561|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
126394308|NCT01357161|454736559|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
126394309|NCT01357161|454736560|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
126394310|NCT01357161|454736561|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
126469184|NCT00785928|455020898|FG004|Treatment Phase|Physician Decision|1|||
126718961|NCT01379534|455920568|FG000|Treatment Phase|Adverse Event|7|||
126718962|NCT01379534|455920569|FG001|Treatment Phase|Adverse Event|7|||
126718963|NCT01379534|455920568|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
126469185|NCT00785928|455020899|FG005|Treatment Phase|Physician Decision|0|||
126718964|NCT01379534|455920569|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
126718965|NCT01379534|455920568|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
126718966|NCT01379534|455920569|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
126718967|NCT01379534|455920568|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
126718968|NCT01379534|455920569|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
126718969|NCT01379534|455920568|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
126718970|NCT01379534|455920569|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
126718971|NCT05372575|455920576|FG000|Overall Study|Protocol Violation|7|||
126718972|NCT05372575|455920577|FG001|Overall Study|Protocol Violation|16|||
126771584|NCT02587325|456117839|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
126394311|NCT02825420|454736563|FG000|Overall Study|Death|30|||
126394312|NCT02825420|454736564|FG001|Overall Study|Death|12|||
126394313|NCT02825420|454736563|FG000|Overall Study|Progressive disease|6|||
126394314|NCT02825420|454736564|FG001|Overall Study|Progressive disease|1|||
126394315|NCT02825420|454736563|FG000|Overall Study|Lost to Follow-up|2|||
126394316|NCT02825420|454736564|FG001|Overall Study|Lost to Follow-up|2|||
126394317|NCT02825420|454736563|FG000|Overall Study|Withdrawal by Subject|1|||
126394318|NCT02825420|454736564|FG001|Overall Study|Withdrawal by Subject|1|||
126394319|NCT02825420|454736563|FG000|Overall Study|Protocol amendment not signed|1|||
126394320|NCT02825420|454736564|FG001|Overall Study|Protocol amendment not signed|1|||
126394321|NCT02825420|454736563|FG000|Overall Study|Physician Decision|1|||
126394322|NCT02825420|454736564|FG001|Overall Study|Physician Decision|0|||
126394323|NCT02825420|454736563|FG000|Overall Study|Did not receive PLD|2|||
126394324|NCT02825420|454736564|FG001|Overall Study|Did not receive PLD|0|||
126394325|NCT04027049|454736565|FG000|Overall Study|Withdrawn by family|1|||
126394326|NCT04027049|454736566|FG001|Overall Study|Withdrawn by family|0|||
126394327|NCT04027049|454736565|FG000|Overall Study|Participant safety|1|||
126394328|NCT04027049|454736566|FG001|Overall Study|Participant safety|0|||
126394329|NCT02226198|454738019|FG000|Lead-in Phase|Protocol Violation|1|||
126394330|NCT02226198|454738020|FG001|Lead-in Phase|Protocol Violation|0|||
126394331|NCT02226198|454738021|FG002|Lead-in Phase|Protocol Violation|0|||
126394332|NCT02226198|454738019|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
126394333|NCT02226198|454738020|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
126394334|NCT02226198|454738021|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
126394335|NCT01288612|454738023|FG000|Overall Study|Unable to contact|11|||
126394336|NCT01288612|454738024|FG001|Overall Study|Unable to contact|16|||
126394337|NCT01288612|454738025|FG002|Overall Study|Unable to contact|20|||
126394338|NCT01288612|454738023|FG000|Overall Study|Declined|78|||
126394339|NCT01288612|454738024|FG001|Overall Study|Declined|63|||
126394340|NCT01288612|454738025|FG002|Overall Study|Declined|62|||
126394341|NCT01288612|454738023|FG000|Overall Study|Unable to intubate|0|||
126394342|NCT01288612|454738024|FG001|Overall Study|Unable to intubate|3|||
126394343|NCT01288612|454738025|FG002|Overall Study|Unable to intubate|0|||
126394344|NCT00871923|454738026|FG000|Overall Study|Death|1|||
126394345|NCT00871923|454738026|FG000|Overall Study|Withdrawal by Subject|1|||
126394346|NCT05599451|454738027|FG000|Overall Study|Not randomized|11|||
126394347|NCT05599451|454738028|FG001|Overall Study|Not randomized|0|||
126394348|NCT05599451|454738029|FG002|Overall Study|Not randomized|0|||
126394349|NCT05599451|454738030|FG003|Overall Study|Not randomized|0|||
126394350|NCT05599451|454738031|FG004|Overall Study|Not randomized|0|||
126394351|NCT05599451|454738027|FG000|Overall Study|Physician Decision|0|||
126394352|NCT05599451|454738028|FG001|Overall Study|Physician Decision|0|||
126394353|NCT05599451|454738029|FG002|Overall Study|Physician Decision|0|||
126394354|NCT05599451|454738030|FG003|Overall Study|Physician Decision|1|||
126394355|NCT05599451|454738031|FG004|Overall Study|Physician Decision|0|||
126394356|NCT01730339|454738032|FG000|Overall Study|Withdrawal by Subject|3|||
126394357|NCT01730339|454738033|FG001|Overall Study|Withdrawal by Subject|2|||
126394358|NCT01730339|454738032|FG000|Overall Study|Lost to Follow-up|1|||
126469186|NCT00785928|455020900|FG006|Treatment Phase|Physician Decision|0|||
126469187|NCT00785928|455020894|FG000|Treatment Phase|Sponsor Decision|1|||
126771585|NCT02587325|456117835|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
126771586|NCT02587325|456117836|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
126394359|NCT01730339|454738033|FG001|Overall Study|Lost to Follow-up|1|||
126394360|NCT01730339|454738032|FG000|Overall Study|Un-specified|1|||
126394361|NCT01730339|454738033|FG001|Overall Study|Un-specified|0|||
126394362|NCT01145352|454738034|FG000|Overall Study|Found to have been registered twice|6|||
126394363|NCT01145352|454738034|FG000|Overall Study|Treated before marketing approval|4|||
126394364|NCT01145352|454738034|FG000|Overall Study|Syringe formulation was used|1|||
126394365|NCT04143217|454738035|FG000|Overall Study|Withdrawal by Subject|42|||
126394366|NCT04143217|454738035|FG000|Overall Study|Adverse Event|29|||
126394367|NCT04143217|454738035|FG000|Overall Study|Lost to Follow-up|29|||
126394368|NCT04143217|454738035|FG000|Overall Study|Lack of Efficacy|15|||
126718973|NCT01096550|455920578|FG000|Overall Study|discontinued site|10|||
126394369|NCT04143217|454738035|FG000|Overall Study|Physician Decision|1|||
126394370|NCT04143217|454738035|FG000|Overall Study|Non-Compliance With Study Drug|6|||
126718974|NCT01096550|455920579|FG001|Overall Study|discontinued site|11|||
126718975|NCT01096550|455920578|FG000|Overall Study|non-regular treatment track at clinic|1|||
126718976|NCT01096550|455920579|FG001|Overall Study|non-regular treatment track at clinic|1|||
126718977|NCT01096550|455920578|FG000|Overall Study|clinic readmission|1|||
126718978|NCT01096550|455920579|FG001|Overall Study|clinic readmission|1|||
126718979|NCT01096550|455920578|FG000|Overall Study|Withdrawal by Subject|0|||
126718980|NCT01096550|455920579|FG001|Overall Study|Withdrawal by Subject|1|||
126718981|NCT01096550|455920578|FG000|Overall Study|non-African American participant|13|||
126718982|NCT01096550|455920579|FG001|Overall Study|non-African American participant|6|||
126718983|NCT01096550|455920578|FG000|Overall Study|Lost to Follow-up|12|||
126718984|NCT01096550|455920579|FG001|Overall Study|Lost to Follow-up|9|||
126718985|NCT01544595|455920582|FG000|Status at Week 68|Adverse Event|3|||
126718986|NCT01544595|455920583|FG001|Status at Week 68|Adverse Event|2|||
126718987|NCT01544595|455920584|FG002|Status at Week 68|Adverse Event|1|||
126718988|NCT01544595|455920585|FG003|Status at Week 68|Adverse Event|0|||
126718989|NCT01544595|455920586|FG004|Status at Week 68|Adverse Event|0|||
126718990|NCT01544595|455920587|FG005|Status at Week 68|Adverse Event|0|||
126718991|NCT01544595|455920582|FG000|Status at Week 68|Lack of Efficacy|1|||
126718992|NCT01544595|455920583|FG001|Status at Week 68|Lack of Efficacy|0|||
126718993|NCT01544595|455920584|FG002|Status at Week 68|Lack of Efficacy|0|||
126718994|NCT01544595|455920585|FG003|Status at Week 68|Lack of Efficacy|0|||
126718995|NCT01544595|455920586|FG004|Status at Week 68|Lack of Efficacy|0|||
126718996|NCT01544595|455920587|FG005|Status at Week 68|Lack of Efficacy|0|||
126718997|NCT01544595|455920582|FG000|Status at Week 68|Lost to Follow-up|1|||
126718998|NCT01544595|455920583|FG001|Status at Week 68|Lost to Follow-up|1|||
126718999|NCT01544595|455920584|FG002|Status at Week 68|Lost to Follow-up|0|||
126719000|NCT01544595|455920585|FG003|Status at Week 68|Lost to Follow-up|0|||
126719001|NCT01544595|455920586|FG004|Status at Week 68|Lost to Follow-up|0|||
126719002|NCT01544595|455920587|FG005|Status at Week 68|Lost to Follow-up|0|||
126719003|NCT01544595|455920582|FG000|Status at Week 68|Non-compliance with study treatment|1|||
126719004|NCT01544595|455920583|FG001|Status at Week 68|Non-compliance with study treatment|0|||
126719005|NCT01544595|455920584|FG002|Status at Week 68|Non-compliance with study treatment|0|||
126719006|NCT01544595|455920585|FG003|Status at Week 68|Non-compliance with study treatment|1|||
126719007|NCT01544595|455920586|FG004|Status at Week 68|Non-compliance with study treatment|0|||
126719008|NCT01544595|455920587|FG005|Status at Week 68|Non-compliance with study treatment|0|||
126719009|NCT01544595|455920582|FG000|Status at Week 68|Protocol Violation|2|||
126719010|NCT01544595|455920583|FG001|Status at Week 68|Protocol Violation|0|||
126719011|NCT01544595|455920584|FG002|Status at Week 68|Protocol Violation|1|||
126719012|NCT01544595|455920585|FG003|Status at Week 68|Protocol Violation|1|||
126719013|NCT01544595|455920586|FG004|Status at Week 68|Protocol Violation|0|||
126719014|NCT01544595|455920587|FG005|Status at Week 68|Protocol Violation|0|||
126719015|NCT01544595|455920582|FG000|Status at Week 68|Technical problems|1|||
126719016|NCT01544595|455920583|FG001|Status at Week 68|Technical problems|0|||
126719017|NCT01544595|455920584|FG002|Status at Week 68|Technical problems|0|||
126719018|NCT01544595|455920585|FG003|Status at Week 68|Technical problems|1|||
126719019|NCT01544595|455920586|FG004|Status at Week 68|Technical problems|0|||
126719020|NCT01544595|455920587|FG005|Status at Week 68|Technical problems|0|||
126719021|NCT01544595|455920582|FG000|Status at Week 68|Withdrawal by Subject|0|||
126719022|NCT01544595|455920583|FG001|Status at Week 68|Withdrawal by Subject|1|||
126719023|NCT01544595|455920584|FG002|Status at Week 68|Withdrawal by Subject|1|||
126719024|NCT01544595|455920585|FG003|Status at Week 68|Withdrawal by Subject|2|||
126719025|NCT01544595|455920586|FG004|Status at Week 68|Withdrawal by Subject|0|||
126719026|NCT01544595|455920587|FG005|Status at Week 68|Withdrawal by Subject|0|||
126719027|NCT01544595|455920582|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
126719028|NCT01544595|455920583|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
126719029|NCT01544595|455920584|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
126719030|NCT01544595|455920585|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
126719031|NCT01544595|455920586|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
126719032|NCT01544595|455920587|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
126719033|NCT01544595|455920582|FG000|Status at Week 156|Withdrawal by Subject|9|||
126719034|NCT01544595|455920583|FG001|Status at Week 156|Withdrawal by Subject|10|||
126719035|NCT01544595|455920584|FG002|Status at Week 156|Withdrawal by Subject|4|||
126719036|NCT01544595|455920585|FG003|Status at Week 156|Withdrawal by Subject|9|||
126719037|NCT01544595|455920586|FG004|Status at Week 156|Withdrawal by Subject|20|||
126719038|NCT01544595|455920587|FG005|Status at Week 156|Withdrawal by Subject|6|||
126719039|NCT01544595|455920582|FG000|Status at Week 156|Adverse Event|9|||
126719040|NCT01544595|455920583|FG001|Status at Week 156|Adverse Event|11|||
126719041|NCT01544595|455920584|FG002|Status at Week 156|Adverse Event|1|||
126719042|NCT01544595|455920585|FG003|Status at Week 156|Adverse Event|3|||
126719043|NCT01544595|455920586|FG004|Status at Week 156|Adverse Event|4|||
126719044|NCT01544595|455920587|FG005|Status at Week 156|Adverse Event|2|||
126719045|NCT01544595|455920582|FG000|Status at Week 156|Lost to Follow-up|4|||
126719046|NCT01544595|455920583|FG001|Status at Week 156|Lost to Follow-up|4|||
126771587|NCT02587325|456117837|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
126554616|NCT01474512|455324039|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
126554617|NCT01474512|455324040|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
126554618|NCT01474512|455324041|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
126554619|NCT01474512|455324042|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
126554620|NCT01474512|455324043|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
126554621|NCT01474512|455324044|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
126554622|NCT01474512|455324045|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
126554623|NCT01474512|455324028|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
126554624|NCT01474512|455324029|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
126554625|NCT01474512|455324030|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
126554626|NCT01474512|455324031|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
126554627|NCT01474512|455324032|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
126554628|NCT01474512|455324033|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
126554629|NCT01474512|455324034|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
126554630|NCT01474512|455324035|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
126554631|NCT01474512|455324036|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
126554632|NCT01474512|455324037|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
126554633|NCT01474512|455324038|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
126554634|NCT01474512|455324039|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
126554635|NCT01474512|455324040|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
126554636|NCT01474512|455324041|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
126554637|NCT01474512|455324042|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
126554638|NCT01474512|455324043|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
126554639|NCT01474512|455324044|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
126394371|NCT04143217|454738035|FG000|Overall Study|Other, Multiple Categories|11|||
126394372|NCT01328041|454738040|FG000|Overall Study|Adverse Event|7|||
126394373|NCT01328041|454738040|FG000|Overall Study|Lack of Efficacy|27|||
126394374|NCT01328041|454738040|FG000|Overall Study|Protocol Violation|7|||
126394375|NCT01328041|454738040|FG000|Overall Study|Lost to Follow-up|7|||
126394376|NCT01328041|454738040|FG000|Overall Study|Physician Decision|2|||
126394377|NCT01328041|454738040|FG000|Overall Study|Withdrawal by Subject|7|||
126394378|NCT02688088|454738044|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
126394379|NCT02688088|454738045|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
126394380|NCT02688088|454738046|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
126394381|NCT02688088|454738047|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
126394382|NCT02688088|454738048|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
126394383|NCT02688088|454738044|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
126394384|NCT02688088|454738045|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
126394385|NCT02688088|454738046|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
126554640|NCT01474512|455324045|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
126554641|NCT01474512|455324028|FG000|Long-Term Extension Period|Physician Decision|0|||
126554642|NCT01474512|455324029|FG001|Long-Term Extension Period|Physician Decision|0|||
126554643|NCT01474512|455324030|FG002|Long-Term Extension Period|Physician Decision|0|||
126554644|NCT01474512|455324031|FG003|Long-Term Extension Period|Physician Decision|0|||
126554645|NCT01474512|455324032|FG004|Long-Term Extension Period|Physician Decision|0|||
126554646|NCT01474512|455324033|FG005|Long-Term Extension Period|Physician Decision|0|||
126554647|NCT01474512|455324034|FG006|Long-Term Extension Period|Physician Decision|0|||
126554648|NCT01474512|455324035|FG007|Long-Term Extension Period|Physician Decision|0|||
126554649|NCT01474512|455324036|FG008|Long-Term Extension Period|Physician Decision|0|||
126554650|NCT01474512|455324037|FG009|Long-Term Extension Period|Physician Decision|0|||
126394386|NCT02688088|454738047|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
126394387|NCT02688088|454738048|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
126394388|NCT02688088|454738044|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
126394389|NCT02688088|454738045|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
126394390|NCT02688088|454738046|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
126394391|NCT02688088|454738047|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
126394392|NCT02688088|454738048|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
126394393|NCT02688088|454738044|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
126394394|NCT02688088|454738045|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
126394395|NCT02688088|454738046|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
126394396|NCT02688088|454738047|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
126394397|NCT02688088|454738048|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
126394398|NCT02688088|454738044|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
126394399|NCT02688088|454738045|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
126394400|NCT02688088|454738046|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
126394401|NCT02688088|454738047|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
126394402|NCT02688088|454738048|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
126394403|NCT02688088|454738044|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
126394404|NCT02688088|454738045|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
126394405|NCT02688088|454738046|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
126394406|NCT02688088|454738047|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
126394407|NCT02688088|454738048|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
126394408|NCT02688088|454738044|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
126394409|NCT02688088|454738045|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
126394410|NCT02688088|454738046|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
126394411|NCT02688088|454738047|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
126469188|NCT00785928|455020895|FG001|Treatment Phase|Sponsor Decision|0|||
126469189|NCT00785928|455020896|FG002|Treatment Phase|Sponsor Decision|0|||
126469190|NCT00785928|455020897|FG003|Treatment Phase|Sponsor Decision|0|||
126469191|NCT00785928|455020898|FG004|Treatment Phase|Sponsor Decision|0|||
126469192|NCT00785928|455020899|FG005|Treatment Phase|Sponsor Decision|0|||
126469193|NCT00785928|455020900|FG006|Treatment Phase|Sponsor Decision|1|||
126469194|NCT00785928|455020894|FG000|Treatment Phase|Withdrawal by Subject|1|||
126469195|NCT00785928|455020895|FG001|Treatment Phase|Withdrawal by Subject|2|||
126469196|NCT00785928|455020896|FG002|Treatment Phase|Withdrawal by Subject|0|||
126469197|NCT00785928|455020897|FG003|Treatment Phase|Withdrawal by Subject|0|||
126469198|NCT00785928|455020898|FG004|Treatment Phase|Withdrawal by Subject|1|||
126469199|NCT00785928|455020899|FG005|Treatment Phase|Withdrawal by Subject|0|||
126469200|NCT00785928|455020900|FG006|Treatment Phase|Withdrawal by Subject|0|||
126469201|NCT00408629|455020905|FG000|Overall Study|Adverse Event|13|||
126469202|NCT00408629|455020906|FG001|Overall Study|Adverse Event|27|||
126469203|NCT00408629|455020905|FG000|Overall Study|Withdrawal by Subject|8|||
126469204|NCT00408629|455020906|FG001|Overall Study|Withdrawal by Subject|4|||
126469205|NCT00408629|455020905|FG000|Overall Study|Lost to Follow-up|1|||
126469206|NCT00408629|455020906|FG001|Overall Study|Lost to Follow-up|1|||
126469207|NCT00408629|455020905|FG000|Overall Study|Lack of Efficacy|63|||
126469208|NCT00408629|455020906|FG001|Overall Study|Lack of Efficacy|73|||
126469209|NCT00408629|455020905|FG000|Overall Study|Protocol Violation|1|||
126469210|NCT00408629|455020906|FG001|Overall Study|Protocol Violation|5|||
126469211|NCT00408629|455020905|FG000|Overall Study|Miscellaneous|11|||
126469212|NCT00408629|455020906|FG001|Overall Study|Miscellaneous|15|||
126469213|NCT00191906|455020907|FG000|Study Period II|Adverse Event|0|||
126469214|NCT00191906|455020908|FG001|Study Period II|Adverse Event|1|||
126469215|NCT00191906|455020909|FG002|Study Period II|Adverse Event|0|||
126469216|NCT00191906|455020910|FG003|Study Period II|Adverse Event|0|||
126554651|NCT01474512|455324038|FG010|Long-Term Extension Period|Physician Decision|0|||
126554652|NCT01474512|455324039|FG011|Long-Term Extension Period|Physician Decision|0|||
126554653|NCT01474512|455324040|FG012|Long-Term Extension Period|Physician Decision|21|||
126554654|NCT01474512|455324041|FG013|Long-Term Extension Period|Physician Decision|21|||
126394412|NCT02688088|454738048|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
126394413|NCT02688088|454738044|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
126394414|NCT02688088|454738045|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
126394415|NCT02688088|454738046|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
126469217|NCT00191906|455020907|FG000|Study Period II|Withdrawal by Subject|0|||
126469218|NCT00191906|455020908|FG001|Study Period II|Withdrawal by Subject|3|||
126469219|NCT00191906|455020909|FG002|Study Period II|Withdrawal by Subject|0|||
126469220|NCT00191906|455020910|FG003|Study Period II|Withdrawal by Subject|0|||
126554655|NCT01474512|455324042|FG014|Long-Term Extension Period|Physician Decision|0|||
126554656|NCT01474512|455324043|FG015|Long-Term Extension Period|Physician Decision|0|||
126554657|NCT01474512|455324044|FG016|Long-Term Extension Period|Physician Decision|0|||
126554658|NCT01474512|455324045|FG017|Long-Term Extension Period|Physician Decision|0|||
126554659|NCT01474512|455324028|FG000|Long-Term Extension Period|Clinical Relapse|0|||
126554660|NCT01474512|455324029|FG001|Long-Term Extension Period|Clinical Relapse|0|||
126554661|NCT01474512|455324030|FG002|Long-Term Extension Period|Clinical Relapse|0|||
126554662|NCT01474512|455324031|FG003|Long-Term Extension Period|Clinical Relapse|0|||
126554663|NCT01474512|455324032|FG004|Long-Term Extension Period|Clinical Relapse|0|||
126554664|NCT01474512|455324033|FG005|Long-Term Extension Period|Clinical Relapse|0|||
126554665|NCT01474512|455324034|FG006|Long-Term Extension Period|Clinical Relapse|0|||
126554666|NCT01474512|455324035|FG007|Long-Term Extension Period|Clinical Relapse|0|||
126554667|NCT01474512|455324036|FG008|Long-Term Extension Period|Clinical Relapse|0|||
126554668|NCT01474512|455324037|FG009|Long-Term Extension Period|Clinical Relapse|0|||
126394416|NCT02688088|454738047|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
126394417|NCT02688088|454738048|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
126469221|NCT00191906|455020907|FG000|Study Period II|Parent/Caregiver Decision|0|||
126469222|NCT00191906|455020908|FG001|Study Period II|Parent/Caregiver Decision|1|||
126469223|NCT00191906|455020909|FG002|Study Period II|Parent/Caregiver Decision|0|||
126469224|NCT00191906|455020910|FG003|Study Period II|Parent/Caregiver Decision|0|||
126554669|NCT01474512|455324038|FG010|Long-Term Extension Period|Clinical Relapse|0|||
126554670|NCT01474512|455324039|FG011|Long-Term Extension Period|Clinical Relapse|0|||
126469225|NCT00191906|455020907|FG000|Study Period II|Entry Criteria Exclusion|0|||
126469226|NCT00191906|455020908|FG001|Study Period II|Entry Criteria Exclusion|0|||
126469227|NCT00191906|455020909|FG002|Study Period II|Entry Criteria Exclusion|1|||
126394418|NCT02688088|454738044|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
126394419|NCT02688088|454738045|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
126394420|NCT02688088|454738046|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
126394421|NCT02688088|454738047|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
126394422|NCT02688088|454738048|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
126394423|NCT01921218|454738051|FG000|Overall Study|Death|2|||
126394424|NCT01921218|454738052|FG001|Overall Study|Death|1|||
126394425|NCT01921218|454738051|FG000|Overall Study|Withdrawal by Subject|0|||
126394426|NCT01921218|454738052|FG001|Overall Study|Withdrawal by Subject|2|||
126394427|NCT01921218|454738051|FG000|Overall Study|Kidney transplant|1|||
126394428|NCT01921218|454738052|FG001|Overall Study|Kidney transplant|1|||
126394429|NCT02449889|454738053|FG000|Overall Study|Adverse Event|1|||
126394430|NCT02449889|454738054|FG001|Overall Study|Adverse Event|2|||
126394431|NCT02449889|454738055|FG002|Overall Study|Adverse Event|0|||
126394432|NCT02449889|454738053|FG000|Overall Study|Protocol Violation|0|||
126394433|NCT02449889|454738054|FG001|Overall Study|Protocol Violation|4|||
126394434|NCT02449889|454738055|FG002|Overall Study|Protocol Violation|1|||
126394435|NCT00090142|454738057|FG000|Treatment Period I|Lost to Follow-up|1|||
126394436|NCT00090142|454738058|FG001|Treatment Period I|Lost to Follow-up|2|||
126394437|NCT00090142|454738057|FG000|Treatment Period I|Protocol Violation|2|||
126394438|NCT00090142|454738058|FG001|Treatment Period I|Protocol Violation|0|||
126394439|NCT00090142|454738057|FG000|Treatment Period I|Withdrawal by Subject|2|||
126394440|NCT00090142|454738058|FG001|Treatment Period I|Withdrawal by Subject|0|||
126394441|NCT00090142|454738057|FG000|Treatment Period I|Other|0|||
126394442|NCT00090142|454738058|FG001|Treatment Period I|Other|1|||
126394443|NCT00090142|454738057|FG000|Treatment Period II|Other|1|||
126719047|NCT01544595|455920584|FG002|Status at Week 156|Lost to Follow-up|0|||
126394444|NCT00090142|454738058|FG001|Treatment Period II|Other|0|||
126394445|NCT00688324|454738059|FG000|Overall Study|Withdrawal by Subject|2|||
126394446|NCT00688324|454738059|FG000|Overall Study|Physician Decision|5|||
126394447|NCT00688324|454738059|FG000|Overall Study|Lost to Follow-up|1|||
126719048|NCT01544595|455920585|FG003|Status at Week 156|Lost to Follow-up|1|||
126719049|NCT01544595|455920586|FG004|Status at Week 156|Lost to Follow-up|4|||
126719050|NCT01544595|455920587|FG005|Status at Week 156|Lost to Follow-up|1|||
126719051|NCT01544595|455920582|FG000|Status at Week 156|Non-compliance with study treatement|0|||
126719052|NCT01544595|455920583|FG001|Status at Week 156|Non-compliance with study treatement|1|||
126719053|NCT01544595|455920584|FG002|Status at Week 156|Non-compliance with study treatement|0|||
126719054|NCT01544595|455920585|FG003|Status at Week 156|Non-compliance with study treatement|1|||
126719055|NCT01544595|455920586|FG004|Status at Week 156|Non-compliance with study treatement|0|||
126719056|NCT01544595|455920587|FG005|Status at Week 156|Non-compliance with study treatement|1|||
126719057|NCT01544595|455920582|FG000|Status at Week 156|Physician Decision|0|||
126719058|NCT01544595|455920583|FG001|Status at Week 156|Physician Decision|3|||
126719059|NCT01544595|455920584|FG002|Status at Week 156|Physician Decision|1|||
126719060|NCT01544595|455920585|FG003|Status at Week 156|Physician Decision|0|||
126719061|NCT01544595|455920586|FG004|Status at Week 156|Physician Decision|0|||
126719062|NCT01544595|455920587|FG005|Status at Week 156|Physician Decision|0|||
126719063|NCT01544595|455920582|FG000|Status at Week 156|Pregnancy|2|||
126719064|NCT01544595|455920583|FG001|Status at Week 156|Pregnancy|3|||
126719065|NCT01544595|455920584|FG002|Status at Week 156|Pregnancy|0|||
126719066|NCT01544595|455920585|FG003|Status at Week 156|Pregnancy|0|||
126719067|NCT01544595|455920586|FG004|Status at Week 156|Pregnancy|0|||
126719068|NCT01544595|455920587|FG005|Status at Week 156|Pregnancy|0|||
126719069|NCT01544595|455920582|FG000|Status at Week 156|Protocol Violation|3|||
126719070|NCT01544595|455920583|FG001|Status at Week 156|Protocol Violation|1|||
126719071|NCT01544595|455920584|FG002|Status at Week 156|Protocol Violation|2|||
126719072|NCT01544595|455920585|FG003|Status at Week 156|Protocol Violation|2|||
126719073|NCT01544595|455920586|FG004|Status at Week 156|Protocol Violation|0|||
126719074|NCT01544595|455920587|FG005|Status at Week 156|Protocol Violation|0|||
126719075|NCT01544595|455920582|FG000|Status at Week 156|Technical problems|3|||
126719076|NCT01544595|455920583|FG001|Status at Week 156|Technical problems|1|||
126719077|NCT01544595|455920584|FG002|Status at Week 156|Technical problems|0|||
126719078|NCT01544595|455920585|FG003|Status at Week 156|Technical problems|1|||
126719079|NCT01544595|455920586|FG004|Status at Week 156|Technical problems|0|||
126719080|NCT01544595|455920587|FG005|Status at Week 156|Technical problems|0|||
126394448|NCT00006046|454738060|FG000|Overall Study|Adverse Event|3|||
126394449|NCT00006046|454738061|FG001|Overall Study|Adverse Event|0|||
126394450|NCT00006046|454738062|FG002|Overall Study|Adverse Event|0|||
126719081|NCT01544595|455920582|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
126719082|NCT01544595|455920583|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
126719083|NCT01544595|455920584|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
126719084|NCT01544595|455920585|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
126394451|NCT00006046|454738063|FG003|Overall Study|Adverse Event|0|||
126771588|NCT02587325|456117838|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
126394452|NCT00006046|454738064|FG004|Overall Study|Adverse Event|0|||
126394453|NCT00006046|454738060|FG000|Overall Study|Disease Progression|2|||
126394454|NCT00006046|454738061|FG001|Overall Study|Disease Progression|0|||
126394455|NCT00006046|454738062|FG002|Overall Study|Disease Progression|0|||
126394456|NCT00006046|454738063|FG003|Overall Study|Disease Progression|0|||
126394457|NCT00006046|454738064|FG004|Overall Study|Disease Progression|0|||
126394458|NCT00596154|454738065|FG000|Overall Study|Not Evaluable|2|||
126394459|NCT00642369|454738066|FG000|Overall Study|Adverse Event|2|||
126394460|NCT00642369|454738067|FG001|Overall Study|Adverse Event|3|||
126394461|NCT00642369|454738066|FG000|Overall Study|Withdrawal by Subject|1|||
126394462|NCT00642369|454738067|FG001|Overall Study|Withdrawal by Subject|0|||
126394463|NCT00642369|454738066|FG000|Overall Study|misdiagnosis|0|||
126394464|NCT00642369|454738067|FG001|Overall Study|misdiagnosis|1|||
126394465|NCT00642369|454738066|FG000|Overall Study|Lack of Efficacy|2|||
126394466|NCT00642369|454738067|FG001|Overall Study|Lack of Efficacy|2|||
126394467|NCT00585546|454738074|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
126394468|NCT00585546|454738074|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
126394469|NCT01535599|454738075|FG000|Overall Study|Adverse Event|6|||
126394470|NCT01535599|454738076|FG001|Overall Study|Adverse Event|15|||
126394471|NCT01535599|454738075|FG000|Overall Study|Lost to Follow-up|3|||
126394472|NCT01535599|454738076|FG001|Overall Study|Lost to Follow-up|4|||
126394473|NCT01535599|454738075|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
126394474|NCT01535599|454738076|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
126394475|NCT01535599|454738075|FG000|Overall Study|Treatment Failure|33|||
126394476|NCT01535599|454738076|FG001|Overall Study|Treatment Failure|66|||
126394477|NCT01535599|454738075|FG000|Overall Study|BL Culture + for Group A Strep|0|||
126394478|NCT01535599|454738076|FG001|Overall Study|BL Culture + for Group A Strep|1|||
126394479|NCT01535599|454738075|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
126394480|NCT01535599|454738076|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
126394481|NCT01535599|454738075|FG000|Overall Study|Randomized in Error|2|||
126394482|NCT01535599|454738076|FG001|Overall Study|Randomized in Error|4|||
126394483|NCT01535599|454738075|FG000|Overall Study|Did not use product|1|||
126394484|NCT01535599|454738076|FG001|Overall Study|Did not use product|0|||
126394485|NCT01535599|454738075|FG000|Overall Study|Other|1|||
126394486|NCT01535599|454738076|FG001|Overall Study|Other|0|||
126394487|NCT01535599|454738075|FG000|Overall Study|Stopped medication|0|||
126394488|NCT01535599|454738076|FG001|Overall Study|Stopped medication|1|||
126394489|NCT01535599|454738075|FG000|Overall Study|Noncompliance|0|||
126394490|NCT01535599|454738076|FG001|Overall Study|Noncompliance|1|||
126394491|NCT01165320|454738077|FG000|Overall Study|Clinical adverse experience|2|||
126394492|NCT01165320|454738078|FG001|Overall Study|Clinical adverse experience|1|||
126394493|NCT01165320|454738079|FG002|Overall Study|Clinical adverse experience|0|||
126394494|NCT01165320|454738077|FG000|Overall Study|Laboratory adverse experience|1|||
126394495|NCT01165320|454738078|FG001|Overall Study|Laboratory adverse experience|0|||
126394496|NCT01165320|454738079|FG002|Overall Study|Laboratory adverse experience|0|||
126394497|NCT01165320|454738077|FG000|Overall Study|Lack of Efficacy|0|||
126394498|NCT01165320|454738078|FG001|Overall Study|Lack of Efficacy|2|||
126394499|NCT01165320|454738079|FG002|Overall Study|Lack of Efficacy|0|||
126394500|NCT01165320|454738077|FG000|Overall Study|Reason unknown|0|||
126394501|NCT01165320|454738078|FG001|Overall Study|Reason unknown|1|||
126394502|NCT01165320|454738079|FG002|Overall Study|Reason unknown|0|||
126394503|NCT00385944|454738080|FG000|1st Maintenance Dose Period|Physician Decision|1|||
126394504|NCT00385944|454738081|FG001|1st Maintenance Dose Period|Physician Decision|0|||
126394505|NCT00385944|454738082|FG002|1st Maintenance Dose Period|Physician Decision|0|||
126394506|NCT00385944|454738080|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
126394507|NCT00385944|454738081|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
126394508|NCT00385944|454738082|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
126394509|NCT00385944|454738080|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
126394510|NCT00385944|454738081|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
126394511|NCT00385944|454738082|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
126394512|NCT00385944|454738080|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
126394513|NCT00385944|454738081|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
126394514|NCT00385944|454738082|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
126469228|NCT00191906|455020910|FG003|Study Period II|Entry Criteria Exclusion|0|||
126469229|NCT00191906|455020907|FG000|Study Period III|Adverse Event|1|||
126469230|NCT00191906|455020908|FG001|Study Period III|Adverse Event|0|||
126469231|NCT00191906|455020909|FG002|Study Period III|Adverse Event|0|||
126469232|NCT00191906|455020910|FG003|Study Period III|Adverse Event|0|||
126469233|NCT00191906|455020907|FG000|Study Period III|Lost to Follow-up|0|||
126469234|NCT00191906|455020908|FG001|Study Period III|Lost to Follow-up|1|||
126469235|NCT00191906|455020909|FG002|Study Period III|Lost to Follow-up|0|||
126394515|NCT00590824|454738086|FG000|Overall Study|Disease could not be resected|0|||
126394516|NCT00590824|454738087|FG001|Overall Study|Disease could not be resected|2|||
126394517|NCT00590824|454738088|FG002|Overall Study|Disease could not be resected|1|||
126394518|NCT00590824|454738089|FG003|Overall Study|Disease could not be resected|0|||
126394519|NCT00590824|454738086|FG000|Overall Study|Adverse Event|0|||
126394520|NCT00590824|454738087|FG001|Overall Study|Adverse Event|0|||
126469236|NCT00191906|455020910|FG003|Study Period III|Lost to Follow-up|0|||
126554671|NCT01474512|455324040|FG012|Long-Term Extension Period|Clinical Relapse|9|||
126554672|NCT01474512|455324041|FG013|Long-Term Extension Period|Clinical Relapse|9|||
126554673|NCT01474512|455324042|FG014|Long-Term Extension Period|Clinical Relapse|0|||
126554674|NCT01474512|455324043|FG015|Long-Term Extension Period|Clinical Relapse|0|||
126554675|NCT01474512|455324044|FG016|Long-Term Extension Period|Clinical Relapse|0|||
126554676|NCT01474512|455324045|FG017|Long-Term Extension Period|Clinical Relapse|0|||
126554677|NCT01474512|455324028|FG000|Long-Term Extension Period|Death|0|||
126394521|NCT00590824|454738088|FG002|Overall Study|Adverse Event|0|||
126554678|NCT01474512|455324029|FG001|Long-Term Extension Period|Death|0|||
126554679|NCT01474512|455324030|FG002|Long-Term Extension Period|Death|0|||
126554680|NCT01474512|455324031|FG003|Long-Term Extension Period|Death|0|||
126554681|NCT01474512|455324032|FG004|Long-Term Extension Period|Death|0|||
126554682|NCT01474512|455324033|FG005|Long-Term Extension Period|Death|0|||
126394522|NCT00590824|454738089|FG003|Overall Study|Adverse Event|1|||
126394523|NCT00791479|454738095|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
126394524|NCT00791479|454738096|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
126394525|NCT00791479|454738097|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
126394526|NCT00791479|454738098|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
126394527|NCT00791479|454738099|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
126394528|NCT00791479|454738100|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
126394529|NCT00791479|454738095|FG000|Overall Study|Adverse Event|0|||
126394530|NCT00791479|454738096|FG001|Overall Study|Adverse Event|1|||
126394531|NCT00791479|454738097|FG002|Overall Study|Adverse Event|0|||
126394532|NCT00791479|454738098|FG003|Overall Study|Adverse Event|2|||
126394533|NCT00791479|454738099|FG004|Overall Study|Adverse Event|0|||
126394534|NCT00791479|454738100|FG005|Overall Study|Adverse Event|1|||
126394535|NCT00791479|454738095|FG000|Overall Study|Lost to Follow-up|0|||
126394536|NCT00791479|454738096|FG001|Overall Study|Lost to Follow-up|1|||
126554683|NCT01474512|455324034|FG006|Long-Term Extension Period|Death|0|||
126554684|NCT01474512|455324035|FG007|Long-Term Extension Period|Death|0|||
126554685|NCT01474512|455324036|FG008|Long-Term Extension Period|Death|0|||
126554686|NCT01474512|455324037|FG009|Long-Term Extension Period|Death|0|||
126554687|NCT01474512|455324038|FG010|Long-Term Extension Period|Death|0|||
126554688|NCT01474512|455324039|FG011|Long-Term Extension Period|Death|0|||
126554689|NCT01474512|455324040|FG012|Long-Term Extension Period|Death|9|||
126554690|NCT01474512|455324041|FG013|Long-Term Extension Period|Death|9|||
126554691|NCT01474512|455324042|FG014|Long-Term Extension Period|Death|0|||
126554692|NCT01474512|455324043|FG015|Long-Term Extension Period|Death|0|||
126554693|NCT01474512|455324044|FG016|Long-Term Extension Period|Death|0|||
126554694|NCT01474512|455324045|FG017|Long-Term Extension Period|Death|0|||
126554695|NCT01474512|455324028|FG000|Long-Term Extension Period|Sponsor Decision|0|||
126554696|NCT01474512|455324029|FG001|Long-Term Extension Period|Sponsor Decision|0|||
126554697|NCT01474512|455324030|FG002|Long-Term Extension Period|Sponsor Decision|0|||
126554698|NCT01474512|455324031|FG003|Long-Term Extension Period|Sponsor Decision|0|||
126554699|NCT01474512|455324032|FG004|Long-Term Extension Period|Sponsor Decision|0|||
126554700|NCT01474512|455324033|FG005|Long-Term Extension Period|Sponsor Decision|0|||
126554701|NCT01474512|455324034|FG006|Long-Term Extension Period|Sponsor Decision|0|||
126554702|NCT01474512|455324035|FG007|Long-Term Extension Period|Sponsor Decision|0|||
126554703|NCT01474512|455324036|FG008|Long-Term Extension Period|Sponsor Decision|0|||
126394537|NCT00791479|454738097|FG002|Overall Study|Lost to Follow-up|0|||
126394538|NCT00791479|454738098|FG003|Overall Study|Lost to Follow-up|0|||
126394539|NCT00791479|454738099|FG004|Overall Study|Lost to Follow-up|0|||
126394540|NCT00791479|454738100|FG005|Overall Study|Lost to Follow-up|1|||
126394541|NCT00791479|454738095|FG000|Overall Study|Protocol Violation|2|||
126394542|NCT00791479|454738096|FG001|Overall Study|Protocol Violation|1|||
126394543|NCT00791479|454738097|FG002|Overall Study|Protocol Violation|0|||
126394544|NCT00791479|454738098|FG003|Overall Study|Protocol Violation|1|||
126394545|NCT00791479|454738099|FG004|Overall Study|Protocol Violation|0|||
126394546|NCT00791479|454738100|FG005|Overall Study|Protocol Violation|0|||
126394547|NCT00791479|454738095|FG000|Overall Study|Withdrawal by Subject|0|||
126394548|NCT00791479|454738096|FG001|Overall Study|Withdrawal by Subject|0|||
126394549|NCT00791479|454738097|FG002|Overall Study|Withdrawal by Subject|0|||
126394550|NCT00791479|454738098|FG003|Overall Study|Withdrawal by Subject|1|||
126394551|NCT00791479|454738099|FG004|Overall Study|Withdrawal by Subject|0|||
126554704|NCT01474512|455324037|FG009|Long-Term Extension Period|Sponsor Decision|0|||
126554705|NCT01474512|455324038|FG010|Long-Term Extension Period|Sponsor Decision|0|||
126554706|NCT01474512|455324039|FG011|Long-Term Extension Period|Sponsor Decision|0|||
126554707|NCT01474512|455324040|FG012|Long-Term Extension Period|Sponsor Decision|6|||
126719085|NCT01544595|455920586|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
126719086|NCT01544595|455920587|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
126719087|NCT01544595|455920582|FG000|Status at Week 156|Lack of Efficacy|1|||
126394552|NCT00791479|454738100|FG005|Overall Study|Withdrawal by Subject|1|||
126394553|NCT01778049|454738101|FG000|Open Label Treatment Period|Adverse Event|5|||
126394554|NCT01778049|454738102|FG001|Open Label Treatment Period|Adverse Event|15|||
126394555|NCT01778049|454738103|FG002|Open Label Treatment Period|Adverse Event|0|||
126394556|NCT01778049|454738104|FG003|Open Label Treatment Period|Adverse Event|0|||
126394557|NCT01778049|454738105|FG004|Open Label Treatment Period|Adverse Event|0|||
126394558|NCT01778049|454738106|FG005|Open Label Treatment Period|Adverse Event|0|||
126394559|NCT01778049|454738101|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
126394560|NCT01778049|454738102|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
126394561|NCT01778049|454738103|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
126394562|NCT01778049|454738104|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
126394563|NCT01778049|454738105|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
126394564|NCT01778049|454738106|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
126394565|NCT01778049|454738101|FG000|Open Label Treatment Period|Protocol Violation|5|||
126394566|NCT01778049|454738102|FG001|Open Label Treatment Period|Protocol Violation|5|||
126394567|NCT01778049|454738103|FG002|Open Label Treatment Period|Protocol Violation|0|||
126394568|NCT01778049|454738104|FG003|Open Label Treatment Period|Protocol Violation|0|||
126394569|NCT01778049|454738105|FG004|Open Label Treatment Period|Protocol Violation|0|||
126394570|NCT01778049|454738106|FG005|Open Label Treatment Period|Protocol Violation|0|||
126394571|NCT01778049|454738101|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
126394572|NCT01778049|454738102|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
126394573|NCT01778049|454738103|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
126394574|NCT01778049|454738104|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
126394575|NCT01778049|454738105|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
126394576|NCT01778049|454738106|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
126394577|NCT01778049|454738101|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
126394578|NCT01778049|454738102|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
126394579|NCT01778049|454738103|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
126394580|NCT01778049|454738104|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
126394581|NCT01778049|454738105|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
126394582|NCT01778049|454738106|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
126394583|NCT01778049|454738101|FG000|Open Label Treatment Period|Not treated|2|||
126394584|NCT01778049|454738102|FG001|Open Label Treatment Period|Not treated|1|||
126394585|NCT01778049|454738103|FG002|Open Label Treatment Period|Not treated|0|||
126394586|NCT01778049|454738104|FG003|Open Label Treatment Period|Not treated|0|||
126394587|NCT01778049|454738105|FG004|Open Label Treatment Period|Not treated|0|||
126394588|NCT01778049|454738106|FG005|Open Label Treatment Period|Not treated|0|||
126394589|NCT01778049|454738101|FG000|Open Label Treatment Period|Other reason not defined above|77|||
126394590|NCT01778049|454738102|FG001|Open Label Treatment Period|Other reason not defined above|94|||
126394591|NCT01778049|454738103|FG002|Open Label Treatment Period|Other reason not defined above|0|||
126394592|NCT01778049|454738104|FG003|Open Label Treatment Period|Other reason not defined above|0|||
126394593|NCT01778049|454738105|FG004|Open Label Treatment Period|Other reason not defined above|0|||
126394594|NCT01778049|454738106|FG005|Open Label Treatment Period|Other reason not defined above|0|||
126394595|NCT01778049|454738101|FG000|Double Blind Treatment Period|Adverse Event|0|||
126394596|NCT01778049|454738102|FG001|Double Blind Treatment Period|Adverse Event|0|||
126394597|NCT01778049|454738103|FG002|Double Blind Treatment Period|Adverse Event|4|||
126394598|NCT01778049|454738104|FG003|Double Blind Treatment Period|Adverse Event|5|||
126394599|NCT01778049|454738105|FG004|Double Blind Treatment Period|Adverse Event|3|||
126394600|NCT01778049|454738106|FG005|Double Blind Treatment Period|Adverse Event|2|||
126394601|NCT01778049|454738101|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
126394602|NCT01778049|454738102|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
126394603|NCT01778049|454738103|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
126394604|NCT01778049|454738104|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
126394605|NCT01778049|454738105|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
126394606|NCT01778049|454738106|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
126394607|NCT01778049|454738101|FG000|Double Blind Treatment Period|Protocol Violation|0|||
126394608|NCT01778049|454738102|FG001|Double Blind Treatment Period|Protocol Violation|0|||
126394609|NCT01778049|454738103|FG002|Double Blind Treatment Period|Protocol Violation|2|||
126394610|NCT01778049|454738104|FG003|Double Blind Treatment Period|Protocol Violation|0|||
126469237|NCT00191906|455020907|FG000|Study Period III|Parent/Caregiver Decision|1|||
126469238|NCT00191906|455020908|FG001|Study Period III|Parent/Caregiver Decision|0|||
126469239|NCT00191906|455020909|FG002|Study Period III|Parent/Caregiver Decision|0|||
126469240|NCT00191906|455020910|FG003|Study Period III|Parent/Caregiver Decision|0|||
126394611|NCT01778049|454738105|FG004|Double Blind Treatment Period|Protocol Violation|0|||
126394612|NCT01778049|454738106|FG005|Double Blind Treatment Period|Protocol Violation|0|||
126394613|NCT01778049|454738101|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
126394614|NCT01778049|454738102|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
126394615|NCT01778049|454738103|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
126394616|NCT01778049|454738104|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
126394617|NCT01778049|454738105|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
126469241|NCT00191906|455020907|FG000|Study Period III|Lack of Efficacy|3|||
126469242|NCT00191906|455020908|FG001|Study Period III|Lack of Efficacy|3|||
126469243|NCT00191906|455020909|FG002|Study Period III|Lack of Efficacy|0|||
126469244|NCT00191906|455020910|FG003|Study Period III|Lack of Efficacy|0|||
126469245|NCT00573937|455020911|FG000|Overall Study|Study Terminated|0|||
126469246|NCT00573937|455020912|FG001|Overall Study|Study Terminated|1|||
126469247|NCT00333801|455020913|FG000|Overall Study|Moved to another state|5|||
126469248|NCT00333801|455020914|FG001|Overall Study|Moved to another state|3|||
126469249|NCT00333801|455020913|FG000|Overall Study|Lost to Follow-up|2|||
126469250|NCT00333801|455020914|FG001|Overall Study|Lost to Follow-up|0|||
126469251|NCT00333801|455020913|FG000|Overall Study|Incarcerated|1|||
126469252|NCT00333801|455020914|FG001|Overall Study|Incarcerated|2|||
126469253|NCT00333801|455020913|FG000|Overall Study|Withdrawal by Subject|0|||
126469254|NCT00333801|455020914|FG001|Overall Study|Withdrawal by Subject|1|||
126469255|NCT04171765|455020915|FG000|Overall Study|Adverse Event|2|||
126469256|NCT04171765|455020916|FG001|Overall Study|Adverse Event|0|||
126469257|NCT04171765|455020917|FG002|Overall Study|Adverse Event|1|||
126469258|NCT04171765|455020918|FG003|Overall Study|Adverse Event|0|||
126469259|NCT04171765|455020915|FG000|Overall Study|Lost to Follow-up|0|||
126469260|NCT04171765|455020916|FG001|Overall Study|Lost to Follow-up|2|||
126469261|NCT04171765|455020917|FG002|Overall Study|Lost to Follow-up|2|||
126469262|NCT04171765|455020918|FG003|Overall Study|Lost to Follow-up|2|||
126469263|NCT04171765|455020915|FG000|Overall Study|Week 58 visit missed|0|||
126469264|NCT04171765|455020916|FG001|Overall Study|Week 58 visit missed|0|||
126469265|NCT04171765|455020917|FG002|Overall Study|Week 58 visit missed|1|||
126469266|NCT04171765|455020918|FG003|Overall Study|Week 58 visit missed|0|||
126469267|NCT04171765|455020915|FG000|Overall Study|Study terminated by sponsor|2|||
126469268|NCT04171765|455020916|FG001|Overall Study|Study terminated by sponsor|0|||
126469269|NCT04171765|455020917|FG002|Overall Study|Study terminated by sponsor|0|||
126469270|NCT04171765|455020918|FG003|Overall Study|Study terminated by sponsor|0|||
126469271|NCT04171765|455020915|FG000|Overall Study|Withdrawal by Subject|1|||
126469272|NCT04171765|455020916|FG001|Overall Study|Withdrawal by Subject|0|||
126469273|NCT04171765|455020917|FG002|Overall Study|Withdrawal by Subject|0|||
126469274|NCT04171765|455020918|FG003|Overall Study|Withdrawal by Subject|3|||
126469275|NCT03633617|455020919|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
126469276|NCT03633617|455020920|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
126469277|NCT03633617|455020921|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
126469278|NCT03633617|455020922|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
126469279|NCT03633617|455020923|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
126469280|NCT03633617|455020924|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
126469281|NCT03633617|455020925|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
126469282|NCT03633617|455020926|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
126469283|NCT03633617|455020927|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
126469284|NCT03633617|455020928|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
126469285|NCT03633617|455020929|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
126469286|NCT03633617|455020919|FG000|Part A|Unconfirmed early termination visit|1|||
126469287|NCT03633617|455020920|FG001|Part A|Unconfirmed early termination visit|0|||
126469288|NCT03633617|455020921|FG002|Part A|Unconfirmed early termination visit|0|||
126469289|NCT03633617|455020922|FG003|Part A|Unconfirmed early termination visit|0|||
126469290|NCT03633617|455020923|FG004|Part A|Unconfirmed early termination visit|0|||
126469291|NCT03633617|455020924|FG005|Part A|Unconfirmed early termination visit|0|||
126469292|NCT03633617|455020925|FG006|Part A|Unconfirmed early termination visit|0|||
126469293|NCT03633617|455020926|FG007|Part A|Unconfirmed early termination visit|0|||
126469294|NCT03633617|455020927|FG008|Part A|Unconfirmed early termination visit|0|||
126469295|NCT03633617|455020928|FG009|Part A|Unconfirmed early termination visit|0|||
126469296|NCT03633617|455020929|FG010|Part A|Unconfirmed early termination visit|0|||
126469297|NCT03633617|455020919|FG000|Part A|Adverse Event|0|||
126469298|NCT03633617|455020920|FG001|Part A|Adverse Event|1|||
126469299|NCT03633617|455020921|FG002|Part A|Adverse Event|0|||
126469300|NCT03633617|455020922|FG003|Part A|Adverse Event|0|||
126469301|NCT03633617|455020923|FG004|Part A|Adverse Event|0|||
126469302|NCT03633617|455020924|FG005|Part A|Adverse Event|0|||
126469303|NCT03633617|455020925|FG006|Part A|Adverse Event|0|||
126469304|NCT03633617|455020926|FG007|Part A|Adverse Event|0|||
126469305|NCT03633617|455020927|FG008|Part A|Adverse Event|0|||
126469306|NCT03633617|455020928|FG009|Part A|Adverse Event|0|||
126554708|NCT01474512|455324041|FG013|Long-Term Extension Period|Sponsor Decision|6|||
126554709|NCT01474512|455324042|FG014|Long-Term Extension Period|Sponsor Decision|0|||
126554710|NCT01474512|455324043|FG015|Long-Term Extension Period|Sponsor Decision|0|||
126469307|NCT03633617|455020929|FG010|Part A|Adverse Event|0|||
126469308|NCT03633617|455020919|FG000|Part A|Pregnancy|1|||
126469309|NCT03633617|455020920|FG001|Part A|Pregnancy|0|||
126469310|NCT03633617|455020921|FG002|Part A|Pregnancy|0|||
126469311|NCT03633617|455020922|FG003|Part A|Pregnancy|0|||
126469312|NCT03633617|455020923|FG004|Part A|Pregnancy|0|||
126554711|NCT01474512|455324044|FG016|Long-Term Extension Period|Sponsor Decision|0|||
126771589|NCT02587325|456117839|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
126469313|NCT03633617|455020924|FG005|Part A|Pregnancy|0|||
126469314|NCT03633617|455020925|FG006|Part A|Pregnancy|0|||
126394618|NCT01778049|454738106|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
126394619|NCT01778049|454738101|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
126394620|NCT01778049|454738102|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
126394621|NCT01778049|454738103|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
126394622|NCT01778049|454738104|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
126394623|NCT01778049|454738105|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
126394624|NCT01778049|454738106|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
126394625|NCT01778049|454738101|FG000|Double Blind Treatment Period|Not treated|0|||
126394626|NCT01778049|454738102|FG001|Double Blind Treatment Period|Not treated|0|||
126394627|NCT01778049|454738103|FG002|Double Blind Treatment Period|Not treated|0|||
126394628|NCT01778049|454738104|FG003|Double Blind Treatment Period|Not treated|2|||
126394629|NCT01778049|454738105|FG004|Double Blind Treatment Period|Not treated|2|||
126394630|NCT01778049|454738106|FG005|Double Blind Treatment Period|Not treated|0|||
126394631|NCT01778049|454738101|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
126394632|NCT01778049|454738102|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
126394633|NCT01778049|454738103|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
126394634|NCT01778049|454738104|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
126394635|NCT01778049|454738105|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
126394636|NCT01778049|454738106|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
126394637|NCT03770728|454738107|FG000|Overall Study|Adverse Event|1|||
126394638|NCT03770728|454738108|FG001|Overall Study|Adverse Event|0|||
126394639|NCT03770728|454738109|FG002|Overall Study|Adverse Event|1|||
126394640|NCT03770728|454738110|FG003|Overall Study|Adverse Event|0|||
126394641|NCT03770728|454738107|FG000|Overall Study|Poor compliance to protocol|0|||
126394642|NCT03770728|454738108|FG001|Overall Study|Poor compliance to protocol|0|||
126394643|NCT03770728|454738109|FG002|Overall Study|Poor compliance to protocol|1|||
126394644|NCT03770728|454738110|FG003|Overall Study|Poor compliance to protocol|0|||
126394645|NCT03770728|454738107|FG000|Overall Study|Withdrawal by Subject|13|||
126394646|NCT03770728|454738108|FG001|Overall Study|Withdrawal by Subject|8|||
126394647|NCT03770728|454738109|FG002|Overall Study|Withdrawal by Subject|9|||
126394648|NCT03770728|454738110|FG003|Overall Study|Withdrawal by Subject|13|||
126394649|NCT03770728|454738107|FG000|Overall Study|Other than specified|24|||
126394650|NCT03770728|454738108|FG001|Overall Study|Other than specified|23|||
126394651|NCT03770728|454738109|FG002|Overall Study|Other than specified|21|||
126394652|NCT03770728|454738110|FG003|Overall Study|Other than specified|22|||
126394653|NCT00503776|454738111|FG000|Overall Study|Withdrawal by Subject|1|||
126394654|NCT00503776|454738112|FG001|Overall Study|Withdrawal by Subject|0|||
126394655|NCT00503776|454738113|FG002|Overall Study|Withdrawal by Subject|1|||
126394656|NCT00503776|454738114|FG003|Overall Study|Withdrawal by Subject|1|||
126394657|NCT00503776|454738111|FG000|Overall Study|Physician Decision|0|||
126394658|NCT00503776|454738112|FG001|Overall Study|Physician Decision|0|||
126394659|NCT00503776|454738113|FG002|Overall Study|Physician Decision|1|||
126394660|NCT00503776|454738114|FG003|Overall Study|Physician Decision|1|||
126394661|NCT02379988|454738115|FG000|Overall Study|Not eligible|1|||
126394662|NCT00107315|454738116|FG000|Overall Study|Disease Progression|9|||
126394663|NCT00107315|454738116|FG000|Overall Study|Adverse Event|4|||
126394664|NCT00107315|454738116|FG000|Overall Study|Withdrawal by Subject|2|||
126394665|NCT02509039|454738119|FG000|Overall Study|Adverse Event|0|||
126394666|NCT02509039|454738120|FG001|Overall Study|Adverse Event|1|||
126394667|NCT02509039|454738121|FG002|Overall Study|Adverse Event|1|||
126394668|NCT02509039|454738122|FG003|Overall Study|Adverse Event|1|||
126394669|NCT02509039|454738119|FG000|Overall Study|Withdrawal by Subject|0|||
126394670|NCT02509039|454738120|FG001|Overall Study|Withdrawal by Subject|0|||
126394671|NCT02509039|454738121|FG002|Overall Study|Withdrawal by Subject|1|||
126394672|NCT02509039|454738122|FG003|Overall Study|Withdrawal by Subject|0|||
126394673|NCT02509039|454738119|FG000|Overall Study|Progressive disease|2|||
126394674|NCT02509039|454738120|FG001|Overall Study|Progressive disease|2|||
126394675|NCT02509039|454738121|FG002|Overall Study|Progressive disease|1|||
126394676|NCT02509039|454738122|FG003|Overall Study|Progressive disease|5|||
126394677|NCT02509039|454738119|FG000|Overall Study|Study terminated by Sponsor|1|||
126394678|NCT02509039|454738120|FG001|Overall Study|Study terminated by Sponsor|0|||
126394679|NCT02509039|454738121|FG002|Overall Study|Study terminated by Sponsor|0|||
126394680|NCT02509039|454738122|FG003|Overall Study|Study terminated by Sponsor|0|||
126394681|NCT05427539|454738127|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
126719088|NCT01544595|455920583|FG001|Status at Week 156|Lack of Efficacy|0|||
126394682|NCT05427539|454738128|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
126394683|NCT05427539|454738127|FG000|Period 1|Withdrawal by Subject|1|||
126394684|NCT05427539|454738128|FG001|Period 1|Withdrawal by Subject|0|||
126394685|NCT00543296|454738129|FG000|Overall Study|Physician Decision|7|||
126394686|NCT00934947|454738130|FG000|Overall Study|Adverse Event|0|||
126469315|NCT03633617|455020926|FG007|Part A|Pregnancy|0|||
126719089|NCT01544595|455920584|FG002|Status at Week 156|Lack of Efficacy|1|||
126394687|NCT00934947|454738131|FG001|Overall Study|Adverse Event|2|||
126394688|NCT03276026|454738134|FG000|Overall Study|Protocol Violation|1|||
126394689|NCT03276026|454738135|FG001|Overall Study|Protocol Violation|0|||
126394690|NCT04049266|454738136|FG000|Overall Study|Adverse Event|16|||
126394691|NCT04049266|454738137|FG001|Overall Study|Adverse Event|9|||
126394692|NCT04049266|454738136|FG000|Overall Study|Non-compliance with study drug|0|||
126394693|NCT04049266|454738137|FG001|Overall Study|Non-compliance with study drug|3|||
126394694|NCT04049266|454738136|FG000|Overall Study|Withdrawal by Subject|6|||
126394695|NCT04049266|454738137|FG001|Overall Study|Withdrawal by Subject|10|||
126394696|NCT04049266|454738136|FG000|Overall Study|Lost to Follow-up|2|||
126469316|NCT03633617|455020927|FG008|Part A|Pregnancy|0|||
126394697|NCT04049266|454738137|FG001|Overall Study|Lost to Follow-up|2|||
126394698|NCT04049266|454738136|FG000|Overall Study|Progressive disease|11|||
126394699|NCT04049266|454738137|FG001|Overall Study|Progressive disease|2|||
126394700|NCT04049266|454738136|FG000|Overall Study|Physician Decision|1|||
126394701|NCT04049266|454738137|FG001|Overall Study|Physician Decision|0|||
126394702|NCT04049266|454738136|FG000|Overall Study|Patient moved out of state|1|||
126394703|NCT04049266|454738137|FG001|Overall Study|Patient moved out of state|0|||
126394704|NCT01703208|454738138|FG000|Overall Study|Death|61|||
126394705|NCT01703208|454738139|FG001|Overall Study|Death|48|||
126394706|NCT01703208|454738138|FG000|Overall Study|Lack of Efficacy|1|||
126394707|NCT01703208|454738139|FG001|Overall Study|Lack of Efficacy|2|||
126394708|NCT01703208|454738138|FG000|Overall Study|Lost to Follow-up|68|||
126469317|NCT03633617|455020928|FG009|Part A|Pregnancy|0|||
126469318|NCT03633617|455020929|FG010|Part A|Pregnancy|0|||
126469319|NCT03633617|455020919|FG000|Part A|Withdrawal by Subject|0|||
126469320|NCT03633617|455020920|FG001|Part A|Withdrawal by Subject|1|||
126469321|NCT03633617|455020921|FG002|Part A|Withdrawal by Subject|0|||
126469322|NCT03633617|455020922|FG003|Part A|Withdrawal by Subject|0|||
126469323|NCT03633617|455020923|FG004|Part A|Withdrawal by Subject|0|||
126469324|NCT03633617|455020924|FG005|Part A|Withdrawal by Subject|0|||
126469325|NCT03633617|455020925|FG006|Part A|Withdrawal by Subject|0|||
126469326|NCT03633617|455020926|FG007|Part A|Withdrawal by Subject|0|||
126469327|NCT03633617|455020927|FG008|Part A|Withdrawal by Subject|0|||
126469328|NCT03633617|455020928|FG009|Part A|Withdrawal by Subject|0|||
126469329|NCT03633617|455020929|FG010|Part A|Withdrawal by Subject|0|||
126469330|NCT03633617|455020919|FG000|Part B|Adverse Event|0|||
126469331|NCT03633617|455020920|FG001|Part B|Adverse Event|0|||
126469332|NCT03633617|455020921|FG002|Part B|Adverse Event|2|||
126469333|NCT03633617|455020922|FG003|Part B|Adverse Event|2|||
126469334|NCT03633617|455020923|FG004|Part B|Adverse Event|1|||
126469335|NCT03633617|455020924|FG005|Part B|Adverse Event|0|||
126469336|NCT03633617|455020925|FG006|Part B|Adverse Event|0|||
126469337|NCT03633617|455020926|FG007|Part B|Adverse Event|0|||
126469338|NCT03633617|455020927|FG008|Part B|Adverse Event|0|||
126469339|NCT03633617|455020928|FG009|Part B|Adverse Event|0|||
126469340|NCT03633617|455020929|FG010|Part B|Adverse Event|0|||
126469341|NCT03633617|455020919|FG000|Part B|Withdrawal by Subject|0|||
126469342|NCT03633617|455020920|FG001|Part B|Withdrawal by Subject|0|||
126469343|NCT03633617|455020921|FG002|Part B|Withdrawal by Subject|1|||
126469344|NCT03633617|455020922|FG003|Part B|Withdrawal by Subject|0|||
126469345|NCT03633617|455020923|FG004|Part B|Withdrawal by Subject|2|||
126469346|NCT03633617|455020924|FG005|Part B|Withdrawal by Subject|0|||
126469347|NCT03633617|455020925|FG006|Part B|Withdrawal by Subject|0|||
126469348|NCT03633617|455020926|FG007|Part B|Withdrawal by Subject|0|||
126469349|NCT03633617|455020927|FG008|Part B|Withdrawal by Subject|0|||
126469350|NCT03633617|455020928|FG009|Part B|Withdrawal by Subject|0|||
126469351|NCT03633617|455020929|FG010|Part B|Withdrawal by Subject|0|||
126469352|NCT03633617|455020919|FG000|Part B|Lost to Follow-up|0|||
126469353|NCT03633617|455020920|FG001|Part B|Lost to Follow-up|0|||
126469354|NCT03633617|455020921|FG002|Part B|Lost to Follow-up|0|||
126469355|NCT03633617|455020922|FG003|Part B|Lost to Follow-up|0|||
126469356|NCT03633617|455020923|FG004|Part B|Lost to Follow-up|1|||
126469357|NCT03633617|455020924|FG005|Part B|Lost to Follow-up|0|||
126469358|NCT03633617|455020925|FG006|Part B|Lost to Follow-up|0|||
126469359|NCT03633617|455020926|FG007|Part B|Lost to Follow-up|0|||
126469360|NCT03633617|455020927|FG008|Part B|Lost to Follow-up|0|||
126469361|NCT03633617|455020928|FG009|Part B|Lost to Follow-up|0|||
126469362|NCT03633617|455020929|FG010|Part B|Lost to Follow-up|0|||
126469363|NCT03633617|455020919|FG000|Part B|Physician Decision|0|||
126469364|NCT03633617|455020920|FG001|Part B|Physician Decision|0|||
126469365|NCT03633617|455020921|FG002|Part B|Physician Decision|0|||
126469366|NCT03633617|455020922|FG003|Part B|Physician Decision|0|||
126469367|NCT03633617|455020923|FG004|Part B|Physician Decision|1|||
126469368|NCT03633617|455020924|FG005|Part B|Physician Decision|0|||
126469369|NCT03633617|455020925|FG006|Part B|Physician Decision|0|||
126469370|NCT03633617|455020926|FG007|Part B|Physician Decision|0|||
126469371|NCT03633617|455020927|FG008|Part B|Physician Decision|0|||
126394709|NCT01703208|454738139|FG001|Overall Study|Lost to Follow-up|62|||
126469372|NCT03633617|455020928|FG009|Part B|Physician Decision|0|||
126394710|NCT01703208|454738138|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126469373|NCT03633617|455020929|FG010|Part B|Physician Decision|0|||
126469374|NCT03633617|455020919|FG000|Part B|COVID-19 Restrictions|0|||
126469375|NCT03633617|455020920|FG001|Part B|COVID-19 Restrictions|0|||
126469376|NCT03633617|455020921|FG002|Part B|COVID-19 Restrictions|1|||
126469377|NCT03633617|455020922|FG003|Part B|COVID-19 Restrictions|0|||
126469378|NCT03633617|455020923|FG004|Part B|COVID-19 Restrictions|0|||
126469379|NCT03633617|455020924|FG005|Part B|COVID-19 Restrictions|0|||
126469380|NCT03633617|455020925|FG006|Part B|COVID-19 Restrictions|0|||
126469381|NCT03633617|455020926|FG007|Part B|COVID-19 Restrictions|0|||
126469382|NCT03633617|455020927|FG008|Part B|COVID-19 Restrictions|0|||
126469383|NCT03633617|455020928|FG009|Part B|COVID-19 Restrictions|0|||
126469384|NCT03633617|455020929|FG010|Part B|COVID-19 Restrictions|0|||
126469385|NCT03633617|455020919|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
126469386|NCT03633617|455020920|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
126469387|NCT03633617|455020921|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
126469388|NCT03633617|455020922|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
126469389|NCT03633617|455020923|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
126469390|NCT03633617|455020924|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
126469391|NCT03633617|455020925|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
126469392|NCT03633617|455020926|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
126469393|NCT03633617|455020927|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
126469394|NCT03633617|455020928|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
126469395|NCT03633617|455020929|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
126469396|NCT03633617|455020919|FG000|Part C (& Follow-up)|Adverse Event|0|||
126469397|NCT03633617|455020920|FG001|Part C (& Follow-up)|Adverse Event|0|||
126469398|NCT03633617|455020921|FG002|Part C (& Follow-up)|Adverse Event|0|||
126469399|NCT03633617|455020922|FG003|Part C (& Follow-up)|Adverse Event|0|||
126469400|NCT03633617|455020923|FG004|Part C (& Follow-up)|Adverse Event|0|||
126469401|NCT03633617|455020924|FG005|Part C (& Follow-up)|Adverse Event|1|||
126469402|NCT03633617|455020925|FG006|Part C (& Follow-up)|Adverse Event|0|||
126469403|NCT03633617|455020926|FG007|Part C (& Follow-up)|Adverse Event|1|||
126469404|NCT03633617|455020927|FG008|Part C (& Follow-up)|Adverse Event|0|||
126469405|NCT03633617|455020928|FG009|Part C (& Follow-up)|Adverse Event|0|||
126469406|NCT03633617|455020929|FG010|Part C (& Follow-up)|Adverse Event|0|||
126469407|NCT03633617|455020919|FG000|Part C (& Follow-up)|Pregnancy|0|||
126469408|NCT03633617|455020920|FG001|Part C (& Follow-up)|Pregnancy|0|||
126469409|NCT03633617|455020921|FG002|Part C (& Follow-up)|Pregnancy|0|||
126469410|NCT03633617|455020922|FG003|Part C (& Follow-up)|Pregnancy|0|||
126469411|NCT03633617|455020923|FG004|Part C (& Follow-up)|Pregnancy|0|||
126469412|NCT03633617|455020924|FG005|Part C (& Follow-up)|Pregnancy|0|||
126771590|NCT02587325|456117835|FG000|32-Week Optional Extension Part|Adverse Event|0|||
126771591|NCT02587325|456117836|FG001|32-Week Optional Extension Part|Adverse Event|0|||
126394711|NCT01703208|454738139|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126394712|NCT01703208|454738138|FG000|Overall Study|Excluded Medication|1|||
126394713|NCT01703208|454738139|FG001|Overall Study|Excluded Medication|2|||
126394714|NCT01703208|454738138|FG000|Overall Study|Site Discontinued Study Participation|23|||
126394715|NCT01703208|454738139|FG001|Overall Study|Site Discontinued Study Participation|27|||
126394716|NCT01703208|454738138|FG000|Overall Study|Physician Decision|11|||
126394717|NCT01703208|454738139|FG001|Overall Study|Physician Decision|13|||
126394718|NCT01703208|454738138|FG000|Overall Study|Progressive disease|2|||
126394719|NCT01703208|454738139|FG001|Overall Study|Progressive disease|2|||
126394720|NCT01703208|454738138|FG000|Overall Study|Protocol Violation|1|||
126394721|NCT01703208|454738139|FG001|Overall Study|Protocol Violation|1|||
126394722|NCT01703208|454738138|FG000|Overall Study|Study Terminated by Sponsor|1710|||
126394723|NCT01703208|454738139|FG001|Overall Study|Study Terminated by Sponsor|1716|||
126394724|NCT01703208|454738138|FG000|Overall Study|Withdrawal by Subject|205|||
126394725|NCT01703208|454738139|FG001|Overall Study|Withdrawal by Subject|209|||
126394726|NCT01703208|454738138|FG000|Overall Study|Adverse Event|14|||
126394727|NCT01703208|454738139|FG001|Overall Study|Adverse Event|19|||
126394728|NCT01703208|454738138|FG000|Overall Study|Technical Problems|0|||
126394729|NCT01703208|454738139|FG001|Overall Study|Technical Problems|1|||
126394730|NCT01703208|454738138|FG000|Overall Study|Protocol Deviation|2|||
126394731|NCT01703208|454738139|FG001|Overall Study|Protocol Deviation|0|||
126394732|NCT01271712|454738147|FG000|Double Blind Treatment|Death|2|||
126394733|NCT01271712|454738148|FG001|Double Blind Treatment|Death|0|||
126394734|NCT01271712|454738147|FG000|Double Blind Treatment|Lack of Efficacy|1|||
126394735|NCT01271712|454738148|FG001|Double Blind Treatment|Lack of Efficacy|0|||
126394736|NCT01271712|454738147|FG000|Double Blind Treatment|Adverse Event|9|||
126394737|NCT01271712|454738148|FG001|Double Blind Treatment|Adverse Event|4|||
126394738|NCT01271712|454738147|FG000|Double Blind Treatment|Progressive disease|23|||
126394739|NCT01271712|454738148|FG001|Double Blind Treatment|Progressive disease|3|||
126394740|NCT01271712|454738147|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
126394741|NCT01271712|454738148|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
126394742|NCT01271712|454738147|FG000|Double Blind Treatment|Non compliance with study drug|2|||
126394743|NCT01271712|454738148|FG001|Double Blind Treatment|Non compliance with study drug|0|||
126394744|NCT01271712|454738147|FG000|Double Blind Treatment|receive no study drug|1|||
126719090|NCT01544595|455920585|FG003|Status at Week 156|Lack of Efficacy|4|||
126719091|NCT01544595|455920586|FG004|Status at Week 156|Lack of Efficacy|10|||
126394745|NCT01271712|454738148|FG001|Double Blind Treatment|receive no study drug|0|||
126394746|NCT01271712|454738147|FG000|Open Label Treatment|Death|6|||
126394747|NCT01271712|454738148|FG001|Open Label Treatment|Death|5|||
126394748|NCT01271712|454738147|FG000|Open Label Treatment|Withdrawal by Subject|6|||
126394749|NCT01271712|454738148|FG001|Open Label Treatment|Withdrawal by Subject|11|||
126394750|NCT01271712|454738147|FG000|Open Label Treatment|Physician Decision|2|||
126394751|NCT01271712|454738148|FG001|Open Label Treatment|Physician Decision|0|||
126394752|NCT01271712|454738147|FG000|Open Label Treatment|Adverse Event|14|||
126394753|NCT01271712|454738148|FG001|Open Label Treatment|Adverse Event|8|||
126394754|NCT01271712|454738147|FG000|Open Label Treatment|Progressive disease|59|||
126394755|NCT01271712|454738148|FG001|Open Label Treatment|Progressive disease|32|||
126394756|NCT01271712|454738147|FG000|Open Label Treatment|transferred to rollover study|1|||
126394757|NCT01271712|454738148|FG001|Open Label Treatment|transferred to rollover study|0|||
126394758|NCT01271712|454738147|FG000|Open Label Treatment|Non-compliance with study drug|1|||
126394759|NCT01271712|454738148|FG001|Open Label Treatment|Non-compliance with study drug|0|||
126394760|NCT01271712|454738147|FG000|Open Label Treatment|Protocol Violation|0|||
126394761|NCT01271712|454738148|FG001|Open Label Treatment|Protocol Violation|1|||
126394762|NCT01271712|454738147|FG000|Open Label Treatment|Switching to other therapy|2|||
126394763|NCT01271712|454738148|FG001|Open Label Treatment|Switching to other therapy|1|||
126394764|NCT01271712|454738147|FG000|Safety Follow-up|Death|11|||
126394765|NCT01271712|454738148|FG001|Safety Follow-up|Death|7|||
126394766|NCT01271712|454738147|FG000|Safety Follow-up|Withdrawal by Subject|4|||
126394767|NCT01271712|454738148|FG001|Safety Follow-up|Withdrawal by Subject|2|||
126394768|NCT01271712|454738147|FG000|Safety Follow-up|Protocol Violation|1|||
126394769|NCT01271712|454738148|FG001|Safety Follow-up|Protocol Violation|1|||
126394770|NCT01271712|454738147|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
126394771|NCT01271712|454738148|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
126394772|NCT01271712|454738147|FG000|Safety Follow-up|No follow-up|1|||
126394773|NCT01271712|454738148|FG001|Safety Follow-up|No follow-up|1|||
126394774|NCT01271712|454738147|FG000|Safety Follow-up|Progressive disease|1|||
126394775|NCT01271712|454738148|FG001|Safety Follow-up|Progressive disease|0|||
126394776|NCT01271712|454738147|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
126394777|NCT01271712|454738148|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
126394778|NCT05593913|454738149|FG000|Overall Study|Insufficient image quality|39|||
126394779|NCT02684058|454738157|FG000|Treatment Period|Progressive disease|4|||
126394780|NCT02684058|454738158|FG001|Treatment Period|Progressive disease|10|||
126394781|NCT02684058|454738159|FG002|Treatment Period|Progressive disease|19|||
126394782|NCT02684058|454738157|FG000|Treatment Period|Adverse Event|3|||
126394783|NCT02684058|454738158|FG001|Treatment Period|Adverse Event|8|||
126394784|NCT02684058|454738159|FG002|Treatment Period|Adverse Event|1|||
126394785|NCT02684058|454738157|FG000|Treatment Period|Physician Decision|5|||
126394786|NCT02684058|454738158|FG001|Treatment Period|Physician Decision|1|||
126394787|NCT02684058|454738159|FG002|Treatment Period|Physician Decision|2|||
126394788|NCT02684058|454738157|FG000|Treatment Period|New therapy for study indication|1|||
126394789|NCT02684058|454738158|FG001|Treatment Period|New therapy for study indication|0|||
126394790|NCT02684058|454738159|FG002|Treatment Period|New therapy for study indication|0|||
126394791|NCT02684058|454738157|FG000|Treatment Period|Protocol deviation|0|||
126394792|NCT02684058|454738158|FG001|Treatment Period|Protocol deviation|1|||
126394793|NCT02684058|454738159|FG002|Treatment Period|Protocol deviation|0|||
126394794|NCT02684058|454738157|FG000|Treatment Period|Subject/guardian decision|4|||
126394795|NCT02684058|454738158|FG001|Treatment Period|Subject/guardian decision|3|||
126394796|NCT02684058|454738159|FG002|Treatment Period|Subject/guardian decision|0|||
126394797|NCT02684058|454738157|FG000|Treatment Period|Death|0|||
126394798|NCT02684058|454738158|FG001|Treatment Period|Death|0|||
126394799|NCT02684058|454738159|FG002|Treatment Period|Death|2|||
126394800|NCT02684058|454738157|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126394801|NCT02684058|454738158|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
126394802|NCT02684058|454738159|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
126394803|NCT02684058|454738157|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
126394804|NCT02684058|454738158|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
126394805|NCT02684058|454738159|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
126394806|NCT02684058|454738157|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
126394807|NCT02684058|454738158|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
126394808|NCT02684058|454738159|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
126394809|NCT02684058|454738157|FG000|Post-treatment Efficacy Follow-up|Death|0|||
126394810|NCT02684058|454738158|FG001|Post-treatment Efficacy Follow-up|Death|0|||
126394811|NCT02684058|454738159|FG002|Post-treatment Efficacy Follow-up|Death|3|||
126394812|NCT02684058|454738157|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
126394813|NCT02684058|454738158|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
126394814|NCT02684058|454738159|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
126469413|NCT03633617|455020925|FG006|Part C (& Follow-up)|Pregnancy|0|||
126469414|NCT03633617|455020926|FG007|Part C (& Follow-up)|Pregnancy|0|||
126469415|NCT03633617|455020927|FG008|Part C (& Follow-up)|Pregnancy|0|||
126469416|NCT03633617|455020928|FG009|Part C (& Follow-up)|Pregnancy|1|||
126469417|NCT03633617|455020929|FG010|Part C (& Follow-up)|Pregnancy|0|||
126469418|NCT03633617|455020919|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
126469419|NCT03633617|455020920|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
126469420|NCT03633617|455020921|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
126469421|NCT03633617|455020922|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
126469422|NCT03633617|455020923|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
126469423|NCT03633617|455020924|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
126469424|NCT03633617|455020925|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
126469425|NCT03633617|455020926|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
126554712|NCT01474512|455324045|FG017|Long-Term Extension Period|Sponsor Decision|0|||
126554713|NCT01474512|455324028|FG000|Long-Term Extension Period|Protocol Violation|0|||
126554714|NCT01474512|455324029|FG001|Long-Term Extension Period|Protocol Violation|0|||
126554715|NCT01474512|455324030|FG002|Long-Term Extension Period|Protocol Violation|0|||
126554716|NCT01474512|455324031|FG003|Long-Term Extension Period|Protocol Violation|0|||
126554717|NCT01474512|455324032|FG004|Long-Term Extension Period|Protocol Violation|0|||
126554718|NCT01474512|455324033|FG005|Long-Term Extension Period|Protocol Violation|0|||
126554719|NCT01474512|455324034|FG006|Long-Term Extension Period|Protocol Violation|0|||
126554720|NCT01474512|455324035|FG007|Long-Term Extension Period|Protocol Violation|0|||
126554721|NCT01474512|455324036|FG008|Long-Term Extension Period|Protocol Violation|0|||
126394815|NCT02684058|454738157|FG000|Post-treatment Survival Follow-up|Death|0|||
126394816|NCT02684058|454738158|FG001|Post-treatment Survival Follow-up|Death|0|||
126394817|NCT02684058|454738159|FG002|Post-treatment Survival Follow-up|Death|7|||
126394818|NCT02684058|454738157|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
126394819|NCT02684058|454738158|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
126394820|NCT02684058|454738159|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
126394821|NCT02684058|454738157|FG000|Crossover Treatment Period|Progressive disease|0|||
126394822|NCT02684058|454738158|FG001|Crossover Treatment Period|Progressive disease|1|||
126394823|NCT02684058|454738159|FG002|Crossover Treatment Period|Progressive disease|0|||
126554722|NCT01474512|455324037|FG009|Long-Term Extension Period|Protocol Violation|0|||
126554723|NCT01474512|455324038|FG010|Long-Term Extension Period|Protocol Violation|0|||
126554724|NCT01474512|455324039|FG011|Long-Term Extension Period|Protocol Violation|0|||
126554725|NCT01474512|455324040|FG012|Long-Term Extension Period|Protocol Violation|5|||
126554726|NCT01474512|455324041|FG013|Long-Term Extension Period|Protocol Violation|5|||
126554727|NCT01474512|455324042|FG014|Long-Term Extension Period|Protocol Violation|0|||
126554728|NCT01474512|455324043|FG015|Long-Term Extension Period|Protocol Violation|0|||
126554729|NCT01474512|455324044|FG016|Long-Term Extension Period|Protocol Violation|0|||
126554730|NCT01474512|455324045|FG017|Long-Term Extension Period|Protocol Violation|0|||
126554731|NCT01474512|455324028|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126554732|NCT01474512|455324029|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126554733|NCT01474512|455324030|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126554734|NCT01474512|455324031|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126554735|NCT01474512|455324032|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126554736|NCT01474512|455324033|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126554737|NCT01474512|455324034|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126554738|NCT01474512|455324035|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126719092|NCT01544595|455920587|FG005|Status at Week 156|Lack of Efficacy|5|||
126719093|NCT03288779|455920595|FG000|Overall Study|Withdrawal by Subject|3|||
126719094|NCT00601523|455920596|FG000|Overall Study|Adverse Event|42|||
126719095|NCT00601523|455920597|FG001|Overall Study|Adverse Event|14|||
126719096|NCT00601523|455920596|FG000|Overall Study|Lack of Efficacy|3|||
126719097|NCT00601523|455920597|FG001|Overall Study|Lack of Efficacy|0|||
126394824|NCT00443053|454738163|FG000|Overall Study|Adverse Event|2|||
126394825|NCT00443053|454738164|FG001|Overall Study|Adverse Event|1|||
126394826|NCT00443053|454738163|FG000|Overall Study|Withdrawal by Subject|9|||
126469426|NCT03633617|455020927|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
126469427|NCT03633617|455020928|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
126469428|NCT03633617|455020929|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
126554739|NCT01474512|455324036|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126554740|NCT01474512|455324037|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126719098|NCT00601523|455920596|FG000|Overall Study|Protocol Violation|5|||
126719099|NCT00601523|455920597|FG001|Overall Study|Protocol Violation|1|||
126719100|NCT00601523|455920596|FG000|Overall Study|Lost to Follow-up|0|||
126469429|NCT03633617|455020919|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
126719101|NCT00601523|455920597|FG001|Overall Study|Lost to Follow-up|1|||
126394827|NCT00443053|454738164|FG001|Overall Study|Withdrawal by Subject|18|||
126469430|NCT03633617|455020920|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
126469431|NCT03633617|455020921|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
126469432|NCT03633617|455020922|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
126719102|NCT00601523|455920596|FG000|Overall Study|Withdrawal by Subject|18|||
126719103|NCT00601523|455920597|FG001|Overall Study|Withdrawal by Subject|9|||
126394828|NCT00443053|454738163|FG000|Overall Study|Lost to Follow-up|4|||
126394829|NCT00443053|454738164|FG001|Overall Study|Lost to Follow-up|5|||
126394830|NCT00443053|454738163|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
126394831|NCT00443053|454738164|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
126394832|NCT00443053|454738163|FG000|Overall Study|Noncompliance|2|||
126394833|NCT00443053|454738164|FG001|Overall Study|Noncompliance|1|||
126394834|NCT00443053|454738163|FG000|Overall Study|Other|3|||
126394835|NCT00443053|454738164|FG001|Overall Study|Other|4|||
126394836|NCT00443053|454738163|FG000|Overall Study|Physician Decision|0|||
126394837|NCT00443053|454738164|FG001|Overall Study|Physician Decision|4|||
126394838|NCT01330628|454738166|FG000|Overall Study|Death|2|||
126394839|NCT01330628|454738167|FG001|Overall Study|Death|3|||
126394840|NCT01330628|454738166|FG000|Overall Study|Lost to Follow-up|5|||
126394841|NCT01330628|454738167|FG001|Overall Study|Lost to Follow-up|6|||
126394842|NCT01330628|454738166|FG000|Overall Study|Adverse Event|44|||
126394843|NCT01330628|454738167|FG001|Overall Study|Adverse Event|25|||
126394844|NCT01330628|454738166|FG000|Overall Study|Withdrawn|18|||
126394845|NCT01330628|454738167|FG001|Overall Study|Withdrawn|6|||
126394846|NCT01330628|454738166|FG000|Overall Study|Didn't receive study treatment|1|||
126394847|NCT01330628|454738167|FG001|Overall Study|Didn't receive study treatment|0|||
126394848|NCT00350272|454738168|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
126394849|NCT00350272|454738169|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
126394850|NCT00350272|454738168|FG000|Blinded 12-Week Treatment|Death|1|||
126394851|NCT00350272|454738169|FG001|Blinded 12-Week Treatment|Death|0|||
126394852|NCT00350272|454738168|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
126394853|NCT00350272|454738169|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
126394854|NCT00350272|454738168|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
126394855|NCT00350272|454738169|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
126394856|NCT00350272|454738168|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
126394857|NCT00350272|454738169|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
126394858|NCT00350272|454738168|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
126394859|NCT00350272|454738169|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
126394860|NCT00350272|454738168|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
126394861|NCT00350272|454738169|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
126394862|NCT00350272|454738168|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
126394863|NCT00350272|454738169|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
126394864|NCT00350272|454738168|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
126394865|NCT00350272|454738169|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
126394866|NCT00350272|454738168|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
126394867|NCT00350272|454738169|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
126394868|NCT00350272|454738168|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
126394869|NCT00350272|454738169|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
126394870|NCT01440517|454739420|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
126394871|NCT01468207|454739421|FG000|Treatment Period 1|Adverse Event|1|||
126394872|NCT01468207|454739422|FG001|Treatment Period 1|Adverse Event|0|||
126394873|NCT01468207|454739423|FG002|Treatment Period 1|Adverse Event|0|||
126394874|NCT01468207|454739424|FG003|Treatment Period 1|Adverse Event|0|||
126394875|NCT01468207|454739425|FG004|Treatment Period 1|Adverse Event|0|||
126394876|NCT01468207|454739426|FG005|Treatment Period 1|Adverse Event|0|||
126394877|NCT01468207|454739421|FG000|Treatment Period 1|Protocol Violation|1|||
126394878|NCT01468207|454739422|FG001|Treatment Period 1|Protocol Violation|1|||
126394879|NCT01468207|454739423|FG002|Treatment Period 1|Protocol Violation|0|||
126394880|NCT01468207|454739424|FG003|Treatment Period 1|Protocol Violation|0|||
126394881|NCT01468207|454739425|FG004|Treatment Period 1|Protocol Violation|0|||
126394882|NCT01468207|454739426|FG005|Treatment Period 1|Protocol Violation|0|||
126394883|NCT01468207|454739421|FG000|Treatment Period 1|Withdrawal by Subject|5|||
126394884|NCT01468207|454739422|FG001|Treatment Period 1|Withdrawal by Subject|4|||
126394885|NCT01468207|454739423|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126394886|NCT01468207|454739424|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126394887|NCT01468207|454739425|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126394888|NCT01468207|454739426|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126394889|NCT01468207|454739421|FG000|Treatment Period 1|Lost to Follow-up|2|||
126394890|NCT01468207|454739422|FG001|Treatment Period 1|Lost to Follow-up|1|||
126394891|NCT01468207|454739423|FG002|Treatment Period 1|Lost to Follow-up|0|||
126554741|NCT01474512|455324038|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126719104|NCT00601523|455920596|FG000|Overall Study|Other|9|||
126719105|NCT00601523|455920597|FG001|Overall Study|Other|1|||
126394892|NCT01468207|454739424|FG003|Treatment Period 1|Lost to Follow-up|0|||
126394893|NCT01468207|454739425|FG004|Treatment Period 1|Lost to Follow-up|0|||
126394894|NCT01468207|454739426|FG005|Treatment Period 1|Lost to Follow-up|0|||
126394895|NCT01468207|454739421|FG000|Treatment Period 1|Other|0|||
126394896|NCT01468207|454739422|FG001|Treatment Period 1|Other|2|||
126394897|NCT01468207|454739423|FG002|Treatment Period 1|Other|0|||
126719106|NCT03643432|455920598|FG000|Overall Study|Lost to Follow-up|1|||
126469433|NCT03633617|455020923|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
126469434|NCT03633617|455020924|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
126469435|NCT03633617|455020925|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
126469436|NCT03633617|455020926|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
126469437|NCT03633617|455020927|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
126469438|NCT03633617|455020928|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
126469439|NCT03633617|455020929|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
126469440|NCT03633617|455020919|FG000|Part C (& Follow-up)|Physician Decision|0|||
126469441|NCT03633617|455020920|FG001|Part C (& Follow-up)|Physician Decision|0|||
126469442|NCT03633617|455020921|FG002|Part C (& Follow-up)|Physician Decision|0|||
126469443|NCT03633617|455020922|FG003|Part C (& Follow-up)|Physician Decision|0|||
126469444|NCT03633617|455020923|FG004|Part C (& Follow-up)|Physician Decision|0|||
126469445|NCT03633617|455020924|FG005|Part C (& Follow-up)|Physician Decision|0|||
126469446|NCT03633617|455020925|FG006|Part C (& Follow-up)|Physician Decision|0|||
126469447|NCT03633617|455020926|FG007|Part C (& Follow-up)|Physician Decision|1|||
126469448|NCT03633617|455020927|FG008|Part C (& Follow-up)|Physician Decision|0|||
126554742|NCT01474512|455324039|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126394898|NCT01468207|454739424|FG003|Treatment Period 1|Other|0|||
126394899|NCT01468207|454739425|FG004|Treatment Period 1|Other|0|||
126394900|NCT01468207|454739426|FG005|Treatment Period 1|Other|0|||
126394901|NCT01468207|454739421|FG000|Treatment Period 2|Adverse Event|0|||
126394902|NCT01468207|454739422|FG001|Treatment Period 2|Adverse Event|0|||
126394903|NCT01468207|454739423|FG002|Treatment Period 2|Adverse Event|6|||
126394904|NCT01468207|454739424|FG003|Treatment Period 2|Adverse Event|1|||
126394905|NCT01468207|454739425|FG004|Treatment Period 2|Adverse Event|2|||
126394906|NCT01468207|454739426|FG005|Treatment Period 2|Adverse Event|1|||
126394907|NCT01468207|454739421|FG000|Treatment Period 2|Lack of Efficacy|0|||
126394908|NCT01468207|454739422|FG001|Treatment Period 2|Lack of Efficacy|0|||
126394909|NCT01468207|454739423|FG002|Treatment Period 2|Lack of Efficacy|1|||
126394910|NCT01468207|454739424|FG003|Treatment Period 2|Lack of Efficacy|1|||
126394911|NCT01468207|454739425|FG004|Treatment Period 2|Lack of Efficacy|0|||
126394912|NCT01468207|454739426|FG005|Treatment Period 2|Lack of Efficacy|2|||
126394913|NCT01468207|454739421|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126394914|NCT01468207|454739422|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126394915|NCT01468207|454739423|FG002|Treatment Period 2|Withdrawal by Subject|5|||
126394916|NCT01468207|454739424|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126394917|NCT01468207|454739425|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126394918|NCT01468207|454739426|FG005|Treatment Period 2|Withdrawal by Subject|2|||
126394919|NCT01468207|454739421|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
126394920|NCT01468207|454739422|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
126394921|NCT01468207|454739423|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
126394922|NCT01468207|454739424|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
126394923|NCT01468207|454739425|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
126394924|NCT01468207|454739426|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
126394925|NCT01468207|454739421|FG000|Treatment Period 2|Lost to Follow-up|0|||
126394926|NCT01468207|454739422|FG001|Treatment Period 2|Lost to Follow-up|0|||
126394927|NCT01468207|454739423|FG002|Treatment Period 2|Lost to Follow-up|5|||
126469449|NCT03633617|455020928|FG009|Part C (& Follow-up)|Physician Decision|0|||
126554743|NCT01474512|455324040|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
126554744|NCT01474512|455324041|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
126554745|NCT01474512|455324042|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126554746|NCT01474512|455324043|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126554747|NCT01474512|455324044|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126554748|NCT01474512|455324045|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
126554749|NCT01474512|455324028|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554750|NCT01474512|455324029|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554751|NCT01474512|455324030|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554752|NCT01474512|455324031|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126394928|NCT01468207|454739424|FG003|Treatment Period 2|Lost to Follow-up|1|||
126394929|NCT01468207|454739425|FG004|Treatment Period 2|Lost to Follow-up|0|||
126394930|NCT01468207|454739426|FG005|Treatment Period 2|Lost to Follow-up|0|||
126394931|NCT01468207|454739421|FG000|Treatment Period 2|Other|0|||
126394932|NCT01468207|454739422|FG001|Treatment Period 2|Other|0|||
126394933|NCT01468207|454739423|FG002|Treatment Period 2|Other|5|||
126394934|NCT01468207|454739424|FG003|Treatment Period 2|Other|1|||
126469450|NCT03633617|455020929|FG010|Part C (& Follow-up)|Physician Decision|1|||
126394935|NCT01468207|454739425|FG004|Treatment Period 2|Other|1|||
126394936|NCT01468207|454739426|FG005|Treatment Period 2|Other|2|||
126394937|NCT00539513|454739427|FG000|Overall Study|Withdrawal by Subject|2|||
126394938|NCT00539513|454739428|FG001|Overall Study|Withdrawal by Subject|1|||
126394939|NCT00539513|454739427|FG000|Overall Study|Lost to Follow-up|0|||
126469451|NCT03633617|455020919|FG000|Part C (& Follow-up)|COVID-19 related|0|||
126469452|NCT03633617|455020920|FG001|Part C (& Follow-up)|COVID-19 related|0|||
126469453|NCT03633617|455020921|FG002|Part C (& Follow-up)|COVID-19 related|0|||
126554753|NCT01474512|455324032|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554754|NCT01474512|455324033|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554755|NCT01474512|455324034|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554756|NCT01474512|455324035|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554757|NCT01474512|455324036|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554758|NCT01474512|455324037|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554759|NCT01474512|455324038|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554760|NCT01474512|455324039|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
126554761|NCT01474512|455324040|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554762|NCT01474512|455324041|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554763|NCT01474512|455324042|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554764|NCT01474512|455324043|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554765|NCT01474512|455324044|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554766|NCT01474512|455324045|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
126554767|NCT01474512|455324028|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
126554768|NCT01474512|455324029|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
126554769|NCT01474512|455324030|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
126554770|NCT01474512|455324031|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
126554771|NCT01474512|455324032|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
126554772|NCT01474512|455324033|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
126554773|NCT01474512|455324034|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
126554774|NCT01474512|455324035|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
126554775|NCT01474512|455324036|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
126554776|NCT01474512|455324037|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
126554777|NCT01474512|455324038|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
126554778|NCT01474512|455324039|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
126554779|NCT01474512|455324040|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
126554780|NCT01474512|455324041|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
126554781|NCT01474512|455324042|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
126554782|NCT01474512|455324043|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
126554783|NCT01474512|455324044|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
126554784|NCT01474512|455324045|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
126554785|NCT01474512|455324028|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554786|NCT01474512|455324029|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554787|NCT01474512|455324030|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554788|NCT01474512|455324031|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554789|NCT01474512|455324032|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554790|NCT01474512|455324033|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554791|NCT01474512|455324034|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554792|NCT01474512|455324035|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554793|NCT01474512|455324036|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554794|NCT01474512|455324037|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554795|NCT01474512|455324038|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554796|NCT01474512|455324039|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554797|NCT01474512|455324040|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554798|NCT01474512|455324041|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
126554799|NCT01474512|455324042|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
126554800|NCT01474512|455324043|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
126554801|NCT01474512|455324044|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
126554802|NCT01474512|455324045|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
126554803|NCT01474512|455324028|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554804|NCT01474512|455324029|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554805|NCT01474512|455324030|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554806|NCT01474512|455324031|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554807|NCT01474512|455324032|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554808|NCT01474512|455324033|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554809|NCT01474512|455324034|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554810|NCT01474512|455324035|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554811|NCT01474512|455324036|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554812|NCT01474512|455324037|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554813|NCT01474512|455324038|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554814|NCT01474512|455324039|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554815|NCT01474512|455324040|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126554816|NCT01474512|455324041|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
126771592|NCT02587325|456117837|FG002|32-Week Optional Extension Part|Adverse Event|1|||
126771593|NCT02587325|456117838|FG003|32-Week Optional Extension Part|Adverse Event|0|||
126554817|NCT01474512|455324042|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
126771594|NCT02587325|456117839|FG004|32-Week Optional Extension Part|Adverse Event|0|||
126771595|NCT02587325|456117835|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
126771596|NCT02587325|456117836|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
126554818|NCT01474512|455324043|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
126469454|NCT03633617|455020922|FG003|Part C (& Follow-up)|COVID-19 related|0|||
126469455|NCT03633617|455020923|FG004|Part C (& Follow-up)|COVID-19 related|0|||
126469456|NCT03633617|455020924|FG005|Part C (& Follow-up)|COVID-19 related|1|||
126469457|NCT03633617|455020925|FG006|Part C (& Follow-up)|COVID-19 related|0|||
126469458|NCT03633617|455020926|FG007|Part C (& Follow-up)|COVID-19 related|0|||
126469459|NCT03633617|455020927|FG008|Part C (& Follow-up)|COVID-19 related|0|||
126469460|NCT03633617|455020928|FG009|Part C (& Follow-up)|COVID-19 related|0|||
126469461|NCT03633617|455020929|FG010|Part C (& Follow-up)|COVID-19 related|0|||
126719107|NCT03643432|455920599|FG001|Overall Study|Lost to Follow-up|0|||
126719108|NCT01064648|455920608|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
126719109|NCT01064648|455920609|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
126719110|NCT01064648|455920610|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
126394940|NCT00539513|454739428|FG001|Overall Study|Lost to Follow-up|1|||
126394941|NCT00908115|454739431|FG000|Overall Study|Other|14|||
126394942|NCT01728077|454739432|FG000|Overall Study|Lack of Efficacy|3|||
126394943|NCT01728077|454739433|FG001|Overall Study|Lack of Efficacy|1|||
126394944|NCT01728077|454739432|FG000|Overall Study|Lost to Follow-up|1|||
126394945|NCT01728077|454739433|FG001|Overall Study|Lost to Follow-up|0|||
126394946|NCT01728077|454739432|FG000|Overall Study|Subject choice|2|||
126394947|NCT01728077|454739433|FG001|Overall Study|Subject choice|3|||
126394948|NCT01728077|454739432|FG000|Overall Study|Death|0|||
126394949|NCT01728077|454739433|FG001|Overall Study|Death|1|||
126394950|NCT01728077|454739432|FG000|Overall Study|Patient moving|1|||
126394951|NCT01728077|454739433|FG001|Overall Study|Patient moving|0|||
126394952|NCT01728077|454739432|FG000|Overall Study|Non compliance|1|||
126394953|NCT01728077|454739433|FG001|Overall Study|Non compliance|0|||
126394954|NCT00347438|454739437|FG000|Overall Study|Withdrawal by Subject|1|||
126394955|NCT00347438|454739437|FG000|Overall Study|Physician Decision|1|||
126394956|NCT00322023|454739438|FG000|Overall Study|various|0|||
126394957|NCT00322023|454739439|FG001|Overall Study|various|2|||
126394958|NCT00322023|454739440|FG002|Overall Study|various|6|||
126394959|NCT00693017|454739441|FG000|Overall Study|Sponsor Decision|2|||
126394960|NCT00693017|454739442|FG001|Overall Study|Sponsor Decision|1|||
126394961|NCT00693017|454739441|FG000|Overall Study|Death|0|||
126394962|NCT00693017|454739442|FG001|Overall Study|Death|1|||
126394963|NCT01082874|454739443|FG000|Overall Study|Lost to Follow-up|10|||
126394964|NCT01082874|454739444|FG001|Overall Study|Lost to Follow-up|10|||
126394965|NCT01082874|454739445|FG002|Overall Study|Lost to Follow-up|6|||
126394966|NCT01082874|454739446|FG003|Overall Study|Lost to Follow-up|10|||
126394967|NCT01082874|454739443|FG000|Overall Study|Withdrawal by Subject|1|||
126394968|NCT01082874|454739444|FG001|Overall Study|Withdrawal by Subject|2|||
126394969|NCT01082874|454739445|FG002|Overall Study|Withdrawal by Subject|5|||
126394970|NCT01082874|454739446|FG003|Overall Study|Withdrawal by Subject|3|||
126394971|NCT01685801|454739464|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
126394972|NCT01685801|454739465|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
126394973|NCT01685801|454739466|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
126394974|NCT01685801|454739467|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
126394975|NCT01685801|454739464|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
126394976|NCT01685801|454739465|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
126394977|NCT01685801|454739466|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
126394978|NCT01685801|454739467|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
126394979|NCT00113399|454739468|FG000|Overall Study|Death|1|||
126394980|NCT00113399|454739469|FG001|Overall Study|Death|1|||
126394981|NCT00113399|454739468|FG000|Overall Study|Withdrawal by Subject|1|||
126394982|NCT00113399|454739469|FG001|Overall Study|Withdrawal by Subject|2|||
126469462|NCT03633617|455020919|FG000|Part C (& Follow-up)|Protocol Violation|0|||
126469463|NCT03633617|455020920|FG001|Part C (& Follow-up)|Protocol Violation|0|||
126394983|NCT00113399|454739468|FG000|Overall Study|Complete Response|0|||
126394984|NCT00113399|454739469|FG001|Overall Study|Complete Response|1|||
126394985|NCT00113399|454739468|FG000|Overall Study|Other|0|||
126394986|NCT00113399|454739469|FG001|Overall Study|Other|1|||
126719111|NCT01064648|455920611|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
126394987|NCT00396136|454739470|FG000|Overall Study|Death|43|||
126394988|NCT00396136|454739470|FG000|Overall Study|Withdrawal by Subject|59|||
126719112|NCT01064648|455920608|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
126719113|NCT01064648|455920609|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
126394989|NCT00396136|454739470|FG000|Overall Study|Lost to Follow-up|15|||
126394990|NCT00396136|454739470|FG000|Overall Study|Study device explanted|8|||
126469464|NCT03633617|455020921|FG002|Part C (& Follow-up)|Protocol Violation|0|||
126469465|NCT03633617|455020922|FG003|Part C (& Follow-up)|Protocol Violation|0|||
126469466|NCT03633617|455020923|FG004|Part C (& Follow-up)|Protocol Violation|0|||
126719114|NCT01064648|455920610|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
126394991|NCT04686084|454739472|FG000|Overall Study|Lost to Follow-up|1|||
126394992|NCT01779856|454739473|FG000|Overall Study|Withdrawal by Subject|15|||
126394993|NCT01779856|454739473|FG000|Overall Study|Death|3|||
126394994|NCT01779856|454739473|FG000|Overall Study|Physician Decision|1|||
126394995|NCT01779856|454739473|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
126394996|NCT01779856|454739473|FG000|Overall Study|Delays in scheduling implant|1|||
126394997|NCT01779856|454739473|FG000|Overall Study|Subject ineligible for Implant|2|||
126394998|NCT03350256|454739475|FG000|Overall Study|Inclusion/exclusion violation|4|||
126394999|NCT03350256|454739475|FG000|Overall Study|Recommended for other therapies|2|||
126395000|NCT03350256|454739475|FG000|Overall Study|Protocol Violation|3|||
126395001|NCT03350256|454739475|FG000|Overall Study|Non compliance|2|||
126395002|NCT03350256|454739475|FG000|Overall Study|Denial by insurance|1|||
126395003|NCT03350256|454739475|FG000|Overall Study|Adverse Event|2|||
126395004|NCT03350256|454739475|FG000|Overall Study|Trial failure|12|||
126395005|NCT03350256|454739475|FG000|Overall Study|Did not proceed to permanent implant|3|||
126395006|NCT03350256|454739475|FG000|Overall Study|Withdrawal by Subject|3|||
126395007|NCT03350256|454739475|FG000|Overall Study|Subject moving out of state|1|||
126395008|NCT03350256|454739475|FG000|Overall Study|Lost to Follow-up|1|||
126395009|NCT03350256|454739475|FG000|Overall Study|Lack of Efficacy|2|||
126395010|NCT04043234|454739478|FG000|Overall Study|Lost to Follow-up|1|||
126395011|NCT04043234|454739478|FG000|Overall Study|Withdrawal by Subject|1|||
126395012|NCT01155466|454739479|FG000|Overall Study|Adverse Event|13|||
126395013|NCT01155466|454739480|FG001|Overall Study|Adverse Event|15|||
126395014|NCT01155466|454739481|FG002|Overall Study|Adverse Event|6|||
126395015|NCT01155466|454739482|FG003|Overall Study|Adverse Event|17|||
126395016|NCT01155466|454739483|FG004|Overall Study|Adverse Event|18|||
126395017|NCT01155466|454739479|FG000|Overall Study|Lost to Follow-up|0|||
126395018|NCT01155466|454739480|FG001|Overall Study|Lost to Follow-up|0|||
126395019|NCT01155466|454739481|FG002|Overall Study|Lost to Follow-up|0|||
126395020|NCT01155466|454739482|FG003|Overall Study|Lost to Follow-up|0|||
126395021|NCT01155466|454739483|FG004|Overall Study|Lost to Follow-up|2|||
126395022|NCT01155466|454739479|FG000|Overall Study|Withdrawal by Subject|7|||
126395023|NCT01155466|454739480|FG001|Overall Study|Withdrawal by Subject|5|||
126395024|NCT01155466|454739481|FG002|Overall Study|Withdrawal by Subject|9|||
126395025|NCT01155466|454739482|FG003|Overall Study|Withdrawal by Subject|4|||
126395026|NCT01155466|454739483|FG004|Overall Study|Withdrawal by Subject|4|||
126395027|NCT01155466|454739479|FG000|Overall Study|Protocol Violation|0|||
126395028|NCT01155466|454739480|FG001|Overall Study|Protocol Violation|0|||
126395029|NCT01155466|454739481|FG002|Overall Study|Protocol Violation|2|||
126395030|NCT01155466|454739482|FG003|Overall Study|Protocol Violation|0|||
126395031|NCT01155466|454739483|FG004|Overall Study|Protocol Violation|1|||
126395032|NCT01155466|454739479|FG000|Overall Study|Administrative|0|||
126395033|NCT01155466|454739480|FG001|Overall Study|Administrative|3|||
126395034|NCT01155466|454739481|FG002|Overall Study|Administrative|0|||
126395035|NCT01155466|454739482|FG003|Overall Study|Administrative|0|||
126395036|NCT01155466|454739483|FG004|Overall Study|Administrative|0|||
126395037|NCT01155466|454739479|FG000|Overall Study|Randomized not treated|2|||
126395038|NCT01155466|454739480|FG001|Overall Study|Randomized not treated|2|||
126395039|NCT01155466|454739481|FG002|Overall Study|Randomized not treated|3|||
126395040|NCT01155466|454739482|FG003|Overall Study|Randomized not treated|0|||
126395041|NCT01155466|454739483|FG004|Overall Study|Randomized not treated|2|||
126395042|NCT02210689|454739484|FG000|Overall Study|Withdrawal by Subject|7|||
126395043|NCT02210689|454739485|FG001|Overall Study|Withdrawal by Subject|4|||
126395044|NCT02210689|454739486|FG002|Overall Study|Withdrawal by Subject|2|||
126395045|NCT02210689|454739484|FG000|Overall Study|Adverse Event|0|||
126395046|NCT02210689|454739485|FG001|Overall Study|Adverse Event|1|||
126395047|NCT02210689|454739486|FG002|Overall Study|Adverse Event|0|||
126395048|NCT02210689|454739484|FG000|Overall Study|Protocol Violation|1|||
126395049|NCT02210689|454739485|FG001|Overall Study|Protocol Violation|0|||
126395050|NCT02210689|454739486|FG002|Overall Study|Protocol Violation|0|||
126395051|NCT02210689|454739484|FG000|Overall Study|Lost to Follow-up|11|||
126395052|NCT02210689|454739485|FG001|Overall Study|Lost to Follow-up|9|||
126395053|NCT02210689|454739486|FG002|Overall Study|Lost to Follow-up|5|||
126395054|NCT02210689|454739484|FG000|Overall Study|Pregnancy|0|||
126395055|NCT02210689|454739485|FG001|Overall Study|Pregnancy|1|||
126395056|NCT02210689|454739486|FG002|Overall Study|Pregnancy|0|||
126395057|NCT02210689|454739484|FG000|Overall Study|Lack of Efficacy|0|||
126395058|NCT02210689|454739485|FG001|Overall Study|Lack of Efficacy|1|||
126395059|NCT02210689|454739486|FG002|Overall Study|Lack of Efficacy|5|||
126395060|NCT02210689|454739484|FG000|Overall Study|Prohibited medication|2|||
126395061|NCT02210689|454739485|FG001|Overall Study|Prohibited medication|8|||
126395062|NCT02210689|454739486|FG002|Overall Study|Prohibited medication|1|||
126395063|NCT02210689|454739484|FG000|Overall Study|Negative Nugent score at baseline|6|||
126395064|NCT02210689|454739485|FG001|Overall Study|Negative Nugent score at baseline|2|||
126395065|NCT02210689|454739486|FG002|Overall Study|Negative Nugent score at baseline|2|||
126395066|NCT02210689|454739484|FG000|Overall Study|Other|25|||
126395067|NCT02210689|454739485|FG001|Overall Study|Other|21|||
126395068|NCT02210689|454739486|FG002|Overall Study|Other|8|||
126395069|NCT00223977|454739493|FG000|Overall Study|Adverse Event|7|||
126395070|NCT00223977|454739494|FG001|Overall Study|Adverse Event|10|||
126395071|NCT00223977|454739495|FG002|Overall Study|Adverse Event|0|||
126395072|NCT00223977|454739493|FG000|Overall Study|Protocol Violation|0|||
126395073|NCT00223977|454739494|FG001|Overall Study|Protocol Violation|0|||
126395074|NCT00223977|454739495|FG002|Overall Study|Protocol Violation|1|||
126395075|NCT00223977|454739493|FG000|Overall Study|Withdrawal by Subject|1|||
126554819|NCT01474512|455324044|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
126554820|NCT01474512|455324045|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
126554821|NCT01474512|455324028|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554822|NCT01474512|455324029|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554823|NCT01474512|455324030|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554824|NCT01474512|455324031|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554825|NCT01474512|455324032|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554826|NCT01474512|455324033|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554827|NCT01474512|455324034|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126719115|NCT01064648|455920611|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
126719116|NCT01064648|455920608|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
126719117|NCT01064648|455920609|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
126719118|NCT01064648|455920610|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
126719119|NCT01064648|455920611|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
126719120|NCT01064648|455920608|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
126719121|NCT01064648|455920609|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
126719122|NCT01064648|455920610|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
126719123|NCT01064648|455920611|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
126719124|NCT01064648|455920608|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
126719125|NCT01064648|455920609|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
126395076|NCT00223977|454739494|FG001|Overall Study|Withdrawal by Subject|1|||
126395077|NCT00223977|454739495|FG002|Overall Study|Withdrawal by Subject|2|||
126395078|NCT00223977|454739493|FG000|Overall Study|Other|1|||
126395079|NCT00223977|454739494|FG001|Overall Study|Other|0|||
126395080|NCT00223977|454739495|FG002|Overall Study|Other|0|||
126395081|NCT03136497|454739496|FG000|Overall Study|Screen Failure|1|||
126395082|NCT03136497|454739497|FG001|Overall Study|Screen Failure|0|||
126395083|NCT03136497|454739498|FG002|Overall Study|Screen Failure|0|||
126395084|NCT00557310|454739501|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
126395085|NCT00557310|454739501|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
126395086|NCT00557310|454739501|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
126395087|NCT00557310|454739501|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
126395088|NCT00557310|454739501|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
126395089|NCT00557310|454739501|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
126395090|NCT00367744|454739504|FG000|Overall Study|Lost to Follow-up|4|||
126395091|NCT00367744|454739505|FG001|Overall Study|Lost to Follow-up|5|||
126395092|NCT00096226|454739507|FG000|Overall Study|Ineligible|2|||
126395093|NCT00096226|454739507|FG000|Overall Study|Protocol treatment not started|1|||
126395094|NCT01666119|454739508|FG000|Overall Study|Adverse Event|6|||
126395095|NCT01666119|454739508|FG000|Overall Study|Withdrawal by Subject|16|||
126395096|NCT01666119|454739508|FG000|Overall Study|Lost to Follow-up|7|||
126395097|NCT01666119|454739508|FG000|Overall Study|non compliance with study medication, pa|18|||
126395098|NCT01666119|454739508|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
126395099|NCT05479097|454739514|FG000|Overall Study|Withdrawal by Subject|2|||
126395100|NCT04003207|454739517|FG000|Overall Study|Protocol Violation|1|||
126395101|NCT03894969|454739520|FG000|Overall Study|Adverse Event|0|||
126395102|NCT03894969|454739521|FG001|Overall Study|Adverse Event|2|||
126395103|NCT03894969|454739522|FG002|Overall Study|Adverse Event|0|||
126395104|NCT03894969|454739523|FG003|Overall Study|Adverse Event|1|||
126395105|NCT03894969|454739524|FG004|Overall Study|Adverse Event|2|||
126395106|NCT03894969|454739520|FG000|Overall Study|Lost to Follow-up|3|||
126395107|NCT03894969|454739521|FG001|Overall Study|Lost to Follow-up|1|||
126395108|NCT03894969|454739522|FG002|Overall Study|Lost to Follow-up|1|||
126395109|NCT03894969|454739523|FG003|Overall Study|Lost to Follow-up|0|||
126395110|NCT03894969|454739524|FG004|Overall Study|Lost to Follow-up|0|||
126395111|NCT03894969|454739520|FG000|Overall Study|Withdrawal by Subject|2|||
126395112|NCT03894969|454739521|FG001|Overall Study|Withdrawal by Subject|1|||
126395113|NCT03894969|454739522|FG002|Overall Study|Withdrawal by Subject|3|||
126395114|NCT03894969|454739523|FG003|Overall Study|Withdrawal by Subject|4|||
126395115|NCT03894969|454739524|FG004|Overall Study|Withdrawal by Subject|8|||
126395116|NCT03894969|454739520|FG000|Overall Study|Other|0|||
126395117|NCT03894969|454739521|FG001|Overall Study|Other|0|||
126395118|NCT03894969|454739522|FG002|Overall Study|Other|0|||
126395119|NCT03894969|454739523|FG003|Overall Study|Other|0|||
126395120|NCT03894969|454739524|FG004|Overall Study|Other|3|||
126554828|NCT01474512|455324035|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554829|NCT01474512|455324036|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554830|NCT01474512|455324037|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126395121|NCT03894969|454739520|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
126395122|NCT03894969|454739521|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
126395123|NCT03894969|454739522|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
126395124|NCT03894969|454739523|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
126395125|NCT03894969|454739524|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
126395126|NCT03894969|454739520|FG000|Overall Study|Solicited Adverse Event|0|||
126554831|NCT01474512|455324038|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554832|NCT01474512|455324039|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554833|NCT01474512|455324040|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554834|NCT01474512|455324041|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554835|NCT01474512|455324042|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554836|NCT01474512|455324043|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
126554837|NCT01474512|455324044|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
126395127|NCT03894969|454739521|FG001|Overall Study|Solicited Adverse Event|1|||
126395128|NCT03894969|454739522|FG002|Overall Study|Solicited Adverse Event|0|||
126395129|NCT03894969|454739523|FG003|Overall Study|Solicited Adverse Event|0|||
126395130|NCT03894969|454739524|FG004|Overall Study|Solicited Adverse Event|0|||
126395131|NCT00468676|454739528|FG000|Overall Study|Lost to Follow-up|14|||
126395132|NCT00468676|454739529|FG001|Overall Study|Lost to Follow-up|11|||
126395133|NCT00468676|454739528|FG000|Overall Study|Death|2|||
126395134|NCT00468676|454739529|FG001|Overall Study|Death|1|||
126395135|NCT00118846|454739533|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
126395136|NCT00118846|454739534|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
126395137|NCT00118846|454739533|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
126395138|NCT00118846|454739534|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
126395139|NCT00118846|454739533|FG000|Overall Study|Physician Decision|1|||
126395140|NCT00118846|454739534|FG001|Overall Study|Physician Decision|0|||
126395141|NCT00118846|454739533|FG000|Overall Study|Medical condition|2|||
126395142|NCT00118846|454739534|FG001|Overall Study|Medical condition|2|||
126395143|NCT00118846|454739533|FG000|Overall Study|Lost to Follow-up|0|||
126395144|NCT00118846|454739534|FG001|Overall Study|Lost to Follow-up|2|||
126395145|NCT00118846|454739533|FG000|Overall Study|Personal reason|4|||
126395146|NCT00118846|454739534|FG001|Overall Study|Personal reason|5|||
126395147|NCT01327053|454739535|FG000|Overall Study|Adverse Event|23|||
126395148|NCT01327053|454739536|FG001|Overall Study|Adverse Event|57|||
126395149|NCT01327053|454739535|FG000|Overall Study|Patient/guardian decision|11|||
126395150|NCT01327053|454739536|FG001|Overall Study|Patient/guardian decision|35|||
126395151|NCT01327053|454739535|FG000|Overall Study|Physician Decision|10|||
126395152|NCT01327053|454739536|FG001|Overall Study|Physician Decision|14|||
126395153|NCT01327053|454739535|FG000|Overall Study|Death|1|||
126395154|NCT01327053|454739536|FG001|Overall Study|Death|5|||
126395155|NCT01327053|454739535|FG000|Overall Study|Lost to Follow-up|2|||
126395156|NCT01327053|454739536|FG001|Overall Study|Lost to Follow-up|4|||
126395157|NCT01327053|454739535|FG000|Overall Study|Non-compliance with study treatment|0|||
126395158|NCT01327053|454739536|FG001|Overall Study|Non-compliance with study treatment|5|||
126395159|NCT01327053|454739535|FG000|Overall Study|Study terminated by Sponsor|1|||
126395160|NCT01327053|454739536|FG001|Overall Study|Study terminated by Sponsor|3|||
126395161|NCT01327053|454739535|FG000|Overall Study|Progressive disease|31|||
126395162|NCT01327053|454739536|FG001|Overall Study|Progressive disease|26|||
126395163|NCT01327053|454739535|FG000|Overall Study|Protocol Violation|0|||
126395164|NCT01327053|454739536|FG001|Overall Study|Protocol Violation|1|||
126395165|NCT01327053|454739535|FG000|Overall Study|Untreated|0|||
126395166|NCT01327053|454739536|FG001|Overall Study|Untreated|1|||
126395167|NCT01574157|454739537|FG000|Overall Study|Withdrawal by Subject|4|||
126395168|NCT01574157|454739538|FG001|Overall Study|Withdrawal by Subject|5|||
126395169|NCT01574157|454739537|FG000|Overall Study|Lost to Follow-up|0|||
126395170|NCT01574157|454739538|FG001|Overall Study|Lost to Follow-up|3|||
126395171|NCT00721578|454739539|FG000|Overall Study|Death|1|||
126395172|NCT00721578|454739540|FG001|Overall Study|Death|1|||
126395173|NCT00721578|454739539|FG000|Overall Study|Withdrawal by Subject|1|||
126395174|NCT00721578|454739540|FG001|Overall Study|Withdrawal by Subject|1|||
126395175|NCT02910401|454739544|FG000|Overall Study|Study closure Study closure|0|||
126395176|NCT02910401|454739545|FG001|Overall Study|Study closure Study closure|0|||
126395177|NCT02910401|454739546|FG002|Overall Study|Study closure Study closure|2|||
126395178|NCT02910401|454739544|FG000|Overall Study|Physician Decision|1|||
126395179|NCT02910401|454739545|FG001|Overall Study|Physician Decision|0|||
126395180|NCT02910401|454739546|FG002|Overall Study|Physician Decision|0|||
126395181|NCT03300024|454739549|FG000|Overall Study|Physician Decision|4|||
126395182|NCT03300024|454739550|FG001|Overall Study|Physician Decision|6|||
126395183|NCT00570037|454739555|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
126395184|NCT00570037|454739556|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
126395185|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
126395186|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
126395187|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Death|0|||
126554838|NCT01474512|455324045|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
126554839|NCT01474512|455324028|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
126395188|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Death|0|||
126395189|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
126395190|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
126395191|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
126395192|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
126395193|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
126719126|NCT01064648|455920610|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
126719127|NCT01064648|455920611|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
126719128|NCT01064648|455920608|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
126719129|NCT01064648|455920609|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
126719130|NCT01064648|455920610|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
126719131|NCT01064648|455920611|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
126719132|NCT01064648|455920608|FG000|Phase II|Adverse Event|0|||
126719133|NCT01064648|455920609|FG001|Phase II|Adverse Event|0|||
126719134|NCT01064648|455920610|FG002|Phase II|Adverse Event|15|||
126719135|NCT01064648|455920611|FG003|Phase II|Adverse Event|8|||
126719136|NCT01064648|455920608|FG000|Phase II|Death|0|||
126719137|NCT01064648|455920609|FG001|Phase II|Death|0|||
126719138|NCT01064648|455920610|FG002|Phase II|Death|4|||
126719139|NCT01064648|455920611|FG003|Phase II|Death|5|||
126719140|NCT01064648|455920608|FG000|Phase II|Withdrawal by Subject|0|||
126719141|NCT01064648|455920609|FG001|Phase II|Withdrawal by Subject|0|||
126719142|NCT01064648|455920610|FG002|Phase II|Withdrawal by Subject|2|||
126719143|NCT01064648|455920611|FG003|Phase II|Withdrawal by Subject|5|||
126719144|NCT01064648|455920608|FG000|Phase II|Progression|0|||
126719145|NCT01064648|455920609|FG001|Phase II|Progression|0|||
126719146|NCT01064648|455920610|FG002|Phase II|Progression|21|||
126719147|NCT01064648|455920611|FG003|Phase II|Progression|27|||
126719148|NCT01064648|455920608|FG000|Phase II|Non-protocol specified|0|||
126719149|NCT01064648|455920609|FG001|Phase II|Non-protocol specified|0|||
126719150|NCT01064648|455920610|FG002|Phase II|Non-protocol specified|5|||
126719151|NCT01064648|455920611|FG003|Phase II|Non-protocol specified|3|||
126719152|NCT01064648|455920608|FG000|Phase II|Under Review|0|||
126719153|NCT01064648|455920609|FG001|Phase II|Under Review|0|||
126719154|NCT01064648|455920610|FG002|Phase II|Under Review|2|||
126719155|NCT01064648|455920611|FG003|Phase II|Under Review|0|||
126719156|NCT04038255|455922962|FG000|Overall Study|Lost to Follow-up|0|||
126719157|NCT04038255|455922963|FG001|Overall Study|Lost to Follow-up|9|||
126719158|NCT04038255|455922964|FG002|Overall Study|Lost to Follow-up|5|||
126719159|NCT04038255|455922962|FG000|Overall Study|Withdrawal by Subject|0|||
126719160|NCT04038255|455922963|FG001|Overall Study|Withdrawal by Subject|0|||
126719161|NCT04038255|455922964|FG002|Overall Study|Withdrawal by Subject|1|||
126719162|NCT01286272|455922965|FG000|Overall Study|Ineligible after beginning treatment|1|||
126719163|NCT01286272|455922966|FG001|Overall Study|Ineligible after beginning treatment|3|||
126719164|NCT01953328|455922971|FG000|Overall Study|Withdrawal by Subject|0|||
126719165|NCT01953328|455922972|FG001|Overall Study|Withdrawal by Subject|0|||
126719166|NCT01953328|455922973|FG002|Overall Study|Withdrawal by Subject|0|||
126719167|NCT01953328|455922974|FG003|Overall Study|Withdrawal by Subject|0|||
126719168|NCT01953328|455922975|FG004|Overall Study|Withdrawal by Subject|1|||
126719169|NCT01953328|455922976|FG005|Overall Study|Withdrawal by Subject|0|||
126719170|NCT01953328|455922977|FG006|Overall Study|Withdrawal by Subject|0|||
126719171|NCT01953328|455922978|FG007|Overall Study|Withdrawal by Subject|0|||
126719172|NCT01953328|455922971|FG000|Overall Study|Lost to Follow-up|0|||
126719173|NCT01953328|455922972|FG001|Overall Study|Lost to Follow-up|0|||
126719174|NCT01953328|455922973|FG002|Overall Study|Lost to Follow-up|0|||
126719175|NCT01953328|455922974|FG003|Overall Study|Lost to Follow-up|0|||
126719176|NCT01953328|455922975|FG004|Overall Study|Lost to Follow-up|1|||
126719177|NCT01953328|455922976|FG005|Overall Study|Lost to Follow-up|0|||
126719178|NCT01953328|455922977|FG006|Overall Study|Lost to Follow-up|0|||
126719179|NCT01953328|455922978|FG007|Overall Study|Lost to Follow-up|0|||
126719180|NCT02364947|455922983|FG000|Overall Study|Withdrawal by Subject|10|||
126719181|NCT02364947|455922984|FG001|Overall Study|Withdrawal by Subject|8|||
126719182|NCT02364947|455922985|FG002|Overall Study|Withdrawal by Subject|9|||
126719183|NCT02364947|455922983|FG000|Overall Study|Adverse Event|45|||
126719184|NCT02364947|455922984|FG001|Overall Study|Adverse Event|33|||
126719185|NCT02364947|455922985|FG002|Overall Study|Adverse Event|11|||
126719186|NCT02364947|455922983|FG000|Overall Study|Protocol Violation|1|||
126719187|NCT02364947|455922984|FG001|Overall Study|Protocol Violation|1|||
126719188|NCT02364947|455922985|FG002|Overall Study|Protocol Violation|1|||
126719189|NCT02364947|455922983|FG000|Overall Study|Physician Decision|3|||
126719190|NCT02364947|455922984|FG001|Overall Study|Physician Decision|2|||
126719191|NCT02364947|455922985|FG002|Overall Study|Physician Decision|5|||
126719192|NCT02364947|455922983|FG000|Overall Study|Death|0|||
126719193|NCT02364947|455922984|FG001|Overall Study|Death|1|||
126719194|NCT02364947|455922985|FG002|Overall Study|Death|0|||
126719195|NCT05525975|455922986|FG000|Overall Study|Surgery cancellation|4|||
126719196|NCT05525975|455922987|FG001|Overall Study|Surgery cancellation|5|||
126719197|NCT05525975|455922986|FG000|Overall Study|didn't fill prescription|1|||
126719198|NCT05525975|455922987|FG001|Overall Study|didn't fill prescription|0|||
126719199|NCT05525975|455922986|FG000|Overall Study|Withdrawal by Subject|0|||
126719200|NCT05525975|455922987|FG001|Overall Study|Withdrawal by Subject|3|||
126719201|NCT00262080|455922988|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
126719202|NCT00262080|455922989|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
126719203|NCT00262080|455922990|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
126719204|NCT00262080|455922988|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
126395194|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
126395195|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
126395196|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
126395197|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
126395198|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
126395199|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
126395200|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
126395201|NCT00433160|454739557|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
126395202|NCT00433160|454739558|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
126395203|NCT00433160|454739557|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
126395204|NCT00433160|454739558|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
126395205|NCT00433160|454739557|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
126395206|NCT00433160|454739558|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
126395207|NCT00433160|454739557|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
126395208|NCT00433160|454739558|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
126395209|NCT00433160|454739557|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
126395210|NCT00433160|454739558|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
126395211|NCT00433160|454739557|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
126395212|NCT00433160|454739558|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
126395213|NCT00433160|454739557|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
126395214|NCT00433160|454739558|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
126395215|NCT00433160|454739557|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
126395216|NCT00433160|454739558|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
126395217|NCT02499900|454739563|FG000|Core Study Period|Other|1|||
126395218|NCT02499900|454739564|FG001|Core Study Period|Other|4|||
126395219|NCT02499900|454739563|FG000|Core Study Period|Lost to Follow-up|1|||
126395220|NCT02499900|454739564|FG001|Core Study Period|Lost to Follow-up|2|||
126395221|NCT02499900|454739563|FG000|Core Study Period|Per sponsor request|0|||
126395222|NCT02499900|454739564|FG001|Core Study Period|Per sponsor request|1|||
126395223|NCT02499900|454739563|FG000|Core Study Period|Pregnancy|1|||
126395224|NCT02499900|454739564|FG001|Core Study Period|Pregnancy|0|||
126395225|NCT02499900|454739563|FG000|Core Study Period|Protocol Violation|3|||
126395226|NCT02499900|454739564|FG001|Core Study Period|Protocol Violation|0|||
126395227|NCT02499900|454739563|FG000|Core Study Period|Withdrawal by Subject|11|||
126395228|NCT02499900|454739564|FG001|Core Study Period|Withdrawal by Subject|10|||
126395229|NCT02499900|454739563|FG000|Core Study Period|Adverse Event|18|||
126395230|NCT02499900|454739564|FG001|Core Study Period|Adverse Event|14|||
126395231|NCT02499900|454739563|FG000|Core Study Period|Death|0|||
126395232|NCT02499900|454739564|FG001|Core Study Period|Death|1|||
126395233|NCT02499900|454739563|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
126395234|NCT02499900|454739564|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
126395235|NCT02499900|454739563|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
126395236|NCT02499900|454739564|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
126395237|NCT02499900|454739563|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
126771597|NCT02587325|456117837|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
126771598|NCT02587325|456117838|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
126771599|NCT02587325|456117839|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
126771600|NCT01831596|456117840|FG000|Overall Study|Other|8|||
126771601|NCT02602080|456117841|FG000|Overall Study|Protocol Violation|6|||
126771602|NCT02602080|456117842|FG001|Overall Study|Protocol Violation|1|||
126771603|NCT02602080|456117843|FG002|Overall Study|Protocol Violation|3|||
126771604|NCT04355767|456117846|FG000|Overall Study|Withdrawal by Subject|2|||
126771605|NCT04355767|456117847|FG001|Overall Study|Withdrawal by Subject|2|||
126771606|NCT04355767|456117846|FG000|Overall Study|Death|5|||
126771607|NCT04355767|456117847|FG001|Overall Study|Death|1|||
126771608|NCT03302299|456119903|FG000|Overall Study|Protocol Violation|1|||
126771609|NCT04318535|456119904|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
126771610|NCT04318535|456119905|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
126771611|NCT04318535|456119906|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
126771612|NCT01901146|456119907|FG000|Neoadjuvant Phase|Death|1|||
126771613|NCT01901146|456119908|FG001|Neoadjuvant Phase|Death|2|||
126771614|NCT01901146|456119909|FG002|Neoadjuvant Phase|Death|0|||
126395238|NCT02499900|454739564|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
126395239|NCT02499900|454739563|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
126395240|NCT02499900|454739564|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
126395241|NCT02499900|454739563|FG000|Extension Study Period|Adverse Event|2|||
126469467|NCT03633617|455020924|FG005|Part C (& Follow-up)|Protocol Violation|0|||
126469468|NCT03633617|455020925|FG006|Part C (& Follow-up)|Protocol Violation|0|||
126469469|NCT03633617|455020926|FG007|Part C (& Follow-up)|Protocol Violation|0|||
126771615|NCT01901146|456119910|FG003|Neoadjuvant Phase|Death|0|||
126771616|NCT01901146|456119911|FG004|Neoadjuvant Phase|Death|0|||
126469470|NCT03633617|455020927|FG008|Part C (& Follow-up)|Protocol Violation|0|||
126469471|NCT03633617|455020928|FG009|Part C (& Follow-up)|Protocol Violation|3|||
126469472|NCT03633617|455020929|FG010|Part C (& Follow-up)|Protocol Violation|1|||
126469473|NCT03633617|455020919|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
126469474|NCT03633617|455020920|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
126469475|NCT03633617|455020921|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
126469476|NCT03633617|455020922|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
126469477|NCT03633617|455020923|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
126469478|NCT03633617|455020924|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
126469479|NCT03633617|455020925|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
126469480|NCT03633617|455020926|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
126469481|NCT03633617|455020927|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
126469482|NCT03633617|455020928|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
126469483|NCT03633617|455020929|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
126469484|NCT01890746|455020930|FG000|Overall Study|Death|39|||
126469485|NCT01890746|455020931|FG001|Overall Study|Death|30|||
126469486|NCT01890746|455020930|FG000|Overall Study|Adverse Event|1|||
126469487|NCT01890746|455020931|FG001|Overall Study|Adverse Event|0|||
126469488|NCT01890746|455020930|FG000|Overall Study|Lost to Follow-up|4|||
126469489|NCT01890746|455020931|FG001|Overall Study|Lost to Follow-up|1|||
126469490|NCT01890746|455020930|FG000|Overall Study|Physician Decision|3|||
126469491|NCT01890746|455020931|FG001|Overall Study|Physician Decision|2|||
126469492|NCT01890746|455020930|FG000|Overall Study|Withdrawal by Subject|5|||
126469493|NCT01890746|455020931|FG001|Overall Study|Withdrawal by Subject|8|||
126469494|NCT02642029|455020932|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
126469495|NCT02642029|455020933|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
126469496|NCT02642029|455020934|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
126469497|NCT02642029|455020935|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
126469498|NCT02642029|455020936|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
126469499|NCT02642029|455020937|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
126469500|NCT02642029|455020932|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
126469501|NCT02642029|455020933|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
126469502|NCT02642029|455020934|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
126469503|NCT02642029|455020935|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
126469504|NCT02642029|455020936|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
126469505|NCT02642029|455020937|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
126469506|NCT02642029|455020932|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
126469507|NCT02642029|455020933|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
126469508|NCT02642029|455020934|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
126469509|NCT02642029|455020935|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
126469510|NCT02642029|455020936|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
126469511|NCT02642029|455020937|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
126469512|NCT02642029|455020932|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
126469513|NCT02642029|455020933|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
126469514|NCT02642029|455020934|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
126469515|NCT02642029|455020935|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
126469516|NCT02642029|455020936|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
126469517|NCT02642029|455020937|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
126469518|NCT02642029|455020932|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
126469519|NCT02642029|455020933|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
126469520|NCT02642029|455020934|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
126469521|NCT02642029|455020935|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
126469522|NCT02642029|455020936|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
126469523|NCT02642029|455020937|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
126719205|NCT00262080|455922989|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
126719206|NCT00262080|455922990|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
126719207|NCT00262080|455922988|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
126719208|NCT00262080|455922989|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
126469524|NCT02642029|455020932|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
126469525|NCT02642029|455020933|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
126469526|NCT02642029|455020934|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
126469527|NCT02642029|455020935|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
126719209|NCT00262080|455922990|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
126469528|NCT02642029|455020936|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
126469529|NCT02642029|455020937|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
126719210|NCT00262080|455922988|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
126469530|NCT00631696|455020944|FG000|Overall Study|Entered, not randomized to treatment|1|||
126469531|NCT00631696|455020945|FG001|Overall Study|Entered, not randomized to treatment|1|||
126469532|NCT00631696|455020944|FG000|Overall Study|Discontinued after database release date|1|||
126554840|NCT01474512|455324029|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
126554841|NCT01474512|455324030|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
126554842|NCT01474512|455324031|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
126554843|NCT01474512|455324032|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
126554844|NCT01474512|455324033|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
126554845|NCT01474512|455324034|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
126554846|NCT01474512|455324035|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
126554847|NCT01474512|455324036|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
126554848|NCT01474512|455324037|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
126554849|NCT01474512|455324038|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
126554850|NCT01474512|455324039|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
126554851|NCT01474512|455324040|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
126719211|NCT00262080|455922989|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
126719212|NCT00262080|455922990|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
126719213|NCT00262080|455922988|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
126719214|NCT00262080|455922989|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
126719215|NCT00262080|455922990|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
126719216|NCT00262080|455922988|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
126719217|NCT00262080|455922989|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
126719218|NCT00262080|455922990|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
126719219|NCT02273752|455922991|FG000|Overall Study|Trial was terminated early|2|||
126719220|NCT02808312|455922992|FG000|Overall Study|Enrolled but Never Treated|0|||
126719221|NCT02808312|455922993|FG001|Overall Study|Enrolled but Never Treated|0|||
126719222|NCT02808312|455922994|FG002|Overall Study|Enrolled but Never Treated|1|||
126719223|NCT02808312|455922995|FG003|Overall Study|Enrolled but Never Treated|0|||
126719224|NCT02808312|455922996|FG004|Overall Study|Enrolled but Never Treated|0|||
126719225|NCT03100942|455923000|FG000|Randomized Treatment Period|Withdrew Consent|4|||
126719226|NCT03100942|455923001|FG001|Randomized Treatment Period|Withdrew Consent|5|||
126719227|NCT03100942|455923002|FG002|Randomized Treatment Period|Withdrew Consent|3|||
126719228|NCT03100942|455923003|FG003|Randomized Treatment Period|Withdrew Consent|3|||
126719229|NCT03100942|455923004|FG004|Randomized Treatment Period|Withdrew Consent|0|||
126719230|NCT03100942|455923005|FG005|Randomized Treatment Period|Withdrew Consent|0|||
126719231|NCT03100942|455923006|FG006|Randomized Treatment Period|Withdrew Consent|0|||
126719232|NCT03100942|455923000|FG000|Randomized Treatment Period|Adverse Event|5|||
126719233|NCT03100942|455923001|FG001|Randomized Treatment Period|Adverse Event|2|||
126719234|NCT03100942|455923002|FG002|Randomized Treatment Period|Adverse Event|1|||
126719235|NCT03100942|455923003|FG003|Randomized Treatment Period|Adverse Event|0|||
126719236|NCT03100942|455923004|FG004|Randomized Treatment Period|Adverse Event|0|||
126719237|NCT03100942|455923005|FG005|Randomized Treatment Period|Adverse Event|0|||
126719238|NCT03100942|455923006|FG006|Randomized Treatment Period|Adverse Event|0|||
126719239|NCT03100942|455923000|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
126719240|NCT03100942|455923001|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
126719241|NCT03100942|455923002|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
126719242|NCT03100942|455923003|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
126719243|NCT03100942|455923004|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
126719244|NCT03100942|455923005|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
126719245|NCT03100942|455923006|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
126719246|NCT03100942|455923000|FG000|Randomized Treatment Period|Protocol Violation|0|||
126719247|NCT03100942|455923001|FG001|Randomized Treatment Period|Protocol Violation|1|||
126719248|NCT03100942|455923002|FG002|Randomized Treatment Period|Protocol Violation|1|||
126719249|NCT03100942|455923003|FG003|Randomized Treatment Period|Protocol Violation|1|||
126719250|NCT03100942|455923004|FG004|Randomized Treatment Period|Protocol Violation|0|||
126719251|NCT03100942|455923005|FG005|Randomized Treatment Period|Protocol Violation|0|||
126719252|NCT03100942|455923006|FG006|Randomized Treatment Period|Protocol Violation|0|||
126719253|NCT03100942|455923000|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
126719254|NCT03100942|455923001|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
126719255|NCT03100942|455923002|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
126719256|NCT03100942|455923003|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
126719257|NCT03100942|455923004|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
126719258|NCT03100942|455923005|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
126719259|NCT03100942|455923006|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
126719260|NCT03100942|455923000|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
126719261|NCT03100942|455923001|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
126719262|NCT03100942|455923002|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
126719263|NCT03100942|455923003|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
126719264|NCT03100942|455923004|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
126554852|NCT01474512|455324041|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
126554853|NCT01474512|455324042|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
126719265|NCT03100942|455923005|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
126395242|NCT02499900|454739564|FG001|Extension Study Period|Adverse Event|4|||
126395243|NCT02499900|454739563|FG000|Extension Study Period|Withdrawal by Subject|5|||
126395244|NCT02499900|454739564|FG001|Extension Study Period|Withdrawal by Subject|2|||
126395245|NCT02499900|454739563|FG000|Extension Study Period|Physician Decision|2|||
126395246|NCT02499900|454739564|FG001|Extension Study Period|Physician Decision|5|||
126395247|NCT02499900|454739563|FG000|Extension Study Period|Pregnancy|1|||
126395248|NCT02499900|454739564|FG001|Extension Study Period|Pregnancy|2|||
126395249|NCT02499900|454739563|FG000|Extension Study Period|Lost to Follow-up|2|||
126395250|NCT02499900|454739564|FG001|Extension Study Period|Lost to Follow-up|5|||
126395251|NCT02499900|454739563|FG000|Extension Study Period|Other|0|||
126395252|NCT02499900|454739564|FG001|Extension Study Period|Other|2|||
126395253|NCT03222973|454739567|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
126395254|NCT03222973|454739568|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
126395255|NCT03222973|454739569|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
126395256|NCT03222973|454739570|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
126395257|NCT03222973|454739567|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
126395258|NCT03222973|454739568|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
126395259|NCT03222973|454739569|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
126395260|NCT03222973|454739570|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
126395261|NCT03222973|454739567|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
126395262|NCT03222973|454739568|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
126395263|NCT03222973|454739569|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
126395264|NCT03222973|454739570|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
126395265|NCT03222973|454739567|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
126395266|NCT03222973|454739568|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
126395267|NCT03222973|454739569|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
126554854|NCT01474512|455324043|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
126554855|NCT01474512|455324044|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
126554856|NCT01474512|455324045|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
126554857|NCT01474512|455324028|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554858|NCT01474512|455324029|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554859|NCT01474512|455324030|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554860|NCT01474512|455324031|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554861|NCT01474512|455324032|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554862|NCT01474512|455324033|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554863|NCT01474512|455324034|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554864|NCT01474512|455324035|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554865|NCT01474512|455324036|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554866|NCT01474512|455324037|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554867|NCT01474512|455324038|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554868|NCT01474512|455324039|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554869|NCT01474512|455324040|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554870|NCT01474512|455324041|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554871|NCT01474512|455324042|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554872|NCT01474512|455324043|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
126554873|NCT01474512|455324044|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
126554874|NCT01474512|455324045|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
126554875|NCT01474512|455324028|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
126554876|NCT01474512|455324029|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
126554877|NCT01474512|455324030|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
126554878|NCT01474512|455324031|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
126554879|NCT01474512|455324032|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
126554880|NCT01474512|455324033|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
126554881|NCT01474512|455324034|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
126554882|NCT01474512|455324035|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
126554883|NCT01474512|455324036|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
126554884|NCT01474512|455324037|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
126554885|NCT01474512|455324038|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
126554886|NCT01474512|455324039|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
126554887|NCT01474512|455324040|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
126554888|NCT01474512|455324041|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
126554889|NCT01474512|455324042|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
126554890|NCT01474512|455324043|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
126554891|NCT01474512|455324044|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
126554892|NCT01474512|455324045|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
126554893|NCT01474512|455324028|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554894|NCT01474512|455324029|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554895|NCT01474512|455324030|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554896|NCT01474512|455324031|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554897|NCT01474512|455324032|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554898|NCT01474512|455324033|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554899|NCT01474512|455324034|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554900|NCT01474512|455324035|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
126395268|NCT03222973|454739570|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
126395269|NCT03222973|454739567|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
126395270|NCT03222973|454739568|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
126395271|NCT03222973|454739569|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
126395272|NCT03222973|454739570|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
126395273|NCT03222973|454739567|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
126395274|NCT03222973|454739568|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
126395275|NCT03222973|454739569|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
126395276|NCT03222973|454739570|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
126395277|NCT03222973|454739567|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
126395278|NCT03222973|454739568|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
126395279|NCT03222973|454739569|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
126395280|NCT03222973|454739570|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
126395281|NCT03222973|454739567|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
126395282|NCT03222973|454739568|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
126395283|NCT03222973|454739569|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
126554901|NCT01474512|455324036|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554902|NCT01474512|455324037|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554903|NCT01474512|455324038|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554904|NCT01474512|455324039|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554905|NCT01474512|455324040|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554906|NCT01474512|455324041|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554907|NCT01474512|455324042|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
126719266|NCT03100942|455923006|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
126719267|NCT03100942|455923000|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
126719268|NCT03100942|455923001|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
126719269|NCT03100942|455923002|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
126719270|NCT03100942|455923003|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
126719271|NCT03100942|455923004|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
126719272|NCT03100942|455923005|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
126719273|NCT03100942|455923006|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
126719274|NCT04009096|455923007|FG000|Overall Study|Withdrawal by Subject|0|||
126719275|NCT04009096|455923008|FG001|Overall Study|Withdrawal by Subject|7|||
126719276|NCT04009096|455923009|FG002|Overall Study|Withdrawal by Subject|0|||
126719277|NCT04009096|455923007|FG000|Overall Study|Physician Decision|0|||
126719278|NCT04009096|455923008|FG001|Overall Study|Physician Decision|1|||
126719279|NCT04009096|455923009|FG002|Overall Study|Physician Decision|0|||
126719280|NCT05151471|455923010|FG000|Overall Study|Adverse Event|21|||
126719281|NCT05151471|455923011|FG001|Overall Study|Adverse Event|16|||
126719282|NCT05151471|455923010|FG000|Overall Study|Death|1|||
126719283|NCT05151471|455923011|FG001|Overall Study|Death|0|||
126719284|NCT05151471|455923010|FG000|Overall Study|Lost to Follow-up|0|||
126719285|NCT05151471|455923011|FG001|Overall Study|Lost to Follow-up|1|||
126719286|NCT05151471|455923010|FG000|Overall Study|Withdrawal by Subject|7|||
126719287|NCT05151471|455923011|FG001|Overall Study|Withdrawal by Subject|9|||
126719288|NCT05151471|455923010|FG000|Overall Study|Study terminated by sponsor|49|||
126719289|NCT05151471|455923011|FG001|Overall Study|Study terminated by sponsor|47|||
126719290|NCT05151471|455923010|FG000|Overall Study|Other|2|||
126719291|NCT05151471|455923011|FG001|Overall Study|Other|1|||
126719292|NCT04263142|455923012|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
126719293|NCT04263142|455923013|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
126719294|NCT04263142|455923014|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
126719295|NCT04263142|455923015|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
126719296|NCT04263142|455923016|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
126719297|NCT04263142|455923012|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
126719298|NCT04263142|455923013|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
126719299|NCT04263142|455923014|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
126719300|NCT04263142|455923015|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
126719301|NCT04263142|455923016|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
126719302|NCT01623531|455923017|FG000|Overall Study|Death|1|||
126719303|NCT01623531|455923018|FG001|Overall Study|Death|0|||
126719304|NCT01623531|455923017|FG000|Overall Study|Protocol Violation|2|||
126719305|NCT01623531|455923018|FG001|Overall Study|Protocol Violation|1|||
126719306|NCT01623531|455923017|FG000|Overall Study|Missing data at primary outcome time poi|1|||
126719307|NCT01623531|455923018|FG001|Overall Study|Missing data at primary outcome time poi|1|||
126719308|NCT01429792|455923019|FG000|Overall Study|Other Reasons|67|||
126719309|NCT01429792|455923019|FG000|Overall Study|Unknown Disposition|94|||
126719310|NCT01429792|455923019|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
126719311|NCT01429792|455923019|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
126719312|NCT01429792|455923019|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
126719313|NCT01429792|455923019|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
126719314|NCT01429792|455923019|FG000|Overall Study|Withdrawal by Subject|70|||
126719315|NCT01429792|455923019|FG000|Overall Study|Lost to Follow-up|88|||
126554908|NCT01474512|455324043|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
126554909|NCT01474512|455324044|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
126395284|NCT03222973|454739570|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
126719316|NCT04184622|455923021|FG000|Primary Treatment Period|Adverse Event|6|||
126719317|NCT04184622|455923022|FG001|Primary Treatment Period|Adverse Event|4|||
126719318|NCT04184622|455923023|FG002|Primary Treatment Period|Adverse Event|8|||
126395285|NCT03222973|454739567|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
126395286|NCT03222973|454739568|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
126395287|NCT03222973|454739569|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
126395288|NCT03222973|454739570|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
126395289|NCT03222973|454739567|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
126395290|NCT03222973|454739568|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
126395291|NCT03222973|454739569|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
126395292|NCT03222973|454739570|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
126395293|NCT03222973|454739567|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
126395294|NCT03222973|454739568|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
126395295|NCT03222973|454739569|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
126395296|NCT03222973|454739570|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
126395297|NCT03222973|454739567|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
126395298|NCT03222973|454739568|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
126395299|NCT03222973|454739569|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
126395300|NCT03222973|454739570|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
126395301|NCT02080481|454739571|FG000|Overall Study|Never received a block.|1|||
126395302|NCT02080481|454739572|FG001|Overall Study|Never received a block.|0|||
126469533|NCT00631696|455020945|FG001|Overall Study|Discontinued after database release date|0|||
126469534|NCT00631696|455020944|FG000|Overall Study|Follow up after database release date|1|||
126469535|NCT00631696|455020945|FG001|Overall Study|Follow up after database release date|0|||
126469536|NCT00631696|455020944|FG000|Overall Study|Lost to Follow-up|7|||
126469537|NCT00631696|455020945|FG001|Overall Study|Lost to Follow-up|10|||
126469538|NCT00631696|455020944|FG000|Overall Study|Withdrawal by Subject|2|||
126469539|NCT00631696|455020945|FG001|Overall Study|Withdrawal by Subject|9|||
126469540|NCT00631696|455020944|FG000|Overall Study|Other|8|||
126469541|NCT00631696|455020945|FG001|Overall Study|Other|8|||
126469542|NCT00631696|455020944|FG000|Overall Study|Protocol Violation|9|||
126469543|NCT00631696|455020945|FG001|Overall Study|Protocol Violation|9|||
126469544|NCT00631696|455020944|FG000|Overall Study|Study terminated by sponsor|3|||
126469545|NCT00631696|455020945|FG001|Overall Study|Study terminated by sponsor|3|||
126469546|NCT00631696|455020944|FG000|Overall Study|Adverse Event|5|||
126469547|NCT00631696|455020945|FG001|Overall Study|Adverse Event|0|||
126469548|NCT01050543|455020947|FG000|Overall Study|Withdrawal by Subject|0|||
126469549|NCT01050543|455020948|FG001|Overall Study|Withdrawal by Subject|2|||
126469550|NCT01050543|455020947|FG000|Overall Study|Protocol Violation|0|||
126469551|NCT01050543|455020948|FG001|Overall Study|Protocol Violation|1|||
126469552|NCT01050543|455020947|FG000|Overall Study|Administrative|4|||
126469553|NCT01050543|455020948|FG001|Overall Study|Administrative|1|||
126469554|NCT00570765|455020949|FG000|DB Phase|Withdrawal by Subject|1|||
126469555|NCT00570765|455020950|FG001|DB Phase|Withdrawal by Subject|0|||
126469556|NCT00570765|455020951|FG002|DB Phase|Withdrawal by Subject|0|||
126469557|NCT00570765|455020952|FG003|DB Phase|Withdrawal by Subject|0|||
126469558|NCT00570765|455020949|FG000|DB Phase|Protocol Violation|0|||
126469559|NCT00570765|455020950|FG001|DB Phase|Protocol Violation|1|||
126469560|NCT00570765|455020951|FG002|DB Phase|Protocol Violation|0|||
126469561|NCT00570765|455020952|FG003|DB Phase|Protocol Violation|0|||
126469562|NCT00570765|455020949|FG000|DB Phase|Adverse Event|3|||
126469563|NCT00570765|455020950|FG001|DB Phase|Adverse Event|6|||
126469564|NCT00570765|455020951|FG002|DB Phase|Adverse Event|0|||
126469565|NCT00570765|455020952|FG003|DB Phase|Adverse Event|0|||
126469566|NCT00570765|455020949|FG000|DB Phase|Did Not Receive Study Drug|0|||
126469567|NCT00570765|455020950|FG001|DB Phase|Did Not Receive Study Drug|0|||
126469568|NCT00570765|455020951|FG002|DB Phase|Did Not Receive Study Drug|1|||
126469569|NCT00570765|455020952|FG003|DB Phase|Did Not Receive Study Drug|0|||
126469570|NCT00570765|455020949|FG000|LTSE Phase|Withdrawal by Subject|0|||
126469571|NCT00570765|455020950|FG001|LTSE Phase|Withdrawal by Subject|0|||
126719319|NCT04184622|455923024|FG003|Primary Treatment Period|Adverse Event|6|||
126719320|NCT04184622|455923021|FG000|Primary Treatment Period|Death|4|||
126469572|NCT00570765|455020951|FG002|LTSE Phase|Withdrawal by Subject|0|||
126469573|NCT00570765|455020952|FG003|LTSE Phase|Withdrawal by Subject|1|||
126469574|NCT00570765|455020949|FG000|LTSE Phase|Adverse Event|0|||
126554910|NCT01474512|455324045|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
126469575|NCT00570765|455020950|FG001|LTSE Phase|Adverse Event|0|||
126469576|NCT00570765|455020951|FG002|LTSE Phase|Adverse Event|0|||
126469577|NCT00570765|455020952|FG003|LTSE Phase|Adverse Event|7|||
126469578|NCT00570765|455020949|FG000|LTSE Phase|Physician Decision|0|||
126469579|NCT00570765|455020950|FG001|LTSE Phase|Physician Decision|0|||
126469580|NCT00570765|455020951|FG002|LTSE Phase|Physician Decision|0|||
126469581|NCT00570765|455020952|FG003|LTSE Phase|Physician Decision|4|||
126469582|NCT03387683|455020953|FG000|Overall Study|In receipt of disallowed medication|1|||
126719321|NCT04184622|455923022|FG001|Primary Treatment Period|Death|4|||
126719322|NCT04184622|455923023|FG002|Primary Treatment Period|Death|2|||
126719323|NCT04184622|455923024|FG003|Primary Treatment Period|Death|1|||
126719324|NCT04184622|455923021|FG000|Primary Treatment Period|Lost to Follow-up|41|||
126719325|NCT04184622|455923022|FG001|Primary Treatment Period|Lost to Follow-up|17|||
126719326|NCT04184622|455923023|FG002|Primary Treatment Period|Lost to Follow-up|15|||
126395303|NCT02723006|454741874|FG000|Overall Study|Withdrawal by Subject|0|||
126395304|NCT02723006|454741875|FG001|Overall Study|Withdrawal by Subject|1|||
126395305|NCT02723006|454741876|FG002|Overall Study|Withdrawal by Subject|1|||
126395306|NCT02723006|454741874|FG000|Overall Study|Study Terminated by Sponsor|1|||
126395307|NCT02723006|454741875|FG001|Overall Study|Study Terminated by Sponsor|6|||
126395308|NCT02723006|454741876|FG002|Overall Study|Study Terminated by Sponsor|6|||
126395309|NCT04258995|454741877|FG000|Overall Study|Lost to Follow-up|1|||
126395310|NCT04258995|454741878|FG001|Overall Study|Lost to Follow-up|1|||
126395311|NCT00983515|454741881|FG000|Ritonavir Alone|liver panel out of range|6|||
126395312|NCT00983515|454741881|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
126395313|NCT00316693|454741882|FG000|Overall Study|Adverse Event|6|||
126395314|NCT00316693|454741883|FG001|Overall Study|Adverse Event|1|||
126395315|NCT00316693|454741882|FG000|Overall Study|Protocol Violation|1|||
126395316|NCT00316693|454741883|FG001|Overall Study|Protocol Violation|0|||
126395317|NCT00316693|454741882|FG000|Overall Study|Withdrawal by Subject|6|||
126395318|NCT00316693|454741883|FG001|Overall Study|Withdrawal by Subject|6|||
126395319|NCT00316693|454741882|FG000|Overall Study|Lost to Follow-up|26|||
126395320|NCT00316693|454741883|FG001|Overall Study|Lost to Follow-up|34|||
126395321|NCT00316693|454741882|FG000|Overall Study|Other|38|||
126395322|NCT00316693|454741883|FG001|Overall Study|Other|44|||
126395323|NCT01967823|454741884|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
126395324|NCT03002818|454741885|FG000|Overall Study|Decision of the investigator|1|||
126395325|NCT00711113|454741889|FG000|Overall Study|Lost to Follow-up|9|||
126395326|NCT00711113|454741889|FG000|Overall Study|Implant lost|2|||
126395327|NCT01606787|454741896|FG000|Overall Study|Withdrawal by Subject|4|||
126395328|NCT01606787|454741897|FG001|Overall Study|Withdrawal by Subject|5|||
126395329|NCT01606787|454741896|FG000|Overall Study|Surgery canceled|0|||
126395330|NCT01606787|454741897|FG001|Overall Study|Surgery canceled|2|||
126395331|NCT00413894|454741898|FG000|Overall Study|Withdrawal by Subject|10|||
126395332|NCT00413894|454741898|FG000|Overall Study|Administrative Reasons|1|||
126395333|NCT00413894|454741898|FG000|Overall Study|Hb <10 grams/deciliter|12|||
126395334|NCT00413894|454741898|FG000|Overall Study|Adverse Event|28|||
126395335|NCT00413894|454741898|FG000|Overall Study|Protocol Violation|11|||
126395336|NCT00413894|454741898|FG000|Overall Study|Other|18|||
126395337|NCT04225676|454741899|FG000|Overall Study|Physician Decision|1|||
126395338|NCT04225676|454741899|FG000|Overall Study|Lack of Efficacy|1|||
126395339|NCT04225676|454741899|FG000|Overall Study|Study terminated by sponsor|3|||
126395340|NCT03245736|454741900|FG000|Overall Study|Adverse Event|1|||
126395341|NCT03245736|454741900|FG000|Overall Study|Progressive Disease|4|||
126395342|NCT01942161|454741901|FG000|Overall Study|Adverse Event|1|||
126395343|NCT01942161|454741902|FG001|Overall Study|Adverse Event|2|||
126395344|NCT01942161|454741903|FG002|Overall Study|Adverse Event|5|||
126395345|NCT01942161|454741901|FG000|Overall Study|Physician Decision|3|||
126395346|NCT01942161|454741902|FG001|Overall Study|Physician Decision|1|||
126395347|NCT01942161|454741903|FG002|Overall Study|Physician Decision|0|||
126395348|NCT01942161|454741901|FG000|Overall Study|Protocol Violation|1|||
126395349|NCT01942161|454741902|FG001|Overall Study|Protocol Violation|0|||
126469583|NCT03387683|455020954|FG001|Overall Study|In receipt of disallowed medication|0|||
126469584|NCT03387683|455020953|FG000|Overall Study|Did not receive treatment|1|||
126469585|NCT03387683|455020954|FG001|Overall Study|Did not receive treatment|0|||
126469586|NCT00875979|455020955|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
126469587|NCT00875979|455020956|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
126469588|NCT00875979|455020955|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
126469589|NCT00875979|455020956|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
126469590|NCT00875979|455020955|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
126469591|NCT00875979|455020956|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
126469592|NCT00875979|455020955|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
126469593|NCT00875979|455020956|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
126469594|NCT00875979|455020955|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
126469595|NCT00875979|455020956|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
126719327|NCT04184622|455923024|FG003|Primary Treatment Period|Lost to Follow-up|13|||
126395350|NCT01942161|454741903|FG002|Overall Study|Protocol Violation|0|||
126395351|NCT01942161|454741901|FG000|Overall Study|Withdrawal by Subject|3|||
126395352|NCT01942161|454741902|FG001|Overall Study|Withdrawal by Subject|3|||
126395353|NCT01942161|454741903|FG002|Overall Study|Withdrawal by Subject|1|||
126395354|NCT05289271|454741906|FG000|Overall Study|Mistakenly allocated, untreated|1|||
126395355|NCT05289271|454741907|FG001|Overall Study|Mistakenly allocated, untreated|0|||
126554911|NCT01474512|455324028|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126719328|NCT04184622|455923021|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
126395356|NCT01257568|454741908|FG000|Overall Study|Lost to Follow-up|2|||
126395357|NCT01257568|454741908|FG000|Overall Study|Withdrawal by Subject|6|||
126554912|NCT01474512|455324029|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554913|NCT01474512|455324030|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554914|NCT01474512|455324031|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554915|NCT01474512|455324032|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554916|NCT01474512|455324033|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554917|NCT01474512|455324034|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554918|NCT01474512|455324035|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126395358|NCT01257568|454741908|FG000|Overall Study|Terminated|1|||
126395359|NCT01257568|454741908|FG000|Overall Study|Component Revision|24|||
126395360|NCT03392883|454741911|FG000|Overall Study|Lost to Follow-up|122|||
126395361|NCT03392883|454741912|FG001|Overall Study|Lost to Follow-up|13|||
126395362|NCT03392883|454741913|FG002|Overall Study|Lost to Follow-up|9|||
126395363|NCT03392883|454741911|FG000|Overall Study|Death|4|||
126395364|NCT03392883|454741912|FG001|Overall Study|Death|0|||
126395365|NCT03392883|454741913|FG002|Overall Study|Death|0|||
126395366|NCT03392883|454741911|FG000|Overall Study|Lack of Efficacy|29|||
126395367|NCT03392883|454741912|FG001|Overall Study|Lack of Efficacy|0|||
126395368|NCT03392883|454741913|FG002|Overall Study|Lack of Efficacy|0|||
126395369|NCT03392883|454741911|FG000|Overall Study|Withdrawal by Subject|180|||
126395370|NCT03392883|454741912|FG001|Overall Study|Withdrawal by Subject|0|||
126395371|NCT03392883|454741913|FG002|Overall Study|Withdrawal by Subject|0|||
126395372|NCT03392883|454741911|FG000|Overall Study|Adverse Event|1|||
126395373|NCT03392883|454741912|FG001|Overall Study|Adverse Event|0|||
126395374|NCT03392883|454741913|FG002|Overall Study|Adverse Event|0|||
126395375|NCT00132691|454741923|FG000|Overall Study|Lost to Follow-up|5|||
126395376|NCT00132691|454741924|FG001|Overall Study|Lost to Follow-up|8|||
126395377|NCT00132691|454741923|FG000|Overall Study|Missed 2-year visit|4|||
126395378|NCT00132691|454741924|FG001|Overall Study|Missed 2-year visit|4|||
126395379|NCT00132691|454741923|FG000|Overall Study|Death|2|||
126395380|NCT00132691|454741924|FG001|Overall Study|Death|0|||
126395381|NCT01739933|454741925|FG000|Overall Study|Death|89|||
126395382|NCT01739933|454741926|FG001|Overall Study|Death|86|||
126395383|NCT01739933|454741925|FG000|Overall Study|Withdrawal by Subject|10|||
126395384|NCT01739933|454741926|FG001|Overall Study|Withdrawal by Subject|8|||
126395385|NCT01739933|454741925|FG000|Overall Study|Lost to Follow-up|3|||
126395386|NCT01739933|454741926|FG001|Overall Study|Lost to Follow-up|10|||
126395387|NCT01739933|454741925|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
126395388|NCT01739933|454741926|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
126395389|NCT04098367|454741927|FG000|Overall Study|Adverse Event|0|||
126395390|NCT04098367|454741928|FG001|Overall Study|Adverse Event|0|||
126395391|NCT04098367|454741929|FG002|Overall Study|Adverse Event|1|||
126395392|NCT04098367|454741927|FG000|Overall Study|Lost to Follow-up|1|||
126395393|NCT04098367|454741928|FG001|Overall Study|Lost to Follow-up|5|||
126395394|NCT04098367|454741929|FG002|Overall Study|Lost to Follow-up|2|||
126395395|NCT04098367|454741927|FG000|Overall Study|Withdrawal by Subject|0|||
126395396|NCT04098367|454741928|FG001|Overall Study|Withdrawal by Subject|0|||
126395397|NCT04098367|454741929|FG002|Overall Study|Withdrawal by Subject|1|||
126395398|NCT04098367|454741927|FG000|Overall Study|Sick . Could not attend visit|1|||
126395399|NCT04098367|454741928|FG001|Overall Study|Sick . Could not attend visit|0|||
126395400|NCT04098367|454741929|FG002|Overall Study|Sick . Could not attend visit|0|||
126395401|NCT01231321|454741936|FG000|Overall Study|Adverse Event|3|||
126395402|NCT01231321|454741936|FG000|Overall Study|Lack of Efficacy|2|||
126395403|NCT00354107|454741938|FG000|Overall Study|Adverse Event|2|||
126395404|NCT00354107|454741938|FG000|Overall Study|Physician Decision|2|||
126395405|NCT00354107|454741938|FG000|Overall Study|Withdrawal by Subject|1|||
126395406|NCT03575065|454741941|FG000|Overall Study|Death|31|||
126395407|NCT03575065|454741942|FG001|Overall Study|Death|12|||
126395408|NCT03575065|454741941|FG000|Overall Study|Sponsor's Decision|28|||
126395409|NCT03575065|454741942|FG001|Overall Study|Sponsor's Decision|13|||
126395410|NCT03575065|454741941|FG000|Overall Study|Withdrawal by Subject|2|||
126395411|NCT03575065|454741942|FG001|Overall Study|Withdrawal by Subject|1|||
126395412|NCT03575065|454741941|FG000|Overall Study|Lost to Follow-up|1|||
126395413|NCT03575065|454741942|FG001|Overall Study|Lost to Follow-up|0|||
126395414|NCT03960580|454741943|FG000|Overall Study|Adverse Event|2|||
126395415|NCT03960580|454741944|FG001|Overall Study|Adverse Event|1|||
126395416|NCT03960580|454741945|FG002|Overall Study|Adverse Event|1|||
126395417|NCT03960580|454741943|FG000|Overall Study|Lost to Follow-up|1|||
126395418|NCT03960580|454741944|FG001|Overall Study|Lost to Follow-up|0|||
126395419|NCT03960580|454741945|FG002|Overall Study|Lost to Follow-up|0|||
126395420|NCT03960580|454741943|FG000|Overall Study|Lack of Efficacy|2|||
126395421|NCT03960580|454741944|FG001|Overall Study|Lack of Efficacy|1|||
126395422|NCT03960580|454741945|FG002|Overall Study|Lack of Efficacy|0|||
126395423|NCT03960580|454741943|FG000|Overall Study|Protocol Violation|0|||
126395424|NCT03960580|454741944|FG001|Overall Study|Protocol Violation|0|||
126395425|NCT03960580|454741945|FG002|Overall Study|Protocol Violation|1|||
126395426|NCT03960580|454741943|FG000|Overall Study|Withdrawal by Subject|1|||
126395427|NCT03960580|454741944|FG001|Overall Study|Withdrawal by Subject|1|||
126719329|NCT04184622|455923022|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
126719330|NCT04184622|455923023|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
126719331|NCT04184622|455923024|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
126719332|NCT04184622|455923021|FG000|Primary Treatment Period|Physician Decision|0|||
126719333|NCT04184622|455923022|FG001|Primary Treatment Period|Physician Decision|0|||
126719334|NCT04184622|455923023|FG002|Primary Treatment Period|Physician Decision|3|||
126719335|NCT04184622|455923024|FG003|Primary Treatment Period|Physician Decision|1|||
126719336|NCT04184622|455923021|FG000|Primary Treatment Period|Pregnancy|4|||
126719337|NCT04184622|455923022|FG001|Primary Treatment Period|Pregnancy|3|||
126719338|NCT04184622|455923023|FG002|Primary Treatment Period|Pregnancy|4|||
126395428|NCT03960580|454741945|FG002|Overall Study|Withdrawal by Subject|1|||
126719339|NCT04184622|455923024|FG003|Primary Treatment Period|Pregnancy|1|||
126719340|NCT04184622|455923021|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
126719341|NCT04184622|455923022|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
126719342|NCT04184622|455923023|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
126719343|NCT04184622|455923024|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
126719344|NCT04184622|455923021|FG000|Additional Treatment Period|Adverse Event|1|||
126719345|NCT04184622|455923022|FG001|Additional Treatment Period|Adverse Event|2|||
126719346|NCT04184622|455923023|FG002|Additional Treatment Period|Adverse Event|1|||
126719347|NCT04184622|455923024|FG003|Additional Treatment Period|Adverse Event|0|||
126719348|NCT04184622|455923021|FG000|Additional Treatment Period|Death|0|||
126719349|NCT04184622|455923022|FG001|Additional Treatment Period|Death|0|||
126719350|NCT04184622|455923023|FG002|Additional Treatment Period|Death|1|||
126719351|NCT04184622|455923024|FG003|Additional Treatment Period|Death|1|||
126719352|NCT04184622|455923021|FG000|Additional Treatment Period|Lost to Follow-up|6|||
126719353|NCT04184622|455923022|FG001|Additional Treatment Period|Lost to Follow-up|4|||
126719354|NCT04184622|455923023|FG002|Additional Treatment Period|Lost to Follow-up|8|||
126719355|NCT04184622|455923024|FG003|Additional Treatment Period|Lost to Follow-up|6|||
126719356|NCT04184622|455923021|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
126719357|NCT04184622|455923022|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
126719358|NCT04184622|455923023|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
126719359|NCT04184622|455923024|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
126719360|NCT04184622|455923021|FG000|Additional Treatment Period|Physician Decision|0|||
126719361|NCT04184622|455923022|FG001|Additional Treatment Period|Physician Decision|0|||
126719362|NCT04184622|455923023|FG002|Additional Treatment Period|Physician Decision|1|||
126719363|NCT04184622|455923024|FG003|Additional Treatment Period|Physician Decision|0|||
126719364|NCT04184622|455923021|FG000|Additional Treatment Period|Pregnancy|0|||
126719365|NCT04184622|455923022|FG001|Additional Treatment Period|Pregnancy|0|||
126719366|NCT04184622|455923023|FG002|Additional Treatment Period|Pregnancy|0|||
126719367|NCT04184622|455923024|FG003|Additional Treatment Period|Pregnancy|1|||
126719368|NCT04184622|455923021|FG000|Additional Treatment Period|Protocol deviation|0|||
126719369|NCT04184622|455923022|FG001|Additional Treatment Period|Protocol deviation|0|||
126719370|NCT04184622|455923023|FG002|Additional Treatment Period|Protocol deviation|1|||
126719371|NCT04184622|455923024|FG003|Additional Treatment Period|Protocol deviation|0|||
126719372|NCT04184622|455923021|FG000|Additional Treatment Period|Site closed|1|||
126719373|NCT04184622|455923022|FG001|Additional Treatment Period|Site closed|0|||
126719374|NCT04184622|455923023|FG002|Additional Treatment Period|Site closed|1|||
126719375|NCT04184622|455923024|FG003|Additional Treatment Period|Site closed|0|||
126719376|NCT04184622|455923021|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
126719377|NCT04184622|455923022|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
126719378|NCT04184622|455923023|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
126719379|NCT04184622|455923024|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
126719380|NCT04184622|455923021|FG000|Safety Follow-up Period|Adverse Event|6|||
126719381|NCT04184622|455923022|FG001|Safety Follow-up Period|Adverse Event|8|||
126719382|NCT04184622|455923023|FG002|Safety Follow-up Period|Adverse Event|9|||
126395429|NCT03960580|454741943|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
126395430|NCT03960580|454741944|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
126395431|NCT03960580|454741945|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
126395432|NCT03447314|454741948|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
126395433|NCT03447314|454741949|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
126395434|NCT03447314|454741950|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
126395435|NCT03447314|454741951|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
126395436|NCT03447314|454741952|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
126395437|NCT03447314|454741953|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
126395438|NCT03447314|454741954|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
126719383|NCT04184622|455923024|FG003|Safety Follow-up Period|Adverse Event|16|||
126395439|NCT03447314|454741955|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126719384|NCT04184622|455923021|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
126719385|NCT04184622|455923022|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
126719386|NCT04184622|455923023|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
126395440|NCT03447314|454741956|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395441|NCT03447314|454741957|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395442|NCT03447314|454741958|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
126395443|NCT03447314|454741959|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
126395444|NCT03447314|454741960|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395445|NCT03447314|454741961|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395446|NCT03447314|454741962|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395447|NCT03447314|454741963|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395448|NCT03447314|454741964|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395449|NCT03447314|454741965|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
126395450|NCT03447314|454741948|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
126395451|NCT03447314|454741949|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395452|NCT03447314|454741950|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
126395453|NCT03447314|454741951|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395454|NCT03447314|454741952|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395455|NCT03447314|454741953|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
126395456|NCT03447314|454741954|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
126469596|NCT00875979|455020955|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
126469597|NCT00875979|455020956|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
126469598|NCT00875979|455020955|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
126469599|NCT00875979|455020956|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
126469600|NCT00875979|455020955|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
126469601|NCT00875979|455020956|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
126469602|NCT00875979|455020955|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
126469603|NCT00875979|455020956|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
126469604|NCT01104155|455020959|FG000|Overall Study|Adverse Event|15|||
126469605|NCT01104155|455020960|FG001|Overall Study|Adverse Event|8|||
126469606|NCT01104155|455020959|FG000|Overall Study|Participant choice|6|||
126554919|NCT01474512|455324036|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126719387|NCT04184622|455923024|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
126719388|NCT04184622|455923021|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
126719389|NCT04184622|455923022|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
126719390|NCT04184622|455923023|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
126719391|NCT04184622|455923024|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
126719392|NCT04184622|455923021|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
126719393|NCT04184622|455923022|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
126719394|NCT04184622|455923023|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
126719395|NCT04184622|455923024|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
126719396|NCT04184622|455923021|FG000|Safety Follow-up Period|Physician Decision|1|||
126719397|NCT04184622|455923022|FG001|Safety Follow-up Period|Physician Decision|0|||
126719398|NCT04184622|455923023|FG002|Safety Follow-up Period|Physician Decision|0|||
126719399|NCT04184622|455923024|FG003|Safety Follow-up Period|Physician Decision|1|||
126719400|NCT04184622|455923021|FG000|Safety Follow-up Period|Pregnancy|1|||
126719401|NCT04184622|455923022|FG001|Safety Follow-up Period|Pregnancy|3|||
126719402|NCT04184622|455923023|FG002|Safety Follow-up Period|Pregnancy|0|||
126719403|NCT04184622|455923024|FG003|Safety Follow-up Period|Pregnancy|6|||
126719404|NCT04184622|455923021|FG000|Safety Follow-up Period|Protocol deviation|1|||
126719405|NCT04184622|455923022|FG001|Safety Follow-up Period|Protocol deviation|0|||
126719406|NCT04184622|455923023|FG002|Safety Follow-up Period|Protocol deviation|0|||
126719407|NCT04184622|455923024|FG003|Safety Follow-up Period|Protocol deviation|0|||
126719408|NCT04184622|455923021|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
126719409|NCT04184622|455923022|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
126719410|NCT04184622|455923023|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
126719411|NCT04184622|455923024|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
126719412|NCT00769704|455923025|FG000|Overall Study|Lost to Follow-up|3|||
126719413|NCT00769704|455923026|FG001|Overall Study|Lost to Follow-up|2|||
126719414|NCT00769704|455923025|FG000|Overall Study|Death|95|||
126719415|NCT00769704|455923026|FG001|Overall Study|Death|190|||
126719416|NCT00769704|455923025|FG000|Overall Study|Withdrawal by Subject|12|||
126719417|NCT00769704|455923026|FG001|Overall Study|Withdrawal by Subject|5|||
126719418|NCT00769704|455923025|FG000|Overall Study|Other|1|||
126719419|NCT00769704|455923026|FG001|Overall Study|Other|2|||
126719420|NCT01617681|455923029|FG000|Period 1 Double Blind|Adverse Event|2|||
126719421|NCT01617681|455923030|FG001|Period 1 Double Blind|Adverse Event|0|||
126719422|NCT01617681|455923031|FG002|Period 1 Double Blind|Adverse Event|0|||
126719423|NCT01617681|455923032|FG003|Period 1 Double Blind|Adverse Event|2|||
126719424|NCT01617681|455923033|FG004|Period 1 Double Blind|Adverse Event|0|||
126469607|NCT01104155|455020960|FG001|Overall Study|Participant choice|5|||
126719425|NCT01617681|455923029|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
126719426|NCT01617681|455923030|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
126554920|NCT01474512|455324037|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554921|NCT01474512|455324038|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554922|NCT01474512|455324039|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554923|NCT01474512|455324040|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554924|NCT01474512|455324041|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554925|NCT01474512|455324042|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
126554926|NCT01474512|455324043|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554927|NCT01474512|455324044|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
126554928|NCT01474512|455324045|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
126554929|NCT01474512|455324028|FG000|Post-Treatment Follow-Up|Death|0|||
126554930|NCT01474512|455324029|FG001|Post-Treatment Follow-Up|Death|0|||
126554931|NCT01474512|455324030|FG002|Post-Treatment Follow-Up|Death|0|||
126554932|NCT01474512|455324031|FG003|Post-Treatment Follow-Up|Death|0|||
126554933|NCT01474512|455324032|FG004|Post-Treatment Follow-Up|Death|0|||
126554934|NCT01474512|455324033|FG005|Post-Treatment Follow-Up|Death|0|||
126554935|NCT01474512|455324034|FG006|Post-Treatment Follow-Up|Death|0|||
126554936|NCT01474512|455324035|FG007|Post-Treatment Follow-Up|Death|0|||
126554937|NCT01474512|455324036|FG008|Post-Treatment Follow-Up|Death|0|||
126719427|NCT01617681|455923031|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
126719428|NCT01617681|455923032|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
126719429|NCT01617681|455923033|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
126719430|NCT01617681|455923029|FG000|Period 2 Open Label|Adverse Event|0|||
126719431|NCT01617681|455923030|FG001|Period 2 Open Label|Adverse Event|0|||
126719432|NCT01617681|455923031|FG002|Period 2 Open Label|Adverse Event|0|||
126719433|NCT01617681|455923032|FG003|Period 2 Open Label|Adverse Event|0|||
126719434|NCT01617681|455923033|FG004|Period 2 Open Label|Adverse Event|3|||
126719435|NCT01617681|455923029|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
126719436|NCT01617681|455923030|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
126719437|NCT01617681|455923031|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
126719438|NCT01617681|455923032|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
126554938|NCT01474512|455324037|FG009|Post-Treatment Follow-Up|Death|0|||
126554939|NCT01474512|455324038|FG010|Post-Treatment Follow-Up|Death|0|||
126719439|NCT01617681|455923033|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
126719440|NCT01856595|455923042|FG000|Overall Study|Withdrawal by Subject|0|||
126719441|NCT01856595|455923043|FG001|Overall Study|Withdrawal by Subject|1|||
126719442|NCT01856595|455923044|FG002|Overall Study|Withdrawal by Subject|0|||
126719443|NCT01856595|455923045|FG003|Overall Study|Withdrawal by Subject|0|||
126719444|NCT01856595|455923046|FG004|Overall Study|Withdrawal by Subject|0|||
126719445|NCT01856595|455923047|FG005|Overall Study|Withdrawal by Subject|0|||
126719446|NCT01856595|455923048|FG006|Overall Study|Withdrawal by Subject|1|||
126719447|NCT01856595|455923049|FG007|Overall Study|Withdrawal by Subject|0|||
126719448|NCT01856595|455923050|FG008|Overall Study|Withdrawal by Subject|0|||
126719449|NCT04426825|455923052|FG000|Overall Study|Death|17|||
126395457|NCT03447314|454741955|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395458|NCT03447314|454741956|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395459|NCT03447314|454741957|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395460|NCT03447314|454741958|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395461|NCT03447314|454741959|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395462|NCT03447314|454741960|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395463|NCT03447314|454741961|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395464|NCT03447314|454741962|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395465|NCT03447314|454741963|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395466|NCT03447314|454741964|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395467|NCT03447314|454741965|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
126395468|NCT03447314|454741948|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395469|NCT03447314|454741949|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395470|NCT03447314|454741950|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
126395471|NCT03447314|454741951|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395472|NCT03447314|454741952|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395473|NCT03447314|454741953|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395474|NCT03447314|454741954|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395475|NCT03447314|454741955|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395476|NCT03447314|454741956|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395477|NCT03447314|454741957|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126554940|NCT01474512|455324039|FG011|Post-Treatment Follow-Up|Death|0|||
126554941|NCT01474512|455324040|FG012|Post-Treatment Follow-Up|Death|0|||
126554942|NCT01474512|455324041|FG013|Post-Treatment Follow-Up|Death|0|||
126554943|NCT01474512|455324042|FG014|Post-Treatment Follow-Up|Death|0|||
126554944|NCT01474512|455324043|FG015|Post-Treatment Follow-Up|Death|0|||
126719450|NCT04426825|455923052|FG000|Overall Study|Lost to Follow-up|1|||
126771617|NCT01901146|456119907|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
126395478|NCT03447314|454741958|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395479|NCT03447314|454741959|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395480|NCT03447314|454741960|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395481|NCT03447314|454741961|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395482|NCT03447314|454741962|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395483|NCT03447314|454741963|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395484|NCT03447314|454741964|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395485|NCT03447314|454741965|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
126395486|NCT03447314|454741948|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395487|NCT03447314|454741949|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395488|NCT03447314|454741950|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
126395489|NCT03447314|454741951|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126469608|NCT01104155|455020959|FG000|Overall Study|Withdrawal of consent|1|||
126469609|NCT01104155|455020960|FG001|Overall Study|Withdrawal of consent|1|||
126469610|NCT01104155|455020959|FG000|Overall Study|Other|3|||
126469611|NCT01104155|455020960|FG001|Overall Study|Other|4|||
126469612|NCT01484132|455020961|FG000|Overall Study|Lost to Follow-up|8|||
126469613|NCT01484132|455020961|FG000|Overall Study|Difficulty with time commitment|2|||
126469614|NCT01484132|455020961|FG000|Overall Study|Ineligible|1|||
126469615|NCT01484132|455020961|FG000|Overall Study|No pre-treatment urine sample collected|1|||
126469616|NCT01484132|455020961|FG000|Overall Study|No post-treatment urine sample collected|10|||
126469617|NCT02939079|455020962|FG000|Overall Study|Adverse Event|2|||
126469618|NCT02939079|455020963|FG001|Overall Study|Adverse Event|1|||
126469619|NCT02939079|455020962|FG000|Overall Study|Lost to Follow-up|0|||
126469620|NCT02939079|455020963|FG001|Overall Study|Lost to Follow-up|2|||
126469621|NCT02939079|455020962|FG000|Overall Study|Protocol Violation|1|||
126469622|NCT02939079|455020963|FG001|Overall Study|Protocol Violation|0|||
126469623|NCT02939079|455020962|FG000|Overall Study|Withdrawal by Subject|0|||
126469624|NCT02939079|455020963|FG001|Overall Study|Withdrawal by Subject|1|||
126469625|NCT02939079|455020962|FG000|Overall Study|relapse during the study|1|||
126469626|NCT02939079|455020963|FG001|Overall Study|relapse during the study|1|||
126469627|NCT04093414|455020964|FG000|3 Month Follow up|Physician Decision|0|||
126469628|NCT04093414|455020965|FG001|3 Month Follow up|Physician Decision|1|||
126469629|NCT04093414|455020964|FG000|6month Follow up|Physician Decision|1|||
126469630|NCT04093414|455020965|FG001|6month Follow up|Physician Decision|3|||
126469631|NCT04209348|455020966|FG000|Overall Study|Lost to Follow-up|1|||
126469632|NCT04209348|455020967|FG001|Overall Study|Lost to Follow-up|0|||
126469633|NCT05394350|455020969|FG000|Overall Study|Death|2|||
126469634|NCT05394350|455020970|FG001|Overall Study|Death|2|||
126469635|NCT05394350|455020971|FG002|Overall Study|Death|4|||
126469636|NCT05394350|455020972|FG003|Overall Study|Death|0|||
126469637|NCT05394350|455020973|FG004|Overall Study|Death|1|||
126719451|NCT04426825|455923052|FG000|Overall Study|Study terminated by sponsor|5|||
126719452|NCT01028651|455923059|FG000|Overall Study|Death|2|||
126719453|NCT01028651|455923059|FG000|Overall Study|Adverse Event|1|||
126719454|NCT01327651|455923062|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
126719455|NCT01327651|455923063|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
126395490|NCT03447314|454741952|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395491|NCT03447314|454741953|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395492|NCT03447314|454741954|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395493|NCT03447314|454741955|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395494|NCT03447314|454741956|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395495|NCT03447314|454741957|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126719456|NCT01327651|455923064|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
126719457|NCT01327651|455923065|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
126771618|NCT01901146|456119908|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
126395496|NCT03447314|454741958|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395497|NCT03447314|454741959|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395498|NCT03447314|454741960|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395499|NCT03447314|454741961|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126469638|NCT05394350|455020974|FG005|Overall Study|Death|0|||
126469639|NCT05394350|455020969|FG000|Overall Study|Study terminated by sponsor|1|||
126469640|NCT05394350|455020970|FG001|Overall Study|Study terminated by sponsor|1|||
126469641|NCT05394350|455020971|FG002|Overall Study|Study terminated by sponsor|7|||
126469642|NCT05394350|455020972|FG003|Overall Study|Study terminated by sponsor|3|||
126469643|NCT05394350|455020973|FG004|Overall Study|Study terminated by sponsor|2|||
126469644|NCT05394350|455020974|FG005|Overall Study|Study terminated by sponsor|4|||
126469645|NCT01336569|455020975|FG000|Overall Study|Lost to Follow-up|4|||
126469646|NCT02963935|455020978|FG000|Overall Study|Adverse Event|12|||
126469647|NCT02963935|455020979|FG001|Overall Study|Adverse Event|6|||
126469648|NCT02963935|455020978|FG000|Overall Study|Protocol Violation|2|||
126469649|NCT02963935|455020979|FG001|Overall Study|Protocol Violation|1|||
126719458|NCT01327651|455923066|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
126719459|NCT01327651|455923067|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
126719460|NCT01327651|455923068|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
126719461|NCT01327651|455923069|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
126719462|NCT01327651|455923070|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
126719463|NCT01327651|455923062|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
126719464|NCT01327651|455923063|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126719465|NCT01327651|455923064|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126719466|NCT01327651|455923065|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126719467|NCT01327651|455923066|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126719468|NCT01327651|455923067|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126719469|NCT01327651|455923068|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126719470|NCT01327651|455923069|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126719471|NCT01327651|455923070|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
126719472|NCT01327651|455923062|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
126719473|NCT01327651|455923063|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
126719474|NCT01327651|455923064|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
126719475|NCT01327651|455923065|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
126719476|NCT01327651|455923066|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
126719477|NCT01327651|455923067|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
126719478|NCT01327651|455923068|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
126719479|NCT01327651|455923069|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
126719480|NCT01327651|455923070|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
126719481|NCT01327651|455923062|FG000|Post Study Follow-up|Lost to Follow-up|0|||
126719482|NCT01327651|455923063|FG001|Post Study Follow-up|Lost to Follow-up|1|||
126719483|NCT01327651|455923064|FG002|Post Study Follow-up|Lost to Follow-up|1|||
126719484|NCT01327651|455923065|FG003|Post Study Follow-up|Lost to Follow-up|0|||
126719485|NCT01327651|455923066|FG004|Post Study Follow-up|Lost to Follow-up|0|||
126719486|NCT01327651|455923067|FG005|Post Study Follow-up|Lost to Follow-up|0|||
126719487|NCT01327651|455923068|FG006|Post Study Follow-up|Lost to Follow-up|4|||
126719488|NCT01327651|455923069|FG007|Post Study Follow-up|Lost to Follow-up|1|||
126719489|NCT01327651|455923070|FG008|Post Study Follow-up|Lost to Follow-up|2|||
126719490|NCT03249792|455923075|FG000|Arms 1, 2, and 4|Death|1|||
126719491|NCT03249792|455923076|FG001|Arms 1, 2, and 4|Death|1|||
126719492|NCT03249792|455923077|FG002|Arms 1, 2, and 4|Death|0|||
126719493|NCT03249792|455923078|FG003|Arms 1, 2, and 4|Death|2|||
126719494|NCT03249792|455923079|FG004|Arms 1, 2, and 4|Death|3|||
126719495|NCT03249792|455923080|FG005|Arms 1, 2, and 4|Death|2|||
126719496|NCT03249792|455923081|FG006|Arms 1, 2, and 4|Death|2|||
126719497|NCT03249792|455923082|FG007|Arms 1, 2, and 4|Death|4|||
126719498|NCT03249792|455923083|FG008|Arms 1, 2, and 4|Death|2|||
126719499|NCT03249792|455923084|FG009|Arms 1, 2, and 4|Death|1|||
126719500|NCT03249792|455923085|FG010|Arms 1, 2, and 4|Death|7|||
126719501|NCT03249792|455923086|FG011|Arms 1, 2, and 4|Death|7|||
126719502|NCT03249792|455923087|FG012|Arms 1, 2, and 4|Death|12|||
126719503|NCT03249792|455923088|FG013|Arms 1, 2, and 4|Death|7|||
126719504|NCT03249792|455923089|FG014|Arms 1, 2, and 4|Death|0|||
126719505|NCT03249792|455923090|FG015|Arms 1, 2, and 4|Death|4|||
126719506|NCT03249792|455923091|FG016|Arms 1, 2, and 4|Death|4|||
126719507|NCT03249792|455923092|FG017|Arms 1, 2, and 4|Death|12|||
126719508|NCT03249792|455923093|FG018|Arms 1, 2, and 4|Death|6|||
126719509|NCT03249792|455923094|FG019|Arms 1, 2, and 4|Death|4|||
126719510|NCT03249792|455923095|FG020|Arms 1, 2, and 4|Death|2|||
126719511|NCT03249792|455923096|FG021|Arms 1, 2, and 4|Death|3|||
126719512|NCT03249792|455923097|FG022|Arms 1, 2, and 4|Death|1|||
126719513|NCT03249792|455923098|FG023|Arms 1, 2, and 4|Death|1|||
126719514|NCT03249792|455923099|FG024|Arms 1, 2, and 4|Death|4|||
126771619|NCT01901146|456119909|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
126395500|NCT03447314|454741962|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126719515|NCT03249792|455923100|FG025|Arms 1, 2, and 4|Death|0|||
126719516|NCT03249792|455923101|FG026|Arms 1, 2, and 4|Death|0|||
126719517|NCT03249792|455923102|FG027|Arms 1, 2, and 4|Death|0|||
126719518|NCT03249792|455923103|FG028|Arms 1, 2, and 4|Death|0|||
126719519|NCT03249792|455923104|FG029|Arms 1, 2, and 4|Death|0|||
126719520|NCT03249792|455923105|FG030|Arms 1, 2, and 4|Death|0|||
126395501|NCT03447314|454741963|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395502|NCT03447314|454741964|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126719521|NCT03249792|455923106|FG031|Arms 1, 2, and 4|Death|0|||
126719522|NCT03249792|455923107|FG032|Arms 1, 2, and 4|Death|0|||
126719523|NCT03249792|455923075|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719524|NCT03249792|455923076|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719525|NCT03249792|455923077|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
126719526|NCT03249792|455923078|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719527|NCT03249792|455923079|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719528|NCT03249792|455923080|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
126719529|NCT03249792|455923081|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
126719530|NCT03249792|455923082|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126469650|NCT02963935|455020978|FG000|Overall Study|Lack of Efficacy|0|||
126469651|NCT02963935|455020979|FG001|Overall Study|Lack of Efficacy|2|||
126469652|NCT02963935|455020978|FG000|Overall Study|Lost to Follow-up|1|||
126469653|NCT02963935|455020979|FG001|Overall Study|Lost to Follow-up|6|||
126469654|NCT02963935|455020978|FG000|Overall Study|Unclassified|13|||
126469655|NCT02963935|455020979|FG001|Overall Study|Unclassified|22|||
126469656|NCT01565642|455020982|FG000|Overall Study|Withdrawal by Subject|2|||
126469657|NCT01565642|455020983|FG001|Overall Study|Withdrawal by Subject|1|||
126469658|NCT04502979|455020986|FG000|Overall Study|Lost to Follow-up|1|||
126469659|NCT04502979|455020987|FG001|Overall Study|Lost to Follow-up|3|||
126469660|NCT04502979|455020986|FG000|Overall Study|Withdrawal by Subject|2|||
126469661|NCT04502979|455020987|FG001|Overall Study|Withdrawal by Subject|1|||
126469662|NCT02906332|455020992|FG000|Overall Study|Withdrawal by Subject|1|||
126469663|NCT02949700|455020993|FG000|Phase I|Withdrawal by Subject|1|||
126469664|NCT02949700|455020994|FG001|Phase I|Withdrawal by Subject|1|||
126469665|NCT02949700|455020995|FG002|Phase I|Withdrawal by Subject|0|||
126469666|NCT02949700|455020996|FG003|Phase I|Withdrawal by Subject|0|||
126469667|NCT02949700|455020993|FG000|Phase I|Protocol Violation|1|||
126469668|NCT02949700|455020994|FG001|Phase I|Protocol Violation|0|||
126469669|NCT02949700|455020995|FG002|Phase I|Protocol Violation|0|||
126469670|NCT02949700|455020996|FG003|Phase I|Protocol Violation|0|||
126469671|NCT02949700|455020993|FG000|Phase II|Withdrawal by Subject|0|||
126469672|NCT02949700|455020994|FG001|Phase II|Withdrawal by Subject|0|||
126469673|NCT02949700|455020995|FG002|Phase II|Withdrawal by Subject|0|||
126469674|NCT02949700|455020996|FG003|Phase II|Withdrawal by Subject|2|||
126469675|NCT02949700|455020993|FG000|Phase II|Protocol Violation|0|||
126469676|NCT02949700|455020994|FG001|Phase II|Protocol Violation|0|||
126469677|NCT02949700|455020995|FG002|Phase II|Protocol Violation|1|||
126469678|NCT02949700|455020996|FG003|Phase II|Protocol Violation|3|||
126469679|NCT01686828|455021000|FG000|Overall Study|Physician Decision|1|||
126469680|NCT01686828|455021001|FG001|Overall Study|Physician Decision|0|||
126469681|NCT01686828|455021002|FG002|Overall Study|Physician Decision|0|||
126469682|NCT01686828|455021003|FG003|Overall Study|Physician Decision|0|||
126719531|NCT03249792|455923083|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
126469683|NCT01686828|455021000|FG000|Overall Study|New Job|0|||
126469684|NCT01686828|455021001|FG001|Overall Study|New Job|1|||
126469685|NCT01686828|455021002|FG002|Overall Study|New Job|0|||
126469686|NCT01686828|455021003|FG003|Overall Study|New Job|0|||
126554945|NCT01474512|455324044|FG016|Post-Treatment Follow-Up|Death|1|||
126719532|NCT03249792|455923084|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
126719533|NCT03249792|455923085|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
126719534|NCT03249792|455923086|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
126719535|NCT03249792|455923087|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
126719536|NCT03249792|455923088|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
126719537|NCT03249792|455923089|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719538|NCT03249792|455923090|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719539|NCT03249792|455923091|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
126719540|NCT03249792|455923092|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126395503|NCT03447314|454741965|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
126395504|NCT03447314|454741948|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395505|NCT03447314|454741949|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395506|NCT03447314|454741950|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395507|NCT03447314|454741951|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395508|NCT03447314|454741952|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395509|NCT03447314|454741953|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395510|NCT03447314|454741954|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395511|NCT03447314|454741955|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395512|NCT03447314|454741956|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395513|NCT03447314|454741957|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126469687|NCT01686828|455021000|FG000|Overall Study|Weight Loss|0|||
126554946|NCT01474512|455324045|FG017|Post-Treatment Follow-Up|Death|0|||
126554947|NCT01023308|455324050|FG000|Overall Study|Abnormal test proceedure results|3|||
126719541|NCT03249792|455923093|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
126719542|NCT03249792|455923094|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126469688|NCT01686828|455021001|FG001|Overall Study|Weight Loss|0|||
126469689|NCT01686828|455021002|FG002|Overall Study|Weight Loss|1|||
126469690|NCT01686828|455021003|FG003|Overall Study|Weight Loss|0|||
126469691|NCT01558739|455021006|FG000|Overall Study|Adverse Event|7|||
126469692|NCT01558739|455021006|FG000|Overall Study|Withdrawal by Subject|2|||
126469693|NCT01558739|455021006|FG000|Overall Study|Death|3|||
126469694|NCT01558739|455021006|FG000|Overall Study|Disease Progression|4|||
126469695|NCT01558739|455021006|FG000|Overall Study|Protocol Violation|1|||
126469696|NCT01067976|455021008|FG000|Overall Study|Study drug never administered|20|||
126719543|NCT03249792|455923095|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719544|NCT03249792|455923096|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719545|NCT03249792|455923097|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
126719546|NCT03249792|455923098|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
126719547|NCT03249792|455923099|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719548|NCT03249792|455923100|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719549|NCT03249792|455923101|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719550|NCT03249792|455923102|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719551|NCT03249792|455923103|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719552|NCT03249792|455923104|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719553|NCT03249792|455923105|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719554|NCT03249792|455923106|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719555|NCT03249792|455923107|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
126719556|NCT03249792|455923075|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
126719557|NCT03249792|455923076|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
126719558|NCT03249792|455923077|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
126719559|NCT03249792|455923078|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
126719560|NCT03249792|455923079|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
126719561|NCT03249792|455923080|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
126719562|NCT03249792|455923081|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
126719563|NCT03249792|455923082|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
126719564|NCT03249792|455923083|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
126719565|NCT03249792|455923084|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
126719566|NCT03249792|455923085|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
126719567|NCT03249792|455923086|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
126719568|NCT03249792|455923087|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
126719569|NCT03249792|455923088|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
126719570|NCT03249792|455923089|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
126719571|NCT03249792|455923090|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
126719572|NCT03249792|455923091|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
126719573|NCT03249792|455923092|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
126719574|NCT03249792|455923093|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
126719575|NCT03249792|455923094|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
126719576|NCT03249792|455923095|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
126719577|NCT03249792|455923096|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
126719578|NCT03249792|455923097|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
126719579|NCT03249792|455923098|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
126719580|NCT03249792|455923099|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
126719581|NCT03249792|455923100|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
126719582|NCT03249792|455923101|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
126719583|NCT03249792|455923102|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
126771620|NCT01901146|456119910|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
126771621|NCT01901146|456119911|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
126771622|NCT01901146|456119907|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
126395514|NCT03447314|454741958|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
126395515|NCT03447314|454741959|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395516|NCT03447314|454741960|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395517|NCT03447314|454741961|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395518|NCT03447314|454741962|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395519|NCT03447314|454741963|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395520|NCT03447314|454741964|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395521|NCT03447314|454741965|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
126395522|NCT03447314|454741948|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395523|NCT03447314|454741949|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395524|NCT03447314|454741950|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395525|NCT03447314|454741951|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
126395526|NCT03447314|454741952|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126469697|NCT01067976|455021008|FG000|Overall Study|Study prematurely discontinued|2|||
126469698|NCT00566111|455021009|FG000|Overall Study|Adverse Event|0|||
126469699|NCT00566111|455021010|FG001|Overall Study|Adverse Event|2|||
126719584|NCT03249792|455923103|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
126719585|NCT03249792|455923104|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
126719586|NCT03249792|455923105|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
126719587|NCT03249792|455923106|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
126719588|NCT03249792|455923107|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
126719589|NCT03249792|455923075|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719590|NCT03249792|455923076|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719591|NCT03249792|455923077|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719592|NCT03249792|455923078|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719593|NCT03249792|455923079|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719594|NCT03249792|455923080|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719595|NCT03249792|455923081|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719596|NCT03249792|455923082|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719597|NCT03249792|455923083|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
126719598|NCT03249792|455923084|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719599|NCT03249792|455923085|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719600|NCT03249792|455923086|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719601|NCT03249792|455923087|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719602|NCT03249792|455923088|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719603|NCT03249792|455923089|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719604|NCT03249792|455923090|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719605|NCT03249792|455923091|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
126719606|NCT03249792|455923092|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
126719607|NCT03249792|455923093|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719608|NCT03249792|455923094|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
126719609|NCT03249792|455923095|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719610|NCT03249792|455923096|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719611|NCT03249792|455923097|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
126771623|NCT01901146|456119908|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
126771624|NCT01901146|456119909|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
126395527|NCT03447314|454741953|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
126395528|NCT03447314|454741954|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395529|NCT03447314|454741955|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395530|NCT03447314|454741956|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395531|NCT03447314|454741957|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395532|NCT03447314|454741958|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395533|NCT03447314|454741959|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395534|NCT03447314|454741960|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395535|NCT03447314|454741961|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395536|NCT03447314|454741962|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395537|NCT03447314|454741963|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395538|NCT03447314|454741964|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395539|NCT03447314|454741965|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
126395540|NCT02359045|454741966|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
126395541|NCT02359045|454741967|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126395542|NCT02359045|454741966|FG000|Overall Study|Lost to Follow-up|1|||
126395543|NCT02359045|454741967|FG001|Overall Study|Lost to Follow-up|1|||
126395544|NCT02359045|454741966|FG000|Overall Study|Adverse Event|0|||
126395545|NCT02359045|454741967|FG001|Overall Study|Adverse Event|1|||
126395546|NCT04600076|454741970|FG000|Overall Study|Lost to Follow-up|3|||
126395547|NCT00541866|454741971|FG000|Overall Study|Adverse Event|3|||
126395548|NCT00541866|454741972|FG001|Overall Study|Adverse Event|0|||
126395549|NCT00541866|454741973|FG002|Overall Study|Adverse Event|0|||
126395550|NCT00541866|454741974|FG003|Overall Study|Adverse Event|0|||
126395551|NCT00541866|454741975|FG004|Overall Study|Adverse Event|0|||
126395552|NCT00541866|454741971|FG000|Overall Study|Death|1|||
126395553|NCT00541866|454741972|FG001|Overall Study|Death|0|||
126395554|NCT00541866|454741973|FG002|Overall Study|Death|0|||
126395555|NCT00541866|454741974|FG003|Overall Study|Death|0|||
126395556|NCT00541866|454741975|FG004|Overall Study|Death|0|||
126395557|NCT00541866|454741971|FG000|Overall Study|Lack of Efficacy|19|||
126395558|NCT00541866|454741972|FG001|Overall Study|Lack of Efficacy|15|||
126395559|NCT00541866|454741973|FG002|Overall Study|Lack of Efficacy|10|||
126395560|NCT00541866|454741974|FG003|Overall Study|Lack of Efficacy|12|||
126395561|NCT00541866|454741975|FG004|Overall Study|Lack of Efficacy|14|||
126395562|NCT00541866|454741971|FG000|Overall Study|Not Reported or Other|11|||
126395563|NCT00541866|454741972|FG001|Overall Study|Not Reported or Other|3|||
126395564|NCT00541866|454741973|FG002|Overall Study|Not Reported or Other|3|||
126395565|NCT00541866|454741974|FG003|Overall Study|Not Reported or Other|3|||
126395566|NCT00541866|454741975|FG004|Overall Study|Not Reported or Other|1|||
126469700|NCT02598960|455023493|FG000|Treatment Period|Disease Progression|4|||
126469701|NCT02598960|455023494|FG001|Treatment Period|Disease Progression|4|||
126469702|NCT02598960|455023495|FG002|Treatment Period|Disease Progression|4|||
126469703|NCT02598960|455023496|FG003|Treatment Period|Disease Progression|6|||
126395567|NCT00541866|454741971|FG000|Overall Study|Physician Decision|0|||
126395568|NCT00541866|454741972|FG001|Overall Study|Physician Decision|0|||
126395569|NCT00541866|454741973|FG002|Overall Study|Physician Decision|2|||
126395570|NCT00541866|454741974|FG003|Overall Study|Physician Decision|1|||
126395571|NCT00541866|454741975|FG004|Overall Study|Physician Decision|0|||
126395572|NCT00957944|454741976|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
126395573|NCT00957944|454741977|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
126469704|NCT02598960|455023497|FG004|Treatment Period|Disease Progression|8|||
126469705|NCT02598960|455023498|FG005|Treatment Period|Disease Progression|2|||
126719612|NCT03249792|455923098|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719613|NCT03249792|455923099|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
126469706|NCT02598960|455023499|FG006|Treatment Period|Disease Progression|2|||
126469707|NCT02598960|455023500|FG007|Treatment Period|Disease Progression|3|||
126469708|NCT02598960|455023501|FG008|Treatment Period|Disease Progression|7|||
126469709|NCT02598960|455023502|FG009|Treatment Period|Disease Progression|9|||
126469710|NCT02598960|455023503|FG010|Treatment Period|Disease Progression|7|||
126469711|NCT02598960|455023504|FG011|Treatment Period|Disease Progression|143|||
126469712|NCT02598960|455023505|FG012|Treatment Period|Disease Progression|23|||
126469713|NCT02598960|455023493|FG000|Treatment Period|Study drug toxicity|0|||
126469714|NCT02598960|455023494|FG001|Treatment Period|Study drug toxicity|0|||
126469715|NCT02598960|455023495|FG002|Treatment Period|Study drug toxicity|0|||
126469716|NCT02598960|455023496|FG003|Treatment Period|Study drug toxicity|0|||
126469717|NCT02598960|455023497|FG004|Treatment Period|Study drug toxicity|0|||
126469718|NCT02598960|455023498|FG005|Treatment Period|Study drug toxicity|0|||
126469719|NCT02598960|455023499|FG006|Treatment Period|Study drug toxicity|0|||
126469720|NCT02598960|455023500|FG007|Treatment Period|Study drug toxicity|0|||
126469721|NCT02598960|455023501|FG008|Treatment Period|Study drug toxicity|0|||
126469722|NCT02598960|455023502|FG009|Treatment Period|Study drug toxicity|1|||
126469723|NCT02598960|455023503|FG010|Treatment Period|Study drug toxicity|0|||
126469724|NCT02598960|455023504|FG011|Treatment Period|Study drug toxicity|3|||
126469725|NCT02598960|455023505|FG012|Treatment Period|Study drug toxicity|0|||
126469726|NCT02598960|455023493|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
126469727|NCT02598960|455023494|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
126469728|NCT02598960|455023495|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
126469729|NCT02598960|455023496|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
126469730|NCT02598960|455023497|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
126469731|NCT02598960|455023498|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
126469732|NCT02598960|455023499|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
126771625|NCT01901146|456119910|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
126771626|NCT01901146|456119911|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
126771627|NCT01901146|456119907|FG000|Neoadjuvant Phase|Physician Decision|1|||
126771628|NCT01901146|456119908|FG001|Neoadjuvant Phase|Physician Decision|2|||
126771629|NCT01901146|456119909|FG002|Neoadjuvant Phase|Physician Decision|0|||
126771630|NCT01901146|456119910|FG003|Neoadjuvant Phase|Physician Decision|0|||
126771631|NCT01901146|456119911|FG004|Neoadjuvant Phase|Physician Decision|0|||
126771632|NCT01901146|456119907|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
126771633|NCT01901146|456119908|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
126771634|NCT01901146|456119909|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
126771635|NCT01901146|456119910|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
126771636|NCT01901146|456119911|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
126771637|NCT01901146|456119907|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
126771638|NCT01901146|456119908|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
126771639|NCT01901146|456119909|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
126771640|NCT01901146|456119910|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
126771641|NCT01901146|456119911|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
126771642|NCT01901146|456119907|FG000|Adjuvant Phase|Other|0|||
126771643|NCT01901146|456119908|FG001|Adjuvant Phase|Other|0|||
126469733|NCT02598960|455023500|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
126469734|NCT02598960|455023501|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
126469735|NCT02598960|455023502|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
126469736|NCT02598960|455023503|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
126469737|NCT02598960|455023504|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
126469738|NCT02598960|455023505|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
126469739|NCT02598960|455023493|FG000|Treatment Period|participant request to discontinue|0|||
126395574|NCT01482169|454741982|FG000|Overall Study|Physician Decision|2|||
126395575|NCT00522418|454741983|FG000|Overall Study|Local IRB Consent Violation|5|||
126395576|NCT00522418|454741984|FG001|Overall Study|Local IRB Consent Violation|5|||
126395577|NCT00522418|454741983|FG000|Overall Study|Early Study Termination|46|||
126395578|NCT00522418|454741984|FG001|Overall Study|Early Study Termination|47|||
126395579|NCT00522418|454741983|FG000|Overall Study|Noncompliance|2|||
126395580|NCT00522418|454741984|FG001|Overall Study|Noncompliance|2|||
126395581|NCT00522418|454741983|FG000|Overall Study|Reason Not Specified|3|||
126395582|NCT00522418|454741984|FG001|Overall Study|Reason Not Specified|1|||
126395583|NCT00522418|454741983|FG000|Overall Study|Consent Withdraw|1|||
126395584|NCT00522418|454741984|FG001|Overall Study|Consent Withdraw|2|||
126395585|NCT00522418|454741983|FG000|Overall Study|Lack of Efficacy|0|||
126469740|NCT02598960|455023494|FG001|Treatment Period|participant request to discontinue|1|||
126469741|NCT02598960|455023495|FG002|Treatment Period|participant request to discontinue|0|||
126469742|NCT02598960|455023496|FG003|Treatment Period|participant request to discontinue|0|||
126395586|NCT00522418|454741984|FG001|Overall Study|Lack of Efficacy|1|||
126771644|NCT01901146|456119909|FG002|Adjuvant Phase|Other|1|||
126771645|NCT01901146|456119910|FG003|Adjuvant Phase|Other|0|||
126771646|NCT01901146|456119911|FG004|Adjuvant Phase|Other|0|||
126771647|NCT01901146|456119907|FG000|Adjuvant Phase|Death|0|||
126469743|NCT02598960|455023497|FG004|Treatment Period|participant request to discontinue|1|||
126469744|NCT02598960|455023498|FG005|Treatment Period|participant request to discontinue|0|||
126469745|NCT02598960|455023499|FG006|Treatment Period|participant request to discontinue|0|||
126469746|NCT02598960|455023500|FG007|Treatment Period|participant request to discontinue|0|||
126469747|NCT02598960|455023501|FG008|Treatment Period|participant request to discontinue|0|||
126469748|NCT02598960|455023502|FG009|Treatment Period|participant request to discontinue|0|||
126469749|NCT02598960|455023503|FG010|Treatment Period|participant request to discontinue|1|||
126469750|NCT02598960|455023504|FG011|Treatment Period|participant request to discontinue|4|||
126469751|NCT02598960|455023505|FG012|Treatment Period|participant request to discontinue|0|||
126469752|NCT02598960|455023493|FG000|Treatment Period|participant withdrew consent|0|||
126469753|NCT02598960|455023494|FG001|Treatment Period|participant withdrew consent|0|||
126469754|NCT02598960|455023495|FG002|Treatment Period|participant withdrew consent|0|||
126554948|NCT01023308|455324051|FG001|Overall Study|Abnormal test proceedure results|8|||
126469755|NCT02598960|455023496|FG003|Treatment Period|participant withdrew consent|0|||
126469756|NCT02598960|455023497|FG004|Treatment Period|participant withdrew consent|0|||
126469757|NCT02598960|455023498|FG005|Treatment Period|participant withdrew consent|0|||
126469758|NCT02598960|455023499|FG006|Treatment Period|participant withdrew consent|0|||
126469759|NCT02598960|455023500|FG007|Treatment Period|participant withdrew consent|0|||
126469760|NCT02598960|455023501|FG008|Treatment Period|participant withdrew consent|0|||
126469761|NCT02598960|455023502|FG009|Treatment Period|participant withdrew consent|0|||
126469762|NCT02598960|455023503|FG010|Treatment Period|participant withdrew consent|0|||
126469763|NCT02598960|455023504|FG011|Treatment Period|participant withdrew consent|3|||
126469764|NCT02598960|455023505|FG012|Treatment Period|participant withdrew consent|0|||
126469765|NCT02598960|455023493|FG000|Treatment Period|No longer meets study criteria|0|||
126469766|NCT02598960|455023494|FG001|Treatment Period|No longer meets study criteria|0|||
126469767|NCT02598960|455023495|FG002|Treatment Period|No longer meets study criteria|0|||
126469768|NCT02598960|455023496|FG003|Treatment Period|No longer meets study criteria|0|||
126469769|NCT02598960|455023497|FG004|Treatment Period|No longer meets study criteria|0|||
126469770|NCT02598960|455023498|FG005|Treatment Period|No longer meets study criteria|0|||
126469771|NCT02598960|455023499|FG006|Treatment Period|No longer meets study criteria|0|||
126469772|NCT02598960|455023500|FG007|Treatment Period|No longer meets study criteria|0|||
126469773|NCT02598960|455023501|FG008|Treatment Period|No longer meets study criteria|0|||
126469774|NCT02598960|455023502|FG009|Treatment Period|No longer meets study criteria|0|||
126469775|NCT02598960|455023503|FG010|Treatment Period|No longer meets study criteria|0|||
126469776|NCT02598960|455023504|FG011|Treatment Period|No longer meets study criteria|1|||
126469777|NCT02598960|455023505|FG012|Treatment Period|No longer meets study criteria|0|||
126469778|NCT02598960|455023493|FG000|Treatment Period|Other Reasons|0|||
126469779|NCT02598960|455023494|FG001|Treatment Period|Other Reasons|0|||
126469780|NCT02598960|455023495|FG002|Treatment Period|Other Reasons|0|||
126469781|NCT02598960|455023496|FG003|Treatment Period|Other Reasons|0|||
126469782|NCT02598960|455023497|FG004|Treatment Period|Other Reasons|0|||
126469783|NCT02598960|455023498|FG005|Treatment Period|Other Reasons|0|||
126469784|NCT02598960|455023499|FG006|Treatment Period|Other Reasons|0|||
126469785|NCT02598960|455023500|FG007|Treatment Period|Other Reasons|0|||
126469786|NCT02598960|455023501|FG008|Treatment Period|Other Reasons|0|||
126469787|NCT02598960|455023502|FG009|Treatment Period|Other Reasons|0|||
126469788|NCT02598960|455023503|FG010|Treatment Period|Other Reasons|0|||
126469789|NCT02598960|455023504|FG011|Treatment Period|Other Reasons|0|||
126469790|NCT02598960|455023505|FG012|Treatment Period|Other Reasons|1|||
126469791|NCT02598960|455023493|FG000|Participants Entering Follow Up Period|Death|1|||
126469792|NCT02598960|455023494|FG001|Participants Entering Follow Up Period|Death|0|||
126469793|NCT02598960|455023495|FG002|Participants Entering Follow Up Period|Death|0|||
126469794|NCT02598960|455023496|FG003|Participants Entering Follow Up Period|Death|0|||
126469795|NCT02598960|455023497|FG004|Participants Entering Follow Up Period|Death|0|||
126469796|NCT02598960|455023498|FG005|Participants Entering Follow Up Period|Death|0|||
126469797|NCT02598960|455023499|FG006|Participants Entering Follow Up Period|Death|0|||
126469798|NCT02598960|455023500|FG007|Participants Entering Follow Up Period|Death|0|||
126469799|NCT02598960|455023501|FG008|Participants Entering Follow Up Period|Death|0|||
126469800|NCT02598960|455023502|FG009|Participants Entering Follow Up Period|Death|1|||
126469801|NCT02598960|455023503|FG010|Participants Entering Follow Up Period|Death|0|||
126469802|NCT02598960|455023504|FG011|Participants Entering Follow Up Period|Death|11|||
126469803|NCT02598960|455023505|FG012|Participants Entering Follow Up Period|Death|2|||
126469804|NCT02598960|455023493|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
126469805|NCT02598960|455023494|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
126469806|NCT02598960|455023495|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
126469807|NCT02598960|455023496|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
126554949|NCT01023308|455324050|FG000|Overall Study|Administrative problems|2|||
126469808|NCT02598960|455023497|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
126469809|NCT02598960|455023498|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
126469810|NCT02598960|455023499|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
126554950|NCT01023308|455324051|FG001|Overall Study|Administrative problems|1|||
126554951|NCT01023308|455324050|FG000|Overall Study|Adverse Event|130|||
126554952|NCT01023308|455324051|FG001|Overall Study|Adverse Event|66|||
126554953|NCT01023308|455324050|FG000|Overall Study|Death|21|||
126554954|NCT01023308|455324051|FG001|Overall Study|Death|17|||
126554955|NCT01023308|455324050|FG000|Overall Study|Disease progression|82|||
126554956|NCT01023308|455324051|FG001|Overall Study|Disease progression|153|||
126554957|NCT01023308|455324050|FG000|Overall Study|New Cancer therapy|4|||
126554958|NCT01023308|455324051|FG001|Overall Study|New Cancer therapy|7|||
126554959|NCT01023308|455324050|FG000|Overall Study|Protocol Violation|3|||
126554960|NCT01023308|455324051|FG001|Overall Study|Protocol Violation|4|||
126395587|NCT01944098|454741985|FG000|Overall Study|Physician Decision|1|||
126395588|NCT01944098|454741986|FG001|Overall Study|Physician Decision|0|||
126395589|NCT00737568|454741987|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
126395590|NCT00737568|454741988|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
126395591|NCT00737568|454741987|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
126395592|NCT00737568|454741988|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
126395593|NCT00737568|454741987|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
126395594|NCT00737568|454741988|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
126395595|NCT00737568|454741987|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
126395596|NCT00737568|454741988|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
126395597|NCT00737568|454741987|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
126395598|NCT00737568|454741988|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
126395599|NCT00737568|454741987|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
126395600|NCT00737568|454741988|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
126395601|NCT00737568|454741987|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
126395602|NCT00737568|454741988|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
126395603|NCT00737568|454741987|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
126395604|NCT00737568|454741988|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
126395605|NCT00737568|454741987|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
126395606|NCT00737568|454741988|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
126395607|NCT00855933|454741989|FG000|Overall Study|Withdrawal by Subject|0|||
126395608|NCT00855933|454741990|FG001|Overall Study|Withdrawal by Subject|1|||
126395609|NCT00951080|454741991|FG000|Overall Study|Adverse Event|3|||
126395610|NCT00951080|454741992|FG001|Overall Study|Adverse Event|3|||
126395611|NCT00951080|454741991|FG000|Overall Study|Lost to Follow-up|0|||
126395612|NCT00951080|454741992|FG001|Overall Study|Lost to Follow-up|1|||
126469811|NCT02598960|455023500|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
126469812|NCT02598960|455023501|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
126469813|NCT02598960|455023502|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
126469814|NCT02598960|455023503|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
126469815|NCT02598960|455023504|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
126469816|NCT02598960|455023505|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
126469817|NCT02598960|455023493|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
126469818|NCT02598960|455023494|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
126469819|NCT02598960|455023495|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
126469820|NCT02598960|455023496|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
126469821|NCT02598960|455023497|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
126469822|NCT02598960|455023498|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
126469823|NCT02598960|455023499|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
126469824|NCT02598960|455023500|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
126469825|NCT02598960|455023501|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
126469826|NCT02598960|455023502|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
126469827|NCT02598960|455023503|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
126469828|NCT02598960|455023504|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
126469829|NCT02598960|455023505|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
126469830|NCT02598960|455023493|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126469831|NCT02598960|455023494|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126469832|NCT02598960|455023495|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126469833|NCT02598960|455023496|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126469834|NCT02598960|455023497|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126554961|NCT01023308|455324050|FG000|Overall Study|Untreated|5|||
126554962|NCT01023308|455324051|FG001|Overall Study|Untreated|5|||
126719614|NCT03249792|455923100|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719615|NCT03249792|455923101|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
126395613|NCT00951080|454741991|FG000|Overall Study|Physician Decision|4|||
126395614|NCT00951080|454741992|FG001|Overall Study|Physician Decision|1|||
126395615|NCT00951080|454741991|FG000|Overall Study|Other|19|||
126395616|NCT00951080|454741992|FG001|Overall Study|Other|22|||
126395617|NCT01960998|454741993|FG000|Overall Study|Lost to Follow-up|3|||
126395618|NCT01960998|454741994|FG001|Overall Study|Lost to Follow-up|7|||
126395619|NCT01960998|454741993|FG000|Overall Study|Death|0|||
126395620|NCT01960998|454741994|FG001|Overall Study|Death|1|||
126395621|NCT01960998|454741993|FG000|Overall Study|Withdrawal by Subject|8|||
126395622|NCT01960998|454741994|FG001|Overall Study|Withdrawal by Subject|2|||
126395623|NCT01960998|454741993|FG000|Overall Study|lost computer access|0|||
126395624|NCT01960998|454741994|FG001|Overall Study|lost computer access|1|||
126395625|NCT01939002|454742000|FG000|Overall Study|Adverse Event|13|||
126395626|NCT01939002|454742001|FG001|Overall Study|Adverse Event|13|||
126395627|NCT01939002|454742000|FG000|Overall Study|Withdrawal by Subject|5|||
126395628|NCT01939002|454742001|FG001|Overall Study|Withdrawal by Subject|3|||
126395629|NCT01939002|454742000|FG000|Overall Study|Other|1|||
126395630|NCT01939002|454742001|FG001|Overall Study|Other|2|||
126395631|NCT03372460|454742003|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
126395632|NCT03372460|454742004|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
126395633|NCT01170065|454742007|FG000|Overall Study|Adverse Event|17|||
126395634|NCT01170065|454742008|FG001|Overall Study|Adverse Event|50|||
126395635|NCT01170065|454742009|FG002|Overall Study|Adverse Event|10|||
126395636|NCT01170065|454742007|FG000|Overall Study|Lost to Follow-up|1|||
126395637|NCT01170065|454742008|FG001|Overall Study|Lost to Follow-up|4|||
126395638|NCT01170065|454742009|FG002|Overall Study|Lost to Follow-up|1|||
126395639|NCT01170065|454742007|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
126395640|NCT01170065|454742008|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
126395641|NCT01170065|454742009|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
126395642|NCT01170065|454742007|FG000|Overall Study|Reason other than specified|3|||
126395643|NCT01170065|454742008|FG001|Overall Study|Reason other than specified|8|||
126395644|NCT01170065|454742009|FG002|Overall Study|Reason other than specified|3|||
126395645|NCT01170065|454742007|FG000|Overall Study|Ongoing after planned observation time|5|||
126395646|NCT01170065|454742008|FG001|Overall Study|Ongoing after planned observation time|26|||
126395647|NCT01170065|454742009|FG002|Overall Study|Ongoing after planned observation time|10|||
126395648|NCT00840060|454744362|FG000|Overall Study|Withdrawal by Subject|1|||
126395649|NCT00840060|454744363|FG001|Overall Study|Withdrawal by Subject|0|||
126395650|NCT00840060|454744362|FG000|Overall Study|Change in emotional/behavioral status|0|||
126395651|NCT00840060|454744363|FG001|Overall Study|Change in emotional/behavioral status|1|||
126395652|NCT01263015|454744364|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
126395653|NCT01263015|454744365|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
126395654|NCT01263015|454744364|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
126395655|NCT01263015|454744365|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
126395656|NCT01263015|454744364|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
126395657|NCT01263015|454744365|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
126395658|NCT01263015|454744364|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
126395659|NCT01263015|454744365|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
126395660|NCT01263015|454744364|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
126395661|NCT01263015|454744365|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
126395662|NCT01263015|454744364|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
126395663|NCT01263015|454744365|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
126395664|NCT01263015|454744364|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
126469835|NCT02598960|455023498|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126469836|NCT02598960|455023499|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126469837|NCT02598960|455023500|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126469838|NCT02598960|455023501|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126469839|NCT02598960|455023502|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126469840|NCT02598960|455023503|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126469841|NCT02598960|455023504|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
126469842|NCT02598960|455023505|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
126469843|NCT02598960|455023493|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
126469844|NCT02598960|455023494|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
126469845|NCT02598960|455023495|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
126469846|NCT02598960|455023496|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
126469847|NCT02598960|455023497|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
126469848|NCT02598960|455023498|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
126469849|NCT02598960|455023499|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
126469850|NCT02598960|455023500|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
126395665|NCT01263015|454744365|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
126395666|NCT01263015|454744364|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
126395667|NCT01263015|454744365|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
126771648|NCT01901146|456119908|FG001|Adjuvant Phase|Death|0|||
126771649|NCT01901146|456119909|FG002|Adjuvant Phase|Death|0|||
126771650|NCT01901146|456119910|FG003|Adjuvant Phase|Death|0|||
126771651|NCT01901146|456119911|FG004|Adjuvant Phase|Death|3|||
126771652|NCT01901146|456119907|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
126771653|NCT01901146|456119908|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
126771654|NCT01901146|456119909|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
126771655|NCT01901146|456119910|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
126771656|NCT01901146|456119911|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
126771657|NCT01901146|456119907|FG000|Adjuvant Phase|Physician Decision|0|||
126771658|NCT01901146|456119908|FG001|Adjuvant Phase|Physician Decision|0|||
126771659|NCT01901146|456119909|FG002|Adjuvant Phase|Physician Decision|9|||
126771660|NCT01901146|456119910|FG003|Adjuvant Phase|Physician Decision|2|||
126771661|NCT01901146|456119911|FG004|Adjuvant Phase|Physician Decision|4|||
126771662|NCT01901146|456119907|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
126771663|NCT01901146|456119908|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
126771664|NCT01901146|456119909|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
126771665|NCT01901146|456119910|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
126771666|NCT01901146|456119911|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
126771667|NCT00606801|456119912|FG000|Intervention|Protocol Violation|3|||
126771668|NCT00606801|456119913|FG001|Intervention|Protocol Violation|3|||
126771669|NCT00303316|456119916|FG000|Overall Study|Protocol Violation|1|||
126771670|NCT00303316|456119917|FG001|Overall Study|Protocol Violation|0|||
126771671|NCT00303316|456119916|FG000|Overall Study|Lost to Follow-up|0|||
126771672|NCT00303316|456119917|FG001|Overall Study|Lost to Follow-up|1|||
126771673|NCT00303316|456119916|FG000|Overall Study|Withdrawal by Subject|1|||
126771674|NCT00303316|456119917|FG001|Overall Study|Withdrawal by Subject|2|||
126771675|NCT00306852|456119925|FG000|Overall Study|Death|14|||
126771676|NCT00306852|456119926|FG001|Overall Study|Death|14|||
126771677|NCT00306852|456119925|FG000|Overall Study|Lost to Follow-up|15|||
126771678|NCT00306852|456119926|FG001|Overall Study|Lost to Follow-up|24|||
126771679|NCT03343054|456119928|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
126771680|NCT03343054|456119929|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
126771681|NCT03343054|456119930|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
126771682|NCT03343054|456119928|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
126771683|NCT03343054|456119929|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
126771684|NCT03343054|456119930|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
126771685|NCT03343054|456119928|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
126771686|NCT03343054|456119929|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
126771687|NCT03343054|456119930|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
126771688|NCT03343054|456119928|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
126395668|NCT01263015|454744364|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
126395669|NCT01263015|454744365|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
126395670|NCT01263015|454744364|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
126395671|NCT01263015|454744365|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
126395672|NCT01263015|454744364|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
126395673|NCT01263015|454744365|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
126395674|NCT01263015|454744364|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
126395675|NCT01263015|454744365|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
126395676|NCT00303446|454744367|FG000|Overall Study|Withdrawal by Subject|2|||
126395677|NCT00303446|454744368|FG001|Overall Study|Withdrawal by Subject|2|||
126395678|NCT00303446|454744367|FG000|Overall Study|Death|0|||
126395679|NCT00303446|454744368|FG001|Overall Study|Death|1|||
126771689|NCT03343054|456119929|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
126771690|NCT03343054|456119930|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
126771691|NCT01467570|456119931|FG000|Overall Study|Lost to Follow-up|8|||
126771692|NCT01467570|456119932|FG001|Overall Study|Lost to Follow-up|9|||
126771693|NCT02766088|456119935|FG000|Overall Study|Sponsor study termination|498|||
126771694|NCT02766088|456119935|FG000|Overall Study|Migrated/moved from the study area|1|||
126771695|NCT02766088|456119935|FG000|Overall Study|Lost to Follow-up|5|||
126771696|NCT02766088|456119935|FG000|Overall Study|Other|1|||
126771697|NCT02766088|456119935|FG000|Overall Study|Death|1|||
126771698|NCT01222715|456119936|FG000|Overall Study|Adverse Event|0|||
126395680|NCT00303446|454744367|FG000|Overall Study|Physician Decision|0|||
126395681|NCT00303446|454744368|FG001|Overall Study|Physician Decision|1|||
126395682|NCT00428220|454744369|FG000|Overall Study|Participant died|8|||
126395683|NCT00428220|454744369|FG000|Overall Study|Global deterioration of health status|7|||
126771699|NCT01222715|456119937|FG001|Overall Study|Adverse Event|4|||
126771700|NCT01222715|456119936|FG000|Overall Study|Death|0|||
126771701|NCT01222715|456119937|FG001|Overall Study|Death|1|||
126771702|NCT01222715|456119936|FG000|Overall Study|Lack of Efficacy|22|||
126771703|NCT01222715|456119937|FG001|Overall Study|Lack of Efficacy|14|||
126771704|NCT01222715|456119936|FG000|Overall Study|Physician Decision|12|||
126771705|NCT01222715|456119937|FG001|Overall Study|Physician Decision|2|||
126395684|NCT00428220|454744369|FG000|Overall Study|Lost to Follow-up|4|||
126719616|NCT03249792|455923102|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719617|NCT03249792|455923103|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719618|NCT03249792|455923104|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719619|NCT03249792|455923105|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719620|NCT03249792|455923106|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719621|NCT03249792|455923107|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
126719622|NCT03249792|455923075|FG000|Switch Over Period|Withdrawal by Subject|0|||
126719623|NCT03249792|455923076|FG001|Switch Over Period|Withdrawal by Subject|0|||
126719624|NCT03249792|455923077|FG002|Switch Over Period|Withdrawal by Subject|0|||
126719625|NCT03249792|455923078|FG003|Switch Over Period|Withdrawal by Subject|0|||
126719626|NCT03249792|455923079|FG004|Switch Over Period|Withdrawal by Subject|0|||
126719627|NCT03249792|455923080|FG005|Switch Over Period|Withdrawal by Subject|0|||
126719628|NCT03249792|455923081|FG006|Switch Over Period|Withdrawal by Subject|0|||
126719629|NCT03249792|455923082|FG007|Switch Over Period|Withdrawal by Subject|0|||
126719630|NCT03249792|455923083|FG008|Switch Over Period|Withdrawal by Subject|0|||
126719631|NCT03249792|455923084|FG009|Switch Over Period|Withdrawal by Subject|0|||
126719632|NCT03249792|455923085|FG010|Switch Over Period|Withdrawal by Subject|0|||
126719633|NCT03249792|455923086|FG011|Switch Over Period|Withdrawal by Subject|0|||
126719634|NCT03249792|455923087|FG012|Switch Over Period|Withdrawal by Subject|0|||
126719635|NCT03249792|455923088|FG013|Switch Over Period|Withdrawal by Subject|0|||
126719636|NCT03249792|455923089|FG014|Switch Over Period|Withdrawal by Subject|0|||
126719637|NCT03249792|455923090|FG015|Switch Over Period|Withdrawal by Subject|0|||
126719638|NCT03249792|455923091|FG016|Switch Over Period|Withdrawal by Subject|0|||
126719639|NCT03249792|455923092|FG017|Switch Over Period|Withdrawal by Subject|0|||
126719640|NCT03249792|455923093|FG018|Switch Over Period|Withdrawal by Subject|0|||
126719641|NCT03249792|455923094|FG019|Switch Over Period|Withdrawal by Subject|0|||
126719642|NCT03249792|455923095|FG020|Switch Over Period|Withdrawal by Subject|0|||
126719643|NCT03249792|455923096|FG021|Switch Over Period|Withdrawal by Subject|0|||
126719644|NCT03249792|455923097|FG022|Switch Over Period|Withdrawal by Subject|0|||
126719645|NCT03249792|455923098|FG023|Switch Over Period|Withdrawal by Subject|0|||
126719646|NCT03249792|455923099|FG024|Switch Over Period|Withdrawal by Subject|0|||
126719647|NCT03249792|455923100|FG025|Switch Over Period|Withdrawal by Subject|0|||
126719648|NCT03249792|455923101|FG026|Switch Over Period|Withdrawal by Subject|0|||
126719649|NCT03249792|455923102|FG027|Switch Over Period|Withdrawal by Subject|0|||
126719650|NCT03249792|455923103|FG028|Switch Over Period|Withdrawal by Subject|0|||
126719651|NCT03249792|455923104|FG029|Switch Over Period|Withdrawal by Subject|0|||
126719652|NCT03249792|455923105|FG030|Switch Over Period|Withdrawal by Subject|0|||
126719653|NCT03249792|455923106|FG031|Switch Over Period|Withdrawal by Subject|1|||
126719654|NCT03249792|455923107|FG032|Switch Over Period|Withdrawal by Subject|0|||
126719655|NCT03249792|455923075|FG000|Switch Over Period|Progressive Disease|0|||
126719656|NCT03249792|455923076|FG001|Switch Over Period|Progressive Disease|0|||
126719657|NCT03249792|455923077|FG002|Switch Over Period|Progressive Disease|0|||
126469851|NCT02598960|455023501|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
126469852|NCT02598960|455023502|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
126469853|NCT02598960|455023503|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
126469854|NCT02598960|455023504|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
126469855|NCT02598960|455023505|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
126469856|NCT00734474|455023510|FG000|Overall Study|Entry Criteria Not Met|0|||
126469857|NCT00734474|455023511|FG001|Overall Study|Entry Criteria Not Met|0|||
126469858|NCT00734474|455023512|FG002|Overall Study|Entry Criteria Not Met|5|||
126719658|NCT03249792|455923078|FG003|Switch Over Period|Progressive Disease|0|||
126719659|NCT03249792|455923079|FG004|Switch Over Period|Progressive Disease|0|||
126719660|NCT03249792|455923080|FG005|Switch Over Period|Progressive Disease|0|||
126719661|NCT03249792|455923081|FG006|Switch Over Period|Progressive Disease|0|||
126719662|NCT03249792|455923082|FG007|Switch Over Period|Progressive Disease|0|||
126719663|NCT03249792|455923083|FG008|Switch Over Period|Progressive Disease|0|||
126719664|NCT03249792|455923084|FG009|Switch Over Period|Progressive Disease|0|||
126719665|NCT03249792|455923085|FG010|Switch Over Period|Progressive Disease|0|||
126719666|NCT03249792|455923086|FG011|Switch Over Period|Progressive Disease|0|||
126719667|NCT03249792|455923087|FG012|Switch Over Period|Progressive Disease|0|||
126719668|NCT03249792|455923088|FG013|Switch Over Period|Progressive Disease|0|||
126719669|NCT03249792|455923089|FG014|Switch Over Period|Progressive Disease|0|||
126719670|NCT03249792|455923090|FG015|Switch Over Period|Progressive Disease|0|||
126719671|NCT03249792|455923091|FG016|Switch Over Period|Progressive Disease|0|||
126719672|NCT03249792|455923092|FG017|Switch Over Period|Progressive Disease|0|||
126719673|NCT03249792|455923093|FG018|Switch Over Period|Progressive Disease|0|||
126719674|NCT03249792|455923094|FG019|Switch Over Period|Progressive Disease|0|||
126719675|NCT03249792|455923095|FG020|Switch Over Period|Progressive Disease|0|||
126719676|NCT03249792|455923096|FG021|Switch Over Period|Progressive Disease|0|||
126719677|NCT03249792|455923097|FG022|Switch Over Period|Progressive Disease|0|||
126719678|NCT03249792|455923098|FG023|Switch Over Period|Progressive Disease|0|||
126719679|NCT03249792|455923099|FG024|Switch Over Period|Progressive Disease|0|||
126719680|NCT03249792|455923100|FG025|Switch Over Period|Progressive Disease|0|||
126719681|NCT03249792|455923101|FG026|Switch Over Period|Progressive Disease|1|||
126395685|NCT00428220|454744369|FG000|Overall Study|Objective progression or relapse|123|||
126395686|NCT00428220|454744369|FG000|Overall Study|Participant refused continued treatment|7|||
126395687|NCT00428220|454744369|FG000|Overall Study|Adverse Event|51|||
126395688|NCT00428220|454744369|FG000|Overall Study|Other|23|||
126395689|NCT00642174|454744378|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
126395690|NCT00642174|454744379|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
126395691|NCT00896363|454744380|FG000|Overall Study|Adverse Event|3|||
126395692|NCT00896363|454744381|FG001|Overall Study|Adverse Event|4|||
126395693|NCT00896363|454744382|FG002|Overall Study|Adverse Event|2|||
126395694|NCT00896363|454744380|FG000|Overall Study|Lack of Efficacy|0|||
126395695|NCT00896363|454744381|FG001|Overall Study|Lack of Efficacy|2|||
126395696|NCT00896363|454744382|FG002|Overall Study|Lack of Efficacy|1|||
126395697|NCT00896363|454744380|FG000|Overall Study|Withdrawal by Subject|3|||
126469859|NCT00734474|455023513|FG003|Overall Study|Entry Criteria Not Met|0|||
126469860|NCT00734474|455023514|FG004|Overall Study|Entry Criteria Not Met|3|||
126469861|NCT00734474|455023515|FG005|Overall Study|Entry Criteria Not Met|1|||
126469862|NCT00734474|455023516|FG006|Overall Study|Entry Criteria Not Met|0|||
126469863|NCT00734474|455023517|FG007|Overall Study|Entry Criteria Not Met|1|||
126469864|NCT00734474|455023518|FG008|Overall Study|Entry Criteria Not Met|1|||
126469865|NCT00734474|455023510|FG000|Overall Study|Lost to Follow-up|1|||
126469866|NCT00734474|455023511|FG001|Overall Study|Lost to Follow-up|0|||
126469867|NCT00734474|455023512|FG002|Overall Study|Lost to Follow-up|13|||
126469868|NCT00734474|455023513|FG003|Overall Study|Lost to Follow-up|0|||
126469869|NCT00734474|455023514|FG004|Overall Study|Lost to Follow-up|11|||
126469870|NCT00734474|455023515|FG005|Overall Study|Lost to Follow-up|1|||
126469871|NCT00734474|455023516|FG006|Overall Study|Lost to Follow-up|0|||
126469872|NCT00734474|455023517|FG007|Overall Study|Lost to Follow-up|9|||
126469873|NCT00734474|455023518|FG008|Overall Study|Lost to Follow-up|4|||
126469874|NCT00734474|455023510|FG000|Overall Study|Withdrawal by Subject|2|||
126469875|NCT00734474|455023511|FG001|Overall Study|Withdrawal by Subject|1|||
126469876|NCT00734474|455023512|FG002|Overall Study|Withdrawal by Subject|18|||
126469877|NCT00734474|455023513|FG003|Overall Study|Withdrawal by Subject|0|||
126469878|NCT00734474|455023514|FG004|Overall Study|Withdrawal by Subject|24|||
126469879|NCT00734474|455023515|FG005|Overall Study|Withdrawal by Subject|2|||
126469880|NCT00734474|455023516|FG006|Overall Study|Withdrawal by Subject|0|||
126469881|NCT00734474|455023517|FG007|Overall Study|Withdrawal by Subject|36|||
126469882|NCT00734474|455023518|FG008|Overall Study|Withdrawal by Subject|21|||
126469883|NCT00734474|455023510|FG000|Overall Study|Physician Decision|0|||
126469884|NCT00734474|455023511|FG001|Overall Study|Physician Decision|0|||
126469885|NCT00734474|455023512|FG002|Overall Study|Physician Decision|4|||
126469886|NCT00734474|455023513|FG003|Overall Study|Physician Decision|1|||
126469887|NCT00734474|455023514|FG004|Overall Study|Physician Decision|11|||
126469888|NCT00734474|455023515|FG005|Overall Study|Physician Decision|0|||
126469889|NCT00734474|455023516|FG006|Overall Study|Physician Decision|0|||
126469890|NCT00734474|455023517|FG007|Overall Study|Physician Decision|9|||
126469891|NCT00734474|455023518|FG008|Overall Study|Physician Decision|9|||
126469892|NCT00734474|455023510|FG000|Overall Study|Adverse Event|4|||
126469893|NCT00734474|455023511|FG001|Overall Study|Adverse Event|4|||
126469894|NCT00734474|455023512|FG002|Overall Study|Adverse Event|63|||
126469895|NCT00734474|455023513|FG003|Overall Study|Adverse Event|1|||
126469896|NCT00734474|455023514|FG004|Overall Study|Adverse Event|64|||
126469897|NCT00734474|455023515|FG005|Overall Study|Adverse Event|0|||
126469898|NCT00734474|455023516|FG006|Overall Study|Adverse Event|1|||
126469899|NCT00734474|455023517|FG007|Overall Study|Adverse Event|65|||
126469900|NCT00734474|455023518|FG008|Overall Study|Adverse Event|39|||
126469901|NCT00734474|455023510|FG000|Overall Study|Protocol Violation|0|||
126469902|NCT00734474|455023511|FG001|Overall Study|Protocol Violation|0|||
126554963|NCT01023308|455324050|FG000|Overall Study|Lost to Follow-up|1|||
126719682|NCT03249792|455923102|FG027|Switch Over Period|Progressive Disease|0|||
126719683|NCT03249792|455923103|FG028|Switch Over Period|Progressive Disease|1|||
126719684|NCT03249792|455923104|FG029|Switch Over Period|Progressive Disease|2|||
126719685|NCT03249792|455923105|FG030|Switch Over Period|Progressive Disease|1|||
126395698|NCT00896363|454744381|FG001|Overall Study|Withdrawal by Subject|5|||
126395699|NCT00896363|454744382|FG002|Overall Study|Withdrawal by Subject|5|||
126395700|NCT02982018|454744387|FG000|Overall Study|Incorrect Lens Dispensed|1|||
126395701|NCT02982018|454744388|FG001|Overall Study|Incorrect Lens Dispensed|0|||
126469903|NCT00734474|455023512|FG002|Overall Study|Protocol Violation|4|||
126469904|NCT00734474|455023513|FG003|Overall Study|Protocol Violation|0|||
126469905|NCT00734474|455023514|FG004|Overall Study|Protocol Violation|3|||
126469906|NCT00734474|455023515|FG005|Overall Study|Protocol Violation|0|||
126719686|NCT03249792|455923106|FG031|Switch Over Period|Progressive Disease|0|||
126719687|NCT03249792|455923107|FG032|Switch Over Period|Progressive Disease|1|||
126469907|NCT00734474|455023516|FG006|Overall Study|Protocol Violation|0|||
126469908|NCT00734474|455023517|FG007|Overall Study|Protocol Violation|3|||
126469909|NCT00734474|455023518|FG008|Overall Study|Protocol Violation|1|||
126469910|NCT00734474|455023510|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
126469911|NCT00734474|455023511|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
126469912|NCT00734474|455023512|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
126719688|NCT03249792|455923075|FG000|Switch Over Period|Adverse Event|0|||
126719689|NCT03249792|455923076|FG001|Switch Over Period|Adverse Event|0|||
126719690|NCT03249792|455923077|FG002|Switch Over Period|Adverse Event|0|||
126719691|NCT03249792|455923078|FG003|Switch Over Period|Adverse Event|0|||
126719692|NCT03249792|455923079|FG004|Switch Over Period|Adverse Event|0|||
126719693|NCT03249792|455923080|FG005|Switch Over Period|Adverse Event|0|||
126719694|NCT03249792|455923081|FG006|Switch Over Period|Adverse Event|0|||
126719695|NCT03249792|455923082|FG007|Switch Over Period|Adverse Event|0|||
126719696|NCT03249792|455923083|FG008|Switch Over Period|Adverse Event|0|||
126719697|NCT03249792|455923084|FG009|Switch Over Period|Adverse Event|0|||
126719698|NCT03249792|455923085|FG010|Switch Over Period|Adverse Event|0|||
126719699|NCT03249792|455923086|FG011|Switch Over Period|Adverse Event|0|||
126719700|NCT03249792|455923087|FG012|Switch Over Period|Adverse Event|0|||
126719701|NCT03249792|455923088|FG013|Switch Over Period|Adverse Event|0|||
126719702|NCT03249792|455923089|FG014|Switch Over Period|Adverse Event|0|||
126719703|NCT03249792|455923090|FG015|Switch Over Period|Adverse Event|0|||
126719704|NCT03249792|455923091|FG016|Switch Over Period|Adverse Event|0|||
126719705|NCT03249792|455923092|FG017|Switch Over Period|Adverse Event|0|||
126719706|NCT03249792|455923093|FG018|Switch Over Period|Adverse Event|0|||
126719707|NCT03249792|455923094|FG019|Switch Over Period|Adverse Event|0|||
126719708|NCT03249792|455923095|FG020|Switch Over Period|Adverse Event|0|||
126719709|NCT03249792|455923096|FG021|Switch Over Period|Adverse Event|0|||
126719710|NCT03249792|455923097|FG022|Switch Over Period|Adverse Event|0|||
126719711|NCT03249792|455923098|FG023|Switch Over Period|Adverse Event|0|||
126719712|NCT03249792|455923099|FG024|Switch Over Period|Adverse Event|0|||
126719713|NCT03249792|455923100|FG025|Switch Over Period|Adverse Event|1|||
126395702|NCT02982018|454744387|FG000|Overall Study|Protocol Violation|1|||
126395703|NCT02982018|454744388|FG001|Overall Study|Protocol Violation|1|||
126395704|NCT02982018|454744387|FG000|Overall Study|Adverse Event|1|||
126395705|NCT02982018|454744388|FG001|Overall Study|Adverse Event|1|||
126395706|NCT02982018|454744387|FG000|Overall Study|Lens Discomfort|2|||
126395707|NCT02982018|454744388|FG001|Overall Study|Lens Discomfort|0|||
126395708|NCT02982018|454744387|FG000|Overall Study|Withdrawal by Subject|0|||
126395709|NCT02982018|454744388|FG001|Overall Study|Withdrawal by Subject|1|||
126395710|NCT00378599|454744394|FG000|Overall Study|Adverse Event|38|||
126395711|NCT00378599|454744394|FG000|Overall Study|Protocol Violation|2|||
126395712|NCT00378599|454744394|FG000|Overall Study|Treatment failure|7|||
126395713|NCT00378599|454744394|FG000|Overall Study|Withdrawal by Subject|5|||
126395714|NCT00416715|454744395|FG000|Overall Study|Not evaluable for joint aches|7|||
126395715|NCT00416715|454744395|FG000|Overall Study|Vitamin D levels not evaluable|8|||
126395716|NCT03812185|454744399|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
126395717|NCT03334851|454744414|FG000|Overall Study|Other|0|||
126395718|NCT03334851|454744415|FG001|Overall Study|Other|0|||
126395719|NCT03334851|454744416|FG002|Overall Study|Other|0|||
126395720|NCT03334851|454744417|FG003|Overall Study|Other|0|||
126395721|NCT03334851|454744418|FG004|Overall Study|Other|0|||
126395722|NCT03334851|454744419|FG005|Overall Study|Other|0|||
126395723|NCT03334851|454744420|FG006|Overall Study|Other|0|||
126395724|NCT03334851|454744421|FG007|Overall Study|Other|1|||
126395725|NCT03334851|454744422|FG008|Overall Study|Other|0|||
126395726|NCT03334851|454744423|FG009|Overall Study|Other|0|||
126554964|NCT01023308|455324051|FG001|Overall Study|Lost to Follow-up|0|||
126554965|NCT01023308|455324050|FG000|Overall Study|Withdrawal by Subject|34|||
126554966|NCT01023308|455324051|FG001|Overall Study|Withdrawal by Subject|18|||
126554967|NCT00551213|455324052|FG000|Overall Study|Adverse Event|6|||
126554968|NCT00551213|455324053|FG001|Overall Study|Adverse Event|3|||
126554969|NCT00551213|455324052|FG000|Overall Study|Progressive Disease|41|||
126554970|NCT00551213|455324053|FG001|Overall Study|Progressive Disease|12|||
126554971|NCT00551213|455324052|FG000|Overall Study|Withdrawal by Subject|2|||
126554972|NCT00551213|455324053|FG001|Overall Study|Withdrawal by Subject|0|||
126554973|NCT00551213|455324052|FG000|Overall Study|Not Treated|1|||
126554974|NCT00551213|455324053|FG001|Overall Study|Not Treated|2|||
126719714|NCT03249792|455923101|FG026|Switch Over Period|Adverse Event|0|||
126719715|NCT03249792|455923102|FG027|Switch Over Period|Adverse Event|1|||
126719716|NCT03249792|455923103|FG028|Switch Over Period|Adverse Event|0|||
126719717|NCT03249792|455923104|FG029|Switch Over Period|Adverse Event|0|||
126719718|NCT03249792|455923105|FG030|Switch Over Period|Adverse Event|0|||
126719719|NCT03249792|455923106|FG031|Switch Over Period|Adverse Event|0|||
126719720|NCT03249792|455923107|FG032|Switch Over Period|Adverse Event|0|||
126719721|NCT02284906|455923110|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126395727|NCT03334851|454744424|FG010|Overall Study|Other|0|||
126395728|NCT03334851|454744425|FG011|Overall Study|Other|0|||
126719722|NCT02284906|455923111|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
126395729|NCT03334851|454744426|FG012|Overall Study|Other|0|||
126395730|NCT03334851|454744414|FG000|Overall Study|Adverse Event|0|||
126554975|NCT01890967|455324054|FG000|Overall Study|Adverse Event|3|||
126554976|NCT01890967|455324055|FG001|Overall Study|Adverse Event|3|||
126554977|NCT01890967|455324056|FG002|Overall Study|Adverse Event|3|||
126719723|NCT02284906|455923112|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
126719724|NCT02284906|455923110|FG000|Overall Study|Major Protocol Deviation|0|||
126719725|NCT02284906|455923111|FG001|Overall Study|Major Protocol Deviation|1|||
126469913|NCT00734474|455023513|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
126395731|NCT03334851|454744415|FG001|Overall Study|Adverse Event|0|||
126395732|NCT03334851|454744416|FG002|Overall Study|Adverse Event|0|||
126395733|NCT03334851|454744417|FG003|Overall Study|Adverse Event|0|||
126395734|NCT03334851|454744418|FG004|Overall Study|Adverse Event|0|||
126395735|NCT03334851|454744419|FG005|Overall Study|Adverse Event|0|||
126395736|NCT03334851|454744420|FG006|Overall Study|Adverse Event|0|||
126395737|NCT03334851|454744421|FG007|Overall Study|Adverse Event|1|||
126395738|NCT03334851|454744422|FG008|Overall Study|Adverse Event|0|||
126395739|NCT03334851|454744423|FG009|Overall Study|Adverse Event|0|||
126395740|NCT03334851|454744424|FG010|Overall Study|Adverse Event|0|||
126395741|NCT03334851|454744425|FG011|Overall Study|Adverse Event|0|||
126395742|NCT03334851|454744426|FG012|Overall Study|Adverse Event|0|||
126395743|NCT03334851|454744414|FG000|Overall Study|Withdrawal by Subject|0|||
126395744|NCT03334851|454744415|FG001|Overall Study|Withdrawal by Subject|0|||
126395745|NCT03334851|454744416|FG002|Overall Study|Withdrawal by Subject|0|||
126395746|NCT03334851|454744417|FG003|Overall Study|Withdrawal by Subject|0|||
126395747|NCT03334851|454744418|FG004|Overall Study|Withdrawal by Subject|0|||
126395748|NCT03334851|454744419|FG005|Overall Study|Withdrawal by Subject|0|||
126395749|NCT03334851|454744420|FG006|Overall Study|Withdrawal by Subject|0|||
126395750|NCT03334851|454744421|FG007|Overall Study|Withdrawal by Subject|0|||
126395751|NCT03334851|454744422|FG008|Overall Study|Withdrawal by Subject|0|||
126395752|NCT03334851|454744423|FG009|Overall Study|Withdrawal by Subject|0|||
126395753|NCT03334851|454744424|FG010|Overall Study|Withdrawal by Subject|1|||
126395754|NCT03334851|454744425|FG011|Overall Study|Withdrawal by Subject|0|||
126395755|NCT03334851|454744426|FG012|Overall Study|Withdrawal by Subject|1|||
126395756|NCT03334851|454744414|FG000|Overall Study|Lost to Follow-up|0|||
126395757|NCT03334851|454744415|FG001|Overall Study|Lost to Follow-up|0|||
126395758|NCT03334851|454744416|FG002|Overall Study|Lost to Follow-up|0|||
126395759|NCT03334851|454744417|FG003|Overall Study|Lost to Follow-up|0|||
126395760|NCT03334851|454744418|FG004|Overall Study|Lost to Follow-up|0|||
126395761|NCT03334851|454744419|FG005|Overall Study|Lost to Follow-up|0|||
126395762|NCT03334851|454744420|FG006|Overall Study|Lost to Follow-up|0|||
126395763|NCT03334851|454744421|FG007|Overall Study|Lost to Follow-up|0|||
126395764|NCT03334851|454744422|FG008|Overall Study|Lost to Follow-up|0|||
126395765|NCT03334851|454744423|FG009|Overall Study|Lost to Follow-up|0|||
126395766|NCT03334851|454744424|FG010|Overall Study|Lost to Follow-up|2|||
126395767|NCT03334851|454744425|FG011|Overall Study|Lost to Follow-up|1|||
126395768|NCT03334851|454744426|FG012|Overall Study|Lost to Follow-up|0|||
126395769|NCT01691885|454744427|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
126395770|NCT01691885|454744428|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
126395771|NCT01691885|454744427|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
126395772|NCT01691885|454744428|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
126395773|NCT03555981|454744429|FG000|Overall Study|Lost to Follow-up|0|||
126395774|NCT03555981|454744430|FG001|Overall Study|Lost to Follow-up|2|||
126395775|NCT02754141|454744434|FG000|Overall Study|Disease progression|11|||
126469914|NCT00734474|455023514|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
126469915|NCT00734474|455023515|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
126469916|NCT00734474|455023516|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
126469917|NCT00734474|455023517|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
126469918|NCT00734474|455023518|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
126469919|NCT00734474|455023510|FG000|Overall Study|Sponsor Decision|0|||
126469920|NCT00734474|455023511|FG001|Overall Study|Sponsor Decision|0|||
126469921|NCT00734474|455023512|FG002|Overall Study|Sponsor Decision|0|||
126469922|NCT00734474|455023513|FG003|Overall Study|Sponsor Decision|0|||
126469923|NCT00734474|455023514|FG004|Overall Study|Sponsor Decision|2|||
126469924|NCT00734474|455023515|FG005|Overall Study|Sponsor Decision|0|||
126719726|NCT02284906|455923112|FG002|Overall Study|Major Protocol Deviation|0|||
126719727|NCT02284906|455923110|FG000|Overall Study|Voluntary Withdrawal|2|||
126719728|NCT02284906|455923111|FG001|Overall Study|Voluntary Withdrawal|4|||
126395776|NCT02754141|454744435|FG001|Overall Study|Disease progression|7|||
126395777|NCT02754141|454744436|FG002|Overall Study|Disease progression|8|||
126395778|NCT02754141|454744437|FG003|Overall Study|Disease progression|5|||
126395779|NCT02754141|454744438|FG004|Overall Study|Disease progression|7|||
126395780|NCT02754141|454744439|FG005|Overall Study|Disease progression|7|||
126395781|NCT02754141|454744440|FG006|Overall Study|Disease progression|7|||
126395782|NCT02754141|454744441|FG007|Overall Study|Disease progression|6|||
126395783|NCT02754141|454744442|FG008|Overall Study|Disease progression|11|||
126395784|NCT02754141|454744443|FG009|Overall Study|Disease progression|16|||
126395785|NCT02754141|454744444|FG010|Overall Study|Disease progression|18|||
126395786|NCT02754141|454744445|FG011|Overall Study|Disease progression|13|||
126395787|NCT02754141|454744446|FG012|Overall Study|Disease progression|10|||
126395788|NCT02754141|454744447|FG013|Overall Study|Disease progression|12|||
126395789|NCT02754141|454744448|FG014|Overall Study|Disease progression|12|||
126469925|NCT00734474|455023516|FG006|Overall Study|Sponsor Decision|0|||
126469926|NCT00734474|455023517|FG007|Overall Study|Sponsor Decision|0|||
126469927|NCT00734474|455023518|FG008|Overall Study|Sponsor Decision|0|||
126719729|NCT02284906|455923112|FG002|Overall Study|Voluntary Withdrawal|5|||
126719730|NCT02284906|455923110|FG000|Overall Study|Study Termination|0|||
126719731|NCT02284906|455923111|FG001|Overall Study|Study Termination|11|||
126395790|NCT02754141|454744449|FG015|Overall Study|Disease progression|14|||
126395791|NCT02754141|454744450|FG016|Overall Study|Disease progression|0|||
126395792|NCT02754141|454744451|FG017|Overall Study|Disease progression|1|||
126395793|NCT02754141|454744434|FG000|Overall Study|Study drug toxicity|1|||
126395794|NCT02754141|454744435|FG001|Overall Study|Study drug toxicity|1|||
126395795|NCT02754141|454744436|FG002|Overall Study|Study drug toxicity|0|||
126395796|NCT02754141|454744437|FG003|Overall Study|Study drug toxicity|0|||
126395797|NCT02754141|454744438|FG004|Overall Study|Study drug toxicity|0|||
126395798|NCT02754141|454744439|FG005|Overall Study|Study drug toxicity|0|||
126395799|NCT02754141|454744440|FG006|Overall Study|Study drug toxicity|0|||
126395800|NCT02754141|454744441|FG007|Overall Study|Study drug toxicity|0|||
126395801|NCT02754141|454744442|FG008|Overall Study|Study drug toxicity|0|||
126395802|NCT02754141|454744443|FG009|Overall Study|Study drug toxicity|0|||
126395803|NCT02754141|454744444|FG010|Overall Study|Study drug toxicity|2|||
126395804|NCT02754141|454744445|FG011|Overall Study|Study drug toxicity|1|||
126395805|NCT02754141|454744446|FG012|Overall Study|Study drug toxicity|1|||
126395806|NCT02754141|454744447|FG013|Overall Study|Study drug toxicity|0|||
126395807|NCT02754141|454744448|FG014|Overall Study|Study drug toxicity|0|||
126395808|NCT02754141|454744449|FG015|Overall Study|Study drug toxicity|0|||
126395809|NCT02754141|454744450|FG016|Overall Study|Study drug toxicity|0|||
126395810|NCT02754141|454744451|FG017|Overall Study|Study drug toxicity|0|||
126395811|NCT02754141|454744434|FG000|Overall Study|AE unrelated to study drug|1|||
126395812|NCT02754141|454744435|FG001|Overall Study|AE unrelated to study drug|1|||
126395813|NCT02754141|454744436|FG002|Overall Study|AE unrelated to study drug|0|||
126395814|NCT02754141|454744437|FG003|Overall Study|AE unrelated to study drug|1|||
126395815|NCT02754141|454744438|FG004|Overall Study|AE unrelated to study drug|3|||
126395816|NCT02754141|454744439|FG005|Overall Study|AE unrelated to study drug|2|||
126395817|NCT02754141|454744440|FG006|Overall Study|AE unrelated to study drug|1|||
126395818|NCT02754141|454744441|FG007|Overall Study|AE unrelated to study drug|0|||
126395819|NCT02754141|454744442|FG008|Overall Study|AE unrelated to study drug|0|||
126395820|NCT02754141|454744443|FG009|Overall Study|AE unrelated to study drug|0|||
126395821|NCT02754141|454744444|FG010|Overall Study|AE unrelated to study drug|0|||
126395822|NCT02754141|454744445|FG011|Overall Study|AE unrelated to study drug|0|||
126395823|NCT02754141|454744446|FG012|Overall Study|AE unrelated to study drug|0|||
126395824|NCT02754141|454744447|FG013|Overall Study|AE unrelated to study drug|0|||
126395825|NCT02754141|454744448|FG014|Overall Study|AE unrelated to study drug|0|||
126395826|NCT02754141|454744449|FG015|Overall Study|AE unrelated to study drug|0|||
126395827|NCT02754141|454744450|FG016|Overall Study|AE unrelated to study drug|0|||
126395828|NCT02754141|454744451|FG017|Overall Study|AE unrelated to study drug|0|||
126395829|NCT02754141|454744434|FG000|Overall Study|Request to discontinue|0|||
126395830|NCT02754141|454744435|FG001|Overall Study|Request to discontinue|0|||
126395831|NCT02754141|454744436|FG002|Overall Study|Request to discontinue|0|||
126395832|NCT02754141|454744437|FG003|Overall Study|Request to discontinue|0|||
126395833|NCT02754141|454744438|FG004|Overall Study|Request to discontinue|0|||
126395834|NCT02754141|454744439|FG005|Overall Study|Request to discontinue|0|||
126395835|NCT02754141|454744440|FG006|Overall Study|Request to discontinue|0|||
126395836|NCT02754141|454744441|FG007|Overall Study|Request to discontinue|0|||
126395837|NCT02754141|454744442|FG008|Overall Study|Request to discontinue|1|||
126395838|NCT02754141|454744443|FG009|Overall Study|Request to discontinue|0|||
126395839|NCT02754141|454744444|FG010|Overall Study|Request to discontinue|0|||
126395840|NCT02754141|454744445|FG011|Overall Study|Request to discontinue|0|||
126395841|NCT02754141|454744446|FG012|Overall Study|Request to discontinue|0|||
126395842|NCT02754141|454744447|FG013|Overall Study|Request to discontinue|1|||
126395843|NCT02754141|454744448|FG014|Overall Study|Request to discontinue|1|||
126395844|NCT02754141|454744449|FG015|Overall Study|Request to discontinue|0|||
126395845|NCT02754141|454744450|FG016|Overall Study|Request to discontinue|0|||
126395846|NCT02754141|454744451|FG017|Overall Study|Request to discontinue|0|||
126395847|NCT02754141|454744434|FG000|Overall Study|Withdrew consent|0|||
126395848|NCT02754141|454744435|FG001|Overall Study|Withdrew consent|0|||
126395849|NCT02754141|454744436|FG002|Overall Study|Withdrew consent|0|||
126395850|NCT02754141|454744437|FG003|Overall Study|Withdrew consent|0|||
126395851|NCT02754141|454744438|FG004|Overall Study|Withdrew consent|0|||
126395852|NCT02754141|454744439|FG005|Overall Study|Withdrew consent|0|||
126395853|NCT02754141|454744440|FG006|Overall Study|Withdrew consent|0|||
126395854|NCT02754141|454744441|FG007|Overall Study|Withdrew consent|0|||
126395855|NCT02754141|454744442|FG008|Overall Study|Withdrew consent|0|||
126395856|NCT02754141|454744443|FG009|Overall Study|Withdrew consent|1|||
126395857|NCT02754141|454744444|FG010|Overall Study|Withdrew consent|0|||
126395858|NCT02754141|454744445|FG011|Overall Study|Withdrew consent|0|||
126395859|NCT02754141|454744446|FG012|Overall Study|Withdrew consent|0|||
126395860|NCT02754141|454744447|FG013|Overall Study|Withdrew consent|0|||
126395861|NCT02754141|454744448|FG014|Overall Study|Withdrew consent|0|||
126395862|NCT02754141|454744449|FG015|Overall Study|Withdrew consent|0|||
126395863|NCT02754141|454744450|FG016|Overall Study|Withdrew consent|0|||
126395864|NCT02754141|454744451|FG017|Overall Study|Withdrew consent|0|||
126395865|NCT02754141|454744434|FG000|Overall Study|Maximum clinical benefit|0|||
126395866|NCT02754141|454744435|FG001|Overall Study|Maximum clinical benefit|0|||
126395867|NCT02754141|454744436|FG002|Overall Study|Maximum clinical benefit|0|||
126395868|NCT02754141|454744437|FG003|Overall Study|Maximum clinical benefit|1|||
126395869|NCT02754141|454744438|FG004|Overall Study|Maximum clinical benefit|0|||
126395870|NCT02754141|454744439|FG005|Overall Study|Maximum clinical benefit|0|||
126395871|NCT02754141|454744440|FG006|Overall Study|Maximum clinical benefit|0|||
126395872|NCT02754141|454744441|FG007|Overall Study|Maximum clinical benefit|0|||
126395873|NCT02754141|454744442|FG008|Overall Study|Maximum clinical benefit|0|||
126395874|NCT02754141|454744443|FG009|Overall Study|Maximum clinical benefit|0|||
126395875|NCT02754141|454744444|FG010|Overall Study|Maximum clinical benefit|0|||
126395876|NCT02754141|454744445|FG011|Overall Study|Maximum clinical benefit|0|||
126395877|NCT02754141|454744446|FG012|Overall Study|Maximum clinical benefit|0|||
126395878|NCT02754141|454744447|FG013|Overall Study|Maximum clinical benefit|0|||
126395879|NCT02754141|454744448|FG014|Overall Study|Maximum clinical benefit|0|||
126395880|NCT02754141|454744449|FG015|Overall Study|Maximum clinical benefit|0|||
126395881|NCT02754141|454744450|FG016|Overall Study|Maximum clinical benefit|0|||
126395882|NCT02754141|454744451|FG017|Overall Study|Maximum clinical benefit|0|||
126395883|NCT02754141|454744434|FG000|Overall Study|No longer meets study criteria|0|||
126395884|NCT02754141|454744435|FG001|Overall Study|No longer meets study criteria|0|||
126395885|NCT02754141|454744436|FG002|Overall Study|No longer meets study criteria|0|||
126395886|NCT02754141|454744437|FG003|Overall Study|No longer meets study criteria|1|||
126395887|NCT02754141|454744438|FG004|Overall Study|No longer meets study criteria|0|||
126395888|NCT02754141|454744439|FG005|Overall Study|No longer meets study criteria|0|||
126395889|NCT02754141|454744440|FG006|Overall Study|No longer meets study criteria|0|||
126395890|NCT02754141|454744441|FG007|Overall Study|No longer meets study criteria|0|||
126395891|NCT02754141|454744442|FG008|Overall Study|No longer meets study criteria|0|||
126395892|NCT02754141|454744443|FG009|Overall Study|No longer meets study criteria|0|||
126395893|NCT02754141|454744444|FG010|Overall Study|No longer meets study criteria|0|||
126395894|NCT02754141|454744445|FG011|Overall Study|No longer meets study criteria|0|||
126395895|NCT02754141|454744446|FG012|Overall Study|No longer meets study criteria|0|||
126395896|NCT02754141|454744447|FG013|Overall Study|No longer meets study criteria|0|||
126395897|NCT02754141|454744448|FG014|Overall Study|No longer meets study criteria|0|||
126395898|NCT02754141|454744449|FG015|Overall Study|No longer meets study criteria|0|||
126395899|NCT02754141|454744450|FG016|Overall Study|No longer meets study criteria|0|||
126395900|NCT02754141|454744451|FG017|Overall Study|No longer meets study criteria|0|||
126395901|NCT02754141|454744434|FG000|Overall Study|Other reasons|0|||
126469928|NCT00734474|455023510|FG000|Overall Study|Death|0|||
126469929|NCT00734474|455023511|FG001|Overall Study|Death|0|||
126469930|NCT00734474|455023512|FG002|Overall Study|Death|1|||
126469931|NCT00734474|455023513|FG003|Overall Study|Death|0|||
126469932|NCT00734474|455023514|FG004|Overall Study|Death|0|||
126469933|NCT00734474|455023515|FG005|Overall Study|Death|0|||
126469934|NCT00734474|455023516|FG006|Overall Study|Death|0|||
126469935|NCT00734474|455023517|FG007|Overall Study|Death|2|||
126469936|NCT00734474|455023518|FG008|Overall Study|Death|1|||
126469937|NCT00734474|455023510|FG000|Overall Study|Lack of Efficacy|0|||
126469938|NCT00734474|455023511|FG001|Overall Study|Lack of Efficacy|0|||
126469939|NCT00734474|455023512|FG002|Overall Study|Lack of Efficacy|4|||
126719732|NCT02284906|455923112|FG002|Overall Study|Study Termination|14|||
126719733|NCT02284906|455923110|FG000|Overall Study|Reason not Specified|1|||
126719734|NCT02284906|455923111|FG001|Overall Study|Reason not Specified|1|||
126719735|NCT02284906|455923112|FG002|Overall Study|Reason not Specified|0|||
126719736|NCT00069576|455923114|FG000|Original Trial|Lost to Follow-up|25|||
126719737|NCT00069576|455923115|FG001|Original Trial|Lost to Follow-up|33|||
126719738|NCT00069576|455923114|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
126719739|NCT00069576|455923115|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
126719740|NCT04060667|455923116|FG000|Overall Study|Lost to Follow-up|75|||
126719741|NCT04060667|455923117|FG001|Overall Study|Lost to Follow-up|10|||
126719742|NCT04333433|455923122|FG000|Overall Study|Withdrawal by Subject|6|||
126719743|NCT04333433|455923123|FG001|Overall Study|Withdrawal by Subject|3|||
126719744|NCT04333433|455923122|FG000|Overall Study|Death|3|||
126719745|NCT04333433|455923123|FG001|Overall Study|Death|0|||
126395902|NCT02754141|454744435|FG001|Overall Study|Other reasons|0|||
126395903|NCT02754141|454744436|FG002|Overall Study|Other reasons|0|||
126395904|NCT02754141|454744437|FG003|Overall Study|Other reasons|0|||
126395905|NCT02754141|454744438|FG004|Overall Study|Other reasons|0|||
126395906|NCT02754141|454744439|FG005|Overall Study|Other reasons|0|||
126395907|NCT02754141|454744440|FG006|Overall Study|Other reasons|0|||
126395908|NCT02754141|454744441|FG007|Overall Study|Other reasons|1|||
126395909|NCT02754141|454744442|FG008|Overall Study|Other reasons|0|||
126469940|NCT00734474|455023513|FG003|Overall Study|Lack of Efficacy|0|||
126469941|NCT00734474|455023514|FG004|Overall Study|Lack of Efficacy|0|||
126469942|NCT00734474|455023515|FG005|Overall Study|Lack of Efficacy|0|||
126719746|NCT04333433|455923122|FG000|Overall Study|Lost to Follow-up|6|||
126719747|NCT04333433|455923123|FG001|Overall Study|Lost to Follow-up|1|||
126756523|NCT02719028|456059454|FG003|Overall Study|Use of prohibited medication|0|||
126756524|NCT02719028|456059451|FG000|Overall Study|Protocol Violation|0|||
126395910|NCT02754141|454744443|FG009|Overall Study|Other reasons|0|||
126395911|NCT02754141|454744444|FG010|Overall Study|Other reasons|0|||
126395912|NCT02754141|454744445|FG011|Overall Study|Other reasons|0|||
126395913|NCT02754141|454744446|FG012|Overall Study|Other reasons|2|||
126395914|NCT02754141|454744447|FG013|Overall Study|Other reasons|0|||
126554978|NCT01890967|455324057|FG003|Overall Study|Adverse Event|2|||
126554979|NCT01890967|455324058|FG004|Overall Study|Adverse Event|1|||
126554980|NCT01890967|455324059|FG005|Overall Study|Adverse Event|7|||
126554981|NCT01890967|455324054|FG000|Overall Study|Death|1|||
126554982|NCT01890967|455324055|FG001|Overall Study|Death|0|||
126554983|NCT01890967|455324056|FG002|Overall Study|Death|0|||
126554984|NCT01890967|455324057|FG003|Overall Study|Death|0|||
126554985|NCT01890967|455324058|FG004|Overall Study|Death|0|||
126554986|NCT01890967|455324059|FG005|Overall Study|Death|0|||
126554987|NCT01890967|455324054|FG000|Overall Study|Lost to Follow-up|1|||
126554988|NCT01890967|455324055|FG001|Overall Study|Lost to Follow-up|1|||
126554989|NCT01890967|455324056|FG002|Overall Study|Lost to Follow-up|1|||
126554990|NCT01890967|455324057|FG003|Overall Study|Lost to Follow-up|1|||
126554991|NCT01890967|455324058|FG004|Overall Study|Lost to Follow-up|0|||
126554992|NCT01890967|455324059|FG005|Overall Study|Lost to Follow-up|1|||
126554993|NCT01890967|455324054|FG000|Overall Study|Protocol Violation|0|||
126554994|NCT01890967|455324055|FG001|Overall Study|Protocol Violation|3|||
126554995|NCT01890967|455324056|FG002|Overall Study|Protocol Violation|3|||
126554996|NCT01890967|455324057|FG003|Overall Study|Protocol Violation|2|||
126554997|NCT01890967|455324058|FG004|Overall Study|Protocol Violation|4|||
126554998|NCT01890967|455324059|FG005|Overall Study|Protocol Violation|1|||
126554999|NCT01890967|455324054|FG000|Overall Study|Sponsor Decision|2|||
126555000|NCT01890967|455324055|FG001|Overall Study|Sponsor Decision|0|||
126555001|NCT01890967|455324056|FG002|Overall Study|Sponsor Decision|1|||
126555002|NCT01890967|455324057|FG003|Overall Study|Sponsor Decision|3|||
126555003|NCT01890967|455324058|FG004|Overall Study|Sponsor Decision|2|||
126555004|NCT01890967|455324059|FG005|Overall Study|Sponsor Decision|3|||
126555005|NCT01890967|455324054|FG000|Overall Study|Withdrawal by Subject|3|||
126555006|NCT01890967|455324055|FG001|Overall Study|Withdrawal by Subject|4|||
126555007|NCT01890967|455324056|FG002|Overall Study|Withdrawal by Subject|2|||
126555008|NCT01890967|455324057|FG003|Overall Study|Withdrawal by Subject|3|||
126555009|NCT01890967|455324058|FG004|Overall Study|Withdrawal by Subject|3|||
126555010|NCT01890967|455324059|FG005|Overall Study|Withdrawal by Subject|1|||
126555011|NCT01383993|455324061|FG000|Overall Study|Adverse Event|1|||
126555012|NCT01383993|455324062|FG001|Overall Study|Adverse Event|1|||
126555013|NCT01383993|455324063|FG002|Overall Study|Adverse Event|0|||
126555014|NCT01383993|455324061|FG000|Overall Study|Withdrawal by Subject|0|||
126555015|NCT01383993|455324062|FG001|Overall Study|Withdrawal by Subject|0|||
126555016|NCT01383993|455324063|FG002|Overall Study|Withdrawal by Subject|1|||
126555017|NCT01383993|455324061|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
126555018|NCT01383993|455324062|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
126555019|NCT01383993|455324063|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
126719748|NCT04333433|455923122|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
126719749|NCT04333433|455923123|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
126719750|NCT00320385|455923124|FG000|Overall Study|Lost to Follow-up|7|||
126719751|NCT00320385|455923125|FG001|Overall Study|Lost to Follow-up|10|||
126719752|NCT00320385|455923124|FG000|Overall Study|Withdrawal by Subject|6|||
126719753|NCT00320385|455923125|FG001|Overall Study|Withdrawal by Subject|7|||
126719754|NCT00320385|455923124|FG000|Overall Study|Sponsor Terminated Study|2|||
126719755|NCT00320385|455923125|FG001|Overall Study|Sponsor Terminated Study|1|||
126719756|NCT00320385|455923124|FG000|Overall Study|Investigator Decision|0|||
126719757|NCT00320385|455923125|FG001|Overall Study|Investigator Decision|1|||
126719758|NCT00320385|455923124|FG000|Overall Study|Death|1|||
126719759|NCT00320385|455923125|FG001|Overall Study|Death|2|||
126719760|NCT00320385|455923124|FG000|Overall Study|Serious Adverse Event|1|||
126719761|NCT00320385|455923125|FG001|Overall Study|Serious Adverse Event|0|||
126719762|NCT00320385|455923124|FG000|Overall Study|Withdrew Consent|1|||
126719763|NCT00320385|455923125|FG001|Overall Study|Withdrew Consent|0|||
126719764|NCT00320385|455923124|FG000|Overall Study|Adverse Event|0|||
126719765|NCT00320385|455923125|FG001|Overall Study|Adverse Event|1|||
126719766|NCT03382899|455923131|FG000|Overall Study|Ineligibility Determined|0|||
126719767|NCT03382899|455923132|FG001|Overall Study|Ineligibility Determined|1|||
126555020|NCT02561455|455324066|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
126555021|NCT02561455|455324067|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
126555022|NCT02561455|455324068|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
126719768|NCT03382899|455923131|FG000|Overall Study|Lost to Follow-up|0|||
126719769|NCT03382899|455923132|FG001|Overall Study|Lost to Follow-up|1|||
126395915|NCT02754141|454744448|FG014|Overall Study|Other reasons|0|||
126395916|NCT02754141|454744449|FG015|Overall Study|Other reasons|0|||
126555023|NCT02561455|455324069|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
126555024|NCT02561455|455324066|FG000|Overall Study|Withdrawal by Subject|1|||
126719770|NCT03382899|455923131|FG000|Overall Study|Sponsor's decision|31|||
126555025|NCT02561455|455324067|FG001|Overall Study|Withdrawal by Subject|0|||
126555026|NCT02561455|455324068|FG002|Overall Study|Withdrawal by Subject|1|||
126555027|NCT02561455|455324069|FG003|Overall Study|Withdrawal by Subject|0|||
126555028|NCT02561455|455324066|FG000|Overall Study|Disease Progression|0|||
126555029|NCT02561455|455324067|FG001|Overall Study|Disease Progression|1|||
126555030|NCT02561455|455324068|FG002|Overall Study|Disease Progression|0|||
126555031|NCT02561455|455324069|FG003|Overall Study|Disease Progression|0|||
126555032|NCT03685708|455324078|FG000|Overall Study|Withdrawal by Subject|0|||
126555033|NCT03685708|455324079|FG001|Overall Study|Withdrawal by Subject|0|||
126555034|NCT03685708|455324080|FG002|Overall Study|Withdrawal by Subject|1|||
126555035|NCT03685708|455324078|FG000|Overall Study|Screen Fail|0|||
126555036|NCT03685708|455324079|FG001|Overall Study|Screen Fail|1|||
126555037|NCT03685708|455324080|FG002|Overall Study|Screen Fail|1|||
126555038|NCT03685708|455324078|FG000|Overall Study|COVID 19 Pandemic|1|||
126555039|NCT03685708|455324079|FG001|Overall Study|COVID 19 Pandemic|1|||
126555040|NCT03685708|455324080|FG002|Overall Study|COVID 19 Pandemic|6|||
126555041|NCT03685708|455324078|FG000|Overall Study|Disease Progression|0|||
126555042|NCT03685708|455324079|FG001|Overall Study|Disease Progression|0|||
126555043|NCT03685708|455324080|FG002|Overall Study|Disease Progression|1|||
126555044|NCT03249376|455324086|FG000|Overall Study|Adverse Event|11|||
126555045|NCT03249376|455324087|FG001|Overall Study|Adverse Event|5|||
126555046|NCT03249376|455324086|FG000|Overall Study|Lack of Efficacy|2|||
126555047|NCT03249376|455324087|FG001|Overall Study|Lack of Efficacy|4|||
126555048|NCT03249376|455324086|FG000|Overall Study|Protocol Violation|3|||
126555049|NCT03249376|455324087|FG001|Overall Study|Protocol Violation|2|||
126555050|NCT03249376|455324086|FG000|Overall Study|Physician Decision|0|||
126555051|NCT03249376|455324087|FG001|Overall Study|Physician Decision|2|||
126555052|NCT03249376|455324086|FG000|Overall Study|Withdrawal by Subject|3|||
126555053|NCT03249376|455324087|FG001|Overall Study|Withdrawal by Subject|9|||
126719771|NCT03382899|455923132|FG001|Overall Study|Sponsor's decision|28|||
126719772|NCT03382899|455923131|FG000|Overall Study|Withdrawal by Subject|0|||
126719773|NCT03382899|455923132|FG001|Overall Study|Withdrawal by Subject|5|||
126719774|NCT01355068|455923133|FG000|First Intervention Period|Adverse Event|0|||
126719775|NCT01355068|455923134|FG001|First Intervention Period|Adverse Event|1|||
126719776|NCT01355068|455923133|FG000|First Intervention Period|Withdrawal by Subject|0|||
126719777|NCT01355068|455923134|FG001|First Intervention Period|Withdrawal by Subject|1|||
126719778|NCT00524745|455923135|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
126719779|NCT00524745|455923136|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
126719780|NCT00524745|455923137|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
126719781|NCT00524745|455923138|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
126719782|NCT00540449|455923139|FG000|Overall Study|Adverse Event|12|||
126719783|NCT00540449|455923140|FG001|Overall Study|Adverse Event|32|||
126719784|NCT00540449|455923139|FG000|Overall Study|Sponsor's Decision|1|||
126719785|NCT00540449|455923140|FG001|Overall Study|Sponsor's Decision|1|||
126719786|NCT00540449|455923139|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
126719787|NCT00540449|455923140|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
126719788|NCT00540449|455923139|FG000|Overall Study|Lost to Follow-up|19|||
126719789|NCT00540449|455923140|FG001|Overall Study|Lost to Follow-up|17|||
126719790|NCT00540449|455923139|FG000|Overall Study|Subject Non-Compliant|7|||
126719791|NCT00540449|455923140|FG001|Overall Study|Subject Non-Compliant|5|||
126719792|NCT00540449|455923139|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
126719793|NCT00540449|455923140|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
126719794|NCT00540449|455923139|FG000|Overall Study|Withdrawal by Subject|10|||
126719795|NCT00540449|455923140|FG001|Overall Study|Withdrawal by Subject|10|||
126719796|NCT00540449|455923139|FG000|Overall Study|Other|1|||
126719797|NCT00540449|455923140|FG001|Overall Study|Other|4|||
126719798|NCT00872170|455923141|FG000|Overall Study|Adverse Event|1|||
126719799|NCT00872170|455923142|FG001|Overall Study|Adverse Event|0|||
126719800|NCT01721408|455923143|FG000|Overall Study|Adverse Event|6|||
126719801|NCT01721408|455923144|FG001|Overall Study|Adverse Event|1|||
126719802|NCT01721408|455923143|FG000|Overall Study|Death|1|||
126719803|NCT01721408|455923144|FG001|Overall Study|Death|0|||
126719804|NCT01721408|455923143|FG000|Overall Study|Insufficient clinical response|15|||
126719805|NCT01721408|455923144|FG001|Overall Study|Insufficient clinical response|6|||
126719806|NCT01721408|455923143|FG000|Overall Study|No longer willing to participate study|9|||
126719807|NCT01721408|455923144|FG001|Overall Study|No longer willing to participate study|10|||
126719808|NCT01721408|455923143|FG000|Overall Study|Protocol Violation|0|||
126719809|NCT01721408|455923144|FG001|Overall Study|Protocol Violation|2|||
126719810|NCT01721408|455923143|FG000|Overall Study|Other|3|||
126719811|NCT01721408|455923144|FG001|Overall Study|Other|3|||
126719812|NCT01721408|455923143|FG000|Overall Study|Lost to Follow-up|1|||
126719813|NCT01721408|455923144|FG001|Overall Study|Lost to Follow-up|2|||
126719814|NCT01721408|455923143|FG000|Overall Study|Does not meet entrance criteria|1|||
126719815|NCT01721408|455923144|FG001|Overall Study|Does not meet entrance criteria|0|||
126719816|NCT02426658|455923145|FG000|Overall Study|Withdrawal by Subject|1|||
126719817|NCT02426658|455923145|FG000|Overall Study|Patient expired before treatment|2|||
126719818|NCT00524316|455923146|FG000|Overall Study|Withdrawal by Subject|2|||
126469943|NCT00734474|455023516|FG006|Overall Study|Lack of Efficacy|0|||
126469944|NCT00734474|455023517|FG007|Overall Study|Lack of Efficacy|4|||
126469945|NCT00734474|455023518|FG008|Overall Study|Lack of Efficacy|6|||
126469946|NCT02570074|455023525|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
126469947|NCT02570074|455023526|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
126469948|NCT02497612|455023527|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
126469949|NCT02497612|455023528|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
126469950|NCT02497612|455023529|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
126469951|NCT02497612|455023530|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
126469952|NCT02497612|455023527|FG000|Overall Study|Participant's request|2|||
126469953|NCT02497612|455023528|FG001|Overall Study|Participant's request|3|||
126469954|NCT02497612|455023529|FG002|Overall Study|Participant's request|4|||
126469955|NCT02497612|455023530|FG003|Overall Study|Participant's request|1|||
126469956|NCT02497612|455023527|FG000|Overall Study|Investigator's judgement|1|||
126469957|NCT02497612|455023528|FG001|Overall Study|Investigator's judgement|0|||
126469958|NCT02497612|455023529|FG002|Overall Study|Investigator's judgement|0|||
126469959|NCT02497612|455023530|FG003|Overall Study|Investigator's judgement|2|||
126469960|NCT02497612|455023527|FG000|Overall Study|Adverse Event|3|||
126469961|NCT02497612|455023528|FG001|Overall Study|Adverse Event|1|||
126469962|NCT02497612|455023529|FG002|Overall Study|Adverse Event|4|||
126469963|NCT02497612|455023530|FG003|Overall Study|Adverse Event|1|||
126469964|NCT02497612|455023527|FG000|Overall Study|Lost to Follow-up|1|||
126469965|NCT02497612|455023528|FG001|Overall Study|Lost to Follow-up|1|||
126469966|NCT02497612|455023529|FG002|Overall Study|Lost to Follow-up|0|||
126469967|NCT02497612|455023530|FG003|Overall Study|Lost to Follow-up|1|||
126469968|NCT02497612|455023527|FG000|Overall Study|Other unspecified|1|||
126469969|NCT02497612|455023528|FG001|Overall Study|Other unspecified|1|||
126469970|NCT02497612|455023529|FG002|Overall Study|Other unspecified|2|||
126469971|NCT02497612|455023530|FG003|Overall Study|Other unspecified|0|||
126469972|NCT02497612|455023527|FG000|Overall Study|Not eligible|1|||
126469973|NCT02497612|455023528|FG001|Overall Study|Not eligible|0|||
126469974|NCT02497612|455023529|FG002|Overall Study|Not eligible|0|||
126469975|NCT02497612|455023530|FG003|Overall Study|Not eligible|1|||
126469976|NCT05021081|455023533|FG000|Phase 2|Subject enrolled in error|1|||
126469977|NCT05021081|455023534|FG001|Phase 2|Subject enrolled in error|1|||
126469978|NCT05021081|455023535|FG002|Phase 2|Subject enrolled in error|0|||
126469979|NCT00369122|455023536|FG000|Overall Study|Ineligible|10|||
126469980|NCT00369122|455023536|FG000|Overall Study|No protocol treatment|1|||
126469981|NCT02651467|455023537|FG000|Overall Study|Withdrawal by Subject|0|||
126469982|NCT02651467|455023538|FG001|Overall Study|Withdrawal by Subject|0|||
126469983|NCT02651467|455023539|FG002|Overall Study|Withdrawal by Subject|2|||
126469984|NCT02651467|455023537|FG000|Overall Study|Other (Not specified)|1|||
126469985|NCT02651467|455023538|FG001|Overall Study|Other (Not specified)|0|||
126469986|NCT02651467|455023539|FG002|Overall Study|Other (Not specified)|2|||
126719819|NCT00524316|455923146|FG000|Overall Study|Adverse Event|7|||
126719820|NCT00524316|455923146|FG000|Overall Study|Disease Progression|7|||
126719821|NCT01199263|455923147|FG000|Overall Study|Ineligible|0|||
126719822|NCT01199263|455923148|FG001|Overall Study|Ineligible|2|||
126719823|NCT01199263|455923147|FG000|Overall Study|Never Treated|6|||
126719824|NCT01199263|455923148|FG001|Overall Study|Never Treated|0|||
126719825|NCT01402284|455923149|FG000|Overall Study|Withdrawal consent|2|||
126719826|NCT01402284|455923149|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
126719827|NCT01402284|455923149|FG000|Overall Study|Physician Decision|1|||
126719828|NCT01402284|455923149|FG000|Overall Study|Disease progression on study|10|||
126719829|NCT02928406|455923152|FG000|Overall Study|Death|780|||
126719830|NCT02928406|455923152|FG000|Overall Study|Progressive disease|3|||
126719831|NCT02928406|455923152|FG000|Overall Study|Lost to Follow-up|49|||
126719832|NCT02928406|455923152|FG000|Overall Study|Non-compliance|2|||
126719833|NCT02928406|455923152|FG000|Overall Study|Withdrawal by Subject|40|||
126719834|NCT02928406|455923152|FG000|Overall Study|Study terminated by sponsor|57|||
126719835|NCT02928406|455923152|FG000|Overall Study|Physician Decision|1|||
126719836|NCT02928406|455923152|FG000|Overall Study|Various reasons|72|||
126719837|NCT02149836|455923153|FG000|Overall Study|Withdrawal by Subject|1|||
126719838|NCT04937816|455923154|FG000|Overall Study|Study drug stopped, reason missing|5|||
126469987|NCT00004635|455023540|FG000|Period One|refused|2|||
126469988|NCT00004635|455023541|FG001|Period One|refused|1|||
126469989|NCT00004635|455023540|FG000|Period One|Withdrawal by Subject|1|||
126719839|NCT04937816|455923155|FG001|Overall Study|Study drug stopped, reason missing|3|||
126719840|NCT04937816|455923156|FG002|Overall Study|Study drug stopped, reason missing|4|||
126719841|NCT04937816|455923157|FG003|Overall Study|Study drug stopped, reason missing|6|||
126719842|NCT04937816|455923158|FG004|Overall Study|Study drug stopped, reason missing|1|||
126719843|NCT04937816|455923159|FG005|Overall Study|Study drug stopped, reason missing|0|||
126719844|NCT04937816|455923160|FG006|Overall Study|Study drug stopped, reason missing|0|||
126719845|NCT04937816|455923154|FG000|Overall Study|Other than stated below|173|||
126469990|NCT00004635|455023541|FG001|Period One|Withdrawal by Subject|1|||
126469991|NCT00004635|455023540|FG000|Period One|Protocol Violation|1|||
126469992|NCT00004635|455023541|FG001|Period One|Protocol Violation|0|||
126771706|NCT01222715|456119936|FG000|Overall Study|Refusal of further protocol therapy|0|||
126771707|NCT01222715|456119937|FG001|Overall Study|Refusal of further protocol therapy|4|||
126771708|NCT01222715|456119936|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
126771709|NCT01222715|456119937|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
126771710|NCT01222715|456119936|FG000|Overall Study|Ineligible|0|||
126771711|NCT01222715|456119937|FG001|Overall Study|Ineligible|1|||
126771712|NCT01222715|456119936|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
126771713|NCT01222715|456119937|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
126771714|NCT03555890|456119946|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126771715|NCT03555890|456119947|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126771716|NCT03555890|456119948|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126771717|NCT03555890|456119949|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
126771718|NCT03372369|456119950|FG000|Qualification Period|Withdrawal by Subject|16|||
126771719|NCT03372369|456119951|FG001|Qualification Period|Withdrawal by Subject|13|||
126771720|NCT03372369|456119950|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
126771721|NCT03372369|456119951|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
126771722|NCT03372369|456119950|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
126771723|NCT03372369|456119951|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
126771724|NCT02239601|456119952|FG000|Overall Study|Withdrawal by Subject|3|||
126771725|NCT02239601|456119953|FG001|Overall Study|Withdrawal by Subject|4|||
126771726|NCT02239601|456119952|FG000|Overall Study|Protocol Violation|4|||
126771727|NCT02239601|456119953|FG001|Overall Study|Protocol Violation|2|||
126771728|NCT01508325|456119954|FG000|Overall Study|Withdrawal by Subject|8|||
126771729|NCT01508325|456119955|FG001|Overall Study|Withdrawal by Subject|9|||
126469993|NCT00004635|455023540|FG000|Period One|PSA did not go <5 ng/mL|1|||
126469994|NCT00004635|455023541|FG001|Period One|PSA did not go <5 ng/mL|0|||
126469995|NCT00004635|455023540|FG000|Period One|second malignancy|1|||
126469996|NCT00004635|455023541|FG001|Period One|second malignancy|0|||
126469997|NCT00004635|455023540|FG000|Period One|progressed|0|||
126771730|NCT01508325|456119954|FG000|Overall Study|Protocol Violation|0|||
126771731|NCT01508325|456119955|FG001|Overall Study|Protocol Violation|3|||
126771732|NCT01508325|456119954|FG000|Overall Study|Physician Decision|2|||
126771733|NCT01508325|456119955|FG001|Overall Study|Physician Decision|1|||
126771734|NCT01508325|456119954|FG000|Overall Study|Adverse Event|1|||
126771735|NCT01508325|456119955|FG001|Overall Study|Adverse Event|0|||
126771736|NCT01508325|456119954|FG000|Overall Study|Lost to Follow-up|5|||
126771737|NCT01508325|456119955|FG001|Overall Study|Lost to Follow-up|6|||
126771738|NCT01508325|456119954|FG000|Overall Study|Other|2|||
126771739|NCT01508325|456119955|FG001|Overall Study|Other|2|||
126771740|NCT04682639|456119956|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
126771741|NCT04682639|456119957|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
126771742|NCT04682639|456119958|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
126771743|NCT04682639|456119959|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
126771744|NCT04682639|456119960|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
126771745|NCT04682639|456119956|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
126771746|NCT04682639|456119957|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
126771747|NCT04682639|456119958|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
126771748|NCT04682639|456119959|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126771749|NCT04682639|456119960|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126771750|NCT04682639|456119956|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
126771751|NCT04682639|456119957|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126771752|NCT04682639|456119958|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126771753|NCT04682639|456119959|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126771754|NCT04682639|456119960|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126771755|NCT04682639|456119956|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
126771756|NCT04682639|456119957|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
126395917|NCT02754141|454744450|FG016|Overall Study|Other reasons|0|||
126395918|NCT02754141|454744451|FG017|Overall Study|Other reasons|0|||
126395919|NCT02754141|454744434|FG000|Overall Study|Completed treatment as per protocol|0|||
126395920|NCT02754141|454744435|FG001|Overall Study|Completed treatment as per protocol|1|||
126395921|NCT02754141|454744436|FG002|Overall Study|Completed treatment as per protocol|0|||
126395922|NCT02754141|454744437|FG003|Overall Study|Completed treatment as per protocol|0|||
126395923|NCT02754141|454744438|FG004|Overall Study|Completed treatment as per protocol|0|||
126395924|NCT02754141|454744439|FG005|Overall Study|Completed treatment as per protocol|0|||
126469998|NCT00004635|455023541|FG001|Period One|progressed|2|||
126469999|NCT00004635|455023540|FG000|Period One|health problem|0|||
126470000|NCT00004635|455023541|FG001|Period One|health problem|1|||
126395925|NCT02754141|454744440|FG006|Overall Study|Completed treatment as per protocol|0|||
126395926|NCT02754141|454744441|FG007|Overall Study|Completed treatment as per protocol|0|||
126470001|NCT00004635|455023540|FG000|Period One|discrepancy in data entry|0|||
126470002|NCT00004635|455023541|FG001|Period One|discrepancy in data entry|1|||
126395927|NCT02754141|454744442|FG008|Overall Study|Completed treatment as per protocol|0|||
126395928|NCT02754141|454744443|FG009|Overall Study|Completed treatment as per protocol|0|||
126395929|NCT02754141|454744444|FG010|Overall Study|Completed treatment as per protocol|0|||
126395930|NCT02754141|454744445|FG011|Overall Study|Completed treatment as per protocol|0|||
126395931|NCT02754141|454744446|FG012|Overall Study|Completed treatment as per protocol|1|||
126395932|NCT02754141|454744447|FG013|Overall Study|Completed treatment as per protocol|0|||
126395933|NCT02754141|454744448|FG014|Overall Study|Completed treatment as per protocol|0|||
126395934|NCT02754141|454744449|FG015|Overall Study|Completed treatment as per protocol|0|||
126395935|NCT02754141|454744450|FG016|Overall Study|Completed treatment as per protocol|0|||
126395936|NCT02754141|454744451|FG017|Overall Study|Completed treatment as per protocol|0|||
126395937|NCT02754141|454744434|FG000|Overall Study|Not completing monotherapy|0|||
126395938|NCT02754141|454744435|FG001|Overall Study|Not completing monotherapy|0|||
126395939|NCT02754141|454744436|FG002|Overall Study|Not completing monotherapy|0|||
126395940|NCT02754141|454744437|FG003|Overall Study|Not completing monotherapy|0|||
126395941|NCT02754141|454744438|FG004|Overall Study|Not completing monotherapy|0|||
126395942|NCT02754141|454744439|FG005|Overall Study|Not completing monotherapy|0|||
126395943|NCT02754141|454744440|FG006|Overall Study|Not completing monotherapy|0|||
126395944|NCT02754141|454744441|FG007|Overall Study|Not completing monotherapy|0|||
126555054|NCT03249376|455324086|FG000|Overall Study|LTFU|2|||
126555055|NCT03249376|455324087|FG001|Overall Study|LTFU|1|||
126555056|NCT00627042|455324088|FG000|Overall Study|Withdrawal by Subject|2|||
126555057|NCT01154036|455324089|FG000|Phase I|Physician Decision|0|||
126555058|NCT01154036|455324090|FG001|Phase I|Physician Decision|1|||
126555059|NCT01154036|455324091|FG002|Phase I|Physician Decision|0|||
126555060|NCT01154036|455324092|FG003|Phase I|Physician Decision|0|||
126555061|NCT01154036|455324093|FG004|Phase I|Physician Decision|0|||
126555062|NCT01154036|455324094|FG005|Phase I|Physician Decision|0|||
126771757|NCT04682639|456119958|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
126771758|NCT04682639|456119959|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
126395945|NCT02754141|454744442|FG008|Overall Study|Not completing monotherapy|0|||
126395946|NCT02754141|454744443|FG009|Overall Study|Not completing monotherapy|0|||
126395947|NCT02754141|454744444|FG010|Overall Study|Not completing monotherapy|0|||
126395948|NCT02754141|454744445|FG011|Overall Study|Not completing monotherapy|0|||
126395949|NCT02754141|454744446|FG012|Overall Study|Not completing monotherapy|0|||
126395950|NCT02754141|454744447|FG013|Overall Study|Not completing monotherapy|1|||
126395951|NCT02754141|454744448|FG014|Overall Study|Not completing monotherapy|0|||
126395952|NCT02754141|454744449|FG015|Overall Study|Not completing monotherapy|0|||
126395953|NCT02754141|454744450|FG016|Overall Study|Not completing monotherapy|0|||
126395954|NCT02754141|454744451|FG017|Overall Study|Not completing monotherapy|0|||
126395955|NCT03361189|454744452|FG000|Overall Study|Received heart transplant|1|||
126395956|NCT03361189|454744453|FG001|Overall Study|Received heart transplant|0|||
126395957|NCT03361189|454744452|FG000|Overall Study|Pacemake replacement|0|||
126395958|NCT03361189|454744453|FG001|Overall Study|Pacemake replacement|1|||
126395959|NCT03344549|454744458|FG000|Overall Study|Withdrawal by Subject|3|||
126395960|NCT03344549|454744459|FG001|Overall Study|Withdrawal by Subject|2|||
126395961|NCT03344549|454744458|FG000|Overall Study|Dialysis|2|||
126395962|NCT03344549|454744459|FG001|Overall Study|Dialysis|0|||
126395963|NCT03344549|454744458|FG000|Overall Study|Cancer|1|||
126395964|NCT03344549|454744459|FG001|Overall Study|Cancer|0|||
126395965|NCT03344549|454744458|FG000|Overall Study|Lack of electronic device|1|||
126395966|NCT03344549|454744459|FG001|Overall Study|Lack of electronic device|0|||
126395967|NCT03344549|454744458|FG000|Overall Study|Transportation difficulty|0|||
126395968|NCT03344549|454744459|FG001|Overall Study|Transportation difficulty|13|||
126395969|NCT02323126|454744460|FG000|Overall Study|Patient / guardian decision|0|||
126395970|NCT02323126|454744461|FG001|Overall Study|Patient / guardian decision|1|||
126395971|NCT02323126|454744462|FG002|Overall Study|Patient / guardian decision|2|||
126395972|NCT02323126|454744460|FG000|Overall Study|Progressive disease|14|||
126395973|NCT02323126|454744461|FG001|Overall Study|Progressive disease|8|||
126395974|NCT02323126|454744462|FG002|Overall Study|Progressive disease|14|||
126395975|NCT02323126|454744460|FG000|Overall Study|Physician Decision|0|||
126395976|NCT02323126|454744461|FG001|Overall Study|Physician Decision|1|||
126395977|NCT02323126|454744462|FG002|Overall Study|Physician Decision|3|||
126395978|NCT02323126|454744460|FG000|Overall Study|Death|1|||
126395979|NCT02323126|454744461|FG001|Overall Study|Death|1|||
126395980|NCT02323126|454744462|FG002|Overall Study|Death|4|||
126395981|NCT02323126|454744460|FG000|Overall Study|Adverse Event|3|||
126395982|NCT02323126|454744461|FG001|Overall Study|Adverse Event|5|||
126395983|NCT02323126|454744462|FG002|Overall Study|Adverse Event|7|||
126395984|NCT03333252|454744463|FG000|Overall Study|Adverse Event|10|||
126395985|NCT03333252|454744464|FG001|Overall Study|Adverse Event|6|||
126395986|NCT03333252|454744465|FG002|Overall Study|Adverse Event|5|||
126395987|NCT03333252|454744466|FG003|Overall Study|Adverse Event|2|||
126395988|NCT03333252|454744463|FG000|Overall Study|Death|1|||
126395989|NCT03333252|454744464|FG001|Overall Study|Death|3|||
126395990|NCT03333252|454744465|FG002|Overall Study|Death|0|||
126395991|NCT03333252|454744466|FG003|Overall Study|Death|0|||
126555063|NCT01154036|455324095|FG006|Phase I|Physician Decision|0|||
126771759|NCT04682639|456119960|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
126771760|NCT04682639|456119956|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
126771761|NCT04682639|456119957|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
126771762|NCT04682639|456119958|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
126771763|NCT04682639|456119959|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
126771764|NCT04682639|456119960|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
126771765|NCT04682639|456119956|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
126771766|NCT04682639|456119957|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
126771767|NCT04682639|456119958|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
126771768|NCT04682639|456119959|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126771769|NCT04682639|456119960|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126771770|NCT04682639|456119956|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
126771771|NCT04682639|456119957|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
126771772|NCT04682639|456119958|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
126771773|NCT04682639|456119959|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
126771774|NCT04682639|456119960|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
126771775|NCT04682639|456119956|FG000|OLE Period (28 Weeks)|Other|1|||
126771776|NCT04682639|456119957|FG001|OLE Period (28 Weeks)|Other|2|||
126771777|NCT04682639|456119958|FG002|OLE Period (28 Weeks)|Other|0|||
126771778|NCT04682639|456119959|FG003|OLE Period (28 Weeks)|Other|0|||
126771779|NCT04682639|456119960|FG004|OLE Period (28 Weeks)|Other|1|||
126771780|NCT04682639|456119956|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
126771781|NCT04682639|456119957|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
126771782|NCT04682639|456119958|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
126771783|NCT04682639|456119959|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
126771784|NCT04682639|456119960|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
126771785|NCT04682639|456119956|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
126771786|NCT04682639|456119957|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
126771787|NCT04682639|456119958|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126771788|NCT04682639|456119959|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126771789|NCT04682639|456119960|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
126771790|NCT04682639|456119956|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
126771791|NCT04682639|456119957|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
126771792|NCT04682639|456119958|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126771793|NCT04682639|456119959|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126470003|NCT00004635|455023540|FG000|Period Two|progression|2|||
126470004|NCT00004635|455023541|FG001|Period Two|progression|3|||
126470005|NCT00004635|455023540|FG000|Period Two|Adverse Event|1|||
126470006|NCT00004635|455023541|FG001|Period Two|Adverse Event|0|||
126470007|NCT00004635|455023540|FG000|Period Two|refused|0|||
126470008|NCT00004635|455023541|FG001|Period Two|refused|2|||
126470009|NCT00004635|455023540|FG000|Period Two|health problem|1|||
126470010|NCT00004635|455023541|FG001|Period Two|health problem|1|||
126771794|NCT04682639|456119960|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
126771795|NCT04682639|456119956|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
126771796|NCT04682639|456119957|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
126771797|NCT04682639|456119958|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
126771798|NCT04682639|456119959|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
126771799|NCT04682639|456119960|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
126771800|NCT00883740|456119961|FG000|First Intervention|Lost to Follow-up|1|||
126771801|NCT00883740|456119962|FG001|First Intervention|Lost to Follow-up|0|||
126771802|NCT00883740|456119961|FG000|First Intervention|No longer willing to participate|2|||
126771803|NCT00883740|456119962|FG001|First Intervention|No longer willing to participate|0|||
126771804|NCT00883740|456119961|FG000|First Intervention|Protocol Violation|3|||
126771805|NCT00883740|456119962|FG001|First Intervention|Protocol Violation|6|||
126771806|NCT00883740|456119961|FG000|First Intervention|Adverse Event|1|||
126771807|NCT00883740|456119962|FG001|First Intervention|Adverse Event|2|||
126771808|NCT00883740|456119961|FG000|Second Intervention|Protocol Violation|1|||
126771809|NCT00883740|456119962|FG001|Second Intervention|Protocol Violation|0|||
126771810|NCT00883740|456119961|FG000|Second Intervention|No longer willing to participate|0|||
126771811|NCT00883740|456119962|FG001|Second Intervention|No longer willing to participate|1|||
126771812|NCT01392170|456119965|FG000|Overall Study|Withdrawal by Subject|1|||
126771813|NCT01392170|456119965|FG000|Overall Study|Ineligible|1|||
126470011|NCT00004635|455023540|FG000|Period Two|travel issues|0|||
126470012|NCT00004635|455023541|FG001|Period Two|travel issues|1|||
126470013|NCT00004635|455023540|FG000|Period Two|secondary malignancy|1|||
126470014|NCT00004635|455023541|FG001|Period Two|secondary malignancy|1|||
126771814|NCT03543046|456119969|FG000|Overall Study|Adverse Event|1|||
126771815|NCT03543046|456119970|FG001|Overall Study|Adverse Event|1|||
126771816|NCT03543046|456119969|FG000|Overall Study|Physician Decision|1|||
126771817|NCT03543046|456119970|FG001|Overall Study|Physician Decision|1|||
126771818|NCT03543046|456119969|FG000|Overall Study|Protocol Violation|1|||
126771819|NCT03543046|456119970|FG001|Overall Study|Protocol Violation|0|||
126470015|NCT00004635|455023540|FG000|Period Two|Lost to Follow-up|1|||
126470016|NCT00004635|455023541|FG001|Period Two|Lost to Follow-up|0|||
126395992|NCT03333252|454744463|FG000|Overall Study|Lack of Efficacy|8|||
126395993|NCT03333252|454744464|FG001|Overall Study|Lack of Efficacy|4|||
126395994|NCT03333252|454744465|FG002|Overall Study|Lack of Efficacy|0|||
126395995|NCT03333252|454744466|FG003|Overall Study|Lack of Efficacy|7|||
126395996|NCT03333252|454744463|FG000|Overall Study|Lost to Follow-up|0|||
126395997|NCT03333252|454744464|FG001|Overall Study|Lost to Follow-up|5|||
126395998|NCT03333252|454744465|FG002|Overall Study|Lost to Follow-up|9|||
126395999|NCT03333252|454744466|FG003|Overall Study|Lost to Follow-up|3|||
126396000|NCT03333252|454744463|FG000|Overall Study|Withdrawal by Subject|14|||
126396001|NCT03333252|454744464|FG001|Overall Study|Withdrawal by Subject|24|||
126396002|NCT03333252|454744465|FG002|Overall Study|Withdrawal by Subject|11|||
126396003|NCT03333252|454744466|FG003|Overall Study|Withdrawal by Subject|17|||
126396004|NCT00666588|454744470|FG000|Overall Study|ineligible|2|||
126396005|NCT00666588|454744471|FG001|Overall Study|ineligible|0|||
126396006|NCT00666588|454744472|FG002|Overall Study|ineligible|0|||
126396007|NCT00666588|454744473|FG003|Overall Study|ineligible|2|||
126396008|NCT00666588|454744470|FG000|Overall Study|inevaluable|2|||
126396009|NCT00666588|454744471|FG001|Overall Study|inevaluable|0|||
126396010|NCT00666588|454744472|FG002|Overall Study|inevaluable|0|||
126396011|NCT00666588|454744473|FG003|Overall Study|inevaluable|0|||
126396012|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
126396013|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
126719846|NCT04937816|455923155|FG001|Overall Study|Other than stated below|143|||
126396014|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
126396015|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
126396016|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
126396017|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
126396018|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
126396019|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
126396020|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
126396021|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
126719847|NCT04937816|455923156|FG002|Overall Study|Other than stated below|125|||
126396022|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Other|1|||
126396023|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Other|1|||
126396024|NCT02075047|454744474|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
126396025|NCT02075047|454744475|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
126396026|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
126396027|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
126396028|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
126719848|NCT04937816|455923157|FG003|Overall Study|Other than stated below|44|||
126719849|NCT04937816|455923158|FG004|Overall Study|Other than stated below|45|||
126719850|NCT04937816|455923159|FG005|Overall Study|Other than stated below|28|||
126719851|NCT04937816|455923160|FG006|Overall Study|Other than stated below|31|||
126719852|NCT04937816|455923154|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
126719853|NCT04937816|455923155|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
126719854|NCT04937816|455923156|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
126719855|NCT04937816|455923157|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
126719856|NCT04937816|455923158|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
126719857|NCT04937816|455923159|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
126719858|NCT04937816|455923160|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
126719859|NCT04937816|455923154|FG000|Overall Study|Lost to Follow-up|15|||
126719860|NCT04937816|455923155|FG001|Overall Study|Lost to Follow-up|9|||
126719861|NCT04937816|455923156|FG002|Overall Study|Lost to Follow-up|6|||
126719862|NCT04937816|455923157|FG003|Overall Study|Lost to Follow-up|6|||
126719863|NCT04937816|455923158|FG004|Overall Study|Lost to Follow-up|16|||
126719864|NCT04937816|455923159|FG005|Overall Study|Lost to Follow-up|11|||
126719865|NCT04937816|455923160|FG006|Overall Study|Lost to Follow-up|17|||
126719866|NCT04937816|455923154|FG000|Overall Study|Protocol Violation|15|||
126719867|NCT04937816|455923155|FG001|Overall Study|Protocol Violation|15|||
126719868|NCT04937816|455923156|FG002|Overall Study|Protocol Violation|12|||
126719869|NCT04937816|455923157|FG003|Overall Study|Protocol Violation|30|||
126719870|NCT04937816|455923158|FG004|Overall Study|Protocol Violation|24|||
126719871|NCT04937816|455923159|FG005|Overall Study|Protocol Violation|5|||
126719872|NCT04937816|455923160|FG006|Overall Study|Protocol Violation|5|||
126719873|NCT04937816|455923154|FG000|Overall Study|Adverse Event|303|||
126719874|NCT04937816|455923155|FG001|Overall Study|Adverse Event|267|||
126719875|NCT04937816|455923156|FG002|Overall Study|Adverse Event|273|||
126396029|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
126396030|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
126396031|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
126396032|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
126396033|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
126396034|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
126396035|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
126396036|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Other|1|||
126396037|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Other|2|||
126396038|NCT02075047|454744474|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
126396039|NCT02075047|454744475|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
126396040|NCT04195438|454744483|FG000|Overall Study|Withdrawal by Subject|1|||
126396041|NCT03006458|454744489|FG000|First Intervention|Unsatisfied Vision|0|||
126396042|NCT03006458|454744490|FG001|First Intervention|Unsatisfied Vision|3|||
126396043|NCT00457821|454744491|FG000|Part 2|Withdrawal by Subject|0|||
126396044|NCT00457821|454744492|FG001|Part 2|Withdrawal by Subject|0|||
126396045|NCT00457821|454744493|FG002|Part 2|Withdrawal by Subject|0|||
126396046|NCT00457821|454744494|FG003|Part 2|Withdrawal by Subject|0|||
126396047|NCT00457821|454744495|FG004|Part 2|Withdrawal by Subject|0|||
126396048|NCT00457821|454744496|FG005|Part 2|Withdrawal by Subject|0|||
126396049|NCT00457821|454744497|FG006|Part 2|Withdrawal by Subject|0|||
126396050|NCT00457821|454744498|FG007|Part 2|Withdrawal by Subject|1|||
126396051|NCT00578877|454744501|FG000|Overall Study|Lost to Follow-up|8|||
126396052|NCT00578877|454744502|FG001|Overall Study|Lost to Follow-up|10|||
126396053|NCT00578877|454744501|FG000|Overall Study|early discontinue|61|||
126396054|NCT00578877|454744502|FG001|Overall Study|early discontinue|101|||
126396055|NCT00578877|454744501|FG000|Overall Study|did not provide follow-up data|12|||
126396056|NCT00578877|454744502|FG001|Overall Study|did not provide follow-up data|17|||
126396057|NCT02437409|454744507|FG000|Overall Study|Withdrawal by Subject|3|||
126396058|NCT02437409|454744507|FG000|Overall Study|Screening failure|12|||
126396059|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
126396060|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
126396061|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
126396062|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
126470017|NCT00004635|455023540|FG000|Period Two|discrepancy in data entry|0|||
126470018|NCT00004635|455023541|FG001|Period Two|discrepancy in data entry|1|||
126470019|NCT02024529|455023544|FG000|Overall Study|Withdrawal by Subject|11|||
126470020|NCT02024529|455023545|FG001|Overall Study|Withdrawal by Subject|21|||
126470021|NCT02024529|455023544|FG000|Overall Study|Lost to Follow-up|2|||
126470022|NCT02024529|455023545|FG001|Overall Study|Lost to Follow-up|4|||
126719876|NCT04937816|455923157|FG003|Overall Study|Adverse Event|553|||
126719877|NCT04937816|455923158|FG004|Overall Study|Adverse Event|575|||
126719878|NCT04937816|455923159|FG005|Overall Study|Adverse Event|343|||
126719879|NCT04937816|455923160|FG006|Overall Study|Adverse Event|337|||
126719880|NCT04937816|455923154|FG000|Overall Study|Not treated|4|||
126719881|NCT04937816|455923155|FG001|Overall Study|Not treated|2|||
126719882|NCT04937816|455923156|FG002|Overall Study|Not treated|2|||
126719883|NCT04937816|455923157|FG003|Overall Study|Not treated|2|||
126719884|NCT04937816|455923158|FG004|Overall Study|Not treated|1|||
126719885|NCT04937816|455923159|FG005|Overall Study|Not treated|4|||
126719886|NCT04937816|455923160|FG006|Overall Study|Not treated|0|||
126719887|NCT00977574|455923165|FG000|Overall Study|Never Treated|4|||
126719888|NCT00977574|455923166|FG001|Overall Study|Never Treated|2|||
126719889|NCT00977574|455923167|FG002|Overall Study|Never Treated|4|||
126719890|NCT05281523|455923168|FG000|Overall Study|Adverse Event|1|||
126719891|NCT05281523|455923169|FG001|Overall Study|Adverse Event|1|||
126719892|NCT05281523|455923168|FG000|Overall Study|Physician Decision|1|||
126719893|NCT05281523|455923169|FG001|Overall Study|Physician Decision|1|||
126719894|NCT05281523|455923168|FG000|Overall Study|Withdrawal by Subject|5|||
126719895|NCT05281523|455923169|FG001|Overall Study|Withdrawal by Subject|15|||
126719896|NCT05281523|455923168|FG000|Overall Study|GCP violations|3|||
126719897|NCT05281523|455923169|FG001|Overall Study|GCP violations|4|||
126719898|NCT05513391|455923170|FG000|Overall Study|Adverse Event|1|||
126719899|NCT05513391|455923171|FG001|Overall Study|Adverse Event|0|||
126719900|NCT05513391|455923170|FG000|Overall Study|Protocol Deviation|0|||
126719901|NCT05513391|455923171|FG001|Overall Study|Protocol Deviation|1|||
126719902|NCT05513391|455923170|FG000|Overall Study|Withdrawal by Subject|3|||
126719903|NCT05513391|455923171|FG001|Overall Study|Withdrawal by Subject|1|||
126396063|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
126396064|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
126396065|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
126719904|NCT05513391|455923170|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126719905|NCT05513391|455923171|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
126719906|NCT05513391|455923170|FG000|Overall Study|Lost to Follow-up|0|||
126719907|NCT05513391|455923171|FG001|Overall Study|Lost to Follow-up|2|||
126719908|NCT05128162|455923172|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
126719909|NCT05128162|455923172|FG000|Overall Study|Physician Decision|1|||
126719910|NCT05183867|455924931|FG000|Overall Study|Withdrawal by Subject|3|||
126719911|NCT05183867|455924932|FG001|Overall Study|Withdrawal by Subject|2|||
126719912|NCT05183867|455924933|FG002|Overall Study|Withdrawal by Subject|0|||
126396066|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
126396067|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
126396068|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
126470023|NCT01426438|455023546|FG000|Overall Study|Lost to Follow-up|1|||
126719913|NCT04491877|455924936|FG000|Overall Study|Protocol Deviation|1|||
126719914|NCT04491877|455924937|FG001|Overall Study|Protocol Deviation|0|||
126719915|NCT04491877|455924938|FG002|Overall Study|Protocol Deviation|2|||
126719916|NCT04491877|455924939|FG003|Overall Study|Protocol Deviation|0|||
126719917|NCT04491877|455924940|FG004|Overall Study|Protocol Deviation|0|||
126719918|NCT04491877|455924941|FG005|Overall Study|Protocol Deviation|0|||
126719919|NCT04491877|455924942|FG006|Overall Study|Protocol Deviation|1|||
126719920|NCT04491877|455924943|FG007|Overall Study|Protocol Deviation|1|||
126719921|NCT04491877|455924944|FG008|Overall Study|Protocol Deviation|0|||
126719922|NCT04491877|455924936|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126719923|NCT04491877|455924937|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126719924|NCT04491877|455924938|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126719925|NCT04491877|455924939|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
126719926|NCT04491877|455924940|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126719927|NCT04491877|455924941|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
126719928|NCT04491877|455924942|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
126719929|NCT04491877|455924943|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
126719930|NCT04491877|455924944|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
126719931|NCT04491877|455924936|FG000|Overall Study|Lost to Follow-up|0|||
126719932|NCT04491877|455924937|FG001|Overall Study|Lost to Follow-up|2|||
126719933|NCT04491877|455924938|FG002|Overall Study|Lost to Follow-up|0|||
126719934|NCT04491877|455924939|FG003|Overall Study|Lost to Follow-up|0|||
126719935|NCT04491877|455924940|FG004|Overall Study|Lost to Follow-up|0|||
126719936|NCT04491877|455924941|FG005|Overall Study|Lost to Follow-up|0|||
126719937|NCT04491877|455924942|FG006|Overall Study|Lost to Follow-up|2|||
126719938|NCT04491877|455924943|FG007|Overall Study|Lost to Follow-up|1|||
126719939|NCT04491877|455924944|FG008|Overall Study|Lost to Follow-up|1|||
126719940|NCT00074412|455924949|FG000|Overall Study|Death|30|||
126719941|NCT00074412|455924950|FG001|Overall Study|Death|26|||
126719942|NCT00074412|455924949|FG000|Overall Study|Lost to Follow-up|52|||
126719943|NCT00074412|455924950|FG001|Overall Study|Lost to Follow-up|58|||
126719944|NCT00418834|455924951|FG000|Overall Study|Adverse Event|16|||
126719945|NCT00418834|455924952|FG001|Overall Study|Adverse Event|9|||
126719946|NCT00418834|455924951|FG000|Overall Study|Lost to Follow-up|0|||
126719947|NCT00418834|455924952|FG001|Overall Study|Lost to Follow-up|1|||
126719948|NCT00418834|455924951|FG000|Overall Study|Protocol Violation|4|||
126719949|NCT00418834|455924952|FG001|Overall Study|Protocol Violation|3|||
126719950|NCT00418834|455924951|FG000|Overall Study|Withdrawal by Subject|3|||
126719951|NCT00418834|455924952|FG001|Overall Study|Withdrawal by Subject|7|||
126719952|NCT01520324|455924956|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
126719953|NCT00423085|455924958|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
126719954|NCT00423085|455924959|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
126719955|NCT00423085|455924960|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
126719956|NCT00423085|455924961|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
126719957|NCT00423085|455924958|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
126719958|NCT00423085|455924959|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
126719959|NCT00423085|455924960|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
126719960|NCT00423085|455924961|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126719961|NCT00423085|455924958|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
126719962|NCT00423085|455924959|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
126719963|NCT00423085|455924960|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
126719964|NCT00423085|455924961|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
126719965|NCT00423085|455924958|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
126719966|NCT00423085|455924959|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
126719967|NCT00423085|455924960|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
126719968|NCT00423085|455924961|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
126719969|NCT00423085|455924958|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
126719970|NCT00423085|455924959|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
126719971|NCT00423085|455924960|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
126719972|NCT00423085|455924961|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
126719973|NCT00423085|455924958|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
126719974|NCT00423085|455924959|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
126719975|NCT00423085|455924960|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
126719976|NCT00423085|455924961|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
126719977|NCT00423085|455924958|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
126719978|NCT00423085|455924959|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
126719979|NCT00423085|455924960|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
126719980|NCT00423085|455924961|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
126719981|NCT00423085|455924958|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
126719982|NCT00423085|455924959|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
126719983|NCT00423085|455924960|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
126719984|NCT00423085|455924961|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
126756525|NCT02719028|456059452|FG001|Overall Study|Protocol Violation|0|||
126470024|NCT01426438|455023547|FG001|Overall Study|Lost to Follow-up|3|||
126470025|NCT01426438|455023546|FG000|Overall Study|Off study Treatment|9|||
126470026|NCT01426438|455023547|FG001|Overall Study|Off study Treatment|3|||
126470027|NCT01426438|455023546|FG000|Overall Study|Poor scan quality|3|||
126470028|NCT01426438|455023547|FG001|Overall Study|Poor scan quality|2|||
126470029|NCT01426438|455023546|FG000|Overall Study|Missed Scan|2|||
126470030|NCT01426438|455023547|FG001|Overall Study|Missed Scan|2|||
126470031|NCT01134731|455023548|FG000|Overall Study|Adverse Event|3|||
126470032|NCT01134731|455023549|FG001|Overall Study|Adverse Event|2|||
126470033|NCT01134731|455023550|FG002|Overall Study|Adverse Event|1|||
126470034|NCT01134731|455023548|FG000|Overall Study|Physician Decision|2|||
126470035|NCT01134731|455023549|FG001|Overall Study|Physician Decision|2|||
126470036|NCT01134731|455023550|FG002|Overall Study|Physician Decision|2|||
126470037|NCT01134731|455023548|FG000|Overall Study|Lack of Efficacy|0|||
126470038|NCT01134731|455023549|FG001|Overall Study|Lack of Efficacy|0|||
126470039|NCT01134731|455023550|FG002|Overall Study|Lack of Efficacy|1|||
126470040|NCT01134731|455023548|FG000|Overall Study|Withdrawal by Subject|3|||
126470041|NCT01134731|455023549|FG001|Overall Study|Withdrawal by Subject|3|||
126470042|NCT01134731|455023550|FG002|Overall Study|Withdrawal by Subject|1|||
126470043|NCT01134731|455023548|FG000|Overall Study|Lost to Follow-up|5|||
126470044|NCT01134731|455023549|FG001|Overall Study|Lost to Follow-up|4|||
126470045|NCT01134731|455023550|FG002|Overall Study|Lost to Follow-up|3|||
126470046|NCT00676338|455023553|FG000|Overall Study|Adverse Event|6|||
126470047|NCT00676338|455023554|FG001|Overall Study|Adverse Event|6|||
126470048|NCT00676338|455023555|FG002|Overall Study|Adverse Event|5|||
126470049|NCT00676338|455023556|FG003|Overall Study|Adverse Event|1|||
126470050|NCT00676338|455023553|FG000|Overall Study|Lost to Follow-up|4|||
126470051|NCT00676338|455023554|FG001|Overall Study|Lost to Follow-up|1|||
126470052|NCT00676338|455023555|FG002|Overall Study|Lost to Follow-up|3|||
126470053|NCT00676338|455023556|FG003|Overall Study|Lost to Follow-up|4|||
126470054|NCT00676338|455023553|FG000|Overall Study|Physician Decision|3|||
126470055|NCT00676338|455023554|FG001|Overall Study|Physician Decision|3|||
126470056|NCT00676338|455023555|FG002|Overall Study|Physician Decision|2|||
126470057|NCT00676338|455023556|FG003|Overall Study|Physician Decision|3|||
126470058|NCT00676338|455023553|FG000|Overall Study|Protocol Violation|5|||
126470059|NCT00676338|455023554|FG001|Overall Study|Protocol Violation|9|||
126470060|NCT00676338|455023555|FG002|Overall Study|Protocol Violation|2|||
126470061|NCT00676338|455023556|FG003|Overall Study|Protocol Violation|5|||
126470062|NCT00676338|455023553|FG000|Overall Study|Withdrawal by Subject|17|||
126470063|NCT00676338|455023554|FG001|Overall Study|Withdrawal by Subject|9|||
126470064|NCT00676338|455023555|FG002|Overall Study|Withdrawal by Subject|12|||
126470065|NCT00676338|455023556|FG003|Overall Study|Withdrawal by Subject|6|||
126470066|NCT00676338|455023553|FG000|Overall Study|Entry Criteria Not Met|0|||
126470067|NCT00676338|455023554|FG001|Overall Study|Entry Criteria Not Met|2|||
126470068|NCT00676338|455023555|FG002|Overall Study|Entry Criteria Not Met|1|||
126470069|NCT00676338|455023556|FG003|Overall Study|Entry Criteria Not Met|1|||
126470070|NCT00676338|455023553|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
126470071|NCT00676338|455023554|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
126470072|NCT00676338|455023555|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
126470073|NCT00676338|455023556|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
126470074|NCT02122458|455023557|FG000|Overall Study|Withdrawal by Subject|0|||
126470075|NCT02122458|455023558|FG001|Overall Study|Withdrawal by Subject|0|||
126470076|NCT02122458|455023559|FG002|Overall Study|Withdrawal by Subject|0|||
126470077|NCT02122458|455023560|FG003|Overall Study|Withdrawal by Subject|4|||
126470078|NCT02122458|455023561|FG004|Overall Study|Withdrawal by Subject|4|||
126470079|NCT02122458|455023562|FG005|Overall Study|Withdrawal by Subject|4|||
126470080|NCT02122458|455023563|FG006|Overall Study|Withdrawal by Subject|0|||
126470081|NCT02122458|455023557|FG000|Overall Study|Lost to Follow-up|1|||
126470082|NCT02122458|455023558|FG001|Overall Study|Lost to Follow-up|3|||
126470083|NCT02122458|455023559|FG002|Overall Study|Lost to Follow-up|0|||
126470084|NCT02122458|455023560|FG003|Overall Study|Lost to Follow-up|7|||
126470085|NCT02122458|455023561|FG004|Overall Study|Lost to Follow-up|5|||
126470086|NCT02122458|455023562|FG005|Overall Study|Lost to Follow-up|15|||
126470087|NCT02122458|455023563|FG006|Overall Study|Lost to Follow-up|1|||
126470088|NCT02122458|455023557|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
126470089|NCT02122458|455023558|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
126470090|NCT02122458|455023559|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
126470091|NCT02122458|455023560|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
126470092|NCT02122458|455023561|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
126470093|NCT02122458|455023562|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
126470094|NCT02122458|455023563|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
126470095|NCT02122458|455023557|FG000|Overall Study|Adverse Event|1|||
126470096|NCT02122458|455023558|FG001|Overall Study|Adverse Event|0|||
126470097|NCT02122458|455023559|FG002|Overall Study|Adverse Event|0|||
126470098|NCT02122458|455023560|FG003|Overall Study|Adverse Event|0|||
126470099|NCT02122458|455023561|FG004|Overall Study|Adverse Event|0|||
126771820|NCT01227954|456119980|FG000|Overall Study|Protocol Violation|6|||
126771821|NCT01227954|456119980|FG000|Overall Study|No protocol treatment|7|||
126771822|NCT02748616|456119982|FG000|Overall Study|Lost to Follow-up|1|||
126771823|NCT02748616|456119982|FG000|Overall Study|Withdrawal by Subject|2|||
126771824|NCT02748616|456119982|FG000|Overall Study|Physician Decision|2|||
126771825|NCT02748616|456119982|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
126771826|NCT01296152|456119983|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
126771827|NCT01414062|456119988|FG000|Overall Study|Lost to Follow-up|3|||
126771828|NCT01414062|456119989|FG001|Overall Study|Lost to Follow-up|2|||
126771829|NCT01414062|456119988|FG000|Overall Study|Left Country|1|||
126771830|NCT01414062|456119989|FG001|Overall Study|Left Country|1|||
126771831|NCT01414062|456119988|FG000|Overall Study|Family Disapproval|1|||
126771832|NCT01414062|456119989|FG001|Overall Study|Family Disapproval|0|||
126771833|NCT01414062|456119988|FG000|Overall Study|Withdrawal by Subject|0|||
126771834|NCT01414062|456119989|FG001|Overall Study|Withdrawal by Subject|1|||
126771835|NCT04057118|456119992|FG000|Overall Study|Adverse Event|1|||
126771836|NCT04057118|456119993|FG001|Overall Study|Adverse Event|0|||
126771837|NCT04057118|456119994|FG002|Overall Study|Adverse Event|1|||
126771838|NCT04057118|456119995|FG003|Overall Study|Adverse Event|1|||
126771839|NCT04057118|456119992|FG000|Overall Study|Physician Decision|0|||
126771840|NCT04057118|456119993|FG001|Overall Study|Physician Decision|0|||
126771841|NCT04057118|456119994|FG002|Overall Study|Physician Decision|1|||
126771842|NCT04057118|456119995|FG003|Overall Study|Physician Decision|1|||
126771843|NCT04057118|456119992|FG000|Overall Study|Withdrawal by Subject|2|||
126771844|NCT04057118|456119993|FG001|Overall Study|Withdrawal by Subject|2|||
126771845|NCT04057118|456119994|FG002|Overall Study|Withdrawal by Subject|0|||
126771846|NCT04057118|456119995|FG003|Overall Study|Withdrawal by Subject|2|||
126771847|NCT04057118|456119992|FG000|Overall Study|Not Specific|0|||
126771848|NCT04057118|456119993|FG001|Overall Study|Not Specific|0|||
126771849|NCT04057118|456119994|FG002|Overall Study|Not Specific|1|||
126771850|NCT04057118|456119995|FG003|Overall Study|Not Specific|1|||
126771851|NCT02787785|456119998|FG000|Overall Study|Death|3|||
126771852|NCT02787785|456119999|FG001|Overall Study|Death|4|||
126771853|NCT02787785|456119998|FG000|Overall Study|Lost to Follow-up|1|||
126771854|NCT02787785|456119999|FG001|Overall Study|Lost to Follow-up|1|||
126771855|NCT02787785|456119998|FG000|Overall Study|Withdrawal by Subject|0|||
126771856|NCT02787785|456119999|FG001|Overall Study|Withdrawal by Subject|5|||
126771857|NCT04333199|456120002|FG000|Evaluated Patients|Lost to Follow-up|0|||
126771858|NCT04333199|456120003|FG001|Evaluated Patients|Lost to Follow-up|1|||
126771859|NCT04333199|456120004|FG002|Evaluated Patients|Lost to Follow-up|2|||
126771860|NCT01155284|456120013|FG000|Overall Study|Withdrawal by Subject|4|||
126771861|NCT01155284|456120014|FG001|Overall Study|Withdrawal by Subject|3|||
126771862|NCT01155284|456120013|FG000|Overall Study|Lost to Follow-up|1|||
126771863|NCT01155284|456120014|FG001|Overall Study|Lost to Follow-up|2|||
126771864|NCT01155284|456120013|FG000|Overall Study|Physician Decision|1|||
126771865|NCT01155284|456120014|FG001|Overall Study|Physician Decision|0|||
126555064|NCT01154036|455324096|FG007|Phase I|Physician Decision|0|||
126771866|NCT01155284|456120013|FG000|Overall Study|Adverse Event|1|||
126771867|NCT01155284|456120014|FG001|Overall Study|Adverse Event|0|||
126771868|NCT02268045|456120015|FG000|Overall Study|Death|4|||
126771869|NCT02268045|456120016|FG001|Overall Study|Death|4|||
126396069|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
126396070|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
126396071|NCT01632241|454744508|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
126396072|NCT01632241|454744509|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
126396073|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
126396074|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
126396075|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
126396076|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
126396077|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
126396078|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
126396079|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
126396080|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
126396081|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
126771870|NCT02268045|456120015|FG000|Overall Study|Disease Progression|2|||
126396082|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
126396083|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
126396084|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
126396085|NCT01632241|454744508|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
126771871|NCT02268045|456120016|FG001|Overall Study|Disease Progression|1|||
126771872|NCT02268045|456120015|FG000|Overall Study|Adverse Event|7|||
126771873|NCT02268045|456120016|FG001|Overall Study|Adverse Event|7|||
126771874|NCT02268045|456120015|FG000|Overall Study|Withdrawal by Subject|2|||
126771875|NCT02268045|456120016|FG001|Overall Study|Withdrawal by Subject|6|||
126771876|NCT02268045|456120015|FG000|Overall Study|Physician Decision|0|||
126771877|NCT02268045|456120016|FG001|Overall Study|Physician Decision|1|||
126470100|NCT02122458|455023562|FG005|Overall Study|Adverse Event|0|||
126470101|NCT02122458|455023563|FG006|Overall Study|Adverse Event|0|||
126470102|NCT02122458|455023557|FG000|Overall Study|Experimental Error|0|||
126470103|NCT02122458|455023558|FG001|Overall Study|Experimental Error|0|||
126470104|NCT02122458|455023559|FG002|Overall Study|Experimental Error|0|||
126470105|NCT02122458|455023560|FG003|Overall Study|Experimental Error|0|||
126470106|NCT02122458|455023561|FG004|Overall Study|Experimental Error|3|||
126470107|NCT02122458|455023562|FG005|Overall Study|Experimental Error|0|||
126470108|NCT02122458|455023563|FG006|Overall Study|Experimental Error|0|||
126470109|NCT02122458|455023557|FG000|Overall Study|Deployed or Moved|0|||
126470110|NCT02122458|455023558|FG001|Overall Study|Deployed or Moved|0|||
126470111|NCT02122458|455023559|FG002|Overall Study|Deployed or Moved|0|||
126470112|NCT02122458|455023560|FG003|Overall Study|Deployed or Moved|0|||
126470113|NCT02122458|455023561|FG004|Overall Study|Deployed or Moved|1|||
126470114|NCT02122458|455023562|FG005|Overall Study|Deployed or Moved|0|||
126470115|NCT02122458|455023563|FG006|Overall Study|Deployed or Moved|0|||
126719985|NCT00423085|455924958|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
126719986|NCT00423085|455924959|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
126719987|NCT00423085|455924960|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
126719988|NCT00423085|455924961|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
126719989|NCT00423085|455924958|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
126719990|NCT00423085|455924959|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
126719991|NCT00423085|455924960|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
126719992|NCT00423085|455924961|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
126719993|NCT00423085|455924958|FG000|52-Week Open-Label Extension Phase|Death|0|||
126719994|NCT00423085|455924959|FG001|52-Week Open-Label Extension Phase|Death|0|||
126719995|NCT00423085|455924960|FG002|52-Week Open-Label Extension Phase|Death|0|||
126719996|NCT00423085|455924961|FG003|52-Week Open-Label Extension Phase|Death|2|||
126719997|NCT02163993|455924962|FG000|Treatment Period|Adverse Event|0|||
126719998|NCT02163993|455924963|FG001|Treatment Period|Adverse Event|1|||
126719999|NCT02163993|455924964|FG002|Treatment Period|Adverse Event|0|||
126720000|NCT02163993|455924965|FG003|Treatment Period|Adverse Event|0|||
126720001|NCT02163993|455924966|FG004|Treatment Period|Adverse Event|1|||
126720002|NCT02163993|455924962|FG000|Treatment Period|Lost to Follow-up|2|||
126720003|NCT02163993|455924963|FG001|Treatment Period|Lost to Follow-up|3|||
126720004|NCT02163993|455924964|FG002|Treatment Period|Lost to Follow-up|1|||
126720005|NCT02163993|455924965|FG003|Treatment Period|Lost to Follow-up|3|||
126720006|NCT02163993|455924966|FG004|Treatment Period|Lost to Follow-up|1|||
126720007|NCT02163993|455924962|FG000|Treatment Period|Physician Decision|1|||
126720008|NCT02163993|455924963|FG001|Treatment Period|Physician Decision|0|||
126720009|NCT02163993|455924964|FG002|Treatment Period|Physician Decision|0|||
126720010|NCT02163993|455924965|FG003|Treatment Period|Physician Decision|0|||
126720011|NCT02163993|455924966|FG004|Treatment Period|Physician Decision|0|||
126720012|NCT02163993|455924962|FG000|Treatment Period|Protocol Violation|2|||
126720013|NCT02163993|455924963|FG001|Treatment Period|Protocol Violation|1|||
126720014|NCT02163993|455924964|FG002|Treatment Period|Protocol Violation|0|||
126720015|NCT02163993|455924965|FG003|Treatment Period|Protocol Violation|1|||
126720016|NCT02163993|455924966|FG004|Treatment Period|Protocol Violation|2|||
126720017|NCT02163993|455924962|FG000|Treatment Period|Withdrawal by Subject|6|||
126720018|NCT02163993|455924963|FG001|Treatment Period|Withdrawal by Subject|4|||
126720019|NCT02163993|455924964|FG002|Treatment Period|Withdrawal by Subject|1|||
126720020|NCT02163993|455924965|FG003|Treatment Period|Withdrawal by Subject|4|||
126720021|NCT02163993|455924966|FG004|Treatment Period|Withdrawal by Subject|1|||
126720022|NCT02163993|455924962|FG000|Treatment Period|Not treated|1|||
126720023|NCT02163993|455924963|FG001|Treatment Period|Not treated|0|||
126720024|NCT02163993|455924964|FG002|Treatment Period|Not treated|0|||
126720025|NCT02163993|455924965|FG003|Treatment Period|Not treated|1|||
126720026|NCT02163993|455924966|FG004|Treatment Period|Not treated|2|||
126720027|NCT02163993|455924962|FG000|Post-treatment Period|Adverse Event|0|||
126720028|NCT02163993|455924963|FG001|Post-treatment Period|Adverse Event|0|||
126720029|NCT02163993|455924964|FG002|Post-treatment Period|Adverse Event|1|||
126720030|NCT02163993|455924965|FG003|Post-treatment Period|Adverse Event|0|||
126470116|NCT02122458|455023557|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
126470117|NCT02122458|455023558|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
126470118|NCT02122458|455023559|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
126470119|NCT02122458|455023560|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
126470120|NCT02122458|455023561|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
126720031|NCT02163993|455924966|FG004|Post-treatment Period|Adverse Event|0|||
126720032|NCT02163993|455924962|FG000|Post-treatment Period|Lost to Follow-up|2|||
126720033|NCT02163993|455924963|FG001|Post-treatment Period|Lost to Follow-up|2|||
126470121|NCT02122458|455023562|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
126470122|NCT02122458|455023563|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
126720034|NCT02163993|455924964|FG002|Post-treatment Period|Lost to Follow-up|3|||
126720035|NCT02163993|455924965|FG003|Post-treatment Period|Lost to Follow-up|1|||
126470123|NCT02122458|455023557|FG000|Overall Study|Noncompliance|0|||
126470124|NCT02122458|455023558|FG001|Overall Study|Noncompliance|1|||
126470125|NCT02122458|455023559|FG002|Overall Study|Noncompliance|0|||
126470126|NCT02122458|455023560|FG003|Overall Study|Noncompliance|0|||
126771878|NCT02268045|456120015|FG000|Overall Study|Protocol Violation|1|||
126771879|NCT02268045|456120016|FG001|Overall Study|Protocol Violation|1|||
126771880|NCT01766310|456120017|FG000|Overall Study|Lost to Follow-up|1|||
126771881|NCT01766310|456120018|FG001|Overall Study|Lost to Follow-up|3|||
126771882|NCT01154673|456120019|FG000|Overall Study|Lost to Follow-up|1|||
126771883|NCT01154673|456120020|FG001|Overall Study|Lost to Follow-up|0|||
126771884|NCT01154673|456120019|FG000|Overall Study|moved out of province|1|||
126771885|NCT01154673|456120020|FG001|Overall Study|moved out of province|0|||
126771886|NCT00646282|456120021|FG000|Overall Study|Protocol terminated|4|||
126771887|NCT00646282|456120022|FG001|Overall Study|Protocol terminated|4|||
126470127|NCT02122458|455023561|FG004|Overall Study|Noncompliance|0|||
126470128|NCT02122458|455023562|FG005|Overall Study|Noncompliance|0|||
126470129|NCT02122458|455023563|FG006|Overall Study|Noncompliance|0|||
126470130|NCT00412542|455023564|FG000|Overall Study|Withdrawal by Subject|0|||
126470131|NCT00412542|455023565|FG001|Overall Study|Withdrawal by Subject|2|||
126470132|NCT00412542|455023564|FG000|Overall Study|Not Eligible|0|||
126470133|NCT00412542|455023565|FG001|Overall Study|Not Eligible|1|||
126470134|NCT03161093|455023568|FG000|Overall Study|Protocol Violation|11|||
126470135|NCT03161093|455023569|FG001|Overall Study|Protocol Violation|14|||
126470136|NCT03161093|455023570|FG002|Overall Study|Protocol Violation|6|||
126470137|NCT03161093|455023571|FG003|Overall Study|Protocol Violation|13|||
126470138|NCT03161093|455023572|FG004|Overall Study|Protocol Violation|1|||
126470139|NCT03161093|455023573|FG005|Overall Study|Protocol Violation|0|||
126470140|NCT03161093|455023568|FG000|Overall Study|Adverse Event|5|||
126470141|NCT03161093|455023569|FG001|Overall Study|Adverse Event|21|||
126470142|NCT03161093|455023570|FG002|Overall Study|Adverse Event|16|||
126470143|NCT03161093|455023571|FG003|Overall Study|Adverse Event|35|||
126470144|NCT03161093|455023572|FG004|Overall Study|Adverse Event|2|||
126470145|NCT03161093|455023573|FG005|Overall Study|Adverse Event|1|||
126470146|NCT03161093|455023568|FG000|Overall Study|Lack of Efficacy|9|||
126470147|NCT03161093|455023569|FG001|Overall Study|Lack of Efficacy|13|||
126470148|NCT03161093|455023570|FG002|Overall Study|Lack of Efficacy|9|||
126470149|NCT03161093|455023571|FG003|Overall Study|Lack of Efficacy|24|||
126470150|NCT03161093|455023572|FG004|Overall Study|Lack of Efficacy|4|||
126470151|NCT03161093|455023573|FG005|Overall Study|Lack of Efficacy|1|||
126470152|NCT03161093|455023568|FG000|Overall Study|Physician Decision|0|||
126470153|NCT03161093|455023569|FG001|Overall Study|Physician Decision|1|||
126470154|NCT03161093|455023570|FG002|Overall Study|Physician Decision|0|||
126470155|NCT03161093|455023571|FG003|Overall Study|Physician Decision|2|||
126470156|NCT03161093|455023572|FG004|Overall Study|Physician Decision|17|||
126470157|NCT03161093|455023573|FG005|Overall Study|Physician Decision|15|||
126470158|NCT03161093|455023568|FG000|Overall Study|Withdrawal by Subject|24|||
126470159|NCT03161093|455023569|FG001|Overall Study|Withdrawal by Subject|73|||
126470160|NCT03161093|455023570|FG002|Overall Study|Withdrawal by Subject|44|||
126470161|NCT03161093|455023571|FG003|Overall Study|Withdrawal by Subject|97|||
126470162|NCT03161093|455023572|FG004|Overall Study|Withdrawal by Subject|11|||
126470163|NCT03161093|455023573|FG005|Overall Study|Withdrawal by Subject|10|||
126470164|NCT03161093|455023568|FG000|Overall Study|Lost to Follow-up|3|||
126470165|NCT03161093|455023569|FG001|Overall Study|Lost to Follow-up|12|||
126470166|NCT03161093|455023570|FG002|Overall Study|Lost to Follow-up|4|||
126470167|NCT03161093|455023571|FG003|Overall Study|Lost to Follow-up|7|||
126470168|NCT03161093|455023572|FG004|Overall Study|Lost to Follow-up|8|||
126470169|NCT03161093|455023573|FG005|Overall Study|Lost to Follow-up|13|||
126470170|NCT03161093|455023568|FG000|Overall Study|Death|3|||
126470171|NCT03161093|455023569|FG001|Overall Study|Death|9|||
126470172|NCT03161093|455023570|FG002|Overall Study|Death|7|||
126470173|NCT03161093|455023571|FG003|Overall Study|Death|9|||
126470174|NCT03161093|455023572|FG004|Overall Study|Death|0|||
126470175|NCT03161093|455023573|FG005|Overall Study|Death|0|||
126771888|NCT01556490|456120023|FG000|Randomized Patients Summary|Protocol Violation|22|||
126470176|NCT03161093|455023568|FG000|Overall Study|Unknown - Not reported|0|||
126470177|NCT03161093|455023569|FG001|Overall Study|Unknown - Not reported|1|||
126470178|NCT03161093|455023570|FG002|Overall Study|Unknown - Not reported|0|||
126470179|NCT03161093|455023571|FG003|Overall Study|Unknown - Not reported|0|||
126470180|NCT03161093|455023572|FG004|Overall Study|Unknown - Not reported|0|||
126470181|NCT03161093|455023573|FG005|Overall Study|Unknown - Not reported|1|||
126470182|NCT02124161|455023574|FG000|Overall Study|Other unspecified|0|||
126470183|NCT02124161|455023575|FG001|Overall Study|Other unspecified|1|||
126470184|NCT02124161|455023574|FG000|Overall Study|Death|1|||
126470185|NCT02124161|455023575|FG001|Overall Study|Death|0|||
126470186|NCT02124161|455023574|FG000|Overall Study|Protocol Violation|2|||
126470187|NCT02124161|455023575|FG001|Overall Study|Protocol Violation|1|||
126470188|NCT02124161|455023574|FG000|Overall Study|Withdrawal by Subject|1|||
126470189|NCT02124161|455023575|FG001|Overall Study|Withdrawal by Subject|2|||
126771889|NCT01556490|456120024|FG001|Randomized Patients Summary|Protocol Violation|23|||
126771890|NCT01556490|456120023|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
126720036|NCT02163993|455924966|FG004|Post-treatment Period|Lost to Follow-up|0|||
126720037|NCT02163993|455924962|FG000|Post-treatment Period|Protocol Violation|0|||
126720038|NCT02163993|455924963|FG001|Post-treatment Period|Protocol Violation|0|||
126720039|NCT02163993|455924964|FG002|Post-treatment Period|Protocol Violation|0|||
126720040|NCT02163993|455924965|FG003|Post-treatment Period|Protocol Violation|0|||
126720041|NCT02163993|455924966|FG004|Post-treatment Period|Protocol Violation|1|||
126720042|NCT02163993|455924962|FG000|Post-treatment Period|Withdrawal by Subject|2|||
126720043|NCT02163993|455924963|FG001|Post-treatment Period|Withdrawal by Subject|4|||
126720044|NCT02163993|455924964|FG002|Post-treatment Period|Withdrawal by Subject|0|||
126720045|NCT02163993|455924965|FG003|Post-treatment Period|Withdrawal by Subject|1|||
126720046|NCT02163993|455924966|FG004|Post-treatment Period|Withdrawal by Subject|2|||
126720047|NCT00853489|455924967|FG000|Overall Study|Lost to Follow-up|5|||
126720048|NCT00853489|455924968|FG001|Overall Study|Lost to Follow-up|2|||
126720049|NCT01998581|455924970|FG000|Overall Study|Refused repeat treatment|20|||
126720050|NCT01998581|455924971|FG001|Overall Study|Refused repeat treatment|4|||
126720051|NCT01998581|455924970|FG000|Overall Study|Protocol Violation|1|||
126720052|NCT01998581|455924971|FG001|Overall Study|Protocol Violation|0|||
126720053|NCT01998581|455924970|FG000|Overall Study|Withdrawal by Subject|8|||
126720054|NCT01998581|455924971|FG001|Overall Study|Withdrawal by Subject|1|||
126720055|NCT01998581|455924970|FG000|Overall Study|Lost to Follow-up|12|||
126720056|NCT01998581|455924971|FG001|Overall Study|Lost to Follow-up|4|||
126720057|NCT01998581|455924970|FG000|Overall Study|Adverse Event|1|||
126720058|NCT01998581|455924971|FG001|Overall Study|Adverse Event|1|||
126720059|NCT01998581|455924970|FG000|Overall Study|Other reasons|3|||
126720060|NCT01998581|455924971|FG001|Overall Study|Other reasons|2|||
126720061|NCT01998581|455924970|FG000|Overall Study|Randomized but withdrew before treatment|1|||
126720062|NCT01998581|455924971|FG001|Overall Study|Randomized but withdrew before treatment|0|||
126720063|NCT01251276|455924972|FG000|Overall Study|Protocol Violation|1|||
126720064|NCT01251276|455924973|FG001|Overall Study|Protocol Violation|0|||
126720065|NCT01251276|455924972|FG000|Overall Study|Lost to Follow-up|0|||
126720066|NCT01251276|455924973|FG001|Overall Study|Lost to Follow-up|1|||
126720067|NCT01345123|455924974|FG000|Overall Study|participants no longer with health plan|79|||
126720068|NCT01345123|455924975|FG001|Overall Study|participants no longer with health plan|85|||
126720069|NCT01345123|455924976|FG002|Overall Study|participants no longer with health plan|88|||
126720070|NCT00441441|455924980|FG000|Overall Study|Adverse Event|2|||
126720071|NCT00441441|455924981|FG001|Overall Study|Adverse Event|1|||
126720072|NCT00441441|455924980|FG000|Overall Study|Protocol Violation|4|||
126720073|NCT00441441|455924981|FG001|Overall Study|Protocol Violation|6|||
126720074|NCT00441441|455924980|FG000|Overall Study|Exacerbation of asthma|1|||
126720075|NCT00441441|455924981|FG001|Overall Study|Exacerbation of asthma|2|||
126720076|NCT00441441|455924980|FG000|Overall Study|Withdrawal by Subject|1|||
126720077|NCT00441441|455924981|FG001|Overall Study|Withdrawal by Subject|2|||
126720078|NCT00441441|455924980|FG000|Overall Study|Other|3|||
126720079|NCT00441441|455924981|FG001|Overall Study|Other|3|||
126720080|NCT01763905|455924984|FG000|Overall Study|Withdrawal by Subject|1|||
126720081|NCT01763905|455924985|FG001|Overall Study|Withdrawal by Subject|1|||
126720082|NCT01763905|455924986|FG002|Overall Study|Withdrawal by Subject|0|||
126720083|NCT01763905|455924987|FG003|Overall Study|Withdrawal by Subject|1|||
126720084|NCT01763905|455924984|FG000|Overall Study|Decision by sponsor|5|||
126720085|NCT01763905|455924985|FG001|Overall Study|Decision by sponsor|0|||
126720086|NCT01763905|455924986|FG002|Overall Study|Decision by sponsor|8|||
126720087|NCT01763905|455924987|FG003|Overall Study|Decision by sponsor|0|||
126720088|NCT01763905|455924984|FG000|Overall Study|Lost to Follow-up|0|||
126720089|NCT01763905|455924985|FG001|Overall Study|Lost to Follow-up|0|||
126720090|NCT01763905|455924986|FG002|Overall Study|Lost to Follow-up|1|||
126720091|NCT01763905|455924987|FG003|Overall Study|Lost to Follow-up|0|||
126720092|NCT04346628|455924988|FG000|Overall Study|Lost to Follow-up|4|||
126720093|NCT04346628|455924989|FG001|Overall Study|Lost to Follow-up|4|||
126720094|NCT04346628|455924988|FG000|Overall Study|Withdrew (had personal reasons)|2|||
126720095|NCT04346628|455924989|FG001|Overall Study|Withdrew (had personal reasons)|5|||
126720096|NCT04346628|455924988|FG000|Overall Study|Withdrew (medication intolerant)|0|||
126720097|NCT04346628|455924989|FG001|Overall Study|Withdrew (medication intolerant)|3|||
126720098|NCT04346628|455924988|FG000|Overall Study|Withdrew (declined intervention)|0|||
126720099|NCT04346628|455924989|FG001|Overall Study|Withdrew (declined intervention)|1|||
126470190|NCT02124161|455023574|FG000|Overall Study|Adverse Event|2|||
126720100|NCT01428063|455924991|FG000|Overall Study|Lack of Efficacy|8|||
126720101|NCT01428063|455924992|FG001|Overall Study|Lack of Efficacy|4|||
126720102|NCT01428063|455924993|FG002|Overall Study|Lack of Efficacy|1|||
126720103|NCT01428063|455924991|FG000|Overall Study|Adverse Event|2|||
126720104|NCT01428063|455924992|FG001|Overall Study|Adverse Event|3|||
126720105|NCT01428063|455924993|FG002|Overall Study|Adverse Event|0|||
126470191|NCT02124161|455023575|FG001|Overall Study|Adverse Event|0|||
126470192|NCT02124161|455023574|FG000|Overall Study|Does not meet entrance criteria|2|||
126720106|NCT01428063|455924991|FG000|Overall Study|Lost to Follow-up|0|||
126720107|NCT01428063|455924992|FG001|Overall Study|Lost to Follow-up|2|||
126720108|NCT01428063|455924993|FG002|Overall Study|Lost to Follow-up|0|||
126720109|NCT01428063|455924991|FG000|Overall Study|No longer meets study criteria|0|||
126470193|NCT02124161|455023575|FG001|Overall Study|Does not meet entrance criteria|3|||
126470194|NCT02124161|455023574|FG000|Overall Study|No longer meets eligibility criteria|5|||
126470195|NCT02124161|455023575|FG001|Overall Study|No longer meets eligibility criteria|4|||
126470196|NCT02124161|455023574|FG000|Overall Study|Lost to Follow-up|3|||
126470197|NCT02124161|455023575|FG001|Overall Study|Lost to Follow-up|4|||
126470198|NCT02517866|455023576|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
126470199|NCT02517866|455023577|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
126470200|NCT02517866|455023578|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
126470201|NCT02517866|455023576|FG000|Overall Study|Significant Protocol Deviation|4|||
126470202|NCT02517866|455023577|FG001|Overall Study|Significant Protocol Deviation|1|||
126470203|NCT02517866|455023578|FG002|Overall Study|Significant Protocol Deviation|0|||
126720110|NCT01428063|455924992|FG001|Overall Study|No longer meets study criteria|1|||
126720111|NCT01428063|455924993|FG002|Overall Study|No longer meets study criteria|0|||
126720112|NCT00850759|455924994|FG000|Overall Study|Lost to Follow-up|7|||
126720113|NCT00850759|455924995|FG001|Overall Study|Lost to Follow-up|5|||
126720114|NCT00850759|455924996|FG002|Overall Study|Lost to Follow-up|5|||
126720115|NCT00850759|455924997|FG003|Overall Study|Lost to Follow-up|3|||
126720116|NCT02575079|455924998|FG000|Overall Study|Death|3|||
126720117|NCT02575079|455924999|FG001|Overall Study|Death|0|||
126720118|NCT02575079|455924998|FG000|Overall Study|Withdrawal by Subject|3|||
126720119|NCT02575079|455924999|FG001|Overall Study|Withdrawal by Subject|0|||
126720120|NCT02918266|455925000|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
126720121|NCT02918266|455925001|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126720122|NCT02918266|455925002|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126720123|NCT02918266|455925003|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126720124|NCT02918266|455925004|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126720125|NCT02918266|455925005|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126720126|NCT02918266|455925006|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
126720127|NCT02918266|455925007|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126720128|NCT02918266|455925008|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
126720129|NCT02918266|455925009|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126720130|NCT02918266|455925010|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
126720131|NCT01259856|455925017|FG000|Overall Study|Adverse Event|12|||
126720132|NCT01259856|455925018|FG001|Overall Study|Adverse Event|9|||
126720133|NCT01259856|455925017|FG000|Overall Study|Death|0|||
126720134|NCT01259856|455925018|FG001|Overall Study|Death|1|||
126720135|NCT01259856|455925017|FG000|Overall Study|Lack of Efficacy|3|||
126720136|NCT01259856|455925018|FG001|Overall Study|Lack of Efficacy|1|||
126720137|NCT01259856|455925017|FG000|Overall Study|Lost to Follow-up|1|||
126720138|NCT01259856|455925018|FG001|Overall Study|Lost to Follow-up|1|||
126720139|NCT01259856|455925017|FG000|Overall Study|Physician Decision|2|||
126720140|NCT01259856|455925018|FG001|Overall Study|Physician Decision|1|||
126720141|NCT01259856|455925017|FG000|Overall Study|Withdrawal by Subject|9|||
126720142|NCT01259856|455925018|FG001|Overall Study|Withdrawal by Subject|10|||
126720143|NCT01259856|455925017|FG000|Overall Study|Treatment never started|0|||
126720144|NCT01259856|455925018|FG001|Overall Study|Treatment never started|6|||
126720145|NCT01259856|455925017|FG000|Overall Study|Study closure by sponsor|40|||
126720146|NCT01259856|455925018|FG001|Overall Study|Study closure by sponsor|41|||
126720147|NCT01259856|455925017|FG000|Overall Study|Patient developed other disease|0|||
126720148|NCT01259856|455925018|FG001|Overall Study|Patient developed other disease|1|||
126720149|NCT01259856|455925017|FG000|Overall Study|Transfer to another study|0|||
126720150|NCT01259856|455925018|FG001|Overall Study|Transfer to another study|1|||
126720151|NCT01259856|455925017|FG000|Overall Study|Unknown/missing|2|||
126720152|NCT01259856|455925018|FG001|Overall Study|Unknown/missing|2|||
126720153|NCT00788775|455925019|FG000|Overall Study|Progressive Disease|8|||
126720154|NCT00788775|455925020|FG001|Overall Study|Progressive Disease|6|||
126720155|NCT00788775|455925019|FG000|Overall Study|Withdrawal by Subject|0|||
126720156|NCT00788775|455925020|FG001|Overall Study|Withdrawal by Subject|2|||
126720157|NCT00788775|455925019|FG000|Overall Study|Patient Non-Compliance|1|||
126720158|NCT00788775|455925020|FG001|Overall Study|Patient Non-Compliance|0|||
126720159|NCT00788775|455925019|FG000|Overall Study|Patient's measurable disease resected.|1|||
126720160|NCT00788775|455925020|FG001|Overall Study|Patient's measurable disease resected.|0|||
126720161|NCT00578864|455925021|FG000|Overall Study|Death|1|||
126720162|NCT00578864|455925022|FG001|Overall Study|Death|0|||
126720163|NCT01087528|455925023|FG000|Overall Study|Withdrawal by Subject|1|||
126720164|NCT01087528|455925023|FG000|Overall Study|Incomplete CE procedure|6|||
126470204|NCT02517866|455023576|FG000|Overall Study|Lost to Follow-up|1|||
126720165|NCT02702193|455925034|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
126720166|NCT02702193|455925035|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
126720167|NCT02702193|455925034|FG000|4 Month Follow up|Withdrawal by Subject|1|||
126720168|NCT02702193|455925035|FG001|4 Month Follow up|Withdrawal by Subject|0|||
126720169|NCT02702193|455925034|FG000|4 Month Follow up|Lost to Follow-up|17|||
126720170|NCT02702193|455925035|FG001|4 Month Follow up|Lost to Follow-up|18|||
126720171|NCT02702193|455925034|FG000|8 Month Follow up|Withdrawal by Subject|1|||
126771891|NCT01556490|456120024|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
126771892|NCT04529499|456120030|FG000|Overall Study|Withdrawal by Subject|9|||
126771893|NCT04529499|456120031|FG001|Overall Study|Withdrawal by Subject|11|||
126771894|NCT04529499|456120030|FG000|Overall Study|Physician Decision|1|||
126555065|NCT01154036|455324089|FG000|Phase I|Lost to Follow-up|0|||
126555066|NCT01154036|455324090|FG001|Phase I|Lost to Follow-up|3|||
126555067|NCT01154036|455324091|FG002|Phase I|Lost to Follow-up|6|||
126555068|NCT01154036|455324092|FG003|Phase I|Lost to Follow-up|0|||
126771895|NCT04529499|456120031|FG001|Overall Study|Physician Decision|2|||
126771896|NCT04529499|456120030|FG000|Overall Study|Adverse Event|4|||
126771897|NCT04529499|456120031|FG001|Overall Study|Adverse Event|4|||
126771898|NCT04529499|456120030|FG000|Overall Study|Death|14|||
126771899|NCT04529499|456120031|FG001|Overall Study|Death|11|||
126771900|NCT04529499|456120030|FG000|Overall Study|Lost to Follow-up|1|||
126771901|NCT04529499|456120031|FG001|Overall Study|Lost to Follow-up|1|||
126771902|NCT04529499|456120030|FG000|Overall Study|Others|7|||
126771903|NCT04529499|456120031|FG001|Overall Study|Others|11|||
126771904|NCT00683904|456120032|FG000|Dose Level 1|Disease progression|2|||
126771905|NCT00683904|456120033|FG001|Dose Level 1|Disease progression|0|||
126771906|NCT00683904|456120032|FG000|Dose Level 1|Adverse Event|1|||
126396086|NCT01632241|454744509|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
126396087|NCT05032690|454744518|FG000|Period 1|Adverse Event|0|||
126396088|NCT05032690|454744519|FG001|Period 1|Adverse Event|1|||
126396089|NCT05032690|454744520|FG002|Period 1|Adverse Event|0|||
126396090|NCT05032690|454744521|FG003|Period 1|Adverse Event|0|||
126396091|NCT05032690|454744518|FG000|Period 1|Withdrawal by Subject|1|||
126396092|NCT05032690|454744519|FG001|Period 1|Withdrawal by Subject|0|||
126396093|NCT05032690|454744520|FG002|Period 1|Withdrawal by Subject|0|||
126396094|NCT05032690|454744521|FG003|Period 1|Withdrawal by Subject|0|||
126396095|NCT05032690|454744518|FG000|Period 1|No longer meets eligibility criteria|0|||
126396096|NCT05032690|454744519|FG001|Period 1|No longer meets eligibility criteria|1|||
126396097|NCT05032690|454744520|FG002|Period 1|No longer meets eligibility criteria|0|||
126396098|NCT05032690|454744521|FG003|Period 1|No longer meets eligibility criteria|0|||
126396099|NCT05032690|454744518|FG000|Period 2|Adverse Event|1|||
126396100|NCT05032690|454744519|FG001|Period 2|Adverse Event|0|||
126396101|NCT05032690|454744520|FG002|Period 2|Adverse Event|0|||
126396102|NCT05032690|454744521|FG003|Period 2|Adverse Event|0|||
126396103|NCT05032690|454744518|FG000|Period 2|Withdrawal by Subject|0|||
126396104|NCT05032690|454744519|FG001|Period 2|Withdrawal by Subject|1|||
126396105|NCT05032690|454744520|FG002|Period 2|Withdrawal by Subject|0|||
126396106|NCT05032690|454744521|FG003|Period 2|Withdrawal by Subject|0|||
126396107|NCT05032690|454744518|FG000|Period 2|No longer meets eligibility criteria|0|||
126396108|NCT05032690|454744519|FG001|Period 2|No longer meets eligibility criteria|1|||
126396109|NCT05032690|454744520|FG002|Period 2|No longer meets eligibility criteria|0|||
126396110|NCT05032690|454744521|FG003|Period 2|No longer meets eligibility criteria|0|||
126396111|NCT05032690|454744518|FG000|Period 3|Adverse Event|0|||
126396112|NCT05032690|454744519|FG001|Period 3|Adverse Event|1|||
126396113|NCT05032690|454744520|FG002|Period 3|Adverse Event|0|||
126396114|NCT05032690|454744521|FG003|Period 3|Adverse Event|0|||
126396115|NCT00759356|454744524|FG000|Overall Study|Adverse Event|0|||
126396116|NCT00759356|454744525|FG001|Overall Study|Adverse Event|1|||
126396117|NCT00759356|454744524|FG000|Overall Study|Withdrawal by Subject|0|||
126396118|NCT00759356|454744525|FG001|Overall Study|Withdrawal by Subject|2|||
126396119|NCT00759356|454744524|FG000|Overall Study|Subject was unable to return|1|||
126396120|NCT00759356|454744525|FG001|Overall Study|Subject was unable to return|0|||
126396121|NCT01713283|454744526|FG000|Overall Study|Lack of Efficacy|10|||
126396122|NCT01713283|454744527|FG001|Overall Study|Lack of Efficacy|2|||
126396123|NCT01713283|454744526|FG000|Overall Study|Lost to Follow-up|1|||
126396124|NCT01713283|454744527|FG001|Overall Study|Lost to Follow-up|1|||
126396125|NCT02403635|454744528|FG000|Overall Study|Not eligible|9|||
126396126|NCT01904149|454744534|FG000|Overall Study|Adverse Event|3|||
126396127|NCT01904149|454744535|FG001|Overall Study|Adverse Event|4|||
126396128|NCT01904149|454744536|FG002|Overall Study|Adverse Event|0|||
126396129|NCT01904149|454744537|FG003|Overall Study|Adverse Event|1|||
126396130|NCT01904149|454744538|FG004|Overall Study|Adverse Event|1|||
126396131|NCT01904149|454744539|FG005|Overall Study|Adverse Event|2|||
126396132|NCT01904149|454744534|FG000|Overall Study|Lack of Efficacy|0|||
126396133|NCT01904149|454744535|FG001|Overall Study|Lack of Efficacy|3|||
126396134|NCT01904149|454744536|FG002|Overall Study|Lack of Efficacy|1|||
126396135|NCT01904149|454744537|FG003|Overall Study|Lack of Efficacy|3|||
126396136|NCT01904149|454744538|FG004|Overall Study|Lack of Efficacy|3|||
126396137|NCT01904149|454744539|FG005|Overall Study|Lack of Efficacy|1|||
126396138|NCT01904149|454744534|FG000|Overall Study|Withdrawal by Subject|1|||
126396139|NCT01904149|454744535|FG001|Overall Study|Withdrawal by Subject|3|||
126396140|NCT01904149|454744536|FG002|Overall Study|Withdrawal by Subject|1|||
126396141|NCT01904149|454744537|FG003|Overall Study|Withdrawal by Subject|0|||
126555069|NCT01154036|455324093|FG004|Phase I|Lost to Follow-up|0|||
126771907|NCT00683904|456120033|FG001|Dose Level 1|Adverse Event|0|||
126771908|NCT00683904|456120032|FG000|Dose Level 2|Adverse Event|0|||
126771909|NCT00683904|456120033|FG001|Dose Level 2|Adverse Event|2|||
126555070|NCT01154036|455324094|FG005|Phase I|Lost to Follow-up|0|||
126555071|NCT01154036|455324095|FG006|Phase I|Lost to Follow-up|0|||
126555072|NCT01154036|455324096|FG007|Phase I|Lost to Follow-up|0|||
126555073|NCT01154036|455324089|FG000|Phase I|Protocol Violation|0|||
126555074|NCT01154036|455324090|FG001|Phase I|Protocol Violation|3|||
126555075|NCT01154036|455324091|FG002|Phase I|Protocol Violation|9|||
126555076|NCT01154036|455324092|FG003|Phase I|Protocol Violation|0|||
126555077|NCT01154036|455324093|FG004|Phase I|Protocol Violation|0|||
126555078|NCT01154036|455324094|FG005|Phase I|Protocol Violation|0|||
126396142|NCT01904149|454744538|FG004|Overall Study|Withdrawal by Subject|1|||
126396143|NCT01904149|454744539|FG005|Overall Study|Withdrawal by Subject|0|||
126396144|NCT01904149|454744534|FG000|Overall Study|Protocol Violation|0|||
126396145|NCT01904149|454744535|FG001|Overall Study|Protocol Violation|1|||
126396146|NCT01904149|454744536|FG002|Overall Study|Protocol Violation|0|||
126396147|NCT01904149|454744537|FG003|Overall Study|Protocol Violation|0|||
126396148|NCT01904149|454744538|FG004|Overall Study|Protocol Violation|0|||
126396149|NCT01904149|454744539|FG005|Overall Study|Protocol Violation|0|||
126396150|NCT01904149|454744534|FG000|Overall Study|non compliance with study drug|1|||
126396151|NCT01904149|454744535|FG001|Overall Study|non compliance with study drug|0|||
126396152|NCT01904149|454744536|FG002|Overall Study|non compliance with study drug|0|||
126396153|NCT01904149|454744537|FG003|Overall Study|non compliance with study drug|0|||
126396154|NCT01904149|454744538|FG004|Overall Study|non compliance with study drug|0|||
126396155|NCT01904149|454744539|FG005|Overall Study|non compliance with study drug|0|||
126470205|NCT02517866|455023577|FG001|Overall Study|Lost to Follow-up|0|||
126470206|NCT02517866|455023578|FG002|Overall Study|Lost to Follow-up|0|||
126555079|NCT01154036|455324095|FG006|Phase I|Protocol Violation|0|||
126555080|NCT01154036|455324096|FG007|Phase I|Protocol Violation|0|||
126555081|NCT01154036|455324089|FG000|Phase I|Withdrawal by Subject|2|||
126555082|NCT01154036|455324090|FG001|Phase I|Withdrawal by Subject|10|||
126555083|NCT01154036|455324091|FG002|Phase I|Withdrawal by Subject|29|||
126555084|NCT01154036|455324092|FG003|Phase I|Withdrawal by Subject|0|||
126555085|NCT01154036|455324093|FG004|Phase I|Withdrawal by Subject|0|||
126555086|NCT01154036|455324094|FG005|Phase I|Withdrawal by Subject|0|||
126555087|NCT01154036|455324095|FG006|Phase I|Withdrawal by Subject|0|||
126555088|NCT01154036|455324096|FG007|Phase I|Withdrawal by Subject|0|||
126555089|NCT01154036|455324089|FG000|Phase I|Adverse Event|1|||
126555090|NCT01154036|455324090|FG001|Phase I|Adverse Event|11|||
126470207|NCT02517866|455023576|FG000|Overall Study|Voluntary Withdrawal|2|||
126470208|NCT02517866|455023577|FG001|Overall Study|Voluntary Withdrawal|2|||
126470209|NCT02517866|455023578|FG002|Overall Study|Voluntary Withdrawal|0|||
126470210|NCT02517866|455023576|FG000|Overall Study|Investigator Decision|2|||
126470211|NCT02517866|455023577|FG001|Overall Study|Investigator Decision|1|||
126470212|NCT02517866|455023578|FG002|Overall Study|Investigator Decision|0|||
126470213|NCT02517866|455023576|FG000|Overall Study|Reason not specified|2|||
126470214|NCT02517866|455023577|FG001|Overall Study|Reason not specified|0|||
126470215|NCT02517866|455023578|FG002|Overall Study|Reason not specified|0|||
126470216|NCT01147640|455023580|FG000|Overall Study|Adverse Event|2|||
126470217|NCT01147640|455023581|FG001|Overall Study|Adverse Event|0|||
126470218|NCT01147640|455023580|FG000|Overall Study|Physician Decision|1|||
126470219|NCT01147640|455023581|FG001|Overall Study|Physician Decision|0|||
126470220|NCT01147640|455023580|FG000|Overall Study|Withdrawal by Subject|1|||
126470221|NCT01147640|455023581|FG001|Overall Study|Withdrawal by Subject|0|||
126470222|NCT01147640|455023580|FG000|Overall Study|Lost to Follow-up|0|||
126470223|NCT01147640|455023581|FG001|Overall Study|Lost to Follow-up|1|||
126470224|NCT01147640|455023580|FG000|Overall Study|Didn't meet eligibility criteria|1|||
126470225|NCT01147640|455023581|FG001|Overall Study|Didn't meet eligibility criteria|0|||
126470226|NCT01797731|455023582|FG000|Overall Study|Didn't have proper radiographs required|3|||
126470227|NCT01797731|455023583|FG001|Overall Study|Didn't have proper radiographs required|3|||
126470228|NCT00091442|455023585|FG000|Overall Study|Progressive Disease|220|||
126470229|NCT00091442|455023586|FG001|Overall Study|Progressive Disease|189|||
126470230|NCT00091442|455023585|FG000|Overall Study|Physician Decision|61|||
126470231|NCT00091442|455023586|FG001|Overall Study|Physician Decision|58|||
126470232|NCT00091442|455023585|FG000|Overall Study|Withdrawal by Subject|38|||
126555091|NCT01154036|455324091|FG002|Phase I|Adverse Event|12|||
126555092|NCT01154036|455324092|FG003|Phase I|Adverse Event|0|||
126470233|NCT00091442|455023586|FG001|Overall Study|Withdrawal by Subject|46|||
126470234|NCT00091442|455023585|FG000|Overall Study|Adverse Event|29|||
126470235|NCT00091442|455023586|FG001|Overall Study|Adverse Event|48|||
126470236|NCT00091442|455023585|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
126470237|NCT00091442|455023586|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
126555093|NCT01154036|455324093|FG004|Phase I|Adverse Event|0|||
126555094|NCT01154036|455324094|FG005|Phase I|Adverse Event|0|||
126555095|NCT01154036|455324095|FG006|Phase I|Adverse Event|0|||
126396156|NCT00835640|454744540|FG000|Second Intervention|Protocol Violation|1|||
126396157|NCT00835640|454744541|FG001|Second Intervention|Protocol Violation|0|||
126470238|NCT00091442|455023585|FG000|Overall Study|Death|9|||
126555096|NCT01154036|455324096|FG007|Phase I|Adverse Event|0|||
126555097|NCT01154036|455324089|FG000|Phase II|Adverse Event|0|||
126555098|NCT01154036|455324090|FG001|Phase II|Adverse Event|0|||
126555099|NCT01154036|455324091|FG002|Phase II|Adverse Event|0|||
126555100|NCT01154036|455324092|FG003|Phase II|Adverse Event|0|||
126720172|NCT02702193|455925035|FG001|8 Month Follow up|Withdrawal by Subject|0|||
126720173|NCT02702193|455925034|FG000|8 Month Follow up|Lost to Follow-up|14|||
126720174|NCT02702193|455925035|FG001|8 Month Follow up|Lost to Follow-up|18|||
126720175|NCT02702193|455925034|FG000|12 Month Follow up|Withdrawal by Subject|1|||
126720176|NCT02702193|455925035|FG001|12 Month Follow up|Withdrawal by Subject|0|||
126720177|NCT02702193|455925034|FG000|12 Month Follow up|Lost to Follow-up|16|||
126720178|NCT02702193|455925035|FG001|12 Month Follow up|Lost to Follow-up|18|||
126720179|NCT01201798|455925039|FG000|Overall Study|Adverse Event|2|||
126720180|NCT01201798|455925040|FG001|Overall Study|Adverse Event|0|||
126720181|NCT01201798|455925039|FG000|Overall Study|Lost to Follow-up|3|||
126720182|NCT01201798|455925040|FG001|Overall Study|Lost to Follow-up|5|||
126720183|NCT01201798|455925039|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
126720184|NCT01201798|455925040|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
126720185|NCT01201798|455925039|FG000|Overall Study|Noncompliance|1|||
126720186|NCT01201798|455925040|FG001|Overall Study|Noncompliance|0|||
126720187|NCT01201798|455925039|FG000|Overall Study|Protocol Violation|1|||
126720188|NCT01201798|455925040|FG001|Overall Study|Protocol Violation|1|||
126720189|NCT01201798|455925039|FG000|Overall Study|Treatment Failure|1|||
126720190|NCT01201798|455925040|FG001|Overall Study|Treatment Failure|8|||
126720191|NCT00525148|455925041|FG000|Overall Study|Other Adverse Event|3|||
126720192|NCT00525148|455925042|FG001|Overall Study|Other Adverse Event|5|||
126720193|NCT00525148|455925043|FG002|Overall Study|Other Adverse Event|1|||
126720194|NCT00525148|455925044|FG003|Overall Study|Other Adverse Event|8|||
126720195|NCT00525148|455925041|FG000|Overall Study|Progressive disease|18|||
126720196|NCT00525148|455925042|FG001|Overall Study|Progressive disease|30|||
126720197|NCT00525148|455925043|FG002|Overall Study|Progressive disease|6|||
126720198|NCT00525148|455925044|FG003|Overall Study|Progressive disease|49|||
126720199|NCT00525148|455925041|FG000|Overall Study|Refused continuation of study medication|0|||
126720200|NCT00525148|455925042|FG001|Overall Study|Refused continuation of study medication|2|||
126720201|NCT00525148|455925043|FG002|Overall Study|Refused continuation of study medication|0|||
126720202|NCT00525148|455925044|FG003|Overall Study|Refused continuation of study medication|1|||
126396158|NCT00068250|454744542|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
126396159|NCT00068250|454744543|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
126396160|NCT00068250|454744544|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
126396161|NCT00068250|454744545|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
126396162|NCT00812006|454744546|FG000|Overall Study|Lost to Follow-up|0|||
126396163|NCT00812006|454744547|FG001|Overall Study|Lost to Follow-up|0|||
126396164|NCT00812006|454744548|FG002|Overall Study|Lost to Follow-up|2|||
126396165|NCT00812006|454744546|FG000|Overall Study|Physician Decision|0|||
126396166|NCT00812006|454744547|FG001|Overall Study|Physician Decision|0|||
126396167|NCT00812006|454744548|FG002|Overall Study|Physician Decision|1|||
126396168|NCT00812006|454744546|FG000|Overall Study|Withdrawal by Subject|2|||
126396169|NCT00812006|454744547|FG001|Overall Study|Withdrawal by Subject|1|||
126396170|NCT00812006|454744548|FG002|Overall Study|Withdrawal by Subject|1|||
126396171|NCT00812006|454744546|FG000|Overall Study|Lack of Qualifying Event|4|||
126396172|NCT00812006|454744547|FG001|Overall Study|Lack of Qualifying Event|2|||
126396173|NCT00812006|454744548|FG002|Overall Study|Lack of Qualifying Event|2|||
126396174|NCT00235391|454744549|FG000|Overall Study|Adverse Event|4|||
126396175|NCT00235391|454744550|FG001|Overall Study|Adverse Event|5|||
126396176|NCT00235391|454744551|FG002|Overall Study|Adverse Event|10|||
126396177|NCT00235391|454744552|FG003|Overall Study|Adverse Event|72|||
126396178|NCT00235391|454744553|FG004|Overall Study|Adverse Event|5|||
126396179|NCT00235391|454744554|FG005|Overall Study|Adverse Event|2|||
126396180|NCT00235391|454744549|FG000|Overall Study|Abnormal laboratory value(s)|3|||
126396181|NCT00235391|454744550|FG001|Overall Study|Abnormal laboratory value(s)|5|||
126396182|NCT00235391|454744551|FG002|Overall Study|Abnormal laboratory value(s)|4|||
126396183|NCT00235391|454744552|FG003|Overall Study|Abnormal laboratory value(s)|27|||
126396184|NCT00235391|454744553|FG004|Overall Study|Abnormal laboratory value(s)|1|||
126396185|NCT00235391|454744554|FG005|Overall Study|Abnormal laboratory value(s)|2|||
126396186|NCT00235391|454744549|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126396187|NCT00235391|454744550|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126555101|NCT01154036|455324093|FG004|Phase II|Adverse Event|1|||
126555102|NCT01154036|455324094|FG005|Phase II|Adverse Event|1|||
126720203|NCT00525148|455925041|FG000|Overall Study|Other than stated|2|||
126720204|NCT00525148|455925042|FG001|Overall Study|Other than stated|1|||
126396188|NCT00235391|454744551|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126396189|NCT00235391|454744552|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
126396190|NCT00235391|454744553|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
126396191|NCT00235391|454744554|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
126396192|NCT00235391|454744549|FG000|Overall Study|Condition no longer requires treatment|3|||
126396193|NCT00235391|454744550|FG001|Overall Study|Condition no longer requires treatment|0|||
126555103|NCT01154036|455324095|FG006|Phase II|Adverse Event|1|||
126720205|NCT00525148|455925043|FG002|Overall Study|Other than stated|0|||
126720206|NCT00525148|455925044|FG003|Overall Study|Other than stated|3|||
126470239|NCT00091442|455023586|FG001|Overall Study|Death|7|||
126470240|NCT00091442|455023585|FG000|Overall Study|Lost to Follow-up|1|||
126470241|NCT00091442|455023586|FG001|Overall Study|Lost to Follow-up|3|||
126470242|NCT00091442|455023585|FG000|Overall Study|Other|2|||
126470243|NCT00091442|455023586|FG001|Overall Study|Other|6|||
126470244|NCT01954342|455023587|FG000|Overall Study|Missing data from 13-16week study visit|0|||
126470245|NCT01954342|455023588|FG001|Overall Study|Missing data from 13-16week study visit|0|||
126470246|NCT01954342|455023589|FG002|Overall Study|Missing data from 13-16week study visit|0|||
126470247|NCT01954342|455023590|FG003|Overall Study|Missing data from 13-16week study visit|1|||
126470248|NCT01954342|455023587|FG000|Overall Study|Miscarriage|0|||
126470249|NCT01954342|455023588|FG001|Overall Study|Miscarriage|0|||
126470250|NCT01954342|455023589|FG002|Overall Study|Miscarriage|0|||
126470251|NCT01954342|455023590|FG003|Overall Study|Miscarriage|3|||
126470252|NCT01954342|455023587|FG000|Overall Study|Lost to Follow-up|0|||
126470253|NCT01954342|455023588|FG001|Overall Study|Lost to Follow-up|0|||
126470254|NCT01954342|455023589|FG002|Overall Study|Lost to Follow-up|0|||
126470255|NCT01954342|455023590|FG003|Overall Study|Lost to Follow-up|5|||
126470256|NCT01954342|455023587|FG000|Overall Study|Preterm delivery|0|||
126470257|NCT01954342|455023588|FG001|Overall Study|Preterm delivery|0|||
126470258|NCT01954342|455023589|FG002|Overall Study|Preterm delivery|0|||
126470259|NCT01954342|455023590|FG003|Overall Study|Preterm delivery|3|||
126470260|NCT01954342|455023587|FG000|Overall Study|Pre-eclampsia|0|||
126470261|NCT01954342|455023588|FG001|Overall Study|Pre-eclampsia|0|||
126470262|NCT01954342|455023589|FG002|Overall Study|Pre-eclampsia|0|||
126470263|NCT01954342|455023590|FG003|Overall Study|Pre-eclampsia|4|||
126470264|NCT01954342|455023587|FG000|Overall Study|Unreliable Data|0|||
126470265|NCT01954342|455023588|FG001|Overall Study|Unreliable Data|0|||
126470266|NCT01954342|455023589|FG002|Overall Study|Unreliable Data|0|||
126470267|NCT01954342|455023590|FG003|Overall Study|Unreliable Data|2|||
126470268|NCT00629772|455023595|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
126470269|NCT00629772|455023596|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
126470270|NCT00629772|455023595|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
126470271|NCT00629772|455023596|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
126470272|NCT00722423|455023597|FG000|Overall Study|Protocol Violation|0|||
126470273|NCT00722423|455023598|FG001|Overall Study|Protocol Violation|1|||
126470274|NCT01497275|455023599|FG000|Overall Study|Death|1|||
126470275|NCT01497275|455023599|FG000|Overall Study|Adverse Event|1|||
126470276|NCT01950169|455023600|FG000|Overall Study|Withdrawal by Subject|2|||
126470277|NCT01950169|455023601|FG001|Overall Study|Withdrawal by Subject|8|||
126470278|NCT01950169|455023602|FG002|Overall Study|Withdrawal by Subject|1|||
126470279|NCT01950169|455023600|FG000|Overall Study|Death|1|||
126470280|NCT01950169|455023601|FG001|Overall Study|Death|0|||
126470281|NCT01950169|455023602|FG002|Overall Study|Death|0|||
126470282|NCT02410551|455023605|FG000|Overall Study|Adverse Event|1|||
126470283|NCT02410551|455023605|FG000|Overall Study|Withdrawal by Subject|1|||
126470284|NCT02410551|455023605|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
126470285|NCT05085730|455023608|FG000|Overall Study|Withdrawal by Subject|4|||
126470286|NCT05085730|455023608|FG000|Overall Study|Physician Decision|1|||
126470287|NCT05447897|455023609|FG000|Overall Study|Did not participate in survey|2|||
126470288|NCT01332331|455023620|FG000|Overall Study|Lost to Follow-up|0|||
126470289|NCT01332331|455023621|FG001|Overall Study|Lost to Follow-up|1|||
126470290|NCT01332331|455023620|FG000|Overall Study|Adverse Event|1|||
126470291|NCT01332331|455023621|FG001|Overall Study|Adverse Event|1|||
126470292|NCT01332331|455023620|FG000|Overall Study|Physician Decision|1|||
126470293|NCT01332331|455023621|FG001|Overall Study|Physician Decision|0|||
126470294|NCT04810481|455023623|FG000|Overall Study|Disqualified data sets|10|||
126470295|NCT04810481|455023624|FG001|Overall Study|Disqualified data sets|28|||
126470296|NCT03605212|455023627|FG000|Treatment Period|Adverse Event|1|||
126470297|NCT03605212|455023628|FG001|Treatment Period|Adverse Event|0|||
126470298|NCT03605212|455023629|FG002|Treatment Period|Adverse Event|0|||
126470299|NCT03605212|455023630|FG003|Treatment Period|Adverse Event|0|||
126470300|NCT03605212|455023631|FG004|Treatment Period|Adverse Event|0|||
126470301|NCT03605212|455023627|FG000|Treatment Period|Physician Decision|0|||
126470302|NCT03605212|455023628|FG001|Treatment Period|Physician Decision|0|||
126470303|NCT03605212|455023629|FG002|Treatment Period|Physician Decision|0|||
126470304|NCT03605212|455023630|FG003|Treatment Period|Physician Decision|0|||
126470305|NCT03605212|455023631|FG004|Treatment Period|Physician Decision|1|||
126470306|NCT01756053|455023632|FG000|Period 1 (10 Days)|Protocol Violation|1|||
126470307|NCT01756053|455023633|FG001|Period 1 (10 Days)|Protocol Violation|1|||
126470308|NCT01756053|455023632|FG000|Period 2 (10 Days)|Protocol Violation|0|||
126470309|NCT01756053|455023633|FG001|Period 2 (10 Days)|Protocol Violation|2|||
126470310|NCT00285818|455023634|FG000|Overall Study|Withdrawal by Subject|3|||
126470311|NCT00285818|455023635|FG001|Overall Study|Withdrawal by Subject|2|||
126470312|NCT00285818|455023634|FG000|Overall Study|Lost to Follow-up|1|||
126470313|NCT00285818|455023635|FG001|Overall Study|Lost to Follow-up|0|||
126470314|NCT01230710|455023640|FG000|Overall Study|Disease Progression|41|||
126470315|NCT01230710|455023640|FG000|Overall Study|Lost to Follow-up|3|||
126470316|NCT01230710|455023640|FG000|Overall Study|Death|4|||
126396194|NCT00235391|454744551|FG002|Overall Study|Condition no longer requires treatment|0|||
126396195|NCT00235391|454744552|FG003|Overall Study|Condition no longer requires treatment|11|||
126396196|NCT00235391|454744553|FG004|Overall Study|Condition no longer requires treatment|1|||
126396197|NCT00235391|454744554|FG005|Overall Study|Condition no longer requires treatment|0|||
126396198|NCT00235391|454744549|FG000|Overall Study|Protocol deviation|0|||
126396199|NCT00235391|454744550|FG001|Overall Study|Protocol deviation|0|||
126396200|NCT00235391|454744551|FG002|Overall Study|Protocol deviation|1|||
126396201|NCT00235391|454744552|FG003|Overall Study|Protocol deviation|11|||
126396202|NCT00235391|454744553|FG004|Overall Study|Protocol deviation|0|||
126396203|NCT00235391|454744554|FG005|Overall Study|Protocol deviation|0|||
126396204|NCT00235391|454744549|FG000|Overall Study|Withdrawal by Subject|2|||
126396205|NCT00235391|454744550|FG001|Overall Study|Withdrawal by Subject|3|||
126396206|NCT00235391|454744551|FG002|Overall Study|Withdrawal by Subject|3|||
126396207|NCT00235391|454744552|FG003|Overall Study|Withdrawal by Subject|61|||
126396208|NCT00235391|454744553|FG004|Overall Study|Withdrawal by Subject|5|||
126555104|NCT01154036|455324096|FG007|Phase II|Adverse Event|1|||
126720207|NCT00114972|455925046|FG000|Overall Study|Withdrawal by Subject|40|||
126720208|NCT00114972|455925047|FG001|Overall Study|Withdrawal by Subject|7|||
126720209|NCT00114972|455925046|FG000|Overall Study|Lost to Follow-up|8|||
126720210|NCT00114972|455925047|FG001|Overall Study|Lost to Follow-up|5|||
126720211|NCT03609359|455925048|FG000|Overall Study|Progression of primary disease (PD)|25|||
126720212|NCT03609359|455925048|FG000|Overall Study|Patient's refusal|1|||
126720213|NCT03609359|455925048|FG000|Overall Study|Physician Decision|1|||
126720214|NCT03609359|455925048|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
126720215|NCT01425190|455925050|FG000|Overall Study|Full dose not consumed.|1|||
126720216|NCT01425190|455925051|FG001|Overall Study|Full dose not consumed.|0|||
126720217|NCT01425190|455925052|FG002|Overall Study|Full dose not consumed.|0|||
126720218|NCT01035255|455925053|FG000|Overall Study|Death|724|||
126720219|NCT01035255|455925054|FG001|Overall Study|Death|844|||
126720220|NCT01035255|455925053|FG000|Overall Study|Lost to Follow-up|2|||
126720221|NCT01035255|455925054|FG001|Overall Study|Lost to Follow-up|5|||
126720222|NCT01035255|455925053|FG000|Overall Study|patient's request|15|||
126720223|NCT01035255|455925054|FG001|Overall Study|patient's request|13|||
126720224|NCT04590937|455925057|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
126720225|NCT01635933|455925058|FG000|Overall Study|Adverse Event|1|||
126720226|NCT01635933|455925059|FG001|Overall Study|Adverse Event|0|||
126720227|NCT01635933|455925058|FG000|Overall Study|Lost to Follow-up|0|||
126720228|NCT01635933|455925059|FG001|Overall Study|Lost to Follow-up|5|||
126720229|NCT01635933|455925058|FG000|Overall Study|Subject decision|1|||
126720230|NCT01635933|455925059|FG001|Overall Study|Subject decision|1|||
126720231|NCT01635933|455925058|FG000|Overall Study|Noncompliance|0|||
126720232|NCT01635933|455925059|FG001|Overall Study|Noncompliance|1|||
126720233|NCT01635933|455925058|FG000|Overall Study|No longer had transportation|0|||
126720234|NCT01635933|455925059|FG001|Overall Study|No longer had transportation|1|||
126720235|NCT04743635|455925062|FG000|Overall Study|Lost to Follow-up|2|||
126720236|NCT04743635|455925063|FG001|Overall Study|Lost to Follow-up|0|||
126720237|NCT03987620|455925064|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
126720238|NCT03987620|455925065|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
126720239|NCT03987620|455925064|FG000|Overall Study|Adverse Event|3|||
126720240|NCT03987620|455925065|FG001|Overall Study|Adverse Event|0|||
126720241|NCT03987620|455925064|FG000|Overall Study|Lost to Follow-up|1|||
126720242|NCT03987620|455925065|FG001|Overall Study|Lost to Follow-up|2|||
126720243|NCT03987620|455925064|FG000|Overall Study|Physician Decision|0|||
126720244|NCT03987620|455925065|FG001|Overall Study|Physician Decision|1|||
126720245|NCT03987620|455925064|FG000|Overall Study|Pregnancy|1|||
126720246|NCT03987620|455925065|FG001|Overall Study|Pregnancy|0|||
126720247|NCT03987620|455925064|FG000|Overall Study|Withdrawal by Subject|7|||
126720248|NCT03987620|455925065|FG001|Overall Study|Withdrawal by Subject|1|||
126720249|NCT03987620|455925064|FG000|Overall Study|Other|2|||
126720250|NCT03987620|455925065|FG001|Overall Study|Other|5|||
126720251|NCT01204658|455925069|FG000|Primary Phase|Adverse Event|0|||
126720252|NCT01204658|455925070|FG001|Primary Phase|Adverse Event|0|||
126720253|NCT01204658|455925071|FG002|Primary Phase|Adverse Event|1|||
126720254|NCT01204658|455925072|FG003|Primary Phase|Adverse Event|0|||
126720255|NCT05513053|455925073|FG000|Overall Study|Lost to Follow-up|9|||
126720256|NCT05513053|455925074|FG001|Overall Study|Lost to Follow-up|11|||
126720257|NCT05513053|455925073|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126720258|NCT05513053|455925074|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126720259|NCT05513053|455925073|FG000|Overall Study|Withdrawal by Subject|2|||
126720260|NCT05513053|455925074|FG001|Overall Study|Withdrawal by Subject|9|||
126720261|NCT05513053|455925073|FG000|Overall Study|Protocol Violation|6|||
126720262|NCT05513053|455925074|FG001|Overall Study|Protocol Violation|3|||
126720263|NCT05513053|455925073|FG000|Overall Study|Adverse Event|0|||
126396209|NCT00235391|454744554|FG005|Overall Study|Withdrawal by Subject|0|||
126396210|NCT00235391|454744549|FG000|Overall Study|Lost to Follow-up|0|||
126396211|NCT00235391|454744550|FG001|Overall Study|Lost to Follow-up|3|||
126396212|NCT00235391|454744551|FG002|Overall Study|Lost to Follow-up|3|||
126470317|NCT01230710|455023640|FG000|Overall Study|Withdrawal of Consent|1|||
126470318|NCT00464269|455023641|FG000|Overall Study|Lack of Efficacy|1|||
126470319|NCT00464269|455023642|FG001|Overall Study|Lack of Efficacy|0|||
126470320|NCT00464269|455023643|FG002|Overall Study|Lack of Efficacy|0|||
126470321|NCT00464269|455023644|FG003|Overall Study|Lack of Efficacy|0|||
126470322|NCT00464269|455023641|FG000|Overall Study|Lost to Follow-up|0|||
126470323|NCT00464269|455023642|FG001|Overall Study|Lost to Follow-up|4|||
126470324|NCT00464269|455023643|FG002|Overall Study|Lost to Follow-up|0|||
126470325|NCT00464269|455023644|FG003|Overall Study|Lost to Follow-up|1|||
126470326|NCT00464269|455023641|FG000|Overall Study|Withdrawal by Subject|0|||
126470327|NCT00464269|455023642|FG001|Overall Study|Withdrawal by Subject|2|||
126470328|NCT00464269|455023643|FG002|Overall Study|Withdrawal by Subject|1|||
126470329|NCT00464269|455023644|FG003|Overall Study|Withdrawal by Subject|1|||
126470330|NCT00464269|455023641|FG000|Overall Study|Other reason|3|||
126470331|NCT00464269|455023642|FG001|Overall Study|Other reason|3|||
126470332|NCT00464269|455023643|FG002|Overall Study|Other reason|1|||
126470333|NCT00464269|455023644|FG003|Overall Study|Other reason|1|||
126470334|NCT00464269|455023641|FG000|Overall Study|AE, serious fatal|0|||
126470335|NCT00464269|455023642|FG001|Overall Study|AE, serious fatal|0|||
126470336|NCT00464269|455023643|FG002|Overall Study|AE, serious fatal|1|||
126470337|NCT00464269|455023644|FG003|Overall Study|AE, serious fatal|1|||
126470338|NCT00464269|455023641|FG000|Overall Study|SAE, non-fatal|0|||
126470339|NCT00464269|455023642|FG001|Overall Study|SAE, non-fatal|0|||
126470340|NCT00464269|455023643|FG002|Overall Study|SAE, non-fatal|0|||
126470341|NCT00464269|455023644|FG003|Overall Study|SAE, non-fatal|1|||
126470342|NCT00464269|455023641|FG000|Overall Study|AE, non-serious non-fatal|2|||
126470343|NCT00464269|455023642|FG001|Overall Study|AE, non-serious non-fatal|8|||
126470344|NCT00464269|455023643|FG002|Overall Study|AE, non-serious non-fatal|3|||
126470345|NCT00464269|455023644|FG003|Overall Study|AE, non-serious non-fatal|4|||
126470346|NCT00464269|455023641|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
126470347|NCT00464269|455023642|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
126470348|NCT00464269|455023643|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
126470349|NCT00464269|455023644|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
126470350|NCT02337738|455023645|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
126470351|NCT02337738|455023646|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
126470352|NCT02337738|455023647|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
126470353|NCT02337738|455023645|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
126470354|NCT02337738|455023646|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
126470355|NCT02337738|455023647|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
126470356|NCT02337738|455023645|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
126470357|NCT02337738|455023646|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
126470358|NCT02337738|455023647|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
126470359|NCT02337738|455023645|FG000|Overall Study|Voluntary Withdrawal|10|||
126470360|NCT02337738|455023646|FG001|Overall Study|Voluntary Withdrawal|5|||
126720264|NCT05513053|455925074|FG001|Overall Study|Adverse Event|2|||
126720265|NCT00492856|455926624|FG000|Induction|Adverse Event|2|||
126720266|NCT00492856|455926625|FG001|Induction|Adverse Event|0|||
126396213|NCT00235391|454744552|FG003|Overall Study|Lost to Follow-up|16|||
126396214|NCT00235391|454744553|FG004|Overall Study|Lost to Follow-up|0|||
126396215|NCT00235391|454744554|FG005|Overall Study|Lost to Follow-up|0|||
126396216|NCT00235391|454744549|FG000|Overall Study|Administrative problems|0|||
126396217|NCT00235391|454744550|FG001|Overall Study|Administrative problems|0|||
126396218|NCT00235391|454744551|FG002|Overall Study|Administrative problems|0|||
126396219|NCT00235391|454744552|FG003|Overall Study|Administrative problems|1|||
126396220|NCT00235391|454744553|FG004|Overall Study|Administrative problems|0|||
126396221|NCT00235391|454744554|FG005|Overall Study|Administrative problems|0|||
126396222|NCT00235391|454744549|FG000|Overall Study|Death|0|||
126396223|NCT00235391|454744550|FG001|Overall Study|Death|0|||
126396224|NCT00235391|454744551|FG002|Overall Study|Death|1|||
126396225|NCT00235391|454744552|FG003|Overall Study|Death|4|||
126396226|NCT00235391|454744553|FG004|Overall Study|Death|0|||
126396227|NCT00235391|454744554|FG005|Overall Study|Death|0|||
126470361|NCT02337738|455023647|FG002|Overall Study|Voluntary Withdrawal|2|||
126470362|NCT02337738|455023645|FG000|Overall Study|Lack of Efficacy|2|||
126470363|NCT02337738|455023646|FG001|Overall Study|Lack of Efficacy|4|||
126470364|NCT02337738|455023647|FG002|Overall Study|Lack of Efficacy|0|||
126470365|NCT02337738|455023645|FG000|Overall Study|Investigator's Judgment|1|||
126470366|NCT02337738|455023646|FG001|Overall Study|Investigator's Judgment|1|||
126720267|NCT00492856|455926626|FG002|Induction|Adverse Event|0|||
126470367|NCT02337738|455023647|FG002|Overall Study|Investigator's Judgment|3|||
126470368|NCT00406354|455023648|FG000|All Randomized Patients|Protocol Violation|0|||
126470369|NCT00406354|455023649|FG001|All Randomized Patients|Protocol Violation|0|||
126396228|NCT03349645|454744555|FG000|Overall Study|Sponsor Terminated Study|75|||
126396229|NCT03349645|454744555|FG000|Overall Study|Withdrawal by Subject|4|||
126396230|NCT03349645|454744555|FG000|Overall Study|Protocol Violation|1|||
126470370|NCT00406354|455023650|FG002|All Randomized Patients|Protocol Violation|1|||
126720268|NCT00492856|455926627|FG003|Induction|Adverse Event|0|||
126555105|NCT01154036|455324089|FG000|Phase II|Physician Decision|0|||
126555106|NCT01154036|455324090|FG001|Phase II|Physician Decision|0|||
126555107|NCT01154036|455324091|FG002|Phase II|Physician Decision|0|||
126396231|NCT03349645|454744555|FG000|Overall Study|Other|2|||
126396232|NCT00580034|454744556|FG000|Overall Study|Toxicity|10|||
126396233|NCT00580034|454744557|FG001|Overall Study|Toxicity|0|||
126396234|NCT00098748|454744560|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
126396235|NCT00098748|454744561|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
126396236|NCT00098748|454744562|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
126396237|NCT00098748|454744560|FG000|Received Study Treatment|Death|2|||
126396238|NCT00098748|454744561|FG001|Received Study Treatment|Death|1|||
126396239|NCT00098748|454744562|FG002|Received Study Treatment|Death|2|||
126396240|NCT00098748|454744560|FG000|Received Study Treatment|Adverse Event|1|||
126396241|NCT00098748|454744561|FG001|Received Study Treatment|Adverse Event|2|||
126396242|NCT00098748|454744562|FG002|Received Study Treatment|Adverse Event|5|||
126396243|NCT00098748|454744560|FG000|Received Study Treatment|Lack of Efficacy|40|||
126396244|NCT00098748|454744561|FG001|Received Study Treatment|Lack of Efficacy|27|||
126396245|NCT00098748|454744562|FG002|Received Study Treatment|Lack of Efficacy|27|||
126396246|NCT00098748|454744560|FG000|Received Study Treatment|Other|2|||
126396247|NCT00098748|454744561|FG001|Received Study Treatment|Other|2|||
126396248|NCT00098748|454744562|FG002|Received Study Treatment|Other|6|||
126396249|NCT00098748|454744560|FG000|Received Study Treatment|Subject defaulted|3|||
126396250|NCT00098748|454744561|FG001|Received Study Treatment|Subject defaulted|4|||
126396251|NCT00098748|454744562|FG002|Received Study Treatment|Subject defaulted|4|||
126396252|NCT00098748|454744560|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
126396253|NCT00098748|454744561|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
126396254|NCT00098748|454744562|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
126396255|NCT00098748|454744560|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
126396256|NCT00098748|454744561|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
126396257|NCT00098748|454744562|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
126396258|NCT00098748|454744560|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
126396259|NCT00098748|454744561|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
126396260|NCT00098748|454744562|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
126396261|NCT00098748|454744560|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
126396262|NCT00098748|454744561|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
126396263|NCT00098748|454744562|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
126396264|NCT00098748|454744560|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
126396265|NCT00098748|454744561|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
126396266|NCT00098748|454744562|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
126396267|NCT02439450|454744566|FG000|Overall Study|Adverse Event|4|||
126396268|NCT02439450|454744567|FG001|Overall Study|Adverse Event|1|||
126396269|NCT02439450|454744568|FG002|Overall Study|Adverse Event|0|||
126396270|NCT02439450|454744569|FG003|Overall Study|Adverse Event|0|||
126396271|NCT02439450|454744566|FG000|Overall Study|Withdrawal by Subject|1|||
126396272|NCT02439450|454744567|FG001|Overall Study|Withdrawal by Subject|2|||
126396273|NCT02439450|454744568|FG002|Overall Study|Withdrawal by Subject|0|||
126396274|NCT02439450|454744569|FG003|Overall Study|Withdrawal by Subject|0|||
126396275|NCT02439450|454744566|FG000|Overall Study|Death|3|||
126396276|NCT02439450|454744567|FG001|Overall Study|Death|0|||
126396277|NCT02439450|454744568|FG002|Overall Study|Death|0|||
126396278|NCT02439450|454744569|FG003|Overall Study|Death|1|||
126396279|NCT02439450|454744566|FG000|Overall Study|Progressive Disease|18|||
126396280|NCT02439450|454744567|FG001|Overall Study|Progressive Disease|41|||
126396281|NCT02439450|454744568|FG002|Overall Study|Progressive Disease|2|||
126396282|NCT02439450|454744569|FG003|Overall Study|Progressive Disease|3|||
126396283|NCT01081301|454744572|FG000|Overall Study|Bereaved|3|||
126396284|NCT01081301|454744572|FG000|Overall Study|Too busy|5|||
126396285|NCT01081301|454744572|FG000|Overall Study|Patient too ill|2|||
126396286|NCT01081301|454744572|FG000|Overall Study|Lost to Follow-up|4|||
126396287|NCT03551665|454744575|FG000|Overall Study|Lost to Follow-up|11|||
126396288|NCT03551665|454744576|FG001|Overall Study|Lost to Follow-up|2|||
126396289|NCT00549900|454745888|FG000|Overall Study|Adverse Event|1|||
126396290|NCT03283098|454745889|FG000|Overall Study|Withdrawal by Subject|0|||
126396291|NCT03283098|454745890|FG001|Overall Study|Withdrawal by Subject|1|||
126396292|NCT02251717|454745893|FG000|Overall Study|Adverse Event|0|||
126396293|NCT02251717|454745894|FG001|Overall Study|Adverse Event|1|||
126396294|NCT02251717|454745893|FG000|Overall Study|Withdrew Consent|1|||
126396295|NCT02251717|454745894|FG001|Overall Study|Withdrew Consent|0|||
126555108|NCT01154036|455324092|FG003|Phase II|Physician Decision|0|||
126396296|NCT03356977|454745895|FG000|Overall Study|Lost to Follow-up|3|||
126396297|NCT03356977|454745895|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126396298|NCT00445939|454745900|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
126396299|NCT00445939|454745901|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
126555109|NCT01154036|455324093|FG004|Phase II|Physician Decision|0|||
126396300|NCT00445939|454745902|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
126555110|NCT01154036|455324094|FG005|Phase II|Physician Decision|0|||
126555111|NCT01154036|455324095|FG006|Phase II|Physician Decision|1|||
126555112|NCT01154036|455324096|FG007|Phase II|Physician Decision|0|||
126555113|NCT01154036|455324089|FG000|Phase II|Lost to Follow-up|0|||
126555114|NCT01154036|455324090|FG001|Phase II|Lost to Follow-up|0|||
126555115|NCT01154036|455324091|FG002|Phase II|Lost to Follow-up|0|||
126555116|NCT01154036|455324092|FG003|Phase II|Lost to Follow-up|1|||
126555117|NCT01154036|455324093|FG004|Phase II|Lost to Follow-up|2|||
126555118|NCT01154036|455324094|FG005|Phase II|Lost to Follow-up|0|||
126555119|NCT01154036|455324095|FG006|Phase II|Lost to Follow-up|2|||
126555120|NCT01154036|455324096|FG007|Phase II|Lost to Follow-up|1|||
126771910|NCT01220128|456120034|FG000|Overall Study|Progressive disease|0|||
126771911|NCT01220128|456120035|FG001|Overall Study|Progressive disease|0|||
126771912|NCT01220128|456120036|FG002|Overall Study|Progressive disease|2|||
126771913|NCT01220128|456120037|FG003|Overall Study|Progressive disease|0|||
126771914|NCT01220128|456120038|FG004|Overall Study|Progressive disease|0|||
126771915|NCT01220128|456120039|FG005|Overall Study|Progressive disease|0|||
126771916|NCT01220128|456120040|FG006|Overall Study|Progressive disease|0|||
126771917|NCT01220128|456120034|FG000|Overall Study|Sponsor study termination|0|||
126771918|NCT01220128|456120035|FG001|Overall Study|Sponsor study termination|1|||
126771919|NCT01220128|456120036|FG002|Overall Study|Sponsor study termination|0|||
126771920|NCT01220128|456120037|FG003|Overall Study|Sponsor study termination|0|||
126771921|NCT01220128|456120038|FG004|Overall Study|Sponsor study termination|0|||
126771922|NCT01220128|456120039|FG005|Overall Study|Sponsor study termination|0|||
126771923|NCT01220128|456120040|FG006|Overall Study|Sponsor study termination|1|||
126771924|NCT01220128|456120034|FG000|Overall Study|Adverse event, serious fatal|2|||
126396301|NCT00445939|454745903|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
126396302|NCT00445939|454745900|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
126396303|NCT00445939|454745901|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
126396304|NCT00445939|454745902|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
126396305|NCT00445939|454745903|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
126396306|NCT00798317|454745904|FG000|Overall Study|Physician Decision|0|||
126396307|NCT00798317|454745905|FG001|Overall Study|Physician Decision|1|||
126396308|NCT00798317|454745904|FG000|Overall Study|Withdrawal by Subject|5|||
126396309|NCT00798317|454745905|FG001|Overall Study|Withdrawal by Subject|4|||
126396310|NCT00798317|454745904|FG000|Overall Study|Lost to Follow-up|2|||
126396311|NCT00798317|454745905|FG001|Overall Study|Lost to Follow-up|2|||
126396312|NCT00798317|454745904|FG000|Overall Study|Adverse Event|2|||
126396313|NCT00798317|454745905|FG001|Overall Study|Adverse Event|0|||
126396314|NCT00798317|454745904|FG000|Overall Study|Death|1|||
126396315|NCT00798317|454745905|FG001|Overall Study|Death|0|||
126396316|NCT00489736|454745906|FG000|Overall Study|Lack of Efficacy|53|||
126396317|NCT00489736|454745907|FG001|Overall Study|Lack of Efficacy|14|||
126396318|NCT00489736|454745906|FG000|Overall Study|Adverse Event|32|||
126396319|NCT00489736|454745907|FG001|Overall Study|Adverse Event|45|||
126396320|NCT00489736|454745906|FG000|Overall Study|Poor compliance|6|||
126396321|NCT00489736|454745907|FG001|Overall Study|Poor compliance|2|||
126396322|NCT00489736|454745906|FG000|Overall Study|Not coded/ Not pre-specified|5|||
126396323|NCT00489736|454745907|FG001|Overall Study|Not coded/ Not pre-specified|8|||
126396324|NCT02576535|454745908|FG000|Overall Study|Withdrawal by Subject|2|||
126396325|NCT02545517|454745909|FG000|Overall Study|Death|2|||
126396326|NCT02545517|454745910|FG001|Overall Study|Death|2|||
126396327|NCT02545517|454745911|FG002|Overall Study|Death|1|||
126396328|NCT02545517|454745909|FG000|Overall Study|Lost to Follow-up|14|||
126396329|NCT02545517|454745910|FG001|Overall Study|Lost to Follow-up|13|||
126396330|NCT02545517|454745911|FG002|Overall Study|Lost to Follow-up|17|||
126396331|NCT02545517|454745909|FG000|Overall Study|Protocol Violation|0|||
126396332|NCT02545517|454745910|FG001|Overall Study|Protocol Violation|1|||
126396333|NCT02545517|454745911|FG002|Overall Study|Protocol Violation|1|||
126396334|NCT02545517|454745909|FG000|Overall Study|Withdrawal by Subject|5|||
126396335|NCT02545517|454745910|FG001|Overall Study|Withdrawal by Subject|8|||
126396336|NCT02545517|454745911|FG002|Overall Study|Withdrawal by Subject|9|||
126396337|NCT02545517|454745909|FG000|Overall Study|Administrative reason|5|||
126396338|NCT02545517|454745910|FG001|Overall Study|Administrative reason|6|||
126396339|NCT02545517|454745911|FG002|Overall Study|Administrative reason|10|||
126396340|NCT02545517|454745909|FG000|Overall Study|Other|2|||
126396341|NCT02545517|454745910|FG001|Overall Study|Other|4|||
126396342|NCT02545517|454745911|FG002|Overall Study|Other|3|||
126396343|NCT01529515|454745914|FG000|TRANSITION PHASE|Adverse Event|16|||
126555121|NCT01154036|455324089|FG000|Phase II|Protocol Violation|0|||
126555122|NCT01154036|455324090|FG001|Phase II|Protocol Violation|0|||
126771925|NCT01220128|456120035|FG001|Overall Study|Adverse event, serious fatal|0|||
126555123|NCT01154036|455324091|FG002|Phase II|Protocol Violation|0|||
126396344|NCT01529515|454745915|FG001|TRANSITION PHASE|Adverse Event|0|||
126396345|NCT01529515|454745916|FG002|TRANSITION PHASE|Adverse Event|0|||
126396346|NCT01529515|454745917|FG003|TRANSITION PHASE|Adverse Event|0|||
126396347|NCT01529515|454745914|FG000|TRANSITION PHASE|Death|1|||
126396348|NCT01529515|454745915|FG001|TRANSITION PHASE|Death|0|||
126396349|NCT01529515|454745916|FG002|TRANSITION PHASE|Death|0|||
126771926|NCT01220128|456120036|FG002|Overall Study|Adverse event, serious fatal|0|||
126396350|NCT01529515|454745917|FG003|TRANSITION PHASE|Death|0|||
126396351|NCT01529515|454745914|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
126396352|NCT01529515|454745915|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
126396353|NCT01529515|454745916|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
126396354|NCT01529515|454745917|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
126396355|NCT01529515|454745914|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
126396356|NCT01529515|454745915|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
126396357|NCT01529515|454745916|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
126396358|NCT01529515|454745917|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
126396359|NCT01529515|454745914|FG000|TRANSITION PHASE|Protocol Violation|4|||
126396360|NCT01529515|454745915|FG001|TRANSITION PHASE|Protocol Violation|0|||
126396361|NCT01529515|454745916|FG002|TRANSITION PHASE|Protocol Violation|0|||
126396362|NCT01529515|454745917|FG003|TRANSITION PHASE|Protocol Violation|0|||
126396363|NCT01529515|454745914|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
126396364|NCT01529515|454745915|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
126396365|NCT01529515|454745916|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
126396366|NCT01529515|454745917|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
126396367|NCT01529515|454745914|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
126396368|NCT01529515|454745915|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
126396369|NCT01529515|454745916|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
126396370|NCT01529515|454745917|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
126396371|NCT01529515|454745914|FG000|TRANSITION PHASE|Other|9|||
126396372|NCT01529515|454745915|FG001|TRANSITION PHASE|Other|0|||
126396373|NCT01529515|454745916|FG002|TRANSITION PHASE|Other|0|||
126396374|NCT01529515|454745917|FG003|TRANSITION PHASE|Other|0|||
126396375|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Adverse Event|0|||
126396376|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Adverse Event|10|||
126396377|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Adverse Event|0|||
126396378|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Adverse Event|0|||
126396379|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
126396380|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
126396381|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
126396382|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
126396383|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
126396384|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
126396385|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
126396386|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
126396387|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
126396388|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
126720269|NCT00492856|455926624|FG000|Induction|Withdrawal by Subject|1|||
126720270|NCT00492856|455926625|FG001|Induction|Withdrawal by Subject|0|||
126720271|NCT00492856|455926626|FG002|Induction|Withdrawal by Subject|0|||
126720272|NCT00492856|455926627|FG003|Induction|Withdrawal by Subject|0|||
126720273|NCT00492856|455926624|FG000|Induction|Death|3|||
126720274|NCT00492856|455926625|FG001|Induction|Death|0|||
126720275|NCT00492856|455926626|FG002|Induction|Death|0|||
126720276|NCT00492856|455926627|FG003|Induction|Death|0|||
126720277|NCT00492856|455926624|FG000|Consolidation|Adverse Event|6|||
126720278|NCT00492856|455926625|FG001|Consolidation|Adverse Event|0|||
126720279|NCT00492856|455926626|FG002|Consolidation|Adverse Event|0|||
126720280|NCT00492856|455926627|FG003|Consolidation|Adverse Event|0|||
126720281|NCT00492856|455926624|FG000|Consolidation|Not protocol specified|2|||
126720282|NCT00492856|455926625|FG001|Consolidation|Not protocol specified|0|||
126720283|NCT00492856|455926626|FG002|Consolidation|Not protocol specified|0|||
126720284|NCT00492856|455926627|FG003|Consolidation|Not protocol specified|0|||
126720285|NCT00492856|455926624|FG000|Consolidation|Lost to Follow-up|1|||
126720286|NCT00492856|455926625|FG001|Consolidation|Lost to Follow-up|0|||
126720287|NCT00492856|455926626|FG002|Consolidation|Lost to Follow-up|0|||
126720288|NCT00492856|455926627|FG003|Consolidation|Lost to Follow-up|0|||
126720289|NCT00492856|455926624|FG000|Post-consolidation|Adverse Event|0|||
126720290|NCT00492856|455926625|FG001|Post-consolidation|Adverse Event|4|||
126720291|NCT00492856|455926626|FG002|Post-consolidation|Adverse Event|0|||
126720292|NCT00492856|455926627|FG003|Post-consolidation|Adverse Event|1|||
126720293|NCT00492856|455926624|FG000|Post-consolidation|Withdrawal by Subject|0|||
126720294|NCT00492856|455926625|FG001|Post-consolidation|Withdrawal by Subject|4|||
126720295|NCT00492856|455926626|FG002|Post-consolidation|Withdrawal by Subject|0|||
126720296|NCT00492856|455926627|FG003|Post-consolidation|Withdrawal by Subject|0|||
126396389|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
126396390|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
126396391|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
126396392|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
126396393|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
126720297|NCT00492856|455926624|FG000|Post-consolidation|Death|0|||
126720298|NCT00492856|455926625|FG001|Post-consolidation|Death|1|||
126720299|NCT00492856|455926626|FG002|Post-consolidation|Death|0|||
126720300|NCT00492856|455926627|FG003|Post-consolidation|Death|0|||
126720301|NCT00492856|455926624|FG000|Post-consolidation|Not protocol specified|0|||
126720302|NCT00492856|455926625|FG001|Post-consolidation|Not protocol specified|1|||
126720303|NCT00492856|455926626|FG002|Post-consolidation|Not protocol specified|0|||
126396394|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
126396395|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
126396396|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
126396397|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
126396398|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
126396399|NCT01529515|454745914|FG000|MAINTENANCE PHASE|Other|0|||
126396400|NCT01529515|454745915|FG001|MAINTENANCE PHASE|Other|10|||
126396401|NCT01529515|454745916|FG002|MAINTENANCE PHASE|Other|0|||
126396402|NCT01529515|454745917|FG003|MAINTENANCE PHASE|Other|0|||
126396403|NCT01529515|454745914|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
126396404|NCT01529515|454745915|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
126396405|NCT01529515|454745916|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
126396406|NCT01529515|454745917|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
126396407|NCT01529515|454745914|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
126396408|NCT01529515|454745915|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
126396409|NCT01529515|454745916|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
126396410|NCT01529515|454745917|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
126396411|NCT01529515|454745914|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
126396412|NCT01529515|454745915|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
126396413|NCT01529515|454745916|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
126396414|NCT01529515|454745917|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
126396415|NCT01529515|454745914|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
126396416|NCT01529515|454745915|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
126396417|NCT01529515|454745916|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
126396418|NCT01529515|454745917|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
126396419|NCT01529515|454745914|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
126555124|NCT01154036|455324092|FG003|Phase II|Protocol Violation|0|||
126555125|NCT01154036|455324093|FG004|Phase II|Protocol Violation|1|||
126555126|NCT01154036|455324094|FG005|Phase II|Protocol Violation|2|||
126555127|NCT01154036|455324095|FG006|Phase II|Protocol Violation|0|||
126555128|NCT01154036|455324096|FG007|Phase II|Protocol Violation|0|||
126555129|NCT01154036|455324089|FG000|Phase II|Withdrawal by Subject|0|||
126555130|NCT01154036|455324090|FG001|Phase II|Withdrawal by Subject|0|||
126555131|NCT01154036|455324091|FG002|Phase II|Withdrawal by Subject|0|||
126555132|NCT01154036|455324092|FG003|Phase II|Withdrawal by Subject|0|||
126555133|NCT01154036|455324093|FG004|Phase II|Withdrawal by Subject|4|||
126555134|NCT01154036|455324094|FG005|Phase II|Withdrawal by Subject|2|||
126555135|NCT01154036|455324095|FG006|Phase II|Withdrawal by Subject|5|||
126720304|NCT00492856|455926627|FG003|Post-consolidation|Not protocol specified|0|||
126720305|NCT00492856|455926624|FG000|Post-consolidation|Lost to Follow-up|0|||
126720306|NCT00492856|455926625|FG001|Post-consolidation|Lost to Follow-up|2|||
126720307|NCT00492856|455926626|FG002|Post-consolidation|Lost to Follow-up|0|||
126720308|NCT00492856|455926627|FG003|Post-consolidation|Lost to Follow-up|0|||
126720309|NCT00492856|455926624|FG000|Post-consolidation|Observation Arm|0|||
126720310|NCT00492856|455926625|FG001|Post-consolidation|Observation Arm|0|||
126720311|NCT00492856|455926626|FG002|Post-consolidation|Observation Arm|27|||
126720312|NCT00492856|455926627|FG003|Post-consolidation|Observation Arm|0|||
126720313|NCT03488472|455926628|FG000|Overall Study|disease progression additional mets|1|||
126720314|NCT03010423|455926630|FG000|Overall Study|Study termination|8|||
126720315|NCT03484923|455926631|FG000|Overall Study|Adverse Event|3|||
126720316|NCT03484923|455926632|FG001|Overall Study|Adverse Event|3|||
126720317|NCT03484923|455926633|FG002|Overall Study|Adverse Event|5|||
126720318|NCT03484923|455926634|FG003|Overall Study|Adverse Event|11|||
126720319|NCT03484923|455926635|FG004|Overall Study|Adverse Event|1|||
126720320|NCT03484923|455926631|FG000|Overall Study|Death|2|||
126720321|NCT03484923|455926632|FG001|Overall Study|Death|2|||
126720322|NCT03484923|455926633|FG002|Overall Study|Death|3|||
126720323|NCT03484923|455926634|FG003|Overall Study|Death|0|||
126720324|NCT03484923|455926635|FG004|Overall Study|Death|1|||
126720325|NCT03484923|455926631|FG000|Overall Study|Physician Decision|6|||
126720326|NCT03484923|455926632|FG001|Overall Study|Physician Decision|7|||
126720327|NCT03484923|455926633|FG002|Overall Study|Physician Decision|6|||
126720328|NCT03484923|455926634|FG003|Overall Study|Physician Decision|3|||
126720329|NCT03484923|455926635|FG004|Overall Study|Physician Decision|2|||
126396420|NCT01529515|454745915|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
126396421|NCT01529515|454745916|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
126396422|NCT01529515|454745917|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
126396423|NCT01529515|454745914|FG000|DOUBLE BLIND PHASE|Other|0|||
126396424|NCT01529515|454745915|FG001|DOUBLE BLIND PHASE|Other|0|||
126396425|NCT01529515|454745916|FG002|DOUBLE BLIND PHASE|Other|9|||
126396426|NCT01529515|454745917|FG003|DOUBLE BLIND PHASE|Other|2|||
126555136|NCT01154036|455324096|FG007|Phase II|Withdrawal by Subject|4|||
126555137|NCT01349907|455324097|FG000|Overall Study|Adverse Event|37|||
126720330|NCT03484923|455926631|FG000|Overall Study|Progressive disease|33|||
126396427|NCT03920293|454745919|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
126396428|NCT03920293|454745920|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
126555138|NCT01349907|455324098|FG001|Overall Study|Adverse Event|11|||
126555139|NCT01349907|455324097|FG000|Overall Study|Treatment failure|13|||
126555140|NCT01349907|455324098|FG001|Overall Study|Treatment failure|4|||
126720331|NCT03484923|455926632|FG001|Overall Study|Progressive disease|28|||
126720332|NCT03484923|455926633|FG002|Overall Study|Progressive disease|26|||
126720333|NCT03484923|455926634|FG003|Overall Study|Progressive disease|30|||
126720334|NCT03484923|455926635|FG004|Overall Study|Progressive disease|16|||
126720335|NCT03484923|455926631|FG000|Overall Study|Subject Decision|1|||
126720336|NCT03484923|455926632|FG001|Overall Study|Subject Decision|3|||
126720337|NCT03484923|455926633|FG002|Overall Study|Subject Decision|3|||
126720338|NCT03484923|455926634|FG003|Overall Study|Subject Decision|0|||
126720339|NCT03484923|455926635|FG004|Overall Study|Subject Decision|1|||
126720340|NCT03165721|455926640|FG000|Overall Study|Refused further treatment|3|||
126720341|NCT03165721|455926641|FG001|Overall Study|Refused further treatment|0|||
126720342|NCT03165721|455926642|FG002|Overall Study|Refused further treatment|0|||
126720343|NCT03165721|455926640|FG000|Overall Study|Physician Decision|1|||
126720344|NCT03165721|455926641|FG001|Overall Study|Physician Decision|0|||
126720345|NCT03165721|455926642|FG002|Overall Study|Physician Decision|0|||
126720346|NCT01863849|455926644|FG000|Overall Study|Lost to Follow-up|1|||
126555141|NCT01349907|455324097|FG000|Overall Study|Lost to Follow-up|25|||
126720347|NCT01863849|455926645|FG001|Overall Study|Lost to Follow-up|0|||
126720348|NCT01457118|455926646|FG000|Overall Study|Adverse Event|1|||
126720349|NCT01457118|455926647|FG001|Overall Study|Adverse Event|0|||
126720350|NCT01457118|455926648|FG002|Overall Study|Adverse Event|0|||
126720351|NCT01457118|455926649|FG003|Overall Study|Adverse Event|1|||
126720352|NCT01457118|455926646|FG000|Overall Study|Clinical Progression|0|||
126720353|NCT01457118|455926647|FG001|Overall Study|Clinical Progression|1|||
126720354|NCT01457118|455926648|FG002|Overall Study|Clinical Progression|0|||
126720355|NCT01457118|455926649|FG003|Overall Study|Clinical Progression|1|||
126720356|NCT01457118|455926646|FG000|Overall Study|Physician Decision|2|||
126720357|NCT01457118|455926647|FG001|Overall Study|Physician Decision|0|||
126720358|NCT01457118|455926648|FG002|Overall Study|Physician Decision|0|||
126720359|NCT01457118|455926649|FG003|Overall Study|Physician Decision|0|||
126720360|NCT01457118|455926646|FG000|Overall Study|Progressive Disease by RECIST|12|||
126720361|NCT01457118|455926647|FG001|Overall Study|Progressive Disease by RECIST|3|||
126720362|NCT01457118|455926648|FG002|Overall Study|Progressive Disease by RECIST|1|||
126720363|NCT01457118|455926649|FG003|Overall Study|Progressive Disease by RECIST|0|||
126720364|NCT01457118|455926646|FG000|Overall Study|Withdrawal by Subject|5|||
126720365|NCT01457118|455926647|FG001|Overall Study|Withdrawal by Subject|0|||
126720366|NCT01457118|455926648|FG002|Overall Study|Withdrawal by Subject|0|||
126720367|NCT01457118|455926649|FG003|Overall Study|Withdrawal by Subject|0|||
126720368|NCT03456713|455926654|FG000|Overall Study|Lost to Follow-up|1|||
126720369|NCT03456713|455926655|FG001|Overall Study|Lost to Follow-up|0|||
126720370|NCT03456713|455926656|FG002|Overall Study|Lost to Follow-up|0|||
126720371|NCT03456713|455926657|FG003|Overall Study|Lost to Follow-up|0|||
126720372|NCT01263691|455926658|FG000|Overall Study|Lost to Follow-up|1|||
126720373|NCT01263691|455926659|FG001|Overall Study|Lost to Follow-up|0|||
126396429|NCT03920293|454745919|FG000|Randomized-Controlled Period|Physician Decision|1|||
126396430|NCT03920293|454745920|FG001|Randomized-Controlled Period|Physician Decision|2|||
126396431|NCT03920293|454745919|FG000|Randomized-Controlled Period|Adverse Event|0|||
126396432|NCT03920293|454745920|FG001|Randomized-Controlled Period|Adverse Event|2|||
126396433|NCT03920293|454745919|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
126396434|NCT03920293|454745920|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
126396435|NCT03920293|454745919|FG000|Randomized-Controlled Period|Death|2|||
126396436|NCT03920293|454745920|FG001|Randomized-Controlled Period|Death|0|||
126396437|NCT03920293|454745919|FG000|Randomized-Controlled Period|Protocol Violation|1|||
126396438|NCT03920293|454745920|FG001|Randomized-Controlled Period|Protocol Violation|0|||
126396439|NCT03920293|454745919|FG000|Randomized-Controlled Period|Noncompliance|1|||
126396440|NCT03920293|454745920|FG001|Randomized-Controlled Period|Noncompliance|0|||
126396441|NCT03920293|454745919|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
126396442|NCT03920293|454745920|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
126396443|NCT03920293|454745919|FG000|Open- Label Extension Period|Death|3|||
126396444|NCT03920293|454745920|FG001|Open- Label Extension Period|Death|3|||
126396445|NCT03920293|454745919|FG000|Open- Label Extension Period|Physician Decision|5|||
126396446|NCT03920293|454745920|FG001|Open- Label Extension Period|Physician Decision|3|||
126396447|NCT03920293|454745919|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
126396448|NCT03920293|454745920|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
126396449|NCT01069861|454745921|FG000|Overall Study|Death|1|||
126396450|NCT01069861|454745921|FG000|Overall Study|Adverse Event|1|||
126396451|NCT01069861|454745921|FG000|Overall Study|Did not meet entrance criteria|1|||
126396452|NCT03272828|454745923|FG000|Overall Study|Lost to Follow-up|7|||
126396453|NCT03272828|454745924|FG001|Overall Study|Lost to Follow-up|7|||
126396454|NCT03272828|454745923|FG000|Overall Study|Withdrawal by Subject|2|||
126396455|NCT03272828|454745924|FG001|Overall Study|Withdrawal by Subject|0|||
126396456|NCT03272828|454745923|FG000|Overall Study|Deceased|1|||
126720374|NCT01263691|455926660|FG002|Overall Study|Lost to Follow-up|1|||
126720375|NCT01263691|455926661|FG003|Overall Study|Lost to Follow-up|1|||
126720376|NCT01263691|455926662|FG004|Overall Study|Lost to Follow-up|0|||
126470371|NCT00406354|455023648|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
126470372|NCT00406354|455023649|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
126470373|NCT00406354|455023650|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
126470374|NCT00406354|455023648|FG000|All Randomized and Treated Patients|Adverse Event|6|||
126470375|NCT00406354|455023649|FG001|All Randomized and Treated Patients|Adverse Event|2|||
126470376|NCT00406354|455023650|FG002|All Randomized and Treated Patients|Adverse Event|1|||
126470377|NCT00406354|455023648|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
126470378|NCT00406354|455023649|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
126470379|NCT00406354|455023650|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
126470380|NCT00406354|455023648|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
126470381|NCT00406354|455023649|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
126470382|NCT00406354|455023650|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
126470383|NCT00406354|455023648|FG000|All Randomized and Treated Patients|Physician Decision|0|||
126470384|NCT00406354|455023649|FG001|All Randomized and Treated Patients|Physician Decision|0|||
126470385|NCT00406354|455023650|FG002|All Randomized and Treated Patients|Physician Decision|1|||
126470386|NCT00747461|455023651|FG000|Overall Study|study terminated by sponsor|5|||
126470387|NCT00961649|455023667|FG000|Overall Study|Adverse Event|4|||
126470388|NCT00961649|455023668|FG001|Overall Study|Adverse Event|0|||
126470389|NCT00961649|455023669|FG002|Overall Study|Adverse Event|0|||
126470390|NCT00961649|455023670|FG003|Overall Study|Adverse Event|2|||
126470391|NCT00961649|455023667|FG000|Overall Study|Inadequate control of IOP|0|||
126470392|NCT00961649|455023668|FG001|Overall Study|Inadequate control of IOP|0|||
126470393|NCT00961649|455023669|FG002|Overall Study|Inadequate control of IOP|0|||
126470394|NCT00961649|455023670|FG003|Overall Study|Inadequate control of IOP|1|||
126470395|NCT00961649|455023667|FG000|Overall Study|Patient has travel plans during holidays|0|||
126470396|NCT00961649|455023668|FG001|Overall Study|Patient has travel plans during holidays|0|||
126470397|NCT00961649|455023669|FG002|Overall Study|Patient has travel plans during holidays|1|||
126470398|NCT00961649|455023670|FG003|Overall Study|Patient has travel plans during holidays|0|||
126470399|NCT00961649|455023667|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
126470400|NCT00961649|455023668|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
126470401|NCT00961649|455023669|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
126470402|NCT00961649|455023670|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
126470403|NCT00961649|455023667|FG000|Overall Study|Study terminated by sponsor|4|||
126470404|NCT00961649|455023668|FG001|Overall Study|Study terminated by sponsor|4|||
126470405|NCT00961649|455023669|FG002|Overall Study|Study terminated by sponsor|4|||
126470406|NCT00961649|455023670|FG003|Overall Study|Study terminated by sponsor|1|||
126470407|NCT02711345|455023671|FG000|Overall Study|Adverse Event|0|||
126470408|NCT02711345|455023672|FG001|Overall Study|Adverse Event|0|||
126470409|NCT02711345|455023673|FG002|Overall Study|Adverse Event|0|||
126470410|NCT02711345|455023674|FG003|Overall Study|Adverse Event|1|||
126470411|NCT02711345|455023675|FG004|Overall Study|Adverse Event|1|||
126470412|NCT02711345|455023676|FG005|Overall Study|Adverse Event|2|||
126470413|NCT02711345|455023677|FG006|Overall Study|Adverse Event|1|||
126720377|NCT01263691|455926663|FG005|Overall Study|Lost to Follow-up|0|||
126720378|NCT01263691|455926658|FG000|Overall Study|Withdrawal by Subject|1|||
126720379|NCT01263691|455926659|FG001|Overall Study|Withdrawal by Subject|0|||
126720380|NCT01263691|455926660|FG002|Overall Study|Withdrawal by Subject|0|||
126720381|NCT01263691|455926661|FG003|Overall Study|Withdrawal by Subject|0|||
126720382|NCT01263691|455926662|FG004|Overall Study|Withdrawal by Subject|0|||
126720383|NCT01263691|455926663|FG005|Overall Study|Withdrawal by Subject|0|||
126720384|NCT01263691|455926658|FG000|Overall Study|Adverse Event|1|||
126720385|NCT01263691|455926659|FG001|Overall Study|Adverse Event|0|||
126720386|NCT01263691|455926660|FG002|Overall Study|Adverse Event|0|||
126720387|NCT01263691|455926661|FG003|Overall Study|Adverse Event|0|||
126720388|NCT01263691|455926662|FG004|Overall Study|Adverse Event|0|||
126720389|NCT01263691|455926663|FG005|Overall Study|Adverse Event|0|||
126720390|NCT01202227|455926666|FG000|Overall Study|Adverse Event|16|||
126720391|NCT01202227|455926666|FG000|Overall Study|Withdrawal by Subject|2|||
126720392|NCT01202227|455926666|FG000|Overall Study|Lack of Efficacy|1|||
126720393|NCT04402008|455926669|FG000|Overall Study|Adverse Event|0|||
126720394|NCT04402008|455926670|FG001|Overall Study|Adverse Event|0|||
126720395|NCT04402008|455926671|FG002|Overall Study|Adverse Event|0|||
126720396|NCT04402008|455926672|FG003|Overall Study|Adverse Event|1|||
126720397|NCT04402008|455926673|FG004|Overall Study|Adverse Event|0|||
126720398|NCT04402008|455926674|FG005|Overall Study|Adverse Event|0|||
126720399|NCT04402008|455926675|FG006|Overall Study|Adverse Event|0|||
126720400|NCT04402008|455926669|FG000|Overall Study|Disease Progression|3|||
126720401|NCT04402008|455926670|FG001|Overall Study|Disease Progression|2|||
126720402|NCT04402008|455926671|FG002|Overall Study|Disease Progression|3|||
126470414|NCT02711345|455023678|FG007|Overall Study|Adverse Event|0|||
126470415|NCT02711345|455023679|FG008|Overall Study|Adverse Event|0|||
126720403|NCT04402008|455926672|FG003|Overall Study|Disease Progression|3|||
126720404|NCT04402008|455926673|FG004|Overall Study|Disease Progression|4|||
126720405|NCT04402008|455926674|FG005|Overall Study|Disease Progression|3|||
126720406|NCT04402008|455926675|FG006|Overall Study|Disease Progression|10|||
126720407|NCT04402008|455926669|FG000|Overall Study|Withdrawal by Subject|0|||
126720408|NCT04402008|455926670|FG001|Overall Study|Withdrawal by Subject|1|||
126771927|NCT01220128|456120037|FG003|Overall Study|Adverse event, serious fatal|0|||
126771928|NCT01220128|456120038|FG004|Overall Study|Adverse event, serious fatal|0|||
126771929|NCT01220128|456120039|FG005|Overall Study|Adverse event, serious fatal|0|||
126771930|NCT01220128|456120040|FG006|Overall Study|Adverse event, serious fatal|1|||
126771931|NCT01220128|456120034|FG000|Overall Study|Adverse event, non-fatal|1|||
126771932|NCT01220128|456120035|FG001|Overall Study|Adverse event, non-fatal|0|||
126771933|NCT01220128|456120036|FG002|Overall Study|Adverse event, non-fatal|0|||
126771934|NCT01220128|456120037|FG003|Overall Study|Adverse event, non-fatal|0|||
126771935|NCT01220128|456120038|FG004|Overall Study|Adverse event, non-fatal|0|||
126771936|NCT01220128|456120039|FG005|Overall Study|Adverse event, non-fatal|0|||
126771937|NCT01220128|456120040|FG006|Overall Study|Adverse event, non-fatal|3|||
126771938|NCT01220128|456120034|FG000|Overall Study|Other|0|||
126771939|NCT01220128|456120035|FG001|Overall Study|Other|0|||
126771940|NCT01220128|456120036|FG002|Overall Study|Other|1|||
126771941|NCT01220128|456120037|FG003|Overall Study|Other|0|||
126771942|NCT01220128|456120038|FG004|Overall Study|Other|0|||
126771943|NCT01220128|456120039|FG005|Overall Study|Other|0|||
126771944|NCT01220128|456120040|FG006|Overall Study|Other|0|||
126771945|NCT01220128|456120034|FG000|Overall Study|Consent withdrawn by subject|1|||
126771946|NCT01220128|456120035|FG001|Overall Study|Consent withdrawn by subject|0|||
126771947|NCT01220128|456120036|FG002|Overall Study|Consent withdrawn by subject|0|||
126555142|NCT01349907|455324098|FG001|Overall Study|Lost to Follow-up|6|||
126555143|NCT01349907|455324097|FG000|Overall Study|Withdrawal by Subject|30|||
126720409|NCT04402008|455926671|FG002|Overall Study|Withdrawal by Subject|0|||
126720410|NCT04402008|455926672|FG003|Overall Study|Withdrawal by Subject|0|||
126720411|NCT04402008|455926673|FG004|Overall Study|Withdrawal by Subject|1|||
126720412|NCT04402008|455926674|FG005|Overall Study|Withdrawal by Subject|0|||
126720413|NCT04402008|455926675|FG006|Overall Study|Withdrawal by Subject|0|||
126720414|NCT04402008|455926669|FG000|Overall Study|Sponsor Decision|0|||
126720415|NCT04402008|455926670|FG001|Overall Study|Sponsor Decision|0|||
126720416|NCT04402008|455926671|FG002|Overall Study|Sponsor Decision|0|||
126720417|NCT04402008|455926672|FG003|Overall Study|Sponsor Decision|0|||
126720418|NCT04402008|455926673|FG004|Overall Study|Sponsor Decision|0|||
126720419|NCT04402008|455926674|FG005|Overall Study|Sponsor Decision|0|||
126720420|NCT04402008|455926675|FG006|Overall Study|Sponsor Decision|3|||
126720421|NCT04402008|455926669|FG000|Overall Study|Death|0|||
126720422|NCT04402008|455926670|FG001|Overall Study|Death|0|||
126720423|NCT04402008|455926671|FG002|Overall Study|Death|0|||
126720424|NCT04402008|455926672|FG003|Overall Study|Death|0|||
126720425|NCT04402008|455926673|FG004|Overall Study|Death|1|||
126720426|NCT04402008|455926674|FG005|Overall Study|Death|0|||
126720427|NCT04402008|455926675|FG006|Overall Study|Death|2|||
126720428|NCT04402008|455926669|FG000|Overall Study|Other|0|||
126720429|NCT04402008|455926670|FG001|Overall Study|Other|0|||
126720430|NCT04402008|455926671|FG002|Overall Study|Other|0|||
126720431|NCT04402008|455926672|FG003|Overall Study|Other|0|||
126720432|NCT04402008|455926673|FG004|Overall Study|Other|0|||
126720433|NCT04402008|455926674|FG005|Overall Study|Other|0|||
126720434|NCT04402008|455926675|FG006|Overall Study|Other|5|||
126720435|NCT00411788|455926676|FG000|Overall Study|Protocol Violation|1|||
126720436|NCT00411788|455926676|FG000|Overall Study|Adverse Event|1|||
126720437|NCT01533935|455926677|FG000|Overall Study|Adverse Event|5|||
126720438|NCT01533935|455926678|FG001|Overall Study|Adverse Event|7|||
126720439|NCT01533935|455926679|FG002|Overall Study|Adverse Event|1|||
126720440|NCT01533935|455926680|FG003|Overall Study|Adverse Event|5|||
126720441|NCT01533935|455926681|FG004|Overall Study|Adverse Event|3|||
126720442|NCT01533935|455926677|FG000|Overall Study|Protocol Violation|0|||
126720443|NCT01533935|455926678|FG001|Overall Study|Protocol Violation|2|||
126720444|NCT01533935|455926679|FG002|Overall Study|Protocol Violation|0|||
126720445|NCT01533935|455926680|FG003|Overall Study|Protocol Violation|0|||
126720446|NCT01533935|455926681|FG004|Overall Study|Protocol Violation|0|||
126720447|NCT01533935|455926677|FG000|Overall Study|Lost to Follow-up|0|||
126771948|NCT01220128|456120037|FG003|Overall Study|Consent withdrawn by subject|0|||
126771949|NCT01220128|456120038|FG004|Overall Study|Consent withdrawn by subject|0|||
126771950|NCT01220128|456120039|FG005|Overall Study|Consent withdrawn by subject|0|||
126771951|NCT01220128|456120040|FG006|Overall Study|Consent withdrawn by subject|0|||
126771952|NCT02524665|456120044|FG000|Overall Study|Lost to Follow-up|1|||
126720448|NCT01533935|455926678|FG001|Overall Study|Lost to Follow-up|0|||
126720449|NCT01533935|455926679|FG002|Overall Study|Lost to Follow-up|1|||
126720450|NCT01533935|455926680|FG003|Overall Study|Lost to Follow-up|0|||
126720451|NCT01533935|455926681|FG004|Overall Study|Lost to Follow-up|0|||
126720452|NCT01533935|455926677|FG000|Overall Study|Withdrawal by Subject|0|||
126720453|NCT01533935|455926678|FG001|Overall Study|Withdrawal by Subject|4|||
126720454|NCT01533935|455926679|FG002|Overall Study|Withdrawal by Subject|5|||
126720455|NCT01533935|455926680|FG003|Overall Study|Withdrawal by Subject|2|||
126720456|NCT01533935|455926681|FG004|Overall Study|Withdrawal by Subject|4|||
126771953|NCT01999322|456120048|FG000|Overall Study|Adverse Event|1|||
126720457|NCT01533935|455926677|FG000|Overall Study|Other reason not defined above|1|||
126720458|NCT01533935|455926678|FG001|Overall Study|Other reason not defined above|0|||
126720459|NCT01533935|455926679|FG002|Overall Study|Other reason not defined above|1|||
126720460|NCT01533935|455926680|FG003|Overall Study|Other reason not defined above|0|||
126720461|NCT01533935|455926681|FG004|Overall Study|Other reason not defined above|1|||
126720462|NCT00630812|455926684|FG000|Randomisation to First Dose|Adverse Event|1|||
126771954|NCT01999322|456120049|FG001|Overall Study|Adverse Event|0|||
126771955|NCT02200614|456120050|FG000|Double Blind Treatment|Adverse Event|86|||
126771956|NCT02200614|456120051|FG001|Double Blind Treatment|Adverse Event|48|||
126771957|NCT02200614|456120050|FG000|Double Blind Treatment|Confirmed metastasis|120|||
126771958|NCT02200614|456120051|FG001|Double Blind Treatment|Confirmed metastasis|140|||
126771959|NCT02200614|456120050|FG000|Double Blind Treatment|Judgment of the investigator|59|||
126771960|NCT02200614|456120051|FG001|Double Blind Treatment|Judgment of the investigator|99|||
126771961|NCT02200614|456120050|FG000|Double Blind Treatment|Metastasis by local reading|1|||
126771962|NCT02200614|456120051|FG001|Double Blind Treatment|Metastasis by local reading|3|||
126771963|NCT02200614|456120050|FG000|Double Blind Treatment|Other reason|6|||
126771964|NCT02200614|456120051|FG001|Double Blind Treatment|Other reason|2|||
126771965|NCT02200614|456120050|FG000|Double Blind Treatment|Personal reason|77|||
126771966|NCT02200614|456120051|FG001|Double Blind Treatment|Personal reason|85|||
126771967|NCT02200614|456120050|FG000|Double Blind Treatment|Protocol deviation|14|||
126771968|NCT02200614|456120051|FG001|Double Blind Treatment|Protocol deviation|7|||
126771969|NCT02200614|456120050|FG000|Double Blind Treatment|Not treated|1|||
126771970|NCT02200614|456120051|FG001|Double Blind Treatment|Not treated|0|||
126771971|NCT02200614|456120050|FG000|Open Label|Adverse Event|41|||
126771972|NCT02200614|456120051|FG001|Open Label|Adverse Event|11|||
126771973|NCT02200614|456120050|FG000|Open Label|Confirmed metastasis|1|||
126771974|NCT02200614|456120051|FG001|Open Label|Confirmed metastasis|0|||
126771975|NCT02200614|456120050|FG000|Open Label|Judgment of the investigator|29|||
126771976|NCT02200614|456120051|FG001|Open Label|Judgment of the investigator|2|||
126771977|NCT02200614|456120050|FG000|Open Label|Metastasis by local reading|138|||
126771978|NCT02200614|456120051|FG001|Open Label|Metastasis by local reading|27|||
126771979|NCT02200614|456120050|FG000|Open Label|Other reason|22|||
126771980|NCT02200614|456120051|FG001|Open Label|Other reason|4|||
126771981|NCT02200614|456120050|FG000|Open Label|Personal reason|60|||
126771982|NCT02200614|456120051|FG001|Open Label|Personal reason|8|||
126771983|NCT02200614|456120050|FG000|Open Label|Protocol deviation|3|||
126771984|NCT02200614|456120051|FG001|Open Label|Protocol deviation|2|||
126771985|NCT02200614|456120050|FG000|Open Label|Missing|2|||
126771986|NCT02200614|456120051|FG001|Open Label|Missing|2|||
126771987|NCT01898884|456120052|FG000|Multiple Dose Period|Adverse Event|0|||
126771988|NCT01898884|456120053|FG001|Multiple Dose Period|Adverse Event|0|||
126771989|NCT01898884|456120054|FG002|Multiple Dose Period|Adverse Event|0|||
126771990|NCT01898884|456120055|FG003|Multiple Dose Period|Adverse Event|0|||
126771991|NCT01898884|456120056|FG004|Multiple Dose Period|Adverse Event|0|||
126771992|NCT01898884|456120057|FG005|Multiple Dose Period|Adverse Event|0|||
126771993|NCT01898884|456120058|FG006|Multiple Dose Period|Adverse Event|1|||
126771994|NCT01898884|456120059|FG007|Multiple Dose Period|Adverse Event|0|||
126771995|NCT01898884|456120060|FG008|Multiple Dose Period|Adverse Event|0|||
126771996|NCT01898884|456120052|FG000|Multiple Dose Period|Randomized Not Treated|0|||
126771997|NCT01898884|456120053|FG001|Multiple Dose Period|Randomized Not Treated|0|||
126771998|NCT01898884|456120054|FG002|Multiple Dose Period|Randomized Not Treated|0|||
126771999|NCT01898884|456120055|FG003|Multiple Dose Period|Randomized Not Treated|0|||
126772000|NCT01898884|456120056|FG004|Multiple Dose Period|Randomized Not Treated|0|||
126772001|NCT01898884|456120057|FG005|Multiple Dose Period|Randomized Not Treated|0|||
126772002|NCT01898884|456120058|FG006|Multiple Dose Period|Randomized Not Treated|0|||
126772003|NCT01898884|456120059|FG007|Multiple Dose Period|Randomized Not Treated|0|||
126772004|NCT01898884|456120060|FG008|Multiple Dose Period|Randomized Not Treated|1|||
126772005|NCT00759759|456120061|FG000|Overall Study|didn't return for period 2|1|||
126772006|NCT00759759|456120062|FG001|Overall Study|didn't return for period 2|0|||
126772007|NCT00759759|456120061|FG000|Overall Study|Didn't receive drug in period 2|1|||
126396457|NCT03272828|454745924|FG001|Overall Study|Deceased|1|||
126396458|NCT03272828|454745923|FG000|Overall Study|Failed implant|1|||
126396459|NCT03272828|454745924|FG001|Overall Study|Failed implant|2|||
126396460|NCT00996281|454745926|FG000|Overall Study|Adverse Event|75|||
126396461|NCT00996281|454745927|FG001|Overall Study|Adverse Event|37|||
126772008|NCT00759759|456120062|FG001|Overall Study|Didn't receive drug in period 2|0|||
126772009|NCT00759759|456120061|FG000|Overall Study|Withdrawal by Subject|2|||
126772010|NCT00759759|456120062|FG001|Overall Study|Withdrawal by Subject|1|||
126772011|NCT00391092|456121976|FG000|Overall Study|Death|78|||
126772012|NCT00391092|456121977|FG001|Overall Study|Death|81|||
126772013|NCT00391092|456121976|FG000|Overall Study|Lost to Follow-up|13|||
126396462|NCT00996281|454745926|FG000|Overall Study|Major Protocol Deviation|6|||
126396463|NCT00996281|454745927|FG001|Overall Study|Major Protocol Deviation|7|||
126720463|NCT00630812|455926685|FG001|Randomisation to First Dose|Adverse Event|1|||
126720464|NCT00630812|455926684|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
126720465|NCT00630812|455926685|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
126396464|NCT00996281|454745926|FG000|Overall Study|Lost to Follow-up|14|||
126396465|NCT00996281|454745927|FG001|Overall Study|Lost to Follow-up|16|||
126396466|NCT00996281|454745926|FG000|Overall Study|Withdrawal by Subject|31|||
126396467|NCT00996281|454745927|FG001|Overall Study|Withdrawal by Subject|20|||
126396468|NCT00996281|454745926|FG000|Overall Study|Lack of Efficacy|0|||
126396469|NCT00996281|454745927|FG001|Overall Study|Lack of Efficacy|2|||
126396470|NCT00996281|454745926|FG000|Overall Study|Other|5|||
126396471|NCT00996281|454745927|FG001|Overall Study|Other|7|||
126396472|NCT01920568|454745930|FG000|Overall Study|Adverse Event|27|||
126396473|NCT01920568|454745931|FG001|Overall Study|Adverse Event|8|||
126396474|NCT01920568|454745930|FG000|Overall Study|Protocol Violation|5|||
126720466|NCT00630812|455926684|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
126720467|NCT00630812|455926685|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
126720468|NCT00630812|455926684|FG000|Randomisation to First Dose|Protocol Violation|4|||
126720469|NCT00630812|455926685|FG001|Randomisation to First Dose|Protocol Violation|1|||
126720470|NCT00630812|455926684|FG000|Double Blind Treatment Period|Adverse Event|13|||
126720471|NCT00630812|455926685|FG001|Double Blind Treatment Period|Adverse Event|5|||
126720472|NCT00630812|455926684|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
126720473|NCT00630812|455926685|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
126720474|NCT00630812|455926684|FG000|Double Blind Treatment Period|Physician Decision|2|||
126720475|NCT00630812|455926685|FG001|Double Blind Treatment Period|Physician Decision|1|||
126720476|NCT00630812|455926684|FG000|Double Blind Treatment Period|Protocol Violation|1|||
126720477|NCT00630812|455926685|FG001|Double Blind Treatment Period|Protocol Violation|0|||
126720478|NCT00630812|455926684|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
126720479|NCT00630812|455926685|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
126720480|NCT00630812|455926684|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
126720481|NCT00630812|455926685|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
126720482|NCT00630812|455926684|FG000|Double Blind Treatment Period|Non-compliance|0|||
126720483|NCT00630812|455926685|FG001|Double Blind Treatment Period|Non-compliance|1|||
126720484|NCT03430245|455926686|FG000|Overall Study|Withdrawal by Subject|6|||
126720485|NCT03430245|455926686|FG000|Overall Study|Lost to Follow-up|1|||
126720486|NCT05628181|455926687|FG000|Overall Study|Death|2|||
126720487|NCT05628181|455926688|FG001|Overall Study|Death|4|||
126720488|NCT05628181|455926689|FG002|Overall Study|Death|0|||
126720489|NCT00316303|455926690|FG000|Overall Study|Lost to Follow-up|11|||
126720490|NCT00316303|455926691|FG001|Overall Study|Lost to Follow-up|16|||
126720491|NCT00532948|455926692|FG000|Overall Study|Protocol Violation|1|||
126720492|NCT00532948|455926693|FG001|Overall Study|Protocol Violation|0|||
126720493|NCT00532948|455926694|FG002|Overall Study|Protocol Violation|0|||
126720494|NCT00532948|455926692|FG000|Overall Study|Death|3|||
126720495|NCT00532948|455926693|FG001|Overall Study|Death|3|||
126720496|NCT00532948|455926694|FG002|Overall Study|Death|4|||
126720497|NCT00532948|455926692|FG000|Overall Study|Violation of selection criteria at entry|0|||
126720498|NCT00532948|455926693|FG001|Overall Study|Violation of selection criteria at entry|1|||
126720499|NCT00532948|455926694|FG002|Overall Study|Violation of selection criteria at entry|0|||
126720500|NCT00532948|455926692|FG000|Overall Study|Failure to return|0|||
126720501|NCT00532948|455926693|FG001|Overall Study|Failure to return|1|||
126720502|NCT00532948|455926694|FG002|Overall Study|Failure to return|0|||
126720503|NCT01753076|455926695|FG000|Overall Study|Adverse Event|17|||
126720504|NCT01753076|455926696|FG001|Overall Study|Adverse Event|18|||
126720505|NCT01753076|455926695|FG000|Overall Study|Lack of Efficacy|3|||
126720506|NCT01753076|455926696|FG001|Overall Study|Lack of Efficacy|1|||
126720507|NCT01753076|455926695|FG000|Overall Study|Lost to Follow-up|2|||
126720508|NCT01753076|455926696|FG001|Overall Study|Lost to Follow-up|1|||
126720509|NCT01753076|455926695|FG000|Overall Study|Physician Decision|4|||
126720510|NCT01753076|455926696|FG001|Overall Study|Physician Decision|2|||
126720511|NCT01753076|455926695|FG000|Overall Study|Withdrawal by Subject|14|||
126720512|NCT01753076|455926696|FG001|Overall Study|Withdrawal by Subject|24|||
126720513|NCT01753076|455926695|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
126772014|NCT00391092|456121977|FG001|Overall Study|Lost to Follow-up|18|||
126772015|NCT00391092|456121976|FG000|Overall Study|Alive on treatment|29|||
126396475|NCT01920568|454745931|FG001|Overall Study|Protocol Violation|3|||
126396476|NCT01920568|454745930|FG000|Overall Study|Lost to Follow-up|2|||
126396477|NCT01920568|454745931|FG001|Overall Study|Lost to Follow-up|2|||
126396478|NCT01920568|454745930|FG000|Overall Study|Physician Decision|13|||
126720514|NCT01753076|455926696|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
126720515|NCT01253044|455926701|FG000|Overall Study|Lost to Follow-up|38|||
126720516|NCT01253044|455926702|FG001|Overall Study|Lost to Follow-up|29|||
126720517|NCT00905307|455926703|FG000|Overall Study|Switched to Open Label Rescue|7|||
126720518|NCT00905307|455926704|FG001|Overall Study|Switched to Open Label Rescue|17|||
126720519|NCT00905307|455926705|FG002|Overall Study|Switched to Open Label Rescue|11|||
126720520|NCT00905307|455926706|FG003|Overall Study|Switched to Open Label Rescue|11|||
126720521|NCT00905307|455926707|FG004|Overall Study|Switched to Open Label Rescue|4|||
126720522|NCT00905307|455926708|FG005|Overall Study|Switched to Open Label Rescue|15|||
126720523|NCT00905307|455926703|FG000|Overall Study|Lost to Follow-up|0|||
126555144|NCT01349907|455324098|FG001|Overall Study|Withdrawal by Subject|8|||
126555145|NCT01349907|455324097|FG000|Overall Study|Protocol Violation|33|||
126772016|NCT00391092|456121977|FG001|Overall Study|Alive on treatment|33|||
126772017|NCT00391092|456121976|FG000|Overall Study|Alive in follow-up|88|||
126772018|NCT00391092|456121977|FG001|Overall Study|Alive in follow-up|84|||
126772019|NCT01614925|456121979|FG000|Overall Study|Withdrawal by Subject|1|||
126772020|NCT01614925|456121980|FG001|Overall Study|Withdrawal by Subject|0|||
126772021|NCT01614925|456121979|FG000|Overall Study|Protocol Violation|3|||
126396479|NCT01920568|454745931|FG001|Overall Study|Physician Decision|4|||
126396480|NCT01920568|454745930|FG000|Overall Study|Withdrawal by Subject|79|||
126396481|NCT01920568|454745931|FG001|Overall Study|Withdrawal by Subject|55|||
126772022|NCT01614925|456121980|FG001|Overall Study|Protocol Violation|2|||
126772023|NCT02437890|456121983|FG000|Overall Study|Non-compliance to study drug|0|||
126772024|NCT02437890|456121984|FG001|Overall Study|Non-compliance to study drug|1|||
126772025|NCT02437890|456121985|FG002|Overall Study|Non-compliance to study drug|0|||
126772026|NCT02437890|456121986|FG003|Overall Study|Non-compliance to study drug|0|||
126772027|NCT02437890|456121987|FG004|Overall Study|Non-compliance to study drug|1|||
126772028|NCT02437890|456121983|FG000|Overall Study|Sponsor's decision|1|||
126772029|NCT02437890|456121984|FG001|Overall Study|Sponsor's decision|1|||
126772030|NCT02437890|456121985|FG002|Overall Study|Sponsor's decision|4|||
126772031|NCT02437890|456121986|FG003|Overall Study|Sponsor's decision|0|||
126772032|NCT02437890|456121987|FG004|Overall Study|Sponsor's decision|2|||
126772033|NCT02437890|456121983|FG000|Overall Study|Physician Decision|0|||
126772034|NCT02437890|456121984|FG001|Overall Study|Physician Decision|0|||
126772035|NCT02437890|456121985|FG002|Overall Study|Physician Decision|0|||
126772036|NCT02437890|456121986|FG003|Overall Study|Physician Decision|1|||
126772037|NCT02437890|456121987|FG004|Overall Study|Physician Decision|0|||
126772038|NCT02437890|456121983|FG000|Overall Study|Unable to attend visit(s)|1|||
126772039|NCT02437890|456121984|FG001|Overall Study|Unable to attend visit(s)|0|||
126772040|NCT02437890|456121985|FG002|Overall Study|Unable to attend visit(s)|0|||
126772041|NCT02437890|456121986|FG003|Overall Study|Unable to attend visit(s)|0|||
126772042|NCT02437890|456121987|FG004|Overall Study|Unable to attend visit(s)|0|||
126772043|NCT02437890|456121983|FG000|Overall Study|Lack of Efficacy|1|||
126772044|NCT02437890|456121984|FG001|Overall Study|Lack of Efficacy|3|||
126772045|NCT02437890|456121985|FG002|Overall Study|Lack of Efficacy|0|||
126772046|NCT02437890|456121986|FG003|Overall Study|Lack of Efficacy|3|||
126772047|NCT02437890|456121987|FG004|Overall Study|Lack of Efficacy|1|||
126772048|NCT02437890|456121983|FG000|Overall Study|Adverse Event|4|||
126772049|NCT02437890|456121984|FG001|Overall Study|Adverse Event|9|||
126772050|NCT02437890|456121985|FG002|Overall Study|Adverse Event|5|||
126772051|NCT02437890|456121986|FG003|Overall Study|Adverse Event|11|||
126772052|NCT02437890|456121987|FG004|Overall Study|Adverse Event|7|||
126772053|NCT02437890|456121983|FG000|Overall Study|Withdrawal by Subject|1|||
126772054|NCT02437890|456121984|FG001|Overall Study|Withdrawal by Subject|2|||
126772055|NCT02437890|456121985|FG002|Overall Study|Withdrawal by Subject|6|||
126772056|NCT02437890|456121986|FG003|Overall Study|Withdrawal by Subject|5|||
126772057|NCT02437890|456121987|FG004|Overall Study|Withdrawal by Subject|5|||
126772058|NCT02437890|456121983|FG000|Overall Study|Death|0|||
126396482|NCT01920568|454745930|FG000|Overall Study|Death due to disease progression|25|||
126396483|NCT01920568|454745931|FG001|Overall Study|Death due to disease progression|12|||
126396484|NCT02891681|454745935|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
126396485|NCT02891681|454745936|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
126396486|NCT02891681|454745937|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
126470416|NCT02711345|455023680|FG009|Overall Study|Adverse Event|2|||
126470417|NCT02711345|455023671|FG000|Overall Study|Physician Decision|0|||
126470418|NCT02711345|455023672|FG001|Overall Study|Physician Decision|0|||
126470419|NCT02711345|455023673|FG002|Overall Study|Physician Decision|1|||
126470420|NCT02711345|455023674|FG003|Overall Study|Physician Decision|0|||
126470421|NCT02711345|455023675|FG004|Overall Study|Physician Decision|0|||
126470422|NCT02711345|455023676|FG005|Overall Study|Physician Decision|0|||
126470423|NCT02711345|455023677|FG006|Overall Study|Physician Decision|0|||
126470424|NCT02711345|455023678|FG007|Overall Study|Physician Decision|0|||
126470425|NCT02711345|455023679|FG008|Overall Study|Physician Decision|1|||
126470426|NCT02711345|455023680|FG009|Overall Study|Physician Decision|0|||
126470427|NCT02711345|455023671|FG000|Overall Study|Progressive disease|1|||
126470428|NCT02711345|455023672|FG001|Overall Study|Progressive disease|3|||
126470429|NCT02711345|455023673|FG002|Overall Study|Progressive disease|5|||
126470430|NCT02711345|455023674|FG003|Overall Study|Progressive disease|3|||
126772059|NCT02437890|456121984|FG001|Overall Study|Death|0|||
126772060|NCT02437890|456121985|FG002|Overall Study|Death|0|||
126772061|NCT02437890|456121986|FG003|Overall Study|Death|2|||
126772062|NCT02437890|456121987|FG004|Overall Study|Death|0|||
126772063|NCT02414854|456121988|FG000|Overall Study|Adverse Event|9|||
126772064|NCT02414854|456121989|FG001|Overall Study|Adverse Event|7|||
126772065|NCT02414854|456121990|FG002|Overall Study|Adverse Event|1|||
126772066|NCT02414854|456121991|FG003|Overall Study|Adverse Event|12|||
126772067|NCT02414854|456121988|FG000|Overall Study|Poor compliance to protocol|1|||
126772068|NCT02414854|456121989|FG001|Overall Study|Poor compliance to protocol|1|||
126396487|NCT02891681|454745935|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
126396488|NCT02891681|454745936|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
126396489|NCT02891681|454745937|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
126396490|NCT02891681|454745935|FG000|Overall Study|Taken off study after first imaging appointment|1|||
126396491|NCT02891681|454745936|FG001|Overall Study|Taken off study after first imaging appointment|0|||
126396492|NCT02891681|454745937|FG002|Overall Study|Taken off study after first imaging appointment|0|||
126396493|NCT03664674|454745940|FG000|Overall Study|Adverse Event|1|||
126396494|NCT03664674|454745941|FG001|Overall Study|Adverse Event|1|||
126396495|NCT03664674|454745940|FG000|Overall Study|Physician Decision|0|||
126396496|NCT03664674|454745941|FG001|Overall Study|Physician Decision|1|||
126470431|NCT02711345|455023675|FG004|Overall Study|Progressive disease|7|||
126470432|NCT02711345|455023676|FG005|Overall Study|Progressive disease|2|||
126470433|NCT02711345|455023677|FG006|Overall Study|Progressive disease|8|||
126470434|NCT02711345|455023678|FG007|Overall Study|Progressive disease|4|||
126470435|NCT02711345|455023679|FG008|Overall Study|Progressive disease|5|||
126470436|NCT02711345|455023680|FG009|Overall Study|Progressive disease|6|||
126555146|NCT01349907|455324098|FG001|Overall Study|Protocol Violation|13|||
126720524|NCT00905307|455926704|FG001|Overall Study|Lost to Follow-up|0|||
126720525|NCT00905307|455926705|FG002|Overall Study|Lost to Follow-up|0|||
126720526|NCT00905307|455926706|FG003|Overall Study|Lost to Follow-up|0|||
126720527|NCT00905307|455926707|FG004|Overall Study|Lost to Follow-up|1|||
126720528|NCT00905307|455926708|FG005|Overall Study|Lost to Follow-up|1|||
126720529|NCT00905307|455926703|FG000|Overall Study|Adverse Event|3|||
126720530|NCT00905307|455926704|FG001|Overall Study|Adverse Event|4|||
126720531|NCT00905307|455926705|FG002|Overall Study|Adverse Event|5|||
126720532|NCT00905307|455926706|FG003|Overall Study|Adverse Event|11|||
126720533|NCT00905307|455926707|FG004|Overall Study|Adverse Event|3|||
126720534|NCT00905307|455926708|FG005|Overall Study|Adverse Event|5|||
126720535|NCT00905307|455926703|FG000|Overall Study|Withdrawal by Subject|5|||
126720536|NCT00905307|455926704|FG001|Overall Study|Withdrawal by Subject|13|||
126720537|NCT00905307|455926705|FG002|Overall Study|Withdrawal by Subject|15|||
126720538|NCT00905307|455926706|FG003|Overall Study|Withdrawal by Subject|11|||
126720539|NCT00905307|455926707|FG004|Overall Study|Withdrawal by Subject|4|||
126720540|NCT00905307|455926708|FG005|Overall Study|Withdrawal by Subject|13|||
126720541|NCT00905307|455926703|FG000|Overall Study|Protocol Violation|1|||
126720542|NCT00905307|455926704|FG001|Overall Study|Protocol Violation|0|||
126720543|NCT00905307|455926705|FG002|Overall Study|Protocol Violation|1|||
126720544|NCT00905307|455926706|FG003|Overall Study|Protocol Violation|0|||
126720545|NCT00905307|455926707|FG004|Overall Study|Protocol Violation|0|||
126720546|NCT00905307|455926708|FG005|Overall Study|Protocol Violation|0|||
126720547|NCT00905307|455926703|FG000|Overall Study|Lack of Efficacy|6|||
126720548|NCT00905307|455926704|FG001|Overall Study|Lack of Efficacy|3|||
126720549|NCT00905307|455926705|FG002|Overall Study|Lack of Efficacy|5|||
126720550|NCT00905307|455926706|FG003|Overall Study|Lack of Efficacy|4|||
126720551|NCT00905307|455926707|FG004|Overall Study|Lack of Efficacy|4|||
126720552|NCT00905307|455926708|FG005|Overall Study|Lack of Efficacy|8|||
126720553|NCT01864018|455926709|FG000|Overall Study|Ineligible|3|||
126720554|NCT01864018|455926710|FG001|Overall Study|Ineligible|1|||
126720555|NCT01912729|455926711|FG000|Overall Study|Withdrawal by Subject|0|||
126720556|NCT01912729|455926712|FG001|Overall Study|Withdrawal by Subject|1|||
126720557|NCT01952834|455926713|FG000|Overall Study|Adverse Event|1|||
126720558|NCT04285346|455926714|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
126720559|NCT04285346|455926715|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
126720560|NCT04285346|455926714|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
126720561|NCT04285346|455926715|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
126720562|NCT04285346|455926714|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
126720563|NCT04285346|455926715|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
126720564|NCT00610935|455926716|FG000|Overall Study|Lost to Follow-up|0|||
126720565|NCT00610935|455926717|FG001|Overall Study|Lost to Follow-up|1|||
126720566|NCT00610935|455926716|FG000|Overall Study|Withdrawal by Subject|0|||
126720567|NCT00610935|455926717|FG001|Overall Study|Withdrawal by Subject|2|||
126720568|NCT00610935|455926716|FG000|Overall Study|Sponsor Discontinuation|1|||
126720569|NCT00610935|455926717|FG001|Overall Study|Sponsor Discontinuation|0|||
126720570|NCT00740779|455926718|FG000|Overall Study|Adverse Event|4|||
126720571|NCT00740779|455926719|FG001|Overall Study|Adverse Event|6|||
126720572|NCT00740779|455926720|FG002|Overall Study|Adverse Event|3|||
126720573|NCT00740779|455926718|FG000|Overall Study|Protocol Violation|1|||
126720574|NCT00740779|455926719|FG001|Overall Study|Protocol Violation|1|||
126720575|NCT00740779|455926720|FG002|Overall Study|Protocol Violation|1|||
126720576|NCT00740779|455926718|FG000|Overall Study|Lack of Efficacy|0|||
126720577|NCT00740779|455926719|FG001|Overall Study|Lack of Efficacy|0|||
126720578|NCT00740779|455926720|FG002|Overall Study|Lack of Efficacy|2|||
126720579|NCT00740779|455926718|FG000|Overall Study|Withdrawal by Subject|2|||
126720580|NCT00740779|455926719|FG001|Overall Study|Withdrawal by Subject|4|||
126720581|NCT00740779|455926720|FG002|Overall Study|Withdrawal by Subject|2|||
126720582|NCT00740779|455926718|FG000|Overall Study|Lost to Follow-up|2|||
126772069|NCT02414854|456121990|FG002|Overall Study|Poor compliance to protocol|2|||
126772070|NCT02414854|456121991|FG003|Overall Study|Poor compliance to protocol|2|||
126772071|NCT02414854|456121988|FG000|Overall Study|Other than specified above|12|||
126772072|NCT02414854|456121989|FG001|Overall Study|Other than specified above|37|||
126772073|NCT02414854|456121990|FG002|Overall Study|Other than specified above|17|||
126772074|NCT02414854|456121991|FG003|Overall Study|Other than specified above|37|||
126772075|NCT04723173|456121992|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
126772076|NCT02996448|456121993|FG000|Overall Study|Study terminated due to adverse effects|3|||
126772077|NCT01586624|456121994|FG000|Overall Study|Adverse Event|3|||
126772078|NCT01586624|456121995|FG001|Overall Study|Adverse Event|0|||
126772079|NCT01586624|456121996|FG002|Overall Study|Adverse Event|2|||
126772080|NCT01586624|456121997|FG003|Overall Study|Adverse Event|1|||
126772081|NCT01586624|456121998|FG004|Overall Study|Adverse Event|3|||
126772082|NCT01586624|456121999|FG005|Overall Study|Adverse Event|3|||
126772083|NCT01586624|456122000|FG006|Overall Study|Adverse Event|2|||
126772084|NCT01586624|456122001|FG007|Overall Study|Adverse Event|3|||
126772085|NCT01586624|456121994|FG000|Overall Study|Physician Decision|0|||
126772086|NCT01586624|456121995|FG001|Overall Study|Physician Decision|1|||
126772087|NCT01586624|456121996|FG002|Overall Study|Physician Decision|1|||
126772088|NCT01586624|456121997|FG003|Overall Study|Physician Decision|0|||
126396497|NCT03664674|454745940|FG000|Overall Study|Withdrawal by Subject|2|||
126396498|NCT03664674|454745941|FG001|Overall Study|Withdrawal by Subject|0|||
126396499|NCT02174523|454745942|FG000|Overall Study|Withdrawal by Subject|1|||
126396500|NCT02174523|454745943|FG001|Overall Study|Withdrawal by Subject|0|||
126396501|NCT00794365|454745944|FG000|Overall Study|Lost to Follow-up|38|||
126396502|NCT00794365|454745944|FG000|Overall Study|Other|17|||
126396503|NCT00794365|454745944|FG000|Overall Study|Poor Compliance|11|||
126396504|NCT00794365|454745944|FG000|Overall Study|Adverse Event|10|||
126396505|NCT00794365|454745944|FG000|Overall Study|Lack of Efficacy|3|||
126396506|NCT00856206|454745945|FG000|Overall Study|Protocol Violation|6|||
126396507|NCT00856206|454745946|FG001|Overall Study|Protocol Violation|18|||
126396508|NCT00856206|454745945|FG000|Overall Study|Adverse Event|10|||
126396509|NCT00856206|454745946|FG001|Overall Study|Adverse Event|46|||
126396510|NCT00856206|454745945|FG000|Overall Study|Lack of Efficacy|1|||
126396511|NCT00856206|454745946|FG001|Overall Study|Lack of Efficacy|2|||
126396512|NCT00856206|454745945|FG000|Overall Study|Withdrawal by Subject|15|||
126396513|NCT00856206|454745946|FG001|Overall Study|Withdrawal by Subject|36|||
126396514|NCT00856206|454745945|FG000|Overall Study|Lost to Follow-up|13|||
126396515|NCT00856206|454745946|FG001|Overall Study|Lost to Follow-up|39|||
126396516|NCT00856206|454745945|FG000|Overall Study|Death|2|||
126396517|NCT00856206|454745946|FG001|Overall Study|Death|2|||
126396518|NCT00856206|454745945|FG000|Overall Study|Decision by the Sponsor|4|||
126396519|NCT00856206|454745946|FG001|Overall Study|Decision by the Sponsor|8|||
126396520|NCT00856206|454745945|FG000|Overall Study|Other than specified above|3|||
126396521|NCT00856206|454745946|FG001|Overall Study|Other than specified above|10|||
126396522|NCT04584346|454745947|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
126396523|NCT04584346|454745948|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
126396524|NCT02780856|454745955|FG000|Overall Study|Lost to Follow-up|1|||
126396525|NCT03640052|454745956|FG000|Overall Study|Lost to Follow-up|0|||
126396526|NCT03640052|454745957|FG001|Overall Study|Lost to Follow-up|1|||
126396527|NCT03640052|454745958|FG002|Overall Study|Lost to Follow-up|0|||
126396528|NCT03640052|454745959|FG003|Overall Study|Lost to Follow-up|0|||
126396529|NCT03640052|454745960|FG004|Overall Study|Lost to Follow-up|0|||
126396530|NCT04422561|454745961|FG000|Overall Study|Lost to Follow-up|25|||
126396531|NCT04422561|454745962|FG001|Overall Study|Lost to Follow-up|11|||
126396532|NCT04239222|454745965|FG000|Baseline|Withdrawal by Subject|0|||
126396533|NCT04239222|454745966|FG001|Baseline|Withdrawal by Subject|0|||
126396534|NCT04239222|454745967|FG002|Baseline|Withdrawal by Subject|1|||
126396535|NCT04239222|454745968|FG003|Baseline|Withdrawal by Subject|1|||
126396536|NCT04239222|454745965|FG000|First Foot Assignment|Withdrawal by Subject|0|||
126396537|NCT04239222|454745966|FG001|First Foot Assignment|Withdrawal by Subject|0|||
126396538|NCT04239222|454745967|FG002|First Foot Assignment|Withdrawal by Subject|1|||
126396539|NCT04239222|454745968|FG003|First Foot Assignment|Withdrawal by Subject|0|||
126396540|NCT04239222|454745965|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
126396541|NCT04239222|454745966|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
126396542|NCT04239222|454745967|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
126396543|NCT04239222|454745968|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
126396544|NCT01468233|454745974|FG000|Treatment Period 1|Adverse Event|5|||
126396545|NCT01468233|454745975|FG001|Treatment Period 1|Adverse Event|3|||
126396546|NCT01468233|454745976|FG002|Treatment Period 1|Adverse Event|0|||
126772089|NCT01586624|456121998|FG004|Overall Study|Physician Decision|2|||
126772090|NCT01586624|456121999|FG005|Overall Study|Physician Decision|0|||
126772091|NCT01586624|456122000|FG006|Overall Study|Physician Decision|1|||
126772092|NCT01586624|456122001|FG007|Overall Study|Physician Decision|1|||
126772093|NCT01586624|456121994|FG000|Overall Study|Withdrawal by Subject|0|||
126772094|NCT01586624|456121995|FG001|Overall Study|Withdrawal by Subject|0|||
126772095|NCT01586624|456121996|FG002|Overall Study|Withdrawal by Subject|0|||
126720583|NCT00740779|455926719|FG001|Overall Study|Lost to Follow-up|3|||
126720584|NCT00740779|455926720|FG002|Overall Study|Lost to Follow-up|5|||
126720585|NCT00850460|455926721|FG000|Overall Study|Lost to Follow-up|4|||
126720586|NCT00850460|455926722|FG001|Overall Study|Lost to Follow-up|4|||
126720587|NCT02399813|455926725|FG000|Overall Study|Progressive Disease-Radiographic|2|||
126720588|NCT02399813|455926725|FG000|Overall Study|Death|20|||
126720589|NCT02399813|455926725|FG000|Overall Study|Withdrawal by Subject|3|||
126720590|NCT02399813|455926725|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
126720591|NCT02399813|455926725|FG000|Overall Study|Lost to Follow-up|2|||
126720592|NCT02399813|455926725|FG000|Overall Study|Other than specified|5|||
126720593|NCT00988559|455926726|FG000|Overall Study|Withdrawal by Subject|1|||
126720594|NCT00988559|455926727|FG001|Overall Study|Withdrawal by Subject|1|||
126720595|NCT00988559|455926728|FG002|Overall Study|Withdrawal by Subject|0|||
126720596|NCT00988559|455926729|FG003|Overall Study|Withdrawal by Subject|1|||
126720597|NCT00988559|455926726|FG000|Overall Study|Pregnancy|0|||
126720598|NCT00988559|455926727|FG001|Overall Study|Pregnancy|1|||
126720599|NCT00988559|455926728|FG002|Overall Study|Pregnancy|1|||
126470437|NCT02711345|455023671|FG000|Overall Study|Subject/guardian decision|0|||
126470438|NCT02711345|455023672|FG001|Overall Study|Subject/guardian decision|0|||
126470439|NCT02711345|455023673|FG002|Overall Study|Subject/guardian decision|0|||
126470440|NCT02711345|455023674|FG003|Overall Study|Subject/guardian decision|0|||
126720600|NCT00988559|455926729|FG003|Overall Study|Pregnancy|0|||
126720601|NCT00988559|455926726|FG000|Overall Study|Lost to Follow-up|0|||
126772096|NCT01586624|456121997|FG003|Overall Study|Withdrawal by Subject|1|||
126396547|NCT01468233|454745977|FG003|Treatment Period 1|Adverse Event|0|||
126396548|NCT01468233|454745978|FG004|Treatment Period 1|Adverse Event|0|||
126396549|NCT01468233|454745979|FG005|Treatment Period 1|Adverse Event|0|||
126396550|NCT01468233|454745974|FG000|Treatment Period 1|Withdrawal by Subject|3|||
126396551|NCT01468233|454745975|FG001|Treatment Period 1|Withdrawal by Subject|4|||
126396552|NCT01468233|454745976|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126396553|NCT01468233|454745977|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126396554|NCT01468233|454745978|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126396555|NCT01468233|454745979|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126396556|NCT01468233|454745974|FG000|Treatment Period 1|Lost to Follow-up|3|||
126396557|NCT01468233|454745975|FG001|Treatment Period 1|Lost to Follow-up|0|||
126396558|NCT01468233|454745976|FG002|Treatment Period 1|Lost to Follow-up|0|||
126396559|NCT01468233|454745977|FG003|Treatment Period 1|Lost to Follow-up|0|||
126396560|NCT01468233|454745978|FG004|Treatment Period 1|Lost to Follow-up|0|||
126396561|NCT01468233|454745979|FG005|Treatment Period 1|Lost to Follow-up|0|||
126396562|NCT01468233|454745974|FG000|Treatment Period 1|Other|1|||
126396563|NCT01468233|454745975|FG001|Treatment Period 1|Other|1|||
126396564|NCT01468233|454745976|FG002|Treatment Period 1|Other|0|||
126396565|NCT01468233|454745977|FG003|Treatment Period 1|Other|0|||
126396566|NCT01468233|454745978|FG004|Treatment Period 1|Other|0|||
126396567|NCT01468233|454745979|FG005|Treatment Period 1|Other|0|||
126396568|NCT01468233|454745974|FG000|Treatment Period 2|Adverse Event|0|||
126396569|NCT01468233|454745975|FG001|Treatment Period 2|Adverse Event|0|||
126396570|NCT01468233|454745976|FG002|Treatment Period 2|Adverse Event|3|||
126470441|NCT02711345|455023675|FG004|Overall Study|Subject/guardian decision|0|||
126772097|NCT01586624|456121998|FG004|Overall Study|Withdrawal by Subject|0|||
126396571|NCT01468233|454745977|FG003|Treatment Period 2|Adverse Event|0|||
126396572|NCT01468233|454745978|FG004|Treatment Period 2|Adverse Event|2|||
126396573|NCT01468233|454745979|FG005|Treatment Period 2|Adverse Event|1|||
126396574|NCT01468233|454745974|FG000|Treatment Period 2|Lack of Efficacy|0|||
126396575|NCT01468233|454745975|FG001|Treatment Period 2|Lack of Efficacy|0|||
126396576|NCT01468233|454745976|FG002|Treatment Period 2|Lack of Efficacy|9|||
126396577|NCT01468233|454745977|FG003|Treatment Period 2|Lack of Efficacy|2|||
126470442|NCT02711345|455023676|FG005|Overall Study|Subject/guardian decision|2|||
126470443|NCT02711345|455023677|FG006|Overall Study|Subject/guardian decision|3|||
126470444|NCT02711345|455023678|FG007|Overall Study|Subject/guardian decision|1|||
126470445|NCT02711345|455023679|FG008|Overall Study|Subject/guardian decision|0|||
126470446|NCT02711345|455023680|FG009|Overall Study|Subject/guardian decision|4|||
126470447|NCT02711345|455023671|FG000|Overall Study|Death|1|||
126470448|NCT02711345|455023672|FG001|Overall Study|Death|0|||
126470449|NCT02711345|455023673|FG002|Overall Study|Death|0|||
126470450|NCT02711345|455023674|FG003|Overall Study|Death|0|||
126470451|NCT02711345|455023675|FG004|Overall Study|Death|0|||
126470452|NCT02711345|455023676|FG005|Overall Study|Death|0|||
126470453|NCT02711345|455023677|FG006|Overall Study|Death|0|||
126470454|NCT02711345|455023678|FG007|Overall Study|Death|1|||
126470455|NCT02711345|455023679|FG008|Overall Study|Death|0|||
126470456|NCT02711345|455023680|FG009|Overall Study|Death|0|||
126470457|NCT04043728|455023681|FG000|Overall Study|Lost to Follow-up|1|||
126470458|NCT04043728|455023682|FG001|Overall Study|Lost to Follow-up|2|||
126470459|NCT04043728|455023683|FG002|Overall Study|Lost to Follow-up|0|||
126470460|NCT01033851|455023684|FG000|Overall Study|Withdrawal by Subject|3|||
126470461|NCT01033851|455023685|FG001|Overall Study|Withdrawal by Subject|7|||
126720602|NCT00988559|455926727|FG001|Overall Study|Lost to Follow-up|0|||
126720603|NCT00988559|455926728|FG002|Overall Study|Lost to Follow-up|1|||
126772098|NCT01586624|456121999|FG005|Overall Study|Withdrawal by Subject|0|||
126720604|NCT00988559|455926729|FG003|Overall Study|Lost to Follow-up|0|||
126720605|NCT03007953|455926730|FG000|Overall Study|Withdrawal by Subject|5|||
126720606|NCT03007953|455926731|FG001|Overall Study|Withdrawal by Subject|2|||
126720607|NCT03007953|455926730|FG000|Overall Study|Death|5|||
126720608|NCT03007953|455926731|FG001|Overall Study|Death|7|||
126720609|NCT03007953|455926730|FG000|Overall Study|Lost to Follow-up|3|||
126720610|NCT03007953|455926731|FG001|Overall Study|Lost to Follow-up|2|||
126720611|NCT03007953|455926730|FG000|Overall Study|Enrolled in Hospice|3|||
126720612|NCT03007953|455926731|FG001|Overall Study|Enrolled in Hospice|2|||
126720613|NCT02224846|455926732|FG000|Period 1 (Month 3)|Adverse Event|2|||
126720614|NCT02224846|455926733|FG001|Period 1 (Month 3)|Adverse Event|1|||
126720615|NCT02224846|455926732|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
126720616|NCT02224846|455926733|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
126720617|NCT02224846|455926732|FG000|Period 1 (Month 3)|Protocol Violation|4|||
126396578|NCT01468233|454745978|FG004|Treatment Period 2|Lack of Efficacy|0|||
126396579|NCT01468233|454745979|FG005|Treatment Period 2|Lack of Efficacy|1|||
126396580|NCT01468233|454745974|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126396581|NCT01468233|454745975|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126396582|NCT01468233|454745976|FG002|Treatment Period 2|Withdrawal by Subject|9|||
126396583|NCT01468233|454745977|FG003|Treatment Period 2|Withdrawal by Subject|1|||
126396584|NCT01468233|454745978|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126396585|NCT01468233|454745979|FG005|Treatment Period 2|Withdrawal by Subject|1|||
126396586|NCT01468233|454745974|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
126396587|NCT01468233|454745975|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
126396588|NCT01468233|454745976|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
126396589|NCT01468233|454745977|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
126396590|NCT01468233|454745978|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
126396591|NCT01468233|454745979|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
126396592|NCT01468233|454745974|FG000|Treatment Period 2|Lost to Follow-up|0|||
126396593|NCT01468233|454745975|FG001|Treatment Period 2|Lost to Follow-up|0|||
126396594|NCT01468233|454745976|FG002|Treatment Period 2|Lost to Follow-up|3|||
126396595|NCT01468233|454745977|FG003|Treatment Period 2|Lost to Follow-up|0|||
126396596|NCT01468233|454745978|FG004|Treatment Period 2|Lost to Follow-up|2|||
126396597|NCT01468233|454745979|FG005|Treatment Period 2|Lost to Follow-up|0|||
126396598|NCT01468233|454745974|FG000|Treatment Period 2|Other|0|||
126396599|NCT01468233|454745975|FG001|Treatment Period 2|Other|0|||
126396600|NCT01468233|454745976|FG002|Treatment Period 2|Other|3|||
126396601|NCT01468233|454745977|FG003|Treatment Period 2|Other|0|||
126396602|NCT01468233|454745978|FG004|Treatment Period 2|Other|1|||
126396603|NCT01468233|454745979|FG005|Treatment Period 2|Other|0|||
126396604|NCT00790647|454745987|FG000|Overall Study|Adverse Event|1|||
126396605|NCT04926831|454745989|FG000|Overall Study|Withdrawal by Subject|2|||
126396606|NCT04926831|454745989|FG000|Overall Study|Adverse Event|2|||
126396607|NCT02701777|454745990|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
126396608|NCT02701777|454745991|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
126396609|NCT02701777|454745992|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
126396610|NCT02701777|454745993|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
126396611|NCT02701777|454745990|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
126396612|NCT02701777|454745991|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
126396613|NCT02701777|454745992|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
126396614|NCT02701777|454745993|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
126396615|NCT03549871|454745996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
126396616|NCT03549871|454745997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
126396617|NCT03549871|454745996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
126396618|NCT03549871|454745997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
126396619|NCT03549871|454745996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
126396620|NCT03549871|454745997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
126396621|NCT03549871|454745996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
126396622|NCT03549871|454745997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
126396623|NCT03549871|454745996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
126396624|NCT03549871|454745997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
126396625|NCT03549871|454745996|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
126396626|NCT03549871|454745997|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
126396627|NCT03549871|454745996|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
126396628|NCT03549871|454745997|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
126470462|NCT02349542|455023686|FG000|Overall Study|Withdrawal by Subject|5|||
126720618|NCT02224846|455926733|FG001|Period 1 (Month 3)|Protocol Violation|8|||
126720619|NCT02224846|455926732|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
126720620|NCT02224846|455926733|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
126772099|NCT01586624|456122000|FG006|Overall Study|Withdrawal by Subject|0|||
126396629|NCT03549871|454745996|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
126396630|NCT03549871|454745997|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
126720621|NCT02224846|455926732|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
126720622|NCT02224846|455926733|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
126720623|NCT02224846|455926732|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
126720624|NCT02224846|455926733|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
126720625|NCT02224846|455926732|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
126720626|NCT02224846|455926733|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
126720627|NCT02224846|455926732|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
126720628|NCT02224846|455926733|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
126720629|NCT02224846|455926732|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
126720630|NCT02224846|455926733|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
126720631|NCT02224846|455926732|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
126720632|NCT02224846|455926733|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
126720633|NCT02224846|455926732|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
126720634|NCT02224846|455926733|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
126720635|NCT02224846|455926732|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
126720636|NCT02224846|455926733|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
126720637|NCT02224846|455926732|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
126720638|NCT02224846|455926733|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
126720639|NCT02224846|455926732|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
126720640|NCT02224846|455926733|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
126720641|NCT02224846|455926732|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
126720642|NCT02224846|455926733|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
126720643|NCT02224846|455926732|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
126720644|NCT02224846|455926733|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
126720645|NCT02224846|455926732|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
126720646|NCT02224846|455926733|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
126720647|NCT03280550|455926734|FG000|Overall Study|Withdrawal by Subject|2|||
126720648|NCT03280550|455926735|FG001|Overall Study|Withdrawal by Subject|2|||
126720649|NCT03280550|455926734|FG000|Overall Study|Physician Decision|0|||
126720650|NCT03280550|455926735|FG001|Overall Study|Physician Decision|1|||
126720651|NCT02203838|455926738|FG000|Overall Study|Lack of Efficacy|7|||
126720652|NCT02203838|455926739|FG001|Overall Study|Lack of Efficacy|0|||
126396631|NCT03549871|454745996|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
126396632|NCT03549871|454745997|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
126396633|NCT03549871|454745996|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
126396634|NCT03549871|454745997|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
126396635|NCT03549871|454745996|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
126396636|NCT03549871|454745997|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
126396637|NCT01133626|454745999|FG000|Overall Study|Adverse Event|0|||
126396638|NCT01133626|454746000|FG001|Overall Study|Adverse Event|1|||
126396639|NCT01133626|454746001|FG002|Overall Study|Adverse Event|0|||
126396640|NCT01133626|454745999|FG000|Overall Study|Withdrawal by Subject|1|||
126396641|NCT01133626|454746000|FG001|Overall Study|Withdrawal by Subject|2|||
126396642|NCT01133626|454746001|FG002|Overall Study|Withdrawal by Subject|2|||
126396643|NCT01133626|454745999|FG000|Overall Study|Other|0|||
126396644|NCT01133626|454746000|FG001|Overall Study|Other|2|||
126396645|NCT01133626|454746001|FG002|Overall Study|Other|0|||
126396646|NCT03298984|454746004|FG000|Overall Study|Physician Decision|1|||
126396647|NCT03298984|454746005|FG001|Overall Study|Physician Decision|0|||
126396648|NCT03298984|454746006|FG002|Overall Study|Physician Decision|0|||
126396649|NCT03298984|454746007|FG003|Overall Study|Physician Decision|6|||
126396650|NCT03298984|454746004|FG000|Overall Study|Lack of Efficacy|0|||
126396651|NCT03298984|454746005|FG001|Overall Study|Lack of Efficacy|1|||
126396652|NCT03298984|454746006|FG002|Overall Study|Lack of Efficacy|1|||
126470463|NCT01011738|455023687|FG000|Overall Study|Death|12|||
126470464|NCT01011738|455023688|FG001|Overall Study|Death|3|||
126470465|NCT01011738|455023689|FG002|Overall Study|Death|0|||
126470466|NCT01011738|455023687|FG000|Overall Study|Unknown reasons|312|||
126470467|NCT01011738|455023688|FG001|Overall Study|Unknown reasons|291|||
126396653|NCT03298984|454746007|FG003|Overall Study|Lack of Efficacy|4|||
126396654|NCT03298984|454746004|FG000|Overall Study|Relapsed disease (following remission)|0|||
126396655|NCT03298984|454746005|FG001|Overall Study|Relapsed disease (following remission)|0|||
126396656|NCT03298984|454746006|FG002|Overall Study|Relapsed disease (following remission)|1|||
126396657|NCT03298984|454746007|FG003|Overall Study|Relapsed disease (following remission)|1|||
126396658|NCT03298984|454746004|FG000|Overall Study|Adverse Event|0|||
126396659|NCT03298984|454746005|FG001|Overall Study|Adverse Event|0|||
126470468|NCT01011738|455023689|FG002|Overall Study|Unknown reasons|17|||
126720653|NCT02203838|455926740|FG002|Overall Study|Lack of Efficacy|1|||
126720654|NCT02203838|455926741|FG003|Overall Study|Lack of Efficacy|1|||
126720655|NCT02203838|455926738|FG000|Overall Study|Adverse Event|46|||
126470469|NCT01163266|455023692|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
126720656|NCT02203838|455926739|FG001|Overall Study|Adverse Event|6|||
126720657|NCT02203838|455926740|FG002|Overall Study|Adverse Event|3|||
126720658|NCT02203838|455926741|FG003|Overall Study|Adverse Event|2|||
126720659|NCT02203838|455926738|FG000|Overall Study|Lost to Follow-up|39|||
126720660|NCT02203838|455926739|FG001|Overall Study|Lost to Follow-up|3|||
126720661|NCT02203838|455926740|FG002|Overall Study|Lost to Follow-up|2|||
126720662|NCT02203838|455926741|FG003|Overall Study|Lost to Follow-up|1|||
126720663|NCT02203838|455926738|FG000|Overall Study|Protocol Violation|7|||
126720664|NCT02203838|455926739|FG001|Overall Study|Protocol Violation|3|||
126720665|NCT02203838|455926740|FG002|Overall Study|Protocol Violation|0|||
126720666|NCT02203838|455926741|FG003|Overall Study|Protocol Violation|0|||
126720667|NCT02203838|455926738|FG000|Overall Study|Withdrawal by Subject|83|||
126720668|NCT02203838|455926739|FG001|Overall Study|Withdrawal by Subject|10|||
126720669|NCT02203838|455926740|FG002|Overall Study|Withdrawal by Subject|8|||
126720670|NCT02203838|455926741|FG003|Overall Study|Withdrawal by Subject|11|||
126720671|NCT02203838|455926738|FG000|Overall Study|Physician Decision|27|||
126720672|NCT02203838|455926739|FG001|Overall Study|Physician Decision|0|||
126720673|NCT02203838|455926740|FG002|Overall Study|Physician Decision|2|||
126720674|NCT02203838|455926741|FG003|Overall Study|Physician Decision|3|||
126720675|NCT02203838|455926738|FG000|Overall Study|Other|1|||
126720676|NCT02203838|455926739|FG001|Overall Study|Other|0|||
126720677|NCT02203838|455926740|FG002|Overall Study|Other|0|||
126720678|NCT02203838|455926741|FG003|Overall Study|Other|0|||
126720679|NCT03196297|455926742|FG000|Main Period|Withdrawal by Subject|4|||
126720680|NCT03196297|455926742|FG000|Extension Period|Withdrawal by Subject|1|||
126720681|NCT03196297|455926742|FG000|Extension Period|Lack of Efficacy|2|||
126720682|NCT02538666|455926743|FG000|Pre-Treatment|Disease progression|1|||
126720683|NCT02538666|455926744|FG001|Pre-Treatment|Disease progression|0|||
126720684|NCT02538666|455926745|FG002|Pre-Treatment|Disease progression|0|||
126720685|NCT02538666|455926743|FG000|Pre-Treatment|no longer meets study criteria|1|||
126720686|NCT02538666|455926744|FG001|Pre-Treatment|no longer meets study criteria|0|||
126720687|NCT02538666|455926745|FG002|Pre-Treatment|no longer meets study criteria|0|||
126720688|NCT02538666|455926743|FG000|Pre-Treatment|Withdrew Consent|0|||
126720689|NCT02538666|455926744|FG001|Pre-Treatment|Withdrew Consent|1|||
126720690|NCT02538666|455926745|FG002|Pre-Treatment|Withdrew Consent|1|||
126720691|NCT02538666|455926743|FG000|Treatment|Disease progression|270|||
126720692|NCT02538666|455926744|FG001|Treatment|Disease progression|227|||
126720693|NCT02538666|455926745|FG002|Treatment|Disease progression|165|||
126720694|NCT02538666|455926743|FG000|Treatment|Study drug toxicity|1|||
126720695|NCT02538666|455926744|FG001|Treatment|Study drug toxicity|29|||
126720696|NCT02538666|455926745|FG002|Treatment|Study drug toxicity|92|||
126720697|NCT02538666|455926743|FG000|Treatment|Death|0|||
126720698|NCT02538666|455926744|FG001|Treatment|Death|2|||
126720699|NCT02538666|455926745|FG002|Treatment|Death|3|||
126720700|NCT02538666|455926743|FG000|Treatment|Adverse event unrelated to study drug|8|||
126720701|NCT02538666|455926744|FG001|Treatment|Adverse event unrelated to study drug|10|||
126720702|NCT02538666|455926745|FG002|Treatment|Adverse event unrelated to study drug|15|||
126720703|NCT02538666|455926743|FG000|Treatment|Participant request to discontinue study treatment|3|||
126720704|NCT02538666|455926744|FG001|Treatment|Participant request to discontinue study treatment|6|||
126720705|NCT02538666|455926745|FG002|Treatment|Participant request to discontinue study treatment|11|||
126720706|NCT02538666|455926743|FG000|Treatment|Participant withdrew consent|2|||
126720707|NCT02538666|455926744|FG001|Treatment|Participant withdrew consent|5|||
126720708|NCT02538666|455926745|FG002|Treatment|Participant withdrew consent|3|||
126720709|NCT02538666|455926743|FG000|Treatment|Lost to Follow-up|0|||
126720710|NCT02538666|455926744|FG001|Treatment|Lost to Follow-up|1|||
126720711|NCT02538666|455926745|FG002|Treatment|Lost to Follow-up|1|||
126720712|NCT02538666|455926743|FG000|Treatment|Maximum clinical benefit|4|||
126720713|NCT02538666|455926744|FG001|Treatment|Maximum clinical benefit|3|||
126720714|NCT02538666|455926745|FG002|Treatment|Maximum clinical benefit|4|||
126720715|NCT02538666|455926743|FG000|Treatment|Poor/non-compliance|0|||
126720716|NCT02538666|455926744|FG001|Treatment|Poor/non-compliance|1|||
126772100|NCT01586624|456122001|FG007|Overall Study|Withdrawal by Subject|0|||
126720717|NCT02538666|455926745|FG002|Treatment|Poor/non-compliance|0|||
126720718|NCT02538666|455926743|FG000|Treatment|Participant no longer meets study criteria|0|||
126772101|NCT01586624|456121994|FG000|Overall Study|Evidence of disease progression|1|||
126396660|NCT03298984|454746006|FG002|Overall Study|Adverse Event|0|||
126396661|NCT03298984|454746007|FG003|Overall Study|Adverse Event|1|||
126720719|NCT02538666|455926744|FG001|Treatment|Participant no longer meets study criteria|2|||
126720720|NCT02538666|455926745|FG002|Treatment|Participant no longer meets study criteria|0|||
126720721|NCT02538666|455926743|FG000|Treatment|Administrative reason by sponsor|0|||
126720722|NCT02538666|455926744|FG001|Treatment|Administrative reason by sponsor|0|||
126772102|NCT01586624|456121995|FG001|Overall Study|Evidence of disease progression|3|||
126720723|NCT02538666|455926745|FG002|Treatment|Administrative reason by sponsor|1|||
126720724|NCT02538666|455926743|FG000|Treatment|Other reasons|8|||
126720725|NCT02538666|455926744|FG001|Treatment|Other reasons|15|||
126720726|NCT02538666|455926745|FG002|Treatment|Other reasons|5|||
126720727|NCT02538666|455926743|FG000|Treatment|Not reported|2|||
126720728|NCT02538666|455926744|FG001|Treatment|Not reported|2|||
126772103|NCT01586624|456121996|FG002|Overall Study|Evidence of disease progression|2|||
126772104|NCT01586624|456121997|FG003|Overall Study|Evidence of disease progression|5|||
126772105|NCT01586624|456121998|FG004|Overall Study|Evidence of disease progression|3|||
126772106|NCT01586624|456121999|FG005|Overall Study|Evidence of disease progression|5|||
126772107|NCT01586624|456122000|FG006|Overall Study|Evidence of disease progression|4|||
126772108|NCT01586624|456122001|FG007|Overall Study|Evidence of disease progression|6|||
126772109|NCT01586624|456121994|FG000|Overall Study|Screen failure (no treatment received)|0|||
126772110|NCT01586624|456121995|FG001|Overall Study|Screen failure (no treatment received)|0|||
126772111|NCT01586624|456121996|FG002|Overall Study|Screen failure (no treatment received)|0|||
126772112|NCT01586624|456121997|FG003|Overall Study|Screen failure (no treatment received)|0|||
126772113|NCT01586624|456121998|FG004|Overall Study|Screen failure (no treatment received)|0|||
126772114|NCT01586624|456121999|FG005|Overall Study|Screen failure (no treatment received)|0|||
126772115|NCT01586624|456122000|FG006|Overall Study|Screen failure (no treatment received)|1|||
126772116|NCT01586624|456122001|FG007|Overall Study|Screen failure (no treatment received)|0|||
126772117|NCT01160198|456122002|FG000|Overall Study|Withdrawal by Subject|2|||
126396662|NCT03298984|454746004|FG000|Overall Study|Death|0|||
126396663|NCT03298984|454746005|FG001|Overall Study|Death|0|||
126396664|NCT03298984|454746006|FG002|Overall Study|Death|0|||
126396665|NCT03298984|454746007|FG003|Overall Study|Death|2|||
126396666|NCT03298984|454746004|FG000|Overall Study|Insurance Company Decision|0|||
126396667|NCT03298984|454746005|FG001|Overall Study|Insurance Company Decision|0|||
126396668|NCT03298984|454746006|FG002|Overall Study|Insurance Company Decision|0|||
126396669|NCT03298984|454746007|FG003|Overall Study|Insurance Company Decision|1|||
126396670|NCT02851407|454746008|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126396671|NCT02851407|454746009|FG001|Overall Study|Withdrawal by parent/guardian|7|||
126396672|NCT02851407|454746008|FG000|Overall Study|Protocol deviation|0|||
126396673|NCT02851407|454746009|FG001|Overall Study|Protocol deviation|1|||
126396674|NCT02851407|454746008|FG000|Overall Study|Transferred to another hospital to continue|1|||
126396675|NCT02851407|454746009|FG001|Overall Study|Transferred to another hospital to continue|0|||
126396676|NCT02851407|454746008|FG000|Overall Study|Other Death|30|||
126396677|NCT02851407|454746009|FG001|Overall Study|Other Death|20|||
126396678|NCT02851407|454746008|FG000|Overall Study|Adverse event, serious fatal|6|||
126396679|NCT02851407|454746009|FG001|Overall Study|Adverse event, serious fatal|8|||
126396680|NCT02851407|454746008|FG000|Overall Study|Consent withdrawn by participant|5|||
126396681|NCT02851407|454746009|FG001|Overall Study|Consent withdrawn by participant|3|||
126396682|NCT02851407|454746008|FG000|Overall Study|Screen failure|2|||
126396683|NCT02851407|454746009|FG001|Overall Study|Screen failure|1|||
126396684|NCT02851407|454746008|FG000|Overall Study|Disease relapse|9|||
126396685|NCT02851407|454746009|FG001|Overall Study|Disease relapse|6|||
126396686|NCT02851407|454746008|FG000|Overall Study|Physician Decision|7|||
126396687|NCT02851407|454746009|FG001|Overall Study|Physician Decision|6|||
126396688|NCT02851407|454746008|FG000|Overall Study|Transferred to hospital closer to home|0|||
126772118|NCT01160198|456122003|FG001|Overall Study|Withdrawal by Subject|1|||
126396689|NCT02851407|454746009|FG001|Overall Study|Transferred to hospital closer to home|1|||
126396690|NCT02851407|454746008|FG000|Overall Study|Enrolled in an investigational study|0|||
126396691|NCT02851407|454746009|FG001|Overall Study|Enrolled in an investigational study|1|||
126396692|NCT02851407|454746008|FG000|Overall Study|Early recovery|1|||
126396693|NCT02851407|454746009|FG001|Overall Study|Early recovery|0|||
126396694|NCT02851407|454746008|FG000|Overall Study|Adverse event, non-fatal|7|||
126396695|NCT02851407|454746009|FG001|Overall Study|Adverse event, non-fatal|5|||
126396696|NCT02851407|454746008|FG000|Overall Study|Lost to Follow-up|0|||
126396697|NCT02851407|454746009|FG001|Overall Study|Lost to Follow-up|2|||
126396698|NCT00294645|454746010|FG000|Overall Study|Death|10|||
126396699|NCT00294645|454746011|FG001|Overall Study|Death|18|||
126396700|NCT00294645|454746010|FG000|Overall Study|Lost to Follow-up|1|||
126396701|NCT00294645|454746011|FG001|Overall Study|Lost to Follow-up|10|||
126396702|NCT00294645|454746010|FG000|Overall Study|Withdrawal by Subject|18|||
126396703|NCT00294645|454746011|FG001|Overall Study|Withdrawal by Subject|34|||
126396704|NCT00294645|454746010|FG000|Overall Study|Physician Decision|15|||
126396705|NCT00294645|454746011|FG001|Overall Study|Physician Decision|20|||
126396706|NCT00294645|454746010|FG000|Overall Study|Other|4|||
126396707|NCT00294645|454746011|FG001|Overall Study|Other|10|||
126396708|NCT00075725|454746012|FG000|Overall Study|Adverse Event|6|||
126396709|NCT00075725|454746013|FG001|Overall Study|Adverse Event|6|||
126396710|NCT00075725|454746014|FG002|Overall Study|Adverse Event|20|||
126396711|NCT00075725|454746015|FG003|Overall Study|Adverse Event|8|||
126396712|NCT00075725|454746016|FG004|Overall Study|Adverse Event|4|||
126396713|NCT00075725|454746017|FG005|Overall Study|Adverse Event|38|||
126396714|NCT00075725|454746018|FG006|Overall Study|Adverse Event|3|||
126772119|NCT01160198|456122004|FG002|Overall Study|Withdrawal by Subject|0|||
126772120|NCT01160198|456122002|FG000|Overall Study|Adverse Event|0|||
126396715|NCT00075725|454746019|FG007|Overall Study|Adverse Event|51|||
126396716|NCT00075725|454746020|FG008|Overall Study|Adverse Event|15|||
126396717|NCT00075725|454746021|FG009|Overall Study|Adverse Event|4|||
126396718|NCT00075725|454746022|FG010|Overall Study|Adverse Event|2|||
126396719|NCT00075725|454746023|FG011|Overall Study|Adverse Event|2|||
126396720|NCT00075725|454746012|FG000|Overall Study|Death|3|||
126396721|NCT00075725|454746013|FG001|Overall Study|Death|5|||
126396722|NCT00075725|454746014|FG002|Overall Study|Death|10|||
126396723|NCT00075725|454746015|FG003|Overall Study|Death|2|||
126396724|NCT00075725|454746016|FG004|Overall Study|Death|3|||
126396725|NCT00075725|454746017|FG005|Overall Study|Death|25|||
126396726|NCT00075725|454746018|FG006|Overall Study|Death|4|||
126396727|NCT00075725|454746019|FG007|Overall Study|Death|22|||
126396728|NCT00075725|454746020|FG008|Overall Study|Death|14|||
126396729|NCT00075725|454746021|FG009|Overall Study|Death|4|||
126396730|NCT00075725|454746022|FG010|Overall Study|Death|3|||
126396731|NCT00075725|454746023|FG011|Overall Study|Death|0|||
126396732|NCT00075725|454746012|FG000|Overall Study|Lost to Follow-up|1|||
126396733|NCT00075725|454746013|FG001|Overall Study|Lost to Follow-up|1|||
126396734|NCT00075725|454746014|FG002|Overall Study|Lost to Follow-up|4|||
126396735|NCT00075725|454746015|FG003|Overall Study|Lost to Follow-up|1|||
126396736|NCT00075725|454746016|FG004|Overall Study|Lost to Follow-up|0|||
126396737|NCT00075725|454746017|FG005|Overall Study|Lost to Follow-up|13|||
126396738|NCT00075725|454746018|FG006|Overall Study|Lost to Follow-up|2|||
126396739|NCT00075725|454746019|FG007|Overall Study|Lost to Follow-up|4|||
126396740|NCT00075725|454746020|FG008|Overall Study|Lost to Follow-up|1|||
126396741|NCT00075725|454746021|FG009|Overall Study|Lost to Follow-up|0|||
126396742|NCT00075725|454746022|FG010|Overall Study|Lost to Follow-up|0|||
126396743|NCT00075725|454746023|FG011|Overall Study|Lost to Follow-up|0|||
126396744|NCT00075725|454746012|FG000|Overall Study|Physician Decision|2|||
126396745|NCT00075725|454746013|FG001|Overall Study|Physician Decision|6|||
126396746|NCT00075725|454746014|FG002|Overall Study|Physician Decision|5|||
126396747|NCT00075725|454746015|FG003|Overall Study|Physician Decision|8|||
126396748|NCT00075725|454746016|FG004|Overall Study|Physician Decision|4|||
126396749|NCT00075725|454746017|FG005|Overall Study|Physician Decision|19|||
126396750|NCT00075725|454746018|FG006|Overall Study|Physician Decision|3|||
126396751|NCT00075725|454746019|FG007|Overall Study|Physician Decision|17|||
126396752|NCT00075725|454746020|FG008|Overall Study|Physician Decision|5|||
126396753|NCT00075725|454746021|FG009|Overall Study|Physician Decision|0|||
126396754|NCT00075725|454746022|FG010|Overall Study|Physician Decision|1|||
126396755|NCT00075725|454746023|FG011|Overall Study|Physician Decision|0|||
126396756|NCT00075725|454746012|FG000|Overall Study|Pregnancy|0|||
126396757|NCT00075725|454746013|FG001|Overall Study|Pregnancy|0|||
126396758|NCT00075725|454746014|FG002|Overall Study|Pregnancy|0|||
126396759|NCT00075725|454746015|FG003|Overall Study|Pregnancy|0|||
126396760|NCT00075725|454746016|FG004|Overall Study|Pregnancy|0|||
126396761|NCT00075725|454746017|FG005|Overall Study|Pregnancy|1|||
126396762|NCT00075725|454746018|FG006|Overall Study|Pregnancy|0|||
126396763|NCT00075725|454746019|FG007|Overall Study|Pregnancy|1|||
126396764|NCT00075725|454746020|FG008|Overall Study|Pregnancy|0|||
126396765|NCT00075725|454746021|FG009|Overall Study|Pregnancy|0|||
126396766|NCT00075725|454746022|FG010|Overall Study|Pregnancy|0|||
126396767|NCT00075725|454746023|FG011|Overall Study|Pregnancy|0|||
126396768|NCT00075725|454746012|FG000|Overall Study|Protocol Violation|1|||
126396769|NCT00075725|454746013|FG001|Overall Study|Protocol Violation|1|||
126396770|NCT00075725|454746014|FG002|Overall Study|Protocol Violation|0|||
126396771|NCT00075725|454746015|FG003|Overall Study|Protocol Violation|3|||
126396772|NCT00075725|454746016|FG004|Overall Study|Protocol Violation|3|||
126396773|NCT00075725|454746017|FG005|Overall Study|Protocol Violation|2|||
126396774|NCT00075725|454746018|FG006|Overall Study|Protocol Violation|1|||
126396775|NCT00075725|454746019|FG007|Overall Study|Protocol Violation|2|||
126470470|NCT01163266|455023693|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
126470471|NCT01163266|455023694|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
126470472|NCT01163266|455023692|FG000|Overall Study|Lack of Efficacy|1|||
126470473|NCT01163266|455023693|FG001|Overall Study|Lack of Efficacy|3|||
126470474|NCT01163266|455023694|FG002|Overall Study|Lack of Efficacy|1|||
126470475|NCT01163266|455023692|FG000|Overall Study|Noncompliance with Study Drug|0|||
126470476|NCT01163266|455023693|FG001|Overall Study|Noncompliance with Study Drug|2|||
126470477|NCT01163266|455023694|FG002|Overall Study|Noncompliance with Study Drug|0|||
126470478|NCT01163266|455023692|FG000|Overall Study|Protocol Deviations|2|||
126470479|NCT01163266|455023693|FG001|Overall Study|Protocol Deviations|2|||
126470480|NCT01163266|455023694|FG002|Overall Study|Protocol Deviations|5|||
126720729|NCT02538666|455926745|FG002|Treatment|Not reported|2|||
126396776|NCT00075725|454746020|FG008|Overall Study|Protocol Violation|3|||
126396777|NCT00075725|454746021|FG009|Overall Study|Protocol Violation|0|||
126720730|NCT00829166|455926746|FG000|Overall Study|Death|305|||
126396778|NCT00075725|454746022|FG010|Overall Study|Protocol Violation|0|||
126396779|NCT00075725|454746023|FG011|Overall Study|Protocol Violation|1|||
126396780|NCT00075725|454746012|FG000|Overall Study|Withdrawal by Subject|12|||
126396781|NCT00075725|454746013|FG001|Overall Study|Withdrawal by Subject|3|||
126396782|NCT00075725|454746014|FG002|Overall Study|Withdrawal by Subject|6|||
126396783|NCT00075725|454746015|FG003|Overall Study|Withdrawal by Subject|10|||
126470481|NCT01163266|455023692|FG000|Overall Study|Withdrawal of Consent|5|||
126396784|NCT00075725|454746016|FG004|Overall Study|Withdrawal by Subject|6|||
126396785|NCT00075725|454746017|FG005|Overall Study|Withdrawal by Subject|27|||
126396786|NCT00075725|454746018|FG006|Overall Study|Withdrawal by Subject|7|||
126720731|NCT00829166|455926747|FG001|Overall Study|Death|333|||
126720732|NCT00829166|455926746|FG000|Overall Study|Lost to Follow-up|5|||
126720733|NCT00829166|455926747|FG001|Overall Study|Lost to Follow-up|4|||
126720734|NCT00829166|455926746|FG000|Overall Study|Physician's Decision|4|||
126720735|NCT00829166|455926747|FG001|Overall Study|Physician's Decision|3|||
126720736|NCT00829166|455926746|FG000|Overall Study|Subject's Decision|41|||
126720737|NCT00829166|455926747|FG001|Overall Study|Subject's Decision|55|||
126720738|NCT00829166|455926746|FG000|Overall Study|Sponsor's Decision|137|||
126720739|NCT00829166|455926747|FG001|Overall Study|Sponsor's Decision|98|||
126720740|NCT00829166|455926746|FG000|Overall Study|Reason Not Specified|3|||
126720741|NCT00829166|455926747|FG001|Overall Study|Reason Not Specified|3|||
126720742|NCT03345836|455926748|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
126720743|NCT03345836|455926749|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
126396787|NCT00075725|454746019|FG007|Overall Study|Withdrawal by Subject|31|||
126396788|NCT00075725|454746020|FG008|Overall Study|Withdrawal by Subject|10|||
126396789|NCT00075725|454746021|FG009|Overall Study|Withdrawal by Subject|2|||
126396790|NCT00075725|454746022|FG010|Overall Study|Withdrawal by Subject|0|||
126396791|NCT00075725|454746023|FG011|Overall Study|Withdrawal by Subject|0|||
126396792|NCT00075725|454746012|FG000|Overall Study|Disease Progression, all other reasons|17|||
126396793|NCT00075725|454746013|FG001|Overall Study|Disease Progression, all other reasons|5|||
126396794|NCT00075725|454746014|FG002|Overall Study|Disease Progression, all other reasons|33|||
126396795|NCT00075725|454746015|FG003|Overall Study|Disease Progression, all other reasons|6|||
126396796|NCT00075725|454746016|FG004|Overall Study|Disease Progression, all other reasons|21|||
126396797|NCT00075725|454746017|FG005|Overall Study|Disease Progression, all other reasons|59|||
126396798|NCT00075725|454746018|FG006|Overall Study|Disease Progression, all other reasons|20|||
126396799|NCT00075725|454746019|FG007|Overall Study|Disease Progression, all other reasons|46|||
126396800|NCT00075725|454746020|FG008|Overall Study|Disease Progression, all other reasons|21|||
126396801|NCT00075725|454746021|FG009|Overall Study|Disease Progression, all other reasons|4|||
126396802|NCT00075725|454746022|FG010|Overall Study|Disease Progression, all other reasons|0|||
126396803|NCT00075725|454746023|FG011|Overall Study|Disease Progression, all other reasons|5|||
126396804|NCT00075725|454746012|FG000|Overall Study|Patient off treatment|0|||
126396805|NCT00075725|454746013|FG001|Overall Study|Patient off treatment|0|||
126396806|NCT00075725|454746014|FG002|Overall Study|Patient off treatment|1|||
126396807|NCT00075725|454746015|FG003|Overall Study|Patient off treatment|2|||
126396808|NCT00075725|454746016|FG004|Overall Study|Patient off treatment|1|||
126396809|NCT00075725|454746017|FG005|Overall Study|Patient off treatment|0|||
126396810|NCT00075725|454746018|FG006|Overall Study|Patient off treatment|0|||
126396811|NCT00075725|454746019|FG007|Overall Study|Patient off treatment|2|||
126396812|NCT00075725|454746020|FG008|Overall Study|Patient off treatment|1|||
126396813|NCT00075725|454746021|FG009|Overall Study|Patient off treatment|0|||
126396814|NCT00075725|454746022|FG010|Overall Study|Patient off treatment|0|||
126396815|NCT00075725|454746023|FG011|Overall Study|Patient off treatment|0|||
126720744|NCT03345836|455926750|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
126720745|NCT03345836|455926751|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
126720746|NCT03345836|455926752|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
126720747|NCT03345836|455926753|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
126720748|NCT03345836|455926748|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
126720749|NCT03345836|455926749|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
126720750|NCT03345836|455926750|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
126720751|NCT03345836|455926751|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
126720752|NCT03345836|455926752|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
126720753|NCT03345836|455926753|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
126720754|NCT03345836|455926748|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
126720755|NCT03345836|455926749|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
126720756|NCT03345836|455926750|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
126396816|NCT00075725|454746012|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
126396817|NCT00075725|454746013|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
126396818|NCT00075725|454746014|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
126396819|NCT00075725|454746015|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
126396820|NCT00075725|454746016|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
126396821|NCT00075725|454746017|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
126396822|NCT00075725|454746018|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
126396823|NCT00075725|454746019|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
126396824|NCT00075725|454746020|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
126396825|NCT00075725|454746021|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
126396826|NCT00075725|454746022|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
126720757|NCT03345836|455926751|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
126772121|NCT01160198|456122003|FG001|Overall Study|Adverse Event|1|||
126396827|NCT00075725|454746023|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
126396828|NCT00075725|454746012|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
126396829|NCT00075725|454746013|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
126720758|NCT03345836|455926752|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
126720759|NCT03345836|455926753|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
126720760|NCT03345836|455926748|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
126720761|NCT03345836|455926749|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
126720762|NCT03345836|455926750|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
126396830|NCT00075725|454746014|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
126396831|NCT00075725|454746015|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
126396832|NCT00075725|454746016|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
126396833|NCT00075725|454746017|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
126396834|NCT00075725|454746018|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
126396835|NCT00075725|454746019|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
126396836|NCT00075725|454746020|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
126396837|NCT00075725|454746021|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
126396838|NCT00075725|454746022|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
126396839|NCT00075725|454746023|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
126396840|NCT00075725|454746012|FG000|Overall Study|Pt non compliant with therapy|2|||
126396841|NCT00075725|454746013|FG001|Overall Study|Pt non compliant with therapy|1|||
126396842|NCT00075725|454746014|FG002|Overall Study|Pt non compliant with therapy|1|||
126396843|NCT00075725|454746015|FG003|Overall Study|Pt non compliant with therapy|0|||
126396844|NCT00075725|454746016|FG004|Overall Study|Pt non compliant with therapy|2|||
126396845|NCT00075725|454746017|FG005|Overall Study|Pt non compliant with therapy|14|||
126396846|NCT00075725|454746018|FG006|Overall Study|Pt non compliant with therapy|2|||
126396847|NCT00075725|454746019|FG007|Overall Study|Pt non compliant with therapy|5|||
126396848|NCT00075725|454746020|FG008|Overall Study|Pt non compliant with therapy|3|||
126396849|NCT00075725|454746021|FG009|Overall Study|Pt non compliant with therapy|0|||
126396850|NCT00075725|454746022|FG010|Overall Study|Pt non compliant with therapy|0|||
126396851|NCT00075725|454746023|FG011|Overall Study|Pt non compliant with therapy|0|||
126396852|NCT00075725|454746012|FG000|Overall Study|Pt age out of range for treatment|0|||
126396853|NCT00075725|454746013|FG001|Overall Study|Pt age out of range for treatment|1|||
126396854|NCT00075725|454746014|FG002|Overall Study|Pt age out of range for treatment|0|||
126396855|NCT00075725|454746015|FG003|Overall Study|Pt age out of range for treatment|0|||
126396856|NCT00075725|454746016|FG004|Overall Study|Pt age out of range for treatment|0|||
126396857|NCT00075725|454746017|FG005|Overall Study|Pt age out of range for treatment|1|||
126396858|NCT00075725|454746018|FG006|Overall Study|Pt age out of range for treatment|0|||
126396859|NCT00075725|454746019|FG007|Overall Study|Pt age out of range for treatment|1|||
126396860|NCT00075725|454746020|FG008|Overall Study|Pt age out of range for treatment|0|||
126396861|NCT00075725|454746021|FG009|Overall Study|Pt age out of range for treatment|0|||
126396862|NCT00075725|454746022|FG010|Overall Study|Pt age out of range for treatment|0|||
126396863|NCT00075725|454746023|FG011|Overall Study|Pt age out of range for treatment|0|||
126396864|NCT00075725|454746012|FG000|Overall Study|Insurance issues|0|||
126396865|NCT00075725|454746013|FG001|Overall Study|Insurance issues|1|||
126396866|NCT00075725|454746014|FG002|Overall Study|Insurance issues|0|||
126396867|NCT00075725|454746015|FG003|Overall Study|Insurance issues|1|||
126396868|NCT00075725|454746016|FG004|Overall Study|Insurance issues|1|||
126396869|NCT00075725|454746017|FG005|Overall Study|Insurance issues|1|||
126396870|NCT00075725|454746018|FG006|Overall Study|Insurance issues|0|||
126396871|NCT00075725|454746019|FG007|Overall Study|Insurance issues|1|||
126396872|NCT00075725|454746020|FG008|Overall Study|Insurance issues|0|||
126396873|NCT00075725|454746021|FG009|Overall Study|Insurance issues|0|||
126396874|NCT00075725|454746022|FG010|Overall Study|Insurance issues|0|||
126396875|NCT00075725|454746023|FG011|Overall Study|Insurance issues|0|||
126396876|NCT00075725|454746012|FG000|Overall Study|MRD positive after extended ind|0|||
126396877|NCT00075725|454746013|FG001|Overall Study|MRD positive after extended ind|1|||
126396878|NCT00075725|454746014|FG002|Overall Study|MRD positive after extended ind|1|||
126396879|NCT00075725|454746015|FG003|Overall Study|MRD positive after extended ind|0|||
126396880|NCT00075725|454746016|FG004|Overall Study|MRD positive after extended ind|1|||
126396881|NCT00075725|454746017|FG005|Overall Study|MRD positive after extended ind|2|||
126396882|NCT00075725|454746018|FG006|Overall Study|MRD positive after extended ind|0|||
126396883|NCT00075725|454746019|FG007|Overall Study|MRD positive after extended ind|1|||
126396884|NCT00075725|454746020|FG008|Overall Study|MRD positive after extended ind|0|||
126396885|NCT00075725|454746021|FG009|Overall Study|MRD positive after extended ind|0|||
126396886|NCT00075725|454746022|FG010|Overall Study|MRD positive after extended ind|0|||
126720763|NCT03345836|455926751|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
126396887|NCT00075725|454746023|FG011|Overall Study|MRD positive after extended ind|0|||
126396888|NCT00075725|454746012|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
126396889|NCT00075725|454746013|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
126396890|NCT00075725|454746014|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
126396891|NCT00075725|454746015|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
126396892|NCT00075725|454746016|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
126470482|NCT01163266|455023693|FG001|Overall Study|Withdrawal of Consent|7|||
126720764|NCT03345836|455926752|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
126470483|NCT01163266|455023694|FG002|Overall Study|Withdrawal of Consent|3|||
126470484|NCT01163266|455023692|FG000|Overall Study|Lost to Follow-up|7|||
126470485|NCT01163266|455023693|FG001|Overall Study|Lost to Follow-up|7|||
126470486|NCT01163266|455023694|FG002|Overall Study|Lost to Follow-up|10|||
126470487|NCT01163266|455023692|FG000|Overall Study|Other|1|||
126470488|NCT01163266|455023693|FG001|Overall Study|Other|1|||
126396893|NCT00075725|454746017|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
126396894|NCT00075725|454746018|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
126396895|NCT00075725|454746019|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
126396896|NCT00075725|454746020|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
126396897|NCT00075725|454746021|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
126396898|NCT00075725|454746022|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
126396899|NCT00075725|454746023|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
126396900|NCT00075725|454746012|FG000|Overall Study|Inevaluable|1|||
126396901|NCT00075725|454746013|FG001|Overall Study|Inevaluable|1|||
126396902|NCT00075725|454746014|FG002|Overall Study|Inevaluable|4|||
126396903|NCT00075725|454746015|FG003|Overall Study|Inevaluable|2|||
126396904|NCT00075725|454746016|FG004|Overall Study|Inevaluable|2|||
126396905|NCT00075725|454746017|FG005|Overall Study|Inevaluable|9|||
126396906|NCT00075725|454746018|FG006|Overall Study|Inevaluable|1|||
126396907|NCT00075725|454746019|FG007|Overall Study|Inevaluable|11|||
126396908|NCT00075725|454746020|FG008|Overall Study|Inevaluable|2|||
126396909|NCT00075725|454746021|FG009|Overall Study|Inevaluable|0|||
126396910|NCT00075725|454746022|FG010|Overall Study|Inevaluable|1|||
126396911|NCT00075725|454746023|FG011|Overall Study|Inevaluable|0|||
126396912|NCT00075725|454746012|FG000|Overall Study|Other|4|||
126396913|NCT00075725|454746013|FG001|Overall Study|Other|2|||
126396914|NCT00075725|454746014|FG002|Overall Study|Other|1|||
126396915|NCT00075725|454746015|FG003|Overall Study|Other|1|||
126396916|NCT00075725|454746016|FG004|Overall Study|Other|1|||
126396917|NCT00075725|454746017|FG005|Overall Study|Other|4|||
126396918|NCT00075725|454746018|FG006|Overall Study|Other|2|||
126396919|NCT00075725|454746019|FG007|Overall Study|Other|9|||
126396920|NCT00075725|454746020|FG008|Overall Study|Other|2|||
126396921|NCT00075725|454746021|FG009|Overall Study|Other|1|||
126396922|NCT00075725|454746022|FG010|Overall Study|Other|0|||
126396923|NCT00075725|454746023|FG011|Overall Study|Other|3|||
126396924|NCT00075725|454746012|FG000|Overall Study|Pt trying to find a BM donor|0|||
126396925|NCT00075725|454746013|FG001|Overall Study|Pt trying to find a BM donor|1|||
126396926|NCT00075725|454746014|FG002|Overall Study|Pt trying to find a BM donor|0|||
126396927|NCT00075725|454746015|FG003|Overall Study|Pt trying to find a BM donor|0|||
126396928|NCT00075725|454746016|FG004|Overall Study|Pt trying to find a BM donor|0|||
126396929|NCT00075725|454746017|FG005|Overall Study|Pt trying to find a BM donor|0|||
126396930|NCT00075725|454746018|FG006|Overall Study|Pt trying to find a BM donor|0|||
126396931|NCT00075725|454746019|FG007|Overall Study|Pt trying to find a BM donor|0|||
126396932|NCT00075725|454746020|FG008|Overall Study|Pt trying to find a BM donor|0|||
126396933|NCT00075725|454746021|FG009|Overall Study|Pt trying to find a BM donor|0|||
126396934|NCT00075725|454746022|FG010|Overall Study|Pt trying to find a BM donor|0|||
126396935|NCT00075725|454746023|FG011|Overall Study|Pt trying to find a BM donor|0|||
126396936|NCT00075725|454746012|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
126396937|NCT00075725|454746013|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
126396938|NCT00075725|454746014|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
126396939|NCT00075725|454746015|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
126396940|NCT00075725|454746016|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
126396941|NCT00075725|454746017|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
126396942|NCT00075725|454746018|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
126396943|NCT00075725|454746019|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
126396944|NCT00075725|454746020|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
126396945|NCT00075725|454746021|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
126396946|NCT00075725|454746022|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
126396947|NCT00075725|454746023|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
126396948|NCT00075725|454746012|FG000|Overall Study|Unsuccessful institutional transfer|0|||
126396949|NCT00075725|454746013|FG001|Overall Study|Unsuccessful institutional transfer|0|||
126396950|NCT00075725|454746014|FG002|Overall Study|Unsuccessful institutional transfer|2|||
126396951|NCT00075725|454746015|FG003|Overall Study|Unsuccessful institutional transfer|0|||
126396952|NCT00075725|454746016|FG004|Overall Study|Unsuccessful institutional transfer|0|||
126396953|NCT00075725|454746017|FG005|Overall Study|Unsuccessful institutional transfer|0|||
126470489|NCT01163266|455023694|FG002|Overall Study|Other|2|||
126470490|NCT02586064|455023695|FG000|Overall Study|Other Obligations|6|||
126772122|NCT01160198|456122004|FG002|Overall Study|Adverse Event|0|||
126396954|NCT00075725|454746018|FG006|Overall Study|Unsuccessful institutional transfer|0|||
126396955|NCT00075725|454746019|FG007|Overall Study|Unsuccessful institutional transfer|0|||
126470491|NCT02586064|455023696|FG001|Overall Study|Other Obligations|6|||
126470492|NCT02586064|455023695|FG000|Overall Study|Other|3|||
126470493|NCT02586064|455023696|FG001|Overall Study|Other|7|||
126470494|NCT02586064|455023695|FG000|Overall Study|Never Started|3|||
126396956|NCT00075725|454746020|FG008|Overall Study|Unsuccessful institutional transfer|0|||
126396957|NCT00075725|454746021|FG009|Overall Study|Unsuccessful institutional transfer|1|||
126396958|NCT00075725|454746022|FG010|Overall Study|Unsuccessful institutional transfer|0|||
126396959|NCT00075725|454746023|FG011|Overall Study|Unsuccessful institutional transfer|0|||
126396960|NCT00075725|454746012|FG000|Overall Study|specimen(s) not submitted|0|||
126396961|NCT00075725|454746013|FG001|Overall Study|specimen(s) not submitted|0|||
126396962|NCT00075725|454746014|FG002|Overall Study|specimen(s) not submitted|2|||
126470495|NCT02586064|455023696|FG001|Overall Study|Never Started|3|||
126470496|NCT02586064|455023695|FG000|Overall Study|Lost Interest|1|||
126470497|NCT02586064|455023696|FG001|Overall Study|Lost Interest|4|||
126470498|NCT02586064|455023695|FG000|Overall Study|Miscellaneous Life Issues|0|||
126470499|NCT02586064|455023696|FG001|Overall Study|Miscellaneous Life Issues|5|||
126470500|NCT02586064|455023695|FG000|Overall Study|Infrequent Attendance|2|||
126470501|NCT02586064|455023696|FG001|Overall Study|Infrequent Attendance|1|||
126470502|NCT02586064|455023695|FG000|Overall Study|Timed Out|2|||
126470503|NCT02586064|455023696|FG001|Overall Study|Timed Out|0|||
126470504|NCT02586064|455023695|FG000|Overall Study|AUD relapse|0|||
126470505|NCT02586064|455023696|FG001|Overall Study|AUD relapse|2|||
126470506|NCT02586064|455023695|FG000|Overall Study|Legal Issue|1|||
126470507|NCT02586064|455023696|FG001|Overall Study|Legal Issue|0|||
126470508|NCT02919696|455023697|FG000|Overall Study|Adverse Event|1|||
126470509|NCT02919696|455023698|FG001|Overall Study|Adverse Event|2|||
126470510|NCT02919696|455023697|FG000|Overall Study|Withdrawal by Subject|2|||
126470511|NCT02919696|455023698|FG001|Overall Study|Withdrawal by Subject|1|||
126470512|NCT02919696|455023697|FG000|Overall Study|Sponsor Decision|1|||
126470513|NCT02919696|455023698|FG001|Overall Study|Sponsor Decision|1|||
126470514|NCT02919696|455023697|FG000|Overall Study|Never Treated|0|||
126470515|NCT02919696|455023698|FG001|Overall Study|Never Treated|1|||
126470516|NCT04308304|455023699|FG000|Overall Study|Withdrawal by Subject|4|||
126470517|NCT04308304|455023700|FG001|Overall Study|Withdrawal by Subject|0|||
126470518|NCT04308304|455023699|FG000|Overall Study|Protocol Violation|1|||
126470519|NCT04308304|455023700|FG001|Overall Study|Protocol Violation|0|||
126470520|NCT00945555|455023701|FG000|Overall Study|Referred to another hospital|5|||
126470521|NCT00945555|455023701|FG000|Overall Study|Worsening condition, intensive care unit|1|||
126470522|NCT00945555|455023701|FG000|Overall Study|Withdrawal by Subject|2|||
126470523|NCT00945555|455023701|FG000|Overall Study|Participant continued treatment at home|1|||
126470524|NCT00945555|455023701|FG000|Overall Study|Death|18|||
126470525|NCT00945555|455023701|FG000|Overall Study|Other|1|||
126470526|NCT03945266|455023703|FG000|Overall Study|Withdrawal by Subject|1|||
126470527|NCT03945266|455023704|FG001|Overall Study|Withdrawal by Subject|0|||
126470528|NCT03945266|455023703|FG000|Overall Study|Miscarriage|0|||
126470529|NCT03945266|455023704|FG001|Overall Study|Miscarriage|2|||
126470530|NCT03945266|455023703|FG000|Overall Study|Lost to Follow-up|1|||
126470531|NCT03945266|455023704|FG001|Overall Study|Lost to Follow-up|0|||
126470532|NCT05274165|455023705|FG000|Overall Study|Withdrawal by Subject|3|||
126470533|NCT05274165|455023706|FG001|Overall Study|Withdrawal by Subject|3|||
126470534|NCT01386008|455023707|FG000|Overall Study|exited w/o incident /study discontinued|17|||
126470535|NCT01386008|455023707|FG000|Overall Study|Adverse Event|3|||
126470536|NCT00589290|455023708|FG000|Overall Study|Withdrawal by Subject|1|||
126470537|NCT01555983|455023709|FG000|Overall Study|Withdrawal by Subject|1|||
126470538|NCT01555983|455023710|FG001|Overall Study|Withdrawal by Subject|0|||
126470539|NCT01555983|455023711|FG002|Overall Study|Withdrawal by Subject|0|||
126470540|NCT01555983|455023712|FG003|Overall Study|Withdrawal by Subject|0|||
126470541|NCT01555983|455023713|FG004|Overall Study|Withdrawal by Subject|1|||
126470542|NCT01555983|455023714|FG005|Overall Study|Withdrawal by Subject|1|||
126470543|NCT00385762|455025350|FG000|Overall Study|Adverse Event|1|||
126470544|NCT00385762|455025350|FG000|Overall Study|Lost to Follow-up|1|||
126470545|NCT00573183|455025351|FG000|Overall Study|Lost to Follow-up|52|||
126470546|NCT00573183|455025352|FG001|Overall Study|Lost to Follow-up|50|||
126470547|NCT00573183|455025351|FG000|Overall Study|Withdrawal by Subject|8|||
126772123|NCT01160198|456122002|FG000|Overall Study|Lost to Follow-up|0|||
126396963|NCT00075725|454746015|FG003|Overall Study|specimen(s) not submitted|0|||
126396964|NCT00075725|454746016|FG004|Overall Study|specimen(s) not submitted|0|||
126470548|NCT00573183|455025352|FG001|Overall Study|Withdrawal by Subject|2|||
126470549|NCT00573183|455025351|FG000|Overall Study|Death|0|||
126470550|NCT00573183|455025352|FG001|Overall Study|Death|1|||
126470551|NCT00573183|455025351|FG000|Overall Study|Adverse Event|2|||
126470552|NCT00573183|455025352|FG001|Overall Study|Adverse Event|0|||
126470553|NCT00573183|455025351|FG000|Overall Study|Incarceration|5|||
126470554|NCT00573183|455025352|FG001|Overall Study|Incarceration|8|||
126470555|NCT00573183|455025351|FG000|Overall Study|Other|5|||
126470556|NCT00573183|455025352|FG001|Overall Study|Other|2|||
126470557|NCT00615108|455025358|FG000|Overall Study|Adverse Event|122|||
126470558|NCT00615108|455025358|FG000|Overall Study|Other|370|||
126470559|NCT00615108|455025358|FG000|Overall Study|Lost to Follow-up|15|||
126470560|NCT00354614|455025359|FG000|Overall Study|Lack of Efficacy|28|||
126470561|NCT01500031|455025360|FG000|Overall Study|Death|1|||
126470562|NCT01500031|455025360|FG000|Overall Study|Withdrawal by Subject|4|||
126470563|NCT01856907|455025361|FG000|Overall Study|Pregnancy|0|||
126470564|NCT01856907|455025362|FG001|Overall Study|Pregnancy|1|||
126470565|NCT01856907|455025363|FG002|Overall Study|Pregnancy|0|||
126470566|NCT01856907|455025361|FG000|Overall Study|Pregnancy|0|||
126470567|NCT01856907|455025362|FG001|Overall Study|Pregnancy|1|||
126470568|NCT01856907|455025363|FG002|Overall Study|Pregnancy|0|||
126470569|NCT01856907|455025361|FG000|Overall Study|Withdrawal by Subject|0|||
126470570|NCT01856907|455025362|FG001|Overall Study|Withdrawal by Subject|1|||
126470571|NCT01856907|455025363|FG002|Overall Study|Withdrawal by Subject|0|||
126470572|NCT01604408|455025366|FG000|Treatment Period 1|Protocol Violation|0|||
126470573|NCT01604408|455025367|FG001|Treatment Period 1|Protocol Violation|1|||
126470574|NCT01604408|455025366|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126470575|NCT01604408|455025367|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126470576|NCT01604408|455025366|FG000|Treatment Period 2|Protocol Violation|1|||
126470577|NCT01604408|455025367|FG001|Treatment Period 2|Protocol Violation|0|||
126470578|NCT01604408|455025366|FG000|Treatment Period 2|Adverse Event|0|||
126470579|NCT01604408|455025367|FG001|Treatment Period 2|Adverse Event|1|||
126470580|NCT01604408|455025366|FG000|Treatment Period 3|Protocol Violation|1|||
126470581|NCT01604408|455025367|FG001|Treatment Period 3|Protocol Violation|1|||
126470582|NCT01604408|455025366|FG000|Treatment Period 3|Adverse Event|0|||
126470583|NCT01604408|455025367|FG001|Treatment Period 3|Adverse Event|3|||
126470584|NCT01604408|455025366|FG000|Treatment Period 3|Withdrawal by Subject|3|||
126470585|NCT01604408|455025367|FG001|Treatment Period 3|Withdrawal by Subject|1|||
126470586|NCT01604408|455025366|FG000|Treatment Period 3|Sponsor Decision|1|||
126470587|NCT01604408|455025367|FG001|Treatment Period 3|Sponsor Decision|0|||
126470588|NCT01604408|455025366|FG000|Treatment Period 4|Death|1|||
126470589|NCT01604408|455025367|FG001|Treatment Period 4|Death|0|||
126470590|NCT01604408|455025366|FG000|Treatment Period 4|Withdrawal by Subject|2|||
126470591|NCT01604408|455025367|FG001|Treatment Period 4|Withdrawal by Subject|1|||
126470592|NCT01604408|455025366|FG000|Treatment Period 4|Adverse Event|0|||
126470593|NCT01604408|455025367|FG001|Treatment Period 4|Adverse Event|1|||
126470594|NCT01604408|455025366|FG000|Treatment Period 5|Adverse Event|4|||
126470595|NCT01604408|455025367|FG001|Treatment Period 5|Adverse Event|0|||
126470596|NCT01604408|455025366|FG000|Treatment Period 6|Lost to Follow-up|0|||
126470597|NCT01604408|455025367|FG001|Treatment Period 6|Lost to Follow-up|1|||
126470598|NCT01604408|455025366|FG000|Treatment Period 6|Adverse Event|2|||
126470599|NCT01604408|455025367|FG001|Treatment Period 6|Adverse Event|0|||
126470600|NCT01604408|455025366|FG000|Treatment Period 6|Sponsor decision|0|||
126470601|NCT01604408|455025367|FG001|Treatment Period 6|Sponsor decision|1|||
126470602|NCT01604408|455025366|FG000|Observation Period|Adverse Event|1|||
126470603|NCT01604408|455025367|FG001|Observation Period|Adverse Event|1|||
126470604|NCT01604408|455025366|FG000|Observation Period|Withdrawal by Subject|0|||
126470605|NCT01604408|455025367|FG001|Observation Period|Withdrawal by Subject|2|||
126470606|NCT05095454|455025368|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
126470607|NCT05095454|455025369|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
126470608|NCT01393301|455025370|FG000|Overall Study|Lost to Follow-up|5|||
126470609|NCT01393301|455025371|FG001|Overall Study|Lost to Follow-up|3|||
126470610|NCT01393301|455025370|FG000|Overall Study|Withdrawal by Subject|2|||
126470611|NCT01393301|455025371|FG001|Overall Study|Withdrawal by Subject|0|||
126470612|NCT01393301|455025370|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
126470613|NCT01393301|455025371|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
126470614|NCT00853073|455025372|FG000|Overall Study|Withdrawal by Subject|3|||
126470615|NCT00853073|455025373|FG001|Overall Study|Withdrawal by Subject|2|||
126470616|NCT02758171|455025374|FG000|Wash-out|Withdrawal by Subject|1|||
126470617|NCT02758171|455025375|FG001|Wash-out|Withdrawal by Subject|0|||
126396965|NCT00075725|454746017|FG005|Overall Study|specimen(s) not submitted|0|||
126396966|NCT00075725|454746018|FG006|Overall Study|specimen(s) not submitted|0|||
126396967|NCT00075725|454746019|FG007|Overall Study|specimen(s) not submitted|0|||
126396968|NCT00075725|454746020|FG008|Overall Study|specimen(s) not submitted|0|||
126396969|NCT00075725|454746021|FG009|Overall Study|specimen(s) not submitted|0|||
126396970|NCT00075725|454746022|FG010|Overall Study|specimen(s) not submitted|0|||
126396971|NCT00075725|454746023|FG011|Overall Study|specimen(s) not submitted|0|||
126470618|NCT02758171|455025374|FG000|Wash-out|Other reason|1|||
126555147|NCT01349907|455324097|FG000|Overall Study|Administrative|1|||
126555148|NCT01349907|455324098|FG001|Overall Study|Administrative|1|||
126396972|NCT00075725|454746012|FG000|Overall Study|Pt went to transplant|0|||
126396973|NCT00075725|454746013|FG001|Overall Study|Pt went to transplant|0|||
126396974|NCT00075725|454746014|FG002|Overall Study|Pt went to transplant|0|||
126396975|NCT00075725|454746015|FG003|Overall Study|Pt went to transplant|1|||
126396976|NCT00075725|454746016|FG004|Overall Study|Pt went to transplant|0|||
126396977|NCT00075725|454746017|FG005|Overall Study|Pt went to transplant|1|||
126396978|NCT00075725|454746018|FG006|Overall Study|Pt went to transplant|0|||
126396979|NCT00075725|454746019|FG007|Overall Study|Pt went to transplant|0|||
126396980|NCT00075725|454746020|FG008|Overall Study|Pt went to transplant|0|||
126396981|NCT00075725|454746021|FG009|Overall Study|Pt went to transplant|0|||
126396982|NCT00075725|454746022|FG010|Overall Study|Pt went to transplant|0|||
126396983|NCT00075725|454746023|FG011|Overall Study|Pt went to transplant|0|||
126720765|NCT03345836|455926753|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
126720766|NCT03345836|455926748|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
126720767|NCT03345836|455926749|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
126720768|NCT03345836|455926750|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
126720769|NCT03345836|455926751|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
126720770|NCT03345836|455926752|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
126720771|NCT03345836|455926753|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
126720772|NCT03345836|455926748|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
126720773|NCT03345836|455926749|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
126720774|NCT03345836|455926750|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
126720775|NCT03345836|455926751|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
126720776|NCT03345836|455926752|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
126720777|NCT03345836|455926753|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
126720778|NCT03345836|455926748|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
126720779|NCT03345836|455926749|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
126720780|NCT03345836|455926750|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
126720781|NCT03345836|455926751|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
126720782|NCT03345836|455926752|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
126720783|NCT03345836|455926753|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
126720784|NCT03345836|455926748|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
126720785|NCT03345836|455926749|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
126720786|NCT03345836|455926750|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
126720787|NCT03345836|455926751|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
126720788|NCT03345836|455926752|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
126720789|NCT03345836|455926753|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
126720790|NCT03345836|455926748|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
126720791|NCT03345836|455926749|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
126720792|NCT03345836|455926750|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
126720793|NCT03345836|455926751|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
126720794|NCT03345836|455926752|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
126720795|NCT03345836|455926753|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
126720796|NCT03345836|455926748|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
126720797|NCT03345836|455926749|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
126720798|NCT03345836|455926750|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
126720799|NCT03345836|455926751|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
126720800|NCT03345836|455926752|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
126720801|NCT03345836|455926753|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
126720802|NCT03345836|455926748|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
126720803|NCT03345836|455926749|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
126720804|NCT03345836|455926750|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
126720805|NCT03345836|455926751|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
126720806|NCT03345836|455926752|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
126720807|NCT03345836|455926753|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
126720808|NCT03510663|455926756|FG000|Overall Study|Withdrawal by Subject|0|||
126720809|NCT03510663|455926757|FG001|Overall Study|Withdrawal by Subject|1|||
126720810|NCT03510663|455926758|FG002|Overall Study|Withdrawal by Subject|0|||
126396984|NCT00075725|454746012|FG000|Overall Study|Pt received additional steroids|0|||
126396985|NCT00075725|454746013|FG001|Overall Study|Pt received additional steroids|0|||
126396986|NCT00075725|454746014|FG002|Overall Study|Pt received additional steroids|0|||
126396987|NCT00075725|454746015|FG003|Overall Study|Pt received additional steroids|1|||
126396988|NCT00075725|454746016|FG004|Overall Study|Pt received additional steroids|0|||
126396989|NCT00075725|454746017|FG005|Overall Study|Pt received additional steroids|0|||
126396990|NCT00075725|454746018|FG006|Overall Study|Pt received additional steroids|0|||
126396991|NCT00075725|454746019|FG007|Overall Study|Pt received additional steroids|0|||
126396992|NCT00075725|454746020|FG008|Overall Study|Pt received additional steroids|0|||
126396993|NCT00075725|454746021|FG009|Overall Study|Pt received additional steroids|0|||
126396994|NCT00075725|454746022|FG010|Overall Study|Pt received additional steroids|0|||
126396995|NCT00075725|454746023|FG011|Overall Study|Pt received additional steroids|0|||
126396996|NCT00075725|454746012|FG000|Overall Study|Pt relocated|0|||
126396997|NCT00075725|454746013|FG001|Overall Study|Pt relocated|0|||
126396998|NCT00075725|454746014|FG002|Overall Study|Pt relocated|0|||
126720811|NCT03510663|455926759|FG003|Overall Study|Withdrawal by Subject|0|||
126720812|NCT03510663|455926760|FG004|Overall Study|Withdrawal by Subject|0|||
126756526|NCT02719028|456059453|FG002|Overall Study|Protocol Violation|0|||
126396999|NCT00075725|454746015|FG003|Overall Study|Pt relocated|2|||
126397000|NCT00075725|454746016|FG004|Overall Study|Pt relocated|0|||
126397001|NCT00075725|454746017|FG005|Overall Study|Pt relocated|1|||
126397002|NCT00075725|454746018|FG006|Overall Study|Pt relocated|1|||
126397003|NCT00075725|454746019|FG007|Overall Study|Pt relocated|2|||
126397004|NCT00075725|454746020|FG008|Overall Study|Pt relocated|1|||
126397005|NCT00075725|454746021|FG009|Overall Study|Pt relocated|0|||
126397006|NCT00075725|454746022|FG010|Overall Study|Pt relocated|0|||
126397007|NCT00075725|454746023|FG011|Overall Study|Pt relocated|0|||
126397008|NCT00075725|454746012|FG000|Overall Study|Institution Terminated|0|||
126397009|NCT00075725|454746013|FG001|Overall Study|Institution Terminated|0|||
126397010|NCT00075725|454746014|FG002|Overall Study|Institution Terminated|0|||
126397011|NCT00075725|454746015|FG003|Overall Study|Institution Terminated|0|||
126397012|NCT00075725|454746016|FG004|Overall Study|Institution Terminated|1|||
126397013|NCT00075725|454746017|FG005|Overall Study|Institution Terminated|0|||
126397014|NCT00075725|454746018|FG006|Overall Study|Institution Terminated|0|||
126397015|NCT00075725|454746019|FG007|Overall Study|Institution Terminated|3|||
126397016|NCT00075725|454746020|FG008|Overall Study|Institution Terminated|0|||
126397017|NCT00075725|454746021|FG009|Overall Study|Institution Terminated|0|||
126397018|NCT00075725|454746022|FG010|Overall Study|Institution Terminated|0|||
126397019|NCT00075725|454746023|FG011|Overall Study|Institution Terminated|0|||
126397020|NCT00075725|454746012|FG000|Overall Study|Study Closure|1|||
126397021|NCT00075725|454746013|FG001|Overall Study|Study Closure|0|||
126397022|NCT00075725|454746014|FG002|Overall Study|Study Closure|0|||
126397023|NCT00075725|454746015|FG003|Overall Study|Study Closure|0|||
126397024|NCT00075725|454746016|FG004|Overall Study|Study Closure|1|||
126397025|NCT00075725|454746017|FG005|Overall Study|Study Closure|3|||
126397026|NCT00075725|454746018|FG006|Overall Study|Study Closure|0|||
126397027|NCT00075725|454746019|FG007|Overall Study|Study Closure|1|||
126397028|NCT00075725|454746020|FG008|Overall Study|Study Closure|0|||
126397029|NCT00075725|454746021|FG009|Overall Study|Study Closure|0|||
126397030|NCT00075725|454746022|FG010|Overall Study|Study Closure|0|||
126397031|NCT00075725|454746023|FG011|Overall Study|Study Closure|0|||
126397032|NCT00075725|454746012|FG000|Overall Study|Other complications|0|||
126397033|NCT00075725|454746013|FG001|Overall Study|Other complications|0|||
126397034|NCT00075725|454746014|FG002|Overall Study|Other complications|0|||
126397035|NCT00075725|454746015|FG003|Overall Study|Other complications|0|||
126397036|NCT00075725|454746016|FG004|Overall Study|Other complications|0|||
126397037|NCT00075725|454746017|FG005|Overall Study|Other complications|1|||
126397038|NCT00075725|454746018|FG006|Overall Study|Other complications|0|||
126397039|NCT00075725|454746019|FG007|Overall Study|Other complications|0|||
126397040|NCT00075725|454746020|FG008|Overall Study|Other complications|0|||
126397041|NCT00075725|454746021|FG009|Overall Study|Other complications|0|||
126397042|NCT00075725|454746022|FG010|Overall Study|Other complications|0|||
126397043|NCT00075725|454746023|FG011|Overall Study|Other complications|0|||
126397044|NCT00075725|454746012|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
126397045|NCT00075725|454746013|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
126397046|NCT00075725|454746014|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
126397047|NCT00075725|454746015|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
126397048|NCT00075725|454746016|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
126397049|NCT00075725|454746017|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
126397050|NCT00075725|454746018|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
126397051|NCT00075725|454746019|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
126397052|NCT00075725|454746020|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
126397053|NCT00075725|454746021|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
126397054|NCT00075725|454746022|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
126720813|NCT03510663|455926761|FG005|Overall Study|Withdrawal by Subject|0|||
126720814|NCT03510663|455926762|FG006|Overall Study|Withdrawal by Subject|0|||
126720815|NCT03510663|455926763|FG007|Overall Study|Withdrawal by Subject|0|||
126720816|NCT01555463|455926766|FG000|Treatment|Adverse Event|6|||
126720817|NCT01555463|455926767|FG001|Treatment|Adverse Event|12|||
126720818|NCT01555463|455926766|FG000|Treatment|Withdrawal by Subject|24|||
126720819|NCT01555463|455926767|FG001|Treatment|Withdrawal by Subject|36|||
126720820|NCT01555463|455926766|FG000|Treatment|Lost to Follow-up|28|||
126720821|NCT01555463|455926767|FG001|Treatment|Lost to Follow-up|23|||
126397055|NCT00075725|454746023|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
126397056|NCT00075725|454746012|FG000|Overall Study|Pt incarcerated|0|||
126397057|NCT00075725|454746013|FG001|Overall Study|Pt incarcerated|0|||
126397058|NCT00075725|454746014|FG002|Overall Study|Pt incarcerated|0|||
126397059|NCT00075725|454746015|FG003|Overall Study|Pt incarcerated|0|||
126397060|NCT00075725|454746016|FG004|Overall Study|Pt incarcerated|0|||
126720822|NCT01555463|455926766|FG000|Treatment|Protocol Violation|4|||
126397061|NCT00075725|454746017|FG005|Overall Study|Pt incarcerated|0|||
126470619|NCT02758171|455025375|FG001|Wash-out|Other reason|0|||
126470620|NCT01999114|455025376|FG000|Overall Study|Adverse Event|8|||
126720823|NCT01555463|455926767|FG001|Treatment|Protocol Violation|5|||
126720824|NCT01555463|455926766|FG000|Treatment|Other reason|2|||
126720825|NCT01555463|455926767|FG001|Treatment|Other reason|3|||
126470621|NCT01999114|455025377|FG001|Overall Study|Adverse Event|7|||
126720826|NCT01555463|455926766|FG000|Follow up|Adverse Event|2|||
126720827|NCT01555463|455926767|FG001|Follow up|Adverse Event|5|||
126720828|NCT01555463|455926766|FG000|Follow up|Death|0|||
126720829|NCT01555463|455926767|FG001|Follow up|Death|1|||
126720830|NCT01555463|455926766|FG000|Follow up|Withdrawal by Subject|22|||
126720831|NCT01555463|455926767|FG001|Follow up|Withdrawal by Subject|22|||
126720832|NCT01555463|455926766|FG000|Follow up|Lost to Follow-up|9|||
126720833|NCT01555463|455926767|FG001|Follow up|Lost to Follow-up|10|||
126720834|NCT01555463|455926766|FG000|Follow up|Protocol Violation|2|||
126720835|NCT01555463|455926767|FG001|Follow up|Protocol Violation|4|||
126720836|NCT01555463|455926766|FG000|Follow up|Other reason|3|||
126720837|NCT01555463|455926767|FG001|Follow up|Other reason|3|||
126720838|NCT02026271|455926768|FG000|Overall Study|Adverse Event|2|||
126720839|NCT02026271|455926769|FG001|Overall Study|Adverse Event|3|||
126720840|NCT02026271|455926770|FG002|Overall Study|Adverse Event|2|||
126720841|NCT02026271|455926771|FG003|Overall Study|Adverse Event|3|||
126720842|NCT02026271|455926772|FG004|Overall Study|Adverse Event|0|||
126720843|NCT02026271|455926768|FG000|Overall Study|Withdrawal by Subject|0|||
126720844|NCT02026271|455926769|FG001|Overall Study|Withdrawal by Subject|0|||
126720845|NCT02026271|455926770|FG002|Overall Study|Withdrawal by Subject|0|||
126720846|NCT02026271|455926771|FG003|Overall Study|Withdrawal by Subject|0|||
126720847|NCT02026271|455926772|FG004|Overall Study|Withdrawal by Subject|1|||
126720848|NCT04370028|455926775|FG000|Overall Study|Withdrawal by Subject|695|||
126720849|NCT04370028|455926775|FG000|Overall Study|Protocol Violation|9|||
126720850|NCT04370028|455926775|FG000|Overall Study|Adverse Event|3|||
126720851|NCT02213198|455926778|FG000|Baseline|No show for intake|7|||
126720852|NCT02213198|455926779|FG001|Baseline|No show for intake|9|||
126720853|NCT02213198|455926778|FG000|Baseline|Withdrawal by Subject|34|||
126720854|NCT02213198|455926779|FG001|Baseline|Withdrawal by Subject|11|||
126720855|NCT02213198|455926778|FG000|Baseline|transferred out of clinic|7|||
126720856|NCT02213198|455926779|FG001|Baseline|transferred out of clinic|9|||
126397062|NCT00075725|454746018|FG006|Overall Study|Pt incarcerated|0|||
126397063|NCT00075725|454746019|FG007|Overall Study|Pt incarcerated|1|||
126397064|NCT00075725|454746020|FG008|Overall Study|Pt incarcerated|0|||
126397065|NCT00075725|454746021|FG009|Overall Study|Pt incarcerated|0|||
126397066|NCT00075725|454746022|FG010|Overall Study|Pt incarcerated|0|||
126397067|NCT00075725|454746023|FG011|Overall Study|Pt incarcerated|0|||
126397068|NCT01444027|454746026|FG000|Overall Study|Withdrawal by Subject|4|||
126397069|NCT01444027|454746027|FG001|Overall Study|Withdrawal by Subject|10|||
126397070|NCT01444027|454746028|FG002|Overall Study|Withdrawal by Subject|24|||
126397071|NCT01444027|454746026|FG000|Overall Study|Lost to Follow-up|26|||
126397072|NCT01444027|454746027|FG001|Overall Study|Lost to Follow-up|20|||
126397073|NCT01444027|454746028|FG002|Overall Study|Lost to Follow-up|14|||
126397074|NCT00737711|454746030|FG000|Overall Study|Adverse Event|2|||
126397075|NCT00737711|454746030|FG000|Overall Study|Death|8|||
126397076|NCT00737711|454746030|FG000|Overall Study|Failure to return|4|||
126397077|NCT00737711|454746030|FG000|Overall Study|Protocol Violation|1|||
126397078|NCT00737711|454746030|FG000|Overall Study|Withdrawal by Subject|5|||
126397079|NCT00737711|454746030|FG000|Overall Study|Blood transfusion|6|||
126397080|NCT00737711|454746030|FG000|Overall Study|Other|5|||
126397081|NCT04035564|454748076|FG000|Overall Study|Protocol Violation|1|||
126397082|NCT04035564|454748077|FG001|Overall Study|Protocol Violation|2|||
126470622|NCT01999114|455025378|FG002|Overall Study|Adverse Event|2|||
126720857|NCT02213198|455926778|FG000|Baseline|Lost to Follow-up|40|||
126720858|NCT02213198|455926779|FG001|Baseline|Lost to Follow-up|21|||
126720859|NCT02213198|455926778|FG000|Baseline|incarcerated,violent|0|||
126720860|NCT02213198|455926779|FG001|Baseline|incarcerated,violent|1|||
126720861|NCT02213198|455926778|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
126720862|NCT02213198|455926779|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
126720863|NCT02213198|455926778|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
126720864|NCT02213198|455926779|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
126720865|NCT02213198|455926778|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
126720866|NCT02213198|455926779|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
126720867|NCT02213198|455926778|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
126772124|NCT01160198|456122003|FG001|Overall Study|Lost to Follow-up|1|||
126397083|NCT04035564|454748076|FG000|Overall Study|No laboratory available|2|||
126397084|NCT04035564|454748077|FG001|Overall Study|No laboratory available|2|||
126397085|NCT04035564|454748076|FG000|Overall Study|Guardian declined consent|1|||
126397086|NCT04035564|454748077|FG001|Overall Study|Guardian declined consent|2|||
126397087|NCT03505788|454748078|FG000|Overall Study|Lost to Follow-up|2|||
126397088|NCT03505788|454748079|FG001|Overall Study|Lost to Follow-up|1|||
126470623|NCT01999114|455025379|FG003|Overall Study|Adverse Event|2|||
126470624|NCT01999114|455025380|FG004|Overall Study|Adverse Event|1|||
126720868|NCT02213198|455926779|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
126720869|NCT02213198|455926778|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
126720870|NCT02213198|455926779|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
126720871|NCT02213198|455926778|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
126470625|NCT01999114|455025376|FG000|Overall Study|Withdrawal by Subject|0|||
126397089|NCT03505788|454748078|FG000|Overall Study|Withdrawal by Subject|1|||
126397090|NCT03505788|454748079|FG001|Overall Study|Withdrawal by Subject|3|||
126397091|NCT03505788|454748078|FG000|Overall Study|Physician Decision|0|||
126397092|NCT03505788|454748079|FG001|Overall Study|Physician Decision|1|||
126397093|NCT01007123|454748084|FG000|Overall Study|Adverse Event|3|||
126397094|NCT01007123|454748085|FG001|Overall Study|Adverse Event|4|||
126397095|NCT01007123|454748086|FG002|Overall Study|Adverse Event|7|||
126397096|NCT01007123|454748087|FG003|Overall Study|Adverse Event|1|||
126397097|NCT01007123|454748084|FG000|Overall Study|Lack of Efficacy|1|||
126397098|NCT01007123|454748085|FG001|Overall Study|Lack of Efficacy|0|||
126397099|NCT01007123|454748086|FG002|Overall Study|Lack of Efficacy|1|||
126397100|NCT01007123|454748087|FG003|Overall Study|Lack of Efficacy|4|||
126397101|NCT01007123|454748084|FG000|Overall Study|Protocol Violation|1|||
126397102|NCT01007123|454748085|FG001|Overall Study|Protocol Violation|1|||
126397103|NCT01007123|454748086|FG002|Overall Study|Protocol Violation|2|||
126397104|NCT01007123|454748087|FG003|Overall Study|Protocol Violation|1|||
126397105|NCT01007123|454748084|FG000|Overall Study|Withdrawal by Subject|1|||
126397106|NCT01007123|454748085|FG001|Overall Study|Withdrawal by Subject|0|||
126397107|NCT01007123|454748086|FG002|Overall Study|Withdrawal by Subject|1|||
126397108|NCT01007123|454748087|FG003|Overall Study|Withdrawal by Subject|0|||
126397109|NCT01007123|454748084|FG000|Overall Study|Lost to Follow-up|0|||
126397110|NCT01007123|454748085|FG001|Overall Study|Lost to Follow-up|1|||
126397111|NCT01007123|454748086|FG002|Overall Study|Lost to Follow-up|0|||
126397112|NCT01007123|454748087|FG003|Overall Study|Lost to Follow-up|0|||
126397113|NCT00149994|454748088|FG000|Overall Study|Administrative problems:|1|||
126397114|NCT00149994|454748089|FG001|Overall Study|Administrative problems:|0|||
126397115|NCT00149994|454748088|FG000|Overall Study|Protocol Violation|0|||
126397116|NCT00149994|454748089|FG001|Overall Study|Protocol Violation|1|||
126397117|NCT02324205|454748092|FG000|Overall Study|Withdrawal by Subject|37|||
126397118|NCT01774097|454748093|FG000|Overall Study|Withdrawal by Subject|1|||
126397119|NCT01774097|454748094|FG001|Overall Study|Withdrawal by Subject|1|||
126397120|NCT01774097|454748093|FG000|Overall Study|Adverse Event|1|||
126397121|NCT01774097|454748094|FG001|Overall Study|Adverse Event|1|||
126397122|NCT00937404|454748096|FG000|Overall Study|Protocol Violation|1|||
126397123|NCT00937404|454748096|FG000|Overall Study|Withdrawal by Subject|1|||
126397124|NCT00230282|454748097|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
126397125|NCT00230282|454748097|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
126397126|NCT00230282|454748097|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
126397127|NCT00230282|454748097|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
126397128|NCT00090233|454748100|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
126397129|NCT00090233|454748101|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
126397130|NCT00090233|454748100|FG000|Overall Study|Adverse Event|214|||
126397131|NCT00090233|454748101|FG001|Overall Study|Adverse Event|198|||
126397132|NCT00090233|454748100|FG000|Overall Study|Lost to Follow-up|68|||
126397133|NCT00090233|454748101|FG001|Overall Study|Lost to Follow-up|95|||
126397134|NCT00090233|454748100|FG000|Overall Study|Protocol Violation|960|||
126397135|NCT00090233|454748101|FG001|Overall Study|Protocol Violation|1022|||
126397136|NCT00090233|454748100|FG000|Overall Study|Withdrawal by Subject|182|||
126397137|NCT00090233|454748101|FG001|Overall Study|Withdrawal by Subject|211|||
126397138|NCT00090233|454748100|FG000|Overall Study|Moved|203|||
126397139|NCT00090233|454748101|FG001|Overall Study|Moved|189|||
126720872|NCT02213198|455926779|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
126720873|NCT00527111|455926782|FG000|Overall Study|Adverse Event|14|||
126720874|NCT00527111|455926783|FG001|Overall Study|Adverse Event|13|||
126720875|NCT00527111|455926782|FG000|Overall Study|Death|0|||
126397140|NCT00090233|454748100|FG000|Overall Study|Other|1211|||
126397141|NCT00090233|454748101|FG001|Overall Study|Other|1160|||
126397142|NCT00090233|454748100|FG000|Overall Study|Data not available at data cut-off point|1552|||
126397143|NCT00090233|454748101|FG001|Overall Study|Data not available at data cut-off point|1563|||
126397144|NCT04863248|454748102|FG000|Overall Study|Sponsor Terminated|4|||
126470626|NCT01999114|455025377|FG001|Overall Study|Withdrawal by Subject|0|||
126470627|NCT01999114|455025378|FG002|Overall Study|Withdrawal by Subject|1|||
126397145|NCT04863248|454748103|FG001|Overall Study|Sponsor Terminated|1|||
126397146|NCT04863248|454748102|FG000|Overall Study|Death|0|||
126397147|NCT04863248|454748103|FG001|Overall Study|Death|1|||
126720876|NCT00527111|455926783|FG001|Overall Study|Death|1|||
126397148|NCT04863248|454748102|FG000|Overall Study|Withdrawal by Subject|0|||
126397149|NCT04863248|454748103|FG001|Overall Study|Withdrawal by Subject|1|||
126397150|NCT01691105|454748104|FG000|1 Month Follow-up|Lost to Follow-up|41|||
126397151|NCT01691105|454748105|FG001|1 Month Follow-up|Lost to Follow-up|38|||
126397152|NCT01691105|454748104|FG000|1 Month Follow-up|Death|2|||
126397153|NCT01691105|454748105|FG001|1 Month Follow-up|Death|3|||
126397154|NCT01691105|454748104|FG000|6 Month Follow-up|Lost to Follow-up|39|||
126397155|NCT01691105|454748105|FG001|6 Month Follow-up|Lost to Follow-up|58|||
126397156|NCT01691105|454748104|FG000|6 Month Follow-up|Death|13|||
126397157|NCT01691105|454748105|FG001|6 Month Follow-up|Death|13|||
126397158|NCT01691105|454748104|FG000|12 Month Follow-up|Lost to Follow-up|50|||
126470628|NCT01999114|455025379|FG003|Overall Study|Withdrawal by Subject|0|||
126397159|NCT01691105|454748105|FG001|12 Month Follow-up|Lost to Follow-up|71|||
126397160|NCT01691105|454748104|FG000|12 Month Follow-up|Death|22|||
126397161|NCT01691105|454748105|FG001|12 Month Follow-up|Death|30|||
126397162|NCT01691105|454748104|FG000|12 Month Biochemical Verification|Death|22|||
126397163|NCT01691105|454748105|FG001|12 Month Biochemical Verification|Death|30|||
126397164|NCT01691105|454748104|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
126397165|NCT01691105|454748105|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
126397166|NCT01691105|454748104|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
126397167|NCT01691105|454748105|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
126397168|NCT03263923|454748106|FG000|Overall Study|Withdrawal by Subject|10|||
126397169|NCT03263923|454748107|FG001|Overall Study|Withdrawal by Subject|8|||
126397170|NCT03263923|454748106|FG000|Overall Study|Lost to Follow-up|15|||
126397171|NCT03263923|454748107|FG001|Overall Study|Lost to Follow-up|13|||
126397172|NCT03362931|454748108|FG000|Overall Study|Adverse Event|1|||
126397173|NCT03362931|454748108|FG000|Overall Study|Death|2|||
126397174|NCT02229214|454748117|FG000|Overall Study|Adverse Event|2|||
126397175|NCT02229214|454748118|FG001|Overall Study|Adverse Event|0|||
126397176|NCT02229214|454748117|FG000|Overall Study|Withdrawal by Subject|4|||
126397177|NCT02229214|454748118|FG001|Overall Study|Withdrawal by Subject|0|||
126397178|NCT00969761|454748119|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
126397179|NCT00969761|454748120|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397180|NCT00969761|454748121|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397181|NCT00969761|454748122|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
126397182|NCT00969761|454748123|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397183|NCT00969761|454748124|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397184|NCT00969761|454748125|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397185|NCT00969761|454748126|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397186|NCT00969761|454748127|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
126397187|NCT00969761|454748128|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
126397188|NCT00969761|454748129|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397189|NCT00969761|454748130|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
126397190|NCT00969761|454748119|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397191|NCT00969761|454748120|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397192|NCT00969761|454748121|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
126397193|NCT00969761|454748122|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397194|NCT00969761|454748123|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397195|NCT00969761|454748124|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397196|NCT00969761|454748125|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397197|NCT00969761|454748126|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397198|NCT00969761|454748127|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397199|NCT00969761|454748128|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397200|NCT00969761|454748129|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397201|NCT00969761|454748130|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
126397202|NCT00969761|454748119|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397203|NCT00969761|454748120|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397204|NCT00969761|454748121|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
126397205|NCT00969761|454748122|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397206|NCT00969761|454748123|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397207|NCT00969761|454748124|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397208|NCT00969761|454748125|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397209|NCT00969761|454748126|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397210|NCT00969761|454748127|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397211|NCT00969761|454748128|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397212|NCT00969761|454748129|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397213|NCT00969761|454748130|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
126397214|NCT00969761|454748119|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397215|NCT00969761|454748120|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397216|NCT00969761|454748121|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397217|NCT00969761|454748122|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397218|NCT00969761|454748123|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397219|NCT00969761|454748124|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397220|NCT00969761|454748125|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126555149|NCT03583541|455324106|FG000|Overall Study|Lost to Follow-up|31|||
126555150|NCT03583541|455324107|FG001|Overall Study|Lost to Follow-up|65|||
126555151|NCT04102540|455324108|FG000|Overall Study|Withdrawn by PI|2|||
126397221|NCT00969761|454748126|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397222|NCT00969761|454748127|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
126397223|NCT00969761|454748128|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397224|NCT00969761|454748129|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397225|NCT00969761|454748130|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
126397226|NCT00969761|454748119|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
126397227|NCT00969761|454748120|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
126397228|NCT00969761|454748121|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
126397229|NCT00969761|454748122|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
126397230|NCT00969761|454748123|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
126397231|NCT00969761|454748124|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
126397232|NCT00969761|454748125|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
126397233|NCT00969761|454748126|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
126397234|NCT00969761|454748127|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
126397235|NCT00969761|454748128|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
126397236|NCT00969761|454748129|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
126397237|NCT00969761|454748130|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
126397238|NCT00969761|454748119|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397239|NCT00969761|454748120|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397240|NCT00969761|454748121|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397241|NCT00969761|454748122|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
126397242|NCT00969761|454748123|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
126397243|NCT00969761|454748124|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397244|NCT00969761|454748125|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397245|NCT00969761|454748126|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397246|NCT00969761|454748127|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
126397247|NCT00969761|454748128|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397248|NCT00969761|454748129|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397249|NCT00969761|454748130|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
126397250|NCT02927925|454748137|FG000|Overall Study|Death|16|||
126397251|NCT02927925|454748137|FG000|Overall Study|Physician Decision|1|||
126397252|NCT02927925|454748137|FG000|Overall Study|Withdrawal by Subject|11|||
126397253|NCT02927925|454748137|FG000|Overall Study|Other|3|||
126397254|NCT02927925|454748137|FG000|Overall Study|Disease progression at clinical cutoff|1|||
126397255|NCT03305081|454748140|FG000|Overall Study|Lost to Follow-up|10|||
126397256|NCT03305081|454748141|FG001|Overall Study|Lost to Follow-up|15|||
126397257|NCT01571284|454748148|FG000|Overall Study|Participant's decision|84|||
126397258|NCT01571284|454748148|FG000|Overall Study|Lost to Follow-up|3|||
126397259|NCT01571284|454748148|FG000|Overall Study|Enrolled but not treated|2|||
126397260|NCT01571284|454748148|FG000|Overall Study|Other than specified above|80|||
126397261|NCT04065074|454748149|FG000|Overall Study|Adverse Event|1|||
126397262|NCT04065074|454748149|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
126397263|NCT00871117|454748150|FG000|Overall Study|Lost to Follow-up|5|||
126397264|NCT00871117|454748151|FG001|Overall Study|Lost to Follow-up|6|||
126397265|NCT00871117|454748150|FG000|Overall Study|Other|0|||
126397266|NCT00871117|454748151|FG001|Overall Study|Other|4|||
126397267|NCT03385265|454748155|FG000|Overall Study|Withdrawal by Subject|5|||
126397268|NCT03385265|454748156|FG001|Overall Study|Withdrawal by Subject|2|||
126397269|NCT03385265|454748157|FG002|Overall Study|Withdrawal by Subject|5|||
126397270|NCT03385265|454748158|FG003|Overall Study|Withdrawal by Subject|2|||
126397271|NCT01560637|454748159|FG000|Overall Study|Adverse Event|63|||
126397272|NCT01560637|454748159|FG000|Overall Study|Death|69|||
126397273|NCT01560637|454748159|FG000|Overall Study|Lost to Follow-up|8|||
126397274|NCT01560637|454748159|FG000|Overall Study|Protocol Violation|8|||
126397275|NCT01560637|454748159|FG000|Overall Study|Withdrawal by Subject|24|||
126397276|NCT01560637|454748159|FG000|Overall Study|Progressive Disease|20|||
126720877|NCT00527111|455926782|FG000|Overall Study|Investigator Request|2|||
126720878|NCT00527111|455926783|FG001|Overall Study|Investigator Request|1|||
126720879|NCT00527111|455926782|FG000|Overall Study|Patient Request|2|||
126720880|NCT00527111|455926783|FG001|Overall Study|Patient Request|5|||
126397277|NCT01560637|454748159|FG000|Overall Study|Other Reason Not Specified|6|||
126397278|NCT02323204|454748165|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
126397279|NCT02323204|454748166|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
126397280|NCT02323204|454748167|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
126397281|NCT02323204|454748168|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
126397282|NCT02323204|454748165|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
126397283|NCT02323204|454748166|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
126397284|NCT02323204|454748167|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
126397285|NCT02323204|454748168|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
126397286|NCT02323204|454748165|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
126720881|NCT00527111|455926782|FG000|Overall Study|Other|2|||
126397287|NCT02323204|454748166|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
126397288|NCT02323204|454748167|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
126397289|NCT02323204|454748168|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
126397290|NCT02323204|454748165|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
126397291|NCT02323204|454748166|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
126397292|NCT02323204|454748167|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
126397293|NCT02323204|454748168|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
126397294|NCT02323204|454748165|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
126397295|NCT02323204|454748166|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
126397296|NCT02323204|454748167|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
126397297|NCT02323204|454748168|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
126397298|NCT02323204|454748165|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
126397299|NCT02323204|454748166|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
126397300|NCT02323204|454748167|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
126397301|NCT02323204|454748168|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
126397302|NCT02323204|454748165|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
126397303|NCT02323204|454748166|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
126397304|NCT02323204|454748167|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
126397305|NCT02323204|454748168|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
126397306|NCT02323204|454748165|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
126397307|NCT02323204|454748166|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
126397308|NCT02323204|454748167|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
126397309|NCT02323204|454748168|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
126397310|NCT02323204|454748165|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
126397311|NCT02323204|454748166|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
126397312|NCT02323204|454748167|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
126397313|NCT02323204|454748168|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
126397314|NCT03831880|454748169|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
126397315|NCT03831880|454748170|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
126397316|NCT03831880|454748169|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
126397317|NCT03831880|454748170|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
126397318|NCT01852825|454748171|FG000|Overall Study|Withdrawal by Subject|2|||
126397319|NCT01852825|454748172|FG001|Overall Study|Withdrawal by Subject|0|||
126397320|NCT01852825|454748173|FG002|Overall Study|Withdrawal by Subject|0|||
126397321|NCT00724854|454748175|FG000|Overall Study|Lack of Efficacy|187|||
126397322|NCT00724854|454748176|FG001|Overall Study|Lack of Efficacy|13|||
126397323|NCT00724854|454748175|FG000|Overall Study|Lost to Follow-up|87|||
126397324|NCT00724854|454748176|FG001|Overall Study|Lost to Follow-up|10|||
126397325|NCT00724854|454748175|FG000|Overall Study|Adverse Event|62|||
126397326|NCT00724854|454748176|FG001|Overall Study|Adverse Event|4|||
126397327|NCT00724854|454748175|FG000|Overall Study|Other|42|||
126397328|NCT00724854|454748176|FG001|Overall Study|Other|3|||
126397329|NCT00724854|454748175|FG000|Overall Study|Death|11|||
126397330|NCT00724854|454748176|FG001|Overall Study|Death|0|||
126397331|NCT00724854|454748175|FG000|Overall Study|Change of treatment|7|||
126397332|NCT00724854|454748176|FG001|Overall Study|Change of treatment|0|||
126720882|NCT00527111|455926783|FG001|Overall Study|Other|2|||
126720883|NCT02689219|455926784|FG000|Overall Study|Death|1|||
126397333|NCT00724854|454748175|FG000|Overall Study|Withdrawal by Subject|5|||
126397334|NCT00724854|454748176|FG001|Overall Study|Withdrawal by Subject|0|||
126397335|NCT00724854|454748175|FG000|Overall Study|Adverse event + lack of efficacy|2|||
126397336|NCT00724854|454748176|FG001|Overall Study|Adverse event + lack of efficacy|1|||
126397337|NCT01095653|454748177|FG000|Overall Study|Lack of Efficacy|3|||
126397338|NCT01095653|454748178|FG001|Overall Study|Lack of Efficacy|0|||
126397339|NCT01095653|454748179|FG002|Overall Study|Lack of Efficacy|0|||
126397340|NCT01095653|454748177|FG000|Overall Study|Adverse Event|1|||
126397341|NCT01095653|454748178|FG001|Overall Study|Adverse Event|4|||
126397342|NCT01095653|454748179|FG002|Overall Study|Adverse Event|4|||
126397343|NCT01095653|454748177|FG000|Overall Study|Lost to Follow-up|1|||
126397344|NCT01095653|454748178|FG001|Overall Study|Lost to Follow-up|0|||
126397345|NCT01095653|454748179|FG002|Overall Study|Lost to Follow-up|4|||
126397346|NCT01095653|454748177|FG000|Overall Study|Withdrawal by Subject|4|||
126397347|NCT01095653|454748178|FG001|Overall Study|Withdrawal by Subject|5|||
126397348|NCT01095653|454748179|FG002|Overall Study|Withdrawal by Subject|3|||
126397349|NCT01095653|454748177|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
126397350|NCT01095653|454748178|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
126397351|NCT01095653|454748179|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
126397352|NCT00171925|454748180|FG000|Overall Study|Adverse Event|10|||
126397353|NCT00171925|454748181|FG001|Overall Study|Adverse Event|6|||
126397354|NCT00171925|454748180|FG000|Overall Study|Protocol Violation|1|||
126397355|NCT00171925|454748181|FG001|Overall Study|Protocol Violation|1|||
126720884|NCT02689219|455926785|FG001|Overall Study|Death|1|||
126720885|NCT02689219|455926784|FG000|Overall Study|Disease Progression|10|||
126397356|NCT00171925|454748180|FG000|Overall Study|Withdrawal by Subject|6|||
126397357|NCT00171925|454748181|FG001|Overall Study|Withdrawal by Subject|9|||
126397358|NCT00171925|454748180|FG000|Overall Study|Lost to Follow-up|2|||
126397359|NCT00171925|454748181|FG001|Overall Study|Lost to Follow-up|2|||
126397360|NCT00171925|454748180|FG000|Overall Study|Administrative problems|10|||
126397361|NCT00171925|454748181|FG001|Overall Study|Administrative problems|11|||
126397362|NCT00171925|454748180|FG000|Overall Study|Death|1|||
126397363|NCT00171925|454748181|FG001|Overall Study|Death|2|||
126397364|NCT02692040|454748182|FG000|Overall Study|Protocol Violation|0|||
126397365|NCT02692040|454748183|FG001|Overall Study|Protocol Violation|0|||
126397366|NCT02692040|454748184|FG002|Overall Study|Protocol Violation|0|||
126397367|NCT02692040|454748185|FG003|Overall Study|Protocol Violation|0|||
126397368|NCT02692040|454748186|FG004|Overall Study|Protocol Violation|0|||
126397369|NCT02692040|454748187|FG005|Overall Study|Protocol Violation|0|||
126397370|NCT02692040|454748188|FG006|Overall Study|Protocol Violation|0|||
126397371|NCT02692040|454748189|FG007|Overall Study|Protocol Violation|0|||
126397372|NCT02692040|454748190|FG008|Overall Study|Protocol Violation|0|||
126397373|NCT02692040|454748191|FG009|Overall Study|Protocol Violation|0|||
126397374|NCT02692040|454748192|FG010|Overall Study|Protocol Violation|0|||
126397375|NCT02692040|454748193|FG011|Overall Study|Protocol Violation|0|||
126397376|NCT02692040|454748194|FG012|Overall Study|Protocol Violation|1|||
126397377|NCT02692040|454748195|FG013|Overall Study|Protocol Violation|0|||
126397378|NCT02692040|454748196|FG014|Overall Study|Protocol Violation|0|||
126397379|NCT02692040|454748197|FG015|Overall Study|Protocol Violation|0|||
126397380|NCT02692040|454748198|FG016|Overall Study|Protocol Violation|0|||
126397381|NCT02692040|454748182|FG000|Overall Study|Adverse Event|0|||
126397382|NCT02692040|454748183|FG001|Overall Study|Adverse Event|0|||
126397383|NCT02692040|454748184|FG002|Overall Study|Adverse Event|0|||
126397384|NCT02692040|454748185|FG003|Overall Study|Adverse Event|0|||
126397385|NCT02692040|454748186|FG004|Overall Study|Adverse Event|0|||
126397386|NCT02692040|454748187|FG005|Overall Study|Adverse Event|0|||
126397387|NCT02692040|454748188|FG006|Overall Study|Adverse Event|0|||
126397388|NCT02692040|454748189|FG007|Overall Study|Adverse Event|0|||
126397389|NCT02692040|454748190|FG008|Overall Study|Adverse Event|0|||
126397390|NCT02692040|454748191|FG009|Overall Study|Adverse Event|0|||
126397391|NCT02692040|454748192|FG010|Overall Study|Adverse Event|0|||
126397392|NCT02692040|454748193|FG011|Overall Study|Adverse Event|0|||
126397393|NCT02692040|454748194|FG012|Overall Study|Adverse Event|0|||
126397394|NCT02692040|454748195|FG013|Overall Study|Adverse Event|3|||
126397395|NCT02692040|454748196|FG014|Overall Study|Adverse Event|1|||
126397396|NCT02692040|454748197|FG015|Overall Study|Adverse Event|1|||
126397397|NCT02692040|454748198|FG016|Overall Study|Adverse Event|0|||
126397398|NCT02752958|454748199|FG000|Overall Study|Adverse Event|3|||
126397399|NCT02752958|454748199|FG000|Overall Study|Lost to Follow-up|1|||
126397400|NCT02752958|454748199|FG000|Overall Study|Protocol Violation|1|||
126397401|NCT02752958|454748199|FG000|Overall Study|Withdrawal by Subject|2|||
126397402|NCT02752958|454748199|FG000|Overall Study|Other (Reason not specified)|2|||
126397403|NCT00853125|454748200|FG000|Overall Study|Study participant's donor was CMV +|1|||
126397404|NCT03746600|454748206|FG000|Overall Study|Withdrawal by Subject|3|||
126397405|NCT03746600|454748207|FG001|Overall Study|Withdrawal by Subject|3|||
126397406|NCT03746600|454748206|FG000|Overall Study|dismissed from study|1|||
126397407|NCT03746600|454748207|FG001|Overall Study|dismissed from study|0|||
126470629|NCT01999114|455025380|FG004|Overall Study|Withdrawal by Subject|1|||
126470630|NCT01999114|455025376|FG000|Overall Study|Lost to Follow-up|0|||
126470631|NCT01999114|455025377|FG001|Overall Study|Lost to Follow-up|0|||
126397408|NCT03746600|454748206|FG000|Overall Study|Lost to Follow-up|1|||
126397409|NCT03746600|454748207|FG001|Overall Study|Lost to Follow-up|0|||
126397410|NCT03023826|454748208|FG000|Period 1|Withdrawal by Subject|0|||
126397411|NCT03023826|454748209|FG001|Period 1|Withdrawal by Subject|0|||
126397412|NCT03023826|454748210|FG002|Period 1|Withdrawal by Subject|0|||
126397413|NCT03023826|454748211|FG003|Period 1|Withdrawal by Subject|0|||
126470632|NCT01999114|455025378|FG002|Overall Study|Lost to Follow-up|1|||
126720886|NCT02689219|455926785|FG001|Overall Study|Disease Progression|6|||
126720887|NCT01477892|455926786|FG000|Overall Study|Withdrawal by Subject|0|||
126397414|NCT03023826|454748212|FG004|Period 1|Withdrawal by Subject|1|||
126397415|NCT03023826|454748213|FG005|Period 1|Withdrawal by Subject|0|||
126397416|NCT00977938|454748214|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
126397417|NCT00977938|454748215|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
126397418|NCT00977938|454748216|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
126397419|NCT00977938|454748217|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
126470633|NCT01999114|455025379|FG003|Overall Study|Lost to Follow-up|0|||
126470634|NCT01999114|455025380|FG004|Overall Study|Lost to Follow-up|0|||
126397420|NCT00977938|454748214|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
126397421|NCT00977938|454748215|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
126397422|NCT00977938|454748216|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
126397423|NCT00977938|454748217|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
126470635|NCT01999114|455025376|FG000|Overall Study|Administrative|0|||
126470636|NCT01999114|455025377|FG001|Overall Study|Administrative|0|||
126470637|NCT01999114|455025378|FG002|Overall Study|Administrative|1|||
126470638|NCT01999114|455025379|FG003|Overall Study|Administrative|1|||
126470639|NCT01999114|455025380|FG004|Overall Study|Administrative|2|||
126470640|NCT01309165|455025383|FG000|Overall Study|Lost to Follow-up|4|||
126470641|NCT01309165|455025384|FG001|Overall Study|Lost to Follow-up|3|||
126470642|NCT01309165|455025383|FG000|Overall Study|Return to work|1|||
126470643|NCT01309165|455025384|FG001|Overall Study|Return to work|2|||
126470644|NCT01309165|455025383|FG000|Overall Study|Left country|0|||
126470645|NCT01309165|455025384|FG001|Overall Study|Left country|1|||
126470646|NCT01309165|455025383|FG000|Overall Study|No transportation|0|||
126470647|NCT01309165|455025384|FG001|Overall Study|No transportation|1|||
126470648|NCT01309165|455025383|FG000|Overall Study|Admitted to hospital for second stroke|1|||
126555152|NCT04102540|455324108|FG000|Overall Study|Lost to Follow-up|6|||
126555153|NCT01009047|455324112|FG000|Overall Study|Adverse Event|5|||
126555154|NCT01009047|455324113|FG001|Overall Study|Adverse Event|0|||
126397424|NCT00977938|454748214|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
126397425|NCT00977938|454748215|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
126397426|NCT00977938|454748216|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
126397427|NCT00977938|454748217|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
126397428|NCT00977938|454748214|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
126397429|NCT00977938|454748215|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
126397430|NCT00977938|454748216|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
126397431|NCT00977938|454748217|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
126397432|NCT00977938|454748214|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
126397433|NCT00977938|454748215|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
126397434|NCT00977938|454748216|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
126397435|NCT00977938|454748217|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
126397436|NCT00977938|454748214|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
126397437|NCT00977938|454748215|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
126397438|NCT00977938|454748216|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
126397439|NCT00977938|454748217|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
126397440|NCT02142283|454748222|FG000|Overall Study|Death|20|||
126397441|NCT02142283|454748223|FG001|Overall Study|Death|18|||
126397442|NCT02142283|454748222|FG000|Overall Study|Withdrawal by Subject|1|||
126397443|NCT02142283|454748223|FG001|Overall Study|Withdrawal by Subject|3|||
126397444|NCT02460783|454748224|FG000|Overall Study|Withdrawal by Subject|1|||
126397445|NCT02460783|454748225|FG001|Overall Study|Withdrawal by Subject|3|||
126397446|NCT02460783|454748224|FG000|Overall Study|Lost to Follow-up|1|||
126397447|NCT02460783|454748225|FG001|Overall Study|Lost to Follow-up|1|||
126397448|NCT01646645|454748226|FG000|Overall Study|No Treated|1|||
126397449|NCT01646645|454748226|FG000|Overall Study|Inevaluable Donor|29|||
126397450|NCT00884039|454748235|FG000|Overall Study|Withdrawal by Subject|0|||
126397451|NCT00884039|454748236|FG001|Overall Study|Withdrawal by Subject|1|||
126397452|NCT00884039|454748235|FG000|Overall Study|Lack of Efficacy|2|||
126397453|NCT00884039|454748236|FG001|Overall Study|Lack of Efficacy|0|||
126397454|NCT00717522|454748237|FG000|Overall Study|Disease Progression|5|||
126397455|NCT00717522|454748237|FG000|Overall Study|Adverse Event|1|||
126397456|NCT00717522|454748237|FG000|Overall Study|Death|1|||
126397457|NCT02182440|454748238|FG000|Overall Study|Adverse Event|0|||
126397458|NCT02182440|454748239|FG001|Overall Study|Adverse Event|1|||
126397459|NCT02182440|454748240|FG002|Overall Study|Adverse Event|0|||
126397460|NCT02182440|454748241|FG003|Overall Study|Adverse Event|0|||
126397461|NCT02182440|454748238|FG000|Overall Study|Death|31|||
126397462|NCT02182440|454748239|FG001|Overall Study|Death|8|||
126397463|NCT02182440|454748240|FG002|Overall Study|Death|5|||
126397464|NCT02182440|454748241|FG003|Overall Study|Death|16|||
126397465|NCT02182440|454748238|FG000|Overall Study|Protocol Violation|0|||
126397466|NCT02182440|454748239|FG001|Overall Study|Protocol Violation|1|||
126397467|NCT02182440|454748240|FG002|Overall Study|Protocol Violation|0|||
126397468|NCT02182440|454748241|FG003|Overall Study|Protocol Violation|0|||
126397469|NCT02182440|454748238|FG000|Overall Study|Physician Decision|1|||
126470649|NCT01309165|455025384|FG001|Overall Study|Admitted to hospital for second stroke|0|||
126470650|NCT01739309|455025386|FG000|Overall Study|Adverse Event|1|||
126470651|NCT01739309|455025386|FG000|Overall Study|Withdrawal by Subject|1|||
126470652|NCT00986830|455025387|FG000|Overall Study|Death|1|||
126470653|NCT00986830|455025387|FG000|Overall Study|Lost to Follow-up|1|||
126470654|NCT00986830|455025387|FG000|Overall Study|Lack of Efficacy|1|||
126470655|NCT00986830|455025387|FG000|Overall Study|Unable to access sinus with device|5|||
126470656|NCT01495975|455025388|FG000|Overall Study|Lost to Follow-up|1|||
126397470|NCT02182440|454748239|FG001|Overall Study|Physician Decision|0|||
126397471|NCT02182440|454748240|FG002|Overall Study|Physician Decision|0|||
126397472|NCT02182440|454748241|FG003|Overall Study|Physician Decision|0|||
126470657|NCT01495975|455025389|FG001|Overall Study|Lost to Follow-up|0|||
126470658|NCT01453725|455025390|FG000|Overall Study|Adverse Event|3|||
126470659|NCT01453725|455025391|FG001|Overall Study|Adverse Event|3|||
126555155|NCT01009047|455324112|FG000|Overall Study|Lost to Follow-up|0|||
126397473|NCT02182440|454748238|FG000|Overall Study|Withdrawal by Subject|1|||
126720888|NCT01477892|455926787|FG001|Overall Study|Withdrawal by Subject|2|||
126720889|NCT00905021|455926789|FG000|Overall Study|Adverse Event|2|||
126397474|NCT02182440|454748239|FG001|Overall Study|Withdrawal by Subject|1|||
126397475|NCT02182440|454748240|FG002|Overall Study|Withdrawal by Subject|3|||
126397476|NCT02182440|454748241|FG003|Overall Study|Withdrawal by Subject|4|||
126397477|NCT02182440|454748238|FG000|Overall Study|different, e.g adm other hospital|12|||
126397478|NCT02182440|454748239|FG001|Overall Study|different, e.g adm other hospital|3|||
126397479|NCT02182440|454748240|FG002|Overall Study|different, e.g adm other hospital|3|||
126397480|NCT02182440|454748241|FG003|Overall Study|different, e.g adm other hospital|10|||
126397481|NCT00072293|454748242|FG000|Overall Study|Lost to Follow-up|1|||
126397482|NCT00072293|454748243|FG001|Overall Study|Lost to Follow-up|1|||
126397483|NCT00072293|454748242|FG000|Overall Study|Withdrawal by Subject|0|||
126397484|NCT00072293|454748243|FG001|Overall Study|Withdrawal by Subject|1|||
126397485|NCT01166958|454748244|FG000|Overall Study|Withdrawal by Subject|1|||
126397486|NCT01166958|454748245|FG001|Overall Study|Withdrawal by Subject|0|||
126397487|NCT02981407|454748250|FG000|Overall Study|Withdrawal by Subject|2|||
126397488|NCT02981407|454748251|FG001|Overall Study|Withdrawal by Subject|0|||
126397489|NCT00355342|454748254|FG000|Overall Study|Adverse Event|13|||
126397490|NCT00355342|454748255|FG001|Overall Study|Adverse Event|15|||
126397491|NCT00355342|454748254|FG000|Overall Study|Lost to Follow-up|4|||
126397492|NCT00355342|454748255|FG001|Overall Study|Lost to Follow-up|2|||
126397493|NCT00355342|454748254|FG000|Overall Study|Withdrawal by Subject|14|||
126397494|NCT00355342|454748255|FG001|Overall Study|Withdrawal by Subject|11|||
126397495|NCT00355342|454748254|FG000|Overall Study|Sponsor terminated study|2|||
126397496|NCT00355342|454748255|FG001|Overall Study|Sponsor terminated study|2|||
126397497|NCT00355342|454748254|FG000|Overall Study|Overcompliant-PI discretion|1|||
126397498|NCT00355342|454748255|FG001|Overall Study|Overcompliant-PI discretion|0|||
126397499|NCT00355342|454748254|FG000|Overall Study|Use of prohibited medication|1|||
126397500|NCT00355342|454748255|FG001|Overall Study|Use of prohibited medication|0|||
126397501|NCT00355342|454748254|FG000|Overall Study|COPD exacerbation|1|||
126397502|NCT00355342|454748255|FG001|Overall Study|COPD exacerbation|1|||
126397503|NCT00355342|454748254|FG000|Overall Study|Dispensed wrong study drug kit|1|||
126397504|NCT00355342|454748255|FG001|Overall Study|Dispensed wrong study drug kit|0|||
126397505|NCT00355342|454748254|FG000|Overall Study|Non-compliance with Dexa scans|1|||
126397506|NCT00355342|454748255|FG001|Overall Study|Non-compliance with Dexa scans|0|||
126397507|NCT00355342|454748254|FG000|Overall Study|Withdrawal by participant and physician|1|||
126470660|NCT01453725|455025390|FG000|Overall Study|Lost to Follow-up|4|||
126470661|NCT01453725|455025391|FG001|Overall Study|Lost to Follow-up|0|||
126470662|NCT01453725|455025390|FG000|Overall Study|Non-compliance With Protocol|1|||
126470663|NCT01453725|455025391|FG001|Overall Study|Non-compliance With Protocol|2|||
126470664|NCT01453725|455025390|FG000|Overall Study|Protocol Violation|1|||
126470665|NCT01453725|455025391|FG001|Overall Study|Protocol Violation|0|||
126470666|NCT01453725|455025390|FG000|Overall Study|Withdrawal by Subject|2|||
126470667|NCT01453725|455025391|FG001|Overall Study|Withdrawal by Subject|3|||
126470668|NCT01453725|455025390|FG000|Overall Study|Pregnancy Wish|0|||
126470669|NCT01453725|455025391|FG001|Overall Study|Pregnancy Wish|2|||
126470670|NCT01453725|455025390|FG000|Overall Study|Pregnancy|1|||
126470671|NCT01453725|455025391|FG001|Overall Study|Pregnancy|0|||
126470672|NCT01453725|455025390|FG000|Overall Study|Physician Decision|1|||
126470673|NCT01453725|455025391|FG001|Overall Study|Physician Decision|1|||
126470674|NCT01986140|455025392|FG000|Overall Study|Withdrawal by Subject|31|||
126470675|NCT01986140|455025393|FG001|Overall Study|Withdrawal by Subject|25|||
126470676|NCT01986140|455025392|FG000|Overall Study|alternative treatment|1|||
126470677|NCT01986140|455025393|FG001|Overall Study|alternative treatment|1|||
126470678|NCT01986140|455025392|FG000|Overall Study|found not eligible|3|||
126470679|NCT01986140|455025393|FG001|Overall Study|found not eligible|0|||
126470680|NCT01986140|455025392|FG000|Overall Study|Adverse Event|0|||
126470681|NCT01986140|455025393|FG001|Overall Study|Adverse Event|1|||
126470682|NCT01986140|455025392|FG000|Overall Study|progression disease|0|||
126470683|NCT01986140|455025393|FG001|Overall Study|progression disease|1|||
126470684|NCT01069627|455025402|FG000|Overall Study|Disease progression|7|||
126470685|NCT01069627|455025402|FG000|Overall Study|Adverse Event|12|||
126720890|NCT00786838|455926790|FG000|Overall Study|Physician Decision|4|||
126720891|NCT00786838|455926790|FG000|Overall Study|Death|4|||
126720892|NCT00786838|455926790|FG000|Overall Study|Adverse Event|6|||
126397508|NCT00355342|454748255|FG001|Overall Study|Withdrawal by participant and physician|0|||
126397509|NCT00355342|454748254|FG000|Overall Study|Participant relocated|0|||
126397510|NCT00355342|454748255|FG001|Overall Study|Participant relocated|1|||
126397511|NCT00355342|454748254|FG000|Overall Study|Participant discontinued study drug|0|||
126397512|NCT00355342|454748255|FG001|Overall Study|Participant discontinued study drug|1|||
126470686|NCT01069627|455025402|FG000|Overall Study|Protocol Violation|1|||
126470687|NCT00471146|455025403|FG000|Overall Study|Adverse Event|32|||
126470688|NCT00471146|455025404|FG001|Overall Study|Adverse Event|33|||
126470689|NCT00471146|455025403|FG000|Overall Study|Withdrawal by Subject|14|||
126470690|NCT00471146|455025404|FG001|Overall Study|Withdrawal by Subject|11|||
126720893|NCT00786838|455926790|FG000|Overall Study|Progressive disease|31|||
126720894|NCT00786838|455926790|FG000|Overall Study|Withdrawal by Subject|4|||
126470691|NCT00471146|455025403|FG000|Overall Study|Death|11|||
126470692|NCT00471146|455025404|FG001|Overall Study|Death|12|||
126470693|NCT00471146|455025403|FG000|Overall Study|Lost to Follow-up|4|||
126470694|NCT00471146|455025404|FG001|Overall Study|Lost to Follow-up|2|||
126470695|NCT00471146|455025403|FG000|Overall Study|Protocol Violation|2|||
126470696|NCT00471146|455025404|FG001|Overall Study|Protocol Violation|2|||
126470697|NCT00471146|455025403|FG000|Overall Study|Objective progression or relapse|84|||
126470698|NCT00471146|455025404|FG001|Overall Study|Objective progression or relapse|87|||
126470699|NCT00471146|455025403|FG000|Overall Study|Global deterioration of health status|12|||
126470700|NCT00471146|455025404|FG001|Overall Study|Global deterioration of health status|14|||
126470701|NCT00471146|455025403|FG000|Overall Study|Randomized but not treated|9|||
126470702|NCT00471146|455025404|FG001|Overall Study|Randomized but not treated|8|||
126470703|NCT00471146|455025403|FG000|Overall Study|Other|4|||
126470704|NCT00471146|455025404|FG001|Overall Study|Other|5|||
126470705|NCT05055128|455025405|FG000|Overall Study|Adverse Event|0|||
126470706|NCT05055128|455025406|FG001|Overall Study|Adverse Event|0|||
126470707|NCT05055128|455025407|FG002|Overall Study|Adverse Event|0|||
126470708|NCT05055128|455025408|FG003|Overall Study|Adverse Event|1|||
126470709|NCT05055128|455025409|FG004|Overall Study|Adverse Event|1|||
126470710|NCT05055128|455025405|FG000|Overall Study|Protocol Violation|0|||
126470711|NCT05055128|455025406|FG001|Overall Study|Protocol Violation|0|||
126470712|NCT05055128|455025407|FG002|Overall Study|Protocol Violation|0|||
126470713|NCT05055128|455025408|FG003|Overall Study|Protocol Violation|1|||
126470714|NCT05055128|455025409|FG004|Overall Study|Protocol Violation|0|||
126470715|NCT05055128|455025405|FG000|Overall Study|Withdrawal by Subject|5|||
126470716|NCT05055128|455025406|FG001|Overall Study|Withdrawal by Subject|2|||
126470717|NCT05055128|455025407|FG002|Overall Study|Withdrawal by Subject|2|||
126470718|NCT05055128|455025408|FG003|Overall Study|Withdrawal by Subject|4|||
126470719|NCT05055128|455025409|FG004|Overall Study|Withdrawal by Subject|2|||
126470720|NCT05055128|455025405|FG000|Overall Study|Randomized By Mistake|0|||
126470721|NCT05055128|455025406|FG001|Overall Study|Randomized By Mistake|1|||
126470722|NCT05055128|455025407|FG002|Overall Study|Randomized By Mistake|0|||
126470723|NCT05055128|455025408|FG003|Overall Study|Randomized By Mistake|0|||
126470724|NCT05055128|455025409|FG004|Overall Study|Randomized By Mistake|0|||
126470725|NCT05055128|455025405|FG000|Overall Study|Other|1|||
126470726|NCT05055128|455025406|FG001|Overall Study|Other|0|||
126470727|NCT05055128|455025407|FG002|Overall Study|Other|0|||
126470728|NCT05055128|455025408|FG003|Overall Study|Other|0|||
126470729|NCT05055128|455025409|FG004|Overall Study|Other|0|||
126470730|NCT01385371|455025410|FG000|Overall Study|Adverse Event|54|||
126470731|NCT01385371|455025411|FG001|Overall Study|Adverse Event|19|||
126470732|NCT01385371|455025410|FG000|Overall Study|Lost to Follow-up|16|||
126470733|NCT01385371|455025411|FG001|Overall Study|Lost to Follow-up|16|||
126470734|NCT01385371|455025410|FG000|Overall Study|Withdrawal by Subject|52|||
126470735|NCT01385371|455025411|FG001|Overall Study|Withdrawal by Subject|39|||
126470736|NCT01385371|455025410|FG000|Overall Study|Protocol Violation|25|||
126470737|NCT01385371|455025411|FG001|Overall Study|Protocol Violation|21|||
126470738|NCT01385371|455025410|FG000|Overall Study|Administrative|2|||
126470739|NCT01385371|455025411|FG001|Overall Study|Administrative|2|||
126470740|NCT02478372|455025412|FG000|Overall Study|Protocol Violation|12|||
126470741|NCT02478372|455025413|FG001|Overall Study|Protocol Violation|8|||
126470742|NCT02478372|455025412|FG000|Overall Study|Lost to Follow-up|1|||
126470743|NCT02478372|455025413|FG001|Overall Study|Lost to Follow-up|4|||
126470744|NCT02478372|455025412|FG000|Overall Study|Death|0|||
126470745|NCT02478372|455025413|FG001|Overall Study|Death|2|||
126470746|NCT00936611|455025414|FG000|Overall Study|Progressive Disease|3|||
126470747|NCT00936611|455025414|FG000|Overall Study|New Systemic Therapy|22|||
126470748|NCT00936611|455025414|FG000|Overall Study|Lost to Follow-up|1|||
126470749|NCT00936611|455025414|FG000|Overall Study|Withdrawal by Subject|2|||
126470750|NCT00936611|455025414|FG000|Overall Study|Still on Follow-up|1|||
126470751|NCT00936611|455025414|FG000|Overall Study|Still on Active Therapy|7|||
126470752|NCT00936611|455025414|FG000|Overall Study|Ineligible for Study Drug|3|||
126470753|NCT02507973|455025415|FG000|Overall Study|Adverse Event|1|||
126470754|NCT02955797|455025416|FG000|Overall Study|Protocol Violation|1|||
126470755|NCT02955797|455025417|FG001|Overall Study|Protocol Violation|0|||
126470756|NCT02955797|455025418|FG002|Overall Study|Protocol Violation|0|||
126470757|NCT02955797|455025419|FG003|Overall Study|Protocol Violation|1|||
126470758|NCT02955797|455025416|FG000|Overall Study|Withdrawal by Subject|2|||
126470759|NCT02955797|455025417|FG001|Overall Study|Withdrawal by Subject|2|||
126756527|NCT02719028|456059454|FG003|Overall Study|Protocol Violation|1|||
126470760|NCT02955797|455025418|FG002|Overall Study|Withdrawal by Subject|0|||
126470761|NCT02955797|455025419|FG003|Overall Study|Withdrawal by Subject|1|||
126470762|NCT02955797|455025416|FG000|Overall Study|Lost to Follow-up|0|||
126470763|NCT02955797|455025417|FG001|Overall Study|Lost to Follow-up|1|||
126470764|NCT02955797|455025418|FG002|Overall Study|Lost to Follow-up|0|||
126470765|NCT02955797|455025419|FG003|Overall Study|Lost to Follow-up|0|||
126470766|NCT00543543|455025420|FG000|Base Study|Adverse Event|1|||
126470767|NCT00543543|455025421|FG001|Base Study|Adverse Event|11|||
126470768|NCT00543543|455025422|FG002|Base Study|Adverse Event|0|||
126470769|NCT00543543|455025423|FG003|Base Study|Adverse Event|5|||
126397513|NCT00355342|454748254|FG000|Overall Study|Study management|0|||
126397514|NCT00355342|454748255|FG001|Overall Study|Study management|1|||
126397515|NCT00355342|454748254|FG000|Overall Study|Protocol Violation|0|||
126397516|NCT00355342|454748255|FG001|Overall Study|Protocol Violation|1|||
126397517|NCT00355342|454748254|FG000|Overall Study|Use of protocol excluded medication|0|||
126397518|NCT00355342|454748255|FG001|Overall Study|Use of protocol excluded medication|1|||
126397519|NCT01416441|454748256|FG000|Overall Study|Lost to Follow-up|5|||
126397520|NCT01416441|454748256|FG000|Overall Study|Adverse Event|6|||
126397521|NCT01416441|454748256|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
126397522|NCT01416441|454748256|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
126397523|NCT01416441|454748256|FG000|Overall Study|Investigator Withdrew Subject|2|||
126397524|NCT01416441|454748256|FG000|Overall Study|Subject Withdrew Consent|12|||
126397525|NCT01416441|454748256|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
126397526|NCT02653495|454748261|FG000|Overall Study|Lost to Follow-up|2|||
126397527|NCT02653495|454748262|FG001|Overall Study|Lost to Follow-up|0|||
126397528|NCT02653495|454748261|FG000|Overall Study|Screening Failure|10|||
126555156|NCT01009047|455324113|FG001|Overall Study|Lost to Follow-up|2|||
126555157|NCT01009047|455324112|FG000|Overall Study|Lack of Efficacy|4|||
126555158|NCT01009047|455324113|FG001|Overall Study|Lack of Efficacy|11|||
126555159|NCT01009047|455324112|FG000|Overall Study|Withdrawal by consent|16|||
126397529|NCT02653495|454748262|FG001|Overall Study|Screening Failure|0|||
126397530|NCT00953680|454748263|FG000|Period 1|Withdrawal by Subject|0|||
126397531|NCT00953680|454748264|FG001|Period 1|Withdrawal by Subject|1|||
126397532|NCT01360398|454748265|FG000|Overall Study|Withdrawal by Subject|14|||
126555160|NCT01009047|455324113|FG001|Overall Study|Withdrawal by consent|11|||
126555161|NCT01009047|455324112|FG000|Overall Study|Other|3|||
126555162|NCT01009047|455324113|FG001|Overall Study|Other|2|||
126555163|NCT03875911|455324114|FG000|Overall Study|Lost to Follow-up|3|||
126555164|NCT03875911|455324115|FG001|Overall Study|Lost to Follow-up|6|||
126555165|NCT03875911|455324116|FG002|Overall Study|Lost to Follow-up|2|||
126555166|NCT03875911|455324114|FG000|Overall Study|Surgery cancelled|1|||
126555167|NCT03875911|455324115|FG001|Overall Study|Surgery cancelled|0|||
126555168|NCT03875911|455324116|FG002|Overall Study|Surgery cancelled|1|||
126555169|NCT03875911|455324114|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
126555170|NCT03875911|455324115|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
126555171|NCT03875911|455324116|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
126555172|NCT03824938|455324117|FG000|Overall Study|Withdrawal by Subject|2|||
126720895|NCT00436215|455926791|FG000|Overall Study|Refused further treatment|3|||
126720896|NCT00436215|455926791|FG000|Overall Study|Small bowel obstruction|1|||
126720897|NCT00309777|455926792|FG000|Overall Study|Adverse Event|13|||
126720898|NCT00309777|455926793|FG001|Overall Study|Adverse Event|2|||
126720899|NCT00309777|455926794|FG002|Overall Study|Adverse Event|8|||
126720900|NCT00309777|455926795|FG003|Overall Study|Adverse Event|1|||
126720901|NCT00309777|455926792|FG000|Overall Study|Protocol Violation|4|||
126720902|NCT00309777|455926793|FG001|Overall Study|Protocol Violation|1|||
126720903|NCT00309777|455926794|FG002|Overall Study|Protocol Violation|3|||
126720904|NCT00309777|455926795|FG003|Overall Study|Protocol Violation|1|||
126720905|NCT00309777|455926792|FG000|Overall Study|Withdrawal by Subject|6|||
126720906|NCT00309777|455926793|FG001|Overall Study|Withdrawal by Subject|5|||
126397533|NCT01360398|454748265|FG000|Overall Study|Other|7|||
126397534|NCT01360398|454748265|FG000|Overall Study|Migrated/moved from study area|1|||
126397535|NCT00624780|454748269|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
126397536|NCT00624780|454748270|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
126397537|NCT00624780|454748271|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
126397538|NCT00624780|454748272|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
126397539|NCT00624780|454748273|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
126397540|NCT00624780|454748274|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
126397541|NCT00624780|454748269|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
126397542|NCT00624780|454748270|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
126397543|NCT00624780|454748271|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
126397544|NCT00624780|454748272|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
126397545|NCT00624780|454748273|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
126397546|NCT00624780|454748274|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
126397547|NCT00624780|454748269|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
126397548|NCT00624780|454748270|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
126397549|NCT00624780|454748271|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
126397550|NCT00624780|454748272|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
126555173|NCT03824938|455324118|FG001|Overall Study|Withdrawal by Subject|1|||
126555174|NCT03824938|455324119|FG002|Overall Study|Withdrawal by Subject|0|||
126555175|NCT03824938|455324120|FG003|Overall Study|Withdrawal by Subject|2|||
126555176|NCT03824938|455324121|FG004|Overall Study|Withdrawal by Subject|0|||
126720907|NCT00309777|455926794|FG002|Overall Study|Withdrawal by Subject|7|||
126720908|NCT00309777|455926795|FG003|Overall Study|Withdrawal by Subject|2|||
126720909|NCT00309777|455926792|FG000|Overall Study|Lost to Follow-up|0|||
126555177|NCT03824938|455324122|FG005|Overall Study|Withdrawal by Subject|1|||
126555178|NCT03824938|455324117|FG000|Overall Study|Lost to Follow-up|0|||
126555179|NCT03824938|455324118|FG001|Overall Study|Lost to Follow-up|1|||
126555180|NCT03824938|455324119|FG002|Overall Study|Lost to Follow-up|0|||
126555181|NCT03824938|455324120|FG003|Overall Study|Lost to Follow-up|0|||
126555182|NCT03824938|455324121|FG004|Overall Study|Lost to Follow-up|1|||
126555183|NCT03824938|455324122|FG005|Overall Study|Lost to Follow-up|0|||
126555184|NCT01990300|455324123|FG000|Overall Study|Case Report Forms Uncollected|89|||
126555185|NCT01990300|455324123|FG000|Overall Study|Protocol Deviation|53|||
126555186|NCT01058863|455324126|FG000|Overall Study|Lost to Follow-up|1|||
126555187|NCT01058863|455324126|FG000|Overall Study|Withdrawal by Subject|1|||
126555188|NCT01058863|455324126|FG000|Overall Study|Sponsor requested withdrawal|1|||
126555189|NCT01058863|455324126|FG000|Overall Study|Randomized in error|1|||
126555190|NCT00681187|455324127|FG000|Overall Study|Withdrawal by Subject|1|||
126555191|NCT00681187|455324128|FG001|Overall Study|Withdrawal by Subject|0|||
126555192|NCT00681187|455324127|FG000|Overall Study|Death|0|||
126555193|NCT00681187|455324128|FG001|Overall Study|Death|1|||
126555194|NCT00681187|455324127|FG000|Overall Study|Adverse Event|0|||
126555195|NCT00681187|455324128|FG001|Overall Study|Adverse Event|1|||
126555196|NCT03653416|455324129|FG000|Overall Study|Protocol Violation|6|||
126555197|NCT03653416|455324130|FG001|Overall Study|Protocol Violation|1|||
126555198|NCT04230980|455324131|FG000|Overall Study|Lost to Follow-up|1|||
126555199|NCT04230980|455324132|FG001|Overall Study|Lost to Follow-up|2|||
126555200|NCT04230980|455324131|FG000|Overall Study|Adverse Event|0|||
126555201|NCT04230980|455324132|FG001|Overall Study|Adverse Event|1|||
126555202|NCT02213055|455324136|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
126555203|NCT02213055|455324137|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
126470770|NCT00543543|455025420|FG000|Base Study|Lost to Follow-up|12|||
126470771|NCT00543543|455025421|FG001|Base Study|Lost to Follow-up|749|||
126470772|NCT00543543|455025422|FG002|Base Study|Lost to Follow-up|9|||
126470773|NCT00543543|455025423|FG003|Base Study|Lost to Follow-up|701|||
126470774|NCT00543543|455025420|FG000|Base Study|Physician Decision|0|||
126470775|NCT00543543|455025421|FG001|Base Study|Physician Decision|4|||
126470776|NCT00543543|455025422|FG002|Base Study|Physician Decision|0|||
126470777|NCT00543543|455025423|FG003|Base Study|Physician Decision|7|||
126470778|NCT00543543|455025420|FG000|Base Study|Protocol Violation|0|||
126470779|NCT00543543|455025421|FG001|Base Study|Protocol Violation|6|||
126470780|NCT00543543|455025422|FG002|Base Study|Protocol Violation|0|||
126470781|NCT00543543|455025423|FG003|Base Study|Protocol Violation|6|||
126470782|NCT00543543|455025420|FG000|Base Study|Withdrawal by Subject|7|||
126470783|NCT00543543|455025421|FG001|Base Study|Withdrawal by Subject|482|||
126470784|NCT00543543|455025422|FG002|Base Study|Withdrawal by Subject|5|||
126470785|NCT00543543|455025423|FG003|Base Study|Withdrawal by Subject|503|||
126470786|NCT00543543|455025420|FG000|Extension Study|Adverse Event|0|||
126470787|NCT00543543|455025421|FG001|Extension Study|Adverse Event|0|||
126470788|NCT00543543|455025422|FG002|Extension Study|Adverse Event|0|||
126470789|NCT00543543|455025423|FG003|Extension Study|Adverse Event|5|||
126555204|NCT02213055|455324136|FG000|Overall Study|Protocol was not Followed during Study|1|||
126555205|NCT02213055|455324137|FG001|Overall Study|Protocol was not Followed during Study|0|||
126555206|NCT02213055|455324136|FG000|Overall Study|Documentation Issue at Enrollment|1|||
126555207|NCT02213055|455324137|FG001|Overall Study|Documentation Issue at Enrollment|0|||
126555208|NCT02213055|455324136|FG000|Overall Study|Documentation Issue during Study|10|||
126555209|NCT02213055|455324137|FG001|Overall Study|Documentation Issue during Study|0|||
126555210|NCT02213055|455324136|FG000|Overall Study|Did not have Live Lice|8|||
126555211|NCT02213055|455324137|FG001|Overall Study|Did not have Live Lice|0|||
126555212|NCT02213055|455324136|FG000|Overall Study|Had another Treatment during the Study|3|||
126555213|NCT02213055|455324137|FG001|Overall Study|Had another Treatment during the Study|0|||
126555214|NCT02213055|455324136|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
126555215|NCT02213055|455324137|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
126555216|NCT02213055|455324136|FG000|Overall Study|Did not Return to School|5|||
126555217|NCT02213055|455324137|FG001|Overall Study|Did not Return to School|0|||
126555218|NCT00231894|455324138|FG000|Overall Study|Withdrawal by Subject|1|||
126555219|NCT00231894|455324139|FG001|Overall Study|Withdrawal by Subject|1|||
126555220|NCT02025205|455324140|FG000|Overall Study|Withdrawal by Subject|1|||
126555221|NCT02025205|455324141|FG001|Overall Study|Withdrawal by Subject|1|||
126555222|NCT02025205|455324140|FG000|Overall Study|Protocol Violation|2|||
126555223|NCT02025205|455324141|FG001|Overall Study|Protocol Violation|1|||
126555224|NCT02025205|455324140|FG000|Overall Study|Death|0|||
126555225|NCT02025205|455324141|FG001|Overall Study|Death|1|||
126555226|NCT01767129|455324142|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
126555227|NCT01767129|455324143|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
126555228|NCT03389893|455324144|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
126470790|NCT00543543|455025420|FG000|Extension Study|Lost to Follow-up|0|||
126470791|NCT00543543|455025421|FG001|Extension Study|Lost to Follow-up|0|||
126470792|NCT00543543|455025422|FG002|Extension Study|Lost to Follow-up|0|||
126470793|NCT00543543|455025423|FG003|Extension Study|Lost to Follow-up|77|||
126470794|NCT00543543|455025420|FG000|Extension Study|Physician Decision|0|||
126720910|NCT00309777|455926793|FG001|Overall Study|Lost to Follow-up|0|||
126720911|NCT00309777|455926794|FG002|Overall Study|Lost to Follow-up|1|||
126720912|NCT00309777|455926795|FG003|Overall Study|Lost to Follow-up|0|||
126720913|NCT00309777|455926792|FG000|Overall Study|Death|0|||
126720914|NCT00309777|455926793|FG001|Overall Study|Death|1|||
126720915|NCT00309777|455926794|FG002|Overall Study|Death|0|||
126720916|NCT00309777|455926795|FG003|Overall Study|Death|0|||
126720917|NCT00833248|455928490|FG000|Overall Study|Adverse Event|3|||
126720918|NCT00833248|455928491|FG001|Overall Study|Adverse Event|0|||
126720919|NCT00833248|455928490|FG000|Overall Study|Protocol Violation|1|||
126720920|NCT00833248|455928491|FG001|Overall Study|Protocol Violation|2|||
126720921|NCT00833248|455928490|FG000|Overall Study|Withdrawal by Subject|0|||
126720922|NCT00833248|455928491|FG001|Overall Study|Withdrawal by Subject|1|||
126720923|NCT01718509|455928492|FG000|Overall Study|Lost to Follow-up|18|||
126720924|NCT01718509|455928493|FG001|Overall Study|Lost to Follow-up|15|||
126720925|NCT01718509|455928492|FG000|Overall Study|Withdrawal by Subject|7|||
126720926|NCT01718509|455928493|FG001|Overall Study|Withdrawal by Subject|13|||
126720927|NCT01718509|455928492|FG000|Overall Study|Adverse Event|5|||
126720928|NCT01718509|455928493|FG001|Overall Study|Adverse Event|7|||
126720929|NCT01718509|455928492|FG000|Overall Study|Other|13|||
126720930|NCT01718509|455928493|FG001|Overall Study|Other|11|||
126720931|NCT01718509|455928492|FG000|Overall Study|Protocol Violation|4|||
126720932|NCT01718509|455928493|FG001|Overall Study|Protocol Violation|2|||
126720933|NCT01718509|455928492|FG000|Overall Study|Lack of Efficacy|1|||
126720934|NCT01718509|455928493|FG001|Overall Study|Lack of Efficacy|0|||
126720935|NCT00643487|455928499|FG000|Overall Study|Technical difficulty|3|||
126720936|NCT00879814|455928501|FG000|Overall Study|Adverse Event|0|||
126720937|NCT00879814|455928502|FG001|Overall Study|Adverse Event|1|||
126720938|NCT00879814|455928503|FG002|Overall Study|Adverse Event|0|||
126720939|NCT00879814|455928504|FG003|Overall Study|Adverse Event|0|||
126720940|NCT00879814|455928501|FG000|Overall Study|Lost to Follow-up|1|||
126720941|NCT00879814|455928502|FG001|Overall Study|Lost to Follow-up|0|||
126720942|NCT00879814|455928503|FG002|Overall Study|Lost to Follow-up|0|||
126720943|NCT00879814|455928504|FG003|Overall Study|Lost to Follow-up|2|||
126720944|NCT00879814|455928501|FG000|Overall Study|Participant Failed to Return|0|||
126720945|NCT00879814|455928502|FG001|Overall Study|Participant Failed to Return|0|||
126720946|NCT00879814|455928503|FG002|Overall Study|Participant Failed to Return|0|||
126720947|NCT00879814|455928504|FG003|Overall Study|Participant Failed to Return|1|||
126720948|NCT00879814|455928501|FG000|Overall Study|Withdrawal by Subject|3|||
126720949|NCT00879814|455928502|FG001|Overall Study|Withdrawal by Subject|1|||
126720950|NCT00879814|455928503|FG002|Overall Study|Withdrawal by Subject|1|||
126720951|NCT00879814|455928504|FG003|Overall Study|Withdrawal by Subject|2|||
126720952|NCT00879814|455928501|FG000|Overall Study|Physician Decision|0|||
126720953|NCT00879814|455928502|FG001|Overall Study|Physician Decision|0|||
126720954|NCT00879814|455928503|FG002|Overall Study|Physician Decision|1|||
126720955|NCT00879814|455928504|FG003|Overall Study|Physician Decision|0|||
126720956|NCT00879814|455928501|FG000|Overall Study|Other|0|||
126720957|NCT00879814|455928502|FG001|Overall Study|Other|0|||
126720958|NCT00879814|455928503|FG002|Overall Study|Other|1|||
126720959|NCT00879814|455928504|FG003|Overall Study|Other|0|||
126720960|NCT01219959|455928515|FG000|Overall Study|Adverse Event|6|||
126720961|NCT01219959|455928516|FG001|Overall Study|Adverse Event|14|||
126720962|NCT01219959|455928515|FG000|Overall Study|Physician Decision|0|||
126720963|NCT01219959|455928516|FG001|Overall Study|Physician Decision|4|||
126720964|NCT01219959|455928515|FG000|Overall Study|Withdrawal by Subject|0|||
126720965|NCT01219959|455928516|FG001|Overall Study|Withdrawal by Subject|2|||
126720966|NCT01219959|455928515|FG000|Overall Study|Renal Transplantation|0|||
126720967|NCT01219959|455928516|FG001|Overall Study|Renal Transplantation|3|||
126720968|NCT01219959|455928515|FG000|Overall Study|Other|1|||
126720969|NCT01219959|455928516|FG001|Overall Study|Other|0|||
126720970|NCT01728584|455928517|FG000|Overall Study|Adverse Event|1|||
126720971|NCT01728584|455928518|FG001|Overall Study|Adverse Event|0|||
126720972|NCT01728584|455928519|FG002|Overall Study|Adverse Event|0|||
126720973|NCT01728584|455928520|FG003|Overall Study|Adverse Event|0|||
126720974|NCT01728584|455928517|FG000|Overall Study|Physician Decision|4|||
126720975|NCT01728584|455928518|FG001|Overall Study|Physician Decision|0|||
126720976|NCT01728584|455928519|FG002|Overall Study|Physician Decision|1|||
126720977|NCT01728584|455928520|FG003|Overall Study|Physician Decision|0|||
126720978|NCT01728584|455928517|FG000|Overall Study|Withdrawal by Subject|1|||
126720979|NCT01728584|455928518|FG001|Overall Study|Withdrawal by Subject|0|||
126720980|NCT01728584|455928519|FG002|Overall Study|Withdrawal by Subject|0|||
126720981|NCT01728584|455928520|FG003|Overall Study|Withdrawal by Subject|0|||
126720982|NCT01728584|455928517|FG000|Overall Study|Screen failure|1|||
126720983|NCT01728584|455928518|FG001|Overall Study|Screen failure|0|||
126720984|NCT01728584|455928519|FG002|Overall Study|Screen failure|0|||
126720985|NCT01728584|455928520|FG003|Overall Study|Screen failure|0|||
126720986|NCT01728584|455928517|FG000|Overall Study|Other reason (not specified)|1|||
126720987|NCT01728584|455928518|FG001|Overall Study|Other reason (not specified)|0|||
126720988|NCT01728584|455928519|FG002|Overall Study|Other reason (not specified)|0|||
126720989|NCT01728584|455928520|FG003|Overall Study|Other reason (not specified)|1|||
126720990|NCT02935634|455928521|FG000|Randomization|Participant withdrew consent|0|||
126720991|NCT02935634|455928522|FG001|Randomization|Participant withdrew consent|1|||
126720992|NCT02935634|455928523|FG002|Randomization|Participant withdrew consent|0|||
126720993|NCT02935634|455928524|FG003|Randomization|Participant withdrew consent|0|||
126720994|NCT02935634|455928525|FG004|Randomization|Participant withdrew consent|0|||
126720995|NCT02935634|455928526|FG005|Randomization|Participant withdrew consent|0|||
126720996|NCT02935634|455928521|FG000|Randomization|Death|2|||
126720997|NCT02935634|455928522|FG001|Randomization|Death|1|||
126397551|NCT00624780|454748273|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
126397552|NCT00624780|454748274|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
126397553|NCT00624780|454748269|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
126397554|NCT00624780|454748270|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
126397555|NCT00624780|454748271|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
126397556|NCT00624780|454748272|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
126397557|NCT00624780|454748273|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
126397558|NCT00624780|454748274|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
126397559|NCT00624780|454748269|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
126720998|NCT02935634|455928523|FG002|Randomization|Death|1|||
126720999|NCT02935634|455928524|FG003|Randomization|Death|0|||
126721000|NCT02935634|455928525|FG004|Randomization|Death|0|||
126721001|NCT02935634|455928526|FG005|Randomization|Death|0|||
126721002|NCT02935634|455928521|FG000|Randomization|Other reasons|0|||
126721003|NCT02935634|455928522|FG001|Randomization|Other reasons|2|||
126721004|NCT02935634|455928523|FG002|Randomization|Other reasons|2|||
126721005|NCT02935634|455928524|FG003|Randomization|Other reasons|0|||
126721006|NCT02935634|455928525|FG004|Randomization|Other reasons|0|||
126721007|NCT02935634|455928526|FG005|Randomization|Other reasons|0|||
126721008|NCT02935634|455928521|FG000|Treatment: Track 1|Disease progression|15|||
126721009|NCT02935634|455928522|FG001|Treatment: Track 1|Disease progression|17|||
126397560|NCT00624780|454748270|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
126397561|NCT00624780|454748271|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
126397562|NCT00624780|454748272|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
126397563|NCT00624780|454748273|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
126397564|NCT00624780|454748274|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
126397565|NCT00624780|454748269|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
126397566|NCT00624780|454748270|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
126397567|NCT00624780|454748271|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
126397568|NCT00624780|454748272|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
126397569|NCT00624780|454748273|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
126397570|NCT00624780|454748274|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
126397571|NCT00624780|454748269|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
126721010|NCT02935634|455928523|FG002|Treatment: Track 1|Disease progression|28|||
126721011|NCT02935634|455928524|FG003|Treatment: Track 1|Disease progression|4|||
126721012|NCT02935634|455928525|FG004|Treatment: Track 1|Disease progression|6|||
126721013|NCT02935634|455928526|FG005|Treatment: Track 1|Disease progression|2|||
126721014|NCT02935634|455928521|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
126721015|NCT02935634|455928522|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
126721016|NCT02935634|455928523|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
126721017|NCT02935634|455928524|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
126721018|NCT02935634|455928525|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
126721019|NCT02935634|455928526|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
126721020|NCT02935634|455928521|FG000|Treatment: Track 1|Lost to Follow-up|1|||
126721021|NCT02935634|455928522|FG001|Treatment: Track 1|Lost to Follow-up|0|||
126721022|NCT02935634|455928523|FG002|Treatment: Track 1|Lost to Follow-up|0|||
126721023|NCT02935634|455928524|FG003|Treatment: Track 1|Lost to Follow-up|0|||
126721024|NCT02935634|455928525|FG004|Treatment: Track 1|Lost to Follow-up|0|||
126721025|NCT02935634|455928526|FG005|Treatment: Track 1|Lost to Follow-up|0|||
126721026|NCT02935634|455928521|FG000|Treatment: Track 1|Study drug toxicity|2|||
126721027|NCT02935634|455928522|FG001|Treatment: Track 1|Study drug toxicity|1|||
126721028|NCT02935634|455928523|FG002|Treatment: Track 1|Study drug toxicity|3|||
126721029|NCT02935634|455928524|FG003|Treatment: Track 1|Study drug toxicity|0|||
126721030|NCT02935634|455928525|FG004|Treatment: Track 1|Study drug toxicity|0|||
126397572|NCT00624780|454748270|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
126397573|NCT00624780|454748271|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
126397574|NCT00624780|454748272|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
126397575|NCT00624780|454748273|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
126397576|NCT00624780|454748274|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
126721031|NCT02935634|455928526|FG005|Treatment: Track 1|Study drug toxicity|1|||
126721032|NCT02935634|455928521|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
126721033|NCT02935634|455928522|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
126721034|NCT02935634|455928523|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
126772125|NCT01160198|456122004|FG002|Overall Study|Lost to Follow-up|0|||
126772126|NCT01160198|456122002|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
126772127|NCT01160198|456122003|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
126772128|NCT01160198|456122004|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
126772129|NCT02016755|456122006|FG000|Overall Study|Major amputation of index limb|2|||
126772130|NCT02016755|456122006|FG000|Overall Study|Adverse Event|2|||
126772131|NCT02016755|456122006|FG000|Overall Study|Physician Decision|1|||
126772132|NCT02016755|456122006|FG000|Overall Study|Death|2|||
126772133|NCT01396161|456122011|FG000|Overall Study|Withdrawal by Subject|0|||
126772134|NCT01396161|456122012|FG001|Overall Study|Withdrawal by Subject|0|||
126772135|NCT01396161|456122013|FG002|Overall Study|Withdrawal by Subject|0|||
126397577|NCT00624780|454748269|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
126397578|NCT00624780|454748270|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
126397579|NCT00624780|454748271|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
126397580|NCT00624780|454748272|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
126397581|NCT00624780|454748273|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
126397582|NCT00624780|454748274|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
126397583|NCT00624780|454748269|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
126397584|NCT00624780|454748270|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
126397585|NCT00624780|454748271|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
126397586|NCT00624780|454748272|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
126397587|NCT00624780|454748273|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
126397588|NCT00624780|454748274|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
126397589|NCT00624780|454748269|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
126397590|NCT00624780|454748270|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
126397591|NCT00624780|454748271|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
126397592|NCT00624780|454748272|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
126397593|NCT00624780|454748273|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
126397594|NCT00624780|454748274|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
126397595|NCT00624780|454748269|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
126397596|NCT00624780|454748270|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
126397597|NCT00624780|454748271|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
126397598|NCT00624780|454748272|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
126397599|NCT00624780|454748273|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
126397600|NCT00624780|454748274|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
126397601|NCT00624780|454748269|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
126397602|NCT00624780|454748270|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
126397603|NCT00624780|454748271|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
126397604|NCT00624780|454748272|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
126397605|NCT00624780|454748273|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
126397606|NCT00624780|454748274|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
126397607|NCT00624780|454748269|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
126397608|NCT00624780|454748270|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
126397609|NCT00624780|454748271|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
126397610|NCT00624780|454748272|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
126397611|NCT00624780|454748273|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
126397612|NCT00624780|454748274|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
126397613|NCT00624780|454748269|FG000|Follow-up (Week 26)|Death|0|||
126397614|NCT00624780|454748270|FG001|Follow-up (Week 26)|Death|0|||
126397615|NCT00624780|454748271|FG002|Follow-up (Week 26)|Death|1|||
126397616|NCT00624780|454748272|FG003|Follow-up (Week 26)|Death|0|||
126397617|NCT00624780|454748273|FG004|Follow-up (Week 26)|Death|0|||
126397618|NCT00624780|454748274|FG005|Follow-up (Week 26)|Death|0|||
126397619|NCT00624780|454748269|FG000|Follow-up (Week 26)|Adverse Event|0|||
126397620|NCT00624780|454748270|FG001|Follow-up (Week 26)|Adverse Event|0|||
126397621|NCT00624780|454748271|FG002|Follow-up (Week 26)|Adverse Event|0|||
126397622|NCT00624780|454748272|FG003|Follow-up (Week 26)|Adverse Event|0|||
126397623|NCT00624780|454748273|FG004|Follow-up (Week 26)|Adverse Event|1|||
126397624|NCT00624780|454748274|FG005|Follow-up (Week 26)|Adverse Event|0|||
126397625|NCT00624780|454748269|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
126397626|NCT00624780|454748270|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
126397627|NCT00624780|454748271|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
126397628|NCT00624780|454748272|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
126397629|NCT00624780|454748273|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
126397630|NCT00624780|454748274|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
126397631|NCT00624780|454748269|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
126397632|NCT00624780|454748270|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
126397633|NCT00624780|454748271|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
126397634|NCT00624780|454748272|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
126772136|NCT01396161|456122014|FG003|Overall Study|Withdrawal by Subject|0|||
126772137|NCT01396161|456122015|FG004|Overall Study|Withdrawal by Subject|1|||
126397635|NCT00624780|454748273|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
126470795|NCT00543543|455025421|FG001|Extension Study|Physician Decision|0|||
126470796|NCT00543543|455025422|FG002|Extension Study|Physician Decision|0|||
126470797|NCT00543543|455025423|FG003|Extension Study|Physician Decision|7|||
126470798|NCT00543543|455025420|FG000|Extension Study|Pregnancy|0|||
126470799|NCT00543543|455025421|FG001|Extension Study|Pregnancy|0|||
126470800|NCT00543543|455025422|FG002|Extension Study|Pregnancy|0|||
126470801|NCT00543543|455025423|FG003|Extension Study|Pregnancy|6|||
126470802|NCT00543543|455025420|FG000|Extension Study|Protocol Violation|0|||
126470803|NCT00543543|455025421|FG001|Extension Study|Protocol Violation|0|||
126470804|NCT00543543|455025422|FG002|Extension Study|Protocol Violation|0|||
126470805|NCT00543543|455025423|FG003|Extension Study|Protocol Violation|11|||
126470806|NCT00543543|455025420|FG000|Extension Study|Withdrawal by Subject|0|||
126470807|NCT00543543|455025421|FG001|Extension Study|Withdrawal by Subject|0|||
126470808|NCT00543543|455025422|FG002|Extension Study|Withdrawal by Subject|0|||
126470809|NCT00543543|455025423|FG003|Extension Study|Withdrawal by Subject|120|||
126470810|NCT01346969|455025424|FG000|Overall Study|Withdrawal by Subject|0|||
126470811|NCT01346969|455025425|FG001|Overall Study|Withdrawal by Subject|0|||
126470812|NCT01346969|455025426|FG002|Overall Study|Withdrawal by Subject|1|||
126470813|NCT01346969|455025427|FG003|Overall Study|Withdrawal by Subject|0|||
126470814|NCT01346969|455025424|FG000|Overall Study|Lost to Follow-up|1|||
126470815|NCT01346969|455025425|FG001|Overall Study|Lost to Follow-up|0|||
126470816|NCT01346969|455025426|FG002|Overall Study|Lost to Follow-up|2|||
126470817|NCT01346969|455025427|FG003|Overall Study|Lost to Follow-up|0|||
126470818|NCT01346969|455025424|FG000|Overall Study|Physician Decision|0|||
126470819|NCT01346969|455025425|FG001|Overall Study|Physician Decision|0|||
126470820|NCT01346969|455025426|FG002|Overall Study|Physician Decision|0|||
126470821|NCT01346969|455025427|FG003|Overall Study|Physician Decision|1|||
126470822|NCT01346969|455025424|FG000|Overall Study|Randomized but not treated|1|||
126772138|NCT01396161|456122016|FG005|Overall Study|Withdrawal by Subject|0|||
126772139|NCT01396161|456122017|FG006|Overall Study|Withdrawal by Subject|0|||
126772140|NCT01396161|456122011|FG000|Overall Study|Other|0|||
126772141|NCT01396161|456122012|FG001|Overall Study|Other|0|||
126772142|NCT01396161|456122013|FG002|Overall Study|Other|0|||
126772143|NCT01396161|456122014|FG003|Overall Study|Other|0|||
126772144|NCT01396161|456122015|FG004|Overall Study|Other|0|||
126772145|NCT01396161|456122016|FG005|Overall Study|Other|0|||
126772146|NCT01396161|456122017|FG006|Overall Study|Other|1|||
126772147|NCT00552617|456122018|FG000|Overall Study|Not Treated|0|||
126772148|NCT00552617|456122019|FG001|Overall Study|Not Treated|0|||
126772149|NCT00552617|456122020|FG002|Overall Study|Not Treated|1|||
126772150|NCT00552617|456122021|FG003|Overall Study|Not Treated|0|||
126470823|NCT01346969|455025425|FG001|Overall Study|Randomized but not treated|0|||
126772151|NCT00552617|456122022|FG004|Overall Study|Not Treated|0|||
126772152|NCT00552617|456122023|FG005|Overall Study|Not Treated|0|||
126772153|NCT00552617|456122024|FG006|Overall Study|Not Treated|0|||
126772154|NCT00552617|456122025|FG007|Overall Study|Not Treated|0|||
126772155|NCT00552617|456122026|FG008|Overall Study|Not Treated|0|||
126470824|NCT01346969|455025426|FG002|Overall Study|Randomized but not treated|0|||
126470825|NCT01346969|455025427|FG003|Overall Study|Randomized but not treated|0|||
126772156|NCT00552617|456122027|FG009|Overall Study|Not Treated|1|||
126772157|NCT00552617|456122018|FG000|Overall Study|Lost to Follow-up|0|||
126772158|NCT00552617|456122019|FG001|Overall Study|Lost to Follow-up|0|||
126772159|NCT00552617|456122020|FG002|Overall Study|Lost to Follow-up|0|||
126772160|NCT00552617|456122021|FG003|Overall Study|Lost to Follow-up|1|||
126772161|NCT00552617|456122022|FG004|Overall Study|Lost to Follow-up|0|||
126772162|NCT00552617|456122023|FG005|Overall Study|Lost to Follow-up|2|||
126772163|NCT00552617|456122024|FG006|Overall Study|Lost to Follow-up|0|||
126772164|NCT00552617|456122025|FG007|Overall Study|Lost to Follow-up|0|||
126772165|NCT00552617|456122026|FG008|Overall Study|Lost to Follow-up|2|||
126470826|NCT00484094|455025428|FG000|Overall Study|Discontinued|39|||
126470827|NCT00484094|455025428|FG000|Overall Study|Other|3|||
126470828|NCT00586625|455025429|FG000|Overall Study|Adverse Event|6|||
126470829|NCT00586625|455025430|FG001|Overall Study|Adverse Event|6|||
126470830|NCT00586625|455025429|FG000|Overall Study|Protocol Violation|3|||
126470831|NCT00586625|455025430|FG001|Overall Study|Protocol Violation|0|||
126470832|NCT00586625|455025429|FG000|Overall Study|Withdrawal by Subject|32|||
126470833|NCT00586625|455025430|FG001|Overall Study|Withdrawal by Subject|10|||
126555229|NCT03389893|455324145|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
126772166|NCT00552617|456122027|FG009|Overall Study|Lost to Follow-up|0|||
126772167|NCT00337129|456122028|FG000|Overall Study|Adverse Event|4|||
126772168|NCT00337129|456122028|FG000|Overall Study|Withdrawal by Subject|1|||
126772169|NCT00337129|456122028|FG000|Overall Study|Lack of Efficacy|32|||
126470834|NCT00586625|455025429|FG000|Overall Study|Subject non-compliance|0|||
126470835|NCT00586625|455025430|FG001|Overall Study|Subject non-compliance|1|||
126470836|NCT00586625|455025429|FG000|Overall Study|Subject unable to return for visit|2|||
126470837|NCT00586625|455025430|FG001|Overall Study|Subject unable to return for visit|0|||
126772170|NCT00337129|456122028|FG000|Overall Study|Death|2|||
126772171|NCT00337129|456122028|FG000|Overall Study|not protocol specified|1|||
126772172|NCT01286207|456122032|FG000|Overall Study|Adverse Event|27|||
126772173|NCT01286207|456122033|FG001|Overall Study|Adverse Event|41|||
126772174|NCT01286207|456122034|FG002|Overall Study|Adverse Event|8|||
126772175|NCT01286207|456122032|FG000|Overall Study|Lost to Follow-up|49|||
126772176|NCT01286207|456122033|FG001|Overall Study|Lost to Follow-up|43|||
126772177|NCT01286207|456122034|FG002|Overall Study|Lost to Follow-up|20|||
126772178|NCT01286207|456122032|FG000|Overall Study|Withdrawal by Subject|93|||
126772179|NCT01286207|456122033|FG001|Overall Study|Withdrawal by Subject|79|||
126772180|NCT01286207|456122034|FG002|Overall Study|Withdrawal by Subject|41|||
126772181|NCT01286207|456122032|FG000|Overall Study|Lack of Response|92|||
126772182|NCT01286207|456122033|FG001|Overall Study|Lack of Response|38|||
126772183|NCT01286207|456122034|FG002|Overall Study|Lack of Response|8|||
126772184|NCT01286207|456122032|FG000|Overall Study|Other|37|||
126772185|NCT01286207|456122033|FG001|Overall Study|Other|47|||
126772186|NCT01286207|456122034|FG002|Overall Study|Other|13|||
126772187|NCT01383954|456122035|FG000|Overall Study|Lack of Efficacy|2|||
126772188|NCT01383954|456122035|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
126772189|NCT01383954|456122035|FG000|Overall Study|Adverse Event|1|||
126772190|NCT01383954|456122035|FG000|Overall Study|Reason Not Specified|9|||
126772191|NCT00450177|456122036|FG000|Overall Study|Adverse Event|7|||
126772192|NCT00450177|456122037|FG001|Overall Study|Adverse Event|4|||
126772193|NCT00450177|456122036|FG000|Overall Study|Withdrawal by Subject|1|||
126772194|NCT00450177|456122037|FG001|Overall Study|Withdrawal by Subject|6|||
126772195|NCT00450177|456122036|FG000|Overall Study|Withdrawal by Primary Team|1|||
126772196|NCT00450177|456122037|FG001|Overall Study|Withdrawal by Primary Team|1|||
126772197|NCT00763269|456122039|FG000|Overall Study|Lost to Follow-up|12|||
126772198|NCT00763269|456122040|FG001|Overall Study|Lost to Follow-up|13|||
126772199|NCT03174925|456122045|FG000|Overall Study|Elastographic images not retrievable|2|||
126772200|NCT03174925|456122045|FG000|Overall Study|Elastography image not interpretable|1|||
126772201|NCT04247594|456122048|FG000|Overall Study|Withdrawal by Subject|4|||
126772202|NCT00589693|456122053|FG000|Overall Study|randomized in error|12|||
126772203|NCT00589693|456122054|FG001|Overall Study|randomized in error|6|||
126772204|NCT00589693|456122053|FG000|Overall Study|Adverse Event|4|||
126772205|NCT00589693|456122054|FG001|Overall Study|Adverse Event|4|||
126772206|NCT00589693|456122053|FG000|Overall Study|Death|26|||
126772207|NCT00589693|456122054|FG001|Overall Study|Death|16|||
126772208|NCT00589693|456122053|FG000|Overall Study|Lack of Efficacy|0|||
126772209|NCT00589693|456122054|FG001|Overall Study|Lack of Efficacy|1|||
126772210|NCT00589693|456122053|FG000|Overall Study|Lost to Follow-up|1|||
126772211|NCT00589693|456122054|FG001|Overall Study|Lost to Follow-up|0|||
126772212|NCT00589693|456122053|FG000|Overall Study|Physician Decision|0|||
126772213|NCT00589693|456122054|FG001|Overall Study|Physician Decision|1|||
126772214|NCT00589693|456122053|FG000|Overall Study|Protocol Violation|1|||
126772215|NCT00589693|456122054|FG001|Overall Study|Protocol Violation|1|||
126772216|NCT02609178|456122055|FG000|First Crown|Withdrawal by Subject|0|||
126772217|NCT02609178|456122056|FG001|First Crown|Withdrawal by Subject|0|||
126772218|NCT02609178|456122057|FG002|First Crown|Withdrawal by Subject|1|||
126772219|NCT02609178|456122058|FG003|First Crown|Withdrawal by Subject|1|||
126772220|NCT02609178|456122059|FG004|First Crown|Withdrawal by Subject|0|||
126772221|NCT02609178|456122060|FG005|First Crown|Withdrawal by Subject|0|||
126772222|NCT01128153|456122061|FG000|Overall Study|Adverse Event|1|||
126772223|NCT01128153|456122062|FG001|Overall Study|Adverse Event|3|||
126772224|NCT01128153|456122061|FG000|Overall Study|Condition under investigation worsened|8|||
126772225|NCT01128153|456122062|FG001|Overall Study|Condition under investigation worsened|7|||
126772226|NCT01128153|456122061|FG000|Overall Study|Withdrawal by Subject|2|||
126772227|NCT01128153|456122062|FG001|Overall Study|Withdrawal by Subject|3|||
126772228|NCT01128153|456122061|FG000|Overall Study|Incorrect enrolment to study|2|||
126772229|NCT01128153|456122062|FG001|Overall Study|Incorrect enrolment to study|1|||
126772230|NCT01128153|456122061|FG000|Overall Study|Protocol Violation|2|||
126772231|NCT01128153|456122062|FG001|Overall Study|Protocol Violation|0|||
126772232|NCT01128153|456122061|FG000|Overall Study|Developed discontinuation criteria|1|||
126772233|NCT01128153|456122062|FG001|Overall Study|Developed discontinuation criteria|1|||
126772234|NCT01682512|456122063|FG000|Overall Study|Adverse Event|6|||
126772235|NCT01682512|456122064|FG001|Overall Study|Adverse Event|5|||
126772236|NCT01682512|456122065|FG002|Overall Study|Adverse Event|2|||
126772237|NCT01682512|456122063|FG000|Overall Study|Withdrawal by Subject|2|||
126772238|NCT01682512|456122064|FG001|Overall Study|Withdrawal by Subject|6|||
126772239|NCT01682512|456122065|FG002|Overall Study|Withdrawal by Subject|3|||
126772240|NCT01682512|456122063|FG000|Overall Study|Physician Decision|0|||
126772241|NCT01682512|456122064|FG001|Overall Study|Physician Decision|2|||
126772242|NCT01682512|456122065|FG002|Overall Study|Physician Decision|0|||
126772243|NCT01682512|456122063|FG000|Overall Study|Study terminated by sponsor|46|||
126772244|NCT01682512|456122064|FG001|Overall Study|Study terminated by sponsor|43|||
126772245|NCT01682512|456122065|FG002|Overall Study|Study terminated by sponsor|0|||
126772246|NCT01682512|456122063|FG000|Overall Study|Lost to Follow-up|3|||
126772247|NCT01682512|456122064|FG001|Overall Study|Lost to Follow-up|0|||
126772248|NCT01682512|456122065|FG002|Overall Study|Lost to Follow-up|2|||
126772249|NCT01682512|456122063|FG000|Overall Study|Protocol Violation|2|||
126772250|NCT01682512|456122064|FG001|Overall Study|Protocol Violation|3|||
126772251|NCT01682512|456122065|FG002|Overall Study|Protocol Violation|2|||
126397636|NCT00624780|454748274|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
126397637|NCT00624780|454748269|FG000|Follow-up (Week 26)|Other|1|||
126397638|NCT00624780|454748270|FG001|Follow-up (Week 26)|Other|1|||
126397639|NCT00624780|454748271|FG002|Follow-up (Week 26)|Other|0|||
126397640|NCT00624780|454748272|FG003|Follow-up (Week 26)|Other|0|||
126397641|NCT00624780|454748273|FG004|Follow-up (Week 26)|Other|0|||
126397642|NCT00624780|454748274|FG005|Follow-up (Week 26)|Other|0|||
126397643|NCT01514240|454750255|FG000|Overall Study|Adverse Event|4|||
126397644|NCT01514240|454750256|FG001|Overall Study|Adverse Event|4|||
126397645|NCT01514240|454750255|FG000|Overall Study|Subject Decision|2|||
126397646|NCT01514240|454750256|FG001|Overall Study|Subject Decision|7|||
126397647|NCT01103063|454750258|FG000|Overall Study|Adverse Event|3|||
126397648|NCT01103063|454750259|FG001|Overall Study|Adverse Event|1|||
126397649|NCT01103063|454750258|FG000|Overall Study|Lost to Follow-up|68|||
126397650|NCT01103063|454750259|FG001|Overall Study|Lost to Follow-up|51|||
126397651|NCT01103063|454750258|FG000|Overall Study|Withdrawal by Subject|60|||
126470838|NCT00165984|455025431|FG000|Overall Study|Death|15|||
126470839|NCT03553927|455025434|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
126470840|NCT03553927|455025435|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
126470841|NCT03553927|455025434|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
126470842|NCT03553927|455025435|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
126470843|NCT04176705|455025436|FG000|Overall Study|Withdrawal by Subject|4|||
126470844|NCT04176705|455025437|FG001|Overall Study|Withdrawal by Subject|4|||
126470845|NCT04176705|455025436|FG000|Overall Study|Death|1|||
126470846|NCT04176705|455025437|FG001|Overall Study|Death|1|||
126470847|NCT04176705|455025436|FG000|Overall Study|Lost to Follow-up|3|||
126470848|NCT04176705|455025437|FG001|Overall Study|Lost to Follow-up|3|||
126470849|NCT02423772|455025438|FG000|Overall Study|Lost to Follow-up|3|||
126470850|NCT02423772|455025439|FG001|Overall Study|Lost to Follow-up|3|||
126470851|NCT02423772|455025438|FG000|Overall Study|Did not begin intervention|2|||
126470852|NCT02423772|455025439|FG001|Overall Study|Did not begin intervention|5|||
126470853|NCT01193842|455025443|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
126470854|NCT01193842|455025444|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
126470855|NCT01193842|455025445|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
126470856|NCT01193842|455025446|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
126470857|NCT01193842|455025447|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
126470858|NCT01193842|455025443|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
126470859|NCT01193842|455025444|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
126470860|NCT01193842|455025445|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
126470861|NCT01193842|455025446|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
126470862|NCT01193842|455025447|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
126470863|NCT01193842|455025443|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
126470864|NCT01193842|455025444|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
126470865|NCT01193842|455025445|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
126470866|NCT01193842|455025446|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
126470867|NCT01193842|455025447|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
126470868|NCT01193842|455025443|FG000|Phase II: Randomized Groups|Death|0|||
126470869|NCT01193842|455025444|FG001|Phase II: Randomized Groups|Death|0|||
126470870|NCT01193842|455025445|FG002|Phase II: Randomized Groups|Death|0|||
126470871|NCT01193842|455025446|FG003|Phase II: Randomized Groups|Death|1|||
126470872|NCT01193842|455025447|FG004|Phase II: Randomized Groups|Death|1|||
126470873|NCT01193842|455025443|FG000|Phase II: Randomized Groups|Adverse Event|0|||
126470874|NCT01193842|455025444|FG001|Phase II: Randomized Groups|Adverse Event|0|||
126470875|NCT01193842|455025445|FG002|Phase II: Randomized Groups|Adverse Event|0|||
126470876|NCT01193842|455025446|FG003|Phase II: Randomized Groups|Adverse Event|5|||
126470877|NCT01193842|455025447|FG004|Phase II: Randomized Groups|Adverse Event|3|||
126470878|NCT01193842|455025443|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
126470879|NCT01193842|455025444|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
126397652|NCT01103063|454750259|FG001|Overall Study|Withdrawal by Subject|15|||
126397653|NCT01103063|454750258|FG000|Overall Study|Other|16|||
126397654|NCT01103063|454750259|FG001|Overall Study|Other|11|||
126397655|NCT01103063|454750258|FG000|Overall Study|Protocol Violation|1|||
126470880|NCT01193842|455025445|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
126470881|NCT01193842|455025446|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
126470882|NCT01193842|455025447|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
126470883|NCT01193842|455025443|FG000|Phase II: Randomized Groups|Ineligible|0|||
126470884|NCT01193842|455025444|FG001|Phase II: Randomized Groups|Ineligible|0|||
126470885|NCT01193842|455025445|FG002|Phase II: Randomized Groups|Ineligible|0|||
126470886|NCT01193842|455025446|FG003|Phase II: Randomized Groups|Ineligible|0|||
126470887|NCT01193842|455025447|FG004|Phase II: Randomized Groups|Ineligible|1|||
126397656|NCT01103063|454750259|FG001|Overall Study|Protocol Violation|0|||
126397657|NCT01103063|454750258|FG000|Overall Study|Study terminated by Sponsor|326|||
126397658|NCT01103063|454750259|FG001|Overall Study|Study terminated by Sponsor|342|||
126397659|NCT01103063|454750258|FG000|Overall Study|Death|3|||
126397660|NCT01103063|454750259|FG001|Overall Study|Death|1|||
126772252|NCT01682512|456122063|FG000|Overall Study|Primary lack of efficacy|10|||
126772253|NCT01682512|456122064|FG001|Overall Study|Primary lack of efficacy|7|||
126772254|NCT01682512|456122065|FG002|Overall Study|Primary lack of efficacy|7|||
126772255|NCT01682512|456122063|FG000|Overall Study|Secondary lack of efficacy|1|||
126772256|NCT01682512|456122064|FG001|Overall Study|Secondary lack of efficacy|1|||
126772257|NCT01682512|456122065|FG002|Overall Study|Secondary lack of efficacy|0|||
126772258|NCT01682512|456122063|FG000|Overall Study|Other than stated above|2|||
126772259|NCT01682512|456122064|FG001|Overall Study|Other than stated above|4|||
126772260|NCT01682512|456122065|FG002|Overall Study|Other than stated above|2|||
126772261|NCT00054275|456122066|FG000|Overall Study|Withdrawal by Subject|4|||
126772262|NCT00054275|456122066|FG000|Overall Study|Adverse Event|5|||
126470888|NCT01193842|455025443|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
126470889|NCT01193842|455025444|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
126470890|NCT01193842|455025445|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
126470891|NCT01193842|455025446|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
126470892|NCT01193842|455025447|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
126470893|NCT03698331|455025448|FG000|Overall Study|Adverse Event|2|||
126470894|NCT03698331|455025449|FG001|Overall Study|Adverse Event|3|||
126470895|NCT03698331|455025448|FG000|Overall Study|Withdrawal by Subject|1|||
126470896|NCT03698331|455025449|FG001|Overall Study|Withdrawal by Subject|1|||
126470897|NCT03698331|455025448|FG000|Overall Study|Lost to Follow-up|0|||
126470898|NCT03698331|455025449|FG001|Overall Study|Lost to Follow-up|2|||
126470899|NCT03698331|455025448|FG000|Overall Study|Non-compliance with study drug|1|||
126470900|NCT03698331|455025449|FG001|Overall Study|Non-compliance with study drug|0|||
126470901|NCT01467583|455025451|FG000|Overall Study|Death|1|||
126470902|NCT01467583|455025452|FG001|Overall Study|Death|1|||
126470903|NCT01467583|455025453|FG002|Overall Study|Death|0|||
126470904|NCT01467583|455025451|FG000|Overall Study|Withdrawal by Subject|1|||
126470905|NCT01467583|455025452|FG001|Overall Study|Withdrawal by Subject|0|||
126470906|NCT01467583|455025453|FG002|Overall Study|Withdrawal by Subject|0|||
126470907|NCT01467583|455025451|FG000|Overall Study|Protocol Violation|0|||
126470908|NCT01467583|455025452|FG001|Overall Study|Protocol Violation|0|||
126470909|NCT01467583|455025453|FG002|Overall Study|Protocol Violation|2|||
126470910|NCT02130024|455025454|FG000|Overall Study|Adverse Event|10|||
126470911|NCT02130024|455025455|FG001|Overall Study|Adverse Event|11|||
126470912|NCT02130024|455025454|FG000|Overall Study|Death|2|||
126470913|NCT02130024|455025455|FG001|Overall Study|Death|2|||
126470914|NCT02130024|455025454|FG000|Overall Study|Lost to Follow-up|1|||
126470915|NCT02130024|455025455|FG001|Overall Study|Lost to Follow-up|1|||
126470916|NCT02130024|455025454|FG000|Overall Study|Physician Decision|1|||
126470917|NCT02130024|455025455|FG001|Overall Study|Physician Decision|3|||
126470918|NCT02130024|455025454|FG000|Overall Study|Protocol Deviation|4|||
126470919|NCT02130024|455025455|FG001|Overall Study|Protocol Deviation|0|||
126470920|NCT02130024|455025454|FG000|Overall Study|Site Administration Problems|1|||
126470921|NCT02130024|455025455|FG001|Overall Study|Site Administration Problems|0|||
126470922|NCT02130024|455025454|FG000|Overall Study|Subject Withdrew Consent|6|||
126470923|NCT02130024|455025455|FG001|Overall Study|Subject Withdrew Consent|14|||
126470924|NCT02484690|455025459|FG000|Overall Study|Adverse Event|1|||
126470925|NCT02484690|455025460|FG001|Overall Study|Adverse Event|3|||
126470926|NCT02484690|455025461|FG002|Overall Study|Adverse Event|0|||
126470927|NCT02484690|455025462|FG003|Overall Study|Adverse Event|0|||
126470928|NCT02484690|455025463|FG004|Overall Study|Adverse Event|5|||
126470929|NCT02484690|455025459|FG000|Overall Study|Death|0|||
126470930|NCT02484690|455025460|FG001|Overall Study|Death|0|||
126470931|NCT02484690|455025461|FG002|Overall Study|Death|0|||
126470932|NCT02484690|455025462|FG003|Overall Study|Death|0|||
126470933|NCT02484690|455025463|FG004|Overall Study|Death|1|||
126470934|NCT02484690|455025459|FG000|Overall Study|Withdrawal by Subject|1|||
126470935|NCT02484690|455025460|FG001|Overall Study|Withdrawal by Subject|3|||
126470936|NCT02484690|455025461|FG002|Overall Study|Withdrawal by Subject|1|||
126470937|NCT02484690|455025462|FG003|Overall Study|Withdrawal by Subject|2|||
126470938|NCT02484690|455025463|FG004|Overall Study|Withdrawal by Subject|0|||
126470939|NCT02484690|455025459|FG000|Overall Study|Physician Decision|2|||
126470940|NCT02484690|455025460|FG001|Overall Study|Physician Decision|0|||
126470941|NCT02484690|455025461|FG002|Overall Study|Physician Decision|1|||
126470942|NCT02484690|455025462|FG003|Overall Study|Physician Decision|0|||
126772263|NCT00054275|456122066|FG000|Overall Study|Progressive disease in cycle 1|1|||
126772264|NCT00054275|456122066|FG000|Overall Study|Physician Decision|1|||
126470943|NCT02484690|455025463|FG004|Overall Study|Physician Decision|0|||
126772265|NCT02030834|456122074|FG000|Overall Study|Death|4|||
126772266|NCT02030834|456122075|FG001|Overall Study|Death|0|||
126772267|NCT02030834|456122076|FG002|Overall Study|Death|0|||
126772268|NCT02030834|456122074|FG000|Overall Study|Manufacturing failure|2|||
126470944|NCT02484690|455025459|FG000|Overall Study|Lost to Follow-up|0|||
126470945|NCT02484690|455025460|FG001|Overall Study|Lost to Follow-up|0|||
126470946|NCT02484690|455025461|FG002|Overall Study|Lost to Follow-up|1|||
126470947|NCT02484690|455025462|FG003|Overall Study|Lost to Follow-up|0|||
126470948|NCT02484690|455025463|FG004|Overall Study|Lost to Follow-up|0|||
126555230|NCT03389893|455324146|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
126555231|NCT03389893|455324147|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
126555232|NCT03389893|455324144|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
126555233|NCT03389893|455324145|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
126555234|NCT03389893|455324146|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
126555235|NCT03389893|455324147|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
126555236|NCT03389893|455324144|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
126555237|NCT03389893|455324145|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
126555238|NCT03389893|455324146|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
126555239|NCT03389893|455324147|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
126555240|NCT03389893|455324144|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
126555241|NCT03389893|455324145|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
126555242|NCT03389893|455324146|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
126555243|NCT03389893|455324147|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
126555244|NCT04212169|455325794|FG000|Overall Study|Adverse Event|0|||
126555245|NCT04212169|455325795|FG001|Overall Study|Adverse Event|0|||
126555246|NCT04212169|455325796|FG002|Overall Study|Adverse Event|0|||
126555247|NCT04212169|455325797|FG003|Overall Study|Adverse Event|2|||
126555248|NCT04212169|455325794|FG000|Overall Study|Lost to Follow-up|1|||
126555249|NCT04212169|455325795|FG001|Overall Study|Lost to Follow-up|0|||
126555250|NCT04212169|455325796|FG002|Overall Study|Lost to Follow-up|0|||
126555251|NCT04212169|455325797|FG003|Overall Study|Lost to Follow-up|2|||
126555252|NCT04212169|455325794|FG000|Overall Study|Withdrawal by Subject|10|||
126555253|NCT04212169|455325795|FG001|Overall Study|Withdrawal by Subject|2|||
126555254|NCT04212169|455325796|FG002|Overall Study|Withdrawal by Subject|5|||
126555255|NCT04212169|455325797|FG003|Overall Study|Withdrawal by Subject|7|||
126555256|NCT04212169|455325794|FG000|Overall Study|Other reason, unspecified|3|||
126555257|NCT04212169|455325795|FG001|Overall Study|Other reason, unspecified|1|||
126555258|NCT04212169|455325796|FG002|Overall Study|Other reason, unspecified|0|||
126555259|NCT04212169|455325797|FG003|Overall Study|Other reason, unspecified|2|||
126555260|NCT04006366|455325798|FG000|Overall Study|Withdrawal by Subject|1|||
126555261|NCT02268552|455325802|FG000|Part 1|Death|1|||
126555262|NCT02268552|455325803|FG001|Part 1|Death|1|||
126555263|NCT02268552|455325804|FG002|Part 1|Death|1|||
126555264|NCT02268552|455325805|FG003|Part 1|Death|2|||
126555265|NCT02268552|455325806|FG004|Part 1|Death|0|||
126555266|NCT02268552|455325807|FG005|Part 1|Death|0|||
126555267|NCT02268552|455325808|FG006|Part 1|Death|0|||
126555268|NCT02268552|455325802|FG000|Part 1|Subject/guardian decision|0|||
126555269|NCT02268552|455325803|FG001|Part 1|Subject/guardian decision|0|||
126555270|NCT02268552|455325804|FG002|Part 1|Subject/guardian decision|0|||
126555271|NCT02268552|455325805|FG003|Part 1|Subject/guardian decision|1|||
126555272|NCT02268552|455325806|FG004|Part 1|Subject/guardian decision|0|||
126555273|NCT02268552|455325807|FG005|Part 1|Subject/guardian decision|0|||
126555274|NCT02268552|455325808|FG006|Part 1|Subject/guardian decision|0|||
126555275|NCT02268552|455325802|FG000|Part 2|Death|0|||
126555276|NCT02268552|455325803|FG001|Part 2|Death|0|||
126555277|NCT02268552|455325804|FG002|Part 2|Death|0|||
126555278|NCT02268552|455325805|FG003|Part 2|Death|0|||
126555279|NCT02268552|455325806|FG004|Part 2|Death|0|||
126555280|NCT02268552|455325807|FG005|Part 2|Death|0|||
126555281|NCT02268552|455325808|FG006|Part 2|Death|2|||
126555282|NCT02268552|455325802|FG000|Part 2|Subject/guardian decision|0|||
126555283|NCT02268552|455325803|FG001|Part 2|Subject/guardian decision|0|||
126555284|NCT02268552|455325804|FG002|Part 2|Subject/guardian decision|0|||
126555285|NCT02268552|455325805|FG003|Part 2|Subject/guardian decision|0|||
126555286|NCT02268552|455325806|FG004|Part 2|Subject/guardian decision|0|||
126555287|NCT02268552|455325807|FG005|Part 2|Subject/guardian decision|0|||
126555288|NCT02268552|455325808|FG006|Part 2|Subject/guardian decision|1|||
126555289|NCT02268552|455325802|FG000|Part 3 Extension|Death|0|||
126555290|NCT02268552|455325803|FG001|Part 3 Extension|Death|1|||
126555291|NCT02268552|455325804|FG002|Part 3 Extension|Death|1|||
126555292|NCT02268552|455325805|FG003|Part 3 Extension|Death|1|||
126555293|NCT02268552|455325806|FG004|Part 3 Extension|Death|1|||
126555294|NCT02268552|455325807|FG005|Part 3 Extension|Death|1|||
126555295|NCT02268552|455325808|FG006|Part 3 Extension|Death|0|||
126555296|NCT02268552|455325802|FG000|Part 3 Extension|Early termination of trial|1|||
126555297|NCT02268552|455325803|FG001|Part 3 Extension|Early termination of trial|0|||
126555298|NCT02268552|455325804|FG002|Part 3 Extension|Early termination of trial|0|||
126721035|NCT02935634|455928524|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
126721036|NCT02935634|455928525|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
126555299|NCT02268552|455325805|FG003|Part 3 Extension|Early termination of trial|0|||
126555300|NCT02268552|455325806|FG004|Part 3 Extension|Early termination of trial|2|||
126555301|NCT02268552|455325807|FG005|Part 3 Extension|Early termination of trial|9|||
126555302|NCT02268552|455325808|FG006|Part 3 Extension|Early termination of trial|11|||
126555303|NCT02268552|455325802|FG000|Part 3 Extension|Subject/guardian decision|0|||
126555304|NCT02268552|455325803|FG001|Part 3 Extension|Subject/guardian decision|0|||
126555305|NCT02268552|455325804|FG002|Part 3 Extension|Subject/guardian decision|0|||
126555306|NCT02268552|455325805|FG003|Part 3 Extension|Subject/guardian decision|0|||
126555307|NCT02268552|455325806|FG004|Part 3 Extension|Subject/guardian decision|0|||
126555308|NCT02268552|455325807|FG005|Part 3 Extension|Subject/guardian decision|0|||
126555309|NCT02268552|455325808|FG006|Part 3 Extension|Subject/guardian decision|1|||
126555310|NCT00997243|455325809|FG000|Overall Study|Early termination of study by sponsor|7|||
126555311|NCT00280293|455325812|FG000|Overall Study|Protocol Violation|3|||
126555312|NCT00280293|455325813|FG001|Overall Study|Protocol Violation|0|||
126555313|NCT00280293|455325812|FG000|Overall Study|Physician Decision|5|||
126555314|NCT00280293|455325813|FG001|Overall Study|Physician Decision|4|||
126555315|NCT00280293|455325812|FG000|Overall Study|Lost to Follow-up|14|||
126555316|NCT00280293|455325813|FG001|Overall Study|Lost to Follow-up|12|||
126555317|NCT00280293|455325812|FG000|Overall Study|Withdrawal by Subject|3|||
126555318|NCT00280293|455325813|FG001|Overall Study|Withdrawal by Subject|5|||
126555319|NCT00280293|455325812|FG000|Overall Study|Incarceration/Legal Reasons|1|||
126555320|NCT00280293|455325813|FG001|Overall Study|Incarceration/Legal Reasons|1|||
126555321|NCT00280293|455325812|FG000|Overall Study|Adverse Event|0|||
126555322|NCT00280293|455325813|FG001|Overall Study|Adverse Event|1|||
126555323|NCT01458249|455325814|FG000|Overall Study|Not treated|1|||
126555324|NCT01458249|455325814|FG000|Overall Study|Adverse Event|4|||
126555325|NCT01458249|455325814|FG000|Overall Study|Other|2|||
126555326|NCT01458249|455325814|FG000|Overall Study|Ongoing|1|||
126555327|NCT01348854|455325817|FG000|Overall Study|Lost to Follow-up|2|||
126555328|NCT01348854|455325818|FG001|Overall Study|Lost to Follow-up|1|||
126555329|NCT01348854|455325817|FG000|Overall Study|Withdrawal by Subject|1|||
126555330|NCT01348854|455325818|FG001|Overall Study|Withdrawal by Subject|0|||
126555331|NCT03220737|455325819|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
126555332|NCT03220737|455325820|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
126555333|NCT03220737|455325821|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
126555334|NCT03220737|455325822|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
126555335|NCT03220737|455325823|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
126555336|NCT03220737|455325824|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
126555337|NCT03220737|455325825|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
126555338|NCT03220737|455325819|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
126555339|NCT03220737|455325820|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
126555340|NCT03220737|455325821|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
126555341|NCT03220737|455325822|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
126555342|NCT03220737|455325823|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
126555343|NCT03220737|455325824|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
126555344|NCT03220737|455325825|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
126555345|NCT03220737|455325819|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
126555346|NCT03220737|455325820|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
126555347|NCT03220737|455325821|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
126555348|NCT03220737|455325822|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
126555349|NCT03220737|455325823|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
126555350|NCT03220737|455325824|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
126555351|NCT03220737|455325825|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
126555352|NCT03220737|455325819|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
126555353|NCT03220737|455325820|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
126555354|NCT03220737|455325821|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
126555355|NCT03220737|455325822|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
126555356|NCT03220737|455325823|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
126555357|NCT03220737|455325824|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
126555358|NCT03220737|455325825|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
126555359|NCT03220737|455325819|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
126555360|NCT03220737|455325820|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
126555361|NCT03220737|455325821|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
126555362|NCT03220737|455325822|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
126555363|NCT03220737|455325823|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
126555364|NCT03220737|455325824|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
126555365|NCT03220737|455325825|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
126555366|NCT03220737|455325819|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
126555367|NCT03220737|455325820|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
126555368|NCT03220737|455325821|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
126555369|NCT03220737|455325822|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
126555370|NCT03220737|455325823|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
126555371|NCT03220737|455325824|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
126555372|NCT03220737|455325825|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
126555373|NCT03220737|455325819|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
126555374|NCT03220737|455325820|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
126555375|NCT03220737|455325821|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
126470949|NCT03360747|455025466|FG000|Overall Study|Voluntary Withdrawal|1|||
126470950|NCT01759511|455025467|FG000|Overall Study|Adverse Event|4|||
126470951|NCT01759511|455025467|FG000|Overall Study|Death|2|||
126470952|NCT01759511|455025467|FG000|Overall Study|Lack of Efficacy|2|||
126470953|NCT01759511|455025467|FG000|Overall Study|Physician Decision|1|||
126470954|NCT01759511|455025467|FG000|Overall Study|Progressive Disease|5|||
126470955|NCT01759511|455025467|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
126470956|NCT01759511|455025467|FG000|Overall Study|Study Terminated by Sponsor|13|||
126470957|NCT01759511|455025467|FG000|Overall Study|Withdrawal by Subject|3|||
126470958|NCT04916769|455025469|FG000|Period 1|Physician Decision|0|||
126470959|NCT04916769|455025470|FG001|Period 1|Physician Decision|0|||
126470960|NCT04916769|455025471|FG002|Period 1|Physician Decision|0|||
126470961|NCT04916769|455025472|FG003|Period 1|Physician Decision|0|||
126470962|NCT04916769|455025473|FG004|Period 1|Physician Decision|0|||
126470963|NCT04916769|455025474|FG005|Period 1|Physician Decision|1|||
126470964|NCT04916769|455025469|FG000|Period 2|Physician Decision|0|||
126470965|NCT04916769|455025470|FG001|Period 2|Physician Decision|1|||
126470966|NCT04916769|455025471|FG002|Period 2|Physician Decision|0|||
126470967|NCT04916769|455025472|FG003|Period 2|Physician Decision|0|||
126470968|NCT04916769|455025473|FG004|Period 2|Physician Decision|0|||
126470969|NCT04916769|455025474|FG005|Period 2|Physician Decision|0|||
126470970|NCT04526509|455025487|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
126470971|NCT04526509|455025488|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
126470972|NCT04526509|455025489|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
126470973|NCT04526509|455025490|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
126470974|NCT04526509|455025491|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
126470975|NCT04526509|455025492|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
126470976|NCT04526509|455025493|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
126470977|NCT04526509|455025487|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
126470978|NCT04526509|455025488|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
126470979|NCT04526509|455025489|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
126470980|NCT04526509|455025490|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
126470981|NCT04526509|455025491|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
126470982|NCT04526509|455025492|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
126470983|NCT04526509|455025493|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
126470984|NCT04526509|455025487|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
126470985|NCT04526509|455025488|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
126470986|NCT04526509|455025489|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
126470987|NCT04526509|455025490|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
126470988|NCT04526509|455025491|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
126470989|NCT04526509|455025492|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
126470990|NCT04526509|455025493|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
126470991|NCT04526509|455025487|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
126470992|NCT04526509|455025488|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
126470993|NCT04526509|455025489|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
126470994|NCT04526509|455025490|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
126470995|NCT04526509|455025491|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
126470996|NCT04526509|455025492|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
126470997|NCT04526509|455025493|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
126470998|NCT04526509|455025487|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
126555376|NCT03220737|455325822|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
126555377|NCT03220737|455325823|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
126555378|NCT03220737|455325824|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
126721037|NCT02935634|455928526|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
126555379|NCT03220737|455325825|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
126555380|NCT03220737|455325819|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
126555381|NCT03220737|455325820|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
126721038|NCT02935634|455928521|FG000|Treatment: Track 1|Participant withdrew consent|2|||
126555382|NCT03220737|455325821|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
126555383|NCT03220737|455325822|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
126555384|NCT03220737|455325823|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
126555385|NCT03220737|455325824|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
126555386|NCT03220737|455325825|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
126555387|NCT04011384|455325826|FG000|Overall Study|Withdrawal by Subject|2|||
126555388|NCT04011384|455325827|FG001|Overall Study|Withdrawal by Subject|0|||
126555389|NCT01094171|455325828|FG000|Overall Study|Lost to Follow-up|2|||
126555390|NCT01094171|455325828|FG000|Overall Study|Informed consent withdrawal|4|||
126555391|NCT01094171|455325828|FG000|Overall Study|Migration from the study area|3|||
126555392|NCT01094171|455325828|FG000|Overall Study|Other|1|||
126555393|NCT00594932|455325829|FG000|First 3 Months|Withdrawal by Subject|1|||
126555394|NCT00594932|455325830|FG001|First 3 Months|Withdrawal by Subject|3|||
126555395|NCT00594932|455325829|FG000|Final 3 Months|Withdrawal by Subject|4|||
126555396|NCT00594932|455325830|FG001|Final 3 Months|Withdrawal by Subject|3|||
126555397|NCT01676220|455325831|FG000|Overall Study|Randomized But Not Treated|4|||
126555398|NCT01676220|455325832|FG001|Overall Study|Randomized But Not Treated|1|||
126555399|NCT01676220|455325831|FG000|Overall Study|Adverse Event|10|||
126555400|NCT01676220|455325832|FG001|Overall Study|Adverse Event|8|||
126555401|NCT01676220|455325831|FG000|Overall Study|Lack of Efficacy|2|||
126397661|NCT01187446|454750262|FG000|Overall Study|Patient started non-protocol therapy|0|||
126397662|NCT01187446|454750263|FG001|Overall Study|Patient started non-protocol therapy|1|||
126397663|NCT00613925|454750264|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
126397664|NCT00613925|454750265|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
126397665|NCT00252694|454750268|FG000|Overall Study|Withdrawal by Subject|83|||
126555402|NCT01676220|455325832|FG001|Overall Study|Lack of Efficacy|5|||
126555403|NCT01676220|455325831|FG000|Overall Study|Protocol Violation|11|||
126555404|NCT01676220|455325832|FG001|Overall Study|Protocol Violation|12|||
126555405|NCT01676220|455325831|FG000|Overall Study|Received Rescue Therapy|14|||
126555406|NCT01676220|455325832|FG001|Overall Study|Received Rescue Therapy|22|||
126555407|NCT01676220|455325831|FG000|Overall Study|Personal Reason|34|||
126555408|NCT01676220|455325832|FG001|Overall Study|Personal Reason|45|||
126555409|NCT01676220|455325831|FG000|Overall Study|Lost to Follow-up|11|||
126555410|NCT01676220|455325832|FG001|Overall Study|Lost to Follow-up|18|||
126555411|NCT01676220|455325831|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
126555412|NCT01676220|455325832|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
126555413|NCT01676220|455325831|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
126555414|NCT01676220|455325832|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
126555415|NCT01676220|455325831|FG000|Overall Study|Perceived Lack of Efficacy|3|||
126555416|NCT01676220|455325832|FG001|Overall Study|Perceived Lack of Efficacy|1|||
126555417|NCT01676220|455325831|FG000|Overall Study|Non Serious Hypoglycemia|2|||
126555418|NCT01676220|455325832|FG001|Overall Study|Non Serious Hypoglycemia|0|||
126555419|NCT01676220|455325831|FG000|Overall Study|No More Need of Insulin|1|||
126555420|NCT01676220|455325832|FG001|Overall Study|No More Need of Insulin|0|||
126555421|NCT02269943|455325833|FG000|Treatment Period|Death|0|||
126555422|NCT02269943|455325834|FG001|Treatment Period|Death|1|||
126555423|NCT02269943|455325833|FG000|Treatment Period|Adverse Event|1|||
126555424|NCT02269943|455325834|FG001|Treatment Period|Adverse Event|10|||
126555425|NCT02269943|455325833|FG000|Treatment Period|Progressive Disease|5|||
126555426|NCT02269943|455325834|FG001|Treatment Period|Progressive Disease|17|||
126555427|NCT02269943|455325833|FG000|Treatment Period|Symptomatic Deterioration|0|||
126555428|NCT02269943|455325834|FG001|Treatment Period|Symptomatic Deterioration|2|||
126555429|NCT02269943|455325833|FG000|Follow-Up Survival Period|Death|3|||
126555430|NCT02269943|455325834|FG001|Follow-Up Survival Period|Death|16|||
126555431|NCT02269943|455325833|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
126555432|NCT02269943|455325834|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
126555433|NCT02269943|455325833|FG000|Follow-Up Survival Period|Alive|2|||
126555434|NCT02269943|455325834|FG001|Follow-Up Survival Period|Alive|8|||
126555435|NCT01024751|455325835|FG000|Enrolled Participants|Ineligible at baseline|3|||
126555436|NCT01024751|455325836|FG001|Enrolled Participants|Ineligible at baseline|4|||
126555437|NCT01024751|455325835|FG000|Eligible Participants|Withdrawal by Subject|0|||
126555438|NCT01024751|455325836|FG001|Eligible Participants|Withdrawal by Subject|1|||
126555439|NCT01024751|455325835|FG000|Eligible Participants|Lost to Follow-up|0|||
126555440|NCT01024751|455325836|FG001|Eligible Participants|Lost to Follow-up|1|||
126555441|NCT01024751|455325835|FG000|Eligible Participants|Ineligible|0|||
126555442|NCT01024751|455325836|FG001|Eligible Participants|Ineligible|1|||
126555443|NCT01232556|455325837|FG000|Overall Study|Withdrawal by Subject|21|||
126555444|NCT01232556|455325838|FG001|Overall Study|Withdrawal by Subject|17|||
126555445|NCT01232556|455325837|FG000|Overall Study|Death|97|||
126555446|NCT01232556|455325838|FG001|Overall Study|Death|97|||
126555447|NCT01232556|455325837|FG000|Overall Study|Lost to Follow-up|0|||
126555448|NCT01232556|455325838|FG001|Overall Study|Lost to Follow-up|2|||
126555449|NCT01232556|455325837|FG000|Overall Study|Terminated by Sponsor|35|||
126555450|NCT01232556|455325838|FG001|Overall Study|Terminated by Sponsor|51|||
126555451|NCT01232556|455325837|FG000|Overall Study|Other|6|||
126555452|NCT01232556|455325838|FG001|Overall Study|Other|4|||
126555453|NCT02448719|455325839|FG000|Overall Study|Withdrawal by Subject|0|||
126555454|NCT02448719|455325840|FG001|Overall Study|Withdrawal by Subject|0|||
126555455|NCT02448719|455325841|FG002|Overall Study|Withdrawal by Subject|0|||
126555456|NCT02448719|455325842|FG003|Overall Study|Withdrawal by Subject|0|||
126555457|NCT02448719|455325843|FG004|Overall Study|Withdrawal by Subject|1|||
126555458|NCT02448719|455325844|FG005|Overall Study|Withdrawal by Subject|0|||
126555459|NCT02448719|455325845|FG006|Overall Study|Withdrawal by Subject|0|||
126555460|NCT02448719|455325846|FG007|Overall Study|Withdrawal by Subject|0|||
126555461|NCT02448719|455325847|FG008|Overall Study|Withdrawal by Subject|0|||
126555462|NCT02448719|455325848|FG009|Overall Study|Withdrawal by Subject|0|||
126555463|NCT02448719|455325849|FG010|Overall Study|Withdrawal by Subject|0|||
126555464|NCT01473420|455325851|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
126555465|NCT01473420|455325852|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
126555466|NCT01473420|455325851|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
126555467|NCT01473420|455325852|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
126555468|NCT01473420|455325851|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
126555469|NCT01473420|455325852|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
126555470|NCT01473420|455325851|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
126555471|NCT01473420|455325852|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
126555472|NCT01473420|455325851|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
126555473|NCT01473420|455325852|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
126555474|NCT01473420|455325851|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
126555475|NCT01473420|455325852|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
126555476|NCT01473420|455325851|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
126555477|NCT01473420|455325852|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
126555478|NCT01473420|455325851|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
126555479|NCT01473420|455325852|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
126555480|NCT01473420|455325851|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
126555481|NCT01473420|455325852|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
126555482|NCT01473420|455325851|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
126555483|NCT01473420|455325852|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
126555484|NCT01473420|455325851|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
126555485|NCT01473420|455325852|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
126555486|NCT01473420|455325851|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
126555487|NCT01473420|455325852|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
126555488|NCT01473420|455325851|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
126555489|NCT01473420|455325852|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
126555490|NCT00388362|455325859|FG000|Enrolled|Ineligible|1|||
126555491|NCT00388362|455325859|FG000|Enrolled|Adverse Event|9|||
126555492|NCT00388362|455325859|FG000|Enrolled|Death|1|||
126555493|NCT00388362|455325859|FG000|Enrolled|Loss insurance|1|||
126555494|NCT00388362|455325859|FG000|Enrolled|Withdrawal by Subject|1|||
126555495|NCT00388362|455325859|FG000|Remained on Study Median of 514 Days|Death|2|||
126555496|NCT01141660|455325860|FG000|Overall Study|Physician Decision|0|||
126555497|NCT01141660|455325861|FG001|Overall Study|Physician Decision|12|||
126555498|NCT00209027|455325862|FG000|Overall Study|study terminated|10|||
126555499|NCT00209027|455325863|FG001|Overall Study|study terminated|0|||
126555500|NCT01932996|455325864|FG000|Overall Study|Protocol Violation|2|||
126555501|NCT01932996|455325865|FG001|Overall Study|Protocol Violation|0|||
126555502|NCT01848834|455325866|FG000|Overall Study|Adverse Event|3|||
126555503|NCT01848834|455325867|FG001|Overall Study|Adverse Event|11|||
126555504|NCT01848834|455325868|FG002|Overall Study|Adverse Event|3|||
126555505|NCT01848834|455325869|FG003|Overall Study|Adverse Event|5|||
126555506|NCT01848834|455325870|FG004|Overall Study|Adverse Event|9|||
126555507|NCT01848834|455325866|FG000|Overall Study|Death|2|||
126555508|NCT01848834|455325867|FG001|Overall Study|Death|11|||
126555509|NCT01848834|455325868|FG002|Overall Study|Death|1|||
126555510|NCT01848834|455325869|FG003|Overall Study|Death|8|||
126555511|NCT01848834|455325870|FG004|Overall Study|Death|27|||
126555512|NCT01848834|455325866|FG000|Overall Study|Excluded Medication|5|||
126555513|NCT01848834|455325867|FG001|Overall Study|Excluded Medication|4|||
126555514|NCT01848834|455325868|FG002|Overall Study|Excluded Medication|3|||
126555515|NCT01848834|455325869|FG003|Overall Study|Excluded Medication|6|||
126555516|NCT01848834|455325870|FG004|Overall Study|Excluded Medication|6|||
126397666|NCT00252694|454750269|FG001|Overall Study|Withdrawal by Subject|91|||
126397667|NCT00252694|454750268|FG000|Overall Study|Death|36|||
126397668|NCT00252694|454750269|FG001|Overall Study|Death|34|||
126397669|NCT00252694|454750268|FG000|Overall Study|Mostly Lost to Follow Up|8|||
126397670|NCT00252694|454750269|FG001|Overall Study|Mostly Lost to Follow Up|13|||
126397671|NCT00252694|454750268|FG000|Overall Study|Patient Moving|17|||
126397672|NCT00252694|454750269|FG001|Overall Study|Patient Moving|16|||
126555517|NCT01848834|455325866|FG000|Overall Study|Lost to Follow-up|5|||
126397673|NCT01342965|454750270|FG000|Overall Study|Death|58|||
126772269|NCT02030834|456122075|FG001|Overall Study|Manufacturing failure|0|||
126397674|NCT01342965|454750271|FG001|Overall Study|Death|57|||
126470999|NCT04526509|455025488|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
126471000|NCT04526509|455025489|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
126471001|NCT04526509|455025490|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
126471002|NCT04526509|455025491|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
126471003|NCT04526509|455025492|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
126471004|NCT04526509|455025493|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
126471005|NCT04526509|455025487|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
126471006|NCT04526509|455025488|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
126471007|NCT04526509|455025489|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
126471008|NCT04526509|455025490|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
126471009|NCT04526509|455025491|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
126471010|NCT04526509|455025492|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
126471011|NCT04526509|455025493|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
126471012|NCT04526509|455025487|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
126471013|NCT04526509|455025488|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
126471014|NCT04526509|455025489|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
126471015|NCT04526509|455025490|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
126471016|NCT04526509|455025491|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
126471017|NCT04526509|455025492|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
126471018|NCT04526509|455025493|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
126471019|NCT04526509|455025487|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
126471020|NCT04526509|455025488|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
126471021|NCT04526509|455025489|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
126471022|NCT04526509|455025490|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
126471023|NCT04526509|455025491|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
126471024|NCT04526509|455025492|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
126471025|NCT04526509|455025493|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
126471026|NCT04526509|455025487|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
126471027|NCT04526509|455025488|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
126471028|NCT04526509|455025489|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
126471029|NCT04526509|455025490|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
126471030|NCT04526509|455025491|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
126471031|NCT04526509|455025492|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
126471032|NCT04526509|455025493|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
126471033|NCT04526509|455025487|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
126471034|NCT04526509|455025488|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
126471035|NCT04526509|455025489|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
126471036|NCT04526509|455025490|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
126471037|NCT04526509|455025491|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
126471038|NCT04526509|455025492|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
126471039|NCT04526509|455025493|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
126471040|NCT04526509|455025487|FG000|Enrolled|Study Terminated by Sponsor|0|||
126471041|NCT04526509|455025488|FG001|Enrolled|Study Terminated by Sponsor|0|||
126471042|NCT04526509|455025489|FG002|Enrolled|Study Terminated by Sponsor|0|||
126471043|NCT04526509|455025490|FG003|Enrolled|Study Terminated by Sponsor|0|||
126471044|NCT04526509|455025491|FG004|Enrolled|Study Terminated by Sponsor|0|||
126471045|NCT04526509|455025492|FG005|Enrolled|Study Terminated by Sponsor|0|||
126471046|NCT04526509|455025493|FG006|Enrolled|Study Terminated by Sponsor|1|||
126471047|NCT04526509|455025487|FG000|Enrolled|Death prior to lymphodepletion|0|||
126471048|NCT04526509|455025488|FG001|Enrolled|Death prior to lymphodepletion|0|||
126471049|NCT04526509|455025489|FG002|Enrolled|Death prior to lymphodepletion|0|||
126471050|NCT04526509|455025490|FG003|Enrolled|Death prior to lymphodepletion|1|||
126471051|NCT04526509|455025491|FG004|Enrolled|Death prior to lymphodepletion|0|||
126471052|NCT04526509|455025492|FG005|Enrolled|Death prior to lymphodepletion|0|||
126471053|NCT04526509|455025493|FG006|Enrolled|Death prior to lymphodepletion|0|||
126471054|NCT04526509|455025487|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
126471055|NCT04526509|455025488|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
126471056|NCT04526509|455025489|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
126471057|NCT04526509|455025490|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
126471058|NCT04526509|455025491|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
126471059|NCT04526509|455025492|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
126471060|NCT04526509|455025493|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
126471061|NCT04526509|455025487|FG000|Enrolled|Physician Decision|0|||
126471062|NCT04526509|455025488|FG001|Enrolled|Physician Decision|1|||
126471063|NCT04526509|455025489|FG002|Enrolled|Physician Decision|0|||
126471064|NCT04526509|455025490|FG003|Enrolled|Physician Decision|0|||
126471065|NCT04526509|455025491|FG004|Enrolled|Physician Decision|0|||
126471066|NCT04526509|455025492|FG005|Enrolled|Physician Decision|0|||
126471067|NCT04526509|455025493|FG006|Enrolled|Physician Decision|0|||
126471068|NCT04340193|455025495|FG000|Overall Study|Other reason|0|||
126471069|NCT04340193|455025496|FG001|Overall Study|Other reason|0|||
126471070|NCT04340193|455025497|FG002|Overall Study|Other reason|1|||
126471071|NCT04340193|455025495|FG000|Overall Study|Disease recurrence|0|||
126471072|NCT04340193|455025496|FG001|Overall Study|Disease recurrence|1|||
126471073|NCT04340193|455025497|FG002|Overall Study|Disease recurrence|0|||
126471074|NCT04340193|455025495|FG000|Overall Study|Study drug toxicity|1|||
126471075|NCT04340193|455025496|FG001|Overall Study|Study drug toxicity|0|||
126471076|NCT04340193|455025497|FG002|Overall Study|Study drug toxicity|0|||
126471077|NCT04340193|455025495|FG000|Overall Study|Disease progression|1|||
126471078|NCT04340193|455025496|FG001|Overall Study|Disease progression|2|||
126471079|NCT04340193|455025497|FG002|Overall Study|Disease progression|3|||
126471080|NCT04340193|455025495|FG000|Overall Study|Administrative reasons by sponsor|0|||
126471081|NCT04340193|455025496|FG001|Overall Study|Administrative reasons by sponsor|1|||
126471082|NCT04340193|455025497|FG002|Overall Study|Administrative reasons by sponsor|0|||
126471083|NCT04340193|455025495|FG000|Overall Study|Adverse Event|1|||
126471084|NCT04340193|455025496|FG001|Overall Study|Adverse Event|1|||
126471085|NCT04340193|455025497|FG002|Overall Study|Adverse Event|0|||
126471086|NCT03001882|455025498|FG000|Overall Study|Death|1|||
126471087|NCT03001882|455025499|FG001|Overall Study|Death|0|||
126471088|NCT03001882|455025500|FG002|Overall Study|Death|0|||
126471089|NCT03001882|455025501|FG003|Overall Study|Death|3|||
126471090|NCT03001882|455025498|FG000|Overall Study|Participant withdrew consent|0|||
126471091|NCT03001882|455025499|FG001|Overall Study|Participant withdrew consent|1|||
126471092|NCT03001882|455025500|FG002|Overall Study|Participant withdrew consent|0|||
126471093|NCT03001882|455025501|FG003|Overall Study|Participant withdrew consent|5|||
126471094|NCT03001882|455025498|FG000|Overall Study|Other reasons|1|||
126471095|NCT03001882|455025499|FG001|Overall Study|Other reasons|2|||
126471096|NCT03001882|455025500|FG002|Overall Study|Other reasons|0|||
126471097|NCT03001882|455025501|FG003|Overall Study|Other reasons|5|||
126471098|NCT03001882|455025498|FG000|Overall Study|Administrative reason by sponsor|0|||
126471099|NCT03001882|455025499|FG001|Overall Study|Administrative reason by sponsor|0|||
126471100|NCT03001882|455025500|FG002|Overall Study|Administrative reason by sponsor|0|||
126471101|NCT03001882|455025501|FG003|Overall Study|Administrative reason by sponsor|1|||
126471102|NCT03001882|455025498|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
126471103|NCT03001882|455025499|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
126471104|NCT03001882|455025500|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
126471105|NCT03001882|455025501|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
126471106|NCT03001882|455025498|FG000|Overall Study|Not reported|0|||
126471107|NCT03001882|455025499|FG001|Overall Study|Not reported|0|||
126471108|NCT03001882|455025500|FG002|Overall Study|Not reported|0|||
126471109|NCT03001882|455025501|FG003|Overall Study|Not reported|6|||
126471110|NCT03001882|455025498|FG000|Overall Study|Maximum clinical benefit|2|||
126555518|NCT01848834|455325867|FG001|Overall Study|Lost to Follow-up|5|||
126471111|NCT03001882|455025499|FG001|Overall Study|Maximum clinical benefit|3|||
126471112|NCT03001882|455025500|FG002|Overall Study|Maximum clinical benefit|0|||
126471113|NCT03001882|455025501|FG003|Overall Study|Maximum clinical benefit|10|||
126471114|NCT03001882|455025498|FG000|Overall Study|AE unrelated to study drug|3|||
126471115|NCT03001882|455025499|FG001|Overall Study|AE unrelated to study drug|3|||
126471116|NCT03001882|455025500|FG002|Overall Study|AE unrelated to study drug|0|||
126471117|NCT03001882|455025501|FG003|Overall Study|AE unrelated to study drug|11|||
126471118|NCT03001882|455025498|FG000|Overall Study|Study Drug Toxicity|8|||
126555519|NCT01848834|455325868|FG002|Overall Study|Lost to Follow-up|3|||
126555520|NCT01848834|455325869|FG003|Overall Study|Lost to Follow-up|0|||
126555521|NCT01848834|455325870|FG004|Overall Study|Lost to Follow-up|3|||
126555522|NCT01848834|455325866|FG000|Overall Study|Physician Decision|1|||
126555523|NCT01848834|455325867|FG001|Overall Study|Physician Decision|3|||
126555524|NCT01848834|455325868|FG002|Overall Study|Physician Decision|4|||
126555525|NCT01848834|455325869|FG003|Overall Study|Physician Decision|0|||
126555526|NCT01848834|455325870|FG004|Overall Study|Physician Decision|11|||
126555527|NCT01848834|455325866|FG000|Overall Study|Protocol Violation|0|||
126555528|NCT01848834|455325867|FG001|Overall Study|Protocol Violation|0|||
126555529|NCT01848834|455325868|FG002|Overall Study|Protocol Violation|0|||
126555530|NCT01848834|455325869|FG003|Overall Study|Protocol Violation|0|||
126555531|NCT01848834|455325870|FG004|Overall Study|Protocol Violation|1|||
126555532|NCT01848834|455325866|FG000|Overall Study|Sponsor Decision|1|||
126555533|NCT01848834|455325867|FG001|Overall Study|Sponsor Decision|1|||
126555534|NCT01848834|455325868|FG002|Overall Study|Sponsor Decision|0|||
126555535|NCT01848834|455325869|FG003|Overall Study|Sponsor Decision|1|||
126555536|NCT01848834|455325870|FG004|Overall Study|Sponsor Decision|1|||
126555537|NCT01848834|455325866|FG000|Overall Study|Withdrawal by Subject|2|||
126555538|NCT01848834|455325867|FG001|Overall Study|Withdrawal by Subject|13|||
126555539|NCT01848834|455325868|FG002|Overall Study|Withdrawal by Subject|10|||
126555540|NCT01848834|455325869|FG003|Overall Study|Withdrawal by Subject|6|||
126555541|NCT01848834|455325870|FG004|Overall Study|Withdrawal by Subject|36|||
126555542|NCT02040090|455325873|FG000|Overall Study|Adverse Event|2|||
126555543|NCT02040090|455325874|FG001|Overall Study|Adverse Event|0|||
126555544|NCT02040090|455325873|FG000|Overall Study|Physician Decision|1|||
126555545|NCT02040090|455325874|FG001|Overall Study|Physician Decision|0|||
126555546|NCT02040090|455325873|FG000|Overall Study|Withdrawal by Subject|0|||
126555547|NCT02040090|455325874|FG001|Overall Study|Withdrawal by Subject|1|||
126555548|NCT02040090|455325873|FG000|Overall Study|Lost to Follow-up|0|||
126555549|NCT02040090|455325874|FG001|Overall Study|Lost to Follow-up|1|||
126555550|NCT03259373|455325881|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
126555551|NCT03259373|455325882|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
126555552|NCT03259373|455325881|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
126555553|NCT03259373|455325882|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
126555554|NCT03259373|455325881|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
126555555|NCT03259373|455325882|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
126555556|NCT03259373|455325881|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
126555557|NCT03259373|455325882|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
126555558|NCT03259373|455325881|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
126555559|NCT03259373|455325882|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
126555560|NCT03259373|455325881|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
126555561|NCT03259373|455325882|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
126555562|NCT04894903|455325883|FG000|Overall Study|Death|1|||
126555563|NCT04894903|455325884|FG001|Overall Study|Death|0|||
126555564|NCT04894903|455325883|FG000|Overall Study|Pregnancy|1|||
126555565|NCT04894903|455325884|FG001|Overall Study|Pregnancy|0|||
126555566|NCT04894903|455325883|FG000|Overall Study|Withdrawal by Subject|1|||
126555567|NCT04894903|455325884|FG001|Overall Study|Withdrawal by Subject|1|||
126555568|NCT04894903|455325883|FG000|Overall Study|moved or exited health system|1|||
126555569|NCT04894903|455325884|FG001|Overall Study|moved or exited health system|3|||
126555570|NCT00895843|455325887|FG000|Overall Study|Protocol Violation|12|||
126555571|NCT00895843|455325888|FG001|Overall Study|Protocol Violation|12|||
126555572|NCT04963062|455325896|FG000|Overall Study|withdrew by the study team|4|||
126555573|NCT04963062|455325897|FG001|Overall Study|withdrew by the study team|2|||
126555574|NCT01857323|455325898|FG000|Overall Study|Adverse Event|1|||
126555575|NCT01857323|455325898|FG000|Overall Study|Withdrawal by Subject|3|||
126555576|NCT01857323|455325898|FG000|Overall Study|Non-compliance|1|||
126555577|NCT01857323|455325898|FG000|Overall Study|Protocol Violation|6|||
126555578|NCT01857323|455325898|FG000|Overall Study|Lost to Follow-up|1|||
126555579|NCT01857323|455325898|FG000|Overall Study|Other|4|||
126555580|NCT01857323|455325898|FG000|Overall Study|Did not complete 180 doses|48|||
126555581|NCT03873246|455325899|FG000|Overall Study|Adverse Event|1|||
126555582|NCT03873246|455325900|FG001|Overall Study|Adverse Event|3|||
126555583|NCT03873246|455325901|FG002|Overall Study|Adverse Event|3|||
126555584|NCT03873246|455325899|FG000|Overall Study|Lost to Follow-up|4|||
126555585|NCT03873246|455325900|FG001|Overall Study|Lost to Follow-up|4|||
126555586|NCT03873246|455325901|FG002|Overall Study|Lost to Follow-up|5|||
126555587|NCT03873246|455325899|FG000|Overall Study|Protocol Violation|0|||
126555588|NCT03873246|455325900|FG001|Overall Study|Protocol Violation|1|||
126555589|NCT03873246|455325901|FG002|Overall Study|Protocol Violation|0|||
126555590|NCT03873246|455325899|FG000|Overall Study|Withdrawal by Subject|0|||
126555591|NCT03873246|455325900|FG001|Overall Study|Withdrawal by Subject|4|||
126555592|NCT03873246|455325901|FG002|Overall Study|Withdrawal by Subject|1|||
126555593|NCT03658811|455325902|FG000|Overall Study|Lost to Follow-up|3|||
126555594|NCT00946647|455325906|FG000|Phase 1 Part|Adverse Event|2|||
126555595|NCT00946647|455325907|FG001|Phase 1 Part|Adverse Event|5|||
126555596|NCT00946647|455325908|FG002|Phase 1 Part|Adverse Event|3|||
126555597|NCT00946647|455325909|FG003|Phase 1 Part|Adverse Event|0|||
126555598|NCT00946647|455325910|FG004|Phase 1 Part|Adverse Event|0|||
126555599|NCT00946647|455325906|FG000|Phase 1 Part|Disease progression|3|||
126555600|NCT00946647|455325907|FG001|Phase 1 Part|Disease progression|6|||
126555601|NCT00946647|455325908|FG002|Phase 1 Part|Disease progression|1|||
126555602|NCT00946647|455325909|FG003|Phase 1 Part|Disease progression|0|||
126555603|NCT00946647|455325910|FG004|Phase 1 Part|Disease progression|0|||
126555604|NCT00946647|455325906|FG000|Phase 1 Part|Withdrawal by Subject|1|||
126555605|NCT00946647|455325907|FG001|Phase 1 Part|Withdrawal by Subject|4|||
126397675|NCT01342965|454750270|FG000|Overall Study|Lost to Follow-up|5|||
126397676|NCT01342965|454750271|FG001|Overall Study|Lost to Follow-up|3|||
126397677|NCT01342965|454750270|FG000|Overall Study|Other Reasons- Unspecified|44|||
126397678|NCT01342965|454750271|FG001|Overall Study|Other Reasons- Unspecified|38|||
126397679|NCT01342965|454750270|FG000|Overall Study|Withdrawal by Subject|2|||
126397680|NCT01342965|454750271|FG001|Overall Study|Withdrawal by Subject|9|||
126397681|NCT03538444|454750282|FG000|Overall Study|opioid withdrawal|1|||
126397682|NCT03538444|454750283|FG001|Overall Study|opioid withdrawal|0|||
126397683|NCT04644237|454750297|FG000|Overall Study|Death|3|||
126397684|NCT04644237|454750298|FG001|Overall Study|Death|2|||
126397685|NCT04644237|454750297|FG000|Overall Study|Adverse Event|15|||
126397686|NCT04644237|454750298|FG001|Overall Study|Adverse Event|12|||
126397687|NCT04644237|454750297|FG000|Overall Study|Progressive Disease|47|||
126397688|NCT04644237|454750298|FG001|Overall Study|Progressive Disease|19|||
126397689|NCT04644237|454750297|FG000|Overall Study|Clinical Progression|4|||
126397690|NCT04644237|454750298|FG001|Overall Study|Clinical Progression|1|||
126555606|NCT00946647|455325908|FG002|Phase 1 Part|Withdrawal by Subject|3|||
126555607|NCT00946647|455325909|FG003|Phase 1 Part|Withdrawal by Subject|0|||
126555608|NCT00946647|455325910|FG004|Phase 1 Part|Withdrawal by Subject|0|||
126555609|NCT00946647|455325906|FG000|Phase 1 Part|Abnormal values|0|||
126555610|NCT00946647|455325907|FG001|Phase 1 Part|Abnormal values|2|||
126555611|NCT00946647|455325908|FG002|Phase 1 Part|Abnormal values|0|||
126555612|NCT00946647|455325909|FG003|Phase 1 Part|Abnormal values|0|||
126555613|NCT00946647|455325910|FG004|Phase 1 Part|Abnormal values|0|||
126555614|NCT00946647|455325906|FG000|Phase 1 Part|Reason missing|0|||
126555615|NCT00946647|455325907|FG001|Phase 1 Part|Reason missing|1|||
126555616|NCT00946647|455325908|FG002|Phase 1 Part|Reason missing|0|||
126555617|NCT00946647|455325909|FG003|Phase 1 Part|Reason missing|0|||
126555618|NCT00946647|455325910|FG004|Phase 1 Part|Reason missing|0|||
126555619|NCT00946647|455325906|FG000|Phase ll Part|Untreated|0|||
126555620|NCT00946647|455325907|FG001|Phase ll Part|Untreated|0|||
126555621|NCT00946647|455325908|FG002|Phase ll Part|Untreated|0|||
126555622|NCT00946647|455325909|FG003|Phase ll Part|Untreated|0|||
126555623|NCT00946647|455325910|FG004|Phase ll Part|Untreated|2|||
126555624|NCT00946647|455325906|FG000|Phase ll Part|Adverse Event|0|||
126555625|NCT00946647|455325907|FG001|Phase ll Part|Adverse Event|0|||
126555626|NCT00946647|455325908|FG002|Phase ll Part|Adverse Event|0|||
126555627|NCT00946647|455325909|FG003|Phase ll Part|Adverse Event|10|||
126555628|NCT00946647|455325910|FG004|Phase ll Part|Adverse Event|6|||
126555629|NCT00946647|455325906|FG000|Phase ll Part|Withdrawal by Subject|0|||
126555630|NCT00946647|455325907|FG001|Phase ll Part|Withdrawal by Subject|0|||
126555631|NCT00946647|455325908|FG002|Phase ll Part|Withdrawal by Subject|0|||
126555632|NCT00946647|455325909|FG003|Phase ll Part|Withdrawal by Subject|8|||
126555633|NCT00946647|455325910|FG004|Phase ll Part|Withdrawal by Subject|6|||
126555634|NCT00946647|455325906|FG000|Phase ll Part|Administrative problems|0|||
126555635|NCT00946647|455325907|FG001|Phase ll Part|Administrative problems|0|||
126555636|NCT00946647|455325908|FG002|Phase ll Part|Administrative problems|0|||
126555637|NCT00946647|455325909|FG003|Phase ll Part|Administrative problems|3|||
126555638|NCT00946647|455325910|FG004|Phase ll Part|Administrative problems|8|||
126555639|NCT00946647|455325906|FG000|Phase ll Part|Death|0|||
126555640|NCT00946647|455325907|FG001|Phase ll Part|Death|0|||
126555641|NCT00946647|455325908|FG002|Phase ll Part|Death|0|||
126772270|NCT02030834|456122076|FG002|Overall Study|Manufacturing failure|1|||
126397691|NCT04644237|454750297|FG000|Overall Study|Withdrawal by Subject|1|||
126397692|NCT04644237|454750298|FG001|Overall Study|Withdrawal by Subject|2|||
126397693|NCT04644237|454750297|FG000|Overall Study|Physician Decision|3|||
126555642|NCT00946647|455325909|FG003|Phase ll Part|Death|7|||
126555643|NCT00946647|455325910|FG004|Phase ll Part|Death|4|||
126555644|NCT00946647|455325906|FG000|Phase ll Part|Disease progression|0|||
126555645|NCT00946647|455325907|FG001|Phase ll Part|Disease progression|0|||
126555646|NCT00946647|455325908|FG002|Phase ll Part|Disease progression|0|||
126555647|NCT00946647|455325909|FG003|Phase ll Part|Disease progression|6|||
126555648|NCT00946647|455325910|FG004|Phase ll Part|Disease progression|14|||
126555649|NCT00946647|455325906|FG000|Phase ll Part|Protocol Violation|0|||
126555650|NCT00946647|455325907|FG001|Phase ll Part|Protocol Violation|0|||
126397694|NCT04644237|454750298|FG001|Overall Study|Physician Decision|0|||
126471119|NCT03001882|455025499|FG001|Overall Study|Study Drug Toxicity|5|||
126555651|NCT00946647|455325908|FG002|Phase ll Part|Protocol Violation|0|||
126471120|NCT03001882|455025500|FG002|Overall Study|Study Drug Toxicity|0|||
126471121|NCT03001882|455025501|FG003|Overall Study|Study Drug Toxicity|37|||
126471122|NCT03001882|455025498|FG000|Overall Study|Disease progression|16|||
126555652|NCT00946647|455325909|FG003|Phase ll Part|Protocol Violation|4|||
126555653|NCT00946647|455325910|FG004|Phase ll Part|Protocol Violation|2|||
126555654|NCT00946647|455325906|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
126555655|NCT00946647|455325907|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
126555656|NCT00946647|455325908|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
126555657|NCT00946647|455325909|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
126555658|NCT00946647|455325910|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
126555659|NCT01368211|455325911|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
126555660|NCT01368211|455325912|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
126555661|NCT01987830|455325914|FG000|Overall Study|Never received baseline scan|1|||
126555662|NCT03990363|455325915|FG000|Overall Study|Withdrawal by Subject|10|||
126555663|NCT03990363|455325916|FG001|Overall Study|Withdrawal by Subject|9|||
126555664|NCT03990363|455325917|FG002|Overall Study|Withdrawal by Subject|18|||
126555665|NCT03990363|455325918|FG003|Overall Study|Withdrawal by Subject|11|||
126555666|NCT03990363|455325919|FG004|Overall Study|Withdrawal by Subject|9|||
126555667|NCT03990363|455325915|FG000|Overall Study|Physician Decision|1|||
126555668|NCT03990363|455325916|FG001|Overall Study|Physician Decision|0|||
126555669|NCT03990363|455325917|FG002|Overall Study|Physician Decision|0|||
126555670|NCT03990363|455325918|FG003|Overall Study|Physician Decision|0|||
126555671|NCT03990363|455325919|FG004|Overall Study|Physician Decision|0|||
126555672|NCT03990363|455325915|FG000|Overall Study|Adverse Event|1|||
126555673|NCT03990363|455325916|FG001|Overall Study|Adverse Event|3|||
126555674|NCT03990363|455325917|FG002|Overall Study|Adverse Event|2|||
126555675|NCT03990363|455325918|FG003|Overall Study|Adverse Event|2|||
126555676|NCT03990363|455325919|FG004|Overall Study|Adverse Event|0|||
126397695|NCT04644237|454750297|FG000|Overall Study|Other|1|||
126397696|NCT04644237|454750298|FG001|Overall Study|Other|0|||
126397697|NCT04644237|454750297|FG000|Overall Study|Randomized but not Treated|1|||
126397698|NCT04644237|454750298|FG001|Overall Study|Randomized but not Treated|0|||
126397699|NCT01779869|454750299|FG000|Overall Study|Physician Decision|2|||
126397700|NCT02233738|454750301|FG000|Overall Study|Lost to Follow-up|5|||
126397701|NCT02233738|454750302|FG001|Overall Study|Lost to Follow-up|12|||
126397702|NCT02233738|454750301|FG000|Overall Study|Death|0|||
126397703|NCT02233738|454750302|FG001|Overall Study|Death|1|||
126397704|NCT02233738|454750301|FG000|Overall Study|Withdrawal by Subject|0|||
126397705|NCT02233738|454750302|FG001|Overall Study|Withdrawal by Subject|1|||
126397706|NCT02233738|454750301|FG000|Overall Study|Did not return after Baseline|3|||
126397707|NCT02233738|454750302|FG001|Overall Study|Did not return after Baseline|2|||
126397708|NCT00096174|454750303|FG000|Overall Study|Lack of Efficacy|9|||
126397709|NCT00096174|454750303|FG000|Overall Study|Adverse Event|15|||
126397710|NCT00096174|454750303|FG000|Overall Study|Death|6|||
126397711|NCT00096174|454750303|FG000|Overall Study|Withdrawal by Subject|15|||
126397712|NCT00096174|454750303|FG000|Overall Study|Not started protocol therapy|3|||
126397713|NCT00096174|454750303|FG000|Overall Study|Ineligible|6|||
126397714|NCT00096174|454750303|FG000|Overall Study|other reason|8|||
126397715|NCT00027378|454750307|FG000|Overall Study|Physician Decision|0|||
126471123|NCT03001882|455025499|FG001|Overall Study|Disease progression|14|||
126471124|NCT03001882|455025500|FG002|Overall Study|Disease progression|1|||
126471125|NCT03001882|455025501|FG003|Overall Study|Disease progression|90|||
126471126|NCT04449861|455025502|FG000|Overall Study|Withdrawal by Subject|4|||
126471127|NCT04449861|455025502|FG000|Overall Study|Lost to Follow-up|5|||
126471128|NCT04449861|455025502|FG000|Overall Study|Death|112|||
126471129|NCT00976677|455025503|FG000|Overall Study|Adverse Event|1|||
126471130|NCT00976677|455025504|FG001|Overall Study|Adverse Event|0|||
126471131|NCT00976677|455025503|FG000|Overall Study|Withdrawal by Subject|0|||
126471132|NCT00976677|455025504|FG001|Overall Study|Withdrawal by Subject|2|||
126471133|NCT00976677|455025503|FG000|Overall Study|Disease progression|1|||
126397716|NCT00027378|454750308|FG001|Overall Study|Physician Decision|3|||
126397717|NCT05605691|454750309|FG000|Overall Study|Lost to Follow-up|1|||
126555677|NCT03990363|455325915|FG000|Overall Study|Death|14|||
126397718|NCT03199053|454750312|FG000|ST Period|Withdrawal by Subject|2|||
126555678|NCT03990363|455325916|FG001|Overall Study|Death|8|||
126555679|NCT03990363|455325917|FG002|Overall Study|Death|14|||
126555680|NCT03990363|455325918|FG003|Overall Study|Death|10|||
126555681|NCT03990363|455325919|FG004|Overall Study|Death|11|||
126397719|NCT03199053|454750313|FG001|ST Period|Withdrawal by Subject|4|||
126397720|NCT03199053|454750314|FG002|ST Period|Withdrawal by Subject|6|||
126397721|NCT03199053|454750312|FG000|ST Period|Withdrawal by parent/guardian|1|||
126397722|NCT03199053|454750313|FG001|ST Period|Withdrawal by parent/guardian|1|||
126471134|NCT00976677|455025504|FG001|Overall Study|Disease progression|1|||
126471135|NCT00976677|455025503|FG000|Overall Study|Trial unblinded|2|||
126555682|NCT03990363|455325915|FG000|Overall Study|Failure to meet randomization criteria|0|||
126555683|NCT03990363|455325916|FG001|Overall Study|Failure to meet randomization criteria|1|||
126555684|NCT03990363|455325917|FG002|Overall Study|Failure to meet randomization criteria|1|||
126555685|NCT03990363|455325918|FG003|Overall Study|Failure to meet randomization criteria|0|||
126555686|NCT03990363|455325919|FG004|Overall Study|Failure to meet randomization criteria|0|||
126397723|NCT03199053|454750314|FG002|ST Period|Withdrawal by parent/guardian|1|||
126397724|NCT03199053|454750312|FG000|ST Period|Lost to Follow-up|2|||
126397725|NCT03199053|454750313|FG001|ST Period|Lost to Follow-up|0|||
126397726|NCT03199053|454750314|FG002|ST Period|Lost to Follow-up|1|||
126397727|NCT03199053|454750312|FG000|LT Period|Withdrawal by Subject|1|||
126555687|NCT03990363|455325915|FG000|Overall Study|Lost to Follow-up|0|||
126555688|NCT03990363|455325916|FG001|Overall Study|Lost to Follow-up|0|||
126555689|NCT03990363|455325917|FG002|Overall Study|Lost to Follow-up|0|||
126555690|NCT03990363|455325918|FG003|Overall Study|Lost to Follow-up|1|||
126555691|NCT03990363|455325919|FG004|Overall Study|Lost to Follow-up|2|||
126555692|NCT03990363|455325915|FG000|Overall Study|Non-compliance with study drug|2|||
126555693|NCT03990363|455325916|FG001|Overall Study|Non-compliance with study drug|1|||
126555694|NCT03990363|455325917|FG002|Overall Study|Non-compliance with study drug|2|||
126555695|NCT03990363|455325918|FG003|Overall Study|Non-compliance with study drug|0|||
126555696|NCT03990363|455325919|FG004|Overall Study|Non-compliance with study drug|0|||
126555697|NCT03990363|455325915|FG000|Overall Study|Study terminated by sponsor|0|||
126555698|NCT03990363|455325916|FG001|Overall Study|Study terminated by sponsor|1|||
126555699|NCT03990363|455325917|FG002|Overall Study|Study terminated by sponsor|0|||
126555700|NCT03990363|455325918|FG003|Overall Study|Study terminated by sponsor|0|||
126555701|NCT03990363|455325919|FG004|Overall Study|Study terminated by sponsor|0|||
126555702|NCT03990363|455325915|FG000|Overall Study|Site terminated by sponsor|2|||
126555703|NCT03990363|455325916|FG001|Overall Study|Site terminated by sponsor|1|||
126555704|NCT03990363|455325917|FG002|Overall Study|Site terminated by sponsor|2|||
126555705|NCT03990363|455325918|FG003|Overall Study|Site terminated by sponsor|0|||
126555706|NCT03990363|455325919|FG004|Overall Study|Site terminated by sponsor|2|||
126555707|NCT03990363|455325915|FG000|Overall Study|Not categorized|5|||
126555708|NCT03990363|455325916|FG001|Overall Study|Not categorized|5|||
126555709|NCT03990363|455325917|FG002|Overall Study|Not categorized|3|||
126555710|NCT03990363|455325918|FG003|Overall Study|Not categorized|2|||
126555711|NCT03990363|455325919|FG004|Overall Study|Not categorized|2|||
126555712|NCT01349660|455325923|FG000|Overall Study|Still Receiving Study Treatment|0|||
126555713|NCT01349660|455325924|FG001|Overall Study|Still Receiving Study Treatment|0|||
126555714|NCT01349660|455325925|FG002|Overall Study|Still Receiving Study Treatment|1|||
126555715|NCT01349660|455325923|FG000|Overall Study|Disease Progression|2|||
126555716|NCT01349660|455325924|FG001|Overall Study|Disease Progression|4|||
126555717|NCT01349660|455325925|FG002|Overall Study|Disease Progression|50|||
126555718|NCT01349660|455325923|FG000|Overall Study|Adverse Event|1|||
126555719|NCT01349660|455325924|FG001|Overall Study|Adverse Event|1|||
126555720|NCT01349660|455325925|FG002|Overall Study|Adverse Event|12|||
126555721|NCT01349660|455325923|FG000|Overall Study|Withdrawal by Subject|2|||
126555722|NCT01349660|455325924|FG001|Overall Study|Withdrawal by Subject|0|||
126555723|NCT01349660|455325925|FG002|Overall Study|Withdrawal by Subject|9|||
126555724|NCT01349660|455325923|FG000|Overall Study|Death|1|||
126555725|NCT01349660|455325924|FG001|Overall Study|Death|1|||
126555726|NCT01349660|455325925|FG002|Overall Study|Death|0|||
126555727|NCT01349660|455325923|FG000|Overall Study|Non-Permitted Interventions|0|||
126555728|NCT01349660|455325924|FG001|Overall Study|Non-Permitted Interventions|0|||
126555729|NCT01349660|455325925|FG002|Overall Study|Non-Permitted Interventions|2|||
126555730|NCT01349660|455325923|FG000|Overall Study|Study Compliance|0|||
126555731|NCT01349660|455325924|FG001|Overall Study|Study Compliance|0|||
126555732|NCT01349660|455325925|FG002|Overall Study|Study Compliance|1|||
126555733|NCT01349660|455325923|FG000|Overall Study|Declining Performance Status|0|||
126555734|NCT01349660|455325924|FG001|Overall Study|Declining Performance Status|0|||
126555735|NCT01349660|455325925|FG002|Overall Study|Declining Performance Status|1|||
126555736|NCT05764239|455325927|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
126555737|NCT05764239|455325927|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
126555738|NCT05764239|455325927|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
126555739|NCT05764239|455325927|FG000|DEP (Part 1)|Adverse Event|1|||
126555740|NCT05764239|455325927|FG000|DEP (Part 1)|Lost to Follow-up|1|||
126555741|NCT05764239|455325927|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
126555742|NCT05764239|455325927|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
126555743|NCT05764239|455325927|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
126555744|NCT05764239|455325927|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
126555745|NCT00057811|455325928|FG000|Overall Study|Lack of Efficacy|1|||
126555746|NCT00057811|455325929|FG001|Overall Study|Lack of Efficacy|4|||
126555747|NCT00057811|455325928|FG000|Overall Study|Physician Decision|1|||
126555748|NCT00057811|455325929|FG001|Overall Study|Physician Decision|0|||
126397728|NCT03199053|454750313|FG001|LT Period|Withdrawal by Subject|3|||
126397729|NCT03199053|454750314|FG002|LT Period|Withdrawal by Subject|3|||
126397730|NCT03199053|454750312|FG000|LT Period|Withdrawal by parent/guardian|0|||
126555749|NCT00057811|455325928|FG000|Overall Study|Withdrawal by Subject|3|||
126555750|NCT00057811|455325929|FG001|Overall Study|Withdrawal by Subject|4|||
126555751|NCT00057811|455325928|FG000|Overall Study|Ineligible|4|||
126397731|NCT03199053|454750313|FG001|LT Period|Withdrawal by parent/guardian|0|||
126397732|NCT03199053|454750314|FG002|LT Period|Withdrawal by parent/guardian|1|||
126555752|NCT00057811|455325929|FG001|Overall Study|Ineligible|2|||
126555753|NCT00057811|455325928|FG000|Overall Study|Inevaluable|1|||
126555754|NCT00057811|455325929|FG001|Overall Study|Inevaluable|2|||
126397733|NCT03199053|454750312|FG000|LT Period|Lost to Follow-up|0|||
126397734|NCT03199053|454750313|FG001|LT Period|Lost to Follow-up|1|||
126397735|NCT03199053|454750314|FG002|LT Period|Lost to Follow-up|1|||
126397736|NCT03199053|454750312|FG000|LT Period|Miscellaneous|0|||
126397737|NCT03199053|454750313|FG001|LT Period|Miscellaneous|0|||
126397738|NCT03199053|454750314|FG002|LT Period|Miscellaneous|2|||
126397739|NCT03199053|454750312|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
126397740|NCT03199053|454750313|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
126397741|NCT03199053|454750314|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
126397742|NCT03199053|454750312|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
126397743|NCT03199053|454750313|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
126772271|NCT02030834|456122074|FG000|Overall Study|Disease progression|2|||
126397744|NCT03199053|454750314|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
126397745|NCT03199053|454750312|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
126397746|NCT03199053|454750313|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
126555755|NCT00556374|455325930|FG000|Overall Study|Withdrawal by Subject|235|||
126555756|NCT00556374|455325931|FG001|Overall Study|Withdrawal by Subject|205|||
126555757|NCT00556374|455325930|FG000|Overall Study|Death|158|||
126555758|NCT00556374|455325931|FG001|Overall Study|Death|127|||
126555759|NCT00556374|455325930|FG000|Overall Study|Lost to Follow-up|24|||
126555760|NCT00556374|455325931|FG001|Overall Study|Lost to Follow-up|17|||
126555761|NCT00556374|455325930|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
126555762|NCT00556374|455325931|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
126555763|NCT00663962|455325932|FG000|Overall Study|somnolence|1|||
126555764|NCT00663962|455325933|FG001|Overall Study|somnolence|0|||
126555765|NCT00519636|455325934|FG000|Treatment Period 1|Adverse Event|1|||
126555766|NCT00519636|455325935|FG001|Treatment Period 1|Adverse Event|0|||
126555767|NCT00519636|455325936|FG002|Treatment Period 1|Adverse Event|1|||
126555768|NCT00519636|455325937|FG003|Treatment Period 1|Adverse Event|0|||
126555769|NCT00519636|455325934|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
126555770|NCT00519636|455325935|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
126555771|NCT00519636|455325936|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
126555772|NCT00519636|455325937|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
126555773|NCT00519636|455325934|FG000|Washout Period|Adverse Event|2|||
126555774|NCT00519636|455325935|FG001|Washout Period|Adverse Event|1|||
126555775|NCT00519636|455325936|FG002|Washout Period|Adverse Event|1|||
126555776|NCT00519636|455325937|FG003|Washout Period|Adverse Event|0|||
126555777|NCT00519636|455325934|FG000|Washout Period|Lost to Follow-up|1|||
126721039|NCT02935634|455928522|FG001|Treatment: Track 1|Participant withdrew consent|0|||
126721040|NCT02935634|455928523|FG002|Treatment: Track 1|Participant withdrew consent|1|||
126721041|NCT02935634|455928524|FG003|Treatment: Track 1|Participant withdrew consent|0|||
126721042|NCT02935634|455928525|FG004|Treatment: Track 1|Participant withdrew consent|1|||
126721043|NCT02935634|455928526|FG005|Treatment: Track 1|Participant withdrew consent|0|||
126721044|NCT02935634|455928521|FG000|Treatment: Track 1|Other reasons|0|||
126721045|NCT02935634|455928522|FG001|Treatment: Track 1|Other reasons|0|||
126721046|NCT02935634|455928523|FG002|Treatment: Track 1|Other reasons|2|||
126721047|NCT02935634|455928524|FG003|Treatment: Track 1|Other reasons|0|||
126721048|NCT02935634|455928525|FG004|Treatment: Track 1|Other reasons|0|||
126721049|NCT02935634|455928526|FG005|Treatment: Track 1|Other reasons|0|||
126721050|NCT02935634|455928521|FG000|Treatment: Track 2|Disease progression|13|||
126721051|NCT02935634|455928522|FG001|Treatment: Track 2|Disease progression|26|||
126721052|NCT02935634|455928523|FG002|Treatment: Track 2|Disease progression|20|||
126721053|NCT02935634|455928524|FG003|Treatment: Track 2|Disease progression|5|||
126555778|NCT00519636|455325935|FG001|Washout Period|Lost to Follow-up|0|||
126555779|NCT00519636|455325936|FG002|Washout Period|Lost to Follow-up|0|||
126721054|NCT02935634|455928525|FG004|Treatment: Track 2|Disease progression|1|||
126721055|NCT02935634|455928526|FG005|Treatment: Track 2|Disease progression|4|||
126721056|NCT02935634|455928521|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
126721057|NCT02935634|455928522|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
126397747|NCT03199053|454750314|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
126555780|NCT00519636|455325937|FG003|Washout Period|Lost to Follow-up|0|||
126555781|NCT00519636|455325934|FG000|Washout Period|Protocol Violation|0|||
126555782|NCT00519636|455325935|FG001|Washout Period|Protocol Violation|0|||
126555783|NCT00519636|455325936|FG002|Washout Period|Protocol Violation|1|||
126555784|NCT00519636|455325937|FG003|Washout Period|Protocol Violation|2|||
126721058|NCT02935634|455928523|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
126721059|NCT02935634|455928524|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
126772272|NCT02030834|456122075|FG001|Overall Study|Disease progression|0|||
126555785|NCT00519636|455325934|FG000|Washout Period|Withdrawal by Subject|1|||
126555786|NCT00519636|455325935|FG001|Washout Period|Withdrawal by Subject|0|||
126555787|NCT00519636|455325936|FG002|Washout Period|Withdrawal by Subject|1|||
126397748|NCT03199053|454750312|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
126397749|NCT03199053|454750313|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
126397750|NCT03199053|454750314|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
126397751|NCT01824823|454750317|FG000|Overall Study|Lack of Efficacy|1|||
126397752|NCT01824823|454750318|FG001|Overall Study|Lack of Efficacy|1|||
126397753|NCT01824823|454750317|FG000|Overall Study|Off-treatment reason not submitted|1|||
126397754|NCT01824823|454750318|FG001|Overall Study|Off-treatment reason not submitted|0|||
126397755|NCT02098369|454750319|FG000|Overall Study|Withdrawal by Subject|1|||
126397756|NCT02098369|454750320|FG001|Overall Study|Withdrawal by Subject|5|||
126397757|NCT02098369|454750321|FG002|Overall Study|Withdrawal by Subject|0|||
126397758|NCT02098369|454750319|FG000|Overall Study|Lost to Follow-up|5|||
126397759|NCT02098369|454750320|FG001|Overall Study|Lost to Follow-up|1|||
126397760|NCT02098369|454750321|FG002|Overall Study|Lost to Follow-up|3|||
126397761|NCT02098369|454750319|FG000|Overall Study|Death|1|||
126397762|NCT02098369|454750320|FG001|Overall Study|Death|1|||
126397763|NCT02098369|454750321|FG002|Overall Study|Death|1|||
126397764|NCT02098369|454750319|FG000|Overall Study|Other|0|||
126397765|NCT02098369|454750320|FG001|Overall Study|Other|2|||
126397766|NCT02098369|454750321|FG002|Overall Study|Other|1|||
126397767|NCT00246025|454750322|FG000|Overall Study|Adverse Event|7|||
126397768|NCT00246025|454750323|FG001|Overall Study|Adverse Event|9|||
126397769|NCT00246025|454750324|FG002|Overall Study|Adverse Event|9|||
126397770|NCT00246025|454750325|FG003|Overall Study|Adverse Event|10|||
126397771|NCT00246025|454750322|FG000|Overall Study|Withdrawal by Subject|3|||
126397772|NCT00246025|454750323|FG001|Overall Study|Withdrawal by Subject|0|||
126397773|NCT00246025|454750324|FG002|Overall Study|Withdrawal by Subject|1|||
126397774|NCT00246025|454750325|FG003|Overall Study|Withdrawal by Subject|2|||
126397775|NCT00246025|454750322|FG000|Overall Study|unsuitable medical history was found|0|||
126397776|NCT00246025|454750323|FG001|Overall Study|unsuitable medical history was found|0|||
126397777|NCT00246025|454750324|FG002|Overall Study|unsuitable medical history was found|0|||
126397778|NCT00246025|454750325|FG003|Overall Study|unsuitable medical history was found|1|||
126397779|NCT03444766|454750330|FG000|Overall Study|Other Reasons|2|||
126397780|NCT03444766|454750330|FG000|Overall Study|Participant Withdrew Consent|5|||
126397781|NCT03444766|454750330|FG000|Overall Study|Lost to Follow-up|2|||
126397782|NCT03444766|454750330|FG000|Overall Study|Death|2|||
126397783|NCT03444766|454750330|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
126397784|NCT03444766|454750330|FG000|Overall Study|Disease Progression|49|||
126397785|NCT02374814|454750334|FG000|Overall Study|Lost to Follow-up|1|||
126397786|NCT02374814|454750335|FG001|Overall Study|Lost to Follow-up|1|||
126397787|NCT02374814|454750336|FG002|Overall Study|Lost to Follow-up|0|||
126397788|NCT02374814|454750337|FG003|Overall Study|Lost to Follow-up|1|||
126397789|NCT02374814|454750338|FG004|Overall Study|Lost to Follow-up|0|||
126397790|NCT02374814|454750339|FG005|Overall Study|Lost to Follow-up|0|||
126397791|NCT02374814|454750334|FG000|Overall Study|Withdrawal by Subject|0|||
126397792|NCT02374814|454750335|FG001|Overall Study|Withdrawal by Subject|0|||
126397793|NCT02374814|454750336|FG002|Overall Study|Withdrawal by Subject|1|||
126397794|NCT02374814|454750337|FG003|Overall Study|Withdrawal by Subject|1|||
126397795|NCT02374814|454750338|FG004|Overall Study|Withdrawal by Subject|0|||
126397796|NCT02374814|454750339|FG005|Overall Study|Withdrawal by Subject|0|||
126397797|NCT04209114|454750342|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
126397798|NCT04209114|454750343|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
126397799|NCT04209114|454750344|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
126397800|NCT04209114|454750342|FG000|Pre-Treatment Phase|Other reasons|0|||
126397801|NCT04209114|454750343|FG001|Pre-Treatment Phase|Other reasons|0|||
126397802|NCT04209114|454750344|FG002|Pre-Treatment Phase|Other reasons|1|||
126397803|NCT04209114|454750342|FG000|Pre-Treatment Phase|Death|0|||
126397804|NCT04209114|454750343|FG001|Pre-Treatment Phase|Death|0|||
126397805|NCT04209114|454750344|FG002|Pre-Treatment Phase|Death|1|||
126397806|NCT04209114|454750342|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
126397807|NCT04209114|454750343|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
126397808|NCT04209114|454750344|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
126397809|NCT04209114|454750342|FG000|Treatment Phase|Other reasons|5|||
126397810|NCT04209114|454750343|FG001|Treatment Phase|Other reasons|3|||
126397811|NCT04209114|454750344|FG002|Treatment Phase|Other reasons|0|||
126397812|NCT04209114|454750342|FG000|Treatment Phase|Lost to Follow-up|1|||
126397813|NCT04209114|454750343|FG001|Treatment Phase|Lost to Follow-up|0|||
126397814|NCT04209114|454750344|FG002|Treatment Phase|Lost to Follow-up|0|||
126397815|NCT04209114|454750342|FG000|Treatment Phase|Participant withdrew consent|1|||
126397816|NCT04209114|454750343|FG001|Treatment Phase|Participant withdrew consent|0|||
126397817|NCT04209114|454750344|FG002|Treatment Phase|Participant withdrew consent|0|||
126397818|NCT04209114|454750342|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
126397819|NCT04209114|454750343|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
126397820|NCT04209114|454750344|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
126397821|NCT04209114|454750342|FG000|Treatment Phase|Death|4|||
126397822|NCT04209114|454750343|FG001|Treatment Phase|Death|1|||
126397823|NCT04209114|454750344|FG002|Treatment Phase|Death|0|||
126397824|NCT04209114|454750342|FG000|Treatment Phase|Study drug toxicity|4|||
126721060|NCT02935634|455928525|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
126721061|NCT02935634|455928526|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
126721062|NCT02935634|455928521|FG000|Treatment: Track 2|Study drug toxicity|7|||
126721063|NCT02935634|455928522|FG001|Treatment: Track 2|Study drug toxicity|3|||
126721064|NCT02935634|455928523|FG002|Treatment: Track 2|Study drug toxicity|0|||
126555788|NCT00519636|455325937|FG003|Washout Period|Withdrawal by Subject|0|||
126555789|NCT00519636|455325934|FG000|Washout Period|Failed to meet continuation criteria|14|||
126721065|NCT02935634|455928524|FG003|Treatment: Track 2|Study drug toxicity|0|||
126721066|NCT02935634|455928525|FG004|Treatment: Track 2|Study drug toxicity|0|||
126721067|NCT02935634|455928526|FG005|Treatment: Track 2|Study drug toxicity|0|||
126721068|NCT02935634|455928521|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
126721069|NCT02935634|455928522|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
126721070|NCT02935634|455928523|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
126721071|NCT02935634|455928524|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
126721072|NCT02935634|455928525|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
126721073|NCT02935634|455928526|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
126721074|NCT02935634|455928521|FG000|Treatment: Track 2|Participant withdrew consent|0|||
126721075|NCT02935634|455928522|FG001|Treatment: Track 2|Participant withdrew consent|1|||
126721076|NCT02935634|455928523|FG002|Treatment: Track 2|Participant withdrew consent|1|||
126721077|NCT02935634|455928524|FG003|Treatment: Track 2|Participant withdrew consent|0|||
126721078|NCT02935634|455928525|FG004|Treatment: Track 2|Participant withdrew consent|1|||
126721079|NCT02935634|455928526|FG005|Treatment: Track 2|Participant withdrew consent|0|||
126721080|NCT05906732|455928527|FG000|Overall Study|Withdrawal by Subject|1|||
126721081|NCT05906732|455928528|FG001|Overall Study|Withdrawal by Subject|0|||
126721082|NCT05906732|455928529|FG002|Overall Study|Withdrawal by Subject|0|||
126721083|NCT05906732|455928530|FG003|Overall Study|Withdrawal by Subject|0|||
126721084|NCT05906732|455928527|FG000|Overall Study|Physician Decision|2|||
126721085|NCT05906732|455928528|FG001|Overall Study|Physician Decision|4|||
126721086|NCT05906732|455928529|FG002|Overall Study|Physician Decision|0|||
126721087|NCT05906732|455928530|FG003|Overall Study|Physician Decision|0|||
126721088|NCT03656926|455928540|FG000|Overall Study|Adverse Event|5|||
126721089|NCT03656926|455928541|FG001|Overall Study|Adverse Event|4|||
126721090|NCT03656926|455928540|FG000|Overall Study|Withdrawal by Subject|7|||
126721091|NCT03656926|455928541|FG001|Overall Study|Withdrawal by Subject|2|||
126721092|NCT03656926|455928540|FG000|Overall Study|Screen fail after randomization|1|||
126721093|NCT03656926|455928541|FG001|Overall Study|Screen fail after randomization|0|||
126721094|NCT03656926|455928540|FG000|Overall Study|PI decision due to patient condition|1|||
126721095|NCT03656926|455928541|FG001|Overall Study|PI decision due to patient condition|0|||
126721096|NCT03656926|455928540|FG000|Overall Study|Patient unresponsiveness|1|||
126721097|NCT03656926|455928541|FG001|Overall Study|Patient unresponsiveness|0|||
126721098|NCT05610176|455928542|FG000|Overall Study|Death|6|||
126721099|NCT00515008|455928545|FG000|Overall Study|Lost to Follow-up|1|||
126721100|NCT00515008|455928546|FG001|Overall Study|Lost to Follow-up|0|||
126721101|NCT00515008|455928545|FG000|Overall Study|Declined|0|||
126721102|NCT00515008|455928546|FG001|Overall Study|Declined|3|||
126721103|NCT00515008|455928545|FG000|Overall Study|Left the Boston Area|1|||
126721104|NCT00515008|455928546|FG001|Overall Study|Left the Boston Area|1|||
126721105|NCT00515008|455928545|FG000|Overall Study|Scheduling conflict|1|||
126721106|NCT00515008|455928546|FG001|Overall Study|Scheduling conflict|0|||
126721107|NCT01915849|455928549|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
126721108|NCT01915849|455928550|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
126721109|NCT01915849|455928551|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
126721110|NCT01915849|455928552|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
126721111|NCT01915849|455928549|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
126721112|NCT01915849|455928550|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126721113|NCT01915849|455928551|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126721114|NCT01915849|455928552|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126721115|NCT05091060|455928553|FG000|Overall Study|Lost to Follow-up|1|||
126721116|NCT01798706|455928554|FG000|Overall Study|Adverse Event|15|||
126721117|NCT01798706|455928555|FG001|Overall Study|Adverse Event|10|||
126721118|NCT01798706|455928554|FG000|Overall Study|Lack of Efficacy|0|||
126721119|NCT01798706|455928555|FG001|Overall Study|Lack of Efficacy|2|||
126721120|NCT01798706|455928554|FG000|Overall Study|Poor compliance to protocol|1|||
126555790|NCT00519636|455325935|FG001|Washout Period|Failed to meet continuation criteria|11|||
126555791|NCT00519636|455325936|FG002|Washout Period|Failed to meet continuation criteria|9|||
126555792|NCT00519636|455325937|FG003|Washout Period|Failed to meet continuation criteria|3|||
126555793|NCT00519636|455325934|FG000|Washout Period|Out of pollen area > 48 hours|1|||
126555794|NCT00519636|455325935|FG001|Washout Period|Out of pollen area > 48 hours|0|||
126555795|NCT00519636|455325936|FG002|Washout Period|Out of pollen area > 48 hours|0|||
126555796|NCT00519636|455325937|FG003|Washout Period|Out of pollen area > 48 hours|0|||
126555797|NCT00519636|455325934|FG000|Washout Period|Participating in study at another site|1|||
126555798|NCT00519636|455325935|FG001|Washout Period|Participating in study at another site|0|||
126471136|NCT00976677|455025504|FG001|Overall Study|Trial unblinded|2|||
126471137|NCT00976677|455025503|FG000|Overall Study|Unknown/Missing|1|||
126471138|NCT00976677|455025504|FG001|Overall Study|Unknown/Missing|0|||
126471139|NCT03507400|455025505|FG000|Overall Study|discontinued|5|||
126471140|NCT03507400|455025506|FG001|Overall Study|discontinued|1|||
126471141|NCT03507400|455025505|FG000|Overall Study|Lost to Follow-up|8|||
126471142|NCT03507400|455025506|FG001|Overall Study|Lost to Follow-up|6|||
126471143|NCT03507400|455025505|FG000|Overall Study|Protocol Violation|0|||
126471144|NCT03507400|455025506|FG001|Overall Study|Protocol Violation|1|||
126471145|NCT00108433|455027381|FG000|Overall Study|Lack of Efficacy|1|||
126471146|NCT00108433|455027382|FG001|Overall Study|Lack of Efficacy|2|||
126471147|NCT00108433|455027381|FG000|Overall Study|Death|3|||
126471148|NCT00108433|455027382|FG001|Overall Study|Death|0|||
126471149|NCT00108433|455027381|FG000|Overall Study|Adverse Event|3|||
126471150|NCT00108433|455027382|FG001|Overall Study|Adverse Event|1|||
126471151|NCT00108433|455027381|FG000|Overall Study|Other|14|||
126471152|NCT00108433|455027382|FG001|Overall Study|Other|14|||
126471153|NCT04195906|455027384|FG000|Part 1|Adverse Event|3|||
126471154|NCT04195906|455027385|FG001|Part 1|Adverse Event|7|||
126555799|NCT00519636|455325936|FG002|Washout Period|Participating in study at another site|0|||
126555800|NCT00519636|455325937|FG003|Washout Period|Participating in study at another site|0|||
126555801|NCT00519636|455325934|FG000|Washout Period|Non-compliant|0|||
126555802|NCT00519636|455325935|FG001|Washout Period|Non-compliant|1|||
126555803|NCT00519636|455325936|FG002|Washout Period|Non-compliant|0|||
126555804|NCT00519636|455325937|FG003|Washout Period|Non-compliant|0|||
126555805|NCT00519636|455325934|FG000|Washout Period|Per doctors request|0|||
126555806|NCT00519636|455325935|FG001|Washout Period|Per doctors request|1|||
126555807|NCT00519636|455325936|FG002|Washout Period|Per doctors request|0|||
126555808|NCT00519636|455325937|FG003|Washout Period|Per doctors request|0|||
126555809|NCT00519636|455325934|FG000|Washout Period|Subject randomized in error|0|||
126555810|NCT00519636|455325935|FG001|Washout Period|Subject randomized in error|0|||
126555811|NCT00519636|455325936|FG002|Washout Period|Subject randomized in error|1|||
126555812|NCT00519636|455325937|FG003|Washout Period|Subject randomized in error|0|||
126555813|NCT00519636|455325934|FG000|Washout Period|Prohibited medications|0|||
126555814|NCT00519636|455325935|FG001|Washout Period|Prohibited medications|0|||
126555815|NCT00519636|455325936|FG002|Washout Period|Prohibited medications|1|||
126721121|NCT01798706|455928555|FG001|Overall Study|Poor compliance to protocol|0|||
126721122|NCT01798706|455928554|FG000|Overall Study|Other than specified above|5|||
126555816|NCT00519636|455325937|FG003|Washout Period|Prohibited medications|0|||
126555817|NCT00519636|455325934|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
126555818|NCT00519636|455325935|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
126555819|NCT00519636|455325936|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
126555820|NCT00519636|455325937|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
126555821|NCT00519636|455325934|FG000|Treatment Period 2|Subject randomized in error|0|||
126555822|NCT00519636|455325935|FG001|Treatment Period 2|Subject randomized in error|1|||
126555823|NCT00519636|455325936|FG002|Treatment Period 2|Subject randomized in error|0|||
126555824|NCT00519636|455325937|FG003|Treatment Period 2|Subject randomized in error|0|||
126555825|NCT00519636|455325934|FG000|Treatment Period 2|Per doctors request|0|||
126555826|NCT00519636|455325935|FG001|Treatment Period 2|Per doctors request|0|||
126555827|NCT00519636|455325936|FG002|Treatment Period 2|Per doctors request|1|||
126555828|NCT00519636|455325937|FG003|Treatment Period 2|Per doctors request|0|||
126397825|NCT04209114|454750343|FG001|Treatment Phase|Study drug toxicity|6|||
126397826|NCT04209114|454750344|FG002|Treatment Phase|Study drug toxicity|0|||
126397827|NCT04209114|454750342|FG000|Treatment Phase|Disease progression|6|||
126397828|NCT04209114|454750343|FG001|Treatment Phase|Disease progression|9|||
126397829|NCT04209114|454750344|FG002|Treatment Phase|Disease progression|0|||
126397830|NCT00624819|454750347|FG000|Follow-up Period: Year 4|Parents decision|0|||
126397831|NCT00624819|454750348|FG001|Follow-up Period: Year 4|Parents decision|0|||
126397832|NCT00624819|454750349|FG002|Follow-up Period: Year 4|Parents decision|1|||
126397833|NCT00624819|454750350|FG003|Follow-up Period: Year 4|Parents decision|0|||
126397834|NCT00624819|454750347|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
126397835|NCT00624819|454750348|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
126397836|NCT00624819|454750349|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
126471155|NCT04195906|455027384|FG000|Part 1|Withdrawal by Subject|0|||
126397837|NCT00624819|454750350|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
126471156|NCT04195906|455027385|FG001|Part 1|Withdrawal by Subject|1|||
126471157|NCT04195906|455027384|FG000|Part 2|Adverse Event|1|||
126471158|NCT04195906|455027385|FG001|Part 2|Adverse Event|1|||
126555829|NCT00519636|455325934|FG000|Treatment Period 2|Subject misrandomized|0|||
126555830|NCT00519636|455325935|FG001|Treatment Period 2|Subject misrandomized|0|||
126555831|NCT00519636|455325936|FG002|Treatment Period 2|Subject misrandomized|0|||
126471159|NCT04195906|455027384|FG000|Part 2|Withdrawal by Subject|0|||
126471160|NCT04195906|455027385|FG001|Part 2|Withdrawal by Subject|3|||
126555832|NCT00519636|455325937|FG003|Treatment Period 2|Subject misrandomized|1|||
126471161|NCT04195906|455027384|FG000|Part 2|Other|1|||
126471162|NCT04195906|455027385|FG001|Part 2|Other|3|||
126721123|NCT01798706|455928555|FG001|Overall Study|Other than specified above|9|||
126555833|NCT00519636|455325934|FG000|Post Study Period|Subject randomized in error|0|||
126555834|NCT00519636|455325935|FG001|Post Study Period|Subject randomized in error|0|||
126555835|NCT00519636|455325936|FG002|Post Study Period|Subject randomized in error|0|||
126555836|NCT00519636|455325937|FG003|Post Study Period|Subject randomized in error|1|||
126555837|NCT02846558|455325944|FG000|Overall Study|Adverse Event|1|||
126555838|NCT02846558|455325945|FG001|Overall Study|Adverse Event|0|||
126555839|NCT02846558|455325946|FG002|Overall Study|Adverse Event|0|||
126555840|NCT02846558|455325947|FG003|Overall Study|Adverse Event|0|||
126555841|NCT02846558|455325944|FG000|Overall Study|Withdrawal by Subject|5|||
126555842|NCT02846558|455325945|FG001|Overall Study|Withdrawal by Subject|4|||
126555843|NCT02846558|455325946|FG002|Overall Study|Withdrawal by Subject|2|||
126555844|NCT02846558|455325947|FG003|Overall Study|Withdrawal by Subject|2|||
126555845|NCT02846558|455325944|FG000|Overall Study|Lost to Follow-up|2|||
126555846|NCT02846558|455325945|FG001|Overall Study|Lost to Follow-up|0|||
126555847|NCT02846558|455325946|FG002|Overall Study|Lost to Follow-up|0|||
126555848|NCT02846558|455325947|FG003|Overall Study|Lost to Follow-up|0|||
126555849|NCT00810641|455325951|FG000|Overall Study|Withdrawal by Subject|0|||
126555850|NCT00810641|455325952|FG001|Overall Study|Withdrawal by Subject|1|||
126555851|NCT00810641|455325953|FG002|Overall Study|Withdrawal by Subject|2|||
126555852|NCT02684903|455325962|FG000|Overall Study|COVID-19 shutdown of lab|4|||
126555853|NCT02684903|455325963|FG001|Overall Study|COVID-19 shutdown of lab|6|||
126555854|NCT02684903|455325962|FG000|Overall Study|Lost to Follow-up|31|||
126555855|NCT02684903|455325963|FG001|Overall Study|Lost to Follow-up|41|||
126555856|NCT00904150|455325964|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
126555857|NCT00904150|455325965|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
126555858|NCT00904150|455325964|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
126555859|NCT00904150|455325965|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
126555860|NCT01475786|455325966|FG000|Overall Study|Adverse Event|0|||
126555861|NCT01475786|455325967|FG001|Overall Study|Adverse Event|1|||
126555862|NCT01475786|455325968|FG002|Overall Study|Adverse Event|0|||
126555863|NCT01475786|455325966|FG000|Overall Study|Lost to Follow-up|1|||
126555864|NCT01475786|455325967|FG001|Overall Study|Lost to Follow-up|2|||
126555865|NCT01475786|455325968|FG002|Overall Study|Lost to Follow-up|1|||
126555866|NCT01475786|455325966|FG000|Overall Study|Withdrawal by Subject|0|||
126555867|NCT01475786|455325967|FG001|Overall Study|Withdrawal by Subject|1|||
126555868|NCT01475786|455325968|FG002|Overall Study|Withdrawal by Subject|1|||
126555869|NCT01475786|455325966|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
126555870|NCT01475786|455325967|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
126555871|NCT01475786|455325968|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
126555872|NCT04129580|455327569|FG000|Overall Study|Lost to Follow-up|14|||
126555873|NCT04129580|455327570|FG001|Overall Study|Lost to Follow-up|25|||
126555874|NCT00224133|455327573|FG000|Overall Study|Adverse Event|93|||
126555875|NCT00224133|455327573|FG000|Overall Study|Protocol Violation|6|||
126555876|NCT00224133|455327573|FG000|Overall Study|Withdrawal by Subject|33|||
126555877|NCT00224133|455327573|FG000|Overall Study|Lack of Efficacy|58|||
126555878|NCT00224133|455327573|FG000|Overall Study|Lost to Follow-up|21|||
126555879|NCT00224133|455327573|FG000|Overall Study|Physician Decision|1|||
126555880|NCT00224133|455327573|FG000|Overall Study|Other|14|||
126555881|NCT02718417|455327575|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
126555882|NCT02718417|455327576|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
126555883|NCT02718417|455327577|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
126555884|NCT02718417|455327575|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
126555885|NCT02718417|455327576|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
126555886|NCT02718417|455327577|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
126555887|NCT02718417|455327575|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
126555888|NCT02718417|455327576|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
126555889|NCT02718417|455327577|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
126555890|NCT02718417|455327575|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
126555891|NCT02718417|455327576|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
126555892|NCT02718417|455327577|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
126555893|NCT02718417|455327575|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
126555894|NCT02718417|455327576|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
126555895|NCT02718417|455327577|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
126555896|NCT02718417|455327575|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
126555897|NCT02718417|455327576|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
126555898|NCT02718417|455327577|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
126555899|NCT02718417|455327575|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
126555900|NCT02718417|455327576|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
126555901|NCT02718417|455327577|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
126555902|NCT02718417|455327575|FG000|Chemotherapy Phase (CP)|Other|2|||
126555903|NCT02718417|455327576|FG001|Chemotherapy Phase (CP)|Other|0|||
126555904|NCT02718417|455327577|FG002|Chemotherapy Phase (CP)|Other|1|||
126555905|NCT02718417|455327575|FG000|Maintenance Phase (MP)|Adverse Event|21|||
126555906|NCT02718417|455327576|FG001|Maintenance Phase (MP)|Adverse Event|26|||
126555907|NCT02718417|455327577|FG002|Maintenance Phase (MP)|Adverse Event|0|||
126555908|NCT02718417|455327575|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
126555909|NCT02718417|455327576|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
126555910|NCT02718417|455327577|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
126555911|NCT02718417|455327575|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
126555912|NCT02718417|455327576|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
126555913|NCT02718417|455327577|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
126555914|NCT02718417|455327575|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
126555915|NCT02718417|455327576|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
126555916|NCT02718417|455327577|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
126555917|NCT02718417|455327575|FG000|Maintenance Phase (MP)|Physician's decision|6|||
126555918|NCT02718417|455327576|FG001|Maintenance Phase (MP)|Physician's decision|7|||
126555919|NCT02718417|455327577|FG002|Maintenance Phase (MP)|Physician's decision|0|||
126555920|NCT02718417|455327575|FG000|Maintenance Phase (MP)|Progressive disease|100|||
126555921|NCT02718417|455327576|FG001|Maintenance Phase (MP)|Progressive disease|88|||
126555922|NCT02718417|455327577|FG002|Maintenance Phase (MP)|Progressive disease|0|||
126555923|NCT02718417|455327575|FG000|Maintenance Phase (MP)|Other|2|||
126555924|NCT02718417|455327576|FG001|Maintenance Phase (MP)|Other|1|||
126555925|NCT02718417|455327577|FG002|Maintenance Phase (MP)|Other|0|||
126555926|NCT02718417|455327575|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
126555927|NCT02718417|455327576|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
126555928|NCT02718417|455327577|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
126555929|NCT02718417|455327575|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
126555930|NCT02718417|455327576|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
126555931|NCT02718417|455327577|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
126555932|NCT02718417|455327575|FG000|Observation Phase (OP)|Adverse Event|0|||
126555933|NCT02718417|455327576|FG001|Observation Phase (OP)|Adverse Event|0|||
126555934|NCT02718417|455327577|FG002|Observation Phase (OP)|Adverse Event|1|||
126555935|NCT02718417|455327575|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
126555936|NCT02718417|455327576|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
126555937|NCT02718417|455327577|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
126555938|NCT02718417|455327575|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
126555939|NCT02718417|455327576|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
126555940|NCT02718417|455327577|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
126555941|NCT02718417|455327575|FG000|Observation Phase (OP)|Physician Decision|0|||
126555942|NCT02718417|455327576|FG001|Observation Phase (OP)|Physician Decision|0|||
126555943|NCT02718417|455327577|FG002|Observation Phase (OP)|Physician Decision|9|||
126555944|NCT02718417|455327575|FG000|Observation Phase (OP)|Progressive disease|0|||
126555945|NCT02718417|455327576|FG001|Observation Phase (OP)|Progressive disease|0|||
126555946|NCT02718417|455327577|FG002|Observation Phase (OP)|Progressive disease|92|||
126555947|NCT02718417|455327575|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
126555948|NCT02718417|455327576|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
126555949|NCT02718417|455327577|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
126555950|NCT02718417|455327575|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
126555951|NCT02718417|455327576|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
126555952|NCT02718417|455327577|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
126555953|NCT02718417|455327575|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
126555954|NCT02718417|455327576|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
126555955|NCT02718417|455327577|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
126555956|NCT02718417|455327575|FG000|Observation Phase (OP)|Other|0|||
126555957|NCT02718417|455327576|FG001|Observation Phase (OP)|Other|0|||
126555958|NCT02718417|455327577|FG002|Observation Phase (OP)|Other|7|||
126555959|NCT02718417|455327575|FG000|Follow-up Phase|Adverse Event|3|||
126555960|NCT02718417|455327576|FG001|Follow-up Phase|Adverse Event|1|||
126555961|NCT02718417|455327577|FG002|Follow-up Phase|Adverse Event|1|||
126555962|NCT02718417|455327575|FG000|Follow-up Phase|Other|4|||
126555963|NCT02718417|455327576|FG001|Follow-up Phase|Other|6|||
126555964|NCT02718417|455327577|FG002|Follow-up Phase|Other|4|||
126555965|NCT02718417|455327575|FG000|Follow-up Phase|Withdrawal by Subject|19|||
126555966|NCT02718417|455327576|FG001|Follow-up Phase|Withdrawal by Subject|17|||
126555967|NCT02718417|455327577|FG002|Follow-up Phase|Withdrawal by Subject|5|||
126555968|NCT02718417|455327575|FG000|Follow-up Phase|Study terminated by sponsor|100|||
126555969|NCT02718417|455327576|FG001|Follow-up Phase|Study terminated by sponsor|138|||
126555970|NCT02718417|455327577|FG002|Follow-up Phase|Study terminated by sponsor|6|||
126555971|NCT02718417|455327575|FG000|Follow-up Phase|Lost to Follow-up|2|||
126555972|NCT02718417|455327576|FG001|Follow-up Phase|Lost to Follow-up|3|||
126555973|NCT02718417|455327577|FG002|Follow-up Phase|Lost to Follow-up|0|||
126555974|NCT02718417|455327575|FG000|Follow-up Phase|Death leading to discontinuation|7|||
126555975|NCT02718417|455327576|FG001|Follow-up Phase|Death leading to discontinuation|7|||
126555976|NCT02718417|455327577|FG002|Follow-up Phase|Death leading to discontinuation|3|||
126555977|NCT02718417|455327575|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
126555978|NCT02718417|455327576|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
126555979|NCT02718417|455327577|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
126555980|NCT02718417|455327575|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
126555981|NCT02718417|455327576|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
126555982|NCT02718417|455327577|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
126555983|NCT02718417|455327575|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
126555984|NCT02718417|455327576|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
126555985|NCT02718417|455327577|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
126555986|NCT02718417|455327575|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
126555987|NCT02718417|455327576|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
126555988|NCT02718417|455327577|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
126555989|NCT02718417|455327575|FG000|Long-term Follow-up Phase|Other|0|||
126555990|NCT02718417|455327576|FG001|Long-term Follow-up Phase|Other|2|||
126555991|NCT02718417|455327577|FG002|Long-term Follow-up Phase|Other|0|||
126555992|NCT00795132|455327583|FG000|Overall Study|Death|1|||
126555993|NCT00795132|455327583|FG000|Overall Study|Relapse|2|||
126555994|NCT02451930|455327584|FG000|Overall Study|Death|0|||
126555995|NCT02451930|455327585|FG001|Overall Study|Death|15|||
126555996|NCT02451930|455327584|FG000|Overall Study|Lost to Follow-up|0|||
126555997|NCT02451930|455327585|FG001|Overall Study|Lost to Follow-up|3|||
126555998|NCT02451930|455327584|FG000|Overall Study|Sponsor Decision|2|||
126555999|NCT02451930|455327585|FG001|Overall Study|Sponsor Decision|10|||
126556000|NCT02451930|455327584|FG000|Overall Study|Withdrawal by Subject|0|||
126556001|NCT02451930|455327585|FG001|Overall Study|Withdrawal by Subject|1|||
126556002|NCT02451930|455327584|FG000|Overall Study|Other|0|||
126556003|NCT02451930|455327585|FG001|Overall Study|Other|1|||
126556004|NCT01440049|455327586|FG000|Overall Study|Adverse Event|5|||
126556005|NCT03415022|455327591|FG000|Overall Study|Withdrawal by Subject|1|||
126556006|NCT03415022|455327592|FG001|Overall Study|Withdrawal by Subject|2|||
126556007|NCT03415022|455327591|FG000|Overall Study|COVID-19 Suspension|2|||
126721124|NCT00496873|455928556|FG000|Overall Study|Ineligible|2|||
126721125|NCT00496873|455928556|FG000|Overall Study|Death|2|||
126556008|NCT03415022|455327592|FG001|Overall Study|COVID-19 Suspension|3|||
126556009|NCT03415022|455327591|FG000|Overall Study|Lost to Follow-up|2|||
126556010|NCT03415022|455327592|FG001|Overall Study|Lost to Follow-up|0|||
126556011|NCT04466618|455327593|FG000|Overall Study|Withdrawal by Subject|0|||
126556012|NCT04466618|455327594|FG001|Overall Study|Withdrawal by Subject|1|||
126556013|NCT02056119|455327602|FG000|Overall Study|Death|1|||
126556014|NCT02056119|455327603|FG001|Overall Study|Death|2|||
126556015|NCT02056119|455327602|FG000|Overall Study|Intubated for less than 24 hrs|2|||
126556016|NCT02056119|455327603|FG001|Overall Study|Intubated for less than 24 hrs|7|||
126556017|NCT02056119|455327602|FG000|Overall Study|No aerosol treatments were given.|3|||
126556018|NCT02056119|455327603|FG001|Overall Study|No aerosol treatments were given.|2|||
126556019|NCT02056119|455327602|FG000|Overall Study|Received Metaneb treatment|0|||
126556020|NCT02056119|455327603|FG001|Overall Study|Received Metaneb treatment|2|||
126556021|NCT02056119|455327602|FG000|Overall Study|Protocol Violation|4|||
126556022|NCT02056119|455327603|FG001|Overall Study|Protocol Violation|7|||
126556023|NCT01720797|455327604|FG000|Overall Study|Withdrawal by Subject|3|||
126556024|NCT01720797|455327605|FG001|Overall Study|Withdrawal by Subject|0|||
126556025|NCT04496167|455327613|FG000|Overall Study|Adverse Event|6|||
126556026|NCT04496167|455327614|FG001|Overall Study|Adverse Event|2|||
126556027|NCT04496167|455327613|FG000|Overall Study|Withdrawal by Subject|7|||
126556028|NCT04496167|455327614|FG001|Overall Study|Withdrawal by Subject|6|||
126556029|NCT04496167|455327613|FG000|Overall Study|Lost to Follow-up|3|||
126556030|NCT04496167|455327614|FG001|Overall Study|Lost to Follow-up|5|||
126556031|NCT04496167|455327613|FG000|Overall Study|Not Treated|1|||
126556032|NCT04496167|455327614|FG001|Overall Study|Not Treated|2|||
126556033|NCT04496167|455327613|FG000|Overall Study|Other Than Specified|1|||
126397838|NCT02826421|454750355|FG000|Overall Study|Adverse Event|1|||
126556034|NCT04496167|455327614|FG001|Overall Study|Other Than Specified|1|||
126556035|NCT03541642|455327615|FG000|Overall Study|Withdrawal by Subject|1|||
126556036|NCT03541642|455327616|FG001|Overall Study|Withdrawal by Subject|2|||
126556037|NCT03541642|455327615|FG000|Overall Study|Lost to Follow-up|16|||
126556038|NCT03541642|455327616|FG001|Overall Study|Lost to Follow-up|12|||
126556039|NCT03541642|455327615|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
126556040|NCT03541642|455327616|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
126556041|NCT01083160|455327621|FG000|Overall Study|Adverse Event|1|||
126556042|NCT01951092|455327624|FG000|Overall Study|Lost to Follow-up|10|||
126556043|NCT01951092|455327624|FG000|Overall Study|Incarceration|1|||
126556044|NCT01951092|455327624|FG000|Overall Study|Transfer of Care|1|||
126556045|NCT00918749|455327625|FG000|Overall Study|Adverse Event|1|||
126556046|NCT00918749|455327626|FG001|Overall Study|Adverse Event|0|||
126556047|NCT00918749|455327627|FG002|Overall Study|Adverse Event|1|||
126556048|NCT00918749|455327625|FG000|Overall Study|Lost to Follow-up|0|||
126556049|NCT00918749|455327626|FG001|Overall Study|Lost to Follow-up|0|||
126556050|NCT00918749|455327627|FG002|Overall Study|Lost to Follow-up|1|||
126556051|NCT00918749|455327625|FG000|Overall Study|Withdrawal by Subject|5|||
126556052|NCT00918749|455327626|FG001|Overall Study|Withdrawal by Subject|3|||
126556053|NCT00918749|455327627|FG002|Overall Study|Withdrawal by Subject|5|||
126556054|NCT00918749|455327625|FG000|Overall Study|No Study Medication Taken|1|||
126556055|NCT00918749|455327626|FG001|Overall Study|No Study Medication Taken|0|||
126556056|NCT00918749|455327627|FG002|Overall Study|No Study Medication Taken|0|||
126556057|NCT01712789|455327628|FG000|Overall Study|Lack of Efficacy|2|||
126556058|NCT01712789|455327628|FG000|Overall Study|Lost to Follow-up|1|||
126556059|NCT01712789|455327628|FG000|Overall Study|Progressive Disease|504|||
126556060|NCT01712789|455327628|FG000|Overall Study|Death|57|||
126556061|NCT01712789|455327628|FG000|Overall Study|Adverse Event|52|||
126556062|NCT01712789|455327628|FG000|Overall Study|Miscellaneous|31|||
126556063|NCT01712789|455327628|FG000|Overall Study|Withdrawal by Subject|21|||
126556064|NCT01712789|455327628|FG000|Overall Study|Transition to Commercial Treatment|8|||
126556065|NCT01712789|455327628|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
126556066|NCT00873093|455327629|FG000|Overall Study|Adverse Event|0|||
126556067|NCT00873093|455327630|FG001|Overall Study|Adverse Event|2|||
126556068|NCT00873093|455327631|FG002|Overall Study|Adverse Event|0|||
126556069|NCT00873093|455327632|FG003|Overall Study|Adverse Event|0|||
126556070|NCT00873093|455327633|FG004|Overall Study|Adverse Event|0|||
126556071|NCT00873093|455327629|FG000|Overall Study|Death|0|||
126556072|NCT00873093|455327630|FG001|Overall Study|Death|3|||
126556073|NCT00873093|455327631|FG002|Overall Study|Death|2|||
126556074|NCT00873093|455327632|FG003|Overall Study|Death|0|||
126556075|NCT00873093|455327633|FG004|Overall Study|Death|0|||
126556076|NCT00873093|455327629|FG000|Overall Study|Physician Decision|0|||
126556077|NCT00873093|455327630|FG001|Overall Study|Physician Decision|17|||
126556078|NCT00873093|455327631|FG002|Overall Study|Physician Decision|10|||
126556079|NCT00873093|455327632|FG003|Overall Study|Physician Decision|10|||
126556080|NCT00873093|455327633|FG004|Overall Study|Physician Decision|2|||
126556081|NCT00873093|455327629|FG000|Overall Study|Withdrawal by Subject|1|||
126556082|NCT00873093|455327630|FG001|Overall Study|Withdrawal by Subject|4|||
126556083|NCT00873093|455327631|FG002|Overall Study|Withdrawal by Subject|4|||
126556084|NCT00873093|455327632|FG003|Overall Study|Withdrawal by Subject|0|||
126556085|NCT00873093|455327633|FG004|Overall Study|Withdrawal by Subject|0|||
126556086|NCT00873093|455327629|FG000|Overall Study|Ineligible|0|||
126556087|NCT00873093|455327630|FG001|Overall Study|Ineligible|1|||
126556088|NCT00873093|455327631|FG002|Overall Study|Ineligible|0|||
126556089|NCT00873093|455327632|FG003|Overall Study|Ineligible|1|||
126556090|NCT00873093|455327633|FG004|Overall Study|Ineligible|0|||
126556091|NCT01708187|455327634|FG000|Overall Study|Lost to Follow-up|0|||
126556092|NCT01708187|455327635|FG001|Overall Study|Lost to Follow-up|1|||
126556093|NCT03018106|455327637|FG000|Overall Study|Lost to Follow-up|0|||
126556094|NCT03018106|455327638|FG001|Overall Study|Lost to Follow-up|1|||
126556095|NCT03055832|455327639|FG000|Week 2|Withdrawal by Subject|1|||
126772273|NCT02030834|456122076|FG002|Overall Study|Disease progression|2|||
126397839|NCT02826421|454750356|FG001|Overall Study|Adverse Event|0|||
126397840|NCT02826421|454750357|FG002|Overall Study|Adverse Event|0|||
126397841|NCT02826421|454750358|FG003|Overall Study|Adverse Event|1|||
126397842|NCT02826421|454750355|FG000|Overall Study|Withdrawal by Subject|1|||
126397843|NCT02826421|454750356|FG001|Overall Study|Withdrawal by Subject|3|||
126397844|NCT02826421|454750357|FG002|Overall Study|Withdrawal by Subject|1|||
126397845|NCT02826421|454750358|FG003|Overall Study|Withdrawal by Subject|1|||
126397846|NCT02826421|454750355|FG000|Overall Study|Reason not given|1|||
126397847|NCT02826421|454750356|FG001|Overall Study|Reason not given|0|||
126397848|NCT02826421|454750357|FG002|Overall Study|Reason not given|1|||
126397849|NCT02826421|454750358|FG003|Overall Study|Reason not given|0|||
126397850|NCT02210221|454750361|FG000|Overall Study|Lack of Efficacy|7|||
126397851|NCT02210221|454750361|FG000|Overall Study|Withdrawal by Subject|43|||
126397852|NCT02141490|454750364|FG000|Overall Study|Screening failures|4|||
126397853|NCT02141490|454750365|FG001|Overall Study|Screening failures|0|||
126556096|NCT03055832|455327640|FG001|Week 2|Withdrawal by Subject|0|||
126772274|NCT02030834|456122074|FG000|Overall Study|Lost to Follow-up|1|||
126397854|NCT02141490|454750366|FG002|Overall Study|Screening failures|0|||
126397855|NCT00405964|454750367|FG000|Overall Study|Treatment Failure|17|||
126397856|NCT00405964|454750368|FG001|Overall Study|Treatment Failure|45|||
126556097|NCT00136916|455327641|FG000|Overall Study|Never received study treatment|3|||
126556098|NCT00136916|455327642|FG001|Overall Study|Never received study treatment|5|||
126556099|NCT00136916|455327641|FG000|Overall Study|Death|1|||
126556100|NCT00136916|455327642|FG001|Overall Study|Death|3|||
126556101|NCT00136916|455327641|FG000|Overall Study|Adverse Event|27|||
126556102|NCT00136916|455327642|FG001|Overall Study|Adverse Event|8|||
126556103|NCT00136916|455327641|FG000|Overall Study|Laboratory abnormality|0|||
126556104|NCT00136916|455327642|FG001|Overall Study|Laboratory abnormality|1|||
126556105|NCT00136916|455327641|FG000|Overall Study|Lack of Efficacy|13|||
126556106|NCT00136916|455327642|FG001|Overall Study|Lack of Efficacy|3|||
126556107|NCT00136916|455327641|FG000|Overall Study|Lost to Follow-up|12|||
126556108|NCT00136916|455327642|FG001|Overall Study|Lost to Follow-up|14|||
126556109|NCT00136916|455327641|FG000|Overall Study|Withdrawal by Subject|44|||
126556110|NCT00136916|455327642|FG001|Overall Study|Withdrawal by Subject|46|||
126556111|NCT00136916|455327641|FG000|Overall Study|Other|22|||
126556112|NCT00136916|455327642|FG001|Overall Study|Other|24|||
126556113|NCT00136916|455327641|FG000|Overall Study|Discontinued in follow up period|3|||
126556114|NCT00136916|455327642|FG001|Overall Study|Discontinued in follow up period|0|||
126556115|NCT01152554|455327643|FG000|Overall Study|Withdrawal by Subject|73|||
126556116|NCT01152554|455327644|FG001|Overall Study|Withdrawal by Subject|28|||
126556117|NCT01152554|455327643|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
126556118|NCT01152554|455327644|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
126556119|NCT01152554|455327643|FG000|Overall Study|Adverse Event|67|||
126556120|NCT01152554|455327644|FG001|Overall Study|Adverse Event|14|||
126556121|NCT01152554|455327643|FG000|Overall Study|Severe non-compliance to protocol|36|||
126556122|NCT01152554|455327644|FG001|Overall Study|Severe non-compliance to protocol|14|||
126556123|NCT01152554|455327643|FG000|Overall Study|Condition under investigation worsened|5|||
126556124|NCT01152554|455327644|FG001|Overall Study|Condition under investigation worsened|2|||
126556125|NCT01152554|455327643|FG000|Overall Study|Lack of Efficacy|20|||
126556126|NCT01152554|455327644|FG001|Overall Study|Lack of Efficacy|3|||
126556127|NCT01152554|455327643|FG000|Overall Study|Study-specific withdrawal criteria|17|||
126556128|NCT01152554|455327644|FG001|Overall Study|Study-specific withdrawal criteria|8|||
126556129|NCT01152554|455327643|FG000|Overall Study|Lost to Follow-up|87|||
126556130|NCT01152554|455327644|FG001|Overall Study|Lost to Follow-up|32|||
126556131|NCT01152554|455327643|FG000|Overall Study|Other|28|||
126556132|NCT01152554|455327644|FG001|Overall Study|Other|8|||
126556133|NCT01152554|455327643|FG000|Overall Study|Death|1|||
126556134|NCT01152554|455327644|FG001|Overall Study|Death|1|||
126556135|NCT03619174|455327645|FG000|Overall Study|Lost to Follow-up|3|||
126556136|NCT03619174|455327646|FG001|Overall Study|Lost to Follow-up|0|||
126556137|NCT03619174|455327645|FG000|Overall Study|Withdrawal by Subject|4|||
126556138|NCT03619174|455327646|FG001|Overall Study|Withdrawal by Subject|3|||
126397857|NCT00405964|454750367|FG000|Overall Study|Adverse Event|7|||
126397858|NCT00405964|454750368|FG001|Overall Study|Adverse Event|16|||
126397859|NCT00405964|454750367|FG000|Overall Study|Lost to Follow-up|5|||
126397860|NCT00405964|454750368|FG001|Overall Study|Lost to Follow-up|5|||
126397861|NCT00405964|454750367|FG000|Overall Study|Withdrawal by Subject|19|||
126397862|NCT00405964|454750368|FG001|Overall Study|Withdrawal by Subject|23|||
126397863|NCT00405964|454750367|FG000|Overall Study|Protocol Violation|11|||
126397864|NCT00405964|454750368|FG001|Overall Study|Protocol Violation|6|||
126397865|NCT03271047|454750376|FG000|Phase 1b: Dose Finding Period|Death|8|||
126397866|NCT03271047|454750377|FG001|Phase 1b: Dose Finding Period|Death|8|||
126397867|NCT03271047|454750378|FG002|Phase 1b: Dose Finding Period|Death|0|||
126397868|NCT03271047|454750379|FG003|Phase 1b: Dose Finding Period|Death|0|||
126397869|NCT03271047|454750376|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
126397870|NCT03271047|454750377|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
126397871|NCT03271047|454750378|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
126397872|NCT03271047|454750379|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
126397873|NCT03271047|454750376|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
126397874|NCT03271047|454750377|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
126397875|NCT03271047|454750378|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
126397876|NCT03271047|454750379|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
126397877|NCT03271047|454750376|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
126397878|NCT03271047|454750377|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
126397879|NCT03271047|454750378|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
126397880|NCT03271047|454750379|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
126397881|NCT03271047|454750376|FG000|Randomized Phase 2 Period|Other|0|||
126397882|NCT03271047|454750377|FG001|Randomized Phase 2 Period|Other|0|||
126397883|NCT03271047|454750378|FG002|Randomized Phase 2 Period|Other|0|||
126397884|NCT03271047|454750379|FG003|Randomized Phase 2 Period|Other|1|||
126397885|NCT03271047|454750376|FG000|Randomized Phase 2 Period|Death|0|||
126397886|NCT03271047|454750377|FG001|Randomized Phase 2 Period|Death|0|||
126397887|NCT03271047|454750378|FG002|Randomized Phase 2 Period|Death|20|||
126397888|NCT03271047|454750379|FG003|Randomized Phase 2 Period|Death|21|||
126397889|NCT03271047|454750376|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
126397890|NCT03271047|454750377|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
126397891|NCT03271047|454750378|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
126397892|NCT03271047|454750379|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
126397893|NCT03271047|454750376|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
126397894|NCT03271047|454750377|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
126397895|NCT03271047|454750378|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
126397896|NCT03271047|454750379|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
126397897|NCT03271047|454750376|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
126397898|NCT03271047|454750377|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
126397899|NCT03271047|454750378|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
126556139|NCT03619174|455327645|FG000|Overall Study|Pregnancy|1|||
126556140|NCT03619174|455327646|FG001|Overall Study|Pregnancy|1|||
126556141|NCT03619174|455327645|FG000|Overall Study|Discomfort during treatment|1|||
126556142|NCT03619174|455327646|FG001|Overall Study|Discomfort during treatment|0|||
126556143|NCT02117544|455327647|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
126556144|NCT02117544|455327648|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
126556145|NCT03486899|455327649|FG000|Overall Study|Lost to Follow-up|4|||
126556146|NCT03486899|455327650|FG001|Overall Study|Lost to Follow-up|1|||
126556147|NCT03486899|455327651|FG002|Overall Study|Lost to Follow-up|4|||
126556148|NCT03486899|455327652|FG003|Overall Study|Lost to Follow-up|3|||
126556149|NCT03486899|455327649|FG000|Overall Study|Death|1|||
126556150|NCT03486899|455327650|FG001|Overall Study|Death|0|||
126556151|NCT03486899|455327651|FG002|Overall Study|Death|0|||
126556152|NCT03486899|455327652|FG003|Overall Study|Death|1|||
126721126|NCT00496873|455928556|FG000|Overall Study|Withdrawal by Subject|3|||
126397900|NCT03271047|454750379|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
126397901|NCT00434759|454750380|FG000|Overall Study|Lack of Efficacy|5|||
126397902|NCT00434759|454750381|FG001|Overall Study|Lack of Efficacy|4|||
126397903|NCT00434759|454750380|FG000|Overall Study|Withdrawal by Subject|17|||
126397904|NCT00434759|454750381|FG001|Overall Study|Withdrawal by Subject|1|||
126397905|NCT00434759|454750380|FG000|Overall Study|family affairs|2|||
126397906|NCT00434759|454750381|FG001|Overall Study|family affairs|0|||
126397907|NCT02436408|454750383|FG000|Overall Study|Death|1|||
126397908|NCT01300819|454750384|FG000|Overall Study|Adverse Event|9|||
126397909|NCT01300819|454750385|FG001|Overall Study|Adverse Event|27|||
126397910|NCT01300819|454750384|FG000|Overall Study|Lack of Efficacy|2|||
126397911|NCT01300819|454750385|FG001|Overall Study|Lack of Efficacy|1|||
126397912|NCT01300819|454750384|FG000|Overall Study|Withdrawal by Subject|10|||
126397913|NCT01300819|454750385|FG001|Overall Study|Withdrawal by Subject|12|||
126397914|NCT01300819|454750384|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
126397915|NCT01300819|454750385|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
126397916|NCT01300819|454750384|FG000|Overall Study|Refusal to down titrate study drug|0|||
126397917|NCT01300819|454750385|FG001|Overall Study|Refusal to down titrate study drug|1|||
126397918|NCT01300819|454750384|FG000|Overall Study|Administrative reason|0|||
126397919|NCT01300819|454750385|FG001|Overall Study|Administrative reason|1|||
126397920|NCT01300819|454750384|FG000|Overall Study|Safety follow up not done by mistake|0|||
126397921|NCT01300819|454750385|FG001|Overall Study|Safety follow up not done by mistake|1|||
126397922|NCT01300819|454750384|FG000|Overall Study|Follow up call was not done|1|||
126397923|NCT01300819|454750385|FG001|Overall Study|Follow up call was not done|0|||
126397924|NCT02649855|454750386|FG000|Overall Study|Refused further treatment|2|||
126397925|NCT02649855|454750387|FG001|Overall Study|Refused further treatment|1|||
126397926|NCT02649855|454750388|FG002|Overall Study|Refused further treatment|1|||
126397927|NCT02649855|454750386|FG000|Overall Study|Withdrew consent|0|||
126397928|NCT02649855|454750387|FG001|Overall Study|Withdrew consent|1|||
126397929|NCT02649855|454750388|FG002|Overall Study|Withdrew consent|0|||
126397930|NCT02649855|454750386|FG000|Overall Study|Switched to alternative treatment|0|||
126397931|NCT02649855|454750387|FG001|Overall Study|Switched to alternative treatment|1|||
126397932|NCT02649855|454750388|FG002|Overall Study|Switched to alternative treatment|1|||
126397933|NCT02649855|454750386|FG000|Overall Study|Principal investigator discretion|0|||
126397934|NCT02649855|454750387|FG001|Overall Study|Principal investigator discretion|1|||
126397935|NCT02649855|454750388|FG002|Overall Study|Principal investigator discretion|1|||
126397936|NCT02649855|454750386|FG000|Overall Study|No treatment, per protocol|1|||
126397937|NCT02649855|454750387|FG001|Overall Study|No treatment, per protocol|0|||
126397938|NCT02649855|454750388|FG002|Overall Study|No treatment, per protocol|0|||
126397939|NCT02649855|454750386|FG000|Overall Study|Initiate new treatment|1|||
126397940|NCT02649855|454750387|FG001|Overall Study|Initiate new treatment|0|||
126397941|NCT02649855|454750388|FG002|Overall Study|Initiate new treatment|0|||
126471163|NCT00371826|455027392|FG000|Core Phase (12 Months)|Adverse Event|15|||
126471164|NCT00371826|455027393|FG001|Core Phase (12 Months)|Adverse Event|4|||
126471165|NCT00371826|455027394|FG002|Core Phase (12 Months)|Adverse Event|9|||
126471166|NCT00371826|455027392|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
126471167|NCT00371826|455027393|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
126471168|NCT00371826|455027394|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
126471169|NCT00371826|455027392|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
126471170|NCT00371826|455027393|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
126471171|NCT00371826|455027394|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
126471172|NCT00371826|455027392|FG000|Core Phase (12 Months)|Protocol Violation|1|||
126471173|NCT00371826|455027393|FG001|Core Phase (12 Months)|Protocol Violation|0|||
126471174|NCT00371826|455027394|FG002|Core Phase (12 Months)|Protocol Violation|1|||
126471175|NCT00371826|455027392|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
126471176|NCT00371826|455027393|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
126471177|NCT00371826|455027394|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
126471178|NCT00371826|455027392|FG000|Core Phase (12 Months)|Administrative problems|1|||
126471179|NCT00371826|455027393|FG001|Core Phase (12 Months)|Administrative problems|0|||
126721127|NCT02775864|455928557|FG000|Overall Study|Data ended end of 2010|1764|||
126721128|NCT02775864|455928558|FG001|Overall Study|Data ended end of 2010|2880|||
126721129|NCT02775864|455928559|FG002|Overall Study|Data ended end of 2010|1140|||
126721130|NCT02775864|455928560|FG003|Overall Study|Data ended end of 2010|1194|||
126721131|NCT02775864|455928557|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
126721132|NCT02775864|455928558|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
126721133|NCT02775864|455928559|FG002|Overall Study|Medicaid eligibility discontinued|720|||
126721134|NCT02775864|455928560|FG003|Overall Study|Medicaid eligibility discontinued|890|||
126721135|NCT03238235|455928561|FG000|Overall Study|Adverse Event|2|||
126721136|NCT03238235|455928562|FG001|Overall Study|Adverse Event|0|||
126721137|NCT03238235|455928561|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
126721138|NCT03238235|455928562|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
126721139|NCT05896761|455928565|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
126721140|NCT05896761|455928566|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
126397942|NCT01319721|454750392|FG000|Overall Study|Lost to Follow-up|1|||
126397943|NCT01319721|454750393|FG001|Overall Study|Lost to Follow-up|6|||
126397944|NCT00461305|454750394|FG000|Treatment|Adverse Event|26|||
126397945|NCT00461305|454750395|FG001|Treatment|Adverse Event|3|||
126397946|NCT00461305|454750394|FG000|Treatment|Lost to Follow-up|4|||
126397947|NCT00461305|454750395|FG001|Treatment|Lost to Follow-up|2|||
126397948|NCT00461305|454750394|FG000|Treatment|Protocol Violation|13|||
126397949|NCT00461305|454750395|FG001|Treatment|Protocol Violation|2|||
126397950|NCT00461305|454750394|FG000|Treatment|Withdrawal by Subject|48|||
126397951|NCT00461305|454750395|FG001|Treatment|Withdrawal by Subject|2|||
126397952|NCT00461305|454750394|FG000|Treatment|Never dispensed|5|||
126397953|NCT00461305|454750395|FG001|Treatment|Never dispensed|0|||
126397954|NCT00461305|454750394|FG000|Treatment|Study drug not taken|1|||
126397955|NCT00461305|454750395|FG001|Treatment|Study drug not taken|0|||
126397956|NCT00461305|454750394|FG000|Treatment|Partially missing diary|2|||
126397957|NCT00461305|454750395|FG001|Treatment|Partially missing diary|0|||
126397958|NCT00461305|454750394|FG000|Treatment|Other (missing drug etc)|2|||
126397959|NCT00461305|454750395|FG001|Treatment|Other (missing drug etc)|0|||
126397960|NCT00461305|454750394|FG000|Continued Treatment|Adverse Event|26|||
126397961|NCT00461305|454750395|FG001|Continued Treatment|Adverse Event|0|||
126397962|NCT00461305|454750394|FG000|Continued Treatment|Lost to Follow-up|4|||
126397963|NCT00461305|454750395|FG001|Continued Treatment|Lost to Follow-up|0|||
126397964|NCT00461305|454750394|FG000|Continued Treatment|Protocol Violation|13|||
126397965|NCT00461305|454750395|FG001|Continued Treatment|Protocol Violation|0|||
126397966|NCT00461305|454750394|FG000|Continued Treatment|Withdrawal by Subject|48|||
126397967|NCT00461305|454750395|FG001|Continued Treatment|Withdrawal by Subject|0|||
126397968|NCT00461305|454750394|FG000|Continued Treatment|Partially missing diary|2|||
126397969|NCT00461305|454750395|FG001|Continued Treatment|Partially missing diary|0|||
126397970|NCT00461305|454750394|FG000|Continued Treatment|Other (missing drug etc)|2|||
126471180|NCT00371826|455027394|FG002|Core Phase (12 Months)|Administrative problems|8|||
126397971|NCT00461305|454750395|FG001|Continued Treatment|Other (missing drug etc)|0|||
126397972|NCT00496197|454752998|FG000|Overall Study|Discontinued study due to death|43|||
126397973|NCT00496197|454752998|FG000|Overall Study|Adverse Event|13|||
126397974|NCT00496197|454752998|FG000|Overall Study|Does not meet entrance criteria|5|||
126397975|NCT00496197|454752998|FG000|Overall Study|Insufficient clinical response|3|||
126397976|NCT00496197|454752998|FG000|Overall Study|Insufficient bacteriological response|10|||
126397977|NCT00496197|454752998|FG000|Overall Study|Lost to Follow-up|11|||
126397978|NCT00496197|454752998|FG000|Overall Study|Withdrawal by Subject|11|||
126471181|NCT00371826|455027392|FG000|Core Phase (12 Months)|Graft Loss|0|||
126471182|NCT00371826|455027393|FG001|Core Phase (12 Months)|Graft Loss|1|||
126471183|NCT00371826|455027394|FG002|Core Phase (12 Months)|Graft Loss|0|||
126471184|NCT00371826|455027392|FG000|Extension Phase (24 Months)|Adverse Event|4|||
126471185|NCT00371826|455027393|FG001|Extension Phase (24 Months)|Adverse Event|5|||
126471186|NCT00371826|455027394|FG002|Extension Phase (24 Months)|Adverse Event|0|||
126471187|NCT00371826|455027392|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
126471188|NCT00371826|455027393|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
126471189|NCT00371826|455027394|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
126471190|NCT00371826|455027392|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
126471191|NCT00371826|455027393|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
126471192|NCT00371826|455027394|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
126471193|NCT00371826|455027392|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
126471194|NCT00371826|455027393|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
126471195|NCT00371826|455027394|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
126471196|NCT00371826|455027392|FG000|Extension Phase (24 Months)|Administrative problems|0|||
126471197|NCT00371826|455027393|FG001|Extension Phase (24 Months)|Administrative problems|0|||
126471198|NCT00371826|455027394|FG002|Extension Phase (24 Months)|Administrative problems|2|||
126471199|NCT00428792|455027397|FG000|Overall Study|Lack of Efficacy|1|||
126471200|NCT00428792|455027398|FG001|Overall Study|Lack of Efficacy|3|||
126471201|NCT00428792|455027397|FG000|Overall Study|Lost to Follow-up|0|||
126471202|NCT00428792|455027398|FG001|Overall Study|Lost to Follow-up|1|||
126556153|NCT03486899|455327649|FG000|Overall Study|Adverse Event|0|||
126556154|NCT03486899|455327650|FG001|Overall Study|Adverse Event|2|||
126556155|NCT03486899|455327651|FG002|Overall Study|Adverse Event|0|||
126556156|NCT03486899|455327652|FG003|Overall Study|Adverse Event|2|||
126556157|NCT03486899|455327649|FG000|Overall Study|Withdrawal by Subject|3|||
126556158|NCT03486899|455327650|FG001|Overall Study|Withdrawal by Subject|7|||
126556159|NCT03486899|455327651|FG002|Overall Study|Withdrawal by Subject|4|||
126556160|NCT03486899|455327652|FG003|Overall Study|Withdrawal by Subject|3|||
126556161|NCT03486899|455327649|FG000|Overall Study|Other Reasons|0|||
126556162|NCT03486899|455327650|FG001|Overall Study|Other Reasons|1|||
126556163|NCT03486899|455327651|FG002|Overall Study|Other Reasons|0|||
126556164|NCT03486899|455327652|FG003|Overall Study|Other Reasons|1|||
126556165|NCT01010217|455327653|FG000|Overall Study|Lost to Follow-up|4|||
126556166|NCT01010217|455327654|FG001|Overall Study|Lost to Follow-up|5|||
126721141|NCT05896761|455928565|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
126397979|NCT00496197|454752998|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
126397980|NCT00496197|454752998|FG000|Overall Study|Other|14|||
126397981|NCT00496197|454752998|FG000|Overall Study|Protocol Violation|8|||
126397982|NCT01344538|454752999|FG000|Overall Study|Adverse Event|1|||
126397983|NCT01344538|454753000|FG001|Overall Study|Adverse Event|1|||
126397984|NCT01344538|454752999|FG000|Overall Study|Lost to Follow-up|1|||
126397985|NCT01344538|454753000|FG001|Overall Study|Lost to Follow-up|0|||
126397986|NCT01655381|454753001|FG000|Overall Study|Investigator Decision|1|||
126397987|NCT01655381|454753001|FG000|Overall Study|Moved to Another City|1|||
126397988|NCT01655381|454753001|FG000|Overall Study|Insufficient Treatment Response|1|||
126397989|NCT00320255|454753002|FG000|Overall Study|Lack of Efficacy|1|||
126397990|NCT00320255|454753003|FG001|Overall Study|Lack of Efficacy|0|||
126397991|NCT00320255|454753004|FG002|Overall Study|Lack of Efficacy|0|||
126397992|NCT00320255|454753005|FG003|Overall Study|Lack of Efficacy|0|||
126397993|NCT00320255|454753006|FG004|Overall Study|Lack of Efficacy|0|||
126397994|NCT00320255|454753007|FG005|Overall Study|Lack of Efficacy|0|||
126397995|NCT00320255|454753002|FG000|Overall Study|Adverse Event|5|||
126397996|NCT00320255|454753003|FG001|Overall Study|Adverse Event|2|||
126397997|NCT00320255|454753004|FG002|Overall Study|Adverse Event|3|||
126397998|NCT00320255|454753005|FG003|Overall Study|Adverse Event|2|||
126397999|NCT00320255|454753006|FG004|Overall Study|Adverse Event|0|||
126398000|NCT00320255|454753007|FG005|Overall Study|Adverse Event|0|||
126398001|NCT00320255|454753002|FG000|Overall Study|Withdrawal by Subject|1|||
126398002|NCT00320255|454753003|FG001|Overall Study|Withdrawal by Subject|2|||
126398003|NCT00320255|454753004|FG002|Overall Study|Withdrawal by Subject|2|||
126398004|NCT00320255|454753005|FG003|Overall Study|Withdrawal by Subject|4|||
126398005|NCT00320255|454753006|FG004|Overall Study|Withdrawal by Subject|0|||
126398006|NCT00320255|454753007|FG005|Overall Study|Withdrawal by Subject|0|||
126398007|NCT00320255|454753002|FG000|Overall Study|Poor compliance/noncompliance|1|||
126398008|NCT00320255|454753003|FG001|Overall Study|Poor compliance/noncompliance|1|||
126398009|NCT00320255|454753004|FG002|Overall Study|Poor compliance/noncompliance|0|||
126398010|NCT00320255|454753005|FG003|Overall Study|Poor compliance/noncompliance|1|||
126398011|NCT00320255|454753006|FG004|Overall Study|Poor compliance/noncompliance|0|||
126398012|NCT00320255|454753007|FG005|Overall Study|Poor compliance/noncompliance|0|||
126398013|NCT00320255|454753002|FG000|Overall Study|No longer meets study criteria|0|||
126398014|NCT00320255|454753003|FG001|Overall Study|No longer meets study criteria|0|||
126398015|NCT00320255|454753004|FG002|Overall Study|No longer meets study criteria|0|||
126398016|NCT00320255|454753005|FG003|Overall Study|No longer meets study criteria|1|||
126398017|NCT00320255|454753006|FG004|Overall Study|No longer meets study criteria|0|||
126398018|NCT00320255|454753007|FG005|Overall Study|No longer meets study criteria|0|||
126398019|NCT00320255|454753002|FG000|Overall Study|Other|3|||
126398020|NCT00320255|454753003|FG001|Overall Study|Other|2|||
126398021|NCT00320255|454753004|FG002|Overall Study|Other|1|||
126398022|NCT00320255|454753005|FG003|Overall Study|Other|0|||
126398023|NCT00320255|454753006|FG004|Overall Study|Other|0|||
126398024|NCT00320255|454753007|FG005|Overall Study|Other|0|||
126556167|NCT01010217|455327655|FG002|Overall Study|Lost to Follow-up|1|||
126721142|NCT05896761|455928566|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
126398025|NCT03405935|454753009|FG000|Overall Study|Adverse Event|3|||
126398026|NCT03405935|454753009|FG000|Overall Study|Death|2|||
126398027|NCT03405935|454753009|FG000|Overall Study|Withdrawal by Subject|1|||
126398028|NCT03405935|454753009|FG000|Overall Study|Lost to Follow-up|2|||
126398029|NCT04979897|454753010|FG000|Overall Study|Death|1|||
126398030|NCT04979897|454753011|FG001|Overall Study|Death|8|||
126556168|NCT01010217|455327656|FG003|Overall Study|Lost to Follow-up|0|||
126556169|NCT01010217|455327657|FG004|Overall Study|Lost to Follow-up|0|||
126398031|NCT04979897|454753010|FG000|Overall Study|Lost to Follow-up|111|||
126398032|NCT04979897|454753011|FG001|Overall Study|Lost to Follow-up|56|||
126398033|NCT04979897|454753010|FG000|Overall Study|Withdrawal by Subject|7|||
126398034|NCT04979897|454753011|FG001|Overall Study|Withdrawal by Subject|2|||
126398035|NCT02781792|454753018|FG000|Overall Study|Adverse Event|1|||
126398036|NCT02781792|454753019|FG001|Overall Study|Adverse Event|2|||
126556170|NCT01010217|455327653|FG000|Overall Study|Withdrawal by Subject|1|||
126471203|NCT00639678|455027399|FG000|Overall Study|Withdrawal by Subject|3|||
126471204|NCT00639678|455027400|FG001|Overall Study|Withdrawal by Subject|0|||
126471205|NCT00639678|455027401|FG002|Overall Study|Withdrawal by Subject|4|||
126471206|NCT00639678|455027402|FG003|Overall Study|Withdrawal by Subject|0|||
126471207|NCT00639678|455027399|FG000|Overall Study|Lost to Follow-up|1|||
126471208|NCT00639678|455027400|FG001|Overall Study|Lost to Follow-up|0|||
126471209|NCT00639678|455027401|FG002|Overall Study|Lost to Follow-up|6|||
126471210|NCT00639678|455027402|FG003|Overall Study|Lost to Follow-up|0|||
126471211|NCT00639678|455027399|FG000|Overall Study|Adverse Event|0|||
126471212|NCT00639678|455027400|FG001|Overall Study|Adverse Event|1|||
126471213|NCT00639678|455027401|FG002|Overall Study|Adverse Event|0|||
126471214|NCT00639678|455027402|FG003|Overall Study|Adverse Event|0|||
126471215|NCT00639678|455027399|FG000|Overall Study|Lack of Compliance|0|||
126471216|NCT00639678|455027400|FG001|Overall Study|Lack of Compliance|0|||
126471217|NCT00639678|455027401|FG002|Overall Study|Lack of Compliance|1|||
126471218|NCT00639678|455027402|FG003|Overall Study|Lack of Compliance|0|||
126471219|NCT01926015|455027403|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126471220|NCT01926015|455027404|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126471221|NCT01926015|455027403|FG000|Overall Study|Randomized not treated|2|||
126471222|NCT01926015|455027404|FG001|Overall Study|Randomized not treated|0|||
126471223|NCT01364649|455027405|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
126471224|NCT01364649|455027406|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
126471225|NCT01364649|455027405|FG000|Overall Study|Lack of Efficacy|6|||
126471226|NCT01364649|455027406|FG001|Overall Study|Lack of Efficacy|0|||
126471227|NCT01364649|455027405|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
126471228|NCT01364649|455027406|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
126471229|NCT01364649|455027405|FG000|Overall Study|Protocol Deviations|4|||
126471230|NCT01364649|455027406|FG001|Overall Study|Protocol Deviations|8|||
126471231|NCT01364649|455027405|FG000|Overall Study|Withdrawal of Consent|9|||
126471232|NCT01364649|455027406|FG001|Overall Study|Withdrawal of Consent|7|||
126471233|NCT01364649|455027405|FG000|Overall Study|Lost to Follow-up|12|||
126471234|NCT01364649|455027406|FG001|Overall Study|Lost to Follow-up|13|||
126471235|NCT01364649|455027405|FG000|Overall Study|Other|4|||
126471236|NCT01364649|455027406|FG001|Overall Study|Other|1|||
126471237|NCT03270644|455027407|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
126471238|NCT03270644|455027407|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
126471239|NCT00902668|455027410|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
126471240|NCT01914757|455027411|FG000|Overall Study|Severe non-compliance to protocol|3|||
126471241|NCT01914757|455027412|FG001|Overall Study|Severe non-compliance to protocol|1|||
126471242|NCT01914757|455027413|FG002|Overall Study|Severe non-compliance to protocol|2|||
126471243|NCT01914757|455027411|FG000|Overall Study|Lost to Follow-up|5|||
126471244|NCT01914757|455027412|FG001|Overall Study|Lost to Follow-up|8|||
126471245|NCT01914757|455027413|FG002|Overall Study|Lost to Follow-up|6|||
126471246|NCT01914757|455027411|FG000|Overall Study|Withdrawal by Subject|15|||
126471247|NCT01914757|455027412|FG001|Overall Study|Withdrawal by Subject|27|||
126471248|NCT01914757|455027413|FG002|Overall Study|Withdrawal by Subject|19|||
126471249|NCT01914757|455027411|FG000|Overall Study|Death|2|||
126471250|NCT01914757|455027412|FG001|Overall Study|Death|2|||
126471251|NCT01914757|455027413|FG002|Overall Study|Death|1|||
126471252|NCT01914757|455027411|FG000|Overall Study|Adverse Event|4|||
126471253|NCT01914757|455027412|FG001|Overall Study|Adverse Event|3|||
126471254|NCT01914757|455027413|FG002|Overall Study|Adverse Event|4|||
126471255|NCT01914757|455027411|FG000|Overall Study|Study specific withdrawal criteria|0|||
126471256|NCT01914757|455027412|FG001|Overall Study|Study specific withdrawal criteria|1|||
126471257|NCT01914757|455027413|FG002|Overall Study|Study specific withdrawal criteria|0|||
126471258|NCT01914757|455027411|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
126471259|NCT01914757|455027412|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126471260|NCT01914757|455027413|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
126471261|NCT01914757|455027411|FG000|Overall Study|Other reasons|5|||
126556171|NCT01010217|455327654|FG001|Overall Study|Withdrawal by Subject|0|||
126556172|NCT01010217|455327655|FG002|Overall Study|Withdrawal by Subject|0|||
126471262|NCT01914757|455027412|FG001|Overall Study|Other reasons|9|||
126471263|NCT01914757|455027413|FG002|Overall Study|Other reasons|4|||
126471264|NCT02833350|455027420|FG000|Overall Study|Adverse Event|0|||
126471265|NCT02833350|455027421|FG001|Overall Study|Adverse Event|3|||
126471266|NCT02833350|455027422|FG002|Overall Study|Adverse Event|4|||
126471267|NCT02833350|455027423|FG003|Overall Study|Adverse Event|4|||
126471268|NCT02833350|455027424|FG004|Overall Study|Adverse Event|1|||
126471269|NCT02833350|455027425|FG005|Overall Study|Adverse Event|0|||
126471270|NCT02833350|455027426|FG006|Overall Study|Adverse Event|1|||
126471271|NCT02833350|455027420|FG000|Overall Study|Death|0|||
126471272|NCT02833350|455027421|FG001|Overall Study|Death|0|||
126471273|NCT02833350|455027422|FG002|Overall Study|Death|1|||
126471274|NCT02833350|455027423|FG003|Overall Study|Death|0|||
126471275|NCT02833350|455027424|FG004|Overall Study|Death|0|||
126471276|NCT02833350|455027425|FG005|Overall Study|Death|0|||
126471277|NCT02833350|455027426|FG006|Overall Study|Death|0|||
126471278|NCT02833350|455027420|FG000|Overall Study|Lack of Efficacy|0|||
126471279|NCT02833350|455027421|FG001|Overall Study|Lack of Efficacy|2|||
126471280|NCT02833350|455027422|FG002|Overall Study|Lack of Efficacy|1|||
126471281|NCT02833350|455027423|FG003|Overall Study|Lack of Efficacy|4|||
126471282|NCT02833350|455027424|FG004|Overall Study|Lack of Efficacy|0|||
126471283|NCT02833350|455027425|FG005|Overall Study|Lack of Efficacy|1|||
126471284|NCT02833350|455027426|FG006|Overall Study|Lack of Efficacy|1|||
126471285|NCT02833350|455027420|FG000|Overall Study|Lost to Follow-up|0|||
126471286|NCT02833350|455027421|FG001|Overall Study|Lost to Follow-up|1|||
126471287|NCT02833350|455027422|FG002|Overall Study|Lost to Follow-up|0|||
126471288|NCT02833350|455027423|FG003|Overall Study|Lost to Follow-up|0|||
126471289|NCT02833350|455027424|FG004|Overall Study|Lost to Follow-up|0|||
126471290|NCT02833350|455027425|FG005|Overall Study|Lost to Follow-up|0|||
126471291|NCT02833350|455027426|FG006|Overall Study|Lost to Follow-up|1|||
126471292|NCT02833350|455027420|FG000|Overall Study|Withdrawal by Subject|3|||
126471293|NCT02833350|455027421|FG001|Overall Study|Withdrawal by Subject|3|||
126471294|NCT02833350|455027422|FG002|Overall Study|Withdrawal by Subject|2|||
126471295|NCT02833350|455027423|FG003|Overall Study|Withdrawal by Subject|0|||
126471296|NCT02833350|455027424|FG004|Overall Study|Withdrawal by Subject|2|||
126471297|NCT02833350|455027425|FG005|Overall Study|Withdrawal by Subject|0|||
126471298|NCT02833350|455027426|FG006|Overall Study|Withdrawal by Subject|2|||
126471299|NCT00917501|455027428|FG000|Overall Study|Lost to Follow-up|4|||
126471300|NCT00917501|455027429|FG001|Overall Study|Lost to Follow-up|1|||
126471301|NCT00917501|455027428|FG000|Overall Study|Withdrawal by Subject|3|||
126471302|NCT00917501|455027429|FG001|Overall Study|Withdrawal by Subject|1|||
126471303|NCT00917501|455027428|FG000|Overall Study|Lack of Efficacy|1|||
126471304|NCT00917501|455027429|FG001|Overall Study|Lack of Efficacy|2|||
126471305|NCT00917501|455027428|FG000|Overall Study|trouble swollowing capsules|0|||
126471306|NCT00917501|455027429|FG001|Overall Study|trouble swollowing capsules|1|||
126471307|NCT03342963|455027430|FG000|Overall Study|Adverse Event|1|||
126471308|NCT03342963|455027431|FG001|Overall Study|Adverse Event|2|||
126471309|NCT03342963|455027432|FG002|Overall Study|Adverse Event|0|||
126471310|NCT03342963|455027433|FG003|Overall Study|Adverse Event|0|||
126471311|NCT03342963|455027430|FG000|Overall Study|Withdrawal by Subject|1|||
126471312|NCT03342963|455027431|FG001|Overall Study|Withdrawal by Subject|0|||
126471313|NCT03342963|455027432|FG002|Overall Study|Withdrawal by Subject|0|||
126471314|NCT03342963|455027433|FG003|Overall Study|Withdrawal by Subject|0|||
126471315|NCT03643575|455027434|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
126471316|NCT03643575|455027435|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
126471317|NCT03643575|455027436|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
126471318|NCT03643575|455027437|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
126471319|NCT03643575|455027438|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
126471320|NCT03643575|455027439|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
126471321|NCT03643575|455027434|FG000|Washout: 7 Days|Adverse Event|1|||
126471322|NCT03643575|455027435|FG001|Washout: 7 Days|Adverse Event|0|||
126471323|NCT03643575|455027436|FG002|Washout: 7 Days|Adverse Event|0|||
126471324|NCT03643575|455027437|FG003|Washout: 7 Days|Adverse Event|0|||
126471325|NCT03643575|455027438|FG004|Washout: 7 Days|Adverse Event|0|||
126471326|NCT03643575|455027439|FG005|Washout: 7 Days|Adverse Event|0|||
126471327|NCT03643575|455027434|FG000|Washout: 7 Days|Non compliance check in|0|||
126471328|NCT03643575|455027435|FG001|Washout: 7 Days|Non compliance check in|1|||
126471329|NCT03643575|455027436|FG002|Washout: 7 Days|Non compliance check in|0|||
126471330|NCT03643575|455027437|FG003|Washout: 7 Days|Non compliance check in|0|||
126471331|NCT03643575|455027438|FG004|Washout: 7 Days|Non compliance check in|0|||
126471332|NCT03643575|455027439|FG005|Washout: 7 Days|Non compliance check in|0|||
126471333|NCT01189604|455027440|FG000|Overall Study|Impossible to visit|0|||
126471334|NCT01189604|455027441|FG001|Overall Study|Impossible to visit|0|||
126556173|NCT01010217|455327656|FG003|Overall Study|Withdrawal by Subject|0|||
126556174|NCT01010217|455327657|FG004|Overall Study|Withdrawal by Subject|0|||
126556175|NCT01010217|455327653|FG000|Overall Study|Physician Decision|0|||
126471335|NCT01189604|455027442|FG002|Overall Study|Impossible to visit|0|||
126471336|NCT01189604|455027443|FG003|Overall Study|Impossible to visit|0|||
126471337|NCT01189604|455027444|FG004|Overall Study|Impossible to visit|0|||
126471338|NCT01189604|455027445|FG005|Overall Study|Impossible to visit|1|||
126471339|NCT01189604|455027446|FG006|Overall Study|Impossible to visit|0|||
126471340|NCT01189604|455027440|FG000|Overall Study|Adverse Event|0|||
126556176|NCT01010217|455327654|FG001|Overall Study|Physician Decision|0|||
126471341|NCT01189604|455027441|FG001|Overall Study|Adverse Event|1|||
126471342|NCT01189604|455027442|FG002|Overall Study|Adverse Event|0|||
126471343|NCT01189604|455027443|FG003|Overall Study|Adverse Event|0|||
126471344|NCT01189604|455027444|FG004|Overall Study|Adverse Event|2|||
126471345|NCT01189604|455027445|FG005|Overall Study|Adverse Event|0|||
126471346|NCT01189604|455027446|FG006|Overall Study|Adverse Event|1|||
126471347|NCT01189604|455027440|FG000|Overall Study|Withdrawal by Subject|1|||
126471348|NCT01189604|455027441|FG001|Overall Study|Withdrawal by Subject|0|||
126471349|NCT01189604|455027442|FG002|Overall Study|Withdrawal by Subject|0|||
126471350|NCT01189604|455027443|FG003|Overall Study|Withdrawal by Subject|0|||
126471351|NCT01189604|455027444|FG004|Overall Study|Withdrawal by Subject|0|||
126471352|NCT01189604|455027445|FG005|Overall Study|Withdrawal by Subject|0|||
126398037|NCT02781792|454753018|FG000|Overall Study|Withdrawal by Subject|3|||
126398038|NCT02781792|454753019|FG001|Overall Study|Withdrawal by Subject|1|||
126398039|NCT02781792|454753018|FG000|Overall Study|Lack of Efficacy|1|||
126398040|NCT02781792|454753019|FG001|Overall Study|Lack of Efficacy|1|||
126398041|NCT02781792|454753018|FG000|Overall Study|Hospice|0|||
126398042|NCT02781792|454753019|FG001|Overall Study|Hospice|1|||
126398043|NCT01703117|454753020|FG000|Overall Study|Adverse Event|4|||
126398044|NCT01703117|454753021|FG001|Overall Study|Adverse Event|3|||
126398045|NCT01703117|454753020|FG000|Overall Study|Withdrawal by Subject|0|||
126398046|NCT01703117|454753021|FG001|Overall Study|Withdrawal by Subject|1|||
126398047|NCT00683917|454753022|FG000|Overall Study|Study prematurely terminated|10|||
126398048|NCT01170598|454753027|FG000|Overall Study|Withdrawal by Subject|1|||
126398049|NCT01170598|454753027|FG000|Overall Study|Death|3|||
126398050|NCT01170598|454753027|FG000|Overall Study|Lost to Follow-up|1|||
126398051|NCT01170598|454753027|FG000|Overall Study|Refused|1|||
126398052|NCT02119156|454753028|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
126398053|NCT02119156|454753029|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
126398054|NCT02119156|454753030|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
126398055|NCT02119156|454753028|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
126398056|NCT02119156|454753029|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
126398057|NCT02119156|454753030|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
126398058|NCT02119156|454753028|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
126398059|NCT02119156|454753029|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
126398060|NCT02119156|454753030|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
126398061|NCT02119156|454753028|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
126398062|NCT02119156|454753029|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
126398063|NCT02119156|454753030|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
126398064|NCT02119156|454753028|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
126398065|NCT02119156|454753029|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
126398066|NCT02119156|454753030|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
126398067|NCT02685748|454753031|FG000|Overall Study|Withdrawal by Subject|3|||
126398068|NCT02685748|454753032|FG001|Overall Study|Withdrawal by Subject|2|||
126398069|NCT02536300|454753036|FG000|Overall Study|Investigator's Discretion|17|||
126398070|NCT02536300|454753037|FG001|Overall Study|Investigator's Discretion|11|||
126398071|NCT02536300|454753038|FG002|Overall Study|Investigator's Discretion|2|||
126398072|NCT02536300|454753036|FG000|Overall Study|Progressive Disease|11|||
126398073|NCT02536300|454753037|FG001|Overall Study|Progressive Disease|7|||
126398074|NCT02536300|454753038|FG002|Overall Study|Progressive Disease|6|||
126398075|NCT02536300|454753036|FG000|Overall Study|Study Terminated by Sponsor|6|||
126398076|NCT02536300|454753037|FG001|Overall Study|Study Terminated by Sponsor|4|||
126398077|NCT02536300|454753038|FG002|Overall Study|Study Terminated by Sponsor|7|||
126398078|NCT02536300|454753036|FG000|Overall Study|Death|7|||
126398079|NCT02536300|454753037|FG001|Overall Study|Death|0|||
126398080|NCT02536300|454753038|FG002|Overall Study|Death|5|||
126398081|NCT02536300|454753036|FG000|Overall Study|Withdrew Consent|4|||
126398082|NCT02536300|454753037|FG001|Overall Study|Withdrew Consent|2|||
126398083|NCT02536300|454753038|FG002|Overall Study|Withdrew Consent|0|||
126398084|NCT02536300|454753036|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
126471353|NCT01189604|455027446|FG006|Overall Study|Withdrawal by Subject|0|||
126471354|NCT04553679|455027449|FG000|Overall Study|Withdrawal by Subject|2|||
126471355|NCT04553679|455027450|FG001|Overall Study|Withdrawal by Subject|0|||
126471356|NCT04553679|455027449|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
126471357|NCT04553679|455027450|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
126471358|NCT02038881|455027451|FG000|Overall Study|Withdrawal by Subject|0|||
126471359|NCT02038881|455027452|FG001|Overall Study|Withdrawal by Subject|0|||
126471360|NCT02038881|455027453|FG002|Overall Study|Withdrawal by Subject|1|||
126471361|NCT02038881|455027451|FG000|Overall Study|Lost to Follow-up|2|||
126471362|NCT02038881|455027452|FG001|Overall Study|Lost to Follow-up|0|||
126471363|NCT02038881|455027453|FG002|Overall Study|Lost to Follow-up|0|||
126471364|NCT02038881|455027451|FG000|Overall Study|incarcerated|1|||
126471365|NCT02038881|455027452|FG001|Overall Study|incarcerated|0|||
126471366|NCT02038881|455027453|FG002|Overall Study|incarcerated|0|||
126471367|NCT00333840|455027454|FG000|First-line Treatment Period|Adverse Event|38|||
126471368|NCT00333840|455027455|FG001|First-line Treatment Period|Adverse Event|37|||
126471369|NCT00333840|455027456|FG002|First-line Treatment Period|Adverse Event|0|||
126471370|NCT00333840|455027457|FG003|First-line Treatment Period|Adverse Event|0|||
126471371|NCT00333840|455027454|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
126471372|NCT00333840|455027455|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
126471373|NCT00333840|455027456|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
126471374|NCT00333840|455027457|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
126471375|NCT00333840|455027454|FG000|First-line Treatment Period|Abnormal procedure|2|||
126556177|NCT01010217|455327655|FG002|Overall Study|Physician Decision|0|||
126556178|NCT01010217|455327656|FG003|Overall Study|Physician Decision|6|||
126556179|NCT01010217|455327657|FG004|Overall Study|Physician Decision|3|||
126556180|NCT01439711|455327660|FG000|Overall Study|Ineligible|13|||
126556181|NCT01439711|455327660|FG000|Overall Study|Cancel|3|||
126556182|NCT01439711|455327660|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
126556183|NCT01439711|455327660|FG000|Overall Study|Adverse Event|5|||
126556184|NCT01439711|455327660|FG000|Overall Study|Withdrawal by Subject|3|||
126556185|NCT01439711|455327660|FG000|Overall Study|Progression During Active Tx|3|||
126556186|NCT01439711|455327660|FG000|Overall Study|Noncompliance|3|||
126556187|NCT01439711|455327660|FG000|Overall Study|No MRI|9|||
126556188|NCT04242875|455327661|FG000|Overall Study|Adverse Event|2|||
126556189|NCT01012973|455327662|FG000|Overall Study|Adverse Event|5|||
126556190|NCT01012973|455327663|FG001|Overall Study|Adverse Event|5|||
126556191|NCT01012973|455327662|FG000|Overall Study|Lack of Efficacy|0|||
126471376|NCT00333840|455027455|FG001|First-line Treatment Period|Abnormal procedure|0|||
126471377|NCT00333840|455027456|FG002|First-line Treatment Period|Abnormal procedure|0|||
126471378|NCT00333840|455027457|FG003|First-line Treatment Period|Abnormal procedure|0|||
126471379|NCT00333840|455027454|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
126471380|NCT00333840|455027455|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
126471381|NCT00333840|455027456|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
126398085|NCT02536300|454753037|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
126471382|NCT00333840|455027457|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
126471383|NCT00333840|455027454|FG000|First-line Treatment Period|No longer required study drug|21|||
126471384|NCT00333840|455027455|FG001|First-line Treatment Period|No longer required study drug|8|||
126471385|NCT00333840|455027456|FG002|First-line Treatment Period|No longer required study drug|0|||
126471386|NCT00333840|455027457|FG003|First-line Treatment Period|No longer required study drug|0|||
126471387|NCT00333840|455027454|FG000|First-line Treatment Period|Protocol Violation|17|||
126471388|NCT00333840|455027455|FG001|First-line Treatment Period|Protocol Violation|17|||
126471389|NCT00333840|455027456|FG002|First-line Treatment Period|Protocol Violation|0|||
126471390|NCT00333840|455027457|FG003|First-line Treatment Period|Protocol Violation|0|||
126471391|NCT00333840|455027454|FG000|First-line Treatment Period|Subject withdrew consent|57|||
126471392|NCT00333840|455027455|FG001|First-line Treatment Period|Subject withdrew consent|77|||
126471393|NCT00333840|455027456|FG002|First-line Treatment Period|Subject withdrew consent|0|||
126471394|NCT00333840|455027457|FG003|First-line Treatment Period|Subject withdrew consent|0|||
126471395|NCT00333840|455027454|FG000|First-line Treatment Period|Lost to Follow-up|15|||
126471396|NCT00333840|455027455|FG001|First-line Treatment Period|Lost to Follow-up|6|||
126471397|NCT00333840|455027456|FG002|First-line Treatment Period|Lost to Follow-up|0|||
126471398|NCT00333840|455027457|FG003|First-line Treatment Period|Lost to Follow-up|0|||
126471399|NCT00333840|455027454|FG000|First-line Treatment Period|Administrative problems|12|||
126471400|NCT00333840|455027455|FG001|First-line Treatment Period|Administrative problems|6|||
126471401|NCT00333840|455027456|FG002|First-line Treatment Period|Administrative problems|0|||
126471402|NCT00333840|455027457|FG003|First-line Treatment Period|Administrative problems|0|||
126471403|NCT00333840|455027454|FG000|First-line Treatment Period|Death|19|||
126471404|NCT00333840|455027455|FG001|First-line Treatment Period|Death|2|||
126471405|NCT00333840|455027456|FG002|First-line Treatment Period|Death|0|||
126556192|NCT01012973|455327663|FG001|Overall Study|Lack of Efficacy|5|||
126556193|NCT01012973|455327662|FG000|Overall Study|Lost to Follow-up|1|||
126556194|NCT01012973|455327663|FG001|Overall Study|Lost to Follow-up|0|||
126556195|NCT01012973|455327662|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
126398086|NCT02536300|454753038|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
126398087|NCT02536300|454753036|FG000|Overall Study|Enrolled but Never Treated|0|||
126398088|NCT02536300|454753037|FG001|Overall Study|Enrolled but Never Treated|0|||
126398089|NCT02536300|454753038|FG002|Overall Study|Enrolled but Never Treated|1|||
126398090|NCT02536300|454753036|FG000|Overall Study|Non-compliance With Study Drug|1|||
126398091|NCT02536300|454753037|FG001|Overall Study|Non-compliance With Study Drug|0|||
126398092|NCT02536300|454753038|FG002|Overall Study|Non-compliance With Study Drug|0|||
126398093|NCT02536300|454753036|FG000|Overall Study|Protocol Violation|0|||
126398094|NCT02536300|454753037|FG001|Overall Study|Protocol Violation|1|||
126398095|NCT02536300|454753038|FG002|Overall Study|Protocol Violation|0|||
126398096|NCT04706273|454753039|FG000|Overall Study|Withdrawal by Subject|27|||
126398097|NCT04706273|454753039|FG000|Overall Study|Physician Decision|1|||
126471406|NCT00333840|455027457|FG003|First-line Treatment Period|Death|0|||
126471407|NCT00333840|455027454|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
126471408|NCT00333840|455027455|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
126471409|NCT00333840|455027456|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
126471410|NCT00333840|455027457|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
126556196|NCT01012973|455327663|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
126556197|NCT01012973|455327662|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
126556198|NCT01012973|455327663|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
126556199|NCT01012973|455327662|FG000|Overall Study|Protocol Violation|5|||
126556200|NCT01012973|455327663|FG001|Overall Study|Protocol Violation|2|||
126556201|NCT01012973|455327662|FG000|Overall Study|Withdrawal by Subject|4|||
126556202|NCT01012973|455327663|FG001|Overall Study|Withdrawal by Subject|6|||
126556203|NCT01782326|455327666|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
126556204|NCT01782326|455327667|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
126556205|NCT01782326|455327666|FG000|Planned Treatment Epoch|Death|29|||
126556206|NCT01782326|455327667|FG001|Planned Treatment Epoch|Death|30|||
126556207|NCT01782326|455327666|FG000|Planned Treatment Epoch|Physician Decision|18|||
126556208|NCT01782326|455327667|FG001|Planned Treatment Epoch|Physician Decision|16|||
126556209|NCT01782326|455327666|FG000|Planned Treatment Epoch|Protocol deviation|2|||
126556210|NCT01782326|455327667|FG001|Planned Treatment Epoch|Protocol deviation|3|||
126556211|NCT01782326|455327666|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
126556212|NCT01782326|455327667|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
126556213|NCT01782326|455327666|FG000|Planned Treatment Epoch|Technical problems|0|||
126556214|NCT01782326|455327667|FG001|Planned Treatment Epoch|Technical problems|4|||
126556215|NCT01782326|455327666|FG000|Double-blind Treatment|Adverse Event|129|||
126556216|NCT01782326|455327667|FG001|Double-blind Treatment|Adverse Event|145|||
126556217|NCT01782326|455327666|FG000|Double-blind Treatment|Subject/guardian decision|111|||
126556218|NCT01782326|455327667|FG001|Double-blind Treatment|Subject/guardian decision|125|||
126556219|NCT01782326|455327666|FG000|Double-blind Treatment|Lack of Efficacy|17|||
126556220|NCT01782326|455327667|FG001|Double-blind Treatment|Lack of Efficacy|22|||
126556221|NCT01782326|455327666|FG000|Double-blind Treatment|Physician Decision|13|||
126556222|NCT01782326|455327667|FG001|Double-blind Treatment|Physician Decision|16|||
126556223|NCT01782326|455327666|FG000|Double-blind Treatment|Protocol deviation|8|||
126556224|NCT01782326|455327667|FG001|Double-blind Treatment|Protocol deviation|7|||
126556225|NCT01782326|455327666|FG000|Double-blind Treatment|Technical problems|0|||
126556226|NCT01782326|455327667|FG001|Double-blind Treatment|Technical problems|5|||
126556227|NCT04172987|455327671|FG000|Lead In Period|Adverse Event|1|||
126398098|NCT04706273|454753039|FG000|Overall Study|Lost to Follow-up|42|||
126398099|NCT04706273|454753039|FG000|Overall Study|Death|85|||
126398100|NCT04706273|454753039|FG000|Overall Study|Amputation that removes study device|2|||
126398101|NCT04706273|454753039|FG000|Overall Study|Surgical bypass|3|||
126398102|NCT04706273|454753039|FG000|Overall Study|Changing hospital|23|||
126398103|NCT04706273|454753039|FG000|Overall Study|Unable to attend hospital|2|||
126398104|NCT01080768|454753045|FG000|Overall Study|Protocol Deviation|2|||
126398105|NCT01080768|454753046|FG001|Overall Study|Protocol Deviation|1|||
126398106|NCT03054350|454753051|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
126398107|NCT03054350|454753052|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
126398108|NCT03054350|454753053|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
126398109|NCT03054350|454753054|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
126398110|NCT03054350|454753055|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
126398111|NCT03054350|454753056|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
126398112|NCT03054350|454753051|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
126398113|NCT03054350|454753052|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
126398114|NCT03054350|454753053|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
126398115|NCT03054350|454753054|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
126398116|NCT03054350|454753055|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
126556228|NCT04172987|455327671|FG000|Lead In Period|Protocol Violation|1|||
126556229|NCT04172987|455327671|FG000|Period 1|Physician Decision|1|||
126556230|NCT04172987|455327671|FG000|Period 2|Adverse Event|5|||
126556231|NCT04172987|455327671|FG000|Period 2|Dosing Termination by Sponsor|4|||
126556232|NCT00738530|455327675|FG000|Overall Study|Death|220|||
126556233|NCT00738530|455327676|FG001|Overall Study|Death|224|||
126556234|NCT00738530|455327675|FG000|Overall Study|Lost to Follow-up|8|||
126556235|NCT00738530|455327676|FG001|Overall Study|Lost to Follow-up|6|||
126556236|NCT00738530|455327675|FG000|Overall Study|Withdrawal by Subject|6|||
126556237|NCT00738530|455327676|FG001|Overall Study|Withdrawal by Subject|8|||
126556238|NCT01628510|455327677|FG000|Overall Study|Withdrawal by Subject|0|||
126556239|NCT01628510|455327678|FG001|Overall Study|Withdrawal by Subject|4|||
126556240|NCT01628510|455327677|FG000|Overall Study|Death|3|||
126556241|NCT01628510|455327678|FG001|Overall Study|Death|1|||
126556242|NCT04179461|455327679|FG000|Overall Study|Lost to Follow-up|4|||
126556243|NCT01653847|455327680|FG000|Overall Study|Withdrawal by Subject|1|||
126556244|NCT01653847|455327681|FG001|Overall Study|Withdrawal by Subject|0|||
126556245|NCT04707391|455327682|FG000|Overall Study|Adverse Event|5|||
126556246|NCT04707391|455327683|FG001|Overall Study|Adverse Event|8|||
126556247|NCT04707391|455327682|FG000|Overall Study|Lost to Follow-up|44|||
126556248|NCT04707391|455327683|FG001|Overall Study|Lost to Follow-up|31|||
126556249|NCT04707391|455327682|FG000|Overall Study|Protocol Violation|1|||
126556250|NCT04707391|455327683|FG001|Overall Study|Protocol Violation|5|||
126556251|NCT04707391|455327682|FG000|Overall Study|Withdrawal by Subject|27|||
126556252|NCT04707391|455327683|FG001|Overall Study|Withdrawal by Subject|25|||
126556253|NCT04707391|455327682|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
126556254|NCT04707391|455327683|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
126398117|NCT03054350|454753056|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
126398118|NCT03054350|454753051|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
126398119|NCT03054350|454753052|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
126398120|NCT03054350|454753053|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
126398121|NCT03054350|454753054|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
126398122|NCT03054350|454753055|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
126398123|NCT03054350|454753056|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
126398124|NCT03054350|454753051|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
126398125|NCT03054350|454753052|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
126471411|NCT00333840|455027454|FG000|Second-line Treatment Period|Adverse Event|0|||
126471412|NCT00333840|455027455|FG001|Second-line Treatment Period|Adverse Event|0|||
126471413|NCT00333840|455027456|FG002|Second-line Treatment Period|Adverse Event|3|||
126471414|NCT00333840|455027457|FG003|Second-line Treatment Period|Adverse Event|34|||
126471415|NCT00333840|455027454|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
126471416|NCT00333840|455027455|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
126471417|NCT00333840|455027456|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
126471418|NCT00333840|455027457|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
126471419|NCT00333840|455027454|FG000|Second-line Treatment Period|Abnormal procedure|0|||
126471420|NCT00333840|455027455|FG001|Second-line Treatment Period|Abnormal procedure|0|||
126471421|NCT00333840|455027456|FG002|Second-line Treatment Period|Abnormal procedure|0|||
126471422|NCT00333840|455027457|FG003|Second-line Treatment Period|Abnormal procedure|1|||
126471423|NCT00333840|455027454|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
126471424|NCT00333840|455027455|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
126471425|NCT00333840|455027456|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
126471426|NCT00333840|455027457|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
126471427|NCT00333840|455027454|FG000|Second-line Treatment Period|No longer required study drug|0|||
126471428|NCT00333840|455027455|FG001|Second-line Treatment Period|No longer required study drug|0|||
126471429|NCT00333840|455027456|FG002|Second-line Treatment Period|No longer required study drug|1|||
126471430|NCT00333840|455027457|FG003|Second-line Treatment Period|No longer required study drug|14|||
126471431|NCT00333840|455027454|FG000|Second-line Treatment Period|Protocol Violation|0|||
126471432|NCT00333840|455027455|FG001|Second-line Treatment Period|Protocol Violation|0|||
126471433|NCT00333840|455027456|FG002|Second-line Treatment Period|Protocol Violation|1|||
126471434|NCT00333840|455027457|FG003|Second-line Treatment Period|Protocol Violation|10|||
126471435|NCT00333840|455027454|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
126471436|NCT00333840|455027455|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
126471437|NCT00333840|455027456|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
126471438|NCT00333840|455027457|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
126471439|NCT00333840|455027454|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
126471440|NCT00333840|455027455|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
126471441|NCT00333840|455027456|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
126471442|NCT00333840|455027457|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
126471443|NCT00333840|455027454|FG000|Second-line Treatment Period|Administrative problems|0|||
126471444|NCT00333840|455027455|FG001|Second-line Treatment Period|Administrative problems|0|||
126471445|NCT00333840|455027456|FG002|Second-line Treatment Period|Administrative problems|0|||
126471446|NCT00333840|455027457|FG003|Second-line Treatment Period|Administrative problems|7|||
126471447|NCT00333840|455027454|FG000|Second-line Treatment Period|Death|0|||
126471448|NCT00333840|455027455|FG001|Second-line Treatment Period|Death|0|||
126471449|NCT00333840|455027456|FG002|Second-line Treatment Period|Death|0|||
126471450|NCT00333840|455027457|FG003|Second-line Treatment Period|Death|9|||
126471451|NCT03719586|455027458|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
126471452|NCT03719586|455027459|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
126471453|NCT03719586|455027460|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
126471454|NCT03719586|455027461|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
126471455|NCT00178633|455027463|FG000|Overall Study|Lost to Follow-up|6|||
126471456|NCT00369707|455027464|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
126471457|NCT00369707|455027464|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
126471458|NCT00369707|455027464|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
126471459|NCT00369707|455027464|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
126471460|NCT00369707|455027464|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
126471461|NCT00369707|455027464|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
126471462|NCT00369707|455027464|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
126471463|NCT00369707|455027464|FG000|Follow up for 2 Years After Treatment|Death|1|||
126471464|NCT00369707|455027464|FG000|Follow up for 2 Years After Treatment|Other|2|||
126471465|NCT01254292|455027467|FG000|Comparative Phase|Adverse Event|25|||
126471466|NCT01254292|455027468|FG001|Comparative Phase|Adverse Event|25|||
126471467|NCT01254292|455027467|FG000|Comparative Phase|Lost to Follow-up|3|||
126471468|NCT01254292|455027468|FG001|Comparative Phase|Lost to Follow-up|21|||
126471469|NCT01254292|455027467|FG000|Comparative Phase|Pregnancy|2|||
126471470|NCT01254292|455027468|FG001|Comparative Phase|Pregnancy|6|||
126398126|NCT03054350|454753053|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
126398127|NCT03054350|454753054|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
126471471|NCT01254292|455027467|FG000|Comparative Phase|Withdrawal by Subject|20|||
126471472|NCT01254292|455027468|FG001|Comparative Phase|Withdrawal by Subject|21|||
126471473|NCT01254292|455027467|FG000|Comparative Phase|Protocol Violation|1|||
126471474|NCT01254292|455027468|FG001|Comparative Phase|Protocol Violation|2|||
126471475|NCT01254292|455027467|FG000|Comparative Phase|Wish for pregnancy|4|||
126471476|NCT01254292|455027468|FG001|Comparative Phase|Wish for pregnancy|6|||
126556255|NCT04707391|455327682|FG000|Overall Study|Other|0|||
126556256|NCT04707391|455327683|FG001|Overall Study|Other|2|||
126398128|NCT03054350|454753055|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
126398129|NCT03054350|454753056|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
126398130|NCT00931723|454753057|FG000|Overall Study|Withdrawal by Subject|11|||
126398131|NCT00931723|454753058|FG001|Overall Study|Withdrawal by Subject|13|||
126398132|NCT00931723|454753057|FG000|Overall Study|Adverse Event|6|||
126398133|NCT00931723|454753058|FG001|Overall Study|Adverse Event|13|||
126398134|NCT00931723|454753057|FG000|Overall Study|Lithium found in blood|0|||
126398135|NCT00931723|454753058|FG001|Overall Study|Lithium found in blood|1|||
126398136|NCT00931723|454753057|FG000|Overall Study|Condition under investigation worsened|1|||
126398137|NCT00931723|454753058|FG001|Overall Study|Condition under investigation worsened|2|||
126398138|NCT00931723|454753057|FG000|Overall Study|Lost to Follow-up|1|||
126398139|NCT00931723|454753058|FG001|Overall Study|Lost to Follow-up|2|||
126398140|NCT00931723|454753057|FG000|Overall Study|Study-specific discontinuation criteria|1|||
126398141|NCT00931723|454753058|FG001|Overall Study|Study-specific discontinuation criteria|1|||
126398142|NCT00931723|454753057|FG000|Overall Study|Severe non-compliance to protocol|2|||
126398143|NCT00931723|454753058|FG001|Overall Study|Severe non-compliance to protocol|0|||
126398144|NCT00931723|454753057|FG000|Overall Study|Safety reasons|0|||
126398145|NCT00931723|454753058|FG001|Overall Study|Safety reasons|1|||
126398146|NCT00931723|454753057|FG000|Overall Study|Took prohibited concomitant medication|0|||
126398147|NCT00931723|454753058|FG001|Overall Study|Took prohibited concomitant medication|1|||
126398148|NCT00931723|454753057|FG000|Overall Study|Lack or insufficient theraputic response|2|||
126398149|NCT00931723|454753058|FG001|Overall Study|Lack or insufficient theraputic response|5|||
126398150|NCT00931723|454753057|FG000|Overall Study|Sponsor decision|1|||
126398151|NCT00931723|454753058|FG001|Overall Study|Sponsor decision|0|||
126398152|NCT00931723|454753057|FG000|Overall Study|Late hospital discharge|1|||
126398153|NCT00931723|454753058|FG001|Overall Study|Late hospital discharge|0|||
126398154|NCT01643850|454753062|FG000|Overall Study|Withdrawal by Subject|0|||
126398155|NCT01643850|454753063|FG001|Overall Study|Withdrawal by Subject|0|||
126398156|NCT01643850|454753064|FG002|Overall Study|Withdrawal by Subject|0|||
126398157|NCT01643850|454753065|FG003|Overall Study|Withdrawal by Subject|0|||
126398158|NCT01643850|454753066|FG004|Overall Study|Withdrawal by Subject|1|||
126398159|NCT01643850|454753067|FG005|Overall Study|Withdrawal by Subject|0|||
126398160|NCT01643850|454753068|FG006|Overall Study|Withdrawal by Subject|0|||
126398161|NCT01643850|454753069|FG007|Overall Study|Withdrawal by Subject|0|||
126398162|NCT01643850|454753070|FG008|Overall Study|Withdrawal by Subject|0|||
126398163|NCT01643850|454753062|FG000|Overall Study|Lost to Follow-up|0|||
126398164|NCT01643850|454753063|FG001|Overall Study|Lost to Follow-up|0|||
126398165|NCT01643850|454753064|FG002|Overall Study|Lost to Follow-up|0|||
126398166|NCT01643850|454753065|FG003|Overall Study|Lost to Follow-up|0|||
126398167|NCT01643850|454753066|FG004|Overall Study|Lost to Follow-up|0|||
126398168|NCT01643850|454753067|FG005|Overall Study|Lost to Follow-up|0|||
126398169|NCT01643850|454753068|FG006|Overall Study|Lost to Follow-up|1|||
126398170|NCT01643850|454753069|FG007|Overall Study|Lost to Follow-up|0|||
126398171|NCT01643850|454753070|FG008|Overall Study|Lost to Follow-up|1|||
126398172|NCT01643850|454753062|FG000|Overall Study|Adverse Event|0|||
126398173|NCT01643850|454753063|FG001|Overall Study|Adverse Event|0|||
126471477|NCT01254292|455027467|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
126471478|NCT01254292|455027468|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
126556257|NCT03246672|455327684|FG000|Overall Study|Lost to Follow-up|2|||
126398174|NCT01643850|454753064|FG002|Overall Study|Adverse Event|0|||
126398175|NCT01643850|454753065|FG003|Overall Study|Adverse Event|0|||
126471479|NCT01254292|455027467|FG000|LCS12 Extension Phase|Adverse Event|9|||
126471480|NCT01254292|455027468|FG001|LCS12 Extension Phase|Adverse Event|0|||
126556258|NCT01347645|455327685|FG000|Overall Study|Death|1|||
126398176|NCT01643850|454753066|FG004|Overall Study|Adverse Event|1|||
126398177|NCT01643850|454753067|FG005|Overall Study|Adverse Event|0|||
126398178|NCT01643850|454753068|FG006|Overall Study|Adverse Event|0|||
126398179|NCT01643850|454753069|FG007|Overall Study|Adverse Event|0|||
126398180|NCT01643850|454753070|FG008|Overall Study|Adverse Event|0|||
126471481|NCT01254292|455027467|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
126556259|NCT01347645|455327686|FG001|Overall Study|Death|5|||
126556260|NCT01347645|455327687|FG002|Overall Study|Death|2|||
126556261|NCT01347645|455327688|FG003|Overall Study|Death|7|||
126556262|NCT01347645|455327689|FG004|Overall Study|Death|7|||
126556263|NCT01347645|455327685|FG000|Overall Study|Lost to Follow-up|1|||
126556264|NCT01347645|455327686|FG001|Overall Study|Lost to Follow-up|1|||
126556265|NCT01347645|455327687|FG002|Overall Study|Lost to Follow-up|0|||
126556266|NCT01347645|455327688|FG003|Overall Study|Lost to Follow-up|1|||
126556267|NCT01347645|455327689|FG004|Overall Study|Lost to Follow-up|1|||
126556268|NCT01347645|455327685|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
126398181|NCT01643850|454753062|FG000|Overall Study|Administrative Problems|0|||
126398182|NCT01643850|454753063|FG001|Overall Study|Administrative Problems|0|||
126398183|NCT01643850|454753064|FG002|Overall Study|Administrative Problems|1|||
126398184|NCT01643850|454753065|FG003|Overall Study|Administrative Problems|0|||
126398185|NCT01643850|454753066|FG004|Overall Study|Administrative Problems|1|||
126398186|NCT01643850|454753067|FG005|Overall Study|Administrative Problems|0|||
126398187|NCT01643850|454753068|FG006|Overall Study|Administrative Problems|0|||
126398188|NCT01643850|454753069|FG007|Overall Study|Administrative Problems|0|||
126398189|NCT01643850|454753070|FG008|Overall Study|Administrative Problems|0|||
126398190|NCT01133405|454753071|FG000|Period 1|Withdrawal by Subject|0|||
126398191|NCT01133405|454753072|FG001|Period 1|Withdrawal by Subject|1|||
126398192|NCT01133405|454753073|FG002|Period 1|Withdrawal by Subject|0|||
126398193|NCT01133405|454753074|FG003|Period 1|Withdrawal by Subject|1|||
126398194|NCT01133405|454753075|FG004|Period 1|Withdrawal by Subject|0|||
126398195|NCT01133405|454753076|FG005|Period 1|Withdrawal by Subject|1|||
126398196|NCT01133405|454753077|FG006|Period 1|Withdrawal by Subject|0|||
126398197|NCT01133405|454753078|FG007|Period 1|Withdrawal by Subject|0|||
126398198|NCT01133405|454753079|FG008|Period 1|Withdrawal by Subject|0|||
126398199|NCT01133405|454753080|FG009|Period 1|Withdrawal by Subject|0|||
126398200|NCT01133405|454753071|FG000|Period 1|Physician Decision|0|||
126398201|NCT01133405|454753072|FG001|Period 1|Physician Decision|0|||
126398202|NCT01133405|454753073|FG002|Period 1|Physician Decision|0|||
126398203|NCT01133405|454753074|FG003|Period 1|Physician Decision|1|||
126398204|NCT01133405|454753075|FG004|Period 1|Physician Decision|0|||
126398205|NCT01133405|454753076|FG005|Period 1|Physician Decision|0|||
126398206|NCT01133405|454753077|FG006|Period 1|Physician Decision|0|||
126398207|NCT01133405|454753078|FG007|Period 1|Physician Decision|0|||
126398208|NCT01133405|454753079|FG008|Period 1|Physician Decision|0|||
126398209|NCT01133405|454753080|FG009|Period 1|Physician Decision|0|||
126398210|NCT01133405|454753071|FG000|Period 1|Discontinued after randomization|1|||
126398211|NCT01133405|454753072|FG001|Period 1|Discontinued after randomization|0|||
126398212|NCT01133405|454753073|FG002|Period 1|Discontinued after randomization|0|||
126398213|NCT01133405|454753074|FG003|Period 1|Discontinued after randomization|0|||
126398214|NCT01133405|454753075|FG004|Period 1|Discontinued after randomization|0|||
126398215|NCT01133405|454753076|FG005|Period 1|Discontinued after randomization|0|||
126398216|NCT01133405|454753077|FG006|Period 1|Discontinued after randomization|1|||
126398217|NCT01133405|454753078|FG007|Period 1|Discontinued after randomization|0|||
126398218|NCT01133405|454753079|FG008|Period 1|Discontinued after randomization|0|||
126398219|NCT01133405|454753080|FG009|Period 1|Discontinued after randomization|0|||
126398220|NCT01133405|454753071|FG000|Period 1|Received drug only in period 2|0|||
126398221|NCT01133405|454753072|FG001|Period 1|Received drug only in period 2|1|||
126398222|NCT01133405|454753073|FG002|Period 1|Received drug only in period 2|0|||
126398223|NCT01133405|454753074|FG003|Period 1|Received drug only in period 2|2|||
126398224|NCT01133405|454753075|FG004|Period 1|Received drug only in period 2|0|||
126398225|NCT01133405|454753076|FG005|Period 1|Received drug only in period 2|1|||
126398226|NCT01133405|454753077|FG006|Period 1|Received drug only in period 2|0|||
126398227|NCT01133405|454753078|FG007|Period 1|Received drug only in period 2|0|||
126398228|NCT01133405|454753079|FG008|Period 1|Received drug only in period 2|0|||
126398229|NCT01133405|454753080|FG009|Period 1|Received drug only in period 2|0|||
126398230|NCT01133405|454753071|FG000|Period 1|Received drug only in period 3|0|||
126398231|NCT01133405|454753072|FG001|Period 1|Received drug only in period 3|1|||
126398232|NCT01133405|454753073|FG002|Period 1|Received drug only in period 3|1|||
126398233|NCT01133405|454753074|FG003|Period 1|Received drug only in period 3|0|||
126398234|NCT01133405|454753075|FG004|Period 1|Received drug only in period 3|0|||
126398235|NCT01133405|454753076|FG005|Period 1|Received drug only in period 3|0|||
126398236|NCT01133405|454753077|FG006|Period 1|Received drug only in period 3|0|||
126398237|NCT01133405|454753078|FG007|Period 1|Received drug only in period 3|0|||
126398238|NCT01133405|454753079|FG008|Period 1|Received drug only in period 3|0|||
126398239|NCT01133405|454753080|FG009|Period 1|Received drug only in period 3|0|||
126398240|NCT01133405|454753071|FG000|Period 2|Adverse Event|0|||
126398241|NCT01133405|454753072|FG001|Period 2|Adverse Event|0|||
126556269|NCT01347645|455327686|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
126640401|NCT00945672|455642768|FG002|Overall Study|Withdrawal by Subject|0|||
126398242|NCT01133405|454753073|FG002|Period 2|Adverse Event|1|||
126398243|NCT01133405|454753074|FG003|Period 2|Adverse Event|0|||
126398244|NCT01133405|454753075|FG004|Period 2|Adverse Event|0|||
126398245|NCT01133405|454753076|FG005|Period 2|Adverse Event|0|||
126398246|NCT01133405|454753077|FG006|Period 2|Adverse Event|0|||
126556270|NCT01347645|455327687|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
126556271|NCT01347645|455327688|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
126556272|NCT01347645|455327689|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
126556273|NCT01347645|455327685|FG000|Overall Study|Other|1|||
126556274|NCT01347645|455327686|FG001|Overall Study|Other|0|||
126556275|NCT01347645|455327687|FG002|Overall Study|Other|0|||
126556276|NCT01347645|455327688|FG003|Overall Study|Other|0|||
126556277|NCT01347645|455327689|FG004|Overall Study|Other|1|||
126556278|NCT01347645|455327685|FG000|Overall Study|Withdrawal by Subject|0|||
126556279|NCT01347645|455327686|FG001|Overall Study|Withdrawal by Subject|0|||
126556280|NCT01347645|455327687|FG002|Overall Study|Withdrawal by Subject|0|||
126556281|NCT01347645|455327688|FG003|Overall Study|Withdrawal by Subject|3|||
126556282|NCT01347645|455327689|FG004|Overall Study|Withdrawal by Subject|3|||
126556283|NCT01347645|455327685|FG000|Overall Study|Physician Decision|0|||
126556284|NCT01347645|455327686|FG001|Overall Study|Physician Decision|0|||
126556285|NCT01347645|455327687|FG002|Overall Study|Physician Decision|0|||
126556286|NCT01347645|455327688|FG003|Overall Study|Physician Decision|0|||
126556287|NCT01347645|455327689|FG004|Overall Study|Physician Decision|1|||
126556288|NCT01347645|455327685|FG000|Overall Study|Adverse Event|0|||
126556289|NCT01347645|455327686|FG001|Overall Study|Adverse Event|0|||
126556290|NCT01347645|455327687|FG002|Overall Study|Adverse Event|0|||
126556291|NCT01347645|455327688|FG003|Overall Study|Adverse Event|1|||
126398247|NCT01133405|454753078|FG007|Period 2|Adverse Event|0|||
126398248|NCT01133405|454753079|FG008|Period 2|Adverse Event|0|||
126398249|NCT01133405|454753080|FG009|Period 2|Adverse Event|0|||
126398250|NCT01133405|454753071|FG000|Period 2|Withdrawal by Subject|0|||
126398251|NCT01133405|454753072|FG001|Period 2|Withdrawal by Subject|0|||
126398252|NCT01133405|454753073|FG002|Period 2|Withdrawal by Subject|0|||
126398253|NCT01133405|454753074|FG003|Period 2|Withdrawal by Subject|1|||
126398254|NCT01133405|454753075|FG004|Period 2|Withdrawal by Subject|0|||
126398255|NCT01133405|454753076|FG005|Period 2|Withdrawal by Subject|1|||
126398256|NCT01133405|454753077|FG006|Period 2|Withdrawal by Subject|0|||
126398257|NCT01133405|454753078|FG007|Period 2|Withdrawal by Subject|0|||
126398258|NCT01133405|454753079|FG008|Period 2|Withdrawal by Subject|0|||
126398259|NCT01133405|454753080|FG009|Period 2|Withdrawal by Subject|0|||
126398260|NCT01133405|454753071|FG000|Period 2|Entry Criteria Not Met|0|||
126398261|NCT01133405|454753072|FG001|Period 2|Entry Criteria Not Met|1|||
126398262|NCT01133405|454753073|FG002|Period 2|Entry Criteria Not Met|0|||
126398263|NCT01133405|454753074|FG003|Period 2|Entry Criteria Not Met|0|||
126398264|NCT01133405|454753075|FG004|Period 2|Entry Criteria Not Met|0|||
126398265|NCT01133405|454753076|FG005|Period 2|Entry Criteria Not Met|0|||
126398266|NCT01133405|454753077|FG006|Period 2|Entry Criteria Not Met|0|||
126398267|NCT01133405|454753078|FG007|Period 2|Entry Criteria Not Met|0|||
126398268|NCT01133405|454753079|FG008|Period 2|Entry Criteria Not Met|0|||
126398269|NCT01133405|454753080|FG009|Period 2|Entry Criteria Not Met|0|||
126398270|NCT01133405|454753071|FG000|Period 2|Physician Decision|0|||
126398271|NCT01133405|454753072|FG001|Period 2|Physician Decision|0|||
126398272|NCT01133405|454753073|FG002|Period 2|Physician Decision|0|||
126398273|NCT01133405|454753074|FG003|Period 2|Physician Decision|0|||
126398274|NCT01133405|454753075|FG004|Period 2|Physician Decision|0|||
126398275|NCT01133405|454753076|FG005|Period 2|Physician Decision|1|||
126398276|NCT01133405|454753077|FG006|Period 2|Physician Decision|0|||
126398277|NCT01133405|454753078|FG007|Period 2|Physician Decision|0|||
126398278|NCT01133405|454753079|FG008|Period 2|Physician Decision|0|||
126398279|NCT01133405|454753080|FG009|Period 2|Physician Decision|0|||
126398280|NCT01238835|454753083|FG000|Overall Study|Death|124|||
126398281|NCT01238835|454753083|FG000|Overall Study|Withdrawal by Subject|9|||
126398282|NCT01238835|454753083|FG000|Overall Study|Lost to Follow-up|1|||
126398283|NCT01238835|454753083|FG000|Overall Study|Site early discontinuation|2|||
126398284|NCT01774253|454753084|FG000|Overall Study|Lack of Efficacy|4|||
126398285|NCT01774253|454753084|FG000|Overall Study|Physician Decision|2|||
126398286|NCT01774253|454753084|FG000|Overall Study|Withdrawal by Subject|2|||
126398287|NCT01774253|454753084|FG000|Overall Study|Death|1|||
126398288|NCT00772369|454753085|FG000|Overall Study|Did not return record release form|1|||
126398289|NCT00554619|454753086|FG000|Overall Study|Adverse Event|1|||
126398290|NCT00554619|454753086|FG000|Overall Study|Physician Decision|1|||
126556292|NCT01347645|455327689|FG004|Overall Study|Adverse Event|1|||
126556293|NCT01163149|455327691|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
126772275|NCT02030834|456122075|FG001|Overall Study|Lost to Follow-up|0|||
126398291|NCT00554619|454753086|FG000|Overall Study|Liver Function Test Abnormality|1|||
126398292|NCT02240368|454753090|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
126398293|NCT02240368|454753091|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
126398294|NCT02240368|454753092|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
126398295|NCT02240368|454753090|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
126398296|NCT02240368|454753091|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
126398297|NCT02240368|454753092|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
126398298|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Death|1|||
126556294|NCT01163149|455327692|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
126556295|NCT01163149|455327693|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
126556296|NCT01163149|455327691|FG000|Extension Treatment Period|Adverse Event|0|||
126556297|NCT01163149|455327692|FG001|Extension Treatment Period|Adverse Event|1|||
126556298|NCT01163149|455327693|FG002|Extension Treatment Period|Adverse Event|0|||
126556299|NCT01163149|455327691|FG000|Extension Treatment Period|Noncompliance|0|||
126556300|NCT01163149|455327692|FG001|Extension Treatment Period|Noncompliance|0|||
126556301|NCT01163149|455327693|FG002|Extension Treatment Period|Noncompliance|1|||
126556302|NCT02806336|455327694|FG000|Overall Study|Physician Decision|1|||
126556303|NCT02806336|455327695|FG001|Overall Study|Physician Decision|0|||
126556304|NCT02806336|455327694|FG000|Overall Study|Withdrawal by Subject|2|||
126556305|NCT02806336|455327695|FG001|Overall Study|Withdrawal by Subject|4|||
126556306|NCT02806336|455327694|FG000|Overall Study|COVID-19 research shut down|3|||
126556307|NCT02806336|455327695|FG001|Overall Study|COVID-19 research shut down|4|||
126556308|NCT02806336|455327694|FG000|Overall Study|Lack of Efficacy|0|||
126556309|NCT02806336|455327695|FG001|Overall Study|Lack of Efficacy|1|||
126556310|NCT00322868|455329137|FG000|Overall Study|disease progression|1|||
126556311|NCT02176928|455329140|FG000|Overall Study|Lost to Follow-up|2|||
126556312|NCT02176928|455329141|FG001|Overall Study|Lost to Follow-up|4|||
126556313|NCT01155726|455329149|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
126556314|NCT01155726|455329150|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
126556315|NCT01155726|455329151|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
126556316|NCT01155726|455329152|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
126556317|NCT02459587|455329153|FG000|3-Month Follow-up Assessment|Death|0|||
126556318|NCT02459587|455329154|FG001|3-Month Follow-up Assessment|Death|2|||
126556319|NCT02459587|455329153|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
126556320|NCT02459587|455329154|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
126556321|NCT02459587|455329153|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
126556322|NCT02459587|455329154|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
126556323|NCT02459587|455329153|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
126556324|NCT02459587|455329154|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
126556325|NCT02459587|455329153|FG000|6-month Follow-up Assessment|Death|2|||
126556326|NCT02459587|455329154|FG001|6-month Follow-up Assessment|Death|1|||
126556327|NCT02459587|455329153|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
126556328|NCT02459587|455329154|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
126556329|NCT02459587|455329153|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
126556330|NCT02459587|455329154|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
126556331|NCT02459587|455329153|FG000|12-month Follow-up Assessment|Death|2|||
126556332|NCT02459587|455329154|FG001|12-month Follow-up Assessment|Death|0|||
126556333|NCT02459587|455329153|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
126556334|NCT02459587|455329154|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
126556335|NCT02459587|455329153|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
126556336|NCT02459587|455329154|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
126556337|NCT02459587|455329153|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
126556338|NCT02459587|455329154|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
126556339|NCT00884286|455329158|FG000|Overall Study|Progressive disease|21|||
126556340|NCT00884286|455329159|FG001|Overall Study|Progressive disease|28|||
126556341|NCT00884286|455329158|FG000|Overall Study|Toxicity|4|||
126556342|NCT00884286|455329159|FG001|Overall Study|Toxicity|1|||
126556343|NCT00884286|455329158|FG000|Overall Study|Death|2|||
126556344|NCT00884286|455329159|FG001|Overall Study|Death|2|||
126556345|NCT00884286|455329158|FG000|Overall Study|Physician Decision|1|||
126556346|NCT00884286|455329159|FG001|Overall Study|Physician Decision|0|||
126556347|NCT00884286|455329158|FG000|Overall Study|Septic shock|1|||
126556348|NCT00884286|455329159|FG001|Overall Study|Septic shock|0|||
126556349|NCT00884286|455329158|FG000|Overall Study|Thrombus in right auricle|1|||
126556350|NCT00884286|455329159|FG001|Overall Study|Thrombus in right auricle|0|||
126556351|NCT00884286|455329158|FG000|Overall Study|Not treated|2|||
126556352|NCT00884286|455329159|FG001|Overall Study|Not treated|1|||
126556353|NCT00884286|455329158|FG000|Overall Study|Comprised lung carcinoma|0|||
126556354|NCT00884286|455329159|FG001|Overall Study|Comprised lung carcinoma|1|||
126556355|NCT01923428|455329170|FG000|Overall Study|Adverse Event|8|||
126556356|NCT01923428|455329171|FG001|Overall Study|Adverse Event|6|||
126556357|NCT01923428|455329172|FG002|Overall Study|Adverse Event|3|||
126398299|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Death|1|||
126398300|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Death|0|||
126398301|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Death|0|||
126398302|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Death|1|||
126398303|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Death|0|||
126556358|NCT01923428|455329173|FG003|Overall Study|Adverse Event|3|||
126556359|NCT01923428|455329170|FG000|Overall Study|Withdrawal by Subject|5|||
126556360|NCT01923428|455329171|FG001|Overall Study|Withdrawal by Subject|3|||
126556361|NCT01923428|455329172|FG002|Overall Study|Withdrawal by Subject|0|||
126556362|NCT01923428|455329173|FG003|Overall Study|Withdrawal by Subject|4|||
126556363|NCT01923428|455329170|FG000|Overall Study|Lost to Follow-up|2|||
126556364|NCT01923428|455329171|FG001|Overall Study|Lost to Follow-up|1|||
126556365|NCT01923428|455329172|FG002|Overall Study|Lost to Follow-up|5|||
126556366|NCT01923428|455329173|FG003|Overall Study|Lost to Follow-up|0|||
126556367|NCT01923428|455329170|FG000|Overall Study|Protocol Violation|3|||
126556368|NCT01923428|455329171|FG001|Overall Study|Protocol Violation|0|||
126556369|NCT01923428|455329172|FG002|Overall Study|Protocol Violation|2|||
126556370|NCT01923428|455329173|FG003|Overall Study|Protocol Violation|1|||
126556371|NCT01923428|455329170|FG000|Overall Study|Non Compliance to treatment|1|||
126556372|NCT01923428|455329171|FG001|Overall Study|Non Compliance to treatment|2|||
126556373|NCT01923428|455329172|FG002|Overall Study|Non Compliance to treatment|0|||
126556374|NCT01923428|455329173|FG003|Overall Study|Non Compliance to treatment|1|||
126556375|NCT01923428|455329170|FG000|Overall Study|Lack of Efficacy|0|||
126556376|NCT01923428|455329171|FG001|Overall Study|Lack of Efficacy|0|||
126556377|NCT01923428|455329172|FG002|Overall Study|Lack of Efficacy|1|||
126556378|NCT01923428|455329173|FG003|Overall Study|Lack of Efficacy|1|||
126556379|NCT02550873|455329174|FG000|Randomized Double Blind|Adverse Event|3|||
126556380|NCT02550873|455329175|FG001|Randomized Double Blind|Adverse Event|1|||
126556381|NCT02550873|455329176|FG002|Randomized Double Blind|Adverse Event|0|||
126556382|NCT02550873|455329174|FG000|Randomized Double Blind|Disease progression|1|||
126556383|NCT02550873|455329175|FG001|Randomized Double Blind|Disease progression|1|||
126556384|NCT02550873|455329176|FG002|Randomized Double Blind|Disease progression|0|||
126556385|NCT02550873|455329174|FG000|Open Label Extension|Study ongoing|0|||
126556386|NCT02550873|455329175|FG001|Open Label Extension|Study ongoing|0|||
126556387|NCT02550873|455329176|FG002|Open Label Extension|Study ongoing|111|||
126556388|NCT01822353|455329177|FG000|Overall Study|Adverse Event|1|||
126556389|NCT01822353|455329178|FG001|Overall Study|Adverse Event|3|||
126556390|NCT01822353|455329179|FG002|Overall Study|Adverse Event|1|||
126556391|NCT01822353|455329177|FG000|Overall Study|Pregnancy|0|||
126556392|NCT01822353|455329178|FG001|Overall Study|Pregnancy|1|||
126556393|NCT01822353|455329179|FG002|Overall Study|Pregnancy|0|||
126556394|NCT01822353|455329177|FG000|Overall Study|Withdrawal by Subject|3|||
126556395|NCT01822353|455329178|FG001|Overall Study|Withdrawal by Subject|1|||
126556396|NCT01822353|455329179|FG002|Overall Study|Withdrawal by Subject|0|||
126556397|NCT04320615|455329180|FG000|Overall Study|Withdrawal by Subject|4|||
126556398|NCT04320615|455329181|FG001|Overall Study|Withdrawal by Subject|10|||
126556399|NCT04320615|455329180|FG000|Overall Study|Physician Decision|2|||
126556400|NCT04320615|455329181|FG001|Overall Study|Physician Decision|0|||
126556401|NCT04320615|455329180|FG000|Overall Study|Other|2|||
126556402|NCT04320615|455329181|FG001|Overall Study|Other|0|||
126556403|NCT04320615|455329180|FG000|Overall Study|Lost to Follow-up|5|||
126556404|NCT04320615|455329181|FG001|Overall Study|Lost to Follow-up|23|||
126556405|NCT04320615|455329180|FG000|Overall Study|Death|35|||
126556406|NCT04320615|455329181|FG001|Overall Study|Death|71|||
126556407|NCT01449721|455329182|FG000|Overall Study|Physician Decision|0|||
126556408|NCT01449721|455329183|FG001|Overall Study|Physician Decision|1|||
126556409|NCT01449721|455329182|FG000|Overall Study|Physician Decision|0|||
126556410|NCT01449721|455329183|FG001|Overall Study|Physician Decision|1|||
126556411|NCT03285711|455329184|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
126556412|NCT03285711|455329185|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
126556413|NCT03285711|455329186|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
126556414|NCT03285711|455329187|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
126556415|NCT03285711|455329184|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
126556416|NCT03285711|455329185|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
126556417|NCT03285711|455329186|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
126556418|NCT03285711|455329187|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
126556419|NCT03285711|455329184|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
126556420|NCT03285711|455329185|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
126556421|NCT03285711|455329186|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
126556422|NCT03285711|455329187|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
126556423|NCT03285711|455329184|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
126556424|NCT03285711|455329185|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
126556425|NCT03285711|455329186|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
126556426|NCT03285711|455329187|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
126556427|NCT02431533|455329188|FG000|Overall Study|Withdrawal by Subject|1|||
126556428|NCT02431533|455329189|FG001|Overall Study|Withdrawal by Subject|3|||
126556429|NCT02431533|455329188|FG000|Overall Study|Developed Exclusionary criteria|1|||
126556430|NCT02431533|455329189|FG001|Overall Study|Developed Exclusionary criteria|0|||
126556431|NCT02107443|455329194|FG000|Overall Study|Death|42|||
126556432|NCT02107443|455329195|FG001|Overall Study|Death|30|||
126556433|NCT02107443|455329194|FG000|Overall Study|Study Protocol Violation|3|||
126556434|NCT02107443|455329195|FG001|Overall Study|Study Protocol Violation|1|||
126556435|NCT02107443|455329194|FG000|Overall Study|Registered but Not Eligible|0|||
126556436|NCT02107443|455329195|FG001|Overall Study|Registered but Not Eligible|1|||
126556437|NCT02107443|455329194|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
126556438|NCT02107443|455329195|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
126556439|NCT02107443|455329194|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
126556440|NCT02107443|455329195|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
126556441|NCT02107443|455329194|FG000|Overall Study|Withdrawal: Changed Mind|2|||
126556442|NCT02107443|455329195|FG001|Overall Study|Withdrawal: Changed Mind|0|||
126556443|NCT02107443|455329194|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
126556444|NCT02107443|455329195|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
126556445|NCT02107443|455329194|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
126556446|NCT02107443|455329195|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
126556447|NCT02107443|455329194|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
126556448|NCT02107443|455329195|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
126556449|NCT02107443|455329194|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
126556450|NCT02107443|455329195|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
126556451|NCT02107443|455329194|FG000|Overall Study|Withdrawal: Other Medical|9|||
126556452|NCT02107443|455329195|FG001|Overall Study|Withdrawal: Other Medical|5|||
126556453|NCT02107443|455329194|FG000|Overall Study|Withdrawal: Disease Progression|4|||
126556454|NCT02107443|455329195|FG001|Overall Study|Withdrawal: Disease Progression|2|||
126556455|NCT02107443|455329194|FG000|Overall Study|Withdrawal: Personal Issues|0|||
126556456|NCT02107443|455329195|FG001|Overall Study|Withdrawal: Personal Issues|3|||
126556457|NCT00885495|455329196|FG000|Overall Study|Adverse Event|1|||
126556458|NCT00885495|455329197|FG001|Overall Study|Adverse Event|2|||
126556459|NCT00885495|455329196|FG000|Overall Study|Protocol Violation|0|||
126556460|NCT00885495|455329197|FG001|Overall Study|Protocol Violation|1|||
126556461|NCT00885495|455329196|FG000|Overall Study|Withdrawal by Subject|1|||
126556462|NCT00885495|455329197|FG001|Overall Study|Withdrawal by Subject|0|||
126556463|NCT01400893|455329198|FG000|Overall Study|Death|27|||
126556464|NCT01400893|455329199|FG001|Overall Study|Death|21|||
126398304|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Death|0|||
126398305|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Death|0|||
126398306|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Death|0|||
126398307|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Death|0|||
126398308|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
126398309|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
126398310|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
126398311|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
126398312|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
126398313|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
126398314|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
126398315|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
126398316|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
126398317|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
126398318|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398319|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398320|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398321|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398322|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
126398323|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398324|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398325|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398326|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398327|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
126398328|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
126398329|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126398330|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126398331|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126398332|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126471482|NCT01254292|455027468|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
126471483|NCT01254292|455027467|FG000|LCS12 Extension Phase|Other unknown|4|||
126471484|NCT01254292|455027468|FG001|LCS12 Extension Phase|Other unknown|0|||
126471485|NCT01254292|455027467|FG000|LCS12 Extension Phase|Pregnancy|2|||
126471486|NCT01254292|455027468|FG001|LCS12 Extension Phase|Pregnancy|0|||
126471487|NCT01254292|455027467|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
126471488|NCT01254292|455027468|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
126556465|NCT01400893|455329198|FG000|Overall Study|Lost to Follow-up|0|||
126556466|NCT01400893|455329199|FG001|Overall Study|Lost to Follow-up|6|||
126398333|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126471489|NCT02149875|455027469|FG000|Overall Study|Lost to Follow-up|3|||
126471490|NCT02149875|455027470|FG001|Overall Study|Lost to Follow-up|4|||
126471491|NCT02149875|455027471|FG002|Overall Study|Lost to Follow-up|5|||
126471492|NCT02149875|455027469|FG000|Overall Study|Withdrawal by Subject|3|||
126556467|NCT01513967|455329207|FG000|Overall Study|Pregnancy|0|||
126556468|NCT01513967|455329208|FG001|Overall Study|Pregnancy|0|||
126556469|NCT01513967|455329209|FG002|Overall Study|Pregnancy|0|||
126556470|NCT01513967|455329210|FG003|Overall Study|Pregnancy|0|||
126556471|NCT01513967|455329211|FG004|Overall Study|Pregnancy|0|||
126556472|NCT01513967|455329212|FG005|Overall Study|Pregnancy|0|||
126556473|NCT01513967|455329213|FG006|Overall Study|Pregnancy|1|||
126556474|NCT01513967|455329214|FG007|Overall Study|Pregnancy|0|||
126721143|NCT03552549|455928568|FG000|Overall Study|Disease progression|25|||
126556475|NCT01513967|455329207|FG000|Overall Study|missed a study visit|0|||
126556476|NCT01513967|455329208|FG001|Overall Study|missed a study visit|0|||
126556477|NCT01513967|455329209|FG002|Overall Study|missed a study visit|0|||
126556478|NCT01513967|455329210|FG003|Overall Study|missed a study visit|0|||
126556479|NCT01513967|455329211|FG004|Overall Study|missed a study visit|0|||
126556480|NCT01513967|455329212|FG005|Overall Study|missed a study visit|0|||
126556481|NCT01513967|455329213|FG006|Overall Study|missed a study visit|1|||
126556482|NCT01513967|455329214|FG007|Overall Study|missed a study visit|0|||
126556483|NCT01513967|455329207|FG000|Overall Study|excluded due to positive drug screen|0|||
126556484|NCT01513967|455329208|FG001|Overall Study|excluded due to positive drug screen|0|||
126556485|NCT01513967|455329209|FG002|Overall Study|excluded due to positive drug screen|0|||
126556486|NCT01513967|455329210|FG003|Overall Study|excluded due to positive drug screen|0|||
126556487|NCT01513967|455329211|FG004|Overall Study|excluded due to positive drug screen|0|||
126556488|NCT01513967|455329212|FG005|Overall Study|excluded due to positive drug screen|0|||
126556489|NCT01513967|455329213|FG006|Overall Study|excluded due to positive drug screen|0|||
126556490|NCT01513967|455329214|FG007|Overall Study|excluded due to positive drug screen|2|||
126556491|NCT01513967|455329207|FG000|Overall Study|Physician Decision|0|||
126556492|NCT01513967|455329208|FG001|Overall Study|Physician Decision|0|||
126556493|NCT01513967|455329209|FG002|Overall Study|Physician Decision|0|||
126556494|NCT01513967|455329210|FG003|Overall Study|Physician Decision|0|||
126556495|NCT01513967|455329211|FG004|Overall Study|Physician Decision|0|||
126556496|NCT01513967|455329212|FG005|Overall Study|Physician Decision|1|||
126556497|NCT01513967|455329213|FG006|Overall Study|Physician Decision|0|||
126556498|NCT01513967|455329214|FG007|Overall Study|Physician Decision|0|||
126556499|NCT02906202|455329215|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
126556500|NCT01563978|455329219|FG000|Overall Study|Physician Decision|1|||
126556501|NCT01563978|455329220|FG001|Overall Study|Physician Decision|0|||
126556502|NCT01563978|455329219|FG000|Overall Study|Lost to Follow-up|1|||
126556503|NCT01563978|455329220|FG001|Overall Study|Lost to Follow-up|0|||
126556504|NCT01563978|455329219|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
126556505|NCT01563978|455329220|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
126556506|NCT01563978|455329219|FG000|Overall Study|Adverse Event|1|||
126556507|NCT01563978|455329220|FG001|Overall Study|Adverse Event|2|||
126556508|NCT00729690|455329221|FG000|Overall Study|IT Catheter Malfunction|0|||
126556509|NCT00729690|455329222|FG001|Overall Study|IT Catheter Malfunction|2|||
126556510|NCT00729690|455329223|FG002|Overall Study|IT Catheter Malfunction|2|||
126556511|NCT04562779|455329226|FG000|Overall Study|Lost to Follow-up|7|||
126556512|NCT04562779|455329227|FG001|Overall Study|Lost to Follow-up|5|||
126556513|NCT04562779|455329228|FG002|Overall Study|Lost to Follow-up|10|||
126556514|NCT04562779|455329226|FG000|Overall Study|Protocol Violation|2|||
126556515|NCT04562779|455329227|FG001|Overall Study|Protocol Violation|2|||
126556516|NCT04562779|455329228|FG002|Overall Study|Protocol Violation|0|||
126556517|NCT00333138|455329229|FG000|Core Study (6 Months)|Adverse Event|4|||
126556518|NCT00333138|455329230|FG001|Core Study (6 Months)|Adverse Event|5|||
126556519|NCT00333138|455329231|FG002|Core Study (6 Months)|Adverse Event|8|||
126556520|NCT00333138|455329229|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
126556521|NCT00333138|455329230|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
126556522|NCT00333138|455329231|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
126556523|NCT00333138|455329229|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
126556524|NCT00333138|455329230|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
126556525|NCT00333138|455329231|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
126556526|NCT00333138|455329229|FG000|Core Study (6 Months)|Protocol Violation|1|||
126556527|NCT00333138|455329230|FG001|Core Study (6 Months)|Protocol Violation|0|||
126556528|NCT00333138|455329231|FG002|Core Study (6 Months)|Protocol Violation|1|||
126556529|NCT00333138|455329229|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
126556530|NCT00333138|455329230|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
126556531|NCT00333138|455329231|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
126556532|NCT00333138|455329229|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
126556533|NCT00333138|455329230|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
126556534|NCT00333138|455329231|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
126556535|NCT00333138|455329229|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
126556536|NCT00333138|455329230|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
126556537|NCT00333138|455329231|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
126556538|NCT00333138|455329229|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
126556539|NCT00333138|455329230|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
126556540|NCT00333138|455329231|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
126556541|NCT00333138|455329229|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
126556542|NCT00333138|455329230|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
126556543|NCT00333138|455329231|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
126556544|NCT00333138|455329229|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
126556545|NCT00333138|455329230|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
126556546|NCT00333138|455329231|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
126556547|NCT00333138|455329229|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
126556548|NCT00333138|455329230|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
126556549|NCT00333138|455329231|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
126556550|NCT00333138|455329229|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
126556551|NCT00333138|455329230|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
126556552|NCT00333138|455329231|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
126556553|NCT00333138|455329229|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
126556554|NCT00333138|455329230|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
126556555|NCT00333138|455329231|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
126556556|NCT00333138|455329229|FG000|Extension Study (Month6 to End of Study)|Death|0|||
126556557|NCT00333138|455329230|FG001|Extension Study (Month6 to End of Study)|Death|1|||
126556558|NCT00333138|455329231|FG002|Extension Study (Month6 to End of Study)|Death|0|||
126556559|NCT04630756|455329232|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
126556560|NCT04630756|455329233|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
126556561|NCT04630756|455329234|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
126556562|NCT05593211|455329235|FG000|Overall Study|Withdrawal by Subject|1|||
126556563|NCT03077620|455329239|FG000|Overall Study|Unable to place lumbar catheter|1|||
126556564|NCT03077620|455329240|FG001|Overall Study|Unable to place lumbar catheter|0|||
126556565|NCT03077620|455329241|FG002|Overall Study|Unable to place lumbar catheter|1|||
126556566|NCT03077620|455329242|FG003|Overall Study|Unable to place lumbar catheter|0|||
126556567|NCT03077620|455329239|FG000|Overall Study|Withdrawal by Subject|0|||
126556568|NCT03077620|455329240|FG001|Overall Study|Withdrawal by Subject|1|||
126556569|NCT03077620|455329241|FG002|Overall Study|Withdrawal by Subject|0|||
126556570|NCT03077620|455329242|FG003|Overall Study|Withdrawal by Subject|0|||
126556571|NCT03077620|455329239|FG000|Overall Study|Physician Decision|0|||
126556572|NCT03077620|455329240|FG001|Overall Study|Physician Decision|0|||
126556573|NCT03077620|455329241|FG002|Overall Study|Physician Decision|1|||
126556574|NCT03077620|455329242|FG003|Overall Study|Physician Decision|0|||
126556575|NCT03225846|455329243|FG000|Overall Study|Adverse Event|0|||
126556576|NCT03225846|455329244|FG001|Overall Study|Adverse Event|0|||
126556577|NCT03225846|455329245|FG002|Overall Study|Adverse Event|0|||
126556578|NCT03225846|455329246|FG003|Overall Study|Adverse Event|0|||
126556579|NCT03225846|455329247|FG004|Overall Study|Adverse Event|0|||
126556580|NCT03225846|455329248|FG005|Overall Study|Adverse Event|0|||
126556581|NCT03225846|455329249|FG006|Overall Study|Adverse Event|6|||
126556582|NCT03225846|455329243|FG000|Overall Study|Withdrawal by Subject|0|||
126556583|NCT03225846|455329244|FG001|Overall Study|Withdrawal by Subject|1|||
126556584|NCT03225846|455329245|FG002|Overall Study|Withdrawal by Subject|0|||
126556585|NCT03225846|455329246|FG003|Overall Study|Withdrawal by Subject|0|||
126556586|NCT03225846|455329247|FG004|Overall Study|Withdrawal by Subject|0|||
126556587|NCT03225846|455329248|FG005|Overall Study|Withdrawal by Subject|0|||
126556588|NCT03225846|455329249|FG006|Overall Study|Withdrawal by Subject|0|||
126556589|NCT03225846|455329243|FG000|Overall Study|Death|0|||
126556590|NCT03225846|455329244|FG001|Overall Study|Death|1|||
126556591|NCT03225846|455329245|FG002|Overall Study|Death|0|||
126556592|NCT03225846|455329246|FG003|Overall Study|Death|0|||
126556593|NCT03225846|455329247|FG004|Overall Study|Death|0|||
126556594|NCT03225846|455329248|FG005|Overall Study|Death|0|||
126556595|NCT03225846|455329249|FG006|Overall Study|Death|0|||
126556596|NCT03225846|455329243|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
126556597|NCT03225846|455329244|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
126556598|NCT03225846|455329245|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
126556599|NCT03225846|455329246|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
126556600|NCT03225846|455329247|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
126556601|NCT03225846|455329248|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
126556602|NCT03225846|455329249|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
126556603|NCT03225846|455329243|FG000|Overall Study|Patient decision|0|||
126556604|NCT03225846|455329244|FG001|Overall Study|Patient decision|0|||
126556605|NCT03225846|455329245|FG002|Overall Study|Patient decision|0|||
126556606|NCT03225846|455329246|FG003|Overall Study|Patient decision|0|||
126556607|NCT03225846|455329247|FG004|Overall Study|Patient decision|0|||
126556608|NCT03225846|455329248|FG005|Overall Study|Patient decision|0|||
126556609|NCT03225846|455329249|FG006|Overall Study|Patient decision|1|||
126556610|NCT00996580|455329250|FG000|Overall Study|Adverse Event|466|||
126556611|NCT00996580|455329250|FG000|Overall Study|Lost to Follow-up|480|||
126556612|NCT00996580|455329250|FG000|Overall Study|Noncompliance with the protocol|137|||
126556613|NCT00996580|455329250|FG000|Overall Study|Physician Decision|5|||
126556614|NCT00996580|455329250|FG000|Overall Study|Pregnancy|68|||
126556615|NCT00996580|455329250|FG000|Overall Study|Protocol Violation|16|||
126556616|NCT00996580|455329250|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
126556617|NCT00996580|455329250|FG000|Overall Study|Withdrawal by Subject|217|||
126556618|NCT00996580|455329250|FG000|Overall Study|Other|29|||
126556619|NCT05708846|455329251|FG000|Overall Study|Death|5|||
126556620|NCT05708846|455329251|FG000|Overall Study|Withdrawal by Subject|20|||
126556621|NCT02036515|455329252|FG000|Overall Study|Adverse Event|1|||
126556622|NCT02036515|455329253|FG001|Overall Study|Adverse Event|1|||
126556623|NCT02036515|455329254|FG002|Overall Study|Adverse Event|2|||
126556624|NCT02036515|455329252|FG000|Overall Study|Lost to Follow-up|0|||
126556625|NCT02036515|455329253|FG001|Overall Study|Lost to Follow-up|2|||
126556626|NCT02036515|455329254|FG002|Overall Study|Lost to Follow-up|0|||
126556627|NCT02036515|455329252|FG000|Overall Study|Non-compliance with study drug|0|||
126556628|NCT02036515|455329253|FG001|Overall Study|Non-compliance with study drug|0|||
126556629|NCT02036515|455329254|FG002|Overall Study|Non-compliance with study drug|2|||
126556630|NCT02036515|455329252|FG000|Overall Study|Screen failure|0|||
126556631|NCT02036515|455329253|FG001|Overall Study|Screen failure|2|||
126556632|NCT02036515|455329254|FG002|Overall Study|Screen failure|0|||
126556633|NCT02036515|455329252|FG000|Overall Study|Withdrawal by Subject|4|||
126556634|NCT02036515|455329253|FG001|Overall Study|Withdrawal by Subject|7|||
126556635|NCT02036515|455329254|FG002|Overall Study|Withdrawal by Subject|9|||
126556636|NCT02036515|455329252|FG000|Overall Study|Hyperglycemia|0|||
126556637|NCT02036515|455329253|FG001|Overall Study|Hyperglycemia|0|||
126556638|NCT02036515|455329254|FG002|Overall Study|Hyperglycemia|1|||
126556639|NCT00238420|455329255|FG000|Overall Study|Protocol Violation|1|||
126556640|NCT00238420|455329256|FG001|Overall Study|Protocol Violation|1|||
126556641|NCT03428815|455329257|FG000|Overall Study|Lost to Follow-up|2|||
126556642|NCT03428815|455329258|FG001|Overall Study|Lost to Follow-up|2|||
126556643|NCT03428815|455329257|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
126556644|NCT03428815|455329258|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
126556645|NCT03428815|455329257|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
126556646|NCT03428815|455329258|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
126556647|NCT04140890|455329261|FG000|Overall Study|Withdrawal by Subject|0|||
126556648|NCT04140890|455329262|FG001|Overall Study|Withdrawal by Subject|1|||
126556649|NCT02102464|455329263|FG000|Randomized Study|Withdrawal by Subject|0|||
126556650|NCT02102464|455329264|FG001|Randomized Study|Withdrawal by Subject|1|||
126556651|NCT02102464|455329265|FG002|Randomized Study|Withdrawal by Subject|0|||
126556652|NCT01700348|455329266|FG000|Overall Study|Withdrawal by Subject|22|||
126556653|NCT01700348|455329266|FG000|Overall Study|Lost to Follow-up|1|||
126556654|NCT03958630|455329267|FG000|Overall Study|Withdrawal by Subject|0|||
126556655|NCT03958630|455329268|FG001|Overall Study|Withdrawal by Subject|0|||
126556656|NCT03958630|455329269|FG002|Overall Study|Withdrawal by Subject|1|||
126556657|NCT03958630|455329267|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
126556658|NCT03958630|455329268|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
126556659|NCT03958630|455329269|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
126556660|NCT01824472|455329274|FG000|Overall Study|Lost to Follow-up|0|||
126556661|NCT01824472|455329275|FG001|Overall Study|Lost to Follow-up|0|||
126556662|NCT01824472|455329276|FG002|Overall Study|Lost to Follow-up|1|||
126556663|NCT01824472|455329274|FG000|Overall Study|Withdrawal by Subject|1|||
126556664|NCT01824472|455329275|FG001|Overall Study|Withdrawal by Subject|5|||
126556665|NCT01824472|455329276|FG002|Overall Study|Withdrawal by Subject|3|||
126556666|NCT01824472|455329274|FG000|Overall Study|Ineligible post randomization&screening|0|||
126556667|NCT01824472|455329275|FG001|Overall Study|Ineligible post randomization&screening|2|||
126556668|NCT01824472|455329276|FG002|Overall Study|Ineligible post randomization&screening|0|||
126556669|NCT01815736|455329277|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
126556670|NCT01815736|455329278|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
126556671|NCT01815736|455329277|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
126556672|NCT01815736|455329278|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
126556673|NCT01815736|455329277|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
126556674|NCT01815736|455329278|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
126556675|NCT01815736|455329277|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
126556676|NCT01815736|455329278|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
126556677|NCT01815736|455329277|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
126556678|NCT01815736|455329278|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
126556679|NCT01815736|455329277|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
126398334|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126556680|NCT01815736|455329278|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
126721144|NCT03552549|455928569|FG001|Overall Study|Disease progression|17|||
126721145|NCT03552549|455928568|FG000|Overall Study|Adverse event in first 12 months|12|||
126721146|NCT03552549|455928569|FG001|Overall Study|Adverse event in first 12 months|8|||
126721147|NCT03552549|455928568|FG000|Overall Study|Withdrawal by Subject|7|||
126721148|NCT03552549|455928569|FG001|Overall Study|Withdrawal by Subject|7|||
126721149|NCT03552549|455928568|FG000|Overall Study|Unknown (no reason provided)|4|||
126721150|NCT03552549|455928569|FG001|Overall Study|Unknown (no reason provided)|2|||
126721151|NCT03552549|455928568|FG000|Overall Study|Not in participant's best interest|2|||
126556681|NCT01815736|455329277|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
126556682|NCT01815736|455329278|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
126556683|NCT01815736|455329277|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
126556684|NCT01815736|455329278|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
126556685|NCT01815736|455329277|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
126556686|NCT01815736|455329278|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
126556687|NCT01815736|455329277|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
126556688|NCT01815736|455329278|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
126556689|NCT01815736|455329277|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
126556690|NCT01815736|455329278|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
126556691|NCT01815736|455329277|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
126556692|NCT01815736|455329278|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
126556693|NCT01815736|455329277|FG000|Extension Treatment Phase- After Week 96|Death|1|||
126556694|NCT01815736|455329278|FG001|Extension Treatment Phase- After Week 96|Death|0|||
126556695|NCT00245011|455329280|FG000|Overall Study|Lack of Efficacy|1|||
126556696|NCT03040687|455329283|FG000|Overall Study|Withdrawal by Subject|1|||
126556697|NCT03040687|455329284|FG001|Overall Study|Withdrawal by Subject|0|||
126556698|NCT03040687|455329285|FG002|Overall Study|Withdrawal by Subject|0|||
126556699|NCT00550173|455329286|FG000|Overall Study|Death|45|||
126556700|NCT00550173|455329287|FG001|Overall Study|Death|38|||
126556701|NCT00550173|455329288|FG002|Overall Study|Death|50|||
126556702|NCT00550173|455329286|FG000|Overall Study|Physician Decision|1|||
126556703|NCT00550173|455329287|FG001|Overall Study|Physician Decision|2|||
126556704|NCT00550173|455329288|FG002|Overall Study|Physician Decision|2|||
126556705|NCT00550173|455329286|FG000|Overall Study|Withdrawal by Subject|9|||
126721152|NCT03552549|455928569|FG001|Overall Study|Not in participant's best interest|1|||
126721153|NCT03552549|455928568|FG000|Overall Study|Did not complete study treatment|2|||
126721154|NCT03552549|455928569|FG001|Overall Study|Did not complete study treatment|3|||
126721155|NCT03552549|455928568|FG000|Overall Study|Did not meet eligibility criteria|1|||
126721156|NCT03552549|455928569|FG001|Overall Study|Did not meet eligibility criteria|0|||
126721157|NCT03552549|455928568|FG000|Overall Study|Administrative|0|||
126721158|NCT03552549|455928569|FG001|Overall Study|Administrative|14|||
126721159|NCT01465178|455928575|FG000|Overall Study|Withdrawal by Subject|1|||
126556706|NCT00550173|455329287|FG001|Overall Study|Withdrawal by Subject|12|||
126556707|NCT00550173|455329288|FG002|Overall Study|Withdrawal by Subject|17|||
126556708|NCT00550173|455329286|FG000|Overall Study|Sponsor Decision|13|||
126556709|NCT00550173|455329287|FG001|Overall Study|Sponsor Decision|7|||
126556710|NCT00550173|455329288|FG002|Overall Study|Sponsor Decision|1|||
126556711|NCT00550173|455329286|FG000|Overall Study|Lost to Follow-up|4|||
126556712|NCT00550173|455329287|FG001|Overall Study|Lost to Follow-up|4|||
126556713|NCT00550173|455329288|FG002|Overall Study|Lost to Follow-up|3|||
126556714|NCT01388543|455329291|FG000|Day 14|Adverse Event|1|||
126556715|NCT01388543|455329292|FG001|Day 14|Adverse Event|4|||
126556716|NCT01556243|455329293|FG000|Overall Study|Ineligible|34|||
126556717|NCT01556243|455329293|FG000|Overall Study|Converted to mastectomy|14|||
126556718|NCT01556243|455329293|FG000|Overall Study|Unable to achieve negative margins|2|||
126556719|NCT01556243|455329293|FG000|Overall Study|Withdrawal by Subject|16|||
126556720|NCT02325713|455329294|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556721|NCT02325713|455329295|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556722|NCT02325713|455329296|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556723|NCT02325713|455329297|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556724|NCT02325713|455329298|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556725|NCT02325713|455329299|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556726|NCT02325713|455329300|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556727|NCT02325713|455329301|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556728|NCT02325713|455329302|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556729|NCT02325713|455329303|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556730|NCT02325713|455329304|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
126556731|NCT02325713|455329305|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556732|NCT02325713|455329306|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556733|NCT02325713|455329307|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556734|NCT02325713|455329308|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126556735|NCT02325713|455329309|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
126721160|NCT01465178|455928576|FG001|Overall Study|Withdrawal by Subject|0|||
126721161|NCT03827473|455928579|FG000|Overall Study|Withdrawal by Subject|1|||
126721162|NCT03827473|455928580|FG001|Overall Study|Withdrawal by Subject|0|||
126721163|NCT01921257|455928581|FG000|Overall Study|Adverse Event|1|||
126721164|NCT01921257|455928581|FG000|Overall Study|Protocol Violation|1|||
126721165|NCT01921257|455928581|FG000|Overall Study|Withdrawal by Subject|1|||
126721166|NCT05515601|455928585|FG000|Overall Study|Withdrawal by Subject|1|||
126721167|NCT05515601|455928586|FG001|Overall Study|Withdrawal by Subject|3|||
126721168|NCT05515601|455928587|FG002|Overall Study|Withdrawal by Subject|2|||
126772276|NCT02030834|456122076|FG002|Overall Study|Lost to Follow-up|0|||
126556736|NCT02325713|455329294|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
126556737|NCT02325713|455329295|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556738|NCT02325713|455329296|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556739|NCT02325713|455329297|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556740|NCT02325713|455329298|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556741|NCT02325713|455329299|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556742|NCT02325713|455329300|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556743|NCT02325713|455329301|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556744|NCT02325713|455329302|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556745|NCT02325713|455329303|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556746|NCT02325713|455329304|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556747|NCT02325713|455329305|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556748|NCT02325713|455329306|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556749|NCT02325713|455329307|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556750|NCT02325713|455329308|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556751|NCT02325713|455329309|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
126556752|NCT02325713|455329294|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556753|NCT02325713|455329295|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556754|NCT02325713|455329296|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556755|NCT02325713|455329297|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556756|NCT02325713|455329298|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556757|NCT02325713|455329299|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556758|NCT02325713|455329300|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556759|NCT02325713|455329301|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556760|NCT02325713|455329302|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556761|NCT02325713|455329303|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
126556762|NCT02325713|455329304|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556763|NCT02325713|455329305|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556764|NCT02325713|455329306|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556765|NCT02325713|455329307|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556766|NCT02325713|455329308|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556767|NCT02325713|455329309|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
126556768|NCT01213173|455329311|FG000|Overall Study|Protocol Violation|2|||
126556769|NCT01213173|455329312|FG001|Overall Study|Protocol Violation|0|||
126556770|NCT01213173|455329311|FG000|Overall Study|Adverse Event|4|||
126556771|NCT01213173|455329312|FG001|Overall Study|Adverse Event|8|||
126556772|NCT01213173|455329311|FG000|Overall Study|Withdrawal by Subject|5|||
126398335|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126398336|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126556773|NCT01213173|455329312|FG001|Overall Study|Withdrawal by Subject|5|||
126556774|NCT01213173|455329311|FG000|Overall Study|Incorrect Enrollment|1|||
126556775|NCT01213173|455329312|FG001|Overall Study|Incorrect Enrollment|3|||
126556776|NCT00107380|455331034|FG000|Overall Study|Adverse Event|7|||
126556777|NCT00107380|455331034|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
126556778|NCT00107380|455331034|FG000|Overall Study|Progression/relapse|4|||
126556779|NCT00107380|455331034|FG000|Overall Study|Death|3|||
126556780|NCT00107380|455331034|FG000|Overall Study|Other - not protocol specified|7|||
126556781|NCT00107380|455331034|FG000|Overall Study|Ineligible|2|||
126556782|NCT03673098|455331035|FG000|Overall Study|Lost to Follow-up|2|||
126556783|NCT03673098|455331036|FG001|Overall Study|Lost to Follow-up|3|||
126556784|NCT03673098|455331035|FG000|Overall Study|Withdrawal by Subject|6|||
126556785|NCT03673098|455331036|FG001|Overall Study|Withdrawal by Subject|1|||
126556786|NCT03673098|455331035|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
126556787|NCT03673098|455331036|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
126721169|NCT05515601|455928588|FG003|Overall Study|Withdrawal by Subject|1|||
126721170|NCT05515601|455928589|FG004|Overall Study|Withdrawal by Subject|1|||
126721171|NCT05515601|455928590|FG005|Overall Study|Withdrawal by Subject|1|||
126721172|NCT05515601|455928585|FG000|Overall Study|Lost to Follow-up|0|||
126721173|NCT05515601|455928586|FG001|Overall Study|Lost to Follow-up|0|||
126721174|NCT05515601|455928587|FG002|Overall Study|Lost to Follow-up|0|||
126721175|NCT05515601|455928588|FG003|Overall Study|Lost to Follow-up|0|||
126721176|NCT05515601|455928589|FG004|Overall Study|Lost to Follow-up|1|||
126556788|NCT03531905|455331038|FG000|Overall Study|Withdrawal by Subject|3|||
126721177|NCT05515601|455928590|FG005|Overall Study|Lost to Follow-up|0|||
126721178|NCT00777491|455928591|FG000|Overall Study|Protocol Violation|0|||
126556789|NCT03531905|455331039|FG001|Overall Study|Withdrawal by Subject|3|||
126556790|NCT03531905|455331040|FG002|Overall Study|Withdrawal by Subject|2|||
126721179|NCT00777491|455928592|FG001|Overall Study|Protocol Violation|2|||
126721180|NCT00777491|455928591|FG000|Overall Study|Did not receive any protocol treatment|2|||
126721181|NCT00777491|455928592|FG001|Overall Study|Did not receive any protocol treatment|0|||
126398337|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
126398338|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
126398339|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
126398340|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
126398341|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
126398342|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
126398343|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
126398344|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
126398345|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
126398346|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
126556791|NCT03531905|455331038|FG000|Overall Study|Lost to Follow-up|2|||
126556792|NCT03531905|455331039|FG001|Overall Study|Lost to Follow-up|2|||
126556793|NCT03531905|455331040|FG002|Overall Study|Lost to Follow-up|1|||
126556794|NCT03531905|455331038|FG000|Overall Study|Participant was out of town|1|||
126556795|NCT03531905|455331039|FG001|Overall Study|Participant was out of town|0|||
126556796|NCT03531905|455331040|FG002|Overall Study|Participant was out of town|0|||
126556797|NCT03531905|455331038|FG000|Overall Study|Could not speak with the participant|1|||
126556798|NCT03531905|455331039|FG001|Overall Study|Could not speak with the participant|0|||
126556799|NCT03531905|455331040|FG002|Overall Study|Could not speak with the participant|0|||
126556800|NCT01536262|455331041|FG000|Overall Study|Adverse Event|6|||
126556801|NCT01536262|455331042|FG001|Overall Study|Adverse Event|1|||
126556802|NCT01536262|455331043|FG002|Overall Study|Adverse Event|2|||
126556803|NCT01536262|455331041|FG000|Overall Study|Withdrawal by Subject|1|||
126556804|NCT01536262|455331042|FG001|Overall Study|Withdrawal by Subject|1|||
126556805|NCT01536262|455331043|FG002|Overall Study|Withdrawal by Subject|0|||
126556806|NCT01536262|455331041|FG000|Overall Study|Other than stated above|1|||
126556807|NCT01536262|455331042|FG001|Overall Study|Other than stated above|0|||
126556808|NCT01536262|455331043|FG002|Overall Study|Other than stated above|0|||
126556809|NCT01781611|455331047|FG000|Overall Study|Adverse Event|4|||
126556810|NCT01781611|455331048|FG001|Overall Study|Adverse Event|0|||
126556811|NCT03639675|455331049|FG000|Overall Study|Withdrawal by Subject|1|||
126556812|NCT02264574|455331050|FG000|Overall Study|Death|21|||
126556813|NCT02264574|455331051|FG001|Overall Study|Death|21|||
126556814|NCT02264574|455331050|FG000|Overall Study|Withdrawal by Subject|8|||
126556815|NCT02264574|455331051|FG001|Overall Study|Withdrawal by Subject|6|||
126556816|NCT02264574|455331050|FG000|Overall Study|Other, Not Specified|0|||
126556817|NCT02264574|455331051|FG001|Overall Study|Other, Not Specified|3|||
126556818|NCT01477749|455331052|FG000|Overall Study|Physician Decision|4|||
126398347|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
126556819|NCT02886728|455331054|FG000|Overall Study|Withdrew Consent|31|||
126556820|NCT02886728|455331055|FG001|Overall Study|Withdrew Consent|13|||
126398348|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
126398349|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398350|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398351|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
126398352|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398353|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398354|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398355|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398356|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398357|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
126398358|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
126398359|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
126398360|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
126398361|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
126398362|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
126398363|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
126398364|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
126398365|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
126556821|NCT02886728|455331056|FG002|Overall Study|Withdrew Consent|11|||
126398366|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
126398367|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
126398368|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
126398369|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
126398370|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
126398371|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398372|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
126556822|NCT02886728|455331057|FG003|Overall Study|Withdrew Consent|47|||
126556823|NCT02886728|455331054|FG000|Overall Study|Lost to Follow-up|12|||
126556824|NCT02886728|455331055|FG001|Overall Study|Lost to Follow-up|6|||
126471493|NCT02149875|455027470|FG001|Overall Study|Withdrawal by Subject|2|||
126471494|NCT02149875|455027471|FG002|Overall Study|Withdrawal by Subject|2|||
126471495|NCT02149875|455027469|FG000|Overall Study|Physician Decision|1|||
126471496|NCT02149875|455027470|FG001|Overall Study|Physician Decision|2|||
126471497|NCT02149875|455027471|FG002|Overall Study|Physician Decision|2|||
126471498|NCT01262573|455027472|FG000|Overall Study|Withdrawal by Subject|0|||
126471499|NCT01262573|455027473|FG001|Overall Study|Withdrawal by Subject|1|||
126471500|NCT03800173|455027480|FG000|Overall Study|Lost to Follow-up|0|||
126471501|NCT03800173|455027481|FG001|Overall Study|Lost to Follow-up|0|||
126471502|NCT03800173|455027482|FG002|Overall Study|Lost to Follow-up|0|||
126471503|NCT03800173|455027483|FG003|Overall Study|Lost to Follow-up|0|||
126471504|NCT03800173|455027484|FG004|Overall Study|Lost to Follow-up|1|||
126471505|NCT02081183|455027486|FG000|Overall Study|Lost to Follow-up|0|||
126398373|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398374|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398375|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398376|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398377|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398378|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
126398379|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126398380|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126398381|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
126398382|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
126398383|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126398384|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126398385|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126398386|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126471506|NCT02081183|455027487|FG001|Overall Study|Lost to Follow-up|1|||
126471507|NCT02081183|455027486|FG000|Overall Study|Protocol Violation|1|||
126471508|NCT02081183|455027487|FG001|Overall Study|Protocol Violation|0|||
126471509|NCT02081183|455027486|FG000|Overall Study|Other|3|||
126471510|NCT02081183|455027487|FG001|Overall Study|Other|3|||
126471511|NCT00910273|455027492|FG000|Overall Study|Lack of Efficacy|6|||
126471512|NCT00910273|455027493|FG001|Overall Study|Lack of Efficacy|9|||
126471513|NCT00910273|455027492|FG000|Overall Study|Adverse Event|1|||
126471514|NCT00910273|455027493|FG001|Overall Study|Adverse Event|1|||
126471515|NCT00910273|455027492|FG000|Overall Study|Withdrawal by Subject|1|||
126471516|NCT00910273|455027493|FG001|Overall Study|Withdrawal by Subject|0|||
126471517|NCT00910273|455027492|FG000|Overall Study|Discontinuation of study by sponsor|8|||
126471518|NCT00910273|455027493|FG001|Overall Study|Discontinuation of study by sponsor|2|||
126471519|NCT00910273|455027492|FG000|Overall Study|Protocol Violation|1|||
126471520|NCT00910273|455027493|FG001|Overall Study|Protocol Violation|0|||
126471521|NCT00910273|455027492|FG000|Overall Study|Lost to Follow-up|1|||
126471522|NCT00910273|455027493|FG001|Overall Study|Lost to Follow-up|1|||
126471523|NCT03841448|455027494|FG000|Double-blind Treatment (DBT) Period|Death|1|||
126471524|NCT03841448|455027495|FG001|Double-blind Treatment (DBT) Period|Death|1|||
126471525|NCT03841448|455027496|FG002|Double-blind Treatment (DBT) Period|Death|0|||
126471526|NCT03841448|455027497|FG003|Double-blind Treatment (DBT) Period|Death|0|||
126471527|NCT03841448|455027494|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
126471528|NCT03841448|455027495|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
126471529|NCT03841448|455027496|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
126471530|NCT03841448|455027497|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
126471531|NCT03841448|455027494|FG000|Open-Label Extension (OLE) Period|Death|0|||
126471532|NCT03841448|455027495|FG001|Open-Label Extension (OLE) Period|Death|0|||
126471533|NCT03841448|455027496|FG002|Open-Label Extension (OLE) Period|Death|0|||
126471534|NCT03841448|455027497|FG003|Open-Label Extension (OLE) Period|Death|1|||
126471535|NCT03841448|455027494|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
126471536|NCT03841448|455027495|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
126471537|NCT03841448|455027496|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
126471538|NCT03841448|455027497|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
126471539|NCT03841448|455027494|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
126471540|NCT03841448|455027495|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
126471541|NCT03841448|455027496|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
126471542|NCT03841448|455027497|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
126471543|NCT03841448|455027494|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
126471544|NCT03841448|455027495|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
126556825|NCT02886728|455331056|FG002|Overall Study|Lost to Follow-up|13|||
126471545|NCT03841448|455027496|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
126471546|NCT03841448|455027497|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
126471547|NCT03896165|455027498|FG000|Overall Study|Withdrawal by Subject|2|||
126471548|NCT03181893|455027499|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
126471549|NCT03181893|455027500|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
126471550|NCT03181893|455027501|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
126471551|NCT03181893|455027502|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
126471552|NCT03181893|455027503|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
126556826|NCT02886728|455331057|FG003|Overall Study|Lost to Follow-up|12|||
126556827|NCT02886728|455331054|FG000|Overall Study|Adverse Event|13|||
126556828|NCT02886728|455331055|FG001|Overall Study|Adverse Event|5|||
126556829|NCT02886728|455331056|FG002|Overall Study|Adverse Event|5|||
126556830|NCT02886728|455331057|FG003|Overall Study|Adverse Event|11|||
126556831|NCT02886728|455331054|FG000|Overall Study|Investigator's Discretion|11|||
126556832|NCT02886728|455331055|FG001|Overall Study|Investigator's Discretion|7|||
126556833|NCT02886728|455331056|FG002|Overall Study|Investigator's Discretion|5|||
126556834|NCT02886728|455331057|FG003|Overall Study|Investigator's Discretion|11|||
126556835|NCT02886728|455331054|FG000|Overall Study|Death|3|||
126556836|NCT02886728|455331055|FG001|Overall Study|Death|1|||
126556837|NCT02886728|455331056|FG002|Overall Study|Death|0|||
126556838|NCT02886728|455331057|FG003|Overall Study|Death|0|||
126556839|NCT02886728|455331054|FG000|Overall Study|Protocol Violation|0|||
126556840|NCT02886728|455331055|FG001|Overall Study|Protocol Violation|0|||
126556841|NCT02886728|455331056|FG002|Overall Study|Protocol Violation|0|||
126556842|NCT02886728|455331057|FG003|Overall Study|Protocol Violation|4|||
126556843|NCT02886728|455331054|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126556844|NCT02886728|455331055|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126556845|NCT02886728|455331056|FG002|Overall Study|Non-Compliance with Study Drug|1|||
126556846|NCT02886728|455331057|FG003|Overall Study|Non-Compliance with Study Drug|0|||
126556847|NCT02886728|455331054|FG000|Overall Study|Pregnancy|0|||
126556848|NCT02886728|455331055|FG001|Overall Study|Pregnancy|0|||
126556849|NCT02886728|455331056|FG002|Overall Study|Pregnancy|1|||
126556850|NCT02886728|455331057|FG003|Overall Study|Pregnancy|0|||
126556851|NCT02886728|455331054|FG000|Overall Study|Randomized but Not Dosed|1|||
126556852|NCT02886728|455331055|FG001|Overall Study|Randomized but Not Dosed|0|||
126556853|NCT02886728|455331056|FG002|Overall Study|Randomized but Not Dosed|0|||
126556854|NCT02886728|455331057|FG003|Overall Study|Randomized but Not Dosed|2|||
126556855|NCT02724020|455331063|FG000|Overall Study|Death|16|||
126556856|NCT02724020|455331064|FG001|Overall Study|Death|18|||
126556857|NCT02724020|455331065|FG002|Overall Study|Death|19|||
126556858|NCT02724020|455331063|FG000|Overall Study|Lost to Follow-up|0|||
126556859|NCT02724020|455331064|FG001|Overall Study|Lost to Follow-up|3|||
126556860|NCT02724020|455331065|FG002|Overall Study|Lost to Follow-up|0|||
126556861|NCT02724020|455331063|FG000|Overall Study|Site Terminated by Sponsor|15|||
126556862|NCT02724020|455331064|FG001|Overall Study|Site Terminated by Sponsor|8|||
126556863|NCT02724020|455331065|FG002|Overall Study|Site Terminated by Sponsor|8|||
126556864|NCT02724020|455331063|FG000|Overall Study|Withdrawal by Subject|1|||
126556865|NCT02724020|455331064|FG001|Overall Study|Withdrawal by Subject|3|||
126556866|NCT02724020|455331065|FG002|Overall Study|Withdrawal by Subject|5|||
126556867|NCT00425503|455331066|FG000|Overall Study|Adverse Event|2|||
126556868|NCT00425503|455331066|FG000|Overall Study|Protocol Violation|1|||
126556869|NCT02118714|455331068|FG000|Overall Study|Lost to Follow-up|2|||
126556870|NCT02118714|455331068|FG000|Overall Study|Protocol Violation|1|||
126556871|NCT01310868|455331069|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
126556872|NCT02411591|455331070|FG000|Overall Study|Adverse Event|0|||
126556873|NCT02411591|455331071|FG001|Overall Study|Adverse Event|4|||
126556874|NCT02411591|455331072|FG002|Overall Study|Adverse Event|2|||
126556875|NCT02411591|455331070|FG000|Overall Study|Withdrawal by Subject|0|||
126556876|NCT02411591|455331071|FG001|Overall Study|Withdrawal by Subject|3|||
126556877|NCT02411591|455331072|FG002|Overall Study|Withdrawal by Subject|0|||
126556878|NCT02411591|455331070|FG000|Overall Study|Physician Decision|0|||
126471553|NCT03181893|455027504|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
126471554|NCT03181893|455027505|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
126471555|NCT03181893|455027506|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
126556879|NCT02411591|455331071|FG001|Overall Study|Physician Decision|3|||
126556880|NCT02411591|455331072|FG002|Overall Study|Physician Decision|1|||
126556881|NCT02491892|455331073|FG000|Overall Study|Adverse Event|1|||
126556882|NCT02491892|455331074|FG001|Overall Study|Adverse Event|1|||
126556883|NCT02491892|455331073|FG000|Overall Study|Death|1|||
126556884|NCT02491892|455331074|FG001|Overall Study|Death|1|||
126556885|NCT02491892|455331073|FG000|Overall Study|Lack of Efficacy|37|||
126556886|NCT02491892|455331074|FG001|Overall Study|Lack of Efficacy|36|||
126556887|NCT02491892|455331073|FG000|Overall Study|Refused Treatment|1|||
126556888|NCT02491892|455331074|FG001|Overall Study|Refused Treatment|0|||
126556889|NCT02491892|455331073|FG000|Overall Study|Lost to Follow-up|1|||
126556890|NCT02491892|455331074|FG001|Overall Study|Lost to Follow-up|0|||
126556891|NCT04227340|455331075|FG000|Overall Study|Withdrawal by Subject|3|||
126556892|NCT01066156|455331076|FG000|Overall Study|ineligible|2|||
126556893|NCT01066156|455331076|FG000|Overall Study|Lost to Follow-up|7|||
126556894|NCT01066156|455331076|FG000|Overall Study|Withdrawal by Subject|1|||
126556895|NCT00661258|455331087|FG000|Overall Study|Death|1|||
126556896|NCT00661258|455331088|FG001|Overall Study|Death|0|||
126556897|NCT00661258|455331087|FG000|Overall Study|caught by police and in detox center|2|||
126556898|NCT00661258|455331088|FG001|Overall Study|caught by police and in detox center|1|||
126556899|NCT01628874|455331089|FG000|Overall Study|Physician Decision|1|||
126556900|NCT01628874|455331090|FG001|Overall Study|Physician Decision|1|||
126556901|NCT01628874|455331089|FG000|Overall Study|Age >4 months|4|||
126556902|NCT01628874|455331090|FG001|Overall Study|Age >4 months|2|||
126556903|NCT00184028|455331091|FG000|Overall Study|Death|1|||
126556904|NCT00184028|455331091|FG000|Overall Study|Lack of Efficacy|4|||
126556905|NCT00184028|455331091|FG000|Overall Study|Adverse Event|2|||
126556906|NCT00184028|455331091|FG000|Overall Study|Withdrawal by Subject|1|||
126556907|NCT00184028|455331091|FG000|Overall Study|Non-compliance|2|||
126556908|NCT01354938|455331094|FG000|Overall Study|Lost to Follow-up|1|||
126556909|NCT02335268|455331095|FG000|Overall Study|Physician Decision|5|||
126556910|NCT02335268|455331096|FG001|Overall Study|Physician Decision|1|||
126556911|NCT02335268|455331095|FG000|Overall Study|Lack of Efficacy|2|||
126556912|NCT02335268|455331096|FG001|Overall Study|Lack of Efficacy|1|||
126556913|NCT02335268|455331095|FG000|Overall Study|Adverse Event|5|||
126556914|NCT02335268|455331096|FG001|Overall Study|Adverse Event|2|||
126556915|NCT02335268|455331095|FG000|Overall Study|increase blasts|2|||
126556916|NCT02335268|455331096|FG001|Overall Study|increase blasts|0|||
126556917|NCT02335268|455331095|FG000|Overall Study|Withdrawal by Subject|3|||
126556918|NCT02335268|455331096|FG001|Overall Study|Withdrawal by Subject|2|||
126556919|NCT01192295|455331100|FG000|Overall Study|Adverse Event|3|||
126556920|NCT01192295|455331101|FG001|Overall Study|Adverse Event|7|||
126556921|NCT01192295|455331100|FG000|Overall Study|Withdrawal by Subject|3|||
126556922|NCT01192295|455331101|FG001|Overall Study|Withdrawal by Subject|4|||
126556923|NCT01192295|455331100|FG000|Overall Study|Lost to Follow-up|0|||
126556924|NCT01192295|455331101|FG001|Overall Study|Lost to Follow-up|1|||
126556925|NCT01192295|455331100|FG000|Overall Study|Lack of Efficacy|0|||
126398387|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
126398388|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126398389|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126556926|NCT01192295|455331101|FG001|Overall Study|Lack of Efficacy|5|||
126556927|NCT01192295|455331100|FG000|Overall Study|Administrative|4|||
126556928|NCT01192295|455331101|FG001|Overall Study|Administrative|6|||
126556929|NCT03785340|455331104|FG000|Overall Study|Lost to Follow-up|2|||
126556930|NCT03785340|455331105|FG001|Overall Study|Lost to Follow-up|0|||
126556931|NCT03785340|455331104|FG000|Overall Study|Adverse Event|1|||
126556932|NCT03785340|455331105|FG001|Overall Study|Adverse Event|0|||
126556933|NCT01670500|455331113|FG000|Overall Study|Withdrawal by Subject|1|||
126556934|NCT01670500|455331114|FG001|Overall Study|Withdrawal by Subject|0|||
126556935|NCT03473756|455331115|FG000|Overall Study|Withdrawal by Subject|1|||
126556936|NCT03473756|455331116|FG001|Overall Study|Withdrawal by Subject|4|||
126556937|NCT03473756|455331115|FG000|Overall Study|Adverse Event|6|||
126556938|NCT03473756|455331116|FG001|Overall Study|Adverse Event|7|||
126556939|NCT03473756|455331115|FG000|Overall Study|Lack of Efficacy|3|||
126556940|NCT03473756|455331116|FG001|Overall Study|Lack of Efficacy|10|||
126556941|NCT03473756|455331115|FG000|Overall Study|Physician Decision|0|||
126556942|NCT03473756|455331116|FG001|Overall Study|Physician Decision|2|||
126556943|NCT03473756|455331115|FG000|Overall Study|End of study treatment|0|||
126556944|NCT03473756|455331116|FG001|Overall Study|End of study treatment|2|||
126556945|NCT03473756|455331115|FG000|Overall Study|Lost to Follow-up|0|||
126556946|NCT03473756|455331116|FG001|Overall Study|Lost to Follow-up|1|||
126556947|NCT02148718|455331117|FG000|Overall Study|Protocol Violation|26|||
126556948|NCT02148718|455331117|FG000|Overall Study|Discontinued Study Prematurely|5|||
126556949|NCT00003509|455331118|FG000|Overall Study|Not evaluable|5|||
126556950|NCT00333788|455331119|FG000|Overall Study|Adverse Event|44|||
126556951|NCT00333788|455331119|FG000|Overall Study|Lack of Efficacy|80|||
126556952|NCT00333788|455331119|FG000|Overall Study|Lost to Follow-up|2|||
126556953|NCT00333788|455331119|FG000|Overall Study|Withdrawal by Subject|24|||
126556954|NCT00333788|455331119|FG000|Overall Study|Other: Non-compliance|2|||
126556955|NCT00333788|455331119|FG000|Overall Study|Other: Moved|2|||
126556956|NCT00333788|455331119|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
126556957|NCT00333788|455331119|FG000|Overall Study|Other: Investigator decision|1|||
126556958|NCT00333788|455331119|FG000|Overall Study|Other: Quality of life concern|1|||
126556959|NCT00333788|455331119|FG000|Overall Study|Other: Sponsor decision|1|||
126556960|NCT00333788|455331119|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
126556961|NCT00333788|455331119|FG000|Overall Study|Other: Medical monitor decision|1|||
126556962|NCT00333788|455331119|FG000|Overall Study|Other: Physician decision|1|||
126721182|NCT04160468|455928593|FG000|Overall Study|Lost to Follow-up|19|||
126721183|NCT04160468|455928594|FG001|Overall Study|Lost to Follow-up|4|||
126721184|NCT04160468|455928593|FG000|Overall Study|Randomized but not dosed|6|||
126721185|NCT04160468|455928594|FG001|Overall Study|Randomized but not dosed|0|||
126721186|NCT04160468|455928593|FG000|Overall Study|Withdrawal by Subject|4|||
126398390|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398391|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126398392|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126398393|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398394|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398395|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398396|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398397|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398398|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398399|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398400|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
126398401|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398402|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
126398403|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398404|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398405|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398406|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398407|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398408|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
126398409|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
126398410|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
126398411|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
126398412|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
126398413|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
126398414|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
126398415|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
126398416|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
126398417|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
126398418|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398419|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398420|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398421|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
126398422|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
126398423|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398424|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398425|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398426|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126471556|NCT03181893|455027507|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
126471557|NCT03181893|455027508|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
126471558|NCT03181893|455027509|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
126471559|NCT03181893|455027499|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
126471560|NCT03181893|455027500|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
126471561|NCT03181893|455027501|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
126471562|NCT03181893|455027502|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
126471563|NCT03181893|455027503|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
126471564|NCT03181893|455027504|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
126471565|NCT03181893|455027505|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
126471566|NCT03181893|455027506|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
126471567|NCT03181893|455027507|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
126721187|NCT04160468|455928594|FG001|Overall Study|Withdrawal by Subject|1|||
126721188|NCT04160468|455928593|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
126721189|NCT04160468|455928594|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
126721190|NCT04160468|455928593|FG000|Overall Study|Participant incarcerated|1|||
126471568|NCT03181893|455027508|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
126471569|NCT03181893|455027509|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
126471570|NCT03181893|455027499|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
126556963|NCT00333788|455331119|FG000|Overall Study|Other: Signed consent for another study|1|||
126556964|NCT04951479|455331120|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
126556965|NCT02711826|455331123|FG000|Overall Study|Physician Decision|0|||
126556966|NCT02711826|455331124|FG001|Overall Study|Physician Decision|0|||
126556967|NCT02711826|455331125|FG002|Overall Study|Physician Decision|0|||
126556968|NCT02711826|455331126|FG003|Overall Study|Physician Decision|1|||
126556969|NCT02711826|455331127|FG004|Overall Study|Physician Decision|0|||
126721191|NCT04160468|455928594|FG001|Overall Study|Participant incarcerated|0|||
126721192|NCT01187901|455928595|FG000|Overall Study|Protocol Violation|1|||
126721193|NCT01187901|455928596|FG001|Overall Study|Protocol Violation|0|||
126721194|NCT01187901|455928595|FG000|Overall Study|Lost to Follow-up|1|||
126721195|NCT01187901|455928596|FG001|Overall Study|Lost to Follow-up|2|||
126556970|NCT02711826|455331123|FG000|Overall Study|Withdrawal by Subject|0|||
126556971|NCT02711826|455331124|FG001|Overall Study|Withdrawal by Subject|1|||
126556972|NCT02711826|455331125|FG002|Overall Study|Withdrawal by Subject|0|||
126556973|NCT02711826|455331126|FG003|Overall Study|Withdrawal by Subject|4|||
126556974|NCT02711826|455331127|FG004|Overall Study|Withdrawal by Subject|0|||
126556975|NCT02711826|455331123|FG000|Overall Study|Failure to manufacture cellular product|0|||
126556976|NCT02711826|455331124|FG001|Overall Study|Failure to manufacture cellular product|0|||
126556977|NCT02711826|455331125|FG002|Overall Study|Failure to manufacture cellular product|5|||
126556978|NCT02711826|455331126|FG003|Overall Study|Failure to manufacture cellular product|0|||
126556979|NCT02711826|455331127|FG004|Overall Study|Failure to manufacture cellular product|0|||
126556980|NCT02711826|455331123|FG000|Overall Study|Infusion canceled for active infection|0|||
126556981|NCT02711826|455331124|FG001|Overall Study|Infusion canceled for active infection|1|||
126556982|NCT02711826|455331125|FG002|Overall Study|Infusion canceled for active infection|0|||
126556983|NCT02711826|455331126|FG003|Overall Study|Infusion canceled for active infection|0|||
126556984|NCT02711826|455331127|FG004|Overall Study|Infusion canceled for active infection|0|||
126556985|NCT02711826|455331123|FG000|Overall Study|Screen failures|0|||
126556986|NCT02711826|455331124|FG001|Overall Study|Screen failures|0|||
126556987|NCT02711826|455331125|FG002|Overall Study|Screen failures|0|||
126556988|NCT02711826|455331126|FG003|Overall Study|Screen failures|4|||
126556989|NCT02711826|455331127|FG004|Overall Study|Screen failures|0|||
126556990|NCT01960790|455331128|FG000|Overall Study|Survey forms could not be recovered|3|||
126556991|NCT01960790|455331128|FG000|Overall Study|Treat with Humira outside survey period|3|||
126556992|NCT01960790|455331128|FG000|Overall Study|Transferred to another hospital|4|||
126556993|NCT01960790|455331128|FG000|Overall Study|Unevaluable for safety|1|||
126556994|NCT02169219|455331131|FG000|Overall Study|Lack of Efficacy|6|||
126556995|NCT02886936|455331138|FG000|Overall Study|Lost to Follow-up|4|||
126556996|NCT02886936|455331139|FG001|Overall Study|Lost to Follow-up|3|||
126556997|NCT02886936|455331140|FG002|Overall Study|Lost to Follow-up|0|||
126556998|NCT02320721|455331141|FG000|Overall Study|Adverse Event|6|||
126556999|NCT02320721|455331142|FG001|Overall Study|Adverse Event|6|||
126557000|NCT02320721|455331141|FG000|Overall Study|Lack of Efficacy|2|||
126557001|NCT02320721|455331142|FG001|Overall Study|Lack of Efficacy|0|||
126557002|NCT02320721|455331141|FG000|Overall Study|Poor compliance to protocol|3|||
126557003|NCT02320721|455331142|FG001|Overall Study|Poor compliance to protocol|7|||
126557004|NCT02320721|455331141|FG000|Overall Study|Randomized but not treated|0|||
126557005|NCT02320721|455331142|FG001|Overall Study|Randomized but not treated|1|||
126557006|NCT02320721|455331141|FG000|Overall Study|Hypoglycemia|1|||
126557007|NCT02320721|455331142|FG001|Overall Study|Hypoglycemia|0|||
126557008|NCT02320721|455331141|FG000|Overall Study|Other than specified above|15|||
126557009|NCT02320721|455331142|FG001|Overall Study|Other than specified above|20|||
126557010|NCT00847301|455331143|FG000|Overall Study|Adverse Event|35|||
126557011|NCT00847301|455331143|FG000|Overall Study|Switch to other anticoagulants|16|||
126557012|NCT00847301|455331143|FG000|Overall Study|Lost to Follow-up|1|||
126557013|NCT00847301|455331143|FG000|Overall Study|No prescription after hospital discharge|1|||
126557014|NCT00847301|455331143|FG000|Overall Study|Other reason not defined above|1|||
126557015|NCT04248465|455331144|FG000|Randomized-Controlled Period|Death|12|||
126557016|NCT04248465|455331145|FG001|Randomized-Controlled Period|Death|5|||
126557017|NCT04248465|455331144|FG000|Randomized-Controlled Period|Adverse Event|2|||
126557018|NCT04248465|455331145|FG001|Randomized-Controlled Period|Adverse Event|0|||
126557019|NCT04248465|455331144|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
126557020|NCT04248465|455331145|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
126557021|NCT04248465|455331144|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
126471571|NCT03181893|455027500|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
126471572|NCT03181893|455027501|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
126471573|NCT03181893|455027502|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
126471574|NCT03181893|455027503|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
126471575|NCT03181893|455027504|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
126471576|NCT03181893|455027505|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
126471577|NCT03181893|455027506|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
126471578|NCT03181893|455027507|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
126471579|NCT03181893|455027508|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
126557022|NCT04248465|455331145|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
126557023|NCT04248465|455331144|FG000|Randomized-Controlled Period|Physician Decision|1|||
126557024|NCT04248465|455331145|FG001|Randomized-Controlled Period|Physician Decision|1|||
126557025|NCT04248465|455331144|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
126557026|NCT04248465|455331145|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
126557027|NCT04248465|455331144|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
126557028|NCT04248465|455331145|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
126557029|NCT04248465|455331144|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
126398427|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398428|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
126557030|NCT04248465|455331145|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
126557031|NCT03621982|455331146|FG000|Overall Study|Withdrawal by Subject|1|||
126557032|NCT03621982|455331147|FG001|Overall Study|Withdrawal by Subject|0|||
126557033|NCT03621982|455331148|FG002|Overall Study|Withdrawal by Subject|0|||
126557034|NCT03621982|455331149|FG003|Overall Study|Withdrawal by Subject|1|||
126557035|NCT03621982|455331150|FG004|Overall Study|Withdrawal by Subject|0|||
126557036|NCT03621982|455331151|FG005|Overall Study|Withdrawal by Subject|1|||
126557037|NCT03621982|455331152|FG006|Overall Study|Withdrawal by Subject|1|||
126557038|NCT03621982|455331153|FG007|Overall Study|Withdrawal by Subject|0|||
126557039|NCT03621982|455331154|FG008|Overall Study|Withdrawal by Subject|1|||
126557040|NCT03621982|455331155|FG009|Overall Study|Withdrawal by Subject|0|||
126557041|NCT03621982|455331156|FG010|Overall Study|Withdrawal by Subject|2|||
126557042|NCT03621982|455331157|FG011|Overall Study|Withdrawal by Subject|1|||
126557043|NCT03621982|455331158|FG012|Overall Study|Withdrawal by Subject|2|||
126557044|NCT03621982|455331159|FG013|Overall Study|Withdrawal by Subject|2|||
126557045|NCT03621982|455331146|FG000|Overall Study|Investigator/Sponsor decision|0|||
126557046|NCT03621982|455331147|FG001|Overall Study|Investigator/Sponsor decision|0|||
126557047|NCT03621982|455331148|FG002|Overall Study|Investigator/Sponsor decision|0|||
126557048|NCT03621982|455331149|FG003|Overall Study|Investigator/Sponsor decision|0|||
126557049|NCT03621982|455331150|FG004|Overall Study|Investigator/Sponsor decision|0|||
126557050|NCT03621982|455331151|FG005|Overall Study|Investigator/Sponsor decision|0|||
126557051|NCT03621982|455331152|FG006|Overall Study|Investigator/Sponsor decision|0|||
126557052|NCT03621982|455331153|FG007|Overall Study|Investigator/Sponsor decision|0|||
126557053|NCT03621982|455331154|FG008|Overall Study|Investigator/Sponsor decision|0|||
126557054|NCT03621982|455331155|FG009|Overall Study|Investigator/Sponsor decision|0|||
126557055|NCT03621982|455331156|FG010|Overall Study|Investigator/Sponsor decision|0|||
126557056|NCT03621982|455331157|FG011|Overall Study|Investigator/Sponsor decision|4|||
126557057|NCT03621982|455331158|FG012|Overall Study|Investigator/Sponsor decision|0|||
126557058|NCT03621982|455331159|FG013|Overall Study|Investigator/Sponsor decision|2|||
126557059|NCT03621982|455331146|FG000|Overall Study|Death|2|||
126557060|NCT03621982|455331147|FG001|Overall Study|Death|4|||
126557061|NCT03621982|455331148|FG002|Overall Study|Death|4|||
126557062|NCT03621982|455331149|FG003|Overall Study|Death|3|||
126557063|NCT03621982|455331150|FG004|Overall Study|Death|8|||
126557064|NCT03621982|455331151|FG005|Overall Study|Death|4|||
126557065|NCT03621982|455331152|FG006|Overall Study|Death|6|||
126557066|NCT03621982|455331153|FG007|Overall Study|Death|3|||
126557067|NCT03621982|455331154|FG008|Overall Study|Death|0|||
126557068|NCT03621982|455331155|FG009|Overall Study|Death|3|||
126557069|NCT03621982|455331156|FG010|Overall Study|Death|8|||
126557070|NCT03621982|455331157|FG011|Overall Study|Death|4|||
126557071|NCT03621982|455331158|FG012|Overall Study|Death|2|||
126557072|NCT03621982|455331159|FG013|Overall Study|Death|2|||
126557073|NCT03621982|455331146|FG000|Overall Study|Lost to Follow-up|0|||
126557074|NCT03621982|455331147|FG001|Overall Study|Lost to Follow-up|0|||
126557075|NCT03621982|455331148|FG002|Overall Study|Lost to Follow-up|1|||
126557076|NCT03621982|455331149|FG003|Overall Study|Lost to Follow-up|0|||
126557077|NCT03621982|455331150|FG004|Overall Study|Lost to Follow-up|0|||
126557078|NCT03621982|455331151|FG005|Overall Study|Lost to Follow-up|0|||
126557079|NCT03621982|455331152|FG006|Overall Study|Lost to Follow-up|1|||
126557080|NCT03621982|455331153|FG007|Overall Study|Lost to Follow-up|0|||
126398429|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398430|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
126557081|NCT03621982|455331154|FG008|Overall Study|Lost to Follow-up|0|||
126557082|NCT03621982|455331155|FG009|Overall Study|Lost to Follow-up|1|||
126557083|NCT03621982|455331156|FG010|Overall Study|Lost to Follow-up|0|||
126557084|NCT03621982|455331157|FG011|Overall Study|Lost to Follow-up|0|||
126557085|NCT03621982|455331158|FG012|Overall Study|Lost to Follow-up|0|||
126557086|NCT03621982|455331159|FG013|Overall Study|Lost to Follow-up|0|||
126398431|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
126557087|NCT00442286|455331160|FG000|Overall Study|Death|2|||
126557088|NCT00442286|455331161|FG001|Overall Study|Death|2|||
126557089|NCT00442286|455331160|FG000|Overall Study|Lost to Follow-up|1|||
126557090|NCT00442286|455331161|FG001|Overall Study|Lost to Follow-up|0|||
126557091|NCT00442286|455331160|FG000|Overall Study|Withdrawal by Subject|2|||
126398432|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
126398433|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398434|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398435|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398436|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398437|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398438|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
126398439|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126557092|NCT00442286|455331161|FG001|Overall Study|Withdrawal by Subject|0|||
126557093|NCT00442286|455331160|FG000|Overall Study|System explanted|1|||
126557094|NCT00442286|455331161|FG001|Overall Study|System explanted|0|||
126557095|NCT00442286|455331160|FG000|Overall Study|Patient Injury|1|||
126557096|NCT00442286|455331161|FG001|Overall Study|Patient Injury|0|||
126557097|NCT01544582|455331164|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
126557098|NCT01544582|455331165|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
126557099|NCT01544582|455331166|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
126557100|NCT01544582|455331167|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
126557101|NCT01544582|455331164|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
126557102|NCT01544582|455331165|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
126557103|NCT01544582|455331166|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
126557104|NCT01544582|455331167|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
126557105|NCT01544582|455331164|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
126557106|NCT01544582|455331165|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
126557107|NCT01544582|455331166|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
126557108|NCT01544582|455331167|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
126557109|NCT01544582|455331164|FG000|Analysis Population|Physician Decision|0|||
126557110|NCT01544582|455331165|FG001|Analysis Population|Physician Decision|13|||
126557111|NCT01544582|455331166|FG002|Analysis Population|Physician Decision|10|||
126557112|NCT01544582|455331167|FG003|Analysis Population|Physician Decision|9|||
126557113|NCT01544582|455331164|FG000|Analysis Population|Safety Reason|0|||
126557114|NCT01544582|455331165|FG001|Analysis Population|Safety Reason|33|||
126557115|NCT01544582|455331166|FG002|Analysis Population|Safety Reason|31|||
126557116|NCT01544582|455331167|FG003|Analysis Population|Safety Reason|8|||
126557117|NCT01544582|455331164|FG000|Analysis Population|Effectiveness Reason|0|||
126557118|NCT01544582|455331165|FG001|Analysis Population|Effectiveness Reason|48|||
126557119|NCT01544582|455331166|FG002|Analysis Population|Effectiveness Reason|29|||
126557120|NCT01544582|455331167|FG003|Analysis Population|Effectiveness Reason|12|||
126557121|NCT01544582|455331164|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
126557122|NCT01544582|455331165|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
126557123|NCT01544582|455331166|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
126557124|NCT01544582|455331167|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
126557125|NCT01544582|455331164|FG000|Analysis Population|Lost to Follow-up|0|||
126557126|NCT01544582|455331165|FG001|Analysis Population|Lost to Follow-up|6|||
126557127|NCT01544582|455331166|FG002|Analysis Population|Lost to Follow-up|6|||
126557128|NCT01544582|455331167|FG003|Analysis Population|Lost to Follow-up|5|||
126557129|NCT01544582|455331164|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
126557130|NCT01544582|455331165|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
126557131|NCT01544582|455331166|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
126557132|NCT01544582|455331167|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
126557133|NCT01544582|455331164|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
126557134|NCT01544582|455331165|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
126557135|NCT01544582|455331166|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
126557136|NCT01544582|455331167|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
126557137|NCT01544582|455331164|FG000|Analysis Population|Intolerance|0|||
126557138|NCT01544582|455331165|FG001|Analysis Population|Intolerance|1|||
126557139|NCT01544582|455331166|FG002|Analysis Population|Intolerance|0|||
126557140|NCT01544582|455331167|FG003|Analysis Population|Intolerance|0|||
126557141|NCT01544582|455331164|FG000|Analysis Population|Liver Transplantation|0|||
126557142|NCT01544582|455331165|FG001|Analysis Population|Liver Transplantation|0|||
126557143|NCT01544582|455331166|FG002|Analysis Population|Liver Transplantation|1|||
126557144|NCT01544582|455331167|FG003|Analysis Population|Liver Transplantation|0|||
126557145|NCT01544582|455331164|FG000|Analysis Population|No Social Insurance|0|||
126557146|NCT01544582|455331165|FG001|Analysis Population|No Social Insurance|0|||
126557147|NCT01544582|455331166|FG002|Analysis Population|No Social Insurance|1|||
126557148|NCT01544582|455331167|FG003|Analysis Population|No Social Insurance|0|||
126557149|NCT01544582|455331164|FG000|Analysis Population|Poor Adherence|0|||
126557150|NCT01544582|455331165|FG001|Analysis Population|Poor Adherence|0|||
126557151|NCT01544582|455331166|FG002|Analysis Population|Poor Adherence|1|||
126557152|NCT01544582|455331167|FG003|Analysis Population|Poor Adherence|0|||
126557153|NCT01544582|455331164|FG000|Analysis Population|Poor Participant Compliance|0|||
126471580|NCT03181893|455027509|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
126471581|NCT03181893|455027499|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
126471582|NCT03181893|455027500|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
126471583|NCT03181893|455027501|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
126471584|NCT03181893|455027502|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
126471585|NCT03181893|455027503|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
126471586|NCT03181893|455027504|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
126471587|NCT03181893|455027505|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
126471588|NCT03181893|455027506|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
126471589|NCT03181893|455027507|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
126471590|NCT03181893|455027508|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
126471591|NCT03181893|455027509|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
126471592|NCT03181893|455027499|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
126471593|NCT03181893|455027500|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
126471594|NCT03181893|455027501|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
126471595|NCT03181893|455027502|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
126471596|NCT03181893|455027503|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
126471597|NCT03181893|455027504|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
126471598|NCT03181893|455027505|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
126471599|NCT03181893|455027506|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
126471600|NCT03181893|455027507|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
126471601|NCT03181893|455027508|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
126471602|NCT03181893|455027509|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
126471603|NCT04128371|455027510|FG000|Overall Study|Lack of Efficacy|1|||
126471604|NCT00968864|455027511|FG000|Overall Study|Protocol exception/ not evaluable|1|||
126471605|NCT00397215|455027514|FG000|Month 0 (Day 0)|Adverse Event|0|||
126471606|NCT00397215|455027515|FG001|Month 0 (Day 0)|Adverse Event|1|||
126557154|NCT01544582|455331165|FG001|Analysis Population|Poor Participant Compliance|1|||
126557155|NCT01544582|455331166|FG002|Analysis Population|Poor Participant Compliance|0|||
126557156|NCT01544582|455331167|FG003|Analysis Population|Poor Participant Compliance|0|||
126471607|NCT00397215|455027516|FG002|Month 0 (Day 0)|Adverse Event|0|||
126471608|NCT00397215|455027517|FG003|Month 0 (Day 0)|Adverse Event|0|||
126471609|NCT00397215|455027514|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
126471610|NCT00397215|455027515|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
126471611|NCT00397215|455027516|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
126471612|NCT00397215|455027517|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
126471613|NCT00397215|455027514|FG000|Month 0 (Day 0)|Other|4|||
126471614|NCT00397215|455027515|FG001|Month 0 (Day 0)|Other|1|||
126471615|NCT00397215|455027516|FG002|Month 0 (Day 0)|Other|3|||
126471616|NCT00397215|455027517|FG003|Month 0 (Day 0)|Other|3|||
126471617|NCT00397215|455027514|FG000|Month 6 (Day 180)|Adverse Event|0|||
126471618|NCT00397215|455027515|FG001|Month 6 (Day 180)|Adverse Event|3|||
126471619|NCT00397215|455027516|FG002|Month 6 (Day 180)|Adverse Event|2|||
126471620|NCT00397215|455027517|FG003|Month 6 (Day 180)|Adverse Event|0|||
126471621|NCT00397215|455027514|FG000|Month 6 (Day 180)|Other|2|||
126471622|NCT00397215|455027515|FG001|Month 6 (Day 180)|Other|0|||
126471623|NCT00397215|455027516|FG002|Month 6 (Day 180)|Other|3|||
126557157|NCT01544582|455331164|FG000|Analysis Population|Programmed Surgery|0|||
126557158|NCT01544582|455331165|FG001|Analysis Population|Programmed Surgery|1|||
126557159|NCT01544582|455331166|FG002|Analysis Population|Programmed Surgery|0|||
126557160|NCT01544582|455331167|FG003|Analysis Population|Programmed Surgery|0|||
126557161|NCT01544582|455331164|FG000|Analysis Population|Participant in Jail|0|||
126557162|NCT01544582|455331165|FG001|Analysis Population|Participant in Jail|0|||
126557163|NCT01544582|455331166|FG002|Analysis Population|Participant in Jail|1|||
126557164|NCT01544582|455331167|FG003|Analysis Population|Participant in Jail|0|||
126557165|NCT03317379|455331170|FG000|Overall Study|Lost to Follow-up|0|||
126557166|NCT03317379|455331171|FG001|Overall Study|Lost to Follow-up|3|||
126557167|NCT03317379|455331172|FG002|Overall Study|Lost to Follow-up|2|||
126557168|NCT02353832|455331179|FG000|Overall Study|Ineligible after enrollment|1|||
126557169|NCT02353832|455331179|FG000|Overall Study|Lost to Follow-up|1|||
126557170|NCT04880161|455331180|FG000|Overall Study|Withdrawal by Subject|1|||
126471624|NCT00397215|455027517|FG003|Month 6 (Day 180)|Other|0|||
126471625|NCT02128932|455027518|FG000|Overall Study|Withdrawal by Subject|11|||
126471626|NCT02128932|455027519|FG001|Overall Study|Withdrawal by Subject|7|||
126557171|NCT04880161|455331181|FG001|Overall Study|Withdrawal by Subject|0|||
126471627|NCT02128932|455027520|FG002|Overall Study|Withdrawal by Subject|8|||
126471628|NCT02128932|455027518|FG000|Overall Study|Death|2|||
126471629|NCT02128932|455027519|FG001|Overall Study|Death|0|||
126471630|NCT02128932|455027520|FG002|Overall Study|Death|2|||
126471631|NCT02128932|455027518|FG000|Overall Study|Lost to Follow-up|2|||
126471632|NCT02128932|455027519|FG001|Overall Study|Lost to Follow-up|1|||
126557172|NCT04880161|455331180|FG000|Overall Study|Lack of Compliance|1|||
126557173|NCT04880161|455331181|FG001|Overall Study|Lack of Compliance|1|||
126721196|NCT01187901|455928595|FG000|Overall Study|Unrelated Health Reasons|1|||
126721197|NCT01187901|455928596|FG001|Overall Study|Unrelated Health Reasons|2|||
126721198|NCT01187901|455928595|FG000|Overall Study|Suspected Allergic Reaction|1|||
126721199|NCT01187901|455928596|FG001|Overall Study|Suspected Allergic Reaction|1|||
126721200|NCT01187901|455928595|FG000|Overall Study|Adverse Event|3|||
126721201|NCT01187901|455928596|FG001|Overall Study|Adverse Event|0|||
126721202|NCT01187901|455928595|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
126398440|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398441|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398442|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
126398443|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398444|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398445|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398446|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398447|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
126398448|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398449|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398450|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398451|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398452|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
126398453|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398454|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398455|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126471633|NCT02128932|455027520|FG002|Overall Study|Lost to Follow-up|1|||
126471634|NCT02128932|455027518|FG000|Overall Study|No reason for withdrawal|12|||
126471635|NCT02128932|455027519|FG001|Overall Study|No reason for withdrawal|11|||
126471636|NCT02128932|455027520|FG002|Overall Study|No reason for withdrawal|7|||
126471637|NCT01361568|455027525|FG000|Overall Study|Adverse Event|0|||
126471638|NCT01361568|455027526|FG001|Overall Study|Adverse Event|0|||
126471639|NCT01361568|455027527|FG002|Overall Study|Adverse Event|0|||
126471640|NCT01361568|455027528|FG003|Overall Study|Adverse Event|0|||
126471641|NCT01361568|455027529|FG004|Overall Study|Adverse Event|1|||
126471642|NCT01361568|455027530|FG005|Overall Study|Adverse Event|0|||
126471643|NCT01361568|455027525|FG000|Overall Study|Physician Decision|0|||
126471644|NCT01361568|455027526|FG001|Overall Study|Physician Decision|0|||
126471645|NCT01361568|455027527|FG002|Overall Study|Physician Decision|0|||
126471646|NCT01361568|455027528|FG003|Overall Study|Physician Decision|0|||
126471647|NCT01361568|455027529|FG004|Overall Study|Physician Decision|0|||
126471648|NCT01361568|455027530|FG005|Overall Study|Physician Decision|1|||
126471649|NCT01361568|455027525|FG000|Overall Study|Withdrawal by Subject|2|||
126471650|NCT01361568|455027526|FG001|Overall Study|Withdrawal by Subject|1|||
126471651|NCT01361568|455027527|FG002|Overall Study|Withdrawal by Subject|0|||
126471652|NCT01361568|455027528|FG003|Overall Study|Withdrawal by Subject|0|||
126471653|NCT01361568|455027529|FG004|Overall Study|Withdrawal by Subject|0|||
126471654|NCT01361568|455027530|FG005|Overall Study|Withdrawal by Subject|1|||
126471655|NCT00657358|455027531|FG000|Overall Study|Lack of Efficacy|6|||
126471656|NCT02959983|455027532|FG000|Overall Study|Protocol Violation|0|||
126471657|NCT02959983|455027533|FG001|Overall Study|Protocol Violation|1|||
126471658|NCT02959983|455027532|FG000|Overall Study|Lack of Efficacy|0|||
126471659|NCT02959983|455027533|FG001|Overall Study|Lack of Efficacy|1|||
126471660|NCT02959983|455027532|FG000|Overall Study|Lost to Follow-up|12|||
126471661|NCT02959983|455027533|FG001|Overall Study|Lost to Follow-up|9|||
126471662|NCT02959983|455027532|FG000|Overall Study|Other|1|||
126471663|NCT02959983|455027533|FG001|Overall Study|Other|1|||
126471664|NCT02959983|455027532|FG000|Overall Study|Physician Decision|1|||
126471665|NCT02959983|455027533|FG001|Overall Study|Physician Decision|0|||
126471666|NCT02959983|455027532|FG000|Overall Study|Adverse Event|5|||
126471667|NCT02959983|455027533|FG001|Overall Study|Adverse Event|1|||
126471668|NCT02959983|455027532|FG000|Overall Study|Withdrawal by Subject|7|||
126471669|NCT02959983|455027533|FG001|Overall Study|Withdrawal by Subject|12|||
126471670|NCT02728596|455027534|FG000|Overall Study|Refusal unrelated to adverse event|3|||
126471671|NCT02728596|455027535|FG001|Overall Study|Refusal unrelated to adverse event|6|||
126471672|NCT02728596|455027536|FG002|Overall Study|Refusal unrelated to adverse event|7|||
126471673|NCT02728596|455027537|FG003|Overall Study|Refusal unrelated to adverse event|7|||
126471674|NCT02728596|455027534|FG000|Overall Study|Death|44|||
126471675|NCT02728596|455027535|FG001|Overall Study|Death|42|||
126471676|NCT02728596|455027536|FG002|Overall Study|Death|123|||
126557174|NCT04880161|455331180|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
126557175|NCT04880161|455331181|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
126557176|NCT04880161|455331180|FG000|Overall Study|Screen Failure|0|||
126557177|NCT04880161|455331181|FG001|Overall Study|Screen Failure|1|||
126557178|NCT01354106|455331182|FG000|Overall Study|Withdrawal by Subject|2|||
126557179|NCT00731042|455332607|FG000|Second Intervention|Did not meet inclusion criteria|0|||
126557180|NCT00731042|455332608|FG001|Second Intervention|Did not meet inclusion criteria|2|||
126557181|NCT02692235|455332609|FG000|Overall Study|Withdrawal by Subject|2|||
126557182|NCT02692235|455332610|FG001|Overall Study|Withdrawal by Subject|1|||
126557183|NCT02692235|455332609|FG000|Overall Study|Adverse Event|1|||
126557184|NCT02692235|455332610|FG001|Overall Study|Adverse Event|2|||
126557185|NCT00802841|455332611|FG000|Overall Study|Administrative problems|1|||
126557186|NCT00802841|455332612|FG001|Overall Study|Administrative problems|0|||
126557187|NCT00802841|455332611|FG000|Overall Study|Lost to Follow-up|2|||
126557188|NCT00802841|455332612|FG001|Overall Study|Lost to Follow-up|1|||
126557189|NCT00802841|455332611|FG000|Overall Study|Death|1|||
126557190|NCT00802841|455332612|FG001|Overall Study|Death|2|||
126557191|NCT00802841|455332611|FG000|Overall Study|Adverse Event|8|||
126557192|NCT00802841|455332612|FG001|Overall Study|Adverse Event|2|||
126398456|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398457|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398458|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398459|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
126398460|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398461|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398462|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
126398463|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398464|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398465|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398466|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398467|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
126398468|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
126398469|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398470|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398471|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398472|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
126398473|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398474|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398475|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398476|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398477|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
126398478|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
126398479|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398480|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
126398481|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398482|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
126398483|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398484|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398485|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398486|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398487|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
126398488|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Other|5|||
126398489|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Other|1|||
126398490|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Other|0|||
126398491|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Other|3|||
126398492|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Other|0|||
126398493|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Other|0|||
126398494|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Other|0|||
126398495|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Other|0|||
126398496|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Other|0|||
126398497|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Other|0|||
126557193|NCT00802841|455332611|FG000|Overall Study|Disease progression|7|||
126398498|NCT03352557|454753093|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398499|NCT03352557|454753094|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398500|NCT03352557|454753095|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398501|NCT03352557|454753096|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398502|NCT03352557|454753097|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
126398503|NCT03352557|454753098|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398504|NCT03352557|454753099|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
126557194|NCT00802841|455332612|FG001|Overall Study|Disease progression|3|||
126557195|NCT00802841|455332611|FG000|Overall Study|Withdrawal by Subject|9|||
126557196|NCT00802841|455332612|FG001|Overall Study|Withdrawal by Subject|5|||
126557197|NCT00802841|455332611|FG000|Overall Study|Protocol deviation|2|||
126557198|NCT00802841|455332612|FG001|Overall Study|Protocol deviation|6|||
126557199|NCT00802841|455332611|FG000|Overall Study|Treatment duration completed|66|||
126557200|NCT00802841|455332612|FG001|Overall Study|Treatment duration completed|76|||
126557201|NCT02711995|455332615|FG000|Washout (90 Days)|Conflicting medication|1|||
126557202|NCT02485353|455332626|FG000|Overall Study|Death|1|||
126557203|NCT02485353|455332626|FG000|Overall Study|Disease Progression|1|||
126557204|NCT01021332|455332627|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
126557205|NCT01021332|455332627|FG000|Overall Study|Adverse Event|43|||
126557206|NCT01021332|455332627|FG000|Overall Study|Lack of Efficacy|19|||
126557207|NCT01021332|455332627|FG000|Overall Study|Withdrawal of Consent|23|||
126557208|NCT01021332|455332627|FG000|Overall Study|Lost to Follow-up|4|||
126557209|NCT01021332|455332627|FG000|Overall Study|Protocol Violation|9|||
126557210|NCT01021332|455332627|FG000|Overall Study|Miscellaneous|3|||
126557211|NCT03487666|455332628|FG000|Overall Study|Disease progression|4|||
126557212|NCT03487666|455332629|FG001|Overall Study|Disease progression|2|||
126557213|NCT03487666|455332630|FG002|Overall Study|Disease progression|0|||
126557214|NCT03487666|455332628|FG000|Overall Study|Adverse Event|0|||
126557215|NCT03487666|455332629|FG001|Overall Study|Adverse Event|0|||
126557216|NCT03487666|455332630|FG002|Overall Study|Adverse Event|1|||
126557217|NCT02748512|455332635|FG000|Overall Study|Lost to Follow-up|1|||
126557218|NCT02748512|455332636|FG001|Overall Study|Lost to Follow-up|1|||
126557219|NCT00557505|455332638|FG000|Overall Study|Death|0|||
126557220|NCT00557505|455332639|FG001|Overall Study|Death|0|||
126557221|NCT00557505|455332640|FG002|Overall Study|Death|0|||
126557222|NCT00557505|455332641|FG003|Overall Study|Death|0|||
126557223|NCT00557505|455332642|FG004|Overall Study|Death|0|||
126557224|NCT00557505|455332643|FG005|Overall Study|Death|0|||
126557225|NCT00557505|455332644|FG006|Overall Study|Death|0|||
126557226|NCT00557505|455332645|FG007|Overall Study|Death|0|||
126557227|NCT00557505|455332646|FG008|Overall Study|Death|1|||
126557228|NCT00557505|455332638|FG000|Overall Study|Adverse Event|0|||
126557229|NCT00557505|455332639|FG001|Overall Study|Adverse Event|0|||
126557230|NCT00557505|455332640|FG002|Overall Study|Adverse Event|1|||
126557231|NCT00557505|455332641|FG003|Overall Study|Adverse Event|0|||
126557232|NCT00557505|455332642|FG004|Overall Study|Adverse Event|0|||
126557233|NCT00557505|455332643|FG005|Overall Study|Adverse Event|0|||
126557234|NCT00557505|455332644|FG006|Overall Study|Adverse Event|1|||
126557235|NCT00557505|455332645|FG007|Overall Study|Adverse Event|0|||
126557236|NCT00557505|455332646|FG008|Overall Study|Adverse Event|0|||
126557237|NCT00557505|455332638|FG000|Overall Study|Global deterioration of health|1|||
126557238|NCT00557505|455332639|FG001|Overall Study|Global deterioration of health|0|||
126557239|NCT00557505|455332640|FG002|Overall Study|Global deterioration of health|0|||
126557240|NCT00557505|455332641|FG003|Overall Study|Global deterioration of health|0|||
126557241|NCT00557505|455332642|FG004|Overall Study|Global deterioration of health|0|||
126557242|NCT00557505|455332643|FG005|Overall Study|Global deterioration of health|0|||
126557243|NCT00557505|455332644|FG006|Overall Study|Global deterioration of health|0|||
126557244|NCT00557505|455332645|FG007|Overall Study|Global deterioration of health|0|||
126557245|NCT00557505|455332646|FG008|Overall Study|Global deterioration of health|0|||
126557246|NCT00557505|455332638|FG000|Overall Study|Objective progression or relapse|2|||
126557247|NCT00557505|455332639|FG001|Overall Study|Objective progression or relapse|3|||
126557248|NCT00557505|455332640|FG002|Overall Study|Objective progression or relapse|3|||
126398505|NCT03352557|454753100|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398506|NCT03352557|454753101|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398507|NCT03352557|454753102|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
126398508|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Death|0|||
126398509|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Death|0|||
126398510|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Death|0|||
126398511|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Death|0|||
126398512|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Death|0|||
126398513|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Death|1|||
126398514|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Death|0|||
126557249|NCT00557505|455332641|FG003|Overall Study|Objective progression or relapse|2|||
126557250|NCT00557505|455332642|FG004|Overall Study|Objective progression or relapse|2|||
126398515|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Death|1|||
126398516|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Death|1|||
126557251|NCT00557505|455332643|FG005|Overall Study|Objective progression or relapse|3|||
126557252|NCT00557505|455332644|FG006|Overall Study|Objective progression or relapse|2|||
126557253|NCT00557505|455332645|FG007|Overall Study|Objective progression or relapse|5|||
126557254|NCT00557505|455332646|FG008|Overall Study|Objective progression or relapse|15|||
126557255|NCT00557505|455332638|FG000|Overall Study|Withdrawal by Subject|0|||
126557256|NCT00557505|455332639|FG001|Overall Study|Withdrawal by Subject|0|||
126557257|NCT00557505|455332640|FG002|Overall Study|Withdrawal by Subject|0|||
126557258|NCT00557505|455332641|FG003|Overall Study|Withdrawal by Subject|1|||
126557259|NCT00557505|455332642|FG004|Overall Study|Withdrawal by Subject|0|||
126557260|NCT00557505|455332643|FG005|Overall Study|Withdrawal by Subject|0|||
126398517|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Death|1|||
126398518|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398519|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398520|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398521|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398522|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398523|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
126398524|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398525|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398526|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398527|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
126398528|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398529|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398530|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398531|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398532|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398533|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398534|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398535|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398536|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
126398537|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
126398538|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
126471677|NCT02728596|455027537|FG003|Overall Study|Death|68|||
126471678|NCT01414608|455027543|FG000|Overall Study|Ineligible|5|||
126471679|NCT01414608|455027544|FG001|Overall Study|Ineligible|2|||
126471680|NCT01736124|455027545|FG000|Post-intervention Assessment|Death|2|||
126471681|NCT01736124|455027546|FG001|Post-intervention Assessment|Death|2|||
126471682|NCT01736124|455027545|FG000|Post-intervention Assessment|lost computer access|1|||
126471683|NCT01736124|455027546|FG001|Post-intervention Assessment|lost computer access|1|||
126471684|NCT01736124|455027545|FG000|Post-intervention Assessment|Moved away|3|||
126471685|NCT01736124|455027546|FG001|Post-intervention Assessment|Moved away|1|||
126471686|NCT01736124|455027545|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
126471687|NCT01736124|455027546|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
126471688|NCT01736124|455027545|FG000|Post-intervention Assessment|Illness|3|||
126471689|NCT01736124|455027546|FG001|Post-intervention Assessment|Illness|2|||
126471690|NCT01736124|455027545|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
126471691|NCT01736124|455027546|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
126471692|NCT01736124|455027545|FG000|Post-intervention Assessment|Temporarily away|3|||
126471693|NCT01736124|455027546|FG001|Post-intervention Assessment|Temporarily away|1|||
126471694|NCT01736124|455027545|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
126471695|NCT01736124|455027546|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
126471696|NCT01736124|455027545|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
126471697|NCT01736124|455027546|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
126471698|NCT01736124|455027545|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
126471699|NCT01736124|455027546|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
126471700|NCT01736124|455027545|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
126471701|NCT01736124|455027546|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
126471702|NCT01736124|455027545|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
126471703|NCT01736124|455027546|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
126471704|NCT01736124|455027545|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
126471705|NCT01736124|455027546|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
126471706|NCT01736124|455027545|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
126471707|NCT01736124|455027546|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
126471708|NCT01736124|455027545|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
126471709|NCT01736124|455027546|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
126471710|NCT01736124|455027545|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
126398539|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
126398540|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
126398541|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
126398542|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
126398543|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
126471711|NCT01736124|455027546|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
126471712|NCT03672643|455027547|FG000|Overall Study|Adverse Event|3|||
126471713|NCT03672643|455027547|FG000|Overall Study|Death|2|||
126471714|NCT03672643|455027547|FG000|Overall Study|Withdrawal by Subject|1|||
126471715|NCT03672643|455027547|FG000|Overall Study|Progressive disease|11|||
126471716|NCT03672643|455027547|FG000|Overall Study|Global deterioration of health status|1|||
126471717|NCT03672643|455027547|FG000|Overall Study|Refused further treatment|7|||
126471718|NCT03672643|455027547|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
126398544|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
126398545|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
126398546|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
126398547|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
126398548|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398549|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398550|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398551|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398552|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398553|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
126398554|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
126398555|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
126398556|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
126398557|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
126398558|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398559|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398560|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398561|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398562|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398563|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126398564|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398565|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126398566|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
126398567|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
126398568|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
126398569|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
126398570|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
126398571|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
126398572|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
126398573|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
126398574|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
126398575|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
126398576|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
126398577|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
126398578|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398579|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398580|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398581|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398582|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398583|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398584|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398585|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
126398586|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
126398587|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
126398588|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398589|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398590|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398591|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398592|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398593|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126471719|NCT05736224|455027548|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
126471720|NCT02557295|455027549|FG000|Overall Study|Withdrawal by Subject|9|||
126471721|NCT02557295|455027550|FG001|Overall Study|Withdrawal by Subject|2|||
126471722|NCT02557295|455027551|FG002|Overall Study|Withdrawal by Subject|4|||
126471723|NCT02557295|455027552|FG003|Overall Study|Withdrawal by Subject|0|||
126398594|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398595|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
126398596|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398597|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
126398598|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398599|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398600|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398601|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398602|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398603|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398604|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398605|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
126398606|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398607|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
126398608|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398609|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398610|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398611|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398612|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398613|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398614|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398615|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
126398616|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
126398617|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
126398618|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398619|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398620|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398621|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398622|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398623|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
126398624|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398625|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398626|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
126398627|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
126398628|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398629|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398630|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398631|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398632|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398633|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398634|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398635|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398636|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
126398637|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
126398638|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398639|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398640|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398641|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398642|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398643|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398644|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398645|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
126398646|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
126398647|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
126398648|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398649|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398650|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398651|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126772277|NCT02030834|456122074|FG000|Overall Study|Withdrawal by Subject|1|||
126398652|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398653|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398654|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398655|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
126398656|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
126398657|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
126398658|NCT03352557|454753093|FG000|LTE Period: Week 80 to Week 173|Other|0|||
126398659|NCT03352557|454753094|FG001|LTE Period: Week 80 to Week 173|Other|0|||
126398660|NCT03352557|454753095|FG002|LTE Period: Week 80 to Week 173|Other|0|||
126398661|NCT03352557|454753096|FG003|LTE Period: Week 80 to Week 173|Other|0|||
126398662|NCT03352557|454753097|FG004|LTE Period: Week 80 to Week 173|Other|0|||
126398663|NCT03352557|454753098|FG005|LTE Period: Week 80 to Week 173|Other|0|||
126398664|NCT03352557|454753099|FG006|LTE Period: Week 80 to Week 173|Other|0|||
126398665|NCT03352557|454753100|FG007|LTE Period: Week 80 to Week 173|Other|1|||
126398666|NCT03352557|454753101|FG008|LTE Period: Week 80 to Week 173|Other|0|||
126398667|NCT03352557|454753102|FG009|LTE Period: Week 80 to Week 173|Other|0|||
126398668|NCT00907803|454753103|FG000|Overall Study|Withdrawal of consent - long commute|1|||
126398669|NCT00907803|454753104|FG001|Overall Study|Withdrawal of consent - long commute|0|||
126398670|NCT00907803|454753105|FG002|Overall Study|Withdrawal of consent - long commute|0|||
126398671|NCT00907803|454753103|FG000|Overall Study|Adverse Event|2|||
126398672|NCT00907803|454753104|FG001|Overall Study|Adverse Event|0|||
126398673|NCT00907803|454753105|FG002|Overall Study|Adverse Event|0|||
126398674|NCT00907803|454753103|FG000|Overall Study|Withdrawal by Subject|0|||
126398675|NCT00907803|454753104|FG001|Overall Study|Withdrawal by Subject|1|||
126398676|NCT00907803|454753105|FG002|Overall Study|Withdrawal by Subject|0|||
126398677|NCT00907803|454753103|FG000|Overall Study|Lost to Follow-up|0|||
126398678|NCT00907803|454753104|FG001|Overall Study|Lost to Follow-up|1|||
126398679|NCT00907803|454753105|FG002|Overall Study|Lost to Follow-up|0|||
126398680|NCT00907803|454753103|FG000|Overall Study|Protocol Violation|0|||
126398681|NCT00907803|454753104|FG001|Overall Study|Protocol Violation|1|||
126398682|NCT00907803|454753105|FG002|Overall Study|Protocol Violation|0|||
126398683|NCT03510468|454753106|FG000|Overall Study|Lost to Follow-up|1|||
126398684|NCT03510468|454753106|FG000|Overall Study|Adverse Event|5|||
126398685|NCT03510468|454753106|FG000|Overall Study|Physician Decision|1|||
126398686|NCT03510468|454753106|FG000|Overall Study|non-compliant with treatment|2|||
126398687|NCT03510468|454753106|FG000|Overall Study|Missed visit|1|||
126398688|NCT04612842|454753107|FG000|Overall Study|Lost to Follow-up|20|||
126398689|NCT04612842|454753108|FG001|Overall Study|Lost to Follow-up|11|||
126398690|NCT04612842|454753107|FG000|Overall Study|Withdrawal by Subject|26|||
126398691|NCT04612842|454753108|FG001|Overall Study|Withdrawal by Subject|15|||
126398692|NCT04612842|454753107|FG000|Overall Study|Death|2|||
126398693|NCT04612842|454753108|FG001|Overall Study|Death|2|||
126398694|NCT02419131|454753109|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
126398695|NCT02419131|454753110|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
126398696|NCT02419131|454753111|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
126398697|NCT02419131|454753109|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
126398698|NCT02419131|454753110|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
126398699|NCT02419131|454753111|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
126398700|NCT05426031|454753112|FG000|Overall Study|Circulatory Arrest|3|||
126398701|NCT05426031|454753113|FG001|Overall Study|Circulatory Arrest|2|||
126398702|NCT04677660|454753114|FG000|Overall Study|Lost to Follow-up|0|||
126398703|NCT04677660|454753115|FG001|Overall Study|Lost to Follow-up|2|||
126398704|NCT04677660|454753114|FG000|Overall Study|Withdrawal by Subject|0|||
126398705|NCT04677660|454753115|FG001|Overall Study|Withdrawal by Subject|1|||
126398706|NCT04677660|454753114|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
126398707|NCT04677660|454753115|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
126398708|NCT00089986|454753116|FG000|Overall Study|Adverse Event|6|||
126398709|NCT00089986|454753117|FG001|Overall Study|Adverse Event|9|||
126398710|NCT00089986|454753118|FG002|Overall Study|Adverse Event|6|||
126398711|NCT00089986|454753116|FG000|Overall Study|Lost to Follow-up|3|||
126398712|NCT00089986|454753117|FG001|Overall Study|Lost to Follow-up|1|||
126398713|NCT00089986|454753118|FG002|Overall Study|Lost to Follow-up|1|||
126398714|NCT00089986|454753116|FG000|Overall Study|Protocol Violation|0|||
126398715|NCT00089986|454753117|FG001|Overall Study|Protocol Violation|1|||
126398716|NCT00089986|454753118|FG002|Overall Study|Protocol Violation|0|||
126398717|NCT00089986|454753116|FG000|Overall Study|Patient transferred to another hospital|2|||
126398718|NCT00089986|454753117|FG001|Overall Study|Patient transferred to another hospital|1|||
126398719|NCT00089986|454753118|FG002|Overall Study|Patient transferred to another hospital|0|||
126398720|NCT00089986|454753116|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
126398721|NCT00089986|454753117|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
126398722|NCT00089986|454753118|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
126398723|NCT00089986|454753116|FG000|Overall Study|Hemohlobin stopping rule|0|||
126398724|NCT00089986|454753117|FG001|Overall Study|Hemohlobin stopping rule|1|||
126398725|NCT00089986|454753118|FG002|Overall Study|Hemohlobin stopping rule|0|||
126471724|NCT02557295|455027553|FG004|Overall Study|Withdrawal by Subject|0|||
126471725|NCT02557295|455027554|FG005|Overall Study|Withdrawal by Subject|0|||
126471726|NCT02557295|455027555|FG006|Overall Study|Withdrawal by Subject|15|||
126471727|NCT02557295|455027556|FG007|Overall Study|Withdrawal by Subject|1|||
126471728|NCT02557295|455027557|FG008|Overall Study|Withdrawal by Subject|3|||
126471729|NCT02557295|455027549|FG000|Overall Study|Disease Progression|0|||
126471730|NCT02557295|455027550|FG001|Overall Study|Disease Progression|0|||
126471731|NCT02557295|455027551|FG002|Overall Study|Disease Progression|0|||
126471732|NCT02557295|455027552|FG003|Overall Study|Disease Progression|0|||
126471733|NCT02557295|455027553|FG004|Overall Study|Disease Progression|0|||
126471734|NCT02557295|455027554|FG005|Overall Study|Disease Progression|0|||
126557261|NCT00557505|455332644|FG006|Overall Study|Withdrawal by Subject|0|||
126772278|NCT02030834|456122075|FG001|Overall Study|Withdrawal by Subject|0|||
126772279|NCT02030834|456122076|FG002|Overall Study|Withdrawal by Subject|0|||
126398726|NCT00089986|454753116|FG000|Overall Study|Investigator decision to withdrew|0|||
126398727|NCT00089986|454753117|FG001|Overall Study|Investigator decision to withdrew|1|||
126398728|NCT00089986|454753118|FG002|Overall Study|Investigator decision to withdrew|0|||
126398729|NCT00089986|454753116|FG000|Overall Study|Enrollment in another study|0|||
126398730|NCT00089986|454753117|FG001|Overall Study|Enrollment in another study|1|||
126398731|NCT00089986|454753118|FG002|Overall Study|Enrollment in another study|0|||
126398732|NCT00089986|454753116|FG000|Overall Study|Family decision|0|||
126398733|NCT00089986|454753117|FG001|Overall Study|Family decision|1|||
126398734|NCT00089986|454753118|FG002|Overall Study|Family decision|0|||
126398735|NCT00089986|454753116|FG000|Overall Study|Do not resuscitate (DNR)|0|||
126398736|NCT00089986|454753117|FG001|Overall Study|Do not resuscitate (DNR)|0|||
126398737|NCT00089986|454753118|FG002|Overall Study|Do not resuscitate (DNR)|1|||
126398738|NCT00089986|454753116|FG000|Overall Study|Withdrawal by Subject|3|||
126398739|NCT00089986|454753117|FG001|Overall Study|Withdrawal by Subject|6|||
126398740|NCT00089986|454753118|FG002|Overall Study|Withdrawal by Subject|2|||
126398741|NCT02334683|454753125|FG000|First 12 Week Period|Lost to Follow-up|1|||
126398742|NCT02334683|454753126|FG001|First 12 Week Period|Lost to Follow-up|0|||
126398743|NCT02334683|454753125|FG000|Second 12 Week Period|Adverse Event|0|||
126398744|NCT02334683|454753126|FG001|Second 12 Week Period|Adverse Event|1|||
126398745|NCT00916058|454753127|FG000|Phase 1|Screen Failure|0|||
126398746|NCT00916058|454753128|FG001|Phase 1|Screen Failure|0|||
126398747|NCT00916058|454753129|FG002|Phase 1|Screen Failure|0|||
126398748|NCT00916058|454753130|FG003|Phase 1|Screen Failure|0|||
126398749|NCT00916058|454753131|FG004|Phase 1|Screen Failure|0|||
126398750|NCT00916058|454753132|FG005|Phase 1|Screen Failure|1|||
126398751|NCT00916058|454753133|FG006|Phase 1|Screen Failure|0|||
126398752|NCT00916058|454753127|FG000|Phase 2|Screen Failure|0|||
126398753|NCT00916058|454753128|FG001|Phase 2|Screen Failure|0|||
126398754|NCT00916058|454753129|FG002|Phase 2|Screen Failure|0|||
126398755|NCT00916058|454753130|FG003|Phase 2|Screen Failure|0|||
126398756|NCT00916058|454753131|FG004|Phase 2|Screen Failure|0|||
126398757|NCT00916058|454753132|FG005|Phase 2|Screen Failure|0|||
126398758|NCT00916058|454753133|FG006|Phase 2|Screen Failure|3|||
126398759|NCT01218100|454753134|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
126398760|NCT01218100|454753135|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
126398761|NCT01218100|454753136|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
126398762|NCT01218100|454753137|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
126398763|NCT01218100|454753134|FG000|Overall Study|Adverse Event|4|||
126398764|NCT01218100|454753135|FG001|Overall Study|Adverse Event|6|||
126398765|NCT01218100|454753136|FG002|Overall Study|Adverse Event|6|||
126471735|NCT02557295|455027555|FG006|Overall Study|Disease Progression|1|||
126471736|NCT02557295|455027556|FG007|Overall Study|Disease Progression|0|||
126471737|NCT02557295|455027557|FG008|Overall Study|Disease Progression|0|||
126471738|NCT02557295|455027549|FG000|Overall Study|Lack of Efficacy|24|||
126471739|NCT02557295|455027550|FG001|Overall Study|Lack of Efficacy|1|||
126557262|NCT00557505|455332645|FG007|Overall Study|Withdrawal by Subject|0|||
126557263|NCT00557505|455332646|FG008|Overall Study|Withdrawal by Subject|1|||
126557264|NCT03019458|455332647|FG000|Overall Study|Death|0|||
126557265|NCT03019458|455332648|FG001|Overall Study|Death|1|||
126557266|NCT01636362|455332651|FG000|Overall Study|Physician Decision|6|||
126557267|NCT01636362|455332651|FG000|Overall Study|Subject healed, not returning|1|||
126557268|NCT01636362|455332651|FG000|Overall Study|Withdrawal by Subject|1|||
126557269|NCT01561079|455332655|FG000|Overall Study|Physician Decision|17|||
126557270|NCT01561079|455332655|FG000|Overall Study|Withdrawal by Subject|59|||
126557271|NCT01561079|455332655|FG000|Overall Study|Protocol Violation|2|||
126557272|NCT04990440|455332666|FG000|Overall Study|Sponsor's Decision|0|||
126557273|NCT04990440|455332667|FG001|Overall Study|Sponsor's Decision|0|||
126557274|NCT04990440|455332668|FG002|Overall Study|Sponsor's Decision|1|||
126557275|NCT03712098|455332669|FG000|Overall Study|Lost to Follow-up|3|||
126557276|NCT03712098|455332670|FG001|Overall Study|Lost to Follow-up|7|||
126557277|NCT03712098|455332669|FG000|Overall Study|Withdrawal by Subject|9|||
126557278|NCT03712098|455332670|FG001|Overall Study|Withdrawal by Subject|4|||
126557279|NCT03712098|455332669|FG000|Overall Study|Protocol Violation|2|||
126557280|NCT03712098|455332670|FG001|Overall Study|Protocol Violation|1|||
126772280|NCT02030834|456122074|FG000|Overall Study|Lack of funding|1|||
126398766|NCT01218100|454753137|FG003|Overall Study|Adverse Event|7|||
126398767|NCT01218100|454753134|FG000|Overall Study|Lack of Efficacy|9|||
126398768|NCT01218100|454753135|FG001|Overall Study|Lack of Efficacy|6|||
126398769|NCT01218100|454753136|FG002|Overall Study|Lack of Efficacy|5|||
126398770|NCT01218100|454753137|FG003|Overall Study|Lack of Efficacy|12|||
126398771|NCT01218100|454753134|FG000|Overall Study|Protocol Violation|0|||
126398772|NCT01218100|454753135|FG001|Overall Study|Protocol Violation|0|||
126398773|NCT01218100|454753136|FG002|Overall Study|Protocol Violation|1|||
126398774|NCT01218100|454753137|FG003|Overall Study|Protocol Violation|1|||
126398775|NCT01218100|454753134|FG000|Overall Study|Withdrawal by Subject|5|||
126398776|NCT01218100|454753135|FG001|Overall Study|Withdrawal by Subject|2|||
126398777|NCT01218100|454753136|FG002|Overall Study|Withdrawal by Subject|6|||
126398778|NCT01218100|454753137|FG003|Overall Study|Withdrawal by Subject|7|||
126398779|NCT01218100|454753134|FG000|Overall Study|Lost to Follow-up|3|||
126398780|NCT01218100|454753135|FG001|Overall Study|Lost to Follow-up|8|||
126398781|NCT01218100|454753136|FG002|Overall Study|Lost to Follow-up|2|||
126398782|NCT01218100|454753137|FG003|Overall Study|Lost to Follow-up|1|||
126398783|NCT01218100|454753134|FG000|Overall Study|Other Reason|2|||
126398784|NCT01218100|454753135|FG001|Overall Study|Other Reason|2|||
126398785|NCT01218100|454753136|FG002|Overall Study|Other Reason|6|||
126398786|NCT01218100|454753137|FG003|Overall Study|Other Reason|4|||
126398787|NCT02437305|454753138|FG000|Overall Study|Lost to Follow-up|18|||
126398788|NCT02437305|454753139|FG001|Overall Study|Lost to Follow-up|12|||
126398789|NCT02434354|454753160|FG000|Overall Study|screen fail|3|||
126398790|NCT00413920|454753161|FG000|Overall Study|Adverse Event|9|||
126398791|NCT00413920|454753162|FG001|Overall Study|Adverse Event|11|||
126398792|NCT00413920|454753161|FG000|Overall Study|Lack of Efficacy|11|||
126398793|NCT00413920|454753162|FG001|Overall Study|Lack of Efficacy|9|||
126398794|NCT00413920|454753161|FG000|Overall Study|Death|3|||
126398795|NCT00413920|454753162|FG001|Overall Study|Death|5|||
126398796|NCT00413920|454753161|FG000|Overall Study|Graft Loss|5|||
126398797|NCT00413920|454753162|FG001|Overall Study|Graft Loss|3|||
126398798|NCT01071200|454753163|FG000|Overall Study|Lack of ovarian response|1|||
126398799|NCT01071200|454753164|FG001|Overall Study|Lack of ovarian response|1|||
126398800|NCT01071200|454753163|FG000|Overall Study|No fertilization|4|||
126398801|NCT01071200|454753164|FG001|Overall Study|No fertilization|0|||
126398802|NCT01071200|454753163|FG000|Overall Study|No oocytes retrieved|1|||
126471740|NCT02557295|455027551|FG002|Overall Study|Lack of Efficacy|3|||
126471741|NCT02557295|455027552|FG003|Overall Study|Lack of Efficacy|0|||
126471742|NCT02557295|455027553|FG004|Overall Study|Lack of Efficacy|0|||
126471743|NCT02557295|455027554|FG005|Overall Study|Lack of Efficacy|0|||
126471744|NCT02557295|455027555|FG006|Overall Study|Lack of Efficacy|12|||
126471745|NCT02557295|455027556|FG007|Overall Study|Lack of Efficacy|1|||
126471746|NCT02557295|455027557|FG008|Overall Study|Lack of Efficacy|0|||
126471747|NCT02557295|455027549|FG000|Overall Study|Adverse Event|16|||
126471748|NCT02557295|455027550|FG001|Overall Study|Adverse Event|2|||
126471749|NCT02557295|455027551|FG002|Overall Study|Adverse Event|3|||
126471750|NCT02557295|455027552|FG003|Overall Study|Adverse Event|0|||
126471751|NCT02557295|455027553|FG004|Overall Study|Adverse Event|0|||
126471752|NCT02557295|455027554|FG005|Overall Study|Adverse Event|0|||
126471753|NCT02557295|455027555|FG006|Overall Study|Adverse Event|2|||
126557281|NCT00724061|455332673|FG000|Dose Escalation Phase|Adverse Event|2|||
126557282|NCT00724061|455332673|FG000|Dose Escalation Phase|Disease Progression|3|||
126557283|NCT00688259|455332678|FG000|Overall Study|Lost to Follow-up|2|||
126557284|NCT00688259|455332679|FG001|Overall Study|Lost to Follow-up|4|||
126398803|NCT01071200|454753164|FG001|Overall Study|No oocytes retrieved|1|||
126398804|NCT01071200|454753163|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
126398805|NCT01071200|454753164|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
126398806|NCT01071200|454753163|FG000|Overall Study|No viable embryos|0|||
126398807|NCT01071200|454753164|FG001|Overall Study|No viable embryos|1|||
126557285|NCT00688259|455332678|FG000|Overall Study|Physician Decision|1|||
126398808|NCT03730961|454753165|FG000|Overall Study|Adverse Event|0|||
126557286|NCT00688259|455332679|FG001|Overall Study|Physician Decision|0|||
126557287|NCT00688259|455332678|FG000|Overall Study|Withdrawal by Subject|2|||
126471754|NCT02557295|455027556|FG007|Overall Study|Adverse Event|1|||
126471755|NCT02557295|455027557|FG008|Overall Study|Adverse Event|1|||
126557288|NCT00688259|455332679|FG001|Overall Study|Withdrawal by Subject|0|||
126471756|NCT02557295|455027549|FG000|Overall Study|Lost to Follow-up|4|||
126471757|NCT02557295|455027550|FG001|Overall Study|Lost to Follow-up|0|||
126471758|NCT02557295|455027551|FG002|Overall Study|Lost to Follow-up|0|||
126557289|NCT00688259|455332678|FG000|Overall Study|Declined Interview|2|||
126471759|NCT02557295|455027552|FG003|Overall Study|Lost to Follow-up|0|||
126471760|NCT02557295|455027553|FG004|Overall Study|Lost to Follow-up|0|||
126471761|NCT02557295|455027554|FG005|Overall Study|Lost to Follow-up|0|||
126471762|NCT02557295|455027555|FG006|Overall Study|Lost to Follow-up|9|||
126471763|NCT02557295|455027556|FG007|Overall Study|Lost to Follow-up|0|||
126471764|NCT02557295|455027557|FG008|Overall Study|Lost to Follow-up|0|||
126557290|NCT00688259|455332679|FG001|Overall Study|Declined Interview|3|||
126471765|NCT02557295|455027549|FG000|Overall Study|Study Close|54|||
126471766|NCT02557295|455027550|FG001|Overall Study|Study Close|3|||
126557291|NCT00688259|455332678|FG000|Overall Study|Hospitalized at Follow-up|0|||
126557292|NCT00688259|455332679|FG001|Overall Study|Hospitalized at Follow-up|1|||
126557293|NCT02954575|455332680|FG000|Overall Study|Withdrawal by Subject|2|||
126557294|NCT02954575|455332680|FG000|Overall Study|Adverse Event|1|||
126557295|NCT03890120|455332682|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
126557296|NCT03890120|455332683|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
126557297|NCT03890120|455332684|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
126557298|NCT03890120|455332685|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
126557299|NCT03890120|455332682|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
126557300|NCT03890120|455332683|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
126557301|NCT03890120|455332684|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
126557302|NCT03890120|455332685|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
126557303|NCT03890120|455332682|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
126557304|NCT03890120|455332683|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
126557305|NCT03890120|455332684|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
126557306|NCT03890120|455332685|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
126557307|NCT03890120|455332682|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
126557308|NCT03890120|455332683|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
126557309|NCT03890120|455332684|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
126557310|NCT03890120|455332685|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
126557311|NCT03890120|455332682|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
126557312|NCT03890120|455332683|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
126557313|NCT03890120|455332684|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
126557314|NCT03890120|455332685|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
126557315|NCT03890120|455332682|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
126557316|NCT03890120|455332683|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
126557317|NCT03890120|455332684|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
126398809|NCT03730961|454753166|FG001|Overall Study|Adverse Event|1|||
126398810|NCT04465877|454753172|FG000|Overall Study|Noncompliant with study requirements|0|||
126398811|NCT04465877|454753173|FG001|Overall Study|Noncompliant with study requirements|0|||
126398812|NCT04465877|454753174|FG002|Overall Study|Noncompliant with study requirements|1|||
126398813|NCT04465877|454753175|FG003|Overall Study|Noncompliant with study requirements|0|||
126398814|NCT03762616|454753176|FG000|Overall Study|Protocol Violation|2|||
126398815|NCT03576755|454753177|FG000|Overall Study|Withdrawal by Subject|1|||
126398816|NCT03576755|454753178|FG001|Overall Study|Withdrawal by Subject|0|||
126398817|NCT03576755|454753179|FG002|Overall Study|Withdrawal by Subject|0|||
126398818|NCT03576755|454753180|FG003|Overall Study|Withdrawal by Subject|0|||
126398819|NCT04962230|454753181|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
126398820|NCT04962230|454753181|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
126398821|NCT03958656|454753184|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
126398822|NCT03958656|454753185|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
126398823|NCT03958656|454753186|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
126398824|NCT03958656|454753187|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
126398825|NCT03958656|454753184|FG000|Overall Study|No longer meets eligibility criteria|0|||
126398826|NCT03958656|454753185|FG001|Overall Study|No longer meets eligibility criteria|0|||
126398827|NCT03958656|454753186|FG002|Overall Study|No longer meets eligibility criteria|1|||
126398828|NCT03958656|454753187|FG003|Overall Study|No longer meets eligibility criteria|0|||
126398829|NCT03958656|454753184|FG000|Overall Study|Started anti-cancer treatment|0|||
126398830|NCT03958656|454753185|FG001|Overall Study|Started anti-cancer treatment|0|||
126398831|NCT03958656|454753186|FG002|Overall Study|Started anti-cancer treatment|1|||
126398832|NCT03958656|454753187|FG003|Overall Study|Started anti-cancer treatment|0|||
126398833|NCT01767493|454753188|FG000|Overall Study|screen failures|3|||
126398834|NCT01598753|454753189|FG000|Overall Study|Adverse Event|1|||
126398835|NCT01598753|454753190|FG001|Overall Study|Adverse Event|9|||
126398836|NCT01598753|454753191|FG002|Overall Study|Adverse Event|1|||
126398837|NCT01598753|454753192|FG003|Overall Study|Adverse Event|7|||
126398838|NCT01598753|454753189|FG000|Overall Study|Lost to Follow-up|4|||
126398839|NCT01598753|454753190|FG001|Overall Study|Lost to Follow-up|3|||
126398840|NCT01598753|454753191|FG002|Overall Study|Lost to Follow-up|7|||
126398841|NCT01598753|454753192|FG003|Overall Study|Lost to Follow-up|5|||
126398842|NCT01598753|454753189|FG000|Overall Study|Physician Decision|0|||
126557318|NCT03890120|455332685|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
126557319|NCT03890120|455332682|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
126721203|NCT01187901|455928596|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
126721204|NCT01187901|455928595|FG000|Overall Study|Pregnancy|0|||
126398843|NCT01598753|454753190|FG001|Overall Study|Physician Decision|1|||
126398844|NCT01598753|454753191|FG002|Overall Study|Physician Decision|0|||
126398845|NCT01598753|454753192|FG003|Overall Study|Physician Decision|2|||
126398846|NCT01598753|454753189|FG000|Overall Study|Withdrawal by Subject|7|||
126398847|NCT01598753|454753190|FG001|Overall Study|Withdrawal by Subject|2|||
126398848|NCT01598753|454753191|FG002|Overall Study|Withdrawal by Subject|0|||
126398849|NCT01598753|454753192|FG003|Overall Study|Withdrawal by Subject|1|||
126398850|NCT03158012|454753193|FG000|Overall Study|Withdrawal by Subject|0|||
126398851|NCT03158012|454753194|FG001|Overall Study|Withdrawal by Subject|1|||
126398852|NCT04346108|454753195|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
126398853|NCT04346108|454753196|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
126398854|NCT04346108|454753197|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
126398855|NCT04346108|454753195|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
126398856|NCT04346108|454753196|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
126398857|NCT04346108|454753197|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
126398858|NCT02788201|454753198|FG000|Overall Study|Death|1|||
126398859|NCT02788201|454753199|FG001|Overall Study|Death|1|||
126398860|NCT02788201|454753200|FG002|Overall Study|Death|1|||
126398861|NCT02788201|454753201|FG003|Overall Study|Death|1|||
126398862|NCT02788201|454753202|FG004|Overall Study|Death|0|||
126398863|NCT02788201|454753203|FG005|Overall Study|Death|1|||
126398864|NCT02788201|454753198|FG000|Overall Study|Ineligible|0|||
126398865|NCT02788201|454753199|FG001|Overall Study|Ineligible|0|||
126398866|NCT02788201|454753200|FG002|Overall Study|Ineligible|0|||
126398867|NCT02788201|454753201|FG003|Overall Study|Ineligible|0|||
126398868|NCT02788201|454753202|FG004|Overall Study|Ineligible|0|||
126398869|NCT02788201|454753203|FG005|Overall Study|Ineligible|1|||
126398870|NCT02788201|454753198|FG000|Overall Study|Withdrawal by Subject|0|||
126557320|NCT03890120|455332683|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
126557321|NCT03890120|455332684|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
126398871|NCT02788201|454753199|FG001|Overall Study|Withdrawal by Subject|0|||
126398872|NCT02788201|454753200|FG002|Overall Study|Withdrawal by Subject|0|||
126398873|NCT02788201|454753201|FG003|Overall Study|Withdrawal by Subject|0|||
126398874|NCT02788201|454753202|FG004|Overall Study|Withdrawal by Subject|0|||
126398875|NCT02788201|454753203|FG005|Overall Study|Withdrawal by Subject|1|||
126398876|NCT02446418|454753208|FG000|Overall Study|Adverse Event|4|||
126398877|NCT02446418|454753209|FG001|Overall Study|Adverse Event|8|||
126398878|NCT02446418|454753208|FG000|Overall Study|Physician Decision|5|||
126398879|NCT02446418|454753209|FG001|Overall Study|Physician Decision|1|||
126398880|NCT02446418|454753208|FG000|Overall Study|Withdrawal by Subject|3|||
126398881|NCT02446418|454753209|FG001|Overall Study|Withdrawal by Subject|3|||
126398882|NCT02446418|454753208|FG000|Overall Study|Lost to Follow-up|2|||
126398883|NCT02446418|454753209|FG001|Overall Study|Lost to Follow-up|2|||
126398884|NCT02446418|454753208|FG000|Overall Study|Protocol Violation|1|||
126398885|NCT02446418|454753209|FG001|Overall Study|Protocol Violation|2|||
126398886|NCT02446418|454753208|FG000|Overall Study|Lack of Efficacy|2|||
126398887|NCT02446418|454753209|FG001|Overall Study|Lack of Efficacy|0|||
126398888|NCT02446418|454753208|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
126398889|NCT02446418|454753209|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
126398890|NCT04508751|454753210|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
126398891|NCT04508751|454753211|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
126398892|NCT04508751|454753212|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
126398893|NCT02014480|454753215|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
126398894|NCT02014480|454753216|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
126398895|NCT02014480|454753217|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
126398896|NCT02014480|454753218|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
126398897|NCT02014480|454753219|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
126398898|NCT02014480|454753220|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
126398899|NCT02014480|454753215|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126398900|NCT02014480|454753216|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126557322|NCT03890120|455332685|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
126557323|NCT03890120|455332682|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
126557324|NCT03890120|455332683|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
126557325|NCT03890120|455332684|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
126557326|NCT03890120|455332685|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
126557327|NCT03890120|455332682|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
126557328|NCT03890120|455332683|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
126557329|NCT03890120|455332684|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
126557330|NCT03890120|455332685|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
126557331|NCT03890120|455332682|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
126557332|NCT03890120|455332683|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
126557333|NCT03890120|455332684|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
126557334|NCT03890120|455332685|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
126557335|NCT03890120|455332682|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
126557336|NCT03890120|455332683|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
126557337|NCT03890120|455332684|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
126398901|NCT02014480|454753217|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126398902|NCT02014480|454753218|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
126398903|NCT02014480|454753219|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126398904|NCT02014480|454753220|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126398905|NCT02014480|454753215|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126398906|NCT02014480|454753216|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126398907|NCT02014480|454753217|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
126398908|NCT02014480|454753218|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126398909|NCT02014480|454753219|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126398910|NCT02014480|454753220|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
126398911|NCT02014480|454753215|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
126398912|NCT02014480|454753216|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
126398913|NCT02014480|454753217|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
126398914|NCT02014480|454753218|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
126398915|NCT02014480|454753219|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126398916|NCT02014480|454753220|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126398917|NCT02014480|454753215|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126398918|NCT02014480|454753216|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
126398919|NCT02014480|454753217|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126398920|NCT02014480|454753218|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126398921|NCT02014480|454753219|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126398922|NCT02014480|454753220|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
126398923|NCT02014480|454753215|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
126398924|NCT02014480|454753216|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
126398925|NCT02014480|454753217|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
126398926|NCT02014480|454753218|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
126398927|NCT02014480|454753219|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
126398928|NCT02014480|454753220|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
126398929|NCT02014480|454753215|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126398930|NCT02014480|454753216|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126398931|NCT02014480|454753217|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126398932|NCT02014480|454753218|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126398933|NCT02014480|454753219|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126398934|NCT02014480|454753220|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
126398935|NCT01865812|454753221|FG000|Primary Treatment Phase|Adverse Event|2|||
126398936|NCT01865812|454753222|FG001|Primary Treatment Phase|Adverse Event|0|||
126398937|NCT01865812|454753221|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
126398938|NCT01865812|454753222|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
126398939|NCT01865812|454753221|FG000|Long-term Safety Extension Phase|Pruritus|0|||
126398940|NCT01865812|454753222|FG001|Long-term Safety Extension Phase|Pruritus|3|||
126398941|NCT01865812|454753221|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
126398942|NCT01865812|454753222|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
126398943|NCT01865812|454753221|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
126398944|NCT01865812|454753222|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
126398945|NCT01338610|454753223|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
126398946|NCT01338610|454753224|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
126398947|NCT01338610|454753225|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
126398948|NCT01338610|454753223|FG000|Overall Study|Protocol Violation|1|||
126398949|NCT01338610|454753224|FG001|Overall Study|Protocol Violation|0|||
126398950|NCT01338610|454753225|FG002|Overall Study|Protocol Violation|1|||
126398951|NCT01338610|454753223|FG000|Overall Study|Adverse Event|3|||
126398952|NCT01338610|454753224|FG001|Overall Study|Adverse Event|0|||
126398953|NCT01338610|454753225|FG002|Overall Study|Adverse Event|0|||
126398954|NCT01414205|454753226|FG000|Overall Study|Death|5|||
126398955|NCT01414205|454753227|FG001|Overall Study|Death|1|||
126398956|NCT01414205|454753226|FG000|Overall Study|Lost to Follow-up|1|||
126398957|NCT01414205|454753227|FG001|Overall Study|Lost to Follow-up|4|||
126398958|NCT01414205|454753226|FG000|Overall Study|Physician Decision|0|||
126398959|NCT01414205|454753227|FG001|Overall Study|Physician Decision|1|||
126398960|NCT01414205|454753226|FG000|Overall Study|Randomized but not Treated|1|||
126398961|NCT01414205|454753227|FG001|Overall Study|Randomized but not Treated|1|||
126398962|NCT02046226|454753230|FG000|Overall Study|Lost to Follow-up|7|||
126398963|NCT01166373|454753233|FG000|Overall Study|Lost to Follow-up|3|||
126398964|NCT01166373|454753234|FG001|Overall Study|Lost to Follow-up|2|||
126398965|NCT01166373|454753235|FG002|Overall Study|Lost to Follow-up|2|||
126398966|NCT01166373|454753236|FG003|Overall Study|Lost to Follow-up|2|||
126398967|NCT01166373|454753233|FG000|Overall Study|Withdrawal by Subject|1|||
126398968|NCT01166373|454753234|FG001|Overall Study|Withdrawal by Subject|2|||
126398969|NCT01166373|454753235|FG002|Overall Study|Withdrawal by Subject|2|||
126398970|NCT01166373|454753236|FG003|Overall Study|Withdrawal by Subject|3|||
126557338|NCT03890120|455332685|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
126398971|NCT01166373|454753233|FG000|Overall Study|Physician Decision|1|||
126398972|NCT01166373|454753234|FG001|Overall Study|Physician Decision|0|||
126398973|NCT01166373|454753235|FG002|Overall Study|Physician Decision|0|||
126398974|NCT01166373|454753236|FG003|Overall Study|Physician Decision|0|||
126398975|NCT01819129|454753237|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
126398976|NCT01819129|454753238|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
126398977|NCT01819129|454753237|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
126398978|NCT01819129|454753238|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
126398979|NCT01819129|454753237|FG000|Overall Study|Other, Subject moved out of the country|0|||
126398980|NCT01819129|454753238|FG001|Overall Study|Other, Subject moved out of the country|1|||
126398981|NCT01819129|454753237|FG000|Overall Study|Withdrawal by Subject|15|||
126398982|NCT01819129|454753238|FG001|Overall Study|Withdrawal by Subject|15|||
126398983|NCT01819129|454753237|FG000|Overall Study|Lost to Follow-up|5|||
126398984|NCT01819129|454753238|FG001|Overall Study|Lost to Follow-up|2|||
126398985|NCT01819129|454753237|FG000|Overall Study|Lack of Efficacy|0|||
126398986|NCT01819129|454753238|FG001|Overall Study|Lack of Efficacy|1|||
126398987|NCT01819129|454753237|FG000|Overall Study|Adverse Event|1|||
126398988|NCT01819129|454753238|FG001|Overall Study|Adverse Event|4|||
126398989|NCT01819129|454753237|FG000|Overall Study|Death|1|||
126398990|NCT01819129|454753238|FG001|Overall Study|Death|1|||
126398991|NCT01819129|454753237|FG000|Overall Study|Withdrawal Criteria|20|||
126398992|NCT01819129|454753238|FG001|Overall Study|Withdrawal Criteria|15|||
126398993|NCT02836873|454753239|FG000|Overall Study|Protocol Violation|0|||
126398994|NCT02836873|454753240|FG001|Overall Study|Protocol Violation|1|||
126398995|NCT02836873|454753239|FG000|Overall Study|Adverse Event|1|||
126398996|NCT02836873|454753240|FG001|Overall Study|Adverse Event|4|||
126398997|NCT02836873|454753239|FG000|Overall Study|Withdrawal by Subject|2|||
126398998|NCT02836873|454753240|FG001|Overall Study|Withdrawal by Subject|2|||
126398999|NCT02836873|454753239|FG000|Overall Study|Lost to Follow-up|1|||
126399000|NCT02836873|454753240|FG001|Overall Study|Lost to Follow-up|3|||
126399001|NCT02836873|454753239|FG000|Overall Study|Physician Decision|0|||
126399002|NCT02836873|454753240|FG001|Overall Study|Physician Decision|1|||
126399003|NCT02836873|454753239|FG000|Overall Study|Other|1|||
126399004|NCT02836873|454753240|FG001|Overall Study|Other|0|||
126399005|NCT02914548|454753243|FG000|Overall Study|Adverse Event|15|||
126399006|NCT02914548|454753244|FG001|Overall Study|Adverse Event|7|||
126399007|NCT02914548|454753245|FG002|Overall Study|Adverse Event|15|||
126399008|NCT02914548|454753243|FG000|Overall Study|Physician Decision|2|||
126399009|NCT02914548|454753244|FG001|Overall Study|Physician Decision|2|||
126399010|NCT02914548|454753245|FG002|Overall Study|Physician Decision|0|||
126399011|NCT02914548|454753243|FG000|Overall Study|Protocol Violation|1|||
126399012|NCT02914548|454753244|FG001|Overall Study|Protocol Violation|0|||
126399013|NCT02914548|454753245|FG002|Overall Study|Protocol Violation|0|||
126399014|NCT02914548|454753243|FG000|Overall Study|Withdrawal by Subject|3|||
126399015|NCT02914548|454753244|FG001|Overall Study|Withdrawal by Subject|4|||
126399016|NCT02914548|454753245|FG002|Overall Study|Withdrawal by Subject|4|||
126399017|NCT02914548|454753243|FG000|Overall Study|>40% of body surface area|0|||
126399018|NCT02914548|454753244|FG001|Overall Study|>40% of body surface area|1|||
126399019|NCT02914548|454753245|FG002|Overall Study|>40% of body surface area|1|||
126399020|NCT02214225|454753246|FG000|Overall Study|Lost to Follow-up|46|||
126399021|NCT02214225|454753247|FG001|Overall Study|Lost to Follow-up|18|||
126399022|NCT02214225|454753248|FG002|Overall Study|Lost to Follow-up|18|||
126399023|NCT02214225|454753246|FG000|Overall Study|Withdrawal by Subject|2|||
126399024|NCT02214225|454753247|FG001|Overall Study|Withdrawal by Subject|0|||
126399025|NCT02214225|454753248|FG002|Overall Study|Withdrawal by Subject|2|||
126399026|NCT02214225|454753246|FG000|Overall Study|Death|5|||
126399027|NCT02214225|454753247|FG001|Overall Study|Death|0|||
126399028|NCT02214225|454753248|FG002|Overall Study|Death|1|||
126399029|NCT02214225|454753246|FG000|Overall Study|randomized in error, not vaccinated|2|||
126399030|NCT02214225|454753247|FG001|Overall Study|randomized in error, not vaccinated|1|||
126399031|NCT02214225|454753248|FG002|Overall Study|randomized in error, not vaccinated|1|||
126399032|NCT01253265|454753249|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
126399033|NCT01253265|454753250|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
126399034|NCT01253265|454753251|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
126399035|NCT01253265|454753252|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
126399036|NCT01253265|454753253|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
126399037|NCT01253265|454753249|FG000|Overall Study|Withdrawal by Subject|0|||
126399038|NCT01253265|454753250|FG001|Overall Study|Withdrawal by Subject|0|||
126399039|NCT01253265|454753251|FG002|Overall Study|Withdrawal by Subject|0|||
126399040|NCT01253265|454753252|FG003|Overall Study|Withdrawal by Subject|0|||
126399041|NCT01253265|454753253|FG004|Overall Study|Withdrawal by Subject|1|||
126399042|NCT00495521|454753254|FG000|Overall Study|Physician Decision|0|||
126399043|NCT00495521|454753255|FG001|Overall Study|Physician Decision|1|||
126399044|NCT02395055|454753260|FG000|Overall Study|Withdrawal by Subject|7|||
126399045|NCT02395055|454753261|FG001|Overall Study|Withdrawal by Subject|3|||
126399046|NCT00787930|454753262|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
126399047|NCT01896271|454753263|FG000|Overall Study|Physician Decision|10|||
126399048|NCT00823212|454755191|FG000|Overall Study|Death|8|||
126399049|NCT00823212|454755192|FG001|Overall Study|Death|10|||
126399050|NCT00823212|454755191|FG000|Overall Study|Withdrawal by Subject|6|||
126399051|NCT00823212|454755192|FG001|Overall Study|Withdrawal by Subject|1|||
126399052|NCT00823212|454755191|FG000|Overall Study|Incarcerated|0|||
126399053|NCT00823212|454755192|FG001|Overall Study|Incarcerated|1|||
126399054|NCT00823212|454755191|FG000|Overall Study|Missed 12-month visit|21|||
126399055|NCT00823212|454755192|FG001|Overall Study|Missed 12-month visit|21|||
126399056|NCT04126564|454755193|FG000|Overall Study|Withdrawal by Subject|0|||
126399057|NCT04126564|454755194|FG001|Overall Study|Withdrawal by Subject|2|||
126399058|NCT04126564|454755193|FG000|Overall Study|Lost to Follow-up|0|||
126399059|NCT04126564|454755194|FG001|Overall Study|Lost to Follow-up|1|||
126399060|NCT03500172|454755195|FG000|Period 1: Baseline Randomization|Death|0|||
126399061|NCT03500172|454755196|FG001|Period 1: Baseline Randomization|Death|0|||
126399062|NCT03500172|454755197|FG002|Period 1: Baseline Randomization|Death|0|||
126399063|NCT03500172|454755198|FG003|Period 1: Baseline Randomization|Death|0|||
126399064|NCT03500172|454755199|FG004|Period 1: Baseline Randomization|Death|0|||
126399065|NCT03500172|454755200|FG005|Period 1: Baseline Randomization|Death|0|||
126399066|NCT03500172|454755201|FG006|Period 1: Baseline Randomization|Death|0|||
126399067|NCT03500172|454755202|FG007|Period 1: Baseline Randomization|Death|0|||
126399068|NCT03500172|454755203|FG008|Period 1: Baseline Randomization|Death|0|||
126399069|NCT03500172|454755204|FG009|Period 1: Baseline Randomization|Death|2|||
126399070|NCT03500172|454755205|FG010|Period 1: Baseline Randomization|Death|0|||
126399071|NCT03500172|454755195|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
126399072|NCT03500172|454755196|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
126399073|NCT03500172|454755197|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
126399074|NCT03500172|454755198|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
126399075|NCT03500172|454755199|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
126399076|NCT03500172|454755200|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
126399077|NCT03500172|454755201|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
126399078|NCT03500172|454755202|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
126399079|NCT03500172|454755203|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
126399080|NCT03500172|454755204|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
126399081|NCT03500172|454755205|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
126399082|NCT03500172|454755195|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
126399083|NCT03500172|454755196|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
126399084|NCT03500172|454755197|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
126399085|NCT03500172|454755198|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
126399086|NCT03500172|454755199|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
126399087|NCT03500172|454755200|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
126399088|NCT03500172|454755201|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
126399089|NCT03500172|454755202|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
126399090|NCT03500172|454755203|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
126399091|NCT03500172|454755204|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
126399092|NCT03500172|454755205|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
126399093|NCT03500172|454755195|FG000|Period 2: Re-Randomization|Death|0|||
126399094|NCT03500172|454755196|FG001|Period 2: Re-Randomization|Death|0|||
126399095|NCT03500172|454755197|FG002|Period 2: Re-Randomization|Death|0|||
126399096|NCT03500172|454755198|FG003|Period 2: Re-Randomization|Death|4|||
126399097|NCT03500172|454755199|FG004|Period 2: Re-Randomization|Death|2|||
126399098|NCT03500172|454755200|FG005|Period 2: Re-Randomization|Death|0|||
126399099|NCT03500172|454755201|FG006|Period 2: Re-Randomization|Death|5|||
126399100|NCT03500172|454755202|FG007|Period 2: Re-Randomization|Death|2|||
126399101|NCT03500172|454755203|FG008|Period 2: Re-Randomization|Death|0|||
126471767|NCT02557295|455027551|FG002|Overall Study|Study Close|5|||
126471768|NCT02557295|455027552|FG003|Overall Study|Study Close|3|||
126471769|NCT02557295|455027553|FG004|Overall Study|Study Close|0|||
126471770|NCT02557295|455027554|FG005|Overall Study|Study Close|0|||
126471771|NCT02557295|455027555|FG006|Overall Study|Study Close|37|||
126471772|NCT02557295|455027556|FG007|Overall Study|Study Close|3|||
126471773|NCT02557295|455027557|FG008|Overall Study|Study Close|19|||
126557339|NCT03890120|455332682|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
126557340|NCT03890120|455332683|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
126721205|NCT01187901|455928596|FG001|Overall Study|Pregnancy|2|||
126399102|NCT03500172|454755204|FG009|Period 2: Re-Randomization|Death|0|||
126399103|NCT03500172|454755205|FG010|Period 2: Re-Randomization|Death|0|||
126399104|NCT02435680|454755211|FG000|Overall Study|Physician Decision|3|||
126399105|NCT02435680|454755212|FG001|Overall Study|Physician Decision|0|||
126399106|NCT02435680|454755213|FG002|Overall Study|Physician Decision|0|||
126399107|NCT02435680|454755211|FG000|Overall Study|subject / guardian decision|0|||
126471774|NCT02557295|455027549|FG000|Overall Study|except for study close|4|||
126471775|NCT02557295|455027550|FG001|Overall Study|except for study close|0|||
126471776|NCT02557295|455027551|FG002|Overall Study|except for study close|0|||
126471777|NCT02557295|455027552|FG003|Overall Study|except for study close|0|||
126471778|NCT02557295|455027553|FG004|Overall Study|except for study close|0|||
126399108|NCT02435680|454755212|FG001|Overall Study|subject / guardian decision|3|||
126399109|NCT02435680|454755213|FG002|Overall Study|subject / guardian decision|2|||
126399110|NCT02435680|454755211|FG000|Overall Study|Adverse Event|8|||
126399111|NCT02435680|454755212|FG001|Overall Study|Adverse Event|3|||
126399112|NCT02435680|454755213|FG002|Overall Study|Adverse Event|2|||
126399113|NCT02435680|454755211|FG000|Overall Study|progressive disease|10|||
126399114|NCT02435680|454755212|FG001|Overall Study|progressive disease|7|||
126399115|NCT02435680|454755213|FG002|Overall Study|progressive disease|11|||
126399116|NCT02435680|454755211|FG000|Overall Study|not treated|0|||
126399117|NCT02435680|454755212|FG001|Overall Study|not treated|0|||
126399118|NCT02435680|454755213|FG002|Overall Study|not treated|1|||
126399119|NCT00445848|454755214|FG000|Overall Study|Adverse Event|14|||
126399120|NCT00445848|454755214|FG000|Overall Study|Withdrawal by Subject|4|||
126399121|NCT00445848|454755214|FG000|Overall Study|Progression|62|||
126399122|NCT00445848|454755214|FG000|Overall Study|Other-Not protocol specified|5|||
126399123|NCT02585830|454755217|FG000|Overall Study|Withdrawal by Subject|3|||
126399124|NCT02509052|454755218|FG000|Overall Study|Non compliance|0|||
126399125|NCT02509052|454755219|FG001|Overall Study|Non compliance|0|||
126399126|NCT02509052|454755220|FG002|Overall Study|Non compliance|1|||
126399127|NCT01323270|454755223|FG000|Overall Study|Withdrawal by Subject|19|||
126399128|NCT01323270|454755224|FG001|Overall Study|Withdrawal by Subject|10|||
126399129|NCT01323270|454755223|FG000|Overall Study|Protocol Violation|9|||
126399130|NCT01323270|454755224|FG001|Overall Study|Protocol Violation|7|||
126399131|NCT01323270|454755223|FG000|Overall Study|Lost to Follow-up|4|||
126399132|NCT01323270|454755224|FG001|Overall Study|Lost to Follow-up|6|||
126399133|NCT01323270|454755223|FG000|Overall Study|Adverse Event|8|||
126399134|NCT01323270|454755224|FG001|Overall Study|Adverse Event|0|||
126399135|NCT01323270|454755223|FG000|Overall Study|Other|0|||
126399136|NCT01323270|454755224|FG001|Overall Study|Other|3|||
126399137|NCT01323270|454755223|FG000|Overall Study|Physician Decision|0|||
126399138|NCT01323270|454755224|FG001|Overall Study|Physician Decision|2|||
126399139|NCT01323270|454755223|FG000|Overall Study|Not eligible|1|||
126399140|NCT01323270|454755224|FG001|Overall Study|Not eligible|1|||
126399141|NCT01323270|454755223|FG000|Overall Study|Death|1|||
126399142|NCT01323270|454755224|FG001|Overall Study|Death|0|||
126399143|NCT01323270|454755223|FG000|Overall Study|Randomized, but not vaccinated|1|||
126399144|NCT01323270|454755224|FG001|Overall Study|Randomized, but not vaccinated|0|||
126399145|NCT03761394|454755228|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
126399146|NCT03761394|454755229|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
126399147|NCT03761394|454755230|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
126399148|NCT03761394|454755231|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
126399149|NCT03761394|454755228|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
126399150|NCT03761394|454755229|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
126399151|NCT03761394|454755230|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
126399152|NCT03761394|454755231|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
126399153|NCT03761394|454755228|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
126399154|NCT03761394|454755229|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
126399155|NCT03761394|454755230|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
126399156|NCT03761394|454755231|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
126399157|NCT03761394|454755228|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
126399158|NCT03761394|454755229|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
126399159|NCT03761394|454755230|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
126399160|NCT03761394|454755231|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
126399161|NCT03242772|454755240|FG000|Overall Study|Lost to Follow-up|2|||
126399162|NCT03242772|454755241|FG001|Overall Study|Lost to Follow-up|0|||
126399163|NCT03242772|454755240|FG000|Overall Study|Physician Decision|0|||
126399164|NCT03242772|454755241|FG001|Overall Study|Physician Decision|1|||
126471779|NCT02557295|455027554|FG005|Overall Study|except for study close|0|||
126471780|NCT02557295|455027555|FG006|Overall Study|except for study close|5|||
126471781|NCT02557295|455027556|FG007|Overall Study|except for study close|1|||
126471782|NCT02557295|455027557|FG008|Overall Study|except for study close|0|||
126471783|NCT00866788|455028778|FG000|Overall Study|Adverse Event|0|||
126399165|NCT03242772|454755240|FG000|Overall Study|Withdrawal by Subject|1|||
126399166|NCT03242772|454755241|FG001|Overall Study|Withdrawal by Subject|0|||
126399167|NCT01062841|454755245|FG000|Overall Study|Indwelling Device Removed|41|||
126399168|NCT01062841|454755246|FG001|Overall Study|Indwelling Device Removed|48|||
126399169|NCT01062841|454755245|FG000|Overall Study|Death|3|||
126399170|NCT01062841|454755246|FG001|Overall Study|Death|5|||
126399171|NCT01062841|454755245|FG000|Overall Study|Withdrawal by Subject|2|||
126471784|NCT00866788|455028779|FG001|Overall Study|Adverse Event|2|||
126471785|NCT00866788|455028780|FG002|Overall Study|Adverse Event|0|||
126471786|NCT00866788|455028781|FG003|Overall Study|Adverse Event|1|||
126471787|NCT00866788|455028778|FG000|Overall Study|Lost to Follow-up|1|||
126399172|NCT01062841|454755246|FG001|Overall Study|Withdrawal by Subject|0|||
126399173|NCT01062841|454755245|FG000|Overall Study|Withdrawal by Study|3|||
126471788|NCT00866788|455028779|FG001|Overall Study|Lost to Follow-up|1|||
126399174|NCT01062841|454755246|FG001|Overall Study|Withdrawal by Study|0|||
126399175|NCT01118520|454755247|FG000|Overall Study|AAA repair|9|||
126399176|NCT01118520|454755248|FG001|Overall Study|AAA repair|7|||
126399177|NCT01118520|454755249|FG002|Overall Study|AAA repair|9|||
126399178|NCT01118520|454755247|FG000|Overall Study|Adverse Event|3|||
126557341|NCT03890120|455332684|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
126399179|NCT01118520|454755248|FG001|Overall Study|Adverse Event|3|||
126399180|NCT01118520|454755249|FG002|Overall Study|Adverse Event|3|||
126399181|NCT01118520|454755247|FG000|Overall Study|Withdrawal by Subject|8|||
126399182|NCT01118520|454755248|FG001|Overall Study|Withdrawal by Subject|13|||
126399183|NCT01118520|454755249|FG002|Overall Study|Withdrawal by Subject|8|||
126399184|NCT01089023|454755252|FG000|Overall Study|Lost to Follow-up|3|||
126399185|NCT01089023|454755252|FG000|Overall Study|Adverse Event|1|||
126399186|NCT01089023|454755252|FG000|Overall Study|Withdrawal by Subject|1|||
126399187|NCT01089023|454755252|FG000|Overall Study|Protocol Violation|1|||
126399188|NCT01089023|454755252|FG000|Overall Study|Lack of Efficacy|1|||
126399189|NCT01185964|454755256|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
126399190|NCT01185964|454755257|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
126399191|NCT01185964|454755258|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
126399192|NCT01185964|454755259|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
126399193|NCT01185964|454755256|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
126399194|NCT01185964|454755257|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
126399195|NCT01185964|454755258|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
126399196|NCT01185964|454755259|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
126399197|NCT01185964|454755256|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
126399198|NCT01185964|454755257|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
126399199|NCT01185964|454755258|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
126399200|NCT01185964|454755259|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
126399201|NCT01185964|454755256|FG000|Phase 1b and Phase 2|Adverse Event|1|||
126399202|NCT01185964|454755257|FG001|Phase 1b and Phase 2|Adverse Event|0|||
126399203|NCT01185964|454755258|FG002|Phase 1b and Phase 2|Adverse Event|2|||
126399204|NCT01185964|454755259|FG003|Phase 1b and Phase 2|Adverse Event|0|||
126399205|NCT01185964|454755256|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
126399206|NCT01185964|454755257|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
126399207|NCT01185964|454755258|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
126399208|NCT01185964|454755259|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
126471789|NCT00866788|455028780|FG002|Overall Study|Lost to Follow-up|0|||
126471790|NCT00866788|455028781|FG003|Overall Study|Lost to Follow-up|2|||
126471791|NCT00866788|455028778|FG000|Overall Study|Withdrawal by Subject|2|||
126471792|NCT00866788|455028779|FG001|Overall Study|Withdrawal by Subject|1|||
126471793|NCT00866788|455028780|FG002|Overall Study|Withdrawal by Subject|0|||
126471794|NCT00866788|455028781|FG003|Overall Study|Withdrawal by Subject|1|||
126471795|NCT00866788|455028778|FG000|Overall Study|Pregnancy|0|||
126471796|NCT00866788|455028779|FG001|Overall Study|Pregnancy|1|||
126471797|NCT00866788|455028780|FG002|Overall Study|Pregnancy|0|||
126471798|NCT00866788|455028781|FG003|Overall Study|Pregnancy|0|||
126471799|NCT00866788|455028778|FG000|Overall Study|Disease progression|3|||
126471800|NCT00866788|455028779|FG001|Overall Study|Disease progression|1|||
126471801|NCT00866788|455028780|FG002|Overall Study|Disease progression|1|||
126471802|NCT00866788|455028781|FG003|Overall Study|Disease progression|0|||
126471803|NCT00866788|455028778|FG000|Overall Study|Physician Decision|0|||
126471804|NCT00866788|455028779|FG001|Overall Study|Physician Decision|0|||
126471805|NCT00866788|455028780|FG002|Overall Study|Physician Decision|1|||
126471806|NCT00866788|455028781|FG003|Overall Study|Physician Decision|1|||
126471807|NCT02742441|455028785|FG000|Overall Study|Lost to Follow-up|4|||
126471808|NCT02742441|455028786|FG001|Overall Study|Lost to Follow-up|4|||
126471809|NCT02742441|455028785|FG000|Overall Study|Withdrawal by Subject|2|||
126471810|NCT02742441|455028786|FG001|Overall Study|Withdrawal by Subject|2|||
126557342|NCT03890120|455332685|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
126557343|NCT03890120|455332682|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
126557344|NCT03890120|455332683|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
126557345|NCT03890120|455332684|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
126557346|NCT03890120|455332685|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
126557347|NCT00683449|455332686|FG000|Overall Study|Lost to Follow-up|0|||
126557348|NCT00683449|455332687|FG001|Overall Study|Lost to Follow-up|1|||
126557349|NCT00683449|455332688|FG002|Overall Study|Lost to Follow-up|0|||
126399209|NCT01185964|454755256|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
126471811|NCT02742441|455028785|FG000|Overall Study|Adverse Event|0|||
126471812|NCT02742441|455028786|FG001|Overall Study|Adverse Event|2|||
126471813|NCT04806503|455028792|FG000|Overall Study|Lost to Follow-up|0|||
126471814|NCT04806503|455028793|FG001|Overall Study|Lost to Follow-up|0|||
126471815|NCT04806503|455028794|FG002|Overall Study|Lost to Follow-up|1|||
126471816|NCT04806503|455028795|FG003|Overall Study|Lost to Follow-up|0|||
126471817|NCT04806503|455028796|FG004|Overall Study|Lost to Follow-up|0|||
126557350|NCT00683449|455332689|FG003|Overall Study|Lost to Follow-up|0|||
126471818|NCT04806503|455028792|FG000|Overall Study|Withdrawal by Subject|1|||
126471819|NCT04806503|455028793|FG001|Overall Study|Withdrawal by Subject|0|||
126471820|NCT04806503|455028794|FG002|Overall Study|Withdrawal by Subject|1|||
126471821|NCT04806503|455028795|FG003|Overall Study|Withdrawal by Subject|1|||
126471822|NCT04806503|455028796|FG004|Overall Study|Withdrawal by Subject|1|||
126471823|NCT04806503|455028792|FG000|Overall Study|Adverse Event|1|||
126471824|NCT04806503|455028793|FG001|Overall Study|Adverse Event|1|||
126471825|NCT04806503|455028794|FG002|Overall Study|Adverse Event|0|||
126471826|NCT04806503|455028795|FG003|Overall Study|Adverse Event|1|||
126471827|NCT04806503|455028796|FG004|Overall Study|Adverse Event|0|||
126471828|NCT03589469|455028797|FG000|Overall Study|Withdrawal by Subject|8|||
126471829|NCT03589469|455028797|FG000|Overall Study|Physician Decision|20|||
126471830|NCT03589469|455028797|FG000|Overall Study|Death|97|||
126471831|NCT03589469|455028797|FG000|Overall Study|Lost to Follow-up|8|||
126471832|NCT03589469|455028797|FG000|Overall Study|Miscellaneous|1|||
126471833|NCT03945214|455028813|FG000|Overall Study|Lost to Follow-up|3|||
126471834|NCT03945214|455028814|FG001|Overall Study|Lost to Follow-up|4|||
126471835|NCT03945214|455028815|FG002|Overall Study|Lost to Follow-up|7|||
126471836|NCT03945214|455028816|FG003|Overall Study|Lost to Follow-up|4|||
126471837|NCT00850070|455028820|FG000|Overall Study|Lack of Efficacy|1|||
126471838|NCT00850070|455028821|FG001|Overall Study|Lack of Efficacy|1|||
126471839|NCT00850070|455028820|FG000|Overall Study|Adverse Event|2|||
126471840|NCT00850070|455028821|FG001|Overall Study|Adverse Event|0|||
126471841|NCT00074984|455028822|FG000|Overall Study|Death|1|||
126471842|NCT00074984|455028823|FG001|Overall Study|Death|2|||
126471843|NCT00074984|455028822|FG000|Overall Study|Withdrawal by Subject|2|||
126471844|NCT00074984|455028823|FG001|Overall Study|Withdrawal by Subject|3|||
126471845|NCT00074984|455028822|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
126471846|NCT00074984|455028823|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
126471847|NCT00538291|455028828|FG000|Overall Study|Adverse Event|2|||
126471848|NCT00538291|455028828|FG000|Overall Study|Withdrawal by Subject|1|||
126471849|NCT00591344|455028829|FG000|Overall Study|Transportation issues|1|||
126471850|NCT00591344|455028830|FG001|Overall Study|Transportation issues|0|||
126471851|NCT00591344|455028829|FG000|Overall Study|Moved out of state|1|||
126471852|NCT00591344|455028830|FG001|Overall Study|Moved out of state|0|||
126471853|NCT00591344|455028829|FG000|Overall Study|Medical complications|1|||
126471854|NCT00591344|455028830|FG001|Overall Study|Medical complications|3|||
126471855|NCT00591344|455028829|FG000|Overall Study|Underwent DBS|2|||
126471856|NCT00591344|455028830|FG001|Overall Study|Underwent DBS|2|||
126471857|NCT00591344|455028829|FG000|Overall Study|Death|0|||
126471858|NCT00591344|455028830|FG001|Overall Study|Death|1|||
126471859|NCT00591344|455028829|FG000|Overall Study|Lost to Follow-up|0|||
126471860|NCT00591344|455028830|FG001|Overall Study|Lost to Follow-up|1|||
126471861|NCT00591344|455028829|FG000|Overall Study|Did not want to come off medication|0|||
126471862|NCT00591344|455028830|FG001|Overall Study|Did not want to come off medication|1|||
126471863|NCT01904058|455028833|FG000|Overall Study|Adverse Event|2|||
126471864|NCT01904058|455028834|FG001|Overall Study|Adverse Event|0|||
126471865|NCT01904058|455028835|FG002|Overall Study|Adverse Event|0|||
126471866|NCT01904058|455028836|FG003|Overall Study|Adverse Event|0|||
126471867|NCT01904058|455028833|FG000|Overall Study|Withdrawal by Subject|1|||
126471868|NCT01904058|455028834|FG001|Overall Study|Withdrawal by Subject|0|||
126471869|NCT01904058|455028835|FG002|Overall Study|Withdrawal by Subject|1|||
126471870|NCT01904058|455028836|FG003|Overall Study|Withdrawal by Subject|0|||
126471871|NCT01904058|455028833|FG000|Overall Study|Pregnancy|0|||
126471872|NCT01904058|455028834|FG001|Overall Study|Pregnancy|0|||
126471873|NCT01904058|455028835|FG002|Overall Study|Pregnancy|0|||
126471874|NCT01904058|455028836|FG003|Overall Study|Pregnancy|1|||
126471875|NCT03096483|455028838|FG000|Overall Study|Withdrawal by site|1|||
126471876|NCT02046733|455028843|FG000|Overall Study|never initiated 'treatment visits'|6|||
126471877|NCT02046733|455028844|FG001|Overall Study|never initiated 'treatment visits'|0|||
126557351|NCT00683449|455332690|FG004|Overall Study|Lost to Follow-up|0|||
126772281|NCT02030834|456122075|FG001|Overall Study|Lack of funding|0|||
126471878|NCT04041375|455028849|FG000|Intervention Phase|Withdrawal by Subject|2|||
126471879|NCT04041375|455028850|FG001|Intervention Phase|Withdrawal by Subject|2|||
126471880|NCT04041375|455028849|FG000|Follow-up Phase|Death|2|||
126471881|NCT04041375|455028850|FG001|Follow-up Phase|Death|0|||
126471882|NCT04041375|455028849|FG000|Follow-up Phase|Lost to Follow-up|2|||
126471883|NCT04041375|455028850|FG001|Follow-up Phase|Lost to Follow-up|1|||
126471884|NCT04041375|455028849|FG000|Follow-up Phase|Too ill|3|||
126471885|NCT04041375|455028850|FG001|Follow-up Phase|Too ill|0|||
126471886|NCT04674644|455028856|FG000|Overall Study|with missing data|37|||
126471887|NCT00199875|455028857|FG000|Overall Study|Withdrawal by Subject|0|||
126471888|NCT00199875|455028858|FG001|Overall Study|Withdrawal by Subject|0|||
126471889|NCT00199875|455028859|FG002|Overall Study|Withdrawal by Subject|0|||
126471890|NCT00199875|455028860|FG003|Overall Study|Withdrawal by Subject|0|||
126471891|NCT00199875|455028861|FG004|Overall Study|Withdrawal by Subject|1|||
126471892|NCT01024231|455028865|FG000|Overall Study|Other Reasons|1|||
126471893|NCT01024231|455028866|FG001|Overall Study|Other Reasons|2|||
126471894|NCT01024231|455028867|FG002|Overall Study|Other Reasons|0|||
126471895|NCT01024231|455028868|FG003|Overall Study|Other Reasons|0|||
126471896|NCT01024231|455028869|FG004|Overall Study|Other Reasons|2|||
126471897|NCT01024231|455028870|FG005|Overall Study|Other Reasons|0|||
126471898|NCT01024231|455028871|FG006|Overall Study|Other Reasons|1|||
126471899|NCT01024231|455028865|FG000|Overall Study|Maximum Clinical Benefit|1|||
126471900|NCT01024231|455028866|FG001|Overall Study|Maximum Clinical Benefit|2|||
126471901|NCT01024231|455028867|FG002|Overall Study|Maximum Clinical Benefit|0|||
126471902|NCT01024231|455028868|FG003|Overall Study|Maximum Clinical Benefit|1|||
126471903|NCT01024231|455028869|FG004|Overall Study|Maximum Clinical Benefit|1|||
126471904|NCT01024231|455028870|FG005|Overall Study|Maximum Clinical Benefit|0|||
126471905|NCT01024231|455028871|FG006|Overall Study|Maximum Clinical Benefit|0|||
126399210|NCT01185964|454755257|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
126399211|NCT01185964|454755258|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
126399212|NCT01185964|454755259|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
126399213|NCT01185964|454755256|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
126399214|NCT01185964|454755257|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
126399215|NCT01185964|454755258|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
126399216|NCT01185964|454755259|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
126399217|NCT01185964|454755256|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
126399218|NCT01185964|454755257|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
126399219|NCT01185964|454755258|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
126399220|NCT01185964|454755259|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
126399221|NCT01920893|454755260|FG000|Overall Study|Adverse Event|5|||
126399222|NCT01920893|454755261|FG001|Overall Study|Adverse Event|2|||
126399223|NCT01920893|454755260|FG000|Overall Study|Lack of Efficacy|2|||
126399224|NCT01920893|454755261|FG001|Overall Study|Lack of Efficacy|0|||
126399225|NCT03440918|454755265|FG000|Overall Study|Protocol Violation|0|||
126399226|NCT03440918|454755266|FG001|Overall Study|Protocol Violation|16|||
126399227|NCT01396265|454755278|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
126399228|NCT02275117|454755281|FG000|Overall Study|Adverse Event|0|||
126399229|NCT02275117|454755282|FG001|Overall Study|Adverse Event|0|||
126399230|NCT02275117|454755283|FG002|Overall Study|Adverse Event|0|||
126399231|NCT02275117|454755284|FG003|Overall Study|Adverse Event|0|||
126399232|NCT02275117|454755285|FG004|Overall Study|Adverse Event|1|||
126399233|NCT02275117|454755281|FG000|Overall Study|Lack of Efficacy|6|||
126399234|NCT02275117|454755282|FG001|Overall Study|Lack of Efficacy|7|||
126399235|NCT02275117|454755283|FG002|Overall Study|Lack of Efficacy|5|||
126399236|NCT02275117|454755284|FG003|Overall Study|Lack of Efficacy|2|||
126399237|NCT02275117|454755285|FG004|Overall Study|Lack of Efficacy|10|||
126399238|NCT02275117|454755281|FG000|Overall Study|Lost to Follow-up|11|||
126399239|NCT02275117|454755282|FG001|Overall Study|Lost to Follow-up|16|||
126399240|NCT02275117|454755283|FG002|Overall Study|Lost to Follow-up|15|||
126399241|NCT02275117|454755284|FG003|Overall Study|Lost to Follow-up|16|||
126399242|NCT02275117|454755285|FG004|Overall Study|Lost to Follow-up|8|||
126399243|NCT02275117|454755281|FG000|Overall Study|Physician Decision|0|||
126399244|NCT02275117|454755282|FG001|Overall Study|Physician Decision|1|||
126399245|NCT02275117|454755283|FG002|Overall Study|Physician Decision|1|||
126399246|NCT02275117|454755284|FG003|Overall Study|Physician Decision|0|||
126399247|NCT02275117|454755285|FG004|Overall Study|Physician Decision|1|||
126399248|NCT02275117|454755281|FG000|Overall Study|Protocol Violation|1|||
126399249|NCT02275117|454755282|FG001|Overall Study|Protocol Violation|0|||
126399250|NCT02275117|454755283|FG002|Overall Study|Protocol Violation|1|||
126399251|NCT02275117|454755284|FG003|Overall Study|Protocol Violation|1|||
126399252|NCT02275117|454755285|FG004|Overall Study|Protocol Violation|0|||
126399253|NCT02275117|454755281|FG000|Overall Study|Withdrawal by Subject|6|||
126399254|NCT02275117|454755282|FG001|Overall Study|Withdrawal by Subject|4|||
126399255|NCT02275117|454755283|FG002|Overall Study|Withdrawal by Subject|7|||
126399256|NCT02275117|454755284|FG003|Overall Study|Withdrawal by Subject|3|||
126399257|NCT02275117|454755285|FG004|Overall Study|Withdrawal by Subject|3|||
126471906|NCT01024231|455028865|FG000|Overall Study|Disease Progression|3|||
126471907|NCT01024231|455028866|FG001|Overall Study|Disease Progression|1|||
126471908|NCT01024231|455028867|FG002|Overall Study|Disease Progression|3|||
126471909|NCT01024231|455028868|FG003|Overall Study|Disease Progression|0|||
126471910|NCT01024231|455028869|FG004|Overall Study|Disease Progression|4|||
126471911|NCT01024231|455028870|FG005|Overall Study|Disease Progression|11|||
126471912|NCT01024231|455028871|FG006|Overall Study|Disease Progression|6|||
126471913|NCT01024231|455028865|FG000|Overall Study|AE unrelated to Study Drug|0|||
126399258|NCT02275117|454755281|FG000|Overall Study|Terminated by Sponsor|4|||
126471914|NCT01024231|455028866|FG001|Overall Study|AE unrelated to Study Drug|1|||
126471915|NCT01024231|455028867|FG002|Overall Study|AE unrelated to Study Drug|0|||
126399259|NCT02275117|454755282|FG001|Overall Study|Terminated by Sponsor|4|||
126399260|NCT02275117|454755283|FG002|Overall Study|Terminated by Sponsor|4|||
126399261|NCT02275117|454755284|FG003|Overall Study|Terminated by Sponsor|6|||
126399262|NCT02275117|454755285|FG004|Overall Study|Terminated by Sponsor|4|||
126399263|NCT02275117|454755281|FG000|Overall Study|Worsening of Study Indication|0|||
126399264|NCT02275117|454755282|FG001|Overall Study|Worsening of Study Indication|1|||
126399265|NCT02275117|454755283|FG002|Overall Study|Worsening of Study Indication|2|||
126399266|NCT02275117|454755284|FG003|Overall Study|Worsening of Study Indication|0|||
126399267|NCT02275117|454755285|FG004|Overall Study|Worsening of Study Indication|0|||
126399268|NCT02275117|454755281|FG000|Overall Study|Study Burden|5|||
126399269|NCT02275117|454755282|FG001|Overall Study|Study Burden|4|||
126399270|NCT02275117|454755283|FG002|Overall Study|Study Burden|7|||
126399271|NCT02275117|454755284|FG003|Overall Study|Study Burden|5|||
126399272|NCT02275117|454755285|FG004|Overall Study|Study Burden|7|||
126399273|NCT02275117|454755281|FG000|Overall Study|Other|1|||
126399274|NCT02275117|454755282|FG001|Overall Study|Other|0|||
126399275|NCT02275117|454755283|FG002|Overall Study|Other|0|||
126399276|NCT02275117|454755284|FG003|Overall Study|Other|0|||
126399277|NCT02275117|454755285|FG004|Overall Study|Other|2|||
126399278|NCT03754582|454755291|FG000|Treatment Phase|Adverse Event|0|||
126399279|NCT03754582|454755292|FG001|Treatment Phase|Adverse Event|1|||
126399280|NCT03754582|454755293|FG002|Treatment Phase|Adverse Event|0|||
126399281|NCT03754582|454755291|FG000|Follow-up Phase|Other|0|||
126399282|NCT03754582|454755292|FG001|Follow-up Phase|Other|0|||
126399283|NCT03754582|454755293|FG002|Follow-up Phase|Other|1|||
126399284|NCT02680574|454755294|FG000|Overall Study|Death|137|||
126399285|NCT02680574|454755295|FG001|Overall Study|Death|137|||
126399286|NCT02680574|454755294|FG000|Overall Study|Withdrawal by Subject|17|||
126399287|NCT02680574|454755295|FG001|Overall Study|Withdrawal by Subject|9|||
126399288|NCT02680574|454755294|FG000|Overall Study|Lost to Follow-up|4|||
126399289|NCT02680574|454755295|FG001|Overall Study|Lost to Follow-up|6|||
126399290|NCT02847858|454755296|FG000|Overall Study|Lost to Follow-up|401|||
126399291|NCT02847858|454755297|FG001|Overall Study|Lost to Follow-up|269|||
126399292|NCT00066469|454755299|FG000|Overall Study|Death|3|||
126399293|NCT00066469|454755299|FG000|Overall Study|Lack of Efficacy|9|||
126399294|NCT00066469|454755299|FG000|Overall Study|Lost to Follow-up|1|||
126399295|NCT00066469|454755299|FG000|Overall Study|Physician Decision|1|||
126399296|NCT00066469|454755299|FG000|Overall Study|Withdrawal by Subject|1|||
126399297|NCT00066469|454755299|FG000|Overall Study|ineligible|1|||
126399298|NCT00711802|454755300|FG000|Overall Study|Not treated (no further detail)|2|||
126399299|NCT00711802|454755301|FG001|Overall Study|Not treated (no further detail)|1|||
126399300|NCT00711802|454755302|FG002|Overall Study|Not treated (no further detail)|2|||
126399301|NCT00711802|454755303|FG003|Overall Study|Not treated (no further detail)|0|||
126399302|NCT00711802|454755304|FG004|Overall Study|Not treated (no further detail)|2|||
126399303|NCT00711802|454755305|FG005|Overall Study|Not treated (no further detail)|0|||
126399304|NCT00711802|454755306|FG006|Overall Study|Not treated (no further detail)|0|||
126399305|NCT00711802|454755307|FG007|Overall Study|Not treated (no further detail)|0|||
126399306|NCT00711802|454755300|FG000|Overall Study|Adverse Event|0|||
126399307|NCT00711802|454755301|FG001|Overall Study|Adverse Event|0|||
126399308|NCT00711802|454755302|FG002|Overall Study|Adverse Event|0|||
126399309|NCT00711802|454755303|FG003|Overall Study|Adverse Event|0|||
126399310|NCT00711802|454755304|FG004|Overall Study|Adverse Event|1|||
126399311|NCT00711802|454755305|FG005|Overall Study|Adverse Event|1|||
126399312|NCT00711802|454755306|FG006|Overall Study|Adverse Event|0|||
126399313|NCT00711802|454755307|FG007|Overall Study|Adverse Event|0|||
126399314|NCT00711802|454755300|FG000|Overall Study|Microbiological failure|0|||
126399315|NCT00711802|454755301|FG001|Overall Study|Microbiological failure|1|||
126399316|NCT00711802|454755302|FG002|Overall Study|Microbiological failure|0|||
126399317|NCT00711802|454755303|FG003|Overall Study|Microbiological failure|0|||
126399318|NCT00711802|454755304|FG004|Overall Study|Microbiological failure|0|||
126399319|NCT00711802|454755305|FG005|Overall Study|Microbiological failure|1|||
126399320|NCT00711802|454755306|FG006|Overall Study|Microbiological failure|0|||
126399321|NCT00711802|454755307|FG007|Overall Study|Microbiological failure|0|||
126399322|NCT00711802|454755300|FG000|Overall Study|Protocol Violation|0|||
126399323|NCT00711802|454755301|FG001|Overall Study|Protocol Violation|0|||
126399324|NCT00711802|454755302|FG002|Overall Study|Protocol Violation|0|||
126399325|NCT00711802|454755303|FG003|Overall Study|Protocol Violation|1|||
126399326|NCT00711802|454755304|FG004|Overall Study|Protocol Violation|0|||
126399327|NCT00711802|454755305|FG005|Overall Study|Protocol Violation|0|||
126399328|NCT00711802|454755306|FG006|Overall Study|Protocol Violation|0|||
126399329|NCT00711802|454755307|FG007|Overall Study|Protocol Violation|0|||
126399330|NCT00711802|454755300|FG000|Overall Study|Physician Decision|0|||
126399331|NCT00711802|454755301|FG001|Overall Study|Physician Decision|2|||
126399332|NCT00711802|454755302|FG002|Overall Study|Physician Decision|0|||
126399333|NCT00711802|454755303|FG003|Overall Study|Physician Decision|0|||
126399334|NCT00711802|454755304|FG004|Overall Study|Physician Decision|0|||
126399335|NCT00711802|454755305|FG005|Overall Study|Physician Decision|0|||
126399336|NCT00711802|454755306|FG006|Overall Study|Physician Decision|0|||
126399337|NCT00711802|454755307|FG007|Overall Study|Physician Decision|0|||
126399338|NCT00711802|454755300|FG000|Overall Study|Withdrawal by Subject|0|||
126399339|NCT00711802|454755301|FG001|Overall Study|Withdrawal by Subject|1|||
126399340|NCT00711802|454755302|FG002|Overall Study|Withdrawal by Subject|0|||
126399341|NCT00711802|454755303|FG003|Overall Study|Withdrawal by Subject|1|||
126399342|NCT00711802|454755304|FG004|Overall Study|Withdrawal by Subject|0|||
126399343|NCT00711802|454755305|FG005|Overall Study|Withdrawal by Subject|0|||
126399344|NCT00711802|454755306|FG006|Overall Study|Withdrawal by Subject|0|||
126399345|NCT00711802|454755307|FG007|Overall Study|Withdrawal by Subject|0|||
126399346|NCT00711802|454755300|FG000|Overall Study|Lost to Follow-up|0|||
126399347|NCT00711802|454755301|FG001|Overall Study|Lost to Follow-up|0|||
126399348|NCT00711802|454755302|FG002|Overall Study|Lost to Follow-up|3|||
126399349|NCT00711802|454755303|FG003|Overall Study|Lost to Follow-up|1|||
126399350|NCT00711802|454755304|FG004|Overall Study|Lost to Follow-up|10|||
126399351|NCT00711802|454755305|FG005|Overall Study|Lost to Follow-up|6|||
126399352|NCT00711802|454755306|FG006|Overall Study|Lost to Follow-up|4|||
126399353|NCT00711802|454755307|FG007|Overall Study|Lost to Follow-up|2|||
126399354|NCT00711802|454755300|FG000|Overall Study|Reason not reported|0|||
126399355|NCT00711802|454755301|FG001|Overall Study|Reason not reported|1|||
126399356|NCT00711802|454755302|FG002|Overall Study|Reason not reported|1|||
126399357|NCT00711802|454755303|FG003|Overall Study|Reason not reported|0|||
126399358|NCT00711802|454755304|FG004|Overall Study|Reason not reported|1|||
126399359|NCT00711802|454755305|FG005|Overall Study|Reason not reported|0|||
126399360|NCT00711802|454755306|FG006|Overall Study|Reason not reported|1|||
126399361|NCT00711802|454755307|FG007|Overall Study|Reason not reported|0|||
126399362|NCT02305849|454755309|FG000|Overall Study|Adverse Event|10|||
126399363|NCT02305849|454755310|FG001|Overall Study|Adverse Event|12|||
126399364|NCT02305849|454755311|FG002|Overall Study|Adverse Event|7|||
126399365|NCT02305849|454755312|FG003|Overall Study|Adverse Event|3|||
126399366|NCT02305849|454755309|FG000|Overall Study|Lack of Efficacy|10|||
126399367|NCT02305849|454755310|FG001|Overall Study|Lack of Efficacy|6|||
126399368|NCT02305849|454755311|FG002|Overall Study|Lack of Efficacy|3|||
126399369|NCT02305849|454755312|FG003|Overall Study|Lack of Efficacy|9|||
126399370|NCT02305849|454755309|FG000|Overall Study|Withdrawal by Subject|2|||
126399371|NCT02305849|454755310|FG001|Overall Study|Withdrawal by Subject|2|||
126399372|NCT02305849|454755311|FG002|Overall Study|Withdrawal by Subject|1|||
126399373|NCT02305849|454755312|FG003|Overall Study|Withdrawal by Subject|4|||
126399374|NCT02305849|454755309|FG000|Overall Study|Lost to Follow-up|0|||
126399375|NCT02305849|454755310|FG001|Overall Study|Lost to Follow-up|2|||
126399376|NCT02305849|454755311|FG002|Overall Study|Lost to Follow-up|0|||
126399377|NCT02305849|454755312|FG003|Overall Study|Lost to Follow-up|0|||
126399378|NCT02305849|454755309|FG000|Overall Study|Protocol Violation|3|||
126399379|NCT02305849|454755310|FG001|Overall Study|Protocol Violation|2|||
126557352|NCT00479674|455332695|FG000|Overall Study|Adverse Event|18|||
126557353|NCT00479674|455332695|FG000|Overall Study|Withdrawal by Subject|6|||
126399380|NCT02305849|454755311|FG002|Overall Study|Protocol Violation|1|||
126399381|NCT02305849|454755312|FG003|Overall Study|Protocol Violation|1|||
126399382|NCT02305849|454755309|FG000|Overall Study|Lab data met discontinuation criteria|0|||
126399383|NCT02305849|454755310|FG001|Overall Study|Lab data met discontinuation criteria|1|||
126399384|NCT02305849|454755311|FG002|Overall Study|Lab data met discontinuation criteria|2|||
126399385|NCT02305849|454755312|FG003|Overall Study|Lab data met discontinuation criteria|1|||
126399386|NCT02305849|454755309|FG000|Overall Study|Miscellaneous|1|||
126399387|NCT02305849|454755310|FG001|Overall Study|Miscellaneous|2|||
126399388|NCT02305849|454755311|FG002|Overall Study|Miscellaneous|4|||
126399389|NCT02305849|454755312|FG003|Overall Study|Miscellaneous|1|||
126399390|NCT02305849|454755309|FG000|Overall Study|Not fulfill eligibility criteria|1|||
126399391|NCT02305849|454755310|FG001|Overall Study|Not fulfill eligibility criteria|1|||
126399392|NCT02305849|454755311|FG002|Overall Study|Not fulfill eligibility criteria|0|||
126399393|NCT02305849|454755312|FG003|Overall Study|Not fulfill eligibility criteria|0|||
126399394|NCT02410824|454755317|FG000|First Intervention (One Week)|Headache|0|||
126399395|NCT02410824|454755318|FG001|First Intervention (One Week)|Headache|1|||
126399396|NCT00392808|454755319|FG000|Overall Study|Lost to Follow-up|3|||
126399397|NCT00392808|454755320|FG001|Overall Study|Lost to Follow-up|2|||
126399398|NCT00392808|454755321|FG002|Overall Study|Lost to Follow-up|1|||
126399399|NCT00392808|454755322|FG003|Overall Study|Lost to Follow-up|2|||
126399400|NCT00392808|454755319|FG000|Overall Study|Unable to withdraw blood|3|||
126399401|NCT00392808|454755320|FG001|Overall Study|Unable to withdraw blood|1|||
126399402|NCT00392808|454755321|FG002|Overall Study|Unable to withdraw blood|1|||
126399403|NCT00392808|454755322|FG003|Overall Study|Unable to withdraw blood|2|||
126399404|NCT02782325|454755323|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
126399405|NCT02782325|454755324|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
126399406|NCT02782325|454755325|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
126399407|NCT02782325|454755323|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
126399408|NCT02782325|454755324|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
126399409|NCT02782325|454755325|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
126399410|NCT02818036|454755328|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
126399411|NCT02818036|454755329|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
126399412|NCT02818036|454755328|FG000|Overall Study|Withdrawal by Subject|1|||
126399413|NCT02818036|454755329|FG001|Overall Study|Withdrawal by Subject|0|||
126399414|NCT01038713|454755330|FG000|Overall Study|Patient to hospice|1|||
126399415|NCT01038713|454755331|FG001|Overall Study|Patient to hospice|1|||
126399416|NCT01038713|454755332|FG002|Overall Study|Patient to hospice|1|||
126399417|NCT01038713|454755330|FG000|Overall Study|Lost to Follow-up|3|||
126399418|NCT01038713|454755331|FG001|Overall Study|Lost to Follow-up|0|||
126399419|NCT01038713|454755332|FG002|Overall Study|Lost to Follow-up|0|||
126399420|NCT01038713|454755330|FG000|Overall Study|Neuroendocrine Tumor|0|||
126399421|NCT01038713|454755331|FG001|Overall Study|Neuroendocrine Tumor|1|||
126399422|NCT01038713|454755332|FG002|Overall Study|Neuroendocrine Tumor|0|||
126399423|NCT01038713|454755330|FG000|Overall Study|died from PEP|0|||
126399424|NCT01038713|454755331|FG001|Overall Study|died from PEP|1|||
126399425|NCT01038713|454755332|FG002|Overall Study|died from PEP|0|||
126399426|NCT01038713|454755330|FG000|Overall Study|Autoimmune Pancreatitis|1|||
126399427|NCT01038713|454755331|FG001|Overall Study|Autoimmune Pancreatitis|0|||
126399428|NCT01038713|454755332|FG002|Overall Study|Autoimmune Pancreatitis|0|||
126399429|NCT01154283|454755333|FG000|0-6 Weeks|Withdrawal by Subject|7|||
126399430|NCT01154283|454755334|FG001|0-6 Weeks|Withdrawal by Subject|2|||
126399431|NCT01154283|454755333|FG000|0-6 Weeks|Death|0|||
126399432|NCT01154283|454755334|FG001|0-6 Weeks|Death|1|||
126399433|NCT01154283|454755333|FG000|7-12 Weeks|Death|1|||
126399434|NCT01154283|454755334|FG001|7-12 Weeks|Death|0|||
126399435|NCT01154283|454755333|FG000|7-12 Weeks|Withdrawal by Subject|0|||
126399436|NCT01154283|454755334|FG001|7-12 Weeks|Withdrawal by Subject|1|||
126399437|NCT03777917|454755335|FG000|Overall Study|Withdrawal by Subject|1|||
126399438|NCT03777917|454755336|FG001|Overall Study|Withdrawal by Subject|0|||
126399439|NCT03777917|454755335|FG000|Overall Study|Physician Decision|1|||
126399440|NCT03777917|454755336|FG001|Overall Study|Physician Decision|0|||
126399441|NCT03777917|454755335|FG000|Overall Study|Lost to Follow-up|6|||
126399442|NCT03777917|454755336|FG001|Overall Study|Lost to Follow-up|2|||
126399443|NCT03777917|454755335|FG000|Overall Study|Other|1|||
126399444|NCT03777917|454755336|FG001|Overall Study|Other|0|||
126399445|NCT00042432|454755337|FG000|Overall Study|Adverse Event|4|||
126399446|NCT00042432|454755338|FG001|Overall Study|Adverse Event|1|||
126399447|NCT00042432|454755337|FG000|Overall Study|Withdrawal by Subject|1|||
126399448|NCT00042432|454755338|FG001|Overall Study|Withdrawal by Subject|3|||
126399449|NCT00042432|454755337|FG000|Overall Study|Death|0|||
126399450|NCT00042432|454755338|FG001|Overall Study|Death|2|||
126399451|NCT00042432|454755337|FG000|Overall Study|Ineligibility determined|1|||
126399452|NCT00042432|454755338|FG001|Overall Study|Ineligibility determined|0|||
126399453|NCT00042432|454755337|FG000|Overall Study|Initiation of maintenance dialysis|1|||
126399454|NCT00042432|454755338|FG001|Overall Study|Initiation of maintenance dialysis|1|||
126399455|NCT00042432|454755337|FG000|Overall Study|Other|2|||
126399456|NCT00042432|454755338|FG001|Overall Study|Other|0|||
126399457|NCT01853072|454755339|FG000|Overall Study|Adverse event prior to treatment|0|||
126399458|NCT01853072|454755340|FG001|Overall Study|Adverse event prior to treatment|1|||
126399459|NCT01853072|454755339|FG000|Overall Study|Adverse Event|0|||
126399460|NCT01853072|454755340|FG001|Overall Study|Adverse Event|3|||
126399461|NCT01853072|454755339|FG000|Overall Study|Death|1|||
126399462|NCT01853072|454755340|FG001|Overall Study|Death|4|||
126399463|NCT01853072|454755339|FG000|Overall Study|Lost to Follow-up|0|||
126399464|NCT01853072|454755340|FG001|Overall Study|Lost to Follow-up|3|||
126399465|NCT01853072|454755339|FG000|Overall Study|Non-compliance with study drug|0|||
126399466|NCT01853072|454755340|FG001|Overall Study|Non-compliance with study drug|1|||
126399467|NCT01853072|454755339|FG000|Overall Study|Physician Decision|1|||
126399468|NCT01853072|454755340|FG001|Overall Study|Physician Decision|1|||
126399469|NCT01853072|454755339|FG000|Overall Study|Withdrawal by Subject|1|||
126399470|NCT01853072|454755340|FG001|Overall Study|Withdrawal by Subject|2|||
126399471|NCT01853072|454755339|FG000|Overall Study|Reason not specified|9|||
126399472|NCT01853072|454755340|FG001|Overall Study|Reason not specified|6|||
126399473|NCT01816906|454755341|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
126399474|NCT01816906|454755342|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
126399475|NCT01816906|454755341|FG000|Six Months|Lost to Follow-up|14|||
126399476|NCT01816906|454755342|FG001|Six Months|Lost to Follow-up|16|||
126399477|NCT01816906|454755341|FG000|12 Months|Adverse Event|2|||
126399478|NCT01816906|454755342|FG001|12 Months|Adverse Event|2|||
126399479|NCT01816906|454755341|FG000|12 Months|Death|0|||
126399480|NCT01816906|454755342|FG001|12 Months|Death|2|||
126399481|NCT01816906|454755341|FG000|12 Months|Lost to Follow-up|2|||
126399482|NCT01816906|454755342|FG001|12 Months|Lost to Follow-up|1|||
126471916|NCT01024231|455028868|FG003|Overall Study|AE unrelated to Study Drug|0|||
126471917|NCT01024231|455028869|FG004|Overall Study|AE unrelated to Study Drug|0|||
126399483|NCT01527383|454755343|FG000|Overall Study|Adverse Event|5|||
126399484|NCT01527383|454755344|FG001|Overall Study|Adverse Event|0|||
126399485|NCT01527383|454755343|FG000|Overall Study|Lost to Follow-up|3|||
126399486|NCT01527383|454755344|FG001|Overall Study|Lost to Follow-up|0|||
126399487|NCT01527383|454755343|FG000|Overall Study|Physician Decision|2|||
126399488|NCT01527383|454755344|FG001|Overall Study|Physician Decision|0|||
126399489|NCT01527383|454755343|FG000|Overall Study|Pregnancy|1|||
126399490|NCT01527383|454755344|FG001|Overall Study|Pregnancy|0|||
126399491|NCT01527383|454755343|FG000|Overall Study|Protocol Violation|1|||
126399492|NCT01527383|454755344|FG001|Overall Study|Protocol Violation|0|||
126399493|NCT01527383|454755343|FG000|Overall Study|Screen failure|1|||
126399494|NCT01527383|454755344|FG001|Overall Study|Screen failure|0|||
126399495|NCT01527383|454755343|FG000|Overall Study|Participant moved|0|||
126399496|NCT01527383|454755344|FG001|Overall Study|Participant moved|1|||
126399497|NCT01527383|454755343|FG000|Overall Study|Withdrawal by Subject|2|||
126399498|NCT01527383|454755344|FG001|Overall Study|Withdrawal by Subject|3|||
126399499|NCT00746733|454755345|FG000|Second Intervention|Adverse Event|1|||
126399500|NCT00746733|454755346|FG001|Second Intervention|Adverse Event|0|||
126399501|NCT00746733|454755345|FG000|Third Intervention|Withdrawal by Subject|1|||
126399502|NCT00746733|454755346|FG001|Third Intervention|Withdrawal by Subject|1|||
126399503|NCT03412604|454755347|FG000|Overall Study|Withdrawal by Subject|1|||
126399504|NCT00930969|454755349|FG000|Overall Study|Death|5|||
126399505|NCT00930969|454755349|FG000|Overall Study|Lost to Follow-up|1|||
126399506|NCT00930969|454755349|FG000|Overall Study|Physician Decision|13|||
126399507|NCT00930969|454755349|FG000|Overall Study|Withdrawal by Subject|19|||
126399508|NCT01287221|454755350|FG000|Overall Study|Lack of Perceived Benefit|1|||
126399509|NCT01287221|454755351|FG001|Overall Study|Lack of Perceived Benefit|1|||
126399510|NCT01287221|454755350|FG000|Overall Study|Adverse Event|3|||
126399511|NCT01287221|454755351|FG001|Overall Study|Adverse Event|3|||
126399512|NCT01287221|454755350|FG000|Overall Study|Withdrawal by Subject|0|||
126399513|NCT01287221|454755351|FG001|Overall Study|Withdrawal by Subject|1|||
126399514|NCT00657150|454755352|FG000|Overall Study|Adverse Event|19|||
126399515|NCT00657150|454755353|FG001|Overall Study|Adverse Event|10|||
126399516|NCT00657150|454755352|FG000|Overall Study|Non-compliant with protocol|5|||
126399517|NCT00657150|454755353|FG001|Overall Study|Non-compliant with protocol|9|||
126399518|NCT00657150|454755352|FG000|Overall Study|Lost to Follow-up|2|||
126399519|NCT00657150|454755353|FG001|Overall Study|Lost to Follow-up|0|||
126399520|NCT00657150|454755352|FG000|Overall Study|Withdrawal by Subject|51|||
126399521|NCT00657150|454755353|FG001|Overall Study|Withdrawal by Subject|36|||
126399522|NCT00657150|454755352|FG000|Overall Study|Other|38|||
126399523|NCT00657150|454755353|FG001|Overall Study|Other|38|||
126399524|NCT00657150|454755352|FG000|Treatment|Adverse Event|60|||
126399525|NCT00657150|454755353|FG001|Treatment|Adverse Event|53|||
126399526|NCT00657150|454755352|FG000|Treatment|Non-compliant with protocol|10|||
126399527|NCT00657150|454755353|FG001|Treatment|Non-compliant with protocol|9|||
126399528|NCT00657150|454755352|FG000|Treatment|Lost to Follow-up|1|||
126399529|NCT00657150|454755353|FG001|Treatment|Lost to Follow-up|0|||
126399530|NCT00657150|454755352|FG000|Treatment|Withdrawal by Subject|23|||
126399531|NCT00657150|454755353|FG001|Treatment|Withdrawal by Subject|20|||
126399532|NCT00657150|454755352|FG000|Treatment|Other|13|||
126399533|NCT00657150|454755353|FG001|Treatment|Other|15|||
126399534|NCT02966795|454755354|FG000|Overall Study|Patient Left the Country|0|||
126399535|NCT02966795|454755355|FG001|Overall Study|Patient Left the Country|1|||
126399536|NCT00787137|454755371|FG000|Overall Study|Study Termination|0|||
126399537|NCT00787137|454755372|FG001|Overall Study|Study Termination|0|||
126399538|NCT00787137|454755373|FG002|Overall Study|Study Termination|1|||
126399539|NCT01367704|454755380|FG000|Overall Study|Lost to Follow-up|47|||
126399540|NCT01367704|454755381|FG001|Overall Study|Lost to Follow-up|161|||
126399541|NCT00526110|454755382|FG000|Overall Study|Adverse Event|2|||
126399542|NCT00526110|454755383|FG001|Overall Study|Adverse Event|9|||
126399543|NCT00526110|454755382|FG000|Overall Study|Disease Progression|0|||
126399544|NCT00526110|454755383|FG001|Overall Study|Disease Progression|19|||
126399545|NCT00526110|454755382|FG000|Overall Study|Maximal Response|0|||
126471918|NCT01024231|455028870|FG005|Overall Study|AE unrelated to Study Drug|0|||
126471919|NCT01024231|455028871|FG006|Overall Study|AE unrelated to Study Drug|0|||
126471920|NCT01024231|455028865|FG000|Overall Study|No longer meets criteria|0|||
126471921|NCT01024231|455028866|FG001|Overall Study|No longer meets criteria|0|||
126471922|NCT01024231|455028867|FG002|Overall Study|No longer meets criteria|0|||
126471923|NCT01024231|455028868|FG003|Overall Study|No longer meets criteria|0|||
126471924|NCT01024231|455028869|FG004|Overall Study|No longer meets criteria|1|||
126471925|NCT01024231|455028870|FG005|Overall Study|No longer meets criteria|0|||
126471926|NCT01024231|455028871|FG006|Overall Study|No longer meets criteria|1|||
126471927|NCT01024231|455028865|FG000|Overall Study|Study Drug Toxicity|1|||
126471928|NCT01024231|455028866|FG001|Overall Study|Study Drug Toxicity|6|||
126471929|NCT01024231|455028867|FG002|Overall Study|Study Drug Toxicity|6|||
126471930|NCT01024231|455028868|FG003|Overall Study|Study Drug Toxicity|4|||
126471931|NCT01024231|455028869|FG004|Overall Study|Study Drug Toxicity|2|||
126471932|NCT01024231|455028870|FG005|Overall Study|Study Drug Toxicity|0|||
126471933|NCT01024231|455028871|FG006|Overall Study|Study Drug Toxicity|7|||
126471934|NCT01024231|455028865|FG000|Overall Study|Death|6|||
126471935|NCT01024231|455028866|FG001|Overall Study|Death|2|||
126471936|NCT01024231|455028867|FG002|Overall Study|Death|1|||
126471937|NCT01024231|455028868|FG003|Overall Study|Death|0|||
126471938|NCT01024231|455028869|FG004|Overall Study|Death|4|||
126471939|NCT01024231|455028870|FG005|Overall Study|Death|3|||
126471940|NCT01024231|455028871|FG006|Overall Study|Death|5|||
126471941|NCT01024231|455028865|FG000|Overall Study|Lost to Follow-up|0|||
126471942|NCT01024231|455028866|FG001|Overall Study|Lost to Follow-up|0|||
126471943|NCT01024231|455028867|FG002|Overall Study|Lost to Follow-up|0|||
126399546|NCT00526110|454755383|FG001|Overall Study|Maximal Response|6|||
126399547|NCT00526110|454755382|FG000|Overall Study|Withdrawal by Subject|0|||
126399548|NCT00526110|454755383|FG001|Overall Study|Withdrawal by Subject|2|||
126399549|NCT00526110|454755382|FG000|Overall Study|Poor Tolerance|0|||
126399550|NCT00526110|454755383|FG001|Overall Study|Poor Tolerance|5|||
126471944|NCT01024231|455028868|FG003|Overall Study|Lost to Follow-up|0|||
126471945|NCT01024231|455028869|FG004|Overall Study|Lost to Follow-up|0|||
126471946|NCT01024231|455028870|FG005|Overall Study|Lost to Follow-up|0|||
126471947|NCT01024231|455028871|FG006|Overall Study|Lost to Follow-up|1|||
126471948|NCT01024231|455028865|FG000|Overall Study|Withdrew Consent|0|||
126471949|NCT01024231|455028866|FG001|Overall Study|Withdrew Consent|1|||
126471950|NCT01024231|455028867|FG002|Overall Study|Withdrew Consent|0|||
126471951|NCT01024231|455028868|FG003|Overall Study|Withdrew Consent|0|||
126471952|NCT01024231|455028869|FG004|Overall Study|Withdrew Consent|0|||
126471953|NCT01024231|455028870|FG005|Overall Study|Withdrew Consent|0|||
126471954|NCT01024231|455028871|FG006|Overall Study|Withdrew Consent|0|||
126471955|NCT01024231|455028865|FG000|Overall Study|Continuing on Treatment|0|||
126471956|NCT01024231|455028866|FG001|Overall Study|Continuing on Treatment|0|||
126471957|NCT01024231|455028867|FG002|Overall Study|Continuing on Treatment|0|||
126471958|NCT01024231|455028868|FG003|Overall Study|Continuing on Treatment|0|||
126471959|NCT01024231|455028869|FG004|Overall Study|Continuing on Treatment|3|||
126471960|NCT01024231|455028870|FG005|Overall Study|Continuing on Treatment|2|||
126471961|NCT01024231|455028871|FG006|Overall Study|Continuing on Treatment|0|||
126471962|NCT03277690|455028872|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
126471963|NCT03277690|455028873|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
126471964|NCT03277690|455028872|FG000|Dose Titration and Maintenance|Physician Decision|1|||
126471965|NCT03277690|455028873|FG001|Dose Titration and Maintenance|Physician Decision|0|||
126471966|NCT03277690|455028872|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
126471967|NCT03277690|455028873|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
126471968|NCT03277690|455028872|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
126471969|NCT03277690|455028873|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
126471970|NCT03277690|455028872|FG000|Dose Titration and Maintenance|Adverse Event|15|||
126471971|NCT03277690|455028873|FG001|Dose Titration and Maintenance|Adverse Event|0|||
126471972|NCT03277690|455028872|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
126471973|NCT03277690|455028873|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
126471974|NCT03277690|455028872|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
126471975|NCT03277690|455028873|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
126471976|NCT00747812|455028874|FG000|Overall Study|Research Site Staff Relocation|5|||
126471977|NCT00747812|455028875|FG001|Overall Study|Research Site Staff Relocation|3|||
126471978|NCT01013350|455028876|FG000|Overall Study|Lost to Follow-up|15|||
126399551|NCT02193087|454755384|FG000|Overall Study|Adverse Event|2|||
126399552|NCT02193087|454755385|FG001|Overall Study|Adverse Event|0|||
126399553|NCT02193087|454755386|FG002|Overall Study|Adverse Event|0|||
126399554|NCT02193087|454755387|FG003|Overall Study|Adverse Event|11|||
126399555|NCT02193087|454755384|FG000|Overall Study|Lost to Follow-up|14|||
126399556|NCT02193087|454755385|FG001|Overall Study|Lost to Follow-up|6|||
126399557|NCT02193087|454755386|FG002|Overall Study|Lost to Follow-up|4|||
126399558|NCT02193087|454755387|FG003|Overall Study|Lost to Follow-up|37|||
126399559|NCT02193087|454755384|FG000|Overall Study|Protocol Violation|2|||
126399560|NCT02193087|454755385|FG001|Overall Study|Protocol Violation|0|||
126399561|NCT02193087|454755386|FG002|Overall Study|Protocol Violation|1|||
126399562|NCT02193087|454755387|FG003|Overall Study|Protocol Violation|2|||
126399563|NCT02193087|454755384|FG000|Overall Study|Withdrawal by Subject|10|||
126399564|NCT02193087|454755385|FG001|Overall Study|Withdrawal by Subject|3|||
126399565|NCT02193087|454755386|FG002|Overall Study|Withdrawal by Subject|1|||
126399566|NCT02193087|454755387|FG003|Overall Study|Withdrawal by Subject|19|||
126399567|NCT02193087|454755384|FG000|Overall Study|Other Reason Not Specified|7|||
126399568|NCT02193087|454755385|FG001|Overall Study|Other Reason Not Specified|2|||
126399569|NCT02193087|454755386|FG002|Overall Study|Other Reason Not Specified|1|||
126399570|NCT02193087|454755387|FG003|Overall Study|Other Reason Not Specified|9|||
126399571|NCT02193087|454755384|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
126399572|NCT02193087|454755385|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
126471979|NCT01013350|455028877|FG001|Overall Study|Lost to Follow-up|95|||
126471980|NCT01013350|455028876|FG000|Overall Study|Adverse Event|0|||
126471981|NCT01013350|455028877|FG001|Overall Study|Adverse Event|1|||
126471982|NCT01013350|455028876|FG000|Overall Study|Physician Decision|4|||
126471983|NCT01013350|455028877|FG001|Overall Study|Physician Decision|20|||
126471984|NCT01013350|455028876|FG000|Overall Study|Withdrawal by Subject|15|||
126471985|NCT01013350|455028877|FG001|Overall Study|Withdrawal by Subject|38|||
126471986|NCT01013350|455028876|FG000|Overall Study|Death|3|||
126471987|NCT01013350|455028877|FG001|Overall Study|Death|5|||
126471988|NCT01013350|455028876|FG000|Overall Study|Participant entered interventional study|0|||
126471989|NCT01013350|455028877|FG001|Overall Study|Participant entered interventional study|8|||
126471990|NCT01013350|455028876|FG000|Overall Study|Other|1|||
126471991|NCT01013350|455028877|FG001|Overall Study|Other|25|||
126471992|NCT01708161|455028878|FG000|Overall Study|Adverse Event|1|||
126471993|NCT01708161|455028879|FG001|Overall Study|Adverse Event|3|||
126471994|NCT01708161|455028880|FG002|Overall Study|Adverse Event|4|||
126399573|NCT02193087|454755386|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
126399574|NCT02193087|454755387|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
126399575|NCT04096820|454755388|FG000|Overall Study|Did not return for intervention|2|||
126399576|NCT04096820|454755388|FG000|Overall Study|Death|1|||
126399577|NCT04030247|454757224|FG000|Overall Study|Withdrawal by Subject|4|||
126399578|NCT04030247|454757224|FG000|Overall Study|Lost to Follow-up|13|||
126399579|NCT00509093|454757225|FG000|Overall Study|Adverse Event|10|||
126399580|NCT00509093|454757225|FG000|Overall Study|Disease Progression|9|||
126399581|NCT00509093|454757225|FG000|Overall Study|Transformed into MDS|1|||
126399582|NCT00509093|454757225|FG000|Overall Study|Withdrawal by Subject|3|||
126399583|NCT00509093|454757225|FG000|Overall Study|Physician Decision|1|||
126399584|NCT05438602|454757227|FG000|Treatment (15 Days)|Adverse Event|2|||
126399585|NCT05438602|454757228|FG001|Treatment (15 Days)|Adverse Event|1|||
126399586|NCT05438602|454757229|FG002|Treatment (15 Days)|Adverse Event|3|||
126399587|NCT05438602|454757227|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
126399588|NCT05438602|454757228|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
126399589|NCT05438602|454757229|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
126399590|NCT05438602|454757227|FG000|Treatment (15 Days)|Other|0|||
126399591|NCT05438602|454757228|FG001|Treatment (15 Days)|Other|0|||
126399592|NCT05438602|454757229|FG002|Treatment (15 Days)|Other|1|||
126399593|NCT05438602|454757227|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
126399594|NCT05438602|454757228|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
126399595|NCT05438602|454757229|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
126399596|NCT05438602|454757227|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
126399597|NCT05438602|454757228|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
126399598|NCT05438602|454757229|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
126399599|NCT05438602|454757227|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
126399600|NCT05438602|454757228|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
126399601|NCT05438602|454757229|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
126399602|NCT05438602|454757227|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
126399603|NCT05438602|454757228|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
126399604|NCT05438602|454757229|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
126399605|NCT05438602|454757227|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
126399606|NCT05438602|454757228|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
126399607|NCT05438602|454757229|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
126399608|NCT05438602|454757227|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
126399609|NCT05438602|454757228|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
126399610|NCT05438602|454757229|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
126399611|NCT05438602|454757227|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
126399612|NCT05438602|454757228|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
126399613|NCT05438602|454757229|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
126399614|NCT04431713|454757232|FG000|Overall Study|Withdrawal by Subject|2|||
126399615|NCT04431713|454757233|FG001|Overall Study|Withdrawal by Subject|0|||
126399616|NCT04431713|454757232|FG000|Overall Study|Death|2|||
126399617|NCT04431713|454757233|FG001|Overall Study|Death|2|||
126399618|NCT03383783|454757236|FG000|Overall Study|Withdrawal by Subject|2|||
126399619|NCT01224821|454757240|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
126399620|NCT01224821|454757240|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
126399621|NCT01224821|454757240|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
126399622|NCT01224821|454757240|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
126399623|NCT01224821|454757240|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
126399624|NCT01224821|454757240|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
126399625|NCT01224821|454757240|FG000|Long-Term Follow-Up|Death|2|||
126399626|NCT01224821|454757240|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
126399627|NCT01340937|454757241|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
126399628|NCT01340937|454757242|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
126399629|NCT01340937|454757243|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
126399630|NCT01340937|454757244|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
126399631|NCT01340937|454757241|FG000|Period 1: Infant Series|Adverse Event|0|||
126399632|NCT01340937|454757242|FG001|Period 1: Infant Series|Adverse Event|1|||
126399633|NCT01340937|454757243|FG002|Period 1: Infant Series|Adverse Event|4|||
126399634|NCT01340937|454757244|FG003|Period 1: Infant Series|Adverse Event|0|||
126399635|NCT01340937|454757241|FG000|Period 1: Infant Series|Death|2|||
126399636|NCT01340937|454757242|FG001|Period 1: Infant Series|Death|0|||
126399637|NCT01340937|454757243|FG002|Period 1: Infant Series|Death|2|||
126399638|NCT01340937|454757244|FG003|Period 1: Infant Series|Death|0|||
126399639|NCT01340937|454757241|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
126399640|NCT01340937|454757242|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
126399641|NCT01340937|454757243|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
126399642|NCT01340937|454757244|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
126399643|NCT01340937|454757241|FG000|Period 1: Infant Series|Physician Decision|2|||
126399644|NCT01340937|454757242|FG001|Period 1: Infant Series|Physician Decision|3|||
126399645|NCT01340937|454757243|FG002|Period 1: Infant Series|Physician Decision|1|||
126399646|NCT01340937|454757244|FG003|Period 1: Infant Series|Physician Decision|0|||
126399647|NCT01340937|454757241|FG000|Period 1: Infant Series|Protocol Violation|1|||
126557354|NCT00479674|455332695|FG000|Overall Study|Physician Decision|14|||
126399648|NCT01340937|454757242|FG001|Period 1: Infant Series|Protocol Violation|4|||
126399649|NCT01340937|454757243|FG002|Period 1: Infant Series|Protocol Violation|4|||
126399650|NCT01340937|454757244|FG003|Period 1: Infant Series|Protocol Violation|3|||
126399651|NCT01340937|454757241|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
126399652|NCT01340937|454757242|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
126399653|NCT01340937|454757243|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
126399654|NCT01340937|454757244|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
126399655|NCT01340937|454757241|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
126399656|NCT01340937|454757242|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
126399657|NCT01340937|454757243|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
126399658|NCT01340937|454757244|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
126399659|NCT01340937|454757241|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
126399660|NCT01340937|454757242|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
126399661|NCT01340937|454757243|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
126399662|NCT01340937|454757244|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
126399663|NCT01340937|454757241|FG000|Period 2: Interim Period|Adverse Event|1|||
126399664|NCT01340937|454757242|FG001|Period 2: Interim Period|Adverse Event|0|||
126399665|NCT01340937|454757243|FG002|Period 2: Interim Period|Adverse Event|1|||
126399666|NCT01340937|454757244|FG003|Period 2: Interim Period|Adverse Event|0|||
126399667|NCT01340937|454757241|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
126399668|NCT01340937|454757242|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
126399669|NCT01340937|454757243|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
126399670|NCT01340937|454757244|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
126399671|NCT01340937|454757241|FG000|Period 2: Interim Period|Physician Decision|0|||
126399672|NCT01340937|454757242|FG001|Period 2: Interim Period|Physician Decision|1|||
126399673|NCT01340937|454757243|FG002|Period 2: Interim Period|Physician Decision|1|||
126399674|NCT01340937|454757244|FG003|Period 2: Interim Period|Physician Decision|0|||
126399675|NCT01340937|454757241|FG000|Period 2: Interim Period|Protocol Violation|5|||
126399676|NCT01340937|454757242|FG001|Period 2: Interim Period|Protocol Violation|3|||
126399677|NCT01340937|454757243|FG002|Period 2: Interim Period|Protocol Violation|6|||
126399678|NCT01340937|454757244|FG003|Period 2: Interim Period|Protocol Violation|3|||
126399679|NCT01340937|454757241|FG000|Period 2: Interim Period|Technical problems|4|||
126399680|NCT01340937|454757242|FG001|Period 2: Interim Period|Technical problems|4|||
126399681|NCT01340937|454757243|FG002|Period 2: Interim Period|Technical problems|6|||
126399682|NCT01340937|454757244|FG003|Period 2: Interim Period|Technical problems|3|||
126399683|NCT01340937|454757241|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
126399684|NCT01340937|454757242|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
126399685|NCT01340937|454757243|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
126399686|NCT01340937|454757244|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
126557355|NCT00479674|455332695|FG000|Overall Study|none provided|3|||
126557356|NCT02059161|455332698|FG000|Overall Study|Pregnancy|0|||
126557357|NCT02059161|455332699|FG001|Overall Study|Pregnancy|2|||
126557358|NCT02059161|455332698|FG000|Overall Study|Adverse Event|2|||
126557359|NCT02059161|455332699|FG001|Overall Study|Adverse Event|6|||
126721206|NCT01912768|455928597|FG000|Overall Study|Adverse Event|2|||
126721207|NCT01912768|455928598|FG001|Overall Study|Adverse Event|0|||
126557360|NCT02059161|455332698|FG000|Overall Study|Lost to Follow-up|20|||
126399687|NCT01340937|454757241|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
126399688|NCT01340937|454757242|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
126399689|NCT01340937|454757243|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
126399690|NCT01340937|454757244|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
126399691|NCT01340937|454757241|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
126399692|NCT01340937|454757242|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
126399693|NCT01340937|454757243|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
126399694|NCT01340937|454757244|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
126399695|NCT01340937|454757241|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
126399696|NCT01340937|454757242|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
126557361|NCT02059161|455332699|FG001|Overall Study|Lost to Follow-up|12|||
126557362|NCT02059161|455332698|FG000|Overall Study|Physician Decision|4|||
126557363|NCT02059161|455332699|FG001|Overall Study|Physician Decision|4|||
126557364|NCT02059161|455332698|FG000|Overall Study|Protocol Violation|1|||
126399697|NCT01340937|454757243|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
126399698|NCT01340937|454757244|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
126399699|NCT02469415|454757248|FG000|Overall Study|Withdrawal by Subject|1|||
126399700|NCT02469415|454757248|FG000|Overall Study|Investigational agent placed on hold|2|||
126557365|NCT02059161|455332699|FG001|Overall Study|Protocol Violation|1|||
126557366|NCT02059161|455332698|FG000|Overall Study|Withdrawal by Subject|16|||
126557367|NCT02059161|455332699|FG001|Overall Study|Withdrawal by Subject|13|||
126721208|NCT01912768|455928597|FG000|Overall Study|Lost to Follow-up|2|||
126721209|NCT01912768|455928598|FG001|Overall Study|Lost to Follow-up|1|||
126399701|NCT00350623|454757251|FG000|Overall Study|Lost to Follow-up|8|||
126399702|NCT00350623|454757252|FG001|Overall Study|Lost to Follow-up|3|||
126399703|NCT00350623|454757253|FG002|Overall Study|Lost to Follow-up|4|||
126399704|NCT00350623|454757251|FG000|Overall Study|Withdrawal by Subject|0|||
126399705|NCT00350623|454757252|FG001|Overall Study|Withdrawal by Subject|1|||
126399706|NCT00350623|454757253|FG002|Overall Study|Withdrawal by Subject|1|||
126399707|NCT00350623|454757251|FG000|Overall Study|patient traveling outside the country|0|||
126399708|NCT00350623|454757252|FG001|Overall Study|patient traveling outside the country|0|||
126399709|NCT00350623|454757253|FG002|Overall Study|patient traveling outside the country|1|||
126399710|NCT00623545|454757254|FG000|Overall Study|Adverse Event|6|||
126399711|NCT00623545|454757254|FG000|Overall Study|Withdrawal by Subject|4|||
126399712|NCT01974752|454757259|FG000|Overall Study|Death|33|||
126399713|NCT01974752|454757260|FG001|Overall Study|Death|11|||
126399714|NCT01974752|454757259|FG000|Overall Study|Lost to Follow-up|2|||
126399715|NCT01974752|454757260|FG001|Overall Study|Lost to Follow-up|0|||
126399716|NCT01974752|454757259|FG000|Overall Study|Withdrawal by Subject|2|||
126399717|NCT01974752|454757260|FG001|Overall Study|Withdrawal by Subject|3|||
126399718|NCT01974752|454757259|FG000|Overall Study|Other Eligibility Criteria|0|||
126399719|NCT01974752|454757260|FG001|Overall Study|Other Eligibility Criteria|1|||
126399720|NCT00330928|454757266|FG000|Overall Study|Lost to Follow-up|6|||
126399721|NCT00330928|454757266|FG000|Overall Study|Physician Decision|9|||
126399722|NCT00330928|454757266|FG000|Overall Study|Death|1|||
126399723|NCT00330928|454757266|FG000|Overall Study|IVUS could not be performed.|1|||
126399724|NCT03028480|454757267|FG000|Overall Study|No revisit after the first prescription date|2|||
126399725|NCT03028480|454757267|FG000|Overall Study|Did not use the drug|1|||
126399726|NCT03028480|454757267|FG000|Overall Study|Violation of the enrollment deadline|10|||
126399727|NCT03028480|454757267|FG000|Overall Study|Case report forms were not collected|21|||
126399728|NCT02279719|454757272|FG000|Overall Study|Patients randomized but never treated|0|||
126399729|NCT02279719|454757273|FG001|Overall Study|Patients randomized but never treated|0|||
126399730|NCT02279719|454757274|FG002|Overall Study|Patients randomized but never treated|0|||
126399731|NCT02279719|454757275|FG003|Overall Study|Patients randomized but never treated|0|||
126399732|NCT02279719|454757276|FG004|Overall Study|Patients randomized but never treated|3|||
126399733|NCT02279719|454757277|FG005|Overall Study|Patients randomized but never treated|0|||
126399734|NCT02279719|454757278|FG006|Overall Study|Patients randomized but never treated|3|||
126399735|NCT03541187|454757279|FG000|Overall Study|Lost to Follow-up|2|||
126399736|NCT03541187|454757280|FG001|Overall Study|Lost to Follow-up|6|||
126399737|NCT03541187|454757279|FG000|Overall Study|Pregnancy|0|||
126399738|NCT03541187|454757280|FG001|Overall Study|Pregnancy|1|||
126399739|NCT03541187|454757279|FG000|Overall Study|Withdrawal by Subject|6|||
126399740|NCT03541187|454757280|FG001|Overall Study|Withdrawal by Subject|2|||
126399741|NCT03541187|454757279|FG000|Overall Study|Moved out of town|1|||
126399742|NCT03541187|454757280|FG001|Overall Study|Moved out of town|0|||
126399743|NCT03541187|454757279|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
126399744|NCT03541187|454757280|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
126399745|NCT03541187|454757279|FG000|Overall Study|Did not meet randomization criteria|1|||
126399746|NCT03541187|454757280|FG001|Overall Study|Did not meet randomization criteria|1|||
126399747|NCT03541187|454757279|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
126399748|NCT03541187|454757280|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
126399749|NCT03541187|454757279|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
126399750|NCT03541187|454757280|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
126399751|NCT00869050|454757283|FG000|Overall Study|Screen Failure|3|||
126399752|NCT01369680|454757287|FG000|Overall Study|Lost to Follow-up|0|||
126399753|NCT01369680|454757288|FG001|Overall Study|Lost to Follow-up|0|||
126399754|NCT01369680|454757289|FG002|Overall Study|Lost to Follow-up|1|||
126399755|NCT01369680|454757290|FG003|Overall Study|Lost to Follow-up|2|||
126399756|NCT00585221|454757293|FG000|Overall Study|Protocol Violation|8|||
126399757|NCT01145053|454757294|FG000|Overall Study|Adverse Event|22|||
126399758|NCT01145053|454757294|FG000|Overall Study|Lost to Follow-up|28|||
126399759|NCT01145053|454757294|FG000|Overall Study|Withdrawal by Subject|25|||
126399760|NCT01145053|454757294|FG000|Overall Study|Other|18|||
126399761|NCT03060512|454757295|FG000|Overall Study|Adverse Event|4|||
126399762|NCT03060512|454757296|FG001|Overall Study|Adverse Event|6|||
126399763|NCT03060512|454757295|FG000|Overall Study|Lost to Follow-up|1|||
126399764|NCT03060512|454757296|FG001|Overall Study|Lost to Follow-up|1|||
126399765|NCT03060512|454757295|FG000|Overall Study|Withdrawal by Subject|1|||
126772282|NCT02030834|456122076|FG002|Overall Study|Lack of funding|0|||
126399766|NCT03060512|454757296|FG001|Overall Study|Withdrawal by Subject|0|||
126399767|NCT03060512|454757295|FG000|Overall Study|Non-compliance with study medication|1|||
126399768|NCT03060512|454757296|FG001|Overall Study|Non-compliance with study medication|2|||
126399769|NCT03220581|454757299|FG000|Overall Study|Withdrawal by Subject|0|||
126399770|NCT03220581|454757300|FG001|Overall Study|Withdrawal by Subject|1|||
126399771|NCT03220581|454757299|FG000|Overall Study|Lost to Follow-up|3|||
126399772|NCT03220581|454757300|FG001|Overall Study|Lost to Follow-up|6|||
126399773|NCT03421743|454757302|FG000|Overall Study|Lack of Efficacy|1|||
126399774|NCT03421743|454757303|FG001|Overall Study|Lack of Efficacy|0|||
126399775|NCT03421743|454757302|FG000|Overall Study|Adverse Event|2|||
126399776|NCT03421743|454757303|FG001|Overall Study|Adverse Event|1|||
126399777|NCT03421743|454757302|FG000|Overall Study|Withdrawal by Subject|0|||
126399778|NCT03421743|454757303|FG001|Overall Study|Withdrawal by Subject|1|||
126399779|NCT00681564|454757307|FG000|Overall Study|Lost to Follow-up|6|||
126399780|NCT00681564|454757308|FG001|Overall Study|Lost to Follow-up|6|||
126399781|NCT00681564|454757307|FG000|Overall Study|Withdrawal by Subject|0|||
126399782|NCT00681564|454757308|FG001|Overall Study|Withdrawal by Subject|1|||
126399783|NCT00681564|454757307|FG000|Overall Study|Death|0|||
126399784|NCT00681564|454757308|FG001|Overall Study|Death|1|||
126399785|NCT01009346|454757311|FG000|Overall Study|Adverse Event|4|||
126399786|NCT00541099|454757315|FG000|Overall Study|Ineligible|3|||
126399787|NCT00432744|454757316|FG000|Months 0-6|Withdrawal by Subject|4|||
126399788|NCT00432744|454757317|FG001|Months 0-6|Withdrawal by Subject|4|||
126399789|NCT00432744|454757316|FG000|Months 0-6|Too disabled to score|1|||
126399790|NCT00432744|454757317|FG001|Months 0-6|Too disabled to score|0|||
126399791|NCT00432744|454757316|FG000|Months 7 - 12|Withdrawal by Subject|1|||
126399792|NCT00432744|454757317|FG001|Months 7 - 12|Withdrawal by Subject|0|||
126399793|NCT00432744|454757316|FG000|Months 7 - 12|Too disabled to score|0|||
126399794|NCT00432744|454757317|FG001|Months 7 - 12|Too disabled to score|1|||
126399795|NCT00468845|454757322|FG000|Overall Study|Adverse Event|9|||
126399796|NCT00468845|454757323|FG001|Overall Study|Adverse Event|14|||
126399797|NCT00468845|454757324|FG002|Overall Study|Adverse Event|11|||
126399798|NCT00468845|454757322|FG000|Overall Study|Lost to Follow-up|2|||
126399799|NCT00468845|454757323|FG001|Overall Study|Lost to Follow-up|1|||
126399800|NCT00468845|454757324|FG002|Overall Study|Lost to Follow-up|2|||
126399801|NCT00468845|454757322|FG000|Overall Study|Other|4|||
126399802|NCT00468845|454757323|FG001|Overall Study|Other|9|||
126399803|NCT00468845|454757324|FG002|Overall Study|Other|5|||
126399804|NCT00468845|454757322|FG000|Overall Study|No longer willing to participate|5|||
126399805|NCT00468845|454757323|FG001|Overall Study|No longer willing to participate|6|||
126399806|NCT00468845|454757324|FG002|Overall Study|No longer willing to participate|10|||
126399807|NCT00468845|454757322|FG000|Overall Study|Randomized, not treated|1|||
126399808|NCT00468845|454757323|FG001|Overall Study|Randomized, not treated|4|||
126399809|NCT00468845|454757324|FG002|Overall Study|Randomized, not treated|2|||
126399810|NCT02759315|454757325|FG000|Overall Study|Adverse Event|0|||
126399811|NCT02759315|454757326|FG001|Overall Study|Adverse Event|0|||
126399812|NCT02759315|454757327|FG002|Overall Study|Adverse Event|0|||
126399813|NCT02759315|454757328|FG003|Overall Study|Adverse Event|1|||
126399814|NCT02759315|454757329|FG004|Overall Study|Adverse Event|0|||
126399815|NCT02759315|454757325|FG000|Overall Study|Death|0|||
126399816|NCT02759315|454757326|FG001|Overall Study|Death|0|||
126399817|NCT02759315|454757327|FG002|Overall Study|Death|1|||
126399818|NCT02759315|454757328|FG003|Overall Study|Death|0|||
126399819|NCT02759315|454757329|FG004|Overall Study|Death|0|||
126399820|NCT02759315|454757325|FG000|Overall Study|Lost to Follow-up|2|||
126399821|NCT02759315|454757326|FG001|Overall Study|Lost to Follow-up|0|||
126399822|NCT02759315|454757327|FG002|Overall Study|Lost to Follow-up|4|||
126399823|NCT02759315|454757328|FG003|Overall Study|Lost to Follow-up|0|||
126399824|NCT02759315|454757329|FG004|Overall Study|Lost to Follow-up|0|||
126399825|NCT02759315|454757325|FG000|Overall Study|Protocol Violation|0|||
126399826|NCT02759315|454757326|FG001|Overall Study|Protocol Violation|1|||
126399827|NCT02759315|454757327|FG002|Overall Study|Protocol Violation|0|||
126399828|NCT02759315|454757328|FG003|Overall Study|Protocol Violation|0|||
126399829|NCT02759315|454757329|FG004|Overall Study|Protocol Violation|0|||
126399830|NCT02759315|454757325|FG000|Overall Study|Study terminated prior to completion|2|||
126399831|NCT02759315|454757326|FG001|Overall Study|Study terminated prior to completion|0|||
126399832|NCT02759315|454757327|FG002|Overall Study|Study terminated prior to completion|5|||
126399833|NCT02759315|454757328|FG003|Overall Study|Study terminated prior to completion|0|||
126399834|NCT02759315|454757329|FG004|Overall Study|Study terminated prior to completion|1|||
126399835|NCT02761694|454757330|FG000|Overall Study|Lack of Efficacy|0|||
126399836|NCT02761694|454757331|FG001|Overall Study|Lack of Efficacy|0|||
126399837|NCT02761694|454757332|FG002|Overall Study|Lack of Efficacy|0|||
126471995|NCT01708161|455028881|FG003|Overall Study|Adverse Event|2|||
126399838|NCT02761694|454757333|FG003|Overall Study|Lack of Efficacy|0|||
126399839|NCT02761694|454757334|FG004|Overall Study|Lack of Efficacy|0|||
126399840|NCT02761694|454757335|FG005|Overall Study|Lack of Efficacy|0|||
126399841|NCT02761694|454757336|FG006|Overall Study|Lack of Efficacy|6|||
126399842|NCT02761694|454757337|FG007|Overall Study|Lack of Efficacy|0|||
126399843|NCT02761694|454757338|FG008|Overall Study|Lack of Efficacy|0|||
126399844|NCT02761694|454757339|FG009|Overall Study|Lack of Efficacy|1|||
126399845|NCT02761694|454757340|FG010|Overall Study|Lack of Efficacy|1|||
126399846|NCT02761694|454757341|FG011|Overall Study|Lack of Efficacy|4|||
126399847|NCT02761694|454757330|FG000|Overall Study|Death|0|||
126399848|NCT02761694|454757331|FG001|Overall Study|Death|0|||
126399849|NCT02761694|454757332|FG002|Overall Study|Death|0|||
126399850|NCT02761694|454757333|FG003|Overall Study|Death|0|||
126399851|NCT02761694|454757334|FG004|Overall Study|Death|0|||
126721210|NCT01912768|455928597|FG000|Overall Study|Withdrawal by Subject|5|||
126399852|NCT02761694|454757335|FG005|Overall Study|Death|0|||
126399853|NCT02761694|454757336|FG006|Overall Study|Death|2|||
126399854|NCT02761694|454757337|FG007|Overall Study|Death|0|||
126399855|NCT02761694|454757338|FG008|Overall Study|Death|2|||
126399856|NCT02761694|454757339|FG009|Overall Study|Death|2|||
126399857|NCT02761694|454757340|FG010|Overall Study|Death|1|||
126399858|NCT02761694|454757341|FG011|Overall Study|Death|0|||
126399859|NCT02761694|454757330|FG000|Overall Study|Physician Decision|0|||
126399860|NCT02761694|454757331|FG001|Overall Study|Physician Decision|0|||
126399861|NCT02761694|454757332|FG002|Overall Study|Physician Decision|0|||
126399862|NCT02761694|454757333|FG003|Overall Study|Physician Decision|0|||
126399863|NCT02761694|454757334|FG004|Overall Study|Physician Decision|0|||
126399864|NCT02761694|454757335|FG005|Overall Study|Physician Decision|0|||
126399865|NCT02761694|454757336|FG006|Overall Study|Physician Decision|1|||
126399866|NCT02761694|454757337|FG007|Overall Study|Physician Decision|0|||
126399867|NCT02761694|454757338|FG008|Overall Study|Physician Decision|0|||
126399868|NCT02761694|454757339|FG009|Overall Study|Physician Decision|0|||
126399869|NCT02761694|454757340|FG010|Overall Study|Physician Decision|0|||
126399870|NCT02761694|454757341|FG011|Overall Study|Physician Decision|0|||
126399871|NCT02761694|454757330|FG000|Overall Study|Withdrawal by Subject|0|||
126399872|NCT02761694|454757331|FG001|Overall Study|Withdrawal by Subject|0|||
126399873|NCT02761694|454757332|FG002|Overall Study|Withdrawal by Subject|0|||
126399874|NCT02761694|454757333|FG003|Overall Study|Withdrawal by Subject|1|||
126399875|NCT02761694|454757334|FG004|Overall Study|Withdrawal by Subject|0|||
126399876|NCT02761694|454757335|FG005|Overall Study|Withdrawal by Subject|0|||
126399877|NCT02761694|454757336|FG006|Overall Study|Withdrawal by Subject|4|||
126399878|NCT02761694|454757337|FG007|Overall Study|Withdrawal by Subject|0|||
126399879|NCT02761694|454757338|FG008|Overall Study|Withdrawal by Subject|2|||
126399880|NCT02761694|454757339|FG009|Overall Study|Withdrawal by Subject|1|||
126399881|NCT02761694|454757340|FG010|Overall Study|Withdrawal by Subject|0|||
126399882|NCT02761694|454757341|FG011|Overall Study|Withdrawal by Subject|0|||
126721211|NCT01912768|455928598|FG001|Overall Study|Withdrawal by Subject|3|||
126399883|NCT02761694|454757330|FG000|Overall Study|Lost to Follow-up|0|||
126399884|NCT02761694|454757331|FG001|Overall Study|Lost to Follow-up|0|||
126399885|NCT02761694|454757332|FG002|Overall Study|Lost to Follow-up|0|||
126399886|NCT02761694|454757333|FG003|Overall Study|Lost to Follow-up|0|||
126399887|NCT02761694|454757334|FG004|Overall Study|Lost to Follow-up|0|||
126399888|NCT02761694|454757335|FG005|Overall Study|Lost to Follow-up|0|||
126399889|NCT02761694|454757336|FG006|Overall Study|Lost to Follow-up|1|||
126399890|NCT02761694|454757337|FG007|Overall Study|Lost to Follow-up|0|||
126399891|NCT02761694|454757338|FG008|Overall Study|Lost to Follow-up|0|||
126399892|NCT02761694|454757339|FG009|Overall Study|Lost to Follow-up|0|||
126399893|NCT02761694|454757340|FG010|Overall Study|Lost to Follow-up|0|||
126399894|NCT02761694|454757341|FG011|Overall Study|Lost to Follow-up|1|||
126399895|NCT02761694|454757330|FG000|Overall Study|Adverse Event|0|||
126399896|NCT02761694|454757331|FG001|Overall Study|Adverse Event|0|||
126471996|NCT01708161|455028882|FG004|Overall Study|Adverse Event|3|||
126471997|NCT01708161|455028883|FG005|Overall Study|Adverse Event|0|||
126399897|NCT02761694|454757332|FG002|Overall Study|Adverse Event|0|||
126399898|NCT02761694|454757333|FG003|Overall Study|Adverse Event|0|||
126399899|NCT02761694|454757334|FG004|Overall Study|Adverse Event|0|||
126399900|NCT02761694|454757335|FG005|Overall Study|Adverse Event|0|||
126399901|NCT02761694|454757336|FG006|Overall Study|Adverse Event|1|||
126399902|NCT02761694|454757337|FG007|Overall Study|Adverse Event|0|||
126471998|NCT01708161|455028878|FG000|Overall Study|Death|0|||
126471999|NCT01708161|455028879|FG001|Overall Study|Death|0|||
126472000|NCT01708161|455028880|FG002|Overall Study|Death|0|||
126399903|NCT02761694|454757338|FG008|Overall Study|Adverse Event|1|||
126399904|NCT02761694|454757339|FG009|Overall Study|Adverse Event|0|||
126399905|NCT02761694|454757340|FG010|Overall Study|Adverse Event|0|||
126399906|NCT02761694|454757341|FG011|Overall Study|Adverse Event|1|||
126399907|NCT02761694|454757330|FG000|Overall Study|Other|4|||
126399908|NCT02761694|454757331|FG001|Overall Study|Other|4|||
126399909|NCT02761694|454757332|FG002|Overall Study|Other|1|||
126399910|NCT02761694|454757333|FG003|Overall Study|Other|2|||
126399911|NCT02761694|454757334|FG004|Overall Study|Other|3|||
126399912|NCT02761694|454757335|FG005|Overall Study|Other|3|||
126399913|NCT02761694|454757336|FG006|Overall Study|Other|18|||
126472001|NCT01708161|455028881|FG003|Overall Study|Death|1|||
126472002|NCT01708161|455028882|FG004|Overall Study|Death|0|||
126472003|NCT01708161|455028883|FG005|Overall Study|Death|1|||
126472004|NCT01708161|455028878|FG000|Overall Study|Withdrawal by Subject|0|||
126472005|NCT01708161|455028879|FG001|Overall Study|Withdrawal by Subject|1|||
126472006|NCT01708161|455028880|FG002|Overall Study|Withdrawal by Subject|1|||
126472007|NCT01708161|455028881|FG003|Overall Study|Withdrawal by Subject|0|||
126472008|NCT01708161|455028882|FG004|Overall Study|Withdrawal by Subject|0|||
126472009|NCT01708161|455028883|FG005|Overall Study|Withdrawal by Subject|0|||
126472010|NCT01708161|455028878|FG000|Overall Study|Administrative problems|0|||
126472011|NCT01708161|455028879|FG001|Overall Study|Administrative problems|1|||
126472012|NCT01708161|455028880|FG002|Overall Study|Administrative problems|0|||
126399914|NCT02761694|454757337|FG007|Overall Study|Other|8|||
126399915|NCT02761694|454757338|FG008|Overall Study|Other|0|||
126399916|NCT02761694|454757339|FG009|Overall Study|Other|1|||
126399917|NCT02761694|454757340|FG010|Overall Study|Other|1|||
126399918|NCT02761694|454757341|FG011|Overall Study|Other|0|||
126399919|NCT03464422|454757348|FG000|Overall Study|Lost to Follow-up|2|||
126399920|NCT03464422|454757348|FG000|Overall Study|Withdrawal by Subject|2|||
126399921|NCT01628367|454757353|FG000|Overall Study|Adverse Event|1|||
126399922|NCT01628367|454757354|FG001|Overall Study|Adverse Event|0|||
126399923|NCT02513823|454757355|FG000|Overall Study|Lost to Follow-up|4|||
126399924|NCT02513823|454757355|FG000|Overall Study|Physician Decision|1|||
126399925|NCT03353922|454757356|FG000|Overall Study|Withdrawal by Subject|1|||
126399926|NCT03353922|454757357|FG001|Overall Study|Withdrawal by Subject|0|||
126399927|NCT03353922|454757358|FG002|Overall Study|Withdrawal by Subject|1|||
126399928|NCT03353922|454757359|FG003|Overall Study|Withdrawal by Subject|1|||
126399929|NCT03353922|454757360|FG004|Overall Study|Withdrawal by Subject|0|||
126399930|NCT03353922|454757361|FG005|Overall Study|Withdrawal by Subject|0|||
126399931|NCT03353922|454757356|FG000|Overall Study|Adverse Event|0|||
126399932|NCT03353922|454757357|FG001|Overall Study|Adverse Event|1|||
126399933|NCT03353922|454757358|FG002|Overall Study|Adverse Event|0|||
126399934|NCT03353922|454757359|FG003|Overall Study|Adverse Event|0|||
126399935|NCT03353922|454757360|FG004|Overall Study|Adverse Event|0|||
126399936|NCT03353922|454757361|FG005|Overall Study|Adverse Event|0|||
126399937|NCT00740714|454757362|FG000|Overall Study|Withdrawal by Subject|17|||
126399938|NCT00740714|454757363|FG001|Overall Study|Withdrawal by Subject|19|||
126399939|NCT00740714|454757364|FG002|Overall Study|Withdrawal by Subject|29|||
126399940|NCT03688555|454757365|FG000|Treatment Period|Adverse Event|0|||
126399941|NCT03688555|454757366|FG001|Treatment Period|Adverse Event|0|||
126399942|NCT03688555|454757367|FG002|Treatment Period|Adverse Event|1|||
126399943|NCT00886119|454757368|FG000|Period 1|Did not meet inclusion criteria|1|||
126399944|NCT00886119|454757369|FG001|Period 1|Did not meet inclusion criteria|0|||
126399945|NCT02743780|454757370|FG000|Part 3 (7 Days)|Adverse Event|0|||
126399946|NCT02743780|454757371|FG001|Part 3 (7 Days)|Adverse Event|0|||
126399947|NCT02743780|454757372|FG002|Part 3 (7 Days)|Adverse Event|1|||
126399948|NCT02743780|454757373|FG003|Part 3 (7 Days)|Adverse Event|0|||
126399949|NCT02743780|454757374|FG004|Part 3 (7 Days)|Adverse Event|0|||
126399950|NCT01294462|454757375|FG000|Overall Study|Lost to Follow-up|1|||
126399951|NCT01294462|454757376|FG001|Overall Study|Lost to Follow-up|0|||
126399952|NCT01294462|454757375|FG000|Overall Study|Withdrawal by Subject|65|||
126399953|NCT01294462|454757376|FG001|Overall Study|Withdrawal by Subject|63|||
126399954|NCT01140568|454757383|FG000|Overall Study|disease progression|31|||
126399955|NCT01140568|454757383|FG000|Overall Study|Withdrawal by Subject|1|||
126399956|NCT01140568|454757383|FG000|Overall Study|Screen Fail|4|||
126399957|NCT01400243|454757384|FG000|Overall Study|Protocol Violation|8|||
126399958|NCT01400243|454757385|FG001|Overall Study|Protocol Violation|11|||
126399959|NCT02279498|454757388|FG000|Overall Study|Adverse Event|3|||
126399960|NCT02279498|454757389|FG001|Overall Study|Adverse Event|0|||
126399961|NCT02279498|454757388|FG000|Overall Study|Lack of Efficacy|4|||
126399962|NCT02279498|454757389|FG001|Overall Study|Lack of Efficacy|0|||
126399963|NCT02279498|454757388|FG000|Overall Study|Lost to Follow-up|0|||
126399964|NCT02279498|454757389|FG001|Overall Study|Lost to Follow-up|1|||
126399965|NCT02279498|454757388|FG000|Overall Study|Withdrawal by Subject|9|||
126399966|NCT02279498|454757389|FG001|Overall Study|Withdrawal by Subject|2|||
126399967|NCT02279498|454757388|FG000|Overall Study|Undefined|2|||
126399968|NCT02279498|454757389|FG001|Overall Study|Undefined|1|||
126399969|NCT01048866|454757390|FG000|Overall Study|Adverse Event|1|||
126399970|NCT01048866|454757391|FG001|Overall Study|Adverse Event|0|||
126399971|NCT01048866|454757390|FG000|Overall Study|Protocol Violation|1|||
126399972|NCT01048866|454757391|FG001|Overall Study|Protocol Violation|0|||
126399973|NCT01048866|454757390|FG000|Overall Study|Physician Decision|1|||
126399974|NCT01048866|454757391|FG001|Overall Study|Physician Decision|0|||
126399975|NCT01048866|454757390|FG000|Overall Study|Withdrawal by Subject|0|||
126399976|NCT01048866|454757391|FG001|Overall Study|Withdrawal by Subject|2|||
126399977|NCT01048866|454757390|FG000|Overall Study|Lost to Follow-up|0|||
126399978|NCT01048866|454757391|FG001|Overall Study|Lost to Follow-up|2|||
126399979|NCT01048866|454757390|FG000|Overall Study|Other|1|||
126399980|NCT01048866|454757391|FG001|Overall Study|Other|1|||
126399981|NCT05320393|454759461|FG000|Overall Study|Withdrawal by Subject|1|||
126399982|NCT05320393|454759462|FG001|Overall Study|Withdrawal by Subject|0|||
126399983|NCT05320393|454759463|FG002|Overall Study|Withdrawal by Subject|2|||
126399984|NCT05320393|454759461|FG000|Overall Study|Lost to Follow-up|1|||
126399985|NCT05320393|454759462|FG001|Overall Study|Lost to Follow-up|2|||
126399986|NCT05320393|454759463|FG002|Overall Study|Lost to Follow-up|1|||
126399987|NCT05320393|454759461|FG000|Overall Study|Moved; too much driving|0|||
126399988|NCT05320393|454759462|FG001|Overall Study|Moved; too much driving|0|||
126399989|NCT05320393|454759463|FG002|Overall Study|Moved; too much driving|2|||
126399990|NCT05320393|454759461|FG000|Overall Study|Did not receive treatment|0|||
126399991|NCT05320393|454759462|FG001|Overall Study|Did not receive treatment|0|||
126399992|NCT05320393|454759463|FG002|Overall Study|Did not receive treatment|1|||
126399993|NCT03187834|454759466|FG000|Overall Study|Lost to Follow-up|0|||
126399994|NCT03187834|454759467|FG001|Overall Study|Lost to Follow-up|1|||
126399995|NCT03187834|454759468|FG002|Overall Study|Lost to Follow-up|2|||
126399996|NCT03187834|454759469|FG003|Overall Study|Lost to Follow-up|2|||
126399997|NCT03187834|454759466|FG000|Overall Study|Had invalid anthropometric measurements|5|||
126399998|NCT03187834|454759467|FG001|Overall Study|Had invalid anthropometric measurements|3|||
126399999|NCT03187834|454759468|FG002|Overall Study|Had invalid anthropometric measurements|4|||
126400000|NCT03187834|454759469|FG003|Overall Study|Had invalid anthropometric measurements|2|||
126400001|NCT03559699|454759470|FG000|Overall Study|Withdrawal by Subject|6|||
126400002|NCT03559699|454759470|FG000|Overall Study|Lost to Follow-up|1|||
126400003|NCT01930890|454759477|FG000|Overall Study|Study Termination|14|||
126400004|NCT01930890|454759478|FG001|Overall Study|Study Termination|28|||
126400005|NCT01930890|454759479|FG002|Overall Study|Study Termination|13|||
126400006|NCT01930890|454759480|FG003|Overall Study|Study Termination|25|||
126400007|NCT01930890|454759477|FG000|Overall Study|Death|0|||
126400008|NCT01930890|454759478|FG001|Overall Study|Death|0|||
126400009|NCT01930890|454759479|FG002|Overall Study|Death|0|||
126400010|NCT01930890|454759480|FG003|Overall Study|Death|1|||
126400011|NCT01930890|454759477|FG000|Overall Study|Investigator Decision|0|||
126400012|NCT01930890|454759478|FG001|Overall Study|Investigator Decision|1|||
126400013|NCT01930890|454759479|FG002|Overall Study|Investigator Decision|0|||
126400014|NCT01930890|454759480|FG003|Overall Study|Investigator Decision|0|||
126400015|NCT01930890|454759477|FG000|Overall Study|Consent Withdrawn|0|||
126400016|NCT01930890|454759478|FG001|Overall Study|Consent Withdrawn|3|||
126400017|NCT01930890|454759479|FG002|Overall Study|Consent Withdrawn|0|||
126400018|NCT01930890|454759480|FG003|Overall Study|Consent Withdrawn|1|||
126400019|NCT01930890|454759477|FG000|Overall Study|Adverse Event|0|||
126400020|NCT01930890|454759478|FG001|Overall Study|Adverse Event|1|||
126400021|NCT01930890|454759479|FG002|Overall Study|Adverse Event|0|||
126400022|NCT01930890|454759480|FG003|Overall Study|Adverse Event|0|||
126400023|NCT02091284|454759481|FG000|Overall Study|Withdrawal by Subject|2|||
126400024|NCT02091284|454759482|FG001|Overall Study|Withdrawal by Subject|1|||
126400025|NCT02091284|454759481|FG000|Overall Study|unreliable data|1|||
126400026|NCT02091284|454759482|FG001|Overall Study|unreliable data|0|||
126400027|NCT01278407|454759483|FG000|Confirmatory Phase|Adverse Event|5|||
126400028|NCT01278407|454759484|FG001|Confirmatory Phase|Adverse Event|10|||
126400029|NCT01278407|454759485|FG002|Confirmatory Phase|Adverse Event|1|||
126400030|NCT01278407|454759486|FG003|Confirmatory Phase|Adverse Event|0|||
126400031|NCT01278407|454759487|FG004|Confirmatory Phase|Adverse Event|0|||
126400032|NCT01278407|454759483|FG000|Confirmatory Phase|Participant's Choice|3|||
126400033|NCT01278407|454759484|FG001|Confirmatory Phase|Participant's Choice|5|||
126400034|NCT01278407|454759485|FG002|Confirmatory Phase|Participant's Choice|3|||
126400035|NCT01278407|454759486|FG003|Confirmatory Phase|Participant's Choice|0|||
126400036|NCT01278407|454759487|FG004|Confirmatory Phase|Participant's Choice|0|||
126400037|NCT01278407|454759483|FG000|Confirmatory Phase|Other|1|||
126400038|NCT01278407|454759484|FG001|Confirmatory Phase|Other|1|||
126400039|NCT01278407|454759485|FG002|Confirmatory Phase|Other|2|||
126400040|NCT01278407|454759486|FG003|Confirmatory Phase|Other|0|||
126400041|NCT01278407|454759487|FG004|Confirmatory Phase|Other|0|||
126400042|NCT01278407|454759483|FG000|Extension Phase|Adverse Event|0|||
126400043|NCT01278407|454759484|FG001|Extension Phase|Adverse Event|0|||
126400044|NCT01278407|454759485|FG002|Extension Phase|Adverse Event|0|||
126400045|NCT01278407|454759486|FG003|Extension Phase|Adverse Event|7|||
126400046|NCT01278407|454759487|FG004|Extension Phase|Adverse Event|16|||
126400047|NCT01278407|454759483|FG000|Extension Phase|Participant's Choice|0|||
126400048|NCT01278407|454759484|FG001|Extension Phase|Participant's Choice|0|||
126400049|NCT01278407|454759485|FG002|Extension Phase|Participant's Choice|0|||
126400050|NCT01278407|454759486|FG003|Extension Phase|Participant's Choice|4|||
126400051|NCT01278407|454759487|FG004|Extension Phase|Participant's Choice|11|||
126400052|NCT01278407|454759483|FG000|Extension Phase|Other|0|||
126400053|NCT01278407|454759484|FG001|Extension Phase|Other|0|||
126400054|NCT01278407|454759485|FG002|Extension Phase|Other|0|||
126400055|NCT01278407|454759486|FG003|Extension Phase|Other|1|||
126472013|NCT01708161|455028881|FG003|Overall Study|Administrative problems|0|||
126472014|NCT01708161|455028882|FG004|Overall Study|Administrative problems|0|||
126472015|NCT01708161|455028883|FG005|Overall Study|Administrative problems|0|||
126472016|NCT01708161|455028878|FG000|Overall Study|Disease progression|3|||
126472017|NCT01708161|455028879|FG001|Overall Study|Disease progression|5|||
126472018|NCT01708161|455028880|FG002|Overall Study|Disease progression|5|||
126400056|NCT01278407|454759487|FG004|Extension Phase|Other|3|||
126400057|NCT02534935|454759488|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
126400058|NCT02534935|454759489|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
126400059|NCT02534935|454759490|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
126400060|NCT02534935|454759488|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
126472019|NCT01708161|455028881|FG003|Overall Study|Disease progression|13|||
126472020|NCT01708161|455028882|FG004|Overall Study|Disease progression|3|||
126472021|NCT01708161|455028883|FG005|Overall Study|Disease progression|0|||
126472022|NCT02019277|455028884|FG000|Overall Study|Withdrawal by Subject|3|||
126472023|NCT02019277|455028884|FG000|Overall Study|Death|7|||
126400061|NCT02534935|454759489|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
126400062|NCT02534935|454759490|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
126400063|NCT02534935|454759488|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
126400064|NCT02534935|454759489|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
126400065|NCT02534935|454759490|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
126400066|NCT02534935|454759488|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
126400067|NCT02534935|454759489|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
126400068|NCT02534935|454759490|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
126400069|NCT02534935|454759488|FG000|Stage 1: 24 Months|Adverse Event|0|||
126400070|NCT02534935|454759489|FG001|Stage 1: 24 Months|Adverse Event|2|||
126400071|NCT02534935|454759490|FG002|Stage 1: 24 Months|Adverse Event|0|||
126400072|NCT02534935|454759488|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
126400073|NCT02534935|454759489|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
126400074|NCT02534935|454759490|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
126400075|NCT02534935|454759488|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
126400076|NCT02534935|454759489|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
126400077|NCT02534935|454759490|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
126400078|NCT01460719|454759491|FG000|Overall Study|Adverse Event|1|||
126400079|NCT01460719|454759491|FG000|Overall Study|Withdrawal by Subject|1|||
126400080|NCT02838901|454759492|FG000|Overall Study|Withdrawal by Subject|1|||
126400081|NCT02838901|454759493|FG001|Overall Study|Withdrawal by Subject|1|||
126400082|NCT02838901|454759492|FG000|Overall Study|Lost to Follow-up|1|||
126400083|NCT02838901|454759493|FG001|Overall Study|Lost to Follow-up|1|||
126400084|NCT00076336|454759494|FG000|Overall Study|Death|13|||
126400085|NCT00076336|454759495|FG001|Overall Study|Death|17|||
126400086|NCT00076336|454759494|FG000|Overall Study|Adverse Event|4|||
126400087|NCT00076336|454759495|FG001|Overall Study|Adverse Event|4|||
126400088|NCT00076336|454759494|FG000|Overall Study|Lost to Follow-up|4|||
126400089|NCT00076336|454759495|FG001|Overall Study|Lost to Follow-up|4|||
126400090|NCT00076336|454759494|FG000|Overall Study|Non-Compliance|2|||
126400091|NCT00076336|454759495|FG001|Overall Study|Non-Compliance|0|||
126400092|NCT00076336|454759494|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
126400093|NCT00076336|454759495|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
126400094|NCT00076336|454759494|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
126400095|NCT00076336|454759495|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
126400096|NCT00076336|454759494|FG000|Overall Study|Liver Transplantation|3|||
126400097|NCT00076336|454759495|FG001|Overall Study|Liver Transplantation|3|||
126400098|NCT00076336|454759494|FG000|Overall Study|Virologic Breakthrough|14|||
126400099|NCT00076336|454759495|FG001|Overall Study|Virologic Breakthrough|16|||
126400100|NCT00076336|454759494|FG000|Overall Study|Treatment failure|4|||
126400101|NCT00076336|454759495|FG001|Overall Study|Treatment failure|5|||
126400102|NCT02285114|454759496|FG000|Main Phase|Investigator's Discretion|0|||
126400103|NCT02285114|454759497|FG001|Main Phase|Investigator's Discretion|2|||
126400104|NCT02285114|454759498|FG002|Main Phase|Investigator's Discretion|0|||
126400105|NCT02285114|454759499|FG003|Main Phase|Investigator's Discretion|0|||
126400106|NCT02285114|454759500|FG004|Main Phase|Investigator's Discretion|0|||
126400107|NCT02285114|454759501|FG005|Main Phase|Investigator's Discretion|0|||
126400108|NCT02285114|454759496|FG000|Main Phase|Enrolled but Never Treated|1|||
126400109|NCT02285114|454759497|FG001|Main Phase|Enrolled but Never Treated|0|||
126400110|NCT02285114|454759498|FG002|Main Phase|Enrolled but Never Treated|0|||
126400111|NCT02285114|454759499|FG003|Main Phase|Enrolled but Never Treated|0|||
126400112|NCT02285114|454759500|FG004|Main Phase|Enrolled but Never Treated|0|||
126400113|NCT02285114|454759501|FG005|Main Phase|Enrolled but Never Treated|0|||
126400114|NCT02285114|454759496|FG000|Main Phase|Withdrew Consent|0|||
126400115|NCT02285114|454759497|FG001|Main Phase|Withdrew Consent|0|||
126472024|NCT02019277|455028884|FG000|Overall Study|Did no Cooperate|1|||
126472025|NCT02019277|455028884|FG000|Overall Study|Adverse Event|1|||
126472026|NCT02633501|455028886|FG000|Overall Study|Adverse Event|0|||
126400116|NCT02285114|454759498|FG002|Main Phase|Withdrew Consent|1|||
126400117|NCT02285114|454759499|FG003|Main Phase|Withdrew Consent|0|||
126472027|NCT02633501|455028887|FG001|Overall Study|Adverse Event|0|||
126400118|NCT02285114|454759500|FG004|Main Phase|Withdrew Consent|0|||
126400119|NCT02285114|454759501|FG005|Main Phase|Withdrew Consent|0|||
126400120|NCT02285114|454759496|FG000|Extension Phase|Investigator's Discretion|0|||
126400121|NCT02285114|454759497|FG001|Extension Phase|Investigator's Discretion|0|||
126400122|NCT02285114|454759498|FG002|Extension Phase|Investigator's Discretion|0|||
126400123|NCT02285114|454759499|FG003|Extension Phase|Investigator's Discretion|14|||
126400124|NCT02285114|454759500|FG004|Extension Phase|Investigator's Discretion|1|||
126400125|NCT02285114|454759501|FG005|Extension Phase|Investigator's Discretion|0|||
126400126|NCT02285114|454759496|FG000|Extension Phase|Lost to Follow-up|0|||
126400127|NCT02285114|454759497|FG001|Extension Phase|Lost to Follow-up|0|||
126400128|NCT02285114|454759498|FG002|Extension Phase|Lost to Follow-up|0|||
126400129|NCT02285114|454759499|FG003|Extension Phase|Lost to Follow-up|1|||
126400130|NCT02285114|454759500|FG004|Extension Phase|Lost to Follow-up|1|||
126400131|NCT02285114|454759501|FG005|Extension Phase|Lost to Follow-up|0|||
126400132|NCT02285114|454759496|FG000|Extension Phase|Non-compliance with Study Drug|0|||
126400133|NCT02285114|454759497|FG001|Extension Phase|Non-compliance with Study Drug|0|||
126400134|NCT02285114|454759498|FG002|Extension Phase|Non-compliance with Study Drug|0|||
126400135|NCT02285114|454759499|FG003|Extension Phase|Non-compliance with Study Drug|2|||
126400136|NCT02285114|454759500|FG004|Extension Phase|Non-compliance with Study Drug|0|||
126400137|NCT02285114|454759501|FG005|Extension Phase|Non-compliance with Study Drug|0|||
126400138|NCT02285114|454759496|FG000|Extension Phase|Pregnancy|0|||
126400139|NCT02285114|454759497|FG001|Extension Phase|Pregnancy|0|||
126400140|NCT02285114|454759498|FG002|Extension Phase|Pregnancy|0|||
126400141|NCT02285114|454759499|FG003|Extension Phase|Pregnancy|1|||
126400142|NCT02285114|454759500|FG004|Extension Phase|Pregnancy|0|||
126400143|NCT02285114|454759501|FG005|Extension Phase|Pregnancy|0|||
126400144|NCT01156389|454759507|FG000|Overall Study|Elevated liver enzymes|4|||
126400145|NCT01156389|454759508|FG001|Overall Study|Elevated liver enzymes|0|||
126400146|NCT01156389|454759507|FG000|Overall Study|Vomiting|0|||
126400147|NCT01156389|454759508|FG001|Overall Study|Vomiting|1|||
126400148|NCT04599166|454759509|FG000|Overall Study|Technological failure connecting to study app|80|||
126400149|NCT01777542|454759510|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
126400150|NCT01777542|454759511|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
126400151|NCT00953524|454759513|FG000|Overall Study|Adverse Event|2|||
126400152|NCT00953524|454759514|FG001|Overall Study|Adverse Event|0|||
126400153|NCT00953524|454759515|FG002|Overall Study|Adverse Event|1|||
126400154|NCT00953524|454759516|FG003|Overall Study|Adverse Event|2|||
126400155|NCT00953524|454759513|FG000|Overall Study|Protocol Violation|18|||
126400156|NCT00953524|454759514|FG001|Overall Study|Protocol Violation|10|||
126400157|NCT00953524|454759515|FG002|Overall Study|Protocol Violation|11|||
126400158|NCT00953524|454759516|FG003|Overall Study|Protocol Violation|6|||
126400159|NCT00953524|454759513|FG000|Overall Study|Lost to Follow-up|0|||
126400160|NCT00953524|454759514|FG001|Overall Study|Lost to Follow-up|1|||
126400161|NCT00953524|454759515|FG002|Overall Study|Lost to Follow-up|1|||
126400162|NCT00953524|454759516|FG003|Overall Study|Lost to Follow-up|0|||
126400163|NCT00953524|454759513|FG000|Overall Study|Withdrawal by Subject|2|||
126400164|NCT00953524|454759514|FG001|Overall Study|Withdrawal by Subject|4|||
126400165|NCT00953524|454759515|FG002|Overall Study|Withdrawal by Subject|1|||
126400166|NCT00953524|454759516|FG003|Overall Study|Withdrawal by Subject|0|||
126400167|NCT03276052|454759518|FG000|Overall Study|Withdrawal by Subject|5|||
126400168|NCT03276052|454759518|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
126400169|NCT01994863|454759519|FG000|Period 1|Adverse Event|4|||
126400170|NCT01994863|454759520|FG001|Period 1|Adverse Event|0|||
126400171|NCT01994863|454759519|FG000|Period 1|Withdrawal by Subject|1|||
126400172|NCT01994863|454759520|FG001|Period 1|Withdrawal by Subject|0|||
126400173|NCT01994863|454759519|FG000|Period 1|Trial stopped by sponsor|1|||
126400174|NCT01994863|454759520|FG001|Period 1|Trial stopped by sponsor|3|||
126400175|NCT01994863|454759519|FG000|Period 1|Lack of Efficacy|1|||
126400176|NCT01994863|454759520|FG001|Period 1|Lack of Efficacy|0|||
126400177|NCT01994863|454759519|FG000|Period 2|Adverse Event|0|||
126400178|NCT01994863|454759520|FG001|Period 2|Adverse Event|1|||
126400179|NCT01994863|454759519|FG000|Period 2|Lack of Efficacy|0|||
126400180|NCT01994863|454759520|FG001|Period 2|Lack of Efficacy|2|||
126400181|NCT01994863|454759519|FG000|Period 2|Withdrawal by Subject|1|||
126400182|NCT01994863|454759520|FG001|Period 2|Withdrawal by Subject|1|||
126400183|NCT03946124|454759521|FG000|Overall Study|Withdrawal by Subject|19|||
126400184|NCT00919867|454759523|FG000|First Intervention|Withdrawal by Subject|0|||
126400185|NCT00919867|454759524|FG001|First Intervention|Withdrawal by Subject|0|||
126400186|NCT00919867|454759525|FG002|First Intervention|Withdrawal by Subject|1|||
126400187|NCT00919867|454759526|FG003|First Intervention|Withdrawal by Subject|0|||
126400188|NCT00919867|454759527|FG004|First Intervention|Withdrawal by Subject|0|||
126400189|NCT00919867|454759528|FG005|First Intervention|Withdrawal by Subject|0|||
126400190|NCT00919867|454759523|FG000|First Intervention|Physician Decision|0|||
126400191|NCT00919867|454759524|FG001|First Intervention|Physician Decision|0|||
126400192|NCT00919867|454759525|FG002|First Intervention|Physician Decision|0|||
126400193|NCT00919867|454759526|FG003|First Intervention|Physician Decision|0|||
126557368|NCT02059161|455332698|FG000|Overall Study|Randomized in error, no study drug|0|||
126400194|NCT00919867|454759527|FG004|First Intervention|Physician Decision|0|||
126400195|NCT00919867|454759528|FG005|First Intervention|Physician Decision|1|||
126400196|NCT01765426|454759531|FG000|Overall Study|Lost to Follow-up|0|||
126400197|NCT01765426|454759532|FG001|Overall Study|Lost to Follow-up|1|||
126400198|NCT01765426|454759533|FG002|Overall Study|Lost to Follow-up|0|||
126400199|NCT01765426|454759534|FG003|Overall Study|Lost to Follow-up|0|||
126400200|NCT01510184|454759535|FG000|Overall Study|Sponsor discretion|28|||
126400201|NCT01510184|454759536|FG001|Overall Study|Sponsor discretion|28|||
126400202|NCT01510184|454759535|FG000|Overall Study|Death|1|||
126400203|NCT01510184|454759536|FG001|Overall Study|Death|2|||
126400204|NCT01510184|454759535|FG000|Overall Study|Withdrawal by Subject|1|||
126400205|NCT01510184|454759536|FG001|Overall Study|Withdrawal by Subject|4|||
126400206|NCT01510184|454759535|FG000|Overall Study|Other|0|||
126400207|NCT01510184|454759536|FG001|Overall Study|Other|1|||
126400208|NCT00694096|454759545|FG000|Overall Study|Withdrawal by Subject|5|||
126400209|NCT02498067|454759554|FG000|Overall Study|Lost to Follow-up|22|||
126400210|NCT02498067|454759554|FG000|Overall Study|Did not meet inclusion criteria|11|||
126400211|NCT01484834|454759555|FG000|Overall Study|Lost to Follow-up|5|||
126400212|NCT01484834|454759556|FG001|Overall Study|Lost to Follow-up|8|||
126400213|NCT01484834|454759557|FG002|Overall Study|Lost to Follow-up|1|||
126400214|NCT01484834|454759558|FG003|Overall Study|Lost to Follow-up|4|||
126400215|NCT00747344|454759559|FG000|Controlled Period|Adverse Event|3|||
126400216|NCT00747344|454759560|FG001|Controlled Period|Adverse Event|0|||
126400217|NCT00747344|454759561|FG002|Controlled Period|Adverse Event|0|||
126400218|NCT00747344|454759562|FG003|Controlled Period|Adverse Event|0|||
126400219|NCT00747344|454759559|FG000|Controlled Period|Lack of Efficacy|2|||
126400220|NCT00747344|454759560|FG001|Controlled Period|Lack of Efficacy|1|||
126400221|NCT00747344|454759561|FG002|Controlled Period|Lack of Efficacy|0|||
126400222|NCT00747344|454759562|FG003|Controlled Period|Lack of Efficacy|0|||
126400223|NCT00747344|454759559|FG000|Controlled Period|Other|0|||
126400224|NCT00747344|454759560|FG001|Controlled Period|Other|3|||
126400225|NCT00747344|454759561|FG002|Controlled Period|Other|0|||
126400226|NCT00747344|454759562|FG003|Controlled Period|Other|0|||
126400227|NCT00747344|454759559|FG000|After Controlled Period|Adverse Event|0|||
126400228|NCT00747344|454759560|FG001|After Controlled Period|Adverse Event|0|||
126400229|NCT00747344|454759561|FG002|After Controlled Period|Adverse Event|0|||
126400230|NCT00747344|454759562|FG003|After Controlled Period|Adverse Event|1|||
126400231|NCT00765882|454759563|FG000|Overall Study|Adverse Event|10|||
126400232|NCT00765882|454759564|FG001|Overall Study|Adverse Event|21|||
126400233|NCT00765882|454759565|FG002|Overall Study|Adverse Event|20|||
126400234|NCT00765882|454759563|FG000|Overall Study|Lack of Efficacy|4|||
126400235|NCT00765882|454759564|FG001|Overall Study|Lack of Efficacy|0|||
126400236|NCT00765882|454759565|FG002|Overall Study|Lack of Efficacy|1|||
126400237|NCT00765882|454759563|FG000|Overall Study|Protocol Violation|4|||
126400238|NCT00765882|454759564|FG001|Overall Study|Protocol Violation|3|||
126400239|NCT00765882|454759565|FG002|Overall Study|Protocol Violation|1|||
126400240|NCT00765882|454759563|FG000|Overall Study|Withdrawal by Subject|2|||
126400241|NCT00765882|454759564|FG001|Overall Study|Withdrawal by Subject|6|||
126400242|NCT00765882|454759565|FG002|Overall Study|Withdrawal by Subject|6|||
126400243|NCT00765882|454759563|FG000|Overall Study|Lost to Follow-up|1|||
126400244|NCT00765882|454759564|FG001|Overall Study|Lost to Follow-up|9|||
126400245|NCT00765882|454759565|FG002|Overall Study|Lost to Follow-up|6|||
126400246|NCT00765882|454759563|FG000|Overall Study|Other Reason|3|||
126400247|NCT00765882|454759564|FG001|Overall Study|Other Reason|1|||
126400248|NCT00765882|454759565|FG002|Overall Study|Other Reason|2|||
126400249|NCT02231762|454759569|FG000|Combination Phase|Adverse Event|10|||
126400250|NCT02231762|454759570|FG001|Combination Phase|Adverse Event|0|||
126400251|NCT02231762|454759571|FG002|Combination Phase|Adverse Event|0|||
126400252|NCT02231762|454759572|FG003|Combination Phase|Adverse Event|0|||
126400253|NCT02231762|454759569|FG000|Combination Phase|Withdrawal by Subject|2|||
126400254|NCT02231762|454759570|FG001|Combination Phase|Withdrawal by Subject|0|||
126400255|NCT02231762|454759571|FG002|Combination Phase|Withdrawal by Subject|0|||
126400256|NCT02231762|454759572|FG003|Combination Phase|Withdrawal by Subject|0|||
126400257|NCT02231762|454759569|FG000|Combination Phase|Disease Progression|6|||
126400258|NCT02231762|454759570|FG001|Combination Phase|Disease Progression|0|||
126400259|NCT02231762|454759571|FG002|Combination Phase|Disease Progression|0|||
126400260|NCT02231762|454759572|FG003|Combination Phase|Disease Progression|0|||
126400261|NCT02231762|454759569|FG000|Combination Phase|Did not meet inclusion criteria|1|||
126400262|NCT02231762|454759570|FG001|Combination Phase|Did not meet inclusion criteria|0|||
126400263|NCT02231762|454759571|FG002|Combination Phase|Did not meet inclusion criteria|0|||
126400264|NCT02231762|454759572|FG003|Combination Phase|Did not meet inclusion criteria|0|||
126400265|NCT02231762|454759569|FG000|Combination Phase|Protocol Violation|1|||
126400266|NCT02231762|454759570|FG001|Combination Phase|Protocol Violation|0|||
126400267|NCT02231762|454759571|FG002|Combination Phase|Protocol Violation|0|||
126400268|NCT02231762|454759572|FG003|Combination Phase|Protocol Violation|0|||
126400269|NCT02231762|454759569|FG000|Maintenance Phase|Disease progression|0|||
126400270|NCT02231762|454759570|FG001|Maintenance Phase|Disease progression|3|||
126400271|NCT02231762|454759571|FG002|Maintenance Phase|Disease progression|4|||
126400272|NCT02231762|454759572|FG003|Maintenance Phase|Disease progression|3|||
126400273|NCT02231762|454759569|FG000|Maintenance Phase|Adverse Event|0|||
126400274|NCT02231762|454759570|FG001|Maintenance Phase|Adverse Event|0|||
126400275|NCT02231762|454759571|FG002|Maintenance Phase|Adverse Event|1|||
126400276|NCT02231762|454759572|FG003|Maintenance Phase|Adverse Event|2|||
126400277|NCT01799239|454759577|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
126400278|NCT01799239|454759578|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
126400279|NCT01799239|454759577|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
126400280|NCT01799239|454759578|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
126400281|NCT01799239|454759577|FG000|Period 1 (7 Days)|Protocol Violation|0|||
126400282|NCT01799239|454759578|FG001|Period 1 (7 Days)|Protocol Violation|1|||
126400283|NCT01799239|454759577|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
126400284|NCT01799239|454759578|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
126400285|NCT01799239|454759577|FG000|Period 2 (7 Days)|Protocol Violation|1|||
126400286|NCT01799239|454759578|FG001|Period 2 (7 Days)|Protocol Violation|0|||
126400287|NCT02813668|454759581|FG000|Overall Study|Death|4|||
126400288|NCT02813668|454759581|FG000|Overall Study|Lost to Follow-up|509|||
126400289|NCT02813668|454759581|FG000|Overall Study|Withdrawal by Subject|148|||
126400290|NCT02813668|454759581|FG000|Overall Study|No longer at worksite|85|||
126400291|NCT02813668|454759581|FG000|Overall Study|Medical reasons not related to the study|4|||
126400292|NCT01286987|454759583|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
126400293|NCT01286987|454759584|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
126400294|NCT01286987|454759585|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
126400295|NCT01286987|454759586|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
126400296|NCT01286987|454759587|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
126400297|NCT01286987|454759588|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
126400298|NCT01286987|454759589|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
126400299|NCT01286987|454759590|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
126400300|NCT01286987|454759591|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
126400301|NCT01286987|454759592|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
126400302|NCT01286987|454759593|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
126400303|NCT01286987|454759594|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
126400304|NCT01286987|454759595|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
126400305|NCT01286987|454759596|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
126400306|NCT01286987|454759597|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
126400307|NCT01286987|454759583|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
126400308|NCT01286987|454759584|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
126400309|NCT01286987|454759585|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
126400310|NCT01286987|454759586|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
126400311|NCT01286987|454759587|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
126400312|NCT01286987|454759588|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
126400313|NCT01286987|454759589|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
126400314|NCT01286987|454759590|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
126400315|NCT01286987|454759591|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
126400316|NCT01286987|454759592|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
126400317|NCT01286987|454759593|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
126400318|NCT01286987|454759594|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
126400319|NCT01286987|454759595|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
126400320|NCT01286987|454759596|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
126400321|NCT01286987|454759597|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
126400322|NCT01286987|454759583|FG000|Part 1: Dose Escalation|Physician Decision|0|||
126400323|NCT01286987|454759584|FG001|Part 1: Dose Escalation|Physician Decision|0|||
126400324|NCT01286987|454759585|FG002|Part 1: Dose Escalation|Physician Decision|0|||
126400325|NCT01286987|454759586|FG003|Part 1: Dose Escalation|Physician Decision|0|||
126400326|NCT01286987|454759587|FG004|Part 1: Dose Escalation|Physician Decision|1|||
126400327|NCT01286987|454759588|FG005|Part 1: Dose Escalation|Physician Decision|0|||
126400328|NCT01286987|454759589|FG006|Part 1: Dose Escalation|Physician Decision|0|||
126400329|NCT01286987|454759590|FG007|Part 1: Dose Escalation|Physician Decision|0|||
126400330|NCT01286987|454759591|FG008|Part 1: Dose Escalation|Physician Decision|0|||
126400331|NCT01286987|454759592|FG009|Part 1: Dose Escalation|Physician Decision|0|||
126400332|NCT01286987|454759593|FG010|Part 1: Dose Escalation|Physician Decision|0|||
126400333|NCT01286987|454759594|FG011|Part 1: Dose Escalation|Physician Decision|0|||
126400334|NCT01286987|454759595|FG012|Part 1: Dose Escalation|Physician Decision|0|||
126400335|NCT01286987|454759596|FG013|Part 1: Dose Escalation|Physician Decision|0|||
126400336|NCT01286987|454759597|FG014|Part 1: Dose Escalation|Physician Decision|0|||
126400337|NCT01286987|454759583|FG000|Part 2: Dose Expansion|Death|0|||
126400338|NCT01286987|454759584|FG001|Part 2: Dose Expansion|Death|0|||
126400339|NCT01286987|454759585|FG002|Part 2: Dose Expansion|Death|0|||
126400340|NCT01286987|454759586|FG003|Part 2: Dose Expansion|Death|0|||
126400341|NCT01286987|454759587|FG004|Part 2: Dose Expansion|Death|0|||
126400342|NCT01286987|454759588|FG005|Part 2: Dose Expansion|Death|0|||
126400343|NCT01286987|454759589|FG006|Part 2: Dose Expansion|Death|0|||
126400344|NCT01286987|454759590|FG007|Part 2: Dose Expansion|Death|0|||
126400345|NCT01286987|454759591|FG008|Part 2: Dose Expansion|Death|0|||
126400346|NCT01286987|454759592|FG009|Part 2: Dose Expansion|Death|0|||
126400347|NCT01286987|454759593|FG010|Part 2: Dose Expansion|Death|0|||
126400348|NCT01286987|454759594|FG011|Part 2: Dose Expansion|Death|0|||
126400349|NCT01286987|454759595|FG012|Part 2: Dose Expansion|Death|1|||
126400350|NCT01286987|454759596|FG013|Part 2: Dose Expansion|Death|1|||
126400351|NCT01286987|454759597|FG014|Part 2: Dose Expansion|Death|0|||
126400352|NCT01286987|454759583|FG000|Part 2: Dose Expansion|Physician Decision|0|||
126400353|NCT01286987|454759584|FG001|Part 2: Dose Expansion|Physician Decision|0|||
126400354|NCT01286987|454759585|FG002|Part 2: Dose Expansion|Physician Decision|0|||
126400355|NCT01286987|454759586|FG003|Part 2: Dose Expansion|Physician Decision|0|||
126400356|NCT01286987|454759587|FG004|Part 2: Dose Expansion|Physician Decision|0|||
126400357|NCT01286987|454759588|FG005|Part 2: Dose Expansion|Physician Decision|0|||
126400358|NCT01286987|454759589|FG006|Part 2: Dose Expansion|Physician Decision|0|||
126400359|NCT01286987|454759590|FG007|Part 2: Dose Expansion|Physician Decision|0|||
126400360|NCT01286987|454759591|FG008|Part 2: Dose Expansion|Physician Decision|0|||
126400361|NCT01286987|454759592|FG009|Part 2: Dose Expansion|Physician Decision|0|||
126400362|NCT01286987|454759593|FG010|Part 2: Dose Expansion|Physician Decision|1|||
126400363|NCT01286987|454759594|FG011|Part 2: Dose Expansion|Physician Decision|1|||
126400364|NCT01286987|454759595|FG012|Part 2: Dose Expansion|Physician Decision|0|||
126400365|NCT01286987|454759596|FG013|Part 2: Dose Expansion|Physician Decision|1|||
126400366|NCT01286987|454759597|FG014|Part 2: Dose Expansion|Physician Decision|0|||
126400367|NCT01286987|454759583|FG000|Part 2: Dose Expansion|Other|0|||
126400368|NCT01286987|454759584|FG001|Part 2: Dose Expansion|Other|0|||
126400369|NCT01286987|454759585|FG002|Part 2: Dose Expansion|Other|0|||
126400370|NCT01286987|454759586|FG003|Part 2: Dose Expansion|Other|0|||
126400371|NCT01286987|454759587|FG004|Part 2: Dose Expansion|Other|0|||
126400372|NCT01286987|454759588|FG005|Part 2: Dose Expansion|Other|0|||
126400373|NCT01286987|454759589|FG006|Part 2: Dose Expansion|Other|0|||
126400374|NCT01286987|454759590|FG007|Part 2: Dose Expansion|Other|0|||
126400375|NCT01286987|454759591|FG008|Part 2: Dose Expansion|Other|0|||
126400376|NCT01286987|454759592|FG009|Part 2: Dose Expansion|Other|0|||
126400377|NCT01286987|454759593|FG010|Part 2: Dose Expansion|Other|0|||
126400378|NCT01286987|454759594|FG011|Part 2: Dose Expansion|Other|0|||
126400379|NCT01286987|454759595|FG012|Part 2: Dose Expansion|Other|0|||
126400380|NCT01286987|454759596|FG013|Part 2: Dose Expansion|Other|1|||
126400381|NCT01286987|454759597|FG014|Part 2: Dose Expansion|Other|0|||
126400382|NCT01286987|454759583|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
126400383|NCT01286987|454759584|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
126400384|NCT01286987|454759585|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
126400385|NCT01286987|454759586|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
126400386|NCT01286987|454759587|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
126400387|NCT01286987|454759588|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
126400388|NCT01286987|454759589|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
126400389|NCT01286987|454759590|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
126400390|NCT01286987|454759591|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
126400391|NCT01286987|454759592|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
126400392|NCT01286987|454759593|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
126400393|NCT01286987|454759594|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
126400394|NCT01286987|454759595|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
126400395|NCT01286987|454759596|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
126400396|NCT01286987|454759597|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
126400397|NCT01286987|454759583|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
126400398|NCT01286987|454759584|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
126400399|NCT01286987|454759585|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
126400400|NCT01286987|454759586|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
126400401|NCT01286987|454759587|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
126400402|NCT01286987|454759588|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
126400403|NCT01286987|454759589|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
126400404|NCT01286987|454759590|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
126400405|NCT01286987|454759591|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
126400406|NCT01286987|454759592|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
126400407|NCT01286987|454759593|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
126400408|NCT01286987|454759594|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
126400409|NCT01286987|454759595|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
126400410|NCT01286987|454759596|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
126400411|NCT01286987|454759597|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
126400412|NCT01286987|454759583|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400413|NCT01286987|454759584|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400414|NCT01286987|454759585|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400415|NCT01286987|454759586|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126557369|NCT02059161|455332699|FG001|Overall Study|Randomized in error, no study drug|1|||
126557370|NCT02059161|455332698|FG000|Overall Study|Non-compliance with study drug|6|||
126557371|NCT02059161|455332699|FG001|Overall Study|Non-compliance with study drug|2|||
126557372|NCT02559817|455332704|FG000|Treatment Period|Adverse Event|1|||
126557373|NCT02559817|455332705|FG001|Treatment Period|Adverse Event|0|||
126400416|NCT01286987|454759587|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400417|NCT01286987|454759588|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400418|NCT01286987|454759589|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400419|NCT01286987|454759590|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400420|NCT01286987|454759591|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400421|NCT01286987|454759592|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126557374|NCT02559817|455332706|FG002|Treatment Period|Adverse Event|1|||
126400422|NCT01286987|454759593|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
126400423|NCT01286987|454759594|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400424|NCT01286987|454759595|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126557375|NCT02559817|455332707|FG003|Treatment Period|Adverse Event|0|||
126557376|NCT02559817|455332708|FG004|Treatment Period|Adverse Event|0|||
126400425|NCT01286987|454759596|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126472028|NCT02633501|455028888|FG002|Overall Study|Adverse Event|1|||
126400426|NCT01286987|454759597|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126400427|NCT02594098|454759598|FG000|Overall Study|Lack of Efficacy|17|||
126400428|NCT02594098|454759599|FG001|Overall Study|Lack of Efficacy|6|||
126400429|NCT02594098|454759598|FG000|Overall Study|Withdrawal by Subject|1|||
126400430|NCT02594098|454759599|FG001|Overall Study|Withdrawal by Subject|3|||
126400431|NCT02594098|454759598|FG000|Overall Study|Terminated participation|6|||
126400432|NCT02594098|454759599|FG001|Overall Study|Terminated participation|2|||
126400433|NCT02594098|454759598|FG000|Overall Study|Seek alternative treatment|2|||
126400434|NCT02594098|454759599|FG001|Overall Study|Seek alternative treatment|1|||
126400435|NCT02594098|454759598|FG000|Overall Study|Other|0|||
126400436|NCT02594098|454759599|FG001|Overall Study|Other|1|||
126400437|NCT00033540|454759600|FG000|Overall Study|Adverse Event|14|||
126400438|NCT00033540|454759600|FG000|Overall Study|Death|1|||
126400439|NCT00033540|454759600|FG000|Overall Study|Progression|26|||
126400440|NCT00033540|454759600|FG000|Overall Study|Withdrawal by Subject|6|||
126400441|NCT00033540|454759600|FG000|Overall Study|Other|5|||
126400442|NCT00033540|454759600|FG000|Overall Study|Ineligible|3|||
126400443|NCT00033540|454759600|FG000|Overall Study|Never received treatment|2|||
126400444|NCT03366103|454759601|FG000|Overall Study|Disease Progression|3|||
126400445|NCT03366103|454759602|FG001|Overall Study|Disease Progression|1|||
126400446|NCT03366103|454759603|FG002|Overall Study|Disease Progression|0|||
126400447|NCT03366103|454759601|FG000|Overall Study|Adverse Event|0|||
126400448|NCT03366103|454759602|FG001|Overall Study|Adverse Event|1|||
126400449|NCT03366103|454759603|FG002|Overall Study|Adverse Event|0|||
126400450|NCT01036529|454759604|FG000|Overall Study|Adverse Event|0|||
126472029|NCT02633501|455028889|FG003|Overall Study|Adverse Event|0|||
126472030|NCT02633501|455028890|FG004|Overall Study|Adverse Event|1|||
126472031|NCT02633501|455028891|FG005|Overall Study|Adverse Event|1|||
126472032|NCT02633501|455028886|FG000|Overall Study|Withdrawal by Subject|2|||
126472033|NCT02633501|455028887|FG001|Overall Study|Withdrawal by Subject|1|||
126472034|NCT02633501|455028888|FG002|Overall Study|Withdrawal by Subject|2|||
126472035|NCT02633501|455028889|FG003|Overall Study|Withdrawal by Subject|2|||
126472036|NCT02633501|455028890|FG004|Overall Study|Withdrawal by Subject|1|||
126472037|NCT02633501|455028891|FG005|Overall Study|Withdrawal by Subject|3|||
126472038|NCT02633501|455028886|FG000|Overall Study|Various other reasons|0|||
126472039|NCT02633501|455028887|FG001|Overall Study|Various other reasons|2|||
126557377|NCT02559817|455332704|FG000|Treatment Period|Lack of Efficacy|0|||
126557378|NCT02559817|455332705|FG001|Treatment Period|Lack of Efficacy|1|||
126400451|NCT01036529|454759605|FG001|Overall Study|Adverse Event|1|||
126400452|NCT01036529|454759604|FG000|Overall Study|Lost to Follow-up|0|||
126400453|NCT01036529|454759605|FG001|Overall Study|Lost to Follow-up|1|||
126400454|NCT01036529|454759604|FG000|Overall Study|Physician Decision|1|||
126400455|NCT01036529|454759605|FG001|Overall Study|Physician Decision|0|||
126400456|NCT01036529|454759604|FG000|Overall Study|Withdrawal by Subject|1|||
126400457|NCT01036529|454759605|FG001|Overall Study|Withdrawal by Subject|1|||
126400458|NCT01036529|454759604|FG000|Overall Study|Sponsor study termination|11|||
126400459|NCT01036529|454759605|FG001|Overall Study|Sponsor study termination|12|||
126400460|NCT01945775|454759606|FG000|Overall Study|Death|214|||
126400461|NCT01945775|454759607|FG001|Overall Study|Death|98|||
126400462|NCT01945775|454759606|FG000|Overall Study|Lost to Follow-up|12|||
126400463|NCT01945775|454759607|FG001|Overall Study|Lost to Follow-up|7|||
126400464|NCT01945775|454759606|FG000|Overall Study|Withdrawal by Subject|11|||
126400465|NCT01945775|454759607|FG001|Overall Study|Withdrawal by Subject|21|||
126400466|NCT01945775|454759606|FG000|Overall Study|Other|50|||
126400467|NCT01945775|454759607|FG001|Overall Study|Other|18|||
126400468|NCT02876328|454759608|FG000|Overall Study|Death|2|||
126400469|NCT02876328|454759609|FG001|Overall Study|Death|1|||
126400470|NCT02876328|454759610|FG002|Overall Study|Death|3|||
126400471|NCT02876328|454759611|FG003|Overall Study|Death|0|||
126472040|NCT02633501|455028888|FG002|Overall Study|Various other reasons|4|||
126557379|NCT02559817|455332706|FG002|Treatment Period|Lack of Efficacy|0|||
126557380|NCT02559817|455332707|FG003|Treatment Period|Lack of Efficacy|0|||
126400472|NCT02876328|454759612|FG004|Overall Study|Death|0|||
126400473|NCT02876328|454759613|FG005|Overall Study|Death|0|||
126400474|NCT02876328|454759614|FG006|Overall Study|Death|1|||
126400475|NCT02876328|454759615|FG007|Overall Study|Death|3|||
126400476|NCT02876328|454759616|FG008|Overall Study|Death|0|||
126400477|NCT02876328|454759617|FG009|Overall Study|Death|1|||
126400478|NCT02876328|454759618|FG010|Overall Study|Death|1|||
126400479|NCT02876328|454759619|FG011|Overall Study|Death|0|||
126400480|NCT02876328|454759620|FG012|Overall Study|Death|0|||
126400481|NCT02876328|454759621|FG013|Overall Study|Death|0|||
126400482|NCT02876328|454759622|FG014|Overall Study|Death|0|||
126400483|NCT02876328|454759623|FG015|Overall Study|Death|0|||
126400484|NCT02876328|454759624|FG016|Overall Study|Death|1|||
126400485|NCT02876328|454759625|FG017|Overall Study|Death|1|||
126472041|NCT02633501|455028889|FG003|Overall Study|Various other reasons|1|||
126472042|NCT02633501|455028890|FG004|Overall Study|Various other reasons|7|||
126400486|NCT02876328|454759626|FG018|Overall Study|Death|0|||
126400487|NCT02876328|454759627|FG019|Overall Study|Death|0|||
126400488|NCT02876328|454759628|FG020|Overall Study|Death|0|||
126400489|NCT02876328|454759629|FG021|Overall Study|Death|1|||
126400490|NCT02876328|454759630|FG022|Overall Study|Death|0|||
126400491|NCT02876328|454759631|FG023|Overall Study|Death|0|||
126400492|NCT02876328|454759608|FG000|Overall Study|Withdrawal by Subject|0|||
126400493|NCT02876328|454759609|FG001|Overall Study|Withdrawal by Subject|2|||
126400494|NCT02876328|454759610|FG002|Overall Study|Withdrawal by Subject|3|||
126400495|NCT02876328|454759611|FG003|Overall Study|Withdrawal by Subject|3|||
126400496|NCT02876328|454759612|FG004|Overall Study|Withdrawal by Subject|0|||
126400497|NCT02876328|454759613|FG005|Overall Study|Withdrawal by Subject|1|||
126400498|NCT02876328|454759614|FG006|Overall Study|Withdrawal by Subject|0|||
126400499|NCT02876328|454759615|FG007|Overall Study|Withdrawal by Subject|1|||
126400500|NCT02876328|454759616|FG008|Overall Study|Withdrawal by Subject|1|||
126400501|NCT02876328|454759617|FG009|Overall Study|Withdrawal by Subject|2|||
126400502|NCT02876328|454759618|FG010|Overall Study|Withdrawal by Subject|0|||
126400503|NCT02876328|454759619|FG011|Overall Study|Withdrawal by Subject|0|||
126400504|NCT02876328|454759620|FG012|Overall Study|Withdrawal by Subject|0|||
126400505|NCT02876328|454759621|FG013|Overall Study|Withdrawal by Subject|0|||
126400506|NCT02876328|454759622|FG014|Overall Study|Withdrawal by Subject|0|||
126400507|NCT02876328|454759623|FG015|Overall Study|Withdrawal by Subject|0|||
126400508|NCT02876328|454759624|FG016|Overall Study|Withdrawal by Subject|1|||
126400509|NCT02876328|454759625|FG017|Overall Study|Withdrawal by Subject|3|||
126400510|NCT02876328|454759626|FG018|Overall Study|Withdrawal by Subject|0|||
126400511|NCT02876328|454759627|FG019|Overall Study|Withdrawal by Subject|0|||
126400512|NCT02876328|454759628|FG020|Overall Study|Withdrawal by Subject|1|||
126400513|NCT02876328|454759629|FG021|Overall Study|Withdrawal by Subject|0|||
126400514|NCT02876328|454759630|FG022|Overall Study|Withdrawal by Subject|0|||
126400515|NCT02876328|454759631|FG023|Overall Study|Withdrawal by Subject|0|||
126400516|NCT02876328|454759608|FG000|Overall Study|Missed 12 Month Visit|15|||
126400517|NCT02876328|454759609|FG001|Overall Study|Missed 12 Month Visit|10|||
126400518|NCT02876328|454759610|FG002|Overall Study|Missed 12 Month Visit|11|||
126400519|NCT02876328|454759611|FG003|Overall Study|Missed 12 Month Visit|6|||
126400520|NCT02876328|454759612|FG004|Overall Study|Missed 12 Month Visit|10|||
126400521|NCT02876328|454759613|FG005|Overall Study|Missed 12 Month Visit|14|||
126400522|NCT02876328|454759614|FG006|Overall Study|Missed 12 Month Visit|3|||
126400523|NCT02876328|454759615|FG007|Overall Study|Missed 12 Month Visit|8|||
126400524|NCT02876328|454759616|FG008|Overall Study|Missed 12 Month Visit|9|||
126400525|NCT02876328|454759617|FG009|Overall Study|Missed 12 Month Visit|5|||
126400526|NCT02876328|454759618|FG010|Overall Study|Missed 12 Month Visit|4|||
126400527|NCT02876328|454759619|FG011|Overall Study|Missed 12 Month Visit|1|||
126400528|NCT02876328|454759620|FG012|Overall Study|Missed 12 Month Visit|5|||
126400529|NCT02876328|454759621|FG013|Overall Study|Missed 12 Month Visit|4|||
126400530|NCT02876328|454759622|FG014|Overall Study|Missed 12 Month Visit|4|||
126400531|NCT02876328|454759623|FG015|Overall Study|Missed 12 Month Visit|4|||
126400532|NCT02876328|454759624|FG016|Overall Study|Missed 12 Month Visit|3|||
126400533|NCT02876328|454759625|FG017|Overall Study|Missed 12 Month Visit|6|||
126400534|NCT02876328|454759626|FG018|Overall Study|Missed 12 Month Visit|2|||
126472043|NCT02633501|455028891|FG005|Overall Study|Various other reasons|11|||
126472044|NCT02633501|455028886|FG000|Overall Study|Lost to Follow-up|0|||
126472045|NCT02633501|455028887|FG001|Overall Study|Lost to Follow-up|0|||
126472046|NCT02633501|455028888|FG002|Overall Study|Lost to Follow-up|0|||
126472047|NCT02633501|455028889|FG003|Overall Study|Lost to Follow-up|1|||
126400535|NCT02876328|454759627|FG019|Overall Study|Missed 12 Month Visit|2|||
126472048|NCT02633501|455028890|FG004|Overall Study|Lost to Follow-up|2|||
126472049|NCT02633501|455028891|FG005|Overall Study|Lost to Follow-up|0|||
126472050|NCT00395733|455028892|FG000|Period 2|Withdrawal by Subject|1|||
126472051|NCT00395733|455028893|FG001|Period 2|Withdrawal by Subject|2|||
126472052|NCT00395733|455028892|FG000|Period 2|Protocol Violation|0|||
126472053|NCT00395733|455028893|FG001|Period 2|Protocol Violation|1|||
126772283|NCT00996918|456122079|FG000|Overall Study|Lack of Efficacy|1|||
126400536|NCT02876328|454759628|FG020|Overall Study|Missed 12 Month Visit|11|||
126400537|NCT02876328|454759629|FG021|Overall Study|Missed 12 Month Visit|7|||
126400538|NCT02876328|454759630|FG022|Overall Study|Missed 12 Month Visit|1|||
126400539|NCT02876328|454759631|FG023|Overall Study|Missed 12 Month Visit|0|||
126400540|NCT03515941|454759632|FG000|Overall Study|Adverse Event|1|||
126400541|NCT03515941|454759633|FG001|Overall Study|Adverse Event|0|||
126400542|NCT00334282|454759636|FG000|Overall Study|Lost to Follow-up|11|||
126400543|NCT00334282|454759637|FG001|Overall Study|Lost to Follow-up|5|||
126400544|NCT00334282|454759636|FG000|Overall Study|Withdrawal by Subject|17|||
126400545|NCT00334282|454759637|FG001|Overall Study|Withdrawal by Subject|3|||
126400546|NCT00334282|454759636|FG000|Overall Study|Death|194|||
126400547|NCT00334282|454759637|FG001|Overall Study|Death|100|||
126472054|NCT00395733|455028892|FG000|Period 2|Adverse Event|0|||
126472055|NCT00395733|455028893|FG001|Period 2|Adverse Event|2|||
126400548|NCT04342689|454759644|FG000|Overall Study|Withdrawal by Subject|32|||
126472056|NCT00395733|455028892|FG000|Period 2|Technical problems|1|||
126472057|NCT00395733|455028893|FG001|Period 2|Technical problems|0|||
126557381|NCT02559817|455332708|FG004|Treatment Period|Lack of Efficacy|0|||
126400549|NCT04342689|454759645|FG001|Overall Study|Withdrawal by Subject|33|||
126400550|NCT04342689|454759644|FG000|Overall Study|Lost to Follow-up|10|||
126400551|NCT04342689|454759645|FG001|Overall Study|Lost to Follow-up|12|||
126400552|NCT01460407|454759646|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
126400553|NCT01460407|454759647|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
126400554|NCT00844805|454759652|FG000|Treatment Phase|Adverse Event|5|||
126400555|NCT00844805|454759653|FG001|Treatment Phase|Adverse Event|1|||
126400556|NCT00844805|454759654|FG002|Treatment Phase|Adverse Event|0|||
126400557|NCT00844805|454759655|FG003|Treatment Phase|Adverse Event|0|||
126400558|NCT00844805|454759652|FG000|Treatment Phase|Withdrawal by Subject|3|||
126400559|NCT00844805|454759653|FG001|Treatment Phase|Withdrawal by Subject|4|||
126400560|NCT00844805|454759654|FG002|Treatment Phase|Withdrawal by Subject|0|||
126400561|NCT00844805|454759655|FG003|Treatment Phase|Withdrawal by Subject|0|||
126400562|NCT00844805|454759652|FG000|Treatment Phase|Noncompliance With Protocol|1|||
126400563|NCT00844805|454759653|FG001|Treatment Phase|Noncompliance With Protocol|0|||
126400564|NCT00844805|454759654|FG002|Treatment Phase|Noncompliance With Protocol|0|||
126400565|NCT00844805|454759655|FG003|Treatment Phase|Noncompliance With Protocol|0|||
126400566|NCT00844805|454759652|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
126400567|NCT00844805|454759653|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
126400568|NCT00844805|454759654|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
126400569|NCT00844805|454759655|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
126400570|NCT00844805|454759652|FG000|Follow-Up Phase|Adverse Event|0|||
126400571|NCT00844805|454759653|FG001|Follow-Up Phase|Adverse Event|0|||
126400572|NCT00844805|454759654|FG002|Follow-Up Phase|Adverse Event|1|||
126400573|NCT00844805|454759655|FG003|Follow-Up Phase|Adverse Event|0|||
126400574|NCT00844805|454759652|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
126400575|NCT00844805|454759653|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
126400576|NCT00844805|454759654|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
126400577|NCT00844805|454759655|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
126400578|NCT00844805|454759652|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
126400579|NCT00844805|454759653|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
126400580|NCT00844805|454759654|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
126400581|NCT00844805|454759655|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
126400582|NCT00844805|454759652|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
126400583|NCT00844805|454759653|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
126400584|NCT00844805|454759654|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
126400585|NCT00844805|454759655|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
126400586|NCT00844805|454759652|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
126400587|NCT00844805|454759653|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
126400588|NCT00844805|454759654|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
126400589|NCT00844805|454759655|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
126400590|NCT04070326|454759656|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
126400591|NCT04070326|454759657|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
126400592|NCT03618628|454759661|FG000|Overall Study|Death|1|||
126400593|NCT03618628|454759661|FG000|Overall Study|Lost to Follow-up|1|||
126400594|NCT01741532|454759663|FG000|Overall Study|Adverse Event|4|||
126400595|NCT01741532|454759664|FG001|Overall Study|Adverse Event|0|||
126400596|NCT01741532|454759663|FG000|Overall Study|Withdrawal by Subject|1|||
126400597|NCT01741532|454759664|FG001|Overall Study|Withdrawal by Subject|1|||
126400598|NCT01741532|454759663|FG000|Overall Study|Protocol Violation|0|||
126400599|NCT01741532|454759664|FG001|Overall Study|Protocol Violation|1|||
126400600|NCT01741532|454759663|FG000|Overall Study|Worsening of the disease|3|||
126400601|NCT01741532|454759664|FG001|Overall Study|Worsening of the disease|1|||
126400602|NCT01741532|454759663|FG000|Overall Study|Sponsor decision|1|||
126400603|NCT01741532|454759664|FG001|Overall Study|Sponsor decision|0|||
126400604|NCT01741532|454759663|FG000|Overall Study|Medical event|1|||
126400605|NCT01741532|454759664|FG001|Overall Study|Medical event|0|||
126400606|NCT00475865|454759665|FG000|Overall Study|Adverse Event|0|||
126400607|NCT00475865|454759666|FG001|Overall Study|Adverse Event|3|||
126400608|NCT00475865|454759667|FG002|Overall Study|Adverse Event|4|||
126400609|NCT00475865|454759665|FG000|Overall Study|Lack of Efficacy|1|||
126400610|NCT00475865|454759666|FG001|Overall Study|Lack of Efficacy|0|||
126400611|NCT00475865|454759667|FG002|Overall Study|Lack of Efficacy|0|||
126400612|NCT00475865|454759665|FG000|Overall Study|Progressive disease|0|||
126400613|NCT00475865|454759666|FG001|Overall Study|Progressive disease|1|||
126400614|NCT00475865|454759667|FG002|Overall Study|Progressive disease|2|||
126400615|NCT00475865|454759665|FG000|Overall Study|Participant did not wish to continue|1|||
126400616|NCT00475865|454759666|FG001|Overall Study|Participant did not wish to continue|0|||
126400617|NCT00475865|454759667|FG002|Overall Study|Participant did not wish to continue|0|||
126400618|NCT00475865|454759665|FG000|Overall Study|Other than above|0|||
126400619|NCT00475865|454759666|FG001|Overall Study|Other than above|1|||
126400620|NCT00475865|454759667|FG002|Overall Study|Other than above|0|||
126400621|NCT01498185|454759669|FG000|Overall Study|Adverse Event|0|||
126400622|NCT01498185|454759670|FG001|Overall Study|Adverse Event|0|||
126772284|NCT00996918|456122080|FG001|Overall Study|Lack of Efficacy|1|||
126400623|NCT01498185|454759671|FG002|Overall Study|Adverse Event|0|||
126400624|NCT01498185|454759672|FG003|Overall Study|Adverse Event|1|||
126400625|NCT01498185|454759673|FG004|Overall Study|Adverse Event|0|||
126400626|NCT01498185|454759669|FG000|Overall Study|Withdrawal by Subject|1|||
126400627|NCT01498185|454759670|FG001|Overall Study|Withdrawal by Subject|1|||
126400628|NCT01498185|454759671|FG002|Overall Study|Withdrawal by Subject|0|||
126400629|NCT01498185|454759672|FG003|Overall Study|Withdrawal by Subject|2|||
126400630|NCT01498185|454759673|FG004|Overall Study|Withdrawal by Subject|1|||
126400631|NCT01498185|454759669|FG000|Overall Study|No longer met criteria, etc|0|||
126400632|NCT01498185|454759670|FG001|Overall Study|No longer met criteria, etc|0|||
126400633|NCT01498185|454759671|FG002|Overall Study|No longer met criteria, etc|0|||
126472058|NCT01672736|455028896|FG000|Overall Study|Available drug expired on 31 May 16|3|||
126472059|NCT02853344|455028901|FG000|Overall Study|Lost to Follow-up|1|||
126472060|NCT02853344|455028902|FG001|Overall Study|Lost to Follow-up|1|||
126472061|NCT02853344|455028901|FG000|Overall Study|Withdrawal by Subject|2|||
126472062|NCT02853344|455028902|FG001|Overall Study|Withdrawal by Subject|4|||
126472063|NCT02853344|455028901|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
126472064|NCT02853344|455028902|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
126472065|NCT02853344|455028901|FG000|Overall Study|Death|70|||
126472066|NCT02853344|455028902|FG001|Overall Study|Death|112|||
126472067|NCT02913612|455028903|FG000|Overall Study|Lost to Follow-up|6|||
126400634|NCT01498185|454759672|FG003|Overall Study|No longer met criteria, etc|0|||
126400635|NCT01498185|454759673|FG004|Overall Study|No longer met criteria, etc|2|||
126400636|NCT00946322|454759674|FG000|Pre-treatment|participant failure to follow up|1|||
126400637|NCT00946322|454759674|FG000|Post-treatment|participant failure to follow up|2|||
126400638|NCT01453946|454759675|FG000|Overall Study|Did not receive drug for the taper phase|1|||
126400639|NCT01453946|454759675|FG000|Overall Study|Protocol Violation|2|||
126400640|NCT01453946|454759675|FG000|Overall Study|Lack of Efficacy|3|||
126400641|NCT01453946|454759675|FG000|Overall Study|Adverse Event|3|||
126400642|NCT02153346|454759676|FG000|Overall Study|Lost to Follow-up|11|||
126400643|NCT00846040|454759677|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
126400644|NCT00846040|454759678|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
126400645|NCT00846040|454759679|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
126400646|NCT00846040|454759677|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
126400647|NCT00846040|454759678|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
126400648|NCT00846040|454759679|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
126400649|NCT03158272|454759683|FG000|Overall Study|Disease progression|3|||
126400650|NCT03158272|454759684|FG001|Overall Study|Disease progression|3|||
126400651|NCT03158272|454759685|FG002|Overall Study|Disease progression|4|||
126400652|NCT03158272|454759686|FG003|Overall Study|Disease progression|6|||
126400653|NCT03158272|454759683|FG000|Overall Study|Death|0|||
126400654|NCT03158272|454759684|FG001|Overall Study|Death|0|||
126400655|NCT03158272|454759685|FG002|Overall Study|Death|1|||
126400656|NCT03158272|454759686|FG003|Overall Study|Death|0|||
126400657|NCT03158272|454759683|FG000|Overall Study|Other reasons|0|||
126400658|NCT03158272|454759684|FG001|Overall Study|Other reasons|0|||
126400659|NCT03158272|454759685|FG002|Overall Study|Other reasons|1|||
126400660|NCT03158272|454759686|FG003|Overall Study|Other reasons|0|||
126400661|NCT03158272|454759683|FG000|Overall Study|Adverse event unrelated to the drug|0|||
126400662|NCT03158272|454759684|FG001|Overall Study|Adverse event unrelated to the drug|1|||
126400663|NCT03158272|454759685|FG002|Overall Study|Adverse event unrelated to the drug|0|||
126400664|NCT03158272|454759686|FG003|Overall Study|Adverse event unrelated to the drug|0|||
126400665|NCT01822535|454759687|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
126400666|NCT01822535|454759688|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
126400667|NCT01822535|454759687|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
126400668|NCT01822535|454759688|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
126400669|NCT01822535|454759687|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
126400670|NCT01822535|454759688|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
126400671|NCT02278614|454759691|FG000|Overall Study|Withdrawal by Subject|3|||
126400672|NCT02278614|454759692|FG001|Overall Study|Withdrawal by Subject|5|||
126400673|NCT02278614|454759691|FG000|Overall Study|Adverse Event|1|||
126400674|NCT02278614|454759692|FG001|Overall Study|Adverse Event|0|||
126472068|NCT02913612|455028904|FG001|Overall Study|Lost to Follow-up|5|||
126472069|NCT02913612|455028905|FG002|Overall Study|Lost to Follow-up|2|||
126472070|NCT02913612|455028906|FG003|Overall Study|Lost to Follow-up|0|||
126472071|NCT02913612|455028903|FG000|Overall Study|Physician Decision|1|||
126472072|NCT02913612|455028904|FG001|Overall Study|Physician Decision|4|||
126721212|NCT01912768|455928597|FG000|Overall Study|Randomized in error|1|||
126400675|NCT02278614|454759691|FG000|Overall Study|left eye was not eligible|1|||
126472073|NCT02913612|455028905|FG002|Overall Study|Physician Decision|1|||
126400676|NCT02278614|454759692|FG001|Overall Study|left eye was not eligible|0|||
126400677|NCT03582813|454759695|FG000|Overall Study|Lost to Follow-up|18|||
126400678|NCT03582813|454759696|FG001|Overall Study|Lost to Follow-up|21|||
126400679|NCT03582813|454759695|FG000|Overall Study|Withdrawal by Subject|1|||
126400680|NCT03582813|454759696|FG001|Overall Study|Withdrawal by Subject|0|||
126400681|NCT02366767|454759699|FG000|Overall Study|left for home after 1 day at camp|1|||
126472074|NCT02913612|455028906|FG003|Overall Study|Physician Decision|0|||
126400682|NCT02366767|454759700|FG001|Overall Study|left for home after 1 day at camp|0|||
126400683|NCT02558400|454759703|FG000|Overall Study|Adverse Event|47|||
126400684|NCT02558400|454759704|FG001|Overall Study|Adverse Event|53|||
126400685|NCT02558400|454759705|FG002|Overall Study|Adverse Event|4|||
126400686|NCT02558400|454759703|FG000|Overall Study|Withdrawal by Subject|13|||
126400687|NCT02558400|454759704|FG001|Overall Study|Withdrawal by Subject|9|||
126400688|NCT02558400|454759705|FG002|Overall Study|Withdrawal by Subject|8|||
126400689|NCT02558400|454759703|FG000|Overall Study|Non-Compliant|0|||
126400690|NCT02558400|454759704|FG001|Overall Study|Non-Compliant|1|||
126400691|NCT02558400|454759705|FG002|Overall Study|Non-Compliant|3|||
126400692|NCT02558400|454759703|FG000|Overall Study|Lost to Follow-up|5|||
126400693|NCT02558400|454759704|FG001|Overall Study|Lost to Follow-up|5|||
126400694|NCT02558400|454759705|FG002|Overall Study|Lost to Follow-up|4|||
126400695|NCT02558400|454759703|FG000|Overall Study|Lack of Efficacy|0|||
126400696|NCT02558400|454759704|FG001|Overall Study|Lack of Efficacy|13|||
126400697|NCT02558400|454759705|FG002|Overall Study|Lack of Efficacy|1|||
126400698|NCT02558400|454759703|FG000|Overall Study|Disallowed Concurrent Medication|6|||
126400699|NCT02558400|454759704|FG001|Overall Study|Disallowed Concurrent Medication|7|||
126400700|NCT02558400|454759705|FG002|Overall Study|Disallowed Concurrent Medication|5|||
126400701|NCT02558400|454759703|FG000|Overall Study|Physician Decision|2|||
126400702|NCT02558400|454759704|FG001|Overall Study|Physician Decision|2|||
126400703|NCT02558400|454759705|FG002|Overall Study|Physician Decision|0|||
126400704|NCT02558400|454759703|FG000|Overall Study|Protocol Violation|6|||
126400705|NCT02558400|454759704|FG001|Overall Study|Protocol Violation|3|||
126400706|NCT02558400|454759705|FG002|Overall Study|Protocol Violation|8|||
126400707|NCT02558400|454759703|FG000|Overall Study|Death|0|||
126400708|NCT02558400|454759704|FG001|Overall Study|Death|1|||
126400709|NCT02558400|454759705|FG002|Overall Study|Death|0|||
126400710|NCT02558400|454759703|FG000|Overall Study|Ineligible for the study|0|||
126400711|NCT02558400|454759704|FG001|Overall Study|Ineligible for the study|2|||
126400712|NCT02558400|454759705|FG002|Overall Study|Ineligible for the study|0|||
126557382|NCT02559817|455332704|FG000|Treatment Period|Lost to Follow-up|0|||
126557383|NCT02559817|455332705|FG001|Treatment Period|Lost to Follow-up|1|||
126557384|NCT02559817|455332706|FG002|Treatment Period|Lost to Follow-up|0|||
126400713|NCT02230683|454759706|FG000|Overall Study|Adverse Event|1|||
126400714|NCT00260065|454759707|FG000|Overall Study|Progressive Disease|22|||
126400715|NCT00260065|454759707|FG000|Overall Study|Adverse Event|17|||
126400716|NCT00260065|454759707|FG000|Overall Study|Death|13|||
126400717|NCT00260065|454759707|FG000|Overall Study|Withdrawal by Subject|13|||
126400718|NCT00260065|454759707|FG000|Overall Study|Physician Decision|19|||
126400719|NCT00260065|454759707|FG000|Overall Study|Not otherwise specified|8|||
126400720|NCT00260065|454759707|FG000|Overall Study|Medication Noncompliance|1|||
126400721|NCT04068519|454759708|FG000|Dose Verification|Death|15|||
126400722|NCT04068519|454759708|FG000|Dose Verification|Withdrawal by Subject|1|||
126400723|NCT04068519|454759708|FG000|Pharmacokinetic Sub-study|Death|35|||
126400724|NCT04068519|454759708|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
126400725|NCT04068519|454759708|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
126400726|NCT04068519|454759708|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
126400727|NCT04068519|454759708|FG000|Indication Expansion|Death|152|||
126400728|NCT04068519|454759708|FG000|Indication Expansion|Withdrawal by Subject|10|||
126400729|NCT04068519|454759708|FG000|Indication Expansion|Lost to Follow-up|7|||
126400730|NCT03959982|454761277|FG000|Overall Study|Withdrawal by Subject|1|||
126400731|NCT03959982|454761278|FG001|Overall Study|Withdrawal by Subject|0|||
126400732|NCT03959982|454761277|FG000|Overall Study|Physician Decision|2|||
126400733|NCT03959982|454761278|FG001|Overall Study|Physician Decision|0|||
126400734|NCT03959982|454761277|FG000|Overall Study|Lost to Follow-up|1|||
126400735|NCT03959982|454761278|FG001|Overall Study|Lost to Follow-up|0|||
126400736|NCT00758589|454761279|FG000|Overall Study|Adverse Event|3|||
126400737|NCT00758589|454761280|FG001|Overall Study|Adverse Event|2|||
126400738|NCT00758589|454761281|FG002|Overall Study|Adverse Event|5|||
126400739|NCT00758589|454761282|FG003|Overall Study|Adverse Event|4|||
126400740|NCT00758589|454761279|FG000|Overall Study|Withdrawal by Subject|0|||
126400741|NCT00758589|454761280|FG001|Overall Study|Withdrawal by Subject|1|||
126557385|NCT02559817|455332707|FG003|Treatment Period|Lost to Follow-up|1|||
126557386|NCT02559817|455332708|FG004|Treatment Period|Lost to Follow-up|0|||
126400742|NCT00758589|454761281|FG002|Overall Study|Withdrawal by Subject|1|||
126400743|NCT00758589|454761282|FG003|Overall Study|Withdrawal by Subject|1|||
126400744|NCT00758589|454761279|FG000|Overall Study|Palm stopped to work|0|||
126400745|NCT00758589|454761280|FG001|Overall Study|Palm stopped to work|0|||
126400746|NCT00758589|454761281|FG002|Overall Study|Palm stopped to work|0|||
126400747|NCT00758589|454761282|FG003|Overall Study|Palm stopped to work|1|||
126400748|NCT04639219|454761291|FG000|Overall Study|Withdrawal by Subject|8|||
126400749|NCT04639219|454761291|FG000|Overall Study|Lost to Follow-up|6|||
126400750|NCT04639219|454761291|FG000|Overall Study|Death|55|||
126400751|NCT03554772|454761296|FG000|Overall Study|Lost to Follow-up|0|||
126557387|NCT02559817|455332704|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
126400752|NCT03554772|454761297|FG001|Overall Study|Lost to Follow-up|0|||
126400753|NCT03554772|454761298|FG002|Overall Study|Lost to Follow-up|0|||
126400754|NCT03554772|454761299|FG003|Overall Study|Lost to Follow-up|2|||
126400755|NCT05136898|454761300|FG000|Overall Study|Adverse Event|2|||
126400756|NCT03784846|454761301|FG000|Pre-COVID Study|Lost to Follow-up|3|||
126400757|NCT03784846|454761302|FG001|Pre-COVID Study|Lost to Follow-up|3|||
126400758|NCT03784846|454761303|FG002|Pre-COVID Study|Lost to Follow-up|2|||
126400759|NCT03784846|454761301|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
126400760|NCT03784846|454761302|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
126400761|NCT03784846|454761303|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
126400762|NCT03784846|454761301|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
126400763|NCT03784846|454761302|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
126400764|NCT03784846|454761303|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
126400765|NCT03784846|454761301|FG000|Post-COVID Study|Lost to Follow-up|3|||
126400766|NCT03784846|454761302|FG001|Post-COVID Study|Lost to Follow-up|5|||
126400767|NCT03784846|454761303|FG002|Post-COVID Study|Lost to Follow-up|1|||
126400768|NCT03784846|454761301|FG000|Post-COVID Study|Withdrawal by Subject|1|||
126400769|NCT03784846|454761302|FG001|Post-COVID Study|Withdrawal by Subject|2|||
126400770|NCT03784846|454761303|FG002|Post-COVID Study|Withdrawal by Subject|0|||
126400771|NCT00867087|454761304|FG000|Overall Study|Other|1|||
126400772|NCT00867087|454761304|FG000|Overall Study|Withdrawal by Subject|4|||
126400773|NCT00867087|454761304|FG000|Overall Study|Death|37|||
126400774|NCT02088073|454761306|FG000|Acute Phase|Withdrawal by Subject|5|||
126400775|NCT02088073|454761307|FG001|Acute Phase|Withdrawal by Subject|0|||
126400776|NCT02088073|454761308|FG002|Acute Phase|Withdrawal by Subject|0|||
126400777|NCT02088073|454761309|FG003|Acute Phase|Withdrawal by Subject|0|||
126400778|NCT02088073|454761310|FG004|Acute Phase|Withdrawal by Subject|0|||
126400779|NCT02088073|454761306|FG000|Acute Phase|Hyperkalemia|2|||
126400780|NCT02088073|454761307|FG001|Acute Phase|Hyperkalemia|0|||
126400781|NCT02088073|454761308|FG002|Acute Phase|Hyperkalemia|0|||
126400782|NCT02088073|454761309|FG003|Acute Phase|Hyperkalemia|0|||
126400783|NCT02088073|454761310|FG004|Acute Phase|Hyperkalemia|0|||
126400784|NCT02088073|454761306|FG000|Maintanance Phase|Withdrawal by Subject|0|||
126400785|NCT02088073|454761307|FG001|Maintanance Phase|Withdrawal by Subject|2|||
126400786|NCT02088073|454761308|FG002|Maintanance Phase|Withdrawal by Subject|0|||
126400787|NCT02088073|454761309|FG003|Maintanance Phase|Withdrawal by Subject|0|||
126400788|NCT02088073|454761310|FG004|Maintanance Phase|Withdrawal by Subject|0|||
126400789|NCT02088073|454761306|FG000|Maintanance Phase|Adverse Event|0|||
126400790|NCT02088073|454761307|FG001|Maintanance Phase|Adverse Event|0|||
126400791|NCT02088073|454761308|FG002|Maintanance Phase|Adverse Event|3|||
126400792|NCT02088073|454761309|FG003|Maintanance Phase|Adverse Event|0|||
126400793|NCT02088073|454761310|FG004|Maintanance Phase|Adverse Event|1|||
126400794|NCT02088073|454761306|FG000|Maintanance Phase|Physician Decision|0|||
126400795|NCT02088073|454761307|FG001|Maintanance Phase|Physician Decision|0|||
126400796|NCT02088073|454761308|FG002|Maintanance Phase|Physician Decision|0|||
126400797|NCT02088073|454761309|FG003|Maintanance Phase|Physician Decision|0|||
126400798|NCT02088073|454761310|FG004|Maintanance Phase|Physician Decision|1|||
126400799|NCT02088073|454761306|FG000|Maintanance Phase|Sponsor's decision|0|||
126400800|NCT02088073|454761307|FG001|Maintanance Phase|Sponsor's decision|2|||
126400801|NCT02088073|454761308|FG002|Maintanance Phase|Sponsor's decision|0|||
126400802|NCT02088073|454761309|FG003|Maintanance Phase|Sponsor's decision|2|||
126400803|NCT02088073|454761310|FG004|Maintanance Phase|Sponsor's decision|1|||
126400804|NCT02088073|454761306|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
126400805|NCT02088073|454761307|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
126400806|NCT02088073|454761308|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
126400807|NCT02088073|454761309|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
126400808|NCT02088073|454761310|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
126400809|NCT02088073|454761306|FG000|Maintanance Phase|Miscellaneous|0|||
126400810|NCT02088073|454761307|FG001|Maintanance Phase|Miscellaneous|2|||
126472075|NCT02913612|455028903|FG000|Overall Study|Withdrawal by Subject|2|||
126472076|NCT02913612|455028904|FG001|Overall Study|Withdrawal by Subject|4|||
126400811|NCT02088073|454761308|FG002|Maintanance Phase|Miscellaneous|1|||
126472077|NCT02913612|455028905|FG002|Overall Study|Withdrawal by Subject|0|||
126400812|NCT02088073|454761309|FG003|Maintanance Phase|Miscellaneous|2|||
126400813|NCT02088073|454761310|FG004|Maintanance Phase|Miscellaneous|1|||
126400814|NCT02088073|454761306|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
126400815|NCT02088073|454761307|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
126400816|NCT02088073|454761308|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
126400817|NCT02088073|454761309|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
126400818|NCT02088073|454761310|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
126400819|NCT02088073|454761306|FG000|Maintanance Phase|Subject compliance|0|||
126400820|NCT02088073|454761307|FG001|Maintanance Phase|Subject compliance|1|||
126472078|NCT02913612|455028906|FG003|Overall Study|Withdrawal by Subject|0|||
126472079|NCT02913612|455028903|FG000|Overall Study|Hemangioma resolved|1|||
126472080|NCT02913612|455028904|FG001|Overall Study|Hemangioma resolved|0|||
126472081|NCT02913612|455028905|FG002|Overall Study|Hemangioma resolved|0|||
126472082|NCT02913612|455028906|FG003|Overall Study|Hemangioma resolved|0|||
126472083|NCT02913612|455028903|FG000|Overall Study|Local IRB decision|1|||
126472084|NCT02913612|455028904|FG001|Overall Study|Local IRB decision|0|||
126400821|NCT02088073|454761308|FG002|Maintanance Phase|Subject compliance|0|||
126400822|NCT02088073|454761309|FG003|Maintanance Phase|Subject compliance|0|||
126400823|NCT02088073|454761310|FG004|Maintanance Phase|Subject compliance|0|||
126400824|NCT00241631|454761311|FG000|Run in (2 Weeks)|Physician Decision|3|||
126400825|NCT00241631|454761312|FG001|Run in (2 Weeks)|Physician Decision|3|||
126400826|NCT00241631|454761311|FG000|Phase 1 (4 Weeks)|sore throat|1|||
126400827|NCT00241631|454761312|FG001|Phase 1 (4 Weeks)|sore throat|0|||
126400828|NCT00241631|454761311|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
126400829|NCT00241631|454761312|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
126400830|NCT00241631|454761311|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
126400831|NCT00241631|454761312|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
126400832|NCT00241631|454761311|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
126400833|NCT00241631|454761312|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
126400834|NCT03883113|454761313|FG000|Overall Study|Physician Decision|4|||
126400835|NCT03883113|454761314|FG001|Overall Study|Physician Decision|2|||
126400836|NCT03883113|454761313|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
126400837|NCT03883113|454761314|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
126400838|NCT03883113|454761313|FG000|Overall Study|Pregnancy|1|||
126400839|NCT03883113|454761314|FG001|Overall Study|Pregnancy|0|||
126400840|NCT03883113|454761313|FG000|Overall Study|Adverse Event|0|||
126400841|NCT03883113|454761314|FG001|Overall Study|Adverse Event|1|||
126400842|NCT03883113|454761313|FG000|Overall Study|Withdrawal by Subject|1|||
126400843|NCT03883113|454761314|FG001|Overall Study|Withdrawal by Subject|2|||
126400844|NCT03883113|454761313|FG000|Overall Study|Lost to Follow-up|1|||
126400845|NCT03883113|454761314|FG001|Overall Study|Lost to Follow-up|0|||
126400846|NCT01457950|454761322|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
126400847|NCT01457950|454761323|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
126400848|NCT01457950|454761324|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
126400849|NCT01457950|454761325|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
126400850|NCT01457950|454761322|FG000|Double-Blind Phase|Protocol Violation|2|||
126400851|NCT01457950|454761323|FG001|Double-Blind Phase|Protocol Violation|1|||
126400852|NCT01457950|454761324|FG002|Double-Blind Phase|Protocol Violation|0|||
126400853|NCT01457950|454761325|FG003|Double-Blind Phase|Protocol Violation|0|||
126400854|NCT01457950|454761322|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
126400855|NCT01457950|454761323|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
126400856|NCT01457950|454761324|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
126400857|NCT01457950|454761325|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
126400858|NCT01457950|454761322|FG000|Open-Label Phase|Adverse Event|0|||
126400859|NCT01457950|454761323|FG001|Open-Label Phase|Adverse Event|0|||
126400860|NCT01457950|454761324|FG002|Open-Label Phase|Adverse Event|0|||
126400861|NCT01457950|454761325|FG003|Open-Label Phase|Adverse Event|1|||
126400862|NCT01457950|454761322|FG000|Open-Label Phase|Protocol Violation|0|||
126400863|NCT01457950|454761323|FG001|Open-Label Phase|Protocol Violation|0|||
126400864|NCT01457950|454761324|FG002|Open-Label Phase|Protocol Violation|0|||
126400865|NCT01457950|454761325|FG003|Open-Label Phase|Protocol Violation|1|||
126400866|NCT01457950|454761322|FG000|Open-Label Phase|Withdrawal by Subject|0|||
126400867|NCT01457950|454761323|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126400868|NCT01457950|454761324|FG002|Open-Label Phase|Withdrawal by Subject|2|||
126400869|NCT01457950|454761325|FG003|Open-Label Phase|Withdrawal by Subject|0|||
126400870|NCT00435162|454761326|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
126400871|NCT00435162|454761327|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
126400872|NCT00435162|454761328|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
126400873|NCT00435162|454761329|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
126400874|NCT00435162|454761330|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
126472085|NCT02913612|455028905|FG002|Overall Study|Local IRB decision|0|||
126472086|NCT02913612|455028906|FG003|Overall Study|Local IRB decision|0|||
126472087|NCT02913612|455028903|FG000|Overall Study|Study drug non-compliance|1|||
126472088|NCT02913612|455028904|FG001|Overall Study|Study drug non-compliance|1|||
126472089|NCT02913612|455028905|FG002|Overall Study|Study drug non-compliance|0|||
126472090|NCT02913612|455028906|FG003|Overall Study|Study drug non-compliance|0|||
126472091|NCT02913612|455028903|FG000|Overall Study|Insurance issues|0|||
126472092|NCT02913612|455028904|FG001|Overall Study|Insurance issues|1|||
126472093|NCT02913612|455028905|FG002|Overall Study|Insurance issues|0|||
126400875|NCT00435162|454761331|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
126400876|NCT03351114|454761332|FG000|Overall Study|Withdrawal by Subject|1|||
126400877|NCT01665430|454761333|FG000|Overall Study|Adverse Event|1|||
126400878|NCT01665430|454761333|FG000|Overall Study|Withdrawal by Subject|6|||
126400879|NCT01665430|454761333|FG000|Overall Study|Other Unspecified|2|||
126400880|NCT02310230|454761334|FG000|Overall Study|Physician Decision|1|||
126400881|NCT02310230|454761335|FG001|Overall Study|Physician Decision|3|||
126400882|NCT02310230|454761334|FG000|Overall Study|monitor baseline taken after induction|2|||
126400883|NCT02310230|454761335|FG001|Overall Study|monitor baseline taken after induction|7|||
126400884|NCT02310230|454761334|FG000|Overall Study|Poor signal quality|5|||
126400885|NCT02310230|454761335|FG001|Overall Study|Poor signal quality|8|||
126400886|NCT02310230|454761334|FG000|Overall Study|Case cancelled|1|||
126400887|NCT02310230|454761335|FG001|Overall Study|Case cancelled|0|||
126400888|NCT01371643|454761336|FG000|Overall Study|Withdrawal by Subject|3|||
126772285|NCT00996918|456122081|FG002|Overall Study|Lack of Efficacy|2|||
126400889|NCT01371643|454761337|FG001|Overall Study|Withdrawal by Subject|0|||
126400890|NCT03249935|454761338|FG000|Overall Study|Discharged from facility early|36|||
126400891|NCT03249935|454761338|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
126400892|NCT03249935|454761338|FG000|Overall Study|Protocol Violation|5|||
126400893|NCT03593681|454761341|FG000|Overall Study|Inadequate sample collected|12|||
126400894|NCT03593681|454761341|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
126400895|NCT03593681|454761341|FG000|Overall Study|Protocol Violation|3|||
126400896|NCT03593681|454761341|FG000|Overall Study|Withdrawal by Subject|3|||
126400897|NCT03593681|454761341|FG000|Overall Study|Procedure not attempted|3|||
126400898|NCT03593681|454761341|FG000|Overall Study|Adverse Event|2|||
126400899|NCT03593681|454761341|FG000|Overall Study|Physician Decision|1|||
126400900|NCT03987932|454761346|FG000|Overall Study|Lost to Follow-up|2|||
126400901|NCT03987932|454761347|FG001|Overall Study|Lost to Follow-up|1|||
126400902|NCT03987932|454761348|FG002|Overall Study|Lost to Follow-up|1|||
126400903|NCT03987932|454761346|FG000|Overall Study|Non-study related elective surgery|0|||
126400904|NCT03987932|454761347|FG001|Overall Study|Non-study related elective surgery|0|||
126400905|NCT03987932|454761348|FG002|Overall Study|Non-study related elective surgery|1|||
126400906|NCT01669421|454761349|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
126400907|NCT01669421|454761349|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
126400908|NCT01561755|454761357|FG000|Overall Study|Lost to Follow-up|0|||
126400909|NCT01561755|454761358|FG001|Overall Study|Lost to Follow-up|1|||
126400910|NCT04662073|454761360|FG000|Overall Study|Withdrawal by Subject|1|||
126400911|NCT04662073|454761361|FG001|Overall Study|Withdrawal by Subject|0|||
126400912|NCT02961790|454761362|FG000|Overall Study|Canceled|4|||
126400913|NCT02961790|454761363|FG001|Overall Study|Canceled|5|||
126400914|NCT02961790|454761364|FG002|Overall Study|Canceled|1|||
126400915|NCT02961790|454761365|FG003|Overall Study|Canceled|4|||
126400916|NCT02961790|454761362|FG000|Overall Study|without baseline data|4|||
126400917|NCT02961790|454761363|FG001|Overall Study|without baseline data|0|||
126400918|NCT02961790|454761364|FG002|Overall Study|without baseline data|1|||
126400919|NCT02961790|454761365|FG003|Overall Study|without baseline data|0|||
126400920|NCT02961790|454761362|FG000|Overall Study|without post baseline data|7|||
126400921|NCT02961790|454761363|FG001|Overall Study|without post baseline data|6|||
126400922|NCT02961790|454761364|FG002|Overall Study|without post baseline data|4|||
126400923|NCT02961790|454761365|FG003|Overall Study|without post baseline data|1|||
126400924|NCT02185014|454761366|FG000|Overall Study|Adverse Event|18|||
126400925|NCT02185014|454761366|FG000|Overall Study|Withdrew Consent|8|||
126400926|NCT02185014|454761366|FG000|Overall Study|Lost to Follow-up|4|||
126400927|NCT02185014|454761366|FG000|Overall Study|Lack of Efficacy|14|||
126400928|NCT02185014|454761366|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
126400929|NCT02185014|454761366|FG000|Overall Study|Subject Noncompliance|1|||
126400930|NCT02185014|454761366|FG000|Overall Study|Other|4|||
126400931|NCT01479595|454761373|FG000|Overall Study|Protocol deviation|0|||
126400932|NCT01479595|454761374|FG001|Overall Study|Protocol deviation|1|||
126472094|NCT02913612|455028906|FG003|Overall Study|Insurance issues|0|||
126472095|NCT02913612|455028903|FG000|Overall Study|Needed to treat second hemangioma|0|||
126472096|NCT02913612|455028904|FG001|Overall Study|Needed to treat second hemangioma|1|||
126472097|NCT02913612|455028905|FG002|Overall Study|Needed to treat second hemangioma|0|||
126472098|NCT02913612|455028906|FG003|Overall Study|Needed to treat second hemangioma|0|||
126472099|NCT02913612|455028903|FG000|Overall Study|Study completion criteria not met|0|||
126400933|NCT01479595|454761373|FG000|Overall Study|Adverse Event|2|||
126400934|NCT01479595|454761374|FG001|Overall Study|Adverse Event|1|||
126400935|NCT02370641|454761375|FG000|Overall Study|dropped study|4|||
126400936|NCT02370641|454761376|FG001|Overall Study|dropped study|2|||
126400937|NCT02255565|454761381|FG000|Overall Study|Withdrawal by Subject|0|||
126400938|NCT02255565|454761382|FG001|Overall Study|Withdrawal by Subject|1|||
126400939|NCT02255565|454761383|FG002|Overall Study|Withdrawal by Subject|0|||
126400940|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
126400941|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
126400942|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
126400943|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
126400944|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
126472100|NCT02913612|455028904|FG001|Overall Study|Study completion criteria not met|1|||
126472101|NCT02913612|455028905|FG002|Overall Study|Study completion criteria not met|0|||
126472102|NCT02913612|455028906|FG003|Overall Study|Study completion criteria not met|0|||
126472103|NCT02913612|455028903|FG000|Overall Study|Ineligible|0|||
126472104|NCT02913612|455028904|FG001|Overall Study|Ineligible|1|||
126472105|NCT02913612|455028905|FG002|Overall Study|Ineligible|0|||
126472106|NCT02913612|455028906|FG003|Overall Study|Ineligible|0|||
126472107|NCT03452228|455028909|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
126472108|NCT03452228|455028910|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
126472109|NCT03452228|455028911|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
126472110|NCT03452228|455028909|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
126400945|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
126400946|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
126400947|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
126400948|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
126400949|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
126400950|NCT03906656|454761384|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
126400951|NCT03906656|454761385|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
126400952|NCT03906656|454761384|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
126400953|NCT03906656|454761385|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
126400954|NCT03906656|454761384|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
126400955|NCT03906656|454761385|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
126400956|NCT03906656|454761384|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
126400957|NCT03906656|454761385|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
126557388|NCT02559817|455332705|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
126557389|NCT02559817|455332706|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
126557390|NCT02559817|455332707|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
126557391|NCT02559817|455332708|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
126557392|NCT02559817|455332704|FG000|Treatment Period|Protocol Violation|0|||
126557393|NCT02559817|455332705|FG001|Treatment Period|Protocol Violation|0|||
126557394|NCT02559817|455332706|FG002|Treatment Period|Protocol Violation|0|||
126400958|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
126400959|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
126400960|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
126400961|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
126400962|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
126400963|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
126400964|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
126400965|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
126400966|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
126400967|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
126400968|NCT03906656|454761384|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
126400969|NCT03906656|454761385|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
126400970|NCT03906656|454761384|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
126400971|NCT03906656|454761385|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
126400972|NCT03906656|454761384|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
126400973|NCT03906656|454761385|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
126400974|NCT03906656|454761384|FG000|Home Use 2 (3 Months)|Death|2|||
126400975|NCT03906656|454761385|FG001|Home Use 2 (3 Months)|Death|0|||
126400976|NCT03906656|454761384|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
126400977|NCT03906656|454761385|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
126400978|NCT03906656|454761384|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
126400979|NCT03906656|454761385|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
126400980|NCT00343915|454761386|FG000|Primary Study|Withdrawal by Subject|1|||
126400981|NCT00343915|454761387|FG001|Primary Study|Withdrawal by Subject|0|||
126400982|NCT00343915|454761386|FG000|Primary Study|Lost to Follow-up|2|||
126400983|NCT00343915|454761387|FG001|Primary Study|Lost to Follow-up|3|||
126400984|NCT00343915|454761386|FG000|Primary Study|Other|1|||
126400985|NCT00343915|454761387|FG001|Primary Study|Other|0|||
126400986|NCT00882908|454761388|FG000|Overall Study|Adverse Event|0|||
126400987|NCT00882908|454761389|FG001|Overall Study|Adverse Event|0|||
126400988|NCT00882908|454761390|FG002|Overall Study|Adverse Event|1|||
126400989|NCT00882908|454761391|FG003|Overall Study|Adverse Event|0|||
126400990|NCT00882908|454761392|FG004|Overall Study|Adverse Event|1|||
126400991|NCT00882908|454761388|FG000|Overall Study|Lost to Follow-up|3|||
126400992|NCT00882908|454761389|FG001|Overall Study|Lost to Follow-up|5|||
126400993|NCT00882908|454761390|FG002|Overall Study|Lost to Follow-up|3|||
126400994|NCT00882908|454761391|FG003|Overall Study|Lost to Follow-up|1|||
126400995|NCT00882908|454761392|FG004|Overall Study|Lost to Follow-up|2|||
126400996|NCT00882908|454761388|FG000|Overall Study|Protocol Violation|0|||
126400997|NCT00882908|454761389|FG001|Overall Study|Protocol Violation|1|||
126400998|NCT00882908|454761390|FG002|Overall Study|Protocol Violation|0|||
126400999|NCT00882908|454761391|FG003|Overall Study|Protocol Violation|0|||
126401000|NCT00882908|454761392|FG004|Overall Study|Protocol Violation|0|||
126401001|NCT00882908|454761388|FG000|Overall Study|Withdrawal by Subject|0|||
126401002|NCT00882908|454761389|FG001|Overall Study|Withdrawal by Subject|0|||
126401003|NCT00882908|454761390|FG002|Overall Study|Withdrawal by Subject|3|||
126401004|NCT00882908|454761391|FG003|Overall Study|Withdrawal by Subject|5|||
126401005|NCT00882908|454761392|FG004|Overall Study|Withdrawal by Subject|2|||
126401006|NCT00882908|454761388|FG000|Overall Study|Subject reached a virologic endpoint|0|||
126401007|NCT00882908|454761389|FG001|Overall Study|Subject reached a virologic endpoint|0|||
126401008|NCT00882908|454761390|FG002|Overall Study|Subject reached a virologic endpoint|0|||
126401009|NCT00882908|454761391|FG003|Overall Study|Subject reached a virologic endpoint|0|||
126557395|NCT02559817|455332707|FG003|Treatment Period|Protocol Violation|1|||
126557396|NCT02559817|455332708|FG004|Treatment Period|Protocol Violation|0|||
126557397|NCT01925170|455332710|FG000|Overall Study|Unverified cancer status|53|||
126557398|NCT00577720|455332711|FG000|Overall Study|Adverse Event|2|||
126557399|NCT00577720|455332712|FG001|Overall Study|Adverse Event|1|||
126557400|NCT00577720|455332713|FG002|Overall Study|Adverse Event|0|||
126557401|NCT00577720|455332714|FG003|Overall Study|Adverse Event|4|||
126557402|NCT00577720|455332711|FG000|Overall Study|Lost to Follow-up|0|||
126557403|NCT00577720|455332712|FG001|Overall Study|Lost to Follow-up|0|||
126557404|NCT00577720|455332713|FG002|Overall Study|Lost to Follow-up|1|||
126557405|NCT00577720|455332714|FG003|Overall Study|Lost to Follow-up|0|||
126557406|NCT00577720|455332711|FG000|Overall Study|Protocol Violation|0|||
126557407|NCT00577720|455332712|FG001|Overall Study|Protocol Violation|0|||
126557408|NCT00577720|455332713|FG002|Overall Study|Protocol Violation|0|||
126557409|NCT00577720|455332714|FG003|Overall Study|Protocol Violation|1|||
126557410|NCT00577720|455332711|FG000|Overall Study|Withdrawal by Subject|2|||
126557411|NCT00577720|455332712|FG001|Overall Study|Withdrawal by Subject|0|||
126557412|NCT00577720|455332713|FG002|Overall Study|Withdrawal by Subject|0|||
126557413|NCT00577720|455332714|FG003|Overall Study|Withdrawal by Subject|2|||
126557414|NCT02839681|455332715|FG000|Overall Study|Death|2|||
126557415|NCT00772928|455332716|FG000|Overall Study|Lost to Follow-up|9|||
126401010|NCT00882908|454761392|FG004|Overall Study|Subject reached a virologic endpoint|1|||
126401011|NCT00882908|454761388|FG000|Overall Study|Study terminated in error|0|||
126401012|NCT00882908|454761389|FG001|Overall Study|Study terminated in error|0|||
126401013|NCT00882908|454761390|FG002|Overall Study|Study terminated in error|0|||
126401014|NCT00882908|454761391|FG003|Overall Study|Study terminated in error|1|||
126401015|NCT00882908|454761392|FG004|Overall Study|Study terminated in error|0|||
126401016|NCT05291936|454761393|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
126401017|NCT05291936|454761394|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
126401018|NCT05291936|454761393|FG000|Period 1|Withdrew Consent during study|1|||
126401019|NCT05291936|454761394|FG001|Period 1|Withdrew Consent during study|0|||
126401020|NCT05291936|454761393|FG000|Period 2|Adverse Event|0|||
126401021|NCT05291936|454761394|FG001|Period 2|Adverse Event|1|||
126401022|NCT05291936|454761393|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
126401023|NCT05291936|454761394|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
126401024|NCT02370095|454761395|FG000|Overall Study|Withdrawal by Subject|0|||
126401025|NCT02370095|454761396|FG001|Overall Study|Withdrawal by Subject|1|||
126401026|NCT01667562|454761400|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
126401027|NCT01667562|454761401|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
126401028|NCT01667562|454761400|FG000|Erlotinib Phase|Lost to Follow-up|0|||
126401029|NCT01667562|454761401|FG001|Erlotinib Phase|Lost to Follow-up|1|||
126401030|NCT01667562|454761400|FG000|Erlotinib Phase|Adverse Event|0|||
126401031|NCT01667562|454761401|FG001|Erlotinib Phase|Adverse Event|1|||
126401032|NCT01667562|454761400|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
126401033|NCT01667562|454761401|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
126401034|NCT02130986|454761402|FG000|Overall Study|Withdrawal by Subject|4|||
126401035|NCT02130986|454761403|FG001|Overall Study|Withdrawal by Subject|4|||
126401036|NCT02130986|454761402|FG000|Overall Study|Lost to Follow-up|151|||
126401037|NCT02130986|454761403|FG001|Overall Study|Lost to Follow-up|160|||
126401038|NCT01129882|454761404|FG000|Overall Study|Adverse Event|39|||
126401039|NCT01129882|454761404|FG000|Overall Study|Death|6|||
126401040|NCT01129882|454761404|FG000|Overall Study|Lack of Efficacy|5|||
126401041|NCT01129882|454761404|FG000|Overall Study|Lost to Follow-up|13|||
126401042|NCT01129882|454761404|FG000|Overall Study|Physician Decision|27|||
126401043|NCT01129882|454761404|FG000|Overall Study|Protocol Deviation|3|||
126401044|NCT01129882|454761404|FG000|Overall Study|Withdrawal Criteria Met|19|||
126401045|NCT01129882|454761404|FG000|Overall Study|Trial Termination by Sponsor|6|||
126401046|NCT01129882|454761404|FG000|Overall Study|Withdrawal by Subject|160|||
126401047|NCT00993499|454761408|FG000|Run-in Period (8 Days)|Adverse Event|0|||
126401048|NCT00993499|454761409|FG001|Run-in Period (8 Days)|Adverse Event|1|||
126401049|NCT00993499|454761410|FG002|Run-in Period (8 Days)|Adverse Event|0|||
126401050|NCT00993499|454761411|FG003|Run-in Period (8 Days)|Adverse Event|0|||
126401051|NCT00993499|454761412|FG004|Run-in Period (8 Days)|Adverse Event|0|||
126401052|NCT00993499|454761413|FG005|Run-in Period (8 Days)|Adverse Event|0|||
126401053|NCT00993499|454761408|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
126557416|NCT00772928|455332717|FG001|Overall Study|Lost to Follow-up|6|||
126401054|NCT00993499|454761409|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
126401055|NCT00993499|454761410|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
126401056|NCT00993499|454761411|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
126401057|NCT00993499|454761412|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
126557417|NCT00772928|455332716|FG000|Overall Study|Protocol Violation|10|||
126557418|NCT00772928|455332717|FG001|Overall Study|Protocol Violation|12|||
126557419|NCT00772928|455332716|FG000|Overall Study|Withdrawal by Subject|25|||
126557420|NCT00772928|455332717|FG001|Overall Study|Withdrawal by Subject|22|||
126557421|NCT00772928|455332716|FG000|Overall Study|Did not receive vaccine|0|||
126557422|NCT00772928|455332717|FG001|Overall Study|Did not receive vaccine|1|||
126557423|NCT03100838|455332718|FG000|Overall Study|Adverse Event|1|||
126557424|NCT03100838|455332719|FG001|Overall Study|Adverse Event|0|||
126557425|NCT03100838|455332720|FG002|Overall Study|Adverse Event|0|||
126557426|NCT03100838|455332721|FG003|Overall Study|Adverse Event|0|||
126557427|NCT03100838|455332718|FG000|Overall Study|Physician Decision|1|||
126557428|NCT03100838|455332719|FG001|Overall Study|Physician Decision|1|||
126557429|NCT03100838|455332720|FG002|Overall Study|Physician Decision|1|||
126401058|NCT00993499|454761413|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
126401059|NCT00993499|454761408|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
126401060|NCT00993499|454761409|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
126401061|NCT00993499|454761410|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
126401062|NCT00993499|454761411|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
126401063|NCT00993499|454761412|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
126401064|NCT00993499|454761413|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
126401065|NCT00993499|454761408|FG000|Run-in Period (8 Days)|Progressive disease|0|||
126401066|NCT00993499|454761409|FG001|Run-in Period (8 Days)|Progressive disease|1|||
126401067|NCT00993499|454761410|FG002|Run-in Period (8 Days)|Progressive disease|1|||
126401068|NCT00993499|454761411|FG003|Run-in Period (8 Days)|Progressive disease|0|||
126401069|NCT00993499|454761412|FG004|Run-in Period (8 Days)|Progressive disease|0|||
126401070|NCT00993499|454761413|FG005|Run-in Period (8 Days)|Progressive disease|0|||
126401071|NCT00993499|454761408|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
126401072|NCT00993499|454761409|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
126401073|NCT00993499|454761410|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
126401074|NCT00993499|454761411|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
126401075|NCT00993499|454761412|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
126401076|NCT00993499|454761413|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
126401077|NCT00993499|454761408|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
126401078|NCT00993499|454761409|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
126401079|NCT00993499|454761410|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
126401080|NCT00993499|454761411|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
126401081|NCT00993499|454761412|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
126401082|NCT00993499|454761413|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
126401083|NCT00993499|454761408|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
126401084|NCT00993499|454761409|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
126401085|NCT00993499|454761410|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
126401086|NCT00993499|454761411|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
126401087|NCT00993499|454761412|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
126401088|NCT00993499|454761413|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
126401089|NCT00993499|454761408|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
126401090|NCT00993499|454761409|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
126401091|NCT00993499|454761410|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
126401092|NCT00993499|454761411|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
126401093|NCT00993499|454761412|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
126401094|NCT00993499|454761413|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
126401095|NCT00993499|454761408|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
126401096|NCT00993499|454761409|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
126401097|NCT00993499|454761410|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
126401098|NCT00993499|454761411|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
126401099|NCT00993499|454761412|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
126401100|NCT00993499|454761413|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
126401101|NCT00993499|454761408|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
126401102|NCT00993499|454761409|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
126401103|NCT00993499|454761410|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
126401104|NCT00993499|454761411|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
126401105|NCT00993499|454761412|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
126401106|NCT00993499|454761413|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
126401107|NCT00993499|454761408|FG000|Discontinued After Starting Course 3|DLT|1|||
126401108|NCT00993499|454761409|FG001|Discontinued After Starting Course 3|DLT|0|||
126401109|NCT00993499|454761410|FG002|Discontinued After Starting Course 3|DLT|2|||
126401110|NCT00993499|454761411|FG003|Discontinued After Starting Course 3|DLT|1|||
126401111|NCT00993499|454761412|FG004|Discontinued After Starting Course 3|DLT|0|||
126401112|NCT00993499|454761413|FG005|Discontinued After Starting Course 3|DLT|0|||
126401113|NCT00993499|454761408|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
126557430|NCT03100838|455332721|FG003|Overall Study|Physician Decision|1|||
126557431|NCT03100838|455332718|FG000|Overall Study|Pregnancy|0|||
126557432|NCT03100838|455332719|FG001|Overall Study|Pregnancy|1|||
126472111|NCT03452228|455028910|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
126472112|NCT03452228|455028911|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
126472113|NCT03452228|455028909|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
126472114|NCT03452228|455028910|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
126472115|NCT03452228|455028911|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
126472116|NCT03452228|455028909|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
126472117|NCT03452228|455028910|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
126472118|NCT03452228|455028911|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
126557433|NCT03100838|455332720|FG002|Overall Study|Pregnancy|0|||
126557434|NCT03100838|455332721|FG003|Overall Study|Pregnancy|0|||
126557435|NCT03100838|455332718|FG000|Overall Study|Lost to Follow-up|0|||
126557436|NCT03100838|455332719|FG001|Overall Study|Lost to Follow-up|0|||
126557437|NCT03100838|455332720|FG002|Overall Study|Lost to Follow-up|1|||
126557438|NCT03100838|455332721|FG003|Overall Study|Lost to Follow-up|0|||
126557439|NCT02554513|455332723|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
126557440|NCT02554513|455332724|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
126557441|NCT04131907|455332728|FG000|Overall Study|Adverse Event|2|||
126557442|NCT04131907|455332729|FG001|Overall Study|Adverse Event|0|||
126557443|NCT04131907|455332730|FG002|Overall Study|Adverse Event|0|||
126557444|NCT04131907|455332728|FG000|Overall Study|Physician Decision|4|||
126557445|NCT04131907|455332729|FG001|Overall Study|Physician Decision|22|||
126401114|NCT00993499|454761409|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
126557446|NCT04131907|455332730|FG002|Overall Study|Physician Decision|0|||
126557447|NCT04131907|455332728|FG000|Overall Study|Withdrawal by Subject|2|||
126557448|NCT04131907|455332729|FG001|Overall Study|Withdrawal by Subject|0|||
126557449|NCT04131907|455332730|FG002|Overall Study|Withdrawal by Subject|1|||
126557450|NCT04131907|455332728|FG000|Overall Study|Treatment failure|2|||
126557451|NCT04131907|455332729|FG001|Overall Study|Treatment failure|0|||
126557452|NCT04131907|455332730|FG002|Overall Study|Treatment failure|1|||
126557453|NCT01778062|455332731|FG000|Overall Study|Adverse Event|1|||
126557454|NCT01778062|455332732|FG001|Overall Study|Adverse Event|3|||
126557455|NCT01778062|455332731|FG000|Overall Study|Consent Withdrawal|1|||
126557456|NCT01778062|455332732|FG001|Overall Study|Consent Withdrawal|5|||
126557457|NCT01778062|455332731|FG000|Overall Study|major protocol deviation|4|||
126557458|NCT01778062|455332732|FG001|Overall Study|major protocol deviation|3|||
126557459|NCT03387514|455332733|FG000|Overall Study|Withdrawal by Subject|2|||
126557460|NCT03387514|455332733|FG000|Overall Study|Physician Decision|1|||
126557461|NCT03387514|455332733|FG000|Overall Study|Lost to Follow-up|2|||
126557462|NCT04445155|455332742|FG000|Overall Study|Lost to Follow-up|11|||
126557463|NCT04445155|455332743|FG001|Overall Study|Lost to Follow-up|2|||
126557464|NCT04445155|455332744|FG002|Overall Study|Lost to Follow-up|3|||
126557465|NCT04445155|455332745|FG003|Overall Study|Lost to Follow-up|0|||
126557466|NCT04445155|455332742|FG000|Overall Study|Withdrawal by Subject|8|||
126557467|NCT04445155|455332743|FG001|Overall Study|Withdrawal by Subject|0|||
126557468|NCT04445155|455332744|FG002|Overall Study|Withdrawal by Subject|0|||
126557469|NCT04445155|455332745|FG003|Overall Study|Withdrawal by Subject|0|||
126557470|NCT04445155|455332742|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
126772286|NCT00996918|456122082|FG003|Overall Study|Lack of Efficacy|2|||
126401115|NCT00993499|454761410|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
126401116|NCT00993499|454761411|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
126401117|NCT00993499|454761412|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
126401118|NCT00993499|454761413|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
126401119|NCT01352741|454761414|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
126401120|NCT01352741|454761415|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
126401121|NCT01352741|454761414|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
126401122|NCT01352741|454761415|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
126401123|NCT01352741|454761414|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
126401124|NCT01352741|454761415|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
126401125|NCT01352741|454761414|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
126401126|NCT01352741|454761415|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
126401127|NCT01352741|454761414|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
126401128|NCT01352741|454761415|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
126401129|NCT01352741|454761414|FG000|Open-label Tapentadol Titration Period|Other|4|||
126401130|NCT01352741|454761415|FG001|Open-label Tapentadol Titration Period|Other|0|||
126557471|NCT04445155|455332743|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
126772287|NCT00996918|456122083|FG004|Overall Study|Lack of Efficacy|0|||
126557472|NCT04445155|455332744|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
126557473|NCT04445155|455332745|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
126557474|NCT04445155|455332742|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
126557475|NCT04445155|455332743|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
126557476|NCT04445155|455332744|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
126557477|NCT04445155|455332745|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
126557478|NCT00394095|455334389|FG000|Screening|Withdrawal by Subject|1|||
126557479|NCT00394095|455334390|FG001|Screening|Withdrawal by Subject|0|||
126401131|NCT01352741|454761414|FG000|Double-blind Comparative Period|Protocol Violation|2|||
126401132|NCT01352741|454761415|FG001|Double-blind Comparative Period|Protocol Violation|0|||
126401133|NCT01352741|454761414|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
126401134|NCT01352741|454761415|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
126401135|NCT01352741|454761414|FG000|Double-blind Comparative Period|Adverse Event|16|||
126401136|NCT01352741|454761415|FG001|Double-blind Comparative Period|Adverse Event|17|||
126401137|NCT01352741|454761414|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
126401138|NCT01352741|454761415|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
126401139|NCT01352741|454761414|FG000|Double-blind Comparative Period|Death|0|||
126401140|NCT01352741|454761415|FG001|Double-blind Comparative Period|Death|1|||
126401141|NCT01352741|454761414|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
126401142|NCT01352741|454761415|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
126401143|NCT01352741|454761414|FG000|Double-blind Comparative Period|Other|1|||
126401144|NCT01352741|454761415|FG001|Double-blind Comparative Period|Other|2|||
126401145|NCT01352741|454761414|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
126401146|NCT01352741|454761415|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
126401147|NCT01352741|454761414|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
126401148|NCT01352741|454761415|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
126772288|NCT00996918|456122079|FG000|Overall Study|Adverse Event|2|||
126772289|NCT00996918|456122080|FG001|Overall Study|Adverse Event|5|||
126772290|NCT00996918|456122081|FG002|Overall Study|Adverse Event|2|||
126772291|NCT00996918|456122082|FG003|Overall Study|Adverse Event|6|||
126772292|NCT00996918|456122083|FG004|Overall Study|Adverse Event|0|||
126772293|NCT00996918|456122079|FG000|Overall Study|Withdrawal by Subject|1|||
126772294|NCT00996918|456122080|FG001|Overall Study|Withdrawal by Subject|4|||
126772295|NCT00996918|456122081|FG002|Overall Study|Withdrawal by Subject|3|||
126557480|NCT00394095|455334389|FG000|Randomized|Withdrawal by Subject|5|||
126557481|NCT00394095|455334390|FG001|Randomized|Withdrawal by Subject|1|||
126557482|NCT00394095|455334389|FG000|Randomized|Adverse Event|1|||
126772296|NCT00996918|456122082|FG003|Overall Study|Withdrawal by Subject|3|||
126772297|NCT00996918|456122083|FG004|Overall Study|Withdrawal by Subject|2|||
126772298|NCT00996918|456122079|FG000|Overall Study|Physician Decision|1|||
126772299|NCT00996918|456122080|FG001|Overall Study|Physician Decision|0|||
126772300|NCT00996918|456122081|FG002|Overall Study|Physician Decision|0|||
126772301|NCT00996918|456122082|FG003|Overall Study|Physician Decision|0|||
126772302|NCT00996918|456122083|FG004|Overall Study|Physician Decision|0|||
126772303|NCT00996918|456122079|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
126772304|NCT00996918|456122080|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
126772305|NCT00996918|456122081|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
126772306|NCT00996918|456122082|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
126772307|NCT00996918|456122083|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
126772308|NCT00996918|456122079|FG000|Overall Study|Loss of Caregiver|0|||
126772309|NCT00996918|456122080|FG001|Overall Study|Loss of Caregiver|1|||
126772310|NCT00996918|456122081|FG002|Overall Study|Loss of Caregiver|0|||
126772311|NCT00996918|456122082|FG003|Overall Study|Loss of Caregiver|0|||
126772312|NCT00996918|456122083|FG004|Overall Study|Loss of Caregiver|0|||
126772313|NCT00996918|456122079|FG000|Overall Study|Other|3|||
126772314|NCT00996918|456122080|FG001|Overall Study|Other|1|||
126772315|NCT00996918|456122081|FG002|Overall Study|Other|0|||
126772316|NCT00996918|456122082|FG003|Overall Study|Other|0|||
126772317|NCT00996918|456122083|FG004|Overall Study|Other|0|||
126772318|NCT04440007|456122088|FG000|Overall Study|Adverse Event|0|||
126772319|NCT04440007|456122089|FG001|Overall Study|Adverse Event|1|||
126772320|NCT04440007|456122088|FG000|Overall Study|Lost to Follow-up|1|||
126772321|NCT04440007|456122089|FG001|Overall Study|Lost to Follow-up|3|||
126772322|NCT04440007|456122088|FG000|Overall Study|Death|7|||
126772323|NCT04440007|456122089|FG001|Overall Study|Death|2|||
126772324|NCT04440007|456122088|FG000|Overall Study|Physician Decision|1|||
126772325|NCT04440007|456122089|FG001|Overall Study|Physician Decision|1|||
126772326|NCT04440007|456122088|FG000|Overall Study|Withdrawal by Subject|2|||
126401149|NCT01352741|454761414|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
126401150|NCT01352741|454761415|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
126401151|NCT01352741|454761414|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
126401152|NCT01352741|454761415|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
126401153|NCT00645528|454761416|FG000|Overall Study|Did not show up for Visit 2|7|||
126401154|NCT02725593|454761419|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
126401155|NCT02725593|454761420|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
126401156|NCT02725593|454761419|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
126772327|NCT04440007|456122089|FG001|Overall Study|Withdrawal by Subject|1|||
126401157|NCT02725593|454761420|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
126401158|NCT02725593|454761419|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
126401159|NCT02725593|454761420|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
126401160|NCT02725593|454761419|FG000|Long Term Extension|Withdrawal by Subject|1|||
126401161|NCT02725593|454761420|FG001|Long Term Extension|Withdrawal by Subject|3|||
126401162|NCT03654885|454762920|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
126401163|NCT03654885|454762921|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
126401164|NCT03654885|454762920|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
126401165|NCT03654885|454762921|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
126401166|NCT03654885|454762920|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
126401167|NCT03654885|454762921|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
126401168|NCT03654885|454762920|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
126401169|NCT03654885|454762921|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
126401170|NCT03654885|454762920|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
126401171|NCT03654885|454762921|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
126401172|NCT03654885|454762920|FG000|Overall Study|Adverse Event in Study Eye|3|||
126401173|NCT03654885|454762921|FG001|Overall Study|Adverse Event in Study Eye|0|||
126401174|NCT03654885|454762920|FG000|Overall Study|Consent Withdrawn|1|||
126401175|NCT03654885|454762921|FG001|Overall Study|Consent Withdrawn|0|||
126401176|NCT03654885|454762920|FG000|Overall Study|Death|3|||
126401177|NCT03654885|454762921|FG001|Overall Study|Death|1|||
126401178|NCT03654885|454762920|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
126401179|NCT03654885|454762921|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
126401180|NCT03654885|454762920|FG000|Overall Study|Lost to Follow-up|3|||
126401181|NCT03654885|454762921|FG001|Overall Study|Lost to Follow-up|3|||
126401182|NCT05275582|454762922|FG000|Overall Study|Lost to Follow-up|1|||
126401183|NCT05275582|454762923|FG001|Overall Study|Lost to Follow-up|0|||
126401184|NCT05275582|454762922|FG000|Overall Study|Withdrawal by Subject|0|||
126401185|NCT05275582|454762923|FG001|Overall Study|Withdrawal by Subject|2|||
126401186|NCT05275582|454762922|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
126401187|NCT05275582|454762923|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
126472119|NCT01710046|455028912|FG000|Overall Study|Lost to Follow-up|1|||
126472120|NCT01710046|455028913|FG001|Overall Study|Lost to Follow-up|0|||
126472121|NCT03673046|455030720|FG000|Overall Study|Adverse Event|1|||
126472122|NCT03673046|455030721|FG001|Overall Study|Adverse Event|1|||
126472123|NCT03673046|455030720|FG000|Overall Study|Withdrawal by Subject|8|||
126472124|NCT03673046|455030721|FG001|Overall Study|Withdrawal by Subject|2|||
126472125|NCT03817879|455030722|FG000|Overall Study|Drop out|5|||
126472126|NCT03817879|455030723|FG001|Overall Study|Drop out|12|||
126472127|NCT03817879|455030722|FG000|Overall Study|Withdrawal by Subject|0|||
126472128|NCT03817879|455030723|FG001|Overall Study|Withdrawal by Subject|1|||
126472129|NCT01896050|455030726|FG000|Overall Study|Adverse Event|37|||
126472130|NCT01896050|455030727|FG001|Overall Study|Adverse Event|2|||
126472131|NCT01896050|455030726|FG000|Overall Study|Death|1|||
126472132|NCT01896050|455030727|FG001|Overall Study|Death|0|||
126472133|NCT00392015|455030728|FG000|Overall Study|Lost to Follow-up|2|||
126472134|NCT00392015|455030729|FG001|Overall Study|Lost to Follow-up|0|||
126472135|NCT00392015|455030730|FG002|Overall Study|Lost to Follow-up|2|||
126472136|NCT00392015|455030731|FG003|Overall Study|Lost to Follow-up|1|||
126472137|NCT00392015|455030732|FG004|Overall Study|Lost to Follow-up|1|||
126472138|NCT00392015|455030733|FG005|Overall Study|Lost to Follow-up|0|||
126472139|NCT00392015|455030728|FG000|Overall Study|Withdrawal by Subject|0|||
126472140|NCT00392015|455030729|FG001|Overall Study|Withdrawal by Subject|0|||
126472141|NCT00392015|455030730|FG002|Overall Study|Withdrawal by Subject|2|||
126472142|NCT00392015|455030731|FG003|Overall Study|Withdrawal by Subject|0|||
126472143|NCT00392015|455030732|FG004|Overall Study|Withdrawal by Subject|0|||
126472144|NCT00392015|455030733|FG005|Overall Study|Withdrawal by Subject|0|||
126472145|NCT00392015|455030728|FG000|Overall Study|Adverse Event|0|||
126472146|NCT00392015|455030729|FG001|Overall Study|Adverse Event|0|||
126472147|NCT00392015|455030730|FG002|Overall Study|Adverse Event|0|||
126472148|NCT00392015|455030731|FG003|Overall Study|Adverse Event|0|||
126472149|NCT00392015|455030732|FG004|Overall Study|Adverse Event|1|||
126472150|NCT00392015|455030733|FG005|Overall Study|Adverse Event|0|||
126472151|NCT00392015|455030728|FG000|Overall Study|Previous trial recipient|0|||
126472152|NCT00392015|455030729|FG001|Overall Study|Previous trial recipient|0|||
126472153|NCT00392015|455030730|FG002|Overall Study|Previous trial recipient|0|||
126472154|NCT00392015|455030731|FG003|Overall Study|Previous trial recipient|0|||
126472155|NCT00392015|455030732|FG004|Overall Study|Previous trial recipient|1|||
126472156|NCT00392015|455030733|FG005|Overall Study|Previous trial recipient|0|||
126472157|NCT02180724|455030734|FG000|Overall Study|Death|26|||
126472158|NCT02180724|455030735|FG001|Overall Study|Death|1|||
126472159|NCT02180724|455030734|FG000|Overall Study|Lost to Follow-up|3|||
126401188|NCT05275582|454762922|FG000|Overall Study|Death|1|||
126401189|NCT05275582|454762923|FG001|Overall Study|Death|0|||
126401190|NCT05275582|454762922|FG000|Overall Study|Protocol Violation|1|||
126401191|NCT05275582|454762923|FG001|Overall Study|Protocol Violation|0|||
126401192|NCT04411420|454762924|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
126401193|NCT04411420|454762925|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
126401194|NCT04411420|454762924|FG000|Survey Subset|Lost to Follow-up|134|||
126401195|NCT04411420|454762925|FG001|Survey Subset|Lost to Follow-up|120|||
126401196|NCT03899064|454762926|FG000|Overall Study|Lost to Follow-up|1|||
126401197|NCT03899064|454762926|FG000|Overall Study|Protocol Violation|2|||
126401198|NCT03899064|454762926|FG000|Overall Study|Withdrawal by Subject|2|||
126401199|NCT03899064|454762926|FG000|Overall Study|Other|2|||
126401200|NCT00031460|454762931|FG000|Overall Study|Lost to Follow-up|0|||
126401201|NCT00031460|454762932|FG001|Overall Study|Lost to Follow-up|1|||
126401202|NCT00031460|454762931|FG000|Overall Study|Withdrawal by Subject|1|||
126401203|NCT00031460|454762932|FG001|Overall Study|Withdrawal by Subject|1|||
126401204|NCT00031460|454762931|FG000|Overall Study|Non-Compliant|1|||
126401205|NCT00031460|454762932|FG001|Overall Study|Non-Compliant|1|||
126401206|NCT00031460|454762931|FG000|Overall Study|Death|0|||
126401207|NCT00031460|454762932|FG001|Overall Study|Death|1|||
126401208|NCT00031460|454762931|FG000|Overall Study|Reactivation of Disease|5|||
126401209|NCT00031460|454762932|FG001|Overall Study|Reactivation of Disease|9|||
126401210|NCT00031460|454762931|FG000|Overall Study|Disruption of blinded drug supply|2|||
126401211|NCT00031460|454762932|FG001|Overall Study|Disruption of blinded drug supply|0|||
126401212|NCT00031460|454762931|FG000|Overall Study|Confirmed unevaluable|0|||
126401213|NCT00031460|454762932|FG001|Overall Study|Confirmed unevaluable|1|||
126401214|NCT02210832|454762933|FG000|Overall Study|Pregnancy termination .|3|||
126401215|NCT02210832|454762934|FG001|Overall Study|Pregnancy termination .|4|||
126401216|NCT02210832|454762935|FG002|Overall Study|Pregnancy termination .|1|||
126401217|NCT02210832|454762933|FG000|Overall Study|Lost to Follow-up|26|||
126401218|NCT02210832|454762934|FG001|Overall Study|Lost to Follow-up|32|||
126401219|NCT02210832|454762935|FG002|Overall Study|Lost to Follow-up|17|||
126401220|NCT02080260|454762939|FG000|Overall Study|Death|18|||
126401221|NCT02080260|454762939|FG000|Overall Study|Withdrawal by Subject|1|||
126401222|NCT00471887|454762943|FG000|Overall Study|Adverse Event|9|||
126401223|NCT00524589|454762953|FG000|Overall Study|Withdrawal by Subject|2|||
126401224|NCT00524589|454762953|FG000|Overall Study|Disease Progression|16|||
126401225|NCT01030874|454762955|FG000|Overall Study|Withdrawal by Subject|1|||
126401226|NCT01030874|454762956|FG001|Overall Study|Withdrawal by Subject|0|||
126401227|NCT01030874|454762955|FG000|Overall Study|Discharged in first 2 weeks|17|||
126401228|NCT01030874|454762956|FG001|Overall Study|Discharged in first 2 weeks|16|||
126401229|NCT01998893|454762957|FG000|Overall Study|Adverse Event|2|||
126401230|NCT01998893|454762957|FG000|Overall Study|Death|1|||
126401231|NCT01998893|454762957|FG000|Overall Study|Lost to Follow-up|8|||
126401232|NCT01998893|454762957|FG000|Overall Study|Physician Decision|2|||
126401233|NCT01998893|454762957|FG000|Overall Study|Protocol Violation|2|||
126401234|NCT01998893|454762957|FG000|Overall Study|Withdrawal by Subject|1|||
126401235|NCT01998893|454762957|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
126401236|NCT02046174|454762958|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
126401237|NCT02046174|454762959|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
126401238|NCT02118597|454762960|FG000|Overall Study|Sponsor terminated the study|14|||
126401239|NCT02118597|454762960|FG000|Overall Study|Serious Adverse Event|1|||
126401240|NCT02118597|454762960|FG000|Overall Study|Investigator's decision|1|||
126401241|NCT01891344|454762961|FG000|Overall Study|Ongoing|6|||
126401242|NCT01891344|454762962|FG001|Overall Study|Ongoing|2|||
126401243|NCT01891344|454762963|FG002|Overall Study|Ongoing|0|||
126401244|NCT01891344|454762964|FG003|Overall Study|Ongoing|1|||
126401245|NCT01891344|454762965|FG004|Overall Study|Ongoing|4|||
126401246|NCT01891344|454762966|FG005|Overall Study|Ongoing|1|||
126401247|NCT01891344|454762967|FG006|Overall Study|Ongoing|0|||
126401248|NCT01891344|454762968|FG007|Overall Study|Ongoing|0|||
126401249|NCT02969590|454762969|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
126401250|NCT02969590|454762970|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
126401251|NCT02969590|454762971|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
126401252|NCT00186537|454762972|FG000|Overall Study|Withdrawal by Subject|4|||
126401253|NCT00186537|454762973|FG001|Overall Study|Withdrawal by Subject|0|||
126401254|NCT00186537|454762974|FG002|Overall Study|Withdrawal by Subject|3|||
126401255|NCT00186537|454762972|FG000|Overall Study|ALT > 1.5 x ULN|3|||
126401256|NCT00186537|454762973|FG001|Overall Study|ALT > 1.5 x ULN|0|||
126401257|NCT00186537|454762974|FG002|Overall Study|ALT > 1.5 x ULN|0|||
126401258|NCT03294135|454762975|FG000|Overall Study|Serious Adverse Event|1|||
126401259|NCT03294135|454762976|FG001|Overall Study|Serious Adverse Event|0|||
126401260|NCT03294135|454762977|FG002|Overall Study|Serious Adverse Event|0|||
126401261|NCT03294135|454762975|FG000|Overall Study|Lost to Follow-up|1|||
126401262|NCT03294135|454762976|FG001|Overall Study|Lost to Follow-up|0|||
126401263|NCT03294135|454762977|FG002|Overall Study|Lost to Follow-up|1|||
126401264|NCT03294135|454762975|FG000|Overall Study|Withdrawal by Subject|0|||
126401265|NCT03294135|454762976|FG001|Overall Study|Withdrawal by Subject|0|||
126557483|NCT00394095|455334390|FG001|Randomized|Adverse Event|1|||
126557484|NCT00394095|455334389|FG000|Randomized|Overdose|1|||
126557485|NCT00394095|455334390|FG001|Randomized|Overdose|0|||
126557486|NCT00394095|455334389|FG000|Randomized|Lost to Follow-up|1|||
126557487|NCT00394095|455334390|FG001|Randomized|Lost to Follow-up|2|||
126557488|NCT01115998|455334394|FG000|Overall Study|Lost to Follow-up|6|||
126557489|NCT01115998|455334395|FG001|Overall Study|Lost to Follow-up|6|||
126557490|NCT01268059|455334396|FG000|Overall Study|Lost to Follow-up|0|||
126557491|NCT01268059|455334397|FG001|Overall Study|Lost to Follow-up|1|||
126557492|NCT01268059|455334398|FG002|Overall Study|Lost to Follow-up|0|||
126557493|NCT01268059|455334399|FG003|Overall Study|Lost to Follow-up|0|||
126557494|NCT01268059|455334396|FG000|Overall Study|Withdrawal by Subject|7|||
126401266|NCT03294135|454762977|FG002|Overall Study|Withdrawal by Subject|1|||
126401267|NCT03294135|454762975|FG000|Overall Study|Other|2|||
126401268|NCT03294135|454762976|FG001|Overall Study|Other|0|||
126401269|NCT03294135|454762977|FG002|Overall Study|Other|0|||
126401270|NCT02590562|454762978|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
126401271|NCT02763254|454762979|FG000|Overall Study|Adverse Event|1|||
126401272|NCT03684304|454762980|FG000|Overall Study|Lost to Follow-up|19|||
126401273|NCT03684304|454762981|FG001|Overall Study|Lost to Follow-up|17|||
126401274|NCT00054691|454762982|FG000|Overall Study|Unmeasurable Disease|2|||
126401275|NCT00054691|454762982|FG000|Overall Study|Noncompliant|1|||
126401276|NCT02078102|454762987|FG000|Overall Study|Adverse Event|1|||
126401277|NCT02078102|454762988|FG001|Overall Study|Adverse Event|0|||
126401278|NCT02078102|454762987|FG000|Overall Study|Withdrawal by Subject|1|||
126401279|NCT02078102|454762988|FG001|Overall Study|Withdrawal by Subject|0|||
126401280|NCT02078102|454762987|FG000|Overall Study|Physician Decision|0|||
126401281|NCT02078102|454762988|FG001|Overall Study|Physician Decision|1|||
126401282|NCT00598078|454762991|FG000|Period 2 (Day 2)|Adverse Event|1|||
126401283|NCT00598078|454762992|FG001|Period 2 (Day 2)|Adverse Event|0|||
126401284|NCT02387164|454762995|FG000|Overall Study|Lost to Follow-up|2|||
126401285|NCT02387164|454762996|FG001|Overall Study|Lost to Follow-up|0|||
126401286|NCT02387164|454762995|FG000|Overall Study|Diagnosed|1|||
126401287|NCT02387164|454762996|FG001|Overall Study|Diagnosed|2|||
126401288|NCT02133664|454762997|FG000|Overall Study|Lost to Follow-up|2|||
126401289|NCT02133664|454762998|FG001|Overall Study|Lost to Follow-up|1|||
126401290|NCT02133664|454762997|FG000|Overall Study|Adverse Event|3|||
126401291|NCT02133664|454762998|FG001|Overall Study|Adverse Event|6|||
126401292|NCT02120365|454763005|FG000|Overall Study|Withdrawal by Subject|0|||
126401293|NCT02120365|454763006|FG001|Overall Study|Withdrawal by Subject|0|||
126401294|NCT02120365|454763007|FG002|Overall Study|Withdrawal by Subject|2|||
126401295|NCT02120365|454763008|FG003|Overall Study|Withdrawal by Subject|4|||
126401296|NCT02120365|454763009|FG004|Overall Study|Withdrawal by Subject|0|||
126401297|NCT02120365|454763010|FG005|Overall Study|Withdrawal by Subject|2|||
126401298|NCT01719003|454763013|FG000|Overall Study|Non compliant with protocol|1|||
126401299|NCT01719003|454763014|FG001|Overall Study|Non compliant with protocol|1|||
126401300|NCT01719003|454763015|FG002|Overall Study|Non compliant with protocol|0|||
126401301|NCT01719003|454763016|FG003|Overall Study|Non compliant with protocol|1|||
126401302|NCT01719003|454763017|FG004|Overall Study|Non compliant with protocol|2|||
126401303|NCT01719003|454763018|FG005|Overall Study|Non compliant with protocol|1|||
126401304|NCT01719003|454763019|FG006|Overall Study|Non compliant with protocol|2|||
126401305|NCT01719003|454763020|FG007|Overall Study|Non compliant with protocol|3|||
126401306|NCT01719003|454763021|FG008|Overall Study|Non compliant with protocol|0|||
126401307|NCT01719003|454763013|FG000|Overall Study|Adverse Event|6|||
126401308|NCT01719003|454763014|FG001|Overall Study|Adverse Event|5|||
126401309|NCT01719003|454763015|FG002|Overall Study|Adverse Event|4|||
126401310|NCT01719003|454763016|FG003|Overall Study|Adverse Event|3|||
126401311|NCT01719003|454763017|FG004|Overall Study|Adverse Event|4|||
126401312|NCT01719003|454763018|FG005|Overall Study|Adverse Event|3|||
126401313|NCT01719003|454763019|FG006|Overall Study|Adverse Event|6|||
126401314|NCT01719003|454763020|FG007|Overall Study|Adverse Event|5|||
126401315|NCT01719003|454763021|FG008|Overall Study|Adverse Event|0|||
126401316|NCT01719003|454763013|FG000|Overall Study|Lost to Follow-up|0|||
126401317|NCT01719003|454763014|FG001|Overall Study|Lost to Follow-up|6|||
126401318|NCT01719003|454763015|FG002|Overall Study|Lost to Follow-up|7|||
126401319|NCT01719003|454763016|FG003|Overall Study|Lost to Follow-up|2|||
126401320|NCT01719003|454763017|FG004|Overall Study|Lost to Follow-up|3|||
126401321|NCT01719003|454763018|FG005|Overall Study|Lost to Follow-up|4|||
126401322|NCT01719003|454763019|FG006|Overall Study|Lost to Follow-up|3|||
126401323|NCT01719003|454763020|FG007|Overall Study|Lost to Follow-up|2|||
126401324|NCT01719003|454763021|FG008|Overall Study|Lost to Follow-up|2|||
126401325|NCT01719003|454763013|FG000|Overall Study|Refusal to continue, not due to AE|2|||
126401326|NCT01719003|454763014|FG001|Overall Study|Refusal to continue, not due to AE|5|||
126401327|NCT01719003|454763015|FG002|Overall Study|Refusal to continue, not due to AE|4|||
126401328|NCT01719003|454763016|FG003|Overall Study|Refusal to continue, not due to AE|4|||
126401329|NCT01719003|454763017|FG004|Overall Study|Refusal to continue, not due to AE|4|||
126557495|NCT01268059|455334397|FG001|Overall Study|Withdrawal by Subject|4|||
126557496|NCT01268059|455334398|FG002|Overall Study|Withdrawal by Subject|0|||
126557497|NCT01268059|455334399|FG003|Overall Study|Withdrawal by Subject|0|||
126401330|NCT01719003|454763018|FG005|Overall Study|Refusal to continue, not due to AE|3|||
126401331|NCT01719003|454763019|FG006|Overall Study|Refusal to continue, not due to AE|8|||
126401332|NCT01719003|454763020|FG007|Overall Study|Refusal to continue, not due to AE|7|||
126401333|NCT01719003|454763021|FG008|Overall Study|Refusal to continue, not due to AE|1|||
126401334|NCT01719003|454763013|FG000|Overall Study|Reason other than those specified|0|||
126401335|NCT01719003|454763014|FG001|Overall Study|Reason other than those specified|0|||
126401336|NCT01719003|454763015|FG002|Overall Study|Reason other than those specified|2|||
126401337|NCT01719003|454763016|FG003|Overall Study|Reason other than those specified|3|||
126401338|NCT01719003|454763017|FG004|Overall Study|Reason other than those specified|4|||
126401339|NCT01719003|454763018|FG005|Overall Study|Reason other than those specified|1|||
126401340|NCT01719003|454763019|FG006|Overall Study|Reason other than those specified|0|||
126401341|NCT01719003|454763020|FG007|Overall Study|Reason other than those specified|3|||
126401342|NCT01719003|454763021|FG008|Overall Study|Reason other than those specified|1|||
126401343|NCT01719003|454763013|FG000|Overall Study|Lack of Efficacy|0|||
126401344|NCT01719003|454763014|FG001|Overall Study|Lack of Efficacy|0|||
126401345|NCT01719003|454763015|FG002|Overall Study|Lack of Efficacy|0|||
126401346|NCT01719003|454763016|FG003|Overall Study|Lack of Efficacy|0|||
126401347|NCT01719003|454763017|FG004|Overall Study|Lack of Efficacy|0|||
126401348|NCT01719003|454763018|FG005|Overall Study|Lack of Efficacy|0|||
126401349|NCT01719003|454763019|FG006|Overall Study|Lack of Efficacy|1|||
126401350|NCT01719003|454763020|FG007|Overall Study|Lack of Efficacy|0|||
126401351|NCT01719003|454763021|FG008|Overall Study|Lack of Efficacy|0|||
126401352|NCT00581828|454763022|FG000|Overall Study|Protocol Violation|1|||
126401353|NCT02525939|454763023|FG000|Overall Study|Lost to Follow-up|27|||
126401354|NCT02525939|454763024|FG001|Overall Study|Lost to Follow-up|24|||
126401355|NCT02525939|454763023|FG000|Overall Study|Physician Decision|0|||
126401356|NCT02525939|454763024|FG001|Overall Study|Physician Decision|1|||
126401357|NCT02525939|454763023|FG000|Overall Study|Withdrawal by Subject|24|||
126401358|NCT02525939|454763024|FG001|Overall Study|Withdrawal by Subject|39|||
126401359|NCT02525939|454763023|FG000|Overall Study|Death|180|||
126401360|NCT02525939|454763024|FG001|Overall Study|Death|179|||
126401361|NCT01996592|454763035|FG000|Overall Study|no response to text/no diary entry|32|||
126401362|NCT01996592|454763035|FG000|Overall Study|change in surgical date|4|||
126401363|NCT01996592|454763035|FG000|Overall Study|Withdrawal by Subject|5|||
126401364|NCT01996592|454763035|FG000|Overall Study|change in mode of delivery|4|||
126401365|NCT01406015|454763036|FG000|Overall Study|Withdrawal by Subject|3|||
126401366|NCT01406015|454763037|FG001|Overall Study|Withdrawal by Subject|3|||
126401367|NCT00394901|454763038|FG000|Baseline Phase|Protocol Violation|0|||
126401368|NCT00394901|454763039|FG001|Baseline Phase|Protocol Violation|0|||
126401369|NCT00394901|454763040|FG002|Baseline Phase|Protocol Violation|1|||
126401370|NCT00394901|454763041|FG003|Baseline Phase|Protocol Violation|0|||
126401371|NCT00394901|454763038|FG000|Double-blind Phase|Adverse Event|5|||
126401372|NCT00394901|454763039|FG001|Double-blind Phase|Adverse Event|7|||
126401373|NCT00394901|454763040|FG002|Double-blind Phase|Adverse Event|16|||
126401374|NCT00394901|454763041|FG003|Double-blind Phase|Adverse Event|20|||
126401375|NCT00394901|454763038|FG000|Double-blind Phase|Lack of Efficacy|6|||
126401376|NCT00394901|454763039|FG001|Double-blind Phase|Lack of Efficacy|4|||
126401377|NCT00394901|454763040|FG002|Double-blind Phase|Lack of Efficacy|1|||
126401378|NCT00394901|454763041|FG003|Double-blind Phase|Lack of Efficacy|3|||
126401379|NCT00394901|454763038|FG000|Double-blind Phase|Withdrawal by Subject|2|||
126401380|NCT00394901|454763039|FG001|Double-blind Phase|Withdrawal by Subject|0|||
126401381|NCT00394901|454763040|FG002|Double-blind Phase|Withdrawal by Subject|0|||
126401382|NCT00394901|454763041|FG003|Double-blind Phase|Withdrawal by Subject|0|||
126401383|NCT00394901|454763038|FG000|Double-blind Phase|Lost to Follow-up|0|||
126401384|NCT00394901|454763039|FG001|Double-blind Phase|Lost to Follow-up|0|||
126401385|NCT00394901|454763040|FG002|Double-blind Phase|Lost to Follow-up|0|||
126401386|NCT00394901|454763041|FG003|Double-blind Phase|Lost to Follow-up|1|||
126401387|NCT00394901|454763038|FG000|Double-blind Phase|Protocol Violation|0|||
126401388|NCT00394901|454763039|FG001|Double-blind Phase|Protocol Violation|0|||
126401389|NCT00394901|454763040|FG002|Double-blind Phase|Protocol Violation|0|||
126401390|NCT00394901|454763041|FG003|Double-blind Phase|Protocol Violation|1|||
126401391|NCT00394901|454763038|FG000|Double-blind Phase|Death|1|||
126401392|NCT00394901|454763039|FG001|Double-blind Phase|Death|0|||
126401393|NCT00394901|454763040|FG002|Double-blind Phase|Death|0|||
126401394|NCT00394901|454763041|FG003|Double-blind Phase|Death|0|||
126401395|NCT00394901|454763038|FG000|Double-blind Phase|Subject's Personal Reason|1|||
126401396|NCT00394901|454763039|FG001|Double-blind Phase|Subject's Personal Reason|0|||
126401397|NCT00394901|454763040|FG002|Double-blind Phase|Subject's Personal Reason|0|||
126401398|NCT00394901|454763041|FG003|Double-blind Phase|Subject's Personal Reason|1|||
126401399|NCT00394901|454763038|FG000|Double-blind Phase|Lack of Compliance|0|||
126401400|NCT00394901|454763039|FG001|Double-blind Phase|Lack of Compliance|3|||
126401401|NCT00394901|454763040|FG002|Double-blind Phase|Lack of Compliance|0|||
126401402|NCT00394901|454763041|FG003|Double-blind Phase|Lack of Compliance|0|||
126401403|NCT00394901|454763038|FG000|Double-blind Phase|Entry into another study was found|0|||
126401404|NCT00394901|454763039|FG001|Double-blind Phase|Entry into another study was found|0|||
126401405|NCT00394901|454763040|FG002|Double-blind Phase|Entry into another study was found|1|||
126401406|NCT00394901|454763041|FG003|Double-blind Phase|Entry into another study was found|0|||
126401407|NCT00394901|454763038|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
126401408|NCT00394901|454763039|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
126401409|NCT00394901|454763040|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
126401410|NCT00394901|454763041|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
126401411|NCT05028517|454763042|FG000|Overall Study|Lost to Follow-up|13|||
126401412|NCT05028517|454763043|FG001|Overall Study|Lost to Follow-up|20|||
126401413|NCT05028517|454763044|FG002|Overall Study|Lost to Follow-up|12|||
126401414|NCT05028517|454763042|FG000|Overall Study|Withdrawal by Subject|0|||
126401415|NCT05028517|454763043|FG001|Overall Study|Withdrawal by Subject|0|||
126401416|NCT05028517|454763044|FG002|Overall Study|Withdrawal by Subject|1|||
126401417|NCT00259298|454763046|FG000|Overall Study|Withdrawal by Subject|1|||
126401418|NCT00259298|454763046|FG000|Overall Study|Physician Decision|2|||
126401419|NCT01886690|454763047|FG000|Overall Study|Protocol Violation|0|||
126401420|NCT01886690|454763048|FG001|Overall Study|Protocol Violation|1|||
126401421|NCT01886690|454763047|FG000|Overall Study|Personal Reasons|0|||
126401422|NCT01886690|454763048|FG001|Overall Study|Personal Reasons|1|||
126401423|NCT02360293|454763051|FG000|Overall Study|Lost to Follow-up|73|||
126401424|NCT02360293|454763052|FG001|Overall Study|Lost to Follow-up|95|||
126401425|NCT02360293|454763051|FG000|Overall Study|Withdrawal by Subject|2|||
126401426|NCT02360293|454763052|FG001|Overall Study|Withdrawal by Subject|1|||
126401427|NCT02360293|454763051|FG000|Overall Study|Excluded|1|||
126401428|NCT02360293|454763052|FG001|Overall Study|Excluded|0|||
126401429|NCT04316741|454763053|FG000|Baseline Enrollment|Lost to Follow-up|1|||
126401430|NCT04316741|454763054|FG001|Baseline Enrollment|Lost to Follow-up|1|||
126401431|NCT04316741|454763053|FG000|Immediate Post-Test|Lost to Follow-up|5|||
126401432|NCT04316741|454763054|FG001|Immediate Post-Test|Lost to Follow-up|1|||
126401433|NCT04316741|454763053|FG000|1-month Post-test|Lost to Follow-up|7|||
126401434|NCT04316741|454763054|FG001|1-month Post-test|Lost to Follow-up|2|||
126401435|NCT04316741|454763053|FG000|3-month Follow-up|Lost to Follow-up|10|||
126401436|NCT04316741|454763054|FG001|3-month Follow-up|Lost to Follow-up|2|||
126401437|NCT01510145|454763055|FG000|Overall Study|Adverse Event|6|||
126401438|NCT01510145|454763055|FG000|Overall Study|Lost to Follow-up|5|||
126401439|NCT01510145|454763055|FG000|Overall Study|Withdrawal by Subject|6|||
126401440|NCT01510145|454763055|FG000|Overall Study|Relative reported subject withdrew|1|||
126401441|NCT02312219|454763056|FG000|Overall Study|Withdrawal by Subject|1|||
126401442|NCT02312219|454763057|FG001|Overall Study|Withdrawal by Subject|2|||
126401443|NCT02312219|454763056|FG000|Overall Study|could not schedule imaging in time|0|||
126401444|NCT02312219|454763057|FG001|Overall Study|could not schedule imaging in time|2|||
126401445|NCT02312219|454763056|FG000|Overall Study|Other|0|||
126401446|NCT02312219|454763057|FG001|Overall Study|Other|1|||
126401447|NCT02312219|454763056|FG000|Overall Study|Not randomized. Ineligible|0|||
126401448|NCT02312219|454763057|FG001|Overall Study|Not randomized. Ineligible|1|||
126401449|NCT01827332|454763059|FG000|Overall Study|Lost to Follow-up|2|||
126401450|NCT01827332|454763060|FG001|Overall Study|Lost to Follow-up|1|||
126401451|NCT00546260|454763061|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
126401452|NCT00546260|454763062|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
126401453|NCT03734029|454763065|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
126401454|NCT03734029|454763066|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
126401455|NCT03734029|454763065|FG000|Overall Study|Adverse Event|60|||
126401456|NCT03734029|454763066|FG001|Overall Study|Adverse Event|14|||
126401457|NCT03734029|454763065|FG000|Overall Study|Withdrawal by Subject|12|||
126401458|NCT03734029|454763066|FG001|Overall Study|Withdrawal by Subject|11|||
126401459|NCT03734029|454763065|FG000|Overall Study|Clinical progression by investigator|10|||
126401460|NCT03734029|454763066|FG001|Overall Study|Clinical progression by investigator|8|||
126401461|NCT03734029|454763065|FG000|Overall Study|Death|5|||
126401462|NCT03734029|454763066|FG001|Overall Study|Death|2|||
126401463|NCT03734029|454763065|FG000|Overall Study|Physician Decision|4|||
126401464|NCT03734029|454763066|FG001|Overall Study|Physician Decision|3|||
126401465|NCT03734029|454763065|FG000|Overall Study|Other|2|||
126401466|NCT03734029|454763066|FG001|Overall Study|Other|0|||
126401467|NCT03734029|454763065|FG000|Overall Study|Lost to Follow-up|0|||
126401468|NCT03734029|454763066|FG001|Overall Study|Lost to Follow-up|1|||
126401469|NCT03734029|454763065|FG000|Overall Study|Randomized, but not treated|2|||
126401470|NCT03734029|454763066|FG001|Overall Study|Randomized, but not treated|12|||
126401471|NCT03081858|454764860|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
126401472|NCT03081858|454764861|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
126401473|NCT03081858|454764862|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
126401474|NCT03081858|454764863|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
126557498|NCT01268059|455334396|FG000|Overall Study|Death|20|||
126401475|NCT00262847|454764866|FG000|Overall Study|Disease Progression|309|||
126401476|NCT00262847|454764867|FG001|Overall Study|Disease Progression|274|||
126401477|NCT00262847|454764868|FG002|Overall Study|Disease Progression|195|||
126401478|NCT00262847|454764866|FG000|Overall Study|Patient Refusal|41|||
126401479|NCT00262847|454764867|FG001|Overall Study|Patient Refusal|52|||
126401480|NCT00262847|454764868|FG002|Overall Study|Patient Refusal|47|||
126401481|NCT00262847|454764866|FG000|Overall Study|Adverse Event|74|||
126401482|NCT00262847|454764867|FG001|Overall Study|Adverse Event|88|||
126401483|NCT00262847|454764868|FG002|Overall Study|Adverse Event|108|||
126401484|NCT00262847|454764866|FG000|Overall Study|Death|8|||
126401485|NCT00262847|454764867|FG001|Overall Study|Death|8|||
126401486|NCT00262847|454764868|FG002|Overall Study|Death|11|||
126401487|NCT00262847|454764866|FG000|Overall Study|Concomitant disease|3|||
126401488|NCT00262847|454764867|FG001|Overall Study|Concomitant disease|2|||
126401489|NCT00262847|454764868|FG002|Overall Study|Concomitant disease|4|||
126401490|NCT00262847|454764866|FG000|Overall Study|Other Reasons|79|||
126401491|NCT00262847|454764867|FG001|Overall Study|Other Reasons|88|||
126401492|NCT00262847|454764868|FG002|Overall Study|Other Reasons|27|||
126401493|NCT00262847|454764866|FG000|Overall Study|Did not receive study treatment|4|||
126401494|NCT00262847|454764867|FG001|Overall Study|Did not receive study treatment|1|||
126401495|NCT00262847|454764868|FG002|Overall Study|Did not receive study treatment|4|||
126401496|NCT03966885|454764869|FG000|Overall Study|Death|1|||
126401497|NCT03966885|454764870|FG001|Overall Study|Death|0|||
126401498|NCT03966885|454764869|FG000|Overall Study|Lost to Follow-up|1|||
126401499|NCT03966885|454764870|FG001|Overall Study|Lost to Follow-up|2|||
126401500|NCT03966885|454764869|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
126401501|NCT03966885|454764870|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
126401502|NCT03966885|454764869|FG000|Overall Study|Moved from study area.|0|||
126401503|NCT03966885|454764870|FG001|Overall Study|Moved from study area.|2|||
126401504|NCT00289198|454764897|FG000|Overall Study|Adverse Event|0|||
126401505|NCT00289198|454764898|FG001|Overall Study|Adverse Event|2|||
126401506|NCT00289198|454764897|FG000|Overall Study|Protocol Violation|2|||
126401507|NCT00289198|454764898|FG001|Overall Study|Protocol Violation|1|||
126401508|NCT00289198|454764897|FG000|Overall Study|Withdrawal by Subject|4|||
126401509|NCT00289198|454764898|FG001|Overall Study|Withdrawal by Subject|1|||
126401510|NCT00289198|454764897|FG000|Overall Study|Lack of Efficacy|2|||
126401511|NCT00289198|454764898|FG001|Overall Study|Lack of Efficacy|0|||
126401512|NCT00289198|454764897|FG000|Overall Study|Other: Low compliance|0|||
126401513|NCT00289198|454764898|FG001|Overall Study|Other: Low compliance|1|||
126401514|NCT00289198|454764897|FG000|Overall Study|Other: Physician's decision|0|||
126401515|NCT00289198|454764898|FG001|Overall Study|Other: Physician's decision|1|||
126401516|NCT00289198|454764897|FG000|Overall Study|Other: Unable to attend on schedule|2|||
126401517|NCT00289198|454764898|FG001|Overall Study|Other: Unable to attend on schedule|1|||
126401518|NCT00289198|454764897|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
126401519|NCT00289198|454764898|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
126401520|NCT00289198|454764897|FG000|Overall Study|Other: Impossible to come on visit|0|||
126401521|NCT00289198|454764898|FG001|Overall Study|Other: Impossible to come on visit|1|||
126401522|NCT01176565|454764899|FG000|Overall Study|Lost to Follow-up|12|||
126401523|NCT01176565|454764900|FG001|Overall Study|Lost to Follow-up|16|||
126401524|NCT01176565|454764899|FG000|Overall Study|Withdrawal by Subject|7|||
126401525|NCT01176565|454764900|FG001|Overall Study|Withdrawal by Subject|1|||
126401526|NCT01176565|454764899|FG000|Overall Study|Not Analyzed (any other reason)|1|||
126401527|NCT01176565|454764900|FG001|Overall Study|Not Analyzed (any other reason)|2|||
126401528|NCT03602885|454764901|FG000|Overall Study|Lost to Follow-up|3|||
126401529|NCT03602885|454764902|FG001|Overall Study|Lost to Follow-up|0|||
126472160|NCT02180724|455030735|FG001|Overall Study|Lost to Follow-up|1|||
126472161|NCT02180724|455030734|FG000|Overall Study|Withdrawal by Subject|4|||
126472162|NCT02180724|455030735|FG001|Overall Study|Withdrawal by Subject|2|||
126472163|NCT02180724|455030734|FG000|Overall Study|PI Decision|5|||
126472164|NCT02180724|455030735|FG001|Overall Study|PI Decision|2|||
126401530|NCT01062061|454764905|FG000|Overall Study|Enrolled more than once|2|||
126472165|NCT02180724|455030734|FG000|Overall Study|Study terminated by sponsor|54|||
126472166|NCT02180724|455030735|FG001|Overall Study|Study terminated by sponsor|8|||
126472167|NCT03693300|455030736|FG000|Overall Study|Withdrawal by Subject|6|||
126401531|NCT01062061|454764905|FG000|Overall Study|Investigated before study start|13|||
126401532|NCT01062061|454764905|FG000|Overall Study|Outside chief indications|10|||
126401533|NCT01062061|454764905|FG000|Overall Study|Failed to meet inclusion criteria|2|||
126401534|NCT01143051|454764912|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
126401535|NCT01143051|454764913|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
126401536|NCT01143051|454764914|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
126401537|NCT01143051|454764915|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
126401538|NCT01143051|454764916|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
126401539|NCT01143051|454764917|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
126401540|NCT01143051|454764912|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
126401541|NCT01143051|454764913|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
126401542|NCT01143051|454764914|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
126472168|NCT03693300|455030737|FG001|Overall Study|Withdrawal by Subject|0|||
126472169|NCT03693300|455030736|FG000|Overall Study|Death|50|||
126472170|NCT03693300|455030737|FG001|Overall Study|Death|2|||
126472171|NCT03693300|455030736|FG000|Overall Study|Lost to Follow-up|2|||
126472172|NCT03693300|455030737|FG001|Overall Study|Lost to Follow-up|0|||
126401543|NCT01143051|454764915|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
126401544|NCT01143051|454764916|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
126401545|NCT01143051|454764917|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
126401546|NCT01605227|454764918|FG000|Overall Study|Did not receive study treatment|2|||
126401547|NCT01605227|454764919|FG001|Overall Study|Did not receive study treatment|3|||
126401548|NCT01605227|454764918|FG000|Overall Study|Adverse Event|228|||
126401549|NCT01605227|454764919|FG001|Overall Study|Adverse Event|42|||
126401550|NCT01605227|454764918|FG000|Overall Study|Progressive Disease|132|||
126401551|NCT01605227|454764919|FG001|Overall Study|Progressive Disease|128|||
126401552|NCT01605227|454764918|FG000|Overall Study|Clinical Deterioration|227|||
126401553|NCT01605227|454764919|FG001|Overall Study|Clinical Deterioration|133|||
126401554|NCT01605227|454764918|FG000|Overall Study|Lost to Follow-up|1|||
126401555|NCT01605227|454764919|FG001|Overall Study|Lost to Follow-up|0|||
126401556|NCT01605227|454764918|FG000|Overall Study|Protocol Violation|1|||
126401557|NCT01605227|454764919|FG001|Overall Study|Protocol Violation|0|||
126401558|NCT01605227|454764918|FG000|Overall Study|Physician Decision|9|||
126401559|NCT01605227|454764919|FG001|Overall Study|Physician Decision|7|||
126401560|NCT01605227|454764918|FG000|Overall Study|Withdrawal by Subject|18|||
126401561|NCT01605227|454764919|FG001|Overall Study|Withdrawal by Subject|14|||
126401562|NCT01605227|454764918|FG000|Overall Study|Sponsor Decision|2|||
126401563|NCT01605227|454764919|FG001|Overall Study|Sponsor Decision|0|||
126401564|NCT01605227|454764918|FG000|Overall Study|Started New Therapy|1|||
126401565|NCT01605227|454764919|FG001|Overall Study|Started New Therapy|0|||
126401566|NCT01605227|454764918|FG000|Overall Study|Subject Decision|0|||
126401567|NCT01605227|454764919|FG001|Overall Study|Subject Decision|1|||
126401568|NCT01605227|454764918|FG000|Overall Study|Dose Held >6 weeks|0|||
126401569|NCT01605227|454764919|FG001|Overall Study|Dose Held >6 weeks|1|||
126401570|NCT03093974|454764920|FG000|Overall Study|Withdrawal by Subject|32|||
126401571|NCT03093974|454764921|FG001|Overall Study|Withdrawal by Subject|27|||
126401572|NCT03093974|454764920|FG000|Overall Study|Adverse Event|17|||
126401573|NCT03093974|454764921|FG001|Overall Study|Adverse Event|24|||
126401574|NCT03093974|454764920|FG000|Overall Study|Death|0|||
126401575|NCT03093974|454764921|FG001|Overall Study|Death|1|||
126401576|NCT03093974|454764920|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126401577|NCT03093974|454764921|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126401578|NCT03093974|454764920|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
126401579|NCT03093974|454764921|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
126401580|NCT03093974|454764920|FG000|Overall Study|Lost to Follow-up|0|||
126401581|NCT03093974|454764921|FG001|Overall Study|Lost to Follow-up|1|||
126401582|NCT03093974|454764920|FG000|Overall Study|Other|1|||
126401583|NCT03093974|454764921|FG001|Overall Study|Other|2|||
126401584|NCT01866423|454764925|FG000|Overall Study|Lack of Efficacy|3|||
126401585|NCT01866423|454764925|FG000|Overall Study|Sponsor Decision|1|||
126401586|NCT01813721|454764926|FG000|Overall Study|Ineligibility determined|63|||
126401587|NCT01813721|454764926|FG000|Overall Study|Withdrawal by Subject|1|||
126401588|NCT00810901|454764927|FG000|Overall Study|Lost to Follow-up|88|||
126401589|NCT00810901|454764928|FG001|Overall Study|Lost to Follow-up|58|||
126401590|NCT00900146|454764929|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
126401591|NCT00900146|454764930|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
126401592|NCT00900146|454764931|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
126401593|NCT00900146|454764932|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
126401594|NCT00900146|454764933|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
126401595|NCT00900146|454764929|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
126401596|NCT00900146|454764930|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
126401597|NCT00900146|454764931|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
126401598|NCT00900146|454764932|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
126401599|NCT00900146|454764933|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
126401600|NCT00900146|454764929|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
126401601|NCT00900146|454764930|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
126401602|NCT00900146|454764931|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
126401603|NCT00900146|454764932|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
126401604|NCT00900146|454764933|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
126401605|NCT00900146|454764929|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
126401606|NCT00900146|454764930|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
126401607|NCT00900146|454764931|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
126401608|NCT00900146|454764932|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
126401609|NCT00900146|454764933|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
126401610|NCT00900146|454764929|FG000|Intermediate: Period III|Lost to Follow-up|2|||
126401611|NCT00900146|454764930|FG001|Intermediate: Period III|Lost to Follow-up|0|||
126401612|NCT00900146|454764931|FG002|Intermediate: Period III|Lost to Follow-up|0|||
126401613|NCT00900146|454764932|FG003|Intermediate: Period III|Lost to Follow-up|0|||
126401614|NCT00900146|454764933|FG004|Intermediate: Period III|Lost to Follow-up|1|||
126401615|NCT00900146|454764929|FG000|Intermediate: Period III|Administrative problems|85|||
126401616|NCT00900146|454764930|FG001|Intermediate: Period III|Administrative problems|92|||
126401617|NCT00900146|454764931|FG002|Intermediate: Period III|Administrative problems|84|||
126401618|NCT00900146|454764932|FG003|Intermediate: Period III|Administrative problems|90|||
126401619|NCT00900146|454764933|FG004|Intermediate: Period III|Administrative problems|163|||
126401620|NCT01133275|454764934|FG000|Overall Study|Withdrawal by Subject|1|||
126401621|NCT01133275|454764934|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
126401622|NCT00700102|454764935|FG000|Overall Study|Died|394|||
126401623|NCT00700102|454764936|FG001|Overall Study|Died|385|||
126401624|NCT00700102|454764935|FG000|Overall Study|Lost to Follow-up|8|||
126401625|NCT00700102|454764936|FG001|Overall Study|Lost to Follow-up|10|||
126401626|NCT01028716|454764941|FG000|Overall Study|Physician Decision|1|||
126401627|NCT05590000|454764942|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
126401628|NCT00536874|454764943|FG000|Overall Study|Adverse Event|1|||
126401629|NCT00536874|454764943|FG000|Overall Study|Death|2|||
126401630|NCT00536874|454764943|FG000|Overall Study|Withdrawal by Subject|1|||
126401631|NCT00762996|454764944|FG000|Period One|Protocol Violation|0|||
126401632|NCT00762996|454764945|FG001|Period One|Protocol Violation|0|||
126401633|NCT00762996|454764946|FG002|Period One|Protocol Violation|1|||
126401634|NCT00762996|454764947|FG003|Period One|Protocol Violation|0|||
126401635|NCT00762996|454764944|FG000|Period One|ineligible|0|||
126401636|NCT00762996|454764945|FG001|Period One|ineligible|0|||
126401637|NCT00762996|454764946|FG002|Period One|ineligible|1|||
126401638|NCT00762996|454764947|FG003|Period One|ineligible|1|||
126401639|NCT00762996|454764944|FG000|Period One|Adverse Event|0|||
126401640|NCT00762996|454764945|FG001|Period One|Adverse Event|0|||
126401641|NCT00762996|454764946|FG002|Period One|Adverse Event|1|||
126401642|NCT00762996|454764947|FG003|Period One|Adverse Event|0|||
126401643|NCT00762996|454764944|FG000|Period One|Withdrawal by Subject|0|||
126401644|NCT00762996|454764945|FG001|Period One|Withdrawal by Subject|0|||
126401645|NCT00762996|454764946|FG002|Period One|Withdrawal by Subject|1|||
126401646|NCT00762996|454764947|FG003|Period One|Withdrawal by Subject|0|||
126401647|NCT02689076|454764948|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
126401648|NCT02689076|454764949|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
126401649|NCT02689076|454764950|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
126401650|NCT02689076|454764948|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
126401651|NCT02689076|454764949|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
126401652|NCT02689076|454764950|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
126401653|NCT02689076|454764948|FG000|Overall Study|Did not have an HIE match|2|||
126401654|NCT02689076|454764949|FG001|Overall Study|Did not have an HIE match|0|||
126401655|NCT02689076|454764950|FG002|Overall Study|Did not have an HIE match|0|||
126401656|NCT02689076|454764948|FG000|Overall Study|Death during non-VA encounter|2|||
126401657|NCT02689076|454764949|FG001|Overall Study|Death during non-VA encounter|5|||
126401658|NCT02689076|454764950|FG002|Overall Study|Death during non-VA encounter|0|||
126401659|NCT02689076|454764948|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
126401660|NCT02689076|454764949|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
126401661|NCT02689076|454764950|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
126401662|NCT02689076|454764948|FG000|Overall Study|Participant no longer active in VA system|1|||
126401663|NCT02689076|454764949|FG001|Overall Study|Participant no longer active in VA system|0|||
126401664|NCT02689076|454764950|FG002|Overall Study|Participant no longer active in VA system|0|||
126401665|NCT02689076|454764948|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
126401666|NCT02689076|454764949|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
126401667|NCT02689076|454764950|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
126401668|NCT01143896|454764952|FG000|Overall Study|Did not complete Baseline Interview|5|||
126401669|NCT01143896|454764953|FG001|Overall Study|Did not complete Baseline Interview|4|||
126401670|NCT01143896|454764952|FG000|Overall Study|Lost to Follow-up|18|||
126401671|NCT01143896|454764953|FG001|Overall Study|Lost to Follow-up|13|||
126401672|NCT01143896|454764952|FG000|Overall Study|Withdrawal by Subject|13|||
126401673|NCT01143896|454764953|FG001|Overall Study|Withdrawal by Subject|5|||
126401674|NCT01143896|454764952|FG000|Overall Study|Death|6|||
126401675|NCT01143896|454764953|FG001|Overall Study|Death|3|||
126401676|NCT02084238|454764954|FG000|Overall Study|Lost to Follow-up|2|||
126401677|NCT00320372|454764955|FG000|Overall Study|Physician Decision|4|||
126401678|NCT00320372|454764956|FG001|Overall Study|Physician Decision|7|||
126557499|NCT01268059|455334397|FG001|Overall Study|Death|30|||
126401679|NCT00320372|454764955|FG000|Overall Study|Death|7|||
126401680|NCT00320372|454764956|FG001|Overall Study|Death|8|||
126401681|NCT00320372|454764955|FG000|Overall Study|Withdrawal by Subject|55|||
126401682|NCT00320372|454764956|FG001|Overall Study|Withdrawal by Subject|37|||
126401683|NCT00320372|454764955|FG000|Overall Study|Non-Compliance|40|||
126401684|NCT00320372|454764956|FG001|Overall Study|Non-Compliance|39|||
126401685|NCT00320372|454764955|FG000|Overall Study|Did not Meet (I/E)|3|||
126557500|NCT01268059|455334398|FG002|Overall Study|Death|3|||
126401686|NCT00320372|454764956|FG001|Overall Study|Did not Meet (I/E)|1|||
126472173|NCT02206048|455030738|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
126472174|NCT02925923|455030742|FG000|Overall Study|blood samples hemolyzed|0|||
126472175|NCT02925923|455030743|FG001|Overall Study|blood samples hemolyzed|2|||
126472176|NCT02202837|455030744|FG000|Overall Study|Enbrel treatment discontinued|36|||
126401687|NCT00320372|454764955|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
126401688|NCT00320372|454764956|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
126401689|NCT00849875|454764957|FG000|Overall Study|Death|28|||
126401690|NCT00849875|454764957|FG000|Overall Study|Ongoing (unknown completion status)|11|||
126401691|NCT00849875|454764957|FG000|Overall Study|Others|6|||
126401692|NCT00849875|454764957|FG000|Overall Study|Lost to Follow-up|2|||
126401693|NCT00086502|454764958|FG000|Overall Study|Adverse Event|11|||
126401694|NCT00086502|454764959|FG001|Overall Study|Adverse Event|2|||
126401695|NCT00086502|454764958|FG000|Overall Study|Lack of Efficacy|0|||
126401696|NCT00086502|454764959|FG001|Overall Study|Lack of Efficacy|2|||
126401697|NCT00086502|454764958|FG000|Overall Study|Lost to Follow-up|3|||
126401698|NCT00086502|454764959|FG001|Overall Study|Lost to Follow-up|1|||
126401699|NCT00086502|454764958|FG000|Overall Study|Physician Decision|1|||
126401700|NCT00086502|454764959|FG001|Overall Study|Physician Decision|1|||
126401701|NCT00086502|454764958|FG000|Overall Study|Pregnancy|0|||
126401702|NCT00086502|454764959|FG001|Overall Study|Pregnancy|1|||
126401703|NCT00086502|454764958|FG000|Overall Study|Protocol Violation|3|||
126401704|NCT00086502|454764959|FG001|Overall Study|Protocol Violation|3|||
126401705|NCT00086502|454764958|FG000|Overall Study|Withdrawal by Subject|5|||
126401706|NCT00086502|454764959|FG001|Overall Study|Withdrawal by Subject|6|||
126401707|NCT00086502|454764958|FG000|Overall Study|Patient Moved|1|||
126401708|NCT00086502|454764959|FG001|Overall Study|Patient Moved|1|||
126401709|NCT00086502|454764958|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
126401710|NCT00086502|454764959|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
126401711|NCT00086502|454764958|FG000|Overall Study|Patient Accidentally Unblinded|1|||
126401712|NCT00086502|454764959|FG001|Overall Study|Patient Accidentally Unblinded|0|||
126401713|NCT01304329|454764960|FG000|Third Intervention (3 Days)|Adverse Event|0|||
126401714|NCT01304329|454764961|FG001|Third Intervention (3 Days)|Adverse Event|1|||
126401715|NCT01304329|454764962|FG002|Third Intervention (3 Days)|Adverse Event|0|||
126401716|NCT01304329|454764963|FG003|Third Intervention (3 Days)|Adverse Event|0|||
126401717|NCT01304329|454764964|FG004|Third Intervention (3 Days)|Adverse Event|0|||
126401718|NCT01304329|454764965|FG005|Third Intervention (3 Days)|Adverse Event|0|||
126401719|NCT02068118|454764973|FG000|18-month Comparative Study Period|Death|90|||
126401720|NCT02068118|454764974|FG001|18-month Comparative Study Period|Death|97|||
126401721|NCT02068118|454764973|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
126401722|NCT02068118|454764974|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
126401723|NCT02068118|454764973|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
126401724|NCT02068118|454764974|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
126401725|NCT02068118|454764973|FG000|18-month Comparative Study Period|Heart transplant|9|||
126401726|NCT02068118|454764974|FG001|18-month Comparative Study Period|Heart transplant|15|||
126401727|NCT02068118|454764973|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
126401728|NCT02068118|454764974|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
126401729|NCT02068118|454764973|FG000|18-month Comparative Study Period|Hemiplegia|0|||
126401730|NCT02068118|454764974|FG001|18-month Comparative Study Period|Hemiplegia|1|||
126401731|NCT02068118|454764973|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
126472177|NCT02202837|455030745|FG001|Overall Study|Enbrel treatment discontinued|4|||
126472178|NCT02202837|455030744|FG000|Overall Study|Other|10|||
126401732|NCT02068118|454764974|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
126401733|NCT02068118|454764973|FG000|18-month Comparative Study Period|Move|0|||
126401734|NCT02068118|454764974|FG001|18-month Comparative Study Period|Move|1|||
126401735|NCT02068118|454764973|FG000|18-month Comparative Study Period|Hearing loss|0|||
126401736|NCT02068118|454764974|FG001|18-month Comparative Study Period|Hearing loss|1|||
126401737|NCT02068118|454764973|FG000|Extension Period|Death|0|||
126401738|NCT02068118|454764974|FG001|Extension Period|Death|2|||
126401739|NCT02068118|454764973|FG000|Extension Period|Withdrawal by Subject|1|||
126472179|NCT02202837|455030745|FG001|Overall Study|Other|0|||
126472180|NCT02202837|455030744|FG000|Overall Study|Lost to Follow-up|7|||
126401740|NCT02068118|454764974|FG001|Extension Period|Withdrawal by Subject|0|||
126401741|NCT02068118|454764973|FG000|Extension Period|Heart transplant|1|||
126401742|NCT02068118|454764974|FG001|Extension Period|Heart transplant|0|||
126401743|NCT02068118|454764973|FG000|Extension Period|Wrong device use|0|||
126401744|NCT02068118|454764974|FG001|Extension Period|Wrong device use|1|||
126401745|NCT00283868|454764975|FG000|Overall Study|Lost to Follow-up|7|||
126401746|NCT00283868|454764976|FG001|Overall Study|Lost to Follow-up|8|||
126557501|NCT01268059|455334399|FG003|Overall Study|Death|5|||
126401747|NCT01515475|454764977|FG000|Overall Study|Lost to Follow-up|20|||
126401748|NCT01515475|454764978|FG001|Overall Study|Lost to Follow-up|15|||
126401749|NCT01515475|454764979|FG002|Overall Study|Lost to Follow-up|12|||
126401750|NCT01515475|454764980|FG003|Overall Study|Lost to Follow-up|12|||
126472181|NCT02202837|455030745|FG001|Overall Study|Lost to Follow-up|1|||
126401751|NCT01420627|454764981|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
126401752|NCT00837876|454764982|FG000|Overall Study|Death|2|||
126401753|NCT00837876|454764982|FG000|Overall Study|Adverse Event|7|||
126401754|NCT00837876|454764982|FG000|Overall Study|Physician Decision|1|||
126401755|NCT00837876|454764982|FG000|Overall Study|Withdrawal by Subject|3|||
126401756|NCT00837876|454764982|FG000|Overall Study|disease progression|24|||
126401757|NCT02075632|454764985|FG000|Overall Study|Adverse Event|1|||
126401758|NCT02075632|454764986|FG001|Overall Study|Adverse Event|1|||
126401759|NCT02075632|454764985|FG000|Overall Study|Lost to Follow-up|0|||
126401760|NCT02075632|454764986|FG001|Overall Study|Lost to Follow-up|3|||
126401761|NCT02075632|454764985|FG000|Overall Study|Withdrawal by Subject|0|||
126401762|NCT02075632|454764986|FG001|Overall Study|Withdrawal by Subject|1|||
126401763|NCT02256267|454764987|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
126401764|NCT02256267|454764987|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
126401765|NCT01969500|454764997|FG000|Overall Study|Death|0|||
126401766|NCT01969500|454764998|FG001|Overall Study|Death|1|||
126401767|NCT01969500|454764997|FG000|Overall Study|extended hospitalization|1|||
126401768|NCT01969500|454764998|FG001|Overall Study|extended hospitalization|1|||
126401769|NCT00613080|454764999|FG000|Overall Study|Ineligible / no protocol treatment|11|||
126401770|NCT03757130|454765000|FG000|Overall Study|Lost to Follow-up|0|||
126401771|NCT03757130|454765001|FG001|Overall Study|Lost to Follow-up|0|||
126401772|NCT03757130|454765002|FG002|Overall Study|Lost to Follow-up|0|||
126401773|NCT03757130|454765003|FG003|Overall Study|Lost to Follow-up|1|||
126401774|NCT03757130|454765004|FG004|Overall Study|Lost to Follow-up|0|||
126401775|NCT03757130|454765005|FG005|Overall Study|Lost to Follow-up|0|||
126401776|NCT03757130|454765006|FG006|Overall Study|Lost to Follow-up|0|||
126401777|NCT03757130|454765007|FG007|Overall Study|Lost to Follow-up|1|||
126401778|NCT03757130|454765000|FG000|Overall Study|Withdrawal by Subject|0|||
126401779|NCT03757130|454765001|FG001|Overall Study|Withdrawal by Subject|0|||
126401780|NCT03757130|454765002|FG002|Overall Study|Withdrawal by Subject|0|||
126401781|NCT03757130|454765003|FG003|Overall Study|Withdrawal by Subject|0|||
126401782|NCT03757130|454765004|FG004|Overall Study|Withdrawal by Subject|0|||
126401783|NCT03757130|454765005|FG005|Overall Study|Withdrawal by Subject|0|||
126401784|NCT03757130|454765006|FG006|Overall Study|Withdrawal by Subject|1|||
126401785|NCT03757130|454765007|FG007|Overall Study|Withdrawal by Subject|0|||
126401786|NCT02226549|454765008|FG000|Overall Study|Randomized but Never Treated|1|||
126401787|NCT02226549|454765009|FG001|Overall Study|Randomized but Never Treated|0|||
126401788|NCT02226549|454765008|FG000|Overall Study|Lost to Follow-up|0|||
126401789|NCT02226549|454765009|FG001|Overall Study|Lost to Follow-up|1|||
126401790|NCT02726880|454765010|FG000|Overall Study|Withdrawal by Subject|2|||
126401791|NCT02726880|454765011|FG001|Overall Study|Withdrawal by Subject|0|||
126401792|NCT02726880|454765010|FG000|Overall Study|Lost to Follow-up|1|||
126401793|NCT02726880|454765011|FG001|Overall Study|Lost to Follow-up|3|||
126401794|NCT01269385|454765012|FG000|Overall Study|Adverse Event|1|||
126401795|NCT01269385|454765013|FG001|Overall Study|Adverse Event|1|||
126401796|NCT01269385|454765014|FG002|Overall Study|Adverse Event|0|||
126401797|NCT01269385|454765015|FG003|Overall Study|Adverse Event|0|||
126401798|NCT04941807|454765016|FG000|Overall Study|Lost to Follow-up|1|||
126401799|NCT04941807|454765017|FG001|Overall Study|Lost to Follow-up|1|||
126401800|NCT03553498|454765018|FG000|Overall Study|Missing primary outcome|1|||
126401801|NCT03553498|454765019|FG001|Overall Study|Missing primary outcome|2|||
126401802|NCT01100567|454765020|FG000|Overall Study|Withdrawal by Subject|5|||
126401803|NCT01100567|454765021|FG001|Overall Study|Withdrawal by Subject|8|||
126401804|NCT01100567|454765020|FG000|Overall Study|Early Hospital Discharge|6|||
126401805|NCT01100567|454765021|FG001|Overall Study|Early Hospital Discharge|4|||
126401806|NCT01100567|454765020|FG000|Overall Study|Lost to Follow-up|1|||
126401807|NCT01100567|454765021|FG001|Overall Study|Lost to Follow-up|2|||
126401808|NCT01100567|454765020|FG000|Overall Study|Physician Decision|0|||
126401809|NCT01100567|454765021|FG001|Overall Study|Physician Decision|1|||
126401810|NCT01100567|454765020|FG000|Overall Study|Deemed ineligible after consent|0|||
126401811|NCT01100567|454765021|FG001|Overall Study|Deemed ineligible after consent|1|||
126401812|NCT02741570|454765022|FG000|Pre-Treatment Period|Other reasons|0|||
126401813|NCT02741570|454765023|FG001|Pre-Treatment Period|Other reasons|3|||
126401814|NCT02741570|454765022|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
126401815|NCT02741570|454765023|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
126401816|NCT02741570|454765022|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
126401817|NCT02741570|454765023|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
126401818|NCT02741570|454765022|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
126401819|NCT02741570|454765023|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
126401820|NCT02741570|454765022|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
126401821|NCT02741570|454765023|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
126401822|NCT02741570|454765022|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
126401823|NCT02741570|454765023|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
126401824|NCT02741570|454765022|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
126401825|NCT02741570|454765023|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126401826|NCT02741570|454765022|FG000|Pre-Treatment Period|Death|0|||
126401827|NCT02741570|454765023|FG001|Pre-Treatment Period|Death|1|||
126401828|NCT02741570|454765022|FG000|Pre-Treatment Period|Disease progression|0|||
126401829|NCT02741570|454765023|FG001|Pre-Treatment Period|Disease progression|1|||
126401830|NCT02741570|454765022|FG000|Treatment Period|Other reasons|47|||
126401831|NCT02741570|454765023|FG001|Treatment Period|Other reasons|12|||
126401832|NCT02741570|454765022|FG000|Treatment Period|Poor/non-compliance|0|||
126401833|NCT02741570|454765023|FG001|Treatment Period|Poor/non-compliance|2|||
126401834|NCT02741570|454765022|FG000|Treatment Period|Maximum clinical benefit|4|||
126401835|NCT02741570|454765023|FG001|Treatment Period|Maximum clinical benefit|6|||
126401836|NCT02741570|454765022|FG000|Treatment Period|Lost to Follow-up|1|||
126401837|NCT02741570|454765023|FG001|Treatment Period|Lost to Follow-up|3|||
126401838|NCT02741570|454765022|FG000|Treatment Period|Participant withdrew consent|9|||
126401839|NCT02741570|454765023|FG001|Treatment Period|Participant withdrew consent|13|||
126401840|NCT02741570|454765022|FG000|Treatment Period|Participant request to discontinue treatment|8|||
126401841|NCT02741570|454765023|FG001|Treatment Period|Participant request to discontinue treatment|23|||
126401842|NCT02741570|454765022|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
126401843|NCT02741570|454765023|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
126401844|NCT02741570|454765022|FG000|Treatment Period|Death|9|||
126401845|NCT02741570|454765023|FG001|Treatment Period|Death|7|||
126401846|NCT02741570|454765022|FG000|Treatment Period|Study drug toxicity|55|||
126401847|NCT02741570|454765023|FG001|Treatment Period|Study drug toxicity|47|||
126401848|NCT02741570|454765022|FG000|Treatment Period|Disease progression|294|||
126401849|NCT02741570|454765023|FG001|Treatment Period|Disease progression|301|||
126401850|NCT02741570|454765022|FG000|Treatment Period|Administrative reason by sponsor|0|||
126401851|NCT02741570|454765023|FG001|Treatment Period|Administrative reason by sponsor|1|||
126401852|NCT03697993|454765035|FG000|Overall Study|Became Ineligible after Enrollment|1|||
126401853|NCT03697993|454765036|FG001|Overall Study|Became Ineligible after Enrollment|3|||
126401854|NCT03697993|454765035|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
126401855|NCT03697993|454765036|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
126401856|NCT03697993|454765035|FG000|Overall Study|Lost to Follow-up|3|||
126401857|NCT03697993|454765036|FG001|Overall Study|Lost to Follow-up|0|||
126401858|NCT03697993|454765035|FG000|Overall Study|Physician Decision|4|||
126401859|NCT03697993|454765036|FG001|Overall Study|Physician Decision|0|||
126401860|NCT03697993|454765035|FG000|Overall Study|Initial Urine Culture Negative|0|||
126401861|NCT03697993|454765036|FG001|Overall Study|Initial Urine Culture Negative|1|||
126401862|NCT03759041|454765037|FG000|Overall Study|Withdrawal by Subject|4|||
126401863|NCT03759041|454765038|FG001|Overall Study|Withdrawal by Subject|10|||
126401864|NCT03759041|454765039|FG002|Overall Study|Withdrawal by Subject|10|||
126401865|NCT03759041|454765037|FG000|Overall Study|Adverse Event|1|||
126401866|NCT03759041|454765038|FG001|Overall Study|Adverse Event|3|||
126401867|NCT03759041|454765039|FG002|Overall Study|Adverse Event|4|||
126401868|NCT03759041|454765037|FG000|Overall Study|Lack of Efficacy|0|||
126401869|NCT03759041|454765038|FG001|Overall Study|Lack of Efficacy|0|||
126401870|NCT03759041|454765039|FG002|Overall Study|Lack of Efficacy|1|||
126401871|NCT03759041|454765037|FG000|Overall Study|Study Terminated by Sponsor|15|||
126401872|NCT03759041|454765038|FG001|Overall Study|Study Terminated by Sponsor|16|||
126401873|NCT03759041|454765039|FG002|Overall Study|Study Terminated by Sponsor|10|||
126472182|NCT02008318|455030751|FG000|Overall Study|Adverse Event|4|||
126472183|NCT02008318|455030752|FG001|Overall Study|Adverse Event|0|||
126401874|NCT03759041|454765037|FG000|Overall Study|Other reason for discontinuation|0|||
126401875|NCT03759041|454765038|FG001|Overall Study|Other reason for discontinuation|2|||
126401876|NCT03759041|454765039|FG002|Overall Study|Other reason for discontinuation|1|||
126401877|NCT03759041|454765037|FG000|Overall Study|Lost to Follow-up|7|||
126401878|NCT03759041|454765038|FG001|Overall Study|Lost to Follow-up|2|||
126401879|NCT03759041|454765039|FG002|Overall Study|Lost to Follow-up|2|||
126401880|NCT03759041|454765037|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
126401881|NCT03759041|454765038|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
126401882|NCT03759041|454765039|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
126472184|NCT02008318|455030751|FG000|Overall Study|Physician Decision|2|||
126472185|NCT02008318|455030752|FG001|Overall Study|Physician Decision|0|||
126472186|NCT02008318|455030751|FG000|Overall Study|Progressive Disease|2|||
126472187|NCT02008318|455030752|FG001|Overall Study|Progressive Disease|0|||
126401883|NCT04384107|454765040|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
126401884|NCT04384107|454765041|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
126401885|NCT04384107|454765040|FG000|Overall Study|Lost to Follow-up|1|||
126401886|NCT04384107|454765041|FG001|Overall Study|Lost to Follow-up|0|||
126401887|NCT00276614|454765042|FG000|Overall Study|Progression of disease under study|3|||
126401888|NCT01522404|454765045|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
126401889|NCT01522404|454765046|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
126401890|NCT01522404|454765045|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
126401891|NCT01522404|454765046|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
126472188|NCT02008318|455030751|FG000|Overall Study|Protocol Violation|1|||
126472189|NCT02008318|455030752|FG001|Overall Study|Protocol Violation|1|||
126472190|NCT02008318|455030751|FG000|Overall Study|Withdrawal by Subject|3|||
126401892|NCT01522404|454765045|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
126401893|NCT01522404|454765046|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
126401894|NCT02698371|454765047|FG000|All Participants Flow|Lost to Follow-up|3|||
126401895|NCT02698371|454765047|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
126401896|NCT02698371|454765047|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
126401897|NCT02698371|454765047|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
126401898|NCT02698371|454765047|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
126401899|NCT02698371|454765047|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
126401900|NCT02698371|454765047|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
126401901|NCT01591863|454765048|FG000|Overall Study|Adverse Event|3|||
126401902|NCT01591863|454765048|FG000|Overall Study|Withdrawal by Subject|1|||
126401903|NCT01591863|454765048|FG000|Overall Study|recurrence|9|||
126401904|NCT01591863|454765048|FG000|Overall Study|Lack of Efficacy|1|||
126401905|NCT03204890|454766398|FG000|Overall Study|Withdrawal by Subject|1|||
126401906|NCT01549873|454766399|FG000|Overall Study|Physician Decision|0|||
126401907|NCT01549873|454766400|FG001|Overall Study|Physician Decision|1|||
126401908|NCT03769311|454766401|FG000|Overall Study|Withdrawal by Subject|1|||
126401909|NCT01596335|454766402|FG000|Overall Study|exacerbation of primary disease|5|||
126401910|NCT01596335|454766403|FG001|Overall Study|exacerbation of primary disease|9|||
126401911|NCT00098722|454766404|FG000|Double Blind Phase|Adverse Event|7|||
126401912|NCT00098722|454766405|FG001|Double Blind Phase|Adverse Event|7|||
126401913|NCT00098722|454766406|FG002|Double Blind Phase|Adverse Event|3|||
126401914|NCT00098722|454766407|FG003|Double Blind Phase|Adverse Event|0|||
126401915|NCT00098722|454766408|FG004|Double Blind Phase|Adverse Event|0|||
126401916|NCT00098722|454766409|FG005|Double Blind Phase|Adverse Event|0|||
126401917|NCT00098722|454766410|FG006|Double Blind Phase|Adverse Event|0|||
126401918|NCT00098722|454766404|FG000|Double Blind Phase|Death|2|||
126401919|NCT00098722|454766405|FG001|Double Blind Phase|Death|5|||
126401920|NCT00098722|454766406|FG002|Double Blind Phase|Death|0|||
126401921|NCT00098722|454766407|FG003|Double Blind Phase|Death|0|||
126401922|NCT00098722|454766408|FG004|Double Blind Phase|Death|0|||
126401923|NCT00098722|454766409|FG005|Double Blind Phase|Death|0|||
126401924|NCT00098722|454766410|FG006|Double Blind Phase|Death|0|||
126401925|NCT00098722|454766404|FG000|Double Blind Phase|Lack of Efficacy|21|||
126401926|NCT00098722|454766405|FG001|Double Blind Phase|Lack of Efficacy|23|||
126401927|NCT00098722|454766406|FG002|Double Blind Phase|Lack of Efficacy|15|||
126401928|NCT00098722|454766407|FG003|Double Blind Phase|Lack of Efficacy|0|||
126401929|NCT00098722|454766408|FG004|Double Blind Phase|Lack of Efficacy|0|||
126401930|NCT00098722|454766409|FG005|Double Blind Phase|Lack of Efficacy|0|||
126401931|NCT00098722|454766410|FG006|Double Blind Phase|Lack of Efficacy|0|||
126401932|NCT00098722|454766404|FG000|Double Blind Phase|Participant defaulted|16|||
126401933|NCT00098722|454766405|FG001|Double Blind Phase|Participant defaulted|11|||
126401934|NCT00098722|454766406|FG002|Double Blind Phase|Participant defaulted|9|||
126401935|NCT00098722|454766407|FG003|Double Blind Phase|Participant defaulted|0|||
126401936|NCT00098722|454766408|FG004|Double Blind Phase|Participant defaulted|0|||
126401937|NCT00098722|454766409|FG005|Double Blind Phase|Participant defaulted|0|||
126401938|NCT00098722|454766410|FG006|Double Blind Phase|Participant defaulted|0|||
126401939|NCT00098722|454766404|FG000|Double Blind Phase|Pregnancy|1|||
126401940|NCT00098722|454766405|FG001|Double Blind Phase|Pregnancy|0|||
126401941|NCT00098722|454766406|FG002|Double Blind Phase|Pregnancy|0|||
126401942|NCT00098722|454766407|FG003|Double Blind Phase|Pregnancy|0|||
126401943|NCT00098722|454766408|FG004|Double Blind Phase|Pregnancy|0|||
126401944|NCT00098722|454766409|FG005|Double Blind Phase|Pregnancy|0|||
126401945|NCT00098722|454766410|FG006|Double Blind Phase|Pregnancy|0|||
126472191|NCT02008318|455030752|FG001|Overall Study|Withdrawal by Subject|0|||
126472192|NCT02281773|455030753|FG000|Overall Study|Adverse Event|6|||
126472193|NCT02281773|455030754|FG001|Overall Study|Adverse Event|1|||
126472194|NCT02281773|455030755|FG002|Overall Study|Adverse Event|4|||
126472195|NCT02281773|455030756|FG003|Overall Study|Adverse Event|8|||
126472196|NCT02281773|455030757|FG004|Overall Study|Adverse Event|9|||
126472197|NCT02281773|455030753|FG000|Overall Study|Protocol Violation|1|||
126557502|NCT01268059|455334396|FG000|Overall Study|Progression of disease|1|||
126401946|NCT00098722|454766404|FG000|Double Blind Phase|Randomized, not treated|4|||
126472198|NCT02281773|455030754|FG001|Overall Study|Protocol Violation|0|||
126472199|NCT02281773|455030755|FG002|Overall Study|Protocol Violation|0|||
126401947|NCT00098722|454766405|FG001|Double Blind Phase|Randomized, not treated|3|||
126401948|NCT00098722|454766406|FG002|Double Blind Phase|Randomized, not treated|3|||
126401949|NCT00098722|454766407|FG003|Double Blind Phase|Randomized, not treated|0|||
126401950|NCT00098722|454766408|FG004|Double Blind Phase|Randomized, not treated|0|||
126401951|NCT00098722|454766409|FG005|Double Blind Phase|Randomized, not treated|0|||
126472200|NCT02281773|455030756|FG003|Overall Study|Protocol Violation|2|||
126557503|NCT01268059|455334397|FG001|Overall Study|Progression of disease|0|||
126557504|NCT01268059|455334398|FG002|Overall Study|Progression of disease|0|||
126401952|NCT00098722|454766410|FG006|Double Blind Phase|Randomized, not treated|0|||
126472201|NCT02281773|455030757|FG004|Overall Study|Protocol Violation|2|||
126557505|NCT01268059|455334399|FG003|Overall Study|Progression of disease|0|||
126401953|NCT00098722|454766404|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
126401954|NCT00098722|454766405|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
126401955|NCT00098722|454766406|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
126401956|NCT00098722|454766407|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
126401957|NCT00098722|454766408|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
126401958|NCT00098722|454766409|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
126401959|NCT00098722|454766410|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
126401960|NCT00098722|454766404|FG000|Double Blind Phase|Other|7|||
126401961|NCT00098722|454766405|FG001|Double Blind Phase|Other|8|||
126401962|NCT00098722|454766406|FG002|Double Blind Phase|Other|7|||
126401963|NCT00098722|454766407|FG003|Double Blind Phase|Other|0|||
126401964|NCT00098722|454766408|FG004|Double Blind Phase|Other|0|||
126401965|NCT00098722|454766409|FG005|Double Blind Phase|Other|0|||
126401966|NCT00098722|454766410|FG006|Double Blind Phase|Other|0|||
126401967|NCT00098722|454766404|FG000|Open Label Phase|Adverse Event|0|||
126401968|NCT00098722|454766405|FG001|Open Label Phase|Adverse Event|0|||
126401969|NCT00098722|454766406|FG002|Open Label Phase|Adverse Event|0|||
126401970|NCT00098722|454766407|FG003|Open Label Phase|Adverse Event|5|||
126401971|NCT00098722|454766408|FG004|Open Label Phase|Adverse Event|0|||
126401972|NCT00098722|454766409|FG005|Open Label Phase|Adverse Event|0|||
126401973|NCT00098722|454766410|FG006|Open Label Phase|Adverse Event|0|||
126401974|NCT00098722|454766404|FG000|Open Label Phase|Death|0|||
126401975|NCT00098722|454766405|FG001|Open Label Phase|Death|0|||
126401976|NCT00098722|454766406|FG002|Open Label Phase|Death|0|||
126401977|NCT00098722|454766407|FG003|Open Label Phase|Death|2|||
126401978|NCT00098722|454766408|FG004|Open Label Phase|Death|0|||
126401979|NCT00098722|454766409|FG005|Open Label Phase|Death|0|||
126401980|NCT00098722|454766410|FG006|Open Label Phase|Death|0|||
126401981|NCT00098722|454766404|FG000|Open Label Phase|Lack of Efficacy|0|||
126401982|NCT00098722|454766405|FG001|Open Label Phase|Lack of Efficacy|0|||
126401983|NCT00098722|454766406|FG002|Open Label Phase|Lack of Efficacy|0|||
126401984|NCT00098722|454766407|FG003|Open Label Phase|Lack of Efficacy|8|||
126401985|NCT00098722|454766408|FG004|Open Label Phase|Lack of Efficacy|0|||
126401986|NCT00098722|454766409|FG005|Open Label Phase|Lack of Efficacy|0|||
126401987|NCT00098722|454766410|FG006|Open Label Phase|Lack of Efficacy|0|||
126401988|NCT00098722|454766404|FG000|Open Label Phase|Pregnancy|0|||
126401989|NCT00098722|454766405|FG001|Open Label Phase|Pregnancy|0|||
126401990|NCT00098722|454766406|FG002|Open Label Phase|Pregnancy|0|||
126401991|NCT00098722|454766407|FG003|Open Label Phase|Pregnancy|1|||
126401992|NCT00098722|454766408|FG004|Open Label Phase|Pregnancy|0|||
126401993|NCT00098722|454766409|FG005|Open Label Phase|Pregnancy|0|||
126401994|NCT00098722|454766410|FG006|Open Label Phase|Pregnancy|0|||
126401995|NCT00098722|454766404|FG000|Open Label Phase|Participant defaulted|0|||
126401996|NCT00098722|454766405|FG001|Open Label Phase|Participant defaulted|0|||
126401997|NCT00098722|454766406|FG002|Open Label Phase|Participant defaulted|0|||
126401998|NCT00098722|454766407|FG003|Open Label Phase|Participant defaulted|18|||
126401999|NCT00098722|454766408|FG004|Open Label Phase|Participant defaulted|0|||
126402000|NCT00098722|454766409|FG005|Open Label Phase|Participant defaulted|0|||
126402001|NCT00098722|454766410|FG006|Open Label Phase|Participant defaulted|0|||
126402002|NCT00098722|454766404|FG000|Open Label Phase|Ongoing at cut-off date|0|||
126402003|NCT00098722|454766405|FG001|Open Label Phase|Ongoing at cut-off date|0|||
126402004|NCT00098722|454766406|FG002|Open Label Phase|Ongoing at cut-off date|0|||
126402005|NCT00098722|454766407|FG003|Open Label Phase|Ongoing at cut-off date|220|||
126402006|NCT00098722|454766408|FG004|Open Label Phase|Ongoing at cut-off date|50|||
126402007|NCT00098722|454766409|FG005|Open Label Phase|Ongoing at cut-off date|0|||
126402008|NCT00098722|454766410|FG006|Open Label Phase|Ongoing at cut-off date|0|||
126402009|NCT00098722|454766404|FG000|Open Label Phase|Other|0|||
126402010|NCT00098722|454766405|FG001|Open Label Phase|Other|0|||
126402011|NCT00098722|454766406|FG002|Open Label Phase|Other|0|||
126402012|NCT00098722|454766407|FG003|Open Label Phase|Other|18|||
126402013|NCT00098722|454766408|FG004|Open Label Phase|Other|0|||
126402014|NCT00098722|454766409|FG005|Open Label Phase|Other|0|||
126402015|NCT00098722|454766410|FG006|Open Label Phase|Other|0|||
126472202|NCT02281773|455030753|FG000|Overall Study|Lost to Follow-up|2|||
126402016|NCT00098722|454766404|FG000|Observation Phase|Death|0|||
126402017|NCT00098722|454766405|FG001|Observation Phase|Death|0|||
126472203|NCT02281773|455030754|FG001|Overall Study|Lost to Follow-up|2|||
126402018|NCT00098722|454766406|FG002|Observation Phase|Death|0|||
126402019|NCT00098722|454766407|FG003|Observation Phase|Death|0|||
126402020|NCT00098722|454766408|FG004|Observation Phase|Death|0|||
126402021|NCT00098722|454766409|FG005|Observation Phase|Death|5|||
126402022|NCT00098722|454766410|FG006|Observation Phase|Death|3|||
126402023|NCT00098722|454766404|FG000|Observation Phase|Lack of Efficacy|0|||
126402024|NCT00098722|454766405|FG001|Observation Phase|Lack of Efficacy|0|||
126402025|NCT00098722|454766406|FG002|Observation Phase|Lack of Efficacy|0|||
126402026|NCT00098722|454766407|FG003|Observation Phase|Lack of Efficacy|0|||
126402027|NCT00098722|454766408|FG004|Observation Phase|Lack of Efficacy|0|||
126402028|NCT00098722|454766409|FG005|Observation Phase|Lack of Efficacy|2|||
126472204|NCT02281773|455030755|FG002|Overall Study|Lost to Follow-up|6|||
126472205|NCT02281773|455030756|FG003|Overall Study|Lost to Follow-up|2|||
126472206|NCT02281773|455030757|FG004|Overall Study|Lost to Follow-up|10|||
126472207|NCT02281773|455030753|FG000|Overall Study|Withdrawal by Subject|2|||
126557506|NCT02819479|455334400|FG000|Overall Study|Adverse Event|2|||
126557507|NCT05310084|455334401|FG000|Overall Study|Withdrawal by Subject|2|||
126402029|NCT00098722|454766410|FG006|Observation Phase|Lack of Efficacy|0|||
126402030|NCT00098722|454766404|FG000|Observation Phase|Participant defaulted|0|||
126402031|NCT00098722|454766405|FG001|Observation Phase|Participant defaulted|0|||
126402032|NCT00098722|454766406|FG002|Observation Phase|Participant defaulted|0|||
126402033|NCT00098722|454766407|FG003|Observation Phase|Participant defaulted|0|||
126402034|NCT00098722|454766408|FG004|Observation Phase|Participant defaulted|0|||
126402035|NCT00098722|454766409|FG005|Observation Phase|Participant defaulted|17|||
126402036|NCT00098722|454766410|FG006|Observation Phase|Participant defaulted|4|||
126402037|NCT00098722|454766404|FG000|Observation Phase|Other|0|||
126402038|NCT00098722|454766405|FG001|Observation Phase|Other|0|||
126402039|NCT00098722|454766406|FG002|Observation Phase|Other|0|||
126402040|NCT00098722|454766407|FG003|Observation Phase|Other|0|||
126402041|NCT00098722|454766408|FG004|Observation Phase|Other|0|||
126402042|NCT00098722|454766409|FG005|Observation Phase|Other|21|||
126402043|NCT00098722|454766410|FG006|Observation Phase|Other|10|||
126402044|NCT02351349|454766411|FG000|Overall Study|Withdrawal by Subject|2|||
126402045|NCT02351349|454766412|FG001|Overall Study|Withdrawal by Subject|3|||
126402046|NCT00440310|454766413|FG000|Overall Study|Lost to Follow-up|4|||
126402047|NCT00440310|454766414|FG001|Overall Study|Lost to Follow-up|5|||
126402048|NCT00440310|454766413|FG000|Overall Study|Protocol Violation|0|||
126402049|NCT00440310|454766414|FG001|Overall Study|Protocol Violation|1|||
126402050|NCT00440310|454766413|FG000|Overall Study|Withdrawal by Subject|15|||
126402051|NCT00440310|454766414|FG001|Overall Study|Withdrawal by Subject|14|||
126402052|NCT00440310|454766413|FG000|Overall Study|No Reply at EOS|7|||
126402053|NCT00440310|454766414|FG001|Overall Study|No Reply at EOS|7|||
126402054|NCT00440310|454766413|FG000|Overall Study|Other|1|||
126402055|NCT00440310|454766414|FG001|Overall Study|Other|0|||
126402056|NCT00440310|454766413|FG000|Overall Study|Status Unknown|1|||
126402057|NCT00440310|454766414|FG001|Overall Study|Status Unknown|3|||
126402058|NCT01610596|454766421|FG000|Overall Study|Lost to Follow-up|0|||
126402059|NCT01610596|454766422|FG001|Overall Study|Lost to Follow-up|1|||
126402060|NCT01519674|454766423|FG000|Overall Study|Adverse Event|3|||
126402061|NCT01519674|454766424|FG001|Overall Study|Adverse Event|3|||
126402062|NCT01519674|454766425|FG002|Overall Study|Adverse Event|0|||
126402063|NCT01519674|454766423|FG000|Overall Study|Lack of Efficacy|1|||
126402064|NCT01519674|454766424|FG001|Overall Study|Lack of Efficacy|1|||
126402065|NCT01519674|454766425|FG002|Overall Study|Lack of Efficacy|1|||
126402066|NCT01519674|454766423|FG000|Overall Study|Protocol Violation|0|||
126402067|NCT01519674|454766424|FG001|Overall Study|Protocol Violation|3|||
126402068|NCT01519674|454766425|FG002|Overall Study|Protocol Violation|1|||
126557508|NCT05310084|455334402|FG001|Overall Study|Withdrawal by Subject|3|||
126557509|NCT05310084|455334401|FG000|Overall Study|Participant availability|0|||
126557510|NCT05310084|455334402|FG001|Overall Study|Participant availability|4|||
126557511|NCT05310084|455334401|FG000|Overall Study|Lost to Follow-up|1|||
126557512|NCT05310084|455334402|FG001|Overall Study|Lost to Follow-up|1|||
126557513|NCT05310084|455334401|FG000|Overall Study|Adverse Event|1|||
126557514|NCT05310084|455334402|FG001|Overall Study|Adverse Event|1|||
126557515|NCT05310084|455334401|FG000|Overall Study|Randomized but not vaccinated|4|||
126557516|NCT05310084|455334402|FG001|Overall Study|Randomized but not vaccinated|2|||
126557517|NCT01646320|455334404|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
126557518|NCT01646320|455334405|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
126557519|NCT01646320|455334404|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
126557520|NCT01646320|455334405|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
126557521|NCT01646320|455334404|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
126557522|NCT01646320|455334405|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
126557523|NCT01646320|455334404|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
126557524|NCT01646320|455334405|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
126557525|NCT01646320|455334404|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
126557526|NCT01646320|455334405|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
126557527|NCT01646320|455334404|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
126557528|NCT01646320|455334405|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
126557529|NCT01646320|455334404|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
126557530|NCT01646320|455334405|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
126557531|NCT01646320|455334404|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
126557532|NCT01646320|455334405|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
126402069|NCT01519674|454766423|FG000|Overall Study|Withdrawal Criteria|7|||
126402070|NCT01519674|454766424|FG001|Overall Study|Withdrawal Criteria|2|||
126402071|NCT01519674|454766425|FG002|Overall Study|Withdrawal Criteria|7|||
126402072|NCT01519674|454766423|FG000|Overall Study|Unsclassified|10|||
126402073|NCT01519674|454766424|FG001|Overall Study|Unsclassified|4|||
126557533|NCT01646320|455334404|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
126557534|NCT01646320|455334405|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
126557535|NCT01646320|455334404|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
126557536|NCT01646320|455334405|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
126402074|NCT01519674|454766425|FG002|Overall Study|Unsclassified|3|||
126402075|NCT00799591|454766426|FG000|Overall Study|De-escalation of doses|20|||
126402076|NCT00799591|454766426|FG000|Overall Study|Death|14|||
126402077|NCT00799591|454766426|FG000|Overall Study|Technical failure|12|||
126402078|NCT00799591|454766426|FG000|Overall Study|Resistant germ|11|||
126402079|NCT00799591|454766426|FG000|Overall Study|New infection|4|||
126402080|NCT00799591|454766426|FG000|Overall Study|Resistance germ and technical failure|2|||
126402081|NCT00799591|454766426|FG000|Overall Study|Persistance of fever undetermined origin|1|||
126402082|NCT00799591|454766426|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
126402083|NCT00799591|454766426|FG000|Overall Study|Infectious origin not probable|1|||
126402084|NCT03106415|454766429|FG000|Phase 1|Withdrawal by Subject|1|||
126402085|NCT03106415|454766430|FG001|Phase 1|Withdrawal by Subject|0|||
126402086|NCT03106415|454766431|FG002|Phase 1|Withdrawal by Subject|0|||
126402087|NCT03106415|454766429|FG000|Phase 1|Adverse Event|1|||
126402088|NCT03106415|454766430|FG001|Phase 1|Adverse Event|1|||
126402089|NCT03106415|454766431|FG002|Phase 1|Adverse Event|0|||
126402090|NCT03106415|454766429|FG000|Phase 1|Protocol Violation|0|||
126402091|NCT03106415|454766430|FG001|Phase 1|Protocol Violation|1|||
126402092|NCT03106415|454766431|FG002|Phase 1|Protocol Violation|0|||
126402093|NCT00293709|454766432|FG000|Overall Study|Other|47|||
126402094|NCT02785458|454766433|FG000|1 Month|Withdrawal by Subject|2|||
126402095|NCT02785458|454766434|FG001|1 Month|Withdrawal by Subject|1|||
126402096|NCT02785458|454766433|FG000|1 Month|Lost to Follow-up|38|||
126402097|NCT02785458|454766434|FG001|1 Month|Lost to Follow-up|31|||
126402098|NCT02785458|454766433|FG000|1 Month|Deemed Ineligible|1|||
126402099|NCT02785458|454766434|FG001|1 Month|Deemed Ineligible|0|||
126402100|NCT02785458|454766433|FG000|1 Month|Completed Evaluation by Baseline|42|||
126402101|NCT02785458|454766434|FG001|1 Month|Completed Evaluation by Baseline|39|||
126402102|NCT02785458|454766433|FG000|1 Month|Partial Interview|0|||
126402103|NCT02785458|454766434|FG001|1 Month|Partial Interview|4|||
126402104|NCT02785458|454766433|FG000|3 Months|Withdrawal by Subject|3|||
126402105|NCT02785458|454766434|FG001|3 Months|Withdrawal by Subject|1|||
126402106|NCT02785458|454766433|FG000|3 Months|Lost to Follow-up|25|||
126402107|NCT02785458|454766434|FG001|3 Months|Lost to Follow-up|21|||
126402108|NCT02785458|454766433|FG000|3 Months|Completed Evaluation at 1 Month|100|||
126402109|NCT02785458|454766434|FG001|3 Months|Completed Evaluation at 1 Month|89|||
126402110|NCT01804582|454766435|FG000|Overall Study|Lost to Follow-up|47|||
126402111|NCT01804582|454766436|FG001|Overall Study|Lost to Follow-up|56|||
126402112|NCT01804582|454766435|FG000|Overall Study|Physician Decision|2|||
126402113|NCT01804582|454766436|FG001|Overall Study|Physician Decision|0|||
126402114|NCT00520013|454766437|FG000|Overall Study|Withdrawal by Subject|0|||
126402115|NCT00520013|454766438|FG001|Overall Study|Withdrawal by Subject|0|||
126402116|NCT00520013|454766439|FG002|Overall Study|Withdrawal by Subject|1|||
126402117|NCT00520013|454766437|FG000|Overall Study|Adverse Event|2|||
126402118|NCT00520013|454766438|FG001|Overall Study|Adverse Event|10|||
126402119|NCT00520013|454766439|FG002|Overall Study|Adverse Event|7|||
126402120|NCT00520013|454766437|FG000|Overall Study|Progressive Disease|7|||
126402121|NCT00520013|454766438|FG001|Overall Study|Progressive Disease|3|||
126402122|NCT00520013|454766439|FG002|Overall Study|Progressive Disease|0|||
126402123|NCT00520013|454766437|FG000|Overall Study|Clinical Progression|3|||
126402124|NCT00520013|454766438|FG001|Overall Study|Clinical Progression|1|||
126402125|NCT00520013|454766439|FG002|Overall Study|Clinical Progression|0|||
126402126|NCT00520013|454766437|FG000|Overall Study|Death|0|||
126402127|NCT00520013|454766438|FG001|Overall Study|Death|1|||
126402128|NCT00520013|454766439|FG002|Overall Study|Death|0|||
126402129|NCT00520013|454766437|FG000|Overall Study|Physician Decision|0|||
126402130|NCT00520013|454766438|FG001|Overall Study|Physician Decision|0|||
126402131|NCT00520013|454766439|FG002|Overall Study|Physician Decision|3|||
126402132|NCT02677844|454766440|FG000|Period 3|Withdrawal by Subject|0|||
126402133|NCT02677844|454766441|FG001|Period 3|Withdrawal by Subject|0|||
126402134|NCT02677844|454766442|FG002|Period 3|Withdrawal by Subject|0|||
126557537|NCT01646320|455334404|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
126402135|NCT02677844|454766443|FG003|Period 3|Withdrawal by Subject|1|||
126402136|NCT02677844|454766444|FG004|Period 3|Withdrawal by Subject|0|||
126402137|NCT02677844|454766445|FG005|Period 3|Withdrawal by Subject|0|||
126402138|NCT02677844|454766446|FG006|Period 3|Withdrawal by Subject|0|||
126402139|NCT01697462|454766447|FG000|Overall Study|Disease Progression|1|||
126402140|NCT01697462|454766447|FG000|Overall Study|Adverse Event|6|||
126402141|NCT01697462|454766447|FG000|Overall Study|Lost to Follow-up|21|||
126402142|NCT01697462|454766447|FG000|Overall Study|Withdrawal by Subject|12|||
126402143|NCT01697462|454766447|FG000|Overall Study|Investigator Decision|21|||
126402144|NCT01697462|454766447|FG000|Overall Study|Death|1|||
126402145|NCT01697462|454766447|FG000|Overall Study|Other|10|||
126402146|NCT01697462|454766447|FG000|Overall Study|Missing|5|||
126402147|NCT03630302|454766448|FG000|Surgery|hardware issue prevented LFP recordings|1|||
126402148|NCT03630302|454766448|FG000|3 Month Visit|Adverse Event|2|||
126402149|NCT03630302|454766448|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
126402150|NCT01135914|454766451|FG000|Overall Study|Withdrawal by Subject|1|||
126402151|NCT01135914|454766452|FG001|Overall Study|Withdrawal by Subject|3|||
126402152|NCT01135914|454766453|FG002|Overall Study|Withdrawal by Subject|6|||
126402153|NCT01135914|454766451|FG000|Overall Study|Lost to Follow-up|1|||
126402154|NCT01135914|454766452|FG001|Overall Study|Lost to Follow-up|0|||
126402155|NCT01135914|454766453|FG002|Overall Study|Lost to Follow-up|1|||
126402156|NCT01135914|454766451|FG000|Overall Study|Protocol Violation|0|||
126402157|NCT01135914|454766452|FG001|Overall Study|Protocol Violation|0|||
126402158|NCT01135914|454766453|FG002|Overall Study|Protocol Violation|3|||
126402159|NCT01135914|454766451|FG000|Overall Study|Lack of Efficacy|2|||
126402160|NCT01135914|454766452|FG001|Overall Study|Lack of Efficacy|1|||
126402161|NCT01135914|454766453|FG002|Overall Study|Lack of Efficacy|10|||
126402162|NCT01135914|454766451|FG000|Overall Study|Adverse Event|0|||
126402163|NCT01135914|454766452|FG001|Overall Study|Adverse Event|1|||
126402164|NCT01135914|454766453|FG002|Overall Study|Adverse Event|2|||
126402165|NCT03532932|454766454|FG000|Overall Study|Protocol Deviation|33|||
126402166|NCT03532932|454766455|FG001|Overall Study|Protocol Deviation|31|||
126402167|NCT03532932|454766454|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
126402168|NCT03532932|454766455|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
126402169|NCT03532932|454766454|FG000|Overall Study|Withdrawal by Subject|2|||
126402170|NCT03532932|454766455|FG001|Overall Study|Withdrawal by Subject|0|||
126402171|NCT03532932|454766454|FG000|Overall Study|Lost to Follow-up|15|||
126402172|NCT03532932|454766455|FG001|Overall Study|Lost to Follow-up|9|||
126402173|NCT03532932|454766454|FG000|Overall Study|Adverse Event|4|||
126402174|NCT03532932|454766455|FG001|Overall Study|Adverse Event|3|||
126402175|NCT03532932|454766454|FG000|Overall Study|Death|0|||
126402176|NCT03532932|454766455|FG001|Overall Study|Death|2|||
126402177|NCT03532932|454766454|FG000|Overall Study|Other|11|||
126402178|NCT03532932|454766455|FG001|Overall Study|Other|16|||
126402179|NCT02699450|454766456|FG000|Overall Study|Death|2|||
126402180|NCT02699450|454766457|FG001|Overall Study|Death|1|||
126402181|NCT02699450|454766458|FG002|Overall Study|Death|2|||
126402182|NCT02699450|454766456|FG000|Overall Study|Met Criteria for Study Exit|0|||
126402183|NCT02699450|454766457|FG001|Overall Study|Met Criteria for Study Exit|0|||
126402184|NCT02699450|454766458|FG002|Overall Study|Met Criteria for Study Exit|1|||
126402185|NCT02699450|454766456|FG000|Overall Study|Protocol Violation|4|||
126402186|NCT02699450|454766457|FG001|Overall Study|Protocol Violation|3|||
126402187|NCT02699450|454766458|FG002|Overall Study|Protocol Violation|5|||
126402188|NCT02699450|454766456|FG000|Overall Study|Lost to Follow-up|3|||
126402189|NCT02699450|454766457|FG001|Overall Study|Lost to Follow-up|0|||
126402190|NCT02699450|454766458|FG002|Overall Study|Lost to Follow-up|5|||
126402191|NCT02699450|454766456|FG000|Overall Study|Physician Decision|2|||
126402192|NCT02699450|454766457|FG001|Overall Study|Physician Decision|0|||
126402193|NCT02699450|454766458|FG002|Overall Study|Physician Decision|0|||
126402194|NCT02699450|454766456|FG000|Overall Study|Withdrawal by Subject|3|||
126402195|NCT02699450|454766457|FG001|Overall Study|Withdrawal by Subject|1|||
126402196|NCT02699450|454766458|FG002|Overall Study|Withdrawal by Subject|2|||
126402197|NCT02699450|454766456|FG000|Overall Study|Adverse Event|1|||
126402198|NCT02699450|454766457|FG001|Overall Study|Adverse Event|0|||
126402199|NCT02699450|454766458|FG002|Overall Study|Adverse Event|0|||
126402200|NCT01344629|454766459|FG000|Crossover Period 2|Withdrawal by Subject|0|||
126402201|NCT01344629|454766460|FG001|Crossover Period 2|Withdrawal by Subject|1|||
126402202|NCT00693472|454766462|FG000|Part 1|Adverse Event|1|||
126402203|NCT00693472|454766463|FG001|Part 1|Adverse Event|1|||
126402204|NCT00693472|454766464|FG002|Part 1|Adverse Event|0|||
126402205|NCT00693472|454766465|FG003|Part 1|Adverse Event|0|||
126402206|NCT00693472|454766462|FG000|Part 1|Lost to Follow-up|0|||
126402207|NCT00693472|454766463|FG001|Part 1|Lost to Follow-up|1|||
126402208|NCT00693472|454766464|FG002|Part 1|Lost to Follow-up|0|||
126402209|NCT00693472|454766465|FG003|Part 1|Lost to Follow-up|0|||
126402210|NCT00693472|454766462|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
126402211|NCT00693472|454766463|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
126402212|NCT00693472|454766464|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
126402213|NCT00693472|454766465|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
126402214|NCT00693472|454766462|FG000|Part 2|Adverse Event|0|||
126402215|NCT00693472|454766463|FG001|Part 2|Adverse Event|0|||
126402216|NCT00693472|454766464|FG002|Part 2|Adverse Event|1|||
126402217|NCT00693472|454766465|FG003|Part 2|Adverse Event|0|||
126402218|NCT00693472|454766462|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
126402219|NCT00693472|454766463|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
126402220|NCT00693472|454766464|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
126402221|NCT00693472|454766465|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
126402222|NCT04063787|454766468|FG000|Overall Study|Inadequate Doppler data|4|||
126402223|NCT04063787|454766468|FG000|Overall Study|Lost to Follow-up|2|||
126402224|NCT04063787|454766468|FG000|Overall Study|Death|3|||
126402225|NCT05545644|454766469|FG000|Overall Study|Lost to Follow-up|4|||
126402226|NCT05545644|454766470|FG001|Overall Study|Lost to Follow-up|3|||
126402227|NCT00453973|454766475|FG000|Overall Study|Adverse Event|4|||
126472208|NCT02281773|455030754|FG001|Overall Study|Withdrawal by Subject|8|||
126402228|NCT00453973|454766476|FG001|Overall Study|Adverse Event|9|||
126402229|NCT00453973|454766475|FG000|Overall Study|Withdrawal by Subject|7|||
126402230|NCT00453973|454766476|FG001|Overall Study|Withdrawal by Subject|6|||
126402231|NCT00453973|454766475|FG000|Overall Study|PI Decision|0|||
126402232|NCT00453973|454766476|FG001|Overall Study|PI Decision|2|||
126402233|NCT00453973|454766475|FG000|Overall Study|Relocation|1|||
126402234|NCT00453973|454766476|FG001|Overall Study|Relocation|0|||
126402235|NCT00453973|454766475|FG000|Overall Study|Renal transplant|1|||
126402236|NCT00453973|454766476|FG001|Overall Study|Renal transplant|1|||
126402237|NCT00453973|454766475|FG000|Overall Study|Site closed by sponsor|3|||
126402238|NCT00453973|454766476|FG001|Overall Study|Site closed by sponsor|0|||
126402239|NCT00453973|454766475|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
126402240|NCT00453973|454766476|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
126402241|NCT00276094|454766477|FG000|Overall Study|Adverse Event|15|||
126402242|NCT00276094|454766478|FG001|Overall Study|Adverse Event|13|||
126402243|NCT00276094|454766479|FG002|Overall Study|Adverse Event|11|||
126402244|NCT00276094|454766477|FG000|Overall Study|Withdrawal by Subject|14|||
126402245|NCT00276094|454766478|FG001|Overall Study|Withdrawal by Subject|14|||
126557538|NCT01646320|455334405|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
126557539|NCT01489020|455334406|FG000|Overall Study|Withdrawal by Subject|1|||
126402246|NCT00276094|454766479|FG002|Overall Study|Withdrawal by Subject|12|||
126402247|NCT00276094|454766477|FG000|Overall Study|Protocol Violation|16|||
126402248|NCT00276094|454766478|FG001|Overall Study|Protocol Violation|7|||
126402249|NCT00276094|454766479|FG002|Overall Study|Protocol Violation|10|||
126402250|NCT00276094|454766477|FG000|Overall Study|Lost to Follow-up|8|||
126402251|NCT00276094|454766478|FG001|Overall Study|Lost to Follow-up|6|||
126402252|NCT00276094|454766479|FG002|Overall Study|Lost to Follow-up|4|||
126402253|NCT00276094|454766477|FG000|Overall Study|Other-Subject moved out of country|1|||
126402254|NCT00276094|454766478|FG001|Overall Study|Other-Subject moved out of country|0|||
126402255|NCT00276094|454766479|FG002|Overall Study|Other-Subject moved out of country|0|||
126402256|NCT00276094|454766477|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
126402257|NCT00276094|454766478|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
126402258|NCT00276094|454766479|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
126402259|NCT00276094|454766477|FG000|Overall Study|Other-Lack of efficacy|1|||
126402260|NCT00276094|454766478|FG001|Overall Study|Other-Lack of efficacy|0|||
126402261|NCT00276094|454766479|FG002|Overall Study|Other-Lack of efficacy|0|||
126402262|NCT00276094|454766477|FG000|Overall Study|Other-Refused follow-up visit|1|||
126402263|NCT00276094|454766478|FG001|Overall Study|Other-Refused follow-up visit|0|||
126402264|NCT00276094|454766479|FG002|Overall Study|Other-Refused follow-up visit|0|||
126402265|NCT00276094|454766477|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
126402266|NCT00276094|454766478|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
126402267|NCT00276094|454766479|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
126402268|NCT00276094|454766477|FG000|Overall Study|Other-Relocation|0|||
126402269|NCT00276094|454766478|FG001|Overall Study|Other-Relocation|1|||
126402270|NCT00276094|454766479|FG002|Overall Study|Other-Relocation|0|||
126402271|NCT00276094|454766477|FG000|Overall Study|Other-Study medication lost|0|||
126402272|NCT00276094|454766478|FG001|Overall Study|Other-Study medication lost|0|||
126402273|NCT00276094|454766479|FG002|Overall Study|Other-Study medication lost|1|||
126402274|NCT03002623|454766482|FG000|Overall Study|Lost to Follow-up|1|||
126402275|NCT03002623|454766483|FG001|Overall Study|Lost to Follow-up|0|||
126402276|NCT03002623|454766482|FG000|Overall Study|Physician Decision|1|||
126402277|NCT03002623|454766483|FG001|Overall Study|Physician Decision|1|||
126402278|NCT00493636|454766485|FG000|Overall Study|Withdrawal by Subject|1|||
126402279|NCT00493636|454766486|FG001|Overall Study|Withdrawal by Subject|0|||
126402280|NCT00493636|454766485|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
126402281|NCT00493636|454766486|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
126402282|NCT00493636|454766485|FG000|Overall Study|Mis-randomization|1|||
126402283|NCT00493636|454766486|FG001|Overall Study|Mis-randomization|1|||
126402284|NCT01873729|454766493|FG000|Overall Study|Withdrawal by Subject|1|||
126402285|NCT02463032|454766494|FG000|Overall Study|Lack of Efficacy|61|||
126402286|NCT02463032|454766495|FG001|Overall Study|Lack of Efficacy|50|||
126402287|NCT02463032|454766494|FG000|Overall Study|Death|8|||
126402288|NCT02463032|454766495|FG001|Overall Study|Death|8|||
126402289|NCT02463032|454766494|FG000|Overall Study|Adverse Event|2|||
126402290|NCT02463032|454766495|FG001|Overall Study|Adverse Event|6|||
126402291|NCT01066780|454766496|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
126402292|NCT01066780|454766497|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
126402293|NCT00160199|454766502|FG000|Overall Study|Adverse Event|5|||
126402294|NCT00160199|454766503|FG001|Overall Study|Adverse Event|14|||
126402295|NCT00160199|454766502|FG000|Overall Study|Lack of Efficacy|0|||
126402296|NCT00160199|454766503|FG001|Overall Study|Lack of Efficacy|1|||
126557540|NCT01489020|455334407|FG001|Overall Study|Withdrawal by Subject|0|||
126402297|NCT00160199|454766502|FG000|Overall Study|Lost to Follow-up|7|||
126402298|NCT00160199|454766503|FG001|Overall Study|Lost to Follow-up|7|||
126402299|NCT00160199|454766502|FG000|Overall Study|Withdrawal by Subject|4|||
126402300|NCT00160199|454766503|FG001|Overall Study|Withdrawal by Subject|6|||
126557541|NCT01489020|455334408|FG002|Overall Study|Withdrawal by Subject|0|||
126557542|NCT01489020|455334409|FG003|Overall Study|Withdrawal by Subject|0|||
126402301|NCT00160199|454766502|FG000|Overall Study|Administrative|0|||
126402302|NCT00160199|454766503|FG001|Overall Study|Administrative|1|||
126402303|NCT00160199|454766502|FG000|Overall Study|Protocol Violation|8|||
126402304|NCT00160199|454766503|FG001|Overall Study|Protocol Violation|8|||
126402305|NCT03352453|454766504|FG000|Overall Study|Miscellaneous Reasons|1|||
126402306|NCT03352453|454766505|FG001|Overall Study|Miscellaneous Reasons|2|||
126402307|NCT03352453|454766504|FG000|Overall Study|Lack of Efficacy|1|||
126402308|NCT03352453|454766505|FG001|Overall Study|Lack of Efficacy|0|||
126402309|NCT03352453|454766504|FG000|Overall Study|Withdrawal by Subject|8|||
126402310|NCT03352453|454766505|FG001|Overall Study|Withdrawal by Subject|14|||
126402311|NCT03352453|454766504|FG000|Overall Study|Study Terminated by Sponsor|2|||
126402312|NCT03352453|454766505|FG001|Overall Study|Study Terminated by Sponsor|1|||
126402313|NCT03352453|454766504|FG000|Overall Study|Protocol Deviation|1|||
126402314|NCT03352453|454766505|FG001|Overall Study|Protocol Deviation|0|||
126402315|NCT03352453|454766504|FG000|Overall Study|Lost to Follow-up|7|||
126402316|NCT03352453|454766505|FG001|Overall Study|Lost to Follow-up|6|||
126402317|NCT03352453|454766504|FG000|Overall Study|Adverse Event|2|||
126402318|NCT03352453|454766505|FG001|Overall Study|Adverse Event|9|||
126402319|NCT01241760|454766508|FG000|Overall Study|Adverse Event|1|||
126402320|NCT01241760|454766509|FG001|Overall Study|Adverse Event|0|||
126402321|NCT01241760|454766508|FG000|Overall Study|Lost to Follow-up|18|||
126402322|NCT01241760|454766509|FG001|Overall Study|Lost to Follow-up|22|||
126402323|NCT01241760|454766508|FG000|Overall Study|Withdrawal by Subject|13|||
126402324|NCT01241760|454766509|FG001|Overall Study|Withdrawal by Subject|13|||
126402325|NCT01241760|454766508|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
126402326|NCT01241760|454766509|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
126402327|NCT01241760|454766508|FG000|Overall Study|Other|1|||
126402328|NCT01241760|454766509|FG001|Overall Study|Other|1|||
126402329|NCT03089944|454766510|FG000|Overall Study|Lost to Follow-up|8|||
126402330|NCT03089944|454766510|FG000|Overall Study|Withdrew Consent|2|||
126402331|NCT03089944|454766510|FG000|Overall Study|Adverse Event|1|||
126402332|NCT03089944|454766510|FG000|Overall Study|Other|1|||
126402333|NCT03780959|454766511|FG000|Part 1|Adverse Event|1|||
126402334|NCT03780959|454766512|FG001|Part 1|Adverse Event|0|||
126402335|NCT03780959|454766513|FG002|Part 1|Adverse Event|0|||
126402336|NCT03780959|454766511|FG000|Part 1|Withdrawal by Subject|1|||
126402337|NCT03780959|454766512|FG001|Part 1|Withdrawal by Subject|0|||
126402338|NCT03780959|454766513|FG002|Part 1|Withdrawal by Subject|0|||
126402339|NCT03780959|454766511|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
126402340|NCT03780959|454766512|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
126402341|NCT03780959|454766513|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
126402342|NCT03780959|454766511|FG000|Part 1|Response Status|2|||
126402343|NCT03780959|454766512|FG001|Part 1|Response Status|0|||
126402344|NCT03780959|454766513|FG002|Part 1|Response Status|0|||
126402345|NCT03780959|454766511|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
126402346|NCT03780959|454766512|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
126402347|NCT03780959|454766513|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
126402348|NCT03780959|454766511|FG000|Part 2|Response Status|0|||
126402349|NCT03780959|454766512|FG001|Part 2|Response Status|18|||
126402350|NCT03780959|454766513|FG002|Part 2|Response Status|6|||
126402351|NCT01636713|454766514|FG000|Overall Study|Adverse Event|16|||
126402352|NCT01636713|454766515|FG001|Overall Study|Adverse Event|16|||
126472209|NCT02281773|455030755|FG002|Overall Study|Withdrawal by Subject|6|||
126472210|NCT02281773|455030756|FG003|Overall Study|Withdrawal by Subject|6|||
126472211|NCT02281773|455030757|FG004|Overall Study|Withdrawal by Subject|8|||
126472212|NCT02281773|455030753|FG000|Overall Study|Other Reason|0|||
126472213|NCT02281773|455030754|FG001|Overall Study|Other Reason|4|||
126472214|NCT02281773|455030755|FG002|Overall Study|Other Reason|2|||
126472215|NCT02281773|455030756|FG003|Overall Study|Other Reason|3|||
126472216|NCT02281773|455030757|FG004|Overall Study|Other Reason|1|||
126472217|NCT02104752|455030758|FG000|Overall Study|Withdrawal by Subject|1|||
126472218|NCT02104752|455030759|FG001|Overall Study|Withdrawal by Subject|0|||
126472219|NCT02104752|455030758|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
126472220|NCT02104752|455030759|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
126472221|NCT00231842|455030760|FG000|Overall Study|Withdrawal by Subject|3|||
126472222|NCT00231842|455030760|FG000|Overall Study|Did not complete the last 3 cycle|8|||
126472223|NCT05439941|455030761|FG000|Overall Study|Lack of Efficacy|8|||
126472224|NCT05439941|455030762|FG001|Overall Study|Lack of Efficacy|5|||
126472225|NCT05439941|455030763|FG002|Overall Study|Lack of Efficacy|3|||
126472226|NCT05439941|455030761|FG000|Overall Study|Treatment Failure|0|||
126402353|NCT01636713|454766516|FG002|Overall Study|Adverse Event|7|||
126402354|NCT01636713|454766514|FG000|Overall Study|Lack of Efficacy|6|||
126402355|NCT01636713|454766515|FG001|Overall Study|Lack of Efficacy|6|||
126472227|NCT05439941|455030762|FG001|Overall Study|Treatment Failure|1|||
126402356|NCT01636713|454766516|FG002|Overall Study|Lack of Efficacy|2|||
126402357|NCT01636713|454766514|FG000|Overall Study|Protocol Violation|3|||
126402358|NCT01636713|454766515|FG001|Overall Study|Protocol Violation|0|||
126402359|NCT01636713|454766516|FG002|Overall Study|Protocol Violation|1|||
126402360|NCT01636713|454766514|FG000|Overall Study|Lost to Follow-up|0|||
126402361|NCT01636713|454766515|FG001|Overall Study|Lost to Follow-up|0|||
126402362|NCT01636713|454766516|FG002|Overall Study|Lost to Follow-up|1|||
126402363|NCT01636713|454766514|FG000|Overall Study|Withdrawal by Subject|5|||
126402364|NCT01636713|454766515|FG001|Overall Study|Withdrawal by Subject|4|||
126402365|NCT01636713|454766516|FG002|Overall Study|Withdrawal by Subject|8|||
126402366|NCT01636713|454766514|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
126402367|NCT01636713|454766515|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
126402368|NCT01636713|454766516|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
126402369|NCT03689244|454766521|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
126402370|NCT03689244|454766522|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
126402371|NCT03689244|454766523|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
126402372|NCT03689244|454766524|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
126402373|NCT03689244|454766521|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
126402374|NCT03689244|454766522|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
126472228|NCT05439941|455030763|FG002|Overall Study|Treatment Failure|0|||
126472229|NCT05439941|455030761|FG000|Overall Study|Adverse Event|1|||
126472230|NCT05439941|455030762|FG001|Overall Study|Adverse Event|3|||
126472231|NCT05439941|455030763|FG002|Overall Study|Adverse Event|0|||
126557543|NCT01489020|455334410|FG004|Overall Study|Withdrawal by Subject|0|||
126557544|NCT01489020|455334411|FG005|Overall Study|Withdrawal by Subject|0|||
126557545|NCT01489020|455334406|FG000|Overall Study|Adverse Event|0|||
126557546|NCT01489020|455334407|FG001|Overall Study|Adverse Event|0|||
126557547|NCT01489020|455334408|FG002|Overall Study|Adverse Event|3|||
126557548|NCT01489020|455334409|FG003|Overall Study|Adverse Event|0|||
126557549|NCT01489020|455334410|FG004|Overall Study|Adverse Event|3|||
126557550|NCT01489020|455334411|FG005|Overall Study|Adverse Event|0|||
126557551|NCT01489020|455334406|FG000|Overall Study|Concomitant disease|0|||
126557552|NCT01489020|455334407|FG001|Overall Study|Concomitant disease|0|||
126557553|NCT01489020|455334408|FG002|Overall Study|Concomitant disease|0|||
126557554|NCT01489020|455334409|FG003|Overall Study|Concomitant disease|0|||
126557555|NCT01489020|455334410|FG004|Overall Study|Concomitant disease|3|||
126557556|NCT01489020|455334411|FG005|Overall Study|Concomitant disease|0|||
126557557|NCT02424344|455334412|FG000|Overall Study|Lack of Efficacy|0|||
126557558|NCT02424344|455334413|FG001|Overall Study|Lack of Efficacy|1|||
126557559|NCT02424344|455334412|FG000|Overall Study|Withdrawal by Subject|2|||
126557560|NCT02424344|455334413|FG001|Overall Study|Withdrawal by Subject|1|||
126557561|NCT02424344|455334412|FG000|Overall Study|Lost to Follow-up|1|||
126557562|NCT02424344|455334413|FG001|Overall Study|Lost to Follow-up|0|||
126557563|NCT02424344|455334412|FG000|Overall Study|Adverse Event|4|||
126557564|NCT02424344|455334413|FG001|Overall Study|Adverse Event|8|||
126557565|NCT01174550|455334414|FG000|Overall Study|Death|75|||
126557566|NCT01174550|455334415|FG001|Overall Study|Death|74|||
126557567|NCT01174550|455334414|FG000|Overall Study|Lost to Follow-up|652|||
126557568|NCT01174550|455334415|FG001|Overall Study|Lost to Follow-up|510|||
126557569|NCT01174550|455334414|FG000|Overall Study|Withdrawal by Subject|543|||
126557570|NCT01174550|455334415|FG001|Overall Study|Withdrawal by Subject|289|||
126557571|NCT05257837|455334416|FG000|Overall Study|Excluded (did not find the guns)|4|||
126557572|NCT05257837|455334417|FG001|Overall Study|Excluded (did not find the guns)|2|||
126557573|NCT05257837|455334418|FG002|Overall Study|Excluded (did not find the guns)|4|||
126557574|NCT05257837|455334419|FG003|Overall Study|Excluded (did not find the guns)|0|||
126557575|NCT01625338|455334420|FG000|Overall Study|Enrolled but not Treated|0|||
126557576|NCT01625338|455334421|FG001|Overall Study|Enrolled but not Treated|0|||
126557577|NCT01625338|455334422|FG002|Overall Study|Enrolled but not Treated|1|||
126557578|NCT01625338|455334420|FG000|Overall Study|Efficacy Failure|27|||
126557579|NCT01625338|455334421|FG001|Overall Study|Efficacy Failure|39|||
126557580|NCT01625338|455334422|FG002|Overall Study|Efficacy Failure|31|||
126472232|NCT05439941|455030761|FG000|Overall Study|Adverse Event - Parent Study|1|||
126472233|NCT05439941|455030762|FG001|Overall Study|Adverse Event - Parent Study|0|||
126472234|NCT05439941|455030763|FG002|Overall Study|Adverse Event - Parent Study|0|||
126472235|NCT05439941|455030761|FG000|Overall Study|Pregnancy|1|||
126472236|NCT05439941|455030762|FG001|Overall Study|Pregnancy|0|||
126472237|NCT05439941|455030763|FG002|Overall Study|Pregnancy|0|||
126472238|NCT05439941|455030761|FG000|Overall Study|Withdrawal by Subject|9|||
126557581|NCT01625338|455334420|FG000|Overall Study|Lost to Follow-up|3|||
126557582|NCT01625338|455334421|FG001|Overall Study|Lost to Follow-up|3|||
126402375|NCT03689244|454766523|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
126472239|NCT05439941|455030762|FG001|Overall Study|Withdrawal by Subject|6|||
126472240|NCT05439941|455030763|FG002|Overall Study|Withdrawal by Subject|10|||
126472241|NCT05439941|455030761|FG000|Overall Study|Non-Compliance|1|||
126557583|NCT01625338|455334422|FG002|Overall Study|Lost to Follow-up|2|||
126557584|NCT01625338|455334420|FG000|Overall Study|Investigator Decision|0|||
126557585|NCT01625338|455334421|FG001|Overall Study|Investigator Decision|2|||
126557586|NCT01625338|455334422|FG002|Overall Study|Investigator Decision|1|||
126557587|NCT01625338|455334420|FG000|Overall Study|Subject Withdrew Consent|1|||
126557588|NCT01625338|455334421|FG001|Overall Study|Subject Withdrew Consent|0|||
126557589|NCT01625338|455334422|FG002|Overall Study|Subject Withdrew Consent|2|||
126402376|NCT03689244|454766524|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
126402377|NCT03689244|454766521|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
126402378|NCT03689244|454766522|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
126402379|NCT03689244|454766523|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
126402380|NCT03689244|454766524|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
126402381|NCT03689244|454766521|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
126402382|NCT03689244|454766522|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
126402383|NCT03689244|454766523|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
126402384|NCT03689244|454766524|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
126402385|NCT03689244|454766521|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
126402386|NCT03689244|454766522|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
126402387|NCT03689244|454766523|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
126402388|NCT03689244|454766524|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
126402389|NCT03689244|454766521|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
126402390|NCT03689244|454766522|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
126402391|NCT03689244|454766523|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
126402392|NCT03689244|454766524|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
126402393|NCT03689244|454766521|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
126402394|NCT03689244|454766522|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
126402395|NCT03689244|454766523|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
126402396|NCT03689244|454766524|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
126402397|NCT03689244|454766521|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
126402398|NCT03689244|454766522|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
126402399|NCT03689244|454766523|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
126402400|NCT03689244|454766524|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
126402401|NCT01565564|454766525|FG000|Overall Study|Lost to Follow-up|5|||
126402402|NCT01565564|454766526|FG001|Overall Study|Lost to Follow-up|1|||
126402403|NCT00969436|454766528|FG000|Overall Study|Protocol Violation|1|||
126402404|NCT00969436|454766529|FG001|Overall Study|Protocol Violation|3|||
126402405|NCT00969436|454766530|FG002|Overall Study|Protocol Violation|0|||
126402406|NCT00969436|454766528|FG000|Overall Study|Migrated/moved from study area|12|||
126402407|NCT00969436|454766529|FG001|Overall Study|Migrated/moved from study area|10|||
126402408|NCT00969436|454766530|FG002|Overall Study|Migrated/moved from study area|2|||
126402409|NCT00969436|454766528|FG000|Overall Study|Father - serious health problem|0|||
126557590|NCT01625338|455334420|FG000|Overall Study|Adverse Event|1|||
126557591|NCT01625338|455334421|FG001|Overall Study|Adverse Event|0|||
126557592|NCT01625338|455334422|FG002|Overall Study|Adverse Event|1|||
126557593|NCT01625338|455334420|FG000|Overall Study|Study Discontinued by Sponsor|0|||
126557594|NCT01625338|455334421|FG001|Overall Study|Study Discontinued by Sponsor|0|||
126557595|NCT01625338|455334422|FG002|Overall Study|Study Discontinued by Sponsor|1|||
126557596|NCT05343455|455334427|FG000|Overall Study|Withdrawal by Subject|4|||
126557597|NCT05343455|455334428|FG001|Overall Study|Withdrawal by Subject|9|||
126557598|NCT05343455|455334429|FG002|Overall Study|Withdrawal by Subject|7|||
126557599|NCT05343455|455334427|FG000|Overall Study|Adverse Event|2|||
126557600|NCT05343455|455334428|FG001|Overall Study|Adverse Event|1|||
126402410|NCT00969436|454766529|FG001|Overall Study|Father - serious health problem|0|||
126402411|NCT00969436|454766530|FG002|Overall Study|Father - serious health problem|1|||
126472242|NCT05439941|455030762|FG001|Overall Study|Non-Compliance|1|||
126472243|NCT05439941|455030763|FG002|Overall Study|Non-Compliance|1|||
126472244|NCT05439941|455030761|FG000|Overall Study|Lost to Follow-up|2|||
126472245|NCT05439941|455030762|FG001|Overall Study|Lost to Follow-up|2|||
126472246|NCT05439941|455030763|FG002|Overall Study|Lost to Follow-up|0|||
126472247|NCT05439941|455030761|FG000|Overall Study|Physician Decision|1|||
126472248|NCT05439941|455030762|FG001|Overall Study|Physician Decision|0|||
126472249|NCT05439941|455030763|FG002|Overall Study|Physician Decision|0|||
126472250|NCT05439941|455030761|FG000|Overall Study|Trial Termination by Sponsor|78|||
126472251|NCT05439941|455030762|FG001|Overall Study|Trial Termination by Sponsor|83|||
126472252|NCT05439941|455030763|FG002|Overall Study|Trial Termination by Sponsor|65|||
126472253|NCT05439941|455030761|FG000|Overall Study|Other than Reasons Listed|2|||
126472254|NCT05439941|455030762|FG001|Overall Study|Other than Reasons Listed|1|||
126472255|NCT05439941|455030763|FG002|Overall Study|Other than Reasons Listed|0|||
126472256|NCT02422303|455030764|FG000|Overall Study|Lost to Follow-up|1|||
126472257|NCT02422303|455030765|FG001|Overall Study|Lost to Follow-up|1|||
126472258|NCT02899299|455030767|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
126472259|NCT02899299|455030768|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
126472260|NCT02899299|455030767|FG000|Pre-treatment|Participant withdrew consent|1|||
126557601|NCT05343455|455334429|FG002|Overall Study|Adverse Event|2|||
126402412|NCT00969436|454766528|FG000|Overall Study|Parents personal problem|0|||
126472261|NCT02899299|455030768|FG001|Pre-treatment|Participant withdrew consent|11|||
126402413|NCT00969436|454766529|FG001|Overall Study|Parents personal problem|0|||
126402414|NCT00969436|454766530|FG002|Overall Study|Parents personal problem|1|||
126557602|NCT05343455|455334427|FG000|Overall Study|Lost to Follow-up|1|||
126557603|NCT05343455|455334428|FG001|Overall Study|Lost to Follow-up|1|||
126557604|NCT05343455|455334429|FG002|Overall Study|Lost to Follow-up|3|||
126557605|NCT05343455|455334427|FG000|Overall Study|Pregnancy|1|||
126557606|NCT05343455|455334428|FG001|Overall Study|Pregnancy|0|||
126557607|NCT05343455|455334429|FG002|Overall Study|Pregnancy|0|||
126557608|NCT05343455|455334427|FG000|Overall Study|Physician Decision|0|||
126402415|NCT00969436|454766528|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
126402416|NCT00969436|454766529|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
126402417|NCT00969436|454766530|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
126402418|NCT00969436|454766528|FG000|Overall Study|Withdrawal by Subject|3|||
126402419|NCT00969436|454766529|FG001|Overall Study|Withdrawal by Subject|0|||
126402420|NCT00969436|454766530|FG002|Overall Study|Withdrawal by Subject|2|||
126402421|NCT00969436|454766528|FG000|Overall Study|Lost to Follow-up|8|||
126402422|NCT00969436|454766529|FG001|Overall Study|Lost to Follow-up|8|||
126402423|NCT00969436|454766530|FG002|Overall Study|Lost to Follow-up|5|||
126402424|NCT00459537|454766540|FG000|Overall Study|Adverse Event|1|||
126402425|NCT00459537|454766541|FG001|Overall Study|Adverse Event|6|||
126402426|NCT00459537|454766540|FG000|Overall Study|Lack of Efficacy|10|||
126402427|NCT00459537|454766541|FG001|Overall Study|Lack of Efficacy|11|||
126402428|NCT00459537|454766540|FG000|Overall Study|Withdrawal by Subject|20|||
126402429|NCT00459537|454766541|FG001|Overall Study|Withdrawal by Subject|26|||
126402430|NCT00459537|454766540|FG000|Overall Study|Lost to Follow-up|27|||
126402431|NCT00459537|454766541|FG001|Overall Study|Lost to Follow-up|30|||
126402432|NCT00459537|454766540|FG000|Overall Study|Administrative problems|3|||
126402433|NCT00459537|454766541|FG001|Overall Study|Administrative problems|0|||
126402434|NCT00459537|454766540|FG000|Overall Study|Protocol Violation|4|||
126402435|NCT00459537|454766541|FG001|Overall Study|Protocol Violation|3|||
126402436|NCT00459537|454766540|FG000|Overall Study|Missing|1|||
126402437|NCT00459537|454766541|FG001|Overall Study|Missing|0|||
126402438|NCT03159104|454766542|FG000|Overall Study|Violation of inclusion criteria|1|||
126402439|NCT03159104|454766543|FG001|Overall Study|Violation of inclusion criteria|2|||
126402440|NCT00456599|454766544|FG000|Overall Study|Non-compliance|1|||
126402441|NCT00456599|454766544|FG000|Overall Study|Withdrawal by Subject|2|||
126402442|NCT01999218|454766545|FG000|Overall Study|Hyperglycemia|18|||
126402443|NCT01999218|454766546|FG001|Overall Study|Hyperglycemia|17|||
126402444|NCT01999218|454766547|FG002|Overall Study|Hyperglycemia|17|||
126402445|NCT01999218|454766545|FG000|Overall Study|Lack of Efficacy|1|||
126402446|NCT01999218|454766546|FG001|Overall Study|Lack of Efficacy|0|||
126402447|NCT01999218|454766547|FG002|Overall Study|Lack of Efficacy|1|||
126402448|NCT01999218|454766545|FG000|Overall Study|Lost to Follow-up|22|||
126402449|NCT01999218|454766546|FG001|Overall Study|Lost to Follow-up|17|||
126402450|NCT01999218|454766547|FG002|Overall Study|Lost to Follow-up|18|||
126402451|NCT01999218|454766545|FG000|Overall Study|Non-Compliance With Study Drug|6|||
126402452|NCT01999218|454766546|FG001|Overall Study|Non-Compliance With Study Drug|4|||
126402453|NCT01999218|454766547|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126402454|NCT01999218|454766545|FG000|Overall Study|Physician Decision|1|||
126402455|NCT01999218|454766546|FG001|Overall Study|Physician Decision|4|||
126402456|NCT01999218|454766547|FG002|Overall Study|Physician Decision|6|||
126402457|NCT01999218|454766545|FG000|Overall Study|Protocol Violation|4|||
126402458|NCT01999218|454766546|FG001|Overall Study|Protocol Violation|5|||
126402459|NCT01999218|454766547|FG002|Overall Study|Protocol Violation|4|||
126402460|NCT01999218|454766545|FG000|Overall Study|Screen failure|0|||
126402461|NCT01999218|454766546|FG001|Overall Study|Screen failure|1|||
126402462|NCT01999218|454766547|FG002|Overall Study|Screen failure|0|||
126402463|NCT01999218|454766545|FG000|Overall Study|Study Terminated By Sponsor|7|||
126402464|NCT01999218|454766546|FG001|Overall Study|Study Terminated By Sponsor|5|||
126402465|NCT01999218|454766547|FG002|Overall Study|Study Terminated By Sponsor|12|||
126472262|NCT02899299|455030767|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
126472263|NCT02899299|455030768|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
126472264|NCT02899299|455030767|FG000|Pre-treatment|Not reported|0|||
126472265|NCT02899299|455030768|FG001|Pre-treatment|Not reported|1|||
126472266|NCT02899299|455030767|FG000|Treatment|Disease Progression|182|||
126472267|NCT02899299|455030768|FG001|Treatment|Disease Progression|43|||
126472268|NCT02899299|455030767|FG000|Treatment|Study Drug Toxicity|60|||
126472269|NCT02899299|455030768|FG001|Treatment|Study Drug Toxicity|24|||
126472270|NCT02899299|455030767|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
126472271|NCT02899299|455030768|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
126472272|NCT02899299|455030767|FG000|Treatment|Participant request to discontinue Study treatment|4|||
126557609|NCT05343455|455334428|FG001|Overall Study|Physician Decision|0|||
126402466|NCT01999218|454766545|FG000|Overall Study|Participant moves|2|||
126402467|NCT01999218|454766546|FG001|Overall Study|Participant moves|5|||
126402468|NCT01999218|454766547|FG002|Overall Study|Participant moves|3|||
126402469|NCT01999218|454766545|FG000|Overall Study|Withdrawal by Subject|28|||
126557610|NCT05343455|455334429|FG002|Overall Study|Physician Decision|1|||
126557611|NCT05343455|455334427|FG000|Overall Study|Protocol Violation|0|||
126402470|NCT01999218|454766546|FG001|Overall Study|Withdrawal by Subject|29|||
126402471|NCT01999218|454766547|FG002|Overall Study|Withdrawal by Subject|34|||
126402472|NCT01999218|454766545|FG000|Overall Study|Creatinine/eGFR|0|||
126402473|NCT01999218|454766546|FG001|Overall Study|Creatinine/eGFR|0|||
126402474|NCT01999218|454766547|FG002|Overall Study|Creatinine/eGFR|1|||
126402475|NCT01999218|454766545|FG000|Overall Study|Death|7|||
126402476|NCT01999218|454766546|FG001|Overall Study|Death|1|||
126402477|NCT01999218|454766547|FG002|Overall Study|Death|2|||
126402478|NCT01999218|454766545|FG000|Overall Study|Excluded Medication|1|||
126402479|NCT01999218|454766546|FG001|Overall Study|Excluded Medication|1|||
126402480|NCT01999218|454766547|FG002|Overall Study|Excluded Medication|2|||
126402481|NCT01999218|454766545|FG000|Overall Study|Adverse Event|9|||
126402482|NCT01999218|454766546|FG001|Overall Study|Adverse Event|7|||
126402483|NCT01999218|454766547|FG002|Overall Study|Adverse Event|7|||
126402484|NCT01999218|454766545|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
126402485|NCT01999218|454766546|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
126402486|NCT01999218|454766547|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
126402487|NCT00664326|454768371|FG000|Overall Study|Adverse Event|14|||
126472273|NCT02899299|455030768|FG001|Treatment|Participant request to discontinue Study treatment|10|||
126472274|NCT02899299|455030767|FG000|Treatment|Participant withdrew consent|6|||
126472275|NCT02899299|455030768|FG001|Treatment|Participant withdrew consent|3|||
126472276|NCT02899299|455030767|FG000|Treatment|Lost to Follow-up|0|||
126557612|NCT05343455|455334428|FG001|Overall Study|Protocol Violation|1|||
126557613|NCT05343455|455334429|FG002|Overall Study|Protocol Violation|1|||
126557614|NCT00765362|455334430|FG000|Overall Study|Death|9|||
126557615|NCT00765362|455334430|FG000|Overall Study|Adverse Event|2|||
126557616|NCT00765362|455334430|FG000|Overall Study|Protocol Violation|18|||
126557617|NCT00765362|455334430|FG000|Overall Study|Withdrawal by Subject|13|||
126721213|NCT01912768|455928598|FG001|Overall Study|Randomized in error|0|||
126721214|NCT00540436|455928601|FG000|First 12-Week Treatment Period|Adverse Event|1|||
126721215|NCT00540436|455928601|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
126721216|NCT00540436|455928601|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
126721217|NCT00540436|455928601|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
126721218|NCT03255291|455928602|FG000|Overall Study|Determined to be ineligible|10|||
126557618|NCT00765362|455334430|FG000|Overall Study|Lost to Follow-up|95|||
126557619|NCT03930186|455334431|FG000|Weeks 0 to 16|Adverse Event|6|||
126557620|NCT03930186|455334431|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
126557621|NCT03930186|455334431|FG000|Weeks 16 to 32|Adverse Event|1|||
126557622|NCT03930186|455334431|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
126402488|NCT00664326|454768371|FG000|Overall Study|Noncompliance with study medication|3|||
126402489|NCT00664326|454768371|FG000|Overall Study|Withdrawal by Subject|1|||
126472277|NCT02899299|455030768|FG001|Treatment|Lost to Follow-up|2|||
126472278|NCT02899299|455030767|FG000|Treatment|Maximum Clinical Benefit|11|||
126472279|NCT02899299|455030768|FG001|Treatment|Maximum Clinical Benefit|2|||
126472280|NCT02899299|455030767|FG000|Treatment|Poor/Non-compliance|1|||
126472281|NCT02899299|455030768|FG001|Treatment|Poor/Non-compliance|0|||
126472282|NCT02899299|455030767|FG000|Treatment|Participant no longer meets Study criteria|4|||
126472283|NCT02899299|455030768|FG001|Treatment|Participant no longer meets Study criteria|0|||
126472284|NCT02899299|455030767|FG000|Treatment|Administrative reason by Sponsor|2|||
126472285|NCT02899299|455030768|FG001|Treatment|Administrative reason by Sponsor|0|||
126472286|NCT02899299|455030767|FG000|Treatment|Other reasons|12|||
126472287|NCT02899299|455030768|FG001|Treatment|Other reasons|2|||
126472288|NCT02899299|455030767|FG000|Treatment|Not reported|7|||
126472289|NCT02899299|455030768|FG001|Treatment|Not reported|0|||
126472290|NCT00313300|455030769|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
126472291|NCT00313300|455030770|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
126472292|NCT00313300|455030771|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
126472293|NCT00313300|455030772|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
126472294|NCT00313300|455030773|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
126472295|NCT00313300|455030769|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
126472296|NCT00313300|455030770|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
126402490|NCT00664326|454768371|FG000|Overall Study|Physician Decision|1|||
126402491|NCT00664326|454768371|FG000|Overall Study|Other Reasons|3|||
126402492|NCT00664326|454768371|FG000|Overall Study|Death|2|||
126472297|NCT00313300|455030771|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
126472298|NCT00313300|455030772|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
126402493|NCT00664326|454768371|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
126402494|NCT00387647|454768372|FG000|Overall Study|Death|18|||
126472299|NCT00313300|455030773|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
126557623|NCT00031447|455334434|FG000|Overall Study|Lost to Follow-up|0|||
126557624|NCT00031447|455334435|FG001|Overall Study|Lost to Follow-up|1|||
126557625|NCT00031447|455334434|FG000|Overall Study|Non-compliant|1|||
126557626|NCT00031447|455334435|FG001|Overall Study|Non-compliant|1|||
126402495|NCT02032407|454768373|FG000|Overall Study|Lost to Follow-up|2|||
126402496|NCT02032407|454768373|FG000|Overall Study|Pregnancy|1|||
126402497|NCT02032407|454768373|FG000|Overall Study|Other Miscellaneous Reasons|2|||
126402498|NCT02191605|454768374|FG000|Overall Study|Lost to Follow-up|9|||
126557627|NCT00031447|455334434|FG000|Overall Study|Re-activation of Disease|2|||
126402499|NCT02191605|454768375|FG001|Overall Study|Lost to Follow-up|4|||
126402500|NCT02191605|454768376|FG002|Overall Study|Lost to Follow-up|7|||
126402501|NCT02191605|454768377|FG003|Overall Study|Lost to Follow-up|3|||
126402502|NCT02191605|454768378|FG004|Overall Study|Lost to Follow-up|4|||
126402503|NCT01309269|454768381|FG000|Overall Study|Adverse Event|56|||
126402504|NCT01309269|454768381|FG000|Overall Study|Withdrawal by Subject|25|||
126402505|NCT01309269|454768381|FG000|Overall Study|Lack of Acceptance|15|||
126402506|NCT01309269|454768381|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
126402507|NCT01309269|454768381|FG000|Overall Study|Kidney Transplant|25|||
126402508|NCT01309269|454768381|FG000|Overall Study|Administrative Problems|141|||
126402509|NCT01309269|454768381|FG000|Overall Study|Other|256|||
126402510|NCT01309269|454768381|FG000|Overall Study|Other|1|||
126402511|NCT01309269|454768381|FG000|Overall Study|Study Completion Data Not Recorded|95|||
126402512|NCT01309269|454768381|FG000|Overall Study|Enrolled but not Treated|107|||
126402513|NCT03647267|454768385|FG000|Overall Study|Lost to Follow-up|1|||
126402514|NCT03647267|454768386|FG001|Overall Study|Lost to Follow-up|0|||
126402515|NCT01350115|454768387|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
126402516|NCT01350115|454768388|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
126402517|NCT01350115|454768387|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
126402518|NCT01350115|454768388|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
126402519|NCT01350115|454768387|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
126402520|NCT01350115|454768388|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
126402521|NCT05079477|454768389|FG000|Overall Study|Lost to Follow-up|2|||
126402522|NCT05079477|454768390|FG001|Overall Study|Lost to Follow-up|0|||
126402523|NCT05079477|454768389|FG000|Overall Study|Withdrawal by Subject|1|||
126402524|NCT05079477|454768390|FG001|Overall Study|Withdrawal by Subject|0|||
126402525|NCT05079477|454768389|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
126402526|NCT05079477|454768390|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
126402527|NCT05079477|454768389|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
126402528|NCT05079477|454768390|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
126402529|NCT05013424|454768393|FG000|Overall Study|Lost to Follow-up|1|||
126402530|NCT05013424|454768394|FG001|Overall Study|Lost to Follow-up|1|||
126402531|NCT05013424|454768395|FG002|Overall Study|Lost to Follow-up|1|||
126402532|NCT05013424|454768393|FG000|Overall Study|Withdrawal by Subject|0|||
126402533|NCT05013424|454768394|FG001|Overall Study|Withdrawal by Subject|1|||
126402534|NCT05013424|454768395|FG002|Overall Study|Withdrawal by Subject|0|||
126402535|NCT00240110|454768397|FG000|Overall Study|Lost to Follow-up|6|||
126402536|NCT00240110|454768398|FG001|Overall Study|Lost to Follow-up|7|||
126402537|NCT00583791|454768399|FG000|Overall Study|Other|67|||
126402538|NCT00583791|454768399|FG000|Overall Study|Death|6|||
126402539|NCT03323736|454768400|FG000|Overall Study|Screen Failure|14|||
126402540|NCT03323736|454768401|FG001|Overall Study|Screen Failure|9|||
126402541|NCT03323736|454768402|FG002|Overall Study|Screen Failure|1|||
126402542|NCT03323736|454768400|FG000|Overall Study|Withdrawal Before Treatment|3|||
126402543|NCT03323736|454768401|FG001|Overall Study|Withdrawal Before Treatment|1|||
126402544|NCT03323736|454768402|FG002|Overall Study|Withdrawal Before Treatment|1|||
126402545|NCT03323736|454768400|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
126402546|NCT03323736|454768401|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
126402547|NCT03323736|454768402|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
126402548|NCT02654236|454768406|FG000|Overall Study|Withdrawal by Subject|0|||
126402549|NCT02654236|454768407|FG001|Overall Study|Withdrawal by Subject|0|||
126402550|NCT02654236|454768408|FG002|Overall Study|Withdrawal by Subject|2|||
126402551|NCT03710876|454768409|FG000|Overall Study|Death|0|||
126402552|NCT03710876|454768410|FG001|Overall Study|Death|2|||
126402553|NCT03710876|454768409|FG000|Overall Study|Withdrawal by Subject|0|||
126402554|NCT03710876|454768410|FG001|Overall Study|Withdrawal by Subject|2|||
126402555|NCT03627065|454768411|FG000|Overall Study|Study Terminated by sponsor|1|||
126402556|NCT03627065|454768411|FG000|Overall Study|Withdrawal by Subject|2|||
126402557|NCT04524455|454768413|FG000|Overall Study|Death|3|||
126402558|NCT04524455|454768414|FG001|Overall Study|Death|3|||
126402559|NCT04524455|454768413|FG000|Overall Study|Decision by Sponsor|0|||
126402560|NCT04524455|454768414|FG001|Overall Study|Decision by Sponsor|2|||
126402561|NCT04524455|454768413|FG000|Overall Study|Withdrawal of Consent From Study|1|||
126402562|NCT04524455|454768414|FG001|Overall Study|Withdrawal of Consent From Study|0|||
126402563|NCT04524455|454768413|FG000|Overall Study|Lost to Follow-up|0|||
126402564|NCT04524455|454768414|FG001|Overall Study|Lost to Follow-up|1|||
126402565|NCT01688739|454768417|FG000|Overall Study|Administrative Decision|1|||
126402566|NCT01688739|454768418|FG001|Overall Study|Administrative Decision|0|||
126402567|NCT01688739|454768419|FG002|Overall Study|Administrative Decision|0|||
126402568|NCT01688739|454768420|FG003|Overall Study|Administrative Decision|0|||
126472300|NCT00313300|455030769|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
126472301|NCT00313300|455030770|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
126402569|NCT01688739|454768421|FG004|Overall Study|Administrative Decision|0|||
126402570|NCT01688739|454768422|FG005|Overall Study|Administrative Decision|0|||
126402571|NCT01688739|454768423|FG006|Overall Study|Administrative Decision|0|||
126402572|NCT01688739|454768424|FG007|Overall Study|Administrative Decision|0|||
126402573|NCT01688739|454768425|FG008|Overall Study|Administrative Decision|0|||
126402574|NCT01688739|454768426|FG009|Overall Study|Administrative Decision|0|||
126402575|NCT00996801|454768427|FG000|Overall Study|Adverse Event|6|||
126402576|NCT00996801|454768428|FG001|Overall Study|Adverse Event|4|||
126402577|NCT00996801|454768429|FG002|Overall Study|Adverse Event|12|||
126402578|NCT00996801|454768430|FG003|Overall Study|Adverse Event|17|||
126402579|NCT00996801|454768431|FG004|Overall Study|Adverse Event|31|||
126402580|NCT00996801|454768432|FG005|Overall Study|Adverse Event|3|||
126402581|NCT00996801|454768427|FG000|Overall Study|Lack of Efficacy|3|||
126402582|NCT00996801|454768428|FG001|Overall Study|Lack of Efficacy|0|||
126402583|NCT00996801|454768429|FG002|Overall Study|Lack of Efficacy|1|||
126402584|NCT00996801|454768430|FG003|Overall Study|Lack of Efficacy|3|||
126402585|NCT00996801|454768431|FG004|Overall Study|Lack of Efficacy|0|||
126402586|NCT00996801|454768432|FG005|Overall Study|Lack of Efficacy|1|||
126402587|NCT00996801|454768427|FG000|Overall Study|Lost to Follow-up|0|||
126402588|NCT00996801|454768428|FG001|Overall Study|Lost to Follow-up|0|||
126402589|NCT00996801|454768429|FG002|Overall Study|Lost to Follow-up|0|||
126402590|NCT00996801|454768430|FG003|Overall Study|Lost to Follow-up|3|||
126402591|NCT00996801|454768431|FG004|Overall Study|Lost to Follow-up|3|||
126402592|NCT00996801|454768432|FG005|Overall Study|Lost to Follow-up|2|||
126402593|NCT00996801|454768427|FG000|Overall Study|Physician Decision|0|||
126402594|NCT00996801|454768428|FG001|Overall Study|Physician Decision|0|||
126402595|NCT00996801|454768429|FG002|Overall Study|Physician Decision|0|||
126402596|NCT00996801|454768430|FG003|Overall Study|Physician Decision|1|||
126402597|NCT00996801|454768431|FG004|Overall Study|Physician Decision|0|||
126402598|NCT00996801|454768432|FG005|Overall Study|Physician Decision|0|||
126402599|NCT00996801|454768427|FG000|Overall Study|Progressive Disease|0|||
126402600|NCT00996801|454768428|FG001|Overall Study|Progressive Disease|1|||
126402601|NCT00996801|454768429|FG002|Overall Study|Progressive Disease|0|||
126402602|NCT00996801|454768430|FG003|Overall Study|Progressive Disease|0|||
126402603|NCT00996801|454768431|FG004|Overall Study|Progressive Disease|0|||
126402604|NCT00996801|454768432|FG005|Overall Study|Progressive Disease|0|||
126402605|NCT00996801|454768427|FG000|Overall Study|Protocol Violation|3|||
126402606|NCT00996801|454768428|FG001|Overall Study|Protocol Violation|4|||
126402607|NCT00996801|454768429|FG002|Overall Study|Protocol Violation|1|||
126402608|NCT00996801|454768430|FG003|Overall Study|Protocol Violation|2|||
126402609|NCT00996801|454768431|FG004|Overall Study|Protocol Violation|3|||
126402610|NCT00996801|454768432|FG005|Overall Study|Protocol Violation|4|||
126402611|NCT00996801|454768427|FG000|Overall Study|Study Terminated by Sponsor|0|||
126402612|NCT00996801|454768428|FG001|Overall Study|Study Terminated by Sponsor|1|||
126402613|NCT00996801|454768429|FG002|Overall Study|Study Terminated by Sponsor|0|||
126402614|NCT00996801|454768430|FG003|Overall Study|Study Terminated by Sponsor|0|||
126402615|NCT00996801|454768431|FG004|Overall Study|Study Terminated by Sponsor|46|||
126402616|NCT00996801|454768432|FG005|Overall Study|Study Terminated by Sponsor|0|||
126472302|NCT00313300|455030771|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
126472303|NCT00313300|455030772|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
126472304|NCT00313300|455030773|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
126472305|NCT00313300|455030769|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
126472306|NCT00313300|455030770|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
126472307|NCT00313300|455030771|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
126472308|NCT00313300|455030772|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
126472309|NCT00313300|455030773|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
126472310|NCT00313300|455030769|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
126472311|NCT00313300|455030770|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
126472312|NCT00313300|455030771|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
126472313|NCT00313300|455030772|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
126472314|NCT00313300|455030773|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
126472315|NCT00313300|455030769|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
126402617|NCT00996801|454768427|FG000|Overall Study|Withdrawal by Subject|8|||
126402618|NCT00996801|454768428|FG001|Overall Study|Withdrawal by Subject|6|||
126402619|NCT00996801|454768429|FG002|Overall Study|Withdrawal by Subject|9|||
126402620|NCT00996801|454768430|FG003|Overall Study|Withdrawal by Subject|5|||
126402621|NCT00996801|454768431|FG004|Overall Study|Withdrawal by Subject|5|||
126402622|NCT00996801|454768432|FG005|Overall Study|Withdrawal by Subject|9|||
126402623|NCT02804750|454768433|FG000|Period 1|Adverse Event|0|||
126402624|NCT02804750|454768434|FG001|Period 1|Adverse Event|2|||
126557628|NCT00031447|455334435|FG001|Overall Study|Re-activation of Disease|1|||
126557629|NCT00031447|455334434|FG000|Overall Study|Disruption of blinded study drug supply|7|||
126402625|NCT02804750|454768433|FG000|Period 1|Withdrawal by Subject|0|||
126402626|NCT02804750|454768434|FG001|Period 1|Withdrawal by Subject|1|||
126402627|NCT02804750|454768433|FG000|Period 2|Adverse Event|1|||
126557630|NCT00031447|455334435|FG001|Overall Study|Disruption of blinded study drug supply|4|||
126402628|NCT02804750|454768434|FG001|Period 2|Adverse Event|0|||
126402629|NCT02804750|454768433|FG000|Period 3|Adverse Event|0|||
126402630|NCT02804750|454768434|FG001|Period 3|Adverse Event|2|||
126402631|NCT02804750|454768433|FG000|Period 4|Adverse Event|0|||
126402632|NCT02804750|454768434|FG001|Period 4|Adverse Event|5|||
126402633|NCT02559414|454768435|FG000|Overall Study|Lost to Follow-up|0|||
126402634|NCT02559414|454768436|FG001|Overall Study|Lost to Follow-up|1|||
126402635|NCT02559414|454768437|FG002|Overall Study|Lost to Follow-up|0|||
126402636|NCT02559414|454768435|FG000|Overall Study|Withdrawal by Subject|1|||
126402637|NCT02559414|454768436|FG001|Overall Study|Withdrawal by Subject|0|||
126402638|NCT02559414|454768437|FG002|Overall Study|Withdrawal by Subject|1|||
126402639|NCT02559414|454768435|FG000|Overall Study|Other|0|||
126402640|NCT02559414|454768436|FG001|Overall Study|Other|1|||
126402641|NCT02559414|454768437|FG002|Overall Study|Other|1|||
126402642|NCT03369431|454768438|FG000|Overall Study|Lost to Follow-up|1|||
126402643|NCT03369431|454768439|FG001|Overall Study|Lost to Follow-up|3|||
126402644|NCT03369431|454768438|FG000|Overall Study|Withdrawal by Subject|2|||
126402645|NCT03369431|454768439|FG001|Overall Study|Withdrawal by Subject|3|||
126402646|NCT03369431|454768438|FG000|Overall Study|Protocol Violation|1|||
126402647|NCT03369431|454768439|FG001|Overall Study|Protocol Violation|1|||
126402648|NCT00046930|454768444|FG000|Overall Study|Ineligible|12|||
126402649|NCT00046930|454768445|FG001|Overall Study|Ineligible|4|||
126402650|NCT01113580|454768446|FG000|Overall Study|Protocol Violation|1|||
126402651|NCT01113580|454768447|FG001|Overall Study|Protocol Violation|0|||
126402652|NCT02317809|454768452|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
126402653|NCT02317809|454768453|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
126402654|NCT02317809|454768452|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
126402655|NCT02317809|454768453|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
126402656|NCT04912895|454768457|FG000|Overall Study|Unable to provide specimen|2|||
126472316|NCT00313300|455030770|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
126472317|NCT00313300|455030771|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
126472318|NCT00313300|455030772|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
126402657|NCT04912895|454768458|FG001|Overall Study|Unable to provide specimen|0|||
126402658|NCT04912895|454768459|FG002|Overall Study|Unable to provide specimen|0|||
126402659|NCT03458702|454768460|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
126402660|NCT03458702|454768461|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
126402661|NCT03458702|454768460|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
126402662|NCT03458702|454768461|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
126402663|NCT01390779|454768462|FG000|Overall Study|Physician Decision|1|||
126402664|NCT00168103|454768465|FG000|Overall Study|Withdrawal by Subject|1|||
126402665|NCT00168103|454768466|FG001|Overall Study|Withdrawal by Subject|2|||
126402666|NCT00168103|454768467|FG002|Overall Study|Withdrawal by Subject|1|||
126402667|NCT00168103|454768468|FG003|Overall Study|Withdrawal by Subject|0|||
126402668|NCT00168103|454768465|FG000|Overall Study|Lost to Follow-up|1|||
126402669|NCT00168103|454768466|FG001|Overall Study|Lost to Follow-up|3|||
126402670|NCT00168103|454768467|FG002|Overall Study|Lost to Follow-up|0|||
126402671|NCT00168103|454768468|FG003|Overall Study|Lost to Follow-up|0|||
126402672|NCT00545532|454768469|FG000|Overall Study|Withdrawal by Subject|1|||
126402673|NCT00545532|454768470|FG001|Overall Study|Withdrawal by Subject|3|||
126402674|NCT00545532|454768469|FG000|Overall Study|Lost to Follow-up|5|||
126402675|NCT00545532|454768470|FG001|Overall Study|Lost to Follow-up|6|||
126402676|NCT00545532|454768469|FG000|Overall Study|Death|0|||
126402677|NCT00545532|454768470|FG001|Overall Study|Death|1|||
126402678|NCT01149486|454768473|FG000|First Intervention|Adverse Event|0|||
126402679|NCT01149486|454768474|FG001|First Intervention|Adverse Event|1|||
126402680|NCT00931801|454768483|FG000|Overall Study|Adverse Event|0|||
126402681|NCT00931801|454768484|FG001|Overall Study|Adverse Event|0|||
126402682|NCT00931801|454768485|FG002|Overall Study|Adverse Event|1|||
126557631|NCT01244763|455334436|FG000|Overall Study|Adverse Event|1|||
126557632|NCT01244763|455334437|FG001|Overall Study|Adverse Event|0|||
126402683|NCT00931801|454768483|FG000|Overall Study|Lost to Follow-up|0|||
126402684|NCT00931801|454768484|FG001|Overall Study|Lost to Follow-up|1|||
126402685|NCT00931801|454768485|FG002|Overall Study|Lost to Follow-up|0|||
126402686|NCT00931801|454768483|FG000|Overall Study|Withdrawal by Subject|1|||
126402687|NCT00931801|454768484|FG001|Overall Study|Withdrawal by Subject|0|||
126472319|NCT00313300|455030773|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
126472320|NCT00313300|455030769|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
126472321|NCT00313300|455030770|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
126472322|NCT00313300|455030771|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
126472323|NCT00313300|455030772|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
126557633|NCT01244763|455334438|FG002|Overall Study|Adverse Event|0|||
126402688|NCT00931801|454768485|FG002|Overall Study|Withdrawal by Subject|0|||
126402689|NCT00931801|454768483|FG000|Overall Study|Confirmed Virologic Failure|0|||
126402690|NCT00931801|454768484|FG001|Overall Study|Confirmed Virologic Failure|0|||
126402691|NCT00931801|454768485|FG002|Overall Study|Confirmed Virologic Failure|3|||
126402692|NCT01635764|454768487|FG000|Overall Study|Adverse Event|46|||
126402693|NCT01635764|454768487|FG000|Overall Study|Lack of Efficacy|76|||
126402694|NCT01635764|454768487|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
126557634|NCT01244763|455334439|FG003|Overall Study|Adverse Event|0|||
126557635|NCT01244763|455334440|FG004|Overall Study|Adverse Event|0|||
126557636|NCT01244763|455334441|FG005|Overall Study|Adverse Event|1|||
126557637|NCT01244763|455334436|FG000|Overall Study|Death|1|||
126557638|NCT01244763|455334437|FG001|Overall Study|Death|0|||
126557639|NCT01244763|455334438|FG002|Overall Study|Death|1|||
126557640|NCT01244763|455334439|FG003|Overall Study|Death|0|||
126557641|NCT01244763|455334440|FG004|Overall Study|Death|2|||
126557642|NCT01244763|455334441|FG005|Overall Study|Death|0|||
126402695|NCT01635764|454768487|FG000|Overall Study|Protocol Deviation|1|||
126402696|NCT01635764|454768487|FG000|Overall Study|Withdrew Consent|67|||
126402697|NCT01635764|454768487|FG000|Overall Study|Lost to Follow-up|53|||
126402698|NCT01635764|454768487|FG000|Overall Study|Other|28|||
126402699|NCT00933244|454768488|FG000|Overall Study|Withdrawal by Subject|5|||
126402700|NCT00933244|454768489|FG001|Overall Study|Withdrawal by Subject|1|||
126402701|NCT00933244|454768490|FG002|Overall Study|Withdrawal by Subject|3|||
126402702|NCT01174004|454768491|FG000|Overall Study|Adverse Event|2|||
126402703|NCT01174004|454768492|FG001|Overall Study|Adverse Event|10|||
126402704|NCT01174004|454768491|FG000|Overall Study|Withdrawal by Subject|2|||
126402705|NCT01174004|454768492|FG001|Overall Study|Withdrawal by Subject|3|||
126402706|NCT01174004|454768491|FG000|Overall Study|At Discretion of Sponsor|2|||
126402707|NCT01174004|454768492|FG001|Overall Study|At Discretion of Sponsor|2|||
126402708|NCT01174004|454768491|FG000|Overall Study|Protocol Violation|0|||
126402709|NCT01174004|454768492|FG001|Overall Study|Protocol Violation|1|||
126402710|NCT01174004|454768491|FG000|Overall Study|Physician Decision|1|||
126402711|NCT01174004|454768492|FG001|Overall Study|Physician Decision|0|||
126402712|NCT02266875|454768496|FG000|Overall Study|Withdrawal by Subject|9|||
126402713|NCT02266875|454768497|FG001|Overall Study|Withdrawal by Subject|0|||
126402714|NCT02266875|454768496|FG000|Overall Study|Lost to Follow-up|2|||
126402715|NCT02266875|454768497|FG001|Overall Study|Lost to Follow-up|0|||
126402716|NCT02956850|454768501|FG000|Overall Study|Withdrawal by Subject|0|||
126402717|NCT02956850|454768502|FG001|Overall Study|Withdrawal by Subject|0|||
126402718|NCT02956850|454768503|FG002|Overall Study|Withdrawal by Subject|0|||
126402719|NCT02956850|454768504|FG003|Overall Study|Withdrawal by Subject|0|||
126402720|NCT02956850|454768505|FG004|Overall Study|Withdrawal by Subject|0|||
126402721|NCT02956850|454768506|FG005|Overall Study|Withdrawal by Subject|0|||
126402722|NCT02956850|454768507|FG006|Overall Study|Withdrawal by Subject|0|||
126402723|NCT02956850|454768508|FG007|Overall Study|Withdrawal by Subject|0|||
126402724|NCT02956850|454768509|FG008|Overall Study|Withdrawal by Subject|0|||
126402725|NCT02956850|454768510|FG009|Overall Study|Withdrawal by Subject|0|||
126402726|NCT02956850|454768511|FG010|Overall Study|Withdrawal by Subject|0|||
126402727|NCT02956850|454768512|FG011|Overall Study|Withdrawal by Subject|0|||
126402728|NCT02956850|454768513|FG012|Overall Study|Withdrawal by Subject|0|||
126402729|NCT02956850|454768514|FG013|Overall Study|Withdrawal by Subject|0|||
126402730|NCT02956850|454768515|FG014|Overall Study|Withdrawal by Subject|0|||
126402731|NCT02956850|454768516|FG015|Overall Study|Withdrawal by Subject|0|||
126402732|NCT02956850|454768517|FG016|Overall Study|Withdrawal by Subject|0|||
126402733|NCT02956850|454768518|FG017|Overall Study|Withdrawal by Subject|1|||
126402734|NCT00391391|454768521|FG000|Overall Study|Adverse Event|0|||
126402735|NCT00391391|454768522|FG001|Overall Study|Adverse Event|0|||
126402736|NCT00391391|454768523|FG002|Overall Study|Adverse Event|0|||
126402737|NCT00391391|454768524|FG003|Overall Study|Adverse Event|1|||
126402738|NCT00391391|454768521|FG000|Overall Study|Lost to Follow-up|1|||
126402739|NCT00391391|454768522|FG001|Overall Study|Lost to Follow-up|3|||
126472324|NCT00313300|455030773|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
126472325|NCT00313300|455030769|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
126472326|NCT00313300|455030770|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
126472327|NCT00313300|455030771|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
126472328|NCT00313300|455030772|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
126472329|NCT00313300|455030773|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
126472330|NCT00313300|455030769|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
126472331|NCT00313300|455030770|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
126472332|NCT00313300|455030771|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
126472333|NCT00313300|455030772|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
126472334|NCT00313300|455030773|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
126472335|NCT00313300|455030769|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
126472336|NCT00313300|455030770|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
126402740|NCT00391391|454768523|FG002|Overall Study|Lost to Follow-up|7|||
126402741|NCT00391391|454768524|FG003|Overall Study|Lost to Follow-up|4|||
126402742|NCT00391391|454768521|FG000|Overall Study|Protocol Violation|2|||
126402743|NCT00391391|454768522|FG001|Overall Study|Protocol Violation|3|||
126402744|NCT00391391|454768523|FG002|Overall Study|Protocol Violation|6|||
126402745|NCT00391391|454768524|FG003|Overall Study|Protocol Violation|7|||
126402746|NCT00391391|454768521|FG000|Overall Study|Withdrawal by Subject|6|||
126557643|NCT01244763|455334436|FG000|Overall Study|Physician Decision|0|||
126557644|NCT01244763|455334437|FG001|Overall Study|Physician Decision|0|||
126557645|NCT01244763|455334438|FG002|Overall Study|Physician Decision|1|||
126402747|NCT00391391|454768522|FG001|Overall Study|Withdrawal by Subject|4|||
126402748|NCT00391391|454768523|FG002|Overall Study|Withdrawal by Subject|10|||
126402749|NCT00391391|454768524|FG003|Overall Study|Withdrawal by Subject|7|||
126402750|NCT04375397|454768527|FG000|Overall Study|Death|1|||
126402751|NCT04375397|454768528|FG001|Overall Study|Death|1|||
126402752|NCT04375397|454768527|FG000|Overall Study|Withdrew consent|2|||
126402753|NCT04375397|454768528|FG001|Overall Study|Withdrew consent|0|||
126557646|NCT01244763|455334439|FG003|Overall Study|Physician Decision|0|||
126557647|NCT01244763|455334440|FG004|Overall Study|Physician Decision|0|||
126557648|NCT01244763|455334441|FG005|Overall Study|Physician Decision|0|||
126557649|NCT01244763|455334436|FG000|Overall Study|Withdrawal by Subject|1|||
126557650|NCT01244763|455334437|FG001|Overall Study|Withdrawal by Subject|2|||
126557651|NCT01244763|455334438|FG002|Overall Study|Withdrawal by Subject|0|||
126557652|NCT01244763|455334439|FG003|Overall Study|Withdrawal by Subject|1|||
126557653|NCT01244763|455334440|FG004|Overall Study|Withdrawal by Subject|1|||
126557654|NCT01244763|455334441|FG005|Overall Study|Withdrawal by Subject|2|||
126557655|NCT01244763|455334436|FG000|Overall Study|Lost to Follow-up|0|||
126557656|NCT01244763|455334437|FG001|Overall Study|Lost to Follow-up|1|||
126557657|NCT01244763|455334438|FG002|Overall Study|Lost to Follow-up|0|||
126557658|NCT01244763|455334439|FG003|Overall Study|Lost to Follow-up|0|||
126557659|NCT01244763|455334440|FG004|Overall Study|Lost to Follow-up|0|||
126557660|NCT01244763|455334441|FG005|Overall Study|Lost to Follow-up|0|||
126557661|NCT01244763|455334436|FG000|Overall Study|Enrolled into the Extension Study|0|||
126557662|NCT01244763|455334437|FG001|Overall Study|Enrolled into the Extension Study|0|||
126557663|NCT01244763|455334438|FG002|Overall Study|Enrolled into the Extension Study|0|||
126721219|NCT03255291|455928603|FG001|Overall Study|Determined to be ineligible|12|||
126721220|NCT03255291|455928604|FG002|Overall Study|Determined to be ineligible|6|||
126557664|NCT01244763|455334439|FG003|Overall Study|Enrolled into the Extension Study|0|||
126402754|NCT04375397|454768527|FG000|Overall Study|Lost to Follow-up|6|||
126402755|NCT04375397|454768528|FG001|Overall Study|Lost to Follow-up|4|||
126402756|NCT04375397|454768527|FG000|Overall Study|Other, not specified|0|||
126402757|NCT04375397|454768528|FG001|Overall Study|Other, not specified|1|||
126402758|NCT00610441|454768531|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
126402759|NCT00610441|454768532|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
126402760|NCT00610441|454768533|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
126402761|NCT00610441|454768534|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
126402762|NCT00610441|454768531|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
126402763|NCT00610441|454768532|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
126402764|NCT00610441|454768533|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
126402765|NCT00610441|454768534|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
126402766|NCT00610441|454768531|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
126402767|NCT00610441|454768532|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
126402768|NCT00610441|454768533|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
126402769|NCT00610441|454768534|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
126402770|NCT00610441|454768531|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
126402771|NCT00610441|454768532|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
126402772|NCT00610441|454768533|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
126402773|NCT00610441|454768534|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
126402774|NCT00610441|454768531|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
126402775|NCT00610441|454768532|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
126402776|NCT00610441|454768533|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
126402777|NCT00610441|454768534|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
126402778|NCT00610441|454768531|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
126402779|NCT00610441|454768532|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
126402780|NCT00610441|454768533|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
126402781|NCT00610441|454768534|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
126402782|NCT00610441|454768531|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
126402783|NCT00610441|454768532|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
126402784|NCT00610441|454768533|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
126402785|NCT00610441|454768534|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
126402786|NCT00610441|454768531|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
126402787|NCT00610441|454768532|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
126402788|NCT00610441|454768533|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
126402789|NCT00610441|454768534|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
126402790|NCT00610441|454768531|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
126557665|NCT01244763|455334440|FG004|Overall Study|Enrolled into the Extension Study|0|||
126557666|NCT01244763|455334441|FG005|Overall Study|Enrolled into the Extension Study|1|||
126402791|NCT00610441|454768532|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
126402792|NCT00610441|454768533|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
126402793|NCT00610441|454768534|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
126402794|NCT01995552|454768537|FG000|Overall Study|Protocol Violation|1|||
126557667|NCT00953160|455334442|FG000|Overall Study|Lost to Follow-up|23|||
126557668|NCT00953160|455334442|FG000|Overall Study|Withdrawal by Subject|4|||
126402795|NCT01995552|454768537|FG000|Overall Study|Lack of Efficacy|15|||
126402796|NCT01995552|454768537|FG000|Overall Study|Death|1|||
126402797|NCT00554099|454768538|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
126402798|NCT00554099|454768539|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
126402799|NCT00554099|454768540|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
126402800|NCT00554099|454768538|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
126402801|NCT00554099|454768539|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
126402802|NCT00554099|454768540|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
126402803|NCT00554099|454768538|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
126402804|NCT00554099|454768539|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
126402805|NCT00554099|454768540|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
126402806|NCT00554099|454768538|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
126402807|NCT00554099|454768539|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
126402808|NCT00554099|454768540|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
126402809|NCT00554099|454768538|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
126402810|NCT00554099|454768539|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
126402811|NCT00554099|454768540|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
126402812|NCT00554099|454768538|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
126402813|NCT00554099|454768539|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
126402814|NCT00554099|454768540|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
126402815|NCT00554099|454768538|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
126402816|NCT00554099|454768539|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
126402817|NCT00554099|454768540|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
126402818|NCT00554099|454768538|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
126402819|NCT00554099|454768539|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
126402820|NCT00554099|454768540|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
126402821|NCT00554099|454768538|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
126402822|NCT00554099|454768539|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
126402823|NCT00554099|454768540|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
126402824|NCT01011933|454768541|FG000|Overall Study|Wrong cell type|1|||
126402825|NCT01011933|454768541|FG000|Overall Study|Improper pre-protocol Rx|1|||
126402826|NCT01011933|454768541|FG000|Overall Study|Inadequate pathology|1|||
126402827|NCT01011933|454768541|FG000|Overall Study|Never treated|1|||
126402828|NCT01439074|454768542|FG000|Overall Study|Lost to Follow-up|3|||
126402829|NCT01439074|454768543|FG001|Overall Study|Lost to Follow-up|4|||
126402830|NCT01439074|454768542|FG000|Overall Study|Subject shedding|1|||
126402831|NCT01439074|454768543|FG001|Overall Study|Subject shedding|0|||
126402832|NCT01439074|454768542|FG000|Overall Study|Withdrawal by Subject|1|||
126402833|NCT01439074|454768543|FG001|Overall Study|Withdrawal by Subject|5|||
126402834|NCT01439074|454768542|FG000|Overall Study|Other|4|||
126402835|NCT01439074|454768543|FG001|Overall Study|Other|4|||
126402836|NCT02639338|454768544|FG000|Overall Study|Lost to Follow-up|2|||
126402837|NCT02639338|454768545|FG001|Overall Study|Lost to Follow-up|2|||
126402838|NCT02639338|454768544|FG000|Overall Study|Withdrew Consent|1|||
126402839|NCT02639338|454768545|FG001|Overall Study|Withdrew Consent|2|||
126402840|NCT02639338|454768544|FG000|Overall Study|Death|1|||
126402841|NCT02639338|454768545|FG001|Overall Study|Death|0|||
126402842|NCT02639338|454768544|FG000|Overall Study|Randomized but Not Treated|0|||
126402843|NCT02639338|454768545|FG001|Overall Study|Randomized but Not Treated|1|||
126402844|NCT00514020|454768546|FG000|Overall Study|Adverse Event|6|||
126402845|NCT00514020|454768546|FG000|Overall Study|Withdrawal by Subject|3|||
126402846|NCT00514020|454768546|FG000|Overall Study|Physician Decision|1|||
126402847|NCT00514020|454768546|FG000|Overall Study|disease progression|9|||
126402848|NCT00514020|454768546|FG000|Overall Study|other complicating disease|2|||
126402849|NCT00514020|454768546|FG000|Overall Study|patient went to radiation treatment|1|||
126402850|NCT00514020|454768546|FG000|Overall Study|"patients moved to the no tx group"|6|||
126402851|NCT01688921|454768547|FG000|Overall Study|Lost to Follow-up|7|||
126402852|NCT01688921|454768548|FG001|Overall Study|Lost to Follow-up|13|||
126402853|NCT01688921|454768547|FG000|Overall Study|Physician Decision|6|||
126402854|NCT01688921|454768548|FG001|Overall Study|Physician Decision|1|||
126402855|NCT01688921|454768547|FG000|Overall Study|Protocol Violation|0|||
126402856|NCT01688921|454768548|FG001|Overall Study|Protocol Violation|1|||
126402857|NCT01688921|454768547|FG000|Overall Study|informed consent|3|||
126402858|NCT01688921|454768548|FG001|Overall Study|informed consent|0|||
126402859|NCT00831701|454768549|FG000|Overall Study|Withdrawal by Subject|2|||
126402860|NCT00831701|454768550|FG001|Overall Study|Withdrawal by Subject|0|||
126402861|NCT00831701|454768549|FG000|Overall Study|Stone expulsion before first medication|2|||
126402862|NCT00831701|454768550|FG001|Overall Study|Stone expulsion before first medication|2|||
126402863|NCT00831701|454768549|FG000|Overall Study|Lost to Follow-up|1|||
126402864|NCT00831701|454768550|FG001|Overall Study|Lost to Follow-up|3|||
126402865|NCT03131596|454770416|FG000|Overall Study|Protocol Violation|3|||
126402866|NCT03131596|454770417|FG001|Overall Study|Protocol Violation|3|||
126402867|NCT03131596|454770416|FG000|Overall Study|Lost to Follow-up|3|||
126402868|NCT03131596|454770417|FG001|Overall Study|Lost to Follow-up|0|||
126402869|NCT00734071|454770418|FG000|Overall Study|Adverse Event|4|||
126402870|NCT00734071|454770419|FG001|Overall Study|Adverse Event|3|||
126402871|NCT00734071|454770418|FG000|Overall Study|Lack of Efficacy|3|||
126402872|NCT00734071|454770419|FG001|Overall Study|Lack of Efficacy|1|||
126402873|NCT00734071|454770418|FG000|Overall Study|Noncompliance|2|||
126402874|NCT00734071|454770419|FG001|Overall Study|Noncompliance|2|||
126402875|NCT00734071|454770418|FG000|Overall Study|Protocol Deviations|3|||
126402876|NCT00734071|454770419|FG001|Overall Study|Protocol Deviations|4|||
126402877|NCT00734071|454770418|FG000|Overall Study|Voluntary Withdrawal|9|||
126402878|NCT00734071|454770419|FG001|Overall Study|Voluntary Withdrawal|7|||
126402879|NCT00734071|454770418|FG000|Overall Study|Lost to Follow-up|16|||
126402880|NCT00734071|454770419|FG001|Overall Study|Lost to Follow-up|8|||
126402881|NCT00734071|454770418|FG000|Overall Study|Other|1|||
126402882|NCT00734071|454770419|FG001|Overall Study|Other|2|||
126402883|NCT00151372|454770420|FG000|Overall Study|Death|12|||
126402884|NCT00151372|454770421|FG001|Overall Study|Death|11|||
126402885|NCT00151372|454770420|FG000|Overall Study|Lost to Follow-up|5|||
126402886|NCT00151372|454770421|FG001|Overall Study|Lost to Follow-up|5|||
126402887|NCT00151372|454770420|FG000|Overall Study|Too sick medically to continue|5|||
126402888|NCT00151372|454770421|FG001|Overall Study|Too sick medically to continue|6|||
126402889|NCT00151372|454770420|FG000|Overall Study|Withdrawal by Subject|7|||
126402890|NCT00151372|454770421|FG001|Overall Study|Withdrawal by Subject|7|||
126402891|NCT00541346|454770422|FG000|Follow-up|Adverse Event|1|||
126402892|NCT04732949|454770423|FG000|Overall Study|Withdrawal by Subject|23|||
126402893|NCT04732949|454770424|FG001|Overall Study|Withdrawal by Subject|27|||
126402894|NCT04732949|454770423|FG000|Overall Study|Protocol Violation|0|||
126402895|NCT04732949|454770424|FG001|Overall Study|Protocol Violation|1|||
126402896|NCT04732949|454770423|FG000|Overall Study|Non-compliance|0|||
126402897|NCT04732949|454770424|FG001|Overall Study|Non-compliance|2|||
126402898|NCT04732949|454770423|FG000|Overall Study|Physician Decision|2|||
126402899|NCT04732949|454770424|FG001|Overall Study|Physician Decision|1|||
126402900|NCT04732949|454770423|FG000|Overall Study|Serious adverse event (Fatal)|16|||
126402901|NCT04732949|454770424|FG001|Overall Study|Serious adverse event (Fatal)|18|||
126402902|NCT04732949|454770423|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
126402903|NCT04732949|454770424|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
126402904|NCT04732949|454770423|FG000|Overall Study|Non-serious adverse event|1|||
126402905|NCT04732949|454770424|FG001|Overall Study|Non-serious adverse event|3|||
126402906|NCT04732949|454770423|FG000|Overall Study|Lost to Follow-up|26|||
126402907|NCT04732949|454770424|FG001|Overall Study|Lost to Follow-up|27|||
126402908|NCT04732949|454770423|FG000|Overall Study|Other|6|||
126402909|NCT04732949|454770424|FG001|Overall Study|Other|3|||
126402910|NCT02853435|454770427|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
126402911|NCT02853435|454770428|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
126402912|NCT02853435|454770429|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
126402913|NCT02853435|454770430|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
126402914|NCT02853435|454770431|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
126402915|NCT02853435|454770432|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
126402916|NCT03747120|454770435|FG000|Overall Study|treatment related toxicity|3|||
126402917|NCT03747120|454770436|FG001|Overall Study|treatment related toxicity|0|||
126402918|NCT03747120|454770437|FG002|Overall Study|treatment related toxicity|0|||
126402919|NCT03747120|454770435|FG000|Overall Study|Withdrawal by Subject|0|||
126402920|NCT03747120|454770436|FG001|Overall Study|Withdrawal by Subject|1|||
126402921|NCT03747120|454770437|FG002|Overall Study|Withdrawal by Subject|2|||
126402922|NCT01266317|454770446|FG000|Overall Study|Withdrawal by Subject|2|||
126402923|NCT00490776|454770447|FG000|Overall Study|Withdrawal by Subject|1|||
126402924|NCT00490776|454770447|FG000|Overall Study|Administrative Problems|1|||
126402925|NCT00490776|454770447|FG000|Overall Study|Death|1|||
126402926|NCT00490776|454770447|FG000|Overall Study|New Cancer Therapy|1|||
126402927|NCT00490776|454770447|FG000|Overall Study|Disease Progression|5|||
126402928|NCT04271475|454770459|FG000|DB Period: Day 1 up to EODBT|Death|1|||
126402929|NCT04271475|454770460|FG001|DB Period: Day 1 up to EODBT|Death|0|||
126402930|NCT04271475|454770461|FG002|DB Period: Day 1 up to EODBT|Death|0|||
126402931|NCT04271475|454770462|FG003|DB Period: Day 1 up to EODBT|Death|0|||
126402932|NCT04271475|454770459|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
126402933|NCT04271475|454770460|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
126402934|NCT04271475|454770461|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
126402935|NCT04271475|454770462|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
126402936|NCT04271475|454770459|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
126402937|NCT04271475|454770460|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
126402938|NCT04271475|454770461|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
126402939|NCT04271475|454770462|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
126402940|NCT04271475|454770459|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
126402941|NCT04271475|454770460|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
126402942|NCT04271475|454770461|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
126402943|NCT04271475|454770462|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
126402944|NCT04271475|454770459|FG000|DB Period: Day 1 up to EODBT|Other|8|||
126402945|NCT04271475|454770460|FG001|DB Period: Day 1 up to EODBT|Other|5|||
126402946|NCT04271475|454770461|FG002|DB Period: Day 1 up to EODBT|Other|0|||
126402947|NCT04271475|454770462|FG003|DB Period: Day 1 up to EODBT|Other|0|||
126402948|NCT04271475|454770459|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
126402949|NCT04271475|454770460|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
126402950|NCT04271475|454770461|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
126402951|NCT04271475|454770462|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
126402952|NCT04271475|454770459|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
126402953|NCT04271475|454770460|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
126402954|NCT04271475|454770461|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
126402955|NCT04271475|454770462|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
126402956|NCT00159913|454770466|FG000|Overall Study|Adverse Event|1|||
126402957|NCT00159913|454770467|FG001|Overall Study|Adverse Event|0|||
126402958|NCT00159913|454770468|FG002|Overall Study|Adverse Event|1|||
126402959|NCT00159913|454770469|FG003|Overall Study|Adverse Event|0|||
126402960|NCT00159913|454770466|FG000|Overall Study|Withdrawal by Subject|0|||
126402961|NCT00159913|454770467|FG001|Overall Study|Withdrawal by Subject|0|||
126402962|NCT00159913|454770468|FG002|Overall Study|Withdrawal by Subject|0|||
126402963|NCT00159913|454770469|FG003|Overall Study|Withdrawal by Subject|1|||
126402964|NCT00159913|454770466|FG000|Overall Study|Lost to Follow-up|0|||
126402965|NCT00159913|454770467|FG001|Overall Study|Lost to Follow-up|0|||
126402966|NCT00159913|454770468|FG002|Overall Study|Lost to Follow-up|0|||
126402967|NCT00159913|454770469|FG003|Overall Study|Lost to Follow-up|1|||
126402968|NCT00159913|454770466|FG000|Overall Study|Protocol Violation|1|||
126402969|NCT00159913|454770467|FG001|Overall Study|Protocol Violation|0|||
126402970|NCT00159913|454770468|FG002|Overall Study|Protocol Violation|1|||
126402971|NCT00159913|454770469|FG003|Overall Study|Protocol Violation|0|||
126402972|NCT00824005|454770470|FG000|Overall Study|Death|0|||
126402973|NCT00824005|454770471|FG001|Overall Study|Death|1|||
126402974|NCT00824005|454770470|FG000|Overall Study|Lost to Follow-up|0|||
126402975|NCT00824005|454770471|FG001|Overall Study|Lost to Follow-up|1|||
126402976|NCT01874275|454770472|FG000|Overall Study|Lost to Follow-up|1|||
126402977|NCT01874275|454770473|FG001|Overall Study|Lost to Follow-up|0|||
126402978|NCT00989235|454770474|FG000|Overall Study|Death|0|||
126402979|NCT00989235|454770475|FG001|Overall Study|Death|1|||
126402980|NCT00989235|454770474|FG000|Overall Study|Adverse Event|0|||
126402981|NCT00989235|454770475|FG001|Overall Study|Adverse Event|1|||
126402982|NCT00989235|454770474|FG000|Overall Study|Lack of Efficacy|1|||
126402983|NCT00989235|454770475|FG001|Overall Study|Lack of Efficacy|0|||
126402984|NCT00989235|454770474|FG000|Overall Study|Withdrawal of Consent|1|||
126402985|NCT00989235|454770475|FG001|Overall Study|Withdrawal of Consent|1|||
126402986|NCT00989235|454770474|FG000|Overall Study|Desire to Become Pregnant|1|||
126402987|NCT00989235|454770475|FG001|Overall Study|Desire to Become Pregnant|0|||
126402988|NCT00989235|454770474|FG000|Overall Study|Randomized by Mistake|0|||
126402989|NCT00989235|454770475|FG001|Overall Study|Randomized by Mistake|2|||
126402990|NCT00989235|454770474|FG000|Overall Study|Lost to Follow-up|0|||
126402991|NCT00989235|454770475|FG001|Overall Study|Lost to Follow-up|1|||
126402992|NCT00875056|454770476|FG000|Overall Study|Adverse Event|6|||
126402993|NCT00875056|454770477|FG001|Overall Study|Adverse Event|1|||
126402994|NCT00875056|454770478|FG002|Overall Study|Adverse Event|2|||
126402995|NCT00875056|454770476|FG000|Overall Study|Progressive Disease|14|||
126402996|NCT00875056|454770477|FG001|Overall Study|Progressive Disease|8|||
126402997|NCT00875056|454770478|FG002|Overall Study|Progressive Disease|3|||
126402998|NCT00875056|454770476|FG000|Overall Study|Withdrawal by Subject|3|||
126402999|NCT00875056|454770477|FG001|Overall Study|Withdrawal by Subject|0|||
126403000|NCT00875056|454770478|FG002|Overall Study|Withdrawal by Subject|1|||
126403001|NCT01318070|454770479|FG000|Overall Study|Adverse Event|1|||
126403002|NCT01318070|454770480|FG001|Overall Study|Adverse Event|1|||
126403003|NCT01318070|454770481|FG002|Overall Study|Adverse Event|5|||
126403004|NCT01318070|454770479|FG000|Overall Study|Withdrawal by Subject|0|||
126403005|NCT01318070|454770480|FG001|Overall Study|Withdrawal by Subject|1|||
126403006|NCT01318070|454770481|FG002|Overall Study|Withdrawal by Subject|1|||
126403007|NCT01318070|454770479|FG000|Overall Study|Lack of Efficacy|0|||
126403008|NCT01318070|454770480|FG001|Overall Study|Lack of Efficacy|0|||
126403009|NCT01318070|454770481|FG002|Overall Study|Lack of Efficacy|1|||
126403010|NCT01318070|454770479|FG000|Overall Study|Principal Investigator Discretion|1|||
126472337|NCT00313300|455030771|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
126403011|NCT01318070|454770480|FG001|Overall Study|Principal Investigator Discretion|0|||
126403012|NCT01318070|454770481|FG002|Overall Study|Principal Investigator Discretion|0|||
126403013|NCT01920152|454770482|FG000|Overall Study|Withdrawal by Subject|1|||
126403014|NCT01920152|454770483|FG001|Overall Study|Withdrawal by Subject|2|||
126403015|NCT00353873|454770485|FG000|Overall Study|Protocol Violation|1|||
126403016|NCT00353873|454770486|FG001|Overall Study|Protocol Violation|2|||
126403017|NCT00353873|454770485|FG000|Overall Study|Exacerbation|1|||
126403018|NCT00353873|454770486|FG001|Overall Study|Exacerbation|0|||
126403019|NCT00353873|454770485|FG000|Overall Study|Adverse Event|1|||
126403020|NCT00353873|454770486|FG001|Overall Study|Adverse Event|0|||
126472338|NCT00313300|455030772|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
126472339|NCT00313300|455030773|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
126472340|NCT00313300|455030769|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
126472341|NCT00313300|455030770|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
126472342|NCT00313300|455030771|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
126472343|NCT00313300|455030772|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
126472344|NCT00313300|455030773|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
126472345|NCT00313300|455030769|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
126472346|NCT00313300|455030770|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
126472347|NCT00313300|455030771|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
126472348|NCT00313300|455030772|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
126472349|NCT00313300|455030773|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
126472350|NCT00313300|455030769|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
126472351|NCT00313300|455030770|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
126472352|NCT00313300|455030771|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
126472353|NCT00313300|455030772|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
126472354|NCT00313300|455030773|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
126472355|NCT00313300|455030769|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
126472356|NCT00313300|455030770|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
126472357|NCT00313300|455030771|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
126472358|NCT00313300|455030772|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
126472359|NCT00313300|455030773|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
126472360|NCT00313300|455030769|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
126472361|NCT00313300|455030770|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
126472362|NCT00313300|455030771|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
126472363|NCT00313300|455030772|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
126472364|NCT00313300|455030773|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
126472365|NCT00313300|455030769|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
126472366|NCT00313300|455030770|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
126403021|NCT00353873|454770485|FG000|Overall Study|Physician Decision|2|||
126403022|NCT00353873|454770486|FG001|Overall Study|Physician Decision|0|||
126557669|NCT00570661|455334449|FG000|Overall Study|Disease worsening|5|||
126557670|NCT00570661|455334449|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
126557671|NCT00570661|455334449|FG000|Overall Study|Adverse Event|1|||
126557672|NCT01734382|455334450|FG000|Part 1|Adverse Event|2|||
126403023|NCT00353873|454770485|FG000|Overall Study|Withdrawal by Subject|1|||
126403024|NCT00353873|454770486|FG001|Overall Study|Withdrawal by Subject|1|||
126403025|NCT00870194|454770489|FG000|Overall Study|Adverse Event|10|||
126403026|NCT00870194|454770490|FG001|Overall Study|Adverse Event|5|||
126403027|NCT00870194|454770489|FG000|Overall Study|Lack of Efficacy|0|||
126403028|NCT00870194|454770490|FG001|Overall Study|Lack of Efficacy|1|||
126403029|NCT00870194|454770489|FG000|Overall Study|Lost to Follow-up|2|||
126403030|NCT00870194|454770490|FG001|Overall Study|Lost to Follow-up|0|||
126403031|NCT00870194|454770489|FG000|Overall Study|Physician Decision|3|||
126403032|NCT00870194|454770490|FG001|Overall Study|Physician Decision|1|||
126403033|NCT00870194|454770489|FG000|Overall Study|Protocol Violation|3|||
126403034|NCT00870194|454770490|FG001|Overall Study|Protocol Violation|3|||
126403035|NCT00870194|454770489|FG000|Overall Study|Entry Criteria Not Met|1|||
126403036|NCT00870194|454770490|FG001|Overall Study|Entry Criteria Not Met|2|||
126403037|NCT00870194|454770489|FG000|Overall Study|Subject Decision|7|||
126403038|NCT00870194|454770490|FG001|Overall Study|Subject Decision|2|||
126403039|NCT02717130|454770491|FG000|Overall Study|Withdrawal by Subject|1|||
126403040|NCT02717130|454770491|FG000|Overall Study|Adverse Event|1|||
126403041|NCT02717130|454770491|FG000|Overall Study|Physician Decision|1|||
126403042|NCT02717130|454770491|FG000|Overall Study|Study Closure|4|||
126403043|NCT00106691|454770492|FG000|Overall Study|Adverse Event|60|||
126403044|NCT00106691|454770493|FG001|Overall Study|Adverse Event|64|||
126403045|NCT00106691|454770492|FG000|Overall Study|Lost to Follow-up|23|||
126472367|NCT00313300|455030771|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
126472368|NCT00313300|455030772|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
126472369|NCT00313300|455030773|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
126472370|NCT00313300|455030769|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
126472371|NCT00313300|455030770|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
126472372|NCT00313300|455030771|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
126472373|NCT00313300|455030772|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
126472374|NCT00313300|455030773|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
126557673|NCT01734382|455334451|FG001|Part 1|Adverse Event|0|||
126403046|NCT00106691|454770493|FG001|Overall Study|Lost to Follow-up|18|||
126403047|NCT00106691|454770492|FG000|Overall Study|Physician Decision|18|||
126403048|NCT00106691|454770493|FG001|Overall Study|Physician Decision|21|||
126403049|NCT00106691|454770492|FG000|Overall Study|Protocol Violation|13|||
126403050|NCT00106691|454770493|FG001|Overall Study|Protocol Violation|18|||
126403051|NCT00106691|454770492|FG000|Overall Study|Withdrawal by Subject|75|||
126403052|NCT00106691|454770493|FG001|Overall Study|Withdrawal by Subject|70|||
126403053|NCT00106691|454770492|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
126403054|NCT00106691|454770493|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
126403055|NCT00106691|454770492|FG000|Overall Study|QTc>480|3|||
126403056|NCT00106691|454770493|FG001|Overall Study|QTc>480|1|||
126403057|NCT00106691|454770492|FG000|Overall Study|mililtary deployment|2|||
126403058|NCT00106691|454770493|FG001|Overall Study|mililtary deployment|0|||
126403059|NCT00106691|454770492|FG000|Overall Study|Study Site Closing/PI Moved|1|||
126403060|NCT00106691|454770493|FG001|Overall Study|Study Site Closing/PI Moved|2|||
126403061|NCT00106691|454770492|FG000|Overall Study|Cardiologist recommendation|1|||
126403062|NCT00106691|454770493|FG001|Overall Study|Cardiologist recommendation|0|||
126403063|NCT00106691|454770492|FG000|Overall Study|Pt. moved to another state|1|||
126403064|NCT00106691|454770493|FG001|Overall Study|Pt. moved to another state|0|||
126403065|NCT00106691|454770492|FG000|Overall Study|Taking exclusionary avodart|1|||
126403066|NCT00106691|454770493|FG001|Overall Study|Taking exclusionary avodart|0|||
126403067|NCT00106691|454770492|FG000|Overall Study|Not able to discontinue plavix|0|||
126403068|NCT00106691|454770493|FG001|Overall Study|Not able to discontinue plavix|1|||
126403069|NCT02322190|454770495|FG000|Overall Study|Death on study|1|||
126403070|NCT02322190|454770496|FG001|Overall Study|Death on study|0|||
126403071|NCT01685983|454770500|FG000|Overall Study|Adverse Event|7|||
126403072|NCT01685983|454770500|FG000|Overall Study|Death|1|||
126403073|NCT01685983|454770500|FG000|Overall Study|Withdrawal by Subject|19|||
126403074|NCT01685983|454770500|FG000|Overall Study|Protocol Violation|2|||
126472375|NCT00313300|455030769|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
126472376|NCT00313300|455030770|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
126472377|NCT00313300|455030771|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
126472378|NCT00313300|455030772|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
126472379|NCT00313300|455030773|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
126472380|NCT00313300|455030769|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
126472381|NCT00313300|455030770|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
126472382|NCT00313300|455030771|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
126472383|NCT00313300|455030772|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
126472384|NCT00313300|455030773|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
126472385|NCT00313300|455030769|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
126472386|NCT00313300|455030770|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
126472387|NCT00313300|455030771|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
126472388|NCT00313300|455030772|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
126472389|NCT00313300|455030773|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
126472390|NCT00313300|455030769|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
126472391|NCT00313300|455030770|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
126472392|NCT00313300|455030771|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
126472393|NCT00313300|455030772|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
126472394|NCT00313300|455030773|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
126472395|NCT02336373|455030774|FG000|Overall Study|Protocol closed early|4|||
126472396|NCT02336373|455030774|FG000|Overall Study|Physician Decision|14|||
126472397|NCT00850343|455030775|FG000|Overall Study|Withdrawal by Subject|11|||
126472398|NCT00850343|455030776|FG001|Overall Study|Withdrawal by Subject|0|||
126472399|NCT00850343|455030777|FG002|Overall Study|Withdrawal by Subject|3|||
126472400|NCT00850343|455030778|FG003|Overall Study|Withdrawal by Subject|2|||
126472401|NCT00850343|455030775|FG000|Overall Study|Adverse Event|15|||
126472402|NCT00850343|455030776|FG001|Overall Study|Adverse Event|2|||
126472403|NCT00850343|455030777|FG002|Overall Study|Adverse Event|6|||
126472404|NCT00850343|455030778|FG003|Overall Study|Adverse Event|6|||
126472405|NCT00850343|455030775|FG000|Overall Study|Pregnancy|0|||
126472406|NCT00850343|455030776|FG001|Overall Study|Pregnancy|0|||
126472407|NCT00850343|455030777|FG002|Overall Study|Pregnancy|0|||
126472408|NCT00850343|455030778|FG003|Overall Study|Pregnancy|1|||
126472409|NCT00850343|455030775|FG000|Overall Study|Lack of Efficacy|17|||
126472410|NCT00850343|455030776|FG001|Overall Study|Lack of Efficacy|0|||
126472411|NCT00850343|455030777|FG002|Overall Study|Lack of Efficacy|3|||
126472412|NCT00850343|455030778|FG003|Overall Study|Lack of Efficacy|2|||
126472413|NCT00850343|455030775|FG000|Overall Study|Non-compliance with Study Procedures|1|||
126472414|NCT00850343|455030776|FG001|Overall Study|Non-compliance with Study Procedures|0|||
126472415|NCT00850343|455030777|FG002|Overall Study|Non-compliance with Study Procedures|1|||
126472416|NCT00850343|455030778|FG003|Overall Study|Non-compliance with Study Procedures|1|||
126472417|NCT00850343|455030775|FG000|Overall Study|Physician Decision|2|||
126403075|NCT01685983|454770500|FG000|Overall Study|Physician Decision|13|||
126403076|NCT01685983|454770500|FG000|Overall Study|Other|7|||
126403077|NCT01685983|454770500|FG000|Overall Study|Progressive Disease|32|||
126403078|NCT01685983|454770500|FG000|Overall Study|Noncompliance with Study Drug|1|||
126403079|NCT01443130|454770501|FG000|Overall Study|Lost to Follow-up|44|||
126403080|NCT01443130|454770502|FG001|Overall Study|Lost to Follow-up|42|||
126472418|NCT00850343|455030776|FG001|Overall Study|Physician Decision|1|||
126403081|NCT01443130|454770503|FG002|Overall Study|Lost to Follow-up|50|||
126403082|NCT01443130|454770504|FG003|Overall Study|Lost to Follow-up|23|||
126403083|NCT01443130|454770505|FG004|Overall Study|Lost to Follow-up|25|||
126403084|NCT01443130|454770506|FG005|Overall Study|Lost to Follow-up|21|||
126403085|NCT01443130|454770501|FG000|Overall Study|Death|0|||
126403086|NCT01443130|454770502|FG001|Overall Study|Death|1|||
126403087|NCT01443130|454770503|FG002|Overall Study|Death|0|||
126403088|NCT01443130|454770504|FG003|Overall Study|Death|7|||
126403089|NCT01443130|454770505|FG004|Overall Study|Death|10|||
126403090|NCT01443130|454770506|FG005|Overall Study|Death|8|||
126403091|NCT01443130|454770501|FG000|Overall Study|Adverse Event|2|||
126403092|NCT01443130|454770502|FG001|Overall Study|Adverse Event|1|||
126403093|NCT01443130|454770503|FG002|Overall Study|Adverse Event|1|||
126403094|NCT01443130|454770504|FG003|Overall Study|Adverse Event|0|||
126403095|NCT01443130|454770505|FG004|Overall Study|Adverse Event|0|||
126403096|NCT01443130|454770506|FG005|Overall Study|Adverse Event|0|||
126403097|NCT01443130|454770501|FG000|Overall Study|Protocol Violation|2|||
126403098|NCT01443130|454770502|FG001|Overall Study|Protocol Violation|1|||
126403099|NCT01443130|454770503|FG002|Overall Study|Protocol Violation|3|||
126403100|NCT01443130|454770504|FG003|Overall Study|Protocol Violation|2|||
126403101|NCT01443130|454770505|FG004|Overall Study|Protocol Violation|2|||
126403102|NCT01443130|454770506|FG005|Overall Study|Protocol Violation|3|||
126403103|NCT01443130|454770501|FG000|Overall Study|Withdrawal by Subject|15|||
126403104|NCT01443130|454770502|FG001|Overall Study|Withdrawal by Subject|14|||
126403105|NCT01443130|454770503|FG002|Overall Study|Withdrawal by Subject|12|||
126403106|NCT01443130|454770504|FG003|Overall Study|Withdrawal by Subject|7|||
126403107|NCT01443130|454770505|FG004|Overall Study|Withdrawal by Subject|7|||
126403108|NCT01443130|454770506|FG005|Overall Study|Withdrawal by Subject|2|||
126403109|NCT01443130|454770501|FG000|Overall Study|Death of Subject's Infant|5|||
126403110|NCT01443130|454770502|FG001|Overall Study|Death of Subject's Infant|10|||
126403111|NCT01443130|454770503|FG002|Overall Study|Death of Subject's Infant|11|||
126403112|NCT01443130|454770504|FG003|Overall Study|Death of Subject's Infant|0|||
126403113|NCT01443130|454770505|FG004|Overall Study|Death of Subject's Infant|0|||
126403114|NCT01443130|454770506|FG005|Overall Study|Death of Subject's Infant|0|||
126403115|NCT01167907|454770508|FG000|Overall Study|Protocol Violation|1|||
126472419|NCT00850343|455030777|FG002|Overall Study|Physician Decision|1|||
126472420|NCT00850343|455030778|FG003|Overall Study|Physician Decision|1|||
126472421|NCT01626456|455030783|FG000|Overall Study|Withdrawal by Subject|21|||
126472422|NCT01626456|455030784|FG001|Overall Study|Withdrawal by Subject|46|||
126472423|NCT01626456|455030783|FG000|Overall Study|Adverse Event|2|||
126472424|NCT01626456|455030784|FG001|Overall Study|Adverse Event|27|||
126472425|NCT01626456|455030783|FG000|Overall Study|Lost to Follow-up|2|||
126472426|NCT01626456|455030784|FG001|Overall Study|Lost to Follow-up|27|||
126472427|NCT01626456|455030783|FG000|Overall Study|Lack of Efficacy|6|||
126472428|NCT01626456|455030784|FG001|Overall Study|Lack of Efficacy|7|||
126472429|NCT01626456|455030783|FG000|Overall Study|Physician Decision|1|||
126472430|NCT01626456|455030784|FG001|Overall Study|Physician Decision|4|||
126472431|NCT01626456|455030783|FG000|Overall Study|Protocol Violation|1|||
126472432|NCT01626456|455030784|FG001|Overall Study|Protocol Violation|1|||
126472433|NCT01626456|455030783|FG000|Overall Study|Site Closure|2|||
126472434|NCT01626456|455030784|FG001|Overall Study|Site Closure|3|||
126472435|NCT01626456|455030783|FG000|Overall Study|Incarceration|0|||
126472436|NCT01626456|455030784|FG001|Overall Study|Incarceration|2|||
126472437|NCT02468232|455030785|FG000|Core Part of Study|Adverse Event|0|||
126472438|NCT02468232|455030786|FG001|Core Part of Study|Adverse Event|1|||
126472439|NCT02468232|455030787|FG002|Core Part of Study|Adverse Event|0|||
126403116|NCT01167907|454770509|FG001|Overall Study|Protocol Violation|0|||
126403117|NCT01167907|454770508|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
126472440|NCT02468232|455030788|FG003|Core Part of Study|Adverse Event|0|||
126472441|NCT02468232|455030785|FG000|Core Part of Study|Death|20|||
126472442|NCT02468232|455030786|FG001|Core Part of Study|Death|17|||
126557674|NCT01734382|455334452|FG002|Part 1|Adverse Event|0|||
126557675|NCT01734382|455334450|FG000|Part 2|Adverse Event|0|||
126403118|NCT01167907|454770509|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
126403119|NCT03461406|454770510|FG000|Overall Study|Death|1|||
126403120|NCT03461406|454770511|FG001|Overall Study|Death|2|||
126472443|NCT02468232|455030787|FG002|Core Part of Study|Death|0|||
126472444|NCT02468232|455030788|FG003|Core Part of Study|Death|0|||
126472445|NCT02468232|455030785|FG000|Core Part of Study|Technical Problems|1|||
126403121|NCT03461406|454770510|FG000|Overall Study|Consent Withdrawn by Participant|0|||
126403122|NCT03461406|454770511|FG001|Overall Study|Consent Withdrawn by Participant|1|||
126403123|NCT03461406|454770510|FG000|Overall Study|Screen Failure|3|||
126403124|NCT03461406|454770511|FG001|Overall Study|Screen Failure|1|||
126472446|NCT02468232|455030786|FG001|Core Part of Study|Technical Problems|1|||
126472447|NCT02468232|455030787|FG002|Core Part of Study|Technical Problems|0|||
126472448|NCT02468232|455030788|FG003|Core Part of Study|Technical Problems|0|||
126557676|NCT01734382|455334451|FG001|Part 2|Adverse Event|0|||
126472449|NCT02468232|455030785|FG000|OLE Part of Study|Adverse Event|0|||
126557677|NCT01734382|455334452|FG002|Part 2|Adverse Event|1|||
126403125|NCT03461406|454770510|FG000|Overall Study|Reason not Specified|1|||
126403126|NCT03461406|454770511|FG001|Overall Study|Reason not Specified|3|||
126403127|NCT03461406|454770510|FG000|Overall Study|Lost to Follow-up|3|||
126403128|NCT03461406|454770511|FG001|Overall Study|Lost to Follow-up|0|||
126403129|NCT00973102|454770514|FG000|Overall Study|Protocol Violation|1|||
126403130|NCT00973102|454770515|FG001|Overall Study|Protocol Violation|0|||
126403131|NCT00973102|454770514|FG000|Overall Study|Prisoner|0|||
126403132|NCT00973102|454770515|FG001|Overall Study|Prisoner|1|||
126403133|NCT00612508|454770518|FG000|Overall Study|Withdrawal by Subject|3|||
126403134|NCT00612508|454770519|FG001|Overall Study|Withdrawal by Subject|4|||
126403135|NCT02012686|454770520|FG000|Overall Study|muscle contraction|0|||
126403136|NCT02012686|454770521|FG001|Overall Study|muscle contraction|1|||
126403137|NCT02012686|454770520|FG000|Overall Study|electrocardiography monitoring noise|0|||
126403138|NCT02012686|454770521|FG001|Overall Study|electrocardiography monitoring noise|1|||
126403139|NCT00787202|454770522|FG000|Overall Study|Adverse Event|3|||
126403140|NCT00787202|454770523|FG001|Overall Study|Adverse Event|2|||
126403141|NCT00787202|454770524|FG002|Overall Study|Adverse Event|0|||
126403142|NCT00787202|454770525|FG003|Overall Study|Adverse Event|0|||
126403143|NCT00787202|454770526|FG004|Overall Study|Adverse Event|2|||
126403144|NCT00787202|454770522|FG000|Overall Study|Lack of Efficacy|5|||
126403145|NCT00787202|454770523|FG001|Overall Study|Lack of Efficacy|6|||
126403146|NCT00787202|454770524|FG002|Overall Study|Lack of Efficacy|5|||
126403147|NCT00787202|454770525|FG003|Overall Study|Lack of Efficacy|2|||
126403148|NCT00787202|454770526|FG004|Overall Study|Lack of Efficacy|1|||
126403149|NCT00787202|454770522|FG000|Overall Study|Lost to Follow-up|1|||
126403150|NCT00787202|454770523|FG001|Overall Study|Lost to Follow-up|0|||
126403151|NCT00787202|454770524|FG002|Overall Study|Lost to Follow-up|0|||
126403152|NCT00787202|454770525|FG003|Overall Study|Lost to Follow-up|0|||
126403153|NCT00787202|454770526|FG004|Overall Study|Lost to Follow-up|0|||
126403154|NCT00787202|454770522|FG000|Overall Study|Withdrawal by Subject|2|||
126403155|NCT00787202|454770523|FG001|Overall Study|Withdrawal by Subject|2|||
126403156|NCT00787202|454770524|FG002|Overall Study|Withdrawal by Subject|2|||
126403157|NCT00787202|454770525|FG003|Overall Study|Withdrawal by Subject|0|||
126403158|NCT00787202|454770526|FG004|Overall Study|Withdrawal by Subject|0|||
126403159|NCT00787202|454770522|FG000|Overall Study|Protocol Violation|2|||
126403160|NCT00787202|454770523|FG001|Overall Study|Protocol Violation|1|||
126403161|NCT00787202|454770524|FG002|Overall Study|Protocol Violation|0|||
126403162|NCT00787202|454770525|FG003|Overall Study|Protocol Violation|0|||
126403163|NCT00787202|454770526|FG004|Overall Study|Protocol Violation|1|||
126403164|NCT00787202|454770522|FG000|Overall Study|Randomized, not treated|1|||
126403165|NCT00787202|454770523|FG001|Overall Study|Randomized, not treated|0|||
126403166|NCT00787202|454770524|FG002|Overall Study|Randomized, not treated|0|||
126403167|NCT00787202|454770525|FG003|Overall Study|Randomized, not treated|0|||
126403168|NCT00787202|454770526|FG004|Overall Study|Randomized, not treated|0|||
126403169|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
126403170|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
126403171|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
126403172|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
126403173|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
126403174|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
126403175|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
126403176|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
126403177|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
126403178|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
126403179|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
126403180|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
126403181|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
126403182|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
126403183|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
126403184|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
126403185|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
126403186|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
126403187|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
126403188|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
126403189|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
126403190|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
126403191|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
126403192|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
126403193|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
126403194|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
126472450|NCT02468232|455030786|FG001|OLE Part of Study|Adverse Event|0|||
126403195|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
126403196|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
126403197|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
126403198|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
126403199|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
126403200|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
126403201|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
126403202|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
126403203|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
126403204|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
126403205|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
126403206|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
126403207|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
126403208|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
126403209|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
126403210|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
126403211|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
126403212|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
126403213|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
126403214|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
126403215|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
126403216|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
126403217|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
126403218|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
126403219|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
126403220|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
126403221|NCT02008357|454770527|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
126403222|NCT02008357|454770528|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
126403223|NCT02008357|454770527|FG000|Open-label Extension Period|Adverse Event|8|||
126403224|NCT02008357|454770528|FG001|Open-label Extension Period|Adverse Event|7|||
126403225|NCT02008357|454770527|FG000|Open-label Extension Period|Death|7|||
126403226|NCT02008357|454770528|FG001|Open-label Extension Period|Death|4|||
126403227|NCT02008357|454770527|FG000|Open-label Extension Period|Lack of Efficacy|9|||
126403228|NCT02008357|454770528|FG001|Open-label Extension Period|Lack of Efficacy|5|||
126403229|NCT02008357|454770527|FG000|Open-label Extension Period|Lost to Follow-up|2|||
126403230|NCT02008357|454770528|FG001|Open-label Extension Period|Lost to Follow-up|2|||
126403231|NCT02008357|454770527|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
126403232|NCT02008357|454770528|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
126403233|NCT02008357|454770527|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
126403234|NCT02008357|454770528|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
126403235|NCT02008357|454770527|FG000|Open-label Extension Period|Safety Risk|2|||
126403236|NCT02008357|454770528|FG001|Open-label Extension Period|Safety Risk|1|||
126403237|NCT02008357|454770527|FG000|Open-label Extension Period|Non-Compliance|0|||
126403238|NCT02008357|454770528|FG001|Open-label Extension Period|Non-Compliance|1|||
126403239|NCT02008357|454770527|FG000|Open-label Extension Period|Investigator Recommendation|0|||
126403240|NCT02008357|454770528|FG001|Open-label Extension Period|Investigator Recommendation|1|||
126403241|NCT02008357|454770527|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
126403242|NCT02008357|454770528|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
126403243|NCT02008357|454770527|FG000|Open-label Extension Period|Coordinating Center Request|2|||
126403244|NCT02008357|454770528|FG001|Open-label Extension Period|Coordinating Center Request|4|||
126403245|NCT02008357|454770527|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
126403246|NCT02008357|454770528|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
126403247|NCT02008357|454770527|FG000|Open-label Extension Period|Study Ended|20|||
126403248|NCT02008357|454770528|FG001|Open-label Extension Period|Study Ended|25|||
126403249|NCT02008357|454770527|FG000|Open-label Extension Period|Personal Reasons|0|||
126403250|NCT02008357|454770528|FG001|Open-label Extension Period|Personal Reasons|1|||
126403251|NCT02008357|454770527|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
126403252|NCT02008357|454770528|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
126403253|NCT02008357|454770527|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
126403254|NCT02008357|454770528|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
126403255|NCT02008357|454770527|FG000|Open-label Extension Period|Other|2|||
126403256|NCT02008357|454770528|FG001|Open-label Extension Period|Other|0|||
126403257|NCT01442064|454770529|FG000|Overall Study|Adverse Event|2|||
126403258|NCT01442064|454770530|FG001|Overall Study|Adverse Event|2|||
126403259|NCT01442064|454770531|FG002|Overall Study|Adverse Event|2|||
126403260|NCT01442064|454770532|FG003|Overall Study|Adverse Event|1|||
126403261|NCT01442064|454770533|FG004|Overall Study|Adverse Event|2|||
126403262|NCT01442064|454770534|FG005|Overall Study|Adverse Event|0|||
126403263|NCT01442064|454770529|FG000|Overall Study|Death|0|||
126403264|NCT01442064|454770530|FG001|Overall Study|Death|1|||
126403265|NCT01442064|454770531|FG002|Overall Study|Death|3|||
126403266|NCT01442064|454770532|FG003|Overall Study|Death|3|||
126403267|NCT01442064|454770533|FG004|Overall Study|Death|1|||
126403268|NCT01442064|454770534|FG005|Overall Study|Death|3|||
126403269|NCT01442064|454770529|FG000|Overall Study|Lost to Follow-up|5|||
126403270|NCT01442064|454770530|FG001|Overall Study|Lost to Follow-up|5|||
126403271|NCT01442064|454770531|FG002|Overall Study|Lost to Follow-up|1|||
126403272|NCT01442064|454770532|FG003|Overall Study|Lost to Follow-up|1|||
126403273|NCT01442064|454770533|FG004|Overall Study|Lost to Follow-up|3|||
126403274|NCT01442064|454770534|FG005|Overall Study|Lost to Follow-up|3|||
126403275|NCT01442064|454770529|FG000|Overall Study|Physician Decision|1|||
126403276|NCT01442064|454770530|FG001|Overall Study|Physician Decision|1|||
126403277|NCT01442064|454770531|FG002|Overall Study|Physician Decision|2|||
126403278|NCT01442064|454770532|FG003|Overall Study|Physician Decision|3|||
126403279|NCT01442064|454770533|FG004|Overall Study|Physician Decision|3|||
126403280|NCT01442064|454770534|FG005|Overall Study|Physician Decision|1|||
126403281|NCT01442064|454770529|FG000|Overall Study|Withdrawal by Subject|6|||
126403282|NCT01442064|454770530|FG001|Overall Study|Withdrawal by Subject|3|||
126403283|NCT01442064|454770531|FG002|Overall Study|Withdrawal by Subject|2|||
126403284|NCT01442064|454770532|FG003|Overall Study|Withdrawal by Subject|2|||
126403285|NCT01442064|454770533|FG004|Overall Study|Withdrawal by Subject|2|||
126403286|NCT01442064|454770534|FG005|Overall Study|Withdrawal by Subject|1|||
126403287|NCT01442064|454770529|FG000|Overall Study|Sponsor decision|82|||
126403288|NCT01442064|454770530|FG001|Overall Study|Sponsor decision|88|||
126403289|NCT01442064|454770531|FG002|Overall Study|Sponsor decision|92|||
126403290|NCT01442064|454770532|FG003|Overall Study|Sponsor decision|88|||
126403291|NCT01442064|454770533|FG004|Overall Study|Sponsor decision|95|||
126403292|NCT01442064|454770534|FG005|Overall Study|Sponsor decision|87|||
126403293|NCT01442064|454770529|FG000|Overall Study|Subject non-compliance|0|||
126403294|NCT01442064|454770530|FG001|Overall Study|Subject non-compliance|0|||
126403295|NCT01442064|454770531|FG002|Overall Study|Subject non-compliance|0|||
126403296|NCT01442064|454770532|FG003|Overall Study|Subject non-compliance|0|||
126403297|NCT01442064|454770533|FG004|Overall Study|Subject non-compliance|0|||
126403298|NCT01442064|454770534|FG005|Overall Study|Subject non-compliance|2|||
126403299|NCT01442064|454770529|FG000|Overall Study|Condition mandated other intervention|1|||
126403300|NCT01442064|454770530|FG001|Overall Study|Condition mandated other intervention|1|||
126403301|NCT01442064|454770531|FG002|Overall Study|Condition mandated other intervention|2|||
126403302|NCT01442064|454770532|FG003|Overall Study|Condition mandated other intervention|0|||
126403303|NCT01442064|454770533|FG004|Overall Study|Condition mandated other intervention|0|||
126403304|NCT01442064|454770534|FG005|Overall Study|Condition mandated other intervention|2|||
126403305|NCT00966719|454770535|FG000|Overall Study|Lost to Follow-up|6|||
126403306|NCT00966719|454770536|FG001|Overall Study|Lost to Follow-up|11|||
126403307|NCT01703065|454770537|FG000|Overall Study|Lack of Efficacy|1|||
126403308|NCT01703065|454770538|FG001|Overall Study|Lack of Efficacy|0|||
126403309|NCT01710527|454770539|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
126403310|NCT01710527|454770540|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
126403311|NCT02635347|454770543|FG000|Overall Study|Failed screening|20|||
126403312|NCT02635347|454770544|FG001|Overall Study|Failed screening|7|||
126403313|NCT02124772|454770546|FG000|Overall Study|Lack of Efficacy|2|||
126403314|NCT02124772|454770547|FG001|Overall Study|Lack of Efficacy|0|||
126403315|NCT02124772|454770548|FG002|Overall Study|Lack of Efficacy|0|||
126403316|NCT02124772|454770549|FG003|Overall Study|Lack of Efficacy|1|||
126403317|NCT02124772|454770550|FG004|Overall Study|Lack of Efficacy|2|||
126403318|NCT02124772|454770551|FG005|Overall Study|Lack of Efficacy|3|||
126403319|NCT02124772|454770552|FG006|Overall Study|Lack of Efficacy|0|||
126403320|NCT02124772|454770553|FG007|Overall Study|Lack of Efficacy|2|||
126403321|NCT02124772|454770554|FG008|Overall Study|Lack of Efficacy|0|||
126403322|NCT02124772|454770555|FG009|Overall Study|Lack of Efficacy|1|||
126403323|NCT02124772|454770556|FG010|Overall Study|Lack of Efficacy|0|||
126403324|NCT02124772|454770557|FG011|Overall Study|Lack of Efficacy|0|||
126403325|NCT02124772|454770558|FG012|Overall Study|Lack of Efficacy|1|||
126403326|NCT02124772|454770546|FG000|Overall Study|Adverse Event|1|||
126403327|NCT02124772|454770547|FG001|Overall Study|Adverse Event|4|||
126403328|NCT02124772|454770548|FG002|Overall Study|Adverse Event|1|||
126403329|NCT02124772|454770549|FG003|Overall Study|Adverse Event|5|||
126403330|NCT02124772|454770550|FG004|Overall Study|Adverse Event|2|||
126403331|NCT02124772|454770551|FG005|Overall Study|Adverse Event|1|||
126403332|NCT02124772|454770552|FG006|Overall Study|Adverse Event|1|||
126403333|NCT02124772|454770553|FG007|Overall Study|Adverse Event|5|||
126403334|NCT02124772|454770554|FG008|Overall Study|Adverse Event|0|||
126403335|NCT02124772|454770555|FG009|Overall Study|Adverse Event|3|||
126403336|NCT02124772|454770556|FG010|Overall Study|Adverse Event|1|||
126403337|NCT02124772|454770557|FG011|Overall Study|Adverse Event|3|||
126403338|NCT02124772|454770558|FG012|Overall Study|Adverse Event|1|||
126403339|NCT02124772|454770546|FG000|Overall Study|Withdrawal consent|0|||
126403340|NCT02124772|454770547|FG001|Overall Study|Withdrawal consent|1|||
126403341|NCT02124772|454770548|FG002|Overall Study|Withdrawal consent|1|||
126403342|NCT02124772|454770549|FG003|Overall Study|Withdrawal consent|1|||
126403343|NCT02124772|454770550|FG004|Overall Study|Withdrawal consent|0|||
126403344|NCT02124772|454770551|FG005|Overall Study|Withdrawal consent|1|||
126403345|NCT02124772|454770552|FG006|Overall Study|Withdrawal consent|1|||
126403346|NCT02124772|454770553|FG007|Overall Study|Withdrawal consent|0|||
126403347|NCT02124772|454770554|FG008|Overall Study|Withdrawal consent|0|||
126403348|NCT02124772|454770555|FG009|Overall Study|Withdrawal consent|1|||
126403349|NCT02124772|454770556|FG010|Overall Study|Withdrawal consent|0|||
126403350|NCT02124772|454770557|FG011|Overall Study|Withdrawal consent|1|||
126403351|NCT02124772|454770558|FG012|Overall Study|Withdrawal consent|0|||
126403352|NCT02124772|454770546|FG000|Overall Study|Investigator discretion|0|||
126403353|NCT02124772|454770547|FG001|Overall Study|Investigator discretion|2|||
126403354|NCT02124772|454770548|FG002|Overall Study|Investigator discretion|2|||
126403355|NCT02124772|454770549|FG003|Overall Study|Investigator discretion|1|||
126403356|NCT02124772|454770550|FG004|Overall Study|Investigator discretion|1|||
126403357|NCT02124772|454770551|FG005|Overall Study|Investigator discretion|0|||
126403358|NCT02124772|454770552|FG006|Overall Study|Investigator discretion|1|||
126403359|NCT02124772|454770553|FG007|Overall Study|Investigator discretion|0|||
126403360|NCT02124772|454770554|FG008|Overall Study|Investigator discretion|0|||
126403361|NCT02124772|454770555|FG009|Overall Study|Investigator discretion|1|||
126403362|NCT02124772|454770556|FG010|Overall Study|Investigator discretion|0|||
126403363|NCT02124772|454770557|FG011|Overall Study|Investigator discretion|1|||
126403364|NCT02124772|454770558|FG012|Overall Study|Investigator discretion|0|||
126403365|NCT02124772|454770546|FG000|Overall Study|Progressive disease|0|||
126403366|NCT02124772|454770547|FG001|Overall Study|Progressive disease|0|||
126403367|NCT02124772|454770548|FG002|Overall Study|Progressive disease|0|||
126403368|NCT02124772|454770549|FG003|Overall Study|Progressive disease|0|||
126403369|NCT02124772|454770550|FG004|Overall Study|Progressive disease|0|||
126403370|NCT02124772|454770551|FG005|Overall Study|Progressive disease|0|||
126403371|NCT02124772|454770552|FG006|Overall Study|Progressive disease|1|||
126403372|NCT02124772|454770553|FG007|Overall Study|Progressive disease|1|||
126403373|NCT02124772|454770554|FG008|Overall Study|Progressive disease|0|||
126403374|NCT02124772|454770555|FG009|Overall Study|Progressive disease|0|||
126403375|NCT02124772|454770556|FG010|Overall Study|Progressive disease|0|||
126403376|NCT02124772|454770557|FG011|Overall Study|Progressive disease|0|||
126403377|NCT02124772|454770558|FG012|Overall Study|Progressive disease|0|||
126403378|NCT02124772|454770546|FG000|Overall Study|Other|0|||
126403379|NCT02124772|454770547|FG001|Overall Study|Other|7|||
126403380|NCT02124772|454770548|FG002|Overall Study|Other|2|||
126403381|NCT02124772|454770549|FG003|Overall Study|Other|5|||
126403382|NCT02124772|454770550|FG004|Overall Study|Other|4|||
126403383|NCT02124772|454770551|FG005|Overall Study|Other|3|||
126403384|NCT02124772|454770552|FG006|Overall Study|Other|4|||
126403385|NCT02124772|454770553|FG007|Overall Study|Other|1|||
126403386|NCT02124772|454770554|FG008|Overall Study|Other|1|||
126403387|NCT02124772|454770555|FG009|Overall Study|Other|1|||
126403388|NCT02124772|454770556|FG010|Overall Study|Other|1|||
126403389|NCT02124772|454770557|FG011|Overall Study|Other|1|||
126403390|NCT02124772|454770558|FG012|Overall Study|Other|0|||
126403391|NCT00780273|454770561|FG000|Overall Study|Death|1|||
126403392|NCT00780273|454770561|FG000|Overall Study|Lost to Follow-up|1|||
126403393|NCT00940485|454771632|FG000|Overall Study|HBeAb positive at Baseline|3|||
126403394|NCT00940485|454771633|FG001|Overall Study|HBeAb positive at Baseline|2|||
126403395|NCT00940485|454771632|FG000|Overall Study|Lost to Follow-up|2|||
126403396|NCT00940485|454771633|FG001|Overall Study|Lost to Follow-up|3|||
126403397|NCT00940485|454771632|FG000|Overall Study|Adverse Event|8|||
126403398|NCT00940485|454771633|FG001|Overall Study|Adverse Event|0|||
126403399|NCT00940485|454771632|FG000|Overall Study|Withdrawal by Subject|1|||
126403400|NCT00940485|454771633|FG001|Overall Study|Withdrawal by Subject|1|||
126403401|NCT00940485|454771632|FG000|Overall Study|Others|1|||
126403402|NCT00940485|454771633|FG001|Overall Study|Others|1|||
126403403|NCT03921554|454771635|FG000|Overall Study|Adverse Event|2|||
126403404|NCT03921554|454771635|FG000|Overall Study|Withdrawal by Subject|1|||
126403405|NCT03921554|454771635|FG000|Overall Study|Death|3|||
126403406|NCT03283150|454771642|FG000|Overall Study|Withdrawal by Subject|6|||
126403407|NCT03283150|454771643|FG001|Overall Study|Withdrawal by Subject|0|||
126403408|NCT03283150|454771644|FG002|Overall Study|Withdrawal by Subject|0|||
126403409|NCT01299571|454771647|FG000|Overall Study|Protocol Violation|107|||
126403410|NCT00864851|454771648|FG000|Overall Study|Withdrawal by Subject|0|||
126403411|NCT00864851|454771649|FG001|Overall Study|Withdrawal by Subject|1|||
126403412|NCT00864851|454771650|FG002|Overall Study|Withdrawal by Subject|0|||
126403413|NCT00864851|454771648|FG000|Overall Study|Physician Decision|1|||
126403414|NCT00864851|454771649|FG001|Overall Study|Physician Decision|0|||
126403415|NCT00864851|454771650|FG002|Overall Study|Physician Decision|0|||
126403416|NCT00864851|454771648|FG000|Overall Study|Death|1|||
126403417|NCT00864851|454771649|FG001|Overall Study|Death|0|||
126403418|NCT00864851|454771650|FG002|Overall Study|Death|0|||
126403419|NCT00864851|454771648|FG000|Overall Study|Patient uncooperative|1|||
126403420|NCT00864851|454771649|FG001|Overall Study|Patient uncooperative|0|||
126403421|NCT00864851|454771650|FG002|Overall Study|Patient uncooperative|0|||
126403422|NCT01842581|454771654|FG000|Overall Study|Adverse Event|6|||
126403423|NCT01842581|454771655|FG001|Overall Study|Adverse Event|4|||
126403424|NCT01842581|454771654|FG000|Overall Study|HE breakthrough|26|||
126403425|NCT01842581|454771655|FG001|Overall Study|HE breakthrough|13|||
126403426|NCT01842581|454771654|FG000|Overall Study|Liver transplant|2|||
126403427|NCT01842581|454771655|FG001|Overall Study|Liver transplant|0|||
126403428|NCT01842581|454771654|FG000|Overall Study|Lost to Follow-up|2|||
126403429|NCT01842581|454771655|FG001|Overall Study|Lost to Follow-up|5|||
126403430|NCT01842581|454771654|FG000|Overall Study|Withdrawal by Subject|5|||
126403431|NCT01842581|454771655|FG001|Overall Study|Withdrawal by Subject|7|||
126403432|NCT01842581|454771654|FG000|Overall Study|Other than specified|3|||
126403433|NCT01842581|454771655|FG001|Overall Study|Other than specified|1|||
126403434|NCT01287195|454771658|FG000|Overall Study|Withdrawal by Subject|2|||
126403435|NCT02006069|454771661|FG000|Overall Study|MPP other programming|239|||
126403436|NCT02006069|454771662|FG001|Overall Study|MPP other programming|0|||
126403437|NCT02006069|454771661|FG000|Overall Study|RV only pacing|0|||
126403438|NCT02006069|454771662|FG001|Overall Study|RV only pacing|3|||
126403439|NCT00530920|454771663|FG000|Overall Study|Randomized but not treated|0|||
126403440|NCT00530920|454771664|FG001|Overall Study|Randomized but not treated|2|||
126403441|NCT00530920|454771665|FG002|Overall Study|Randomized but not treated|0|||
126403442|NCT00530920|454771663|FG000|Overall Study|Adverse Event|0|||
126403443|NCT00530920|454771664|FG001|Overall Study|Adverse Event|0|||
126403444|NCT00530920|454771665|FG002|Overall Study|Adverse Event|3|||
126403445|NCT00530920|454771663|FG000|Overall Study|Withdrawal by Subject|0|||
126403446|NCT00530920|454771664|FG001|Overall Study|Withdrawal by Subject|0|||
126403447|NCT00530920|454771665|FG002|Overall Study|Withdrawal by Subject|1|||
126403448|NCT04957758|454771666|FG000|Overall Study|Adverse Event|1|||
126403449|NCT04957758|454771667|FG001|Overall Study|Adverse Event|0|||
126403450|NCT04957758|454771666|FG000|Overall Study|Lost to Follow-up|0|||
126403451|NCT04957758|454771667|FG001|Overall Study|Lost to Follow-up|2|||
126403452|NCT04957758|454771666|FG000|Overall Study|Withdrawal by Subject|4|||
126403453|NCT04957758|454771667|FG001|Overall Study|Withdrawal by Subject|2|||
126403454|NCT04957758|454771666|FG000|Overall Study|Protocol Violation|0|||
126403455|NCT04957758|454771667|FG001|Overall Study|Protocol Violation|1|||
126403456|NCT00707746|454771668|FG000|Treatment Period|Adverse Event|2|||
126403457|NCT00707746|454771669|FG001|Treatment Period|Adverse Event|4|||
126403458|NCT00707746|454771668|FG000|Treatment Period|Ineligibility|0|||
126403459|NCT00707746|454771669|FG001|Treatment Period|Ineligibility|1|||
126403460|NCT00685373|454771671|FG000|Overall Study|Adverse Event|3|||
126403461|NCT00685373|454771671|FG000|Overall Study|Withdrawal by Subject|5|||
126403462|NCT00685373|454771671|FG000|Overall Study|Lack of Efficacy|3|||
126403463|NCT00685373|454771671|FG000|Overall Study|Condition no longer requires study drug|1|||
126403464|NCT00685373|454771671|FG000|Overall Study|Lost to Follow-up|2|||
126403465|NCT00685373|454771671|FG000|Overall Study|Protocol Violation|1|||
126472451|NCT02468232|455030787|FG002|OLE Part of Study|Adverse Event|4|||
126472452|NCT02468232|455030788|FG003|OLE Part of Study|Adverse Event|5|||
126472453|NCT02468232|455030785|FG000|OLE Part of Study|Death|0|||
126403466|NCT02642965|454771672|FG000|Overall Study|Lack of Efficacy|4|||
126403467|NCT02642965|454771672|FG000|Overall Study|Physician Decision|9|||
126403468|NCT00857948|454771673|FG000|Overall Study|Withdrawal by Subject|2|||
126403469|NCT00857948|454771674|FG001|Overall Study|Withdrawal by Subject|0|||
126403470|NCT00857948|454771675|FG002|Overall Study|Withdrawal by Subject|0|||
126472454|NCT02468232|455030786|FG001|OLE Part of Study|Death|0|||
126403471|NCT00857948|454771676|FG003|Overall Study|Withdrawal by Subject|0|||
126403472|NCT00857948|454771673|FG000|Overall Study|Protocol Violation|1|||
126403473|NCT00857948|454771674|FG001|Overall Study|Protocol Violation|0|||
126403474|NCT00857948|454771675|FG002|Overall Study|Protocol Violation|1|||
126403475|NCT00857948|454771676|FG003|Overall Study|Protocol Violation|0|||
126472455|NCT02468232|455030787|FG002|OLE Part of Study|Death|4|||
126403476|NCT03077698|454771679|FG000|Progestin Monotherapy|Stable Disease|8|||
126403477|NCT03077698|454771680|FG001|Progestin Monotherapy|Stable Disease|0|||
126403478|NCT03077698|454771679|FG000|Progestin Monotherapy|Adverse Event|1|||
126403479|NCT03077698|454771680|FG001|Progestin Monotherapy|Adverse Event|0|||
126403480|NCT03077698|454771679|FG000|Progestin Monotherapy|Death|1|||
126403481|NCT03077698|454771680|FG001|Progestin Monotherapy|Death|0|||
126403482|NCT03077698|454771679|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
126403483|NCT03077698|454771680|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
126403484|NCT03077698|454771679|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
126403485|NCT03077698|454771680|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
126403486|NCT03077698|454771679|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
126403487|NCT03077698|454771680|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
126403488|NCT03077698|454771679|FG000|Safety Follow Up|Withdrawal by Subject|2|||
126472456|NCT02468232|455030788|FG003|OLE Part of Study|Death|2|||
126403489|NCT03077698|454771680|FG001|Safety Follow Up|Withdrawal by Subject|1|||
126403490|NCT03077698|454771679|FG000|Safety Follow Up|Transfer of care to hospice|1|||
126403491|NCT03077698|454771680|FG001|Safety Follow Up|Transfer of care to hospice|0|||
126403492|NCT03099148|454771683|FG000|Wash-out|scheduling conflict|0|||
126403493|NCT03099148|454771684|FG001|Wash-out|scheduling conflict|1|||
126403494|NCT03099148|454771685|FG002|Wash-out|scheduling conflict|0|||
126403495|NCT03099148|454771686|FG003|Wash-out|scheduling conflict|0|||
126403496|NCT03099148|454771683|FG000|Wash-out|Adverse Event|0|||
126403497|NCT03099148|454771684|FG001|Wash-out|Adverse Event|1|||
126403498|NCT03099148|454771685|FG002|Wash-out|Adverse Event|0|||
126403499|NCT03099148|454771686|FG003|Wash-out|Adverse Event|0|||
126403500|NCT01439126|454771687|FG000|Overall Study|Adverse Event|2|||
126403501|NCT01439126|454771688|FG001|Overall Study|Adverse Event|0|||
126403502|NCT01439126|454771687|FG000|Overall Study|Withdrawal by Subject|5|||
126403503|NCT01439126|454771688|FG001|Overall Study|Withdrawal by Subject|21|||
126403504|NCT01439126|454771687|FG000|Overall Study|Protocol Violation|6|||
126403505|NCT01439126|454771688|FG001|Overall Study|Protocol Violation|4|||
126403506|NCT01439126|454771687|FG000|Overall Study|Lost to Follow-up|6|||
126403507|NCT01439126|454771688|FG001|Overall Study|Lost to Follow-up|3|||
126403508|NCT01439126|454771687|FG000|Overall Study|Other-Use of prohibited treatment|0|||
126403509|NCT01439126|454771688|FG001|Overall Study|Other-Use of prohibited treatment|2|||
126403510|NCT01439126|454771687|FG000|Overall Study|Other-Miscellaneous|12|||
126403511|NCT01439126|454771688|FG001|Overall Study|Other-Miscellaneous|12|||
126403512|NCT01617447|454771689|FG000|Overall Study|Adverse Event|0|||
126403513|NCT01617447|454771690|FG001|Overall Study|Adverse Event|1|||
126403514|NCT01617447|454771689|FG000|Overall Study|Physician Decision|0|||
126403515|NCT01617447|454771690|FG001|Overall Study|Physician Decision|2|||
126403516|NCT02713529|454771692|FG000|Overall Study|Withdrawal by Subject|3|||
126403517|NCT02713529|454771693|FG001|Overall Study|Withdrawal by Subject|1|||
126403518|NCT02713529|454771694|FG002|Overall Study|Withdrawal by Subject|4|||
126403519|NCT02713529|454771695|FG003|Overall Study|Withdrawal by Subject|2|||
126403520|NCT02713529|454771696|FG004|Overall Study|Withdrawal by Subject|0|||
126403521|NCT02713529|454771697|FG005|Overall Study|Withdrawal by Subject|1|||
126403522|NCT02713529|454771698|FG006|Overall Study|Withdrawal by Subject|1|||
126403523|NCT02713529|454771692|FG000|Overall Study|Lost to Follow-up|1|||
126403524|NCT02713529|454771693|FG001|Overall Study|Lost to Follow-up|0|||
126403525|NCT02713529|454771694|FG002|Overall Study|Lost to Follow-up|1|||
126403526|NCT02713529|454771695|FG003|Overall Study|Lost to Follow-up|0|||
126403527|NCT02713529|454771696|FG004|Overall Study|Lost to Follow-up|0|||
126403528|NCT02713529|454771697|FG005|Overall Study|Lost to Follow-up|0|||
126403529|NCT02713529|454771698|FG006|Overall Study|Lost to Follow-up|0|||
126403530|NCT02713529|454771692|FG000|Overall Study|Death|3|||
126403531|NCT02713529|454771693|FG001|Overall Study|Death|3|||
126403532|NCT02713529|454771694|FG002|Overall Study|Death|26|||
126403533|NCT02713529|454771695|FG003|Overall Study|Death|27|||
126403534|NCT02713529|454771696|FG004|Overall Study|Death|3|||
126403535|NCT02713529|454771697|FG005|Overall Study|Death|13|||
126403536|NCT02713529|454771698|FG006|Overall Study|Death|3|||
126403537|NCT02827500|454771699|FG000|Overall Study|Death|7|||
126403538|NCT02827500|454771700|FG001|Overall Study|Death|3|||
126403539|NCT02827500|454771699|FG000|Overall Study|Lost to Follow-up|1|||
126403540|NCT02827500|454771700|FG001|Overall Study|Lost to Follow-up|1|||
126403541|NCT02827500|454771699|FG000|Overall Study|Withdrawal by Subject|3|||
126403542|NCT02827500|454771700|FG001|Overall Study|Withdrawal by Subject|1|||
126403543|NCT02827500|454771699|FG000|Overall Study|Missing primary endpoint data|3|||
126472457|NCT02468232|455030785|FG000|OLE Part of Study|Physician Decision|0|||
126472458|NCT02468232|455030786|FG001|OLE Part of Study|Physician Decision|0|||
126472459|NCT02468232|455030787|FG002|OLE Part of Study|Physician Decision|4|||
126472460|NCT02468232|455030788|FG003|OLE Part of Study|Physician Decision|0|||
126472461|NCT02468232|455030785|FG000|OLE Part of Study|Subject/Guardian decision|0|||
126472462|NCT02468232|455030786|FG001|OLE Part of Study|Subject/Guardian decision|0|||
126403544|NCT02827500|454771700|FG001|Overall Study|Missing primary endpoint data|1|||
126403545|NCT02827500|454771699|FG000|Overall Study|Other|5|||
126403546|NCT02827500|454771700|FG001|Overall Study|Other|1|||
126403547|NCT02358044|454771701|FG000|Overall Study|Adverse Event|0|||
126403548|NCT02358044|454771702|FG001|Overall Study|Adverse Event|1|||
126403549|NCT02358044|454771701|FG000|Overall Study|Lost to Follow-up|2|||
126403550|NCT02358044|454771702|FG001|Overall Study|Lost to Follow-up|1|||
126403551|NCT02358044|454771701|FG000|Overall Study|Physician Decision|0|||
126472463|NCT02468232|455030787|FG002|OLE Part of Study|Subject/Guardian decision|2|||
126472464|NCT02468232|455030788|FG003|OLE Part of Study|Subject/Guardian decision|5|||
126403552|NCT02358044|454771702|FG001|Overall Study|Physician Decision|1|||
126403553|NCT02358044|454771701|FG000|Overall Study|Withdrawal by Subject|0|||
126403554|NCT02358044|454771702|FG001|Overall Study|Withdrawal by Subject|4|||
126403555|NCT01739803|454771703|FG000|Overall Study|Lost to Follow-up|9|||
126403556|NCT01739803|454771704|FG001|Overall Study|Lost to Follow-up|6|||
126403557|NCT02525094|454771712|FG000|Overall Study|Lost to Follow-up|2|||
126472465|NCT00506662|455030789|FG000|Overall Study|Adverse Event|0|||
126472466|NCT00506662|455030790|FG001|Overall Study|Adverse Event|2|||
126403558|NCT02525094|454771713|FG001|Overall Study|Lost to Follow-up|1|||
126403559|NCT02525094|454771712|FG000|Overall Study|Withdrawal by Subject|5|||
126403560|NCT02525094|454771713|FG001|Overall Study|Withdrawal by Subject|6|||
126403561|NCT02525094|454771712|FG000|Overall Study|Not Treated|1|||
126403562|NCT02525094|454771713|FG001|Overall Study|Not Treated|1|||
126403563|NCT01751776|454771715|FG000|Overall Study|Adverse Event|0|||
126403564|NCT01751776|454771716|FG001|Overall Study|Adverse Event|0|||
126403565|NCT01751776|454771717|FG002|Overall Study|Adverse Event|0|||
126403566|NCT01751776|454771718|FG003|Overall Study|Adverse Event|0|||
126403567|NCT01751776|454771719|FG004|Overall Study|Adverse Event|0|||
126403568|NCT01751776|454771720|FG005|Overall Study|Adverse Event|0|||
126403569|NCT01751776|454771721|FG006|Overall Study|Adverse Event|4|||
126403570|NCT01751776|454771722|FG007|Overall Study|Adverse Event|2|||
126403571|NCT01751776|454771715|FG000|Overall Study|Consent withdrawn|0|||
126403572|NCT01751776|454771716|FG001|Overall Study|Consent withdrawn|0|||
126403573|NCT01751776|454771717|FG002|Overall Study|Consent withdrawn|0|||
126403574|NCT01751776|454771718|FG003|Overall Study|Consent withdrawn|0|||
126403575|NCT01751776|454771719|FG004|Overall Study|Consent withdrawn|0|||
126403576|NCT01751776|454771720|FG005|Overall Study|Consent withdrawn|0|||
126403577|NCT01751776|454771721|FG006|Overall Study|Consent withdrawn|0|||
126403578|NCT01751776|454771722|FG007|Overall Study|Consent withdrawn|1|||
126403579|NCT01751776|454771715|FG000|Overall Study|Other reason not specified above|0|||
126403580|NCT01751776|454771716|FG001|Overall Study|Other reason not specified above|0|||
126403581|NCT01751776|454771717|FG002|Overall Study|Other reason not specified above|0|||
126403582|NCT01751776|454771718|FG003|Overall Study|Other reason not specified above|0|||
126403583|NCT01751776|454771719|FG004|Overall Study|Other reason not specified above|0|||
126403584|NCT01751776|454771720|FG005|Overall Study|Other reason not specified above|0|||
126403585|NCT01751776|454771721|FG006|Overall Study|Other reason not specified above|0|||
126403586|NCT01751776|454771722|FG007|Overall Study|Other reason not specified above|1|||
126403587|NCT05219669|454771723|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
126403588|NCT05219669|454771724|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
126403589|NCT05219669|454771725|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
126472467|NCT00506662|455030789|FG000|Overall Study|Lack of Efficacy|1|||
126472468|NCT00506662|455030790|FG001|Overall Study|Lack of Efficacy|0|||
126472469|NCT00506662|455030789|FG000|Overall Study|Protocol Violation|2|||
126472470|NCT00506662|455030790|FG001|Overall Study|Protocol Violation|4|||
126472471|NCT00506662|455030789|FG000|Overall Study|Trial terminated|10|||
126472472|NCT00506662|455030790|FG001|Overall Study|Trial terminated|16|||
126472473|NCT00506662|455030789|FG000|Overall Study|Not recorded|4|||
126472474|NCT00506662|455030790|FG001|Overall Study|Not recorded|6|||
126472475|NCT00246753|455030791|FG000|Overall Study|Withdrawal by Subject|2|||
126472476|NCT00246753|455030791|FG000|Overall Study|Physician Decision|2|||
126472477|NCT00246753|455030791|FG000|Overall Study|Adverse Event|2|||
126472478|NCT00246753|455030791|FG000|Overall Study|Unacceptable toxicity|2|||
126472479|NCT02764333|455030795|FG000|Overall Study|Ineligible|1|||
126472480|NCT00617851|455030796|FG000|Overall Study|Death|0|||
126472481|NCT00617851|455030797|FG001|Overall Study|Death|0|||
126472482|NCT00617851|455030798|FG002|Overall Study|Death|0|||
126472483|NCT00617851|455030799|FG003|Overall Study|Death|1|||
126472484|NCT00617851|455030796|FG000|Overall Study|Withdrawal by Subject|14|||
126472485|NCT00617851|455030797|FG001|Overall Study|Withdrawal by Subject|7|||
126472486|NCT00617851|455030798|FG002|Overall Study|Withdrawal by Subject|12|||
126472487|NCT00617851|455030799|FG003|Overall Study|Withdrawal by Subject|4|||
126472488|NCT00617851|455030796|FG000|Overall Study|Lost to Follow-up|27|||
126472489|NCT00617851|455030797|FG001|Overall Study|Lost to Follow-up|29|||
126472490|NCT00617851|455030798|FG002|Overall Study|Lost to Follow-up|31|||
126472491|NCT00617851|455030799|FG003|Overall Study|Lost to Follow-up|19|||
126472492|NCT00617851|455030796|FG000|Overall Study|Inappropriate Enrollment|5|||
126472493|NCT00617851|455030797|FG001|Overall Study|Inappropriate Enrollment|4|||
126472494|NCT00617851|455030798|FG002|Overall Study|Inappropriate Enrollment|1|||
126472495|NCT00617851|455030799|FG003|Overall Study|Inappropriate Enrollment|1|||
126472496|NCT00617851|455030796|FG000|Overall Study|Unable to classify|1|||
126557678|NCT01734382|455334450|FG000|Part 2|Lack of Efficacy|0|||
126557679|NCT01734382|455334451|FG001|Part 2|Lack of Efficacy|1|||
126472497|NCT00617851|455030797|FG001|Overall Study|Unable to classify|0|||
126557680|NCT01734382|455334452|FG002|Part 2|Lack of Efficacy|1|||
126403590|NCT05219669|454771726|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
126403591|NCT05219669|454771727|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
126403592|NCT05219669|454771728|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
126403593|NCT02242981|454771733|FG000|Overall Study|Withdrawal by Subject|1|||
126403594|NCT03474081|454771734|FG000|Overall Study|Adverse Event|6|||
126403595|NCT03474081|454771735|FG001|Overall Study|Adverse Event|3|||
126403596|NCT03474081|454771734|FG000|Overall Study|Lost to Follow-up|2|||
126472498|NCT00617851|455030798|FG002|Overall Study|Unable to classify|1|||
126472499|NCT00617851|455030799|FG003|Overall Study|Unable to classify|0|||
126472500|NCT01788046|455030810|FG000|Overall Study|Withdrawal by Subject|12|||
126472501|NCT01788046|455030811|FG001|Overall Study|Withdrawal by Subject|12|||
126472502|NCT01788046|455030810|FG000|Overall Study|Lost to Follow-up|12|||
126472503|NCT01788046|455030811|FG001|Overall Study|Lost to Follow-up|19|||
126403597|NCT03474081|454771735|FG001|Overall Study|Lost to Follow-up|1|||
126403598|NCT03474081|454771734|FG000|Overall Study|Physician Decision|3|||
126403599|NCT03474081|454771735|FG001|Overall Study|Physician Decision|2|||
126403600|NCT03474081|454771734|FG000|Overall Study|Withdrawal by Subject|5|||
126403601|NCT03474081|454771735|FG001|Overall Study|Withdrawal by Subject|7|||
126403602|NCT03474081|454771734|FG000|Overall Study|Investigator site closed|1|||
126403603|NCT03474081|454771735|FG001|Overall Study|Investigator site closed|0|||
126403604|NCT02210091|454771738|FG000|Overall Study|Physician Decision|0|||
126403605|NCT02210091|454771739|FG001|Overall Study|Physician Decision|1|||
126403606|NCT02210091|454771738|FG000|Overall Study|Withdrawal by Sponsor|0|||
126403607|NCT02210091|454771739|FG001|Overall Study|Withdrawal by Sponsor|1|||
126403608|NCT02290938|454771740|FG000|Overall Study|Lost to Follow-up|14|||
126403609|NCT02290938|454771741|FG001|Overall Study|Lost to Follow-up|43|||
126403610|NCT01831817|454771742|FG000|Overall Study|Lost to Follow-up|1|||
126472504|NCT01788046|455030810|FG000|Overall Study|Death|7|||
126403611|NCT01831817|454771743|FG001|Overall Study|Lost to Follow-up|0|||
126403612|NCT01831817|454771744|FG002|Overall Study|Lost to Follow-up|0|||
126403613|NCT01831817|454771745|FG003|Overall Study|Lost to Follow-up|0|||
126403614|NCT01831817|454771742|FG000|Overall Study|Withdrawl of Consent|3|||
126403615|NCT01831817|454771743|FG001|Overall Study|Withdrawl of Consent|0|||
126403616|NCT01831817|454771744|FG002|Overall Study|Withdrawl of Consent|0|||
126403617|NCT01831817|454771745|FG003|Overall Study|Withdrawl of Consent|0|||
126403618|NCT02198235|454771747|FG000|Overall Study|Lost to Follow-up|3|||
126403619|NCT02198235|454771748|FG001|Overall Study|Lost to Follow-up|2|||
126403620|NCT02198235|454771749|FG002|Overall Study|Lost to Follow-up|2|||
126403621|NCT05065190|454773583|FG000|Overall Study|Other than listed|2|||
126403622|NCT05065190|454773584|FG001|Overall Study|Other than listed|12|||
126403623|NCT05065190|454773583|FG000|Overall Study|Lack of Efficacy|4|||
126403624|NCT05065190|454773584|FG001|Overall Study|Lack of Efficacy|0|||
126403625|NCT05065190|454773583|FG000|Overall Study|Adverse Event|1|||
126403626|NCT05065190|454773584|FG001|Overall Study|Adverse Event|10|||
126403627|NCT05565937|454773585|FG000|Overall Study|Adverse Event|0|||
126403628|NCT05565937|454773586|FG001|Overall Study|Adverse Event|1|||
126403629|NCT05565937|454773585|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
126403630|NCT05565937|454773586|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
126403631|NCT05565937|454773585|FG000|Overall Study|Lost to Follow-up|2|||
126403632|NCT05565937|454773586|FG001|Overall Study|Lost to Follow-up|0|||
126403633|NCT05565937|454773585|FG000|Overall Study|Pregnancy|0|||
126403634|NCT05565937|454773586|FG001|Overall Study|Pregnancy|2|||
126403635|NCT05565937|454773585|FG000|Overall Study|Anisometropia|0|||
126403636|NCT05565937|454773586|FG001|Overall Study|Anisometropia|1|||
126403637|NCT02783170|454773589|FG000|Overall Study|Randomized but not Vaccinated|1|||
126403638|NCT02783170|454773590|FG001|Overall Study|Randomized but not Vaccinated|0|||
126403639|NCT04938037|454773591|FG000|Overall Study|Lost to Follow-up|4|||
126403640|NCT04938037|454773592|FG001|Overall Study|Lost to Follow-up|3|||
126403641|NCT03320330|454773595|FG000|Overall Study|Lack of Efficacy|5|||
126403642|NCT03320330|454773596|FG001|Overall Study|Lack of Efficacy|5|||
126403643|NCT03320330|454773597|FG002|Overall Study|Lack of Efficacy|14|||
126403644|NCT03320330|454773595|FG000|Overall Study|Physician Decision|1|||
126403645|NCT03320330|454773596|FG001|Overall Study|Physician Decision|0|||
126403646|NCT03320330|454773597|FG002|Overall Study|Physician Decision|0|||
126403647|NCT00203021|454773598|FG000|Overall Study|Death|4|||
126403648|NCT00203021|454773599|FG001|Overall Study|Death|1|||
126403649|NCT00203021|454773598|FG000|Overall Study|Adverse Event|10|||
126403650|NCT00203021|454773599|FG001|Overall Study|Adverse Event|5|||
126403651|NCT00203021|454773598|FG000|Overall Study|Withdrawal by Subject|45|||
126472505|NCT01788046|455030811|FG001|Overall Study|Death|5|||
126472506|NCT01788046|455030810|FG000|Overall Study|Protocol Specified Criteria|25|||
126472507|NCT01788046|455030811|FG001|Overall Study|Protocol Specified Criteria|1|||
126472508|NCT01031706|455030812|FG000|Overall Study|Adverse Event|1|||
126472509|NCT01031706|455030813|FG001|Overall Study|Adverse Event|0|||
126472510|NCT01031706|455030812|FG000|Overall Study|Withdrawal by Subject|1|||
126472511|NCT01031706|455030813|FG001|Overall Study|Withdrawal by Subject|1|||
126403652|NCT00203021|454773599|FG001|Overall Study|Withdrawal by Subject|48|||
126403653|NCT00203021|454773598|FG000|Overall Study|Lost to Follow-up|9|||
126403654|NCT00203021|454773599|FG001|Overall Study|Lost to Follow-up|7|||
126403655|NCT00203021|454773598|FG000|Overall Study|Other than specified|11|||
126403656|NCT00203021|454773599|FG001|Overall Study|Other than specified|16|||
126403657|NCT01282294|454773602|FG000|Overall Study|Lost to Follow-up|14|||
126403658|NCT01282294|454773602|FG000|Overall Study|Screening failure|1|||
126403659|NCT01282294|454773602|FG000|Overall Study|Adverse Event|1|||
126403660|NCT01282294|454773602|FG000|Overall Study|Patient non-compliance|2|||
126403661|NCT01282294|454773602|FG000|Overall Study|Physician Decision|1|||
126403662|NCT04692077|454773603|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
126403663|NCT01657760|454773610|FG000|Overall Study|Withdrawal by Subject|0|||
126403664|NCT01657760|454773611|FG001|Overall Study|Withdrawal by Subject|0|||
126403665|NCT01657760|454773612|FG002|Overall Study|Withdrawal by Subject|0|||
126472512|NCT03626168|455030817|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
126472513|NCT03626168|455030818|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
126472514|NCT03626168|455030817|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
126472515|NCT03626168|455030818|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
126472516|NCT03626168|455030817|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
126472517|NCT03626168|455030818|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
126472518|NCT02248701|455030819|FG000|Overall Study|Withdrawal by Subject|2|||
126472519|NCT02248701|455030820|FG001|Overall Study|Withdrawal by Subject|1|||
126403666|NCT01657760|454773613|FG003|Overall Study|Withdrawal by Subject|1|||
126403667|NCT01657760|454773610|FG000|Overall Study|Physician Decision|1|||
126403668|NCT01657760|454773611|FG001|Overall Study|Physician Decision|1|||
126403669|NCT01657760|454773612|FG002|Overall Study|Physician Decision|1|||
126403670|NCT01657760|454773613|FG003|Overall Study|Physician Decision|2|||
126403671|NCT06250738|454773626|FG000|Overall Study|Lost to Follow-up|1|||
126403672|NCT02936284|454773628|FG000|Overall Study|Withdrawal by Subject|3|||
126403673|NCT02936284|454773629|FG001|Overall Study|Withdrawal by Subject|1|||
126403674|NCT02936284|454773628|FG000|Overall Study|Lost to Follow-up|7|||
126403675|NCT02936284|454773629|FG001|Overall Study|Lost to Follow-up|8|||
126403676|NCT01068249|454773632|FG000|Overall Study|Death|1|||
126472520|NCT02248701|455030819|FG000|Overall Study|Physician Decision|0|||
126472521|NCT02248701|455030820|FG001|Overall Study|Physician Decision|1|||
126472522|NCT02248701|455030819|FG000|Overall Study|Adverse Event|1|||
126472523|NCT02248701|455030820|FG001|Overall Study|Adverse Event|0|||
126472524|NCT02248701|455030819|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
126472525|NCT02248701|455030820|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
126403677|NCT01068249|454773632|FG000|Overall Study|Withdrawal by Subject|3|||
126403678|NCT04284813|454773633|FG000|Overall Study|Withdrawal by Subject|1|||
126472526|NCT00808483|455030821|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
126472527|NCT00808483|455030822|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
126472528|NCT00808483|455030821|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
126472529|NCT00808483|455030822|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
126472530|NCT00808483|455030821|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
126472531|NCT00808483|455030822|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
126472532|NCT02357979|455030823|FG000|Overall Study|Lost to Follow-up|5|||
126472533|NCT02357979|455030824|FG001|Overall Study|Lost to Follow-up|5|||
126472534|NCT00880542|455030825|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
126472535|NCT00880542|455030825|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
126472536|NCT00880542|455030825|FG000|REP: Surgical Resection|progressive disease|1|||
126472537|NCT05047770|455030826|FG000|Overall Study|Withdrawal by Subject|15|||
126472538|NCT05047770|455030827|FG001|Overall Study|Withdrawal by Subject|10|||
126472539|NCT05047770|455030828|FG002|Overall Study|Withdrawal by Subject|6|||
126472540|NCT05047770|455030829|FG003|Overall Study|Withdrawal by Subject|12|||
126472541|NCT05047770|455030826|FG000|Overall Study|Lost to Follow-up|7|||
126472542|NCT05047770|455030827|FG001|Overall Study|Lost to Follow-up|5|||
126472543|NCT05047770|455030828|FG002|Overall Study|Lost to Follow-up|12|||
126472544|NCT05047770|455030829|FG003|Overall Study|Lost to Follow-up|13|||
126472545|NCT05047770|455030826|FG000|Overall Study|Other|1|||
126472546|NCT05047770|455030827|FG001|Overall Study|Other|0|||
126472547|NCT05047770|455030828|FG002|Overall Study|Other|1|||
126472548|NCT05047770|455030829|FG003|Overall Study|Other|0|||
126472549|NCT04289623|455030832|FG000|Wave 1 Emails|Email was not delivered|268|||
126472550|NCT04289623|455030833|FG001|Wave 1 Emails|Email was not delivered|257|||
126472551|NCT04289623|455030834|FG002|Wave 1 Emails|Email was not delivered|0|||
126472552|NCT04289623|455030835|FG003|Wave 1 Emails|Email was not delivered|0|||
126472553|NCT04289623|455030836|FG004|Wave 1 Emails|Email was not delivered|0|||
126472554|NCT04289623|455030837|FG005|Wave 1 Emails|Email was not delivered|0|||
126472555|NCT03758443|455030838|FG000|Induction Period|Adverse Event|2|||
126472556|NCT03758443|455030839|FG001|Induction Period|Adverse Event|4|||
126472557|NCT03758443|455030840|FG002|Induction Period|Adverse Event|2|||
126472558|NCT03758443|455030841|FG003|Induction Period|Adverse Event|3|||
126472559|NCT03758443|455030838|FG000|Induction Period|Physician Decision|1|||
126472560|NCT03758443|455030839|FG001|Induction Period|Physician Decision|1|||
126472561|NCT03758443|455030840|FG002|Induction Period|Physician Decision|3|||
126472562|NCT03758443|455030841|FG003|Induction Period|Physician Decision|0|||
126472563|NCT03758443|455030838|FG000|Induction Period|Protocol Violation|0|||
126472564|NCT03758443|455030839|FG001|Induction Period|Protocol Violation|0|||
126472565|NCT03758443|455030840|FG002|Induction Period|Protocol Violation|0|||
126403679|NCT01146652|454773638|FG000|Overall Study|Adverse Event|506|||
126472566|NCT03758443|455030841|FG003|Induction Period|Protocol Violation|1|||
126472567|NCT03758443|455030838|FG000|Induction Period|Withdrawal by Subject|3|||
126472568|NCT03758443|455030839|FG001|Induction Period|Withdrawal by Subject|2|||
126557681|NCT01734382|455334450|FG000|Part 2|Other|0|||
126403680|NCT01146652|454773639|FG001|Overall Study|Adverse Event|15|||
126403681|NCT01146652|454773638|FG000|Overall Study|Lack of Efficacy|91|||
126403682|NCT01146652|454773639|FG001|Overall Study|Lack of Efficacy|7|||
126472569|NCT03758443|455030840|FG002|Induction Period|Withdrawal by Subject|2|||
126403683|NCT01146652|454773638|FG000|Overall Study|Poor compliance to protocol|38|||
126403684|NCT01146652|454773639|FG001|Overall Study|Poor compliance to protocol|1|||
126403685|NCT01146652|454773638|FG000|Overall Study|Other unspecified reasons|314|||
126403686|NCT01146652|454773639|FG001|Overall Study|Other unspecified reasons|22|||
126403687|NCT01146652|454773638|FG000|Overall Study|Enrolled but not treated|2|||
126403688|NCT01146652|454773639|FG001|Overall Study|Enrolled but not treated|0|||
126403689|NCT01300351|454773643|FG000|Overall Study|Did not receive treatment|2|||
126403690|NCT01300351|454773644|FG001|Overall Study|Did not receive treatment|0|||
126403691|NCT01300351|454773643|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
126403692|NCT01300351|454773644|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
126403693|NCT01300351|454773643|FG000|Overall Study|Lost to Follow-up|0|||
126403694|NCT01300351|454773644|FG001|Overall Study|Lost to Follow-up|1|||
126403695|NCT01300351|454773643|FG000|Overall Study|Adverse Event|0|||
126403696|NCT01300351|454773644|FG001|Overall Study|Adverse Event|4|||
126403697|NCT01300351|454773643|FG000|Overall Study|Withdrawal by Subject|7|||
126403698|NCT01300351|454773644|FG001|Overall Study|Withdrawal by Subject|10|||
126403699|NCT00431951|454773645|FG000|Overall Study|Inability to follow study procedures|1|||
126403700|NCT00431951|454773646|FG001|Overall Study|Inability to follow study procedures|0|||
126403701|NCT00431951|454773647|FG002|Overall Study|Inability to follow study procedures|1|||
126403702|NCT00431951|454773648|FG003|Overall Study|Inability to follow study procedures|2|||
126403703|NCT00431951|454773645|FG000|Overall Study|Lost to Follow-up|0|||
126403704|NCT00431951|454773646|FG001|Overall Study|Lost to Follow-up|1|||
126403705|NCT00431951|454773647|FG002|Overall Study|Lost to Follow-up|0|||
126403706|NCT00431951|454773648|FG003|Overall Study|Lost to Follow-up|0|||
126403707|NCT00431951|454773645|FG000|Overall Study|Withdrawal by Subject|0|||
126403708|NCT00431951|454773646|FG001|Overall Study|Withdrawal by Subject|1|||
126403709|NCT00431951|454773647|FG002|Overall Study|Withdrawal by Subject|0|||
126403710|NCT00431951|454773648|FG003|Overall Study|Withdrawal by Subject|0|||
126403711|NCT00431951|454773645|FG000|Overall Study|Adverse Event|0|||
126403712|NCT00431951|454773646|FG001|Overall Study|Adverse Event|0|||
126403713|NCT00431951|454773647|FG002|Overall Study|Adverse Event|1|||
126403714|NCT00431951|454773648|FG003|Overall Study|Adverse Event|0|||
126403715|NCT00096018|454773651|FG000|Overall Study|Became Ineligible (not treated)|0|||
126403716|NCT00096018|454773652|FG001|Overall Study|Became Ineligible (not treated)|3|||
126403717|NCT00096018|454773651|FG000|Overall Study|Miscellaneous (not treated)|0|||
126403718|NCT00096018|454773652|FG001|Overall Study|Miscellaneous (not treated)|2|||
126403719|NCT00096018|454773651|FG000|Overall Study|Adverse Event|0|||
126403720|NCT00096018|454773652|FG001|Overall Study|Adverse Event|5|||
126403721|NCT00096018|454773651|FG000|Overall Study|Death|0|||
126472570|NCT03758443|455030841|FG003|Induction Period|Withdrawal by Subject|4|||
126472571|NCT03758443|455030838|FG000|Extended Induction Period|Adverse Event|1|||
126472572|NCT03758443|455030839|FG001|Extended Induction Period|Adverse Event|1|||
126472573|NCT03758443|455030840|FG002|Extended Induction Period|Adverse Event|0|||
126472574|NCT03758443|455030841|FG003|Extended Induction Period|Adverse Event|1|||
126472575|NCT03758443|455030838|FG000|Extended Induction Period|Lost to Follow-up|1|||
126472576|NCT03758443|455030839|FG001|Extended Induction Period|Lost to Follow-up|0|||
126472577|NCT03758443|455030840|FG002|Extended Induction Period|Lost to Follow-up|0|||
126472578|NCT03758443|455030841|FG003|Extended Induction Period|Lost to Follow-up|0|||
126472579|NCT03758443|455030838|FG000|Extended Induction Period|Physician Decision|2|||
126472580|NCT03758443|455030839|FG001|Extended Induction Period|Physician Decision|1|||
126472581|NCT03758443|455030840|FG002|Extended Induction Period|Physician Decision|2|||
126557682|NCT01734382|455334451|FG001|Part 2|Other|0|||
126557683|NCT01734382|455334452|FG002|Part 2|Other|1|||
126557684|NCT01734382|455334450|FG000|Part 2|Physician Decision|0|||
126557685|NCT01734382|455334451|FG001|Part 2|Physician Decision|0|||
126557686|NCT01734382|455334452|FG002|Part 2|Physician Decision|3|||
126557687|NCT01734382|455334450|FG000|Part 2|Protocol Violation|0|||
126557688|NCT01734382|455334451|FG001|Part 2|Protocol Violation|1|||
126557689|NCT01734382|455334452|FG002|Part 2|Protocol Violation|0|||
126557690|NCT01734382|455334450|FG000|Part 2|Withdrawal by Subject|0|||
126557691|NCT01734382|455334451|FG001|Part 2|Withdrawal by Subject|0|||
126557692|NCT01734382|455334452|FG002|Part 2|Withdrawal by Subject|1|||
126557693|NCT02400307|455334453|FG000|Overall Study|Enrolled and Never Dosed|1|||
126557694|NCT02400307|455334454|FG001|Overall Study|Enrolled and Never Dosed|0|||
126557695|NCT01052662|455334457|FG000|Overall Study|Lost to Follow-up|15|||
126557696|NCT01052662|455334458|FG001|Overall Study|Lost to Follow-up|13|||
126557697|NCT01052662|455334459|FG002|Overall Study|Lost to Follow-up|18|||
126557698|NCT01052662|455334457|FG000|Overall Study|Withdrawal by Subject|3|||
126403722|NCT00096018|454773652|FG001|Overall Study|Death|1|||
126403723|NCT00096018|454773651|FG000|Overall Study|Withdrawal by Subject|0|||
126403724|NCT00096018|454773652|FG001|Overall Study|Withdrawal by Subject|2|||
126403725|NCT00096018|454773651|FG000|Overall Study|Miscellaneous|2|||
126403726|NCT00096018|454773652|FG001|Overall Study|Miscellaneous|1|||
126403727|NCT00673881|454773653|FG000|Overall Study|Withdrawal by Subject|1|||
126403728|NCT00689793|454773654|FG000|Overall Study|Lost to Follow-up|4|||
126472582|NCT03758443|455030841|FG003|Extended Induction Period|Physician Decision|2|||
126557699|NCT01052662|455334458|FG001|Overall Study|Withdrawal by Subject|2|||
126557700|NCT01052662|455334459|FG002|Overall Study|Withdrawal by Subject|1|||
126557701|NCT01052662|455334457|FG000|Overall Study|Pharmacy issue|1|||
126557702|NCT01052662|455334458|FG001|Overall Study|Pharmacy issue|3|||
126557703|NCT01052662|455334459|FG002|Overall Study|Pharmacy issue|3|||
126557704|NCT01052662|455334457|FG000|Overall Study|Adverse Event|1|||
126557705|NCT01052662|455334458|FG001|Overall Study|Adverse Event|1|||
126557706|NCT01052662|455334459|FG002|Overall Study|Adverse Event|0|||
126557707|NCT01052662|455334457|FG000|Overall Study|Legal Problem|2|||
126403729|NCT00689793|454773655|FG001|Overall Study|Lost to Follow-up|5|||
126403730|NCT01100528|454773656|FG000|Overall Study|Death|1|||
126403731|NCT01100528|454773656|FG000|Overall Study|Withdrawal by Subject|2|||
126403732|NCT03968159|454773657|FG000|Overall Study|Adverse Event|4|||
126403733|NCT03968159|454773658|FG001|Overall Study|Adverse Event|4|||
126403734|NCT03968159|454773657|FG000|Overall Study|Lost to Follow-up|1|||
126403735|NCT03968159|454773658|FG001|Overall Study|Lost to Follow-up|1|||
126403736|NCT03968159|454773657|FG000|Overall Study|Use of prohibited medication|0|||
126403737|NCT03968159|454773658|FG001|Overall Study|Use of prohibited medication|1|||
126403738|NCT03968159|454773657|FG000|Overall Study|Protocol Violation|2|||
126403739|NCT03968159|454773658|FG001|Overall Study|Protocol Violation|2|||
126403740|NCT03968159|454773657|FG000|Overall Study|Withdrawal by Subject|4|||
126403741|NCT03968159|454773658|FG001|Overall Study|Withdrawal by Subject|6|||
126403742|NCT03968159|454773657|FG000|Overall Study|Lack of Efficacy|0|||
126403743|NCT03968159|454773658|FG001|Overall Study|Lack of Efficacy|1|||
126403744|NCT03968159|454773657|FG000|Overall Study|Not further specified|2|||
126403745|NCT03968159|454773658|FG001|Overall Study|Not further specified|0|||
126403746|NCT02308488|454773666|FG000|Overall Study|Withdrawal by Subject|2|||
126403747|NCT01541917|454773667|FG000|Overall Study|Lost to Follow-up|2|||
126403748|NCT01541917|454773668|FG001|Overall Study|Lost to Follow-up|2|||
126403749|NCT01541917|454773667|FG000|Overall Study|Withdrawal by Subject|13|||
126403750|NCT01541917|454773668|FG001|Overall Study|Withdrawal by Subject|7|||
126403751|NCT00094107|454773673|FG000|Overall Study|Lack of Efficacy|23|||
126403752|NCT00094107|454773673|FG000|Overall Study|Death|5|||
126403753|NCT00094107|454773673|FG000|Overall Study|Adverse Event|3|||
126403754|NCT00094107|454773673|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
126403755|NCT00525824|454773674|FG000|Overall Study|Adverse Event|7|||
126403756|NCT00525824|454773675|FG001|Overall Study|Adverse Event|11|||
126403757|NCT00525824|454773676|FG002|Overall Study|Adverse Event|6|||
126403758|NCT00525824|454773677|FG003|Overall Study|Adverse Event|7|||
126403759|NCT00525824|454773674|FG000|Overall Study|Withdrawal by Subject|5|||
126403760|NCT00525824|454773675|FG001|Overall Study|Withdrawal by Subject|9|||
126403761|NCT00525824|454773676|FG002|Overall Study|Withdrawal by Subject|3|||
126403762|NCT00525824|454773677|FG003|Overall Study|Withdrawal by Subject|4|||
126403763|NCT00525824|454773674|FG000|Overall Study|Lost to Follow-up|4|||
126403764|NCT00525824|454773675|FG001|Overall Study|Lost to Follow-up|2|||
126403765|NCT00525824|454773676|FG002|Overall Study|Lost to Follow-up|4|||
126403766|NCT00525824|454773677|FG003|Overall Study|Lost to Follow-up|0|||
126403767|NCT00525824|454773674|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
126403768|NCT00525824|454773675|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
126403769|NCT00525824|454773676|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
126403770|NCT00525824|454773677|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
126403771|NCT00525824|454773674|FG000|Overall Study|Severe non-compliance|0|||
126403772|NCT00525824|454773675|FG001|Overall Study|Severe non-compliance|1|||
126403773|NCT00525824|454773676|FG002|Overall Study|Severe non-compliance|1|||
126403774|NCT00525824|454773677|FG003|Overall Study|Severe non-compliance|1|||
126557708|NCT01052662|455334458|FG001|Overall Study|Legal Problem|0|||
126557709|NCT01052662|455334459|FG002|Overall Study|Legal Problem|0|||
126557710|NCT01052662|455334457|FG000|Overall Study|Administrative|0|||
126557711|NCT01052662|455334458|FG001|Overall Study|Administrative|3|||
126557712|NCT01052662|455334459|FG002|Overall Study|Administrative|0|||
126557713|NCT02015663|455334461|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
126403775|NCT00525824|454773674|FG000|Overall Study|Safety reasons|1|||
126557714|NCT02015663|455334462|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
126403776|NCT00525824|454773675|FG001|Overall Study|Safety reasons|0|||
126403777|NCT00525824|454773676|FG002|Overall Study|Safety reasons|1|||
126403778|NCT00525824|454773677|FG003|Overall Study|Safety reasons|0|||
126557715|NCT02015663|455334461|FG000|Overall Study|Withdrawal by Subject|1|||
126403779|NCT00525824|454773674|FG000|Overall Study|Other|1|||
126403780|NCT00525824|454773675|FG001|Overall Study|Other|3|||
126403781|NCT00525824|454773676|FG002|Overall Study|Other|3|||
126403782|NCT00525824|454773677|FG003|Overall Study|Other|1|||
126403783|NCT01378429|454773681|FG000|Overall Study|Noncompliance with study drug|1|||
126403784|NCT01378429|454773682|FG001|Overall Study|Noncompliance with study drug|0|||
126403785|NCT01490294|454773685|FG000|Overall Study|Prematurely discontinuation|4|||
126403786|NCT01490294|454773686|FG001|Overall Study|Prematurely discontinuation|0|||
126403787|NCT01490294|454773687|FG002|Overall Study|Prematurely discontinuation|1|||
126403788|NCT01490294|454773688|FG003|Overall Study|Prematurely discontinuation|1|||
126557716|NCT02015663|455334462|FG001|Overall Study|Withdrawal by Subject|0|||
126557717|NCT02015663|455334461|FG000|Overall Study|Protocol Violation|0|||
126403789|NCT01490294|454773685|FG000|Overall Study|Adverse Event|1|||
126472583|NCT03758443|455030838|FG000|Extended Induction Period|Protocol Violation|0|||
126472584|NCT03758443|455030839|FG001|Extended Induction Period|Protocol Violation|0|||
126472585|NCT03758443|455030840|FG002|Extended Induction Period|Protocol Violation|0|||
126472586|NCT03758443|455030841|FG003|Extended Induction Period|Protocol Violation|1|||
126472587|NCT03758443|455030838|FG000|Extended Induction Period|Withdrawal by Subject|8|||
126472588|NCT03758443|455030839|FG001|Extended Induction Period|Withdrawal by Subject|1|||
126557718|NCT02015663|455334462|FG001|Overall Study|Protocol Violation|1|||
126557719|NCT02015663|455334461|FG000|Overall Study|Adverse Event|3|||
126557720|NCT02015663|455334462|FG001|Overall Study|Adverse Event|0|||
126557721|NCT02015663|455334461|FG000|Overall Study|Administrative problems|10|||
126557722|NCT02015663|455334462|FG001|Overall Study|Administrative problems|11|||
126557723|NCT01113463|455334463|FG000|Overall Study|Physician Decision|5|||
126557724|NCT00146640|455334467|FG000|Overall Study|Adverse Event|12|||
126557725|NCT00146640|455334468|FG001|Overall Study|Adverse Event|10|||
126557726|NCT00146640|455334467|FG000|Overall Study|Medical Reasons|3|||
126557727|NCT00146640|455334468|FG001|Overall Study|Medical Reasons|0|||
126557728|NCT00146640|455334467|FG000|Overall Study|Non-Medical Reasons|8|||
126557729|NCT00146640|455334468|FG001|Overall Study|Non-Medical Reasons|4|||
126557730|NCT03293485|455334469|FG000|Overall Study|Death|1|||
126403790|NCT01490294|454773686|FG001|Overall Study|Adverse Event|0|||
126403791|NCT01490294|454773687|FG002|Overall Study|Adverse Event|0|||
126403792|NCT01490294|454773688|FG003|Overall Study|Adverse Event|0|||
126403793|NCT02404649|454773689|FG000|Overall Study|Adverse Event|1|||
126403794|NCT02404649|454773690|FG001|Overall Study|Adverse Event|2|||
126403795|NCT00330668|454773694|FG000|BID Dosing Period|Adverse Event|1|||
126403796|NCT00330668|454773694|FG000|BID Dosing Period|Lost to Follow-up|7|||
126403797|NCT00330668|454773694|FG000|BID Dosing Period|Non-Compliance|5|||
126403798|NCT00330668|454773694|FG000|BID Dosing Period|Withdrawal by Subject|19|||
126557731|NCT03293485|455334469|FG000|Overall Study|Screen Failure|2|||
126557732|NCT03293485|455334469|FG000|Overall Study|Withdrawal by Subject|2|||
126557733|NCT01237678|455334470|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
126557734|NCT01237678|455334471|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
126557735|NCT01237678|455334472|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
126557736|NCT01237678|455334470|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
126557737|NCT01237678|455334471|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
126557738|NCT01237678|455334472|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
126557739|NCT01237678|455334470|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
126557740|NCT01237678|455334471|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
126557741|NCT01237678|455334472|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
126557742|NCT01237678|455334470|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
126557743|NCT01237678|455334471|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
126557744|NCT01237678|455334472|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
126557745|NCT01237678|455334470|FG000|Phase II|Adverse Event|0|||
126557746|NCT01237678|455334471|FG001|Phase II|Adverse Event|39|||
126403799|NCT00330668|454773694|FG000|BID Dosing Period|Sponsor's decision|1|||
126403800|NCT00330668|454773694|FG000|BID Dosing Period|Other|3|||
126403801|NCT00330668|454773694|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
126403802|NCT00330668|454773694|FG000|QD Dosing Period|Other|1|||
126403803|NCT00330668|454773694|FG000|QD Dosing Period|Withdrawal by Subject|1|||
126403804|NCT00330668|454773694|FG000|QD Dosing Period|Lost to Follow-up|2|||
126403805|NCT01839656|454773695|FG000|Overall Study|Withdrawal by Subject|1|||
126403806|NCT01839656|454773696|FG001|Overall Study|Withdrawal by Subject|1|||
126403807|NCT01839656|454773695|FG000|Overall Study|Adverse event, serious fatal|1|||
126403808|NCT01839656|454773696|FG001|Overall Study|Adverse event, serious fatal|4|||
126403809|NCT01839656|454773695|FG000|Overall Study|Early study closure|0|||
126403810|NCT01839656|454773696|FG001|Overall Study|Early study closure|11|||
126403811|NCT01839656|454773695|FG000|Overall Study|Adverse Event|1|||
126472589|NCT03758443|455030840|FG002|Extended Induction Period|Withdrawal by Subject|7|||
126472590|NCT03758443|455030841|FG003|Extended Induction Period|Withdrawal by Subject|3|||
126472591|NCT03758443|455030838|FG000|Extended Induction Period|Miscellaneous|1|||
126472592|NCT03758443|455030839|FG001|Extended Induction Period|Miscellaneous|0|||
126472593|NCT03758443|455030840|FG002|Extended Induction Period|Miscellaneous|0|||
126472594|NCT03758443|455030841|FG003|Extended Induction Period|Miscellaneous|0|||
126472595|NCT03758443|455030838|FG000|Maintenance Period|Adverse Event|1|||
126472596|NCT03758443|455030839|FG001|Maintenance Period|Adverse Event|2|||
126557747|NCT01237678|455334472|FG002|Phase II|Adverse Event|9|||
126557748|NCT01237678|455334470|FG000|Phase II|Death|0|||
126557749|NCT01237678|455334471|FG001|Phase II|Death|0|||
126557750|NCT01237678|455334472|FG002|Phase II|Death|2|||
126557751|NCT01237678|455334470|FG000|Phase II|Lack of Efficacy|0|||
126557752|NCT01237678|455334471|FG001|Phase II|Lack of Efficacy|25|||
126557753|NCT01237678|455334472|FG002|Phase II|Lack of Efficacy|3|||
126403812|NCT01839656|454773696|FG001|Overall Study|Adverse Event|0|||
126403813|NCT02621073|454773706|FG000|Overall Study|Lost to Follow-up|0|||
126403814|NCT02621073|454773707|FG001|Overall Study|Lost to Follow-up|1|||
126403815|NCT02621073|454773706|FG000|Overall Study|Physician Decision|3|||
126403816|NCT02621073|454773707|FG001|Overall Study|Physician Decision|2|||
126403817|NCT01595581|454773708|FG000|Overall Study|Withdrawal by Subject|1|||
126403818|NCT01595581|454773709|FG001|Overall Study|Withdrawal by Subject|0|||
126403819|NCT01440881|454773710|FG000|Overall Study|Death|0|||
126403820|NCT01440881|454773711|FG001|Overall Study|Death|1|||
126403821|NCT02920957|454773714|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
126403822|NCT02920957|454773715|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
126403823|NCT02920957|454773714|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
126403824|NCT02920957|454773715|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
126403825|NCT02920957|454773714|FG000|First Intervention : 1 Month|Adverse Event|1|||
126403826|NCT02920957|454773715|FG001|First Intervention : 1 Month|Adverse Event|0|||
126403827|NCT02920957|454773714|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
126403828|NCT02920957|454773715|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
126403829|NCT02644356|454773719|FG000|Overall Study|Withdrawal by Subject|2|||
126403830|NCT02739321|454773726|FG000|Overall Study|Lack of Efficacy|1|||
126403831|NCT02739321|454773727|FG001|Overall Study|Lack of Efficacy|1|||
126403832|NCT02739321|454773726|FG000|Overall Study|Lost to Follow-up|1|||
126403833|NCT02739321|454773727|FG001|Overall Study|Lost to Follow-up|1|||
126403834|NCT02739321|454773726|FG000|Overall Study|Withdrawal by Subject|1|||
126403835|NCT02739321|454773727|FG001|Overall Study|Withdrawal by Subject|2|||
126403836|NCT01711866|454773728|FG000|Overall Study|Noncompliant|3|||
126403837|NCT01711866|454773728|FG000|Overall Study|Withdrawal by Subject|3|||
126403838|NCT01711866|454773728|FG000|Overall Study|Adverse Event|2|||
126472597|NCT03758443|455030840|FG002|Maintenance Period|Adverse Event|0|||
126472598|NCT03758443|455030841|FG003|Maintenance Period|Adverse Event|0|||
126472599|NCT03758443|455030838|FG000|Maintenance Period|Lost to Follow-up|0|||
126472600|NCT03758443|455030839|FG001|Maintenance Period|Lost to Follow-up|0|||
126472601|NCT03758443|455030840|FG002|Maintenance Period|Lost to Follow-up|0|||
126472602|NCT03758443|455030841|FG003|Maintenance Period|Lost to Follow-up|1|||
126472603|NCT03758443|455030838|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
126472604|NCT03758443|455030839|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
126472605|NCT03758443|455030840|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
126472606|NCT03758443|455030841|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
126472607|NCT03758443|455030838|FG000|Maintenance Period|Protocol Violation|0|||
126472608|NCT03758443|455030839|FG001|Maintenance Period|Protocol Violation|1|||
126472609|NCT03758443|455030840|FG002|Maintenance Period|Protocol Violation|0|||
126472610|NCT03758443|455030841|FG003|Maintenance Period|Protocol Violation|0|||
126472611|NCT03758443|455030838|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
126472612|NCT03758443|455030839|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
126472613|NCT03758443|455030840|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
126472614|NCT03758443|455030841|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
126472615|NCT03758443|455030838|FG000|Maintenance Period|Withdrawal by Subject|1|||
126557754|NCT01237678|455334470|FG000|Phase II|Withdrawal by Subject|0|||
126557755|NCT01237678|455334471|FG001|Phase II|Withdrawal by Subject|1|||
126557756|NCT01237678|455334472|FG002|Phase II|Withdrawal by Subject|5|||
126557757|NCT01237678|455334470|FG000|Phase II|Completed Cycles 4-6|0|||
126557758|NCT01237678|455334471|FG001|Phase II|Completed Cycles 4-6|11|||
126557759|NCT01237678|455334472|FG002|Phase II|Completed Cycles 4-6|21|||
126557760|NCT01237678|455334470|FG000|Phase II|Sponsor Decision/Study Closed|0|||
126557761|NCT01237678|455334471|FG001|Phase II|Sponsor Decision/Study Closed|18|||
126557762|NCT01237678|455334472|FG002|Phase II|Sponsor Decision/Study Closed|7|||
126557763|NCT01237678|455334470|FG000|Phase II|Randomized but were not treated|0|||
126557764|NCT01237678|455334471|FG001|Phase II|Randomized but were not treated|4|||
126557765|NCT01237678|455334472|FG002|Phase II|Randomized but were not treated|3|||
126557766|NCT01723826|455334473|FG000|Overall Study|Adverse Event|4|||
126557767|NCT01723826|455334474|FG001|Overall Study|Adverse Event|1|||
126557768|NCT01723826|455334475|FG002|Overall Study|Adverse Event|4|||
126557769|NCT01723826|455334476|FG003|Overall Study|Adverse Event|5|||
126557770|NCT01723826|455334473|FG000|Overall Study|Death according to AE eCRF|2|||
126557771|NCT01723826|455334474|FG001|Overall Study|Death according to AE eCRF|3|||
126557772|NCT01723826|455334475|FG002|Overall Study|Death according to AE eCRF|3|||
126557773|NCT01723826|455334476|FG003|Overall Study|Death according to AE eCRF|7|||
126403839|NCT01345682|454773729|FG000|Overall Study|Progressive disease per RECIST|226|||
126403840|NCT01345682|454773730|FG001|Overall Study|Progressive disease per RECIST|93|||
126403841|NCT01345682|454773729|FG000|Overall Study|Worsening of underlying cancer disease|23|||
126472616|NCT03758443|455030839|FG001|Maintenance Period|Withdrawal by Subject|0|||
126557774|NCT01723826|455334473|FG000|Overall Study|Lost to Follow-up|1|||
126557775|NCT01723826|455334474|FG001|Overall Study|Lost to Follow-up|3|||
126557776|NCT01723826|455334475|FG002|Overall Study|Lost to Follow-up|1|||
126557777|NCT01723826|455334476|FG003|Overall Study|Lost to Follow-up|1|||
126557778|NCT01723826|455334473|FG000|Overall Study|Non-compliance|0|||
126403842|NCT01345682|454773730|FG001|Overall Study|Worsening of underlying cancer disease|12|||
126403843|NCT01345682|454773729|FG000|Overall Study|Adverse Event|51|||
126403844|NCT01345682|454773730|FG001|Overall Study|Adverse Event|41|||
126472617|NCT03758443|455030840|FG002|Maintenance Period|Withdrawal by Subject|1|||
126472618|NCT03758443|455030841|FG003|Maintenance Period|Withdrawal by Subject|1|||
126472619|NCT03758443|455030838|FG000|Maintenance Period|Miscellaneous|0|||
126472620|NCT03758443|455030839|FG001|Maintenance Period|Miscellaneous|0|||
126472621|NCT03758443|455030840|FG002|Maintenance Period|Miscellaneous|1|||
126472622|NCT03758443|455030841|FG003|Maintenance Period|Miscellaneous|0|||
126472623|NCT01436396|455030842|FG000|Overall Study|Protocol Violation|7|||
126472624|NCT01436396|455030843|FG001|Overall Study|Protocol Violation|5|||
126472625|NCT01436396|455030842|FG000|Overall Study|Adverse Event|1|||
126472626|NCT01436396|455030843|FG001|Overall Study|Adverse Event|2|||
126472627|NCT01436396|455030842|FG000|Overall Study|Withdrawal by Subject|19|||
126472628|NCT01436396|455030843|FG001|Overall Study|Withdrawal by Subject|29|||
126472629|NCT01436396|455030842|FG000|Overall Study|Serious adverse event|2|||
126472630|NCT01436396|455030843|FG001|Overall Study|Serious adverse event|3|||
126472631|NCT01436396|455030842|FG000|Overall Study|Lost to Follow-up|3|||
126472632|NCT01436396|455030843|FG001|Overall Study|Lost to Follow-up|3|||
126472633|NCT01772160|455030847|FG000|Overall Study|Death|3|||
126472634|NCT01772160|455030847|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
126472635|NCT01772160|455030847|FG000|Overall Study|Consent withdrawal|3|||
126472636|NCT01772160|455030847|FG000|Overall Study|Migrated / moved from the study area|4|||
126472637|NCT01772160|455030847|FG000|Overall Study|Lost to Follow-up|30|||
126472638|NCT01772160|455030847|FG000|Overall Study|Other|5|||
126472639|NCT01522248|455030848|FG000|Overall Study|Lost to Follow-up|1|||
126472640|NCT01522248|455030849|FG001|Overall Study|Lost to Follow-up|0|||
126472641|NCT00694707|455030850|FG000|Overall Study|Did Not Receive Treatment|0|||
126472642|NCT00694707|455030851|FG001|Overall Study|Did Not Receive Treatment|0|||
126472643|NCT00694707|455030852|FG002|Overall Study|Did Not Receive Treatment|1|||
126472644|NCT00694707|455030853|FG003|Overall Study|Did Not Receive Treatment|1|||
126472645|NCT00694707|455030854|FG004|Overall Study|Did Not Receive Treatment|1|||
126472646|NCT00694707|455030850|FG000|Overall Study|Adverse Event|22|||
126557779|NCT01723826|455334474|FG001|Overall Study|Non-compliance|1|||
126557780|NCT01723826|455334475|FG002|Overall Study|Non-compliance|3|||
126557781|NCT01723826|455334476|FG003|Overall Study|Non-compliance|3|||
126472647|NCT00694707|455030851|FG001|Overall Study|Adverse Event|14|||
126472648|NCT00694707|455030852|FG002|Overall Study|Adverse Event|8|||
126472649|NCT00694707|455030853|FG003|Overall Study|Adverse Event|12|||
126472650|NCT00694707|455030854|FG004|Overall Study|Adverse Event|13|||
126472651|NCT00694707|455030850|FG000|Overall Study|Insufficient Therapeutic Response|33|||
126472652|NCT00694707|455030851|FG001|Overall Study|Insufficient Therapeutic Response|18|||
126472653|NCT00694707|455030852|FG002|Overall Study|Insufficient Therapeutic Response|17|||
126472654|NCT00694707|455030853|FG003|Overall Study|Insufficient Therapeutic Response|15|||
126472655|NCT00694707|455030854|FG004|Overall Study|Insufficient Therapeutic Response|10|||
126472656|NCT00694707|455030850|FG000|Overall Study|Protocol Violation|1|||
126472657|NCT00694707|455030851|FG001|Overall Study|Protocol Violation|2|||
126557782|NCT01723826|455334473|FG000|Overall Study|Non-compliance With Study Drug|0|||
126557783|NCT01723826|455334474|FG001|Overall Study|Non-compliance With Study Drug|1|||
126557784|NCT01723826|455334475|FG002|Overall Study|Non-compliance With Study Drug|0|||
126403845|NCT01345682|454773729|FG000|Overall Study|Non-compliance with protocol|0|||
126403846|NCT01345682|454773730|FG001|Overall Study|Non-compliance with protocol|1|||
126403847|NCT01345682|454773729|FG000|Overall Study|Lost to Follow-up|0|||
126403848|NCT01345682|454773730|FG001|Overall Study|Lost to Follow-up|1|||
126403849|NCT01345682|454773729|FG000|Overall Study|Refused to continue trial medication|16|||
126403850|NCT01345682|454773730|FG001|Overall Study|Refused to continue trial medication|9|||
126403851|NCT01345682|454773729|FG000|Overall Study|Not treated|2|||
126403852|NCT01345682|454773730|FG001|Overall Study|Not treated|1|||
126403853|NCT01345682|454773729|FG000|Overall Study|Reason other than those specified above|4|||
126403854|NCT01345682|454773730|FG001|Overall Study|Reason other than those specified above|3|||
126403855|NCT00897390|454773733|FG000|Overall Study|Adverse Event|2|||
126403856|NCT00897390|454773733|FG000|Overall Study|No Longer Met Study Criteria|1|||
126403857|NCT00897390|454773733|FG000|Overall Study|Personal Reasons|1|||
126403858|NCT00897390|454773733|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
126403859|NCT00958217|454773737|FG000|Overall Study|Death|2|||
126403860|NCT00958217|454773738|FG001|Overall Study|Death|1|||
126403861|NCT00958217|454773737|FG000|Overall Study|Withdrawal by Subject|4|||
126403862|NCT00958217|454773738|FG001|Overall Study|Withdrawal by Subject|3|||
126403863|NCT00958217|454773737|FG000|Overall Study|Lost to Follow-up|17|||
126403864|NCT00958217|454773738|FG001|Overall Study|Lost to Follow-up|19|||
126472658|NCT00694707|455030852|FG002|Overall Study|Protocol Violation|1|||
126472659|NCT00694707|455030853|FG003|Overall Study|Protocol Violation|3|||
126472660|NCT00694707|455030854|FG004|Overall Study|Protocol Violation|1|||
126472661|NCT00694707|455030850|FG000|Overall Study|Withdrawal of Consent|14|||
126472662|NCT00694707|455030851|FG001|Overall Study|Withdrawal of Consent|18|||
126472663|NCT00694707|455030852|FG002|Overall Study|Withdrawal of Consent|22|||
126472664|NCT00694707|455030853|FG003|Overall Study|Withdrawal of Consent|16|||
126472665|NCT00694707|455030854|FG004|Overall Study|Withdrawal of Consent|15|||
126403865|NCT00958217|454773737|FG000|Overall Study|Moved out of area|1|||
126472666|NCT00694707|455030850|FG000|Overall Study|Lost to Follow-up|0|||
126403866|NCT00958217|454773738|FG001|Overall Study|Moved out of area|1|||
126403867|NCT00958217|454773737|FG000|Overall Study|Inpatient hospitalization|0|||
126403868|NCT00958217|454773738|FG001|Overall Study|Inpatient hospitalization|1|||
126403869|NCT01075984|454773741|FG000|Treatment Phase|Adverse Event|0|||
126403870|NCT01075984|454773742|FG001|Treatment Phase|Adverse Event|1|||
126403871|NCT01075984|454773743|FG002|Treatment Phase|Adverse Event|3|||
126403872|NCT01075984|454773744|FG003|Treatment Phase|Adverse Event|7|||
126403873|NCT01075984|454773745|FG004|Treatment Phase|Adverse Event|35|||
126403874|NCT01075984|454773741|FG000|Treatment Phase|Protocol Violation|0|||
126403875|NCT01075984|454773742|FG001|Treatment Phase|Protocol Violation|0|||
126403876|NCT01075984|454773743|FG002|Treatment Phase|Protocol Violation|1|||
126403877|NCT01075984|454773744|FG003|Treatment Phase|Protocol Violation|0|||
126403878|NCT01075984|454773745|FG004|Treatment Phase|Protocol Violation|3|||
126403879|NCT01075984|454773741|FG000|Treatment Phase|Withdrawal by Subject|0|||
126403880|NCT01075984|454773742|FG001|Treatment Phase|Withdrawal by Subject|0|||
126403881|NCT01075984|454773743|FG002|Treatment Phase|Withdrawal by Subject|2|||
126403882|NCT01075984|454773744|FG003|Treatment Phase|Withdrawal by Subject|0|||
126403883|NCT01075984|454773745|FG004|Treatment Phase|Withdrawal by Subject|15|||
126403884|NCT01075984|454773741|FG000|Treatment Phase|Treatment Failure|0|||
126403885|NCT01075984|454773742|FG001|Treatment Phase|Treatment Failure|0|||
126403886|NCT01075984|454773743|FG002|Treatment Phase|Treatment Failure|1|||
126403887|NCT01075984|454773744|FG003|Treatment Phase|Treatment Failure|0|||
126403888|NCT01075984|454773745|FG004|Treatment Phase|Treatment Failure|5|||
126403889|NCT01075984|454773741|FG000|Treatment Phase|Progression of disease|0|||
126403890|NCT01075984|454773742|FG001|Treatment Phase|Progression of disease|0|||
126403891|NCT01075984|454773743|FG002|Treatment Phase|Progression of disease|0|||
126403892|NCT01075984|454773744|FG003|Treatment Phase|Progression of disease|0|||
126403893|NCT01075984|454773745|FG004|Treatment Phase|Progression of disease|2|||
126403894|NCT01075984|454773741|FG000|Follow-up Phase|Protocol Violation|0|||
126403895|NCT01075984|454773742|FG001|Follow-up Phase|Protocol Violation|0|||
126403896|NCT01075984|454773743|FG002|Follow-up Phase|Protocol Violation|1|||
126403897|NCT01075984|454773744|FG003|Follow-up Phase|Protocol Violation|0|||
126403898|NCT01075984|454773745|FG004|Follow-up Phase|Protocol Violation|3|||
126403899|NCT01075984|454773741|FG000|Follow-up Phase|Adverse Event|0|||
126403900|NCT01075984|454773742|FG001|Follow-up Phase|Adverse Event|0|||
126403901|NCT01075984|454773743|FG002|Follow-up Phase|Adverse Event|0|||
126403902|NCT01075984|454773744|FG003|Follow-up Phase|Adverse Event|2|||
126403903|NCT01075984|454773745|FG004|Follow-up Phase|Adverse Event|27|||
126403904|NCT01075984|454773741|FG000|Follow-up Phase|Administrative|0|||
126403905|NCT01075984|454773742|FG001|Follow-up Phase|Administrative|0|||
126403906|NCT01075984|454773743|FG002|Follow-up Phase|Administrative|0|||
126403907|NCT01075984|454773744|FG003|Follow-up Phase|Administrative|0|||
126403908|NCT01075984|454773745|FG004|Follow-up Phase|Administrative|1|||
126403909|NCT01075984|454773741|FG000|Follow-up Phase|Withdrawal by Subject|0|||
126403910|NCT01075984|454773742|FG001|Follow-up Phase|Withdrawal by Subject|0|||
126403911|NCT01075984|454773743|FG002|Follow-up Phase|Withdrawal by Subject|0|||
126403912|NCT01075984|454773744|FG003|Follow-up Phase|Withdrawal by Subject|0|||
126403913|NCT01075984|454773745|FG004|Follow-up Phase|Withdrawal by Subject|10|||
126403914|NCT01075984|454773741|FG000|Follow-up Phase|Progression of disease|0|||
126403915|NCT01075984|454773742|FG001|Follow-up Phase|Progression of disease|0|||
126403916|NCT01075984|454773743|FG002|Follow-up Phase|Progression of disease|0|||
126403917|NCT01075984|454773744|FG003|Follow-up Phase|Progression of disease|0|||
126403918|NCT01075984|454773745|FG004|Follow-up Phase|Progression of disease|2|||
126403919|NCT01075984|454773741|FG000|Follow-up Phase|Treatment failure|0|||
126403920|NCT01075984|454773742|FG001|Follow-up Phase|Treatment failure|0|||
126403921|NCT01075984|454773743|FG002|Follow-up Phase|Treatment failure|0|||
126403922|NCT01075984|454773744|FG003|Follow-up Phase|Treatment failure|0|||
126403923|NCT01075984|454773745|FG004|Follow-up Phase|Treatment failure|4|||
126403924|NCT02440789|454773746|FG000|Overall Study|Withdrawal by Subject|3|||
126403925|NCT02440789|454773746|FG000|Overall Study|Not willing to adhere to reqs|1|||
126403926|NCT04573881|454773748|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
126403927|NCT02564978|454773751|FG000|Overall Study|Adverse Event|8|||
126403928|NCT02564978|454773751|FG000|Overall Study|Death|1|||
126403929|NCT02564978|454773751|FG000|Overall Study|Lost to Follow-up|1|||
126472667|NCT00694707|455030851|FG001|Overall Study|Lost to Follow-up|1|||
126403930|NCT02564978|454773751|FG000|Overall Study|Withdrawal by Subject|15|||
126403931|NCT02564978|454773751|FG000|Overall Study|Early Study Closure|2|||
126403932|NCT02564978|454773751|FG000|Overall Study|Other Reason|5|||
126472668|NCT00694707|455030852|FG002|Overall Study|Lost to Follow-up|2|||
126472669|NCT00694707|455030853|FG003|Overall Study|Lost to Follow-up|0|||
126403933|NCT03684694|454773752|FG000|Phase 1|Withdrawal by Subject|1|||
126403934|NCT03684694|454773753|FG001|Phase 1|Withdrawal by Subject|0|||
126403935|NCT03684694|454773754|FG002|Phase 1|Withdrawal by Subject|0|||
126403936|NCT03684694|454773755|FG003|Phase 1|Withdrawal by Subject|0|||
126403937|NCT03684694|454773756|FG004|Phase 1|Withdrawal by Subject|0|||
126403938|NCT03684694|454773757|FG005|Phase 1|Withdrawal by Subject|0|||
126472670|NCT00694707|455030854|FG004|Overall Study|Lost to Follow-up|0|||
126403939|NCT03684694|454773752|FG000|Phase 1|Investigator/Sponsor Decision|12|||
126472671|NCT00694707|455030850|FG000|Overall Study|Jeopardizing Parole Status|1|||
126472672|NCT00694707|455030851|FG001|Overall Study|Jeopardizing Parole Status|0|||
126472673|NCT00694707|455030852|FG002|Overall Study|Jeopardizing Parole Status|0|||
126472674|NCT00694707|455030853|FG003|Overall Study|Jeopardizing Parole Status|0|||
126472675|NCT00694707|455030854|FG004|Overall Study|Jeopardizing Parole Status|0|||
126472676|NCT00694707|455030850|FG000|Overall Study|Death in the Family|1|||
126472677|NCT00694707|455030851|FG001|Overall Study|Death in the Family|0|||
126472678|NCT00694707|455030852|FG002|Overall Study|Death in the Family|0|||
126472679|NCT00694707|455030853|FG003|Overall Study|Death in the Family|0|||
126403940|NCT03684694|454773753|FG001|Phase 1|Investigator/Sponsor Decision|2|||
126403941|NCT03684694|454773754|FG002|Phase 1|Investigator/Sponsor Decision|1|||
126403942|NCT03684694|454773755|FG003|Phase 1|Investigator/Sponsor Decision|0|||
126403943|NCT03684694|454773756|FG004|Phase 1|Investigator/Sponsor Decision|0|||
126403944|NCT03684694|454773757|FG005|Phase 1|Investigator/Sponsor Decision|0|||
126403945|NCT03684694|454773752|FG000|Phase 1|Death|24|||
126403946|NCT03684694|454773753|FG001|Phase 1|Death|0|||
126403947|NCT03684694|454773754|FG002|Phase 1|Death|3|||
126403948|NCT03684694|454773755|FG003|Phase 1|Death|0|||
126403949|NCT03684694|454773756|FG004|Phase 1|Death|0|||
126403950|NCT03684694|454773757|FG005|Phase 1|Death|0|||
126403951|NCT03684694|454773752|FG000|Phase 1|Lost to Follow-up|0|||
126403952|NCT03684694|454773753|FG001|Phase 1|Lost to Follow-up|0|||
126403953|NCT03684694|454773754|FG002|Phase 1|Lost to Follow-up|1|||
126403954|NCT03684694|454773755|FG003|Phase 1|Lost to Follow-up|0|||
126403955|NCT03684694|454773756|FG004|Phase 1|Lost to Follow-up|0|||
126403956|NCT03684694|454773757|FG005|Phase 1|Lost to Follow-up|0|||
126403957|NCT03684694|454773752|FG000|Phase 1|Miscellaneous|0|||
126403958|NCT03684694|454773753|FG001|Phase 1|Miscellaneous|1|||
126403959|NCT03684694|454773754|FG002|Phase 1|Miscellaneous|0|||
126403960|NCT03684694|454773755|FG003|Phase 1|Miscellaneous|0|||
126403961|NCT03684694|454773756|FG004|Phase 1|Miscellaneous|0|||
126403962|NCT03684694|454773757|FG005|Phase 1|Miscellaneous|0|||
126403963|NCT03684694|454773752|FG000|Phase 2|Withdrawal by Subject|0|||
126403964|NCT03684694|454773753|FG001|Phase 2|Withdrawal by Subject|0|||
126403965|NCT03684694|454773754|FG002|Phase 2|Withdrawal by Subject|0|||
126403966|NCT03684694|454773755|FG003|Phase 2|Withdrawal by Subject|0|||
126403967|NCT03684694|454773756|FG004|Phase 2|Withdrawal by Subject|0|||
126403968|NCT03684694|454773757|FG005|Phase 2|Withdrawal by Subject|1|||
126403969|NCT03684694|454773752|FG000|Phase 2|Investigator/Sponsor Decision|0|||
126403970|NCT03684694|454773753|FG001|Phase 2|Investigator/Sponsor Decision|0|||
126403971|NCT03684694|454773754|FG002|Phase 2|Investigator/Sponsor Decision|0|||
126403972|NCT03684694|454773755|FG003|Phase 2|Investigator/Sponsor Decision|17|||
126403973|NCT03684694|454773756|FG004|Phase 2|Investigator/Sponsor Decision|16|||
126403974|NCT03684694|454773757|FG005|Phase 2|Investigator/Sponsor Decision|6|||
126403975|NCT03684694|454773752|FG000|Phase 2|Death|0|||
126403976|NCT03684694|454773753|FG001|Phase 2|Death|0|||
126403977|NCT03684694|454773754|FG002|Phase 2|Death|0|||
126403978|NCT03684694|454773755|FG003|Phase 2|Death|28|||
126403979|NCT03684694|454773756|FG004|Phase 2|Death|14|||
126403980|NCT03684694|454773757|FG005|Phase 2|Death|3|||
126403981|NCT03684694|454773752|FG000|Phase 2|Lost to Follow-up|0|||
126403982|NCT03684694|454773753|FG001|Phase 2|Lost to Follow-up|0|||
126403983|NCT03684694|454773754|FG002|Phase 2|Lost to Follow-up|0|||
126403984|NCT03684694|454773755|FG003|Phase 2|Lost to Follow-up|1|||
126403985|NCT03684694|454773756|FG004|Phase 2|Lost to Follow-up|0|||
126472680|NCT00694707|455030854|FG004|Overall Study|Death in the Family|0|||
126472681|NCT00694707|455030850|FG000|Overall Study|Arrest by Police|0|||
126472682|NCT00694707|455030851|FG001|Overall Study|Arrest by Police|1|||
126472683|NCT00694707|455030852|FG002|Overall Study|Arrest by Police|0|||
126472684|NCT00694707|455030853|FG003|Overall Study|Arrest by Police|0|||
126472685|NCT00694707|455030854|FG004|Overall Study|Arrest by Police|0|||
126472686|NCT00694707|455030850|FG000|Overall Study|Administrative Reasons|0|||
126472687|NCT00694707|455030851|FG001|Overall Study|Administrative Reasons|1|||
126403986|NCT03684694|454773757|FG005|Phase 2|Lost to Follow-up|0|||
126403987|NCT03684694|454773752|FG000|Phase 2|Miscellaneous|0|||
126403988|NCT03684694|454773753|FG001|Phase 2|Miscellaneous|0|||
126403989|NCT03684694|454773754|FG002|Phase 2|Miscellaneous|0|||
126403990|NCT03684694|454773755|FG003|Phase 2|Miscellaneous|3|||
126403991|NCT03684694|454773756|FG004|Phase 2|Miscellaneous|0|||
126403992|NCT03684694|454773757|FG005|Phase 2|Miscellaneous|0|||
126403993|NCT01825941|454775560|FG000|Overall Study|Lost to Follow-up|4|||
126403994|NCT01825941|454775561|FG001|Overall Study|Lost to Follow-up|1|||
126403995|NCT00528996|454775562|FG000|Overall Study|Other reasons than listing|6|||
126472688|NCT00694707|455030852|FG002|Overall Study|Administrative Reasons|0|||
126472689|NCT00694707|455030853|FG003|Overall Study|Administrative Reasons|2|||
126472690|NCT00694707|455030854|FG004|Overall Study|Administrative Reasons|0|||
126472691|NCT00694707|455030850|FG000|Overall Study|Notification of Past Head Injury|0|||
126403996|NCT00528996|454775563|FG001|Overall Study|Other reasons than listing|7|||
126403997|NCT00528996|454775564|FG002|Overall Study|Other reasons than listing|14|||
126403998|NCT00528996|454775565|FG003|Overall Study|Other reasons than listing|11|||
126403999|NCT00528996|454775566|FG004|Overall Study|Other reasons than listing|5|||
126404000|NCT00528996|454775562|FG000|Overall Study|Refused continue medication|16|||
126404001|NCT00528996|454775563|FG001|Overall Study|Refused continue medication|0|||
126404002|NCT00528996|454775564|FG002|Overall Study|Refused continue medication|3|||
126404003|NCT00528996|454775565|FG003|Overall Study|Refused continue medication|3|||
126404004|NCT00528996|454775566|FG004|Overall Study|Refused continue medication|6|||
126404005|NCT00528996|454775562|FG000|Overall Study|Lost to Follow-up|2|||
126404006|NCT00528996|454775563|FG001|Overall Study|Lost to Follow-up|0|||
126404007|NCT00528996|454775564|FG002|Overall Study|Lost to Follow-up|4|||
126404008|NCT00528996|454775565|FG003|Overall Study|Lost to Follow-up|1|||
126404009|NCT00528996|454775566|FG004|Overall Study|Lost to Follow-up|3|||
126404010|NCT00528996|454775562|FG000|Overall Study|Protocol Violation|1|||
126404011|NCT00528996|454775563|FG001|Overall Study|Protocol Violation|2|||
126404012|NCT00528996|454775564|FG002|Overall Study|Protocol Violation|3|||
126404013|NCT00528996|454775565|FG003|Overall Study|Protocol Violation|3|||
126404014|NCT00528996|454775566|FG004|Overall Study|Protocol Violation|2|||
126404015|NCT00528996|454775562|FG000|Overall Study|Lack of Efficacy|7|||
126404016|NCT00528996|454775563|FG001|Overall Study|Lack of Efficacy|2|||
126404017|NCT00528996|454775564|FG002|Overall Study|Lack of Efficacy|1|||
126404018|NCT00528996|454775565|FG003|Overall Study|Lack of Efficacy|3|||
126404019|NCT00528996|454775566|FG004|Overall Study|Lack of Efficacy|3|||
126404020|NCT00528996|454775562|FG000|Overall Study|Adverse Event|32|||
126404021|NCT00528996|454775563|FG001|Overall Study|Adverse Event|13|||
126404022|NCT00528996|454775564|FG002|Overall Study|Adverse Event|18|||
126404023|NCT00528996|454775565|FG003|Overall Study|Adverse Event|29|||
126404024|NCT00528996|454775566|FG004|Overall Study|Adverse Event|18|||
126404025|NCT01022424|454775570|FG000|Overall Study|Adverse Event|1|||
126404026|NCT01022424|454775570|FG000|Overall Study|Physician Decision|1|||
126404027|NCT01022424|454775570|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
126404028|NCT01806064|454775573|FG000|Overall Study|Randomized Not Enrolled|0|||
126404029|NCT01806064|454775574|FG001|Overall Study|Randomized Not Enrolled|0|||
126404030|NCT01806064|454775575|FG002|Overall Study|Randomized Not Enrolled|0|||
126404031|NCT01806064|454775576|FG003|Overall Study|Randomized Not Enrolled|1|||
126404032|NCT01806064|454775577|FG004|Overall Study|Randomized Not Enrolled|2|||
126404033|NCT05160766|454775580|FG000|Overall Study|Adverse Event|0|||
126404034|NCT05160766|454775581|FG001|Overall Study|Adverse Event|1|||
126404035|NCT05160766|454775582|FG002|Overall Study|Adverse Event|0|||
126404036|NCT05160766|454775583|FG003|Overall Study|Adverse Event|0|||
126404037|NCT05160766|454775580|FG000|Overall Study|COVID-19 infection|0|||
126404038|NCT05160766|454775581|FG001|Overall Study|COVID-19 infection|1|||
126404039|NCT05160766|454775582|FG002|Overall Study|COVID-19 infection|0|||
126404040|NCT05160766|454775583|FG003|Overall Study|COVID-19 infection|0|||
126404041|NCT05160766|454775580|FG000|Overall Study|travel time|1|||
126404042|NCT05160766|454775581|FG001|Overall Study|travel time|0|||
126404043|NCT05160766|454775582|FG002|Overall Study|travel time|0|||
126404044|NCT05160766|454775583|FG003|Overall Study|travel time|1|||
126404045|NCT05160766|454775580|FG000|Overall Study|Withdrawal by Subject|3|||
126472692|NCT00694707|455030851|FG001|Overall Study|Notification of Past Head Injury|0|||
126472693|NCT00694707|455030852|FG002|Overall Study|Notification of Past Head Injury|0|||
126472694|NCT00694707|455030853|FG003|Overall Study|Notification of Past Head Injury|1|||
126472695|NCT00694707|455030854|FG004|Overall Study|Notification of Past Head Injury|0|||
126472696|NCT00973674|455030859|FG000|Overall Study|Protocol Violation|2|||
126472697|NCT00973674|455030860|FG001|Overall Study|Protocol Violation|0|||
126472698|NCT02713204|455030861|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
126472699|NCT02713204|455030862|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
126472700|NCT02713204|455030863|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
126472701|NCT02713204|455030864|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
126472702|NCT02713204|455030865|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
126472703|NCT02713204|455030866|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
126472704|NCT02713204|455030867|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
126472705|NCT02713204|455030868|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
126472706|NCT02713204|455030861|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126472707|NCT02713204|455030862|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126404046|NCT05160766|454775581|FG001|Overall Study|Withdrawal by Subject|5|||
126472708|NCT02713204|455030863|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
126404047|NCT05160766|454775582|FG002|Overall Study|Withdrawal by Subject|4|||
126472709|NCT02713204|455030864|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126557785|NCT01723826|455334476|FG003|Overall Study|Non-compliance With Study Drug|0|||
126404048|NCT05160766|454775583|FG003|Overall Study|Withdrawal by Subject|2|||
126404049|NCT05160766|454775580|FG000|Overall Study|Death|0|||
126404050|NCT05160766|454775581|FG001|Overall Study|Death|0|||
126404051|NCT05160766|454775582|FG002|Overall Study|Death|2|||
126404052|NCT05160766|454775583|FG003|Overall Study|Death|5|||
126404053|NCT05160766|454775580|FG000|Overall Study|Lost to Follow-up|0|||
126404054|NCT05160766|454775581|FG001|Overall Study|Lost to Follow-up|0|||
126404055|NCT05160766|454775582|FG002|Overall Study|Lost to Follow-up|1|||
126557786|NCT01723826|455334473|FG000|Overall Study|Other Reason|8|||
126404056|NCT05160766|454775583|FG003|Overall Study|Lost to Follow-up|2|||
126404057|NCT05160766|454775580|FG000|Overall Study|No show|0|||
126404058|NCT05160766|454775581|FG001|Overall Study|No show|0|||
126404059|NCT05160766|454775582|FG002|Overall Study|No show|1|||
126404060|NCT05160766|454775583|FG003|Overall Study|No show|1|||
126404061|NCT05160766|454775580|FG000|Overall Study|Physician Decision|0|||
126404062|NCT05160766|454775581|FG001|Overall Study|Physician Decision|0|||
126404063|NCT05160766|454775582|FG002|Overall Study|Physician Decision|0|||
126404064|NCT05160766|454775583|FG003|Overall Study|Physician Decision|1|||
126404065|NCT05160766|454775580|FG000|Overall Study|Protocol Violation|0|||
126404066|NCT05160766|454775581|FG001|Overall Study|Protocol Violation|0|||
126404067|NCT05160766|454775582|FG002|Overall Study|Protocol Violation|1|||
126404068|NCT05160766|454775583|FG003|Overall Study|Protocol Violation|0|||
126404069|NCT02943915|454775584|FG000|Overall Study|Withdrawal by Subject|2|||
126404070|NCT02943915|454775585|FG001|Overall Study|Withdrawal by Subject|1|||
126404071|NCT02943915|454775586|FG002|Overall Study|Withdrawal by Subject|0|||
126404072|NCT02943915|454775587|FG003|Overall Study|Withdrawal by Subject|0|||
126404073|NCT02943915|454775584|FG000|Overall Study|Lost to Follow-up|3|||
126404074|NCT02943915|454775585|FG001|Overall Study|Lost to Follow-up|1|||
126404075|NCT02943915|454775586|FG002|Overall Study|Lost to Follow-up|0|||
126404076|NCT02943915|454775587|FG003|Overall Study|Lost to Follow-up|0|||
126404077|NCT02943915|454775584|FG000|Overall Study|excluded|0|||
126404078|NCT02943915|454775585|FG001|Overall Study|excluded|1|||
126404079|NCT02943915|454775586|FG002|Overall Study|excluded|0|||
126404080|NCT02943915|454775587|FG003|Overall Study|excluded|0|||
126404081|NCT00004445|454775589|FG000|Overall Study|Physician Decision|2|||
126404082|NCT00004445|454775589|FG000|Overall Study|Withdrawal by Subject|1|||
126404083|NCT02753127|454775590|FG000|Overall Study|Lost to Follow-up|13|||
126404084|NCT02753127|454775591|FG001|Overall Study|Lost to Follow-up|11|||
126404085|NCT02753127|454775590|FG000|Overall Study|Withdrawal by Subject|37|||
126404086|NCT02753127|454775591|FG001|Overall Study|Withdrawal by Subject|47|||
126404087|NCT02753127|454775590|FG000|Overall Study|Other|3|||
126404088|NCT02753127|454775591|FG001|Overall Study|Other|8|||
126404089|NCT02753127|454775590|FG000|Overall Study|Hospice|0|||
126404090|NCT02753127|454775591|FG001|Overall Study|Hospice|2|||
126404091|NCT03826342|454775592|FG000|Overall Study|Withdrawal by Subject|8|||
126404092|NCT03826342|454775593|FG001|Overall Study|Withdrawal by Subject|1|||
126404093|NCT03826342|454775592|FG000|Overall Study|Lost to Follow-up|7|||
126404094|NCT03826342|454775593|FG001|Overall Study|Lost to Follow-up|7|||
126404095|NCT03826342|454775592|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
126404096|NCT03826342|454775593|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
126404097|NCT01818284|454775594|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
126404098|NCT01818284|454775595|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
126404099|NCT01818284|454775594|FG000|Overall Study|Death|0|||
126404100|NCT01818284|454775595|FG001|Overall Study|Death|2|||
126404101|NCT03681678|454775596|FG000|Overall Study|Lost to Follow-up|20|||
126404102|NCT04030962|454775598|FG000|Stage 2|Adverse Event|0|||
126404103|NCT04030962|454775599|FG001|Stage 2|Adverse Event|0|||
126404104|NCT04030962|454775600|FG002|Stage 2|Adverse Event|0|||
126404105|NCT04030962|454775601|FG003|Stage 2|Adverse Event|0|||
126404106|NCT04030962|454775602|FG004|Stage 2|Adverse Event|0|||
126404107|NCT04030962|454775603|FG005|Stage 2|Adverse Event|0|||
126404108|NCT04030962|454775604|FG006|Stage 2|Adverse Event|0|||
126404109|NCT04030962|454775605|FG007|Stage 2|Adverse Event|0|||
126404110|NCT04030962|454775606|FG008|Stage 2|Adverse Event|1|||
126404111|NCT04030962|454775607|FG009|Stage 2|Adverse Event|0|||
126404112|NCT04030962|454775608|FG010|Stage 2|Adverse Event|1|||
126404113|NCT04030962|454775609|FG011|Stage 2|Adverse Event|1|||
126404114|NCT04030962|454775610|FG012|Stage 2|Adverse Event|1|||
126404115|NCT04030962|454775598|FG000|Stage 2|Withdrawal by Subject|0|||
126404116|NCT04030962|454775599|FG001|Stage 2|Withdrawal by Subject|0|||
126404117|NCT04030962|454775600|FG002|Stage 2|Withdrawal by Subject|0|||
126404118|NCT04030962|454775601|FG003|Stage 2|Withdrawal by Subject|0|||
126404119|NCT04030962|454775602|FG004|Stage 2|Withdrawal by Subject|0|||
126404120|NCT04030962|454775603|FG005|Stage 2|Withdrawal by Subject|0|||
126404121|NCT04030962|454775604|FG006|Stage 2|Withdrawal by Subject|0|||
126404122|NCT04030962|454775605|FG007|Stage 2|Withdrawal by Subject|0|||
126404123|NCT04030962|454775606|FG008|Stage 2|Withdrawal by Subject|1|||
126404124|NCT04030962|454775607|FG009|Stage 2|Withdrawal by Subject|0|||
126404125|NCT04030962|454775608|FG010|Stage 2|Withdrawal by Subject|0|||
126557787|NCT01723826|455334474|FG001|Overall Study|Other Reason|6|||
126557788|NCT01723826|455334475|FG002|Overall Study|Other Reason|12|||
126404126|NCT04030962|454775609|FG011|Stage 2|Withdrawal by Subject|2|||
126404127|NCT04030962|454775610|FG012|Stage 2|Withdrawal by Subject|1|||
126404128|NCT04030962|454775598|FG000|Stage 2|Lost to Follow-up|0|||
126557789|NCT01723826|455334476|FG003|Overall Study|Other Reason|14|||
126404129|NCT04030962|454775599|FG001|Stage 2|Lost to Follow-up|0|||
126404130|NCT04030962|454775600|FG002|Stage 2|Lost to Follow-up|0|||
126404131|NCT04030962|454775601|FG003|Stage 2|Lost to Follow-up|0|||
126404132|NCT04030962|454775602|FG004|Stage 2|Lost to Follow-up|0|||
126404133|NCT04030962|454775603|FG005|Stage 2|Lost to Follow-up|0|||
126404134|NCT04030962|454775604|FG006|Stage 2|Lost to Follow-up|0|||
126404135|NCT04030962|454775605|FG007|Stage 2|Lost to Follow-up|0|||
126404136|NCT04030962|454775606|FG008|Stage 2|Lost to Follow-up|1|||
126557790|NCT01723826|455334473|FG000|Overall Study|Physician Decision|1|||
126472710|NCT02713204|455030865|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126404137|NCT04030962|454775607|FG009|Stage 2|Lost to Follow-up|0|||
126404138|NCT04030962|454775608|FG010|Stage 2|Lost to Follow-up|0|||
126404139|NCT04030962|454775609|FG011|Stage 2|Lost to Follow-up|0|||
126404140|NCT04030962|454775610|FG012|Stage 2|Lost to Follow-up|0|||
126404141|NCT04030962|454775598|FG000|Stage 2|Technical Problems|0|||
126404142|NCT04030962|454775599|FG001|Stage 2|Technical Problems|0|||
126404143|NCT04030962|454775600|FG002|Stage 2|Technical Problems|0|||
126404144|NCT04030962|454775601|FG003|Stage 2|Technical Problems|0|||
126404145|NCT04030962|454775602|FG004|Stage 2|Technical Problems|0|||
126404146|NCT04030962|454775603|FG005|Stage 2|Technical Problems|0|||
126404147|NCT04030962|454775604|FG006|Stage 2|Technical Problems|0|||
126404148|NCT04030962|454775605|FG007|Stage 2|Technical Problems|0|||
126404149|NCT04030962|454775606|FG008|Stage 2|Technical Problems|0|||
126404150|NCT04030962|454775607|FG009|Stage 2|Technical Problems|0|||
126404151|NCT04030962|454775608|FG010|Stage 2|Technical Problems|0|||
126404152|NCT04030962|454775609|FG011|Stage 2|Technical Problems|1|||
126404153|NCT04030962|454775610|FG012|Stage 2|Technical Problems|0|||
126404154|NCT05288166|454775611|FG000|Overall Study|Adverse Event|1|||
126404155|NCT05288166|454775612|FG001|Overall Study|Adverse Event|0|||
126404156|NCT05288166|454775611|FG000|Overall Study|Lost to Follow-up|2|||
126404157|NCT05288166|454775612|FG001|Overall Study|Lost to Follow-up|0|||
126404158|NCT05288166|454775611|FG000|Overall Study|Physician Decision|0|||
126404159|NCT05288166|454775612|FG001|Overall Study|Physician Decision|2|||
126404160|NCT05288166|454775611|FG000|Overall Study|Screen Failure|1|||
126404161|NCT05288166|454775612|FG001|Overall Study|Screen Failure|1|||
126404162|NCT05288166|454775611|FG000|Overall Study|Withdrawal by Subject|4|||
126404163|NCT05288166|454775612|FG001|Overall Study|Withdrawal by Subject|2|||
126404164|NCT05288166|454775611|FG000|Overall Study|On Study Treatment|408|||
126404165|NCT05288166|454775612|FG001|Overall Study|On Study Treatment|418|||
126404166|NCT01114360|454775613|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
126404167|NCT01114360|454775614|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
126404168|NCT03007745|454775615|FG000|Overall Study|Sleep test negative for OSA|53|||
126404169|NCT03007745|454775616|FG001|Overall Study|Sleep test negative for OSA|49|||
126404170|NCT03007745|454775615|FG000|Overall Study|Physician Decision|6|||
126404171|NCT03007745|454775616|FG001|Overall Study|Physician Decision|9|||
126472711|NCT02713204|455030866|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126472712|NCT02713204|455030867|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126472713|NCT02713204|455030868|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126472714|NCT02713204|455030861|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126472715|NCT02713204|455030862|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
126472716|NCT02713204|455030863|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126472717|NCT02713204|455030864|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126472718|NCT02713204|455030865|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126472719|NCT02713204|455030866|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126472720|NCT02713204|455030867|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126472721|NCT02713204|455030868|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126472722|NCT02713204|455030861|FG000|From Week 12 up to Week 36|Adverse Event|1|||
126472723|NCT02713204|455030862|FG001|From Week 12 up to Week 36|Adverse Event|0|||
126472724|NCT02713204|455030863|FG002|From Week 12 up to Week 36|Adverse Event|0|||
126472725|NCT02713204|455030864|FG003|From Week 12 up to Week 36|Adverse Event|1|||
126472726|NCT02713204|455030865|FG004|From Week 12 up to Week 36|Adverse Event|1|||
126472727|NCT02713204|455030866|FG005|From Week 12 up to Week 36|Adverse Event|0|||
126472728|NCT02713204|455030867|FG006|From Week 12 up to Week 36|Adverse Event|2|||
126472729|NCT02713204|455030868|FG007|From Week 12 up to Week 36|Adverse Event|1|||
126472730|NCT02713204|455030861|FG000|From Week 12 up to Week 36|Death|0|||
126472731|NCT02713204|455030862|FG001|From Week 12 up to Week 36|Death|0|||
126472732|NCT02713204|455030863|FG002|From Week 12 up to Week 36|Death|0|||
126472733|NCT02713204|455030864|FG003|From Week 12 up to Week 36|Death|1|||
126472734|NCT02713204|455030865|FG004|From Week 12 up to Week 36|Death|0|||
126404172|NCT03007745|454775615|FG000|Overall Study|Withdrawal by Subject|38|||
126404173|NCT03007745|454775616|FG001|Overall Study|Withdrawal by Subject|16|||
126404174|NCT03007745|454775615|FG000|Overall Study|Lost to Follow-up|19|||
126404175|NCT03007745|454775616|FG001|Overall Study|Lost to Follow-up|25|||
126404176|NCT03007745|454775615|FG000|Overall Study|Unable to login to website|17|||
126472735|NCT02713204|455030866|FG005|From Week 12 up to Week 36|Death|1|||
126472736|NCT02713204|455030867|FG006|From Week 12 up to Week 36|Death|0|||
126404177|NCT03007745|454775616|FG001|Overall Study|Unable to login to website|4|||
126404178|NCT01146288|454775618|FG000|First Intervention(1 Day)|Adverse Event|0|||
126557791|NCT01723826|455334474|FG001|Overall Study|Physician Decision|3|||
126404179|NCT01146288|454775619|FG001|First Intervention(1 Day)|Adverse Event|1|||
126472737|NCT02713204|455030868|FG007|From Week 12 up to Week 36|Death|3|||
126472738|NCT02713204|455030861|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
126472739|NCT02713204|455030862|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
126404180|NCT00385723|454775620|FG000|Overall Study|Lost to Follow-up|1|||
126404181|NCT00385723|454775621|FG001|Overall Study|Lost to Follow-up|1|||
126404182|NCT00385723|454775622|FG002|Overall Study|Lost to Follow-up|0|||
126472740|NCT02713204|455030863|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
126404183|NCT00385723|454775620|FG000|Overall Study|Withdrawal by Subject|1|||
126404184|NCT00385723|454775621|FG001|Overall Study|Withdrawal by Subject|0|||
126472741|NCT02713204|455030864|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
126472742|NCT02713204|455030865|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
126472743|NCT02713204|455030866|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
126472744|NCT02713204|455030867|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
126472745|NCT02713204|455030868|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
126472746|NCT02713204|455030861|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
126472747|NCT02713204|455030862|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
126472748|NCT02713204|455030863|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
126472749|NCT02713204|455030864|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
126472750|NCT02713204|455030865|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
126472751|NCT02713204|455030866|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
126472752|NCT02713204|455030867|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
126472753|NCT02713204|455030868|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
126472754|NCT03000569|455030877|FG000|Overall Study|Withdrawal by Subject|1|||
126472755|NCT03000569|455030878|FG001|Overall Study|Withdrawal by Subject|0|||
126472756|NCT04815031|455030879|FG000|Overall Study|No adverse event information (missing information)|33|||
126472757|NCT04122534|455030880|FG000|Overall Study|Lost to Follow-up|4|||
126472758|NCT01254630|455030884|FG000|Overall Study|Adverse Event|36|||
126472759|NCT01254630|455030885|FG001|Overall Study|Adverse Event|15|||
126472760|NCT01254630|455030886|FG002|Overall Study|Adverse Event|40|||
126472761|NCT01254630|455030887|FG003|Overall Study|Adverse Event|8|||
126404185|NCT00385723|454775622|FG002|Overall Study|Withdrawal by Subject|2|||
126404186|NCT03455829|454775623|FG000|Overall Study|Death|2|||
126404187|NCT03455829|454775624|FG001|Overall Study|Death|3|||
126404188|NCT03455829|454775625|FG002|Overall Study|Death|2|||
126404189|NCT03455829|454775626|FG003|Overall Study|Death|4|||
126404190|NCT03455829|454775627|FG004|Overall Study|Death|2|||
126404191|NCT03455829|454775623|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
126404192|NCT03455829|454775624|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
126404193|NCT03455829|454775625|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
126404194|NCT03455829|454775626|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
126404195|NCT03455829|454775627|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
126404196|NCT03455829|454775623|FG000|Overall Study|Disease progression|0|||
126404197|NCT03455829|454775624|FG001|Overall Study|Disease progression|0|||
126404198|NCT03455829|454775625|FG002|Overall Study|Disease progression|0|||
126404199|NCT03455829|454775626|FG003|Overall Study|Disease progression|1|||
126404200|NCT03455829|454775627|FG004|Overall Study|Disease progression|1|||
126404201|NCT05824936|454775629|FG000|Overall Study|Lost to Follow-up|1|||
126404202|NCT03689712|454775630|FG000|Overall Study|Adverse Event|1|||
126404203|NCT03689712|454775631|FG001|Overall Study|Adverse Event|0|||
126404204|NCT03689712|454775630|FG000|Overall Study|Death|20|||
126404205|NCT03689712|454775631|FG001|Overall Study|Death|10|||
126404206|NCT03689712|454775630|FG000|Overall Study|Lost to Follow-up|6|||
126404207|NCT03689712|454775631|FG001|Overall Study|Lost to Follow-up|6|||
126404208|NCT03689712|454775630|FG000|Overall Study|Other|1|||
126404209|NCT03689712|454775631|FG001|Overall Study|Other|0|||
126404210|NCT03689712|454775630|FG000|Overall Study|Patient Non-Compliance|0|||
126404211|NCT03689712|454775631|FG001|Overall Study|Patient Non-Compliance|1|||
126404212|NCT03689712|454775630|FG000|Overall Study|Withdrawal by Subject|20|||
126404213|NCT03689712|454775631|FG001|Overall Study|Withdrawal by Subject|4|||
126404214|NCT03689712|454775630|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
126404215|NCT03689712|454775631|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
126472762|NCT01254630|455030884|FG000|Overall Study|Death|461|||
126472763|NCT01254630|455030885|FG001|Overall Study|Death|151|||
126472764|NCT01254630|455030886|FG002|Overall Study|Death|478|||
126472765|NCT01254630|455030887|FG003|Overall Study|Death|139|||
126472766|NCT01254630|455030884|FG000|Overall Study|Lost to Follow-up|80|||
126472767|NCT01254630|455030885|FG001|Overall Study|Lost to Follow-up|26|||
126404216|NCT03689712|454775630|FG000|Overall Study|Randomized but not Treated|13|||
126404217|NCT03689712|454775631|FG001|Overall Study|Randomized but not Treated|7|||
126404218|NCT03689712|454775630|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
126404219|NCT03689712|454775631|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
126404220|NCT01533922|454775635|FG000|Overall Study|Adverse Event|5|||
126472768|NCT01254630|455030886|FG002|Overall Study|Lost to Follow-up|89|||
126472769|NCT01254630|455030887|FG003|Overall Study|Lost to Follow-up|32|||
126472770|NCT01254630|455030884|FG000|Overall Study|Physician Decision|24|||
126472771|NCT01254630|455030885|FG001|Overall Study|Physician Decision|8|||
126472772|NCT01254630|455030886|FG002|Overall Study|Physician Decision|16|||
126472773|NCT01254630|455030887|FG003|Overall Study|Physician Decision|7|||
126404221|NCT01533922|454775636|FG001|Overall Study|Adverse Event|8|||
126404222|NCT01533922|454775637|FG002|Overall Study|Adverse Event|6|||
126404223|NCT01533922|454775638|FG003|Overall Study|Adverse Event|3|||
126404224|NCT01533922|454775639|FG004|Overall Study|Adverse Event|4|||
126404225|NCT01533922|454775635|FG000|Overall Study|Lack of Efficacy|0|||
126404226|NCT01533922|454775636|FG001|Overall Study|Lack of Efficacy|0|||
126404227|NCT01533922|454775637|FG002|Overall Study|Lack of Efficacy|1|||
126404228|NCT01533922|454775638|FG003|Overall Study|Lack of Efficacy|0|||
126404229|NCT01533922|454775639|FG004|Overall Study|Lack of Efficacy|0|||
126404230|NCT01533922|454775635|FG000|Overall Study|Protocol Violation|0|||
126404231|NCT01533922|454775636|FG001|Overall Study|Protocol Violation|3|||
126404232|NCT01533922|454775637|FG002|Overall Study|Protocol Violation|0|||
126404233|NCT01533922|454775638|FG003|Overall Study|Protocol Violation|0|||
126404234|NCT01533922|454775639|FG004|Overall Study|Protocol Violation|1|||
126404235|NCT01533922|454775635|FG000|Overall Study|Withdrawal by Subject|3|||
126404236|NCT01533922|454775636|FG001|Overall Study|Withdrawal by Subject|1|||
126404237|NCT01533922|454775637|FG002|Overall Study|Withdrawal by Subject|2|||
126404238|NCT01533922|454775638|FG003|Overall Study|Withdrawal by Subject|2|||
126404239|NCT01533922|454775639|FG004|Overall Study|Withdrawal by Subject|1|||
126404240|NCT01533922|454775635|FG000|Overall Study|Other reason not defined above|2|||
126404241|NCT01533922|454775636|FG001|Overall Study|Other reason not defined above|0|||
126404242|NCT01533922|454775637|FG002|Overall Study|Other reason not defined above|1|||
126404243|NCT01533922|454775638|FG003|Overall Study|Other reason not defined above|0|||
126404244|NCT01533922|454775639|FG004|Overall Study|Other reason not defined above|0|||
126404245|NCT02634606|454775640|FG000|Overall Study|unable to obtain the drug at start|13|||
126404246|NCT00286221|454775641|FG000|Overall Study|Protocol Violation|2|||
126404247|NCT00286221|454775642|FG001|Overall Study|Protocol Violation|1|||
126404248|NCT00286221|454775643|FG002|Overall Study|Protocol Violation|6|||
126404249|NCT00286221|454775644|FG003|Overall Study|Protocol Violation|4|||
126404250|NCT00286221|454775641|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
126404251|NCT00286221|454775642|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
126404252|NCT00286221|454775643|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
126404253|NCT00286221|454775644|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
126404254|NCT00286221|454775641|FG000|Overall Study|Inability to trigger PCA|2|||
126404255|NCT00286221|454775642|FG001|Overall Study|Inability to trigger PCA|0|||
126404256|NCT00286221|454775643|FG002|Overall Study|Inability to trigger PCA|0|||
126404257|NCT00286221|454775644|FG003|Overall Study|Inability to trigger PCA|0|||
126404258|NCT00286221|454775641|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
126404259|NCT00286221|454775642|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
126404260|NCT00286221|454775643|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
126404261|NCT00286221|454775644|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
126404262|NCT02553538|454775646|FG000|Overall Study|Could Not Reach by Telephone|133|||
126404263|NCT02553538|454775647|FG001|Overall Study|Could Not Reach by Telephone|0|||
126404264|NCT02553538|454775646|FG000|Overall Study|Died or Left Network|54|||
126404265|NCT02553538|454775647|FG001|Overall Study|Died or Left Network|56|||
126404266|NCT02276547|454775648|FG000|Overall Study|Death|2|||
126404267|NCT02276547|454775648|FG000|Overall Study|Explant|2|||
126404268|NCT01754194|454775649|FG000|Overall Study|Lost to Follow-up|39|||
126404269|NCT01754194|454775650|FG001|Overall Study|Lost to Follow-up|14|||
126404270|NCT01754194|454775649|FG000|Overall Study|Withdrawal by Subject|4|||
126404271|NCT01754194|454775650|FG001|Overall Study|Withdrawal by Subject|5|||
126404272|NCT01754194|454775649|FG000|Overall Study|Other|9|||
126404273|NCT01754194|454775650|FG001|Overall Study|Other|8|||
126404274|NCT02066129|454775652|FG000|Overall Study|Lost to Follow-up|13|||
126404275|NCT02066129|454775653|FG001|Overall Study|Lost to Follow-up|12|||
126472774|NCT01254630|455030884|FG000|Overall Study|Withdrawal by Subject|201|||
126472775|NCT01254630|455030885|FG001|Overall Study|Withdrawal by Subject|94|||
126472776|NCT01254630|455030886|FG002|Overall Study|Withdrawal by Subject|188|||
126472777|NCT01254630|455030887|FG003|Overall Study|Withdrawal by Subject|89|||
126472778|NCT01254630|455030884|FG000|Overall Study|Study terminated by sponsor|0|||
126472779|NCT01254630|455030885|FG001|Overall Study|Study terminated by sponsor|994|||
126472780|NCT01254630|455030886|FG002|Overall Study|Study terminated by sponsor|0|||
126472781|NCT01254630|455030887|FG003|Overall Study|Study terminated by sponsor|1010|||
126472782|NCT01254630|455030884|FG000|Overall Study|Status not recorded|0|||
126404276|NCT02066129|454775652|FG000|Overall Study|Withdrawal by Subject|7|||
126404277|NCT02066129|454775653|FG001|Overall Study|Withdrawal by Subject|10|||
126404278|NCT02066129|454775652|FG000|Overall Study|Lack of Efficacy|8|||
126472783|NCT01254630|455030885|FG001|Overall Study|Status not recorded|0|||
126472784|NCT01254630|455030886|FG002|Overall Study|Status not recorded|1|||
126557792|NCT01723826|455334475|FG002|Overall Study|Physician Decision|4|||
126472785|NCT01254630|455030887|FG003|Overall Study|Status not recorded|0|||
126472786|NCT02020577|455030888|FG000|Overall Study|Progressive disease|3|||
126404279|NCT02066129|454775653|FG001|Overall Study|Lack of Efficacy|10|||
126404280|NCT02066129|454775652|FG000|Overall Study|Physician Decision|1|||
126404281|NCT02066129|454775653|FG001|Overall Study|Physician Decision|1|||
126404282|NCT03344640|454775654|FG000|Overall Study|Adverse Event|1|||
126404283|NCT03344640|454775655|FG001|Overall Study|Adverse Event|0|||
126404284|NCT03344640|454775654|FG000|Overall Study|Physician Decision|1|||
126404285|NCT03344640|454775655|FG001|Overall Study|Physician Decision|1|||
126404286|NCT03344640|454775654|FG000|Overall Study|Withdrawal by Subject|1|||
126404287|NCT03344640|454775655|FG001|Overall Study|Withdrawal by Subject|2|||
126404288|NCT03344640|454775654|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
126404289|NCT03344640|454775655|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
126404290|NCT00357656|454775656|FG000|Overall Study|Other, No surgery performed|0|||
126404291|NCT00357656|454775657|FG001|Overall Study|Other, No surgery performed|3|||
126404292|NCT02573246|454775658|FG000|Overall Study|Lost to Follow-up|2|||
126404293|NCT02573246|454775659|FG001|Overall Study|Lost to Follow-up|0|||
126404294|NCT02573246|454775660|FG002|Overall Study|Lost to Follow-up|0|||
126404295|NCT02573246|454775661|FG003|Overall Study|Lost to Follow-up|0|||
126404296|NCT02573246|454775662|FG004|Overall Study|Lost to Follow-up|1|||
126404297|NCT02573246|454775658|FG000|Overall Study|Withdrawal by Subject|0|||
126404298|NCT02573246|454775659|FG001|Overall Study|Withdrawal by Subject|0|||
126404299|NCT02573246|454775660|FG002|Overall Study|Withdrawal by Subject|0|||
126404300|NCT02573246|454775661|FG003|Overall Study|Withdrawal by Subject|0|||
126404301|NCT02573246|454775662|FG004|Overall Study|Withdrawal by Subject|1|||
126404302|NCT02573246|454775658|FG000|Overall Study|Physician Decision|1|||
126404303|NCT02573246|454775659|FG001|Overall Study|Physician Decision|1|||
126404304|NCT02573246|454775660|FG002|Overall Study|Physician Decision|3|||
126404305|NCT02573246|454775661|FG003|Overall Study|Physician Decision|2|||
126404306|NCT02573246|454775662|FG004|Overall Study|Physician Decision|2|||
126404307|NCT01219933|454775663|FG000|Overall Study|Adverse Event|8|||
126404308|NCT01219933|454775663|FG000|Overall Study|No LDA reached|5|||
126404309|NCT01219933|454775663|FG000|Overall Study|No LDA maintained|7|||
126404310|NCT01219933|454775663|FG000|Overall Study|Lost to Follow-up|3|||
126404311|NCT01219933|454775663|FG000|Overall Study|GC free|1|||
126404312|NCT01219933|454775663|FG000|Overall Study|Withdrawal by Subject|5|||
126404313|NCT01219933|454775663|FG000|Overall Study|Protocol Violation|8|||
126404314|NCT01219933|454775663|FG000|Overall Study|Lack of Efficacy|1|||
126404315|NCT01902888|454775667|FG000|Overall Study|Study Terminated|3|||
126404316|NCT00316888|454775668|FG000|Overall Study|Adverse Event|4|||
126404317|NCT00316888|454775669|FG001|Overall Study|Adverse Event|5|||
126404318|NCT00316888|454775668|FG000|Overall Study|Withdrawal by Subject|2|||
126404319|NCT00316888|454775669|FG001|Overall Study|Withdrawal by Subject|2|||
126404320|NCT00316888|454775668|FG000|Overall Study|Not start protocol therapy|0|||
126404321|NCT00316888|454775669|FG001|Overall Study|Not start protocol therapy|1|||
126404322|NCT03149003|454775670|FG000|Overall Study|Randomized but not treated|0|||
126404323|NCT03149003|454775671|FG001|Overall Study|Randomized but not treated|1|||
126404324|NCT03149003|454775672|FG002|Overall Study|Randomized but not treated|18|||
126404325|NCT00815191|454775673|FG000|Overall Study|Protocol Violation|1|||
126404326|NCT00815191|454775674|FG001|Overall Study|Protocol Violation|1|||
126404327|NCT01814670|454775677|FG000|Overall Study|Protocol Violation|12|||
126404328|NCT01565941|454775678|FG000|Overall Study|Withdrawn by parent/guardian|3|||
126404329|NCT01565941|454775679|FG001|Overall Study|Withdrawn by parent/guardian|2|||
126404330|NCT01565941|454775678|FG000|Overall Study|Randomized; did not receive intevention|8|||
126404331|NCT01565941|454775679|FG001|Overall Study|Randomized; did not receive intevention|2|||
126404332|NCT04047420|454775680|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
126404333|NCT04047420|454775680|FG000|Washout Period|Refused Participation|2|||
126404334|NCT03443427|454775681|FG000|Overall Study|Adverse Event|2|||
126404335|NCT03443427|454775682|FG001|Overall Study|Adverse Event|3|||
126404336|NCT03443427|454775681|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
126404337|NCT03443427|454775682|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
126404338|NCT03443427|454775681|FG000|Overall Study|Other|4|||
126404339|NCT03443427|454775682|FG001|Overall Study|Other|6|||
126404340|NCT02576860|454775683|FG000|Overall Study|Adverse Event|6|||
126404341|NCT02576860|454775684|FG001|Overall Study|Adverse Event|6|||
126404342|NCT02576860|454775683|FG000|Overall Study|Lost to Follow-up|5|||
126404343|NCT02576860|454775684|FG001|Overall Study|Lost to Follow-up|7|||
126404344|NCT02576860|454775683|FG000|Overall Study|Physician Decision|0|||
126404345|NCT02576860|454775684|FG001|Overall Study|Physician Decision|1|||
126404346|NCT02576860|454775683|FG000|Overall Study|Protocol Violation|0|||
126472787|NCT02020577|455030889|FG001|Overall Study|Progressive disease|38|||
126472788|NCT02020577|455030888|FG000|Overall Study|Other AE or clinical progression|0|||
126472789|NCT02020577|455030889|FG001|Overall Study|Other AE or clinical progression|15|||
126472790|NCT02020577|455030888|FG000|Overall Study|Withdrawal by Subject|0|||
126404347|NCT02576860|454775684|FG001|Overall Study|Protocol Violation|2|||
126404348|NCT02576860|454775683|FG000|Overall Study|Withdrawal by Subject|13|||
126404349|NCT02576860|454775684|FG001|Overall Study|Withdrawal by Subject|8|||
126404350|NCT02576860|454775683|FG000|Overall Study|Disallowed medication|1|||
126404351|NCT02576860|454775684|FG001|Overall Study|Disallowed medication|0|||
126404352|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
126404353|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
126404354|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
126404355|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
126404356|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
126404357|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
126472791|NCT02020577|455030889|FG001|Overall Study|Withdrawal by Subject|1|||
126404358|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
126404359|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
126404360|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
126404361|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
126404362|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
126404363|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
126404364|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
126404365|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
126404366|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
126404367|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
126404368|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
126404369|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
126404370|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
126404371|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
126404372|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
126404373|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
126404374|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
126404375|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
126404376|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
126404377|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
126404378|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
126404379|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
126404380|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
126404381|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
126404382|NCT00121641|454775687|FG000|24-week Short-term Treatment Period|Other Reason|1|||
126404383|NCT00121641|454775688|FG001|24-week Short-term Treatment Period|Other Reason|0|||
126404384|NCT00121641|454775689|FG002|24-week Short-term Treatment Period|Other Reason|0|||
126404385|NCT00121641|454775690|FG003|24-week Short-term Treatment Period|Other Reason|0|||
126404386|NCT00121641|454775691|FG004|24-week Short-term Treatment Period|Other Reason|0|||
126404387|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
126404388|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
126404389|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
126404390|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
126404391|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
126404392|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
126404393|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
126404394|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
126404395|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
126404396|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
126404397|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
126404398|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
126404399|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
126404400|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
126404401|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
126404402|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
126404403|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
126404404|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
126404405|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
126404406|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
126404407|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
126404408|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
126404409|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
126404410|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
126404411|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
126404412|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
126472792|NCT02020577|455030888|FG000|Overall Study|Other than stated above|0|||
126472793|NCT02020577|455030889|FG001|Overall Study|Other than stated above|1|||
126472794|NCT04032652|455030892|FG000|Overall Study|The study was terminated and the PI has|1|||
126472795|NCT04032652|455030893|FG001|Overall Study|The study was terminated and the PI has|1|||
126472796|NCT00761631|455030894|FG000|Overall Study|Parent/legal guardian request|8|||
126472797|NCT00761631|455030895|FG001|Overall Study|Parent/legal guardian request|3|||
126472798|NCT00761631|455030896|FG002|Overall Study|Parent/legal guardian request|8|||
126472799|NCT00761631|455030897|FG003|Overall Study|Parent/legal guardian request|0|||
126472800|NCT00761631|455030898|FG004|Overall Study|Parent/legal guardian request|5|||
126472801|NCT00761631|455030899|FG005|Overall Study|Parent/legal guardian request|0|||
126404413|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
126404414|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
126404415|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
126404416|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
126404417|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
126404418|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
126404419|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
126404420|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
126404421|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
126404422|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
126404423|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
126404424|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
126404425|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
126404426|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
126404427|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Death|0|||
126404428|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Death|0|||
126404429|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Death|0|||
126404430|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Death|1|||
126404431|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Death|0|||
126404432|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Missing|0|||
126404433|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Missing|0|||
126404434|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Missing|1|||
126404435|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Missing|0|||
126404436|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Missing|0|||
126404437|NCT00121641|454775687|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
126404438|NCT00121641|454775688|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
126404439|NCT00121641|454775689|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
126404440|NCT00121641|454775690|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
126404441|NCT00121641|454775691|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
126404442|NCT02356887|454775737|FG000|Overall Study|poor compliance|2|||
126404443|NCT00199888|454775740|FG000|Overall Study|Lost to Follow-up|1|||
126404444|NCT02544373|454775744|FG000|Overall Study|Lost to Follow-up|5|||
126404445|NCT02544373|454775745|FG001|Overall Study|Lost to Follow-up|3|||
126404446|NCT02544373|454775744|FG000|Overall Study|Withdrawal by Subject|8|||
126404447|NCT02544373|454775745|FG001|Overall Study|Withdrawal by Subject|2|||
126404448|NCT03172130|454776729|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
126404449|NCT03172130|454776730|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
126404450|NCT02831933|454776734|FG000|Overall Study|Physician Decision|11|||
126404451|NCT04619004|454776741|FG000|Overall Study|Death|114|||
126404452|NCT04619004|454776742|FG001|Overall Study|Death|28|||
126404453|NCT04619004|454776741|FG000|Overall Study|Lost to Follow-up|1|||
126404454|NCT04619004|454776742|FG001|Overall Study|Lost to Follow-up|1|||
126404455|NCT04619004|454776741|FG000|Overall Study|Withdrawal by Subject|24|||
126404456|NCT04619004|454776742|FG001|Overall Study|Withdrawal by Subject|7|||
126404457|NCT04619004|454776741|FG000|Overall Study|Other - Not specified|0|||
126404458|NCT04619004|454776742|FG001|Overall Study|Other - Not specified|1|||
126404459|NCT05601102|454776744|FG000|Overall Study|Death|1|||
126404460|NCT05601102|454776745|FG001|Overall Study|Death|2|||
126404461|NCT05601102|454776744|FG000|Overall Study|Withdrawal by Subject|1|||
126404462|NCT05601102|454776745|FG001|Overall Study|Withdrawal by Subject|1|||
126404463|NCT05601102|454776744|FG000|Overall Study|Lost to Follow-up|0|||
126404464|NCT05601102|454776745|FG001|Overall Study|Lost to Follow-up|2|||
126404465|NCT02981524|454776747|FG000|Overall Study|Progressive Disease|14|||
126404466|NCT02981524|454776747|FG000|Overall Study|Death (unrelated)|1|||
126404467|NCT02981524|454776747|FG000|Overall Study|Treatment Related Toxicity|1|||
126404468|NCT02981524|454776747|FG000|Overall Study|Withdrawal by Subject|1|||
126404469|NCT00483041|454776748|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
126404470|NCT00483041|454776749|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
126472802|NCT00761631|455030894|FG000|Overall Study|Lost to Follow-up|2|||
126472803|NCT00761631|455030895|FG001|Overall Study|Lost to Follow-up|4|||
126472804|NCT00761631|455030896|FG002|Overall Study|Lost to Follow-up|7|||
126472805|NCT00761631|455030897|FG003|Overall Study|Lost to Follow-up|1|||
126472806|NCT00761631|455030898|FG004|Overall Study|Lost to Follow-up|6|||
126404471|NCT02258529|454776752|FG000|Overall Study|Study Terminated by Sponsor|9|||
126404472|NCT02258529|454776752|FG000|Overall Study|Adverse Event|1|||
126404473|NCT00413010|454776753|FG000|Overall Study|Adverse Event|8|||
126472807|NCT00761631|455030899|FG005|Overall Study|Lost to Follow-up|1|||
126404474|NCT00413010|454776754|FG001|Overall Study|Adverse Event|4|||
126404475|NCT00413010|454776753|FG000|Overall Study|Laboratory abnormality|0|||
126404476|NCT00413010|454776754|FG001|Overall Study|Laboratory abnormality|2|||
126472808|NCT00761631|455030894|FG000|Overall Study|Protocol Violation|2|||
126472809|NCT00761631|455030895|FG001|Overall Study|Protocol Violation|0|||
126404477|NCT00413010|454776753|FG000|Overall Study|Lack of Efficacy|0|||
126404478|NCT00413010|454776754|FG001|Overall Study|Lack of Efficacy|3|||
126404479|NCT00413010|454776753|FG000|Overall Study|Lost to Follow-up|3|||
126404480|NCT00413010|454776754|FG001|Overall Study|Lost to Follow-up|0|||
126404481|NCT00413010|454776753|FG000|Overall Study|Withdrawal by Subject|7|||
126404482|NCT00413010|454776754|FG001|Overall Study|Withdrawal by Subject|2|||
126404483|NCT00413010|454776753|FG000|Overall Study|Due to termination of the study|54|||
126404484|NCT00413010|454776754|FG001|Overall Study|Due to termination of the study|52|||
126404485|NCT00708734|454776757|FG000|Overall Study|scheduling conflict|2|||
126404486|NCT00708734|454776757|FG000|Overall Study|moved|1|||
126404487|NCT00708734|454776757|FG000|Overall Study|leg injury|1|||
126404488|NCT00708734|454776757|FG000|Overall Study|knee replacement|1|||
126404489|NCT00708734|454776757|FG000|Overall Study|vertigo|1|||
126404490|NCT00708734|454776757|FG000|Overall Study|leg fracture|1|||
126404491|NCT05432167|454776758|FG000|Overall Study|Adverse Event|0|||
126404492|NCT05432167|454776759|FG001|Overall Study|Adverse Event|2|||
126404493|NCT05432167|454776760|FG002|Overall Study|Adverse Event|1|||
126404494|NCT05432167|454776758|FG000|Overall Study|Lost to Follow-up|3|||
126404495|NCT05432167|454776759|FG001|Overall Study|Lost to Follow-up|3|||
126404496|NCT05432167|454776760|FG002|Overall Study|Lost to Follow-up|2|||
126404497|NCT05432167|454776758|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
126404498|NCT05432167|454776759|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
126404499|NCT05432167|454776760|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
126404500|NCT05432167|454776758|FG000|Overall Study|Physician Decision|1|||
126404501|NCT05432167|454776759|FG001|Overall Study|Physician Decision|0|||
126404502|NCT05432167|454776760|FG002|Overall Study|Physician Decision|0|||
126404503|NCT05432167|454776758|FG000|Overall Study|Withdrawal by Subject|7|||
126404504|NCT05432167|454776759|FG001|Overall Study|Withdrawal by Subject|4|||
126404505|NCT05432167|454776760|FG002|Overall Study|Withdrawal by Subject|11|||
126404506|NCT05432167|454776758|FG000|Overall Study|Other|0|||
126404507|NCT05432167|454776759|FG001|Overall Study|Other|0|||
126404508|NCT05432167|454776760|FG002|Overall Study|Other|1|||
126404509|NCT01267175|454776762|FG000|Overall Study|Withdrawal by Subject|1|||
126404510|NCT01267175|454776762|FG000|Overall Study|Lost to Follow-up|1|||
126404511|NCT00895661|454776763|FG000|Overall Study|Death|1|||
126404512|NCT00895661|454776763|FG000|Overall Study|reason unknown|2|||
126404513|NCT04094584|454776766|FG000|Overall Study|No interest in study|88|||
126404514|NCT04094584|454776766|FG000|Overall Study|Unwilling to undergo screening tests|36|||
126404515|NCT04094584|454776766|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
126404516|NCT04094584|454776766|FG000|Overall Study|Opioid use|7|||
126404517|NCT04094584|454776766|FG000|Overall Study|Need for major surgery in study period|4|||
126404518|NCT04094584|454776766|FG000|Overall Study|eligible but declined enrollment|4|||
126404519|NCT04094584|454776766|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
126404520|NCT04094584|454776766|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
126404521|NCT04094584|454776766|FG000|Overall Study|Lost to Follow-up|3|||
126404522|NCT04094584|454776766|FG000|Overall Study|Withdrawal by Subject|2|||
126404523|NCT02690649|454776767|FG000|Overall Study|Withdrawal by Subject|1|||
126404524|NCT02690649|454776768|FG001|Overall Study|Withdrawal by Subject|1|||
126404525|NCT02690649|454776767|FG000|Overall Study|Protocol Violation|0|||
126404526|NCT02690649|454776768|FG001|Overall Study|Protocol Violation|3|||
126404527|NCT00907296|454776769|FG000|Overall Study|Ineligibility Determined|1|||
126404528|NCT00907296|454776770|FG001|Overall Study|Ineligibility Determined|0|||
126472810|NCT00761631|455030896|FG002|Overall Study|Protocol Violation|0|||
126472811|NCT00761631|455030897|FG003|Overall Study|Protocol Violation|1|||
126472812|NCT00761631|455030898|FG004|Overall Study|Protocol Violation|5|||
126472813|NCT00761631|455030899|FG005|Overall Study|Protocol Violation|1|||
126404529|NCT00907296|454776771|FG002|Overall Study|Ineligibility Determined|0|||
126404530|NCT00907296|454776772|FG003|Overall Study|Ineligibility Determined|1|||
126404531|NCT00907296|454776773|FG004|Overall Study|Ineligibility Determined|0|||
126404532|NCT00907296|454776774|FG005|Overall Study|Ineligibility Determined|0|||
126404533|NCT00907296|454776775|FG006|Overall Study|Ineligibility Determined|0|||
126404534|NCT00907296|454776776|FG007|Overall Study|Ineligibility Determined|1|||
126404535|NCT00907296|454776777|FG008|Overall Study|Ineligibility Determined|0|||
126404536|NCT00907296|454776778|FG009|Overall Study|Ineligibility Determined|0|||
126472814|NCT00761631|455030894|FG000|Overall Study|Randomized, not treated|1|||
126472815|NCT00761631|455030895|FG001|Overall Study|Randomized, not treated|0|||
126472816|NCT00761631|455030896|FG002|Overall Study|Randomized, not treated|0|||
126472817|NCT00761631|455030897|FG003|Overall Study|Randomized, not treated|0|||
126472818|NCT00761631|455030898|FG004|Overall Study|Randomized, not treated|0|||
126472819|NCT00761631|455030899|FG005|Overall Study|Randomized, not treated|0|||
126472820|NCT00761631|455030894|FG000|Overall Study|Failed to return|1|||
126472821|NCT00761631|455030895|FG001|Overall Study|Failed to return|0|||
126472822|NCT00761631|455030896|FG002|Overall Study|Failed to return|1|||
126472823|NCT00761631|455030897|FG003|Overall Study|Failed to return|1|||
126472824|NCT00761631|455030898|FG004|Overall Study|Failed to return|5|||
126472825|NCT00761631|455030899|FG005|Overall Study|Failed to return|2|||
126472826|NCT00761631|455030894|FG000|Overall Study|Physician Decision|1|||
126472827|NCT00761631|455030895|FG001|Overall Study|Physician Decision|0|||
126472828|NCT00761631|455030896|FG002|Overall Study|Physician Decision|0|||
126472829|NCT00761631|455030897|FG003|Overall Study|Physician Decision|0|||
126472830|NCT00761631|455030898|FG004|Overall Study|Physician Decision|0|||
126472831|NCT00761631|455030899|FG005|Overall Study|Physician Decision|0|||
126472832|NCT00761631|455030894|FG000|Overall Study|Other|0|||
126472833|NCT00761631|455030895|FG001|Overall Study|Other|0|||
126472834|NCT00761631|455030896|FG002|Overall Study|Other|0|||
126472835|NCT00761631|455030897|FG003|Overall Study|Other|0|||
126472836|NCT00761631|455030898|FG004|Overall Study|Other|1|||
126472837|NCT00761631|455030899|FG005|Overall Study|Other|1|||
126472838|NCT01863953|455032168|FG000|Overall Study|Adverse Event|0|||
126472839|NCT01863953|455032169|FG001|Overall Study|Adverse Event|0|||
126472840|NCT01863953|455032170|FG002|Overall Study|Adverse Event|1|||
126472841|NCT01824342|455032172|FG000|Overall Study|Withdrawal by Subject|0|||
126472842|NCT01824342|455032173|FG001|Overall Study|Withdrawal by Subject|3|||
126472843|NCT01824342|455032172|FG000|Overall Study|Adverse Event|1|||
126472844|NCT01824342|455032173|FG001|Overall Study|Adverse Event|1|||
126472845|NCT01824342|455032172|FG000|Overall Study|Disease Progression|1|||
126472846|NCT01824342|455032173|FG001|Overall Study|Disease Progression|1|||
126472847|NCT01824342|455032172|FG000|Overall Study|Physician Decision|5|||
126472848|NCT01824342|455032173|FG001|Overall Study|Physician Decision|0|||
126472849|NCT01824342|455032172|FG000|Overall Study|Death|2|||
126472850|NCT01824342|455032173|FG001|Overall Study|Death|0|||
126472851|NCT01313858|455032174|FG000|Overall Study|Premature Treatment Termination|251|||
126472852|NCT01313858|455032175|FG001|Overall Study|Premature Treatment Termination|219|||
126472853|NCT01313858|455032176|FG002|Overall Study|Premature Treatment Termination|191|||
126404537|NCT00907296|454776769|FG000|Overall Study|Protocol Deviation|0|||
126404538|NCT00907296|454776770|FG001|Overall Study|Protocol Deviation|1|||
126404539|NCT00907296|454776771|FG002|Overall Study|Protocol Deviation|0|||
126404540|NCT00907296|454776772|FG003|Overall Study|Protocol Deviation|0|||
126404541|NCT00907296|454776773|FG004|Overall Study|Protocol Deviation|0|||
126404542|NCT00907296|454776774|FG005|Overall Study|Protocol Deviation|0|||
126404543|NCT00907296|454776775|FG006|Overall Study|Protocol Deviation|0|||
126404544|NCT00907296|454776776|FG007|Overall Study|Protocol Deviation|0|||
126404545|NCT00907296|454776777|FG008|Overall Study|Protocol Deviation|0|||
126404546|NCT00907296|454776778|FG009|Overall Study|Protocol Deviation|0|||
126404547|NCT00907296|454776769|FG000|Overall Study|Noncompliance|1|||
126404548|NCT00907296|454776770|FG001|Overall Study|Noncompliance|1|||
126404549|NCT00907296|454776771|FG002|Overall Study|Noncompliance|1|||
126404550|NCT00907296|454776772|FG003|Overall Study|Noncompliance|0|||
126404551|NCT00907296|454776773|FG004|Overall Study|Noncompliance|0|||
126404552|NCT00907296|454776774|FG005|Overall Study|Noncompliance|1|||
126404553|NCT00907296|454776775|FG006|Overall Study|Noncompliance|0|||
126404554|NCT00907296|454776776|FG007|Overall Study|Noncompliance|2|||
126404555|NCT00907296|454776777|FG008|Overall Study|Noncompliance|0|||
126404556|NCT00907296|454776778|FG009|Overall Study|Noncompliance|0|||
126404557|NCT00907296|454776769|FG000|Overall Study|Adverse Event|2|||
126404558|NCT00907296|454776770|FG001|Overall Study|Adverse Event|0|||
126404559|NCT00907296|454776771|FG002|Overall Study|Adverse Event|0|||
126404560|NCT00907296|454776772|FG003|Overall Study|Adverse Event|0|||
126472854|NCT01313858|455032174|FG000|Overall Study|Lost to Follow-up|35|||
126472855|NCT01313858|455032175|FG001|Overall Study|Lost to Follow-up|51|||
126472856|NCT01313858|455032176|FG002|Overall Study|Lost to Follow-up|47|||
126472857|NCT01200524|455032188|FG000|Overall Study|Withdrawal by Subject|1|||
126472858|NCT01200524|455032189|FG001|Overall Study|Withdrawal by Subject|1|||
126472859|NCT01200524|455032190|FG002|Overall Study|Withdrawal by Subject|3|||
126472860|NCT01200524|455032188|FG000|Overall Study|Adverse Event|1|||
126472861|NCT01200524|455032189|FG001|Overall Study|Adverse Event|0|||
126472862|NCT01200524|455032190|FG002|Overall Study|Adverse Event|0|||
126557793|NCT01723826|455334476|FG003|Overall Study|Physician Decision|11|||
126472863|NCT01200524|455032188|FG000|Overall Study|Non availability of study nurse|0|||
126472864|NCT01200524|455032189|FG001|Overall Study|Non availability of study nurse|0|||
126557794|NCT01723826|455334473|FG000|Overall Study|Protocol Violation|1|||
126404561|NCT00907296|454776773|FG004|Overall Study|Adverse Event|0|||
126404562|NCT00907296|454776774|FG005|Overall Study|Adverse Event|0|||
126404563|NCT00907296|454776775|FG006|Overall Study|Adverse Event|1|||
126404564|NCT00907296|454776776|FG007|Overall Study|Adverse Event|0|||
126472865|NCT01200524|455032190|FG002|Overall Study|Non availability of study nurse|1|||
126472866|NCT01303861|455032191|FG000|Overall Study|Lost to Follow-up|34|||
126472867|NCT01303861|455032192|FG001|Overall Study|Lost to Follow-up|14|||
126472868|NCT01303861|455032193|FG002|Overall Study|Lost to Follow-up|27|||
126472869|NCT01303861|455032194|FG003|Overall Study|Lost to Follow-up|31|||
126557795|NCT01723826|455334474|FG001|Overall Study|Protocol Violation|1|||
126404565|NCT00907296|454776777|FG008|Overall Study|Adverse Event|0|||
126472870|NCT01303861|455032191|FG000|Overall Study|Lack of Efficacy|3|||
126472871|NCT01303861|455032192|FG001|Overall Study|Lack of Efficacy|2|||
126472872|NCT01303861|455032193|FG002|Overall Study|Lack of Efficacy|1|||
126472873|NCT01303861|455032194|FG003|Overall Study|Lack of Efficacy|0|||
126404566|NCT00907296|454776778|FG009|Overall Study|Adverse Event|1|||
126404567|NCT00907296|454776769|FG000|Overall Study|Withdrawal by Subject|7|||
126404568|NCT00907296|454776770|FG001|Overall Study|Withdrawal by Subject|2|||
126404569|NCT00907296|454776771|FG002|Overall Study|Withdrawal by Subject|1|||
126404570|NCT00907296|454776772|FG003|Overall Study|Withdrawal by Subject|1|||
126404571|NCT00907296|454776773|FG004|Overall Study|Withdrawal by Subject|1|||
126404572|NCT00907296|454776774|FG005|Overall Study|Withdrawal by Subject|5|||
126404573|NCT00907296|454776775|FG006|Overall Study|Withdrawal by Subject|3|||
126404574|NCT00907296|454776776|FG007|Overall Study|Withdrawal by Subject|2|||
126404575|NCT00907296|454776777|FG008|Overall Study|Withdrawal by Subject|4|||
126404576|NCT00907296|454776778|FG009|Overall Study|Withdrawal by Subject|2|||
126404577|NCT00907296|454776769|FG000|Overall Study|Lost to Follow-up|9|||
126404578|NCT00907296|454776770|FG001|Overall Study|Lost to Follow-up|1|||
126404579|NCT00907296|454776771|FG002|Overall Study|Lost to Follow-up|0|||
126404580|NCT00907296|454776772|FG003|Overall Study|Lost to Follow-up|2|||
126404581|NCT00907296|454776773|FG004|Overall Study|Lost to Follow-up|0|||
126404582|NCT00907296|454776774|FG005|Overall Study|Lost to Follow-up|3|||
126404583|NCT00907296|454776775|FG006|Overall Study|Lost to Follow-up|2|||
126404584|NCT00907296|454776776|FG007|Overall Study|Lost to Follow-up|2|||
126404585|NCT00907296|454776777|FG008|Overall Study|Lost to Follow-up|0|||
126404586|NCT00907296|454776778|FG009|Overall Study|Lost to Follow-up|4|||
126404587|NCT00791557|454776779|FG000|Overall Study|Adverse Event|1|||
126404588|NCT04135859|454776782|FG000|Overall Study|Withdrawal by Subject|1|||
126404589|NCT04135859|454776783|FG001|Overall Study|Withdrawal by Subject|0|||
126404590|NCT04135859|454776782|FG000|Overall Study|Withdrawal due to screening failure|1|||
126404591|NCT04135859|454776783|FG001|Overall Study|Withdrawal due to screening failure|2|||
126404592|NCT04135859|454776782|FG000|Overall Study|Did not complete stress test|3|||
126472874|NCT01303861|455032191|FG000|Overall Study|Withdrawal by Subject|16|||
126472875|NCT01303861|455032192|FG001|Overall Study|Withdrawal by Subject|8|||
126472876|NCT01303861|455032193|FG002|Overall Study|Withdrawal by Subject|8|||
126472877|NCT01303861|455032194|FG003|Overall Study|Withdrawal by Subject|23|||
126472878|NCT01303861|455032191|FG000|Overall Study|Adverse Event|4|||
126472879|NCT01303861|455032192|FG001|Overall Study|Adverse Event|1|||
126472880|NCT01303861|455032193|FG002|Overall Study|Adverse Event|0|||
126472881|NCT01303861|455032194|FG003|Overall Study|Adverse Event|5|||
126472882|NCT01303861|455032191|FG000|Overall Study|Pregnancy|1|||
126557796|NCT01723826|455334475|FG002|Overall Study|Protocol Violation|3|||
126557797|NCT01723826|455334476|FG003|Overall Study|Protocol Violation|1|||
126557798|NCT01723826|455334473|FG000|Overall Study|Withdrawal by Subject|10|||
126557799|NCT01723826|455334474|FG001|Overall Study|Withdrawal by Subject|17|||
126557800|NCT01723826|455334475|FG002|Overall Study|Withdrawal by Subject|27|||
126557801|NCT01723826|455334476|FG003|Overall Study|Withdrawal by Subject|48|||
126557802|NCT03023332|455334477|FG000|Overall Study|Withdrawal by Subject|10|||
126557803|NCT03023332|455334478|FG001|Overall Study|Withdrawal by Subject|5|||
126557804|NCT03023332|455334479|FG002|Overall Study|Withdrawal by Subject|4|||
126557805|NCT03023332|455334480|FG003|Overall Study|Withdrawal by Subject|7|||
126557806|NCT03023332|455334477|FG000|Overall Study|Lost to Follow-up|13|||
126557807|NCT03023332|455334478|FG001|Overall Study|Lost to Follow-up|16|||
126557808|NCT03023332|455334479|FG002|Overall Study|Lost to Follow-up|8|||
126557809|NCT03023332|455334480|FG003|Overall Study|Lost to Follow-up|13|||
126557810|NCT03023332|455334477|FG000|Overall Study|Death|1|||
126557811|NCT03023332|455334478|FG001|Overall Study|Death|0|||
126557812|NCT03023332|455334479|FG002|Overall Study|Death|0|||
126557813|NCT03023332|455334480|FG003|Overall Study|Death|0|||
126557814|NCT01818700|455334481|FG000|Overall Study|Adverse Event|67|||
126557815|NCT01818700|455334481|FG000|Overall Study|Lack of Efficacy|2|||
126557816|NCT01818700|455334481|FG000|Overall Study|Lost to Follow-up|5|||
126557817|NCT01818700|455334481|FG000|Overall Study|Withdrawal by Subject|27|||
126557818|NCT01818700|455334481|FG000|Overall Study|Protocol Violation|2|||
126557819|NCT01818700|455334481|FG000|Overall Study|Other|1|||
126557820|NCT02408549|455334484|FG000|Overall Study|Adverse Event|15|||
126557821|NCT02408549|455334484|FG000|Overall Study|Death|4|||
126404593|NCT04135859|454776783|FG001|Overall Study|Did not complete stress test|3|||
126472883|NCT01303861|455032192|FG001|Overall Study|Pregnancy|0|||
126557822|NCT02408549|455334484|FG000|Overall Study|Lack of Efficacy|17|||
126557823|NCT02408549|455334484|FG000|Overall Study|Protocol Violation|4|||
126557824|NCT02408549|455334484|FG000|Overall Study|Lost to Follow-up|6|||
126557825|NCT02408549|455334484|FG000|Overall Study|Consent withdrawn|30|||
126557826|NCT02408549|455334484|FG000|Overall Study|Neurology research program closing at site|1|||
126557827|NCT02408549|455334484|FG000|Overall Study|Site closure|1|||
126557828|NCT02408549|455334484|FG000|Overall Study|Pregnancy|1|||
126404594|NCT04135859|454776782|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
126472884|NCT01303861|455032193|FG002|Overall Study|Pregnancy|0|||
126557829|NCT02408549|455334484|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
126557830|NCT02408549|455334484|FG000|Overall Study|Subject moved to another place, far from site|1|||
126557831|NCT02408549|455334484|FG000|Overall Study|Study terminated at site|1|||
126557832|NCT01272011|455334485|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
126472885|NCT01303861|455032194|FG003|Overall Study|Pregnancy|0|||
126404595|NCT04135859|454776783|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
126404596|NCT03242018|454776784|FG000|Overall Study|Adverse Event|7|||
126404597|NCT03242018|454776785|FG001|Overall Study|Adverse Event|7|||
126404598|NCT03242018|454776786|FG002|Overall Study|Adverse Event|6|||
126404599|NCT03242018|454776784|FG000|Overall Study|Lost to Follow-up|2|||
126404600|NCT03242018|454776785|FG001|Overall Study|Lost to Follow-up|2|||
126404601|NCT03242018|454776786|FG002|Overall Study|Lost to Follow-up|2|||
126404602|NCT03242018|454776784|FG000|Overall Study|At the Participant's Own Request|5|||
126404603|NCT03242018|454776785|FG001|Overall Study|At the Participant's Own Request|1|||
126404604|NCT03242018|454776786|FG002|Overall Study|At the Participant's Own Request|4|||
126404605|NCT03242018|454776784|FG000|Overall Study|Reason Not Specified|3|||
126404606|NCT03242018|454776785|FG001|Overall Study|Reason Not Specified|4|||
126404607|NCT03242018|454776786|FG002|Overall Study|Reason Not Specified|1|||
126404608|NCT03242018|454776784|FG000|Overall Study|Study Terminated by Sponsor|1|||
126404609|NCT03242018|454776785|FG001|Overall Study|Study Terminated by Sponsor|0|||
126404610|NCT03242018|454776786|FG002|Overall Study|Study Terminated by Sponsor|1|||
126404611|NCT03262116|454776787|FG000|Overall Study|Physician Decision|0|||
126404612|NCT03262116|454776788|FG001|Overall Study|Physician Decision|2|||
126404613|NCT03262116|454776789|FG002|Overall Study|Physician Decision|1|||
126404614|NCT03262116|454776790|FG003|Overall Study|Physician Decision|1|||
126404615|NCT03262116|454776791|FG004|Overall Study|Physician Decision|1|||
126404616|NCT03262116|454776792|FG005|Overall Study|Physician Decision|2|||
126404617|NCT02365285|454776793|FG000|Overall Study|Physician Decision|0|||
126404618|NCT02365285|454776794|FG001|Overall Study|Physician Decision|1|||
126404619|NCT02365285|454776795|FG002|Overall Study|Physician Decision|1|||
126404620|NCT02365285|454776796|FG003|Overall Study|Physician Decision|0|||
126404621|NCT02365285|454776793|FG000|Overall Study|Adverse Event|0|||
126404622|NCT02365285|454776794|FG001|Overall Study|Adverse Event|0|||
126404623|NCT02365285|454776795|FG002|Overall Study|Adverse Event|0|||
126404624|NCT02365285|454776796|FG003|Overall Study|Adverse Event|2|||
126404625|NCT02608450|454776799|FG000|Overall Study|Lost to Follow-up|39|||
126404626|NCT02608450|454776800|FG001|Overall Study|Lost to Follow-up|32|||
126404627|NCT02608450|454776799|FG000|Overall Study|Withdrawal by Subject|21|||
126404628|NCT02608450|454776800|FG001|Overall Study|Withdrawal by Subject|15|||
126404629|NCT02608450|454776799|FG000|Overall Study|Adverse Event|3|||
126404630|NCT02608450|454776800|FG001|Overall Study|Adverse Event|6|||
126404631|NCT02608450|454776799|FG000|Overall Study|Withdrawal by parent|2|||
126404632|NCT02608450|454776800|FG001|Overall Study|Withdrawal by parent|3|||
126404633|NCT02608450|454776799|FG000|Overall Study|Lack of Efficacy|0|||
126404634|NCT02608450|454776800|FG001|Overall Study|Lack of Efficacy|3|||
126404635|NCT02608450|454776799|FG000|Overall Study|Noncompliance with study drug|0|||
126404636|NCT02608450|454776800|FG001|Overall Study|Noncompliance with study drug|2|||
126404637|NCT02608450|454776799|FG000|Overall Study|Physician Decision|0|||
126404638|NCT02608450|454776800|FG001|Overall Study|Physician Decision|1|||
126404639|NCT02608450|454776799|FG000|Overall Study|Pregnancy|0|||
126404640|NCT02608450|454776800|FG001|Overall Study|Pregnancy|1|||
126404641|NCT02608450|454776799|FG000|Overall Study|Progressive disease|1|||
126404642|NCT02608450|454776800|FG001|Overall Study|Progressive disease|0|||
126557833|NCT01272011|455334486|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
126557834|NCT01272011|455334487|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
126557835|NCT02013687|455334488|FG000|Overall Study|Lost to Follow-up|0|||
126557836|NCT02013687|455334489|FG001|Overall Study|Lost to Follow-up|0|||
126557837|NCT02013687|455334490|FG002|Overall Study|Lost to Follow-up|1|||
126557838|NCT02013687|455334491|FG003|Overall Study|Lost to Follow-up|0|||
126557839|NCT02013687|455334488|FG000|Overall Study|Protocol Violation|0|||
126557840|NCT02013687|455334489|FG001|Overall Study|Protocol Violation|0|||
126557841|NCT02013687|455334490|FG002|Overall Study|Protocol Violation|0|||
126557842|NCT02013687|455334491|FG003|Overall Study|Protocol Violation|1|||
126557843|NCT02013687|455334488|FG000|Overall Study|Withdrawal by Subject|0|||
126557844|NCT02013687|455334489|FG001|Overall Study|Withdrawal by Subject|0|||
126557845|NCT02013687|455334490|FG002|Overall Study|Withdrawal by Subject|0|||
126557846|NCT02013687|455334491|FG003|Overall Study|Withdrawal by Subject|1|||
126557847|NCT02013687|455334488|FG000|Overall Study|Missed visits due to patient travel|0|||
126404643|NCT02608450|454776799|FG000|Overall Study|Multiple reasons|0|||
126557848|NCT02013687|455334489|FG001|Overall Study|Missed visits due to patient travel|0|||
126404644|NCT02608450|454776800|FG001|Overall Study|Multiple reasons|2|||
126404645|NCT02636946|454776801|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
126404646|NCT02636946|454776802|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
126404647|NCT02636946|454776801|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
126404648|NCT02636946|454776802|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
126404649|NCT02636946|454776801|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
126404650|NCT02636946|454776802|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
126404651|NCT02636946|454776801|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
126404652|NCT02636946|454776802|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
126557849|NCT02013687|455334490|FG002|Overall Study|Missed visits due to patient travel|1|||
126557850|NCT02013687|455334491|FG003|Overall Study|Missed visits due to patient travel|0|||
126557851|NCT01627340|455334492|FG000|Overall Study|Adverse Event|1|||
126557852|NCT01627340|455334493|FG001|Overall Study|Adverse Event|0|||
126557853|NCT01627340|455334492|FG000|Overall Study|Lost to Follow-up|8|||
126557854|NCT01627340|455334493|FG001|Overall Study|Lost to Follow-up|4|||
126557855|NCT01627340|455334492|FG000|Overall Study|Pregnancy|1|||
126557856|NCT01627340|455334493|FG001|Overall Study|Pregnancy|0|||
126557857|NCT01627340|455334492|FG000|Overall Study|Withdrawal by Subject|2|||
126557858|NCT01627340|455334493|FG001|Overall Study|Withdrawal by Subject|0|||
126557859|NCT01657032|455334494|FG000|Overall Study|Lost to Follow-up|0|||
126557860|NCT01657032|455334495|FG001|Overall Study|Lost to Follow-up|7|||
126557861|NCT03633903|455334496|FG000|Overall Study|Withdrawal by Subject|1|||
126557862|NCT03633903|455334497|FG001|Overall Study|Withdrawal by Subject|2|||
126557863|NCT03633903|455334496|FG000|Overall Study|Lost to Follow-up|5|||
126404653|NCT02636946|454776801|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
126404654|NCT02636946|454776802|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
126404655|NCT02636946|454776801|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
126404656|NCT02636946|454776802|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
126404657|NCT00477269|454776803|FG000|Core Study|Adverse Event|6|||
126404658|NCT00477269|454776804|FG001|Core Study|Adverse Event|4|||
126404659|NCT00477269|454776805|FG002|Core Study|Adverse Event|0|||
126404660|NCT00477269|454776803|FG000|Core Study|Death|3|||
126404661|NCT00477269|454776804|FG001|Core Study|Death|3|||
126404662|NCT00477269|454776805|FG002|Core Study|Death|0|||
126404663|NCT00477269|454776803|FG000|Core Study|Withdrawn Consent|0|||
126404664|NCT00477269|454776804|FG001|Core Study|Withdrawn Consent|1|||
126404665|NCT00477269|454776805|FG002|Core Study|Withdrawn Consent|0|||
126404666|NCT00477269|454776803|FG000|Open Label Extension|Adverse Event|0|||
126404667|NCT00477269|454776804|FG001|Open Label Extension|Adverse Event|0|||
126404668|NCT00477269|454776805|FG002|Open Label Extension|Adverse Event|4|||
126721221|NCT03255291|455928605|FG003|Overall Study|Determined to be ineligible|6|||
126721222|NCT03255291|455928606|FG004|Overall Study|Determined to be ineligible|5|||
126404669|NCT00477269|454776803|FG000|Open Label Extension|Abnormal laboratory values|0|||
126404670|NCT00477269|454776804|FG001|Open Label Extension|Abnormal laboratory values|0|||
126404671|NCT00477269|454776805|FG002|Open Label Extension|Abnormal laboratory values|1|||
126404672|NCT00477269|454776803|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
126404673|NCT00477269|454776804|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
126404674|NCT00477269|454776805|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
126404675|NCT00477269|454776803|FG000|Open Label Extension|Adminiatrative problems|0|||
126404676|NCT00477269|454776804|FG001|Open Label Extension|Adminiatrative problems|0|||
126404677|NCT00477269|454776805|FG002|Open Label Extension|Adminiatrative problems|2|||
126404678|NCT00477269|454776803|FG000|Open Label Extension|Death|0|||
126404679|NCT00477269|454776804|FG001|Open Label Extension|Death|0|||
126404680|NCT00477269|454776805|FG002|Open Label Extension|Death|4|||
126404681|NCT01792518|454776806|FG000|Overall Study|Adverse Event|3|||
126404682|NCT01792518|454776807|FG001|Overall Study|Adverse Event|4|||
126404683|NCT01792518|454776806|FG000|Overall Study|Protocol Violation|0|||
126404684|NCT01792518|454776807|FG001|Overall Study|Protocol Violation|1|||
126404685|NCT01792518|454776806|FG000|Overall Study|Lost to Follow-up|3|||
126404686|NCT01792518|454776807|FG001|Overall Study|Lost to Follow-up|1|||
126404687|NCT01792518|454776806|FG000|Overall Study|Withdrawal by Subject|2|||
126404688|NCT01792518|454776807|FG001|Overall Study|Withdrawal by Subject|0|||
126404689|NCT01792518|454776806|FG000|Overall Study|Other Reason|0|||
126404690|NCT01792518|454776807|FG001|Overall Study|Other Reason|1|||
126404691|NCT00249613|454776811|FG000|12 Month Follow-up|Death|1|||
126404692|NCT00249613|454776812|FG001|12 Month Follow-up|Death|1|||
126404693|NCT00249613|454776811|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
126721223|NCT03255291|455928607|FG005|Overall Study|Determined to be ineligible|10|||
126721224|NCT03255291|455928602|FG000|Overall Study|Baseline data collection issues|3|||
126721225|NCT03255291|455928603|FG001|Overall Study|Baseline data collection issues|0|||
126721226|NCT03255291|455928604|FG002|Overall Study|Baseline data collection issues|0|||
126404694|NCT00249613|454776812|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
126404695|NCT00249613|454776811|FG000|12 Month Follow-up|Lost to Follow-up|10|||
126404696|NCT00249613|454776812|FG001|12 Month Follow-up|Lost to Follow-up|8|||
126404697|NCT00806442|454776814|FG000|Overall Study|Lost to Follow-up|3|||
126404698|NCT00806442|454776815|FG001|Overall Study|Lost to Follow-up|2|||
126404699|NCT00806442|454776814|FG000|Overall Study|Withdrawal by Subject|1|||
126404700|NCT00806442|454776815|FG001|Overall Study|Withdrawal by Subject|5|||
126404701|NCT00654004|454776816|FG000|Overall Study|Lost to Follow-up|1|||
126404702|NCT00654004|454776817|FG001|Overall Study|Lost to Follow-up|0|||
126404703|NCT01264770|454776818|FG000|Overall Study|Not reported|0|||
126404704|NCT01264770|454776819|FG001|Overall Study|Not reported|0|||
126404705|NCT01264770|454776820|FG002|Overall Study|Not reported|1|||
126404706|NCT01264770|454776821|FG003|Overall Study|Not reported|0|||
126404707|NCT01264770|454776822|FG004|Overall Study|Not reported|0|||
126404708|NCT01264770|454776823|FG005|Overall Study|Not reported|0|||
126404709|NCT01264770|454776818|FG000|Overall Study|e.g., change in circumstances|8|||
126404710|NCT01264770|454776819|FG001|Overall Study|e.g., change in circumstances|3|||
126557864|NCT03633903|455334497|FG001|Overall Study|Lost to Follow-up|5|||
126472886|NCT02476201|455032198|FG000|Overall Study|Unable to program MPP|9|||
126472887|NCT02476201|455032198|FG000|Overall Study|Study echo not performed|5|||
126472888|NCT02476201|455032198|FG000|Overall Study|Adverse Event|4|||
126472889|NCT02476201|455032198|FG000|Overall Study|Death|2|||
126472890|NCT02476201|455032198|FG000|Overall Study|Lost to Follow-up|2|||
126472891|NCT02476201|455032198|FG000|Overall Study|MPP programmed to OFF|2|||
126472892|NCT02476201|455032198|FG000|Overall Study|Withdrawal by Subject|1|||
126472893|NCT02476201|455032198|FG000|Overall Study|Unsuccessful implant|1|||
126472894|NCT03840174|455032203|FG000|Overall Study|Withdrawal by Subject|1|||
126472895|NCT03840174|455032204|FG001|Overall Study|Withdrawal by Subject|0|||
126472896|NCT03840174|455032205|FG002|Overall Study|Withdrawal by Subject|0|||
126472897|NCT03840174|455032206|FG003|Overall Study|Withdrawal by Subject|0|||
126472898|NCT00131508|455032209|FG000|Overall Study|Disease progression|0|||
126472899|NCT00131508|455032210|FG001|Overall Study|Disease progression|2|||
126472900|NCT00131508|455032209|FG000|Overall Study|Non-Compliance|2|||
126472901|NCT00131508|455032210|FG001|Overall Study|Non-Compliance|4|||
126472902|NCT00131508|455032209|FG000|Overall Study|Withdrawal by Subject|1|||
126472903|NCT00131508|455032210|FG001|Overall Study|Withdrawal by Subject|2|||
126472904|NCT01268150|455032220|FG000|Treatment Phase|Progression of disease|18|||
126472905|NCT01268150|455032220|FG000|Treatment Phase|Adverse Event|3|||
126472906|NCT01268150|455032220|FG000|Treatment Phase|Withdrawal by Subject|3|||
126472907|NCT01268150|455032220|FG000|Treatment Phase|Other|4|||
126472908|NCT01268150|455032220|FG000|Extension Phase|Adverse Event|3|||
126472909|NCT01268150|455032220|FG000|Extension Phase|Disease progression|18|||
126472910|NCT01268150|455032220|FG000|Extension Phase|Other|6|||
126472911|NCT03725852|455032221|FG000|Overall Study|Death|1|||
126472912|NCT03725852|455032222|FG001|Overall Study|Death|0|||
126472913|NCT03725852|455032221|FG000|Overall Study|Withdrawal by Subject|1|||
126472914|NCT03725852|455032222|FG001|Overall Study|Withdrawal by Subject|0|||
126472915|NCT03725852|455032221|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
126472916|NCT03725852|455032222|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
126721227|NCT03255291|455928605|FG003|Overall Study|Baseline data collection issues|0|||
126721228|NCT03255291|455928606|FG004|Overall Study|Baseline data collection issues|2|||
126721229|NCT03255291|455928607|FG005|Overall Study|Baseline data collection issues|0|||
126721230|NCT01745393|455928612|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
126721231|NCT01745393|455928613|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
126721232|NCT01745393|455928612|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
126721233|NCT01745393|455928613|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
126404711|NCT01264770|454776820|FG002|Overall Study|e.g., change in circumstances|3|||
126404712|NCT01264770|454776821|FG003|Overall Study|e.g., change in circumstances|3|||
126404713|NCT01264770|454776822|FG004|Overall Study|e.g., change in circumstances|4|||
126404714|NCT01264770|454776823|FG005|Overall Study|e.g., change in circumstances|4|||
126404715|NCT01264770|454776818|FG000|Overall Study|Severe non-compliance to protocol|0|||
126404716|NCT01264770|454776819|FG001|Overall Study|Severe non-compliance to protocol|0|||
126404717|NCT01264770|454776820|FG002|Overall Study|Severe non-compliance to protocol|1|||
126404718|NCT01264770|454776821|FG003|Overall Study|Severe non-compliance to protocol|1|||
126404719|NCT01264770|454776822|FG004|Overall Study|Severe non-compliance to protocol|0|||
126404720|NCT01264770|454776823|FG005|Overall Study|Severe non-compliance to protocol|0|||
126404721|NCT01264770|454776818|FG000|Overall Study|Lack of therapeutic response|1|||
126404722|NCT01264770|454776819|FG001|Overall Study|Lack of therapeutic response|0|||
126404723|NCT01264770|454776820|FG002|Overall Study|Lack of therapeutic response|2|||
126404724|NCT01264770|454776821|FG003|Overall Study|Lack of therapeutic response|1|||
126404725|NCT01264770|454776822|FG004|Overall Study|Lack of therapeutic response|1|||
126404726|NCT01264770|454776823|FG005|Overall Study|Lack of therapeutic response|0|||
126404727|NCT01264770|454776818|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
126404728|NCT01264770|454776819|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
126404729|NCT01264770|454776820|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
126404730|NCT01264770|454776821|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
126404731|NCT01264770|454776822|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
126404732|NCT01264770|454776823|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
126404733|NCT01264770|454776818|FG000|Overall Study|Lost to Follow-up|0|||
126404734|NCT01264770|454776819|FG001|Overall Study|Lost to Follow-up|0|||
126404735|NCT01264770|454776820|FG002|Overall Study|Lost to Follow-up|1|||
126404736|NCT01264770|454776821|FG003|Overall Study|Lost to Follow-up|1|||
126472917|NCT04738734|455032224|FG000|Overall Study|Withdrawal by Subject|2|||
126472918|NCT04738734|455032225|FG001|Overall Study|Withdrawal by Subject|4|||
126472919|NCT04738734|455032224|FG000|Overall Study|Lost to Follow-up|5|||
126472920|NCT04738734|455032225|FG001|Overall Study|Lost to Follow-up|2|||
126472921|NCT04738734|455032224|FG000|Overall Study|Physician Decision|0|||
126472922|NCT04738734|455032225|FG001|Overall Study|Physician Decision|1|||
126557865|NCT05968482|455334498|FG000|First Crossover Period|Withdrawal by Subject|0|||
126472923|NCT04738734|455032224|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
126472924|NCT04738734|455032225|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
126404737|NCT01264770|454776822|FG004|Overall Study|Lost to Follow-up|0|||
126404738|NCT01264770|454776823|FG005|Overall Study|Lost to Follow-up|0|||
126404739|NCT01264770|454776818|FG000|Overall Study|Adverse Event|7|||
126404740|NCT01264770|454776819|FG001|Overall Study|Adverse Event|7|||
126404741|NCT01264770|454776820|FG002|Overall Study|Adverse Event|8|||
126404742|NCT01264770|454776821|FG003|Overall Study|Adverse Event|0|||
126404743|NCT01264770|454776822|FG004|Overall Study|Adverse Event|2|||
126404744|NCT01264770|454776823|FG005|Overall Study|Adverse Event|1|||
126404745|NCT00424190|454776825|FG000|Overall Study|Withdrew consent|3|||
126404746|NCT00424190|454776826|FG001|Overall Study|Withdrew consent|4|||
126404747|NCT00424190|454776825|FG000|Overall Study|Death|3|||
126404748|NCT00424190|454776826|FG001|Overall Study|Death|0|||
126404749|NCT00424190|454776825|FG000|Overall Study|Noncompliance|1|||
126472925|NCT02435147|455032228|FG000|Overall Study|non-evaluable DXA scan|11|||
126472926|NCT00116428|455032229|FG000|Overall Study|Withdrawal by Subject|2|||
126472927|NCT00116428|455032230|FG001|Overall Study|Withdrawal by Subject|5|||
126472928|NCT00116428|455032229|FG000|Overall Study|Did not meet inclusion criteria|1|||
126472929|NCT00116428|455032230|FG001|Overall Study|Did not meet inclusion criteria|0|||
126472930|NCT00669396|455032231|FG000|Overall Study|Lost to Follow-up|10|||
126472931|NCT00669396|455032232|FG001|Overall Study|Lost to Follow-up|12|||
126472932|NCT04402060|455032233|FG000|Overall Study|Death|1|||
126472933|NCT04402060|455032234|FG001|Overall Study|Death|12|||
126472934|NCT04402060|455032235|FG002|Overall Study|Death|7|||
126472935|NCT04402060|455032233|FG000|Overall Study|Adverse Event|0|||
126472936|NCT04402060|455032234|FG001|Overall Study|Adverse Event|0|||
126472937|NCT04402060|455032235|FG002|Overall Study|Adverse Event|1|||
126472938|NCT04402060|455032233|FG000|Overall Study|Withdrawal by Subject|0|||
126472939|NCT04402060|455032234|FG001|Overall Study|Withdrawal by Subject|1|||
126472940|NCT04402060|455032235|FG002|Overall Study|Withdrawal by Subject|2|||
126472941|NCT04402060|455032233|FG000|Overall Study|Sponsor Request|0|||
126472942|NCT04402060|455032234|FG001|Overall Study|Sponsor Request|2|||
126472943|NCT04402060|455032235|FG002|Overall Study|Sponsor Request|0|||
126472944|NCT04402060|455032233|FG000|Overall Study|Physician Decision|0|||
126472945|NCT04402060|455032234|FG001|Overall Study|Physician Decision|0|||
126472946|NCT04402060|455032235|FG002|Overall Study|Physician Decision|1|||
126472947|NCT04402060|455032233|FG000|Overall Study|Other|0|||
126472948|NCT04402060|455032234|FG001|Overall Study|Other|1|||
126472949|NCT04402060|455032235|FG002|Overall Study|Other|0|||
126472950|NCT01297920|455032238|FG000|Overall Study|Adverse Event|42|||
126472951|NCT01297920|455032239|FG001|Overall Study|Adverse Event|10|||
126472952|NCT01297920|455032240|FG002|Overall Study|Adverse Event|38|||
126472953|NCT01297920|455032238|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
126472954|NCT01297920|455032239|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
126472955|NCT01297920|455032240|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
126472956|NCT01297920|455032238|FG000|Overall Study|Noncompliance|1|||
126472957|NCT01297920|455032239|FG001|Overall Study|Noncompliance|0|||
126472958|NCT01297920|455032240|FG002|Overall Study|Noncompliance|0|||
126472959|NCT01297920|455032238|FG000|Overall Study|Protocol Violation|1|||
126472960|NCT01297920|455032239|FG001|Overall Study|Protocol Violation|3|||
126472961|NCT01297920|455032240|FG002|Overall Study|Protocol Violation|0|||
126472962|NCT01297920|455032238|FG000|Overall Study|Inadequate Control of IOP|7|||
126472963|NCT01297920|455032239|FG001|Overall Study|Inadequate Control of IOP|9|||
126472964|NCT01297920|455032240|FG002|Overall Study|Inadequate Control of IOP|17|||
126472965|NCT01297920|455032238|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
126472966|NCT01297920|455032239|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
126472967|NCT01297920|455032240|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
126472968|NCT00474760|455032242|FG000|Overall Study|Death|0|||
126472969|NCT00474760|455032243|FG001|Overall Study|Death|0|||
126472970|NCT00474760|455032244|FG002|Overall Study|Death|0|||
126472971|NCT00474760|455032245|FG003|Overall Study|Death|0|||
126472972|NCT00474760|455032246|FG004|Overall Study|Death|2|||
126472973|NCT00474760|455032247|FG005|Overall Study|Death|0|||
126472974|NCT00474760|455032248|FG006|Overall Study|Death|0|||
126472975|NCT00474760|455032242|FG000|Overall Study|Adverse Event|0|||
126472976|NCT00474760|455032243|FG001|Overall Study|Adverse Event|0|||
126472977|NCT00474760|455032244|FG002|Overall Study|Adverse Event|0|||
126557866|NCT05968482|455334499|FG001|First Crossover Period|Withdrawal by Subject|0|||
126557867|NCT05968482|455334500|FG002|First Crossover Period|Withdrawal by Subject|1|||
126557868|NCT05968482|455334501|FG003|First Crossover Period|Withdrawal by Subject|0|||
126557869|NCT05968482|455334502|FG004|First Crossover Period|Withdrawal by Subject|0|||
126557870|NCT05968482|455334503|FG005|First Crossover Period|Withdrawal by Subject|0|||
126404750|NCT00424190|454776826|FG001|Overall Study|Noncompliance|2|||
126404751|NCT00424190|454776825|FG000|Overall Study|Request of sponsor or investigator|0|||
126472978|NCT00474760|455032245|FG003|Overall Study|Adverse Event|0|||
126472979|NCT00474760|455032246|FG004|Overall Study|Adverse Event|1|||
126404752|NCT00424190|454776826|FG001|Overall Study|Request of sponsor or investigator|2|||
126472980|NCT00474760|455032247|FG005|Overall Study|Adverse Event|7|||
126472981|NCT00474760|455032248|FG006|Overall Study|Adverse Event|0|||
126472982|NCT00474760|455032242|FG000|Overall Study|Laboratory abnormality|0|||
126404753|NCT00424190|454776825|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
126404754|NCT00424190|454776826|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
126404755|NCT00424190|454776825|FG000|Overall Study|Other|15|||
126404756|NCT00424190|454776826|FG001|Overall Study|Other|21|||
126404757|NCT00351273|454776827|FG000|Overall Study|Lost to Follow-up|1|||
126404758|NCT00351273|454776828|FG001|Overall Study|Lost to Follow-up|2|||
126404759|NCT00351273|454776829|FG002|Overall Study|Lost to Follow-up|5|||
126404760|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
126404761|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
126404762|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
126404763|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
126404764|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
126404765|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
126404766|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
126404767|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
126404768|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
126404769|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
126404770|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
126404771|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
126404772|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
126404773|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
126404774|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
126404775|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
126404776|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
126404777|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
126404778|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
126404779|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
126404780|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
126404781|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
126404782|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
126404783|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
126404784|NCT01672866|454776830|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
126404785|NCT01672866|454776831|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
126404786|NCT01672866|454776832|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
126404787|NCT01672866|454776830|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
126404788|NCT01672866|454776831|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
126404789|NCT01672866|454776832|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
126404790|NCT01672866|454776830|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
126404791|NCT01672866|454776831|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
126404792|NCT01672866|454776832|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
126404793|NCT01672866|454776830|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
126404794|NCT01672866|454776831|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
126404795|NCT01672866|454776832|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
126404796|NCT01672866|454776830|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
126404797|NCT01672866|454776831|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
126404798|NCT01672866|454776832|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
126404799|NCT02241187|454776833|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
126404800|NCT00160654|454776836|FG000|Overall Study|Adverse Event|14|||
126404801|NCT00160654|454776836|FG000|Overall Study|Lack of Efficacy|4|||
126404802|NCT00160654|454776836|FG000|Overall Study|Lost to Follow-up|2|||
126404803|NCT00160654|454776836|FG000|Overall Study|Intake of expired drug|7|||
126404804|NCT00160654|454776836|FG000|Overall Study|Psychological trauma|1|||
126404805|NCT00160654|454776836|FG000|Overall Study|Sponsor decision|1|||
126404806|NCT00160654|454776836|FG000|Overall Study|Patient met exclusion criteria|1|||
126404807|NCT00160654|454776836|FG000|Overall Study|Patient decision|1|||
126404808|NCT00160654|454776836|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
126404809|NCT00160654|454776836|FG000|Overall Study|Met exclusion criteria|1|||
126404810|NCT02383433|454776839|FG000|Overall Study|Disease progression|2|||
126404811|NCT02535416|454776840|FG000|Overall Study|Family bereavement overseas|1|||
126404812|NCT02535416|454776841|FG001|Overall Study|Family bereavement overseas|0|||
126404813|NCT02535416|454776842|FG002|Overall Study|Family bereavement overseas|0|||
126404814|NCT02535416|454776843|FG003|Overall Study|Family bereavement overseas|0|||
126404815|NCT02535416|454776844|FG004|Overall Study|Family bereavement overseas|0|||
126404816|NCT02535416|454776845|FG005|Overall Study|Family bereavement overseas|0|||
126404817|NCT02535416|454776846|FG006|Overall Study|Family bereavement overseas|0|||
126404818|NCT02535416|454776847|FG007|Overall Study|Family bereavement overseas|0|||
126404819|NCT02535416|454776848|FG008|Overall Study|Family bereavement overseas|0|||
126404820|NCT04544683|454778064|FG000|Overall Study|Lost to Follow-up|2|||
126404821|NCT04544683|454778064|FG000|Overall Study|Underwent cervical spine surgery|6|||
126404822|NCT01073930|454778065|FG000|Overall Study|Withdrawal by Subject|3|||
126404823|NCT01073930|454778066|FG001|Overall Study|Withdrawal by Subject|2|||
126404824|NCT01073930|454778065|FG000|Overall Study|Lost to Follow-up|0|||
126404825|NCT01073930|454778066|FG001|Overall Study|Lost to Follow-up|1|||
126404826|NCT01073930|454778065|FG000|Overall Study|Adverse Event|0|||
126404827|NCT01073930|454778066|FG001|Overall Study|Adverse Event|1|||
126404828|NCT01073930|454778065|FG000|Overall Study|Noncompliance with study drug|0|||
126404829|NCT01073930|454778066|FG001|Overall Study|Noncompliance with study drug|1|||
126404830|NCT01073930|454778065|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
126404831|NCT01073930|454778066|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
126404832|NCT02081599|454778067|FG000|Period 1：Double-blind Period|Adverse Event|3|||
126404833|NCT02081599|454778068|FG001|Period 1：Double-blind Period|Adverse Event|0|||
126404834|NCT02081599|454778067|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
126404835|NCT02081599|454778068|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
126404836|NCT02081599|454778067|FG000|Period 1：Double-blind Period|Physician Decision|1|||
126404837|NCT02081599|454778068|FG001|Period 1：Double-blind Period|Physician Decision|0|||
126404838|NCT02081599|454778067|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
126404839|NCT02081599|454778068|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
126404840|NCT02081599|454778067|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
126404841|NCT02081599|454778068|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
126404842|NCT02081599|454778067|FG000|Period 1：Double-blind Period|stopping criteria|1|||
126404843|NCT02081599|454778068|FG001|Period 1：Double-blind Period|stopping criteria|0|||
126404844|NCT02081599|454778067|FG000|Period 2：Open-label Period|Adverse Event|1|||
126404845|NCT02081599|454778068|FG001|Period 2：Open-label Period|Adverse Event|0|||
126404846|NCT02081599|454778067|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
126404847|NCT02081599|454778068|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
126404848|NCT02081599|454778067|FG000|Period 2：Open-label Period|Physician Decision|1|||
126404849|NCT02081599|454778068|FG001|Period 2：Open-label Period|Physician Decision|0|||
126404850|NCT02081599|454778067|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
126404851|NCT02081599|454778068|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
126404852|NCT01266590|454778069|FG000|Overall Study|Adverse Event|3|||
126404853|NCT01266590|454778069|FG000|Overall Study|Lost to Follow-up|1|||
126404854|NCT01266590|454778069|FG000|Overall Study|Withdrawal by Subject|1|||
126404855|NCT01266590|454778069|FG000|Overall Study|Physician Decision|1|||
126404856|NCT00720343|454778072|FG000|Overall Study|Lost to Follow-up|1|||
126404857|NCT00720343|454778073|FG001|Overall Study|Lost to Follow-up|0|||
126404858|NCT00720343|454778072|FG000|Overall Study|Protocol Violation|0|||
126404859|NCT00720343|454778073|FG001|Overall Study|Protocol Violation|2|||
126404860|NCT02008773|454778074|FG000|Overall Study|Adverse Event|3|||
126404861|NCT02008773|454778075|FG001|Overall Study|Adverse Event|3|||
126404862|NCT02008773|454778076|FG002|Overall Study|Adverse Event|1|||
126404863|NCT02008773|454778077|FG003|Overall Study|Adverse Event|2|||
126404864|NCT02008773|454778074|FG000|Overall Study|Medication Non-compliance|2|||
126404865|NCT02008773|454778075|FG001|Overall Study|Medication Non-compliance|1|||
126404866|NCT02008773|454778076|FG002|Overall Study|Medication Non-compliance|3|||
126404867|NCT02008773|454778077|FG003|Overall Study|Medication Non-compliance|2|||
126404868|NCT02008773|454778074|FG000|Overall Study|Withdrawal by Subject|8|||
126404869|NCT02008773|454778075|FG001|Overall Study|Withdrawal by Subject|4|||
126404870|NCT02008773|454778076|FG002|Overall Study|Withdrawal by Subject|7|||
126404871|NCT02008773|454778077|FG003|Overall Study|Withdrawal by Subject|6|||
126404872|NCT02008773|454778074|FG000|Overall Study|Lost to Follow-up|0|||
126404873|NCT02008773|454778075|FG001|Overall Study|Lost to Follow-up|1|||
126404874|NCT02008773|454778076|FG002|Overall Study|Lost to Follow-up|3|||
126404875|NCT02008773|454778077|FG003|Overall Study|Lost to Follow-up|2|||
126404876|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
126404877|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
126404878|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
126404879|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
126404880|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
126557871|NCT05968482|455334498|FG000|First Crossover Period|Adverse Event|0|||
126557872|NCT05968482|455334499|FG001|First Crossover Period|Adverse Event|0|||
126404881|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
126404882|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
126404883|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
126404884|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
126404885|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
126404886|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
126404887|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
126404888|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
126404889|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
126404890|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
126404891|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
126404892|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
126404893|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
126472983|NCT00474760|455032243|FG001|Overall Study|Laboratory abnormality|0|||
126472984|NCT00474760|455032244|FG002|Overall Study|Laboratory abnormality|0|||
126472985|NCT00474760|455032245|FG003|Overall Study|Laboratory abnormality|0|||
126472986|NCT00474760|455032246|FG004|Overall Study|Laboratory abnormality|0|||
126472987|NCT00474760|455032247|FG005|Overall Study|Laboratory abnormality|1|||
126472988|NCT00474760|455032248|FG006|Overall Study|Laboratory abnormality|0|||
126472989|NCT00474760|455032242|FG000|Overall Study|Withdrawal by Subject|0|||
126472990|NCT00474760|455032243|FG001|Overall Study|Withdrawal by Subject|0|||
126472991|NCT00474760|455032244|FG002|Overall Study|Withdrawal by Subject|0|||
126472992|NCT00474760|455032245|FG003|Overall Study|Withdrawal by Subject|1|||
126472993|NCT00474760|455032246|FG004|Overall Study|Withdrawal by Subject|0|||
126472994|NCT00474760|455032247|FG005|Overall Study|Withdrawal by Subject|1|||
126472995|NCT00474760|455032248|FG006|Overall Study|Withdrawal by Subject|1|||
126472996|NCT00474760|455032242|FG000|Overall Study|Other|0|||
126472997|NCT00474760|455032243|FG001|Overall Study|Other|1|||
126472998|NCT00474760|455032244|FG002|Overall Study|Other|0|||
126472999|NCT00474760|455032245|FG003|Overall Study|Other|0|||
126473000|NCT00474760|455032246|FG004|Overall Study|Other|1|||
126473001|NCT00474760|455032247|FG005|Overall Study|Other|0|||
126473002|NCT00474760|455032248|FG006|Overall Study|Other|0|||
126473003|NCT00474760|455032242|FG000|Overall Study|Progressive disease|3|||
126473004|NCT00474760|455032243|FG001|Overall Study|Progressive disease|2|||
126473005|NCT00474760|455032244|FG002|Overall Study|Progressive disease|3|||
126473006|NCT00474760|455032245|FG003|Overall Study|Progressive disease|2|||
126473007|NCT00474760|455032246|FG004|Overall Study|Progressive disease|8|||
126473008|NCT00474760|455032247|FG005|Overall Study|Progressive disease|20|||
126473009|NCT00474760|455032248|FG006|Overall Study|Progressive disease|7|||
126473010|NCT00474760|455032242|FG000|Overall Study|Terminated by sponsor|0|||
126473011|NCT00474760|455032243|FG001|Overall Study|Terminated by sponsor|0|||
126473012|NCT00474760|455032244|FG002|Overall Study|Terminated by sponsor|0|||
126473013|NCT00474760|455032245|FG003|Overall Study|Terminated by sponsor|0|||
126473014|NCT00474760|455032246|FG004|Overall Study|Terminated by sponsor|0|||
126473015|NCT00474760|455032247|FG005|Overall Study|Terminated by sponsor|0|||
126473016|NCT00474760|455032248|FG006|Overall Study|Terminated by sponsor|2|||
126473017|NCT00331422|455032251|FG000|Overall Study|Did not receive entire study regimen|5|||
126473018|NCT02345226|455032252|FG000|Double-Blind Phase|Adverse Event|5|||
126557873|NCT05968482|455334500|FG002|First Crossover Period|Adverse Event|0|||
126557874|NCT05968482|455334501|FG003|First Crossover Period|Adverse Event|0|||
126557875|NCT05968482|455334502|FG004|First Crossover Period|Adverse Event|0|||
126557876|NCT05968482|455334503|FG005|First Crossover Period|Adverse Event|1|||
126557877|NCT05968482|455334498|FG000|Second Crossover Period|Withdrawal by Subject|0|||
126557878|NCT05968482|455334499|FG001|Second Crossover Period|Withdrawal by Subject|0|||
126557879|NCT05968482|455334500|FG002|Second Crossover Period|Withdrawal by Subject|0|||
126557880|NCT05968482|455334501|FG003|Second Crossover Period|Withdrawal by Subject|0|||
126557881|NCT05968482|455334502|FG004|Second Crossover Period|Withdrawal by Subject|1|||
126557882|NCT05968482|455334503|FG005|Second Crossover Period|Withdrawal by Subject|0|||
126404894|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
126404895|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
126404896|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
126404897|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
126404898|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
126404899|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
126404900|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
126404901|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
126404902|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
126404903|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
126557883|NCT05968482|455334498|FG000|Third Crossover Period|Adverse Event|0|||
126404904|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
126404905|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
126404906|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
126404907|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
126473019|NCT02345226|455032253|FG001|Double-Blind Phase|Adverse Event|6|||
126473020|NCT02345226|455032252|FG000|Double-Blind Phase|Death|3|||
126557884|NCT05968482|455334499|FG001|Third Crossover Period|Adverse Event|0|||
126473021|NCT02345226|455032253|FG001|Double-Blind Phase|Death|0|||
126473022|NCT02345226|455032252|FG000|Double-Blind Phase|Pregnancy|0|||
126473023|NCT02345226|455032253|FG001|Double-Blind Phase|Pregnancy|1|||
126473024|NCT02345226|455032252|FG000|Double-Blind Phase|Lack of Efficacy|1|||
126473025|NCT02345226|455032253|FG001|Double-Blind Phase|Lack of Efficacy|0|||
126473026|NCT02345226|455032252|FG000|Double-Blind Phase|Investigator's Discretion|4|||
126473027|NCT02345226|455032253|FG001|Double-Blind Phase|Investigator's Discretion|3|||
126473028|NCT02345226|455032252|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
126473029|NCT02345226|455032253|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
126557885|NCT05968482|455334500|FG002|Third Crossover Period|Adverse Event|0|||
126557886|NCT05968482|455334501|FG003|Third Crossover Period|Adverse Event|0|||
126404908|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
126404909|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
126404910|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
126404911|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
126404912|NCT02198794|454778078|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
126404913|NCT02198794|454778079|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
126404914|NCT02198794|454778080|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
126404915|NCT02198794|454778081|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
126404916|NCT02198794|454778078|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
126404917|NCT02198794|454778079|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
126404918|NCT02198794|454778080|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
126404919|NCT02198794|454778081|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
126404920|NCT02198794|454778078|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
126404921|NCT02198794|454778079|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
126404922|NCT02198794|454778080|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
126404923|NCT02198794|454778081|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
126404924|NCT02198794|454778078|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
126404925|NCT02198794|454778079|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
126404926|NCT02198794|454778080|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
126404927|NCT02198794|454778081|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
126404928|NCT02198794|454778078|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
126404929|NCT02198794|454778079|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
126404930|NCT02198794|454778080|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
126404931|NCT02198794|454778081|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
126404932|NCT02198794|454778078|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
126404933|NCT02198794|454778079|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
126404934|NCT02198794|454778080|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
126404935|NCT02198794|454778081|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
126404936|NCT00701805|454778082|FG000|Overall Study|Withdrawal by Subject|3|||
126404937|NCT00701805|454778083|FG001|Overall Study|Withdrawal by Subject|1|||
126404938|NCT00701805|454778084|FG002|Overall Study|Withdrawal by Subject|4|||
126404939|NCT00701805|454778085|FG003|Overall Study|Withdrawal by Subject|3|||
126404940|NCT00701805|454778082|FG000|Overall Study|Adverse Event|0|||
126404941|NCT00701805|454778083|FG001|Overall Study|Adverse Event|1|||
126404942|NCT00701805|454778084|FG002|Overall Study|Adverse Event|1|||
126404943|NCT00701805|454778085|FG003|Overall Study|Adverse Event|0|||
126404944|NCT00701805|454778082|FG000|Overall Study|Missed 7 consecutive doses|0|||
126404945|NCT00701805|454778083|FG001|Overall Study|Missed 7 consecutive doses|1|||
126404946|NCT00701805|454778084|FG002|Overall Study|Missed 7 consecutive doses|0|||
126404947|NCT00701805|454778085|FG003|Overall Study|Missed 7 consecutive doses|0|||
126404948|NCT00701805|454778082|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
126404949|NCT00701805|454778083|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
126404950|NCT00701805|454778084|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
126404951|NCT00701805|454778085|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
126404952|NCT00701805|454778082|FG000|Overall Study|Physician decision, change of therapy|0|||
126404953|NCT00701805|454778083|FG001|Overall Study|Physician decision, change of therapy|0|||
126404954|NCT00701805|454778084|FG002|Overall Study|Physician decision, change of therapy|0|||
126404955|NCT00701805|454778085|FG003|Overall Study|Physician decision, change of therapy|1|||
126404956|NCT00701805|454778082|FG000|Overall Study|Difficult to travel to dialysis site|0|||
126404957|NCT00701805|454778083|FG001|Overall Study|Difficult to travel to dialysis site|0|||
126404958|NCT00701805|454778084|FG002|Overall Study|Difficult to travel to dialysis site|1|||
126404959|NCT00701805|454778085|FG003|Overall Study|Difficult to travel to dialysis site|0|||
126404960|NCT00701805|454778082|FG000|Overall Study|Resumption criteria were not met|0|||
126404961|NCT00701805|454778083|FG001|Overall Study|Resumption criteria were not met|1|||
126404962|NCT00701805|454778084|FG002|Overall Study|Resumption criteria were not met|0|||
126404963|NCT00701805|454778085|FG003|Overall Study|Resumption criteria were not met|0|||
126404964|NCT02252965|454778089|FG000|Overall Study|Adverse Event|9|||
126404965|NCT02252965|454778090|FG001|Overall Study|Adverse Event|14|||
126404966|NCT02252965|454778089|FG000|Overall Study|Lost to Follow-up|16|||
126404967|NCT02252965|454778090|FG001|Overall Study|Lost to Follow-up|8|||
126404968|NCT02252965|454778089|FG000|Overall Study|Protocol Violation|4|||
126404969|NCT02252965|454778090|FG001|Overall Study|Protocol Violation|5|||
126404970|NCT02252965|454778089|FG000|Overall Study|Lack of Efficacy|0|||
126404971|NCT02252965|454778090|FG001|Overall Study|Lack of Efficacy|2|||
126404972|NCT02252965|454778089|FG000|Overall Study|Withdrawal by Subject|7|||
126404973|NCT02252965|454778090|FG001|Overall Study|Withdrawal by Subject|9|||
126404974|NCT02252965|454778089|FG000|Overall Study|Other|4|||
126404975|NCT02252965|454778090|FG001|Overall Study|Other|5|||
126557887|NCT05968482|455334502|FG004|Third Crossover Period|Adverse Event|1|||
126557888|NCT05968482|455334503|FG005|Third Crossover Period|Adverse Event|0|||
126404976|NCT04435600|454778094|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404977|NCT04435600|454778095|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404978|NCT04435600|454778096|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
126404979|NCT04435600|454778097|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404980|NCT04435600|454778098|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404981|NCT04435600|454778099|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404982|NCT04435600|454778100|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404983|NCT04435600|454778101|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404984|NCT04435600|454778102|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404985|NCT04435600|454778103|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
126404986|NCT04435600|454778094|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404987|NCT04435600|454778095|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404988|NCT04435600|454778096|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404989|NCT04435600|454778097|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404990|NCT04435600|454778098|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404991|NCT04435600|454778099|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404992|NCT04435600|454778100|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404993|NCT04435600|454778101|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404994|NCT04435600|454778102|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
126404995|NCT04435600|454778103|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
126404996|NCT04435600|454778094|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126404997|NCT04435600|454778095|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126404998|NCT04435600|454778096|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126404999|NCT04435600|454778097|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126405000|NCT04435600|454778098|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126405001|NCT04435600|454778099|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126405002|NCT04435600|454778100|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126405003|NCT04435600|454778101|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126405004|NCT04435600|454778102|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
126405005|NCT04435600|454778103|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
126405006|NCT04435600|454778094|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405007|NCT04435600|454778095|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405008|NCT04435600|454778096|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405009|NCT04435600|454778097|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405010|NCT04435600|454778098|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405011|NCT04435600|454778099|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405012|NCT04435600|454778100|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405013|NCT04435600|454778101|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405014|NCT04435600|454778102|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
126405015|NCT04435600|454778103|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
126405016|NCT02797184|454778105|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
126405017|NCT02797184|454778106|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
126405018|NCT05149313|454778107|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
126405019|NCT05149313|454778108|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
126405020|NCT05149313|454778109|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
126405021|NCT05149313|454778110|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
126405022|NCT05149313|454778107|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
126405023|NCT05149313|454778108|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
126405024|NCT05149313|454778109|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
126405025|NCT05149313|454778110|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
126405026|NCT05149313|454778107|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
126405027|NCT05149313|454778108|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
126405028|NCT05149313|454778109|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
126405029|NCT05149313|454778110|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
126405030|NCT05149313|454778107|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
126405031|NCT05149313|454778108|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
126405032|NCT05149313|454778109|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
126405033|NCT05149313|454778110|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
126405034|NCT05149313|454778107|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
126405035|NCT05149313|454778108|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
126405036|NCT05149313|454778109|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
126405037|NCT05149313|454778110|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
126405038|NCT05149313|454778107|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
126405039|NCT05149313|454778108|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
126405040|NCT05149313|454778109|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
126473030|NCT02345226|455032252|FG000|Double-Blind Phase|Withdrew Consent|41|||
126473031|NCT02345226|455032253|FG001|Double-Blind Phase|Withdrew Consent|39|||
126473032|NCT02345226|455032252|FG000|Double-Blind Phase|Lost to Follow-up|12|||
126473033|NCT02345226|455032253|FG001|Double-Blind Phase|Lost to Follow-up|16|||
126473034|NCT02345226|455032252|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
126473035|NCT02345226|455032253|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
126473036|NCT02345226|455032252|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
126473037|NCT02345226|455032253|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
126473038|NCT03386474|455032263|FG000|Overall Study|Death|1|||
126473039|NCT03386474|455032264|FG001|Overall Study|Death|0|||
126473040|NCT03386474|455032263|FG000|Overall Study|Adverse Event|0|||
126473041|NCT03386474|455032264|FG001|Overall Study|Adverse Event|1|||
126473042|NCT02282358|455032265|FG000|Overall Study|Nonevaluable|1|||
126473043|NCT02155881|455032266|FG000|Overall Study|Withdrawal by Subject|0|||
126473044|NCT02155881|455032267|FG001|Overall Study|Withdrawal by Subject|2|||
126473045|NCT02155881|455032266|FG000|Overall Study|Inappropriately randomized|2|||
126473046|NCT02155881|455032267|FG001|Overall Study|Inappropriately randomized|2|||
126473047|NCT04357782|455032268|FG000|Overall Study|Discharged from hospital|1|||
126473048|NCT04357782|455032269|FG001|Overall Study|Discharged from hospital|0|||
126473049|NCT04357782|455032268|FG000|Overall Study|Death|0|||
126473050|NCT04357782|455032269|FG001|Overall Study|Death|2|||
126473051|NCT01786148|455032270|FG000|Overall Study|Lost to Follow-up|21|||
126473052|NCT01786148|455032271|FG001|Overall Study|Lost to Follow-up|13|||
126473053|NCT01786148|455032270|FG000|Overall Study|Death|0|||
126405041|NCT05149313|454778110|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
126405042|NCT05149313|454778107|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
126405043|NCT05149313|454778108|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
126405044|NCT05149313|454778109|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
126405045|NCT05149313|454778110|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
126405046|NCT05149313|454778107|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126405047|NCT05149313|454778108|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126405048|NCT05149313|454778109|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
126405049|NCT05149313|454778110|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
126405050|NCT05149313|454778107|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
126405051|NCT05149313|454778108|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
126405052|NCT05149313|454778109|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
126405053|NCT05149313|454778110|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
126405054|NCT05149313|454778107|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126405055|NCT05149313|454778108|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126405056|NCT05149313|454778109|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
126405057|NCT05149313|454778110|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126405058|NCT05149313|454778107|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
126405059|NCT05149313|454778108|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
126405060|NCT05149313|454778109|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
126405061|NCT05149313|454778110|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
126405062|NCT03199391|454778115|FG000|Overall Study|Death|1|||
126405063|NCT03199391|454778115|FG000|Overall Study|Lost to Follow-up|3|||
126405064|NCT03199391|454778115|FG000|Overall Study|Adverse Event|2|||
126405065|NCT03199391|454778115|FG000|Overall Study|Withdrawal by Subject|10|||
126405066|NCT04736628|454778116|FG000|Overall Study|Not treated|0|||
126405067|NCT04736628|454778117|FG001|Overall Study|Not treated|0|||
126405068|NCT04736628|454778118|FG002|Overall Study|Not treated|0|||
126405069|NCT04736628|454778119|FG003|Overall Study|Not treated|2|||
126405070|NCT04736628|454778116|FG000|Overall Study|Other reason than listed|1|||
126405071|NCT04736628|454778117|FG001|Overall Study|Other reason than listed|2|||
126405072|NCT04736628|454778118|FG002|Overall Study|Other reason than listed|2|||
126405073|NCT04736628|454778119|FG003|Overall Study|Other reason than listed|3|||
126405074|NCT04736628|454778116|FG000|Overall Study|Protocol deviation|0|||
126405075|NCT04736628|454778117|FG001|Overall Study|Protocol deviation|0|||
126405076|NCT04736628|454778118|FG002|Overall Study|Protocol deviation|0|||
126473054|NCT01786148|455032271|FG001|Overall Study|Death|1|||
126473055|NCT01786148|455032270|FG000|Overall Study|Withdrawal by Subject|0|||
126473056|NCT01786148|455032271|FG001|Overall Study|Withdrawal by Subject|7|||
126473057|NCT01786148|455032270|FG000|Overall Study|Incarceration|1|||
126473058|NCT01786148|455032271|FG001|Overall Study|Incarceration|1|||
126473059|NCT03780543|455032273|FG000|Overall Study|Adverse Event|1|||
126473060|NCT03780543|455032274|FG001|Overall Study|Adverse Event|0|||
126473061|NCT03780543|455032275|FG002|Overall Study|Adverse Event|2|||
126473062|NCT03780543|455032273|FG000|Overall Study|Lost to Follow-up|2|||
126473063|NCT03780543|455032274|FG001|Overall Study|Lost to Follow-up|0|||
126473064|NCT03780543|455032275|FG002|Overall Study|Lost to Follow-up|1|||
126473065|NCT03780543|455032273|FG000|Overall Study|Study terminated by Sponsor|8|||
126473066|NCT03780543|455032274|FG001|Overall Study|Study terminated by Sponsor|7|||
126473067|NCT03780543|455032275|FG002|Overall Study|Study terminated by Sponsor|13|||
126473068|NCT03780543|455032273|FG000|Overall Study|Withdrawal by Subject|1|||
126473069|NCT03780543|455032274|FG001|Overall Study|Withdrawal by Subject|8|||
126473070|NCT03780543|455032275|FG002|Overall Study|Withdrawal by Subject|1|||
126473071|NCT03780543|455032273|FG000|Overall Study|Noncompliance with study drug|1|||
126473072|NCT03780543|455032274|FG001|Overall Study|Noncompliance with study drug|0|||
126473073|NCT03780543|455032275|FG002|Overall Study|Noncompliance with study drug|0|||
126473074|NCT00066729|455032276|FG000|Overall Study|Lost to Follow-up|1|||
126473075|NCT00066729|455032276|FG000|Overall Study|Disease progression|1|||
126473076|NCT02158975|455032277|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
126473077|NCT02663908|455032278|FG000|Overall Study|Withdrawal by Subject|8|||
126473078|NCT02663908|455032279|FG001|Overall Study|Withdrawal by Subject|5|||
126473079|NCT02663908|455032278|FG000|Overall Study|Lost to Follow-up|1|||
126473080|NCT02663908|455032279|FG001|Overall Study|Lost to Follow-up|5|||
126473081|NCT02663908|455032278|FG000|Overall Study|Adverse Event|13|||
126473082|NCT02663908|455032279|FG001|Overall Study|Adverse Event|11|||
126473083|NCT02663908|455032278|FG000|Overall Study|Protocol Violation|1|||
126473084|NCT02663908|455032279|FG001|Overall Study|Protocol Violation|2|||
126473085|NCT02663908|455032278|FG000|Overall Study|Lack of therapeutic response|2|||
126473086|NCT02663908|455032279|FG001|Overall Study|Lack of therapeutic response|0|||
126473087|NCT02663908|455032278|FG000|Overall Study|COVID-19|1|||
126473088|NCT02663908|455032279|FG001|Overall Study|COVID-19|0|||
126473089|NCT02663908|455032278|FG000|Overall Study|Site closed|1|||
126473090|NCT02663908|455032279|FG001|Overall Study|Site closed|0|||
126473091|NCT02663908|455032278|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
126473092|NCT02663908|455032279|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
126473093|NCT02663908|455032278|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
126473094|NCT02663908|455032279|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
126473095|NCT02663908|455032278|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
126473096|NCT02663908|455032279|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
126473097|NCT02663908|455032278|FG000|Overall Study|Death|1|||
126473098|NCT02663908|455032279|FG001|Overall Study|Death|0|||
126473099|NCT02663908|455032278|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
126473100|NCT02663908|455032279|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
126473101|NCT02663908|455032278|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
126473102|NCT02663908|455032279|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
126473103|NCT03308786|455032280|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
126473104|NCT00319501|455032281|FG000|Double-blind Period|Withdrawal by Subject|0|||
126473105|NCT00319501|455032282|FG001|Double-blind Period|Withdrawal by Subject|3|||
126473106|NCT00319501|455032281|FG000|Double-blind Period|Sponsor Request|1|||
126473107|NCT00319501|455032282|FG001|Double-blind Period|Sponsor Request|0|||
126473108|NCT00319501|455032281|FG000|Double-blind Period|Did not receive treatment|42|||
126473109|NCT00319501|455032282|FG001|Double-blind Period|Did not receive treatment|29|||
126473110|NCT00319501|455032281|FG000|Open-label Period|Adverse Event|5|||
126473111|NCT00319501|455032282|FG001|Open-label Period|Adverse Event|0|||
126473112|NCT00319501|455032281|FG000|Open-label Period|Protocol Violation|6|||
126473113|NCT00319501|455032282|FG001|Open-label Period|Protocol Violation|0|||
126473114|NCT00319501|455032281|FG000|Open-label Period|Withdrawal by Subject|38|||
126473115|NCT00319501|455032282|FG001|Open-label Period|Withdrawal by Subject|0|||
126473116|NCT00319501|455032281|FG000|Open-label Period|Principal Investigator decision|6|||
126473117|NCT00319501|455032282|FG001|Open-label Period|Principal Investigator decision|0|||
126473118|NCT00319501|455032281|FG000|Open-label Period|Sponsor request|12|||
126473119|NCT00319501|455032282|FG001|Open-label Period|Sponsor request|0|||
126473120|NCT00319501|455032281|FG000|Open-label Period|Lost to Follow-up|5|||
126473121|NCT00319501|455032282|FG001|Open-label Period|Lost to Follow-up|0|||
126473122|NCT00319501|455032281|FG000|Open-label Period|Did not receive treatment|33|||
126473123|NCT00319501|455032282|FG001|Open-label Period|Did not receive treatment|0|||
126473124|NCT00319501|455032281|FG000|Open-label Period|Other|11|||
126473125|NCT00319501|455032282|FG001|Open-label Period|Other|0|||
126473126|NCT00319501|455032281|FG000|Open-label Extension Period|Adverse Event|2|||
126473127|NCT00319501|455032282|FG001|Open-label Extension Period|Adverse Event|0|||
126473128|NCT00319501|455032281|FG000|Open-label Extension Period|Did not receive treatment|18|||
126473129|NCT00319501|455032282|FG001|Open-label Extension Period|Did not receive treatment|0|||
126473130|NCT00319501|455032281|FG000|Open-label Extension Period|Other|1|||
126473131|NCT00319501|455032282|FG001|Open-label Extension Period|Other|0|||
126473132|NCT00319501|455032281|FG000|Open-label Extension Period|Principal investigator decision|2|||
126473133|NCT00319501|455032282|FG001|Open-label Extension Period|Principal investigator decision|0|||
126473134|NCT00319501|455032281|FG000|Open-label Extension Period|Sponsor request|26|||
126473135|NCT00319501|455032282|FG001|Open-label Extension Period|Sponsor request|0|||
126473136|NCT00319501|455032281|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
126557889|NCT05968482|455334498|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
126473137|NCT00319501|455032282|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
126557890|NCT05968482|455334499|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
126557891|NCT05968482|455334500|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
126405077|NCT04736628|454778119|FG003|Overall Study|Protocol deviation|1|||
126405078|NCT04736628|454778116|FG000|Overall Study|Burden of study procedures|1|||
126405079|NCT04736628|454778117|FG001|Overall Study|Burden of study procedures|0|||
126405080|NCT04736628|454778118|FG002|Overall Study|Burden of study procedures|0|||
126405081|NCT04736628|454778119|FG003|Overall Study|Burden of study procedures|1|||
126405082|NCT04736628|454778116|FG000|Overall Study|Change of residence|0|||
126405083|NCT04736628|454778117|FG001|Overall Study|Change of residence|1|||
126405084|NCT04736628|454778118|FG002|Overall Study|Change of residence|0|||
126405085|NCT04736628|454778119|FG003|Overall Study|Change of residence|0|||
126405086|NCT04736628|454778116|FG000|Overall Study|Perceived lack of efficacy|1|||
126405087|NCT04736628|454778117|FG001|Overall Study|Perceived lack of efficacy|0|||
126405088|NCT04736628|454778118|FG002|Overall Study|Perceived lack of efficacy|0|||
126405089|NCT04736628|454778119|FG003|Overall Study|Perceived lack of efficacy|1|||
126405090|NCT04736628|454778116|FG000|Overall Study|Adverse Event|3|||
126405091|NCT04736628|454778117|FG001|Overall Study|Adverse Event|2|||
126405092|NCT04736628|454778118|FG002|Overall Study|Adverse Event|4|||
126405093|NCT04736628|454778119|FG003|Overall Study|Adverse Event|3|||
126405094|NCT02046070|454778128|FG000|Overall Study|Progressive Disease|18|||
126405095|NCT02046070|454778129|FG001|Overall Study|Progressive Disease|11|||
126405096|NCT02046070|454778130|FG002|Overall Study|Progressive Disease|40|||
126405097|NCT02046070|454778128|FG000|Overall Study|Adverse Event|8|||
126405098|NCT02046070|454778129|FG001|Overall Study|Adverse Event|10|||
126405099|NCT02046070|454778130|FG002|Overall Study|Adverse Event|17|||
126405100|NCT02046070|454778128|FG000|Overall Study|Withdrawal by Subject|1|||
126405101|NCT02046070|454778129|FG001|Overall Study|Withdrawal by Subject|2|||
126405102|NCT02046070|454778130|FG002|Overall Study|Withdrawal by Subject|6|||
126405103|NCT02046070|454778128|FG000|Overall Study|Study Terminated by Sponsor|1|||
126405104|NCT02046070|454778129|FG001|Overall Study|Study Terminated by Sponsor|1|||
126405105|NCT02046070|454778130|FG002|Overall Study|Study Terminated by Sponsor|1|||
126405106|NCT02046070|454778128|FG000|Overall Study|Reason not Specified|4|||
126405107|NCT02046070|454778129|FG001|Overall Study|Reason not Specified|4|||
126405108|NCT02046070|454778130|FG002|Overall Study|Reason not Specified|6|||
126405109|NCT02616393|454778143|FG000|Overall Study|Death|5|||
126405110|NCT02616393|454778144|FG001|Overall Study|Death|12|||
126405111|NCT02616393|454778145|FG002|Overall Study|Death|1|||
126405112|NCT02616393|454778143|FG000|Overall Study|Termination by Sponsor|4|||
126405113|NCT02616393|454778144|FG001|Overall Study|Termination by Sponsor|5|||
126405114|NCT02616393|454778145|FG002|Overall Study|Termination by Sponsor|2|||
126405115|NCT02616393|454778143|FG000|Overall Study|Other|3|||
126405116|NCT02616393|454778144|FG001|Overall Study|Other|0|||
126405117|NCT02616393|454778145|FG002|Overall Study|Other|0|||
126405118|NCT02616393|454778143|FG000|Overall Study|Withdrawal by Subject|1|||
126405119|NCT02616393|454778144|FG001|Overall Study|Withdrawal by Subject|1|||
126405120|NCT02616393|454778145|FG002|Overall Study|Withdrawal by Subject|0|||
126405121|NCT02616393|454778143|FG000|Overall Study|Lost to Follow-up|0|||
126405122|NCT02616393|454778144|FG001|Overall Study|Lost to Follow-up|2|||
126405123|NCT02616393|454778145|FG002|Overall Study|Lost to Follow-up|0|||
126405124|NCT02758301|454778147|FG000|Overall Study|Death|12|||
126405125|NCT02758301|454778148|FG001|Overall Study|Death|0|||
126405126|NCT02758301|454778147|FG000|Overall Study|Physician Decision|10|||
126405127|NCT02758301|454778148|FG001|Overall Study|Physician Decision|1|||
126473138|NCT01790932|455032288|FG000|Overall Study|Disease Progression|41|||
126473139|NCT01790932|455032288|FG000|Overall Study|Adverse Event|7|||
126473140|NCT01790932|455032288|FG000|Overall Study|Physician Decision|1|||
126473141|NCT01790932|455032288|FG000|Overall Study|Withdrawal by Subject|1|||
126473142|NCT04223973|455032289|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
126473143|NCT04223973|455032290|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
126473144|NCT04223973|455032289|FG000|Overall Study|Adverse Event|4|||
126473145|NCT04223973|455032290|FG001|Overall Study|Adverse Event|0|||
126473146|NCT04223973|455032289|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
126473147|NCT04223973|455032290|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
126557892|NCT05968482|455334501|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
126557893|NCT05968482|455334502|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
126405128|NCT02758301|454778147|FG000|Overall Study|Withdrawal by Subject|5|||
126405129|NCT02758301|454778148|FG001|Overall Study|Withdrawal by Subject|6|||
126405130|NCT02758301|454778147|FG000|Overall Study|Lost to Follow-up|7|||
126405131|NCT02758301|454778148|FG001|Overall Study|Lost to Follow-up|0|||
126557894|NCT05968482|455334503|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
126405132|NCT02758301|454778147|FG000|Overall Study|Protocol Violation|0|||
126405133|NCT02758301|454778148|FG001|Overall Study|Protocol Violation|1|||
126405134|NCT00364533|454778149|FG000|Overall Study|Adverse Event|8|||
126405135|NCT00364533|454778150|FG001|Overall Study|Adverse Event|7|||
126405136|NCT00364533|454778151|FG002|Overall Study|Adverse Event|15|||
126405137|NCT00364533|454778152|FG003|Overall Study|Adverse Event|5|||
126405138|NCT00364533|454778153|FG004|Overall Study|Adverse Event|2|||
126405139|NCT00364533|454778149|FG000|Overall Study|Withdrawal by Subject|4|||
126405140|NCT00364533|454778150|FG001|Overall Study|Withdrawal by Subject|8|||
126405141|NCT00364533|454778151|FG002|Overall Study|Withdrawal by Subject|6|||
126405142|NCT00364533|454778152|FG003|Overall Study|Withdrawal by Subject|6|||
126405143|NCT00364533|454778153|FG004|Overall Study|Withdrawal by Subject|6|||
126405144|NCT00364533|454778149|FG000|Overall Study|Lack of Efficacy|22|||
126405145|NCT00364533|454778150|FG001|Overall Study|Lack of Efficacy|22|||
126405146|NCT00364533|454778151|FG002|Overall Study|Lack of Efficacy|21|||
126405147|NCT00364533|454778152|FG003|Overall Study|Lack of Efficacy|17|||
126405148|NCT00364533|454778153|FG004|Overall Study|Lack of Efficacy|42|||
126405149|NCT00364533|454778149|FG000|Overall Study|Subject discharged from hospital|4|||
126405150|NCT00364533|454778150|FG001|Overall Study|Subject discharged from hospital|1|||
126405151|NCT00364533|454778151|FG002|Overall Study|Subject discharged from hospital|2|||
126405152|NCT00364533|454778152|FG003|Overall Study|Subject discharged from hospital|3|||
126405153|NCT00364533|454778153|FG004|Overall Study|Subject discharged from hospital|1|||
126405154|NCT00364533|454778149|FG000|Overall Study|Variations in drug compliance|2|||
126405155|NCT00364533|454778150|FG001|Overall Study|Variations in drug compliance|1|||
126405156|NCT00364533|454778151|FG002|Overall Study|Variations in drug compliance|1|||
126405157|NCT00364533|454778152|FG003|Overall Study|Variations in drug compliance|0|||
126405158|NCT00364533|454778153|FG004|Overall Study|Variations in drug compliance|0|||
126405159|NCT00364533|454778149|FG000|Overall Study|Non-compliance|1|||
126405160|NCT00364533|454778150|FG001|Overall Study|Non-compliance|0|||
126405161|NCT00364533|454778151|FG002|Overall Study|Non-compliance|0|||
126405162|NCT00364533|454778152|FG003|Overall Study|Non-compliance|0|||
126405163|NCT00364533|454778153|FG004|Overall Study|Non-compliance|0|||
126405164|NCT00364533|454778149|FG000|Overall Study|Protocol Violation|1|||
126405165|NCT00364533|454778150|FG001|Overall Study|Protocol Violation|1|||
126405166|NCT00364533|454778151|FG002|Overall Study|Protocol Violation|0|||
126405167|NCT00364533|454778152|FG003|Overall Study|Protocol Violation|0|||
126405168|NCT00364533|454778153|FG004|Overall Study|Protocol Violation|0|||
126405169|NCT00652899|454778154|FG000|Overall Study|Death|1|||
126405170|NCT00652899|454778154|FG000|Overall Study|Treating physician decision|1|||
126405171|NCT02900170|454778157|FG000|Overall Study|Lost to Follow-up|8|||
126405172|NCT00551291|454778158|FG000|Overall Study|Physician Decision|1|||
126405173|NCT01943552|454778159|FG000|Overall Study|Adverse Event|3|||
126405174|NCT01943552|454778160|FG001|Overall Study|Adverse Event|2|||
126405175|NCT01943552|454778159|FG000|Overall Study|Withdrawal by Subject|6|||
126405176|NCT01943552|454778160|FG001|Overall Study|Withdrawal by Subject|6|||
126405177|NCT01943552|454778159|FG000|Overall Study|Other Reasons|16|||
126405178|NCT01943552|454778160|FG001|Overall Study|Other Reasons|17|||
126405179|NCT01600053|454778161|FG000|Overall Study|Adverse Event|2|||
126405180|NCT01600053|454778161|FG000|Overall Study|trial will not meet the interim endpoint|9|||
126405181|NCT02445573|454778162|FG000|Overall Study|Withdrawal by Subject|1|||
126405182|NCT02445573|454778163|FG001|Overall Study|Withdrawal by Subject|1|||
126405183|NCT02445573|454778162|FG000|Overall Study|Lost to Follow-up|0|||
126405184|NCT02445573|454778163|FG001|Overall Study|Lost to Follow-up|1|||
126405185|NCT02855944|454778164|FG000|Period 1: Treatment|Ongoing|14|||
126405186|NCT02855944|454778165|FG001|Period 1: Treatment|Ongoing|0|||
126405187|NCT02855944|454778164|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
126405188|NCT02855944|454778165|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
126405189|NCT02855944|454778164|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
126405190|NCT02855944|454778165|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
126405191|NCT01475162|454778172|FG000|Overall Study|Physician Decision|1|||
126405192|NCT01475162|454778172|FG000|Overall Study|Death|10|||
126405193|NCT01475162|454778172|FG000|Overall Study|Study closed for safety|3|||
126405194|NCT00490022|454778173|FG000|Overall Study|Adverse Event|0|||
126405195|NCT00490022|454778174|FG001|Overall Study|Adverse Event|2|||
126405196|NCT00490022|454778173|FG000|Overall Study|Withdrawal by Subject|1|||
126405197|NCT00490022|454778174|FG001|Overall Study|Withdrawal by Subject|0|||
126405198|NCT00490022|454778173|FG000|Overall Study|Subject failed to disclose concommitant|0|||
126405199|NCT00490022|454778174|FG001|Overall Study|Subject failed to disclose concommitant|1|||
126405200|NCT01283542|454778175|FG000|Main Phase|Acute or progressive vision loss|1|||
126405201|NCT01283542|454778175|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
126405202|NCT01283542|454778175|FG000|Main Phase|abnormal laboratory values|5|||
126405203|NCT01283542|454778175|FG000|Extension Phase|Physician Decision|1|||
126405204|NCT01283542|454778175|FG000|Extension Phase|Adverse Event|1|||
126405205|NCT01283542|454778175|FG000|Extension Phase|Administrative problems|1|||
126405206|NCT00576472|454778177|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405207|NCT00576472|454778178|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405208|NCT00576472|454778179|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405209|NCT00576472|454778180|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
126405210|NCT00576472|454778181|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
126557895|NCT00761774|455334505|FG000|Overall Study|Adverse Event|17|||
126405211|NCT00576472|454778182|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405212|NCT00576472|454778183|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405213|NCT00576472|454778184|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405214|NCT00576472|454778185|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405215|NCT00576472|454778186|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405216|NCT00576472|454778187|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405217|NCT00576472|454778188|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405218|NCT00576472|454778189|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405219|NCT00576472|454778190|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405220|NCT00576472|454778191|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
126405221|NCT00576472|454778177|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
126405222|NCT00576472|454778178|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
126405223|NCT00576472|454778179|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
126405224|NCT00576472|454778180|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
126405225|NCT00576472|454778181|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
126405226|NCT00576472|454778182|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
126405227|NCT00576472|454778183|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
126405228|NCT00576472|454778184|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
126405229|NCT00576472|454778185|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
126405230|NCT00576472|454778186|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
126405231|NCT00576472|454778187|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
126405232|NCT00576472|454778188|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
126405233|NCT00576472|454778189|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
126405234|NCT00576472|454778190|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
126405235|NCT00576472|454778191|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
126405236|NCT00576472|454778177|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405237|NCT00576472|454778178|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126557896|NCT00761774|455334505|FG000|Overall Study|Lack of Efficacy|37|||
126557897|NCT00761774|455334505|FG000|Overall Study|Lost to Follow-up|2|||
126557898|NCT00761774|455334505|FG000|Overall Study|Withdrawal by Subject|9|||
126557899|NCT00761774|455334505|FG000|Overall Study|Non-compliance|4|||
126557900|NCT00761774|455334505|FG000|Overall Study|End of study|2|||
126557901|NCT00761774|455334505|FG000|Overall Study|Reclassification of seizures|1|||
126557902|NCT00761774|455334505|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
126557903|NCT00761774|455334505|FG000|Overall Study|Sponsor decision|1|||
126405238|NCT00576472|454778179|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405239|NCT00576472|454778180|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
126405240|NCT00576472|454778181|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405241|NCT00576472|454778182|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405242|NCT00576472|454778183|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405243|NCT00576472|454778184|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405244|NCT00576472|454778185|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405245|NCT00576472|454778186|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405246|NCT00576472|454778187|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405247|NCT00576472|454778188|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405248|NCT00576472|454778189|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405249|NCT00576472|454778190|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405250|NCT00576472|454778191|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
126405251|NCT00576472|454778177|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
126405252|NCT00576472|454778178|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
126405253|NCT00576472|454778179|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
126405254|NCT00576472|454778180|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
126405255|NCT00576472|454778181|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
126405256|NCT00576472|454778182|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
126405257|NCT00576472|454778183|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
126405258|NCT00576472|454778184|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
126405259|NCT00576472|454778185|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
126405260|NCT00576472|454778186|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
126405261|NCT00576472|454778187|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
126405262|NCT00576472|454778188|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
126405263|NCT00576472|454778189|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
126405264|NCT00576472|454778190|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
126405265|NCT00576472|454778191|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
126405266|NCT00576472|454778177|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
126557904|NCT00761774|455334505|FG000|Overall Study|Investigator clinical judgement|1|||
126405267|NCT00576472|454778178|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405268|NCT00576472|454778179|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405269|NCT00576472|454778180|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
126405270|NCT00576472|454778181|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405271|NCT00576472|454778182|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
126557905|NCT00761774|455334505|FG000|Overall Study|Patient moved out of study area|1|||
126405272|NCT00576472|454778183|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405273|NCT00576472|454778184|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405274|NCT00576472|454778185|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405275|NCT00576472|454778186|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405276|NCT00576472|454778187|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405277|NCT00576472|454778188|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405278|NCT00576472|454778189|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405279|NCT00576472|454778190|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405280|NCT00576472|454778191|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
126405281|NCT00576472|454778177|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405282|NCT00576472|454778178|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405283|NCT00576472|454778179|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405284|NCT00576472|454778180|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405285|NCT00576472|454778181|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405286|NCT00576472|454778182|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405287|NCT00576472|454778183|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
126405288|NCT00576472|454778184|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405289|NCT00576472|454778185|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405290|NCT00576472|454778186|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405291|NCT00576472|454778187|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405292|NCT00576472|454778188|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405293|NCT00576472|454778189|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405294|NCT00576472|454778190|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405295|NCT00576472|454778191|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
126405296|NCT00576472|454778177|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
126405297|NCT00576472|454778178|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
126405298|NCT00576472|454778179|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
126405299|NCT00576472|454778180|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
126405300|NCT00576472|454778181|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
126405301|NCT00576472|454778182|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
126405302|NCT00576472|454778183|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
126405303|NCT00576472|454778184|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
126405304|NCT00576472|454778185|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
126405305|NCT00576472|454778186|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
126405306|NCT00576472|454778187|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
126405307|NCT00576472|454778188|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
126405308|NCT00576472|454778189|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
126405309|NCT00576472|454778190|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
126405310|NCT00576472|454778191|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
126405311|NCT00576472|454778177|FG000|MPH Cross Over Phase|Physician Decision|0|||
126405312|NCT00576472|454778178|FG001|MPH Cross Over Phase|Physician Decision|0|||
126405313|NCT00576472|454778179|FG002|MPH Cross Over Phase|Physician Decision|0|||
126405314|NCT00576472|454778180|FG003|MPH Cross Over Phase|Physician Decision|0|||
126405315|NCT00576472|454778181|FG004|MPH Cross Over Phase|Physician Decision|0|||
126405316|NCT00576472|454778182|FG005|MPH Cross Over Phase|Physician Decision|0|||
126405317|NCT00576472|454778183|FG006|MPH Cross Over Phase|Physician Decision|4|||
126405318|NCT00576472|454778184|FG007|MPH Cross Over Phase|Physician Decision|0|||
126405319|NCT00576472|454778185|FG008|MPH Cross Over Phase|Physician Decision|0|||
126405320|NCT00576472|454778186|FG009|MPH Cross Over Phase|Physician Decision|0|||
126405321|NCT00576472|454778187|FG010|MPH Cross Over Phase|Physician Decision|0|||
126405322|NCT00576472|454778188|FG011|MPH Cross Over Phase|Physician Decision|0|||
126405323|NCT00576472|454778189|FG012|MPH Cross Over Phase|Physician Decision|0|||
126405324|NCT00576472|454778190|FG013|MPH Cross Over Phase|Physician Decision|0|||
126405325|NCT00576472|454778191|FG014|MPH Cross Over Phase|Physician Decision|0|||
126405326|NCT00576472|454778177|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405327|NCT00576472|454778178|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405328|NCT00576472|454778179|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405329|NCT00576472|454778180|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405330|NCT00576472|454778181|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405331|NCT00576472|454778182|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405332|NCT00576472|454778183|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405333|NCT00576472|454778184|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405334|NCT00576472|454778185|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
126405335|NCT00576472|454778186|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
126473148|NCT04223973|455032289|FG000|Overall Study|Physician Decision|1|||
126473149|NCT04223973|455032290|FG001|Overall Study|Physician Decision|1|||
126473150|NCT04223973|455032289|FG000|Overall Study|Withdrawal by Subject|0|||
126473151|NCT04223973|455032290|FG001|Overall Study|Withdrawal by Subject|1|||
126473152|NCT02612129|455032293|FG000|Single Dose Treatment Period|Screening Failure|1|||
126473153|NCT02612129|455032294|FG001|Single Dose Treatment Period|Screening Failure|0|||
126473154|NCT02612129|455032295|FG002|Single Dose Treatment Period|Screening Failure|0|||
126557906|NCT00761774|455334505|FG000|Overall Study|Coordinator leaving site|1|||
126557907|NCT00761774|455334505|FG000|Overall Study|Subject IP non-compliance|1|||
126557908|NCT00761774|455334505|FG000|Overall Study|IP stopped by hospital physician|1|||
126557909|NCT01077024|455334508|FG000|Overall Study|Lost to Follow-up|20|||
126557910|NCT01077024|455334509|FG001|Overall Study|Lost to Follow-up|14|||
126557911|NCT01077024|455334508|FG000|Overall Study|Withdrawal by Subject|0|||
126557912|NCT01077024|455334509|FG001|Overall Study|Withdrawal by Subject|2|||
126557913|NCT01077024|455334508|FG000|Overall Study|Incarcerated|7|||
126557914|NCT01077024|455334509|FG001|Overall Study|Incarcerated|8|||
126557915|NCT01077024|455334508|FG000|Overall Study|Other|4|||
126557916|NCT01077024|455334509|FG001|Overall Study|Other|4|||
126557917|NCT03379233|455334510|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
126557918|NCT03379233|455334511|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
126557919|NCT01603121|455334512|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
126557920|NCT01603121|455334513|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
126557921|NCT02300311|455334516|FG000|Overall Study|Other than the reason specified|1|||
126557922|NCT02300311|455334517|FG001|Overall Study|Other than the reason specified|0|||
126557923|NCT02300311|455334516|FG000|Overall Study|Refused to continue taking medication|18|||
126557924|NCT02300311|455334517|FG001|Overall Study|Refused to continue taking medication|0|||
126557925|NCT00419003|455334518|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
126557926|NCT00419003|455334519|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
126557927|NCT00419003|455334518|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
126557928|NCT00419003|455334519|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
126557929|NCT02687919|455334520|FG000|Overall Study|Withdrawal by Subject|6|||
126557930|NCT02687919|455334521|FG001|Overall Study|Withdrawal by Subject|6|||
126557931|NCT02687919|455334520|FG000|Overall Study|Protocol Violation|2|||
126557932|NCT02687919|455334521|FG001|Overall Study|Protocol Violation|0|||
126557933|NCT01656759|455334522|FG000|Overall Study|Protocol Violation|2|||
126557934|NCT01656759|455334523|FG001|Overall Study|Protocol Violation|3|||
126557935|NCT02531438|455334524|FG000|Overall Study|Adverse Event|7|||
126557936|NCT02531438|455334525|FG001|Overall Study|Adverse Event|9|||
126557937|NCT02531438|455334524|FG000|Overall Study|Lost to Follow-up|0|||
126557938|NCT02531438|455334525|FG001|Overall Study|Lost to Follow-up|3|||
126557939|NCT02531438|455334524|FG000|Overall Study|Withdrawal by Subject|7|||
126557940|NCT02531438|455334525|FG001|Overall Study|Withdrawal by Subject|8|||
126557941|NCT02531438|455334524|FG000|Overall Study|Physician Decision|0|||
126557942|NCT02531438|455334525|FG001|Overall Study|Physician Decision|1|||
126557943|NCT02531438|455334524|FG000|Overall Study|Death|6|||
126557944|NCT02531438|455334525|FG001|Overall Study|Death|3|||
126557945|NCT02531438|455334524|FG000|Overall Study|Randomized, but Not Treated|4|||
126557946|NCT02531438|455334525|FG001|Overall Study|Randomized, but Not Treated|0|||
126557947|NCT02531438|455334524|FG000|Overall Study|Missed EOT/PTE Visit|5|||
126557948|NCT02531438|455334525|FG001|Overall Study|Missed EOT/PTE Visit|2|||
126557949|NCT02531438|455334524|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
126557950|NCT02531438|455334525|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
126405336|NCT00576472|454778187|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
126405337|NCT00576472|454778188|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
126405338|NCT00576472|454778189|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405339|NCT00576472|454778190|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405340|NCT00576472|454778191|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
126405341|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405342|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405343|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405344|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405345|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405346|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405347|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126557951|NCT00801242|455334532|FG000|Overall Study|Adverse Event|10|||
126557952|NCT00801242|455334532|FG000|Overall Study|Withdrawal by Subject|13|||
126557953|NCT00801242|455334532|FG000|Overall Study|Protocol Violation|5|||
126557954|NCT00801242|455334532|FG000|Overall Study|Physician Decision|3|||
126557955|NCT00801242|455334532|FG000|Overall Study|Lost to Follow-up|1|||
126557956|NCT00801242|455334532|FG000|Overall Study|Miscellaneous reasons|20|||
126405348|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405349|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126557957|NCT02015195|455334533|FG000|Overall Study|Adverse Event|0|||
126557958|NCT02015195|455334534|FG001|Overall Study|Adverse Event|0|||
126557959|NCT02015195|455334535|FG002|Overall Study|Adverse Event|0|||
126557960|NCT02015195|455334536|FG003|Overall Study|Adverse Event|1|||
126405350|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405351|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126557961|NCT02015195|455334537|FG004|Overall Study|Adverse Event|0|||
126557962|NCT02015195|455334538|FG005|Overall Study|Adverse Event|0|||
126557963|NCT02015195|455334539|FG006|Overall Study|Adverse Event|0|||
126405352|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126473155|NCT02612129|455032293|FG000|Continuous Treatment Period|Early Escape|0|||
126473156|NCT02612129|455032294|FG001|Continuous Treatment Period|Early Escape|2|||
126473157|NCT02612129|455032295|FG002|Continuous Treatment Period|Early Escape|0|||
126473158|NCT02612129|455032293|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
126473159|NCT02612129|455032294|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
126473160|NCT02612129|455032295|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
126473161|NCT02612129|455032293|FG000|Continuous Treatment Period|Safety Reasons|0|||
126473162|NCT02612129|455032294|FG001|Continuous Treatment Period|Safety Reasons|3|||
126473163|NCT02612129|455032295|FG002|Continuous Treatment Period|Safety Reasons|0|||
126473164|NCT02612129|455032293|FG000|Continuous Treatment Period|Death|0|||
126473165|NCT02612129|455032294|FG001|Continuous Treatment Period|Death|1|||
126473166|NCT02612129|455032295|FG002|Continuous Treatment Period|Death|0|||
126473167|NCT02612129|455032293|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
126473168|NCT02612129|455032294|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
126405353|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126473169|NCT02612129|455032295|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
126473170|NCT06238362|455032296|FG000|Overall Study|Insufficient total sleep time|1|||
126473171|NCT06238362|455032297|FG001|Overall Study|Insufficient total sleep time|0|||
126473172|NCT06238362|455032296|FG000|Overall Study|Inadequate signal quality|1|||
126473173|NCT06238362|455032297|FG001|Overall Study|Inadequate signal quality|0|||
126473174|NCT05136690|455032298|FG000|Period 1|Withdrawal by Subject|0|||
126473175|NCT05136690|455032299|FG001|Period 1|Withdrawal by Subject|1|||
126473176|NCT05136690|455032298|FG000|Period 2|Lost to Follow-up|0|||
126473177|NCT05136690|455032299|FG001|Period 2|Lost to Follow-up|3|||
126473178|NCT05136690|455032298|FG000|Period 2|Withdrawal by Subject|0|||
126473179|NCT05136690|455032299|FG001|Period 2|Withdrawal by Subject|1|||
126473180|NCT00531934|455034502|FG000|Overall Study|Adverse Event|4|||
126473181|NCT00531934|455034503|FG001|Overall Study|Adverse Event|8|||
126473182|NCT00531934|455034502|FG000|Overall Study|Progression|52|||
126473183|NCT00531934|455034503|FG001|Overall Study|Progression|42|||
126473184|NCT00531934|455034502|FG000|Overall Study|Death|7|||
126473185|NCT00531934|455034503|FG001|Overall Study|Death|10|||
126473186|NCT00531934|455034502|FG000|Overall Study|Withdrawal by Subject|1|||
126473187|NCT00531934|455034503|FG001|Overall Study|Withdrawal by Subject|1|||
126473188|NCT00531934|455034502|FG000|Overall Study|Other|2|||
126473189|NCT00531934|455034503|FG001|Overall Study|Other|2|||
126473190|NCT01543698|455034508|FG000|Phase 1b|Disease progression|2|||
126473191|NCT01543698|455034509|FG001|Phase 1b|Disease progression|4|||
126473192|NCT01543698|455034510|FG002|Phase 1b|Disease progression|3|||
126473193|NCT01543698|455034511|FG003|Phase 1b|Disease progression|2|||
126473194|NCT01543698|455034512|FG004|Phase 1b|Disease progression|10|||
126473195|NCT01543698|455034513|FG005|Phase 1b|Disease progression|6|||
126473196|NCT01543698|455034514|FG006|Phase 1b|Disease progression|5|||
126405354|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
126405355|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
126405356|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
126405357|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
126405358|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
126405359|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
126405360|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
126405361|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
126405362|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
126405363|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
126405364|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
126405365|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
126405366|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
126405367|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
126405368|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
126405369|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
126405370|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
126405371|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
126473197|NCT01543698|455034515|FG007|Phase 1b|Disease progression|3|||
126473198|NCT01543698|455034516|FG008|Phase 1b|Disease progression|4|||
126473199|NCT01543698|455034517|FG009|Phase 1b|Disease progression|5|||
126473200|NCT01543698|455034518|FG010|Phase 1b|Disease progression|1|||
126473201|NCT01543698|455034519|FG011|Phase 1b|Disease progression|0|||
126473202|NCT01543698|455034520|FG012|Phase 1b|Disease progression|0|||
126473203|NCT01543698|455034521|FG013|Phase 1b|Disease progression|0|||
126405372|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
126473204|NCT01543698|455034522|FG014|Phase 1b|Disease progression|0|||
126405373|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
126405374|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
126405375|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
126405376|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
126405377|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
126405378|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
126405379|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
126405380|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
126405381|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
126405382|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
126405383|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
126405384|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
126405385|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
126405386|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Side effects|0|||
126405387|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Side effects|0|||
126405388|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Side effects|0|||
126405389|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Side effects|0|||
126405390|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Side effects|0|||
126405391|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Side effects|0|||
126405392|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Side effects|0|||
126405393|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Side effects|0|||
126405394|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Side effects|0|||
126405395|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Side effects|0|||
126405396|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Side effects|0|||
126405397|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Side effects|0|||
126405398|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Side effects|0|||
126405399|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Side effects|0|||
126405400|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Side effects|8|||
126405401|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405402|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405403|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405404|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405405|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405406|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405407|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405408|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405409|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405410|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405411|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405412|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405413|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405414|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
126405415|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
126405416|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
126405417|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
126405418|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
126405419|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
126405420|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
126405421|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
126405422|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
126405423|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
126557964|NCT01318811|455334540|FG000|Overall Study|Physician Decision|1|||
126557965|NCT01318811|455334541|FG001|Overall Study|Physician Decision|1|||
126557966|NCT01318811|455334540|FG000|Overall Study|CRRT stopped for head CT|0|||
126557967|NCT01318811|455334541|FG001|Overall Study|CRRT stopped for head CT|1|||
126557968|NCT01318811|455334540|FG000|Overall Study|Death|0|||
126405424|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
126557969|NCT01318811|455334541|FG001|Overall Study|Death|1|||
126557970|NCT01318811|455334540|FG000|Overall Study|CRRT stopped for head MRI|0|||
126405425|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
126405426|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
126405427|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
126405428|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
126557971|NCT01318811|455334541|FG001|Overall Study|CRRT stopped for head MRI|1|||
126405429|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
126405430|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
126405431|NCT00576472|454778177|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405432|NCT00576472|454778178|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405433|NCT00576472|454778179|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405434|NCT00576472|454778180|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405435|NCT00576472|454778181|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126557972|NCT00811187|455334542|FG000|Overall Study|Unable to place device / procedure abort|3|||
126557973|NCT00811187|455334543|FG001|Overall Study|Unable to place device / procedure abort|3|||
126557974|NCT00131911|455334544|FG000|Overall Study|Withdrawal by Subject|1|||
126557975|NCT00131911|455334545|FG001|Overall Study|Withdrawal by Subject|0|||
126557976|NCT00329303|455334546|FG000|Overall Study|Lack of Efficacy|1|||
126557977|NCT00329303|455334547|FG001|Overall Study|Lack of Efficacy|0|||
126557978|NCT00329303|455334546|FG000|Overall Study|Decision of the sponsor|0|||
126557979|NCT00329303|455334547|FG001|Overall Study|Decision of the sponsor|1|||
126557980|NCT00329303|455334546|FG000|Overall Study|Patient no longer available|1|||
126557981|NCT00329303|455334547|FG001|Overall Study|Patient no longer available|0|||
126557982|NCT00329303|455334546|FG000|Overall Study|Patient relocated|0|||
126557983|NCT00329303|455334547|FG001|Overall Study|Patient relocated|1|||
126557984|NCT00994279|455334552|FG000|Overall Study|Withdrawal by Subject|2|||
126557985|NCT00994279|455334553|FG001|Overall Study|Withdrawal by Subject|2|||
126557986|NCT00994279|455334552|FG000|Overall Study|Toxicity|1|||
126557987|NCT00994279|455334553|FG001|Overall Study|Toxicity|0|||
126557988|NCT00994279|455334552|FG000|Overall Study|Multiple reasons|1|||
126557989|NCT00994279|455334553|FG001|Overall Study|Multiple reasons|3|||
126557990|NCT01606189|455334554|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
126557991|NCT01606189|455334555|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
126557992|NCT01606189|455334556|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
126557993|NCT01606189|455334557|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
126557994|NCT01606189|455334558|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
126557995|NCT01606189|455334559|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
126557996|NCT01606189|455334554|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
126557997|NCT01606189|455334555|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
126557998|NCT01606189|455334556|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
126557999|NCT01606189|455334557|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
126558000|NCT01606189|455334558|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
126558001|NCT01606189|455334559|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
126558002|NCT00162942|455334560|FG000|Overall Study|Adverse Event|10|||
126558003|NCT00162942|455334561|FG001|Overall Study|Adverse Event|6|||
126558004|NCT00162942|455334560|FG000|Overall Study|Death|1|||
126558005|NCT00162942|455334561|FG001|Overall Study|Death|0|||
126558006|NCT00162942|455334560|FG000|Overall Study|Withdrawal by Subject|3|||
126558007|NCT00162942|455334561|FG001|Overall Study|Withdrawal by Subject|6|||
126558008|NCT00162942|455334560|FG000|Overall Study|Physician Decision|1|||
126558009|NCT00162942|455334561|FG001|Overall Study|Physician Decision|0|||
126558010|NCT00162942|455334560|FG000|Overall Study|Enter Open-Label Study|76|||
126558011|NCT00162942|455334561|FG001|Overall Study|Enter Open-Label Study|35|||
126558012|NCT00162942|455334560|FG000|Overall Study|Alternate Therapy|6|||
126558013|NCT00162942|455334561|FG001|Overall Study|Alternate Therapy|2|||
126558014|NCT00162942|455334560|FG000|Overall Study|Lack of Efficacy|1|||
126558015|NCT00162942|455334561|FG001|Overall Study|Lack of Efficacy|0|||
126558016|NCT00162942|455334560|FG000|Overall Study|Flare During Active Treatment|7|||
126558017|NCT00162942|455334561|FG001|Overall Study|Flare During Active Treatment|3|||
126558018|NCT00162942|455334560|FG000|Overall Study|2 or more consecutive treatments missed|1|||
126558019|NCT00162942|455334561|FG001|Overall Study|2 or more consecutive treatments missed|0|||
126558020|NCT02162732|455334562|FG000|Overall Study|Biopsy not performed.|18|||
126558021|NCT00410384|455334563|FG000|Overall Study|Withdrawal by Subject|28|||
126558022|NCT00410384|455334564|FG001|Overall Study|Withdrawal by Subject|17|||
126558023|NCT00410384|455334565|FG002|Overall Study|Withdrawal by Subject|20|||
126558024|NCT00410384|455334563|FG000|Overall Study|Adverse Event|23|||
126558025|NCT00410384|455334564|FG001|Overall Study|Adverse Event|18|||
126558026|NCT00410384|455334565|FG002|Overall Study|Adverse Event|23|||
126558027|NCT00410384|455334563|FG000|Overall Study|Lack of Efficacy|20|||
126558028|NCT00410384|455334564|FG001|Overall Study|Lack of Efficacy|12|||
126558029|NCT00410384|455334565|FG002|Overall Study|Lack of Efficacy|17|||
126558030|NCT00410384|455334563|FG000|Overall Study|Lack of Compliance|2|||
126558031|NCT00410384|455334564|FG001|Overall Study|Lack of Compliance|2|||
126558032|NCT00410384|455334565|FG002|Overall Study|Lack of Compliance|2|||
126405436|NCT00576472|454778182|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405437|NCT00576472|454778183|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405438|NCT00576472|454778184|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126558033|NCT00410384|455334563|FG000|Overall Study|Lost to Follow-up|4|||
126558034|NCT00410384|455334564|FG001|Overall Study|Lost to Follow-up|6|||
126558035|NCT00410384|455334565|FG002|Overall Study|Lost to Follow-up|6|||
126558036|NCT00410384|455334563|FG000|Overall Study|Protocol Violation|6|||
126558037|NCT00410384|455334564|FG001|Overall Study|Protocol Violation|6|||
126558038|NCT00410384|455334565|FG002|Overall Study|Protocol Violation|6|||
126558039|NCT00410384|455334563|FG000|Overall Study|Physician Decision|3|||
126558040|NCT00410384|455334564|FG001|Overall Study|Physician Decision|3|||
126558041|NCT00410384|455334565|FG002|Overall Study|Physician Decision|4|||
126558042|NCT00410384|455334563|FG000|Overall Study|Other|3|||
126558043|NCT00410384|455334564|FG001|Overall Study|Other|8|||
126558044|NCT00410384|455334565|FG002|Overall Study|Other|4|||
126405439|NCT00576472|454778185|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405440|NCT00576472|454778186|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405441|NCT00576472|454778187|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405442|NCT00576472|454778188|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405443|NCT00576472|454778189|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405444|NCT00576472|454778190|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
126405445|NCT00576472|454778191|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
126405446|NCT03263780|454778194|FG000|Overall Study|Withdrawal by Subject|3|||
126405447|NCT03263780|454778194|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
126405448|NCT01504204|454778197|FG000|Overall Study|Lost to Follow-up|1|||
126405449|NCT01504204|454778198|FG001|Overall Study|Lost to Follow-up|1|||
126405450|NCT00903331|454778199|FG000|Overall Study|Death|4|||
126405451|NCT00903331|454778200|FG001|Overall Study|Death|8|||
126405452|NCT00903331|454778199|FG000|Overall Study|Withdrawal of consent|1|||
126405453|NCT00903331|454778200|FG001|Overall Study|Withdrawal of consent|8|||
126405454|NCT00903331|454778199|FG000|Overall Study|Lung transplant|0|||
126405455|NCT00903331|454778200|FG001|Overall Study|Lung transplant|2|||
126405456|NCT02723175|454778201|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
126405457|NCT02723175|454778202|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
126405458|NCT02723175|454778201|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
126405459|NCT02723175|454778202|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
126405460|NCT00257660|454778205|FG000|Overall Study|Lack of Efficacy|5|||
126405461|NCT00257660|454778206|FG001|Overall Study|Lack of Efficacy|23|||
126405462|NCT00257660|454778205|FG000|Overall Study|Withdrawal by Subject|2|||
126405463|NCT00257660|454778206|FG001|Overall Study|Withdrawal by Subject|0|||
126405464|NCT00257660|454778205|FG000|Overall Study|Lost to Follow-up|1|||
126405465|NCT00257660|454778206|FG001|Overall Study|Lost to Follow-up|0|||
126405466|NCT00257660|454778205|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
126405467|NCT00257660|454778206|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
126405468|NCT00257660|454778205|FG000|Overall Study|No longer wanted to do blood draws|1|||
126405469|NCT00257660|454778206|FG001|Overall Study|No longer wanted to do blood draws|0|||
126405470|NCT01977690|454778209|FG000|Overall Study|Withdrawal by Subject|0|||
126405471|NCT01977690|454778210|FG001|Overall Study|Withdrawal by Subject|4|||
126405472|NCT00447122|454778211|FG000|Overall Study|worsening medical condition -came off|0|||
126405473|NCT00447122|454778212|FG001|Overall Study|worsening medical condition -came off|1|||
126405474|NCT00447122|454778213|FG002|Overall Study|worsening medical condition -came off|0|||
126405475|NCT00447122|454778214|FG003|Overall Study|worsening medical condition -came off|0|||
126405476|NCT01174173|454778219|FG000|Overall Study|drug-drug interaction|1|||
126405477|NCT03938324|454779427|FG000|Overall Study|Lost to Follow-up|42|||
126405478|NCT03938324|454779428|FG001|Overall Study|Lost to Follow-up|21|||
126405479|NCT03938324|454779427|FG000|Overall Study|Withdrawal by Subject|6|||
126405480|NCT03938324|454779428|FG001|Overall Study|Withdrawal by Subject|1|||
126405481|NCT02769962|454779429|FG000|Overall Study|Physician Decision|0|||
126405482|NCT02769962|454779430|FG001|Overall Study|Physician Decision|0|||
126405483|NCT02769962|454779431|FG002|Overall Study|Physician Decision|0|||
126405484|NCT02769962|454779432|FG003|Overall Study|Physician Decision|0|||
126405485|NCT02769962|454779433|FG004|Overall Study|Physician Decision|0|||
126405486|NCT02769962|454779434|FG005|Overall Study|Physician Decision|1|||
126405487|NCT02769962|454779435|FG006|Overall Study|Physician Decision|0|||
126405488|NCT02769962|454779436|FG007|Overall Study|Physician Decision|1|||
126405489|NCT02769962|454779429|FG000|Overall Study|Refused further treatment|0|||
126405490|NCT02769962|454779430|FG001|Overall Study|Refused further treatment|0|||
126405491|NCT02769962|454779431|FG002|Overall Study|Refused further treatment|0|||
126405492|NCT02769962|454779432|FG003|Overall Study|Refused further treatment|0|||
126405493|NCT02769962|454779433|FG004|Overall Study|Refused further treatment|0|||
126405494|NCT02769962|454779434|FG005|Overall Study|Refused further treatment|1|||
126405495|NCT02769962|454779435|FG006|Overall Study|Refused further treatment|1|||
126405496|NCT02769962|454779436|FG007|Overall Study|Refused further treatment|0|||
126405497|NCT00837759|454779437|FG000|Overall Study|Protocol Violation|3|||
126405498|NCT00837759|454779437|FG000|Overall Study|Lost to Follow-up|1|||
126405499|NCT01918332|454779438|FG000|Overall Study|Adverse Event|0|||
126405500|NCT01918332|454779439|FG001|Overall Study|Adverse Event|0|||
126405501|NCT01918332|454779440|FG002|Overall Study|Adverse Event|0|||
126405502|NCT01918332|454779441|FG003|Overall Study|Adverse Event|1|||
126405503|NCT01918332|454779438|FG000|Overall Study|Withdrawal by Subject|2|||
126405504|NCT01918332|454779439|FG001|Overall Study|Withdrawal by Subject|3|||
126405505|NCT01918332|454779440|FG002|Overall Study|Withdrawal by Subject|2|||
126405506|NCT01918332|454779441|FG003|Overall Study|Withdrawal by Subject|3|||
126405507|NCT01918332|454779438|FG000|Overall Study|Protocol Violation|6|||
126405508|NCT01918332|454779439|FG001|Overall Study|Protocol Violation|2|||
126405509|NCT01918332|454779440|FG002|Overall Study|Protocol Violation|6|||
126405510|NCT01918332|454779441|FG003|Overall Study|Protocol Violation|3|||
126405511|NCT01918332|454779438|FG000|Overall Study|lipid result by central lab did not meet|0|||
126405512|NCT01918332|454779439|FG001|Overall Study|lipid result by central lab did not meet|0|||
126405513|NCT01918332|454779440|FG002|Overall Study|lipid result by central lab did not meet|1|||
126558045|NCT01167023|455334566|FG000|Overall Study|Lost to Follow-up|0|||
126558046|NCT01167023|455334567|FG001|Overall Study|Lost to Follow-up|1|||
126558047|NCT01167023|455334568|FG002|Overall Study|Lost to Follow-up|1|||
126558048|NCT01167023|455334566|FG000|Overall Study|Screen Failure|0|||
126558049|NCT01167023|455334567|FG001|Overall Study|Screen Failure|1|||
126405514|NCT01918332|454779441|FG003|Overall Study|lipid result by central lab did not meet|0|||
126405515|NCT02408523|454779442|FG000|Overall Study|Adverse Event|4|||
126405516|NCT02408523|454779443|FG001|Overall Study|Adverse Event|10|||
126405517|NCT02408523|454779442|FG000|Overall Study|Lack of Efficacy|0|||
126405518|NCT02408523|454779443|FG001|Overall Study|Lack of Efficacy|1|||
126405519|NCT02408523|454779442|FG000|Overall Study|Protocol Violation|1|||
126405520|NCT02408523|454779443|FG001|Overall Study|Protocol Violation|2|||
126405521|NCT02408523|454779442|FG000|Overall Study|Lost to Follow-up|2|||
126405522|NCT02408523|454779443|FG001|Overall Study|Lost to Follow-up|3|||
126405523|NCT02408523|454779442|FG000|Overall Study|Withdrawal by Subject|3|||
126405524|NCT02408523|454779443|FG001|Overall Study|Withdrawal by Subject|1|||
126405525|NCT02408523|454779442|FG000|Overall Study|Sponsor request|1|||
126405526|NCT02408523|454779443|FG001|Overall Study|Sponsor request|0|||
126405527|NCT02408523|454779442|FG000|Overall Study|Did not satisfy extension conditions|0|||
126405528|NCT02408523|454779443|FG001|Overall Study|Did not satisfy extension conditions|1|||
126405529|NCT05063539|454779444|FG000|Overall Study|Adverse Event|1|||
126405530|NCT05063539|454779445|FG001|Overall Study|Adverse Event|2|||
126405531|NCT05063539|454779446|FG002|Overall Study|Adverse Event|1|||
126405532|NCT05063539|454779444|FG000|Overall Study|Death|0|||
126405533|NCT05063539|454779445|FG001|Overall Study|Death|1|||
126405534|NCT05063539|454779446|FG002|Overall Study|Death|1|||
126405535|NCT05063539|454779444|FG000|Overall Study|Lost to Follow-up|0|||
126405536|NCT05063539|454779445|FG001|Overall Study|Lost to Follow-up|1|||
126405537|NCT05063539|454779446|FG002|Overall Study|Lost to Follow-up|0|||
126405538|NCT05063539|454779444|FG000|Overall Study|Physician Decision|4|||
126405539|NCT05063539|454779445|FG001|Overall Study|Physician Decision|3|||
126405540|NCT05063539|454779446|FG002|Overall Study|Physician Decision|1|||
126405541|NCT05063539|454779444|FG000|Overall Study|Progressive Disease|0|||
126405542|NCT05063539|454779445|FG001|Overall Study|Progressive Disease|2|||
126405543|NCT05063539|454779446|FG002|Overall Study|Progressive Disease|0|||
126405544|NCT05063539|454779444|FG000|Overall Study|Withdrawal by Subject|17|||
126405545|NCT05063539|454779445|FG001|Overall Study|Withdrawal by Subject|26|||
126405546|NCT05063539|454779446|FG002|Overall Study|Withdrawal by Subject|14|||
126405547|NCT05063539|454779444|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
126405548|NCT05063539|454779445|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
126405549|NCT05063539|454779446|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
126405550|NCT05063539|454779444|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
126405551|NCT05063539|454779445|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
126405552|NCT05063539|454779446|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
126405553|NCT05063539|454779444|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
126405554|NCT05063539|454779445|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
126405555|NCT05063539|454779446|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
126405556|NCT05063539|454779444|FG000|Overall Study|Discontinued due to Common Close Design|0|||
126405557|NCT05063539|454779445|FG001|Overall Study|Discontinued due to Common Close Design|1|||
126405558|NCT05063539|454779446|FG002|Overall Study|Discontinued due to Common Close Design|0|||
126405559|NCT05063539|454779444|FG000|Overall Study|Participant not co-operative|0|||
126405560|NCT05063539|454779445|FG001|Overall Study|Participant not co-operative|1|||
126405561|NCT05063539|454779446|FG002|Overall Study|Participant not co-operative|0|||
126405562|NCT05063539|454779444|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
126405563|NCT05063539|454779445|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
126405564|NCT05063539|454779446|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
126405565|NCT05063539|454779444|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
126405566|NCT05063539|454779445|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
126405567|NCT05063539|454779446|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
126405568|NCT04256512|454779447|FG000|Overall Study|Withdrawal by Subject|1|||
126405569|NCT01751139|454779448|FG000|Overall Study|Other|135|||
126405570|NCT01751139|454779448|FG000|Overall Study|Sponsor study termination|1609|||
126405571|NCT01751139|454779448|FG000|Overall Study|Lost to Follow-up|240|||
126405572|NCT01751139|454779448|FG000|Overall Study|Withdrawal by Subject|251|||
126405573|NCT01751139|454779448|FG000|Overall Study|Adverse Event|1|||
126405574|NCT01751139|454779448|FG000|Overall Study|Death|31|||
126405575|NCT01867086|454779449|FG000|Overall Study|Disease Progression|1|||
126405576|NCT04279613|454779450|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
126558050|NCT01167023|455334568|FG002|Overall Study|Screen Failure|0|||
126558051|NCT01167023|455334566|FG000|Overall Study|Sponsor Decision|0|||
126558052|NCT01167023|455334567|FG001|Overall Study|Sponsor Decision|1|||
126405577|NCT04279613|454779451|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
126405578|NCT04279613|454779452|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
126405579|NCT04279613|454779453|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
126405580|NCT04279613|454779454|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
126405581|NCT04279613|454779450|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
126405582|NCT04279613|454779451|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
126405583|NCT04279613|454779452|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
126405584|NCT04279613|454779453|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
126405585|NCT04279613|454779454|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
126405586|NCT04279613|454779450|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
126405587|NCT04279613|454779451|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
126405588|NCT04279613|454779452|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
126405589|NCT04279613|454779453|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
126405590|NCT04279613|454779454|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
126405591|NCT04279613|454779450|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
126405592|NCT04279613|454779451|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
126405593|NCT04279613|454779452|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
126405594|NCT04279613|454779453|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
126405595|NCT04279613|454779454|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
126405596|NCT04279613|454779450|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
126405597|NCT04279613|454779451|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
126405598|NCT04279613|454779452|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
126405599|NCT04279613|454779453|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
126405600|NCT04279613|454779454|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
126405601|NCT04428151|454779455|FG000|Overall Study|Death|100|||
126405602|NCT04428151|454779456|FG001|Overall Study|Death|86|||
126405603|NCT04428151|454779457|FG002|Overall Study|Death|57|||
126405604|NCT04428151|454779455|FG000|Overall Study|Lost to Follow-up|1|||
126405605|NCT04428151|454779456|FG001|Overall Study|Lost to Follow-up|1|||
126405606|NCT04428151|454779457|FG002|Overall Study|Lost to Follow-up|0|||
126405607|NCT04428151|454779455|FG000|Overall Study|Withdrawal by Subject|2|||
126405608|NCT04428151|454779456|FG001|Overall Study|Withdrawal by Subject|2|||
126405609|NCT04428151|454779457|FG002|Overall Study|Withdrawal by Subject|3|||
126405610|NCT04428151|454779455|FG000|Overall Study|Participant Ongoing in Study|41|||
126405611|NCT04428151|454779456|FG001|Overall Study|Participant Ongoing in Study|53|||
126405612|NCT04428151|454779457|FG002|Overall Study|Participant Ongoing in Study|28|||
126405613|NCT02704689|454779458|FG000|Overall Study|Physician Decision|1|||
126405614|NCT02704689|454779458|FG000|Overall Study|Study device not implanted|2|||
126405615|NCT02212678|454779461|FG000|Overall Study|Adverse Event|1|||
126405616|NCT02337634|454779462|FG000|Overall Study|Protocol Violation|3|||
126405617|NCT02337634|454779463|FG001|Overall Study|Protocol Violation|1|||
126405618|NCT02337634|454779462|FG000|Overall Study|Lost to Follow-up|1|||
126405619|NCT02337634|454779463|FG001|Overall Study|Lost to Follow-up|0|||
126405620|NCT04068610|454779464|FG000|Overall Study|Death|4|||
126405621|NCT04068610|454779465|FG001|Overall Study|Death|8|||
126405622|NCT04068610|454779466|FG002|Overall Study|Death|13|||
126405623|NCT04068610|454779464|FG000|Overall Study|Lost to Follow-up|0|||
126405624|NCT04068610|454779465|FG001|Overall Study|Lost to Follow-up|2|||
126405625|NCT04068610|454779466|FG002|Overall Study|Lost to Follow-up|0|||
126405626|NCT04068610|454779464|FG000|Overall Study|Withdrawal by Subject|0|||
126405627|NCT04068610|454779465|FG001|Overall Study|Withdrawal by Subject|4|||
126405628|NCT04068610|454779466|FG002|Overall Study|Withdrawal by Subject|2|||
126405629|NCT04068610|454779464|FG000|Overall Study|Other|3|||
126405630|NCT04068610|454779465|FG001|Overall Study|Other|12|||
126405631|NCT04068610|454779466|FG002|Overall Study|Other|11|||
126405632|NCT02428205|454779467|FG000|Overall Study|Lack of Efficacy|1|||
126405633|NCT02428205|454779468|FG001|Overall Study|Lack of Efficacy|0|||
126405634|NCT02428205|454779467|FG000|Overall Study|Lost to Follow-up|1|||
126405635|NCT02428205|454779468|FG001|Overall Study|Lost to Follow-up|1|||
126405636|NCT02428205|454779467|FG000|Overall Study|Worse behavior|0|||
126405637|NCT02428205|454779468|FG001|Overall Study|Worse behavior|1|||
126405638|NCT00527319|454779469|FG000|Overall Study|Withdrawal by Subject|5|||
126405639|NCT00527319|454779470|FG001|Overall Study|Withdrawal by Subject|0|||
126405640|NCT00527319|454779471|FG002|Overall Study|Withdrawal by Subject|1|||
126405641|NCT00527319|454779469|FG000|Overall Study|Lost to Follow-up|1|||
126405642|NCT00527319|454779470|FG001|Overall Study|Lost to Follow-up|0|||
126405643|NCT00527319|454779471|FG002|Overall Study|Lost to Follow-up|0|||
126405644|NCT00527319|454779469|FG000|Overall Study|Death|0|||
126405645|NCT00527319|454779470|FG001|Overall Study|Death|3|||
126405646|NCT00527319|454779471|FG002|Overall Study|Death|1|||
126405647|NCT00527319|454779469|FG000|Overall Study|Intercurrent Medical Illness|0|||
126405648|NCT00527319|454779470|FG001|Overall Study|Intercurrent Medical Illness|1|||
126558053|NCT01167023|455334568|FG002|Overall Study|Sponsor Decision|0|||
126405649|NCT00527319|454779471|FG002|Overall Study|Intercurrent Medical Illness|3|||
126405650|NCT00527319|454779469|FG000|Overall Study|Adverse Event|0|||
126405651|NCT00527319|454779470|FG001|Overall Study|Adverse Event|0|||
126558054|NCT01167023|455334566|FG000|Overall Study|Withdrawal by Subject|0|||
126558055|NCT01167023|455334567|FG001|Overall Study|Withdrawal by Subject|0|||
126558056|NCT01167023|455334568|FG002|Overall Study|Withdrawal by Subject|1|||
126558057|NCT01253200|455334571|FG000|Overall Study|Death|1|||
126558058|NCT01253200|455334572|FG001|Overall Study|Death|0|||
126558059|NCT01253200|455334573|FG002|Overall Study|Death|0|||
126558060|NCT01253200|455334574|FG003|Overall Study|Death|0|||
126558061|NCT01253200|455334575|FG004|Overall Study|Death|0|||
126558062|NCT01253200|455334571|FG000|Overall Study|Lost to Follow-up|1|||
126558063|NCT01253200|455334572|FG001|Overall Study|Lost to Follow-up|1|||
126558064|NCT01253200|455334573|FG002|Overall Study|Lost to Follow-up|0|||
126558065|NCT01253200|455334574|FG003|Overall Study|Lost to Follow-up|0|||
126558066|NCT01253200|455334575|FG004|Overall Study|Lost to Follow-up|0|||
126558067|NCT01253200|455334571|FG000|Overall Study|Withdrawal by Subject|2|||
126558068|NCT01253200|455334572|FG001|Overall Study|Withdrawal by Subject|0|||
126558069|NCT01253200|455334573|FG002|Overall Study|Withdrawal by Subject|0|||
126558070|NCT01253200|455334574|FG003|Overall Study|Withdrawal by Subject|0|||
126558071|NCT01253200|455334575|FG004|Overall Study|Withdrawal by Subject|0|||
126558072|NCT01253200|455334571|FG000|Overall Study|Protocol Violation|1|||
126558073|NCT01253200|455334572|FG001|Overall Study|Protocol Violation|4|||
126558074|NCT01253200|455334573|FG002|Overall Study|Protocol Violation|0|||
126558075|NCT01253200|455334574|FG003|Overall Study|Protocol Violation|0|||
126558076|NCT01253200|455334575|FG004|Overall Study|Protocol Violation|5|||
126558077|NCT01253200|455334571|FG000|Overall Study|intents|10|||
126558078|NCT01253200|455334572|FG001|Overall Study|intents|10|||
126558079|NCT01253200|455334573|FG002|Overall Study|intents|1|||
126721234|NCT01745393|455928612|FG000|12-month Follow-up|Lost to Follow-up|6|||
126721235|NCT01745393|455928613|FG001|12-month Follow-up|Lost to Follow-up|5|||
126721236|NCT00471445|455928615|FG000|Overall Study|Withdrawal by Subject|1|||
126558080|NCT01253200|455334574|FG003|Overall Study|intents|3|||
126558081|NCT01253200|455334575|FG004|Overall Study|intents|0|||
126558082|NCT01253200|455334571|FG000|Overall Study|Attempts|6|||
126558083|NCT01253200|455334572|FG001|Overall Study|Attempts|4|||
126558084|NCT01253200|455334573|FG002|Overall Study|Attempts|1|||
126558085|NCT01253200|455334574|FG003|Overall Study|Attempts|2|||
126558086|NCT01253200|455334575|FG004|Overall Study|Attempts|0|||
126558087|NCT02049437|455334576|FG000|Period 1|Adverse Event|1|||
126405652|NCT00527319|454779471|FG002|Overall Study|Adverse Event|1|||
126405653|NCT00680368|454779477|FG000|Overall Study|not supervised, not eligible|15|||
126405654|NCT00443781|454779482|FG000|Overall Study|Lost to Follow-up|10|||
126405655|NCT00443781|454779482|FG000|Overall Study|Physician Decision|2|||
126405656|NCT00443781|454779482|FG000|Overall Study|Protocol Violation|1|||
126405657|NCT00443781|454779482|FG000|Overall Study|Withdrawal by Subject|6|||
126405658|NCT00443781|454779482|FG000|Overall Study|Unable to comply with study follow up|2|||
126405659|NCT00443781|454779482|FG000|Overall Study|Investigator terminated participation|1|||
126405660|NCT00443781|454779482|FG000|Overall Study|Insurance not covered|2|||
126405661|NCT00443781|454779482|FG000|Overall Study|PD/FAD not done|1|||
126405662|NCT02066415|454779483|FG000|Overall Study|Decision by Sponsor|5|||
126405663|NCT02066415|454779484|FG001|Overall Study|Decision by Sponsor|4|||
126405664|NCT02066415|454779485|FG002|Overall Study|Decision by Sponsor|2|||
126405665|NCT02066415|454779483|FG000|Overall Study|Withdrawal by Subject|9|||
126405666|NCT02066415|454779484|FG001|Overall Study|Withdrawal by Subject|1|||
126405667|NCT02066415|454779485|FG002|Overall Study|Withdrawal by Subject|4|||
126405668|NCT02066415|454779483|FG000|Overall Study|Lost to Follow-up|7|||
126405669|NCT02066415|454779484|FG001|Overall Study|Lost to Follow-up|2|||
126405670|NCT02066415|454779485|FG002|Overall Study|Lost to Follow-up|2|||
126405671|NCT00430937|454779486|FG000|Overall Study|Adverse Event|3|||
126405672|NCT00430937|454779487|FG001|Overall Study|Adverse Event|8|||
126405673|NCT00430937|454779486|FG000|Overall Study|Death|0|||
126405674|NCT00430937|454779487|FG001|Overall Study|Death|1|||
126405675|NCT00430937|454779486|FG000|Overall Study|Lost to Follow-up|6|||
126558088|NCT02049437|455334577|FG001|Period 1|Adverse Event|1|||
126558089|NCT02049437|455334576|FG000|Period 1|Adverse Event|1|||
126558090|NCT02049437|455334577|FG001|Period 1|Adverse Event|0|||
126558091|NCT05567952|455336112|FG000|Overall Study|Lost to Follow-up|3|||
126558092|NCT05567952|455336113|FG001|Overall Study|Lost to Follow-up|2|||
126558093|NCT05567952|455336112|FG000|Overall Study|Withdrawal by Subject|6|||
126558094|NCT05567952|455336113|FG001|Overall Study|Withdrawal by Subject|3|||
126558095|NCT05567952|455336112|FG000|Overall Study|Other|3|||
126405676|NCT00430937|454779487|FG001|Overall Study|Lost to Follow-up|6|||
126405677|NCT00430937|454779486|FG000|Overall Study|Withdrawal by Subject|5|||
126405678|NCT00430937|454779487|FG001|Overall Study|Withdrawal by Subject|2|||
126405679|NCT00430937|454779486|FG000|Overall Study|Protocol Violation|3|||
126405680|NCT00430937|454779487|FG001|Overall Study|Protocol Violation|2|||
126558096|NCT05567952|455336113|FG001|Overall Study|Other|1|||
126558097|NCT00777803|455336114|FG000|Overall Study|Lost to Follow-up|12|||
126558098|NCT00777803|455336115|FG001|Overall Study|Lost to Follow-up|5|||
126558099|NCT00777803|455336114|FG000|Overall Study|Adverse Event|1|||
126558100|NCT00777803|455336115|FG001|Overall Study|Adverse Event|0|||
126558101|NCT00777803|455336114|FG000|Overall Study|Non-compliance|2|||
126558102|NCT00777803|455336115|FG001|Overall Study|Non-compliance|2|||
126558103|NCT04213846|455336116|FG000|Overall Study|Withdrawal by Subject|7|||
126405681|NCT00430937|454779486|FG000|Overall Study|Lack of Efficacy|6|||
126405682|NCT00430937|454779487|FG001|Overall Study|Lack of Efficacy|5|||
126405683|NCT00430937|454779486|FG000|Overall Study|Inappropriate enrollment|2|||
126405684|NCT00430937|454779487|FG001|Overall Study|Inappropriate enrollment|1|||
126405685|NCT00430937|454779486|FG000|Overall Study|Administrative reasons|1|||
126405686|NCT00430937|454779487|FG001|Overall Study|Administrative reasons|0|||
126405687|NCT00430937|454779486|FG000|Overall Study|Protocol discontinuation criteria met|1|||
126405688|NCT00430937|454779487|FG001|Overall Study|Protocol discontinuation criteria met|2|||
126405689|NCT00430937|454779486|FG000|Overall Study|Unable to classify|0|||
126405690|NCT00430937|454779487|FG001|Overall Study|Unable to classify|1|||
126405691|NCT00582738|454779490|FG000|Overall Study|Administrative Problems|7|||
126405692|NCT00582738|454779491|FG001|Overall Study|Administrative Problems|8|||
126405693|NCT00582738|454779490|FG000|Overall Study|Adverse Event|0|||
126405694|NCT00582738|454779491|FG001|Overall Study|Adverse Event|5|||
126405695|NCT00582738|454779490|FG000|Overall Study|Graft Lost|0|||
126405696|NCT00582738|454779491|FG001|Overall Study|Graft Lost|1|||
126405697|NCT00582738|454779490|FG000|Overall Study|Other|1|||
126405698|NCT00582738|454779491|FG001|Overall Study|Other|0|||
126405699|NCT00582738|454779490|FG000|Overall Study|Protocol Violation|1|||
126405700|NCT00582738|454779491|FG001|Overall Study|Protocol Violation|1|||
126405701|NCT00582738|454779490|FG000|Overall Study|Withdrawal by Subject|0|||
126405702|NCT00582738|454779491|FG001|Overall Study|Withdrawal by Subject|3|||
126405703|NCT01639755|454779492|FG000|Overall Study|Study Ongoing|15|||
126405704|NCT01639755|454779492|FG000|Overall Study|Patient had device explantation|4|||
126405705|NCT05059977|454779498|FG000|Overall Study|Withdrawal by Subject|0|||
126405706|NCT05059977|454779499|FG001|Overall Study|Withdrawal by Subject|0|||
126405707|NCT05059977|454779500|FG002|Overall Study|Withdrawal by Subject|1|||
126405708|NCT04109976|454779509|FG000|Overall Study|Withdrawal by Subject|1|||
126405709|NCT04109976|454779510|FG001|Overall Study|Withdrawal by Subject|0|||
126405710|NCT02449018|454779513|FG000|Overall Study|Abnormal laboratory value|0|||
126405711|NCT02449018|454779514|FG001|Overall Study|Abnormal laboratory value|1|||
126405712|NCT02449018|454779513|FG000|Overall Study|Administrative problems|1|||
126405713|NCT02449018|454779514|FG001|Overall Study|Administrative problems|0|||
126405714|NCT02449018|454779513|FG000|Overall Study|Adverse Event|5|||
126405715|NCT02449018|454779514|FG001|Overall Study|Adverse Event|1|||
126405716|NCT02449018|454779513|FG000|Overall Study|Protocol deviation|4|||
126405717|NCT02449018|454779514|FG001|Overall Study|Protocol deviation|0|||
126405718|NCT02449018|454779513|FG000|Overall Study|Patient decision|2|||
126405719|NCT02449018|454779514|FG001|Overall Study|Patient decision|0|||
126405720|NCT03995355|454779515|FG000|Overall Study|Adverse Event|1|||
126405721|NCT03995355|454779516|FG001|Overall Study|Adverse Event|0|||
126405722|NCT03995355|454779515|FG000|Overall Study|Withdrawal by Subject|1|||
126405723|NCT03995355|454779516|FG001|Overall Study|Withdrawal by Subject|0|||
126405724|NCT03995355|454779515|FG000|Overall Study|Scheduling Issues|0|||
126405725|NCT03995355|454779516|FG001|Overall Study|Scheduling Issues|1|||
126405726|NCT03426631|454779517|FG000|Overall Study|Lost to Follow-up|0|||
126405727|NCT03426631|454779518|FG001|Overall Study|Lost to Follow-up|1|||
126405728|NCT03831945|454779519|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
126405729|NCT03831945|454779520|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
126405730|NCT03831945|454779519|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
126405731|NCT03831945|454779520|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
126405732|NCT03831945|454779519|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
126473205|NCT01543698|455034508|FG000|Phase 1b|Death|0|||
126473206|NCT01543698|455034509|FG001|Phase 1b|Death|0|||
126473207|NCT01543698|455034510|FG002|Phase 1b|Death|1|||
126473208|NCT01543698|455034511|FG003|Phase 1b|Death|1|||
126473209|NCT01543698|455034512|FG004|Phase 1b|Death|0|||
126473210|NCT01543698|455034513|FG005|Phase 1b|Death|0|||
126473211|NCT01543698|455034514|FG006|Phase 1b|Death|0|||
126473212|NCT01543698|455034515|FG007|Phase 1b|Death|0|||
126473213|NCT01543698|455034516|FG008|Phase 1b|Death|0|||
126473214|NCT01543698|455034517|FG009|Phase 1b|Death|0|||
126473215|NCT01543698|455034518|FG010|Phase 1b|Death|1|||
126473216|NCT01543698|455034519|FG011|Phase 1b|Death|0|||
126473217|NCT01543698|455034520|FG012|Phase 1b|Death|0|||
126473218|NCT01543698|455034521|FG013|Phase 1b|Death|0|||
126473219|NCT01543698|455034522|FG014|Phase 1b|Death|0|||
126473220|NCT01543698|455034508|FG000|Phase 1b|Withdrawal by Subject|0|||
126473221|NCT01543698|455034509|FG001|Phase 1b|Withdrawal by Subject|1|||
126473222|NCT01543698|455034510|FG002|Phase 1b|Withdrawal by Subject|0|||
126473223|NCT01543698|455034511|FG003|Phase 1b|Withdrawal by Subject|1|||
126473224|NCT01543698|455034512|FG004|Phase 1b|Withdrawal by Subject|0|||
126473225|NCT01543698|455034513|FG005|Phase 1b|Withdrawal by Subject|0|||
126473226|NCT01543698|455034514|FG006|Phase 1b|Withdrawal by Subject|1|||
126473227|NCT01543698|455034515|FG007|Phase 1b|Withdrawal by Subject|0|||
126473228|NCT01543698|455034516|FG008|Phase 1b|Withdrawal by Subject|0|||
126473229|NCT01543698|455034517|FG009|Phase 1b|Withdrawal by Subject|0|||
126473230|NCT01543698|455034518|FG010|Phase 1b|Withdrawal by Subject|0|||
126405733|NCT03831945|454779520|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
126405734|NCT00710385|454779529|FG000|Overall Study|Did not qualify|1|||
126405735|NCT00710385|454779529|FG000|Overall Study|Withdrawal by Subject|1|||
126405736|NCT00710385|454779529|FG000|Overall Study|Undisclosed back pain|1|||
126405737|NCT00710385|454779529|FG000|Overall Study|Physician Decision|1|||
126405738|NCT00710385|454779529|FG000|Overall Study|Undisclosed excessive methadone use|1|||
126405739|NCT03691779|454779534|FG000|Part B (24 Weeks)|Adverse Event|0|||
126405740|NCT03691779|454779535|FG001|Part B (24 Weeks)|Adverse Event|1|||
126558104|NCT04213846|455336117|FG001|Overall Study|Withdrawal by Subject|6|||
126558105|NCT04213846|455336116|FG000|Overall Study|Lost to Follow-up|15|||
126558106|NCT04213846|455336117|FG001|Overall Study|Lost to Follow-up|21|||
126405741|NCT03691779|454779534|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
126405742|NCT03691779|454779535|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
126405743|NCT00267150|454779538|FG000|Overall Study|Adverse Event|1|||
126405744|NCT00521222|454779540|FG000|Overall Study|Lost to Follow-up|0|||
126405745|NCT00521222|454779541|FG001|Overall Study|Lost to Follow-up|0|||
126405746|NCT00521222|454779542|FG002|Overall Study|Lost to Follow-up|1|||
126405747|NCT00521222|454779543|FG003|Overall Study|Lost to Follow-up|1|||
126405748|NCT00521222|454779540|FG000|Overall Study|Withdrawal by Subject|0|||
126405749|NCT00521222|454779541|FG001|Overall Study|Withdrawal by Subject|0|||
126405750|NCT00521222|454779542|FG002|Overall Study|Withdrawal by Subject|2|||
126405751|NCT00521222|454779543|FG003|Overall Study|Withdrawal by Subject|0|||
126405752|NCT00521222|454779540|FG000|Overall Study|Physician Decision|0|||
126405753|NCT00521222|454779541|FG001|Overall Study|Physician Decision|1|||
126405754|NCT00521222|454779542|FG002|Overall Study|Physician Decision|0|||
126405755|NCT00521222|454779543|FG003|Overall Study|Physician Decision|1|||
126405756|NCT03332160|454779546|FG000|Overall Study|Withdrawal by Subject|1|||
126405757|NCT03332160|454779547|FG001|Overall Study|Withdrawal by Subject|1|||
126405758|NCT03332160|454779546|FG000|Overall Study|Adverse Event|0|||
126405759|NCT03332160|454779547|FG001|Overall Study|Adverse Event|1|||
126405760|NCT03332160|454779546|FG000|Overall Study|Developed Exclusion Criteria|0|||
126405761|NCT03332160|454779547|FG001|Overall Study|Developed Exclusion Criteria|1|||
126405762|NCT03332160|454779546|FG000|Overall Study|Non-adherence to treatment|0|||
126405763|NCT03332160|454779547|FG001|Overall Study|Non-adherence to treatment|2|||
126405764|NCT01561963|454779548|FG000|Overall Study|Adverse Event|1|||
126405765|NCT04208087|454779551|FG000|Overall Study|Adverse Event|1|||
126405766|NCT04208087|454779552|FG001|Overall Study|Adverse Event|0|||
126405767|NCT04208087|454779553|FG002|Overall Study|Adverse Event|0|||
126405768|NCT04208087|454779554|FG003|Overall Study|Adverse Event|0|||
126405769|NCT04208087|454779555|FG004|Overall Study|Adverse Event|0|||
126405770|NCT04208087|454779551|FG000|Overall Study|Withdrawal by Subject|0|||
126405771|NCT04208087|454779552|FG001|Overall Study|Withdrawal by Subject|0|||
126405772|NCT04208087|454779553|FG002|Overall Study|Withdrawal by Subject|1|||
126405773|NCT04208087|454779554|FG003|Overall Study|Withdrawal by Subject|0|||
126405774|NCT04208087|454779555|FG004|Overall Study|Withdrawal by Subject|0|||
126405775|NCT04208087|454779551|FG000|Overall Study|Other|0|||
126405776|NCT04208087|454779552|FG001|Overall Study|Other|0|||
126405777|NCT04208087|454779553|FG002|Overall Study|Other|0|||
126405778|NCT04208087|454779554|FG003|Overall Study|Other|0|||
126405779|NCT04208087|454779555|FG004|Overall Study|Other|1|||
126405780|NCT00952614|454779556|FG000|Overall Study|Death|3|||
126405781|NCT00952614|454779556|FG000|Overall Study|Lost to Follow-up|3|||
126405782|NCT00952614|454779556|FG000|Overall Study|other reason|1|||
126405783|NCT04023682|454779557|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
126405784|NCT00637572|454779559|FG000|Overall Study|Adverse Event|1|||
126405785|NCT00637572|454779560|FG001|Overall Study|Adverse Event|2|||
126405786|NCT00637572|454779559|FG000|Overall Study|Death|0|||
126405787|NCT00637572|454779560|FG001|Overall Study|Death|1|||
126405788|NCT00637572|454779559|FG000|Overall Study|Lost to Follow-up|0|||
126405789|NCT00637572|454779560|FG001|Overall Study|Lost to Follow-up|1|||
126405790|NCT00637572|454779559|FG000|Overall Study|Physician Decision|1|||
126405791|NCT00637572|454779560|FG001|Overall Study|Physician Decision|1|||
126405792|NCT00637572|454779559|FG000|Overall Study|Withdrawal by Subject|0|||
126405793|NCT00637572|454779560|FG001|Overall Study|Withdrawal by Subject|2|||
126405794|NCT00637572|454779559|FG000|Overall Study|Illicit Drug Use|1|||
126405795|NCT00637572|454779560|FG001|Overall Study|Illicit Drug Use|0|||
126405796|NCT04268745|454779568|FG000|Overall Study|Lost to Follow-up|2|||
126405797|NCT04268745|454779569|FG001|Overall Study|Lost to Follow-up|3|||
126405798|NCT04268745|454779568|FG000|Overall Study|Withdrawal by Subject|4|||
126405799|NCT04268745|454779569|FG001|Overall Study|Withdrawal by Subject|2|||
126405800|NCT04268745|454779568|FG000|Overall Study|Death in the family|1|||
126405801|NCT04268745|454779569|FG001|Overall Study|Death in the family|0|||
126405802|NCT02540291|454779571|FG000|Overall Study|Death|7|||
126405803|NCT02540291|454779572|FG001|Overall Study|Death|7|||
126405804|NCT02540291|454779573|FG002|Overall Study|Death|5|||
126721237|NCT00471445|455928616|FG001|Overall Study|Withdrawal by Subject|1|||
126405805|NCT02540291|454779574|FG003|Overall Study|Death|7|||
126405806|NCT02540291|454779571|FG000|Overall Study|Lost to Follow-up|0|||
126405807|NCT02540291|454779572|FG001|Overall Study|Lost to Follow-up|0|||
126405808|NCT02540291|454779573|FG002|Overall Study|Lost to Follow-up|1|||
126405809|NCT02540291|454779574|FG003|Overall Study|Lost to Follow-up|0|||
126405810|NCT02540291|454779571|FG000|Overall Study|Withdrawal Of Consent|0|||
126405811|NCT02540291|454779572|FG001|Overall Study|Withdrawal Of Consent|1|||
126405812|NCT02540291|454779573|FG002|Overall Study|Withdrawal Of Consent|0|||
126405813|NCT02540291|454779574|FG003|Overall Study|Withdrawal Of Consent|0|||
126405814|NCT02540291|454779571|FG000|Overall Study|Study Terminated By Sponsor|1|||
126405815|NCT02540291|454779572|FG001|Overall Study|Study Terminated By Sponsor|0|||
126405816|NCT02540291|454779573|FG002|Overall Study|Study Terminated By Sponsor|0|||
126405817|NCT02540291|454779574|FG003|Overall Study|Study Terminated By Sponsor|0|||
126405818|NCT02540291|454779571|FG000|Overall Study|Other|0|||
126405819|NCT02540291|454779572|FG001|Overall Study|Other|0|||
126405820|NCT02540291|454779573|FG002|Overall Study|Other|1|||
126405821|NCT02540291|454779574|FG003|Overall Study|Other|0|||
126405822|NCT00707954|454781206|FG000|Overall Study|Physician Decision|0|||
126405823|NCT00707954|454781207|FG001|Overall Study|Physician Decision|0|||
126405824|NCT00707954|454781208|FG002|Overall Study|Physician Decision|0|||
126405825|NCT00707954|454781209|FG003|Overall Study|Physician Decision|0|||
126405826|NCT00707954|454781210|FG004|Overall Study|Physician Decision|1|||
126405827|NCT01306656|454781211|FG000|Overall Study|Lost to Follow-up|1|||
126405828|NCT01306656|454781212|FG001|Overall Study|Lost to Follow-up|0|||
126405829|NCT01286077|454781213|FG000|Overall Study|Adverse Event|2|||
126405830|NCT01286077|454781214|FG001|Overall Study|Adverse Event|0|||
126405831|NCT01286077|454781213|FG000|Overall Study|Death|1|||
126405832|NCT01286077|454781214|FG001|Overall Study|Death|0|||
126405833|NCT01286077|454781213|FG000|Overall Study|Protocol Violation|1|||
126405834|NCT01286077|454781214|FG001|Overall Study|Protocol Violation|1|||
126405835|NCT01286077|454781213|FG000|Overall Study|Withdrawal by Subject|0|||
126405836|NCT01286077|454781214|FG001|Overall Study|Withdrawal by Subject|2|||
126405837|NCT01286077|454781213|FG000|Overall Study|Intercurrent illness|1|||
126405838|NCT01286077|454781214|FG001|Overall Study|Intercurrent illness|0|||
126405839|NCT01286077|454781213|FG000|Overall Study|Non-compliance|1|||
126405840|NCT01286077|454781214|FG001|Overall Study|Non-compliance|0|||
126405841|NCT01286077|454781213|FG000|Overall Study|The subject starts with alternative MMY|0|||
126405842|NCT01286077|454781214|FG001|Overall Study|The subject starts with alternative MMY|3|||
126405843|NCT01286077|454781213|FG000|Overall Study|Patient's decision to stop treatment|3|||
126405844|NCT01286077|454781214|FG001|Overall Study|Patient's decision to stop treatment|0|||
126405845|NCT01286077|454781213|FG000|Overall Study|Progression of disease|0|||
126405846|NCT01286077|454781214|FG001|Overall Study|Progression of disease|1|||
126405847|NCT01286077|454781213|FG000|Overall Study|refill medication not received in time|1|||
126405848|NCT01286077|454781214|FG001|Overall Study|refill medication not received in time|0|||
126405849|NCT01571232|454781215|FG000|Overall Study|Lost to Follow-up|0|||
126405850|NCT01571232|454781216|FG001|Overall Study|Lost to Follow-up|1|||
126405851|NCT01571232|454781215|FG000|Overall Study|Withdrawal by Subject|1|||
126405852|NCT01571232|454781216|FG001|Overall Study|Withdrawal by Subject|0|||
126405853|NCT01646203|454781217|FG000|Overall Study|Adverse Event|2|||
126405854|NCT01646203|454781218|FG001|Overall Study|Adverse Event|0|||
126405855|NCT01646203|454781219|FG002|Overall Study|Adverse Event|1|||
126405856|NCT01646203|454781217|FG000|Overall Study|Withdrawal by Subject|0|||
126405857|NCT01646203|454781218|FG001|Overall Study|Withdrawal by Subject|1|||
126405858|NCT01646203|454781219|FG002|Overall Study|Withdrawal by Subject|0|||
126405859|NCT01646203|454781217|FG000|Overall Study|Physician's Decision|0|||
126405860|NCT01646203|454781218|FG001|Overall Study|Physician's Decision|1|||
126405861|NCT01646203|454781219|FG002|Overall Study|Physician's Decision|0|||
126405862|NCT03242252|454781221|FG000|Overall Study|At the Participant's own Request|18|||
126405863|NCT03242252|454781222|FG001|Overall Study|At the Participant's own Request|10|||
126405864|NCT03242252|454781223|FG002|Overall Study|At the Participant's own Request|15|||
126405865|NCT03242252|454781221|FG000|Overall Study|Adverse Event|8|||
126405866|NCT03242252|454781222|FG001|Overall Study|Adverse Event|6|||
126405867|NCT03242252|454781223|FG002|Overall Study|Adverse Event|9|||
126405868|NCT03242252|454781221|FG000|Overall Study|Poor Compliance to Protocol|0|||
126405869|NCT03242252|454781222|FG001|Overall Study|Poor Compliance to Protocol|2|||
126405870|NCT03242252|454781223|FG002|Overall Study|Poor Compliance to Protocol|3|||
126405871|NCT03242252|454781221|FG000|Overall Study|Study Terminated by Sponsor|1|||
126405872|NCT03242252|454781222|FG001|Overall Study|Study Terminated by Sponsor|0|||
126405873|NCT03242252|454781223|FG002|Overall Study|Study Terminated by Sponsor|0|||
126405874|NCT03242252|454781221|FG000|Overall Study|Reason not Specified|4|||
126405875|NCT03242252|454781222|FG001|Overall Study|Reason not Specified|4|||
126405876|NCT03242252|454781223|FG002|Overall Study|Reason not Specified|1|||
126473231|NCT01543698|455034519|FG011|Phase 1b|Withdrawal by Subject|0|||
126405877|NCT03242252|454781221|FG000|Overall Study|Lost to Follow-up|5|||
126405878|NCT03242252|454781222|FG001|Overall Study|Lost to Follow-up|1|||
126405879|NCT03242252|454781223|FG002|Overall Study|Lost to Follow-up|4|||
126405880|NCT01659255|454781224|FG000|Overall Study|Adverse Event|0|||
126405881|NCT01659255|454781225|FG001|Overall Study|Adverse Event|0|||
126405882|NCT01659255|454781226|FG002|Overall Study|Adverse Event|0|||
126405883|NCT01659255|454781227|FG003|Overall Study|Adverse Event|0|||
126405884|NCT01659255|454781228|FG004|Overall Study|Adverse Event|0|||
126405885|NCT01659255|454781229|FG005|Overall Study|Adverse Event|1|||
126405886|NCT01659255|454781230|FG006|Overall Study|Adverse Event|1|||
126405887|NCT01659255|454781231|FG007|Overall Study|Adverse Event|0|||
126405888|NCT01659255|454781232|FG008|Overall Study|Adverse Event|0|||
126405889|NCT01659255|454781233|FG009|Overall Study|Adverse Event|1|||
126405890|NCT01659255|454781234|FG010|Overall Study|Adverse Event|0|||
126405891|NCT01659255|454781235|FG011|Overall Study|Adverse Event|1|||
126405892|NCT01659255|454781236|FG012|Overall Study|Adverse Event|0|||
126405893|NCT01659255|454781237|FG013|Overall Study|Adverse Event|2|||
126405894|NCT01659255|454781238|FG014|Overall Study|Adverse Event|0|||
126405895|NCT01659255|454781239|FG015|Overall Study|Adverse Event|1|||
126405896|NCT01659255|454781240|FG016|Overall Study|Adverse Event|0|||
126405897|NCT01659255|454781224|FG000|Overall Study|Death|0|||
126405898|NCT01659255|454781225|FG001|Overall Study|Death|1|||
126405899|NCT01659255|454781226|FG002|Overall Study|Death|0|||
126405900|NCT01659255|454781227|FG003|Overall Study|Death|0|||
126405901|NCT01659255|454781228|FG004|Overall Study|Death|0|||
126405902|NCT01659255|454781229|FG005|Overall Study|Death|0|||
126405903|NCT01659255|454781230|FG006|Overall Study|Death|0|||
126405904|NCT01659255|454781231|FG007|Overall Study|Death|1|||
126405905|NCT01659255|454781232|FG008|Overall Study|Death|1|||
126405906|NCT01659255|454781233|FG009|Overall Study|Death|0|||
126405907|NCT01659255|454781234|FG010|Overall Study|Death|0|||
126405908|NCT01659255|454781235|FG011|Overall Study|Death|0|||
126405909|NCT01659255|454781236|FG012|Overall Study|Death|1|||
126405910|NCT01659255|454781237|FG013|Overall Study|Death|1|||
126405911|NCT01659255|454781238|FG014|Overall Study|Death|2|||
126405912|NCT01659255|454781239|FG015|Overall Study|Death|1|||
126405913|NCT01659255|454781240|FG016|Overall Study|Death|0|||
126405914|NCT01659255|454781224|FG000|Overall Study|Progressive Disease|2|||
126405915|NCT01659255|454781225|FG001|Overall Study|Progressive Disease|0|||
126405916|NCT01659255|454781226|FG002|Overall Study|Progressive Disease|0|||
126405917|NCT01659255|454781227|FG003|Overall Study|Progressive Disease|0|||
126405918|NCT01659255|454781228|FG004|Overall Study|Progressive Disease|0|||
126405919|NCT01659255|454781229|FG005|Overall Study|Progressive Disease|0|||
126405920|NCT01659255|454781230|FG006|Overall Study|Progressive Disease|0|||
126405921|NCT01659255|454781231|FG007|Overall Study|Progressive Disease|1|||
126405922|NCT01659255|454781232|FG008|Overall Study|Progressive Disease|0|||
126405923|NCT01659255|454781233|FG009|Overall Study|Progressive Disease|2|||
126405924|NCT01659255|454781234|FG010|Overall Study|Progressive Disease|2|||
126405925|NCT01659255|454781235|FG011|Overall Study|Progressive Disease|3|||
126405926|NCT01659255|454781236|FG012|Overall Study|Progressive Disease|5|||
126405927|NCT01659255|454781237|FG013|Overall Study|Progressive Disease|13|||
126405928|NCT01659255|454781238|FG014|Overall Study|Progressive Disease|6|||
126405929|NCT01659255|454781239|FG015|Overall Study|Progressive Disease|2|||
126405930|NCT01659255|454781240|FG016|Overall Study|Progressive Disease|3|||
126405931|NCT01659255|454781224|FG000|Overall Study|Withdrew Consent|0|||
126405932|NCT01659255|454781225|FG001|Overall Study|Withdrew Consent|0|||
126405933|NCT01659255|454781226|FG002|Overall Study|Withdrew Consent|0|||
126405934|NCT01659255|454781227|FG003|Overall Study|Withdrew Consent|0|||
126405935|NCT01659255|454781228|FG004|Overall Study|Withdrew Consent|0|||
126405936|NCT01659255|454781229|FG005|Overall Study|Withdrew Consent|0|||
126405937|NCT01659255|454781230|FG006|Overall Study|Withdrew Consent|0|||
126405938|NCT01659255|454781231|FG007|Overall Study|Withdrew Consent|0|||
126405939|NCT01659255|454781232|FG008|Overall Study|Withdrew Consent|0|||
126405940|NCT01659255|454781233|FG009|Overall Study|Withdrew Consent|0|||
126405941|NCT01659255|454781234|FG010|Overall Study|Withdrew Consent|1|||
126405942|NCT01659255|454781235|FG011|Overall Study|Withdrew Consent|0|||
126405943|NCT01659255|454781236|FG012|Overall Study|Withdrew Consent|0|||
126405944|NCT01659255|454781237|FG013|Overall Study|Withdrew Consent|1|||
126405945|NCT01659255|454781238|FG014|Overall Study|Withdrew Consent|0|||
126405946|NCT01659255|454781239|FG015|Overall Study|Withdrew Consent|0|||
126405947|NCT01659255|454781240|FG016|Overall Study|Withdrew Consent|0|||
126405948|NCT01659255|454781224|FG000|Overall Study|Investigator Decision|0|||
126405949|NCT01659255|454781225|FG001|Overall Study|Investigator Decision|0|||
126405950|NCT01659255|454781226|FG002|Overall Study|Investigator Decision|0|||
126405951|NCT01659255|454781227|FG003|Overall Study|Investigator Decision|0|||
126405952|NCT01659255|454781228|FG004|Overall Study|Investigator Decision|0|||
126405953|NCT01659255|454781229|FG005|Overall Study|Investigator Decision|0|||
126405954|NCT01659255|454781230|FG006|Overall Study|Investigator Decision|0|||
126405955|NCT01659255|454781231|FG007|Overall Study|Investigator Decision|0|||
126405956|NCT01659255|454781232|FG008|Overall Study|Investigator Decision|0|||
126405957|NCT01659255|454781233|FG009|Overall Study|Investigator Decision|0|||
126473232|NCT01543698|455034520|FG012|Phase 1b|Withdrawal by Subject|0|||
126405958|NCT01659255|454781234|FG010|Overall Study|Investigator Decision|0|||
126405959|NCT01659255|454781235|FG011|Overall Study|Investigator Decision|0|||
126405960|NCT01659255|454781236|FG012|Overall Study|Investigator Decision|1|||
126405961|NCT01659255|454781237|FG013|Overall Study|Investigator Decision|1|||
126405962|NCT01659255|454781238|FG014|Overall Study|Investigator Decision|0|||
126558107|NCT04423393|455336118|FG000|Overall Study|Withdrawal by Subject|0|||
126558108|NCT04423393|455336119|FG001|Overall Study|Withdrawal by Subject|0|||
126558109|NCT04423393|455336120|FG002|Overall Study|Withdrawal by Subject|0|||
126558110|NCT04423393|455336121|FG003|Overall Study|Withdrawal by Subject|0|||
126558111|NCT04423393|455336122|FG004|Overall Study|Withdrawal by Subject|0|||
126558112|NCT04423393|455336123|FG005|Overall Study|Withdrawal by Subject|1|||
126558113|NCT04423393|455336124|FG006|Overall Study|Withdrawal by Subject|0|||
126558114|NCT04423393|455336125|FG007|Overall Study|Withdrawal by Subject|0|||
126558115|NCT04423393|455336126|FG008|Overall Study|Withdrawal by Subject|0|||
126558116|NCT04423393|455336127|FG009|Overall Study|Withdrawal by Subject|0|||
126558117|NCT04423393|455336128|FG010|Overall Study|Withdrawal by Subject|0|||
126558118|NCT04423393|455336129|FG011|Overall Study|Withdrawal by Subject|0|||
126558119|NCT04423393|455336130|FG012|Overall Study|Withdrawal by Subject|0|||
126558120|NCT04423393|455336131|FG013|Overall Study|Withdrawal by Subject|1|||
126558121|NCT04423393|455336132|FG014|Overall Study|Withdrawal by Subject|0|||
126558122|NCT04423393|455336133|FG015|Overall Study|Withdrawal by Subject|0|||
126558123|NCT04423393|455336134|FG016|Overall Study|Withdrawal by Subject|0|||
126558124|NCT04423393|455336135|FG017|Overall Study|Withdrawal by Subject|0|||
126558125|NCT04423393|455336118|FG000|Overall Study|Sponsor Decision|0|||
126558126|NCT04423393|455336119|FG001|Overall Study|Sponsor Decision|0|||
126558127|NCT04423393|455336120|FG002|Overall Study|Sponsor Decision|0|||
126405963|NCT01659255|454781239|FG015|Overall Study|Investigator Decision|0|||
126405964|NCT01659255|454781240|FG016|Overall Study|Investigator Decision|0|||
126405965|NCT01659255|454781224|FG000|Overall Study|Sponsor's Decision|0|||
126405966|NCT01659255|454781225|FG001|Overall Study|Sponsor's Decision|0|||
126405967|NCT01659255|454781226|FG002|Overall Study|Sponsor's Decision|0|||
126405968|NCT01659255|454781227|FG003|Overall Study|Sponsor's Decision|0|||
126405969|NCT01659255|454781228|FG004|Overall Study|Sponsor's Decision|0|||
126405970|NCT01659255|454781229|FG005|Overall Study|Sponsor's Decision|0|||
126405971|NCT01659255|454781230|FG006|Overall Study|Sponsor's Decision|1|||
126405972|NCT01659255|454781231|FG007|Overall Study|Sponsor's Decision|0|||
126405973|NCT01659255|454781232|FG008|Overall Study|Sponsor's Decision|0|||
126405974|NCT01659255|454781233|FG009|Overall Study|Sponsor's Decision|0|||
126405975|NCT01659255|454781234|FG010|Overall Study|Sponsor's Decision|0|||
126405976|NCT01659255|454781235|FG011|Overall Study|Sponsor's Decision|0|||
126405977|NCT01659255|454781236|FG012|Overall Study|Sponsor's Decision|0|||
126405978|NCT01659255|454781237|FG013|Overall Study|Sponsor's Decision|0|||
126405979|NCT01659255|454781238|FG014|Overall Study|Sponsor's Decision|0|||
126405980|NCT01659255|454781239|FG015|Overall Study|Sponsor's Decision|0|||
126558128|NCT04423393|455336121|FG003|Overall Study|Sponsor Decision|0|||
126558129|NCT04423393|455336122|FG004|Overall Study|Sponsor Decision|0|||
126558130|NCT04423393|455336123|FG005|Overall Study|Sponsor Decision|0|||
126558131|NCT04423393|455336124|FG006|Overall Study|Sponsor Decision|0|||
126558132|NCT04423393|455336125|FG007|Overall Study|Sponsor Decision|0|||
126558133|NCT04423393|455336126|FG008|Overall Study|Sponsor Decision|0|||
126558134|NCT04423393|455336127|FG009|Overall Study|Sponsor Decision|0|||
126405981|NCT01659255|454781240|FG016|Overall Study|Sponsor's Decision|0|||
126405982|NCT01659255|454781224|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405983|NCT01659255|454781225|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405984|NCT01659255|454781226|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405985|NCT01659255|454781227|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405986|NCT01659255|454781228|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405987|NCT01659255|454781229|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405988|NCT01659255|454781230|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405989|NCT01659255|454781231|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405990|NCT01659255|454781232|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405991|NCT01659255|454781233|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405992|NCT01659255|454781234|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405993|NCT01659255|454781235|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405994|NCT01659255|454781236|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405995|NCT01659255|454781237|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405996|NCT01659255|454781238|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405997|NCT01659255|454781239|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
126405998|NCT01659255|454781240|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
126405999|NCT01659255|454781224|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
126406000|NCT01659255|454781225|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
126558135|NCT04423393|455336128|FG010|Overall Study|Sponsor Decision|0|||
126558136|NCT04423393|455336129|FG011|Overall Study|Sponsor Decision|0|||
126558137|NCT04423393|455336130|FG012|Overall Study|Sponsor Decision|0|||
126558138|NCT04423393|455336131|FG013|Overall Study|Sponsor Decision|1|||
126558139|NCT04423393|455336132|FG014|Overall Study|Sponsor Decision|0|||
126558140|NCT04423393|455336133|FG015|Overall Study|Sponsor Decision|0|||
126558141|NCT04423393|455336134|FG016|Overall Study|Sponsor Decision|0|||
126558142|NCT04423393|455336135|FG017|Overall Study|Sponsor Decision|0|||
126406001|NCT01659255|454781226|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
126406002|NCT01659255|454781227|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
126558143|NCT00432159|455336144|FG000|Overall Study|Death|0|||
126558144|NCT00432159|455336145|FG001|Overall Study|Death|1|||
126558145|NCT00432159|455336146|FG002|Overall Study|Death|0|||
126406003|NCT01659255|454781228|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
126406004|NCT01659255|454781229|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
126406005|NCT01659255|454781230|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
126406006|NCT01659255|454781231|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
126406007|NCT01659255|454781232|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
126406008|NCT01659255|454781233|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
126406009|NCT01659255|454781234|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
126406010|NCT01659255|454781235|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
126406011|NCT01659255|454781236|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
126406012|NCT01659255|454781237|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
126406013|NCT01659255|454781238|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
126406014|NCT01659255|454781239|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
126406015|NCT01659255|454781240|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
126406016|NCT01116427|454781241|FG000|Core Phase|Adverse Event|0|||
126406017|NCT01116427|454781242|FG001|Core Phase|Adverse Event|1|||
126406018|NCT01116427|454781241|FG000|Core Phase|Lost to Follow-up|1|||
126406019|NCT01116427|454781242|FG001|Core Phase|Lost to Follow-up|0|||
126406020|NCT01116427|454781241|FG000|Core Phase|Withdrawal by Subject|3|||
126406021|NCT01116427|454781242|FG001|Core Phase|Withdrawal by Subject|0|||
126406022|NCT01116427|454781241|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
126406023|NCT01116427|454781242|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
126406024|NCT01116427|454781241|FG000|Extension Phase|Adverse Event|1|||
126406025|NCT01116427|454781242|FG001|Extension Phase|Adverse Event|1|||
126406026|NCT01116427|454781241|FG000|Extension Phase|Lost to Follow-up|2|||
126406027|NCT01116427|454781242|FG001|Extension Phase|Lost to Follow-up|0|||
126406028|NCT01116427|454781241|FG000|Extension Phase|Withdrawal by Subject|5|||
126406029|NCT01116427|454781242|FG001|Extension Phase|Withdrawal by Subject|1|||
126406030|NCT01116427|454781241|FG000|Extension Phase|Not using appropriate birth control|1|||
126406031|NCT01116427|454781242|FG001|Extension Phase|Not using appropriate birth control|0|||
126406032|NCT02989805|454781243|FG000|Overall Study|invalid consent|6|||
126406033|NCT02989805|454781244|FG001|Overall Study|invalid consent|4|||
126406034|NCT02211313|454781245|FG000|Overall Study|Treatment Failure|5|||
126406035|NCT02211313|454781246|FG001|Overall Study|Treatment Failure|2|||
126406036|NCT02211313|454781245|FG000|Overall Study|No Follow up Questionnaires|1|||
126406037|NCT02211313|454781246|FG001|Overall Study|No Follow up Questionnaires|1|||
126406038|NCT02648217|454781249|FG000|Overall Study|Adverse Event|0|||
126406039|NCT02648217|454781250|FG001|Overall Study|Adverse Event|1|||
126406040|NCT02648217|454781249|FG000|Overall Study|Lost to Follow-up|1|||
126406041|NCT02648217|454781250|FG001|Overall Study|Lost to Follow-up|1|||
126406042|NCT02648217|454781249|FG000|Overall Study|Withdrawal by Subject|4|||
126406043|NCT02648217|454781250|FG001|Overall Study|Withdrawal by Subject|3|||
126406044|NCT02648217|454781249|FG000|Overall Study|Unclassified|5|||
126406045|NCT02648217|454781250|FG001|Overall Study|Unclassified|0|||
126406046|NCT03316950|454781251|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
126406047|NCT03316950|454781252|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
126406048|NCT03316950|454781253|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
126406049|NCT03316950|454781254|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
126406050|NCT03316950|454781251|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
126406051|NCT03316950|454781252|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
126406052|NCT03316950|454781253|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
126406053|NCT03316950|454781254|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
126406054|NCT03316950|454781251|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
126406055|NCT03316950|454781252|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
126473233|NCT01543698|455034521|FG013|Phase 1b|Withdrawal by Subject|0|||
126473234|NCT01543698|455034522|FG014|Phase 1b|Withdrawal by Subject|0|||
126473235|NCT01543698|455034508|FG000|Phase 1b|Adverse Event|1|||
126473236|NCT01543698|455034509|FG001|Phase 1b|Adverse Event|0|||
126473237|NCT01543698|455034510|FG002|Phase 1b|Adverse Event|0|||
126473238|NCT01543698|455034511|FG003|Phase 1b|Adverse Event|1|||
126473239|NCT01543698|455034512|FG004|Phase 1b|Adverse Event|2|||
126473240|NCT01543698|455034513|FG005|Phase 1b|Adverse Event|2|||
126406056|NCT03316950|454781253|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
126406057|NCT03316950|454781254|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
126406058|NCT02392403|454781255|FG000|Overall Study|Adverse Event|1|||
126406059|NCT02392403|454781255|FG000|Overall Study|Death|1|||
126406060|NCT02392403|454781255|FG000|Overall Study|Withdrawal by Subject|1|||
126406061|NCT02335424|454781259|FG000|Overall Study|Withdrawal by Subject|19|||
126406062|NCT02335424|454781259|FG000|Overall Study|Adverse Event|25|||
126473241|NCT01543698|455034514|FG006|Phase 1b|Adverse Event|0|||
126558146|NCT00432159|455336147|FG003|Overall Study|Death|0|||
126558147|NCT00432159|455336148|FG004|Overall Study|Death|0|||
126558148|NCT00432159|455336144|FG000|Overall Study|Failure|9|||
126558149|NCT00432159|455336145|FG001|Overall Study|Failure|5|||
126558150|NCT00432159|455336146|FG002|Overall Study|Failure|3|||
126558151|NCT00432159|455336147|FG003|Overall Study|Failure|2|||
126558152|NCT00432159|455336148|FG004|Overall Study|Failure|3|||
126558153|NCT00432159|455336144|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
126558154|NCT00432159|455336145|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
126558155|NCT00432159|455336146|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
126406063|NCT02335424|454781259|FG000|Overall Study|Death|273|||
126406064|NCT02335424|454781259|FG000|Overall Study|Lost to Follow-up|3|||
126406065|NCT02335424|454781259|FG000|Overall Study|Physician Decision|13|||
126406066|NCT02335424|454781259|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
126406067|NCT02335424|454781259|FG000|Overall Study|Protocol Violation|1|||
126406068|NCT02335424|454781259|FG000|Overall Study|Screen failure|1|||
126406069|NCT02776033|454781262|FG000|Overall Study|Withdrawal by Subject|0|||
126406070|NCT02776033|454781263|FG001|Overall Study|Withdrawal by Subject|0|||
126406071|NCT02776033|454781264|FG002|Overall Study|Withdrawal by Subject|2|||
126406072|NCT02776033|454781262|FG000|Overall Study|Physician Decision|2|||
126406073|NCT02776033|454781263|FG001|Overall Study|Physician Decision|0|||
126406074|NCT02776033|454781264|FG002|Overall Study|Physician Decision|0|||
126406075|NCT02776033|454781262|FG000|Overall Study|Lost to Follow-up|1|||
126406076|NCT02776033|454781263|FG001|Overall Study|Lost to Follow-up|0|||
126406077|NCT02776033|454781264|FG002|Overall Study|Lost to Follow-up|0|||
126406078|NCT02776033|454781262|FG000|Overall Study|Adverse Event|1|||
126406079|NCT02776033|454781263|FG001|Overall Study|Adverse Event|2|||
126406080|NCT02776033|454781264|FG002|Overall Study|Adverse Event|0|||
126406081|NCT00657371|454781265|FG000|Overall Study|Poor bowel preparation|15|||
126406082|NCT00657371|454781265|FG000|Overall Study|Unable to intubate the cecum|5|||
126406083|NCT00657371|454781265|FG000|Overall Study|Protocol Violation|2|||
126406084|NCT00657371|454781265|FG000|Overall Study|Device- related reasons|13|||
126406085|NCT00657371|454781265|FG000|Overall Study|Pre-existing medical condition|4|||
126406086|NCT02712424|454781266|FG000|Overall Study|Lost to Follow-up|34|||
126406087|NCT02712424|454781267|FG001|Overall Study|Lost to Follow-up|32|||
126406088|NCT02713867|454781273|FG000|Randomization|Other Reason|2|||
126406089|NCT02713867|454781274|FG001|Randomization|Other Reason|1|||
126406090|NCT02713867|454781273|FG000|Randomization|Participant Withdrew consent|0|||
126406091|NCT02713867|454781274|FG001|Randomization|Participant Withdrew consent|2|||
126406092|NCT02713867|454781273|FG000|Treatment Period|Other Reasons|22|||
126406093|NCT02713867|454781274|FG001|Treatment Period|Other Reasons|28|||
126406094|NCT02713867|454781273|FG000|Treatment Period|Administrative reason by sponsor|21|||
126406095|NCT02713867|454781274|FG001|Treatment Period|Administrative reason by sponsor|16|||
126406096|NCT02713867|454781273|FG000|Treatment Period|No longer meets study criteria|2|||
126406097|NCT02713867|454781274|FG001|Treatment Period|No longer meets study criteria|1|||
126406098|NCT02713867|454781273|FG000|Treatment Period|Poor/Non Compliance|1|||
126406099|NCT02713867|454781274|FG001|Treatment Period|Poor/Non Compliance|0|||
126406100|NCT02713867|454781273|FG000|Treatment Period|Maximum Clinical Benefit|5|||
126406101|NCT02713867|454781274|FG001|Treatment Period|Maximum Clinical Benefit|6|||
126406102|NCT02713867|454781273|FG000|Treatment Period|Withdrew consent|3|||
126406103|NCT02713867|454781274|FG001|Treatment Period|Withdrew consent|6|||
126406104|NCT02713867|454781273|FG000|Treatment Period|Requested to Discontinue|8|||
126406105|NCT02713867|454781274|FG001|Treatment Period|Requested to Discontinue|8|||
126406106|NCT02713867|454781273|FG000|Treatment Period|AE unrelated to Study Drug|11|||
126406107|NCT02713867|454781274|FG001|Treatment Period|AE unrelated to Study Drug|10|||
126406108|NCT02713867|454781273|FG000|Treatment Period|Death|7|||
126406109|NCT02713867|454781274|FG001|Treatment Period|Death|3|||
126558156|NCT00432159|455336147|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
126558157|NCT00432159|455336148|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
126558158|NCT03850444|455336152|FG000|Overall Study|Adverse Event|16|||
126558159|NCT03850444|455336153|FG001|Overall Study|Adverse Event|10|||
126558160|NCT03850444|455336152|FG000|Overall Study|Death|87|||
126558161|NCT03850444|455336153|FG001|Overall Study|Death|107|||
126406110|NCT02713867|454781273|FG000|Treatment Period|Study Drug Toxicity|16|||
126406111|NCT02713867|454781274|FG001|Treatment Period|Study Drug Toxicity|19|||
126406112|NCT02713867|454781273|FG000|Treatment Period|Disease Progression|82|||
126406113|NCT02713867|454781274|FG001|Treatment Period|Disease Progression|83|||
126406114|NCT02715726|454781278|FG000|Overall Study|Adverse Event|2|||
126406115|NCT02715726|454781279|FG001|Overall Study|Adverse Event|6|||
126406116|NCT02715726|454781278|FG000|Overall Study|Protocol Violation|1|||
126406117|NCT02715726|454781279|FG001|Overall Study|Protocol Violation|0|||
126406118|NCT02715726|454781278|FG000|Overall Study|Death|2|||
126406119|NCT02715726|454781279|FG001|Overall Study|Death|1|||
126406120|NCT02715726|454781278|FG000|Overall Study|Participant moved|1|||
126406121|NCT02715726|454781279|FG001|Overall Study|Participant moved|3|||
126558162|NCT03850444|455336152|FG000|Overall Study|Lost to Follow-up|1|||
126558163|NCT03850444|455336153|FG001|Overall Study|Lost to Follow-up|1|||
126558164|NCT03850444|455336152|FG000|Overall Study|Withdrawal by Subject|1|||
126406122|NCT02715726|454781278|FG000|Overall Study|Other than specified above|11|||
126406123|NCT02715726|454781279|FG001|Overall Study|Other than specified above|15|||
126406124|NCT02715726|454781278|FG000|Overall Study|Randomized but not treated|1|||
126406125|NCT02715726|454781279|FG001|Overall Study|Randomized but not treated|2|||
126406126|NCT03230292|454781280|FG000|Overall Study|Adverse Event|1|||
126406127|NCT03230292|454781280|FG000|Overall Study|Protocol Violation|1|||
126406128|NCT03230292|454781280|FG000|Overall Study|Lost to Follow-up|1|||
126406129|NCT03230292|454781280|FG000|Overall Study|Withdrawal by Subject|3|||
126406130|NCT03629912|454781281|FG000|Overall Study|Lost to Follow-up|19|||
126406131|NCT03629912|454781282|FG001|Overall Study|Lost to Follow-up|7|||
126406132|NCT03629912|454781283|FG002|Overall Study|Lost to Follow-up|5|||
126406133|NCT03629912|454781284|FG003|Overall Study|Lost to Follow-up|1|||
126406134|NCT03629912|454781281|FG000|Overall Study|Withdrawal by Subject|6|||
126406135|NCT03629912|454781282|FG001|Overall Study|Withdrawal by Subject|0|||
126406136|NCT03629912|454781283|FG002|Overall Study|Withdrawal by Subject|1|||
126406137|NCT03629912|454781284|FG003|Overall Study|Withdrawal by Subject|2|||
126406138|NCT03629912|454781281|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
126406139|NCT03629912|454781282|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
126406140|NCT03629912|454781283|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
126406141|NCT03629912|454781284|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
126406142|NCT03629912|454781281|FG000|Overall Study|Death|1|||
126406143|NCT03629912|454781282|FG001|Overall Study|Death|0|||
126406144|NCT03629912|454781283|FG002|Overall Study|Death|0|||
126406145|NCT03629912|454781284|FG003|Overall Study|Death|0|||
126406146|NCT02598128|454781293|FG000|Period A: Days -7 to -1|Adverse Event|1|||
126406147|NCT02598128|454781294|FG001|Period A: Days -7 to -1|Adverse Event|0|||
126406148|NCT02598128|454781295|FG002|Period A: Days -7 to -1|Adverse Event|0|||
126406149|NCT02598128|454781296|FG003|Period A: Days -7 to -1|Adverse Event|0|||
126406150|NCT01459913|454781297|FG000|Overall Study|Adverse Event|0|||
126406151|NCT01459913|454781298|FG001|Overall Study|Adverse Event|0|||
126406152|NCT01459913|454781299|FG002|Overall Study|Adverse Event|0|||
126406153|NCT01459913|454781300|FG003|Overall Study|Adverse Event|3|||
126406154|NCT01459913|454781297|FG000|Overall Study|Withdrawal by Subject|4|||
126406155|NCT01459913|454781298|FG001|Overall Study|Withdrawal by Subject|0|||
126406156|NCT01459913|454781299|FG002|Overall Study|Withdrawal by Subject|0|||
126406157|NCT01459913|454781300|FG003|Overall Study|Withdrawal by Subject|5|||
126406158|NCT01459913|454781297|FG000|Overall Study|Lost to Follow-up|7|||
126406159|NCT01459913|454781298|FG001|Overall Study|Lost to Follow-up|4|||
126406160|NCT01459913|454781299|FG002|Overall Study|Lost to Follow-up|1|||
126406161|NCT01459913|454781300|FG003|Overall Study|Lost to Follow-up|8|||
126406162|NCT01459913|454781297|FG000|Overall Study|Death|0|||
126406163|NCT01459913|454781298|FG001|Overall Study|Death|0|||
126406164|NCT01459913|454781299|FG002|Overall Study|Death|0|||
126406165|NCT01459913|454781300|FG003|Overall Study|Death|1|||
126406166|NCT01459913|454781297|FG000|Overall Study|Non- Compliance|0|||
126406167|NCT01459913|454781298|FG001|Overall Study|Non- Compliance|0|||
126406168|NCT01459913|454781299|FG002|Overall Study|Non- Compliance|0|||
126406169|NCT01459913|454781300|FG003|Overall Study|Non- Compliance|3|||
126406170|NCT01459913|454781297|FG000|Overall Study|Physician Decision|0|||
126406171|NCT01459913|454781298|FG001|Overall Study|Physician Decision|1|||
126406172|NCT01459913|454781299|FG002|Overall Study|Physician Decision|0|||
126406173|NCT01459913|454781300|FG003|Overall Study|Physician Decision|0|||
126406174|NCT01459913|454781297|FG000|Overall Study|Study Terminated by Sponsor|30|||
126406175|NCT01459913|454781298|FG001|Overall Study|Study Terminated by Sponsor|15|||
126406176|NCT01459913|454781299|FG002|Overall Study|Study Terminated by Sponsor|9|||
126406177|NCT01459913|454781300|FG003|Overall Study|Study Terminated by Sponsor|11|||
126406178|NCT01459913|454781297|FG000|Overall Study|Other|0|||
126406179|NCT01459913|454781298|FG001|Overall Study|Other|0|||
126406180|NCT01459913|454781299|FG002|Overall Study|Other|3|||
126406181|NCT01459913|454781300|FG003|Overall Study|Other|1|||
126406182|NCT01459913|454781297|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
126406183|NCT01459913|454781298|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
126406184|NCT01459913|454781299|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
126406185|NCT01459913|454781300|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
126406186|NCT01064687|454781303|FG000|Overall Study|Adverse Event|9|||
126406187|NCT01064687|454781304|FG001|Overall Study|Adverse Event|4|||
126406188|NCT01064687|454781305|FG002|Overall Study|Adverse Event|10|||
126406189|NCT01064687|454781306|FG003|Overall Study|Adverse Event|3|||
126558165|NCT03850444|455336153|FG001|Overall Study|Withdrawal by Subject|5|||
126406190|NCT01064687|454781303|FG000|Overall Study|Death|1|||
126406191|NCT01064687|454781304|FG001|Overall Study|Death|1|||
126406192|NCT01064687|454781305|FG002|Overall Study|Death|0|||
126406193|NCT01064687|454781306|FG003|Overall Study|Death|0|||
126406194|NCT01064687|454781303|FG000|Overall Study|Entry Criteria Not Met|3|||
126406195|NCT01064687|454781304|FG001|Overall Study|Entry Criteria Not Met|0|||
126406196|NCT01064687|454781305|FG002|Overall Study|Entry Criteria Not Met|0|||
126406197|NCT01064687|454781306|FG003|Overall Study|Entry Criteria Not Met|0|||
126406198|NCT01064687|454781303|FG000|Overall Study|Lack of Efficacy|1|||
126406199|NCT01064687|454781304|FG001|Overall Study|Lack of Efficacy|0|||
126406200|NCT01064687|454781305|FG002|Overall Study|Lack of Efficacy|2|||
126406201|NCT01064687|454781306|FG003|Overall Study|Lack of Efficacy|3|||
126406202|NCT01064687|454781303|FG000|Overall Study|Lost to Follow-up|7|||
126406203|NCT01064687|454781304|FG001|Overall Study|Lost to Follow-up|10|||
126406204|NCT01064687|454781305|FG002|Overall Study|Lost to Follow-up|13|||
126406205|NCT01064687|454781306|FG003|Overall Study|Lost to Follow-up|5|||
126406206|NCT01064687|454781303|FG000|Overall Study|Physician Decision|2|||
126406207|NCT01064687|454781304|FG001|Overall Study|Physician Decision|2|||
126406208|NCT01064687|454781305|FG002|Overall Study|Physician Decision|0|||
126406209|NCT01064687|454781306|FG003|Overall Study|Physician Decision|0|||
126406210|NCT01064687|454781303|FG000|Overall Study|Protocol Violation|1|||
126406211|NCT01064687|454781304|FG001|Overall Study|Protocol Violation|1|||
126406212|NCT01064687|454781305|FG002|Overall Study|Protocol Violation|0|||
126406213|NCT01064687|454781306|FG003|Overall Study|Protocol Violation|1|||
126406214|NCT01064687|454781303|FG000|Overall Study|Sponsor Decision|0|||
126406215|NCT01064687|454781304|FG001|Overall Study|Sponsor Decision|0|||
126406216|NCT01064687|454781305|FG002|Overall Study|Sponsor Decision|3|||
126406217|NCT01064687|454781306|FG003|Overall Study|Sponsor Decision|0|||
126406218|NCT01064687|454781303|FG000|Overall Study|Withdrawal by Subject|9|||
126406219|NCT01064687|454781304|FG001|Overall Study|Withdrawal by Subject|7|||
126406220|NCT01064687|454781305|FG002|Overall Study|Withdrawal by Subject|12|||
126406221|NCT01064687|454781306|FG003|Overall Study|Withdrawal by Subject|5|||
126406222|NCT01064687|454781303|FG000|Overall Study|Treatment Noncompliance|1|||
126406223|NCT01064687|454781304|FG001|Overall Study|Treatment Noncompliance|1|||
126406224|NCT01064687|454781305|FG002|Overall Study|Treatment Noncompliance|1|||
126406225|NCT01064687|454781306|FG003|Overall Study|Treatment Noncompliance|0|||
126406226|NCT03134183|454781309|FG000|Overall Study|Withdrawal by Subject|1|||
126406227|NCT03134183|454781310|FG001|Overall Study|Withdrawal by Subject|1|||
126406228|NCT00845065|454781311|FG000|Overall Study|Adverse Event|3|||
126406229|NCT00845065|454781312|FG001|Overall Study|Adverse Event|23|||
126406230|NCT00845065|454781311|FG000|Overall Study|Lack of Efficacy|43|||
126406231|NCT00845065|454781312|FG001|Overall Study|Lack of Efficacy|21|||
126406232|NCT00845065|454781311|FG000|Overall Study|Non-Medical Reasons|1|||
126406233|NCT00845065|454781312|FG001|Overall Study|Non-Medical Reasons|11|||
126406234|NCT02299076|454781313|FG000|Overall Study|Fraudulent Entries|20|||
126406235|NCT02299076|454781314|FG001|Overall Study|Fraudulent Entries|14|||
126406236|NCT00162266|454781315|FG000|Double-Blind Period|Adverse Event|5|||
126406237|NCT00162266|454781316|FG001|Double-Blind Period|Adverse Event|9|||
126406238|NCT00162266|454781317|FG002|Double-Blind Period|Adverse Event|11|||
126406239|NCT00162266|454781318|FG003|Double-Blind Period|Adverse Event|0|||
126406240|NCT00162266|454781315|FG000|Double-Blind Period|Death|0|||
126406241|NCT00162266|454781316|FG001|Double-Blind Period|Death|1|||
126406242|NCT00162266|454781317|FG002|Double-Blind Period|Death|0|||
126406243|NCT00162266|454781318|FG003|Double-Blind Period|Death|0|||
126406244|NCT00162266|454781315|FG000|Double-Blind Period|Lost to Follow-up|1|||
126406245|NCT00162266|454781316|FG001|Double-Blind Period|Lost to Follow-up|2|||
126406246|NCT00162266|454781317|FG002|Double-Blind Period|Lost to Follow-up|0|||
126406247|NCT00162266|454781318|FG003|Double-Blind Period|Lost to Follow-up|0|||
126406248|NCT00162266|454781315|FG000|Double-Blind Period|Other Reason|1|||
126406249|NCT00162266|454781316|FG001|Double-Blind Period|Other Reason|0|||
126406250|NCT00162266|454781317|FG002|Double-Blind Period|Other Reason|1|||
126406251|NCT00162266|454781318|FG003|Double-Blind Period|Other Reason|0|||
126406252|NCT00162266|454781315|FG000|Double-Blind Period|Lack of Efficacy|13|||
126406253|NCT00162266|454781316|FG001|Double-Blind Period|Lack of Efficacy|17|||
126406254|NCT00162266|454781317|FG002|Double-Blind Period|Lack of Efficacy|30|||
126406255|NCT00162266|454781318|FG003|Double-Blind Period|Lack of Efficacy|0|||
126406256|NCT00162266|454781315|FG000|Double-Blind Period|Withdrawal by Subject|5|||
126406257|NCT00162266|454781316|FG001|Double-Blind Period|Withdrawal by Subject|2|||
126406258|NCT00162266|454781317|FG002|Double-Blind Period|Withdrawal by Subject|6|||
126406259|NCT00162266|454781318|FG003|Double-Blind Period|Withdrawal by Subject|0|||
126406260|NCT00162266|454781315|FG000|Open-Label Period|Death|0|||
126406261|NCT00162266|454781316|FG001|Open-Label Period|Death|0|||
126406262|NCT00162266|454781317|FG002|Open-Label Period|Death|0|||
126406263|NCT00162266|454781318|FG003|Open-Label Period|Death|7|||
126406264|NCT00162266|454781315|FG000|Open-Label Period|Adverse Event|0|||
126406265|NCT00162266|454781316|FG001|Open-Label Period|Adverse Event|0|||
126406266|NCT00162266|454781317|FG002|Open-Label Period|Adverse Event|0|||
126406267|NCT00162266|454781318|FG003|Open-Label Period|Adverse Event|46|||
126406268|NCT00162266|454781315|FG000|Open-Label Period|Lack of Efficacy|0|||
126406269|NCT00162266|454781316|FG001|Open-Label Period|Lack of Efficacy|0|||
126406270|NCT00162266|454781317|FG002|Open-Label Period|Lack of Efficacy|0|||
126406271|NCT00162266|454781318|FG003|Open-Label Period|Lack of Efficacy|26|||
126406272|NCT00162266|454781315|FG000|Open-Label Period|Lost to Follow-up|0|||
126406273|NCT00162266|454781316|FG001|Open-Label Period|Lost to Follow-up|0|||
126406274|NCT00162266|454781317|FG002|Open-Label Period|Lost to Follow-up|0|||
126406275|NCT00162266|454781318|FG003|Open-Label Period|Lost to Follow-up|3|||
126406276|NCT00162266|454781315|FG000|Open-Label Period|Withdrawal by Subject|0|||
126406277|NCT00162266|454781316|FG001|Open-Label Period|Withdrawal by Subject|0|||
126406278|NCT00162266|454781317|FG002|Open-Label Period|Withdrawal by Subject|0|||
126406279|NCT00162266|454781318|FG003|Open-Label Period|Withdrawal by Subject|31|||
126406280|NCT00162266|454781315|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
126406281|NCT00162266|454781316|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
126406282|NCT00162266|454781317|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
126406283|NCT00162266|454781318|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
126406284|NCT00162266|454781315|FG000|Open-Label Period|Other Reasons|0|||
126406285|NCT00162266|454781316|FG001|Open-Label Period|Other Reasons|0|||
126406286|NCT00162266|454781317|FG002|Open-Label Period|Other Reasons|0|||
126406287|NCT00162266|454781318|FG003|Open-Label Period|Other Reasons|15|||
126406288|NCT01969721|454781319|FG000|Overall Study|Adverse Event|3|||
126406289|NCT01969721|454781320|FG001|Overall Study|Adverse Event|8|||
126406290|NCT01969721|454781321|FG002|Overall Study|Adverse Event|3|||
126406291|NCT01969721|454781322|FG003|Overall Study|Adverse Event|2|||
126406292|NCT01969721|454781319|FG000|Overall Study|Lack of Efficacy|0|||
126406293|NCT01969721|454781320|FG001|Overall Study|Lack of Efficacy|0|||
126406294|NCT01969721|454781321|FG002|Overall Study|Lack of Efficacy|1|||
126406295|NCT01969721|454781322|FG003|Overall Study|Lack of Efficacy|0|||
126406296|NCT01969721|454781319|FG000|Overall Study|Non compliant with protocol|1|||
126406297|NCT01969721|454781320|FG001|Overall Study|Non compliant with protocol|1|||
126406298|NCT01969721|454781321|FG002|Overall Study|Non compliant with protocol|0|||
126406299|NCT01969721|454781322|FG003|Overall Study|Non compliant with protocol|2|||
126406300|NCT01969721|454781319|FG000|Overall Study|Other not defined above|0|||
126406301|NCT01969721|454781320|FG001|Overall Study|Other not defined above|2|||
126406302|NCT01969721|454781321|FG002|Overall Study|Other not defined above|0|||
126406303|NCT01969721|454781322|FG003|Overall Study|Other not defined above|0|||
126406304|NCT01969721|454781319|FG000|Overall Study|Discontinued during washout periods.|0|||
126406305|NCT01969721|454781320|FG001|Overall Study|Discontinued during washout periods.|1|||
126406306|NCT01969721|454781321|FG002|Overall Study|Discontinued during washout periods.|1|||
126406307|NCT01969721|454781322|FG003|Overall Study|Discontinued during washout periods.|2|||
126406308|NCT01012323|454781324|FG000|Overall Study|Investigator Judgment|1|||
126406309|NCT00495755|454781325|FG000|Overall Study|Adverse Event|3|||
126406310|NCT02117349|454781326|FG000|Overall Study|Withdrawal by Subject|1|||
126406311|NCT02117349|454781327|FG001|Overall Study|Withdrawal by Subject|0|||
126406312|NCT02117349|454781326|FG000|Overall Study|Lost to Follow-up|1|||
126406313|NCT02117349|454781327|FG001|Overall Study|Lost to Follow-up|1|||
126406314|NCT02117349|454781326|FG000|Overall Study|Death|1|||
126406315|NCT02117349|454781327|FG001|Overall Study|Death|0|||
126406316|NCT02265796|454781328|FG000|Overall Study|Death|1|||
126406317|NCT02265796|454781329|FG001|Overall Study|Death|0|||
126406318|NCT02265796|454781328|FG000|Overall Study|started on excluded medication|1|||
126406319|NCT02265796|454781329|FG001|Overall Study|started on excluded medication|0|||
126406320|NCT02265796|454781328|FG000|Overall Study|Withdrawal by Subject|1|||
126406321|NCT02265796|454781329|FG001|Overall Study|Withdrawal by Subject|1|||
126406322|NCT02477553|454781330|FG000|Overall Study|Screening up-to-date|12|||
126406323|NCT02477553|454781331|FG001|Overall Study|Screening up-to-date|13|||
126406324|NCT02477553|454781330|FG000|Overall Study|No MD visit|1|||
126406325|NCT02477553|454781331|FG001|Overall Study|No MD visit|1|||
126406326|NCT02477553|454781330|FG000|Overall Study|Workup consistent w/CRC|1|||
126406327|NCT02477553|454781331|FG001|Overall Study|Workup consistent w/CRC|1|||
126406328|NCT02477553|454781330|FG000|Overall Study|Technical issues with intervention|2|||
126406329|NCT02477553|454781331|FG001|Overall Study|Technical issues with intervention|0|||
126406330|NCT02477553|454781330|FG000|Overall Study|Elevated risk for CRC|2|||
126406331|NCT02477553|454781331|FG001|Overall Study|Elevated risk for CRC|2|||
126406332|NCT02477553|454781330|FG000|Overall Study|MD advised against screening|1|||
126406333|NCT02477553|454781331|FG001|Overall Study|MD advised against screening|3|||
126406334|NCT02477553|454781330|FG000|Overall Study|patient deceased|1|||
126406335|NCT02477553|454781331|FG001|Overall Study|patient deceased|0|||
126406336|NCT02963701|454781332|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
126406337|NCT02963701|454781333|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
126406338|NCT00896649|454781336|FG000|Overall Study|Physician Decision|1|||
126406339|NCT00896649|454781336|FG000|Overall Study|Pregnancy|1|||
126406340|NCT00896649|454781336|FG000|Overall Study|missing documentation|1|||
126406341|NCT00896649|454781336|FG000|Overall Study|technical difficulties|2|||
126406342|NCT03652675|454781337|FG000|Overall Study|Lost to Follow-up|4|||
126406343|NCT03652675|454781338|FG001|Overall Study|Lost to Follow-up|4|||
126406344|NCT01638559|454781339|FG000|Overall Study|Lost to Follow-up|1|||
126406345|NCT01638559|454781339|FG000|Overall Study|Withdrawal by Subject|1|||
126406346|NCT01638559|454781339|FG000|Overall Study|Subject declined to travel for biopsy|1|||
126406347|NCT00483002|454781342|FG000|Overall Study|Adverse Event|68|||
126406348|NCT00483002|454781342|FG000|Overall Study|Lack of Efficacy|555|||
126406349|NCT00483002|454781342|FG000|Overall Study|Lost to Follow-up|962|||
126406350|NCT00483002|454781342|FG000|Overall Study|Other|2|||
126406351|NCT00483002|454781342|FG000|Overall Study|Other|967|||
126406352|NCT03442296|454781343|FG000|3 Month Follow-up|Death|3|||
126406353|NCT03442296|454781344|FG001|3 Month Follow-up|Death|1|||
126406354|NCT03442296|454781343|FG000|3 Month Follow-up|Lost to Follow-up|1|||
126406355|NCT03442296|454781344|FG001|3 Month Follow-up|Lost to Follow-up|1|||
126406356|NCT03442296|454781343|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
126406357|NCT03442296|454781344|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
126406358|NCT03442296|454781343|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
126406359|NCT03442296|454781344|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
126406360|NCT03442296|454781343|FG000|12 Month Follow-up|Incomplete measurement|1|||
126406361|NCT03442296|454781344|FG001|12 Month Follow-up|Incomplete measurement|1|||
126406362|NCT01403116|454781345|FG000|Overall Study|Adverse Event|7|||
126406363|NCT01403116|454781346|FG001|Overall Study|Adverse Event|4|||
126406364|NCT01403116|454781345|FG000|Overall Study|Lost to Follow-up|7|||
126406365|NCT01403116|454781346|FG001|Overall Study|Lost to Follow-up|5|||
126406366|NCT01403116|454781345|FG000|Overall Study|Withdrawal by Subject|12|||
126406367|NCT01403116|454781346|FG001|Overall Study|Withdrawal by Subject|15|||
126406368|NCT01403116|454781345|FG000|Overall Study|Non-compliance of study drug|3|||
126406369|NCT01403116|454781346|FG001|Overall Study|Non-compliance of study drug|0|||
126473242|NCT01543698|455034515|FG007|Phase 1b|Adverse Event|0|||
126473243|NCT01543698|455034516|FG008|Phase 1b|Adverse Event|1|||
126473244|NCT01543698|455034517|FG009|Phase 1b|Adverse Event|1|||
126473245|NCT01543698|455034518|FG010|Phase 1b|Adverse Event|2|||
126406370|NCT01403116|454781345|FG000|Overall Study|Protocol Violation|0|||
126406371|NCT01403116|454781346|FG001|Overall Study|Protocol Violation|1|||
126406372|NCT01403116|454781345|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
126406373|NCT01403116|454781346|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
126406374|NCT01403116|454781345|FG000|Overall Study|Hct >54%|2|||
126406375|NCT01403116|454781346|FG001|Overall Study|Hct >54%|0|||
126406376|NCT01403116|454781345|FG000|Overall Study|unable to keep appointments|0|||
126406377|NCT01403116|454781346|FG001|Overall Study|unable to keep appointments|2|||
126406378|NCT01895309|454781347|FG000|Overall Study|Adverse Event|13|||
126406379|NCT01895309|454781348|FG001|Overall Study|Adverse Event|17|||
126406380|NCT01895309|454781347|FG000|Overall Study|Protocol Violation|1|||
126406381|NCT01895309|454781348|FG001|Overall Study|Protocol Violation|0|||
126406382|NCT01895309|454781347|FG000|Overall Study|Lack of Efficacy|1|||
126406383|NCT01895309|454781348|FG001|Overall Study|Lack of Efficacy|3|||
126406384|NCT01895309|454781347|FG000|Overall Study|Lost to Follow-up|1|||
126406385|NCT01895309|454781348|FG001|Overall Study|Lost to Follow-up|3|||
126406386|NCT01895309|454781347|FG000|Overall Study|Physician Decision|15|||
126406387|NCT01895309|454781348|FG001|Overall Study|Physician Decision|10|||
126406388|NCT01895309|454781347|FG000|Overall Study|Withdrawal by Subject|9|||
126406389|NCT01895309|454781348|FG001|Overall Study|Withdrawal by Subject|18|||
126473246|NCT01543698|455034519|FG011|Phase 1b|Adverse Event|0|||
126473247|NCT01543698|455034520|FG012|Phase 1b|Adverse Event|0|||
126473248|NCT01543698|455034521|FG013|Phase 1b|Adverse Event|0|||
126473249|NCT01543698|455034522|FG014|Phase 1b|Adverse Event|0|||
126473250|NCT01543698|455034508|FG000|Phase 1b|Administrative problems|1|||
126473251|NCT01543698|455034509|FG001|Phase 1b|Administrative problems|0|||
126473252|NCT01543698|455034510|FG002|Phase 1b|Administrative problems|0|||
126473253|NCT01543698|455034511|FG003|Phase 1b|Administrative problems|0|||
126473254|NCT01543698|455034512|FG004|Phase 1b|Administrative problems|1|||
126473255|NCT01543698|455034513|FG005|Phase 1b|Administrative problems|0|||
126473256|NCT01543698|455034514|FG006|Phase 1b|Administrative problems|0|||
126473257|NCT01543698|455034515|FG007|Phase 1b|Administrative problems|1|||
126473258|NCT01543698|455034516|FG008|Phase 1b|Administrative problems|0|||
126473259|NCT01543698|455034517|FG009|Phase 1b|Administrative problems|0|||
126473260|NCT01543698|455034518|FG010|Phase 1b|Administrative problems|2|||
126473261|NCT01543698|455034519|FG011|Phase 1b|Administrative problems|0|||
126558166|NCT03850444|455336152|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
126558167|NCT03850444|455336153|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
126558168|NCT04096365|455336154|FG000|Overall Study|Adverse Event|1|||
126558169|NCT01598987|455336156|FG000|Baseline to Month 12|Administrative problems|2|||
126558170|NCT01598987|455336156|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
126558171|NCT01598987|455336156|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
126558172|NCT01598987|455336156|FG000|Baseline to 24 Month|Administrative problems|2|||
126558173|NCT01598987|455336156|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
126406390|NCT03517969|454783076|FG000|Overall Study|Never started protocol treatment|3|||
126473262|NCT01543698|455034520|FG012|Phase 1b|Administrative problems|0|||
126473263|NCT01543698|455034521|FG013|Phase 1b|Administrative problems|0|||
126473264|NCT01543698|455034522|FG014|Phase 1b|Administrative problems|0|||
126406391|NCT03517969|454783077|FG001|Overall Study|Never started protocol treatment|5|||
126406392|NCT03517969|454783076|FG000|Overall Study|Disease progression|11|||
126406393|NCT03517969|454783077|FG001|Overall Study|Disease progression|16|||
126406394|NCT03517969|454783076|FG000|Overall Study|PSA progression|8|||
126406395|NCT03517969|454783077|FG001|Overall Study|PSA progression|1|||
126406396|NCT03517969|454783076|FG000|Overall Study|Clinical progression|4|||
126406397|NCT03517969|454783077|FG001|Overall Study|Clinical progression|2|||
126473265|NCT01543698|455034508|FG000|Phase 1b|Protocol Violation|2|||
126473266|NCT01543698|455034509|FG001|Phase 1b|Protocol Violation|0|||
126473267|NCT01543698|455034510|FG002|Phase 1b|Protocol Violation|0|||
126406398|NCT03517969|454783076|FG000|Overall Study|Adverse Event|5|||
126406399|NCT03517969|454783077|FG001|Overall Study|Adverse Event|4|||
126406400|NCT03517969|454783076|FG000|Overall Study|Intercurrent illness|1|||
126406401|NCT03517969|454783077|FG001|Overall Study|Intercurrent illness|2|||
126406402|NCT03517969|454783076|FG000|Overall Study|Death|1|||
126406403|NCT03517969|454783077|FG001|Overall Study|Death|1|||
126406404|NCT03517969|454783076|FG000|Overall Study|Withdrawal by Subject|1|||
126406405|NCT03517969|454783077|FG001|Overall Study|Withdrawal by Subject|2|||
126406406|NCT03517969|454783076|FG000|Overall Study|Physician Decision|1|||
126406407|NCT03517969|454783077|FG001|Overall Study|Physician Decision|1|||
126406408|NCT03517969|454783076|FG000|Overall Study|No clinical benefit|1|||
126406409|NCT03517969|454783077|FG001|Overall Study|No clinical benefit|0|||
126406410|NCT03517969|454783076|FG000|Overall Study|Delayed treatment for dental treatment|1|||
126406411|NCT03517969|454783077|FG001|Overall Study|Delayed treatment for dental treatment|0|||
126406412|NCT03517969|454783076|FG000|Overall Study|Difficult to maintain appointment|0|||
126406413|NCT03517969|454783077|FG001|Overall Study|Difficult to maintain appointment|1|||
126406414|NCT03517969|454783076|FG000|Overall Study|Protocol Violation|0|||
126406415|NCT03517969|454783077|FG001|Overall Study|Protocol Violation|1|||
126406416|NCT04051827|454783082|FG000|Overall Study|Death|1|||
126406417|NCT04051827|454783082|FG000|Overall Study|Withdrawal by Subject|4|||
126406418|NCT04051827|454783082|FG000|Overall Study|Progressive disease|16|||
126406419|NCT04051827|454783082|FG000|Overall Study|Physician Decision|1|||
126406420|NCT04051827|454783082|FG000|Overall Study|Other|4|||
126406421|NCT03344172|454783085|FG000|Overall Study|Received <1 dose of treatment|1|||
126406422|NCT03344172|454783086|FG001|Overall Study|Received <1 dose of treatment|0|||
126406423|NCT03779503|454783087|FG000|First Intervention|Adverse Event|0|||
126406424|NCT03779503|454783088|FG001|First Intervention|Adverse Event|1|||
126406425|NCT03779503|454783087|FG000|First Intervention|Withdrawal by Subject|1|||
126406426|NCT03779503|454783088|FG001|First Intervention|Withdrawal by Subject|0|||
126406427|NCT01177969|454783089|FG000|Overall Study|Protocol Violation|2|||
126406428|NCT01177969|454783090|FG001|Overall Study|Protocol Violation|1|||
126406429|NCT01177969|454783089|FG000|Overall Study|Withdrawal by Subject|1|||
126406430|NCT01177969|454783090|FG001|Overall Study|Withdrawal by Subject|2|||
126406431|NCT00687609|454783091|FG000|Overall Study|Physician Decision|1|||
126406432|NCT00687609|454783091|FG000|Overall Study|Withdrawal by Subject|2|||
126406433|NCT00908037|454783092|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406434|NCT00908037|454783093|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406435|NCT00908037|454783094|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406436|NCT00908037|454783095|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406437|NCT00908037|454783096|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
126406438|NCT00908037|454783097|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406439|NCT00908037|454783098|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
126406440|NCT00908037|454783099|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406441|NCT00908037|454783100|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
126406442|NCT00908037|454783101|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406443|NCT00908037|454783102|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406444|NCT00908037|454783103|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
126406445|NCT00908037|454783092|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406446|NCT00908037|454783093|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406447|NCT00908037|454783094|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406448|NCT00908037|454783095|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126721238|NCT00471445|455928615|FG000|Overall Study|Ineligible|1|||
126721239|NCT00471445|455928616|FG001|Overall Study|Ineligible|0|||
126721240|NCT00471445|455928615|FG000|Overall Study|Protocol Violation|0|||
126721241|NCT00471445|455928616|FG001|Overall Study|Protocol Violation|1|||
126406449|NCT00908037|454783096|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
126406450|NCT00908037|454783097|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406451|NCT00908037|454783098|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406452|NCT00908037|454783099|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406453|NCT00908037|454783100|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
126406454|NCT00908037|454783101|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406455|NCT00908037|454783102|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406456|NCT00908037|454783103|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
126406457|NCT00908037|454783092|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126473268|NCT01543698|455034511|FG003|Phase 1b|Protocol Violation|0|||
126473269|NCT01543698|455034512|FG004|Phase 1b|Protocol Violation|0|||
126406458|NCT00908037|454783093|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126473270|NCT01543698|455034513|FG005|Phase 1b|Protocol Violation|0|||
126473271|NCT01543698|455034514|FG006|Phase 1b|Protocol Violation|0|||
126473272|NCT01543698|455034515|FG007|Phase 1b|Protocol Violation|0|||
126473273|NCT01543698|455034516|FG008|Phase 1b|Protocol Violation|0|||
126473274|NCT01543698|455034517|FG009|Phase 1b|Protocol Violation|0|||
126473275|NCT01543698|455034518|FG010|Phase 1b|Protocol Violation|0|||
126558174|NCT02107274|455336157|FG000|Treatment vs. Placebo|Adverse Event|3|||
126558175|NCT02107274|455336158|FG001|Treatment vs. Placebo|Adverse Event|0|||
126558176|NCT02107274|455336157|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
126558177|NCT02107274|455336158|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
126558178|NCT02107274|455336157|FG000|Control Phase|Lost to Follow-up|1|||
126558179|NCT02107274|455336158|FG001|Control Phase|Lost to Follow-up|1|||
126558180|NCT02107274|455336157|FG000|Control Phase|Death|2|||
126406459|NCT00908037|454783094|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406460|NCT00908037|454783095|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
126406461|NCT00908037|454783096|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406462|NCT00908037|454783097|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406463|NCT00908037|454783098|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
126406464|NCT00908037|454783099|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406465|NCT00908037|454783100|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406466|NCT00908037|454783101|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406467|NCT00908037|454783102|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406468|NCT00908037|454783103|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
126406469|NCT00908037|454783092|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406470|NCT00908037|454783093|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406471|NCT00908037|454783094|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406472|NCT00908037|454783095|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406473|NCT00908037|454783096|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406474|NCT00908037|454783097|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406475|NCT00908037|454783098|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406476|NCT00908037|454783099|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406477|NCT00908037|454783100|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406478|NCT00908037|454783101|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406479|NCT00908037|454783102|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
126406480|NCT00908037|454783103|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
126406481|NCT00908037|454783092|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406482|NCT00908037|454783093|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406483|NCT00908037|454783094|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406484|NCT00908037|454783095|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406485|NCT00908037|454783096|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406486|NCT00908037|454783097|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406487|NCT00908037|454783098|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406488|NCT00908037|454783099|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406489|NCT00908037|454783100|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406490|NCT00908037|454783101|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
126406491|NCT00908037|454783102|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
126406492|NCT00908037|454783103|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
126406493|NCT00908037|454783092|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406494|NCT00908037|454783093|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406495|NCT00908037|454783094|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406496|NCT00908037|454783095|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406497|NCT00908037|454783096|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406498|NCT00908037|454783097|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406499|NCT00908037|454783098|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406500|NCT00908037|454783099|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406501|NCT00908037|454783100|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406502|NCT00908037|454783101|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
126406503|NCT00908037|454783102|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406504|NCT00908037|454783103|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
126406505|NCT00908037|454783092|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406506|NCT00908037|454783093|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406507|NCT00908037|454783094|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406508|NCT00908037|454783095|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406509|NCT00908037|454783096|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406510|NCT00908037|454783097|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406511|NCT00908037|454783098|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406512|NCT00908037|454783099|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406513|NCT00908037|454783100|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406514|NCT00908037|454783101|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126558181|NCT02107274|455336158|FG001|Control Phase|Death|0|||
126558182|NCT02107274|455336157|FG000|Control Phase|Adverse Event|0|||
126558183|NCT02107274|455336158|FG001|Control Phase|Adverse Event|1|||
126558184|NCT01036087|455336159|FG000|Overall Study|Adverse Event|2|||
126558185|NCT01036087|455336159|FG000|Overall Study|Lack of Efficacy|1|||
126558186|NCT01021878|455336163|FG000|Overall Study|Lost to Follow-up|4|||
126406515|NCT00908037|454783102|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
126406516|NCT00908037|454783103|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
126406517|NCT00908037|454783092|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406518|NCT00908037|454783093|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406519|NCT00908037|454783094|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406520|NCT00908037|454783095|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406521|NCT00908037|454783096|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406522|NCT00908037|454783097|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406523|NCT00908037|454783098|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406524|NCT00908037|454783099|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406525|NCT00908037|454783100|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406526|NCT00908037|454783101|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
126406527|NCT00908037|454783102|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406528|NCT00908037|454783103|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
126406529|NCT00908037|454783092|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406530|NCT00908037|454783093|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406531|NCT00908037|454783094|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406532|NCT00908037|454783095|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406533|NCT00908037|454783096|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406534|NCT00908037|454783097|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406535|NCT00908037|454783098|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406536|NCT00908037|454783099|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406537|NCT00908037|454783100|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406538|NCT00908037|454783101|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126558187|NCT01021878|455336164|FG001|Overall Study|Lost to Follow-up|3|||
126558188|NCT01021878|455336163|FG000|Overall Study|Death|0|||
126558189|NCT01021878|455336164|FG001|Overall Study|Death|1|||
126558190|NCT01021878|455336163|FG000|Overall Study|Adverse Event|6|||
126558191|NCT01021878|455336164|FG001|Overall Study|Adverse Event|5|||
126558192|NCT01021878|455336163|FG000|Overall Study|Transplantation|6|||
126558193|NCT01021878|455336164|FG001|Overall Study|Transplantation|1|||
126558194|NCT05305040|455336168|FG000|Overall Study|Not Dosed|37|||
126558195|NCT05305040|455336169|FG001|Overall Study|Not Dosed|37|||
126558196|NCT05305040|455336168|FG000|Overall Study|Study Closure|34|||
126558197|NCT05305040|455336169|FG001|Overall Study|Study Closure|46|||
126558198|NCT05305040|455336168|FG000|Overall Study|Death|14|||
126558199|NCT05305040|455336169|FG001|Overall Study|Death|13|||
126558200|NCT05305040|455336168|FG000|Overall Study|Withdrawal by Subject|15|||
126406539|NCT00908037|454783102|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
126406540|NCT00908037|454783103|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
126406541|NCT00869401|454783105|FG000|Overall Study|Withdrawal by Subject|0|||
126558201|NCT05305040|455336169|FG001|Overall Study|Withdrawal by Subject|10|||
126558202|NCT05305040|455336168|FG000|Overall Study|Other|13|||
126558203|NCT05305040|455336169|FG001|Overall Study|Other|10|||
126558204|NCT05305040|455336168|FG000|Overall Study|Primary Malignancy Relapse|3|||
126558205|NCT05305040|455336169|FG001|Overall Study|Primary Malignancy Relapse|4|||
126558206|NCT05305040|455336168|FG000|Overall Study|Adverse Event|3|||
126558207|NCT05305040|455336169|FG001|Overall Study|Adverse Event|3|||
126558208|NCT05305040|455336168|FG000|Overall Study|Lost to Follow-up|2|||
126558209|NCT05305040|455336169|FG001|Overall Study|Lost to Follow-up|1|||
126558210|NCT05305040|455336168|FG000|Overall Study|Graft versus host disease|2|||
126558211|NCT05305040|455336169|FG001|Overall Study|Graft versus host disease|0|||
126558212|NCT05305040|455336168|FG000|Overall Study|Investigator's Decision|1|||
126558213|NCT05305040|455336169|FG001|Overall Study|Investigator's Decision|1|||
126558214|NCT05305040|455336168|FG000|Overall Study|COVID-19 Reasons|1|||
126558215|NCT05305040|455336169|FG001|Overall Study|COVID-19 Reasons|0|||
126558216|NCT00465361|455336170|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
126558217|NCT05406791|455336171|FG000|Overall Study|Lost to Follow-up|13|||
126558218|NCT05406791|455336172|FG001|Overall Study|Lost to Follow-up|10|||
126558219|NCT01333943|455336176|FG000|Overall Study|Known neuropathy|1|||
126558220|NCT01333943|455336177|FG001|Overall Study|Known neuropathy|0|||
126558221|NCT01511536|455336184|FG000|Phase 1|Other|0|||
126558222|NCT01511536|455336185|FG001|Phase 1|Other|1|||
126558223|NCT01511536|455336186|FG002|Phase 1|Other|0|||
126558224|NCT01511536|455336184|FG000|Phase 2|Other|0|||
126558225|NCT01511536|455336185|FG001|Phase 2|Other|0|||
126558226|NCT01511536|455336186|FG002|Phase 2|Other|9|||
126558227|NCT00519779|455336191|FG000|Overall Study|Withdrawal by Subject|0|||
126473276|NCT01543698|455034519|FG011|Phase 1b|Protocol Violation|0|||
126473277|NCT01543698|455034520|FG012|Phase 1b|Protocol Violation|0|||
126473278|NCT01543698|455034521|FG013|Phase 1b|Protocol Violation|0|||
126473279|NCT01543698|455034522|FG014|Phase 1b|Protocol Violation|0|||
126473280|NCT01543698|455034508|FG000|Phase 2|Protocol Violation|0|||
126473281|NCT01543698|455034509|FG001|Phase 2|Protocol Violation|0|||
126473282|NCT01543698|455034510|FG002|Phase 2|Protocol Violation|0|||
126473283|NCT01543698|455034511|FG003|Phase 2|Protocol Violation|0|||
126473284|NCT01543698|455034512|FG004|Phase 2|Protocol Violation|0|||
126473285|NCT01543698|455034513|FG005|Phase 2|Protocol Violation|0|||
126473286|NCT01543698|455034514|FG006|Phase 2|Protocol Violation|0|||
126473287|NCT01543698|455034515|FG007|Phase 2|Protocol Violation|0|||
126473288|NCT01543698|455034516|FG008|Phase 2|Protocol Violation|0|||
126473289|NCT01543698|455034517|FG009|Phase 2|Protocol Violation|0|||
126473290|NCT01543698|455034518|FG010|Phase 2|Protocol Violation|0|||
126473291|NCT01543698|455034519|FG011|Phase 2|Protocol Violation|0|||
126473292|NCT01543698|455034520|FG012|Phase 2|Protocol Violation|1|||
126473293|NCT01543698|455034521|FG013|Phase 2|Protocol Violation|0|||
126473294|NCT01543698|455034522|FG014|Phase 2|Protocol Violation|0|||
126473295|NCT01543698|455034508|FG000|Phase 2|Disease progression|0|||
126473296|NCT01543698|455034509|FG001|Phase 2|Disease progression|0|||
126473297|NCT01543698|455034510|FG002|Phase 2|Disease progression|0|||
126473298|NCT01543698|455034511|FG003|Phase 2|Disease progression|0|||
126473299|NCT01543698|455034512|FG004|Phase 2|Disease progression|0|||
126473300|NCT01543698|455034513|FG005|Phase 2|Disease progression|0|||
126473301|NCT01543698|455034514|FG006|Phase 2|Disease progression|0|||
126473302|NCT01543698|455034515|FG007|Phase 2|Disease progression|0|||
126473303|NCT01543698|455034516|FG008|Phase 2|Disease progression|0|||
126473304|NCT01543698|455034517|FG009|Phase 2|Disease progression|0|||
126473305|NCT01543698|455034518|FG010|Phase 2|Disease progression|0|||
126473306|NCT01543698|455034519|FG011|Phase 2|Disease progression|10|||
126473307|NCT01543698|455034520|FG012|Phase 2|Disease progression|21|||
126473308|NCT01543698|455034521|FG013|Phase 2|Disease progression|30|||
126473309|NCT01543698|455034522|FG014|Phase 2|Disease progression|25|||
126473310|NCT01543698|455034508|FG000|Phase 2|Death|0|||
126473311|NCT01543698|455034509|FG001|Phase 2|Death|0|||
126473312|NCT01543698|455034510|FG002|Phase 2|Death|0|||
126473313|NCT01543698|455034511|FG003|Phase 2|Death|0|||
126473314|NCT01543698|455034512|FG004|Phase 2|Death|0|||
126473315|NCT01543698|455034513|FG005|Phase 2|Death|0|||
126473316|NCT01543698|455034514|FG006|Phase 2|Death|0|||
126473317|NCT01543698|455034515|FG007|Phase 2|Death|0|||
126473318|NCT01543698|455034516|FG008|Phase 2|Death|0|||
126473319|NCT01543698|455034517|FG009|Phase 2|Death|0|||
126473320|NCT01543698|455034518|FG010|Phase 2|Death|0|||
126473321|NCT01543698|455034519|FG011|Phase 2|Death|0|||
126473322|NCT01543698|455034520|FG012|Phase 2|Death|1|||
126473323|NCT01543698|455034521|FG013|Phase 2|Death|1|||
126473324|NCT01543698|455034522|FG014|Phase 2|Death|1|||
126473325|NCT01543698|455034508|FG000|Phase 2|Administrative problems|0|||
126473326|NCT01543698|455034509|FG001|Phase 2|Administrative problems|0|||
126473327|NCT01543698|455034510|FG002|Phase 2|Administrative problems|0|||
126473328|NCT01543698|455034511|FG003|Phase 2|Administrative problems|0|||
126473329|NCT01543698|455034512|FG004|Phase 2|Administrative problems|0|||
126473330|NCT01543698|455034513|FG005|Phase 2|Administrative problems|0|||
126473331|NCT01543698|455034514|FG006|Phase 2|Administrative problems|0|||
126473332|NCT01543698|455034515|FG007|Phase 2|Administrative problems|0|||
126473333|NCT01543698|455034516|FG008|Phase 2|Administrative problems|0|||
126473334|NCT01543698|455034517|FG009|Phase 2|Administrative problems|0|||
126473335|NCT01543698|455034518|FG010|Phase 2|Administrative problems|0|||
126473336|NCT01543698|455034519|FG011|Phase 2|Administrative problems|0|||
126473337|NCT01543698|455034520|FG012|Phase 2|Administrative problems|0|||
126473338|NCT01543698|455034521|FG013|Phase 2|Administrative problems|3|||
126473339|NCT01543698|455034522|FG014|Phase 2|Administrative problems|1|||
126473340|NCT01543698|455034508|FG000|Phase 2|Withdrawal by Subject|0|||
126473341|NCT01543698|455034509|FG001|Phase 2|Withdrawal by Subject|0|||
126473342|NCT01543698|455034510|FG002|Phase 2|Withdrawal by Subject|0|||
126473343|NCT01543698|455034511|FG003|Phase 2|Withdrawal by Subject|0|||
126473344|NCT01543698|455034512|FG004|Phase 2|Withdrawal by Subject|0|||
126473345|NCT01543698|455034513|FG005|Phase 2|Withdrawal by Subject|0|||
126473346|NCT01543698|455034514|FG006|Phase 2|Withdrawal by Subject|0|||
126473347|NCT01543698|455034515|FG007|Phase 2|Withdrawal by Subject|0|||
126473348|NCT01543698|455034516|FG008|Phase 2|Withdrawal by Subject|0|||
126473349|NCT01543698|455034517|FG009|Phase 2|Withdrawal by Subject|0|||
126473350|NCT01543698|455034518|FG010|Phase 2|Withdrawal by Subject|0|||
126473351|NCT01543698|455034519|FG011|Phase 2|Withdrawal by Subject|0|||
126473352|NCT01543698|455034520|FG012|Phase 2|Withdrawal by Subject|0|||
126473353|NCT01543698|455034521|FG013|Phase 2|Withdrawal by Subject|3|||
126473354|NCT01543698|455034522|FG014|Phase 2|Withdrawal by Subject|1|||
126473355|NCT01543698|455034508|FG000|Phase 2|Adverse Event|0|||
126473356|NCT01543698|455034509|FG001|Phase 2|Adverse Event|0|||
126473357|NCT01543698|455034510|FG002|Phase 2|Adverse Event|0|||
126473358|NCT01543698|455034511|FG003|Phase 2|Adverse Event|0|||
126473359|NCT01543698|455034512|FG004|Phase 2|Adverse Event|0|||
126473360|NCT01543698|455034513|FG005|Phase 2|Adverse Event|0|||
126473361|NCT01543698|455034514|FG006|Phase 2|Adverse Event|0|||
126473362|NCT01543698|455034515|FG007|Phase 2|Adverse Event|0|||
126473363|NCT01543698|455034516|FG008|Phase 2|Adverse Event|0|||
126473364|NCT01543698|455034517|FG009|Phase 2|Adverse Event|0|||
126473365|NCT01543698|455034518|FG010|Phase 2|Adverse Event|0|||
126473366|NCT01543698|455034519|FG011|Phase 2|Adverse Event|1|||
126473367|NCT01543698|455034520|FG012|Phase 2|Adverse Event|3|||
126473368|NCT01543698|455034521|FG013|Phase 2|Adverse Event|5|||
126473369|NCT01543698|455034522|FG014|Phase 2|Adverse Event|14|||
126473370|NCT00150709|455034523|FG000|Overall Study|Protocol Violation|7|||
126473371|NCT00150709|455034524|FG001|Overall Study|Protocol Violation|8|||
126473372|NCT00150709|455034525|FG002|Overall Study|Protocol Violation|3|||
126473373|NCT00150709|455034526|FG003|Overall Study|Protocol Violation|1|||
126473374|NCT00150709|455034523|FG000|Overall Study|Adverse Event|8|||
126473375|NCT00150709|455034524|FG001|Overall Study|Adverse Event|2|||
126473376|NCT00150709|455034525|FG002|Overall Study|Adverse Event|2|||
126473377|NCT00150709|455034526|FG003|Overall Study|Adverse Event|3|||
126473378|NCT00150709|455034523|FG000|Overall Study|Lack of Efficacy|6|||
126473379|NCT00150709|455034524|FG001|Overall Study|Lack of Efficacy|11|||
126473380|NCT00150709|455034525|FG002|Overall Study|Lack of Efficacy|9|||
126473381|NCT00150709|455034526|FG003|Overall Study|Lack of Efficacy|0|||
126473382|NCT00150709|455034523|FG000|Overall Study|Withdrawal by Subject|7|||
126473383|NCT00150709|455034524|FG001|Overall Study|Withdrawal by Subject|10|||
126473384|NCT00150709|455034525|FG002|Overall Study|Withdrawal by Subject|5|||
126473385|NCT00150709|455034526|FG003|Overall Study|Withdrawal by Subject|0|||
126473386|NCT00150709|455034523|FG000|Overall Study|Lost to Follow-up|3|||
126473387|NCT00150709|455034524|FG001|Overall Study|Lost to Follow-up|2|||
126473388|NCT00150709|455034525|FG002|Overall Study|Lost to Follow-up|0|||
126473389|NCT00150709|455034526|FG003|Overall Study|Lost to Follow-up|0|||
126473390|NCT00150709|455034523|FG000|Overall Study|Sponsor decision|0|||
126473391|NCT00150709|455034524|FG001|Overall Study|Sponsor decision|0|||
126473392|NCT00150709|455034525|FG002|Overall Study|Sponsor decision|0|||
126473393|NCT00150709|455034526|FG003|Overall Study|Sponsor decision|1|||
126473394|NCT00150709|455034523|FG000|Overall Study|Site/Investigator discontinued the study|5|||
126473395|NCT00150709|455034524|FG001|Overall Study|Site/Investigator discontinued the study|5|||
126473396|NCT00150709|455034525|FG002|Overall Study|Site/Investigator discontinued the study|2|||
126473397|NCT00150709|455034526|FG003|Overall Study|Site/Investigator discontinued the study|0|||
126473398|NCT00150709|455034523|FG000|Overall Study|Decision of parent(s)|1|||
126473399|NCT00150709|455034524|FG001|Overall Study|Decision of parent(s)|2|||
126473400|NCT00150709|455034525|FG002|Overall Study|Decision of parent(s)|0|||
126473401|NCT00150709|455034526|FG003|Overall Study|Decision of parent(s)|0|||
126473402|NCT00150709|455034523|FG000|Overall Study|Decision of parent(s) and investigator|3|||
126473403|NCT00150709|455034524|FG001|Overall Study|Decision of parent(s) and investigator|0|||
126473404|NCT00150709|455034525|FG002|Overall Study|Decision of parent(s) and investigator|0|||
126473405|NCT00150709|455034526|FG003|Overall Study|Decision of parent(s) and investigator|0|||
126473406|NCT00150709|455034523|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
126473407|NCT00150709|455034524|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
126473408|NCT00150709|455034525|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
126473409|NCT00150709|455034526|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
126473410|NCT00150709|455034523|FG000|Overall Study|Investigator decision|1|||
126473411|NCT00150709|455034524|FG001|Overall Study|Investigator decision|0|||
126473412|NCT00150709|455034525|FG002|Overall Study|Investigator decision|0|||
126473413|NCT00150709|455034526|FG003|Overall Study|Investigator decision|1|||
126473414|NCT00150709|455034523|FG000|Overall Study|Subject relocated|2|||
126473415|NCT00150709|455034524|FG001|Overall Study|Subject relocated|2|||
126473416|NCT00150709|455034525|FG002|Overall Study|Subject relocated|1|||
126473417|NCT00150709|455034526|FG003|Overall Study|Subject relocated|0|||
126473418|NCT00150709|455034523|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
126473419|NCT00150709|455034524|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
126473420|NCT00150709|455034525|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
126473421|NCT00150709|455034526|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
126473422|NCT00150709|455034523|FG000|Overall Study|Convenience|0|||
126473423|NCT00150709|455034524|FG001|Overall Study|Convenience|1|||
126473424|NCT00150709|455034525|FG002|Overall Study|Convenience|0|||
126473425|NCT00150709|455034526|FG003|Overall Study|Convenience|0|||
126473426|NCT00150709|455034523|FG000|Overall Study|Subject entered new drug study|0|||
126473427|NCT00150709|455034524|FG001|Overall Study|Subject entered new drug study|1|||
126558228|NCT00519779|455336192|FG001|Overall Study|Withdrawal by Subject|1|||
126473428|NCT00150709|455034525|FG002|Overall Study|Subject entered new drug study|0|||
126473429|NCT00150709|455034526|FG003|Overall Study|Subject entered new drug study|0|||
126473430|NCT00150709|455034523|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
126473431|NCT00150709|455034524|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
126473432|NCT00150709|455034525|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
126473433|NCT00150709|455034526|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
126640402|NCT00945672|455642769|FG003|Overall Study|Withdrawal by Subject|1|||
126406542|NCT00869401|454783106|FG001|Overall Study|Withdrawal by Subject|0|||
126406543|NCT00869401|454783107|FG002|Overall Study|Withdrawal by Subject|0|||
126406544|NCT00869401|454783108|FG003|Overall Study|Withdrawal by Subject|5|||
126406545|NCT00869401|454783109|FG004|Overall Study|Withdrawal by Subject|3|||
126406546|NCT01147900|454783110|FG000|At Year 10|Lost to Follow-up|0|||
126406547|NCT01147900|454783111|FG001|At Year 10|Lost to Follow-up|1|||
126406548|NCT01147900|454783112|FG002|At Year 10|Lost to Follow-up|0|||
126406549|NCT00581360|454783115|FG000|Overall Study|Withdrawal by Subject|1|||
126406550|NCT04405245|454783116|FG000|Overall Study|Adverse Event|0|||
126406551|NCT04405245|454783117|FG001|Overall Study|Adverse Event|1|||
126406552|NCT04405245|454783118|FG002|Overall Study|Adverse Event|0|||
126406553|NCT02391961|454783119|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
126406554|NCT02391961|454783120|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
126406555|NCT02391961|454783119|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
126406556|NCT02391961|454783120|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
126406557|NCT02391961|454783119|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126406558|NCT02391961|454783120|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126406559|NCT00491608|454783124|FG000|Overall Study|Death|2|||
126406560|NCT00491608|454783124|FG000|Overall Study|Withdrawal by Subject|1|||
126406561|NCT00025155|454783125|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
126406562|NCT00025155|454783125|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
126406563|NCT00413374|454783126|FG000|Overall Study|Ineligible due to screening criteria.|3|||
126406564|NCT00413374|454783127|FG001|Overall Study|Ineligible due to screening criteria.|0|||
126406565|NCT00413374|454783126|FG000|Overall Study|Adverse Event|1|||
126406566|NCT00413374|454783127|FG001|Overall Study|Adverse Event|0|||
126406567|NCT00413374|454783126|FG000|Overall Study|Lost to Follow-up|1|||
126406568|NCT00413374|454783127|FG001|Overall Study|Lost to Follow-up|0|||
126406569|NCT00413374|454783126|FG000|Overall Study|Surgery|1|||
126406570|NCT00413374|454783127|FG001|Overall Study|Surgery|0|||
126406571|NCT00552760|454783128|FG000|Overall Study|Adverse Event|3|||
126406572|NCT00552760|454783129|FG001|Overall Study|Adverse Event|5|||
126406573|NCT00552760|454783128|FG000|Overall Study|Relapsed- Depressed Event|10|||
126406574|NCT00552760|454783129|FG001|Overall Study|Relapsed- Depressed Event|16|||
126406575|NCT00552760|454783128|FG000|Overall Study|Relapse- Manic Event|3|||
126406576|NCT00552760|454783129|FG001|Overall Study|Relapse- Manic Event|3|||
126406577|NCT00552760|454783128|FG000|Overall Study|Relapsed- Mixed Event|3|||
126406578|NCT00552760|454783129|FG001|Overall Study|Relapsed- Mixed Event|5|||
126406579|NCT00552760|454783128|FG000|Overall Study|Protocol Violation|0|||
126406580|NCT00552760|454783129|FG001|Overall Study|Protocol Violation|1|||
126406581|NCT00552760|454783128|FG000|Overall Study|Lost to Follow-up|1|||
126406582|NCT00552760|454783129|FG001|Overall Study|Lost to Follow-up|1|||
126406583|NCT00552760|454783128|FG000|Overall Study|Non-compliance|1|||
126406584|NCT00552760|454783129|FG001|Overall Study|Non-compliance|1|||
126406585|NCT00552760|454783128|FG000|Overall Study|Medical Condition|1|||
126406586|NCT00552760|454783129|FG001|Overall Study|Medical Condition|1|||
126406587|NCT00552760|454783128|FG000|Overall Study|Withdrawal by Subject|3|||
126406588|NCT00552760|454783129|FG001|Overall Study|Withdrawal by Subject|0|||
126406589|NCT00552760|454783128|FG000|Overall Study|Medication Change|1|||
126406590|NCT00552760|454783129|FG001|Overall Study|Medication Change|0|||
126406591|NCT00924404|454783133|FG000|Overall Study|Lost to Follow-up|6|||
126406592|NCT00924404|454783134|FG001|Overall Study|Lost to Follow-up|4|||
126406593|NCT02613169|454783135|FG000|Overall Study|Withdrawal by Subject|4|||
126406594|NCT02613169|454783136|FG001|Overall Study|Withdrawal by Subject|1|||
126406595|NCT02613169|454783135|FG000|Overall Study|Lost to Follow-up|0|||
126406596|NCT02613169|454783136|FG001|Overall Study|Lost to Follow-up|5|||
126406597|NCT02613169|454783135|FG000|Overall Study|HIV|0|||
126406598|NCT02613169|454783136|FG001|Overall Study|HIV|2|||
126406599|NCT02613169|454783135|FG000|Overall Study|No TB infection endpoint|14|||
126406600|NCT02613169|454783136|FG001|Overall Study|No TB infection endpoint|9|||
126406601|NCT00343382|454783137|FG000|Overall Study|Adverse Event|2|||
126406602|NCT00343382|454783138|FG001|Overall Study|Adverse Event|10|||
126406603|NCT00343382|454783139|FG002|Overall Study|Adverse Event|7|||
126406604|NCT00343382|454783137|FG000|Overall Study|Withdrawal by Subject|1|||
126406605|NCT00343382|454783138|FG001|Overall Study|Withdrawal by Subject|2|||
126473434|NCT00150709|455034523|FG000|Overall Study|Lack of ease of swallowing|0|||
126473435|NCT00150709|455034524|FG001|Overall Study|Lack of ease of swallowing|1|||
126406606|NCT00343382|454783139|FG002|Overall Study|Withdrawal by Subject|6|||
126406607|NCT00343382|454783137|FG000|Overall Study|Other Reason Not Specified|1|||
126406608|NCT00343382|454783138|FG001|Overall Study|Other Reason Not Specified|2|||
126406609|NCT00343382|454783139|FG002|Overall Study|Other Reason Not Specified|4|||
126406610|NCT01985360|454783140|FG000|Overall Study|Withdrawal by Subject|4|||
126406611|NCT01985360|454783141|FG001|Overall Study|Withdrawal by Subject|0|||
126406612|NCT01985360|454783140|FG000|Overall Study|Lost to Follow-up|5|||
126406613|NCT01985360|454783141|FG001|Overall Study|Lost to Follow-up|3|||
126406614|NCT02976103|454783142|FG000|Overall Study|Withdrawal by Subject|1|||
126406615|NCT02976103|454783143|FG001|Overall Study|Withdrawal by Subject|0|||
126406616|NCT02976103|454783142|FG000|Overall Study|Lost to Follow-up|12|||
126558229|NCT03330119|455336193|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
126558230|NCT03330119|455336194|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
126558231|NCT00664521|455336206|FG000|Overall Study|Adverse Event|4|||
126558232|NCT00664521|455336207|FG001|Overall Study|Adverse Event|1|||
126558233|NCT00664521|455336206|FG000|Overall Study|Lost to Follow-up|1|||
126558234|NCT00664521|455336207|FG001|Overall Study|Lost to Follow-up|0|||
126558235|NCT00664521|455336206|FG000|Overall Study|Other|1|||
126558236|NCT00664521|455336207|FG001|Overall Study|Other|0|||
126558237|NCT02459964|455336208|FG000|Overall Study|Withdrawal by Subject|0|||
126558238|NCT02459964|455336209|FG001|Overall Study|Withdrawal by Subject|0|||
126558239|NCT02459964|455336210|FG002|Overall Study|Withdrawal by Subject|1|||
126558240|NCT02459964|455336208|FG000|Overall Study|Abnormal EKG changes|0|||
126558241|NCT02459964|455336209|FG001|Overall Study|Abnormal EKG changes|0|||
126558242|NCT02459964|455336210|FG002|Overall Study|Abnormal EKG changes|1|||
126558243|NCT00367237|455336211|FG000|Overall Study|Adverse Event|7|||
126558244|NCT00367237|455336212|FG001|Overall Study|Adverse Event|2|||
126473436|NCT00150709|455034525|FG002|Overall Study|Lack of ease of swallowing|0|||
126558245|NCT00367237|455336211|FG000|Overall Study|Lost to Follow-up|1|||
126558246|NCT00367237|455336212|FG001|Overall Study|Lost to Follow-up|0|||
126558247|NCT00367237|455336211|FG000|Overall Study|Withdrawal by Subject|0|||
126558248|NCT00367237|455336212|FG001|Overall Study|Withdrawal by Subject|4|||
126558249|NCT00367237|455336211|FG000|Overall Study|Protocol Violation|2|||
126558250|NCT00367237|455336212|FG001|Overall Study|Protocol Violation|5|||
126558251|NCT00550732|455336213|FG000|Overall Study|Death|4|||
126558252|NCT00550732|455336213|FG000|Overall Study|Withdrawal by Subject|2|||
126558253|NCT00550732|455336213|FG000|Overall Study|Physician Decision|2|||
126558254|NCT00550732|455336213|FG000|Overall Study|Lost to Follow-up|1|||
126558255|NCT00550732|455336213|FG000|Overall Study|Palliative care|1|||
126558256|NCT00550732|455336213|FG000|Overall Study|Adverse Event|1|||
126558257|NCT03302910|455336218|FG000|Overall Study|Protocol Violation|1|||
126558258|NCT03302910|455336219|FG001|Overall Study|Protocol Violation|0|||
126558259|NCT02800928|455336222|FG000|Overall Study|Withdrawal by Subject|1|||
126558260|NCT02800928|455336223|FG001|Overall Study|Withdrawal by Subject|1|||
126558261|NCT02800928|455336222|FG000|Overall Study|Protocol Violation|1|||
126558262|NCT02800928|455336223|FG001|Overall Study|Protocol Violation|1|||
126558263|NCT04004208|455336232|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126558264|NCT04004208|455336233|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126558265|NCT04004208|455336232|FG000|Overall Study|Death|3|||
126558266|NCT04004208|455336233|FG001|Overall Study|Death|0|||
126558267|NCT04004208|455336232|FG000|Overall Study|COVID-19 pandemic|1|||
126558268|NCT04004208|455336233|FG001|Overall Study|COVID-19 pandemic|0|||
126558269|NCT04004208|455336232|FG000|Overall Study|Physician Decision|1|||
126558270|NCT04004208|455336233|FG001|Overall Study|Physician Decision|0|||
126558271|NCT04004208|455336232|FG000|Overall Study|Adverse Event|1|||
126558272|NCT04004208|455336233|FG001|Overall Study|Adverse Event|1|||
126558273|NCT00087490|455336239|FG000|Overall Study|Death|6|||
126558274|NCT00087490|455336240|FG001|Overall Study|Death|4|||
126558275|NCT00087490|455336239|FG000|Overall Study|Adverse Event|3|||
126558276|NCT00087490|455336240|FG001|Overall Study|Adverse Event|8|||
126558277|NCT00087490|455336239|FG000|Overall Study|Lack of Efficacy|0|||
126558278|NCT00087490|455336240|FG001|Overall Study|Lack of Efficacy|2|||
126558279|NCT00087490|455336239|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
126558280|NCT00087490|455336240|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
126558281|NCT00087490|455336239|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
126558282|NCT00087490|455336240|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
126558283|NCT00087490|455336239|FG000|Overall Study|Randomized but not treated|7|||
126558284|NCT00087490|455336240|FG001|Overall Study|Randomized but not treated|18|||
126558285|NCT02034435|455336241|FG000|Overall Study|Withdrawal by Subject|1|||
126473437|NCT00150709|455034526|FG003|Overall Study|Lack of ease of swallowing|0|||
126473438|NCT02975336|455034527|FG000|DBPC (52 Weeks)|Adverse Event|16|||
126473439|NCT02975336|455034528|FG001|DBPC (52 Weeks)|Adverse Event|17|||
126473440|NCT02975336|455034529|FG002|DBPC (52 Weeks)|Adverse Event|13|||
126473441|NCT02975336|455034530|FG003|DBPC (52 Weeks)|Adverse Event|18|||
126473442|NCT02975336|455034531|FG004|DBPC (52 Weeks)|Adverse Event|0|||
126473443|NCT02975336|455034532|FG005|DBPC (52 Weeks)|Adverse Event|0|||
126473444|NCT02975336|455034533|FG006|DBPC (52 Weeks)|Adverse Event|0|||
126473445|NCT02975336|455034534|FG007|DBPC (52 Weeks)|Adverse Event|0|||
126473446|NCT02975336|455034527|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
126558286|NCT02034435|455336242|FG001|Overall Study|Withdrawal by Subject|0|||
126473447|NCT02975336|455034528|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
126558287|NCT02034435|455336243|FG002|Overall Study|Withdrawal by Subject|0|||
126558288|NCT02034435|455336244|FG003|Overall Study|Withdrawal by Subject|0|||
126558289|NCT02034435|455336241|FG000|Overall Study|Illness|0|||
126558290|NCT02034435|455336242|FG001|Overall Study|Illness|2|||
126558291|NCT02034435|455336243|FG002|Overall Study|Illness|0|||
126558292|NCT02034435|455336244|FG003|Overall Study|Illness|0|||
126473448|NCT02975336|455034529|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
126473449|NCT02975336|455034530|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
126558293|NCT02034435|455336241|FG000|Overall Study|Inadequate IV access|1|||
126558294|NCT02034435|455336242|FG001|Overall Study|Inadequate IV access|0|||
126558295|NCT02034435|455336243|FG002|Overall Study|Inadequate IV access|0|||
126558296|NCT02034435|455336244|FG003|Overall Study|Inadequate IV access|1|||
126558297|NCT01700530|455336247|FG000|Overall Study|Withdrawal by Subject|0|||
126558298|NCT01700530|455336248|FG001|Overall Study|Withdrawal by Subject|3|||
126558299|NCT01700530|455336249|FG002|Overall Study|Withdrawal by Subject|1|||
126558300|NCT04529538|455336254|FG000|Overall Study|Lost to Follow-up|3|||
126558301|NCT04529538|455336255|FG001|Overall Study|Lost to Follow-up|2|||
126558302|NCT04529538|455336256|FG002|Overall Study|Lost to Follow-up|1|||
126558303|NCT04529538|455336257|FG003|Overall Study|Lost to Follow-up|0|||
126558304|NCT04529538|455336258|FG004|Overall Study|Lost to Follow-up|1|||
126558305|NCT04529538|455336259|FG005|Overall Study|Lost to Follow-up|1|||
126558306|NCT04529538|455336260|FG006|Overall Study|Lost to Follow-up|2|||
126558307|NCT04529538|455336261|FG007|Overall Study|Lost to Follow-up|0|||
126558308|NCT04529538|455336254|FG000|Overall Study|Not eligible at enrollment|0|||
126406617|NCT02976103|454783143|FG001|Overall Study|Lost to Follow-up|8|||
126406618|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
126406619|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
126558309|NCT04529538|455336255|FG001|Overall Study|Not eligible at enrollment|1|||
126558310|NCT04529538|455336256|FG002|Overall Study|Not eligible at enrollment|2|||
126558311|NCT04529538|455336257|FG003|Overall Study|Not eligible at enrollment|1|||
126558312|NCT04529538|455336258|FG004|Overall Study|Not eligible at enrollment|0|||
126558313|NCT04529538|455336259|FG005|Overall Study|Not eligible at enrollment|0|||
126558314|NCT04529538|455336260|FG006|Overall Study|Not eligible at enrollment|0|||
126558315|NCT04529538|455336261|FG007|Overall Study|Not eligible at enrollment|1|||
126558316|NCT04529538|455336254|FG000|Overall Study|Withdrawal by Subject|0|||
126558317|NCT04529538|455336255|FG001|Overall Study|Withdrawal by Subject|1|||
126558318|NCT04529538|455336256|FG002|Overall Study|Withdrawal by Subject|1|||
126558319|NCT04529538|455336257|FG003|Overall Study|Withdrawal by Subject|2|||
126558320|NCT04529538|455336258|FG004|Overall Study|Withdrawal by Subject|0|||
126558321|NCT04529538|455336259|FG005|Overall Study|Withdrawal by Subject|2|||
126558322|NCT04529538|455336260|FG006|Overall Study|Withdrawal by Subject|3|||
126558323|NCT04529538|455336261|FG007|Overall Study|Withdrawal by Subject|0|||
126558324|NCT04529538|455336254|FG000|Overall Study|Other|0|||
126558325|NCT04529538|455336255|FG001|Overall Study|Other|1|||
126558326|NCT04529538|455336256|FG002|Overall Study|Other|0|||
126558327|NCT04529538|455336257|FG003|Overall Study|Other|0|||
126558328|NCT04529538|455336258|FG004|Overall Study|Other|0|||
126558329|NCT04529538|455336259|FG005|Overall Study|Other|0|||
126558330|NCT04529538|455336260|FG006|Overall Study|Other|0|||
126558331|NCT04529538|455336261|FG007|Overall Study|Other|0|||
126558332|NCT04529538|455336254|FG000|Overall Study|Adverse Event|0|||
126558333|NCT04529538|455336255|FG001|Overall Study|Adverse Event|0|||
126558334|NCT04529538|455336256|FG002|Overall Study|Adverse Event|0|||
126558335|NCT04529538|455336257|FG003|Overall Study|Adverse Event|1|||
126558336|NCT04529538|455336258|FG004|Overall Study|Adverse Event|0|||
126558337|NCT04529538|455336259|FG005|Overall Study|Adverse Event|0|||
126558338|NCT04529538|455336260|FG006|Overall Study|Adverse Event|0|||
126558339|NCT04529538|455336261|FG007|Overall Study|Adverse Event|0|||
126558340|NCT04529538|455336254|FG000|Overall Study|Protocol Deviation|0|||
126558341|NCT04529538|455336255|FG001|Overall Study|Protocol Deviation|0|||
126558342|NCT04529538|455336256|FG002|Overall Study|Protocol Deviation|0|||
126558343|NCT04529538|455336257|FG003|Overall Study|Protocol Deviation|1|||
126406620|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
126406621|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
126406622|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
126406623|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
126406624|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
126406625|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
126406626|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
126406627|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
126558344|NCT04529538|455336258|FG004|Overall Study|Protocol Deviation|0|||
126558345|NCT04529538|455336259|FG005|Overall Study|Protocol Deviation|0|||
126558346|NCT04529538|455336260|FG006|Overall Study|Protocol Deviation|0|||
126558347|NCT04529538|455336261|FG007|Overall Study|Protocol Deviation|0|||
126558348|NCT04529538|455336254|FG000|Overall Study|Physician Decision|0|||
126558349|NCT04529538|455336255|FG001|Overall Study|Physician Decision|0|||
126558350|NCT04529538|455336256|FG002|Overall Study|Physician Decision|0|||
126406628|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
126406629|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
126406630|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
126558351|NCT04529538|455336257|FG003|Overall Study|Physician Decision|0|||
126558352|NCT04529538|455336258|FG004|Overall Study|Physician Decision|0|||
126558353|NCT04529538|455336259|FG005|Overall Study|Physician Decision|1|||
126558354|NCT04529538|455336260|FG006|Overall Study|Physician Decision|0|||
126558355|NCT04529538|455336261|FG007|Overall Study|Physician Decision|1|||
126558356|NCT02234310|455336264|FG000|Overall Study|Physician Decision|1|||
126406631|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
126406632|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
126406633|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
126406634|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
126406635|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
126406636|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
126406637|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
126406638|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
126406639|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
126406640|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
126406641|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
126406642|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
126406643|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
126406644|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
126406645|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
126406646|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
126406647|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
126406648|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
126406649|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
126406650|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
126406651|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
126406652|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
126406653|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
126406654|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
126406655|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
126406656|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
126406657|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
126406658|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
126406659|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
126406660|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
126406661|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
126406662|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406663|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406664|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
126406665|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406666|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406667|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
126406668|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406669|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406670|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406671|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406672|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
126406673|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
126406674|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406675|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406676|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406677|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406678|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406679|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406680|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406681|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406682|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406683|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
126406684|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406685|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406686|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
126406687|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406688|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406689|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406690|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406691|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406692|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406693|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126406694|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
126473450|NCT02975336|455034531|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
126473451|NCT02975336|455034532|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
126558357|NCT02234310|455336264|FG000|Overall Study|Adverse Event|1|||
126558358|NCT02234310|455336264|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
126558359|NCT02234310|455336264|FG000|Overall Study|Withdrawal by Subject|2|||
126558360|NCT00235495|455336265|FG000|Overall Study|Death|52|||
126558361|NCT00235495|455336266|FG001|Overall Study|Death|42|||
126558362|NCT00235495|455336265|FG000|Overall Study|Withdrawal by Subject|5|||
126558363|NCT00235495|455336266|FG001|Overall Study|Withdrawal by Subject|3|||
126558364|NCT00235495|455336265|FG000|Overall Study|Lost to Follow-up|11|||
126558365|NCT00235495|455336266|FG001|Overall Study|Lost to Follow-up|13|||
126558366|NCT00235495|455336265|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
126558367|NCT00235495|455336266|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
126558368|NCT03289455|455336268|FG000|Overall Study|Death|1|||
126558369|NCT03289455|455336269|FG001|Overall Study|Death|0|||
126558370|NCT03289455|455336270|FG002|Overall Study|Death|0|||
126558371|NCT03289455|455336268|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
126558372|NCT03289455|455336269|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
126558373|NCT03289455|455336270|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
126558374|NCT03289455|455336268|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
126558375|NCT03289455|455336269|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
126558376|NCT03289455|455336270|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
126558377|NCT03289455|455336268|FG000|Overall Study|Progressive disease|3|||
126558378|NCT03289455|455336269|FG001|Overall Study|Progressive disease|4|||
126558379|NCT03289455|455336270|FG002|Overall Study|Progressive disease|5|||
126558380|NCT02192359|455336273|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
126558381|NCT02192359|455336274|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
126558382|NCT02192359|455336275|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
126558383|NCT02192359|455336276|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
126558384|NCT02192359|455336273|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
126558385|NCT02192359|455336274|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
126558386|NCT02192359|455336275|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
126558387|NCT02192359|455336276|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
126558388|NCT02192359|455336273|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
126558389|NCT02192359|455336274|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
126558390|NCT02192359|455336275|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
126558391|NCT02192359|455336276|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
126558392|NCT04060680|455336280|FG000|Overall Study|Unsuccessful implant|17|||
126558393|NCT04060680|455336281|FG001|Overall Study|Unsuccessful implant|2|||
126558394|NCT04060680|455336280|FG000|Overall Study|Adverse Event|3|||
126558395|NCT04060680|455336281|FG001|Overall Study|Adverse Event|0|||
126558396|NCT04060680|455336280|FG000|Overall Study|Death|2|||
126558397|NCT04060680|455336281|FG001|Overall Study|Death|0|||
126558398|NCT04060680|455336280|FG000|Overall Study|Study product no longer in use|1|||
126558399|NCT04060680|455336281|FG001|Overall Study|Study product no longer in use|0|||
126558400|NCT04060680|455336280|FG000|Overall Study|Withdrawal by Subject|1|||
126558401|NCT04060680|455336281|FG001|Overall Study|Withdrawal by Subject|0|||
126558402|NCT02322775|455336282|FG000|Overall Study|Adverse Event|1|||
126558403|NCT02322775|455336283|FG001|Overall Study|Adverse Event|0|||
126558404|NCT02322775|455336282|FG000|Overall Study|Lost to Follow-up|0|||
126558405|NCT02322775|455336283|FG001|Overall Study|Lost to Follow-up|1|||
126721242|NCT03591146|455928617|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
126721243|NCT03591146|455928618|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
126721244|NCT03591146|455928619|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
126721245|NCT03591146|455928620|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
126721246|NCT03591146|455928621|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
126721247|NCT03591146|455928617|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
126473452|NCT02975336|455034533|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
126473453|NCT02975336|455034534|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
126473454|NCT02975336|455034527|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
126473455|NCT02975336|455034528|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
126473456|NCT02975336|455034529|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
126473457|NCT02975336|455034530|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
126473458|NCT02975336|455034531|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
126473459|NCT02975336|455034532|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
126473460|NCT02975336|455034533|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
126473461|NCT02975336|455034534|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
126473462|NCT02975336|455034527|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
126473463|NCT02975336|455034528|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
126473464|NCT02975336|455034529|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
126473465|NCT02975336|455034530|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
126721248|NCT03591146|455928618|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
126721249|NCT03591146|455928619|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
126721250|NCT03591146|455928620|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
126721251|NCT03591146|455928621|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
126721252|NCT03591146|455928617|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
126721253|NCT03591146|455928618|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
126721254|NCT03591146|455928619|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
126721255|NCT03591146|455928620|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
126721256|NCT03591146|455928621|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
126721257|NCT03591146|455928617|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
126721258|NCT03591146|455928618|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
126721259|NCT03591146|455928619|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
126721260|NCT03591146|455928620|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
126721261|NCT03591146|455928621|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
126721262|NCT04737031|455928624|FG000|Overall Study|Patients who did not have a treatment visit|0|||
126406695|NCT02914561|454783144|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
126406696|NCT02914561|454783145|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
126406697|NCT02914561|454783146|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
126406698|NCT02914561|454783147|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
126406699|NCT02914561|454783148|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
126406700|NCT02914561|454783149|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
126406701|NCT02914561|454783150|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
126406702|NCT02914561|454783151|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
126406703|NCT02914561|454783152|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
126406704|NCT02914561|454783153|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
126406705|NCT02914561|454783154|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
126406706|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
126406707|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
126406708|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
126406709|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
126406710|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
126406711|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
126406712|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
126406713|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
126406714|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
126406715|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
126406716|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
126406717|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
126406718|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
126406719|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
126406720|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
126406721|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
126406722|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
126406723|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
126406724|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
126406725|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
126406726|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
126406727|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
126406728|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
126406729|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
126406730|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
126406731|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
126406732|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
126406733|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
126406734|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
126406735|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
126406736|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
126406737|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
126406738|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
126406739|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406740|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406741|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406742|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406743|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126721263|NCT04737031|455928625|FG001|Overall Study|Patients who did not have a treatment visit|31|||
126558406|NCT02322775|455336282|FG000|Overall Study|Protocol Violation|1|||
126406744|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406745|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
126406746|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406747|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
126406748|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
126406749|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
126406750|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406751|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406752|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406753|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406754|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406755|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406756|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
126406757|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
126406758|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
126406759|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
126406760|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
126406761|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406762|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406763|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406764|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406765|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406766|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406767|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
126406768|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406769|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
126406770|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406771|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
126406772|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406773|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406774|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406775|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406776|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406777|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406778|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406779|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406780|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
126406781|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406782|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
126406783|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406784|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406785|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406786|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406787|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406788|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406789|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
126406790|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406791|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406792|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406793|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
126406794|NCT02914561|454783144|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406795|NCT02914561|454783145|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406796|NCT02914561|454783146|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406797|NCT02914561|454783147|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406798|NCT02914561|454783148|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406799|NCT02914561|454783149|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406800|NCT02914561|454783150|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406801|NCT02914561|454783151|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
126406802|NCT02914561|454783152|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
126558407|NCT02322775|455336283|FG001|Overall Study|Protocol Violation|0|||
126558408|NCT02322775|455336282|FG000|Overall Study|Withdrawal by Subject|3|||
126406803|NCT02914561|454783153|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
126406804|NCT02914561|454783154|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
126558409|NCT02322775|455336283|FG001|Overall Study|Withdrawal by Subject|4|||
126406805|NCT01455220|454783157|FG000|Overall Study|screen fail|30|||
126406806|NCT04881747|454783158|FG000|Period 2 Washout|Adverse Event|1|||
126406807|NCT04881747|454783159|FG001|Period 2 Washout|Adverse Event|0|||
126406808|NCT04881747|454783160|FG002|Period 2 Washout|Adverse Event|0|||
126406809|NCT04881747|454783161|FG003|Period 2 Washout|Adverse Event|0|||
126406810|NCT04881747|454783162|FG004|Period 2 Washout|Adverse Event|1|||
126406811|NCT04881747|454783163|FG005|Period 2 Washout|Adverse Event|0|||
126406812|NCT04881747|454783158|FG000|Period 2 Washout|Withdrawal by Subject|1|||
126406813|NCT04881747|454783159|FG001|Period 2 Washout|Withdrawal by Subject|0|||
126406814|NCT04881747|454783160|FG002|Period 2 Washout|Withdrawal by Subject|0|||
126406815|NCT04881747|454783161|FG003|Period 2 Washout|Withdrawal by Subject|1|||
126406816|NCT04881747|454783162|FG004|Period 2 Washout|Withdrawal by Subject|0|||
126406817|NCT04881747|454783163|FG005|Period 2 Washout|Withdrawal by Subject|0|||
126406818|NCT04598269|454783164|FG000|Overall Study|Adverse Event|0|||
126406819|NCT04598269|454783165|FG001|Overall Study|Adverse Event|3|||
126406820|NCT04598269|454783164|FG000|Overall Study|Withdrawal by Subject|1|||
126406821|NCT04598269|454783165|FG001|Overall Study|Withdrawal by Subject|4|||
126406822|NCT04598269|454783164|FG000|Overall Study|Lost to Follow-up|1|||
126406823|NCT04598269|454783165|FG001|Overall Study|Lost to Follow-up|0|||
126406824|NCT04598269|454783164|FG000|Overall Study|Not Treated|2|||
126406825|NCT04598269|454783165|FG001|Overall Study|Not Treated|0|||
126406826|NCT03869333|454783166|FG000|Overall Study|Lost to Follow-up|1|||
126406827|NCT03869333|454783167|FG001|Overall Study|Lost to Follow-up|0|||
126406828|NCT03869333|454783168|FG002|Overall Study|Lost to Follow-up|0|||
126406829|NCT03869333|454783169|FG003|Overall Study|Lost to Follow-up|0|||
126406830|NCT03869333|454783166|FG000|Overall Study|Pregnancy|1|||
126406831|NCT03869333|454783167|FG001|Overall Study|Pregnancy|0|||
126406832|NCT03869333|454783168|FG002|Overall Study|Pregnancy|0|||
126406833|NCT03869333|454783169|FG003|Overall Study|Pregnancy|0|||
126473466|NCT02975336|455034531|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
126473467|NCT02975336|455034532|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
126473468|NCT02975336|455034533|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
126473469|NCT02975336|455034534|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
126473470|NCT02975336|455034527|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
126473471|NCT02975336|455034528|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
126473472|NCT02975336|455034529|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
126473473|NCT02975336|455034530|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
126473474|NCT02975336|455034531|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
126473475|NCT02975336|455034532|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
126473476|NCT02975336|455034533|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
126558410|NCT02322775|455336282|FG000|Overall Study|Not willing to perform all FU visits|0|||
126558411|NCT02322775|455336283|FG001|Overall Study|Not willing to perform all FU visits|1|||
126558412|NCT01852162|455338709|FG000|Overall Study|Adverse Event|1|||
126558413|NCT01852162|455338710|FG001|Overall Study|Adverse Event|0|||
126558414|NCT01852162|455338709|FG000|Overall Study|Withdrawal by Subject|3|||
126721264|NCT04737031|455928626|FG002|Overall Study|Patients who did not have a treatment visit|93|||
126721265|NCT04737031|455928627|FG003|Overall Study|Patients who did not have a treatment visit|227|||
126721266|NCT01067508|455928630|FG000|Overall Study|Physician Decision|0|||
126721267|NCT01067508|455928631|FG001|Overall Study|Physician Decision|1|||
126721268|NCT01067508|455928630|FG000|Overall Study|Withdrawal by Subject|0|||
126721269|NCT01067508|455928631|FG001|Overall Study|Withdrawal by Subject|1|||
126721270|NCT00444626|455928632|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
126721271|NCT00444626|455928632|FG000|Initial Treatment Period|Adverse Event|1|||
126721272|NCT00444626|455928632|FG000|Initial Treatment Period|Lost to Follow-up|9|||
126721273|NCT01468909|455928635|FG000|Overall Study|Never Treated|2|||
126721274|NCT01468909|455928636|FG001|Overall Study|Never Treated|2|||
126721275|NCT01511419|455928637|FG000|Dose 2|Physician Decision|1|||
126721276|NCT01511419|455928638|FG001|Dose 2|Physician Decision|0|||
126721277|NCT04594239|455928639|FG000|Overall Study|Withdrawal by Subject|3|||
126721278|NCT04594239|455928640|FG001|Overall Study|Withdrawal by Subject|4|||
126721279|NCT04594239|455928641|FG002|Overall Study|Withdrawal by Subject|2|||
126721280|NCT04594239|455928642|FG003|Overall Study|Withdrawal by Subject|4|||
126721281|NCT04594239|455928639|FG000|Overall Study|Lost to Follow-up|8|||
126721282|NCT04594239|455928640|FG001|Overall Study|Lost to Follow-up|5|||
126721283|NCT04594239|455928641|FG002|Overall Study|Lost to Follow-up|4|||
126721284|NCT04594239|455928642|FG003|Overall Study|Lost to Follow-up|6|||
126406834|NCT03869333|454783166|FG000|Overall Study|Physician Decision|0|||
126406835|NCT03869333|454783167|FG001|Overall Study|Physician Decision|1|||
126406836|NCT03869333|454783168|FG002|Overall Study|Physician Decision|0|||
126406837|NCT03869333|454783169|FG003|Overall Study|Physician Decision|0|||
126406838|NCT01927055|454783170|FG000|Open-label|Adverse Event|6|||
126721285|NCT04594239|455928639|FG000|Overall Study|Subject relocated|0|||
126721286|NCT04594239|455928640|FG001|Overall Study|Subject relocated|0|||
126406839|NCT01927055|454783171|FG001|Open-label|Adverse Event|0|||
126406840|NCT01927055|454783172|FG002|Open-label|Adverse Event|0|||
126473477|NCT02975336|455034534|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
126558415|NCT01852162|455338710|FG001|Overall Study|Withdrawal by Subject|1|||
126406841|NCT01927055|454783170|FG000|Open-label|Withdrawal by Subject|1|||
126406842|NCT01927055|454783171|FG001|Open-label|Withdrawal by Subject|0|||
126406843|NCT01927055|454783172|FG002|Open-label|Withdrawal by Subject|0|||
126406844|NCT01927055|454783170|FG000|Open-label|Study Stopped|4|||
126406845|NCT01927055|454783171|FG001|Open-label|Study Stopped|0|||
126406846|NCT01927055|454783172|FG002|Open-label|Study Stopped|0|||
126406847|NCT01927055|454783170|FG000|Open-label|Supine Hypertension|4|||
126406848|NCT01927055|454783171|FG001|Open-label|Supine Hypertension|0|||
126406849|NCT01927055|454783172|FG002|Open-label|Supine Hypertension|0|||
126406850|NCT01927055|454783170|FG000|Open-label|Difficulty attending study visits|1|||
126406851|NCT01927055|454783171|FG001|Open-label|Difficulty attending study visits|0|||
126406852|NCT01927055|454783172|FG002|Open-label|Difficulty attending study visits|0|||
126406853|NCT01927055|454783170|FG000|Double-Blind|Adverse Event|0|||
126406854|NCT01927055|454783171|FG001|Double-Blind|Adverse Event|1|||
126406855|NCT01927055|454783172|FG002|Double-Blind|Adverse Event|1|||
126406856|NCT01927055|454783170|FG000|Double-Blind|Protocol Violation|0|||
126406857|NCT01927055|454783171|FG001|Double-Blind|Protocol Violation|0|||
126406858|NCT01927055|454783172|FG002|Double-Blind|Protocol Violation|1|||
126406859|NCT01927055|454783170|FG000|Double-Blind|Withdrawal by Subject|0|||
126406860|NCT01927055|454783171|FG001|Double-Blind|Withdrawal by Subject|2|||
126406861|NCT01927055|454783172|FG002|Double-Blind|Withdrawal by Subject|3|||
126406862|NCT01927055|454783170|FG000|Double-Blind|Study Stopped|0|||
126406863|NCT01927055|454783171|FG001|Double-Blind|Study Stopped|7|||
126406864|NCT01927055|454783172|FG002|Double-Blind|Study Stopped|7|||
126406865|NCT01927055|454783170|FG000|Double-Blind|Supine Hypertension|0|||
126406866|NCT01927055|454783171|FG001|Double-Blind|Supine Hypertension|0|||
126406867|NCT01927055|454783172|FG002|Double-Blind|Supine Hypertension|1|||
126406868|NCT01927055|454783170|FG000|Double-Blind|Extended Vacation|0|||
126406869|NCT01927055|454783171|FG001|Double-Blind|Extended Vacation|1|||
126406870|NCT01927055|454783172|FG002|Double-Blind|Extended Vacation|0|||
126406871|NCT02966015|454783175|FG000|Inclusion Visit|did not answer questionnaire|8|||
126406872|NCT02966015|454783176|FG001|Inclusion Visit|did not answer questionnaire|3|||
126406873|NCT00619489|454783177|FG000|Overall Study|Adverse Event|0|||
126406874|NCT00619489|454783178|FG001|Overall Study|Adverse Event|7|||
126406875|NCT00619489|454783177|FG000|Overall Study|Withdrawal by Subject|1|||
126406876|NCT00619489|454783178|FG001|Overall Study|Withdrawal by Subject|1|||
126406877|NCT00619489|454783177|FG000|Overall Study|Lack of Efficacy|0|||
126406878|NCT00619489|454783178|FG001|Overall Study|Lack of Efficacy|11|||
126406879|NCT00619489|454783177|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
126406880|NCT00619489|454783178|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
126406881|NCT01198509|454783185|FG000|Overall Study|Withdrawal by Subject|1|||
126406882|NCT01198509|454783186|FG001|Overall Study|Withdrawal by Subject|0|||
126406883|NCT01198509|454783187|FG002|Overall Study|Withdrawal by Subject|0|||
126406884|NCT01198509|454783188|FG003|Overall Study|Withdrawal by Subject|0|||
126406885|NCT01198509|454783189|FG004|Overall Study|Withdrawal by Subject|0|||
126406886|NCT01198509|454783190|FG005|Overall Study|Withdrawal by Subject|0|||
126406887|NCT00499746|454783191|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
126406888|NCT00499746|454783191|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
126406889|NCT00499746|454783191|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
126406890|NCT00499746|454783191|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
126406891|NCT02745535|454783193|FG000|Overall Study|Death|1|||
126406892|NCT02745535|454783193|FG000|Overall Study|Adverse Event|3|||
126406893|NCT02745535|454783193|FG000|Overall Study|Lost to Follow-up|2|||
126406894|NCT01291277|454783194|FG000|Overall Study|Death|2|||
126406895|NCT01291277|454783195|FG001|Overall Study|Death|2|||
126406896|NCT01291277|454783194|FG000|Overall Study|Lost to Follow-up|3|||
126406897|NCT01291277|454783195|FG001|Overall Study|Lost to Follow-up|1|||
126406898|NCT00849108|454783196|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
126406899|NCT00849108|454783197|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
126406900|NCT00849108|454783196|FG000|Cohort 2 Efficacy|Adverse Event|0|||
126406901|NCT00849108|454783197|FG001|Cohort 2 Efficacy|Adverse Event|1|||
126406902|NCT00849108|454783196|FG000|Cohort 2 Efficacy|Other|0|||
126406903|NCT00849108|454783197|FG001|Cohort 2 Efficacy|Other|9|||
126406904|NCT03480009|454783198|FG000|Overall Study|Lost to Follow-up|4|||
126406905|NCT03480009|454783199|FG001|Overall Study|Lost to Follow-up|5|||
126406906|NCT03480009|454783200|FG002|Overall Study|Lost to Follow-up|4|||
126406907|NCT03480009|454783201|FG003|Overall Study|Lost to Follow-up|0|||
126406908|NCT01563172|454783202|FG000|Overall Study|Adverse Event|5|||
126406909|NCT01563172|454783202|FG000|Overall Study|Lost to Follow-up|2|||
126406910|NCT01563172|454783202|FG000|Overall Study|Other (Protocol deviation)|5|||
126406911|NCT01563172|454783202|FG000|Overall Study|Other (Not specified)|1|||
126473478|NCT02975336|455034527|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
126721287|NCT04594239|455928641|FG002|Overall Study|Subject relocated|0|||
126406912|NCT01105377|454783203|FG000|Overall Study|Withdrawal by Subject|0|||
126406913|NCT01105377|454783204|FG001|Overall Study|Withdrawal by Subject|1|||
126406914|NCT02014584|454783212|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126406915|NCT02014584|454783213|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
126406916|NCT02014584|454783214|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126406917|NCT02014584|454783215|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126406918|NCT02014584|454783216|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126406919|NCT02014584|454783217|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126406920|NCT02014584|454783212|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
126406921|NCT02014584|454783213|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
126406922|NCT02014584|454783214|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126406923|NCT02014584|454783215|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126406924|NCT02014584|454783216|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126406925|NCT02014584|454783217|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126406926|NCT02014584|454783212|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
126473479|NCT02975336|455034528|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
126473480|NCT02975336|455034529|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
126473481|NCT02975336|455034530|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
126473482|NCT02975336|455034531|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
126473483|NCT02975336|455034532|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
126473484|NCT02975336|455034533|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
126473485|NCT02975336|455034534|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
126473486|NCT02975336|455034527|FG000|LTE (104 Weeks)|Adverse Event|0|||
126473487|NCT02975336|455034528|FG001|LTE (104 Weeks)|Adverse Event|0|||
126473488|NCT02975336|455034529|FG002|LTE (104 Weeks)|Adverse Event|0|||
126406927|NCT02014584|454783213|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
126406928|NCT02014584|454783214|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
126406929|NCT02014584|454783215|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
126406930|NCT02014584|454783216|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
126406931|NCT02014584|454783217|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
126406932|NCT02014584|454783212|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
126406933|NCT02014584|454783213|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
126406934|NCT02014584|454783214|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
126406935|NCT02014584|454783215|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
126406936|NCT02014584|454783216|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
126406937|NCT02014584|454783217|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
126406938|NCT02014584|454783212|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
126406939|NCT02014584|454783213|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
126406940|NCT02014584|454783214|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
126406941|NCT02014584|454783215|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
126406942|NCT02014584|454783216|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
126406943|NCT02014584|454783217|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
126406944|NCT01624090|454783218|FG000|Overall Study|DLT, taken off therapy|0|||
126406945|NCT01624090|454783219|FG001|Overall Study|DLT, taken off therapy|1|||
126406946|NCT01624090|454783220|FG002|Overall Study|DLT, taken off therapy|0|||
126406947|NCT01624090|454783221|FG003|Overall Study|DLT, taken off therapy|0|||
126406948|NCT01624090|454783218|FG000|Overall Study|Withdrew prior to treatment|0|||
126406949|NCT01624090|454783219|FG001|Overall Study|Withdrew prior to treatment|1|||
126406950|NCT01624090|454783220|FG002|Overall Study|Withdrew prior to treatment|0|||
126406951|NCT01624090|454783221|FG003|Overall Study|Withdrew prior to treatment|0|||
126406952|NCT01624090|454783218|FG000|Overall Study|Died on study|0|||
126406953|NCT01624090|454783219|FG001|Overall Study|Died on study|0|||
126406954|NCT01624090|454783220|FG002|Overall Study|Died on study|2|||
126406955|NCT01624090|454783221|FG003|Overall Study|Died on study|0|||
126406956|NCT01624090|454783218|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
126406957|NCT01624090|454783219|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
126406958|NCT01624090|454783220|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
126473489|NCT02975336|455034530|FG003|LTE (104 Weeks)|Adverse Event|0|||
126473490|NCT02975336|455034531|FG004|LTE (104 Weeks)|Adverse Event|7|||
126473491|NCT02975336|455034532|FG005|LTE (104 Weeks)|Adverse Event|4|||
126473492|NCT02975336|455034533|FG006|LTE (104 Weeks)|Adverse Event|2|||
126473493|NCT02975336|455034534|FG007|LTE (104 Weeks)|Adverse Event|0|||
126473494|NCT02975336|455034527|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
126558416|NCT02123966|455338715|FG000|Overall Study|Intercurrent Illness|1|||
126406959|NCT01624090|454783221|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
126406960|NCT01624090|454783218|FG000|Overall Study|Dose escalated|0|||
126406961|NCT01624090|454783219|FG001|Overall Study|Dose escalated|0|||
126406962|NCT01624090|454783220|FG002|Overall Study|Dose escalated|3|||
126406963|NCT01624090|454783221|FG003|Overall Study|Dose escalated|0|||
126558417|NCT01460381|455338716|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
126558418|NCT01460381|455338717|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
126558419|NCT02297503|455338721|FG000|Overall Study|Withdrawal by Subject|1|||
126406964|NCT00772109|454783222|FG000|Overall Study|Serious adverse event|1|||
126473495|NCT02975336|455034528|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
126473496|NCT02975336|455034529|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
126473497|NCT02975336|455034530|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
126558420|NCT02297503|455338722|FG001|Overall Study|Withdrawal by Subject|1|||
126406965|NCT00772109|454783223|FG001|Overall Study|Serious adverse event|0|||
126406966|NCT00772109|454783224|FG002|Overall Study|Serious adverse event|1|||
126406967|NCT00772109|454783225|FG003|Overall Study|Serious adverse event|0|||
126406968|NCT00772109|454783222|FG000|Overall Study|Protocol Violation|5|||
126406969|NCT00772109|454783223|FG001|Overall Study|Protocol Violation|8|||
126406970|NCT00772109|454783224|FG002|Overall Study|Protocol Violation|7|||
126406971|NCT00772109|454783225|FG003|Overall Study|Protocol Violation|6|||
126406972|NCT00772109|454783222|FG000|Overall Study|Lost to Follow-up|7|||
126406973|NCT00772109|454783223|FG001|Overall Study|Lost to Follow-up|3|||
126406974|NCT00772109|454783224|FG002|Overall Study|Lost to Follow-up|5|||
126406975|NCT00772109|454783225|FG003|Overall Study|Lost to Follow-up|9|||
126406976|NCT00772109|454783222|FG000|Overall Study|Withdrawal by Subject|8|||
126406977|NCT00772109|454783223|FG001|Overall Study|Withdrawal by Subject|8|||
126406978|NCT00772109|454783224|FG002|Overall Study|Withdrawal by Subject|6|||
126406979|NCT00772109|454783225|FG003|Overall Study|Withdrawal by Subject|16|||
126406980|NCT00752726|454783226|FG000|Overall Study|Lost to Follow-up|2|||
126406981|NCT00752726|454783227|FG001|Overall Study|Lost to Follow-up|1|||
126406982|NCT00752726|454783226|FG000|Overall Study|Adverse Event|3|||
126406983|NCT00752726|454783227|FG001|Overall Study|Adverse Event|0|||
126406984|NCT00752726|454783226|FG000|Overall Study|Withdrawal by Subject|5|||
126406985|NCT00752726|454783227|FG001|Overall Study|Withdrawal by Subject|10|||
126406986|NCT00752726|454783226|FG000|Overall Study|Other Reason|1|||
126406987|NCT00752726|454783227|FG001|Overall Study|Other Reason|2|||
126406988|NCT00042666|454783228|FG000|Overall Study|Adverse Event|2|||
126406989|NCT00042666|454783228|FG000|Overall Study|Death|4|||
126406990|NCT00042666|454783228|FG000|Overall Study|Protocol Violation|1|||
126406991|NCT00042666|454783228|FG000|Overall Study|Participant/Physician Perception|1|||
126406992|NCT00042666|454783228|FG000|Overall Study|Progressive Disease|41|||
126406993|NCT00042666|454783228|FG000|Overall Study|Other|1|||
126406994|NCT00042666|454783228|FG000|Overall Study|Other|4|||
126406995|NCT04232215|454783229|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
126406996|NCT04232215|454783230|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
126406997|NCT01555125|454783233|FG000|Induction Period|Lost to Follow-up|0|||
126406998|NCT01555125|454783234|FG001|Induction Period|Lost to Follow-up|2|||
126406999|NCT01555125|454783235|FG002|Induction Period|Lost to Follow-up|0|||
126407000|NCT01555125|454783236|FG003|Induction Period|Lost to Follow-up|0|||
126407001|NCT01555125|454783237|FG004|Induction Period|Lost to Follow-up|0|||
126407002|NCT01555125|454783233|FG000|Induction Period|Adverse Event|0|||
126407003|NCT01555125|454783234|FG001|Induction Period|Adverse Event|1|||
126407004|NCT01555125|454783235|FG002|Induction Period|Adverse Event|0|||
126407005|NCT01555125|454783236|FG003|Induction Period|Adverse Event|0|||
126407006|NCT01555125|454783237|FG004|Induction Period|Adverse Event|1|||
126407007|NCT01555125|454783233|FG000|Induction Period|Subject / guardian decision|0|||
126407008|NCT01555125|454783234|FG001|Induction Period|Subject / guardian decision|0|||
126473498|NCT02975336|455034531|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
126473499|NCT02975336|455034532|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
126473500|NCT02975336|455034533|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
126473501|NCT02975336|455034534|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
126473502|NCT02975336|455034527|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
126473503|NCT02975336|455034528|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
126473504|NCT02975336|455034529|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
126473505|NCT02975336|455034530|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
126473506|NCT02975336|455034531|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
126473507|NCT02975336|455034532|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
126473508|NCT02975336|455034533|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
126473509|NCT02975336|455034534|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
126473510|NCT02975336|455034527|FG000|LTE (104 Weeks)|Other|0|||
126473511|NCT02975336|455034528|FG001|LTE (104 Weeks)|Other|0|||
126473512|NCT02975336|455034529|FG002|LTE (104 Weeks)|Other|0|||
126473513|NCT02975336|455034530|FG003|LTE (104 Weeks)|Other|0|||
126473514|NCT02975336|455034531|FG004|LTE (104 Weeks)|Other|55|||
126473515|NCT02975336|455034532|FG005|LTE (104 Weeks)|Other|63|||
126473516|NCT02975336|455034533|FG006|LTE (104 Weeks)|Other|76|||
126407009|NCT01555125|454783235|FG002|Induction Period|Subject / guardian decision|0|||
126407010|NCT01555125|454783236|FG003|Induction Period|Subject / guardian decision|0|||
126407011|NCT01555125|454783237|FG004|Induction Period|Subject / guardian decision|2|||
126407012|NCT01555125|454783233|FG000|Induction Period|Death|1|||
126407013|NCT01555125|454783234|FG001|Induction Period|Death|0|||
126407014|NCT01555125|454783235|FG002|Induction Period|Death|0|||
126407015|NCT01555125|454783236|FG003|Induction Period|Death|0|||
126407016|NCT01555125|454783237|FG004|Induction Period|Death|0|||
126407017|NCT01555125|454783233|FG000|Maintenance Period|Adverse Event|1|||
126407018|NCT01555125|454783234|FG001|Maintenance Period|Adverse Event|1|||
126407019|NCT01555125|454783235|FG002|Maintenance Period|Adverse Event|0|||
126407020|NCT01555125|454783236|FG003|Maintenance Period|Adverse Event|0|||
126473517|NCT02975336|455034534|FG007|LTE (104 Weeks)|Other|72|||
126473518|NCT04015336|455034535|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
126473519|NCT01816074|455034540|FG000|Phase 1|Time commitment issues|0|||
126473520|NCT01816074|455034541|FG001|Phase 1|Time commitment issues|0|||
126407021|NCT01555125|454783237|FG004|Maintenance Period|Adverse Event|0|||
126407022|NCT01555125|454783233|FG000|Maintenance Period|Subject / guardian decision|1|||
126407023|NCT01555125|454783234|FG001|Maintenance Period|Subject / guardian decision|2|||
126407024|NCT01555125|454783235|FG002|Maintenance Period|Subject / guardian decision|0|||
126407025|NCT01555125|454783236|FG003|Maintenance Period|Subject / guardian decision|0|||
126407026|NCT01555125|454783237|FG004|Maintenance Period|Subject / guardian decision|0|||
126407027|NCT01555125|454783233|FG000|Maintenance Period|Lost to Follow-up|2|||
126407028|NCT01555125|454783234|FG001|Maintenance Period|Lost to Follow-up|0|||
126407029|NCT01555125|454783235|FG002|Maintenance Period|Lost to Follow-up|0|||
126407030|NCT01555125|454783236|FG003|Maintenance Period|Lost to Follow-up|1|||
126407031|NCT01555125|454783237|FG004|Maintenance Period|Lost to Follow-up|0|||
126407032|NCT01555125|454783233|FG000|Maintenance Period|Lack of Efficacy|6|||
126407033|NCT01555125|454783234|FG001|Maintenance Period|Lack of Efficacy|1|||
126407034|NCT01555125|454783235|FG002|Maintenance Period|Lack of Efficacy|3|||
126407035|NCT01555125|454783236|FG003|Maintenance Period|Lack of Efficacy|0|||
126407036|NCT01555125|454783237|FG004|Maintenance Period|Lack of Efficacy|0|||
126407037|NCT01555125|454783233|FG000|Maintenance Period|Physician Decision|0|||
126407038|NCT01555125|454783234|FG001|Maintenance Period|Physician Decision|0|||
126407039|NCT01555125|454783235|FG002|Maintenance Period|Physician Decision|1|||
126407040|NCT01555125|454783236|FG003|Maintenance Period|Physician Decision|0|||
126407041|NCT01555125|454783237|FG004|Maintenance Period|Physician Decision|0|||
126407042|NCT01555125|454783233|FG000|Maintenance Period|Death|0|||
126407043|NCT01555125|454783234|FG001|Maintenance Period|Death|0|||
126407044|NCT01555125|454783235|FG002|Maintenance Period|Death|0|||
126407045|NCT01555125|454783236|FG003|Maintenance Period|Death|1|||
126407046|NCT01555125|454783237|FG004|Maintenance Period|Death|0|||
126407047|NCT01555125|454783233|FG000|Extension|Adverse Event|1|||
126407048|NCT01555125|454783234|FG001|Extension|Adverse Event|2|||
126407049|NCT01555125|454783235|FG002|Extension|Adverse Event|1|||
126407050|NCT01555125|454783236|FG003|Extension|Adverse Event|1|||
126407051|NCT01555125|454783237|FG004|Extension|Adverse Event|0|||
126407052|NCT01555125|454783233|FG000|Extension|Protocol deviation|1|||
126407053|NCT01555125|454783234|FG001|Extension|Protocol deviation|0|||
126407054|NCT01555125|454783235|FG002|Extension|Protocol deviation|0|||
126407055|NCT01555125|454783236|FG003|Extension|Protocol deviation|0|||
126407056|NCT01555125|454783237|FG004|Extension|Protocol deviation|0|||
126407057|NCT01555125|454783233|FG000|Extension|Lack of Efficacy|7|||
126407058|NCT01555125|454783234|FG001|Extension|Lack of Efficacy|6|||
126407059|NCT01555125|454783235|FG002|Extension|Lack of Efficacy|3|||
126407060|NCT01555125|454783236|FG003|Extension|Lack of Efficacy|0|||
126407061|NCT01555125|454783237|FG004|Extension|Lack of Efficacy|0|||
126407062|NCT01555125|454783233|FG000|Extension|Lost to Follow-up|2|||
126407063|NCT01555125|454783234|FG001|Extension|Lost to Follow-up|1|||
126407064|NCT01555125|454783235|FG002|Extension|Lost to Follow-up|2|||
126407065|NCT01555125|454783236|FG003|Extension|Lost to Follow-up|0|||
126407066|NCT01555125|454783237|FG004|Extension|Lost to Follow-up|0|||
126407067|NCT01555125|454783233|FG000|Extension|Study terminated by sponsor|32|||
126407068|NCT01555125|454783234|FG001|Extension|Study terminated by sponsor|33|||
126407069|NCT01555125|454783235|FG002|Extension|Study terminated by sponsor|16|||
126407070|NCT01555125|454783236|FG003|Extension|Study terminated by sponsor|20|||
126407071|NCT01555125|454783237|FG004|Extension|Study terminated by sponsor|0|||
126407072|NCT01555125|454783233|FG000|Extension|Subject/guardian decision|1|||
126407073|NCT01555125|454783234|FG001|Extension|Subject/guardian decision|9|||
126407074|NCT01555125|454783235|FG002|Extension|Subject/guardian decision|1|||
126407075|NCT01555125|454783236|FG003|Extension|Subject/guardian decision|0|||
126407076|NCT01555125|454783237|FG004|Extension|Subject/guardian decision|0|||
126407077|NCT01555125|454783233|FG000|Extension|Technical Problems|1|||
126407078|NCT01555125|454783234|FG001|Extension|Technical Problems|0|||
126407079|NCT01555125|454783235|FG002|Extension|Technical Problems|0|||
126407080|NCT01555125|454783236|FG003|Extension|Technical Problems|1|||
126473521|NCT01816074|455034542|FG002|Phase 1|Time commitment issues|1|||
126473522|NCT01816074|455034543|FG003|Phase 1|Time commitment issues|0|||
126407081|NCT01555125|454783237|FG004|Extension|Technical Problems|0|||
126407082|NCT01555125|454783233|FG000|Follow-Up Period|Lost to Follow-up|1|||
126407083|NCT01555125|454783234|FG001|Follow-Up Period|Lost to Follow-up|0|||
126407084|NCT01555125|454783235|FG002|Follow-Up Period|Lost to Follow-up|0|||
126407085|NCT01555125|454783236|FG003|Follow-Up Period|Lost to Follow-up|0|||
126407086|NCT01555125|454783237|FG004|Follow-Up Period|Lost to Follow-up|0|||
126407087|NCT01555125|454783233|FG000|Follow-Up Period|Subject / guardian decision|3|||
126407088|NCT01555125|454783234|FG001|Follow-Up Period|Subject / guardian decision|1|||
126407089|NCT01555125|454783235|FG002|Follow-Up Period|Subject / guardian decision|1|||
126407090|NCT01555125|454783236|FG003|Follow-Up Period|Subject / guardian decision|1|||
126407091|NCT01555125|454783237|FG004|Follow-Up Period|Subject / guardian decision|0|||
126407092|NCT02651220|454783238|FG000|Overall Study|Adverse Event|1|||
126407093|NCT02651220|454783239|FG001|Overall Study|Adverse Event|5|||
126407094|NCT02651220|454783240|FG002|Overall Study|Adverse Event|1|||
126407095|NCT02651220|454783238|FG000|Overall Study|Lost to Follow-up|8|||
126407096|NCT02651220|454783239|FG001|Overall Study|Lost to Follow-up|14|||
126473523|NCT01816074|455034540|FG000|Phase 2|Time commitment Issues|0|||
126407097|NCT02651220|454783240|FG002|Overall Study|Lost to Follow-up|14|||
126407098|NCT02651220|454783238|FG000|Overall Study|Non-Compliance with Study Drug|4|||
126407099|NCT02651220|454783239|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126407100|NCT02651220|454783240|FG002|Overall Study|Non-Compliance with Study Drug|1|||
126407101|NCT02651220|454783238|FG000|Overall Study|Pregnancy|1|||
126407102|NCT02651220|454783239|FG001|Overall Study|Pregnancy|0|||
126407103|NCT02651220|454783240|FG002|Overall Study|Pregnancy|1|||
126407104|NCT02651220|454783238|FG000|Overall Study|Protocol Violation|0|||
126407105|NCT02651220|454783239|FG001|Overall Study|Protocol Violation|0|||
126407106|NCT02651220|454783240|FG002|Overall Study|Protocol Violation|1|||
126407107|NCT02651220|454783238|FG000|Overall Study|Withdrawal by Subject|5|||
126407108|NCT02651220|454783239|FG001|Overall Study|Withdrawal by Subject|6|||
126407109|NCT02651220|454783240|FG002|Overall Study|Withdrawal by Subject|8|||
126407110|NCT02651220|454783238|FG000|Overall Study|Miscellaneous|4|||
126407111|NCT02651220|454783239|FG001|Overall Study|Miscellaneous|1|||
126407112|NCT02651220|454783240|FG002|Overall Study|Miscellaneous|2|||
126407113|NCT02651220|454783238|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126407114|NCT02651220|454783239|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126407115|NCT02651220|454783240|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
126407116|NCT04046250|454783256|FG000|Overall Study|Death|0|||
126407117|NCT04046250|454783257|FG001|Overall Study|Death|1|||
126407118|NCT04046250|454783256|FG000|Overall Study|Withdrawal by Subject|3|||
126407119|NCT04046250|454783257|FG001|Overall Study|Withdrawal by Subject|3|||
126407120|NCT04576897|454783262|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
126407121|NCT00527332|454783263|FG000|Overall Study|Protocol Violation|4|||
126407122|NCT00527332|454783264|FG001|Overall Study|Protocol Violation|8|||
126407123|NCT00527332|454783263|FG000|Overall Study|Withdrew consent|5|||
126407124|NCT00527332|454783264|FG001|Overall Study|Withdrew consent|1|||
126407125|NCT02666105|454783265|FG000|Overall Study|Death|1|||
126407126|NCT01078168|454783266|FG000|Overall Study|Physician Decision|0|||
126407127|NCT01078168|454783267|FG001|Overall Study|Physician Decision|1|||
126407128|NCT01264419|454783269|FG000|Overall Study|Lost to Follow-up|3|||
126407129|NCT02720692|454785752|FG000|Overall Study|Withdrawal by Subject|3|||
126407130|NCT02720692|454785753|FG001|Overall Study|Withdrawal by Subject|0|||
126407131|NCT02720692|454785752|FG000|Overall Study|Physician Decision|1|||
126407132|NCT02720692|454785753|FG001|Overall Study|Physician Decision|0|||
126407133|NCT02720692|454785752|FG000|Overall Study|Lost to Follow-up|8|||
126407134|NCT02720692|454785753|FG001|Overall Study|Lost to Follow-up|3|||
126407135|NCT02720692|454785752|FG000|Overall Study|Subject unable to return for visit|1|||
126407136|NCT02720692|454785753|FG001|Overall Study|Subject unable to return for visit|0|||
126407137|NCT05011513|454785754|FG000|Overall Study|Death|0|||
126407138|NCT05011513|454785755|FG001|Overall Study|Death|1|||
126407139|NCT05011513|454785754|FG000|Overall Study|Lost to Follow-up|4|||
126407140|NCT05011513|454785755|FG001|Overall Study|Lost to Follow-up|0|||
126407141|NCT05011513|454785754|FG000|Overall Study|Withdrawal by Subject|18|||
126407142|NCT05011513|454785755|FG001|Overall Study|Withdrawal by Subject|17|||
126407143|NCT05011513|454785754|FG000|Overall Study|Other|4|||
126407144|NCT05011513|454785755|FG001|Overall Study|Other|2|||
126407145|NCT03878758|454785756|FG000|Overall Study|Withdrawal by Subject|1|||
126407146|NCT03878758|454785756|FG000|Overall Study|Protocol defined|2|||
126721288|NCT04594239|455928642|FG003|Overall Study|Subject relocated|1|||
126721289|NCT00091390|455928643|FG000|Overall Study|Protocol Violation|1|||
126721290|NCT00091390|455928643|FG000|Overall Study|No protocol treatment|3|||
126721291|NCT03229759|455928644|FG000|Overall Study|Screen Failure|30|||
126721292|NCT03050359|455929903|FG000|Overall Study|Randomized But Not Treated|2|||
126721293|NCT03050359|455929904|FG001|Overall Study|Randomized But Not Treated|0|||
126721294|NCT03050359|455929903|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
126721295|NCT03050359|455929904|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
126721296|NCT03050359|455929903|FG000|Overall Study|Significant Protocol Deviation|2|||
126721297|NCT03050359|455929904|FG001|Overall Study|Significant Protocol Deviation|3|||
126558421|NCT02297503|455338721|FG000|Overall Study|Protocol Violation|1|||
126558422|NCT02297503|455338722|FG001|Overall Study|Protocol Violation|0|||
126558423|NCT02297503|455338721|FG000|Overall Study|Pregnancy|0|||
126558424|NCT02297503|455338722|FG001|Overall Study|Pregnancy|1|||
126407147|NCT03878758|454785756|FG000|Overall Study|Improper consent documentation|1|||
126407148|NCT02315560|454785757|FG000|Overall Study|noncompliance by subjects|3|||
126407149|NCT00358436|454785759|FG000|Overall Study|Adverse Event|29|||
126407150|NCT00358436|454785760|FG001|Overall Study|Adverse Event|13|||
126407151|NCT00358436|454785759|FG000|Overall Study|Lack of Efficacy|34|||
126558425|NCT02297503|455338721|FG000|Overall Study|Lost to Follow-up|0|||
126558426|NCT02297503|455338722|FG001|Overall Study|Lost to Follow-up|1|||
126407152|NCT00358436|454785760|FG001|Overall Study|Lack of Efficacy|36|||
126407153|NCT00358436|454785759|FG000|Overall Study|Lost to Follow-up|11|||
126407154|NCT00358436|454785760|FG001|Overall Study|Lost to Follow-up|6|||
126407155|NCT00358436|454785759|FG000|Overall Study|Protocol Violation|8|||
126407156|NCT00358436|454785760|FG001|Overall Study|Protocol Violation|3|||
126407157|NCT00358436|454785759|FG000|Overall Study|Withdrawal by Subject|40|||
126558427|NCT02297503|455338721|FG000|Overall Study|Medical reason|0|||
126558428|NCT02297503|455338722|FG001|Overall Study|Medical reason|1|||
126558429|NCT04337489|455338728|FG000|Overall Study|Withdrawal by Subject|1|||
126558430|NCT00972543|455338729|FG000|Overall Study|Adverse Event|1|||
126558431|NCT00972543|455338730|FG001|Overall Study|Adverse Event|0|||
126558432|NCT00972543|455338729|FG000|Overall Study|Early study termination by sponsor|4|||
126558433|NCT00972543|455338730|FG001|Overall Study|Early study termination by sponsor|1|||
126558434|NCT00562965|455338735|FG000|Overall Study|Withdrawal by Subject|0|||
126407158|NCT00358436|454785760|FG001|Overall Study|Withdrawal by Subject|17|||
126407159|NCT00358436|454785759|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
126407160|NCT00358436|454785760|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
126407161|NCT00358436|454785759|FG000|Overall Study|COPD exacerbation|22|||
126407162|NCT00358436|454785760|FG001|Overall Study|COPD exacerbation|10|||
126407163|NCT00358436|454785759|FG000|Overall Study|Other|6|||
126407164|NCT00358436|454785760|FG001|Overall Study|Other|1|||
126407165|NCT02905006|454785764|FG000|Overall Study|Adverse Event|1|||
126407166|NCT02905006|454785765|FG001|Overall Study|Adverse Event|1|||
126407167|NCT02905006|454785766|FG002|Overall Study|Adverse Event|1|||
126407168|NCT02905006|454785767|FG003|Overall Study|Adverse Event|1|||
126407169|NCT02905006|454785768|FG004|Overall Study|Adverse Event|0|||
126407170|NCT02905006|454785769|FG005|Overall Study|Adverse Event|1|||
126407171|NCT02905006|454785764|FG000|Overall Study|Lack of Efficacy|1|||
126407172|NCT02905006|454785765|FG001|Overall Study|Lack of Efficacy|0|||
126407173|NCT02905006|454785766|FG002|Overall Study|Lack of Efficacy|0|||
126407174|NCT02905006|454785767|FG003|Overall Study|Lack of Efficacy|0|||
126407175|NCT02905006|454785768|FG004|Overall Study|Lack of Efficacy|0|||
126407176|NCT02905006|454785769|FG005|Overall Study|Lack of Efficacy|0|||
126407177|NCT02905006|454785764|FG000|Overall Study|Protocol Violation|2|||
126407178|NCT02905006|454785765|FG001|Overall Study|Protocol Violation|0|||
126407179|NCT02905006|454785766|FG002|Overall Study|Protocol Violation|0|||
126407180|NCT02905006|454785767|FG003|Overall Study|Protocol Violation|0|||
126407181|NCT02905006|454785768|FG004|Overall Study|Protocol Violation|0|||
126407182|NCT02905006|454785769|FG005|Overall Study|Protocol Violation|0|||
126407183|NCT02905006|454785764|FG000|Overall Study|Lost to Follow-up|0|||
126407184|NCT02905006|454785765|FG001|Overall Study|Lost to Follow-up|0|||
126407185|NCT02905006|454785766|FG002|Overall Study|Lost to Follow-up|0|||
126407186|NCT02905006|454785767|FG003|Overall Study|Lost to Follow-up|1|||
126407187|NCT02905006|454785768|FG004|Overall Study|Lost to Follow-up|1|||
126407188|NCT02905006|454785769|FG005|Overall Study|Lost to Follow-up|0|||
126558435|NCT00562965|455338736|FG001|Overall Study|Withdrawal by Subject|1|||
126558436|NCT00562965|455338735|FG000|Overall Study|Death|2|||
126558437|NCT00562965|455338736|FG001|Overall Study|Death|4|||
126558438|NCT00562965|455338735|FG000|Overall Study|Lost to Follow-up|1|||
126558439|NCT00562965|455338736|FG001|Overall Study|Lost to Follow-up|0|||
126558440|NCT00562965|455338735|FG000|Overall Study|Other|0|||
126558441|NCT00562965|455338736|FG001|Overall Study|Other|1|||
126558442|NCT01657682|455338737|FG000|Overall Study|Lost to Follow-up|1|||
126558443|NCT01657682|455338738|FG001|Overall Study|Lost to Follow-up|0|||
126558444|NCT01657682|455338739|FG002|Overall Study|Lost to Follow-up|0|||
126558445|NCT01657682|455338737|FG000|Overall Study|Withdrawal by Subject|0|||
126558446|NCT01657682|455338738|FG001|Overall Study|Withdrawal by Subject|1|||
126558447|NCT01657682|455338739|FG002|Overall Study|Withdrawal by Subject|1|||
126558448|NCT01657682|455338737|FG000|Overall Study|Adverse Event|0|||
126558449|NCT01657682|455338738|FG001|Overall Study|Adverse Event|1|||
126407189|NCT02905006|454785764|FG000|Overall Study|Withdrawal by Subject|0|||
126407190|NCT02905006|454785765|FG001|Overall Study|Withdrawal by Subject|0|||
126407191|NCT02905006|454785766|FG002|Overall Study|Withdrawal by Subject|1|||
126407192|NCT02905006|454785767|FG003|Overall Study|Withdrawal by Subject|1|||
126407193|NCT02905006|454785768|FG004|Overall Study|Withdrawal by Subject|0|||
126407194|NCT02905006|454785769|FG005|Overall Study|Withdrawal by Subject|1|||
126407195|NCT02905006|454785764|FG000|Overall Study|Screening exclusion criteria met|1|||
126407196|NCT02905006|454785765|FG001|Overall Study|Screening exclusion criteria met|0|||
126407197|NCT02905006|454785766|FG002|Overall Study|Screening exclusion criteria met|0|||
126407198|NCT02905006|454785767|FG003|Overall Study|Screening exclusion criteria met|0|||
126407199|NCT02905006|454785768|FG004|Overall Study|Screening exclusion criteria met|0|||
126407200|NCT02905006|454785769|FG005|Overall Study|Screening exclusion criteria met|0|||
126407201|NCT02905006|454785764|FG000|Overall Study|Lab withdrawal criterion met|0|||
126407202|NCT02905006|454785765|FG001|Overall Study|Lab withdrawal criterion met|1|||
126407203|NCT02905006|454785766|FG002|Overall Study|Lab withdrawal criterion met|2|||
126407204|NCT02905006|454785767|FG003|Overall Study|Lab withdrawal criterion met|2|||
126407205|NCT02905006|454785768|FG004|Overall Study|Lab withdrawal criterion met|2|||
126407206|NCT02905006|454785769|FG005|Overall Study|Lab withdrawal criterion met|1|||
126407207|NCT02905006|454785764|FG000|Overall Study|Positive for Tuberculosis|0|||
126407208|NCT02905006|454785765|FG001|Overall Study|Positive for Tuberculosis|1|||
126558450|NCT01657682|455338739|FG002|Overall Study|Adverse Event|0|||
126558451|NCT01719861|455338743|FG000|Cycle 1|Death|4|||
126558452|NCT01719861|455338743|FG000|Cycle 2|Death|1|||
126721298|NCT03050359|455929903|FG000|Overall Study|Lost to Follow-up|2|||
126407209|NCT02905006|454785766|FG002|Overall Study|Positive for Tuberculosis|0|||
126407210|NCT02905006|454785767|FG003|Overall Study|Positive for Tuberculosis|0|||
126407211|NCT02905006|454785768|FG004|Overall Study|Positive for Tuberculosis|0|||
126407212|NCT02905006|454785769|FG005|Overall Study|Positive for Tuberculosis|0|||
126407213|NCT02905006|454785764|FG000|Overall Study|Subject positive for Hep B|0|||
126407214|NCT02905006|454785765|FG001|Overall Study|Subject positive for Hep B|0|||
126407215|NCT02905006|454785766|FG002|Overall Study|Subject positive for Hep B|1|||
126407216|NCT02905006|454785767|FG003|Overall Study|Subject positive for Hep B|0|||
126407217|NCT02905006|454785768|FG004|Overall Study|Subject positive for Hep B|0|||
126407218|NCT02905006|454785769|FG005|Overall Study|Subject positive for Hep B|0|||
126407219|NCT02905006|454785764|FG000|Overall Study|Patient moved abroad|0|||
126407220|NCT02905006|454785765|FG001|Overall Study|Patient moved abroad|0|||
126407221|NCT02905006|454785766|FG002|Overall Study|Patient moved abroad|0|||
126407222|NCT02905006|454785767|FG003|Overall Study|Patient moved abroad|1|||
126407223|NCT02905006|454785768|FG004|Overall Study|Patient moved abroad|0|||
126407224|NCT02905006|454785769|FG005|Overall Study|Patient moved abroad|0|||
126407225|NCT02905006|454785764|FG000|Overall Study|Patient randomized by mistake|0|||
126407226|NCT02905006|454785765|FG001|Overall Study|Patient randomized by mistake|0|||
126407227|NCT02905006|454785766|FG002|Overall Study|Patient randomized by mistake|0|||
126407228|NCT02905006|454785767|FG003|Overall Study|Patient randomized by mistake|0|||
126407229|NCT02905006|454785768|FG004|Overall Study|Patient randomized by mistake|0|||
126407230|NCT02905006|454785769|FG005|Overall Study|Patient randomized by mistake|1|||
126407231|NCT02429791|454785774|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
126407232|NCT02429791|454785775|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
126407233|NCT02429791|454785774|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
126407234|NCT02429791|454785775|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
126407235|NCT02429791|454785774|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
126407236|NCT02429791|454785775|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
126407237|NCT02429791|454785774|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
126407238|NCT02429791|454785775|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
126407239|NCT02429791|454785774|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
126407240|NCT02429791|454785775|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
126407241|NCT02429791|454785774|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
126407242|NCT02429791|454785775|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
126407243|NCT02429791|454785774|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
126407244|NCT02429791|454785775|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
126407245|NCT02429791|454785774|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
126407246|NCT02429791|454785775|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
126407247|NCT02429791|454785774|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
126407248|NCT02429791|454785775|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
126407249|NCT02429791|454785774|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
126407250|NCT02429791|454785775|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
126407251|NCT02429791|454785774|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
126407252|NCT02429791|454785775|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
126407253|NCT02429791|454785774|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
126407254|NCT02429791|454785775|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
126407255|NCT02429791|454785774|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
126407256|NCT02429791|454785775|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
126407257|NCT02429791|454785774|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
126407258|NCT02429791|454785775|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
126407259|NCT02429791|454785774|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
126407260|NCT02429791|454785775|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
126407261|NCT02429791|454785774|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
126407262|NCT02429791|454785775|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
126407263|NCT02429791|454785774|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
126407264|NCT02429791|454785775|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
126407265|NCT02429791|454785774|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
126407266|NCT02429791|454785775|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
126407267|NCT04201093|454785776|FG000|Overall Study|Adverse Event|6|||
126473524|NCT01816074|455034541|FG001|Phase 2|Time commitment Issues|2|||
126721299|NCT03050359|455929904|FG001|Overall Study|Lost to Follow-up|1|||
126721300|NCT03050359|455929903|FG000|Overall Study|Voluntary Withdrawal|4|||
126407268|NCT04201093|454785777|FG001|Overall Study|Adverse Event|29|||
126407269|NCT04201093|454785778|FG002|Overall Study|Adverse Event|35|||
126407270|NCT04201093|454785776|FG000|Overall Study|Death|2|||
126407271|NCT04201093|454785777|FG001|Overall Study|Death|1|||
126407272|NCT04201093|454785778|FG002|Overall Study|Death|0|||
126407273|NCT04201093|454785776|FG000|Overall Study|Lack of Efficacy|5|||
126407274|NCT04201093|454785777|FG001|Overall Study|Lack of Efficacy|1|||
126407275|NCT04201093|454785778|FG002|Overall Study|Lack of Efficacy|2|||
126407276|NCT04201093|454785776|FG000|Overall Study|Lost to Follow-up|0|||
126407277|NCT04201093|454785777|FG001|Overall Study|Lost to Follow-up|0|||
126407278|NCT04201093|454785778|FG002|Overall Study|Lost to Follow-up|1|||
126721301|NCT03050359|455929904|FG001|Overall Study|Voluntary Withdrawal|6|||
126721302|NCT03050359|455929903|FG000|Overall Study|Pregnancy|1|||
126721303|NCT03050359|455929904|FG001|Overall Study|Pregnancy|0|||
126721304|NCT03050359|455929903|FG000|Overall Study|Reason Not Specified|1|||
126407279|NCT04201093|454785776|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
126407280|NCT04201093|454785777|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
126407281|NCT04201093|454785778|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
126407282|NCT04201093|454785776|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
126407283|NCT04201093|454785777|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
126407284|NCT04201093|454785778|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
126407285|NCT04201093|454785776|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
126407286|NCT04201093|454785777|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
126407287|NCT04201093|454785778|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
126407288|NCT04201093|454785776|FG000|Overall Study|Physician Decision|1|||
126407289|NCT04201093|454785777|FG001|Overall Study|Physician Decision|0|||
126407290|NCT04201093|454785778|FG002|Overall Study|Physician Decision|0|||
126772328|NCT04440007|456122088|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
126772329|NCT04440007|456122089|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
126772330|NCT04440007|456122088|FG000|Overall Study|Discontinued prior to dosing|0|||
126407291|NCT04201093|454785776|FG000|Overall Study|Protocol Deviation|1|||
126407292|NCT04201093|454785777|FG001|Overall Study|Protocol Deviation|0|||
126407293|NCT04201093|454785778|FG002|Overall Study|Protocol Deviation|0|||
126407294|NCT04201093|454785776|FG000|Overall Study|Site Terminated by Sponsor|5|||
126407295|NCT04201093|454785777|FG001|Overall Study|Site Terminated by Sponsor|3|||
126407296|NCT04201093|454785778|FG002|Overall Study|Site Terminated by Sponsor|1|||
126407297|NCT04201093|454785776|FG000|Overall Study|Withdrawal by Subject|7|||
126407298|NCT04201093|454785777|FG001|Overall Study|Withdrawal by Subject|8|||
126407299|NCT04201093|454785778|FG002|Overall Study|Withdrawal by Subject|15|||
126407300|NCT04201093|454785776|FG000|Overall Study|Other|0|||
126407301|NCT04201093|454785777|FG001|Overall Study|Other|1|||
126407302|NCT04201093|454785778|FG002|Overall Study|Other|2|||
126407303|NCT00881504|454785779|FG000|Overall Study|Withdrawal by Subject|1|||
126407304|NCT00007020|454785780|FG000|Overall Study|Death|16|||
126407305|NCT00007020|454785780|FG000|Overall Study|Lost to Follow-up|13|||
126407306|NCT00007020|454785780|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
126407307|NCT00007020|454785780|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
126407308|NCT00007020|454785780|FG000|Overall Study|Pt cared for by outside physician|4|||
126407309|NCT00007020|454785780|FG000|Overall Study|No evidence of treatment|6|||
126407310|NCT01276223|454785781|FG000|Overall Study|Adverse Event|7|||
126407311|NCT01276223|454785782|FG001|Overall Study|Adverse Event|4|||
126407312|NCT01276223|454785783|FG002|Overall Study|Adverse Event|1|||
126407313|NCT01276223|454785781|FG000|Overall Study|Lost to Follow-up|0|||
126407314|NCT01276223|454785782|FG001|Overall Study|Lost to Follow-up|0|||
126407315|NCT01276223|454785783|FG002|Overall Study|Lost to Follow-up|1|||
126407316|NCT01276223|454785781|FG000|Overall Study|Other|0|||
126407317|NCT01276223|454785782|FG001|Overall Study|Other|0|||
126407318|NCT01276223|454785783|FG002|Overall Study|Other|1|||
126407319|NCT01276223|454785781|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
126407320|NCT01276223|454785782|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
126721305|NCT03050359|455929904|FG001|Overall Study|Reason Not Specified|0|||
126721306|NCT02614287|455929907|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
126721307|NCT02614287|455929908|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
126721308|NCT02614287|455929907|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
126721309|NCT02614287|455929908|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
126721310|NCT02614287|455929907|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
126721311|NCT02614287|455929908|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
126407321|NCT01276223|454785783|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
126407322|NCT01276223|454785781|FG000|Overall Study|Protocol Violation|1|||
126407323|NCT01276223|454785782|FG001|Overall Study|Protocol Violation|0|||
126407324|NCT01276223|454785783|FG002|Overall Study|Protocol Violation|0|||
126407325|NCT05856227|454785784|FG000|Overall Study|Adverse Event|0|||
126407326|NCT05856227|454785785|FG001|Overall Study|Adverse Event|1|||
126407327|NCT05856227|454785784|FG000|Overall Study|Due to Investigator absence|1|||
126407328|NCT05856227|454785785|FG001|Overall Study|Due to Investigator absence|0|||
126721312|NCT02614287|455929907|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
126407329|NCT05856227|454785784|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
126407330|NCT05856227|454785785|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
126407331|NCT00771615|454785787|FG000|Overall Study|Withdrawal by Subject|0|||
126407332|NCT00771615|454785788|FG001|Overall Study|Withdrawal by Subject|1|||
126407333|NCT00771615|454785789|FG002|Overall Study|Withdrawal by Subject|0|||
126407334|NCT00771615|454785790|FG003|Overall Study|Withdrawal by Subject|0|||
126407335|NCT00771615|454785791|FG004|Overall Study|Withdrawal by Subject|0|||
126407336|NCT00771615|454785792|FG005|Overall Study|Withdrawal by Subject|0|||
126407337|NCT00771615|454785793|FG006|Overall Study|Withdrawal by Subject|0|||
126407338|NCT00771615|454785794|FG007|Overall Study|Withdrawal by Subject|1|||
126407339|NCT00771615|454785795|FG008|Overall Study|Withdrawal by Subject|0|||
126407340|NCT00771615|454785787|FG000|Overall Study|Lost to Follow-up|1|||
126407341|NCT00771615|454785788|FG001|Overall Study|Lost to Follow-up|1|||
126407342|NCT00771615|454785789|FG002|Overall Study|Lost to Follow-up|1|||
126407343|NCT00771615|454785790|FG003|Overall Study|Lost to Follow-up|1|||
126407344|NCT00771615|454785791|FG004|Overall Study|Lost to Follow-up|0|||
126407345|NCT00771615|454785792|FG005|Overall Study|Lost to Follow-up|1|||
126407346|NCT00771615|454785793|FG006|Overall Study|Lost to Follow-up|1|||
126407347|NCT00771615|454785794|FG007|Overall Study|Lost to Follow-up|0|||
126407348|NCT00771615|454785795|FG008|Overall Study|Lost to Follow-up|0|||
126407349|NCT02455076|454785796|FG000|Inpatient|Withdrawal by Subject|1|||
126407350|NCT02455076|454785797|FG001|Inpatient|Withdrawal by Subject|0|||
126407351|NCT02455076|454785798|FG002|Inpatient|Withdrawal by Subject|0|||
126407352|NCT02455076|454785799|FG003|Inpatient|Withdrawal by Subject|0|||
126407353|NCT02455076|454785800|FG004|Inpatient|Withdrawal by Subject|0|||
126407354|NCT02455076|454785796|FG000|Inpatient|Discharged <24 h after admission|0|||
126407355|NCT02455076|454785797|FG001|Inpatient|Discharged <24 h after admission|1|||
126473525|NCT01816074|455034542|FG002|Phase 2|Time commitment Issues|0|||
126473526|NCT01816074|455034543|FG003|Phase 2|Time commitment Issues|0|||
126473527|NCT01816074|455034540|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
126473528|NCT01816074|455034541|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
126473529|NCT01816074|455034542|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
126473530|NCT01816074|455034543|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
126473531|NCT01816074|455034540|FG000|Phase 2|Physician Decision|0|||
126473532|NCT01816074|455034541|FG001|Phase 2|Physician Decision|0|||
126473533|NCT01816074|455034542|FG002|Phase 2|Physician Decision|0|||
126473534|NCT01816074|455034543|FG003|Phase 2|Physician Decision|1|||
126473535|NCT01816074|455034540|FG000|Phase 2|Withdrawal by Subject|1|||
126473536|NCT01816074|455034541|FG001|Phase 2|Withdrawal by Subject|0|||
126473537|NCT01816074|455034542|FG002|Phase 2|Withdrawal by Subject|0|||
126473538|NCT01816074|455034543|FG003|Phase 2|Withdrawal by Subject|0|||
126473539|NCT01868503|455034544|FG000|Overall Study|Withdrawal by Subject|1|||
126473540|NCT01868503|455034544|FG000|Overall Study|Protocol Violation|1|||
126473541|NCT03650556|455034545|FG000|Overall Study|Death|2|||
126473542|NCT03650556|455034545|FG000|Overall Study|Withdrawal by Subject|20|||
126473543|NCT03650556|455034545|FG000|Overall Study|Physician Decision|2|||
126473544|NCT03650556|455034545|FG000|Overall Study|Lost to Follow-up|8|||
126473545|NCT03650556|455034545|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
126473546|NCT03650556|455034545|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
126473547|NCT00691301|455034546|FG000|Overall Study|Adverse Event|10|||
126473548|NCT00691301|455034546|FG000|Overall Study|Death|2|||
126473549|NCT00691301|455034546|FG000|Overall Study|Lack of Efficacy|32|||
126473550|NCT00691301|455034546|FG000|Overall Study|Withdrawal by Subject|4|||
126473551|NCT00691301|455034546|FG000|Overall Study|Concurrent illness|2|||
126473552|NCT00691301|455034546|FG000|Overall Study|other reason|3|||
126473553|NCT00691301|455034546|FG000|Overall Study|Did not initiate study treatment|1|||
126473554|NCT01823146|455034547|FG000|Overall Study|Withdrawal by Subject|0|||
126473555|NCT01823146|455034548|FG001|Overall Study|Withdrawal by Subject|1|||
126473556|NCT01823146|455034547|FG000|Overall Study|Lost to Follow-up|2|||
126473557|NCT01823146|455034548|FG001|Overall Study|Lost to Follow-up|1|||
126473558|NCT00463580|455034549|FG000|Overall Study|Lost to Follow-up|1|||
126473559|NCT00463580|455034550|FG001|Overall Study|Lost to Follow-up|0|||
126473560|NCT00463580|455034549|FG000|Overall Study|Schedule conflict|2|||
126473561|NCT00463580|455034550|FG001|Overall Study|Schedule conflict|0|||
126473562|NCT00463580|455034549|FG000|Overall Study|Medical/psychiatric complications|0|||
126473563|NCT00463580|455034550|FG001|Overall Study|Medical/psychiatric complications|2|||
126473564|NCT03917459|455034551|FG000|Overall Study|Adverse Event|1|||
126473565|NCT03917459|455034552|FG001|Overall Study|Adverse Event|0|||
126473566|NCT03917459|455034551|FG000|Overall Study|Withdrawal by Subject|0|||
126473567|NCT03917459|455034552|FG001|Overall Study|Withdrawal by Subject|1|||
126473568|NCT00491764|455034553|FG000|Overall Study|Adverse Event|1|||
126473569|NCT00491764|455034554|FG001|Overall Study|Adverse Event|2|||
126473570|NCT00491764|455034555|FG002|Overall Study|Adverse Event|4|||
126473571|NCT00491764|455034556|FG003|Overall Study|Adverse Event|4|||
126473572|NCT00491764|455034557|FG004|Overall Study|Adverse Event|0|||
126407356|NCT02455076|454785798|FG002|Inpatient|Discharged <24 h after admission|0|||
126407357|NCT02455076|454785799|FG003|Inpatient|Discharged <24 h after admission|0|||
126473573|NCT00491764|455034558|FG005|Overall Study|Adverse Event|1|||
126407358|NCT02455076|454785800|FG004|Inpatient|Discharged <24 h after admission|0|||
126407359|NCT02455076|454785796|FG000|Inpatient|Adverse Event|3|||
126407360|NCT02455076|454785797|FG001|Inpatient|Adverse Event|0|||
126407361|NCT02455076|454785798|FG002|Inpatient|Adverse Event|0|||
126407362|NCT02455076|454785799|FG003|Inpatient|Adverse Event|0|||
126407363|NCT02455076|454785800|FG004|Inpatient|Adverse Event|0|||
126407364|NCT02455076|454785796|FG000|Outpatient|Adverse Event|0|||
126407365|NCT02455076|454785797|FG001|Outpatient|Adverse Event|0|||
126407366|NCT02455076|454785798|FG002|Outpatient|Adverse Event|0|||
126407367|NCT02455076|454785799|FG003|Outpatient|Adverse Event|5|||
126407368|NCT02455076|454785800|FG004|Outpatient|Adverse Event|0|||
126407369|NCT02455076|454785796|FG000|Outpatient|Lost to Follow-up|0|||
126407370|NCT02455076|454785797|FG001|Outpatient|Lost to Follow-up|0|||
126407371|NCT02455076|454785798|FG002|Outpatient|Lost to Follow-up|0|||
126407372|NCT02455076|454785799|FG003|Outpatient|Lost to Follow-up|1|||
126407373|NCT02455076|454785800|FG004|Outpatient|Lost to Follow-up|12|||
126407374|NCT03743064|454785805|FG000|Overall Study|Adverse Event|7|||
126407375|NCT03743064|454785806|FG001|Overall Study|Adverse Event|9|||
126407376|NCT03743064|454785805|FG000|Overall Study|Death|25|||
126407377|NCT03743064|454785806|FG001|Overall Study|Death|28|||
126407378|NCT03743064|454785805|FG000|Overall Study|Lost to Follow-up|3|||
126407379|NCT03743064|454785806|FG001|Overall Study|Lost to Follow-up|6|||
126407380|NCT03743064|454785805|FG000|Overall Study|Withdrawal by Subject|28|||
126407381|NCT03743064|454785806|FG001|Overall Study|Withdrawal by Subject|25|||
126407382|NCT03743064|454785805|FG000|Overall Study|Physician Decision|2|||
126407383|NCT03743064|454785806|FG001|Overall Study|Physician Decision|4|||
126407384|NCT03743064|454785805|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
126407385|NCT03743064|454785806|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
126407386|NCT02771626|454785809|FG000|Overall Study|Adverse Event|1|||
126407387|NCT02771626|454785810|FG001|Overall Study|Adverse Event|5|||
126407388|NCT02771626|454785811|FG002|Overall Study|Adverse Event|3|||
126558453|NCT00965484|455338744|FG000|Overall Study|Protocol Violation|1|||
126558454|NCT00965484|455338744|FG000|Overall Study|Withdrawal by Subject|1|||
126558455|NCT00848211|455338745|FG000|Overall Study|Protocol Violation|0|||
126558456|NCT00848211|455338746|FG001|Overall Study|Protocol Violation|1|||
126558457|NCT00848211|455338747|FG002|Overall Study|Protocol Violation|1|||
126558458|NCT00848211|455338748|FG003|Overall Study|Protocol Violation|0|||
126558459|NCT00848211|455338745|FG000|Overall Study|Adverse Event|0|||
126558460|NCT00848211|455338746|FG001|Overall Study|Adverse Event|0|||
126558461|NCT00848211|455338747|FG002|Overall Study|Adverse Event|0|||
126558462|NCT00848211|455338748|FG003|Overall Study|Adverse Event|0|||
126558463|NCT01124617|455338749|FG000|Overall Study|Adverse Event|5|||
126558464|NCT01124617|455338750|FG001|Overall Study|Adverse Event|2|||
126558465|NCT01124617|455338749|FG000|Overall Study|Lack of Efficacy|2|||
126558466|NCT01124617|455338750|FG001|Overall Study|Lack of Efficacy|1|||
126558467|NCT01124617|455338749|FG000|Overall Study|Protocol Violation|1|||
126558468|NCT01124617|455338750|FG001|Overall Study|Protocol Violation|1|||
126558469|NCT01124617|455338749|FG000|Overall Study|Withdrawal by Subject|9|||
126558470|NCT01124617|455338750|FG001|Overall Study|Withdrawal by Subject|1|||
126558471|NCT01124617|455338749|FG000|Overall Study|Other|2|||
126558472|NCT01124617|455338750|FG001|Overall Study|Other|1|||
126558473|NCT00945477|455338751|FG000|Overall Study|Adverse Event|3|||
126558474|NCT00945477|455338751|FG000|Overall Study|Lack of Efficacy|2|||
126558475|NCT00945477|455338751|FG000|Overall Study|Withdrawal by Subject|1|||
126558476|NCT00619151|455338752|FG000|Overall Study|Study terminated prior to followup|1|||
126558477|NCT00619151|455338753|FG001|Overall Study|Study terminated prior to followup|0|||
126558478|NCT03582137|455338756|FG000|Overall Study|Adverse Event|1|||
126558479|NCT03582137|455338757|FG001|Overall Study|Adverse Event|0|||
126558480|NCT01982760|455338759|FG000|Overall Study|Physician Decision|1|||
126558481|NCT01982760|455338760|FG001|Overall Study|Physician Decision|0|||
126558482|NCT02303574|455338761|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126558483|NCT02303574|455338762|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126558484|NCT02303574|455338763|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
126407389|NCT02771626|454785812|FG003|Overall Study|Adverse Event|0|||
126407390|NCT02771626|454785813|FG004|Overall Study|Adverse Event|1|||
126407391|NCT02771626|454785814|FG005|Overall Study|Adverse Event|1|||
126407392|NCT02771626|454785809|FG000|Overall Study|Radiologic Disease Progression|6|||
126558485|NCT02303574|455338764|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126558486|NCT02303574|455338765|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126558487|NCT02303574|455338766|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126721313|NCT02614287|455929908|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
126721314|NCT02614287|455929907|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
126407393|NCT02771626|454785810|FG001|Overall Study|Radiologic Disease Progression|13|||
126407394|NCT02771626|454785811|FG002|Overall Study|Radiologic Disease Progression|10|||
126407395|NCT02771626|454785812|FG003|Overall Study|Radiologic Disease Progression|7|||
126407396|NCT02771626|454785813|FG004|Overall Study|Radiologic Disease Progression|28|||
126407397|NCT02771626|454785814|FG005|Overall Study|Radiologic Disease Progression|15|||
126407398|NCT02771626|454785809|FG000|Overall Study|Symptomatic Deterioration|0|||
126407399|NCT02771626|454785810|FG001|Overall Study|Symptomatic Deterioration|4|||
126558488|NCT02303574|455338767|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126407400|NCT02771626|454785811|FG002|Overall Study|Symptomatic Deterioration|2|||
126558489|NCT02303574|455338768|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126407401|NCT02771626|454785812|FG003|Overall Study|Symptomatic Deterioration|0|||
126407402|NCT02771626|454785813|FG004|Overall Study|Symptomatic Deterioration|5|||
126407403|NCT02771626|454785814|FG005|Overall Study|Symptomatic Deterioration|2|||
126407404|NCT02771626|454785809|FG000|Overall Study|Participant Request|0|||
126407405|NCT02771626|454785810|FG001|Overall Study|Participant Request|1|||
126407406|NCT02771626|454785811|FG002|Overall Study|Participant Request|0|||
126407407|NCT02771626|454785812|FG003|Overall Study|Participant Request|2|||
126407408|NCT02771626|454785813|FG004|Overall Study|Participant Request|0|||
126407409|NCT02771626|454785814|FG005|Overall Study|Participant Request|1|||
126407410|NCT02771626|454785809|FG000|Overall Study|Investigator Decision|0|||
126407411|NCT02771626|454785810|FG001|Overall Study|Investigator Decision|1|||
126407412|NCT02771626|454785811|FG002|Overall Study|Investigator Decision|0|||
126407413|NCT02771626|454785812|FG003|Overall Study|Investigator Decision|0|||
126407414|NCT02771626|454785813|FG004|Overall Study|Investigator Decision|1|||
126407415|NCT02771626|454785814|FG005|Overall Study|Investigator Decision|0|||
126407416|NCT02771626|454785809|FG000|Overall Study|Study Termination by Sponsor|0|||
126407417|NCT02771626|454785810|FG001|Overall Study|Study Termination by Sponsor|2|||
126407418|NCT02771626|454785811|FG002|Overall Study|Study Termination by Sponsor|1|||
126407419|NCT02771626|454785812|FG003|Overall Study|Study Termination by Sponsor|0|||
126407420|NCT02771626|454785813|FG004|Overall Study|Study Termination by Sponsor|1|||
126407421|NCT02771626|454785814|FG005|Overall Study|Study Termination by Sponsor|0|||
126407422|NCT02771626|454785809|FG000|Overall Study|Informed Consent Withdrawn|0|||
126407423|NCT02771626|454785810|FG001|Overall Study|Informed Consent Withdrawn|0|||
126407424|NCT02771626|454785811|FG002|Overall Study|Informed Consent Withdrawn|1|||
126407425|NCT02771626|454785812|FG003|Overall Study|Informed Consent Withdrawn|0|||
126407426|NCT02771626|454785813|FG004|Overall Study|Informed Consent Withdrawn|1|||
126407427|NCT02771626|454785814|FG005|Overall Study|Informed Consent Withdrawn|1|||
126407428|NCT02771626|454785809|FG000|Overall Study|Other, Not Specified|1|||
126407429|NCT02771626|454785810|FG001|Overall Study|Other, Not Specified|0|||
126407430|NCT02771626|454785811|FG002|Overall Study|Other, Not Specified|0|||
126407431|NCT02771626|454785812|FG003|Overall Study|Other, Not Specified|0|||
126407432|NCT02771626|454785813|FG004|Overall Study|Other, Not Specified|0|||
126407433|NCT02771626|454785814|FG005|Overall Study|Other, Not Specified|1|||
126407434|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
126407435|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
126407436|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
126407437|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
126407438|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
126407439|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
126407440|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
126407441|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
126407442|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
126407443|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
126407444|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
126407445|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
126407446|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
126407447|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
126407448|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
126407449|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
126407450|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
126407451|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
126407452|NCT01302054|454785815|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
126407453|NCT01302054|454785816|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
126407454|NCT01302054|454785817|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
126407455|NCT01302054|454785815|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
126407456|NCT01302054|454785816|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
126407457|NCT01302054|454785817|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
126407458|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126407459|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
126407460|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
126407461|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126407462|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
126407463|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
126407464|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126407465|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
126407466|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
126407467|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
126407468|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
126407469|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
126407470|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
126407471|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
126407472|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
126407473|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
126407474|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
126407475|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
126407476|NCT01302054|454785815|FG000|Double-Blind Treatment Phase|Other|0|||
126407477|NCT01302054|454785816|FG001|Double-Blind Treatment Phase|Other|4|||
126407478|NCT01302054|454785817|FG002|Double-Blind Treatment Phase|Other|9|||
126407479|NCT02809053|454785818|FG000|Overall Study|Death|0|||
126407480|NCT02809053|454785819|FG001|Overall Study|Death|1|||
126407481|NCT02809053|454785818|FG000|Overall Study|Lost to Follow-up|3|||
126407482|NCT02809053|454785819|FG001|Overall Study|Lost to Follow-up|1|||
126407483|NCT02809053|454785818|FG000|Overall Study|Withdrawal by Subject|2|||
126407484|NCT02809053|454785819|FG001|Overall Study|Withdrawal by Subject|3|||
126407485|NCT02809053|454785818|FG000|Overall Study|Disease Progression|2|||
126407486|NCT02809053|454785819|FG001|Overall Study|Disease Progression|1|||
126407487|NCT02565810|454785823|FG000|Overall Study|Withdrawal by Subject|1|||
126407488|NCT00635089|454785824|FG000|Overall Study|Adverse Event|7|||
126407489|NCT00635089|454785824|FG000|Overall Study|Lack of Efficacy|28|||
126407490|NCT00635089|454785824|FG000|Overall Study|Protocol Deviation|4|||
126407491|NCT00635089|454785824|FG000|Overall Study|Lost to Follow-up|8|||
126407492|NCT00635089|454785824|FG000|Overall Study|Other|31|||
126407493|NCT00444067|454785829|FG000|Overall Study|Lost to Follow-up|0|||
126407494|NCT00444067|454785830|FG001|Overall Study|Lost to Follow-up|1|||
126407495|NCT01300455|454785831|FG000|Washout|Withdrawal by Subject|1|||
126407496|NCT01300455|454785832|FG001|Washout|Withdrawal by Subject|0|||
126407497|NCT00084487|454785833|FG000|Overall Study|Death|1|||
126407498|NCT02528357|454785834|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407499|NCT02528357|454785835|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
126407500|NCT02528357|454785836|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407501|NCT02528357|454785837|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407502|NCT02528357|454785838|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407503|NCT02528357|454785839|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407504|NCT02528357|454785840|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407505|NCT02528357|454785841|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407506|NCT02528357|454785842|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407507|NCT02528357|454785843|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407508|NCT02528357|454785844|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407509|NCT02528357|454785845|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407510|NCT02528357|454785846|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407511|NCT02528357|454785847|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407512|NCT02528357|454785848|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407513|NCT02528357|454785849|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407514|NCT02528357|454785850|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407515|NCT02528357|454785851|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407516|NCT02528357|454785852|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
126407517|NCT02528357|454785834|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407518|NCT02528357|454785835|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407519|NCT02528357|454785836|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407520|NCT02528357|454785837|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
126407521|NCT02528357|454785838|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407522|NCT02528357|454785839|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
126473574|NCT00491764|455034553|FG000|Overall Study|Lost to Follow-up|0|||
126473575|NCT00491764|455034554|FG001|Overall Study|Lost to Follow-up|1|||
126473576|NCT00491764|455034555|FG002|Overall Study|Lost to Follow-up|0|||
126473577|NCT00491764|455034556|FG003|Overall Study|Lost to Follow-up|1|||
126473578|NCT00491764|455034557|FG004|Overall Study|Lost to Follow-up|0|||
126473579|NCT00491764|455034558|FG005|Overall Study|Lost to Follow-up|3|||
126473580|NCT00491764|455034553|FG000|Overall Study|Withdrawal by Subject|2|||
126473581|NCT00491764|455034554|FG001|Overall Study|Withdrawal by Subject|3|||
126473582|NCT00491764|455034555|FG002|Overall Study|Withdrawal by Subject|1|||
126473583|NCT00491764|455034556|FG003|Overall Study|Withdrawal by Subject|2|||
126473584|NCT00491764|455034557|FG004|Overall Study|Withdrawal by Subject|2|||
126473585|NCT00491764|455034558|FG005|Overall Study|Withdrawal by Subject|4|||
126407523|NCT02528357|454785840|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407524|NCT02528357|454785841|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
126407525|NCT02528357|454785842|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407526|NCT02528357|454785843|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126473586|NCT00491764|455034553|FG000|Overall Study|Non Compliance with the Protocol|1|||
126558490|NCT02303574|455338769|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126407527|NCT02528357|454785844|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407528|NCT02528357|454785845|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407529|NCT02528357|454785846|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407530|NCT02528357|454785847|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407531|NCT02528357|454785848|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407532|NCT02528357|454785849|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407533|NCT02528357|454785850|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407534|NCT02528357|454785851|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407535|NCT02528357|454785852|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
126407536|NCT02528357|454785834|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407537|NCT02528357|454785835|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407538|NCT02528357|454785836|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
126407539|NCT02528357|454785837|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407540|NCT02528357|454785838|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
126407541|NCT02528357|454785839|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407542|NCT02528357|454785840|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
126407543|NCT02528357|454785841|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
126407544|NCT02528357|454785842|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407545|NCT02528357|454785843|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407546|NCT02528357|454785844|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407547|NCT02528357|454785845|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407548|NCT02528357|454785846|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407549|NCT02528357|454785847|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407550|NCT02528357|454785848|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407551|NCT02528357|454785849|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407552|NCT02528357|454785850|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407553|NCT02528357|454785851|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407554|NCT02528357|454785852|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
126407555|NCT02528357|454785834|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407556|NCT02528357|454785835|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407557|NCT02528357|454785836|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407558|NCT02528357|454785837|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407559|NCT02528357|454785838|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
126407560|NCT02528357|454785839|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407561|NCT02528357|454785840|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407562|NCT02528357|454785841|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407563|NCT02528357|454785842|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407564|NCT02528357|454785843|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407565|NCT02528357|454785844|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407566|NCT02528357|454785845|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407567|NCT02528357|454785846|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407568|NCT02528357|454785847|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407569|NCT02528357|454785848|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407570|NCT02528357|454785849|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407571|NCT02528357|454785850|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407572|NCT02528357|454785851|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407573|NCT02528357|454785852|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407574|NCT02528357|454785834|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407575|NCT02528357|454785835|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407576|NCT02528357|454785836|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407577|NCT02528357|454785837|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407578|NCT02528357|454785838|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407579|NCT02528357|454785839|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407580|NCT02528357|454785840|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126473587|NCT00491764|455034554|FG001|Overall Study|Non Compliance with the Protocol|0|||
126473588|NCT00491764|455034555|FG002|Overall Study|Non Compliance with the Protocol|0|||
126473589|NCT00491764|455034556|FG003|Overall Study|Non Compliance with the Protocol|0|||
126721315|NCT02614287|455929908|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
126407581|NCT02528357|454785841|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407582|NCT02528357|454785842|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407583|NCT02528357|454785843|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407584|NCT02528357|454785844|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407585|NCT02528357|454785845|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407586|NCT02528357|454785846|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407587|NCT02528357|454785847|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
126407588|NCT02528357|454785848|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
126407589|NCT02528357|454785849|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407590|NCT02528357|454785850|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407591|NCT02528357|454785851|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407592|NCT02528357|454785852|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
126407593|NCT02528357|454785834|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407594|NCT02528357|454785835|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407595|NCT02528357|454785836|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407596|NCT02528357|454785837|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407597|NCT02528357|454785838|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407598|NCT02528357|454785839|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407599|NCT02528357|454785840|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407600|NCT02528357|454785841|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407601|NCT02528357|454785842|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407602|NCT02528357|454785843|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407603|NCT02528357|454785844|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407604|NCT02528357|454785845|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407605|NCT02528357|454785846|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407606|NCT02528357|454785847|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
126407607|NCT02528357|454785848|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407608|NCT02528357|454785849|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407609|NCT02528357|454785850|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407610|NCT02528357|454785851|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407611|NCT02528357|454785852|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
126407612|NCT02528357|454785834|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407613|NCT02528357|454785835|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407614|NCT02528357|454785836|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407615|NCT02528357|454785837|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407616|NCT02528357|454785838|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407617|NCT02528357|454785839|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407618|NCT02528357|454785840|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407619|NCT02528357|454785841|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407620|NCT02528357|454785842|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407621|NCT02528357|454785843|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407622|NCT02528357|454785844|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
126407623|NCT02528357|454785845|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407624|NCT02528357|454785846|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
126407625|NCT02528357|454785847|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
126407626|NCT02528357|454785848|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
126407627|NCT02528357|454785849|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407628|NCT02528357|454785850|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407629|NCT02528357|454785851|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407630|NCT02528357|454785852|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
126407631|NCT02528357|454785834|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407632|NCT02528357|454785835|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407633|NCT02528357|454785836|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407634|NCT02528357|454785837|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407635|NCT02528357|454785838|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407636|NCT02528357|454785839|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407637|NCT02528357|454785840|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126721316|NCT02614287|455929907|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
126721317|NCT02614287|455929908|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
126407638|NCT02528357|454785841|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407639|NCT02528357|454785842|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
126407640|NCT02528357|454785843|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
126407641|NCT02528357|454785844|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407642|NCT02528357|454785845|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
126407643|NCT02528357|454785846|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
126407644|NCT02528357|454785847|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
126407645|NCT02528357|454785848|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
126407646|NCT02528357|454785849|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407647|NCT02528357|454785850|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407648|NCT02528357|454785851|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407649|NCT02528357|454785852|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407650|NCT02528357|454785834|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407651|NCT02528357|454785835|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407652|NCT02528357|454785836|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407653|NCT02528357|454785837|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407654|NCT02528357|454785838|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407655|NCT02528357|454785839|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407656|NCT02528357|454785840|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407657|NCT02528357|454785841|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407658|NCT02528357|454785842|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407659|NCT02528357|454785843|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407660|NCT02528357|454785844|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407661|NCT02528357|454785845|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407662|NCT02528357|454785846|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407663|NCT02528357|454785847|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407664|NCT02528357|454785848|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407665|NCT02528357|454785849|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407666|NCT02528357|454785850|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
126407667|NCT02528357|454785851|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407668|NCT02528357|454785852|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
126407669|NCT02528357|454785834|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407670|NCT02528357|454785835|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407671|NCT02528357|454785836|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407672|NCT02528357|454785837|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407673|NCT02528357|454785838|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407674|NCT02528357|454785839|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407675|NCT02528357|454785840|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407676|NCT02528357|454785841|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407677|NCT02528357|454785842|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407678|NCT02528357|454785843|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407679|NCT02528357|454785844|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407680|NCT02528357|454785845|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407681|NCT02528357|454785846|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126473590|NCT00491764|455034557|FG004|Overall Study|Non Compliance with the Protocol|0|||
126473591|NCT00491764|455034558|FG005|Overall Study|Non Compliance with the Protocol|0|||
126473592|NCT00491764|455034553|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
126473593|NCT00491764|455034554|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
126473594|NCT00491764|455034555|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
126721318|NCT02614287|455929907|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
126721319|NCT02614287|455929908|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
126721320|NCT02614287|455929907|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
126721321|NCT02614287|455929908|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
126721322|NCT02006667|455929914|FG000|Overall Study|Adverse Event|3|||
126721323|NCT02006667|455929914|FG000|Overall Study|Death|2|||
126721324|NCT02006667|455929914|FG000|Overall Study|Withdrawal by Subject|1|||
126721325|NCT03580382|455929915|FG000|Overall Study|Early Termination of Study|0|||
126407682|NCT02528357|454785847|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407683|NCT02528357|454785848|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407684|NCT02528357|454785849|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
126407685|NCT02528357|454785850|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
126407686|NCT02528357|454785851|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
126407687|NCT02528357|454785852|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
126407688|NCT02438813|454785858|FG000|Overall Study|Patient Decision|59|||
126407689|NCT02438813|454785858|FG000|Overall Study|Patient Lost to Follow-Up|137|||
126407690|NCT02438813|454785858|FG000|Overall Study|Study Ended by Sponsor|80|||
126407691|NCT02438813|454785858|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
126407692|NCT03040986|454785860|FG000|Overall Study|Hospice|1|||
126407693|NCT03040986|454785861|FG001|Overall Study|Hospice|0|||
126407694|NCT03040986|454785860|FG000|Overall Study|Adverse Event|2|||
126407695|NCT03040986|454785861|FG001|Overall Study|Adverse Event|1|||
126407696|NCT03040986|454785860|FG000|Overall Study|Disease progression on study|3|||
126407697|NCT03040986|454785861|FG001|Overall Study|Disease progression on study|1|||
126407698|NCT01183468|454785864|FG000|Overall Study|Lost to Follow-up|2|||
126407699|NCT01183468|454785865|FG001|Overall Study|Lost to Follow-up|1|||
126407700|NCT01183468|454785866|FG002|Overall Study|Lost to Follow-up|0|||
126407701|NCT01183468|454785867|FG003|Overall Study|Lost to Follow-up|0|||
126407702|NCT01183468|454785864|FG000|Overall Study|Physician Decision|1|||
126407703|NCT01183468|454785865|FG001|Overall Study|Physician Decision|0|||
126407704|NCT01183468|454785866|FG002|Overall Study|Physician Decision|0|||
126407705|NCT01183468|454785867|FG003|Overall Study|Physician Decision|0|||
126407706|NCT01183468|454785864|FG000|Overall Study|Withdrawal by Subject|0|||
126407707|NCT01183468|454785865|FG001|Overall Study|Withdrawal by Subject|1|||
126407708|NCT01183468|454785866|FG002|Overall Study|Withdrawal by Subject|0|||
126407709|NCT01183468|454785867|FG003|Overall Study|Withdrawal by Subject|0|||
126407710|NCT02228096|454785876|FG000|Overall Study|Study terminated by Sponsor|24|||
126407711|NCT02228096|454785876|FG000|Overall Study|Lack of Efficacy|18|||
126407712|NCT02228096|454785876|FG000|Overall Study|Death|12|||
126407713|NCT02228096|454785876|FG000|Overall Study|Physician Decision|3|||
126407714|NCT02228096|454785876|FG000|Overall Study|Subject/guardian decision|2|||
126407715|NCT02228096|454785876|FG000|Overall Study|New therapy for study indication|1|||
126407716|NCT02228096|454785876|FG000|Overall Study|Enrolled, not infused|11|||
126407717|NCT02273960|454785877|FG000|Short Term Period|Lost to Follow-up|1|||
126407718|NCT02273960|454785878|FG001|Short Term Period|Lost to Follow-up|0|||
126407719|NCT02273960|454785879|FG002|Short Term Period|Lost to Follow-up|0|||
126407720|NCT02273960|454785880|FG003|Short Term Period|Lost to Follow-up|0|||
126407721|NCT02273960|454785877|FG000|Short Term Period|Lack of Efficacy|0|||
126407722|NCT02273960|454785878|FG001|Short Term Period|Lack of Efficacy|0|||
126407723|NCT02273960|454785879|FG002|Short Term Period|Lack of Efficacy|0|||
126407724|NCT02273960|454785880|FG003|Short Term Period|Lack of Efficacy|1|||
126407725|NCT02273960|454785877|FG000|Short Term Period|ST complete, not entering LTE|4|||
126407726|NCT02273960|454785878|FG001|Short Term Period|ST complete, not entering LTE|6|||
126407727|NCT02273960|454785879|FG002|Short Term Period|ST complete, not entering LTE|4|||
126407728|NCT02273960|454785880|FG003|Short Term Period|ST complete, not entering LTE|5|||
126407729|NCT02273960|454785877|FG000|Long Term Extension|Death|0|||
126407730|NCT02273960|454785878|FG001|Long Term Extension|Death|0|||
126407731|NCT02273960|454785879|FG002|Long Term Extension|Death|0|||
126407732|NCT02273960|454785880|FG003|Long Term Extension|Death|1|||
126407733|NCT00558272|454785881|FG000|Overall Study|Adverse Event|10|||
126407734|NCT00558272|454785882|FG001|Overall Study|Adverse Event|0|||
126407735|NCT00558272|454785881|FG000|Overall Study|Death|1|||
126407736|NCT00558272|454785882|FG001|Overall Study|Death|0|||
126407737|NCT00558272|454785881|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
126407738|NCT00558272|454785882|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
126407739|NCT00558272|454785881|FG000|Overall Study|AZ study team decision|0|||
126407740|NCT00558272|454785882|FG001|Overall Study|AZ study team decision|1|||
126407741|NCT00558272|454785881|FG000|Overall Study|Incorrectly enrolled|1|||
126721326|NCT03580382|455929916|FG001|Overall Study|Early Termination of Study|3|||
126721327|NCT05619172|455929920|FG000|Safety Cohort 1|Death|7|||
126558491|NCT02303574|455338770|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
126558492|NCT02303574|455338761|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126558493|NCT02303574|455338762|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126721328|NCT05619172|455929921|FG001|Safety Cohort 1|Death|0|||
126407742|NCT00558272|454785882|FG001|Overall Study|Incorrectly enrolled|0|||
126407743|NCT00558272|454785881|FG000|Overall Study|Withdrawal by Subject|0|||
126407744|NCT00558272|454785882|FG001|Overall Study|Withdrawal by Subject|1|||
126407745|NCT00454649|454785883|FG000|Overall Study|Lack of Efficacy|2|||
126407746|NCT00454649|454785884|FG001|Overall Study|Lack of Efficacy|2|||
126407747|NCT00454649|454785885|FG002|Overall Study|Lack of Efficacy|10|||
126407748|NCT00454649|454785886|FG003|Overall Study|Lack of Efficacy|3|||
126407749|NCT00454649|454785887|FG004|Overall Study|Lack of Efficacy|0|||
126407750|NCT00454649|454785888|FG005|Overall Study|Lack of Efficacy|4|||
126407751|NCT00454649|454785889|FG006|Overall Study|Lack of Efficacy|5|||
126407752|NCT00454649|454785890|FG007|Overall Study|Lack of Efficacy|13|||
126407753|NCT00454649|454785891|FG008|Overall Study|Lack of Efficacy|10|||
126407754|NCT00454649|454785892|FG009|Overall Study|Lack of Efficacy|2|||
126407755|NCT00454649|454785883|FG000|Overall Study|Adverse Event|0|||
126407756|NCT00454649|454785884|FG001|Overall Study|Adverse Event|1|||
126407757|NCT00454649|454785885|FG002|Overall Study|Adverse Event|3|||
126407758|NCT00454649|454785886|FG003|Overall Study|Adverse Event|0|||
126407759|NCT00454649|454785887|FG004|Overall Study|Adverse Event|1|||
126407760|NCT00454649|454785888|FG005|Overall Study|Adverse Event|2|||
126407761|NCT00454649|454785889|FG006|Overall Study|Adverse Event|3|||
126407762|NCT00454649|454785890|FG007|Overall Study|Adverse Event|4|||
126407763|NCT00454649|454785891|FG008|Overall Study|Adverse Event|6|||
126407764|NCT00454649|454785892|FG009|Overall Study|Adverse Event|2|||
126407765|NCT00454649|454785883|FG000|Overall Study|Lost to Follow-up|0|||
126407766|NCT00454649|454785884|FG001|Overall Study|Lost to Follow-up|0|||
126407767|NCT00454649|454785885|FG002|Overall Study|Lost to Follow-up|1|||
126407768|NCT00454649|454785886|FG003|Overall Study|Lost to Follow-up|0|||
126407769|NCT00454649|454785887|FG004|Overall Study|Lost to Follow-up|0|||
126407770|NCT00454649|454785888|FG005|Overall Study|Lost to Follow-up|0|||
126407771|NCT00454649|454785889|FG006|Overall Study|Lost to Follow-up|1|||
126407772|NCT00454649|454785890|FG007|Overall Study|Lost to Follow-up|0|||
126407773|NCT00454649|454785891|FG008|Overall Study|Lost to Follow-up|0|||
126407774|NCT00454649|454785892|FG009|Overall Study|Lost to Follow-up|0|||
126407775|NCT00454649|454785883|FG000|Overall Study|Other|1|||
126407776|NCT00454649|454785884|FG001|Overall Study|Other|1|||
126407777|NCT00454649|454785885|FG002|Overall Study|Other|5|||
126407778|NCT00454649|454785886|FG003|Overall Study|Other|3|||
126407779|NCT00454649|454785887|FG004|Overall Study|Other|0|||
126407780|NCT00454649|454785888|FG005|Overall Study|Other|0|||
126407781|NCT00454649|454785889|FG006|Overall Study|Other|0|||
126407782|NCT00454649|454785890|FG007|Overall Study|Other|0|||
126407783|NCT00454649|454785891|FG008|Overall Study|Other|3|||
126407784|NCT00454649|454785892|FG009|Overall Study|Other|1|||
126407785|NCT00454649|454785883|FG000|Overall Study|Withdrawal by Subject|0|||
126407786|NCT00454649|454785884|FG001|Overall Study|Withdrawal by Subject|0|||
126407787|NCT00454649|454785885|FG002|Overall Study|Withdrawal by Subject|0|||
126407788|NCT00454649|454785886|FG003|Overall Study|Withdrawal by Subject|0|||
126407789|NCT00454649|454785887|FG004|Overall Study|Withdrawal by Subject|0|||
126407790|NCT00454649|454785888|FG005|Overall Study|Withdrawal by Subject|1|||
126407791|NCT00454649|454785889|FG006|Overall Study|Withdrawal by Subject|0|||
126407792|NCT00454649|454785890|FG007|Overall Study|Withdrawal by Subject|2|||
126407793|NCT00454649|454785891|FG008|Overall Study|Withdrawal by Subject|1|||
126407794|NCT00454649|454785892|FG009|Overall Study|Withdrawal by Subject|0|||
126407795|NCT01789606|454785893|FG000|Overall Study|Participant not Purchased the Product|0|||
126407796|NCT01789606|454785894|FG001|Overall Study|Participant not Purchased the Product|20|||
126407797|NCT01789606|454785893|FG000|Overall Study|Withdrawal by Subject|0|||
126407798|NCT01789606|454785894|FG001|Overall Study|Withdrawal by Subject|1|||
126407799|NCT01789606|454785893|FG000|Overall Study|Ineligible|6|||
126407800|NCT01789606|454785894|FG001|Overall Study|Ineligible|2|||
126407801|NCT01789606|454785893|FG000|Overall Study|Administrative Reasons|17|||
126407802|NCT01789606|454785894|FG001|Overall Study|Administrative Reasons|6|||
126407803|NCT01789606|454785893|FG000|Overall Study|No Study Medication Taken|0|||
126407804|NCT01789606|454785894|FG001|Overall Study|No Study Medication Taken|1|||
126407805|NCT01789606|454785893|FG000|Overall Study|Protocol Violation|0|||
126407806|NCT01789606|454785894|FG001|Overall Study|Protocol Violation|55|||
126407807|NCT01789606|454785893|FG000|Overall Study|Adverse Event|0|||
126407808|NCT01789606|454785894|FG001|Overall Study|Adverse Event|3|||
126473595|NCT00491764|455034556|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
126473596|NCT00491764|455034557|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
126473597|NCT00491764|455034558|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
126473598|NCT00491764|455034553|FG000|Overall Study|Administrative|1|||
126473599|NCT00491764|455034554|FG001|Overall Study|Administrative|0|||
126473600|NCT00491764|455034555|FG002|Overall Study|Administrative|2|||
126407809|NCT01789606|454785893|FG000|Overall Study|Lost to Follow-up|0|||
126473601|NCT00491764|455034556|FG003|Overall Study|Administrative|1|||
126407810|NCT01789606|454785894|FG001|Overall Study|Lost to Follow-up|14|||
126407811|NCT01789606|454785893|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
126407812|NCT01789606|454785894|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
126407813|NCT00279812|454785900|FG000|Overall Study|Protocol Violation|1|||
126407814|NCT00279812|454785901|FG001|Overall Study|Protocol Violation|1|||
126407815|NCT00279812|454785902|FG002|Overall Study|Protocol Violation|0|||
126407816|NCT00279812|454785903|FG003|Overall Study|Protocol Violation|0|||
126407817|NCT00279812|454785904|FG004|Overall Study|Protocol Violation|1|||
126407818|NCT00279812|454785905|FG005|Overall Study|Protocol Violation|0|||
126407819|NCT00279812|454785900|FG000|Overall Study|Withdrawal by Subject|0|||
126407820|NCT00279812|454785901|FG001|Overall Study|Withdrawal by Subject|4|||
126407821|NCT00279812|454785902|FG002|Overall Study|Withdrawal by Subject|2|||
126407822|NCT00279812|454785903|FG003|Overall Study|Withdrawal by Subject|0|||
126407823|NCT00279812|454785904|FG004|Overall Study|Withdrawal by Subject|0|||
126407824|NCT00279812|454785905|FG005|Overall Study|Withdrawal by Subject|0|||
126407825|NCT00279812|454785900|FG000|Overall Study|Adverse Event|0|||
126407826|NCT00279812|454785901|FG001|Overall Study|Adverse Event|1|||
126407827|NCT00279812|454785902|FG002|Overall Study|Adverse Event|1|||
126407828|NCT00279812|454785903|FG003|Overall Study|Adverse Event|0|||
126407829|NCT00279812|454785904|FG004|Overall Study|Adverse Event|2|||
126407830|NCT00279812|454785905|FG005|Overall Study|Adverse Event|1|||
126407831|NCT01274429|454785906|FG000|Overall Study|Study closed do to lack of funding|5|||
126407832|NCT01879072|454785914|FG000|Overall Study|Withdrawal by Subject|121|||
126407833|NCT01879072|454785914|FG000|Overall Study|Not Transplanted|30|||
126407834|NCT05327361|454785915|FG000|Overall Study|Lost to Follow-up|4|||
126407835|NCT01439373|454785925|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
126407836|NCT01439373|454785926|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
126407837|NCT01439373|454785925|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
126407838|NCT01439373|454785926|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
126407839|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
126407840|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
126407841|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
126407842|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
126407843|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
126407844|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
126407845|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
126407846|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
126407847|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Death|0|||
126407848|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Death|1|||
126407849|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
126407850|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
126407851|NCT03281304|454785927|FG000|Treatment Phase (up to 42 Months)|Other|0|||
126407852|NCT03281304|454785928|FG001|Treatment Phase (up to 42 Months)|Other|2|||
126407853|NCT03281304|454785927|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
126407854|NCT03281304|454785928|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
126407855|NCT00626405|454785929|FG000|Overall Study|Deemed Ineligible|1|||
126407856|NCT00626405|454785930|FG001|Overall Study|Deemed Ineligible|0|||
126407857|NCT00626405|454785929|FG000|Overall Study|Withdrawal by Subject|0|||
126407858|NCT00626405|454785930|FG001|Overall Study|Withdrawal by Subject|1|||
126407859|NCT03834220|454785931|FG000|Overall Study|Adverse Event|1|||
126407860|NCT03834220|454785932|FG001|Overall Study|Adverse Event|0|||
126407861|NCT03834220|454785933|FG002|Overall Study|Adverse Event|0|||
126407862|NCT03834220|454785931|FG000|Overall Study|Death|8|||
126407863|NCT03834220|454785932|FG001|Overall Study|Death|1|||
126407864|NCT03834220|454785933|FG002|Overall Study|Death|17|||
126407865|NCT03834220|454785931|FG000|Overall Study|Reason not Specified|9|||
126407866|NCT03834220|454785932|FG001|Overall Study|Reason not Specified|0|||
126407867|NCT03834220|454785933|FG002|Overall Study|Reason not Specified|6|||
126407868|NCT03834220|454785931|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
126407869|NCT03834220|454785932|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
126407870|NCT03834220|454785933|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
126407871|NCT03834220|454785931|FG000|Overall Study|Withdrawal of Consent|2|||
126407872|NCT03834220|454785932|FG001|Overall Study|Withdrawal of Consent|2|||
126407873|NCT03834220|454785933|FG002|Overall Study|Withdrawal of Consent|2|||
126407874|NCT02593318|454785934|FG000|Overall Study|Withdrawal by Subject|1|||
126407875|NCT02593318|454785935|FG001|Overall Study|Withdrawal by Subject|1|||
126407876|NCT02100969|454787248|FG000|Overall Study|Did not pass screening phase|1|||
126407877|NCT01629953|454787249|FG000|Overall Study|Death|3|||
126407878|NCT01629953|454787250|FG001|Overall Study|Death|1|||
126407879|NCT01629953|454787249|FG000|Overall Study|Lost to Follow-up|10|||
126407880|NCT01629953|454787250|FG001|Overall Study|Lost to Follow-up|14|||
126407881|NCT06359080|454787251|FG000|Overall Study|Withdrawal by Subject|3|||
126407882|NCT00306527|454787252|FG000|Overall Study|Lost to Follow-up|3|||
126473602|NCT00491764|455034557|FG004|Overall Study|Administrative|0|||
126473603|NCT00491764|455034558|FG005|Overall Study|Administrative|0|||
126473604|NCT00697788|455034561|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
126473605|NCT00697788|455034562|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
126473606|NCT00697788|455034563|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
126473607|NCT00697788|455034564|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
126473608|NCT00697788|455034565|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
126473609|NCT00697788|455034566|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
126407883|NCT00306527|454787253|FG001|Overall Study|Lost to Follow-up|4|||
126407884|NCT00306527|454787254|FG002|Overall Study|Lost to Follow-up|3|||
126407885|NCT00306527|454787255|FG003|Overall Study|Lost to Follow-up|0|||
126407886|NCT00306527|454787252|FG000|Overall Study|Withdrawal by Subject|2|||
126407887|NCT00306527|454787253|FG001|Overall Study|Withdrawal by Subject|3|||
126407888|NCT00306527|454787254|FG002|Overall Study|Withdrawal by Subject|0|||
126407889|NCT00306527|454787255|FG003|Overall Study|Withdrawal by Subject|3|||
126407890|NCT00306527|454787252|FG000|Overall Study|Adverse Event|0|||
126407891|NCT00306527|454787253|FG001|Overall Study|Adverse Event|0|||
126407892|NCT00306527|454787254|FG002|Overall Study|Adverse Event|1|||
126407893|NCT00306527|454787255|FG003|Overall Study|Adverse Event|1|||
126407894|NCT00306527|454787252|FG000|Overall Study|Death|1|||
126407895|NCT00306527|454787253|FG001|Overall Study|Death|0|||
126407896|NCT00306527|454787254|FG002|Overall Study|Death|1|||
126407897|NCT00306527|454787255|FG003|Overall Study|Death|2|||
126407898|NCT04037254|454787256|FG000|Overall Study|Protocol Violation|1|||
126407899|NCT04037254|454787257|FG001|Overall Study|Protocol Violation|0|||
126407900|NCT04037254|454787258|FG002|Overall Study|Protocol Violation|0|||
126407901|NCT04037254|454787259|FG003|Overall Study|Protocol Violation|0|||
126407902|NCT04037254|454787260|FG004|Overall Study|Protocol Violation|0|||
126407903|NCT04037254|454787256|FG000|Overall Study|Withdrawal by Subject|0|||
126407904|NCT04037254|454787257|FG001|Overall Study|Withdrawal by Subject|0|||
126407905|NCT04037254|454787258|FG002|Overall Study|Withdrawal by Subject|1|||
126407906|NCT04037254|454787259|FG003|Overall Study|Withdrawal by Subject|0|||
126407907|NCT04037254|454787260|FG004|Overall Study|Withdrawal by Subject|0|||
126407908|NCT04037254|454787256|FG000|Overall Study|Delayed or incomplete treatment|0|||
126407909|NCT04037254|454787257|FG001|Overall Study|Delayed or incomplete treatment|2|||
126407910|NCT04037254|454787258|FG002|Overall Study|Delayed or incomplete treatment|1|||
126407911|NCT04037254|454787259|FG003|Overall Study|Delayed or incomplete treatment|0|||
126407912|NCT04037254|454787260|FG004|Overall Study|Delayed or incomplete treatment|0|||
126407913|NCT00417963|454787264|FG000|Overall Study|Lost to Follow-up|3|||
126407914|NCT00417963|454787264|FG000|Overall Study|Withdrawal by Subject|18|||
126407915|NCT00417963|454787264|FG000|Overall Study|Death|17|||
126407916|NCT00417963|454787264|FG000|Overall Study|Study device could not be deployed|3|||
126407917|NCT00477152|454787278|FG000|Overall Study|Parent withdrew consent|2|||
126407918|NCT00477152|454787278|FG000|Overall Study|Adverse Event|1|||
126407919|NCT01023672|454787279|FG000|Overall Study|Worsening disease|2|||
126407920|NCT01023672|454787279|FG000|Overall Study|Death|1|||
126407921|NCT02504580|454787280|FG000|Overall Study|Other|1|||
126407922|NCT02504580|454787281|FG001|Overall Study|Other|0|||
126407923|NCT02504580|454787282|FG002|Overall Study|Other|0|||
126407924|NCT02504580|454787283|FG003|Overall Study|Other|2|||
126407925|NCT02504580|454787284|FG004|Overall Study|Other|1|||
126407926|NCT02504580|454787285|FG005|Overall Study|Other|1|||
126407927|NCT02504580|454787286|FG006|Overall Study|Other|1|||
126407928|NCT02504580|454787287|FG007|Overall Study|Other|2|||
126407929|NCT02504580|454787288|FG008|Overall Study|Other|0|||
126407930|NCT02504580|454787289|FG009|Overall Study|Other|0|||
126407931|NCT02504580|454787290|FG010|Overall Study|Other|0|||
126473610|NCT00697788|455034567|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
126473611|NCT00697788|455034568|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
126473612|NCT00697788|455034561|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
126473613|NCT00697788|455034562|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
126473614|NCT00697788|455034563|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
126473615|NCT00697788|455034564|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
126473616|NCT00697788|455034565|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
126473617|NCT00697788|455034566|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
126473618|NCT00697788|455034567|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
126473619|NCT00697788|455034568|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
126473620|NCT00075218|455034577|FG000|Double-Blind Treatment|Adverse Event|23|||
126473621|NCT00075218|455034578|FG001|Double-Blind Treatment|Adverse Event|4|||
126473622|NCT00075218|455034579|FG002|Double-Blind Treatment|Adverse Event|0|||
126473623|NCT00075218|455034577|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
126473624|NCT00075218|455034578|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
126473625|NCT00075218|455034579|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
126407932|NCT02504580|454787291|FG011|Overall Study|Other|2|||
126407933|NCT02504580|454787280|FG000|Overall Study|Subject refusal to continue|0|||
126407934|NCT02504580|454787281|FG001|Overall Study|Subject refusal to continue|1|||
126407935|NCT02504580|454787282|FG002|Overall Study|Subject refusal to continue|0|||
126473626|NCT00075218|455034577|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
126407936|NCT02504580|454787283|FG003|Overall Study|Subject refusal to continue|0|||
126407937|NCT02504580|454787284|FG004|Overall Study|Subject refusal to continue|0|||
126407938|NCT02504580|454787285|FG005|Overall Study|Subject refusal to continue|0|||
126407939|NCT02504580|454787286|FG006|Overall Study|Subject refusal to continue|0|||
126407940|NCT02504580|454787287|FG007|Overall Study|Subject refusal to continue|0|||
126407941|NCT02504580|454787288|FG008|Overall Study|Subject refusal to continue|0|||
126407942|NCT02504580|454787289|FG009|Overall Study|Subject refusal to continue|0|||
126407943|NCT02504580|454787290|FG010|Overall Study|Subject refusal to continue|0|||
126407944|NCT02504580|454787291|FG011|Overall Study|Subject refusal to continue|0|||
126407945|NCT00448747|454787293|FG000|Overall Study|collapsed veins|1|||
126407946|NCT00448747|454787294|FG001|Overall Study|collapsed veins|0|||
126407947|NCT02166463|454787297|FG000|Overall Study|Lost to Follow-up|0|||
126407948|NCT02166463|454787298|FG001|Overall Study|Lost to Follow-up|1|||
126407949|NCT02166463|454787297|FG000|Overall Study|Physician Decision|10|||
126407950|NCT02166463|454787298|FG001|Overall Study|Physician Decision|10|||
126407951|NCT02166463|454787297|FG000|Overall Study|Ineligible|11|||
126407952|NCT02166463|454787298|FG001|Overall Study|Ineligible|2|||
126407953|NCT02166463|454787297|FG000|Overall Study|Progressive Disease|9|||
126407954|NCT02166463|454787298|FG001|Overall Study|Progressive Disease|6|||
126407955|NCT02166463|454787297|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
126407956|NCT02166463|454787298|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
126407957|NCT02166463|454787297|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
126407958|NCT02166463|454787298|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
126407959|NCT02166463|454787297|FG000|Overall Study|Refusal of further protocol therapy|5|||
126407960|NCT02166463|454787298|FG001|Overall Study|Refusal of further protocol therapy|6|||
126407961|NCT02478164|454787299|FG000|Overall Study|Lack of Efficacy|13|||
126407962|NCT02478164|454787299|FG000|Overall Study|Adverse Event|1|||
126407963|NCT02478164|454787299|FG000|Overall Study|Withdrawal by Subject|1|||
126407964|NCT04588389|454787300|FG000|Overall Study|Issues with anesthesia during surgery|2|||
126407965|NCT04588389|454787301|FG001|Overall Study|Issues with anesthesia during surgery|0|||
126407966|NCT04588389|454787302|FG002|Overall Study|Issues with anesthesia during surgery|0|||
126407967|NCT05779007|454787303|FG000|Overall Study|not meeting eligibility criteria|3517|||
126407968|NCT05779007|454787304|FG001|Overall Study|not meeting eligibility criteria|2009|||
126407969|NCT01424566|454787305|FG000|Single-blind Treatment|Adverse Event|71|||
126407970|NCT01424566|454787306|FG001|Single-blind Treatment|Adverse Event|0|||
126407971|NCT01424566|454787307|FG002|Single-blind Treatment|Adverse Event|0|||
126407972|NCT01424566|454787305|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
126407973|NCT01424566|454787306|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
126407974|NCT01424566|454787307|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
126407975|NCT01424566|454787305|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
126407976|NCT01424566|454787306|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
126407977|NCT01424566|454787307|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
126407978|NCT01424566|454787305|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
126407979|NCT01424566|454787306|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
126407980|NCT01424566|454787307|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
126407981|NCT01424566|454787305|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
126407982|NCT01424566|454787306|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
126407983|NCT01424566|454787307|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
126407984|NCT01424566|454787305|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
126407985|NCT01424566|454787306|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
126407986|NCT01424566|454787307|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
126407987|NCT01424566|454787305|FG000|Double-blind Treatment|Adverse Event|0|||
126407988|NCT01424566|454787306|FG001|Double-blind Treatment|Adverse Event|21|||
126407989|NCT01424566|454787307|FG002|Double-blind Treatment|Adverse Event|13|||
126407990|NCT01424566|454787305|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
126407991|NCT01424566|454787306|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
126407992|NCT01424566|454787307|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
126407993|NCT01424566|454787305|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
126407994|NCT01424566|454787306|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
126407995|NCT01424566|454787307|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
126407996|NCT01424566|454787305|FG000|Double-blind Treatment|Lack of Efficacy|0|||
126407997|NCT01424566|454787306|FG001|Double-blind Treatment|Lack of Efficacy|1|||
126407998|NCT01424566|454787307|FG002|Double-blind Treatment|Lack of Efficacy|1|||
126407999|NCT05147662|454787320|FG000|Overall Study|Withdrawal by parent/guardian|3|||
126408000|NCT05147662|454787320|FG000|Overall Study|Assigned to treatment but never treated|1|||
126408001|NCT04676867|454787321|FG000|Overall Study|Screen failure|0|||
126408002|NCT04676867|454787322|FG001|Overall Study|Screen failure|0|||
126408003|NCT04676867|454787323|FG002|Overall Study|Screen failure|6|||
126408004|NCT04676867|454787324|FG003|Overall Study|Screen failure|2|||
126408005|NCT04676867|454787321|FG000|Overall Study|Death|0|||
126408006|NCT04676867|454787322|FG001|Overall Study|Death|0|||
126408007|NCT04676867|454787323|FG002|Overall Study|Death|1|||
126473627|NCT00075218|455034578|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
126408008|NCT04676867|454787324|FG003|Overall Study|Death|0|||
126408009|NCT04676867|454787321|FG000|Overall Study|Withdrawal by Subject|2|||
126408010|NCT04676867|454787322|FG001|Overall Study|Withdrawal by Subject|2|||
126408011|NCT04676867|454787323|FG002|Overall Study|Withdrawal by Subject|4|||
126408012|NCT04676867|454787324|FG003|Overall Study|Withdrawal by Subject|4|||
126408013|NCT04676867|454787321|FG000|Overall Study|Lost to Follow-up|1|||
126408014|NCT04676867|454787322|FG001|Overall Study|Lost to Follow-up|0|||
126408015|NCT04676867|454787323|FG002|Overall Study|Lost to Follow-up|0|||
126408016|NCT04676867|454787324|FG003|Overall Study|Lost to Follow-up|0|||
126408017|NCT00549770|454787325|FG000|Overall Study|Protocol deviation|1|||
126558494|NCT02303574|455338763|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126558495|NCT02303574|455338764|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126558496|NCT02303574|455338765|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126721329|NCT05619172|455929920|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
126721330|NCT05619172|455929921|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
126721331|NCT05619172|455929920|FG000|Safety Cohort 2|Death|0|||
126721332|NCT05619172|455929921|FG001|Safety Cohort 2|Death|1|||
126721333|NCT05619172|455929920|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
126721334|NCT05619172|455929921|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
126721335|NCT00450372|455929924|FG000|Overall Study|Physician Decision|1|||
126721336|NCT00520676|455929926|FG000|Overall Study|Death|84|||
126721337|NCT00520676|455929927|FG001|Overall Study|Death|81|||
126721338|NCT00520676|455929926|FG000|Overall Study|Lost to Follow-up|6|||
126721339|NCT00520676|455929927|FG001|Overall Study|Lost to Follow-up|10|||
126721340|NCT00520676|455929926|FG000|Overall Study|Physician Decision|4|||
126721341|NCT00520676|455929927|FG001|Overall Study|Physician Decision|1|||
126721342|NCT00520676|455929926|FG000|Overall Study|Withdrawal by Subject|7|||
126721343|NCT00520676|455929927|FG001|Overall Study|Withdrawal by Subject|11|||
126721344|NCT02179515|455929928|FG000|Overall Study|switched to alternative treatment|0|||
126721345|NCT02179515|455929929|FG001|Overall Study|switched to alternative treatment|1|||
126721346|NCT02179515|455929930|FG002|Overall Study|switched to alternative treatment|1|||
126721347|NCT02179515|455929928|FG000|Overall Study|Death|0|||
126721348|NCT02179515|455929929|FG001|Overall Study|Death|1|||
126721349|NCT02179515|455929930|FG002|Overall Study|Death|1|||
126721350|NCT02179515|455929928|FG000|Overall Study|refused further treatment|0|||
126721351|NCT02179515|455929929|FG001|Overall Study|refused further treatment|3|||
126408018|NCT00549770|454787326|FG001|Overall Study|Protocol deviation|1|||
126408019|NCT00549770|454787327|FG002|Overall Study|Protocol deviation|1|||
126408020|NCT00549770|454787328|FG003|Overall Study|Protocol deviation|2|||
126408021|NCT00549770|454787329|FG004|Overall Study|Protocol deviation|2|||
126408022|NCT00549770|454787330|FG005|Overall Study|Protocol deviation|2|||
126721352|NCT02179515|455929930|FG002|Overall Study|refused further treatment|4|||
126408023|NCT00549770|454787331|FG006|Overall Study|Protocol deviation|1|||
126408024|NCT00549770|454787332|FG007|Overall Study|Protocol deviation|2|||
126408025|NCT00549770|454787325|FG000|Overall Study|Administrative problems|0|||
126473628|NCT00075218|455034579|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
126473629|NCT00075218|455034577|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
126473630|NCT00075218|455034578|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
126473631|NCT00075218|455034579|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
126473632|NCT00075218|455034577|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
126473633|NCT00075218|455034578|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
126473634|NCT00075218|455034579|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
126473635|NCT00075218|455034577|FG000|Double-Blind Treatment|No study medication taken|2|||
126473636|NCT00075218|455034578|FG001|Double-Blind Treatment|No study medication taken|0|||
126473637|NCT00075218|455034579|FG002|Double-Blind Treatment|No study medication taken|0|||
126473638|NCT00075218|455034577|FG000|Open-Label Treatment|Lack of Efficacy|0|||
126473639|NCT00075218|455034578|FG001|Open-Label Treatment|Lack of Efficacy|0|||
126473640|NCT00075218|455034579|FG002|Open-Label Treatment|Lack of Efficacy|174|||
126473641|NCT00075218|455034577|FG000|Open-Label Treatment|Adverse Event|0|||
126473642|NCT00075218|455034578|FG001|Open-Label Treatment|Adverse Event|0|||
126473643|NCT00075218|455034579|FG002|Open-Label Treatment|Adverse Event|51|||
126473644|NCT00075218|455034577|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
126473645|NCT00075218|455034578|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
126473646|NCT00075218|455034579|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
126473647|NCT00075218|455034577|FG000|Open-Label Treatment|Decision of Sponsor|0|||
126473648|NCT00075218|455034578|FG001|Open-Label Treatment|Decision of Sponsor|0|||
126473649|NCT00075218|455034579|FG002|Open-Label Treatment|Decision of Sponsor|8|||
126473650|NCT00075218|455034577|FG000|Open-Label Treatment|Protocol Violation|0|||
126473651|NCT00075218|455034578|FG001|Open-Label Treatment|Protocol Violation|0|||
126473652|NCT00075218|455034579|FG002|Open-Label Treatment|Protocol Violation|1|||
126473653|NCT00075218|455034577|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
126473654|NCT00075218|455034578|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
126473655|NCT00075218|455034579|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
126473656|NCT00845858|455034582|FG000|Overall Study|Withdrawal by Subject|5|||
126721353|NCT02179515|455929928|FG000|Overall Study|Disease progression on study|2|||
126721354|NCT02179515|455929929|FG001|Overall Study|Disease progression on study|11|||
126473657|NCT00845858|455034583|FG001|Overall Study|Withdrawal by Subject|1|||
126473658|NCT00845858|455034584|FG002|Overall Study|Withdrawal by Subject|1|||
126721355|NCT02179515|455929930|FG002|Overall Study|Disease progression on study|8|||
126721356|NCT00115349|455929931|FG000|Overall Study|Study closed due to low enrollment.|11|||
126721357|NCT00115349|455929932|FG001|Overall Study|Study closed due to low enrollment.|9|||
126721358|NCT02116660|455929933|FG000|Overall Study|Deteriorating renal function|0|||
126408026|NCT00549770|454787326|FG001|Overall Study|Administrative problems|1|||
126408027|NCT00549770|454787327|FG002|Overall Study|Administrative problems|0|||
126408028|NCT00549770|454787328|FG003|Overall Study|Administrative problems|0|||
126408029|NCT00549770|454787329|FG004|Overall Study|Administrative problems|0|||
126408030|NCT00549770|454787330|FG005|Overall Study|Administrative problems|0|||
126408031|NCT00549770|454787331|FG006|Overall Study|Administrative problems|0|||
126408032|NCT00549770|454787332|FG007|Overall Study|Administrative problems|1|||
126408033|NCT00549770|454787325|FG000|Overall Study|Lost to Follow-up|0|||
126408034|NCT00549770|454787326|FG001|Overall Study|Lost to Follow-up|0|||
126408035|NCT00549770|454787327|FG002|Overall Study|Lost to Follow-up|2|||
126408036|NCT00549770|454787328|FG003|Overall Study|Lost to Follow-up|2|||
126408037|NCT00549770|454787329|FG004|Overall Study|Lost to Follow-up|3|||
126408038|NCT00549770|454787330|FG005|Overall Study|Lost to Follow-up|2|||
126408039|NCT00549770|454787331|FG006|Overall Study|Lost to Follow-up|0|||
126408040|NCT00549770|454787332|FG007|Overall Study|Lost to Follow-up|0|||
126408041|NCT00549770|454787325|FG000|Overall Study|Withdrawal by Subject|4|||
126408042|NCT00549770|454787326|FG001|Overall Study|Withdrawal by Subject|6|||
126408043|NCT00549770|454787327|FG002|Overall Study|Withdrawal by Subject|4|||
126408044|NCT00549770|454787328|FG003|Overall Study|Withdrawal by Subject|5|||
126408045|NCT00549770|454787329|FG004|Overall Study|Withdrawal by Subject|6|||
126408046|NCT00549770|454787330|FG005|Overall Study|Withdrawal by Subject|6|||
126408047|NCT00549770|454787331|FG006|Overall Study|Withdrawal by Subject|4|||
126408048|NCT00549770|454787332|FG007|Overall Study|Withdrawal by Subject|9|||
126408049|NCT00549770|454787325|FG000|Overall Study|Lack of Efficacy|1|||
126408050|NCT00549770|454787326|FG001|Overall Study|Lack of Efficacy|0|||
126408051|NCT00549770|454787327|FG002|Overall Study|Lack of Efficacy|2|||
126408052|NCT00549770|454787328|FG003|Overall Study|Lack of Efficacy|3|||
126408053|NCT00549770|454787329|FG004|Overall Study|Lack of Efficacy|5|||
126408054|NCT00549770|454787330|FG005|Overall Study|Lack of Efficacy|1|||
126408055|NCT00549770|454787331|FG006|Overall Study|Lack of Efficacy|3|||
126408056|NCT00549770|454787332|FG007|Overall Study|Lack of Efficacy|8|||
126408057|NCT00549770|454787325|FG000|Overall Study|Abnormal test procedure results|0|||
126408058|NCT00549770|454787326|FG001|Overall Study|Abnormal test procedure results|0|||
126408059|NCT00549770|454787327|FG002|Overall Study|Abnormal test procedure results|0|||
126408060|NCT00549770|454787328|FG003|Overall Study|Abnormal test procedure results|2|||
126408061|NCT00549770|454787329|FG004|Overall Study|Abnormal test procedure results|0|||
126408062|NCT00549770|454787330|FG005|Overall Study|Abnormal test procedure results|1|||
126473659|NCT00845858|455034582|FG000|Overall Study|Adverse Event|3|||
126473660|NCT00845858|455034583|FG001|Overall Study|Adverse Event|8|||
126473661|NCT00845858|455034584|FG002|Overall Study|Adverse Event|4|||
126473662|NCT00845858|455034582|FG000|Overall Study|Protocol Violation|0|||
126473663|NCT00845858|455034583|FG001|Overall Study|Protocol Violation|0|||
126473664|NCT00845858|455034584|FG002|Overall Study|Protocol Violation|1|||
126473665|NCT00845858|455034582|FG000|Overall Study|not eligible|0|||
126473666|NCT00845858|455034583|FG001|Overall Study|not eligible|3|||
126473667|NCT00845858|455034584|FG002|Overall Study|not eligible|2|||
126473668|NCT02191137|455034585|FG000|Treatment|Death|4|||
126473669|NCT02191137|455034585|FG000|Treatment|Withdrawal by Subject|3|||
126473670|NCT02191137|455034585|FG000|Treatment|Adverse Event|2|||
126473671|NCT02191137|455034585|FG000|Treatment|Other|1|||
126473672|NCT02191137|455034585|FG000|Follow-up|Lost to Follow-up|2|||
126473673|NCT02191137|455034585|FG000|Follow-up|Ongoing/unknown|2|||
126473674|NCT02191137|455034585|FG000|Follow-up|Adverse Event|1|||
126473675|NCT00071396|455034588|FG000|Overall Study|Withdrawal by Subject|1|||
126473676|NCT00071396|455034588|FG000|Overall Study|Physician Decision|2|||
126473677|NCT01811225|455034589|FG000|Treatment Period 1|Adverse Event|2|||
126473678|NCT01811225|455034590|FG001|Treatment Period 1|Adverse Event|3|||
126473679|NCT01811225|455034589|FG000|Treatment Period 1|Lost to Follow-up|12|||
126473680|NCT01811225|455034590|FG001|Treatment Period 1|Lost to Follow-up|8|||
126473681|NCT01811225|455034589|FG000|Treatment Period 1|transporation|1|||
126408063|NCT00549770|454787331|FG006|Overall Study|Abnormal test procedure results|1|||
126408064|NCT00549770|454787332|FG007|Overall Study|Abnormal test procedure results|1|||
126408065|NCT00549770|454787325|FG000|Overall Study|Abnormal laboratory values|0|||
126408066|NCT00549770|454787326|FG001|Overall Study|Abnormal laboratory values|0|||
126408067|NCT00549770|454787327|FG002|Overall Study|Abnormal laboratory values|0|||
126408068|NCT00549770|454787328|FG003|Overall Study|Abnormal laboratory values|0|||
126408069|NCT00549770|454787329|FG004|Overall Study|Abnormal laboratory values|0|||
126408070|NCT00549770|454787330|FG005|Overall Study|Abnormal laboratory values|1|||
126408071|NCT00549770|454787331|FG006|Overall Study|Abnormal laboratory values|0|||
126408072|NCT00549770|454787332|FG007|Overall Study|Abnormal laboratory values|0|||
126408073|NCT00549770|454787325|FG000|Overall Study|Adverse Event|1|||
126408074|NCT00549770|454787326|FG001|Overall Study|Adverse Event|3|||
126408075|NCT00549770|454787327|FG002|Overall Study|Adverse Event|1|||
126408076|NCT00549770|454787328|FG003|Overall Study|Adverse Event|2|||
126473682|NCT01811225|455034590|FG001|Treatment Period 1|transporation|0|||
126473683|NCT01811225|455034589|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
126473684|NCT01811225|455034590|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
126473685|NCT01811225|455034589|FG000|Treatment Period 2|Lost to Follow-up|1|||
126473686|NCT01811225|455034590|FG001|Treatment Period 2|Lost to Follow-up|2|||
126473687|NCT01811225|455034589|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
126408077|NCT00549770|454787329|FG004|Overall Study|Adverse Event|1|||
126408078|NCT00549770|454787330|FG005|Overall Study|Adverse Event|0|||
126408079|NCT00549770|454787331|FG006|Overall Study|Adverse Event|5|||
126408080|NCT00549770|454787332|FG007|Overall Study|Adverse Event|4|||
126408081|NCT01079936|454787333|FG000|Phase I: MTD|First Remission Status|2|||
126408082|NCT01079936|454787334|FG001|Phase I: MTD|First Remission Status|0|||
126408083|NCT01079936|454787335|FG002|Phase I: MTD|First Remission Status|0|||
126408084|NCT01079936|454787336|FG003|Phase I: MTD|First Remission Status|0|||
126408085|NCT01079936|454787337|FG004|Phase I: MTD|First Remission Status|0|||
126408086|NCT01079936|454787333|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
126408087|NCT01079936|454787334|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
126408088|NCT01079936|454787335|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
126408089|NCT01079936|454787336|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
126408090|NCT01079936|454787337|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
126408091|NCT01079936|454787333|FG000|Phase II|Adverse Event|0|||
126408092|NCT01079936|454787334|FG001|Phase II|Adverse Event|0|||
126408093|NCT01079936|454787335|FG002|Phase II|Adverse Event|1|||
126408094|NCT01079936|454787336|FG003|Phase II|Adverse Event|0|||
126408095|NCT01079936|454787337|FG004|Phase II|Adverse Event|0|||
126408096|NCT01079936|454787333|FG000|Phase II|Insurance Issue|0|||
126408097|NCT01079936|454787334|FG001|Phase II|Insurance Issue|0|||
126408098|NCT01079936|454787335|FG002|Phase II|Insurance Issue|0|||
126408099|NCT01079936|454787336|FG003|Phase II|Insurance Issue|0|||
126408100|NCT01079936|454787337|FG004|Phase II|Insurance Issue|1|||
126408101|NCT02294734|454787338|FG000|Overall Study|Adverse Event|5|||
126408102|NCT02294734|454787339|FG001|Overall Study|Adverse Event|5|||
126408103|NCT02294734|454787338|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
126408104|NCT02294734|454787339|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
126473688|NCT01811225|455034590|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
126473689|NCT02840721|455034593|FG000|Treatment Period|Adverse Event|1|||
126473690|NCT02840721|455034593|FG000|Follow-Up|Lack of Efficacy|1|||
126473691|NCT02840721|455034593|FG000|Follow-Up|Withdrawal by Subject|4|||
126473692|NCT02840721|455034593|FG000|Follow-Up|Withdrawal of Consent|2|||
126473693|NCT01967173|455034594|FG000|Overall Study|Lost to Follow-up|5|||
126473694|NCT01967173|455034595|FG001|Overall Study|Lost to Follow-up|3|||
126473695|NCT01967173|455034596|FG002|Overall Study|Lost to Follow-up|2|||
126473696|NCT01967173|455034597|FG003|Overall Study|Lost to Follow-up|4|||
126473697|NCT01967173|455034598|FG004|Overall Study|Lost to Follow-up|8|||
126473698|NCT01967173|455034599|FG005|Overall Study|Lost to Follow-up|12|||
126473699|NCT01967173|455034600|FG006|Overall Study|Lost to Follow-up|6|||
126473700|NCT01967173|455034601|FG007|Overall Study|Lost to Follow-up|8|||
126473701|NCT01967173|455034594|FG000|Overall Study|Physician Decision|2|||
126558497|NCT02303574|455338766|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126408105|NCT02294734|454787338|FG000|Overall Study|Lost to Follow-up|2|||
126408106|NCT02294734|454787339|FG001|Overall Study|Lost to Follow-up|0|||
126408107|NCT02294734|454787338|FG000|Overall Study|Physician Decision|2|||
126408108|NCT02294734|454787339|FG001|Overall Study|Physician Decision|1|||
126408109|NCT02294734|454787338|FG000|Overall Study|Withdrawal by Subject|4|||
126408110|NCT02294734|454787339|FG001|Overall Study|Withdrawal by Subject|2|||
126408111|NCT00548717|454787340|FG000|Overall Study|Death|5|||
126408112|NCT00548717|454787341|FG001|Overall Study|Death|2|||
126408113|NCT00548717|454787340|FG000|Overall Study|Relapse|3|||
126408114|NCT00548717|454787341|FG001|Overall Study|Relapse|0|||
126408115|NCT00548717|454787340|FG000|Overall Study|Alternative treatment for GVHD|1|||
126408116|NCT00548717|454787341|FG001|Overall Study|Alternative treatment for GVHD|0|||
126408117|NCT03157583|454787342|FG000|Overall Study|Other (did not meet study criteria)|1|||
126408118|NCT00847015|454787346|FG000|Overall Study|Withdrawal by Subject|1|||
126408119|NCT00847015|454787346|FG000|Overall Study|declined any surgery|1|||
126408120|NCT00847015|454787346|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
126408121|NCT01141478|454787347|FG000|Overall Study|Withdrawal by Subject|1|||
126408122|NCT01141478|454787348|FG001|Overall Study|Withdrawal by Subject|1|||
126408123|NCT01732913|454787356|FG000|Overall Study|Study Terminated by Sponsor|105|||
126408124|NCT01732913|454787357|FG001|Overall Study|Study Terminated by Sponsor|55|||
126408125|NCT01732913|454787356|FG000|Overall Study|Withdrawal by Subject|27|||
126408126|NCT01732913|454787357|FG001|Overall Study|Withdrawal by Subject|4|||
126408127|NCT01732913|454787356|FG000|Overall Study|Physician Decision|14|||
126408128|NCT01732913|454787357|FG001|Overall Study|Physician Decision|7|||
126408129|NCT01732913|454787356|FG000|Overall Study|Other|7|||
126408130|NCT01732913|454787357|FG001|Overall Study|Other|1|||
126408131|NCT01732913|454787356|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
126408132|NCT01732913|454787357|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
126408133|NCT02925741|454787358|FG000|Overall Study|Withdrawal by Subject|11|||
126408134|NCT02925741|454787359|FG001|Overall Study|Withdrawal by Subject|0|||
126473702|NCT01967173|455034595|FG001|Overall Study|Physician Decision|0|||
126473703|NCT01967173|455034596|FG002|Overall Study|Physician Decision|2|||
126473704|NCT01967173|455034597|FG003|Overall Study|Physician Decision|1|||
126473705|NCT01967173|455034598|FG004|Overall Study|Physician Decision|1|||
126473706|NCT01967173|455034599|FG005|Overall Study|Physician Decision|1|||
126408135|NCT05086510|454787360|FG000|Overall Study|Lost to Follow-up|0|||
126408136|NCT05086510|454787361|FG001|Overall Study|Lost to Follow-up|2|||
126408137|NCT05086510|454787360|FG000|Overall Study|Death|0|||
126408138|NCT05086510|454787361|FG001|Overall Study|Death|2|||
126408139|NCT03022981|454787362|FG000|Overall Study|Adverse Event|0|||
126408140|NCT03022981|454787363|FG001|Overall Study|Adverse Event|1|||
126408141|NCT03022981|454787364|FG002|Overall Study|Adverse Event|0|||
126408142|NCT03022981|454787362|FG000|Overall Study|Investigator's Discretion|0|||
126408143|NCT03022981|454787363|FG001|Overall Study|Investigator's Discretion|1|||
126408144|NCT03022981|454787364|FG002|Overall Study|Investigator's Discretion|2|||
126408145|NCT03022981|454787362|FG000|Overall Study|Lost to Follow-up|6|||
126408146|NCT03022981|454787363|FG001|Overall Study|Lost to Follow-up|2|||
126408147|NCT03022981|454787364|FG002|Overall Study|Lost to Follow-up|1|||
126408148|NCT03022981|454787362|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126473707|NCT01967173|455034600|FG006|Overall Study|Physician Decision|1|||
126473708|NCT01967173|455034601|FG007|Overall Study|Physician Decision|0|||
126473709|NCT01967173|455034594|FG000|Overall Study|Lack of Efficacy|2|||
126473710|NCT01967173|455034595|FG001|Overall Study|Lack of Efficacy|0|||
126473711|NCT01967173|455034596|FG002|Overall Study|Lack of Efficacy|2|||
126473712|NCT01967173|455034597|FG003|Overall Study|Lack of Efficacy|2|||
126473713|NCT01967173|455034598|FG004|Overall Study|Lack of Efficacy|0|||
126473714|NCT01967173|455034599|FG005|Overall Study|Lack of Efficacy|1|||
126473715|NCT01967173|455034600|FG006|Overall Study|Lack of Efficacy|0|||
126473716|NCT01967173|455034601|FG007|Overall Study|Lack of Efficacy|2|||
126473717|NCT01967173|455034594|FG000|Overall Study|Pregnancy|0|||
126473718|NCT01967173|455034595|FG001|Overall Study|Pregnancy|0|||
126473719|NCT01967173|455034596|FG002|Overall Study|Pregnancy|0|||
126473720|NCT01967173|455034597|FG003|Overall Study|Pregnancy|0|||
126473721|NCT01967173|455034598|FG004|Overall Study|Pregnancy|0|||
126473722|NCT01967173|455034599|FG005|Overall Study|Pregnancy|0|||
126473723|NCT01967173|455034600|FG006|Overall Study|Pregnancy|1|||
126473724|NCT01967173|455034601|FG007|Overall Study|Pregnancy|1|||
126473725|NCT01967173|455034594|FG000|Overall Study|Adverse Event|0|||
126473726|NCT01967173|455034595|FG001|Overall Study|Adverse Event|0|||
126473727|NCT01967173|455034596|FG002|Overall Study|Adverse Event|0|||
126473728|NCT01967173|455034597|FG003|Overall Study|Adverse Event|0|||
126473729|NCT01967173|455034598|FG004|Overall Study|Adverse Event|0|||
126473730|NCT01967173|455034599|FG005|Overall Study|Adverse Event|0|||
126473731|NCT01967173|455034600|FG006|Overall Study|Adverse Event|0|||
126473732|NCT01967173|455034601|FG007|Overall Study|Adverse Event|1|||
126473733|NCT01967173|455034594|FG000|Overall Study|Withdrawal by Subject|15|||
126473734|NCT01967173|455034595|FG001|Overall Study|Withdrawal by Subject|14|||
126473735|NCT01967173|455034596|FG002|Overall Study|Withdrawal by Subject|10|||
126473736|NCT01967173|455034597|FG003|Overall Study|Withdrawal by Subject|7|||
126473737|NCT01967173|455034598|FG004|Overall Study|Withdrawal by Subject|8|||
126473738|NCT01967173|455034599|FG005|Overall Study|Withdrawal by Subject|9|||
126473739|NCT01967173|455034600|FG006|Overall Study|Withdrawal by Subject|10|||
126473740|NCT01967173|455034601|FG007|Overall Study|Withdrawal by Subject|12|||
126473741|NCT03307785|455034605|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
126473742|NCT03307785|455034606|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
126473743|NCT03307785|455034607|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
126473744|NCT03307785|455034608|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
126473745|NCT03307785|455034609|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
126473746|NCT03307785|455034610|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
126473747|NCT03307785|455034611|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
126473748|NCT03307785|455034612|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
126473749|NCT03307785|455034613|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
126473750|NCT03307785|455034614|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
126473751|NCT03307785|455034615|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
126473752|NCT03307785|455034605|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
126473753|NCT03307785|455034606|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
126408149|NCT03022981|454787363|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126408150|NCT03022981|454787364|FG002|Overall Study|Non-Compliance With Study Drug|2|||
126408151|NCT03022981|454787362|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
126408152|NCT03022981|454787363|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
126408153|NCT03022981|454787364|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
126473754|NCT03307785|455034607|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
126473755|NCT03307785|455034608|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
126473756|NCT03307785|455034609|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
126408154|NCT00295932|454787365|FG000|Overall Study|Not Treated|0|||
126473757|NCT03307785|455034610|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
126473758|NCT03307785|455034611|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
126473759|NCT03307785|455034612|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
126473760|NCT03307785|455034613|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
126473761|NCT03307785|455034614|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
126473762|NCT03307785|455034615|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
126721359|NCT02116660|455929934|FG001|Overall Study|Deteriorating renal function|1|||
126721360|NCT02116660|455929933|FG000|Overall Study|Adverse Event|1|||
126721361|NCT02116660|455929934|FG001|Overall Study|Adverse Event|1|||
126721362|NCT02116660|455929933|FG000|Overall Study|Withdrawal by Subject|0|||
126721363|NCT02116660|455929934|FG001|Overall Study|Withdrawal by Subject|2|||
126721364|NCT02116660|455929933|FG000|Overall Study|Organization reason|1|||
126721365|NCT02116660|455929934|FG001|Overall Study|Organization reason|0|||
126721366|NCT00390416|455929935|FG000|Overall Study|Withdrawal by Subject|1|||
126721367|NCT00390416|455929935|FG000|Overall Study|Not treated|3|||
126721368|NCT00506077|455929936|FG000|Treatment Period 1|Adverse Event|2|||
126721369|NCT00506077|455929937|FG001|Treatment Period 1|Adverse Event|1|||
126721370|NCT00506077|455929936|FG000|Treatment Period 1|Lost to Follow-up|0|||
126721371|NCT00506077|455929937|FG001|Treatment Period 1|Lost to Follow-up|2|||
126721372|NCT00506077|455929936|FG000|Treatment Period 1|Withdrawal by Subject|2|||
126721373|NCT00506077|455929937|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126721374|NCT00506077|455929936|FG000|Treatment Period 2|Adverse Event|0|||
126721375|NCT00506077|455929937|FG001|Treatment Period 2|Adverse Event|1|||
126721376|NCT00506077|455929936|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126721377|NCT00506077|455929937|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126721378|NCT01727713|455929941|FG000|Overall Study|Lost to Follow-up|5|||
126721379|NCT01727713|455929941|FG000|Overall Study|Adverse Event|10|||
126721380|NCT01727713|455929941|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
126721381|NCT01727713|455929941|FG000|Overall Study|Withdrawal by Subject|13|||
126721382|NCT01727713|455929941|FG000|Overall Study|Protocol Deviation|2|||
126721383|NCT00471536|455929946|FG000|Overall Study|Withdrawal by Subject|1|||
126721384|NCT02651194|455929947|FG000|Overall Study|Lost to Follow-up|3|||
126721385|NCT02651194|455929947|FG000|Overall Study|Other|2|||
126721386|NCT03885726|455929950|FG000|Overall Study|Staffing issues/lost interest|1|||
126721387|NCT03885726|455929950|FG000|Overall Study|Early discharge from hospital|3|||
126721388|NCT01217190|455929951|FG000|Second Dosing|Withdrawal by Subject|0|||
126721389|NCT01217190|455929952|FG001|Second Dosing|Withdrawal by Subject|2|||
126721390|NCT03116399|455929953|FG000|Overall Study|Death|8|||
126721391|NCT03116399|455929954|FG001|Overall Study|Death|3|||
126721392|NCT03116399|455929953|FG000|Overall Study|Lost to Follow-up|7|||
126721393|NCT03116399|455929954|FG001|Overall Study|Lost to Follow-up|11|||
126721394|NCT03116399|455929953|FG000|Overall Study|Investigator Decision|1|||
126408155|NCT00295932|454787366|FG001|Overall Study|Not Treated|0|||
126408156|NCT00295932|454787367|FG002|Overall Study|Not Treated|0|||
126408157|NCT00295932|454787368|FG003|Overall Study|Not Treated|0|||
126408158|NCT00295932|454787369|FG004|Overall Study|Not Treated|0|||
126408159|NCT00295932|454787370|FG005|Overall Study|Not Treated|0|||
126408160|NCT00295932|454787371|FG006|Overall Study|Not Treated|0|||
126408161|NCT00295932|454787372|FG007|Overall Study|Not Treated|0|||
126408162|NCT00295932|454787373|FG008|Overall Study|Not Treated|0|||
126408163|NCT00295932|454787374|FG009|Overall Study|Not Treated|0|||
126408164|NCT00295932|454787375|FG010|Overall Study|Not Treated|1|||
126408165|NCT04891107|454787376|FG000|Overall Study|Physician Decision|1|||
126473763|NCT03307785|455034605|FG000|Part A: Up to 28.5 Months|Death|4|||
126473764|NCT03307785|455034606|FG001|Part A: Up to 28.5 Months|Death|4|||
126473765|NCT03307785|455034607|FG002|Part A: Up to 28.5 Months|Death|0|||
126473766|NCT03307785|455034608|FG003|Part A: Up to 28.5 Months|Death|0|||
126473767|NCT03307785|455034609|FG004|Part A: Up to 28.5 Months|Death|0|||
126473768|NCT03307785|455034610|FG005|Part A: Up to 28.5 Months|Death|0|||
126473769|NCT03307785|455034611|FG006|Part A: Up to 28.5 Months|Death|0|||
126473770|NCT03307785|455034612|FG007|Part A: Up to 28.5 Months|Death|0|||
126473771|NCT03307785|455034613|FG008|Part A: Up to 28.5 Months|Death|0|||
126473772|NCT03307785|455034614|FG009|Part A: Up to 28.5 Months|Death|0|||
126473773|NCT03307785|455034615|FG010|Part A: Up to 28.5 Months|Death|0|||
126473774|NCT03307785|455034605|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
126473775|NCT03307785|455034606|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
126473776|NCT03307785|455034607|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
126721395|NCT03116399|455929954|FG001|Overall Study|Investigator Decision|1|||
126721396|NCT03116399|455929953|FG000|Overall Study|Withdrawal by Subject|24|||
126721397|NCT03116399|455929954|FG001|Overall Study|Withdrawal by Subject|9|||
126721398|NCT02868216|455929955|FG000|Overall Study|Death|0|||
126721399|NCT02868216|455929956|FG001|Overall Study|Death|1|||
126408166|NCT04891107|454787376|FG000|Overall Study|Withdrawal by Subject|1|||
126408167|NCT04891107|454787376|FG000|Overall Study|Screen failure after consent|1|||
126408168|NCT01571453|454787377|FG000|Overall Study|Adverse Event|14|||
126408169|NCT01571453|454787378|FG001|Overall Study|Adverse Event|32|||
126408170|NCT01571453|454787377|FG000|Overall Study|Lack of Efficacy|8|||
126408171|NCT01571453|454787378|FG001|Overall Study|Lack of Efficacy|3|||
126473777|NCT03307785|455034608|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
126473778|NCT03307785|455034609|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
126473779|NCT03307785|455034610|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
126721400|NCT02868216|455929955|FG000|Overall Study|coronary artery bypass|1|||
126721401|NCT02868216|455929956|FG001|Overall Study|coronary artery bypass|0|||
126721402|NCT02868216|455929955|FG000|Overall Study|Withdrawal by Subject|7|||
126721403|NCT02868216|455929956|FG001|Overall Study|Withdrawal by Subject|5|||
126721404|NCT02496585|455929957|FG000|Overall Study|Death|3|||
126408172|NCT01571453|454787377|FG000|Overall Study|Non-compliance|2|||
126408173|NCT01571453|454787378|FG001|Overall Study|Non-compliance|4|||
126408174|NCT01571453|454787377|FG000|Overall Study|Protocol Violation|1|||
126408175|NCT01571453|454787378|FG001|Overall Study|Protocol Violation|5|||
126408176|NCT01571453|454787377|FG000|Overall Study|Withdrawal of consent|5|||
126408177|NCT01571453|454787378|FG001|Overall Study|Withdrawal of consent|13|||
126408178|NCT01571453|454787377|FG000|Overall Study|Lost to Follow-up|4|||
126408179|NCT01571453|454787378|FG001|Overall Study|Lost to Follow-up|2|||
126408180|NCT01571453|454787377|FG000|Overall Study|Administrative or other reason(s)|4|||
126408181|NCT01571453|454787378|FG001|Overall Study|Administrative or other reason(s)|3|||
126408182|NCT04033068|454787385|FG000|Overall Study|Withdrawal by Subject|0|||
126408183|NCT04033068|454787386|FG001|Overall Study|Withdrawal by Subject|0|||
126408184|NCT04033068|454787387|FG002|Overall Study|Withdrawal by Subject|1|||
126408185|NCT04033068|454787388|FG003|Overall Study|Withdrawal by Subject|0|||
126408186|NCT04033068|454787385|FG000|Overall Study|Lost to Follow-up|0|||
126408187|NCT04033068|454787386|FG001|Overall Study|Lost to Follow-up|1|||
126408188|NCT04033068|454787387|FG002|Overall Study|Lost to Follow-up|0|||
126408189|NCT04033068|454787388|FG003|Overall Study|Lost to Follow-up|0|||
126408190|NCT04033068|454787385|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
126408191|NCT04033068|454787386|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
126408192|NCT04033068|454787387|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
126408193|NCT04033068|454787388|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
126408194|NCT02039856|454787389|FG000|Overall Study|Death|5|||
126408195|NCT02039856|454787390|FG001|Overall Study|Death|3|||
126408196|NCT02039856|454787389|FG000|Overall Study|Partial survey completion|61|||
126408197|NCT02039856|454787390|FG001|Overall Study|Partial survey completion|26|||
126408198|NCT02039856|454787389|FG000|Overall Study|Lost to Follow-up|388|||
126408199|NCT02039856|454787390|FG001|Overall Study|Lost to Follow-up|206|||
126408200|NCT02039856|454787389|FG000|Overall Study|Withdrawal by Subject|1573|||
126408201|NCT02039856|454787390|FG001|Overall Study|Withdrawal by Subject|618|||
126408202|NCT02409342|454787393|FG000|Overall Study|Death|211|||
126408203|NCT02409342|454787394|FG001|Overall Study|Death|201|||
126408204|NCT02409342|454787393|FG000|Overall Study|Withdrawal by Subject|24|||
126408205|NCT02409342|454787394|FG001|Overall Study|Withdrawal by Subject|17|||
126408206|NCT02409342|454787393|FG000|Overall Study|Study Terminated By Sponsor|48|||
126408207|NCT02409342|454787394|FG001|Overall Study|Study Terminated By Sponsor|59|||
126408208|NCT02409342|454787393|FG000|Overall Study|Lost to Follow-up|3|||
126408209|NCT02409342|454787394|FG001|Overall Study|Lost to Follow-up|5|||
126408210|NCT02409342|454787393|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
126408211|NCT02409342|454787394|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
126408212|NCT02409342|454787393|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
126408213|NCT02409342|454787394|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
126408214|NCT02409342|454787393|FG000|Overall Study|Sponsor Decision|1|||
126408215|NCT02409342|454787394|FG001|Overall Study|Sponsor Decision|0|||
126408216|NCT03908970|454787395|FG000|Overall Study|Adverse Event|7|||
126408217|NCT03908970|454787396|FG001|Overall Study|Adverse Event|21|||
126408218|NCT03908970|454787395|FG000|Overall Study|Physician Decision|1|||
126408219|NCT03908970|454787396|FG001|Overall Study|Physician Decision|4|||
126408220|NCT03908970|454787395|FG000|Overall Study|Withdrawal by Subject|9|||
126408221|NCT03908970|454787396|FG001|Overall Study|Withdrawal by Subject|22|||
126408222|NCT04327024|454789719|FG000|Overall Study|Death|1|||
126408223|NCT04327024|454789720|FG001|Overall Study|Death|2|||
126408224|NCT04327024|454789721|FG002|Overall Study|Death|1|||
126408225|NCT04327024|454789719|FG000|Overall Study|Non-compliance with study drug|0|||
126408226|NCT04327024|454789720|FG001|Overall Study|Non-compliance with study drug|1|||
126408227|NCT04327024|454789721|FG002|Overall Study|Non-compliance with study drug|0|||
126408228|NCT04327024|454789719|FG000|Overall Study|Withdrawal by Subject|1|||
126408229|NCT04327024|454789720|FG001|Overall Study|Withdrawal by Subject|1|||
126408230|NCT04327024|454789721|FG002|Overall Study|Withdrawal by Subject|2|||
126408231|NCT01192568|454789725|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
126408232|NCT01192568|454789726|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
126408233|NCT01192568|454789727|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
126408234|NCT01192568|454789728|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
126408235|NCT01192568|454789725|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
126408236|NCT01192568|454789726|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
126408237|NCT01192568|454789727|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
126408238|NCT01192568|454789728|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
126408239|NCT00652951|454789729|FG000|Booster Phase|Adverse event, non-fatal|0|||
126408240|NCT00652951|454789730|FG001|Booster Phase|Adverse event, non-fatal|1|||
126408241|NCT00652951|454789731|FG002|Booster Phase|Adverse event, non-fatal|0|||
126408242|NCT00652951|454789729|FG000|Booster Phase|Other|1|||
126408243|NCT00652951|454789730|FG001|Booster Phase|Other|0|||
126408244|NCT00652951|454789731|FG002|Booster Phase|Other|0|||
126408245|NCT01206582|454789732|FG000|Overall Study|Withdrew prior to study|1|||
126408246|NCT01206582|454789733|FG001|Overall Study|Withdrew prior to study|0|||
126721405|NCT02496585|455929958|FG001|Overall Study|Death|0|||
126721406|NCT02496585|455929957|FG000|Overall Study|Lost to Follow-up|2|||
126408247|NCT01206582|454789732|FG000|Overall Study|Discontinued intervention before week 8|1|||
126408248|NCT01206582|454789733|FG001|Overall Study|Discontinued intervention before week 8|2|||
126408249|NCT00387725|454789736|FG000|Overall Study|Adverse Event|0|||
126408250|NCT00387725|454789737|FG001|Overall Study|Adverse Event|0|||
126408251|NCT00387725|454789738|FG002|Overall Study|Adverse Event|0|||
126408252|NCT00387725|454789739|FG003|Overall Study|Adverse Event|1|||
126408253|NCT00387725|454789736|FG000|Overall Study|Protocol Violation|0|||
126408254|NCT00387725|454789737|FG001|Overall Study|Protocol Violation|1|||
126408255|NCT00387725|454789738|FG002|Overall Study|Protocol Violation|0|||
126408256|NCT00387725|454789739|FG003|Overall Study|Protocol Violation|0|||
126408257|NCT00387725|454789736|FG000|Overall Study|Withdrawal by Subject|1|||
126408258|NCT00387725|454789737|FG001|Overall Study|Withdrawal by Subject|0|||
126408259|NCT00387725|454789738|FG002|Overall Study|Withdrawal by Subject|1|||
126408260|NCT00387725|454789739|FG003|Overall Study|Withdrawal by Subject|0|||
126408261|NCT00387725|454789736|FG000|Overall Study|Parent/legal guardian request|0|||
126408262|NCT00387725|454789737|FG001|Overall Study|Parent/legal guardian request|0|||
126408263|NCT00387725|454789738|FG002|Overall Study|Parent/legal guardian request|1|||
126408264|NCT00387725|454789739|FG003|Overall Study|Parent/legal guardian request|1|||
126408265|NCT00568126|454789740|FG000|Overall Study|Adverse Event|3|||
126721407|NCT02496585|455929958|FG001|Overall Study|Lost to Follow-up|0|||
126721408|NCT02496585|455929957|FG000|Overall Study|Withdrawal by Subject|1|||
126721409|NCT02496585|455929958|FG001|Overall Study|Withdrawal by Subject|2|||
126721410|NCT02496585|455929957|FG000|Overall Study|Progression of Malignancy|4|||
126408266|NCT00568126|454789741|FG001|Overall Study|Adverse Event|0|||
126408267|NCT00568126|454789740|FG000|Overall Study|Withdrawal by Subject|2|||
126408268|NCT00568126|454789741|FG001|Overall Study|Withdrawal by Subject|3|||
126408269|NCT00568126|454789740|FG000|Overall Study|Lost to Follow-up|4|||
126408270|NCT00568126|454789741|FG001|Overall Study|Lost to Follow-up|3|||
126408271|NCT00568126|454789740|FG000|Overall Study|Lack of Efficacy|0|||
126408272|NCT00568126|454789741|FG001|Overall Study|Lack of Efficacy|1|||
126408273|NCT00568126|454789740|FG000|Overall Study|Physician Decision|2|||
126408274|NCT00568126|454789741|FG001|Overall Study|Physician Decision|2|||
126408275|NCT02615691|454789742|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
126408276|NCT02615691|454789742|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
126408277|NCT02615691|454789742|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
126408278|NCT02615691|454789742|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
126408279|NCT02017522|454789743|FG000|Overall Study|Withdrawal by Subject|1|||
126408280|NCT01272869|454789744|FG000|Period 2 (14 Days)|Adverse Event|1|||
126408281|NCT01272869|454789745|FG001|Period 2 (14 Days)|Adverse Event|0|||
126408282|NCT00859937|454789747|FG000|Overall Study|Protocol Violation|1|||
126408283|NCT00859937|454789748|FG001|Overall Study|Protocol Violation|0|||
126408284|NCT00615030|454789749|FG000|Period I|Administrative problem|0|||
126408285|NCT00615030|454789750|FG001|Period I|Administrative problem|0|||
126408286|NCT00615030|454789751|FG002|Period I|Administrative problem|0|||
126408287|NCT00615030|454789752|FG003|Period I|Administrative problem|0|||
126408288|NCT00615030|454789753|FG004|Period I|Administrative problem|1|||
126408289|NCT00615030|454789754|FG005|Period I|Administrative problem|0|||
126408290|NCT00615030|454789755|FG006|Period I|Administrative problem|0|||
126408291|NCT00615030|454789756|FG007|Period I|Administrative problem|0|||
126408292|NCT00615030|454789757|FG008|Period I|Administrative problem|0|||
126408293|NCT00615030|454789758|FG009|Period I|Administrative problem|0|||
126408294|NCT00615030|454789759|FG010|Period I|Administrative problem|0|||
126408295|NCT00615030|454789760|FG011|Period I|Administrative problem|0|||
126408296|NCT00615030|454789749|FG000|Period I|Protocol deviation|1|||
126408297|NCT00615030|454789750|FG001|Period I|Protocol deviation|0|||
126408298|NCT00615030|454789751|FG002|Period I|Protocol deviation|0|||
126408299|NCT00615030|454789752|FG003|Period I|Protocol deviation|0|||
126408300|NCT00615030|454789753|FG004|Period I|Protocol deviation|0|||
126408301|NCT00615030|454789754|FG005|Period I|Protocol deviation|0|||
126408302|NCT00615030|454789755|FG006|Period I|Protocol deviation|0|||
126408303|NCT00615030|454789756|FG007|Period I|Protocol deviation|0|||
126408304|NCT00615030|454789757|FG008|Period I|Protocol deviation|0|||
126408305|NCT00615030|454789758|FG009|Period I|Protocol deviation|0|||
126408306|NCT00615030|454789759|FG010|Period I|Protocol deviation|0|||
126408307|NCT00615030|454789760|FG011|Period I|Protocol deviation|0|||
126408308|NCT00615030|454789749|FG000|Period I|Subject withdrew consent|0|||
126408309|NCT00615030|454789750|FG001|Period I|Subject withdrew consent|0|||
126408310|NCT00615030|454789751|FG002|Period I|Subject withdrew consent|0|||
126408311|NCT00615030|454789752|FG003|Period I|Subject withdrew consent|0|||
126408312|NCT00615030|454789753|FG004|Period I|Subject withdrew consent|0|||
126408313|NCT00615030|454789754|FG005|Period I|Subject withdrew consent|0|||
126408314|NCT00615030|454789755|FG006|Period I|Subject withdrew consent|0|||
126408315|NCT00615030|454789756|FG007|Period I|Subject withdrew consent|0|||
126408316|NCT00615030|454789757|FG008|Period I|Subject withdrew consent|1|||
126408317|NCT00615030|454789758|FG009|Period I|Subject withdrew consent|0|||
126408318|NCT00615030|454789759|FG010|Period I|Subject withdrew consent|1|||
126408319|NCT00615030|454789760|FG011|Period I|Subject withdrew consent|1|||
126408320|NCT00615030|454789749|FG000|Period I|Abnormal laboratory value(s)|0|||
126408321|NCT00615030|454789750|FG001|Period I|Abnormal laboratory value(s)|0|||
126408322|NCT00615030|454789751|FG002|Period I|Abnormal laboratory value(s)|0|||
126408323|NCT00615030|454789752|FG003|Period I|Abnormal laboratory value(s)|0|||
126408324|NCT00615030|454789753|FG004|Period I|Abnormal laboratory value(s)|0|||
126408325|NCT00615030|454789754|FG005|Period I|Abnormal laboratory value(s)|1|||
126408326|NCT00615030|454789755|FG006|Period I|Abnormal laboratory value(s)|0|||
126408327|NCT00615030|454789756|FG007|Period I|Abnormal laboratory value(s)|0|||
126408328|NCT00615030|454789757|FG008|Period I|Abnormal laboratory value(s)|0|||
126408329|NCT00615030|454789758|FG009|Period I|Abnormal laboratory value(s)|0|||
126408330|NCT00615030|454789759|FG010|Period I|Abnormal laboratory value(s)|0|||
126408331|NCT00615030|454789760|FG011|Period I|Abnormal laboratory value(s)|0|||
126408332|NCT00615030|454789749|FG000|Period II|Adverse Event|0|||
126408333|NCT00615030|454789750|FG001|Period II|Adverse Event|0|||
126408334|NCT00615030|454789751|FG002|Period II|Adverse Event|1|||
126408335|NCT00615030|454789752|FG003|Period II|Adverse Event|0|||
126473780|NCT03307785|455034611|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
126473781|NCT03307785|455034612|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
126473782|NCT03307785|455034613|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
126473783|NCT03307785|455034614|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
126473784|NCT03307785|455034615|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
126473785|NCT03307785|455034605|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
126473786|NCT03307785|455034606|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
126473787|NCT03307785|455034607|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
126473788|NCT03307785|455034608|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
126473789|NCT03307785|455034609|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
126473790|NCT03307785|455034610|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
126558498|NCT02303574|455338767|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126558499|NCT02303574|455338768|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
126408336|NCT00615030|454789753|FG004|Period II|Adverse Event|0|||
126408337|NCT00615030|454789754|FG005|Period II|Adverse Event|0|||
126408338|NCT00615030|454789755|FG006|Period II|Adverse Event|0|||
126408339|NCT00615030|454789756|FG007|Period II|Adverse Event|0|||
126408340|NCT00615030|454789757|FG008|Period II|Adverse Event|1|||
126408341|NCT00615030|454789758|FG009|Period II|Adverse Event|0|||
126408342|NCT00615030|454789759|FG010|Period II|Adverse Event|0|||
126408343|NCT00615030|454789760|FG011|Period II|Adverse Event|0|||
126408344|NCT00615030|454789749|FG000|Period II|Subject withdrew consent|0|||
126408345|NCT00615030|454789750|FG001|Period II|Subject withdrew consent|0|||
126408346|NCT00615030|454789751|FG002|Period II|Subject withdrew consent|0|||
126408347|NCT00615030|454789752|FG003|Period II|Subject withdrew consent|1|||
126408348|NCT00615030|454789753|FG004|Period II|Subject withdrew consent|0|||
126408349|NCT00615030|454789754|FG005|Period II|Subject withdrew consent|0|||
126408350|NCT00615030|454789755|FG006|Period II|Subject withdrew consent|1|||
126408351|NCT00615030|454789756|FG007|Period II|Subject withdrew consent|0|||
126408352|NCT00615030|454789757|FG008|Period II|Subject withdrew consent|0|||
126408353|NCT00615030|454789758|FG009|Period II|Subject withdrew consent|0|||
126408354|NCT00615030|454789759|FG010|Period II|Subject withdrew consent|0|||
126473791|NCT03307785|455034611|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
126473792|NCT03307785|455034612|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
126473793|NCT03307785|455034613|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
126558500|NCT02303574|455338769|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126558501|NCT02303574|455338770|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
126558502|NCT00859014|455338771|FG000|Overall Study|Death|4|||
126721411|NCT02496585|455929958|FG001|Overall Study|Progression of Malignancy|1|||
126721412|NCT04891770|455929959|FG000|Overall Study|Withdrew consent|1|||
126721413|NCT04891770|455929960|FG001|Overall Study|Withdrew consent|3|||
126721414|NCT04891770|455929961|FG002|Overall Study|Withdrew consent|0|||
126721415|NCT04891770|455929959|FG000|Overall Study|Enrolled but never treated|0|||
126721416|NCT04891770|455929960|FG001|Overall Study|Enrolled but never treated|0|||
126408355|NCT00615030|454789760|FG011|Period II|Subject withdrew consent|0|||
126408356|NCT00615030|454789749|FG000|Period III|Administrative problems|1|||
126408357|NCT00615030|454789750|FG001|Period III|Administrative problems|0|||
126408358|NCT00615030|454789751|FG002|Period III|Administrative problems|0|||
126408359|NCT00615030|454789752|FG003|Period III|Administrative problems|1|||
126408360|NCT00615030|454789753|FG004|Period III|Administrative problems|0|||
126408361|NCT00615030|454789754|FG005|Period III|Administrative problems|0|||
126408362|NCT00615030|454789755|FG006|Period III|Administrative problems|0|||
126408363|NCT00615030|454789756|FG007|Period III|Administrative problems|0|||
126408364|NCT00615030|454789757|FG008|Period III|Administrative problems|0|||
126473794|NCT03307785|455034614|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
126473795|NCT03307785|455034615|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
126721417|NCT04891770|455929961|FG002|Overall Study|Enrolled but never treated|1|||
126721418|NCT04891770|455929959|FG000|Overall Study|Investigator's discretion|0|||
126408365|NCT00615030|454789758|FG009|Period III|Administrative problems|0|||
126408366|NCT00615030|454789759|FG010|Period III|Administrative problems|0|||
126408367|NCT00615030|454789760|FG011|Period III|Administrative problems|0|||
126408368|NCT00151476|454789761|FG000|FAP Identified Subjects|Protocol Violation|0|||
126408369|NCT00151476|454789762|FG001|FAP Identified Subjects|Protocol Violation|1|||
126408370|NCT00151476|454789761|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
126408371|NCT00151476|454789762|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
126408372|NCT00151476|454789761|FG000|FAP Analyzed Subjects|Other study participation|0|||
126408373|NCT00151476|454789762|FG001|FAP Analyzed Subjects|Other study participation|1|||
126408374|NCT03908476|454789770|FG000|Overall Study|Death|3|||
126408375|NCT03908476|454789771|FG001|Overall Study|Death|0|||
126408376|NCT03908476|454789770|FG000|Overall Study|Lost to Follow-up|3|||
126408377|NCT03908476|454789771|FG001|Overall Study|Lost to Follow-up|1|||
126408378|NCT03908476|454789770|FG000|Overall Study|Withdrawal by Subject|7|||
126408379|NCT03908476|454789771|FG001|Overall Study|Withdrawal by Subject|1|||
126408380|NCT03908476|454789770|FG000|Overall Study|Physician Decision|2|||
126408381|NCT03908476|454789771|FG001|Overall Study|Physician Decision|0|||
126408382|NCT03908476|454789770|FG000|Overall Study|System Explanted and not Replaced|4|||
126408383|NCT03908476|454789771|FG001|Overall Study|System Explanted and not Replaced|0|||
126408384|NCT03908476|454789770|FG000|Overall Study|Intrathecal Pump|1|||
126408385|NCT03908476|454789771|FG001|Overall Study|Intrathecal Pump|0|||
126408386|NCT03908476|454789770|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
126408387|NCT03908476|454789771|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
126408388|NCT05194267|454789772|FG000|Overall Study|Withdrawal by Subject|2|||
126408389|NCT00802893|454789773|FG000|Overall Study|study terminated|3|||
126408390|NCT02868229|454789774|FG000|Overall Study|Adverse Event|1|||
126408391|NCT02868229|454789775|FG001|Overall Study|Adverse Event|0|||
126408392|NCT02868229|454789776|FG002|Overall Study|Adverse Event|0|||
126408393|NCT02868229|454789777|FG003|Overall Study|Adverse Event|1|||
126408394|NCT02868229|454789774|FG000|Overall Study|Death|0|||
126408395|NCT02868229|454789775|FG001|Overall Study|Death|0|||
126408396|NCT02868229|454789776|FG002|Overall Study|Death|1|||
126408397|NCT02868229|454789777|FG003|Overall Study|Death|1|||
126408398|NCT02868229|454789774|FG000|Overall Study|Missed dose|0|||
126408399|NCT02868229|454789775|FG001|Overall Study|Missed dose|0|||
126408400|NCT02868229|454789776|FG002|Overall Study|Missed dose|0|||
126408401|NCT02868229|454789777|FG003|Overall Study|Missed dose|3|||
126408402|NCT06151288|454789778|FG000|Overall Study|Lost to Follow-up|4|||
126408403|NCT06151288|454789779|FG001|Overall Study|Lost to Follow-up|2|||
126408404|NCT06151288|454789780|FG002|Overall Study|Lost to Follow-up|4|||
126408405|NCT06151288|454789781|FG003|Overall Study|Lost to Follow-up|3|||
126408406|NCT06151288|454789778|FG000|Overall Study|Withdrawal by Subject|4|||
126408407|NCT06151288|454789779|FG001|Overall Study|Withdrawal by Subject|5|||
126408408|NCT06151288|454789780|FG002|Overall Study|Withdrawal by Subject|1|||
126408409|NCT06151288|454789781|FG003|Overall Study|Withdrawal by Subject|1|||
126408410|NCT02911142|454789782|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
126408411|NCT02911142|454789782|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
126473796|NCT03307785|455034605|FG000|Part B: Up to Approx. 66 Months|Death|0|||
126473797|NCT03307785|455034606|FG001|Part B: Up to Approx. 66 Months|Death|0|||
126473798|NCT03307785|455034607|FG002|Part B: Up to Approx. 66 Months|Death|7|||
126473799|NCT03307785|455034608|FG003|Part B: Up to Approx. 66 Months|Death|0|||
126473800|NCT03307785|455034609|FG004|Part B: Up to Approx. 66 Months|Death|0|||
126473801|NCT03307785|455034610|FG005|Part B: Up to Approx. 66 Months|Death|0|||
126473802|NCT03307785|455034611|FG006|Part B: Up to Approx. 66 Months|Death|0|||
126473803|NCT03307785|455034612|FG007|Part B: Up to Approx. 66 Months|Death|0|||
126473804|NCT03307785|455034613|FG008|Part B: Up to Approx. 66 Months|Death|0|||
126473805|NCT03307785|455034614|FG009|Part B: Up to Approx. 66 Months|Death|0|||
126473806|NCT03307785|455034615|FG010|Part B: Up to Approx. 66 Months|Death|0|||
126473807|NCT03307785|455034605|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
126408412|NCT02911142|454789782|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
126408413|NCT02911142|454789782|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
126408414|NCT02883062|454789783|FG000|Overall Study|Withdrawal by Subject|6|||
126408415|NCT02883062|454789784|FG001|Overall Study|Withdrawal by Subject|0|||
126408416|NCT02888743|454789785|FG000|Overall Study|Withdrawal by Subject|1|||
126408417|NCT02888743|454789786|FG001|Overall Study|Withdrawal by Subject|2|||
126408418|NCT02888743|454789787|FG002|Overall Study|Withdrawal by Subject|2|||
126473808|NCT03307785|455034606|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
126473809|NCT03307785|455034607|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
126473810|NCT03307785|455034608|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
126473811|NCT03307785|455034609|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
126473812|NCT03307785|455034610|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
126473813|NCT03307785|455034611|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
126473814|NCT03307785|455034612|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
126473815|NCT03307785|455034613|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
126473816|NCT03307785|455034614|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
126408419|NCT02888743|454789788|FG003|Overall Study|Withdrawal by Subject|0|||
126408420|NCT02888743|454789789|FG004|Overall Study|Withdrawal by Subject|1|||
126408421|NCT02888743|454789785|FG000|Overall Study|Disease progression before treatment|2|||
126408422|NCT02888743|454789786|FG001|Overall Study|Disease progression before treatment|0|||
126408423|NCT02888743|454789787|FG002|Overall Study|Disease progression before treatment|2|||
126408424|NCT02888743|454789788|FG003|Overall Study|Disease progression before treatment|0|||
126408425|NCT02888743|454789789|FG004|Overall Study|Disease progression before treatment|0|||
126408426|NCT02888743|454789785|FG000|Overall Study|Patient ineligible|1|||
126408427|NCT02888743|454789786|FG001|Overall Study|Patient ineligible|2|||
126408428|NCT02888743|454789787|FG002|Overall Study|Patient ineligible|0|||
126408429|NCT02888743|454789788|FG003|Overall Study|Patient ineligible|0|||
126408430|NCT02888743|454789789|FG004|Overall Study|Patient ineligible|0|||
126408431|NCT04816721|454789790|FG000|Overall Study|Withdrawal by Subject|0|||
126408432|NCT04816721|454789791|FG001|Overall Study|Withdrawal by Subject|2|||
126408433|NCT04816721|454789792|FG002|Overall Study|Withdrawal by Subject|0|||
126408434|NCT04816721|454789793|FG003|Overall Study|Withdrawal by Subject|1|||
126408435|NCT04816721|454789794|FG004|Overall Study|Withdrawal by Subject|1|||
126408436|NCT04816721|454789795|FG005|Overall Study|Withdrawal by Subject|0|||
126408437|NCT04816721|454789796|FG006|Overall Study|Withdrawal by Subject|0|||
126408438|NCT04816721|454789797|FG007|Overall Study|Withdrawal by Subject|0|||
126408439|NCT04816721|454789790|FG000|Overall Study|Miscellaneous|0|||
126408440|NCT04816721|454789791|FG001|Overall Study|Miscellaneous|0|||
126408441|NCT04816721|454789792|FG002|Overall Study|Miscellaneous|0|||
126408442|NCT04816721|454789793|FG003|Overall Study|Miscellaneous|0|||
126408443|NCT04816721|454789794|FG004|Overall Study|Miscellaneous|0|||
126408444|NCT04816721|454789795|FG005|Overall Study|Miscellaneous|1|||
126408445|NCT04816721|454789796|FG006|Overall Study|Miscellaneous|0|||
126408446|NCT04816721|454789797|FG007|Overall Study|Miscellaneous|0|||
126408447|NCT04816721|454789790|FG000|Overall Study|Lost to Follow-up|0|||
126408448|NCT04816721|454789791|FG001|Overall Study|Lost to Follow-up|0|||
126408449|NCT04816721|454789792|FG002|Overall Study|Lost to Follow-up|0|||
126408450|NCT04816721|454789793|FG003|Overall Study|Lost to Follow-up|1|||
126408451|NCT04816721|454789794|FG004|Overall Study|Lost to Follow-up|0|||
126408452|NCT04816721|454789795|FG005|Overall Study|Lost to Follow-up|0|||
126408453|NCT04816721|454789796|FG006|Overall Study|Lost to Follow-up|0|||
126408454|NCT04816721|454789797|FG007|Overall Study|Lost to Follow-up|0|||
126408455|NCT00026312|454789798|FG000|Overall Study|Adverse Event|0|||
126408456|NCT00026312|454789799|FG001|Overall Study|Adverse Event|32|||
126408457|NCT00026312|454789798|FG000|Overall Study|Death|1|||
126408458|NCT00026312|454789799|FG001|Overall Study|Death|7|||
126408459|NCT00026312|454789798|FG000|Overall Study|Lack of Efficacy|19|||
126408460|NCT00026312|454789799|FG001|Overall Study|Lack of Efficacy|114|||
126408461|NCT00026312|454789798|FG000|Overall Study|Lost to Follow-up|0|||
126408462|NCT00026312|454789799|FG001|Overall Study|Lost to Follow-up|5|||
126408463|NCT00026312|454789798|FG000|Overall Study|Physician Decision|1|||
126408464|NCT00026312|454789799|FG001|Overall Study|Physician Decision|37|||
126408465|NCT00026312|454789798|FG000|Overall Study|Protocol Violation|0|||
126408466|NCT00026312|454789799|FG001|Overall Study|Protocol Violation|3|||
126408467|NCT00026312|454789798|FG000|Overall Study|Withdrawal by Subject|1|||
126408468|NCT00026312|454789799|FG001|Overall Study|Withdrawal by Subject|6|||
126408469|NCT00026312|454789798|FG000|Overall Study|Ineligible|4|||
126408470|NCT00026312|454789799|FG001|Overall Study|Ineligible|5|||
126408471|NCT00026312|454789798|FG000|Overall Study|Entry onto another COG study|0|||
126408472|NCT00026312|454789799|FG001|Overall Study|Entry onto another COG study|1|||
126408473|NCT00026312|454789798|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
126408474|NCT00026312|454789799|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
126408475|NCT01638546|454789800|FG000|Overall Study|Adverse Event|1|||
126408476|NCT01638546|454789801|FG001|Overall Study|Adverse Event|3|||
126473817|NCT03307785|455034615|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
126473818|NCT03307785|455034605|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
126473819|NCT03307785|455034606|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
126473820|NCT03307785|455034607|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
126473821|NCT03307785|455034608|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
126473822|NCT03307785|455034609|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
126408477|NCT03194438|454789804|FG000|Overall Study|Withdrawal by Subject|2|||
126408478|NCT02250664|454789811|FG000|Overall Study|Lost to Follow-up|18|||
126408479|NCT02250664|454789812|FG001|Overall Study|Lost to Follow-up|28|||
126408480|NCT02250664|454789813|FG002|Overall Study|Lost to Follow-up|33|||
126408481|NCT02250664|454789811|FG000|Overall Study|Personal Reasons|7|||
126408482|NCT02250664|454789812|FG001|Overall Study|Personal Reasons|8|||
126408483|NCT02250664|454789813|FG002|Overall Study|Personal Reasons|14|||
126408484|NCT02250664|454789811|FG000|Overall Study|Adverse Event|6|||
126408485|NCT02250664|454789812|FG001|Overall Study|Adverse Event|3|||
126408486|NCT02250664|454789813|FG002|Overall Study|Adverse Event|8|||
126408487|NCT02250664|454789811|FG000|Overall Study|Incarcerated|2|||
126408488|NCT02250664|454789812|FG001|Overall Study|Incarcerated|1|||
126721419|NCT04891770|455929960|FG001|Overall Study|Investigator's discretion|1|||
126721420|NCT04891770|455929961|FG002|Overall Study|Investigator's discretion|0|||
126721421|NCT00195260|455929968|FG000|Part 1: Dose Escalation|Adverse Event|0|||
126721422|NCT00195260|455929969|FG001|Part 1: Dose Escalation|Adverse Event|1|||
126408489|NCT02250664|454789813|FG002|Overall Study|Incarcerated|2|||
126408490|NCT02250664|454789811|FG000|Overall Study|Withdrawal by Subject|0|||
126473823|NCT03307785|455034610|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
126473824|NCT03307785|455034611|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
126473825|NCT03307785|455034612|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
126473826|NCT03307785|455034613|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
126473827|NCT03307785|455034614|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
126473828|NCT03307785|455034615|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
126473829|NCT03307785|455034605|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
126473830|NCT03307785|455034606|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
126408491|NCT02250664|454789812|FG001|Overall Study|Withdrawal by Subject|1|||
126408492|NCT02250664|454789813|FG002|Overall Study|Withdrawal by Subject|2|||
126408493|NCT02250664|454789811|FG000|Overall Study|Death|0|||
126408494|NCT02250664|454789812|FG001|Overall Study|Death|1|||
126408495|NCT02250664|454789813|FG002|Overall Study|Death|1|||
126408496|NCT02250664|454789811|FG000|Overall Study|Physician Decision|1|||
126408497|NCT02250664|454789812|FG001|Overall Study|Physician Decision|3|||
126408498|NCT02250664|454789813|FG002|Overall Study|Physician Decision|1|||
126408499|NCT02250664|454789811|FG000|Overall Study|Protocol Violation|1|||
126408500|NCT02250664|454789812|FG001|Overall Study|Protocol Violation|0|||
126408501|NCT02250664|454789813|FG002|Overall Study|Protocol Violation|1|||
126408502|NCT02250664|454789811|FG000|Overall Study|Reason unknown|1|||
126408503|NCT02250664|454789812|FG001|Overall Study|Reason unknown|0|||
126408504|NCT02250664|454789813|FG002|Overall Study|Reason unknown|0|||
126408505|NCT03847909|454789814|FG000|Overall Study|Withdrawal by Subject|1|||
126408506|NCT03847909|454789815|FG001|Overall Study|Withdrawal by Subject|1|||
126408507|NCT00117793|454789816|FG000|Overall Study|Withdrawal by Subject|12|||
126408508|NCT04268173|454789817|FG000|Overall Study|Lost to Follow-up|75|||
126408509|NCT04268173|454789818|FG001|Overall Study|Lost to Follow-up|108|||
126408510|NCT00975143|454789819|FG000|Overall Study|Adverse Event|19|||
126408511|NCT00975143|454789820|FG001|Overall Study|Adverse Event|15|||
126408512|NCT00975143|454789819|FG000|Overall Study|Withdrawal by Subject|15|||
126408513|NCT00975143|454789820|FG001|Overall Study|Withdrawal by Subject|15|||
126408514|NCT00975143|454789819|FG000|Overall Study|Lost to Follow-up|20|||
126408515|NCT00975143|454789820|FG001|Overall Study|Lost to Follow-up|16|||
126408516|NCT00975143|454789819|FG000|Overall Study|Non-compliance|5|||
126408517|NCT00975143|454789820|FG001|Overall Study|Non-compliance|8|||
126408518|NCT00975143|454789819|FG000|Overall Study|Physician Decision|1|||
126408519|NCT00975143|454789820|FG001|Overall Study|Physician Decision|2|||
126408520|NCT00975143|454789819|FG000|Overall Study|Details not available|10|||
126408521|NCT00975143|454789820|FG001|Overall Study|Details not available|4|||
126408522|NCT01375608|454789821|FG000|Overall Study|Withdrawal by Subject|2|||
126408523|NCT00545103|454789822|FG000|Overall Study|Lack of Efficacy|48|||
126408524|NCT00545103|454789823|FG001|Overall Study|Lack of Efficacy|45|||
126408525|NCT00545103|454789824|FG002|Overall Study|Lack of Efficacy|31|||
126408526|NCT00545103|454789825|FG003|Overall Study|Lack of Efficacy|27|||
126408527|NCT00545103|454789822|FG000|Overall Study|Withdrawal by Subject|6|||
126408528|NCT00545103|454789823|FG001|Overall Study|Withdrawal by Subject|10|||
126408529|NCT00545103|454789824|FG002|Overall Study|Withdrawal by Subject|18|||
126473831|NCT03307785|455034607|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
126473832|NCT03307785|455034608|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
126473833|NCT03307785|455034609|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
126473834|NCT03307785|455034610|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
126473835|NCT03307785|455034611|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
126473836|NCT03307785|455034612|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
126473837|NCT03307785|455034613|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
126721423|NCT00195260|455929970|FG002|Part 1: Dose Escalation|Adverse Event|0|||
126721424|NCT00195260|455929971|FG003|Part 1: Dose Escalation|Adverse Event|1|||
126408530|NCT00545103|454789825|FG003|Overall Study|Withdrawal by Subject|22|||
126408531|NCT00545103|454789822|FG000|Overall Study|Adverse Event|11|||
126408532|NCT00545103|454789823|FG001|Overall Study|Adverse Event|12|||
126408533|NCT00545103|454789824|FG002|Overall Study|Adverse Event|17|||
126408534|NCT00545103|454789825|FG003|Overall Study|Adverse Event|10|||
126408535|NCT00545103|454789822|FG000|Overall Study|Lost to Follow-up|4|||
126408536|NCT00545103|454789823|FG001|Overall Study|Lost to Follow-up|6|||
126408537|NCT00545103|454789824|FG002|Overall Study|Lost to Follow-up|3|||
126408538|NCT00545103|454789825|FG003|Overall Study|Lost to Follow-up|4|||
126408539|NCT00545103|454789822|FG000|Overall Study|Protocol Violation|1|||
126408540|NCT00545103|454789823|FG001|Overall Study|Protocol Violation|2|||
126408541|NCT00545103|454789824|FG002|Overall Study|Protocol Violation|3|||
126408542|NCT00545103|454789825|FG003|Overall Study|Protocol Violation|0|||
126408543|NCT00545103|454789822|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
126408544|NCT00545103|454789823|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
126408545|NCT00545103|454789824|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
126408546|NCT00545103|454789825|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
126408547|NCT00545103|454789822|FG000|Overall Study|Difficult to open package|0|||
126408548|NCT00545103|454789823|FG001|Overall Study|Difficult to open package|0|||
126408549|NCT00545103|454789824|FG002|Overall Study|Difficult to open package|0|||
126408550|NCT00545103|454789825|FG003|Overall Study|Difficult to open package|1|||
126408551|NCT00545103|454789822|FG000|Overall Study|Investigational product not taken|1|||
126408552|NCT00545103|454789823|FG001|Overall Study|Investigational product not taken|0|||
126408553|NCT00545103|454789824|FG002|Overall Study|Investigational product not taken|0|||
126408554|NCT00545103|454789825|FG003|Overall Study|Investigational product not taken|1|||
126408555|NCT00545103|454789822|FG000|Overall Study|Wish to start a family|0|||
126408556|NCT00545103|454789823|FG001|Overall Study|Wish to start a family|0|||
126408557|NCT00545103|454789824|FG002|Overall Study|Wish to start a family|0|||
126408558|NCT00545103|454789825|FG003|Overall Study|Wish to start a family|1|||
126408559|NCT00545103|454789822|FG000|Overall Study|Diverticulitis crisis|0|||
126408560|NCT00545103|454789823|FG001|Overall Study|Diverticulitis crisis|0|||
126408561|NCT00545103|454789824|FG002|Overall Study|Diverticulitis crisis|0|||
126408562|NCT00545103|454789825|FG003|Overall Study|Diverticulitis crisis|1|||
126408563|NCT00545103|454789822|FG000|Overall Study|Personal reasons|1|||
126408564|NCT00545103|454789823|FG001|Overall Study|Personal reasons|0|||
126408565|NCT00545103|454789824|FG002|Overall Study|Personal reasons|0|||
126408566|NCT00545103|454789825|FG003|Overall Study|Personal reasons|0|||
126408567|NCT00545103|454789822|FG000|Overall Study|Subject's decision|1|||
126408568|NCT00545103|454789823|FG001|Overall Study|Subject's decision|0|||
126408569|NCT00545103|454789824|FG002|Overall Study|Subject's decision|0|||
126408570|NCT00545103|454789825|FG003|Overall Study|Subject's decision|0|||
126408571|NCT00545103|454789822|FG000|Overall Study|Noncompliance|0|||
126408572|NCT00545103|454789823|FG001|Overall Study|Noncompliance|1|||
126408573|NCT00545103|454789824|FG002|Overall Study|Noncompliance|0|||
126408574|NCT00545103|454789825|FG003|Overall Study|Noncompliance|0|||
126408575|NCT00545103|454789822|FG000|Overall Study|Investigator decision|0|||
126408576|NCT00545103|454789823|FG001|Overall Study|Investigator decision|0|||
126408577|NCT00545103|454789824|FG002|Overall Study|Investigator decision|1|||
126408578|NCT00545103|454789825|FG003|Overall Study|Investigator decision|0|||
126408579|NCT00545103|454789822|FG000|Overall Study|Subject moved|0|||
126408580|NCT00545103|454789823|FG001|Overall Study|Subject moved|1|||
126408581|NCT00545103|454789824|FG002|Overall Study|Subject moved|0|||
126408582|NCT00545103|454789825|FG003|Overall Study|Subject moved|0|||
126408583|NCT00545103|454789822|FG000|Overall Study|Use of prohibited medication|0|||
126408584|NCT00545103|454789823|FG001|Overall Study|Use of prohibited medication|0|||
126408585|NCT00545103|454789824|FG002|Overall Study|Use of prohibited medication|1|||
126408586|NCT00545103|454789825|FG003|Overall Study|Use of prohibited medication|0|||
126408587|NCT00545103|454789822|FG000|Overall Study|Does not want to take study drug anymore|1|||
126408588|NCT00545103|454789823|FG001|Overall Study|Does not want to take study drug anymore|0|||
126408589|NCT00545103|454789824|FG002|Overall Study|Does not want to take study drug anymore|1|||
126408590|NCT00545103|454789825|FG003|Overall Study|Does not want to take study drug anymore|0|||
126408591|NCT00545103|454789822|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
126408592|NCT00545103|454789823|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
126408593|NCT00545103|454789824|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
126408594|NCT00545103|454789825|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
126408595|NCT00545103|454789822|FG000|Overall Study|Death|0|||
126408596|NCT00545103|454789823|FG001|Overall Study|Death|1|||
126408597|NCT00545103|454789824|FG002|Overall Study|Death|0|||
126408598|NCT00545103|454789825|FG003|Overall Study|Death|0|||
126408599|NCT01953913|454789826|FG000|Overall Study|Disease Progression|349|||
126408600|NCT01953913|454789826|FG000|Overall Study|Worsening of underlying cancer|22|||
126408601|NCT01953913|454789826|FG000|Overall Study|Adverse Event|20|||
126408602|NCT01953913|454789826|FG000|Overall Study|Protocol Violation|6|||
126408603|NCT01953913|454789826|FG000|Overall Study|Lost to Follow-up|4|||
126408604|NCT01953913|454789826|FG000|Overall Study|Withdrawal by Subject|32|||
126408605|NCT01953913|454789826|FG000|Overall Study|Other than listed|108|||
126408606|NCT01953913|454789826|FG000|Overall Study|Not Treated|1|||
126408607|NCT00082381|454789827|FG000|Overall Study|Adverse Event|27|||
126408608|NCT00082381|454789828|FG001|Overall Study|Adverse Event|2|||
126408609|NCT00082381|454789827|FG000|Overall Study|Lost to Follow-up|5|||
126408610|NCT00082381|454789828|FG001|Overall Study|Lost to Follow-up|7|||
126408611|NCT00082381|454789827|FG000|Overall Study|Patient Decision|8|||
126408612|NCT00082381|454789828|FG001|Overall Study|Patient Decision|4|||
126408613|NCT00082381|454789827|FG000|Overall Study|Physician Decision|1|||
126408614|NCT00082381|454789828|FG001|Overall Study|Physician Decision|2|||
126408615|NCT00082381|454789827|FG000|Overall Study|Protocol Violation|10|||
126408616|NCT00082381|454789828|FG001|Overall Study|Protocol Violation|11|||
126408617|NCT00082381|454789827|FG000|Overall Study|Loss of Glucose Control|4|||
126408618|NCT00082381|454789828|FG001|Overall Study|Loss of Glucose Control|0|||
126408619|NCT02049138|454789829|FG000|Overall Study|Adverse Event|46|||
126408620|NCT02049138|454789830|FG001|Overall Study|Adverse Event|25|||
126408621|NCT02049138|454789831|FG002|Overall Study|Adverse Event|1|||
126408622|NCT02049138|454789829|FG000|Overall Study|Withdrawal by Subject|57|||
126408623|NCT02049138|454789830|FG001|Overall Study|Withdrawal by Subject|21|||
126408624|NCT02049138|454789831|FG002|Overall Study|Withdrawal by Subject|5|||
126408625|NCT02049138|454789829|FG000|Overall Study|Lost to Follow-up|18|||
126408626|NCT02049138|454789830|FG001|Overall Study|Lost to Follow-up|5|||
126408627|NCT02049138|454789831|FG002|Overall Study|Lost to Follow-up|1|||
126408628|NCT02049138|454789829|FG000|Overall Study|Lack of Efficacy|10|||
126408629|NCT02049138|454789830|FG001|Overall Study|Lack of Efficacy|26|||
126408630|NCT02049138|454789831|FG002|Overall Study|Lack of Efficacy|1|||
126408631|NCT02049138|454789829|FG000|Overall Study|Non-Compliance|15|||
126408632|NCT02049138|454789830|FG001|Overall Study|Non-Compliance|6|||
126408633|NCT02049138|454789831|FG002|Overall Study|Non-Compliance|0|||
126408634|NCT02049138|454789829|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
126408635|NCT02049138|454789830|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
126408636|NCT02049138|454789831|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
126408637|NCT02049138|454789829|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
126408638|NCT02049138|454789830|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
126408639|NCT02049138|454789831|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
126408640|NCT02049138|454789829|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
126408641|NCT02049138|454789830|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
126408642|NCT02049138|454789831|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
126408643|NCT02049138|454789829|FG000|Overall Study|Other|15|||
126408644|NCT02049138|454789830|FG001|Overall Study|Other|13|||
126408645|NCT02049138|454789831|FG002|Overall Study|Other|0|||
126408646|NCT02049138|454789829|FG000|Overall Study|Missing|0|||
126408647|NCT02049138|454789830|FG001|Overall Study|Missing|1|||
126408648|NCT02049138|454789831|FG002|Overall Study|Missing|0|||
126408649|NCT00109577|454789832|FG000|Overall Study|Withdrawal by Subject|3|||
126408650|NCT00109577|454789833|FG001|Overall Study|Withdrawal by Subject|3|||
126408651|NCT00884832|454789834|FG000|Overall Study|Withdrawal by Subject|0|||
126408652|NCT00884832|454789835|FG001|Overall Study|Withdrawal by Subject|1|||
126408653|NCT02096263|454789836|FG000|Overall Study|Adverse Event|1|||
126408654|NCT02096263|454789837|FG001|Overall Study|Adverse Event|0|||
126408655|NCT02096263|454789838|FG002|Overall Study|Adverse Event|1|||
126408656|NCT02096263|454789836|FG000|Overall Study|Lost to Follow-up|14|||
126408657|NCT02096263|454789837|FG001|Overall Study|Lost to Follow-up|18|||
126408658|NCT02096263|454789838|FG002|Overall Study|Lost to Follow-up|15|||
126408659|NCT02096263|454789836|FG000|Overall Study|Other|7|||
126408660|NCT02096263|454789837|FG001|Overall Study|Other|9|||
126408661|NCT02096263|454789838|FG002|Overall Study|Other|6|||
126408662|NCT02096263|454789836|FG000|Overall Study|Sponsor study termination|0|||
126408663|NCT02096263|454789837|FG001|Overall Study|Sponsor study termination|0|||
126408664|NCT02096263|454789838|FG002|Overall Study|Sponsor study termination|1|||
126408665|NCT02096263|454789836|FG000|Overall Study|Protocol Violation|7|||
126408666|NCT02096263|454789837|FG001|Overall Study|Protocol Violation|2|||
126408667|NCT02096263|454789838|FG002|Overall Study|Protocol Violation|8|||
126408668|NCT02096263|454789836|FG000|Overall Study|Withdrawal by Subject|5|||
126408669|NCT02096263|454789837|FG001|Overall Study|Withdrawal by Subject|7|||
126408670|NCT02096263|454789838|FG002|Overall Study|Withdrawal by Subject|8|||
126408671|NCT03322423|454789839|FG000|Period 1|Subject no longer eligible|0|||
126408672|NCT03322423|454789840|FG001|Period 1|Subject no longer eligible|1|||
126408673|NCT03322423|454789839|FG000|Period 1|Withdrawal by Subject|0|||
126408674|NCT03322423|454789840|FG001|Period 1|Withdrawal by Subject|1|||
126408675|NCT03322423|454789839|FG000|Period 1|Incorrect Lens Dispensed|1|||
126408676|NCT03322423|454789840|FG001|Period 1|Incorrect Lens Dispensed|0|||
126408677|NCT03322423|454789839|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
126408678|NCT03322423|454789840|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
126408679|NCT03322423|454789839|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
126408680|NCT03322423|454789840|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
126408681|NCT03322423|454789839|FG000|Period 2|Protocol Violation|1|||
126558503|NCT00859014|455338771|FG000|Overall Study|Lost to Follow-up|1|||
126408682|NCT03322423|454789840|FG001|Period 2|Protocol Violation|0|||
126408683|NCT03322423|454789839|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
126408684|NCT03322423|454789840|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
126408685|NCT02337725|454789841|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
126408686|NCT02337725|454789842|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
126408687|NCT02337725|454789841|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
126408688|NCT02337725|454789842|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
126408689|NCT02337725|454789841|FG000|Overall Study|Major Protocol Deviation|0|||
126408690|NCT02337725|454789842|FG001|Overall Study|Major Protocol Deviation|1|||
126408691|NCT02337725|454789841|FG000|Overall Study|Voluntary Withdrawal|14|||
126408692|NCT02337725|454789842|FG001|Overall Study|Voluntary Withdrawal|3|||
126408693|NCT02337725|454789841|FG000|Overall Study|Lack of Efficacy|4|||
126408694|NCT02337725|454789842|FG001|Overall Study|Lack of Efficacy|0|||
126408695|NCT02453555|454789843|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
126408696|NCT02453555|454789844|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
126408697|NCT02453555|454789845|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
126408698|NCT02453555|454789846|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
126408699|NCT02453555|454789847|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
126408700|NCT02453555|454789848|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
126408701|NCT02453555|454789843|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
126408702|NCT02453555|454789844|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
126408703|NCT02453555|454789845|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
126408704|NCT02453555|454789846|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
126408705|NCT02453555|454789847|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
126408706|NCT02453555|454789848|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
126408707|NCT02453555|454789843|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
126408708|NCT02453555|454789844|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
126408709|NCT02453555|454789845|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126408710|NCT02453555|454789846|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126408711|NCT02453555|454789847|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126408712|NCT02453555|454789848|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126408713|NCT02453555|454789843|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
126408714|NCT02453555|454789844|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
126408715|NCT02453555|454789845|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
126408716|NCT02453555|454789846|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
126408717|NCT02453555|454789847|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
126408718|NCT02453555|454789848|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
126408719|NCT02453555|454789843|FG000|Extension Period|Adverse Event|0|||
126408720|NCT02453555|454789844|FG001|Extension Period|Adverse Event|0|||
126408721|NCT02453555|454789845|FG002|Extension Period|Adverse Event|1|||
126408722|NCT02453555|454789846|FG003|Extension Period|Adverse Event|2|||
126408723|NCT02453555|454789847|FG004|Extension Period|Adverse Event|1|||
126408724|NCT02453555|454789848|FG005|Extension Period|Adverse Event|1|||
126408725|NCT02453555|454789843|FG000|Extension Period|Protocol Violation|0|||
126408726|NCT02453555|454789844|FG001|Extension Period|Protocol Violation|0|||
126408727|NCT02453555|454789845|FG002|Extension Period|Protocol Violation|1|||
126408728|NCT02453555|454789846|FG003|Extension Period|Protocol Violation|0|||
126408729|NCT02453555|454789847|FG004|Extension Period|Protocol Violation|0|||
126408730|NCT02453555|454789848|FG005|Extension Period|Protocol Violation|0|||
126408731|NCT02453555|454789843|FG000|Extension Period|Withdrawal by Subject|0|||
126408732|NCT02453555|454789844|FG001|Extension Period|Withdrawal by Subject|0|||
126408733|NCT02453555|454789845|FG002|Extension Period|Withdrawal by Subject|1|||
126408734|NCT02453555|454789846|FG003|Extension Period|Withdrawal by Subject|0|||
126408735|NCT02453555|454789847|FG004|Extension Period|Withdrawal by Subject|0|||
126408736|NCT02453555|454789848|FG005|Extension Period|Withdrawal by Subject|0|||
126408737|NCT00500760|454789849|FG000|Overall Study|Death|32|||
126408738|NCT00500760|454789850|FG001|Overall Study|Death|15|||
126408739|NCT00500760|454789849|FG000|Overall Study|Withdrawal by Subject|5|||
126408740|NCT00500760|454789850|FG001|Overall Study|Withdrawal by Subject|7|||
126408741|NCT00500760|454789849|FG000|Overall Study|Administrative decision|2|||
126408742|NCT00500760|454789850|FG001|Overall Study|Administrative decision|0|||
126408743|NCT00500760|454789849|FG000|Overall Study|Lost to Follow-up|3|||
126408744|NCT00500760|454789850|FG001|Overall Study|Lost to Follow-up|0|||
126408745|NCT00500760|454789849|FG000|Overall Study|Other|1|||
126408746|NCT00500760|454789850|FG001|Overall Study|Other|2|||
126408747|NCT00129961|454789852|FG000|Overall Study|Adverse Event|1|||
126408748|NCT00129961|454789853|FG001|Overall Study|Adverse Event|0|||
126408749|NCT00129961|454789852|FG000|Overall Study|Death|1|||
126408750|NCT00129961|454789853|FG001|Overall Study|Death|1|||
126408751|NCT00129961|454789852|FG000|Overall Study|Withdrawal by Sponsor|14|||
126408752|NCT00129961|454789853|FG001|Overall Study|Withdrawal by Sponsor|20|||
126408753|NCT00129961|454789852|FG000|Overall Study|Physician Decision|1|||
126408754|NCT00129961|454789853|FG001|Overall Study|Physician Decision|0|||
126408755|NCT00129961|454789852|FG000|Overall Study|Withdrawal by Subject|2|||
126408756|NCT00129961|454789853|FG001|Overall Study|Withdrawal by Subject|1|||
126408757|NCT00129961|454789852|FG000|Overall Study|Missing Record|0|||
126408758|NCT00129961|454789853|FG001|Overall Study|Missing Record|1|||
126408759|NCT03178669|454789854|FG000|Overall Study|Adverse Event|4|||
126408760|NCT03178669|454789855|FG001|Overall Study|Adverse Event|1|||
126408761|NCT03178669|454789856|FG002|Overall Study|Adverse Event|4|||
126408762|NCT03178669|454789857|FG003|Overall Study|Adverse Event|2|||
126408763|NCT03178669|454789858|FG004|Overall Study|Adverse Event|2|||
126408764|NCT03178669|454789854|FG000|Overall Study|Lack of Efficacy|0|||
126408765|NCT03178669|454789855|FG001|Overall Study|Lack of Efficacy|0|||
126408766|NCT03178669|454789856|FG002|Overall Study|Lack of Efficacy|2|||
126408767|NCT03178669|454789857|FG003|Overall Study|Lack of Efficacy|0|||
126408768|NCT03178669|454789858|FG004|Overall Study|Lack of Efficacy|1|||
126408769|NCT03178669|454789854|FG000|Overall Study|Physician Decision|0|||
126408770|NCT03178669|454789855|FG001|Overall Study|Physician Decision|0|||
126408771|NCT03178669|454789856|FG002|Overall Study|Physician Decision|0|||
126408772|NCT03178669|454789857|FG003|Overall Study|Physician Decision|0|||
126408773|NCT03178669|454789858|FG004|Overall Study|Physician Decision|1|||
126408774|NCT03178669|454789854|FG000|Overall Study|Withdrawal by Subject|1|||
126408775|NCT03178669|454789855|FG001|Overall Study|Withdrawal by Subject|0|||
126408776|NCT03178669|454789856|FG002|Overall Study|Withdrawal by Subject|1|||
126408777|NCT03178669|454789857|FG003|Overall Study|Withdrawal by Subject|1|||
126408778|NCT03178669|454789858|FG004|Overall Study|Withdrawal by Subject|0|||
126408779|NCT03178669|454789854|FG000|Overall Study|Lost to Follow-up|0|||
126408780|NCT03178669|454789855|FG001|Overall Study|Lost to Follow-up|0|||
126408781|NCT03178669|454789856|FG002|Overall Study|Lost to Follow-up|0|||
126408782|NCT03178669|454789857|FG003|Overall Study|Lost to Follow-up|1|||
126408783|NCT03178669|454789858|FG004|Overall Study|Lost to Follow-up|0|||
126408784|NCT01600092|454789859|FG000|Overall Study|Adverse Event|2|||
126408785|NCT01600092|454789860|FG001|Overall Study|Adverse Event|0|||
126408786|NCT01600092|454789859|FG000|Overall Study|Lost to Follow-up|4|||
126408787|NCT01600092|454789860|FG001|Overall Study|Lost to Follow-up|6|||
126408788|NCT01600092|454789859|FG000|Overall Study|Withdrawal by parent/guardian|8|||
126408789|NCT01600092|454789860|FG001|Overall Study|Withdrawal by parent/guardian|6|||
126408790|NCT01600092|454789859|FG000|Overall Study|Physician Decision|1|||
126408791|NCT01600092|454789860|FG001|Overall Study|Physician Decision|1|||
126408792|NCT01600092|454789859|FG000|Overall Study|Randomized but not vaccinated|3|||
126408793|NCT01600092|454789860|FG001|Overall Study|Randomized but not vaccinated|3|||
126408794|NCT00079677|454789861|FG000|Overall Study|Adverse Event|5|||
126408795|NCT00079677|454789862|FG001|Overall Study|Adverse Event|6|||
126408796|NCT00079677|454789861|FG000|Overall Study|Lack of Efficacy|1|||
126408797|NCT00079677|454789862|FG001|Overall Study|Lack of Efficacy|0|||
126408798|NCT00079677|454789861|FG000|Overall Study|Lost to Follow-up|2|||
126408799|NCT00079677|454789862|FG001|Overall Study|Lost to Follow-up|2|||
126408800|NCT00079677|454789861|FG000|Overall Study|Physician Decision|3|||
126408801|NCT00079677|454789862|FG001|Overall Study|Physician Decision|0|||
126408802|NCT00079677|454789861|FG000|Overall Study|Protocol Violation|2|||
126408803|NCT00079677|454789862|FG001|Overall Study|Protocol Violation|3|||
126408804|NCT00079677|454789861|FG000|Overall Study|Withdrawal by Subject|5|||
126408805|NCT00079677|454789862|FG001|Overall Study|Withdrawal by Subject|3|||
126408806|NCT00079677|454789861|FG000|Overall Study|Miscellaneous|2|||
126408807|NCT00079677|454789862|FG001|Overall Study|Miscellaneous|0|||
126408808|NCT00565136|454789863|FG000|Overall Study|Lost to Follow-up|1|||
126408809|NCT00565136|454789863|FG000|Overall Study|Withdrawal by Subject|1|||
126408810|NCT00565136|454789863|FG000|Overall Study|Protocol Violation|1|||
126408811|NCT04284774|454789865|FG000|Overall Study|Progressive disease|5|||
126408812|NCT01270256|454789866|FG000|Overall Study|Withdrawal by Subject|1|||
126408813|NCT01270256|454789867|FG001|Overall Study|Withdrawal by Subject|0|||
126408814|NCT02879578|454789868|FG000|Overall Study|Adverse Event|1|||
126408815|NCT02879578|454789869|FG001|Overall Study|Adverse Event|2|||
126408816|NCT02879578|454789870|FG002|Overall Study|Adverse Event|14|||
126408817|NCT02879578|454789868|FG000|Overall Study|Protocol Violation|0|||
126408818|NCT02879578|454789869|FG001|Overall Study|Protocol Violation|1|||
126408819|NCT02879578|454789870|FG002|Overall Study|Protocol Violation|1|||
126408820|NCT02879578|454789868|FG000|Overall Study|Withdrawal by Subject|8|||
126408821|NCT02879578|454789869|FG001|Overall Study|Withdrawal by Subject|6|||
126408822|NCT02879578|454789870|FG002|Overall Study|Withdrawal by Subject|9|||
126408823|NCT02879578|454789868|FG000|Overall Study|Lost to Follow-up|1|||
126408824|NCT02879578|454789869|FG001|Overall Study|Lost to Follow-up|0|||
126408825|NCT02879578|454789870|FG002|Overall Study|Lost to Follow-up|4|||
126408826|NCT02879578|454789868|FG000|Overall Study|Physician Decision|0|||
126408827|NCT02879578|454789869|FG001|Overall Study|Physician Decision|0|||
126408828|NCT02879578|454789870|FG002|Overall Study|Physician Decision|4|||
126408829|NCT02925728|454789876|FG000|Overall Study|Death|3|||
126408830|NCT02925728|454789877|FG001|Overall Study|Death|5|||
126408831|NCT02925728|454789876|FG000|Overall Study|Physician Decision|1|||
126473838|NCT03307785|455034614|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
126473839|NCT03307785|455034615|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
126408832|NCT02925728|454789877|FG001|Overall Study|Physician Decision|0|||
126408833|NCT02925728|454789876|FG000|Overall Study|Withdrawal by Subject|1|||
126408834|NCT02925728|454789877|FG001|Overall Study|Withdrawal by Subject|0|||
126408835|NCT05098509|454789878|FG000|Overall Study|Withdrawal by Subject|0|||
126408836|NCT05098509|454789879|FG001|Overall Study|Withdrawal by Subject|0|||
126408837|NCT05098509|454789880|FG002|Overall Study|Withdrawal by Subject|1|||
126408838|NCT05098509|454789881|FG003|Overall Study|Withdrawal by Subject|0|||
126408839|NCT05098509|454789878|FG000|Overall Study|Early study termination|1|||
126408840|NCT05098509|454789879|FG001|Overall Study|Early study termination|1|||
126408841|NCT05098509|454789880|FG002|Overall Study|Early study termination|1|||
126408842|NCT05098509|454789881|FG003|Overall Study|Early study termination|0|||
126408843|NCT02986854|454789883|FG000|Overall Study|Withdrawal by Subject|0|||
126408844|NCT02986854|454789884|FG001|Overall Study|Withdrawal by Subject|1|||
126408845|NCT02986854|454789885|FG002|Overall Study|Withdrawal by Subject|1|||
126408846|NCT02986854|454789883|FG000|Overall Study|Lost to Follow-up|3|||
126408847|NCT02986854|454789884|FG001|Overall Study|Lost to Follow-up|11|||
126408848|NCT02986854|454789885|FG002|Overall Study|Lost to Follow-up|2|||
126408849|NCT00324233|454789886|FG000|First Period|unable to insert catheter|1|||
126408850|NCT00324233|454789887|FG001|First Period|unable to insert catheter|0|||
126408851|NCT00324233|454789886|FG000|Second Period|unable to insert catheter|1|||
126408852|NCT00324233|454789887|FG001|Second Period|unable to insert catheter|1|||
126408853|NCT00324233|454789886|FG000|Second Period|Protocol Violation|4|||
126408854|NCT00324233|454789887|FG001|Second Period|Protocol Violation|6|||
126408855|NCT00086411|454789899|FG000|Overall Study|Lost to Follow-up|11|||
126408856|NCT00086411|454789900|FG001|Overall Study|Lost to Follow-up|11|||
126408857|NCT00086411|454789901|FG002|Overall Study|Lost to Follow-up|13|||
126408858|NCT00086411|454789902|FG003|Overall Study|Lost to Follow-up|12|||
126408859|NCT01740401|454791683|FG000|Overall Study|Progression of disease|6|||
126408860|NCT01740401|454791683|FG000|Overall Study|Adverse Event|2|||
126408861|NCT01740401|454791683|FG000|Overall Study|Did not reach primary endpoint|2|||
126408862|NCT03667690|454791684|FG000|Overall Study|Adverse Event|0|||
126408863|NCT03667690|454791685|FG001|Overall Study|Adverse Event|3|||
126408864|NCT03667690|454791684|FG000|Overall Study|Death|22|||
126408865|NCT03667690|454791685|FG001|Overall Study|Death|21|||
126408866|NCT03667690|454791684|FG000|Overall Study|Lost to Follow-up|4|||
126408867|NCT03667690|454791685|FG001|Overall Study|Lost to Follow-up|5|||
126408868|NCT03667690|454791684|FG000|Overall Study|Withdrawal by Subject|7|||
126408869|NCT03667690|454791685|FG001|Overall Study|Withdrawal by Subject|8|||
126408870|NCT03667690|454791684|FG000|Overall Study|Subject could not return for additional investigational product|1|||
126408871|NCT03667690|454791685|FG001|Overall Study|Subject could not return for additional investigational product|0|||
126408872|NCT03667690|454791684|FG000|Overall Study|Subject discharged to hospice care|2|||
126408873|NCT03667690|454791685|FG001|Overall Study|Subject discharged to hospice care|0|||
126408874|NCT03667690|454791684|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
126408875|NCT03667690|454791685|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
126408876|NCT03667690|454791684|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
126408877|NCT03667690|454791685|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
126408878|NCT03667690|454791684|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
126408879|NCT03667690|454791685|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
126408880|NCT03667690|454791684|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
126408881|NCT03667690|454791685|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
126408882|NCT03667690|454791684|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
126408883|NCT03667690|454791685|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
126408884|NCT03495102|454791686|FG000|Overall Study|Adverse Event|5|||
126408885|NCT03495102|454791687|FG001|Overall Study|Adverse Event|7|||
126408886|NCT03495102|454791688|FG002|Overall Study|Adverse Event|10|||
126408887|NCT03495102|454791686|FG000|Overall Study|Death|3|||
126408888|NCT03495102|454791687|FG001|Overall Study|Death|4|||
126408889|NCT03495102|454791688|FG002|Overall Study|Death|4|||
126408890|NCT03495102|454791686|FG000|Overall Study|Lost to Follow-up|15|||
126408891|NCT03495102|454791687|FG001|Overall Study|Lost to Follow-up|16|||
126408892|NCT03495102|454791688|FG002|Overall Study|Lost to Follow-up|17|||
126408893|NCT03495102|454791686|FG000|Overall Study|Physician Decision|2|||
126408894|NCT03495102|454791687|FG001|Overall Study|Physician Decision|0|||
126408895|NCT03495102|454791688|FG002|Overall Study|Physician Decision|2|||
126408896|NCT03495102|454791686|FG000|Overall Study|Withdrawal by Subject|25|||
126408897|NCT03495102|454791687|FG001|Overall Study|Withdrawal by Subject|36|||
126408898|NCT03495102|454791688|FG002|Overall Study|Withdrawal by Subject|18|||
126408899|NCT03495102|454791686|FG000|Overall Study|Protocol Violation|1|||
126408900|NCT03495102|454791687|FG001|Overall Study|Protocol Violation|1|||
126408901|NCT03495102|454791688|FG002|Overall Study|Protocol Violation|0|||
126408902|NCT03495102|454791686|FG000|Overall Study|Site Closure|3|||
126408903|NCT03495102|454791687|FG001|Overall Study|Site Closure|1|||
126408904|NCT03495102|454791688|FG002|Overall Study|Site Closure|2|||
126408905|NCT03495102|454791686|FG000|Overall Study|Non-compliance|1|||
126408906|NCT03495102|454791687|FG001|Overall Study|Non-compliance|0|||
126408907|NCT03495102|454791688|FG002|Overall Study|Non-compliance|0|||
126408908|NCT03495102|454791686|FG000|Overall Study|Participant Duplicated at Another Site|0|||
126408909|NCT03495102|454791687|FG001|Overall Study|Participant Duplicated at Another Site|0|||
126408910|NCT03495102|454791688|FG002|Overall Study|Participant Duplicated at Another Site|1|||
126408911|NCT03495102|454791686|FG000|Overall Study|Primary Care Physician Recommendation|0|||
126408912|NCT03495102|454791687|FG001|Overall Study|Primary Care Physician Recommendation|1|||
126408913|NCT03495102|454791688|FG002|Overall Study|Primary Care Physician Recommendation|0|||
126408914|NCT03495102|454791686|FG000|Overall Study|Relocated to Another Country|0|||
126408915|NCT03495102|454791687|FG001|Overall Study|Relocated to Another Country|1|||
126408916|NCT03495102|454791688|FG002|Overall Study|Relocated to Another Country|0|||
126408917|NCT03495102|454791686|FG000|Overall Study|Participant was in Rehabilitation|1|||
126408918|NCT03495102|454791687|FG001|Overall Study|Participant was in Rehabilitation|0|||
126408919|NCT03495102|454791688|FG002|Overall Study|Participant was in Rehabilitation|0|||
126408920|NCT01161537|454791690|FG000|Part B|Withdrawal by Subject|2|||
126408921|NCT00321464|454791693|FG000|Overall Study|Death|169|||
126408922|NCT00321464|454791694|FG001|Overall Study|Death|174|||
126408923|NCT00321464|454791693|FG000|Overall Study|Disease progression|124|||
126408924|NCT00321464|454791694|FG001|Overall Study|Disease progression|124|||
126408925|NCT00321464|454791693|FG000|Overall Study|Withdrawal by Subject|117|||
126408926|NCT00321464|454791694|FG001|Overall Study|Withdrawal by Subject|118|||
126408927|NCT00321464|454791693|FG000|Overall Study|Participant request|57|||
126408928|NCT00321464|454791694|FG001|Overall Study|Participant request|61|||
126408929|NCT00321464|454791693|FG000|Overall Study|Adverse Event|43|||
126408930|NCT00321464|454791694|FG001|Overall Study|Adverse Event|28|||
126408931|NCT00321464|454791693|FG000|Overall Study|Physician Decision|15|||
126408932|NCT00321464|454791694|FG001|Overall Study|Physician Decision|14|||
126408933|NCT00321464|454791693|FG000|Overall Study|Noncompliance|4|||
126408934|NCT00321464|454791694|FG001|Overall Study|Noncompliance|10|||
126408935|NCT00321464|454791693|FG000|Overall Study|Lost to Follow-up|7|||
126473840|NCT03307785|455034605|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
126473841|NCT03307785|455034606|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
126408936|NCT00321464|454791694|FG001|Overall Study|Lost to Follow-up|8|||
126408937|NCT00321464|454791693|FG000|Overall Study|Protocol deviation|0|||
126408938|NCT00321464|454791694|FG001|Overall Study|Protocol deviation|2|||
126408939|NCT00321464|454791693|FG000|Overall Study|Ineligibility determined|2|||
126408940|NCT00321464|454791694|FG001|Overall Study|Ineligibility determined|1|||
126408941|NCT00321464|454791693|FG000|Overall Study|Other|21|||
126408942|NCT00321464|454791694|FG001|Overall Study|Other|18|||
126408943|NCT02593825|454791695|FG000|Intervention|Lost to Follow-up|10|||
126473842|NCT03307785|455034607|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
126473843|NCT03307785|455034608|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
126473844|NCT03307785|455034609|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
126473845|NCT03307785|455034610|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
126473846|NCT03307785|455034611|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
126473847|NCT03307785|455034612|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
126473848|NCT03307785|455034613|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
126473849|NCT03307785|455034614|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
126473850|NCT03307785|455034615|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
126473851|NCT03307785|455034605|FG000|Part C: Up to Approx. 60 Months|Death|0|||
126473852|NCT03307785|455034606|FG001|Part C: Up to Approx. 60 Months|Death|0|||
126473853|NCT03307785|455034607|FG002|Part C: Up to Approx. 60 Months|Death|0|||
126473854|NCT03307785|455034608|FG003|Part C: Up to Approx. 60 Months|Death|2|||
126558504|NCT04796935|455338772|FG000|Overall Study|Withdrawal by Subject|0|||
126558505|NCT04796935|455338773|FG001|Overall Study|Withdrawal by Subject|1|||
126558506|NCT04796935|455338772|FG000|Overall Study|Physician Decision|0|||
126558507|NCT04796935|455338773|FG001|Overall Study|Physician Decision|1|||
126558508|NCT04796935|455338772|FG000|Overall Study|Device not available|1|||
126558509|NCT04796935|455338773|FG001|Overall Study|Device not available|0|||
126558510|NCT04796935|455338772|FG000|Overall Study|Trained provider not available|1|||
126558511|NCT04796935|455338773|FG001|Overall Study|Trained provider not available|0|||
126558512|NCT00783718|455338774|FG000|Induction Phase|Adverse Event|4|||
126558513|NCT00783718|455338775|FG001|Induction Phase|Adverse Event|0|||
126558514|NCT00783718|455338776|FG002|Induction Phase|Adverse Event|7|||
126558515|NCT00783718|455338777|FG003|Induction Phase|Adverse Event|0|||
126558516|NCT00783718|455338778|FG004|Induction Phase|Adverse Event|0|||
126558517|NCT00783718|455338779|FG005|Induction Phase|Adverse Event|0|||
126558518|NCT00783718|455338780|FG006|Induction Phase|Adverse Event|0|||
126558519|NCT00783718|455338774|FG000|Induction Phase|Protocol Violation|1|||
126558520|NCT00783718|455338775|FG001|Induction Phase|Protocol Violation|1|||
126408944|NCT02593825|454791696|FG001|Intervention|Lost to Follow-up|12|||
126408945|NCT02522325|454791697|FG000|Overall Study|Adverse Event|0|||
126408946|NCT02522325|454791698|FG001|Overall Study|Adverse Event|1|||
126408947|NCT01209078|454791699|FG000|Overall Study|Adverse Event|5|||
126408948|NCT01209078|454791700|FG001|Overall Study|Adverse Event|0|||
126408949|NCT01209078|454791699|FG000|Overall Study|Lost to Follow-up|4|||
126408950|NCT01209078|454791700|FG001|Overall Study|Lost to Follow-up|0|||
126408951|NCT01209078|454791699|FG000|Overall Study|Physician Decision|5|||
126473855|NCT03307785|455034609|FG004|Part C: Up to Approx. 60 Months|Death|5|||
126558521|NCT00783718|455338776|FG002|Induction Phase|Protocol Violation|6|||
126558522|NCT00783718|455338777|FG003|Induction Phase|Protocol Violation|0|||
126558523|NCT00783718|455338778|FG004|Induction Phase|Protocol Violation|0|||
126408952|NCT01209078|454791700|FG001|Overall Study|Physician Decision|2|||
126408953|NCT01209078|454791699|FG000|Overall Study|Withdrawal by Subject|2|||
126558524|NCT00783718|455338779|FG005|Induction Phase|Protocol Violation|0|||
126408954|NCT01209078|454791700|FG001|Overall Study|Withdrawal by Subject|1|||
126408955|NCT00924508|454791701|FG000|Overall Study|Withdrawal by Subject|3|||
126408956|NCT00495625|454791704|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
126408957|NCT01912339|454791705|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
126408958|NCT01912339|454791706|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
126408959|NCT01912339|454791707|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
126408960|NCT01912339|454791705|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
126408961|NCT01912339|454791706|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
126408962|NCT01912339|454791707|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
126408963|NCT01912339|454791705|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
126408964|NCT01912339|454791706|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
126408965|NCT01912339|454791707|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
126408966|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
126408967|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
126408968|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
126408969|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
126408970|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
126408971|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
126473856|NCT03307785|455034610|FG005|Part C: Up to Approx. 60 Months|Death|0|||
126473857|NCT03307785|455034611|FG006|Part C: Up to Approx. 60 Months|Death|0|||
126473858|NCT03307785|455034612|FG007|Part C: Up to Approx. 60 Months|Death|0|||
126473859|NCT03307785|455034613|FG008|Part C: Up to Approx. 60 Months|Death|0|||
126473860|NCT03307785|455034614|FG009|Part C: Up to Approx. 60 Months|Death|0|||
126473861|NCT03307785|455034615|FG010|Part C: Up to Approx. 60 Months|Death|0|||
126473862|NCT03307785|455034605|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
126473863|NCT03307785|455034606|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
126473864|NCT03307785|455034607|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
126473865|NCT03307785|455034608|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
126473866|NCT03307785|455034609|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
126473867|NCT03307785|455034610|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
126473868|NCT03307785|455034611|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
126473869|NCT03307785|455034612|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
126473870|NCT03307785|455034613|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
126473871|NCT03307785|455034614|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
126473872|NCT03307785|455034615|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
126473873|NCT03307785|455034605|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
126473874|NCT03307785|455034606|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
126473875|NCT03307785|455034607|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
126473876|NCT03307785|455034608|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
126473877|NCT03307785|455034609|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
126473878|NCT03307785|455034610|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
126473879|NCT03307785|455034611|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
126473880|NCT03307785|455034612|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
126473881|NCT03307785|455034613|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
126473882|NCT03307785|455034614|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
126473883|NCT03307785|455034615|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
126473884|NCT03307785|455034605|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
126473885|NCT03307785|455034606|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
126473886|NCT03307785|455034607|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
126473887|NCT03307785|455034608|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
126473888|NCT03307785|455034609|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
126473889|NCT03307785|455034610|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
126473890|NCT03307785|455034611|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
126473891|NCT03307785|455034612|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
126473892|NCT03307785|455034613|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
126473893|NCT03307785|455034614|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
126473894|NCT03307785|455034615|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
126473895|NCT03307785|455034605|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
126473896|NCT03307785|455034606|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
126473897|NCT03307785|455034607|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
126473898|NCT03307785|455034608|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
126473899|NCT03307785|455034609|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
126772331|NCT04440007|456122089|FG001|Overall Study|Discontinued prior to dosing|2|||
126408972|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
126473900|NCT03307785|455034610|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
126473901|NCT03307785|455034611|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
126473902|NCT03307785|455034612|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
126408973|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
126721425|NCT00195260|455929972|FG004|Part 1: Dose Escalation|Adverse Event|1|||
126721426|NCT00195260|455929973|FG005|Part 1: Dose Escalation|Adverse Event|0|||
126721427|NCT00195260|455929974|FG006|Part 1: Dose Escalation|Adverse Event|3|||
126721428|NCT00195260|455929975|FG007|Part 1: Dose Escalation|Adverse Event|0|||
126721429|NCT00195260|455929976|FG008|Part 1: Dose Escalation|Adverse Event|0|||
126721430|NCT00195260|455929977|FG009|Part 1: Dose Escalation|Adverse Event|0|||
126408974|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
126408975|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
126408976|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
126408977|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
126408978|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
126408979|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
126408980|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
126408981|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
126408982|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
126408983|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
126408984|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
126408985|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
126408986|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
126408987|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
126408988|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
126408989|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
126408990|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
126408991|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
126408992|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
126408993|NCT01912339|454791705|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
126408994|NCT01912339|454791706|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
126408995|NCT01912339|454791707|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
126408996|NCT01754493|454791709|FG000|Overall Study|Adverse Event|1|||
126408997|NCT01754493|454791709|FG000|Overall Study|Lost to Follow-up|3|||
126408998|NCT01754493|454791709|FG000|Overall Study|Withdrawal by Subject|1|||
126408999|NCT01754493|454791709|FG000|Overall Study|Moved out of town|1|||
126409000|NCT01754493|454791709|FG000|Overall Study|Scheduling conflict|1|||
126409001|NCT03464019|454791710|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
126409002|NCT03464019|454791711|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
126409003|NCT03464019|454791712|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
126409004|NCT03464019|454791710|FG000|NODE-301 Part 1|Ablation|0|||
126409005|NCT03464019|454791711|FG001|NODE-301 Part 1|Ablation|0|||
126409006|NCT03464019|454791712|FG002|NODE-301 Part 1|Ablation|16|||
126409007|NCT03464019|454791710|FG000|NODE-301 Part 1|Test Dose Failure|0|||
126409008|NCT03464019|454791711|FG001|NODE-301 Part 1|Test Dose Failure|0|||
126409009|NCT03464019|454791712|FG002|NODE-301 Part 1|Test Dose Failure|8|||
126409010|NCT03464019|454791710|FG000|NODE-301 Part 1|Adverse Event|0|||
126409011|NCT03464019|454791711|FG001|NODE-301 Part 1|Adverse Event|0|||
126409012|NCT03464019|454791712|FG002|NODE-301 Part 1|Adverse Event|5|||
126409013|NCT03464019|454791710|FG000|NODE-301 Part 1|Physician Decision|0|||
126409014|NCT03464019|454791711|FG001|NODE-301 Part 1|Physician Decision|0|||
126409015|NCT03464019|454791712|FG002|NODE-301 Part 1|Physician Decision|4|||
126409016|NCT03464019|454791710|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
126409017|NCT03464019|454791711|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
126409018|NCT03464019|454791712|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
126409019|NCT03464019|454791710|FG000|NODE-301 Part 1|Protocol Violation|0|||
126409020|NCT03464019|454791711|FG001|NODE-301 Part 1|Protocol Violation|0|||
126721431|NCT00195260|455929978|FG010|Part 1: Dose Escalation|Adverse Event|0|||
126721432|NCT00195260|455929968|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126721433|NCT00195260|455929969|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126721434|NCT00195260|455929970|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126721435|NCT00195260|455929971|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126721436|NCT00195260|455929972|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
126409021|NCT03464019|454791712|FG002|NODE-301 Part 1|Protocol Violation|2|||
126409022|NCT03464019|454791710|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
126409023|NCT03464019|454791711|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
126409024|NCT03464019|454791712|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
126409025|NCT03464019|454791710|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
126409026|NCT03464019|454791711|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
126409027|NCT03464019|454791712|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
126409028|NCT03464019|454791710|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
126409029|NCT03464019|454791711|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
126721437|NCT00195260|455929973|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126409030|NCT03464019|454791712|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
126409031|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
126409032|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
126409033|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
126409034|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
126409035|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
126409036|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
126409037|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
126409038|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
126409039|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
126409040|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
126409041|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
126409042|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
126409043|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
126409044|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
126409045|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
126409046|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
126409047|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
126409048|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
126409049|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
126409050|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
126409051|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
126409052|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
126409053|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
126409054|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
126409055|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
126409056|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
126409057|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
126409058|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
126409059|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
126409060|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
126409061|NCT03464019|454791710|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
126409062|NCT03464019|454791711|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
126409063|NCT03464019|454791712|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
126409064|NCT00511134|454791713|FG000|Overall Study|Withdrawal by Subject|0|||
126409065|NCT00511134|454791714|FG001|Overall Study|Withdrawal by Subject|2|||
126409066|NCT01949090|454791715|FG000|Overall Study|Serious Adverse Event|0|||
126409067|NCT01949090|454791716|FG001|Overall Study|Serious Adverse Event|1|||
126409068|NCT01949090|454791717|FG002|Overall Study|Serious Adverse Event|2|||
126409069|NCT01949090|454791718|FG003|Overall Study|Serious Adverse Event|0|||
126409070|NCT01949090|454791719|FG004|Overall Study|Serious Adverse Event|1|||
126409071|NCT01949090|454791715|FG000|Overall Study|Withdrawal by Subject|2|||
126409072|NCT01949090|454791716|FG001|Overall Study|Withdrawal by Subject|0|||
126409073|NCT01949090|454791717|FG002|Overall Study|Withdrawal by Subject|0|||
126409074|NCT01949090|454791718|FG003|Overall Study|Withdrawal by Subject|0|||
126409075|NCT01949090|454791719|FG004|Overall Study|Withdrawal by Subject|1|||
126409076|NCT01949090|454791715|FG000|Overall Study|Protocol non-compliance|0|||
126409077|NCT01949090|454791716|FG001|Overall Study|Protocol non-compliance|0|||
126409078|NCT01949090|454791717|FG002|Overall Study|Protocol non-compliance|0|||
126409079|NCT01949090|454791718|FG003|Overall Study|Protocol non-compliance|0|||
126409080|NCT01949090|454791719|FG004|Overall Study|Protocol non-compliance|1|||
126409081|NCT01949090|454791715|FG000|Overall Study|Lost to Follow-up|2|||
126409082|NCT01949090|454791716|FG001|Overall Study|Lost to Follow-up|1|||
126409083|NCT01949090|454791717|FG002|Overall Study|Lost to Follow-up|0|||
126409084|NCT01949090|454791718|FG003|Overall Study|Lost to Follow-up|1|||
126409085|NCT01949090|454791719|FG004|Overall Study|Lost to Follow-up|1|||
126409086|NCT03459365|454791720|FG000|Overall Study|Withdrawal by Subject|6|||
126409087|NCT03459365|454791720|FG000|Overall Study|Protocol Violation|8|||
126409088|NCT01543776|454791721|FG000|Overall Study|Withdrawal by Subject|2|||
126409089|NCT01543776|454791722|FG001|Overall Study|Withdrawal by Subject|2|||
126409090|NCT00785980|454791725|FG000|7 Day Washout Period|Protocol Violation|3|||
126409091|NCT03055013|454791726|FG000|Overall Study|Adverse Event|78|||
126409092|NCT03055013|454791727|FG001|Overall Study|Adverse Event|0|||
126409093|NCT03055013|454791726|FG000|Overall Study|Death|6|||
126409094|NCT03055013|454791727|FG001|Overall Study|Death|0|||
126409095|NCT03055013|454791726|FG000|Overall Study|Disease relapse|33|||
126409096|NCT03055013|454791727|FG001|Overall Study|Disease relapse|0|||
126409097|NCT03055013|454791726|FG000|Overall Study|Withdrawal by Subject|28|||
126409098|NCT03055013|454791727|FG001|Overall Study|Withdrawal by Subject|0|||
126409099|NCT03055013|454791726|FG000|Overall Study|Other complicating disease|5|||
126409100|NCT03055013|454791727|FG001|Overall Study|Other complicating disease|0|||
126558525|NCT00783718|455338780|FG006|Induction Phase|Protocol Violation|0|||
126409101|NCT03055013|454791726|FG000|Overall Study|Physician Decision|1|||
126409102|NCT03055013|454791727|FG001|Overall Study|Physician Decision|0|||
126409103|NCT03055013|454791726|FG000|Overall Study|Benign mass/non-RCC|4|||
126409104|NCT03055013|454791727|FG001|Overall Study|Benign mass/non-RCC|0|||
126409105|NCT03055013|454791726|FG000|Overall Study|Enrolled in another trial|1|||
126409106|NCT03055013|454791727|FG001|Overall Study|Enrolled in another trial|0|||
126409107|NCT03055013|454791726|FG000|Overall Study|Non-protocol therapy|1|||
126409108|NCT03055013|454791727|FG001|Overall Study|Non-protocol therapy|0|||
126409109|NCT03055013|454791726|FG000|Overall Study|Incompliance|1|||
126409110|NCT03055013|454791727|FG001|Overall Study|Incompliance|0|||
126409111|NCT03055013|454791726|FG000|Overall Study|Insurance issues|1|||
126409112|NCT03055013|454791727|FG001|Overall Study|Insurance issues|0|||
126409113|NCT03055013|454791726|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
126409114|NCT03055013|454791727|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
126409115|NCT03055013|454791726|FG000|Overall Study|Did not receive nivolumab|10|||
126409116|NCT03055013|454791727|FG001|Overall Study|Did not receive nivolumab|0|||
126409117|NCT03055013|454791726|FG000|Overall Study|Did not receive surgery|0|||
126409118|NCT03055013|454791727|FG001|Overall Study|Did not receive surgery|28|||
126409119|NCT00528801|454791728|FG000|Overall Study|Withdrawal by Subject|1|||
126409120|NCT00528801|454791729|FG001|Overall Study|Withdrawal by Subject|1|||
126409121|NCT00528801|454791728|FG000|Overall Study|Protocol Violation|11|||
126409122|NCT00528801|454791729|FG001|Overall Study|Protocol Violation|5|||
126409123|NCT00528801|454791728|FG000|Overall Study|Lost to Follow-up|15|||
126409124|NCT00528801|454791729|FG001|Overall Study|Lost to Follow-up|4|||
126409125|NCT00528801|454791728|FG000|Overall Study|Administrative Reasons|0|||
126409126|NCT00528801|454791729|FG001|Overall Study|Administrative Reasons|1|||
126409127|NCT00344500|454791730|FG000|Overall Study|Adverse Event|6|||
126409128|NCT00344500|454791731|FG001|Overall Study|Adverse Event|2|||
126409129|NCT00344500|454791732|FG002|Overall Study|Adverse Event|0|||
126409130|NCT00344500|454791730|FG000|Overall Study|Lost to Follow-up|5|||
126409131|NCT00344500|454791731|FG001|Overall Study|Lost to Follow-up|13|||
126409132|NCT00344500|454791732|FG002|Overall Study|Lost to Follow-up|1|||
126409133|NCT00344500|454791730|FG000|Overall Study|Withdrawal by Subject|7|||
126409134|NCT00344500|454791731|FG001|Overall Study|Withdrawal by Subject|10|||
126409135|NCT00344500|454791732|FG002|Overall Study|Withdrawal by Subject|0|||
126409136|NCT00344500|454791730|FG000|Overall Study|Protocol Violation|4|||
126409137|NCT00344500|454791731|FG001|Overall Study|Protocol Violation|7|||
126409138|NCT00344500|454791732|FG002|Overall Study|Protocol Violation|1|||
126409139|NCT00344500|454791730|FG000|Overall Study|Not Noted|1|||
126409140|NCT00344500|454791731|FG001|Overall Study|Not Noted|3|||
126409141|NCT00344500|454791732|FG002|Overall Study|Not Noted|0|||
126409142|NCT02207491|454791733|FG000|Overall Study|Adverse Event|20|||
126409143|NCT02207491|454791734|FG001|Overall Study|Adverse Event|4|||
126409144|NCT02207491|454791733|FG000|Overall Study|Withdrawal by Subject|3|||
126409145|NCT02207491|454791734|FG001|Overall Study|Withdrawal by Subject|2|||
126409146|NCT02207491|454791733|FG000|Overall Study|Non-compliant|0|||
126409147|NCT02207491|454791734|FG001|Overall Study|Non-compliant|1|||
126409148|NCT02207491|454791733|FG000|Overall Study|Lost to Follow-up|0|||
126409149|NCT02207491|454791734|FG001|Overall Study|Lost to Follow-up|1|||
126409150|NCT02207491|454791733|FG000|Overall Study|Lack of Efficacy|3|||
126409151|NCT02207491|454791734|FG001|Overall Study|Lack of Efficacy|0|||
126409152|NCT02207491|454791733|FG000|Overall Study|Physician Decision|2|||
126409153|NCT02207491|454791734|FG001|Overall Study|Physician Decision|0|||
126409154|NCT02207491|454791733|FG000|Overall Study|Protocol Violation|3|||
126409155|NCT02207491|454791734|FG001|Overall Study|Protocol Violation|5|||
126409156|NCT00126776|454791735|FG000|Overall Study|follow up complete on all patients|0|||
126409157|NCT00126776|454791736|FG001|Overall Study|follow up complete on all patients|0|||
126409158|NCT00599755|454791737|FG000|Overall Study|Adverse Event|11|||
126409159|NCT00599755|454791737|FG000|Overall Study|Withdrawal by Subject|2|||
126409160|NCT00599755|454791737|FG000|Overall Study|Progression of Disease|3|||
126721438|NCT00195260|455929974|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126721439|NCT00195260|455929975|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
126409161|NCT00599755|454791737|FG000|Overall Study|Other Reason|2|||
126409162|NCT00599755|454791737|FG000|Overall Study|No data available|1|||
126721440|NCT00195260|455929976|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126721441|NCT00195260|455929977|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126721442|NCT00195260|455929978|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126721443|NCT00195260|455929968|FG000|Part 1: Dose Escalation|Death|0|||
126409163|NCT03626545|454791741|FG000|Overall Study|Progressive disease|3|||
126409164|NCT03626545|454791742|FG001|Overall Study|Progressive disease|82|||
126409165|NCT03626545|454791743|FG002|Overall Study|Progressive disease|85|||
126409166|NCT03626545|454791741|FG000|Overall Study|Adverse Event|3|||
126409167|NCT03626545|454791742|FG001|Overall Study|Adverse Event|13|||
126409168|NCT03626545|454791743|FG002|Overall Study|Adverse Event|10|||
126409169|NCT03626545|454791741|FG000|Overall Study|Physician Decision|1|||
126409170|NCT03626545|454791742|FG001|Overall Study|Physician Decision|18|||
126409171|NCT03626545|454791743|FG002|Overall Study|Physician Decision|14|||
126409172|NCT03626545|454791741|FG000|Overall Study|Subject Decision|0|||
126409173|NCT03626545|454791742|FG001|Overall Study|Subject Decision|5|||
126409174|NCT03626545|454791743|FG002|Overall Study|Subject Decision|5|||
126409175|NCT03626545|454791741|FG000|Overall Study|Death|1|||
126409176|NCT03626545|454791742|FG001|Overall Study|Death|1|||
126409177|NCT03626545|454791743|FG002|Overall Study|Death|1|||
126409178|NCT03626545|454791741|FG000|Overall Study|Protocol Deviation|0|||
126409179|NCT03626545|454791742|FG001|Overall Study|Protocol Deviation|1|||
126409180|NCT03626545|454791743|FG002|Overall Study|Protocol Deviation|1|||
126409181|NCT03626545|454791741|FG000|Overall Study|Guardian Decision|0|||
126409182|NCT03626545|454791742|FG001|Overall Study|Guardian Decision|0|||
126409183|NCT03626545|454791743|FG002|Overall Study|Guardian Decision|1|||
126409184|NCT01939366|454791745|FG000|Overall Study|Adverse Event|8|||
126409185|NCT01939366|454791746|FG001|Overall Study|Adverse Event|17|||
126409186|NCT01939366|454791747|FG002|Overall Study|Adverse Event|30|||
126409187|NCT01939366|454791748|FG003|Overall Study|Adverse Event|8|||
126409188|NCT01939366|454791749|FG004|Overall Study|Adverse Event|5|||
126409189|NCT01939366|454791745|FG000|Overall Study|Lack of Efficacy|2|||
126409190|NCT01939366|454791746|FG001|Overall Study|Lack of Efficacy|1|||
126409191|NCT01939366|454791747|FG002|Overall Study|Lack of Efficacy|1|||
126409192|NCT01939366|454791748|FG003|Overall Study|Lack of Efficacy|1|||
126409193|NCT01939366|454791749|FG004|Overall Study|Lack of Efficacy|3|||
126409194|NCT01939366|454791745|FG000|Overall Study|Lost to Follow-up|1|||
126409195|NCT01939366|454791746|FG001|Overall Study|Lost to Follow-up|1|||
126409196|NCT01939366|454791747|FG002|Overall Study|Lost to Follow-up|0|||
126409197|NCT01939366|454791748|FG003|Overall Study|Lost to Follow-up|0|||
126409198|NCT01939366|454791749|FG004|Overall Study|Lost to Follow-up|0|||
126409199|NCT01939366|454791745|FG000|Overall Study|Withdrawal by Subject|1|||
126409200|NCT01939366|454791746|FG001|Overall Study|Withdrawal by Subject|0|||
126409201|NCT01939366|454791747|FG002|Overall Study|Withdrawal by Subject|2|||
126409202|NCT01939366|454791748|FG003|Overall Study|Withdrawal by Subject|2|||
126409203|NCT01939366|454791749|FG004|Overall Study|Withdrawal by Subject|3|||
126409204|NCT01939366|454791745|FG000|Overall Study|Inclusion criteria not met|0|||
126409205|NCT01939366|454791746|FG001|Overall Study|Inclusion criteria not met|1|||
126409206|NCT01939366|454791747|FG002|Overall Study|Inclusion criteria not met|1|||
126409207|NCT01939366|454791748|FG003|Overall Study|Inclusion criteria not met|0|||
126409208|NCT01939366|454791749|FG004|Overall Study|Inclusion criteria not met|1|||
126409209|NCT01939366|454791745|FG000|Overall Study|Other|0|||
126409210|NCT01939366|454791746|FG001|Overall Study|Other|0|||
126409211|NCT01939366|454791747|FG002|Overall Study|Other|2|||
126409212|NCT01939366|454791748|FG003|Overall Study|Other|2|||
126409213|NCT01939366|454791749|FG004|Overall Study|Other|1|||
126409214|NCT01939366|454791745|FG000|Overall Study|Protocol Violation|0|||
126409215|NCT01939366|454791746|FG001|Overall Study|Protocol Violation|0|||
126409216|NCT01939366|454791747|FG002|Overall Study|Protocol Violation|0|||
126409217|NCT01939366|454791748|FG003|Overall Study|Protocol Violation|1|||
126409218|NCT01939366|454791749|FG004|Overall Study|Protocol Violation|0|||
126409219|NCT01939366|454791745|FG000|Overall Study|Sponsor decision|0|||
126409220|NCT01939366|454791746|FG001|Overall Study|Sponsor decision|0|||
126409221|NCT01939366|454791747|FG002|Overall Study|Sponsor decision|0|||
126409222|NCT01939366|454791748|FG003|Overall Study|Sponsor decision|0|||
126409223|NCT01939366|454791749|FG004|Overall Study|Sponsor decision|2|||
126409224|NCT01939366|454791745|FG000|Overall Study|GCP non-compliance at site|2|||
126409225|NCT01939366|454791746|FG001|Overall Study|GCP non-compliance at site|3|||
126409226|NCT01939366|454791747|FG002|Overall Study|GCP non-compliance at site|2|||
126409227|NCT01939366|454791748|FG003|Overall Study|GCP non-compliance at site|3|||
126409228|NCT01939366|454791749|FG004|Overall Study|GCP non-compliance at site|3|||
126409229|NCT03909152|454791754|FG000|Overall Study|Adverse Event|14|||
126409230|NCT03909152|454791755|FG001|Overall Study|Adverse Event|5|||
126409231|NCT03909152|454791756|FG002|Overall Study|Adverse Event|1|||
126409232|NCT03909152|454791757|FG003|Overall Study|Adverse Event|14|||
126409233|NCT02702414|454791758|FG000|Overall Study|Death|96|||
126409234|NCT02702414|454791759|FG001|Overall Study|Death|42|||
126409235|NCT02702414|454791758|FG000|Overall Study|Lost to Follow-up|0|||
126409236|NCT02702414|454791759|FG001|Overall Study|Lost to Follow-up|1|||
126409237|NCT02702414|454791758|FG000|Overall Study|Withdrawal by Subject|0|||
126409238|NCT02702414|454791759|FG001|Overall Study|Withdrawal by Subject|1|||
126409239|NCT02702414|454791758|FG000|Overall Study|Protocol Violation|1|||
126721444|NCT00195260|455929969|FG001|Part 1: Dose Escalation|Death|0|||
126721445|NCT00195260|455929970|FG002|Part 1: Dose Escalation|Death|0|||
126409240|NCT02702414|454791759|FG001|Overall Study|Protocol Violation|0|||
126409241|NCT02702414|454791758|FG000|Overall Study|Sponsor Decision|8|||
126409242|NCT02702414|454791759|FG001|Overall Study|Sponsor Decision|7|||
126409243|NCT02596230|454791760|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
126409244|NCT02596230|454791761|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
126409245|NCT02596230|454791762|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
126409246|NCT02596230|454791763|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
126409247|NCT02596230|454791764|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
126409248|NCT02596230|454791760|FG000|Objective 2, One Year|Lost to Follow-up|0|||
126409249|NCT02596230|454791761|FG001|Objective 2, One Year|Lost to Follow-up|41|||
126409250|NCT02596230|454791762|FG002|Objective 2, One Year|Lost to Follow-up|41|||
126409251|NCT02596230|454791763|FG003|Objective 2, One Year|Lost to Follow-up|32|||
126409252|NCT02596230|454791764|FG004|Objective 2, One Year|Lost to Follow-up|46|||
126409253|NCT02596230|454791760|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
126409254|NCT02596230|454791761|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
126409255|NCT02596230|454791762|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
126409256|NCT02596230|454791763|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
126409257|NCT02596230|454791764|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
126409258|NCT02596230|454791760|FG000|Objective 2, One Year|Adverse drug reaction|0|||
126409259|NCT02596230|454791761|FG001|Objective 2, One Year|Adverse drug reaction|1|||
126409260|NCT02596230|454791762|FG002|Objective 2, One Year|Adverse drug reaction|0|||
126409261|NCT02596230|454791763|FG003|Objective 2, One Year|Adverse drug reaction|0|||
126409262|NCT02596230|454791764|FG004|Objective 2, One Year|Adverse drug reaction|0|||
126409263|NCT02596230|454791760|FG000|Objective 2, One Year|Death|0|||
126409264|NCT02596230|454791761|FG001|Objective 2, One Year|Death|12|||
126409265|NCT02596230|454791762|FG002|Objective 2, One Year|Death|41|||
126409266|NCT02596230|454791763|FG003|Objective 2, One Year|Death|21|||
126409267|NCT02596230|454791764|FG004|Objective 2, One Year|Death|30|||
126409268|NCT02596230|454791760|FG000|Objective 2, One Year|Other|0|||
126409269|NCT02596230|454791761|FG001|Objective 2, One Year|Other|3|||
126409270|NCT02596230|454791762|FG002|Objective 2, One Year|Other|2|||
126409271|NCT02596230|454791763|FG003|Objective 2, One Year|Other|0|||
126409272|NCT02596230|454791764|FG004|Objective 2, One Year|Other|0|||
126409273|NCT02271945|454791765|FG000|Overall Study|Death|3|||
126409274|NCT02271945|454791766|FG001|Overall Study|Death|3|||
126409275|NCT02271945|454791765|FG000|Overall Study|Withdrawal by Subject|1|||
126409276|NCT02271945|454791766|FG001|Overall Study|Withdrawal by Subject|1|||
126409277|NCT02271945|454791765|FG000|Overall Study|Other|1|||
126409278|NCT02271945|454791766|FG001|Overall Study|Other|1|||
126409279|NCT03446456|454791767|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
126409280|NCT03446456|454791768|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
126409281|NCT03446456|454791767|FG000|Overall Study|Lost to Follow-up|1|||
126409282|NCT03446456|454791768|FG001|Overall Study|Lost to Follow-up|3|||
126409283|NCT03446456|454791767|FG000|Overall Study|Participant failed the toxicology test|1|||
126409284|NCT03446456|454791768|FG001|Overall Study|Participant failed the toxicology test|0|||
126409285|NCT03446456|454791767|FG000|Overall Study|Break down of the experimental equipment|1|||
126409286|NCT03446456|454791768|FG001|Overall Study|Break down of the experimental equipment|0|||
126409287|NCT04099511|454791770|FG000|Overall Study|Lost to Follow-up|2|||
126409288|NCT04099511|454791771|FG001|Overall Study|Lost to Follow-up|2|||
126409289|NCT04099511|454791770|FG000|Overall Study|Withdrawal by Subject|8|||
126409290|NCT04099511|454791771|FG001|Overall Study|Withdrawal by Subject|4|||
126409291|NCT03002311|454791774|FG000|Overall Study|Lost to Follow-up|13|||
126409292|NCT03002311|454791775|FG001|Overall Study|Lost to Follow-up|26|||
126409293|NCT03002311|454791774|FG000|Overall Study|Referral provider called to schedule app|3|||
126409294|NCT03002311|454791775|FG001|Overall Study|Referral provider called to schedule app|3|||
126409295|NCT03002311|454791774|FG000|Overall Study|Physician Decision|3|||
126409296|NCT03002311|454791775|FG001|Overall Study|Physician Decision|1|||
126473903|NCT03307785|455034613|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
126473904|NCT03307785|455034614|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
126473905|NCT03307785|455034615|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
126473906|NCT03307785|455034605|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
126473907|NCT03307785|455034606|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
126473908|NCT03307785|455034607|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
126473909|NCT03307785|455034608|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
126473910|NCT03307785|455034609|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
126473911|NCT03307785|455034610|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
126558526|NCT00783718|455338774|FG000|Induction Phase|Lack of Efficacy|5|||
126558527|NCT00783718|455338775|FG001|Induction Phase|Lack of Efficacy|2|||
126558528|NCT00783718|455338776|FG002|Induction Phase|Lack of Efficacy|14|||
126558529|NCT00783718|455338777|FG003|Induction Phase|Lack of Efficacy|0|||
126558530|NCT00783718|455338778|FG004|Induction Phase|Lack of Efficacy|0|||
126558531|NCT00783718|455338779|FG005|Induction Phase|Lack of Efficacy|0|||
126558532|NCT00783718|455338780|FG006|Induction Phase|Lack of Efficacy|0|||
126409297|NCT00320424|454791776|FG000|Overall Study|Adverse Event|3|||
126409298|NCT00320424|454791776|FG000|Overall Study|Other|3|||
126409299|NCT00658814|454791777|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
126409300|NCT00658814|454791778|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
126409301|NCT00658814|454791777|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
126409302|NCT00658814|454791778|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
126473912|NCT03307785|455034611|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
126473913|NCT03307785|455034612|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
126409303|NCT00658814|454791777|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
126409304|NCT00658814|454791778|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
126558533|NCT00783718|455338774|FG000|Induction Phase|Withdrawal by Subject|3|||
126558534|NCT00783718|455338775|FG001|Induction Phase|Withdrawal by Subject|4|||
126409305|NCT00658814|454791777|FG000|Remission Induction Chemotherapy|Death|1|||
126409306|NCT00658814|454791778|FG001|Remission Induction Chemotherapy|Death|4|||
126409307|NCT00658814|454791777|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
126409308|NCT00658814|454791778|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
126409309|NCT00658814|454791777|FG000|Remission Induction Chemotherapy|Not eligible|1|||
126409310|NCT00658814|454791778|FG001|Remission Induction Chemotherapy|Not eligible|2|||
126409311|NCT00658814|454791777|FG000|Consolidation Therapy|Not protocol specified|0|||
126409312|NCT00658814|454791778|FG001|Consolidation Therapy|Not protocol specified|1|||
126409313|NCT00658814|454791777|FG000|Consolidation Therapy|Not eligible|2|||
126409314|NCT00658814|454791778|FG001|Consolidation Therapy|Not eligible|2|||
126409315|NCT00658814|454791777|FG000|Maintenance Therapy|Adverse Event|1|||
126409316|NCT00658814|454791778|FG001|Maintenance Therapy|Adverse Event|1|||
126409317|NCT00658814|454791777|FG000|Maintenance Therapy|Not protocol specified|1|||
126409318|NCT00658814|454791778|FG001|Maintenance Therapy|Not protocol specified|0|||
126409319|NCT00658814|454791777|FG000|Maintenance Therapy|Not eligible|1|||
126409320|NCT00658814|454791778|FG001|Maintenance Therapy|Not eligible|0|||
126409321|NCT02708485|454791786|FG000|Overall Study|Withdrawal by Subject|3|||
126409322|NCT02708485|454791787|FG001|Overall Study|Withdrawal by Subject|2|||
126409323|NCT00231413|454791788|FG000|Overall Study|Non-serious AE|0|||
126409324|NCT00231413|454791789|FG001|Overall Study|Non-serious AE|0|||
126409325|NCT00231413|454791790|FG002|Overall Study|Non-serious AE|1|||
126409326|NCT00231413|454791791|FG003|Overall Study|Non-serious AE|0|||
126409327|NCT00231413|454791792|FG004|Overall Study|Non-serious AE|0|||
126409328|NCT00231413|454791793|FG005|Overall Study|Non-serious AE|0|||
126409329|NCT00231413|454791794|FG006|Overall Study|Non-serious AE|1|||
126409330|NCT00231413|454791788|FG000|Overall Study|Withdrawal by Subject|3|||
126409331|NCT00231413|454791789|FG001|Overall Study|Withdrawal by Subject|1|||
126409332|NCT00231413|454791790|FG002|Overall Study|Withdrawal by Subject|4|||
126409333|NCT00231413|454791791|FG003|Overall Study|Withdrawal by Subject|2|||
126409334|NCT00231413|454791792|FG004|Overall Study|Withdrawal by Subject|2|||
126409335|NCT00231413|454791793|FG005|Overall Study|Withdrawal by Subject|0|||
126409336|NCT00231413|454791794|FG006|Overall Study|Withdrawal by Subject|3|||
126409337|NCT00231413|454791788|FG000|Overall Study|Migrated/moved from study area|0|||
126409338|NCT00231413|454791789|FG001|Overall Study|Migrated/moved from study area|0|||
126409339|NCT00231413|454791790|FG002|Overall Study|Migrated/moved from study area|1|||
126409340|NCT00231413|454791791|FG003|Overall Study|Migrated/moved from study area|0|||
126409341|NCT00231413|454791792|FG004|Overall Study|Migrated/moved from study area|0|||
126409342|NCT00231413|454791793|FG005|Overall Study|Migrated/moved from study area|1|||
126409343|NCT00231413|454791794|FG006|Overall Study|Migrated/moved from study area|0|||
126409344|NCT00231413|454791788|FG000|Overall Study|Lost to Follow-up|4|||
126409345|NCT00231413|454791789|FG001|Overall Study|Lost to Follow-up|4|||
126409346|NCT00231413|454791790|FG002|Overall Study|Lost to Follow-up|1|||
126409347|NCT00231413|454791791|FG003|Overall Study|Lost to Follow-up|1|||
126409348|NCT00231413|454791792|FG004|Overall Study|Lost to Follow-up|1|||
126409349|NCT00231413|454791793|FG005|Overall Study|Lost to Follow-up|4|||
126409350|NCT00231413|454791794|FG006|Overall Study|Lost to Follow-up|0|||
126409351|NCT00231413|454791788|FG000|Overall Study|Pregnancy|1|||
126409352|NCT00231413|454791789|FG001|Overall Study|Pregnancy|0|||
126409353|NCT00231413|454791790|FG002|Overall Study|Pregnancy|0|||
126409354|NCT00231413|454791791|FG003|Overall Study|Pregnancy|0|||
126409355|NCT00231413|454791792|FG004|Overall Study|Pregnancy|0|||
126409356|NCT00231413|454791793|FG005|Overall Study|Pregnancy|0|||
126409357|NCT00231413|454791794|FG006|Overall Study|Pregnancy|0|||
126409358|NCT03266172|454791795|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
126558535|NCT00783718|455338776|FG002|Induction Phase|Withdrawal by Subject|8|||
126558536|NCT00783718|455338777|FG003|Induction Phase|Withdrawal by Subject|0|||
126558537|NCT00783718|455338778|FG004|Induction Phase|Withdrawal by Subject|0|||
126558538|NCT00783718|455338779|FG005|Induction Phase|Withdrawal by Subject|0|||
126558539|NCT00783718|455338780|FG006|Induction Phase|Withdrawal by Subject|0|||
126721446|NCT00195260|455929971|FG003|Part 1: Dose Escalation|Death|0|||
126409359|NCT03266172|454791796|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
126409360|NCT03266172|454791797|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
126409361|NCT03266172|454791795|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
126721447|NCT00195260|455929972|FG004|Part 1: Dose Escalation|Death|0|||
126721448|NCT00195260|455929973|FG005|Part 1: Dose Escalation|Death|0|||
126409362|NCT03266172|454791796|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
126409363|NCT03266172|454791797|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
126409364|NCT03266172|454791795|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
126409365|NCT03266172|454791796|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
126409366|NCT03266172|454791797|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
126409367|NCT03266172|454791795|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
126409368|NCT03266172|454791796|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
126409369|NCT03266172|454791797|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
126409370|NCT03266172|454791795|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
126409371|NCT03266172|454791796|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
126409372|NCT03266172|454791797|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
126409373|NCT03266172|454791795|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
126409374|NCT03266172|454791796|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
126409375|NCT03266172|454791797|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
126409376|NCT01554514|454791800|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
126409377|NCT01554514|454791800|FG000|Overall Study|Physician Decision|1|||
126409378|NCT05222555|454791801|FG000|Overall Study|Ongoing|2|||
126409379|NCT05222555|454791802|FG001|Overall Study|Ongoing|18|||
126409380|NCT05222555|454791801|FG000|Overall Study|Adverse Event|1|||
126409381|NCT05222555|454791802|FG001|Overall Study|Adverse Event|1|||
126409382|NCT05222555|454791801|FG000|Overall Study|Death|0|||
126409383|NCT05222555|454791802|FG001|Overall Study|Death|6|||
126409384|NCT05222555|454791801|FG000|Overall Study|Withdrawal by Subject|0|||
126409385|NCT05222555|454791802|FG001|Overall Study|Withdrawal by Subject|11|||
126409386|NCT00300365|454791803|FG000|Overall Study|Lost to Follow-up|1|||
126409387|NCT00300365|454791804|FG001|Overall Study|Lost to Follow-up|0|||
126409388|NCT00300365|454791803|FG000|Overall Study|Physician Decision|2|||
126409389|NCT00300365|454791804|FG001|Overall Study|Physician Decision|0|||
126409390|NCT00300365|454791803|FG000|Overall Study|Withdrawal by Subject|1|||
126409391|NCT00300365|454791804|FG001|Overall Study|Withdrawal by Subject|0|||
126409392|NCT00300365|454791803|FG000|Overall Study|Adverse Event|0|||
126409393|NCT00300365|454791804|FG001|Overall Study|Adverse Event|2|||
126409394|NCT01422824|454791805|FG000|Overall Study|Case record form not evaluated|1|||
126409395|NCT01422824|454791805|FG000|Overall Study|Lost to Follow-up|37|||
126409396|NCT01581619|454791806|FG000|Overall Study|Withdrawal by Subject|1|||
126409397|NCT01581619|454791806|FG000|Overall Study|Lost to Follow-up|1|||
126409398|NCT01818492|454791807|FG000|Overall Study|Adverse Event|2|||
126409399|NCT01818492|454791807|FG000|Overall Study|Death|3|||
126409400|NCT01818492|454791807|FG000|Overall Study|Withdrawal by Subject|1|||
126409401|NCT01818492|454791807|FG000|Overall Study|Additional therapy when not allowed PP|4|||
126409402|NCT00587847|454791809|FG000|Overall Study|Lack of Efficacy|5|||
126409403|NCT00587847|454791809|FG000|Overall Study|Adverse Event|2|||
126409404|NCT01972789|454791810|FG000|Overall Study|Adverse Event|11|||
126409405|NCT01972789|454791811|FG001|Overall Study|Adverse Event|4|||
126409406|NCT01972789|454791810|FG000|Overall Study|Subject withdrew consent|14|||
126409407|NCT01972789|454791811|FG001|Overall Study|Subject withdrew consent|12|||
126409408|NCT01972789|454791810|FG000|Overall Study|Lost to Follow-up|4|||
126409409|NCT01972789|454791811|FG001|Overall Study|Lost to Follow-up|7|||
126409410|NCT01972789|454791810|FG000|Overall Study|Death|7|||
126409411|NCT01972789|454791811|FG001|Overall Study|Death|5|||
126409412|NCT01972789|454791810|FG000|Overall Study|Protocol deviation|1|||
126409413|NCT01972789|454791811|FG001|Overall Study|Protocol deviation|0|||
126409414|NCT01972789|454791810|FG000|Overall Study|Physician Decision|3|||
126409415|NCT01972789|454791811|FG001|Overall Study|Physician Decision|2|||
126409416|NCT04407234|454791814|FG000|Overall Study|Adverse Event|3|||
126409417|NCT04407234|454791815|FG001|Overall Study|Adverse Event|3|||
126409418|NCT00727558|454791818|FG000|Overall Study|Lens issue|0|||
126409419|NCT00727558|454791819|FG001|Overall Study|Lens issue|1|||
126409420|NCT00727558|454791818|FG000|Overall Study|Adverse Event|0|||
126409421|NCT00727558|454791819|FG001|Overall Study|Adverse Event|1|||
126409422|NCT00727558|454791818|FG000|Overall Study|Subject unable to return for follow-up|1|||
126409423|NCT00727558|454791819|FG001|Overall Study|Subject unable to return for follow-up|1|||
126409424|NCT00727558|454791818|FG000|Overall Study|Lost to Follow-up|1|||
126409425|NCT00727558|454791819|FG001|Overall Study|Lost to Follow-up|0|||
126409426|NCT03268941|454793694|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
126473914|NCT03307785|455034613|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
126473915|NCT03307785|455034614|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
126721449|NCT00195260|455929974|FG006|Part 1: Dose Escalation|Death|0|||
126721450|NCT00195260|455929975|FG007|Part 1: Dose Escalation|Death|1|||
126409427|NCT03268941|454793695|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
126409428|NCT03268941|454793696|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
126409429|NCT03268941|454793697|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
126409430|NCT03268941|454793698|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
126409431|NCT03268941|454793699|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
126409432|NCT03268941|454793700|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
126473916|NCT03307785|455034615|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
126409433|NCT03268941|454793694|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
126473917|NCT03307785|455034605|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
126409434|NCT03268941|454793695|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
126721451|NCT00195260|455929976|FG008|Part 1: Dose Escalation|Death|0|||
126409435|NCT03268941|454793696|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
126409436|NCT03268941|454793697|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
126409437|NCT03268941|454793698|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
126409438|NCT03268941|454793699|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
126409439|NCT03268941|454793700|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
126409440|NCT03268941|454793694|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
126409441|NCT03268941|454793695|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
126409442|NCT03268941|454793696|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
126409443|NCT03268941|454793697|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
126409444|NCT03268941|454793698|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
126409445|NCT03268941|454793699|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
126409446|NCT03268941|454793700|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
126409447|NCT03268941|454793694|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
126409448|NCT03268941|454793695|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
126409449|NCT03268941|454793696|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
126409450|NCT03268941|454793697|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
126409451|NCT03268941|454793698|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
126409452|NCT03268941|454793699|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
126409453|NCT03268941|454793700|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
126409454|NCT03268941|454793694|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
126409455|NCT03268941|454793695|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
126409456|NCT03268941|454793696|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
126409457|NCT03268941|454793697|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
126409458|NCT03268941|454793698|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
126409459|NCT03268941|454793699|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
126409460|NCT03268941|454793700|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
126409461|NCT01216683|454793701|FG000|Induction|Never started treatment|0|||
126409462|NCT01216683|454793702|FG001|Induction|Never started treatment|6|||
126409463|NCT01216683|454793703|FG002|Induction|Never started treatment|3|||
126409464|NCT01216683|454793701|FG000|Induction|Lack of Efficacy|4|||
126409465|NCT01216683|454793702|FG001|Induction|Lack of Efficacy|3|||
126409466|NCT01216683|454793703|FG002|Induction|Lack of Efficacy|7|||
126409467|NCT01216683|454793701|FG000|Induction|Adverse Event|0|||
126409468|NCT01216683|454793702|FG001|Induction|Adverse Event|5|||
126409469|NCT01216683|454793703|FG002|Induction|Adverse Event|5|||
126409470|NCT01216683|454793701|FG000|Induction|Death|0|||
126409471|NCT01216683|454793702|FG001|Induction|Death|0|||
126409472|NCT01216683|454793703|FG002|Induction|Death|2|||
126409473|NCT01216683|454793701|FG000|Induction|Withdrawal by Subject|0|||
126409474|NCT01216683|454793702|FG001|Induction|Withdrawal by Subject|4|||
126409475|NCT01216683|454793703|FG002|Induction|Withdrawal by Subject|2|||
126409476|NCT01216683|454793701|FG000|Induction|Other disease|0|||
126409477|NCT01216683|454793702|FG001|Induction|Other disease|1|||
126409478|NCT01216683|454793703|FG002|Induction|Other disease|2|||
126409479|NCT01216683|454793701|FG000|Continuation|Lack of Efficacy|3|||
126409480|NCT01216683|454793702|FG001|Continuation|Lack of Efficacy|2|||
126409481|NCT01216683|454793703|FG002|Continuation|Lack of Efficacy|7|||
126409482|NCT01216683|454793701|FG000|Continuation|Adverse Event|5|||
126409483|NCT01216683|454793702|FG001|Continuation|Adverse Event|3|||
126409484|NCT01216683|454793703|FG002|Continuation|Adverse Event|16|||
126409485|NCT01216683|454793701|FG000|Continuation|Death|1|||
126409486|NCT01216683|454793702|FG001|Continuation|Death|0|||
126409487|NCT01216683|454793703|FG002|Continuation|Death|2|||
126409488|NCT01216683|454793701|FG000|Continuation|Withdrawal by Subject|4|||
126409489|NCT01216683|454793702|FG001|Continuation|Withdrawal by Subject|5|||
126409490|NCT01216683|454793703|FG002|Continuation|Withdrawal by Subject|9|||
126409491|NCT01216683|454793701|FG000|Continuation|Other diseases|0|||
126409492|NCT01216683|454793702|FG001|Continuation|Other diseases|2|||
126409493|NCT01216683|454793703|FG002|Continuation|Other diseases|1|||
126409494|NCT01216683|454793701|FG000|Continuation|Physician Decision|1|||
126409495|NCT01216683|454793702|FG001|Continuation|Physician Decision|0|||
126409496|NCT01216683|454793703|FG002|Continuation|Physician Decision|1|||
126409497|NCT01216683|454793701|FG000|Continuation|Non-compliance|1|||
126409498|NCT01216683|454793702|FG001|Continuation|Non-compliance|0|||
126409499|NCT01216683|454793703|FG002|Continuation|Non-compliance|1|||
126409500|NCT01216683|454793701|FG000|Continuation|Insurance change|0|||
126409501|NCT01216683|454793702|FG001|Continuation|Insurance change|1|||
126409502|NCT01216683|454793703|FG002|Continuation|Insurance change|0|||
126409503|NCT01216683|454793701|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
126409504|NCT01216683|454793702|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
126409505|NCT01216683|454793703|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
126409506|NCT01216683|454793701|FG000|Continuation|Not reported|0|||
126409507|NCT01216683|454793702|FG001|Continuation|Not reported|0|||
126409508|NCT01216683|454793703|FG002|Continuation|Not reported|1|||
126409509|NCT01216683|454793701|FG000|Continuation|Never started treatment|0|||
126409510|NCT01216683|454793702|FG001|Continuation|Never started treatment|1|||
126409511|NCT01216683|454793703|FG002|Continuation|Never started treatment|5|||
126409512|NCT02503501|454793705|FG000|Overall Study|Physician Decision|1|||
126409513|NCT02503501|454793706|FG001|Overall Study|Physician Decision|0|||
126409514|NCT02503501|454793705|FG000|Overall Study|Protocol Violation|0|||
126409515|NCT02503501|454793706|FG001|Overall Study|Protocol Violation|1|||
126409516|NCT02503501|454793705|FG000|Overall Study|Withdrawal by Subject|0|||
126409517|NCT02503501|454793706|FG001|Overall Study|Withdrawal by Subject|2|||
126409518|NCT02806960|454793707|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
126409519|NCT02806960|454793708|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
126409520|NCT02806960|454793709|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
126409521|NCT02806960|454793710|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
126409522|NCT02702180|454793716|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
126409523|NCT02702180|454793717|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
126409524|NCT02702180|454793718|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126409525|NCT02702180|454793716|FG000|Double-blind Treatment Period|Adverse Event|0|||
126409526|NCT02702180|454793717|FG001|Double-blind Treatment Period|Adverse Event|0|||
126409527|NCT02702180|454793718|FG002|Double-blind Treatment Period|Adverse Event|1|||
126409528|NCT02702180|454793716|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
126409529|NCT02702180|454793717|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
126409530|NCT02702180|454793718|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
126409531|NCT02702180|454793716|FG000|Double-blind Treatment Period|Protocol Violation|0|||
126409532|NCT02702180|454793717|FG001|Double-blind Treatment Period|Protocol Violation|0|||
126409533|NCT02702180|454793718|FG002|Double-blind Treatment Period|Protocol Violation|2|||
126409534|NCT02702180|454793716|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
126409535|NCT02702180|454793717|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
126409536|NCT02702180|454793718|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
126409537|NCT02702180|454793716|FG000|Open-label Treatment Period|Withdrawn in error|0|||
126409538|NCT02702180|454793717|FG001|Open-label Treatment Period|Withdrawn in error|0|||
126409539|NCT02702180|454793718|FG002|Open-label Treatment Period|Withdrawn in error|1|||
126409540|NCT00567359|454793719|FG000|Overall Study|Withdrawal by Subject|1|||
126409541|NCT04680975|454793720|FG000|Overall Study|Adverse Event|3|||
126409542|NCT04680975|454793720|FG000|Overall Study|Death|1|||
126409543|NCT04680975|454793720|FG000|Overall Study|Progressive Disease|1|||
126409544|NCT04680975|454793720|FG000|Overall Study|Withdrawal by Subject|1|||
126409545|NCT03270891|454793725|FG000|Overall Study|Lost to Follow-up|3|||
126409546|NCT03270891|454793726|FG001|Overall Study|Lost to Follow-up|6|||
126409547|NCT03270891|454793727|FG002|Overall Study|Lost to Follow-up|0|||
126409548|NCT03270891|454793725|FG000|Overall Study|Withdrawal by Subject|1|||
126409549|NCT03270891|454793726|FG001|Overall Study|Withdrawal by Subject|0|||
126409550|NCT03270891|454793727|FG002|Overall Study|Withdrawal by Subject|0|||
126409551|NCT03270891|454793725|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
126409552|NCT03270891|454793726|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
126409553|NCT03270891|454793727|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
126409554|NCT02540668|454793728|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
126409555|NCT02540668|454793729|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
126409556|NCT00290498|454793731|FG000|Overall Study|Death|2|||
126409557|NCT00290498|454793732|FG001|Overall Study|Death|0|||
126409558|NCT00290498|454793731|FG000|Overall Study|Physician Decision|1|||
126409559|NCT00290498|454793732|FG001|Overall Study|Physician Decision|0|||
126409560|NCT00290498|454793731|FG000|Overall Study|Withdrawal by Subject|1|||
126409561|NCT00290498|454793732|FG001|Overall Study|Withdrawal by Subject|0|||
126409562|NCT00290498|454793731|FG000|Overall Study|Ineligible|3|||
126409563|NCT00290498|454793732|FG001|Overall Study|Ineligible|0|||
126409564|NCT00290498|454793731|FG000|Overall Study|Non-Compliance|1|||
126409565|NCT00290498|454793732|FG001|Overall Study|Non-Compliance|0|||
126409566|NCT01716104|454793734|FG000|Overall Study|Do not meet inclusion criteria|6|||
126409567|NCT01716104|454793735|FG001|Overall Study|Do not meet inclusion criteria|7|||
126409568|NCT01753401|454793738|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
126409569|NCT01753401|454793739|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
126409570|NCT01753401|454793740|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
126409571|NCT01753401|454793741|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
126409572|NCT01753401|454793738|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
126409573|NCT01753401|454793739|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
126721452|NCT00195260|455929977|FG009|Part 1: Dose Escalation|Death|0|||
126721453|NCT00195260|455929978|FG010|Part 1: Dose Escalation|Death|0|||
126409574|NCT01753401|454793740|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
126473918|NCT03307785|455034606|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
126473919|NCT03307785|455034607|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
126473920|NCT03307785|455034608|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
126473921|NCT03307785|455034609|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
126721454|NCT00195260|455929968|FG000|Part 1: Dose Escalation|Disease Progression|3|||
126409575|NCT01753401|454793741|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
126409576|NCT01753401|454793738|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
126409577|NCT01753401|454793739|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
126409578|NCT01753401|454793740|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
126473922|NCT03307785|455034610|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
126409579|NCT01753401|454793741|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
126409580|NCT01753401|454793738|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
126409581|NCT01753401|454793739|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
126409582|NCT01753401|454793740|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
126409583|NCT01753401|454793741|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
126409584|NCT01753401|454793738|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
126409585|NCT01753401|454793739|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
126409586|NCT01753401|454793740|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
126409587|NCT01753401|454793741|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
126409588|NCT01753401|454793738|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
126409589|NCT01753401|454793739|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
126409590|NCT01753401|454793740|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
126409591|NCT01753401|454793741|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
126409592|NCT01753401|454793738|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
126409593|NCT01753401|454793739|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
126409594|NCT01753401|454793740|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
126409595|NCT01753401|454793741|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
126409596|NCT03129360|454793742|FG000|Overall Study|Did not meet entry criteria|0|||
126409597|NCT03129360|454793743|FG001|Overall Study|Did not meet entry criteria|2|||
126409598|NCT03129360|454793744|FG002|Overall Study|Did not meet entry criteria|1|||
126409599|NCT03129360|454793742|FG000|Overall Study|Excluded due to motion in scanner|1|||
126409600|NCT03129360|454793743|FG001|Overall Study|Excluded due to motion in scanner|0|||
126409601|NCT03129360|454793744|FG002|Overall Study|Excluded due to motion in scanner|0|||
126409602|NCT03006887|454793745|FG000|Overall Study|Adverse Event|1|||
126409603|NCT05026853|454793746|FG000|Overall Study|Cancelled appointment|1|||
126409604|NCT05026853|454793747|FG001|Overall Study|Cancelled appointment|0|||
126409605|NCT05026853|454793746|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
126409606|NCT05026853|454793747|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
126409607|NCT05026853|454793746|FG000|Overall Study|Did not complete 12-week survey|16|||
126409608|NCT05026853|454793747|FG001|Overall Study|Did not complete 12-week survey|16|||
126409609|NCT03836677|454793748|FG000|Period 1|Adverse Event|0|||
126409610|NCT03836677|454793749|FG001|Period 1|Adverse Event|1|||
126409611|NCT03836677|454793748|FG000|Period 2|Severe non-compliance to protocol|1|||
126409612|NCT03836677|454793749|FG001|Period 2|Severe non-compliance to protocol|0|||
126409613|NCT01353911|454793750|FG000|Overall Study|Lost to Follow-up|2|||
126409614|NCT01353911|454793751|FG001|Overall Study|Lost to Follow-up|6|||
126409615|NCT01353911|454793752|FG002|Overall Study|Lost to Follow-up|4|||
126409616|NCT01353911|454793753|FG003|Overall Study|Lost to Follow-up|0|||
126409617|NCT01353911|454793754|FG004|Overall Study|Lost to Follow-up|4|||
126409618|NCT01353911|454793755|FG005|Overall Study|Lost to Follow-up|4|||
126409619|NCT01353911|454793756|FG006|Overall Study|Lost to Follow-up|3|||
126409620|NCT01353911|454793757|FG007|Overall Study|Lost to Follow-up|6|||
126409621|NCT01353911|454793750|FG000|Overall Study|Withdrawal by Subject|2|||
126409622|NCT01353911|454793751|FG001|Overall Study|Withdrawal by Subject|3|||
126409623|NCT01353911|454793752|FG002|Overall Study|Withdrawal by Subject|4|||
126409624|NCT01353911|454793753|FG003|Overall Study|Withdrawal by Subject|2|||
126409625|NCT01353911|454793754|FG004|Overall Study|Withdrawal by Subject|2|||
126409626|NCT01353911|454793755|FG005|Overall Study|Withdrawal by Subject|3|||
126409627|NCT01353911|454793756|FG006|Overall Study|Withdrawal by Subject|3|||
126409628|NCT01353911|454793757|FG007|Overall Study|Withdrawal by Subject|9|||
126409629|NCT01353911|454793750|FG000|Overall Study|Status Not Recorded|4|||
126409630|NCT01353911|454793751|FG001|Overall Study|Status Not Recorded|0|||
126409631|NCT01353911|454793752|FG002|Overall Study|Status Not Recorded|1|||
126409632|NCT01353911|454793753|FG003|Overall Study|Status Not Recorded|0|||
126409633|NCT01353911|454793754|FG004|Overall Study|Status Not Recorded|0|||
126409634|NCT01353911|454793755|FG005|Overall Study|Status Not Recorded|0|||
126409635|NCT01353911|454793756|FG006|Overall Study|Status Not Recorded|0|||
126409636|NCT01353911|454793757|FG007|Overall Study|Status Not Recorded|0|||
126409637|NCT00462748|454793762|FG000|Overall Study|Adverse Event|7|||
126473923|NCT03307785|455034611|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
126473924|NCT03307785|455034612|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
126473925|NCT03307785|455034613|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
126473926|NCT03307785|455034614|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
126558540|NCT00783718|455338774|FG000|Induction Phase|Lost to Follow-up|1|||
126409638|NCT00462748|454793763|FG001|Overall Study|Adverse Event|5|||
126409639|NCT00462748|454793764|FG002|Overall Study|Adverse Event|9|||
126409640|NCT00462748|454793762|FG000|Overall Study|Protocol Violation|0|||
126409641|NCT00462748|454793763|FG001|Overall Study|Protocol Violation|2|||
126409642|NCT00462748|454793764|FG002|Overall Study|Protocol Violation|1|||
126409643|NCT00462748|454793762|FG000|Overall Study|Withdrew consent|3|||
126409644|NCT00462748|454793763|FG001|Overall Study|Withdrew consent|3|||
126409645|NCT00462748|454793764|FG002|Overall Study|Withdrew consent|0|||
126409646|NCT00462748|454793762|FG000|Overall Study|Lost to Follow-up|1|||
126409647|NCT00462748|454793763|FG001|Overall Study|Lost to Follow-up|1|||
126558541|NCT00783718|455338775|FG001|Induction Phase|Lost to Follow-up|0|||
126558542|NCT00783718|455338776|FG002|Induction Phase|Lost to Follow-up|1|||
126558543|NCT00783718|455338777|FG003|Induction Phase|Lost to Follow-up|0|||
126558544|NCT00783718|455338778|FG004|Induction Phase|Lost to Follow-up|0|||
126558545|NCT00783718|455338779|FG005|Induction Phase|Lost to Follow-up|0|||
126558546|NCT00783718|455338780|FG006|Induction Phase|Lost to Follow-up|0|||
126558547|NCT00783718|455338774|FG000|Maintenance Phase|Adverse Event|12|||
126558548|NCT00783718|455338775|FG001|Maintenance Phase|Adverse Event|0|||
126558549|NCT00783718|455338776|FG002|Maintenance Phase|Adverse Event|0|||
126558550|NCT00783718|455338777|FG003|Maintenance Phase|Adverse Event|15|||
126558551|NCT00783718|455338778|FG004|Maintenance Phase|Adverse Event|7|||
126558552|NCT00783718|455338779|FG005|Maintenance Phase|Adverse Event|6|||
126558553|NCT00783718|455338780|FG006|Maintenance Phase|Adverse Event|16|||
126558554|NCT00783718|455338774|FG000|Maintenance Phase|Protocol Violation|1|||
126558555|NCT00783718|455338775|FG001|Maintenance Phase|Protocol Violation|0|||
126558556|NCT00783718|455338776|FG002|Maintenance Phase|Protocol Violation|0|||
126558557|NCT00783718|455338777|FG003|Maintenance Phase|Protocol Violation|0|||
126558558|NCT00783718|455338778|FG004|Maintenance Phase|Protocol Violation|0|||
126558559|NCT00783718|455338779|FG005|Maintenance Phase|Protocol Violation|0|||
126558560|NCT00783718|455338780|FG006|Maintenance Phase|Protocol Violation|2|||
126558561|NCT00783718|455338774|FG000|Maintenance Phase|Lack of Efficacy|83|||
126558562|NCT00783718|455338775|FG001|Maintenance Phase|Lack of Efficacy|0|||
126558563|NCT00783718|455338776|FG002|Maintenance Phase|Lack of Efficacy|0|||
126558564|NCT00783718|455338777|FG003|Maintenance Phase|Lack of Efficacy|61|||
126558565|NCT00783718|455338778|FG004|Maintenance Phase|Lack of Efficacy|31|||
126558566|NCT00783718|455338779|FG005|Maintenance Phase|Lack of Efficacy|33|||
126558567|NCT00783718|455338780|FG006|Maintenance Phase|Lack of Efficacy|155|||
126558568|NCT00783718|455338774|FG000|Maintenance Phase|Withdrawal by Subject|6|||
126558569|NCT00783718|455338775|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126558570|NCT00783718|455338776|FG002|Maintenance Phase|Withdrawal by Subject|0|||
126558571|NCT00783718|455338777|FG003|Maintenance Phase|Withdrawal by Subject|2|||
126558572|NCT00783718|455338778|FG004|Maintenance Phase|Withdrawal by Subject|5|||
126558573|NCT00783718|455338779|FG005|Maintenance Phase|Withdrawal by Subject|2|||
126558574|NCT00783718|455338780|FG006|Maintenance Phase|Withdrawal by Subject|20|||
126558575|NCT00783718|455338774|FG000|Maintenance Phase|Lost to Follow-up|3|||
126558576|NCT00783718|455338775|FG001|Maintenance Phase|Lost to Follow-up|0|||
126558577|NCT00783718|455338776|FG002|Maintenance Phase|Lost to Follow-up|0|||
126558578|NCT00783718|455338777|FG003|Maintenance Phase|Lost to Follow-up|0|||
126558579|NCT00783718|455338778|FG004|Maintenance Phase|Lost to Follow-up|2|||
126558580|NCT00783718|455338779|FG005|Maintenance Phase|Lost to Follow-up|0|||
126558581|NCT00783718|455338780|FG006|Maintenance Phase|Lost to Follow-up|2|||
126558582|NCT00630539|455338781|FG000|Overall Study|Adverse Event|1|||
126409648|NCT00462748|454793764|FG002|Overall Study|Lost to Follow-up|1|||
126409649|NCT00462748|454793762|FG000|Overall Study|Discontinued after 41 days Rx|1|||
126409650|NCT00462748|454793763|FG001|Overall Study|Discontinued after 41 days Rx|0|||
126409651|NCT00462748|454793764|FG002|Overall Study|Discontinued after 41 days Rx|0|||
126409652|NCT03233438|454793765|FG000|Overall Study|Lost to Follow-up|4|||
126409653|NCT03233438|454793766|FG001|Overall Study|Lost to Follow-up|9|||
126409654|NCT03233438|454793765|FG000|Overall Study|Withdrawal by Subject|2|||
126409655|NCT03233438|454793766|FG001|Overall Study|Withdrawal by Subject|1|||
126409656|NCT03233438|454793765|FG000|Overall Study|No recording of dalbavancin|0|||
126409657|NCT03233438|454793766|FG001|Overall Study|No recording of dalbavancin|1|||
126409658|NCT03429543|454793767|FG000|Overall Study|Adverse Event|1|||
126409659|NCT03429543|454793768|FG001|Overall Study|Adverse Event|1|||
126558583|NCT00630539|455338782|FG001|Overall Study|Adverse Event|3|||
126409660|NCT03429543|454793769|FG002|Overall Study|Adverse Event|0|||
126409661|NCT03429543|454793770|FG003|Overall Study|Adverse Event|0|||
126409662|NCT03429543|454793771|FG004|Overall Study|Adverse Event|0|||
126409663|NCT03429543|454793772|FG005|Overall Study|Adverse Event|2|||
126409664|NCT03429543|454793773|FG006|Overall Study|Adverse Event|0|||
126409665|NCT03429543|454793767|FG000|Overall Study|Lost to Follow-up|1|||
126409666|NCT03429543|454793768|FG001|Overall Study|Lost to Follow-up|0|||
126409667|NCT03429543|454793769|FG002|Overall Study|Lost to Follow-up|0|||
126558584|NCT00630539|455338783|FG002|Overall Study|Adverse Event|1|||
126558585|NCT00630539|455338784|FG003|Overall Study|Adverse Event|2|||
126409668|NCT03429543|454793770|FG003|Overall Study|Lost to Follow-up|0|||
126409669|NCT03429543|454793771|FG004|Overall Study|Lost to Follow-up|1|||
126409670|NCT03429543|454793772|FG005|Overall Study|Lost to Follow-up|0|||
126409671|NCT03429543|454793773|FG006|Overall Study|Lost to Follow-up|0|||
126409672|NCT03429543|454793767|FG000|Overall Study|Withdrawal by Subject|5|||
126409673|NCT03429543|454793768|FG001|Overall Study|Withdrawal by Subject|0|||
126558586|NCT00630539|455338781|FG000|Overall Study|Withdrawal by Subject|0|||
126558587|NCT00630539|455338782|FG001|Overall Study|Withdrawal by Subject|1|||
126558588|NCT00630539|455338783|FG002|Overall Study|Withdrawal by Subject|0|||
126558589|NCT00630539|455338784|FG003|Overall Study|Withdrawal by Subject|1|||
126409674|NCT03429543|454793769|FG002|Overall Study|Withdrawal by Subject|1|||
126558590|NCT04833855|455338793|FG000|Overall Study|Decision by sponsor|0|||
126558591|NCT04833855|455338794|FG001|Overall Study|Decision by sponsor|1|||
126409675|NCT03429543|454793770|FG003|Overall Study|Withdrawal by Subject|2|||
126409676|NCT03429543|454793771|FG004|Overall Study|Withdrawal by Subject|6|||
126409677|NCT03429543|454793772|FG005|Overall Study|Withdrawal by Subject|3|||
126409678|NCT03429543|454793773|FG006|Overall Study|Withdrawal by Subject|1|||
126409679|NCT03429543|454793767|FG000|Overall Study|Other reason than listed|0|||
126409680|NCT03429543|454793768|FG001|Overall Study|Other reason than listed|1|||
126409681|NCT03429543|454793769|FG002|Overall Study|Other reason than listed|0|||
126409682|NCT03429543|454793770|FG003|Overall Study|Other reason than listed|0|||
126409683|NCT03429543|454793771|FG004|Overall Study|Other reason than listed|4|||
126409684|NCT03429543|454793772|FG005|Overall Study|Other reason than listed|4|||
126409685|NCT03429543|454793773|FG006|Overall Study|Other reason than listed|0|||
126409686|NCT03429543|454793767|FG000|Overall Study|Not treated|0|||
126558592|NCT04833855|455338795|FG002|Overall Study|Decision by sponsor|0|||
126558593|NCT04833855|455338796|FG003|Overall Study|Decision by sponsor|0|||
126558594|NCT04833855|455338793|FG000|Overall Study|Withdrawal by Subject|4|||
126558595|NCT04833855|455338794|FG001|Overall Study|Withdrawal by Subject|1|||
126558596|NCT04833855|455338795|FG002|Overall Study|Withdrawal by Subject|3|||
126558597|NCT04833855|455338796|FG003|Overall Study|Withdrawal by Subject|1|||
126409687|NCT03429543|454793768|FG001|Overall Study|Not treated|0|||
126409688|NCT03429543|454793769|FG002|Overall Study|Not treated|0|||
126409689|NCT03429543|454793770|FG003|Overall Study|Not treated|0|||
126409690|NCT03429543|454793771|FG004|Overall Study|Not treated|1|||
126409691|NCT03429543|454793772|FG005|Overall Study|Not treated|0|||
126409692|NCT03429543|454793773|FG006|Overall Study|Not treated|0|||
126409693|NCT01729208|454793774|FG000|Baseline|Physician Decision|5|||
126409694|NCT01729208|454793775|FG001|Baseline|Physician Decision|4|||
126409695|NCT01729208|454793774|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
126409696|NCT01729208|454793775|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
126409697|NCT01729208|454793774|FG000|12 Months Follow-up|Lost to Follow-up|3|||
126409698|NCT01729208|454793775|FG001|12 Months Follow-up|Lost to Follow-up|3|||
126409699|NCT01729208|454793774|FG000|24 Months Follow-up|Lost to Follow-up|3|||
126409700|NCT01729208|454793775|FG001|24 Months Follow-up|Lost to Follow-up|0|||
126409701|NCT01729208|454793774|FG000|36 Months Follow-up|Physician Decision|1|||
126409702|NCT01729208|454793775|FG001|36 Months Follow-up|Physician Decision|0|||
126409703|NCT01729208|454793774|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
126409704|NCT01729208|454793775|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
126409705|NCT02428413|454793777|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
126409706|NCT02428413|454793778|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
126409707|NCT02428413|454793777|FG000|Overall Study|Protocol Violation|1|||
126409708|NCT02428413|454793778|FG001|Overall Study|Protocol Violation|2|||
126409709|NCT02428413|454793777|FG000|Overall Study|Case Cancelled|2|||
126409710|NCT02428413|454793778|FG001|Overall Study|Case Cancelled|0|||
126409711|NCT02428413|454793777|FG000|Overall Study|Missed Cases|1|||
126409712|NCT02428413|454793778|FG001|Overall Study|Missed Cases|2|||
126409713|NCT02428413|454793777|FG000|Overall Study|Nurse Refusal|1|||
126409714|NCT02428413|454793778|FG001|Overall Study|Nurse Refusal|0|||
126409715|NCT03688100|454793783|FG000|Overall Study|Lost to Follow-up|21|||
126409716|NCT03688100|454793784|FG001|Overall Study|Lost to Follow-up|15|||
126409717|NCT03688100|454793785|FG002|Overall Study|Lost to Follow-up|15|||
126409718|NCT03688100|454793786|FG003|Overall Study|Lost to Follow-up|18|||
126409719|NCT03688100|454793783|FG000|Overall Study|Withdrawal by Subject|19|||
126409720|NCT03688100|454793784|FG001|Overall Study|Withdrawal by Subject|16|||
126409721|NCT03688100|454793785|FG002|Overall Study|Withdrawal by Subject|0|||
126409722|NCT03688100|454793786|FG003|Overall Study|Withdrawal by Subject|0|||
126409723|NCT03688100|454793783|FG000|Overall Study|Death|36|||
126409724|NCT03688100|454793784|FG001|Overall Study|Death|27|||
126409725|NCT03688100|454793785|FG002|Overall Study|Death|0|||
126409726|NCT03688100|454793786|FG003|Overall Study|Death|0|||
126409727|NCT02345330|454793787|FG000|Overall Study|Death|1|||
126409728|NCT02345330|454793787|FG000|Overall Study|Progressive Disease|2|||
126409729|NCT00494507|454793788|FG000|Double-Blind Phase|Adverse Event|2|||
126409730|NCT00494507|454793789|FG001|Double-Blind Phase|Adverse Event|0|||
126409731|NCT00494507|454793790|FG002|Double-Blind Phase|Adverse Event|1|||
126409732|NCT00494507|454793791|FG003|Double-Blind Phase|Adverse Event|0|||
126409733|NCT00494507|454793788|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
126409734|NCT00494507|454793789|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
126409735|NCT00494507|454793790|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
126409736|NCT00494507|454793791|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
126409737|NCT00494507|454793788|FG000|Double-Blind Phase|Subject Non-compliance|0|||
126409738|NCT00494507|454793789|FG001|Double-Blind Phase|Subject Non-compliance|0|||
126409739|NCT00494507|454793790|FG002|Double-Blind Phase|Subject Non-compliance|1|||
126409740|NCT00494507|454793791|FG003|Double-Blind Phase|Subject Non-compliance|0|||
126409741|NCT00494507|454793788|FG000|Double-Blind Phase|Negative DNA test|0|||
126409742|NCT00494507|454793789|FG001|Double-Blind Phase|Negative DNA test|0|||
126409743|NCT00494507|454793790|FG002|Double-Blind Phase|Negative DNA test|0|||
126409744|NCT00494507|454793791|FG003|Double-Blind Phase|Negative DNA test|1|||
126409745|NCT00494507|454793788|FG000|Open-Label Phase|Adverse Event|0|||
126409746|NCT00494507|454793789|FG001|Open-Label Phase|Adverse Event|1|||
126558598|NCT04833855|455338793|FG000|Overall Study|Lost to Follow-up|1|||
126409747|NCT00494507|454793790|FG002|Open-Label Phase|Adverse Event|5|||
126409748|NCT00494507|454793791|FG003|Open-Label Phase|Adverse Event|3|||
126409749|NCT00494507|454793788|FG000|Open-Label Phase|Worsening Disease|0|||
126409750|NCT00494507|454793789|FG001|Open-Label Phase|Worsening Disease|0|||
126409751|NCT00494507|454793790|FG002|Open-Label Phase|Worsening Disease|0|||
126409752|NCT00494507|454793791|FG003|Open-Label Phase|Worsening Disease|2|||
126409753|NCT03615066|454793792|FG000|Main Study|Withdrew Consent|0|||
126409754|NCT03615066|454793793|FG001|Main Study|Withdrew Consent|1|||
126409755|NCT03615066|454793794|FG002|Main Study|Withdrew Consent|1|||
126409756|NCT03615066|454793792|FG000|Main Study|Lost to Follow-up|0|||
126409757|NCT03615066|454793793|FG001|Main Study|Lost to Follow-up|0|||
126409758|NCT03615066|454793794|FG002|Main Study|Lost to Follow-up|1|||
126409759|NCT03615066|454793792|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
126409760|NCT03615066|454793793|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
126409761|NCT03615066|454793794|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
126409762|NCT03615066|454793792|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
126409763|NCT03615066|454793793|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
126409764|NCT03615066|454793794|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
126409765|NCT03615066|454793792|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
126409766|NCT03615066|454793793|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
126409767|NCT03615066|454793794|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
126409768|NCT02437084|454793795|FG000|Overall Study|Withdrawal by Subject|2|||
126409769|NCT02437084|454793795|FG000|Overall Study|Physician Decision|1|||
126409770|NCT03729245|454793796|FG000|Overall Study|Lost to Follow-up|5|||
126473927|NCT03307785|455034615|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
126473928|NCT03307785|455034605|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
126473929|NCT03307785|455034606|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
126473930|NCT03307785|455034607|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
126473931|NCT03307785|455034608|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
126473932|NCT03307785|455034609|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
126473933|NCT03307785|455034610|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
126473934|NCT03307785|455034611|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
126473935|NCT03307785|455034612|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
126473936|NCT03307785|455034613|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
126473937|NCT03307785|455034614|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
126473938|NCT03307785|455034615|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
126473939|NCT03307785|455034605|FG000|Part E: Up to 4.4 Months|Death|0|||
126473940|NCT03307785|455034606|FG001|Part E: Up to 4.4 Months|Death|0|||
126473941|NCT03307785|455034607|FG002|Part E: Up to 4.4 Months|Death|0|||
126473942|NCT03307785|455034608|FG003|Part E: Up to 4.4 Months|Death|0|||
126473943|NCT03307785|455034609|FG004|Part E: Up to 4.4 Months|Death|0|||
126473944|NCT03307785|455034610|FG005|Part E: Up to 4.4 Months|Death|0|||
126473945|NCT03307785|455034611|FG006|Part E: Up to 4.4 Months|Death|1|||
126473946|NCT03307785|455034612|FG007|Part E: Up to 4.4 Months|Death|0|||
126473947|NCT03307785|455034613|FG008|Part E: Up to 4.4 Months|Death|0|||
126473948|NCT03307785|455034614|FG009|Part E: Up to 4.4 Months|Death|0|||
126473949|NCT03307785|455034615|FG010|Part E: Up to 4.4 Months|Death|0|||
126473950|NCT03307785|455034605|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
126473951|NCT03307785|455034606|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
126473952|NCT03307785|455034607|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
126473953|NCT03307785|455034608|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
126473954|NCT03307785|455034609|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
126473955|NCT03307785|455034610|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
126473956|NCT03307785|455034611|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
126473957|NCT03307785|455034612|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
126473958|NCT03307785|455034613|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
126473959|NCT03307785|455034614|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
126473960|NCT03307785|455034615|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
126473961|NCT03307785|455034605|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
126473962|NCT03307785|455034606|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
126409771|NCT03729245|454793797|FG001|Overall Study|Lost to Follow-up|6|||
126473963|NCT03307785|455034607|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
126409772|NCT03729245|454793796|FG000|Overall Study|Withdrawal by Subject|16|||
126409773|NCT03729245|454793797|FG001|Overall Study|Withdrawal by Subject|19|||
126409774|NCT03729245|454793796|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
126473964|NCT03307785|455034608|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
126473965|NCT03307785|455034609|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
126473966|NCT03307785|455034610|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
126473967|NCT03307785|455034611|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
126473968|NCT03307785|455034612|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
126558599|NCT04833855|455338794|FG001|Overall Study|Lost to Follow-up|0|||
126558600|NCT04833855|455338795|FG002|Overall Study|Lost to Follow-up|2|||
126558601|NCT04833855|455338796|FG003|Overall Study|Lost to Follow-up|2|||
126558602|NCT04833855|455338793|FG000|Overall Study|Protocol specified criteria|0|||
126558603|NCT04833855|455338794|FG001|Overall Study|Protocol specified criteria|0|||
126558604|NCT04833855|455338795|FG002|Overall Study|Protocol specified criteria|2|||
126409775|NCT03729245|454793797|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
126409776|NCT00989781|454793807|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
126409777|NCT00989781|454793808|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
126409778|NCT00694304|454793809|FG000|Overall Study|Adverse Event|42|||
126409779|NCT00694304|454793809|FG000|Overall Study|Lack of Efficacy|35|||
126409780|NCT00694304|454793809|FG000|Overall Study|Non-compliance With Study Product|16|||
126409781|NCT00694304|454793809|FG000|Overall Study|Protocol Violation|6|||
126409782|NCT00694304|454793809|FG000|Overall Study|Withdrawal of Consent|61|||
126409783|NCT00694304|454793809|FG000|Overall Study|Lost to Follow-up|15|||
126409784|NCT00694304|454793809|FG000|Overall Study|Administrative or Other Reasons|32|||
126409785|NCT03517566|454793812|FG000|Overall Study|Adverse Event|5|||
126409786|NCT03517566|454793813|FG001|Overall Study|Adverse Event|2|||
126409787|NCT03517566|454793814|FG002|Overall Study|Adverse Event|2|||
126409788|NCT03517566|454793815|FG003|Overall Study|Adverse Event|8|||
126409789|NCT03517566|454793816|FG004|Overall Study|Adverse Event|7|||
126558605|NCT04833855|455338796|FG003|Overall Study|Protocol specified criteria|1|||
126558606|NCT03682536|455338798|FG000|Randomization|Withdrawal by Subject|0|||
126558607|NCT03682536|455338799|FG001|Randomization|Withdrawal by Subject|2|||
126558608|NCT03682536|455338798|FG000|Treatment|Other Reasons|8|||
126558609|NCT03682536|455338799|FG001|Treatment|Other Reasons|7|||
126558610|NCT03682536|455338798|FG000|Treatment|Physician Decision|5|||
126558611|NCT03682536|455338799|FG001|Treatment|Physician Decision|5|||
126558612|NCT03682536|455338798|FG000|Treatment|Protocol Violation|1|||
126558613|NCT03682536|455338799|FG001|Treatment|Protocol Violation|0|||
126558614|NCT03682536|455338798|FG000|Treatment|Study Terminated by Sponsor|1|||
126558615|NCT03682536|455338799|FG001|Treatment|Study Terminated by Sponsor|2|||
126558616|NCT03682536|455338798|FG000|Treatment|Lost to Follow-up|0|||
126558617|NCT03682536|455338799|FG001|Treatment|Lost to Follow-up|1|||
126558618|NCT03682536|455338798|FG000|Treatment|Withdrawal by Subject|16|||
126558619|NCT03682536|455338799|FG001|Treatment|Withdrawal by Subject|18|||
126558620|NCT03682536|455338798|FG000|Treatment|Lack of Efficacy|41|||
126558621|NCT03682536|455338799|FG001|Treatment|Lack of Efficacy|68|||
126558622|NCT03682536|455338798|FG000|Treatment|Disease Progression|9|||
126558623|NCT03682536|455338799|FG001|Treatment|Disease Progression|7|||
126558624|NCT03682536|455338798|FG000|Treatment|Adverse Event|9|||
126558625|NCT03682536|455338799|FG001|Treatment|Adverse Event|5|||
126558626|NCT03682536|455338798|FG000|Treatment|Death|14|||
126558627|NCT03682536|455338799|FG001|Treatment|Death|13|||
126558628|NCT03008122|455338800|FG000|Overall Study|Physician Decision|3|||
126558629|NCT03008122|455338801|FG001|Overall Study|Physician Decision|2|||
126558630|NCT03008122|455338802|FG002|Overall Study|Physician Decision|0|||
126558631|NCT03008122|455338800|FG000|Overall Study|Withdrawal by Subject|1|||
126558632|NCT03008122|455338801|FG001|Overall Study|Withdrawal by Subject|3|||
126558633|NCT03008122|455338802|FG002|Overall Study|Withdrawal by Subject|0|||
126558634|NCT03008122|455338800|FG000|Overall Study|Lost to Follow-up|4|||
126558635|NCT03008122|455338801|FG001|Overall Study|Lost to Follow-up|8|||
126558636|NCT03008122|455338802|FG002|Overall Study|Lost to Follow-up|3|||
126558637|NCT03008122|455338800|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
126558638|NCT03008122|455338801|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
126558639|NCT03008122|455338802|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
126558640|NCT03008122|455338800|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
126558641|NCT03008122|455338801|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
126558642|NCT03008122|455338802|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
126558643|NCT03008122|455338800|FG000|Overall Study|Death|0|||
126558644|NCT03008122|455338801|FG001|Overall Study|Death|0|||
126558645|NCT03008122|455338802|FG002|Overall Study|Death|1|||
126558646|NCT02338609|455338803|FG000|Overall Study|Physician Decision|1|||
126558647|NCT02338609|455338803|FG000|Overall Study|Death|1|||
126558648|NCT02223182|455338806|FG000|Double-Blind Period|Adverse Event|0|||
126558649|NCT02223182|455338807|FG001|Double-Blind Period|Adverse Event|2|||
126409790|NCT03517566|454793812|FG000|Overall Study|Lack of Efficacy|3|||
126409791|NCT03517566|454793813|FG001|Overall Study|Lack of Efficacy|2|||
126558650|NCT02223182|455338808|FG002|Double-Blind Period|Adverse Event|1|||
126558651|NCT02223182|455338809|FG003|Double-Blind Period|Adverse Event|0|||
126558652|NCT02223182|455338806|FG000|Double-Blind Period|Withdrawal by Subject|1|||
126558653|NCT02223182|455338807|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126558654|NCT02223182|455338808|FG002|Double-Blind Period|Withdrawal by Subject|1|||
126558655|NCT02223182|455338809|FG003|Double-Blind Period|Withdrawal by Subject|0|||
126558656|NCT02223182|455338806|FG000|Double-Blind Period|Lost to Follow-up|0|||
126409792|NCT03517566|454793814|FG002|Overall Study|Lack of Efficacy|1|||
126409793|NCT03517566|454793815|FG003|Overall Study|Lack of Efficacy|1|||
126558657|NCT02223182|455338807|FG001|Double-Blind Period|Lost to Follow-up|1|||
126409794|NCT03517566|454793816|FG004|Overall Study|Lack of Efficacy|4|||
126409795|NCT03517566|454793812|FG000|Overall Study|Lost to Follow-up|3|||
126409796|NCT03517566|454793813|FG001|Overall Study|Lost to Follow-up|1|||
126409797|NCT03517566|454793814|FG002|Overall Study|Lost to Follow-up|1|||
126409798|NCT03517566|454793815|FG003|Overall Study|Lost to Follow-up|1|||
126409799|NCT03517566|454793816|FG004|Overall Study|Lost to Follow-up|0|||
126409800|NCT03517566|454793812|FG000|Overall Study|Physician Decision|1|||
126409801|NCT03517566|454793813|FG001|Overall Study|Physician Decision|1|||
126409802|NCT03517566|454793814|FG002|Overall Study|Physician Decision|0|||
126409803|NCT03517566|454793815|FG003|Overall Study|Physician Decision|1|||
126409804|NCT03517566|454793816|FG004|Overall Study|Physician Decision|0|||
126409805|NCT03517566|454793812|FG000|Overall Study|Pregnancy|0|||
126409806|NCT03517566|454793813|FG001|Overall Study|Pregnancy|1|||
126409807|NCT03517566|454793814|FG002|Overall Study|Pregnancy|0|||
126409808|NCT03517566|454793815|FG003|Overall Study|Pregnancy|0|||
126409809|NCT03517566|454793816|FG004|Overall Study|Pregnancy|0|||
126409810|NCT03517566|454793812|FG000|Overall Study|Protocol Deviation|0|||
126409811|NCT03517566|454793813|FG001|Overall Study|Protocol Deviation|1|||
126409812|NCT03517566|454793814|FG002|Overall Study|Protocol Deviation|0|||
126409813|NCT03517566|454793815|FG003|Overall Study|Protocol Deviation|1|||
126409814|NCT03517566|454793816|FG004|Overall Study|Protocol Deviation|1|||
126409815|NCT03517566|454793812|FG000|Overall Study|Study terminated by Sponsor|11|||
126409816|NCT03517566|454793813|FG001|Overall Study|Study terminated by Sponsor|5|||
126409817|NCT03517566|454793814|FG002|Overall Study|Study terminated by Sponsor|6|||
126409818|NCT03517566|454793815|FG003|Overall Study|Study terminated by Sponsor|14|||
126409819|NCT03517566|454793816|FG004|Overall Study|Study terminated by Sponsor|12|||
126409820|NCT03517566|454793812|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
126409821|NCT03517566|454793813|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
126409822|NCT03517566|454793814|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
126409823|NCT03517566|454793815|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
126409824|NCT03517566|454793816|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
126409825|NCT04566692|454793817|FG000|Overall Study|Adverse Event|2|||
126409826|NCT04566692|454793818|FG001|Overall Study|Adverse Event|0|||
126409827|NCT04566692|454793817|FG000|Overall Study|Withdrawal by Subject|1|||
126409828|NCT04566692|454793818|FG001|Overall Study|Withdrawal by Subject|1|||
126409829|NCT00671437|454793819|FG000|Overall Study|Progressive disease before C1 week 8|8|||
126409830|NCT00671437|454793819|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
126409831|NCT00671437|454793819|FG000|Overall Study|Adverse Event|3|||
126409832|NCT00671437|454793819|FG000|Overall Study|Ineligible post-hoc|1|||
126409833|NCT04311463|454793822|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
126409834|NCT04311463|454793823|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
126409835|NCT04311463|454793822|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
126409836|NCT04311463|454793823|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
126409837|NCT04311463|454793822|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
126409838|NCT04311463|454793823|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
126409839|NCT03203291|454793828|FG000|Overall Study|Withdrawal by Subject|1|||
126409840|NCT00737633|454793830|FG000|Overall Study|Study terminated by sponsor|44|||
126409841|NCT00737633|454793831|FG001|Overall Study|Study terminated by sponsor|55|||
126409842|NCT00737633|454793830|FG000|Overall Study|Lost to Follow-up|0|||
126409843|NCT00737633|454793831|FG001|Overall Study|Lost to Follow-up|1|||
126409844|NCT00737633|454793830|FG000|Overall Study|protocol non-compliance|0|||
126409845|NCT00737633|454793831|FG001|Overall Study|protocol non-compliance|1|||
126409846|NCT01300260|454793836|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
126409847|NCT01300260|454793837|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
126409848|NCT01300260|454793836|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
126409849|NCT01300260|454793837|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
126473969|NCT03307785|455034613|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
126473970|NCT03307785|455034614|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
126473971|NCT03307785|455034615|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
126473972|NCT03021304|455034616|FG000|Overall Study|Lack of Efficacy|1|||
126473973|NCT00492531|455034618|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
126721455|NCT00195260|455929969|FG001|Part 1: Dose Escalation|Disease Progression|2|||
126409850|NCT01300260|454793836|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
126409851|NCT01300260|454793837|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
126409852|NCT00377364|454793838|FG000|Overall Study|Lost to Follow-up|1|||
126409853|NCT00377364|454793839|FG001|Overall Study|Lost to Follow-up|0|||
126409854|NCT00377364|454793838|FG000|Overall Study|Withdrawal by Subject|1|||
126721456|NCT00195260|455929970|FG002|Part 1: Dose Escalation|Disease Progression|5|||
126409855|NCT00377364|454793839|FG001|Overall Study|Withdrawal by Subject|0|||
126409856|NCT02540265|454793847|FG000|Overall Study|Lost to Follow-up|0|||
126409857|NCT02540265|454793848|FG001|Overall Study|Lost to Follow-up|0|||
126409858|NCT02540265|454793849|FG002|Overall Study|Lost to Follow-up|1|||
126409859|NCT03157037|454793855|FG000|Overall Study|Death|1|||
126409860|NCT02102399|454793856|FG000|Overall Study|Withdrawal by Subject|6|||
126409861|NCT02102399|454793857|FG001|Overall Study|Withdrawal by Subject|4|||
126409862|NCT03101085|454793858|FG000|Overall Study|Lost to Follow-up|0|||
126409863|NCT03101085|454793859|FG001|Overall Study|Lost to Follow-up|1|||
126409864|NCT00695864|454793860|FG000|Placebo|Withdrawal by Subject|1|||
126409865|NCT00695864|454793860|FG000|Placebo|Physician Decision|4|||
126409866|NCT01704456|454793861|FG000|Overall Study|Lost to Follow-up|8|||
126409867|NCT01704456|454793862|FG001|Overall Study|Lost to Follow-up|14|||
126409868|NCT00718770|454793863|FG000|Overall Study|Adverse Event|1|||
126409869|NCT00718770|454793863|FG000|Overall Study|Lack of Efficacy|1|||
126409870|NCT00718770|454793863|FG000|Overall Study|Lack of Efficacy|1|||
126409871|NCT00718770|454793863|FG000|Overall Study|Adverse Event|1|||
126409872|NCT00718770|454793863|FG000|Overall Study|Lack of Efficacy|1|||
126409873|NCT00718770|454793863|FG000|Overall Study|Adverse Event|1|||
126409874|NCT00718770|454793863|FG000|Overall Study|Lack of Efficacy|1|||
126409875|NCT00718770|454793863|FG000|Overall Study|Adverse Event|1|||
126409876|NCT00498355|454793864|FG000|Overall Study|Lost to Follow-up|1|||
126409877|NCT04583956|454793865|FG000|Overall Study|Death|9|||
126409878|NCT04583956|454793866|FG001|Overall Study|Death|11|||
126409879|NCT04583956|454793865|FG000|Overall Study|Lost to Follow-up|7|||
126409880|NCT04583956|454793866|FG001|Overall Study|Lost to Follow-up|9|||
126409881|NCT04583956|454793865|FG000|Overall Study|Protocol Violation|2|||
126409882|NCT04583956|454793866|FG001|Overall Study|Protocol Violation|0|||
126409883|NCT04583956|454793865|FG000|Overall Study|Withdrawal by Subject|0|||
126409884|NCT04583956|454793866|FG001|Overall Study|Withdrawal by Subject|2|||
126409885|NCT04583956|454793865|FG000|Overall Study|Randomized but not dosed|2|||
126409886|NCT04583956|454793866|FG001|Overall Study|Randomized but not dosed|3|||
126473974|NCT00492531|455034619|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
126473975|NCT00423514|455034621|FG000|Overall Study|Ineligible|1|||
126473976|NCT00423514|455034622|FG001|Overall Study|Ineligible|0|||
126473977|NCT03685123|455034623|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
126473978|NCT03685123|455034624|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
126473979|NCT03685123|455034625|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
126473980|NCT03685123|455034623|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
126473981|NCT03685123|455034624|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
126473982|NCT03685123|455034625|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
126473983|NCT03685123|455034623|FG000|Weight Loss Phase|Lost to Follow-up|1|||
126473984|NCT03685123|455034624|FG001|Weight Loss Phase|Lost to Follow-up|0|||
126473985|NCT03685123|455034625|FG002|Weight Loss Phase|Lost to Follow-up|0|||
126473986|NCT03685123|455034623|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
126409887|NCT04583956|454793865|FG000|Overall Study|Withdrawal of consent before product administration|1|||
126409888|NCT04583956|454793866|FG001|Overall Study|Withdrawal of consent before product administration|0|||
126409889|NCT02100475|454795433|FG000|Overall Study|Unclassified|1|||
126409890|NCT02100475|454795434|FG001|Overall Study|Unclassified|2|||
126409891|NCT02100475|454795433|FG000|Overall Study|Withdrawal criteria|1|||
126409892|NCT02100475|454795434|FG001|Overall Study|Withdrawal criteria|0|||
126409893|NCT04599465|454795435|FG000|Overall Study|Physician Decision|1|||
126409894|NCT04599465|454795435|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
126409895|NCT00765063|454795436|FG000|Overall Study|Lack of Efficacy|5|||
126409896|NCT00765063|454795436|FG000|Overall Study|Withdrawal by Subject|1|||
126409897|NCT00765063|454795436|FG000|Overall Study|Other|16|||
126409898|NCT00765063|454795436|FG000|Overall Study|Protocol Violation|6|||
126409899|NCT00765063|454795436|FG000|Overall Study|Adverse Event|4|||
126409900|NCT01041287|454795439|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
126473987|NCT03685123|455034624|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
126409901|NCT01041287|454795440|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
126473988|NCT03685123|455034625|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
126473989|NCT03685123|455034623|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
126473990|NCT03685123|455034624|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
126473991|NCT03685123|455034625|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
126473992|NCT03685123|455034623|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
126473993|NCT03685123|455034624|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
126473994|NCT03685123|455034625|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
126473995|NCT00400764|455034626|FG000|Phase Ib|Adverse Event|1|||
126473996|NCT00400764|455034627|FG001|Phase Ib|Adverse Event|0|||
126409902|NCT01041287|454795439|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
126409903|NCT01041287|454795440|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
126409904|NCT02814175|454795441|FG000|Part 1|Adverse Event|2|||
126409905|NCT02814175|454795442|FG001|Part 1|Adverse Event|3|||
126409906|NCT02814175|454795443|FG002|Part 1|Adverse Event|0|||
126409907|NCT02814175|454795444|FG003|Part 1|Adverse Event|0|||
126409908|NCT02814175|454795445|FG004|Part 1|Adverse Event|0|||
126473997|NCT00400764|455034628|FG002|Phase Ib|Adverse Event|0|||
126473998|NCT00400764|455034629|FG003|Phase Ib|Adverse Event|0|||
126473999|NCT00400764|455034630|FG004|Phase Ib|Adverse Event|0|||
126474000|NCT00400764|455034626|FG000|Phase Ib|Death|1|||
126409909|NCT02814175|454795446|FG005|Part 1|Adverse Event|0|||
126409910|NCT02814175|454795441|FG000|Part 1|Withdrawal Consent|8|||
126409911|NCT02814175|454795442|FG001|Part 1|Withdrawal Consent|1|||
126409912|NCT02814175|454795443|FG002|Part 1|Withdrawal Consent|0|||
126409913|NCT02814175|454795444|FG003|Part 1|Withdrawal Consent|0|||
126409914|NCT02814175|454795445|FG004|Part 1|Withdrawal Consent|0|||
126409915|NCT02814175|454795446|FG005|Part 1|Withdrawal Consent|0|||
126409916|NCT02814175|454795441|FG000|Part 1|Lost to Follow-up|1|||
126409917|NCT02814175|454795442|FG001|Part 1|Lost to Follow-up|0|||
126409918|NCT02814175|454795443|FG002|Part 1|Lost to Follow-up|0|||
126409919|NCT02814175|454795444|FG003|Part 1|Lost to Follow-up|0|||
126409920|NCT02814175|454795445|FG004|Part 1|Lost to Follow-up|0|||
126409921|NCT02814175|454795446|FG005|Part 1|Lost to Follow-up|0|||
126409922|NCT02814175|454795441|FG000|Part 1|Lack of Efficacy|1|||
126409923|NCT02814175|454795442|FG001|Part 1|Lack of Efficacy|2|||
126409924|NCT02814175|454795443|FG002|Part 1|Lack of Efficacy|0|||
126409925|NCT02814175|454795444|FG003|Part 1|Lack of Efficacy|0|||
126409926|NCT02814175|454795445|FG004|Part 1|Lack of Efficacy|0|||
126409927|NCT02814175|454795446|FG005|Part 1|Lack of Efficacy|0|||
126409928|NCT02814175|454795441|FG000|Part 2|Adverse Event|0|||
126409929|NCT02814175|454795442|FG001|Part 2|Adverse Event|0|||
126409930|NCT02814175|454795443|FG002|Part 2|Adverse Event|0|||
126409931|NCT02814175|454795444|FG003|Part 2|Adverse Event|1|||
126409932|NCT02814175|454795445|FG004|Part 2|Adverse Event|1|||
126409933|NCT02814175|454795446|FG005|Part 2|Adverse Event|2|||
126409934|NCT02814175|454795441|FG000|Part 2|Withdrawal Consent|0|||
126409935|NCT02814175|454795442|FG001|Part 2|Withdrawal Consent|0|||
126409936|NCT02814175|454795443|FG002|Part 2|Withdrawal Consent|0|||
126409937|NCT02814175|454795444|FG003|Part 2|Withdrawal Consent|2|||
126409938|NCT02814175|454795445|FG004|Part 2|Withdrawal Consent|1|||
126409939|NCT02814175|454795446|FG005|Part 2|Withdrawal Consent|1|||
126409940|NCT02814175|454795441|FG000|Part 2|Lost to Follow-up|0|||
126409941|NCT02814175|454795442|FG001|Part 2|Lost to Follow-up|0|||
126409942|NCT02814175|454795443|FG002|Part 2|Lost to Follow-up|0|||
126409943|NCT02814175|454795444|FG003|Part 2|Lost to Follow-up|1|||
126409944|NCT02814175|454795445|FG004|Part 2|Lost to Follow-up|0|||
126409945|NCT02814175|454795446|FG005|Part 2|Lost to Follow-up|0|||
126409946|NCT02814175|454795441|FG000|Part 2|Lack of Efficacy|0|||
126409947|NCT02814175|454795442|FG001|Part 2|Lack of Efficacy|0|||
126409948|NCT02814175|454795443|FG002|Part 2|Lack of Efficacy|0|||
126409949|NCT02814175|454795444|FG003|Part 2|Lack of Efficacy|0|||
126409950|NCT02814175|454795445|FG004|Part 2|Lack of Efficacy|0|||
126409951|NCT02814175|454795446|FG005|Part 2|Lack of Efficacy|3|||
126409952|NCT01673620|454795447|FG000|Overall Study|Adverse Event|1|||
126409953|NCT01673620|454795448|FG001|Overall Study|Adverse Event|0|||
126409954|NCT03416127|454795449|FG000|Overall Study|Withdrawal by Subject|0|||
126409955|NCT03416127|454795450|FG001|Overall Study|Withdrawal by Subject|1|||
126409956|NCT03416127|454795451|FG002|Overall Study|Withdrawal by Subject|1|||
126409957|NCT02397057|454795452|FG000|Overall Study|Withdrawal by Subject|6|||
126409958|NCT02397057|454795453|FG001|Overall Study|Withdrawal by Subject|7|||
126409959|NCT02397057|454795452|FG000|Overall Study|Lost to Follow-up|4|||
126409960|NCT02397057|454795453|FG001|Overall Study|Lost to Follow-up|3|||
126409961|NCT02397057|454795452|FG000|Overall Study|Death|1|||
126409962|NCT02397057|454795453|FG001|Overall Study|Death|0|||
126409963|NCT02397057|454795452|FG000|Overall Study|Adverse Event|0|||
126409964|NCT02397057|454795453|FG001|Overall Study|Adverse Event|1|||
126409965|NCT02397057|454795452|FG000|Overall Study|Physician Decision|0|||
126409966|NCT02397057|454795453|FG001|Overall Study|Physician Decision|1|||
126409967|NCT02397057|454795452|FG000|Overall Study|Subject did not receive study drug|0|||
126409968|NCT02397057|454795453|FG001|Overall Study|Subject did not receive study drug|1|||
126409969|NCT00753454|454795458|FG000|Overall Study|Adverse Event|4|||
126409970|NCT00753454|454795458|FG000|Overall Study|Lack of Efficacy|1|||
126474001|NCT00400764|455034627|FG001|Phase Ib|Death|0|||
126474002|NCT00400764|455034628|FG002|Phase Ib|Death|0|||
126409971|NCT00753454|454795458|FG000|Overall Study|Lost to Follow-up|3|||
126409972|NCT00753454|454795458|FG000|Overall Study|Withdrawal by Subject|5|||
126409973|NCT00753454|454795458|FG000|Overall Study|Investigator Decision|1|||
126409974|NCT03927144|454795459|FG000|Core Phase|Adverse Event|9|||
126409975|NCT03927144|454795460|FG001|Core Phase|Adverse Event|5|||
126409976|NCT03927144|454795459|FG000|Core Phase|Lost to Follow-up|3|||
126474003|NCT00400764|455034629|FG003|Phase Ib|Death|0|||
126409977|NCT03927144|454795460|FG001|Core Phase|Lost to Follow-up|2|||
126409978|NCT03927144|454795459|FG000|Core Phase|New Therapy for Study Indication|0|||
126409979|NCT03927144|454795460|FG001|Core Phase|New Therapy for Study Indication|1|||
126409980|NCT03927144|454795459|FG000|Core Phase|No Longer Clinically Benefiting|4|||
126409981|NCT03927144|454795460|FG001|Core Phase|No Longer Clinically Benefiting|4|||
126409982|NCT03927144|454795459|FG000|Core Phase|Physician Decision|2|||
126409983|NCT03927144|454795460|FG001|Core Phase|Physician Decision|8|||
126409984|NCT03927144|454795459|FG000|Core Phase|Protocol Violation|2|||
126409985|NCT03927144|454795460|FG001|Core Phase|Protocol Violation|2|||
126409986|NCT03927144|454795459|FG000|Core Phase|Withdrawal by Subject|16|||
126409987|NCT03927144|454795460|FG001|Core Phase|Withdrawal by Subject|40|||
126409988|NCT03927144|454795459|FG000|Extension Phase|Adverse Event|2|||
126409989|NCT03927144|454795460|FG001|Extension Phase|Adverse Event|1|||
126409990|NCT03927144|454795459|FG000|Extension Phase|No longer clinically benefiting|4|||
126409991|NCT03927144|454795460|FG001|Extension Phase|No longer clinically benefiting|5|||
126474004|NCT00400764|455034630|FG004|Phase Ib|Death|0|||
126409992|NCT03927144|454795459|FG000|Extension Phase|Pregnancy|1|||
126409993|NCT03927144|454795460|FG001|Extension Phase|Pregnancy|0|||
126474005|NCT00400764|455034626|FG000|Phase Ib|Disease Progression|4|||
126474006|NCT00400764|455034627|FG001|Phase Ib|Disease Progression|4|||
126474007|NCT00400764|455034628|FG002|Phase Ib|Disease Progression|0|||
126474008|NCT00400764|455034629|FG003|Phase Ib|Disease Progression|0|||
126409994|NCT03927144|454795459|FG000|Extension Phase|Protocol Violation|0|||
126409995|NCT03927144|454795460|FG001|Extension Phase|Protocol Violation|1|||
126409996|NCT03927144|454795459|FG000|Extension Phase|Withdrawal by Subject|8|||
126409997|NCT03927144|454795460|FG001|Extension Phase|Withdrawal by Subject|3|||
126409998|NCT01452919|454795467|FG000|Open-Label Treatment|Adverse Event|5|||
126409999|NCT01452919|454795468|FG001|Open-Label Treatment|Adverse Event|0|||
126410000|NCT01452919|454795469|FG002|Open-Label Treatment|Adverse Event|0|||
126410001|NCT01452919|454795467|FG000|Open-Label Treatment|Lost to Follow-up|4|||
126410002|NCT01452919|454795468|FG001|Open-Label Treatment|Lost to Follow-up|0|||
126410003|NCT01452919|454795469|FG002|Open-Label Treatment|Lost to Follow-up|0|||
126410004|NCT01452919|454795467|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
126410005|NCT01452919|454795468|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
126410006|NCT01452919|454795469|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
126410007|NCT01452919|454795467|FG000|Open-Label Treatment|Protocol Violation|4|||
126410008|NCT01452919|454795468|FG001|Open-Label Treatment|Protocol Violation|0|||
126410009|NCT01452919|454795469|FG002|Open-Label Treatment|Protocol Violation|0|||
126410010|NCT01452919|454795467|FG000|Open-Label Treatment|Sponsor Decision|1|||
126410011|NCT01452919|454795468|FG001|Open-Label Treatment|Sponsor Decision|0|||
126410012|NCT01452919|454795469|FG002|Open-Label Treatment|Sponsor Decision|0|||
126410013|NCT01452919|454795467|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
126410014|NCT01452919|454795468|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
126410015|NCT01452919|454795469|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
126410016|NCT01452919|454795467|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
126410017|NCT01452919|454795468|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
126410018|NCT01452919|454795469|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
126410019|NCT01452919|454795467|FG000|Randomization Treatment|Adverse Event|0|||
126410020|NCT01452919|454795468|FG001|Randomization Treatment|Adverse Event|0|||
126410021|NCT01452919|454795469|FG002|Randomization Treatment|Adverse Event|2|||
126410022|NCT01452919|454795467|FG000|Randomization Treatment|Sponsor Decision|0|||
126410023|NCT01452919|454795468|FG001|Randomization Treatment|Sponsor Decision|1|||
126410024|NCT01452919|454795469|FG002|Randomization Treatment|Sponsor Decision|0|||
126410025|NCT01452919|454795467|FG000|Randomization Treatment|Withdrawal by Subject|0|||
126410026|NCT01452919|454795468|FG001|Randomization Treatment|Withdrawal by Subject|1|||
126410027|NCT01452919|454795469|FG002|Randomization Treatment|Withdrawal by Subject|0|||
126410028|NCT01452919|454795467|FG000|Randomization Treatment|Subject is moving or has moved|0|||
126410029|NCT01452919|454795468|FG001|Randomization Treatment|Subject is moving or has moved|1|||
126410030|NCT01452919|454795469|FG002|Randomization Treatment|Subject is moving or has moved|0|||
126410031|NCT01192412|454795470|FG000|Overall Study|Lost to Follow-up|2|||
126410032|NCT01192412|454795471|FG001|Overall Study|Lost to Follow-up|1|||
126410033|NCT01192412|454795470|FG000|Overall Study|Withdrawal by Subject|2|||
126410034|NCT01192412|454795471|FG001|Overall Study|Withdrawal by Subject|1|||
126410035|NCT02421588|454795472|FG000|Overall Study|Non-treatment-related AE|8|||
126410036|NCT02421588|454795473|FG001|Overall Study|Non-treatment-related AE|8|||
126410037|NCT02421588|454795472|FG000|Overall Study|Progressive disease|152|||
126410038|NCT02421588|454795473|FG001|Overall Study|Progressive disease|135|||
126410039|NCT02421588|454795472|FG000|Overall Study|Death|11|||
126410040|NCT02421588|454795473|FG001|Overall Study|Death|3|||
126410041|NCT02421588|454795472|FG000|Overall Study|Physician Decision|8|||
126410042|NCT02421588|454795473|FG001|Overall Study|Physician Decision|17|||
126410043|NCT02421588|454795472|FG000|Overall Study|Other reason not specified|3|||
126410044|NCT02421588|454795473|FG001|Overall Study|Other reason not specified|1|||
126474009|NCT00400764|455034630|FG004|Phase Ib|Disease Progression|0|||
126474010|NCT00400764|455034626|FG000|Phase II|Death|0|||
126474011|NCT00400764|455034627|FG001|Phase II|Death|0|||
126474012|NCT00400764|455034628|FG002|Phase II|Death|1|||
126721457|NCT00195260|455929971|FG003|Part 1: Dose Escalation|Disease Progression|6|||
126410045|NCT02421588|454795472|FG000|Overall Study|Symptomatic deterioration|13|||
126410046|NCT02421588|454795473|FG001|Overall Study|Symptomatic deterioration|19|||
126410047|NCT02421588|454795472|FG000|Overall Study|Treatment-related AE|10|||
126410048|NCT02421588|454795473|FG001|Overall Study|Treatment-related AE|14|||
126410049|NCT02421588|454795472|FG000|Overall Study|Withdrawal by Subject|14|||
126410050|NCT02421588|454795473|FG001|Overall Study|Withdrawal by Subject|16|||
126410051|NCT02421588|454795472|FG000|Overall Study|Not treated|2|||
126410052|NCT02421588|454795473|FG001|Overall Study|Not treated|8|||
126474013|NCT00400764|455034629|FG003|Phase II|Death|2|||
126410053|NCT01359943|454795474|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
126410054|NCT01359943|454795475|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
126474014|NCT00400764|455034630|FG004|Phase II|Death|0|||
126474015|NCT00400764|455034626|FG000|Phase II|Lost to Follow-up|0|||
126474016|NCT00400764|455034627|FG001|Phase II|Lost to Follow-up|0|||
126474017|NCT00400764|455034628|FG002|Phase II|Lost to Follow-up|1|||
126410055|NCT01359943|454795476|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
126410056|NCT01359943|454795474|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
126410057|NCT01359943|454795475|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
126410058|NCT01359943|454795476|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
126410059|NCT01359943|454795474|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
126410060|NCT01359943|454795475|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
126410061|NCT01359943|454795476|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
126410062|NCT01359943|454795474|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
126410063|NCT01359943|454795475|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
126410064|NCT01359943|454795476|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
126410065|NCT01359943|454795474|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
126410066|NCT01359943|454795475|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
126410067|NCT01359943|454795476|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
126410068|NCT01359943|454795474|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
126410069|NCT01359943|454795475|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
126410070|NCT01359943|454795476|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
126410071|NCT01359943|454795474|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
126410072|NCT01359943|454795475|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
126410073|NCT01359943|454795476|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
126410074|NCT01359943|454795474|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
126410075|NCT01359943|454795475|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
126410076|NCT01359943|454795476|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
126410077|NCT01359943|454795474|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
126410078|NCT01359943|454795475|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
126410079|NCT01359943|454795476|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
126410080|NCT01359943|454795474|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
126410081|NCT01359943|454795475|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
126410082|NCT01359943|454795476|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
126410083|NCT01359943|454795474|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
126410084|NCT01359943|454795475|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
126410085|NCT01359943|454795476|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
126410086|NCT01359943|454795474|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
126410087|NCT01359943|454795475|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
126410088|NCT01359943|454795476|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
126410089|NCT01359943|454795474|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
126410090|NCT01359943|454795475|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
126410091|NCT01359943|454795476|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
126410092|NCT01359943|454795474|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
126410093|NCT01359943|454795475|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
126410094|NCT01359943|454795476|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
126410095|NCT01359943|454795474|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
126410096|NCT01359943|454795475|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
126410097|NCT01359943|454795476|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
126410098|NCT03194646|454795486|FG000|Overall Study|Adverse Event|24|||
126410099|NCT03194646|454795487|FG001|Overall Study|Adverse Event|25|||
126410100|NCT03194646|454795488|FG002|Overall Study|Adverse Event|14|||
126410101|NCT03194646|454795489|FG003|Overall Study|Adverse Event|17|||
126410102|NCT03194646|454795486|FG000|Overall Study|Lack of Efficacy|4|||
126410103|NCT03194646|454795487|FG001|Overall Study|Lack of Efficacy|2|||
126410104|NCT03194646|454795488|FG002|Overall Study|Lack of Efficacy|2|||
126410105|NCT03194646|454795489|FG003|Overall Study|Lack of Efficacy|12|||
126410106|NCT03194646|454795486|FG000|Overall Study|Lost to Follow-up|30|||
126410107|NCT03194646|454795487|FG001|Overall Study|Lost to Follow-up|22|||
126410108|NCT03194646|454795488|FG002|Overall Study|Lost to Follow-up|12|||
126410109|NCT03194646|454795489|FG003|Overall Study|Lost to Follow-up|35|||
126410110|NCT03194646|454795486|FG000|Overall Study|Non-compliance with study drug|4|||
126410111|NCT03194646|454795487|FG001|Overall Study|Non-compliance with study drug|0|||
126410112|NCT03194646|454795488|FG002|Overall Study|Non-compliance with study drug|1|||
126410113|NCT03194646|454795489|FG003|Overall Study|Non-compliance with study drug|1|||
126410114|NCT03194646|454795486|FG000|Overall Study|Other|89|||
126410115|NCT03194646|454795487|FG001|Overall Study|Other|68|||
126474018|NCT00400764|455034629|FG003|Phase II|Lost to Follow-up|0|||
126474019|NCT00400764|455034630|FG004|Phase II|Lost to Follow-up|0|||
126474020|NCT00400764|455034626|FG000|Phase II|Physician Decision|0|||
126474021|NCT00400764|455034627|FG001|Phase II|Physician Decision|0|||
126410116|NCT03194646|454795488|FG002|Overall Study|Other|34|||
126474022|NCT00400764|455034628|FG002|Phase II|Physician Decision|1|||
126410117|NCT03194646|454795489|FG003|Overall Study|Other|31|||
126410118|NCT03194646|454795486|FG000|Overall Study|Physician Decision|7|||
126474023|NCT00400764|455034629|FG003|Phase II|Physician Decision|1|||
126474024|NCT00400764|455034630|FG004|Phase II|Physician Decision|0|||
126410119|NCT03194646|454795487|FG001|Overall Study|Physician Decision|9|||
126410120|NCT03194646|454795488|FG002|Overall Study|Physician Decision|5|||
126410121|NCT03194646|454795489|FG003|Overall Study|Physician Decision|4|||
126410122|NCT03194646|454795486|FG000|Overall Study|Pregnancy|4|||
126410123|NCT03194646|454795487|FG001|Overall Study|Pregnancy|5|||
126410124|NCT03194646|454795488|FG002|Overall Study|Pregnancy|1|||
126410125|NCT03194646|454795489|FG003|Overall Study|Pregnancy|2|||
126410126|NCT03194646|454795486|FG000|Overall Study|Protocol Violation|4|||
126410127|NCT03194646|454795487|FG001|Overall Study|Protocol Violation|2|||
126410128|NCT03194646|454795488|FG002|Overall Study|Protocol Violation|1|||
126410129|NCT03194646|454795489|FG003|Overall Study|Protocol Violation|1|||
126410130|NCT03194646|454795486|FG000|Overall Study|Site terminated by sponsor|0|||
126410131|NCT03194646|454795487|FG001|Overall Study|Site terminated by sponsor|0|||
126410132|NCT03194646|454795488|FG002|Overall Study|Site terminated by sponsor|2|||
126410133|NCT03194646|454795489|FG003|Overall Study|Site terminated by sponsor|0|||
126410134|NCT03194646|454795486|FG000|Overall Study|Study terminated by sponsor|62|||
126410135|NCT03194646|454795487|FG001|Overall Study|Study terminated by sponsor|61|||
126410136|NCT03194646|454795488|FG002|Overall Study|Study terminated by sponsor|30|||
126410137|NCT03194646|454795489|FG003|Overall Study|Study terminated by sponsor|34|||
126410138|NCT03194646|454795486|FG000|Overall Study|Withdrawal by Subject|75|||
126410139|NCT03194646|454795487|FG001|Overall Study|Withdrawal by Subject|74|||
126410140|NCT03194646|454795488|FG002|Overall Study|Withdrawal by Subject|36|||
126410141|NCT03194646|454795489|FG003|Overall Study|Withdrawal by Subject|131|||
126410142|NCT03194646|454795486|FG000|Overall Study|Missing|1|||
126410143|NCT03194646|454795487|FG001|Overall Study|Missing|0|||
126410144|NCT03194646|454795488|FG002|Overall Study|Missing|1|||
126410145|NCT03194646|454795489|FG003|Overall Study|Missing|12|||
126410146|NCT02649894|454795490|FG000|Overall Study|Adverse Event|1|||
126410147|NCT02649894|454795491|FG001|Overall Study|Adverse Event|0|||
126410148|NCT02649894|454795490|FG000|Overall Study|Physician Decision|0|||
126410149|NCT02649894|454795491|FG001|Overall Study|Physician Decision|1|||
126410150|NCT02649894|454795490|FG000|Overall Study|Withdrawal by Subject|5|||
126410151|NCT02649894|454795491|FG001|Overall Study|Withdrawal by Subject|2|||
126410152|NCT02649894|454795490|FG000|Overall Study|Lost to Follow-up|2|||
126410153|NCT02649894|454795491|FG001|Overall Study|Lost to Follow-up|1|||
126410154|NCT02649894|454795490|FG000|Overall Study|Death|30|||
126410155|NCT02649894|454795491|FG001|Overall Study|Death|7|||
126410156|NCT02649894|454795490|FG000|Overall Study|Other, not specified|6|||
126410157|NCT02649894|454795491|FG001|Overall Study|Other, not specified|0|||
126410158|NCT00719680|454795492|FG000|Overall Study|Adverse Event|1|||
126410159|NCT00719680|454795492|FG000|Overall Study|Lost to Follow-up|1|||
126410160|NCT00719680|454795492|FG000|Overall Study|Withdrawal by Subject|3|||
126410161|NCT02141360|454795493|FG000|Overall Study|Withdrawal by Subject|6|||
126410162|NCT02141360|454795494|FG001|Overall Study|Withdrawal by Subject|0|||
126410163|NCT02141360|454795495|FG002|Overall Study|Withdrawal by Subject|0|||
126410164|NCT02141360|454795493|FG000|Overall Study|Study Terminated before Visit|1|||
126410165|NCT02141360|454795494|FG001|Overall Study|Study Terminated before Visit|0|||
126410166|NCT02141360|454795495|FG002|Overall Study|Study Terminated before Visit|0|||
126410167|NCT04071158|454795496|FG000|Overall Study|Lost to Follow-up|1|||
126410168|NCT04071158|454795497|FG001|Overall Study|Lost to Follow-up|2|||
126410169|NCT04071158|454795498|FG002|Overall Study|Lost to Follow-up|3|||
126410170|NCT04071158|454795499|FG003|Overall Study|Lost to Follow-up|3|||
126410171|NCT04071158|454795500|FG004|Overall Study|Lost to Follow-up|5|||
126410172|NCT04071158|454795496|FG000|Overall Study|Randomized but not treated|2|||
126474025|NCT00400764|455034626|FG000|Phase II|Sponsor's decision to terminate|0|||
126474026|NCT00400764|455034627|FG001|Phase II|Sponsor's decision to terminate|0|||
126474027|NCT00400764|455034628|FG002|Phase II|Sponsor's decision to terminate|18|||
126474028|NCT00400764|455034629|FG003|Phase II|Sponsor's decision to terminate|22|||
126474029|NCT00400764|455034630|FG004|Phase II|Sponsor's decision to terminate|11|||
126410173|NCT04071158|454795497|FG001|Overall Study|Randomized but not treated|2|||
126410174|NCT04071158|454795498|FG002|Overall Study|Randomized but not treated|0|||
126410175|NCT04071158|454795499|FG003|Overall Study|Randomized but not treated|0|||
126410176|NCT04071158|454795500|FG004|Overall Study|Randomized but not treated|0|||
126410177|NCT01178099|454795501|FG000|Overall Study|Physician Decision|0|||
126410178|NCT01178099|454795502|FG001|Overall Study|Physician Decision|1|||
126410179|NCT02516592|454795503|FG000|Overall Study|Patient withdrew consent|5|||
126410180|NCT02516592|454795504|FG001|Overall Study|Patient withdrew consent|2|||
126410181|NCT02516592|454795503|FG000|Overall Study|Protocol deviation|4|||
126410182|NCT02516592|454795504|FG001|Overall Study|Protocol deviation|4|||
126410183|NCT02516592|454795503|FG000|Overall Study|Lost to Follow-up|2|||
126410184|NCT02516592|454795504|FG001|Overall Study|Lost to Follow-up|3|||
126410185|NCT02516592|454795503|FG000|Overall Study|Patient/guardian decision|2|||
126410186|NCT02516592|454795504|FG001|Overall Study|Patient/guardian decision|1|||
126410187|NCT02516592|454795503|FG000|Overall Study|Adverse Event|1|||
126474030|NCT00400764|455034626|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
126474031|NCT00400764|455034627|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
126410188|NCT02516592|454795504|FG001|Overall Study|Adverse Event|2|||
126410189|NCT02516592|454795503|FG000|Overall Study|Abnormal test procedure result|1|||
126410190|NCT02516592|454795504|FG001|Overall Study|Abnormal test procedure result|0|||
126410191|NCT02516592|454795503|FG000|Overall Study|Death|1|||
126410192|NCT02516592|454795504|FG001|Overall Study|Death|1|||
126410193|NCT01286740|454795505|FG000|Overall Study|Enrolled but not treated|1|||
126410194|NCT01286740|454795505|FG000|Overall Study|Protocol Violation|1|||
126410195|NCT01110382|454795507|FG000|Overall Study|Withdrawal by Subject|0|||
126410196|NCT01110382|454795508|FG001|Overall Study|Withdrawal by Subject|1|||
126410197|NCT01110382|454795507|FG000|Overall Study|Protocol Violation|0|||
126410198|NCT01110382|454795508|FG001|Overall Study|Protocol Violation|1|||
126410199|NCT00902174|454795510|FG000|Overall Study|Adverse Event|27|||
126410200|NCT00902174|454795511|FG001|Overall Study|Adverse Event|7|||
126410201|NCT00902174|454795510|FG000|Overall Study|Lack of Efficacy|1|||
126410202|NCT00902174|454795511|FG001|Overall Study|Lack of Efficacy|5|||
126410203|NCT00902174|454795510|FG000|Overall Study|Death|2|||
126410204|NCT00902174|454795511|FG001|Overall Study|Death|2|||
126410205|NCT00902174|454795510|FG000|Overall Study|Withdrawal by Subject|2|||
126410206|NCT00902174|454795511|FG001|Overall Study|Withdrawal by Subject|1|||
126410207|NCT00902174|454795510|FG000|Overall Study|Abnormal labs|1|||
126410208|NCT00902174|454795511|FG001|Overall Study|Abnormal labs|1|||
126410209|NCT00902174|454795510|FG000|Overall Study|Protocol Violation|1|||
126410210|NCT00902174|454795511|FG001|Overall Study|Protocol Violation|1|||
126410211|NCT00902174|454795510|FG000|Overall Study|Administration problem|0|||
126410212|NCT00902174|454795511|FG001|Overall Study|Administration problem|1|||
126410213|NCT00576576|454795519|FG000|Overall Study|Lost to Follow-up|6|||
126410214|NCT00576576|454795519|FG000|Overall Study|Protocol Violation|1|||
126410215|NCT01805037|454795525|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
126410216|NCT01805037|454795526|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
126410217|NCT01805037|454795525|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
126410218|NCT01805037|454795526|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
126410219|NCT01805037|454795525|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
126410220|NCT01805037|454795526|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
126410221|NCT01805037|454795525|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
126410222|NCT01805037|454795526|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
126410223|NCT01805037|454795525|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
126410224|NCT01805037|454795526|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
126410225|NCT01805037|454795525|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
126410226|NCT01805037|454795526|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
126410227|NCT01805037|454795525|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
126410228|NCT01805037|454795526|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
126410229|NCT01805037|454795525|FG000|Follow Up (up to 3 Years)|Death|0|||
126410230|NCT01805037|454795526|FG001|Follow Up (up to 3 Years)|Death|2|||
126410231|NCT01805037|454795525|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
126410232|NCT01805037|454795526|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
126410233|NCT01805037|454795525|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
126410234|NCT01805037|454795526|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
126410235|NCT02177838|454795527|FG000|Overall Study|Withdrawal by Subject|1|||
126410236|NCT02177838|454795527|FG000|Overall Study|Physician Decision|1|||
126410237|NCT02177838|454795527|FG000|Overall Study|Death|1|||
126410238|NCT03927404|454795533|FG000|Overall Study|Withdrawal by Subject|1|||
126410239|NCT00293020|454795537|FG000|Overall Study|Withdrawal by Subject|34|||
126410240|NCT00293020|454795537|FG000|Overall Study|Adverse Event|30|||
126410241|NCT00293020|454795537|FG000|Overall Study|Death|32|||
126410242|NCT00293020|454795537|FG000|Overall Study|Lack of Efficacy|12|||
126410243|NCT00293020|454795537|FG000|Overall Study|Lost to Follow-up|4|||
126410244|NCT00293020|454795537|FG000|Overall Study|Protocol Violation|6|||
126410245|NCT00293020|454795537|FG000|Overall Study|Physician Decision|21|||
126410246|NCT00293020|454795537|FG000|Overall Study|Other Reason|22|||
126410247|NCT00293020|454795537|FG000|Overall Study|No dose taken|1|||
126410248|NCT01147848|454795538|FG000|Run-in Period|Screen Failure|623|||
126410249|NCT01147848|454795539|FG001|Run-in Period|Screen Failure|0|||
126410250|NCT01147848|454795540|FG002|Run-in Period|Screen Failure|0|||
126410251|NCT01147848|454795538|FG000|Run-in Period|Run-in Failure|135|||
126410252|NCT01147848|454795539|FG001|Run-in Period|Run-in Failure|0|||
126410253|NCT01147848|454795540|FG002|Run-in Period|Run-in Failure|0|||
126410254|NCT01147848|454795538|FG000|Randomized Phase|Adverse Event|0|||
126410255|NCT01147848|454795539|FG001|Randomized Phase|Adverse Event|6|||
126410256|NCT01147848|454795540|FG002|Randomized Phase|Adverse Event|8|||
126410257|NCT01147848|454795538|FG000|Randomized Phase|Lack of Efficacy|0|||
126410258|NCT01147848|454795539|FG001|Randomized Phase|Lack of Efficacy|20|||
126410259|NCT01147848|454795540|FG002|Randomized Phase|Lack of Efficacy|11|||
126410260|NCT01147848|454795538|FG000|Randomized Phase|Protocol Violation|0|||
126410261|NCT01147848|454795539|FG001|Randomized Phase|Protocol Violation|7|||
126410262|NCT01147848|454795540|FG002|Randomized Phase|Protocol Violation|10|||
126410263|NCT01147848|454795538|FG000|Randomized Phase|Lost to Follow-up|0|||
126410264|NCT01147848|454795539|FG001|Randomized Phase|Lost to Follow-up|5|||
126410265|NCT01147848|454795540|FG002|Randomized Phase|Lost to Follow-up|7|||
126410266|NCT01147848|454795538|FG000|Randomized Phase|Physician Decision|0|||
126558658|NCT02223182|455338808|FG002|Double-Blind Period|Lost to Follow-up|0|||
126410267|NCT01147848|454795539|FG001|Randomized Phase|Physician Decision|0|||
126410268|NCT01147848|454795540|FG002|Randomized Phase|Physician Decision|1|||
126558659|NCT02223182|455338809|FG003|Double-Blind Period|Lost to Follow-up|0|||
126410269|NCT01147848|454795538|FG000|Randomized Phase|Withdrawal by Subject|0|||
126410270|NCT01147848|454795539|FG001|Randomized Phase|Withdrawal by Subject|7|||
126410271|NCT01147848|454795540|FG002|Randomized Phase|Withdrawal by Subject|9|||
126410272|NCT03180307|454795541|FG000|Overall Study|Lost to Follow-up|2|||
126410273|NCT03180307|454795542|FG001|Overall Study|Lost to Follow-up|0|||
126410274|NCT03180307|454795541|FG000|Overall Study|Death|1|||
126410275|NCT03180307|454795542|FG001|Overall Study|Death|0|||
126410276|NCT03180307|454795541|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
126410277|NCT03180307|454795542|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
126410278|NCT04349033|454795544|FG000|Overall Study|Lost to Follow-up|3|||
126410279|NCT04349033|454795545|FG001|Overall Study|Lost to Follow-up|1|||
126410280|NCT04349033|454795546|FG002|Overall Study|Lost to Follow-up|1|||
126410281|NCT03596450|454795547|FG000|Overall Study|Death|9|||
126410282|NCT03596450|454795548|FG001|Overall Study|Death|9|||
126410283|NCT03596450|454795547|FG000|Overall Study|Protocol Violation|18|||
126410284|NCT03596450|454795548|FG001|Overall Study|Protocol Violation|26|||
126410285|NCT03596450|454795547|FG000|Overall Study|Lost to Follow-up|50|||
126410286|NCT03596450|454795548|FG001|Overall Study|Lost to Follow-up|56|||
126410287|NCT03596450|454795547|FG000|Overall Study|Adverse Event|14|||
126410288|NCT03596450|454795548|FG001|Overall Study|Adverse Event|7|||
126410289|NCT03596450|454795547|FG000|Overall Study|Withdrawal by Subject|38|||
126410290|NCT03596450|454795548|FG001|Overall Study|Withdrawal by Subject|36|||
126410291|NCT03596450|454795547|FG000|Overall Study|Accidentally Randomized|2|||
126410292|NCT03596450|454795548|FG001|Overall Study|Accidentally Randomized|0|||
126410293|NCT03596450|454795547|FG000|Overall Study|Other reasons|48|||
126410294|NCT03596450|454795548|FG001|Overall Study|Other reasons|53|||
126410295|NCT03596450|454795547|FG000|Overall Study|Pregnancy|2|||
126410296|NCT03596450|454795548|FG001|Overall Study|Pregnancy|0|||
126410297|NCT02332291|454795549|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
126410298|NCT02332291|454795550|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
126410299|NCT02332291|454795549|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
126410300|NCT02332291|454795550|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
126410301|NCT02332291|454795549|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
126410302|NCT02332291|454795550|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
126410303|NCT02332291|454795549|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
126410304|NCT02332291|454795550|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
126410305|NCT02332291|454795549|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
126410306|NCT02332291|454795550|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
126410307|NCT02332291|454795549|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
126410308|NCT02332291|454795550|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
126410309|NCT02220712|454795551|FG000|Overall Study|Adverse Event|1|||
126410310|NCT02220712|454795551|FG000|Overall Study|Withdrawal by Subject|2|||
126474032|NCT00400764|455034628|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
126474033|NCT00400764|455034629|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
126474034|NCT00400764|455034630|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
126474035|NCT00400764|455034626|FG000|Phase II|Withdrawal by Subject|0|||
126474036|NCT00400764|455034627|FG001|Phase II|Withdrawal by Subject|0|||
126474037|NCT00400764|455034628|FG002|Phase II|Withdrawal by Subject|1|||
126474038|NCT00400764|455034629|FG003|Phase II|Withdrawal by Subject|1|||
126474039|NCT00400764|455034630|FG004|Phase II|Withdrawal by Subject|0|||
126474040|NCT02628938|455034631|FG000|Overall Study|Did not attend the follow up recall|2|||
126474041|NCT02628938|455034632|FG001|Overall Study|Did not attend the follow up recall|2|||
126474042|NCT02628938|455034633|FG002|Overall Study|Did not attend the follow up recall|1|||
126474043|NCT02628938|455034631|FG000|Overall Study|Failure to comply with the instructions|3|||
126474044|NCT02628938|455034632|FG001|Overall Study|Failure to comply with the instructions|0|||
126474045|NCT02628938|455034633|FG002|Overall Study|Failure to comply with the instructions|3|||
126721458|NCT00195260|455929972|FG004|Part 1: Dose Escalation|Disease Progression|4|||
126410311|NCT02220712|454795551|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
126410312|NCT03624127|454795552|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
126410313|NCT03624127|454795553|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
126410314|NCT03624127|454795554|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
126410315|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
126410316|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
126410317|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
126410318|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Death|0|||
126410319|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Death|1|||
126474046|NCT03113916|455034634|FG000|Overall Study|Withdrawal by Subject|9|||
126474047|NCT03113916|455034635|FG001|Overall Study|Withdrawal by Subject|7|||
126474048|NCT03113916|455034634|FG000|Overall Study|Pregnancy|1|||
126474049|NCT03113916|455034635|FG001|Overall Study|Pregnancy|3|||
126474050|NCT03113916|455034634|FG000|Overall Study|Lost to Follow-up|1|||
126474051|NCT03113916|455034635|FG001|Overall Study|Lost to Follow-up|2|||
126474052|NCT00241358|455034636|FG000|Overall Study|Determined to be not ineligible|0|||
126474053|NCT00241358|455034637|FG001|Overall Study|Determined to be not ineligible|1|||
126474054|NCT00241358|455034638|FG002|Overall Study|Determined to be not ineligible|1|||
126474055|NCT00621959|455034639|FG000|Overall Study|Adverse Event|4|||
126474056|NCT00621959|455034640|FG001|Overall Study|Adverse Event|2|||
126474057|NCT00621959|455034639|FG000|Overall Study|Lack of Efficacy|1|||
126474058|NCT00621959|455034640|FG001|Overall Study|Lack of Efficacy|1|||
126474059|NCT00621959|455034639|FG000|Overall Study|Lost to Follow-up|0|||
126474060|NCT00621959|455034640|FG001|Overall Study|Lost to Follow-up|2|||
126474061|NCT00621959|455034639|FG000|Overall Study|Withdrawal by Subject|1|||
126474062|NCT00621959|455034640|FG001|Overall Study|Withdrawal by Subject|1|||
126474063|NCT00621959|455034639|FG000|Overall Study|Other|1|||
126474064|NCT00621959|455034640|FG001|Overall Study|Other|3|||
126474065|NCT01758523|455034641|FG000|Overall Study|Adverse Event|2|||
126474066|NCT01758523|455034642|FG001|Overall Study|Adverse Event|1|||
126474067|NCT01758523|455034641|FG000|Overall Study|Lack of Efficacy|4|||
126474068|NCT01758523|455034642|FG001|Overall Study|Lack of Efficacy|2|||
126474069|NCT01758523|455034641|FG000|Overall Study|Lost to Follow-up|3|||
126474070|NCT01758523|455034642|FG001|Overall Study|Lost to Follow-up|4|||
126474071|NCT01758523|455034641|FG000|Overall Study|Withdrawal by Subject|12|||
126474072|NCT01758523|455034642|FG001|Overall Study|Withdrawal by Subject|7|||
126474073|NCT00590135|455034643|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
126474074|NCT03439657|455034644|FG000|Overall Study|Adverse Event|2|||
126474075|NCT03439657|455034645|FG001|Overall Study|Adverse Event|3|||
126474076|NCT03439657|455034644|FG000|Overall Study|Lost to Follow-up|1|||
126474077|NCT03439657|455034645|FG001|Overall Study|Lost to Follow-up|0|||
126474078|NCT03439657|455034644|FG000|Overall Study|Protocol Violation|1|||
126474079|NCT03439657|455034645|FG001|Overall Study|Protocol Violation|1|||
126474080|NCT03439657|455034644|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
126474081|NCT03439657|455034645|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
126474082|NCT00370071|455034649|FG000|Overall Study|Withdrawal by Subject|2|||
126474083|NCT00289016|455034652|FG000|Overall Study|Disease Progression|29|||
126474084|NCT00289016|455034652|FG000|Overall Study|Death|2|||
126474085|NCT00289016|455034652|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
126474086|NCT00289016|455034652|FG000|Overall Study|Withdrawal by Subject|2|||
126474087|NCT00289016|455034652|FG000|Overall Study|Adverse Event|1|||
126474088|NCT00289016|455034652|FG000|Overall Study|Other|1|||
126474089|NCT02764697|455034653|FG000|Overall Study|Lack of Efficacy|3|||
126474090|NCT00302107|455034654|FG000|Overall Study|Lost to Follow-up|6|||
126474091|NCT00302107|455034655|FG001|Overall Study|Lost to Follow-up|5|||
126474092|NCT00302107|455034654|FG000|Overall Study|Protocol Violation|1|||
126474093|NCT00302107|455034655|FG001|Overall Study|Protocol Violation|0|||
126474094|NCT00302107|455034654|FG000|Overall Study|Relocation|0|||
126474095|NCT00302107|455034655|FG001|Overall Study|Relocation|1|||
126474096|NCT00302107|455034654|FG000|Overall Study|Withdrawal by Subject|0|||
126474097|NCT00302107|455034655|FG001|Overall Study|Withdrawal by Subject|3|||
126474098|NCT00302107|455034654|FG000|Overall Study|Adverse Event|1|||
126474099|NCT00302107|455034655|FG001|Overall Study|Adverse Event|0|||
126474100|NCT01441180|455034656|FG000|Overall Study|Lost to Follow-up|1|||
126474101|NCT01441180|455034657|FG001|Overall Study|Lost to Follow-up|1|||
126474102|NCT01441180|455034658|FG002|Overall Study|Lost to Follow-up|1|||
126474103|NCT01441180|455034656|FG000|Overall Study|Discontinued|0|||
126474104|NCT01441180|455034657|FG001|Overall Study|Discontinued|0|||
126474105|NCT01441180|455034658|FG002|Overall Study|Discontinued|2|||
126474106|NCT01402011|455034661|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
126474107|NCT01402011|455034662|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
126558660|NCT02223182|455338806|FG000|Double-Blind Period|Non Compliance|0|||
126558661|NCT02223182|455338807|FG001|Double-Blind Period|Non Compliance|0|||
126558662|NCT02223182|455338808|FG002|Double-Blind Period|Non Compliance|0|||
126558663|NCT02223182|455338809|FG003|Double-Blind Period|Non Compliance|1|||
126558664|NCT02223182|455338806|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
126558665|NCT02223182|455338807|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
126558666|NCT02223182|455338808|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
126474108|NCT01402011|455034663|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
126474109|NCT01402011|455034661|FG000|Active Treatment Period|Withdrawal by Subject|1|||
126474110|NCT01402011|455034662|FG001|Active Treatment Period|Withdrawal by Subject|3|||
126474111|NCT01402011|455034663|FG002|Active Treatment Period|Withdrawal by Subject|0|||
126474112|NCT01402011|455034661|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
126474113|NCT01402011|455034662|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
126474114|NCT01402011|455034663|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
126558667|NCT02223182|455338809|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
126474115|NCT02569671|455034665|FG000|Overall Study|Lost to Follow-up|2|||
126474116|NCT02569671|455034666|FG001|Overall Study|Lost to Follow-up|1|||
126410320|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Death|0|||
126410321|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
126410322|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
126410323|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
126410324|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
126410325|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
126410326|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
126410327|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
126410328|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
126410329|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
126410330|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
126410331|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
126410332|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
126410333|NCT03624127|454795552|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
126410334|NCT03624127|454795553|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
126410335|NCT03624127|454795554|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
126410336|NCT03624127|454795552|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
126410337|NCT03624127|454795553|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
126410338|NCT03624127|454795554|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
126410339|NCT03624127|454795552|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
126410340|NCT03624127|454795553|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
126410341|NCT03624127|454795554|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
126410342|NCT03624127|454795552|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
126410343|NCT03624127|454795553|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
126410344|NCT03624127|454795554|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
126410345|NCT03624127|454795552|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
126410346|NCT03624127|454795553|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
126410347|NCT03624127|454795554|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
126410348|NCT03624127|454795552|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
126410349|NCT03624127|454795553|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
126410350|NCT03624127|454795554|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
126410351|NCT03624127|454795552|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
126410352|NCT03624127|454795553|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
126410353|NCT03624127|454795554|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
126410354|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
126410355|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
126410356|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
126410357|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
126410358|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
126410359|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
126410360|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
126410361|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
126410362|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
126410363|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
126410364|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
126410365|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
126410366|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
126410367|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
126410368|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
126474117|NCT02569671|455034665|FG000|Overall Study|Withdrawal by Subject|1|||
126474118|NCT02569671|455034666|FG001|Overall Study|Withdrawal by Subject|3|||
126474119|NCT02110238|455036239|FG000|12 Week Pivotal Phase|Adverse Event|3|||
126474120|NCT02110238|455036240|FG001|12 Week Pivotal Phase|Adverse Event|0|||
126474121|NCT02110238|455036239|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
126474122|NCT02110238|455036240|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
126474123|NCT02110238|455036239|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
126474124|NCT02110238|455036240|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
126410369|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
126410370|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
126410371|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
126410372|NCT03624127|454795552|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
126410373|NCT03624127|454795553|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
126410374|NCT03624127|454795554|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
126410375|NCT02607228|454795555|FG000|Overall Study|Progressive Disease|4|||
126410376|NCT02607228|454795556|FG001|Overall Study|Progressive Disease|3|||
126410377|NCT02607228|454795557|FG002|Overall Study|Progressive Disease|1|||
126410378|NCT02607228|454795558|FG003|Overall Study|Progressive Disease|5|||
126474125|NCT02110238|455036239|FG000|12 Week Pivotal Phase|Physician Decision|0|||
126410379|NCT02607228|454795559|FG004|Overall Study|Progressive Disease|4|||
126410380|NCT02607228|454795560|FG005|Overall Study|Progressive Disease|3|||
126474126|NCT02110238|455036240|FG001|12 Week Pivotal Phase|Physician Decision|2|||
126474127|NCT02110238|455036239|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
126474128|NCT02110238|455036240|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
126410381|NCT02607228|454795561|FG006|Overall Study|Progressive Disease|1|||
126410382|NCT02607228|454795555|FG000|Overall Study|Adverse Event|1|||
126410383|NCT02607228|454795556|FG001|Overall Study|Adverse Event|0|||
126410384|NCT02607228|454795557|FG002|Overall Study|Adverse Event|1|||
126410385|NCT02607228|454795558|FG003|Overall Study|Adverse Event|0|||
126410386|NCT02607228|454795559|FG004|Overall Study|Adverse Event|1|||
126410387|NCT02607228|454795560|FG005|Overall Study|Adverse Event|1|||
126474129|NCT02110238|455036239|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
126474130|NCT02110238|455036240|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
126474131|NCT02110238|455036239|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
126474132|NCT02110238|455036240|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
126474133|NCT02110238|455036239|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
126474134|NCT02110238|455036240|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
126474135|NCT02110238|455036239|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
126474136|NCT02110238|455036240|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
126474137|NCT02110238|455036239|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
126474138|NCT02110238|455036240|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
126474139|NCT02110238|455036239|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
126558668|NCT02223182|455338806|FG000|Open-Label 500 Period|Adverse Event|1|||
126558669|NCT02223182|455338807|FG001|Open-Label 500 Period|Adverse Event|0|||
126558670|NCT02223182|455338808|FG002|Open-Label 500 Period|Adverse Event|2|||
126474140|NCT02110238|455036240|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
126474141|NCT01419626|455036247|FG000|Overall Study|Protocol Violation|3|||
126474142|NCT01419626|455036248|FG001|Overall Study|Protocol Violation|2|||
126474143|NCT01419626|455036249|FG002|Overall Study|Protocol Violation|2|||
126474144|NCT01419626|455036247|FG000|Overall Study|Withdrawal by Subject|1|||
126474145|NCT01419626|455036248|FG001|Overall Study|Withdrawal by Subject|0|||
126474146|NCT01419626|455036249|FG002|Overall Study|Withdrawal by Subject|0|||
126474147|NCT01419626|455036247|FG000|Overall Study|Lost to Follow-up|0|||
126474148|NCT01419626|455036248|FG001|Overall Study|Lost to Follow-up|1|||
126474149|NCT01419626|455036249|FG002|Overall Study|Lost to Follow-up|1|||
126474150|NCT01365052|455036250|FG000|Overall Study|Adverse Event|4|||
126474151|NCT01365052|455036251|FG001|Overall Study|Adverse Event|4|||
126474152|NCT01145625|455036252|FG000|Overall Study|Lost to Follow-up|8|||
126474153|NCT01145625|455036253|FG001|Overall Study|Lost to Follow-up|9|||
126474154|NCT01145625|455036252|FG000|Overall Study|Adverse Event|6|||
126474155|NCT01145625|455036253|FG001|Overall Study|Adverse Event|4|||
126474156|NCT01145625|455036252|FG000|Overall Study|Protocol Violation|3|||
126474157|NCT01145625|455036253|FG001|Overall Study|Protocol Violation|1|||
126474158|NCT01145625|455036252|FG000|Overall Study|Withdrawal by Subject|7|||
126474159|NCT01145625|455036253|FG001|Overall Study|Withdrawal by Subject|16|||
126474160|NCT01145625|455036252|FG000|Overall Study|Pregnancy|0|||
126474161|NCT01145625|455036253|FG001|Overall Study|Pregnancy|1|||
126474162|NCT03080454|455036254|FG000|Baseline|Adverse Event|2|||
126474163|NCT03080454|455036254|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
126474164|NCT03080454|455036254|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
126474165|NCT00216476|455036255|FG000|Overall Study|Withdrawal by Subject|59|||
126474166|NCT00216476|455036256|FG001|Overall Study|Withdrawal by Subject|72|||
126474167|NCT00216476|455036257|FG002|Overall Study|Withdrawal by Subject|9|||
126474168|NCT00216476|455036255|FG000|Overall Study|Lost to Follow-up|10|||
126474169|NCT00216476|455036256|FG001|Overall Study|Lost to Follow-up|9|||
126474170|NCT00216476|455036257|FG002|Overall Study|Lost to Follow-up|1|||
126558671|NCT02223182|455338809|FG003|Open-Label 500 Period|Adverse Event|1|||
126558672|NCT02223182|455338806|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
126558673|NCT02223182|455338807|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
126558674|NCT02223182|455338808|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
126558675|NCT02223182|455338809|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
126558676|NCT02223182|455338806|FG000|Open-Label 500 Period|Physician Decision|0|||
126410388|NCT02607228|454795561|FG006|Overall Study|Adverse Event|1|||
126410389|NCT02607228|454795555|FG000|Overall Study|Investigator's Discretion|0|||
126410390|NCT02607228|454795556|FG001|Overall Study|Investigator's Discretion|0|||
126474171|NCT00216476|455036255|FG000|Overall Study|Adverse Event|6|||
126474172|NCT00216476|455036256|FG001|Overall Study|Adverse Event|10|||
126474173|NCT00216476|455036257|FG002|Overall Study|Adverse Event|1|||
126474174|NCT00216476|455036255|FG000|Overall Study|Lack of Efficacy|4|||
126558677|NCT02223182|455338807|FG001|Open-Label 500 Period|Physician Decision|0|||
126558678|NCT02223182|455338808|FG002|Open-Label 500 Period|Physician Decision|0|||
126410391|NCT02607228|454795557|FG002|Overall Study|Investigator's Discretion|1|||
126410392|NCT02607228|454795558|FG003|Overall Study|Investigator's Discretion|0|||
126474175|NCT00216476|455036256|FG001|Overall Study|Lack of Efficacy|3|||
126558679|NCT02223182|455338809|FG003|Open-Label 500 Period|Physician Decision|1|||
126474176|NCT00216476|455036257|FG002|Overall Study|Lack of Efficacy|0|||
126474177|NCT00216476|455036255|FG000|Overall Study|Death|2|||
126410393|NCT02607228|454795559|FG004|Overall Study|Investigator's Discretion|0|||
126410394|NCT02607228|454795560|FG005|Overall Study|Investigator's Discretion|1|||
126474178|NCT00216476|455036256|FG001|Overall Study|Death|0|||
126474179|NCT00216476|455036257|FG002|Overall Study|Death|0|||
126410395|NCT02607228|454795561|FG006|Overall Study|Investigator's Discretion|0|||
126410396|NCT02607228|454795555|FG000|Overall Study|Withdrew Consent|0|||
126410397|NCT02607228|454795556|FG001|Overall Study|Withdrew Consent|1|||
126410398|NCT02607228|454795557|FG002|Overall Study|Withdrew Consent|0|||
126410399|NCT02607228|454795558|FG003|Overall Study|Withdrew Consent|0|||
126410400|NCT02607228|454795559|FG004|Overall Study|Withdrew Consent|0|||
126410401|NCT02607228|454795560|FG005|Overall Study|Withdrew Consent|1|||
126410402|NCT02607228|454795561|FG006|Overall Study|Withdrew Consent|0|||
126410403|NCT02607228|454795555|FG000|Overall Study|Study Terminated by Sponsor|0|||
126410404|NCT02607228|454795556|FG001|Overall Study|Study Terminated by Sponsor|0|||
126410405|NCT02607228|454795557|FG002|Overall Study|Study Terminated by Sponsor|0|||
126410406|NCT02607228|454795558|FG003|Overall Study|Study Terminated by Sponsor|1|||
126410407|NCT02607228|454795559|FG004|Overall Study|Study Terminated by Sponsor|0|||
126410408|NCT02607228|454795560|FG005|Overall Study|Study Terminated by Sponsor|0|||
126410409|NCT02607228|454795561|FG006|Overall Study|Study Terminated by Sponsor|0|||
126410410|NCT01990859|454795562|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
126410411|NCT01990859|454795562|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
126410412|NCT02262754|454795564|FG000|Overall Study|Adverse Event|3|||
126410413|NCT02262754|454795565|FG001|Overall Study|Adverse Event|4|||
126410414|NCT02262754|454795566|FG002|Overall Study|Adverse Event|0|||
126410415|NCT02262754|454795564|FG000|Overall Study|Lack of Efficacy|2|||
126410416|NCT02262754|454795565|FG001|Overall Study|Lack of Efficacy|0|||
126410417|NCT02262754|454795566|FG002|Overall Study|Lack of Efficacy|1|||
126410418|NCT02262754|454795564|FG000|Overall Study|Lost to Follow-up|0|||
126410419|NCT02262754|454795565|FG001|Overall Study|Lost to Follow-up|0|||
126410420|NCT02262754|454795566|FG002|Overall Study|Lost to Follow-up|1|||
126410421|NCT02262754|454795564|FG000|Overall Study|No longer meets eligibility criteria|0|||
126410422|NCT02262754|454795565|FG001|Overall Study|No longer meets eligibility criteria|1|||
126410423|NCT02262754|454795566|FG002|Overall Study|No longer meets eligibility criteria|0|||
126410424|NCT02262754|454795564|FG000|Overall Study|Study terminated by sponsor|5|||
126410425|NCT02262754|454795565|FG001|Overall Study|Study terminated by sponsor|4|||
126410426|NCT02262754|454795566|FG002|Overall Study|Study terminated by sponsor|4|||
126410427|NCT02262754|454795564|FG000|Overall Study|Protocol Violation|1|||
126410428|NCT02262754|454795565|FG001|Overall Study|Protocol Violation|0|||
126410429|NCT02262754|454795566|FG002|Overall Study|Protocol Violation|0|||
126410430|NCT02262754|454795564|FG000|Overall Study|Withdrawal by Subject|1|||
126410431|NCT02262754|454795565|FG001|Overall Study|Withdrawal by Subject|0|||
126410432|NCT02262754|454795566|FG002|Overall Study|Withdrawal by Subject|1|||
126410433|NCT02262754|454795564|FG000|Overall Study|Other|4|||
126410434|NCT02262754|454795565|FG001|Overall Study|Other|0|||
126410435|NCT02262754|454795566|FG002|Overall Study|Other|2|||
126410436|NCT02577016|454795567|FG000|Overall Study|Adverse Event|2|||
126410437|NCT02577016|454795568|FG001|Overall Study|Adverse Event|1|||
126410438|NCT02577016|454795567|FG000|Overall Study|Physician Decision|0|||
126410439|NCT02577016|454795568|FG001|Overall Study|Physician Decision|1|||
126410440|NCT02126839|454795569|FG000|Overall Study|Adverse Event|0|||
126410441|NCT02126839|454795570|FG001|Overall Study|Adverse Event|1|||
126410442|NCT02126839|454795569|FG000|Overall Study|Withdrawal by Subject|1|||
126410443|NCT02126839|454795570|FG001|Overall Study|Withdrawal by Subject|0|||
126410444|NCT02126839|454795569|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126474180|NCT00216476|455036255|FG000|Overall Study|Pregnancy|0|||
126474181|NCT00216476|455036256|FG001|Overall Study|Pregnancy|1|||
126474182|NCT00216476|455036257|FG002|Overall Study|Pregnancy|1|||
126474183|NCT00216476|455036255|FG000|Overall Study|Other|0|||
126474184|NCT00216476|455036256|FG001|Overall Study|Other|0|||
126474185|NCT00216476|455036257|FG002|Overall Study|Other|1|||
126410445|NCT02126839|454795570|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126410446|NCT02126839|454795569|FG000|Overall Study|Protocol Violation|2|||
126410447|NCT02126839|454795570|FG001|Overall Study|Protocol Violation|3|||
126410448|NCT02126839|454795569|FG000|Overall Study|Sponsor request|0|||
126410449|NCT02126839|454795570|FG001|Overall Study|Sponsor request|1|||
126410450|NCT02126839|454795569|FG000|Overall Study|Lost to Follow-up|1|||
126410451|NCT02126839|454795570|FG001|Overall Study|Lost to Follow-up|4|||
126410452|NCT02126839|454795569|FG000|Overall Study|Other|5|||
126410453|NCT02126839|454795570|FG001|Overall Study|Other|5|||
126410454|NCT00812565|454795571|FG000|Overall Study|Did Not Receive Study Medication|1|||
126410455|NCT00812565|454795572|FG001|Overall Study|Did Not Receive Study Medication|1|||
126410456|NCT00812565|454795573|FG002|Overall Study|Did Not Receive Study Medication|0|||
126410457|NCT00812565|454795574|FG003|Overall Study|Did Not Receive Study Medication|0|||
126410458|NCT00812565|454795575|FG004|Overall Study|Did Not Receive Study Medication|0|||
126410459|NCT00812565|454795576|FG005|Overall Study|Did Not Receive Study Medication|0|||
126410460|NCT00812565|454795577|FG006|Overall Study|Did Not Receive Study Medication|0|||
126410461|NCT00812565|454795578|FG007|Overall Study|Did Not Receive Study Medication|0|||
126410462|NCT00812565|454795571|FG000|Overall Study|Adverse Event|0|||
126410463|NCT00812565|454795572|FG001|Overall Study|Adverse Event|0|||
126410464|NCT00812565|454795573|FG002|Overall Study|Adverse Event|0|||
126410465|NCT00812565|454795574|FG003|Overall Study|Adverse Event|2|||
126474186|NCT00216476|455036255|FG000|Overall Study|Refuses Injection|11|||
126410466|NCT00812565|454795575|FG004|Overall Study|Adverse Event|0|||
126410467|NCT00812565|454795576|FG005|Overall Study|Adverse Event|0|||
126410468|NCT00812565|454795577|FG006|Overall Study|Adverse Event|0|||
126410469|NCT00812565|454795578|FG007|Overall Study|Adverse Event|1|||
126410470|NCT00812565|454795571|FG000|Overall Study|Did Not Come to Study Visit|1|||
126410471|NCT00812565|454795572|FG001|Overall Study|Did Not Come to Study Visit|0|||
126410472|NCT00812565|454795573|FG002|Overall Study|Did Not Come to Study Visit|0|||
126410473|NCT00812565|454795574|FG003|Overall Study|Did Not Come to Study Visit|0|||
126410474|NCT00812565|454795575|FG004|Overall Study|Did Not Come to Study Visit|0|||
126410475|NCT00812565|454795576|FG005|Overall Study|Did Not Come to Study Visit|0|||
126410476|NCT00812565|454795577|FG006|Overall Study|Did Not Come to Study Visit|0|||
126410477|NCT00812565|454795578|FG007|Overall Study|Did Not Come to Study Visit|0|||
126410478|NCT00812565|454795571|FG000|Overall Study|Withdrawal of Consent|1|||
126410479|NCT00812565|454795572|FG001|Overall Study|Withdrawal of Consent|0|||
126410480|NCT00812565|454795573|FG002|Overall Study|Withdrawal of Consent|0|||
126410481|NCT00812565|454795574|FG003|Overall Study|Withdrawal of Consent|0|||
126410482|NCT00812565|454795575|FG004|Overall Study|Withdrawal of Consent|1|||
126410483|NCT00812565|454795576|FG005|Overall Study|Withdrawal of Consent|0|||
126410484|NCT00812565|454795577|FG006|Overall Study|Withdrawal of Consent|0|||
126410485|NCT00812565|454795578|FG007|Overall Study|Withdrawal of Consent|0|||
126410486|NCT00812565|454795571|FG000|Overall Study|Reason Not Specified|0|||
126410487|NCT00812565|454795572|FG001|Overall Study|Reason Not Specified|0|||
126410488|NCT00812565|454795573|FG002|Overall Study|Reason Not Specified|0|||
126410489|NCT00812565|454795574|FG003|Overall Study|Reason Not Specified|0|||
126410490|NCT00812565|454795575|FG004|Overall Study|Reason Not Specified|0|||
126410491|NCT00812565|454795576|FG005|Overall Study|Reason Not Specified|1|||
126410492|NCT00812565|454795577|FG006|Overall Study|Reason Not Specified|0|||
126410493|NCT00812565|454795578|FG007|Overall Study|Reason Not Specified|0|||
126410494|NCT03614325|454797933|FG000|Overall Study|Withdrawal by Subject|0|||
126410495|NCT03614325|454797934|FG001|Overall Study|Withdrawal by Subject|2|||
126410496|NCT03614325|454797933|FG000|Overall Study|Surgery Cancelled|2|||
126410497|NCT03614325|454797934|FG001|Overall Study|Surgery Cancelled|1|||
126410498|NCT03614325|454797933|FG000|Overall Study|Lost to Follow-up|2|||
126410499|NCT03614325|454797934|FG001|Overall Study|Lost to Follow-up|1|||
126410500|NCT03614325|454797933|FG000|Overall Study|Surgery never scheduled|1|||
126410501|NCT03614325|454797934|FG001|Overall Study|Surgery never scheduled|0|||
126410502|NCT01597635|454797941|FG000|Part A|Adverse Event|3|||
126410503|NCT01597635|454797942|FG001|Part A|Adverse Event|0|||
126410504|NCT01597635|454797943|FG002|Part A|Adverse Event|0|||
126410505|NCT01597635|454797941|FG000|Part B|Adverse Event|0|||
126410506|NCT01597635|454797942|FG001|Part B|Adverse Event|0|||
126410507|NCT01597635|454797943|FG002|Part B|Adverse Event|1|||
126410508|NCT01597635|454797941|FG000|Part B|Protocol Violation|0|||
126410509|NCT01597635|454797942|FG001|Part B|Protocol Violation|1|||
126410510|NCT01597635|454797943|FG002|Part B|Protocol Violation|0|||
126410511|NCT01597635|454797941|FG000|Part B|Protocol-defined stopping criteria|0|||
126410512|NCT01597635|454797942|FG001|Part B|Protocol-defined stopping criteria|4|||
126410513|NCT01597635|454797943|FG002|Part B|Protocol-defined stopping criteria|3|||
126410514|NCT01597635|454797941|FG000|Part B|Withdrawal by Subject|0|||
126410515|NCT01597635|454797942|FG001|Part B|Withdrawal by Subject|1|||
126410516|NCT01597635|454797943|FG002|Part B|Withdrawal by Subject|0|||
126410517|NCT01363661|454797944|FG000|Overall Study|Adverse Event|9|||
126410518|NCT01363661|454797945|FG001|Overall Study|Adverse Event|2|||
126410519|NCT01363661|454797944|FG000|Overall Study|Withdrawal by Subject|1|||
126410520|NCT01363661|454797945|FG001|Overall Study|Withdrawal by Subject|1|||
126410521|NCT01363661|454797944|FG000|Overall Study|Protocol Violation|1|||
126410522|NCT01363661|454797945|FG001|Overall Study|Protocol Violation|0|||
126410523|NCT01363661|454797944|FG000|Overall Study|Lost to Follow-up|3|||
126410524|NCT01363661|454797945|FG001|Overall Study|Lost to Follow-up|1|||
126410525|NCT01971008|454797946|FG000|Overall Study|Protocol Violation|2|||
126410526|NCT01971008|454797947|FG001|Overall Study|Protocol Violation|1|||
126410527|NCT03775512|454797948|FG000|Overall Study|Death|1|||
126410528|NCT03775512|454797949|FG001|Overall Study|Death|1|||
126410529|NCT03775512|454797948|FG000|Overall Study|Withdrawal by Subject|7|||
126410530|NCT03775512|454797949|FG001|Overall Study|Withdrawal by Subject|4|||
126410531|NCT03775512|454797948|FG000|Overall Study|Lost to Follow-up|5|||
126410532|NCT03775512|454797949|FG001|Overall Study|Lost to Follow-up|5|||
126410533|NCT03775512|454797948|FG000|Overall Study|Excluded before Catheter insertion|14|||
126410534|NCT03775512|454797949|FG001|Overall Study|Excluded before Catheter insertion|5|||
126410535|NCT03775512|454797948|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
126410536|NCT03775512|454797949|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
126410537|NCT03775512|454797948|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
126410538|NCT03775512|454797949|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
126410539|NCT01378325|454797950|FG000|Overall Study|Protocol Violation|0|||
126410540|NCT01378325|454797951|FG001|Overall Study|Protocol Violation|1|||
126410541|NCT00767806|454797954|FG000|Overall Study|Adverse Event|30|||
126410542|NCT00767806|454797955|FG001|Overall Study|Adverse Event|11|||
126410543|NCT00767806|454797954|FG000|Overall Study|Withdrawal by Subject|8|||
126474187|NCT00216476|455036256|FG001|Overall Study|Refuses Injection|0|||
126474188|NCT00216476|455036257|FG002|Overall Study|Refuses Injection|0|||
126474189|NCT00216476|455036255|FG000|Overall Study|No Further Need for Treatment|3|||
126474190|NCT00216476|455036256|FG001|Overall Study|No Further Need for Treatment|4|||
126474191|NCT00216476|455036257|FG002|Overall Study|No Further Need for Treatment|1|||
126474192|NCT00216476|455036255|FG000|Overall Study|Non-compliance|0|||
126474193|NCT00216476|455036256|FG001|Overall Study|Non-compliance|4|||
126474194|NCT00216476|455036257|FG002|Overall Study|Non-compliance|1|||
126474195|NCT00216476|455036255|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
126474196|NCT00216476|455036256|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
126474197|NCT00216476|455036257|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
126474198|NCT00216476|455036255|FG000|Overall Study|Administrative Reasons|1|||
126474199|NCT00216476|455036256|FG001|Overall Study|Administrative Reasons|1|||
126474200|NCT00216476|455036257|FG002|Overall Study|Administrative Reasons|0|||
126474201|NCT00216476|455036255|FG000|Overall Study|Protocol Deviation|5|||
126474202|NCT00216476|455036256|FG001|Overall Study|Protocol Deviation|1|||
126474203|NCT00216476|455036257|FG002|Overall Study|Protocol Deviation|0|||
126474204|NCT00216476|455036255|FG000|Overall Study|Patient Moved|2|||
126474205|NCT00216476|455036256|FG001|Overall Study|Patient Moved|2|||
126474206|NCT00216476|455036257|FG002|Overall Study|Patient Moved|0|||
126474207|NCT02202980|455036260|FG000|Overall Study|Lack of Efficacy|1|||
126474208|NCT02202980|455036261|FG001|Overall Study|Lack of Efficacy|0|||
126474209|NCT02202980|455036262|FG002|Overall Study|Lack of Efficacy|7|||
126474210|NCT02202980|455036263|FG003|Overall Study|Lack of Efficacy|0|||
126474211|NCT02202980|455036264|FG004|Overall Study|Lack of Efficacy|3|||
126474212|NCT02202980|455036265|FG005|Overall Study|Lack of Efficacy|1|||
126474213|NCT02202980|455036266|FG006|Overall Study|Lack of Efficacy|11|||
126474214|NCT02202980|455036267|FG007|Overall Study|Lack of Efficacy|2|||
126474215|NCT02202980|455036268|FG008|Overall Study|Lack of Efficacy|2|||
126474216|NCT02202980|455036269|FG009|Overall Study|Lack of Efficacy|0|||
126474217|NCT02202980|455036270|FG010|Overall Study|Lack of Efficacy|0|||
126474218|NCT02202980|455036271|FG011|Overall Study|Lack of Efficacy|3|||
126474219|NCT02202980|455036272|FG012|Overall Study|Lack of Efficacy|10|||
126474220|NCT02202980|455036273|FG013|Overall Study|Lack of Efficacy|0|||
126474221|NCT02202980|455036260|FG000|Overall Study|Protocol Violation|0|||
126474222|NCT02202980|455036261|FG001|Overall Study|Protocol Violation|0|||
126474223|NCT02202980|455036262|FG002|Overall Study|Protocol Violation|0|||
126474224|NCT02202980|455036263|FG003|Overall Study|Protocol Violation|3|||
126474225|NCT02202980|455036264|FG004|Overall Study|Protocol Violation|3|||
126474226|NCT02202980|455036265|FG005|Overall Study|Protocol Violation|0|||
126474227|NCT02202980|455036266|FG006|Overall Study|Protocol Violation|0|||
126474228|NCT02202980|455036267|FG007|Overall Study|Protocol Violation|0|||
126474229|NCT02202980|455036268|FG008|Overall Study|Protocol Violation|0|||
126474230|NCT02202980|455036269|FG009|Overall Study|Protocol Violation|0|||
126474231|NCT02202980|455036270|FG010|Overall Study|Protocol Violation|0|||
126474232|NCT02202980|455036271|FG011|Overall Study|Protocol Violation|0|||
126474233|NCT02202980|455036272|FG012|Overall Study|Protocol Violation|0|||
126474234|NCT02202980|455036273|FG013|Overall Study|Protocol Violation|0|||
126474235|NCT02202980|455036260|FG000|Overall Study|Lost to Follow-up|0|||
126474236|NCT02202980|455036261|FG001|Overall Study|Lost to Follow-up|1|||
126474237|NCT02202980|455036262|FG002|Overall Study|Lost to Follow-up|1|||
126474238|NCT02202980|455036263|FG003|Overall Study|Lost to Follow-up|1|||
126474239|NCT02202980|455036264|FG004|Overall Study|Lost to Follow-up|0|||
126474240|NCT02202980|455036265|FG005|Overall Study|Lost to Follow-up|0|||
126474241|NCT02202980|455036266|FG006|Overall Study|Lost to Follow-up|0|||
126474242|NCT02202980|455036267|FG007|Overall Study|Lost to Follow-up|1|||
126474243|NCT02202980|455036268|FG008|Overall Study|Lost to Follow-up|1|||
126474244|NCT02202980|455036269|FG009|Overall Study|Lost to Follow-up|0|||
126558680|NCT02223182|455338806|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
126558681|NCT02223182|455338807|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
126474245|NCT02202980|455036270|FG010|Overall Study|Lost to Follow-up|0|||
126558682|NCT02223182|455338808|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
126474246|NCT02202980|455036271|FG011|Overall Study|Lost to Follow-up|0|||
126474247|NCT02202980|455036272|FG012|Overall Study|Lost to Follow-up|1|||
126474248|NCT02202980|455036273|FG013|Overall Study|Lost to Follow-up|0|||
126474249|NCT02202980|455036260|FG000|Overall Study|Withdrew Consent|0|||
126474250|NCT02202980|455036261|FG001|Overall Study|Withdrew Consent|1|||
126474251|NCT02202980|455036262|FG002|Overall Study|Withdrew Consent|2|||
126474252|NCT02202980|455036263|FG003|Overall Study|Withdrew Consent|0|||
126474253|NCT02202980|455036264|FG004|Overall Study|Withdrew Consent|0|||
126474254|NCT02202980|455036265|FG005|Overall Study|Withdrew Consent|0|||
126474255|NCT02202980|455036266|FG006|Overall Study|Withdrew Consent|0|||
126474256|NCT02202980|455036267|FG007|Overall Study|Withdrew Consent|0|||
126474257|NCT02202980|455036268|FG008|Overall Study|Withdrew Consent|1|||
126474258|NCT02202980|455036269|FG009|Overall Study|Withdrew Consent|0|||
126474259|NCT02202980|455036270|FG010|Overall Study|Withdrew Consent|0|||
126474260|NCT02202980|455036271|FG011|Overall Study|Withdrew Consent|0|||
126474261|NCT02202980|455036272|FG012|Overall Study|Withdrew Consent|0|||
126474262|NCT02202980|455036273|FG013|Overall Study|Withdrew Consent|0|||
126474263|NCT00696800|455036274|FG000|Overall Study|Adverse Event|16|||
126474264|NCT00696800|455036275|FG001|Overall Study|Adverse Event|3|||
126474265|NCT00696800|455036274|FG000|Overall Study|Insufficient compliance with medication|2|||
126474266|NCT00696800|455036275|FG001|Overall Study|Insufficient compliance with medication|1|||
126474267|NCT00696800|455036274|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
126474268|NCT00696800|455036275|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
126474269|NCT00696800|455036274|FG000|Overall Study|Insufficient ovarian response|4|||
126474270|NCT00696800|455036275|FG001|Overall Study|Insufficient ovarian response|1|||
126474271|NCT00696800|455036274|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
126474272|NCT00696800|455036275|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
126474273|NCT00696800|455036274|FG000|Overall Study|Too high ovarian response|6|||
126474274|NCT00696800|455036275|FG001|Overall Study|Too high ovarian response|1|||
126474275|NCT00696800|455036274|FG000|Overall Study|No/too few/bad quality oocytes|4|||
126474276|NCT00696800|455036275|FG001|Overall Study|No/too few/bad quality oocytes|3|||
126474277|NCT00696800|455036274|FG000|Overall Study|No/abnormal fertilization|11|||
126474278|NCT00696800|455036275|FG001|Overall Study|No/abnormal fertilization|13|||
126474279|NCT00696800|455036274|FG000|Overall Study|No/too few/bad quality embryos|24|||
126474280|NCT00696800|455036275|FG001|Overall Study|No/too few/bad quality embryos|18|||
126474281|NCT00696800|455036274|FG000|Overall Study|Other Reasons|5|||
126474282|NCT00696800|455036275|FG001|Overall Study|Other Reasons|3|||
126474283|NCT00696800|455036274|FG000|Overall Study|Not treated|1|||
126474284|NCT00696800|455036275|FG001|Overall Study|Not treated|2|||
126474285|NCT05224141|455036280|FG000|Overall Study|Ongoing|75|||
126474286|NCT05224141|455036281|FG001|Overall Study|Ongoing|88|||
126474287|NCT05224141|455036280|FG000|Overall Study|Withdrawal by Subject|2|||
126474288|NCT05224141|455036281|FG001|Overall Study|Withdrawal by Subject|4|||
126474289|NCT05224141|455036280|FG000|Overall Study|Death|153|||
126474290|NCT05224141|455036281|FG001|Overall Study|Death|138|||
126474291|NCT02404220|455036285|FG000|Overall Study|Adverse Event|0|||
126474292|NCT02404220|455036286|FG001|Overall Study|Adverse Event|0|||
126474293|NCT02404220|455036287|FG002|Overall Study|Adverse Event|1|||
126474294|NCT02404220|455036288|FG003|Overall Study|Adverse Event|0|||
126474295|NCT02404220|455036285|FG000|Overall Study|Death|5|||
126474296|NCT02404220|455036286|FG001|Overall Study|Death|5|||
126474297|NCT02404220|455036287|FG002|Overall Study|Death|3|||
126474298|NCT02404220|455036288|FG003|Overall Study|Death|8|||
126474299|NCT02404220|455036285|FG000|Overall Study|Progressive Disease|0|||
126474300|NCT02404220|455036286|FG001|Overall Study|Progressive Disease|0|||
126474301|NCT02404220|455036287|FG002|Overall Study|Progressive Disease|1|||
126474302|NCT02404220|455036288|FG003|Overall Study|Progressive Disease|1|||
126474303|NCT02404220|455036285|FG000|Overall Study|Study Terminated by Sponsor|0|||
126474304|NCT02404220|455036286|FG001|Overall Study|Study Terminated by Sponsor|0|||
126474305|NCT02404220|455036287|FG002|Overall Study|Study Terminated by Sponsor|2|||
126474306|NCT02404220|455036288|FG003|Overall Study|Study Terminated by Sponsor|1|||
126474307|NCT02404220|455036285|FG000|Overall Study|Withdrawal by Subject|0|||
126474308|NCT02404220|455036286|FG001|Overall Study|Withdrawal by Subject|1|||
126474309|NCT02404220|455036287|FG002|Overall Study|Withdrawal by Subject|0|||
126474310|NCT02404220|455036288|FG003|Overall Study|Withdrawal by Subject|0|||
126474311|NCT02404220|455036285|FG000|Overall Study|Enrolled but Never Treated|0|||
126474312|NCT02404220|455036286|FG001|Overall Study|Enrolled but Never Treated|2|||
126474313|NCT02404220|455036287|FG002|Overall Study|Enrolled but Never Treated|0|||
126474314|NCT02404220|455036288|FG003|Overall Study|Enrolled but Never Treated|0|||
126474315|NCT03469934|455036291|FG000|Overall Study|Withdrawal by Subject|0|||
126474316|NCT03469934|455036292|FG001|Overall Study|Withdrawal by Subject|1|||
126474317|NCT02329080|455036293|FG000|Overall Study|Adverse Event|1|||
126474318|NCT02329080|455036293|FG000|Overall Study|Death|4|||
126474319|NCT02329080|455036293|FG000|Overall Study|Lack of Efficacy|22|||
126474320|NCT02329080|455036293|FG000|Overall Study|Lost to Follow-up|1|||
126474321|NCT02329080|455036293|FG000|Overall Study|Physician Decision|2|||
126474322|NCT02329080|455036293|FG000|Overall Study|Partial response|4|||
126474323|NCT02329080|455036293|FG000|Overall Study|Complete response|4|||
126474324|NCT03082261|455036304|FG000|Overall Study|Death|4|||
126474325|NCT03082261|455036304|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
126474326|NCT03082261|455036304|FG000|Overall Study|Insurance denial|1|||
126474327|NCT03082261|455036304|FG000|Overall Study|Peripheral lead added|1|||
126474328|NCT03082261|455036304|FG000|Overall Study|Withdrawal by Subject|40|||
126474329|NCT03082261|455036304|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
126474330|NCT03082261|455036304|FG000|Overall Study|Subject implanted with device other than study device|1|||
126474331|NCT03082261|455036304|FG000|Overall Study|Lost to Follow-up|14|||
126474332|NCT03082261|455036304|FG000|Overall Study|Subject moved to a different state|1|||
126474333|NCT03082261|455036304|FG000|Overall Study|Subject non-compliance|2|||
126474334|NCT03082261|455036304|FG000|Overall Study|Subject participation terminated by investigator|9|||
126474335|NCT03082261|455036304|FG000|Overall Study|Subject participation terminated by sponsor|4|||
126474336|NCT03082261|455036304|FG000|Overall Study|System explant|19|||
126474337|NCT03082261|455036304|FG000|Overall Study|Unable to place lead(s)|2|||
126410544|NCT00767806|454797955|FG001|Overall Study|Withdrawal by Subject|13|||
126410545|NCT00767806|454797954|FG000|Overall Study|Protocol Violation|6|||
126410546|NCT00767806|454797955|FG001|Overall Study|Protocol Violation|5|||
126558683|NCT02223182|455338809|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
126772332|NCT01466673|456122090|FG000|Overall Study|Non-compliance with study treatment|2|||
126410547|NCT00767806|454797954|FG000|Overall Study|Lack of Efficacy|1|||
126410548|NCT00767806|454797955|FG001|Overall Study|Lack of Efficacy|9|||
126410549|NCT00767806|454797954|FG000|Overall Study|Physician Decision|4|||
126410550|NCT00767806|454797955|FG001|Overall Study|Physician Decision|3|||
126410551|NCT00767806|454797954|FG000|Overall Study|Lost to Follow-up|1|||
126410552|NCT00767806|454797955|FG001|Overall Study|Lost to Follow-up|4|||
126410553|NCT00767806|454797954|FG000|Overall Study|Entry Criteria Not Met|1|||
126410554|NCT00767806|454797955|FG001|Overall Study|Entry Criteria Not Met|1|||
126410555|NCT00767806|454797954|FG000|Overall Study|Sponsor Decision|0|||
126410556|NCT00767806|454797955|FG001|Overall Study|Sponsor Decision|1|||
126410557|NCT02489942|454797956|FG000|Overall Study|Request by patient|602|||
126410558|NCT02489942|454797956|FG000|Overall Study|Improvement/remission|157|||
126410559|NCT02489942|454797956|FG000|Overall Study|No change/Progressive disease|263|||
126410560|NCT02489942|454797956|FG000|Overall Study|Adverse Event|522|||
126410561|NCT02489942|454797956|FG000|Overall Study|Other personal reasons|1218|||
126410562|NCT02489942|454797956|FG000|Overall Study|Lost to Follow-up|456|||
126410563|NCT02489942|454797956|FG000|Overall Study|Not continuously investigated|7|||
126410564|NCT02489942|454797956|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
126410565|NCT02489942|454797956|FG000|Overall Study|Multiple registration|1|||
126410566|NCT02489942|454797956|FG000|Overall Study|No patient visit after entry|100|||
126410567|NCT02489942|454797956|FG000|Overall Study|No treatment with Jardiance|2|||
126410568|NCT02489942|454797956|FG000|Overall Study|Patient received Jardiance before registration|1|||
126410569|NCT02489942|454797956|FG000|Overall Study|No CRF collected|86|||
126410570|NCT00858208|454797957|FG000|Overall Study|Adverse Event|3|||
126410571|NCT00858208|454797957|FG000|Overall Study|Lost to Follow-up|26|||
126410572|NCT00858208|454797957|FG000|Overall Study|Participant refused|40|||
126410573|NCT00858208|454797957|FG000|Overall Study|Other|10|||
126410574|NCT01393639|454797958|FG000|Overall Study|Protocol Violation|0|||
126474338|NCT03082261|455036304|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
126474339|NCT02639546|455036305|FG000|Overall Study|Death|2|||
126474340|NCT02639546|455036306|FG001|Overall Study|Death|2|||
126474341|NCT02639546|455036307|FG002|Overall Study|Death|1|||
126474342|NCT02639546|455036308|FG003|Overall Study|Death|2|||
126474343|NCT02639546|455036309|FG004|Overall Study|Death|2|||
126474344|NCT02639546|455036310|FG005|Overall Study|Death|2|||
126474345|NCT02639546|455036311|FG006|Overall Study|Death|0|||
126474346|NCT02639546|455036312|FG007|Overall Study|Death|0|||
126474347|NCT02639546|455036305|FG000|Overall Study|Lost to Follow-up|0|||
126474348|NCT02639546|455036306|FG001|Overall Study|Lost to Follow-up|0|||
126474349|NCT02639546|455036307|FG002|Overall Study|Lost to Follow-up|1|||
126474350|NCT02639546|455036308|FG003|Overall Study|Lost to Follow-up|0|||
126474351|NCT02639546|455036309|FG004|Overall Study|Lost to Follow-up|1|||
126474352|NCT02639546|455036310|FG005|Overall Study|Lost to Follow-up|1|||
126474353|NCT02639546|455036311|FG006|Overall Study|Lost to Follow-up|0|||
126474354|NCT02639546|455036312|FG007|Overall Study|Lost to Follow-up|1|||
126474355|NCT02639546|455036305|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
126474356|NCT02639546|455036306|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
126474357|NCT02639546|455036307|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
126474358|NCT02639546|455036308|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
126474359|NCT02639546|455036309|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
126474360|NCT02639546|455036310|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
126474361|NCT02639546|455036311|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
126474362|NCT02639546|455036312|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
126474363|NCT02639546|455036305|FG000|Overall Study|Study Terminated By Sponsor|0|||
126410575|NCT01393639|454797959|FG001|Overall Study|Protocol Violation|0|||
126410576|NCT01393639|454797960|FG002|Overall Study|Protocol Violation|0|||
126410577|NCT01393639|454797961|FG003|Overall Study|Protocol Violation|1|||
126410578|NCT01393639|454797962|FG004|Overall Study|Protocol Violation|0|||
126410579|NCT01393639|454797963|FG005|Overall Study|Protocol Violation|0|||
126410580|NCT01393639|454797964|FG006|Overall Study|Protocol Violation|0|||
126410581|NCT01393639|454797958|FG000|Overall Study|Other|0|||
126410582|NCT01393639|454797959|FG001|Overall Study|Other|2|||
126410583|NCT01393639|454797960|FG002|Overall Study|Other|0|||
126410584|NCT01393639|454797961|FG003|Overall Study|Other|2|||
126410585|NCT01393639|454797962|FG004|Overall Study|Other|1|||
126410586|NCT01393639|454797963|FG005|Overall Study|Other|0|||
126410587|NCT01393639|454797964|FG006|Overall Study|Other|1|||
126410588|NCT01393639|454797958|FG000|Overall Study|Withdrawal by Subject|1|||
126410589|NCT01393639|454797959|FG001|Overall Study|Withdrawal by Subject|1|||
126410590|NCT01393639|454797960|FG002|Overall Study|Withdrawal by Subject|0|||
126474364|NCT02639546|455036306|FG001|Overall Study|Study Terminated By Sponsor|2|||
126474365|NCT02639546|455036307|FG002|Overall Study|Study Terminated By Sponsor|3|||
126474366|NCT02639546|455036308|FG003|Overall Study|Study Terminated By Sponsor|4|||
126474367|NCT02639546|455036309|FG004|Overall Study|Study Terminated By Sponsor|4|||
126474368|NCT02639546|455036310|FG005|Overall Study|Study Terminated By Sponsor|3|||
126474369|NCT02639546|455036311|FG006|Overall Study|Study Terminated By Sponsor|3|||
126474370|NCT02639546|455036312|FG007|Overall Study|Study Terminated By Sponsor|9|||
126474371|NCT02639546|455036305|FG000|Overall Study|Withdrawal by Subject|2|||
126474372|NCT02639546|455036306|FG001|Overall Study|Withdrawal by Subject|2|||
126474373|NCT02639546|455036307|FG002|Overall Study|Withdrawal by Subject|1|||
126474374|NCT02639546|455036308|FG003|Overall Study|Withdrawal by Subject|0|||
126474375|NCT02639546|455036309|FG004|Overall Study|Withdrawal by Subject|0|||
126474376|NCT02639546|455036310|FG005|Overall Study|Withdrawal by Subject|1|||
126721459|NCT00195260|455929973|FG005|Part 1: Dose Escalation|Disease Progression|6|||
126721460|NCT00195260|455929974|FG006|Part 1: Dose Escalation|Disease Progression|7|||
126410591|NCT01393639|454797961|FG003|Overall Study|Withdrawal by Subject|0|||
126410592|NCT01393639|454797962|FG004|Overall Study|Withdrawal by Subject|0|||
126410593|NCT01393639|454797963|FG005|Overall Study|Withdrawal by Subject|0|||
126410594|NCT01393639|454797964|FG006|Overall Study|Withdrawal by Subject|1|||
126410595|NCT01393639|454797958|FG000|Overall Study|Medication error without associated AE|0|||
126410596|NCT01393639|454797959|FG001|Overall Study|Medication error without associated AE|0|||
126410597|NCT01393639|454797960|FG002|Overall Study|Medication error without associated AE|0|||
126410598|NCT01393639|454797961|FG003|Overall Study|Medication error without associated AE|0|||
126410599|NCT01393639|454797962|FG004|Overall Study|Medication error without associated AE|0|||
126410600|NCT01393639|454797963|FG005|Overall Study|Medication error without associated AE|0|||
126410601|NCT01393639|454797964|FG006|Overall Study|Medication error without associated AE|1|||
126410602|NCT01393639|454797958|FG000|Overall Study|Lost to Follow-up|0|||
126410603|NCT01393639|454797959|FG001|Overall Study|Lost to Follow-up|1|||
126410604|NCT01393639|454797960|FG002|Overall Study|Lost to Follow-up|0|||
126410605|NCT01393639|454797961|FG003|Overall Study|Lost to Follow-up|0|||
126410606|NCT01393639|454797962|FG004|Overall Study|Lost to Follow-up|0|||
126410607|NCT01393639|454797963|FG005|Overall Study|Lost to Follow-up|0|||
126410608|NCT01393639|454797964|FG006|Overall Study|Lost to Follow-up|1|||
126410609|NCT01393639|454797958|FG000|Overall Study|Lack of Efficacy|0|||
126410610|NCT01393639|454797959|FG001|Overall Study|Lack of Efficacy|0|||
126410611|NCT01393639|454797960|FG002|Overall Study|Lack of Efficacy|0|||
126474377|NCT02639546|455036311|FG006|Overall Study|Withdrawal by Subject|2|||
126474378|NCT02639546|455036312|FG007|Overall Study|Withdrawal by Subject|1|||
126474379|NCT01032174|455036315|FG000|Overall Study|Adverse Event|0|||
126474380|NCT01032174|455036316|FG001|Overall Study|Adverse Event|1|||
126474381|NCT00113087|455036318|FG000|Overall Study|Death or Transplant|14|||
126474382|NCT00113087|455036319|FG001|Overall Study|Death or Transplant|16|||
126474383|NCT00113087|455036318|FG000|Overall Study|Family or MD withdrew subject|10|||
126474384|NCT00113087|455036319|FG001|Overall Study|Family or MD withdrew subject|5|||
126474385|NCT01281137|455036320|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
126474386|NCT01281137|455036321|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
126474387|NCT01281137|455036320|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
126474388|NCT01281137|455036321|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
126474389|NCT01281137|455036320|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
126474390|NCT01281137|455036321|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
126474391|NCT01281137|455036320|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
126474392|NCT01281137|455036321|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
126474393|NCT01281137|455036320|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
126474394|NCT01281137|455036321|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
126474395|NCT00386607|455036324|FG000|Core|Adverse Event|40|||
126474396|NCT00386607|455036325|FG001|Core|Adverse Event|0|||
126474397|NCT00386607|455036324|FG000|Core|Abnormal laboratory value(s)|3|||
126474398|NCT00386607|455036325|FG001|Core|Abnormal laboratory value(s)|0|||
126474399|NCT00386607|455036324|FG000|Core|Unsatisfactory therapeutic effect|23|||
126474400|NCT00386607|455036325|FG001|Core|Unsatisfactory therapeutic effect|0|||
126474401|NCT00386607|455036324|FG000|Core|Condition no longer requires study drug|4|||
126474402|NCT00386607|455036325|FG001|Core|Condition no longer requires study drug|0|||
126410612|NCT01393639|454797961|FG003|Overall Study|Lack of Efficacy|0|||
126474403|NCT00386607|455036324|FG000|Core|Patient withdrew consent|15|||
126474404|NCT00386607|455036325|FG001|Core|Patient withdrew consent|0|||
126474405|NCT00386607|455036324|FG000|Core|Lost to Follow-up|23|||
126474406|NCT00386607|455036325|FG001|Core|Lost to Follow-up|0|||
126410613|NCT01393639|454797962|FG004|Overall Study|Lack of Efficacy|0|||
126410614|NCT01393639|454797963|FG005|Overall Study|Lack of Efficacy|0|||
126410615|NCT01393639|454797964|FG006|Overall Study|Lack of Efficacy|1|||
126410616|NCT01393639|454797958|FG000|Overall Study|Adverse Event|2|||
126410617|NCT01393639|454797959|FG001|Overall Study|Adverse Event|3|||
126410618|NCT01393639|454797960|FG002|Overall Study|Adverse Event|1|||
126410619|NCT01393639|454797961|FG003|Overall Study|Adverse Event|2|||
126410620|NCT01393639|454797962|FG004|Overall Study|Adverse Event|0|||
126410621|NCT01393639|454797963|FG005|Overall Study|Adverse Event|2|||
126410622|NCT01393639|454797964|FG006|Overall Study|Adverse Event|3|||
126410623|NCT00679172|454797965|FG000|Overall Study|Non-compliance|1|||
126410624|NCT00679172|454797966|FG001|Overall Study|Non-compliance|1|||
126410625|NCT00679172|454797967|FG002|Overall Study|Non-compliance|0|||
126410626|NCT00679172|454797968|FG003|Overall Study|Non-compliance|1|||
126410627|NCT00679172|454797969|FG004|Overall Study|Non-compliance|0|||
126410628|NCT00679172|454797965|FG000|Overall Study|Other not specified|0|||
126410629|NCT00679172|454797966|FG001|Overall Study|Other not specified|0|||
126410630|NCT00679172|454797967|FG002|Overall Study|Other not specified|1|||
126410631|NCT00679172|454797968|FG003|Overall Study|Other not specified|0|||
126410632|NCT00679172|454797969|FG004|Overall Study|Other not specified|0|||
126410633|NCT00793325|454797970|FG000|Overall Study|Protocol Violation|18|||
126410634|NCT00793325|454797970|FG000|Overall Study|Lost to Follow-up|1|||
126410635|NCT01815840|454797971|FG000|Overall Study|Missing|1|||
126410636|NCT01815840|454797972|FG001|Overall Study|Missing|0|||
126410637|NCT01815840|454797971|FG000|Overall Study|Withdrew Consent|31|||
126410638|NCT01815840|454797972|FG001|Overall Study|Withdrew Consent|30|||
126410639|NCT01815840|454797971|FG000|Overall Study|Administrative/Other|1|||
126410640|NCT01815840|454797972|FG001|Overall Study|Administrative/Other|3|||
126410641|NCT01815840|454797971|FG000|Overall Study|Adverse Event|10|||
126410642|NCT01815840|454797972|FG001|Overall Study|Adverse Event|16|||
126410643|NCT01815840|454797971|FG000|Overall Study|Death|2|||
126410644|NCT01815840|454797972|FG001|Overall Study|Death|2|||
126410645|NCT01815840|454797971|FG000|Overall Study|Disease progression|3|||
126410646|NCT01815840|454797972|FG001|Overall Study|Disease progression|2|||
126410647|NCT01815840|454797971|FG000|Overall Study|Investigators Decision|2|||
126410648|NCT01815840|454797972|FG001|Overall Study|Investigators Decision|3|||
126410649|NCT01815840|454797971|FG000|Overall Study|Lost to Follow-up|3|||
126410650|NCT01815840|454797972|FG001|Overall Study|Lost to Follow-up|6|||
126410651|NCT01815840|454797971|FG000|Overall Study|Refused Treatment|5|||
126410652|NCT01815840|454797972|FG001|Overall Study|Refused Treatment|1|||
126410653|NCT01815840|454797971|FG000|Overall Study|Sponsor Termination Treatment|1|||
126410654|NCT01815840|454797972|FG001|Overall Study|Sponsor Termination Treatment|0|||
126410655|NCT03221842|454797973|FG000|Period 1 (Open-label)|Adverse Event|4|||
126410656|NCT03221842|454797974|FG001|Period 1 (Open-label)|Adverse Event|0|||
126410657|NCT03221842|454797973|FG000|Period 1 (Open-label)|Physician Decision|2|||
126410658|NCT03221842|454797974|FG001|Period 1 (Open-label)|Physician Decision|0|||
126410659|NCT03221842|454797973|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
126410660|NCT03221842|454797974|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
126410661|NCT03221842|454797973|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
126410662|NCT03221842|454797974|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
126410663|NCT03221842|454797973|FG000|Period 1 (Open-label)|Other|2|||
126410664|NCT03221842|454797974|FG001|Period 1 (Open-label)|Other|0|||
126410665|NCT03221842|454797973|FG000|Period 2 (Randomized, Blinded)|Death|0|||
126410666|NCT03221842|454797974|FG001|Period 2 (Randomized, Blinded)|Death|1|||
126410667|NCT03221842|454797973|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
126410668|NCT03221842|454797974|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
126410669|NCT00704288|454797976|FG000|Overall Treatment Period|Adverse Event|11|||
126410670|NCT00704288|454797977|FG001|Overall Treatment Period|Adverse Event|8|||
126410671|NCT00704288|454797978|FG002|Overall Treatment Period|Adverse Event|22|||
126410672|NCT00704288|454797976|FG000|Overall Treatment Period|Death|0|||
126410673|NCT00704288|454797977|FG001|Overall Treatment Period|Death|0|||
126410674|NCT00704288|454797978|FG002|Overall Treatment Period|Death|1|||
126410675|NCT00704288|454797976|FG000|Overall Treatment Period|Physician Decision|0|||
126410676|NCT00704288|454797977|FG001|Overall Treatment Period|Physician Decision|2|||
126410677|NCT00704288|454797978|FG002|Overall Treatment Period|Physician Decision|0|||
126410678|NCT00704288|454797976|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
126410679|NCT00704288|454797977|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
126721461|NCT00195260|455929975|FG007|Part 1: Dose Escalation|Disease Progression|4|||
126721462|NCT00195260|455929976|FG008|Part 1: Dose Escalation|Disease Progression|0|||
126410680|NCT00704288|454797978|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
126410681|NCT00704288|454797976|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
126410682|NCT00704288|454797977|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
126410683|NCT00704288|454797978|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
126410684|NCT00704288|454797976|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
126410685|NCT00704288|454797977|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
126410686|NCT00704288|454797978|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
126410687|NCT00704288|454797976|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
126410688|NCT00704288|454797977|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
126410689|NCT00704288|454797978|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
126410690|NCT00704288|454797976|FG000|Overall Treatment Period|Roll-over to another study|1|||
126410691|NCT00704288|454797977|FG001|Overall Treatment Period|Roll-over to another study|0|||
126410692|NCT00704288|454797978|FG002|Overall Treatment Period|Roll-over to another study|4|||
126410693|NCT00704288|454797976|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
126410694|NCT00704288|454797977|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
126410695|NCT00704288|454797978|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
126410696|NCT00704288|454797976|FG000|Extended Post Treatment Follow Up Period|Death|41|||
126410697|NCT00704288|454797977|FG001|Extended Post Treatment Follow Up Period|Death|50|||
126410698|NCT00704288|454797978|FG002|Extended Post Treatment Follow Up Period|Death|93|||
126410699|NCT00704288|454797976|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
126410700|NCT00704288|454797977|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
126410701|NCT00704288|454797978|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
126410702|NCT00704288|454797976|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
126410703|NCT00704288|454797977|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
126410704|NCT00704288|454797978|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
126410705|NCT00704288|454797976|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
126410706|NCT00704288|454797977|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
126410707|NCT00704288|454797978|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
126410708|NCT04395690|454797979|FG000|Overall Study|Lost to Follow-up|1|||
126410709|NCT04395690|454797980|FG001|Overall Study|Lost to Follow-up|1|||
126410710|NCT03387020|454797982|FG000|Overall Study|Adverse Event|0|||
126410711|NCT03387020|454797983|FG001|Overall Study|Adverse Event|2|||
126410712|NCT03387020|454797984|FG002|Overall Study|Adverse Event|0|||
126410713|NCT03387020|454797982|FG000|Overall Study|Withdrawal by Subject|2|||
126410714|NCT03387020|454797983|FG001|Overall Study|Withdrawal by Subject|0|||
126410715|NCT03387020|454797984|FG002|Overall Study|Withdrawal by Subject|0|||
126410716|NCT00434642|454797985|FG000|Blinded Treatment Phase|Adverse Event|12|||
126410717|NCT00434642|454797986|FG001|Blinded Treatment Phase|Adverse Event|58|||
126410718|NCT00434642|454797985|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
126410719|NCT00434642|454797986|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
126410720|NCT00434642|454797985|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
126410721|NCT00434642|454797986|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
126410722|NCT00434642|454797985|FG000|Blinded Treatment Phase|Physician Decision|19|||
126410723|NCT00434642|454797986|FG001|Blinded Treatment Phase|Physician Decision|27|||
126410724|NCT00434642|454797985|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
126410725|NCT00434642|454797986|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
126410726|NCT00434642|454797985|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
126410727|NCT00434642|454797986|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
126410728|NCT00434642|454797985|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
126410729|NCT00434642|454797986|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
126410730|NCT00434642|454797985|FG000|Open-label Treatment Phase|Adverse Event|0|||
126410731|NCT00434642|454797986|FG001|Open-label Treatment Phase|Adverse Event|5|||
126410732|NCT00434642|454797985|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
126410733|NCT00434642|454797986|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
126410734|NCT04512976|454797991|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
126410735|NCT04512976|454797992|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
126410736|NCT04512976|454797993|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
126410737|NCT04512976|454797994|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
126410738|NCT04512976|454797995|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
126410739|NCT04512976|454797996|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
126410740|NCT00527982|454797997|FG000|Overall Study|Physician Decision|1|||
126410741|NCT00527982|454797998|FG001|Overall Study|Physician Decision|0|||
126410742|NCT02241343|454798003|FG000|Overall Study|Adverse Event|1|||
126410743|NCT04541628|454798005|FG000|Overall Study|Study Terminated|1|||
126410744|NCT04541628|454798006|FG001|Overall Study|Study Terminated|1|||
126410745|NCT04541628|454798007|FG002|Overall Study|Study Terminated|1|||
126410746|NCT05011058|454798008|FG000|Overall Study|Sponsor Decision|2|||
126410747|NCT05011058|454798009|FG001|Overall Study|Sponsor Decision|0|||
126410748|NCT05011058|454798010|FG002|Overall Study|Sponsor Decision|14|||
126410749|NCT05011058|454798011|FG003|Overall Study|Sponsor Decision|0|||
126410750|NCT05011058|454798012|FG004|Overall Study|Sponsor Decision|0|||
126410751|NCT05011058|454798013|FG005|Overall Study|Sponsor Decision|1|||
126410752|NCT05011058|454798014|FG006|Overall Study|Sponsor Decision|0|||
126410753|NCT05011058|454798015|FG007|Overall Study|Sponsor Decision|5|||
126410754|NCT00308074|454798019|FG000|Overall Study|Withdrawal by Subject|1|||
126410755|NCT01329939|454798022|FG000|Overall Study|Lost to Follow-up|3|||
126410756|NCT01329939|454798023|FG001|Overall Study|Lost to Follow-up|0|||
126410757|NCT01329939|454798024|FG002|Overall Study|Lost to Follow-up|1|||
126410758|NCT01329939|454798025|FG003|Overall Study|Lost to Follow-up|2|||
126410759|NCT01329939|454798022|FG000|Overall Study|Withdrawal by Subject|0|||
126410760|NCT01329939|454798023|FG001|Overall Study|Withdrawal by Subject|1|||
126410761|NCT01329939|454798024|FG002|Overall Study|Withdrawal by Subject|0|||
126410762|NCT01329939|454798025|FG003|Overall Study|Withdrawal by Subject|0|||
126410763|NCT01329939|454798022|FG000|Overall Study|Adverse Event|0|||
126410764|NCT01329939|454798023|FG001|Overall Study|Adverse Event|0|||
126410765|NCT01329939|454798024|FG002|Overall Study|Adverse Event|0|||
126410766|NCT01329939|454798025|FG003|Overall Study|Adverse Event|3|||
126410767|NCT02942485|454798026|FG000|Overall Study|Lost to Follow-up|1|||
126410768|NCT02942485|454798027|FG001|Overall Study|Lost to Follow-up|0|||
126410769|NCT04369950|454798029|FG000|Overall Study|Protocol Violation|2|||
126410770|NCT04369950|454798030|FG001|Overall Study|Protocol Violation|2|||
126410771|NCT00989963|454798031|FG000|Overall Study|Adverse Event|1|||
126410772|NCT00989963|454798032|FG001|Overall Study|Adverse Event|1|||
126410773|NCT00989963|454798033|FG002|Overall Study|Adverse Event|1|||
126410774|NCT01240200|454798034|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
126410775|NCT01240200|454798035|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
126410776|NCT01529034|454798038|FG000|Overall Study|Discontinued prior to study treatment|14|||
126410777|NCT01529034|454798038|FG000|Overall Study|Site closure|62|||
126410778|NCT01529034|454798038|FG000|Overall Study|Study termination|29|||
126410779|NCT01529034|454798038|FG000|Overall Study|Withdrawal by Subject|25|||
126410780|NCT01529034|454798038|FG000|Overall Study|No treated SCs within protocol window|13|||
126410781|NCT01529034|454798038|FG000|Overall Study|Noncompliance|8|||
126410782|NCT01529034|454798038|FG000|Overall Study|Caregiver no longer available|7|||
126410783|NCT01529034|454798038|FG000|Overall Study|Adverse Event|4|||
126410784|NCT01529034|454798038|FG000|Overall Study|Protocol Violation|4|||
126410785|NCT01529034|454798038|FG000|Overall Study|Lack of Efficacy|4|||
126410786|NCT01529034|454798038|FG000|Overall Study|Investigator no longer available|2|||
126410787|NCT01529034|454798038|FG000|Overall Study|Study drug not available|2|||
126410788|NCT00646399|454798040|FG000|Overall Study|Death|63|||
126410789|NCT00646399|454798041|FG001|Overall Study|Death|53|||
126410790|NCT00646399|454798040|FG000|Overall Study|Withdrawal by Subject|9|||
126410791|NCT00646399|454798041|FG001|Overall Study|Withdrawal by Subject|10|||
126410792|NCT00646399|454798040|FG000|Overall Study|Other Reason|11|||
126410793|NCT00646399|454798041|FG001|Overall Study|Other Reason|11|||
126410794|NCT02473367|454798044|FG000|Wait 1|Withdrawal by Subject|1|||
126410795|NCT02473367|454798044|FG000|Period 4|Lost to Follow-up|1|||
126410796|NCT02678923|454798045|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
126410797|NCT02678923|454798046|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
126410798|NCT02678923|454798045|FG000|Overall Study|Withdrawal by Subject|3|||
126410799|NCT02678923|454798046|FG001|Overall Study|Withdrawal by Subject|2|||
126410800|NCT02678923|454798045|FG000|Overall Study|Lost to Follow-up|1|||
126410801|NCT02678923|454798046|FG001|Overall Study|Lost to Follow-up|0|||
126410802|NCT02678923|454798045|FG000|Overall Study|Did Not Return for Study Visits|1|||
126410803|NCT02678923|454798046|FG001|Overall Study|Did Not Return for Study Visits|0|||
126410804|NCT00455143|454798047|FG000|Overall Study|Physician Decision|1|||
126410805|NCT00455143|454798047|FG000|Overall Study|Withdrawal by Subject|1|||
126410806|NCT00455143|454798047|FG000|Overall Study|Staff was not avail to follow patient|2|||
126410807|NCT00455143|454798047|FG000|Overall Study|No longer met Inclusion Criteria|1|||
126410808|NCT00455143|454798047|FG000|Overall Study|Surgical time, staff not available|1|||
126410809|NCT01966445|454798048|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
126410810|NCT01966445|454798049|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
126410811|NCT01966445|454798050|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
126410812|NCT01966445|454798051|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
126410813|NCT01966445|454798052|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
126410814|NCT01966445|454798053|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
126474407|NCT00386607|455036324|FG000|Core|Administrative problems|1|||
126721463|NCT00195260|455929977|FG009|Part 1: Dose Escalation|Disease Progression|0|||
126721464|NCT00195260|455929978|FG010|Part 1: Dose Escalation|Disease Progression|0|||
126721465|NCT00195260|455929968|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
126721466|NCT00195260|455929969|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
126721467|NCT00195260|455929970|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
126410815|NCT01966445|454798054|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
126410816|NCT01966445|454798048|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
126410817|NCT01966445|454798049|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
126410818|NCT01966445|454798050|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
126410819|NCT01966445|454798051|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
126410820|NCT01966445|454798052|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
126410821|NCT01966445|454798053|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
126410822|NCT01966445|454798054|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
126410823|NCT01966445|454798048|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
126410824|NCT01966445|454798049|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
126474408|NCT00386607|455036325|FG001|Core|Administrative problems|0|||
126474409|NCT00386607|455036324|FG000|Core|Protocol Deviation|6|||
126474410|NCT00386607|455036325|FG001|Core|Protocol Deviation|0|||
126474411|NCT00386607|455036324|FG000|Extension|Adverse Event|0|||
126474412|NCT00386607|455036325|FG001|Extension|Adverse Event|6|||
126474413|NCT00386607|455036324|FG000|Extension|Abnormal laboratory value(s)|0|||
126474414|NCT00386607|455036325|FG001|Extension|Abnormal laboratory value(s)|1|||
126474415|NCT00386607|455036324|FG000|Extension|Administrative problems|0|||
126474416|NCT00386607|455036325|FG001|Extension|Administrative problems|1|||
126474417|NCT00386607|455036324|FG000|Extension|Lost to Follow-up|0|||
126474418|NCT00386607|455036325|FG001|Extension|Lost to Follow-up|3|||
126474419|NCT00386607|455036324|FG000|Extension|Patient withdrew consent|0|||
126474420|NCT00386607|455036325|FG001|Extension|Patient withdrew consent|5|||
126474421|NCT00386607|455036324|FG000|Extension|Unsatisfactory therapeutic effect|0|||
126474422|NCT00386607|455036325|FG001|Extension|Unsatisfactory therapeutic effect|1|||
126474423|NCT04251273|455036328|FG000|Overall Study|Lost to Follow-up|331|||
126474424|NCT04251273|455036329|FG001|Overall Study|Lost to Follow-up|290|||
126474425|NCT01986907|455036330|FG000|Overall Study|Adverse Event|11|||
126474426|NCT01986907|455036330|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
126474427|NCT01986907|455036330|FG000|Overall Study|Protocol Violation|4|||
126474428|NCT01986907|455036330|FG000|Overall Study|Withdrawal by Subject|76|||
126474429|NCT01986907|455036330|FG000|Overall Study|Lost to Follow-up|38|||
126474430|NCT01986907|455036330|FG000|Overall Study|Death|9|||
126474431|NCT00810693|455036331|FG000|Treatment Period|Adverse Event|8|||
126474432|NCT00810693|455036332|FG001|Treatment Period|Adverse Event|1|||
126474433|NCT00810693|455036333|FG002|Treatment Period|Adverse Event|7|||
126474434|NCT00810693|455036331|FG000|Treatment Period|Death|0|||
126474435|NCT00810693|455036332|FG001|Treatment Period|Death|1|||
126474436|NCT00810693|455036333|FG002|Treatment Period|Death|2|||
126474437|NCT00810693|455036331|FG000|Treatment Period|Lack of Efficacy|0|||
126474438|NCT00810693|455036332|FG001|Treatment Period|Lack of Efficacy|0|||
126474439|NCT00810693|455036333|FG002|Treatment Period|Lack of Efficacy|1|||
126474440|NCT00810693|455036331|FG000|Treatment Period|Lost to Follow-up|1|||
126474441|NCT00810693|455036332|FG001|Treatment Period|Lost to Follow-up|0|||
126474442|NCT00810693|455036333|FG002|Treatment Period|Lost to Follow-up|0|||
126474443|NCT00810693|455036331|FG000|Treatment Period|Non-compliance|1|||
126474444|NCT00810693|455036332|FG001|Treatment Period|Non-compliance|0|||
126474445|NCT00810693|455036333|FG002|Treatment Period|Non-compliance|0|||
126474446|NCT00810693|455036331|FG000|Treatment Period|Protocol Violation|1|||
126474447|NCT00810693|455036332|FG001|Treatment Period|Protocol Violation|2|||
126474448|NCT00810693|455036333|FG002|Treatment Period|Protocol Violation|2|||
126474449|NCT00810693|455036331|FG000|Treatment Period|Withdrawal by Subject|6|||
126474450|NCT00810693|455036332|FG001|Treatment Period|Withdrawal by Subject|2|||
126474451|NCT00810693|455036333|FG002|Treatment Period|Withdrawal by Subject|3|||
126474452|NCT00810693|455036331|FG000|Treatment Period|Not treated|0|||
126474453|NCT00810693|455036332|FG001|Treatment Period|Not treated|1|||
126474454|NCT00810693|455036333|FG002|Treatment Period|Not treated|1|||
126474455|NCT00810693|455036331|FG000|Follow-up Period (FUP)|Adverse Event|3|||
126474456|NCT00810693|455036332|FG001|Follow-up Period (FUP)|Adverse Event|1|||
126474457|NCT00810693|455036333|FG002|Follow-up Period (FUP)|Adverse Event|1|||
126474458|NCT00810693|455036331|FG000|Follow-up Period (FUP)|Death|2|||
126474459|NCT00810693|455036332|FG001|Follow-up Period (FUP)|Death|0|||
126474460|NCT00810693|455036333|FG002|Follow-up Period (FUP)|Death|1|||
126474461|NCT00810693|455036331|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
126474462|NCT00810693|455036332|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
126474463|NCT00810693|455036333|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
126474464|NCT00810693|455036331|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
126474465|NCT00810693|455036332|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
126474466|NCT00810693|455036333|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
126474467|NCT00810693|455036331|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
126474468|NCT00810693|455036332|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
126474469|NCT00810693|455036333|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
126474470|NCT03212690|455036334|FG000|Overall Study|Protocol Violation|1|||
126474471|NCT04203797|455036342|FG000|Overall Study|Adverse Event|1|||
126474472|NCT04203797|455036343|FG001|Overall Study|Adverse Event|0|||
126474473|NCT04203797|455036342|FG000|Overall Study|Did not complete End of Study follow-up|1|||
126474474|NCT04203797|455036343|FG001|Overall Study|Did not complete End of Study follow-up|0|||
126721468|NCT00195260|455929971|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126721469|NCT00195260|455929972|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126474475|NCT00516074|455036345|FG000|Overall Study|Adverse Event|0|||
126474476|NCT00516074|455036346|FG001|Overall Study|Adverse Event|1|||
126474477|NCT00516074|455036345|FG000|Overall Study|Subject Decision|4|||
126474478|NCT00516074|455036346|FG001|Overall Study|Subject Decision|2|||
126474479|NCT00516074|455036345|FG000|Overall Study|Loss of Glucose Control|2|||
126474480|NCT00516074|455036346|FG001|Overall Study|Loss of Glucose Control|0|||
126474481|NCT00633750|455036347|FG000|Overall Study|Adverse Event|2|||
126474482|NCT00633750|455036347|FG000|Overall Study|Withdrawal by Subject|3|||
126474483|NCT02215096|455036350|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
126410825|NCT01966445|454798050|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
126410826|NCT01966445|454798051|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
126410827|NCT01966445|454798052|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
126410828|NCT01966445|454798053|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
126410829|NCT01966445|454798054|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
126410830|NCT01966445|454798048|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
126410831|NCT01966445|454798049|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
126410832|NCT01966445|454798050|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
126410833|NCT01966445|454798051|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
126410834|NCT01966445|454798052|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
126410835|NCT01966445|454798053|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
126410836|NCT01966445|454798054|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
126410837|NCT01966445|454798048|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
126410838|NCT01966445|454798049|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
126410839|NCT01966445|454798050|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
126410840|NCT01966445|454798051|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
126410841|NCT01966445|454798052|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
126410842|NCT01966445|454798053|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
126410843|NCT01966445|454798054|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
126410844|NCT01641822|454798055|FG000|Run-in Phase|Noncompliance with study drug|1|||
126410845|NCT01641822|454798056|FG001|Run-in Phase|Noncompliance with study drug|0|||
126410846|NCT01641822|454798057|FG002|Run-in Phase|Noncompliance with study drug|0|||
126410847|NCT01641822|454798055|FG000|Run-in Phase|Adverse Event|3|||
126410848|NCT01641822|454798056|FG001|Run-in Phase|Adverse Event|0|||
126410849|NCT01641822|454798057|FG002|Run-in Phase|Adverse Event|0|||
126410850|NCT01641822|454798055|FG000|Run-in Phase|Withdrew consent|1|||
126410851|NCT01641822|454798056|FG001|Run-in Phase|Withdrew consent|0|||
126410852|NCT01641822|454798057|FG002|Run-in Phase|Withdrew consent|0|||
126410853|NCT01641822|454798055|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
126410854|NCT01641822|454798056|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
126410855|NCT01641822|454798057|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
126410856|NCT01641822|454798055|FG000|Comparative Phase|Noncompliance with study drug|0|||
126410857|NCT01641822|454798056|FG001|Comparative Phase|Noncompliance with study drug|1|||
126410858|NCT01641822|454798057|FG002|Comparative Phase|Noncompliance with study drug|0|||
126410859|NCT01641822|454798055|FG000|Comparative Phase|Investigator's discretion|0|||
126410860|NCT01641822|454798056|FG001|Comparative Phase|Investigator's discretion|0|||
126410861|NCT01641822|454798057|FG002|Comparative Phase|Investigator's discretion|1|||
126410862|NCT01641822|454798055|FG000|Comparative Phase|Pregnancy|0|||
126410863|NCT01641822|454798056|FG001|Comparative Phase|Pregnancy|0|||
126410864|NCT01641822|454798057|FG002|Comparative Phase|Pregnancy|1|||
126410865|NCT01641822|454798055|FG000|Comparative Phase|Adverse event, serious fatal|0|||
126410866|NCT01641822|454798056|FG001|Comparative Phase|Adverse event, serious fatal|1|||
126410867|NCT01641822|454798057|FG002|Comparative Phase|Adverse event, serious fatal|0|||
126410868|NCT01641822|454798055|FG000|Comparative Phase|Withdrew consent|0|||
126410869|NCT01641822|454798056|FG001|Comparative Phase|Withdrew consent|3|||
126410870|NCT01641822|454798057|FG002|Comparative Phase|Withdrew consent|7|||
126410871|NCT01641822|454798055|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
126558684|NCT02223182|455338806|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
126558685|NCT02223182|455338807|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
126410872|NCT01641822|454798056|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
126410873|NCT01641822|454798057|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
126410874|NCT00454584|454798058|FG000|Controlled Period|Adverse Event|5|||
126410875|NCT00454584|454798059|FG001|Controlled Period|Adverse Event|2|||
126410876|NCT00454584|454798060|FG002|Controlled Period|Adverse Event|1|||
126410877|NCT00454584|454798061|FG003|Controlled Period|Adverse Event|0|||
126410878|NCT00454584|454798062|FG004|Controlled Period|Adverse Event|0|||
126410879|NCT00454584|454798063|FG005|Controlled Period|Adverse Event|0|||
126410880|NCT00454584|454798058|FG000|Controlled Period|Lost to Follow-up|1|||
126410881|NCT00454584|454798059|FG001|Controlled Period|Lost to Follow-up|2|||
126558686|NCT02223182|455338808|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
126558687|NCT02223182|455338809|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
126558688|NCT02223182|455338806|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
126410882|NCT00454584|454798060|FG002|Controlled Period|Lost to Follow-up|2|||
126410883|NCT00454584|454798061|FG003|Controlled Period|Lost to Follow-up|0|||
126558689|NCT02223182|455338807|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
126410884|NCT00454584|454798062|FG004|Controlled Period|Lost to Follow-up|0|||
126410885|NCT00454584|454798063|FG005|Controlled Period|Lost to Follow-up|0|||
126410886|NCT00454584|454798058|FG000|Controlled Period|Other|5|||
126410887|NCT00454584|454798059|FG001|Controlled Period|Other|4|||
126410888|NCT00454584|454798060|FG002|Controlled Period|Other|2|||
126410889|NCT00454584|454798061|FG003|Controlled Period|Other|0|||
126410890|NCT00454584|454798062|FG004|Controlled Period|Other|0|||
126410891|NCT00454584|454798063|FG005|Controlled Period|Other|0|||
126410892|NCT00454584|454798058|FG000|After Controlled Period|Adverse Event|0|||
126410893|NCT00454584|454798059|FG001|After Controlled Period|Adverse Event|0|||
126410894|NCT00454584|454798060|FG002|After Controlled Period|Adverse Event|0|||
126410895|NCT00454584|454798061|FG003|After Controlled Period|Adverse Event|9|||
126410896|NCT00454584|454798062|FG004|After Controlled Period|Adverse Event|3|||
126410897|NCT00454584|454798063|FG005|After Controlled Period|Adverse Event|9|||
126410898|NCT00454584|454798058|FG000|After Controlled Period|Lack of Efficacy|0|||
126410899|NCT00454584|454798059|FG001|After Controlled Period|Lack of Efficacy|0|||
126410900|NCT00454584|454798060|FG002|After Controlled Period|Lack of Efficacy|0|||
126410901|NCT00454584|454798061|FG003|After Controlled Period|Lack of Efficacy|1|||
126410902|NCT00454584|454798062|FG004|After Controlled Period|Lack of Efficacy|0|||
126410903|NCT00454584|454798063|FG005|After Controlled Period|Lack of Efficacy|0|||
126410904|NCT00454584|454798058|FG000|After Controlled Period|Lost to Follow-up|0|||
126410905|NCT00454584|454798059|FG001|After Controlled Period|Lost to Follow-up|0|||
126410906|NCT00454584|454798060|FG002|After Controlled Period|Lost to Follow-up|0|||
126410907|NCT00454584|454798061|FG003|After Controlled Period|Lost to Follow-up|2|||
126410908|NCT00454584|454798062|FG004|After Controlled Period|Lost to Follow-up|4|||
126410909|NCT00454584|454798063|FG005|After Controlled Period|Lost to Follow-up|6|||
126410910|NCT00454584|454798058|FG000|After Controlled Period|Other|0|||
126410911|NCT00454584|454798059|FG001|After Controlled Period|Other|0|||
126410912|NCT00454584|454798060|FG002|After Controlled Period|Other|0|||
126410913|NCT00454584|454798061|FG003|After Controlled Period|Other|1|||
126410914|NCT00454584|454798062|FG004|After Controlled Period|Other|0|||
126410915|NCT00454584|454798063|FG005|After Controlled Period|Other|0|||
126410916|NCT00454584|454798058|FG000|After Controlled Period|Other|0|||
126410917|NCT00454584|454798059|FG001|After Controlled Period|Other|0|||
126410918|NCT00454584|454798060|FG002|After Controlled Period|Other|0|||
126410919|NCT00454584|454798061|FG003|After Controlled Period|Other|13|||
126410920|NCT00454584|454798062|FG004|After Controlled Period|Other|5|||
126410921|NCT00454584|454798063|FG005|After Controlled Period|Other|17|||
126410922|NCT02421601|454798064|FG000|Overall Study|Adverse Event|4|||
126410923|NCT02421601|454798064|FG000|Overall Study|Lack of Efficacy|5|||
126410924|NCT02421601|454798064|FG000|Overall Study|Physician Decision|1|||
126410925|NCT02421601|454798064|FG000|Overall Study|Withdrawal by Subject|31|||
126410926|NCT02421601|454798064|FG000|Overall Study|Others|41|||
126410927|NCT00470418|454798065|FG000|Overall Study|Withdrawal by Subject|1|||
126410928|NCT00470418|454798066|FG001|Overall Study|Withdrawal by Subject|0|||
126410929|NCT00599638|454798067|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
126410930|NCT00599638|454798068|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
126410931|NCT00599638|454798069|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
126410932|NCT00599638|454798070|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
126410933|NCT00599638|454798067|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
126410934|NCT00599638|454798068|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
126410935|NCT00599638|454798069|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
126410936|NCT00599638|454798070|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
126410937|NCT00599638|454798067|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
126410938|NCT00599638|454798068|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
126410939|NCT00599638|454798069|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
126410940|NCT00599638|454798070|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
126410941|NCT00599638|454798067|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
126410942|NCT00599638|454798068|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
126410943|NCT00599638|454798069|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
126410944|NCT00599638|454798070|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
126410945|NCT00599638|454798067|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
126410946|NCT00599638|454798068|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
126410947|NCT00599638|454798069|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
126410948|NCT00599638|454798070|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
126410949|NCT00599638|454798067|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
126410950|NCT00599638|454798068|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
126410951|NCT00599638|454798069|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
126474484|NCT02215096|455036351|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
126410952|NCT00599638|454798070|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
126474485|NCT02215096|455036352|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
126721470|NCT00195260|455929973|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
126410953|NCT00599638|454798067|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
126410954|NCT00599638|454798068|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
126410955|NCT00599638|454798069|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
126410956|NCT00599638|454798070|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
126410957|NCT00599638|454798067|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
126410958|NCT00599638|454798068|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
126474486|NCT02215096|455036353|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
126410959|NCT00599638|454798069|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
126410960|NCT00599638|454798070|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
126410961|NCT00599638|454798067|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
126410962|NCT00599638|454798068|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
126410963|NCT00599638|454798069|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
126410964|NCT00599638|454798070|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
126410965|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
126410966|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
126410967|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
126410968|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
126410969|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
126410970|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
126410971|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
126410972|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
126410973|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
126410974|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
126410975|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
126410976|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
126410977|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
126410978|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
126410979|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
126410980|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
126410981|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
126410982|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
126410983|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
126410984|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
126410985|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
126410986|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
126410987|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
126410988|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
126410989|NCT01532869|454798074|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
126410990|NCT01532869|454798075|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
126410991|NCT01532869|454798074|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
126410992|NCT01532869|454798075|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
126410993|NCT01532869|454798074|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
126410994|NCT01532869|454798075|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
126410995|NCT01532869|454798074|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
126410996|NCT01532869|454798075|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
126410997|NCT01532869|454798074|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
126410998|NCT01532869|454798075|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
126410999|NCT00409344|454798076|FG000|Overall Study|no enrollment|0|||
126411000|NCT00409344|454798077|FG001|Overall Study|no enrollment|0|||
126411001|NCT01424228|454798078|FG000|Overall Study|Withdrawal by Subject|27|||
126411002|NCT01424228|454798079|FG001|Overall Study|Withdrawal by Subject|11|||
126411003|NCT01424228|454798078|FG000|Overall Study|Adverse Event|10|||
126411004|NCT01424228|454798079|FG001|Overall Study|Adverse Event|14|||
126411005|NCT01424228|454798078|FG000|Overall Study|Sponsor's decision|9|||
126411006|NCT01424228|454798079|FG001|Overall Study|Sponsor's decision|12|||
126411007|NCT01424228|454798078|FG000|Overall Study|Lack of Efficacy|5|||
126411008|NCT01424228|454798079|FG001|Overall Study|Lack of Efficacy|7|||
126411009|NCT01424228|454798078|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
126411010|NCT01424228|454798079|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
126411011|NCT01424228|454798078|FG000|Overall Study|Non-compliance|2|||
126411012|NCT01424228|454798079|FG001|Overall Study|Non-compliance|0|||
126411013|NCT01424228|454798078|FG000|Overall Study|Worsening of symptoms|1|||
126411014|NCT01424228|454798079|FG001|Overall Study|Worsening of symptoms|0|||
126411015|NCT01424228|454798078|FG000|Overall Study|Unplanned journey|0|||
126411016|NCT01424228|454798079|FG001|Overall Study|Unplanned journey|1|||
126411017|NCT00410605|454798093|FG000|Overall Study|Adverse Event|12|||
126411018|NCT00410605|454798093|FG000|Overall Study|Physician Decision|3|||
126411019|NCT00410605|454798093|FG000|Overall Study|Withdrawal by Subject|5|||
126411020|NCT00410605|454798093|FG000|Overall Study|Started Non-Protocol Therapy|3|||
126411021|NCT00410605|454798093|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
126411022|NCT00410605|454798093|FG000|Overall Study|Transferred to another Institution|1|||
126411023|NCT04058886|454798094|FG000|Overall Study|Withdrawal by Subject|4|||
126411024|NCT04058886|454798094|FG000|Overall Study|Inadequate deafness interpreter service|1|||
126411025|NCT00760838|454798098|FG000|Overall Study|Adverse Event|1|||
126411026|NCT00760838|454798099|FG001|Overall Study|Adverse Event|1|||
126411027|NCT00760838|454798098|FG000|Overall Study|Lack of Efficacy|1|||
126411028|NCT00760838|454798099|FG001|Overall Study|Lack of Efficacy|0|||
126411029|NCT00760838|454798098|FG000|Overall Study|Lost to Follow-up|2|||
126411030|NCT00760838|454798099|FG001|Overall Study|Lost to Follow-up|0|||
126411031|NCT00760838|454798098|FG000|Overall Study|Withdrawal by Subject|1|||
126411032|NCT00760838|454798099|FG001|Overall Study|Withdrawal by Subject|1|||
126411033|NCT02999633|454798100|FG000|Overall Study|Adverse Event|2|||
126411034|NCT02999633|454798100|FG000|Overall Study|Progressive disease|12|||
126411035|NCT04356040|454798103|FG000|Overall Study|Death|2|||
126411036|NCT04356040|454798104|FG001|Overall Study|Death|0|||
126411037|NCT04356040|454798103|FG000|Overall Study|Lost to Follow-up|1|||
126411038|NCT04356040|454798104|FG001|Overall Study|Lost to Follow-up|0|||
126411039|NCT04356040|454798103|FG000|Overall Study|Physician Decision|0|||
126411040|NCT04356040|454798104|FG001|Overall Study|Physician Decision|1|||
126411041|NCT04356040|454798103|FG000|Overall Study|Withdrawal by Subject|13|||
126411042|NCT04356040|454798104|FG001|Overall Study|Withdrawal by Subject|1|||
126411043|NCT04356040|454798103|FG000|Overall Study|Enrollment Pause|10|||
126411044|NCT04356040|454798104|FG001|Overall Study|Enrollment Pause|0|||
126411045|NCT04356040|454798103|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
126411046|NCT04356040|454798104|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
126474487|NCT02215096|455036354|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
126474488|NCT02215096|455036350|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
126474489|NCT02215096|455036351|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
126474490|NCT02215096|455036352|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
126474491|NCT02215096|455036353|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
126474492|NCT02215096|455036354|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
126474493|NCT02215096|455036350|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
126474494|NCT02215096|455036351|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
126474495|NCT02215096|455036352|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
126474496|NCT02215096|455036353|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
126474497|NCT02215096|455036354|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
126474498|NCT02215096|455036350|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
126474499|NCT02215096|455036351|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
126474500|NCT02215096|455036352|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
126474501|NCT02215096|455036353|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
126474502|NCT02215096|455036354|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
126474503|NCT00287365|455036355|FG000|Overall Study|sample not acquired|13|||
126474504|NCT02298023|455036356|FG000|Overall Study|Withdrawal by Subject|1|||
126474505|NCT02298023|455036357|FG001|Overall Study|Withdrawal by Subject|0|||
126474506|NCT02298023|455036358|FG002|Overall Study|Withdrawal by Subject|0|||
126474507|NCT00843856|455036361|FG000|Overall Study|Lost to Follow-up|1|||
126474508|NCT00843856|455036362|FG001|Overall Study|Lost to Follow-up|2|||
126474509|NCT01893203|455036363|FG000|Overall Study|Withdrawal by Subject|1|||
126474510|NCT04729621|455036364|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
126474511|NCT04729621|455036365|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
126474512|NCT04729621|455036366|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
126474513|NCT04729621|455036367|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
126474514|NCT04729621|455036368|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
126474515|NCT04729621|455036364|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
126474516|NCT04729621|455036365|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
126474517|NCT04729621|455036366|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
126474518|NCT04729621|455036367|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
126474519|NCT04729621|455036368|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
126474520|NCT04729621|455036364|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
126474521|NCT04729621|455036365|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
126474522|NCT04729621|455036366|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
126474523|NCT04729621|455036367|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
126474524|NCT04729621|455036368|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
126474525|NCT04729621|455036364|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
126474526|NCT04729621|455036365|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
126474527|NCT04729621|455036366|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
126474528|NCT04729621|455036367|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
126411047|NCT04356040|454798103|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
126411048|NCT04356040|454798104|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
126411049|NCT04356040|454798103|FG000|Overall Study|PI left institution|3|||
126411050|NCT04356040|454798104|FG001|Overall Study|PI left institution|0|||
126411051|NCT00788710|454798105|FG000|Overall Study|Adverse Event|1|||
126411052|NCT00788710|454798106|FG001|Overall Study|Adverse Event|3|||
126411053|NCT00788710|454798107|FG002|Overall Study|Adverse Event|4|||
126411054|NCT00788710|454798105|FG000|Overall Study|Lack of Efficacy|0|||
126411055|NCT00788710|454798106|FG001|Overall Study|Lack of Efficacy|0|||
126411056|NCT00788710|454798107|FG002|Overall Study|Lack of Efficacy|1|||
126411057|NCT00788710|454798105|FG000|Overall Study|Lost to Follow-up|0|||
126411058|NCT00788710|454798106|FG001|Overall Study|Lost to Follow-up|1|||
126411059|NCT00788710|454798107|FG002|Overall Study|Lost to Follow-up|0|||
126411060|NCT00788710|454798105|FG000|Overall Study|Physician Decision|2|||
126411061|NCT00788710|454798106|FG001|Overall Study|Physician Decision|1|||
126411062|NCT00788710|454798107|FG002|Overall Study|Physician Decision|0|||
126411063|NCT00788710|454798105|FG000|Overall Study|Protocol Violation|0|||
126411064|NCT00788710|454798106|FG001|Overall Study|Protocol Violation|1|||
126411065|NCT00788710|454798107|FG002|Overall Study|Protocol Violation|1|||
126411066|NCT00788710|454798105|FG000|Overall Study|Withdrawal by Subject|2|||
126411067|NCT00788710|454798106|FG001|Overall Study|Withdrawal by Subject|2|||
126411068|NCT00788710|454798107|FG002|Overall Study|Withdrawal by Subject|0|||
126411069|NCT01717326|454798108|FG000|Overall Study|Death|0|||
126411070|NCT01717326|454798109|FG001|Overall Study|Death|0|||
126411071|NCT01717326|454798110|FG002|Overall Study|Death|0|||
126411072|NCT01717326|454798111|FG003|Overall Study|Death|0|||
126411073|NCT01717326|454798112|FG004|Overall Study|Death|0|||
126411074|NCT01717326|454798113|FG005|Overall Study|Death|0|||
126411075|NCT01717326|454798114|FG006|Overall Study|Death|0|||
126411076|NCT01717326|454798115|FG007|Overall Study|Death|0|||
126411077|NCT01717326|454798116|FG008|Overall Study|Death|0|||
126411078|NCT01717326|454798117|FG009|Overall Study|Death|0|||
126411079|NCT01717326|454798118|FG010|Overall Study|Death|1|||
126411080|NCT01717326|454798119|FG011|Overall Study|Death|0|||
126411081|NCT01717326|454798120|FG012|Overall Study|Death|0|||
126411082|NCT01717326|454798121|FG013|Overall Study|Death|0|||
126411083|NCT01717326|454798122|FG014|Overall Study|Death|0|||
126411084|NCT01717326|454798123|FG015|Overall Study|Death|0|||
126411085|NCT01717326|454798124|FG016|Overall Study|Death|0|||
126411086|NCT01717326|454798125|FG017|Overall Study|Death|0|||
126411087|NCT01717326|454798126|FG018|Overall Study|Death|0|||
126411088|NCT01717326|454798127|FG019|Overall Study|Death|0|||
126411089|NCT01717326|454798108|FG000|Overall Study|Lost to Follow-up|3|||
126411090|NCT01717326|454798109|FG001|Overall Study|Lost to Follow-up|0|||
126411091|NCT01717326|454798110|FG002|Overall Study|Lost to Follow-up|0|||
126411092|NCT01717326|454798111|FG003|Overall Study|Lost to Follow-up|2|||
126411093|NCT01717326|454798112|FG004|Overall Study|Lost to Follow-up|1|||
126411094|NCT01717326|454798113|FG005|Overall Study|Lost to Follow-up|0|||
126411095|NCT01717326|454798114|FG006|Overall Study|Lost to Follow-up|1|||
126411096|NCT01717326|454798115|FG007|Overall Study|Lost to Follow-up|0|||
126411097|NCT01717326|454798116|FG008|Overall Study|Lost to Follow-up|0|||
126411098|NCT01717326|454798117|FG009|Overall Study|Lost to Follow-up|0|||
126411099|NCT01717326|454798118|FG010|Overall Study|Lost to Follow-up|1|||
126411100|NCT01717326|454798119|FG011|Overall Study|Lost to Follow-up|0|||
126411101|NCT01717326|454798120|FG012|Overall Study|Lost to Follow-up|0|||
126411102|NCT01717326|454798121|FG013|Overall Study|Lost to Follow-up|0|||
126411103|NCT01717326|454798122|FG014|Overall Study|Lost to Follow-up|0|||
126411104|NCT01717326|454798123|FG015|Overall Study|Lost to Follow-up|2|||
126411105|NCT01717326|454798124|FG016|Overall Study|Lost to Follow-up|1|||
126411106|NCT01717326|454798125|FG017|Overall Study|Lost to Follow-up|0|||
126411107|NCT01717326|454798126|FG018|Overall Study|Lost to Follow-up|2|||
126411108|NCT01717326|454798127|FG019|Overall Study|Lost to Follow-up|3|||
126411109|NCT01717326|454798108|FG000|Overall Study|Physician Decision|0|||
126411110|NCT01717326|454798109|FG001|Overall Study|Physician Decision|0|||
126411111|NCT01717326|454798110|FG002|Overall Study|Physician Decision|0|||
126411112|NCT01717326|454798111|FG003|Overall Study|Physician Decision|0|||
126411113|NCT01717326|454798112|FG004|Overall Study|Physician Decision|0|||
126411114|NCT01717326|454798113|FG005|Overall Study|Physician Decision|0|||
126411115|NCT01717326|454798114|FG006|Overall Study|Physician Decision|0|||
126558690|NCT02223182|455338808|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
126411116|NCT01717326|454798115|FG007|Overall Study|Physician Decision|0|||
126411117|NCT01717326|454798116|FG008|Overall Study|Physician Decision|0|||
126558691|NCT02223182|455338809|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
126558692|NCT02223182|455338806|FG000|Open-Label 300 Period|Non Compliance|0|||
126558693|NCT02223182|455338807|FG001|Open-Label 300 Period|Non Compliance|2|||
126411118|NCT01717326|454798117|FG009|Overall Study|Physician Decision|1|||
126411119|NCT01717326|454798118|FG010|Overall Study|Physician Decision|0|||
126411120|NCT01717326|454798119|FG011|Overall Study|Physician Decision|0|||
126411121|NCT01717326|454798120|FG012|Overall Study|Physician Decision|0|||
126411122|NCT01717326|454798121|FG013|Overall Study|Physician Decision|0|||
126411123|NCT01717326|454798122|FG014|Overall Study|Physician Decision|0|||
126411124|NCT01717326|454798123|FG015|Overall Study|Physician Decision|0|||
126411125|NCT01717326|454798124|FG016|Overall Study|Physician Decision|0|||
126411126|NCT01717326|454798125|FG017|Overall Study|Physician Decision|0|||
126411127|NCT01717326|454798126|FG018|Overall Study|Physician Decision|0|||
126411128|NCT01717326|454798127|FG019|Overall Study|Physician Decision|0|||
126411129|NCT01717326|454798108|FG000|Overall Study|Protocol Violation|0|||
126411130|NCT01717326|454798109|FG001|Overall Study|Protocol Violation|0|||
126411131|NCT01717326|454798110|FG002|Overall Study|Protocol Violation|0|||
126411132|NCT01717326|454798111|FG003|Overall Study|Protocol Violation|0|||
126411133|NCT01717326|454798112|FG004|Overall Study|Protocol Violation|1|||
126411134|NCT01717326|454798113|FG005|Overall Study|Protocol Violation|0|||
126411135|NCT01717326|454798114|FG006|Overall Study|Protocol Violation|0|||
126411136|NCT01717326|454798115|FG007|Overall Study|Protocol Violation|0|||
126411137|NCT01717326|454798116|FG008|Overall Study|Protocol Violation|0|||
126411138|NCT01717326|454798117|FG009|Overall Study|Protocol Violation|0|||
126411139|NCT01717326|454798118|FG010|Overall Study|Protocol Violation|0|||
126411140|NCT01717326|454798119|FG011|Overall Study|Protocol Violation|0|||
126411141|NCT01717326|454798120|FG012|Overall Study|Protocol Violation|0|||
126411142|NCT01717326|454798121|FG013|Overall Study|Protocol Violation|0|||
126411143|NCT01717326|454798122|FG014|Overall Study|Protocol Violation|0|||
126411144|NCT01717326|454798123|FG015|Overall Study|Protocol Violation|0|||
126411145|NCT01717326|454798124|FG016|Overall Study|Protocol Violation|0|||
126411146|NCT01717326|454798125|FG017|Overall Study|Protocol Violation|0|||
126411147|NCT01717326|454798126|FG018|Overall Study|Protocol Violation|0|||
126411148|NCT01717326|454798127|FG019|Overall Study|Protocol Violation|0|||
126411149|NCT01717326|454798108|FG000|Overall Study|Withdrawal by Subject|0|||
126411150|NCT01717326|454798109|FG001|Overall Study|Withdrawal by Subject|1|||
126411151|NCT01717326|454798110|FG002|Overall Study|Withdrawal by Subject|0|||
126411152|NCT01717326|454798111|FG003|Overall Study|Withdrawal by Subject|0|||
126411153|NCT01717326|454798112|FG004|Overall Study|Withdrawal by Subject|0|||
126411154|NCT01717326|454798113|FG005|Overall Study|Withdrawal by Subject|0|||
126411155|NCT01717326|454798114|FG006|Overall Study|Withdrawal by Subject|0|||
126411156|NCT01717326|454798115|FG007|Overall Study|Withdrawal by Subject|0|||
126411157|NCT01717326|454798116|FG008|Overall Study|Withdrawal by Subject|0|||
126411158|NCT01717326|454798117|FG009|Overall Study|Withdrawal by Subject|1|||
126411159|NCT01717326|454798118|FG010|Overall Study|Withdrawal by Subject|0|||
126411160|NCT01717326|454798119|FG011|Overall Study|Withdrawal by Subject|0|||
126411161|NCT01717326|454798120|FG012|Overall Study|Withdrawal by Subject|1|||
126411162|NCT01717326|454798121|FG013|Overall Study|Withdrawal by Subject|0|||
126411163|NCT01717326|454798122|FG014|Overall Study|Withdrawal by Subject|0|||
126411164|NCT01717326|454798123|FG015|Overall Study|Withdrawal by Subject|1|||
126411165|NCT01717326|454798124|FG016|Overall Study|Withdrawal by Subject|0|||
126411166|NCT01717326|454798125|FG017|Overall Study|Withdrawal by Subject|0|||
126411167|NCT01717326|454798126|FG018|Overall Study|Withdrawal by Subject|2|||
126474529|NCT04729621|455036368|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
126474530|NCT04729621|455036364|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
126474531|NCT04729621|455036365|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
126474532|NCT04729621|455036366|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
126474533|NCT04729621|455036367|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
126474534|NCT04729621|455036368|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
126474535|NCT04729621|455036364|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
126474536|NCT04729621|455036365|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
126474537|NCT04729621|455036366|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
126474538|NCT04729621|455036367|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
126474539|NCT04729621|455036368|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
126474540|NCT01999868|455036370|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
126474541|NCT01999868|455036371|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
126474542|NCT01999868|455036372|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
126474543|NCT01999868|455036370|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
126474544|NCT01999868|455036371|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
126474545|NCT01999868|455036372|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
126474546|NCT01999868|455036370|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
126474547|NCT01999868|455036371|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
126474548|NCT01999868|455036372|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
126474549|NCT01999868|455036370|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
126474550|NCT01999868|455036371|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
126474551|NCT01999868|455036372|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
126411168|NCT01717326|454798127|FG019|Overall Study|Withdrawal by Subject|3|||
126411169|NCT00605345|454798132|FG000|Overall Study|Withdrawal by Subject|1|||
126411170|NCT00605345|454798133|FG001|Overall Study|Withdrawal by Subject|0|||
126411171|NCT00605345|454798132|FG000|Overall Study|Adverse Event|0|||
126474552|NCT01999868|455036370|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
126474553|NCT01999868|455036371|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
126411172|NCT00605345|454798133|FG001|Overall Study|Adverse Event|1|||
126411173|NCT00605345|454798132|FG000|Overall Study|Protocol Violation|0|||
126411174|NCT00605345|454798133|FG001|Overall Study|Protocol Violation|2|||
126411175|NCT02596945|454798136|FG000|Overall Study|No documentation of study drug dosing|3|||
126411176|NCT02596945|454798136|FG000|Overall Study|Other|32|||
126411177|NCT02596945|454798136|FG000|Overall Study|Change to hemodialysis|15|||
126411178|NCT02596945|454798136|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
126474554|NCT01999868|455036372|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
126474555|NCT01999868|455036370|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
126411179|NCT02596945|454798136|FG000|Overall Study|Withdrawal by Subject|1|||
126411180|NCT02596945|454798136|FG000|Overall Study|Missing|1|||
126411181|NCT00422383|454798137|FG000|Overall Study|Adverse Event|5|||
126411182|NCT00422383|454798138|FG001|Overall Study|Adverse Event|3|||
126411183|NCT00422383|454798139|FG002|Overall Study|Adverse Event|1|||
126411184|NCT00422383|454798140|FG003|Overall Study|Adverse Event|1|||
126411185|NCT00422383|454798141|FG004|Overall Study|Adverse Event|0|||
126411186|NCT00422383|454798137|FG000|Overall Study|Lack of Efficacy|4|||
126411187|NCT00422383|454798138|FG001|Overall Study|Lack of Efficacy|4|||
126411188|NCT00422383|454798139|FG002|Overall Study|Lack of Efficacy|2|||
126411189|NCT00422383|454798140|FG003|Overall Study|Lack of Efficacy|1|||
126411190|NCT00422383|454798141|FG004|Overall Study|Lack of Efficacy|1|||
126411191|NCT00422383|454798137|FG000|Overall Study|Lost to Follow-up|0|||
126411192|NCT00422383|454798138|FG001|Overall Study|Lost to Follow-up|1|||
126411193|NCT00422383|454798139|FG002|Overall Study|Lost to Follow-up|0|||
126411194|NCT00422383|454798140|FG003|Overall Study|Lost to Follow-up|0|||
126411195|NCT00422383|454798141|FG004|Overall Study|Lost to Follow-up|1|||
126411196|NCT00422383|454798137|FG000|Overall Study|Protocol Violation|1|||
126411197|NCT00422383|454798138|FG001|Overall Study|Protocol Violation|1|||
126411198|NCT00422383|454798139|FG002|Overall Study|Protocol Violation|1|||
126411199|NCT00422383|454798140|FG003|Overall Study|Protocol Violation|0|||
126411200|NCT00422383|454798141|FG004|Overall Study|Protocol Violation|0|||
126411201|NCT00422383|454798137|FG000|Overall Study|Withdrawal by Subject|5|||
126411202|NCT00422383|454798138|FG001|Overall Study|Withdrawal by Subject|5|||
126411203|NCT00422383|454798139|FG002|Overall Study|Withdrawal by Subject|0|||
126411204|NCT00422383|454798140|FG003|Overall Study|Withdrawal by Subject|0|||
126411205|NCT00422383|454798141|FG004|Overall Study|Withdrawal by Subject|1|||
126411206|NCT05066165|454799641|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
126411207|NCT05066165|454799642|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
126411208|NCT05066165|454799641|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
126411209|NCT05066165|454799642|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
126411210|NCT03738618|454799643|FG000|Overall Study|Protocol deviation|23|||
126411211|NCT03738618|454799644|FG001|Overall Study|Protocol deviation|0|||
126411212|NCT03738618|454799643|FG000|Overall Study|Adverse Event|4|||
126411213|NCT03738618|454799644|FG001|Overall Study|Adverse Event|0|||
126411214|NCT03738618|454799643|FG000|Overall Study|Lost to Follow-up|2|||
126411215|NCT03738618|454799644|FG001|Overall Study|Lost to Follow-up|0|||
126411216|NCT03738618|454799643|FG000|Overall Study|Randomization failure|1|||
126411217|NCT03738618|454799644|FG001|Overall Study|Randomization failure|0|||
126411218|NCT03738618|454799643|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
126411219|NCT03738618|454799644|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
126411220|NCT03738618|454799643|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
126411221|NCT03738618|454799644|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
126411222|NCT00649428|454799645|FG000|Overall Study|Adverse Event|2|||
126411223|NCT00649428|454799646|FG001|Overall Study|Adverse Event|2|||
126411224|NCT00649428|454799645|FG000|Overall Study|Withdrawal by Subject|6|||
126411225|NCT00649428|454799646|FG001|Overall Study|Withdrawal by Subject|6|||
126411226|NCT00649428|454799645|FG000|Overall Study|Lost to Follow-up|1|||
126411227|NCT00649428|454799646|FG001|Overall Study|Lost to Follow-up|3|||
126411228|NCT00649428|454799645|FG000|Overall Study|Insufficient manufacturing yield|5|||
126411229|NCT00649428|454799646|FG001|Overall Study|Insufficient manufacturing yield|1|||
126474556|NCT01999868|455036371|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
126474557|NCT01999868|455036372|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
126474558|NCT01999868|455036370|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
126474559|NCT01999868|455036371|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
126474560|NCT01999868|455036372|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
126474561|NCT01999868|455036370|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
126411230|NCT00649428|454799645|FG000|Overall Study|Protocol Violation|6|||
126411231|NCT00649428|454799646|FG001|Overall Study|Protocol Violation|2|||
126411232|NCT00649428|454799645|FG000|Overall Study|Physician Decision|0|||
126411233|NCT00649428|454799646|FG001|Overall Study|Physician Decision|1|||
126411234|NCT00742417|454799647|FG000|Randomized|Withdrawal by legal representative|0|||
126411235|NCT00742417|454799648|FG001|Randomized|Withdrawal by legal representative|1|||
126411236|NCT00742417|454799647|FG000|Randomized|Withdrawal by Subject|1|||
126411237|NCT00742417|454799648|FG001|Randomized|Withdrawal by Subject|0|||
126474562|NCT01999868|455036371|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
126474563|NCT01999868|455036372|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
126411238|NCT00742417|454799647|FG000|Randomized|Physician Decision|1|||
126411239|NCT00742417|454799648|FG001|Randomized|Physician Decision|0|||
126411240|NCT00742417|454799647|FG000|Intensive Period|Withdrawal by Subject|1|||
126411241|NCT00742417|454799648|FG001|Intensive Period|Withdrawal by Subject|1|||
126411242|NCT00742417|454799647|FG000|Intensive Period|Adverse Event|2|||
126411243|NCT00742417|454799648|FG001|Intensive Period|Adverse Event|0|||
126411244|NCT04566601|454799653|FG000|Overall Study|Other than listed|13|||
126411245|NCT04566601|454799654|FG001|Overall Study|Other than listed|4|||
126411246|NCT04566601|454799655|FG002|Overall Study|Other than listed|2|||
126411247|NCT04566601|454799656|FG003|Overall Study|Other than listed|1|||
126411248|NCT04566601|454799657|FG004|Overall Study|Other than listed|4|||
126411249|NCT04566601|454799653|FG000|Overall Study|Protocol deviation|3|||
126411250|NCT04566601|454799654|FG001|Overall Study|Protocol deviation|0|||
126411251|NCT04566601|454799655|FG002|Overall Study|Protocol deviation|1|||
126411252|NCT04566601|454799656|FG003|Overall Study|Protocol deviation|1|||
126411253|NCT04566601|454799657|FG004|Overall Study|Protocol deviation|1|||
126411254|NCT04566601|454799653|FG000|Overall Study|Technical problems|0|||
126411255|NCT04566601|454799654|FG001|Overall Study|Technical problems|0|||
126411256|NCT04566601|454799655|FG002|Overall Study|Technical problems|1|||
126411257|NCT04566601|454799656|FG003|Overall Study|Technical problems|0|||
126411258|NCT04566601|454799657|FG004|Overall Study|Technical problems|0|||
126411259|NCT04566601|454799653|FG000|Overall Study|No reason available|3|||
126411260|NCT04566601|454799654|FG001|Overall Study|No reason available|2|||
126411261|NCT04566601|454799655|FG002|Overall Study|No reason available|7|||
126411262|NCT04566601|454799656|FG003|Overall Study|No reason available|1|||
126411263|NCT04566601|454799657|FG004|Overall Study|No reason available|5|||
126411264|NCT04566601|454799653|FG000|Overall Study|Burden of study procedures|3|||
126411265|NCT04566601|454799654|FG001|Overall Study|Burden of study procedures|0|||
126411266|NCT04566601|454799655|FG002|Overall Study|Burden of study procedures|0|||
126411267|NCT04566601|454799656|FG003|Overall Study|Burden of study procedures|3|||
126411268|NCT04566601|454799657|FG004|Overall Study|Burden of study procedures|1|||
126411269|NCT04566601|454799653|FG000|Overall Study|Change of residence|2|||
126411270|NCT04566601|454799654|FG001|Overall Study|Change of residence|2|||
126411271|NCT04566601|454799655|FG002|Overall Study|Change of residence|0|||
126411272|NCT04566601|454799656|FG003|Overall Study|Change of residence|1|||
126411273|NCT04566601|454799657|FG004|Overall Study|Change of residence|2|||
126411274|NCT04566601|454799653|FG000|Overall Study|Perceived lack of efficacy|2|||
126411275|NCT04566601|454799654|FG001|Overall Study|Perceived lack of efficacy|0|||
126411276|NCT04566601|454799655|FG002|Overall Study|Perceived lack of efficacy|1|||
126411277|NCT04566601|454799656|FG003|Overall Study|Perceived lack of efficacy|1|||
126411278|NCT04566601|454799657|FG004|Overall Study|Perceived lack of efficacy|2|||
126411279|NCT04566601|454799653|FG000|Overall Study|Adverse Event|7|||
126411280|NCT04566601|454799654|FG001|Overall Study|Adverse Event|4|||
126411281|NCT04566601|454799655|FG002|Overall Study|Adverse Event|6|||
126411282|NCT04566601|454799656|FG003|Overall Study|Adverse Event|5|||
126411283|NCT04566601|454799657|FG004|Overall Study|Adverse Event|12|||
126411284|NCT01450098|454799658|FG000|Period 3|Protocol Violation|0|||
126411285|NCT01450098|454799659|FG001|Period 3|Protocol Violation|1|||
126411286|NCT01450098|454799658|FG000|Period 3|Withdrawal by Subject|0|||
126411287|NCT01450098|454799659|FG001|Period 3|Withdrawal by Subject|2|||
126411288|NCT01272635|454799662|FG000|Overall Study|Lost to Follow-up|31|||
126411289|NCT01272635|454799663|FG001|Overall Study|Lost to Follow-up|20|||
126411290|NCT01272635|454799664|FG002|Overall Study|Lost to Follow-up|31|||
126411291|NCT01272635|454799665|FG003|Overall Study|Lost to Follow-up|23|||
126411292|NCT00372697|454799668|FG000|Overall Study|Protocol Violation|1|||
126411293|NCT00372697|454799669|FG001|Overall Study|Protocol Violation|1|||
126411294|NCT01832155|454799670|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
126411295|NCT01832155|454799671|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
126411296|NCT01832155|454799670|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
126411297|NCT01832155|454799671|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
126411298|NCT01055314|454799672|FG000|Overall Study|Adverse Event|7|||
126411299|NCT01055314|454799673|FG001|Overall Study|Adverse Event|4|||
126411300|NCT01055314|454799672|FG000|Overall Study|Death|2|||
126558694|NCT02223182|455338808|FG002|Open-Label 300 Period|Non Compliance|1|||
126558695|NCT02223182|455338809|FG003|Open-Label 300 Period|Non Compliance|0|||
126558696|NCT03714022|455338810|FG000|Overall Study|Adverse Event|1|||
126558697|NCT03714022|455338811|FG001|Overall Study|Adverse Event|0|||
126558698|NCT03714022|455338810|FG000|Overall Study|Consent withdrawal|0|||
126411301|NCT01055314|454799673|FG001|Overall Study|Death|1|||
126411302|NCT01055314|454799672|FG000|Overall Study|Lack of Efficacy|11|||
126411303|NCT01055314|454799673|FG001|Overall Study|Lack of Efficacy|19|||
126411304|NCT01055314|454799672|FG000|Overall Study|Physician Decision|10|||
126411305|NCT01055314|454799673|FG001|Overall Study|Physician Decision|5|||
126411306|NCT01055314|454799672|FG000|Overall Study|Withdrawal by Subject|1|||
126411307|NCT01055314|454799673|FG001|Overall Study|Withdrawal by Subject|0|||
126411308|NCT01055314|454799672|FG000|Overall Study|Ineligible|3|||
126411309|NCT01055314|454799673|FG001|Overall Study|Ineligible|5|||
126558699|NCT03714022|455338811|FG001|Overall Study|Consent withdrawal|1|||
126558700|NCT03714022|455338810|FG000|Overall Study|Lost to Follow-up|3|||
126558701|NCT03714022|455338811|FG001|Overall Study|Lost to Follow-up|2|||
126411310|NCT01055314|454799672|FG000|Overall Study|Refusal of further protocol therapy|10|||
126411311|NCT01055314|454799673|FG001|Overall Study|Refusal of further protocol therapy|4|||
126411312|NCT01055314|454799672|FG000|Overall Study|No treatment|1|||
126411313|NCT01055314|454799673|FG001|Overall Study|No treatment|0|||
126411314|NCT01279616|454799674|FG000|Overall Study|donor could not be located|5|||
126411315|NCT01279616|454799674|FG000|Overall Study|no signs of sickle cell disease|2|||
126411316|NCT02462720|454799675|FG000|Part 2|Withdrawal by Subject|1|||
126411317|NCT02462720|454799676|FG001|Part 2|Withdrawal by Subject|0|||
126411318|NCT02462720|454799675|FG000|Part 2|Protocol Violation|0|||
126411319|NCT02462720|454799676|FG001|Part 2|Protocol Violation|1|||
126411320|NCT00183625|454799679|FG000|Overall Study|Withdrawal by Subject|18|||
126411321|NCT00183625|454799680|FG001|Overall Study|Withdrawal by Subject|18|||
126411322|NCT00183625|454799681|FG002|Overall Study|Withdrawal by Subject|19|||
126411323|NCT00183625|454799682|FG003|Overall Study|Withdrawal by Subject|14|||
126411324|NCT05249569|454799685|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
126411325|NCT03722524|454799686|FG000|Overall Study|Protocol Violation|86|||
126411326|NCT03722524|454799686|FG000|Overall Study|Adverse Event|7|||
126411327|NCT03722524|454799686|FG000|Overall Study|Lost to Follow-up|1|||
126411328|NCT03722524|454799686|FG000|Overall Study|Reason is not stated|1|||
126411329|NCT03722524|454799686|FG000|Overall Study|Physician Decision|1|||
126411330|NCT03722524|454799686|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
126411331|NCT01423916|454799689|FG000|Overall Study|Adverse Event|5|||
126411332|NCT01423916|454799690|FG001|Overall Study|Adverse Event|9|||
126411333|NCT01423916|454799691|FG002|Overall Study|Adverse Event|2|||
126411334|NCT01423916|454799689|FG000|Overall Study|Met Withdrawal Criteria|1|||
126411335|NCT01423916|454799690|FG001|Overall Study|Met Withdrawal Criteria|1|||
126411336|NCT01423916|454799691|FG002|Overall Study|Met Withdrawal Criteria|1|||
126411337|NCT01423916|454799689|FG000|Overall Study|Physician Decision|1|||
126411338|NCT01423916|454799690|FG001|Overall Study|Physician Decision|0|||
126411339|NCT01423916|454799691|FG002|Overall Study|Physician Decision|1|||
126411340|NCT01423916|454799689|FG000|Overall Study|Withdrawal by Subject|3|||
126411341|NCT01423916|454799690|FG001|Overall Study|Withdrawal by Subject|10|||
126411342|NCT01423916|454799691|FG002|Overall Study|Withdrawal by Subject|3|||
126411343|NCT01423916|454799689|FG000|Overall Study|Protocol Deviation|1|||
126411344|NCT01423916|454799690|FG001|Overall Study|Protocol Deviation|0|||
126411345|NCT01423916|454799691|FG002|Overall Study|Protocol Deviation|0|||
126411346|NCT01374178|454799696|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
126411347|NCT01374178|454799697|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
126411348|NCT01374178|454799696|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
126411349|NCT01374178|454799697|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
126411350|NCT04856904|454799700|FG000|Overall Study|Physician Decision|1|||
126411351|NCT04856904|454799701|FG001|Overall Study|Physician Decision|1|||
126411352|NCT04856904|454799700|FG000|Overall Study|Withdrawal by Subject|13|||
126411353|NCT04856904|454799701|FG001|Overall Study|Withdrawal by Subject|13|||
126411354|NCT04856904|454799700|FG000|Overall Study|Adverse Event|1|||
126411355|NCT04856904|454799701|FG001|Overall Study|Adverse Event|1|||
126411356|NCT04856904|454799700|FG000|Overall Study|Non-compliance with study drug|1|||
126411357|NCT04856904|454799701|FG001|Overall Study|Non-compliance with study drug|1|||
126411358|NCT04856904|454799700|FG000|Overall Study|Lost to Follow-up|4|||
126411359|NCT04856904|454799701|FG001|Overall Study|Lost to Follow-up|4|||
126411360|NCT04856904|454799700|FG000|Overall Study|Withdrawal by Subject|1|||
126411361|NCT04856904|454799701|FG001|Overall Study|Withdrawal by Subject|1|||
126411362|NCT04856904|454799700|FG000|Overall Study|Protocol Violation|1|||
126411363|NCT04856904|454799701|FG001|Overall Study|Protocol Violation|1|||
126411364|NCT00077649|454799702|FG000|Overall Study|Adverse Event|5|||
126411365|NCT00077649|454799703|FG001|Overall Study|Adverse Event|1|||
126411366|NCT00077649|454799704|FG002|Overall Study|Adverse Event|7|||
126411367|NCT00077649|454799705|FG003|Overall Study|Adverse Event|9|||
126411368|NCT00077649|454799702|FG000|Overall Study|Lack of Efficacy|5|||
126411369|NCT00077649|454799703|FG001|Overall Study|Lack of Efficacy|3|||
126411370|NCT00077649|454799704|FG002|Overall Study|Lack of Efficacy|3|||
126411371|NCT00077649|454799705|FG003|Overall Study|Lack of Efficacy|2|||
126411372|NCT00077649|454799702|FG000|Overall Study|Withdrawal by Subject|0|||
126411373|NCT00077649|454799703|FG001|Overall Study|Withdrawal by Subject|1|||
126411374|NCT00077649|454799704|FG002|Overall Study|Withdrawal by Subject|1|||
126411375|NCT00077649|454799705|FG003|Overall Study|Withdrawal by Subject|2|||
126411376|NCT00077649|454799702|FG000|Overall Study|Lost to Follow-up|2|||
126411377|NCT00077649|454799703|FG001|Overall Study|Lost to Follow-up|2|||
126721471|NCT00195260|455929974|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126411378|NCT00077649|454799704|FG002|Overall Study|Lost to Follow-up|3|||
126411379|NCT00077649|454799705|FG003|Overall Study|Lost to Follow-up|2|||
126411380|NCT00077649|454799702|FG000|Overall Study|Abnormality of Laboratory Test|1|||
126411381|NCT00077649|454799703|FG001|Overall Study|Abnormality of Laboratory Test|2|||
126411382|NCT00077649|454799704|FG002|Overall Study|Abnormality of Laboratory Test|1|||
126411383|NCT00077649|454799705|FG003|Overall Study|Abnormality of Laboratory Test|2|||
126411384|NCT00077649|454799702|FG000|Overall Study|Randomized but never dosed|1|||
126411385|NCT00077649|454799703|FG001|Overall Study|Randomized but never dosed|0|||
126411386|NCT00077649|454799704|FG002|Overall Study|Randomized but never dosed|0|||
126411387|NCT00077649|454799705|FG003|Overall Study|Randomized but never dosed|0|||
126721472|NCT00195260|455929975|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126721473|NCT00195260|455929976|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126721474|NCT00195260|455929977|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126721475|NCT00195260|455929978|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
126721476|NCT00195260|455929968|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126411388|NCT02895945|454799706|FG000|Overall Study|Physician Decision|2|||
126411389|NCT02895945|454799707|FG001|Overall Study|Physician Decision|1|||
126411390|NCT00454181|454799711|FG000|Overall Study|Adverse Event|1|||
126411391|NCT00454181|454799712|FG001|Overall Study|Adverse Event|1|||
126411392|NCT00454181|454799711|FG000|Overall Study|Lost to Follow-up|11|||
126411393|NCT00454181|454799712|FG001|Overall Study|Lost to Follow-up|1|||
126411394|NCT00454181|454799711|FG000|Overall Study|Protocol Violation|1|||
126411395|NCT00454181|454799712|FG001|Overall Study|Protocol Violation|1|||
126411396|NCT00454181|454799711|FG000|Overall Study|Withdrawal by Subject|2|||
126411397|NCT00454181|454799712|FG001|Overall Study|Withdrawal by Subject|0|||
126411398|NCT04032080|454799713|FG000|Overall Study|Death|6|||
126411399|NCT02409719|454799725|FG000|Overall Study|Lost to Follow-up|3|||
126411400|NCT02409719|454799726|FG001|Overall Study|Lost to Follow-up|3|||
126411401|NCT03689855|454799727|FG000|Overall Study|Adverse Event|3|||
126411402|NCT03689855|454799727|FG000|Overall Study|Withdrawal by Subject|1|||
126411403|NCT02479139|454799728|FG000|Overall Study|Lost to Follow-up|2|||
126411404|NCT02479139|454799729|FG001|Overall Study|Lost to Follow-up|4|||
126411405|NCT02479139|454799730|FG002|Overall Study|Lost to Follow-up|4|||
126411406|NCT02479139|454799731|FG003|Overall Study|Lost to Follow-up|2|||
126411407|NCT02479139|454799732|FG004|Overall Study|Lost to Follow-up|3|||
126411408|NCT02479139|454799733|FG005|Overall Study|Lost to Follow-up|5|||
126411409|NCT02479139|454799728|FG000|Overall Study|Withdrew Consent|5|||
126411410|NCT02479139|454799729|FG001|Overall Study|Withdrew Consent|6|||
126411411|NCT02479139|454799730|FG002|Overall Study|Withdrew Consent|1|||
126411412|NCT02479139|454799731|FG003|Overall Study|Withdrew Consent|4|||
126411413|NCT02479139|454799732|FG004|Overall Study|Withdrew Consent|1|||
126411414|NCT02479139|454799733|FG005|Overall Study|Withdrew Consent|1|||
126411415|NCT02479139|454799728|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
126411416|NCT02479139|454799729|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
126411417|NCT02479139|454799730|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
126411418|NCT02479139|454799731|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
126411419|NCT02479139|454799732|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
126411420|NCT02479139|454799733|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
126411421|NCT02479139|454799728|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126411422|NCT02479139|454799729|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126411423|NCT02479139|454799730|FG002|Overall Study|Other Miscellaneous Reasons|1|||
126411424|NCT02479139|454799731|FG003|Overall Study|Other Miscellaneous Reasons|1|||
126411425|NCT02479139|454799732|FG004|Overall Study|Other Miscellaneous Reasons|1|||
126411426|NCT02479139|454799733|FG005|Overall Study|Other Miscellaneous Reasons|0|||
126411427|NCT00764673|454799734|FG000|Overall Study|Death|1|||
126411428|NCT00764673|454799734|FG000|Overall Study|Lost to Follow-up|3|||
126411429|NCT00764673|454799734|FG000|Overall Study|Withdrawal by Subject|6|||
126411430|NCT00764673|454799734|FG000|Overall Study|Revision of Device|2|||
126411431|NCT01438177|454799735|FG000|Overall Study|Withdrawal by Subject|1|||
126411432|NCT01438177|454799735|FG000|Overall Study|Initiation of new therapy|1|||
126411433|NCT01727336|454799738|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
126411434|NCT01727336|454799739|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
126411435|NCT01727336|454799740|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
126411436|NCT01727336|454799741|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
126411437|NCT01727336|454799742|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
126411438|NCT01727336|454799743|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
126411439|NCT01727336|454799738|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
126411440|NCT01727336|454799739|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
126721477|NCT00195260|455929969|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126411441|NCT01727336|454799740|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
126411442|NCT01727336|454799741|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
126411443|NCT01727336|454799742|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
126721478|NCT00195260|455929970|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126411444|NCT01727336|454799743|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
126411445|NCT01727336|454799738|FG000|Part 2 Blinded|Death|0|||
126411446|NCT01727336|454799739|FG001|Part 2 Blinded|Death|0|||
126721479|NCT00195260|455929971|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126721480|NCT00195260|455929972|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126411447|NCT01727336|454799740|FG002|Part 2 Blinded|Death|0|||
126411448|NCT01727336|454799741|FG003|Part 2 Blinded|Death|0|||
126411449|NCT01727336|454799742|FG004|Part 2 Blinded|Death|20|||
126411450|NCT01727336|454799743|FG005|Part 2 Blinded|Death|16|||
126411451|NCT01727336|454799738|FG000|Part 2 Blinded|Lack of Efficacy|0|||
126411452|NCT01727336|454799739|FG001|Part 2 Blinded|Lack of Efficacy|0|||
126411453|NCT01727336|454799740|FG002|Part 2 Blinded|Lack of Efficacy|0|||
126721481|NCT00195260|455929973|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126721482|NCT00195260|455929974|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126721483|NCT00195260|455929975|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
126721484|NCT00195260|455929976|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
126721485|NCT00195260|455929977|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
126721486|NCT00195260|455929978|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
126721487|NCT00195260|455929968|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126721488|NCT00195260|455929969|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126411454|NCT01727336|454799741|FG003|Part 2 Blinded|Lack of Efficacy|0|||
126411455|NCT01727336|454799742|FG004|Part 2 Blinded|Lack of Efficacy|42|||
126411456|NCT01727336|454799743|FG005|Part 2 Blinded|Lack of Efficacy|44|||
126411457|NCT01727336|454799738|FG000|Part 2 Blinded|Lost to Follow-up|0|||
126411458|NCT01727336|454799739|FG001|Part 2 Blinded|Lost to Follow-up|0|||
126411459|NCT01727336|454799740|FG002|Part 2 Blinded|Lost to Follow-up|0|||
126411460|NCT01727336|454799741|FG003|Part 2 Blinded|Lost to Follow-up|0|||
126411461|NCT01727336|454799742|FG004|Part 2 Blinded|Lost to Follow-up|0|||
126411462|NCT01727336|454799743|FG005|Part 2 Blinded|Lost to Follow-up|1|||
126411463|NCT01727336|454799738|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
126411464|NCT01727336|454799739|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
126411465|NCT01727336|454799740|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
126411466|NCT01727336|454799741|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
126411467|NCT01727336|454799742|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
126411468|NCT01727336|454799743|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
126411469|NCT01727336|454799738|FG000|Part 2 Blinded|use of prohibited medications|0|||
126411470|NCT01727336|454799739|FG001|Part 2 Blinded|use of prohibited medications|0|||
126411471|NCT01727336|454799740|FG002|Part 2 Blinded|use of prohibited medications|0|||
126411472|NCT01727336|454799741|FG003|Part 2 Blinded|use of prohibited medications|0|||
126411473|NCT01727336|454799742|FG004|Part 2 Blinded|use of prohibited medications|1|||
126411474|NCT01727336|454799743|FG005|Part 2 Blinded|use of prohibited medications|3|||
126411475|NCT00619099|454799744|FG000|Overall Study|Progressive Disease|7|||
126411476|NCT00619099|454799745|FG001|Overall Study|Progressive Disease|5|||
126411477|NCT00619099|454799744|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
126411478|NCT00619099|454799745|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
126411479|NCT00619099|454799744|FG000|Overall Study|Adverse Event|4|||
126411480|NCT00619099|454799745|FG001|Overall Study|Adverse Event|3|||
126411481|NCT00619099|454799744|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
126411482|NCT00619099|454799745|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
126411483|NCT00619099|454799744|FG000|Overall Study|Withdrawal by Subject|10|||
126411484|NCT00619099|454799745|FG001|Overall Study|Withdrawal by Subject|2|||
126411485|NCT00619099|454799744|FG000|Overall Study|Physician Decision|9|||
126411486|NCT00619099|454799745|FG001|Overall Study|Physician Decision|6|||
126411487|NCT00885482|454799746|FG000|Overall Study|Pregnancy|1|||
126411488|NCT00885482|454799746|FG000|Overall Study|Lack of Efficacy|1|||
126411489|NCT00885482|454799746|FG000|Overall Study|Death|1|||
126411490|NCT00885482|454799746|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
126411491|NCT00084656|454799747|FG000|Overall Study|Other reasons|0|||
126411492|NCT00084656|454799748|FG001|Overall Study|Other reasons|12|||
126411493|NCT00084656|454799749|FG002|Overall Study|Other reasons|11|||
126411494|NCT00084656|454799747|FG000|Overall Study|Withdrawal by Subject|15|||
126411495|NCT00084656|454799748|FG001|Overall Study|Withdrawal by Subject|4|||
126411496|NCT00084656|454799749|FG002|Overall Study|Withdrawal by Subject|4|||
126411497|NCT00084656|454799747|FG000|Overall Study|Disease relapse|0|||
126411498|NCT00084656|454799748|FG001|Overall Study|Disease relapse|9|||
126411499|NCT00084656|454799749|FG002|Overall Study|Disease relapse|10|||
126411500|NCT00084656|454799747|FG000|Overall Study|Disease progression|9|||
126411501|NCT00084656|454799748|FG001|Overall Study|Disease progression|0|||
126411502|NCT00084656|454799749|FG002|Overall Study|Disease progression|0|||
126411503|NCT00084656|454799747|FG000|Overall Study|Lost to Follow-up|1|||
126411504|NCT00084656|454799748|FG001|Overall Study|Lost to Follow-up|0|||
126411505|NCT00084656|454799749|FG002|Overall Study|Lost to Follow-up|1|||
126411506|NCT02772978|454799750|FG000|Overall Study|Withdrawal by Subject|1|||
126411507|NCT02772978|454799751|FG001|Overall Study|Withdrawal by Subject|1|||
126411508|NCT00129467|454799752|FG000|Received Intervention|Death|1|||
126411509|NCT00129467|454799753|FG001|Received Intervention|Death|1|||
126411510|NCT00129467|454799752|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
126411511|NCT00129467|454799753|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
126411512|NCT00129467|454799752|FG000|Received Intervention|Delirium|2|||
126411513|NCT00129467|454799753|FG001|Received Intervention|Delirium|0|||
126411514|NCT00129467|454799752|FG000|Received Intervention|Withdrawal by Subject|1|||
126411515|NCT00129467|454799753|FG001|Received Intervention|Withdrawal by Subject|0|||
126411516|NCT00129467|454799752|FG000|Received Intervention|Nausea|1|||
126411517|NCT00129467|454799753|FG001|Received Intervention|Nausea|0|||
126411518|NCT00129467|454799752|FG000|Received Intervention|Intolerance to citalopram|0|||
126411519|NCT00129467|454799753|FG001|Received Intervention|Intolerance to citalopram|1|||
126411520|NCT00129467|454799752|FG000|Received Intervention|Dizzyness, fatigue|0|||
126411521|NCT00129467|454799753|FG001|Received Intervention|Dizzyness, fatigue|1|||
126474564|NCT01999868|455036370|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
126474565|NCT01999868|455036371|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
126474566|NCT01999868|455036372|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
126474567|NCT01999868|455036370|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
126474568|NCT01999868|455036371|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
126474569|NCT01999868|455036372|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
126474570|NCT01999868|455036370|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
126474571|NCT01999868|455036371|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
126474572|NCT01999868|455036372|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
126474573|NCT01999868|455036370|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
126474574|NCT01999868|455036371|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
126474575|NCT01999868|455036372|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
126474576|NCT01999868|455036370|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
126474577|NCT01999868|455036371|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
126474578|NCT01999868|455036372|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
126558702|NCT00114959|455338820|FG000|Overall Study|Lack of Efficacy|6|||
126558703|NCT00114959|455338820|FG000|Overall Study|Physician Decision|1|||
126558704|NCT00114959|455338820|FG000|Overall Study|Death|1|||
126558705|NCT03251378|455338821|FG000|Overall Study|Death|3|||
126558706|NCT03251378|455338822|FG001|Overall Study|Death|2|||
126558707|NCT03251378|455338823|FG002|Overall Study|Death|3|||
126411522|NCT00129467|454799752|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
126411523|NCT00129467|454799753|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
126411524|NCT00129467|454799752|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
126411525|NCT00129467|454799753|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
126411526|NCT01331291|454799754|FG000|Overall Study|Lack of Efficacy|2|||
126411527|NCT01331291|454799755|FG001|Overall Study|Lack of Efficacy|8|||
126411528|NCT01331291|454799754|FG000|Overall Study|Death|0|||
126411529|NCT01331291|454799755|FG001|Overall Study|Death|1|||
126411530|NCT01026220|454799756|FG000|Induction|Death|1|||
126411531|NCT01026220|454799757|FG001|Induction|Death|0|||
126411532|NCT01026220|454799758|FG002|Induction|Death|0|||
126411533|NCT01026220|454799756|FG000|Induction|Lack of Efficacy|2|||
126411534|NCT01026220|454799757|FG001|Induction|Lack of Efficacy|0|||
126411535|NCT01026220|454799758|FG002|Induction|Lack of Efficacy|0|||
126411536|NCT01026220|454799756|FG000|Induction|Physician Decision|12|||
126411537|NCT01026220|454799757|FG001|Induction|Physician Decision|0|||
126411538|NCT01026220|454799758|FG002|Induction|Physician Decision|0|||
126411539|NCT01026220|454799756|FG000|Induction|Withdrawal by Subject|9|||
126411540|NCT01026220|454799757|FG001|Induction|Withdrawal by Subject|0|||
126411541|NCT01026220|454799758|FG002|Induction|Withdrawal by Subject|0|||
126411542|NCT01026220|454799756|FG000|Induction|Ineligible|1|||
126411543|NCT01026220|454799757|FG001|Induction|Ineligible|0|||
126411544|NCT01026220|454799758|FG002|Induction|Ineligible|0|||
126411545|NCT01026220|454799756|FG000|Consolidation Maintenance|Death|0|||
126411546|NCT01026220|454799757|FG001|Consolidation Maintenance|Death|1|||
126411547|NCT01026220|454799758|FG002|Consolidation Maintenance|Death|0|||
126411548|NCT01026220|454799756|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
126411549|NCT01026220|454799757|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
126411550|NCT01026220|454799758|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
126411551|NCT01026220|454799756|FG000|Consolidation Maintenance|Physician Decision|0|||
126411552|NCT01026220|454799757|FG001|Consolidation Maintenance|Physician Decision|2|||
126411553|NCT01026220|454799758|FG002|Consolidation Maintenance|Physician Decision|7|||
126411554|NCT01026220|454799756|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
126411555|NCT01026220|454799757|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
126411556|NCT01026220|454799758|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
126411557|NCT00778895|454799759|FG000|Active Phase|Adverse Event|3|||
126411558|NCT00778895|454799760|FG001|Active Phase|Adverse Event|1|||
126411559|NCT00778895|454799761|FG002|Active Phase|Adverse Event|0|||
126558708|NCT03251378|455338824|FG003|Overall Study|Death|30|||
126558709|NCT03251378|455338825|FG004|Overall Study|Death|24|||
126411560|NCT00778895|454799759|FG000|Active Phase|Withdrawal by Subject|1|||
126411561|NCT00778895|454799760|FG001|Active Phase|Withdrawal by Subject|4|||
126411562|NCT00778895|454799761|FG002|Active Phase|Withdrawal by Subject|0|||
126411563|NCT00778895|454799759|FG000|Active Phase|Lost to Follow-up|1|||
126411564|NCT00778895|454799760|FG001|Active Phase|Lost to Follow-up|1|||
126411565|NCT00778895|454799761|FG002|Active Phase|Lost to Follow-up|0|||
126411566|NCT00778895|454799759|FG000|Active Phase|Other|2|||
126411567|NCT00778895|454799760|FG001|Active Phase|Other|0|||
126558710|NCT03251378|455338826|FG005|Overall Study|Death|12|||
126411568|NCT00778895|454799761|FG002|Active Phase|Other|0|||
126411569|NCT00778895|454799759|FG000|ESFU Phase|Adverse Event|2|||
126411570|NCT00778895|454799760|FG001|ESFU Phase|Adverse Event|1|||
126558711|NCT03251378|455338827|FG006|Overall Study|Death|12|||
126558712|NCT03251378|455338821|FG000|Overall Study|Lost to Follow-up|0|||
126411571|NCT00778895|454799761|FG002|ESFU Phase|Adverse Event|0|||
126411572|NCT00778895|454799759|FG000|ESFU Phase|Withdrawal by Subject|1|||
126411573|NCT00778895|454799760|FG001|ESFU Phase|Withdrawal by Subject|4|||
126411574|NCT00778895|454799761|FG002|ESFU Phase|Withdrawal by Subject|0|||
126411575|NCT00778895|454799759|FG000|ESFU Phase|Lost to Follow-up|6|||
126411576|NCT00778895|454799760|FG001|ESFU Phase|Lost to Follow-up|7|||
126411577|NCT00778895|454799761|FG002|ESFU Phase|Lost to Follow-up|2|||
126411578|NCT00778895|454799759|FG000|ESFU Phase|Other|2|||
126411579|NCT00778895|454799760|FG001|ESFU Phase|Other|0|||
126411580|NCT00778895|454799761|FG002|ESFU Phase|Other|0|||
126411581|NCT02540993|454799763|FG000|Overall Study|Lost to Follow-up|5|||
126411582|NCT02540993|454799764|FG001|Overall Study|Lost to Follow-up|3|||
126411583|NCT02540993|454799763|FG000|Overall Study|Withdrawal by Subject|4|||
126411584|NCT02540993|454799764|FG001|Overall Study|Withdrawal by Subject|6|||
126411585|NCT02540993|454799763|FG000|Overall Study|GCP violations|33|||
126411586|NCT02540993|454799764|FG001|Overall Study|GCP violations|27|||
126411587|NCT03550404|454799765|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
126411588|NCT03550404|454799766|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
126411589|NCT03550404|454799767|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
126411590|NCT03550404|454799765|FG000|Phase 2|Vacated position|1|||
126411591|NCT03550404|454799766|FG001|Phase 2|Vacated position|0|||
126411592|NCT03550404|454799767|FG002|Phase 2|Vacated position|0|||
126411593|NCT01009086|454799769|FG000|Overall Study|Lack of Efficacy|16|||
126411594|NCT01009086|454799770|FG001|Overall Study|Lack of Efficacy|15|||
126411595|NCT01009086|454799771|FG002|Overall Study|Lack of Efficacy|9|||
126411596|NCT01009086|454799769|FG000|Overall Study|Lost to Follow-up|4|||
126411597|NCT01009086|454799770|FG001|Overall Study|Lost to Follow-up|5|||
126411598|NCT01009086|454799771|FG002|Overall Study|Lost to Follow-up|3|||
126411599|NCT01009086|454799769|FG000|Overall Study|Adverse Event|12|||
126411600|NCT01009086|454799770|FG001|Overall Study|Adverse Event|11|||
126411601|NCT01009086|454799771|FG002|Overall Study|Adverse Event|8|||
126411602|NCT01009086|454799769|FG000|Overall Study|Withdrawal by Subject|9|||
126411603|NCT01009086|454799770|FG001|Overall Study|Withdrawal by Subject|11|||
126411604|NCT01009086|454799771|FG002|Overall Study|Withdrawal by Subject|13|||
126411605|NCT01009086|454799769|FG000|Overall Study|Other|3|||
126411606|NCT01009086|454799770|FG001|Overall Study|Other|5|||
126411607|NCT01009086|454799771|FG002|Overall Study|Other|1|||
126411608|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
126411609|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
126411610|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
126411611|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
126411612|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
126411613|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
126411614|NCT01389323|454799772|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
126411615|NCT01389323|454799772|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
126411616|NCT01389323|454799772|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
126411617|NCT01389323|454799772|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
126411618|NCT01389323|454799772|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
126411619|NCT00590577|454799774|FG000|Overall Study|Lack of Efficacy|31|||
126411620|NCT00590577|454799775|FG001|Overall Study|Lack of Efficacy|28|||
126411621|NCT00590577|454799776|FG002|Overall Study|Lack of Efficacy|23|||
126411622|NCT00590577|454799777|FG003|Overall Study|Lack of Efficacy|45|||
126411623|NCT00590577|454799774|FG000|Overall Study|Withdrawal by Subject|23|||
126411624|NCT00590577|454799775|FG001|Overall Study|Withdrawal by Subject|28|||
126411625|NCT00590577|454799776|FG002|Overall Study|Withdrawal by Subject|30|||
126411626|NCT00590577|454799777|FG003|Overall Study|Withdrawal by Subject|26|||
126411627|NCT00590577|454799774|FG000|Overall Study|Adverse Event|10|||
126411628|NCT00590577|454799775|FG001|Overall Study|Adverse Event|10|||
126411629|NCT00590577|454799776|FG002|Overall Study|Adverse Event|13|||
126411630|NCT00590577|454799777|FG003|Overall Study|Adverse Event|11|||
126411631|NCT00590577|454799774|FG000|Overall Study|Lost to Follow-up|12|||
126411632|NCT00590577|454799775|FG001|Overall Study|Lost to Follow-up|6|||
126411633|NCT00590577|454799776|FG002|Overall Study|Lost to Follow-up|6|||
126411634|NCT00590577|454799777|FG003|Overall Study|Lost to Follow-up|9|||
126411635|NCT00590577|454799774|FG000|Overall Study|Pregnancy|0|||
126411636|NCT00590577|454799775|FG001|Overall Study|Pregnancy|1|||
126411637|NCT00590577|454799776|FG002|Overall Study|Pregnancy|0|||
126411638|NCT00590577|454799777|FG003|Overall Study|Pregnancy|0|||
126411639|NCT00590577|454799774|FG000|Overall Study|Various reasons|1|||
126411640|NCT00590577|454799775|FG001|Overall Study|Various reasons|3|||
126411641|NCT00590577|454799776|FG002|Overall Study|Various reasons|1|||
126411642|NCT00590577|454799777|FG003|Overall Study|Various reasons|2|||
126411643|NCT00844558|454799778|FG000|Overall Study|Withdrawal by Subject|9|||
126411644|NCT00844558|454799779|FG001|Overall Study|Withdrawal by Subject|2|||
126558713|NCT03251378|455338822|FG001|Overall Study|Lost to Follow-up|0|||
126411645|NCT00844558|454799778|FG000|Overall Study|Death|1|||
126411646|NCT00844558|454799779|FG001|Overall Study|Death|0|||
126411647|NCT00844558|454799778|FG000|Overall Study|Protocol Violation|1|||
126411648|NCT00844558|454799779|FG001|Overall Study|Protocol Violation|1|||
126411649|NCT00844558|454799778|FG000|Overall Study|Lost to Follow-up|0|||
126411650|NCT00844558|454799779|FG001|Overall Study|Lost to Follow-up|1|||
126411651|NCT00844558|454799778|FG000|Overall Study|Physician Decision|1|||
126411652|NCT00844558|454799779|FG001|Overall Study|Physician Decision|0|||
126411653|NCT01229449|454799780|FG000|Overall Study|Withdrawal by Subject|0|||
126411654|NCT01229449|454799781|FG001|Overall Study|Withdrawal by Subject|3|||
126411655|NCT01229449|454799782|FG002|Overall Study|Withdrawal by Subject|0|||
126411656|NCT01229449|454799783|FG003|Overall Study|Withdrawal by Subject|1|||
126411657|NCT01229449|454799784|FG004|Overall Study|Withdrawal by Subject|1|||
126411658|NCT01229449|454799780|FG000|Overall Study|Lost to Follow-up|1|||
126411659|NCT01229449|454799781|FG001|Overall Study|Lost to Follow-up|1|||
126411660|NCT01229449|454799782|FG002|Overall Study|Lost to Follow-up|1|||
126411661|NCT01229449|454799783|FG003|Overall Study|Lost to Follow-up|0|||
126411662|NCT01229449|454799784|FG004|Overall Study|Lost to Follow-up|0|||
126411663|NCT01229449|454799780|FG000|Overall Study|Physician Decision|0|||
126411664|NCT01229449|454799781|FG001|Overall Study|Physician Decision|0|||
126411665|NCT01229449|454799782|FG002|Overall Study|Physician Decision|1|||
126411666|NCT01229449|454799783|FG003|Overall Study|Physician Decision|0|||
126411667|NCT01229449|454799784|FG004|Overall Study|Physician Decision|0|||
126411668|NCT01894022|454799785|FG000|Overall Study|Death|1|||
126411669|NCT01894022|454799786|FG001|Overall Study|Death|0|||
126411670|NCT01894022|454799785|FG000|Overall Study|Adverse Event, non-fatal|1|||
126411671|NCT01894022|454799786|FG001|Overall Study|Adverse Event, non-fatal|0|||
126411672|NCT01894022|454799785|FG000|Overall Study|Study Closed/terminated|7|||
126411673|NCT01894022|454799786|FG001|Overall Study|Study Closed/terminated|10|||
126411674|NCT04496453|454799788|FG000|Overall Study|Lost to Follow-up|6|||
126411675|NCT03235089|454799796|FG000|Overall Study|Lost to Follow-up|1|||
126411676|NCT03235089|454799797|FG001|Overall Study|Lost to Follow-up|1|||
126411677|NCT03235089|454799796|FG000|Overall Study|Physician Decision|2|||
126411678|NCT03235089|454799797|FG001|Overall Study|Physician Decision|2|||
126411679|NCT03238924|454799798|FG000|Overall Study|Withdrawal by Subject|2|||
126411680|NCT03238924|454799799|FG001|Overall Study|Withdrawal by Subject|2|||
126411681|NCT03576716|454799800|FG000|Overall Study|Withdrawal by Subject|0|||
126411682|NCT03576716|454799801|FG001|Overall Study|Withdrawal by Subject|1|||
126411683|NCT02516228|454799804|FG000|Overall Study|Lost to Follow-up|1|||
126411684|NCT02516228|454799804|FG000|Overall Study|Withdrawal by Subject|1|||
126411685|NCT02516228|454799804|FG000|Overall Study|Physician Decision|1|||
126411686|NCT03916484|454799805|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126411687|NCT03916484|454799806|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
126411688|NCT03916484|454799807|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126411689|NCT03916484|454799808|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
126411690|NCT03916484|454799805|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
126411691|NCT03916484|454799806|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
126411692|NCT03916484|454799807|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
126411693|NCT03916484|454799808|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
126411694|NCT01769196|454801799|FG000|Overall Study|Adverse Event|24|||
126411695|NCT01769196|454801800|FG001|Overall Study|Adverse Event|20|||
126411696|NCT01769196|454801799|FG000|Overall Study|Death|21|||
126474579|NCT01999868|455036370|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
126474580|NCT01999868|455036371|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
126474581|NCT01999868|455036372|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
126474582|NCT01999868|455036370|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
126474583|NCT01999868|455036371|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
126474584|NCT01999868|455036372|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
126474585|NCT01757535|455036381|FG000|Overall Study|Disease Relapse|151|||
126474586|NCT01757535|455036382|FG001|Overall Study|Disease Relapse|181|||
126474587|NCT01757535|455036381|FG000|Overall Study|Other Reasons|28|||
126474588|NCT01757535|455036382|FG001|Overall Study|Other Reasons|27|||
126474589|NCT01757535|455036381|FG000|Overall Study|Adverse Event|31|||
126474590|NCT01757535|455036382|FG001|Overall Study|Adverse Event|11|||
126474591|NCT01757535|455036381|FG000|Overall Study|Withdrew Consent|19|||
126411697|NCT01769196|454801800|FG001|Overall Study|Death|26|||
126411698|NCT01769196|454801799|FG000|Overall Study|Investigator Discretion|7|||
126411699|NCT01769196|454801800|FG001|Overall Study|Investigator Discretion|3|||
126411700|NCT01769196|454801799|FG000|Overall Study|Lack of Efficacy|3|||
126411701|NCT01769196|454801800|FG001|Overall Study|Lack of Efficacy|2|||
126411702|NCT01769196|454801799|FG000|Overall Study|Progressive disease|11|||
126474592|NCT01757535|455036382|FG001|Overall Study|Withdrew Consent|13|||
126411703|NCT01769196|454801800|FG001|Overall Study|Progressive disease|6|||
126411704|NCT01769196|454801799|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
126411705|NCT01769196|454801800|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
126411706|NCT01769196|454801799|FG000|Overall Study|Protocol Violation|0|||
126411707|NCT01769196|454801800|FG001|Overall Study|Protocol Violation|3|||
126411708|NCT01769196|454801799|FG000|Overall Study|Study terminated by sponsor|160|||
126411709|NCT01769196|454801800|FG001|Overall Study|Study terminated by sponsor|161|||
126411710|NCT01769196|454801799|FG000|Overall Study|Participant never dosed with study drug|1|||
126411711|NCT01769196|454801800|FG001|Overall Study|Participant never dosed with study drug|0|||
126411712|NCT01769196|454801799|FG000|Overall Study|Withdrew consent|36|||
126411713|NCT01769196|454801800|FG001|Overall Study|Withdrew consent|40|||
126411714|NCT00655629|454801803|FG000|Overall Study|Adverse Event|4|||
126411715|NCT00655629|454801804|FG001|Overall Study|Adverse Event|1|||
126411716|NCT00655629|454801803|FG000|Overall Study|Lack of Efficacy|2|||
126411717|NCT00655629|454801804|FG001|Overall Study|Lack of Efficacy|12|||
126411718|NCT00655629|454801803|FG000|Overall Study|Lost to Follow-up|4|||
126411719|NCT00655629|454801804|FG001|Overall Study|Lost to Follow-up|3|||
126411720|NCT00655629|454801803|FG000|Overall Study|Protocol Violation|5|||
126411721|NCT00655629|454801804|FG001|Overall Study|Protocol Violation|3|||
126411722|NCT00655629|454801803|FG000|Overall Study|consent withdrawn|6|||
126411723|NCT00655629|454801804|FG001|Overall Study|consent withdrawn|4|||
126411724|NCT00705367|454801805|FG000|Long-term Extension Period|Adverse Event|2|||
126411725|NCT00705367|454801806|FG001|Long-term Extension Period|Adverse Event|0|||
126411726|NCT00705367|454801805|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
126411727|NCT00705367|454801806|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
126411728|NCT00705367|454801805|FG000|Long-term Extension Period|Lack of Efficacy|1|||
126411729|NCT00705367|454801806|FG001|Long-term Extension Period|Lack of Efficacy|0|||
126411730|NCT00705367|454801805|FG000|Long-term Extension Period|No longer met study criteria|1|||
126411731|NCT00705367|454801806|FG001|Long-term Extension Period|No longer met study criteria|0|||
126411732|NCT00705367|454801805|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
126411733|NCT00705367|454801806|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
126411734|NCT05096312|454801807|FG000|Overall Study|Lost to Follow-up|2|||
126411735|NCT05096312|454801808|FG001|Overall Study|Lost to Follow-up|4|||
126411736|NCT05096312|454801807|FG000|Overall Study|Adverse Event|1|||
126411737|NCT05096312|454801808|FG001|Overall Study|Adverse Event|0|||
126411738|NCT03135210|454801809|FG000|Overall Study|Death|0|||
126411739|NCT03135210|454801810|FG001|Overall Study|Death|1|||
126411740|NCT00820222|454801812|FG000|Overall Study|Lost to Follow-up|10|||
126411741|NCT00820222|454801813|FG001|Overall Study|Lost to Follow-up|9|||
126411742|NCT00820222|454801812|FG000|Overall Study|Withdrawal by Subject|19|||
126411743|NCT00820222|454801813|FG001|Overall Study|Withdrawal by Subject|21|||
126411744|NCT00820222|454801812|FG000|Overall Study|Physician Decision|93|||
126411745|NCT00820222|454801813|FG001|Overall Study|Physician Decision|88|||
126411746|NCT00820222|454801812|FG000|Overall Study|Sponsor Terminated Study|43|||
126411747|NCT00820222|454801813|FG001|Overall Study|Sponsor Terminated Study|65|||
126411748|NCT00820222|454801812|FG000|Overall Study|Unkown|11|||
126411749|NCT00820222|454801813|FG001|Overall Study|Unkown|7|||
126411750|NCT00699335|454801830|FG000|Overall Study|Combination of multiple reasons|176|||
126411751|NCT00699335|454801830|FG000|Overall Study|Missing data|52|||
126411752|NCT01887353|454801831|FG000|Overall Study|Study stopped early|4|||
126411753|NCT01887353|454801832|FG001|Overall Study|Study stopped early|3|||
126411754|NCT01069705|454801833|FG000|Overall Study|Adverse Event|1|||
126411755|NCT01069705|454801833|FG000|Overall Study|Withdrawal by Subject|2|||
126411756|NCT02726022|454801834|FG000|Overall Study|Adverse Event|14|||
126411757|NCT02726022|454801834|FG000|Overall Study|Treatment Failure|8|||
126411758|NCT02726022|454801834|FG000|Overall Study|Poor Compliance|13|||
126411759|NCT02726022|454801834|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
126411760|NCT01545050|454801835|FG000|Overall Study|Lack of Efficacy|0|||
126411761|NCT01545050|454801836|FG001|Overall Study|Lack of Efficacy|0|||
126411762|NCT01545050|454801837|FG002|Overall Study|Lack of Efficacy|0|||
126411763|NCT01545050|454801838|FG003|Overall Study|Lack of Efficacy|3|||
126411764|NCT01545050|454801839|FG004|Overall Study|Lack of Efficacy|2|||
126411765|NCT01545050|454801835|FG000|Overall Study|Adverse Event|1|||
126411766|NCT01545050|454801836|FG001|Overall Study|Adverse Event|1|||
126411767|NCT01545050|454801837|FG002|Overall Study|Adverse Event|2|||
126474593|NCT01757535|455036381|FG000|Overall Study|Physician Decision|7|||
126411768|NCT01545050|454801838|FG003|Overall Study|Adverse Event|2|||
126411769|NCT01545050|454801839|FG004|Overall Study|Adverse Event|0|||
126411770|NCT01545050|454801835|FG000|Overall Study|Discontinued study treatment|1|||
126411771|NCT01545050|454801836|FG001|Overall Study|Discontinued study treatment|0|||
126411772|NCT01545050|454801837|FG002|Overall Study|Discontinued study treatment|0|||
126411773|NCT01545050|454801838|FG003|Overall Study|Discontinued study treatment|0|||
126411774|NCT01545050|454801839|FG004|Overall Study|Discontinued study treatment|0|||
126411775|NCT01545050|454801835|FG000|Overall Study|Withdrawal by Subject|1|||
126411776|NCT01545050|454801836|FG001|Overall Study|Withdrawal by Subject|0|||
126411777|NCT01545050|454801837|FG002|Overall Study|Withdrawal by Subject|0|||
126411778|NCT01545050|454801838|FG003|Overall Study|Withdrawal by Subject|2|||
126411779|NCT01545050|454801839|FG004|Overall Study|Withdrawal by Subject|1|||
126411780|NCT01545050|454801835|FG000|Overall Study|Participant no longer meets study criteria|0|||
126411781|NCT01545050|454801836|FG001|Overall Study|Participant no longer meets study criteria|2|||
126411782|NCT01545050|454801837|FG002|Overall Study|Participant no longer meets study criteria|0|||
126411783|NCT01545050|454801838|FG003|Overall Study|Participant no longer meets study criteria|0|||
126411784|NCT01545050|454801839|FG004|Overall Study|Participant no longer meets study criteria|1|||
126474594|NCT01757535|455036382|FG001|Overall Study|Physician Decision|0|||
126474595|NCT01757535|455036381|FG000|Overall Study|Death|2|||
126474596|NCT01757535|455036382|FG001|Overall Study|Death|2|||
126474597|NCT03487549|455036383|FG000|Overall Study|Protocol Violation|0|||
126474598|NCT03487549|455036384|FG001|Overall Study|Protocol Violation|1|||
126411785|NCT01545050|454801835|FG000|Overall Study|Administrative reason by sponsor|4|||
126411786|NCT01545050|454801836|FG001|Overall Study|Administrative reason by sponsor|2|||
126411787|NCT01545050|454801837|FG002|Overall Study|Administrative reason by sponsor|3|||
126411788|NCT01545050|454801838|FG003|Overall Study|Administrative reason by sponsor|5|||
126411789|NCT01545050|454801839|FG004|Overall Study|Administrative reason by sponsor|5|||
126411790|NCT03262441|454801840|FG000|Overall Study|Withdrawal by Subject|1|||
126411791|NCT00559988|454801844|FG000|Overall Study|Death|147|||
126411792|NCT00559988|454801845|FG001|Overall Study|Death|140|||
126411793|NCT00559988|454801844|FG000|Overall Study|Withdrawal by Subject|152|||
126411794|NCT00559988|454801845|FG001|Overall Study|Withdrawal by Subject|139|||
126411795|NCT00559988|454801844|FG000|Overall Study|Lost to Follow-up|42|||
126411796|NCT00559988|454801845|FG001|Overall Study|Lost to Follow-up|56|||
126411797|NCT00559988|454801844|FG000|Overall Study|ICD device explanted|10|||
126411798|NCT00559988|454801845|FG001|Overall Study|ICD device explanted|17|||
126411799|NCT02249182|454801846|FG000|Treatment Phase|Lost to Follow-up|4|||
126411800|NCT02249182|454801847|FG001|Treatment Phase|Lost to Follow-up|0|||
126411801|NCT02249182|454801848|FG002|Treatment Phase|Lost to Follow-up|0|||
126411802|NCT02249182|454801849|FG003|Treatment Phase|Lost to Follow-up|0|||
126411803|NCT02249182|454801850|FG004|Treatment Phase|Lost to Follow-up|0|||
126411804|NCT01455194|454801851|FG000|Overall Study|Screen Failure|20|||
126411805|NCT01455194|454801852|FG001|Overall Study|Screen Failure|0|||
126411806|NCT01455194|454801853|FG002|Overall Study|Screen Failure|0|||
126411807|NCT01455194|454801854|FG003|Overall Study|Screen Failure|0|||
126411808|NCT01455194|454801851|FG000|Overall Study|Randomisation Failure|90|||
126411809|NCT01455194|454801852|FG001|Overall Study|Randomisation Failure|0|||
126411810|NCT01455194|454801853|FG002|Overall Study|Randomisation Failure|0|||
126411811|NCT01455194|454801854|FG003|Overall Study|Randomisation Failure|0|||
126411812|NCT01455194|454801851|FG000|Overall Study|Deterioration in asthma|12|||
126411813|NCT01455194|454801852|FG001|Overall Study|Deterioration in asthma|6|||
126411814|NCT01455194|454801853|FG002|Overall Study|Deterioration in asthma|14|||
126411815|NCT01455194|454801854|FG003|Overall Study|Deterioration in asthma|9|||
126411816|NCT01455194|454801851|FG000|Overall Study|Adverse Event|1|||
126411817|NCT01455194|454801852|FG001|Overall Study|Adverse Event|1|||
126411818|NCT01455194|454801853|FG002|Overall Study|Adverse Event|1|||
126411819|NCT01455194|454801854|FG003|Overall Study|Adverse Event|3|||
126411820|NCT01455194|454801851|FG000|Overall Study|Withdrawal by Subject|21|||
126411821|NCT01455194|454801852|FG001|Overall Study|Withdrawal by Subject|16|||
126474599|NCT03487549|455036383|FG000|Overall Study|Lost to Follow-up|2|||
126474600|NCT03487549|455036384|FG001|Overall Study|Lost to Follow-up|1|||
126474601|NCT03487549|455036383|FG000|Overall Study|Withdrawal by Subject|2|||
126474602|NCT03487549|455036384|FG001|Overall Study|Withdrawal by Subject|0|||
126474603|NCT05147428|455036385|FG000|Overall Study|Removed prior to mailing|289|||
126474604|NCT05147428|455036386|FG001|Overall Study|Removed prior to mailing|306|||
126474605|NCT05147428|455036387|FG002|Overall Study|Removed prior to mailing|270|||
126474606|NCT05147428|455036385|FG000|Overall Study|Died or disenrolled during blackout period|239|||
126474607|NCT05147428|455036386|FG001|Overall Study|Died or disenrolled during blackout period|278|||
126474608|NCT05147428|455036387|FG002|Overall Study|Died or disenrolled during blackout period|273|||
126474609|NCT00217620|455037996|FG000|Overall Study|Adverse Event|2|||
126474610|NCT00217620|455037996|FG000|Overall Study|Progression|31|||
126474611|NCT00217620|455037996|FG000|Overall Study|Not Protocol Specified|4|||
126474612|NCT00217620|455037996|FG000|Overall Study|Ineligible|13|||
126474613|NCT00217620|455037996|FG000|Overall Study|Never received treatment|1|||
126474614|NCT00825682|455038002|FG000|Overall Study|personal reasons/ inconvenience|13|||
126474615|NCT00825682|455038003|FG001|Overall Study|personal reasons/ inconvenience|5|||
126474616|NCT00316719|455038004|FG000|Overall Study|Adverse Event|0|||
126474617|NCT00316719|455038005|FG001|Overall Study|Adverse Event|6|||
126474618|NCT00316719|455038004|FG000|Overall Study|Consent withdrawn|2|||
126474619|NCT00316719|455038005|FG001|Overall Study|Consent withdrawn|0|||
126411822|NCT01455194|454801853|FG002|Overall Study|Withdrawal by Subject|12|||
126411823|NCT01455194|454801854|FG003|Overall Study|Withdrawal by Subject|9|||
126411824|NCT01455194|454801851|FG000|Overall Study|Lost to Follow-up|2|||
126474620|NCT02468674|455038008|FG000|Overall Study|Adverse Event|0|||
126474621|NCT02468674|455038009|FG001|Overall Study|Adverse Event|0|||
126474622|NCT02468674|455038010|FG002|Overall Study|Adverse Event|0|||
126474623|NCT02468674|455038011|FG003|Overall Study|Adverse Event|1|||
126558714|NCT03251378|455338823|FG002|Overall Study|Lost to Follow-up|1|||
126411825|NCT01455194|454801852|FG001|Overall Study|Lost to Follow-up|0|||
126411826|NCT01455194|454801853|FG002|Overall Study|Lost to Follow-up|1|||
126411827|NCT01455194|454801854|FG003|Overall Study|Lost to Follow-up|1|||
126411828|NCT01455194|454801851|FG000|Overall Study|Pregnancy|0|||
126411829|NCT01455194|454801852|FG001|Overall Study|Pregnancy|1|||
126411830|NCT01455194|454801853|FG002|Overall Study|Pregnancy|1|||
126411831|NCT01455194|454801854|FG003|Overall Study|Pregnancy|0|||
126558715|NCT03251378|455338824|FG003|Overall Study|Lost to Follow-up|3|||
126558716|NCT03251378|455338825|FG004|Overall Study|Lost to Follow-up|0|||
126558717|NCT03251378|455338826|FG005|Overall Study|Lost to Follow-up|0|||
126558718|NCT03251378|455338827|FG006|Overall Study|Lost to Follow-up|0|||
126558719|NCT03251378|455338821|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
126721489|NCT00195260|455929970|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126721490|NCT00195260|455929971|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126411832|NCT01455194|454801851|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
126411833|NCT01455194|454801852|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
126411834|NCT01455194|454801853|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
126411835|NCT01455194|454801854|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
126411836|NCT01455194|454801851|FG000|Overall Study|Miscellaneous|4|||
126411837|NCT01455194|454801852|FG001|Overall Study|Miscellaneous|5|||
126411838|NCT01455194|454801853|FG002|Overall Study|Miscellaneous|1|||
126411839|NCT01455194|454801854|FG003|Overall Study|Miscellaneous|4|||
126411840|NCT00504894|454801857|FG000|Overall Study|fMRI technical problems|1|||
126411841|NCT00504894|454801858|FG001|Overall Study|fMRI technical problems|1|||
126411842|NCT00504894|454801859|FG002|Overall Study|fMRI technical problems|0|||
126411843|NCT00504894|454801857|FG000|Overall Study|Withdrawal by Subject|0|||
126411844|NCT00504894|454801858|FG001|Overall Study|Withdrawal by Subject|1|||
126411845|NCT00504894|454801859|FG002|Overall Study|Withdrawal by Subject|0|||
126411846|NCT00504894|454801857|FG000|Overall Study|Infusion technical problems|0|||
126411847|NCT00504894|454801858|FG001|Overall Study|Infusion technical problems|1|||
126411848|NCT00504894|454801859|FG002|Overall Study|Infusion technical problems|0|||
126411849|NCT00504894|454801857|FG000|Overall Study|poor subject data|2|||
126411850|NCT00504894|454801858|FG001|Overall Study|poor subject data|0|||
126411851|NCT00504894|454801859|FG002|Overall Study|poor subject data|0|||
126411852|NCT01196416|454801860|FG000|Overall Study|Withdrawal by Subject|2|||
126411853|NCT02673684|454801861|FG000|Overall Study|Study not completed d/t loss of funding|9|||
126411854|NCT02673684|454801862|FG001|Overall Study|Study not completed d/t loss of funding|8|||
126411855|NCT01092663|454801863|FG000|Overall Study|Withdrawal by Subject|3|||
126411856|NCT01092663|454801864|FG001|Overall Study|Withdrawal by Subject|2|||
126411857|NCT01092663|454801863|FG000|Overall Study|Glucose >300mg/dL|1|||
126411858|NCT01092663|454801864|FG001|Overall Study|Glucose >300mg/dL|0|||
126411859|NCT01092663|454801863|FG000|Overall Study|High fasting triglyceride|2|||
126411860|NCT01092663|454801864|FG001|Overall Study|High fasting triglyceride|0|||
126411861|NCT01092663|454801863|FG000|Overall Study|Adverse Event|1|||
126411862|NCT01092663|454801864|FG001|Overall Study|Adverse Event|1|||
126411863|NCT01092663|454801863|FG000|Overall Study|Protocol Violation|0|||
126411864|NCT01092663|454801864|FG001|Overall Study|Protocol Violation|1|||
126411865|NCT03688620|454801865|FG000|Overall Study|Other|0|||
126411866|NCT03688620|454801866|FG001|Overall Study|Other|0|||
126411867|NCT03688620|454801867|FG002|Overall Study|Other|1|||
126411868|NCT03688620|454801865|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
126411869|NCT03688620|454801866|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
126411870|NCT03688620|454801867|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
126411871|NCT03688620|454801865|FG000|Overall Study|Lost to Follow-up|16|||
126411872|NCT03688620|454801866|FG001|Overall Study|Lost to Follow-up|0|||
126411873|NCT03688620|454801867|FG002|Overall Study|Lost to Follow-up|1|||
126411874|NCT03688620|454801865|FG000|Overall Study|Withdrawal by Subject|0|||
126411875|NCT03688620|454801866|FG001|Overall Study|Withdrawal by Subject|0|||
126411876|NCT03688620|454801867|FG002|Overall Study|Withdrawal by Subject|6|||
126411877|NCT01008904|454801868|FG000|Overall Study|Lost to Follow-up|1|||
126411878|NCT01008904|454801868|FG000|Overall Study|Adverse Event|2|||
126411879|NCT01008904|454801868|FG000|Overall Study|unexpected unrelated surgery|1|||
126411880|NCT01183065|454801869|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
126411881|NCT02456857|454801870|FG000|Overall Study|Disease Progression|4|||
126411882|NCT00781859|454801871|FG000|Overall Study|Adverse Event|2|||
126411883|NCT00781859|454801872|FG001|Overall Study|Adverse Event|2|||
126411884|NCT00781859|454801871|FG000|Overall Study|Withdrawal by Subject|8|||
126411885|NCT00781859|454801872|FG001|Overall Study|Withdrawal by Subject|4|||
126411886|NCT00781859|454801871|FG000|Overall Study|Lost to Follow-up|6|||
126411887|NCT00781859|454801872|FG001|Overall Study|Lost to Follow-up|3|||
126411888|NCT00781859|454801871|FG000|Overall Study|Death|3|||
126411889|NCT00781859|454801872|FG001|Overall Study|Death|0|||
126411890|NCT01983774|454801876|FG000|Overall Study|Lung Transplant|0|||
126411891|NCT01983774|454801877|FG001|Overall Study|Lung Transplant|1|||
126721491|NCT00195260|455929972|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126411892|NCT01983774|454801876|FG000|Overall Study|Lost to Follow-up|1|||
126411893|NCT01983774|454801877|FG001|Overall Study|Lost to Follow-up|0|||
126411894|NCT01008449|454801878|FG000|Overall Study|Lost to Follow-up|29|||
126411895|NCT01008449|454801879|FG001|Overall Study|Lost to Follow-up|19|||
126411896|NCT01220180|454801880|FG000|Overall Study|Lost to Follow-up|76|||
126558720|NCT03251378|455338822|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
126411897|NCT01220180|454801880|FG000|Overall Study|Other|72|||
126411898|NCT01220180|454801880|FG000|Overall Study|Adverse Event|35|||
126411899|NCT01220180|454801880|FG000|Overall Study|Lack of Efficacy|22|||
126411900|NCT01220180|454801880|FG000|Overall Study|Death|1|||
126411901|NCT01220180|454801880|FG000|Overall Study|Randomized but not treated|1|||
126474624|NCT02468674|455038012|FG004|Overall Study|Adverse Event|0|||
126474625|NCT02468674|455038013|FG005|Overall Study|Adverse Event|1|||
126474626|NCT02468674|455038014|FG006|Overall Study|Adverse Event|0|||
126474627|NCT02468674|455038015|FG007|Overall Study|Adverse Event|0|||
126474628|NCT02468674|455038016|FG008|Overall Study|Adverse Event|0|||
126474629|NCT02468674|455038008|FG000|Overall Study|Lost to Follow-up|1|||
126474630|NCT02468674|455038009|FG001|Overall Study|Lost to Follow-up|0|||
126474631|NCT02468674|455038010|FG002|Overall Study|Lost to Follow-up|0|||
126558721|NCT03251378|455338823|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
126558722|NCT03251378|455338824|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
126558723|NCT03251378|455338825|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
126558724|NCT03251378|455338826|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
126558725|NCT03251378|455338827|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
126558726|NCT03251378|455338821|FG000|Overall Study|Progressive disease|2|||
126558727|NCT03251378|455338822|FG001|Overall Study|Progressive disease|0|||
126558728|NCT03251378|455338823|FG002|Overall Study|Progressive disease|0|||
126558729|NCT03251378|455338824|FG003|Overall Study|Progressive disease|1|||
126558730|NCT03251378|455338825|FG004|Overall Study|Progressive disease|0|||
126558731|NCT03251378|455338826|FG005|Overall Study|Progressive disease|0|||
126558732|NCT03251378|455338827|FG006|Overall Study|Progressive disease|0|||
126558733|NCT03251378|455338821|FG000|Overall Study|Physician Decision|0|||
126558734|NCT03251378|455338822|FG001|Overall Study|Physician Decision|2|||
126558735|NCT03251378|455338823|FG002|Overall Study|Physician Decision|0|||
126558736|NCT03251378|455338824|FG003|Overall Study|Physician Decision|0|||
126558737|NCT03251378|455338825|FG004|Overall Study|Physician Decision|0|||
126558738|NCT03251378|455338826|FG005|Overall Study|Physician Decision|0|||
126558739|NCT03251378|455338827|FG006|Overall Study|Physician Decision|0|||
126558740|NCT03251378|455338821|FG000|Overall Study|Other|2|||
126558741|NCT03251378|455338822|FG001|Overall Study|Other|3|||
126558742|NCT03251378|455338823|FG002|Overall Study|Other|2|||
126558743|NCT03251378|455338824|FG003|Overall Study|Other|0|||
126558744|NCT03251378|455338825|FG004|Overall Study|Other|1|||
126558745|NCT03251378|455338826|FG005|Overall Study|Other|1|||
126558746|NCT03251378|455338827|FG006|Overall Study|Other|1|||
126558747|NCT03251378|455338821|FG000|Overall Study|Other|0|||
126558748|NCT03251378|455338822|FG001|Overall Study|Other|0|||
126411902|NCT01067469|454801886|FG000|Overall Study|Withdrawal by Subject|0|||
126411903|NCT01067469|454801887|FG001|Overall Study|Withdrawal by Subject|1|||
126411904|NCT01067469|454801886|FG000|Overall Study|Disease Progression|0|||
126411905|NCT01067469|454801887|FG001|Overall Study|Disease Progression|1|||
126411906|NCT01299116|454801889|FG000|Overall Study|Lost to Follow-up|65|||
126411907|NCT01299116|454801890|FG001|Overall Study|Lost to Follow-up|9|||
126411908|NCT01299116|454801891|FG002|Overall Study|Lost to Follow-up|11|||
126411909|NCT01123707|454801893|FG000|Overall Study|Lost to Follow-up|3|||
126411910|NCT01123707|454801894|FG001|Overall Study|Lost to Follow-up|1|||
126411911|NCT01123707|454801895|FG002|Overall Study|Lost to Follow-up|3|||
126411912|NCT01123707|454801896|FG003|Overall Study|Lost to Follow-up|2|||
126411913|NCT01123707|454801893|FG000|Overall Study|Adverse Event|5|||
126411914|NCT01123707|454801894|FG001|Overall Study|Adverse Event|7|||
126411915|NCT01123707|454801895|FG002|Overall Study|Adverse Event|5|||
126411916|NCT01123707|454801896|FG003|Overall Study|Adverse Event|3|||
126411917|NCT01123707|454801893|FG000|Overall Study|Sponsor Discontinued Study|30|||
126411918|NCT01123707|454801894|FG001|Overall Study|Sponsor Discontinued Study|24|||
126474632|NCT02468674|455038011|FG003|Overall Study|Lost to Follow-up|0|||
126474633|NCT02468674|455038012|FG004|Overall Study|Lost to Follow-up|0|||
126474634|NCT02468674|455038013|FG005|Overall Study|Lost to Follow-up|0|||
126558749|NCT03251378|455338823|FG002|Overall Study|Other|0|||
126721492|NCT00195260|455929973|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126411919|NCT01123707|454801895|FG002|Overall Study|Sponsor Discontinued Study|25|||
126411920|NCT01123707|454801896|FG003|Overall Study|Sponsor Discontinued Study|40|||
126411921|NCT01123707|454801893|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
126411922|NCT01123707|454801894|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
126411923|NCT01123707|454801895|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
126411924|NCT01123707|454801896|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
126558750|NCT03251378|455338824|FG003|Overall Study|Other|4|||
126474635|NCT02468674|455038014|FG006|Overall Study|Lost to Follow-up|0|||
126474636|NCT02468674|455038015|FG007|Overall Study|Lost to Follow-up|1|||
126474637|NCT02468674|455038016|FG008|Overall Study|Lost to Follow-up|1|||
126558751|NCT03251378|455338825|FG004|Overall Study|Other|13|||
126558752|NCT03251378|455338826|FG005|Overall Study|Other|0|||
126558753|NCT03251378|455338827|FG006|Overall Study|Other|0|||
126558754|NCT04739423|455338832|FG000|Overall Study|Protocol Violation|0|||
126558755|NCT04739423|455338833|FG001|Overall Study|Protocol Violation|1|||
126558756|NCT04739423|455338834|FG002|Overall Study|Protocol Violation|0|||
126474638|NCT02468674|455038008|FG000|Overall Study|Physician Decision|0|||
126474639|NCT02468674|455038009|FG001|Overall Study|Physician Decision|0|||
126474640|NCT02468674|455038010|FG002|Overall Study|Physician Decision|0|||
126474641|NCT02468674|455038011|FG003|Overall Study|Physician Decision|0|||
126474642|NCT02468674|455038012|FG004|Overall Study|Physician Decision|0|||
126474643|NCT02468674|455038013|FG005|Overall Study|Physician Decision|0|||
126474644|NCT02468674|455038014|FG006|Overall Study|Physician Decision|1|||
126474645|NCT02468674|455038015|FG007|Overall Study|Physician Decision|0|||
126474646|NCT02468674|455038016|FG008|Overall Study|Physician Decision|0|||
126474647|NCT02468674|455038008|FG000|Overall Study|Patient/Guardian Decision|0|||
126474648|NCT02468674|455038009|FG001|Overall Study|Patient/Guardian Decision|0|||
126721493|NCT00195260|455929974|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126411925|NCT01123707|454801893|FG000|Overall Study|Investigator Withdrew Participant|0|||
126411926|NCT01123707|454801894|FG001|Overall Study|Investigator Withdrew Participant|1|||
126411927|NCT01123707|454801895|FG002|Overall Study|Investigator Withdrew Participant|1|||
126411928|NCT01123707|454801896|FG003|Overall Study|Investigator Withdrew Participant|1|||
126411929|NCT01123707|454801893|FG000|Overall Study|Subject Withdrew Consent|4|||
126411930|NCT01123707|454801894|FG001|Overall Study|Subject Withdrew Consent|5|||
126411931|NCT01123707|454801895|FG002|Overall Study|Subject Withdrew Consent|1|||
126411932|NCT01123707|454801896|FG003|Overall Study|Subject Withdrew Consent|2|||
126411933|NCT01123707|454801893|FG000|Overall Study|Lack of Efficacy|1|||
126411934|NCT01123707|454801894|FG001|Overall Study|Lack of Efficacy|2|||
126411935|NCT01123707|454801895|FG002|Overall Study|Lack of Efficacy|1|||
126411936|NCT01123707|454801896|FG003|Overall Study|Lack of Efficacy|0|||
126411937|NCT01123707|454801893|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
126411938|NCT01123707|454801894|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
126411939|NCT01123707|454801895|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
126411940|NCT01123707|454801896|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
126411941|NCT04378114|454801897|FG000|Overall Study|Withdrawal by Subject|5|||
126411942|NCT01959243|454801900|FG000|Overall Study|Investigator Decision|3|||
126411943|NCT01959243|454801901|FG001|Overall Study|Investigator Decision|0|||
126411944|NCT01959243|454801900|FG000|Overall Study|Adverse Event|5|||
126411945|NCT01959243|454801901|FG001|Overall Study|Adverse Event|2|||
126411946|NCT01959243|454801900|FG000|Overall Study|Administrative reasons|2|||
126411947|NCT01959243|454801901|FG001|Overall Study|Administrative reasons|1|||
126411948|NCT01959243|454801900|FG000|Overall Study|Lost to Follow-up|3|||
126721494|NCT00195260|455929975|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
126721495|NCT00195260|455929976|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
126721496|NCT00195260|455929977|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
126721497|NCT00195260|455929978|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
126411949|NCT01959243|454801901|FG001|Overall Study|Lost to Follow-up|1|||
126411950|NCT00629798|454801904|FG000|Overall Study|Not Treated|4|||
126411951|NCT02554981|454801905|FG000|Overall Study|Adverse Event|1|||
126411952|NCT02554981|454801905|FG000|Overall Study|Administrative Reasons|1|||
126411953|NCT02554981|454801905|FG000|Overall Study|Other Miscellaneous Reasons|3|||
126411954|NCT01114438|454801906|FG000|Overall Study|Adverse Event|10|||
126411955|NCT01114438|454801906|FG000|Overall Study|concomitant medication|1|||
126411956|NCT01114438|454801906|FG000|Overall Study|Physician Decision|1|||
126411957|NCT01114438|454801906|FG000|Overall Study|Withdrawal by Subject|2|||
126411958|NCT00428844|454801907|FG000|Completed Study Drug Treatment|Adverse Event|2|||
126411959|NCT00428844|454801908|FG001|Completed Study Drug Treatment|Adverse Event|4|||
126411960|NCT00428844|454801909|FG002|Completed Study Drug Treatment|Adverse Event|4|||
126411961|NCT00428844|454801907|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
126411962|NCT00428844|454801908|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
126411963|NCT00428844|454801909|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
126411964|NCT00428844|454801907|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
126411965|NCT00428844|454801908|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
126411966|NCT00428844|454801909|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
126411967|NCT00428844|454801907|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
126411968|NCT00428844|454801908|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
126411969|NCT00428844|454801909|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
126411970|NCT00428844|454801907|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
126721498|NCT00195260|455929968|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126721499|NCT00195260|455929969|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126721500|NCT00195260|455929970|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126411971|NCT00428844|454801908|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
126411972|NCT00428844|454801909|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
126411973|NCT00428844|454801907|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
126411974|NCT00428844|454801908|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
126411975|NCT00428844|454801909|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
126474649|NCT02468674|455038010|FG002|Overall Study|Patient/Guardian Decision|0|||
126474650|NCT02468674|455038011|FG003|Overall Study|Patient/Guardian Decision|0|||
126411976|NCT00428844|454801907|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
126411977|NCT00428844|454801908|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
126411978|NCT00428844|454801909|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
126411979|NCT00428844|454801907|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
126411980|NCT00428844|454801908|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
126411981|NCT00428844|454801909|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
126411982|NCT00428844|454801907|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
126411983|NCT00428844|454801908|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
126411984|NCT00428844|454801909|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
126411985|NCT00488826|454801912|FG000|Overall Study|Withdrawal by Subject|40|||
126411986|NCT00488826|454801913|FG001|Overall Study|Withdrawal by Subject|35|||
126411987|NCT00488826|454801914|FG002|Overall Study|Withdrawal by Subject|19|||
126411988|NCT00488826|454801912|FG000|Overall Study|Protocol Violation|0|||
126411989|NCT00488826|454801913|FG001|Overall Study|Protocol Violation|0|||
126411990|NCT00488826|454801914|FG002|Overall Study|Protocol Violation|2|||
126411991|NCT00488826|454801912|FG000|Overall Study|Adverse Event|9|||
126411992|NCT00488826|454801913|FG001|Overall Study|Adverse Event|15|||
126411993|NCT00488826|454801914|FG002|Overall Study|Adverse Event|4|||
126411994|NCT00488826|454801912|FG000|Overall Study|Lost to Follow-up|5|||
126411995|NCT00488826|454801913|FG001|Overall Study|Lost to Follow-up|1|||
126411996|NCT00488826|454801914|FG002|Overall Study|Lost to Follow-up|0|||
126411997|NCT00488826|454801912|FG000|Overall Study|Protocol Deviations|2|||
126411998|NCT00488826|454801913|FG001|Overall Study|Protocol Deviations|1|||
126411999|NCT00488826|454801914|FG002|Overall Study|Protocol Deviations|1|||
126412000|NCT02292706|454801915|FG000|Overall Study|Lost to Follow-up|20|||
126412001|NCT02292706|454801916|FG001|Overall Study|Lost to Follow-up|44|||
126412002|NCT02292706|454801917|FG002|Overall Study|Lost to Follow-up|24|||
126412003|NCT02292706|454801918|FG003|Overall Study|Lost to Follow-up|61|||
126412004|NCT02292706|454801919|FG004|Overall Study|Lost to Follow-up|21|||
126412005|NCT02292706|454801920|FG005|Overall Study|Lost to Follow-up|52|||
126412006|NCT02292706|454801921|FG006|Overall Study|Lost to Follow-up|25|||
126412007|NCT02292706|454801922|FG007|Overall Study|Lost to Follow-up|0|||
126412008|NCT02292706|454801915|FG000|Overall Study|Withdrew consent|15|||
126412009|NCT02292706|454801916|FG001|Overall Study|Withdrew consent|56|||
126412010|NCT02292706|454801917|FG002|Overall Study|Withdrew consent|43|||
126412011|NCT02292706|454801918|FG003|Overall Study|Withdrew consent|36|||
126412012|NCT02292706|454801919|FG004|Overall Study|Withdrew consent|13|||
126412013|NCT02292706|454801920|FG005|Overall Study|Withdrew consent|51|||
126412014|NCT02292706|454801921|FG006|Overall Study|Withdrew consent|20|||
126412015|NCT02292706|454801922|FG007|Overall Study|Withdrew consent|0|||
126412016|NCT02292706|454801915|FG000|Overall Study|Death|3|||
126412017|NCT02292706|454801916|FG001|Overall Study|Death|11|||
126412018|NCT02292706|454801917|FG002|Overall Study|Death|16|||
126412019|NCT02292706|454801918|FG003|Overall Study|Death|22|||
126412020|NCT02292706|454801919|FG004|Overall Study|Death|8|||
126412021|NCT02292706|454801920|FG005|Overall Study|Death|17|||
126412022|NCT02292706|454801921|FG006|Overall Study|Death|3|||
126412023|NCT02292706|454801922|FG007|Overall Study|Death|0|||
126412024|NCT02292706|454801915|FG000|Overall Study|Study terminated by sponsor|0|||
126412025|NCT02292706|454801916|FG001|Overall Study|Study terminated by sponsor|9|||
126412026|NCT02292706|454801917|FG002|Overall Study|Study terminated by sponsor|4|||
126474651|NCT02468674|455038012|FG004|Overall Study|Patient/Guardian Decision|1|||
126474652|NCT02468674|455038013|FG005|Overall Study|Patient/Guardian Decision|0|||
126474653|NCT02468674|455038014|FG006|Overall Study|Patient/Guardian Decision|0|||
126474654|NCT02468674|455038015|FG007|Overall Study|Patient/Guardian Decision|2|||
126474655|NCT02468674|455038016|FG008|Overall Study|Patient/Guardian Decision|1|||
126474656|NCT02468674|455038008|FG000|Overall Study|Protocol Deviation|0|||
126474657|NCT02468674|455038009|FG001|Overall Study|Protocol Deviation|0|||
126474658|NCT02468674|455038010|FG002|Overall Study|Protocol Deviation|0|||
126474659|NCT02468674|455038011|FG003|Overall Study|Protocol Deviation|0|||
126412027|NCT02292706|454801918|FG003|Overall Study|Study terminated by sponsor|21|||
126412028|NCT02292706|454801919|FG004|Overall Study|Study terminated by sponsor|11|||
126412029|NCT02292706|454801920|FG005|Overall Study|Study terminated by sponsor|13|||
126412030|NCT02292706|454801921|FG006|Overall Study|Study terminated by sponsor|3|||
126412031|NCT02292706|454801922|FG007|Overall Study|Study terminated by sponsor|0|||
126474660|NCT02468674|455038012|FG004|Overall Study|Protocol Deviation|0|||
126558757|NCT04739423|455338835|FG003|Overall Study|Protocol Violation|0|||
126412032|NCT02292706|454801915|FG000|Overall Study|Investigator's discretion|4|||
126558758|NCT04739423|455338836|FG004|Overall Study|Protocol Violation|0|||
126412033|NCT02292706|454801916|FG001|Overall Study|Investigator's discretion|9|||
126412034|NCT02292706|454801917|FG002|Overall Study|Investigator's discretion|7|||
126412035|NCT02292706|454801918|FG003|Overall Study|Investigator's discretion|11|||
126412036|NCT02292706|454801919|FG004|Overall Study|Investigator's discretion|4|||
126412037|NCT02292706|454801920|FG005|Overall Study|Investigator's discretion|10|||
126412038|NCT02292706|454801921|FG006|Overall Study|Investigator's discretion|1|||
126412039|NCT02292706|454801922|FG007|Overall Study|Investigator's discretion|0|||
126474661|NCT02468674|455038013|FG005|Overall Study|Protocol Deviation|0|||
126558759|NCT04739423|455338837|FG005|Overall Study|Protocol Violation|0|||
126474662|NCT02468674|455038014|FG006|Overall Study|Protocol Deviation|0|||
126474663|NCT02468674|455038015|FG007|Overall Study|Protocol Deviation|1|||
126474664|NCT02468674|455038016|FG008|Overall Study|Protocol Deviation|1|||
126474665|NCT01644565|455038017|FG000|Overall Study|Undisclosed Medical History|1|||
126474666|NCT01644565|455038018|FG001|Overall Study|Undisclosed Medical History|0|||
126474667|NCT01644565|455038019|FG002|Overall Study|Undisclosed Medical History|0|||
126474668|NCT01644565|455038020|FG003|Overall Study|Undisclosed Medical History|0|||
126474669|NCT01644565|455038021|FG004|Overall Study|Undisclosed Medical History|0|||
126412040|NCT02292706|454801915|FG000|Overall Study|Liver transplant|1|||
126474670|NCT01644565|455038022|FG005|Overall Study|Undisclosed Medical History|0|||
126412041|NCT02292706|454801916|FG001|Overall Study|Liver transplant|1|||
126412042|NCT02292706|454801917|FG002|Overall Study|Liver transplant|11|||
126412043|NCT02292706|454801918|FG003|Overall Study|Liver transplant|16|||
126412044|NCT02292706|454801919|FG004|Overall Study|Liver transplant|5|||
126412045|NCT02292706|454801920|FG005|Overall Study|Liver transplant|6|||
126412046|NCT02292706|454801921|FG006|Overall Study|Liver transplant|5|||
126412047|NCT02292706|454801922|FG007|Overall Study|Liver transplant|0|||
126412048|NCT02292706|454801915|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
126412049|NCT02292706|454801916|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
126412050|NCT02292706|454801917|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
126412051|NCT02292706|454801918|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
126412052|NCT02292706|454801919|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
126412053|NCT02292706|454801920|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
126412054|NCT02292706|454801921|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
126412055|NCT02292706|454801922|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
126412056|NCT02292706|454801915|FG000|Overall Study|Subject terminated by sponsor|1|||
126412057|NCT02292706|454801916|FG001|Overall Study|Subject terminated by sponsor|0|||
126412058|NCT02292706|454801917|FG002|Overall Study|Subject terminated by sponsor|0|||
126412059|NCT02292706|454801918|FG003|Overall Study|Subject terminated by sponsor|2|||
126412060|NCT02292706|454801919|FG004|Overall Study|Subject terminated by sponsor|1|||
126412061|NCT02292706|454801920|FG005|Overall Study|Subject terminated by sponsor|0|||
126412062|NCT02292706|454801921|FG006|Overall Study|Subject terminated by sponsor|0|||
126412063|NCT02292706|454801922|FG007|Overall Study|Subject terminated by sponsor|0|||
126412064|NCT02292706|454801915|FG000|Overall Study|Missing|0|||
126412065|NCT02292706|454801916|FG001|Overall Study|Missing|0|||
126412066|NCT02292706|454801917|FG002|Overall Study|Missing|1|||
126412067|NCT02292706|454801918|FG003|Overall Study|Missing|1|||
126412068|NCT02292706|454801919|FG004|Overall Study|Missing|0|||
126412069|NCT02292706|454801920|FG005|Overall Study|Missing|1|||
126412070|NCT02292706|454801921|FG006|Overall Study|Missing|0|||
126412071|NCT02292706|454801922|FG007|Overall Study|Missing|0|||
126412072|NCT02292706|454801915|FG000|Overall Study|Virologic relapse or reinfection|1|||
126412073|NCT02292706|454801916|FG001|Overall Study|Virologic relapse or reinfection|0|||
126412074|NCT02292706|454801917|FG002|Overall Study|Virologic relapse or reinfection|0|||
126412075|NCT02292706|454801918|FG003|Overall Study|Virologic relapse or reinfection|1|||
126412076|NCT02292706|454801919|FG004|Overall Study|Virologic relapse or reinfection|0|||
126412077|NCT02292706|454801920|FG005|Overall Study|Virologic relapse or reinfection|1|||
126412078|NCT02292706|454801921|FG006|Overall Study|Virologic relapse or reinfection|0|||
126412079|NCT02292706|454801922|FG007|Overall Study|Virologic relapse or reinfection|0|||
126412080|NCT02725866|454801925|FG000|Overall Study|Failure to return|6|||
126412081|NCT02725866|454801925|FG000|Overall Study|Withdrew consent|3|||
126412082|NCT02725866|454801925|FG000|Overall Study|Insufficient virological response|1|||
126412083|NCT02725866|454801925|FG000|Overall Study|Other, not specified|4|||
126474671|NCT01644565|455038023|FG006|Overall Study|Undisclosed Medical History|0|||
126474672|NCT01644565|455038024|FG007|Overall Study|Undisclosed Medical History|0|||
126474673|NCT01644565|455038025|FG008|Overall Study|Undisclosed Medical History|0|||
126474674|NCT01644565|455038017|FG000|Overall Study|Lost to Follow-up|0|||
126474675|NCT01644565|455038018|FG001|Overall Study|Lost to Follow-up|0|||
126474676|NCT01644565|455038019|FG002|Overall Study|Lost to Follow-up|0|||
126558760|NCT04739423|455338832|FG000|Overall Study|Adverse Event|0|||
126558761|NCT04739423|455338833|FG001|Overall Study|Adverse Event|0|||
126474677|NCT01644565|455038020|FG003|Overall Study|Lost to Follow-up|1|||
126474678|NCT01644565|455038021|FG004|Overall Study|Lost to Follow-up|0|||
126474679|NCT01644565|455038022|FG005|Overall Study|Lost to Follow-up|0|||
126474680|NCT01644565|455038023|FG006|Overall Study|Lost to Follow-up|0|||
126721501|NCT00195260|455929971|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126721502|NCT00195260|455929972|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126474681|NCT01644565|455038024|FG007|Overall Study|Lost to Follow-up|2|||
126412084|NCT04667104|454801932|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
126412085|NCT04667104|454801933|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
126412086|NCT04667104|454801934|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
126412087|NCT03043651|454801935|FG000|Overall Study|Death|1|||
126412088|NCT03043651|454801935|FG000|Overall Study|Progressive Disease|2|||
126412089|NCT03043651|454801935|FG000|Overall Study|Adverse Event|2|||
126412090|NCT03043651|454801935|FG000|Overall Study|Withdrawal by Subject|4|||
126412091|NCT03043651|454801935|FG000|Overall Study|Study Terminated by Sponsor|39|||
126412092|NCT01630889|454801936|FG000|Overall Study|Death|2|||
126412093|NCT01630889|454801936|FG000|Overall Study|Withdrawal by Subject|1|||
126412094|NCT01630889|454801936|FG000|Overall Study|Other than Specified|2|||
126412095|NCT01630889|454801936|FG000|Overall Study|Lost to Follow-up|4|||
126412096|NCT01630889|454801936|FG000|Overall Study|Other|1|||
126412097|NCT03208088|454801941|FG000|Period 2|Withdrawal by Subject|0|||
126412098|NCT03208088|454801942|FG001|Period 2|Withdrawal by Subject|0|||
126412099|NCT03208088|454801943|FG002|Period 2|Withdrawal by Subject|0|||
126412100|NCT03208088|454801944|FG003|Period 2|Withdrawal by Subject|0|||
126412101|NCT03208088|454801945|FG004|Period 2|Withdrawal by Subject|0|||
126412102|NCT03208088|454801946|FG005|Period 2|Withdrawal by Subject|0|||
126412103|NCT03208088|454801947|FG006|Period 2|Withdrawal by Subject|0|||
126412104|NCT03208088|454801948|FG007|Period 2|Withdrawal by Subject|0|||
126412105|NCT03208088|454801949|FG008|Period 2|Withdrawal by Subject|1|||
126412106|NCT03208088|454801950|FG009|Period 2|Withdrawal by Subject|0|||
126721503|NCT00195260|455929973|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126721504|NCT00195260|455929974|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126721505|NCT00195260|455929975|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
126412107|NCT03208088|454801941|FG000|Period 3|Unsatisfactory Test Article|0|||
126721506|NCT00195260|455929976|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
126412108|NCT03208088|454801942|FG001|Period 3|Unsatisfactory Test Article|0|||
126412109|NCT03208088|454801943|FG002|Period 3|Unsatisfactory Test Article|0|||
126412110|NCT03208088|454801944|FG003|Period 3|Unsatisfactory Test Article|1|||
126412111|NCT03208088|454801945|FG004|Period 3|Unsatisfactory Test Article|0|||
126412112|NCT03208088|454801946|FG005|Period 3|Unsatisfactory Test Article|0|||
126412113|NCT03208088|454801947|FG006|Period 3|Unsatisfactory Test Article|0|||
126412114|NCT03208088|454801948|FG007|Period 3|Unsatisfactory Test Article|0|||
126412115|NCT03208088|454801949|FG008|Period 3|Unsatisfactory Test Article|0|||
126412116|NCT03208088|454801950|FG009|Period 3|Unsatisfactory Test Article|0|||
126412117|NCT03208088|454801941|FG000|Period 4|Unsatisfactory Test Article|0|||
126412118|NCT03208088|454801942|FG001|Period 4|Unsatisfactory Test Article|0|||
126412119|NCT03208088|454801943|FG002|Period 4|Unsatisfactory Test Article|0|||
126412120|NCT03208088|454801944|FG003|Period 4|Unsatisfactory Test Article|1|||
126412121|NCT03208088|454801945|FG004|Period 4|Unsatisfactory Test Article|0|||
126412122|NCT03208088|454801946|FG005|Period 4|Unsatisfactory Test Article|0|||
126412123|NCT03208088|454801947|FG006|Period 4|Unsatisfactory Test Article|0|||
126412124|NCT03208088|454801948|FG007|Period 4|Unsatisfactory Test Article|0|||
126412125|NCT03208088|454801949|FG008|Period 4|Unsatisfactory Test Article|0|||
126412126|NCT03208088|454801950|FG009|Period 4|Unsatisfactory Test Article|0|||
126412127|NCT00566254|454801951|FG000|Overall Study|Adverse Event|3|||
126412128|NCT00566254|454801952|FG001|Overall Study|Adverse Event|1|||
126412129|NCT00566254|454801951|FG000|Overall Study|Protocol Violation|1|||
126412130|NCT00566254|454801952|FG001|Overall Study|Protocol Violation|3|||
126412131|NCT00566254|454801951|FG000|Overall Study|Withdrawal by Subject|1|||
126412132|NCT00566254|454801952|FG001|Overall Study|Withdrawal by Subject|2|||
126412133|NCT00566254|454801951|FG000|Overall Study|Lack of Efficacy|5|||
126412134|NCT00566254|454801952|FG001|Overall Study|Lack of Efficacy|6|||
126412135|NCT00566254|454801951|FG000|Overall Study|Other|0|||
126474682|NCT01644565|455038025|FG008|Overall Study|Lost to Follow-up|0|||
126474683|NCT01644565|455038017|FG000|Overall Study|Family emergency|0|||
126474684|NCT01644565|455038018|FG001|Overall Study|Family emergency|0|||
126474685|NCT01644565|455038019|FG002|Overall Study|Family emergency|0|||
126474686|NCT01644565|455038020|FG003|Overall Study|Family emergency|0|||
126474687|NCT01644565|455038021|FG004|Overall Study|Family emergency|1|||
126474688|NCT01644565|455038022|FG005|Overall Study|Family emergency|0|||
126474689|NCT01644565|455038023|FG006|Overall Study|Family emergency|0|||
126474690|NCT01644565|455038024|FG007|Overall Study|Family emergency|0|||
126474691|NCT01644565|455038025|FG008|Overall Study|Family emergency|0|||
126474692|NCT01644565|455038017|FG000|Overall Study|Relocation|0|||
126474693|NCT01644565|455038018|FG001|Overall Study|Relocation|0|||
126474694|NCT01644565|455038019|FG002|Overall Study|Relocation|0|||
126474695|NCT01644565|455038020|FG003|Overall Study|Relocation|0|||
126474696|NCT01644565|455038021|FG004|Overall Study|Relocation|0|||
126412136|NCT00566254|454801952|FG001|Overall Study|Other|2|||
126412137|NCT00238238|454801953|FG000|Overall Study|Withdrawal by Subject|0|||
126412138|NCT00238238|454801954|FG001|Overall Study|Withdrawal by Subject|3|||
126412139|NCT00238238|454801955|FG002|Overall Study|Withdrawal by Subject|0|||
126412140|NCT01345669|454801956|FG000|Overall Study|Primary tumour recurrence|53|||
126412141|NCT01345669|454801957|FG001|Overall Study|Primary tumour recurrence|32|||
126412142|NCT01345669|454801956|FG000|Overall Study|Second primary tumour|4|||
126412143|NCT01345669|454801957|FG001|Overall Study|Second primary tumour|3|||
126412144|NCT01345669|454801956|FG000|Overall Study|Adverse Event|63|||
126412145|NCT01345669|454801957|FG001|Overall Study|Adverse Event|9|||
126412146|NCT01345669|454801956|FG000|Overall Study|Protocol Violation|3|||
126412147|NCT01345669|454801957|FG001|Overall Study|Protocol Violation|1|||
126412148|NCT01345669|454801956|FG000|Overall Study|Lost to Follow-up|1|||
126474697|NCT01644565|455038022|FG005|Overall Study|Relocation|0|||
126412149|NCT01345669|454801957|FG001|Overall Study|Lost to Follow-up|1|||
126412150|NCT01345669|454801956|FG000|Overall Study|Withdrawal by Subject|52|||
126412151|NCT01345669|454801957|FG001|Overall Study|Withdrawal by Subject|13|||
126412152|NCT01345669|454801956|FG000|Overall Study|Other Reasons|111|||
126412153|NCT01345669|454801957|FG001|Overall Study|Other Reasons|60|||
126412154|NCT01793883|454801958|FG000|Overall Study|Withdrawal by Subject|3|||
126412155|NCT01793883|454801959|FG001|Overall Study|Withdrawal by Subject|7|||
126412156|NCT01793883|454801960|FG002|Overall Study|Withdrawal by Subject|3|||
126412157|NCT01793883|454801958|FG000|Overall Study|Subject noncompliance|0|||
126412158|NCT01793883|454801959|FG001|Overall Study|Subject noncompliance|1|||
126412159|NCT01793883|454801960|FG002|Overall Study|Subject noncompliance|1|||
126412160|NCT01793883|454801958|FG000|Overall Study|Lost to Follow-up|5|||
126412161|NCT01793883|454801959|FG001|Overall Study|Lost to Follow-up|1|||
126412162|NCT01793883|454801960|FG002|Overall Study|Lost to Follow-up|3|||
126412163|NCT01793883|454801958|FG000|Overall Study|Randomized in error|1|||
126412164|NCT01793883|454801959|FG001|Overall Study|Randomized in error|0|||
126412165|NCT01793883|454801960|FG002|Overall Study|Randomized in error|0|||
126412166|NCT01793883|454801958|FG000|Overall Study|Unable to complete spriometry|1|||
126412167|NCT01793883|454801959|FG001|Overall Study|Unable to complete spriometry|0|||
126412168|NCT01793883|454801960|FG002|Overall Study|Unable to complete spriometry|0|||
126412169|NCT01793883|454801958|FG000|Overall Study|Unable to complete measurements|1|||
126412170|NCT01793883|454801959|FG001|Overall Study|Unable to complete measurements|0|||
126412171|NCT01793883|454801960|FG002|Overall Study|Unable to complete measurements|0|||
126412172|NCT01793883|454801958|FG000|Overall Study|Met exclusion criteria|1|||
126412173|NCT01793883|454801959|FG001|Overall Study|Met exclusion criteria|0|||
126412174|NCT01793883|454801960|FG002|Overall Study|Met exclusion criteria|0|||
126412175|NCT01793883|454801958|FG000|Overall Study|Dosing error|0|||
126412176|NCT01793883|454801959|FG001|Overall Study|Dosing error|1|||
126412177|NCT01793883|454801960|FG002|Overall Study|Dosing error|0|||
126412178|NCT01793883|454801958|FG000|Overall Study|Respiratory distress during spirometry|0|||
126412179|NCT01793883|454801959|FG001|Overall Study|Respiratory distress during spirometry|0|||
126412180|NCT01793883|454801960|FG002|Overall Study|Respiratory distress during spirometry|1|||
126412181|NCT02478255|454801961|FG000|Overall Study|Physician Decision|6|||
126412182|NCT02478255|454801962|FG001|Overall Study|Physician Decision|0|||
126412183|NCT02478255|454801961|FG000|Overall Study|Withdrawal by Subject|2|||
126412184|NCT02478255|454801962|FG001|Overall Study|Withdrawal by Subject|0|||
126412185|NCT00761527|454801964|FG000|Overall Study|Adverse Event|3|||
126412186|NCT00761527|454801964|FG000|Overall Study|Poor Compliance|8|||
126412187|NCT00761527|454801964|FG000|Overall Study|Lost to Follow-up|9|||
126412188|NCT00761527|454801964|FG000|Overall Study|Unknown reason|2|||
126474698|NCT01644565|455038023|FG006|Overall Study|Relocation|0|||
126474699|NCT01644565|455038024|FG007|Overall Study|Relocation|0|||
126474700|NCT01644565|455038025|FG008|Overall Study|Relocation|1|||
126474701|NCT01550289|455038026|FG000|Overall Study|Protocol Violation|1|||
126474702|NCT01550289|455038027|FG001|Overall Study|Protocol Violation|0|||
126474703|NCT01550289|455038026|FG000|Overall Study|Lost to Follow-up|1|||
126474704|NCT01550289|455038027|FG001|Overall Study|Lost to Follow-up|1|||
126474705|NCT01550289|455038026|FG000|Overall Study|Withdrawal by Subject|11|||
126474706|NCT01550289|455038027|FG001|Overall Study|Withdrawal by Subject|3|||
126474707|NCT00094172|455038033|FG000|Overall Study|Adverse Event|0|||
126474708|NCT00094172|455038034|FG001|Overall Study|Adverse Event|1|||
126474709|NCT00094172|455038033|FG000|Overall Study|Lost to Follow-up|2|||
126474710|NCT00094172|455038034|FG001|Overall Study|Lost to Follow-up|0|||
126474711|NCT00094172|455038033|FG000|Overall Study|Protocol Violation|0|||
126474712|NCT00094172|455038034|FG001|Overall Study|Protocol Violation|1|||
126412189|NCT01730586|454801965|FG000|Overall Study|Progressive Disease|2|||
126412190|NCT01730586|454801965|FG000|Overall Study|Inadequate Trial|8|||
126412191|NCT01730586|454801965|FG000|Overall Study|Adverse Event|2|||
126412192|NCT01730586|454801965|FG000|Overall Study|Hospice|1|||
126412193|NCT00061633|454801966|FG000|Overall Study|Adverse Event|1|||
126412194|NCT00061633|454801967|FG001|Overall Study|Adverse Event|2|||
126412195|NCT00061633|454801966|FG000|Overall Study|Withdrawal by Subject|2|||
126412196|NCT00061633|454801967|FG001|Overall Study|Withdrawal by Subject|2|||
126412197|NCT00061633|454801966|FG000|Overall Study|Lost to Follow-up|1|||
126412198|NCT00061633|454801967|FG001|Overall Study|Lost to Follow-up|4|||
126412199|NCT00061633|454801966|FG000|Overall Study|Other|1|||
126412200|NCT00061633|454801967|FG001|Overall Study|Other|1|||
126412201|NCT00061633|454801966|FG000|Overall Study|Never received study treatment|0|||
126412202|NCT00061633|454801967|FG001|Overall Study|Never received study treatment|2|||
126412203|NCT01431963|454801968|FG000|Overall Study|Adverse Event|18|||
126412204|NCT01431963|454801968|FG000|Overall Study|Lack of Efficacy|7|||
126412205|NCT01431963|454801968|FG000|Overall Study|Protocol Violation|1|||
126412206|NCT01431963|454801968|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
126412207|NCT01431963|454801968|FG000|Overall Study|Physician Decision|4|||
126474713|NCT00094172|455038033|FG000|Overall Study|Withdrawal by Subject|10|||
126474714|NCT00094172|455038034|FG001|Overall Study|Withdrawal by Subject|5|||
126474715|NCT00094172|455038033|FG000|Overall Study|Primary endpoint met.|1|||
126474716|NCT00094172|455038034|FG001|Overall Study|Primary endpoint met.|0|||
126721507|NCT00195260|455929977|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
126721508|NCT00195260|455929978|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
126721509|NCT00195260|455929968|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126721510|NCT00195260|455929969|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126412208|NCT01431963|454801968|FG000|Overall Study|Withdrawal by Subject|3|||
126412209|NCT02921087|454801971|FG000|Overall Study|Withdrawal by Subject|0|||
126412210|NCT02921087|454801972|FG001|Overall Study|Withdrawal by Subject|1|||
126412211|NCT00687531|454801973|FG000|Overall Study|Did not meet protocol eligibility|104|||
126412212|NCT00687531|454801973|FG000|Overall Study|Adverse Event|5|||
126412213|NCT00687531|454801973|FG000|Overall Study|Lost to Follow-up|26|||
126412214|NCT03848949|454801974|FG000|Overall Study|Lost to Follow-up|5|||
126412215|NCT03848949|454801975|FG001|Overall Study|Lost to Follow-up|7|||
126412216|NCT02353728|454801976|FG000|Overall Study|Subject non-compliance|1|||
126412217|NCT00619307|454801979|FG000|Overall Study|Adverse Event|0|||
126412218|NCT00619307|454801980|FG001|Overall Study|Adverse Event|1|||
126412219|NCT00619307|454801979|FG000|Overall Study|Lost to Follow-up|0|||
126412220|NCT00619307|454801980|FG001|Overall Study|Lost to Follow-up|1|||
126412221|NCT00619307|454801979|FG000|Overall Study|Protocol Violation|3|||
126412222|NCT00619307|454801980|FG001|Overall Study|Protocol Violation|0|||
126412223|NCT00619307|454801979|FG000|Overall Study|Withdrew consent|1|||
126412224|NCT00619307|454801980|FG001|Overall Study|Withdrew consent|0|||
126412225|NCT00619307|454801979|FG000|Overall Study|Severe migraine|0|||
126412226|NCT00619307|454801980|FG001|Overall Study|Severe migraine|1|||
126412227|NCT00619307|454801979|FG000|Overall Study|MS attack plus steroids|0|||
126412228|NCT00619307|454801980|FG001|Overall Study|MS attack plus steroids|1|||
126412229|NCT00547521|454801981|FG000|Short Term Study (4 Months)|Adverse Event|1|||
126412230|NCT00547521|454801982|FG001|Short Term Study (4 Months)|Adverse Event|0|||
126412231|NCT00547521|454801981|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
126412232|NCT00547521|454801982|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
126412233|NCT00547521|454801981|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
126412234|NCT00547521|454801982|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
126412235|NCT00547521|454801981|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
126412236|NCT00547521|454801982|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
126412237|NCT00547521|454801981|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
126412238|NCT00547521|454801982|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
126412239|NCT00547521|454801981|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
126412240|NCT00547521|454801982|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
126412241|NCT00547521|454801981|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
126412242|NCT00547521|454801982|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
126412243|NCT00547521|454801981|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
126412244|NCT00547521|454801982|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
126412245|NCT00547521|454801981|FG000|Long Term Extension (LTE) Study|Other|0|||
126412246|NCT00547521|454801982|FG001|Long Term Extension (LTE) Study|Other|2|||
126412247|NCT00547521|454801981|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
126412248|NCT00547521|454801982|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
126412249|NCT03109184|454803739|FG000|Overall Study|Lost to Follow-up|6|||
126412250|NCT03109184|454803740|FG001|Overall Study|Lost to Follow-up|6|||
126412251|NCT03109184|454803739|FG000|Overall Study|Withdrawal by Subject|1|||
126412252|NCT03109184|454803740|FG001|Overall Study|Withdrawal by Subject|1|||
126412253|NCT00602420|454803741|FG000|Overall Study|Death|1|||
126412254|NCT00602420|454803742|FG001|Overall Study|Death|4|||
126474717|NCT00094172|455038033|FG000|Overall Study|Started other MS therapy due to disease|1|||
126474718|NCT00094172|455038034|FG001|Overall Study|Started other MS therapy due to disease|0|||
126474719|NCT00533897|455038039|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
126474720|NCT00533897|455038040|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
126474721|NCT00533897|455038041|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
126721511|NCT00195260|455929970|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126412255|NCT00602420|454803741|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
126412256|NCT00602420|454803742|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
126412257|NCT00602420|454803741|FG000|Overall Study|Withdrawal by Subject|18|||
126412258|NCT00602420|454803742|FG001|Overall Study|Withdrawal by Subject|17|||
126412259|NCT00602420|454803741|FG000|Overall Study|Adverse Event|1|||
126412260|NCT00602420|454803742|FG001|Overall Study|Adverse Event|0|||
126412261|NCT00703924|454803745|FG000|Overall Study|Withdrawal by Subject|1|||
126412262|NCT00703924|454803746|FG001|Overall Study|Withdrawal by Subject|1|||
126412263|NCT02008227|454803747|FG000|Overall Study|Lost to Follow-up|7|||
126412264|NCT02008227|454803748|FG001|Overall Study|Lost to Follow-up|9|||
126412265|NCT02008227|454803747|FG000|Overall Study|Death|494|||
126412266|NCT02008227|454803748|FG001|Overall Study|Death|485|||
126412267|NCT02008227|454803747|FG000|Overall Study|Withdrawal by Subject|67|||
126412268|NCT02008227|454803748|FG001|Overall Study|Withdrawal by Subject|36|||
126412269|NCT02008227|454803747|FG000|Overall Study|Study Terminated By Sponsor|44|||
126412270|NCT02008227|454803748|FG001|Overall Study|Study Terminated By Sponsor|83|||
126412271|NCT03499314|454803749|FG000|Overall Study|Time Commitment|1|||
126412272|NCT03499314|454803750|FG001|Overall Study|Time Commitment|2|||
126412273|NCT03499314|454803749|FG000|Overall Study|Medical issue unrelated to research study|1|||
126412274|NCT03499314|454803750|FG001|Overall Study|Medical issue unrelated to research study|1|||
126412275|NCT01271725|454803751|FG000|Part A|Progressive disease according to RECIST|8|||
126412276|NCT01271725|454803752|FG001|Part A|Progressive disease according to RECIST|0|||
126412277|NCT01271725|454803751|FG000|Part A|Clinical signs/symptoms of progression|2|||
126412278|NCT01271725|454803752|FG001|Part A|Clinical signs/symptoms of progression|0|||
126412279|NCT01271725|454803751|FG000|Part A|Other Adverse Event|8|||
126412280|NCT01271725|454803752|FG001|Part A|Other Adverse Event|0|||
126412281|NCT01271725|454803751|FG000|Part A|Lost to Follow-up|1|||
126412282|NCT01271725|454803752|FG001|Part A|Lost to Follow-up|0|||
126412283|NCT01271725|454803751|FG000|Part A|Withdrawal by Subject|12|||
126412284|NCT01271725|454803752|FG001|Part A|Withdrawal by Subject|0|||
126412285|NCT01271725|454803751|FG000|Part A|Other than specified|3|||
126412286|NCT01271725|454803752|FG001|Part A|Other than specified|0|||
126412287|NCT01271725|454803751|FG000|Part A|Protocol Violation|1|||
126412288|NCT01271725|454803752|FG001|Part A|Protocol Violation|0|||
126412289|NCT01271725|454803751|FG000|Part B|Other than specified|0|||
126412290|NCT01271725|454803752|FG001|Part B|Other than specified|2|||
126412291|NCT01271725|454803751|FG000|Part B|Clinical signs/symptoms of progression|0|||
126412292|NCT01271725|454803752|FG001|Part B|Clinical signs/symptoms of progression|2|||
126412293|NCT01271725|454803751|FG000|Part B|Other Adverse Event|0|||
126412294|NCT01271725|454803752|FG001|Part B|Other Adverse Event|1|||
126412295|NCT01271725|454803751|FG000|Part B|Protocol Violation|0|||
126412296|NCT01271725|454803752|FG001|Part B|Protocol Violation|1|||
126412297|NCT01271725|454803751|FG000|Part B|Withdrawal by Subject|0|||
126412298|NCT01271725|454803752|FG001|Part B|Withdrawal by Subject|6|||
126412299|NCT01702025|454803753|FG000|Overall Study|Equipment failure|1|||
126412300|NCT01702025|454803754|FG001|Overall Study|Equipment failure|0|||
126412301|NCT01702025|454803755|FG002|Overall Study|Equipment failure|0|||
126412302|NCT01702025|454803756|FG003|Overall Study|Equipment failure|0|||
126412303|NCT01702025|454803753|FG000|Overall Study|Adverse Event|1|||
126412304|NCT01702025|454803754|FG001|Overall Study|Adverse Event|1|||
126412305|NCT01702025|454803755|FG002|Overall Study|Adverse Event|1|||
126412306|NCT01702025|454803756|FG003|Overall Study|Adverse Event|0|||
126412307|NCT03354273|454803757|FG000|Overall Study|Adverse Event|5|||
126412308|NCT03354273|454803757|FG000|Overall Study|Screen Failure|21|||
126412309|NCT03354273|454803757|FG000|Overall Study|Withdrawal by Subject|34|||
126412310|NCT03354273|454803757|FG000|Overall Study|Technical Problems|30|||
126412311|NCT03354273|454803757|FG000|Overall Study|Lost to Follow-up|4|||
126412312|NCT03354273|454803757|FG000|Overall Study|Investigator Decision|3|||
126412313|NCT03354273|454803757|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
126412314|NCT03354273|454803757|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
126412315|NCT03354273|454803757|FG000|Overall Study|COVID-19 Restrictions|9|||
126412316|NCT03354273|454803757|FG000|Overall Study|Other|5|||
126412317|NCT03149055|454803764|FG000|Overall Study|Not treated|4|||
126412318|NCT04440813|454803765|FG000|Overall Study|Lost to Follow-up|5|||
126412319|NCT04440813|454803766|FG001|Overall Study|Lost to Follow-up|5|||
126412320|NCT02629822|454803767|FG000|Base Study|Lost to Follow-up|2|||
126412321|NCT02629822|454803767|FG000|Base Study|Non-Compliance With Study Drug|1|||
126412322|NCT02629822|454803767|FG000|Extension Study|Adverse Event|1|||
126412323|NCT02629822|454803767|FG000|Extension Study|Lost to Follow-up|1|||
126412324|NCT00741013|454803768|FG000|Overall Study|Adverse Event|1|||
126412325|NCT00741013|454803769|FG001|Overall Study|Adverse Event|0|||
126412326|NCT00741013|454803770|FG002|Overall Study|Adverse Event|0|||
126412327|NCT00741013|454803768|FG000|Overall Study|Withdrawal by Subject|0|||
126412328|NCT00741013|454803769|FG001|Overall Study|Withdrawal by Subject|0|||
126474722|NCT00533897|455038042|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
126474723|NCT00533897|455038043|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
126474724|NCT00533897|455038044|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
126474725|NCT00533897|455038045|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
126474726|NCT00533897|455038046|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
126412329|NCT00741013|454803770|FG002|Overall Study|Withdrawal by Subject|1|||
126412330|NCT00741013|454803768|FG000|Overall Study|Discovered failed screen after enrolled|0|||
126474727|NCT00533897|455038039|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
126412331|NCT00741013|454803769|FG001|Overall Study|Discovered failed screen after enrolled|2|||
126412332|NCT00741013|454803770|FG002|Overall Study|Discovered failed screen after enrolled|0|||
126412333|NCT00193180|454803774|FG000|Overall Study|Lack of Efficacy|1|||
126474728|NCT00533897|455038040|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
126474729|NCT00533897|455038041|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
126412334|NCT00193180|454803774|FG000|Overall Study|Adverse Event|8|||
126412335|NCT00193180|454803774|FG000|Overall Study|Protocol Violation|1|||
126412336|NCT00539305|454803775|FG000|Overall Study|Adverse Event|1|||
126412337|NCT00539305|454803776|FG001|Overall Study|Adverse Event|0|||
126412338|NCT00539305|454803775|FG000|Overall Study|Substance Use|0|||
126412339|NCT00539305|454803776|FG001|Overall Study|Substance Use|1|||
126412340|NCT00539305|454803775|FG000|Overall Study|Withdrawal by Subject|0|||
126721512|NCT00195260|455929971|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126721513|NCT00195260|455929972|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126721514|NCT00195260|455929973|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126721515|NCT00195260|455929974|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126721516|NCT00195260|455929975|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
126721517|NCT00195260|455929976|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
126412341|NCT00539305|454803776|FG001|Overall Study|Withdrawal by Subject|1|||
126412342|NCT00239928|454803782|FG000|Overall Study|Lack of Efficacy|1|||
126412343|NCT00239928|454803782|FG000|Overall Study|Adverse Event|4|||
126412344|NCT00239928|454803782|FG000|Overall Study|Not need to continue study|3|||
126412345|NCT00239928|454803782|FG000|Overall Study|Withdrawal by Subject|2|||
126412346|NCT00774800|454803785|FG000|Intervention 4|Withdrawal by Subject|1|||
126412347|NCT01331109|454803790|FG000|Overall Study|Adverse Event|6|||
126412348|NCT01331109|454803790|FG000|Overall Study|Lack of Efficacy|2|||
126412349|NCT01331109|454803790|FG000|Overall Study|Protocol Violation|3|||
126412350|NCT01331109|454803790|FG000|Overall Study|Withdrawal by Subject|7|||
126412351|NCT01331109|454803790|FG000|Overall Study|Lost to Follow-up|1|||
126412352|NCT01331109|454803790|FG000|Overall Study|Study Terminated by Sponsor|38|||
126412353|NCT00479856|454803791|FG000|Overall Study|Adverse Event|1|||
126412354|NCT00479856|454803791|FG000|Overall Study|Withdrawal by Subject|1|||
126412355|NCT00479856|454803791|FG000|Overall Study|Physician Decision|1|||
126412356|NCT00661622|454803794|FG000|Overall Study|Protocol Violation|1|||
126412357|NCT00661622|454803795|FG001|Overall Study|Protocol Violation|0|||
126412358|NCT00098306|454803801|FG000|Double Blind|Randomized, not treated|9|||
126412359|NCT00098306|454803802|FG001|Double Blind|Randomized, not treated|5|||
126412360|NCT00098306|454803803|FG002|Double Blind|Randomized, not treated|2|||
126412361|NCT00098306|454803804|FG003|Double Blind|Randomized, not treated|0|||
126412362|NCT00098306|454803805|FG004|Double Blind|Randomized, not treated|0|||
126412363|NCT00098306|454803806|FG005|Double Blind|Randomized, not treated|0|||
126412364|NCT00098306|454803807|FG006|Double Blind|Randomized, not treated|0|||
126412365|NCT00098306|454803801|FG000|Double Blind|Ongoing at cut-off date|151|||
126412366|NCT00098306|454803802|FG001|Double Blind|Ongoing at cut-off date|166|||
126412367|NCT00098306|454803803|FG002|Double Blind|Ongoing at cut-off date|72|||
126412368|NCT00098306|454803804|FG003|Double Blind|Ongoing at cut-off date|0|||
126412369|NCT00098306|454803805|FG004|Double Blind|Ongoing at cut-off date|0|||
126412370|NCT00098306|454803806|FG005|Double Blind|Ongoing at cut-off date|0|||
126412371|NCT00098306|454803807|FG006|Double Blind|Ongoing at cut-off date|0|||
126412372|NCT00098306|454803801|FG000|Double Blind|Adverse Event|11|||
126412373|NCT00098306|454803802|FG001|Double Blind|Adverse Event|10|||
126412374|NCT00098306|454803803|FG002|Double Blind|Adverse Event|6|||
126412375|NCT00098306|454803804|FG003|Double Blind|Adverse Event|0|||
126412376|NCT00098306|454803805|FG004|Double Blind|Adverse Event|0|||
126412377|NCT00098306|454803806|FG005|Double Blind|Adverse Event|0|||
126412378|NCT00098306|454803807|FG006|Double Blind|Adverse Event|0|||
126412379|NCT00098306|454803801|FG000|Double Blind|Lack of Efficacy|43|||
126412380|NCT00098306|454803802|FG001|Double Blind|Lack of Efficacy|34|||
126412381|NCT00098306|454803803|FG002|Double Blind|Lack of Efficacy|17|||
126412382|NCT00098306|454803804|FG003|Double Blind|Lack of Efficacy|0|||
126412383|NCT00098306|454803805|FG004|Double Blind|Lack of Efficacy|0|||
126412384|NCT00098306|454803806|FG005|Double Blind|Lack of Efficacy|0|||
126412385|NCT00098306|454803807|FG006|Double Blind|Lack of Efficacy|0|||
126412386|NCT00098306|454803801|FG000|Double Blind|Death|1|||
126412387|NCT00098306|454803802|FG001|Double Blind|Death|4|||
126412388|NCT00098306|454803803|FG002|Double Blind|Death|1|||
126412389|NCT00098306|454803804|FG003|Double Blind|Death|0|||
126412390|NCT00098306|454803805|FG004|Double Blind|Death|0|||
126412391|NCT00098306|454803806|FG005|Double Blind|Death|0|||
126412392|NCT00098306|454803807|FG006|Double Blind|Death|0|||
126412393|NCT00098306|454803801|FG000|Double Blind|Participant defaulted|19|||
126412394|NCT00098306|454803802|FG001|Double Blind|Participant defaulted|18|||
126412395|NCT00098306|454803803|FG002|Double Blind|Participant defaulted|11|||
126412396|NCT00098306|454803804|FG003|Double Blind|Participant defaulted|0|||
126412397|NCT00098306|454803805|FG004|Double Blind|Participant defaulted|0|||
126412398|NCT00098306|454803806|FG005|Double Blind|Participant defaulted|0|||
126412399|NCT00098306|454803807|FG006|Double Blind|Participant defaulted|0|||
126412400|NCT00098306|454803801|FG000|Double Blind|Un-specified|7|||
126412401|NCT00098306|454803802|FG001|Double Blind|Un-specified|3|||
126412402|NCT00098306|454803803|FG002|Double Blind|Un-specified|11|||
126412403|NCT00098306|454803804|FG003|Double Blind|Un-specified|0|||
126412404|NCT00098306|454803805|FG004|Double Blind|Un-specified|0|||
126721518|NCT00195260|455929977|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
126721519|NCT00195260|455929978|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
126412405|NCT00098306|454803806|FG005|Double Blind|Un-specified|0|||
126412406|NCT00098306|454803807|FG006|Double Blind|Un-specified|0|||
126412407|NCT00098306|454803801|FG000|Open Label|Lack of Efficacy|0|||
126412408|NCT00098306|454803802|FG001|Open Label|Lack of Efficacy|0|||
126412409|NCT00098306|454803803|FG002|Open Label|Lack of Efficacy|0|||
126412410|NCT00098306|454803804|FG003|Open Label|Lack of Efficacy|13|||
126412411|NCT00098306|454803805|FG004|Open Label|Lack of Efficacy|0|||
126474730|NCT00533897|455038042|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
126474731|NCT00533897|455038043|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
126474732|NCT00533897|455038044|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
126474733|NCT00533897|455038045|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
126474734|NCT00533897|455038046|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
126474735|NCT00533897|455038039|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
126474736|NCT00533897|455038040|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
126474737|NCT00533897|455038041|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
126474738|NCT00533897|455038042|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
126474739|NCT00533897|455038043|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
126474740|NCT00533897|455038044|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
126474741|NCT00533897|455038045|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
126474742|NCT00533897|455038046|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
126474743|NCT00533897|455038039|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
126474744|NCT00533897|455038040|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
126474745|NCT00533897|455038041|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
126474746|NCT00533897|455038042|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
126474747|NCT00533897|455038043|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
126474748|NCT00533897|455038044|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
126474749|NCT00533897|455038045|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
126474750|NCT00533897|455038046|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
126474751|NCT00533897|455038039|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
126474752|NCT00533897|455038040|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
126474753|NCT00533897|455038041|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
126412412|NCT00098306|454803806|FG005|Open Label|Lack of Efficacy|0|||
126412413|NCT00098306|454803807|FG006|Open Label|Lack of Efficacy|0|||
126412414|NCT00098306|454803801|FG000|Open Label|Adverse Event|0|||
126412415|NCT00098306|454803802|FG001|Open Label|Adverse Event|0|||
126412416|NCT00098306|454803803|FG002|Open Label|Adverse Event|0|||
126412417|NCT00098306|454803804|FG003|Open Label|Adverse Event|2|||
126412418|NCT00098306|454803805|FG004|Open Label|Adverse Event|0|||
126412419|NCT00098306|454803806|FG005|Open Label|Adverse Event|0|||
126412420|NCT00098306|454803807|FG006|Open Label|Adverse Event|0|||
126412421|NCT00098306|454803801|FG000|Open Label|Death|0|||
126412422|NCT00098306|454803802|FG001|Open Label|Death|0|||
126412423|NCT00098306|454803803|FG002|Open Label|Death|0|||
126412424|NCT00098306|454803804|FG003|Open Label|Death|4|||
126412425|NCT00098306|454803805|FG004|Open Label|Death|0|||
126412426|NCT00098306|454803806|FG005|Open Label|Death|0|||
126412427|NCT00098306|454803807|FG006|Open Label|Death|0|||
126412428|NCT00098306|454803801|FG000|Open Label|Participant defaulted|0|||
126412429|NCT00098306|454803802|FG001|Open Label|Participant defaulted|0|||
126412430|NCT00098306|454803803|FG002|Open Label|Participant defaulted|0|||
126412431|NCT00098306|454803804|FG003|Open Label|Participant defaulted|24|||
126412432|NCT00098306|454803805|FG004|Open Label|Participant defaulted|0|||
126412433|NCT00098306|454803806|FG005|Open Label|Participant defaulted|0|||
126412434|NCT00098306|454803807|FG006|Open Label|Participant defaulted|0|||
126412435|NCT00098306|454803801|FG000|Open Label|Un-specified|0|||
126412436|NCT00098306|454803802|FG001|Open Label|Un-specified|0|||
126412437|NCT00098306|454803803|FG002|Open Label|Un-specified|0|||
126412438|NCT00098306|454803804|FG003|Open Label|Un-specified|15|||
126412439|NCT00098306|454803805|FG004|Open Label|Un-specified|0|||
126412440|NCT00098306|454803806|FG005|Open Label|Un-specified|0|||
126412441|NCT00098306|454803807|FG006|Open Label|Un-specified|0|||
126412442|NCT00098306|454803801|FG000|Open Label|Ongoing at cut-off date|0|||
126412443|NCT00098306|454803802|FG001|Open Label|Ongoing at cut-off date|0|||
126412444|NCT00098306|454803803|FG002|Open Label|Ongoing at cut-off date|0|||
126412445|NCT00098306|454803804|FG003|Open Label|Ongoing at cut-off date|269|||
126412446|NCT00098306|454803805|FG004|Open Label|Ongoing at cut-off date|62|||
126474754|NCT00533897|455038042|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
126474755|NCT00533897|455038043|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
126474756|NCT00533897|455038044|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
126412447|NCT00098306|454803806|FG005|Open Label|Ongoing at cut-off date|0|||
126412448|NCT00098306|454803807|FG006|Open Label|Ongoing at cut-off date|0|||
126412449|NCT00098306|454803801|FG000|Observational Phase|Death|0|||
126412450|NCT00098306|454803802|FG001|Observational Phase|Death|0|||
126412451|NCT00098306|454803803|FG002|Observational Phase|Death|0|||
126412452|NCT00098306|454803804|FG003|Observational Phase|Death|0|||
126412453|NCT00098306|454803805|FG004|Observational Phase|Death|0|||
126412454|NCT00098306|454803806|FG005|Observational Phase|Death|5|||
126474757|NCT00533897|455038045|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
126474758|NCT00533897|455038046|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
126474759|NCT00533897|455038039|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
126412455|NCT00098306|454803807|FG006|Observational Phase|Death|4|||
126412456|NCT00098306|454803801|FG000|Observational Phase|Participant defaulted|0|||
126412457|NCT00098306|454803802|FG001|Observational Phase|Participant defaulted|0|||
126412458|NCT00098306|454803803|FG002|Observational Phase|Participant defaulted|0|||
126412459|NCT00098306|454803804|FG003|Observational Phase|Participant defaulted|0|||
126558762|NCT04739423|455338834|FG002|Overall Study|Adverse Event|1|||
126558763|NCT04739423|455338835|FG003|Overall Study|Adverse Event|0|||
126558764|NCT04739423|455338836|FG004|Overall Study|Adverse Event|1|||
126558765|NCT04739423|455338837|FG005|Overall Study|Adverse Event|0|||
126412460|NCT00098306|454803805|FG004|Observational Phase|Participant defaulted|0|||
126412461|NCT00098306|454803806|FG005|Observational Phase|Participant defaulted|34|||
126412462|NCT00098306|454803807|FG006|Observational Phase|Participant defaulted|18|||
126412463|NCT00098306|454803801|FG000|Observational Phase|Un-specified|0|||
126412464|NCT00098306|454803802|FG001|Observational Phase|Un-specified|0|||
126412465|NCT00098306|454803803|FG002|Observational Phase|Un-specified|0|||
126412466|NCT00098306|454803804|FG003|Observational Phase|Un-specified|0|||
126412467|NCT00098306|454803805|FG004|Observational Phase|Un-specified|0|||
126412468|NCT00098306|454803806|FG005|Observational Phase|Un-specified|7|||
126412469|NCT00098306|454803807|FG006|Observational Phase|Un-specified|4|||
126412470|NCT02760810|454803808|FG000|Overall Study|Protocol Violation|1|||
126412471|NCT00932165|454803809|FG000|Overall Study|Lost to Follow-up|1|||
126412472|NCT00588094|454803810|FG000|Overall Study|Adverse Event|3|||
126412473|NCT00588094|454803810|FG000|Overall Study|Progression of Disease|2|||
126412474|NCT01336023|454803811|FG000|Week 0 to Week 26|Adverse Event|8|||
126412475|NCT01336023|454803812|FG001|Week 0 to Week 26|Adverse Event|10|||
126412476|NCT01336023|454803813|FG002|Week 0 to Week 26|Adverse Event|24|||
126412477|NCT01336023|454803811|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
126412478|NCT01336023|454803812|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
126412479|NCT01336023|454803813|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
126412480|NCT01336023|454803811|FG000|Week 0 to Week 26|Protocol Violation|1|||
126412481|NCT01336023|454803812|FG001|Week 0 to Week 26|Protocol Violation|2|||
126412482|NCT01336023|454803813|FG002|Week 0 to Week 26|Protocol Violation|0|||
126412483|NCT01336023|454803811|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
126412484|NCT01336023|454803812|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
126412485|NCT01336023|454803813|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
126412486|NCT01336023|454803811|FG000|Week 0 to Week 26|Unclassified|5|||
126412487|NCT01336023|454803812|FG001|Week 0 to Week 26|Unclassified|16|||
126412488|NCT01336023|454803813|FG002|Week 0 to Week 26|Unclassified|9|||
126412489|NCT01336023|454803811|FG000|Week 27 to 52|Adverse Event|1|||
126412490|NCT01336023|454803812|FG001|Week 27 to 52|Adverse Event|5|||
126412491|NCT01336023|454803813|FG002|Week 27 to 52|Adverse Event|2|||
126412492|NCT01336023|454803811|FG000|Week 27 to 52|Protocol Violation|0|||
126412493|NCT01336023|454803812|FG001|Week 27 to 52|Protocol Violation|2|||
126412494|NCT01336023|454803813|FG002|Week 27 to 52|Protocol Violation|1|||
126412495|NCT01336023|454803811|FG000|Week 27 to 52|Withdrawal Criteria|14|||
126412496|NCT01336023|454803812|FG001|Week 27 to 52|Withdrawal Criteria|19|||
126412497|NCT01336023|454803813|FG002|Week 27 to 52|Withdrawal Criteria|16|||
126412498|NCT01336023|454803811|FG000|Week 27 to 52|Unclassified|13|||
126412499|NCT01336023|454803812|FG001|Week 27 to 52|Unclassified|18|||
126412500|NCT01336023|454803813|FG002|Week 27 to 52|Unclassified|9|||
126412501|NCT00391625|454803819|FG000|Month 14|Withdrawal by Subject|1|||
126412502|NCT00391625|454803819|FG000|Month 50|Physician Decision|1|||
126412503|NCT01361178|454803820|FG000|Overall Study|Death|13|||
126412504|NCT01361178|454803821|FG001|Overall Study|Death|0|||
126412505|NCT03997825|454803822|FG000|Overall Study|Death|3|||
126412506|NCT03997825|454803822|FG000|Overall Study|Lost to Follow-up|10|||
126412507|NCT03997825|454803822|FG000|Overall Study|Withdrawal by Subject|3|||
126412508|NCT03997825|454803822|FG000|Overall Study|Refused participation|1|||
126412509|NCT00383162|454803823|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
126412510|NCT00383162|454803824|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
126412511|NCT00383162|454803823|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
126412512|NCT00383162|454803824|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
126412513|NCT00383162|454803823|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
126412514|NCT00383162|454803824|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
126412515|NCT00383162|454803823|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
126412516|NCT00383162|454803824|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
126412517|NCT00383162|454803823|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
126412518|NCT00383162|454803824|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
126412519|NCT00383162|454803823|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
126412520|NCT00383162|454803824|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
126412521|NCT00383162|454803823|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
126412522|NCT00383162|454803824|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
126412523|NCT00383162|454803823|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
126412524|NCT00383162|454803824|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
126412525|NCT00383162|454803823|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
126558766|NCT04739423|455338832|FG000|Overall Study|Withdrawal by Subject|0|||
126558767|NCT04739423|455338833|FG001|Overall Study|Withdrawal by Subject|0|||
126412526|NCT00383162|454803824|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
126412527|NCT00767819|454803825|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
126558768|NCT04739423|455338834|FG002|Overall Study|Withdrawal by Subject|0|||
126412528|NCT00767819|454803826|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
126412529|NCT00767819|454803827|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126412530|NCT00767819|454803825|FG000|Overall Study|Withdrawal by Subject|1|||
126412531|NCT00767819|454803826|FG001|Overall Study|Withdrawal by Subject|1|||
126412532|NCT00767819|454803827|FG002|Overall Study|Withdrawal by Subject|0|||
126412533|NCT00767819|454803825|FG000|Overall Study|Administrative problems|0|||
126412534|NCT00767819|454803826|FG001|Overall Study|Administrative problems|1|||
126412535|NCT00767819|454803827|FG002|Overall Study|Administrative problems|0|||
126412536|NCT00767819|454803825|FG000|Overall Study|Death|2|||
126412537|NCT00767819|454803826|FG001|Overall Study|Death|3|||
126412538|NCT00767819|454803827|FG002|Overall Study|Death|0|||
126412539|NCT00767819|454803825|FG000|Overall Study|Adverse Event|2|||
126412540|NCT00767819|454803826|FG001|Overall Study|Adverse Event|0|||
126412541|NCT00767819|454803827|FG002|Overall Study|Adverse Event|0|||
126412542|NCT00767819|454803825|FG000|Overall Study|Abnormal lab values|1|||
126412543|NCT00767819|454803826|FG001|Overall Study|Abnormal lab values|0|||
126412544|NCT00767819|454803827|FG002|Overall Study|Abnormal lab values|0|||
126412545|NCT00767819|454803825|FG000|Overall Study|Lost to Follow-up|1|||
126412546|NCT00767819|454803826|FG001|Overall Study|Lost to Follow-up|0|||
126412547|NCT00767819|454803827|FG002|Overall Study|Lost to Follow-up|0|||
126412548|NCT05392803|454803828|FG000|Overall Study|Lost to Follow-up|0|||
126412549|NCT05392803|454803829|FG001|Overall Study|Lost to Follow-up|2|||
126412550|NCT04294147|454803830|FG000|Overall Study|Protocol Violation|2|||
126412551|NCT04294147|454803831|FG001|Overall Study|Protocol Violation|0|||
126412552|NCT00915551|454803832|FG000|Overall Study|Withdrawal by Subject|0|||
126412553|NCT00915551|454803833|FG001|Overall Study|Withdrawal by Subject|1|||
126412554|NCT00235716|454803834|FG000|Overall Study|Death|26|||
126412555|NCT00235716|454803835|FG001|Overall Study|Death|39|||
126412556|NCT00235716|454803836|FG002|Overall Study|Death|32|||
126412557|NCT00235716|454803837|FG003|Overall Study|Death|31|||
126412558|NCT00235716|454803834|FG000|Overall Study|Withdrawal by Subject|23|||
126412559|NCT00235716|454803835|FG001|Overall Study|Withdrawal by Subject|19|||
126412560|NCT00235716|454803836|FG002|Overall Study|Withdrawal by Subject|17|||
126412561|NCT00235716|454803837|FG003|Overall Study|Withdrawal by Subject|18|||
126412562|NCT00235716|454803834|FG000|Overall Study|Lost to Follow-up|12|||
126412563|NCT00235716|454803835|FG001|Overall Study|Lost to Follow-up|7|||
126412564|NCT00235716|454803836|FG002|Overall Study|Lost to Follow-up|14|||
126412565|NCT00235716|454803837|FG003|Overall Study|Lost to Follow-up|10|||
126412566|NCT00235716|454803834|FG000|Overall Study|Adverse Event|1|||
126412567|NCT00235716|454803835|FG001|Overall Study|Adverse Event|1|||
126721520|NCT01975272|455929983|FG000|Overall Study|Excluded after protocol amendment|1|||
126721521|NCT01975272|455929984|FG001|Overall Study|Excluded after protocol amendment|1|||
126721522|NCT01975272|455929985|FG002|Overall Study|Excluded after protocol amendment|2|||
126721523|NCT02028338|455929988|FG000|Overall Study|Withdrawal by Subject|3|||
126721524|NCT02028338|455929989|FG001|Overall Study|Withdrawal by Subject|1|||
126721525|NCT02028338|455929988|FG000|Overall Study|Unable to contact participant|1|||
126721526|NCT02028338|455929989|FG001|Overall Study|Unable to contact participant|0|||
126721527|NCT02761993|455929995|FG000|Overall Study|Adverse Event|0|||
126721528|NCT02761993|455929996|FG001|Overall Study|Adverse Event|2|||
126721529|NCT02761993|455929997|FG002|Overall Study|Adverse Event|0|||
126412568|NCT00235716|454803836|FG002|Overall Study|Adverse Event|1|||
126412569|NCT00235716|454803837|FG003|Overall Study|Adverse Event|0|||
126412570|NCT00235716|454803834|FG000|Overall Study|Physician Decision|0|||
126412571|NCT00235716|454803835|FG001|Overall Study|Physician Decision|1|||
126412572|NCT00235716|454803836|FG002|Overall Study|Physician Decision|1|||
126412573|NCT00235716|454803837|FG003|Overall Study|Physician Decision|3|||
126412574|NCT04390841|454803838|FG000|Overall Study|Withdrawal by Subject|2|||
126412575|NCT02188849|454803849|FG000|Overall Study|Lost to Follow-up|3|||
126412576|NCT02188849|454803850|FG001|Overall Study|Lost to Follow-up|8|||
126412577|NCT05090852|454803857|FG000|Overall Study|Physician Decision|5|||
126412578|NCT00148941|454803861|FG000|Overall Study|Lost to Follow-up|17|||
126412579|NCT00148941|454803862|FG001|Overall Study|Lost to Follow-up|24|||
126412580|NCT00148941|454803863|FG002|Overall Study|Lost to Follow-up|18|||
126412581|NCT00148941|454803864|FG003|Overall Study|Lost to Follow-up|22|||
126412582|NCT00148941|454803861|FG000|Overall Study|Withdrawal by Subject|1|||
126412583|NCT00148941|454803862|FG001|Overall Study|Withdrawal by Subject|0|||
126412584|NCT00148941|454803863|FG002|Overall Study|Withdrawal by Subject|1|||
126412585|NCT00148941|454803864|FG003|Overall Study|Withdrawal by Subject|0|||
126412586|NCT00148941|454803861|FG000|Overall Study|Other|0|||
126558769|NCT04739423|455338835|FG003|Overall Study|Withdrawal by Subject|0|||
126721530|NCT02761993|455929995|FG000|Overall Study|Lost to Follow-up|1|||
126412587|NCT00148941|454803862|FG001|Overall Study|Other|0|||
126412588|NCT00148941|454803863|FG002|Overall Study|Other|1|||
126412589|NCT00148941|454803864|FG003|Overall Study|Other|2|||
126412590|NCT03244826|454803865|FG000|Overall Study|Withdrawal by Subject|2|||
126412591|NCT03244826|454803866|FG001|Overall Study|Withdrawal by Subject|0|||
126558770|NCT04739423|455338836|FG004|Overall Study|Withdrawal by Subject|0|||
126721531|NCT02761993|455929996|FG001|Overall Study|Lost to Follow-up|3|||
126721532|NCT02761993|455929997|FG002|Overall Study|Lost to Follow-up|2|||
126412592|NCT03244826|454803865|FG000|Overall Study|Transplant delayed or withdrawn|12|||
126412593|NCT03244826|454803866|FG001|Overall Study|Transplant delayed or withdrawn|10|||
126412594|NCT00416455|454803872|FG000|Overall Study|PET / CT not done|3|||
126412595|NCT00416455|454803873|FG001|Overall Study|PET / CT not done|5|||
126412596|NCT00416455|454803872|FG000|Overall Study|PET / CT poor quality|2|||
126412597|NCT00416455|454803873|FG001|Overall Study|PET / CT poor quality|1|||
126412598|NCT00416455|454803872|FG000|Overall Study|Inadequate pathology|11|||
126412599|NCT00416455|454803873|FG001|Overall Study|Inadequate pathology|2|||
126412600|NCT01620944|454803875|FG000|Overall Study|Early termination of Study|2|||
126412601|NCT01620944|454803876|FG001|Overall Study|Early termination of Study|1|||
126412602|NCT04079114|454803877|FG000|Overall Study|Study prematuely terminated.|166|||
126412603|NCT01364389|454803879|FG000|Overall Study|Withdrawal by Subject|0|||
126412604|NCT01364389|454803880|FG001|Overall Study|Withdrawal by Subject|1|||
126412605|NCT01364389|454803881|FG002|Overall Study|Withdrawal by Subject|0|||
126412606|NCT01364389|454803879|FG000|Overall Study|Protocol deviation|0|||
126412607|NCT01364389|454803880|FG001|Overall Study|Protocol deviation|0|||
126412608|NCT01364389|454803881|FG002|Overall Study|Protocol deviation|1|||
126412609|NCT01364389|454803879|FG000|Overall Study|Administrative problems|1|||
126412610|NCT01364389|454803880|FG001|Overall Study|Administrative problems|0|||
126412611|NCT01364389|454803881|FG002|Overall Study|Administrative problems|0|||
126412612|NCT01364389|454803879|FG000|Overall Study|Adverse Event|1|||
126412613|NCT01364389|454803880|FG001|Overall Study|Adverse Event|0|||
126412614|NCT01364389|454803881|FG002|Overall Study|Adverse Event|0|||
126412615|NCT02687581|454803882|FG000|Overall Study|Withdrawal by Subject|1|||
126412616|NCT02687581|454803883|FG001|Overall Study|Withdrawal by Subject|0|||
126412617|NCT02687581|454803884|FG002|Overall Study|Withdrawal by Subject|0|||
126412618|NCT02687581|454803885|FG003|Overall Study|Withdrawal by Subject|1|||
126412619|NCT02687581|454803882|FG000|Overall Study|Lost to Follow-up|2|||
126412620|NCT02687581|454803883|FG001|Overall Study|Lost to Follow-up|2|||
126412621|NCT02687581|454803884|FG002|Overall Study|Lost to Follow-up|0|||
126412622|NCT02687581|454803885|FG003|Overall Study|Lost to Follow-up|0|||
126412623|NCT02687581|454803882|FG000|Overall Study|the device is too small for the patient.|1|||
126412624|NCT02687581|454803883|FG001|Overall Study|the device is too small for the patient.|0|||
126412625|NCT02687581|454803884|FG002|Overall Study|the device is too small for the patient.|0|||
126412626|NCT02687581|454803885|FG003|Overall Study|the device is too small for the patient.|0|||
126412627|NCT00991406|454803898|FG000|Overall Study|One participant did not respond to FES.|1|||
126412628|NCT02160145|454803899|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
126412629|NCT02160145|454803900|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
126412630|NCT02160145|454803901|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
126412631|NCT02160145|454803899|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
126412632|NCT02160145|454803900|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
126412633|NCT02160145|454803901|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
126412634|NCT02160145|454803899|FG000|Randomized Double-blind Period|Subject decision|0|||
126412635|NCT02160145|454803900|FG001|Randomized Double-blind Period|Subject decision|21|||
126412636|NCT02160145|454803901|FG002|Randomized Double-blind Period|Subject decision|20|||
126412637|NCT02160145|454803899|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
126412638|NCT02160145|454803900|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
126412639|NCT02160145|454803901|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
126412640|NCT02160145|454803899|FG000|Randomized Double-blind Period|Physician Decision|0|||
126412641|NCT02160145|454803900|FG001|Randomized Double-blind Period|Physician Decision|7|||
126412642|NCT02160145|454803901|FG002|Randomized Double-blind Period|Physician Decision|5|||
126412643|NCT03597061|454803902|FG000|Overall Study|Lost to Follow-up|1|||
126412644|NCT03597061|454803903|FG001|Overall Study|Lost to Follow-up|0|||
126412645|NCT03597061|454803902|FG000|Overall Study|Protocol Violation|0|||
126412646|NCT03597061|454803903|FG001|Overall Study|Protocol Violation|1|||
126412647|NCT00375518|454803904|FG000|Overall Study|Withdrawal by Subject|2|||
126412648|NCT00375518|454803905|FG001|Overall Study|Withdrawal by Subject|10|||
126412649|NCT00375518|454803904|FG000|Overall Study|Patient Not Treated|6|||
126412650|NCT00375518|454803905|FG001|Overall Study|Patient Not Treated|6|||
126412651|NCT00375518|454803904|FG000|Overall Study|Death|0|||
126412652|NCT00375518|454803905|FG001|Overall Study|Death|1|||
126412653|NCT04699461|454803906|FG000|Overall Study|Withdrawal by Subject|1|||
126412654|NCT04699461|454803907|FG001|Overall Study|Withdrawal by Subject|0|||
126412655|NCT04699461|454803906|FG000|Overall Study|Study termination by sponsor|2|||
126412656|NCT04699461|454803907|FG001|Overall Study|Study termination by sponsor|1|||
126412657|NCT04699461|454803906|FG000|Overall Study|Death|1|||
126412658|NCT04699461|454803907|FG001|Overall Study|Death|0|||
126412659|NCT04699461|454803906|FG000|Overall Study|Radiographic progression|0|||
126412660|NCT04699461|454803907|FG001|Overall Study|Radiographic progression|1|||
126412661|NCT03068767|454803908|FG000|Overall Study|Lost to Follow-up|7|||
126412662|NCT03068767|454803909|FG001|Overall Study|Lost to Follow-up|3|||
126412663|NCT03068767|454803908|FG000|Overall Study|Protocol Violation|3|||
126412664|NCT03068767|454803909|FG001|Overall Study|Protocol Violation|0|||
126412665|NCT02301624|454803910|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
126412666|NCT02301624|454803911|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
126412667|NCT02301624|454803910|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
126412668|NCT02301624|454803911|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
126412669|NCT02301624|454803910|FG000|Open-label Maintenance Phase|Adverse Event|2|||
126412670|NCT02301624|454803911|FG001|Open-label Maintenance Phase|Adverse Event|5|||
126412671|NCT02301624|454803910|FG000|Open-label Maintenance Phase|Physician Decision|3|||
126412672|NCT02301624|454803911|FG001|Open-label Maintenance Phase|Physician Decision|3|||
126412673|NCT02301624|454803910|FG000|Open-label Maintenance Phase|Death|2|||
126412674|NCT02301624|454803911|FG001|Open-label Maintenance Phase|Death|1|||
126412675|NCT02301624|454803910|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
126412676|NCT02301624|454803911|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
126412677|NCT00895310|454803912|FG000|Overall Study|Withdrawal by Subject|1|||
126412678|NCT03077919|454805722|FG000|Overall Study|Lost to Follow-up|4|||
126412679|NCT03077919|454805723|FG001|Overall Study|Lost to Follow-up|1|||
126412680|NCT01031979|454805726|FG000|Overall Study|Lost to Follow-up|5|||
126412681|NCT01031979|454805727|FG001|Overall Study|Lost to Follow-up|4|||
126412682|NCT03592368|454805729|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
126412683|NCT03592368|454805730|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
126412684|NCT03592368|454805731|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
126412685|NCT03592368|454805732|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
126412686|NCT03592368|454805729|FG000|Overall Study|Adverse Event|0|||
126412687|NCT03592368|454805730|FG001|Overall Study|Adverse Event|0|||
126412688|NCT03592368|454805731|FG002|Overall Study|Adverse Event|0|||
126412689|NCT03592368|454805732|FG003|Overall Study|Adverse Event|1|||
126412690|NCT03592368|454805729|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
126412691|NCT03592368|454805730|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
126412692|NCT03592368|454805731|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
126412693|NCT03592368|454805732|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
126412694|NCT03831100|454805733|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
126412695|NCT03831100|454805734|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
126412696|NCT01618695|454805741|FG000|Core Phase|Adverse Event|4|||
126412697|NCT01618695|454805742|FG001|Core Phase|Adverse Event|5|||
126412698|NCT01618695|454805743|FG002|Core Phase|Adverse Event|15|||
126412699|NCT01618695|454805744|FG003|Core Phase|Adverse Event|20|||
126412700|NCT01618695|454805741|FG000|Core Phase|Lost to Follow-up|0|||
126412701|NCT01618695|454805742|FG001|Core Phase|Lost to Follow-up|0|||
126412702|NCT01618695|454805743|FG002|Core Phase|Lost to Follow-up|1|||
126412703|NCT01618695|454805744|FG003|Core Phase|Lost to Follow-up|0|||
126412704|NCT01618695|454805741|FG000|Core Phase|Withdrawal by Subject|16|||
126412705|NCT01618695|454805742|FG001|Core Phase|Withdrawal by Subject|11|||
126412706|NCT01618695|454805743|FG002|Core Phase|Withdrawal by Subject|9|||
126412707|NCT01618695|454805744|FG003|Core Phase|Withdrawal by Subject|13|||
126412708|NCT01618695|454805741|FG000|Core Phase|Pregnancy|2|||
126412709|NCT01618695|454805742|FG001|Core Phase|Pregnancy|0|||
126412710|NCT01618695|454805743|FG002|Core Phase|Pregnancy|0|||
126412711|NCT01618695|454805744|FG003|Core Phase|Pregnancy|0|||
126412712|NCT01618695|454805741|FG000|Core Phase|Lack of Efficacy|1|||
126412713|NCT01618695|454805742|FG001|Core Phase|Lack of Efficacy|2|||
126412714|NCT01618695|454805743|FG002|Core Phase|Lack of Efficacy|1|||
126412715|NCT01618695|454805744|FG003|Core Phase|Lack of Efficacy|1|||
126412716|NCT01618695|454805741|FG000|Core Phase|Other than specified|1|||
126412717|NCT01618695|454805742|FG001|Core Phase|Other than specified|2|||
126412718|NCT01618695|454805743|FG002|Core Phase|Other than specified|2|||
126412719|NCT01618695|454805744|FG003|Core Phase|Other than specified|2|||
126412720|NCT01618695|454805741|FG000|Core Phase|Not treated|1|||
126412721|NCT01618695|454805742|FG001|Core Phase|Not treated|0|||
126412722|NCT01618695|454805743|FG002|Core Phase|Not treated|2|||
126412723|NCT01618695|454805744|FG003|Core Phase|Not treated|0|||
126474760|NCT00533897|455038040|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
126474761|NCT00533897|455038041|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
126474762|NCT00533897|455038042|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
126474763|NCT00533897|455038043|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
126474764|NCT00533897|455038044|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
126412724|NCT01618695|454805741|FG000|Extension Phase|Lack of Efficacy|17|||
126412725|NCT01618695|454805742|FG001|Extension Phase|Lack of Efficacy|33|||
126412726|NCT01618695|454805743|FG002|Extension Phase|Lack of Efficacy|26|||
126412727|NCT01618695|454805744|FG003|Extension Phase|Lack of Efficacy|24|||
126412728|NCT01618695|454805741|FG000|Extension Phase|Pregnancy|2|||
126412729|NCT01618695|454805742|FG001|Extension Phase|Pregnancy|0|||
126474765|NCT00533897|455038045|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
126412730|NCT01618695|454805743|FG002|Extension Phase|Pregnancy|1|||
126412731|NCT01618695|454805744|FG003|Extension Phase|Pregnancy|1|||
126474766|NCT00533897|455038046|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
126474767|NCT00533897|455038039|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
126474768|NCT00533897|455038040|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
126474769|NCT00533897|455038041|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
126474770|NCT00533897|455038042|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
126474771|NCT00533897|455038043|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
126474772|NCT00533897|455038044|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
126474773|NCT00533897|455038045|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
126474774|NCT00533897|455038046|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
126474775|NCT00533897|455038039|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
126474776|NCT00533897|455038040|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
126474777|NCT00533897|455038041|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
126474778|NCT00533897|455038042|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
126474779|NCT00533897|455038043|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
126474780|NCT00533897|455038044|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
126474781|NCT00533897|455038045|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
126474782|NCT00533897|455038046|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
126474783|NCT00533897|455038039|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
126474784|NCT00533897|455038040|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
126474785|NCT00533897|455038041|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
126474786|NCT00533897|455038042|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
126474787|NCT00533897|455038043|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
126474788|NCT00533897|455038044|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
126474789|NCT00533897|455038045|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
126474790|NCT00533897|455038046|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
126474791|NCT00533897|455038039|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
126474792|NCT00533897|455038040|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
126474793|NCT00533897|455038041|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
126474794|NCT00533897|455038042|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
126474795|NCT00533897|455038043|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
126474796|NCT00533897|455038044|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
126412732|NCT01618695|454805741|FG000|Extension Phase|Withdrawal by Subject|43|||
126412733|NCT01618695|454805742|FG001|Extension Phase|Withdrawal by Subject|48|||
126412734|NCT01618695|454805743|FG002|Extension Phase|Withdrawal by Subject|42|||
126412735|NCT01618695|454805744|FG003|Extension Phase|Withdrawal by Subject|33|||
126412736|NCT01618695|454805741|FG000|Extension Phase|Adverse Event|18|||
126412737|NCT01618695|454805742|FG001|Extension Phase|Adverse Event|16|||
126412738|NCT01618695|454805743|FG002|Extension Phase|Adverse Event|9|||
126412739|NCT01618695|454805744|FG003|Extension Phase|Adverse Event|20|||
126412740|NCT01618695|454805741|FG000|Extension Phase|Lost to Follow-up|2|||
126412741|NCT01618695|454805742|FG001|Extension Phase|Lost to Follow-up|1|||
126412742|NCT01618695|454805743|FG002|Extension Phase|Lost to Follow-up|1|||
126412743|NCT01618695|454805744|FG003|Extension Phase|Lost to Follow-up|1|||
126412744|NCT01618695|454805741|FG000|Extension Phase|Other than specified|13|||
126412745|NCT01618695|454805742|FG001|Extension Phase|Other than specified|18|||
126412746|NCT01618695|454805743|FG002|Extension Phase|Other than specified|13|||
126412747|NCT01618695|454805744|FG003|Extension Phase|Other than specified|18|||
126412748|NCT02454478|454805746|FG000|Overall Study|Incomplete DLT Evaluation|1|||
126412749|NCT02950480|454805755|FG000|Overall Study|Withdrawal by Subject|1|||
126412750|NCT02950480|454805756|FG001|Overall Study|Withdrawal by Subject|0|||
126412751|NCT03229109|454805761|FG000|Overall Study|Withdrawal by Subject|0|||
126412752|NCT03229109|454805762|FG001|Overall Study|Withdrawal by Subject|0|||
126412753|NCT03229109|454805763|FG002|Overall Study|Withdrawal by Subject|0|||
126412754|NCT03229109|454805764|FG003|Overall Study|Withdrawal by Subject|1|||
126412755|NCT04207749|454805765|FG000|Overall Study|Lost to Follow-up|0|||
126412756|NCT04207749|454805766|FG001|Overall Study|Lost to Follow-up|2|||
126412757|NCT04207749|454805765|FG000|Overall Study|Protocol Violation|0|||
126474797|NCT00533897|455038045|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
126558771|NCT04739423|455338837|FG005|Overall Study|Withdrawal by Subject|1|||
126412758|NCT04207749|454805766|FG001|Overall Study|Protocol Violation|1|||
126412759|NCT04207749|454805765|FG000|Overall Study|Withdrawal by Subject|3|||
126412760|NCT04207749|454805766|FG001|Overall Study|Withdrawal by Subject|0|||
126412761|NCT04207749|454805765|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
126412762|NCT04207749|454805766|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
126412763|NCT01835223|454805767|FG000|Overall Study|Adverse Event|1|||
126412764|NCT01835223|454805768|FG001|Overall Study|Adverse Event|0|||
126412765|NCT01835223|454805767|FG000|Overall Study|Withdrawal by Subject|2|||
126412766|NCT01835223|454805768|FG001|Overall Study|Withdrawal by Subject|0|||
126474798|NCT00533897|455038046|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
126474799|NCT00533897|455038039|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
126474800|NCT00533897|455038040|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
126474801|NCT00533897|455038041|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
126474802|NCT00533897|455038042|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
126474803|NCT00533897|455038043|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
126474804|NCT00533897|455038044|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
126474805|NCT00533897|455038045|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
126474806|NCT00533897|455038046|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
126474807|NCT00533897|455038039|FG000|Long Term Extension (LTE)|Death|0|||
126474808|NCT00533897|455038040|FG001|Long Term Extension (LTE)|Death|0|||
126474809|NCT00533897|455038041|FG002|Long Term Extension (LTE)|Death|0|||
126474810|NCT00533897|455038042|FG003|Long Term Extension (LTE)|Death|0|||
126474811|NCT00533897|455038043|FG004|Long Term Extension (LTE)|Death|0|||
126474812|NCT00533897|455038044|FG005|Long Term Extension (LTE)|Death|0|||
126474813|NCT00533897|455038045|FG006|Long Term Extension (LTE)|Death|1|||
126474814|NCT00533897|455038046|FG007|Long Term Extension (LTE)|Death|3|||
126474815|NCT00533897|455038039|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
126474816|NCT00533897|455038040|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
126474817|NCT00533897|455038041|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
126474818|NCT00533897|455038042|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
126474819|NCT00533897|455038043|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
126474820|NCT00533897|455038044|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
126474821|NCT00533897|455038045|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
126474822|NCT00533897|455038046|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
126474823|NCT00533897|455038039|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
126474824|NCT00533897|455038040|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
126474825|NCT00533897|455038041|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
126474826|NCT00533897|455038042|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
126474827|NCT00533897|455038043|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
126474828|NCT00533897|455038044|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
126474829|NCT00533897|455038045|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
126474830|NCT00533897|455038046|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
126474831|NCT00533897|455038039|FG000|Long Term Extension (LTE)|Adverse Event|0|||
126474832|NCT00533897|455038040|FG001|Long Term Extension (LTE)|Adverse Event|0|||
126474833|NCT00533897|455038041|FG002|Long Term Extension (LTE)|Adverse Event|0|||
126474834|NCT00533897|455038042|FG003|Long Term Extension (LTE)|Adverse Event|0|||
126474835|NCT00533897|455038043|FG004|Long Term Extension (LTE)|Adverse Event|0|||
126474836|NCT00533897|455038044|FG005|Long Term Extension (LTE)|Adverse Event|0|||
126474837|NCT00533897|455038045|FG006|Long Term Extension (LTE)|Adverse Event|2|||
126474838|NCT00533897|455038046|FG007|Long Term Extension (LTE)|Adverse Event|5|||
126474839|NCT00533897|455038039|FG000|Long Term Extension (LTE)|Pregnancy|0|||
126474840|NCT00533897|455038040|FG001|Long Term Extension (LTE)|Pregnancy|0|||
126474841|NCT00533897|455038041|FG002|Long Term Extension (LTE)|Pregnancy|0|||
126474842|NCT00533897|455038042|FG003|Long Term Extension (LTE)|Pregnancy|0|||
126474843|NCT00533897|455038043|FG004|Long Term Extension (LTE)|Pregnancy|0|||
126474844|NCT00533897|455038044|FG005|Long Term Extension (LTE)|Pregnancy|0|||
126474845|NCT00533897|455038045|FG006|Long Term Extension (LTE)|Pregnancy|0|||
126474846|NCT00533897|455038046|FG007|Long Term Extension (LTE)|Pregnancy|2|||
126474847|NCT00533897|455038039|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
126474848|NCT00533897|455038040|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
126474849|NCT00533897|455038041|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
126474850|NCT00533897|455038042|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
126474851|NCT00533897|455038043|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
126474852|NCT00533897|455038044|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
126474853|NCT00533897|455038045|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
126558772|NCT01007552|455338841|FG000|Overall Study|Withdrawal by Subject|1|||
126558773|NCT04482855|455338845|FG000|Overall Study|Lost to Follow-up|1|||
126558774|NCT04482855|455338846|FG001|Overall Study|Lost to Follow-up|0|||
126558775|NCT04482855|455338845|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
126558776|NCT04482855|455338846|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
126558777|NCT04482855|455338845|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
126558778|NCT04482855|455338846|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
126721533|NCT02761993|455929995|FG000|Overall Study|Withdrawal by Subject|1|||
126474854|NCT00533897|455038046|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
126474855|NCT00533897|455038039|FG000|Long Term Extension (LTE)|Other|0|||
126474856|NCT00533897|455038040|FG001|Long Term Extension (LTE)|Other|0|||
126474857|NCT00533897|455038041|FG002|Long Term Extension (LTE)|Other|0|||
126474858|NCT00533897|455038042|FG003|Long Term Extension (LTE)|Other|0|||
126474859|NCT00533897|455038043|FG004|Long Term Extension (LTE)|Other|0|||
126474860|NCT00533897|455038044|FG005|Long Term Extension (LTE)|Other|0|||
126474861|NCT00533897|455038045|FG006|Long Term Extension (LTE)|Other|1|||
126474862|NCT00533897|455038046|FG007|Long Term Extension (LTE)|Other|6|||
126474863|NCT00713323|455038047|FG000|Overall Study|Adverse Event|75|||
126474864|NCT00713323|455038047|FG000|Overall Study|Withdrawal by Subject|15|||
126474865|NCT00713323|455038047|FG000|Overall Study|Lost to Follow-up|11|||
126474866|NCT00713323|455038047|FG000|Overall Study|Lack of Efficacy|36|||
126474867|NCT00713323|455038047|FG000|Overall Study|Low creatine clearance at screening|1|||
126474868|NCT00713323|455038047|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
126474869|NCT00713323|455038047|FG000|Overall Study|Surgery cured allodynic pain|1|||
126474870|NCT00713323|455038047|FG000|Overall Study|Pain free|1|||
126474871|NCT00713323|455038047|FG000|Overall Study|Non-compliance|1|||
126474872|NCT00713323|455038047|FG000|Overall Study|Pain resolved|1|||
126474873|NCT00713323|455038047|FG000|Overall Study|Subject travelling to USA|1|||
126474874|NCT00713323|455038047|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
126474875|NCT00713323|455038047|FG000|Overall Study|Treatment that may interact with Sativex|1|||
126474876|NCT02478632|455038048|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
126474877|NCT02478632|455038049|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
126474878|NCT02478632|455038048|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
126474879|NCT02478632|455038049|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
126474880|NCT02478632|455038048|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
126474881|NCT02478632|455038049|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
126474882|NCT04622306|455038050|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
126474883|NCT04622306|455038051|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
126474884|NCT04622306|455038052|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
126474885|NCT04622306|455038053|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
126474886|NCT04622306|455038054|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
126474887|NCT04622306|455038055|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
126474888|NCT04622306|455038050|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
126474889|NCT04622306|455038051|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
126474890|NCT04622306|455038052|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
126474891|NCT04622306|455038053|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
126474892|NCT04622306|455038054|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
126474893|NCT04622306|455038055|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
126474894|NCT00864721|455038056|FG000|Overall Study|Patient request|11|||
126474895|NCT00864721|455038056|FG000|Overall Study|Hospitalized|1|||
126474896|NCT00864721|455038056|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
126474897|NCT00864721|455038056|FG000|Overall Study|Adverse Event|21|||
126474898|NCT00736944|455038057|FG000|Induction|Death|1|||
126474899|NCT00736944|455038057|FG000|Definitive Treatment|Physician Decision|1|||
126474900|NCT05350410|455038058|FG000|Overall Study|Withdrawal by Subject|1|||
126474901|NCT01601132|455038059|FG000|Overall Study|Patient withdrew consent|1|||
126474902|NCT01601132|455038059|FG000|Overall Study|Protocol deviation|1|||
126558779|NCT03212365|455338852|FG000|Overall Study|Discharged prior to Xa level|12|||
126558780|NCT03212365|455338853|FG001|Overall Study|Discharged prior to Xa level|8|||
126558781|NCT03212365|455338852|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
126558782|NCT03212365|455338853|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
126558783|NCT03212365|455338852|FG000|Overall Study|Refused study medication|3|||
126558784|NCT03212365|455338853|FG001|Overall Study|Refused study medication|0|||
126558785|NCT03212365|455338852|FG000|Overall Study|Initiated heparin infusion on floor|1|||
126474903|NCT01030536|455038060|FG000|Overall Study|Withdrawal by Subject|0|||
126474904|NCT01030536|455038061|FG001|Overall Study|Withdrawal by Subject|0|||
126474905|NCT01030536|455038062|FG002|Overall Study|Withdrawal by Subject|1|||
126474906|NCT01030536|455038063|FG003|Overall Study|Withdrawal by Subject|0|||
126474907|NCT01030536|455038064|FG004|Overall Study|Withdrawal by Subject|0|||
126474908|NCT01030536|455038060|FG000|Overall Study|undefined|1|||
126474909|NCT01030536|455038061|FG001|Overall Study|undefined|0|||
126558786|NCT03212365|455338853|FG001|Overall Study|Initiated heparin infusion on floor|1|||
126558787|NCT03212365|455338852|FG000|Overall Study|Unexpected return to OR|1|||
126558788|NCT03212365|455338853|FG001|Overall Study|Unexpected return to OR|1|||
126474910|NCT01030536|455038062|FG002|Overall Study|undefined|1|||
126474911|NCT01030536|455038063|FG003|Overall Study|undefined|1|||
126474912|NCT01030536|455038064|FG004|Overall Study|undefined|0|||
126474913|NCT01030536|455038060|FG000|Overall Study|Adverse Event|0|||
126474914|NCT01030536|455038061|FG001|Overall Study|Adverse Event|3|||
126558789|NCT03212365|455338852|FG000|Overall Study|Medication distribution error|1|||
126558790|NCT03212365|455338853|FG001|Overall Study|Medication distribution error|0|||
126558791|NCT03212365|455338852|FG000|Overall Study|Required epidural placement|1|||
126558792|NCT03212365|455338853|FG001|Overall Study|Required epidural placement|0|||
126474915|NCT01030536|455038062|FG002|Overall Study|Adverse Event|1|||
126474916|NCT01030536|455038063|FG003|Overall Study|Adverse Event|0|||
126474917|NCT01030536|455038064|FG004|Overall Study|Adverse Event|1|||
126412767|NCT01835223|454805767|FG000|Overall Study|Disease progression|2|||
126412768|NCT01835223|454805768|FG001|Overall Study|Disease progression|1|||
126412769|NCT01835223|454805767|FG000|Overall Study|Became Inelligible|4|||
126412770|NCT01835223|454805768|FG001|Overall Study|Became Inelligible|0|||
126412771|NCT01504841|454805769|FG000|Overall Study|Withdrawal by Subject|1|||
126412772|NCT01504841|454805770|FG001|Overall Study|Withdrawal by Subject|1|||
126412773|NCT01504841|454805771|FG002|Overall Study|Withdrawal by Subject|0|||
126412774|NCT01610336|454805772|FG000|Overall Study|Progressive Disease|4|||
126412775|NCT01610336|454805773|FG001|Overall Study|Progressive Disease|6|||
126412776|NCT01610336|454805774|FG002|Overall Study|Progressive Disease|6|||
126412777|NCT01610336|454805775|FG003|Overall Study|Progressive Disease|5|||
126412778|NCT01610336|454805776|FG004|Overall Study|Progressive Disease|3|||
126412779|NCT01610336|454805777|FG005|Overall Study|Progressive Disease|10|||
126412780|NCT01610336|454805778|FG006|Overall Study|Progressive Disease|1|||
126412781|NCT01610336|454805779|FG007|Overall Study|Progressive Disease|6|||
126412782|NCT01610336|454805780|FG008|Overall Study|Progressive Disease|6|||
126412783|NCT01610336|454805781|FG009|Overall Study|Progressive Disease|40|||
126412784|NCT01610336|454805782|FG010|Overall Study|Progressive Disease|36|||
126412785|NCT01610336|454805772|FG000|Overall Study|Adverse Event|0|||
126412786|NCT01610336|454805773|FG001|Overall Study|Adverse Event|0|||
126412787|NCT01610336|454805774|FG002|Overall Study|Adverse Event|0|||
126412788|NCT01610336|454805775|FG003|Overall Study|Adverse Event|1|||
126412789|NCT01610336|454805776|FG004|Overall Study|Adverse Event|1|||
126412790|NCT01610336|454805777|FG005|Overall Study|Adverse Event|1|||
126412791|NCT01610336|454805778|FG006|Overall Study|Adverse Event|0|||
126412792|NCT01610336|454805779|FG007|Overall Study|Adverse Event|0|||
126412793|NCT01610336|454805780|FG008|Overall Study|Adverse Event|2|||
126412794|NCT01610336|454805781|FG009|Overall Study|Adverse Event|8|||
126412795|NCT01610336|454805782|FG010|Overall Study|Adverse Event|6|||
126412796|NCT01610336|454805772|FG000|Overall Study|Subject/Guardian decision|1|||
126412797|NCT01610336|454805773|FG001|Overall Study|Subject/Guardian decision|1|||
126412798|NCT01610336|454805774|FG002|Overall Study|Subject/Guardian decision|0|||
126412799|NCT01610336|454805775|FG003|Overall Study|Subject/Guardian decision|1|||
126412800|NCT01610336|454805776|FG004|Overall Study|Subject/Guardian decision|0|||
126412801|NCT01610336|454805777|FG005|Overall Study|Subject/Guardian decision|0|||
126412802|NCT01610336|454805778|FG006|Overall Study|Subject/Guardian decision|0|||
126412803|NCT01610336|454805779|FG007|Overall Study|Subject/Guardian decision|1|||
126412804|NCT01610336|454805780|FG008|Overall Study|Subject/Guardian decision|0|||
126412805|NCT01610336|454805781|FG009|Overall Study|Subject/Guardian decision|2|||
126412806|NCT01610336|454805782|FG010|Overall Study|Subject/Guardian decision|2|||
126412807|NCT01610336|454805772|FG000|Overall Study|Death|0|||
126412808|NCT01610336|454805773|FG001|Overall Study|Death|0|||
126412809|NCT01610336|454805774|FG002|Overall Study|Death|0|||
126412810|NCT01610336|454805775|FG003|Overall Study|Death|0|||
126412811|NCT01610336|454805776|FG004|Overall Study|Death|0|||
126412812|NCT01610336|454805777|FG005|Overall Study|Death|1|||
126412813|NCT01610336|454805778|FG006|Overall Study|Death|3|||
126412814|NCT01610336|454805779|FG007|Overall Study|Death|0|||
126412815|NCT01610336|454805780|FG008|Overall Study|Death|0|||
126412816|NCT01610336|454805781|FG009|Overall Study|Death|1|||
126412817|NCT01610336|454805782|FG010|Overall Study|Death|2|||
126412818|NCT01610336|454805772|FG000|Overall Study|Non-Compliance with study treatment|0|||
126412819|NCT01610336|454805773|FG001|Overall Study|Non-Compliance with study treatment|0|||
126412820|NCT01610336|454805774|FG002|Overall Study|Non-Compliance with study treatment|0|||
126412821|NCT01610336|454805775|FG003|Overall Study|Non-Compliance with study treatment|0|||
126412822|NCT01610336|454805776|FG004|Overall Study|Non-Compliance with study treatment|0|||
126412823|NCT01610336|454805777|FG005|Overall Study|Non-Compliance with study treatment|0|||
126474918|NCT01030536|455038060|FG000|Overall Study|Progressive disease|6|||
126474919|NCT01030536|455038061|FG001|Overall Study|Progressive disease|2|||
126474920|NCT01030536|455038062|FG002|Overall Study|Progressive disease|3|||
126474921|NCT01030536|455038063|FG003|Overall Study|Progressive disease|2|||
126474922|NCT01030536|455038064|FG004|Overall Study|Progressive disease|0|||
126474923|NCT01030536|455038060|FG000|Overall Study|Death|0|||
126721534|NCT02761993|455929996|FG001|Overall Study|Withdrawal by Subject|1|||
126721535|NCT02761993|455929997|FG002|Overall Study|Withdrawal by Subject|2|||
126721536|NCT01842620|455929998|FG000|Period 1|Withdrawal by Subject|1|||
126412824|NCT01610336|454805778|FG006|Overall Study|Non-Compliance with study treatment|0|||
126412825|NCT01610336|454805779|FG007|Overall Study|Non-Compliance with study treatment|0|||
126412826|NCT01610336|454805780|FG008|Overall Study|Non-Compliance with study treatment|0|||
126412827|NCT01610336|454805781|FG009|Overall Study|Non-Compliance with study treatment|1|||
126412828|NCT01610336|454805782|FG010|Overall Study|Non-Compliance with study treatment|0|||
126412829|NCT01610336|454805772|FG000|Overall Study|Physician Decision|0|||
126412830|NCT01610336|454805773|FG001|Overall Study|Physician Decision|0|||
126412831|NCT01610336|454805774|FG002|Overall Study|Physician Decision|0|||
126412832|NCT01610336|454805775|FG003|Overall Study|Physician Decision|0|||
126412833|NCT01610336|454805776|FG004|Overall Study|Physician Decision|0|||
126412834|NCT01610336|454805777|FG005|Overall Study|Physician Decision|0|||
126412835|NCT01610336|454805778|FG006|Overall Study|Physician Decision|1|||
126474924|NCT01030536|455038061|FG001|Overall Study|Death|1|||
126474925|NCT01030536|455038062|FG002|Overall Study|Death|0|||
126474926|NCT01030536|455038063|FG003|Overall Study|Death|0|||
126474927|NCT01030536|455038064|FG004|Overall Study|Death|0|||
126474928|NCT01146912|455038065|FG000|Overall Study|Already received influenza vaccination|817|||
126474929|NCT01146912|455038066|FG001|Overall Study|Already received influenza vaccination|822|||
126474930|NCT01146912|455038067|FG002|Overall Study|Already received influenza vaccination|13|||
126474931|NCT01146912|455038068|FG003|Overall Study|Already received influenza vaccination|15|||
126474932|NCT01146912|455038069|FG004|Overall Study|Already received influenza vaccination|41|||
126474933|NCT01146912|455038070|FG005|Overall Study|Already received influenza vaccination|61|||
126474934|NCT01146912|455038071|FG006|Overall Study|Already received influenza vaccination|56|||
126474935|NCT01146912|455038072|FG007|Overall Study|Already received influenza vaccination|0|||
126474936|NCT01146912|455038065|FG000|Overall Study|< 14 weeks gestational age|0|||
126474937|NCT01146912|455038066|FG001|Overall Study|< 14 weeks gestational age|0|||
126474938|NCT01146912|455038067|FG002|Overall Study|< 14 weeks gestational age|3|||
126474939|NCT01146912|455038068|FG003|Overall Study|< 14 weeks gestational age|2|||
126474940|NCT01146912|455038069|FG004|Overall Study|< 14 weeks gestational age|0|||
126474941|NCT01146912|455038070|FG005|Overall Study|< 14 weeks gestational age|0|||
126474942|NCT01146912|455038071|FG006|Overall Study|< 14 weeks gestational age|0|||
126474943|NCT01146912|455038072|FG007|Overall Study|< 14 weeks gestational age|0|||
126558793|NCT03212365|455338852|FG000|Overall Study|Withdrawal by Subject|0|||
126558794|NCT03212365|455338853|FG001|Overall Study|Withdrawal by Subject|1|||
126558795|NCT03212365|455338852|FG000|Overall Study|developed acute renal failure|0|||
126412836|NCT01610336|454805779|FG007|Overall Study|Physician Decision|0|||
126412837|NCT01610336|454805780|FG008|Overall Study|Physician Decision|0|||
126412838|NCT01610336|454805781|FG009|Overall Study|Physician Decision|0|||
126412839|NCT01610336|454805782|FG010|Overall Study|Physician Decision|0|||
126412840|NCT01610336|454805772|FG000|Overall Study|Protocol Deviation|0|||
126412841|NCT01610336|454805773|FG001|Overall Study|Protocol Deviation|0|||
126412842|NCT01610336|454805774|FG002|Overall Study|Protocol Deviation|0|||
126412843|NCT01610336|454805775|FG003|Overall Study|Protocol Deviation|0|||
126412844|NCT01610336|454805776|FG004|Overall Study|Protocol Deviation|0|||
126412845|NCT01610336|454805777|FG005|Overall Study|Protocol Deviation|0|||
126412846|NCT01610336|454805778|FG006|Overall Study|Protocol Deviation|0|||
126412847|NCT01610336|454805779|FG007|Overall Study|Protocol Deviation|0|||
126412848|NCT01610336|454805780|FG008|Overall Study|Protocol Deviation|0|||
126412849|NCT01610336|454805781|FG009|Overall Study|Protocol Deviation|1|||
126412850|NCT01610336|454805782|FG010|Overall Study|Protocol Deviation|0|||
126412851|NCT01610336|454805772|FG000|Overall Study|Transfer to another trial|0|||
126412852|NCT01610336|454805773|FG001|Overall Study|Transfer to another trial|0|||
126412853|NCT01610336|454805774|FG002|Overall Study|Transfer to another trial|0|||
126412854|NCT01610336|454805775|FG003|Overall Study|Transfer to another trial|0|||
126412855|NCT01610336|454805776|FG004|Overall Study|Transfer to another trial|0|||
126412856|NCT01610336|454805777|FG005|Overall Study|Transfer to another trial|0|||
126412857|NCT01610336|454805778|FG006|Overall Study|Transfer to another trial|0|||
126412858|NCT01610336|454805779|FG007|Overall Study|Transfer to another trial|0|||
126412859|NCT01610336|454805780|FG008|Overall Study|Transfer to another trial|0|||
126412860|NCT01610336|454805781|FG009|Overall Study|Transfer to another trial|0|||
126412861|NCT01610336|454805782|FG010|Overall Study|Transfer to another trial|1|||
126412862|NCT03679624|454805783|FG000|Overall Study|Adverse Event|1|||
126412863|NCT03679624|454805784|FG001|Overall Study|Adverse Event|0|||
126412864|NCT01559675|454805787|FG000|Overall Study|Protocol Violation|1|||
126412865|NCT01559675|454805788|FG001|Overall Study|Protocol Violation|2|||
126412866|NCT01559675|454805787|FG000|Overall Study|2nd operation on same patient excluded|14|||
126412867|NCT01559675|454805788|FG001|Overall Study|2nd operation on same patient excluded|12|||
126412868|NCT01496469|454805789|FG000|Overall Study|Adverse Event|1|||
126412869|NCT01496469|454805790|FG001|Overall Study|Adverse Event|0|||
126412870|NCT01496469|454805789|FG000|Overall Study|Protocol Violation|2|||
126412871|NCT01496469|454805790|FG001|Overall Study|Protocol Violation|0|||
126412872|NCT01496469|454805789|FG000|Overall Study|Lost to Follow-up|1|||
126412873|NCT01496469|454805790|FG001|Overall Study|Lost to Follow-up|1|||
126412874|NCT01496469|454805789|FG000|Overall Study|Withdrawal by Subject|4|||
126412875|NCT01496469|454805790|FG001|Overall Study|Withdrawal by Subject|4|||
126412876|NCT01496469|454805789|FG000|Overall Study|BP exceeds protocol limits|1|||
126412877|NCT01496469|454805790|FG001|Overall Study|BP exceeds protocol limits|2|||
126412878|NCT01496469|454805789|FG000|Overall Study|Other|1|||
126474944|NCT01146912|455038065|FG000|Overall Study|Duplicate patient|0|||
126474945|NCT01146912|455038066|FG001|Overall Study|Duplicate patient|0|||
126474946|NCT01146912|455038067|FG002|Overall Study|Duplicate patient|1|||
126412879|NCT01496469|454805790|FG001|Overall Study|Other|1|||
126558796|NCT03212365|455338853|FG001|Overall Study|developed acute renal failure|1|||
126412880|NCT00291018|454805791|FG000|Overall Study|Not Consented or Declined PAS|12|||
126412881|NCT00291018|454805792|FG001|Overall Study|Not Consented or Declined PAS|15|||
126412882|NCT00291018|454805793|FG002|Overall Study|Not Consented or Declined PAS|15|||
126412883|NCT00291018|454805791|FG000|Overall Study|Death|3|||
126412884|NCT00291018|454805792|FG001|Overall Study|Death|3|||
126412885|NCT00291018|454805793|FG002|Overall Study|Death|4|||
126412886|NCT00291018|454805791|FG000|Overall Study|Withdrawal by Subject|2|||
126474947|NCT01146912|455038068|FG003|Overall Study|Duplicate patient|0|||
126474948|NCT01146912|455038069|FG004|Overall Study|Duplicate patient|0|||
126474949|NCT01146912|455038070|FG005|Overall Study|Duplicate patient|0|||
126474950|NCT01146912|455038071|FG006|Overall Study|Duplicate patient|0|||
126474951|NCT01146912|455038072|FG007|Overall Study|Duplicate patient|0|||
126474952|NCT04889222|455038077|FG000|Overall Study|Did not meet eligibility criteria|8|||
126474953|NCT04889222|455038077|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
126474954|NCT04889222|455038077|FG000|Overall Study|Did not proceed due to time constraints|5|||
126474955|NCT01609231|455038078|FG000|Overall Study|Adverse Event|1|||
126474956|NCT01609231|455038079|FG001|Overall Study|Adverse Event|3|||
126474957|NCT01609231|455038078|FG000|Overall Study|Physician Decision|1|||
126474958|NCT01609231|455038079|FG001|Overall Study|Physician Decision|0|||
126474959|NCT01609231|455038078|FG000|Overall Study|Withdrawal by Subject|1|||
126474960|NCT01609231|455038079|FG001|Overall Study|Withdrawal by Subject|0|||
126474961|NCT01180647|455038080|FG000|Overall Study|Lost to Follow-up|5|||
126474962|NCT01180647|455038081|FG001|Overall Study|Lost to Follow-up|6|||
126474963|NCT00702689|455038088|FG000|Overall Study|Withdrawal by Subject|4|||
126474964|NCT00702689|455038088|FG000|Overall Study|Recurrent malignancy|1|||
126474965|NCT00702689|455038088|FG000|Overall Study|Adverse Event|1|||
126474966|NCT02846324|455038092|FG000|Overall Study|Other|1|||
126474967|NCT02846324|455038093|FG001|Overall Study|Other|0|||
126474968|NCT02846324|455038094|FG002|Overall Study|Other|0|||
126474969|NCT02846324|455038095|FG003|Overall Study|Other|0|||
126474970|NCT02846324|455038092|FG000|Overall Study|Withdrawal by Subject|1|||
126474971|NCT02846324|455038093|FG001|Overall Study|Withdrawal by Subject|0|||
126474972|NCT02846324|455038094|FG002|Overall Study|Withdrawal by Subject|4|||
126474973|NCT02846324|455038095|FG003|Overall Study|Withdrawal by Subject|0|||
126474974|NCT01927627|455038103|FG000|Overall Study|Adverse Event|3|||
126474975|NCT01927627|455038103|FG000|Overall Study|Lack of Efficacy|1|||
126474976|NCT01927627|455038103|FG000|Overall Study|Financial Concerns|1|||
126474977|NCT00467857|455038104|FG000|Overall Study|Adverse Event|1|||
126474978|NCT00467857|455038105|FG001|Overall Study|Adverse Event|0|||
126474979|NCT00467857|455038104|FG000|Overall Study|Withdrew consent|2|||
126474980|NCT00467857|455038105|FG001|Overall Study|Withdrew consent|0|||
126474981|NCT00467857|455038104|FG000|Overall Study|Death|0|||
126474982|NCT00467857|455038105|FG001|Overall Study|Death|1|||
126474983|NCT00467857|455038104|FG000|Overall Study|Discharged from court service|0|||
126474984|NCT00467857|455038105|FG001|Overall Study|Discharged from court service|1|||
126474985|NCT00467857|455038104|FG000|Overall Study|Emergency care required|0|||
126474986|NCT00467857|455038105|FG001|Overall Study|Emergency care required|1|||
126474987|NCT00467857|455038104|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
126474988|NCT00467857|455038105|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
126474989|NCT00467857|455038104|FG000|Overall Study|Discontinuation reason missing|0|||
126474990|NCT00467857|455038105|FG001|Overall Study|Discontinuation reason missing|3|||
126474991|NCT03576495|455038109|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
126474992|NCT03576495|455038110|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
126474993|NCT03208127|455038112|FG000|Overall Study|Death|1|||
126474994|NCT00579098|455038117|FG000|Overall Study|Lost to Follow-up|2|||
126474995|NCT00579098|455038118|FG001|Overall Study|Lost to Follow-up|0|||
126474996|NCT00579098|455038117|FG000|Overall Study|Adverse Event|2|||
126474997|NCT00579098|455038118|FG001|Overall Study|Adverse Event|3|||
126474998|NCT00579098|455038117|FG000|Overall Study|Withdrawal by Subject|2|||
126474999|NCT00579098|455038118|FG001|Overall Study|Withdrawal by Subject|3|||
126475000|NCT00579098|455038117|FG000|Overall Study|AF returned after ablation|3|||
126475001|NCT00579098|455038118|FG001|Overall Study|AF returned after ablation|2|||
126475002|NCT02121522|455038119|FG000|Overall Study|Adverse Event|1|||
126475003|NCT00338104|455038120|FG000|Overall Study|Protocol Violation|2|||
126475004|NCT00338104|455038121|FG001|Overall Study|Protocol Violation|1|||
126475005|NCT00338104|455038122|FG002|Overall Study|Protocol Violation|3|||
126475006|NCT03666624|455038124|FG000|Overall Study|participant grieving over recent death of parent|1|||
126475007|NCT03666624|455038125|FG001|Overall Study|participant grieving over recent death of parent|0|||
126475008|NCT00569270|455038130|FG000|Period: First Intervention|Protocol Violation|0|||
126475009|NCT00569270|455038131|FG001|Period: First Intervention|Protocol Violation|1|||
126475010|NCT00447005|455038132|FG000|Overall Study|Adverse Event|1|||
126475011|NCT00447005|455038132|FG000|Overall Study|Lack of Efficacy|11|||
126475012|NCT03822182|455038133|FG000|Overall Study|Protocol Violation|0|||
126475013|NCT03822182|455038134|FG001|Overall Study|Protocol Violation|1|||
126475014|NCT03822182|455038135|FG002|Overall Study|Protocol Violation|1|||
126475015|NCT00810355|455038136|FG000|Overall Study|Lost to Follow-up|13|||
126475016|NCT00810355|455038137|FG001|Overall Study|Lost to Follow-up|17|||
126475017|NCT00810355|455038138|FG002|Overall Study|Lost to Follow-up|11|||
126558797|NCT02507219|455338854|FG000|Overall Study|Physician Decision|1|||
126475018|NCT00810355|455038136|FG000|Overall Study|Withdrawal by Subject|1|||
126475019|NCT00810355|455038137|FG001|Overall Study|Withdrawal by Subject|0|||
126475020|NCT00810355|455038138|FG002|Overall Study|Withdrawal by Subject|0|||
126475021|NCT01484275|455038139|FG000|Overall Study|Study terminated by sponsor|28|||
126475022|NCT01484275|455038140|FG001|Overall Study|Study terminated by sponsor|32|||
126412887|NCT00291018|454805792|FG001|Overall Study|Withdrawal by Subject|8|||
126412888|NCT00291018|454805793|FG002|Overall Study|Withdrawal by Subject|1|||
126412889|NCT00291018|454805791|FG000|Overall Study|Failures|5|||
126412890|NCT00291018|454805792|FG001|Overall Study|Failures|12|||
126412891|NCT00291018|454805793|FG002|Overall Study|Failures|5|||
126412892|NCT00291018|454805791|FG000|Overall Study|Lost to Follow-up|3|||
126412893|NCT00291018|454805792|FG001|Overall Study|Lost to Follow-up|4|||
126412894|NCT00291018|454805793|FG002|Overall Study|Lost to Follow-up|18|||
126412895|NCT00630344|454805794|FG000|Overall Study|Adverse Event|5|||
126412896|NCT00630344|454805794|FG000|Overall Study|Progressive Disease|19|||
126412897|NCT00630344|454805794|FG000|Overall Study|Physician Decision|9|||
126412898|NCT00630344|454805794|FG000|Overall Study|Withdrawal by Subject|1|||
126412899|NCT00630344|454805794|FG000|Overall Study|Intercurrent Illness|1|||
126412900|NCT00630344|454805794|FG000|Overall Study|Other|1|||
126412901|NCT01357551|454805795|FG000|Overall Study|Withdrawal by Subject|6|||
126412902|NCT01357551|454805796|FG001|Overall Study|Withdrawal by Subject|4|||
126412903|NCT01357551|454805795|FG000|Overall Study|Death|0|||
126412904|NCT01357551|454805796|FG001|Overall Study|Death|1|||
126412905|NCT01357551|454805795|FG000|Overall Study|Lost to Follow-up|16|||
126412906|NCT01357551|454805796|FG001|Overall Study|Lost to Follow-up|6|||
126412907|NCT00413036|454805797|FG000|Overall Study|Adverse Event|44|||
126412908|NCT00413036|454805797|FG000|Overall Study|Lack of Efficacy|129|||
126412909|NCT00413036|454805797|FG000|Overall Study|Withdrawal by Subject|7|||
126412910|NCT00413036|454805797|FG000|Overall Study|Death|9|||
126412911|NCT00413036|454805797|FG000|Overall Study|Other|26|||
126412912|NCT00413036|454805797|FG000|Overall Study|Missing|2|||
126412913|NCT01369641|454805798|FG000|Overall Study|Withdrawal by Subject|1|||
126412914|NCT00842543|454805799|FG000|Overall Study|Withdrawal by Subject|2|||
126412915|NCT00842543|454805800|FG001|Overall Study|Withdrawal by Subject|0|||
126412916|NCT00842543|454805801|FG002|Overall Study|Withdrawal by Subject|3|||
126412917|NCT00842543|454805802|FG003|Overall Study|Withdrawal by Subject|4|||
126412918|NCT01483183|454805807|FG000|Overall Study|Physician Decision|0|||
126412919|NCT01483183|454805808|FG001|Overall Study|Physician Decision|0|||
126412920|NCT01483183|454805809|FG002|Overall Study|Physician Decision|0|||
126412921|NCT01483183|454805810|FG003|Overall Study|Physician Decision|0|||
126412922|NCT01483183|454805811|FG004|Overall Study|Physician Decision|0|||
126412923|NCT01483183|454805812|FG005|Overall Study|Physician Decision|0|||
126412924|NCT01483183|454805813|FG006|Overall Study|Physician Decision|2|||
126412925|NCT01483183|454805814|FG007|Overall Study|Physician Decision|0|||
126412926|NCT01483183|454805815|FG008|Overall Study|Physician Decision|0|||
126412927|NCT01483183|454805816|FG009|Overall Study|Physician Decision|0|||
126412928|NCT01483183|454805807|FG000|Overall Study|Withdrawal by Subject|0|||
126412929|NCT01483183|454805808|FG001|Overall Study|Withdrawal by Subject|0|||
126412930|NCT01483183|454805809|FG002|Overall Study|Withdrawal by Subject|0|||
126412931|NCT01483183|454805810|FG003|Overall Study|Withdrawal by Subject|0|||
126412932|NCT01483183|454805811|FG004|Overall Study|Withdrawal by Subject|0|||
126412933|NCT01483183|454805812|FG005|Overall Study|Withdrawal by Subject|0|||
126412934|NCT01483183|454805813|FG006|Overall Study|Withdrawal by Subject|0|||
126412935|NCT01483183|454805814|FG007|Overall Study|Withdrawal by Subject|0|||
126412936|NCT01483183|454805815|FG008|Overall Study|Withdrawal by Subject|0|||
126412937|NCT01483183|454805816|FG009|Overall Study|Withdrawal by Subject|1|||
126412938|NCT02524158|454805818|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
126412939|NCT02524158|454805819|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
126412940|NCT02524158|454805818|FG000|12-weeks Assessment|Lost to Follow-up|18|||
126412941|NCT02524158|454805819|FG001|12-weeks Assessment|Lost to Follow-up|12|||
126412942|NCT02524158|454805818|FG000|6-month Assessment|Withdrawal by Subject|1|||
126412943|NCT02524158|454805819|FG001|6-month Assessment|Withdrawal by Subject|1|||
126412944|NCT02524158|454805818|FG000|6-month Assessment|Lost to Follow-up|21|||
126412945|NCT02524158|454805819|FG001|6-month Assessment|Lost to Follow-up|20|||
126475023|NCT01484275|455038139|FG000|Overall Study|Other|10|||
126475024|NCT01484275|455038140|FG001|Overall Study|Other|0|||
126412946|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126412947|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126412948|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
126475025|NCT01484275|455038139|FG000|Overall Study|Death|3|||
126412949|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
126412950|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
126475026|NCT01484275|455038140|FG001|Overall Study|Death|4|||
126475027|NCT01484275|455038139|FG000|Overall Study|Withdrawal by Subject|1|||
126412951|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126412952|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
126412953|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
126412954|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
126412955|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126412956|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126475028|NCT01484275|455038140|FG001|Overall Study|Withdrawal by Subject|5|||
126412957|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126475029|NCT01484275|455038139|FG000|Overall Study|Lost to Follow-up|1|||
126412958|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
126412959|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
126412960|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
126412961|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
126412962|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
126412963|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
126412964|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
126412965|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
126412966|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
126412967|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
126412968|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
126412969|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
126412970|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
126412971|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
126412972|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412973|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
126412974|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
126412975|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412976|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412977|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
126412978|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
126412979|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412980|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412981|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412982|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412983|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412984|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
126412985|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412986|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
126412987|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
126412988|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412989|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126475030|NCT01484275|455038140|FG001|Overall Study|Lost to Follow-up|1|||
126475031|NCT00003487|455038141|FG000|Overall Study|Not evaluable|2|||
126475032|NCT04154930|455038144|FG000|Overall Study|Withdrawal by Subject|15|||
126475033|NCT04154930|455038145|FG001|Overall Study|Withdrawal by Subject|6|||
126475034|NCT04154930|455038144|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
126475035|NCT04154930|455038145|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
126475036|NCT04154930|455038144|FG000|Overall Study|Lost to Follow-up|14|||
126475037|NCT04154930|455038145|FG001|Overall Study|Lost to Follow-up|6|||
126475038|NCT04154930|455038144|FG000|Overall Study|Other|6|||
126475039|NCT04154930|455038145|FG001|Overall Study|Other|0|||
126475040|NCT03855228|455038147|FG000|Overall Study|Adverse Event|2|||
126475041|NCT03855228|455038148|FG001|Overall Study|Adverse Event|4|||
126475042|NCT03855228|455038149|FG002|Overall Study|Adverse Event|4|||
126475043|NCT03855228|455038150|FG003|Overall Study|Adverse Event|8|||
126475044|NCT03855228|455038147|FG000|Overall Study|Treatment Failure|1|||
126475045|NCT03855228|455038148|FG001|Overall Study|Treatment Failure|2|||
126475046|NCT03855228|455038149|FG002|Overall Study|Treatment Failure|1|||
126475047|NCT03855228|455038150|FG003|Overall Study|Treatment Failure|8|||
126475048|NCT03855228|455038147|FG000|Overall Study|Lost to Follow-up|0|||
126475049|NCT03855228|455038148|FG001|Overall Study|Lost to Follow-up|0|||
126475050|NCT03855228|455038149|FG002|Overall Study|Lost to Follow-up|0|||
126475051|NCT03855228|455038150|FG003|Overall Study|Lost to Follow-up|1|||
126475052|NCT03855228|455038147|FG000|Overall Study|Protocol Violation|0|||
126475053|NCT03855228|455038148|FG001|Overall Study|Protocol Violation|1|||
126475054|NCT03855228|455038149|FG002|Overall Study|Protocol Violation|2|||
126475055|NCT03855228|455038150|FG003|Overall Study|Protocol Violation|1|||
126475056|NCT03855228|455038147|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
126475057|NCT03855228|455038148|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
126475058|NCT03855228|455038149|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
126475059|NCT03855228|455038150|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
126475060|NCT02130297|455038155|FG000|Overall Study|Lost to Follow-up|4|||
126475061|NCT02004522|455038166|FG000|Overall Study|Adverse Event|55|||
126475062|NCT02004522|455038167|FG001|Overall Study|Adverse Event|6|||
126475063|NCT02004522|455038166|FG000|Overall Study|Withdrawal by Subject|13|||
126475064|NCT02004522|455038167|FG001|Overall Study|Withdrawal by Subject|7|||
126475065|NCT02004522|455038166|FG000|Overall Study|Death|12|||
126475066|NCT02004522|455038167|FG001|Overall Study|Death|3|||
126475067|NCT02004522|455038166|FG000|Overall Study|Physician Decision|3|||
126475068|NCT02004522|455038167|FG001|Overall Study|Physician Decision|4|||
126475069|NCT02004522|455038166|FG000|Overall Study|Protocol Violation|1|||
126475070|NCT02004522|455038167|FG001|Overall Study|Protocol Violation|0|||
126475071|NCT02004522|455038166|FG000|Overall Study|Other is reason listed by PI|4|||
126475072|NCT02004522|455038167|FG001|Overall Study|Other is reason listed by PI|1|||
126475073|NCT02004522|455038166|FG000|Overall Study|Never Dosed|2|||
126475074|NCT02004522|455038167|FG001|Overall Study|Never Dosed|4|||
126475075|NCT02004522|455038166|FG000|Overall Study|Disease Progression|35|||
126475076|NCT02004522|455038167|FG001|Overall Study|Disease Progression|31|||
126475077|NCT02004522|455038166|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
126475078|NCT02004522|455038167|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
126475079|NCT01787331|455038168|FG000|Overall Study|Physician Decision|1|||
126475080|NCT01787331|455038168|FG000|Overall Study|Withdrawal by Subject|1|||
126475081|NCT00450255|455038171|FG000|Overall Study|Prior RFA ablation of liver|1|||
126475082|NCT01696071|455038172|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
126475083|NCT01696071|455038173|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
126475084|NCT00678080|455038174|FG000|Overall Study|Physician Decision|2|||
126475085|NCT00678080|455038175|FG001|Overall Study|Physician Decision|0|||
126475086|NCT00678080|455038174|FG000|Overall Study|Lost to Follow-up|1|||
126475087|NCT00678080|455038175|FG001|Overall Study|Lost to Follow-up|0|||
126475088|NCT00678080|455038174|FG000|Overall Study|Withdrawal by Subject|0|||
126475089|NCT00678080|455038175|FG001|Overall Study|Withdrawal by Subject|1|||
126475090|NCT03730012|455038176|FG000|Overall Study|Adverse Event|0|||
126475091|NCT03730012|455038177|FG001|Overall Study|Adverse Event|1|||
126475092|NCT03730012|455038176|FG000|Overall Study|Lack of Efficacy|1|||
126475093|NCT03730012|455038177|FG001|Overall Study|Lack of Efficacy|5|||
126475094|NCT03730012|455038176|FG000|Overall Study|Withdrawal by Subject|0|||
126475095|NCT03730012|455038177|FG001|Overall Study|Withdrawal by Subject|1|||
126475096|NCT03730012|455038176|FG000|Overall Study|Miscellaneous|2|||
126475097|NCT03730012|455038177|FG001|Overall Study|Miscellaneous|1|||
126475098|NCT03320057|455039886|FG000|Overall Study|Lost to Follow-up|4|||
126475099|NCT03320057|455039887|FG001|Overall Study|Lost to Follow-up|17|||
126475100|NCT03320057|455039886|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
126475101|NCT03320057|455039887|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
126475102|NCT01367002|455039890|FG000|Overall Study|Withdrawal by Subject|1|||
126475103|NCT01367002|455039891|FG001|Overall Study|Withdrawal by Subject|0|||
126475104|NCT01367002|455039890|FG000|Overall Study|Physician Decision|0|||
126475105|NCT01367002|455039891|FG001|Overall Study|Physician Decision|2|||
126475106|NCT00717093|455039893|FG000|Overall Study|Adverse Event|19|||
126475107|NCT00717093|455039894|FG001|Overall Study|Adverse Event|9|||
126475108|NCT00717093|455039893|FG000|Overall Study|Lack of Efficacy|3|||
126475109|NCT00717093|455039894|FG001|Overall Study|Lack of Efficacy|13|||
126475110|NCT00717093|455039893|FG000|Overall Study|Lost to Follow-up|9|||
126475111|NCT00717093|455039894|FG001|Overall Study|Lost to Follow-up|6|||
126475112|NCT00717093|455039893|FG000|Overall Study|Withdrawal by Subject|12|||
126475113|NCT00717093|455039894|FG001|Overall Study|Withdrawal by Subject|19|||
126475114|NCT00717093|455039893|FG000|Overall Study|Other|0|||
126475115|NCT00717093|455039894|FG001|Overall Study|Other|1|||
126475116|NCT00717093|455039893|FG000|Overall Study|Randomized but not treated|1|||
126475117|NCT00717093|455039894|FG001|Overall Study|Randomized but not treated|0|||
126475118|NCT01516437|455039895|FG000|Overall Study|Reason not specified|0|||
126475119|NCT01516437|455039896|FG001|Overall Study|Reason not specified|0|||
126475120|NCT01516437|455039897|FG002|Overall Study|Reason not specified|1|||
126558798|NCT02507219|455338855|FG001|Overall Study|Physician Decision|0|||
126558799|NCT02507219|455338856|FG002|Overall Study|Physician Decision|0|||
126558800|NCT02507219|455338857|FG003|Overall Study|Physician Decision|0|||
126558801|NCT02507219|455338858|FG004|Overall Study|Physician Decision|0|||
126558802|NCT02507219|455338859|FG005|Overall Study|Physician Decision|0|||
126558803|NCT02507219|455338854|FG000|Overall Study|Withdrawal by Subject|0|||
126558804|NCT02507219|455338855|FG001|Overall Study|Withdrawal by Subject|0|||
126558805|NCT02507219|455338856|FG002|Overall Study|Withdrawal by Subject|0|||
126558806|NCT02507219|455338857|FG003|Overall Study|Withdrawal by Subject|0|||
126558807|NCT02507219|455338858|FG004|Overall Study|Withdrawal by Subject|1|||
126558808|NCT02507219|455338859|FG005|Overall Study|Withdrawal by Subject|0|||
126721537|NCT01842620|455929999|FG001|Period 1|Withdrawal by Subject|0|||
126475121|NCT01516437|455039898|FG003|Overall Study|Reason not specified|1|||
126475122|NCT01897454|455039903|FG000|Overall Study|Withdrawal by Subject|1|||
126721538|NCT02739594|455930002|FG000|Overall Study|Undesired Event|3|||
126475123|NCT03689530|455039908|FG000|Overall Study|Withdrawal by Subject|53|||
126475124|NCT03689530|455039909|FG001|Overall Study|Withdrawal by Subject|16|||
126558809|NCT01342887|455338869|FG000|Overall Study|Death|2|||
126558810|NCT00209274|455338870|FG000|Overall Study|Missed visit|3|||
126721539|NCT02739594|455930003|FG001|Overall Study|Undesired Event|4|||
126475125|NCT01392443|455039910|FG000|Overall Study|Disease progression|30|||
126475126|NCT01392443|455039910|FG000|Overall Study|Adverse Event|24|||
126558811|NCT00209274|455338871|FG001|Overall Study|Missed visit|2|||
126558812|NCT00209274|455338870|FG000|Overall Study|Death|32|||
126558813|NCT00209274|455338871|FG001|Overall Study|Death|15|||
126558814|NCT00209274|455338870|FG000|Overall Study|Withdrawal by Subject|30|||
126558815|NCT00209274|455338871|FG001|Overall Study|Withdrawal by Subject|15|||
126558816|NCT00209274|455338870|FG000|Overall Study|Randomized not treated (RNT)|6|||
126558817|NCT00209274|455338871|FG001|Overall Study|Randomized not treated (RNT)|15|||
126558818|NCT02753530|455338872|FG000|Overall Study|Adverse Event|7|||
126412990|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412991|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
126412992|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412993|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
126412994|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412995|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412996|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412997|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
126412998|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126412999|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413000|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413001|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
126413002|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413003|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413004|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413005|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
126413006|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413007|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413008|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413009|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413010|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
126413011|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413012|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413013|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413014|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
126413015|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413016|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413017|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
126413018|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413019|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413020|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413021|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413022|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413023|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
126413024|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413025|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
126413026|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413027|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413028|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413029|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413030|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413031|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413032|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413033|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413034|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413035|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413036|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
126413037|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
126413038|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413039|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413040|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413041|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413042|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413043|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413044|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413045|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413046|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413047|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413048|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413049|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
126413050|NCT03100058|454805820|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413051|NCT03100058|454805821|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413052|NCT03100058|454805822|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413053|NCT03100058|454805823|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413054|NCT03100058|454805824|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413055|NCT03100058|454805825|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126558819|NCT02753530|455338873|FG001|Overall Study|Adverse Event|1|||
126558820|NCT02753530|455338872|FG000|Overall Study|Death|0|||
126413056|NCT03100058|454805826|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
126558821|NCT02753530|455338873|FG001|Overall Study|Death|1|||
126558822|NCT02753530|455338872|FG000|Overall Study|Physician Decision|0|||
126558823|NCT02753530|455338873|FG001|Overall Study|Physician Decision|1|||
126558824|NCT02753530|455338872|FG000|Overall Study|Protocol Violation|1|||
126558825|NCT02753530|455338873|FG001|Overall Study|Protocol Violation|0|||
126558826|NCT02753530|455338872|FG000|Overall Study|Withdrawal by Subject|4|||
126558827|NCT02753530|455338873|FG001|Overall Study|Withdrawal by Subject|3|||
126558828|NCT00429793|455338882|FG000|Overall Study|Improper pre-protocol treatment|3|||
126558829|NCT00429793|455338882|FG000|Overall Study|Required test not done|1|||
126558830|NCT00429793|455338882|FG000|Overall Study|Never treated|1|||
126558831|NCT00429793|455338882|FG000|Overall Study|Non-measurable|1|||
126558832|NCT01641861|455338883|FG000|Overall Study|Lost to Follow-up|21|||
126558833|NCT01641861|455338884|FG001|Overall Study|Lost to Follow-up|16|||
126558834|NCT01641861|455338883|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
126558835|NCT01641861|455338884|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
126558836|NCT01641861|455338883|FG000|Overall Study|Died due to drowning|0|||
126558837|NCT01641861|455338884|FG001|Overall Study|Died due to drowning|1|||
126558838|NCT00163215|455340565|FG000|Overall Study|Lack of Efficacy|3|||
126558839|NCT00163215|455340565|FG000|Overall Study|Withdrawal by Subject|5|||
126558840|NCT00163215|455340565|FG000|Overall Study|Other|7|||
126558841|NCT00231179|455340566|FG000|Overall Study|Lost to Follow-up|21|||
126558842|NCT00231179|455340567|FG001|Overall Study|Lost to Follow-up|21|||
126558843|NCT00231179|455340566|FG000|Overall Study|Withdrawal by Subject|3|||
126558844|NCT00231179|455340567|FG001|Overall Study|Withdrawal by Subject|3|||
126558845|NCT04034238|455340568|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
126558846|NCT04034238|455340569|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
126558847|NCT04034238|455340570|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
126558848|NCT04034238|455340571|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126558849|NCT04034238|455340568|FG000|Dose Escalation Phase|Screen failures|0|||
126558850|NCT04034238|455340569|FG001|Dose Escalation Phase|Screen failures|0|||
126558851|NCT04034238|455340570|FG002|Dose Escalation Phase|Screen failures|0|||
126558852|NCT04034238|455340571|FG003|Dose Escalation Phase|Screen failures|2|||
126558853|NCT04034238|455340568|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
126558854|NCT04034238|455340569|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
126558855|NCT04034238|455340570|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
126558856|NCT04034238|455340571|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
126558857|NCT04034238|455340568|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
126558858|NCT04034238|455340569|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
126558859|NCT04034238|455340570|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
126558860|NCT04034238|455340571|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
126558861|NCT02652130|455340572|FG000|Overall Study|Death|1|||
126558862|NCT02028884|455340573|FG000|Double-blind Period|Adverse Event|5|||
126721540|NCT02739594|455930002|FG000|Overall Study|Violation of Eligibility Criteria|1|||
126721541|NCT02739594|455930003|FG001|Overall Study|Violation of Eligibility Criteria|2|||
126721542|NCT02739594|455930002|FG000|Overall Study|Protocol Violation|5|||
126721543|NCT02739594|455930003|FG001|Overall Study|Protocol Violation|6|||
126721544|NCT02739594|455930002|FG000|Overall Study|Death|4|||
126721545|NCT02739594|455930003|FG001|Overall Study|Death|2|||
126413057|NCT03100058|454805827|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413058|NCT03100058|454805828|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413059|NCT03100058|454805829|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413060|NCT03100058|454805830|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413061|NCT03100058|454805831|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413062|NCT03100058|454805832|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
126413063|NCT03100058|454805820|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413064|NCT03100058|454805821|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413065|NCT03100058|454805822|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413066|NCT03100058|454805823|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413067|NCT03100058|454805824|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126558863|NCT02028884|455340574|FG001|Double-blind Period|Adverse Event|3|||
126558864|NCT02028884|455340575|FG002|Double-blind Period|Adverse Event|0|||
126558865|NCT02028884|455340573|FG000|Double-blind Period|Eligibility Violation|1|||
126721546|NCT02739594|455930002|FG000|Overall Study|Renal Insufficiency|4|||
126721547|NCT02739594|455930003|FG001|Overall Study|Renal Insufficiency|6|||
126721548|NCT02739594|455930002|FG000|Overall Study|Administrative Reasons|1|||
126721549|NCT02739594|455930003|FG001|Overall Study|Administrative Reasons|3|||
126558866|NCT02028884|455340574|FG001|Double-blind Period|Eligibility Violation|0|||
126558867|NCT02028884|455340575|FG002|Double-blind Period|Eligibility Violation|0|||
126558868|NCT02028884|455340573|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
126413068|NCT03100058|454805825|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413069|NCT03100058|454805826|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413070|NCT03100058|454805827|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413071|NCT03100058|454805828|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413072|NCT03100058|454805829|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
126413073|NCT03100058|454805830|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
126413074|NCT03100058|454805831|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
126413075|NCT03100058|454805832|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
126413076|NCT03100058|454805820|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413077|NCT03100058|454805821|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413078|NCT03100058|454805822|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413079|NCT03100058|454805823|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413080|NCT03100058|454805824|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413081|NCT03100058|454805825|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413082|NCT03100058|454805826|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413083|NCT03100058|454805827|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413084|NCT03100058|454805828|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413085|NCT03100058|454805829|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413086|NCT03100058|454805830|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
126413087|NCT03100058|454805831|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
126413088|NCT03100058|454805832|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
126413089|NCT03100058|454805820|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413090|NCT03100058|454805821|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413091|NCT03100058|454805822|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413092|NCT03100058|454805823|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413093|NCT03100058|454805824|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413094|NCT03100058|454805825|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413095|NCT03100058|454805826|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413096|NCT03100058|454805827|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413097|NCT03100058|454805828|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413098|NCT03100058|454805829|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
126413099|NCT03100058|454805830|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
126413100|NCT03100058|454805831|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
126413101|NCT03100058|454805832|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
126413102|NCT03100058|454805820|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413103|NCT03100058|454805821|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413104|NCT03100058|454805822|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413105|NCT03100058|454805823|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413106|NCT03100058|454805824|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413107|NCT03100058|454805825|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413108|NCT03100058|454805826|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413109|NCT03100058|454805827|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413110|NCT03100058|454805828|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413111|NCT03100058|454805829|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413112|NCT03100058|454805830|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
126413113|NCT03100058|454805831|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413114|NCT03100058|454805832|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
126413115|NCT03100058|454805820|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413116|NCT03100058|454805821|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413117|NCT03100058|454805822|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413118|NCT03100058|454805823|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413119|NCT03100058|454805824|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413120|NCT03100058|454805825|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413121|NCT03100058|454805826|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413122|NCT03100058|454805827|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413123|NCT03100058|454805828|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413124|NCT03100058|454805829|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413125|NCT03100058|454805830|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126413126|NCT03100058|454805831|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
126475127|NCT01392443|455039910|FG000|Overall Study|Death|7|||
126413127|NCT03100058|454805832|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
126475128|NCT01392443|455039910|FG000|Overall Study|Withdrawal by Subject|5|||
126475129|NCT01392443|455039910|FG000|Overall Study|Lost to Follow-up|1|||
126475130|NCT01392443|455039910|FG000|Overall Study|Protocol Violation|1|||
126475131|NCT01977794|455039913|FG000|Overall Study|Adverse Event|2|||
126475132|NCT01977794|455039914|FG001|Overall Study|Adverse Event|2|||
126475133|NCT01977794|455039913|FG000|Overall Study|Lost to Follow-up|2|||
126475134|NCT01977794|455039914|FG001|Overall Study|Lost to Follow-up|1|||
126413128|NCT03100058|454805820|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413129|NCT03100058|454805821|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413130|NCT03100058|454805822|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413131|NCT03100058|454805823|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413132|NCT03100058|454805824|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413133|NCT03100058|454805825|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413134|NCT03100058|454805826|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413135|NCT03100058|454805827|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413136|NCT03100058|454805828|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413137|NCT03100058|454805829|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
126413138|NCT03100058|454805830|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413139|NCT03100058|454805831|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413140|NCT03100058|454805832|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
126413141|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
126413142|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
126413143|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
126413144|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
126413145|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Death|2|||
126413146|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Death|2|||
126413147|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Death|0|||
126413148|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Death|0|||
126413149|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
126413150|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
126413151|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
126413152|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
126413153|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
126413154|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
126413155|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
126413156|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
126413157|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
126413158|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
126413159|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
126413160|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
126413161|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
126413162|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
126413163|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
126413164|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
126413165|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
126413166|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
126413167|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
126413168|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
126413169|NCT03068754|454805840|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
126413170|NCT03068754|454805841|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
126413171|NCT03068754|454805842|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
126413172|NCT03068754|454805843|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
126413173|NCT03068754|454805840|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
126413174|NCT03068754|454805841|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
126413175|NCT03068754|454805842|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
126413176|NCT03068754|454805843|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
126413177|NCT03068754|454805840|FG000|Open Label Extension Period (OLE)|Death|0|||
126413178|NCT03068754|454805841|FG001|Open Label Extension Period (OLE)|Death|0|||
126413179|NCT03068754|454805842|FG002|Open Label Extension Period (OLE)|Death|0|||
126413180|NCT03068754|454805843|FG003|Open Label Extension Period (OLE)|Death|1|||
126413181|NCT03068754|454805840|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
126413182|NCT03068754|454805841|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
126413183|NCT03068754|454805842|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
126413184|NCT03068754|454805843|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
126413185|NCT03068754|454805840|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
126413186|NCT03068754|454805841|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
126475135|NCT01977794|455039913|FG000|Overall Study|Protocol Violation|1|||
126475136|NCT01977794|455039914|FG001|Overall Study|Protocol Violation|0|||
126475137|NCT01977794|455039913|FG000|Overall Study|Death|1|||
126475138|NCT01977794|455039914|FG001|Overall Study|Death|1|||
126475139|NCT01977794|455039913|FG000|Overall Study|Withdrew consent|2|||
126475140|NCT01977794|455039914|FG001|Overall Study|Withdrew consent|1|||
126475141|NCT01977794|455039913|FG000|Overall Study|Other|0|||
126475142|NCT01977794|455039914|FG001|Overall Study|Other|1|||
126475143|NCT02555683|455039915|FG000|Overall Study|Physician Decision|1|||
126475144|NCT02555683|455039916|FG001|Overall Study|Physician Decision|0|||
126475145|NCT02555683|455039917|FG002|Overall Study|Physician Decision|2|||
126475146|NCT02555683|455039915|FG000|Overall Study|Lost to Follow-up|2|||
126475147|NCT02555683|455039916|FG001|Overall Study|Lost to Follow-up|1|||
126475148|NCT02555683|455039917|FG002|Overall Study|Lost to Follow-up|2|||
126558869|NCT02028884|455340574|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
126413187|NCT03068754|454805842|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
126413188|NCT03068754|454805843|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
126413189|NCT03068754|454805840|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
126413190|NCT03068754|454805841|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
126413191|NCT03068754|454805842|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
126413192|NCT03068754|454805843|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
126413193|NCT03068754|454805840|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
126413194|NCT03068754|454805841|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
126413195|NCT03068754|454805842|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
126413196|NCT03068754|454805843|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
126413197|NCT02690714|454805844|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
126413198|NCT02690714|454805844|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
126413199|NCT00666965|454805845|FG000|Overall Study|Adverse Event|0|||
126413200|NCT00666965|454805846|FG001|Overall Study|Adverse Event|2|||
126413201|NCT00666965|454805847|FG002|Overall Study|Adverse Event|1|||
126413202|NCT00666965|454805848|FG003|Overall Study|Adverse Event|9|||
126413203|NCT00666965|454805845|FG000|Overall Study|Lack of Efficacy|1|||
126413204|NCT00666965|454805846|FG001|Overall Study|Lack of Efficacy|1|||
126413205|NCT00666965|454805847|FG002|Overall Study|Lack of Efficacy|0|||
126413206|NCT00666965|454805848|FG003|Overall Study|Lack of Efficacy|0|||
126413207|NCT00666965|454805845|FG000|Overall Study|Protocol Violation|0|||
126413208|NCT00666965|454805846|FG001|Overall Study|Protocol Violation|0|||
126413209|NCT00666965|454805847|FG002|Overall Study|Protocol Violation|0|||
126413210|NCT00666965|454805848|FG003|Overall Study|Protocol Violation|2|||
126413211|NCT00666965|454805845|FG000|Overall Study|Discontinuation criteria|2|||
126413212|NCT00666965|454805846|FG001|Overall Study|Discontinuation criteria|1|||
126413213|NCT00666965|454805847|FG002|Overall Study|Discontinuation criteria|1|||
126413214|NCT00666965|454805848|FG003|Overall Study|Discontinuation criteria|2|||
126413215|NCT00666965|454805845|FG000|Overall Study|Withdrawal by Subject|0|||
126413216|NCT00666965|454805846|FG001|Overall Study|Withdrawal by Subject|0|||
126413217|NCT00666965|454805847|FG002|Overall Study|Withdrawal by Subject|0|||
126413218|NCT00666965|454805848|FG003|Overall Study|Withdrawal by Subject|2|||
126413219|NCT02202538|454805852|FG000|Overall Study|Withdrawal by Subject|5|||
126413220|NCT02202538|454805852|FG000|Overall Study|Did not meet all inclusion criteria|2|||
126413221|NCT02202538|454805852|FG000|Overall Study|Investigator Decision|1|||
126413222|NCT01853878|454805853|FG000|Overall Study|Recurrence|2|||
126413223|NCT01853878|454805854|FG001|Overall Study|Recurrence|0|||
126413224|NCT01853878|454805853|FG000|Overall Study|Adverse Event|2|||
126413225|NCT01853878|454805854|FG001|Overall Study|Adverse Event|0|||
126413226|NCT01853878|454805853|FG000|Overall Study|Withdrawal by Subject|3|||
126413227|NCT01853878|454805854|FG001|Overall Study|Withdrawal by Subject|1|||
126413228|NCT01853878|454805853|FG000|Overall Study|Migrated/moved from the study area|1|||
126413229|NCT01853878|454805854|FG001|Overall Study|Migrated/moved from the study area|0|||
126413230|NCT01853878|454805853|FG000|Overall Study|Other|55|||
126413231|NCT01853878|454805854|FG001|Overall Study|Other|43|||
126413232|NCT02161757|454805855|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
126475149|NCT02555683|455039915|FG000|Overall Study|Technical Problems|1|||
126475150|NCT02555683|455039916|FG001|Overall Study|Technical Problems|1|||
126475151|NCT02555683|455039917|FG002|Overall Study|Technical Problems|0|||
126475152|NCT02555683|455039915|FG000|Overall Study|Protocol deviation|0|||
126558870|NCT02028884|455340575|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
126721550|NCT02739594|455930002|FG000|Overall Study|Withdrawal by Subject|1|||
126475153|NCT02555683|455039916|FG001|Overall Study|Protocol deviation|1|||
126475154|NCT02555683|455039917|FG002|Overall Study|Protocol deviation|0|||
126475155|NCT02555683|455039915|FG000|Overall Study|Lack of Efficacy|2|||
126413233|NCT02161757|454805856|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
126413234|NCT02161757|454805857|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
126413235|NCT02161757|454805855|FG000|Treatment Through Study Completion|Adverse Event|1|||
126413236|NCT02161757|454805856|FG001|Treatment Through Study Completion|Adverse Event|1|||
126413237|NCT02161757|454805857|FG002|Treatment Through Study Completion|Adverse Event|0|||
126413238|NCT02161757|454805855|FG000|Treatment Through Study Completion|Protocol Violation|0|||
126413239|NCT02161757|454805856|FG001|Treatment Through Study Completion|Protocol Violation|1|||
126413240|NCT02161757|454805857|FG002|Treatment Through Study Completion|Protocol Violation|2|||
126413241|NCT02161757|454805855|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
126413242|NCT02161757|454805856|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
126413243|NCT02161757|454805857|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
126413244|NCT02161757|454805855|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
126413245|NCT02161757|454805856|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
126413246|NCT02161757|454805857|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
126413247|NCT02161757|454805855|FG000|Treatment Through Study Completion|Other|20|||
126413248|NCT02161757|454805856|FG001|Treatment Through Study Completion|Other|19|||
126413249|NCT02161757|454805857|FG002|Treatment Through Study Completion|Other|12|||
126413250|NCT02161757|454805855|FG000|Treatment Through Study Completion|Death|2|||
126413251|NCT02161757|454805856|FG001|Treatment Through Study Completion|Death|1|||
126413252|NCT02161757|454805857|FG002|Treatment Through Study Completion|Death|1|||
126413253|NCT03916081|454805862|FG000|Overall Study|Adverse Event|1|||
126413254|NCT03916081|454805863|FG001|Overall Study|Adverse Event|0|||
126413255|NCT03916081|454805864|FG002|Overall Study|Adverse Event|0|||
126413256|NCT03916081|454805862|FG000|Overall Study|Physician Decision|0|||
126413257|NCT03916081|454805863|FG001|Overall Study|Physician Decision|0|||
126413258|NCT03916081|454805864|FG002|Overall Study|Physician Decision|1|||
126413259|NCT03916081|454805862|FG000|Overall Study|Lost to Follow-up|0|||
126413260|NCT03916081|454805863|FG001|Overall Study|Lost to Follow-up|1|||
126413261|NCT03916081|454805864|FG002|Overall Study|Lost to Follow-up|0|||
126413262|NCT03916081|454805862|FG000|Overall Study|Withdrawal by Subject|3|||
126413263|NCT03916081|454805863|FG001|Overall Study|Withdrawal by Subject|0|||
126413264|NCT03916081|454805864|FG002|Overall Study|Withdrawal by Subject|1|||
126413265|NCT03916081|454805862|FG000|Overall Study|Worsening of AD|0|||
126413266|NCT03916081|454805863|FG001|Overall Study|Worsening of AD|0|||
126413267|NCT03916081|454805864|FG002|Overall Study|Worsening of AD|1|||
126413268|NCT00465647|454805867|FG000|Overall Study|Administrative|2|||
126413269|NCT00465647|454805868|FG001|Overall Study|Administrative|2|||
126413270|NCT00465647|454805869|FG002|Overall Study|Administrative|3|||
126413271|NCT00465647|454805870|FG003|Overall Study|Administrative|2|||
126413272|NCT00465647|454805867|FG000|Overall Study|Adverse Event|2|||
126413273|NCT00465647|454805868|FG001|Overall Study|Adverse Event|0|||
126413274|NCT00465647|454805869|FG002|Overall Study|Adverse Event|3|||
126413275|NCT00465647|454805870|FG003|Overall Study|Adverse Event|2|||
126413276|NCT00465647|454805867|FG000|Overall Study|Withdrawal by Subject|1|||
126413277|NCT00465647|454805868|FG001|Overall Study|Withdrawal by Subject|2|||
126413278|NCT00465647|454805869|FG002|Overall Study|Withdrawal by Subject|2|||
126413279|NCT00465647|454805870|FG003|Overall Study|Withdrawal by Subject|7|||
126413280|NCT00465647|454805867|FG000|Overall Study|"The other reasons included loss of IV"|8|||
126413281|NCT00465647|454805868|FG001|Overall Study|"The other reasons included loss of IV"|4|||
126413282|NCT00465647|454805869|FG002|Overall Study|"The other reasons included loss of IV"|3|||
126413283|NCT00465647|454805870|FG003|Overall Study|"The other reasons included loss of IV"|2|||
126413284|NCT02891382|454805871|FG000|Overall Study|Lost to Follow-up|3|||
126413285|NCT02891382|454805872|FG001|Overall Study|Lost to Follow-up|4|||
126413286|NCT02891382|454805873|FG002|Overall Study|Lost to Follow-up|5|||
126413287|NCT02891382|454805874|FG003|Overall Study|Lost to Follow-up|3|||
126413288|NCT02891382|454805875|FG004|Overall Study|Lost to Follow-up|4|||
126413289|NCT02828020|454805878|FG000|Treatment Period|Adverse Event|3|||
126413290|NCT02828020|454805879|FG001|Treatment Period|Adverse Event|1|||
126413291|NCT02828020|454805880|FG002|Treatment Period|Adverse Event|1|||
126413292|NCT02828020|454805878|FG000|Treatment Period|Withdrawal of Consent|10|||
126413293|NCT02828020|454805879|FG001|Treatment Period|Withdrawal of Consent|14|||
126413294|NCT02828020|454805880|FG002|Treatment Period|Withdrawal of Consent|9|||
126413295|NCT02828020|454805878|FG000|Treatment Period|Lost to Follow-up|21|||
126413296|NCT02828020|454805879|FG001|Treatment Period|Lost to Follow-up|24|||
126413297|NCT02828020|454805880|FG002|Treatment Period|Lost to Follow-up|18|||
126413298|NCT02828020|454805878|FG000|Treatment Period|Lack of Qualifying Event|44|||
126413299|NCT02828020|454805879|FG001|Treatment Period|Lack of Qualifying Event|53|||
126413300|NCT02828020|454805880|FG002|Treatment Period|Lack of Qualifying Event|43|||
126413301|NCT02828020|454805878|FG000|Treatment Period|Pregnancy|0|||
126413302|NCT02828020|454805879|FG001|Treatment Period|Pregnancy|2|||
126413303|NCT02828020|454805880|FG002|Treatment Period|Pregnancy|0|||
126413304|NCT02828020|454805878|FG000|Treatment Period|Protocol Violation|2|||
126413305|NCT02828020|454805879|FG001|Treatment Period|Protocol Violation|4|||
126413306|NCT02828020|454805880|FG002|Treatment Period|Protocol Violation|7|||
126413307|NCT02828020|454805878|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
126413308|NCT02828020|454805879|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
126413309|NCT02828020|454805880|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
126413310|NCT02828020|454805878|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
126413311|NCT02828020|454805879|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
126413312|NCT02828020|454805880|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
126413313|NCT02828020|454805878|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
126413314|NCT02828020|454805879|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
126413315|NCT02828020|454805880|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
126413316|NCT02828020|454805878|FG000|Safety Follow-up Period|Protocol Violation|0|||
126413317|NCT02828020|454805879|FG001|Safety Follow-up Period|Protocol Violation|2|||
126413318|NCT02828020|454805880|FG002|Safety Follow-up Period|Protocol Violation|1|||
126413319|NCT02828020|454805878|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
126413320|NCT02828020|454805879|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
126475156|NCT02555683|455039916|FG001|Overall Study|Lack of Efficacy|0|||
126475157|NCT02555683|455039917|FG002|Overall Study|Lack of Efficacy|0|||
126475158|NCT02555683|455039915|FG000|Overall Study|Death|0|||
126721551|NCT02739594|455930003|FG001|Overall Study|Withdrawal by Subject|1|||
126721552|NCT02739594|455930002|FG000|Overall Study|Lost to Follow-up|0|||
126721553|NCT02739594|455930003|FG001|Overall Study|Lost to Follow-up|1|||
126413321|NCT02828020|454805880|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
126413322|NCT01339897|454805881|FG000|Overall Study|Adverse Event|1|||
126413323|NCT01339897|454805882|FG001|Overall Study|Adverse Event|0|||
126413324|NCT01339897|454805883|FG002|Overall Study|Adverse Event|0|||
126413325|NCT01339897|454805884|FG003|Overall Study|Adverse Event|1|||
126413326|NCT01138501|454805885|FG000|Overall Study|Protocol Violation|2|||
126413327|NCT01138501|454805885|FG000|Overall Study|Withdrawal by Subject|3|||
126413328|NCT00847197|454805888|FG000|Overall Study|Adverse Event|21|||
126413329|NCT00847197|454805889|FG001|Overall Study|Adverse Event|3|||
126413330|NCT00847197|454805888|FG000|Overall Study|Protocol Violation|0|||
126413331|NCT00847197|454805889|FG001|Overall Study|Protocol Violation|1|||
126413332|NCT00847197|454805888|FG000|Overall Study|Withdrawal by Subject|3|||
126413333|NCT00847197|454805889|FG001|Overall Study|Withdrawal by Subject|1|||
126413334|NCT00622388|454805890|FG000|Overall Study|Disease Progression|47|||
126413335|NCT00622388|454805890|FG000|Overall Study|Adverse Event|6|||
126413336|NCT00622388|454805890|FG000|Overall Study|Protocol Violation|3|||
126413337|NCT00622388|454805890|FG000|Overall Study|Participant Refusal|1|||
126413338|NCT00622388|454805890|FG000|Overall Study|Death|3|||
126413339|NCT00622388|454805890|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
126413340|NCT00622388|454805890|FG000|Overall Study|Took Prohibited Medication|2|||
126413341|NCT00622388|454805890|FG000|Overall Study|Withdrew Consent|1|||
126413342|NCT00622388|454805890|FG000|Overall Study|Insurance Expired|1|||
126413343|NCT00348309|454805891|FG000|Overall Study|Adverse Event|56|||
126413344|NCT00348309|454805892|FG001|Overall Study|Adverse Event|28|||
126413345|NCT00348309|454805893|FG002|Overall Study|Adverse Event|63|||
126413346|NCT00348309|454805891|FG000|Overall Study|Lost to Follow-up|6|||
126413347|NCT00348309|454805892|FG001|Overall Study|Lost to Follow-up|7|||
126413348|NCT00348309|454805893|FG002|Overall Study|Lost to Follow-up|4|||
126413349|NCT00348309|454805891|FG000|Overall Study|Protocol Violation|7|||
126413350|NCT00348309|454805892|FG001|Overall Study|Protocol Violation|12|||
126413351|NCT00348309|454805893|FG002|Overall Study|Protocol Violation|7|||
126413352|NCT00348309|454805891|FG000|Overall Study|Withdrawal by Subject|33|||
126413353|NCT00348309|454805892|FG001|Overall Study|Withdrawal by Subject|37|||
126413354|NCT00348309|454805893|FG002|Overall Study|Withdrawal by Subject|40|||
126413355|NCT00348309|454805891|FG000|Overall Study|Non-compliance|8|||
126413356|NCT00348309|454805892|FG001|Overall Study|Non-compliance|6|||
126413357|NCT00348309|454805893|FG002|Overall Study|Non-compliance|8|||
126413358|NCT00348309|454805891|FG000|Overall Study|Death of caregiver|1|||
126413359|NCT00348309|454805892|FG001|Overall Study|Death of caregiver|0|||
126413360|NCT00348309|454805893|FG002|Overall Study|Death of caregiver|1|||
126413361|NCT00348309|454805891|FG000|Overall Study|Lack of insight, dementia|1|||
126413362|NCT00348309|454805892|FG001|Overall Study|Lack of insight, dementia|0|||
126413363|NCT00348309|454805893|FG002|Overall Study|Lack of insight, dementia|0|||
126413364|NCT00348309|454805891|FG000|Overall Study|Wrong bottle allocated|1|||
126413365|NCT00348309|454805892|FG001|Overall Study|Wrong bottle allocated|0|||
126413366|NCT00348309|454805893|FG002|Overall Study|Wrong bottle allocated|0|||
126413367|NCT00348309|454805891|FG000|Overall Study|Caregiver sick|1|||
126413368|NCT00348309|454805892|FG001|Overall Study|Caregiver sick|0|||
126413369|NCT00348309|454805893|FG002|Overall Study|Caregiver sick|0|||
126413370|NCT00348309|454805891|FG000|Overall Study|Use of prohibited medication|5|||
126413371|NCT00348309|454805892|FG001|Overall Study|Use of prohibited medication|2|||
126413372|NCT00348309|454805893|FG002|Overall Study|Use of prohibited medication|2|||
126721554|NCT02739594|455930002|FG000|Overall Study|Elevated Serum Creatinine|0|||
126413373|NCT00348309|454805891|FG000|Overall Study|Caregiver withdrawal|3|||
126413374|NCT00348309|454805892|FG001|Overall Study|Caregiver withdrawal|0|||
126413375|NCT00348309|454805893|FG002|Overall Study|Caregiver withdrawal|7|||
126721555|NCT02739594|455930003|FG001|Overall Study|Elevated Serum Creatinine|1|||
126721556|NCT02739594|455930002|FG000|Overall Study|Other|6|||
126413376|NCT00348309|454805891|FG000|Overall Study|Unable to complete ET visit|1|||
126721557|NCT02739594|455930003|FG001|Overall Study|Other|2|||
126721558|NCT00875017|455930008|FG000|First Intervention|Withdrawal by Subject|1|||
126413377|NCT00348309|454805892|FG001|Overall Study|Unable to complete ET visit|0|||
126413378|NCT00348309|454805893|FG002|Overall Study|Unable to complete ET visit|0|||
126413379|NCT00348309|454805891|FG000|Overall Study|PI closing medical practice|1|||
126413380|NCT00348309|454805892|FG001|Overall Study|PI closing medical practice|0|||
126413381|NCT00348309|454805893|FG002|Overall Study|PI closing medical practice|0|||
126413382|NCT00348309|454805891|FG000|Overall Study|Principal investigator's decision|1|||
126413383|NCT00348309|454805892|FG001|Overall Study|Principal investigator's decision|0|||
126475159|NCT02555683|455039916|FG001|Overall Study|Death|1|||
126721559|NCT00875017|455930009|FG001|First Intervention|Withdrawal by Subject|0|||
126413384|NCT00348309|454805893|FG002|Overall Study|Principal investigator's decision|0|||
126413385|NCT00348309|454805891|FG000|Overall Study|No disponibility of medication|1|||
126413386|NCT00348309|454805892|FG001|Overall Study|No disponibility of medication|0|||
126721560|NCT00875017|455930010|FG002|First Intervention|Withdrawal by Subject|1|||
126721561|NCT00875017|455930011|FG003|First Intervention|Withdrawal by Subject|0|||
126721562|NCT00875017|455930012|FG004|First Intervention|Withdrawal by Subject|0|||
126721563|NCT00875017|455930013|FG005|First Intervention|Withdrawal by Subject|0|||
126721564|NCT00875017|455930008|FG000|First Intervention|Adverse Event|0|||
126413387|NCT00348309|454805893|FG002|Overall Study|No disponibility of medication|0|||
126413388|NCT00348309|454805891|FG000|Overall Study|Worsened neurodegenerative disease|1|||
126413389|NCT00348309|454805892|FG001|Overall Study|Worsened neurodegenerative disease|0|||
126413390|NCT00348309|454805893|FG002|Overall Study|Worsened neurodegenerative disease|0|||
126413391|NCT00348309|454805891|FG000|Overall Study|Cognitive and behaviour worsening|2|||
126413392|NCT00348309|454805892|FG001|Overall Study|Cognitive and behaviour worsening|0|||
126413393|NCT00348309|454805893|FG002|Overall Study|Cognitive and behaviour worsening|0|||
126413394|NCT00348309|454805891|FG000|Overall Study|Worsening of alzheimer|1|||
126413395|NCT00348309|454805892|FG001|Overall Study|Worsening of alzheimer|0|||
126413396|NCT00348309|454805893|FG002|Overall Study|Worsening of alzheimer|1|||
126413397|NCT00348309|454805891|FG000|Overall Study|Did not appear in time for Visit 3|1|||
126413398|NCT00348309|454805892|FG001|Overall Study|Did not appear in time for Visit 3|0|||
126413399|NCT00348309|454805893|FG002|Overall Study|Did not appear in time for Visit 3|0|||
126413400|NCT00348309|454805891|FG000|Overall Study|Participant died|2|||
126413401|NCT00348309|454805892|FG001|Overall Study|Participant died|1|||
126413402|NCT00348309|454805893|FG002|Overall Study|Participant died|1|||
126413403|NCT00348309|454805891|FG000|Overall Study|Decision of sponsor|1|||
126413404|NCT00348309|454805892|FG001|Overall Study|Decision of sponsor|0|||
126413405|NCT00348309|454805893|FG002|Overall Study|Decision of sponsor|0|||
126413406|NCT00348309|454805891|FG000|Overall Study|Ineffectiveness of treatment|0|||
126413407|NCT00348309|454805892|FG001|Overall Study|Ineffectiveness of treatment|1|||
126413408|NCT00348309|454805893|FG002|Overall Study|Ineffectiveness of treatment|0|||
126413409|NCT00348309|454805891|FG000|Overall Study|A foul of exclusion criteria|0|||
126413410|NCT00348309|454805892|FG001|Overall Study|A foul of exclusion criteria|1|||
126413411|NCT00348309|454805893|FG002|Overall Study|A foul of exclusion criteria|0|||
126413412|NCT00348309|454805891|FG000|Overall Study|Participant was hospitalized|0|||
126413413|NCT00348309|454805892|FG001|Overall Study|Participant was hospitalized|1|||
126413414|NCT00348309|454805893|FG002|Overall Study|Participant was hospitalized|0|||
126413415|NCT00348309|454805891|FG000|Overall Study|Sponsor refuseal|0|||
126413416|NCT00348309|454805892|FG001|Overall Study|Sponsor refuseal|1|||
126413417|NCT00348309|454805893|FG002|Overall Study|Sponsor refuseal|1|||
126413418|NCT00348309|454805891|FG000|Overall Study|Forgot often medication|0|||
126413419|NCT00348309|454805892|FG001|Overall Study|Forgot often medication|1|||
126413420|NCT00348309|454805893|FG002|Overall Study|Forgot often medication|0|||
126413421|NCT00348309|454805891|FG000|Overall Study|Medical Monitor decision|0|||
126413422|NCT00348309|454805892|FG001|Overall Study|Medical Monitor decision|0|||
126413423|NCT00348309|454805893|FG002|Overall Study|Medical Monitor decision|1|||
126413424|NCT00348309|454805891|FG000|Overall Study|Increased dose of Aricept|0|||
126413425|NCT00348309|454805892|FG001|Overall Study|Increased dose of Aricept|0|||
126413426|NCT00348309|454805893|FG002|Overall Study|Increased dose of Aricept|1|||
126413427|NCT00348309|454805891|FG000|Overall Study|Site closure|0|||
126413428|NCT00348309|454805892|FG001|Overall Study|Site closure|0|||
126413429|NCT00348309|454805893|FG002|Overall Study|Site closure|1|||
126413430|NCT00348309|454805891|FG000|Overall Study|Adverse event not attended|0|||
126413431|NCT00348309|454805892|FG001|Overall Study|Adverse event not attended|0|||
126413432|NCT00348309|454805893|FG002|Overall Study|Adverse event not attended|1|||
126413433|NCT00348309|454805891|FG000|Overall Study|ECG abnormal|0|||
126413434|NCT00348309|454805892|FG001|Overall Study|ECG abnormal|0|||
126413435|NCT00348309|454805893|FG002|Overall Study|ECG abnormal|2|||
126413436|NCT00348309|454805891|FG000|Overall Study|Cardiologist recommendations|0|||
126413437|NCT00348309|454805892|FG001|Overall Study|Cardiologist recommendations|0|||
126475160|NCT02555683|455039917|FG002|Overall Study|Death|2|||
126475161|NCT02555683|455039915|FG000|Overall Study|Adverse Event|1|||
126475162|NCT02555683|455039916|FG001|Overall Study|Adverse Event|0|||
126475163|NCT02555683|455039917|FG002|Overall Study|Adverse Event|1|||
126475164|NCT02555683|455039915|FG000|Overall Study|Subject/guardian decision|12|||
126475165|NCT02555683|455039916|FG001|Overall Study|Subject/guardian decision|12|||
126475166|NCT02555683|455039917|FG002|Overall Study|Subject/guardian decision|22|||
126475167|NCT02555683|455039915|FG000|Overall Study|Death post Treatment/safety period|0|||
126475168|NCT02555683|455039916|FG001|Overall Study|Death post Treatment/safety period|1|||
126475169|NCT02555683|455039917|FG002|Overall Study|Death post Treatment/safety period|0|||
126475170|NCT05074667|455039918|FG000|Overall Study|Death|1|||
126475171|NCT05074667|455039918|FG000|Overall Study|Withdrawal by Subject|4|||
126475172|NCT05074667|455039918|FG000|Overall Study|Lost to Follow-up|10|||
126475173|NCT01826604|455039920|FG000|Overall Study|Lost to Follow-up|8|||
126475174|NCT01826604|455039921|FG001|Overall Study|Lost to Follow-up|9|||
126475175|NCT00491075|455039922|FG000|Overall Study|Withdrawal by Subject|1|||
126413438|NCT00348309|454805893|FG002|Overall Study|Cardiologist recommendations|1|||
126413439|NCT00348309|454805891|FG000|Overall Study|HCV career|0|||
126413440|NCT00348309|454805892|FG001|Overall Study|HCV career|0|||
126413441|NCT00348309|454805893|FG002|Overall Study|HCV career|1|||
126413442|NCT01894243|454805894|FG000|Overall Study|Adverse Event|0|||
126413443|NCT01894243|454805895|FG001|Overall Study|Adverse Event|1|||
126413444|NCT01894243|454805896|FG002|Overall Study|Adverse Event|2|||
126413445|NCT01894243|454805894|FG000|Overall Study|Death|0|||
126413446|NCT01894243|454805895|FG001|Overall Study|Death|0|||
126413447|NCT01894243|454805896|FG002|Overall Study|Death|3|||
126413448|NCT01894243|454805894|FG000|Overall Study|Lack of Efficacy|3|||
126413449|NCT01894243|454805895|FG001|Overall Study|Lack of Efficacy|3|||
126413450|NCT01894243|454805896|FG002|Overall Study|Lack of Efficacy|1|||
126413451|NCT01894243|454805894|FG000|Overall Study|Condition under investigation worsened|8|||
126413452|NCT01894243|454805895|FG001|Overall Study|Condition under investigation worsened|6|||
126413453|NCT01894243|454805896|FG002|Overall Study|Condition under investigation worsened|2|||
126413454|NCT01894243|454805894|FG000|Overall Study|Subject decision|1|||
126413455|NCT01894243|454805895|FG001|Overall Study|Subject decision|0|||
126413456|NCT01894243|454805896|FG002|Overall Study|Subject decision|0|||
126413457|NCT01894243|454805894|FG000|Overall Study|Other|1|||
126413458|NCT01894243|454805895|FG001|Overall Study|Other|0|||
126413459|NCT01894243|454805896|FG002|Overall Study|Other|0|||
126413460|NCT01108523|454805900|FG000|Overall Study|Protocol Violation|4|||
126413461|NCT03755661|454805905|FG000|Overall Study|Lost to Follow-up|1|||
126413462|NCT03755661|454805906|FG001|Overall Study|Lost to Follow-up|0|||
126413463|NCT02277119|454805907|FG000|Overall Study|Lack of Efficacy|1|||
126413464|NCT02277119|454805908|FG001|Overall Study|Lack of Efficacy|1|||
126413465|NCT02277119|454805909|FG002|Overall Study|Lack of Efficacy|1|||
126413466|NCT02277119|454805907|FG000|Overall Study|Protocol Violation|2|||
126413467|NCT02277119|454805908|FG001|Overall Study|Protocol Violation|3|||
126413468|NCT02277119|454805909|FG002|Overall Study|Protocol Violation|7|||
126413469|NCT03210961|454808694|FG000|Overall Study|Adverse Event|0|||
126413470|NCT03210961|454808695|FG001|Overall Study|Adverse Event|0|||
126413471|NCT03210961|454808696|FG002|Overall Study|Adverse Event|0|||
126413472|NCT03210961|454808697|FG003|Overall Study|Adverse Event|0|||
126413473|NCT03210961|454808698|FG004|Overall Study|Adverse Event|0|||
126413474|NCT03210961|454808699|FG005|Overall Study|Adverse Event|0|||
126413475|NCT03210961|454808700|FG006|Overall Study|Adverse Event|0|||
126413476|NCT03210961|454808701|FG007|Overall Study|Adverse Event|0|||
126413477|NCT03210961|454808702|FG008|Overall Study|Adverse Event|0|||
126413478|NCT03210961|454808703|FG009|Overall Study|Adverse Event|0|||
126413479|NCT03210961|454808704|FG010|Overall Study|Adverse Event|0|||
126413480|NCT03210961|454808705|FG011|Overall Study|Adverse Event|0|||
126413481|NCT03210961|454808706|FG012|Overall Study|Adverse Event|0|||
126413482|NCT03210961|454808707|FG013|Overall Study|Adverse Event|1|||
126413483|NCT03210961|454808708|FG014|Overall Study|Adverse Event|0|||
126413484|NCT03210961|454808694|FG000|Overall Study|Lost to Follow-up|0|||
126413485|NCT03210961|454808695|FG001|Overall Study|Lost to Follow-up|0|||
126413486|NCT03210961|454808696|FG002|Overall Study|Lost to Follow-up|0|||
126413487|NCT03210961|454808697|FG003|Overall Study|Lost to Follow-up|0|||
126413488|NCT03210961|454808698|FG004|Overall Study|Lost to Follow-up|0|||
126413489|NCT03210961|454808699|FG005|Overall Study|Lost to Follow-up|0|||
126413490|NCT03210961|454808700|FG006|Overall Study|Lost to Follow-up|0|||
126413491|NCT03210961|454808701|FG007|Overall Study|Lost to Follow-up|0|||
126413492|NCT03210961|454808702|FG008|Overall Study|Lost to Follow-up|0|||
126413493|NCT03210961|454808703|FG009|Overall Study|Lost to Follow-up|0|||
126413494|NCT03210961|454808704|FG010|Overall Study|Lost to Follow-up|0|||
126413495|NCT03210961|454808705|FG011|Overall Study|Lost to Follow-up|0|||
126721565|NCT00875017|455930009|FG001|First Intervention|Adverse Event|0|||
126721566|NCT00875017|455930010|FG002|First Intervention|Adverse Event|0|||
126721567|NCT00875017|455930011|FG003|First Intervention|Adverse Event|1|||
126721568|NCT00875017|455930012|FG004|First Intervention|Adverse Event|0|||
126721569|NCT00875017|455930013|FG005|First Intervention|Adverse Event|0|||
126413496|NCT03210961|454808706|FG012|Overall Study|Lost to Follow-up|0|||
126413497|NCT03210961|454808707|FG013|Overall Study|Lost to Follow-up|0|||
126413498|NCT03210961|454808708|FG014|Overall Study|Lost to Follow-up|1|||
126721570|NCT00875017|455930008|FG000|First Intervention|Problems collecting rectal effluent|1|||
126413499|NCT03210961|454808694|FG000|Overall Study|Withdrawal by Subject|0|||
126558871|NCT02028884|455340573|FG000|Double-blind Period|Withdrawal by Subject|2|||
126721571|NCT00875017|455930009|FG001|First Intervention|Problems collecting rectal effluent|0|||
126721572|NCT00875017|455930010|FG002|First Intervention|Problems collecting rectal effluent|0|||
126413500|NCT03210961|454808695|FG001|Overall Study|Withdrawal by Subject|0|||
126413501|NCT03210961|454808696|FG002|Overall Study|Withdrawal by Subject|0|||
126413502|NCT03210961|454808697|FG003|Overall Study|Withdrawal by Subject|0|||
126413503|NCT03210961|454808698|FG004|Overall Study|Withdrawal by Subject|0|||
126413504|NCT03210961|454808699|FG005|Overall Study|Withdrawal by Subject|0|||
126413505|NCT03210961|454808700|FG006|Overall Study|Withdrawal by Subject|0|||
126413506|NCT03210961|454808701|FG007|Overall Study|Withdrawal by Subject|0|||
126413507|NCT03210961|454808702|FG008|Overall Study|Withdrawal by Subject|0|||
126413508|NCT03210961|454808703|FG009|Overall Study|Withdrawal by Subject|0|||
126413509|NCT03210961|454808704|FG010|Overall Study|Withdrawal by Subject|0|||
126413510|NCT03210961|454808705|FG011|Overall Study|Withdrawal by Subject|0|||
126413511|NCT03210961|454808706|FG012|Overall Study|Withdrawal by Subject|0|||
126413512|NCT03210961|454808707|FG013|Overall Study|Withdrawal by Subject|0|||
126413513|NCT03210961|454808708|FG014|Overall Study|Withdrawal by Subject|1|||
126413514|NCT03210961|454808694|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413515|NCT03210961|454808695|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413516|NCT03210961|454808696|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413517|NCT03210961|454808697|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413518|NCT03210961|454808698|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413519|NCT03210961|454808699|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413520|NCT03210961|454808700|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413521|NCT03210961|454808701|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413522|NCT03210961|454808702|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413523|NCT03210961|454808703|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413524|NCT03210961|454808704|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413525|NCT03210961|454808705|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413526|NCT03210961|454808706|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413527|NCT03210961|454808707|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
126413528|NCT03210961|454808708|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
126413529|NCT03210961|454808694|FG000|Overall Study|Other|0|||
126413530|NCT03210961|454808695|FG001|Overall Study|Other|0|||
126413531|NCT03210961|454808696|FG002|Overall Study|Other|0|||
126413532|NCT03210961|454808697|FG003|Overall Study|Other|1|||
126413533|NCT03210961|454808698|FG004|Overall Study|Other|0|||
126413534|NCT03210961|454808699|FG005|Overall Study|Other|0|||
126413535|NCT03210961|454808700|FG006|Overall Study|Other|1|||
126413536|NCT03210961|454808701|FG007|Overall Study|Other|0|||
126413537|NCT03210961|454808702|FG008|Overall Study|Other|0|||
126413538|NCT03210961|454808703|FG009|Overall Study|Other|0|||
126413539|NCT03210961|454808704|FG010|Overall Study|Other|1|||
126413540|NCT03210961|454808705|FG011|Overall Study|Other|0|||
126413541|NCT03210961|454808706|FG012|Overall Study|Other|2|||
126413542|NCT03210961|454808707|FG013|Overall Study|Other|2|||
126413543|NCT03210961|454808708|FG014|Overall Study|Other|0|||
126413544|NCT01487265|454808709|FG000|Overall Study|Adverse Event|8|||
126413545|NCT01487265|454808709|FG000|Overall Study|Withdrawal by Subject|5|||
126413546|NCT01487265|454808709|FG000|Overall Study|Disease Progression|21|||
126413547|NCT01487265|454808709|FG000|Overall Study|Death|2|||
126413548|NCT01487265|454808709|FG000|Overall Study|Still on Treatment|1|||
126413549|NCT02291419|454808711|FG000|Overall Study|Early study termination|1|||
126413550|NCT02291419|454808712|FG001|Overall Study|Early study termination|5|||
126475176|NCT00491075|455039922|FG000|Overall Study|Physician Decision|1|||
126475177|NCT00827502|455039923|FG000|Overall Study|randomized but not treated|11|||
126475178|NCT00827502|455039923|FG000|Overall Study|Adverse Event|1|||
126475179|NCT00827502|455039923|FG000|Overall Study|Lost to Follow-up|4|||
126475180|NCT00827502|455039923|FG000|Overall Study|Withdrawal by Subject|5|||
126475181|NCT03019185|455039924|FG000|Overall Study|Lost to Follow-up|3|||
126475182|NCT03019185|455039925|FG001|Overall Study|Lost to Follow-up|0|||
126475183|NCT03019185|455039926|FG002|Overall Study|Lost to Follow-up|2|||
126475184|NCT03019185|455039924|FG000|Overall Study|Withdrawal by Subject|1|||
126475185|NCT03019185|455039925|FG001|Overall Study|Withdrawal by Subject|1|||
126475186|NCT03019185|455039926|FG002|Overall Study|Withdrawal by Subject|0|||
126475187|NCT03019185|455039924|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
126475188|NCT03019185|455039925|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
126475189|NCT03019185|455039926|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
126475190|NCT03019185|455039924|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
126475191|NCT03019185|455039925|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
126475192|NCT03019185|455039926|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
126475193|NCT03355365|455039929|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
126475194|NCT03355365|455039930|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
126475195|NCT03355365|455039929|FG000|Year 1, First Intervention|Protocol Violation|1|||
126475196|NCT03355365|455039930|FG001|Year 1, First Intervention|Protocol Violation|0|||
126475197|NCT03355365|455039929|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
126475198|NCT03355365|455039930|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
126475199|NCT03355365|455039929|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
126475200|NCT03355365|455039930|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
126413551|NCT00965575|454808716|FG000|Overall Study|subject unwillingness to swallow study c|1|||
126413552|NCT00965575|454808717|FG001|Overall Study|subject unwillingness to swallow study c|0|||
126413553|NCT01732770|454808725|FG000|Overall Study|Lost to Follow-up|2|||
126413554|NCT01732770|454808726|FG001|Overall Study|Lost to Follow-up|3|||
126413555|NCT01732770|454808725|FG000|Overall Study|Withdrawal by Subject|5|||
126413556|NCT01732770|454808726|FG001|Overall Study|Withdrawal by Subject|3|||
126413557|NCT01732770|454808725|FG000|Overall Study|Decision by Sponsor|2|||
126413558|NCT01732770|454808726|FG001|Overall Study|Decision by Sponsor|2|||
126413559|NCT01732770|454808725|FG000|Overall Study|Death|1|||
126413560|NCT01732770|454808726|FG001|Overall Study|Death|0|||
126413561|NCT03047031|454808729|FG000|Overall Study|Other than listed|1|||
126413562|NCT03047031|454808730|FG001|Overall Study|Other than listed|0|||
126413563|NCT03047031|454808731|FG002|Overall Study|Other than listed|0|||
126413564|NCT03047031|454808729|FG000|Overall Study|Lost to Follow-up|4|||
126413565|NCT03047031|454808730|FG001|Overall Study|Lost to Follow-up|0|||
126413566|NCT03047031|454808731|FG002|Overall Study|Lost to Follow-up|0|||
126413567|NCT03047031|454808729|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
126413568|NCT03047031|454808730|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
126413569|NCT03047031|454808731|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
126413570|NCT03047031|454808729|FG000|Overall Study|Adverse Event|1|||
126413571|NCT03047031|454808730|FG001|Overall Study|Adverse Event|0|||
126413572|NCT03047031|454808731|FG002|Overall Study|Adverse Event|0|||
126413573|NCT03047031|454808729|FG000|Overall Study|Withdrawal by Subject|2|||
126413574|NCT03047031|454808730|FG001|Overall Study|Withdrawal by Subject|0|||
126413575|NCT03047031|454808731|FG002|Overall Study|Withdrawal by Subject|0|||
126413576|NCT03047031|454808729|FG000|Overall Study|Change to other medication|2|||
126413577|NCT03047031|454808730|FG001|Overall Study|Change to other medication|0|||
126413578|NCT03047031|454808731|FG002|Overall Study|Change to other medication|0|||
126413579|NCT03047031|454808729|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
126413580|NCT03047031|454808730|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
126413581|NCT03047031|454808731|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
126413582|NCT03521141|454808732|FG000|Overall Study|Death|1|||
126413583|NCT03521141|454808733|FG001|Overall Study|Death|0|||
126413584|NCT03521141|454808734|FG002|Overall Study|Death|1|||
126413585|NCT01959139|454808744|FG000|Phase II|Disease progression|0|||
126413586|NCT01959139|454808745|FG001|Phase II|Disease progression|0|||
126413587|NCT01959139|454808746|FG002|Phase II|Disease progression|26|||
126413588|NCT01959139|454808747|FG003|Phase II|Disease progression|34|||
126413589|NCT01959139|454808744|FG000|Phase II|Adverse Event|0|||
126413590|NCT01959139|454808745|FG001|Phase II|Adverse Event|0|||
126413591|NCT01959139|454808746|FG002|Phase II|Adverse Event|10|||
126413592|NCT01959139|454808747|FG003|Phase II|Adverse Event|11|||
126413593|NCT01959139|454808744|FG000|Phase II|Patient Refusal|0|||
126413594|NCT01959139|454808745|FG001|Phase II|Patient Refusal|0|||
126413595|NCT01959139|454808746|FG002|Phase II|Patient Refusal|5|||
126413596|NCT01959139|454808747|FG003|Phase II|Patient Refusal|4|||
126413597|NCT01959139|454808744|FG000|Phase II|Death|0|||
126413598|NCT01959139|454808745|FG001|Phase II|Death|0|||
126413599|NCT01959139|454808746|FG002|Phase II|Death|3|||
126413600|NCT01959139|454808747|FG003|Phase II|Death|1|||
126413601|NCT01959139|454808744|FG000|Phase II|Other/Unknown|0|||
126413602|NCT01959139|454808745|FG001|Phase II|Other/Unknown|0|||
126413603|NCT01959139|454808746|FG002|Phase II|Other/Unknown|8|||
126413604|NCT01959139|454808747|FG003|Phase II|Other/Unknown|5|||
126413605|NCT01959139|454808744|FG000|Phase II|On treatment|0|||
126413606|NCT01959139|454808745|FG001|Phase II|On treatment|0|||
126413607|NCT01959139|454808746|FG002|Phase II|On treatment|4|||
126413608|NCT01959139|454808747|FG003|Phase II|On treatment|0|||
126413609|NCT05362058|454808750|FG000|Treatment Period|Adverse Event|3|||
126413610|NCT05362058|454808751|FG001|Treatment Period|Adverse Event|3|||
126413611|NCT05362058|454808750|FG000|Treatment Period|Assigned treatment by mistake|3|||
126413612|NCT05362058|454808751|FG001|Treatment Period|Assigned treatment by mistake|4|||
126413613|NCT05362058|454808750|FG000|Treatment Period|Death|1|||
126413614|NCT05362058|454808751|FG001|Treatment Period|Death|1|||
126475201|NCT03355365|455039929|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
126475202|NCT03355365|455039930|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
126475203|NCT03355365|455039929|FG000|Year 2, Crossover Intervention|severe COVID|0|||
126475204|NCT03355365|455039930|FG001|Year 2, Crossover Intervention|severe COVID|1|||
126475205|NCT03355365|455039929|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
126475206|NCT03355365|455039930|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
126413615|NCT05362058|454808750|FG000|Treatment Period|Lost to Follow-up|6|||
126413616|NCT05362058|454808751|FG001|Treatment Period|Lost to Follow-up|3|||
126413617|NCT05362058|454808750|FG000|Treatment Period|Non-compliance with study drug|0|||
126475207|NCT01705730|455039931|FG000|Overall Study|Lack of Efficacy|1|||
126475208|NCT01705730|455039931|FG000|Overall Study|Adverse Event|3|||
126413618|NCT05362058|454808751|FG001|Treatment Period|Non-compliance with study drug|1|||
126413619|NCT05362058|454808750|FG000|Treatment Period|Physician Decision|1|||
126413620|NCT05362058|454808751|FG001|Treatment Period|Physician Decision|0|||
126413621|NCT05362058|454808750|FG000|Treatment Period|Protocol deviation|1|||
126413622|NCT05362058|454808751|FG001|Treatment Period|Protocol deviation|0|||
126413623|NCT05362058|454808750|FG000|Treatment Period|Withdrawal by Subject|10|||
126413624|NCT05362058|454808751|FG001|Treatment Period|Withdrawal by Subject|11|||
126413625|NCT05362058|454808750|FG000|Follow-Up Period|Death|1|||
126413626|NCT05362058|454808751|FG001|Follow-Up Period|Death|0|||
126413627|NCT05362058|454808750|FG000|Follow-Up Period|Lost to Follow-up|2|||
126413628|NCT05362058|454808751|FG001|Follow-Up Period|Lost to Follow-up|1|||
126413629|NCT05362058|454808750|FG000|Follow-Up Period|Protocol deviation|1|||
126413630|NCT05362058|454808751|FG001|Follow-Up Period|Protocol deviation|1|||
126413631|NCT05362058|454808750|FG000|Follow-Up Period|Withdrawal by Subject|0|||
126413632|NCT05362058|454808751|FG001|Follow-Up Period|Withdrawal by Subject|3|||
126413633|NCT00930553|454808754|FG000|Overall Study|Adverse Event|1|||
126413634|NCT00930553|454808754|FG000|Overall Study|Lack of Efficacy|7|||
126413635|NCT00930553|454808754|FG000|Overall Study|Physician Decision|39|||
126413636|NCT00930553|454808754|FG000|Overall Study|Protocol Violation|1|||
126413637|NCT00930553|454808754|FG000|Overall Study|Pregnancy|1|||
126413638|NCT00930553|454808754|FG000|Overall Study|Withdrawal by Subject|88|||
126413639|NCT00930553|454808754|FG000|Overall Study|Lost to Follow-up|25|||
126413640|NCT00930553|454808754|FG000|Overall Study|Death|9|||
126413641|NCT00930553|454808754|FG000|Overall Study|Study terminated by sponsor|24|||
126413642|NCT00930553|454808754|FG000|Overall Study|Other than specified above|28|||
126413643|NCT01964963|454808755|FG000|Overall Study|Case Report Forms Uncollected|888|||
126413644|NCT01964963|454808755|FG000|Overall Study|Protocol Deviation|50|||
126413645|NCT01964963|454808755|FG000|Overall Study|Data Reliability was not Assured|5|||
126413646|NCT01235234|454808756|FG000|Overall Study|Adverse Event|2|||
126413647|NCT01235234|454808757|FG001|Overall Study|Adverse Event|2|||
126413648|NCT01235234|454808758|FG002|Overall Study|Adverse Event|1|||
126413649|NCT02352753|454808759|FG000|6-Month Dosing Period|Decision by sponsor|2|||
126413650|NCT02352753|454808759|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
126413651|NCT02352753|454808759|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
126413652|NCT02352753|454808759|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
126413653|NCT02352753|454808759|FG000|3-Month Dosing Period|Decision by sponsor|14|||
126413654|NCT02352753|454808759|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
126413655|NCT04042909|454808760|FG000|Overall Study|Withdrawal by Subject|1|||
126413656|NCT04042909|454808761|FG001|Overall Study|Withdrawal by Subject|0|||
126413657|NCT04042909|454808762|FG002|Overall Study|Withdrawal by Subject|0|||
126413658|NCT04042909|454808760|FG000|Overall Study|duplicate cases|2|||
126475209|NCT01705730|455039931|FG000|Overall Study|Lost to Follow-up|1|||
126475210|NCT01705730|455039931|FG000|Overall Study|Reason not Specified|4|||
126475211|NCT00142935|455039932|FG000|Overall Study|Other reason|1|||
126475212|NCT00142935|455039933|FG001|Overall Study|Other reason|1|||
126475213|NCT00142935|455039934|FG002|Overall Study|Other reason|1|||
126475214|NCT00142935|455039932|FG000|Overall Study|Lost to Follow-up|2|||
126475215|NCT00142935|455039933|FG001|Overall Study|Lost to Follow-up|5|||
126475216|NCT00142935|455039934|FG002|Overall Study|Lost to Follow-up|5|||
126475217|NCT00142935|455039932|FG000|Overall Study|Death|0|||
126475218|NCT00142935|455039933|FG001|Overall Study|Death|2|||
126475219|NCT00142935|455039934|FG002|Overall Study|Death|1|||
126475220|NCT03228433|455039937|FG000|Overall Study|Lost to Follow-up|1|||
126475221|NCT03228433|455039938|FG001|Overall Study|Lost to Follow-up|0|||
126475222|NCT03228433|455039939|FG002|Overall Study|Lost to Follow-up|0|||
126475223|NCT03228433|455039940|FG003|Overall Study|Lost to Follow-up|0|||
126475224|NCT03228433|455039941|FG004|Overall Study|Lost to Follow-up|0|||
126475225|NCT03228433|455039942|FG005|Overall Study|Lost to Follow-up|0|||
126475226|NCT03228433|455039937|FG000|Overall Study|Positive alcohol test|0|||
126475227|NCT03228433|455039938|FG001|Overall Study|Positive alcohol test|0|||
126475228|NCT03228433|455039939|FG002|Overall Study|Positive alcohol test|0|||
126475229|NCT03228433|455039940|FG003|Overall Study|Positive alcohol test|1|||
126475230|NCT03228433|455039941|FG004|Overall Study|Positive alcohol test|0|||
126475231|NCT03228433|455039942|FG005|Overall Study|Positive alcohol test|0|||
126475232|NCT01773733|455039943|FG000|Overall Study|Adverse Event|3286|||
126475233|NCT01773733|455039944|FG001|Overall Study|Adverse Event|540|||
126475234|NCT01773733|455039943|FG000|Overall Study|Pregnancy|28|||
126475235|NCT01773733|455039944|FG001|Overall Study|Pregnancy|0|||
126475236|NCT01773733|455039943|FG000|Overall Study|Other different categories of not compl|55415|||
126475237|NCT01773733|455039944|FG001|Overall Study|Other different categories of not compl|7781|||
126475238|NCT01330030|455039949|FG000|Overall Study|Lost to Follow-up|16|||
126475239|NCT01330030|455039950|FG001|Overall Study|Lost to Follow-up|17|||
126475240|NCT02609828|455039953|FG000|Overall Study|Adverse Event|8|||
126475241|NCT02609828|455039954|FG001|Overall Study|Adverse Event|1|||
126475242|NCT02609828|455039955|FG002|Overall Study|Adverse Event|0|||
126475243|NCT02609828|455039956|FG003|Overall Study|Adverse Event|6|||
126475244|NCT02609828|455039953|FG000|Overall Study|Death|15|||
126475245|NCT02609828|455039954|FG001|Overall Study|Death|1|||
126475246|NCT02609828|455039955|FG002|Overall Study|Death|1|||
126413659|NCT04042909|454808761|FG001|Overall Study|duplicate cases|0|||
126475247|NCT02609828|455039956|FG003|Overall Study|Death|19|||
126475248|NCT02609828|455039953|FG000|Overall Study|Insufficient clinical response|2|||
126413660|NCT04042909|454808762|FG002|Overall Study|duplicate cases|0|||
126475249|NCT02609828|455039954|FG001|Overall Study|Insufficient clinical response|1|||
126475250|NCT02609828|455039955|FG002|Overall Study|Insufficient clinical response|0|||
126475251|NCT02609828|455039956|FG003|Overall Study|Insufficient clinical response|0|||
126721573|NCT00875017|455930011|FG003|First Intervention|Problems collecting rectal effluent|0|||
126721574|NCT00875017|455930012|FG004|First Intervention|Problems collecting rectal effluent|0|||
126721575|NCT00875017|455930013|FG005|First Intervention|Problems collecting rectal effluent|0|||
126721576|NCT00875017|455930008|FG000|First Intervention|Intolerance to nasogastric tube|0|||
126721577|NCT00875017|455930009|FG001|First Intervention|Intolerance to nasogastric tube|0|||
126721578|NCT00875017|455930010|FG002|First Intervention|Intolerance to nasogastric tube|0|||
126721579|NCT00875017|455930011|FG003|First Intervention|Intolerance to nasogastric tube|0|||
126413661|NCT04042909|454808760|FG000|Overall Study|technical problem|0|||
126413662|NCT04042909|454808761|FG001|Overall Study|technical problem|1|||
126413663|NCT04042909|454808762|FG002|Overall Study|technical problem|0|||
126413664|NCT00286494|454808763|FG000|Overall Study|Hyperglycemic rescue|12|||
126413665|NCT00286494|454808764|FG001|Overall Study|Hyperglycemic rescue|19|||
126413666|NCT00286494|454808765|FG002|Overall Study|Hyperglycemic rescue|18|||
126413667|NCT00286494|454808763|FG000|Overall Study|Withdrawal by Subject|2|||
126413668|NCT00286494|454808764|FG001|Overall Study|Withdrawal by Subject|10|||
126413669|NCT00286494|454808765|FG002|Overall Study|Withdrawal by Subject|9|||
126413670|NCT00286494|454808763|FG000|Overall Study|Adverse Event|3|||
126475252|NCT02609828|455039953|FG000|Overall Study|Lost to Follow-up|0|||
126475253|NCT02609828|455039954|FG001|Overall Study|Lost to Follow-up|0|||
126475254|NCT02609828|455039955|FG002|Overall Study|Lost to Follow-up|0|||
126475255|NCT02609828|455039956|FG003|Overall Study|Lost to Follow-up|1|||
126475256|NCT02609828|455039953|FG000|Overall Study|Protocol Violation|2|||
126475257|NCT02609828|455039954|FG001|Overall Study|Protocol Violation|0|||
126475258|NCT02609828|455039955|FG002|Overall Study|Protocol Violation|0|||
126475259|NCT02609828|455039956|FG003|Overall Study|Protocol Violation|1|||
126475260|NCT02609828|455039953|FG000|Overall Study|Withdrawal by Subject|12|||
126475261|NCT02609828|455039954|FG001|Overall Study|Withdrawal by Subject|1|||
126475262|NCT02609828|455039955|FG002|Overall Study|Withdrawal by Subject|0|||
126475263|NCT02609828|455039956|FG003|Overall Study|Withdrawal by Subject|10|||
126475264|NCT02609828|455039953|FG000|Overall Study|Other|3|||
126475265|NCT02609828|455039954|FG001|Overall Study|Other|0|||
126475266|NCT02609828|455039955|FG002|Overall Study|Other|0|||
126475267|NCT02609828|455039956|FG003|Overall Study|Other|6|||
126475268|NCT02609828|455039953|FG000|Overall Study|Randomized but not treated|1|||
126475269|NCT02609828|455039954|FG001|Overall Study|Randomized but not treated|0|||
126475270|NCT02609828|455039955|FG002|Overall Study|Randomized but not treated|0|||
126475271|NCT02609828|455039956|FG003|Overall Study|Randomized but not treated|0|||
126475272|NCT04891978|455039959|FG000|Baseline|Protocol Violation|2|||
126475273|NCT04891978|455039960|FG001|Baseline|Protocol Violation|1|||
126475274|NCT04891978|455039961|FG002|Baseline|Protocol Violation|0|||
126475275|NCT04891978|455039959|FG000|Baseline|Missing AIRQ|1|||
126475276|NCT04891978|455039960|FG001|Baseline|Missing AIRQ|0|||
126475277|NCT04891978|455039961|FG002|Baseline|Missing AIRQ|0|||
126475278|NCT04891978|455039959|FG000|Baseline|Did not attend a baseline visit|0|||
126475279|NCT04891978|455039960|FG001|Baseline|Did not attend a baseline visit|0|||
126475280|NCT04891978|455039961|FG002|Baseline|Did not attend a baseline visit|9|||
126475281|NCT01781975|455039968|FG000|Overall Study|Death|1|||
126475282|NCT01781975|455039969|FG001|Overall Study|Death|0|||
126475283|NCT01781975|455039968|FG000|Overall Study|Withdrawal by Subject|1|||
126475284|NCT01781975|455039969|FG001|Overall Study|Withdrawal by Subject|1|||
126475285|NCT01622231|455039970|FG000|Overall Study|Physician Decision|1|||
126475286|NCT01622231|455039970|FG000|Overall Study|Withdrawal by Subject|1|||
126475287|NCT02589405|455039972|FG000|Overall Study|Adverse Event|3|||
126475288|NCT02589405|455039972|FG000|Overall Study|Withdrawal by Subject|1|||
126475289|NCT02905149|455039974|FG000|Overall Study|Lost to Follow-up|2|||
126475290|NCT02905149|455039975|FG001|Overall Study|Lost to Follow-up|0|||
126475291|NCT02264639|455039977|FG000|Overall Study|Death (after completing single-dose phase)|1|||
126475292|NCT02264639|455039978|FG001|Overall Study|Death (after completing single-dose phase)|0|||
126475293|NCT02264639|455039979|FG002|Overall Study|Death (after completing single-dose phase)|0|||
126475294|NCT02264639|455039980|FG003|Overall Study|Death (after completing single-dose phase)|0|||
126475295|NCT02264639|455039981|FG004|Overall Study|Death (after completing single-dose phase)|0|||
126475296|NCT02264639|455039977|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
126475297|NCT02264639|455039978|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
126475298|NCT02264639|455039979|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
126475299|NCT02264639|455039980|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
126475300|NCT02264639|455039981|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
126475301|NCT02264639|455039977|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
126475302|NCT02264639|455039978|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
126475303|NCT02264639|455039979|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
126721580|NCT00875017|455930012|FG004|First Intervention|Intolerance to nasogastric tube|1|||
126721581|NCT00875017|455930013|FG005|First Intervention|Intolerance to nasogastric tube|0|||
126721582|NCT00875017|455930008|FG000|Washout|Problem collecting rectal effluent|0|||
126475304|NCT02264639|455039980|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
126475305|NCT02264639|455039981|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
126475306|NCT02264639|455039977|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
126475307|NCT02264639|455039978|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
126475308|NCT02264639|455039979|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
126475309|NCT02264639|455039980|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
126475310|NCT02264639|455039981|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
126475311|NCT00839852|455039982|FG000|Overall Study|Adverse Event|10|||
126475312|NCT00839852|455039982|FG000|Overall Study|Insufficient Therapeutic Response|3|||
126475313|NCT00839852|455039982|FG000|Overall Study|Protocol Violation|9|||
126475314|NCT00839852|455039982|FG000|Overall Study|Withdrawal of Consent|16|||
126475315|NCT00839852|455039982|FG000|Overall Study|Lost to Follow-up|7|||
126475316|NCT00839852|455039982|FG000|Overall Study|Lack of Compliance While in Jail|1|||
126475317|NCT00839852|455039982|FG000|Overall Study|Pregnancy|1|||
126475318|NCT02761733|455039983|FG000|Overall Study|Death|3|||
126475319|NCT02761733|455039984|FG001|Overall Study|Death|5|||
126475320|NCT02761733|455039985|FG002|Overall Study|Death|1|||
126475321|NCT02761733|455039986|FG003|Overall Study|Death|1|||
126475322|NCT02761733|455039983|FG000|Overall Study|Lost to Follow-up|6|||
126475323|NCT02761733|455039984|FG001|Overall Study|Lost to Follow-up|7|||
126475324|NCT02761733|455039985|FG002|Overall Study|Lost to Follow-up|0|||
126475325|NCT02761733|455039986|FG003|Overall Study|Lost to Follow-up|3|||
126475326|NCT02761733|455039983|FG000|Overall Study|Physician Decision|4|||
126475327|NCT02761733|455039984|FG001|Overall Study|Physician Decision|0|||
126475328|NCT02761733|455039985|FG002|Overall Study|Physician Decision|0|||
126475329|NCT02761733|455039986|FG003|Overall Study|Physician Decision|0|||
126475330|NCT02761733|455039983|FG000|Overall Study|Withdrawal by Subject|2|||
126475331|NCT02761733|455039984|FG001|Overall Study|Withdrawal by Subject|0|||
126475332|NCT02761733|455039985|FG002|Overall Study|Withdrawal by Subject|0|||
126475333|NCT02761733|455039986|FG003|Overall Study|Withdrawal by Subject|0|||
126475334|NCT02761733|455039983|FG000|Overall Study|Discharged from Study Site|10|||
126475335|NCT02761733|455039984|FG001|Overall Study|Discharged from Study Site|9|||
126475336|NCT02761733|455039985|FG002|Overall Study|Discharged from Study Site|25|||
126475337|NCT02761733|455039986|FG003|Overall Study|Discharged from Study Site|11|||
126475338|NCT02761733|455039983|FG000|Overall Study|Cognitive Impairment|5|||
126475339|NCT02761733|455039984|FG001|Overall Study|Cognitive Impairment|0|||
126558872|NCT02028884|455340574|FG001|Double-blind Period|Withdrawal by Subject|0|||
126558873|NCT02028884|455340575|FG002|Double-blind Period|Withdrawal by Subject|0|||
126413671|NCT00286494|454808764|FG001|Overall Study|Adverse Event|8|||
126413672|NCT00286494|454808765|FG002|Overall Study|Adverse Event|6|||
126413673|NCT00286494|454808763|FG000|Overall Study|Physician Decision|5|||
126413674|NCT00286494|454808764|FG001|Overall Study|Physician Decision|5|||
126413675|NCT00286494|454808765|FG002|Overall Study|Physician Decision|1|||
126413676|NCT00286494|454808763|FG000|Overall Study|Lost to Follow-up|3|||
126413677|NCT00286494|454808764|FG001|Overall Study|Lost to Follow-up|1|||
126413678|NCT00286494|454808765|FG002|Overall Study|Lost to Follow-up|3|||
126413679|NCT00286494|454808763|FG000|Overall Study|Protocol Violation|1|||
126413680|NCT00286494|454808764|FG001|Overall Study|Protocol Violation|1|||
126413681|NCT00286494|454808765|FG002|Overall Study|Protocol Violation|2|||
126413682|NCT04776317|454808766|FG000|Overall Study|Physician Decision|0|||
126413683|NCT04776317|454808767|FG001|Overall Study|Physician Decision|1|||
126413684|NCT04776317|454808768|FG002|Overall Study|Physician Decision|0|||
126413685|NCT04776317|454808769|FG003|Overall Study|Physician Decision|0|||
126413686|NCT04776317|454808770|FG004|Overall Study|Physician Decision|0|||
126413687|NCT04776317|454808771|FG005|Overall Study|Physician Decision|0|||
126413688|NCT04776317|454808772|FG006|Overall Study|Physician Decision|0|||
126413689|NCT04776317|454808773|FG007|Overall Study|Physician Decision|0|||
126413690|NCT04776317|454808774|FG008|Overall Study|Physician Decision|0|||
126413691|NCT04776317|454808775|FG009|Overall Study|Physician Decision|0|||
126413692|NCT04776317|454808776|FG010|Overall Study|Physician Decision|0|||
126475340|NCT02761733|455039985|FG002|Overall Study|Cognitive Impairment|1|||
126558874|NCT02028884|455340573|FG000|Open-label Extension Period|Adverse Event|3|||
126721583|NCT00875017|455930009|FG001|Washout|Problem collecting rectal effluent|0|||
126413693|NCT04776317|454808777|FG011|Overall Study|Physician Decision|0|||
126721584|NCT00875017|455930010|FG002|Washout|Problem collecting rectal effluent|1|||
126413694|NCT04776317|454808778|FG012|Overall Study|Physician Decision|0|||
126413695|NCT04776317|454808779|FG013|Overall Study|Physician Decision|0|||
126413696|NCT04776317|454808780|FG014|Overall Study|Physician Decision|0|||
126413697|NCT04776317|454808766|FG000|Overall Study|Protocol Violation|0|||
126413698|NCT04776317|454808767|FG001|Overall Study|Protocol Violation|0|||
126475341|NCT02761733|455039986|FG003|Overall Study|Cognitive Impairment|0|||
126475342|NCT04295772|455039989|FG000|Overall Study|Protocol Violation|1|||
126475343|NCT04295772|455039990|FG001|Overall Study|Protocol Violation|0|||
126475344|NCT04295772|455039989|FG000|Overall Study|Ongoing for safety monitoring|14|||
126475345|NCT04295772|455039990|FG001|Overall Study|Ongoing for safety monitoring|1|||
126558875|NCT02028884|455340574|FG001|Open-label Extension Period|Adverse Event|1|||
126413699|NCT04776317|454808768|FG002|Overall Study|Protocol Violation|1|||
126413700|NCT04776317|454808769|FG003|Overall Study|Protocol Violation|0|||
126413701|NCT04776317|454808770|FG004|Overall Study|Protocol Violation|0|||
126558876|NCT02028884|455340575|FG002|Open-label Extension Period|Adverse Event|0|||
126558877|NCT02028884|455340573|FG000|Open-label Extension Period|Lack of Efficacy|3|||
126558878|NCT02028884|455340574|FG001|Open-label Extension Period|Lack of Efficacy|0|||
126558879|NCT02028884|455340575|FG002|Open-label Extension Period|Lack of Efficacy|0|||
126413702|NCT04776317|454808771|FG005|Overall Study|Protocol Violation|0|||
126413703|NCT04776317|454808772|FG006|Overall Study|Protocol Violation|0|||
126413704|NCT04776317|454808773|FG007|Overall Study|Protocol Violation|0|||
126413705|NCT04776317|454808774|FG008|Overall Study|Protocol Violation|0|||
126413706|NCT04776317|454808775|FG009|Overall Study|Protocol Violation|0|||
126413707|NCT04776317|454808776|FG010|Overall Study|Protocol Violation|0|||
126413708|NCT04776317|454808777|FG011|Overall Study|Protocol Violation|0|||
126413709|NCT04776317|454808778|FG012|Overall Study|Protocol Violation|0|||
126413710|NCT04776317|454808779|FG013|Overall Study|Protocol Violation|0|||
126413711|NCT04776317|454808780|FG014|Overall Study|Protocol Violation|0|||
126413712|NCT04776317|454808766|FG000|Overall Study|Withdrawal by Subject|0|||
126413713|NCT04776317|454808767|FG001|Overall Study|Withdrawal by Subject|0|||
126413714|NCT04776317|454808768|FG002|Overall Study|Withdrawal by Subject|0|||
126413715|NCT04776317|454808769|FG003|Overall Study|Withdrawal by Subject|0|||
126413716|NCT04776317|454808770|FG004|Overall Study|Withdrawal by Subject|1|||
126413717|NCT04776317|454808771|FG005|Overall Study|Withdrawal by Subject|0|||
126413718|NCT04776317|454808772|FG006|Overall Study|Withdrawal by Subject|0|||
126413719|NCT04776317|454808773|FG007|Overall Study|Withdrawal by Subject|0|||
126413720|NCT04776317|454808774|FG008|Overall Study|Withdrawal by Subject|0|||
126413721|NCT04776317|454808775|FG009|Overall Study|Withdrawal by Subject|0|||
126413722|NCT04776317|454808776|FG010|Overall Study|Withdrawal by Subject|0|||
126413723|NCT04776317|454808777|FG011|Overall Study|Withdrawal by Subject|0|||
126413724|NCT04776317|454808778|FG012|Overall Study|Withdrawal by Subject|0|||
126413725|NCT04776317|454808779|FG013|Overall Study|Withdrawal by Subject|0|||
126413726|NCT04776317|454808780|FG014|Overall Study|Withdrawal by Subject|0|||
126413727|NCT03671304|454808781|FG000|Overall Study|study terminated|7|||
126413728|NCT01856582|454808782|FG000|Overall Study|Died prior to Boost infusion|1|||
126413729|NCT01457846|454808783|FG000|Overall Study|Death before treatment|1|||
126413730|NCT01457846|454808784|FG001|Overall Study|Death before treatment|2|||
126413731|NCT01457846|454808783|FG000|Overall Study|Did not receive treatment|0|||
126413732|NCT01457846|454808784|FG001|Overall Study|Did not receive treatment|1|||
126413733|NCT01457846|454808783|FG000|Overall Study|Death|27|||
126413734|NCT01457846|454808784|FG001|Overall Study|Death|16|||
126413735|NCT01457846|454808783|FG000|Overall Study|Unclassified reason for not completed|11|||
126413736|NCT01457846|454808784|FG001|Overall Study|Unclassified reason for not completed|10|||
126413737|NCT01457846|454808783|FG000|Overall Study|Withdrawal by Subject|1|||
126413738|NCT01457846|454808784|FG001|Overall Study|Withdrawal by Subject|1|||
126413739|NCT01457846|454808783|FG000|Overall Study|Lost to Follow-up|1|||
126413740|NCT01457846|454808784|FG001|Overall Study|Lost to Follow-up|0|||
126413741|NCT01240135|454808785|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
126413742|NCT01240135|454808786|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
126413743|NCT01240135|454808785|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
126413744|NCT01240135|454808786|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
126413745|NCT01371305|454808787|FG000|Overall Study|Adverse Event|0|||
126413746|NCT01371305|454808788|FG001|Overall Study|Adverse Event|0|||
126413747|NCT01371305|454808789|FG002|Overall Study|Adverse Event|0|||
126413748|NCT01371305|454808790|FG003|Overall Study|Adverse Event|2|||
126413749|NCT01371305|454808791|FG004|Overall Study|Adverse Event|1|||
126413750|NCT01371305|454808792|FG005|Overall Study|Adverse Event|0|||
126558880|NCT02028884|455340573|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
126558881|NCT02028884|455340574|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
126558882|NCT02028884|455340575|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
126413751|NCT01371305|454808787|FG000|Overall Study|Study terminated by sponsor|0|||
126413752|NCT01371305|454808788|FG001|Overall Study|Study terminated by sponsor|0|||
126413753|NCT01371305|454808789|FG002|Overall Study|Study terminated by sponsor|0|||
126413754|NCT01371305|454808790|FG003|Overall Study|Study terminated by sponsor|0|||
126558883|NCT02028884|455340573|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
126558884|NCT02028884|455340574|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
126558885|NCT02028884|455340575|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
126413755|NCT01371305|454808791|FG004|Overall Study|Study terminated by sponsor|3|||
126413756|NCT01371305|454808792|FG005|Overall Study|Study terminated by sponsor|1|||
126413757|NCT01371305|454808787|FG000|Overall Study|Subject request|0|||
126413758|NCT01371305|454808788|FG001|Overall Study|Subject request|0|||
126413759|NCT01371305|454808789|FG002|Overall Study|Subject request|0|||
126413760|NCT01371305|454808790|FG003|Overall Study|Subject request|0|||
126413761|NCT01371305|454808791|FG004|Overall Study|Subject request|0|||
126413762|NCT01371305|454808792|FG005|Overall Study|Subject request|1|||
126413763|NCT01628965|454808793|FG000|Overall Study|Adverse Event|30|||
126413764|NCT01628965|454808793|FG000|Overall Study|Lack of Efficacy|7|||
126413765|NCT01628965|454808793|FG000|Overall Study|Withdrawal by Subject|3|||
126413766|NCT01628965|454808793|FG000|Overall Study|Lost to Follow-up|1|||
126413767|NCT01628965|454808793|FG000|Overall Study|Discontinuation criteria|8|||
126413768|NCT04356352|454808794|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
126413769|NCT04356352|454808795|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
126413770|NCT04356352|454808796|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
126413771|NCT04356352|454808794|FG000|Overall Study|Protocol Violation|0|||
126413772|NCT04356352|454808795|FG001|Overall Study|Protocol Violation|3|||
126413773|NCT04356352|454808796|FG002|Overall Study|Protocol Violation|1|||
126413774|NCT00379912|454808801|FG000|Overall Study|Lack of Efficacy|1|||
126413775|NCT00379912|454808802|FG001|Overall Study|Lack of Efficacy|0|||
126413776|NCT01128946|454808803|FG000|Period I|Protocol Violation|0|||
126413777|NCT01128946|454808804|FG001|Period I|Protocol Violation|1|||
126413778|NCT01128946|454808805|FG002|Period I|Protocol Violation|0|||
126413779|NCT01128946|454808806|FG003|Period I|Protocol Violation|0|||
126413780|NCT01128946|454808803|FG000|Period I|Withdrawal by Subject|0|||
126413781|NCT01128946|454808804|FG001|Period I|Withdrawal by Subject|0|||
126413782|NCT01128946|454808805|FG002|Period I|Withdrawal by Subject|1|||
126413783|NCT01128946|454808806|FG003|Period I|Withdrawal by Subject|1|||
126413784|NCT01128946|454808803|FG000|Period II|Protocol Violation|0|||
126413785|NCT01128946|454808804|FG001|Period II|Protocol Violation|1|||
126413786|NCT01128946|454808805|FG002|Period II|Protocol Violation|0|||
126413787|NCT01128946|454808806|FG003|Period II|Protocol Violation|0|||
126413788|NCT01128946|454808803|FG000|Period II|Withdrawal by Subject|0|||
126413789|NCT01128946|454808804|FG001|Period II|Withdrawal by Subject|0|||
126413790|NCT01128946|454808805|FG002|Period II|Withdrawal by Subject|0|||
126413791|NCT01128946|454808806|FG003|Period II|Withdrawal by Subject|1|||
126413792|NCT01128946|454808803|FG000|Period III|Protocol Violation|1|||
126413793|NCT01128946|454808804|FG001|Period III|Protocol Violation|0|||
126413794|NCT01128946|454808805|FG002|Period III|Protocol Violation|0|||
126413795|NCT01128946|454808806|FG003|Period III|Protocol Violation|0|||
126413796|NCT01371734|454808807|FG000|Overall Study|Other|2|||
126413797|NCT01371734|454808808|FG001|Overall Study|Other|1|||
126413798|NCT01371734|454808809|FG002|Overall Study|Other|2|||
126413799|NCT01371734|454808807|FG000|Overall Study|Withdrawal by Subject|3|||
126413800|NCT01371734|454808808|FG001|Overall Study|Withdrawal by Subject|4|||
126413801|NCT01371734|454808809|FG002|Overall Study|Withdrawal by Subject|9|||
126413802|NCT01371734|454808807|FG000|Overall Study|Lost to Follow-up|5|||
126558886|NCT02028884|455340573|FG000|Open-label Extension Period|Switched to another treatment option|3|||
126558887|NCT02028884|455340574|FG001|Open-label Extension Period|Switched to another treatment option|0|||
126558888|NCT02028884|455340575|FG002|Open-label Extension Period|Switched to another treatment option|0|||
126413803|NCT01371734|454808808|FG001|Overall Study|Lost to Follow-up|3|||
126413804|NCT01371734|454808809|FG002|Overall Study|Lost to Follow-up|1|||
126413805|NCT01371734|454808807|FG000|Overall Study|Protocol Violation|3|||
126413806|NCT01371734|454808808|FG001|Overall Study|Protocol Violation|1|||
126413807|NCT01371734|454808809|FG002|Overall Study|Protocol Violation|2|||
126413808|NCT01371734|454808807|FG000|Overall Study|Adverse Event|8|||
126413809|NCT01371734|454808808|FG001|Overall Study|Adverse Event|8|||
126413810|NCT01371734|454808809|FG002|Overall Study|Adverse Event|3|||
126413811|NCT01371734|454808807|FG000|Overall Study|Lack of Efficacy|2|||
126413812|NCT01371734|454808808|FG001|Overall Study|Lack of Efficacy|2|||
126413813|NCT01371734|454808809|FG002|Overall Study|Lack of Efficacy|0|||
126413814|NCT00621140|454808810|FG000|Overall Study|Adverse Event|4|||
126413815|NCT00621140|454808811|FG001|Overall Study|Adverse Event|5|||
126413816|NCT00621140|454808810|FG000|Overall Study|Lost to Follow-up|1|||
126413817|NCT00621140|454808811|FG001|Overall Study|Lost to Follow-up|2|||
126413818|NCT00621140|454808810|FG000|Overall Study|Withdrawal by Subject|4|||
126413819|NCT00621140|454808811|FG001|Overall Study|Withdrawal by Subject|6|||
126413820|NCT00621140|454808810|FG000|Overall Study|Other incl. lack of efficacy|6|||
126413821|NCT00621140|454808811|FG001|Overall Study|Other incl. lack of efficacy|5|||
126413822|NCT00360568|454808813|FG000|Overall Study|Adverse Event|1|||
126413823|NCT00360568|454808814|FG001|Overall Study|Adverse Event|2|||
126413824|NCT00360568|454808813|FG000|Overall Study|Lack of Efficacy|1|||
126413825|NCT00360568|454808814|FG001|Overall Study|Lack of Efficacy|0|||
126413826|NCT00360568|454808813|FG000|Overall Study|Withdrawal by Subject|0|||
126413827|NCT00360568|454808814|FG001|Overall Study|Withdrawal by Subject|3|||
126413828|NCT03565237|454808815|FG000|Overall Study|Non-compliance of Investigational Product|1|||
126413829|NCT03565237|454808815|FG000|Overall Study|Physician Decision|1|||
126413830|NCT02873338|454808820|FG000|Overall Study|Adverse Event|0|||
126413831|NCT02873338|454808821|FG001|Overall Study|Adverse Event|2|||
126413832|NCT02873338|454808822|FG002|Overall Study|Adverse Event|1|||
126413833|NCT02873338|454808820|FG000|Overall Study|Death|2|||
126413834|NCT02873338|454808821|FG001|Overall Study|Death|1|||
126413835|NCT02873338|454808822|FG002|Overall Study|Death|1|||
126413836|NCT02873338|454808820|FG000|Overall Study|Withdrawal by Subject|2|||
126413837|NCT02873338|454808821|FG001|Overall Study|Withdrawal by Subject|1|||
126413838|NCT02873338|454808822|FG002|Overall Study|Withdrawal by Subject|3|||
126413839|NCT02873338|454808820|FG000|Overall Study|Lack of Efficacy|0|||
126413840|NCT02873338|454808821|FG001|Overall Study|Lack of Efficacy|2|||
126413841|NCT02873338|454808822|FG002|Overall Study|Lack of Efficacy|0|||
126413842|NCT02873338|454808820|FG000|Overall Study|Other or Missing|14|||
126475346|NCT04295772|455039989|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
126475347|NCT04295772|455039990|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
126475348|NCT02716805|455039991|FG000|Overall Study|Progressive disease|2|||
126475349|NCT02716805|455039992|FG001|Overall Study|Progressive disease|0|||
126475350|NCT02716805|455039993|FG002|Overall Study|Progressive disease|0|||
126475351|NCT02716805|455039994|FG003|Overall Study|Progressive disease|0|||
126475352|NCT02635776|455040001|FG000|Overall Study|Physician Decision|1|||
126475353|NCT02635776|455040002|FG001|Overall Study|Physician Decision|0|||
126475354|NCT02635776|455040001|FG000|Overall Study|Adverse Event|51|||
126475355|NCT02635776|455040002|FG001|Overall Study|Adverse Event|3|||
126475356|NCT02635776|455040001|FG000|Overall Study|Withdrawal by Subject|41|||
126475357|NCT02635776|455040002|FG001|Overall Study|Withdrawal by Subject|7|||
126475358|NCT02635776|455040001|FG000|Overall Study|Lost to Follow-up|4|||
126475359|NCT02635776|455040002|FG001|Overall Study|Lost to Follow-up|0|||
126475360|NCT02635776|455040001|FG000|Overall Study|Other reasons|5|||
126475361|NCT02635776|455040002|FG001|Overall Study|Other reasons|1|||
126475362|NCT00660673|455040004|FG000|Overall Study|Adverse Event|84|||
126475363|NCT00660673|455040004|FG000|Overall Study|Lack of Efficacy|7|||
126475364|NCT00660673|455040004|FG000|Overall Study|Withdrawal by Subject|22|||
126475365|NCT00660673|455040004|FG000|Overall Study|Administrative|2|||
126475366|NCT00660673|455040004|FG000|Overall Study|Protocol Violation|2|||
126475367|NCT00239590|455040005|FG000|Randomized|Lost to Follow-up|0|||
126475368|NCT00239590|455040006|FG001|Randomized|Lost to Follow-up|1|||
126475369|NCT00239590|455040005|FG000|Randomized|Withdrawal by Subject|0|||
126475370|NCT00239590|455040006|FG001|Randomized|Withdrawal by Subject|1|||
126475371|NCT00239590|455040005|FG000|Completed Study Protocol|Adverse Event|1|||
126475372|NCT00239590|455040006|FG001|Completed Study Protocol|Adverse Event|1|||
126475373|NCT00239590|455040005|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
126475374|NCT00239590|455040006|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
126475375|NCT02362269|455040007|FG000|Overall Study|Moved|1|||
126475376|NCT02362269|455040008|FG001|Overall Study|Moved|0|||
126475377|NCT02362269|455040007|FG000|Overall Study|Lost to Follow-up|0|||
126475378|NCT02362269|455040008|FG001|Overall Study|Lost to Follow-up|6|||
126475379|NCT01903031|455040009|FG000|Overall Study|Not Able to Attend Clinic|1|||
126475380|NCT01903031|455040010|FG001|Overall Study|Not Able to Attend Clinic|1|||
126475381|NCT01903031|455040011|FG002|Overall Study|Not Able to Attend Clinic|0|||
126475382|NCT01903031|455040009|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
126475383|NCT01903031|455040010|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
126475384|NCT01903031|455040011|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
126475385|NCT01903031|455040009|FG000|Overall Study|Adverse Event|0|||
126475386|NCT01903031|455040010|FG001|Overall Study|Adverse Event|1|||
126475387|NCT01903031|455040011|FG002|Overall Study|Adverse Event|0|||
126475388|NCT01903031|455040009|FG000|Overall Study|Withdrawal by Subject|0|||
126475389|NCT01903031|455040010|FG001|Overall Study|Withdrawal by Subject|1|||
126475390|NCT01903031|455040011|FG002|Overall Study|Withdrawal by Subject|1|||
126475391|NCT01903031|455040009|FG000|Overall Study|Protocol Violation|0|||
126475392|NCT01903031|455040010|FG001|Overall Study|Protocol Violation|0|||
126475393|NCT01903031|455040011|FG002|Overall Study|Protocol Violation|2|||
126475394|NCT01903031|455040009|FG000|Overall Study|Lost to Follow-up|0|||
126475395|NCT01903031|455040010|FG001|Overall Study|Lost to Follow-up|0|||
126475396|NCT01903031|455040011|FG002|Overall Study|Lost to Follow-up|1|||
126475397|NCT01903031|455040009|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
126475398|NCT01903031|455040010|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
126475399|NCT01903031|455040011|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
126475400|NCT03540030|455040012|FG000|Overall Study|Withdrawal by Subject|2|||
126475401|NCT03540030|455040013|FG001|Overall Study|Withdrawal by Subject|1|||
126475402|NCT03540030|455040012|FG000|Overall Study|screen fail|7|||
126475403|NCT03540030|455040013|FG001|Overall Study|screen fail|1|||
126475404|NCT03540030|455040012|FG000|Overall Study|never had surgery after signing consent|9|||
126475405|NCT03540030|455040013|FG001|Overall Study|never had surgery after signing consent|1|||
126475406|NCT00347360|455040023|FG000|Overall Study|Adverse Event|1|||
126475407|NCT00347360|455040024|FG001|Overall Study|Adverse Event|2|||
126475408|NCT00347360|455040025|FG002|Overall Study|Adverse Event|0|||
126475409|NCT00347360|455040026|FG003|Overall Study|Adverse Event|4|||
126475410|NCT00347360|455040027|FG004|Overall Study|Adverse Event|1|||
126475411|NCT00347360|455040028|FG005|Overall Study|Adverse Event|2|||
126475412|NCT00347360|455040029|FG006|Overall Study|Adverse Event|2|||
126475413|NCT00347360|455040030|FG007|Overall Study|Adverse Event|0|||
126475414|NCT00347360|455040031|FG008|Overall Study|Adverse Event|2|||
126475415|NCT00347360|455040032|FG009|Overall Study|Adverse Event|3|||
126475416|NCT00347360|455040033|FG010|Overall Study|Adverse Event|3|||
126475417|NCT00347360|455040034|FG011|Overall Study|Adverse Event|1|||
126475418|NCT00347360|455040035|FG012|Overall Study|Adverse Event|3|||
126475419|NCT00347360|455040036|FG013|Overall Study|Adverse Event|2|||
126475420|NCT00347360|455040037|FG014|Overall Study|Adverse Event|2|||
126475421|NCT00347360|455040023|FG000|Overall Study|Lost to Follow-up|0|||
126475422|NCT00347360|455040024|FG001|Overall Study|Lost to Follow-up|0|||
126475423|NCT00347360|455040025|FG002|Overall Study|Lost to Follow-up|0|||
126413843|NCT02873338|454808821|FG001|Overall Study|Other or Missing|15|||
126413844|NCT02873338|454808822|FG002|Overall Study|Other or Missing|13|||
126413845|NCT03657095|454808823|FG000|Overall Study|Withdrawal by Subject|1|||
126413846|NCT03657095|454808824|FG001|Overall Study|Withdrawal by Subject|1|||
126413847|NCT03657095|454808823|FG000|Overall Study|Adverse Event|0|||
126413848|NCT03657095|454808824|FG001|Overall Study|Adverse Event|3|||
126475424|NCT00347360|455040026|FG003|Overall Study|Lost to Follow-up|2|||
126475425|NCT00347360|455040027|FG004|Overall Study|Lost to Follow-up|1|||
126475426|NCT00347360|455040028|FG005|Overall Study|Lost to Follow-up|1|||
126475427|NCT00347360|455040029|FG006|Overall Study|Lost to Follow-up|0|||
126475428|NCT00347360|455040030|FG007|Overall Study|Lost to Follow-up|1|||
126475429|NCT00347360|455040031|FG008|Overall Study|Lost to Follow-up|1|||
126475430|NCT00347360|455040032|FG009|Overall Study|Lost to Follow-up|2|||
126475431|NCT00347360|455040033|FG010|Overall Study|Lost to Follow-up|0|||
126475432|NCT00347360|455040034|FG011|Overall Study|Lost to Follow-up|0|||
126475433|NCT00347360|455040035|FG012|Overall Study|Lost to Follow-up|1|||
126475434|NCT00347360|455040036|FG013|Overall Study|Lost to Follow-up|0|||
126475435|NCT00347360|455040037|FG014|Overall Study|Lost to Follow-up|0|||
126475436|NCT00347360|455040023|FG000|Overall Study|Protocol Violation|2|||
126475437|NCT00347360|455040024|FG001|Overall Study|Protocol Violation|3|||
126475438|NCT00347360|455040025|FG002|Overall Study|Protocol Violation|1|||
126475439|NCT00347360|455040026|FG003|Overall Study|Protocol Violation|2|||
126475440|NCT00347360|455040027|FG004|Overall Study|Protocol Violation|1|||
126475441|NCT00347360|455040028|FG005|Overall Study|Protocol Violation|2|||
126475442|NCT00347360|455040029|FG006|Overall Study|Protocol Violation|0|||
126475443|NCT00347360|455040030|FG007|Overall Study|Protocol Violation|0|||
126475444|NCT00347360|455040031|FG008|Overall Study|Protocol Violation|1|||
126475445|NCT00347360|455040032|FG009|Overall Study|Protocol Violation|2|||
126475446|NCT00347360|455040033|FG010|Overall Study|Protocol Violation|0|||
126475447|NCT00347360|455040034|FG011|Overall Study|Protocol Violation|0|||
126475448|NCT00347360|455040035|FG012|Overall Study|Protocol Violation|0|||
126475449|NCT00347360|455040036|FG013|Overall Study|Protocol Violation|1|||
126475450|NCT00347360|455040037|FG014|Overall Study|Protocol Violation|0|||
126475451|NCT00347360|455040023|FG000|Overall Study|Withdrawal by Subject|0|||
126475452|NCT00347360|455040024|FG001|Overall Study|Withdrawal by Subject|1|||
126475453|NCT00347360|455040025|FG002|Overall Study|Withdrawal by Subject|2|||
126475454|NCT00347360|455040026|FG003|Overall Study|Withdrawal by Subject|4|||
126475455|NCT00347360|455040027|FG004|Overall Study|Withdrawal by Subject|1|||
126475456|NCT00347360|455040028|FG005|Overall Study|Withdrawal by Subject|2|||
126475457|NCT00347360|455040029|FG006|Overall Study|Withdrawal by Subject|1|||
126475458|NCT00347360|455040030|FG007|Overall Study|Withdrawal by Subject|1|||
126475459|NCT00347360|455040031|FG008|Overall Study|Withdrawal by Subject|1|||
126475460|NCT00347360|455040032|FG009|Overall Study|Withdrawal by Subject|1|||
126475461|NCT00347360|455040033|FG010|Overall Study|Withdrawal by Subject|0|||
126475462|NCT00347360|455040034|FG011|Overall Study|Withdrawal by Subject|3|||
126475463|NCT00347360|455040035|FG012|Overall Study|Withdrawal by Subject|4|||
126475464|NCT00347360|455040036|FG013|Overall Study|Withdrawal by Subject|2|||
126475465|NCT00347360|455040037|FG014|Overall Study|Withdrawal by Subject|1|||
126475466|NCT00347360|455040023|FG000|Overall Study|Lack of Efficacy|1|||
126475467|NCT00347360|455040024|FG001|Overall Study|Lack of Efficacy|1|||
126475468|NCT00347360|455040025|FG002|Overall Study|Lack of Efficacy|3|||
126475469|NCT00347360|455040026|FG003|Overall Study|Lack of Efficacy|1|||
126475470|NCT00347360|455040027|FG004|Overall Study|Lack of Efficacy|0|||
126475471|NCT00347360|455040028|FG005|Overall Study|Lack of Efficacy|1|||
126475472|NCT00347360|455040029|FG006|Overall Study|Lack of Efficacy|0|||
126475473|NCT00347360|455040030|FG007|Overall Study|Lack of Efficacy|1|||
126475474|NCT00347360|455040031|FG008|Overall Study|Lack of Efficacy|1|||
126475475|NCT00347360|455040032|FG009|Overall Study|Lack of Efficacy|0|||
126475476|NCT00347360|455040033|FG010|Overall Study|Lack of Efficacy|0|||
126475477|NCT00347360|455040034|FG011|Overall Study|Lack of Efficacy|0|||
126475478|NCT00347360|455040035|FG012|Overall Study|Lack of Efficacy|0|||
126475479|NCT00347360|455040036|FG013|Overall Study|Lack of Efficacy|0|||
126413849|NCT03657095|454808823|FG000|Overall Study|Study Terminated by Sponsor|58|||
126475480|NCT00347360|455040037|FG014|Overall Study|Lack of Efficacy|0|||
126475481|NCT00347360|455040023|FG000|Overall Study|Reason not listed/blank|1|||
126475482|NCT00347360|455040024|FG001|Overall Study|Reason not listed/blank|0|||
126475483|NCT00347360|455040025|FG002|Overall Study|Reason not listed/blank|0|||
126475484|NCT00347360|455040026|FG003|Overall Study|Reason not listed/blank|0|||
126475485|NCT00347360|455040027|FG004|Overall Study|Reason not listed/blank|0|||
126475486|NCT00347360|455040028|FG005|Overall Study|Reason not listed/blank|0|||
126475487|NCT00347360|455040029|FG006|Overall Study|Reason not listed/blank|1|||
126413850|NCT03657095|454808824|FG001|Overall Study|Study Terminated by Sponsor|49|||
126413851|NCT01743040|454808825|FG000|Overall Study|Death|1|||
126413852|NCT01743040|454808825|FG000|Overall Study|Lost to Follow-up|66|||
126413853|NCT01743040|454808825|FG000|Overall Study|Physician Decision|40|||
126475488|NCT00347360|455040030|FG007|Overall Study|Reason not listed/blank|0|||
126475489|NCT00347360|455040031|FG008|Overall Study|Reason not listed/blank|0|||
126475490|NCT00347360|455040032|FG009|Overall Study|Reason not listed/blank|0|||
126475491|NCT00347360|455040033|FG010|Overall Study|Reason not listed/blank|0|||
126413854|NCT01743040|454808825|FG000|Overall Study|Protocol Violation|1|||
126413855|NCT01743040|454808825|FG000|Overall Study|Withdrawal by Subject|121|||
126413856|NCT00828750|454808826|FG000|Overall Study|Lack of Efficacy|3|||
126413857|NCT00828750|454808826|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
126413858|NCT00830180|454808827|FG000|Overall Study|Adverse Event|6|||
126413859|NCT00830180|454808827|FG000|Overall Study|Death|11|||
126413860|NCT00830180|454808827|FG000|Overall Study|Insufficient clinical response|1|||
126413861|NCT00830180|454808827|FG000|Overall Study|Withdrawal by Subject|5|||
126413862|NCT00830180|454808827|FG000|Overall Study|Progressive disease|2|||
126413863|NCT00830180|454808827|FG000|Overall Study|Other - Unspecified|1|||
126413864|NCT01832532|454808828|FG000|Overall Study|Withdrawal by Subject|5|||
126413865|NCT01832532|454808829|FG001|Overall Study|Withdrawal by Subject|2|||
126413866|NCT01990612|454808830|FG000|Overall Study|Lost to Follow-up|2|||
126413867|NCT01990612|454808831|FG001|Overall Study|Lost to Follow-up|1|||
126413868|NCT01990612|454808830|FG000|Overall Study|Withdrawal by Subject|5|||
126413869|NCT01990612|454808831|FG001|Overall Study|Withdrawal by Subject|2|||
126413870|NCT02974842|454808832|FG000|Overall Study|Withdrawal by Subject|4|||
126413871|NCT02974842|454808832|FG000|Overall Study|Screen failures|4|||
126413872|NCT01068158|454808840|FG000|Overall Study|Withdrawal by Subject|1|||
126413873|NCT01068158|454808841|FG001|Overall Study|Withdrawal by Subject|2|||
126413874|NCT01068158|454808840|FG000|Overall Study|Lost to Follow-up|7|||
126413875|NCT01068158|454808841|FG001|Overall Study|Lost to Follow-up|0|||
126413876|NCT01068158|454808840|FG000|Overall Study|Protocol Violation|0|||
126413877|NCT01068158|454808841|FG001|Overall Study|Protocol Violation|2|||
126413878|NCT01300572|454808842|FG000|Overall Study|HAMA + post dosimetry|1|||
126413879|NCT00411632|454808844|FG000|Overall Study|Death|1|||
126413880|NCT01748825|454808859|FG000|Dose Escalation|Refused further treatment|2|||
126413881|NCT01748825|454808860|FG001|Dose Escalation|Refused further treatment|2|||
126413882|NCT01748825|454808861|FG002|Dose Escalation|Refused further treatment|0|||
126413883|NCT01748825|454808862|FG003|Dose Escalation|Refused further treatment|0|||
126413884|NCT01748825|454808863|FG004|Dose Escalation|Refused further treatment|1|||
126413885|NCT01748825|454808864|FG005|Dose Escalation|Refused further treatment|2|||
126413886|NCT01748825|454808865|FG006|Dose Escalation|Refused further treatment|0|||
126413887|NCT01748825|454808866|FG007|Dose Escalation|Refused further treatment|0|||
126413888|NCT01748825|454808867|FG008|Dose Escalation|Refused further treatment|0|||
126413889|NCT01748825|454808868|FG009|Dose Escalation|Refused further treatment|0|||
126413890|NCT01748825|454808859|FG000|Dose Escalation|Switched to alternative treatment|0|||
126413891|NCT01748825|454808860|FG001|Dose Escalation|Switched to alternative treatment|0|||
126413892|NCT01748825|454808861|FG002|Dose Escalation|Switched to alternative treatment|0|||
126413893|NCT01748825|454808862|FG003|Dose Escalation|Switched to alternative treatment|1|||
126413894|NCT01748825|454808863|FG004|Dose Escalation|Switched to alternative treatment|0|||
126413895|NCT01748825|454808864|FG005|Dose Escalation|Switched to alternative treatment|0|||
126413896|NCT01748825|454808865|FG006|Dose Escalation|Switched to alternative treatment|0|||
126413897|NCT01748825|454808866|FG007|Dose Escalation|Switched to alternative treatment|0|||
126413898|NCT01748825|454808867|FG008|Dose Escalation|Switched to alternative treatment|0|||
126413899|NCT01748825|454808868|FG009|Dose Escalation|Switched to alternative treatment|0|||
126413900|NCT01748825|454808859|FG000|Dose Escalation|Adverse Event|0|||
126413901|NCT01748825|454808860|FG001|Dose Escalation|Adverse Event|0|||
126413902|NCT01748825|454808861|FG002|Dose Escalation|Adverse Event|0|||
126413903|NCT01748825|454808862|FG003|Dose Escalation|Adverse Event|0|||
126413904|NCT01748825|454808863|FG004|Dose Escalation|Adverse Event|0|||
126413905|NCT01748825|454808864|FG005|Dose Escalation|Adverse Event|0|||
126413906|NCT01748825|454808865|FG006|Dose Escalation|Adverse Event|1|||
126413907|NCT01748825|454808866|FG007|Dose Escalation|Adverse Event|0|||
126413908|NCT01748825|454808867|FG008|Dose Escalation|Adverse Event|0|||
126475492|NCT00347360|455040034|FG011|Overall Study|Reason not listed/blank|0|||
126475493|NCT00347360|455040035|FG012|Overall Study|Reason not listed/blank|0|||
126475494|NCT00347360|455040036|FG013|Overall Study|Reason not listed/blank|1|||
126475495|NCT00347360|455040037|FG014|Overall Study|Reason not listed/blank|0|||
126475496|NCT00347360|455040023|FG000|Overall Study|Per sponsors instruction|0|||
126475497|NCT00347360|455040024|FG001|Overall Study|Per sponsors instruction|1|||
126475498|NCT00347360|455040025|FG002|Overall Study|Per sponsors instruction|0|||
126413909|NCT01748825|454808868|FG009|Dose Escalation|Adverse Event|0|||
126413910|NCT01748825|454808859|FG000|Dose Expansion|Refused further treatment|0|||
126413911|NCT01748825|454808860|FG001|Dose Expansion|Refused further treatment|0|||
126413912|NCT01748825|454808861|FG002|Dose Expansion|Refused further treatment|0|||
126413913|NCT01748825|454808862|FG003|Dose Expansion|Refused further treatment|0|||
126413914|NCT01748825|454808863|FG004|Dose Expansion|Refused further treatment|0|||
126413915|NCT01748825|454808864|FG005|Dose Expansion|Refused further treatment|0|||
126413916|NCT01748825|454808865|FG006|Dose Expansion|Refused further treatment|0|||
126475499|NCT00347360|455040026|FG003|Overall Study|Per sponsors instruction|0|||
126413917|NCT01748825|454808866|FG007|Dose Expansion|Refused further treatment|0|||
126413918|NCT01748825|454808867|FG008|Dose Expansion|Refused further treatment|1|||
126413919|NCT01748825|454808868|FG009|Dose Expansion|Refused further treatment|1|||
126413920|NCT01748825|454808859|FG000|Dose Expansion|Switched to alternative treatment|0|||
126413921|NCT01748825|454808860|FG001|Dose Expansion|Switched to alternative treatment|0|||
126413922|NCT01748825|454808861|FG002|Dose Expansion|Switched to alternative treatment|0|||
126413923|NCT01748825|454808862|FG003|Dose Expansion|Switched to alternative treatment|0|||
126413924|NCT01748825|454808863|FG004|Dose Expansion|Switched to alternative treatment|0|||
126413925|NCT01748825|454808864|FG005|Dose Expansion|Switched to alternative treatment|0|||
126413926|NCT01748825|454808865|FG006|Dose Expansion|Switched to alternative treatment|0|||
126413927|NCT01748825|454808866|FG007|Dose Expansion|Switched to alternative treatment|0|||
126413928|NCT01748825|454808867|FG008|Dose Expansion|Switched to alternative treatment|0|||
126413929|NCT01748825|454808868|FG009|Dose Expansion|Switched to alternative treatment|1|||
126413930|NCT01748825|454808859|FG000|Dose Expansion|Adverse Event|0|||
126413931|NCT01748825|454808860|FG001|Dose Expansion|Adverse Event|0|||
126413932|NCT01748825|454808861|FG002|Dose Expansion|Adverse Event|0|||
126413933|NCT01748825|454808862|FG003|Dose Expansion|Adverse Event|0|||
126413934|NCT01748825|454808863|FG004|Dose Expansion|Adverse Event|0|||
126413935|NCT01748825|454808864|FG005|Dose Expansion|Adverse Event|0|||
126413936|NCT01748825|454808865|FG006|Dose Expansion|Adverse Event|0|||
126413937|NCT01748825|454808866|FG007|Dose Expansion|Adverse Event|0|||
126413938|NCT01748825|454808867|FG008|Dose Expansion|Adverse Event|0|||
126413939|NCT01748825|454808868|FG009|Dose Expansion|Adverse Event|3|||
126413940|NCT01748825|454808859|FG000|Dose Expansion|Physician Decision|0|||
126413941|NCT01748825|454808860|FG001|Dose Expansion|Physician Decision|0|||
126413942|NCT01748825|454808861|FG002|Dose Expansion|Physician Decision|0|||
126413943|NCT01748825|454808862|FG003|Dose Expansion|Physician Decision|0|||
126413944|NCT01748825|454808863|FG004|Dose Expansion|Physician Decision|0|||
126413945|NCT01748825|454808864|FG005|Dose Expansion|Physician Decision|0|||
126413946|NCT01748825|454808865|FG006|Dose Expansion|Physician Decision|0|||
126413947|NCT01748825|454808866|FG007|Dose Expansion|Physician Decision|0|||
126413948|NCT01748825|454808867|FG008|Dose Expansion|Physician Decision|1|||
126413949|NCT01748825|454808868|FG009|Dose Expansion|Physician Decision|0|||
126413950|NCT00852241|454808870|FG000|Overall Study|Physician Decision|18|||
126413951|NCT00659230|454808872|FG000|Overall Study|Lost to Follow-up|2|||
126413952|NCT00659230|454808873|FG001|Overall Study|Lost to Follow-up|5|||
126413953|NCT00659230|454808872|FG000|Overall Study|Lost source documentation|5|||
126413954|NCT00659230|454808873|FG001|Overall Study|Lost source documentation|4|||
126413955|NCT00659230|454808872|FG000|Overall Study|Did not return post-randomization|2|||
126413956|NCT00659230|454808873|FG001|Overall Study|Did not return post-randomization|3|||
126413957|NCT00118430|454808874|FG000|Overall Study|Withdrawal by Subject|6|||
126413958|NCT00118430|454808875|FG001|Overall Study|Withdrawal by Subject|2|||
126413959|NCT00118430|454808876|FG002|Overall Study|Withdrawal by Subject|0|||
126413960|NCT00118430|454808874|FG000|Overall Study|Lost to Follow-up|15|||
126413961|NCT00118430|454808875|FG001|Overall Study|Lost to Follow-up|22|||
126413962|NCT00118430|454808876|FG002|Overall Study|Lost to Follow-up|28|||
126413963|NCT02069392|454808879|FG000|Overall Study|Withdrawal by Subject|4|||
126413964|NCT02069392|454808880|FG001|Overall Study|Withdrawal by Subject|2|||
126413965|NCT00269633|454808881|FG000|Overall Study|Withdrawal by Subject|1|||
126413966|NCT00269633|454808882|FG001|Overall Study|Withdrawal by Subject|0|||
126475500|NCT00347360|455040027|FG004|Overall Study|Per sponsors instruction|0|||
126475501|NCT00347360|455040028|FG005|Overall Study|Per sponsors instruction|0|||
126475502|NCT00347360|455040029|FG006|Overall Study|Per sponsors instruction|0|||
126475503|NCT00347360|455040030|FG007|Overall Study|Per sponsors instruction|0|||
126475504|NCT00347360|455040031|FG008|Overall Study|Per sponsors instruction|0|||
126475505|NCT00347360|455040032|FG009|Overall Study|Per sponsors instruction|0|||
126413967|NCT04412707|454808883|FG000|Cycle 1|Death|0|||
126413968|NCT04412707|454808884|FG001|Cycle 1|Death|3|||
126413969|NCT04412707|454808883|FG000|Cycle 1|Disease progression|1|||
126413970|NCT04412707|454808884|FG001|Cycle 1|Disease progression|2|||
126413971|NCT04412707|454808883|FG000|Cycle 2|Death|0|||
126413972|NCT04412707|454808884|FG001|Cycle 2|Death|1|||
126413973|NCT04412707|454808883|FG000|Cycle 2|Disease progression|3|||
126475506|NCT00347360|455040033|FG010|Overall Study|Per sponsors instruction|0|||
126475507|NCT00347360|455040034|FG011|Overall Study|Per sponsors instruction|0|||
126475508|NCT00347360|455040035|FG012|Overall Study|Per sponsors instruction|0|||
126558889|NCT00354029|455340576|FG000|Overall Study|Protocol Violation|4|||
126558890|NCT00354029|455340577|FG001|Overall Study|Protocol Violation|2|||
126558891|NCT00723294|455340578|FG000|Overall Study|Lobular histology|2|||
126413974|NCT04412707|454808884|FG001|Cycle 2|Disease progression|0|||
126413975|NCT04412707|454808883|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
126413976|NCT04412707|454808884|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
126413977|NCT04412707|454808883|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
126413978|NCT04412707|454808884|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
126413979|NCT04412707|454808883|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
126413980|NCT04412707|454808884|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
126475509|NCT00347360|455040036|FG013|Overall Study|Per sponsors instruction|0|||
126558892|NCT00723294|455340578|FG000|Overall Study|>25% intraductal component|1|||
126413981|NCT04412707|454808883|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
126413982|NCT04412707|454808884|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
126413983|NCT02476006|454808885|FG000|Overall Study|Death|4|||
126413984|NCT02476006|454808885|FG000|Overall Study|Lack of treatment efficacy|2|||
126558893|NCT00723294|455340578|FG000|Overall Study|No MRI tumor enhancement|1|||
126558894|NCT00723294|455340578|FG000|Overall Study|1.0-Tesla MRI|1|||
126558895|NCT00723294|455340578|FG000|Overall Study|No cryoabalation|2|||
126558896|NCT00723294|455340578|FG000|Overall Study|Did not undergo surgery|1|||
126558897|NCT00723294|455340578|FG000|Overall Study|Treated prior to registration|1|||
126558898|NCT00723294|455340578|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
126558899|NCT00723294|455340578|FG000|Overall Study|Benign lesion|1|||
126558900|NCT00723294|455340578|FG000|Overall Study|Withdrawal by Subject|1|||
126558901|NCT00723294|455340578|FG000|Overall Study|No treatment due to probe failure|1|||
126413985|NCT02476006|454808885|FG000|Overall Study|Pregnancy|1|||
126413986|NCT02476006|454808885|FG000|Overall Study|Participant did not wish to continue|39|||
126413987|NCT02476006|454808885|FG000|Overall Study|Adverse Event|41|||
126413988|NCT02476006|454808885|FG000|Overall Study|Poor compliance to study protocol|3|||
126413989|NCT02476006|454808885|FG000|Overall Study|Sponsor decision|6|||
126413990|NCT02476006|454808885|FG000|Overall Study|Lost to Follow-up|5|||
126413991|NCT02476006|454808885|FG000|Overall Study|Physician Decision|5|||
126413992|NCT02476006|454808885|FG000|Overall Study|Study ended treatment not available|4|||
126413993|NCT02476006|454808885|FG000|Overall Study|Switched to commercial drug|4|||
126413994|NCT02476006|454808885|FG000|Overall Study|Excluded from study|1|||
126413995|NCT02476006|454808885|FG000|Overall Study|Protocol Violation|1|||
126413996|NCT02476006|454808885|FG000|Overall Study|Enrolled but not treated|4|||
126413997|NCT02467582|454811232|FG000|Allocation|Withdrawal by Subject|1|||
126413998|NCT02467582|454811233|FG001|Allocation|Withdrawal by Subject|0|||
126413999|NCT02467582|454811232|FG000|Follow-up|Death|5|||
126414000|NCT02467582|454811233|FG001|Follow-up|Death|4|||
126414001|NCT02467582|454811232|FG000|Follow-up|Lost to Follow-up|6|||
126414002|NCT02467582|454811233|FG001|Follow-up|Lost to Follow-up|5|||
126414003|NCT01370265|454811234|FG000|First Intervention|Adverse Event|1|||
126414004|NCT01370265|454811235|FG001|First Intervention|Adverse Event|1|||
126414005|NCT01959841|454811236|FG000|Overall Study|Adverse Event|1|||
126414006|NCT01959841|454811237|FG001|Overall Study|Adverse Event|3|||
126414007|NCT01959841|454811238|FG002|Overall Study|Adverse Event|2|||
126414008|NCT01959841|454811236|FG000|Overall Study|Lack of Efficacy|5|||
126414009|NCT01959841|454811237|FG001|Overall Study|Lack of Efficacy|0|||
126414010|NCT01959841|454811238|FG002|Overall Study|Lack of Efficacy|0|||
126414011|NCT01959841|454811236|FG000|Overall Study|Lost to Follow-up|1|||
126414012|NCT01959841|454811237|FG001|Overall Study|Lost to Follow-up|1|||
126414013|NCT01959841|454811238|FG002|Overall Study|Lost to Follow-up|0|||
126414014|NCT01959841|454811236|FG000|Overall Study|Physician Decision|0|||
126414015|NCT01959841|454811237|FG001|Overall Study|Physician Decision|2|||
126414016|NCT01959841|454811238|FG002|Overall Study|Physician Decision|3|||
126414017|NCT01959841|454811236|FG000|Overall Study|Protocol Violation|16|||
126414018|NCT01959841|454811237|FG001|Overall Study|Protocol Violation|23|||
126414019|NCT01959841|454811238|FG002|Overall Study|Protocol Violation|16|||
126414020|NCT01959841|454811236|FG000|Overall Study|Withdrawal by Subject|7|||
126414021|NCT01959841|454811237|FG001|Overall Study|Withdrawal by Subject|7|||
126414022|NCT01959841|454811238|FG002|Overall Study|Withdrawal by Subject|5|||
126414023|NCT01959841|454811236|FG000|Overall Study|Clinical laboratory value|2|||
126414024|NCT01959841|454811237|FG001|Overall Study|Clinical laboratory value|6|||
126414025|NCT01959841|454811238|FG002|Overall Study|Clinical laboratory value|6|||
126414026|NCT01959841|454811236|FG000|Overall Study|Platelet count below on day1 or 4|11|||
126414027|NCT01959841|454811237|FG001|Overall Study|Platelet count below on day1 or 4|15|||
126414028|NCT01959841|454811238|FG002|Overall Study|Platelet count below on day1 or 4|11|||
126414029|NCT00780416|454811239|FG000|Overall Study|Physician Decision|3|||
126414030|NCT00780416|454811240|FG001|Overall Study|Physician Decision|3|||
126414031|NCT00780416|454811239|FG000|Overall Study|Protocol Violation|1|||
126414032|NCT00780416|454811240|FG001|Overall Study|Protocol Violation|0|||
126414033|NCT00780416|454811239|FG000|Overall Study|Withdrawal by Subject|8|||
126414034|NCT00780416|454811240|FG001|Overall Study|Withdrawal by Subject|6|||
126414035|NCT00666224|454811243|FG000|Double-Blind|Adverse Event|15|||
126414036|NCT00666224|454811244|FG001|Double-Blind|Adverse Event|5|||
126414037|NCT00666224|454811243|FG000|Double-Blind|Lost to Follow-up|2|||
126414038|NCT00666224|454811244|FG001|Double-Blind|Lost to Follow-up|2|||
126414039|NCT00666224|454811243|FG000|Double-Blind|Withdrawal by Subject|18|||
126414040|NCT00666224|454811244|FG001|Double-Blind|Withdrawal by Subject|14|||
126414041|NCT00666224|454811243|FG000|Double-Blind|Physician Decision|0|||
126414042|NCT00666224|454811244|FG001|Double-Blind|Physician Decision|3|||
126414043|NCT00666224|454811243|FG000|Double-Blind|Sponsor decision|1|||
126558902|NCT00826280|455340579|FG000|Overall Study|Randomized but drug not received|1|||
126414044|NCT00666224|454811244|FG001|Double-Blind|Sponsor decision|0|||
126414045|NCT00666224|454811243|FG000|Double-Blind|Pregnancy|3|||
126414046|NCT00666224|454811244|FG001|Double-Blind|Pregnancy|2|||
126414047|NCT00666224|454811243|FG000|Double-Blind|Noncompliance|1|||
126414048|NCT00666224|454811244|FG001|Double-Blind|Noncompliance|0|||
126414049|NCT00666224|454811243|FG000|Double-Blind|Death|1|||
126558903|NCT00826280|455340580|FG001|Overall Study|Randomized but drug not received|0|||
126414050|NCT00666224|454811244|FG001|Double-Blind|Death|0|||
126414051|NCT00666224|454811243|FG000|Double-Blind|Undefined/Unknown|4|||
126414052|NCT00666224|454811244|FG001|Double-Blind|Undefined/Unknown|1|||
126414053|NCT00666224|454811243|FG000|Open-Label|Adverse Event|8|||
126414054|NCT00666224|454811244|FG001|Open-Label|Adverse Event|43|||
126414055|NCT00666224|454811243|FG000|Open-Label|Lost to Follow-up|4|||
126414056|NCT00666224|454811244|FG001|Open-Label|Lost to Follow-up|5|||
126414057|NCT00666224|454811243|FG000|Open-Label|Withdrawal by Subject|12|||
126414058|NCT00666224|454811244|FG001|Open-Label|Withdrawal by Subject|25|||
126414059|NCT00666224|454811243|FG000|Open-Label|Physician Decision|7|||
126414060|NCT00666224|454811244|FG001|Open-Label|Physician Decision|5|||
126414061|NCT00666224|454811243|FG000|Open-Label|Pregnancy|1|||
126414062|NCT00666224|454811244|FG001|Open-Label|Pregnancy|5|||
126414063|NCT00666224|454811243|FG000|Open-Label|Noncompliance|2|||
126414064|NCT00666224|454811244|FG001|Open-Label|Noncompliance|1|||
126414065|NCT00666224|454811243|FG000|Open-Label|Undefined/Unknown|1|||
126414066|NCT00666224|454811244|FG001|Open-Label|Undefined/Unknown|1|||
126414067|NCT00871338|454811248|FG000|Prior to Booster|Withdrawal by Subject|1|||
126414068|NCT00871338|454811249|FG001|Prior to Booster|Withdrawal by Subject|3|||
126414069|NCT00871338|454811248|FG000|Prior to Booster|Lost to Follow-up|1|||
126414070|NCT00871338|454811249|FG001|Prior to Booster|Lost to Follow-up|0|||
126414071|NCT00265317|454811252|FG000|Lead-In|Objective progression or relapse|6|||
126414072|NCT00265317|454811253|FG001|Lead-In|Objective progression or relapse|11|||
126414073|NCT00265317|454811254|FG002|Lead-In|Objective progression or relapse|0|||
126414074|NCT00265317|454811255|FG003|Lead-In|Objective progression or relapse|0|||
126414075|NCT00265317|454811252|FG000|Lead-In|Adverse Event|2|||
126414076|NCT00265317|454811253|FG001|Lead-In|Adverse Event|1|||
126414077|NCT00265317|454811254|FG002|Lead-In|Adverse Event|0|||
126414078|NCT00265317|454811255|FG003|Lead-In|Adverse Event|0|||
126414079|NCT00265317|454811252|FG000|Lead-In|Death|3|||
126414080|NCT00265317|454811253|FG001|Lead-In|Death|5|||
126414081|NCT00265317|454811254|FG002|Lead-In|Death|0|||
126414082|NCT00265317|454811255|FG003|Lead-In|Death|0|||
126414083|NCT00265317|454811252|FG000|Lead-In|Withdrawal/other than adverse event|1|||
126414084|NCT00265317|454811253|FG001|Lead-In|Withdrawal/other than adverse event|0|||
126414085|NCT00265317|454811254|FG002|Lead-In|Withdrawal/other than adverse event|0|||
126414086|NCT00265317|454811255|FG003|Lead-In|Withdrawal/other than adverse event|0|||
126414087|NCT00265317|454811252|FG000|Phase 2|Objective progression or relapse|0|||
126414088|NCT00265317|454811253|FG001|Phase 2|Objective progression or relapse|0|||
126414089|NCT00265317|454811254|FG002|Phase 2|Objective progression or relapse|37|||
126414090|NCT00265317|454811255|FG003|Phase 2|Objective progression or relapse|38|||
126414091|NCT00265317|454811252|FG000|Phase 2|Global deterioration of health status|0|||
126414092|NCT00265317|454811253|FG001|Phase 2|Global deterioration of health status|0|||
126414093|NCT00265317|454811254|FG002|Phase 2|Global deterioration of health status|3|||
126414094|NCT00265317|454811255|FG003|Phase 2|Global deterioration of health status|0|||
126414095|NCT00265317|454811252|FG000|Phase 2|Adverse Event|0|||
126414096|NCT00265317|454811253|FG001|Phase 2|Adverse Event|0|||
126414097|NCT00265317|454811254|FG002|Phase 2|Adverse Event|7|||
126414098|NCT00265317|454811255|FG003|Phase 2|Adverse Event|5|||
126414099|NCT00265317|454811252|FG000|Phase 2|Death|0|||
126414100|NCT00265317|454811253|FG001|Phase 2|Death|0|||
126475510|NCT00347360|455040037|FG014|Overall Study|Per sponsors instruction|0|||
126475511|NCT00347360|455040023|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
126475512|NCT00347360|455040024|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
126475513|NCT00347360|455040025|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
126475514|NCT00347360|455040026|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
126475515|NCT00347360|455040027|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
126475516|NCT00347360|455040028|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
126475517|NCT00347360|455040029|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
126475518|NCT00347360|455040030|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
126475519|NCT00347360|455040031|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
126721585|NCT00875017|455930011|FG003|Washout|Problem collecting rectal effluent|0|||
126721586|NCT00875017|455930012|FG004|Washout|Problem collecting rectal effluent|0|||
126414101|NCT00265317|454811254|FG002|Phase 2|Death|12|||
126414102|NCT00265317|454811255|FG003|Phase 2|Death|15|||
126414103|NCT00265317|454811252|FG000|Phase 2|Protocol Violation|0|||
126475520|NCT00347360|455040032|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
126475521|NCT00347360|455040033|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
126475522|NCT00347360|455040034|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
126721587|NCT00875017|455930013|FG005|Washout|Problem collecting rectal effluent|0|||
126414104|NCT00265317|454811253|FG001|Phase 2|Protocol Violation|0|||
126414105|NCT00265317|454811254|FG002|Phase 2|Protocol Violation|1|||
126721588|NCT00875017|455930008|FG000|Second Intervention|Adverse Event|0|||
126414106|NCT00265317|454811255|FG003|Phase 2|Protocol Violation|4|||
126414107|NCT00265317|454811252|FG000|Phase 2|Lost to Follow-up|0|||
126414108|NCT00265317|454811253|FG001|Phase 2|Lost to Follow-up|0|||
126414109|NCT00265317|454811254|FG002|Phase 2|Lost to Follow-up|0|||
126414110|NCT00265317|454811255|FG003|Phase 2|Lost to Follow-up|1|||
126414111|NCT00265317|454811252|FG000|Phase 2|Withdrawal/other than adverse event|0|||
126414112|NCT00265317|454811253|FG001|Phase 2|Withdrawal/other than adverse event|0|||
126414113|NCT00265317|454811254|FG002|Phase 2|Withdrawal/other than adverse event|2|||
126721589|NCT00875017|455930009|FG001|Second Intervention|Adverse Event|0|||
126721590|NCT00875017|455930010|FG002|Second Intervention|Adverse Event|0|||
126721591|NCT00875017|455930011|FG003|Second Intervention|Adverse Event|1|||
126721592|NCT00875017|455930012|FG004|Second Intervention|Adverse Event|0|||
126721593|NCT00875017|455930013|FG005|Second Intervention|Adverse Event|0|||
126721594|NCT00875017|455930008|FG000|Washout|Problems collecting rectal effluent|0|||
126721595|NCT00875017|455930009|FG001|Washout|Problems collecting rectal effluent|1|||
126721596|NCT00875017|455930010|FG002|Washout|Problems collecting rectal effluent|0|||
126721597|NCT00875017|455930011|FG003|Washout|Problems collecting rectal effluent|0|||
126721598|NCT00875017|455930012|FG004|Washout|Problems collecting rectal effluent|0|||
126721599|NCT00875017|455930013|FG005|Washout|Problems collecting rectal effluent|0|||
126721600|NCT00875017|455930008|FG000|Third Intervention|Adverse Event|0|||
126721601|NCT00875017|455930009|FG001|Third Intervention|Adverse Event|1|||
126414114|NCT00265317|454811255|FG003|Phase 2|Withdrawal/other than adverse event|1|||
126414115|NCT00265317|454811252|FG000|Phase 2|Study terminated by sponsor|0|||
126414116|NCT00265317|454811253|FG001|Phase 2|Study terminated by sponsor|0|||
126414117|NCT00265317|454811254|FG002|Phase 2|Study terminated by sponsor|1|||
126721602|NCT00875017|455930010|FG002|Third Intervention|Adverse Event|1|||
126721603|NCT00875017|455930011|FG003|Third Intervention|Adverse Event|0|||
126721604|NCT00875017|455930012|FG004|Third Intervention|Adverse Event|0|||
126721605|NCT00875017|455930013|FG005|Third Intervention|Adverse Event|0|||
126414118|NCT00265317|454811255|FG003|Phase 2|Study terminated by sponsor|0|||
126414119|NCT00265317|454811252|FG000|Phase 2|Other|0|||
126414120|NCT00265317|454811253|FG001|Phase 2|Other|0|||
126414121|NCT00265317|454811254|FG002|Phase 2|Other|1|||
126414122|NCT00265317|454811255|FG003|Phase 2|Other|1|||
126414123|NCT00711971|454811258|FG000|Overall Study|Lost to Follow-up|3|||
126414124|NCT00711971|454811259|FG001|Overall Study|Lost to Follow-up|4|||
126414125|NCT00711971|454811260|FG002|Overall Study|Lost to Follow-up|1|||
126414126|NCT00536471|454811269|FG000|Overall Study|Lost to Follow-up|48|||
126721606|NCT00875017|455930008|FG000|Washout|Withdrawal by Subject|0|||
126414127|NCT00536471|454811270|FG001|Overall Study|Lost to Follow-up|23|||
126414128|NCT00536471|454811271|FG002|Overall Study|Lost to Follow-up|48|||
126414129|NCT00536471|454811272|FG003|Overall Study|Lost to Follow-up|22|||
126414130|NCT00536471|454811269|FG000|Overall Study|Adverse Event|32|||
126414131|NCT00536471|454811270|FG001|Overall Study|Adverse Event|16|||
126414132|NCT00536471|454811271|FG002|Overall Study|Adverse Event|28|||
126414133|NCT00536471|454811272|FG003|Overall Study|Adverse Event|13|||
126414134|NCT00536471|454811269|FG000|Overall Study|Withdrawal by Subject|40|||
126414135|NCT00536471|454811270|FG001|Overall Study|Withdrawal by Subject|24|||
126414136|NCT00536471|454811271|FG002|Overall Study|Withdrawal by Subject|43|||
126414137|NCT00536471|454811272|FG003|Overall Study|Withdrawal by Subject|21|||
126414138|NCT00536471|454811269|FG000|Overall Study|Lack of Efficacy|17|||
126414139|NCT00536471|454811270|FG001|Overall Study|Lack of Efficacy|18|||
126721607|NCT00875017|455930009|FG001|Washout|Withdrawal by Subject|0|||
126721608|NCT00875017|455930010|FG002|Washout|Withdrawal by Subject|0|||
126721609|NCT00875017|455930011|FG003|Washout|Withdrawal by Subject|0|||
126721610|NCT00875017|455930012|FG004|Washout|Withdrawal by Subject|1|||
126721611|NCT00875017|455930013|FG005|Washout|Withdrawal by Subject|0|||
126414140|NCT00536471|454811271|FG002|Overall Study|Lack of Efficacy|11|||
126721612|NCT00875017|455930008|FG000|Fourth Intervention|Inability to comply with fasting|0|||
126414141|NCT00536471|454811272|FG003|Overall Study|Lack of Efficacy|9|||
126414142|NCT00536471|454811269|FG000|Overall Study|Protocol Violation|8|||
126414143|NCT00536471|454811270|FG001|Overall Study|Protocol Violation|1|||
126414144|NCT00536471|454811271|FG002|Overall Study|Protocol Violation|2|||
126414145|NCT00536471|454811272|FG003|Overall Study|Protocol Violation|3|||
126414146|NCT00536471|454811269|FG000|Overall Study|Physician Decision|11|||
126414147|NCT00536471|454811270|FG001|Overall Study|Physician Decision|1|||
126414148|NCT00536471|454811271|FG002|Overall Study|Physician Decision|3|||
126475523|NCT00347360|455040035|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
126475524|NCT00347360|455040036|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
126475525|NCT00347360|455040037|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
126475526|NCT00347360|455040023|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
126475527|NCT00347360|455040024|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
126475528|NCT00347360|455040025|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
126475529|NCT00347360|455040026|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
126475530|NCT00347360|455040027|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
126475531|NCT00347360|455040028|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
126475532|NCT00347360|455040029|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
126475533|NCT00347360|455040030|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
126475534|NCT00347360|455040031|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
126475535|NCT00347360|455040032|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
126475536|NCT00347360|455040033|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
126475537|NCT00347360|455040034|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
126475538|NCT00347360|455040035|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
126475539|NCT00347360|455040036|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
126414149|NCT00536471|454811272|FG003|Overall Study|Physician Decision|2|||
126414150|NCT00536471|454811269|FG000|Overall Study|Death|0|||
126414151|NCT00536471|454811270|FG001|Overall Study|Death|0|||
126414152|NCT00536471|454811271|FG002|Overall Study|Death|1|||
126414153|NCT00536471|454811272|FG003|Overall Study|Death|2|||
126414154|NCT00536471|454811269|FG000|Overall Study|Sponsor Decision|0|||
126414155|NCT00536471|454811270|FG001|Overall Study|Sponsor Decision|1|||
126414156|NCT00536471|454811271|FG002|Overall Study|Sponsor Decision|3|||
126414157|NCT00536471|454811272|FG003|Overall Study|Sponsor Decision|2|||
126414158|NCT01440816|454811278|FG000|Overall Study|Disease Progression|0|||
126414159|NCT01440816|454811279|FG001|Overall Study|Disease Progression|9|||
126414160|NCT01440816|454811278|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
126414161|NCT01440816|454811279|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
126414162|NCT00856544|454811280|FG000|Overall Study|Randomized but not treated|3|||
126414163|NCT00856544|454811281|FG001|Overall Study|Randomized but not treated|0|||
126414164|NCT00856544|454811282|FG002|Overall Study|Randomized but not treated|0|||
126414165|NCT00856544|454811283|FG003|Overall Study|Randomized but not treated|0|||
126414166|NCT00856544|454811280|FG000|Overall Study|Death|0|||
126414167|NCT00856544|454811281|FG001|Overall Study|Death|2|||
126414168|NCT00856544|454811282|FG002|Overall Study|Death|0|||
126414169|NCT00856544|454811283|FG003|Overall Study|Death|0|||
126414170|NCT00856544|454811280|FG000|Overall Study|Adverse Event|20|||
126414171|NCT00856544|454811281|FG001|Overall Study|Adverse Event|29|||
126414172|NCT00856544|454811282|FG002|Overall Study|Adverse Event|2|||
126414173|NCT00856544|454811283|FG003|Overall Study|Adverse Event|3|||
126414174|NCT00856544|454811280|FG000|Overall Study|Lack of Efficacy|16|||
126414175|NCT00856544|454811281|FG001|Overall Study|Lack of Efficacy|12|||
126414176|NCT00856544|454811282|FG002|Overall Study|Lack of Efficacy|3|||
126414177|NCT00856544|454811283|FG003|Overall Study|Lack of Efficacy|3|||
126414178|NCT00856544|454811280|FG000|Overall Study|Other|9|||
126414179|NCT00856544|454811281|FG001|Overall Study|Other|16|||
126414180|NCT00856544|454811282|FG002|Overall Study|Other|1|||
126414181|NCT00856544|454811283|FG003|Overall Study|Other|6|||
126414182|NCT00856544|454811280|FG000|Overall Study|Lost to Follow-up|1|||
126414183|NCT00856544|454811281|FG001|Overall Study|Lost to Follow-up|2|||
126414184|NCT00856544|454811282|FG002|Overall Study|Lost to Follow-up|2|||
126414185|NCT00856544|454811283|FG003|Overall Study|Lost to Follow-up|0|||
126414186|NCT00856544|454811280|FG000|Overall Study|Withdrawal by Subject|8|||
126414187|NCT00856544|454811281|FG001|Overall Study|Withdrawal by Subject|5|||
126414188|NCT00856544|454811282|FG002|Overall Study|Withdrawal by Subject|0|||
126414189|NCT00856544|454811283|FG003|Overall Study|Withdrawal by Subject|1|||
126414190|NCT01687101|454811284|FG000|Overall Study|Lost to Follow-up|7|||
126414191|NCT03250182|454811287|FG000|Overall Study|Withdrawal by Subject|1|||
126414192|NCT01858740|454811288|FG000|Overall Study|Death|4|||
126414193|NCT00894361|454811295|FG000|Overall Study|deaths and less than 2 years followup|24|||
126414194|NCT00894361|454811296|FG001|Overall Study|deaths and less than 2 years followup|64|||
126414195|NCT04207060|454811301|FG000|Overall Study|Lost to Follow-up|2|||
126414196|NCT04207060|454811302|FG001|Overall Study|Lost to Follow-up|0|||
126414197|NCT02718716|454811304|FG000|Overall Study|Lack of Efficacy|1|||
126414198|NCT02718716|454811305|FG001|Overall Study|Lack of Efficacy|0|||
126414199|NCT02718716|454811306|FG002|Overall Study|Lack of Efficacy|0|||
126414200|NCT02718716|454811307|FG003|Overall Study|Lack of Efficacy|0|||
126414201|NCT02718716|454811308|FG004|Overall Study|Lack of Efficacy|0|||
126414202|NCT00296140|454811312|FG000|Overall Study|Lost to Follow-up|1|||
126414203|NCT00296140|454811313|FG001|Overall Study|Lost to Follow-up|0|||
126414204|NCT00296140|454811312|FG000|Overall Study|Withdrawal by Subject|1|||
126414205|NCT00296140|454811313|FG001|Overall Study|Withdrawal by Subject|0|||
126414206|NCT00296140|454811312|FG000|Overall Study|Discharge to Nursing Home|1|||
126414207|NCT00296140|454811313|FG001|Overall Study|Discharge to Nursing Home|0|||
126414208|NCT03245398|454811318|FG000|Overall Study|Travelled to another island|1|||
126414209|NCT03245398|454811319|FG001|Overall Study|Travelled to another island|0|||
126414210|NCT00596830|454811322|FG000|Overall Study|Death|258|||
126414211|NCT00596830|454811323|FG001|Overall Study|Death|247|||
126414212|NCT00596830|454811322|FG000|Overall Study|Lost to Follow-up|7|||
126414213|NCT00596830|454811323|FG001|Overall Study|Lost to Follow-up|11|||
126414214|NCT00596830|454811322|FG000|Overall Study|Withdrawal by Subject|22|||
126414215|NCT00596830|454811323|FG001|Overall Study|Withdrawal by Subject|12|||
126721613|NCT00875017|455930009|FG001|Fourth Intervention|Inability to comply with fasting|0|||
126414216|NCT00596830|454811322|FG000|Overall Study|Study terminated by sponsor|51|||
126414217|NCT00596830|454811323|FG001|Overall Study|Study terminated by sponsor|62|||
126414218|NCT00596830|454811322|FG000|Overall Study|Follow-up was discontinued|1|||
126414219|NCT00596830|454811323|FG001|Overall Study|Follow-up was discontinued|0|||
126414220|NCT00596830|454811322|FG000|Overall Study|Randomized but not treated|3|||
126414221|NCT00596830|454811323|FG001|Overall Study|Randomized but not treated|7|||
126414222|NCT00887926|454811324|FG000|Overall Study|Withdrawal by Subject|0|||
126414223|NCT00887926|454811325|FG001|Overall Study|Withdrawal by Subject|1|||
126414224|NCT00887926|454811326|FG002|Overall Study|Withdrawal by Subject|0|||
126414225|NCT00887926|454811327|FG003|Overall Study|Withdrawal by Subject|0|||
126414226|NCT00880191|454811328|FG000|Overall Study|Refused further treatment|4|||
126414227|NCT00880191|454811329|FG001|Overall Study|Refused further treatment|1|||
126414228|NCT00880191|454811328|FG000|Overall Study|Adverse Event|8|||
126414229|NCT00880191|454811329|FG001|Overall Study|Adverse Event|6|||
126414230|NCT00880191|454811328|FG000|Overall Study|Hospitalization/efficacy|1|||
126414231|NCT00880191|454811329|FG001|Overall Study|Hospitalization/efficacy|1|||
126414232|NCT02097030|454811330|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
126414233|NCT02097030|454811331|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
126414234|NCT02097030|454811330|FG000|First Intervention (3 Days)|Visual Acuity|0|||
126414235|NCT02097030|454811331|FG001|First Intervention (3 Days)|Visual Acuity|1|||
126414236|NCT01919801|454811332|FG000|Overall Study|Withdrawal by Subject|1|||
126414237|NCT01919801|454811333|FG001|Overall Study|Withdrawal by Subject|0|||
126414238|NCT01919801|454811332|FG000|Overall Study|Physician Decision|0|||
126414239|NCT01919801|454811333|FG001|Overall Study|Physician Decision|1|||
126414240|NCT01919801|454811332|FG000|Overall Study|Lost to Follow-up|0|||
126414241|NCT01919801|454811333|FG001|Overall Study|Lost to Follow-up|1|||
126475540|NCT00347360|455040037|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
126475541|NCT00347360|455040023|FG000|Overall Study|Abnormal lab values|0|||
126475542|NCT00347360|455040024|FG001|Overall Study|Abnormal lab values|0|||
126475543|NCT00347360|455040025|FG002|Overall Study|Abnormal lab values|0|||
126475544|NCT00347360|455040026|FG003|Overall Study|Abnormal lab values|0|||
126475545|NCT00347360|455040027|FG004|Overall Study|Abnormal lab values|0|||
126475546|NCT00347360|455040028|FG005|Overall Study|Abnormal lab values|0|||
126475547|NCT00347360|455040029|FG006|Overall Study|Abnormal lab values|1|||
126475548|NCT00347360|455040030|FG007|Overall Study|Abnormal lab values|0|||
126475549|NCT00347360|455040031|FG008|Overall Study|Abnormal lab values|0|||
126475550|NCT00347360|455040032|FG009|Overall Study|Abnormal lab values|0|||
126475551|NCT00347360|455040033|FG010|Overall Study|Abnormal lab values|0|||
126475552|NCT00347360|455040034|FG011|Overall Study|Abnormal lab values|0|||
126475553|NCT00347360|455040035|FG012|Overall Study|Abnormal lab values|0|||
126475554|NCT00347360|455040036|FG013|Overall Study|Abnormal lab values|0|||
126475555|NCT00347360|455040037|FG014|Overall Study|Abnormal lab values|0|||
126475556|NCT00347360|455040023|FG000|Overall Study|PI recommended early withdrawal|0|||
126475557|NCT00347360|455040024|FG001|Overall Study|PI recommended early withdrawal|0|||
126475558|NCT00347360|455040025|FG002|Overall Study|PI recommended early withdrawal|0|||
126475559|NCT00347360|455040026|FG003|Overall Study|PI recommended early withdrawal|0|||
126475560|NCT00347360|455040027|FG004|Overall Study|PI recommended early withdrawal|0|||
126475561|NCT00347360|455040028|FG005|Overall Study|PI recommended early withdrawal|0|||
126475562|NCT00347360|455040029|FG006|Overall Study|PI recommended early withdrawal|0|||
126475563|NCT00347360|455040030|FG007|Overall Study|PI recommended early withdrawal|0|||
126475564|NCT00347360|455040031|FG008|Overall Study|PI recommended early withdrawal|0|||
126475565|NCT00347360|455040032|FG009|Overall Study|PI recommended early withdrawal|1|||
126475566|NCT00347360|455040033|FG010|Overall Study|PI recommended early withdrawal|0|||
126475567|NCT00347360|455040034|FG011|Overall Study|PI recommended early withdrawal|0|||
126475568|NCT00347360|455040035|FG012|Overall Study|PI recommended early withdrawal|0|||
126475569|NCT00347360|455040036|FG013|Overall Study|PI recommended early withdrawal|0|||
126475570|NCT00347360|455040037|FG014|Overall Study|PI recommended early withdrawal|0|||
126475571|NCT00347360|455040023|FG000|Overall Study|Did not meet criteria before ABPM|0|||
126475572|NCT00347360|455040024|FG001|Overall Study|Did not meet criteria before ABPM|0|||
126475573|NCT00347360|455040025|FG002|Overall Study|Did not meet criteria before ABPM|0|||
126475574|NCT00347360|455040026|FG003|Overall Study|Did not meet criteria before ABPM|0|||
126475575|NCT00347360|455040027|FG004|Overall Study|Did not meet criteria before ABPM|0|||
126475576|NCT00347360|455040028|FG005|Overall Study|Did not meet criteria before ABPM|0|||
126475577|NCT00347360|455040029|FG006|Overall Study|Did not meet criteria before ABPM|0|||
126475578|NCT00347360|455040030|FG007|Overall Study|Did not meet criteria before ABPM|0|||
126475579|NCT00347360|455040031|FG008|Overall Study|Did not meet criteria before ABPM|0|||
126475580|NCT00347360|455040032|FG009|Overall Study|Did not meet criteria before ABPM|0|||
126475581|NCT00347360|455040033|FG010|Overall Study|Did not meet criteria before ABPM|1|||
126475582|NCT00347360|455040034|FG011|Overall Study|Did not meet criteria before ABPM|0|||
126475583|NCT00347360|455040035|FG012|Overall Study|Did not meet criteria before ABPM|0|||
126414242|NCT01919801|454811332|FG000|Overall Study|Other|0|||
126414243|NCT01919801|454811333|FG001|Overall Study|Other|1|||
126475584|NCT00347360|455040036|FG013|Overall Study|Did not meet criteria before ABPM|0|||
126475585|NCT00347360|455040037|FG014|Overall Study|Did not meet criteria before ABPM|0|||
126475586|NCT00347360|455040023|FG000|Overall Study|Randomized in error|0|||
126772333|NCT01466673|456122091|FG001|Overall Study|Non-compliance with study treatment|0|||
126475587|NCT00347360|455040024|FG001|Overall Study|Randomized in error|0|||
126475588|NCT00347360|455040025|FG002|Overall Study|Randomized in error|0|||
126475589|NCT00347360|455040026|FG003|Overall Study|Randomized in error|0|||
126772334|NCT01466673|456122090|FG000|Overall Study|Lost to Follow-up|3|||
126475590|NCT00347360|455040027|FG004|Overall Study|Randomized in error|0|||
126772335|NCT01466673|456122091|FG001|Overall Study|Lost to Follow-up|5|||
126414244|NCT01843062|454811334|FG000|Overall Study|Protocol Violation|1|||
126414245|NCT01843062|454811335|FG001|Overall Study|Protocol Violation|0|||
126414246|NCT01843062|454811334|FG000|Overall Study|New treatment following progression|2|||
126414247|NCT01843062|454811335|FG001|Overall Study|New treatment following progression|0|||
126721614|NCT00875017|455930010|FG002|Fourth Intervention|Inability to comply with fasting|0|||
126721615|NCT00875017|455930011|FG003|Fourth Intervention|Inability to comply with fasting|0|||
126414248|NCT01843062|454811334|FG000|Overall Study|Pregnancy|1|||
126414249|NCT01843062|454811335|FG001|Overall Study|Pregnancy|0|||
126414250|NCT01843062|454811334|FG000|Overall Study|Adverse Event|2|||
126414251|NCT01843062|454811335|FG001|Overall Study|Adverse Event|0|||
126414252|NCT01843062|454811334|FG000|Overall Study|Incorrect randomisation|1|||
126414253|NCT01843062|454811335|FG001|Overall Study|Incorrect randomisation|0|||
126414254|NCT01843062|454811334|FG000|Overall Study|Withdrawal by Subject|12|||
126475591|NCT00347360|455040028|FG005|Overall Study|Randomized in error|0|||
126475592|NCT00347360|455040029|FG006|Overall Study|Randomized in error|0|||
126475593|NCT00347360|455040030|FG007|Overall Study|Randomized in error|0|||
126475594|NCT00347360|455040031|FG008|Overall Study|Randomized in error|0|||
126475595|NCT00347360|455040032|FG009|Overall Study|Randomized in error|0|||
126475596|NCT00347360|455040033|FG010|Overall Study|Randomized in error|0|||
126475597|NCT00347360|455040034|FG011|Overall Study|Randomized in error|1|||
126475598|NCT00347360|455040035|FG012|Overall Study|Randomized in error|0|||
126475599|NCT00347360|455040036|FG013|Overall Study|Randomized in error|0|||
126475600|NCT00347360|455040037|FG014|Overall Study|Randomized in error|0|||
126475601|NCT00347360|455040023|FG000|Overall Study|Failed inclusion criteria #4|0|||
126475602|NCT00347360|455040024|FG001|Overall Study|Failed inclusion criteria #4|0|||
126475603|NCT00347360|455040025|FG002|Overall Study|Failed inclusion criteria #4|0|||
126475604|NCT00347360|455040026|FG003|Overall Study|Failed inclusion criteria #4|0|||
126475605|NCT00347360|455040027|FG004|Overall Study|Failed inclusion criteria #4|0|||
126475606|NCT00347360|455040028|FG005|Overall Study|Failed inclusion criteria #4|0|||
126475607|NCT00347360|455040029|FG006|Overall Study|Failed inclusion criteria #4|0|||
126475608|NCT00347360|455040030|FG007|Overall Study|Failed inclusion criteria #4|0|||
126475609|NCT00347360|455040031|FG008|Overall Study|Failed inclusion criteria #4|0|||
126475610|NCT00347360|455040032|FG009|Overall Study|Failed inclusion criteria #4|0|||
126475611|NCT00347360|455040033|FG010|Overall Study|Failed inclusion criteria #4|0|||
126475612|NCT00347360|455040034|FG011|Overall Study|Failed inclusion criteria #4|1|||
126475613|NCT00347360|455040035|FG012|Overall Study|Failed inclusion criteria #4|0|||
126475614|NCT00347360|455040036|FG013|Overall Study|Failed inclusion criteria #4|0|||
126475615|NCT00347360|455040037|FG014|Overall Study|Failed inclusion criteria #4|0|||
126475616|NCT00347360|455040023|FG000|Overall Study|Prolonged duration between visits|0|||
126475617|NCT00347360|455040024|FG001|Overall Study|Prolonged duration between visits|0|||
126475618|NCT00347360|455040025|FG002|Overall Study|Prolonged duration between visits|0|||
126721616|NCT00875017|455930012|FG004|Fourth Intervention|Inability to comply with fasting|0|||
126721617|NCT00875017|455930013|FG005|Fourth Intervention|Inability to comply with fasting|1|||
126721618|NCT03342469|455930014|FG000|Overall Study|Withdrawal by Subject|0|||
126721619|NCT03342469|455930015|FG001|Overall Study|Withdrawal by Subject|1|||
126721620|NCT03342469|455930016|FG002|Overall Study|Withdrawal by Subject|0|||
126721621|NCT03342469|455930017|FG003|Overall Study|Withdrawal by Subject|0|||
126721622|NCT03136185|455930024|FG000|Overall Study|Adverse Event|0|||
126721623|NCT03136185|455930025|FG001|Overall Study|Adverse Event|1|||
126721624|NCT03136185|455930026|FG002|Overall Study|Adverse Event|3|||
126721625|NCT03136185|455930027|FG003|Overall Study|Adverse Event|1|||
126721626|NCT03136185|455930028|FG004|Overall Study|Adverse Event|2|||
126721627|NCT03136185|455930029|FG005|Overall Study|Adverse Event|2|||
126721628|NCT03136185|455930030|FG006|Overall Study|Adverse Event|5|||
126721629|NCT03136185|455930031|FG007|Overall Study|Adverse Event|1|||
126721630|NCT03136185|455930032|FG008|Overall Study|Adverse Event|1|||
126721631|NCT03136185|455930024|FG000|Overall Study|Death|0|||
126721632|NCT03136185|455930025|FG001|Overall Study|Death|0|||
126414255|NCT01843062|454811335|FG001|Overall Study|Withdrawal by Subject|3|||
126414256|NCT01843062|454811334|FG000|Overall Study|Death|1|||
126414257|NCT01843062|454811335|FG001|Overall Study|Death|2|||
126414258|NCT01843062|454811334|FG000|Overall Study|Lost to Follow-up|2|||
126475619|NCT00347360|455040026|FG003|Overall Study|Prolonged duration between visits|0|||
126475620|NCT00347360|455040027|FG004|Overall Study|Prolonged duration between visits|0|||
126475621|NCT00347360|455040028|FG005|Overall Study|Prolonged duration between visits|0|||
126475622|NCT00347360|455040029|FG006|Overall Study|Prolonged duration between visits|0|||
126414259|NCT01843062|454811335|FG001|Overall Study|Lost to Follow-up|4|||
126414260|NCT01677858|454811336|FG000|Overall Study|Adverse Event|0|||
126475623|NCT00347360|455040030|FG007|Overall Study|Prolonged duration between visits|0|||
126475624|NCT00347360|455040031|FG008|Overall Study|Prolonged duration between visits|0|||
126475625|NCT00347360|455040032|FG009|Overall Study|Prolonged duration between visits|0|||
126475626|NCT00347360|455040033|FG010|Overall Study|Prolonged duration between visits|0|||
126475627|NCT00347360|455040034|FG011|Overall Study|Prolonged duration between visits|0|||
126475628|NCT00347360|455040035|FG012|Overall Study|Prolonged duration between visits|1|||
126475629|NCT00347360|455040036|FG013|Overall Study|Prolonged duration between visits|0|||
126721633|NCT03136185|455930026|FG002|Overall Study|Death|0|||
126721634|NCT03136185|455930027|FG003|Overall Study|Death|1|||
126721635|NCT03136185|455930028|FG004|Overall Study|Death|1|||
126414261|NCT01677858|454811337|FG001|Overall Study|Adverse Event|0|||
126414262|NCT01677858|454811338|FG002|Overall Study|Adverse Event|2|||
126414263|NCT01677858|454811339|FG003|Overall Study|Adverse Event|3|||
126414264|NCT01677858|454811340|FG004|Overall Study|Adverse Event|13|||
126414265|NCT01677858|454811336|FG000|Overall Study|Death|0|||
126414266|NCT01677858|454811337|FG001|Overall Study|Death|0|||
126414267|NCT01677858|454811338|FG002|Overall Study|Death|0|||
126558904|NCT00826280|455340581|FG002|Overall Study|Randomized but drug not received|1|||
126558905|NCT00826280|455340579|FG000|Overall Study|Adverse Event|1|||
126558906|NCT00826280|455340580|FG001|Overall Study|Adverse Event|3|||
126558907|NCT00826280|455340581|FG002|Overall Study|Adverse Event|0|||
126558908|NCT00826280|455340579|FG000|Overall Study|Lost to Follow-up|0|||
126558909|NCT00826280|455340580|FG001|Overall Study|Lost to Follow-up|1|||
126558910|NCT00826280|455340581|FG002|Overall Study|Lost to Follow-up|0|||
126558911|NCT00826280|455340579|FG000|Overall Study|Sponsor discontinued subject or study|1|||
126558912|NCT00826280|455340580|FG001|Overall Study|Sponsor discontinued subject or study|0|||
126558913|NCT00826280|455340581|FG002|Overall Study|Sponsor discontinued subject or study|0|||
126558914|NCT00826280|455340579|FG000|Overall Study|Reversible ischemic defect not present|43|||
126558915|NCT00826280|455340580|FG001|Overall Study|Reversible ischemic defect not present|40|||
126558916|NCT00826280|455340581|FG002|Overall Study|Reversible ischemic defect not present|44|||
126558917|NCT00826280|455340579|FG000|Overall Study|Interpretation Failure|1|||
126558918|NCT00826280|455340580|FG001|Overall Study|Interpretation Failure|0|||
126558919|NCT00826280|455340581|FG002|Overall Study|Interpretation Failure|0|||
126558920|NCT00826280|455340579|FG000|Overall Study|Machine Failure|1|||
126558921|NCT00826280|455340580|FG001|Overall Study|Machine Failure|1|||
126558922|NCT00826280|455340581|FG002|Overall Study|Machine Failure|0|||
126558923|NCT00826280|455340579|FG000|Overall Study|One or more non-interpretable scan|0|||
126558924|NCT00826280|455340580|FG001|Overall Study|One or more non-interpretable scan|1|||
126558925|NCT00826280|455340581|FG002|Overall Study|One or more non-interpretable scan|1|||
126558926|NCT03201757|455340582|FG000|Overall Study|Withdrawal by Subject|133|||
126558927|NCT03201757|455340582|FG000|Overall Study|Adverse Event|44|||
126558928|NCT03201757|455340582|FG000|Overall Study|Lost to Follow-up|37|||
126558929|NCT03201757|455340582|FG000|Overall Study|Pregnancy|2|||
126558930|NCT03201757|455340582|FG000|Overall Study|Lack of Efficacy|1|||
126558931|NCT03201757|455340582|FG000|Overall Study|Protocol Violation|20|||
126558932|NCT03201757|455340582|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
126558933|NCT03201757|455340582|FG000|Overall Study|Not Yet Determined|5|||
126721636|NCT03136185|455930029|FG005|Overall Study|Death|0|||
126721637|NCT03136185|455930030|FG006|Overall Study|Death|1|||
126721638|NCT03136185|455930031|FG007|Overall Study|Death|0|||
126721639|NCT03136185|455930032|FG008|Overall Study|Death|0|||
126721640|NCT03136185|455930024|FG000|Overall Study|Physician Decision|3|||
126721641|NCT03136185|455930025|FG001|Overall Study|Physician Decision|1|||
126414268|NCT01677858|454811339|FG003|Overall Study|Death|0|||
126414269|NCT01677858|454811340|FG004|Overall Study|Death|1|||
126414270|NCT01677858|454811336|FG000|Overall Study|Physician Decision|1|||
126414271|NCT01677858|454811337|FG001|Overall Study|Physician Decision|0|||
126414272|NCT01677858|454811338|FG002|Overall Study|Physician Decision|2|||
126414273|NCT01677858|454811339|FG003|Overall Study|Physician Decision|0|||
126414274|NCT01677858|454811340|FG004|Overall Study|Physician Decision|12|||
126414275|NCT01677858|454811336|FG000|Overall Study|Progressive Disease|2|||
126414276|NCT01677858|454811337|FG001|Overall Study|Progressive Disease|1|||
126414277|NCT01677858|454811338|FG002|Overall Study|Progressive Disease|9|||
126414278|NCT01677858|454811339|FG003|Overall Study|Progressive Disease|3|||
126414279|NCT01677858|454811340|FG004|Overall Study|Progressive Disease|43|||
126414280|NCT01677858|454811336|FG000|Overall Study|Withdrawal by Subject|0|||
126475630|NCT00347360|455040037|FG014|Overall Study|Prolonged duration between visits|0|||
126475631|NCT00347360|455040023|FG000|Overall Study|Subject left town, ran out of study drug|0|||
126475632|NCT00347360|455040024|FG001|Overall Study|Subject left town, ran out of study drug|0|||
126475633|NCT00347360|455040025|FG002|Overall Study|Subject left town, ran out of study drug|0|||
126475634|NCT00347360|455040026|FG003|Overall Study|Subject left town, ran out of study drug|0|||
126475635|NCT00347360|455040027|FG004|Overall Study|Subject left town, ran out of study drug|0|||
126475636|NCT00347360|455040028|FG005|Overall Study|Subject left town, ran out of study drug|0|||
126475637|NCT00347360|455040029|FG006|Overall Study|Subject left town, ran out of study drug|0|||
126475638|NCT00347360|455040030|FG007|Overall Study|Subject left town, ran out of study drug|0|||
126475639|NCT00347360|455040031|FG008|Overall Study|Subject left town, ran out of study drug|0|||
126475640|NCT00347360|455040032|FG009|Overall Study|Subject left town, ran out of study drug|0|||
126414281|NCT01677858|454811337|FG001|Overall Study|Withdrawal by Subject|1|||
126558934|NCT03201757|455340582|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
126558935|NCT03201757|455340582|FG000|Overall Study|Other|20|||
126558936|NCT01254305|455340583|FG000|Overall Study|Adverse Event|6|||
126558937|NCT01254305|455340584|FG001|Overall Study|Adverse Event|3|||
126558938|NCT01254305|455340585|FG002|Overall Study|Adverse Event|2|||
126558939|NCT01254305|455340583|FG000|Overall Study|Lack of Efficacy|1|||
126558940|NCT01254305|455340584|FG001|Overall Study|Lack of Efficacy|0|||
126721642|NCT03136185|455930026|FG002|Overall Study|Physician Decision|1|||
126414282|NCT01677858|454811338|FG002|Overall Study|Withdrawal by Subject|1|||
126414283|NCT01677858|454811339|FG003|Overall Study|Withdrawal by Subject|0|||
126475641|NCT00347360|455040033|FG010|Overall Study|Subject left town, ran out of study drug|0|||
126475642|NCT00347360|455040034|FG011|Overall Study|Subject left town, ran out of study drug|0|||
126475643|NCT00347360|455040035|FG012|Overall Study|Subject left town, ran out of study drug|0|||
126475644|NCT00347360|455040036|FG013|Overall Study|Subject left town, ran out of study drug|1|||
126475645|NCT00347360|455040037|FG014|Overall Study|Subject left town, ran out of study drug|0|||
126475646|NCT00347360|455040023|FG000|Overall Study|Subject refuse to sign updated consent|0|||
126414284|NCT01677858|454811340|FG004|Overall Study|Withdrawal by Subject|15|||
126414285|NCT01677858|454811336|FG000|Overall Study|Lost to Follow-up|0|||
126414286|NCT01677858|454811337|FG001|Overall Study|Lost to Follow-up|0|||
126414287|NCT01677858|454811338|FG002|Overall Study|Lost to Follow-up|0|||
126414288|NCT01677858|454811339|FG003|Overall Study|Lost to Follow-up|0|||
126414289|NCT01677858|454811340|FG004|Overall Study|Lost to Follow-up|1|||
126414290|NCT00773747|454811341|FG000|Overall Study|Lack of Efficacy|112|||
126414291|NCT00773747|454811342|FG001|Overall Study|Lack of Efficacy|144|||
126414292|NCT00773747|454811341|FG000|Overall Study|Physician Decision|26|||
126414293|NCT00773747|454811342|FG001|Overall Study|Physician Decision|18|||
126414294|NCT00773747|454811341|FG000|Overall Study|Lost to Follow-up|0|||
126414295|NCT00773747|454811342|FG001|Overall Study|Lost to Follow-up|1|||
126414296|NCT00773747|454811341|FG000|Overall Study|Protocol Violation|2|||
126414297|NCT00773747|454811342|FG001|Overall Study|Protocol Violation|2|||
126414298|NCT00773747|454811341|FG000|Overall Study|Withdrawal by Subject|89|||
126414299|NCT00773747|454811342|FG001|Overall Study|Withdrawal by Subject|61|||
126414300|NCT00773747|454811341|FG000|Overall Study|Adverse Event|61|||
126414301|NCT00773747|454811342|FG001|Overall Study|Adverse Event|62|||
126414302|NCT00773747|454811341|FG000|Overall Study|Death|5|||
126414303|NCT00773747|454811342|FG001|Overall Study|Death|8|||
126414304|NCT00773747|454811341|FG000|Overall Study|Not Treated|2|||
126414305|NCT00773747|454811342|FG001|Overall Study|Not Treated|0|||
126414306|NCT02669212|454811345|FG000|Overall Study|Lost to Follow-up|1|||
126414307|NCT02669212|454811346|FG001|Overall Study|Lost to Follow-up|0|||
126414308|NCT02669212|454811345|FG000|Overall Study|Medical Condition|3|||
126414309|NCT02669212|454811346|FG001|Overall Study|Medical Condition|4|||
126414310|NCT02669212|454811345|FG000|Overall Study|Withdrawal by Subject|0|||
126475647|NCT00347360|455040024|FG001|Overall Study|Subject refuse to sign updated consent|0|||
126475648|NCT00347360|455040025|FG002|Overall Study|Subject refuse to sign updated consent|0|||
126475649|NCT00347360|455040026|FG003|Overall Study|Subject refuse to sign updated consent|0|||
126475650|NCT00347360|455040027|FG004|Overall Study|Subject refuse to sign updated consent|0|||
126475651|NCT00347360|455040028|FG005|Overall Study|Subject refuse to sign updated consent|0|||
126475652|NCT00347360|455040029|FG006|Overall Study|Subject refuse to sign updated consent|0|||
126475653|NCT00347360|455040030|FG007|Overall Study|Subject refuse to sign updated consent|0|||
126475654|NCT00347360|455040031|FG008|Overall Study|Subject refuse to sign updated consent|0|||
126475655|NCT00347360|455040032|FG009|Overall Study|Subject refuse to sign updated consent|0|||
126475656|NCT00347360|455040033|FG010|Overall Study|Subject refuse to sign updated consent|0|||
126475657|NCT00347360|455040034|FG011|Overall Study|Subject refuse to sign updated consent|0|||
126475658|NCT00347360|455040035|FG012|Overall Study|Subject refuse to sign updated consent|0|||
126475659|NCT00347360|455040036|FG013|Overall Study|Subject refuse to sign updated consent|0|||
126475660|NCT00347360|455040037|FG014|Overall Study|Subject refuse to sign updated consent|1|||
126475661|NCT00347360|455040023|FG000|Overall Study|Visits conflicted with new job|0|||
126475662|NCT00347360|455040024|FG001|Overall Study|Visits conflicted with new job|0|||
126475663|NCT00347360|455040025|FG002|Overall Study|Visits conflicted with new job|0|||
126475664|NCT00347360|455040026|FG003|Overall Study|Visits conflicted with new job|0|||
126475665|NCT00347360|455040027|FG004|Overall Study|Visits conflicted with new job|0|||
126475666|NCT00347360|455040028|FG005|Overall Study|Visits conflicted with new job|0|||
126475667|NCT00347360|455040029|FG006|Overall Study|Visits conflicted with new job|1|||
126475668|NCT00347360|455040030|FG007|Overall Study|Visits conflicted with new job|0|||
126475669|NCT00347360|455040031|FG008|Overall Study|Visits conflicted with new job|0|||
126475670|NCT00347360|455040032|FG009|Overall Study|Visits conflicted with new job|0|||
126475671|NCT00347360|455040033|FG010|Overall Study|Visits conflicted with new job|0|||
126475672|NCT00347360|455040034|FG011|Overall Study|Visits conflicted with new job|0|||
126475673|NCT00347360|455040035|FG012|Overall Study|Visits conflicted with new job|0|||
126475674|NCT00347360|455040036|FG013|Overall Study|Visits conflicted with new job|0|||
126475675|NCT00347360|455040037|FG014|Overall Study|Visits conflicted with new job|0|||
126558941|NCT01254305|455340585|FG002|Overall Study|Lack of Efficacy|1|||
126558942|NCT01254305|455340583|FG000|Overall Study|Protocol Violation|1|||
126721643|NCT03136185|455930027|FG003|Overall Study|Physician Decision|2|||
126475676|NCT00913380|455040043|FG000|Clinical Outcomes|Lost to Follow-up|6|||
126558943|NCT01254305|455340584|FG001|Overall Study|Protocol Violation|7|||
126721644|NCT03136185|455930028|FG004|Overall Study|Physician Decision|1|||
126721645|NCT03136185|455930029|FG005|Overall Study|Physician Decision|2|||
126558944|NCT01254305|455340585|FG002|Overall Study|Protocol Violation|3|||
126721646|NCT03136185|455930030|FG006|Overall Study|Physician Decision|1|||
126414311|NCT02669212|454811346|FG001|Overall Study|Withdrawal by Subject|2|||
126414312|NCT02669212|454811345|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
126414313|NCT02669212|454811346|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
126414314|NCT03549104|454811347|FG000|Overall Study|Withdrawal by Subject|5|||
126414315|NCT03549104|454811348|FG001|Overall Study|Withdrawal by Subject|2|||
126414316|NCT03549104|454811347|FG000|Overall Study|Covid shelter in place|1|||
126414317|NCT03549104|454811348|FG001|Overall Study|Covid shelter in place|2|||
126414318|NCT04869358|454811349|FG000|Overall Study|Wish to have children.|1|||
126414319|NCT04869358|454811350|FG001|Overall Study|Wish to have children.|0|||
126414320|NCT04869358|454811351|FG002|Overall Study|Wish to have children.|0|||
126414321|NCT04869358|454811352|FG003|Overall Study|Wish to have children.|0|||
126414322|NCT04164732|454811353|FG000|Treatment run-in Period|Adverse Event|4|||
126414323|NCT04164732|454811354|FG001|Treatment run-in Period|Adverse Event|0|||
126414324|NCT04164732|454811355|FG002|Treatment run-in Period|Adverse Event|0|||
126414325|NCT04164732|454811353|FG000|Treatment run-in Period|Physician Decision|1|||
126414326|NCT04164732|454811354|FG001|Treatment run-in Period|Physician Decision|0|||
126414327|NCT04164732|454811355|FG002|Treatment run-in Period|Physician Decision|0|||
126414328|NCT04164732|454811353|FG000|Treatment run-in Period|Screen Failure|1|||
126414329|NCT04164732|454811354|FG001|Treatment run-in Period|Screen Failure|0|||
126414330|NCT04164732|454811355|FG002|Treatment run-in Period|Screen Failure|0|||
126414331|NCT04164732|454811353|FG000|Randomized Treatment Period|Adverse Event|0|||
126414332|NCT04164732|454811354|FG001|Randomized Treatment Period|Adverse Event|1|||
126414333|NCT04164732|454811355|FG002|Randomized Treatment Period|Adverse Event|0|||
126414334|NCT04164732|454811353|FG000|Randomized Treatment Period|Protocol Deviation|0|||
126414335|NCT04164732|454811354|FG001|Randomized Treatment Period|Protocol Deviation|1|||
126414336|NCT04164732|454811355|FG002|Randomized Treatment Period|Protocol Deviation|1|||
126414337|NCT04164732|454811353|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
126414338|NCT04164732|454811354|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
126414339|NCT04164732|454811355|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
126414340|NCT01844778|454811361|FG000|Overall Study|Protocol deviation|0|||
126414341|NCT01844778|454811362|FG001|Overall Study|Protocol deviation|1|||
126414342|NCT01844778|454811363|FG002|Overall Study|Protocol deviation|2|||
126414343|NCT01844778|454811361|FG000|Overall Study|Withdrawal by Subject|2|||
126414344|NCT01844778|454811362|FG001|Overall Study|Withdrawal by Subject|0|||
126414345|NCT01844778|454811363|FG002|Overall Study|Withdrawal by Subject|0|||
126414346|NCT01844778|454811361|FG000|Overall Study|Adverse Event|0|||
126414347|NCT01844778|454811362|FG001|Overall Study|Adverse Event|2|||
126414348|NCT01844778|454811363|FG002|Overall Study|Adverse Event|2|||
126414349|NCT02951429|454811369|FG000|Overall Study|Adverse Event|3|||
126414350|NCT02951429|454811370|FG001|Overall Study|Adverse Event|7|||
126414351|NCT02951429|454811369|FG000|Overall Study|Death|28|||
126414352|NCT02951429|454811370|FG001|Overall Study|Death|36|||
126414353|NCT02951429|454811369|FG000|Overall Study|Lack of Efficacy|0|||
126414354|NCT02951429|454811370|FG001|Overall Study|Lack of Efficacy|1|||
126414355|NCT02951429|454811369|FG000|Overall Study|Lost to Follow-up|0|||
126414356|NCT02951429|454811370|FG001|Overall Study|Lost to Follow-up|1|||
126414357|NCT02951429|454811369|FG000|Overall Study|Lung Transplantation|9|||
126414358|NCT02951429|454811370|FG001|Overall Study|Lung Transplantation|6|||
126414359|NCT02951429|454811369|FG000|Overall Study|Other|1|||
126414360|NCT02951429|454811370|FG001|Overall Study|Other|3|||
126414361|NCT02951429|454811369|FG000|Overall Study|Progressive Disease|1|||
126414362|NCT02951429|454811370|FG001|Overall Study|Progressive Disease|1|||
126414363|NCT02951429|454811369|FG000|Overall Study|Withdrawal by Subject|7|||
126414364|NCT02951429|454811370|FG001|Overall Study|Withdrawal by Subject|11|||
126414365|NCT02951429|454811369|FG000|Overall Study|Participant ongoing in the study|23|||
126414366|NCT02951429|454811370|FG001|Overall Study|Participant ongoing in the study|17|||
126414367|NCT01620528|454811371|FG000|Treatment Period|Did Not Receive Study Drug|0|||
126414368|NCT01620528|454811372|FG001|Treatment Period|Did Not Receive Study Drug|0|||
126414369|NCT01620528|454811373|FG002|Treatment Period|Did Not Receive Study Drug|1|||
126414370|NCT01620528|454811371|FG000|Treatment Period|Withdrawal by Subject|35|||
126414371|NCT01620528|454811372|FG001|Treatment Period|Withdrawal by Subject|21|||
126414372|NCT01620528|454811373|FG002|Treatment Period|Withdrawal by Subject|16|||
126414373|NCT01620528|454811371|FG000|Treatment Period|Adverse Event|17|||
126414374|NCT01620528|454811372|FG001|Treatment Period|Adverse Event|13|||
126414375|NCT01620528|454811373|FG002|Treatment Period|Adverse Event|21|||
126414376|NCT01620528|454811371|FG000|Treatment Period|Lost to Follow-up|16|||
126414377|NCT01620528|454811372|FG001|Treatment Period|Lost to Follow-up|8|||
126414378|NCT01620528|454811373|FG002|Treatment Period|Lost to Follow-up|14|||
126414379|NCT01620528|454811371|FG000|Treatment Period|Other|9|||
126414380|NCT01620528|454811372|FG001|Treatment Period|Other|5|||
126475677|NCT00913380|455040044|FG001|Clinical Outcomes|Lost to Follow-up|6|||
126475678|NCT00806351|455040045|FG000|Overall Study|Death|5|||
126414381|NCT01620528|454811373|FG002|Treatment Period|Other|7|||
126414382|NCT01620528|454811371|FG000|Treatment Period|Subject Noncompliant|11|||
126414383|NCT01620528|454811372|FG001|Treatment Period|Subject Noncompliant|2|||
126414384|NCT01620528|454811373|FG002|Treatment Period|Subject Noncompliant|2|||
126414385|NCT01620528|454811371|FG000|Treatment Period|Pregnancy|7|||
126414386|NCT01620528|454811372|FG001|Treatment Period|Pregnancy|2|||
126414387|NCT01620528|454811373|FG002|Treatment Period|Pregnancy|2|||
126414388|NCT01620528|454811371|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
126414389|NCT01620528|454811372|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
126414390|NCT01620528|454811373|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
126414391|NCT01620528|454811371|FG000|Treatment Period|Exclusionary Medication Received|0|||
126414392|NCT01620528|454811372|FG001|Treatment Period|Exclusionary Medication Received|1|||
126414393|NCT01620528|454811373|FG002|Treatment Period|Exclusionary Medication Received|0|||
126414394|NCT01620528|454811371|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
126414395|NCT01620528|454811372|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
126414396|NCT01620528|454811373|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
126414397|NCT01620528|454811371|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
126414398|NCT01620528|454811372|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
126414399|NCT01620528|454811373|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
126414400|NCT01620528|454811371|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
126414401|NCT01620528|454811372|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
126414402|NCT01620528|454811373|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
126414403|NCT01620528|454811371|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
126414404|NCT01620528|454811372|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
126414405|NCT01620528|454811373|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
126414406|NCT01620528|454811371|FG000|Post-Treatment Follow-Up Period|Other|6|||
126414407|NCT01620528|454811372|FG001|Post-Treatment Follow-Up Period|Other|4|||
126414408|NCT01620528|454811373|FG002|Post-Treatment Follow-Up Period|Other|2|||
126414409|NCT04006392|454811374|FG000|Overall Study|Lost to Follow-up|0|||
126414410|NCT04006392|454811375|FG001|Overall Study|Lost to Follow-up|1|||
126414411|NCT03824587|454811376|FG000|Run-in Period|Screen Failure|0|||
126414412|NCT03824587|454811377|FG001|Run-in Period|Screen Failure|275|||
126414413|NCT03824587|454811376|FG000|Treatment Period|Adverse Event|4|||
126414414|NCT03824587|454811377|FG001|Treatment Period|Adverse Event|1|||
126414415|NCT03824587|454811376|FG000|Treatment Period|Withdrawal by Subject|0|||
126414416|NCT03824587|454811377|FG001|Treatment Period|Withdrawal by Subject|1|||
126414417|NCT03824587|454811376|FG000|Treatment Period|Kidney Transplant|1|||
126414418|NCT03824587|454811377|FG001|Treatment Period|Kidney Transplant|1|||
126414419|NCT00986362|454811378|FG000|Overall Study|Death|2|||
126414420|NCT00986362|454811379|FG001|Overall Study|Death|0|||
126414421|NCT00986362|454811378|FG000|Overall Study|Lost to Follow-up|0|||
126414422|NCT00986362|454811379|FG001|Overall Study|Lost to Follow-up|1|||
126414423|NCT00384332|454811380|FG000|Overall Study|Lost to Follow-up|4|||
126414424|NCT00384332|454811381|FG001|Overall Study|Lost to Follow-up|0|||
126414425|NCT02006979|454811382|FG000|Overall Study|Withdrawal by Subject|1|||
126414426|NCT02006979|454811383|FG001|Overall Study|Withdrawal by Subject|1|||
126414427|NCT02006979|454811382|FG000|Overall Study|Protocol Violation|0|||
126414428|NCT02006979|454811383|FG001|Overall Study|Protocol Violation|1|||
126414429|NCT03170193|454811384|FG000|Overall Study|Withdrawal by Subject|0|||
126414430|NCT03170193|454811385|FG001|Overall Study|Withdrawal by Subject|0|||
126414431|NCT03170193|454811386|FG002|Overall Study|Withdrawal by Subject|0|||
126414432|NCT03170193|454811387|FG003|Overall Study|Withdrawal by Subject|1|||
126414433|NCT03170193|454811388|FG004|Overall Study|Withdrawal by Subject|0|||
126414434|NCT03170193|454811389|FG005|Overall Study|Withdrawal by Subject|0|||
126414435|NCT03170193|454811390|FG006|Overall Study|Withdrawal by Subject|0|||
126414436|NCT03170193|454811384|FG000|Overall Study|Lost to Follow-up|1|||
126414437|NCT03170193|454811385|FG001|Overall Study|Lost to Follow-up|1|||
126414438|NCT03170193|454811386|FG002|Overall Study|Lost to Follow-up|0|||
126414439|NCT03170193|454811387|FG003|Overall Study|Lost to Follow-up|0|||
126414440|NCT03170193|454811388|FG004|Overall Study|Lost to Follow-up|0|||
126414441|NCT03170193|454811389|FG005|Overall Study|Lost to Follow-up|0|||
126414442|NCT03170193|454811390|FG006|Overall Study|Lost to Follow-up|0|||
126414443|NCT01368081|454811391|FG000|Overall Study|Adverse Event|4|||
126414444|NCT01368081|454811392|FG001|Overall Study|Adverse Event|4|||
126414445|NCT01368081|454811393|FG002|Overall Study|Adverse Event|3|||
126414446|NCT01368081|454811394|FG003|Overall Study|Adverse Event|2|||
126414447|NCT01368081|454811395|FG004|Overall Study|Adverse Event|2|||
126414448|NCT01368081|454811396|FG005|Overall Study|Adverse Event|5|||
126558945|NCT01254305|455340583|FG000|Overall Study|Withdrawal by Subject|4|||
126558946|NCT01254305|455340584|FG001|Overall Study|Withdrawal by Subject|2|||
126414449|NCT01368081|454811397|FG006|Overall Study|Adverse Event|6|||
126414450|NCT01368081|454811398|FG007|Overall Study|Adverse Event|2|||
126414451|NCT01368081|454811399|FG008|Overall Study|Adverse Event|3|||
126414452|NCT01368081|454811400|FG009|Overall Study|Adverse Event|5|||
126414453|NCT01368081|454811401|FG010|Overall Study|Adverse Event|6|||
126414454|NCT01368081|454811402|FG011|Overall Study|Adverse Event|1|||
126414455|NCT01368081|454811403|FG012|Overall Study|Adverse Event|3|||
126414456|NCT01368081|454811391|FG000|Overall Study|Lack of Efficacy|0|||
126414457|NCT01368081|454811392|FG001|Overall Study|Lack of Efficacy|1|||
126414458|NCT01368081|454811393|FG002|Overall Study|Lack of Efficacy|0|||
126414459|NCT01368081|454811394|FG003|Overall Study|Lack of Efficacy|1|||
126414460|NCT01368081|454811395|FG004|Overall Study|Lack of Efficacy|0|||
126414461|NCT01368081|454811396|FG005|Overall Study|Lack of Efficacy|0|||
126475679|NCT00806351|455040046|FG001|Overall Study|Death|4|||
126475680|NCT02187744|455040047|FG000|Study|Participant refused further follow-up|1|||
126475681|NCT02187744|455040048|FG001|Study|Participant refused further follow-up|0|||
126475682|NCT02187744|455040047|FG000|Study|Other|2|||
126475683|NCT02187744|455040048|FG001|Study|Other|1|||
126475684|NCT02187744|455040047|FG000|Study|Lost to Follow-up|0|||
126475685|NCT02187744|455040048|FG001|Study|Lost to Follow-up|2|||
126475686|NCT02187744|455040047|FG000|Study|Related adverse event, not serious|0|||
126475687|NCT02187744|455040048|FG001|Study|Related adverse event, not serious|2|||
126475688|NCT02187744|455040047|FG000|Study|Death|1|||
126475689|NCT02187744|455040048|FG001|Study|Death|0|||
126475690|NCT02187744|455040047|FG000|Study|Related adverse event, serious non-fatal|0|||
126475691|NCT02187744|455040048|FG001|Study|Related adverse event, serious non-fatal|1|||
126475692|NCT02187744|455040047|FG000|Treatment|Death|1|||
126475693|NCT02187744|455040048|FG001|Treatment|Death|0|||
126475694|NCT02187744|455040047|FG000|Treatment|Related adverse event, serious non-fatal|0|||
126475695|NCT02187744|455040048|FG001|Treatment|Related adverse event, serious non-fatal|1|||
126475696|NCT02187744|455040047|FG000|Treatment|Related adverse event, not serious|0|||
126475697|NCT02187744|455040048|FG001|Treatment|Related adverse event, not serious|2|||
126475698|NCT02187744|455040047|FG000|Treatment|Lost to Follow-up|0|||
126475699|NCT02187744|455040048|FG001|Treatment|Lost to Follow-up|1|||
126475700|NCT02187744|455040047|FG000|Treatment|Other|2|||
126475701|NCT02187744|455040048|FG001|Treatment|Other|0|||
126475702|NCT02187744|455040047|FG000|Treatment|Participant refused continued treatment|1|||
126475703|NCT02187744|455040048|FG001|Treatment|Participant refused continued treatment|1|||
126475704|NCT00508755|455040054|FG000|Overall Study|Withdrawal by Subject|1|||
126475705|NCT00667875|455040058|FG000|Overall Study|Adverse Event|0|||
126475706|NCT00667875|455040059|FG001|Overall Study|Adverse Event|2|||
126475707|NCT00667875|455040060|FG002|Overall Study|Adverse Event|6|||
126475708|NCT00667875|455040058|FG000|Overall Study|Withdrawal by Subject|10|||
126475709|NCT00667875|455040059|FG001|Overall Study|Withdrawal by Subject|9|||
126475710|NCT00667875|455040060|FG002|Overall Study|Withdrawal by Subject|7|||
126475711|NCT00437983|455040061|FG000|Overall Study|Adverse Event|6|||
126475712|NCT00437983|455040062|FG001|Overall Study|Adverse Event|6|||
126475713|NCT00437983|455040061|FG000|Overall Study|Protocol Violation|2|||
126475714|NCT00437983|455040062|FG001|Overall Study|Protocol Violation|1|||
126475715|NCT00437983|455040061|FG000|Overall Study|Withdrawal by Subject|5|||
126475716|NCT00437983|455040062|FG001|Overall Study|Withdrawal by Subject|6|||
126475717|NCT00300274|455040063|FG000|Overall Study|Withdrawal by Subject|12|||
126475718|NCT00300274|455040064|FG001|Overall Study|Withdrawal by Subject|3|||
126475719|NCT00300274|455040065|FG002|Overall Study|Withdrawal by Subject|14|||
126475720|NCT00300274|455040063|FG000|Overall Study|Lost to Follow-up|3|||
126475721|NCT00300274|455040064|FG001|Overall Study|Lost to Follow-up|4|||
126475722|NCT00300274|455040065|FG002|Overall Study|Lost to Follow-up|5|||
126475723|NCT00300274|455040063|FG000|Overall Study|Death|31|||
126475724|NCT00300274|455040064|FG001|Overall Study|Death|20|||
126475725|NCT00300274|455040065|FG002|Overall Study|Death|25|||
126475726|NCT00300274|455040063|FG000|Overall Study|Re-transplant|0|||
126475727|NCT00300274|455040064|FG001|Overall Study|Re-transplant|0|||
126475728|NCT00300274|455040065|FG002|Overall Study|Re-transplant|1|||
126475729|NCT04439201|455040066|FG000|Overall Study|Ineligible|2|||
126475730|NCT04439201|455040066|FG000|Overall Study|Never start protocol therapy|1|||
126475731|NCT04439201|455040066|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
126475732|NCT04439201|455040066|FG000|Overall Study|Mutation status not confirmed|4|||
126475733|NCT04439201|455040066|FG000|Overall Study|Adverse Event|1|||
126475734|NCT04439201|455040066|FG000|Overall Study|Death|7|||
126475735|NCT04439201|455040066|FG000|Overall Study|Withdrawal by Subject|2|||
126475736|NCT04439201|455040066|FG000|Overall Study|Disease progression|20|||
126475737|NCT04439201|455040066|FG000|Overall Study|Alternative therapy|1|||
126475738|NCT04439201|455040066|FG000|Overall Study|Physician Decision|1|||
126475739|NCT04680052|455041167|FG000|Overall Study|Ongoing|244|||
126475740|NCT04680052|455041168|FG001|Overall Study|Ongoing|229|||
126475741|NCT04680052|455041169|FG002|Overall Study|Ongoing|39|||
126475742|NCT04680052|455041170|FG003|Overall Study|Ongoing|46|||
126475743|NCT04680052|455041167|FG000|Overall Study|Death|15|||
126414462|NCT01368081|454811397|FG006|Overall Study|Lack of Efficacy|0|||
126414463|NCT01368081|454811398|FG007|Overall Study|Lack of Efficacy|2|||
126414464|NCT01368081|454811399|FG008|Overall Study|Lack of Efficacy|0|||
126414465|NCT01368081|454811400|FG009|Overall Study|Lack of Efficacy|0|||
126414466|NCT01368081|454811401|FG010|Overall Study|Lack of Efficacy|0|||
126414467|NCT01368081|454811402|FG011|Overall Study|Lack of Efficacy|0|||
126414468|NCT01368081|454811403|FG012|Overall Study|Lack of Efficacy|0|||
126414469|NCT01368081|454811391|FG000|Overall Study|Protocol Violation|0|||
126414470|NCT01368081|454811392|FG001|Overall Study|Protocol Violation|0|||
126414471|NCT01368081|454811393|FG002|Overall Study|Protocol Violation|0|||
126414472|NCT01368081|454811394|FG003|Overall Study|Protocol Violation|0|||
126414473|NCT01368081|454811395|FG004|Overall Study|Protocol Violation|0|||
126414474|NCT01368081|454811396|FG005|Overall Study|Protocol Violation|1|||
126414475|NCT01368081|454811397|FG006|Overall Study|Protocol Violation|0|||
126414476|NCT01368081|454811398|FG007|Overall Study|Protocol Violation|1|||
126721647|NCT03136185|455930031|FG007|Overall Study|Physician Decision|0|||
126721648|NCT03136185|455930032|FG008|Overall Study|Physician Decision|1|||
126721649|NCT03136185|455930024|FG000|Overall Study|Protocol Defined Disease Progression|0|||
126721650|NCT03136185|455930025|FG001|Overall Study|Protocol Defined Disease Progression|0|||
126721651|NCT03136185|455930026|FG002|Overall Study|Protocol Defined Disease Progression|1|||
126721652|NCT03136185|455930027|FG003|Overall Study|Protocol Defined Disease Progression|0|||
126721653|NCT03136185|455930028|FG004|Overall Study|Protocol Defined Disease Progression|0|||
126721654|NCT03136185|455930029|FG005|Overall Study|Protocol Defined Disease Progression|1|||
126414477|NCT01368081|454811399|FG008|Overall Study|Protocol Violation|0|||
126414478|NCT01368081|454811400|FG009|Overall Study|Protocol Violation|0|||
126414479|NCT01368081|454811401|FG010|Overall Study|Protocol Violation|0|||
126414480|NCT01368081|454811402|FG011|Overall Study|Protocol Violation|0|||
126414481|NCT01368081|454811403|FG012|Overall Study|Protocol Violation|0|||
126414482|NCT01368081|454811391|FG000|Overall Study|Lost to Follow-up|0|||
126414483|NCT01368081|454811392|FG001|Overall Study|Lost to Follow-up|0|||
126414484|NCT01368081|454811393|FG002|Overall Study|Lost to Follow-up|0|||
126414485|NCT01368081|454811394|FG003|Overall Study|Lost to Follow-up|0|||
126414486|NCT01368081|454811395|FG004|Overall Study|Lost to Follow-up|0|||
126414487|NCT01368081|454811396|FG005|Overall Study|Lost to Follow-up|0|||
126414488|NCT01368081|454811397|FG006|Overall Study|Lost to Follow-up|0|||
126414489|NCT01368081|454811398|FG007|Overall Study|Lost to Follow-up|0|||
126414490|NCT01368081|454811399|FG008|Overall Study|Lost to Follow-up|0|||
126414491|NCT01368081|454811400|FG009|Overall Study|Lost to Follow-up|0|||
126414492|NCT01368081|454811401|FG010|Overall Study|Lost to Follow-up|0|||
126414493|NCT01368081|454811402|FG011|Overall Study|Lost to Follow-up|0|||
126414494|NCT01368081|454811403|FG012|Overall Study|Lost to Follow-up|1|||
126414495|NCT01368081|454811391|FG000|Overall Study|Withdrawal by Subject|4|||
126414496|NCT01368081|454811392|FG001|Overall Study|Withdrawal by Subject|4|||
126414497|NCT01368081|454811393|FG002|Overall Study|Withdrawal by Subject|1|||
126414498|NCT01368081|454811394|FG003|Overall Study|Withdrawal by Subject|1|||
126414499|NCT01368081|454811395|FG004|Overall Study|Withdrawal by Subject|0|||
126414500|NCT01368081|454811396|FG005|Overall Study|Withdrawal by Subject|3|||
126414501|NCT01368081|454811397|FG006|Overall Study|Withdrawal by Subject|4|||
126414502|NCT01368081|454811398|FG007|Overall Study|Withdrawal by Subject|2|||
126414503|NCT01368081|454811399|FG008|Overall Study|Withdrawal by Subject|5|||
126414504|NCT01368081|454811400|FG009|Overall Study|Withdrawal by Subject|4|||
126414505|NCT01368081|454811401|FG010|Overall Study|Withdrawal by Subject|3|||
126414506|NCT01368081|454811402|FG011|Overall Study|Withdrawal by Subject|2|||
126414507|NCT01368081|454811403|FG012|Overall Study|Withdrawal by Subject|0|||
126414508|NCT01368081|454811391|FG000|Overall Study|Other reason not defined above|2|||
126414509|NCT01368081|454811392|FG001|Overall Study|Other reason not defined above|0|||
126414510|NCT01368081|454811393|FG002|Overall Study|Other reason not defined above|0|||
126414511|NCT01368081|454811394|FG003|Overall Study|Other reason not defined above|1|||
126414512|NCT01368081|454811395|FG004|Overall Study|Other reason not defined above|0|||
126414513|NCT01368081|454811396|FG005|Overall Study|Other reason not defined above|1|||
126414514|NCT01368081|454811397|FG006|Overall Study|Other reason not defined above|2|||
126414515|NCT01368081|454811398|FG007|Overall Study|Other reason not defined above|0|||
126414516|NCT01368081|454811399|FG008|Overall Study|Other reason not defined above|0|||
126414517|NCT01368081|454811400|FG009|Overall Study|Other reason not defined above|1|||
126414518|NCT01368081|454811401|FG010|Overall Study|Other reason not defined above|0|||
126414519|NCT01368081|454811402|FG011|Overall Study|Other reason not defined above|0|||
126414520|NCT01368081|454811403|FG012|Overall Study|Other reason not defined above|3|||
126414521|NCT02560012|454811404|FG000|Overall Study|Study Terminated|2|||
126414522|NCT01007838|454811405|FG000|Overall Study|Withdrawal by Subject|1|||
126414523|NCT01007838|454811406|FG001|Overall Study|Withdrawal by Subject|0|||
126414524|NCT01007838|454811407|FG002|Overall Study|Withdrawal by Subject|0|||
126414525|NCT01007838|454811408|FG003|Overall Study|Withdrawal by Subject|0|||
126414526|NCT01007838|454811405|FG000|Overall Study|Physician Decision|1|||
126414527|NCT01007838|454811406|FG001|Overall Study|Physician Decision|0|||
126414528|NCT01007838|454811407|FG002|Overall Study|Physician Decision|0|||
126414529|NCT01007838|454811408|FG003|Overall Study|Physician Decision|0|||
126414530|NCT01007838|454811405|FG000|Overall Study|Started home haemodialysis|1|||
126414531|NCT01007838|454811406|FG001|Overall Study|Started home haemodialysis|0|||
126414532|NCT01007838|454811407|FG002|Overall Study|Started home haemodialysis|0|||
126414533|NCT01007838|454811408|FG003|Overall Study|Started home haemodialysis|0|||
126414534|NCT04167137|454811409|FG000|Overall Study|Disease progression|1|||
126414535|NCT04167137|454811410|FG001|Overall Study|Disease progression|1|||
126414536|NCT04167137|454811411|FG002|Overall Study|Disease progression|3|||
126414537|NCT04167137|454811412|FG003|Overall Study|Disease progression|3|||
126414538|NCT04167137|454811413|FG004|Overall Study|Disease progression|2|||
126414539|NCT04167137|454811414|FG005|Overall Study|Disease progression|3|||
126721655|NCT03136185|455930030|FG006|Overall Study|Protocol Defined Disease Progression|0|||
126414540|NCT04167137|454811415|FG006|Overall Study|Disease progression|2|||
126414541|NCT04167137|454811416|FG007|Overall Study|Disease progression|2|||
126414542|NCT04167137|454811409|FG000|Overall Study|Withdrawal by Subject|1|||
126414543|NCT04167137|454811410|FG001|Overall Study|Withdrawal by Subject|0|||
126414544|NCT04167137|454811411|FG002|Overall Study|Withdrawal by Subject|0|||
126475744|NCT04680052|455041168|FG001|Overall Study|Death|22|||
126414545|NCT04167137|454811412|FG003|Overall Study|Withdrawal by Subject|1|||
126414546|NCT04167137|454811413|FG004|Overall Study|Withdrawal by Subject|0|||
126414547|NCT04167137|454811414|FG005|Overall Study|Withdrawal by Subject|2|||
126414548|NCT04167137|454811415|FG006|Overall Study|Withdrawal by Subject|1|||
126414549|NCT04167137|454811416|FG007|Overall Study|Withdrawal by Subject|0|||
126414550|NCT04167137|454811409|FG000|Overall Study|Adverse Event|0|||
126414551|NCT04167137|454811410|FG001|Overall Study|Adverse Event|0|||
126414552|NCT04167137|454811411|FG002|Overall Study|Adverse Event|0|||
126414553|NCT04167137|454811412|FG003|Overall Study|Adverse Event|0|||
126414554|NCT04167137|454811413|FG004|Overall Study|Adverse Event|0|||
126475745|NCT04680052|455041169|FG002|Overall Study|Death|7|||
126475746|NCT04680052|455041170|FG003|Overall Study|Death|1|||
126475747|NCT04680052|455041167|FG000|Overall Study|Lost to Follow-up|3|||
126475748|NCT04680052|455041168|FG001|Overall Study|Lost to Follow-up|2|||
126475749|NCT04680052|455041169|FG002|Overall Study|Lost to Follow-up|0|||
126475750|NCT04680052|455041170|FG003|Overall Study|Lost to Follow-up|1|||
126475751|NCT04680052|455041167|FG000|Overall Study|Withdrawal by Subject|11|||
126475752|NCT04680052|455041168|FG001|Overall Study|Withdrawal by Subject|19|||
126475753|NCT04680052|455041169|FG002|Overall Study|Withdrawal by Subject|7|||
126475754|NCT04680052|455041170|FG003|Overall Study|Withdrawal by Subject|5|||
126475755|NCT04680052|455041167|FG000|Overall Study|Missing|0|||
126475756|NCT04680052|455041168|FG001|Overall Study|Missing|1|||
126475757|NCT04680052|455041169|FG002|Overall Study|Missing|0|||
126475758|NCT04680052|455041170|FG003|Overall Study|Missing|0|||
126475759|NCT04680052|455041167|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
126475760|NCT04680052|455041168|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
126475761|NCT04680052|455041169|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
126475762|NCT04680052|455041170|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
126475763|NCT04680052|455041167|FG000|Overall Study|Physician Decision|0|||
126475764|NCT04680052|455041168|FG001|Overall Study|Physician Decision|1|||
126475765|NCT04680052|455041169|FG002|Overall Study|Physician Decision|0|||
126475766|NCT04680052|455041170|FG003|Overall Study|Physician Decision|0|||
126475767|NCT03372096|455041171|FG000|Overall Study|Study Closed|8|||
126475768|NCT01546207|455041174|FG000|Overall Study|Death|1|||
126475769|NCT01947582|455041179|FG000|Overall Study|Withdrawal by Subject|1|||
126475770|NCT01603355|455041180|FG000|Overall Study|Lack of Efficacy|2|||
126475771|NCT00705289|455041187|FG000|Overall Study|Subject or treating physician's choice|131|||
126475772|NCT02601027|455041191|FG000|Registration to Surgery|Withdrawal by Subject|20|||
126475773|NCT02601027|455041192|FG001|Registration to Surgery|Withdrawal by Subject|10|||
126475774|NCT02980783|455041193|FG000|Overall Study|Lost to Follow-up|1|||
126475775|NCT01540838|455041194|FG000|Overall Study|Open nasogastric tube|9|||
126475776|NCT01540838|455041195|FG001|Overall Study|Open nasogastric tube|7|||
126475777|NCT01540838|455041194|FG000|Overall Study|Treatment doses missing|8|||
126475778|NCT01540838|455041195|FG001|Overall Study|Treatment doses missing|12|||
126475779|NCT01540838|455041194|FG000|Overall Study|Additional antibiotic treatment|1|||
126475780|NCT01540838|455041195|FG001|Overall Study|Additional antibiotic treatment|2|||
126475781|NCT01540838|455041194|FG000|Overall Study|Died before treatment initiation|1|||
126475782|NCT01540838|455041195|FG001|Overall Study|Died before treatment initiation|1|||
126475783|NCT01540838|455041194|FG000|Overall Study|Not BM. Other treatment|3|||
126475784|NCT01540838|455041195|FG001|Overall Study|Not BM. Other treatment|1|||
126475785|NCT02130570|455041196|FG000|Overall Study|Death|3|||
126475786|NCT02130570|455041197|FG001|Overall Study|Death|5|||
126475787|NCT02130570|455041196|FG000|Overall Study|Withdrawal by Subject|6|||
126475788|NCT02130570|455041197|FG001|Overall Study|Withdrawal by Subject|3|||
126475789|NCT02130570|455041196|FG000|Overall Study|Part of practice that discontinued study|0|||
126475790|NCT02130570|455041197|FG001|Overall Study|Part of practice that discontinued study|5|||
126475791|NCT01696695|455041198|FG000|Overall Study|Disease progression|373|||
126475792|NCT01696695|455041198|FG000|Overall Study|Death|29|||
126475793|NCT01696695|455041198|FG000|Overall Study|Adverse Event|74|||
126558947|NCT01254305|455340585|FG002|Overall Study|Withdrawal by Subject|4|||
126558948|NCT01254305|455340583|FG000|Overall Study|Lost to Follow-up|10|||
126558949|NCT01254305|455340584|FG001|Overall Study|Lost to Follow-up|6|||
126475794|NCT01696695|455041198|FG000|Overall Study|Withdrawal by Subject|92|||
126475795|NCT01696695|455041198|FG000|Overall Study|Lost to Follow-up|48|||
126475796|NCT01696695|455041198|FG000|Overall Study|Other|74|||
126475797|NCT01696695|455041198|FG000|Overall Study|Major Protocol Violation|192|||
126475798|NCT03173313|455041201|FG000|Overall Study|Lost to Follow-up|2|||
126475799|NCT03173313|455041202|FG001|Overall Study|Lost to Follow-up|3|||
126475800|NCT03173313|455041201|FG000|Overall Study|Withdrawal by Subject|0|||
126475801|NCT03173313|455041202|FG001|Overall Study|Withdrawal by Subject|1|||
126475802|NCT03173313|455041201|FG000|Overall Study|Death|5|||
126475803|NCT03173313|455041202|FG001|Overall Study|Death|0|||
126558950|NCT01254305|455340585|FG002|Overall Study|Lost to Follow-up|5|||
126414555|NCT04167137|454811414|FG005|Overall Study|Adverse Event|1|||
126414556|NCT04167137|454811415|FG006|Overall Study|Adverse Event|0|||
126475804|NCT03173313|455041201|FG000|Overall Study|Physician Decision|1|||
126475805|NCT03173313|455041202|FG001|Overall Study|Physician Decision|0|||
126475806|NCT03173313|455041201|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
126475807|NCT03173313|455041202|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
126475808|NCT03173313|455041201|FG000|Overall Study|Bone Fracture|1|||
126475809|NCT03173313|455041202|FG001|Overall Study|Bone Fracture|0|||
126475810|NCT03863197|455041203|FG000|Overall Study|Lost to Follow-up|2|||
126475811|NCT03863197|455041204|FG001|Overall Study|Lost to Follow-up|3|||
126475812|NCT03863197|455041203|FG000|Overall Study|Withdrawal by Subject|4|||
126475813|NCT03863197|455041204|FG001|Overall Study|Withdrawal by Subject|0|||
126475814|NCT03863197|455041203|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
126475815|NCT03863197|455041204|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
126475816|NCT01065597|455041212|FG000|Overall Study|Adverse Event|1|||
126475817|NCT00413244|455041213|FG000|Overall Study|Withdrawal by Subject|10|||
126475818|NCT00413244|455041214|FG001|Overall Study|Withdrawal by Subject|1|||
126475819|NCT02805972|455041218|FG000|Washout Period|Lost to Follow-up|3|||
126475820|NCT02805972|455041219|FG001|Washout Period|Lost to Follow-up|0|||
126475821|NCT01206166|455041220|FG000|Overall Study|No evaluable data|2|||
126475822|NCT01206166|455041221|FG001|Overall Study|No evaluable data|3|||
126475823|NCT00932126|455041222|FG000|Overall Study|Adverse Event|0|||
126475824|NCT00932126|455041223|FG001|Overall Study|Adverse Event|0|||
126475825|NCT00932126|455041224|FG002|Overall Study|Adverse Event|0|||
126475826|NCT00932126|455041225|FG003|Overall Study|Adverse Event|0|||
126475827|NCT00932126|455041226|FG004|Overall Study|Adverse Event|0|||
126475828|NCT00932126|455041227|FG005|Overall Study|Adverse Event|0|||
126475829|NCT00932126|455041228|FG006|Overall Study|Adverse Event|1|||
126475830|NCT00932126|455041229|FG007|Overall Study|Adverse Event|2|||
126414557|NCT04167137|454811416|FG007|Overall Study|Adverse Event|1|||
126414558|NCT04167137|454811409|FG000|Overall Study|Physician Decision|0|||
126475831|NCT00932126|455041222|FG000|Overall Study|Protocol Violation|0|||
126475832|NCT00932126|455041223|FG001|Overall Study|Protocol Violation|0|||
126475833|NCT00932126|455041224|FG002|Overall Study|Protocol Violation|0|||
126475834|NCT00932126|455041225|FG003|Overall Study|Protocol Violation|0|||
126475835|NCT00932126|455041226|FG004|Overall Study|Protocol Violation|1|||
126475836|NCT00932126|455041227|FG005|Overall Study|Protocol Violation|0|||
126475837|NCT00932126|455041228|FG006|Overall Study|Protocol Violation|0|||
126475838|NCT00932126|455041229|FG007|Overall Study|Protocol Violation|0|||
126475839|NCT00932126|455041222|FG000|Overall Study|Withdrawal by Subject|0|||
126475840|NCT00932126|455041223|FG001|Overall Study|Withdrawal by Subject|0|||
126475841|NCT00932126|455041224|FG002|Overall Study|Withdrawal by Subject|1|||
126475842|NCT00932126|455041225|FG003|Overall Study|Withdrawal by Subject|0|||
126475843|NCT00932126|455041226|FG004|Overall Study|Withdrawal by Subject|0|||
126475844|NCT00932126|455041227|FG005|Overall Study|Withdrawal by Subject|0|||
126475845|NCT00932126|455041228|FG006|Overall Study|Withdrawal by Subject|0|||
126475846|NCT00932126|455041229|FG007|Overall Study|Withdrawal by Subject|1|||
126475847|NCT00932126|455041222|FG000|Overall Study|Objective progression or relapse|3|||
126475848|NCT00932126|455041223|FG001|Overall Study|Objective progression or relapse|3|||
126475849|NCT00932126|455041224|FG002|Overall Study|Objective progression or relapse|2|||
126475850|NCT00932126|455041225|FG003|Overall Study|Objective progression or relapse|3|||
126475851|NCT00932126|455041226|FG004|Overall Study|Objective progression or relapse|3|||
126475852|NCT00932126|455041227|FG005|Overall Study|Objective progression or relapse|3|||
126558951|NCT01254305|455340583|FG000|Overall Study|Other Reasons|0|||
126558952|NCT01254305|455340584|FG001|Overall Study|Other Reasons|0|||
126721656|NCT03136185|455930031|FG007|Overall Study|Protocol Defined Disease Progression|1|||
126414559|NCT04167137|454811410|FG001|Overall Study|Physician Decision|0|||
126414560|NCT04167137|454811411|FG002|Overall Study|Physician Decision|0|||
126414561|NCT04167137|454811412|FG003|Overall Study|Physician Decision|1|||
126414562|NCT04167137|454811413|FG004|Overall Study|Physician Decision|0|||
126414563|NCT04167137|454811414|FG005|Overall Study|Physician Decision|0|||
126414564|NCT04167137|454811415|FG006|Overall Study|Physician Decision|1|||
126414565|NCT04167137|454811416|FG007|Overall Study|Physician Decision|0|||
126414566|NCT04167137|454811409|FG000|Overall Study|Death|0|||
126414567|NCT04167137|454811410|FG001|Overall Study|Death|1|||
126414568|NCT04167137|454811411|FG002|Overall Study|Death|0|||
126414569|NCT04167137|454811412|FG003|Overall Study|Death|0|||
126475853|NCT00932126|455041228|FG006|Overall Study|Objective progression or relapse|3|||
126475854|NCT00932126|455041229|FG007|Overall Study|Objective progression or relapse|5|||
126475855|NCT00932126|455041222|FG000|Overall Study|Other|0|||
126475856|NCT00932126|455041223|FG001|Overall Study|Other|0|||
126475857|NCT00932126|455041224|FG002|Overall Study|Other|0|||
126475858|NCT00932126|455041225|FG003|Overall Study|Other|0|||
126475859|NCT00932126|455041226|FG004|Overall Study|Other|1|||
126475860|NCT00932126|455041227|FG005|Overall Study|Other|0|||
126475861|NCT00932126|455041228|FG006|Overall Study|Other|1|||
126475862|NCT00932126|455041229|FG007|Overall Study|Other|2|||
126414570|NCT04167137|454811413|FG004|Overall Study|Death|0|||
126414571|NCT04167137|454811414|FG005|Overall Study|Death|0|||
126414572|NCT04167137|454811415|FG006|Overall Study|Death|0|||
126475863|NCT00066365|455041230|FG000|Overall Study|Adverse Event|1|||
126475864|NCT00066365|455041231|FG001|Overall Study|Adverse Event|0|||
126475865|NCT00066365|455041230|FG000|Overall Study|Lack of Efficacy|15|||
126414573|NCT04167137|454811416|FG007|Overall Study|Death|0|||
126414574|NCT04167137|454811409|FG000|Overall Study|Study terminated by Sponsor|0|||
126414575|NCT04167137|454811410|FG001|Overall Study|Study terminated by Sponsor|0|||
126414576|NCT04167137|454811411|FG002|Overall Study|Study terminated by Sponsor|0|||
126414577|NCT04167137|454811412|FG003|Overall Study|Study terminated by Sponsor|0|||
126414578|NCT04167137|454811413|FG004|Overall Study|Study terminated by Sponsor|0|||
126414579|NCT04167137|454811414|FG005|Overall Study|Study terminated by Sponsor|0|||
126414580|NCT04167137|454811415|FG006|Overall Study|Study terminated by Sponsor|0|||
126414581|NCT04167137|454811416|FG007|Overall Study|Study terminated by Sponsor|1|||
126414582|NCT02147288|454811417|FG000|Overall Study|post-operative hematoma|1|||
126414583|NCT02147288|454811418|FG001|Overall Study|post-operative hematoma|1|||
126414584|NCT02147288|454811419|FG002|Overall Study|post-operative hematoma|0|||
126414585|NCT02147288|454811420|FG003|Overall Study|post-operative hematoma|0|||
126414586|NCT02147288|454811421|FG004|Overall Study|post-operative hematoma|0|||
126414587|NCT02147288|454811422|FG005|Overall Study|post-operative hematoma|0|||
126414588|NCT02147288|454811423|FG006|Overall Study|post-operative hematoma|0|||
126414589|NCT02147288|454811424|FG007|Overall Study|post-operative hematoma|0|||
126414590|NCT02147288|454811425|FG008|Overall Study|post-operative hematoma|0|||
126414591|NCT02147288|454811426|FG009|Overall Study|post-operative hematoma|0|||
126414592|NCT02147288|454811417|FG000|Overall Study|complications from concurrent hernia rep|0|||
126414593|NCT02147288|454811418|FG001|Overall Study|complications from concurrent hernia rep|1|||
126414594|NCT02147288|454811419|FG002|Overall Study|complications from concurrent hernia rep|0|||
126414595|NCT02147288|454811420|FG003|Overall Study|complications from concurrent hernia rep|0|||
126414596|NCT02147288|454811421|FG004|Overall Study|complications from concurrent hernia rep|0|||
126414597|NCT02147288|454811422|FG005|Overall Study|complications from concurrent hernia rep|0|||
126414598|NCT02147288|454811423|FG006|Overall Study|complications from concurrent hernia rep|0|||
126414599|NCT02147288|454811424|FG007|Overall Study|complications from concurrent hernia rep|0|||
126414600|NCT02147288|454811425|FG008|Overall Study|complications from concurrent hernia rep|0|||
126414601|NCT02147288|454811426|FG009|Overall Study|complications from concurrent hernia rep|0|||
126414602|NCT02611817|454812918|FG000|Open-label Induction Phase|Reason not Specified|9|||
126414603|NCT02611817|454812919|FG001|Open-label Induction Phase|Reason not Specified|0|||
126414604|NCT02611817|454812920|FG002|Open-label Induction Phase|Reason not Specified|0|||
126414605|NCT02611817|454812918|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
126414606|NCT02611817|454812919|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
126414607|NCT02611817|454812920|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
126414608|NCT02611817|454812918|FG000|Open-label Induction Phase|Pregnancy|1|||
126414609|NCT02611817|454812919|FG001|Open-label Induction Phase|Pregnancy|0|||
126414610|NCT02611817|454812920|FG002|Open-label Induction Phase|Pregnancy|0|||
126414611|NCT02611817|454812918|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
126414612|NCT02611817|454812919|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
126414613|NCT02611817|454812920|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
126414614|NCT02611817|454812918|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
126414615|NCT02611817|454812919|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
126414616|NCT02611817|454812920|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
126414617|NCT02611817|454812918|FG000|Open-label Induction Phase|Protocol Violation|5|||
126414618|NCT02611817|454812919|FG001|Open-label Induction Phase|Protocol Violation|0|||
126414619|NCT02611817|454812920|FG002|Open-label Induction Phase|Protocol Violation|0|||
126414620|NCT02611817|454812918|FG000|Open-label Induction Phase|Adverse Event|16|||
126414621|NCT02611817|454812919|FG001|Open-label Induction Phase|Adverse Event|0|||
126414622|NCT02611817|454812920|FG002|Open-label Induction Phase|Adverse Event|0|||
126414623|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
126414624|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
126414625|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
126414626|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
126414627|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
126414628|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
126414629|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
126414630|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
126414631|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
126414632|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
126414633|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
126414634|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
126414635|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
126414636|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
126414637|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
126414638|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
126414639|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
126414640|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
126414641|NCT02611817|454812918|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
126414642|NCT02611817|454812919|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
126414643|NCT02611817|454812920|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
126414644|NCT03412812|454812927|FG000|Level 1|Death|3|||
126414645|NCT03412812|454812928|FG001|Level 1|Death|0|||
126414646|NCT03412812|454812927|FG000|Level 1|Adverse Event|0|||
126414647|NCT03412812|454812928|FG001|Level 1|Adverse Event|1|||
126414648|NCT02391363|454812929|FG000|Overall Study|Lost to Follow-up|5|||
126414649|NCT02391363|454812930|FG001|Overall Study|Lost to Follow-up|5|||
126414650|NCT02391363|454812929|FG000|Overall Study|Withdrawal by Subject|6|||
126414651|NCT02391363|454812930|FG001|Overall Study|Withdrawal by Subject|3|||
126414652|NCT03828617|454812931|FG000|Overall Study|Lost to Follow-up|22|||
126414653|NCT03828617|454812932|FG001|Overall Study|Lost to Follow-up|12|||
126414654|NCT03828617|454812933|FG002|Overall Study|Lost to Follow-up|23|||
126414655|NCT03828617|454812934|FG003|Overall Study|Lost to Follow-up|7|||
126414656|NCT03828617|454812931|FG000|Overall Study|No longer met eligibility criteria|0|||
126414657|NCT03828617|454812932|FG001|Overall Study|No longer met eligibility criteria|1|||
126414658|NCT03828617|454812933|FG002|Overall Study|No longer met eligibility criteria|1|||
126414659|NCT03828617|454812934|FG003|Overall Study|No longer met eligibility criteria|3|||
126414660|NCT03828617|454812931|FG000|Overall Study|Protocol Violation|0|||
126414661|NCT03828617|454812932|FG001|Overall Study|Protocol Violation|2|||
126414662|NCT03828617|454812933|FG002|Overall Study|Protocol Violation|0|||
126414663|NCT03828617|454812934|FG003|Overall Study|Protocol Violation|0|||
126414664|NCT03828617|454812931|FG000|Overall Study|Withdrawal by Subject|2|||
126414665|NCT03828617|454812932|FG001|Overall Study|Withdrawal by Subject|0|||
126414666|NCT03828617|454812933|FG002|Overall Study|Withdrawal by Subject|2|||
126414667|NCT03828617|454812934|FG003|Overall Study|Withdrawal by Subject|0|||
126414668|NCT02510001|454812935|FG000|Overall Study|Early disease progression|0|||
126414669|NCT02510001|454812936|FG001|Overall Study|Early disease progression|0|||
126414670|NCT02510001|454812937|FG002|Overall Study|Early disease progression|0|||
126414671|NCT02510001|454812938|FG003|Overall Study|Early disease progression|1|||
126414672|NCT02510001|454812939|FG004|Overall Study|Early disease progression|1|||
126414673|NCT02510001|454812940|FG005|Overall Study|Early disease progression|1|||
126414674|NCT02510001|454812941|FG006|Overall Study|Early disease progression|0|||
126414675|NCT02510001|454812942|FG007|Overall Study|Early disease progression|0|||
126414676|NCT02510001|454812935|FG000|Overall Study|Adverse Event|0|||
126414677|NCT02510001|454812936|FG001|Overall Study|Adverse Event|0|||
126414678|NCT02510001|454812937|FG002|Overall Study|Adverse Event|0|||
126414679|NCT02510001|454812938|FG003|Overall Study|Adverse Event|1|||
126414680|NCT02510001|454812939|FG004|Overall Study|Adverse Event|2|||
126414681|NCT02510001|454812940|FG005|Overall Study|Adverse Event|1|||
126414682|NCT02510001|454812941|FG006|Overall Study|Adverse Event|2|||
126414683|NCT02510001|454812942|FG007|Overall Study|Adverse Event|5|||
126414684|NCT02510001|454812935|FG000|Overall Study|Physician Decision|0|||
126414685|NCT02510001|454812936|FG001|Overall Study|Physician Decision|0|||
126414686|NCT02510001|454812937|FG002|Overall Study|Physician Decision|0|||
126414687|NCT02510001|454812938|FG003|Overall Study|Physician Decision|0|||
126414688|NCT02510001|454812939|FG004|Overall Study|Physician Decision|1|||
126414689|NCT02510001|454812940|FG005|Overall Study|Physician Decision|0|||
126414690|NCT02510001|454812941|FG006|Overall Study|Physician Decision|0|||
126414691|NCT02510001|454812942|FG007|Overall Study|Physician Decision|0|||
126414692|NCT02510001|454812935|FG000|Overall Study|Withdrawal by Subject|0|||
126414693|NCT02510001|454812936|FG001|Overall Study|Withdrawal by Subject|0|||
126414694|NCT02510001|454812937|FG002|Overall Study|Withdrawal by Subject|0|||
126414695|NCT02510001|454812938|FG003|Overall Study|Withdrawal by Subject|0|||
126414696|NCT02510001|454812939|FG004|Overall Study|Withdrawal by Subject|0|||
126414697|NCT02510001|454812940|FG005|Overall Study|Withdrawal by Subject|0|||
126475866|NCT00066365|455041231|FG001|Overall Study|Lack of Efficacy|12|||
126475867|NCT00066365|455041230|FG000|Overall Study|Physician Decision|1|||
126475868|NCT00066365|455041231|FG001|Overall Study|Physician Decision|0|||
126721657|NCT03136185|455930032|FG008|Overall Study|Protocol Defined Disease Progression|1|||
126721658|NCT03136185|455930024|FG000|Overall Study|Withdrawal by Subject|1|||
126721659|NCT03136185|455930025|FG001|Overall Study|Withdrawal by Subject|0|||
126414698|NCT02510001|454812941|FG006|Overall Study|Withdrawal by Subject|0|||
126721660|NCT03136185|455930026|FG002|Overall Study|Withdrawal by Subject|1|||
126414699|NCT02510001|454812942|FG007|Overall Study|Withdrawal by Subject|2|||
126414700|NCT00303485|454812946|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
126414701|NCT00303485|454812947|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
126414702|NCT00303485|454812946|FG000|Overall Study|Failure to return|0|||
126414703|NCT00303485|454812947|FG001|Overall Study|Failure to return|1|||
126414704|NCT00303485|454812946|FG000|Overall Study|Withdrawal by Subject|1|||
126475869|NCT00066365|455041230|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
126475870|NCT00066365|455041231|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
126414705|NCT00303485|454812947|FG001|Overall Study|Withdrawal by Subject|0|||
126414706|NCT01363908|454812956|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
126414707|NCT01363908|454812957|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
126414708|NCT01363908|454812956|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
126414709|NCT01363908|454812957|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
126414710|NCT01363908|454812956|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
126414711|NCT01363908|454812957|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
126414712|NCT01363908|454812956|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
126414713|NCT01363908|454812957|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
126414714|NCT02644343|454812958|FG000|Overall Study|Withdrawal by Subject|1|||
126414715|NCT03437577|454812959|FG000|Pre-Randomization|Withdrawal by Subject|0|||
126414716|NCT03437577|454812960|FG001|Pre-Randomization|Withdrawal by Subject|0|||
126414717|NCT03437577|454812961|FG002|Pre-Randomization|Withdrawal by Subject|10|||
126414718|NCT03437577|454812959|FG000|Post-Randomization|Physician Decision|0|||
126414719|NCT03437577|454812960|FG001|Post-Randomization|Physician Decision|2|||
126414720|NCT03437577|454812961|FG002|Post-Randomization|Physician Decision|0|||
126414721|NCT04878211|454812962|FG000|Overall Study|Lost to Follow-up|0|||
126414722|NCT04878211|454812963|FG001|Overall Study|Lost to Follow-up|0|||
126414723|NCT04878211|454812964|FG002|Overall Study|Lost to Follow-up|0|||
126414724|NCT04878211|454812965|FG003|Overall Study|Lost to Follow-up|1|||
126414725|NCT04878211|454812966|FG004|Overall Study|Lost to Follow-up|0|||
126414726|NCT04878211|454812967|FG005|Overall Study|Lost to Follow-up|1|||
126414727|NCT04878211|454812962|FG000|Overall Study|Protocol deviation|1|||
126414728|NCT04878211|454812963|FG001|Overall Study|Protocol deviation|0|||
126414729|NCT04878211|454812964|FG002|Overall Study|Protocol deviation|0|||
126414730|NCT04878211|454812965|FG003|Overall Study|Protocol deviation|0|||
126414731|NCT04878211|454812966|FG004|Overall Study|Protocol deviation|0|||
126414732|NCT04878211|454812967|FG005|Overall Study|Protocol deviation|0|||
126414733|NCT04878211|454812962|FG000|Overall Study|Study terminated by sponsor|0|||
126414734|NCT04878211|454812963|FG001|Overall Study|Study terminated by sponsor|0|||
126414735|NCT04878211|454812964|FG002|Overall Study|Study terminated by sponsor|0|||
126414736|NCT04878211|454812965|FG003|Overall Study|Study terminated by sponsor|0|||
126414737|NCT04878211|454812966|FG004|Overall Study|Study terminated by sponsor|9|||
126414738|NCT04878211|454812967|FG005|Overall Study|Study terminated by sponsor|4|||
126414739|NCT04878211|454812962|FG000|Overall Study|Subject decision|0|||
126414740|NCT04878211|454812963|FG001|Overall Study|Subject decision|0|||
126414741|NCT04878211|454812964|FG002|Overall Study|Subject decision|0|||
126414742|NCT04878211|454812965|FG003|Overall Study|Subject decision|0|||
126414743|NCT04878211|454812966|FG004|Overall Study|Subject decision|1|||
126414744|NCT04878211|454812967|FG005|Overall Study|Subject decision|0|||
126414745|NCT04774926|454812974|FG000|Overall Study|Adverse Event|15|||
126414746|NCT04774926|454812974|FG000|Overall Study|Lost to Follow-up|3|||
126414747|NCT04774926|454812974|FG000|Overall Study|Physician Decision|6|||
126414748|NCT04774926|454812974|FG000|Overall Study|Withdrawal by Subject|3|||
126414749|NCT04774926|454812974|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
126414750|NCT02783599|454812975|FG000|Overall Study|Progressive disease|23|||
126414751|NCT02783599|454812975|FG000|Overall Study|Surgical Resection|10|||
126414752|NCT02783599|454812975|FG000|Overall Study|Adverse Event|4|||
126414753|NCT02783599|454812975|FG000|Overall Study|Physician Decision|2|||
126414754|NCT02783599|454812975|FG000|Overall Study|Death|1|||
126414755|NCT00787189|454812976|FG000|Overall Study|Lost to Follow-up|2|||
126414756|NCT00787189|454812977|FG001|Overall Study|Lost to Follow-up|2|||
126414757|NCT00847886|454812978|FG000|Overall Study|Adverse Event|0|||
126414758|NCT00847886|454812979|FG001|Overall Study|Adverse Event|1|||
126414759|NCT03920254|454812984|FG000|Overall Study|Adverse Event|1|||
126414760|NCT03920254|454812985|FG001|Overall Study|Adverse Event|0|||
126414761|NCT03920254|454812986|FG002|Overall Study|Adverse Event|0|||
126414762|NCT03920254|454812984|FG000|Overall Study|Physician Decision|0|||
126414763|NCT03920254|454812985|FG001|Overall Study|Physician Decision|1|||
126414764|NCT03920254|454812986|FG002|Overall Study|Physician Decision|2|||
126414765|NCT03920254|454812984|FG000|Overall Study|Study Terminated By Sponsor|12|||
126414766|NCT03920254|454812985|FG001|Overall Study|Study Terminated By Sponsor|17|||
126414767|NCT03920254|454812986|FG002|Overall Study|Study Terminated By Sponsor|12|||
126414768|NCT03920254|454812984|FG000|Overall Study|Withdrawal by Subject|0|||
126414769|NCT03920254|454812985|FG001|Overall Study|Withdrawal by Subject|0|||
126414770|NCT03920254|454812986|FG002|Overall Study|Withdrawal by Subject|1|||
126414771|NCT05274269|454812987|FG000|Overall Study|Adverse Event|0|||
126414772|NCT05274269|454812988|FG001|Overall Study|Adverse Event|3|||
126721661|NCT03136185|455930027|FG003|Overall Study|Withdrawal by Subject|1|||
126414773|NCT05274269|454812987|FG000|Overall Study|Death|0|||
126414774|NCT05274269|454812988|FG001|Overall Study|Death|1|||
126414775|NCT05274269|454812987|FG000|Overall Study|Other|0|||
126414776|NCT05274269|454812988|FG001|Overall Study|Other|2|||
126414777|NCT05274269|454812987|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
126414778|NCT05274269|454812988|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
126414779|NCT03078855|454812989|FG000|Overall Study|Lack of Efficacy|62|||
126414780|NCT03078855|454812990|FG001|Overall Study|Lack of Efficacy|31|||
126414781|NCT03078855|454812989|FG000|Overall Study|Death|1|||
126414782|NCT03078855|454812990|FG001|Overall Study|Death|0|||
126721662|NCT03136185|455930028|FG004|Overall Study|Withdrawal by Subject|1|||
126414783|NCT03078855|454812989|FG000|Overall Study|Withdrawal by Subject|12|||
126414784|NCT03078855|454812990|FG001|Overall Study|Withdrawal by Subject|6|||
126414785|NCT03078855|454812989|FG000|Overall Study|Physician Decision|3|||
126414786|NCT03078855|454812990|FG001|Overall Study|Physician Decision|2|||
126414787|NCT03078855|454812989|FG000|Overall Study|Second Malignancy|4|||
126414788|NCT03078855|454812990|FG001|Overall Study|Second Malignancy|0|||
126414789|NCT03078855|454812989|FG000|Overall Study|Ineligible|2|||
126414790|NCT03078855|454812990|FG001|Overall Study|Ineligible|0|||
126414791|NCT03078855|454812989|FG000|Overall Study|Withdrew before day 1 treatment|2|||
126414792|NCT03078855|454812990|FG001|Overall Study|Withdrew before day 1 treatment|1|||
126414793|NCT00391027|454812992|FG000|Overall Study|Adverse Event|8|||
126414794|NCT00391027|454812993|FG001|Overall Study|Adverse Event|8|||
126414795|NCT00391027|454812992|FG000|Overall Study|Lack of Efficacy|3|||
126414796|NCT00391027|454812993|FG001|Overall Study|Lack of Efficacy|0|||
126414797|NCT00391027|454812992|FG000|Overall Study|Withdrawal by Subject|10|||
126414798|NCT00391027|454812993|FG001|Overall Study|Withdrawal by Subject|1|||
126414799|NCT00391027|454812992|FG000|Overall Study|Other|4|||
126414800|NCT00391027|454812993|FG001|Overall Study|Other|3|||
126414801|NCT04124705|454812996|FG000|Titration Period|Adverse Event|9|||
126414802|NCT04124705|454812997|FG001|Titration Period|Adverse Event|5|||
126475871|NCT00066365|455041230|FG000|Overall Study|Ineligible|4|||
126475872|NCT00066365|455041231|FG001|Overall Study|Ineligible|2|||
126475873|NCT00788073|455041233|FG000|STX209 Then Placebo|Adverse Event|1|||
126475874|NCT00788073|455041234|FG001|STX209 Then Placebo|Adverse Event|0|||
126475875|NCT00788073|455041233|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
126475876|NCT00788073|455041234|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
126475877|NCT00788073|455041233|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
126475878|NCT00788073|455041234|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
126475879|NCT00788073|455041233|FG000|STX209 Then Placebo|unable to return due to travel|0|||
126475880|NCT00788073|455041234|FG001|STX209 Then Placebo|unable to return due to travel|1|||
126475881|NCT00788073|455041233|FG000|Placebo Then STX209|Adverse Event|2|||
126475882|NCT00788073|455041234|FG001|Placebo Then STX209|Adverse Event|0|||
126475883|NCT00788073|455041233|FG000|Placebo Then STX209|Protocol Violation|0|||
126475884|NCT00788073|455041234|FG001|Placebo Then STX209|Protocol Violation|1|||
126475885|NCT03608254|455041235|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
126475886|NCT03608254|455041235|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
126475887|NCT02058693|455041244|FG000|Phase 1|Withdrawal by Subject|3|||
126475888|NCT02058693|455041245|FG001|Phase 1|Withdrawal by Subject|2|||
126475889|NCT02058693|455041244|FG000|Phase 1|Adverse Event|0|||
126475890|NCT02058693|455041245|FG001|Phase 1|Adverse Event|1|||
126475891|NCT02058693|455041244|FG000|Phase 1|Lack of Efficacy|1|||
126475892|NCT02058693|455041245|FG001|Phase 1|Lack of Efficacy|0|||
126475893|NCT02058693|455041244|FG000|Phase 1|Physician Decision|1|||
126475894|NCT02058693|455041245|FG001|Phase 1|Physician Decision|1|||
126475895|NCT02058693|455041244|FG000|Phase 2|Withdrawal by Subject|0|||
126475896|NCT02058693|455041245|FG001|Phase 2|Withdrawal by Subject|2|||
126475897|NCT00722800|455041246|FG000|Overall Study|Withdrawal by Subject|1|||
126475898|NCT00722800|455041247|FG001|Overall Study|Withdrawal by Subject|0|||
126475899|NCT00722800|455041246|FG000|Overall Study|Physician Decision|1|||
126475900|NCT00722800|455041247|FG001|Overall Study|Physician Decision|0|||
126475901|NCT01449539|455041248|FG000|Overall Study|Withdrawal by Subject|3|||
126475902|NCT01449539|455041248|FG000|Overall Study|Toxicity not study related|1|||
126475903|NCT01972568|455041249|FG000|Overall Study|Other events|3|||
126475904|NCT01972568|455041250|FG001|Overall Study|Other events|0|||
126475905|NCT01972568|455041251|FG002|Overall Study|Other events|0|||
126475906|NCT01972568|455041249|FG000|Overall Study|Lack of Efficacy|0|||
126475907|NCT01972568|455041250|FG001|Overall Study|Lack of Efficacy|1|||
126475908|NCT01972568|455041251|FG002|Overall Study|Lack of Efficacy|2|||
126475909|NCT01972568|455041249|FG000|Overall Study|Protocol Violation|1|||
126475910|NCT01972568|455041250|FG001|Overall Study|Protocol Violation|2|||
126414803|NCT04124705|454812996|FG000|Titration Period|Withdrawal by Subject|6|||
126414804|NCT04124705|454812997|FG001|Titration Period|Withdrawal by Subject|3|||
126414805|NCT04124705|454812996|FG000|Titration Period|Lost to Follow-up|0|||
126414806|NCT04124705|454812997|FG001|Titration Period|Lost to Follow-up|1|||
126414807|NCT04124705|454812996|FG000|Titration Period|Death|1|||
126475911|NCT01972568|455041251|FG002|Overall Study|Protocol Violation|2|||
126475912|NCT01972568|455041249|FG000|Overall Study|Withdrawal by Subject|6|||
126475913|NCT01972568|455041250|FG001|Overall Study|Withdrawal by Subject|3|||
126475914|NCT01972568|455041251|FG002|Overall Study|Withdrawal by Subject|7|||
126475915|NCT01972568|455041249|FG000|Overall Study|Lost to Follow-up|1|||
126475916|NCT01972568|455041250|FG001|Overall Study|Lost to Follow-up|0|||
126475917|NCT01972568|455041251|FG002|Overall Study|Lost to Follow-up|0|||
126475918|NCT01972568|455041249|FG000|Overall Study|Adverse Event|5|||
126414808|NCT04124705|454812997|FG001|Titration Period|Death|1|||
126475919|NCT01972568|455041250|FG001|Overall Study|Adverse Event|6|||
126475920|NCT01972568|455041251|FG002|Overall Study|Adverse Event|5|||
126475921|NCT02572401|455041252|FG000|Overall Study|Lost to Follow-up|5|||
126475922|NCT02572401|455041253|FG001|Overall Study|Lost to Follow-up|8|||
126475923|NCT02572401|455041254|FG002|Overall Study|Lost to Follow-up|9|||
126475924|NCT02572401|455041255|FG003|Overall Study|Lost to Follow-up|9|||
126475925|NCT02572401|455041252|FG000|Overall Study|Death|0|||
126475926|NCT02572401|455041253|FG001|Overall Study|Death|0|||
126475927|NCT02572401|455041254|FG002|Overall Study|Death|0|||
126475928|NCT02572401|455041255|FG003|Overall Study|Death|1|||
126475929|NCT00306189|455041256|FG000|Overall Study|Physician Decision|0|||
126475930|NCT00306189|455041257|FG001|Overall Study|Physician Decision|0|||
126475931|NCT00306189|455041258|FG002|Overall Study|Physician Decision|0|||
126475932|NCT00306189|455041259|FG003|Overall Study|Physician Decision|1|||
126475933|NCT00306189|455041256|FG000|Overall Study|Adverse Event|3|||
126475934|NCT00306189|455041257|FG001|Overall Study|Adverse Event|3|||
126475935|NCT00306189|455041258|FG002|Overall Study|Adverse Event|2|||
126475936|NCT00306189|455041259|FG003|Overall Study|Adverse Event|2|||
126475937|NCT00306189|455041256|FG000|Overall Study|Withdrawal by Subject|4|||
126475938|NCT00306189|455041257|FG001|Overall Study|Withdrawal by Subject|2|||
126475939|NCT00306189|455041258|FG002|Overall Study|Withdrawal by Subject|8|||
126475940|NCT00306189|455041259|FG003|Overall Study|Withdrawal by Subject|1|||
126475941|NCT00306189|455041256|FG000|Overall Study|Ineligibility determined|1|||
126475942|NCT00306189|455041257|FG001|Overall Study|Ineligibility determined|1|||
126475943|NCT00306189|455041258|FG002|Overall Study|Ineligibility determined|1|||
126475944|NCT00306189|455041259|FG003|Overall Study|Ineligibility determined|1|||
126475945|NCT00306189|455041256|FG000|Overall Study|Other|1|||
126475946|NCT00306189|455041257|FG001|Overall Study|Other|0|||
126475947|NCT00306189|455041258|FG002|Overall Study|Other|0|||
126475948|NCT00306189|455041259|FG003|Overall Study|Other|0|||
126475949|NCT00945893|455041260|FG000|Overall Study|Lost to Follow-up|2|||
126475950|NCT00945893|455041261|FG001|Overall Study|Lost to Follow-up|8|||
126475951|NCT00945893|455041260|FG000|Overall Study|Withdrawal of consent|1|||
126475952|NCT00945893|455041261|FG001|Overall Study|Withdrawal of consent|2|||
126475953|NCT01187433|455041262|FG000|Overall Study|Protocol Violation|6|||
126475954|NCT01187433|455041263|FG001|Overall Study|Protocol Violation|2|||
126475955|NCT01187433|455041262|FG000|Overall Study|Withdrawal by Subject|5|||
126475956|NCT01187433|455041263|FG001|Overall Study|Withdrawal by Subject|2|||
126475957|NCT00672646|455041267|FG000|Overall Study|Lost to Follow-up|0|||
126475958|NCT00672646|455041268|FG001|Overall Study|Lost to Follow-up|1|||
126475959|NCT00672646|455041269|FG002|Overall Study|Lost to Follow-up|2|||
126475960|NCT00672646|455041267|FG000|Overall Study|Withdrawal by Subject|0|||
126475961|NCT00672646|455041268|FG001|Overall Study|Withdrawal by Subject|0|||
126475962|NCT00672646|455041269|FG002|Overall Study|Withdrawal by Subject|1|||
126475963|NCT00142298|455041272|FG000|Overall Study|Adverse Event|10|||
126475964|NCT00142298|455041273|FG001|Overall Study|Adverse Event|10|||
126475965|NCT00142298|455041274|FG002|Overall Study|Adverse Event|1|||
126475966|NCT00142298|455041275|FG003|Overall Study|Adverse Event|5|||
126475967|NCT00142298|455041276|FG004|Overall Study|Adverse Event|2|||
126475968|NCT00142298|455041277|FG005|Overall Study|Adverse Event|2|||
126475969|NCT00142298|455041278|FG006|Overall Study|Adverse Event|0|||
126475970|NCT00142298|455041279|FG007|Overall Study|Adverse Event|0|||
126475971|NCT00142298|455041280|FG008|Overall Study|Adverse Event|0|||
126475972|NCT00142298|455041281|FG009|Overall Study|Adverse Event|0|||
126475973|NCT00142298|455041272|FG000|Overall Study|Clinical disease progression|1|||
126475974|NCT00142298|455041273|FG001|Overall Study|Clinical disease progression|0|||
126475975|NCT00142298|455041274|FG002|Overall Study|Clinical disease progression|0|||
126475976|NCT00142298|455041275|FG003|Overall Study|Clinical disease progression|0|||
126475977|NCT00142298|455041276|FG004|Overall Study|Clinical disease progression|0|||
126475978|NCT00142298|455041277|FG005|Overall Study|Clinical disease progression|0|||
126475979|NCT00142298|455041278|FG006|Overall Study|Clinical disease progression|0|||
126475980|NCT00142298|455041279|FG007|Overall Study|Clinical disease progression|0|||
126475981|NCT00142298|455041280|FG008|Overall Study|Clinical disease progression|0|||
126475982|NCT00142298|455041281|FG009|Overall Study|Clinical disease progression|0|||
126475983|NCT00142298|455041272|FG000|Overall Study|Death|1|||
126475984|NCT00142298|455041273|FG001|Overall Study|Death|1|||
126475985|NCT00142298|455041274|FG002|Overall Study|Death|1|||
126475986|NCT00142298|455041275|FG003|Overall Study|Death|0|||
126475987|NCT00142298|455041276|FG004|Overall Study|Death|0|||
126475988|NCT00142298|455041277|FG005|Overall Study|Death|6|||
126721663|NCT03136185|455930029|FG005|Overall Study|Withdrawal by Subject|1|||
126721664|NCT03136185|455930030|FG006|Overall Study|Withdrawal by Subject|2|||
126721665|NCT03136185|455930031|FG007|Overall Study|Withdrawal by Subject|3|||
126475989|NCT00142298|455041278|FG006|Overall Study|Death|0|||
126475990|NCT00142298|455041279|FG007|Overall Study|Death|0|||
126475991|NCT00142298|455041280|FG008|Overall Study|Death|0|||
126475992|NCT00142298|455041281|FG009|Overall Study|Death|0|||
126475993|NCT00142298|455041272|FG000|Overall Study|Lack of Efficacy|44|||
126475994|NCT00142298|455041273|FG001|Overall Study|Lack of Efficacy|62|||
126475995|NCT00142298|455041274|FG002|Overall Study|Lack of Efficacy|9|||
126475996|NCT00142298|455041275|FG003|Overall Study|Lack of Efficacy|12|||
126475997|NCT00142298|455041276|FG004|Overall Study|Lack of Efficacy|1|||
126475998|NCT00142298|455041277|FG005|Overall Study|Lack of Efficacy|0|||
126475999|NCT00142298|455041278|FG006|Overall Study|Lack of Efficacy|0|||
126558953|NCT01254305|455340585|FG002|Overall Study|Other Reasons|2|||
126414809|NCT04124705|454812996|FG000|Titration Period|Lack of Efficacy|2|||
126414810|NCT04124705|454812997|FG001|Titration Period|Lack of Efficacy|0|||
126414811|NCT04124705|454812996|FG000|Titration Period|Physician Decision|2|||
126414812|NCT04124705|454812997|FG001|Titration Period|Physician Decision|0|||
126414813|NCT04124705|454812996|FG000|Titration Period|Non-compliance with Study Drug|2|||
126414814|NCT04124705|454812997|FG001|Titration Period|Non-compliance with Study Drug|0|||
126414815|NCT04124705|454812996|FG000|Titration Period|Other|4|||
126414816|NCT04124705|454812997|FG001|Titration Period|Other|9|||
126414817|NCT04124705|454812996|FG000|Stabilization Period|Adverse Event|4|||
126414818|NCT04124705|454812997|FG001|Stabilization Period|Adverse Event|2|||
126414819|NCT04124705|454812996|FG000|Stabilization Period|Withdrawal by Subject|1|||
126414820|NCT04124705|454812997|FG001|Stabilization Period|Withdrawal by Subject|1|||
126414821|NCT04124705|454812996|FG000|Stabilization Period|Lost to Follow-up|0|||
126414822|NCT04124705|454812997|FG001|Stabilization Period|Lost to Follow-up|1|||
126414823|NCT04124705|454812996|FG000|Stabilization Period|Lack of Efficacy|4|||
126414824|NCT04124705|454812997|FG001|Stabilization Period|Lack of Efficacy|2|||
126414825|NCT04124705|454812996|FG000|Stabilization Period|Protocol Deviation|0|||
126414826|NCT04124705|454812997|FG001|Stabilization Period|Protocol Deviation|2|||
126414827|NCT04124705|454812996|FG000|Stabilization Period|Other|2|||
126414828|NCT04124705|454812997|FG001|Stabilization Period|Other|2|||
126414829|NCT01973998|454812998|FG000|Overall Study|Death|2|||
126414830|NCT01973998|454812999|FG001|Overall Study|Death|2|||
126414831|NCT04302545|454813002|FG000|Overall Study|Lost to Follow-up|3|||
126414832|NCT04302545|454813003|FG001|Overall Study|Lost to Follow-up|4|||
126414833|NCT01636986|454813007|FG000|Overall Study|Withdrawal by Subject|0|||
126414834|NCT01636986|454813008|FG001|Overall Study|Withdrawal by Subject|1|||
126414835|NCT01636986|454813007|FG000|Overall Study|Corneal Staining|0|||
126414836|NCT01636986|454813008|FG001|Overall Study|Corneal Staining|1|||
126414837|NCT02106403|454813013|FG000|Follow-Up Visit 3|Other Reason|0|||
126414838|NCT02106403|454813014|FG001|Follow-Up Visit 3|Other Reason|0|||
126414839|NCT02106403|454813015|FG002|Follow-Up Visit 3|Other Reason|0|||
126414840|NCT02106403|454813016|FG003|Follow-Up Visit 3|Other Reason|0|||
126414841|NCT02106403|454813017|FG004|Follow-Up Visit 3|Other Reason|0|||
126414842|NCT02106403|454813018|FG005|Follow-Up Visit 3|Other Reason|1|||
126414843|NCT04038567|454813020|FG000|Overall Study|Lost to Follow-up|6|||
126414844|NCT04038567|454813021|FG001|Overall Study|Lost to Follow-up|4|||
126414845|NCT04038567|454813022|FG002|Overall Study|Lost to Follow-up|5|||
126414846|NCT04038567|454813023|FG003|Overall Study|Lost to Follow-up|4|||
126414847|NCT04038567|454813024|FG004|Overall Study|Lost to Follow-up|6|||
126414848|NCT04038567|454813025|FG005|Overall Study|Lost to Follow-up|4|||
126414849|NCT04038567|454813026|FG006|Overall Study|Lost to Follow-up|4|||
126414850|NCT04038567|454813027|FG007|Overall Study|Lost to Follow-up|1|||
126414851|NCT04038567|454813020|FG000|Overall Study|Withdrawal by Subject|2|||
126414852|NCT04038567|454813021|FG001|Overall Study|Withdrawal by Subject|1|||
126414853|NCT04038567|454813022|FG002|Overall Study|Withdrawal by Subject|1|||
126414854|NCT04038567|454813023|FG003|Overall Study|Withdrawal by Subject|1|||
126414855|NCT04038567|454813024|FG004|Overall Study|Withdrawal by Subject|4|||
126414856|NCT04038567|454813025|FG005|Overall Study|Withdrawal by Subject|1|||
126414857|NCT04038567|454813026|FG006|Overall Study|Withdrawal by Subject|1|||
126414858|NCT04038567|454813027|FG007|Overall Study|Withdrawal by Subject|1|||
126476000|NCT00142298|455041279|FG007|Overall Study|Lack of Efficacy|1|||
126476001|NCT00142298|455041280|FG008|Overall Study|Lack of Efficacy|0|||
126476002|NCT00142298|455041281|FG009|Overall Study|Lack of Efficacy|0|||
126476003|NCT00142298|455041272|FG000|Overall Study|Non-compliance|15|||
126476004|NCT00142298|455041273|FG001|Overall Study|Non-compliance|13|||
126476005|NCT00142298|455041274|FG002|Overall Study|Non-compliance|0|||
126476006|NCT00142298|455041275|FG003|Overall Study|Non-compliance|6|||
126476007|NCT00142298|455041276|FG004|Overall Study|Non-compliance|1|||
126476008|NCT00142298|455041277|FG005|Overall Study|Non-compliance|0|||
126476009|NCT00142298|455041278|FG006|Overall Study|Non-compliance|0|||
126476010|NCT00142298|455041279|FG007|Overall Study|Non-compliance|3|||
126476011|NCT00142298|455041280|FG008|Overall Study|Non-compliance|3|||
126476012|NCT00142298|455041281|FG009|Overall Study|Non-compliance|0|||
126414859|NCT04038567|454813020|FG000|Overall Study|missed survey window|1|||
126414860|NCT04038567|454813021|FG001|Overall Study|missed survey window|2|||
126414861|NCT04038567|454813022|FG002|Overall Study|missed survey window|0|||
126414862|NCT04038567|454813023|FG003|Overall Study|missed survey window|0|||
126414863|NCT04038567|454813024|FG004|Overall Study|missed survey window|1|||
126414864|NCT04038567|454813025|FG005|Overall Study|missed survey window|1|||
126476013|NCT00142298|455041272|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
126476014|NCT00142298|455041273|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
126476015|NCT00142298|455041274|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
126476016|NCT00142298|455041275|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
126772336|NCT01466673|456122090|FG000|Overall Study|Adverse Event|2|||
126414865|NCT04038567|454813026|FG006|Overall Study|missed survey window|2|||
126414866|NCT04038567|454813027|FG007|Overall Study|missed survey window|2|||
126414867|NCT04038567|454813020|FG000|Overall Study|technical issues|0|||
126414868|NCT04038567|454813021|FG001|Overall Study|technical issues|0|||
126558954|NCT02703532|455340586|FG000|Overall Study|Withdrawal by Subject|0|||
126558955|NCT02703532|455340587|FG001|Overall Study|Withdrawal by Subject|1|||
126558956|NCT02703532|455340588|FG002|Overall Study|Withdrawal by Subject|0|||
126558957|NCT02703532|455340589|FG003|Overall Study|Withdrawal by Subject|1|||
126414869|NCT04038567|454813022|FG002|Overall Study|technical issues|0|||
126414870|NCT04038567|454813023|FG003|Overall Study|technical issues|0|||
126414871|NCT04038567|454813024|FG004|Overall Study|technical issues|0|||
126414872|NCT04038567|454813025|FG005|Overall Study|technical issues|0|||
126414873|NCT04038567|454813026|FG006|Overall Study|technical issues|1|||
126414874|NCT04038567|454813027|FG007|Overall Study|technical issues|0|||
126414875|NCT04038567|454813020|FG000|Overall Study|Medical issues (i.e., illness)|0|||
126414876|NCT04038567|454813021|FG001|Overall Study|Medical issues (i.e., illness)|1|||
126414877|NCT04038567|454813022|FG002|Overall Study|Medical issues (i.e., illness)|2|||
126414878|NCT04038567|454813023|FG003|Overall Study|Medical issues (i.e., illness)|1|||
126414879|NCT04038567|454813024|FG004|Overall Study|Medical issues (i.e., illness)|1|||
126414880|NCT04038567|454813025|FG005|Overall Study|Medical issues (i.e., illness)|1|||
126414881|NCT04038567|454813026|FG006|Overall Study|Medical issues (i.e., illness)|0|||
126414882|NCT04038567|454813027|FG007|Overall Study|Medical issues (i.e., illness)|0|||
126414883|NCT04038567|454813020|FG000|Overall Study|Death|0|||
126414884|NCT04038567|454813021|FG001|Overall Study|Death|0|||
126414885|NCT04038567|454813022|FG002|Overall Study|Death|0|||
126414886|NCT04038567|454813023|FG003|Overall Study|Death|1|||
126414887|NCT04038567|454813024|FG004|Overall Study|Death|1|||
126414888|NCT04038567|454813025|FG005|Overall Study|Death|0|||
126414889|NCT04038567|454813026|FG006|Overall Study|Death|0|||
126414890|NCT04038567|454813027|FG007|Overall Study|Death|1|||
126414891|NCT01496846|454813031|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
126414892|NCT01496846|454813032|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
126414893|NCT01496846|454813033|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
126414894|NCT01496846|454813034|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
126414895|NCT01496846|454813035|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
126414896|NCT01496846|454813036|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
126414897|NCT01772576|454813039|FG000|Overall Study|Death|15|||
126414898|NCT01772576|454813039|FG000|Overall Study|Protocol Violation|1|||
126414899|NCT01772576|454813039|FG000|Overall Study|Lost to Follow-up|3|||
126414900|NCT01772576|454813039|FG000|Overall Study|Study device not used|3|||
126414901|NCT01772576|454813039|FG000|Overall Study|Adverse Event|6|||
126414902|NCT01772576|454813039|FG000|Overall Study|Withdrawal by Subject|6|||
126414903|NCT00923845|454813040|FG000|Induction Therapy|Poor performance status|0|||
126414904|NCT00923845|454813041|FG001|Induction Therapy|Poor performance status|2|||
126414905|NCT01534195|454813048|FG000|Overall Study|Withdrawal by Subject|1|||
126414906|NCT01534195|454813049|FG001|Overall Study|Withdrawal by Subject|1|||
126414907|NCT03052816|454813052|FG000|Overall Study|Withdrawal by Subject|1|||
126414908|NCT03052816|454813053|FG001|Overall Study|Withdrawal by Subject|0|||
126414909|NCT03052816|454813052|FG000|Overall Study|Desired opioids|2|||
126414910|NCT03052816|454813053|FG001|Overall Study|Desired opioids|0|||
126414911|NCT01278797|454813054|FG000|Period 1|Adverse Event|0|||
126414912|NCT01278797|454813055|FG001|Period 1|Adverse Event|1|||
126414913|NCT01278797|454813054|FG000|Period 1|Protocol Violation|1|||
126414914|NCT01278797|454813055|FG001|Period 1|Protocol Violation|0|||
126414915|NCT00895453|454813056|FG000|Overall Study|Lost to Follow-up|25|||
126414916|NCT00895453|454813057|FG001|Overall Study|Lost to Follow-up|25|||
126414917|NCT00895453|454813058|FG002|Overall Study|Lost to Follow-up|23|||
126414918|NCT01736618|454813060|FG000|Overall Study|Death|294|||
126414919|NCT01736618|454813060|FG000|Overall Study|Lost to Follow-up|193|||
126414920|NCT01736618|454813060|FG000|Overall Study|Withdrawal by Subject|54|||
126414921|NCT01736618|454813060|FG000|Overall Study|Subject unable to be followed at study location|223|||
126414922|NCT01736618|454813060|FG000|Overall Study|Physician Decision|33|||
126414923|NCT01736618|454813060|FG000|Overall Study|Transplant or removal of target organ|19|||
126414924|NCT01736618|454813060|FG000|Overall Study|Change in indication or condition|78|||
126414925|NCT01736618|454813060|FG000|Overall Study|Study device explant|103|||
126558958|NCT02703532|455340586|FG000|Overall Study|Lost to Follow-up|2|||
126414926|NCT01736618|454813060|FG000|Overall Study|Unable to complete implant|2|||
126414927|NCT00400569|454813065|FG000|Overall Study|Death|1|||
126414928|NCT00620113|454813068|FG000|Overall Study|Adverse Event|3|||
126414929|NCT00620113|454813069|FG001|Overall Study|Adverse Event|2|||
126414930|NCT00620113|454813070|FG002|Overall Study|Adverse Event|2|||
126414931|NCT00620113|454813071|FG003|Overall Study|Adverse Event|1|||
126414932|NCT00620113|454813068|FG000|Overall Study|Lack of Efficacy|2|||
126414933|NCT00620113|454813069|FG001|Overall Study|Lack of Efficacy|3|||
126558959|NCT02703532|455340587|FG001|Overall Study|Lost to Follow-up|0|||
126558960|NCT02703532|455340588|FG002|Overall Study|Lost to Follow-up|2|||
126558961|NCT02703532|455340589|FG003|Overall Study|Lost to Follow-up|0|||
126414934|NCT00620113|454813070|FG002|Overall Study|Lack of Efficacy|0|||
126414935|NCT00620113|454813071|FG003|Overall Study|Lack of Efficacy|2|||
126414936|NCT00620113|454813068|FG000|Overall Study|Physician Decision|1|||
126414937|NCT00620113|454813069|FG001|Overall Study|Physician Decision|0|||
126476017|NCT00142298|455041276|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
126476018|NCT00142298|455041277|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
126476019|NCT00142298|455041278|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
126476020|NCT00142298|455041279|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
126476021|NCT00142298|455041280|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
126476022|NCT00142298|455041281|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
126476023|NCT00142298|455041272|FG000|Overall Study|Pregnancy|4|||
126476024|NCT00142298|455041273|FG001|Overall Study|Pregnancy|4|||
126476025|NCT00142298|455041274|FG002|Overall Study|Pregnancy|2|||
126476026|NCT00142298|455041275|FG003|Overall Study|Pregnancy|3|||
126476027|NCT00142298|455041276|FG004|Overall Study|Pregnancy|0|||
126476028|NCT00142298|455041277|FG005|Overall Study|Pregnancy|0|||
126476029|NCT00142298|455041278|FG006|Overall Study|Pregnancy|0|||
126476030|NCT00142298|455041279|FG007|Overall Study|Pregnancy|0|||
126476031|NCT00142298|455041280|FG008|Overall Study|Pregnancy|1|||
126476032|NCT00142298|455041281|FG009|Overall Study|Pregnancy|0|||
126476033|NCT00142298|455041272|FG000|Overall Study|Virologic breakthrough|19|||
126476034|NCT00142298|455041273|FG001|Overall Study|Virologic breakthrough|23|||
126476035|NCT00142298|455041274|FG002|Overall Study|Virologic breakthrough|9|||
126476036|NCT00142298|455041275|FG003|Overall Study|Virologic breakthrough|7|||
126476037|NCT00142298|455041276|FG004|Overall Study|Virologic breakthrough|2|||
126476038|NCT00142298|455041277|FG005|Overall Study|Virologic breakthrough|3|||
126476039|NCT00142298|455041278|FG006|Overall Study|Virologic breakthrough|3|||
126476040|NCT00142298|455041279|FG007|Overall Study|Virologic breakthrough|0|||
126476041|NCT00142298|455041280|FG008|Overall Study|Virologic breakthrough|0|||
126476042|NCT00142298|455041281|FG009|Overall Study|Virologic breakthrough|0|||
126476043|NCT00142298|455041272|FG000|Overall Study|Other- not specified|0|||
126476044|NCT00142298|455041273|FG001|Overall Study|Other- not specified|3|||
126476045|NCT00142298|455041274|FG002|Overall Study|Other- not specified|0|||
126476046|NCT00142298|455041275|FG003|Overall Study|Other- not specified|1|||
126476047|NCT00142298|455041276|FG004|Overall Study|Other- not specified|0|||
126476048|NCT00142298|455041277|FG005|Overall Study|Other- not specified|0|||
126476049|NCT00142298|455041278|FG006|Overall Study|Other- not specified|0|||
126476050|NCT00142298|455041279|FG007|Overall Study|Other- not specified|0|||
126476051|NCT00142298|455041280|FG008|Overall Study|Other- not specified|0|||
126476052|NCT00142298|455041281|FG009|Overall Study|Other- not specified|0|||
126476053|NCT00142298|455041272|FG000|Overall Study|Lost to Follow-up|0|||
126476054|NCT00142298|455041273|FG001|Overall Study|Lost to Follow-up|0|||
126476055|NCT00142298|455041274|FG002|Overall Study|Lost to Follow-up|0|||
126476056|NCT00142298|455041275|FG003|Overall Study|Lost to Follow-up|0|||
126476057|NCT00142298|455041276|FG004|Overall Study|Lost to Follow-up|0|||
126476058|NCT00142298|455041277|FG005|Overall Study|Lost to Follow-up|0|||
126476059|NCT00142298|455041278|FG006|Overall Study|Lost to Follow-up|2|||
126476060|NCT00142298|455041279|FG007|Overall Study|Lost to Follow-up|0|||
126476061|NCT00142298|455041280|FG008|Overall Study|Lost to Follow-up|0|||
126476062|NCT00142298|455041281|FG009|Overall Study|Lost to Follow-up|0|||
126476063|NCT00142298|455041272|FG000|Overall Study|Treatment Failure|0|||
126476064|NCT00142298|455041273|FG001|Overall Study|Treatment Failure|0|||
126476065|NCT00142298|455041274|FG002|Overall Study|Treatment Failure|0|||
126476066|NCT00142298|455041275|FG003|Overall Study|Treatment Failure|0|||
126476067|NCT00142298|455041276|FG004|Overall Study|Treatment Failure|0|||
126476068|NCT00142298|455041277|FG005|Overall Study|Treatment Failure|2|||
126476069|NCT00142298|455041278|FG006|Overall Study|Treatment Failure|2|||
126476070|NCT00142298|455041279|FG007|Overall Study|Treatment Failure|0|||
126476071|NCT00142298|455041280|FG008|Overall Study|Treatment Failure|0|||
126476072|NCT00142298|455041281|FG009|Overall Study|Treatment Failure|0|||
126476073|NCT00242216|455041282|FG000|Overall Study|Lost to Follow-up|12|||
126476074|NCT00242216|455041283|FG001|Overall Study|Lost to Follow-up|17|||
126476075|NCT00242216|455041282|FG000|Overall Study|Death|4|||
126476076|NCT00242216|455041283|FG001|Overall Study|Death|2|||
126476077|NCT00242216|455041282|FG000|Overall Study|Lack of Efficacy|1|||
126476078|NCT00242216|455041283|FG001|Overall Study|Lack of Efficacy|2|||
126476079|NCT00242216|455041282|FG000|Overall Study|no medicaiton dispensed|1|||
126476080|NCT00242216|455041283|FG001|Overall Study|no medicaiton dispensed|1|||
126476081|NCT03128047|455041284|FG000|Overall Study|Withdrawal by Subject|1|||
126476082|NCT06956170|455042908|FG000|Overall Study|Death|2|||
126476083|NCT06956170|455042909|FG001|Overall Study|Death|1|||
126476084|NCT06956170|455042908|FG000|Overall Study|Withdrawal by Subject|1|||
126476085|NCT06956170|455042909|FG001|Overall Study|Withdrawal by Subject|0|||
126476086|NCT06956170|455042908|FG000|Overall Study|Ongoing|7|||
126476087|NCT06956170|455042909|FG001|Overall Study|Ongoing|10|||
126476088|NCT02400333|455042910|FG000|Overall Study|Withdrawal by Subject|0|||
126476089|NCT02400333|455042911|FG001|Overall Study|Withdrawal by Subject|1|||
126476090|NCT02400333|455042912|FG002|Overall Study|Withdrawal by Subject|0|||
126476091|NCT02400333|455042913|FG003|Overall Study|Withdrawal by Subject|1|||
126476092|NCT02400333|455042910|FG000|Overall Study|Protocol Violation|1|||
126476093|NCT02400333|455042911|FG001|Overall Study|Protocol Violation|0|||
126476094|NCT02400333|455042912|FG002|Overall Study|Protocol Violation|2|||
126476095|NCT02400333|455042913|FG003|Overall Study|Protocol Violation|1|||
126414938|NCT00620113|454813070|FG002|Overall Study|Physician Decision|0|||
126414939|NCT00620113|454813071|FG003|Overall Study|Physician Decision|2|||
126414940|NCT00620113|454813068|FG000|Overall Study|Protocol Violation|2|||
126414941|NCT00620113|454813069|FG001|Overall Study|Protocol Violation|1|||
126414942|NCT00620113|454813070|FG002|Overall Study|Protocol Violation|0|||
126414943|NCT00620113|454813071|FG003|Overall Study|Protocol Violation|0|||
126414944|NCT00620113|454813068|FG000|Overall Study|Withdrawal by Subject|5|||
126414945|NCT00620113|454813069|FG001|Overall Study|Withdrawal by Subject|1|||
126414946|NCT00620113|454813070|FG002|Overall Study|Withdrawal by Subject|3|||
126414947|NCT00620113|454813071|FG003|Overall Study|Withdrawal by Subject|5|||
126414948|NCT02461745|454813074|FG000|Overall Study|Lack of Efficacy|9|||
126414949|NCT02461745|454813075|FG001|Overall Study|Lack of Efficacy|1|||
126414950|NCT02461745|454813074|FG000|Overall Study|Lost to Follow-up|2|||
126414951|NCT02461745|454813075|FG001|Overall Study|Lost to Follow-up|2|||
126414952|NCT02461745|454813074|FG000|Overall Study|Withdrawal by Subject|3|||
126414953|NCT02461745|454813075|FG001|Overall Study|Withdrawal by Subject|1|||
126414954|NCT00211887|454813078|FG000|Overall Study|Adverse Event|8|||
126414955|NCT00211887|454813079|FG001|Overall Study|Adverse Event|4|||
126414956|NCT00211887|454813080|FG002|Overall Study|Adverse Event|6|||
126414957|NCT00211887|454813078|FG000|Overall Study|Death|1|||
126414958|NCT00211887|454813079|FG001|Overall Study|Death|1|||
126414959|NCT00211887|454813080|FG002|Overall Study|Death|1|||
126414960|NCT00211887|454813078|FG000|Overall Study|Lost to Follow-up|28|||
126414961|NCT00211887|454813079|FG001|Overall Study|Lost to Follow-up|13|||
126414962|NCT00211887|454813080|FG002|Overall Study|Lost to Follow-up|9|||
126414963|NCT00211887|454813078|FG000|Overall Study|Non-medical reason|31|||
126414964|NCT00211887|454813079|FG001|Overall Study|Non-medical reason|14|||
126414965|NCT00211887|454813080|FG002|Overall Study|Non-medical reason|8|||
126414966|NCT00211887|454813078|FG000|Overall Study|Other medical reason|15|||
126414967|NCT00211887|454813079|FG001|Overall Study|Other medical reason|11|||
126414968|NCT00211887|454813080|FG002|Overall Study|Other medical reason|7|||
126414969|NCT00211887|454813078|FG000|Overall Study|Side effects|19|||
126414970|NCT00211887|454813079|FG001|Overall Study|Side effects|13|||
126414971|NCT00211887|454813080|FG002|Overall Study|Side effects|5|||
126414972|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Adverse Event|33|||
126414973|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
126414974|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
126414975|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
126414976|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Physician Decision|6|||
126414977|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
126414978|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
126414979|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
126414980|NCT00965419|454813084|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
126414981|NCT00965419|454813084|FG000|Follow-up Phase|Adverse Event|9|||
126414982|NCT00965419|454813084|FG000|Follow-up Phase|Protocol Violation|4|||
126414983|NCT00965419|454813084|FG000|Follow-up Phase|Withdrawal by Subject|8|||
126414984|NCT00965419|454813084|FG000|Follow-up Phase|Physician Decision|4|||
126414985|NCT00965419|454813084|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
126414986|NCT00965419|454813084|FG000|Follow-up Phase|Lack of Efficacy|28|||
126414987|NCT02927938|454813085|FG000|Overall Study|Death|0|||
126414988|NCT02927938|454813086|FG001|Overall Study|Death|1|||
126414989|NCT02927938|454813087|FG002|Overall Study|Death|0|||
126414990|NCT02927938|454813088|FG003|Overall Study|Death|4|||
126414991|NCT02927938|454813085|FG000|Overall Study|Early Study Termination|1|||
126414992|NCT02927938|454813086|FG001|Overall Study|Early Study Termination|5|||
126414993|NCT02927938|454813087|FG002|Overall Study|Early Study Termination|4|||
126414994|NCT02927938|454813088|FG003|Overall Study|Early Study Termination|3|||
126414995|NCT00931606|454814957|FG000|Overall Study|Death|1|||
126414996|NCT00931606|454814958|FG001|Overall Study|Death|3|||
126414997|NCT00931606|454814959|FG002|Overall Study|Death|2|||
126414998|NCT00931606|454814960|FG003|Overall Study|Death|0|||
126414999|NCT00931606|454814957|FG000|Overall Study|Lost to Follow-up|0|||
126415000|NCT00931606|454814958|FG001|Overall Study|Lost to Follow-up|1|||
126415001|NCT00931606|454814959|FG002|Overall Study|Lost to Follow-up|0|||
126415002|NCT00931606|454814960|FG003|Overall Study|Lost to Follow-up|0|||
126476096|NCT02280304|455042919|FG000|Overall Study|Lost to Follow-up|7|||
126476097|NCT02280304|455042920|FG001|Overall Study|Lost to Follow-up|8|||
126415003|NCT00931606|454814957|FG000|Overall Study|Physician Decision|0|||
126415004|NCT00931606|454814958|FG001|Overall Study|Physician Decision|0|||
126415005|NCT00931606|454814959|FG002|Overall Study|Physician Decision|3|||
126415006|NCT00931606|454814960|FG003|Overall Study|Physician Decision|0|||
126415007|NCT00931606|454814957|FG000|Overall Study|Sponsor Decision|1|||
126415008|NCT00931606|454814958|FG001|Overall Study|Sponsor Decision|4|||
126415009|NCT00931606|454814959|FG002|Overall Study|Sponsor Decision|0|||
126415010|NCT00931606|454814960|FG003|Overall Study|Sponsor Decision|2|||
126415011|NCT00931606|454814957|FG000|Overall Study|Withdrawal by Subject|3|||
126476098|NCT00934089|455042924|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
126415012|NCT00931606|454814958|FG001|Overall Study|Withdrawal by Subject|1|||
126476099|NCT00934089|455042925|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
126476100|NCT00934089|455042924|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
126476101|NCT00934089|455042925|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
126476102|NCT00003473|455042926|FG000|Overall Study|Three patients were not evaluable.|3|||
126476103|NCT00680017|455042930|FG000|Overall Study|Adverse Event|13|||
126476104|NCT00680017|455042931|FG001|Overall Study|Adverse Event|7|||
126476105|NCT00680017|455042930|FG000|Overall Study|Withdrawal by Subject|2|||
126476106|NCT00680017|455042931|FG001|Overall Study|Withdrawal by Subject|5|||
126476107|NCT00680017|455042930|FG000|Overall Study|Lost to Follow-up|2|||
126476108|NCT00680017|455042931|FG001|Overall Study|Lost to Follow-up|0|||
126721666|NCT03136185|455930032|FG008|Overall Study|Withdrawal by Subject|3|||
126721667|NCT03136185|455930024|FG000|Overall Study|Not Reported|4|||
126721668|NCT03136185|455930025|FG001|Overall Study|Not Reported|1|||
126721669|NCT03136185|455930026|FG002|Overall Study|Not Reported|0|||
126721670|NCT03136185|455930027|FG003|Overall Study|Not Reported|1|||
126721671|NCT03136185|455930028|FG004|Overall Study|Not Reported|0|||
126721672|NCT03136185|455930029|FG005|Overall Study|Not Reported|2|||
126721673|NCT03136185|455930030|FG006|Overall Study|Not Reported|1|||
126476109|NCT00434954|455042933|FG000|Overall Study|Adverse Event|17|||
126476110|NCT00434954|455042934|FG001|Overall Study|Adverse Event|2|||
126476111|NCT00434954|455042933|FG000|Overall Study|Entry criteria not met|14|||
126476112|NCT00434954|455042934|FG001|Overall Study|Entry criteria not met|16|||
126476113|NCT00434954|455042933|FG000|Overall Study|Lost to Follow-up|0|||
126476114|NCT00434954|455042934|FG001|Overall Study|Lost to Follow-up|1|||
126476115|NCT00434954|455042933|FG000|Overall Study|Physician Decision|6|||
126476116|NCT00434954|455042934|FG001|Overall Study|Physician Decision|3|||
126476117|NCT00434954|455042933|FG000|Overall Study|Protocol Violation|36|||
126476118|NCT00434954|455042934|FG001|Overall Study|Protocol Violation|27|||
126476119|NCT00434954|455042933|FG000|Overall Study|Sponsor decision|1|||
126476120|NCT00434954|455042934|FG001|Overall Study|Sponsor decision|0|||
126476121|NCT00434954|455042933|FG000|Overall Study|Subject decision|8|||
126476122|NCT00434954|455042934|FG001|Overall Study|Subject decision|22|||
126476123|NCT00894166|455042935|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
126476124|NCT00894166|455042936|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
126476125|NCT00894166|455042937|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
126476126|NCT00894166|455042938|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
126476127|NCT00894166|455042939|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
126476128|NCT00894166|455042940|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
126476129|NCT00894166|455042941|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
126476130|NCT00894166|455042942|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
126476131|NCT00894166|455042935|FG000|Overall Study|Death|0|||
126476132|NCT00894166|455042936|FG001|Overall Study|Death|0|||
126476133|NCT00894166|455042937|FG002|Overall Study|Death|0|||
126476134|NCT00894166|455042938|FG003|Overall Study|Death|1|||
126476135|NCT00894166|455042939|FG004|Overall Study|Death|0|||
126476136|NCT00894166|455042940|FG005|Overall Study|Death|0|||
126476137|NCT00894166|455042941|FG006|Overall Study|Death|0|||
126476138|NCT00894166|455042942|FG007|Overall Study|Death|0|||
126476139|NCT03750955|455042950|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
126476140|NCT03750955|455042951|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
126476141|NCT03750955|455042950|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
126476142|NCT03750955|455042951|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
126476143|NCT01180985|455042954|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
126476144|NCT01180985|455042955|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
126476145|NCT03345914|455042958|FG000|Overall Study|Transition to another study at week 16|80|||
126476146|NCT03345914|455042959|FG001|Overall Study|Transition to another study at week 16|86|||
126476147|NCT03345914|455042960|FG002|Overall Study|Transition to another study at week 16|78|||
126476148|NCT03345914|455042958|FG000|Overall Study|Transition to OLE during follow-up|37|||
126476149|NCT03345914|455042959|FG001|Overall Study|Transition to OLE during follow-up|33|||
126476150|NCT03345914|455042960|FG002|Overall Study|Transition to OLE during follow-up|39|||
126476151|NCT03345914|455042958|FG000|Overall Study|Physician Decision|0|||
126476152|NCT03345914|455042959|FG001|Overall Study|Physician Decision|1|||
126476153|NCT03345914|455042960|FG002|Overall Study|Physician Decision|1|||
126476154|NCT03345914|455042958|FG000|Overall Study|Withdrawal by Subject|5|||
126476155|NCT03345914|455042959|FG001|Overall Study|Withdrawal by Subject|1|||
126476156|NCT03345914|455042960|FG002|Overall Study|Withdrawal by Subject|2|||
126476157|NCT03345914|455042958|FG000|Overall Study|Other|1|||
126476158|NCT03345914|455042959|FG001|Overall Study|Other|1|||
126476159|NCT03345914|455042960|FG002|Overall Study|Other|1|||
126476160|NCT03345914|455042958|FG000|Overall Study|Ongoing|0|||
126476161|NCT03345914|455042959|FG001|Overall Study|Ongoing|0|||
126476162|NCT03345914|455042960|FG002|Overall Study|Ongoing|1|||
126476163|NCT01952145|455042963|FG000|Overall Study|Protocol Violation|2|||
126476164|NCT01952145|455042964|FG001|Overall Study|Protocol Violation|1|||
126476165|NCT01952145|455042963|FG000|Overall Study|Death|0|||
126476166|NCT01952145|455042964|FG001|Overall Study|Death|1|||
126476167|NCT01952145|455042963|FG000|Overall Study|Adverse Event|9|||
126476168|NCT01952145|455042964|FG001|Overall Study|Adverse Event|0|||
126476169|NCT01952145|455042963|FG000|Overall Study|Withdrawal Criteria|16|||
126476170|NCT01952145|455042964|FG001|Overall Study|Withdrawal Criteria|11|||
126476171|NCT01952145|455042963|FG000|Overall Study|Unclassified|1|||
126476172|NCT01952145|455042964|FG001|Overall Study|Unclassified|1|||
126476173|NCT03758066|455042965|FG000|Overall Study|Lost to Follow-up|14|||
126476174|NCT04138810|455042969|FG000|Overall Study|Withdrawal by Subject|0|||
126476175|NCT04138810|455042970|FG001|Overall Study|Withdrawal by Subject|1|||
126476176|NCT04138810|455042969|FG000|Overall Study|Subject cancelled surgery|1|||
126476177|NCT04138810|455042970|FG001|Overall Study|Subject cancelled surgery|0|||
126476178|NCT01786668|455042971|FG000|Overall Study|Adverse Event|0|||
126476179|NCT01786668|455042972|FG001|Overall Study|Adverse Event|1|||
126476180|NCT01786668|455042973|FG002|Overall Study|Adverse Event|1|||
126476181|NCT01786668|455042974|FG003|Overall Study|Adverse Event|2|||
126476182|NCT01786668|455042971|FG000|Overall Study|Withdrawal by Subject|0|||
126476183|NCT01786668|455042972|FG001|Overall Study|Withdrawal by Subject|0|||
126476184|NCT01786668|455042973|FG002|Overall Study|Withdrawal by Subject|3|||
126476185|NCT01786668|455042974|FG003|Overall Study|Withdrawal by Subject|1|||
126476186|NCT01786668|455042971|FG000|Overall Study|Pregnancy|0|||
126476187|NCT01786668|455042972|FG001|Overall Study|Pregnancy|0|||
126476188|NCT01786668|455042973|FG002|Overall Study|Pregnancy|0|||
126476189|NCT01786668|455042974|FG003|Overall Study|Pregnancy|1|||
126476190|NCT01786668|455042971|FG000|Overall Study|Lost to Follow-up|1|||
126476191|NCT01786668|455042972|FG001|Overall Study|Lost to Follow-up|0|||
126721674|NCT03136185|455930031|FG007|Overall Study|Not Reported|1|||
126721675|NCT03136185|455930032|FG008|Overall Study|Not Reported|0|||
126721676|NCT00364845|455930038|FG000|Overall Study|Adverse Event|1|||
126476192|NCT01786668|455042973|FG002|Overall Study|Lost to Follow-up|1|||
126476193|NCT01786668|455042974|FG003|Overall Study|Lost to Follow-up|0|||
126476194|NCT00762385|455042977|FG000|First Intervention|Lens Issue|1|||
126476195|NCT00762385|455042978|FG001|First Intervention|Lens Issue|1|||
126476196|NCT00762385|455042977|FG000|First Intervention|Lost to Follow-up|0|||
126476197|NCT00762385|455042978|FG001|First Intervention|Lost to Follow-up|2|||
126476198|NCT00762385|455042977|FG000|First Intervention|Ineligible|1|||
126476199|NCT00762385|455042978|FG001|First Intervention|Ineligible|0|||
126476200|NCT00762385|455042977|FG000|First Intervention|Protocol Violation|0|||
126476201|NCT00762385|455042978|FG001|First Intervention|Protocol Violation|1|||
126476202|NCT00762385|455042977|FG000|Second Intervention|Protocol Violation|3|||
126476203|NCT00762385|455042978|FG001|Second Intervention|Protocol Violation|3|||
126476204|NCT01776840|455042979|FG000|Overall Study|Lost to Follow-up|12|||
126476205|NCT01776840|455042980|FG001|Overall Study|Lost to Follow-up|7|||
126476206|NCT01776840|455042979|FG000|Overall Study|Withdrawal by Subject|32|||
126476207|NCT01776840|455042980|FG001|Overall Study|Withdrawal by Subject|48|||
126476208|NCT01776840|455042979|FG000|Overall Study|Sponsor decision|89|||
126476209|NCT01776840|455042980|FG001|Overall Study|Sponsor decision|87|||
126476210|NCT00493025|455042981|FG000|Overall Study|Physician Decision|19|||
126476211|NCT03641339|455042982|FG000|Overall Study|Physician Decision|1|||
126476212|NCT03641339|455042983|FG001|Overall Study|Physician Decision|0|||
126476213|NCT03641339|455042984|FG002|Overall Study|Physician Decision|0|||
126476214|NCT03641339|455042985|FG003|Overall Study|Physician Decision|0|||
126476215|NCT03641339|455042986|FG004|Overall Study|Physician Decision|0|||
126476216|NCT03641339|455042987|FG005|Overall Study|Physician Decision|0|||
126476217|NCT03641339|455042982|FG000|Overall Study|Withdrawal by Subject|0|||
126476218|NCT03641339|455042983|FG001|Overall Study|Withdrawal by Subject|2|||
126476219|NCT03641339|455042984|FG002|Overall Study|Withdrawal by Subject|0|||
126476220|NCT03641339|455042985|FG003|Overall Study|Withdrawal by Subject|2|||
126476221|NCT03641339|455042986|FG004|Overall Study|Withdrawal by Subject|0|||
126476222|NCT03641339|455042987|FG005|Overall Study|Withdrawal by Subject|1|||
126476223|NCT03068455|455042988|FG000|Pre-treatment Period|Disease progression|0|||
126476224|NCT03068455|455042989|FG001|Pre-treatment Period|Disease progression|1|||
126476225|NCT03068455|455042988|FG000|Pre-treatment Period|Participant withdrew consent|1|||
126476226|NCT03068455|455042989|FG001|Pre-treatment Period|Participant withdrew consent|1|||
126476227|NCT03068455|455042988|FG000|Pre-treatment Period|Poor/non-compliance|0|||
126721677|NCT00364845|455930039|FG001|Overall Study|Adverse Event|0|||
126476228|NCT03068455|455042989|FG001|Pre-treatment Period|Poor/non-compliance|1|||
126476229|NCT03068455|455042988|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
126476230|NCT03068455|455042989|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
126476231|NCT03068455|455042988|FG000|Pre-treatment Period|Not reported|2|||
126476232|NCT03068455|455042989|FG001|Pre-treatment Period|Not reported|1|||
126476233|NCT03068455|455042988|FG000|Treatment Period|Disease progression|166|||
126476234|NCT03068455|455042989|FG001|Treatment Period|Disease progression|208|||
126476235|NCT03068455|455042988|FG000|Treatment Period|Study drug toxicity|317|||
126476236|NCT03068455|455042989|FG001|Treatment Period|Study drug toxicity|104|||
126476237|NCT03068455|455042988|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
126476238|NCT03068455|455042989|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
126476239|NCT03068455|455042988|FG000|Treatment Period|Participant request to stop therapy|33|||
126476240|NCT03068455|455042989|FG001|Treatment Period|Participant request to stop therapy|20|||
126476241|NCT03068455|455042988|FG000|Treatment Period|Participant withdrew consent|5|||
126476242|NCT03068455|455042989|FG001|Treatment Period|Participant withdrew consent|10|||
126476243|NCT03068455|455042988|FG000|Treatment Period|Poor/non-compliance|3|||
126476244|NCT03068455|455042989|FG001|Treatment Period|Poor/non-compliance|0|||
126476245|NCT03068455|455042988|FG000|Treatment Period|Participant no longer meets study criteria|1|||
126476246|NCT03068455|455042989|FG001|Treatment Period|Participant no longer meets study criteria|3|||
126476247|NCT03068455|455042988|FG000|Treatment Period|Other reasons|12|||
126476248|NCT03068455|455042989|FG001|Treatment Period|Other reasons|4|||
126476249|NCT01876420|455042990|FG000|Overall Study|Missed 30 day visit|1|||
126476250|NCT05338216|455042991|FG000|Overall Study|Withdrawal by Subject|1|||
126476251|NCT05338216|455042992|FG001|Overall Study|Withdrawal by Subject|1|||
126476252|NCT04515394|455042993|FG000|Overall Study|Participant did not receive treatment|1|||
126476253|NCT00446251|455042994|FG000|Overall Study|On-study Transplants|2|||
126476254|NCT00446251|455042994|FG000|Overall Study|Rituximab Infusion Reaction|2|||
126476255|NCT00446251|455042994|FG000|Overall Study|Lost to Follow-up|1|||
126476256|NCT01058655|455042997|FG000|Overall Study|Withdrawal by Subject|1|||
126476257|NCT01058655|455042998|FG001|Overall Study|Withdrawal by Subject|0|||
126476258|NCT01058655|455042999|FG002|Overall Study|Withdrawal by Subject|3|||
126476259|NCT01058655|455043000|FG003|Overall Study|Withdrawal by Subject|4|||
126476260|NCT01058655|455042997|FG000|Overall Study|Prolonged Treatment Delay|0|||
126476261|NCT01058655|455042998|FG001|Overall Study|Prolonged Treatment Delay|0|||
126476262|NCT01058655|455042999|FG002|Overall Study|Prolonged Treatment Delay|0|||
126476263|NCT01058655|455043000|FG003|Overall Study|Prolonged Treatment Delay|2|||
126476264|NCT01058655|455042997|FG000|Overall Study|Symptomatic Deterioration|0|||
126476265|NCT01058655|455042998|FG001|Overall Study|Symptomatic Deterioration|0|||
126476266|NCT01058655|455042999|FG002|Overall Study|Symptomatic Deterioration|0|||
126476267|NCT01058655|455043000|FG003|Overall Study|Symptomatic Deterioration|1|||
126476268|NCT01058655|455042997|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
126476269|NCT01058655|455042998|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
126476270|NCT01058655|455042999|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
126476271|NCT01058655|455043000|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
126476272|NCT01058655|455042997|FG000|Overall Study|Death|0|||
126476273|NCT01058655|455042998|FG001|Overall Study|Death|1|||
126476274|NCT01058655|455042999|FG002|Overall Study|Death|1|||
126476275|NCT01058655|455043000|FG003|Overall Study|Death|0|||
126476276|NCT01058655|455042997|FG000|Overall Study|Disease Progression|1|||
126476277|NCT01058655|455042998|FG001|Overall Study|Disease Progression|2|||
126476278|NCT01058655|455042999|FG002|Overall Study|Disease Progression|4|||
126476279|NCT01058655|455043000|FG003|Overall Study|Disease Progression|24|||
126476280|NCT01058655|455042997|FG000|Overall Study|Other|0|||
126476281|NCT01058655|455042998|FG001|Overall Study|Other|0|||
126476282|NCT01058655|455042999|FG002|Overall Study|Other|0|||
126476283|NCT01058655|455043000|FG003|Overall Study|Other|4|||
126476284|NCT04472429|455043004|FG000|Randomized Period|Ongoing|90|||
126476285|NCT04472429|455043005|FG001|Randomized Period|Ongoing|40|||
126476286|NCT04472429|455043006|FG002|Randomized Period|Ongoing|0|||
126721678|NCT00364845|455930038|FG000|Overall Study|Withdrawal by Subject|2|||
126721679|NCT00364845|455930039|FG001|Overall Study|Withdrawal by Subject|1|||
126476287|NCT04472429|455043004|FG000|Randomized Period|Death|52|||
126476288|NCT04472429|455043005|FG001|Randomized Period|Death|37|||
126476289|NCT04472429|455043006|FG002|Randomized Period|Death|0|||
126476290|NCT04472429|455043004|FG000|Randomized Period|Lost to Follow-up|4|||
126476291|NCT04472429|455043005|FG001|Randomized Period|Lost to Follow-up|0|||
126476292|NCT04472429|455043006|FG002|Randomized Period|Lost to Follow-up|0|||
126476293|NCT04472429|455043004|FG000|Randomized Period|Physician Decision|1|||
126476294|NCT04472429|455043005|FG001|Randomized Period|Physician Decision|2|||
126476295|NCT04472429|455043006|FG002|Randomized Period|Physician Decision|0|||
126476296|NCT04472429|455043004|FG000|Randomized Period|Withdrawal by Subject|6|||
126476297|NCT04472429|455043005|FG001|Randomized Period|Withdrawal by Subject|5|||
126476298|NCT04472429|455043006|FG002|Randomized Period|Withdrawal by Subject|0|||
126476299|NCT04472429|455043004|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
126721680|NCT00364845|455930038|FG000|Overall Study|Physician Decision|8|||
126721681|NCT00364845|455930039|FG001|Overall Study|Physician Decision|8|||
126476300|NCT04472429|455043005|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
126476301|NCT04472429|455043006|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
126476302|NCT04472429|455043004|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
126476303|NCT04472429|455043005|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
126476304|NCT04472429|455043006|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
126476305|NCT04472429|455043004|FG000|Open-label Monotherapy Period|Ongoing|0|||
126476306|NCT04472429|455043005|FG001|Open-label Monotherapy Period|Ongoing|0|||
126476307|NCT04472429|455043006|FG002|Open-label Monotherapy Period|Ongoing|32|||
126476308|NCT04472429|455043004|FG000|Open-label Monotherapy Period|Death|0|||
126476309|NCT04472429|455043005|FG001|Open-label Monotherapy Period|Death|0|||
126476310|NCT04472429|455043006|FG002|Open-label Monotherapy Period|Death|35|||
126721682|NCT00364845|455930038|FG000|Overall Study|Lost to Follow-up|0|||
126721683|NCT00364845|455930039|FG001|Overall Study|Lost to Follow-up|1|||
126476311|NCT04472429|455043004|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
126476312|NCT04472429|455043005|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
126476313|NCT04472429|455043006|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
126476314|NCT01416272|455043007|FG000|Overall Study|Unacceptable distance visual acuity|2|||
126476315|NCT01416272|455043007|FG000|Overall Study|Lost to Follow-up|1|||
126476316|NCT01416272|455043007|FG000|Overall Study|Study related complaints|1|||
126476317|NCT04545060|455043008|FG000|Overall Study|Adverse Event|0|||
126476318|NCT04545060|455043009|FG001|Overall Study|Adverse Event|1|||
126476319|NCT04545060|455043008|FG000|Overall Study|Death|0|||
126476320|NCT04545060|455043009|FG001|Overall Study|Death|5|||
126476321|NCT04545060|455043008|FG000|Overall Study|Lost to Follow-up|10|||
126476322|NCT04545060|455043009|FG001|Overall Study|Lost to Follow-up|13|||
126476323|NCT04545060|455043008|FG000|Overall Study|Physician Decision|3|||
126476324|NCT04545060|455043009|FG001|Overall Study|Physician Decision|0|||
126476325|NCT04545060|455043008|FG000|Overall Study|Withdrawal by Subject|17|||
126476326|NCT04545060|455043009|FG001|Overall Study|Withdrawal by Subject|22|||
126476327|NCT00619177|455043012|FG000|Overall Study|Adverse Event|18|||
126476328|NCT00619177|455043012|FG000|Overall Study|Lost to Follow-up|2|||
126476329|NCT00619177|455043012|FG000|Overall Study|Lack of Efficacy|1|||
126476330|NCT00619177|455043012|FG000|Overall Study|Missing termination information|481|||
126476331|NCT00619177|455043012|FG000|Overall Study|Not specified reasons|6|||
126476332|NCT02319837|455043013|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
126476333|NCT02319837|455043014|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
126476334|NCT02319837|455043015|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
126476335|NCT02319837|455043013|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
126476336|NCT02319837|455043014|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
126476337|NCT02319837|455043015|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
126476338|NCT02319837|455043013|FG000|Study Treatment Phase|Adverse Event|73|||
126476339|NCT02319837|455043014|FG001|Study Treatment Phase|Adverse Event|36|||
126476340|NCT02319837|455043015|FG002|Study Treatment Phase|Adverse Event|63|||
126476341|NCT02319837|455043013|FG000|Study Treatment Phase|Development of castration resistance|0|||
126476342|NCT02319837|455043014|FG001|Study Treatment Phase|Development of castration resistance|2|||
126476343|NCT02319837|455043015|FG002|Study Treatment Phase|Development of castration resistance|0|||
126476344|NCT02319837|455043013|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
126476345|NCT02319837|455043014|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
126476346|NCT02319837|455043015|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
126476347|NCT02319837|455043013|FG000|Study Treatment Phase|Protocol Violation|2|||
126476348|NCT02319837|455043014|FG001|Study Treatment Phase|Protocol Violation|2|||
126476349|NCT02319837|455043015|FG002|Study Treatment Phase|Protocol Violation|1|||
126476350|NCT02319837|455043013|FG000|Study Treatment Phase|Lost to Follow-up|0|||
126476351|NCT02319837|455043014|FG001|Study Treatment Phase|Lost to Follow-up|1|||
126476352|NCT02319837|455043015|FG002|Study Treatment Phase|Lost to Follow-up|0|||
126476353|NCT02319837|455043013|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
126476354|NCT02319837|455043014|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
126476355|NCT02319837|455043015|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
126476356|NCT02319837|455043013|FG000|Study Treatment Phase|Other|0|||
126476357|NCT02319837|455043014|FG001|Study Treatment Phase|Other|1|||
126476358|NCT02319837|455043015|FG002|Study Treatment Phase|Other|0|||
126476359|NCT02319837|455043013|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
126476360|NCT02319837|455043014|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
126476361|NCT02319837|455043015|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
126476362|NCT02319837|455043013|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
126476363|NCT02319837|455043014|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
126476364|NCT02319837|455043015|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
126476365|NCT02319837|455043013|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
126476366|NCT02319837|455043014|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
126476367|NCT02319837|455043015|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
126476368|NCT02319837|455043013|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
126476369|NCT02319837|455043014|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
126476370|NCT02319837|455043015|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
126476371|NCT02319837|455043013|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
126476372|NCT02319837|455043014|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
126476373|NCT02319837|455043015|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
126476374|NCT02319837|455043013|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
126415013|NCT00931606|454814959|FG002|Overall Study|Withdrawal by Subject|1|||
126415014|NCT00931606|454814960|FG003|Overall Study|Withdrawal by Subject|1|||
126415015|NCT04794270|454814967|FG000|Period 1|Non Compliance|1|||
126415016|NCT04794270|454814968|FG001|Period 1|Non Compliance|0|||
126415017|NCT04794270|454814967|FG000|Period 1|Adverse Event|1|||
126415018|NCT04794270|454814968|FG001|Period 1|Adverse Event|0|||
126415019|NCT04794270|454814967|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
126415020|NCT04794270|454814968|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
126415021|NCT03826186|454814971|FG000|Overall Study|Protocol Violation|2|||
126415022|NCT03826186|454814972|FG001|Overall Study|Protocol Violation|0|||
126415023|NCT03826186|454814971|FG000|Overall Study|Withdrawal by Subject|1|||
126415024|NCT03826186|454814972|FG001|Overall Study|Withdrawal by Subject|0|||
126415025|NCT03688074|454814974|FG000|Overall Study|Adverse Event|0|||
126415026|NCT03688074|454814975|FG001|Overall Study|Adverse Event|1|||
126415027|NCT03688074|454814974|FG000|Overall Study|Other|1|||
126415028|NCT03688074|454814975|FG001|Overall Study|Other|0|||
126415029|NCT00082407|454814985|FG000|Overall Study|Adverse Event|20|||
126415030|NCT00082407|454814986|FG001|Overall Study|Adverse Event|0|||
126415031|NCT00082407|454814985|FG000|Overall Study|Protocol Violation|14|||
126415032|NCT00082407|454814986|FG001|Overall Study|Protocol Violation|12|||
126415033|NCT00082407|454814985|FG000|Overall Study|Patient Decision|13|||
126415034|NCT00082407|454814986|FG001|Overall Study|Patient Decision|6|||
126415035|NCT00082407|454814985|FG000|Overall Study|Physician Decision|5|||
126415036|NCT00082407|454814986|FG001|Overall Study|Physician Decision|3|||
126415037|NCT00082407|454814985|FG000|Overall Study|Loss of Glucose Control|2|||
126415038|NCT00082407|454814986|FG001|Overall Study|Loss of Glucose Control|2|||
126415039|NCT00082407|454814985|FG000|Overall Study|Death|2|||
126415040|NCT00082407|454814986|FG001|Overall Study|Death|1|||
126415041|NCT00082407|454814985|FG000|Overall Study|Lost to Follow-up|0|||
126415042|NCT00082407|454814986|FG001|Overall Study|Lost to Follow-up|3|||
126415043|NCT00891228|454814988|FG000|Overall Study|Adverse Event|0|||
126415044|NCT00891228|454814989|FG001|Overall Study|Adverse Event|2|||
126415045|NCT00891228|454814990|FG002|Overall Study|Adverse Event|3|||
126415046|NCT00891228|454814988|FG000|Overall Study|Withdrawal by Subject|2|||
126415047|NCT00891228|454814989|FG001|Overall Study|Withdrawal by Subject|4|||
126415048|NCT00891228|454814990|FG002|Overall Study|Withdrawal by Subject|5|||
126415049|NCT00891228|454814988|FG000|Overall Study|Protocol Violation|3|||
126415050|NCT00891228|454814989|FG001|Overall Study|Protocol Violation|1|||
126415051|NCT00891228|454814990|FG002|Overall Study|Protocol Violation|2|||
126415052|NCT00891228|454814988|FG000|Overall Study|Physician Decision|2|||
126415053|NCT00891228|454814989|FG001|Overall Study|Physician Decision|1|||
126415054|NCT00891228|454814990|FG002|Overall Study|Physician Decision|0|||
126415055|NCT00891228|454814988|FG000|Overall Study|Lost to Follow-up|4|||
126415056|NCT00891228|454814989|FG001|Overall Study|Lost to Follow-up|4|||
126415057|NCT00891228|454814990|FG002|Overall Study|Lost to Follow-up|5|||
126415058|NCT00891228|454814988|FG000|Overall Study|Pregnancy|0|||
126415059|NCT00891228|454814989|FG001|Overall Study|Pregnancy|1|||
126415060|NCT00891228|454814990|FG002|Overall Study|Pregnancy|0|||
126415061|NCT02688985|454814993|FG000|Overall Study|Adverse Event|1|||
126415062|NCT02688985|454814994|FG001|Overall Study|Adverse Event|2|||
126415063|NCT02688985|454814995|FG002|Overall Study|Adverse Event|2|||
126415064|NCT02688985|454814996|FG003|Overall Study|Adverse Event|0|||
126415065|NCT02688985|454814997|FG004|Overall Study|Adverse Event|0|||
126415066|NCT02688985|454814993|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
126415067|NCT02688985|454814994|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
126415068|NCT02688985|454814995|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
126415069|NCT02688985|454814996|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
126415070|NCT02688985|454814997|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
126415071|NCT02688985|454814993|FG000|Overall Study|Death|0|||
126415072|NCT02688985|454814994|FG001|Overall Study|Death|0|||
126415073|NCT02688985|454814995|FG002|Overall Study|Death|0|||
126415074|NCT02688985|454814996|FG003|Overall Study|Death|0|||
126415075|NCT02688985|454814997|FG004|Overall Study|Death|1|||
126415076|NCT02688985|454814993|FG000|Overall Study|Lack of Efficacy|0|||
126415077|NCT02688985|454814994|FG001|Overall Study|Lack of Efficacy|0|||
126415078|NCT02688985|454814995|FG002|Overall Study|Lack of Efficacy|0|||
126415079|NCT02688985|454814996|FG003|Overall Study|Lack of Efficacy|0|||
126415080|NCT02688985|454814997|FG004|Overall Study|Lack of Efficacy|1|||
126415081|NCT02688985|454814993|FG000|Overall Study|Lost to Follow-up|2|||
126415082|NCT02688985|454814994|FG001|Overall Study|Lost to Follow-up|0|||
126415083|NCT02688985|454814995|FG002|Overall Study|Lost to Follow-up|1|||
126476375|NCT02319837|455043014|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
126476376|NCT02319837|455043015|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
126415084|NCT02688985|454814996|FG003|Overall Study|Lost to Follow-up|1|||
126415085|NCT02688985|454814997|FG004|Overall Study|Lost to Follow-up|1|||
126415086|NCT02688985|454814993|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126415087|NCT02688985|454814994|FG001|Overall Study|Non-Compliance With Study Drug|3|||
126415088|NCT02688985|454814995|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126415089|NCT02688985|454814996|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126415090|NCT02688985|454814997|FG004|Overall Study|Non-Compliance With Study Drug|1|||
126415091|NCT02688985|454814993|FG000|Overall Study|Other|3|||
126415092|NCT02688985|454814994|FG001|Overall Study|Other|4|||
126415093|NCT02688985|454814995|FG002|Overall Study|Other|1|||
126415094|NCT02688985|454814996|FG003|Overall Study|Other|0|||
126415095|NCT02688985|454814997|FG004|Overall Study|Other|0|||
126415096|NCT02688985|454814993|FG000|Overall Study|Physician Decision|2|||
126415097|NCT02688985|454814994|FG001|Overall Study|Physician Decision|2|||
126415098|NCT02688985|454814995|FG002|Overall Study|Physician Decision|0|||
126415099|NCT02688985|454814996|FG003|Overall Study|Physician Decision|0|||
126415100|NCT02688985|454814997|FG004|Overall Study|Physician Decision|1|||
126415101|NCT02688985|454814993|FG000|Overall Study|Pregnancy|0|||
126415102|NCT02688985|454814994|FG001|Overall Study|Pregnancy|0|||
126415103|NCT02688985|454814995|FG002|Overall Study|Pregnancy|2|||
126415104|NCT02688985|454814996|FG003|Overall Study|Pregnancy|1|||
126415105|NCT02688985|454814997|FG004|Overall Study|Pregnancy|0|||
126415106|NCT02688985|454814993|FG000|Overall Study|Study Terminated By Sponsor|0|||
126415107|NCT02688985|454814994|FG001|Overall Study|Study Terminated By Sponsor|0|||
126415108|NCT02688985|454814995|FG002|Overall Study|Study Terminated By Sponsor|0|||
126415109|NCT02688985|454814996|FG003|Overall Study|Study Terminated By Sponsor|1|||
126415110|NCT02688985|454814997|FG004|Overall Study|Study Terminated By Sponsor|0|||
126415111|NCT02688985|454814993|FG000|Overall Study|Withdrawal by Subject|2|||
126415112|NCT02688985|454814994|FG001|Overall Study|Withdrawal by Subject|8|||
126415113|NCT02688985|454814995|FG002|Overall Study|Withdrawal by Subject|7|||
126415114|NCT02688985|454814996|FG003|Overall Study|Withdrawal by Subject|1|||
126415115|NCT02688985|454814997|FG004|Overall Study|Withdrawal by Subject|4|||
126415116|NCT01726582|454814998|FG000|Overall Study|Physician Decision|99|||
126415117|NCT01726582|454814998|FG000|Overall Study|Death|85|||
126415118|NCT03704688|454814999|FG000|Overall Study|Adverse Event|0|||
126415119|NCT03704688|454815000|FG001|Overall Study|Adverse Event|0|||
126415120|NCT03704688|454815001|FG002|Overall Study|Adverse Event|0|||
126415121|NCT03704688|454815002|FG003|Overall Study|Adverse Event|4|||
126415122|NCT03704688|454815003|FG004|Overall Study|Adverse Event|1|||
126415123|NCT03704688|454815004|FG005|Overall Study|Adverse Event|0|||
126415124|NCT03704688|454814999|FG000|Overall Study|Disease Progression|0|||
126415125|NCT03704688|454815000|FG001|Overall Study|Disease Progression|0|||
126415126|NCT03704688|454815001|FG002|Overall Study|Disease Progression|0|||
126415127|NCT03704688|454815002|FG003|Overall Study|Disease Progression|3|||
126415128|NCT03704688|454815003|FG004|Overall Study|Disease Progression|1|||
126415129|NCT03704688|454815004|FG005|Overall Study|Disease Progression|0|||
126415130|NCT03704688|454814999|FG000|Overall Study|Death|0|||
126415131|NCT03704688|454815000|FG001|Overall Study|Death|0|||
126415132|NCT03704688|454815001|FG002|Overall Study|Death|0|||
126415133|NCT03704688|454815002|FG003|Overall Study|Death|0|||
126415134|NCT03704688|454815003|FG004|Overall Study|Death|3|||
126415135|NCT03704688|454815004|FG005|Overall Study|Death|0|||
126415136|NCT02206035|454815005|FG000|Overall Study|Physician Decision|10|||
126415137|NCT02206035|454815006|FG001|Overall Study|Physician Decision|0|||
126415138|NCT02206035|454815007|FG002|Overall Study|Physician Decision|175|||
126415139|NCT05173012|454815009|FG000|Overall Study|Adverse Event|2|||
126415140|NCT05173012|454815010|FG001|Overall Study|Adverse Event|3|||
126415141|NCT05173012|454815011|FG002|Overall Study|Adverse Event|4|||
126415142|NCT05173012|454815012|FG003|Overall Study|Adverse Event|13|||
126415143|NCT05173012|454815013|FG004|Overall Study|Adverse Event|0|||
126415144|NCT05173012|454815014|FG005|Overall Study|Adverse Event|0|||
126415145|NCT05173012|454815015|FG006|Overall Study|Adverse Event|2|||
126415146|NCT05173012|454815016|FG007|Overall Study|Adverse Event|4|||
126415147|NCT05173012|454815009|FG000|Overall Study|Lost to Follow-up|0|||
126415148|NCT05173012|454815010|FG001|Overall Study|Lost to Follow-up|0|||
126415149|NCT05173012|454815011|FG002|Overall Study|Lost to Follow-up|0|||
126415150|NCT05173012|454815012|FG003|Overall Study|Lost to Follow-up|1|||
126415151|NCT05173012|454815013|FG004|Overall Study|Lost to Follow-up|0|||
126476377|NCT02319837|455043013|FG000|Long-Term Follow-Up Phase|Death|33|||
126476378|NCT02319837|455043014|FG001|Long-Term Follow-Up Phase|Death|54|||
126476379|NCT02319837|455043015|FG002|Long-Term Follow-Up Phase|Death|42|||
126415152|NCT05173012|454815014|FG005|Overall Study|Lost to Follow-up|0|||
126415153|NCT05173012|454815015|FG006|Overall Study|Lost to Follow-up|0|||
126415154|NCT05173012|454815016|FG007|Overall Study|Lost to Follow-up|0|||
126415155|NCT05173012|454815009|FG000|Overall Study|Withdrawal by Subject|1|||
126415156|NCT05173012|454815010|FG001|Overall Study|Withdrawal by Subject|0|||
126415157|NCT05173012|454815011|FG002|Overall Study|Withdrawal by Subject|1|||
126476380|NCT00753766|455043020|FG000|Overall Study|Physician Decision|1|||
126415158|NCT05173012|454815012|FG003|Overall Study|Withdrawal by Subject|3|||
126415159|NCT05173012|454815013|FG004|Overall Study|Withdrawal by Subject|1|||
126415160|NCT05173012|454815014|FG005|Overall Study|Withdrawal by Subject|0|||
126415161|NCT05173012|454815015|FG006|Overall Study|Withdrawal by Subject|1|||
126415162|NCT05173012|454815016|FG007|Overall Study|Withdrawal by Subject|0|||
126415163|NCT05173012|454815009|FG000|Overall Study|Protocol Deviation|0|||
126415164|NCT05173012|454815010|FG001|Overall Study|Protocol Deviation|0|||
126415165|NCT05173012|454815011|FG002|Overall Study|Protocol Deviation|0|||
126415166|NCT05173012|454815012|FG003|Overall Study|Protocol Deviation|1|||
126415167|NCT05173012|454815013|FG004|Overall Study|Protocol Deviation|0|||
126415168|NCT05173012|454815014|FG005|Overall Study|Protocol Deviation|0|||
126415169|NCT05173012|454815015|FG006|Overall Study|Protocol Deviation|0|||
126415170|NCT05173012|454815016|FG007|Overall Study|Protocol Deviation|0|||
126415171|NCT05173012|454815009|FG000|Overall Study|Other|0|||
126415172|NCT05173012|454815010|FG001|Overall Study|Other|0|||
126415173|NCT05173012|454815011|FG002|Overall Study|Other|0|||
126415174|NCT05173012|454815012|FG003|Overall Study|Other|2|||
126415175|NCT05173012|454815013|FG004|Overall Study|Other|0|||
126415176|NCT05173012|454815014|FG005|Overall Study|Other|0|||
126415177|NCT05173012|454815015|FG006|Overall Study|Other|0|||
126415178|NCT05173012|454815016|FG007|Overall Study|Other|0|||
126476381|NCT00753766|455043021|FG001|Overall Study|Physician Decision|0|||
126476382|NCT04545554|455043022|FG000|Overall Study|Withdrawal by Subject|0|||
126476383|NCT04545554|455043023|FG001|Overall Study|Withdrawal by Subject|0|||
126476384|NCT04545554|455043024|FG002|Overall Study|Withdrawal by Subject|0|||
126476385|NCT04545554|455043025|FG003|Overall Study|Withdrawal by Subject|1|||
126476386|NCT04545554|455043026|FG004|Overall Study|Withdrawal by Subject|0|||
126476387|NCT04545554|455043027|FG005|Overall Study|Withdrawal by Subject|0|||
126476388|NCT00494299|455043028|FG000|Overall Study|Adverse Event|93|||
126476389|NCT00494299|455043029|FG001|Overall Study|Adverse Event|13|||
126476390|NCT00494299|455043028|FG000|Overall Study|Lost to Follow-up|1|||
126476391|NCT00494299|455043029|FG001|Overall Study|Lost to Follow-up|0|||
126476392|NCT00494299|455043028|FG000|Overall Study|Physician Decision|0|||
126476393|NCT00494299|455043029|FG001|Overall Study|Physician Decision|2|||
126476394|NCT00494299|455043028|FG000|Overall Study|Protocol Violation|1|||
126476395|NCT00494299|455043029|FG001|Overall Study|Protocol Violation|2|||
126476396|NCT00494299|455043028|FG000|Overall Study|Withdrawal by Subject|8|||
126476397|NCT00494299|455043029|FG001|Overall Study|Withdrawal by Subject|3|||
126476398|NCT00494299|455043028|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
126476399|NCT00494299|455043029|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
126476400|NCT00494299|455043028|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
126476401|NCT00494299|455043029|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
126476402|NCT00494299|455043028|FG000|Overall Study|Site Closed by Sponsor|6|||
126476403|NCT00494299|455043029|FG001|Overall Study|Site Closed by Sponsor|0|||
126476404|NCT00494299|455043028|FG000|Overall Study|Protocol Driven Decision Point|11|||
126476405|NCT00494299|455043029|FG001|Overall Study|Protocol Driven Decision Point|22|||
126476406|NCT05213481|455043032|FG000|Overall Study|Adverse Event|3|||
126476407|NCT05213481|455043032|FG000|Overall Study|Lost to Follow-up|1|||
126476408|NCT00415168|455043033|FG000|Overall Study|Death|26|||
126476409|NCT00415168|455043033|FG000|Overall Study|Lost to Follow-up|3|||
126476410|NCT00415168|455043033|FG000|Overall Study|Physician Decision|13|||
126476411|NCT00415168|455043033|FG000|Overall Study|Sponsor Decision|4|||
126476412|NCT00415168|455043033|FG000|Overall Study|Withdrawal by Subject|6|||
126476413|NCT02925117|455043038|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
126476414|NCT02925117|455043039|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
126476415|NCT02925117|455043040|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
126476416|NCT02925117|455043041|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
126476417|NCT02925117|455043042|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
126476418|NCT02925117|455043043|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
126476419|NCT02925117|455043044|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
126476420|NCT02925117|455043045|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
126476421|NCT02925117|455043046|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
126476422|NCT02925117|455043047|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
126476423|NCT02925117|455043048|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
126476424|NCT02925117|455043049|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
126476425|NCT02925117|455043038|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
126476426|NCT02925117|455043039|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
126476427|NCT02925117|455043040|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
126476428|NCT02925117|455043041|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
126476429|NCT02925117|455043042|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
126476430|NCT02925117|455043043|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
126476431|NCT02925117|455043044|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
126558962|NCT02263885|455340590|FG000|Overall Study|Withdrawal by Subject|7|||
126558963|NCT02263885|455340590|FG000|Overall Study|Alternative Treatment|3|||
126558964|NCT02688621|455340591|FG000|Overall Study|Pregnancy|1|||
126558965|NCT02688621|455340592|FG001|Overall Study|Pregnancy|3|||
126558966|NCT02688621|455340591|FG000|Overall Study|Lost to Follow-up|38|||
126558967|NCT02688621|455340592|FG001|Overall Study|Lost to Follow-up|15|||
126558968|NCT02688621|455340591|FG000|Overall Study|Withdrawal by Subject|1|||
126558969|NCT02688621|455340592|FG001|Overall Study|Withdrawal by Subject|0|||
126558970|NCT03239210|455340593|FG000|Overall Study|Lost to Follow-up|2|||
126558971|NCT03239210|455340594|FG001|Overall Study|Lost to Follow-up|2|||
126415179|NCT03668613|454815017|FG000|Overall Study|Adverse Event|1|||
126415180|NCT03668613|454815018|FG001|Overall Study|Adverse Event|2|||
126415181|NCT03668613|454815017|FG000|Overall Study|Lack of Efficacy|5|||
126415182|NCT03668613|454815018|FG001|Overall Study|Lack of Efficacy|1|||
126415183|NCT03668613|454815017|FG000|Overall Study|Pregnancy|0|||
126772337|NCT01466673|456122091|FG001|Overall Study|Adverse Event|1|||
126415184|NCT03668613|454815018|FG001|Overall Study|Pregnancy|2|||
126415185|NCT03668613|454815017|FG000|Overall Study|Protocol Violation|1|||
126415186|NCT03668613|454815018|FG001|Overall Study|Protocol Violation|0|||
126415187|NCT03668613|454815017|FG000|Overall Study|Physician Decision|1|||
126415188|NCT03668613|454815018|FG001|Overall Study|Physician Decision|0|||
126415189|NCT03668613|454815017|FG000|Overall Study|Withdrawal by Subject|2|||
126415190|NCT03668613|454815018|FG001|Overall Study|Withdrawal by Subject|1|||
126415191|NCT03668613|454815017|FG000|Overall Study|Guardian decision|1|||
126415192|NCT03668613|454815018|FG001|Overall Study|Guardian decision|0|||
126415193|NCT01068769|454815021|FG000|Overall Study|Ineligible|1|||
126415194|NCT00709618|454815022|FG000|Overall Study|Withdrawal by Subject|4|||
126415195|NCT00709618|454815022|FG000|Overall Study|Lost to Follow-up|1|||
126415196|NCT00709618|454815022|FG000|Overall Study|Study Closed/Terminated|25|||
126415197|NCT01948063|454815025|FG000|Overall Study|Boston MCI halted research protocol|0|||
126415198|NCT01948063|454815026|FG001|Overall Study|Boston MCI halted research protocol|1|||
126415199|NCT01948063|454815025|FG000|Overall Study|Discovered an enrollment in other study|0|||
126415200|NCT01948063|454815026|FG001|Overall Study|Discovered an enrollment in other study|1|||
126415201|NCT01948063|454815025|FG000|Overall Study|Blood samples were accidentally thawed|1|||
126415202|NCT01948063|454815026|FG001|Overall Study|Blood samples were accidentally thawed|0|||
126415203|NCT03781414|454815029|FG000|Overall Study|Study terminated by sponsor|39|||
126415204|NCT03781414|454815030|FG001|Overall Study|Study terminated by sponsor|34|||
126415205|NCT03781414|454815031|FG002|Overall Study|Study terminated by sponsor|25|||
126415206|NCT03781414|454815029|FG000|Overall Study|Adverse Event|3|||
126415207|NCT03781414|454815030|FG001|Overall Study|Adverse Event|6|||
126415208|NCT03781414|454815031|FG002|Overall Study|Adverse Event|3|||
126415209|NCT03781414|454815029|FG000|Overall Study|Physician Decision|2|||
126415210|NCT03781414|454815030|FG001|Overall Study|Physician Decision|0|||
126415211|NCT03781414|454815031|FG002|Overall Study|Physician Decision|1|||
126415212|NCT03781414|454815029|FG000|Overall Study|Withdrawal by Subject|2|||
126415213|NCT03781414|454815030|FG001|Overall Study|Withdrawal by Subject|3|||
126415214|NCT03781414|454815031|FG002|Overall Study|Withdrawal by Subject|3|||
126415215|NCT03781414|454815029|FG000|Overall Study|Death|1|||
126415216|NCT03781414|454815030|FG001|Overall Study|Death|4|||
126415217|NCT03781414|454815031|FG002|Overall Study|Death|0|||
126415218|NCT03781414|454815029|FG000|Overall Study|Lost to Follow-up|1|||
126415219|NCT03781414|454815030|FG001|Overall Study|Lost to Follow-up|1|||
126415220|NCT03781414|454815031|FG002|Overall Study|Lost to Follow-up|0|||
126415221|NCT04752358|454815032|FG000|Overall Study|Death|2|||
126415222|NCT04752358|454815033|FG001|Overall Study|Death|1|||
126415223|NCT00719355|454815034|FG000|Overall Study|Death|0|||
126415224|NCT00719355|454815035|FG001|Overall Study|Death|1|||
126415225|NCT00719355|454815034|FG000|Overall Study|Medical|14|||
126415226|NCT00719355|454815035|FG001|Overall Study|Medical|5|||
126476432|NCT02925117|455043045|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
126476433|NCT02925117|455043046|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
126476434|NCT02925117|455043047|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
126476435|NCT02925117|455043048|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
126476436|NCT02925117|455043049|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
126476437|NCT02925117|455043038|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
126476438|NCT02925117|455043039|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
126476439|NCT02925117|455043040|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
126476440|NCT02925117|455043041|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
126476441|NCT02925117|455043042|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
126476442|NCT02925117|455043043|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
126476443|NCT02925117|455043044|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
126476444|NCT02925117|455043045|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
126476445|NCT02925117|455043046|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
126476446|NCT02925117|455043047|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
126476447|NCT02925117|455043048|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
126476448|NCT02925117|455043049|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
126476449|NCT02925117|455043038|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
126476450|NCT02925117|455043039|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
126476451|NCT02925117|455043040|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
126476452|NCT02925117|455043041|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
126476453|NCT02925117|455043042|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
126476454|NCT02925117|455043043|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
126476455|NCT02925117|455043044|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
126476456|NCT02925117|455043045|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
126415227|NCT00719355|454815034|FG000|Overall Study|Compliance|4|||
126415228|NCT00719355|454815035|FG001|Overall Study|Compliance|6|||
126415229|NCT00719355|454815034|FG000|Overall Study|Moved|0|||
126415230|NCT00719355|454815035|FG001|Overall Study|Moved|1|||
126415231|NCT03364738|454815036|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
126415232|NCT03364738|454815036|FG000|Overall Study|Withdrawal by Subject|1|||
126415233|NCT03364738|454815036|FG000|Overall Study|Adverse Event|1|||
126476457|NCT02925117|455043046|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
126476458|NCT02925117|455043047|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
126476459|NCT02925117|455043048|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
126476460|NCT02925117|455043049|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
126476461|NCT02925117|455043038|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
126476462|NCT02925117|455043039|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
126476463|NCT02925117|455043040|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
126476464|NCT02925117|455043041|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
126476465|NCT02925117|455043042|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
126476466|NCT02925117|455043043|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
126476467|NCT02925117|455043044|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
126476468|NCT02925117|455043045|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
126476469|NCT02925117|455043046|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
126476470|NCT02925117|455043047|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
126476471|NCT02925117|455043048|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
126476472|NCT02925117|455043049|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
126476473|NCT02925117|455043038|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
126476474|NCT02925117|455043039|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
126476475|NCT02925117|455043040|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
126476476|NCT02925117|455043041|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
126476477|NCT02925117|455043042|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
126476478|NCT02925117|455043043|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
126476479|NCT02925117|455043044|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
126476480|NCT02925117|455043045|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
126476481|NCT02925117|455043046|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
126476482|NCT02925117|455043047|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
126476483|NCT02925117|455043048|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
126476484|NCT02925117|455043049|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
126476485|NCT02925117|455043038|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
126476486|NCT02925117|455043039|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
126476487|NCT02925117|455043040|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
126476488|NCT02925117|455043041|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
126476489|NCT02925117|455043042|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
126476490|NCT02925117|455043043|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
126476491|NCT02925117|455043044|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
126476492|NCT02925117|455043045|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
126476493|NCT02925117|455043046|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
126476494|NCT02925117|455043047|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
126476495|NCT02925117|455043048|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
126476496|NCT02925117|455043049|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
126476497|NCT02925117|455043038|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
126476498|NCT02925117|455043039|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
126476499|NCT02925117|455043040|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
126476500|NCT02925117|455043041|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
126476501|NCT02925117|455043042|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
126476502|NCT02925117|455043043|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
126476503|NCT02925117|455043044|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
126476504|NCT02925117|455043045|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
126476505|NCT02925117|455043046|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
126476506|NCT02925117|455043047|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
126476507|NCT02925117|455043048|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
126476508|NCT02925117|455043049|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
126476509|NCT02059408|455043054|FG000|Overall Study|Did not get tested|0|||
126476510|NCT02059408|455043055|FG001|Overall Study|Did not get tested|330|||
126476511|NCT02059408|455043056|FG002|Overall Study|Did not get tested|358|||
126476512|NCT01681472|455043058|FG000|Overall Study|Adverse Event|0|||
126476513|NCT01681472|455043059|FG001|Overall Study|Adverse Event|1|||
126476514|NCT01681472|455043060|FG002|Overall Study|Adverse Event|0|||
126476515|NCT01681472|455043061|FG003|Overall Study|Adverse Event|0|||
126476516|NCT01995825|455044959|FG000|Overall Study|Withdrawal by Subject|1|||
126476517|NCT01995825|455044960|FG001|Overall Study|Withdrawal by Subject|0|||
126476518|NCT01385566|455044961|FG000|Overall Study|Lost to Follow-up|1|||
126476519|NCT01385566|455044962|FG001|Overall Study|Lost to Follow-up|0|||
126476520|NCT01385566|455044963|FG002|Overall Study|Lost to Follow-up|0|||
126476521|NCT01385566|455044964|FG003|Overall Study|Lost to Follow-up|0|||
126476522|NCT01385566|455044965|FG004|Overall Study|Lost to Follow-up|0|||
126476523|NCT01385566|455044966|FG005|Overall Study|Lost to Follow-up|0|||
126476524|NCT01385566|455044961|FG000|Overall Study|Withdrawal by Subject|0|||
126476525|NCT01385566|455044962|FG001|Overall Study|Withdrawal by Subject|0|||
126476526|NCT01385566|455044963|FG002|Overall Study|Withdrawal by Subject|0|||
126476527|NCT01385566|455044964|FG003|Overall Study|Withdrawal by Subject|1|||
126476528|NCT01385566|455044965|FG004|Overall Study|Withdrawal by Subject|0|||
126476529|NCT01385566|455044966|FG005|Overall Study|Withdrawal by Subject|0|||
126476530|NCT00403234|455044969|FG000|Overall Study|Withdrawal by Subject|0|||
126476531|NCT00403234|455044970|FG001|Overall Study|Withdrawal by Subject|1|||
126476532|NCT00403234|455044971|FG002|Overall Study|Withdrawal by Subject|0|||
126721684|NCT00364845|455930038|FG000|Overall Study|Death|0|||
126415234|NCT00988091|454815044|FG000|Double-blind Period|Withdrawal by Subject|15|||
126415235|NCT00988091|454815045|FG001|Double-blind Period|Withdrawal by Subject|13|||
126415236|NCT00988091|454815044|FG000|Double-blind Period|Lost to Follow-up|12|||
126415237|NCT00988091|454815045|FG001|Double-blind Period|Lost to Follow-up|14|||
126415238|NCT00988091|454815044|FG000|Double-blind Period|Other|8|||
126415239|NCT00988091|454815045|FG001|Double-blind Period|Other|8|||
126415240|NCT00988091|454815044|FG000|Double-blind Period|Adverse Event|6|||
126415241|NCT00988091|454815045|FG001|Double-blind Period|Adverse Event|9|||
126415242|NCT00988091|454815044|FG000|Double-blind Period|Use of exclusionary medication|2|||
126415243|NCT00988091|454815045|FG001|Double-blind Period|Use of exclusionary medication|3|||
126415244|NCT00988091|454815044|FG000|Open-label Period|Adverse Event|4|||
126415245|NCT00988091|454815045|FG001|Open-label Period|Adverse Event|7|||
126415246|NCT00988091|454815044|FG000|Open-label Period|Use of exclusionary medication|1|||
126415247|NCT00988091|454815045|FG001|Open-label Period|Use of exclusionary medication|1|||
126415248|NCT00988091|454815044|FG000|Open-label Period|Protocol Violation|1|||
126415249|NCT00988091|454815045|FG001|Open-label Period|Protocol Violation|1|||
126415250|NCT00988091|454815044|FG000|Open-label Period|Withdrawal by Subject|10|||
126415251|NCT00988091|454815045|FG001|Open-label Period|Withdrawal by Subject|16|||
126415252|NCT00988091|454815044|FG000|Open-label Period|Lost to Follow-up|3|||
126415253|NCT00988091|454815045|FG001|Open-label Period|Lost to Follow-up|5|||
126415254|NCT00988091|454815044|FG000|Open-label Period|Other|2|||
126415255|NCT00988091|454815045|FG001|Open-label Period|Other|3|||
126415256|NCT00994422|454815046|FG000|Overall Study|Lost to Follow-up|7|||
126415257|NCT00994422|454815047|FG001|Overall Study|Lost to Follow-up|1|||
126415258|NCT01846741|454815049|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
126415259|NCT03664765|454815050|FG000|Overall Study|Withdrawal by Subject|4|||
126415260|NCT03664765|454815051|FG001|Overall Study|Withdrawal by Subject|1|||
126415261|NCT03664765|454815050|FG000|Overall Study|Lost to Follow-up|0|||
126415262|NCT03664765|454815051|FG001|Overall Study|Lost to Follow-up|1|||
126415263|NCT01153698|454815052|FG000|Overall Study|Adverse Event|12|||
126415264|NCT01153698|454815052|FG000|Overall Study|Lost to Follow-up|4|||
126415265|NCT01153698|454815052|FG000|Overall Study|Withdrawal by Subject|2|||
126415266|NCT01153698|454815052|FG000|Overall Study|Switch to other anticoagulants|4|||
126415267|NCT01153698|454815052|FG000|Overall Study|Other|2|||
126415268|NCT01153698|454815052|FG000|Overall Study|Not treated with Pradaxa|5|||
126415269|NCT01090063|454815053|FG000|Screen|Screen Failed|4|||
126415270|NCT01090063|454815053|FG000|Treatment|Withdrawal by Subject|4|||
126415271|NCT01817959|454815054|FG000|Overall Study|Graft loss|1|||
126415272|NCT01817959|454815055|FG001|Overall Study|Graft loss|1|||
126415273|NCT01817959|454815054|FG000|Overall Study|forbidden medication|1|||
126415274|NCT01817959|454815055|FG001|Overall Study|forbidden medication|1|||
126415275|NCT01817959|454815054|FG000|Overall Study|Adverse Event|1|||
126415276|NCT01817959|454815055|FG001|Overall Study|Adverse Event|0|||
126415277|NCT01817959|454815054|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
126415278|NCT01817959|454815055|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
126415279|NCT00330681|454815061|FG000|Overall Study|Adverse Event|3|||
126415280|NCT00330681|454815062|FG001|Overall Study|Adverse Event|6|||
126415281|NCT00330681|454815061|FG000|Overall Study|Protocol Violation|0|||
126415282|NCT00330681|454815062|FG001|Overall Study|Protocol Violation|1|||
126415283|NCT00330681|454815061|FG000|Overall Study|Withdrawal by Subject|5|||
126415284|NCT00330681|454815062|FG001|Overall Study|Withdrawal by Subject|5|||
126415285|NCT00330681|454815061|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
126415286|NCT00330681|454815062|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
126415287|NCT02578186|454815063|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
126415288|NCT02578186|454815064|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
126415289|NCT02578186|454815063|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
126415290|NCT02578186|454815064|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
126415291|NCT01140061|454815065|FG000|Part I|Adverse Event|1|||
126415292|NCT01140061|454815066|FG001|Part I|Adverse Event|0|||
126415293|NCT01140061|454815067|FG002|Part I|Adverse Event|0|||
126415294|NCT01140061|454815068|FG003|Part I|Adverse Event|0|||
126415295|NCT01140061|454815069|FG004|Part I|Adverse Event|0|||
126415296|NCT01140061|454815070|FG005|Part I|Adverse Event|0|||
126415297|NCT01140061|454815071|FG006|Part I|Adverse Event|0|||
126415298|NCT01140061|454815072|FG007|Part I|Adverse Event|0|||
126415299|NCT01140061|454815073|FG008|Part I|Adverse Event|0|||
126415300|NCT01140061|454815074|FG009|Part I|Adverse Event|0|||
126415301|NCT01140061|454815065|FG000|Extension|Laboratory Adverse Event|0|||
126415302|NCT01140061|454815066|FG001|Extension|Laboratory Adverse Event|0|||
126415303|NCT01140061|454815067|FG002|Extension|Laboratory Adverse Event|0|||
126415304|NCT01140061|454815068|FG003|Extension|Laboratory Adverse Event|0|||
126415305|NCT01140061|454815069|FG004|Extension|Laboratory Adverse Event|0|||
126415306|NCT01140061|454815070|FG005|Extension|Laboratory Adverse Event|0|||
126415307|NCT01140061|454815071|FG006|Extension|Laboratory Adverse Event|0|||
126415308|NCT01140061|454815072|FG007|Extension|Laboratory Adverse Event|0|||
126415309|NCT01140061|454815073|FG008|Extension|Laboratory Adverse Event|0|||
126415310|NCT01140061|454815074|FG009|Extension|Laboratory Adverse Event|1|||
126558972|NCT03239210|455340593|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
126558973|NCT03239210|455340594|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
126558974|NCT03239210|455340593|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
126415311|NCT00428389|454815075|FG000|Core Phase|Adverse Event|6|||
126415312|NCT00428389|454815076|FG001|Core Phase|Adverse Event|4|||
126415313|NCT00428389|454815075|FG000|Core Phase|Lack of Efficacy|2|||
126415314|NCT00428389|454815076|FG001|Core Phase|Lack of Efficacy|0|||
126415315|NCT00428389|454815075|FG000|Core Phase|Abnormal test procedure result(s)|0|||
126415316|NCT00428389|454815076|FG001|Core Phase|Abnormal test procedure result(s)|1|||
126415317|NCT00428389|454815075|FG000|Core Phase|Withdrawal by Subject|3|||
126415318|NCT00428389|454815076|FG001|Core Phase|Withdrawal by Subject|4|||
126415319|NCT00428389|454815075|FG000|Core Phase|Protocol deviation|0|||
126415320|NCT00428389|454815076|FG001|Core Phase|Protocol deviation|2|||
126415321|NCT00428389|454815075|FG000|Extension Phase|Adverse Event|17|||
126415322|NCT00428389|454815076|FG001|Extension Phase|Adverse Event|11|||
126415323|NCT00428389|454815075|FG000|Extension Phase|Lack of Efficacy|4|||
126415324|NCT00428389|454815076|FG001|Extension Phase|Lack of Efficacy|3|||
126415325|NCT00428389|454815075|FG000|Extension Phase|Withdrawal by Subject|6|||
126415326|NCT00428389|454815076|FG001|Extension Phase|Withdrawal by Subject|6|||
126415327|NCT00428389|454815075|FG000|Extension Phase|Lost to Follow-up|0|||
126476533|NCT00403234|455044972|FG003|Overall Study|Withdrawal by Subject|0|||
126476534|NCT00403234|455044969|FG000|Overall Study|Adverse Event|1|||
126476535|NCT00403234|455044970|FG001|Overall Study|Adverse Event|0|||
126476536|NCT00403234|455044971|FG002|Overall Study|Adverse Event|1|||
126476537|NCT00403234|455044972|FG003|Overall Study|Adverse Event|0|||
126476538|NCT04092582|455044973|FG000|Overall Study|Death|1|||
126476539|NCT04092582|455044974|FG001|Overall Study|Death|1|||
126476540|NCT04092582|455044973|FG000|Overall Study|Withdrawal by Subject|4|||
126476541|NCT04092582|455044974|FG001|Overall Study|Withdrawal by Subject|1|||
126476542|NCT04092582|455044973|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
126476543|NCT04092582|455044974|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
126476544|NCT00560105|455044981|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
126476545|NCT00560105|455044982|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
126476546|NCT02025621|455044986|FG000|Overall Study|Withdrawal by Subject|1|||
126476547|NCT02025621|455044987|FG001|Overall Study|Withdrawal by Subject|0|||
126476548|NCT02025621|455044986|FG000|Overall Study|Death|0|||
126476549|NCT02025621|455044987|FG001|Overall Study|Death|1|||
126476550|NCT02025621|455044986|FG000|Overall Study|No longer eligible|10|||
126476551|NCT02025621|455044987|FG001|Overall Study|No longer eligible|15|||
126476552|NCT02025621|455044986|FG000|Overall Study|Surgery initiated before infusion|3|||
126476553|NCT02025621|455044987|FG001|Overall Study|Surgery initiated before infusion|3|||
126476554|NCT00739674|455044988|FG000|Overall Study|Screening failures|19|||
126476555|NCT00739674|455044989|FG001|Overall Study|Screening failures|17|||
126476556|NCT00739674|455044988|FG000|Overall Study|Site 212 removal|19|||
126476557|NCT00739674|455044989|FG001|Overall Study|Site 212 removal|13|||
126476558|NCT00739674|455044988|FG000|Overall Study|No follow-up data|33|||
126476559|NCT00739674|455044989|FG001|Overall Study|No follow-up data|18|||
126476560|NCT00739674|455044988|FG000|Overall Study|Dietician consultation >30 days|1|||
126476561|NCT00739674|455044989|FG001|Overall Study|Dietician consultation >30 days|9|||
126476562|NCT00739674|455044988|FG000|Overall Study|Adverse Event|22|||
126476563|NCT00739674|455044989|FG001|Overall Study|Adverse Event|13|||
126476564|NCT00739674|455044988|FG000|Overall Study|Death|1|||
126476565|NCT00739674|455044989|FG001|Overall Study|Death|0|||
126476566|NCT00739674|455044988|FG000|Overall Study|Lack of Efficacy|1|||
126476567|NCT00739674|455044989|FG001|Overall Study|Lack of Efficacy|0|||
126476568|NCT00739674|455044988|FG000|Overall Study|Lost to Follow-up|52|||
126476569|NCT00739674|455044989|FG001|Overall Study|Lost to Follow-up|30|||
126476570|NCT00739674|455044988|FG000|Overall Study|Protocol Violation|5|||
126476571|NCT00739674|455044989|FG001|Overall Study|Protocol Violation|5|||
126476572|NCT00739674|455044988|FG000|Overall Study|Withdrawal by Subject|9|||
126476573|NCT00739674|455044989|FG001|Overall Study|Withdrawal by Subject|9|||
126415328|NCT00428389|454815076|FG001|Extension Phase|Lost to Follow-up|3|||
126415329|NCT00428389|454815075|FG000|Extension Phase|Death|1|||
126415330|NCT00428389|454815076|FG001|Extension Phase|Death|0|||
126415331|NCT00428389|454815075|FG000|Extension Phase|Protocol Violation|3|||
126415332|NCT00428389|454815076|FG001|Extension Phase|Protocol Violation|2|||
126415333|NCT00428389|454815075|FG000|Extension Phase|Administrative problems|1|||
126415334|NCT00428389|454815076|FG001|Extension Phase|Administrative problems|1|||
126415335|NCT02669121|454815077|FG000|Overall Study|Adverse Event|4|||
126476574|NCT00739674|455044988|FG000|Overall Study|Reason missing|2|||
126476575|NCT00739674|455044989|FG001|Overall Study|Reason missing|0|||
126476576|NCT00739674|455044988|FG000|Overall Study|Clinic closed|6|||
126476577|NCT00739674|455044989|FG001|Overall Study|Clinic closed|4|||
126476578|NCT00739674|455044988|FG000|Overall Study|Patient moved|3|||
126476579|NCT00739674|455044989|FG001|Overall Study|Patient moved|2|||
126476580|NCT00739674|455044988|FG000|Overall Study|Non compliant|4|||
126476581|NCT00739674|455044989|FG001|Overall Study|Non compliant|0|||
126476582|NCT00739674|455044988|FG000|Overall Study|Unable to attend visit|3|||
126476583|NCT00739674|455044989|FG001|Overall Study|Unable to attend visit|1|||
126476584|NCT00739674|455044988|FG000|Overall Study|Home monitoring off meds|1|||
126476585|NCT00739674|455044989|FG001|Overall Study|Home monitoring off meds|0|||
126476586|NCT00739674|455044988|FG000|Overall Study|Erectile dysfunction|0|||
126476587|NCT00739674|455044989|FG001|Overall Study|Erectile dysfunction|1|||
126476588|NCT04805541|455044991|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
126476589|NCT00283400|455044995|FG000|Overall Study|Withdrawal by Subject|1|||
126476590|NCT00283400|455044996|FG001|Overall Study|Withdrawal by Subject|1|||
126476591|NCT00283400|455044997|FG002|Overall Study|Withdrawal by Subject|0|||
126476592|NCT00283400|455044998|FG003|Overall Study|Withdrawal by Subject|0|||
126476593|NCT00283400|455044995|FG000|Overall Study|Death|1|||
126476594|NCT00283400|455044996|FG001|Overall Study|Death|0|||
126476595|NCT00283400|455044997|FG002|Overall Study|Death|1|||
126476596|NCT00283400|455044998|FG003|Overall Study|Death|0|||
126476597|NCT01034631|455045000|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
126476598|NCT01034631|455045001|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
126476599|NCT01034631|455045002|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
126476600|NCT01034631|455045000|FG000|Phase II|Not Evaluable per protocol|0|||
126476601|NCT01034631|455045001|FG001|Phase II|Not Evaluable per protocol|0|||
126476602|NCT01034631|455045002|FG002|Phase II|Not Evaluable per protocol|2|||
126476603|NCT01034631|455045000|FG000|Phase II|Determined Ineligible per protocol|0|||
126476604|NCT01034631|455045001|FG001|Phase II|Determined Ineligible per protocol|1|||
126476605|NCT01034631|455045002|FG002|Phase II|Determined Ineligible per protocol|0|||
126476606|NCT01560403|455045003|FG000|Overall Study|Lost to Follow-up|0|||
126476607|NCT01560403|455045004|FG001|Overall Study|Lost to Follow-up|1|||
126476608|NCT04218695|455045005|FG000|Overall Study|Adverse Event|1|||
126476609|NCT04218695|455045006|FG001|Overall Study|Adverse Event|0|||
126476610|NCT00983437|455045007|FG000|Overall Study|Adverse Event|9|||
126476611|NCT00983437|455045007|FG000|Overall Study|Lack of Efficacy|1|||
126476612|NCT00983437|455045007|FG000|Overall Study|Withdrawal by Subject|8|||
126476613|NCT00983437|455045007|FG000|Overall Study|Noncompliance to Study Procedures|1|||
126476614|NCT00983437|455045007|FG000|Overall Study|Lost to Follow-up|2|||
126476615|NCT00983437|455045007|FG000|Overall Study|Other Reason|26|||
126476616|NCT01890473|455045008|FG000|Overall Study|Lost to Follow-up|1|||
126476617|NCT01890473|455045009|FG001|Overall Study|Lost to Follow-up|0|||
126476618|NCT01890473|455045008|FG000|Overall Study|Poor/non-compliance|1|||
126476619|NCT01890473|455045009|FG001|Overall Study|Poor/non-compliance|0|||
126476620|NCT04019288|455045010|FG000|Overall Study|Death|1|||
126476621|NCT04019288|455045011|FG001|Overall Study|Death|0|||
126476622|NCT04019288|455045012|FG002|Overall Study|Death|0|||
126476623|NCT03166735|455045013|FG000|Overall Study|Not Treated|1|||
126476624|NCT03166735|455045014|FG001|Overall Study|Not Treated|0|||
126476625|NCT03166735|455045015|FG002|Overall Study|Not Treated|0|||
126476626|NCT03166735|455045016|FG003|Overall Study|Not Treated|0|||
126476627|NCT03166735|455045017|FG004|Overall Study|Not Treated|0|||
126476628|NCT03166735|455045013|FG000|Overall Study|follow-up not completed as planned|0|||
126476629|NCT03166735|455045014|FG001|Overall Study|follow-up not completed as planned|1|||
126476630|NCT03166735|455045015|FG002|Overall Study|follow-up not completed as planned|1|||
126476631|NCT03166735|455045016|FG003|Overall Study|follow-up not completed as planned|0|||
126476632|NCT03166735|455045017|FG004|Overall Study|follow-up not completed as planned|1|||
126476633|NCT03166735|455045013|FG000|Overall Study|Withdrawal by Subject|0|||
126476634|NCT03166735|455045014|FG001|Overall Study|Withdrawal by Subject|0|||
126476635|NCT03166735|455045015|FG002|Overall Study|Withdrawal by Subject|1|||
126476636|NCT03166735|455045016|FG003|Overall Study|Withdrawal by Subject|1|||
126476637|NCT03166735|455045017|FG004|Overall Study|Withdrawal by Subject|2|||
126476638|NCT03166735|455045013|FG000|Overall Study|Lost to Follow-up|0|||
126476639|NCT03166735|455045014|FG001|Overall Study|Lost to Follow-up|2|||
126476640|NCT03166735|455045015|FG002|Overall Study|Lost to Follow-up|1|||
126476641|NCT03166735|455045016|FG003|Overall Study|Lost to Follow-up|0|||
126476642|NCT03166735|455045017|FG004|Overall Study|Lost to Follow-up|1|||
126476643|NCT01020981|455045021|FG000|Overall Study|Did not return mailed survey|74|||
126476644|NCT01020981|455045022|FG001|Overall Study|Did not return mailed survey|58|||
126476645|NCT01020981|455045021|FG000|Overall Study|Survey returned undeliverable|8|||
126476646|NCT01020981|455045022|FG001|Overall Study|Survey returned undeliverable|32|||
126476647|NCT01020981|455045021|FG000|Overall Study|Participant declined to complete survey|2|||
126476648|NCT01020981|455045022|FG001|Overall Study|Participant declined to complete survey|0|||
126476649|NCT00040365|455045033|FG000|Overall Study|Death|1|||
126476650|NCT00040365|455045033|FG000|Overall Study|Progressive disease|7|||
126558975|NCT03239210|455340594|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
126476651|NCT00040365|455045033|FG000|Overall Study|Lost to Follow-up|3|||
126476652|NCT00541931|455045034|FG000|Overall Study|Adverse Event|1|||
126476653|NCT00541931|455045035|FG001|Overall Study|Adverse Event|0|||
126476654|NCT00541931|455045034|FG000|Overall Study|Lost to Follow-up|3|||
126558976|NCT01403987|455340596|FG000|Overall Study|Residents forgot their secret PIN|18|||
126476655|NCT00541931|455045035|FG001|Overall Study|Lost to Follow-up|3|||
126476656|NCT00541931|455045034|FG000|Overall Study|Withdrawal by Subject|1|||
126415336|NCT02669121|454815078|FG001|Overall Study|Adverse Event|5|||
126415337|NCT02669121|454815077|FG000|Overall Study|Lost to Follow-up|15|||
126415338|NCT02669121|454815078|FG001|Overall Study|Lost to Follow-up|27|||
126415339|NCT02669121|454815077|FG000|Overall Study|Withdrawal by Subject|132|||
126415340|NCT02669121|454815078|FG001|Overall Study|Withdrawal by Subject|140|||
126415341|NCT02669121|454815077|FG000|Overall Study|Pregnancy|0|||
126415342|NCT02669121|454815078|FG001|Overall Study|Pregnancy|1|||
126415343|NCT02669121|454815077|FG000|Overall Study|Discharged from US Military Active Service|117|||
126415344|NCT02669121|454815078|FG001|Overall Study|Discharged from US Military Active Service|91|||
126415345|NCT02669121|454815077|FG000|Overall Study|Reason not Specified|22|||
126415346|NCT02669121|454815078|FG001|Overall Study|Reason not Specified|18|||
126415347|NCT03216746|454815079|FG000|Overall Study|Lost to Follow-up|6|||
126415348|NCT03216746|454815080|FG001|Overall Study|Lost to Follow-up|8|||
126415349|NCT03216746|454815081|FG002|Overall Study|Lost to Follow-up|5|||
126415350|NCT03216746|454815082|FG003|Overall Study|Lost to Follow-up|6|||
126415351|NCT04384523|454815083|FG000|Overall Study|Lost to Follow-up|0|||
126415352|NCT04384523|454815084|FG001|Overall Study|Lost to Follow-up|0|||
126415353|NCT04384523|454815085|FG002|Overall Study|Lost to Follow-up|0|||
126415354|NCT04384523|454815086|FG003|Overall Study|Lost to Follow-up|0|||
126415355|NCT04384523|454815087|FG004|Overall Study|Lost to Follow-up|0|||
126415356|NCT04384523|454815088|FG005|Overall Study|Lost to Follow-up|1|||
126415357|NCT04384523|454815083|FG000|Overall Study|Protocol Violation|0|||
126415358|NCT04384523|454815084|FG001|Overall Study|Protocol Violation|1|||
126415359|NCT04384523|454815085|FG002|Overall Study|Protocol Violation|0|||
126415360|NCT04384523|454815086|FG003|Overall Study|Protocol Violation|0|||
126415361|NCT04384523|454815087|FG004|Overall Study|Protocol Violation|0|||
126415362|NCT04384523|454815088|FG005|Overall Study|Protocol Violation|0|||
126415363|NCT04384523|454815083|FG000|Overall Study|Withdrawal by Subject|1|||
126415364|NCT04384523|454815084|FG001|Overall Study|Withdrawal by Subject|0|||
126415365|NCT04384523|454815085|FG002|Overall Study|Withdrawal by Subject|0|||
126415366|NCT04384523|454815086|FG003|Overall Study|Withdrawal by Subject|0|||
126415367|NCT04384523|454815087|FG004|Overall Study|Withdrawal by Subject|0|||
126415368|NCT04384523|454815088|FG005|Overall Study|Withdrawal by Subject|0|||
126721685|NCT00364845|455930039|FG001|Overall Study|Death|1|||
126721686|NCT00488033|455930040|FG000|Overall Study|Withdrawal by Subject|1|||
126721687|NCT00488033|455930041|FG001|Overall Study|Withdrawal by Subject|0|||
126721688|NCT04715230|455930044|FG000|Overall Study|Withdrawal by Subject|1|||
126415369|NCT04405076|454815089|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
126415370|NCT04405076|454815090|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
126415371|NCT04405076|454815091|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
126415372|NCT04405076|454815092|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
126415373|NCT04405076|454815093|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
126415374|NCT04405076|454815094|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
126415375|NCT04405076|454815095|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
126415376|NCT04405076|454815096|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
126415377|NCT04405076|454815097|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
126415378|NCT04405076|454815089|FG000|Part A (Blinded Phase)|Physician Decision|1|||
126476657|NCT00541931|455045035|FG001|Overall Study|Withdrawal by Subject|0|||
126476658|NCT00541931|455045034|FG000|Overall Study|Transportation Issue|0|||
126476659|NCT00541931|455045035|FG001|Overall Study|Transportation Issue|1|||
126476660|NCT01086033|455045036|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
126476661|NCT01086033|455045036|FG000|Overall Study|Lost to Follow-up|86|||
126476662|NCT01086033|455045036|FG000|Overall Study|Adverse Event|42|||
126476663|NCT01086033|455045036|FG000|Overall Study|Withdrawal by Subject|41|||
126476664|NCT01086033|455045036|FG000|Overall Study|Other|14|||
126476665|NCT01086033|455045036|FG000|Overall Study|Other|13|||
126476666|NCT01086033|455045036|FG000|Overall Study|AE and Withdrew Consent|5|||
126476667|NCT01086033|455045036|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
126476668|NCT01086033|455045036|FG000|Overall Study|Withdrew consent and Other Reason|4|||
126476669|NCT01086033|455045036|FG000|Overall Study|AE and Lack of Efficacy|4|||
126558977|NCT01403987|455340597|FG001|Overall Study|Residents forgot their secret PIN|17|||
126721689|NCT04715230|455930045|FG001|Overall Study|Withdrawal by Subject|0|||
126558978|NCT01403987|455340598|FG002|Overall Study|Residents forgot their secret PIN|18|||
126558979|NCT00751790|455340599|FG000|Overall Study|Lost to Follow-up|1|||
126721690|NCT04715230|455930046|FG002|Overall Study|Withdrawal by Subject|0|||
126415379|NCT04405076|454815090|FG001|Part A (Blinded Phase)|Physician Decision|2|||
126415380|NCT04405076|454815091|FG002|Part A (Blinded Phase)|Physician Decision|0|||
126415381|NCT04405076|454815092|FG003|Part A (Blinded Phase)|Physician Decision|0|||
126415382|NCT04405076|454815093|FG004|Part A (Blinded Phase)|Physician Decision|0|||
126415383|NCT04405076|454815094|FG005|Part A (Blinded Phase)|Physician Decision|0|||
126415384|NCT04405076|454815095|FG006|Part A (Blinded Phase)|Physician Decision|0|||
126415385|NCT04405076|454815096|FG007|Part A (Blinded Phase)|Physician Decision|0|||
126415386|NCT04405076|454815097|FG008|Part A (Blinded Phase)|Physician Decision|0|||
126476670|NCT01086033|455045036|FG000|Overall Study|Death|1|||
126721691|NCT04715230|455930044|FG000|Overall Study|Lost to Follow-up|0|||
126415387|NCT04405076|454815089|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
126415388|NCT04405076|454815090|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
126415389|NCT04405076|454815091|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
126415390|NCT04405076|454815092|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
126415391|NCT04405076|454815093|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
126415392|NCT04405076|454815094|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
126415393|NCT04405076|454815095|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
126415394|NCT04405076|454815096|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
126415395|NCT04405076|454815097|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
126415396|NCT04405076|454815089|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
126415397|NCT04405076|454815090|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415398|NCT04405076|454815091|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415399|NCT04405076|454815092|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415400|NCT04405076|454815093|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415401|NCT04405076|454815094|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415402|NCT04405076|454815095|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415403|NCT04405076|454815096|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415404|NCT04405076|454815097|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
126415405|NCT04405076|454815089|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
126415406|NCT04405076|454815090|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
126415407|NCT04405076|454815091|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415408|NCT04405076|454815092|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415409|NCT04405076|454815093|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415410|NCT04405076|454815094|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415411|NCT04405076|454815095|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415412|NCT04405076|454815096|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415413|NCT04405076|454815097|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
126415414|NCT04405076|454815089|FG000|Part A (Blinded Phase)|Other than Specified|0|||
126415415|NCT04405076|454815090|FG001|Part A (Blinded Phase)|Other than Specified|0|||
126415416|NCT04405076|454815091|FG002|Part A (Blinded Phase)|Other than Specified|3|||
126415417|NCT04405076|454815092|FG003|Part A (Blinded Phase)|Other than Specified|0|||
126415418|NCT04405076|454815093|FG004|Part A (Blinded Phase)|Other than Specified|0|||
126415419|NCT04405076|454815094|FG005|Part A (Blinded Phase)|Other than Specified|0|||
126415420|NCT04405076|454815095|FG006|Part A (Blinded Phase)|Other than Specified|0|||
126415421|NCT04405076|454815096|FG007|Part A (Blinded Phase)|Other than Specified|0|||
126415422|NCT04405076|454815097|FG008|Part A (Blinded Phase)|Other than Specified|0|||
126415423|NCT04405076|454815089|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
126415424|NCT04405076|454815090|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
126415425|NCT04405076|454815091|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
126415426|NCT04405076|454815092|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
126415427|NCT04405076|454815093|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
126415428|NCT04405076|454815094|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
126415429|NCT04405076|454815095|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
126415430|NCT04405076|454815096|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
126415431|NCT04405076|454815097|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
126415432|NCT04405076|454815089|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415433|NCT04405076|454815090|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415434|NCT04405076|454815091|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415435|NCT04405076|454815092|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415436|NCT04405076|454815093|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
126415437|NCT04405076|454815094|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415438|NCT04405076|454815095|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415439|NCT04405076|454815096|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415440|NCT04405076|454815097|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
126415441|NCT04405076|454815089|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
126415442|NCT04405076|454815090|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
126415443|NCT04405076|454815091|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
126415444|NCT04405076|454815092|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
126415445|NCT04405076|454815093|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
126415446|NCT04405076|454815094|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
126415447|NCT04405076|454815095|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
126415448|NCT04405076|454815096|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
126415449|NCT04405076|454815097|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
126415450|NCT04405076|454815089|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415451|NCT04405076|454815090|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415452|NCT04405076|454815091|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415453|NCT04405076|454815092|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415454|NCT04405076|454815093|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415455|NCT04405076|454815094|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415456|NCT04405076|454815095|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
126415457|NCT04405076|454815096|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
126415458|NCT04405076|454815097|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
126415459|NCT04405076|454815089|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415460|NCT04405076|454815090|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415461|NCT04405076|454815091|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415462|NCT04405076|454815092|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415463|NCT04405076|454815093|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415464|NCT04405076|454815094|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415465|NCT04405076|454815095|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
126415466|NCT04405076|454815096|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415467|NCT04405076|454815097|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
126415468|NCT00392990|454815100|FG000|Treatment on Study|Adverse Event|3|||
126415469|NCT00392990|454815101|FG001|Treatment on Study|Adverse Event|1|||
126415470|NCT00392990|454815100|FG000|Follow up for 2 Years|Death|4|||
126415471|NCT00392990|454815101|FG001|Follow up for 2 Years|Death|0|||
126415472|NCT02980133|454815102|FG000|Overall Study|Other than specified|1|||
126415473|NCT02980133|454815103|FG001|Overall Study|Other than specified|1|||
126415474|NCT02980133|454815104|FG002|Overall Study|Other than specified|2|||
126415475|NCT02980133|454815105|FG003|Overall Study|Other than specified|2|||
126415476|NCT02980133|454815102|FG000|Overall Study|Lost to Follow-up|0|||
126415477|NCT02980133|454815103|FG001|Overall Study|Lost to Follow-up|0|||
126415478|NCT02980133|454815104|FG002|Overall Study|Lost to Follow-up|1|||
126415479|NCT02980133|454815105|FG003|Overall Study|Lost to Follow-up|3|||
126415480|NCT02980133|454815102|FG000|Overall Study|Protocol Violation|0|||
126415481|NCT02980133|454815103|FG001|Overall Study|Protocol Violation|1|||
126415482|NCT02980133|454815104|FG002|Overall Study|Protocol Violation|0|||
126415483|NCT02980133|454815105|FG003|Overall Study|Protocol Violation|0|||
126415484|NCT02980133|454815102|FG000|Overall Study|Withdrawal by parent/guardian|6|||
126415485|NCT02980133|454815103|FG001|Overall Study|Withdrawal by parent/guardian|3|||
126415486|NCT02980133|454815104|FG002|Overall Study|Withdrawal by parent/guardian|3|||
126415487|NCT02980133|454815105|FG003|Overall Study|Withdrawal by parent/guardian|1|||
126415488|NCT02980133|454815102|FG000|Overall Study|Withdrawal by Subject|0|||
126415489|NCT02980133|454815103|FG001|Overall Study|Withdrawal by Subject|0|||
126415490|NCT02980133|454815104|FG002|Overall Study|Withdrawal by Subject|1|||
126415491|NCT02980133|454815105|FG003|Overall Study|Withdrawal by Subject|0|||
126415492|NCT00825812|454815106|FG000|Overall Study|Never entered follow up|0|||
126415493|NCT00825812|454815107|FG001|Overall Study|Never entered follow up|0|||
126415494|NCT00825812|454815108|FG002|Overall Study|Never entered follow up|0|||
126415495|NCT00825812|454815109|FG003|Overall Study|Never entered follow up|1|||
126415496|NCT00825812|454815106|FG000|Overall Study|Adverse Event|0|||
126415497|NCT00825812|454815107|FG001|Overall Study|Adverse Event|0|||
126415498|NCT00825812|454815108|FG002|Overall Study|Adverse Event|0|||
126415499|NCT00825812|454815109|FG003|Overall Study|Adverse Event|1|||
126415500|NCT00825812|454815106|FG000|Overall Study|Subject withdrew consent|0|||
126415501|NCT00825812|454815107|FG001|Overall Study|Subject withdrew consent|0|||
126415502|NCT00825812|454815108|FG002|Overall Study|Subject withdrew consent|3|||
126415503|NCT00825812|454815109|FG003|Overall Study|Subject withdrew consent|2|||
126415504|NCT00825812|454815106|FG000|Overall Study|Non-compliance with protocol|0|||
126415505|NCT00825812|454815107|FG001|Overall Study|Non-compliance with protocol|0|||
126415506|NCT00825812|454815108|FG002|Overall Study|Non-compliance with protocol|0|||
126415507|NCT00825812|454815109|FG003|Overall Study|Non-compliance with protocol|1|||
126415508|NCT00825812|454815106|FG000|Overall Study|Administrative|0|||
126415509|NCT00825812|454815107|FG001|Overall Study|Administrative|1|||
126415510|NCT00825812|454815108|FG002|Overall Study|Administrative|3|||
126415511|NCT00825812|454815109|FG003|Overall Study|Administrative|5|||
126415512|NCT00172042|454815110|FG000|Overall Study|Adverse Event|27|||
126415513|NCT00172042|454815111|FG001|Overall Study|Adverse Event|13|||
126415514|NCT00172042|454815110|FG000|Overall Study|Abnormal laboratory value(s)|5|||
126415515|NCT00172042|454815111|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126415516|NCT00172042|454815110|FG000|Overall Study|Abnormal test procedure(s)|0|||
126415517|NCT00172042|454815111|FG001|Overall Study|Abnormal test procedure(s)|3|||
126415518|NCT00172042|454815110|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
126415519|NCT00172042|454815111|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
126415520|NCT00172042|454815110|FG000|Overall Study|Patient no longer requires study drug|10|||
126415521|NCT00172042|454815111|FG001|Overall Study|Patient no longer requires study drug|8|||
126415522|NCT00172042|454815110|FG000|Overall Study|Protocol Violation|8|||
126415523|NCT00172042|454815111|FG001|Overall Study|Protocol Violation|7|||
126415524|NCT00172042|454815110|FG000|Overall Study|Withdrawal by Subject|37|||
126476671|NCT01086033|455045036|FG000|Overall Study|AE and Lost to Follow-up|1|||
126476672|NCT01086033|455045036|FG000|Overall Study|AE and Other Reason|1|||
126476673|NCT01086033|455045036|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
126476674|NCT05154578|455045037|FG000|Overall Study|Withdrawal by Subject|2|||
126476675|NCT05154578|455045038|FG001|Overall Study|Withdrawal by Subject|3|||
126476676|NCT05154578|455045039|FG002|Overall Study|Withdrawal by Subject|2|||
126476677|NCT05154578|455045040|FG003|Overall Study|Withdrawal by Subject|4|||
126476678|NCT05154578|455045041|FG004|Overall Study|Withdrawal by Subject|0|||
126476679|NCT05154578|455045037|FG000|Overall Study|Lost to Follow-up|0|||
126476680|NCT05154578|455045038|FG001|Overall Study|Lost to Follow-up|1|||
126476681|NCT05154578|455045039|FG002|Overall Study|Lost to Follow-up|0|||
126476682|NCT05154578|455045040|FG003|Overall Study|Lost to Follow-up|3|||
126476683|NCT05154578|455045041|FG004|Overall Study|Lost to Follow-up|0|||
126476684|NCT05154578|455045037|FG000|Overall Study|Adverse Event|0|||
126476685|NCT05154578|455045038|FG001|Overall Study|Adverse Event|0|||
126476686|NCT05154578|455045039|FG002|Overall Study|Adverse Event|0|||
126476687|NCT05154578|455045040|FG003|Overall Study|Adverse Event|1|||
126476688|NCT05154578|455045041|FG004|Overall Study|Adverse Event|0|||
126476689|NCT05154578|455045037|FG000|Overall Study|Relocated to another province|0|||
126476690|NCT05154578|455045038|FG001|Overall Study|Relocated to another province|0|||
126476691|NCT05154578|455045039|FG002|Overall Study|Relocated to another province|1|||
126476692|NCT05154578|455045040|FG003|Overall Study|Relocated to another province|0|||
126476693|NCT05154578|455045041|FG004|Overall Study|Relocated to another province|1|||
126476694|NCT05154578|455045037|FG000|Overall Study|Baby loss|0|||
126476695|NCT05154578|455045038|FG001|Overall Study|Baby loss|1|||
126476696|NCT05154578|455045039|FG002|Overall Study|Baby loss|0|||
126476697|NCT05154578|455045040|FG003|Overall Study|Baby loss|0|||
126476698|NCT05154578|455045041|FG004|Overall Study|Baby loss|0|||
126476699|NCT04572633|455045047|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
126476700|NCT02924571|455045048|FG000|Overall Study|Lost to Follow-up|1|||
126476701|NCT02924571|455045049|FG001|Overall Study|Lost to Follow-up|1|||
126476702|NCT02924571|455045050|FG002|Overall Study|Lost to Follow-up|0|||
126476703|NCT00129272|455045056|FG000|Overall Study|Lost to Follow-up|12|||
126476704|NCT00129272|455045057|FG001|Overall Study|Lost to Follow-up|11|||
126476705|NCT00129272|455045056|FG000|Overall Study|Withdrawal by Subject|5|||
126476706|NCT00129272|455045057|FG001|Overall Study|Withdrawal by Subject|11|||
126415525|NCT00172042|454815111|FG001|Overall Study|Withdrawal by Subject|25|||
126415526|NCT00172042|454815110|FG000|Overall Study|Lost to Follow-up|3|||
126415527|NCT00172042|454815111|FG001|Overall Study|Lost to Follow-up|5|||
126415528|NCT00172042|454815110|FG000|Overall Study|Administrative problems|13|||
126415529|NCT00172042|454815111|FG001|Overall Study|Administrative problems|10|||
126415530|NCT00172042|454815110|FG000|Overall Study|Death|42|||
126415531|NCT00172042|454815111|FG001|Overall Study|Death|42|||
126415532|NCT00483938|454815112|FG000|Overall Study|Protocol Violation|0|||
126415533|NCT00483938|454815113|FG001|Overall Study|Protocol Violation|0|||
126415534|NCT00483938|454815114|FG002|Overall Study|Protocol Violation|0|||
126415535|NCT00483938|454815115|FG003|Overall Study|Protocol Violation|0|||
126415536|NCT00483938|454815116|FG004|Overall Study|Protocol Violation|0|||
126415537|NCT00483938|454815117|FG005|Overall Study|Protocol Violation|0|||
126415538|NCT00483938|454815118|FG006|Overall Study|Protocol Violation|3|||
126415539|NCT00483938|454815112|FG000|Overall Study|Withdrawal by Subject|1|||
126415540|NCT00483938|454815113|FG001|Overall Study|Withdrawal by Subject|6|||
126415541|NCT00483938|454815114|FG002|Overall Study|Withdrawal by Subject|0|||
126415542|NCT00483938|454815115|FG003|Overall Study|Withdrawal by Subject|0|||
126415543|NCT00483938|454815116|FG004|Overall Study|Withdrawal by Subject|1|||
126415544|NCT00483938|454815117|FG005|Overall Study|Withdrawal by Subject|3|||
126415545|NCT00483938|454815118|FG006|Overall Study|Withdrawal by Subject|2|||
126415546|NCT00483938|454815112|FG000|Overall Study|Lost to Follow-up|1|||
126415547|NCT00483938|454815113|FG001|Overall Study|Lost to Follow-up|2|||
126415548|NCT00483938|454815114|FG002|Overall Study|Lost to Follow-up|0|||
126415549|NCT00483938|454815115|FG003|Overall Study|Lost to Follow-up|2|||
126415550|NCT00483938|454815116|FG004|Overall Study|Lost to Follow-up|1|||
126476707|NCT03570697|455045060|FG000|Overall Study|Lost to Follow-up|0|||
126476708|NCT03570697|455045061|FG001|Overall Study|Lost to Follow-up|1|||
126476709|NCT03570697|455045060|FG000|Overall Study|Death|2|||
126476710|NCT03570697|455045061|FG001|Overall Study|Death|0|||
126415551|NCT00483938|454815117|FG005|Overall Study|Lost to Follow-up|1|||
126415552|NCT00483938|454815118|FG006|Overall Study|Lost to Follow-up|3|||
126415553|NCT00483938|454815112|FG000|Overall Study|Death|0|||
126415554|NCT00483938|454815113|FG001|Overall Study|Death|2|||
126415555|NCT00483938|454815114|FG002|Overall Study|Death|0|||
126415556|NCT00483938|454815115|FG003|Overall Study|Death|0|||
126476711|NCT03570697|455045060|FG000|Overall Study|Withdrawal by Subject|4|||
126476712|NCT03570697|455045061|FG001|Overall Study|Withdrawal by Subject|2|||
126476713|NCT01849783|455045062|FG000|Overall Study|Adverse Event|5|||
126476714|NCT01849783|455045062|FG000|Overall Study|Death|2|||
126476715|NCT01849783|455045062|FG000|Overall Study|Physician Decision|1|||
126476716|NCT01849783|455045062|FG000|Overall Study|Withdrawal by Subject|1|||
126476717|NCT01849783|455045062|FG000|Overall Study|Unable to comply|2|||
126415557|NCT00483938|454815116|FG004|Overall Study|Death|0|||
126415558|NCT00483938|454815117|FG005|Overall Study|Death|0|||
126415559|NCT00483938|454815118|FG006|Overall Study|Death|0|||
126415560|NCT00483938|454815112|FG000|Overall Study|Other|3|||
126415561|NCT00483938|454815113|FG001|Overall Study|Other|9|||
126415562|NCT00483938|454815114|FG002|Overall Study|Other|0|||
126415563|NCT00483938|454815115|FG003|Overall Study|Other|4|||
126415564|NCT00483938|454815116|FG004|Overall Study|Other|0|||
126415565|NCT00483938|454815117|FG005|Overall Study|Other|4|||
126415566|NCT00483938|454815118|FG006|Overall Study|Other|32|||
126415567|NCT02218008|454815119|FG000|Stage 1 (S1)|Adverse Event|6|||
126415568|NCT02218008|454815120|FG001|Stage 1 (S1)|Adverse Event|5|||
126415569|NCT02218008|454815121|FG002|Stage 1 (S1)|Adverse Event|11|||
126415570|NCT02218008|454815122|FG003|Stage 1 (S1)|Adverse Event|0|||
126415571|NCT02218008|454815123|FG004|Stage 1 (S1)|Adverse Event|0|||
126415572|NCT02218008|454815124|FG005|Stage 1 (S1)|Adverse Event|0|||
126415573|NCT02218008|454815119|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
126415574|NCT02218008|454815120|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
126415575|NCT02218008|454815121|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
126415576|NCT02218008|454815122|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
126415577|NCT02218008|454815123|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
126415578|NCT02218008|454815124|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
126415579|NCT02218008|454815119|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
126415580|NCT02218008|454815120|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
126415581|NCT02218008|454815121|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
126415582|NCT02218008|454815122|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
126415583|NCT02218008|454815123|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
126415584|NCT02218008|454815124|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
126415585|NCT02218008|454815119|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
126415586|NCT02218008|454815120|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
126415587|NCT02218008|454815121|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
126415588|NCT02218008|454815122|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
126415589|NCT02218008|454815123|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
126415590|NCT02218008|454815124|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
126415591|NCT02218008|454815119|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
126415592|NCT02218008|454815120|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
126415593|NCT02218008|454815121|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
126415594|NCT02218008|454815122|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
126415595|NCT02218008|454815123|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
126415596|NCT02218008|454815124|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
126415597|NCT02218008|454815119|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
126415598|NCT02218008|454815120|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
126415599|NCT02218008|454815121|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
126415600|NCT02218008|454815122|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
126415601|NCT02218008|454815123|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
126415602|NCT02218008|454815124|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
126415603|NCT02218008|454815119|FG000|Stage 1 (S1)|Pregnancy|0|||
126415604|NCT02218008|454815120|FG001|Stage 1 (S1)|Pregnancy|0|||
126415605|NCT02218008|454815121|FG002|Stage 1 (S1)|Pregnancy|1|||
126415606|NCT02218008|454815122|FG003|Stage 1 (S1)|Pregnancy|0|||
126415607|NCT02218008|454815123|FG004|Stage 1 (S1)|Pregnancy|0|||
126415608|NCT02218008|454815124|FG005|Stage 1 (S1)|Pregnancy|0|||
126415609|NCT02218008|454815119|FG000|Stage 1 (S1)|Protocol Violation|0|||
126415610|NCT02218008|454815120|FG001|Stage 1 (S1)|Protocol Violation|0|||
126415611|NCT02218008|454815121|FG002|Stage 1 (S1)|Protocol Violation|1|||
126721692|NCT04715230|455930045|FG001|Overall Study|Lost to Follow-up|5|||
126721693|NCT04715230|455930046|FG002|Overall Study|Lost to Follow-up|1|||
126415612|NCT02218008|454815122|FG003|Stage 1 (S1)|Protocol Violation|0|||
126415613|NCT02218008|454815123|FG004|Stage 1 (S1)|Protocol Violation|0|||
126415614|NCT02218008|454815124|FG005|Stage 1 (S1)|Protocol Violation|0|||
126415615|NCT02218008|454815119|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
126415616|NCT02218008|454815120|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
126415617|NCT02218008|454815121|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
126415618|NCT02218008|454815122|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
126476718|NCT01849783|455045062|FG000|Overall Study|Disease progression|11|||
126476719|NCT03948581|455045064|FG000|Overall Study|Lost to Follow-up|0|||
126415619|NCT02218008|454815123|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
126415620|NCT02218008|454815124|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
126415621|NCT02218008|454815119|FG000|Stage 2 (S2)|Adverse Event|0|||
126415622|NCT02218008|454815120|FG001|Stage 2 (S2)|Adverse Event|0|||
126415623|NCT02218008|454815121|FG002|Stage 2 (S2)|Adverse Event|0|||
126415624|NCT02218008|454815122|FG003|Stage 2 (S2)|Adverse Event|2|||
126415625|NCT02218008|454815123|FG004|Stage 2 (S2)|Adverse Event|3|||
126415626|NCT02218008|454815124|FG005|Stage 2 (S2)|Adverse Event|3|||
126415627|NCT02218008|454815119|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
126415628|NCT02218008|454815120|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
126415629|NCT02218008|454815121|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
126415630|NCT02218008|454815122|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
126415631|NCT02218008|454815123|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
126415632|NCT02218008|454815124|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
126415633|NCT02218008|454815119|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
126415634|NCT02218008|454815120|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
126415635|NCT02218008|454815121|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
126415636|NCT02218008|454815122|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
126415637|NCT02218008|454815123|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
126415638|NCT02218008|454815124|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
126415639|NCT02218008|454815119|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
126415640|NCT02218008|454815120|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
126415641|NCT02218008|454815121|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
126415642|NCT02218008|454815122|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
126415643|NCT02218008|454815123|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
126415644|NCT02218008|454815124|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
126415645|NCT02218008|454815119|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
126415646|NCT02218008|454815120|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
126415647|NCT02218008|454815121|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
126415648|NCT02218008|454815122|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
126415649|NCT02218008|454815123|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
126415650|NCT02218008|454815124|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
126415651|NCT00106353|454815125|FG000|Part 1|Disease progression|3|||
126415652|NCT00106353|454815126|FG001|Part 1|Disease progression|4|||
126415653|NCT00106353|454815127|FG002|Part 1|Disease progression|1|||
126415654|NCT00106353|454815128|FG003|Part 1|Disease progression|3|||
126415655|NCT00106353|454815129|FG004|Part 1|Disease progression|0|||
126415656|NCT00106353|454815130|FG005|Part 1|Disease progression|0|||
126415657|NCT00106353|454815131|FG006|Part 1|Disease progression|0|||
126415658|NCT00106353|454815125|FG000|Part 1|Withdrawal by Subject|0|||
126415659|NCT00106353|454815126|FG001|Part 1|Withdrawal by Subject|0|||
126415660|NCT00106353|454815127|FG002|Part 1|Withdrawal by Subject|1|||
126415661|NCT00106353|454815128|FG003|Part 1|Withdrawal by Subject|2|||
126415662|NCT00106353|454815129|FG004|Part 1|Withdrawal by Subject|0|||
126415663|NCT00106353|454815130|FG005|Part 1|Withdrawal by Subject|0|||
126415664|NCT00106353|454815131|FG006|Part 1|Withdrawal by Subject|0|||
126415665|NCT00106353|454815125|FG000|Part 1|Symptomatic deterioration|0|||
126415666|NCT00106353|454815126|FG001|Part 1|Symptomatic deterioration|0|||
126415667|NCT00106353|454815127|FG002|Part 1|Symptomatic deterioration|1|||
126415668|NCT00106353|454815128|FG003|Part 1|Symptomatic deterioration|0|||
126415669|NCT00106353|454815129|FG004|Part 1|Symptomatic deterioration|0|||
126415670|NCT00106353|454815130|FG005|Part 1|Symptomatic deterioration|0|||
126415671|NCT00106353|454815131|FG006|Part 1|Symptomatic deterioration|0|||
126415672|NCT00106353|454815125|FG000|Part 1|Entered follow-up phase|1|||
126415673|NCT00106353|454815126|FG001|Part 1|Entered follow-up phase|1|||
126415674|NCT00106353|454815127|FG002|Part 1|Entered follow-up phase|0|||
126415675|NCT00106353|454815128|FG003|Part 1|Entered follow-up phase|1|||
126415676|NCT00106353|454815129|FG004|Part 1|Entered follow-up phase|0|||
126415677|NCT00106353|454815130|FG005|Part 1|Entered follow-up phase|0|||
126415678|NCT00106353|454815131|FG006|Part 1|Entered follow-up phase|0|||
126415679|NCT00106353|454815125|FG000|Part 1|Adverse Event|0|||
126415680|NCT00106353|454815126|FG001|Part 1|Adverse Event|0|||
126415681|NCT00106353|454815127|FG002|Part 1|Adverse Event|0|||
126415682|NCT00106353|454815128|FG003|Part 1|Adverse Event|1|||
126415683|NCT00106353|454815129|FG004|Part 1|Adverse Event|0|||
126415684|NCT00106353|454815130|FG005|Part 1|Adverse Event|0|||
126415685|NCT00106353|454815131|FG006|Part 1|Adverse Event|0|||
126415686|NCT00106353|454815125|FG000|Part 2|Disease progression|0|||
126415687|NCT00106353|454815126|FG001|Part 2|Disease progression|0|||
126476720|NCT03948581|455045065|FG001|Overall Study|Lost to Follow-up|1|||
126415688|NCT00106353|454815127|FG002|Part 2|Disease progression|0|||
126415689|NCT00106353|454815128|FG003|Part 2|Disease progression|0|||
126415690|NCT00106353|454815129|FG004|Part 2|Disease progression|8|||
126415691|NCT00106353|454815130|FG005|Part 2|Disease progression|14|||
126415692|NCT00106353|454815131|FG006|Part 2|Disease progression|13|||
126415693|NCT00106353|454815125|FG000|Part 2|Death|0|||
126415694|NCT00106353|454815126|FG001|Part 2|Death|0|||
126415695|NCT00106353|454815127|FG002|Part 2|Death|0|||
126415696|NCT00106353|454815128|FG003|Part 2|Death|0|||
126415697|NCT00106353|454815129|FG004|Part 2|Death|3|||
126415698|NCT00106353|454815130|FG005|Part 2|Death|0|||
126415699|NCT00106353|454815131|FG006|Part 2|Death|1|||
126415700|NCT00106353|454815125|FG000|Part 2|Symptomatic deterioration|0|||
126415701|NCT00106353|454815126|FG001|Part 2|Symptomatic deterioration|0|||
126415702|NCT00106353|454815127|FG002|Part 2|Symptomatic deterioration|0|||
126415703|NCT00106353|454815128|FG003|Part 2|Symptomatic deterioration|0|||
126415704|NCT00106353|454815129|FG004|Part 2|Symptomatic deterioration|3|||
126415705|NCT00106353|454815130|FG005|Part 2|Symptomatic deterioration|0|||
126415706|NCT00106353|454815131|FG006|Part 2|Symptomatic deterioration|0|||
126476721|NCT01042678|455045067|FG000|Overall Study|Physician Decision|1|||
126415707|NCT00106353|454815125|FG000|Part 2|Adverse Event|0|||
126415708|NCT00106353|454815126|FG001|Part 2|Adverse Event|0|||
126415709|NCT00106353|454815127|FG002|Part 2|Adverse Event|0|||
126415710|NCT00106353|454815128|FG003|Part 2|Adverse Event|0|||
126415711|NCT00106353|454815129|FG004|Part 2|Adverse Event|0|||
126415712|NCT00106353|454815130|FG005|Part 2|Adverse Event|2|||
126415713|NCT00106353|454815131|FG006|Part 2|Adverse Event|1|||
126415714|NCT00106353|454815125|FG000|Part 2|Other|0|||
126415715|NCT00106353|454815126|FG001|Part 2|Other|0|||
126415716|NCT00106353|454815127|FG002|Part 2|Other|0|||
126415717|NCT00106353|454815128|FG003|Part 2|Other|0|||
126415718|NCT00106353|454815129|FG004|Part 2|Other|1|||
126415719|NCT00106353|454815130|FG005|Part 2|Other|1|||
126415720|NCT00106353|454815131|FG006|Part 2|Other|1|||
126415721|NCT00106353|454815125|FG000|Part 2|Withdrawal by Subject|0|||
126415722|NCT00106353|454815126|FG001|Part 2|Withdrawal by Subject|0|||
126415723|NCT00106353|454815127|FG002|Part 2|Withdrawal by Subject|0|||
126415724|NCT00106353|454815128|FG003|Part 2|Withdrawal by Subject|0|||
126415725|NCT00106353|454815129|FG004|Part 2|Withdrawal by Subject|1|||
126415726|NCT00106353|454815130|FG005|Part 2|Withdrawal by Subject|0|||
126415727|NCT00106353|454815131|FG006|Part 2|Withdrawal by Subject|0|||
126415728|NCT00106353|454815125|FG000|Part 2|Physician Decision|0|||
126415729|NCT00106353|454815126|FG001|Part 2|Physician Decision|0|||
126415730|NCT00106353|454815127|FG002|Part 2|Physician Decision|0|||
126415731|NCT00106353|454815128|FG003|Part 2|Physician Decision|0|||
126415732|NCT00106353|454815129|FG004|Part 2|Physician Decision|0|||
126415733|NCT00106353|454815130|FG005|Part 2|Physician Decision|1|||
126415734|NCT00106353|454815131|FG006|Part 2|Physician Decision|0|||
126415735|NCT00408434|454815132|FG000|Overall Study|Adverse Event|0|||
126415736|NCT00408434|454815133|FG001|Overall Study|Adverse Event|0|||
126415737|NCT00408434|454815134|FG002|Overall Study|Adverse Event|1|||
126415738|NCT00408434|454815135|FG003|Overall Study|Adverse Event|0|||
126415739|NCT00408434|454815136|FG004|Overall Study|Adverse Event|0|||
126415740|NCT00408434|454815137|FG005|Overall Study|Adverse Event|0|||
126415741|NCT00408434|454815138|FG006|Overall Study|Adverse Event|0|||
126415742|NCT00408434|454815132|FG000|Overall Study|Progressive disease|6|||
126415743|NCT00408434|454815133|FG001|Overall Study|Progressive disease|3|||
126415744|NCT00408434|454815134|FG002|Overall Study|Progressive disease|4|||
126415745|NCT00408434|454815135|FG003|Overall Study|Progressive disease|3|||
126415746|NCT00408434|454815136|FG004|Overall Study|Progressive disease|3|||
126415747|NCT00408434|454815137|FG005|Overall Study|Progressive disease|1|||
126415748|NCT00408434|454815138|FG006|Overall Study|Progressive disease|4|||
126415749|NCT00408434|454815132|FG000|Overall Study|Other|0|||
126415750|NCT00408434|454815133|FG001|Overall Study|Other|0|||
126415751|NCT00408434|454815134|FG002|Overall Study|Other|1|||
126415752|NCT00408434|454815135|FG003|Overall Study|Other|0|||
126415753|NCT00408434|454815136|FG004|Overall Study|Other|2|||
126415754|NCT00408434|454815137|FG005|Overall Study|Other|1|||
126415755|NCT00408434|454815138|FG006|Overall Study|Other|0|||
126415756|NCT00408434|454815132|FG000|Overall Study|Terminated by Investigator|0|||
126415757|NCT00408434|454815133|FG001|Overall Study|Terminated by Investigator|0|||
126415758|NCT00408434|454815134|FG002|Overall Study|Terminated by Investigator|0|||
126415759|NCT00408434|454815135|FG003|Overall Study|Terminated by Investigator|0|||
126415760|NCT00408434|454815136|FG004|Overall Study|Terminated by Investigator|1|||
126415761|NCT00408434|454815137|FG005|Overall Study|Terminated by Investigator|1|||
126415762|NCT00408434|454815138|FG006|Overall Study|Terminated by Investigator|0|||
126415763|NCT00588354|454815139|FG000|Baseline to 2 Weeks|Adverse Event|1|||
126415764|NCT00588354|454815140|FG001|Baseline to 2 Weeks|Adverse Event|0|||
126415765|NCT00588354|454815139|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
126415766|NCT00588354|454815140|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
126476722|NCT01042678|455045068|FG001|Overall Study|Physician Decision|0|||
126476723|NCT01042678|455045069|FG002|Overall Study|Physician Decision|0|||
126415767|NCT00588354|454815139|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
126415768|NCT00588354|454815140|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
126415769|NCT04000581|454815141|FG000|Overall Study|Withdrawal by Subject|0|||
126415770|NCT04000581|454815142|FG001|Overall Study|Withdrawal by Subject|1|||
126415771|NCT03477838|454815143|FG000|Overall Study|Lost to Follow-up|14|||
126415772|NCT02519595|454815147|FG000|Overall Study|Protocol Violation|8|||
126415773|NCT02519595|454815148|FG001|Overall Study|Protocol Violation|22|||
126415774|NCT02519595|454815149|FG002|Overall Study|Protocol Violation|16|||
126415775|NCT03188510|454815152|FG000|Overall Study|Inappropriate behavior with site staff|0|||
126415776|NCT03188510|454815153|FG001|Overall Study|Inappropriate behavior with site staff|1|||
126415777|NCT03188510|454815154|FG002|Overall Study|Inappropriate behavior with site staff|0|||
126476724|NCT01042678|455045070|FG003|Overall Study|Physician Decision|0|||
126476725|NCT01042678|455045071|FG004|Overall Study|Physician Decision|0|||
126476726|NCT01042678|455045072|FG005|Overall Study|Physician Decision|0|||
126415778|NCT03052049|454815161|FG000|Overall Study|Withdrawal by Subject|2|||
126415779|NCT00999518|454815162|FG000|Overall Study|Adverse Event|1|||
126415780|NCT00999518|454815163|FG001|Overall Study|Adverse Event|6|||
126415781|NCT00999518|454815164|FG002|Overall Study|Adverse Event|3|||
126415782|NCT00999518|454815165|FG003|Overall Study|Adverse Event|1|||
126415783|NCT00999518|454815166|FG004|Overall Study|Adverse Event|2|||
126415784|NCT00999518|454815162|FG000|Overall Study|Lack of Efficacy|2|||
126415785|NCT00999518|454815163|FG001|Overall Study|Lack of Efficacy|0|||
126415786|NCT00999518|454815164|FG002|Overall Study|Lack of Efficacy|0|||
126415787|NCT00999518|454815165|FG003|Overall Study|Lack of Efficacy|2|||
126415788|NCT00999518|454815166|FG004|Overall Study|Lack of Efficacy|2|||
126415789|NCT00999518|454815162|FG000|Overall Study|Lost to Follow-up|0|||
126415790|NCT00999518|454815163|FG001|Overall Study|Lost to Follow-up|0|||
126415791|NCT00999518|454815164|FG002|Overall Study|Lost to Follow-up|0|||
126415792|NCT00999518|454815165|FG003|Overall Study|Lost to Follow-up|4|||
126415793|NCT00999518|454815166|FG004|Overall Study|Lost to Follow-up|1|||
126415794|NCT00999518|454815162|FG000|Overall Study|Did not meet entrance criteria|0|||
126415795|NCT00999518|454815163|FG001|Overall Study|Did not meet entrance criteria|0|||
126415796|NCT00999518|454815164|FG002|Overall Study|Did not meet entrance criteria|0|||
126415797|NCT00999518|454815165|FG003|Overall Study|Did not meet entrance criteria|0|||
126415798|NCT00999518|454815166|FG004|Overall Study|Did not meet entrance criteria|1|||
126415799|NCT00999518|454815162|FG000|Overall Study|Study terminated by sponsor|10|||
126415800|NCT00999518|454815163|FG001|Overall Study|Study terminated by sponsor|6|||
126415801|NCT00999518|454815164|FG002|Overall Study|Study terminated by sponsor|5|||
126415802|NCT00999518|454815165|FG003|Overall Study|Study terminated by sponsor|5|||
126415803|NCT00999518|454815166|FG004|Overall Study|Study terminated by sponsor|9|||
126415804|NCT00999518|454815162|FG000|Overall Study|Pregnancy|0|||
126415805|NCT00999518|454815163|FG001|Overall Study|Pregnancy|0|||
126415806|NCT00999518|454815164|FG002|Overall Study|Pregnancy|1|||
126415807|NCT00999518|454815165|FG003|Overall Study|Pregnancy|0|||
126415808|NCT00999518|454815166|FG004|Overall Study|Pregnancy|0|||
126415809|NCT00999518|454815162|FG000|Overall Study|Protocol Violation|0|||
126415810|NCT00999518|454815163|FG001|Overall Study|Protocol Violation|1|||
126415811|NCT00999518|454815164|FG002|Overall Study|Protocol Violation|0|||
126415812|NCT00999518|454815165|FG003|Overall Study|Protocol Violation|0|||
126415813|NCT00999518|454815166|FG004|Overall Study|Protocol Violation|2|||
126415814|NCT00999518|454815162|FG000|Overall Study|Withdrawal by Subject|5|||
126415815|NCT00999518|454815163|FG001|Overall Study|Withdrawal by Subject|4|||
126415816|NCT00999518|454815164|FG002|Overall Study|Withdrawal by Subject|10|||
126415817|NCT00999518|454815165|FG003|Overall Study|Withdrawal by Subject|6|||
126415818|NCT00999518|454815166|FG004|Overall Study|Withdrawal by Subject|1|||
126415819|NCT00999518|454815162|FG000|Overall Study|Other|5|||
126415820|NCT00999518|454815163|FG001|Overall Study|Other|7|||
126415821|NCT00999518|454815164|FG002|Overall Study|Other|1|||
126415822|NCT00999518|454815165|FG003|Overall Study|Other|4|||
126415823|NCT00999518|454815166|FG004|Overall Study|Other|5|||
126415824|NCT00999518|454815162|FG000|Overall Study|Randomized but not Treated|1|||
126415825|NCT00999518|454815163|FG001|Overall Study|Randomized but not Treated|1|||
126415826|NCT00999518|454815164|FG002|Overall Study|Randomized but not Treated|2|||
126415827|NCT00999518|454815165|FG003|Overall Study|Randomized but not Treated|0|||
126415828|NCT00999518|454815166|FG004|Overall Study|Randomized but not Treated|1|||
126415829|NCT01088399|454815170|FG000|Overall Study|Adverse Event|211|||
126415830|NCT01088399|454815171|FG001|Overall Study|Adverse Event|16|||
126415831|NCT01088399|454815172|FG002|Overall Study|Adverse Event|0|||
126415832|NCT01088399|454815170|FG000|Overall Study|Death|204|||
126415833|NCT01088399|454815171|FG001|Overall Study|Death|45|||
126415834|NCT01088399|454815172|FG002|Overall Study|Death|0|||
126415835|NCT01088399|454815170|FG000|Overall Study|Lack of Efficacy|298|||
126415836|NCT01088399|454815171|FG001|Overall Study|Lack of Efficacy|7|||
126415837|NCT01088399|454815172|FG002|Overall Study|Lack of Efficacy|5|||
126415838|NCT01088399|454815170|FG000|Overall Study|Lost to Follow-up|1070|||
126415839|NCT01088399|454815171|FG001|Overall Study|Lost to Follow-up|278|||
126415840|NCT01088399|454815172|FG002|Overall Study|Lost to Follow-up|58|||
126415841|NCT01088399|454815170|FG000|Overall Study|Physician Decision|531|||
126415842|NCT01088399|454815171|FG001|Overall Study|Physician Decision|88|||
126476727|NCT01313312|455045077|FG000|Overall Study|Adverse Event|5|||
126476728|NCT01313312|455045077|FG000|Overall Study|Withdrawal by Subject|18|||
126476729|NCT01313312|455045077|FG000|Overall Study|Lack of Efficacy|3|||
126476730|NCT01313312|455045077|FG000|Overall Study|Investigator Decision|1|||
126476731|NCT01313312|455045077|FG000|Overall Study|Observational Phase|1|||
126476732|NCT01313312|455045077|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
126476733|NCT01313312|455045077|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
126476734|NCT00892047|455045078|FG000|Overall Study|Adverse Event|2|||
126476735|NCT00892047|455045079|FG001|Overall Study|Adverse Event|2|||
126476736|NCT00892047|455045078|FG000|Overall Study|subject burden|2|||
126476737|NCT00892047|455045079|FG001|Overall Study|subject burden|3|||
126415843|NCT01088399|454815172|FG002|Overall Study|Physician Decision|16|||
126476738|NCT00892047|455045078|FG000|Overall Study|Lack of Efficacy|0|||
126476739|NCT00892047|455045079|FG001|Overall Study|Lack of Efficacy|2|||
126415844|NCT01088399|454815170|FG000|Overall Study|Withdrawal by Subject|544|||
126476740|NCT05306977|455045080|FG000|Overall Study|Withdrawal by Subject|1|||
126415845|NCT01088399|454815171|FG001|Overall Study|Withdrawal by Subject|195|||
126415846|NCT01088399|454815172|FG002|Overall Study|Withdrawal by Subject|33|||
126415847|NCT01088399|454815170|FG000|Overall Study|Change to or start of somatropin therapy|234|||
126415848|NCT01088399|454815171|FG001|Overall Study|Change to or start of somatropin therapy|17|||
126415849|NCT01088399|454815172|FG002|Overall Study|Change to or start of somatropin therapy|12|||
126476741|NCT01387789|455045086|FG000|Overall Study|Adverse Event|5|||
126415850|NCT01088399|454815170|FG000|Overall Study|Sponsor decision|1573|||
126415851|NCT01088399|454815171|FG001|Overall Study|Sponsor decision|298|||
126415852|NCT01088399|454815172|FG002|Overall Study|Sponsor decision|7|||
126721694|NCT03453151|455930047|FG000|Overall Study|Withdrawal by Subject|1|||
126721695|NCT03453151|455930047|FG000|Overall Study|Physician Decision|3|||
126721696|NCT02939937|455931240|FG000|Overall Study|Adverse Event|5|||
126721697|NCT02939937|455931241|FG001|Overall Study|Adverse Event|0|||
126721698|NCT02939937|455931240|FG000|Overall Study|Lost to Follow-up|1|||
126415853|NCT01088399|454815170|FG000|Overall Study|Protocol Violation|10|||
126415854|NCT01088399|454815171|FG001|Overall Study|Protocol Violation|1|||
126415855|NCT01088399|454815172|FG002|Overall Study|Protocol Violation|0|||
126415856|NCT01088399|454815170|FG000|Overall Study|Enrollment criteria not met|48|||
126415857|NCT01088399|454815171|FG001|Overall Study|Enrollment criteria not met|119|||
126415858|NCT01088399|454815172|FG002|Overall Study|Enrollment criteria not met|70|||
126415859|NCT01088399|454815170|FG000|Overall Study|Study summary visit not completed|2398|||
126415860|NCT01088399|454815171|FG001|Overall Study|Study summary visit not completed|283|||
126415861|NCT01088399|454815172|FG002|Overall Study|Study summary visit not completed|80|||
126415862|NCT00782483|454815173|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
126415863|NCT03343626|454816652|FG000|Overall Study|Lost to Follow-up|4|||
126415864|NCT03343626|454816653|FG001|Overall Study|Lost to Follow-up|3|||
126415865|NCT03343626|454816654|FG002|Overall Study|Lost to Follow-up|2|||
126415866|NCT03343626|454816655|FG003|Overall Study|Lost to Follow-up|5|||
126415867|NCT03343626|454816656|FG004|Overall Study|Lost to Follow-up|4|||
126415868|NCT03343626|454816657|FG005|Overall Study|Lost to Follow-up|4|||
126415869|NCT03343626|454816658|FG006|Overall Study|Lost to Follow-up|4|||
126415870|NCT03343626|454816659|FG007|Overall Study|Lost to Follow-up|7|||
126415871|NCT03343626|454816652|FG000|Overall Study|Withdrawal of Consent|2|||
126415872|NCT03343626|454816653|FG001|Overall Study|Withdrawal of Consent|1|||
126415873|NCT03343626|454816654|FG002|Overall Study|Withdrawal of Consent|0|||
126415874|NCT03343626|454816655|FG003|Overall Study|Withdrawal of Consent|3|||
126415875|NCT03343626|454816656|FG004|Overall Study|Withdrawal of Consent|3|||
126415876|NCT03343626|454816657|FG005|Overall Study|Withdrawal of Consent|1|||
126415877|NCT03343626|454816658|FG006|Overall Study|Withdrawal of Consent|1|||
126415878|NCT03343626|454816659|FG007|Overall Study|Withdrawal of Consent|2|||
126415879|NCT03343626|454816652|FG000|Overall Study|Reason not Specified|0|||
126415880|NCT03343626|454816653|FG001|Overall Study|Reason not Specified|1|||
126415881|NCT03343626|454816654|FG002|Overall Study|Reason not Specified|0|||
126415882|NCT03343626|454816655|FG003|Overall Study|Reason not Specified|0|||
126415883|NCT03343626|454816656|FG004|Overall Study|Reason not Specified|0|||
126415884|NCT03343626|454816657|FG005|Overall Study|Reason not Specified|0|||
126415885|NCT03343626|454816658|FG006|Overall Study|Reason not Specified|0|||
126415886|NCT03343626|454816659|FG007|Overall Study|Reason not Specified|1|||
126415887|NCT03343626|454816652|FG000|Overall Study|Data Entry Error|0|||
126415888|NCT03343626|454816653|FG001|Overall Study|Data Entry Error|0|||
126415889|NCT03343626|454816654|FG002|Overall Study|Data Entry Error|0|||
126415890|NCT03343626|454816655|FG003|Overall Study|Data Entry Error|0|||
126415891|NCT03343626|454816656|FG004|Overall Study|Data Entry Error|0|||
126415892|NCT03343626|454816657|FG005|Overall Study|Data Entry Error|0|||
126415893|NCT03343626|454816658|FG006|Overall Study|Data Entry Error|0|||
126415894|NCT03343626|454816659|FG007|Overall Study|Data Entry Error|1|||
126415895|NCT02475278|454816667|FG000|Overall Study|Lost to Follow-up|1|||
126415896|NCT02475278|454816667|FG000|Overall Study|Reason Not Specified|1|||
126415897|NCT00826618|454816668|FG000|Overall Study|Withdrawal by Subject|1|||
126415898|NCT03712787|454816669|FG000|Overall Study|Adverse Event|2|||
126415899|NCT03712787|454816670|FG001|Overall Study|Adverse Event|3|||
126415900|NCT03712787|454816671|FG002|Overall Study|Adverse Event|0|||
126415901|NCT03712787|454816672|FG003|Overall Study|Adverse Event|4|||
126415902|NCT03712787|454816669|FG000|Overall Study|Withdrawal by Subject|4|||
126415903|NCT03712787|454816670|FG001|Overall Study|Withdrawal by Subject|14|||
126415904|NCT03712787|454816671|FG002|Overall Study|Withdrawal by Subject|12|||
126415905|NCT03712787|454816672|FG003|Overall Study|Withdrawal by Subject|8|||
126415906|NCT03712787|454816669|FG000|Overall Study|Lost to Follow-up|1|||
126415907|NCT03712787|454816670|FG001|Overall Study|Lost to Follow-up|1|||
126476742|NCT01387789|455045086|FG000|Overall Study|Lack of Efficacy|2|||
126721699|NCT02939937|455931241|FG001|Overall Study|Lost to Follow-up|3|||
126721700|NCT04281030|455931250|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
126415908|NCT03712787|454816671|FG002|Overall Study|Lost to Follow-up|2|||
126415909|NCT03712787|454816672|FG003|Overall Study|Lost to Follow-up|1|||
126415910|NCT03712787|454816669|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
126415911|NCT03712787|454816670|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
126415912|NCT03712787|454816671|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
126415913|NCT03712787|454816672|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
126415914|NCT03712787|454816669|FG000|Overall Study|COVID-19 Infection|0|||
126415915|NCT03712787|454816670|FG001|Overall Study|COVID-19 Infection|1|||
126415916|NCT03712787|454816671|FG002|Overall Study|COVID-19 Infection|0|||
126415917|NCT03712787|454816672|FG003|Overall Study|COVID-19 Infection|0|||
126415918|NCT03712787|454816669|FG000|Overall Study|Other, Not Specified|79|||
126415919|NCT03712787|454816670|FG001|Overall Study|Other, Not Specified|77|||
126415920|NCT03712787|454816671|FG002|Overall Study|Other, Not Specified|74|||
126415921|NCT03712787|454816672|FG003|Overall Study|Other, Not Specified|78|||
126415922|NCT00732875|454816676|FG000|Overall Study|Adverse Event|16|||
126415923|NCT00732875|454816676|FG000|Overall Study|Withdrawal by Subject|6|||
126415924|NCT00732875|454816676|FG000|Overall Study|Lack of Efficacy|13|||
126415925|NCT03056339|454816681|FG000|Overall Study|Failed Requirements|0|||
126415926|NCT03056339|454816682|FG001|Overall Study|Failed Requirements|2|||
126415927|NCT03056339|454816683|FG002|Overall Study|Failed Requirements|7|||
126415928|NCT03056339|454816684|FG003|Overall Study|Failed Requirements|1|||
126415929|NCT01128244|454816690|FG000|Overall Study|Adverse Event|1|||
126415930|NCT01128244|454816690|FG000|Overall Study|Scheduling conflict|2|||
126415931|NCT02219334|454816691|FG000|Overall Study|Withdrawal by Subject|1|||
126415932|NCT02219334|454816692|FG001|Overall Study|Withdrawal by Subject|0|||
126415933|NCT02219334|454816691|FG000|Overall Study|Protocol Violation|7|||
126415934|NCT02219334|454816692|FG001|Overall Study|Protocol Violation|3|||
126415935|NCT04171219|454816695|FG000|Overall Study|Adverse Event|1|||
126415936|NCT04171219|454816696|FG001|Overall Study|Adverse Event|0|||
126415937|NCT04171219|454816695|FG000|Overall Study|Death|0|||
126415938|NCT04171219|454816696|FG001|Overall Study|Death|1|||
126415939|NCT04171219|454816695|FG000|Overall Study|Lack of Efficacy|9|||
126415940|NCT04171219|454816696|FG001|Overall Study|Lack of Efficacy|13|||
126415941|NCT04171219|454816695|FG000|Overall Study|Withdrawal by Subject|1|||
126415942|NCT04171219|454816696|FG001|Overall Study|Withdrawal by Subject|2|||
126415943|NCT04171219|454816695|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
126476743|NCT01387789|455045086|FG000|Overall Study|Lost to Follow-up|1|||
126476744|NCT00181155|455045087|FG000|Overall Study|Physician Decision|1|||
126476745|NCT00181155|455045088|FG001|Overall Study|Physician Decision|0|||
126476746|NCT00181155|455045087|FG000|Overall Study|Withdrawal by Subject|1|||
126476747|NCT00181155|455045088|FG001|Overall Study|Withdrawal by Subject|0|||
126415944|NCT04171219|454816696|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
126415945|NCT04171219|454816695|FG000|Overall Study|Clinical PD/Patient choice|1|||
126415946|NCT04171219|454816696|FG001|Overall Study|Clinical PD/Patient choice|0|||
126415947|NCT04171219|454816695|FG000|Overall Study|Toxicity/ Patient choice|1|||
126415948|NCT04171219|454816696|FG001|Overall Study|Toxicity/ Patient choice|0|||
126415949|NCT04809285|454816699|FG000|Phase 1|Lost to Follow-up|6|||
126415950|NCT04809285|454816699|FG000|Phase 1|Protocol Violation|2|||
126415951|NCT04809285|454816699|FG000|Phase 1|Physician Decision|3|||
126415952|NCT04809285|454816699|FG000|Phase 1|Withdrawal by Subject|29|||
126415953|NCT04809285|454816699|FG000|Phase 2|Protocol Violation|3|||
126415954|NCT04809285|454816699|FG000|Phase 2|Withdrawal by Subject|4|||
126415955|NCT04838626|454816701|FG000|Overall Study|Adverse Event|2|||
126415956|NCT04838626|454816701|FG000|Overall Study|Physician Decision|6|||
126476748|NCT01788228|455045089|FG000|Overall Study|Migrated/moved from study area|1|||
126476749|NCT01788228|455045090|FG001|Overall Study|Migrated/moved from study area|0|||
126476750|NCT01548287|455045093|FG000|Screening|No reason provided|0|||
126476751|NCT01548287|455045094|FG001|Screening|No reason provided|0|||
126476752|NCT01548287|455045095|FG002|Screening|No reason provided|0|||
126476753|NCT01548287|455045096|FG003|Screening|No reason provided|0|||
126476754|NCT01548287|455045097|FG004|Screening|No reason provided|9|||
126476755|NCT01548287|455045093|FG000|Screening|Did not meet eligibility criteria|0|||
126476756|NCT01548287|455045094|FG001|Screening|Did not meet eligibility criteria|0|||
126476757|NCT01548287|455045095|FG002|Screening|Did not meet eligibility criteria|0|||
126476758|NCT01548287|455045096|FG003|Screening|Did not meet eligibility criteria|0|||
126476759|NCT01548287|455045097|FG004|Screening|Did not meet eligibility criteria|74|||
126415957|NCT04838626|454816701|FG000|Overall Study|Protocol Violation|3|||
126415958|NCT04838626|454816701|FG000|Overall Study|Withdrawal by Subject|9|||
126415959|NCT04838626|454816701|FG000|Overall Study|Technical Problems|2|||
126415960|NCT02630472|454816706|FG000|Overall Study|Physician Decision|10|||
126476760|NCT01548287|455045093|FG000|Randomized Period|Did not meet inclusion criteria|0|||
126476761|NCT01548287|455045094|FG001|Randomized Period|Did not meet inclusion criteria|0|||
126476762|NCT01548287|455045095|FG002|Randomized Period|Did not meet inclusion criteria|2|||
126476763|NCT01548287|455045096|FG003|Randomized Period|Did not meet inclusion criteria|0|||
126476764|NCT01548287|455045097|FG004|Randomized Period|Did not meet inclusion criteria|0|||
126476765|NCT01548287|455045093|FG000|Randomized Period|Adverse Event|0|||
126476766|NCT01548287|455045094|FG001|Randomized Period|Adverse Event|2|||
126476767|NCT01548287|455045095|FG002|Randomized Period|Adverse Event|5|||
126476768|NCT01548287|455045096|FG003|Randomized Period|Adverse Event|0|||
126476769|NCT01548287|455045097|FG004|Randomized Period|Adverse Event|0|||
126476770|NCT00289783|455045104|FG000|Primary Phase|Adverse Event|10|||
126476771|NCT00289783|455045105|FG001|Primary Phase|Adverse Event|1|||
126415961|NCT02630472|454816707|FG001|Overall Study|Physician Decision|0|||
126415962|NCT01934010|454816708|FG000|Overall Study|Adverse Event|1|||
126415963|NCT01934010|454816709|FG001|Overall Study|Adverse Event|1|||
126415964|NCT01934010|454816710|FG002|Overall Study|Adverse Event|0|||
126415965|NCT01934010|454816708|FG000|Overall Study|Withdrawal by Subject|15|||
126476772|NCT00289783|455045104|FG000|Primary Phase|Protocol Violation|27|||
126415966|NCT01934010|454816709|FG001|Overall Study|Withdrawal by Subject|6|||
126415967|NCT01934010|454816710|FG002|Overall Study|Withdrawal by Subject|2|||
126415968|NCT01934010|454816708|FG000|Overall Study|Lost to Follow-up|7|||
126415969|NCT01934010|454816709|FG001|Overall Study|Lost to Follow-up|4|||
126415970|NCT01934010|454816710|FG002|Overall Study|Lost to Follow-up|0|||
126415971|NCT01393821|454816711|FG000|Overall Study|Cancel|1|||
126415972|NCT01393821|454816712|FG001|Overall Study|Cancel|1|||
126415973|NCT01393821|454816711|FG000|Overall Study|not evaluable for primary endpoint|4|||
126415974|NCT01393821|454816712|FG001|Overall Study|not evaluable for primary endpoint|2|||
126415975|NCT01858766|454816713|FG000|Overall Study|Randomized but Never Treated|0|||
126415976|NCT01858766|454816714|FG001|Overall Study|Randomized but Never Treated|0|||
126415977|NCT01858766|454816715|FG002|Overall Study|Randomized but Never Treated|0|||
126415978|NCT01858766|454816716|FG003|Overall Study|Randomized but Never Treated|0|||
126415979|NCT01858766|454816717|FG004|Overall Study|Randomized but Never Treated|0|||
126415980|NCT01858766|454816718|FG005|Overall Study|Randomized but Never Treated|1|||
126415981|NCT01858766|454816719|FG006|Overall Study|Randomized but Never Treated|0|||
126415982|NCT01858766|454816720|FG007|Overall Study|Randomized but Never Treated|0|||
126415983|NCT01858766|454816721|FG008|Overall Study|Randomized but Never Treated|0|||
126415984|NCT01858766|454816722|FG009|Overall Study|Randomized but Never Treated|0|||
126415985|NCT01858766|454816723|FG010|Overall Study|Randomized but Never Treated|0|||
126415986|NCT01858766|454816724|FG011|Overall Study|Randomized but Never Treated|0|||
126415987|NCT01858766|454816725|FG012|Overall Study|Randomized but Never Treated|0|||
126415988|NCT01858766|454816726|FG013|Overall Study|Randomized but Never Treated|0|||
126415989|NCT01858766|454816727|FG014|Overall Study|Randomized but Never Treated|0|||
126415990|NCT01858766|454816728|FG015|Overall Study|Randomized but Never Treated|0|||
126415991|NCT01858766|454816729|FG016|Overall Study|Randomized but Never Treated|0|||
126415992|NCT01858766|454816730|FG017|Overall Study|Randomized but Never Treated|1|||
126415993|NCT01858766|454816731|FG018|Overall Study|Randomized but Never Treated|0|||
126415994|NCT01858766|454816713|FG000|Overall Study|Death|0|||
126415995|NCT01858766|454816714|FG001|Overall Study|Death|0|||
126415996|NCT01858766|454816715|FG002|Overall Study|Death|1|||
126415997|NCT01858766|454816716|FG003|Overall Study|Death|0|||
126415998|NCT01858766|454816717|FG004|Overall Study|Death|0|||
126415999|NCT01858766|454816718|FG005|Overall Study|Death|0|||
126416000|NCT01858766|454816719|FG006|Overall Study|Death|0|||
126416001|NCT01858766|454816720|FG007|Overall Study|Death|0|||
126416002|NCT01858766|454816721|FG008|Overall Study|Death|0|||
126416003|NCT01858766|454816722|FG009|Overall Study|Death|0|||
126416004|NCT01858766|454816723|FG010|Overall Study|Death|0|||
126416005|NCT01858766|454816724|FG011|Overall Study|Death|0|||
126416006|NCT01858766|454816725|FG012|Overall Study|Death|0|||
126416007|NCT01858766|454816726|FG013|Overall Study|Death|0|||
126416008|NCT01858766|454816727|FG014|Overall Study|Death|0|||
126416009|NCT01858766|454816728|FG015|Overall Study|Death|0|||
126416010|NCT01858766|454816729|FG016|Overall Study|Death|0|||
126416011|NCT01858766|454816730|FG017|Overall Study|Death|0|||
126416012|NCT01858766|454816731|FG018|Overall Study|Death|0|||
126416013|NCT01858766|454816713|FG000|Overall Study|Lack of Efficacy|1|||
126416014|NCT01858766|454816714|FG001|Overall Study|Lack of Efficacy|0|||
126416015|NCT01858766|454816715|FG002|Overall Study|Lack of Efficacy|0|||
126416016|NCT01858766|454816716|FG003|Overall Study|Lack of Efficacy|0|||
126416017|NCT01858766|454816717|FG004|Overall Study|Lack of Efficacy|1|||
126416018|NCT01858766|454816718|FG005|Overall Study|Lack of Efficacy|2|||
126416019|NCT01858766|454816719|FG006|Overall Study|Lack of Efficacy|0|||
126416020|NCT01858766|454816720|FG007|Overall Study|Lack of Efficacy|0|||
126416021|NCT01858766|454816721|FG008|Overall Study|Lack of Efficacy|0|||
126416022|NCT01858766|454816722|FG009|Overall Study|Lack of Efficacy|0|||
126416023|NCT01858766|454816723|FG010|Overall Study|Lack of Efficacy|0|||
126416024|NCT01858766|454816724|FG011|Overall Study|Lack of Efficacy|3|||
126416025|NCT01858766|454816725|FG012|Overall Study|Lack of Efficacy|5|||
126416026|NCT01858766|454816726|FG013|Overall Study|Lack of Efficacy|3|||
126416027|NCT01858766|454816727|FG014|Overall Study|Lack of Efficacy|5|||
126558980|NCT00751790|455340599|FG000|Overall Study|Death|3|||
126416028|NCT01858766|454816728|FG015|Overall Study|Lack of Efficacy|5|||
126416029|NCT01858766|454816729|FG016|Overall Study|Lack of Efficacy|2|||
126416030|NCT01858766|454816730|FG017|Overall Study|Lack of Efficacy|3|||
126416031|NCT01858766|454816731|FG018|Overall Study|Lack of Efficacy|3|||
126416032|NCT01858766|454816713|FG000|Overall Study|Lost to Follow-up|0|||
126416033|NCT01858766|454816714|FG001|Overall Study|Lost to Follow-up|0|||
126416034|NCT01858766|454816715|FG002|Overall Study|Lost to Follow-up|0|||
126416035|NCT01858766|454816716|FG003|Overall Study|Lost to Follow-up|0|||
126416036|NCT01858766|454816717|FG004|Overall Study|Lost to Follow-up|0|||
126416037|NCT01858766|454816718|FG005|Overall Study|Lost to Follow-up|1|||
126416038|NCT01858766|454816719|FG006|Overall Study|Lost to Follow-up|0|||
126416039|NCT01858766|454816720|FG007|Overall Study|Lost to Follow-up|2|||
126558981|NCT00751790|455340599|FG000|Overall Study|Withdrawal by Subject|1|||
126416040|NCT01858766|454816721|FG008|Overall Study|Lost to Follow-up|0|||
126416041|NCT01858766|454816722|FG009|Overall Study|Lost to Follow-up|0|||
126416042|NCT01858766|454816723|FG010|Overall Study|Lost to Follow-up|0|||
126416043|NCT01858766|454816724|FG011|Overall Study|Lost to Follow-up|1|||
126416044|NCT01858766|454816725|FG012|Overall Study|Lost to Follow-up|0|||
126558982|NCT03606460|455340602|FG000|Overall Study|Lost to Follow-up|1|||
126416045|NCT01858766|454816726|FG013|Overall Study|Lost to Follow-up|0|||
126476773|NCT00289783|455045105|FG001|Primary Phase|Protocol Violation|6|||
126476774|NCT00289783|455045104|FG000|Primary Phase|Withdrawal by Subject|93|||
126476775|NCT00289783|455045105|FG001|Primary Phase|Withdrawal by Subject|40|||
126416046|NCT01858766|454816727|FG014|Overall Study|Lost to Follow-up|3|||
126416047|NCT01858766|454816728|FG015|Overall Study|Lost to Follow-up|1|||
126416048|NCT01858766|454816729|FG016|Overall Study|Lost to Follow-up|1|||
126416049|NCT01858766|454816730|FG017|Overall Study|Lost to Follow-up|0|||
126416050|NCT01858766|454816731|FG018|Overall Study|Lost to Follow-up|1|||
126416051|NCT01858766|454816713|FG000|Overall Study|Withdrew Consent|0|||
126416052|NCT01858766|454816714|FG001|Overall Study|Withdrew Consent|0|||
126416053|NCT01858766|454816715|FG002|Overall Study|Withdrew Consent|0|||
126416054|NCT01858766|454816716|FG003|Overall Study|Withdrew Consent|0|||
126416055|NCT01858766|454816717|FG004|Overall Study|Withdrew Consent|0|||
126416056|NCT01858766|454816718|FG005|Overall Study|Withdrew Consent|0|||
126416057|NCT01858766|454816719|FG006|Overall Study|Withdrew Consent|0|||
126416058|NCT01858766|454816720|FG007|Overall Study|Withdrew Consent|0|||
126416059|NCT01858766|454816721|FG008|Overall Study|Withdrew Consent|0|||
126416060|NCT01858766|454816722|FG009|Overall Study|Withdrew Consent|0|||
126416061|NCT01858766|454816723|FG010|Overall Study|Withdrew Consent|0|||
126416062|NCT01858766|454816724|FG011|Overall Study|Withdrew Consent|1|||
126416063|NCT01858766|454816725|FG012|Overall Study|Withdrew Consent|0|||
126416064|NCT01858766|454816726|FG013|Overall Study|Withdrew Consent|0|||
126416065|NCT01858766|454816727|FG014|Overall Study|Withdrew Consent|0|||
126416066|NCT01858766|454816728|FG015|Overall Study|Withdrew Consent|0|||
126416067|NCT01858766|454816729|FG016|Overall Study|Withdrew Consent|0|||
126416068|NCT01858766|454816730|FG017|Overall Study|Withdrew Consent|0|||
126416069|NCT01858766|454816731|FG018|Overall Study|Withdrew Consent|0|||
126416070|NCT03517228|454816734|FG000|Overall Study|Withdrawal by Subject|2|||
126416071|NCT03517228|454816734|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
126416072|NCT03517228|454816734|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
126416073|NCT03517228|454816734|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
126416074|NCT03517228|454816734|FG000|Overall Study|Canceled due to device being updated|1|||
126416075|NCT03517228|454816734|FG000|Overall Study|No V Cares in stock|1|||
126416076|NCT03517228|454816734|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
126416077|NCT01835158|454816740|FG000|Overall Study|Withdrawal by Subject|1|||
126416078|NCT01835158|454816741|FG001|Overall Study|Withdrawal by Subject|6|||
126416079|NCT03422536|454816748|FG000|Randomized|Physician Decision|1|||
126416080|NCT03422536|454816749|FG001|Randomized|Physician Decision|1|||
126416081|NCT03422536|454816748|FG000|Allocation - Received Intervention|Disease progression|19|||
126416082|NCT03422536|454816749|FG001|Allocation - Received Intervention|Disease progression|25|||
126416083|NCT03422536|454816748|FG000|Allocation - Received Intervention|Death|1|||
126416084|NCT03422536|454816749|FG001|Allocation - Received Intervention|Death|3|||
126416085|NCT03422536|454816748|FG000|Allocation - Received Intervention|Adverse Event|1|||
126416086|NCT03422536|454816749|FG001|Allocation - Received Intervention|Adverse Event|0|||
126416087|NCT03422536|454816748|FG000|Allocation - Received Intervention|Physician Decision|1|||
126416088|NCT03422536|454816749|FG001|Allocation - Received Intervention|Physician Decision|1|||
126416089|NCT03422536|454816748|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
126416090|NCT03422536|454816749|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
126416091|NCT03422536|454816748|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
126416092|NCT03422536|454816749|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
126416093|NCT02023996|454816750|FG000|Overall Study|Protocol Violation|6|||
126416094|NCT04929249|454816751|FG000|Overall Study|Adverse Event|2|||
126416095|NCT04929249|454816752|FG001|Overall Study|Adverse Event|1|||
126416096|NCT04929249|454816751|FG000|Overall Study|Death|2|||
126416097|NCT04929249|454816752|FG001|Overall Study|Death|1|||
126416098|NCT04929249|454816751|FG000|Overall Study|Lost to Follow-up|3|||
126416099|NCT04929249|454816752|FG001|Overall Study|Lost to Follow-up|11|||
126476776|NCT00289783|455045104|FG000|Primary Phase|Lost to Follow-up|60|||
126476777|NCT00289783|455045105|FG001|Primary Phase|Lost to Follow-up|14|||
126476778|NCT00289783|455045104|FG000|Primary Phase|Migration from the study area|26|||
126476779|NCT00289783|455045105|FG001|Primary Phase|Migration from the study area|10|||
126416100|NCT04929249|454816751|FG000|Overall Study|Technical problems|0|||
126476780|NCT00289783|455045104|FG000|Primary Phase|Other|32|||
126416101|NCT04929249|454816752|FG001|Overall Study|Technical problems|1|||
126416102|NCT04929249|454816751|FG000|Overall Study|Subject decision|6|||
126416103|NCT04929249|454816752|FG001|Overall Study|Subject decision|8|||
126416104|NCT04929249|454816751|FG000|Overall Study|Withdrew consent|0|||
126416105|NCT04929249|454816752|FG001|Overall Study|Withdrew consent|8|||
126416106|NCT00395850|454816765|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
126416107|NCT00395850|454816766|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
126416108|NCT00395850|454816767|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
126416109|NCT00395850|454816768|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
126416110|NCT00395850|454816765|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
126476781|NCT00289783|455045105|FG001|Primary Phase|Other|12|||
126416111|NCT00395850|454816766|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
126416112|NCT00395850|454816767|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
126416113|NCT00395850|454816768|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
126416114|NCT00395850|454816765|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
126416115|NCT00395850|454816766|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
126416116|NCT00395850|454816767|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
126416117|NCT00395850|454816768|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
126416118|NCT00395850|454816765|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
126416119|NCT00395850|454816766|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
126416120|NCT00395850|454816767|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
126416121|NCT00395850|454816768|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
126416122|NCT00395850|454816765|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
126416123|NCT00395850|454816766|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
126416124|NCT00395850|454816767|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
126416125|NCT00395850|454816768|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
126416126|NCT00395850|454816765|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
126416127|NCT00395850|454816766|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
126416128|NCT00395850|454816767|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
126416129|NCT00395850|454816768|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
126416130|NCT00395850|454816765|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
126416131|NCT00395850|454816766|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
126416132|NCT00395850|454816767|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
126416133|NCT00395850|454816768|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
126416134|NCT01620762|454816771|FG000|Overall Study|Protocol Violation|1|||
126416135|NCT01620762|454816772|FG001|Overall Study|Protocol Violation|1|||
126416136|NCT01620762|454816773|FG002|Overall Study|Protocol Violation|1|||
126416137|NCT01620762|454816771|FG000|Overall Study|Adverse Event|9|||
126416138|NCT01620762|454816772|FG001|Overall Study|Adverse Event|5|||
126416139|NCT01620762|454816773|FG002|Overall Study|Adverse Event|2|||
126416140|NCT01620762|454816771|FG000|Overall Study|Withdrawal by Subject|23|||
126416141|NCT01620762|454816772|FG001|Overall Study|Withdrawal by Subject|26|||
126416142|NCT01620762|454816773|FG002|Overall Study|Withdrawal by Subject|27|||
126416143|NCT01620762|454816771|FG000|Overall Study|Lost to Follow-up|11|||
126416144|NCT01620762|454816772|FG001|Overall Study|Lost to Follow-up|17|||
126416145|NCT01620762|454816773|FG002|Overall Study|Lost to Follow-up|10|||
126416146|NCT01620762|454816771|FG000|Overall Study|Protocol deviation|1|||
126416147|NCT01620762|454816772|FG001|Overall Study|Protocol deviation|1|||
126416148|NCT01620762|454816773|FG002|Overall Study|Protocol deviation|6|||
126416149|NCT01620762|454816771|FG000|Overall Study|Subject deterioration|0|||
126416150|NCT01620762|454816772|FG001|Overall Study|Subject deterioration|1|||
126416151|NCT01620762|454816773|FG002|Overall Study|Subject deterioration|1|||
126416152|NCT01620762|454816771|FG000|Overall Study|Non-specified|3|||
126416153|NCT01620762|454816772|FG001|Overall Study|Non-specified|6|||
126416154|NCT01620762|454816773|FG002|Overall Study|Non-specified|5|||
126416155|NCT01620762|454816771|FG000|Overall Study|Use of prohibted therapies|0|||
126416156|NCT01620762|454816772|FG001|Overall Study|Use of prohibted therapies|1|||
126416157|NCT01620762|454816773|FG002|Overall Study|Use of prohibted therapies|1|||
126416158|NCT00705146|454816778|FG000|Overall Study|Lost to Follow-up|1|||
126416159|NCT00705146|454816779|FG001|Overall Study|Lost to Follow-up|1|||
126416160|NCT00095173|454816782|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
126416161|NCT00095173|454816783|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
126416162|NCT00095173|454816784|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
126416163|NCT00095173|454816785|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
126416164|NCT00095173|454816786|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
126416165|NCT00095173|454816787|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
126416166|NCT00095173|454816782|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
126416167|NCT00095173|454816783|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
126416168|NCT00095173|454816784|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
126416169|NCT00095173|454816785|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
126416170|NCT00095173|454816786|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
126416171|NCT00095173|454816787|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
126416172|NCT00095173|454816782|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
126416173|NCT00095173|454816783|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
126476782|NCT00289783|455045104|FG000|Fourth Dose Phase|Adverse Event|1|||
126476783|NCT00289783|455045105|FG001|Fourth Dose Phase|Adverse Event|0|||
126416174|NCT00095173|454816784|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
126416175|NCT00095173|454816785|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
126416176|NCT00095173|454816786|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
126416177|NCT00095173|454816787|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
126416178|NCT00095173|454816782|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
126416179|NCT00095173|454816783|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
126416180|NCT00095173|454816784|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
126721701|NCT04281030|455931251|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
126721702|NCT04281030|455931250|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
126416181|NCT00095173|454816785|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
126416182|NCT00095173|454816786|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
126416183|NCT00095173|454816787|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
126416184|NCT00095173|454816782|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
126416185|NCT00095173|454816783|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
126416186|NCT00095173|454816784|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
126416187|NCT00095173|454816785|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
126416188|NCT00095173|454816786|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
126416189|NCT00095173|454816787|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
126416190|NCT00095173|454816782|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
126416191|NCT00095173|454816783|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
126416192|NCT00095173|454816784|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
126416193|NCT00095173|454816785|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
126416194|NCT00095173|454816786|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
126416195|NCT00095173|454816787|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
126416196|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Death|0|||
126416197|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Death|0|||
126416198|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Death|0|||
126416199|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Death|0|||
126416200|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Death|0|||
126416201|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Death|1|||
126416202|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
126416203|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
126416204|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
126416205|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
126416206|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
126416207|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
126416208|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
126416209|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
126416210|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
126416211|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
126416212|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
126416213|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
126416214|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
126416215|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
126416216|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
126416217|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
126416218|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
126416219|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
126416220|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
126416221|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
126416222|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
126416223|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
126416224|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
126416225|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
126416226|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
126416227|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
126416228|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
126416229|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
126416230|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
126476784|NCT00289783|455045104|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
126721703|NCT04281030|455931251|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
126721704|NCT01361009|455931252|FG000|Overall Study|Protocol Violation|116|||
126721705|NCT01826422|455931253|FG000|Overall Study|Withdrawal by Subject|1|||
126721706|NCT01826422|455931254|FG001|Overall Study|Withdrawal by Subject|3|||
126721707|NCT03439748|455931257|FG000|Overall Study|Withdrawal by Subject|11|||
126721708|NCT03439748|455931258|FG001|Overall Study|Withdrawal by Subject|17|||
126416231|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
126416232|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
126416233|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
126416234|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
126416235|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
126416236|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
126416237|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
126416238|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
126416239|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
126416240|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
126416241|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
126416242|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
126416243|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
126416244|NCT00095173|454816782|FG000|Open-Label Extension Phase (Period C)|Other|0|||
126416245|NCT00095173|454816783|FG001|Open-Label Extension Phase (Period C)|Other|0|||
126416246|NCT00095173|454816784|FG002|Open-Label Extension Phase (Period C)|Other|0|||
126416247|NCT00095173|454816785|FG003|Open-Label Extension Phase (Period C)|Other|4|||
126416248|NCT00095173|454816786|FG004|Open-Label Extension Phase (Period C)|Other|6|||
126416249|NCT00095173|454816787|FG005|Open-Label Extension Phase (Period C)|Other|8|||
126416250|NCT01771250|454816794|FG000|Period 1|Met exclusion criteria|1|||
126416251|NCT01771250|454816795|FG001|Period 1|Met exclusion criteria|0|||
126416252|NCT02038075|454816796|FG000|Overall Study|Withdrawal by Subject|3|||
126416253|NCT02038075|454816797|FG001|Overall Study|Withdrawal by Subject|0|||
126416254|NCT00850538|454816798|FG000|Overall Study|unable/unwilling to complete MRI|13|||
126416255|NCT00850538|454816798|FG000|Overall Study|specimen missed due to scheduling error|14|||
126416256|NCT00850538|454816798|FG000|Overall Study|specimen unusable|7|||
126416257|NCT00850538|454816798|FG000|Overall Study|Withdrawal by Subject|3|||
126416258|NCT00850538|454816798|FG000|Overall Study|radiology error|2|||
126416259|NCT00850538|454816798|FG000|Overall Study|Protocol Violation|2|||
126416260|NCT02328027|454816799|FG000|Overall Study|Withdrawal by Subject|0|||
126416261|NCT02328027|454816800|FG001|Overall Study|Withdrawal by Subject|1|||
126416262|NCT03319212|454816801|FG000|Overall Study|Discontinued as moving out of local area|0|||
126416263|NCT03319212|454816802|FG001|Overall Study|Discontinued as moving out of local area|1|||
126416264|NCT03319212|454816801|FG000|Overall Study|Adverse Event|2|||
126721709|NCT05131451|455931259|FG000|Overall Study|Protocol Violation|1|||
126721710|NCT05131451|455931260|FG001|Overall Study|Protocol Violation|0|||
126721711|NCT00782418|455931261|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
126416265|NCT03319212|454816802|FG001|Overall Study|Adverse Event|2|||
126416266|NCT03319212|454816801|FG000|Overall Study|Withdrawal by Subject|0|||
126416267|NCT03319212|454816802|FG001|Overall Study|Withdrawal by Subject|1|||
126416268|NCT03319212|454816801|FG000|Overall Study|Lost to Follow-up|0|||
126416269|NCT03319212|454816802|FG001|Overall Study|Lost to Follow-up|1|||
126416270|NCT03319212|454816801|FG000|Overall Study|Physician Decision|1|||
126416271|NCT03319212|454816802|FG001|Overall Study|Physician Decision|0|||
126416272|NCT00250276|454816803|FG000|Overall Study|Serious Adverse Event|0|||
126416273|NCT00250276|454816804|FG001|Overall Study|Serious Adverse Event|0|||
126416274|NCT00250276|454816805|FG002|Overall Study|Serious Adverse Event|1|||
126416275|NCT00250276|454816806|FG003|Overall Study|Serious Adverse Event|0|||
126416276|NCT00250276|454816803|FG000|Overall Study|Non-serious Adverse Event|2|||
126416277|NCT00250276|454816804|FG001|Overall Study|Non-serious Adverse Event|0|||
126416278|NCT00250276|454816805|FG002|Overall Study|Non-serious Adverse Event|0|||
126416279|NCT00250276|454816806|FG003|Overall Study|Non-serious Adverse Event|2|||
126721712|NCT00782418|455931262|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
126721713|NCT00782418|455931263|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
126416280|NCT00250276|454816803|FG000|Overall Study|Protocol Violation|0|||
126416281|NCT00250276|454816804|FG001|Overall Study|Protocol Violation|1|||
126416282|NCT00250276|454816805|FG002|Overall Study|Protocol Violation|0|||
126416283|NCT00250276|454816806|FG003|Overall Study|Protocol Violation|0|||
126721714|NCT00782418|455931264|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
126721715|NCT00782418|455931265|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
126721716|NCT00782418|455931266|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
126721717|NCT00782418|455931267|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
126721718|NCT00782418|455931261|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
126756528|NCT03287960|456059455|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
126416284|NCT00250276|454816803|FG000|Overall Study|Withdrawal by Subject|1|||
126416285|NCT00250276|454816804|FG001|Overall Study|Withdrawal by Subject|2|||
126416286|NCT00250276|454816805|FG002|Overall Study|Withdrawal by Subject|3|||
126416287|NCT00250276|454816806|FG003|Overall Study|Withdrawal by Subject|2|||
126416288|NCT00250276|454816803|FG000|Overall Study|Migrated/moved from study area|3|||
126416289|NCT00250276|454816804|FG001|Overall Study|Migrated/moved from study area|0|||
126416290|NCT00250276|454816805|FG002|Overall Study|Migrated/moved from study area|2|||
126416291|NCT00250276|454816806|FG003|Overall Study|Migrated/moved from study area|7|||
126416292|NCT00250276|454816803|FG000|Overall Study|Lost to Follow-up|11|||
126416293|NCT00250276|454816804|FG001|Overall Study|Lost to Follow-up|18|||
126416294|NCT00250276|454816805|FG002|Overall Study|Lost to Follow-up|13|||
126416295|NCT00250276|454816806|FG003|Overall Study|Lost to Follow-up|8|||
126416296|NCT01811186|454816807|FG000|Overall Study|Adverse Event|54|||
126416297|NCT01811186|454816808|FG001|Overall Study|Adverse Event|38|||
126416298|NCT01811186|454816807|FG000|Overall Study|Protocol Violation|5|||
126416299|NCT01811186|454816808|FG001|Overall Study|Protocol Violation|6|||
126416300|NCT01811186|454816807|FG000|Overall Study|Withdrawal by Subject|5|||
126416301|NCT01811186|454816808|FG001|Overall Study|Withdrawal by Subject|10|||
126416302|NCT01811186|454816807|FG000|Overall Study|Lack of Efficacy|3|||
126416303|NCT01811186|454816808|FG001|Overall Study|Lack of Efficacy|6|||
126416304|NCT01811186|454816807|FG000|Overall Study|Lost to Follow-up|4|||
126416305|NCT01811186|454816808|FG001|Overall Study|Lost to Follow-up|2|||
126416306|NCT03369236|454816813|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
126416307|NCT03369236|454816814|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
126416308|NCT03369236|454816813|FG000|Open-label Extension Period|Lack of Efficacy|2|||
126416309|NCT03369236|454816814|FG001|Open-label Extension Period|Lack of Efficacy|1|||
126416310|NCT03369236|454816813|FG000|Open-label Extension Period|Adverse Event|0|||
126416311|NCT03369236|454816814|FG001|Open-label Extension Period|Adverse Event|1|||
126416312|NCT03369236|454816813|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
126416313|NCT03369236|454816814|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
126416314|NCT01865448|454818535|FG000|Overall Study|Adverse Event|1|||
126416315|NCT01865448|454818536|FG001|Overall Study|Adverse Event|1|||
126416316|NCT01865448|454818535|FG000|Overall Study|Pregnancy|0|||
126416317|NCT01865448|454818536|FG001|Overall Study|Pregnancy|1|||
126416318|NCT01865448|454818535|FG000|Overall Study|dropout unrelated to study|1|||
126416319|NCT01865448|454818536|FG001|Overall Study|dropout unrelated to study|1|||
126416320|NCT05111249|454818539|FG000|Overall Study|Lost to Follow-up|0|||
126416321|NCT05111249|454818540|FG001|Overall Study|Lost to Follow-up|2|||
126416322|NCT05111249|454818539|FG000|Overall Study|Physician Decision|0|||
126416323|NCT05111249|454818540|FG001|Overall Study|Physician Decision|1|||
126416324|NCT05111249|454818539|FG000|Overall Study|Participant decision|1|||
126416325|NCT05111249|454818540|FG001|Overall Study|Participant decision|5|||
126416326|NCT05128578|454818541|FG000|Overall Study|Withdrawal by Subject|9|||
126416327|NCT05128578|454818541|FG000|Overall Study|Lost to Follow-up|5|||
126416328|NCT01016600|454818545|FG000|Overall Study|Did not start treatment|1|||
126416329|NCT01016600|454818546|FG001|Overall Study|Did not start treatment|0|||
126416330|NCT01016600|454818547|FG002|Overall Study|Did not start treatment|0|||
126416331|NCT01016600|454818548|FG003|Overall Study|Did not start treatment|0|||
126416332|NCT00872599|454818549|FG000|Second Washout Period|Adverse Event|1|||
126416333|NCT00872599|454818550|FG001|Second Washout Period|Adverse Event|1|||
126416334|NCT02679755|454818551|FG000|Overall Study|Death|0|||
126416335|NCT02679755|454818552|FG001|Overall Study|Death|3|||
126416336|NCT02679755|454818551|FG000|Overall Study|Global deterioration of health status|1|||
126416337|NCT02679755|454818552|FG001|Overall Study|Global deterioration of health status|8|||
126416338|NCT02679755|454818551|FG000|Overall Study|Lost to Follow-up|1|||
126416339|NCT02679755|454818552|FG001|Overall Study|Lost to Follow-up|0|||
126416340|NCT02679755|454818551|FG000|Overall Study|Objective progression or relapse|24|||
126416341|NCT02679755|454818552|FG001|Overall Study|Objective progression or relapse|83|||
126416342|NCT02679755|454818551|FG000|Overall Study|Not defined|0|||
126416343|NCT02679755|454818552|FG001|Overall Study|Not defined|2|||
126416344|NCT02679755|454818551|FG000|Overall Study|Withdrawal by participant|6|||
126416345|NCT02679755|454818552|FG001|Overall Study|Withdrawal by participant|3|||
126416346|NCT02679755|454818551|FG000|Overall Study|Adverse Event|1|||
126416347|NCT02679755|454818552|FG001|Overall Study|Adverse Event|4|||
126416348|NCT02679755|454818551|FG000|Overall Study|Adverse events not related to study drug|1|||
126416349|NCT02679755|454818552|FG001|Overall Study|Adverse events not related to study drug|2|||
126416350|NCT00801229|454818553|FG000|Signed Consent|Withdrawal by Subject|2|||
126416351|NCT00801229|454818554|FG001|Signed Consent|Withdrawal by Subject|2|||
126416352|NCT00801229|454818553|FG000|Signed Consent|Found Ineligible|1|||
126416353|NCT00801229|454818554|FG001|Signed Consent|Found Ineligible|1|||
126416354|NCT00801229|454818553|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
126416355|NCT00801229|454818554|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
126416356|NCT00801229|454818553|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
126416357|NCT00801229|454818554|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
126416358|NCT00801229|454818553|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
126416359|NCT00801229|454818554|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
126721719|NCT00782418|455931262|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
126721720|NCT00782418|455931263|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
126721721|NCT00782418|455931264|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
126721722|NCT00782418|455931265|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
126416360|NCT00801229|454818553|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
126416361|NCT00801229|454818554|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
126416362|NCT00801229|454818553|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
126416363|NCT00801229|454818554|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
126416364|NCT00801229|454818553|FG000|Received Study Drug/Placebo|Adverse Event|1|||
126756529|NCT03287960|456059455|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
126416365|NCT00801229|454818554|FG001|Received Study Drug/Placebo|Adverse Event|1|||
126416366|NCT02451917|454818555|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
126721723|NCT00782418|455931266|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
126416367|NCT02451917|454818556|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
126416368|NCT02451917|454818555|FG000|First Intervention (24 Weeks)|Death|0|||
126416369|NCT02451917|454818556|FG001|First Intervention (24 Weeks)|Death|1|||
126416370|NCT02451917|454818555|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
126416371|NCT02451917|454818556|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
126416372|NCT02300259|454818559|FG000|Period 1|Adverse Event|0|||
126416373|NCT02300259|454818560|FG001|Period 1|Adverse Event|0|||
126416374|NCT02300259|454818561|FG002|Period 1|Adverse Event|1|||
126416375|NCT02300259|454818559|FG000|Period 1|Withdrawal by Subject|0|||
126416376|NCT02300259|454818560|FG001|Period 1|Withdrawal by Subject|0|||
126416377|NCT02300259|454818561|FG002|Period 1|Withdrawal by Subject|1|||
126416378|NCT02300259|454818559|FG000|Period 2|Adverse Event|1|||
126416379|NCT02300259|454818560|FG001|Period 2|Adverse Event|0|||
126416380|NCT02300259|454818561|FG002|Period 2|Adverse Event|0|||
126416381|NCT02300259|454818559|FG000|Period 2|Withdrawal by Subject|0|||
126416382|NCT02300259|454818560|FG001|Period 2|Withdrawal by Subject|0|||
126416383|NCT02300259|454818561|FG002|Period 2|Withdrawal by Subject|1|||
126416384|NCT04737278|454818562|FG000|Overall Study|Lost to Follow-up|1|||
126416385|NCT04737278|454818563|FG001|Overall Study|Lost to Follow-up|1|||
126416386|NCT04737278|454818562|FG000|Overall Study|Withdrawal by Subject|1|||
126416387|NCT04737278|454818563|FG001|Overall Study|Withdrawal by Subject|0|||
126416388|NCT04737278|454818562|FG000|Overall Study|Protocol Violation|1|||
126416389|NCT04737278|454818563|FG001|Overall Study|Protocol Violation|1|||
126416390|NCT04737278|454818562|FG000|Overall Study|failure to complete questionnaire|1|||
126416391|NCT04737278|454818563|FG001|Overall Study|failure to complete questionnaire|1|||
126416392|NCT00546000|454818564|FG000|Overall Study|Adverse Event|1|||
126416393|NCT00546000|454818564|FG000|Overall Study|Lost to Follow-up|1|||
126416394|NCT00546000|454818564|FG000|Overall Study|Baseline HPA Axis Supression|2|||
126416395|NCT02255461|454818565|FG000|Overall Study|Adverse Event|0|||
126416396|NCT02255461|454818566|FG001|Overall Study|Adverse Event|1|||
126416397|NCT02255461|454818567|FG002|Overall Study|Adverse Event|0|||
126416398|NCT02255461|454818568|FG003|Overall Study|Adverse Event|0|||
126416399|NCT02255461|454818569|FG004|Overall Study|Adverse Event|1|||
126416400|NCT02255461|454818565|FG000|Overall Study|Withdrawal by Subject|0|||
126476785|NCT00289783|455045105|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
126476786|NCT00289783|455045104|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
126476787|NCT00289783|455045105|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
126476788|NCT00289783|455045104|FG000|Fourth Dose Phase|Migration from the study area|1|||
126476789|NCT00289783|455045105|FG001|Fourth Dose Phase|Migration from the study area|1|||
126416401|NCT02255461|454818566|FG001|Overall Study|Withdrawal by Subject|0|||
126416402|NCT02255461|454818567|FG002|Overall Study|Withdrawal by Subject|1|||
126416403|NCT02255461|454818568|FG003|Overall Study|Withdrawal by Subject|0|||
126416404|NCT02255461|454818569|FG004|Overall Study|Withdrawal by Subject|1|||
126416405|NCT02255461|454818565|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
126416406|NCT02255461|454818566|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
126416407|NCT02255461|454818567|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
126416408|NCT02255461|454818568|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
126416409|NCT02255461|454818569|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
126476790|NCT00289783|455045104|FG000|Fourth Dose Phase|Other|22|||
126476791|NCT00289783|455045105|FG001|Fourth Dose Phase|Other|10|||
126476792|NCT00566995|455045108|FG000|Overall Study|Toxicity|4|||
126476793|NCT00566995|455045108|FG000|Overall Study|Withdrew consent|3|||
126476794|NCT00594659|455045116|FG000|Overall Study|Lost to Follow-up|13|||
126476795|NCT00594659|455045117|FG001|Overall Study|Lost to Follow-up|9|||
126476796|NCT00594659|455045118|FG002|Overall Study|Lost to Follow-up|7|||
126476797|NCT00660699|455045119|FG000|Overall Study|Withdrawal by Subject|2|||
126476798|NCT05358444|455045130|FG000|Overall Study|Withdrawal by Subject|0|||
126476799|NCT05358444|455045131|FG001|Overall Study|Withdrawal by Subject|1|||
126476800|NCT05358444|455045130|FG000|Overall Study|Lost to Follow-up|0|||
126476801|NCT05358444|455045131|FG001|Overall Study|Lost to Follow-up|3|||
126476802|NCT01752985|455045132|FG000|Treatment Period|Subject request to discontinue treatment|1|||
126476803|NCT01752985|455045133|FG001|Treatment Period|Subject request to discontinue treatment|0|||
126476804|NCT01752985|455045134|FG002|Treatment Period|Subject request to discontinue treatment|1|||
126476805|NCT01752985|455045132|FG000|Treatment Period|Subject no longer meets study criteria|0|||
126476806|NCT01752985|455045133|FG001|Treatment Period|Subject no longer meets study criteria|1|||
126476807|NCT01752985|455045134|FG002|Treatment Period|Subject no longer meets study criteria|1|||
126476808|NCT01752985|455045132|FG000|Treatment Period|Adverse Event|2|||
126476809|NCT01752985|455045133|FG001|Treatment Period|Adverse Event|1|||
126476810|NCT01752985|455045134|FG002|Treatment Period|Adverse Event|2|||
126476811|NCT01752985|455045132|FG000|Treatment Period|Withdrawal by Subject|1|||
126476812|NCT01752985|455045133|FG001|Treatment Period|Withdrawal by Subject|1|||
126476813|NCT01752985|455045134|FG002|Treatment Period|Withdrawal by Subject|0|||
126476814|NCT01752985|455045132|FG000|Treatment Period|Lost to Follow-up|0|||
126476815|NCT01752985|455045133|FG001|Treatment Period|Lost to Follow-up|0|||
126476816|NCT01752985|455045134|FG002|Treatment Period|Lost to Follow-up|1|||
126416410|NCT01504412|454818570|FG000|Overall Study|Adverse Event|1|||
126416411|NCT01504412|454818571|FG001|Overall Study|Adverse Event|8|||
126416412|NCT01504412|454818572|FG002|Overall Study|Adverse Event|1|||
126416413|NCT01504412|454818573|FG003|Overall Study|Adverse Event|7|||
126416414|NCT01504412|454818574|FG004|Overall Study|Adverse Event|10|||
126416415|NCT01504412|454818570|FG000|Overall Study|Withdrawal by Subject|2|||
126416416|NCT01504412|454818571|FG001|Overall Study|Withdrawal by Subject|1|||
126416417|NCT01504412|454818572|FG002|Overall Study|Withdrawal by Subject|1|||
126416418|NCT01504412|454818573|FG003|Overall Study|Withdrawal by Subject|5|||
126416419|NCT01504412|454818574|FG004|Overall Study|Withdrawal by Subject|1|||
126416420|NCT01504412|454818570|FG000|Overall Study|Other|2|||
126416421|NCT01504412|454818571|FG001|Overall Study|Other|1|||
126416422|NCT01504412|454818572|FG002|Overall Study|Other|1|||
126416423|NCT01504412|454818573|FG003|Overall Study|Other|6|||
126416424|NCT01504412|454818574|FG004|Overall Study|Other|1|||
126416425|NCT01504412|454818570|FG000|Overall Study|Lost to Follow-up|0|||
126416426|NCT01504412|454818571|FG001|Overall Study|Lost to Follow-up|2|||
126416427|NCT01504412|454818572|FG002|Overall Study|Lost to Follow-up|0|||
126416428|NCT01504412|454818573|FG003|Overall Study|Lost to Follow-up|0|||
126416429|NCT01504412|454818574|FG004|Overall Study|Lost to Follow-up|0|||
126416430|NCT01504412|454818570|FG000|Overall Study|Lack of Efficacy|0|||
126416431|NCT01504412|454818571|FG001|Overall Study|Lack of Efficacy|0|||
126416432|NCT01504412|454818572|FG002|Overall Study|Lack of Efficacy|1|||
126416433|NCT01504412|454818573|FG003|Overall Study|Lack of Efficacy|0|||
126416434|NCT01504412|454818574|FG004|Overall Study|Lack of Efficacy|1|||
126416435|NCT01504412|454818570|FG000|Overall Study|Death|0|||
126416436|NCT01504412|454818571|FG001|Overall Study|Death|0|||
126416437|NCT01504412|454818572|FG002|Overall Study|Death|0|||
126416438|NCT01504412|454818573|FG003|Overall Study|Death|1|||
126416439|NCT01504412|454818574|FG004|Overall Study|Death|0|||
126416440|NCT01449006|454818575|FG000|Overall Study|Lost to Follow-up|1|||
126416441|NCT01449006|454818576|FG001|Overall Study|Lost to Follow-up|0|||
126416442|NCT01449006|454818575|FG000|Overall Study|Withdrawal by Subject|1|||
126416443|NCT01449006|454818576|FG001|Overall Study|Withdrawal by Subject|0|||
126416444|NCT01449006|454818575|FG000|Overall Study|Protocol Violation|1|||
126416445|NCT01449006|454818576|FG001|Overall Study|Protocol Violation|0|||
126416446|NCT03350815|454818577|FG000|Period 1|Adverse Event|10|||
126416447|NCT03350815|454818578|FG001|Period 1|Adverse Event|0|||
126416448|NCT03350815|454818579|FG002|Period 1|Adverse Event|0|||
126416449|NCT03350815|454818580|FG003|Period 1|Adverse Event|0|||
126416450|NCT03350815|454818577|FG000|Period 1|Technical problems|1|||
126416451|NCT03350815|454818578|FG001|Period 1|Technical problems|0|||
126416452|NCT03350815|454818579|FG002|Period 1|Technical problems|0|||
126416453|NCT03350815|454818580|FG003|Period 1|Technical problems|0|||
126416454|NCT03350815|454818577|FG000|Period 1|Lost to Follow-up|3|||
126416455|NCT03350815|454818578|FG001|Period 1|Lost to Follow-up|0|||
126416456|NCT03350815|454818579|FG002|Period 1|Lost to Follow-up|0|||
126416457|NCT03350815|454818580|FG003|Period 1|Lost to Follow-up|0|||
126416458|NCT03350815|454818577|FG000|Period 1|Physician Decision|1|||
126416459|NCT03350815|454818578|FG001|Period 1|Physician Decision|0|||
126416460|NCT03350815|454818579|FG002|Period 1|Physician Decision|0|||
126416461|NCT03350815|454818580|FG003|Period 1|Physician Decision|0|||
126416462|NCT03350815|454818577|FG000|Period 1|Withdrawal by Subject|8|||
126416463|NCT03350815|454818578|FG001|Period 1|Withdrawal by Subject|0|||
126416464|NCT03350815|454818579|FG002|Period 1|Withdrawal by Subject|0|||
126416465|NCT03350815|454818580|FG003|Period 1|Withdrawal by Subject|0|||
126416466|NCT03350815|454818577|FG000|Period 1|Lack of Efficacy|15|||
126416467|NCT03350815|454818578|FG001|Period 1|Lack of Efficacy|0|||
126416468|NCT03350815|454818579|FG002|Period 1|Lack of Efficacy|0|||
126416469|NCT03350815|454818580|FG003|Period 1|Lack of Efficacy|0|||
126416470|NCT03350815|454818577|FG000|Period 1|Non-compliance with study treatment|2|||
126416471|NCT03350815|454818578|FG001|Period 1|Non-compliance with study treatment|0|||
126416472|NCT03350815|454818579|FG002|Period 1|Non-compliance with study treatment|0|||
126416473|NCT03350815|454818580|FG003|Period 1|Non-compliance with study treatment|0|||
126416474|NCT03350815|454818577|FG000|Period 1|Protocol Violation|3|||
126476817|NCT01945281|455046561|FG000|Overall Study|Adverse Event|1|||
126476818|NCT01945281|455046562|FG001|Overall Study|Adverse Event|0|||
126416475|NCT03350815|454818578|FG001|Period 1|Protocol Violation|0|||
126476819|NCT01945281|455046561|FG000|Overall Study|Death|3|||
126476820|NCT01945281|455046562|FG001|Overall Study|Death|3|||
126476821|NCT01945281|455046561|FG000|Overall Study|Physician Decision|1|||
126476822|NCT01945281|455046562|FG001|Overall Study|Physician Decision|1|||
126416476|NCT03350815|454818579|FG002|Period 1|Protocol Violation|0|||
126416477|NCT03350815|454818580|FG003|Period 1|Protocol Violation|0|||
126416478|NCT03350815|454818577|FG000|Period 2|Adverse Event|0|||
126416479|NCT03350815|454818578|FG001|Period 2|Adverse Event|3|||
126416480|NCT03350815|454818579|FG002|Period 2|Adverse Event|5|||
126416481|NCT03350815|454818580|FG003|Period 2|Adverse Event|0|||
126416482|NCT03350815|454818577|FG000|Period 2|Technical problem|0|||
126416483|NCT03350815|454818578|FG001|Period 2|Technical problem|1|||
126416484|NCT03350815|454818579|FG002|Period 2|Technical problem|0|||
126416485|NCT03350815|454818580|FG003|Period 2|Technical problem|0|||
126558983|NCT03606460|455340603|FG001|Overall Study|Lost to Follow-up|8|||
126558984|NCT04170023|455340604|FG000|LTE Period|Withdrawal by Subject|1|||
126558985|NCT04170023|455340605|FG001|LTE Period|Withdrawal by Subject|0|||
126558986|NCT04170023|455340606|FG002|LTE Period|Withdrawal by Subject|0|||
126558987|NCT04170023|455340604|FG000|LTE Period|Study Termination|11|||
126558988|NCT04170023|455340605|FG001|LTE Period|Study Termination|11|||
126558989|NCT04170023|455340606|FG002|LTE Period|Study Termination|5|||
126558990|NCT03836664|455340607|FG000|Overall Study|Didn't complete forms and lost drug|3|||
126558991|NCT03836664|455340608|FG001|Overall Study|Didn't complete forms and lost drug|3|||
126558992|NCT01427907|455340609|FG000|Overall Study|Withdrawal by Subject|3|||
126558993|NCT01427907|455340610|FG001|Overall Study|Withdrawal by Subject|4|||
126558994|NCT02179918|455340611|FG000|Overall Study|Death|0|||
126558995|NCT02179918|455340612|FG001|Overall Study|Death|0|||
126558996|NCT02179918|455340613|FG002|Overall Study|Death|0|||
126558997|NCT02179918|455340614|FG003|Overall Study|Death|1|||
126558998|NCT02179918|455340615|FG004|Overall Study|Death|0|||
126558999|NCT02179918|455340611|FG000|Overall Study|Lost to Follow-up|0|||
126559000|NCT02179918|455340612|FG001|Overall Study|Lost to Follow-up|0|||
126559001|NCT02179918|455340613|FG002|Overall Study|Lost to Follow-up|1|||
126559002|NCT02179918|455340614|FG003|Overall Study|Lost to Follow-up|0|||
126559003|NCT02179918|455340615|FG004|Overall Study|Lost to Follow-up|0|||
126559004|NCT02179918|455340611|FG000|Overall Study|Progressive Disease|4|||
126559005|NCT02179918|455340612|FG001|Overall Study|Progressive Disease|1|||
126559006|NCT02179918|455340613|FG002|Overall Study|Progressive Disease|1|||
126559007|NCT02179918|455340614|FG003|Overall Study|Progressive Disease|2|||
126559008|NCT02179918|455340615|FG004|Overall Study|Progressive Disease|6|||
126559009|NCT02179918|455340611|FG000|Overall Study|Other|0|||
126559010|NCT02179918|455340612|FG001|Overall Study|Other|1|||
126559011|NCT02179918|455340613|FG002|Overall Study|Other|0|||
126559012|NCT02179918|455340614|FG003|Overall Study|Other|0|||
126559013|NCT02179918|455340615|FG004|Overall Study|Other|1|||
126559014|NCT02179918|455340611|FG000|Overall Study|Subject refused further follow-up|0|||
126559015|NCT02179918|455340612|FG001|Overall Study|Subject refused further follow-up|1|||
126721724|NCT00782418|455931267|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
126721725|NCT02324842|455931268|FG000|Overall Study|Lost to Follow-up|1|||
126721726|NCT02324842|455931269|FG001|Overall Study|Lost to Follow-up|1|||
126721727|NCT02324842|455931270|FG002|Overall Study|Lost to Follow-up|2|||
126721728|NCT02750800|455931271|FG000|Overall Study|Adverse Event|18|||
126721729|NCT02750800|455931271|FG000|Overall Study|Lost to Follow-up|12|||
126721730|NCT02750800|455931271|FG000|Overall Study|Investigator decision|53|||
126721731|NCT02750800|455931271|FG000|Overall Study|Patient request|12|||
126416486|NCT03350815|454818577|FG000|Period 2|Lost to Follow-up|0|||
126416487|NCT03350815|454818578|FG001|Period 2|Lost to Follow-up|3|||
126416488|NCT03350815|454818579|FG002|Period 2|Lost to Follow-up|3|||
126416489|NCT03350815|454818580|FG003|Period 2|Lost to Follow-up|0|||
126416490|NCT03350815|454818577|FG000|Period 2|Physician Decision|0|||
126416491|NCT03350815|454818578|FG001|Period 2|Physician Decision|0|||
126416492|NCT03350815|454818579|FG002|Period 2|Physician Decision|1|||
126416493|NCT03350815|454818580|FG003|Period 2|Physician Decision|0|||
126416494|NCT03350815|454818577|FG000|Period 2|Withdrawal by Subject|0|||
126416495|NCT03350815|454818578|FG001|Period 2|Withdrawal by Subject|3|||
126416496|NCT03350815|454818579|FG002|Period 2|Withdrawal by Subject|4|||
126416497|NCT03350815|454818580|FG003|Period 2|Withdrawal by Subject|0|||
126416498|NCT03350815|454818577|FG000|Period 2|Lack of Efficacy|0|||
126416499|NCT03350815|454818578|FG001|Period 2|Lack of Efficacy|6|||
126416500|NCT03350815|454818579|FG002|Period 2|Lack of Efficacy|2|||
126416501|NCT03350815|454818580|FG003|Period 2|Lack of Efficacy|0|||
126416502|NCT03350815|454818577|FG000|Period 2|Protocol Violation|0|||
126416503|NCT03350815|454818578|FG001|Period 2|Protocol Violation|0|||
126416504|NCT03350815|454818579|FG002|Period 2|Protocol Violation|1|||
126416505|NCT03350815|454818580|FG003|Period 2|Protocol Violation|0|||
126416506|NCT03350815|454818577|FG000|Period 2|New therapy for study indication|0|||
126416507|NCT03350815|454818578|FG001|Period 2|New therapy for study indication|0|||
126416508|NCT03350815|454818579|FG002|Period 2|New therapy for study indication|1|||
126416509|NCT03350815|454818580|FG003|Period 2|New therapy for study indication|0|||
126416510|NCT03040674|454818585|FG000|Overall Study|Lost to Follow-up|225|||
126416511|NCT03040674|454818585|FG000|Overall Study|Death|23|||
126416512|NCT02936843|454818586|FG000|Overall Study|Lost to Follow-up|3|||
126559016|NCT02179918|455340613|FG002|Overall Study|Subject refused further follow-up|0|||
126559017|NCT02179918|455340614|FG003|Overall Study|Subject refused further follow-up|0|||
126559018|NCT02179918|455340615|FG004|Overall Study|Subject refused further follow-up|1|||
126559019|NCT04537949|455340620|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
126559020|NCT04537949|455340621|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
126559021|NCT04537949|455340622|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
126559022|NCT04537949|455340623|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
126559023|NCT04537949|455340624|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
126721732|NCT02750800|455931271|FG000|Overall Study|Other, not specified|3|||
126416513|NCT02936843|454818587|FG001|Overall Study|Lost to Follow-up|1|||
126416514|NCT02936843|454818586|FG000|Overall Study|Withdrawal by Subject|1|||
126416515|NCT02936843|454818587|FG001|Overall Study|Withdrawal by Subject|1|||
126416516|NCT03386487|454818588|FG000|Overall Study|Lost to Follow-up|5|||
126416517|NCT03386487|454818589|FG001|Overall Study|Lost to Follow-up|6|||
126416518|NCT03386487|454818588|FG000|Overall Study|Withdrawal by Subject|11|||
126416519|NCT03386487|454818589|FG001|Overall Study|Withdrawal by Subject|7|||
126416520|NCT03386487|454818588|FG000|Overall Study|Physician Decision|11|||
126416521|NCT03386487|454818589|FG001|Overall Study|Physician Decision|8|||
126416522|NCT02703324|454818590|FG000|Period Two|Withdrawal by Subject|0|||
126416523|NCT02703324|454818591|FG001|Period Two|Withdrawal by Subject|0|||
126416524|NCT02703324|454818592|FG002|Period Two|Withdrawal by Subject|1|||
126416525|NCT02703324|454818593|FG003|Period Two|Withdrawal by Subject|0|||
126416526|NCT02703324|454818594|FG004|Period Two|Withdrawal by Subject|0|||
126721733|NCT03298412|455931272|FG000|Run-in Period|Other, Not Specified|1|||
126721734|NCT03298412|455931272|FG000|Run-in Period|Disease Progression|1|||
126416527|NCT02703324|454818595|FG005|Period Two|Withdrawal by Subject|0|||
126416528|NCT04303572|454818596|FG000|Overall Study|Study closed due to poor enrollment|1|||
126416529|NCT06312592|454818597|FG000|Overall Study|Lost to Follow-up|29|||
126416530|NCT06312592|454818598|FG001|Overall Study|Lost to Follow-up|13|||
126416531|NCT00475709|454818603|FG000|Overall Study|Did not meet eligibility criteria|8|||
126416532|NCT00475709|454818603|FG000|Overall Study|Death|41|||
126416533|NCT00475709|454818603|FG000|Overall Study|Device Explant|6|||
126416534|NCT00475709|454818603|FG000|Overall Study|Lost to Follow-up|21|||
126416535|NCT00555672|454818604|FG000|Overall Study|Death|0|||
126416536|NCT00555672|454818605|FG001|Overall Study|Death|2|||
126416537|NCT00555672|454818604|FG000|Overall Study|Adverse Event|8|||
126416538|NCT00555672|454818605|FG001|Overall Study|Adverse Event|2|||
126416539|NCT00555672|454818604|FG000|Overall Study|Objective progression or relapse|11|||
126416540|NCT00555672|454818605|FG001|Overall Study|Objective progression or relapse|5|||
126416541|NCT00555672|454818604|FG000|Overall Study|Other|3|||
126416542|NCT00555672|454818605|FG001|Overall Study|Other|1|||
126416543|NCT00555672|454818604|FG000|Overall Study|Participant refused|2|||
126416544|NCT00555672|454818605|FG001|Overall Study|Participant refused|0|||
126416545|NCT01415401|454818610|FG000|Overall Study|Adverse Event|5|||
126416546|NCT01415401|454818610|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
126416547|NCT01415401|454818610|FG000|Overall Study|Terminated by Sponsor|1|||
126416548|NCT00836186|454818616|FG000|Overall Study|Blood could not be drawn|1|||
126416549|NCT00532298|454818617|FG000|Overall Study|Adverse Event|1|||
126416550|NCT00532298|454818618|FG001|Overall Study|Adverse Event|0|||
126416551|NCT00532298|454818619|FG002|Overall Study|Adverse Event|0|||
126416552|NCT00532298|454818620|FG003|Overall Study|Adverse Event|0|||
126416553|NCT00532298|454818621|FG004|Overall Study|Adverse Event|1|||
126416554|NCT00532298|454818622|FG005|Overall Study|Adverse Event|1|||
126416555|NCT00532298|454818617|FG000|Overall Study|Lost to Follow-up|1|||
126416556|NCT00532298|454818618|FG001|Overall Study|Lost to Follow-up|1|||
126416557|NCT00532298|454818619|FG002|Overall Study|Lost to Follow-up|1|||
126416558|NCT00532298|454818620|FG003|Overall Study|Lost to Follow-up|0|||
126416559|NCT00532298|454818621|FG004|Overall Study|Lost to Follow-up|0|||
126416560|NCT00532298|454818622|FG005|Overall Study|Lost to Follow-up|1|||
126416561|NCT04531241|454818623|FG000|Period 1|Withdrawal by Subject|2|||
126416562|NCT04531241|454818624|FG001|Period 1|Withdrawal by Subject|0|||
126416563|NCT04531241|454818623|FG000|Period 1|Dispesed incorrect lens power|1|||
126721735|NCT03298412|455931272|FG000|Run-in Period|Ineligibility Determined|1|||
126721736|NCT03298412|455931272|FG000|Run-in Period|Decision by Sponsor|6|||
126721737|NCT05631548|455931274|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
126721738|NCT05631548|455931275|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
126416564|NCT04531241|454818624|FG001|Period 1|Dispesed incorrect lens power|0|||
126416565|NCT04531241|454818623|FG000|Period 1|Protocol Violation|1|||
126416566|NCT04531241|454818624|FG001|Period 1|Protocol Violation|0|||
126416567|NCT04531241|454818623|FG000|Period 1|No longer eligible|0|||
126416568|NCT04531241|454818624|FG001|Period 1|No longer eligible|1|||
126416569|NCT04531241|454818623|FG000|Period 1|Lens Discomfort|0|||
126416570|NCT04531241|454818624|FG001|Period 1|Lens Discomfort|1|||
126476823|NCT01945281|455046561|FG000|Overall Study|Technical Problems|1|||
126476824|NCT01945281|455046562|FG001|Overall Study|Technical Problems|0|||
126476825|NCT04401423|455046563|FG000|Overall Study|Withdrawal by Subject|3|||
126476826|NCT04401423|455046564|FG001|Overall Study|Withdrawal by Subject|1|||
126416571|NCT04531241|454818623|FG000|Period 2|Covid-19 Related|1|||
126721739|NCT00995345|455931280|FG000|Overall Study|Withdrawal by Subject|4|||
126721740|NCT00995345|455931281|FG001|Overall Study|Withdrawal by Subject|2|||
126721741|NCT00995345|455931282|FG002|Overall Study|Withdrawal by Subject|1|||
126721742|NCT00995345|455931283|FG003|Overall Study|Withdrawal by Subject|3|||
126416572|NCT04531241|454818624|FG001|Period 2|Covid-19 Related|1|||
126416573|NCT04698993|454818629|FG000|Overall Study|PCR results not accessible|2|||
126416574|NCT04698993|454818630|FG001|Overall Study|PCR results not accessible|7|||
126721743|NCT00995345|455931284|FG004|Overall Study|Withdrawal by Subject|1|||
126416575|NCT04698993|454818629|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
126416576|NCT04698993|454818630|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
126476827|NCT04401423|455046563|FG000|Overall Study|Physician Decision|2|||
126559024|NCT04537949|455340625|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
126721744|NCT00995345|455931280|FG000|Overall Study|Adverse Event|3|||
126721745|NCT00995345|455931281|FG001|Overall Study|Adverse Event|1|||
126416577|NCT00527904|454818631|FG000|Overall Study|Adverse Event|45|||
126416578|NCT00527904|454818631|FG000|Overall Study|Withdrawal by Subject|21|||
126416579|NCT00527904|454818631|FG000|Overall Study|Lost to Follow-up|8|||
126416580|NCT00527904|454818631|FG000|Overall Study|misc|22|||
126416581|NCT02708355|454818633|FG000|Overall Study|Adverse Event|1|||
126416582|NCT02708355|454818634|FG001|Overall Study|Adverse Event|0|||
126416583|NCT02708355|454818635|FG002|Overall Study|Adverse Event|0|||
126416584|NCT01320202|454818636|FG000|Overall Study|Adverse Event|5|||
126416585|NCT01320202|454818637|FG001|Overall Study|Adverse Event|5|||
126416586|NCT01320202|454818636|FG000|Overall Study|Death|5|||
126416587|NCT01320202|454818637|FG001|Overall Study|Death|3|||
126416588|NCT01320202|454818636|FG000|Overall Study|Lost to Follow-up|1|||
126416589|NCT01320202|454818637|FG001|Overall Study|Lost to Follow-up|0|||
126416590|NCT01320202|454818636|FG000|Overall Study|Physician Decision|3|||
126416591|NCT01320202|454818637|FG001|Overall Study|Physician Decision|1|||
126416592|NCT01320202|454818636|FG000|Overall Study|Protocol Violation|2|||
126416593|NCT01320202|454818637|FG001|Overall Study|Protocol Violation|1|||
126416594|NCT01320202|454818636|FG000|Overall Study|Withdrawal by Subject|10|||
126416595|NCT01320202|454818637|FG001|Overall Study|Withdrawal by Subject|3|||
126416596|NCT01320202|454818636|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
126416597|NCT01320202|454818637|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
126416598|NCT01320202|454818636|FG000|Overall Study|kidney transplant|1|||
126416599|NCT01320202|454818637|FG001|Overall Study|kidney transplant|2|||
126416600|NCT01320202|454818636|FG000|Overall Study|blood transfusion|1|||
126416601|NCT01320202|454818637|FG001|Overall Study|blood transfusion|7|||
126416602|NCT01320202|454818636|FG000|Overall Study|moved/changed dialysis|5|||
126416603|NCT01320202|454818637|FG001|Overall Study|moved/changed dialysis|2|||
126416604|NCT01320202|454818636|FG000|Overall Study|sponsor request|2|||
126416605|NCT01320202|454818637|FG001|Overall Study|sponsor request|0|||
126416606|NCT01320202|454818636|FG000|Overall Study|ineligible|3|||
126416607|NCT01320202|454818637|FG001|Overall Study|ineligible|0|||
126416608|NCT01320202|454818636|FG000|Overall Study|regained renal function|1|||
126416609|NCT01320202|454818637|FG001|Overall Study|regained renal function|0|||
126416610|NCT00635882|454818638|FG000|Overall Study|Protocol Violation|1|||
126416611|NCT00635882|454818639|FG001|Overall Study|Protocol Violation|0|||
126416612|NCT00635882|454818640|FG002|Overall Study|Protocol Violation|0|||
126416613|NCT00635882|454818641|FG003|Overall Study|Protocol Violation|0|||
126416614|NCT00635882|454818642|FG004|Overall Study|Protocol Violation|0|||
126416615|NCT00635882|454818643|FG005|Overall Study|Protocol Violation|0|||
126416616|NCT00835341|454818644|FG000|Overall Study|Lost to Follow-up|3|||
126416617|NCT00835341|454818645|FG001|Overall Study|Lost to Follow-up|12|||
126416618|NCT01019369|454818647|FG000|Overall Study|Lost to Follow-up|10|||
126416619|NCT01019369|454818648|FG001|Overall Study|Lost to Follow-up|6|||
126416620|NCT01019369|454818647|FG000|Overall Study|Withdrawal by Subject|0|||
126416621|NCT01019369|454818648|FG001|Overall Study|Withdrawal by Subject|1|||
126416622|NCT02513472|454818649|FG000|Overall Study|Radiological Disease Progression|45|||
126416623|NCT02513472|454818650|FG001|Overall Study|Radiological Disease Progression|57|||
126416624|NCT02513472|454818649|FG000|Overall Study|Clinical Disease Progression|5|||
126416625|NCT02513472|454818650|FG001|Overall Study|Clinical Disease Progression|13|||
126416626|NCT02513472|454818649|FG000|Overall Study|Adverse Event|8|||
126416627|NCT02513472|454818650|FG001|Overall Study|Adverse Event|11|||
126416628|NCT02513472|454818649|FG000|Overall Study|Withdrawal by Subject|0|||
126416629|NCT02513472|454818650|FG001|Overall Study|Withdrawal by Subject|4|||
126416630|NCT02513472|454818649|FG000|Overall Study|Subject Choice|2|||
126416631|NCT02513472|454818650|FG001|Overall Study|Subject Choice|7|||
126416632|NCT02513472|454818649|FG000|Overall Study|Treatment Completed as per Protocol|3|||
126416633|NCT02513472|454818650|FG001|Overall Study|Treatment Completed as per Protocol|3|||
126416634|NCT02513472|454818649|FG000|Overall Study|Other|3|||
126416635|NCT02513472|454818650|FG001|Overall Study|Other|6|||
126559025|NCT04537949|455340626|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
126416636|NCT01380834|454818651|FG000|Overall Study|Physician Decision|1|||
126721746|NCT00995345|455931282|FG002|Overall Study|Adverse Event|2|||
126721747|NCT00995345|455931283|FG003|Overall Study|Adverse Event|0|||
126416637|NCT01380834|454818652|FG001|Overall Study|Physician Decision|0|||
126416638|NCT04310566|454818653|FG000|Period 1|Study Termination due to COVID-19|15|||
126416639|NCT04310566|454818654|FG001|Period 1|Study Termination due to COVID-19|17|||
126416640|NCT04310566|454818653|FG000|Period 1|Protocol Violation|0|||
126416641|NCT04310566|454818654|FG001|Period 1|Protocol Violation|1|||
126416642|NCT04310566|454818653|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
126416643|NCT04310566|454818654|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
126416644|NCT04310566|454818653|FG000|Period 1|Lost to Follow-up|1|||
126416645|NCT04310566|454818654|FG001|Period 1|Lost to Follow-up|0|||
126416646|NCT04310566|454818653|FG000|Period 1|Withdrawal by Subject|0|||
126416647|NCT04310566|454818654|FG001|Period 1|Withdrawal by Subject|1|||
126416648|NCT04310566|454818653|FG000|Period 2|Study Termination|7|||
126721748|NCT00995345|455931284|FG004|Overall Study|Adverse Event|1|||
126416649|NCT04310566|454818654|FG001|Period 2|Study Termination|5|||
126416650|NCT04565951|454818655|FG000|Overall Study|Lost to Follow-up|66|||
126416651|NCT04565951|454818656|FG001|Overall Study|Lost to Follow-up|38|||
126416652|NCT04565951|454818655|FG000|Overall Study|Withdrawal by Subject|14|||
126416653|NCT04565951|454818656|FG001|Overall Study|Withdrawal by Subject|7|||
126416654|NCT04565951|454818655|FG000|Overall Study|Death|0|||
126416655|NCT04565951|454818656|FG001|Overall Study|Death|1|||
126416656|NCT01711645|454818657|FG000|Overall Study|Withdrawal by Subject|8|||
126416657|NCT01711645|454818657|FG000|Overall Study|Lost to Follow-up|6|||
126416658|NCT01711645|454818657|FG000|Overall Study|Physician Decision|5|||
126416659|NCT01746173|454818663|FG000|Overall Study|Disease Progression|2|||
126416660|NCT01153724|454818666|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126416661|NCT01153724|454818666|FG000|Treatment Period 2|Adverse Event|1|||
126416662|NCT01153724|454818666|FG000|Treatment Period 2|Other reason not defined above|1|||
126416663|NCT04230213|454818672|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
126416664|NCT04230213|454818673|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
126416665|NCT04230213|454818674|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
126416666|NCT04230213|454818672|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
126416667|NCT04230213|454818673|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
126416668|NCT04230213|454818674|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
126416669|NCT04230213|454818672|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
126416670|NCT04230213|454818673|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
126416671|NCT04230213|454818674|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
126416672|NCT04230213|454818672|FG000|TP2: Week 10 to Week 16|Other|0|||
126416673|NCT04230213|454818673|FG001|TP2: Week 10 to Week 16|Other|2|||
126416674|NCT04230213|454818674|FG002|TP2: Week 10 to Week 16|Other|1|||
126416675|NCT04230213|454818672|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
126416676|NCT04230213|454818673|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
126416677|NCT04230213|454818674|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
126416678|NCT04230213|454818672|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
126416679|NCT04230213|454818673|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
126416680|NCT04230213|454818674|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
126416681|NCT04230213|454818672|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
126416682|NCT04230213|454818673|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
126416683|NCT04230213|454818674|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
126416684|NCT04230213|454818672|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
126416685|NCT04230213|454818673|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
126416686|NCT04230213|454818674|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
126416687|NCT04230213|454818672|FG000|TP3: Week 16 to Week 22|Other|0|||
126416688|NCT04230213|454818673|FG001|TP3: Week 16 to Week 22|Other|1|||
126416689|NCT04230213|454818674|FG002|TP3: Week 16 to Week 22|Other|3|||
126416690|NCT04230213|454818672|FG000|TP4: Week 22 to Week 32|Other|0|||
126416691|NCT04230213|454818673|FG001|TP4: Week 22 to Week 32|Other|5|||
126416692|NCT04230213|454818674|FG002|TP4: Week 22 to Week 32|Other|5|||
126416693|NCT04230213|454818672|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
126416694|NCT04230213|454818673|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
126416695|NCT04230213|454818674|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
126416696|NCT04230213|454818672|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
126416697|NCT04230213|454818673|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
126416698|NCT04230213|454818674|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
126416699|NCT04230213|454818672|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
126416700|NCT04230213|454818673|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
126416701|NCT04230213|454818674|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
126416702|NCT04230213|454818672|FG000|Follow up: Week 32 to Week 36|Other|0|||
126416703|NCT04230213|454818673|FG001|Follow up: Week 32 to Week 36|Other|1|||
126416704|NCT04230213|454818674|FG002|Follow up: Week 32 to Week 36|Other|1|||
126416705|NCT02508428|454818677|FG000|Overall Study|Death|32|||
126416706|NCT02508428|454818678|FG001|Overall Study|Death|33|||
126416707|NCT02508428|454818677|FG000|Overall Study|Liner revised|3|||
126416708|NCT02508428|454818678|FG001|Overall Study|Liner revised|19|||
126721749|NCT00995345|455931280|FG000|Overall Study|Lost to Follow-up|2|||
126721750|NCT00995345|455931281|FG001|Overall Study|Lost to Follow-up|2|||
126416709|NCT02508428|454818677|FG000|Overall Study|Incomplete follow-up|17|||
126416710|NCT02508428|454818678|FG001|Overall Study|Incomplete follow-up|15|||
126416711|NCT00534976|454818686|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
126721751|NCT00995345|455931282|FG002|Overall Study|Lost to Follow-up|2|||
126416712|NCT00534976|454818687|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
126416713|NCT00534976|454818686|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
126416714|NCT00534976|454818687|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
126416715|NCT00534976|454818686|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
126416716|NCT00534976|454818687|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
126416717|NCT00861471|454818688|FG000|Overall Study|Withdrawal by Subject|1|||
126416718|NCT00861471|454818688|FG000|Overall Study|Adverse Event|2|||
126416719|NCT00861471|454818688|FG000|Overall Study|Lack of Efficacy|3|||
126416720|NCT00861471|454818688|FG000|Overall Study|treatment for lumbar laminectomy|1|||
126416721|NCT00861471|454818688|FG000|Overall Study|Physician Decision|2|||
126416722|NCT02834247|454818689|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
126416723|NCT02834247|454818690|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
126416724|NCT02834247|454818691|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
126416725|NCT02834247|454818692|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
126416726|NCT02834247|454818689|FG000|Dose Escalation Phase|Death|5|||
126416727|NCT02834247|454818690|FG001|Dose Escalation Phase|Death|6|||
126416728|NCT02834247|454818691|FG002|Dose Escalation Phase|Death|5|||
126416729|NCT02834247|454818692|FG003|Dose Escalation Phase|Death|0|||
126416730|NCT02834247|454818689|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
126416731|NCT02834247|454818690|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
126416732|NCT02834247|454818691|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
126416733|NCT02834247|454818692|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
126416734|NCT02834247|454818689|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
126416735|NCT02834247|454818690|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
126416736|NCT02834247|454818691|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
126416737|NCT02834247|454818692|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126416738|NCT02834247|454818689|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
126416739|NCT02834247|454818690|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
126416740|NCT02834247|454818691|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
126416741|NCT02834247|454818692|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
126416742|NCT02834247|454818689|FG000|Dose Expansion Phase|Death|0|||
126416743|NCT02834247|454818690|FG001|Dose Expansion Phase|Death|0|||
126416744|NCT02834247|454818691|FG002|Dose Expansion Phase|Death|0|||
126416745|NCT02834247|454818692|FG003|Dose Expansion Phase|Death|8|||
126416746|NCT02834247|454818689|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
126416747|NCT02834247|454818690|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
126416748|NCT02834247|454818691|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
126416749|NCT02834247|454818692|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
126416750|NCT02834247|454818689|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
126416751|NCT02834247|454818690|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
126416752|NCT02834247|454818691|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
126416753|NCT02834247|454818692|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
126416754|NCT02610777|454821014|FG000|Overall Study|Lost to Follow-up|1|||
126416755|NCT02610777|454821015|FG001|Overall Study|Lost to Follow-up|0|||
126416756|NCT02610777|454821014|FG000|Overall Study|Site Terminated by Sponsor|9|||
126416757|NCT02610777|454821015|FG001|Overall Study|Site Terminated by Sponsor|8|||
126416758|NCT02610777|454821014|FG000|Overall Study|Withdrawal by Subject|2|||
126416759|NCT02610777|454821015|FG001|Overall Study|Withdrawal by Subject|2|||
126416760|NCT02610777|454821014|FG000|Overall Study|Reason not Specified|0|||
126416761|NCT02610777|454821015|FG001|Overall Study|Reason not Specified|1|||
126416762|NCT02610777|454821014|FG000|Overall Study|Death|50|||
126416763|NCT02610777|454821015|FG001|Overall Study|Death|47|||
126416764|NCT02737475|454821018|FG000|Overall Study|Other reasons|0|||
126416765|NCT02737475|454821019|FG001|Overall Study|Other reasons|0|||
126416766|NCT02737475|454821020|FG002|Overall Study|Other reasons|0|||
126416767|NCT02737475|454821021|FG003|Overall Study|Other reasons|0|||
126416768|NCT02737475|454821022|FG004|Overall Study|Other reasons|1|||
126416769|NCT02737475|454821023|FG005|Overall Study|Other reasons|1|||
126416770|NCT02737475|454821024|FG006|Overall Study|Other reasons|0|||
126416771|NCT02737475|454821025|FG007|Overall Study|Other reasons|0|||
126416772|NCT02737475|454821026|FG008|Overall Study|Other reasons|1|||
126416773|NCT02737475|454821027|FG009|Overall Study|Other reasons|0|||
126416774|NCT02737475|454821028|FG010|Overall Study|Other reasons|1|||
126416775|NCT02737475|454821029|FG011|Overall Study|Other reasons|0|||
126416776|NCT02737475|454821030|FG012|Overall Study|Other reasons|0|||
126416777|NCT02737475|454821031|FG013|Overall Study|Other reasons|0|||
126416778|NCT02737475|454821032|FG014|Overall Study|Other reasons|0|||
126416779|NCT02737475|454821033|FG015|Overall Study|Other reasons|0|||
126416780|NCT02737475|454821034|FG016|Overall Study|Other reasons|0|||
126416781|NCT02737475|454821035|FG017|Overall Study|Other reasons|0|||
126416782|NCT02737475|454821036|FG018|Overall Study|Other reasons|0|||
126416783|NCT02737475|454821037|FG019|Overall Study|Other reasons|0|||
126416784|NCT02737475|454821038|FG020|Overall Study|Other reasons|0|||
126416785|NCT02737475|454821039|FG021|Overall Study|Other reasons|1|||
126416786|NCT02737475|454821040|FG022|Overall Study|Other reasons|0|||
126416787|NCT02737475|454821041|FG023|Overall Study|Other reasons|1|||
126416788|NCT02737475|454821042|FG024|Overall Study|Other reasons|1|||
126416789|NCT02737475|454821043|FG025|Overall Study|Other reasons|1|||
126416790|NCT02737475|454821044|FG026|Overall Study|Other reasons|0|||
126416791|NCT02737475|454821018|FG000|Overall Study|Death|1|||
126416792|NCT02737475|454821019|FG001|Overall Study|Death|0|||
126416793|NCT02737475|454821020|FG002|Overall Study|Death|0|||
126416794|NCT02737475|454821021|FG003|Overall Study|Death|1|||
126416795|NCT02737475|454821022|FG004|Overall Study|Death|0|||
126416796|NCT02737475|454821023|FG005|Overall Study|Death|0|||
126416797|NCT02737475|454821024|FG006|Overall Study|Death|0|||
126416798|NCT02737475|454821025|FG007|Overall Study|Death|2|||
126416799|NCT02737475|454821026|FG008|Overall Study|Death|0|||
126416800|NCT02737475|454821027|FG009|Overall Study|Death|0|||
126416801|NCT02737475|454821028|FG010|Overall Study|Death|0|||
126416802|NCT02737475|454821029|FG011|Overall Study|Death|4|||
126416803|NCT02737475|454821030|FG012|Overall Study|Death|2|||
126416804|NCT02737475|454821031|FG013|Overall Study|Death|2|||
126416805|NCT02737475|454821032|FG014|Overall Study|Death|0|||
126416806|NCT02737475|454821033|FG015|Overall Study|Death|2|||
126416807|NCT02737475|454821034|FG016|Overall Study|Death|2|||
126416808|NCT02737475|454821035|FG017|Overall Study|Death|2|||
126416809|NCT02737475|454821036|FG018|Overall Study|Death|1|||
126416810|NCT02737475|454821037|FG019|Overall Study|Death|0|||
126416811|NCT02737475|454821038|FG020|Overall Study|Death|0|||
126416812|NCT02737475|454821039|FG021|Overall Study|Death|0|||
126416813|NCT02737475|454821040|FG022|Overall Study|Death|0|||
126416814|NCT02737475|454821041|FG023|Overall Study|Death|0|||
126416815|NCT02737475|454821042|FG024|Overall Study|Death|0|||
126416816|NCT02737475|454821043|FG025|Overall Study|Death|0|||
126416817|NCT02737475|454821044|FG026|Overall Study|Death|0|||
126416818|NCT02737475|454821018|FG000|Overall Study|Participant withdrew consent|0|||
126416819|NCT02737475|454821019|FG001|Overall Study|Participant withdrew consent|0|||
126416820|NCT02737475|454821020|FG002|Overall Study|Participant withdrew consent|0|||
126416821|NCT02737475|454821021|FG003|Overall Study|Participant withdrew consent|0|||
126416822|NCT02737475|454821022|FG004|Overall Study|Participant withdrew consent|0|||
126416823|NCT02737475|454821023|FG005|Overall Study|Participant withdrew consent|2|||
126416824|NCT02737475|454821024|FG006|Overall Study|Participant withdrew consent|0|||
126416825|NCT02737475|454821025|FG007|Overall Study|Participant withdrew consent|0|||
126416826|NCT02737475|454821026|FG008|Overall Study|Participant withdrew consent|0|||
126416827|NCT02737475|454821027|FG009|Overall Study|Participant withdrew consent|0|||
126416828|NCT02737475|454821028|FG010|Overall Study|Participant withdrew consent|0|||
126416829|NCT02737475|454821029|FG011|Overall Study|Participant withdrew consent|0|||
126416830|NCT02737475|454821030|FG012|Overall Study|Participant withdrew consent|0|||
126416831|NCT02737475|454821031|FG013|Overall Study|Participant withdrew consent|0|||
126416832|NCT02737475|454821032|FG014|Overall Study|Participant withdrew consent|1|||
126416833|NCT02737475|454821033|FG015|Overall Study|Participant withdrew consent|0|||
126416834|NCT02737475|454821034|FG016|Overall Study|Participant withdrew consent|0|||
126416835|NCT02737475|454821035|FG017|Overall Study|Participant withdrew consent|2|||
126416836|NCT02737475|454821036|FG018|Overall Study|Participant withdrew consent|1|||
126416837|NCT02737475|454821037|FG019|Overall Study|Participant withdrew consent|0|||
126416838|NCT02737475|454821038|FG020|Overall Study|Participant withdrew consent|2|||
126416839|NCT02737475|454821039|FG021|Overall Study|Participant withdrew consent|0|||
126416840|NCT02737475|454821040|FG022|Overall Study|Participant withdrew consent|0|||
126416841|NCT02737475|454821041|FG023|Overall Study|Participant withdrew consent|0|||
126416842|NCT02737475|454821042|FG024|Overall Study|Participant withdrew consent|0|||
126416843|NCT02737475|454821043|FG025|Overall Study|Participant withdrew consent|0|||
126416844|NCT02737475|454821044|FG026|Overall Study|Participant withdrew consent|0|||
126416845|NCT02737475|454821018|FG000|Overall Study|Lost to Follow-up|0|||
126416846|NCT02737475|454821019|FG001|Overall Study|Lost to Follow-up|0|||
126416847|NCT02737475|454821020|FG002|Overall Study|Lost to Follow-up|0|||
126416848|NCT02737475|454821021|FG003|Overall Study|Lost to Follow-up|0|||
126416849|NCT02737475|454821022|FG004|Overall Study|Lost to Follow-up|0|||
126416850|NCT02737475|454821023|FG005|Overall Study|Lost to Follow-up|0|||
126416851|NCT02737475|454821024|FG006|Overall Study|Lost to Follow-up|0|||
126416852|NCT02737475|454821025|FG007|Overall Study|Lost to Follow-up|0|||
126416853|NCT02737475|454821026|FG008|Overall Study|Lost to Follow-up|0|||
126416854|NCT02737475|454821027|FG009|Overall Study|Lost to Follow-up|0|||
126416855|NCT02737475|454821028|FG010|Overall Study|Lost to Follow-up|0|||
126721752|NCT00995345|455931283|FG003|Overall Study|Lost to Follow-up|1|||
126416856|NCT02737475|454821029|FG011|Overall Study|Lost to Follow-up|0|||
126416857|NCT02737475|454821030|FG012|Overall Study|Lost to Follow-up|0|||
126721753|NCT00995345|455931284|FG004|Overall Study|Lost to Follow-up|0|||
126721754|NCT00995345|455931280|FG000|Overall Study|all other reasons combined|2|||
126416858|NCT02737475|454821031|FG013|Overall Study|Lost to Follow-up|0|||
126416859|NCT02737475|454821032|FG014|Overall Study|Lost to Follow-up|0|||
126416860|NCT02737475|454821033|FG015|Overall Study|Lost to Follow-up|1|||
126416861|NCT02737475|454821034|FG016|Overall Study|Lost to Follow-up|0|||
126416862|NCT02737475|454821035|FG017|Overall Study|Lost to Follow-up|0|||
126416863|NCT02737475|454821036|FG018|Overall Study|Lost to Follow-up|0|||
126476828|NCT04401423|455046564|FG001|Overall Study|Physician Decision|1|||
126476829|NCT00799383|455046565|FG000|Overall Study|Protocol Violation|1|||
126416864|NCT02737475|454821037|FG019|Overall Study|Lost to Follow-up|0|||
126416865|NCT02737475|454821038|FG020|Overall Study|Lost to Follow-up|0|||
126416866|NCT02737475|454821039|FG021|Overall Study|Lost to Follow-up|0|||
126416867|NCT02737475|454821040|FG022|Overall Study|Lost to Follow-up|0|||
126416868|NCT02737475|454821041|FG023|Overall Study|Lost to Follow-up|0|||
126416869|NCT02737475|454821042|FG024|Overall Study|Lost to Follow-up|0|||
126721755|NCT00995345|455931281|FG001|Overall Study|all other reasons combined|2|||
126721756|NCT00995345|455931282|FG002|Overall Study|all other reasons combined|2|||
126721757|NCT00995345|455931283|FG003|Overall Study|all other reasons combined|1|||
126721758|NCT00995345|455931284|FG004|Overall Study|all other reasons combined|3|||
126721759|NCT01860534|455931285|FG000|ROP #1|Needed treatment for ROP|0|||
126721760|NCT01860534|455931286|FG001|ROP #1|Needed treatment for ROP|1|||
126721761|NCT01860534|455931285|FG000|ROP #2|discharged prior to ROP #2|1|||
126721762|NCT01860534|455931286|FG001|ROP #2|discharged prior to ROP #2|0|||
126416870|NCT02737475|454821043|FG025|Overall Study|Lost to Follow-up|0|||
126416871|NCT02737475|454821044|FG026|Overall Study|Lost to Follow-up|0|||
126416872|NCT02737475|454821018|FG000|Overall Study|Disease Progression|0|||
126416873|NCT02737475|454821019|FG001|Overall Study|Disease Progression|0|||
126416874|NCT02737475|454821020|FG002|Overall Study|Disease Progression|0|||
126416875|NCT02737475|454821021|FG003|Overall Study|Disease Progression|0|||
126416876|NCT02737475|454821022|FG004|Overall Study|Disease Progression|0|||
126416877|NCT02737475|454821023|FG005|Overall Study|Disease Progression|0|||
126416878|NCT02737475|454821024|FG006|Overall Study|Disease Progression|0|||
126416879|NCT02737475|454821025|FG007|Overall Study|Disease Progression|0|||
126416880|NCT02737475|454821026|FG008|Overall Study|Disease Progression|0|||
126416881|NCT02737475|454821027|FG009|Overall Study|Disease Progression|0|||
126416882|NCT02737475|454821028|FG010|Overall Study|Disease Progression|0|||
126416883|NCT02737475|454821029|FG011|Overall Study|Disease Progression|0|||
126416884|NCT02737475|454821030|FG012|Overall Study|Disease Progression|0|||
126416885|NCT02737475|454821031|FG013|Overall Study|Disease Progression|0|||
126416886|NCT02737475|454821032|FG014|Overall Study|Disease Progression|0|||
126416887|NCT02737475|454821033|FG015|Overall Study|Disease Progression|0|||
126476830|NCT00799383|455046566|FG001|Overall Study|Protocol Violation|1|||
126476831|NCT00799383|455046565|FG000|Overall Study|Adverse Event|0|||
126476832|NCT00799383|455046566|FG001|Overall Study|Adverse Event|1|||
126476833|NCT00799383|455046565|FG000|Overall Study|Lost to Follow-up|1|||
126416888|NCT02737475|454821034|FG016|Overall Study|Disease Progression|0|||
126416889|NCT02737475|454821035|FG017|Overall Study|Disease Progression|0|||
126416890|NCT02737475|454821036|FG018|Overall Study|Disease Progression|0|||
126416891|NCT02737475|454821037|FG019|Overall Study|Disease Progression|0|||
126416892|NCT02737475|454821038|FG020|Overall Study|Disease Progression|0|||
126416893|NCT02737475|454821039|FG021|Overall Study|Disease Progression|0|||
126416894|NCT02737475|454821040|FG022|Overall Study|Disease Progression|0|||
126416895|NCT02737475|454821041|FG023|Overall Study|Disease Progression|0|||
126416896|NCT02737475|454821042|FG024|Overall Study|Disease Progression|0|||
126416897|NCT02737475|454821043|FG025|Overall Study|Disease Progression|0|||
126416898|NCT02737475|454821044|FG026|Overall Study|Disease Progression|1|||
126416899|NCT00660179|454821046|FG000|Overall Study|Death|44|||
126416900|NCT00660179|454821047|FG001|Overall Study|Death|47|||
126416901|NCT00660179|454821048|FG002|Overall Study|Death|34|||
126416902|NCT00660179|454821046|FG000|Overall Study|Withdrawal of consent|4|||
126416903|NCT00660179|454821047|FG001|Overall Study|Withdrawal of consent|6|||
126416904|NCT00660179|454821048|FG002|Overall Study|Withdrawal of consent|4|||
126416905|NCT00660179|454821046|FG000|Overall Study|Lost to Follow-up|7|||
126416906|NCT00660179|454821047|FG001|Overall Study|Lost to Follow-up|5|||
126416907|NCT00660179|454821048|FG002|Overall Study|Lost to Follow-up|2|||
126476834|NCT00799383|455046566|FG001|Overall Study|Lost to Follow-up|2|||
126476835|NCT00799383|455046565|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
126476836|NCT00799383|455046566|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
126476837|NCT00799383|455046565|FG000|Overall Study|Withdrawal by Subject|0|||
126476838|NCT00799383|455046566|FG001|Overall Study|Withdrawal by Subject|1|||
126476839|NCT00726986|455046567|FG000|Induction Phase|Adverse Event|4|||
126476840|NCT00726986|455046567|FG000|Induction Phase|Withdrawal by Subject|2|||
126476841|NCT00726986|455046567|FG000|Induction Phase|Death|2|||
126559026|NCT04537949|455340627|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
126721763|NCT05122650|455931290|FG000|Overall Study|Adverse Event|4|||
126721764|NCT05122650|455931291|FG001|Overall Study|Adverse Event|16|||
126721765|NCT05122650|455931292|FG002|Overall Study|Adverse Event|11|||
126416908|NCT00660179|454821046|FG000|Overall Study|Administrative reason|0|||
126416909|NCT00660179|454821047|FG001|Overall Study|Administrative reason|0|||
126476842|NCT00726986|455046567|FG000|Induction Phase|Lack of Efficacy|5|||
126476843|NCT00726986|455046567|FG000|Induction Phase|Secondary Disease|2|||
126476844|NCT00726986|455046567|FG000|Maintenance Phase|Adverse Event|1|||
126476845|NCT00726986|455046567|FG000|Maintenance Phase|Lack of Efficacy|2|||
126721766|NCT05122650|455931293|FG003|Overall Study|Adverse Event|12|||
126721767|NCT05122650|455931290|FG000|Overall Study|Lack of Efficacy|0|||
126721768|NCT05122650|455931291|FG001|Overall Study|Lack of Efficacy|1|||
126721769|NCT05122650|455931292|FG002|Overall Study|Lack of Efficacy|1|||
126416910|NCT00660179|454821048|FG002|Overall Study|Administrative reason|1|||
126416911|NCT00660179|454821046|FG000|Overall Study|Incorrect randomization|1|||
126416912|NCT00660179|454821047|FG001|Overall Study|Incorrect randomization|0|||
126416913|NCT00660179|454821048|FG002|Overall Study|Incorrect randomization|0|||
126416914|NCT01036321|454821049|FG000|Overall Study|Ineligible after randomization|0|||
126416915|NCT01036321|454821050|FG001|Overall Study|Ineligible after randomization|1|||
126416916|NCT01036321|454821049|FG000|Overall Study|Withdrawal by Subject|3|||
126416917|NCT01036321|454821050|FG001|Overall Study|Withdrawal by Subject|2|||
126416918|NCT01036321|454821049|FG000|Overall Study|Adverse Event|2|||
126416919|NCT01036321|454821050|FG001|Overall Study|Adverse Event|1|||
126416920|NCT00381693|454821053|FG000|Overall Study|Death|1|||
126416921|NCT00381693|454821053|FG000|Overall Study|Adverse Event|4|||
126416922|NCT00381693|454821053|FG000|Overall Study|Patient Choice|1|||
126416923|NCT00381693|454821053|FG000|Overall Study|Progression|2|||
126416924|NCT02506192|454821065|FG000|Overall Study|Withdrawal by Subject|1|||
126416925|NCT02506192|454821066|FG001|Overall Study|Withdrawal by Subject|1|||
126416926|NCT02221674|454821068|FG000|Overall Study|Lost to Follow-up|1|||
126416927|NCT02221674|454821069|FG001|Overall Study|Lost to Follow-up|0|||
126416928|NCT02221674|454821070|FG002|Overall Study|Lost to Follow-up|0|||
126416929|NCT05292131|454821071|FG000|Overall Study|Lost to Follow-up|1|||
126416930|NCT05292131|454821072|FG001|Overall Study|Lost to Follow-up|1|||
126416931|NCT05292131|454821071|FG000|Overall Study|Withdrawal by Subject|0|||
126416932|NCT05292131|454821072|FG001|Overall Study|Withdrawal by Subject|1|||
126416933|NCT04390880|454821074|FG000|Overall Study|Withdrawal by Subject|1|||
126416934|NCT02557542|454821075|FG000|Overall Study|Poor recruitment|3|||
126416935|NCT02557542|454821076|FG001|Overall Study|Poor recruitment|0|||
126416936|NCT06136897|454821077|FG000|Overall Study|Ineligible|3|||
126416937|NCT06136897|454821077|FG000|Overall Study|Mutation status not confirmed|7|||
126416938|NCT06136897|454821077|FG000|Overall Study|Adverse Event|2|||
126416939|NCT06136897|454821077|FG000|Overall Study|Death|1|||
126416940|NCT06136897|454821077|FG000|Overall Study|Disease progression|18|||
126416941|NCT06136897|454821077|FG000|Overall Study|Other complicating disease|1|||
126416942|NCT06136897|454821077|FG000|Overall Study|Withdrawal by Subject|1|||
126416943|NCT06136897|454821077|FG000|Overall Study|Still on treatment|1|||
126416944|NCT06136897|454821077|FG000|Overall Study|Lost to Follow-up|1|||
126416945|NCT03705559|454821078|FG000|Overall Study|COVID Shut down|1|||
126416946|NCT01979952|454821079|FG000|Overall Study|Adverse Event|4|||
126416947|NCT01979952|454821080|FG001|Overall Study|Adverse Event|5|||
126416948|NCT01979952|454821079|FG000|Overall Study|Protocol Violation|1|||
126416949|NCT01979952|454821080|FG001|Overall Study|Protocol Violation|0|||
126416950|NCT01979952|454821079|FG000|Overall Study|Withdrawal by Subject|2|||
126416951|NCT01979952|454821080|FG001|Overall Study|Withdrawal by Subject|1|||
126416952|NCT01979952|454821079|FG000|Overall Study|Other than specified above|1|||
126416953|NCT01979952|454821080|FG001|Overall Study|Other than specified above|0|||
126416954|NCT05438576|454821081|FG000|Overall Study|Death|1|||
126416955|NCT05438576|454821082|FG001|Overall Study|Death|1|||
126416956|NCT05438576|454821081|FG000|Overall Study|Withdrawal by Subject|4|||
126416957|NCT05438576|454821082|FG001|Overall Study|Withdrawal by Subject|2|||
126416958|NCT05438576|454821081|FG000|Overall Study|Not Eligible|2|||
126416959|NCT05438576|454821082|FG001|Overall Study|Not Eligible|1|||
126416960|NCT05438576|454821081|FG000|Overall Study|Did not complete baseline testing|22|||
126416961|NCT05438576|454821082|FG001|Overall Study|Did not complete baseline testing|4|||
126416962|NCT01067144|454821088|FG000|Treatment|Did not receive allocated intervention|4|||
126416963|NCT01067144|454821089|FG001|Treatment|Did not receive allocated intervention|7|||
126416964|NCT01067144|454821088|FG000|Follow-up|Lost to Follow-up|22|||
126416965|NCT01067144|454821089|FG001|Follow-up|Lost to Follow-up|12|||
126416966|NCT01067144|454821088|FG000|Follow-up|Censored owing to second surgery|19|||
126416967|NCT01067144|454821089|FG001|Follow-up|Censored owing to second surgery|28|||
126416968|NCT01067144|454821088|FG000|Follow-up|Withdrawal by Subject|18|||
126416969|NCT01067144|454821089|FG001|Follow-up|Withdrawal by Subject|14|||
126416970|NCT01067144|454821088|FG000|Follow-up|Surgery cancelled|0|||
126416971|NCT01067144|454821089|FG001|Follow-up|Surgery cancelled|1|||
126416972|NCT01067144|454821088|FG000|Follow-up|Death|0|||
126416973|NCT01067144|454821089|FG001|Follow-up|Death|1|||
126416974|NCT00203424|454821091|FG000|Treatment Period|Withdrawal by Subject|4|||
126416975|NCT00203424|454821091|FG000|Treatment Period|Adverse Event|5|||
126416976|NCT00203424|454821091|FG000|Treatment Period|progressive disease|2|||
126416977|NCT00203424|454821091|FG000|Follow-up Period|Withdrawal by Subject|1|||
126416978|NCT00203424|454821091|FG000|Follow-up Period|progressive disease|4|||
126416979|NCT00203424|454821091|FG000|Follow-up Period|Lost to Follow-up|1|||
126416980|NCT01053988|454821092|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
126416981|NCT01053988|454821093|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126416982|NCT01053988|454821094|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126416983|NCT01053988|454821095|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126416984|NCT01053988|454821096|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126416985|NCT01053988|454821097|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
126416986|NCT01053988|454821092|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
126476846|NCT00612040|455046568|FG000|Overall Study|Adverse Event|0|||
126416987|NCT01053988|454821093|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126416988|NCT01053988|454821094|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126416989|NCT01053988|454821095|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126416990|NCT01053988|454821096|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126416991|NCT01053988|454821097|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
126416992|NCT01053988|454821092|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
126416993|NCT01053988|454821093|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126416994|NCT01053988|454821094|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126416995|NCT01053988|454821095|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126416996|NCT01053988|454821096|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126416997|NCT01053988|454821097|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
126416998|NCT01053988|454821092|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
126416999|NCT01053988|454821093|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
126417000|NCT01053988|454821094|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
126417001|NCT01053988|454821095|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
126417002|NCT01053988|454821096|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
126417003|NCT01053988|454821097|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
126417004|NCT01053988|454821092|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
126417005|NCT01053988|454821093|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
126417006|NCT01053988|454821094|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
126417007|NCT01053988|454821095|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
126417008|NCT01053988|454821096|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
126417009|NCT01053988|454821097|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
126417010|NCT01053988|454821092|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
126417011|NCT01053988|454821093|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126417012|NCT01053988|454821094|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126417013|NCT01053988|454821095|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126417014|NCT01053988|454821096|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126417015|NCT01053988|454821097|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
126417016|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
126417017|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
126417018|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
126417019|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
126417020|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
126417021|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
126417022|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126417023|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
126417024|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
126417025|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
126417026|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
126417027|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
126417028|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
126417029|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
126417030|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
126417031|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
126417032|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
126417033|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
126417034|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
126417035|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
126417036|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
126417037|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
126417038|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
126417039|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
126417040|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
126417041|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
126417042|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
126417043|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
126417044|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
126417045|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
126417046|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126417047|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
126417048|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126417049|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
126417050|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
126417051|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
126417052|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
126417053|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
126417054|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
126417055|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
126417056|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
126417057|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
126417058|NCT01053988|454821092|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126417059|NCT01053988|454821093|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
126417060|NCT01053988|454821094|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
126417061|NCT01053988|454821095|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
126417062|NCT01053988|454821096|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
126417063|NCT01053988|454821097|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
126417064|NCT01824355|454821098|FG000|Overall Study|Adverse Event|2|||
126417065|NCT01824355|454821098|FG000|Overall Study|unevaluable reference method results per|1|||
126417066|NCT02576795|454821100|FG000|Overall Study|Lost to Follow-up|0|||
126417067|NCT02576795|454821101|FG001|Overall Study|Lost to Follow-up|0|||
126417068|NCT02576795|454821102|FG002|Overall Study|Lost to Follow-up|1|||
126417069|NCT02576795|454821103|FG003|Overall Study|Lost to Follow-up|0|||
126417070|NCT04427072|454821104|FG000|Randomized Treatment Phase|Progressive disease|9|||
126417071|NCT04427072|454821105|FG001|Randomized Treatment Phase|Progressive disease|4|||
126417072|NCT04427072|454821104|FG000|Randomized Treatment Phase|Adverse Event|3|||
126417073|NCT04427072|454821105|FG001|Randomized Treatment Phase|Adverse Event|1|||
126417074|NCT04427072|454821104|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
126417075|NCT04427072|454821105|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
126417076|NCT04427072|454821104|FG000|Randomized Treatment Phase|Death|0|||
126417077|NCT04427072|454821105|FG001|Randomized Treatment Phase|Death|1|||
126417078|NCT04427072|454821104|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
126417079|NCT04427072|454821105|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
126417080|NCT04427072|454821104|FG000|Extension Treatment Phase|Progressive disease|0|||
126417081|NCT04427072|454821105|FG001|Extension Treatment Phase|Progressive disease|5|||
126417082|NCT05232864|454821106|FG000|Overall Study|Adverse Event|0|||
126417083|NCT05232864|454821107|FG001|Overall Study|Adverse Event|1|||
126417084|NCT05232864|454821106|FG000|Overall Study|Study terminated by sponsor|16|||
126417085|NCT05232864|454821107|FG001|Overall Study|Study terminated by sponsor|14|||
126417086|NCT04765202|454821122|FG000|Overall Study|Lost to Follow-up|1|||
126417087|NCT04765202|454821123|FG001|Overall Study|Lost to Follow-up|1|||
126417088|NCT04765202|454821124|FG002|Overall Study|Lost to Follow-up|2|||
126417089|NCT04765202|454821125|FG003|Overall Study|Lost to Follow-up|2|||
126417090|NCT04765202|454821122|FG000|Overall Study|Physician Decision|0|||
126417091|NCT04765202|454821123|FG001|Overall Study|Physician Decision|0|||
126417092|NCT04765202|454821124|FG002|Overall Study|Physician Decision|1|||
126417093|NCT04765202|454821125|FG003|Overall Study|Physician Decision|1|||
126417094|NCT00465452|454821126|FG000|Overall Study|Adverse Event|1|||
126417095|NCT02104947|454821133|FG000|Overall Study|Withdrawal by Subject|10|||
126417096|NCT02104947|454821134|FG001|Overall Study|Withdrawal by Subject|3|||
126417097|NCT02104947|454821133|FG000|Overall Study|Lost to Follow-up|4|||
126417098|NCT02104947|454821134|FG001|Overall Study|Lost to Follow-up|4|||
126417099|NCT02104947|454821133|FG000|Overall Study|Protocol Violation|6|||
126417100|NCT02104947|454821134|FG001|Overall Study|Protocol Violation|8|||
126417101|NCT02104947|454821133|FG000|Overall Study|Adverse Event|57|||
126417102|NCT02104947|454821134|FG001|Overall Study|Adverse Event|38|||
126417103|NCT02104947|454821133|FG000|Overall Study|Other than stated above|2|||
126417104|NCT02104947|454821134|FG001|Overall Study|Other than stated above|3|||
126417105|NCT00145574|454821135|FG000|Double Blind|Adverse Event|0|||
126417106|NCT00145574|454821136|FG001|Double Blind|Adverse Event|3|||
126417107|NCT00145574|454821137|FG002|Double Blind|Adverse Event|1|||
126417108|NCT00145574|454821135|FG000|Double Blind|Withdrawal by Subject|1|||
126417109|NCT00145574|454821136|FG001|Double Blind|Withdrawal by Subject|1|||
126417110|NCT00145574|454821137|FG002|Double Blind|Withdrawal by Subject|1|||
126417111|NCT00145574|454821135|FG000|Double Blind|required restricted medicine|0|||
126417112|NCT00145574|454821136|FG001|Double Blind|required restricted medicine|1|||
126417113|NCT00145574|454821137|FG002|Double Blind|required restricted medicine|0|||
126417114|NCT00145574|454821135|FG000|Open Label Long-term Extension|Adverse Event|0|||
126417115|NCT00145574|454821136|FG001|Open Label Long-term Extension|Adverse Event|0|||
126417116|NCT00145574|454821137|FG002|Open Label Long-term Extension|Adverse Event|5|||
126417117|NCT00145574|454821135|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
126417118|NCT00145574|454821136|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
126417119|NCT00145574|454821137|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
126417120|NCT00145574|454821135|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
126417121|NCT00145574|454821136|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
126721770|NCT05122650|455931293|FG003|Overall Study|Lack of Efficacy|2|||
126417122|NCT00145574|454821137|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
126417123|NCT00145574|454821135|FG000|Open Label Long-term Extension|required restricted medicine|0|||
126417124|NCT00145574|454821136|FG001|Open Label Long-term Extension|required restricted medicine|0|||
126417125|NCT00145574|454821137|FG002|Open Label Long-term Extension|required restricted medicine|1|||
126417126|NCT00858637|454821141|FG000|Active Comparison Phase|Adverse Event|14|||
126417127|NCT00858637|454821142|FG001|Active Comparison Phase|Adverse Event|0|||
126417128|NCT00858637|454821143|FG002|Active Comparison Phase|Adverse Event|0|||
126417129|NCT00858637|454821144|FG003|Active Comparison Phase|Adverse Event|9|||
126417130|NCT00858637|454821145|FG004|Active Comparison Phase|Adverse Event|0|||
126417131|NCT00858637|454821146|FG005|Active Comparison Phase|Adverse Event|0|||
126417132|NCT00858637|454821141|FG000|Active Comparison Phase|Death|1|||
126417133|NCT00858637|454821142|FG001|Active Comparison Phase|Death|0|||
126417134|NCT00858637|454821143|FG002|Active Comparison Phase|Death|0|||
126417135|NCT00858637|454821144|FG003|Active Comparison Phase|Death|1|||
126417136|NCT00858637|454821145|FG004|Active Comparison Phase|Death|0|||
126417137|NCT00858637|454821146|FG005|Active Comparison Phase|Death|0|||
126417138|NCT00858637|454821141|FG000|Active Comparison Phase|Physician Decision|1|||
126417139|NCT00858637|454821142|FG001|Active Comparison Phase|Physician Decision|0|||
126417140|NCT00858637|454821143|FG002|Active Comparison Phase|Physician Decision|0|||
126417141|NCT00858637|454821144|FG003|Active Comparison Phase|Physician Decision|1|||
126417142|NCT00858637|454821145|FG004|Active Comparison Phase|Physician Decision|0|||
126417143|NCT00858637|454821146|FG005|Active Comparison Phase|Physician Decision|0|||
126417144|NCT00858637|454821141|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
126417145|NCT00858637|454821142|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
126417146|NCT00858637|454821143|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
126417147|NCT00858637|454821144|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
126417148|NCT00858637|454821145|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
126417149|NCT00858637|454821146|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
126417150|NCT00858637|454821141|FG000|Active Comparison Phase|Other Reasons|1|||
126417151|NCT00858637|454821142|FG001|Active Comparison Phase|Other Reasons|0|||
126417152|NCT00858637|454821143|FG002|Active Comparison Phase|Other Reasons|0|||
126417153|NCT00858637|454821144|FG003|Active Comparison Phase|Other Reasons|1|||
126417154|NCT00858637|454821145|FG004|Active Comparison Phase|Other Reasons|0|||
126417155|NCT00858637|454821146|FG005|Active Comparison Phase|Other Reasons|0|||
126417156|NCT00858637|454821141|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
126417157|NCT00858637|454821142|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
126417158|NCT00858637|454821143|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
126417159|NCT00858637|454821144|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
126417160|NCT00858637|454821145|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
126417161|NCT00858637|454821146|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
126417162|NCT00858637|454821141|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
126417163|NCT00858637|454821142|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
126417164|NCT00858637|454821143|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
126417165|NCT00858637|454821144|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
126417166|NCT00858637|454821145|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
126417167|NCT00858637|454821146|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
126417168|NCT02305238|454821147|FG000|Overall Study|Death|2|||
126417169|NCT02305238|454821148|FG001|Overall Study|Death|1|||
126417170|NCT02305238|454821149|FG002|Overall Study|Death|0|||
126417171|NCT02305238|454821147|FG000|Overall Study|Progressive disease|4|||
126417172|NCT02305238|454821148|FG001|Overall Study|Progressive disease|4|||
126417173|NCT02305238|454821149|FG002|Overall Study|Progressive disease|0|||
126417174|NCT02305238|454821147|FG000|Overall Study|Logistical difficulties|1|||
126417175|NCT02305238|454821148|FG001|Overall Study|Logistical difficulties|3|||
126417176|NCT02305238|454821149|FG002|Overall Study|Logistical difficulties|0|||
126417177|NCT02305238|454821147|FG000|Overall Study|Protocol Violation|0|||
126417178|NCT02305238|454821148|FG001|Overall Study|Protocol Violation|3|||
126417179|NCT02305238|454821149|FG002|Overall Study|Protocol Violation|0|||
126417180|NCT02305238|454821147|FG000|Overall Study|Physician Decision|2|||
126417181|NCT02305238|454821148|FG001|Overall Study|Physician Decision|1|||
126417182|NCT02305238|454821149|FG002|Overall Study|Physician Decision|0|||
126417183|NCT02305238|454821147|FG000|Overall Study|Adverse Event|4|||
126417184|NCT02305238|454821148|FG001|Overall Study|Adverse Event|2|||
126417185|NCT02305238|454821149|FG002|Overall Study|Adverse Event|0|||
126417186|NCT02305238|454821147|FG000|Overall Study|Withdrawal by Subject|3|||
126417187|NCT02305238|454821148|FG001|Overall Study|Withdrawal by Subject|4|||
126417188|NCT02305238|454821149|FG002|Overall Study|Withdrawal by Subject|0|||
126417189|NCT02305238|454821147|FG000|Overall Study|Randomized failure|0|||
126417190|NCT02305238|454821148|FG001|Overall Study|Randomized failure|0|||
126417191|NCT02305238|454821149|FG002|Overall Study|Randomized failure|8|||
126417192|NCT02305238|454821147|FG000|Overall Study|Required procedure failed|0|||
126417193|NCT02305238|454821148|FG001|Overall Study|Required procedure failed|1|||
126476847|NCT00612040|455046569|FG001|Overall Study|Adverse Event|2|||
126417194|NCT02305238|454821149|FG002|Overall Study|Required procedure failed|0|||
126417195|NCT04677504|454821155|FG000|Overall Study|Death|51|||
126417196|NCT04677504|454821156|FG001|Overall Study|Death|49|||
126417197|NCT04677504|454821155|FG000|Overall Study|Progressive Disease|1|||
126417198|NCT04677504|454821156|FG001|Overall Study|Progressive Disease|0|||
126417199|NCT04677504|454821155|FG000|Overall Study|Symptomatic Deterioration|1|||
126417200|NCT04677504|454821156|FG001|Overall Study|Symptomatic Deterioration|0|||
126417201|NCT04677504|454821155|FG000|Overall Study|Withdrawal by Subject|2|||
126417202|NCT04677504|454821156|FG001|Overall Study|Withdrawal by Subject|5|||
126417203|NCT04677504|454821155|FG000|Overall Study|Study Terminated By Sponsor|28|||
126417204|NCT04677504|454821156|FG001|Overall Study|Study Terminated By Sponsor|24|||
126417205|NCT04677504|454821155|FG000|Overall Study|Adverse Event|0|||
126417206|NCT04677504|454821156|FG001|Overall Study|Adverse Event|1|||
126417207|NCT01371552|454821167|FG000|Part 1, First 3 Days|Inconvenience|0|||
126417208|NCT01371552|454821168|FG001|Part 1, First 3 Days|Inconvenience|0|||
126417209|NCT01371552|454821169|FG002|Part 1, First 3 Days|Inconvenience|1|||
126417210|NCT01371552|454821170|FG003|Part 1, First 3 Days|Inconvenience|0|||
126417211|NCT01371552|454821171|FG004|Part 1, First 3 Days|Inconvenience|0|||
126417212|NCT01371552|454821172|FG005|Part 1, First 3 Days|Inconvenience|0|||
126417213|NCT00167310|454821173|FG000|Overall Study|Protocol Violation|5|||
126417214|NCT00167310|454821174|FG001|Overall Study|Protocol Violation|3|||
126417215|NCT00167310|454821173|FG000|Overall Study|Withdrawal by Subject|3|||
126417216|NCT00167310|454821174|FG001|Overall Study|Withdrawal by Subject|7|||
126417217|NCT03543137|454821175|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
126417218|NCT03543137|454821176|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
126417219|NCT03543137|454821175|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
126417220|NCT03543137|454821176|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
126417221|NCT03543137|454821175|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
126417222|NCT03543137|454821176|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
126417223|NCT04072887|454821177|FG000|Overall Study|Withdrawal by Subject|3|||
126417224|NCT04072887|454821178|FG001|Overall Study|Withdrawal by Subject|8|||
126417225|NCT04072887|454821179|FG002|Overall Study|Withdrawal by Subject|1|||
126417226|NCT04072887|454821180|FG003|Overall Study|Withdrawal by Subject|3|||
126417227|NCT04072887|454821181|FG004|Overall Study|Withdrawal by Subject|3|||
126417228|NCT04072887|454821182|FG005|Overall Study|Withdrawal by Subject|13|||
126417229|NCT04072887|454821177|FG000|Overall Study|Adverse Event|2|||
126417230|NCT04072887|454821178|FG001|Overall Study|Adverse Event|4|||
126417231|NCT04072887|454821179|FG002|Overall Study|Adverse Event|1|||
126417232|NCT04072887|454821180|FG003|Overall Study|Adverse Event|4|||
126417233|NCT04072887|454821181|FG004|Overall Study|Adverse Event|0|||
126417234|NCT04072887|454821182|FG005|Overall Study|Adverse Event|1|||
126417235|NCT04072887|454821177|FG000|Overall Study|Physician Decision|2|||
126417236|NCT04072887|454821178|FG001|Overall Study|Physician Decision|0|||
126417237|NCT04072887|454821179|FG002|Overall Study|Physician Decision|0|||
126417238|NCT04072887|454821180|FG003|Overall Study|Physician Decision|0|||
126417239|NCT04072887|454821181|FG004|Overall Study|Physician Decision|0|||
126417240|NCT04072887|454821182|FG005|Overall Study|Physician Decision|1|||
126417241|NCT04072887|454821177|FG000|Overall Study|Lost to Follow-up|1|||
126417242|NCT04072887|454821178|FG001|Overall Study|Lost to Follow-up|3|||
126417243|NCT04072887|454821179|FG002|Overall Study|Lost to Follow-up|0|||
126417244|NCT04072887|454821180|FG003|Overall Study|Lost to Follow-up|0|||
126417245|NCT04072887|454821181|FG004|Overall Study|Lost to Follow-up|0|||
126417246|NCT04072887|454821182|FG005|Overall Study|Lost to Follow-up|0|||
126417247|NCT04072887|454821177|FG000|Overall Study|Death|0|||
126417248|NCT04072887|454821178|FG001|Overall Study|Death|2|||
126417249|NCT04072887|454821179|FG002|Overall Study|Death|0|||
126417250|NCT04072887|454821180|FG003|Overall Study|Death|2|||
126417251|NCT04072887|454821181|FG004|Overall Study|Death|3|||
126417252|NCT04072887|454821182|FG005|Overall Study|Death|0|||
126417253|NCT03193736|454821183|FG000|Overall Study|Death|2|||
126417254|NCT03193736|454821183|FG000|Overall Study|Withdrawal by Subject|1|||
126417255|NCT03193736|454821183|FG000|Overall Study|Lost to Follow-up|1|||
126417256|NCT03193736|454821183|FG000|Overall Study|implant not received|1|||
126417257|NCT00423449|454821184|FG000|Overall Study|Clinical Adverse Event|1|||
126417258|NCT00423449|454821185|FG001|Overall Study|Clinical Adverse Event|0|||
126417259|NCT00423449|454821186|FG002|Overall Study|Clinical Adverse Event|1|||
126417260|NCT00423449|454821187|FG003|Overall Study|Clinical Adverse Event|8|||
126417261|NCT00423449|454821188|FG004|Overall Study|Clinical Adverse Event|2|||
126417262|NCT00423449|454821184|FG000|Overall Study|Death|1|||
126417263|NCT00423449|454821185|FG001|Overall Study|Death|0|||
126417264|NCT00423449|454821186|FG002|Overall Study|Death|2|||
126417265|NCT00423449|454821187|FG003|Overall Study|Death|1|||
126417266|NCT00423449|454821188|FG004|Overall Study|Death|1|||
126417267|NCT00423449|454821184|FG000|Overall Study|Progressive Disease|1|||
126417268|NCT00423449|454821185|FG001|Overall Study|Progressive Disease|3|||
126417269|NCT00423449|454821186|FG002|Overall Study|Progressive Disease|8|||
126417270|NCT00423449|454821187|FG003|Overall Study|Progressive Disease|11|||
126417271|NCT00423449|454821188|FG004|Overall Study|Progressive Disease|4|||
126417272|NCT00423449|454821184|FG000|Overall Study|Laboratory Adverse Event|0|||
126417273|NCT00423449|454821185|FG001|Overall Study|Laboratory Adverse Event|1|||
126417274|NCT00423449|454821186|FG002|Overall Study|Laboratory Adverse Event|2|||
126417275|NCT00423449|454821187|FG003|Overall Study|Laboratory Adverse Event|0|||
126417276|NCT00423449|454821188|FG004|Overall Study|Laboratory Adverse Event|0|||
126417277|NCT00423449|454821184|FG000|Overall Study|Other|0|||
126417278|NCT00423449|454821185|FG001|Overall Study|Other|0|||
126417279|NCT00423449|454821186|FG002|Overall Study|Other|0|||
126417280|NCT00423449|454821187|FG003|Overall Study|Other|1|||
126417281|NCT00423449|454821188|FG004|Overall Study|Other|0|||
126417282|NCT00423449|454821184|FG000|Overall Study|Protocol Violation|0|||
126417283|NCT00423449|454821185|FG001|Overall Study|Protocol Violation|0|||
126417284|NCT00423449|454821186|FG002|Overall Study|Protocol Violation|2|||
126417285|NCT00423449|454821187|FG003|Overall Study|Protocol Violation|1|||
126417286|NCT00423449|454821188|FG004|Overall Study|Protocol Violation|0|||
126417287|NCT02697435|454821189|FG000|Overall Study|Withdrawal by Subject|1|||
126417288|NCT02697435|454821190|FG001|Overall Study|Withdrawal by Subject|0|||
126417289|NCT02697435|454821189|FG000|Overall Study|Physician Decision|0|||
126417290|NCT02697435|454821190|FG001|Overall Study|Physician Decision|4|||
126417291|NCT04371666|454821197|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
126417292|NCT04371666|454821198|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
126417293|NCT04371666|454821197|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
126417294|NCT04371666|454821198|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
126417295|NCT04371666|454821197|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
126417296|NCT04371666|454821198|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
126417297|NCT04371666|454821197|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
126417298|NCT04371666|454821198|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
126417299|NCT04371666|454821197|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
126417300|NCT04371666|454821198|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
126417301|NCT04371666|454821197|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
126417302|NCT04371666|454821198|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
126417303|NCT01445080|454821199|FG000|Overall Study|Adverse Event|5|||
126417304|NCT01445080|454821200|FG001|Overall Study|Adverse Event|3|||
126417305|NCT01445080|454821201|FG002|Overall Study|Adverse Event|11|||
126417306|NCT01445080|454821202|FG003|Overall Study|Adverse Event|6|||
126417307|NCT01445080|454821203|FG004|Overall Study|Adverse Event|2|||
126417308|NCT01445080|454821204|FG005|Overall Study|Adverse Event|3|||
126559027|NCT04537949|455340620|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
126559028|NCT04537949|455340621|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
126417309|NCT01445080|454821205|FG006|Overall Study|Adverse Event|0|||
126417310|NCT01445080|454821206|FG007|Overall Study|Adverse Event|3|||
126417311|NCT01445080|454821207|FG008|Overall Study|Adverse Event|10|||
126417312|NCT01445080|454821199|FG000|Overall Study|Physician Decision|0|||
126417313|NCT01445080|454821200|FG001|Overall Study|Physician Decision|0|||
126417314|NCT01445080|454821201|FG002|Overall Study|Physician Decision|1|||
126417315|NCT01445080|454821202|FG003|Overall Study|Physician Decision|0|||
126417316|NCT01445080|454821203|FG004|Overall Study|Physician Decision|0|||
126417317|NCT01445080|454821204|FG005|Overall Study|Physician Decision|3|||
126417318|NCT01445080|454821205|FG006|Overall Study|Physician Decision|2|||
126417319|NCT01445080|454821206|FG007|Overall Study|Physician Decision|2|||
126417320|NCT01445080|454821207|FG008|Overall Study|Physician Decision|0|||
126417321|NCT01445080|454821199|FG000|Overall Study|Withdrawal by Subject|1|||
126417322|NCT01445080|454821200|FG001|Overall Study|Withdrawal by Subject|0|||
126417323|NCT01445080|454821201|FG002|Overall Study|Withdrawal by Subject|0|||
126417324|NCT01445080|454821202|FG003|Overall Study|Withdrawal by Subject|1|||
126417325|NCT01445080|454821203|FG004|Overall Study|Withdrawal by Subject|0|||
126417326|NCT01445080|454821204|FG005|Overall Study|Withdrawal by Subject|0|||
126417327|NCT01445080|454821205|FG006|Overall Study|Withdrawal by Subject|0|||
126417328|NCT01445080|454821206|FG007|Overall Study|Withdrawal by Subject|0|||
126417329|NCT01445080|454821207|FG008|Overall Study|Withdrawal by Subject|2|||
126417330|NCT01445080|454821199|FG000|Overall Study|Ineligible/Inevaluable|1|||
126417331|NCT01445080|454821200|FG001|Overall Study|Ineligible/Inevaluable|2|||
126417332|NCT01445080|454821201|FG002|Overall Study|Ineligible/Inevaluable|0|||
126417333|NCT01445080|454821202|FG003|Overall Study|Ineligible/Inevaluable|1|||
126417334|NCT01445080|454821203|FG004|Overall Study|Ineligible/Inevaluable|2|||
126417335|NCT01445080|454821204|FG005|Overall Study|Ineligible/Inevaluable|3|||
126417336|NCT01445080|454821205|FG006|Overall Study|Ineligible/Inevaluable|0|||
126417337|NCT01445080|454821206|FG007|Overall Study|Ineligible/Inevaluable|0|||
126417338|NCT01445080|454821207|FG008|Overall Study|Ineligible/Inevaluable|6|||
126417339|NCT00445770|454821208|FG000|Overall Study|Adverse Event|9|||
126417340|NCT00445770|454821209|FG001|Overall Study|Adverse Event|15|||
126417341|NCT00445770|454821210|FG002|Overall Study|Adverse Event|19|||
126417342|NCT00445770|454821208|FG000|Overall Study|Lack of Efficacy|38|||
126417343|NCT00445770|454821209|FG001|Overall Study|Lack of Efficacy|13|||
126417344|NCT00445770|454821210|FG002|Overall Study|Lack of Efficacy|6|||
126417345|NCT00445770|454821208|FG000|Overall Study|Lost to Follow-up|0|||
126417346|NCT00445770|454821209|FG001|Overall Study|Lost to Follow-up|2|||
126417347|NCT00445770|454821210|FG002|Overall Study|Lost to Follow-up|0|||
126417348|NCT00445770|454821208|FG000|Overall Study|Other|6|||
126417349|NCT00445770|454821209|FG001|Overall Study|Other|5|||
126417350|NCT00445770|454821210|FG002|Overall Study|Other|6|||
126417351|NCT03857542|454821211|FG000|Overall Study|Adverse Event|1|||
126417352|NCT03857542|454821212|FG001|Overall Study|Adverse Event|3|||
126559029|NCT04537949|455340622|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
126417353|NCT03857542|454821211|FG000|Overall Study|Withdrawal by Subject|2|||
126417354|NCT03857542|454821212|FG001|Overall Study|Withdrawal by Subject|1|||
126417355|NCT03857542|454821211|FG000|Overall Study|Lost to Follow-up|2|||
126417356|NCT03857542|454821212|FG001|Overall Study|Lost to Follow-up|1|||
126417357|NCT03857542|454821211|FG000|Overall Study|Reason not Specified|1|||
126417358|NCT03857542|454821212|FG001|Overall Study|Reason not Specified|0|||
126417359|NCT02123576|454821213|FG000|Overall Study|Adverse Event|1|||
126417360|NCT02123576|454821214|FG001|Overall Study|Adverse Event|0|||
126417361|NCT00934128|454821215|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
126417362|NCT00934128|454821216|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
126417363|NCT00934128|454821215|FG000|First Intervention (2 Hours)|Adverse Event|4|||
126417364|NCT00934128|454821216|FG001|First Intervention (2 Hours)|Adverse Event|1|||
126417365|NCT00934128|454821215|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
126417366|NCT00934128|454821216|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
126417367|NCT00934128|454821215|FG000|Washout Period (1 Hour)|Patient preference|1|||
126417368|NCT00934128|454821216|FG001|Washout Period (1 Hour)|Patient preference|3|||
126417369|NCT00934128|454821215|FG000|Washout Period (1 Hour)|Pain|1|||
126417370|NCT00934128|454821216|FG001|Washout Period (1 Hour)|Pain|0|||
126417371|NCT00934128|454821215|FG000|Washout Period (1 Hour)|Too tired|1|||
126417372|NCT00934128|454821216|FG001|Washout Period (1 Hour)|Too tired|0|||
126417373|NCT00934128|454821215|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
126417374|NCT00934128|454821216|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
126417375|NCT00934128|454821215|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
126417376|NCT00934128|454821216|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
126417377|NCT01946152|454822833|FG000|Overall Study|Adverse Event|1|||
126417378|NCT01946152|454822834|FG001|Overall Study|Adverse Event|0|||
126417379|NCT01946152|454822835|FG002|Overall Study|Adverse Event|0|||
126417380|NCT01946152|454822836|FG003|Overall Study|Adverse Event|0|||
126417381|NCT01946152|454822833|FG000|Overall Study|Withdrawal by Subject|0|||
126417382|NCT01946152|454822834|FG001|Overall Study|Withdrawal by Subject|2|||
126417383|NCT01946152|454822835|FG002|Overall Study|Withdrawal by Subject|0|||
126417384|NCT01946152|454822836|FG003|Overall Study|Withdrawal by Subject|0|||
126417385|NCT01946152|454822833|FG000|Overall Study|Progression|0|||
126417386|NCT01946152|454822834|FG001|Overall Study|Progression|1|||
126417387|NCT01946152|454822835|FG002|Overall Study|Progression|4|||
126417388|NCT01946152|454822836|FG003|Overall Study|Progression|7|||
126417389|NCT01946152|454822833|FG000|Overall Study|Physician Decision|0|||
126417390|NCT01946152|454822834|FG001|Overall Study|Physician Decision|0|||
126417391|NCT01946152|454822835|FG002|Overall Study|Physician Decision|1|||
126417392|NCT01946152|454822836|FG003|Overall Study|Physician Decision|0|||
126417393|NCT01946152|454822833|FG000|Overall Study|Second malignancy|0|||
126417394|NCT01946152|454822834|FG001|Overall Study|Second malignancy|0|||
126417395|NCT01946152|454822835|FG002|Overall Study|Second malignancy|1|||
126417396|NCT01946152|454822836|FG003|Overall Study|Second malignancy|0|||
126417397|NCT01946152|454822833|FG000|Overall Study|Adverse Event|0|||
126417398|NCT01946152|454822834|FG001|Overall Study|Adverse Event|0|||
126417399|NCT01946152|454822835|FG002|Overall Study|Adverse Event|0|||
126417400|NCT01946152|454822836|FG003|Overall Study|Adverse Event|1|||
126417401|NCT01698814|454822837|FG000|Overall Study|Adverse Event|0|||
126417402|NCT01698814|454822838|FG001|Overall Study|Adverse Event|2|||
126417403|NCT01698814|454822837|FG000|Overall Study|Lost to Follow-up|0|||
126417404|NCT01698814|454822838|FG001|Overall Study|Lost to Follow-up|1|||
126417405|NCT01698814|454822837|FG000|Overall Study|Pregnancy|1|||
126417406|NCT01698814|454822838|FG001|Overall Study|Pregnancy|0|||
126417407|NCT01698814|454822837|FG000|Overall Study|Randomized in error|1|||
126417408|NCT01698814|454822838|FG001|Overall Study|Randomized in error|0|||
126417409|NCT01061359|454822843|FG000|Overall Study|Death|32|||
126417410|NCT01061359|454822843|FG000|Overall Study|Lost to Follow-up|1072|||
126417411|NCT01061359|454822843|FG000|Overall Study|Relapse|187|||
126417412|NCT01061359|454822843|FG000|Overall Study|Secondary neoplasm|11|||
126417413|NCT04014062|454822844|FG000|Period I: Dosing|Medical Grounds|4|||
126417414|NCT04014062|454822845|FG001|Period I: Dosing|Medical Grounds|5|||
126417415|NCT04014062|454822844|FG000|Period I: Dosing|Withdrawal by Subject|3|||
126417416|NCT04014062|454822845|FG001|Period I: Dosing|Withdrawal by Subject|1|||
126417417|NCT03038126|454822846|FG000|Overall Study|Death|1|||
126417418|NCT03038126|454822847|FG001|Overall Study|Death|1|||
126417419|NCT03038126|454822846|FG000|Overall Study|Withdrawal by Subject|5|||
126417420|NCT03038126|454822847|FG001|Overall Study|Withdrawal by Subject|0|||
126417421|NCT03038126|454822846|FG000|Overall Study|Lost to Follow-up|0|||
126417422|NCT03038126|454822847|FG001|Overall Study|Lost to Follow-up|1|||
126417423|NCT03038126|454822846|FG000|Overall Study|Long Term Hospitalization|2|||
126417424|NCT03038126|454822847|FG001|Overall Study|Long Term Hospitalization|0|||
126417425|NCT03038126|454822846|FG000|Overall Study|Too Ill to Participate|1|||
126417426|NCT03038126|454822847|FG001|Overall Study|Too Ill to Participate|2|||
126417427|NCT01724866|454822848|FG000|Overall Study|Adverse Event|0|||
126417428|NCT01724866|454822849|FG001|Overall Study|Adverse Event|0|||
126417429|NCT01724866|454822850|FG002|Overall Study|Adverse Event|1|||
126417430|NCT01724866|454822851|FG003|Overall Study|Adverse Event|1|||
126417431|NCT01724866|454822848|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
126417432|NCT01724866|454822849|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
126417433|NCT01724866|454822850|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
126417434|NCT01724866|454822851|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
126417435|NCT01724866|454822848|FG000|Overall Study|Investigator's Discretion|0|||
126417436|NCT01724866|454822849|FG001|Overall Study|Investigator's Discretion|1|||
126417437|NCT01724866|454822850|FG002|Overall Study|Investigator's Discretion|1|||
126417438|NCT01724866|454822851|FG003|Overall Study|Investigator's Discretion|0|||
126417439|NCT01724866|454822848|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
126417440|NCT01724866|454822849|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
126417441|NCT01724866|454822850|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
126417442|NCT01724866|454822851|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
126417443|NCT01724866|454822848|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
126417444|NCT01724866|454822849|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
126417445|NCT01724866|454822850|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
126417446|NCT01724866|454822851|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
126417447|NCT01424501|454822852|FG000|Overall Study|Withdrawal by Subject|1|||
126417448|NCT01424501|454822853|FG001|Overall Study|Withdrawal by Subject|0|||
126417449|NCT01424501|454822854|FG002|Overall Study|Withdrawal by Subject|1|||
126417450|NCT01424501|454822855|FG003|Overall Study|Withdrawal by Subject|0|||
126417451|NCT01424501|454822856|FG004|Overall Study|Withdrawal by Subject|0|||
126417452|NCT01424501|454822857|FG005|Overall Study|Withdrawal by Subject|0|||
126417453|NCT01424501|454822852|FG000|Overall Study|Lost to Follow-up|0|||
126417454|NCT01424501|454822853|FG001|Overall Study|Lost to Follow-up|1|||
126417455|NCT01424501|454822854|FG002|Overall Study|Lost to Follow-up|1|||
126417456|NCT01424501|454822855|FG003|Overall Study|Lost to Follow-up|0|||
126417457|NCT01424501|454822856|FG004|Overall Study|Lost to Follow-up|0|||
126417458|NCT01424501|454822857|FG005|Overall Study|Lost to Follow-up|0|||
126417459|NCT01980095|454822858|FG000|Overall Study|Lost to Follow-up|6|||
126417460|NCT01980095|454822859|FG001|Overall Study|Lost to Follow-up|7|||
126417461|NCT01980095|454822858|FG000|Overall Study|Withdrawal by Subject|2|||
126417462|NCT01980095|454822859|FG001|Overall Study|Withdrawal by Subject|3|||
126417463|NCT01980095|454822858|FG000|Overall Study|Poor compliance|5|||
126417464|NCT01980095|454822859|FG001|Overall Study|Poor compliance|0|||
126417465|NCT01980095|454822858|FG000|Overall Study|Safety issue|0|||
126417466|NCT01980095|454822859|FG001|Overall Study|Safety issue|1|||
126417467|NCT01980095|454822858|FG000|Overall Study|Study drug discontinued|1|||
126417468|NCT01980095|454822859|FG001|Overall Study|Study drug discontinued|0|||
126417469|NCT01980095|454822858|FG000|Overall Study|Randomized by mistake|1|||
126417470|NCT01980095|454822859|FG001|Overall Study|Randomized by mistake|0|||
126417471|NCT02974257|454822863|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
126417472|NCT02974257|454822864|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
126417473|NCT02974257|454822863|FG000|Overall Study|Clinical indication for thiamine|1|||
126417474|NCT02974257|454822864|FG001|Overall Study|Clinical indication for thiamine|0|||
126417475|NCT02974257|454822863|FG000|Overall Study|Already on thiamine|1|||
126417476|NCT02974257|454822864|FG001|Overall Study|Already on thiamine|0|||
126417477|NCT02974257|454822863|FG000|Overall Study|Extubated prior to study drug|0|||
126417478|NCT02974257|454822864|FG001|Overall Study|Extubated prior to study drug|1|||
126417479|NCT02974257|454822863|FG000|Overall Study|Death|0|||
126417480|NCT02974257|454822864|FG001|Overall Study|Death|1|||
126417481|NCT02837029|454822865|FG000|Screening|Failed to meet screening requirements.|7|||
126417482|NCT02837029|454822866|FG001|Screening|Failed to meet screening requirements.|3|||
126417483|NCT02837029|454822867|FG002|Screening|Failed to meet screening requirements.|0|||
126417484|NCT02837029|454822865|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
126417485|NCT02837029|454822866|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
126417486|NCT02837029|454822867|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
126417487|NCT02837029|454822865|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
126417488|NCT02837029|454822866|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
126417489|NCT02837029|454822867|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
126417490|NCT02837029|454822865|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
126417491|NCT02837029|454822866|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
126417492|NCT02837029|454822867|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
126417493|NCT02837029|454822865|FG000|Cycle 2 and Beyond|Adverse Event|1|||
126417494|NCT02837029|454822866|FG001|Cycle 2 and Beyond|Adverse Event|0|||
126476848|NCT00612040|455046570|FG002|Overall Study|Adverse Event|1|||
126476849|NCT00612040|455046568|FG000|Overall Study|Protocol Violation|1|||
126476850|NCT00612040|455046569|FG001|Overall Study|Protocol Violation|2|||
126476851|NCT00612040|455046570|FG002|Overall Study|Protocol Violation|1|||
126417495|NCT02837029|454822867|FG002|Cycle 2 and Beyond|Adverse Event|0|||
126417496|NCT02837029|454822865|FG000|2 Year Follow-up|Death|6|||
126417497|NCT02837029|454822866|FG001|2 Year Follow-up|Death|7|||
126417498|NCT02837029|454822867|FG002|2 Year Follow-up|Death|0|||
126417499|NCT00398567|454822868|FG000|Overall Study|Disease Progression|3|||
126417500|NCT00398567|454822869|FG001|Overall Study|Disease Progression|4|||
126417501|NCT00398567|454822870|FG002|Overall Study|Disease Progression|27|||
126417502|NCT00398567|454822868|FG000|Overall Study|Withdrawal by Subject|1|||
126417503|NCT00398567|454822869|FG001|Overall Study|Withdrawal by Subject|0|||
126417504|NCT00398567|454822870|FG002|Overall Study|Withdrawal by Subject|4|||
126417505|NCT00398567|454822868|FG000|Overall Study|Adverse Event|0|||
126417506|NCT00398567|454822869|FG001|Overall Study|Adverse Event|0|||
126417507|NCT00398567|454822870|FG002|Overall Study|Adverse Event|2|||
126417508|NCT00398567|454822868|FG000|Overall Study|Protocol Violation|0|||
126417509|NCT00398567|454822869|FG001|Overall Study|Protocol Violation|0|||
126417510|NCT00398567|454822870|FG002|Overall Study|Protocol Violation|1|||
126417511|NCT02034877|454822871|FG000|Overall Study|Lost to Follow-up|0|||
126417512|NCT02034877|454822872|FG001|Overall Study|Lost to Follow-up|3|||
126417513|NCT02034877|454822871|FG000|Overall Study|No Longer Willing to Participate|0|||
126417514|NCT02034877|454822872|FG001|Overall Study|No Longer Willing to Participate|3|||
126417515|NCT04426318|454822875|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
126417516|NCT04426318|454822876|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
126417517|NCT04273893|454822877|FG000|Overall Study|Withdrawal by Subject|0|||
126417518|NCT04273893|454822878|FG001|Overall Study|Withdrawal by Subject|2|||
126417519|NCT04273893|454822877|FG000|Overall Study|Treatment of Disease Progression|0|||
126417520|NCT04273893|454822878|FG001|Overall Study|Treatment of Disease Progression|2|||
126417521|NCT04273893|454822877|FG000|Overall Study|Death|1|||
126417522|NCT04273893|454822878|FG001|Overall Study|Death|2|||
126417523|NCT04273893|454822877|FG000|Overall Study|Lost to Follow-up|0|||
126417524|NCT04273893|454822878|FG001|Overall Study|Lost to Follow-up|2|||
126417525|NCT04273893|454822877|FG000|Overall Study|Physician Decision|1|||
126417526|NCT04273893|454822878|FG001|Overall Study|Physician Decision|0|||
126417527|NCT03906071|454822879|FG000|Overall Study|Death|180|||
126417528|NCT03906071|454822880|FG001|Overall Study|Death|185|||
126417529|NCT03906071|454822879|FG000|Overall Study|Lost to Follow-up|3|||
126417530|NCT03906071|454822880|FG001|Overall Study|Lost to Follow-up|3|||
126417531|NCT03906071|454822879|FG000|Overall Study|Withdrawal by Subject|15|||
126417532|NCT03906071|454822880|FG001|Overall Study|Withdrawal by Subject|27|||
126417533|NCT03906071|454822879|FG000|Overall Study|Other|2|||
126417534|NCT03906071|454822880|FG001|Overall Study|Other|1|||
126417535|NCT01564732|454822893|FG000|Overall Study|Early termination by the study sponsor|6|||
126417536|NCT01564732|454822894|FG001|Overall Study|Early termination by the study sponsor|5|||
126417537|NCT01957202|454822897|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417538|NCT01957202|454822898|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
126417539|NCT01957202|454822899|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417540|NCT01957202|454822900|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417541|NCT01957202|454822901|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417542|NCT01957202|454822902|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417543|NCT01957202|454822903|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417544|NCT01957202|454822904|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417545|NCT01957202|454822905|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417546|NCT01957202|454822906|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417547|NCT01957202|454822907|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417548|NCT01957202|454822908|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417549|NCT01957202|454822909|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417550|NCT01957202|454822910|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417551|NCT01957202|454822911|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417552|NCT01957202|454822912|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417553|NCT01957202|454822913|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
126417554|NCT01957202|454822914|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
126417555|NCT01957202|454822897|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417556|NCT01957202|454822898|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417557|NCT01957202|454822899|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417558|NCT01957202|454822900|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417559|NCT01957202|454822901|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417560|NCT01957202|454822902|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417561|NCT01957202|454822903|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417562|NCT01957202|454822904|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417563|NCT01957202|454822905|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417564|NCT01957202|454822906|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417565|NCT01957202|454822907|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417566|NCT01957202|454822908|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417567|NCT01957202|454822909|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417568|NCT01957202|454822910|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417569|NCT01957202|454822911|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417570|NCT01957202|454822912|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417571|NCT01957202|454822913|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
126417572|NCT01957202|454822914|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
126417573|NCT02598297|454822915|FG000|Overall Study|Study terminated by Sponsor|21|||
126417574|NCT02598297|454822916|FG001|Overall Study|Study terminated by Sponsor|23|||
126417575|NCT02598297|454822915|FG000|Overall Study|Adverse Event|1|||
126417576|NCT02598297|454822916|FG001|Overall Study|Adverse Event|1|||
126417577|NCT02598297|454822915|FG000|Overall Study|Physician Decision|1|||
126417578|NCT02598297|454822916|FG001|Overall Study|Physician Decision|0|||
126417579|NCT02598297|454822915|FG000|Overall Study|Subject/guardian decision|1|||
126417580|NCT02598297|454822916|FG001|Overall Study|Subject/guardian decision|0|||
126417581|NCT02598297|454822915|FG000|Overall Study|Followed for survival|1|||
126417582|NCT02598297|454822916|FG001|Overall Study|Followed for survival|0|||
126417583|NCT00394706|454822918|FG000|Overall Study|Withdrawal by Subject|2|||
126417584|NCT00394706|454822919|FG001|Overall Study|Withdrawal by Subject|0|||
126417585|NCT00394706|454822920|FG002|Overall Study|Withdrawal by Subject|1|||
126417586|NCT00394706|454822921|FG003|Overall Study|Withdrawal by Subject|0|||
126417587|NCT00394706|454822922|FG004|Overall Study|Withdrawal by Subject|0|||
126417588|NCT00394706|454822923|FG005|Overall Study|Withdrawal by Subject|2|||
126417589|NCT00394706|454822924|FG006|Overall Study|Withdrawal by Subject|1|||
126417590|NCT00394706|454822925|FG007|Overall Study|Withdrawal by Subject|0|||
126417591|NCT00394706|454822918|FG000|Overall Study|Lost to Follow-up|2|||
126417592|NCT00394706|454822919|FG001|Overall Study|Lost to Follow-up|2|||
126417593|NCT00394706|454822920|FG002|Overall Study|Lost to Follow-up|8|||
126417594|NCT00394706|454822921|FG003|Overall Study|Lost to Follow-up|1|||
126417595|NCT00394706|454822922|FG004|Overall Study|Lost to Follow-up|2|||
126417596|NCT00394706|454822923|FG005|Overall Study|Lost to Follow-up|5|||
126417597|NCT00394706|454822924|FG006|Overall Study|Lost to Follow-up|2|||
126417598|NCT00394706|454822925|FG007|Overall Study|Lost to Follow-up|0|||
126417599|NCT02003534|454822928|FG000|Overall Study|Lost to Follow-up|47|||
126417600|NCT03534141|454822929|FG000|Overall Study|Enrolled in other clinical trial|1|||
126417601|NCT03534141|454822930|FG001|Overall Study|Enrolled in other clinical trial|0|||
126417602|NCT03534141|454822929|FG000|Overall Study|Liver transplant aborted after randomization|0|||
126417603|NCT03534141|454822930|FG001|Overall Study|Liver transplant aborted after randomization|2|||
126417604|NCT03534141|454822929|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
126417605|NCT03534141|454822930|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
126417606|NCT03785405|454822934|FG000|Overall Study|Adverse Event|16|||
126417607|NCT03785405|454822935|FG001|Overall Study|Adverse Event|1|||
126417608|NCT03785405|454822934|FG000|Overall Study|Death|6|||
126417609|NCT03785405|454822935|FG001|Overall Study|Death|4|||
126417610|NCT03785405|454822934|FG000|Overall Study|Guardian decision|4|||
126417611|NCT03785405|454822935|FG001|Overall Study|Guardian decision|1|||
126417612|NCT03785405|454822934|FG000|Overall Study|Lost to Follow-up|1|||
126417613|NCT03785405|454822935|FG001|Overall Study|Lost to Follow-up|0|||
126417614|NCT03785405|454822934|FG000|Overall Study|Physician Decision|8|||
126417615|NCT03785405|454822935|FG001|Overall Study|Physician Decision|5|||
126417616|NCT03785405|454822934|FG000|Overall Study|Participant decision|2|||
126417617|NCT03785405|454822935|FG001|Overall Study|Participant decision|0|||
126417618|NCT03785405|454822934|FG000|Overall Study|Other|1|||
126417619|NCT03785405|454822935|FG001|Overall Study|Other|0|||
126417620|NCT03785405|454822934|FG000|Overall Study|No treatment was received|0|||
126417621|NCT03785405|454822935|FG001|Overall Study|No treatment was received|1|||
126417622|NCT02881762|454822938|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
126417623|NCT02881762|454822939|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
126417624|NCT01922271|454822942|FG000|WASHOUT Period|Withdrawal by Subject|1|||
126417625|NCT01922271|454822943|FG001|WASHOUT Period|Withdrawal by Subject|0|||
126417626|NCT01635855|454822950|FG000|Overall Study|Withdrawal by Subject|4|||
126417627|NCT03828019|454822951|FG000|Overall Study|Withdrawal by Subject|3|||
126417628|NCT03828019|454822952|FG001|Overall Study|Withdrawal by Subject|8|||
126417629|NCT03828019|454822951|FG000|Overall Study|Lost to Follow-up|1|||
126417630|NCT03828019|454822952|FG001|Overall Study|Lost to Follow-up|6|||
126417631|NCT03828019|454822951|FG000|Overall Study|Incarcerated|1|||
126417632|NCT03828019|454822952|FG001|Overall Study|Incarcerated|0|||
126417633|NCT03828019|454822951|FG000|Overall Study|Adverse Event|0|||
126417634|NCT03828019|454822952|FG001|Overall Study|Adverse Event|1|||
126417635|NCT03400176|454822953|FG000|Dose Escalation|Progressive disease|1|||
126417636|NCT03400176|454822954|FG001|Dose Escalation|Progressive disease|1|||
126417637|NCT03400176|454822955|FG002|Dose Escalation|Progressive disease|0|||
126417638|NCT03400176|454822956|FG003|Dose Escalation|Progressive disease|0|||
126417639|NCT03400176|454822957|FG004|Dose Escalation|Progressive disease|1|||
126417640|NCT03400176|454822953|FG000|Dose Escalation|Patient decision|0|||
126417641|NCT03400176|454822954|FG001|Dose Escalation|Patient decision|0|||
126417642|NCT03400176|454822955|FG002|Dose Escalation|Patient decision|0|||
126417643|NCT03400176|454822956|FG003|Dose Escalation|Patient decision|0|||
126417644|NCT03400176|454822957|FG004|Dose Escalation|Patient decision|1|||
126417645|NCT03400176|454822953|FG000|Dose Expansion|Patient decision|0|||
126417646|NCT03400176|454822954|FG001|Dose Expansion|Patient decision|0|||
126417647|NCT03400176|454822955|FG002|Dose Expansion|Patient decision|0|||
126417648|NCT03400176|454822956|FG003|Dose Expansion|Patient decision|1|||
126417649|NCT03400176|454822957|FG004|Dose Expansion|Patient decision|0|||
126417650|NCT03400176|454822953|FG000|Dose Expansion|Adverse Event|0|||
126417651|NCT03400176|454822954|FG001|Dose Expansion|Adverse Event|0|||
126417652|NCT03400176|454822955|FG002|Dose Expansion|Adverse Event|0|||
126417653|NCT03400176|454822956|FG003|Dose Expansion|Adverse Event|1|||
126417654|NCT03400176|454822957|FG004|Dose Expansion|Adverse Event|0|||
126417655|NCT03400176|454822953|FG000|Dose Expansion|Physician Decision|0|||
126417656|NCT03400176|454822954|FG001|Dose Expansion|Physician Decision|0|||
126417657|NCT03400176|454822955|FG002|Dose Expansion|Physician Decision|0|||
126417658|NCT03400176|454822956|FG003|Dose Expansion|Physician Decision|1|||
126417659|NCT03400176|454822957|FG004|Dose Expansion|Physician Decision|0|||
126417660|NCT03400176|454822953|FG000|Dose Expansion|Progressive disease|0|||
126417661|NCT03400176|454822954|FG001|Dose Expansion|Progressive disease|0|||
126417662|NCT03400176|454822955|FG002|Dose Expansion|Progressive disease|1|||
126417663|NCT03400176|454822956|FG003|Dose Expansion|Progressive disease|1|||
126417664|NCT03400176|454822957|FG004|Dose Expansion|Progressive disease|0|||
126417665|NCT00206440|454822958|FG000|Overall Study|Protocol Violation|1|||
126417666|NCT00206440|454822959|FG001|Overall Study|Protocol Violation|2|||
126417667|NCT00206440|454822958|FG000|Overall Study|Adverse Event|4|||
126417668|NCT00206440|454822959|FG001|Overall Study|Adverse Event|2|||
126417669|NCT01298765|454822960|FG000|Titration Period|Adverse Event|26|||
126417670|NCT01298765|454822960|FG000|Titration Period|Death|1|||
126417671|NCT01298765|454822960|FG000|Titration Period|Lack of Efficacy|21|||
126417672|NCT01298765|454822960|FG000|Titration Period|Lost to Follow-up|9|||
126417673|NCT01298765|454822960|FG000|Titration Period|Physician Decision|1|||
126417674|NCT01298765|454822960|FG000|Titration Period|Withdrawal by Subject|10|||
126417675|NCT01298765|454822960|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
126417676|NCT01298765|454822960|FG000|Long-Term Treatment Period|Adverse Event|19|||
126417677|NCT01298765|454822960|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
126417678|NCT01298765|454822960|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
126417679|NCT01298765|454822960|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
126417680|NCT01298765|454822960|FG000|Long-Term Treatment Period|Physician Decision|1|||
126417681|NCT01298765|454822960|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
126417682|NCT03302247|454822963|FG000|Overall Study|the study has closed prematurely|2|||
126417683|NCT03302247|454822963|FG000|Overall Study|Death|1|||
126417684|NCT04090242|454822964|FG000|Overall Study|Withdrawal by Subject|1|||
126417685|NCT04090242|454822965|FG001|Overall Study|Withdrawal by Subject|0|||
126417686|NCT03214406|454822966|FG000|Overall Study|did not meet enrollment criteria|9|||
126417687|NCT03214406|454822967|FG001|Overall Study|did not meet enrollment criteria|13|||
126417688|NCT03214406|454822966|FG000|Overall Study|Withdrawal by Subject|1|||
126417689|NCT03214406|454822967|FG001|Overall Study|Withdrawal by Subject|0|||
126417690|NCT03214406|454822966|FG000|Overall Study|Lost to Follow-up|0|||
126417691|NCT03214406|454822967|FG001|Overall Study|Lost to Follow-up|2|||
126417692|NCT01098305|454822970|FG000|Overall Study|Lost to Follow-up|31|||
126417693|NCT01098305|454822971|FG001|Overall Study|Lost to Follow-up|33|||
126417694|NCT03182907|454822973|FG000|Overall Study|Death|3|||
126417695|NCT03182907|454822974|FG001|Overall Study|Death|0|||
126417696|NCT03182907|454822973|FG000|Overall Study|Protocol Violation|4|||
126417697|NCT03182907|454822974|FG001|Overall Study|Protocol Violation|0|||
126417698|NCT03182907|454822973|FG000|Overall Study|Lost to Follow-up|1|||
126417699|NCT03182907|454822974|FG001|Overall Study|Lost to Follow-up|0|||
126417700|NCT03182907|454822973|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126417701|NCT03182907|454822974|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
126417702|NCT00429169|454822975|FG000|Overall Study|Lost to Follow-up|0|||
126417703|NCT00429169|454822976|FG001|Overall Study|Lost to Follow-up|1|||
126417704|NCT00429169|454822975|FG000|Overall Study|Ineligibility discovered after entry|2|||
126417705|NCT00429169|454822976|FG001|Overall Study|Ineligibility discovered after entry|1|||
126417706|NCT01180296|454822981|FG000|Overall Study|Protocol Violation|1|||
126417707|NCT01180296|454822982|FG001|Overall Study|Protocol Violation|2|||
126417708|NCT03364309|454822987|FG000|Induction Period|Adverse Event|4|||
126417709|NCT03364309|454822988|FG001|Induction Period|Adverse Event|0|||
126417710|NCT03364309|454822989|FG002|Induction Period|Adverse Event|1|||
126417711|NCT03364309|454822990|FG003|Induction Period|Adverse Event|0|||
126417712|NCT03364309|454822991|FG004|Induction Period|Adverse Event|0|||
126476852|NCT00612040|455046568|FG000|Overall Study|Lack of Efficacy|2|||
126417713|NCT03364309|454822992|FG005|Induction Period|Adverse Event|0|||
126417714|NCT03364309|454822993|FG006|Induction Period|Adverse Event|0|||
126417715|NCT03364309|454822994|FG007|Induction Period|Adverse Event|0|||
126417716|NCT03364309|454822995|FG008|Induction Period|Adverse Event|0|||
126417717|NCT03364309|454822996|FG009|Induction Period|Adverse Event|0|||
126417718|NCT03364309|454822997|FG010|Induction Period|Adverse Event|0|||
126417719|NCT03364309|454822998|FG011|Induction Period|Adverse Event|0|||
126476853|NCT00612040|455046569|FG001|Overall Study|Lack of Efficacy|1|||
126417720|NCT03364309|454822999|FG012|Induction Period|Adverse Event|0|||
126417721|NCT03364309|454823000|FG013|Induction Period|Adverse Event|0|||
126476854|NCT00612040|455046570|FG002|Overall Study|Lack of Efficacy|0|||
126417722|NCT03364309|454823001|FG014|Induction Period|Adverse Event|0|||
126417723|NCT03364309|454823002|FG015|Induction Period|Adverse Event|0|||
126417724|NCT03364309|454823003|FG016|Induction Period|Adverse Event|0|||
126417725|NCT03364309|454823004|FG017|Induction Period|Adverse Event|0|||
126417726|NCT03364309|454823005|FG018|Induction Period|Adverse Event|0|||
126417727|NCT03364309|454822987|FG000|Induction Period|Withdrawal by Subject|1|||
126417728|NCT03364309|454822988|FG001|Induction Period|Withdrawal by Subject|3|||
126417729|NCT03364309|454822989|FG002|Induction Period|Withdrawal by Subject|0|||
126417730|NCT03364309|454822990|FG003|Induction Period|Withdrawal by Subject|0|||
126417731|NCT03364309|454822991|FG004|Induction Period|Withdrawal by Subject|0|||
126417732|NCT03364309|454822992|FG005|Induction Period|Withdrawal by Subject|0|||
126417733|NCT03364309|454822993|FG006|Induction Period|Withdrawal by Subject|0|||
126417734|NCT03364309|454822994|FG007|Induction Period|Withdrawal by Subject|0|||
126417735|NCT03364309|454822995|FG008|Induction Period|Withdrawal by Subject|0|||
126417736|NCT03364309|454822996|FG009|Induction Period|Withdrawal by Subject|0|||
126417737|NCT03364309|454822997|FG010|Induction Period|Withdrawal by Subject|0|||
126417738|NCT03364309|454822998|FG011|Induction Period|Withdrawal by Subject|0|||
126417739|NCT03364309|454822999|FG012|Induction Period|Withdrawal by Subject|0|||
126417740|NCT03364309|454823000|FG013|Induction Period|Withdrawal by Subject|0|||
126417741|NCT03364309|454823001|FG014|Induction Period|Withdrawal by Subject|0|||
126417742|NCT03364309|454823002|FG015|Induction Period|Withdrawal by Subject|0|||
126417743|NCT03364309|454823003|FG016|Induction Period|Withdrawal by Subject|0|||
126417744|NCT03364309|454823004|FG017|Induction Period|Withdrawal by Subject|0|||
126417745|NCT03364309|454823005|FG018|Induction Period|Withdrawal by Subject|0|||
126417746|NCT03364309|454822987|FG000|Induction Period|Lost to Follow-up|1|||
126417747|NCT03364309|454822988|FG001|Induction Period|Lost to Follow-up|0|||
126417748|NCT03364309|454822989|FG002|Induction Period|Lost to Follow-up|0|||
126417749|NCT03364309|454822990|FG003|Induction Period|Lost to Follow-up|0|||
126417750|NCT03364309|454822991|FG004|Induction Period|Lost to Follow-up|0|||
126417751|NCT03364309|454822992|FG005|Induction Period|Lost to Follow-up|0|||
126417752|NCT03364309|454822993|FG006|Induction Period|Lost to Follow-up|0|||
126417753|NCT03364309|454822994|FG007|Induction Period|Lost to Follow-up|0|||
126417754|NCT03364309|454822995|FG008|Induction Period|Lost to Follow-up|0|||
126417755|NCT03364309|454822996|FG009|Induction Period|Lost to Follow-up|0|||
126417756|NCT03364309|454822997|FG010|Induction Period|Lost to Follow-up|0|||
126417757|NCT03364309|454822998|FG011|Induction Period|Lost to Follow-up|0|||
126417758|NCT03364309|454822999|FG012|Induction Period|Lost to Follow-up|0|||
126417759|NCT03364309|454823000|FG013|Induction Period|Lost to Follow-up|0|||
126417760|NCT03364309|454823001|FG014|Induction Period|Lost to Follow-up|0|||
126417761|NCT03364309|454823002|FG015|Induction Period|Lost to Follow-up|0|||
126417762|NCT03364309|454823003|FG016|Induction Period|Lost to Follow-up|0|||
126417763|NCT03364309|454823004|FG017|Induction Period|Lost to Follow-up|0|||
126417764|NCT03364309|454823005|FG018|Induction Period|Lost to Follow-up|0|||
126417765|NCT03364309|454822987|FG000|Induction Period|Physician Decision|0|||
126417766|NCT03364309|454822988|FG001|Induction Period|Physician Decision|1|||
126417767|NCT03364309|454822989|FG002|Induction Period|Physician Decision|0|||
126417768|NCT03364309|454822990|FG003|Induction Period|Physician Decision|0|||
126417769|NCT03364309|454822991|FG004|Induction Period|Physician Decision|0|||
126417770|NCT03364309|454822992|FG005|Induction Period|Physician Decision|0|||
126417771|NCT03364309|454822993|FG006|Induction Period|Physician Decision|0|||
126417772|NCT03364309|454822994|FG007|Induction Period|Physician Decision|0|||
126417773|NCT03364309|454822995|FG008|Induction Period|Physician Decision|0|||
126417774|NCT03364309|454822996|FG009|Induction Period|Physician Decision|0|||
126417775|NCT03364309|454822997|FG010|Induction Period|Physician Decision|0|||
126417776|NCT03364309|454822998|FG011|Induction Period|Physician Decision|0|||
126417777|NCT03364309|454822999|FG012|Induction Period|Physician Decision|0|||
126417778|NCT03364309|454823000|FG013|Induction Period|Physician Decision|0|||
126417779|NCT03364309|454823001|FG014|Induction Period|Physician Decision|0|||
126417780|NCT03364309|454823002|FG015|Induction Period|Physician Decision|0|||
126721771|NCT05122650|455931290|FG000|Overall Study|Lost to Follow-up|1|||
126721772|NCT05122650|455931291|FG001|Overall Study|Lost to Follow-up|1|||
126721773|NCT05122650|455931292|FG002|Overall Study|Lost to Follow-up|3|||
126417781|NCT03364309|454823003|FG016|Induction Period|Physician Decision|0|||
126721774|NCT05122650|455931293|FG003|Overall Study|Lost to Follow-up|0|||
126721775|NCT05122650|455931290|FG000|Overall Study|Non-compliance with study intervention|0|||
126721776|NCT05122650|455931291|FG001|Overall Study|Non-compliance with study intervention|0|||
126721777|NCT05122650|455931292|FG002|Overall Study|Non-compliance with study intervention|0|||
126721778|NCT05122650|455931293|FG003|Overall Study|Non-compliance with study intervention|2|||
126721779|NCT05122650|455931290|FG000|Overall Study|Protocol Violation|0|||
126721780|NCT05122650|455931291|FG001|Overall Study|Protocol Violation|1|||
126417782|NCT03364309|454823004|FG017|Induction Period|Physician Decision|0|||
126417783|NCT03364309|454823005|FG018|Induction Period|Physician Decision|0|||
126417784|NCT03364309|454822987|FG000|Maintenance Period|Withdrawal by Subject|0|||
126721781|NCT05122650|455931292|FG002|Overall Study|Protocol Violation|0|||
126417785|NCT03364309|454822988|FG001|Maintenance Period|Withdrawal by Subject|0|||
126417786|NCT03364309|454822989|FG002|Maintenance Period|Withdrawal by Subject|0|||
126417787|NCT03364309|454822990|FG003|Maintenance Period|Withdrawal by Subject|1|||
126417788|NCT03364309|454822991|FG004|Maintenance Period|Withdrawal by Subject|3|||
126417789|NCT03364309|454822992|FG005|Maintenance Period|Withdrawal by Subject|1|||
126417790|NCT03364309|454822993|FG006|Maintenance Period|Withdrawal by Subject|3|||
126417791|NCT03364309|454822994|FG007|Maintenance Period|Withdrawal by Subject|0|||
126417792|NCT03364309|454822995|FG008|Maintenance Period|Withdrawal by Subject|1|||
126417793|NCT03364309|454822996|FG009|Maintenance Period|Withdrawal by Subject|1|||
126417794|NCT03364309|454822997|FG010|Maintenance Period|Withdrawal by Subject|2|||
126417795|NCT03364309|454822998|FG011|Maintenance Period|Withdrawal by Subject|0|||
126417796|NCT03364309|454822999|FG012|Maintenance Period|Withdrawal by Subject|0|||
126417797|NCT03364309|454823000|FG013|Maintenance Period|Withdrawal by Subject|0|||
126417798|NCT03364309|454823001|FG014|Maintenance Period|Withdrawal by Subject|0|||
126417799|NCT03364309|454823002|FG015|Maintenance Period|Withdrawal by Subject|0|||
126417800|NCT03364309|454823003|FG016|Maintenance Period|Withdrawal by Subject|0|||
126417801|NCT03364309|454823004|FG017|Maintenance Period|Withdrawal by Subject|0|||
126417802|NCT03364309|454823005|FG018|Maintenance Period|Withdrawal by Subject|0|||
126417803|NCT03364309|454822987|FG000|Maintenance Period|Adverse Event|0|||
126417804|NCT03364309|454822988|FG001|Maintenance Period|Adverse Event|0|||
126417805|NCT03364309|454822989|FG002|Maintenance Period|Adverse Event|0|||
126417806|NCT03364309|454822990|FG003|Maintenance Period|Adverse Event|0|||
126417807|NCT03364309|454822991|FG004|Maintenance Period|Adverse Event|2|||
126417808|NCT03364309|454822992|FG005|Maintenance Period|Adverse Event|0|||
126417809|NCT03364309|454822993|FG006|Maintenance Period|Adverse Event|3|||
126417810|NCT03364309|454822994|FG007|Maintenance Period|Adverse Event|0|||
126417811|NCT03364309|454822995|FG008|Maintenance Period|Adverse Event|1|||
126417812|NCT03364309|454822996|FG009|Maintenance Period|Adverse Event|0|||
126417813|NCT03364309|454822997|FG010|Maintenance Period|Adverse Event|2|||
126417814|NCT03364309|454822998|FG011|Maintenance Period|Adverse Event|0|||
126417815|NCT03364309|454822999|FG012|Maintenance Period|Adverse Event|0|||
126417816|NCT03364309|454823000|FG013|Maintenance Period|Adverse Event|0|||
126417817|NCT03364309|454823001|FG014|Maintenance Period|Adverse Event|0|||
126417818|NCT03364309|454823002|FG015|Maintenance Period|Adverse Event|0|||
126417819|NCT03364309|454823003|FG016|Maintenance Period|Adverse Event|0|||
126417820|NCT03364309|454823004|FG017|Maintenance Period|Adverse Event|0|||
126417821|NCT03364309|454823005|FG018|Maintenance Period|Adverse Event|0|||
126417822|NCT03364309|454822987|FG000|Maintenance Period|Relapsed|0|||
126417823|NCT03364309|454822988|FG001|Maintenance Period|Relapsed|0|||
126417824|NCT03364309|454822989|FG002|Maintenance Period|Relapsed|0|||
126417825|NCT03364309|454822990|FG003|Maintenance Period|Relapsed|43|||
126417826|NCT03364309|454822991|FG004|Maintenance Period|Relapsed|7|||
126417827|NCT03364309|454822992|FG005|Maintenance Period|Relapsed|45|||
126417828|NCT03364309|454822993|FG006|Maintenance Period|Relapsed|10|||
126417829|NCT03364309|454822994|FG007|Maintenance Period|Relapsed|2|||
126417830|NCT03364309|454822995|FG008|Maintenance Period|Relapsed|0|||
126417831|NCT03364309|454822996|FG009|Maintenance Period|Relapsed|0|||
126417832|NCT03364309|454822997|FG010|Maintenance Period|Relapsed|0|||
126417833|NCT03364309|454822998|FG011|Maintenance Period|Relapsed|0|||
126417834|NCT03364309|454822999|FG012|Maintenance Period|Relapsed|0|||
126417835|NCT03364309|454823000|FG013|Maintenance Period|Relapsed|0|||
126417836|NCT03364309|454823001|FG014|Maintenance Period|Relapsed|0|||
126417837|NCT03364309|454823002|FG015|Maintenance Period|Relapsed|0|||
126417838|NCT03364309|454823003|FG016|Maintenance Period|Relapsed|0|||
126417839|NCT03364309|454823004|FG017|Maintenance Period|Relapsed|0|||
126417840|NCT03364309|454823005|FG018|Maintenance Period|Relapsed|0|||
126417841|NCT03364309|454822987|FG000|Maintenance Period|Lack of Efficacy|0|||
126417842|NCT03364309|454822988|FG001|Maintenance Period|Lack of Efficacy|0|||
126417843|NCT03364309|454822989|FG002|Maintenance Period|Lack of Efficacy|0|||
126417844|NCT03364309|454822990|FG003|Maintenance Period|Lack of Efficacy|0|||
126417845|NCT03364309|454822991|FG004|Maintenance Period|Lack of Efficacy|0|||
126417846|NCT03364309|454822992|FG005|Maintenance Period|Lack of Efficacy|0|||
126417847|NCT03364309|454822993|FG006|Maintenance Period|Lack of Efficacy|0|||
126417848|NCT03364309|454822994|FG007|Maintenance Period|Lack of Efficacy|0|||
126417849|NCT03364309|454822995|FG008|Maintenance Period|Lack of Efficacy|1|||
126417850|NCT03364309|454822996|FG009|Maintenance Period|Lack of Efficacy|3|||
126417851|NCT03364309|454822997|FG010|Maintenance Period|Lack of Efficacy|2|||
126417852|NCT03364309|454822998|FG011|Maintenance Period|Lack of Efficacy|0|||
126417853|NCT03364309|454822999|FG012|Maintenance Period|Lack of Efficacy|0|||
126417854|NCT03364309|454823000|FG013|Maintenance Period|Lack of Efficacy|0|||
126417855|NCT03364309|454823001|FG014|Maintenance Period|Lack of Efficacy|0|||
126417856|NCT03364309|454823002|FG015|Maintenance Period|Lack of Efficacy|0|||
126417857|NCT03364309|454823003|FG016|Maintenance Period|Lack of Efficacy|0|||
126417858|NCT03364309|454823004|FG017|Maintenance Period|Lack of Efficacy|0|||
126417859|NCT03364309|454823005|FG018|Maintenance Period|Lack of Efficacy|0|||
126417860|NCT03364309|454822987|FG000|Maintenance Period|Death|0|||
126417861|NCT03364309|454822988|FG001|Maintenance Period|Death|0|||
126417862|NCT03364309|454822989|FG002|Maintenance Period|Death|0|||
126417863|NCT03364309|454822990|FG003|Maintenance Period|Death|0|||
126417864|NCT03364309|454822991|FG004|Maintenance Period|Death|0|||
126417865|NCT03364309|454822992|FG005|Maintenance Period|Death|0|||
126417866|NCT03364309|454822993|FG006|Maintenance Period|Death|0|||
126417867|NCT03364309|454822994|FG007|Maintenance Period|Death|0|||
126417868|NCT03364309|454822995|FG008|Maintenance Period|Death|1|||
126417869|NCT03364309|454822996|FG009|Maintenance Period|Death|0|||
126417870|NCT03364309|454822997|FG010|Maintenance Period|Death|0|||
126417871|NCT03364309|454822998|FG011|Maintenance Period|Death|0|||
126417872|NCT03364309|454822999|FG012|Maintenance Period|Death|0|||
126417873|NCT03364309|454823000|FG013|Maintenance Period|Death|0|||
126417874|NCT03364309|454823001|FG014|Maintenance Period|Death|0|||
126417875|NCT03364309|454823002|FG015|Maintenance Period|Death|0|||
126417876|NCT03364309|454823003|FG016|Maintenance Period|Death|0|||
126417877|NCT03364309|454823004|FG017|Maintenance Period|Death|0|||
126417878|NCT03364309|454823005|FG018|Maintenance Period|Death|0|||
126417879|NCT03364309|454822987|FG000|Maintenance Period|Lost to Follow-up|0|||
126417880|NCT03364309|454822988|FG001|Maintenance Period|Lost to Follow-up|0|||
126417881|NCT03364309|454822989|FG002|Maintenance Period|Lost to Follow-up|0|||
126417882|NCT03364309|454822990|FG003|Maintenance Period|Lost to Follow-up|0|||
126417883|NCT03364309|454822991|FG004|Maintenance Period|Lost to Follow-up|0|||
126417884|NCT03364309|454822992|FG005|Maintenance Period|Lost to Follow-up|0|||
126417885|NCT03364309|454822993|FG006|Maintenance Period|Lost to Follow-up|0|||
126417886|NCT03364309|454822994|FG007|Maintenance Period|Lost to Follow-up|0|||
126417887|NCT03364309|454822995|FG008|Maintenance Period|Lost to Follow-up|1|||
126417888|NCT03364309|454822996|FG009|Maintenance Period|Lost to Follow-up|0|||
126417889|NCT03364309|454822997|FG010|Maintenance Period|Lost to Follow-up|0|||
126417890|NCT03364309|454822998|FG011|Maintenance Period|Lost to Follow-up|0|||
126417891|NCT03364309|454822999|FG012|Maintenance Period|Lost to Follow-up|0|||
126417892|NCT03364309|454823000|FG013|Maintenance Period|Lost to Follow-up|0|||
126417893|NCT03364309|454823001|FG014|Maintenance Period|Lost to Follow-up|0|||
126417894|NCT03364309|454823002|FG015|Maintenance Period|Lost to Follow-up|0|||
126417895|NCT03364309|454823003|FG016|Maintenance Period|Lost to Follow-up|0|||
126417896|NCT03364309|454823004|FG017|Maintenance Period|Lost to Follow-up|0|||
126417897|NCT03364309|454823005|FG018|Maintenance Period|Lost to Follow-up|0|||
126417898|NCT03364309|454822987|FG000|Maintenance Period|Miscellaneous|0|||
126417899|NCT03364309|454822988|FG001|Maintenance Period|Miscellaneous|0|||
126417900|NCT03364309|454822989|FG002|Maintenance Period|Miscellaneous|0|||
126417901|NCT03364309|454822990|FG003|Maintenance Period|Miscellaneous|0|||
126417902|NCT03364309|454822991|FG004|Maintenance Period|Miscellaneous|0|||
126417903|NCT03364309|454822992|FG005|Maintenance Period|Miscellaneous|0|||
126417904|NCT03364309|454822993|FG006|Maintenance Period|Miscellaneous|0|||
126417905|NCT03364309|454822994|FG007|Maintenance Period|Miscellaneous|0|||
126417906|NCT03364309|454822995|FG008|Maintenance Period|Miscellaneous|1|||
126417907|NCT03364309|454822996|FG009|Maintenance Period|Miscellaneous|0|||
126417908|NCT03364309|454822997|FG010|Maintenance Period|Miscellaneous|0|||
126417909|NCT03364309|454822998|FG011|Maintenance Period|Miscellaneous|0|||
126417910|NCT03364309|454822999|FG012|Maintenance Period|Miscellaneous|0|||
126417911|NCT03364309|454823000|FG013|Maintenance Period|Miscellaneous|0|||
126417912|NCT03364309|454823001|FG014|Maintenance Period|Miscellaneous|0|||
126417913|NCT03364309|454823002|FG015|Maintenance Period|Miscellaneous|0|||
126417914|NCT03364309|454823003|FG016|Maintenance Period|Miscellaneous|0|||
126417915|NCT03364309|454823004|FG017|Maintenance Period|Miscellaneous|0|||
126417916|NCT03364309|454823005|FG018|Maintenance Period|Miscellaneous|0|||
126417917|NCT03364309|454822987|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417918|NCT03364309|454822988|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417919|NCT03364309|454822989|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417920|NCT03364309|454822990|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417921|NCT03364309|454822991|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417922|NCT03364309|454822992|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417923|NCT03364309|454822993|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417924|NCT03364309|454822994|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417925|NCT03364309|454822995|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417926|NCT03364309|454822996|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126476855|NCT00612040|455046568|FG000|Overall Study|Unclassified|2|||
126476856|NCT00612040|455046569|FG001|Overall Study|Unclassified|2|||
126476857|NCT00612040|455046570|FG002|Overall Study|Unclassified|5|||
126417927|NCT03364309|454822997|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417928|NCT03364309|454822998|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417929|NCT03364309|454822999|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417930|NCT03364309|454823000|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
126417931|NCT03364309|454823001|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
126417932|NCT03364309|454823002|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
126417933|NCT03364309|454823003|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417934|NCT03364309|454823004|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126417935|NCT03364309|454823005|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
126476858|NCT00885846|455046572|FG000|Overall Study|Withdrawal by Subject|2|||
126417936|NCT03364309|454822987|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417937|NCT03364309|454822988|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417938|NCT03364309|454822989|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417939|NCT03364309|454822990|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417940|NCT03364309|454822991|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417941|NCT03364309|454822992|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417942|NCT03364309|454822993|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417943|NCT03364309|454822994|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417944|NCT03364309|454822995|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417945|NCT03364309|454822996|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417946|NCT03364309|454822997|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417947|NCT03364309|454822998|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417948|NCT03364309|454822999|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417949|NCT03364309|454823000|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417950|NCT03364309|454823001|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
126417951|NCT03364309|454823002|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417952|NCT03364309|454823003|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417953|NCT03364309|454823004|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417954|NCT03364309|454823005|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
126417955|NCT03364309|454822987|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
126417956|NCT03364309|454822988|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
126417957|NCT03364309|454822989|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
126417958|NCT03364309|454822990|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
126417959|NCT03364309|454822991|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
126417960|NCT03364309|454822992|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
126417961|NCT03364309|454822993|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
126417962|NCT03364309|454822994|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
126417963|NCT03364309|454822995|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
126417964|NCT03364309|454822996|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
126417965|NCT03364309|454822997|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
126417966|NCT03364309|454822998|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
126417967|NCT03364309|454822999|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
126417968|NCT03364309|454823000|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
126417969|NCT03364309|454823001|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
126417970|NCT03364309|454823002|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
126417971|NCT03364309|454823003|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
126417972|NCT03364309|454823004|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
126417973|NCT03364309|454823005|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
126417974|NCT03364309|454822987|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417975|NCT03364309|454822988|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417976|NCT03364309|454822989|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417977|NCT03364309|454822990|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417978|NCT03364309|454822991|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417979|NCT03364309|454822992|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417980|NCT03364309|454822993|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417981|NCT03364309|454822994|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417982|NCT03364309|454822995|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417983|NCT03364309|454822996|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417984|NCT03364309|454822997|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417985|NCT03364309|454822998|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417986|NCT03364309|454822999|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417987|NCT03364309|454823000|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417988|NCT03364309|454823001|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417989|NCT03364309|454823002|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
126417990|NCT03364309|454823003|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
126417991|NCT03364309|454823004|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
126417992|NCT03364309|454823005|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
126417993|NCT03364309|454822987|FG000|Post-Treatment Followup Period|Adverse Event|0|||
126417994|NCT03364309|454822988|FG001|Post-Treatment Followup Period|Adverse Event|0|||
126417995|NCT03364309|454822989|FG002|Post-Treatment Followup Period|Adverse Event|0|||
126417996|NCT03364309|454822990|FG003|Post-Treatment Followup Period|Adverse Event|0|||
126417997|NCT03364309|454822991|FG004|Post-Treatment Followup Period|Adverse Event|0|||
126417998|NCT03364309|454822992|FG005|Post-Treatment Followup Period|Adverse Event|0|||
126417999|NCT03364309|454822993|FG006|Post-Treatment Followup Period|Adverse Event|0|||
126418000|NCT03364309|454822994|FG007|Post-Treatment Followup Period|Adverse Event|0|||
126476859|NCT00885846|455046573|FG001|Overall Study|Withdrawal by Subject|5|||
126476860|NCT00885846|455046574|FG002|Overall Study|Withdrawal by Subject|2|||
126476861|NCT00444912|455046582|FG000|Overall Study|Death|1|||
126476862|NCT00444912|455046583|FG001|Overall Study|Death|2|||
126476863|NCT00444912|455046582|FG000|Overall Study|Lost to Follow-up|1|||
126476864|NCT00444912|455046583|FG001|Overall Study|Lost to Follow-up|0|||
126476865|NCT00444912|455046582|FG000|Overall Study|Participant Failed Mobilization|1|||
126418001|NCT03364309|454822995|FG008|Post-Treatment Followup Period|Adverse Event|0|||
126418002|NCT03364309|454822996|FG009|Post-Treatment Followup Period|Adverse Event|0|||
126418003|NCT03364309|454822997|FG010|Post-Treatment Followup Period|Adverse Event|0|||
126418004|NCT03364309|454822998|FG011|Post-Treatment Followup Period|Adverse Event|0|||
126418005|NCT03364309|454822999|FG012|Post-Treatment Followup Period|Adverse Event|0|||
126418006|NCT03364309|454823000|FG013|Post-Treatment Followup Period|Adverse Event|0|||
126418007|NCT03364309|454823001|FG014|Post-Treatment Followup Period|Adverse Event|0|||
126418008|NCT03364309|454823002|FG015|Post-Treatment Followup Period|Adverse Event|0|||
126418009|NCT03364309|454823003|FG016|Post-Treatment Followup Period|Adverse Event|2|||
126418010|NCT03364309|454823004|FG017|Post-Treatment Followup Period|Adverse Event|6|||
126418011|NCT03364309|454823005|FG018|Post-Treatment Followup Period|Adverse Event|1|||
126418012|NCT03364309|454822987|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418013|NCT03364309|454822988|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418014|NCT03364309|454822989|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418015|NCT03364309|454822990|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418016|NCT03364309|454822991|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418017|NCT03364309|454822992|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418018|NCT03364309|454822993|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418019|NCT03364309|454822994|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418020|NCT03364309|454822995|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418021|NCT03364309|454822996|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418022|NCT03364309|454822997|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418023|NCT03364309|454822998|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418024|NCT03364309|454822999|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418025|NCT03364309|454823000|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418026|NCT03364309|454823001|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418027|NCT03364309|454823002|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418028|NCT03364309|454823003|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418029|NCT03364309|454823004|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
126418030|NCT03364309|454823005|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
126418031|NCT03364309|454822987|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
126418032|NCT03364309|454822988|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
126418033|NCT03364309|454822989|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
126418034|NCT03364309|454822990|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
126418035|NCT03364309|454822991|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
126418036|NCT03364309|454822992|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
126418037|NCT03364309|454822993|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
126418038|NCT03364309|454822994|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
126418039|NCT03364309|454822995|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
126418040|NCT03364309|454822996|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
126418041|NCT03364309|454822997|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
126418042|NCT03364309|454822998|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
126418043|NCT03364309|454822999|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
126418044|NCT03364309|454823000|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
126418045|NCT03364309|454823001|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
126418046|NCT03364309|454823002|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
126418047|NCT03364309|454823003|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
126418048|NCT03364309|454823004|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
126418049|NCT03364309|454823005|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
126418050|NCT03304873|454823006|FG000|Overall Study|Lost to Follow-up|1|||
126418051|NCT03304873|454823007|FG001|Overall Study|Lost to Follow-up|8|||
126418052|NCT01546688|454823008|FG000|Overall Study|Adverse Event|0|||
126418053|NCT01546688|454823009|FG001|Overall Study|Adverse Event|4|||
126418054|NCT01546688|454823008|FG000|Overall Study|Withdrawal by Subject|2|||
126418055|NCT01546688|454823009|FG001|Overall Study|Withdrawal by Subject|1|||
126418056|NCT01546688|454823008|FG000|Overall Study|Lack of Efficacy|1|||
126418057|NCT01546688|454823009|FG001|Overall Study|Lack of Efficacy|0|||
126418058|NCT01052077|454823013|FG000|Phase A|Lost to Follow-up|22|||
126418059|NCT01052077|454823014|FG001|Phase A|Lost to Follow-up|0|||
126418060|NCT01052077|454823015|FG002|Phase A|Lost to Follow-up|0|||
126418061|NCT01052077|454823016|FG003|Phase A|Lost to Follow-up|0|||
126418062|NCT01052077|454823013|FG000|Phase A|Adverse Event|32|||
126418063|NCT01052077|454823014|FG001|Phase A|Adverse Event|0|||
126418064|NCT01052077|454823015|FG002|Phase A|Adverse Event|0|||
126418065|NCT01052077|454823016|FG003|Phase A|Adverse Event|0|||
126418066|NCT01052077|454823013|FG000|Phase A|Met Withdrawal Criteria|26|||
126418067|NCT01052077|454823014|FG001|Phase A|Met Withdrawal Criteria|0|||
126418068|NCT01052077|454823015|FG002|Phase A|Met Withdrawal Criteria|0|||
126418069|NCT01052077|454823016|FG003|Phase A|Met Withdrawal Criteria|0|||
126418070|NCT01052077|454823013|FG000|Phase A|Physician Decision|10|||
126418071|NCT01052077|454823014|FG001|Phase A|Physician Decision|0|||
126418072|NCT01052077|454823015|FG002|Phase A|Physician Decision|0|||
126418073|NCT01052077|454823016|FG003|Phase A|Physician Decision|0|||
126418074|NCT01052077|454823013|FG000|Phase A|Withdrawal by Subject|29|||
126418075|NCT01052077|454823014|FG001|Phase A|Withdrawal by Subject|0|||
126418076|NCT01052077|454823015|FG002|Phase A|Withdrawal by Subject|0|||
126418077|NCT01052077|454823016|FG003|Phase A|Withdrawal by Subject|0|||
126418078|NCT01052077|454823013|FG000|Phase A|Protocol Deviation|27|||
126418079|NCT01052077|454823014|FG001|Phase A|Protocol Deviation|0|||
126418080|NCT01052077|454823015|FG002|Phase A|Protocol Deviation|0|||
126418081|NCT01052077|454823016|FG003|Phase A|Protocol Deviation|0|||
126418082|NCT01052077|454823013|FG000|Phase B|Lost to Follow-up|0|||
126418083|NCT01052077|454823014|FG001|Phase B|Lost to Follow-up|2|||
126418084|NCT01052077|454823015|FG002|Phase B|Lost to Follow-up|3|||
126418085|NCT01052077|454823016|FG003|Phase B|Lost to Follow-up|0|||
126418086|NCT01052077|454823013|FG000|Phase B|Adverse Event|0|||
126418087|NCT01052077|454823014|FG001|Phase B|Adverse Event|9|||
126418088|NCT01052077|454823015|FG002|Phase B|Adverse Event|2|||
126418089|NCT01052077|454823016|FG003|Phase B|Adverse Event|0|||
126418090|NCT01052077|454823013|FG000|Phase B|Met Withdrawal Criteria|0|||
126418091|NCT01052077|454823014|FG001|Phase B|Met Withdrawal Criteria|2|||
126418092|NCT01052077|454823015|FG002|Phase B|Met Withdrawal Criteria|1|||
126418093|NCT01052077|454823016|FG003|Phase B|Met Withdrawal Criteria|0|||
126418094|NCT01052077|454823013|FG000|Phase B|Physician Decision|0|||
126418095|NCT01052077|454823014|FG001|Phase B|Physician Decision|1|||
126418096|NCT01052077|454823015|FG002|Phase B|Physician Decision|1|||
126418097|NCT01052077|454823016|FG003|Phase B|Physician Decision|0|||
126418098|NCT01052077|454823013|FG000|Phase B|Withdrawal by Subject|0|||
126418099|NCT01052077|454823014|FG001|Phase B|Withdrawal by Subject|0|||
126418100|NCT01052077|454823015|FG002|Phase B|Withdrawal by Subject|5|||
126418101|NCT01052077|454823016|FG003|Phase B|Withdrawal by Subject|0|||
126418102|NCT01052077|454823013|FG000|Phase B|Protocol Deviation|0|||
126418103|NCT01052077|454823014|FG001|Phase B|Protocol Deviation|3|||
126418104|NCT01052077|454823015|FG002|Phase B|Protocol Deviation|4|||
126418105|NCT01052077|454823016|FG003|Phase B|Protocol Deviation|0|||
126418106|NCT01052077|454823013|FG000|Phase B|Lack of Efficacy|0|||
126418107|NCT01052077|454823014|FG001|Phase B|Lack of Efficacy|1|||
126418108|NCT01052077|454823015|FG002|Phase B|Lack of Efficacy|0|||
126418109|NCT01052077|454823016|FG003|Phase B|Lack of Efficacy|0|||
126418110|NCT01052077|454823013|FG000|Phase A+|Lost to Follow-up|0|||
126418111|NCT01052077|454823014|FG001|Phase A+|Lost to Follow-up|0|||
126418112|NCT01052077|454823015|FG002|Phase A+|Lost to Follow-up|0|||
126418113|NCT01052077|454823016|FG003|Phase A+|Lost to Follow-up|8|||
126418114|NCT01052077|454823013|FG000|Phase A+|Adverse Event|0|||
126418115|NCT01052077|454823014|FG001|Phase A+|Adverse Event|0|||
126418116|NCT01052077|454823015|FG002|Phase A+|Adverse Event|0|||
126418117|NCT01052077|454823016|FG003|Phase A+|Adverse Event|4|||
126418118|NCT01052077|454823013|FG000|Phase A+|Met Withdrawal Criteria|0|||
126418119|NCT01052077|454823014|FG001|Phase A+|Met Withdrawal Criteria|0|||
126418120|NCT01052077|454823015|FG002|Phase A+|Met Withdrawal Criteria|0|||
126418121|NCT01052077|454823016|FG003|Phase A+|Met Withdrawal Criteria|2|||
126418122|NCT01052077|454823013|FG000|Phase A+|Withdrawal by Subject|0|||
126418123|NCT01052077|454823014|FG001|Phase A+|Withdrawal by Subject|0|||
126418124|NCT01052077|454823015|FG002|Phase A+|Withdrawal by Subject|0|||
126418125|NCT01052077|454823016|FG003|Phase A+|Withdrawal by Subject|7|||
126418126|NCT02465203|454823017|FG000|Overall Study|Protocol Violation|1|||
126418127|NCT02465203|454823018|FG001|Overall Study|Protocol Violation|1|||
126418128|NCT02465203|454823019|FG002|Overall Study|Protocol Violation|1|||
126418129|NCT02465203|454823017|FG000|Overall Study|Study terminated by sponsor|50|||
126418130|NCT02465203|454823018|FG001|Overall Study|Study terminated by sponsor|34|||
126418131|NCT02465203|454823019|FG002|Overall Study|Study terminated by sponsor|11|||
126418132|NCT02465203|454823017|FG000|Overall Study|New therapy for study indication|4|||
126418133|NCT02465203|454823018|FG001|Overall Study|New therapy for study indication|0|||
126418134|NCT02465203|454823019|FG002|Overall Study|New therapy for study indication|0|||
126418135|NCT02465203|454823017|FG000|Overall Study|Patient/guardian decision|1|||
126418136|NCT02465203|454823018|FG001|Overall Study|Patient/guardian decision|1|||
126418137|NCT02465203|454823019|FG002|Overall Study|Patient/guardian decision|1|||
126418138|NCT00042991|454823020|FG000|Overall Study|Adverse Event|1|||
126418139|NCT00042991|454823021|FG001|Overall Study|Adverse Event|4|||
126418140|NCT00042991|454823022|FG002|Overall Study|Adverse Event|2|||
126418141|NCT00042991|454823023|FG003|Overall Study|Adverse Event|0|||
126418142|NCT00042991|454823024|FG004|Overall Study|Adverse Event|0|||
126476866|NCT00444912|455046583|FG001|Overall Study|Participant Failed Mobilization|0|||
126476867|NCT02747875|455046584|FG000|Overall Study|Physician Decision|1|||
126418143|NCT00042991|454823025|FG005|Overall Study|Adverse Event|1|||
126418144|NCT00042991|454823026|FG006|Overall Study|Adverse Event|0|||
126418145|NCT00042991|454823020|FG000|Overall Study|Withdrawal by Subject|0|||
126418146|NCT00042991|454823021|FG001|Overall Study|Withdrawal by Subject|7|||
126418147|NCT00042991|454823022|FG002|Overall Study|Withdrawal by Subject|2|||
126418148|NCT00042991|454823023|FG003|Overall Study|Withdrawal by Subject|0|||
126418149|NCT00042991|454823024|FG004|Overall Study|Withdrawal by Subject|1|||
126418150|NCT00042991|454823025|FG005|Overall Study|Withdrawal by Subject|0|||
126418151|NCT00042991|454823026|FG006|Overall Study|Withdrawal by Subject|0|||
126476868|NCT02747875|455046585|FG001|Overall Study|Physician Decision|0|||
126476869|NCT02747875|455046584|FG000|Overall Study|Adverse Event|0|||
126418152|NCT00042991|454823020|FG000|Overall Study|Disease Progression|5|||
126418153|NCT00042991|454823021|FG001|Overall Study|Disease Progression|29|||
126418154|NCT00042991|454823022|FG002|Overall Study|Disease Progression|2|||
126418155|NCT00042991|454823023|FG003|Overall Study|Disease Progression|2|||
126418156|NCT00042991|454823024|FG004|Overall Study|Disease Progression|1|||
126418157|NCT00042991|454823025|FG005|Overall Study|Disease Progression|4|||
126418158|NCT00042991|454823026|FG006|Overall Study|Disease Progression|2|||
126418159|NCT00042991|454823020|FG000|Overall Study|Alternative Therapy|0|||
126418160|NCT00042991|454823021|FG001|Overall Study|Alternative Therapy|0|||
126418161|NCT00042991|454823022|FG002|Overall Study|Alternative Therapy|0|||
126418162|NCT00042991|454823023|FG003|Overall Study|Alternative Therapy|0|||
126418163|NCT00042991|454823024|FG004|Overall Study|Alternative Therapy|1|||
126418164|NCT00042991|454823025|FG005|Overall Study|Alternative Therapy|0|||
126418165|NCT00042991|454823026|FG006|Overall Study|Alternative Therapy|0|||
126418166|NCT03058692|454825125|FG000|Overall Study|Lost to Follow-up|2|||
126418167|NCT03058692|454825126|FG001|Overall Study|Lost to Follow-up|1|||
126418168|NCT03058692|454825125|FG000|Overall Study|Withdrawal by Subject|1|||
126418169|NCT03058692|454825126|FG001|Overall Study|Withdrawal by Subject|1|||
126418170|NCT01392547|454825127|FG000|Overall Study|Adverse Event|2|||
126418171|NCT01392547|454825127|FG000|Overall Study|Non-compliance|2|||
126418172|NCT01392547|454825127|FG000|Overall Study|Withdrawal criteria|3|||
126418173|NCT01392547|454825127|FG000|Overall Study|Unclassified|1|||
126418174|NCT00799266|454825132|FG000|Overall Study|Adverse Event|0|||
126418175|NCT00799266|454825133|FG001|Overall Study|Adverse Event|1|||
126418176|NCT00799266|454825132|FG000|Overall Study|Subject withdrew consent|3|||
126418177|NCT00799266|454825133|FG001|Overall Study|Subject withdrew consent|0|||
126418178|NCT02828436|454825145|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
126418179|NCT02828436|454825146|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
126418180|NCT02828436|454825145|FG000|Period 1|Lost to Follow-up|0|||
126418181|NCT02828436|454825146|FG001|Period 1|Lost to Follow-up|1|||
126418182|NCT02828436|454825145|FG000|Period 2|Withdrawal by Subject|4|||
126418183|NCT02828436|454825146|FG001|Period 2|Withdrawal by Subject|0|||
126418184|NCT02828436|454825145|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
126418185|NCT02828436|454825146|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
126418186|NCT02828436|454825145|FG000|Period 2|Lost to Follow-up|1|||
126418187|NCT02828436|454825146|FG001|Period 2|Lost to Follow-up|0|||
126418188|NCT01136408|454825147|FG000|Overall Study|Adverse Event|4|||
126418189|NCT01136408|454825148|FG001|Overall Study|Adverse Event|8|||
126418190|NCT01136408|454825149|FG002|Overall Study|Adverse Event|4|||
126418191|NCT01136408|454825147|FG000|Overall Study|Protocol Violation|1|||
126418192|NCT01136408|454825148|FG001|Overall Study|Protocol Violation|1|||
126418193|NCT01136408|454825149|FG002|Overall Study|Protocol Violation|1|||
126418194|NCT04421482|454825153|FG000|Overall Study|Physician Decision|1|||
126418195|NCT02128724|454825156|FG000|Overall Study|Death|1|||
126418196|NCT02128724|454825157|FG001|Overall Study|Death|0|||
126418197|NCT02128724|454825158|FG002|Overall Study|Death|0|||
126418198|NCT02128724|454825159|FG003|Overall Study|Death|0|||
126418199|NCT02128724|454825156|FG000|Overall Study|Adverse Event|0|||
126418200|NCT02128724|454825157|FG001|Overall Study|Adverse Event|1|||
126418201|NCT02128724|454825158|FG002|Overall Study|Adverse Event|0|||
126418202|NCT02128724|454825159|FG003|Overall Study|Adverse Event|0|||
126418203|NCT02128724|454825156|FG000|Overall Study|Physician Decision|0|||
126418204|NCT02128724|454825157|FG001|Overall Study|Physician Decision|0|||
126418205|NCT02128724|454825158|FG002|Overall Study|Physician Decision|0|||
126418206|NCT02128724|454825159|FG003|Overall Study|Physician Decision|2|||
126418207|NCT02128724|454825156|FG000|Overall Study|Withdrawal by Subject|0|||
126418208|NCT02128724|454825157|FG001|Overall Study|Withdrawal by Subject|0|||
126418209|NCT02128724|454825158|FG002|Overall Study|Withdrawal by Subject|0|||
126418210|NCT02128724|454825159|FG003|Overall Study|Withdrawal by Subject|1|||
126418211|NCT03329092|454825160|FG000|Overall Study|Other|2|||
126418212|NCT03329092|454825161|FG001|Overall Study|Other|2|||
126418213|NCT03329092|454825160|FG000|Overall Study|Withdrawal by Subject|16|||
126418214|NCT03329092|454825161|FG001|Overall Study|Withdrawal by Subject|3|||
126418215|NCT03329092|454825160|FG000|Overall Study|Physician Decision|1|||
126418216|NCT03329092|454825161|FG001|Overall Study|Physician Decision|0|||
126418217|NCT03329092|454825160|FG000|Overall Study|Death|17|||
126418218|NCT03329092|454825161|FG001|Overall Study|Death|11|||
126418219|NCT03329092|454825160|FG000|Overall Study|Adverse Event|3|||
126418220|NCT03329092|454825161|FG001|Overall Study|Adverse Event|1|||
126418221|NCT03329092|454825160|FG000|Overall Study|Lost to Follow-up|1|||
126418222|NCT03329092|454825161|FG001|Overall Study|Lost to Follow-up|1|||
126418223|NCT05786508|454825162|FG000|Overall Study|Withdrawal by Subject|2|||
126418224|NCT05786508|454825163|FG001|Overall Study|Withdrawal by Subject|0|||
126418225|NCT01456169|454825165|FG000|Overall Study|Adverse Event|1|||
126418226|NCT01456169|454825166|FG001|Overall Study|Adverse Event|2|||
126418227|NCT01456169|454825167|FG002|Overall Study|Adverse Event|7|||
126418228|NCT01456169|454825165|FG000|Overall Study|Major Protocol Deviation|3|||
126418229|NCT01456169|454825166|FG001|Overall Study|Major Protocol Deviation|2|||
126418230|NCT01456169|454825167|FG002|Overall Study|Major Protocol Deviation|3|||
126418231|NCT01456169|454825165|FG000|Overall Study|Voluntary Withdrawal|3|||
126418232|NCT01456169|454825166|FG001|Overall Study|Voluntary Withdrawal|0|||
126418233|NCT01456169|454825167|FG002|Overall Study|Voluntary Withdrawal|2|||
126418234|NCT01456169|454825165|FG000|Overall Study|Lack of Efficacy|2|||
126418235|NCT01456169|454825166|FG001|Overall Study|Lack of Efficacy|0|||
126418236|NCT01456169|454825167|FG002|Overall Study|Lack of Efficacy|0|||
126418237|NCT01456169|454825165|FG000|Overall Study|Other|1|||
126418238|NCT01456169|454825166|FG001|Overall Study|Other|1|||
126418239|NCT01456169|454825167|FG002|Overall Study|Other|0|||
126418240|NCT02652156|454825173|FG000|Overall Study|Physician Decision|1|||
126418241|NCT02652156|454825174|FG001|Overall Study|Physician Decision|0|||
126418242|NCT02652156|454825175|FG002|Overall Study|Physician Decision|0|||
126418243|NCT02342223|454825177|FG000|Overall Study|Lost to Follow-up|1|||
126418244|NCT00496080|454825180|FG000|Overall Study|Lost to Follow-up|9|||
126418245|NCT00496080|454825180|FG000|Overall Study|Surgical re-intervention|7|||
126418246|NCT00496080|454825180|FG000|Overall Study|Withdrawal by Subject|5|||
126418247|NCT00496080|454825180|FG000|Overall Study|Physician Decision|6|||
126418248|NCT01200368|454825185|FG000|Infant Series|Adverse Event|2|||
126418249|NCT01200368|454825186|FG001|Infant Series|Adverse Event|2|||
126418250|NCT01200368|454825187|FG002|Infant Series|Adverse Event|3|||
126418251|NCT01200368|454825185|FG000|Infant Series|Withdrawal by Subject|0|||
126418252|NCT01200368|454825186|FG001|Infant Series|Withdrawal by Subject|2|||
126418253|NCT01200368|454825187|FG002|Infant Series|Withdrawal by Subject|2|||
126418254|NCT01200368|454825185|FG000|Infant Series|Did not meet entrance criteria|0|||
126418255|NCT01200368|454825186|FG001|Infant Series|Did not meet entrance criteria|1|||
126418256|NCT01200368|454825187|FG002|Infant Series|Did not meet entrance criteria|0|||
126418257|NCT01200368|454825185|FG000|Infant Series|Randomized, not vaccinated|0|||
126418258|NCT01200368|454825186|FG001|Infant Series|Randomized, not vaccinated|1|||
126418259|NCT01200368|454825187|FG002|Infant Series|Randomized, not vaccinated|1|||
126418260|NCT01200368|454825185|FG000|Infant Series|Other|1|||
126418261|NCT01200368|454825186|FG001|Infant Series|Other|0|||
126418262|NCT01200368|454825187|FG002|Infant Series|Other|0|||
126418263|NCT01200368|454825185|FG000|After Infant Series|Adverse Event|6|||
126418264|NCT01200368|454825186|FG001|After Infant Series|Adverse Event|6|||
126418265|NCT01200368|454825187|FG002|After Infant Series|Adverse Event|3|||
126418266|NCT01200368|454825185|FG000|After Infant Series|Withdrawal by Subject|10|||
126418267|NCT01200368|454825186|FG001|After Infant Series|Withdrawal by Subject|8|||
126418268|NCT01200368|454825187|FG002|After Infant Series|Withdrawal by Subject|4|||
126418269|NCT01200368|454825185|FG000|After Infant Series|Lost to Follow-up|1|||
126418270|NCT01200368|454825186|FG001|After Infant Series|Lost to Follow-up|0|||
126418271|NCT01200368|454825187|FG002|After Infant Series|Lost to Follow-up|0|||
126418272|NCT01200368|454825185|FG000|After Infant Series|Other|1|||
126418273|NCT01200368|454825186|FG001|After Infant Series|Other|2|||
126418274|NCT01200368|454825187|FG002|After Infant Series|Other|2|||
126418275|NCT01200368|454825185|FG000|Toddler Dose|Adverse Event|0|||
126418276|NCT01200368|454825186|FG001|Toddler Dose|Adverse Event|3|||
126418277|NCT01200368|454825187|FG002|Toddler Dose|Adverse Event|1|||
126418278|NCT00570310|454825188|FG000|Overall Study|Adverse Event|1|||
126418279|NCT00570310|454825189|FG001|Overall Study|Adverse Event|2|||
126418280|NCT00570310|454825188|FG000|Overall Study|Lack of Efficacy|1|||
126418281|NCT00570310|454825189|FG001|Overall Study|Lack of Efficacy|4|||
126418282|NCT00108862|454825190|FG000|Overall Study|Death|31|||
126418283|NCT00108862|454825191|FG001|Overall Study|Death|37|||
126418284|NCT00108862|454825190|FG000|Overall Study|Withdrawal by Subject|10|||
126418285|NCT00108862|454825191|FG001|Overall Study|Withdrawal by Subject|6|||
126418286|NCT00108862|454825190|FG000|Overall Study|Lost to Follow-up|27|||
126418287|NCT00108862|454825191|FG001|Overall Study|Lost to Follow-up|19|||
126418288|NCT00577824|454825194|FG000|Overall Study|Adverse Event|6|||
126418289|NCT00577824|454825195|FG001|Overall Study|Adverse Event|18|||
126418290|NCT00577824|454825196|FG002|Overall Study|Adverse Event|1|||
126418291|NCT00577824|454825194|FG000|Overall Study|Patient decision|0|||
126418292|NCT00577824|454825195|FG001|Overall Study|Patient decision|1|||
126418293|NCT00577824|454825196|FG002|Overall Study|Patient decision|1|||
126418294|NCT00577824|454825194|FG000|Overall Study|Protocol Violation|1|||
126418295|NCT00577824|454825195|FG001|Overall Study|Protocol Violation|1|||
126476870|NCT02747875|455046585|FG001|Overall Study|Adverse Event|1|||
126418296|NCT00577824|454825196|FG002|Overall Study|Protocol Violation|0|||
126418297|NCT04079816|454825197|FG000|Overall Study|Request of Subject|2|||
126418298|NCT04079816|454825197|FG000|Overall Study|Unable to draw samples|1|||
126418299|NCT04137731|454825198|FG000|Overall Study|Surgery Cancellation|1|||
126418300|NCT04137731|454825199|FG001|Overall Study|Surgery Cancellation|2|||
126418301|NCT04137731|454825198|FG000|Overall Study|Withdrawal by Subject|2|||
126418302|NCT04137731|454825199|FG001|Overall Study|Withdrawal by Subject|0|||
126418303|NCT04137731|454825198|FG000|Overall Study|Protocol Violation|0|||
126476871|NCT03478657|455046586|FG000|Overall Study|Withdrawal by Subject|0|||
126418304|NCT04137731|454825199|FG001|Overall Study|Protocol Violation|1|||
126418305|NCT00362648|454825200|FG000|Overall Study|Adverse Event|12|||
126418306|NCT00362648|454825201|FG001|Overall Study|Adverse Event|21|||
126418307|NCT00362648|454825202|FG002|Overall Study|Adverse Event|1|||
126418308|NCT00362648|454825203|FG003|Overall Study|Adverse Event|0|||
126476872|NCT03478657|455046587|FG001|Overall Study|Withdrawal by Subject|1|||
126418309|NCT00362648|454825200|FG000|Overall Study|Lost to Follow-up|62|||
126418310|NCT00362648|454825201|FG001|Overall Study|Lost to Follow-up|69|||
126418311|NCT00362648|454825202|FG002|Overall Study|Lost to Follow-up|4|||
126418312|NCT00362648|454825203|FG003|Overall Study|Lost to Follow-up|3|||
126418313|NCT00362648|454825200|FG000|Overall Study|Protocol Violation|4|||
126418314|NCT00362648|454825201|FG001|Overall Study|Protocol Violation|2|||
126418315|NCT00362648|454825202|FG002|Overall Study|Protocol Violation|2|||
126418316|NCT00362648|454825203|FG003|Overall Study|Protocol Violation|2|||
126418317|NCT00362648|454825200|FG000|Overall Study|Withdrawal by Subject|48|||
126418318|NCT00362648|454825201|FG001|Overall Study|Withdrawal by Subject|42|||
126418319|NCT00362648|454825202|FG002|Overall Study|Withdrawal by Subject|2|||
126418320|NCT00362648|454825203|FG003|Overall Study|Withdrawal by Subject|6|||
126418321|NCT03983304|454825204|FG000|Overall Study|Withdrawal by Subject|5|||
126418322|NCT03983304|454825204|FG000|Overall Study|Lost to Follow-up|2|||
126418323|NCT00310817|454825205|FG000|Overall Study|AE or Death|3|||
126418324|NCT00310817|454825206|FG001|Overall Study|AE or Death|1|||
126418325|NCT00310817|454825207|FG002|Overall Study|AE or Death|0|||
126418326|NCT00310817|454825208|FG003|Overall Study|AE or Death|0|||
126418327|NCT00310817|454825205|FG000|Overall Study|Withdrawal by Subject|1|||
126418328|NCT00310817|454825206|FG001|Overall Study|Withdrawal by Subject|4|||
126418329|NCT00310817|454825207|FG002|Overall Study|Withdrawal by Subject|6|||
126418330|NCT00310817|454825208|FG003|Overall Study|Withdrawal by Subject|7|||
126418331|NCT00310817|454825205|FG000|Overall Study|Lost to Follow-up|2|||
126418332|NCT00310817|454825206|FG001|Overall Study|Lost to Follow-up|1|||
126418333|NCT00310817|454825207|FG002|Overall Study|Lost to Follow-up|0|||
126418334|NCT00310817|454825208|FG003|Overall Study|Lost to Follow-up|0|||
126418335|NCT00310817|454825205|FG000|Overall Study|Inappropriate Enrollment|1|||
126418336|NCT00310817|454825206|FG001|Overall Study|Inappropriate Enrollment|0|||
126418337|NCT00310817|454825207|FG002|Overall Study|Inappropriate Enrollment|1|||
126418338|NCT00310817|454825208|FG003|Overall Study|Inappropriate Enrollment|0|||
126418339|NCT00310817|454825205|FG000|Overall Study|Protocol Violation|1|||
126418340|NCT00310817|454825206|FG001|Overall Study|Protocol Violation|1|||
126418341|NCT00310817|454825207|FG002|Overall Study|Protocol Violation|1|||
126418342|NCT00310817|454825208|FG003|Overall Study|Protocol Violation|1|||
126418343|NCT00310817|454825205|FG000|Overall Study|Unable to classify|3|||
126418344|NCT00310817|454825206|FG001|Overall Study|Unable to classify|1|||
126418345|NCT00310817|454825207|FG002|Overall Study|Unable to classify|0|||
126418346|NCT00310817|454825208|FG003|Overall Study|Unable to classify|0|||
126418347|NCT01702246|454825209|FG000|Overall Study|Lost to Follow-up|2|||
126418348|NCT01702246|454825209|FG000|Overall Study|Withdrawal by Subject|2|||
126418349|NCT01702246|454825209|FG000|Overall Study|Physician Decision|1|||
126418350|NCT01587040|454825210|FG000|Overall Study|Protocol Violation|0|||
126418351|NCT01587040|454825211|FG001|Overall Study|Protocol Violation|0|||
126418352|NCT01587040|454825212|FG002|Overall Study|Protocol Violation|1|||
126418353|NCT01587040|454825213|FG003|Overall Study|Protocol Violation|0|||
126418354|NCT01587040|454825210|FG000|Overall Study|Adverse Event|0|||
126418355|NCT01587040|454825211|FG001|Overall Study|Adverse Event|1|||
126418356|NCT01587040|454825212|FG002|Overall Study|Adverse Event|10|||
126418357|NCT01587040|454825213|FG003|Overall Study|Adverse Event|0|||
126418358|NCT01587040|454825210|FG000|Overall Study|Disease progression|12|||
126418359|NCT01587040|454825211|FG001|Overall Study|Disease progression|1|||
126418360|NCT01587040|454825212|FG002|Overall Study|Disease progression|15|||
126418361|NCT01587040|454825213|FG003|Overall Study|Disease progression|3|||
126418362|NCT01587040|454825210|FG000|Overall Study|Other than specified|5|||
126418363|NCT01587040|454825211|FG001|Overall Study|Other than specified|1|||
126418364|NCT01587040|454825212|FG002|Overall Study|Other than specified|11|||
126418365|NCT01587040|454825213|FG003|Overall Study|Other than specified|1|||
126418366|NCT01518374|454825216|FG000|Overall Study|Withdrawal by Subject|2|||
126418367|NCT01518374|454825216|FG000|Overall Study|Protocol Violation|3|||
126418368|NCT01518374|454825216|FG000|Overall Study|Lost to Follow-up|2|||
126418369|NCT04300309|454825217|FG000|Overall Study|Lost to Follow-up|1|||
126418370|NCT04300309|454825218|FG001|Overall Study|Lost to Follow-up|0|||
126418371|NCT03724890|454825221|FG000|Overall Study|Death|2|||
126418372|NCT03724890|454825222|FG001|Overall Study|Death|6|||
126418373|NCT03724890|454825223|FG002|Overall Study|Death|3|||
126418374|NCT03724890|454825224|FG003|Overall Study|Death|5|||
126418375|NCT03724890|454825225|FG004|Overall Study|Death|2|||
126418376|NCT03724890|454825226|FG005|Overall Study|Death|0|||
126418377|NCT03724890|454825227|FG006|Overall Study|Death|2|||
126418378|NCT03724890|454825228|FG007|Overall Study|Death|3|||
126418379|NCT03724890|454825229|FG008|Overall Study|Death|4|||
126418380|NCT03724890|454825230|FG009|Overall Study|Death|2|||
126418381|NCT03724890|454825231|FG010|Overall Study|Death|2|||
126418382|NCT03724890|454825221|FG000|Overall Study|Lost to Follow-up|0|||
126418383|NCT03724890|454825222|FG001|Overall Study|Lost to Follow-up|3|||
126418384|NCT03724890|454825223|FG002|Overall Study|Lost to Follow-up|0|||
126476873|NCT02590003|455046588|FG000|Overall Study|Death|1|||
126476874|NCT02590003|455046589|FG001|Overall Study|Death|2|||
126418385|NCT03724890|454825224|FG003|Overall Study|Lost to Follow-up|1|||
126418386|NCT03724890|454825225|FG004|Overall Study|Lost to Follow-up|2|||
126418387|NCT03724890|454825226|FG005|Overall Study|Lost to Follow-up|2|||
126418388|NCT03724890|454825227|FG006|Overall Study|Lost to Follow-up|1|||
126418389|NCT03724890|454825228|FG007|Overall Study|Lost to Follow-up|0|||
126418390|NCT03724890|454825229|FG008|Overall Study|Lost to Follow-up|2|||
126418391|NCT03724890|454825230|FG009|Overall Study|Lost to Follow-up|0|||
126418392|NCT03724890|454825231|FG010|Overall Study|Lost to Follow-up|0|||
126418393|NCT03724890|454825221|FG000|Overall Study|Withdrawal by Subject|1|||
126418394|NCT03724890|454825222|FG001|Overall Study|Withdrawal by Subject|2|||
126418395|NCT03724890|454825223|FG002|Overall Study|Withdrawal by Subject|1|||
126476875|NCT03330288|455046597|FG000|Overall Study|Other reason|1|||
126476876|NCT03330288|455046598|FG001|Overall Study|Other reason|1|||
126476877|NCT03330288|455046597|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
126476878|NCT03330288|455046598|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
126476879|NCT03330288|455046597|FG000|Overall Study|Adverse Event|1|||
126476880|NCT03330288|455046598|FG001|Overall Study|Adverse Event|0|||
126476881|NCT03330288|455046597|FG000|Overall Study|Withdrawal by Subject|1|||
126476882|NCT03330288|455046598|FG001|Overall Study|Withdrawal by Subject|0|||
126476883|NCT03330288|455046597|FG000|Overall Study|Lost to Follow-up|26|||
126476884|NCT03330288|455046598|FG001|Overall Study|Lost to Follow-up|7|||
126476885|NCT01719783|455046604|FG000|Dose 2|Physician Decision|1|||
126559030|NCT04537949|455340623|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
126559031|NCT04537949|455340624|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
126559032|NCT04537949|455340625|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
126559033|NCT04537949|455340626|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
126418396|NCT03724890|454825224|FG003|Overall Study|Withdrawal by Subject|0|||
126418397|NCT03724890|454825225|FG004|Overall Study|Withdrawal by Subject|0|||
126418398|NCT03724890|454825226|FG005|Overall Study|Withdrawal by Subject|1|||
126418399|NCT03724890|454825227|FG006|Overall Study|Withdrawal by Subject|0|||
126418400|NCT03724890|454825228|FG007|Overall Study|Withdrawal by Subject|0|||
126418401|NCT03724890|454825229|FG008|Overall Study|Withdrawal by Subject|2|||
126418402|NCT03724890|454825230|FG009|Overall Study|Withdrawal by Subject|2|||
126418403|NCT03724890|454825231|FG010|Overall Study|Withdrawal by Subject|1|||
126418404|NCT03724890|454825221|FG000|Overall Study|Other|1|||
126418405|NCT03724890|454825222|FG001|Overall Study|Other|0|||
126418406|NCT03724890|454825223|FG002|Overall Study|Other|0|||
126418407|NCT03724890|454825224|FG003|Overall Study|Other|0|||
126418408|NCT03724890|454825225|FG004|Overall Study|Other|0|||
126418409|NCT03724890|454825226|FG005|Overall Study|Other|0|||
126418410|NCT03724890|454825227|FG006|Overall Study|Other|0|||
126418411|NCT03724890|454825228|FG007|Overall Study|Other|1|||
126418412|NCT03724890|454825229|FG008|Overall Study|Other|1|||
126418413|NCT03724890|454825230|FG009|Overall Study|Other|0|||
126418414|NCT03724890|454825231|FG010|Overall Study|Other|2|||
126418415|NCT04607837|454825234|FG000|Overall Study|Adverse Event|8|||
126418416|NCT04607837|454825235|FG001|Overall Study|Adverse Event|2|||
126418417|NCT04607837|454825234|FG000|Overall Study|Withdrawal by Subject|8|||
126418418|NCT04607837|454825235|FG001|Overall Study|Withdrawal by Subject|7|||
126418419|NCT04607837|454825234|FG000|Overall Study|Physician Decision|2|||
126418420|NCT04607837|454825235|FG001|Overall Study|Physician Decision|0|||
126418421|NCT04607837|454825234|FG000|Overall Study|Lack of Efficacy|2|||
126418422|NCT04607837|454825235|FG001|Overall Study|Lack of Efficacy|0|||
126418423|NCT04607837|454825234|FG000|Overall Study|Participant terminated by sponsor|1|||
126418424|NCT04607837|454825235|FG001|Overall Study|Participant terminated by sponsor|0|||
126418425|NCT04607837|454825234|FG000|Overall Study|Disease worsening|36|||
126418426|NCT04607837|454825235|FG001|Overall Study|Disease worsening|36|||
126418427|NCT04607837|454825234|FG000|Overall Study|Other|1|||
126418428|NCT04607837|454825235|FG001|Overall Study|Other|0|||
126418429|NCT02362464|454825236|FG000|Overall Study|Switched to alternative therapy|1|||
126418430|NCT02362464|454825236|FG000|Overall Study|Refused further treatment|1|||
126418431|NCT02362464|454825236|FG000|Overall Study|Physician Decision|4|||
126418432|NCT02123823|454825238|FG000|Overall Study|Lack of Efficacy|0|||
126418433|NCT02123823|454825239|FG001|Overall Study|Lack of Efficacy|2|||
126418434|NCT02123823|454825240|FG002|Overall Study|Lack of Efficacy|8|||
126559034|NCT04537949|455340627|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
126559035|NCT04537949|455340620|FG000|Follow-up Phase|Lost to Follow-up|0|||
126559036|NCT04537949|455340621|FG001|Follow-up Phase|Lost to Follow-up|3|||
126559037|NCT04537949|455340622|FG002|Follow-up Phase|Lost to Follow-up|0|||
126559038|NCT04537949|455340623|FG003|Follow-up Phase|Lost to Follow-up|0|||
126418435|NCT02123823|454825241|FG003|Overall Study|Lack of Efficacy|10|||
126559039|NCT04537949|455340624|FG004|Follow-up Phase|Lost to Follow-up|0|||
126418436|NCT02123823|454825238|FG000|Overall Study|Progressive disease|3|||
126418437|NCT02123823|454825239|FG001|Overall Study|Progressive disease|19|||
126418438|NCT02123823|454825240|FG002|Overall Study|Progressive disease|52|||
126476886|NCT01719783|455046605|FG001|Dose 2|Physician Decision|0|||
126559040|NCT04537949|455340625|FG005|Follow-up Phase|Lost to Follow-up|0|||
126559041|NCT04537949|455340626|FG006|Follow-up Phase|Lost to Follow-up|0|||
126418439|NCT02123823|454825241|FG003|Overall Study|Progressive disease|53|||
126418440|NCT02123823|454825238|FG000|Overall Study|Withdrawal by Subject|0|||
126418441|NCT02123823|454825239|FG001|Overall Study|Withdrawal by Subject|0|||
126418442|NCT02123823|454825240|FG002|Overall Study|Withdrawal by Subject|7|||
126418443|NCT02123823|454825241|FG003|Overall Study|Withdrawal by Subject|2|||
126418444|NCT02123823|454825238|FG000|Overall Study|Adverse Event|0|||
126418445|NCT02123823|454825239|FG001|Overall Study|Adverse Event|0|||
126418446|NCT02123823|454825240|FG002|Overall Study|Adverse Event|3|||
126418447|NCT02123823|454825241|FG003|Overall Study|Adverse Event|5|||
126418448|NCT04346654|454825243|FG000|Overall Study|Adverse Event|2|||
126418449|NCT04346654|454825244|FG001|Overall Study|Adverse Event|0|||
126418450|NCT04346654|454825243|FG000|Overall Study|Non-response|1|||
126418451|NCT04346654|454825244|FG001|Overall Study|Non-response|1|||
126418452|NCT04346654|454825243|FG000|Overall Study|Withdrawal by Subject|2|||
126418453|NCT04346654|454825244|FG001|Overall Study|Withdrawal by Subject|0|||
126418454|NCT04346654|454825243|FG000|Overall Study|Lost to Follow-up|0|||
126418455|NCT04346654|454825244|FG001|Overall Study|Lost to Follow-up|1|||
126418456|NCT04346654|454825243|FG000|Overall Study|Pregnancy|0|||
126418457|NCT04346654|454825244|FG001|Overall Study|Pregnancy|1|||
126418458|NCT05715242|454825245|FG000|Overall Study|Lost to Follow-up|0|||
126418459|NCT05715242|454825246|FG001|Overall Study|Lost to Follow-up|0|||
126418460|NCT05715242|454825247|FG002|Overall Study|Lost to Follow-up|1|||
126418461|NCT05715242|454825248|FG003|Overall Study|Lost to Follow-up|0|||
126418462|NCT05715242|454825249|FG004|Overall Study|Lost to Follow-up|0|||
126418463|NCT05715242|454825250|FG005|Overall Study|Lost to Follow-up|1|||
126418464|NCT05715242|454825251|FG006|Overall Study|Lost to Follow-up|0|||
126418465|NCT05715242|454825252|FG007|Overall Study|Lost to Follow-up|0|||
126418466|NCT05715242|454825253|FG008|Overall Study|Lost to Follow-up|0|||
126418467|NCT05715242|454825254|FG009|Overall Study|Lost to Follow-up|0|||
126418468|NCT05715242|454825255|FG010|Overall Study|Lost to Follow-up|0|||
126418469|NCT05715242|454825256|FG011|Overall Study|Lost to Follow-up|0|||
126418470|NCT05715242|454825257|FG012|Overall Study|Lost to Follow-up|0|||
126418471|NCT05715242|454825258|FG013|Overall Study|Lost to Follow-up|0|||
126418472|NCT05715242|454825259|FG014|Overall Study|Lost to Follow-up|0|||
126418473|NCT05715242|454825260|FG015|Overall Study|Lost to Follow-up|0|||
126418474|NCT02915978|454825261|FG000|Overall Study|Adverse Event|2|||
126418475|NCT02915978|454825262|FG001|Overall Study|Adverse Event|1|||
126418476|NCT02915978|454825263|FG002|Overall Study|Adverse Event|0|||
126418477|NCT02343406|454825269|FG000|Overall Study|Progressive disease|72|||
126418478|NCT02343406|454825270|FG001|Overall Study|Progressive disease|70|||
126418479|NCT02343406|454825271|FG002|Overall Study|Progressive disease|43|||
126418480|NCT02343406|454825272|FG003|Overall Study|Progressive disease|15|||
126418481|NCT02343406|454825273|FG004|Overall Study|Progressive disease|5|||
126418482|NCT02343406|454825269|FG000|Overall Study|Adverse Event|6|||
126418483|NCT02343406|454825270|FG001|Overall Study|Adverse Event|8|||
126418484|NCT02343406|454825271|FG002|Overall Study|Adverse Event|6|||
126418485|NCT02343406|454825272|FG003|Overall Study|Adverse Event|3|||
126476887|NCT01254331|455046607|FG000|Initial Phase|Adverse Event|3|||
126476888|NCT01254331|455046607|FG000|Initial Phase|Withdrawal by Subject|1|||
126476889|NCT01254331|455046607|FG000|Initial Phase|Pregnancy|1|||
126476890|NCT01254331|455046607|FG000|Extension Phase|Lack of Efficacy|1|||
126476891|NCT01254331|455046607|FG000|Extension Phase|Lost to Follow-up|3|||
126476892|NCT01443078|455046608|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
126476893|NCT01443078|455046608|FG000|Overall Study|Withdrawal by Subject|1|||
126476894|NCT01443078|455046608|FG000|Overall Study|Patient had brain mets|1|||
126476895|NCT01612858|455046609|FG000|Overall Study|Withdrawal by Subject|5|||
126476896|NCT01612858|455046610|FG001|Overall Study|Withdrawal by Subject|1|||
126476897|NCT03988088|455046617|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
126476898|NCT03988088|455046618|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
126476899|NCT03988088|455046619|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
126476900|NCT03988088|455046620|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
126476901|NCT03988088|455046617|FG000|Open-Label Addendum|Lost to Follow-up|0|||
126476902|NCT03988088|455046618|FG001|Open-Label Addendum|Lost to Follow-up|0|||
126476903|NCT03988088|455046619|FG002|Open-Label Addendum|Lost to Follow-up|1|||
126476904|NCT03988088|455046620|FG003|Open-Label Addendum|Lost to Follow-up|0|||
126476905|NCT02993757|455046624|FG000|Overall Study|Non compliance with the protocol|155|||
126476906|NCT02993757|455046625|FG001|Overall Study|Non compliance with the protocol|170|||
126476907|NCT02993757|455046624|FG000|Overall Study|Lost to Follow-up|1|||
126476908|NCT02993757|455046625|FG001|Overall Study|Lost to Follow-up|0|||
126476909|NCT02993757|455046624|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
126476910|NCT02993757|455046625|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
126418486|NCT02343406|454825273|FG004|Overall Study|Adverse Event|0|||
126476911|NCT02762578|455046628|FG000|Overall Study|Adverse Event|1|||
126418487|NCT02343406|454825269|FG000|Overall Study|Withdrawal by Subject|6|||
126418488|NCT02343406|454825270|FG001|Overall Study|Withdrawal by Subject|4|||
126418489|NCT02343406|454825271|FG002|Overall Study|Withdrawal by Subject|8|||
126418490|NCT02343406|454825272|FG003|Overall Study|Withdrawal by Subject|3|||
126418491|NCT02343406|454825273|FG004|Overall Study|Withdrawal by Subject|0|||
126418492|NCT02343406|454825269|FG000|Overall Study|Death|2|||
126418493|NCT02343406|454825270|FG001|Overall Study|Death|1|||
126418494|NCT02343406|454825271|FG002|Overall Study|Death|0|||
126418495|NCT02343406|454825272|FG003|Overall Study|Death|0|||
126418496|NCT02343406|454825273|FG004|Overall Study|Death|0|||
126418497|NCT02343406|454825269|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
126418498|NCT02343406|454825270|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
126418499|NCT02343406|454825271|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
126418500|NCT02343406|454825272|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
126418501|NCT02343406|454825273|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
126418502|NCT02343406|454825269|FG000|Overall Study|Other primary malignancy|0|||
126418503|NCT02343406|454825270|FG001|Overall Study|Other primary malignancy|1|||
126418504|NCT02343406|454825271|FG002|Overall Study|Other primary malignancy|0|||
126418505|NCT02343406|454825272|FG003|Overall Study|Other primary malignancy|0|||
126418506|NCT02343406|454825273|FG004|Overall Study|Other primary malignancy|0|||
126418507|NCT02343406|454825269|FG000|Overall Study|Other, not specified|2|||
126418508|NCT02343406|454825270|FG001|Overall Study|Other, not specified|1|||
126418509|NCT02343406|454825271|FG002|Overall Study|Other, not specified|1|||
126418510|NCT02343406|454825272|FG003|Overall Study|Other, not specified|4|||
126418511|NCT02343406|454825273|FG004|Overall Study|Other, not specified|0|||
126418512|NCT02451124|454825274|FG000|Overall Study|Withdrawal by Subject|1|||
126418513|NCT00766051|454825275|FG000|Overall Study|Withdrawal by Subject|2|||
126418514|NCT00766051|454825276|FG001|Overall Study|Withdrawal by Subject|0|||
126418515|NCT00856297|454825282|FG000|Overall Study|Unable to classify|2|||
126418516|NCT00856297|454825283|FG001|Overall Study|Unable to classify|0|||
126418517|NCT00856297|454825284|FG002|Overall Study|Unable to classify|0|||
126418518|NCT00856297|454825285|FG003|Overall Study|Unable to classify|0|||
126418519|NCT00856297|454825286|FG004|Overall Study|Unable to classify|0|||
126418520|NCT01362608|454826660|FG000|Overall Study|Protocol Violation|0|||
126418521|NCT01362608|454826661|FG001|Overall Study|Protocol Violation|1|||
126418522|NCT01362608|454826660|FG000|Overall Study|Lost to Follow-up|3|||
126418523|NCT01362608|454826661|FG001|Overall Study|Lost to Follow-up|1|||
126418524|NCT01362608|454826660|FG000|Overall Study|Withdrawal by Subject|1|||
126418525|NCT01362608|454826661|FG001|Overall Study|Withdrawal by Subject|2|||
126418526|NCT01362608|454826660|FG000|Overall Study|Lack of Efficacy|0|||
126418527|NCT01362608|454826661|FG001|Overall Study|Lack of Efficacy|2|||
126418528|NCT01362608|454826660|FG000|Overall Study|Adverse Event|0|||
126418529|NCT01362608|454826661|FG001|Overall Study|Adverse Event|2|||
126418530|NCT04506502|454826664|FG000|Overall Study|Withdrawal by Subject|1|||
126418531|NCT04506502|454826664|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
126418532|NCT03526146|454826665|FG000|Overall Study|Lost to Follow-up|5|||
126418533|NCT03526146|454826665|FG000|Overall Study|Withdrawal by Subject|6|||
126418534|NCT03526146|454826665|FG000|Overall Study|class canceled due to COVID-19|4|||
126418535|NCT02517541|454826668|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
126418536|NCT02517541|454826668|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
126418537|NCT02517541|454826668|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
126418538|NCT02517541|454826668|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
126418539|NCT02517541|454826668|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
126418540|NCT02517541|454826668|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
126418541|NCT00699608|454826669|FG000|First Intervention|Withdrawal by Subject|0|||
126418542|NCT00699608|454826670|FG001|First Intervention|Withdrawal by Subject|0|||
126418543|NCT00699608|454826671|FG002|First Intervention|Withdrawal by Subject|1|||
126418544|NCT00699608|454826672|FG003|First Intervention|Withdrawal by Subject|0|||
126418545|NCT00699608|454826673|FG004|First Intervention|Withdrawal by Subject|0|||
126418546|NCT00699608|454826674|FG005|First Intervention|Withdrawal by Subject|0|||
126418547|NCT00699608|454826669|FG000|First Intervention|Protocol Violation|0|||
126418548|NCT00699608|454826670|FG001|First Intervention|Protocol Violation|0|||
126418549|NCT00699608|454826671|FG002|First Intervention|Protocol Violation|0|||
126418550|NCT00699608|454826672|FG003|First Intervention|Protocol Violation|0|||
126418551|NCT00699608|454826673|FG004|First Intervention|Protocol Violation|1|||
126418552|NCT00699608|454826674|FG005|First Intervention|Protocol Violation|0|||
126418553|NCT00699608|454826669|FG000|Second Intervention|Adverse Event|0|||
126418554|NCT00699608|454826670|FG001|Second Intervention|Adverse Event|0|||
126418555|NCT00699608|454826671|FG002|Second Intervention|Adverse Event|1|||
126418556|NCT00699608|454826672|FG003|Second Intervention|Adverse Event|0|||
126418557|NCT00699608|454826673|FG004|Second Intervention|Adverse Event|0|||
126418558|NCT00699608|454826674|FG005|Second Intervention|Adverse Event|0|||
126418559|NCT00699608|454826669|FG000|Second Intervention|Withdrawal by Subject|0|||
126418560|NCT00699608|454826670|FG001|Second Intervention|Withdrawal by Subject|0|||
126418561|NCT00699608|454826671|FG002|Second Intervention|Withdrawal by Subject|0|||
126418562|NCT00699608|454826672|FG003|Second Intervention|Withdrawal by Subject|1|||
126418563|NCT00699608|454826673|FG004|Second Intervention|Withdrawal by Subject|0|||
126418564|NCT00699608|454826674|FG005|Second Intervention|Withdrawal by Subject|0|||
126418565|NCT01510158|454826675|FG000|Overall Study|Adverse Event|7|||
126418566|NCT01510158|454826676|FG001|Overall Study|Adverse Event|8|||
126418567|NCT01510158|454826677|FG002|Overall Study|Adverse Event|5|||
126418568|NCT01510158|454826675|FG000|Overall Study|Gout flare|1|||
126418569|NCT01510158|454826676|FG001|Overall Study|Gout flare|0|||
126418570|NCT01510158|454826677|FG002|Overall Study|Gout flare|0|||
126418571|NCT01510158|454826675|FG000|Overall Study|Protocol Violation|17|||
126418572|NCT01510158|454826676|FG001|Overall Study|Protocol Violation|16|||
126418573|NCT01510158|454826677|FG002|Overall Study|Protocol Violation|24|||
126418574|NCT01510158|454826675|FG000|Overall Study|Sponsor terminated study.|2|||
126418575|NCT01510158|454826676|FG001|Overall Study|Sponsor terminated study.|0|||
126418576|NCT01510158|454826677|FG002|Overall Study|Sponsor terminated study.|2|||
126418577|NCT01510158|454826675|FG000|Overall Study|Lost to Follow-up|13|||
126418578|NCT01510158|454826676|FG001|Overall Study|Lost to Follow-up|16|||
126418579|NCT01510158|454826677|FG002|Overall Study|Lost to Follow-up|9|||
126418580|NCT01510158|454826675|FG000|Overall Study|Withdrawal by Subject|10|||
126418581|NCT01510158|454826676|FG001|Overall Study|Withdrawal by Subject|13|||
126418582|NCT01510158|454826677|FG002|Overall Study|Withdrawal by Subject|10|||
126418583|NCT01510158|454826675|FG000|Overall Study|Death|1|||
126418584|NCT01510158|454826676|FG001|Overall Study|Death|0|||
126418585|NCT01510158|454826677|FG002|Overall Study|Death|0|||
126418586|NCT03010319|454826680|FG000|Overall Study|Adverse Event|15|||
126418587|NCT03010319|454826681|FG001|Overall Study|Adverse Event|9|||
126418588|NCT03010319|454826680|FG000|Overall Study|Withdrawal by Subject|1|||
126418589|NCT03010319|454826681|FG001|Overall Study|Withdrawal by Subject|6|||
126418590|NCT03010319|454826680|FG000|Overall Study|Physician Decision|2|||
126418591|NCT03010319|454826681|FG001|Overall Study|Physician Decision|4|||
126418592|NCT03010319|454826680|FG000|Overall Study|Sponsor requested withdrawal|2|||
126418593|NCT03010319|454826681|FG001|Overall Study|Sponsor requested withdrawal|2|||
126418594|NCT03010319|454826680|FG000|Overall Study|Death|1|||
126418595|NCT03010319|454826681|FG001|Overall Study|Death|0|||
126418596|NCT03010319|454826680|FG000|Overall Study|Lost to Follow-up|0|||
126418597|NCT03010319|454826681|FG001|Overall Study|Lost to Follow-up|1|||
126418598|NCT03010319|454826680|FG000|Overall Study|Other Reason|5|||
126418599|NCT03010319|454826681|FG001|Overall Study|Other Reason|7|||
126418600|NCT04720417|454826682|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
126418601|NCT03574779|454826683|FG000|Overall Study|Screening failure|13|||
126418602|NCT03574779|454826684|FG001|Overall Study|Screening failure|83|||
126418603|NCT02588261|454826687|FG000|Overall Study|Study Terminated by Sponsor|157|||
126418604|NCT02588261|454826688|FG001|Overall Study|Study Terminated by Sponsor|142|||
126418605|NCT02588261|454826687|FG000|Overall Study|Protocol Deviation|1|||
126418606|NCT02588261|454826688|FG001|Overall Study|Protocol Deviation|0|||
126418607|NCT02588261|454826687|FG000|Overall Study|Death|1|||
126418608|NCT02588261|454826688|FG001|Overall Study|Death|2|||
126418609|NCT02588261|454826687|FG000|Overall Study|Withdrawal by Subject|12|||
126418610|NCT02588261|454826688|FG001|Overall Study|Withdrawal by Subject|8|||
126418611|NCT02588261|454826687|FG000|Overall Study|Noncompliance with Study Drug|0|||
126418612|NCT02588261|454826688|FG001|Overall Study|Noncompliance with Study Drug|1|||
126418613|NCT02588261|454826687|FG000|Overall Study|Miscellaneous|5|||
126418614|NCT02588261|454826688|FG001|Overall Study|Miscellaneous|4|||
126418615|NCT02588261|454826687|FG000|Overall Study|Progressive Disease|61|||
126418616|NCT02588261|454826688|FG001|Overall Study|Progressive Disease|82|||
126418617|NCT02588261|454826687|FG000|Overall Study|Adverse Event|29|||
126418618|NCT02588261|454826688|FG001|Overall Study|Adverse Event|24|||
126418619|NCT02588261|454826687|FG000|Overall Study|Lost to Follow-up|1|||
126418620|NCT02588261|454826688|FG001|Overall Study|Lost to Follow-up|0|||
126418621|NCT03781778|454826689|FG000|Overall Study|Withdrawal by Subject|2|||
126418622|NCT03781778|454826690|FG001|Overall Study|Withdrawal by Subject|2|||
126418623|NCT02287467|454826691|FG000|Overall Study|Protocol Violation|12|||
126418624|NCT02287467|454826692|FG001|Overall Study|Protocol Violation|9|||
126418625|NCT03472950|454826695|FG000|Overall Study|Lost to Follow-up|0|||
126418626|NCT03472950|454826696|FG001|Overall Study|Lost to Follow-up|1|||
126418627|NCT03472950|454826695|FG000|Overall Study|Adverse Event|0|||
126418628|NCT03472950|454826696|FG001|Overall Study|Adverse Event|3|||
126418629|NCT00517361|454826701|FG000|Overall Study|Death|6|||
126418630|NCT00517361|454826701|FG000|Overall Study|The study was terminated|5|||
126418631|NCT00195091|454826702|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
126418632|NCT00245037|454826708|FG000|Overall Study|Death|17|||
126418633|NCT06964165|454826713|FG000|Overall Study|Withdrawal by Subject|0|||
126418634|NCT06964165|454826714|FG001|Overall Study|Withdrawal by Subject|1|||
126418635|NCT06964165|454826713|FG000|Overall Study|Ongoing at the time of analysis|15|||
126418636|NCT06964165|454826714|FG001|Overall Study|Ongoing at the time of analysis|14|||
126418637|NCT06964165|454826713|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
126418638|NCT06964165|454826714|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
126418639|NCT06964165|454826713|FG000|Overall Study|Participant removed due to non-compliance|0|||
126418640|NCT06964165|454826714|FG001|Overall Study|Participant removed due to non-compliance|1|||
126418641|NCT01514201|454826728|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
126418642|NCT01514201|454826729|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
126476912|NCT02762578|455046629|FG001|Overall Study|Adverse Event|6|||
126476913|NCT02762578|455046628|FG000|Overall Study|Protocol Violation|4|||
126476914|NCT02762578|455046629|FG001|Overall Study|Protocol Violation|2|||
126721782|NCT05122650|455931293|FG003|Overall Study|Protocol Violation|1|||
126418643|NCT01514201|454826730|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
126418644|NCT01514201|454826731|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
126418645|NCT01514201|454826728|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
126418646|NCT01514201|454826729|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
126418647|NCT01514201|454826730|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
126418648|NCT01514201|454826731|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
126418649|NCT01514201|454826728|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
126418650|NCT01514201|454826729|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
126418651|NCT01514201|454826730|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
126418652|NCT01514201|454826731|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
126418653|NCT01514201|454826728|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
126418654|NCT01514201|454826729|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
126418655|NCT01514201|454826730|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
126418656|NCT01514201|454826731|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
126418657|NCT01514201|454826728|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
126418658|NCT01514201|454826729|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
126418659|NCT01514201|454826730|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
126418660|NCT01514201|454826731|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
126418661|NCT01514201|454826728|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
126418662|NCT01514201|454826729|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
126418663|NCT01514201|454826730|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
126418664|NCT01514201|454826731|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
126418665|NCT01514201|454826728|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
126418666|NCT01514201|454826729|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
126476915|NCT02762578|455046628|FG000|Overall Study|Withdrawal by Subject|4|||
126476916|NCT02762578|455046629|FG001|Overall Study|Withdrawal by Subject|2|||
126721783|NCT05122650|455931290|FG000|Overall Study|Randomized by mistake|0|||
126721784|NCT05122650|455931291|FG001|Overall Study|Randomized by mistake|0|||
126721785|NCT05122650|455931292|FG002|Overall Study|Randomized by mistake|3|||
126721786|NCT05122650|455931293|FG003|Overall Study|Randomized by mistake|2|||
126721787|NCT05122650|455931290|FG000|Overall Study|Sponsor request|0|||
126721788|NCT05122650|455931291|FG001|Overall Study|Sponsor request|1|||
126721789|NCT05122650|455931292|FG002|Overall Study|Sponsor request|1|||
126721790|NCT05122650|455931293|FG003|Overall Study|Sponsor request|2|||
126721791|NCT05122650|455931290|FG000|Overall Study|Withdrawal by Subject|3|||
126476917|NCT02762578|455046628|FG000|Overall Study|Unclassified|6|||
126476918|NCT02762578|455046629|FG001|Overall Study|Unclassified|0|||
126476919|NCT00259610|455046630|FG000|Overall Study|Withdrawal by Subject|33|||
126476920|NCT00259610|455046631|FG001|Overall Study|Withdrawal by Subject|25|||
126721792|NCT05122650|455931291|FG001|Overall Study|Withdrawal by Subject|7|||
126721793|NCT05122650|455931292|FG002|Overall Study|Withdrawal by Subject|4|||
126721794|NCT05122650|455931293|FG003|Overall Study|Withdrawal by Subject|8|||
126721795|NCT05122650|455931290|FG000|Overall Study|Other|5|||
126721796|NCT05122650|455931291|FG001|Overall Study|Other|0|||
126721797|NCT05122650|455931292|FG002|Overall Study|Other|0|||
126721798|NCT05122650|455931293|FG003|Overall Study|Other|0|||
126476921|NCT00259610|455046632|FG002|Overall Study|Withdrawal by Subject|29|||
126476922|NCT00259610|455046633|FG003|Overall Study|Withdrawal by Subject|19|||
126476923|NCT00259610|455046630|FG000|Overall Study|Lost to Follow-up|19|||
126476924|NCT00259610|455046631|FG001|Overall Study|Lost to Follow-up|8|||
126476925|NCT00259610|455046632|FG002|Overall Study|Lost to Follow-up|18|||
126476926|NCT00259610|455046633|FG003|Overall Study|Lost to Follow-up|15|||
126476927|NCT00259610|455046630|FG000|Overall Study|Physician Decision|6|||
126476928|NCT00259610|455046631|FG001|Overall Study|Physician Decision|4|||
126476929|NCT00259610|455046632|FG002|Overall Study|Physician Decision|7|||
126476930|NCT00259610|455046633|FG003|Overall Study|Physician Decision|2|||
126476931|NCT00259610|455046630|FG000|Overall Study|Death|1|||
126476932|NCT00259610|455046631|FG001|Overall Study|Death|1|||
126476933|NCT00259610|455046632|FG002|Overall Study|Death|2|||
126476934|NCT00259610|455046633|FG003|Overall Study|Death|0|||
126476935|NCT00259610|455046630|FG000|Overall Study|non medical reason|6|||
126476936|NCT00259610|455046631|FG001|Overall Study|non medical reason|2|||
126476937|NCT00259610|455046632|FG002|Overall Study|non medical reason|10|||
126721799|NCT01401010|455931294|FG000|Overall Study|Could not interpret assay results|1|||
126721800|NCT01401010|455931295|FG001|Overall Study|Could not interpret assay results|0|||
126721801|NCT04360187|455931301|FG000|Double-Blind Treatment|Adverse Event|9|||
126721802|NCT04360187|455931302|FG001|Double-Blind Treatment|Adverse Event|11|||
126721803|NCT04360187|455931301|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
126476938|NCT00259610|455046633|FG003|Overall Study|non medical reason|3|||
126476939|NCT00259610|455046630|FG000|Overall Study|Adverse Event|3|||
126476940|NCT00259610|455046631|FG001|Overall Study|Adverse Event|4|||
126476941|NCT00259610|455046632|FG002|Overall Study|Adverse Event|5|||
126721804|NCT04360187|455931302|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
126721805|NCT04360187|455931301|FG000|Double-Blind Treatment|Physician Decision|1|||
126721806|NCT04360187|455931302|FG001|Double-Blind Treatment|Physician Decision|0|||
126721807|NCT04360187|455931301|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
126721808|NCT04360187|455931302|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
126721809|NCT04360187|455931301|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
126721810|NCT04360187|455931302|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
126721811|NCT04360187|455931301|FG000|Follow-Up|Lost to Follow-up|1|||
126721812|NCT04360187|455931302|FG001|Follow-Up|Lost to Follow-up|0|||
126721813|NCT00222729|455931311|FG000|Overall Study|Adverse Event|3|||
126721814|NCT01318083|455931312|FG000|Overall Study|Adverse Event|4|||
126721815|NCT01318083|455931313|FG001|Overall Study|Adverse Event|1|||
126721816|NCT01318083|455931314|FG002|Overall Study|Adverse Event|2|||
126721817|NCT01318083|455931312|FG000|Overall Study|Withdrawal by Subject|1|||
126721818|NCT01318083|455931313|FG001|Overall Study|Withdrawal by Subject|0|||
126721819|NCT01318083|455931314|FG002|Overall Study|Withdrawal by Subject|2|||
126721820|NCT01318083|455931312|FG000|Overall Study|Lack of Efficacy|0|||
126721821|NCT01318083|455931313|FG001|Overall Study|Lack of Efficacy|0|||
126721822|NCT01318083|455931314|FG002|Overall Study|Lack of Efficacy|1|||
126721823|NCT01318083|455931312|FG000|Overall Study|Treatment Complications|1|||
126721824|NCT01318083|455931313|FG001|Overall Study|Treatment Complications|0|||
126721825|NCT01318083|455931314|FG002|Overall Study|Treatment Complications|0|||
126721826|NCT01318083|455931312|FG000|Overall Study|Lack of Study Medication Compliance|0|||
126721827|NCT01318083|455931313|FG001|Overall Study|Lack of Study Medication Compliance|1|||
126721828|NCT01318083|455931314|FG002|Overall Study|Lack of Study Medication Compliance|0|||
126721829|NCT00256867|455931315|FG000|Overall Study|Adverse Event|0|||
126721830|NCT00256867|455931316|FG001|Overall Study|Adverse Event|1|||
126721831|NCT00256867|455931317|FG002|Overall Study|Adverse Event|1|||
126721832|NCT00256867|455931318|FG003|Overall Study|Adverse Event|1|||
126721833|NCT00256867|455931319|FG004|Overall Study|Adverse Event|2|||
126721834|NCT00256867|455931320|FG005|Overall Study|Adverse Event|2|||
126721835|NCT00256867|455931321|FG006|Overall Study|Adverse Event|1|||
126721836|NCT00256867|455931322|FG007|Overall Study|Adverse Event|4|||
126721837|NCT00256867|455931315|FG000|Overall Study|Lost to Follow-up|2|||
126721838|NCT00256867|455931316|FG001|Overall Study|Lost to Follow-up|2|||
126721839|NCT00256867|455931317|FG002|Overall Study|Lost to Follow-up|2|||
126721840|NCT00256867|455931318|FG003|Overall Study|Lost to Follow-up|3|||
126721841|NCT00256867|455931319|FG004|Overall Study|Lost to Follow-up|2|||
126721842|NCT00256867|455931320|FG005|Overall Study|Lost to Follow-up|0|||
126721843|NCT00256867|455931321|FG006|Overall Study|Lost to Follow-up|1|||
126721844|NCT00256867|455931322|FG007|Overall Study|Lost to Follow-up|2|||
126721845|NCT00256867|455931315|FG000|Overall Study|Protocol Violation|0|||
126721846|NCT00256867|455931316|FG001|Overall Study|Protocol Violation|0|||
126721847|NCT00256867|455931317|FG002|Overall Study|Protocol Violation|0|||
126721848|NCT00256867|455931318|FG003|Overall Study|Protocol Violation|1|||
126721849|NCT00256867|455931319|FG004|Overall Study|Protocol Violation|0|||
126721850|NCT00256867|455931320|FG005|Overall Study|Protocol Violation|1|||
126721851|NCT00256867|455931321|FG006|Overall Study|Protocol Violation|0|||
126721852|NCT00256867|455931322|FG007|Overall Study|Protocol Violation|1|||
126721853|NCT00256867|455931315|FG000|Overall Study|Withdrawal by Subject|0|||
126721854|NCT00256867|455931316|FG001|Overall Study|Withdrawal by Subject|0|||
126721855|NCT00256867|455931317|FG002|Overall Study|Withdrawal by Subject|1|||
126721856|NCT00256867|455931318|FG003|Overall Study|Withdrawal by Subject|1|||
126721857|NCT00256867|455931319|FG004|Overall Study|Withdrawal by Subject|2|||
126721858|NCT00256867|455931320|FG005|Overall Study|Withdrawal by Subject|2|||
126721859|NCT00256867|455931321|FG006|Overall Study|Withdrawal by Subject|3|||
126721860|NCT00256867|455931322|FG007|Overall Study|Withdrawal by Subject|2|||
126721861|NCT00256867|455931315|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126721862|NCT00256867|455931316|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
126721863|NCT00256867|455931317|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126721864|NCT00256867|455931318|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126721865|NCT00256867|455931319|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126721866|NCT00256867|455931320|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126721867|NCT00256867|455931321|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126721868|NCT00256867|455931322|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
126721869|NCT00256867|455931315|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126721870|NCT00256867|455931316|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126721871|NCT00256867|455931317|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126721872|NCT00256867|455931318|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126721873|NCT00256867|455931319|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126721874|NCT00256867|455931320|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126721875|NCT00256867|455931321|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
126721876|NCT00256867|455931322|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
126721877|NCT00256867|455931315|FG000|Overall Study|Investigator's Decision|0|||
126721878|NCT00256867|455931316|FG001|Overall Study|Investigator's Decision|0|||
126721879|NCT00256867|455931317|FG002|Overall Study|Investigator's Decision|0|||
126476942|NCT00259610|455046633|FG003|Overall Study|Adverse Event|2|||
126476943|NCT00259610|455046630|FG000|Overall Study|Serious Adverse Event|8|||
126476944|NCT00259610|455046631|FG001|Overall Study|Serious Adverse Event|2|||
126476945|NCT00259610|455046632|FG002|Overall Study|Serious Adverse Event|2|||
126476946|NCT00259610|455046633|FG003|Overall Study|Serious Adverse Event|2|||
126476947|NCT00957580|455046636|FG000|Overall Study|Ongoing at data cut-off|0|||
126476948|NCT00957580|455046637|FG001|Overall Study|Ongoing at data cut-off|1|||
126476949|NCT00957580|455046638|FG002|Overall Study|Ongoing at data cut-off|0|||
126476950|NCT00957580|455046636|FG000|Overall Study|Enrolled but not treated|0|||
126476951|NCT00957580|455046637|FG001|Overall Study|Enrolled but not treated|1|||
126476952|NCT00957580|455046638|FG002|Overall Study|Enrolled but not treated|0|||
126476953|NCT01090492|455046639|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
126476954|NCT01090492|455046640|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
126559042|NCT04537949|455340627|FG007|Follow-up Phase|Lost to Follow-up|0|||
126559043|NCT04537949|455340620|FG000|Follow-up Phase|personal reasons|0|||
126559044|NCT04537949|455340621|FG001|Follow-up Phase|personal reasons|0|||
126559045|NCT04537949|455340622|FG002|Follow-up Phase|personal reasons|0|||
126559046|NCT04537949|455340623|FG003|Follow-up Phase|personal reasons|1|||
126418667|NCT01514201|454826730|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
126418668|NCT01514201|454826731|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
126418669|NCT01514201|454826728|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
126418670|NCT01514201|454826729|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
126559047|NCT04537949|455340624|FG004|Follow-up Phase|personal reasons|1|||
126559048|NCT04537949|455340625|FG005|Follow-up Phase|personal reasons|0|||
126559049|NCT04537949|455340626|FG006|Follow-up Phase|personal reasons|0|||
126559050|NCT04537949|455340627|FG007|Follow-up Phase|personal reasons|0|||
126559051|NCT04537949|455340620|FG000|Follow-up Phase|Withdrawal by Subject|0|||
126559052|NCT04537949|455340621|FG001|Follow-up Phase|Withdrawal by Subject|0|||
126559053|NCT04537949|455340622|FG002|Follow-up Phase|Withdrawal by Subject|0|||
126559054|NCT04537949|455340623|FG003|Follow-up Phase|Withdrawal by Subject|0|||
126559055|NCT04537949|455340624|FG004|Follow-up Phase|Withdrawal by Subject|1|||
126559056|NCT04537949|455340625|FG005|Follow-up Phase|Withdrawal by Subject|0|||
126559057|NCT04537949|455340626|FG006|Follow-up Phase|Withdrawal by Subject|0|||
126559058|NCT04537949|455340627|FG007|Follow-up Phase|Withdrawal by Subject|0|||
126559059|NCT04003974|455340629|FG000|Overall Study|Missing|1|||
126559060|NCT04003974|455340630|FG001|Overall Study|Missing|0|||
126559061|NCT04003974|455340629|FG000|Overall Study|Withdrawal by Subject|0|||
126559062|NCT04003974|455340630|FG001|Overall Study|Withdrawal by Subject|2|||
126559063|NCT04296942|455340631|FG000|Overall Study|Study closure by sponsor|1|||
126559064|NCT04296942|455340632|FG001|Overall Study|Study closure by sponsor|0|||
126559065|NCT04296942|455340633|FG002|Overall Study|Study closure by sponsor|0|||
126559066|NCT00335153|455340634|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
126559067|NCT00335153|455340634|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
126559068|NCT00335153|455340634|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
126559069|NCT00335153|455340634|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
126559070|NCT00335153|455340634|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
126559071|NCT00335153|455340634|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
126559072|NCT00335153|455340634|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
126559073|NCT00335153|455340634|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
126559074|NCT00335153|455340634|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
126559075|NCT00335153|455340634|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
126559076|NCT02478359|455340637|FG000|Overall Study|Disenrolled from health plan|106|||
126418671|NCT01514201|454826730|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
126418672|NCT01514201|454826731|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
126418673|NCT01514201|454826728|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
126418674|NCT01514201|454826729|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
126418675|NCT01514201|454826730|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
126418676|NCT01514201|454826731|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
126418677|NCT01514201|454826728|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
126418678|NCT01514201|454826729|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
126418679|NCT01514201|454826730|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
126418680|NCT01514201|454826731|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
126418681|NCT01514201|454826728|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
126476955|NCT01090492|455046641|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
126476956|NCT01090492|455046642|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
126559077|NCT02478359|455340638|FG001|Overall Study|Disenrolled from health plan|65|||
126559078|NCT00372528|455340639|FG000|Overall Study|Lack of Efficacy|1|||
126559079|NCT00372528|455340639|FG000|Overall Study|Adverse Event|1|||
126559080|NCT00372528|455340639|FG000|Overall Study|Study Terminated by Sponsor|18|||
126559081|NCT00372528|455340639|FG000|Overall Study|Other|1|||
126559082|NCT02412761|455340640|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126418682|NCT01514201|454826729|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
126418683|NCT01514201|454826730|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
126418684|NCT01514201|454826731|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
126418685|NCT01514201|454826728|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
126418686|NCT01514201|454826729|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
126418687|NCT01514201|454826730|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
126418688|NCT01514201|454826731|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
126418689|NCT05888181|454826732|FG000|Overall Study|Lost to Follow-up|1|||
126418690|NCT05888181|454826733|FG001|Overall Study|Lost to Follow-up|1|||
126418691|NCT05888181|454826734|FG002|Overall Study|Lost to Follow-up|0|||
126418692|NCT02735343|454826738|FG000|Overall Study|screen fail|0|||
126418693|NCT02735343|454826739|FG001|Overall Study|screen fail|2|||
126418694|NCT00637416|454826740|FG000|Overall Study|Lost to Follow-up|1|||
126418695|NCT00637416|454826741|FG001|Overall Study|Lost to Follow-up|1|||
126418696|NCT00637416|454826740|FG000|Overall Study|Unable to take study drug|0|||
126418697|NCT00637416|454826741|FG001|Overall Study|Unable to take study drug|1|||
126418698|NCT02534909|454826745|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
126418699|NCT01625000|454826748|FG000|Overall Study|Physician Decision|15|||
126418700|NCT01625000|454826749|FG001|Overall Study|Physician Decision|7|||
126418701|NCT01625000|454826750|FG002|Overall Study|Physician Decision|7|||
126418702|NCT01625000|454826751|FG003|Overall Study|Physician Decision|2|||
126418703|NCT01625000|454826752|FG004|Overall Study|Physician Decision|15|||
126418704|NCT01625000|454826748|FG000|Overall Study|Protocol Violation|3|||
126418705|NCT01625000|454826749|FG001|Overall Study|Protocol Violation|10|||
126418706|NCT01625000|454826750|FG002|Overall Study|Protocol Violation|4|||
126418707|NCT01625000|454826751|FG003|Overall Study|Protocol Violation|1|||
126418708|NCT01625000|454826752|FG004|Overall Study|Protocol Violation|2|||
126418709|NCT01625000|454826748|FG000|Overall Study|Withdrawal by Subject|19|||
126418710|NCT01625000|454826749|FG001|Overall Study|Withdrawal by Subject|16|||
126418711|NCT01625000|454826750|FG002|Overall Study|Withdrawal by Subject|11|||
126418712|NCT01625000|454826751|FG003|Overall Study|Withdrawal by Subject|9|||
126476957|NCT01090492|455046643|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
126476958|NCT01090492|455046644|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
126476959|NCT01090492|455046645|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
126476960|NCT01090492|455046646|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
126476961|NCT01090492|455046639|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
126476962|NCT01090492|455046640|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
126476963|NCT01090492|455046641|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
126476964|NCT01090492|455046642|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
126476965|NCT01090492|455046643|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
126476966|NCT01090492|455046644|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
126476967|NCT01090492|455046645|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
126476968|NCT01090492|455046646|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
126476969|NCT01090492|455046639|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126476970|NCT01090492|455046640|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126476971|NCT01090492|455046641|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
126476972|NCT01090492|455046642|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126476973|NCT01090492|455046643|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126476974|NCT01090492|455046644|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126476975|NCT01090492|455046645|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126476976|NCT01090492|455046646|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126476977|NCT01090492|455046639|FG000|First Intervention Period (4 Weeks)|Other|0|||
126476978|NCT01090492|455046640|FG001|First Intervention Period (4 Weeks)|Other|0|||
126476979|NCT01090492|455046641|FG002|First Intervention Period (4 Weeks)|Other|1|||
126418713|NCT01625000|454826752|FG004|Overall Study|Withdrawal by Subject|17|||
126418714|NCT01625000|454826748|FG000|Overall Study|Adverse Event (including Death)|15|||
126418715|NCT01625000|454826749|FG001|Overall Study|Adverse Event (including Death)|19|||
126418716|NCT01625000|454826750|FG002|Overall Study|Adverse Event (including Death)|11|||
126418717|NCT01625000|454826751|FG003|Overall Study|Adverse Event (including Death)|7|||
126418718|NCT01625000|454826752|FG004|Overall Study|Adverse Event (including Death)|21|||
126418719|NCT00566852|454826753|FG000|Overall Study|Protocol Violation|22|||
126418720|NCT00566852|454826754|FG001|Overall Study|Protocol Violation|24|||
126418721|NCT00566852|454826753|FG000|Overall Study|Death|95|||
126418722|NCT00566852|454826754|FG001|Overall Study|Death|78|||
126418723|NCT00566852|454826753|FG000|Overall Study|Withdrawal by Subject|30|||
126418724|NCT00566852|454826754|FG001|Overall Study|Withdrawal by Subject|25|||
126418725|NCT00566852|454826753|FG000|Overall Study|Patient refusal|37|||
126418726|NCT00566852|454826754|FG001|Overall Study|Patient refusal|37|||
126476980|NCT01090492|455046642|FG003|First Intervention Period (4 Weeks)|Other|1|||
126418727|NCT00566852|454826753|FG000|Overall Study|Not tested due to disability|6|||
126476981|NCT01090492|455046643|FG004|First Intervention Period (4 Weeks)|Other|2|||
126418728|NCT00566852|454826754|FG001|Overall Study|Not tested due to disability|12|||
126418729|NCT00566852|454826753|FG000|Overall Study|Missing reason not specified|1|||
126418730|NCT00566852|454826754|FG001|Overall Study|Missing reason not specified|2|||
126418731|NCT00566852|454826753|FG000|Overall Study|Missing reason not reported|16|||
126418732|NCT00566852|454826754|FG001|Overall Study|Missing reason not reported|20|||
126418733|NCT05870865|454826759|FG000|Randomized|Did not receive study treatment|2|||
126418734|NCT05870865|454826760|FG001|Randomized|Did not receive study treatment|4|||
126418735|NCT05870865|454826761|FG002|Randomized|Did not receive study treatment|4|||
126418736|NCT05870865|454826762|FG003|Randomized|Did not receive study treatment|3|||
126418737|NCT05870865|454826759|FG000|Treatment Period|Adverse Event|1|||
126418738|NCT05870865|454826760|FG001|Treatment Period|Adverse Event|1|||
126476982|NCT01090492|455046644|FG005|First Intervention Period (4 Weeks)|Other|0|||
126476983|NCT01090492|455046645|FG006|First Intervention Period (4 Weeks)|Other|0|||
126476984|NCT01090492|455046646|FG007|First Intervention Period (4 Weeks)|Other|0|||
126476985|NCT01090492|455046639|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
126476986|NCT01090492|455046640|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
126476987|NCT01090492|455046641|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
126476988|NCT01090492|455046642|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
126476989|NCT01090492|455046643|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
126476990|NCT01090492|455046644|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
126476991|NCT01090492|455046645|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
126476992|NCT01090492|455046646|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
126476993|NCT01090492|455046639|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
126476994|NCT01090492|455046640|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
126476995|NCT01090492|455046641|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
126476996|NCT01090492|455046642|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
126476997|NCT01090492|455046643|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
126476998|NCT01090492|455046644|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
126476999|NCT01090492|455046645|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
126477000|NCT01090492|455046646|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
126477001|NCT01090492|455046639|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
126477002|NCT01090492|455046640|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
126477003|NCT01090492|455046641|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
126477004|NCT01090492|455046642|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
126477005|NCT01090492|455046643|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
126477006|NCT01090492|455046644|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
126477007|NCT01090492|455046645|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
126477008|NCT01090492|455046646|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
126477009|NCT01090492|455046639|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
126477010|NCT01090492|455046640|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
126477011|NCT01090492|455046641|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
126477012|NCT01090492|455046642|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
126477013|NCT01090492|455046643|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
126477014|NCT01090492|455046644|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
126477015|NCT01090492|455046645|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
126477016|NCT01090492|455046646|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
126477017|NCT01090492|455046639|FG000|Second Intervention Period (4 Weeks)|Other|0|||
126477018|NCT01090492|455046640|FG001|Second Intervention Period (4 Weeks)|Other|1|||
126477019|NCT01090492|455046641|FG002|Second Intervention Period (4 Weeks)|Other|1|||
126477020|NCT01090492|455046642|FG003|Second Intervention Period (4 Weeks)|Other|0|||
126477021|NCT01090492|455046643|FG004|Second Intervention Period (4 Weeks)|Other|0|||
126477022|NCT01090492|455046644|FG005|Second Intervention Period (4 Weeks)|Other|0|||
126477023|NCT01090492|455046645|FG006|Second Intervention Period (4 Weeks)|Other|0|||
126477024|NCT01090492|455046646|FG007|Second Intervention Period (4 Weeks)|Other|0|||
126477025|NCT01090492|455046639|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
126477026|NCT01090492|455046640|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
126477027|NCT01090492|455046641|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
126477028|NCT01090492|455046642|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
126721880|NCT00256867|455931318|FG003|Overall Study|Investigator's Decision|0|||
126721881|NCT00256867|455931319|FG004|Overall Study|Investigator's Decision|1|||
126721882|NCT00256867|455931320|FG005|Overall Study|Investigator's Decision|0|||
126721883|NCT00256867|455931321|FG006|Overall Study|Investigator's Decision|0|||
126721884|NCT00256867|455931322|FG007|Overall Study|Investigator's Decision|0|||
126418739|NCT05870865|454826761|FG002|Treatment Period|Adverse Event|1|||
126418740|NCT05870865|454826762|FG003|Treatment Period|Adverse Event|1|||
126418741|NCT05870865|454826759|FG000|Treatment Period|Lost to Follow-up|0|||
126418742|NCT05870865|454826760|FG001|Treatment Period|Lost to Follow-up|1|||
126418743|NCT05870865|454826761|FG002|Treatment Period|Lost to Follow-up|2|||
126721885|NCT00256867|455931315|FG000|Overall Study|Non-compliance with study medication|0|||
126418744|NCT05870865|454826762|FG003|Treatment Period|Lost to Follow-up|0|||
126418745|NCT05870865|454826759|FG000|Treatment Period|Protocol Violation|0|||
126418746|NCT05870865|454826760|FG001|Treatment Period|Protocol Violation|0|||
126418747|NCT05870865|454826761|FG002|Treatment Period|Protocol Violation|0|||
126418748|NCT05870865|454826762|FG003|Treatment Period|Protocol Violation|1|||
126418749|NCT05870865|454826759|FG000|Treatment Period|Withdrawal by Subject|0|||
126418750|NCT05870865|454826760|FG001|Treatment Period|Withdrawal by Subject|1|||
126418751|NCT05870865|454826761|FG002|Treatment Period|Withdrawal by Subject|1|||
126418752|NCT05870865|454826762|FG003|Treatment Period|Withdrawal by Subject|1|||
126418753|NCT04752332|454826763|FG000|Overall Study|Adverse Event|3|||
126418754|NCT04752332|454826764|FG001|Overall Study|Adverse Event|1|||
126418755|NCT04752332|454826763|FG000|Overall Study|Disease Relapse|1|||
126418756|NCT04752332|454826764|FG001|Overall Study|Disease Relapse|0|||
126418757|NCT04752332|454826763|FG000|Overall Study|Non-compliance With Study Drug|2|||
126418758|NCT04752332|454826764|FG001|Overall Study|Non-compliance With Study Drug|0|||
126721886|NCT00256867|455931316|FG001|Overall Study|Non-compliance with study medication|0|||
126721887|NCT00256867|455931317|FG002|Overall Study|Non-compliance with study medication|0|||
126721888|NCT00256867|455931318|FG003|Overall Study|Non-compliance with study medication|0|||
126721889|NCT00256867|455931319|FG004|Overall Study|Non-compliance with study medication|0|||
126721890|NCT00256867|455931320|FG005|Overall Study|Non-compliance with study medication|0|||
126721891|NCT00256867|455931321|FG006|Overall Study|Non-compliance with study medication|0|||
126721892|NCT00256867|455931322|FG007|Overall Study|Non-compliance with study medication|1|||
126721893|NCT00256867|455931315|FG000|Overall Study|Participant travelled Overseas|0|||
126721894|NCT00256867|455931316|FG001|Overall Study|Participant travelled Overseas|1|||
126721895|NCT00256867|455931317|FG002|Overall Study|Participant travelled Overseas|0|||
126721896|NCT00256867|455931318|FG003|Overall Study|Participant travelled Overseas|0|||
126721897|NCT00256867|455931319|FG004|Overall Study|Participant travelled Overseas|0|||
126721898|NCT00256867|455931320|FG005|Overall Study|Participant travelled Overseas|0|||
126721899|NCT00256867|455931321|FG006|Overall Study|Participant travelled Overseas|0|||
126721900|NCT00256867|455931322|FG007|Overall Study|Participant travelled Overseas|0|||
126721901|NCT00256867|455931315|FG000|Overall Study|Participant out of assessment window|0|||
126418759|NCT04752332|454826763|FG000|Overall Study|Physician Decision|2|||
126418760|NCT04752332|454826764|FG001|Overall Study|Physician Decision|1|||
126418761|NCT04752332|454826763|FG000|Overall Study|Protocol Violation|1|||
126418762|NCT04752332|454826764|FG001|Overall Study|Protocol Violation|1|||
126418763|NCT04752332|454826763|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
126418764|NCT04752332|454826764|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
126418765|NCT04752332|454826763|FG000|Overall Study|Study Terminated by Sponsor|10|||
126418766|NCT04752332|454826764|FG001|Overall Study|Study Terminated by Sponsor|48|||
126418767|NCT04752332|454826763|FG000|Overall Study|Withdrawal by Subject|11|||
126418768|NCT04752332|454826764|FG001|Overall Study|Withdrawal by Subject|3|||
126418769|NCT00958165|454826765|FG000|Overall Study|Lost to Follow-up|5|||
126418770|NCT00958165|454826765|FG000|Overall Study|Not eligible|9|||
126418771|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
126418772|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
126418773|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
126418774|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Death|0|||
126418775|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Death|2|||
126418776|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Death|0|||
126418777|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
126418778|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
126418779|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
126418780|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
126418781|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
126418782|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
126418783|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
126418784|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
126418785|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
126418786|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
126418787|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
126418788|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
126418789|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
126559083|NCT02412761|455340641|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126721902|NCT00256867|455931316|FG001|Overall Study|Participant out of assessment window|0|||
126721903|NCT00256867|455931317|FG002|Overall Study|Participant out of assessment window|1|||
126721904|NCT00256867|455931318|FG003|Overall Study|Participant out of assessment window|0|||
126721905|NCT00256867|455931319|FG004|Overall Study|Participant out of assessment window|0|||
126721906|NCT00256867|455931320|FG005|Overall Study|Participant out of assessment window|0|||
126418790|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
126418791|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
126559084|NCT02412761|455340642|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126418792|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Recovery|1|||
126418793|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Recovery|0|||
126418794|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Recovery|1|||
126418795|NCT00195663|454826767|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
126418796|NCT00195663|454826768|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
126418797|NCT00195663|454826769|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
126418798|NCT00195663|454826767|FG000|Open-Label Extension Period|Adverse Event|21|||
126418799|NCT00195663|454826768|FG001|Open-Label Extension Period|Adverse Event|32|||
126418800|NCT00195663|454826769|FG002|Open-Label Extension Period|Adverse Event|36|||
126418801|NCT00195663|454826767|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
126418802|NCT00195663|454826768|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
126418803|NCT00195663|454826769|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
126418804|NCT00195663|454826767|FG000|Open-Label Extension Period|Recovery|0|||
126418805|NCT00195663|454826768|FG001|Open-Label Extension Period|Recovery|2|||
126418806|NCT00195663|454826769|FG002|Open-Label Extension Period|Recovery|2|||
126418807|NCT00195663|454826767|FG000|Open-Label Extension Period|Protocol Violation|3|||
126418808|NCT00195663|454826768|FG001|Open-Label Extension Period|Protocol Violation|4|||
126418809|NCT00195663|454826769|FG002|Open-Label Extension Period|Protocol Violation|4|||
126418810|NCT00195663|454826767|FG000|Open-Label Extension Period|Death|2|||
126418811|NCT00195663|454826768|FG001|Open-Label Extension Period|Death|2|||
126418812|NCT00195663|454826769|FG002|Open-Label Extension Period|Death|2|||
126418813|NCT00195663|454826767|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
126418814|NCT00195663|454826768|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
126418815|NCT00195663|454826769|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
126418816|NCT00195663|454826767|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
126418817|NCT00195663|454826768|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
126418818|NCT00195663|454826769|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
126418819|NCT00195663|454826767|FG000|Open-Label Extension Period|Administrative reasons|11|||
126418820|NCT00195663|454826768|FG001|Open-Label Extension Period|Administrative reasons|11|||
126418821|NCT00195663|454826769|FG002|Open-Label Extension Period|Administrative reasons|13|||
126418822|NCT00604695|454826770|FG000|Overall Study|Did not receive first bolus.|0|||
126418823|NCT00604695|454826771|FG001|Overall Study|Did not receive first bolus.|4|||
126418824|NCT02058563|454826775|FG000|Overall Study|Lost to Follow-up|26|||
126418825|NCT02058563|454826776|FG001|Overall Study|Lost to Follow-up|22|||
126418826|NCT02058563|454826775|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
126418827|NCT02058563|454826776|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
126418828|NCT02058563|454826775|FG000|Overall Study|Consent Withdrawal|1|||
126418829|NCT02058563|454826776|FG001|Overall Study|Consent Withdrawal|1|||
126418830|NCT02058563|454826775|FG000|Overall Study|Other (patient incarcerated)|0|||
126418831|NCT02058563|454826776|FG001|Overall Study|Other (patient incarcerated)|1|||
126418832|NCT00166439|454826777|FG000|Overall Study|Ineligible|5|||
126418833|NCT04039217|454826778|FG000|Overall Study|Lost to Follow-up|1|||
126418834|NCT00615992|454826779|FG000|Overall Study|Protocol Violation|67|||
126418835|NCT04522141|454826780|FG000|Overall Study|Withdrawal by Subject|1|||
126418836|NCT04522141|454826781|FG001|Overall Study|Withdrawal by Subject|0|||
126418837|NCT01868477|454826782|FG000|Overall Study|Adverse Event|2|||
126418838|NCT01868477|454826783|FG001|Overall Study|Adverse Event|4|||
126418839|NCT01868477|454826782|FG000|Overall Study|Disease progression|1|||
126418840|NCT01868477|454826783|FG001|Overall Study|Disease progression|1|||
126418841|NCT01868477|454826782|FG000|Overall Study|Withdrawal by Subject|1|||
126418842|NCT01868477|454826783|FG001|Overall Study|Withdrawal by Subject|0|||
126418843|NCT00811174|454826784|FG000|Overall Study|Protocol Violation|2|||
126418844|NCT00811174|454826784|FG000|Overall Study|Sponsors Decision|1|||
126418845|NCT04864639|454828036|FG000|Overall Study|Death|1|||
126418846|NCT04864639|454828036|FG000|Overall Study|Lost to Follow-up|1|||
126418847|NCT00615017|454828037|FG000|Overall Study|Adverse Event|0|||
126418848|NCT00615017|454828038|FG001|Overall Study|Adverse Event|1|||
126418849|NCT00615017|454828039|FG002|Overall Study|Adverse Event|2|||
126418850|NCT00615017|454828040|FG003|Overall Study|Adverse Event|0|||
126418851|NCT00615017|454828041|FG004|Overall Study|Adverse Event|0|||
126418852|NCT00615017|454828042|FG005|Overall Study|Adverse Event|1|||
126418853|NCT00615017|454828037|FG000|Overall Study|Death|0|||
126418854|NCT00615017|454828038|FG001|Overall Study|Death|0|||
126418855|NCT00615017|454828039|FG002|Overall Study|Death|2|||
126418856|NCT00615017|454828040|FG003|Overall Study|Death|0|||
126418857|NCT00615017|454828041|FG004|Overall Study|Death|1|||
126418858|NCT00615017|454828042|FG005|Overall Study|Death|1|||
126418859|NCT00615017|454828037|FG000|Overall Study|Sepsis resolved|0|||
126418860|NCT00615017|454828038|FG001|Overall Study|Sepsis resolved|0|||
126418861|NCT00615017|454828039|FG002|Overall Study|Sepsis resolved|1|||
126418862|NCT00615017|454828040|FG003|Overall Study|Sepsis resolved|0|||
126418863|NCT00615017|454828041|FG004|Overall Study|Sepsis resolved|0|||
126418864|NCT00615017|454828042|FG005|Overall Study|Sepsis resolved|0|||
126418865|NCT00615017|454828037|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
126418866|NCT00615017|454828038|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
126418867|NCT00615017|454828039|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
126418868|NCT00615017|454828040|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
126418869|NCT00615017|454828041|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
126418870|NCT00615017|454828042|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
126418871|NCT00615017|454828037|FG000|Overall Study|Physician discontinued drug|0|||
126721907|NCT00256867|455931321|FG006|Overall Study|Participant out of assessment window|0|||
126721908|NCT00256867|455931322|FG007|Overall Study|Participant out of assessment window|0|||
126721909|NCT00256867|455931315|FG000|Overall Study|Withdrawal by participant|0|||
126721910|NCT00256867|455931316|FG001|Overall Study|Withdrawal by participant|0|||
126721911|NCT00256867|455931317|FG002|Overall Study|Withdrawal by participant|0|||
126721912|NCT00256867|455931318|FG003|Overall Study|Withdrawal by participant|0|||
126721913|NCT00256867|455931319|FG004|Overall Study|Withdrawal by participant|0|||
126418872|NCT00615017|454828038|FG001|Overall Study|Physician discontinued drug|0|||
126418873|NCT00615017|454828039|FG002|Overall Study|Physician discontinued drug|0|||
126418874|NCT00615017|454828040|FG003|Overall Study|Physician discontinued drug|0|||
126721914|NCT00256867|455931320|FG005|Overall Study|Withdrawal by participant|1|||
126418875|NCT00615017|454828041|FG004|Overall Study|Physician discontinued drug|0|||
126418876|NCT00615017|454828042|FG005|Overall Study|Physician discontinued drug|1|||
126418877|NCT00806988|454828043|FG000|Overall Study|Death|15|||
126418878|NCT00806988|454828044|FG001|Overall Study|Death|16|||
126418879|NCT00806988|454828043|FG000|Overall Study|Withdrawal by Subject|8|||
126418880|NCT00806988|454828044|FG001|Overall Study|Withdrawal by Subject|8|||
126418881|NCT00806988|454828043|FG000|Overall Study|Lost to Follow-up|4|||
126418882|NCT00806988|454828044|FG001|Overall Study|Lost to Follow-up|19|||
126418883|NCT03078556|454828047|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
126418884|NCT03078556|454828048|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
126418885|NCT03078556|454828049|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
126418886|NCT03078556|454828050|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
126418887|NCT03078556|454828047|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
126418888|NCT03078556|454828048|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
126418889|NCT03078556|454828049|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
126418890|NCT03078556|454828050|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
126418891|NCT03078556|454828047|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
126418892|NCT03078556|454828048|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
126418893|NCT03078556|454828049|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
126418894|NCT03078556|454828050|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
126418895|NCT03078556|454828047|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
126418896|NCT03078556|454828048|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
126418897|NCT03078556|454828049|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
126418898|NCT03078556|454828050|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
126418899|NCT03314987|454828051|FG000|Overall Study|Lost to Follow-up|13|||
126418900|NCT03314987|454828052|FG001|Overall Study|Lost to Follow-up|13|||
126418901|NCT02751580|454828053|FG000|Overall Study|Lost to Follow-up|4|||
126418902|NCT02751580|454828053|FG000|Overall Study|Death|2|||
126418903|NCT02152761|454828060|FG000|Epoch: Treatment Epoch|Technical problems|0|||
126418904|NCT02152761|454828061|FG001|Epoch: Treatment Epoch|Technical problems|0|||
126418905|NCT02152761|454828062|FG002|Epoch: Treatment Epoch|Technical problems|0|||
126418906|NCT02152761|454828063|FG003|Epoch: Treatment Epoch|Technical problems|1|||
126418907|NCT02152761|454828060|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
126418908|NCT02152761|454828061|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
126418909|NCT02152761|454828062|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
126418910|NCT02152761|454828063|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
126418911|NCT02152761|454828060|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
126418912|NCT02152761|454828061|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
126418913|NCT02152761|454828062|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
126418914|NCT02152761|454828063|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
126418915|NCT02152761|454828060|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
126418916|NCT02152761|454828061|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
126418917|NCT02152761|454828062|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
126418918|NCT02152761|454828063|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
126721915|NCT00256867|455931321|FG006|Overall Study|Withdrawal by participant|0|||
126721916|NCT00256867|455931322|FG007|Overall Study|Withdrawal by participant|0|||
126418919|NCT02152761|454828060|FG000|Epoch: Treatment Epoch|Death|0|||
126418920|NCT02152761|454828061|FG001|Epoch: Treatment Epoch|Death|3|||
126418921|NCT02152761|454828062|FG002|Epoch: Treatment Epoch|Death|1|||
126418922|NCT02152761|454828063|FG003|Epoch: Treatment Epoch|Death|0|||
126418923|NCT02152761|454828060|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
126418924|NCT02152761|454828061|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
126418925|NCT02152761|454828062|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
126418926|NCT02152761|454828063|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
126418927|NCT02152761|454828060|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
126721917|NCT02993224|455931323|FG000|Core Phase - Period 1|Adverse Event|4|||
126721918|NCT02993224|455931323|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
126721919|NCT02993224|455931323|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
126418928|NCT02152761|454828061|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
126418929|NCT02152761|454828062|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
126418930|NCT02152761|454828063|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
126418931|NCT02152761|454828060|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
126418932|NCT02152761|454828061|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
126418933|NCT02152761|454828062|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
126418934|NCT02152761|454828063|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
126418935|NCT02152761|454828060|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
126418936|NCT02152761|454828061|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
126418937|NCT02152761|454828062|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
126418938|NCT02152761|454828063|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
126418939|NCT02152761|454828060|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
126418940|NCT02152761|454828061|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
126418941|NCT02152761|454828062|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
126418942|NCT02152761|454828063|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
126418943|NCT03755882|454828064|FG000|Period 1|Protocol Violation|1|||
126418944|NCT03755882|454828065|FG001|Period 1|Protocol Violation|0|||
126418945|NCT03755882|454828064|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
126418946|NCT03755882|454828065|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
126418947|NCT02292446|454828066|FG000|Overall Study|Adverse Event|12|||
126418948|NCT02292446|454828066|FG000|Overall Study|Death|1|||
126418949|NCT02292446|454828066|FG000|Overall Study|Disease progression|2|||
126418950|NCT02292446|454828066|FG000|Overall Study|Subject/guardian decision|2|||
126418951|NCT02292446|454828066|FG000|Overall Study|Withdrawal by Subject|3|||
126418952|NCT00887549|454828069|FG000|Induction Therapy|Adverse Event|8|||
126418953|NCT00887549|454828069|FG000|Induction Therapy|Physician Decision|1|||
126418954|NCT00887549|454828069|FG000|Induction Therapy|Progressive Disease|13|||
126418955|NCT00887549|454828069|FG000|Induction Therapy|Death due to Study Disease|4|||
126418956|NCT00887549|454828069|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
126418957|NCT00887549|454828069|FG000|Maintenance Therapy|Adverse Event|16|||
126418958|NCT00887549|454828069|FG000|Maintenance Therapy|Physician Decision|1|||
126418959|NCT00887549|454828069|FG000|Maintenance Therapy|Progressive Disease|25|||
126418960|NCT00887549|454828069|FG000|Maintenance Therapy|Death due to adverse event|1|||
126418961|NCT03329846|454828072|FG000|Overall Study|Disease progression|4|||
126418962|NCT03329846|454828073|FG001|Overall Study|Disease progression|6|||
126418963|NCT03329846|454828072|FG000|Overall Study|Study drug toxicity|1|||
126418964|NCT03329846|454828073|FG001|Overall Study|Study drug toxicity|0|||
126418965|NCT03329846|454828072|FG000|Overall Study|Participant request to discontinue treatment|0|||
126418966|NCT03329846|454828073|FG001|Overall Study|Participant request to discontinue treatment|1|||
126418967|NCT03329846|454828072|FG000|Overall Study|Participant withdrew consent|1|||
126418968|NCT03329846|454828073|FG001|Overall Study|Participant withdrew consent|0|||
126418969|NCT03329846|454828072|FG000|Overall Study|Other reasons|2|||
126418970|NCT03329846|454828073|FG001|Overall Study|Other reasons|2|||
126418971|NCT00479336|454828074|FG000|Overall Study|Adverse Event|1|||
126418972|NCT00479336|454828075|FG001|Overall Study|Adverse Event|1|||
126418973|NCT00479336|454828076|FG002|Overall Study|Adverse Event|1|||
126418974|NCT00479336|454828077|FG003|Overall Study|Adverse Event|3|||
126418975|NCT00479336|454828074|FG000|Overall Study|Lack of Efficacy|1|||
126418976|NCT00479336|454828075|FG001|Overall Study|Lack of Efficacy|0|||
126418977|NCT00479336|454828076|FG002|Overall Study|Lack of Efficacy|0|||
126418978|NCT00479336|454828077|FG003|Overall Study|Lack of Efficacy|0|||
126418979|NCT00479336|454828074|FG000|Overall Study|Protocol Violation|0|||
126477029|NCT01090492|455046643|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
126477030|NCT01090492|455046644|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
126477031|NCT01090492|455046645|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
126418980|NCT00479336|454828075|FG001|Overall Study|Protocol Violation|1|||
126418981|NCT00479336|454828076|FG002|Overall Study|Protocol Violation|0|||
126418982|NCT00479336|454828077|FG003|Overall Study|Protocol Violation|0|||
126418983|NCT00479336|454828074|FG000|Overall Study|Withdrawal by Subject|1|||
126418984|NCT00479336|454828075|FG001|Overall Study|Withdrawal by Subject|2|||
126418985|NCT00479336|454828076|FG002|Overall Study|Withdrawal by Subject|0|||
126418986|NCT00479336|454828077|FG003|Overall Study|Withdrawal by Subject|0|||
126418987|NCT00479336|454828074|FG000|Overall Study|Physician Decision|0|||
126418988|NCT00479336|454828075|FG001|Overall Study|Physician Decision|1|||
126418989|NCT00479336|454828076|FG002|Overall Study|Physician Decision|0|||
126418990|NCT00479336|454828077|FG003|Overall Study|Physician Decision|2|||
126418991|NCT00479336|454828074|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
126418992|NCT00479336|454828075|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
126477032|NCT01090492|455046646|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
126418993|NCT00479336|454828076|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
126418994|NCT00479336|454828077|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
126418995|NCT03066193|454828078|FG000|Overall Study|Withdrawal by Subject|1|||
126418996|NCT02021643|454828079|FG000|Overall Study|Enrolled but Never Treated|1|||
126721920|NCT02993224|455931323|FG000|Core Phase- Period 2|Adverse Event|1|||
126721921|NCT02993224|455931323|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
126721922|NCT02993224|455931323|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
126418997|NCT02021643|454828080|FG001|Overall Study|Enrolled but Never Treated|0|||
126418998|NCT02021643|454828081|FG002|Overall Study|Enrolled but Never Treated|0|||
126418999|NCT02021643|454828082|FG003|Overall Study|Enrolled but Never Treated|0|||
126419000|NCT02021643|454828079|FG000|Overall Study|Adverse Event|0|||
126419001|NCT02021643|454828080|FG001|Overall Study|Adverse Event|1|||
126419002|NCT02021643|454828081|FG002|Overall Study|Adverse Event|0|||
126419003|NCT02021643|454828082|FG003|Overall Study|Adverse Event|0|||
126419004|NCT02021643|454828079|FG000|Overall Study|Death|0|||
126419005|NCT02021643|454828080|FG001|Overall Study|Death|1|||
126419006|NCT02021643|454828081|FG002|Overall Study|Death|0|||
126419007|NCT02021643|454828082|FG003|Overall Study|Death|0|||
126419008|NCT02021643|454828079|FG000|Overall Study|Investigator's Discretion|1|||
126419009|NCT02021643|454828080|FG001|Overall Study|Investigator's Discretion|0|||
126419010|NCT02021643|454828081|FG002|Overall Study|Investigator's Discretion|0|||
126419011|NCT02021643|454828082|FG003|Overall Study|Investigator's Discretion|0|||
126419012|NCT02021643|454828079|FG000|Overall Study|Lack of Efficacy|7|||
126419013|NCT02021643|454828080|FG001|Overall Study|Lack of Efficacy|6|||
126419014|NCT02021643|454828081|FG002|Overall Study|Lack of Efficacy|0|||
126419015|NCT02021643|454828082|FG003|Overall Study|Lack of Efficacy|12|||
126419016|NCT02021643|454828079|FG000|Overall Study|Lost to Follow-up|0|||
126419017|NCT02021643|454828080|FG001|Overall Study|Lost to Follow-up|1|||
126419018|NCT02021643|454828081|FG002|Overall Study|Lost to Follow-up|0|||
126419019|NCT02021643|454828082|FG003|Overall Study|Lost to Follow-up|0|||
126419020|NCT02021643|454828079|FG000|Overall Study|Withdrew Consent|0|||
126419021|NCT02021643|454828080|FG001|Overall Study|Withdrew Consent|1|||
126419022|NCT02021643|454828081|FG002|Overall Study|Withdrew Consent|0|||
126419023|NCT02021643|454828082|FG003|Overall Study|Withdrew Consent|0|||
126419024|NCT04854551|454828083|FG000|Overall Study|Withdrawal by Subject|1|||
126419025|NCT04854551|454828084|FG001|Overall Study|Withdrawal by Subject|1|||
126419026|NCT02631551|454828085|FG000|Overall Study|Adverse Event|1|||
126419027|NCT02631551|454828086|FG001|Overall Study|Adverse Event|2|||
126419028|NCT02631551|454828087|FG002|Overall Study|Adverse Event|4|||
126419029|NCT02631551|454828088|FG003|Overall Study|Adverse Event|0|||
126419030|NCT02631551|454828085|FG000|Overall Study|Lack of Efficacy|0|||
126419031|NCT02631551|454828086|FG001|Overall Study|Lack of Efficacy|0|||
126419032|NCT02631551|454828087|FG002|Overall Study|Lack of Efficacy|1|||
126419033|NCT02631551|454828088|FG003|Overall Study|Lack of Efficacy|0|||
126419034|NCT02631551|454828085|FG000|Overall Study|Lost to Follow-up|1|||
126419035|NCT02631551|454828086|FG001|Overall Study|Lost to Follow-up|2|||
126419036|NCT02631551|454828087|FG002|Overall Study|Lost to Follow-up|0|||
126419037|NCT02631551|454828088|FG003|Overall Study|Lost to Follow-up|3|||
126419038|NCT02631551|454828085|FG000|Overall Study|Withdrawal by Subject|2|||
126419039|NCT02631551|454828086|FG001|Overall Study|Withdrawal by Subject|2|||
126419040|NCT02631551|454828087|FG002|Overall Study|Withdrawal by Subject|0|||
126419041|NCT02631551|454828088|FG003|Overall Study|Withdrawal by Subject|5|||
126419042|NCT02631551|454828085|FG000|Overall Study|Protocol deviation|3|||
126419043|NCT02631551|454828086|FG001|Overall Study|Protocol deviation|6|||
126419044|NCT02631551|454828087|FG002|Overall Study|Protocol deviation|3|||
126419045|NCT02631551|454828088|FG003|Overall Study|Protocol deviation|0|||
126419046|NCT02631551|454828085|FG000|Overall Study|Non-compliance with study procedures|0|||
126419047|NCT02631551|454828086|FG001|Overall Study|Non-compliance with study procedures|0|||
126419048|NCT02631551|454828087|FG002|Overall Study|Non-compliance with study procedures|1|||
126419049|NCT02631551|454828088|FG003|Overall Study|Non-compliance with study procedures|1|||
126419050|NCT02631551|454828085|FG000|Overall Study|Non-compliance with study drug|1|||
126419051|NCT02631551|454828086|FG001|Overall Study|Non-compliance with study drug|0|||
126419052|NCT02631551|454828087|FG002|Overall Study|Non-compliance with study drug|0|||
126419053|NCT02631551|454828088|FG003|Overall Study|Non-compliance with study drug|0|||
126419054|NCT02631551|454828085|FG000|Overall Study|Other, specific reasons not collected|5|||
126721923|NCT02993224|455931323|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
126721924|NCT02993224|455931323|FG000|Extension Phase|Adverse Event|3|||
126721925|NCT02993224|455931323|FG000|Extension Phase|Withdrawal by Subject|3|||
126721926|NCT02993224|455931323|FG000|Extension Phase|Lost to Follow-up|2|||
126419055|NCT02631551|454828086|FG001|Overall Study|Other, specific reasons not collected|7|||
126419056|NCT02631551|454828087|FG002|Overall Study|Other, specific reasons not collected|2|||
126419057|NCT02631551|454828088|FG003|Overall Study|Other, specific reasons not collected|2|||
126419058|NCT04112303|454828089|FG000|Overall Study|Death|1|||
126419059|NCT00377858|454828098|FG000|Overall Study|Withdrawal by Subject|12|||
126419060|NCT00377858|454828099|FG001|Overall Study|Withdrawal by Subject|11|||
126419061|NCT00377858|454828098|FG000|Overall Study|Lost to Follow-up|6|||
126419062|NCT00377858|454828099|FG001|Overall Study|Lost to Follow-up|1|||
126419063|NCT00377858|454828098|FG000|Overall Study|Physician Decision|5|||
126419064|NCT00377858|454828099|FG001|Overall Study|Physician Decision|5|||
126419065|NCT00377858|454828098|FG000|Overall Study|Protocol Violation|3|||
126419066|NCT00377858|454828099|FG001|Overall Study|Protocol Violation|4|||
126419067|NCT00377858|454828098|FG000|Overall Study|Adverse Event|2|||
126419068|NCT00377858|454828099|FG001|Overall Study|Adverse Event|1|||
126419069|NCT00377858|454828098|FG000|Overall Study|Entry Criteria Not Met|2|||
126419070|NCT00377858|454828099|FG001|Overall Study|Entry Criteria Not Met|0|||
126419071|NCT00377858|454828098|FG000|Overall Study|Sponsor Decision|1|||
126419072|NCT00377858|454828099|FG001|Overall Study|Sponsor Decision|2|||
126477033|NCT01090492|455046639|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126477034|NCT01090492|455046640|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126477035|NCT01090492|455046641|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126477036|NCT01090492|455046642|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126477037|NCT01090492|455046643|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126477038|NCT01090492|455046644|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126477039|NCT01090492|455046645|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
126477040|NCT01090492|455046646|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
126477041|NCT03113071|455046647|FG000|Overall Study|Withdrawal by Subject|1|||
126477042|NCT03113071|455046648|FG001|Overall Study|Withdrawal by Subject|0|||
126477043|NCT01602120|455046649|FG000|Overall Study|Adverse Event|3|||
126477044|NCT01602120|455046650|FG001|Overall Study|Adverse Event|6|||
126477045|NCT01602120|455046651|FG002|Overall Study|Adverse Event|0|||
126477046|NCT01602120|455046652|FG003|Overall Study|Adverse Event|2|||
126477047|NCT01602120|455046649|FG000|Overall Study|Death|0|||
126419073|NCT00377858|454828098|FG000|Overall Study|Death|0|||
126419074|NCT00377858|454828099|FG001|Overall Study|Death|3|||
126419075|NCT05636852|454828100|FG000|Overall Study|Withdrawal by Subject|1|||
126419076|NCT05636852|454828100|FG000|Overall Study|Other than specified|1|||
126419077|NCT01685697|454828101|FG000|Overall Study|Protocol Violation|3|||
126419078|NCT01685697|454828102|FG001|Overall Study|Protocol Violation|3|||
126419079|NCT01076036|454828103|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
126419080|NCT04034004|454828108|FG000|Overall Study|Withdrawal by Subject|1|||
126477048|NCT01602120|455046650|FG001|Overall Study|Death|4|||
126477049|NCT01602120|455046651|FG002|Overall Study|Death|0|||
126477050|NCT01602120|455046652|FG003|Overall Study|Death|0|||
126756530|NCT03730987|456059456|FG000|Overall Study|Lost to Follow-up|2|||
126419081|NCT04034004|454828109|FG001|Overall Study|Withdrawal by Subject|2|||
126419082|NCT04034004|454828110|FG002|Overall Study|Withdrawal by Subject|2|||
126419083|NCT04034004|454828111|FG003|Overall Study|Withdrawal by Subject|3|||
126419084|NCT04034004|454828108|FG000|Overall Study|could not find vein to administer IV|2|||
126419085|NCT04034004|454828109|FG001|Overall Study|could not find vein to administer IV|1|||
126419086|NCT04034004|454828110|FG002|Overall Study|could not find vein to administer IV|0|||
126419087|NCT04034004|454828111|FG003|Overall Study|could not find vein to administer IV|0|||
126419088|NCT04034004|454828108|FG000|Overall Study|nurse accidentally unblinded subject|0|||
126419089|NCT04034004|454828109|FG001|Overall Study|nurse accidentally unblinded subject|0|||
126419090|NCT04034004|454828110|FG002|Overall Study|nurse accidentally unblinded subject|0|||
126419091|NCT04034004|454828111|FG003|Overall Study|nurse accidentally unblinded subject|1|||
126419092|NCT01345188|454828112|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
126419093|NCT01345188|454828112|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
126419094|NCT01397461|454828113|FG000|Overall Study|Withdrawal by Subject|2|||
126419095|NCT01397461|454828114|FG001|Overall Study|Withdrawal by Subject|1|||
126419096|NCT01397461|454828115|FG002|Overall Study|Withdrawal by Subject|0|||
126419097|NCT01397461|454828113|FG000|Overall Study|Lost to Follow-up|0|||
126419098|NCT01397461|454828114|FG001|Overall Study|Lost to Follow-up|2|||
126419099|NCT01397461|454828115|FG002|Overall Study|Lost to Follow-up|1|||
126419100|NCT01397461|454828113|FG000|Overall Study|Lack of Efficacy|0|||
126419101|NCT01397461|454828114|FG001|Overall Study|Lack of Efficacy|3|||
126419102|NCT01397461|454828115|FG002|Overall Study|Lack of Efficacy|0|||
126419103|NCT01397461|454828113|FG000|Overall Study|Not treated|0|||
126419104|NCT01397461|454828114|FG001|Overall Study|Not treated|0|||
126419105|NCT01397461|454828115|FG002|Overall Study|Not treated|1|||
126419106|NCT05729568|454828132|FG000|Overall Study|Still on Study|52|||
126419107|NCT05729568|454828133|FG001|Overall Study|Still on Study|26|||
126419108|NCT05729568|454828132|FG000|Overall Study|Randomized but Never Treated|3|||
126419109|NCT05729568|454828133|FG001|Overall Study|Randomized but Never Treated|0|||
126477051|NCT01602120|455046649|FG000|Overall Study|Lost to Follow-up|0|||
126477052|NCT01602120|455046650|FG001|Overall Study|Lost to Follow-up|1|||
126477053|NCT01602120|455046651|FG002|Overall Study|Lost to Follow-up|0|||
126477054|NCT01602120|455046652|FG003|Overall Study|Lost to Follow-up|1|||
126477055|NCT01602120|455046649|FG000|Overall Study|Protocol Violation|1|||
126756531|NCT03730987|456059457|FG001|Overall Study|Lost to Follow-up|0|||
126419110|NCT05729568|454828132|FG000|Overall Study|Adverse Event|0|||
126419111|NCT05729568|454828133|FG001|Overall Study|Adverse Event|1|||
126419112|NCT05729568|454828132|FG000|Overall Study|Investigator's Discretion|1|||
126419113|NCT05729568|454828133|FG001|Overall Study|Investigator's Discretion|0|||
126419114|NCT04181762|454828134|FG000|Overall Study|Adverse Event|1|||
126419115|NCT04181762|454828135|FG001|Overall Study|Adverse Event|3|||
126419116|NCT04181762|454828134|FG000|Overall Study|Lost to Follow-up|1|||
126419117|NCT04181762|454828135|FG001|Overall Study|Lost to Follow-up|1|||
126419118|NCT04181762|454828134|FG000|Overall Study|Physician Decision|1|||
126419119|NCT04181762|454828135|FG001|Overall Study|Physician Decision|3|||
126419120|NCT04181762|454828134|FG000|Overall Study|Pregnancy|0|||
126419121|NCT04181762|454828135|FG001|Overall Study|Pregnancy|1|||
126419122|NCT04181762|454828134|FG000|Overall Study|Lack of Efficacy|2|||
126419123|NCT04181762|454828135|FG001|Overall Study|Lack of Efficacy|2|||
126419124|NCT04181762|454828134|FG000|Overall Study|Study terminated by sponsor|95|||
126419125|NCT04181762|454828135|FG001|Overall Study|Study terminated by sponsor|97|||
126419126|NCT04181762|454828134|FG000|Overall Study|Subject decision|11|||
126419127|NCT04181762|454828135|FG001|Overall Study|Subject decision|4|||
126419128|NCT04181762|454828134|FG000|Overall Study|Death|1|||
126419129|NCT04181762|454828135|FG001|Overall Study|Death|1|||
126419130|NCT04181762|454828134|FG000|Overall Study|Protocol deviation|1|||
126419131|NCT04181762|454828135|FG001|Overall Study|Protocol deviation|0|||
126419132|NCT04181762|454828134|FG000|Overall Study|Withdrawal of informed consent|1|||
126419133|NCT04181762|454828135|FG001|Overall Study|Withdrawal of informed consent|3|||
126419134|NCT04526145|454828136|FG000|Overall Study|Withdrawal by Subject|5|||
126419135|NCT01221350|454828142|FG000|Overall Study|Discontinued intervention (GERD)|1|||
126419136|NCT01221350|454828143|FG001|Overall Study|Discontinued intervention (GERD)|0|||
126419137|NCT01221350|454828142|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
126419138|NCT01221350|454828143|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
126419139|NCT01221350|454828142|FG000|Overall Study|Withdrawal by Subject|4|||
126419140|NCT01221350|454828143|FG001|Overall Study|Withdrawal by Subject|2|||
126419141|NCT00048347|454828159|FG000|Overall Study|Screen failure|2|||
126419142|NCT03508609|454828160|FG000|Overall Study|Withdrawal by Subject|1|||
126419143|NCT00555217|454828161|FG000|Overall Study|Withdrawal by Subject|35|||
126419144|NCT00555217|454828162|FG001|Overall Study|Withdrawal by Subject|31|||
126419145|NCT00555217|454828161|FG000|Overall Study|Lost to Follow-up|19|||
126419146|NCT00555217|454828162|FG001|Overall Study|Lost to Follow-up|20|||
126419147|NCT00555217|454828161|FG000|Overall Study|close out sites|21|||
126419148|NCT00555217|454828162|FG001|Overall Study|close out sites|17|||
126419149|NCT00367835|454828164|FG000|Overall Study|Adverse Event|14|||
126419150|NCT00367835|454828165|FG001|Overall Study|Adverse Event|1|||
126419151|NCT00367835|454828164|FG000|Overall Study|Protocol Violation|1|||
126419152|NCT00367835|454828165|FG001|Overall Study|Protocol Violation|7|||
126419153|NCT00367835|454828164|FG000|Overall Study|Withdrawal by Subject|7|||
126419154|NCT00367835|454828165|FG001|Overall Study|Withdrawal by Subject|6|||
126419155|NCT00367835|454828164|FG000|Overall Study|Lost to Follow-up|1|||
126419156|NCT00367835|454828165|FG001|Overall Study|Lost to Follow-up|4|||
126419157|NCT00367835|454828164|FG000|Overall Study|Lack of Efficacy|3|||
126419158|NCT00367835|454828165|FG001|Overall Study|Lack of Efficacy|12|||
126419159|NCT00367835|454828164|FG000|Overall Study|Subject in juvenile detention center|1|||
126419160|NCT00367835|454828165|FG001|Overall Study|Subject in juvenile detention center|0|||
126419161|NCT00367835|454828164|FG000|Overall Study|refused blood collection|1|||
126419162|NCT00367835|454828165|FG001|Overall Study|refused blood collection|0|||
126419163|NCT00367835|454828164|FG000|Overall Study|Did not respond to calls|1|||
126419164|NCT00367835|454828165|FG001|Overall Study|Did not respond to calls|0|||
126419165|NCT00367835|454828164|FG000|Overall Study|History of lead poisoning|0|||
126419166|NCT00367835|454828165|FG001|Overall Study|History of lead poisoning|1|||
126419167|NCT03761810|454828169|FG000|Overall Study|Adverse Event|12|||
126419168|NCT03761810|454828170|FG001|Overall Study|Adverse Event|0|||
126419169|NCT03761810|454828169|FG000|Overall Study|Lost to Follow-up|15|||
126419170|NCT03761810|454828170|FG001|Overall Study|Lost to Follow-up|7|||
126419171|NCT03761810|454828169|FG000|Overall Study|Pregnancy|1|||
126419172|NCT03761810|454828170|FG001|Overall Study|Pregnancy|0|||
126419173|NCT03761810|454828169|FG000|Overall Study|Withdrawal by Subject|14|||
126419174|NCT03761810|454828170|FG001|Overall Study|Withdrawal by Subject|5|||
126419175|NCT03761810|454828169|FG000|Overall Study|Physician Decision|1|||
126419176|NCT03761810|454828170|FG001|Overall Study|Physician Decision|0|||
126419177|NCT03761810|454828169|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
126419178|NCT03761810|454828170|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126419179|NCT03761810|454828169|FG000|Overall Study|Other Than Specified|1|||
126419180|NCT03761810|454828170|FG001|Overall Study|Other Than Specified|0|||
126419181|NCT01574651|454828171|FG000|Overall Study|Lost to Follow-up|2|||
126419182|NCT01574651|454828172|FG001|Overall Study|Lost to Follow-up|4|||
126419183|NCT01574651|454828171|FG000|Overall Study|Administrative problems|0|||
126419184|NCT01574651|454828172|FG001|Overall Study|Administrative problems|1|||
126419185|NCT01574651|454828171|FG000|Overall Study|Death|3|||
126419186|NCT01574651|454828172|FG001|Overall Study|Death|3|||
126419187|NCT01574651|454828171|FG000|Overall Study|Patient's inability to use the device|0|||
126419188|NCT01574651|454828172|FG001|Overall Study|Patient's inability to use the device|1|||
126419189|NCT01574651|454828171|FG000|Overall Study|Adverse Event|36|||
126419190|NCT01574651|454828172|FG001|Overall Study|Adverse Event|27|||
126419191|NCT01574651|454828171|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126419192|NCT01574651|454828172|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126419193|NCT01574651|454828171|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126419194|NCT01574651|454828172|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126419195|NCT01574651|454828171|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
126419196|NCT01574651|454828172|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126419197|NCT01574651|454828171|FG000|Overall Study|Protocol Violation|3|||
126419198|NCT01574651|454828172|FG001|Overall Study|Protocol Violation|5|||
126419199|NCT01574651|454828171|FG000|Overall Study|Withdrawal by Subject|9|||
126419200|NCT01574651|454828172|FG001|Overall Study|Withdrawal by Subject|10|||
126419201|NCT03887221|454828173|FG000|Overall Study|Protocol Violation|1|||
126419202|NCT03887221|454828174|FG001|Overall Study|Protocol Violation|0|||
126419203|NCT02487030|454828175|FG000|Overall Study|Lack of Efficacy|2|||
126419204|NCT02487030|454828176|FG001|Overall Study|Lack of Efficacy|4|||
126419205|NCT02487030|454828177|FG002|Overall Study|Lack of Efficacy|1|||
126419206|NCT02487030|454828178|FG003|Overall Study|Lack of Efficacy|0|||
126419207|NCT02487030|454828179|FG004|Overall Study|Lack of Efficacy|1|||
126419208|NCT02487030|454828180|FG005|Overall Study|Lack of Efficacy|0|||
126419209|NCT02487030|454828181|FG006|Overall Study|Lack of Efficacy|0|||
126419210|NCT02487030|454828175|FG000|Overall Study|Lost to Follow-up|0|||
126419211|NCT02487030|454828176|FG001|Overall Study|Lost to Follow-up|0|||
126419212|NCT02487030|454828177|FG002|Overall Study|Lost to Follow-up|1|||
126419213|NCT02487030|454828178|FG003|Overall Study|Lost to Follow-up|1|||
126419214|NCT02487030|454828179|FG004|Overall Study|Lost to Follow-up|0|||
126419215|NCT02487030|454828180|FG005|Overall Study|Lost to Follow-up|1|||
126419216|NCT02487030|454828181|FG006|Overall Study|Lost to Follow-up|0|||
126419217|NCT02487030|454828175|FG000|Overall Study|Adverse Event|0|||
126419218|NCT02487030|454828176|FG001|Overall Study|Adverse Event|0|||
126419219|NCT02487030|454828177|FG002|Overall Study|Adverse Event|0|||
126419220|NCT02487030|454828178|FG003|Overall Study|Adverse Event|1|||
126419221|NCT02487030|454828179|FG004|Overall Study|Adverse Event|0|||
126419222|NCT02487030|454828180|FG005|Overall Study|Adverse Event|0|||
126419223|NCT02487030|454828181|FG006|Overall Study|Adverse Event|0|||
126419224|NCT02487030|454828175|FG000|Overall Study|Death|0|||
126419225|NCT02487030|454828176|FG001|Overall Study|Death|0|||
126419226|NCT02487030|454828177|FG002|Overall Study|Death|0|||
126419227|NCT02487030|454828178|FG003|Overall Study|Death|0|||
126419228|NCT02487030|454828179|FG004|Overall Study|Death|1|||
126419229|NCT02487030|454828180|FG005|Overall Study|Death|0|||
126419230|NCT02487030|454828181|FG006|Overall Study|Death|0|||
126419231|NCT02092025|454828182|FG000|Overall Study|Case Report Forms Uncollected|44|||
126419232|NCT02092025|454828182|FG000|Overall Study|Protocol Deviation|24|||
126419233|NCT00264537|454828183|FG000|Overall Study|Death|0|||
126419234|NCT00264537|454828184|FG001|Overall Study|Death|3|||
126419235|NCT00264537|454828185|FG002|Overall Study|Death|3|||
126419236|NCT00264537|454828186|FG003|Overall Study|Death|2|||
126419237|NCT00264537|454828183|FG000|Overall Study|Lost to Follow-up|3|||
126419238|NCT00264537|454828184|FG001|Overall Study|Lost to Follow-up|4|||
126419239|NCT00264537|454828185|FG002|Overall Study|Lost to Follow-up|7|||
126419240|NCT00264537|454828186|FG003|Overall Study|Lost to Follow-up|6|||
126419241|NCT00264537|454828183|FG000|Overall Study|Adverse Event|21|||
126419242|NCT00264537|454828184|FG001|Overall Study|Adverse Event|32|||
126419243|NCT00264537|454828185|FG002|Overall Study|Adverse Event|24|||
126419244|NCT00264537|454828186|FG003|Overall Study|Adverse Event|34|||
126419245|NCT00264537|454828183|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
126419246|NCT00264537|454828184|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
126419247|NCT00264537|454828185|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
126419248|NCT00264537|454828186|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
126419249|NCT00264537|454828183|FG000|Overall Study|Other|21|||
126419250|NCT00264537|454828184|FG001|Overall Study|Other|11|||
126419251|NCT00264537|454828185|FG002|Overall Study|Other|10|||
126419252|NCT00264537|454828186|FG003|Overall Study|Other|11|||
126419253|NCT00264537|454828183|FG000|Overall Study|Not treated|0|||
126559085|NCT02412761|455340643|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126419254|NCT00264537|454828184|FG001|Overall Study|Not treated|2|||
126419255|NCT00264537|454828185|FG002|Overall Study|Not treated|1|||
126419256|NCT00264537|454828186|FG003|Overall Study|Not treated|0|||
126419257|NCT03228212|454828188|FG000|Period 1|Adverse Event|1|||
126419258|NCT03228212|454828189|FG001|Period 1|Adverse Event|0|||
126419259|NCT03228212|454828188|FG000|Period 1|no longer meets eligibility criteria|0|||
126419260|NCT03228212|454828189|FG001|Period 1|no longer meets eligibility criteria|1|||
126419261|NCT03228212|454828188|FG000|Period 2|Lost to Follow-up|1|||
126419262|NCT03228212|454828189|FG001|Period 2|Lost to Follow-up|0|||
126419263|NCT01807299|454828190|FG000|Overall Study|Protocol Violation|3|||
126419264|NCT01807299|454828191|FG001|Overall Study|Protocol Violation|1|||
126419265|NCT01807299|454828192|FG002|Overall Study|Protocol Violation|0|||
126419266|NCT01807299|454828193|FG003|Overall Study|Protocol Violation|2|||
126419267|NCT00999544|454829930|FG000|Overall Study|Withdrawal by Subject|1|||
126419268|NCT02407223|454829932|FG000|Overall Study|Adverse Event|1|||
126419269|NCT02407223|454829933|FG001|Overall Study|Adverse Event|0|||
126419270|NCT02407223|454829934|FG002|Overall Study|Adverse Event|1|||
126419271|NCT02407223|454829932|FG000|Overall Study|Lack of Efficacy|6|||
126559086|NCT02412761|455340644|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126419272|NCT02407223|454829933|FG001|Overall Study|Lack of Efficacy|6|||
126419273|NCT02407223|454829934|FG002|Overall Study|Lack of Efficacy|4|||
126419274|NCT02407223|454829932|FG000|Overall Study|Lost to Follow-up|1|||
126419275|NCT02407223|454829933|FG001|Overall Study|Lost to Follow-up|0|||
126419276|NCT02407223|454829934|FG002|Overall Study|Lost to Follow-up|2|||
126419277|NCT02407223|454829932|FG000|Overall Study|Withdrawal by Subject|2|||
126419278|NCT02407223|454829933|FG001|Overall Study|Withdrawal by Subject|4|||
126419279|NCT02407223|454829934|FG002|Overall Study|Withdrawal by Subject|4|||
126419280|NCT02407223|454829932|FG000|Overall Study|Study Terminated by Sponsor|77|||
126419281|NCT02407223|454829933|FG001|Overall Study|Study Terminated by Sponsor|80|||
126419282|NCT02407223|454829934|FG002|Overall Study|Study Terminated by Sponsor|86|||
126419283|NCT02407223|454829932|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
126419284|NCT02407223|454829933|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
126419285|NCT02407223|454829934|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
126419286|NCT02407223|454829932|FG000|Overall Study|Other|29|||
126419287|NCT02407223|454829933|FG001|Overall Study|Other|27|||
126419288|NCT02407223|454829934|FG002|Overall Study|Other|25|||
126419289|NCT01478971|454829943|FG000|Standard of Care Period|Adverse Event|1|||
126419290|NCT01478971|454829943|FG000|Standard of Care Period|Withdrawal by Subject|3|||
126419291|NCT01478971|454829943|FG000|Standard of Care Period|Death|8|||
126419292|NCT01478971|454829943|FG000|Standard of Care Period|Lost to Follow-up|9|||
126419293|NCT01478971|454829943|FG000|Standard of Care Period|Other|4|||
126419294|NCT01478971|454829943|FG000|Peginesatide Treatment Period|Adverse Event|1|||
126419295|NCT01478971|454829943|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
126419296|NCT01478971|454829943|FG000|Peginesatide Treatment Period|Death|4|||
126419297|NCT01478971|454829943|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
126419298|NCT01478971|454829943|FG000|Peginesatide Treatment Period|Other|4|||
126419299|NCT00584012|454829944|FG000|Overall Study|Withdrawal by Subject|1|||
126419300|NCT01525615|454829945|FG000|Overall Study|Adverse Event|11|||
126419301|NCT01525615|454829946|FG001|Overall Study|Adverse Event|7|||
126419302|NCT01525615|454829947|FG002|Overall Study|Adverse Event|5|||
126419303|NCT01525615|454829945|FG000|Overall Study|Lost to Follow-up|1|||
126419304|NCT01525615|454829946|FG001|Overall Study|Lost to Follow-up|0|||
126419305|NCT01525615|454829947|FG002|Overall Study|Lost to Follow-up|0|||
126419306|NCT01525615|454829945|FG000|Overall Study|Withdrawal by Subject|1|||
126419307|NCT01525615|454829946|FG001|Overall Study|Withdrawal by Subject|0|||
126419308|NCT01525615|454829947|FG002|Overall Study|Withdrawal by Subject|0|||
126419309|NCT01525615|454829945|FG000|Overall Study|Other reason not described above|1|||
126419310|NCT01525615|454829946|FG001|Overall Study|Other reason not described above|0|||
126419311|NCT01525615|454829947|FG002|Overall Study|Other reason not described above|1|||
126419312|NCT04050618|454829948|FG000|First Intervention|Withdrawal by Subject|2|||
126419313|NCT04050618|454829949|FG001|First Intervention|Withdrawal by Subject|0|||
126419314|NCT04050618|454829948|FG000|Second Intervention|Withdrawal by Subject|1|||
126419315|NCT04050618|454829949|FG001|Second Intervention|Withdrawal by Subject|0|||
126419316|NCT04404556|454829950|FG000|Intervention|Withdrawal by Subject|15|||
126419317|NCT04404556|454829951|FG001|Intervention|Withdrawal by Subject|3|||
126419318|NCT04404556|454829950|FG000|Intervention|Did not complete all intervention sessions|2|||
126419319|NCT04404556|454829951|FG001|Intervention|Did not complete all intervention sessions|1|||
126419320|NCT04404556|454829950|FG000|Post-Intervention|Missing Data|1|||
126419321|NCT04404556|454829951|FG001|Post-Intervention|Missing Data|2|||
126419322|NCT04404556|454829950|FG000|Follow-up 1|Withdrawal by Subject|5|||
126419323|NCT04404556|454829951|FG001|Follow-up 1|Withdrawal by Subject|1|||
126419324|NCT04404556|454829950|FG000|Follow-up 1|Missing Data|4|||
126419325|NCT04404556|454829951|FG001|Follow-up 1|Missing Data|7|||
126419326|NCT04404556|454829950|FG000|Follow-up 2|Withdrawal by Subject|1|||
126419327|NCT04404556|454829951|FG001|Follow-up 2|Withdrawal by Subject|1|||
126419328|NCT04404556|454829950|FG000|Follow-up 2|Missing Data|6|||
126419329|NCT04404556|454829951|FG001|Follow-up 2|Missing Data|5|||
126419330|NCT04775953|454829952|FG000|Overall Study|Lost to Follow-up|6|||
126419331|NCT04775953|454829953|FG001|Overall Study|Lost to Follow-up|11|||
126419332|NCT04775953|454829952|FG000|Overall Study|Death|5|||
126419333|NCT04775953|454829953|FG001|Overall Study|Death|4|||
126419334|NCT04775953|454829952|FG000|Overall Study|Withdrawal by Subject|3|||
126419335|NCT04775953|454829953|FG001|Overall Study|Withdrawal by Subject|3|||
126419336|NCT04775953|454829952|FG000|Overall Study|Protocol Violation|2|||
126419337|NCT04775953|454829953|FG001|Overall Study|Protocol Violation|0|||
126419338|NCT04775953|454829952|FG000|Overall Study|Participant non-compliance|0|||
126419339|NCT04775953|454829953|FG001|Overall Study|Participant non-compliance|1|||
126419340|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
126419341|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
126419342|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
126419343|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
126419344|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
126419345|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
126419346|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
126419347|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
126419348|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
126419349|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
126419350|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
126419351|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
126419352|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
126419353|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
126419354|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
126419355|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
126419356|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
126419357|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
126419358|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
126419359|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
126419360|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
126419361|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
126419362|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
126419363|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
126419364|NCT03777059|454829954|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
126419365|NCT03777059|454829955|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
126419366|NCT03777059|454829956|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
126419367|NCT03777059|454829957|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
126419368|NCT03777059|454829954|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
126419369|NCT03777059|454829955|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
126419370|NCT03777059|454829956|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
126419371|NCT03777059|454829957|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
126419372|NCT03777059|454829954|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
126419373|NCT03777059|454829955|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
126419374|NCT03777059|454829956|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
126419375|NCT03777059|454829957|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
126419376|NCT03777059|454829954|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
126419377|NCT03777059|454829955|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
126419378|NCT03777059|454829956|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
126419379|NCT03777059|454829957|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
126419380|NCT03777059|454829954|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
126419381|NCT03777059|454829955|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
126419382|NCT03777059|454829956|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
126419383|NCT03777059|454829957|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
126419384|NCT00855959|454829958|FG000|Overall Study|Adverse Event|2|||
126419385|NCT00855959|454829958|FG000|Overall Study|Lost to Follow-up|2|||
126419386|NCT00855959|454829958|FG000|Overall Study|Withdrawal by Subject|3|||
126419387|NCT00855959|454829958|FG000|Overall Study|Pregnancy|1|||
126419388|NCT00855959|454829958|FG000|Overall Study|Incorrect enrolment|1|||
126419389|NCT02813889|454829959|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
126419390|NCT02813889|454829960|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
126419391|NCT02451943|454829967|FG000|Overall Study|Withdrawal by Subject|13|||
126419392|NCT02451943|454829968|FG001|Overall Study|Withdrawal by Subject|16|||
126419393|NCT02451943|454829967|FG000|Overall Study|Lost to Follow-up|3|||
126419394|NCT02451943|454829968|FG001|Overall Study|Lost to Follow-up|4|||
126419395|NCT02451943|454829967|FG000|Overall Study|Sponsor Decision|0|||
126419396|NCT02451943|454829968|FG001|Overall Study|Sponsor Decision|4|||
126419397|NCT00368641|454829969|FG000|Overall Study|Adverse Event|2|||
126419398|NCT00368641|454829970|FG001|Overall Study|Adverse Event|1|||
126419399|NCT00368641|454829969|FG000|Overall Study|Death|1|||
126419400|NCT00368641|454829970|FG001|Overall Study|Death|0|||
126419401|NCT00368641|454829969|FG000|Overall Study|Withdrawal by Subject|1|||
126419402|NCT00368641|454829970|FG001|Overall Study|Withdrawal by Subject|0|||
126419403|NCT00368641|454829969|FG000|Overall Study|Sponsor decision to terminate study|2|||
126419404|NCT00368641|454829970|FG001|Overall Study|Sponsor decision to terminate study|5|||
126419405|NCT01101035|454829972|FG000|Overall Study|Adverse Event|191|||
126419406|NCT01101035|454829973|FG001|Overall Study|Adverse Event|172|||
126419407|NCT01101035|454829972|FG000|Overall Study|Major Protocol Deviation|52|||
126419408|NCT01101035|454829973|FG001|Overall Study|Major Protocol Deviation|46|||
126419409|NCT01101035|454829972|FG000|Overall Study|Lost to Follow-up|226|||
126419410|NCT01101035|454829973|FG001|Overall Study|Lost to Follow-up|223|||
126419411|NCT01101035|454829972|FG000|Overall Study|Voluntary Withdrawal|595|||
126419412|NCT01101035|454829973|FG001|Overall Study|Voluntary Withdrawal|587|||
126419413|NCT01101035|454829972|FG000|Overall Study|Reason not Specified|333|||
126419414|NCT01101035|454829973|FG001|Overall Study|Reason not Specified|363|||
126419415|NCT00763386|454829974|FG000|Overall Study|Adverse Event|43|||
126419416|NCT00763386|454829975|FG001|Overall Study|Adverse Event|33|||
126419417|NCT00763386|454829974|FG000|Overall Study|Death|1|||
126419418|NCT00763386|454829975|FG001|Overall Study|Death|2|||
126419419|NCT00763386|454829974|FG000|Overall Study|Lost to Follow-up|3|||
126419420|NCT00763386|454829975|FG001|Overall Study|Lost to Follow-up|3|||
126419421|NCT00763386|454829974|FG000|Overall Study|Withdrawal by Subject|0|||
126419422|NCT00763386|454829975|FG001|Overall Study|Withdrawal by Subject|1|||
126419423|NCT00763386|454829974|FG000|Overall Study|CRF missing|0|||
126419424|NCT00763386|454829975|FG001|Overall Study|CRF missing|1|||
126419425|NCT00763386|454829974|FG000|Overall Study|Study Prosthesis Removed|1|||
126419426|NCT00763386|454829975|FG001|Overall Study|Study Prosthesis Removed|0|||
126419427|NCT00681629|454829978|FG000|Overall Study|Study termination|4|||
126419428|NCT00681629|454829979|FG001|Overall Study|Study termination|2|||
126419429|NCT00681629|454829978|FG000|Overall Study|Adverse Event|1|||
126419430|NCT00681629|454829979|FG001|Overall Study|Adverse Event|0|||
126419431|NCT00411671|454829980|FG000|Overall Study|Adverse Event|15|||
126419432|NCT00411671|454829980|FG000|Overall Study|Death|2|||
126419433|NCT00411671|454829980|FG000|Overall Study|Lost to Follow-up|3|||
126419434|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
126419435|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126419436|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126419437|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126419438|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126419439|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
126419440|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126419441|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126419442|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126419443|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126419444|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
126419445|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126419446|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126419447|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126419448|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126419449|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
126419450|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126419451|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126419452|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126419453|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126419454|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
126419455|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126419456|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126419457|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126419458|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126419459|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
126419460|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126419461|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126419462|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126419463|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126419464|NCT01173601|454829984|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
126419465|NCT01173601|454829985|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126419466|NCT01173601|454829986|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126419467|NCT01173601|454829987|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126419468|NCT01173601|454829988|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126419469|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
126419470|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
126419471|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
126419472|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
126419473|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
126419474|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
126419475|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
126419476|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
126419477|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
126419478|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
126419479|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
126419480|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
126419481|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
126419482|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
126419483|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
126419484|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126419485|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
126419486|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126419487|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
126477056|NCT01602120|455046650|FG001|Overall Study|Protocol Violation|1|||
126477057|NCT01602120|455046651|FG002|Overall Study|Protocol Violation|0|||
126477058|NCT01602120|455046652|FG003|Overall Study|Protocol Violation|0|||
126477059|NCT01602120|455046649|FG000|Overall Study|Non-compliance|0|||
126477060|NCT01602120|455046650|FG001|Overall Study|Non-compliance|3|||
126477061|NCT01602120|455046651|FG002|Overall Study|Non-compliance|0|||
126477062|NCT01602120|455046652|FG003|Overall Study|Non-compliance|1|||
126477063|NCT01602120|455046649|FG000|Overall Study|Withdrawal by Subject|8|||
126477064|NCT01602120|455046650|FG001|Overall Study|Withdrawal by Subject|17|||
126477065|NCT01602120|455046651|FG002|Overall Study|Withdrawal by Subject|0|||
126477066|NCT01602120|455046652|FG003|Overall Study|Withdrawal by Subject|3|||
126477067|NCT01602120|455046649|FG000|Overall Study|Study Terminated by Sponsor|12|||
126477068|NCT01602120|455046650|FG001|Overall Study|Study Terminated by Sponsor|24|||
126477069|NCT01602120|455046651|FG002|Overall Study|Study Terminated by Sponsor|17|||
126477070|NCT01602120|455046652|FG003|Overall Study|Study Terminated by Sponsor|44|||
126477071|NCT01602120|455046649|FG000|Overall Study|Physician Decision|2|||
126477072|NCT01602120|455046650|FG001|Overall Study|Physician Decision|3|||
126477073|NCT01602120|455046651|FG002|Overall Study|Physician Decision|0|||
126477074|NCT01602120|455046652|FG003|Overall Study|Physician Decision|0|||
126477075|NCT01602120|455046649|FG000|Overall Study|Unspecified Reason|3|||
126477076|NCT01602120|455046650|FG001|Overall Study|Unspecified Reason|1|||
126477077|NCT01602120|455046651|FG002|Overall Study|Unspecified Reason|0|||
126477078|NCT01602120|455046652|FG003|Overall Study|Unspecified Reason|2|||
126477079|NCT01611155|455046653|FG000|Overall Study|Adverse Event|1|||
126477080|NCT01611155|455046654|FG001|Overall Study|Adverse Event|1|||
126477081|NCT01611155|455046653|FG000|Overall Study|Refused further treatment|6|||
126477082|NCT01611155|455046654|FG001|Overall Study|Refused further treatment|4|||
126477083|NCT01611155|455046653|FG000|Overall Study|Disease progression|1|||
126477084|NCT01611155|455046654|FG001|Overall Study|Disease progression|0|||
126477085|NCT01611155|455046653|FG000|Overall Study|Withdrawal by Subject|1|||
126477086|NCT01611155|455046654|FG001|Overall Study|Withdrawal by Subject|0|||
126477087|NCT01611155|455046653|FG000|Overall Study|Alternative treatment|0|||
126477088|NCT01611155|455046654|FG001|Overall Study|Alternative treatment|1|||
126477089|NCT01611155|455046653|FG000|Overall Study|Ineligible patient|0|||
126477090|NCT01611155|455046654|FG001|Overall Study|Ineligible patient|1|||
126477091|NCT00868608|455046661|FG000|Overall Study|Withdrawal by Subject|3|||
126477092|NCT00868608|455046662|FG001|Overall Study|Withdrawal by Subject|1|||
126477093|NCT00868608|455046663|FG002|Overall Study|Withdrawal by Subject|0|||
126477094|NCT00868608|455046661|FG000|Overall Study|Lost to Follow-up|3|||
126477095|NCT00868608|455046662|FG001|Overall Study|Lost to Follow-up|0|||
126477096|NCT00868608|455046663|FG002|Overall Study|Lost to Follow-up|1|||
126477097|NCT00868608|455046661|FG000|Overall Study|Death|16|||
126477098|NCT00868608|455046662|FG001|Overall Study|Death|2|||
126477099|NCT00868608|455046663|FG002|Overall Study|Death|4|||
126477100|NCT00868608|455046661|FG000|Overall Study|Other - Unspecified|1|||
126477101|NCT00868608|455046662|FG001|Overall Study|Other - Unspecified|0|||
126477102|NCT00868608|455046663|FG002|Overall Study|Other - Unspecified|0|||
126477103|NCT03344796|455046664|FG000|Overall Study|Lost to Follow-up|0|||
126477104|NCT03344796|455046665|FG001|Overall Study|Lost to Follow-up|0|||
126477105|NCT03344796|455046666|FG002|Overall Study|Lost to Follow-up|0|||
126419488|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
126419489|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
126419490|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
126419491|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
126419492|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
126419493|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
126419494|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
126419495|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
126419496|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
126419497|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
126419498|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
126419499|NCT01173601|454829984|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
126419500|NCT01173601|454829985|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
126419501|NCT01173601|454829986|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
126477106|NCT03344796|455046667|FG003|Overall Study|Lost to Follow-up|0|||
126477107|NCT03344796|455046668|FG004|Overall Study|Lost to Follow-up|0|||
126477108|NCT03344796|455046669|FG005|Overall Study|Lost to Follow-up|2|||
126477109|NCT01999179|455046672|FG000|Overall Study|Adverse Event|1|||
126477110|NCT01999179|455046672|FG000|Overall Study|Lost to Follow-up|1|||
126477111|NCT01999179|455046672|FG000|Overall Study|Change in Therapy|3|||
126477112|NCT01999179|455046672|FG000|Overall Study|New catheter|2|||
126477113|NCT02564796|455046673|FG000|Overall Study|Physician Decision|2|||
126477114|NCT02564796|455046674|FG001|Overall Study|Physician Decision|2|||
126477115|NCT00453063|455046675|FG000|Overall Study|Adverse Event|1|||
126477116|NCT00453063|455046676|FG001|Overall Study|Adverse Event|2|||
126477117|NCT00453063|455046675|FG000|Overall Study|Withdrawal by Subject|1|||
126477118|NCT00453063|455046676|FG001|Overall Study|Withdrawal by Subject|1|||
126477119|NCT00453063|455046675|FG000|Overall Study|Protocol Violation|1|||
126477120|NCT00453063|455046676|FG001|Overall Study|Protocol Violation|0|||
126419502|NCT01173601|454829987|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
126419503|NCT01173601|454829988|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
126419504|NCT03951077|454829989|FG000|Overall Study|Adverse Event|1|||
126419505|NCT03951077|454829990|FG001|Overall Study|Adverse Event|0|||
126419506|NCT03951077|454829991|FG002|Overall Study|Adverse Event|0|||
126419507|NCT03951077|454829992|FG003|Overall Study|Adverse Event|0|||
126419508|NCT03951077|454829993|FG004|Overall Study|Adverse Event|0|||
126419509|NCT03951077|454829994|FG005|Overall Study|Adverse Event|0|||
126419510|NCT03951077|454829989|FG000|Overall Study|Withdrawal by Subject|3|||
126419511|NCT03951077|454829990|FG001|Overall Study|Withdrawal by Subject|3|||
126419512|NCT03951077|454829991|FG002|Overall Study|Withdrawal by Subject|0|||
126419513|NCT03951077|454829992|FG003|Overall Study|Withdrawal by Subject|3|||
126419514|NCT03951077|454829993|FG004|Overall Study|Withdrawal by Subject|3|||
126419515|NCT03951077|454829994|FG005|Overall Study|Withdrawal by Subject|2|||
126419516|NCT03951077|454829989|FG000|Overall Study|Lost to Follow-up|1|||
126419517|NCT03951077|454829990|FG001|Overall Study|Lost to Follow-up|1|||
126419518|NCT03951077|454829991|FG002|Overall Study|Lost to Follow-up|2|||
126419519|NCT03951077|454829992|FG003|Overall Study|Lost to Follow-up|3|||
126419520|NCT03951077|454829993|FG004|Overall Study|Lost to Follow-up|2|||
126419521|NCT03951077|454829994|FG005|Overall Study|Lost to Follow-up|3|||
126419522|NCT03951077|454829989|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
126419523|NCT03951077|454829990|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
126419524|NCT03951077|454829991|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
126477121|NCT03128411|455046679|FG000|Treatment Phase|Adverse Event|21|||
126477122|NCT03128411|455046679|FG000|Treatment Phase|Physician Decision|1|||
126477123|NCT03128411|455046679|FG000|Treatment Phase|Other|2|||
126477124|NCT03128411|455046679|FG000|Long Term Follow-up Phase|Death|2|||
126477125|NCT00228384|455046680|FG000|Overall Study|Death|9|||
126477126|NCT00228384|455046681|FG001|Overall Study|Death|3|||
126477127|NCT00228384|455046680|FG000|Overall Study|Lost to Follow-up|6|||
126477128|NCT00228384|455046681|FG001|Overall Study|Lost to Follow-up|10|||
126477129|NCT00228384|455046680|FG000|Overall Study|Surgical Intervention (bypass)|5|||
126477130|NCT00228384|455046681|FG001|Overall Study|Surgical Intervention (bypass)|5|||
126477131|NCT00228384|455046680|FG000|Overall Study|Withdrawal by Subject|9|||
126477132|NCT00228384|455046681|FG001|Overall Study|Withdrawal by Subject|10|||
126477133|NCT00228384|455046680|FG000|Overall Study|Physician Decision|0|||
126477134|NCT00228384|455046681|FG001|Overall Study|Physician Decision|1|||
126477135|NCT01785069|455046687|FG000|Overall Study|Implanted with nonstudy device|1|||
126477136|NCT01785069|455046688|FG001|Overall Study|Implanted with nonstudy device|2|||
126477137|NCT01785069|455046689|FG002|Overall Study|Implanted with nonstudy device|1|||
126477138|NCT01785069|455046690|FG003|Overall Study|Implanted with nonstudy device|0|||
126477139|NCT01785069|455046687|FG000|Overall Study|Death|0|||
126477140|NCT01785069|455046688|FG001|Overall Study|Death|0|||
126477141|NCT01785069|455046689|FG002|Overall Study|Death|2|||
126419525|NCT03951077|454829992|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
126419526|NCT03951077|454829993|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
126419527|NCT03951077|454829994|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
126419528|NCT03951077|454829989|FG000|Overall Study|Other, Not Specified|12|||
126419529|NCT03951077|454829990|FG001|Overall Study|Other, Not Specified|10|||
126419530|NCT03951077|454829991|FG002|Overall Study|Other, Not Specified|10|||
126419531|NCT03951077|454829992|FG003|Overall Study|Other, Not Specified|5|||
126419532|NCT03951077|454829993|FG004|Overall Study|Other, Not Specified|9|||
126419533|NCT03951077|454829994|FG005|Overall Study|Other, Not Specified|6|||
126419534|NCT03951077|454829989|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
126477142|NCT01785069|455046690|FG003|Overall Study|Death|0|||
126559087|NCT02412761|455340645|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126419535|NCT03951077|454829990|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
126419536|NCT03951077|454829991|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
126419537|NCT03951077|454829992|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
126419538|NCT03951077|454829993|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
126419539|NCT03951077|454829994|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
126419540|NCT01395901|454829997|FG000|Overall Study|Lost to Follow-up|4|||
126419541|NCT01395901|454829998|FG001|Overall Study|Lost to Follow-up|0|||
126419542|NCT01395901|454829997|FG000|Overall Study|Randomized but not received study drug|5|||
126419543|NCT01395901|454829998|FG001|Overall Study|Randomized but not received study drug|4|||
126477143|NCT01785069|455046687|FG000|Overall Study|Subject choice|2|||
126477144|NCT01785069|455046688|FG001|Overall Study|Subject choice|2|||
126559088|NCT02240680|455340646|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
126477145|NCT01785069|455046689|FG002|Overall Study|Subject choice|0|||
126477146|NCT01785069|455046690|FG003|Overall Study|Subject choice|1|||
126477147|NCT01785069|455046687|FG000|Overall Study|Lost to Follow-up|1|||
126477148|NCT01785069|455046688|FG001|Overall Study|Lost to Follow-up|2|||
126477149|NCT01785069|455046689|FG002|Overall Study|Lost to Follow-up|4|||
126559089|NCT02240680|455340647|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
126477150|NCT01785069|455046690|FG003|Overall Study|Lost to Follow-up|1|||
126477151|NCT01785069|455046687|FG000|Overall Study|Reason not Specified|1|||
126477152|NCT01785069|455046688|FG001|Overall Study|Reason not Specified|2|||
126477153|NCT01785069|455046689|FG002|Overall Study|Reason not Specified|1|||
126477154|NCT01785069|455046690|FG003|Overall Study|Reason not Specified|4|||
126477155|NCT01785069|455046687|FG000|Overall Study|Not evaluable|7|||
126477156|NCT01785069|455046688|FG001|Overall Study|Not evaluable|4|||
126477157|NCT01785069|455046689|FG002|Overall Study|Not evaluable|5|||
126477158|NCT01785069|455046690|FG003|Overall Study|Not evaluable|8|||
126477159|NCT02900976|455046696|FG000|Overall Study|Adverse Event|0|||
126477160|NCT02900976|455046697|FG001|Overall Study|Adverse Event|1|||
126477161|NCT02900976|455046696|FG000|Overall Study|Physician Decision|0|||
126477162|NCT02900976|455046697|FG001|Overall Study|Physician Decision|2|||
126477163|NCT02900976|455046696|FG000|Overall Study|Progressive disease|0|||
126477164|NCT02900976|455046697|FG001|Overall Study|Progressive disease|6|||
126477165|NCT04997304|455046698|FG000|Overall Study|Lost to Follow-up|11|||
126477166|NCT04997304|455046698|FG000|Overall Study|Death|1|||
126477167|NCT04997304|455046698|FG000|Overall Study|Withdrawal by Subject|14|||
126477168|NCT06934993|455046699|FG000|Overall Study|Withdrawal by Subject|29|||
126477169|NCT06934993|455046699|FG000|Overall Study|elevated postoperative creatinine level|11|||
126477170|NCT06934993|455046699|FG000|Overall Study|Death|3|||
126477171|NCT01594281|455048191|FG000|Interventional Core Phase|Protocol Deviation|1|||
126477172|NCT01594281|455048192|FG001|Interventional Core Phase|Protocol Deviation|0|||
126477173|NCT01594281|455048193|FG002|Interventional Core Phase|Protocol Deviation|0|||
126477174|NCT01594281|455048191|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
126477175|NCT01594281|455048192|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
126477176|NCT01594281|455048193|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
126477177|NCT01594281|455048191|FG000|Interventional Core Phase|Death|1|||
126477178|NCT01594281|455048192|FG001|Interventional Core Phase|Death|1|||
126477179|NCT01594281|455048193|FG002|Interventional Core Phase|Death|2|||
126477180|NCT01594281|455048191|FG000|Interventional Core Phase|Lost to Follow-up|1|||
126477181|NCT01594281|455048192|FG001|Interventional Core Phase|Lost to Follow-up|4|||
126477182|NCT01594281|455048193|FG002|Interventional Core Phase|Lost to Follow-up|1|||
126477183|NCT01594281|455048191|FG000|Interventional Core Phase|Adverse Event|4|||
126477184|NCT01594281|455048192|FG001|Interventional Core Phase|Adverse Event|4|||
126477185|NCT01594281|455048193|FG002|Interventional Core Phase|Adverse Event|4|||
126477186|NCT01594281|455048191|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
126477187|NCT01594281|455048192|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
126477188|NCT01594281|455048193|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
126419544|NCT01395901|454829997|FG000|Overall Study|Adverse Event|0|||
126419545|NCT01395901|454829998|FG001|Overall Study|Adverse Event|1|||
126419546|NCT01395901|454829997|FG000|Overall Study|Withdrawal of consent|1|||
126419547|NCT01395901|454829998|FG001|Overall Study|Withdrawal of consent|0|||
126419548|NCT00713544|454830004|FG000|Overall Study|Adverse Event|5|||
126419549|NCT00713544|454830005|FG001|Overall Study|Adverse Event|3|||
126419550|NCT00713544|454830006|FG002|Overall Study|Adverse Event|7|||
126419551|NCT00713544|454830007|FG003|Overall Study|Adverse Event|7|||
126419552|NCT00713544|454830008|FG004|Overall Study|Adverse Event|3|||
126419553|NCT00713544|454830009|FG005|Overall Study|Adverse Event|5|||
126419554|NCT00713544|454830004|FG000|Overall Study|Withdrawal by Subject|2|||
126419555|NCT00713544|454830005|FG001|Overall Study|Withdrawal by Subject|0|||
126419556|NCT00713544|454830006|FG002|Overall Study|Withdrawal by Subject|3|||
126419557|NCT00713544|454830007|FG003|Overall Study|Withdrawal by Subject|2|||
126419558|NCT00713544|454830008|FG004|Overall Study|Withdrawal by Subject|3|||
126419559|NCT00713544|454830009|FG005|Overall Study|Withdrawal by Subject|1|||
126419560|NCT00713544|454830004|FG000|Overall Study|Protocol Violation|0|||
126419561|NCT00713544|454830005|FG001|Overall Study|Protocol Violation|0|||
126419562|NCT00713544|454830006|FG002|Overall Study|Protocol Violation|0|||
126419563|NCT00713544|454830007|FG003|Overall Study|Protocol Violation|0|||
126419564|NCT00713544|454830008|FG004|Overall Study|Protocol Violation|0|||
126477189|NCT01594281|455048191|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
126477190|NCT01594281|455048192|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
126477191|NCT01594281|455048193|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
126477192|NCT01594281|455048191|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
126477193|NCT01594281|455048192|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
126477194|NCT01594281|455048193|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
126477195|NCT01871532|455048194|FG000|Overall Study|Withdrawal by Subject|1|||
126477196|NCT01871532|455048195|FG001|Overall Study|Withdrawal by Subject|2|||
126477197|NCT02195583|455048197|FG000|Overall Study|Lost to Follow-up|1|||
126477198|NCT02195583|455048197|FG000|Overall Study|Withdrawal by Subject|4|||
126477199|NCT02195583|455048197|FG000|Overall Study|Adverse Event|2|||
126419565|NCT00713544|454830009|FG005|Overall Study|Protocol Violation|1|||
126419566|NCT00713544|454830004|FG000|Overall Study|Physician Decision|0|||
126419567|NCT00713544|454830005|FG001|Overall Study|Physician Decision|0|||
126419568|NCT00713544|454830006|FG002|Overall Study|Physician Decision|0|||
126419569|NCT00713544|454830007|FG003|Overall Study|Physician Decision|0|||
126419570|NCT00713544|454830008|FG004|Overall Study|Physician Decision|0|||
126419571|NCT00713544|454830009|FG005|Overall Study|Physician Decision|2|||
126419572|NCT00713544|454830004|FG000|Overall Study|Lack of Efficacy|0|||
126419573|NCT00713544|454830005|FG001|Overall Study|Lack of Efficacy|1|||
126419574|NCT00713544|454830006|FG002|Overall Study|Lack of Efficacy|0|||
126419575|NCT00713544|454830007|FG003|Overall Study|Lack of Efficacy|1|||
126419576|NCT00713544|454830008|FG004|Overall Study|Lack of Efficacy|1|||
126419577|NCT00713544|454830009|FG005|Overall Study|Lack of Efficacy|0|||
126419578|NCT00713544|454830004|FG000|Overall Study|Lost to Follow-up|0|||
126419579|NCT00713544|454830005|FG001|Overall Study|Lost to Follow-up|0|||
126419580|NCT00713544|454830006|FG002|Overall Study|Lost to Follow-up|1|||
126419581|NCT00713544|454830007|FG003|Overall Study|Lost to Follow-up|0|||
126419582|NCT00713544|454830008|FG004|Overall Study|Lost to Follow-up|0|||
126419583|NCT00713544|454830009|FG005|Overall Study|Lost to Follow-up|0|||
126419584|NCT00713544|454830004|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
126419585|NCT00713544|454830005|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
126419586|NCT00713544|454830006|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
126419587|NCT00713544|454830007|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
126419588|NCT00713544|454830008|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
126419589|NCT00713544|454830009|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
126419590|NCT00713544|454830004|FG000|Overall Study|Incorrect enrollment|0|||
126419591|NCT00713544|454830005|FG001|Overall Study|Incorrect enrollment|1|||
126419592|NCT00713544|454830006|FG002|Overall Study|Incorrect enrollment|0|||
126419593|NCT00713544|454830007|FG003|Overall Study|Incorrect enrollment|0|||
126419594|NCT00713544|454830008|FG004|Overall Study|Incorrect enrollment|0|||
126419595|NCT00713544|454830009|FG005|Overall Study|Incorrect enrollment|0|||
126419596|NCT00713544|454830004|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
126419597|NCT00713544|454830005|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
126419598|NCT00713544|454830006|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
126419599|NCT00713544|454830007|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
126419600|NCT00713544|454830008|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
126419601|NCT00713544|454830009|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
126419602|NCT02380287|454830010|FG000|Overall Study|Adverse Event|0|||
126419603|NCT02380287|454830011|FG001|Overall Study|Adverse Event|0|||
126419604|NCT02380287|454830012|FG002|Overall Study|Adverse Event|1|||
126419605|NCT02380287|454830013|FG003|Overall Study|Adverse Event|0|||
126419606|NCT02380287|454830014|FG004|Overall Study|Adverse Event|0|||
126419607|NCT02380287|454830015|FG005|Overall Study|Adverse Event|0|||
126419608|NCT02380287|454830016|FG006|Overall Study|Adverse Event|0|||
126419609|NCT02380287|454830017|FG007|Overall Study|Adverse Event|0|||
126419610|NCT01290757|454830018|FG000|Overall Study|Adverse Event|1|||
126419611|NCT01290757|454830019|FG001|Overall Study|Adverse Event|0|||
126419612|NCT01290757|454830018|FG000|Overall Study|Protocol Violation|1|||
126419613|NCT01290757|454830019|FG001|Overall Study|Protocol Violation|1|||
126419614|NCT01290757|454830018|FG000|Overall Study|Other|0|||
126419615|NCT01290757|454830019|FG001|Overall Study|Other|1|||
126419616|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Death|0|||
126419617|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Death|0|||
126419618|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Death|0|||
126419619|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Death|0|||
126419620|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Death|1|||
126419621|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Death|0|||
126419622|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Death|0|||
126419623|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Death|0|||
126419624|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
126477200|NCT02195583|455048197|FG000|Overall Study|Other Reason|2|||
126477201|NCT01709513|455048198|FG000|Overall Study|Randomized but not treated|0|||
126477202|NCT01709513|455048199|FG001|Overall Study|Randomized but not treated|1|||
126477203|NCT01709513|455048200|FG002|Overall Study|Randomized but not treated|0|||
126477204|NCT01709513|455048198|FG000|Overall Study|Adverse Event|16|||
126477205|NCT01709513|455048199|FG001|Overall Study|Adverse Event|31|||
126477206|NCT01709513|455048200|FG002|Overall Study|Adverse Event|23|||
126477207|NCT01709513|455048198|FG000|Overall Study|Poor compliance to protocol|2|||
126477208|NCT01709513|455048199|FG001|Overall Study|Poor compliance to protocol|0|||
126477209|NCT01709513|455048200|FG002|Overall Study|Poor compliance to protocol|0|||
126419625|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
126419626|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
126477210|NCT01709513|455048198|FG000|Overall Study|Other|3|||
126477211|NCT01709513|455048199|FG001|Overall Study|Other|11|||
126419627|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
126419628|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
126419629|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
126419630|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
126419631|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
126477212|NCT01709513|455048200|FG002|Overall Study|Other|7|||
126477213|NCT01543958|455048201|FG000|Overall Study|Loss to follow-up|3|||
126419632|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
126419633|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
126419634|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
126419635|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
126419636|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
126419637|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
126419638|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
126419639|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
126419640|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
126419641|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
126419642|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
126419643|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
126419644|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
126419645|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
126419646|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
126419647|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
126419648|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
126419649|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
126419650|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
126419651|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
126419652|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
126419653|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
126419654|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
126419655|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
126419656|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
126419657|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
126419658|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
126419659|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
126419660|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
126419661|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
126419662|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
126419663|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
126419664|NCT00726232|454830022|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
126419665|NCT00726232|454830023|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
126419666|NCT00726232|454830024|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
126419667|NCT00726232|454830025|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
126419668|NCT00726232|454830026|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
126419669|NCT00726232|454830027|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
126477214|NCT01543958|455048201|FG000|Overall Study|ART initiation|1|||
126477215|NCT02165215|455048208|FG000|Induction Phase|Adverse Event|1|||
126477216|NCT02165215|455048209|FG001|Induction Phase|Adverse Event|0|||
126477217|NCT02165215|455048210|FG002|Induction Phase|Adverse Event|0|||
126721927|NCT02993224|455931323|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
126419670|NCT00726232|454830028|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
126419671|NCT00726232|454830029|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
126419672|NCT00726232|454830022|FG000|Expansion Phase|Death|0|||
126419673|NCT00726232|454830023|FG001|Expansion Phase|Death|0|||
126419674|NCT00726232|454830024|FG002|Expansion Phase|Death|0|||
126419675|NCT00726232|454830025|FG003|Expansion Phase|Death|0|||
126419676|NCT00726232|454830026|FG004|Expansion Phase|Death|0|||
126419677|NCT00726232|454830027|FG005|Expansion Phase|Death|0|||
126419678|NCT00726232|454830028|FG006|Expansion Phase|Death|0|||
126419679|NCT00726232|454830029|FG007|Expansion Phase|Death|1|||
126419680|NCT00726232|454830022|FG000|Expansion Phase|Adverse Event|0|||
126419681|NCT00726232|454830023|FG001|Expansion Phase|Adverse Event|0|||
126419682|NCT00726232|454830024|FG002|Expansion Phase|Adverse Event|0|||
126419683|NCT00726232|454830025|FG003|Expansion Phase|Adverse Event|0|||
126419684|NCT00726232|454830026|FG004|Expansion Phase|Adverse Event|0|||
126419685|NCT00726232|454830027|FG005|Expansion Phase|Adverse Event|0|||
126419686|NCT00726232|454830028|FG006|Expansion Phase|Adverse Event|6|||
126419687|NCT00726232|454830029|FG007|Expansion Phase|Adverse Event|11|||
126477218|NCT02165215|455048208|FG000|Induction Phase|Withdrawal by Subject|10|||
126477219|NCT02165215|455048209|FG001|Induction Phase|Withdrawal by Subject|0|||
126477220|NCT02165215|455048210|FG002|Induction Phase|Withdrawal by Subject|0|||
126477221|NCT02165215|455048208|FG000|Induction Phase|Protocol Violation|1|||
126721928|NCT01930799|455931325|FG000|Overall Study|Withdrawal by Subject|3|||
126419688|NCT00726232|454830022|FG000|Expansion Phase|Withdrawal by Subject|0|||
126419689|NCT00726232|454830023|FG001|Expansion Phase|Withdrawal by Subject|0|||
126419690|NCT00726232|454830024|FG002|Expansion Phase|Withdrawal by Subject|0|||
126419691|NCT00726232|454830025|FG003|Expansion Phase|Withdrawal by Subject|0|||
126477222|NCT02165215|455048209|FG001|Induction Phase|Protocol Violation|0|||
126419692|NCT00726232|454830026|FG004|Expansion Phase|Withdrawal by Subject|0|||
126419693|NCT00726232|454830027|FG005|Expansion Phase|Withdrawal by Subject|0|||
126419694|NCT00726232|454830028|FG006|Expansion Phase|Withdrawal by Subject|2|||
126419695|NCT00726232|454830029|FG007|Expansion Phase|Withdrawal by Subject|3|||
126419696|NCT00726232|454830022|FG000|Expansion Phase|Disease progression|0|||
126419697|NCT00726232|454830023|FG001|Expansion Phase|Disease progression|0|||
126419698|NCT00726232|454830024|FG002|Expansion Phase|Disease progression|0|||
126419699|NCT00726232|454830025|FG003|Expansion Phase|Disease progression|0|||
126419700|NCT00726232|454830026|FG004|Expansion Phase|Disease progression|0|||
126419701|NCT00726232|454830027|FG005|Expansion Phase|Disease progression|0|||
126419702|NCT00726232|454830028|FG006|Expansion Phase|Disease progression|4|||
126419703|NCT00726232|454830029|FG007|Expansion Phase|Disease progression|0|||
126419704|NCT00726232|454830022|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
126419705|NCT00726232|454830023|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
126419706|NCT00726232|454830024|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
126419707|NCT00726232|454830025|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
126419708|NCT00726232|454830026|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
126419709|NCT00726232|454830027|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
126419710|NCT00726232|454830028|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
126419711|NCT00726232|454830029|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
126419712|NCT00726232|454830022|FG000|Expansion Phase|Per Investigator: lack of response|0|||
126419713|NCT00726232|454830023|FG001|Expansion Phase|Per Investigator: lack of response|0|||
126419714|NCT00726232|454830024|FG002|Expansion Phase|Per Investigator: lack of response|0|||
126419715|NCT00726232|454830025|FG003|Expansion Phase|Per Investigator: lack of response|0|||
126419716|NCT00726232|454830026|FG004|Expansion Phase|Per Investigator: lack of response|0|||
126419717|NCT00726232|454830027|FG005|Expansion Phase|Per Investigator: lack of response|0|||
126419718|NCT00726232|454830028|FG006|Expansion Phase|Per Investigator: lack of response|1|||
126419719|NCT00726232|454830029|FG007|Expansion Phase|Per Investigator: lack of response|7|||
126419720|NCT00726232|454830022|FG000|Expansion Phase|Unspecified reason|0|||
126419721|NCT00726232|454830023|FG001|Expansion Phase|Unspecified reason|0|||
126419722|NCT00726232|454830024|FG002|Expansion Phase|Unspecified reason|0|||
126419723|NCT00726232|454830025|FG003|Expansion Phase|Unspecified reason|0|||
126419724|NCT00726232|454830026|FG004|Expansion Phase|Unspecified reason|0|||
126419725|NCT00726232|454830027|FG005|Expansion Phase|Unspecified reason|0|||
126419726|NCT00726232|454830028|FG006|Expansion Phase|Unspecified reason|1|||
126419727|NCT00726232|454830029|FG007|Expansion Phase|Unspecified reason|0|||
126419728|NCT03088917|454830030|FG000|Overall Study|In care/cured elsewhere|15|||
126419729|NCT03088917|454830030|FG000|Overall Study|Refuse re-evaluation|13|||
126419730|NCT03088917|454830030|FG000|Overall Study|Contact not established|13|||
126419731|NCT03088917|454830030|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
126419732|NCT03088917|454830030|FG000|Overall Study|Moved outside study region|50|||
126419733|NCT05447663|454830032|FG000|Overall Study|Study terminated by Sponsor|5|||
126419734|NCT05447663|454830032|FG000|Overall Study|Death|2|||
126419735|NCT05447663|454830032|FG000|Overall Study|Withdrawal by Subject|1|||
126419736|NCT06041919|454830033|FG000|Overall Study|Lost to Follow-up|1|||
126419737|NCT06041919|454830034|FG001|Overall Study|Lost to Follow-up|0|||
126419738|NCT06041919|454830035|FG002|Overall Study|Lost to Follow-up|0|||
126419739|NCT06041919|454830036|FG003|Overall Study|Lost to Follow-up|0|||
126419740|NCT06041919|454830037|FG004|Overall Study|Lost to Follow-up|0|||
126419741|NCT06041919|454830033|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
126419742|NCT06041919|454830034|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
126419743|NCT06041919|454830035|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
126419744|NCT06041919|454830036|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
126419745|NCT06041919|454830037|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
126419746|NCT01502228|454830038|FG000|Overall Study|Death|1|||
126419747|NCT02204072|454830041|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
126419748|NCT02204072|454830042|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
126419749|NCT02204072|454830043|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
126419750|NCT02204072|454830044|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
126419751|NCT02204072|454830045|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
126419752|NCT02204072|454830041|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
126419753|NCT02204072|454830042|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
126419754|NCT02204072|454830043|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
126419755|NCT02204072|454830044|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
126419756|NCT02204072|454830045|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
126419757|NCT02204072|454830041|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
126419758|NCT02204072|454830042|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
126477223|NCT02165215|455048210|FG002|Induction Phase|Protocol Violation|0|||
126477224|NCT02165215|455048208|FG000|Induction Phase|Physician Decision|1|||
126721929|NCT01930799|455931325|FG000|Overall Study|Lost to Follow-up|5|||
126721930|NCT00952289|455931329|FG000|All Participants|Death|9|||
126721931|NCT00952289|455931330|FG001|All Participants|Death|9|||
126721932|NCT00952289|455931329|FG000|All Participants|Adverse Event|8|||
126721933|NCT00952289|455931330|FG001|All Participants|Adverse Event|8|||
126419759|NCT02204072|454830043|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
126419760|NCT02204072|454830044|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
126419761|NCT02204072|454830045|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
126419762|NCT02204072|454830041|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
126419763|NCT02204072|454830042|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
126419764|NCT02204072|454830043|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
126419765|NCT02204072|454830044|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
126419766|NCT02204072|454830045|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
126419767|NCT04209205|454830046|FG000|Overall Study|Adverse Event|2|||
126419768|NCT04209205|454830047|FG001|Overall Study|Adverse Event|3|||
126419769|NCT04209205|454830046|FG000|Overall Study|Lost to Follow-up|3|||
126419770|NCT04209205|454830047|FG001|Overall Study|Lost to Follow-up|1|||
126419771|NCT04209205|454830046|FG000|Overall Study|Physician Decision|1|||
126419772|NCT04209205|454830047|FG001|Overall Study|Physician Decision|1|||
126419773|NCT04209205|454830046|FG000|Overall Study|Subject decision|10|||
126419774|NCT04209205|454830047|FG001|Overall Study|Subject decision|10|||
126419775|NCT04209205|454830046|FG000|Overall Study|Progressive disease|1|||
126419776|NCT04209205|454830047|FG001|Overall Study|Progressive disease|0|||
126419777|NCT04209205|454830046|FG000|Overall Study|Protocol deviation|0|||
126419778|NCT04209205|454830047|FG001|Overall Study|Protocol deviation|1|||
126419779|NCT04209205|454830046|FG000|Overall Study|New therapy for study indication|1|||
126419780|NCT04209205|454830047|FG001|Overall Study|New therapy for study indication|0|||
126419781|NCT04209205|454830046|FG000|Overall Study|Adverse event - placebo not switched|0|||
126419782|NCT04209205|454830047|FG001|Overall Study|Adverse event - placebo not switched|1|||
126419783|NCT04209205|454830046|FG000|Overall Study|Subject decision - placebo not switched|0|||
126419784|NCT04209205|454830047|FG001|Overall Study|Subject decision - placebo not switched|5|||
126419785|NCT04209205|454830046|FG000|Overall Study|Death - placebo not switched|0|||
126419786|NCT04209205|454830047|FG001|Overall Study|Death - placebo not switched|1|||
126419787|NCT05236257|454830080|FG000|Overall Study|Ongoing with study treatment|29|||
126419788|NCT05236257|454830081|FG001|Overall Study|Ongoing with study treatment|1|||
126419789|NCT05236257|454830080|FG000|Overall Study|Discontinued study treatment|22|||
126419790|NCT05236257|454830081|FG001|Overall Study|Discontinued study treatment|41|||
126419791|NCT00924443|454830085|FG000|Overall Study|Physician Decision|2|||
126419792|NCT00924443|454830085|FG000|Overall Study|Protocol Violation|1|||
126419793|NCT00874848|454830086|FG000|Overall Study|Adverse Event|13|||
126419794|NCT00874848|454830087|FG001|Overall Study|Adverse Event|2|||
126419795|NCT00874848|454830086|FG000|Overall Study|Progressive neoplastic disease|38|||
126419796|NCT00874848|454830087|FG001|Overall Study|Progressive neoplastic disease|18|||
126419797|NCT00874848|454830086|FG000|Overall Study|Withdrawal by Subject|7|||
126419798|NCT00874848|454830087|FG001|Overall Study|Withdrawal by Subject|4|||
126419799|NCT00874848|454830086|FG000|Overall Study|Noncompliance|1|||
126419800|NCT00874848|454830087|FG001|Overall Study|Noncompliance|1|||
126419801|NCT00874848|454830086|FG000|Overall Study|Failure to comply with protocol|0|||
126419802|NCT00874848|454830087|FG001|Overall Study|Failure to comply with protocol|1|||
126419803|NCT00874848|454830086|FG000|Overall Study|Physician Decision|0|||
126419804|NCT00874848|454830087|FG001|Overall Study|Physician Decision|2|||
126419805|NCT01746225|454830092|FG000|Overall Study|Death|1|||
126419806|NCT01746225|454830093|FG001|Overall Study|Death|0|||
126419807|NCT01746225|454830094|FG002|Overall Study|Death|1|||
126419808|NCT01746225|454830092|FG000|Overall Study|Withdrawal by Subject|5|||
126419809|NCT01746225|454830093|FG001|Overall Study|Withdrawal by Subject|15|||
126419810|NCT01746225|454830094|FG002|Overall Study|Withdrawal by Subject|19|||
126419811|NCT01746225|454830092|FG000|Overall Study|Physician Decision|14|||
126419812|NCT01746225|454830093|FG001|Overall Study|Physician Decision|11|||
126419813|NCT01746225|454830094|FG002|Overall Study|Physician Decision|3|||
126419814|NCT01746225|454830092|FG000|Overall Study|Adverse Event|15|||
126419815|NCT01746225|454830093|FG001|Overall Study|Adverse Event|12|||
126419816|NCT01746225|454830094|FG002|Overall Study|Adverse Event|17|||
126721934|NCT00952289|455931329|FG000|All Participants|Disease progression|3|||
126721935|NCT00952289|455931330|FG001|All Participants|Disease progression|12|||
126721936|NCT00952289|455931329|FG000|All Participants|Withdrawal by Subject|1|||
126721937|NCT00952289|455931330|FG001|All Participants|Withdrawal by Subject|10|||
126419817|NCT01746225|454830092|FG000|Overall Study|Continuing Treatment|5|||
126419818|NCT01746225|454830093|FG001|Overall Study|Continuing Treatment|8|||
126419819|NCT01746225|454830094|FG002|Overall Study|Continuing Treatment|3|||
126419820|NCT03405818|454830097|FG000|Overall Study|Withdrawal by Subject|4|||
126419821|NCT03405818|454830097|FG000|Overall Study|Lost to Follow-up|4|||
126419822|NCT03197376|454830101|FG000|Primary and Booster Phase|Adverse Event|0|||
126419823|NCT03197376|454830102|FG001|Primary and Booster Phase|Adverse Event|0|||
126721938|NCT00952289|455931329|FG000|All Participants|Data lost during site relocation|0|||
126419824|NCT03197376|454830103|FG002|Primary and Booster Phase|Adverse Event|0|||
126419825|NCT03197376|454830104|FG003|Primary and Booster Phase|Adverse Event|1|||
126419826|NCT03197376|454830101|FG000|Primary and Booster Phase|Death|1|||
126419827|NCT03197376|454830102|FG001|Primary and Booster Phase|Death|0|||
126419828|NCT03197376|454830103|FG002|Primary and Booster Phase|Death|0|||
126419829|NCT03197376|454830104|FG003|Primary and Booster Phase|Death|2|||
126419830|NCT03197376|454830101|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
126419831|NCT03197376|454830102|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
126419832|NCT03197376|454830103|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
126419833|NCT03197376|454830104|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
126419834|NCT03197376|454830101|FG000|Primary and Booster Phase|Physician Decision|1|||
126419835|NCT03197376|454830102|FG001|Primary and Booster Phase|Physician Decision|0|||
126419836|NCT03197376|454830103|FG002|Primary and Booster Phase|Physician Decision|1|||
126419837|NCT03197376|454830104|FG003|Primary and Booster Phase|Physician Decision|3|||
126419838|NCT03197376|454830101|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
126419839|NCT03197376|454830102|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
126419840|NCT03197376|454830103|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
126419841|NCT03197376|454830104|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
126419842|NCT03197376|454830101|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
126419843|NCT03197376|454830102|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
126419844|NCT03197376|454830103|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
126419845|NCT03197376|454830104|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
126419846|NCT03197376|454830101|FG000|Primary and Booster Phase|Not vaccine related|1|||
126419847|NCT03197376|454830102|FG001|Primary and Booster Phase|Not vaccine related|2|||
126419848|NCT03197376|454830103|FG002|Primary and Booster Phase|Not vaccine related|0|||
126419849|NCT03197376|454830104|FG003|Primary and Booster Phase|Not vaccine related|6|||
126419850|NCT03197376|454830101|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
126477225|NCT02165215|455048209|FG001|Induction Phase|Physician Decision|0|||
126419851|NCT03197376|454830102|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
126419852|NCT03197376|454830103|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
126419853|NCT03197376|454830104|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
126419854|NCT03197376|454830101|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
126419855|NCT03197376|454830102|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
126419856|NCT03197376|454830103|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
126419857|NCT03197376|454830104|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
126419858|NCT03197376|454830101|FG000|Immune Persistence Phase|Not vaccine related|1|||
126419859|NCT03197376|454830102|FG001|Immune Persistence Phase|Not vaccine related|0|||
126419860|NCT03197376|454830103|FG002|Immune Persistence Phase|Not vaccine related|1|||
126419861|NCT03197376|454830104|FG003|Immune Persistence Phase|Not vaccine related|1|||
126419862|NCT00003199|454830105|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
126419863|NCT00003199|454830105|FG000|Overall Study|Lack of insurance clearance|2|||
126419864|NCT00003199|454830105|FG000|Overall Study|Screen fail|15|||
126419865|NCT01223183|454830107|FG000|Imaging Day 1|Physician Decision|0|||
126419866|NCT01223183|454830108|FG001|Imaging Day 1|Physician Decision|1|||
126419867|NCT01223183|454830107|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
126419868|NCT01223183|454830108|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
126419869|NCT01223183|454830107|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
126419870|NCT01223183|454830108|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
126419871|NCT01641601|454831822|FG000|Overall Study|Study discontinued.|3|||
126419872|NCT01641601|454831823|FG001|Overall Study|Study discontinued.|5|||
126419873|NCT00950846|454831829|FG000|Overall Study|Death|6|||
126419874|NCT00950846|454831829|FG000|Overall Study|Lost to Follow-up|3|||
126419875|NCT00950846|454831829|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
126419876|NCT01799226|454831830|FG000|Overall Study|Withdrawal by Subject|1|||
126419877|NCT01799226|454831831|FG001|Overall Study|Withdrawal by Subject|0|||
126419878|NCT01799226|454831830|FG000|Overall Study|Disqualified at Day 14|1|||
126419879|NCT01799226|454831831|FG001|Overall Study|Disqualified at Day 14|0|||
126419880|NCT02178995|454831832|FG000|Double Blind|Adverse Event|0|||
126419881|NCT02178995|454831833|FG001|Double Blind|Adverse Event|0|||
126419882|NCT02178995|454831834|FG002|Double Blind|Adverse Event|0|||
126419883|NCT02178995|454831835|FG003|Double Blind|Adverse Event|0|||
126419884|NCT02178995|454831836|FG004|Double Blind|Adverse Event|0|||
126419885|NCT02178995|454831837|FG005|Double Blind|Adverse Event|1|||
126419886|NCT02178995|454831838|FG006|Double Blind|Adverse Event|0|||
126419887|NCT02178995|454831839|FG007|Double Blind|Adverse Event|1|||
126419888|NCT02178995|454831840|FG008|Double Blind|Adverse Event|1|||
126419889|NCT02178995|454831832|FG000|Double Blind|Lost to Follow-up|0|||
126419890|NCT02178995|454831833|FG001|Double Blind|Lost to Follow-up|1|||
126419891|NCT02178995|454831834|FG002|Double Blind|Lost to Follow-up|0|||
126419892|NCT02178995|454831835|FG003|Double Blind|Lost to Follow-up|0|||
126419893|NCT02178995|454831836|FG004|Double Blind|Lost to Follow-up|0|||
126419894|NCT02178995|454831837|FG005|Double Blind|Lost to Follow-up|0|||
126419895|NCT02178995|454831838|FG006|Double Blind|Lost to Follow-up|0|||
126419896|NCT02178995|454831839|FG007|Double Blind|Lost to Follow-up|1|||
126419897|NCT02178995|454831840|FG008|Double Blind|Lost to Follow-up|0|||
126419898|NCT02178995|454831832|FG000|Open Label|Adverse Event|2|||
126419899|NCT02178995|454831833|FG001|Open Label|Adverse Event|0|||
126419900|NCT02178995|454831834|FG002|Open Label|Adverse Event|0|||
126419901|NCT02178995|454831835|FG003|Open Label|Adverse Event|0|||
126419902|NCT02178995|454831836|FG004|Open Label|Adverse Event|0|||
126419903|NCT02178995|454831837|FG005|Open Label|Adverse Event|0|||
126419904|NCT02178995|454831838|FG006|Open Label|Adverse Event|0|||
126419905|NCT02178995|454831839|FG007|Open Label|Adverse Event|0|||
126419906|NCT02178995|454831840|FG008|Open Label|Adverse Event|0|||
126419907|NCT00587158|454831841|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
126419908|NCT00587158|454831842|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
126419909|NCT00587158|454831841|FG000|Overall Study|Physician Decision|0|||
126419910|NCT00587158|454831842|FG001|Overall Study|Physician Decision|1|||
126419911|NCT00587158|454831841|FG000|Overall Study|Lost to Follow-up|1|||
126419912|NCT00587158|454831842|FG001|Overall Study|Lost to Follow-up|2|||
126419913|NCT00587158|454831841|FG000|Overall Study|Death|0|||
126419914|NCT00587158|454831842|FG001|Overall Study|Death|1|||
126419915|NCT00587158|454831841|FG000|Overall Study|Subject did not want to take study med|0|||
126419916|NCT00587158|454831842|FG001|Overall Study|Subject did not want to take study med|1|||
126419917|NCT02274792|454831843|FG000|Overall Study|Withdrawal by Subject|13|||
126419918|NCT02274792|454831843|FG000|Overall Study|Lost to Follow-up|8|||
126419919|NCT02274792|454831843|FG000|Overall Study|Protocol Specified Criteria|2|||
126419920|NCT02274792|454831843|FG000|Overall Study|Sponsor Decision|2|||
126419921|NCT05258149|454831850|FG000|Period 1|Protocol Deviation|1|||
126419922|NCT05258149|454831851|FG001|Period 1|Protocol Deviation|0|||
126419923|NCT05258149|454831850|FG000|Period 1|Adverse Event|0|||
126419924|NCT05258149|454831851|FG001|Period 1|Adverse Event|1|||
126419925|NCT05258149|454831850|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
126419926|NCT05258149|454831851|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
126419927|NCT05258149|454831850|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
126419928|NCT05258149|454831851|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
126419929|NCT05258149|454831850|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
126419930|NCT05258149|454831851|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
126419931|NCT00832416|454831854|FG000|Overall Study|Lack of Efficacy|17|||
126419932|NCT00832416|454831855|FG001|Overall Study|Lack of Efficacy|15|||
126419933|NCT00832416|454831856|FG002|Overall Study|Lack of Efficacy|13|||
126419934|NCT00832416|454831857|FG003|Overall Study|Lack of Efficacy|52|||
126419935|NCT00832416|454831854|FG000|Overall Study|Withdrawal by Subject|5|||
126419936|NCT00832416|454831855|FG001|Overall Study|Withdrawal by Subject|7|||
126419937|NCT00832416|454831856|FG002|Overall Study|Withdrawal by Subject|2|||
126419938|NCT00832416|454831857|FG003|Overall Study|Withdrawal by Subject|10|||
126419939|NCT00832416|454831854|FG000|Overall Study|Physician Decision|2|||
126419940|NCT00832416|454831855|FG001|Overall Study|Physician Decision|12|||
126419941|NCT00832416|454831856|FG002|Overall Study|Physician Decision|5|||
126419942|NCT00832416|454831857|FG003|Overall Study|Physician Decision|10|||
126419943|NCT00832416|454831854|FG000|Overall Study|Administrative|0|||
126419944|NCT00832416|454831855|FG001|Overall Study|Administrative|0|||
126419945|NCT00832416|454831856|FG002|Overall Study|Administrative|0|||
126419946|NCT00832416|454831857|FG003|Overall Study|Administrative|1|||
126419947|NCT00832416|454831854|FG000|Overall Study|Adverse Event|21|||
126419948|NCT00832416|454831855|FG001|Overall Study|Adverse Event|19|||
126419949|NCT00832416|454831856|FG002|Overall Study|Adverse Event|41|||
126419950|NCT00832416|454831857|FG003|Overall Study|Adverse Event|10|||
126419951|NCT00832416|454831854|FG000|Overall Study|Death|1|||
126419952|NCT00832416|454831855|FG001|Overall Study|Death|0|||
126419953|NCT00832416|454831856|FG002|Overall Study|Death|0|||
126419954|NCT00832416|454831857|FG003|Overall Study|Death|0|||
126419955|NCT02114606|454831858|FG000|Overall Study|Unable to swallow Cytosponge|6|||
126419956|NCT00981461|454831859|FG000|Overall Study|Lost to Follow-up|5|||
126419957|NCT00981461|454831860|FG001|Overall Study|Lost to Follow-up|2|||
126419958|NCT03361293|454831869|FG000|Overall Study|Lost to Follow-up|0|||
126419959|NCT03361293|454831870|FG001|Overall Study|Lost to Follow-up|2|||
126419960|NCT03361293|454831869|FG000|Overall Study|Withdrawal by Subject|1|||
126419961|NCT03361293|454831870|FG001|Overall Study|Withdrawal by Subject|3|||
126419962|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
126419963|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
126419964|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
126419965|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
126419966|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
126419967|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
126419968|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
126419969|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
126419970|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
126419971|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
126419972|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
126419973|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
126477226|NCT02165215|455048210|FG002|Induction Phase|Physician Decision|0|||
126477227|NCT02165215|455048208|FG000|Induction Phase|Lack of Efficacy|2|||
126419974|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
126419975|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
126419976|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
126419977|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
126419978|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
126419979|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
126419980|NCT01910402|454831873|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
126419981|NCT01910402|454831874|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
126419982|NCT01910402|454831875|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
126419983|NCT01910402|454831873|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
126419984|NCT01910402|454831874|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
126419985|NCT01910402|454831875|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
126419986|NCT01910402|454831873|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
126419987|NCT01910402|454831874|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
126419988|NCT01910402|454831875|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
126419989|NCT01910402|454831873|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
126419990|NCT01910402|454831874|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
126419991|NCT01910402|454831875|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
126419992|NCT01910402|454831873|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
126419993|NCT01910402|454831874|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
126419994|NCT01910402|454831875|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
126419995|NCT01910402|454831873|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
126419996|NCT01910402|454831874|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
126419997|NCT01910402|454831875|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
126419998|NCT01910402|454831873|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
126419999|NCT01910402|454831874|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
126420000|NCT01910402|454831875|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
126420001|NCT00483405|454831876|FG000|Overall Study|Adverse Event|8|||
126420002|NCT00483405|454831876|FG000|Overall Study|Lack of Efficacy|14|||
126420003|NCT00483405|454831876|FG000|Overall Study|Death|3|||
126420004|NCT00483405|454831876|FG000|Overall Study|Withdrawal by Subject|2|||
126420005|NCT00483405|454831876|FG000|Overall Study|Other complicating disease|1|||
126420006|NCT00571038|454831877|FG000|Overall Study|Lost to Follow-up|1|||
126420007|NCT00571038|454831878|FG001|Overall Study|Lost to Follow-up|4|||
126420008|NCT00571038|454831877|FG000|Overall Study|Death|7|||
126420009|NCT00571038|454831878|FG001|Overall Study|Death|5|||
126420010|NCT00571038|454831877|FG000|Overall Study|Withdrawal by Subject|1|||
126420011|NCT00571038|454831878|FG001|Overall Study|Withdrawal by Subject|3|||
126420012|NCT00571038|454831877|FG000|Overall Study|Moved out of state|2|||
126420013|NCT00571038|454831878|FG001|Overall Study|Moved out of state|2|||
126420014|NCT01442714|454831879|FG000|Overall Study|Death|11|||
126420015|NCT01442714|454831879|FG000|Overall Study|Withdrawal by Subject|1|||
126420016|NCT04306510|454831880|FG000|Overall Study|Voluntarily withdrawal|1|||
126420017|NCT04306510|454831880|FG000|Overall Study|Enrolled but Not Treated|1|||
126420018|NCT04829916|454831890|FG000|Overall Study|Withdrawal by Subject|1|||
126420019|NCT04829916|454831891|FG001|Overall Study|Withdrawal by Subject|0|||
126420020|NCT04343755|454831892|FG000|Overall Study|Death|11|||
126420021|NCT04343755|454831892|FG000|Overall Study|Screen Failure|1|||
126420022|NCT00193206|454831893|FG000|Preoperative Therapy|Lack of Efficacy|2|||
126420023|NCT00193206|454831893|FG000|Preoperative Therapy|Adverse Event|2|||
126420024|NCT00193206|454831893|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
126420025|NCT00193206|454831893|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
126420026|NCT00193206|454831893|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
126420027|NCT00193206|454831893|FG000|Postoperative Therapy|Physician Decision|3|||
126420028|NCT00193206|454831893|FG000|Postoperative Therapy|Intercurrent Illness|2|||
126420029|NCT00193206|454831893|FG000|Postoperative Therapy|Lack of Efficacy|1|||
126420030|NCT00193206|454831893|FG000|Postoperative Therapy|Protocol Violation|1|||
126420031|NCT02859246|454831896|FG000|Overall Study|Screen fails|3|||
126477228|NCT02165215|455048209|FG001|Induction Phase|Lack of Efficacy|0|||
126477229|NCT02165215|455048210|FG002|Induction Phase|Lack of Efficacy|0|||
126477230|NCT02165215|455048208|FG000|Induction Phase|Non-Compliance|2|||
126420032|NCT02859246|454831896|FG000|Overall Study|Adverse Event|1|||
126420033|NCT02859246|454831896|FG000|Overall Study|Withdrawal by Subject|1|||
126420034|NCT00100789|454831897|FG000|Overall Study|Adverse Event|10|||
126420035|NCT00100789|454831897|FG000|Overall Study|Withdrawal by Subject|1|||
126420036|NCT00100789|454831897|FG000|Overall Study|Progression/relapse|42|||
126420037|NCT00100789|454831897|FG000|Overall Study|Death|2|||
126420038|NCT00100789|454831897|FG000|Overall Study|Not protocol specified|5|||
126477231|NCT02165215|455048209|FG001|Induction Phase|Non-Compliance|0|||
126420039|NCT00100789|454831897|FG000|Overall Study|Ineligible|3|||
126420040|NCT00100789|454831897|FG000|Overall Study|Never received treatment|1|||
126420041|NCT01746368|454831898|FG000|Overall Study|Lost to Follow-up|2|||
126420042|NCT01746368|454831899|FG001|Overall Study|Lost to Follow-up|0|||
126420043|NCT01746368|454831898|FG000|Overall Study|Withdrawal by Subject|0|||
126420044|NCT01746368|454831899|FG001|Overall Study|Withdrawal by Subject|1|||
126420045|NCT05280717|454831900|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
126420046|NCT05280717|454831901|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
126420047|NCT05280717|454831902|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
126420048|NCT05280717|454831903|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
126420049|NCT05280717|454831904|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
126420050|NCT05280717|454831905|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
126420051|NCT05280717|454831906|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
126420052|NCT05280717|454831900|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
126420053|NCT05280717|454831901|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
126420054|NCT05280717|454831902|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
126420055|NCT05280717|454831903|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
126420056|NCT05280717|454831904|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
126420057|NCT05280717|454831905|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
126420058|NCT05280717|454831906|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
126420059|NCT05280717|454831900|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
126420060|NCT05280717|454831901|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
126420061|NCT05280717|454831902|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
126420062|NCT05280717|454831903|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
126420063|NCT05280717|454831904|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
126420064|NCT05280717|454831905|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
126420065|NCT05280717|454831906|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
126420066|NCT05280717|454831900|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
126420067|NCT05280717|454831901|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
126420068|NCT05280717|454831902|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
126420069|NCT05280717|454831903|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
126420070|NCT05280717|454831904|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
126420071|NCT05280717|454831905|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
126420072|NCT05280717|454831906|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
126420073|NCT05280717|454831900|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
126420074|NCT05280717|454831901|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
126420075|NCT05280717|454831902|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
126420076|NCT05280717|454831903|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
126420077|NCT05280717|454831904|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
126420078|NCT05280717|454831905|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
126420079|NCT05280717|454831906|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
126420080|NCT05280717|454831900|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
126420081|NCT05280717|454831901|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
126420082|NCT05280717|454831902|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
126420083|NCT05280717|454831903|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
126420084|NCT05280717|454831904|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
126420085|NCT05280717|454831905|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
126420086|NCT05280717|454831906|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
126420087|NCT00080301|454831907|FG000|Overall Study|Randomized but Never Treated|5|||
126420088|NCT00080301|454831908|FG001|Overall Study|Randomized but Never Treated|10|||
126420089|NCT00080301|454831907|FG000|Overall Study|Still on Treatment as of CSR date|0|||
126420090|NCT00080301|454831908|FG001|Overall Study|Still on Treatment as of CSR date|1|||
126420091|NCT02940496|454831909|FG000|Overall Study|Adverse Event|1|||
126420092|NCT02940496|454831910|FG001|Overall Study|Adverse Event|0|||
126420093|NCT02940496|454831909|FG000|Overall Study|Death|2|||
126420094|NCT02940496|454831910|FG001|Overall Study|Death|0|||
126420095|NCT02940496|454831909|FG000|Overall Study|Hospice Care|1|||
126420096|NCT02940496|454831910|FG001|Overall Study|Hospice Care|0|||
126420097|NCT02940496|454831909|FG000|Overall Study|No MRE Done|1|||
126420098|NCT02940496|454831910|FG001|Overall Study|No MRE Done|0|||
126420099|NCT02940496|454831909|FG000|Overall Study|MRE Failure|1|||
126420100|NCT02940496|454831910|FG001|Overall Study|MRE Failure|0|||
126559090|NCT02240680|455340648|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
126559091|NCT02240680|455340649|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
126420101|NCT01147055|454831918|FG000|First Intervention Period|Lost to Follow-up|1|||
126420102|NCT01147055|454831919|FG001|First Intervention Period|Lost to Follow-up|0|||
126420103|NCT00132808|454831920|FG000|Stratum I|Adverse Event|2|||
126420104|NCT00132808|454831921|FG001|Stratum I|Adverse Event|1|||
126420105|NCT00132808|454831922|FG002|Stratum I|Adverse Event|0|||
126420106|NCT00132808|454831920|FG000|Stratum I|Lost to Follow-up|3|||
126420107|NCT00132808|454831921|FG001|Stratum I|Lost to Follow-up|4|||
126420108|NCT00132808|454831922|FG002|Stratum I|Lost to Follow-up|1|||
126420109|NCT00132808|454831920|FG000|Stratum I|Withdrawal by Subject|4|||
126420110|NCT00132808|454831921|FG001|Stratum I|Withdrawal by Subject|7|||
126420111|NCT00132808|454831922|FG002|Stratum I|Withdrawal by Subject|3|||
126420112|NCT00132808|454831920|FG000|Stratum I|Abnormal test procedure result (s)|0|||
126420113|NCT00132808|454831921|FG001|Stratum I|Abnormal test procedure result (s)|0|||
126420114|NCT00132808|454831922|FG002|Stratum I|Abnormal test procedure result (s)|1|||
126420115|NCT00132808|454831920|FG000|Stratum II|Adverse Event|1|||
126420116|NCT00132808|454831921|FG001|Stratum II|Adverse Event|2|||
126420117|NCT00132808|454831922|FG002|Stratum II|Adverse Event|1|||
126420118|NCT00132808|454831920|FG000|Stratum II|Death|1|||
126420119|NCT00132808|454831921|FG001|Stratum II|Death|0|||
126420120|NCT00132808|454831922|FG002|Stratum II|Death|0|||
126420121|NCT00132808|454831920|FG000|Stratum II|Lost to Follow-up|2|||
126420122|NCT00132808|454831921|FG001|Stratum II|Lost to Follow-up|2|||
126420123|NCT00132808|454831922|FG002|Stratum II|Lost to Follow-up|1|||
126420124|NCT00132808|454831920|FG000|Stratum II|Protocol Violation|0|||
126420125|NCT00132808|454831921|FG001|Stratum II|Protocol Violation|2|||
126420126|NCT00132808|454831922|FG002|Stratum II|Protocol Violation|1|||
126420127|NCT00132808|454831920|FG000|Stratum II|Withdrawal by Subject|4|||
126420128|NCT00132808|454831921|FG001|Stratum II|Withdrawal by Subject|9|||
126420129|NCT00132808|454831922|FG002|Stratum II|Withdrawal by Subject|6|||
126420130|NCT02863328|454831933|FG000|Overall Study|Lost to Follow-up|4|||
126420131|NCT02863328|454831934|FG001|Overall Study|Lost to Follow-up|10|||
126420132|NCT02863328|454831933|FG000|Overall Study|Withdrawal by Subject|7|||
126420133|NCT02863328|454831934|FG001|Overall Study|Withdrawal by Subject|12|||
126420134|NCT02863328|454831933|FG000|Overall Study|Died|0|||
126420135|NCT02863328|454831934|FG001|Overall Study|Died|1|||
126420136|NCT01870726|454831935|FG000|Overall Study|Withdrawal of informed consent|0|||
126420137|NCT01870726|454831936|FG001|Overall Study|Withdrawal of informed consent|0|||
126420138|NCT01870726|454831937|FG002|Overall Study|Withdrawal of informed consent|0|||
126420139|NCT01870726|454831938|FG003|Overall Study|Withdrawal of informed consent|1|||
126420140|NCT01870726|454831939|FG004|Overall Study|Withdrawal of informed consent|0|||
126420141|NCT01870726|454831940|FG005|Overall Study|Withdrawal of informed consent|0|||
126420142|NCT01870726|454831941|FG006|Overall Study|Withdrawal of informed consent|0|||
126420143|NCT01870726|454831935|FG000|Overall Study|Withdrawal by Subject|0|||
126420144|NCT01870726|454831936|FG001|Overall Study|Withdrawal by Subject|1|||
126420145|NCT01870726|454831937|FG002|Overall Study|Withdrawal by Subject|0|||
126420146|NCT01870726|454831938|FG003|Overall Study|Withdrawal by Subject|0|||
126420147|NCT01870726|454831939|FG004|Overall Study|Withdrawal by Subject|0|||
126420148|NCT01870726|454831940|FG005|Overall Study|Withdrawal by Subject|0|||
126420149|NCT01870726|454831941|FG006|Overall Study|Withdrawal by Subject|0|||
126420150|NCT01870726|454831935|FG000|Overall Study|Adverse Event|0|||
126559092|NCT02240680|455340646|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
126420151|NCT01870726|454831936|FG001|Overall Study|Adverse Event|0|||
126420152|NCT01870726|454831937|FG002|Overall Study|Adverse Event|0|||
126420153|NCT01870726|454831938|FG003|Overall Study|Adverse Event|0|||
126420154|NCT01870726|454831939|FG004|Overall Study|Adverse Event|1|||
126559093|NCT02240680|455340647|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
126559094|NCT02240680|455340648|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
126559095|NCT02240680|455340649|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
126559096|NCT02240680|455340646|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
126420155|NCT01870726|454831940|FG005|Overall Study|Adverse Event|1|||
126420156|NCT01870726|454831941|FG006|Overall Study|Adverse Event|0|||
126420157|NCT01870726|454831935|FG000|Overall Study|Progressive disease|5|||
126420158|NCT01870726|454831936|FG001|Overall Study|Progressive disease|5|||
126420159|NCT01870726|454831937|FG002|Overall Study|Progressive disease|4|||
126420160|NCT01870726|454831938|FG003|Overall Study|Progressive disease|5|||
126420161|NCT01870726|454831939|FG004|Overall Study|Progressive disease|6|||
126420162|NCT01870726|454831940|FG005|Overall Study|Progressive disease|4|||
126420163|NCT01870726|454831941|FG006|Overall Study|Progressive disease|10|||
126420164|NCT00286429|454831942|FG000|Overall Study|Adverse Event|4|||
126420165|NCT00286429|454831943|FG001|Overall Study|Adverse Event|1|||
126420166|NCT00286429|454831944|FG002|Overall Study|Adverse Event|6|||
126420167|NCT00286429|454831942|FG000|Overall Study|Lack of Efficacy|52|||
126420168|NCT00286429|454831943|FG001|Overall Study|Lack of Efficacy|27|||
126420169|NCT00286429|454831944|FG002|Overall Study|Lack of Efficacy|25|||
126559097|NCT02240680|455340647|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
126420170|NCT00286429|454831942|FG000|Overall Study|Lost to Follow-up|2|||
126420171|NCT00286429|454831943|FG001|Overall Study|Lost to Follow-up|4|||
126420172|NCT00286429|454831944|FG002|Overall Study|Lost to Follow-up|3|||
126420173|NCT00286429|454831942|FG000|Overall Study|Physician Decision|10|||
126420174|NCT00286429|454831943|FG001|Overall Study|Physician Decision|7|||
126420175|NCT00286429|454831944|FG002|Overall Study|Physician Decision|7|||
126420176|NCT00286429|454831942|FG000|Overall Study|Protocol Violation|3|||
126420177|NCT00286429|454831943|FG001|Overall Study|Protocol Violation|5|||
126420178|NCT00286429|454831944|FG002|Overall Study|Protocol Violation|4|||
126420179|NCT00286429|454831942|FG000|Overall Study|Withdrawal by Subject|3|||
126420180|NCT00286429|454831943|FG001|Overall Study|Withdrawal by Subject|2|||
126420181|NCT00286429|454831944|FG002|Overall Study|Withdrawal by Subject|6|||
126420182|NCT00286429|454831942|FG000|Overall Study|Administrative Error|1|||
126420183|NCT00286429|454831943|FG001|Overall Study|Administrative Error|1|||
126420184|NCT00286429|454831944|FG002|Overall Study|Administrative Error|1|||
126420185|NCT00286429|454831942|FG000|Overall Study|Administrative Decision|0|||
126420186|NCT00286429|454831943|FG001|Overall Study|Administrative Decision|1|||
126420187|NCT00286429|454831944|FG002|Overall Study|Administrative Decision|0|||
126420188|NCT00595478|454831945|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
126420189|NCT00595478|454831946|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
126420190|NCT00595478|454831945|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
126420191|NCT00595478|454831946|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
126420192|NCT01123395|454831948|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
126420193|NCT01123395|454831949|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
126420194|NCT03691571|454831950|FG000|Overall Study|Withdrawal by Subject|9|||
126420195|NCT03691571|454831951|FG001|Overall Study|Withdrawal by Subject|2|||
126420196|NCT00186901|454831954|FG000|Overall Study|Pregnancy|6|||
126420197|NCT00186901|454831955|FG001|Overall Study|Pregnancy|3|||
126420198|NCT00186901|454831956|FG002|Overall Study|Pregnancy|0|||
126420199|NCT00186901|454831954|FG000|Overall Study|Lost to Follow-up|6|||
126420200|NCT00186901|454831955|FG001|Overall Study|Lost to Follow-up|3|||
126420201|NCT00186901|454831956|FG002|Overall Study|Lost to Follow-up|0|||
126420202|NCT00186901|454831954|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
126420203|NCT00186901|454831955|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
126420204|NCT00186901|454831956|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
126420205|NCT00186901|454831954|FG000|Overall Study|ALL relapse or second malignancy|1|||
126420206|NCT00186901|454831955|FG001|Overall Study|ALL relapse or second malignancy|2|||
126420207|NCT00186901|454831956|FG002|Overall Study|ALL relapse or second malignancy|0|||
126420208|NCT00186901|454831954|FG000|Overall Study|Withdrawal by Subject|4|||
126420209|NCT00186901|454831955|FG001|Overall Study|Withdrawal by Subject|5|||
126420210|NCT00186901|454831956|FG002|Overall Study|Withdrawal by Subject|0|||
126420211|NCT00186901|454831954|FG000|Overall Study|Open label|3|||
126420212|NCT00186901|454831955|FG001|Overall Study|Open label|2|||
126420213|NCT00186901|454831956|FG002|Overall Study|Open label|0|||
126420214|NCT00186901|454831954|FG000|Overall Study|Limited adherence to study requirements|20|||
126420215|NCT00186901|454831955|FG001|Overall Study|Limited adherence to study requirements|23|||
126420216|NCT00186901|454831956|FG002|Overall Study|Limited adherence to study requirements|0|||
126420217|NCT00186901|454831954|FG000|Overall Study|Bone Mineral Density > 0|0|||
126420218|NCT00186901|454831955|FG001|Overall Study|Bone Mineral Density > 0|0|||
126420219|NCT00186901|454831956|FG002|Overall Study|Bone Mineral Density > 0|149|||
126420220|NCT00291486|454831962|FG000|Overall Study|Adverse Event|0|||
126420221|NCT00291486|454831963|FG001|Overall Study|Adverse Event|3|||
126420222|NCT00291486|454831964|FG002|Overall Study|Adverse Event|0|||
126420223|NCT00291486|454831965|FG003|Overall Study|Adverse Event|1|||
126420224|NCT00291486|454831966|FG004|Overall Study|Adverse Event|0|||
126420225|NCT00291486|454831962|FG000|Overall Study|Withdrawal by Subject|0|||
126420226|NCT00291486|454831963|FG001|Overall Study|Withdrawal by Subject|0|||
126420227|NCT00291486|454831964|FG002|Overall Study|Withdrawal by Subject|0|||
126420228|NCT00291486|454831965|FG003|Overall Study|Withdrawal by Subject|0|||
126420229|NCT00291486|454831966|FG004|Overall Study|Withdrawal by Subject|1|||
126420230|NCT00291486|454831962|FG000|Overall Study|Disease progression|1|||
126420231|NCT00291486|454831963|FG001|Overall Study|Disease progression|0|||
126420232|NCT00291486|454831964|FG002|Overall Study|Disease progression|1|||
126420233|NCT00291486|454831965|FG003|Overall Study|Disease progression|0|||
126420234|NCT00291486|454831966|FG004|Overall Study|Disease progression|0|||
126420235|NCT01099397|454831969|FG000|Overall Study|Lost to Follow-up|4|||
126420236|NCT01099397|454831969|FG000|Overall Study|Protocol Violation|4|||
126420237|NCT01099397|454831969|FG000|Overall Study|Withdrawal by Subject|5|||
126420238|NCT02363959|454831970|FG000|Overall Study|Medical instability|1|||
126420239|NCT02363959|454831971|FG001|Overall Study|Medical instability|0|||
126420240|NCT00950248|454831974|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
126420241|NCT00950248|454831975|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
126420242|NCT00950248|454831976|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
126420243|NCT00950248|454831974|FG000|Year 1: Baseline|worsening of symptoms|2|||
126420244|NCT00950248|454831975|FG001|Year 1: Baseline|worsening of symptoms|0|||
126420245|NCT00950248|454831976|FG002|Year 1: Baseline|worsening of symptoms|0|||
126420246|NCT00950248|454831974|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
126420247|NCT00950248|454831975|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
126420248|NCT00950248|454831976|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
126420249|NCT00950248|454831974|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
126420250|NCT00950248|454831975|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
126420251|NCT00950248|454831976|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
126420252|NCT00950248|454831974|FG000|Year 2&3 Treatment Randomization|Death|0|||
126420253|NCT00950248|454831975|FG001|Year 2&3 Treatment Randomization|Death|0|||
126420254|NCT00950248|454831976|FG002|Year 2&3 Treatment Randomization|Death|1|||
126420255|NCT00950248|454831974|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
126420256|NCT00950248|454831975|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
126420257|NCT00950248|454831976|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
126420258|NCT01900652|454831978|FG000|Overall Study|Progressive Disease|1|||
126420259|NCT01900652|454831979|FG001|Overall Study|Progressive Disease|0|||
126420260|NCT01900652|454831978|FG000|Overall Study|Consent withdrawn by subject|1|||
126420261|NCT01900652|454831979|FG001|Overall Study|Consent withdrawn by subject|1|||
126420262|NCT01900652|454831978|FG000|Overall Study|Death|3|||
126420263|NCT01900652|454831979|FG001|Overall Study|Death|0|||
126420264|NCT01900652|454831978|FG000|Overall Study|Adverse Event|2|||
126420265|NCT01900652|454831979|FG001|Overall Study|Adverse Event|1|||
126420266|NCT01900652|454831978|FG000|Overall Study|Physician Decision|1|||
126420267|NCT01900652|454831979|FG001|Overall Study|Physician Decision|1|||
126420268|NCT00869518|454831982|FG000|Overall Study|Lost to Follow-up|1|||
126420269|NCT00869518|454831983|FG001|Overall Study|Lost to Follow-up|1|||
126420270|NCT00947115|454831984|FG000|Overall Study|Missed reporting interval|3|||
126420271|NCT00947115|454831985|FG001|Overall Study|Missed reporting interval|4|||
126420272|NCT00947115|454831986|FG002|Overall Study|Missed reporting interval|2|||
126420273|NCT00947115|454831984|FG000|Overall Study|Physician Decision|0|||
126420274|NCT00947115|454831985|FG001|Overall Study|Physician Decision|2|||
126420275|NCT00947115|454831986|FG002|Overall Study|Physician Decision|0|||
126420276|NCT00947115|454831984|FG000|Overall Study|Death|0|||
126420277|NCT00947115|454831985|FG001|Overall Study|Death|1|||
126420278|NCT00947115|454831986|FG002|Overall Study|Death|1|||
126420279|NCT00947115|454831984|FG000|Overall Study|Migrated from study area|2|||
126420280|NCT00947115|454831985|FG001|Overall Study|Migrated from study area|0|||
126420281|NCT00947115|454831986|FG002|Overall Study|Migrated from study area|0|||
126420282|NCT00947115|454831984|FG000|Overall Study|Withdrawal by Subject|1|||
126420283|NCT00947115|454831985|FG001|Overall Study|Withdrawal by Subject|3|||
126420284|NCT00947115|454831986|FG002|Overall Study|Withdrawal by Subject|4|||
126420285|NCT00947115|454831984|FG000|Overall Study|Lost to Follow-up|11|||
126420286|NCT00947115|454831985|FG001|Overall Study|Lost to Follow-up|12|||
126420287|NCT00947115|454831986|FG002|Overall Study|Lost to Follow-up|8|||
126420288|NCT00900029|454831989|FG000|Overall Study|Lost to Follow-up|0|||
126420289|NCT00900029|454831990|FG001|Overall Study|Lost to Follow-up|2|||
126420290|NCT00900029|454831991|FG002|Overall Study|Lost to Follow-up|1|||
126420291|NCT00900029|454831992|FG003|Overall Study|Lost to Follow-up|4|||
126420292|NCT00900029|454831993|FG004|Overall Study|Lost to Follow-up|4|||
126420293|NCT00900029|454831989|FG000|Overall Study|Withdrawal by Subject|2|||
126420294|NCT00900029|454831990|FG001|Overall Study|Withdrawal by Subject|2|||
126420295|NCT00900029|454831991|FG002|Overall Study|Withdrawal by Subject|1|||
126420296|NCT00900029|454831992|FG003|Overall Study|Withdrawal by Subject|1|||
126420297|NCT00900029|454831993|FG004|Overall Study|Withdrawal by Subject|1|||
126420298|NCT00900029|454831989|FG000|Overall Study|Adverse Event|0|||
126420299|NCT00900029|454831990|FG001|Overall Study|Adverse Event|0|||
126420300|NCT00900029|454831991|FG002|Overall Study|Adverse Event|1|||
126420301|NCT00900029|454831992|FG003|Overall Study|Adverse Event|1|||
126420302|NCT00900029|454831993|FG004|Overall Study|Adverse Event|1|||
126420303|NCT00900029|454831989|FG000|Overall Study|Death|1|||
126420304|NCT00900029|454831990|FG001|Overall Study|Death|0|||
126420305|NCT00900029|454831991|FG002|Overall Study|Death|0|||
126420306|NCT00900029|454831992|FG003|Overall Study|Death|1|||
126420307|NCT00900029|454831993|FG004|Overall Study|Death|0|||
126420308|NCT02587819|454831994|FG000|Overall Study|Adverse Event|1|||
126420309|NCT02587819|454831994|FG000|Overall Study|Lost to Follow-up|1|||
126420310|NCT00511238|454831995|FG000|Overall Study|Adverse Event|13|||
126420311|NCT00511238|454831996|FG001|Overall Study|Adverse Event|33|||
126420312|NCT00511238|454831995|FG000|Overall Study|Withdrawal by Subject|2|||
126420313|NCT00511238|454831996|FG001|Overall Study|Withdrawal by Subject|22|||
126420314|NCT00511238|454831995|FG000|Overall Study|Progressive Disease|23|||
126420315|NCT00511238|454831996|FG001|Overall Study|Progressive Disease|157|||
126420316|NCT00511238|454831995|FG000|Overall Study|various reasons|4|||
126420317|NCT00511238|454831996|FG001|Overall Study|various reasons|14|||
126420318|NCT03772665|454831999|FG000|Overall Study|Protocol Violation|1|||
126420319|NCT03772665|454832000|FG001|Overall Study|Protocol Violation|0|||
126420320|NCT00163020|454832001|FG000|Overall Study|Lost to Follow-up|0|||
126420321|NCT00163020|454832002|FG001|Overall Study|Lost to Follow-up|2|||
126420322|NCT02871635|454833611|FG000|Overall Study|Primary lack of efficacy|4|||
126420323|NCT02871635|454833612|FG001|Overall Study|Primary lack of efficacy|4|||
126420324|NCT02871635|454833611|FG000|Overall Study|Protocol Violation|3|||
126420325|NCT02871635|454833612|FG001|Overall Study|Protocol Violation|1|||
126420326|NCT02871635|454833611|FG000|Overall Study|Lost to Follow-up|1|||
126420327|NCT02871635|454833612|FG001|Overall Study|Lost to Follow-up|2|||
126420328|NCT02871635|454833611|FG000|Overall Study|Pregnancy|0|||
126420329|NCT02871635|454833612|FG001|Overall Study|Pregnancy|2|||
126420330|NCT02871635|454833611|FG000|Overall Study|Physician Decision|1|||
126420331|NCT02871635|454833612|FG001|Overall Study|Physician Decision|1|||
126420332|NCT02871635|454833611|FG000|Overall Study|Withdrawal by Subject|3|||
126420333|NCT02871635|454833612|FG001|Overall Study|Withdrawal by Subject|4|||
126420334|NCT02871635|454833611|FG000|Overall Study|Adverse Event|4|||
126477232|NCT02165215|455048210|FG002|Induction Phase|Non-Compliance|0|||
126477233|NCT02165215|455048208|FG000|Induction Phase|Lost to Follow-up|6|||
126477234|NCT02165215|455048209|FG001|Induction Phase|Lost to Follow-up|0|||
126477235|NCT02165215|455048210|FG002|Induction Phase|Lost to Follow-up|0|||
126477236|NCT02165215|455048208|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126477237|NCT02165215|455048209|FG001|Maintenance Phase|Withdrawal by Subject|7|||
126477238|NCT02165215|455048210|FG002|Maintenance Phase|Withdrawal by Subject|3|||
126477239|NCT02165215|455048208|FG000|Maintenance Phase|Multiple reasons|0|||
126477240|NCT02165215|455048209|FG001|Maintenance Phase|Multiple reasons|2|||
126477241|NCT02165215|455048210|FG002|Maintenance Phase|Multiple reasons|1|||
126477242|NCT02165215|455048208|FG000|Maintenance Phase|Lost to Follow-up|0|||
126477243|NCT02165215|455048209|FG001|Maintenance Phase|Lost to Follow-up|2|||
126477244|NCT02165215|455048210|FG002|Maintenance Phase|Lost to Follow-up|0|||
126477245|NCT02165215|455048208|FG000|Maintenance Phase|Adverse Event|0|||
126477246|NCT02165215|455048209|FG001|Maintenance Phase|Adverse Event|1|||
126477247|NCT02165215|455048210|FG002|Maintenance Phase|Adverse Event|1|||
126477248|NCT00064337|455048211|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
126477249|NCT00064337|455048211|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
126477250|NCT00064337|455048211|FG000|PBSCC or Induction/PBSCC|Progression|3|||
126477251|NCT00064337|455048211|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
126477252|NCT00064337|455048211|FG000|PBSCC or Induction/PBSCC|Death|2|||
126477253|NCT00064337|455048211|FG000|Transplant|Adverse Event|9|||
126477254|NCT00064337|455048211|FG000|Transplant|Not protocol-specified|5|||
126477255|NCT00064337|455048211|FG000|Transplant|Death|3|||
126477256|NCT00064337|455048211|FG000|Transplant|Patient Refusal|2|||
126477257|NCT00064337|455048211|FG000|Transplant|Progression|2|||
126721939|NCT00952289|455931330|FG001|All Participants|Data lost during site relocation|1|||
126721940|NCT00952289|455931329|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
126721941|NCT00952289|455931330|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
126420335|NCT02871635|454833612|FG001|Overall Study|Adverse Event|4|||
126420336|NCT02871635|454833611|FG000|Overall Study|Secondary lack of efficacy|2|||
126420337|NCT02871635|454833612|FG001|Overall Study|Secondary lack of efficacy|1|||
126420338|NCT02420379|454833613|FG000|Overall Study|Withdrawal by Subject|0|||
126420339|NCT02420379|454833614|FG001|Overall Study|Withdrawal by Subject|3|||
126420340|NCT02420379|454833613|FG000|Overall Study|Unable to complete due to schooling|0|||
126420341|NCT02420379|454833614|FG001|Overall Study|Unable to complete due to schooling|1|||
126420342|NCT02420379|454833613|FG000|Overall Study|Transitioned to commercial drug|1|||
126420343|NCT02420379|454833614|FG001|Overall Study|Transitioned to commercial drug|0|||
126420344|NCT00502671|454833615|FG000|Overall Study|Disease Progression|13|||
126420345|NCT00502671|454833615|FG000|Overall Study|Personal Reasons|22|||
126420346|NCT00502671|454833615|FG000|Overall Study|Lost to Follow-up|7|||
126420347|NCT00502671|454833615|FG000|Overall Study|Protocol Violation|16|||
126420348|NCT00502671|454833615|FG000|Overall Study|Adverse Event|19|||
126420349|NCT00412893|454833624|FG000|Overall Study|Adverse Event|31|||
126420350|NCT00412893|454833625|FG001|Overall Study|Adverse Event|53|||
126420351|NCT00412893|454833624|FG000|Overall Study|Death|17|||
126420352|NCT00412893|454833625|FG001|Overall Study|Death|21|||
126420353|NCT00412893|454833624|FG000|Overall Study|Insufficient Therapeutic Response|39|||
126420354|NCT00412893|454833625|FG001|Overall Study|Insufficient Therapeutic Response|23|||
126420355|NCT00412893|454833624|FG000|Overall Study|Lost to Follow-up|2|||
126420356|NCT00412893|454833625|FG001|Overall Study|Lost to Follow-up|1|||
126420357|NCT00412893|454833624|FG000|Overall Study|Violation of Selection at Entry|17|||
126477258|NCT00064337|455048211|FG000|Maintenance|Adverse Event|3|||
126477259|NCT00064337|455048211|FG000|Maintenance|Progression|2|||
126420358|NCT00412893|454833625|FG001|Overall Study|Violation of Selection at Entry|10|||
126420359|NCT00412893|454833624|FG000|Overall Study|Other Protocol Violation|10|||
126420360|NCT00412893|454833625|FG001|Overall Study|Other Protocol Violation|6|||
126420361|NCT00412893|454833624|FG000|Overall Study|Did Not Cooperate|12|||
126477260|NCT00064337|455048211|FG000|Maintenance|On treatment at time of analysis|2|||
126477261|NCT00064337|455048211|FG000|Maintenance|Not protocol-specified|2|||
126477262|NCT00064337|455048211|FG000|Maintenance|Death|1|||
126721942|NCT00952289|455931329|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
126477263|NCT02279420|455048212|FG000|Overall Study|Lost to Follow-up|23|||
126477264|NCT05096221|455048215|FG000|Part 2|Physician Decision|0|||
126477265|NCT05096221|455048216|FG001|Part 2|Physician Decision|1|||
126477266|NCT04678661|455048217|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
126420362|NCT00412893|454833625|FG001|Overall Study|Did Not Cooperate|9|||
126420363|NCT00412893|454833624|FG000|Overall Study|Administrative Reason|12|||
126420364|NCT00412893|454833625|FG001|Overall Study|Administrative Reason|15|||
126477267|NCT04678661|455048218|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
126420365|NCT00412893|454833624|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
126420366|NCT00412893|454833625|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
126420367|NCT00853151|454833626|FG000|Overall Study|Adverse Event|1|||
126420368|NCT00853151|454833627|FG001|Overall Study|Adverse Event|4|||
126420369|NCT00853151|454833628|FG002|Overall Study|Adverse Event|2|||
126420370|NCT00853151|454833629|FG003|Overall Study|Adverse Event|0|||
126420371|NCT00853151|454833626|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
126420372|NCT00853151|454833627|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126420373|NCT00853151|454833628|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126420374|NCT00853151|454833629|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126420375|NCT00853151|454833626|FG000|Overall Study|Lost to Follow-up|2|||
126420376|NCT00853151|454833627|FG001|Overall Study|Lost to Follow-up|0|||
126420377|NCT00853151|454833628|FG002|Overall Study|Lost to Follow-up|3|||
126420378|NCT00853151|454833629|FG003|Overall Study|Lost to Follow-up|0|||
126420379|NCT00853151|454833626|FG000|Overall Study|Death|1|||
126420380|NCT00853151|454833627|FG001|Overall Study|Death|0|||
126420381|NCT00853151|454833628|FG002|Overall Study|Death|0|||
126420382|NCT00853151|454833629|FG003|Overall Study|Death|1|||
126420383|NCT00853151|454833626|FG000|Overall Study|Protocol Violation|0|||
126420384|NCT00853151|454833627|FG001|Overall Study|Protocol Violation|0|||
126420385|NCT00853151|454833628|FG002|Overall Study|Protocol Violation|0|||
126420386|NCT00853151|454833629|FG003|Overall Study|Protocol Violation|1|||
126420387|NCT00853151|454833626|FG000|Overall Study|Withdrawal by Subject|5|||
126420388|NCT00853151|454833627|FG001|Overall Study|Withdrawal by Subject|4|||
126420389|NCT00853151|454833628|FG002|Overall Study|Withdrawal by Subject|2|||
126420390|NCT00853151|454833629|FG003|Overall Study|Withdrawal by Subject|1|||
126420391|NCT00853151|454833626|FG000|Overall Study|Physician Decision|0|||
126420392|NCT00853151|454833627|FG001|Overall Study|Physician Decision|2|||
126420393|NCT00853151|454833628|FG002|Overall Study|Physician Decision|1|||
126420394|NCT00853151|454833629|FG003|Overall Study|Physician Decision|0|||
126420395|NCT00853151|454833626|FG000|Overall Study|Sponsor Decision|0|||
126420396|NCT00853151|454833627|FG001|Overall Study|Sponsor Decision|3|||
126420397|NCT00853151|454833628|FG002|Overall Study|Sponsor Decision|0|||
126420398|NCT00853151|454833629|FG003|Overall Study|Sponsor Decision|0|||
126420399|NCT00269919|454833630|FG000|Overall Study|Other|26|||
126420400|NCT00269919|454833630|FG000|Overall Study|Started but not treated|1|||
126420401|NCT04473963|454833631|FG000|Overall Study|Withdrawal by Subject|1|||
126420402|NCT04473963|454833632|FG001|Overall Study|Withdrawal by Subject|1|||
126420403|NCT04473963|454833633|FG002|Overall Study|Withdrawal by Subject|0|||
126420404|NCT04473963|454833631|FG000|Overall Study|Not inducible in AF|0|||
126420405|NCT04473963|454833632|FG001|Overall Study|Not inducible in AF|0|||
126420406|NCT04473963|454833633|FG002|Overall Study|Not inducible in AF|2|||
126420407|NCT01550757|454833634|FG000|Overall Study|Lost to Follow-up|21|||
126420408|NCT01550757|454833635|FG001|Overall Study|Lost to Follow-up|14|||
126420409|NCT01550757|454833636|FG002|Overall Study|Lost to Follow-up|42|||
126420410|NCT01550757|454833637|FG003|Overall Study|Lost to Follow-up|53|||
126420411|NCT01550757|454833634|FG000|Overall Study|Withdrawal by Subject|2|||
126420412|NCT01550757|454833635|FG001|Overall Study|Withdrawal by Subject|0|||
126420413|NCT01550757|454833636|FG002|Overall Study|Withdrawal by Subject|3|||
126420414|NCT01550757|454833637|FG003|Overall Study|Withdrawal by Subject|1|||
126420415|NCT04098809|454833639|FG000|Overall Study|Withdrawal by Subject|1|||
126477268|NCT04678661|455048217|FG000|Overall Study|Protocol Violation|2|||
126477269|NCT04678661|455048218|FG001|Overall Study|Protocol Violation|0|||
126721943|NCT00952289|455931330|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
126420416|NCT04098809|454833640|FG001|Overall Study|Withdrawal by Subject|3|||
126420417|NCT04098809|454833639|FG000|Overall Study|Physician Decision|2|||
126420418|NCT04098809|454833640|FG001|Overall Study|Physician Decision|1|||
126420419|NCT02741596|454833641|FG000|Overall Study|Adverse Event|1|||
126420420|NCT02741596|454833642|FG001|Overall Study|Adverse Event|5|||
126420421|NCT02741596|454833641|FG000|Overall Study|Lost to Follow-up|1|||
126420422|NCT02741596|454833642|FG001|Overall Study|Lost to Follow-up|1|||
126420423|NCT02741596|454833641|FG000|Overall Study|Physician Decision|2|||
126420424|NCT02741596|454833642|FG001|Overall Study|Physician Decision|1|||
126420425|NCT02741596|454833641|FG000|Overall Study|Pregnancy|3|||
126420426|NCT02741596|454833642|FG001|Overall Study|Pregnancy|1|||
126420427|NCT02741596|454833641|FG000|Overall Study|Other (Unspecified)|0|||
126420428|NCT02741596|454833642|FG001|Overall Study|Other (Unspecified)|3|||
126420429|NCT02741596|454833641|FG000|Overall Study|Subject withdrawn-Other|17|||
126420430|NCT02741596|454833642|FG001|Overall Study|Subject withdrawn-Other|4|||
126420431|NCT02741596|454833641|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
126420432|NCT02741596|454833642|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
126420433|NCT01426958|454833643|FG000|Overall Study|Adverse Event|2|||
126420434|NCT00991939|454833644|FG000|Overall Study|Lost to Follow-up|0|||
126420435|NCT00991939|454833645|FG001|Overall Study|Lost to Follow-up|1|||
126721944|NCT00952289|455931329|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
126420436|NCT00991939|454833644|FG000|Overall Study|Withdrawal by Subject|1|||
126420437|NCT00991939|454833645|FG001|Overall Study|Withdrawal by Subject|0|||
126420438|NCT00991939|454833644|FG000|Overall Study|Entire study terminated|4|||
126420439|NCT00991939|454833645|FG001|Overall Study|Entire study terminated|1|||
126420440|NCT00714415|454833646|FG000|Overall Study|Lack of Efficacy|1|||
126420441|NCT00714415|454833647|FG001|Overall Study|Lack of Efficacy|0|||
126420442|NCT00714415|454833646|FG000|Overall Study|Death|1|||
126420443|NCT00714415|454833647|FG001|Overall Study|Death|0|||
126420444|NCT00740584|454833650|FG000|Overall Study|Withdrawal by Subject|1|||
126420445|NCT02073682|454833660|FG000|Overall Study|Low Creatinine Clearance|1|||
126420446|NCT02073682|454833661|FG001|Overall Study|Low Creatinine Clearance|2|||
126420447|NCT02073682|454833660|FG000|Overall Study|Death|86|||
126420448|NCT02073682|454833661|FG001|Overall Study|Death|100|||
126420449|NCT02073682|454833660|FG000|Overall Study|Cancer Cured|10|||
126420450|NCT02073682|454833661|FG001|Overall Study|Cancer Cured|15|||
126420451|NCT02073682|454833660|FG000|Overall Study|ID: Patient Noncompliance|1|||
126420452|NCT02073682|454833661|FG001|Overall Study|ID: Patient Noncompliance|2|||
126420453|NCT02073682|454833660|FG000|Overall Study|ID: Palliative Treatment Only|10|||
126420454|NCT02073682|454833661|FG001|Overall Study|ID: Palliative Treatment Only|7|||
126420455|NCT02073682|454833660|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
126420456|NCT02073682|454833661|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
126420457|NCT02073682|454833660|FG000|Overall Study|Platelet Count <50,000/mL|1|||
126420458|NCT02073682|454833661|FG001|Overall Study|Platelet Count <50,000/mL|2|||
126420459|NCT02073682|454833660|FG000|Overall Study|Surgery/Medical Procedure|3|||
126420460|NCT02073682|454833661|FG001|Overall Study|Surgery/Medical Procedure|1|||
126420461|NCT02073682|454833660|FG000|Overall Study|Withdrawal by Subject|6|||
126420462|NCT02073682|454833661|FG001|Overall Study|Withdrawal by Subject|8|||
126420463|NCT02073682|454833660|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
126420464|NCT02073682|454833661|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
126420465|NCT02073682|454833660|FG000|Overall Study|Cancer Progression|53|||
126420466|NCT02073682|454833661|FG001|Overall Study|Cancer Progression|33|||
126420467|NCT02073682|454833660|FG000|Overall Study|Protocol Violation|1|||
126420468|NCT02073682|454833661|FG001|Overall Study|Protocol Violation|0|||
126420469|NCT02073682|454833660|FG000|Overall Study|Adverse Event|79|||
126559098|NCT02240680|455340648|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
126420470|NCT02073682|454833661|FG001|Overall Study|Adverse Event|62|||
126420471|NCT02073682|454833660|FG000|Overall Study|No reason provided|11|||
126420472|NCT02073682|454833661|FG001|Overall Study|No reason provided|9|||
126420473|NCT02073682|454833660|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
126420474|NCT02073682|454833661|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
126420475|NCT02073682|454833660|FG000|Overall Study|Lost to Follow-up|1|||
126420476|NCT02073682|454833661|FG001|Overall Study|Lost to Follow-up|1|||
126420477|NCT02073682|454833660|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
126420478|NCT02073682|454833661|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
126420479|NCT03461146|454833662|FG000|Overall Study|Adverse Event|2|||
126420480|NCT03461146|454833662|FG000|Overall Study|Physician Decision|1|||
126420481|NCT00181766|454833663|FG000|Overall Study|Lost to Follow-up|6|||
126420482|NCT00181766|454833663|FG000|Overall Study|Adverse Event|4|||
126420483|NCT00181766|454833663|FG000|Overall Study|non-compliance|2|||
126420484|NCT00855816|454833664|FG000|Overall Study|Withdrawal by Subject|22|||
126420485|NCT00855816|454833665|FG001|Overall Study|Withdrawal by Subject|15|||
126420486|NCT00855816|454833664|FG000|Overall Study|Lost to Follow-up|3|||
126420487|NCT00855816|454833665|FG001|Overall Study|Lost to Follow-up|5|||
126420488|NCT00855816|454833664|FG000|Overall Study|Death|1|||
126420489|NCT00855816|454833665|FG001|Overall Study|Death|0|||
126420490|NCT00855816|454833664|FG000|Overall Study|Became ineligible|0|||
126420491|NCT00855816|454833665|FG001|Overall Study|Became ineligible|1|||
126420492|NCT01965704|454833669|FG000|Overall Study|Withdrawal by Subject|2|||
126420493|NCT01965704|454833670|FG001|Overall Study|Withdrawal by Subject|2|||
126420494|NCT01965704|454833671|FG002|Overall Study|Withdrawal by Subject|1|||
126420495|NCT01965704|454833672|FG003|Overall Study|Withdrawal by Subject|1|||
126420496|NCT01965704|454833669|FG000|Overall Study|Delivered at home|1|||
126420497|NCT01965704|454833670|FG001|Overall Study|Delivered at home|1|||
126420498|NCT01965704|454833671|FG002|Overall Study|Delivered at home|0|||
126420499|NCT01965704|454833672|FG003|Overall Study|Delivered at home|0|||
126420500|NCT01965704|454833669|FG000|Overall Study|Experienced complications|0|||
126559099|NCT02240680|455340649|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
126559100|NCT02240680|455340646|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
126559101|NCT02240680|455340647|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
126559102|NCT02240680|455340648|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
126559103|NCT02240680|455340649|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
126559104|NCT02240680|455340646|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
126559105|NCT02240680|455340647|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
126756532|NCT03730987|456059458|FG002|Overall Study|Lost to Follow-up|2|||
126420501|NCT01965704|454833670|FG001|Overall Study|Experienced complications|0|||
126420502|NCT01965704|454833671|FG002|Overall Study|Experienced complications|2|||
126420503|NCT01965704|454833672|FG003|Overall Study|Experienced complications|2|||
126420504|NCT01965704|454833669|FG000|Overall Study|Adverse Event|0|||
126420505|NCT01965704|454833670|FG001|Overall Study|Adverse Event|0|||
126420506|NCT01965704|454833671|FG002|Overall Study|Adverse Event|1|||
126420507|NCT01965704|454833672|FG003|Overall Study|Adverse Event|1|||
126420508|NCT01965704|454833669|FG000|Overall Study|Did not meet inclusion criteria|0|||
126420509|NCT01965704|454833670|FG001|Overall Study|Did not meet inclusion criteria|0|||
126420510|NCT01965704|454833671|FG002|Overall Study|Did not meet inclusion criteria|1|||
126420511|NCT01965704|454833672|FG003|Overall Study|Did not meet inclusion criteria|1|||
126420512|NCT00687804|454833680|FG000|Core Study|Adverse Event|5|||
126420513|NCT00687804|454833681|FG001|Core Study|Adverse Event|3|||
126420514|NCT00687804|454833682|FG002|Core Study|Adverse Event|3|||
126420515|NCT00687804|454833680|FG000|Core Study|Abnormal laboratory value(s)|1|||
126420516|NCT00687804|454833681|FG001|Core Study|Abnormal laboratory value(s)|0|||
126420517|NCT00687804|454833682|FG002|Core Study|Abnormal laboratory value(s)|0|||
126420518|NCT00687804|454833680|FG000|Core Study|Lack of Efficacy|1|||
126420519|NCT00687804|454833681|FG001|Core Study|Lack of Efficacy|1|||
126420520|NCT00687804|454833682|FG002|Core Study|Lack of Efficacy|1|||
126420521|NCT00687804|454833680|FG000|Core Study|Withdrawal by Subject|4|||
126420522|NCT00687804|454833681|FG001|Core Study|Withdrawal by Subject|7|||
126420523|NCT00687804|454833682|FG002|Core Study|Withdrawal by Subject|7|||
126420524|NCT00687804|454833680|FG000|Core Study|Lost to Follow-up|0|||
126420525|NCT00687804|454833681|FG001|Core Study|Lost to Follow-up|1|||
126420526|NCT00687804|454833682|FG002|Core Study|Lost to Follow-up|0|||
126420527|NCT00687804|454833680|FG000|Core Study|Death|2|||
126420528|NCT00687804|454833681|FG001|Core Study|Death|2|||
126420529|NCT00687804|454833682|FG002|Core Study|Death|2|||
126420530|NCT00687804|454833680|FG000|Core Study|Protocol Violation|1|||
126420531|NCT00687804|454833681|FG001|Core Study|Protocol Violation|1|||
126420532|NCT00687804|454833682|FG002|Core Study|Protocol Violation|0|||
126420533|NCT00687804|454833680|FG000|Open-Label Extension Study|Adverse Event|2|||
126420534|NCT00687804|454833681|FG001|Open-Label Extension Study|Adverse Event|2|||
126420535|NCT00687804|454833682|FG002|Open-Label Extension Study|Adverse Event|2|||
126420536|NCT00687804|454833680|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
126420537|NCT00687804|454833681|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
126420538|NCT00687804|454833682|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
126420539|NCT00687804|454833680|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
126420540|NCT00687804|454833681|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
126420541|NCT00687804|454833682|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
126420542|NCT00687804|454833680|FG000|Open-Label Extension Study|Administrative problems|1|||
126420543|NCT00687804|454833681|FG001|Open-Label Extension Study|Administrative problems|1|||
126420544|NCT00687804|454833682|FG002|Open-Label Extension Study|Administrative problems|0|||
126420545|NCT00687804|454833680|FG000|Open-Label Extension Study|Death|2|||
126420546|NCT00687804|454833681|FG001|Open-Label Extension Study|Death|3|||
126420547|NCT00687804|454833682|FG002|Open-Label Extension Study|Death|3|||
126420548|NCT04390243|454833683|FG000|Overall Study|Death|1|||
126420549|NCT04390243|454833683|FG000|Overall Study|Disease Progression|4|||
126420550|NCT04390243|454833683|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
126420551|NCT00413218|454833687|FG000|Overall Study|Randomized but didn't receive study drug|2|||
126420552|NCT00413218|454833688|FG001|Overall Study|Randomized but didn't receive study drug|8|||
126420553|NCT00413218|454833687|FG000|Overall Study|Death|57|||
126420554|NCT00413218|454833688|FG001|Overall Study|Death|56|||
126420555|NCT00413218|454833687|FG000|Overall Study|Lost to Follow-up|14|||
126420556|NCT00413218|454833688|FG001|Overall Study|Lost to Follow-up|17|||
126420557|NCT00413218|454833687|FG000|Overall Study|Admin|20|||
126420558|NCT00413218|454833688|FG001|Overall Study|Admin|14|||
126420559|NCT00413218|454833687|FG000|Overall Study|Missing|1|||
126420560|NCT00413218|454833688|FG001|Overall Study|Missing|0|||
126420561|NCT00413218|454833687|FG000|Overall Study|Withdrawal by Subject|9|||
126420562|NCT00413218|454833688|FG001|Overall Study|Withdrawal by Subject|1|||
126420563|NCT01196026|454833690|FG000|Overall Study|Withdrawal by Subject|1|||
126420564|NCT01196026|454833691|FG001|Overall Study|Withdrawal by Subject|4|||
126420565|NCT01196026|454833692|FG002|Overall Study|Withdrawal by Subject|0|||
126420566|NCT01196026|454833693|FG003|Overall Study|Withdrawal by Subject|0|||
126420567|NCT01196026|454833694|FG004|Overall Study|Withdrawal by Subject|0|||
126420568|NCT01196026|454833695|FG005|Overall Study|Withdrawal by Subject|0|||
126420569|NCT01196026|454833690|FG000|Overall Study|Lost to Follow-up|0|||
126420570|NCT01196026|454833691|FG001|Overall Study|Lost to Follow-up|3|||
126420571|NCT01196026|454833692|FG002|Overall Study|Lost to Follow-up|0|||
126477270|NCT04678661|455048217|FG000|Overall Study|Withdrawal by Subject|1|||
126721945|NCT00952289|455931330|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
126721946|NCT00952289|455931329|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
126420572|NCT01196026|454833693|FG003|Overall Study|Lost to Follow-up|0|||
126420573|NCT01196026|454833694|FG004|Overall Study|Lost to Follow-up|1|||
126420574|NCT01196026|454833695|FG005|Overall Study|Lost to Follow-up|0|||
126420575|NCT01196026|454833690|FG000|Overall Study|Other|0|||
126420576|NCT01196026|454833691|FG001|Overall Study|Other|1|||
126420577|NCT01196026|454833692|FG002|Overall Study|Other|0|||
126420578|NCT01196026|454833693|FG003|Overall Study|Other|0|||
126420579|NCT01196026|454833694|FG004|Overall Study|Other|0|||
126420580|NCT01196026|454833695|FG005|Overall Study|Other|0|||
126420581|NCT01687296|454833696|FG000|Overall Study|Lack of Efficacy|1|||
126420582|NCT01687296|454833697|FG001|Overall Study|Lack of Efficacy|1|||
126420583|NCT01687296|454833696|FG000|Overall Study|Protocol Violation|0|||
126420584|NCT01687296|454833697|FG001|Overall Study|Protocol Violation|1|||
126420585|NCT01687296|454833696|FG000|Overall Study|Withdrawal by Subject|6|||
126559106|NCT02240680|455340648|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
126559107|NCT02240680|455340649|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
126559108|NCT02240680|455340646|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
126559109|NCT02240680|455340647|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
126559110|NCT02240680|455340648|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
126420586|NCT01687296|454833697|FG001|Overall Study|Withdrawal by Subject|3|||
126420587|NCT03672292|454833701|FG000|Overall Study|Adverse Event|3|||
126420588|NCT03672292|454833702|FG001|Overall Study|Adverse Event|1|||
126420589|NCT03672292|454833701|FG000|Overall Study|Physician Decision|0|||
126420590|NCT03672292|454833702|FG001|Overall Study|Physician Decision|1|||
126420591|NCT03672292|454833701|FG000|Overall Study|Withdrawal by Subject|1|||
126420592|NCT03672292|454833702|FG001|Overall Study|Withdrawal by Subject|2|||
126420593|NCT00799903|454833703|FG000|Overall Study|Investigator Site Closed|25|||
126420594|NCT00799903|454833704|FG001|Overall Study|Investigator Site Closed|23|||
126420595|NCT00799903|454833703|FG000|Overall Study|Withdrawal by Subject|179|||
126420596|NCT00799903|454833704|FG001|Overall Study|Withdrawal by Subject|175|||
126420597|NCT00799903|454833703|FG000|Overall Study|Lost to Follow-up|69|||
126420598|NCT00799903|454833704|FG001|Overall Study|Lost to Follow-up|80|||
126420599|NCT02518971|454833705|FG000|Overall Study|Lost to Follow-up|0|||
126420600|NCT02518971|454833706|FG001|Overall Study|Lost to Follow-up|1|||
126420601|NCT02518971|454833705|FG000|Overall Study|Physician Decision|6|||
126420602|NCT02518971|454833706|FG001|Overall Study|Physician Decision|6|||
126420603|NCT02518971|454833705|FG000|Overall Study|Protocol Violation|6|||
126420604|NCT02518971|454833706|FG001|Overall Study|Protocol Violation|4|||
126420605|NCT02518971|454833705|FG000|Overall Study|Withdrawal by Subject|4|||
126420606|NCT02518971|454833706|FG001|Overall Study|Withdrawal by Subject|5|||
126420607|NCT02518971|454833705|FG000|Overall Study|Side effects|1|||
126420608|NCT02518971|454833706|FG001|Overall Study|Side effects|0|||
126420609|NCT02518971|454833705|FG000|Overall Study|medication lost in mail|0|||
126420610|NCT02518971|454833706|FG001|Overall Study|medication lost in mail|1|||
126420611|NCT02518971|454833705|FG000|Overall Study|eligibility criteria no longer met|6|||
126420612|NCT02518971|454833706|FG001|Overall Study|eligibility criteria no longer met|3|||
126420613|NCT02336230|454833707|FG000|Overall Study|Adverse Event|1|||
126420614|NCT02336230|454833707|FG000|Overall Study|Withdrawal of consent|1|||
126420615|NCT02336230|454833707|FG000|Overall Study|Death|9|||
126420616|NCT02336230|454833707|FG000|Overall Study|Dose not received due to shipping delay|1|||
126420617|NCT02336230|454833707|FG000|Overall Study|Discontinuation of MSC infusion|1|||
126420618|NCT02524171|454833708|FG000|6-month Follow-up|Lost to Follow-up|53|||
126420619|NCT02524171|454833709|FG001|6-month Follow-up|Lost to Follow-up|45|||
126420620|NCT02524171|454833708|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
126420621|NCT02524171|454833709|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
126420622|NCT00757237|454833712|FG000|Overall Study|Lost to Follow-up|0|||
126420623|NCT00757237|454833713|FG001|Overall Study|Lost to Follow-up|1|||
126420624|NCT00757237|454833712|FG000|Overall Study|Protocol Violation|0|||
126420625|NCT00757237|454833713|FG001|Overall Study|Protocol Violation|2|||
126420626|NCT00757237|454833712|FG000|Overall Study|Physician Decision|2|||
126420627|NCT00757237|454833713|FG001|Overall Study|Physician Decision|3|||
126420628|NCT00757237|454833712|FG000|Overall Study|Withdrawal by Subject|8|||
126477271|NCT04678661|455048218|FG001|Overall Study|Withdrawal by Subject|0|||
126477272|NCT04678661|455048217|FG000|Overall Study|Lost to Follow-up|2|||
126477273|NCT04678661|455048218|FG001|Overall Study|Lost to Follow-up|0|||
126477274|NCT04678661|455048217|FG000|Overall Study|Death|2|||
126477275|NCT04678661|455048218|FG001|Overall Study|Death|0|||
126477276|NCT01397890|455048219|FG000|Overall Study|Withdrawal by Subject|7|||
126477277|NCT01397890|455048220|FG001|Overall Study|Withdrawal by Subject|11|||
126477278|NCT01397890|455048219|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
126477279|NCT01397890|455048220|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
126477280|NCT01397890|455048219|FG000|Overall Study|Death|2|||
126477281|NCT01397890|455048220|FG001|Overall Study|Death|3|||
126477282|NCT01397890|455048219|FG000|Overall Study|Lost to Follow-up|1|||
126420629|NCT00757237|454833713|FG001|Overall Study|Withdrawal by Subject|12|||
126420630|NCT00757237|454833712|FG000|Overall Study|Safety or Tolerability|3|||
126420631|NCT00757237|454833713|FG001|Overall Study|Safety or Tolerability|5|||
126420632|NCT00757237|454833712|FG000|Overall Study|Other|0|||
126420633|NCT00757237|454833713|FG001|Overall Study|Other|2|||
126420634|NCT05150990|454833714|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
126420635|NCT05150990|454833715|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
126420636|NCT05150990|454833714|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
126420637|NCT05150990|454833715|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
126477283|NCT01397890|455048220|FG001|Overall Study|Lost to Follow-up|4|||
126559111|NCT02240680|455340649|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
126420638|NCT05150990|454833714|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
126721947|NCT00952289|455931330|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
126721948|NCT00952289|455931329|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
126721949|NCT00952289|455931330|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
126721950|NCT00634244|455931335|FG000|Overall Study|Never started treatment|0|||
126420639|NCT05150990|454833715|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
126420640|NCT05150990|454833714|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
126420641|NCT05150990|454833715|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
126420642|NCT05150990|454833714|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
126420643|NCT05150990|454833715|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
126420644|NCT05150990|454833714|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
126420645|NCT05150990|454833715|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
126420646|NCT05150990|454833714|FG000|Overall Study|Death (unrelated to the intervention)|1|||
126420647|NCT05150990|454833715|FG001|Overall Study|Death (unrelated to the intervention)|2|||
126420648|NCT00466921|454833716|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
126420649|NCT00466921|454833716|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
126420650|NCT00466921|454833716|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
126420651|NCT00466921|454833716|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
126420652|NCT00466921|454833716|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
126420653|NCT00466921|454833716|FG000|Follow up for a Minimum of 1 Year|Death|6|||
126420654|NCT01100320|454833717|FG000|Period 1|Withdrawal by Subject|2|||
126420655|NCT01100320|454833718|FG001|Period 1|Withdrawal by Subject|4|||
126420656|NCT01100320|454833717|FG000|Period 1|Positive Drug Screen|1|||
126420657|NCT01100320|454833718|FG001|Period 1|Positive Drug Screen|1|||
126420658|NCT01100320|454833717|FG000|Period 1|Adverse Event|2|||
126420659|NCT01100320|454833718|FG001|Period 1|Adverse Event|2|||
126420660|NCT01100320|454833717|FG000|Period 2|Withdrawal by Subject|1|||
126420661|NCT01100320|454833718|FG001|Period 2|Withdrawal by Subject|1|||
126420662|NCT03797586|454833719|FG000|Overall Study|Lost to Follow-up|3|||
126420663|NCT03797586|454833720|FG001|Overall Study|Lost to Follow-up|6|||
126420664|NCT03797586|454833719|FG000|Overall Study|Death|1|||
126420665|NCT03797586|454833720|FG001|Overall Study|Death|1|||
126420666|NCT03797586|454833719|FG000|Overall Study|Adverse Event|0|||
126420667|NCT03797586|454833720|FG001|Overall Study|Adverse Event|2|||
126420668|NCT02864901|454833721|FG000|Overall Study|Withdrawal by Subject|1|||
126420669|NCT02864901|454833722|FG001|Overall Study|Withdrawal by Subject|0|||
126420670|NCT05730387|454833723|FG000|Overall Study|Stillbirth|0|||
126420671|NCT05730387|454833724|FG001|Overall Study|Stillbirth|262|||
126420672|NCT05730387|454833723|FG000|Overall Study|Died during or after delivery|2|||
126420673|NCT05730387|454833724|FG001|Overall Study|Died during or after delivery|85|||
126420674|NCT05730387|454833723|FG000|Overall Study|Died after being admitted|0|||
126420675|NCT05730387|454833724|FG001|Overall Study|Died after being admitted|44|||
126420676|NCT05730387|454833723|FG000|Overall Study|Lost to Follow-up|69|||
126420677|NCT05730387|454833724|FG001|Overall Study|Lost to Follow-up|77|||
126420678|NCT01219985|454833725|FG000|Overall Study|Physician Decision|20|||
126420679|NCT00596752|454833726|FG000|Overall Study|Other Reason|44|||
126420680|NCT00596752|454833727|FG001|Overall Study|Other Reason|49|||
126420681|NCT00596752|454833726|FG000|Overall Study|Adverse Event|34|||
126420682|NCT00596752|454833727|FG001|Overall Study|Adverse Event|34|||
126420683|NCT00596752|454833726|FG000|Overall Study|Lost to Follow-up|22|||
126420684|NCT00596752|454833727|FG001|Overall Study|Lost to Follow-up|38|||
126420685|NCT00596752|454833726|FG000|Overall Study|Withdrawal by Subject|12|||
126420686|NCT00596752|454833727|FG001|Overall Study|Withdrawal by Subject|9|||
126420687|NCT00596752|454833726|FG000|Overall Study|Unsatisfactory Compliance|9|||
126420688|NCT00596752|454833727|FG001|Overall Study|Unsatisfactory Compliance|6|||
126420689|NCT00596752|454833726|FG000|Overall Study|Lack of Efficacy|4|||
126420690|NCT00596752|454833727|FG001|Overall Study|Lack of Efficacy|7|||
126420691|NCT00596752|454833726|FG000|Overall Study|Protocol Violation|1|||
126420692|NCT00596752|454833727|FG001|Overall Study|Protocol Violation|0|||
126420693|NCT04797780|454833728|FG000|Overall Study|Lost to Follow-up|1|||
126420694|NCT04797780|454833729|FG001|Overall Study|Lost to Follow-up|1|||
126420695|NCT04797780|454833728|FG000|Overall Study|Withdrawal by Subject|14|||
126420696|NCT04797780|454833729|FG001|Overall Study|Withdrawal by Subject|9|||
126420697|NCT04797780|454833728|FG000|Overall Study|Death|49|||
126420698|NCT04797780|454833729|FG001|Overall Study|Death|20|||
126721951|NCT00634244|455931336|FG001|Overall Study|Never started treatment|1|||
126420699|NCT04669301|454833730|FG000|Overall Study|Lost to Follow-up|0|||
126420700|NCT04669301|454833731|FG001|Overall Study|Lost to Follow-up|1|||
126420701|NCT04669301|454833732|FG002|Overall Study|Lost to Follow-up|0|||
126420702|NCT04669301|454833730|FG000|Overall Study|Withdrawal by Subject|3|||
126420703|NCT04669301|454833731|FG001|Overall Study|Withdrawal by Subject|2|||
126420704|NCT04669301|454833732|FG002|Overall Study|Withdrawal by Subject|0|||
126559112|NCT02240680|455340646|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
126420705|NCT05973006|454833733|FG000|Overall Study|Early termination|3|||
126420706|NCT05973006|454833734|FG001|Overall Study|Early termination|9|||
126420707|NCT00398320|454833735|FG000|Overall Study|Death|1|||
126420708|NCT00398320|454833735|FG000|Overall Study|Adverse Event|4|||
126420709|NCT00398320|454833735|FG000|Overall Study|Physician Decision|1|||
126420710|NCT02663622|454833741|FG000|Overall Study|Death|3|||
126420711|NCT02663622|454833742|FG001|Overall Study|Death|1|||
126420712|NCT02663622|454833743|FG002|Overall Study|Death|1|||
126420713|NCT02663622|454833744|FG003|Overall Study|Death|8|||
126420714|NCT02663622|454833741|FG000|Overall Study|Protocol Violation|0|||
126420715|NCT02663622|454833742|FG001|Overall Study|Protocol Violation|0|||
126420716|NCT02663622|454833743|FG002|Overall Study|Protocol Violation|0|||
126420717|NCT02663622|454833744|FG003|Overall Study|Protocol Violation|1|||
126420718|NCT03553758|454835069|FG000|Overall Study|Lost to Follow-up|1|||
126420719|NCT00447226|454835071|FG000|12-Week Open-label Phase|Adverse Event|0|||
126420720|NCT00447226|454835072|FG001|12-Week Open-label Phase|Adverse Event|3|||
126420721|NCT00447226|454835071|FG000|12-Week Open-label Phase|Protocol Violation|0|||
126420722|NCT00447226|454835072|FG001|12-Week Open-label Phase|Protocol Violation|1|||
126420723|NCT00447226|454835071|FG000|12-Week Open-label Phase|Disease Progression|0|||
126420724|NCT00447226|454835072|FG001|12-Week Open-label Phase|Disease Progression|20|||
126420725|NCT00447226|454835071|FG000|12-Week Open-label Phase|Physician Decision|0|||
126420726|NCT00447226|454835072|FG001|12-Week Open-label Phase|Physician Decision|1|||
126420727|NCT00447226|454835071|FG000|Double-blind Phase|Disease Progression|4|||
126420728|NCT00447226|454835072|FG001|Double-blind Phase|Disease Progression|3|||
126420729|NCT01473732|454835084|FG000|Overall Study|Adverse Event|1|||
126420730|NCT01473732|454835085|FG001|Overall Study|Adverse Event|0|||
126420731|NCT01473732|454835084|FG000|Overall Study|Death|1|||
126420732|NCT01473732|454835085|FG001|Overall Study|Death|0|||
126420733|NCT03579940|454835091|FG000|Period 2|Withdrawal by Subject|0|||
126420734|NCT03579940|454835092|FG001|Period 2|Withdrawal by Subject|0|||
126420735|NCT03579940|454835093|FG002|Period 2|Withdrawal by Subject|1|||
126420736|NCT03579940|454835094|FG003|Period 2|Withdrawal by Subject|0|||
126420737|NCT03579940|454835095|FG004|Period 2|Withdrawal by Subject|0|||
126420738|NCT03579940|454835096|FG005|Period 2|Withdrawal by Subject|0|||
126420739|NCT03579940|454835097|FG006|Period 2|Withdrawal by Subject|0|||
126420740|NCT03579940|454835098|FG007|Period 2|Withdrawal by Subject|0|||
126420741|NCT03579940|454835099|FG008|Period 2|Withdrawal by Subject|0|||
126420742|NCT03579940|454835100|FG009|Period 2|Withdrawal by Subject|0|||
126420743|NCT03579940|454835101|FG010|Period 2|Withdrawal by Subject|0|||
126420744|NCT01217944|454835102|FG000|Overall Study|Protocol Violation|1|||
126420745|NCT01217944|454835103|FG001|Overall Study|Protocol Violation|1|||
126420746|NCT01217944|454835104|FG002|Overall Study|Protocol Violation|0|||
126420747|NCT01217944|454835102|FG000|Overall Study|Lost to Follow-up|3|||
126420748|NCT01217944|454835103|FG001|Overall Study|Lost to Follow-up|1|||
126420749|NCT01217944|454835104|FG002|Overall Study|Lost to Follow-up|0|||
126420750|NCT01217944|454835102|FG000|Overall Study|Withdrawal by Subject|1|||
126420751|NCT01217944|454835103|FG001|Overall Study|Withdrawal by Subject|2|||
126420752|NCT01217944|454835104|FG002|Overall Study|Withdrawal by Subject|0|||
126420753|NCT01217944|454835102|FG000|Overall Study|Lack of Efficacy|1|||
126420754|NCT01217944|454835103|FG001|Overall Study|Lack of Efficacy|0|||
126420755|NCT01217944|454835104|FG002|Overall Study|Lack of Efficacy|0|||
126420756|NCT00671034|454835105|FG000|Overall Study|Adverse Event|5|||
126420757|NCT00671034|454835106|FG001|Overall Study|Adverse Event|7|||
126420758|NCT00671034|454835107|FG002|Overall Study|Adverse Event|1|||
126420759|NCT00671034|454835105|FG000|Overall Study|Death|3|||
126420760|NCT00671034|454835106|FG001|Overall Study|Death|2|||
126420761|NCT00671034|454835107|FG002|Overall Study|Death|1|||
126420762|NCT00671034|454835105|FG000|Overall Study|Physician Decision|12|||
126420763|NCT00671034|454835106|FG001|Overall Study|Physician Decision|4|||
126420764|NCT00671034|454835107|FG002|Overall Study|Physician Decision|5|||
126420765|NCT00671034|454835105|FG000|Overall Study|VHR ALL feature|8|||
126420766|NCT00671034|454835106|FG001|Overall Study|VHR ALL feature|3|||
126420767|NCT00671034|454835107|FG002|Overall Study|VHR ALL feature|5|||
126420768|NCT00671034|454835105|FG000|Overall Study|Refusal|5|||
126420769|NCT00671034|454835106|FG001|Overall Study|Refusal|3|||
126420770|NCT00671034|454835107|FG002|Overall Study|Refusal|5|||
126420771|NCT00671034|454835105|FG000|Overall Study|includes Alternative therapy, etc.|6|||
126420772|NCT00671034|454835106|FG001|Overall Study|includes Alternative therapy, etc.|1|||
126420773|NCT00671034|454835107|FG002|Overall Study|includes Alternative therapy, etc.|7|||
126420774|NCT01751984|454835110|FG000|Overall Study|Adverse Event|5|||
126420775|NCT01751984|454835111|FG001|Overall Study|Adverse Event|3|||
126420776|NCT01751984|454835110|FG000|Overall Study|Withdrawal by Subject|0|||
126420777|NCT01751984|454835111|FG001|Overall Study|Withdrawal by Subject|1|||
126420778|NCT01751984|454835110|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
126420779|NCT01751984|454835111|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
126420780|NCT01388907|454835112|FG000|Overall Study|Adverse Event|2|||
126420781|NCT01388907|454835113|FG001|Overall Study|Adverse Event|0|||
126420782|NCT01797263|454835114|FG000|Overall Study|Withdrawal by Subject|21|||
126420783|NCT01797263|454835115|FG001|Overall Study|Withdrawal by Subject|25|||
126420784|NCT01797263|454835114|FG000|Overall Study|Death|1|||
126420785|NCT01797263|454835115|FG001|Overall Study|Death|0|||
126420786|NCT01797263|454835114|FG000|Overall Study|Lost to Follow-up|15|||
126420787|NCT01797263|454835115|FG001|Overall Study|Lost to Follow-up|15|||
126420788|NCT03187132|454835116|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
126420789|NCT03187132|454835117|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
126420790|NCT03187132|454835116|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
126420791|NCT03187132|454835117|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
126420792|NCT03187132|454835116|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
126420793|NCT03187132|454835117|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
126420794|NCT03187132|454835116|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
126420795|NCT03187132|454835117|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
126420796|NCT03187132|454835116|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
126420797|NCT03187132|454835117|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
126420798|NCT03187132|454835116|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
126420799|NCT03187132|454835117|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
126420800|NCT03187132|454835116|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
126420801|NCT03187132|454835117|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
126420802|NCT03187132|454835116|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
126420803|NCT03187132|454835117|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
126420804|NCT03187132|454835116|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
126420805|NCT03187132|454835117|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
126420806|NCT03187132|454835116|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
126420807|NCT03187132|454835117|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
126420808|NCT03187132|454835116|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
126420809|NCT03187132|454835117|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
126420810|NCT02045095|454835118|FG000|Overall Study|Other|0|||
126420811|NCT02045095|454835119|FG001|Overall Study|Other|0|||
126420812|NCT02045095|454835120|FG002|Overall Study|Other|1|||
126420813|NCT02045095|454835121|FG003|Overall Study|Other|0|||
126420814|NCT02045095|454835122|FG004|Overall Study|Other|0|||
126420815|NCT02045095|454835123|FG005|Overall Study|Other|2|||
126420816|NCT02045095|454835124|FG006|Overall Study|Other|0|||
126420817|NCT02045095|454835118|FG000|Overall Study|Progressive Disease|3|||
126420818|NCT02045095|454835119|FG001|Overall Study|Progressive Disease|3|||
126420819|NCT02045095|454835120|FG002|Overall Study|Progressive Disease|2|||
126420820|NCT02045095|454835121|FG003|Overall Study|Progressive Disease|4|||
126420821|NCT02045095|454835122|FG004|Overall Study|Progressive Disease|2|||
126420822|NCT02045095|454835123|FG005|Overall Study|Progressive Disease|4|||
126420823|NCT02045095|454835124|FG006|Overall Study|Progressive Disease|1|||
126420824|NCT02045095|454835118|FG000|Overall Study|Withdrawal by Subject|0|||
126420825|NCT02045095|454835119|FG001|Overall Study|Withdrawal by Subject|0|||
126420826|NCT02045095|454835120|FG002|Overall Study|Withdrawal by Subject|0|||
126420827|NCT02045095|454835121|FG003|Overall Study|Withdrawal by Subject|0|||
126420828|NCT02045095|454835122|FG004|Overall Study|Withdrawal by Subject|3|||
126420829|NCT02045095|454835123|FG005|Overall Study|Withdrawal by Subject|0|||
126420830|NCT02045095|454835124|FG006|Overall Study|Withdrawal by Subject|0|||
126420831|NCT02045095|454835118|FG000|Overall Study|Adverse Event|0|||
126420832|NCT02045095|454835119|FG001|Overall Study|Adverse Event|1|||
126420833|NCT02045095|454835120|FG002|Overall Study|Adverse Event|1|||
126420834|NCT02045095|454835121|FG003|Overall Study|Adverse Event|0|||
126420835|NCT02045095|454835122|FG004|Overall Study|Adverse Event|0|||
126420836|NCT02045095|454835123|FG005|Overall Study|Adverse Event|2|||
126420837|NCT02045095|454835124|FG006|Overall Study|Adverse Event|0|||
126420838|NCT03594773|454835125|FG000|Overall Study|Withdrawal by Subject|3|||
126420839|NCT03594773|454835126|FG001|Overall Study|Withdrawal by Subject|2|||
126420840|NCT03594773|454835125|FG000|Overall Study|Lost to Follow-up|3|||
126420841|NCT03594773|454835126|FG001|Overall Study|Lost to Follow-up|4|||
126420842|NCT01461707|454835132|FG000|Overall Study|Withdrawal by Subject|1|||
126420843|NCT01461707|454835133|FG001|Overall Study|Withdrawal by Subject|0|||
126420844|NCT01450761|454835134|FG000|Randomization|Subject no longer meets study criteria|1|||
126420845|NCT01450761|454835135|FG001|Randomization|Subject no longer meets study criteria|2|||
126477284|NCT01397890|455048219|FG000|Overall Study|Condition under Investigation Worsened|1|||
126477285|NCT01397890|455048220|FG001|Overall Study|Condition under Investigation Worsened|3|||
126420846|NCT01450761|454835134|FG000|Randomization|Withdrawal by Subject|2|||
126420847|NCT01450761|454835135|FG001|Randomization|Withdrawal by Subject|0|||
126420848|NCT01450761|454835134|FG000|Randomization|Disease progression|0|||
126477286|NCT01397890|455048219|FG000|Overall Study|Adverse Event|1|||
126477287|NCT01397890|455048220|FG001|Overall Study|Adverse Event|2|||
126756533|NCT03730987|456059459|FG003|Overall Study|Lost to Follow-up|0|||
126420849|NCT01450761|454835135|FG001|Randomization|Disease progression|2|||
126420850|NCT01450761|454835134|FG000|Randomization|Adverse Event unrelated to study drug|1|||
126420851|NCT01450761|454835135|FG001|Randomization|Adverse Event unrelated to study drug|0|||
126420852|NCT01450761|454835134|FG000|Randomization|Other|0|||
126420853|NCT01450761|454835135|FG001|Randomization|Other|1|||
126420854|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Disease progression|33|||
126420855|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Disease progression|32|||
126420856|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
126420857|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
126420858|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
126420859|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
126420860|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
126420861|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
126420862|NCT01450761|454835134|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
126420863|NCT01450761|454835135|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
126420864|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Death|3|||
126420865|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Death|3|||
126420866|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Other|2|||
126420867|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Other|2|||
126420868|NCT01450761|454835134|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
126420869|NCT01450761|454835135|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
126420870|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
126420871|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
126420872|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
126477288|NCT01397890|455048219|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
126477289|NCT01397890|455048220|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
126477290|NCT01397890|455048219|FG000|Overall Study|Others|2|||
126477291|NCT01397890|455048220|FG001|Overall Study|Others|1|||
126477292|NCT03741062|455048221|FG000|Overall Study|Protocol Violation|1|||
126477293|NCT03741062|455048222|FG001|Overall Study|Protocol Violation|0|||
126477294|NCT03417219|455048223|FG000|Overall Study|Lost to Follow-up|0|||
126477295|NCT03417219|455048224|FG001|Overall Study|Lost to Follow-up|3|||
126477296|NCT02021331|455048225|FG000|Overall Study|Adverse Event|0|||
126477297|NCT02021331|455048226|FG001|Overall Study|Adverse Event|2|||
126477298|NCT00762229|455048227|FG000|Overall Study|Lost to Follow-up|1|||
126420873|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
126420874|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
126420875|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
126420876|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
126420877|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
126420878|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
126420879|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
126420880|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Death|5|||
126420881|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Death|6|||
126420882|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
126420883|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
126420884|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
126420885|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
126420886|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
126420887|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
126420888|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
126420889|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
126420890|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
126420891|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
126420892|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
126420893|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
126420894|NCT01450761|454835134|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
126420895|NCT01450761|454835135|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
126420896|NCT00337207|454835148|FG000|Overall Study|Withdrawal by Subject|3|||
126420897|NCT01338818|454835152|FG000|Overall Study|Adverse Event|8|||
126420898|NCT01338818|454835152|FG000|Overall Study|Lack of Efficacy|5|||
126420899|NCT01338818|454835152|FG000|Overall Study|no longer require study drug|1|||
126420900|NCT01338818|454835152|FG000|Overall Study|Withdrawal by Subject|11|||
126420901|NCT01338818|454835152|FG000|Overall Study|Lost to Follow-up|4|||
126420902|NCT01338818|454835152|FG000|Overall Study|Administrative problems|3|||
126420903|NCT01338818|454835152|FG000|Overall Study|Protocol Deviation|4|||
126420904|NCT00556998|454835157|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
126420905|NCT00556998|454835157|FG000|Voriconazole Intravenous (IV)|Other|4|||
126477299|NCT00762229|455048228|FG001|Overall Study|Lost to Follow-up|1|||
126477300|NCT00762229|455048227|FG000|Overall Study|did not recveive intervention|0|||
126721952|NCT00634244|455931337|FG002|Overall Study|Never started treatment|0|||
126420906|NCT00556998|454835157|FG000|Voriconazole Oral|Adverse Event|1|||
126420907|NCT00556998|454835157|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
126420908|NCT00216671|454835160|FG000|Overall Study|Adverse Event|4|||
126420909|NCT00216671|454835161|FG001|Overall Study|Adverse Event|9|||
126477301|NCT00762229|455048228|FG001|Overall Study|did not recveive intervention|1|||
126477302|NCT00319553|455048231|FG000|Overall Study|Protocol Violation|1|||
126477303|NCT00319553|455048232|FG001|Overall Study|Protocol Violation|2|||
126477304|NCT00319553|455048231|FG000|Overall Study|Lost to Follow-up|2|||
126477305|NCT00319553|455048232|FG001|Overall Study|Lost to Follow-up|1|||
126477306|NCT00319553|455048231|FG000|Overall Study|Withdrawal by Subject|1|||
126477307|NCT00319553|455048232|FG001|Overall Study|Withdrawal by Subject|1|||
126477308|NCT01896102|455048235|FG000|Overall Study|Death|1|||
126477309|NCT01896102|455048235|FG000|Overall Study|Participant to receive allogenic transplant|2|||
126477310|NCT01281865|455048238|FG000|Overall Study|Adverse Event|1|||
126477311|NCT01281865|455048239|FG001|Overall Study|Adverse Event|1|||
126559113|NCT02240680|455340647|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
126721953|NCT00634244|455931335|FG000|Overall Study|Death|1|||
126420910|NCT00216671|454835160|FG000|Overall Study|Pregnancy|0|||
126420911|NCT00216671|454835161|FG001|Overall Study|Pregnancy|1|||
126420912|NCT00216671|454835160|FG000|Overall Study|Withdrawal by Subject|4|||
126420913|NCT00216671|454835161|FG001|Overall Study|Withdrawal by Subject|2|||
126420914|NCT00216671|454835160|FG000|Overall Study|Refused Injections|3|||
126420915|NCT00216671|454835161|FG001|Overall Study|Refused Injections|13|||
126420916|NCT00216671|454835160|FG000|Overall Study|No Need to Continue Medication|1|||
126420917|NCT00216671|454835161|FG001|Overall Study|No Need to Continue Medication|1|||
126420918|NCT00216671|454835160|FG000|Overall Study|Insufficient Response|9|||
126420919|NCT00216671|454835161|FG001|Overall Study|Insufficient Response|4|||
126420920|NCT00216671|454835160|FG000|Overall Study|Lost to Follow-up|3|||
126420921|NCT00216671|454835161|FG001|Overall Study|Lost to Follow-up|5|||
126420922|NCT00216671|454835160|FG000|Overall Study|Non compliant|2|||
126420923|NCT00216671|454835161|FG001|Overall Study|Non compliant|2|||
126420924|NCT00216671|454835160|FG000|Overall Study|Ineligible|0|||
126420925|NCT00216671|454835161|FG001|Overall Study|Ineligible|2|||
126420926|NCT00216671|454835160|FG000|Overall Study|Physician Decision|1|||
126420927|NCT00216671|454835161|FG001|Overall Study|Physician Decision|1|||
126420928|NCT00216671|454835160|FG000|Overall Study|Protocol Violation|3|||
126420929|NCT00216671|454835161|FG001|Overall Study|Protocol Violation|5|||
126420930|NCT00216671|454835160|FG000|Overall Study|Relapse|1|||
126420931|NCT00216671|454835161|FG001|Overall Study|Relapse|0|||
126420932|NCT00216671|454835160|FG000|Overall Study|Investigator Illness|0|||
126420933|NCT00216671|454835161|FG001|Overall Study|Investigator Illness|1|||
126420934|NCT00216671|454835160|FG000|Overall Study|Patient Moved|0|||
126420935|NCT00216671|454835161|FG001|Overall Study|Patient Moved|1|||
126420936|NCT00216671|454835160|FG000|Overall Study|Ineligible, no efficacy data|2|||
126420937|NCT00216671|454835161|FG001|Overall Study|Ineligible, no efficacy data|2|||
126420938|NCT00216671|454835160|FG000|Overall Study|Insufficient Response Adverse Event|2|||
126420939|NCT00216671|454835161|FG001|Overall Study|Insufficient Response Adverse Event|1|||
126420940|NCT04980612|454835163|FG000|Overall Study|Withdrawal by Subject|7|||
126420941|NCT04980612|454835164|FG001|Overall Study|Withdrawal by Subject|5|||
126420942|NCT01369784|454835167|FG000|Overall Study|Protocol Violation|12|||
126420943|NCT02446717|454835168|FG000|Overall Study|Adverse Event|0|||
126420944|NCT02446717|454835169|FG001|Overall Study|Adverse Event|0|||
126420945|NCT02446717|454835170|FG002|Overall Study|Adverse Event|1|||
126420946|NCT02446717|454835171|FG003|Overall Study|Adverse Event|0|||
126420947|NCT02446717|454835172|FG004|Overall Study|Adverse Event|0|||
126420948|NCT02446717|454835168|FG000|Overall Study|Lost to Follow-up|0|||
126420949|NCT02446717|454835169|FG001|Overall Study|Lost to Follow-up|1|||
126420950|NCT02446717|454835170|FG002|Overall Study|Lost to Follow-up|1|||
126420951|NCT02446717|454835171|FG003|Overall Study|Lost to Follow-up|0|||
126420952|NCT02446717|454835172|FG004|Overall Study|Lost to Follow-up|1|||
126420953|NCT02446717|454835168|FG000|Overall Study|Withdrew consent|0|||
126420954|NCT02446717|454835169|FG001|Overall Study|Withdrew consent|0|||
126420955|NCT02446717|454835170|FG002|Overall Study|Withdrew consent|0|||
126420956|NCT02446717|454835171|FG003|Overall Study|Withdrew consent|1|||
126420957|NCT02446717|454835172|FG004|Overall Study|Withdrew consent|0|||
126420958|NCT02680665|454835173|FG000|Overall Study|No visit after the first prescription|5|||
126477312|NCT01281865|455048238|FG000|Overall Study|Withdrawal by Subject|1|||
126477313|NCT01281865|455048239|FG001|Overall Study|Withdrawal by Subject|0|||
126721954|NCT00634244|455931336|FG001|Overall Study|Death|6|||
126420959|NCT04378270|454835180|FG000|Overall Study|Lack of Efficacy|1|||
126420960|NCT04378270|454835180|FG000|Overall Study|Withdrawal by Subject|1|||
126420961|NCT04378270|454835180|FG000|Overall Study|Screen Failure|1|||
126420962|NCT04378270|454835180|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
126420963|NCT01327599|454835181|FG000|Overall Study|Adverse Event|1|||
126420964|NCT01327599|454835181|FG000|Overall Study|Could Not Attend Visit|1|||
126420965|NCT01327599|454835181|FG000|Overall Study|Withdrawal of Consent|1|||
126420966|NCT04544956|454835184|FG000|Overall Study|Withdrawal by Subject|1|||
126420967|NCT00548145|454835187|FG000|Overall Study|Death|0|||
126420968|NCT00548145|454835188|FG001|Overall Study|Death|1|||
126420969|NCT00548145|454835187|FG000|Overall Study|Withdrawal by Subject|0|||
126420970|NCT00548145|454835188|FG001|Overall Study|Withdrawal by Subject|2|||
126420971|NCT00548145|454835187|FG000|Overall Study|Physician Decision|1|||
126420972|NCT00548145|454835188|FG001|Overall Study|Physician Decision|1|||
126477314|NCT01281865|455048238|FG000|Overall Study|Lack of Efficacy|1|||
126477315|NCT01281865|455048239|FG001|Overall Study|Lack of Efficacy|0|||
126477316|NCT01702805|455048240|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
126477317|NCT01702805|455048241|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
126477318|NCT01702805|455048240|FG000|Overall Study|Incomplete Follow-up|18|||
126477319|NCT01702805|455048241|FG001|Overall Study|Incomplete Follow-up|15|||
126477320|NCT01702805|455048240|FG000|Overall Study|Vital Status Assessment Only|40|||
126477321|NCT01702805|455048241|FG001|Overall Study|Vital Status Assessment Only|39|||
126477322|NCT01702805|455048240|FG000|Overall Study|Lost to Follow-up|5|||
126477323|NCT01702805|455048241|FG001|Overall Study|Lost to Follow-up|5|||
126477324|NCT01350492|455048244|FG000|Intervention|Lost to Follow-up|2|||
126721955|NCT00634244|455931337|FG002|Overall Study|Death|0|||
126721956|NCT00634244|455931335|FG000|Overall Study|Adverse Event|0|||
126721957|NCT00634244|455931336|FG001|Overall Study|Adverse Event|2|||
126721958|NCT00634244|455931337|FG002|Overall Study|Adverse Event|0|||
126721959|NCT00634244|455931335|FG000|Overall Study|Withdrawal by Subject|0|||
126721960|NCT00634244|455931336|FG001|Overall Study|Withdrawal by Subject|1|||
126721961|NCT00634244|455931337|FG002|Overall Study|Withdrawal by Subject|0|||
126721962|NCT00634244|455931335|FG000|Overall Study|Physician Decision|0|||
126721963|NCT00634244|455931336|FG001|Overall Study|Physician Decision|1|||
126721964|NCT00634244|455931337|FG002|Overall Study|Physician Decision|0|||
126721965|NCT00634244|455931335|FG000|Overall Study|Disease progression/relapse|0|||
126721966|NCT00634244|455931336|FG001|Overall Study|Disease progression/relapse|1|||
126721967|NCT00634244|455931337|FG002|Overall Study|Disease progression/relapse|0|||
126721968|NCT00634244|455931335|FG000|Overall Study|Other complicating disease|0|||
126721969|NCT00634244|455931336|FG001|Overall Study|Other complicating disease|1|||
126721970|NCT00634244|455931337|FG002|Overall Study|Other complicating disease|0|||
126721971|NCT02635737|455931347|FG000|Overall Study|Protocol Violation|1|||
126420973|NCT02119663|454835189|FG000|Overall Study|Disease progression|26|||
126420974|NCT02119663|454835190|FG001|Overall Study|Disease progression|27|||
126420975|NCT02119663|454835189|FG000|Overall Study|Adverse Event|5|||
126420976|NCT02119663|454835190|FG001|Overall Study|Adverse Event|5|||
126420977|NCT02119663|454835189|FG000|Overall Study|Death|3|||
126420978|NCT02119663|454835190|FG001|Overall Study|Death|2|||
126420979|NCT02119663|454835189|FG000|Overall Study|Physician Decision|1|||
126420980|NCT02119663|454835190|FG001|Overall Study|Physician Decision|2|||
126420981|NCT02119663|454835189|FG000|Overall Study|Other unspecified|2|||
126420982|NCT02119663|454835190|FG001|Overall Study|Other unspecified|0|||
126420983|NCT02119663|454835189|FG000|Overall Study|Subject decision|0|||
126420984|NCT02119663|454835190|FG001|Overall Study|Subject decision|1|||
126420985|NCT02119663|454835189|FG000|Overall Study|Study Terminated by the Sponsor|3|||
126420986|NCT02119663|454835190|FG001|Overall Study|Study Terminated by the Sponsor|4|||
126420987|NCT00892775|454835191|FG000|Overall Study|Protocol Violation|1|||
126420988|NCT00892775|454835192|FG001|Overall Study|Protocol Violation|0|||
126420989|NCT00892775|454835191|FG000|Overall Study|Subject difficulties with blood drawing|1|||
126420990|NCT00892775|454835192|FG001|Overall Study|Subject difficulties with blood drawing|0|||
126420991|NCT00892775|454835191|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
126420992|NCT00892775|454835192|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
126420993|NCT00892775|454835191|FG000|Overall Study|Migrated/ moved from study area|1|||
126420994|NCT00892775|454835192|FG001|Overall Study|Migrated/ moved from study area|0|||
126420995|NCT00892775|454835191|FG000|Overall Study|Withdrawal by Subject|0|||
126420996|NCT00892775|454835192|FG001|Overall Study|Withdrawal by Subject|1|||
126420997|NCT00892775|454835191|FG000|Overall Study|Lost to Follow-up|1|||
126420998|NCT00892775|454835192|FG001|Overall Study|Lost to Follow-up|0|||
126420999|NCT00699660|454835193|FG000|Overall Study|Lost to Follow-up|4|||
126421000|NCT00699660|454835194|FG001|Overall Study|Lost to Follow-up|2|||
126421001|NCT00699660|454835193|FG000|Overall Study|missing reports and recording failures|10|||
126421002|NCT00699660|454835194|FG001|Overall Study|missing reports and recording failures|6|||
126421003|NCT00064792|454835195|FG000|Overall Study|Withdrawal by Subject|2|||
126421004|NCT00064792|454835196|FG001|Overall Study|Withdrawal by Subject|0|||
126421005|NCT00064792|454835195|FG000|Overall Study|Adverse Event|3|||
126477325|NCT01350492|455048245|FG001|Intervention|Lost to Follow-up|5|||
126721972|NCT00937768|455931348|FG000|Overall Study|Refused Further Treatment|3|||
126721973|NCT00937768|455931349|FG001|Overall Study|Refused Further Treatment|2|||
126421006|NCT00064792|454835196|FG001|Overall Study|Adverse Event|0|||
126421007|NCT03301350|454835197|FG000|Overall Study|Withdrawal by Subject|4|||
126421008|NCT03301350|454835197|FG000|Overall Study|Adverse Event|1|||
126721974|NCT00937768|455931348|FG000|Overall Study|Disease Progression|1|||
126721975|NCT00937768|455931349|FG001|Overall Study|Disease Progression|1|||
126721976|NCT00937768|455931348|FG000|Overall Study|Alternate Treatment|0|||
126421009|NCT03301350|454835197|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
126421010|NCT03301350|454835197|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
126421011|NCT03301350|454835197|FG000|Overall Study|no detail provided|1|||
126421012|NCT01248949|454835200|FG000|Overall Study|Lost to Follow-up|2|||
126421013|NCT01248949|454835201|FG001|Overall Study|Lost to Follow-up|2|||
126477326|NCT01350492|455048244|FG000|Intervention|Withdrawal by Subject|3|||
126477327|NCT01350492|455048245|FG001|Intervention|Withdrawal by Subject|1|||
126721977|NCT00937768|455931349|FG001|Overall Study|Alternate Treatment|1|||
126421014|NCT01248949|454835202|FG002|Overall Study|Lost to Follow-up|2|||
126421015|NCT01248949|454835203|FG003|Overall Study|Lost to Follow-up|1|||
126421016|NCT01248949|454835204|FG004|Overall Study|Lost to Follow-up|0|||
126421017|NCT01248949|454835200|FG000|Overall Study|Withdrawal by Subject|5|||
126421018|NCT01248949|454835201|FG001|Overall Study|Withdrawal by Subject|3|||
126421019|NCT01248949|454835202|FG002|Overall Study|Withdrawal by Subject|11|||
126421020|NCT01248949|454835203|FG003|Overall Study|Withdrawal by Subject|3|||
126421021|NCT01248949|454835204|FG004|Overall Study|Withdrawal by Subject|1|||
126421022|NCT01248949|454835200|FG000|Overall Study|Death|22|||
126421023|NCT01248949|454835201|FG001|Overall Study|Death|7|||
126421024|NCT01248949|454835202|FG002|Overall Study|Death|21|||
126421025|NCT01248949|454835203|FG003|Overall Study|Death|6|||
126421026|NCT01248949|454835204|FG004|Overall Study|Death|2|||
126421027|NCT01248949|454835200|FG000|Overall Study|Alternative Therapy|1|||
126421028|NCT01248949|454835201|FG001|Overall Study|Alternative Therapy|0|||
126421029|NCT01248949|454835202|FG002|Overall Study|Alternative Therapy|0|||
126421030|NCT01248949|454835203|FG003|Overall Study|Alternative Therapy|0|||
126421031|NCT01248949|454835204|FG004|Overall Study|Alternative Therapy|0|||
126421032|NCT01248949|454835200|FG000|Overall Study|Alternative Therapy.|1|||
126421033|NCT01248949|454835201|FG001|Overall Study|Alternative Therapy.|0|||
126421034|NCT01248949|454835202|FG002|Overall Study|Alternative Therapy.|0|||
126421035|NCT01248949|454835203|FG003|Overall Study|Alternative Therapy.|0|||
126421036|NCT01248949|454835204|FG004|Overall Study|Alternative Therapy.|0|||
126421037|NCT01248949|454835200|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
126421038|NCT01248949|454835201|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
126421039|NCT01248949|454835202|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
126421040|NCT01248949|454835203|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
126421041|NCT01248949|454835204|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
126421042|NCT01248949|454835200|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
126421043|NCT01248949|454835201|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
126421044|NCT01248949|454835202|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
126421045|NCT01248949|454835203|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
126421046|NCT01248949|454835204|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
126421047|NCT01248949|454835200|FG000|Overall Study|Participant Went To Hospice|0|||
126421048|NCT01248949|454835201|FG001|Overall Study|Participant Went To Hospice|0|||
126421049|NCT01248949|454835202|FG002|Overall Study|Participant Went To Hospice|1|||
126421050|NCT01248949|454835203|FG003|Overall Study|Participant Went To Hospice|0|||
126421051|NCT01248949|454835204|FG004|Overall Study|Participant Went To Hospice|0|||
126421052|NCT01248949|454835200|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
126421053|NCT01248949|454835201|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
126421054|NCT01248949|454835202|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
126421055|NCT01248949|454835203|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
126421056|NCT01248949|454835204|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
126421057|NCT01248949|454835200|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
126421058|NCT01248949|454835201|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
126421059|NCT01248949|454835202|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
126421060|NCT01248949|454835203|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
126421061|NCT01248949|454835204|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
126421062|NCT01248949|454835200|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
126421063|NCT01248949|454835201|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
126421064|NCT01248949|454835202|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
126421065|NCT01248949|454835203|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
126421066|NCT01248949|454835204|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
126421067|NCT01248949|454835200|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
126421068|NCT01248949|454835201|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
126421069|NCT01248949|454835202|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
126421070|NCT01248949|454835203|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
126421071|NCT01248949|454835204|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
126421072|NCT03915470|454835207|FG000|Overall Study|Death|3|||
126421073|NCT03915470|454835208|FG001|Overall Study|Death|1|||
126421074|NCT03915470|454835207|FG000|Overall Study|Adverse Event|1|||
126421075|NCT03915470|454835208|FG001|Overall Study|Adverse Event|0|||
126421076|NCT03915470|454835207|FG000|Overall Study|Physician Decision|1|||
126421077|NCT03915470|454835208|FG001|Overall Study|Physician Decision|0|||
126421078|NCT03915470|454835207|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
126421079|NCT03915470|454835208|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
126421080|NCT03160898|454835209|FG000|Overall Study|Adverse Event|4|||
126421081|NCT03160898|454835210|FG001|Overall Study|Adverse Event|8|||
126421082|NCT03160898|454835211|FG002|Overall Study|Adverse Event|7|||
126421083|NCT03160898|454835212|FG003|Overall Study|Adverse Event|10|||
126421084|NCT03160898|454835209|FG000|Overall Study|Death|1|||
126421085|NCT03160898|454835210|FG001|Overall Study|Death|0|||
126421086|NCT03160898|454835211|FG002|Overall Study|Death|0|||
126421087|NCT03160898|454835212|FG003|Overall Study|Death|1|||
126421088|NCT03160898|454835209|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
126421089|NCT03160898|454835210|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
126421090|NCT03160898|454835211|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
126421091|NCT03160898|454835212|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
126421092|NCT03160898|454835209|FG000|Overall Study|Lost to Follow-up|1|||
126421093|NCT03160898|454835210|FG001|Overall Study|Lost to Follow-up|1|||
126421094|NCT03160898|454835211|FG002|Overall Study|Lost to Follow-up|1|||
126421095|NCT03160898|454835212|FG003|Overall Study|Lost to Follow-up|2|||
126421096|NCT03160898|454835209|FG000|Overall Study|Physician Decision|1|||
126421097|NCT03160898|454835210|FG001|Overall Study|Physician Decision|0|||
126421098|NCT03160898|454835211|FG002|Overall Study|Physician Decision|0|||
126421099|NCT03160898|454835212|FG003|Overall Study|Physician Decision|1|||
126421100|NCT03160898|454835209|FG000|Overall Study|Progressive Disease|4|||
126421101|NCT03160898|454835210|FG001|Overall Study|Progressive Disease|1|||
126421102|NCT03160898|454835211|FG002|Overall Study|Progressive Disease|2|||
126421103|NCT03160898|454835212|FG003|Overall Study|Progressive Disease|1|||
126421104|NCT03160898|454835209|FG000|Overall Study|Protocol Violation|1|||
126421105|NCT03160898|454835210|FG001|Overall Study|Protocol Violation|0|||
126421106|NCT03160898|454835211|FG002|Overall Study|Protocol Violation|2|||
126421107|NCT03160898|454835212|FG003|Overall Study|Protocol Violation|0|||
126421108|NCT03160898|454835209|FG000|Overall Study|Sponsor Discretion|2|||
126421109|NCT03160898|454835210|FG001|Overall Study|Sponsor Discretion|0|||
126421110|NCT03160898|454835211|FG002|Overall Study|Sponsor Discretion|0|||
126421111|NCT03160898|454835212|FG003|Overall Study|Sponsor Discretion|0|||
126421112|NCT03160898|454835209|FG000|Overall Study|Withdrawal by Subject|1|||
126421113|NCT03160898|454835210|FG001|Overall Study|Withdrawal by Subject|3|||
126421114|NCT03160898|454835211|FG002|Overall Study|Withdrawal by Subject|2|||
126421115|NCT03160898|454835212|FG003|Overall Study|Withdrawal by Subject|1|||
126421116|NCT03160898|454835209|FG000|Overall Study|Other|2|||
126421117|NCT03160898|454835210|FG001|Overall Study|Other|0|||
126421118|NCT03160898|454835211|FG002|Overall Study|Other|2|||
126421119|NCT03160898|454835212|FG003|Overall Study|Other|2|||
126421120|NCT03245775|454835215|FG000|Overall Study|Lost to Follow-up|25|||
126421121|NCT03245775|454835216|FG001|Overall Study|Lost to Follow-up|26|||
126421122|NCT03245775|454835217|FG002|Overall Study|Lost to Follow-up|16|||
126421123|NCT03245775|454835218|FG003|Overall Study|Lost to Follow-up|16|||
126421124|NCT02713828|454835219|FG000|Overall Study|Death|2|||
126421125|NCT02713828|454835220|FG001|Overall Study|Death|0|||
126421126|NCT02713828|454835219|FG000|Overall Study|Withdrawal by Subject|1|||
126421127|NCT02713828|454835220|FG001|Overall Study|Withdrawal by Subject|0|||
126421128|NCT02713828|454835219|FG000|Overall Study|study terminated but patient allowed to|2|||
126421129|NCT02713828|454835220|FG001|Overall Study|study terminated but patient allowed to|0|||
126421130|NCT00434109|454835221|FG000|Overall Study|Physician Decision|9|||
126421131|NCT00434109|454835221|FG000|Overall Study|Adverse Event|5|||
126421132|NCT00434109|454835221|FG000|Overall Study|Protocol Violation|1|||
126421133|NCT00434109|454835221|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
126421134|NCT02978833|454835224|FG000|Overall Study|Study terminated|1|||
126421135|NCT02978833|454835225|FG001|Overall Study|Study terminated|1|||
126421136|NCT00103740|454835226|FG000|Period 1 - Core|Adverse Event|1|||
126421137|NCT00103740|454835227|FG001|Period 1 - Core|Adverse Event|0|||
126421138|NCT00103740|454835226|FG000|Period 1 - Core|Protocol Violation|3|||
126421139|NCT00103740|454835227|FG001|Period 1 - Core|Protocol Violation|2|||
126421140|NCT00103740|454835226|FG000|Period 1 - Core|Patient withdrew consent|3|||
126421141|NCT00103740|454835227|FG001|Period 1 - Core|Patient withdrew consent|2|||
126421142|NCT00103740|454835226|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
126421143|NCT00103740|454835227|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
126421144|NCT00103740|454835226|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
126421145|NCT00103740|454835227|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
126421146|NCT00103740|454835226|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
126421147|NCT00103740|454835227|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
126421148|NCT00103740|454835226|FG000|Period 2 - Extended Observation Period|Death|6|||
126421149|NCT00103740|454835227|FG001|Period 2 - Extended Observation Period|Death|2|||
126421150|NCT00103740|454835226|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
126421151|NCT00103740|454835227|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
126421152|NCT04178720|454835231|FG000|Overall Study|Withdrawal by Subject|2|||
126421153|NCT04178720|454835232|FG001|Overall Study|Withdrawal by Subject|0|||
126421154|NCT04178720|454835231|FG000|Overall Study|Relocation|0|||
126559114|NCT02240680|455340648|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
126559115|NCT02240680|455340649|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
126559116|NCT02240680|455340646|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
126559117|NCT02240680|455340647|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
126559118|NCT02240680|455340648|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
126721978|NCT00937768|455931348|FG000|Overall Study|No Further Funding|4|||
126721979|NCT00937768|455931349|FG001|Overall Study|No Further Funding|4|||
126477328|NCT01350492|455048244|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
126477329|NCT01350492|455048245|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
126477330|NCT01350492|455048244|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
126477331|NCT01350492|455048245|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
126477332|NCT04203498|455048246|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
126477333|NCT04203498|455048247|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
126477334|NCT04203498|455048246|FG000|Overall Study|Withdrawal of patient consent|7|||
126477335|NCT04203498|455048247|FG001|Overall Study|Withdrawal of patient consent|2|||
126477336|NCT04203498|455048246|FG000|Overall Study|Adverse Event|4|||
126477337|NCT04203498|455048247|FG001|Overall Study|Adverse Event|1|||
126477338|NCT04203498|455048246|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
126477339|NCT04203498|455048247|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
126477340|NCT04203498|455048246|FG000|Overall Study|Did not receive IMP|2|||
126477341|NCT04203498|455048247|FG001|Overall Study|Did not receive IMP|0|||
126477342|NCT00939640|455048248|FG000|Overall Study|Physician Decision|1|||
126477343|NCT02106975|455048255|FG000|Overall Study|Death|25|||
126477344|NCT02106975|455048256|FG001|Overall Study|Death|39|||
126477345|NCT01768286|455048257|FG000|Overall Study|Randomized But Not Treated|0|||
126477346|NCT01768286|455048258|FG001|Overall Study|Randomized But Not Treated|0|||
126477347|NCT01768286|455048259|FG002|Overall Study|Randomized But Not Treated|1|||
126477348|NCT01768286|455048260|FG003|Overall Study|Randomized But Not Treated|0|||
126477349|NCT01768286|455048257|FG000|Overall Study|Lack of Efficacy|7|||
126477350|NCT01768286|455048258|FG001|Overall Study|Lack of Efficacy|4|||
126477351|NCT01768286|455048259|FG002|Overall Study|Lack of Efficacy|0|||
126477352|NCT01768286|455048260|FG003|Overall Study|Lack of Efficacy|1|||
126477353|NCT01768286|455048257|FG000|Overall Study|Withdrew Consent|0|||
126477354|NCT01768286|455048258|FG001|Overall Study|Withdrew Consent|0|||
126477355|NCT01768286|455048259|FG002|Overall Study|Withdrew Consent|1|||
126477356|NCT01768286|455048260|FG003|Overall Study|Withdrew Consent|0|||
126477357|NCT02699593|455048262|FG000|Period 1|Unsatisfactory Visual Response|0|||
126477358|NCT02699593|455048263|FG001|Period 1|Unsatisfactory Visual Response|1|||
126477359|NCT02699593|455048262|FG000|Period 1|Torn Contact Len|4|||
126477360|NCT02699593|455048263|FG001|Period 1|Torn Contact Len|3|||
126477361|NCT02699593|455048262|FG000|Period 1|Protocol Violation|0|||
126477362|NCT02699593|455048263|FG001|Period 1|Protocol Violation|1|||
126477363|NCT02699593|455048262|FG000|Period 1|Withdrawal by Subject|0|||
126477364|NCT02699593|455048263|FG001|Period 1|Withdrawal by Subject|1|||
126477365|NCT02699593|455048262|FG000|Period 1|Adverse Event|1|||
126477366|NCT02699593|455048263|FG001|Period 1|Adverse Event|1|||
126477367|NCT02699593|455048262|FG000|Period 2|Adverse Event|1|||
126477368|NCT02699593|455048263|FG001|Period 2|Adverse Event|1|||
126477369|NCT02699593|455048262|FG000|Period 2|Lost Contact Lens|0|||
126477370|NCT02699593|455048263|FG001|Period 2|Lost Contact Lens|1|||
126477371|NCT02699593|455048262|FG000|Period 2|Torn Contact Lens|1|||
126477372|NCT02699593|455048263|FG001|Period 2|Torn Contact Lens|0|||
126477373|NCT00911547|455048264|FG000|Overall Study|Adverse Event|8|||
126477374|NCT00911547|455048265|FG001|Overall Study|Adverse Event|27|||
126477375|NCT00911547|455048266|FG002|Overall Study|Adverse Event|11|||
126477376|NCT00911547|455048267|FG003|Overall Study|Adverse Event|6|||
126477377|NCT00911547|455048264|FG000|Overall Study|Lost to Follow-up|0|||
126477378|NCT00911547|455048265|FG001|Overall Study|Lost to Follow-up|0|||
126477379|NCT00911547|455048266|FG002|Overall Study|Lost to Follow-up|2|||
126477380|NCT00911547|455048267|FG003|Overall Study|Lost to Follow-up|1|||
126477381|NCT00911547|455048264|FG000|Overall Study|Protocol Violation|0|||
126477382|NCT00911547|455048265|FG001|Overall Study|Protocol Violation|5|||
126477383|NCT00911547|455048266|FG002|Overall Study|Protocol Violation|5|||
126477384|NCT00911547|455048267|FG003|Overall Study|Protocol Violation|1|||
126477385|NCT00911547|455048264|FG000|Overall Study|Withdrawal by Subject|3|||
126477386|NCT00911547|455048265|FG001|Overall Study|Withdrawal by Subject|10|||
126477387|NCT00911547|455048266|FG002|Overall Study|Withdrawal by Subject|4|||
126477388|NCT00911547|455048267|FG003|Overall Study|Withdrawal by Subject|8|||
126477389|NCT00915278|455048268|FG000|Overall Study|Death|1|||
126477390|NCT00915278|455048269|FG001|Overall Study|Death|0|||
126477391|NCT00915278|455048270|FG002|Overall Study|Death|0|||
126477392|NCT00915278|455048271|FG003|Overall Study|Death|0|||
126477393|NCT00915278|455048272|FG004|Overall Study|Death|0|||
126477394|NCT00915278|455048273|FG005|Overall Study|Death|0|||
126477395|NCT00915278|455048268|FG000|Overall Study|Lost to Follow-up|0|||
126477396|NCT00915278|455048269|FG001|Overall Study|Lost to Follow-up|1|||
126477397|NCT00915278|455048270|FG002|Overall Study|Lost to Follow-up|0|||
126477398|NCT00915278|455048271|FG003|Overall Study|Lost to Follow-up|0|||
126477399|NCT00915278|455048272|FG004|Overall Study|Lost to Follow-up|0|||
126477400|NCT00915278|455048273|FG005|Overall Study|Lost to Follow-up|0|||
126477401|NCT00915278|455048268|FG000|Overall Study|Withdrawal by Subject|0|||
126477402|NCT00915278|455048269|FG001|Overall Study|Withdrawal by Subject|1|||
126477403|NCT00915278|455048270|FG002|Overall Study|Withdrawal by Subject|0|||
126477404|NCT00915278|455048271|FG003|Overall Study|Withdrawal by Subject|0|||
126477405|NCT00915278|455048272|FG004|Overall Study|Withdrawal by Subject|1|||
126477406|NCT00915278|455048273|FG005|Overall Study|Withdrawal by Subject|4|||
126421155|NCT04178720|454835232|FG001|Overall Study|Relocation|1|||
126421156|NCT01792115|454835233|FG000|Overall Study|Lost to Follow-up|0|||
126421157|NCT01792115|454835234|FG001|Overall Study|Lost to Follow-up|1|||
126421158|NCT01792115|454835235|FG002|Overall Study|Lost to Follow-up|0|||
126421159|NCT01594931|454838579|FG000|Overall Study|Adverse Event|3|||
126421160|NCT01594931|454838580|FG001|Overall Study|Adverse Event|1|||
126421161|NCT01594931|454838581|FG002|Overall Study|Adverse Event|1|||
126421162|NCT01594931|454838579|FG000|Overall Study|Withdrawal by Subject|2|||
126421163|NCT01594931|454838580|FG001|Overall Study|Withdrawal by Subject|1|||
126421164|NCT01594931|454838581|FG002|Overall Study|Withdrawal by Subject|1|||
126421165|NCT01594931|454838579|FG000|Overall Study|Lack of Efficacy|7|||
126421166|NCT01594931|454838580|FG001|Overall Study|Lack of Efficacy|2|||
126421167|NCT01594931|454838581|FG002|Overall Study|Lack of Efficacy|2|||
126421168|NCT01594931|454838579|FG000|Overall Study|Lost to Follow-up|4|||
126421169|NCT01594931|454838580|FG001|Overall Study|Lost to Follow-up|3|||
126421170|NCT01594931|454838581|FG002|Overall Study|Lost to Follow-up|3|||
126421171|NCT01594931|454838579|FG000|Overall Study|Protocol Violation|2|||
126421172|NCT01594931|454838580|FG001|Overall Study|Protocol Violation|1|||
126421173|NCT01594931|454838581|FG002|Overall Study|Protocol Violation|0|||
126421174|NCT01594931|454838579|FG000|Overall Study|No defiined|11|||
126421175|NCT01594931|454838580|FG001|Overall Study|No defiined|4|||
126421176|NCT01594931|454838581|FG002|Overall Study|No defiined|7|||
126421177|NCT02936635|454838590|FG000|Overall Study|Adverse Event|43|||
126421178|NCT02936635|454838591|FG001|Overall Study|Adverse Event|25|||
126421179|NCT02936635|454838590|FG000|Overall Study|Progressive Disease|10|||
126421180|NCT02936635|454838591|FG001|Overall Study|Progressive Disease|18|||
126421181|NCT02936635|454838590|FG000|Overall Study|Sponsor Discretion|10|||
126421182|NCT02936635|454838591|FG001|Overall Study|Sponsor Discretion|16|||
126421183|NCT02936635|454838590|FG000|Overall Study|Death|9|||
126421184|NCT02936635|454838591|FG001|Overall Study|Death|15|||
126421185|NCT02936635|454838590|FG000|Overall Study|Withdrawal by Subject|8|||
126421186|NCT02936635|454838591|FG001|Overall Study|Withdrawal by Subject|15|||
126421187|NCT02936635|454838590|FG000|Overall Study|Physician Decision|2|||
126421188|NCT02936635|454838591|FG001|Overall Study|Physician Decision|9|||
126421189|NCT02936635|454838590|FG000|Overall Study|Lost to Follow-up|1|||
126421190|NCT02936635|454838591|FG001|Overall Study|Lost to Follow-up|2|||
126421191|NCT02936635|454838590|FG000|Overall Study|Protocol Violation|1|||
126421192|NCT02936635|454838591|FG001|Overall Study|Protocol Violation|0|||
126477407|NCT00915278|455048268|FG000|Overall Study|Adverse Event|4|||
126477408|NCT00915278|455048269|FG001|Overall Study|Adverse Event|1|||
126477409|NCT00915278|455048270|FG002|Overall Study|Adverse Event|0|||
126477410|NCT00915278|455048271|FG003|Overall Study|Adverse Event|0|||
126477411|NCT00915278|455048272|FG004|Overall Study|Adverse Event|0|||
126477412|NCT00915278|455048273|FG005|Overall Study|Adverse Event|0|||
126477413|NCT00915278|455048268|FG000|Overall Study|Progressive disease/clinical progression|0|||
126477414|NCT00915278|455048269|FG001|Overall Study|Progressive disease/clinical progression|0|||
126477415|NCT00915278|455048270|FG002|Overall Study|Progressive disease/clinical progression|0|||
126477416|NCT00915278|455048271|FG003|Overall Study|Progressive disease/clinical progression|3|||
126477417|NCT00915278|455048272|FG004|Overall Study|Progressive disease/clinical progression|1|||
126477418|NCT00915278|455048273|FG005|Overall Study|Progressive disease/clinical progression|2|||
126477419|NCT00915278|455048268|FG000|Overall Study|Infusion related AEs|0|||
126477420|NCT00915278|455048269|FG001|Overall Study|Infusion related AEs|0|||
126477421|NCT00915278|455048270|FG002|Overall Study|Infusion related AEs|0|||
126477422|NCT00915278|455048271|FG003|Overall Study|Infusion related AEs|0|||
126477423|NCT00915278|455048272|FG004|Overall Study|Infusion related AEs|0|||
126477424|NCT00915278|455048273|FG005|Overall Study|Infusion related AEs|2|||
126477425|NCT00915278|455048268|FG000|Overall Study|Admission to hospice|0|||
126477426|NCT00915278|455048269|FG001|Overall Study|Admission to hospice|0|||
126477427|NCT00915278|455048270|FG002|Overall Study|Admission to hospice|1|||
126477428|NCT00915278|455048271|FG003|Overall Study|Admission to hospice|0|||
126477429|NCT00915278|455048272|FG004|Overall Study|Admission to hospice|0|||
126477430|NCT00915278|455048273|FG005|Overall Study|Admission to hospice|0|||
126477431|NCT00939770|455048276|FG000|Overall Study|Adverse Event|1|||
126559119|NCT02240680|455340649|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
126559120|NCT02825043|455340653|FG000|Overall Study|Lost to Follow-up|4|||
126559121|NCT03704298|455340659|FG000|Overall Study|Death|3|||
126559122|NCT03704298|455340660|FG001|Overall Study|Death|1|||
126421193|NCT02936635|454838590|FG000|Overall Study|Lack of effect/Entry into other study|31|||
126477432|NCT00939770|455048277|FG001|Overall Study|Adverse Event|1|||
126559123|NCT03704298|455340661|FG002|Overall Study|Death|1|||
126559124|NCT03704298|455340662|FG003|Overall Study|Death|0|||
126421194|NCT02936635|454838591|FG001|Overall Study|Lack of effect/Entry into other study|65|||
126421195|NCT01633788|454838592|FG000|Overall Study|Adverse Event|1|||
126421196|NCT01633788|454838593|FG001|Overall Study|Adverse Event|3|||
126421197|NCT01633788|454838594|FG002|Overall Study|Adverse Event|3|||
126421198|NCT01633788|454838595|FG003|Overall Study|Adverse Event|3|||
126421199|NCT01633788|454838592|FG000|Overall Study|Lost to Follow-up|2|||
126477433|NCT00939770|455048278|FG002|Overall Study|Adverse Event|0|||
126421200|NCT01633788|454838593|FG001|Overall Study|Lost to Follow-up|2|||
126421201|NCT01633788|454838594|FG002|Overall Study|Lost to Follow-up|2|||
126421202|NCT01633788|454838595|FG003|Overall Study|Lost to Follow-up|0|||
126421203|NCT01633788|454838592|FG000|Overall Study|Personal Reasons|3|||
126421204|NCT01633788|454838593|FG001|Overall Study|Personal Reasons|1|||
126421205|NCT01633788|454838594|FG002|Overall Study|Personal Reasons|1|||
126421206|NCT01633788|454838595|FG003|Overall Study|Personal Reasons|3|||
126421207|NCT01633788|454838592|FG000|Overall Study|Protocol Violation|1|||
126421208|NCT01633788|454838593|FG001|Overall Study|Protocol Violation|0|||
126421209|NCT01633788|454838594|FG002|Overall Study|Protocol Violation|1|||
126421210|NCT01633788|454838595|FG003|Overall Study|Protocol Violation|0|||
126421211|NCT01633788|454838592|FG000|Overall Study|Other Reasons|0|||
126477434|NCT00939770|455048279|FG003|Overall Study|Adverse Event|0|||
126477435|NCT00939770|455048280|FG004|Overall Study|Adverse Event|6|||
126477436|NCT00939770|455048281|FG005|Overall Study|Adverse Event|2|||
126477437|NCT00939770|455048282|FG006|Overall Study|Adverse Event|1|||
126477438|NCT00939770|455048283|FG007|Overall Study|Adverse Event|1|||
126477439|NCT00939770|455048276|FG000|Overall Study|Lack of Efficacy|4|||
126477440|NCT00939770|455048277|FG001|Overall Study|Lack of Efficacy|6|||
126477441|NCT00939770|455048278|FG002|Overall Study|Lack of Efficacy|13|||
126477442|NCT00939770|455048279|FG003|Overall Study|Lack of Efficacy|9|||
126477443|NCT00939770|455048280|FG004|Overall Study|Lack of Efficacy|16|||
126477444|NCT00939770|455048281|FG005|Overall Study|Lack of Efficacy|8|||
126477445|NCT00939770|455048282|FG006|Overall Study|Lack of Efficacy|11|||
126477446|NCT00939770|455048283|FG007|Overall Study|Lack of Efficacy|1|||
126477447|NCT00939770|455048276|FG000|Overall Study|Lost to Follow-up|0|||
126477448|NCT00939770|455048277|FG001|Overall Study|Lost to Follow-up|0|||
126477449|NCT00939770|455048278|FG002|Overall Study|Lost to Follow-up|0|||
126477450|NCT00939770|455048279|FG003|Overall Study|Lost to Follow-up|0|||
126477451|NCT00939770|455048280|FG004|Overall Study|Lost to Follow-up|1|||
126477452|NCT00939770|455048281|FG005|Overall Study|Lost to Follow-up|0|||
126477453|NCT00939770|455048282|FG006|Overall Study|Lost to Follow-up|0|||
126477454|NCT00939770|455048283|FG007|Overall Study|Lost to Follow-up|0|||
126477455|NCT00939770|455048276|FG000|Overall Study|Physician Decision|0|||
126477456|NCT00939770|455048277|FG001|Overall Study|Physician Decision|0|||
126421212|NCT01633788|454838593|FG001|Overall Study|Other Reasons|2|||
126421213|NCT01633788|454838594|FG002|Overall Study|Other Reasons|3|||
126421214|NCT01633788|454838595|FG003|Overall Study|Other Reasons|7|||
126421215|NCT01929226|454838596|FG000|Overall Study|Lost to Follow-up|4|||
126421216|NCT01929226|454838597|FG001|Overall Study|Lost to Follow-up|0|||
126421217|NCT01929226|454838596|FG000|Overall Study|Withdrawal by Subject|1|||
126421218|NCT01929226|454838597|FG001|Overall Study|Withdrawal by Subject|1|||
126421219|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
126421220|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
126421221|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
126421222|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
126421223|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
126421224|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
126421225|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
126421226|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
126421227|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
126477457|NCT00939770|455048278|FG002|Overall Study|Physician Decision|2|||
126477458|NCT00939770|455048279|FG003|Overall Study|Physician Decision|0|||
126721980|NCT01687413|455931350|FG000|Overall Study|Withdrawal by Subject|0|||
126721981|NCT01687413|455931351|FG001|Overall Study|Withdrawal by Subject|2|||
126721982|NCT01687413|455931350|FG000|Overall Study|Not eligible|0|||
126721983|NCT01687413|455931351|FG001|Overall Study|Not eligible|2|||
126721984|NCT01687413|455931350|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
126721985|NCT01687413|455931351|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
126721986|NCT00488618|455931356|FG000|Overall Study|Adverse Event|13|||
126721987|NCT00488618|455931357|FG001|Overall Study|Adverse Event|17|||
126421228|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
126421229|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
126421230|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
126477459|NCT00939770|455048280|FG004|Overall Study|Physician Decision|7|||
126477460|NCT00939770|455048281|FG005|Overall Study|Physician Decision|1|||
126477461|NCT00939770|455048282|FG006|Overall Study|Physician Decision|0|||
126477462|NCT00939770|455048283|FG007|Overall Study|Physician Decision|6|||
126477463|NCT00939770|455048276|FG000|Overall Study|Protocol Violation|0|||
126477464|NCT00939770|455048277|FG001|Overall Study|Protocol Violation|0|||
126477465|NCT00939770|455048278|FG002|Overall Study|Protocol Violation|0|||
126721988|NCT00488618|455931356|FG000|Overall Study|Insufficient Therapeutic Response|18|||
126477466|NCT00939770|455048279|FG003|Overall Study|Protocol Violation|0|||
126477467|NCT00939770|455048280|FG004|Overall Study|Protocol Violation|1|||
126477468|NCT00939770|455048281|FG005|Overall Study|Protocol Violation|0|||
126477469|NCT00939770|455048282|FG006|Overall Study|Protocol Violation|0|||
126477470|NCT00939770|455048283|FG007|Overall Study|Protocol Violation|0|||
126421231|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
126421232|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
126421233|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
126421234|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
126421235|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
126421236|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
126421237|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
126421238|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
126421239|NCT03573323|454838600|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
126421240|NCT03573323|454838601|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
126421241|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
126421242|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
126421243|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
126421244|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
126421245|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
126421246|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
126421247|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
126421248|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
126421249|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
126421250|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
126421251|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
126421252|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
126421253|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
126421254|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
126421255|NCT03573323|454838600|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
126421256|NCT03573323|454838601|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
126421257|NCT00837213|454838605|FG000|Overall Study|Lost to Follow-up|3|||
126421258|NCT00837213|454838606|FG001|Overall Study|Lost to Follow-up|2|||
126421259|NCT00837213|454838605|FG000|Overall Study|Withdrawal by Subject|2|||
126421260|NCT00837213|454838606|FG001|Overall Study|Withdrawal by Subject|2|||
126421261|NCT00837213|454838605|FG000|Overall Study|not stated|1|||
126421262|NCT00837213|454838606|FG001|Overall Study|not stated|1|||
126421263|NCT02698826|454838608|FG000|Overall Study|Death|13|||
126421264|NCT02698826|454838608|FG000|Overall Study|Adverse Event|1|||
126421265|NCT04317040|454838614|FG000|Overall Study|Lost to Follow-up|2|||
126421266|NCT04317040|454838615|FG001|Overall Study|Lost to Follow-up|0|||
126421267|NCT04317040|454838614|FG000|Overall Study|Death|16|||
126421268|NCT04317040|454838615|FG001|Overall Study|Death|18|||
126421269|NCT04317040|454838614|FG000|Overall Study|Withdrawal by Subject|0|||
126421270|NCT04317040|454838615|FG001|Overall Study|Withdrawal by Subject|1|||
126421271|NCT04317040|454838614|FG000|Overall Study|Incomplete assessments|0|||
126421272|NCT04317040|454838615|FG001|Overall Study|Incomplete assessments|1|||
126421273|NCT02366195|454838619|FG000|Overall Study|Protocol-specified criteria|3|||
126421274|NCT02366195|454838619|FG000|Overall Study|Withdrawal by Subject|9|||
126421275|NCT02366195|454838619|FG000|Overall Study|Lost to Follow-up|1|||
126421276|NCT02366195|454838619|FG000|Overall Study|Death|41|||
126421277|NCT04961541|454838626|FG000|Overall Study|Adverse Event|0|||
126421278|NCT04961541|454838627|FG001|Overall Study|Adverse Event|0|||
126421279|NCT04961541|454838628|FG002|Overall Study|Adverse Event|0|||
126421280|NCT04961541|454838629|FG003|Overall Study|Adverse Event|0|||
126421281|NCT04961541|454838630|FG004|Overall Study|Adverse Event|0|||
126421282|NCT04961541|454838631|FG005|Overall Study|Adverse Event|1|||
126421283|NCT04961541|454838632|FG006|Overall Study|Adverse Event|0|||
126421284|NCT04961541|454838633|FG007|Overall Study|Adverse Event|0|||
126421285|NCT04961541|454838634|FG008|Overall Study|Adverse Event|0|||
126421286|NCT04961541|454838635|FG009|Overall Study|Adverse Event|0|||
126421287|NCT04961541|454838636|FG010|Overall Study|Adverse Event|0|||
126421288|NCT04961541|454838637|FG011|Overall Study|Adverse Event|0|||
126421289|NCT04961541|454838638|FG012|Overall Study|Adverse Event|0|||
126421290|NCT04961541|454838639|FG013|Overall Study|Adverse Event|0|||
126421291|NCT04961541|454838626|FG000|Overall Study|Lost to Follow-up|0|||
126421292|NCT04961541|454838627|FG001|Overall Study|Lost to Follow-up|0|||
126421293|NCT04961541|454838628|FG002|Overall Study|Lost to Follow-up|3|||
126421294|NCT04961541|454838629|FG003|Overall Study|Lost to Follow-up|0|||
126421295|NCT04961541|454838630|FG004|Overall Study|Lost to Follow-up|0|||
126421296|NCT04961541|454838631|FG005|Overall Study|Lost to Follow-up|0|||
126421297|NCT04961541|454838632|FG006|Overall Study|Lost to Follow-up|1|||
126421298|NCT04961541|454838633|FG007|Overall Study|Lost to Follow-up|1|||
126421299|NCT04961541|454838634|FG008|Overall Study|Lost to Follow-up|0|||
126421300|NCT04961541|454838635|FG009|Overall Study|Lost to Follow-up|1|||
126421301|NCT04961541|454838636|FG010|Overall Study|Lost to Follow-up|0|||
126421302|NCT04961541|454838637|FG011|Overall Study|Lost to Follow-up|0|||
126421303|NCT04961541|454838638|FG012|Overall Study|Lost to Follow-up|1|||
126421304|NCT04961541|454838639|FG013|Overall Study|Lost to Follow-up|0|||
126421305|NCT04961541|454838626|FG000|Overall Study|Withdrawal by Subject|0|||
126421306|NCT04961541|454838627|FG001|Overall Study|Withdrawal by Subject|0|||
126421307|NCT04961541|454838628|FG002|Overall Study|Withdrawal by Subject|1|||
126421308|NCT04961541|454838629|FG003|Overall Study|Withdrawal by Subject|1|||
126421309|NCT04961541|454838630|FG004|Overall Study|Withdrawal by Subject|0|||
126421310|NCT04961541|454838631|FG005|Overall Study|Withdrawal by Subject|0|||
126421311|NCT04961541|454838632|FG006|Overall Study|Withdrawal by Subject|0|||
126421312|NCT04961541|454838633|FG007|Overall Study|Withdrawal by Subject|0|||
126421313|NCT04961541|454838634|FG008|Overall Study|Withdrawal by Subject|0|||
126421314|NCT04961541|454838635|FG009|Overall Study|Withdrawal by Subject|1|||
126421315|NCT04961541|454838636|FG010|Overall Study|Withdrawal by Subject|0|||
126421316|NCT04961541|454838637|FG011|Overall Study|Withdrawal by Subject|0|||
126421317|NCT04961541|454838638|FG012|Overall Study|Withdrawal by Subject|0|||
126421318|NCT04961541|454838639|FG013|Overall Study|Withdrawal by Subject|0|||
126421319|NCT01843023|454838641|FG000|Overall Study|Death|1|||
126421320|NCT01843023|454838642|FG001|Overall Study|Death|0|||
126421321|NCT01843023|454838641|FG000|Overall Study|Lost to Follow-up|24|||
126421322|NCT01843023|454838642|FG001|Overall Study|Lost to Follow-up|29|||
126421323|NCT01843023|454838641|FG000|Overall Study|Withdrawal by Subject|8|||
126421324|NCT01843023|454838642|FG001|Overall Study|Withdrawal by Subject|6|||
126421325|NCT03305770|454838643|FG000|Overall Study|Physician Decision - prior to dispense|0|||
126421326|NCT03305770|454838644|FG001|Overall Study|Physician Decision - prior to dispense|1|||
126421327|NCT03305770|454838643|FG000|Overall Study|Subject moved|1|||
126421328|NCT03305770|454838644|FG001|Overall Study|Subject moved|0|||
126421329|NCT03539601|454838645|FG000|Overall Study|Withdraw by parent/guardian|1|||
126421330|NCT03539601|454838646|FG001|Overall Study|Withdraw by parent/guardian|0|||
126421331|NCT03539601|454838647|FG002|Overall Study|Withdraw by parent/guardian|1|||
126421332|NCT03539601|454838648|FG003|Overall Study|Withdraw by parent/guardian|0|||
126421333|NCT03539601|454838645|FG000|Overall Study|Adverse Event|0|||
126421334|NCT03539601|454838646|FG001|Overall Study|Adverse Event|2|||
126421335|NCT03539601|454838647|FG002|Overall Study|Adverse Event|0|||
126421336|NCT03539601|454838648|FG003|Overall Study|Adverse Event|0|||
126421337|NCT03539601|454838645|FG000|Overall Study|Lost to Follow-up|2|||
126421338|NCT03539601|454838646|FG001|Overall Study|Lost to Follow-up|4|||
126421339|NCT03539601|454838647|FG002|Overall Study|Lost to Follow-up|5|||
126421340|NCT03539601|454838648|FG003|Overall Study|Lost to Follow-up|0|||
126421341|NCT03539601|454838645|FG000|Overall Study|Withdrawal by Subject|2|||
126421342|NCT03539601|454838646|FG001|Overall Study|Withdrawal by Subject|0|||
126421343|NCT03539601|454838647|FG002|Overall Study|Withdrawal by Subject|0|||
126421344|NCT03539601|454838648|FG003|Overall Study|Withdrawal by Subject|1|||
126421345|NCT03539601|454838645|FG000|Overall Study|Randomized but not treated|1|||
126421346|NCT03539601|454838646|FG001|Overall Study|Randomized but not treated|1|||
126421347|NCT03539601|454838647|FG002|Overall Study|Randomized but not treated|0|||
126421348|NCT03539601|454838648|FG003|Overall Study|Randomized but not treated|0|||
126421349|NCT01970306|454838649|FG000|Overall Study|Not eligible|3|||
126421350|NCT01970306|454838649|FG000|Overall Study|Not able to be treated|9|||
126421351|NCT00226811|454838650|FG000|Overall Study|Death|8|||
126421352|NCT00226811|454838650|FG000|Overall Study|Adverse Event|11|||
126421353|NCT00226811|454838650|FG000|Overall Study|Lack of Efficacy|55|||
126421354|NCT00226811|454838650|FG000|Overall Study|Withdrawal by Subject|2|||
126421355|NCT02741635|454838651|FG000|Overall Study|Withdrawal by Subject|1|||
126421356|NCT01427933|454838652|FG000|Overall Study|Withdrawal by Subject|5|||
126421357|NCT01427933|454838653|FG001|Overall Study|Withdrawal by Subject|8|||
126421358|NCT01427933|454838652|FG000|Overall Study|Lost to Follow-up|1|||
126421359|NCT01427933|454838653|FG001|Overall Study|Lost to Follow-up|5|||
126421360|NCT01427933|454838652|FG000|Overall Study|Other|1|||
126421361|NCT01427933|454838653|FG001|Overall Study|Other|0|||
126559125|NCT03704298|455340659|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
126421362|NCT01427933|454838652|FG000|Overall Study|Investigator's Decision|1|||
126421363|NCT01427933|454838653|FG001|Overall Study|Investigator's Decision|0|||
126421364|NCT01633541|454838656|FG000|Overall Study|Death|1|||
126421365|NCT01633541|454838657|FG001|Overall Study|Death|0|||
126421366|NCT01010971|454838658|FG000|Overall Study|Adverse Event|2|||
126421367|NCT01010971|454838659|FG001|Overall Study|Adverse Event|4|||
126421368|NCT01010971|454838660|FG002|Overall Study|Adverse Event|3|||
126421369|NCT01010971|454838658|FG000|Overall Study|Withdrawal by Subject|0|||
126421370|NCT01010971|454838659|FG001|Overall Study|Withdrawal by Subject|2|||
126421371|NCT01010971|454838660|FG002|Overall Study|Withdrawal by Subject|5|||
126421372|NCT01010971|454838658|FG000|Overall Study|Lost to Follow-up|0|||
126421373|NCT01010971|454838659|FG001|Overall Study|Lost to Follow-up|2|||
126421374|NCT01010971|454838660|FG002|Overall Study|Lost to Follow-up|3|||
126421375|NCT01010971|454838658|FG000|Overall Study|Other|1|||
126421376|NCT01010971|454838659|FG001|Overall Study|Other|0|||
126421377|NCT01010971|454838660|FG002|Overall Study|Other|2|||
126421378|NCT03472326|454838661|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
126421379|NCT03472326|454838662|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
126421380|NCT03472326|454838663|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
126421381|NCT03472326|454838664|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
126421382|NCT03472326|454838661|FG000|Part 2: Combination Therapy|Pregnancy|0|||
126421383|NCT03472326|454838662|FG001|Part 2: Combination Therapy|Pregnancy|0|||
126421384|NCT03472326|454838663|FG002|Part 2: Combination Therapy|Pregnancy|0|||
126421385|NCT03472326|454838664|FG003|Part 2: Combination Therapy|Pregnancy|1|||
126421386|NCT03386721|454838665|FG000|Overall Study|Death|12|||
126421387|NCT03386721|454838666|FG001|Overall Study|Death|21|||
126421388|NCT03386721|454838667|FG002|Overall Study|Death|2|||
126421389|NCT03386721|454838668|FG003|Overall Study|Death|5|||
126421390|NCT03386721|454838669|FG004|Overall Study|Death|1|||
126421391|NCT03386721|454838670|FG005|Overall Study|Death|12|||
126421392|NCT03386721|454838671|FG006|Overall Study|Death|1|||
126421393|NCT03386721|454838672|FG007|Overall Study|Death|1|||
126421394|NCT03386721|454838673|FG008|Overall Study|Death|12|||
126421395|NCT03386721|454838674|FG009|Overall Study|Death|20|||
126421396|NCT03386721|454838675|FG010|Overall Study|Death|21|||
126421397|NCT03386721|454838676|FG011|Overall Study|Death|21|||
126421398|NCT03386721|454838677|FG012|Overall Study|Death|14|||
126421399|NCT03386721|454838678|FG013|Overall Study|Death|2|||
126421400|NCT03386721|454838679|FG014|Overall Study|Death|1|||
126421401|NCT03386721|454838665|FG000|Overall Study|Lost to Follow-up|1|||
126421402|NCT03386721|454838666|FG001|Overall Study|Lost to Follow-up|3|||
126421403|NCT03386721|454838667|FG002|Overall Study|Lost to Follow-up|0|||
126421404|NCT03386721|454838668|FG003|Overall Study|Lost to Follow-up|0|||
126421405|NCT03386721|454838669|FG004|Overall Study|Lost to Follow-up|0|||
126421406|NCT03386721|454838670|FG005|Overall Study|Lost to Follow-up|2|||
126421407|NCT03386721|454838671|FG006|Overall Study|Lost to Follow-up|1|||
126421408|NCT03386721|454838672|FG007|Overall Study|Lost to Follow-up|0|||
126421409|NCT03386721|454838673|FG008|Overall Study|Lost to Follow-up|1|||
126421410|NCT03386721|454838674|FG009|Overall Study|Lost to Follow-up|2|||
126421411|NCT03386721|454838675|FG010|Overall Study|Lost to Follow-up|1|||
126421412|NCT03386721|454838676|FG011|Overall Study|Lost to Follow-up|0|||
126421413|NCT03386721|454838677|FG012|Overall Study|Lost to Follow-up|0|||
126421414|NCT03386721|454838678|FG013|Overall Study|Lost to Follow-up|0|||
126421415|NCT03386721|454838679|FG014|Overall Study|Lost to Follow-up|0|||
126421416|NCT03386721|454838665|FG000|Overall Study|Reason not specified|3|||
126421417|NCT03386721|454838666|FG001|Overall Study|Reason not specified|0|||
126421418|NCT03386721|454838667|FG002|Overall Study|Reason not specified|0|||
126421419|NCT03386721|454838668|FG003|Overall Study|Reason not specified|0|||
126421420|NCT03386721|454838669|FG004|Overall Study|Reason not specified|0|||
126421421|NCT03386721|454838670|FG005|Overall Study|Reason not specified|3|||
126421422|NCT03386721|454838671|FG006|Overall Study|Reason not specified|1|||
126421423|NCT03386721|454838672|FG007|Overall Study|Reason not specified|0|||
126421424|NCT03386721|454838673|FG008|Overall Study|Reason not specified|0|||
126421425|NCT03386721|454838674|FG009|Overall Study|Reason not specified|1|||
126421426|NCT03386721|454838675|FG010|Overall Study|Reason not specified|2|||
126421427|NCT03386721|454838676|FG011|Overall Study|Reason not specified|6|||
126421428|NCT03386721|454838677|FG012|Overall Study|Reason not specified|1|||
126421429|NCT03386721|454838678|FG013|Overall Study|Reason not specified|0|||
126421430|NCT03386721|454838679|FG014|Overall Study|Reason not specified|0|||
126421431|NCT03386721|454838665|FG000|Overall Study|Progressive Disease|0|||
126421432|NCT03386721|454838666|FG001|Overall Study|Progressive Disease|0|||
126421433|NCT03386721|454838667|FG002|Overall Study|Progressive Disease|1|||
126421434|NCT03386721|454838668|FG003|Overall Study|Progressive Disease|0|||
126421435|NCT03386721|454838669|FG004|Overall Study|Progressive Disease|0|||
126421436|NCT03386721|454838670|FG005|Overall Study|Progressive Disease|1|||
126421437|NCT03386721|454838671|FG006|Overall Study|Progressive Disease|0|||
126421438|NCT03386721|454838672|FG007|Overall Study|Progressive Disease|0|||
126421439|NCT03386721|454838673|FG008|Overall Study|Progressive Disease|2|||
126421440|NCT03386721|454838674|FG009|Overall Study|Progressive Disease|1|||
126421441|NCT03386721|454838675|FG010|Overall Study|Progressive Disease|1|||
126421442|NCT03386721|454838676|FG011|Overall Study|Progressive Disease|0|||
126421443|NCT03386721|454838677|FG012|Overall Study|Progressive Disease|1|||
126421444|NCT03386721|454838678|FG013|Overall Study|Progressive Disease|0|||
126421445|NCT03386721|454838679|FG014|Overall Study|Progressive Disease|0|||
126421446|NCT03386721|454838665|FG000|Overall Study|Site Terminated by Sponsor|5|||
126421447|NCT03386721|454838666|FG001|Overall Study|Site Terminated by Sponsor|5|||
126421448|NCT03386721|454838667|FG002|Overall Study|Site Terminated by Sponsor|0|||
126421449|NCT03386721|454838668|FG003|Overall Study|Site Terminated by Sponsor|0|||
126421450|NCT03386721|454838669|FG004|Overall Study|Site Terminated by Sponsor|1|||
126421451|NCT03386721|454838670|FG005|Overall Study|Site Terminated by Sponsor|3|||
126421452|NCT03386721|454838671|FG006|Overall Study|Site Terminated by Sponsor|0|||
126421453|NCT03386721|454838672|FG007|Overall Study|Site Terminated by Sponsor|1|||
126421454|NCT03386721|454838673|FG008|Overall Study|Site Terminated by Sponsor|4|||
126421455|NCT03386721|454838674|FG009|Overall Study|Site Terminated by Sponsor|5|||
126421456|NCT03386721|454838675|FG010|Overall Study|Site Terminated by Sponsor|3|||
126421457|NCT03386721|454838676|FG011|Overall Study|Site Terminated by Sponsor|11|||
126421458|NCT03386721|454838677|FG012|Overall Study|Site Terminated by Sponsor|6|||
126421459|NCT03386721|454838678|FG013|Overall Study|Site Terminated by Sponsor|0|||
126421460|NCT03386721|454838679|FG014|Overall Study|Site Terminated by Sponsor|0|||
126421461|NCT03386721|454838665|FG000|Overall Study|Symptomatic Deterioration|0|||
126421462|NCT03386721|454838666|FG001|Overall Study|Symptomatic Deterioration|0|||
126421463|NCT03386721|454838667|FG002|Overall Study|Symptomatic Deterioration|0|||
126421464|NCT03386721|454838668|FG003|Overall Study|Symptomatic Deterioration|0|||
126421465|NCT03386721|454838669|FG004|Overall Study|Symptomatic Deterioration|0|||
126421466|NCT03386721|454838670|FG005|Overall Study|Symptomatic Deterioration|0|||
126421467|NCT03386721|454838671|FG006|Overall Study|Symptomatic Deterioration|0|||
126421468|NCT03386721|454838672|FG007|Overall Study|Symptomatic Deterioration|0|||
126421469|NCT03386721|454838673|FG008|Overall Study|Symptomatic Deterioration|1|||
126421470|NCT03386721|454838674|FG009|Overall Study|Symptomatic Deterioration|0|||
126421471|NCT03386721|454838675|FG010|Overall Study|Symptomatic Deterioration|0|||
126421472|NCT03386721|454838676|FG011|Overall Study|Symptomatic Deterioration|1|||
126421473|NCT03386721|454838677|FG012|Overall Study|Symptomatic Deterioration|0|||
126421474|NCT03386721|454838678|FG013|Overall Study|Symptomatic Deterioration|0|||
126421475|NCT03386721|454838679|FG014|Overall Study|Symptomatic Deterioration|0|||
126421476|NCT03386721|454838665|FG000|Overall Study|Withdrawal by Subject|1|||
126421477|NCT03386721|454838666|FG001|Overall Study|Withdrawal by Subject|2|||
126421478|NCT03386721|454838667|FG002|Overall Study|Withdrawal by Subject|0|||
126421479|NCT03386721|454838668|FG003|Overall Study|Withdrawal by Subject|0|||
126421480|NCT03386721|454838669|FG004|Overall Study|Withdrawal by Subject|0|||
126421481|NCT03386721|454838670|FG005|Overall Study|Withdrawal by Subject|0|||
126421482|NCT03386721|454838671|FG006|Overall Study|Withdrawal by Subject|0|||
126421483|NCT03386721|454838672|FG007|Overall Study|Withdrawal by Subject|0|||
126421484|NCT03386721|454838673|FG008|Overall Study|Withdrawal by Subject|2|||
126421485|NCT03386721|454838674|FG009|Overall Study|Withdrawal by Subject|1|||
126421486|NCT03386721|454838675|FG010|Overall Study|Withdrawal by Subject|3|||
126421487|NCT03386721|454838676|FG011|Overall Study|Withdrawal by Subject|2|||
126421488|NCT03386721|454838677|FG012|Overall Study|Withdrawal by Subject|3|||
126421489|NCT03386721|454838678|FG013|Overall Study|Withdrawal by Subject|0|||
126421490|NCT03386721|454838679|FG014|Overall Study|Withdrawal by Subject|0|||
126421491|NCT03081884|454838680|FG000|Overall Study|deferred prostate cancer treatment|1|||
126721989|NCT00488618|455931357|FG001|Overall Study|Insufficient Therapeutic Response|11|||
126721990|NCT00488618|455931356|FG000|Overall Study|Protocol Violation|0|||
126721991|NCT00488618|455931357|FG001|Overall Study|Protocol Violation|2|||
126721992|NCT00488618|455931356|FG000|Overall Study|Withdrawal of Consent|15|||
126721993|NCT00488618|455931357|FG001|Overall Study|Withdrawal of Consent|13|||
126421492|NCT03081884|454838680|FG000|Overall Study|metastasis managed with systemic therapy|3|||
126421493|NCT03948334|454838682|FG000|Overall Study|Adverse Event|1|||
126421494|NCT03948334|454838683|FG001|Overall Study|Adverse Event|4|||
126421495|NCT03948334|454838682|FG000|Overall Study|Lack of Efficacy|2|||
126421496|NCT03948334|454838683|FG001|Overall Study|Lack of Efficacy|0|||
126421497|NCT03948334|454838682|FG000|Overall Study|Lost to Follow-up|1|||
126421498|NCT03948334|454838683|FG001|Overall Study|Lost to Follow-up|0|||
126421499|NCT03948334|454838682|FG000|Overall Study|Physician Decision|1|||
126421500|NCT03948334|454838683|FG001|Overall Study|Physician Decision|0|||
126421501|NCT03948334|454838682|FG000|Overall Study|Pregnancy|0|||
126421502|NCT03948334|454838683|FG001|Overall Study|Pregnancy|1|||
126421503|NCT03948334|454838682|FG000|Overall Study|Protocol Deviation|1|||
126421504|NCT03948334|454838683|FG001|Overall Study|Protocol Deviation|0|||
126421505|NCT03948334|454838682|FG000|Overall Study|Study terminated by Sponsor|50|||
126421506|NCT03948334|454838683|FG001|Overall Study|Study terminated by Sponsor|51|||
126421507|NCT03948334|454838682|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
126421508|NCT03948334|454838683|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
126421509|NCT05114473|454838684|FG000|Overall Study|Lost to Follow-up|2|||
126421510|NCT05114473|454838685|FG001|Overall Study|Lost to Follow-up|2|||
126421511|NCT05114473|454838686|FG002|Overall Study|Lost to Follow-up|0|||
126421512|NCT00700713|454838687|FG000|Overall Study|Protocol Violation|1|||
126421513|NCT00700713|454838688|FG001|Overall Study|Protocol Violation|0|||
126421514|NCT00700713|454838689|FG002|Overall Study|Protocol Violation|1|||
126421515|NCT00700713|454838687|FG000|Overall Study|Withdrawal by Subject|0|||
126421516|NCT00700713|454838688|FG001|Overall Study|Withdrawal by Subject|0|||
126421517|NCT00700713|454838689|FG002|Overall Study|Withdrawal by Subject|1|||
126421518|NCT00550953|454838691|FG000|Overall Study|Adverse Event|4|||
126421519|NCT00550953|454838692|FG001|Overall Study|Adverse Event|3|||
126421520|NCT00550953|454838691|FG000|Overall Study|Not able to visit the site|2|||
126477471|NCT00939770|455048276|FG000|Overall Study|Withdrawal by Subject|0|||
126421521|NCT00550953|454838692|FG001|Overall Study|Not able to visit the site|3|||
126421522|NCT02905266|454838693|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
126421523|NCT02905266|454838694|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
126421524|NCT02905266|454838693|FG000|Treatment Phase Part 1|Disease Progression|6|||
126421525|NCT02905266|454838694|FG001|Treatment Phase Part 1|Disease Progression|7|||
126421526|NCT02905266|454838693|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
126421527|NCT02905266|454838694|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
126721994|NCT00488618|455931356|FG000|Overall Study|Lost to Follow-up|1|||
126421528|NCT02905266|454838693|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
126421529|NCT02905266|454838694|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
126421530|NCT02905266|454838693|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
126421531|NCT02905266|454838694|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
126421532|NCT02905266|454838693|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
126421533|NCT02905266|454838694|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
126421534|NCT02905266|454838693|FG000|Transition From Part 1 to Part 2|Death|0|||
126421535|NCT02905266|454838694|FG001|Transition From Part 1 to Part 2|Death|1|||
126421536|NCT02905266|454838693|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
126421537|NCT02905266|454838694|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
126421538|NCT02905266|454838693|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
126421539|NCT02905266|454838694|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
126421540|NCT02905266|454838693|FG000|Maintenance Phase Part 2|Disease Progression|9|||
126421541|NCT02905266|454838694|FG001|Maintenance Phase Part 2|Disease Progression|2|||
126421542|NCT02905266|454838693|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
126421543|NCT02905266|454838694|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
126421544|NCT02905266|454838693|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
126421545|NCT02905266|454838694|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
126421546|NCT01132313|454838695|FG000|Overall Study|Lack of Efficacy|1|||
126421547|NCT01132313|454838696|FG001|Overall Study|Lack of Efficacy|0|||
126421548|NCT01132313|454838697|FG002|Overall Study|Lack of Efficacy|0|||
126421549|NCT01132313|454838698|FG003|Overall Study|Lack of Efficacy|0|||
126421550|NCT01132313|454838699|FG004|Overall Study|Lack of Efficacy|0|||
126421551|NCT01132313|454838700|FG005|Overall Study|Lack of Efficacy|0|||
126421552|NCT01132313|454838701|FG006|Overall Study|Lack of Efficacy|0|||
126421553|NCT01132313|454838702|FG007|Overall Study|Lack of Efficacy|3|||
126421554|NCT01132313|454838703|FG008|Overall Study|Lack of Efficacy|14|||
126421555|NCT01132313|454838704|FG009|Overall Study|Lack of Efficacy|16|||
126421556|NCT01132313|454838705|FG010|Overall Study|Lack of Efficacy|0|||
126421557|NCT01132313|454838706|FG011|Overall Study|Lack of Efficacy|0|||
126421558|NCT01132313|454838695|FG000|Overall Study|Not treated|2|||
126421559|NCT01132313|454838696|FG001|Overall Study|Not treated|0|||
126421560|NCT01132313|454838697|FG002|Overall Study|Not treated|0|||
126421561|NCT01132313|454838698|FG003|Overall Study|Not treated|0|||
126421562|NCT01132313|454838699|FG004|Overall Study|Not treated|2|||
126421563|NCT01132313|454838700|FG005|Overall Study|Not treated|1|||
126421564|NCT01132313|454838701|FG006|Overall Study|Not treated|3|||
126421565|NCT01132313|454838702|FG007|Overall Study|Not treated|0|||
126421566|NCT01132313|454838703|FG008|Overall Study|Not treated|0|||
126421567|NCT01132313|454838704|FG009|Overall Study|Not treated|0|||
126421568|NCT01132313|454838705|FG010|Overall Study|Not treated|0|||
126421569|NCT01132313|454838706|FG011|Overall Study|Not treated|0|||
126421570|NCT01132313|454838695|FG000|Overall Study|Adverse Event|0|||
126421571|NCT01132313|454838696|FG001|Overall Study|Adverse Event|0|||
126421572|NCT01132313|454838697|FG002|Overall Study|Adverse Event|4|||
126421573|NCT01132313|454838698|FG003|Overall Study|Adverse Event|10|||
126421574|NCT01132313|454838699|FG004|Overall Study|Adverse Event|19|||
126421575|NCT01132313|454838700|FG005|Overall Study|Adverse Event|6|||
126421576|NCT01132313|454838701|FG006|Overall Study|Adverse Event|5|||
126421577|NCT01132313|454838702|FG007|Overall Study|Adverse Event|3|||
126421578|NCT01132313|454838703|FG008|Overall Study|Adverse Event|7|||
126421579|NCT01132313|454838704|FG009|Overall Study|Adverse Event|2|||
126421580|NCT01132313|454838705|FG010|Overall Study|Adverse Event|0|||
126421581|NCT01132313|454838706|FG011|Overall Study|Adverse Event|0|||
126421582|NCT01132313|454838695|FG000|Overall Study|Protocol Violation|0|||
126421583|NCT01132313|454838696|FG001|Overall Study|Protocol Violation|0|||
126421584|NCT01132313|454838697|FG002|Overall Study|Protocol Violation|0|||
126421585|NCT01132313|454838698|FG003|Overall Study|Protocol Violation|1|||
126421586|NCT01132313|454838699|FG004|Overall Study|Protocol Violation|0|||
126421587|NCT01132313|454838700|FG005|Overall Study|Protocol Violation|0|||
126559126|NCT03704298|455340660|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
126559127|NCT03704298|455340661|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
126421588|NCT01132313|454838701|FG006|Overall Study|Protocol Violation|0|||
126421589|NCT01132313|454838702|FG007|Overall Study|Protocol Violation|0|||
126421590|NCT01132313|454838703|FG008|Overall Study|Protocol Violation|0|||
126421591|NCT01132313|454838704|FG009|Overall Study|Protocol Violation|0|||
126421592|NCT01132313|454838705|FG010|Overall Study|Protocol Violation|0|||
126421593|NCT01132313|454838706|FG011|Overall Study|Protocol Violation|0|||
126421594|NCT01132313|454838695|FG000|Overall Study|Lost to Follow-up|0|||
126421595|NCT01132313|454838696|FG001|Overall Study|Lost to Follow-up|0|||
126421596|NCT01132313|454838697|FG002|Overall Study|Lost to Follow-up|1|||
126421597|NCT01132313|454838698|FG003|Overall Study|Lost to Follow-up|0|||
126421598|NCT01132313|454838699|FG004|Overall Study|Lost to Follow-up|0|||
126421599|NCT01132313|454838700|FG005|Overall Study|Lost to Follow-up|0|||
126421600|NCT01132313|454838701|FG006|Overall Study|Lost to Follow-up|0|||
126421601|NCT01132313|454838702|FG007|Overall Study|Lost to Follow-up|1|||
126421602|NCT01132313|454838703|FG008|Overall Study|Lost to Follow-up|0|||
126421603|NCT01132313|454838704|FG009|Overall Study|Lost to Follow-up|0|||
126721995|NCT00488618|455931357|FG001|Overall Study|Lost to Follow-up|0|||
126421604|NCT01132313|454838705|FG010|Overall Study|Lost to Follow-up|0|||
126421605|NCT01132313|454838706|FG011|Overall Study|Lost to Follow-up|0|||
126421606|NCT01132313|454838695|FG000|Overall Study|Withdrawal by Subject|0|||
126721996|NCT03675737|455931359|FG000|Overall Study|Death|593|||
126477472|NCT00939770|455048277|FG001|Overall Study|Withdrawal by Subject|1|||
126477473|NCT00939770|455048278|FG002|Overall Study|Withdrawal by Subject|5|||
126421607|NCT01132313|454838696|FG001|Overall Study|Withdrawal by Subject|0|||
126421608|NCT01132313|454838697|FG002|Overall Study|Withdrawal by Subject|3|||
126421609|NCT01132313|454838698|FG003|Overall Study|Withdrawal by Subject|3|||
126421610|NCT01132313|454838699|FG004|Overall Study|Withdrawal by Subject|6|||
126421611|NCT01132313|454838700|FG005|Overall Study|Withdrawal by Subject|0|||
126421612|NCT01132313|454838701|FG006|Overall Study|Withdrawal by Subject|1|||
126421613|NCT01132313|454838702|FG007|Overall Study|Withdrawal by Subject|0|||
126421614|NCT01132313|454838703|FG008|Overall Study|Withdrawal by Subject|0|||
126421615|NCT01132313|454838704|FG009|Overall Study|Withdrawal by Subject|2|||
126421616|NCT01132313|454838705|FG010|Overall Study|Withdrawal by Subject|0|||
126421617|NCT01132313|454838706|FG011|Overall Study|Withdrawal by Subject|0|||
126421618|NCT01132313|454838695|FG000|Overall Study|Lack of antiviral response|0|||
126421619|NCT01132313|454838696|FG001|Overall Study|Lack of antiviral response|0|||
126421620|NCT01132313|454838697|FG002|Overall Study|Lack of antiviral response|12|||
126477474|NCT00939770|455048279|FG003|Overall Study|Withdrawal by Subject|2|||
126477475|NCT00939770|455048280|FG004|Overall Study|Withdrawal by Subject|6|||
126477476|NCT00939770|455048281|FG005|Overall Study|Withdrawal by Subject|0|||
126477477|NCT00939770|455048282|FG006|Overall Study|Withdrawal by Subject|2|||
126421621|NCT01132313|454838698|FG003|Overall Study|Lack of antiviral response|18|||
126421622|NCT01132313|454838699|FG004|Overall Study|Lack of antiviral response|18|||
126421623|NCT01132313|454838700|FG005|Overall Study|Lack of antiviral response|18|||
126421624|NCT01132313|454838701|FG006|Overall Study|Lack of antiviral response|21|||
126421625|NCT01132313|454838702|FG007|Overall Study|Lack of antiviral response|0|||
126421626|NCT01132313|454838703|FG008|Overall Study|Lack of antiviral response|0|||
126421627|NCT01132313|454838704|FG009|Overall Study|Lack of antiviral response|0|||
126421628|NCT01132313|454838705|FG010|Overall Study|Lack of antiviral response|1|||
126421629|NCT01132313|454838706|FG011|Overall Study|Lack of antiviral response|0|||
126421630|NCT01132313|454838695|FG000|Overall Study|Other reason not defined above|0|||
126421631|NCT01132313|454838696|FG001|Overall Study|Other reason not defined above|0|||
126421632|NCT01132313|454838697|FG002|Overall Study|Other reason not defined above|0|||
126421633|NCT01132313|454838698|FG003|Overall Study|Other reason not defined above|0|||
126421634|NCT01132313|454838699|FG004|Overall Study|Other reason not defined above|0|||
126421635|NCT01132313|454838700|FG005|Overall Study|Other reason not defined above|0|||
126421636|NCT01132313|454838701|FG006|Overall Study|Other reason not defined above|0|||
126421637|NCT01132313|454838702|FG007|Overall Study|Other reason not defined above|1|||
126421638|NCT01132313|454838703|FG008|Overall Study|Other reason not defined above|0|||
126421639|NCT01132313|454838704|FG009|Overall Study|Other reason not defined above|0|||
126421640|NCT01132313|454838705|FG010|Overall Study|Other reason not defined above|0|||
126421641|NCT01132313|454838706|FG011|Overall Study|Other reason not defined above|0|||
126477478|NCT00939770|455048283|FG007|Overall Study|Withdrawal by Subject|2|||
126721997|NCT03675737|455931360|FG001|Overall Study|Death|660|||
126721998|NCT03675737|455931359|FG000|Overall Study|Lost to Follow-up|1|||
126477479|NCT01817530|455048288|FG000|Overall Study|Exclusionary Medication Received|0|||
126477480|NCT01817530|455048289|FG001|Overall Study|Exclusionary Medication Received|0|||
126477481|NCT01817530|455048290|FG002|Overall Study|Exclusionary Medication Received|0|||
126477482|NCT01817530|455048291|FG003|Overall Study|Exclusionary Medication Received|0|||
126477483|NCT01817530|455048292|FG004|Overall Study|Exclusionary Medication Received|1|||
126477484|NCT01817530|455048293|FG005|Overall Study|Exclusionary Medication Received|0|||
126477485|NCT01817530|455048294|FG006|Overall Study|Exclusionary Medication Received|0|||
126721999|NCT03675737|455931360|FG001|Overall Study|Lost to Follow-up|5|||
126722000|NCT03675737|455931359|FG000|Overall Study|Physician Decision|1|||
126722001|NCT03675737|455931360|FG001|Overall Study|Physician Decision|0|||
126722002|NCT03675737|455931359|FG000|Overall Study|Withdrawal by Subject|14|||
126421642|NCT02715609|454838708|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
126477486|NCT01817530|455048295|FG007|Overall Study|Exclusionary Medication Received|0|||
126559128|NCT03704298|455340662|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
126559129|NCT03704298|455340659|FG000|Overall Study|Withdrawal by Subject|1|||
126722003|NCT03675737|455931360|FG001|Overall Study|Withdrawal by Subject|12|||
126722004|NCT03675737|455931359|FG000|Overall Study|Ongoing in Study|181|||
126722005|NCT03675737|455931360|FG001|Overall Study|Ongoing in Study|112|||
126421643|NCT02715609|454838709|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
126421644|NCT02715609|454838710|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
126421645|NCT02715609|454838708|FG000|Overall Study|Withdrawal by Subject|0|||
126421646|NCT02715609|454838709|FG001|Overall Study|Withdrawal by Subject|0|||
126421647|NCT02715609|454838710|FG002|Overall Study|Withdrawal by Subject|1|||
126421648|NCT03201419|454838711|FG000|Overall Study|Adverse Event|3|||
126421649|NCT03201419|454838712|FG001|Overall Study|Adverse Event|1|||
126421650|NCT03201419|454838713|FG002|Overall Study|Adverse Event|0|||
126421651|NCT03201419|454838714|FG003|Overall Study|Adverse Event|0|||
126421652|NCT03201419|454838715|FG004|Overall Study|Adverse Event|1|||
126421653|NCT03201419|454838716|FG005|Overall Study|Adverse Event|1|||
126421654|NCT03201419|454838717|FG006|Overall Study|Adverse Event|5|||
126421655|NCT03201419|454838718|FG007|Overall Study|Adverse Event|0|||
126421656|NCT03201419|454838719|FG008|Overall Study|Adverse Event|0|||
126421657|NCT03201419|454838711|FG000|Overall Study|Lost to Follow-up|1|||
126421658|NCT03201419|454838712|FG001|Overall Study|Lost to Follow-up|0|||
126421659|NCT03201419|454838713|FG002|Overall Study|Lost to Follow-up|0|||
126421660|NCT03201419|454838714|FG003|Overall Study|Lost to Follow-up|0|||
126421661|NCT03201419|454838715|FG004|Overall Study|Lost to Follow-up|0|||
126421662|NCT03201419|454838716|FG005|Overall Study|Lost to Follow-up|0|||
126421663|NCT03201419|454838717|FG006|Overall Study|Lost to Follow-up|0|||
126421664|NCT03201419|454838718|FG007|Overall Study|Lost to Follow-up|0|||
126421665|NCT03201419|454838719|FG008|Overall Study|Lost to Follow-up|0|||
126421666|NCT03201419|454838711|FG000|Overall Study|Protocol Deviation|0|||
126421667|NCT03201419|454838712|FG001|Overall Study|Protocol Deviation|0|||
126421668|NCT03201419|454838713|FG002|Overall Study|Protocol Deviation|0|||
126421669|NCT03201419|454838714|FG003|Overall Study|Protocol Deviation|0|||
126421670|NCT03201419|454838715|FG004|Overall Study|Protocol Deviation|0|||
126421671|NCT03201419|454838716|FG005|Overall Study|Protocol Deviation|0|||
126421672|NCT03201419|454838717|FG006|Overall Study|Protocol Deviation|1|||
126421673|NCT03201419|454838718|FG007|Overall Study|Protocol Deviation|0|||
126421674|NCT03201419|454838719|FG008|Overall Study|Protocol Deviation|0|||
126421675|NCT03201419|454838711|FG000|Overall Study|Withdrawal by Subject|4|||
126421676|NCT03201419|454838712|FG001|Overall Study|Withdrawal by Subject|2|||
126421677|NCT03201419|454838713|FG002|Overall Study|Withdrawal by Subject|1|||
126421678|NCT03201419|454838714|FG003|Overall Study|Withdrawal by Subject|0|||
126421679|NCT03201419|454838715|FG004|Overall Study|Withdrawal by Subject|0|||
126421680|NCT03201419|454838716|FG005|Overall Study|Withdrawal by Subject|0|||
126421681|NCT03201419|454838717|FG006|Overall Study|Withdrawal by Subject|0|||
126421682|NCT03201419|454838718|FG007|Overall Study|Withdrawal by Subject|1|||
126421683|NCT03201419|454838719|FG008|Overall Study|Withdrawal by Subject|2|||
126421684|NCT03201419|454838711|FG000|Overall Study|Other|0|||
126421685|NCT03201419|454838712|FG001|Overall Study|Other|0|||
126421686|NCT03201419|454838713|FG002|Overall Study|Other|1|||
126421687|NCT03201419|454838714|FG003|Overall Study|Other|0|||
126421688|NCT03201419|454838715|FG004|Overall Study|Other|0|||
126421689|NCT03201419|454838716|FG005|Overall Study|Other|0|||
126421690|NCT03201419|454838717|FG006|Overall Study|Other|0|||
126421691|NCT03201419|454838718|FG007|Overall Study|Other|0|||
126421692|NCT03201419|454838719|FG008|Overall Study|Other|0|||
126421693|NCT05907395|454838720|FG000|Period 1|No longer met eligibility criteria|0|||
126421694|NCT05907395|454838721|FG001|Period 1|No longer met eligibility criteria|1|||
126421695|NCT05907395|454838722|FG002|Period 1|No longer met eligibility criteria|0|||
126421696|NCT05907395|454838723|FG003|Period 1|No longer met eligibility criteria|0|||
126421697|NCT05907395|454838724|FG004|Period 1|No longer met eligibility criteria|0|||
126421698|NCT05907395|454838725|FG005|Period 1|No longer met eligibility criteria|1|||
126421699|NCT05907395|454838726|FG006|Period 1|No longer met eligibility criteria|1|||
126421700|NCT05907395|454838727|FG007|Period 1|No longer met eligibility criteria|0|||
126421701|NCT05907395|454838728|FG008|Period 1|No longer met eligibility criteria|0|||
126421702|NCT05907395|454838729|FG009|Period 1|No longer met eligibility criteria|0|||
126421703|NCT05907395|454838730|FG010|Period 1|No longer met eligibility criteria|0|||
126421704|NCT05907395|454838731|FG011|Period 1|No longer met eligibility criteria|0|||
126421705|NCT05907395|454838720|FG000|Period 2|Adverse Event|0|||
126421706|NCT05907395|454838721|FG001|Period 2|Adverse Event|0|||
126421707|NCT05907395|454838722|FG002|Period 2|Adverse Event|0|||
126421708|NCT05907395|454838723|FG003|Period 2|Adverse Event|1|||
126421709|NCT05907395|454838724|FG004|Period 2|Adverse Event|0|||
126421710|NCT05907395|454838725|FG005|Period 2|Adverse Event|0|||
126421711|NCT05907395|454838726|FG006|Period 2|Adverse Event|0|||
126421712|NCT05907395|454838727|FG007|Period 2|Adverse Event|1|||
126421713|NCT05907395|454838728|FG008|Period 2|Adverse Event|0|||
126421714|NCT05907395|454838729|FG009|Period 2|Adverse Event|0|||
126421715|NCT05907395|454838730|FG010|Period 2|Adverse Event|0|||
126421716|NCT05907395|454838731|FG011|Period 2|Adverse Event|0|||
126421717|NCT05907395|454838720|FG000|Period 2|Personal reason|0|||
126421718|NCT05907395|454838721|FG001|Period 2|Personal reason|0|||
126421719|NCT05907395|454838722|FG002|Period 2|Personal reason|0|||
126421720|NCT05907395|454838723|FG003|Period 2|Personal reason|0|||
126421721|NCT05907395|454838724|FG004|Period 2|Personal reason|0|||
126421722|NCT05907395|454838725|FG005|Period 2|Personal reason|0|||
126421723|NCT05907395|454838726|FG006|Period 2|Personal reason|0|||
126421724|NCT05907395|454838727|FG007|Period 2|Personal reason|0|||
126421725|NCT05907395|454838728|FG008|Period 2|Personal reason|0|||
126421726|NCT05907395|454838729|FG009|Period 2|Personal reason|1|||
126421727|NCT05907395|454838730|FG010|Period 2|Personal reason|0|||
126421728|NCT05907395|454838731|FG011|Period 2|Personal reason|0|||
126421729|NCT05907395|454838720|FG000|Period 3|Adverse Event|0|||
126421730|NCT05907395|454838721|FG001|Period 3|Adverse Event|0|||
126421731|NCT05907395|454838722|FG002|Period 3|Adverse Event|0|||
126421732|NCT05907395|454838723|FG003|Period 3|Adverse Event|0|||
126421733|NCT05907395|454838724|FG004|Period 3|Adverse Event|1|||
126421734|NCT05907395|454838725|FG005|Period 3|Adverse Event|0|||
126421735|NCT05907395|454838726|FG006|Period 3|Adverse Event|0|||
126421736|NCT05907395|454838727|FG007|Period 3|Adverse Event|0|||
126421737|NCT05907395|454838728|FG008|Period 3|Adverse Event|0|||
126421738|NCT05907395|454838729|FG009|Period 3|Adverse Event|0|||
126421739|NCT05907395|454838730|FG010|Period 3|Adverse Event|0|||
126421740|NCT05907395|454838731|FG011|Period 3|Adverse Event|0|||
126421741|NCT04896593|454838732|FG000|Overall Study|Withdrawal by Subject|2|||
126421742|NCT04896593|454838732|FG000|Overall Study|Lost to Follow-up|1|||
126421743|NCT04896593|454838732|FG000|Overall Study|Did not complete onboarding|2|||
126421744|NCT02777827|454838733|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
126421745|NCT02777827|454838734|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
126421746|NCT02777827|454838735|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
126421747|NCT02777827|454838736|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
126421748|NCT02777827|454838737|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
126421749|NCT02777827|454838738|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
126421750|NCT00369577|454838739|FG000|Overall Study|Withdrawal by Subject|0|||
126421751|NCT00369577|454838740|FG001|Overall Study|Withdrawal by Subject|0|||
126421752|NCT00369577|454838741|FG002|Overall Study|Withdrawal by Subject|1|||
126421753|NCT04177212|454838750|FG000|Overall Study|Withdrawal by Subject|9|||
126421754|NCT04177212|454838751|FG001|Overall Study|Withdrawal by Subject|7|||
126421755|NCT04177212|454838750|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
126421756|NCT04177212|454838751|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
126421757|NCT04177212|454838750|FG000|Overall Study|Physician Decision|1|||
126421758|NCT04177212|454838751|FG001|Overall Study|Physician Decision|0|||
126421759|NCT04177212|454838750|FG000|Overall Study|Lost to Follow-up|0|||
126421760|NCT04177212|454838751|FG001|Overall Study|Lost to Follow-up|3|||
126421761|NCT04177212|454838750|FG000|Overall Study|Adverse Event|0|||
126421762|NCT04177212|454838751|FG001|Overall Study|Adverse Event|1|||
126421763|NCT04177212|454838750|FG000|Overall Study|Other|1|||
126421764|NCT04177212|454838751|FG001|Overall Study|Other|2|||
126421765|NCT04725500|454838752|FG000|Screening|Screen Failure|26|||
126421766|NCT04725500|454838752|FG000|Screening|Withdrawal by Subject|1|||
126421767|NCT04725500|454838752|FG000|2 Week Take Home|Screen Fail|5|||
126421768|NCT00930930|454838754|FG000|Overall Study|Death|1|||
126421769|NCT00930930|454838755|FG001|Overall Study|Death|0|||
126421770|NCT00930930|454838754|FG000|Overall Study|Physician Decision|1|||
126421771|NCT00930930|454838755|FG001|Overall Study|Physician Decision|0|||
126421772|NCT00930930|454838754|FG000|Overall Study|Adverse Event|13|||
126421773|NCT00930930|454838755|FG001|Overall Study|Adverse Event|3|||
126421774|NCT00930930|454838754|FG000|Overall Study|Withdrawal by Subject|3|||
126421775|NCT00930930|454838755|FG001|Overall Study|Withdrawal by Subject|1|||
126421776|NCT00930930|454838754|FG000|Overall Study|Disease progression|2|||
126421777|NCT00930930|454838755|FG001|Overall Study|Disease progression|3|||
126421778|NCT00930930|454838754|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
126421779|NCT00930930|454838755|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
126421780|NCT00930930|454838754|FG000|Overall Study|patients not compliant|1|||
126421781|NCT00930930|454838755|FG001|Overall Study|patients not compliant|1|||
126421782|NCT04618744|454838756|FG000|Overall Study|Adverse Event|0|||
126421783|NCT04618744|454838757|FG001|Overall Study|Adverse Event|1|||
126421784|NCT04618744|454838756|FG000|Overall Study|Withdrawal by Subject|0|||
126421785|NCT04618744|454838757|FG001|Overall Study|Withdrawal by Subject|1|||
126421786|NCT02709330|454838758|FG000|Overall Study|Death|5|||
126421787|NCT02709330|454838759|FG001|Overall Study|Death|0|||
126421788|NCT02709330|454838758|FG000|Overall Study|Lost to Follow-up|2|||
126421789|NCT02709330|454838759|FG001|Overall Study|Lost to Follow-up|0|||
126722006|NCT02349789|455933224|FG000|Overall Study|Withdrawal by Subject|2|||
126421790|NCT02709330|454838758|FG000|Overall Study|Physician Decision|2|||
126421791|NCT02709330|454838759|FG001|Overall Study|Physician Decision|0|||
126421792|NCT02709330|454838758|FG000|Overall Study|Withdrawal by Subject|4|||
126421793|NCT02709330|454838759|FG001|Overall Study|Withdrawal by Subject|0|||
126421794|NCT01467505|454840567|FG000|Overall Study|Adverse Event|1|||
126421795|NCT01467505|454840568|FG001|Overall Study|Adverse Event|0|||
126421796|NCT01467505|454840567|FG000|Overall Study|Withdrawal by Subject|4|||
126421797|NCT01467505|454840568|FG001|Overall Study|Withdrawal by Subject|0|||
126421798|NCT01467505|454840567|FG000|Overall Study|Study Terminated by Sponsor|28|||
126421799|NCT01467505|454840568|FG001|Overall Study|Study Terminated by Sponsor|3|||
126722007|NCT00683475|455933225|FG000|Overall Study|Withdrawal by Subject|1|||
126722008|NCT00683475|455933226|FG001|Overall Study|Withdrawal by Subject|0|||
126722009|NCT00683475|455933225|FG000|Overall Study|Never Treated: Adverse Event|2|||
126421800|NCT02807623|454840569|FG000|Overall Study|Lost to Follow-up|23|||
126421801|NCT02807623|454840570|FG001|Overall Study|Lost to Follow-up|18|||
126421802|NCT02807623|454840571|FG002|Overall Study|Lost to Follow-up|22|||
126421803|NCT02807623|454840569|FG000|Overall Study|Drug intolerance|0|||
126421804|NCT02807623|454840570|FG001|Overall Study|Drug intolerance|1|||
126421805|NCT02807623|454840571|FG002|Overall Study|Drug intolerance|0|||
126421806|NCT02807623|454840569|FG000|Overall Study|incomplete blood draw|0|||
126421807|NCT02807623|454840570|FG001|Overall Study|incomplete blood draw|2|||
126421808|NCT02807623|454840571|FG002|Overall Study|incomplete blood draw|1|||
126421809|NCT03449758|454840572|FG000|Overall Study|Major protocol deviation|1|||
126421810|NCT03449758|454840572|FG000|Overall Study|Treatment inefficacy|5|||
126421811|NCT03449758|454840572|FG000|Overall Study|Adverse Event|9|||
126421812|NCT03449758|454840572|FG000|Overall Study|Consent withdrawal|1|||
126421813|NCT03449758|454840572|FG000|Overall Study|Other unspecified reason|3|||
126421814|NCT00922623|454840576|FG000|Overall Study|Other|4|||
126421815|NCT00922623|454840576|FG000|Overall Study|Lost to Follow-up|1|||
126421816|NCT01402817|454840577|FG000|Overall Study|Withdrawal by Subject|3|||
126421817|NCT01402817|454840577|FG000|Overall Study|Study Suspended by FDA|8|||
126421818|NCT00086047|454840578|FG000|Overall Study|Lost to Follow-up|7|||
126421819|NCT00086047|454840579|FG001|Overall Study|Lost to Follow-up|6|||
126421820|NCT00086047|454840578|FG000|Overall Study|Physician Decision|0|||
126421821|NCT00086047|454840579|FG001|Overall Study|Physician Decision|1|||
126421822|NCT02471014|454840580|FG000|Overall Study|Lost to Follow-up|2|||
126421823|NCT02471014|454840581|FG001|Overall Study|Lost to Follow-up|2|||
126421824|NCT01172535|454840582|FG000|Overall Study|Death|3|||
126421825|NCT01172535|454840582|FG000|Overall Study|Withdrawal by Subject|2|||
126421826|NCT01172535|454840582|FG000|Overall Study|Lost to Follow-up|1|||
126421827|NCT01172535|454840582|FG000|Overall Study|Ineligible at study entry|1|||
126421828|NCT01172535|454840582|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
126421829|NCT00988598|454840583|FG000|Overall Study|Withdrawal by Subject|2|||
126421830|NCT00988598|454840584|FG001|Overall Study|Withdrawal by Subject|0|||
126421831|NCT01618669|454840585|FG000|Overall Study|Lost to Follow-up|1|||
126421832|NCT01618669|454840586|FG001|Overall Study|Lost to Follow-up|1|||
126421833|NCT01618669|454840585|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
126421834|NCT01618669|454840586|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
126421835|NCT01618669|454840585|FG000|Overall Study|Adverse Event|16|||
126421836|NCT01618669|454840586|FG001|Overall Study|Adverse Event|7|||
126421837|NCT01618669|454840585|FG000|Overall Study|Protocol Violation|5|||
126421838|NCT01618669|454840586|FG001|Overall Study|Protocol Violation|3|||
126421839|NCT01618669|454840585|FG000|Overall Study|Withdrawal by Subject|9|||
126421840|NCT01618669|454840586|FG001|Overall Study|Withdrawal by Subject|9|||
126421841|NCT01618669|454840585|FG000|Overall Study|Miscellaneous Reason|0|||
126421842|NCT01618669|454840586|FG001|Overall Study|Miscellaneous Reason|1|||
126421843|NCT01177007|454840591|FG000|Overall Study|Lost to Follow-up|2|||
126421844|NCT01177007|454840591|FG000|Overall Study|Death|4|||
126421845|NCT01177007|454840591|FG000|Overall Study|Entered hospice care|5|||
126421846|NCT01177007|454840591|FG000|Overall Study|Required additional Y90 treatment|6|||
126421847|NCT01177007|454840591|FG000|Overall Study|Change in treatment modality|21|||
126421848|NCT01702558|454840593|FG000|Overall Study|Withdrawal by Subject|0|||
126421849|NCT01702558|454840594|FG001|Overall Study|Withdrawal by Subject|0|||
126421850|NCT01702558|454840595|FG002|Overall Study|Withdrawal by Subject|0|||
126421851|NCT01702558|454840596|FG003|Overall Study|Withdrawal by Subject|12|||
126421852|NCT01702558|454840597|FG004|Overall Study|Withdrawal by Subject|4|||
126421853|NCT01702558|454840593|FG000|Overall Study|Lost to Follow-up|0|||
126421854|NCT01702558|454840594|FG001|Overall Study|Lost to Follow-up|0|||
126421855|NCT01702558|454840595|FG002|Overall Study|Lost to Follow-up|0|||
126421856|NCT01702558|454840596|FG003|Overall Study|Lost to Follow-up|3|||
126421857|NCT01702558|454840597|FG004|Overall Study|Lost to Follow-up|0|||
126421858|NCT01702558|454840593|FG000|Overall Study|Death|4|||
126421859|NCT01702558|454840594|FG001|Overall Study|Death|3|||
126421860|NCT01702558|454840595|FG002|Overall Study|Death|3|||
126421861|NCT01702558|454840596|FG003|Overall Study|Death|16|||
126421862|NCT01702558|454840597|FG004|Overall Study|Death|20|||
126421863|NCT01702558|454840593|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
126421864|NCT01702558|454840594|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
126421865|NCT01702558|454840595|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
126421866|NCT01702558|454840596|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
126421867|NCT01702558|454840597|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
126421868|NCT01702558|454840593|FG000|Overall Study|Study Terminated by Sponsor|0|||
126421869|NCT01702558|454840594|FG001|Overall Study|Study Terminated by Sponsor|1|||
126421870|NCT01702558|454840595|FG002|Overall Study|Study Terminated by Sponsor|0|||
126421871|NCT01702558|454840596|FG003|Overall Study|Study Terminated by Sponsor|0|||
126421872|NCT01702558|454840597|FG004|Overall Study|Study Terminated by Sponsor|1|||
126421873|NCT01702558|454840593|FG000|Overall Study|Other|0|||
126421874|NCT01702558|454840594|FG001|Overall Study|Other|0|||
126421875|NCT01702558|454840595|FG002|Overall Study|Other|0|||
126421876|NCT01702558|454840596|FG003|Overall Study|Other|16|||
126421877|NCT01702558|454840597|FG004|Overall Study|Other|17|||
126421878|NCT03259087|454840602|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
126421879|NCT03259087|454840603|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
126421880|NCT03259087|454840604|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
126421881|NCT03259087|454840605|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
126421882|NCT03259087|454840606|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
126722010|NCT00683475|455933226|FG001|Overall Study|Never Treated: Adverse Event|3|||
126722011|NCT00683475|455933225|FG000|Overall Study|Never Treated: Progressive Disease|1|||
126722012|NCT00683475|455933226|FG001|Overall Study|Never Treated: Progressive Disease|0|||
126722013|NCT02922634|455933227|FG000|Overall Study|Withdrawal by Subject|5|||
126722014|NCT02922634|455933227|FG000|Overall Study|Did not have their surgery|5|||
126722015|NCT02723604|455933228|FG000|Overall Study|ineligible|1|||
126722016|NCT02723604|455933228|FG000|Overall Study|never received treatment|1|||
126722017|NCT00352755|455933229|FG000|Overall Study|Physician Decision|1|||
126421883|NCT03259087|454840602|FG000|Period 2 of Part 2|Adverse Event|0|||
126421884|NCT03259087|454840603|FG001|Period 2 of Part 2|Adverse Event|0|||
126421885|NCT03259087|454840604|FG002|Period 2 of Part 2|Adverse Event|0|||
126421886|NCT03259087|454840605|FG003|Period 2 of Part 2|Adverse Event|0|||
126421887|NCT03259087|454840606|FG004|Period 2 of Part 2|Adverse Event|1|||
126421888|NCT04950465|454840607|FG000|Overall Study|Lost to Follow-up|1|||
126421889|NCT04950465|454840608|FG001|Overall Study|Lost to Follow-up|0|||
126421890|NCT04950465|454840609|FG002|Overall Study|Lost to Follow-up|0|||
126421891|NCT01788566|454840610|FG000|Overall Study|Death|4|||
126421892|NCT01788566|454840610|FG000|Overall Study|Adverse Event|1|||
126421893|NCT01788566|454840610|FG000|Overall Study|Clinical Progressive Disease|3|||
126421894|NCT01620086|454840613|FG000|Overall Study|Withdrawal by Subject|3|||
126421895|NCT01620086|454840614|FG001|Overall Study|Withdrawal by Subject|3|||
126421896|NCT01620086|454840615|FG002|Overall Study|Withdrawal by Subject|0|||
126421897|NCT01620086|454840613|FG000|Overall Study|failed study criteria|1|||
126421898|NCT01620086|454840614|FG001|Overall Study|failed study criteria|4|||
126421899|NCT01620086|454840615|FG002|Overall Study|failed study criteria|0|||
126421900|NCT01620086|454840613|FG000|Overall Study|Physician Decision|1|||
126421901|NCT01620086|454840614|FG001|Overall Study|Physician Decision|0|||
126421902|NCT01620086|454840615|FG002|Overall Study|Physician Decision|0|||
126421903|NCT02562716|454840616|FG000|Overall Study|Adverse Event|7|||
126421904|NCT02562716|454840617|FG001|Overall Study|Adverse Event|14|||
126421905|NCT02562716|454840616|FG000|Overall Study|Withdrawal unrelated to AE|7|||
126421906|NCT02562716|454840617|FG001|Overall Study|Withdrawal unrelated to AE|1|||
126421907|NCT02562716|454840616|FG000|Overall Study|Progression|8|||
126421908|NCT02562716|454840617|FG001|Overall Study|Progression|10|||
126421909|NCT02562716|454840616|FG000|Overall Study|Death|2|||
126421910|NCT02562716|454840617|FG001|Overall Study|Death|1|||
126421911|NCT02562716|454840616|FG000|Overall Study|Not protocol specified|4|||
126421912|NCT02562716|454840617|FG001|Overall Study|Not protocol specified|2|||
126421913|NCT03030417|454840620|FG000|Dose Expansion|Disease progression before treatment|0|||
126421914|NCT03030417|454840621|FG001|Dose Expansion|Disease progression before treatment|0|||
126421915|NCT03030417|454840622|FG002|Dose Expansion|Disease progression before treatment|0|||
126421916|NCT03030417|454840623|FG003|Dose Expansion|Disease progression before treatment|0|||
126421917|NCT03030417|454840624|FG004|Dose Expansion|Disease progression before treatment|0|||
126421918|NCT03030417|454840625|FG005|Dose Expansion|Disease progression before treatment|0|||
126421919|NCT03030417|454840626|FG006|Dose Expansion|Disease progression before treatment|0|||
126421920|NCT03030417|454840627|FG007|Dose Expansion|Disease progression before treatment|0|||
126421921|NCT03030417|454840628|FG008|Dose Expansion|Disease progression before treatment|0|||
126421922|NCT03030417|454840629|FG009|Dose Expansion|Disease progression before treatment|0|||
126421923|NCT03030417|454840630|FG010|Dose Expansion|Disease progression before treatment|0|||
126421924|NCT03030417|454840631|FG011|Dose Expansion|Disease progression before treatment|0|||
126421925|NCT03030417|454840632|FG012|Dose Expansion|Disease progression before treatment|1|||
126421926|NCT01076959|454840633|FG000|Overall Study|Adverse Event|767|||
126421927|NCT01076959|454840633|FG000|Overall Study|Lack of Efficacy|849|||
126421928|NCT01076959|454840633|FG000|Overall Study|Non-compliance|274|||
126421929|NCT01076959|454840633|FG000|Overall Study|Lost to Follow-up|241|||
126421930|NCT01076959|454840633|FG000|Overall Study|Other|119|||
126421931|NCT01078441|454840634|FG000|Overall Study|Withdrawal by Subject|1|||
126421932|NCT01425801|454840635|FG000|Period 1|Withdrawal by Subject|0|||
126421933|NCT01425801|454840636|FG001|Period 1|Withdrawal by Subject|0|||
126421934|NCT01425801|454840637|FG002|Period 1|Withdrawal by Subject|0|||
126421935|NCT01425801|454840638|FG003|Period 1|Withdrawal by Subject|0|||
126722018|NCT00352755|455933229|FG000|Overall Study|Adverse Event|1|||
126722019|NCT01694420|455933231|FG000|Overall Study|Lost to Follow-up|3|||
126722020|NCT03987919|455933232|FG000|Overall Study|Adverse Event|1|||
126421936|NCT01425801|454840639|FG004|Period 1|Withdrawal by Subject|1|||
126421937|NCT01425801|454840640|FG005|Period 1|Withdrawal by Subject|0|||
126421938|NCT01425801|454840635|FG000|Period 2|Withdrawal by Subject|0|||
126421939|NCT01425801|454840636|FG001|Period 2|Withdrawal by Subject|0|||
126421940|NCT01425801|454840637|FG002|Period 2|Withdrawal by Subject|0|||
126421941|NCT01425801|454840638|FG003|Period 2|Withdrawal by Subject|0|||
126421942|NCT01425801|454840639|FG004|Period 2|Withdrawal by Subject|1|||
126421943|NCT01425801|454840640|FG005|Period 2|Withdrawal by Subject|0|||
126421944|NCT01425801|454840635|FG000|Period 3|Stability criteria not fullfilled|0|||
126421945|NCT01425801|454840636|FG001|Period 3|Stability criteria not fullfilled|0|||
126722021|NCT03987919|455933233|FG001|Overall Study|Adverse Event|4|||
126722022|NCT03987919|455933234|FG002|Overall Study|Adverse Event|1|||
126722023|NCT03987919|455933235|FG003|Overall Study|Adverse Event|3|||
126477487|NCT01817530|455048288|FG000|Overall Study|Adverse Event|6|||
126477488|NCT01817530|455048289|FG001|Overall Study|Adverse Event|3|||
126477489|NCT01817530|455048290|FG002|Overall Study|Adverse Event|2|||
126477490|NCT01817530|455048291|FG003|Overall Study|Adverse Event|5|||
126477491|NCT01817530|455048292|FG004|Overall Study|Adverse Event|0|||
126477492|NCT01817530|455048293|FG005|Overall Study|Adverse Event|10|||
126477493|NCT01817530|455048294|FG006|Overall Study|Adverse Event|5|||
126477494|NCT01817530|455048295|FG007|Overall Study|Adverse Event|8|||
126477495|NCT01817530|455048288|FG000|Overall Study|Subject Noncompliant|3|||
126722024|NCT03987919|455933232|FG000|Overall Study|Death|4|||
126421946|NCT01425801|454840637|FG002|Period 3|Stability criteria not fullfilled|1|||
126421947|NCT01425801|454840638|FG003|Period 3|Stability criteria not fullfilled|0|||
126421948|NCT01425801|454840639|FG004|Period 3|Stability criteria not fullfilled|0|||
126421949|NCT01425801|454840640|FG005|Period 3|Stability criteria not fullfilled|0|||
126421950|NCT01425801|454840635|FG000|Period 4|Not able to maintain visit schedule|0|||
126421951|NCT01425801|454840636|FG001|Period 4|Not able to maintain visit schedule|0|||
126421952|NCT01425801|454840637|FG002|Period 4|Not able to maintain visit schedule|1|||
126421953|NCT01425801|454840638|FG003|Period 4|Not able to maintain visit schedule|0|||
126421954|NCT01425801|454840639|FG004|Period 4|Not able to maintain visit schedule|0|||
126421955|NCT01425801|454840640|FG005|Period 4|Not able to maintain visit schedule|0|||
126421956|NCT02868554|454840641|FG000|Overall Study|Lost to Follow-up|3|||
126421957|NCT02868554|454840642|FG001|Overall Study|Lost to Follow-up|0|||
126421958|NCT02868554|454840643|FG002|Overall Study|Lost to Follow-up|1|||
126421959|NCT02175017|454840644|FG000|Overall Study|Did not receive the investigational product|1|||
126421960|NCT02175017|454840645|FG001|Overall Study|Did not receive the investigational product|2|||
126421961|NCT02175017|454840644|FG000|Overall Study|Withdrawal by Subject|6|||
126421962|NCT02175017|454840645|FG001|Overall Study|Withdrawal by Subject|3|||
126421963|NCT02175017|454840644|FG000|Overall Study|Met an exclusion criteria|0|||
126421964|NCT02175017|454840645|FG001|Overall Study|Met an exclusion criteria|1|||
126421965|NCT02175017|454840644|FG000|Overall Study|Adverse Event|3|||
126421966|NCT02175017|454840645|FG001|Overall Study|Adverse Event|10|||
126421967|NCT02175017|454840644|FG000|Overall Study|Disease progression|20|||
126421968|NCT02175017|454840645|FG001|Overall Study|Disease progression|27|||
126421969|NCT02175017|454840644|FG000|Overall Study|Other than above reasons|3|||
126421970|NCT02175017|454840645|FG001|Overall Study|Other than above reasons|0|||
126421971|NCT01684202|454840646|FG000|Dose-escalation Period|Adverse Event|0|||
126421972|NCT01684202|454840647|FG001|Dose-escalation Period|Adverse Event|1|||
126421973|NCT01684202|454840648|FG002|Dose-escalation Period|Adverse Event|0|||
126421974|NCT01684202|454840649|FG003|Dose-escalation Period|Adverse Event|0|||
126421975|NCT01684202|454840646|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
126421976|NCT01684202|454840647|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
126421977|NCT01684202|454840648|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
126421978|NCT01684202|454840649|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
126421979|NCT01684202|454840646|FG000|Maintenance Period|Adverse Event|1|||
126421980|NCT01684202|454840647|FG001|Maintenance Period|Adverse Event|1|||
126421981|NCT01684202|454840648|FG002|Maintenance Period|Adverse Event|1|||
126421982|NCT01684202|454840649|FG003|Maintenance Period|Adverse Event|1|||
126421983|NCT01684202|454840646|FG000|Maintenance Period|Physician Decision|0|||
126421984|NCT01684202|454840647|FG001|Maintenance Period|Physician Decision|1|||
126421985|NCT01684202|454840648|FG002|Maintenance Period|Physician Decision|0|||
126421986|NCT01684202|454840649|FG003|Maintenance Period|Physician Decision|0|||
126421987|NCT01684202|454840646|FG000|Maintenance Period|Withdrawal by Subject|0|||
126421988|NCT01684202|454840647|FG001|Maintenance Period|Withdrawal by Subject|1|||
126421989|NCT01684202|454840648|FG002|Maintenance Period|Withdrawal by Subject|0|||
126421990|NCT01684202|454840649|FG003|Maintenance Period|Withdrawal by Subject|0|||
126421991|NCT00191308|454840650|FG000|Overall Study|Adverse Event|1|||
126421992|NCT00779025|454840651|FG000|Overall Study|Withdrawal by Subject|1|||
126421993|NCT03710642|454840652|FG000|Overall Study|Adverse Event|5|||
126421994|NCT03710642|454840653|FG001|Overall Study|Adverse Event|1|||
126421995|NCT03710642|454840652|FG000|Overall Study|non-site physician recommendation|1|||
126421996|NCT03710642|454840653|FG001|Overall Study|non-site physician recommendation|0|||
126421997|NCT03710642|454840652|FG000|Overall Study|Participant unwilling or unable to participate|1|||
126421998|NCT03710642|454840653|FG001|Overall Study|Participant unwilling or unable to participate|1|||
126421999|NCT03710642|454840652|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
126422000|NCT03710642|454840653|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
126422001|NCT03710642|454840652|FG000|Overall Study|NA-no code provided|1|||
126422002|NCT03710642|454840653|FG001|Overall Study|NA-no code provided|0|||
126422003|NCT03710642|454840652|FG000|Overall Study|Withdrawal by Subject|1|||
126722025|NCT03987919|455933233|FG001|Overall Study|Death|4|||
126422004|NCT03710642|454840653|FG001|Overall Study|Withdrawal by Subject|0|||
126422005|NCT00782717|454840654|FG000|Overall Study|Adverse Event|2|||
126422006|NCT00782717|454840655|FG001|Overall Study|Adverse Event|5|||
126477496|NCT01817530|455048289|FG001|Overall Study|Subject Noncompliant|1|||
126477497|NCT01817530|455048290|FG002|Overall Study|Subject Noncompliant|0|||
126477498|NCT01817530|455048291|FG003|Overall Study|Subject Noncompliant|4|||
126422007|NCT00782717|454840654|FG000|Overall Study|Patient decision unrelated to AE|6|||
126422008|NCT00782717|454840655|FG001|Overall Study|Patient decision unrelated to AE|3|||
126422009|NCT00782717|454840654|FG000|Overall Study|Noncompliance|2|||
126422010|NCT00782717|454840655|FG001|Overall Study|Noncompliance|1|||
126422011|NCT00782717|454840654|FG000|Overall Study|Treatment failure|3|||
126422012|NCT00782717|454840655|FG001|Overall Study|Treatment failure|14|||
126422013|NCT00782717|454840654|FG000|Overall Study|Enrollment close prior to surgery|1|||
126422014|NCT00782717|454840655|FG001|Overall Study|Enrollment close prior to surgery|0|||
126422015|NCT00782717|454840654|FG000|Overall Study|Did not meet entrance criteria|1|||
126422016|NCT00782717|454840655|FG001|Overall Study|Did not meet entrance criteria|3|||
126422017|NCT00782717|454840654|FG000|Overall Study|Exited in error|0|||
126422018|NCT00782717|454840655|FG001|Overall Study|Exited in error|2|||
126422019|NCT02292719|454840656|FG000|Overall Study|Withdrawal by Subject|0|||
126422020|NCT02292719|454840657|FG001|Overall Study|Withdrawal by Subject|0|||
126422021|NCT02292719|454840658|FG002|Overall Study|Withdrawal by Subject|0|||
126422022|NCT02292719|454840659|FG003|Overall Study|Withdrawal by Subject|1|||
126422023|NCT02292719|454840660|FG004|Overall Study|Withdrawal by Subject|1|||
126422024|NCT02292719|454840661|FG005|Overall Study|Withdrawal by Subject|0|||
126422025|NCT02292719|454840656|FG000|Overall Study|Subject enrolled in new study.|0|||
126422026|NCT02292719|454840657|FG001|Overall Study|Subject enrolled in new study.|0|||
126422027|NCT02292719|454840658|FG002|Overall Study|Subject enrolled in new study.|1|||
126422028|NCT02292719|454840659|FG003|Overall Study|Subject enrolled in new study.|0|||
126422029|NCT02292719|454840660|FG004|Overall Study|Subject enrolled in new study.|0|||
126422030|NCT02292719|454840661|FG005|Overall Study|Subject enrolled in new study.|0|||
126422031|NCT02586727|454840667|FG000|Overall Study|Lost to Follow-up|1|||
126422032|NCT02586727|454840668|FG001|Overall Study|Lost to Follow-up|0|||
126422033|NCT04628780|454840673|FG000|Overall Study|Death|0|||
126422034|NCT04628780|454840674|FG001|Overall Study|Death|1|||
126422035|NCT04628780|454840675|FG002|Overall Study|Death|0|||
126422036|NCT04628780|454840676|FG003|Overall Study|Death|0|||
126422037|NCT04628780|454840677|FG004|Overall Study|Death|1|||
126422038|NCT04628780|454840678|FG005|Overall Study|Death|0|||
126422039|NCT04628780|454840673|FG000|Overall Study|Physician Decision|2|||
126422040|NCT04628780|454840674|FG001|Overall Study|Physician Decision|0|||
126422041|NCT04628780|454840675|FG002|Overall Study|Physician Decision|0|||
126422042|NCT04628780|454840676|FG003|Overall Study|Physician Decision|0|||
126422043|NCT04628780|454840677|FG004|Overall Study|Physician Decision|2|||
126422044|NCT04628780|454840678|FG005|Overall Study|Physician Decision|0|||
126422045|NCT04628780|454840673|FG000|Overall Study|Progressive disease|2|||
126422046|NCT04628780|454840674|FG001|Overall Study|Progressive disease|2|||
126422047|NCT04628780|454840675|FG002|Overall Study|Progressive disease|2|||
126422048|NCT04628780|454840676|FG003|Overall Study|Progressive disease|3|||
126422049|NCT04628780|454840677|FG004|Overall Study|Progressive disease|9|||
126422050|NCT04628780|454840678|FG005|Overall Study|Progressive disease|4|||
126422051|NCT04628780|454840673|FG000|Overall Study|Withdrawal by Subject|0|||
126422052|NCT04628780|454840674|FG001|Overall Study|Withdrawal by Subject|1|||
126422053|NCT04628780|454840675|FG002|Overall Study|Withdrawal by Subject|2|||
126422054|NCT04628780|454840676|FG003|Overall Study|Withdrawal by Subject|0|||
126422055|NCT04628780|454840677|FG004|Overall Study|Withdrawal by Subject|3|||
126422056|NCT04628780|454840678|FG005|Overall Study|Withdrawal by Subject|1|||
126422057|NCT04628780|454840673|FG000|Overall Study|Global deterioration of health status|0|||
126722026|NCT03987919|455933234|FG002|Overall Study|Death|4|||
126722027|NCT03987919|455933235|FG003|Overall Study|Death|1|||
126722028|NCT03987919|455933232|FG000|Overall Study|Lost to Follow-up|5|||
126722029|NCT03987919|455933233|FG001|Overall Study|Lost to Follow-up|6|||
126722030|NCT03987919|455933234|FG002|Overall Study|Lost to Follow-up|8|||
126722031|NCT03987919|455933235|FG003|Overall Study|Lost to Follow-up|12|||
126722032|NCT03987919|455933232|FG000|Overall Study|Physician Decision|0|||
126722033|NCT03987919|455933233|FG001|Overall Study|Physician Decision|2|||
126722034|NCT03987919|455933234|FG002|Overall Study|Physician Decision|0|||
126722035|NCT03987919|455933235|FG003|Overall Study|Physician Decision|4|||
126722036|NCT03987919|455933232|FG000|Overall Study|Pregnancy|1|||
126422058|NCT04628780|454840674|FG001|Overall Study|Global deterioration of health status|0|||
126422059|NCT04628780|454840675|FG002|Overall Study|Global deterioration of health status|0|||
126422060|NCT04628780|454840676|FG003|Overall Study|Global deterioration of health status|0|||
126422061|NCT04628780|454840677|FG004|Overall Study|Global deterioration of health status|1|||
126422062|NCT04628780|454840678|FG005|Overall Study|Global deterioration of health status|1|||
126422063|NCT03622814|454840680|FG000|Overall Study|Lost to Follow-up|8|||
126722037|NCT03987919|455933233|FG001|Overall Study|Pregnancy|0|||
126422064|NCT03622814|454840681|FG001|Overall Study|Lost to Follow-up|14|||
126422065|NCT01288989|454840684|FG000|Overall Study|Death|0|||
126422066|NCT01288989|454840685|FG001|Overall Study|Death|0|||
126422067|NCT01288989|454840686|FG002|Overall Study|Death|0|||
126422068|NCT01288989|454840687|FG003|Overall Study|Death|1|||
126422069|NCT01288989|454840688|FG004|Overall Study|Death|0|||
126422070|NCT01288989|454840684|FG000|Overall Study|Dose limiting toxicity|1|||
126722038|NCT03987919|455933234|FG002|Overall Study|Pregnancy|1|||
126722039|NCT03987919|455933235|FG003|Overall Study|Pregnancy|1|||
126422071|NCT01288989|454840685|FG001|Overall Study|Dose limiting toxicity|0|||
126422072|NCT01288989|454840686|FG002|Overall Study|Dose limiting toxicity|0|||
126422073|NCT01288989|454840687|FG003|Overall Study|Dose limiting toxicity|0|||
126422074|NCT01288989|454840688|FG004|Overall Study|Dose limiting toxicity|0|||
126422075|NCT01288989|454840684|FG000|Overall Study|Adverse Event|0|||
126422076|NCT01288989|454840685|FG001|Overall Study|Adverse Event|0|||
126422077|NCT01288989|454840686|FG002|Overall Study|Adverse Event|0|||
126422078|NCT01288989|454840687|FG003|Overall Study|Adverse Event|0|||
126422079|NCT01288989|454840688|FG004|Overall Study|Adverse Event|2|||
126422080|NCT01288989|454840684|FG000|Overall Study|Physician Decision|0|||
126422081|NCT01288989|454840685|FG001|Overall Study|Physician Decision|0|||
126422082|NCT01288989|454840686|FG002|Overall Study|Physician Decision|0|||
126422083|NCT01288989|454840687|FG003|Overall Study|Physician Decision|0|||
126422084|NCT01288989|454840688|FG004|Overall Study|Physician Decision|1|||
126422085|NCT01288989|454840684|FG000|Overall Study|Withdrawal by Subject|0|||
126422086|NCT01288989|454840685|FG001|Overall Study|Withdrawal by Subject|0|||
126422087|NCT01288989|454840686|FG002|Overall Study|Withdrawal by Subject|0|||
126422088|NCT01288989|454840687|FG003|Overall Study|Withdrawal by Subject|0|||
126422089|NCT01288989|454840688|FG004|Overall Study|Withdrawal by Subject|3|||
126422090|NCT01156714|454840689|FG000|Overall Study|Withdrawal by Subject|9|||
126422091|NCT01156714|454840690|FG001|Overall Study|Withdrawal by Subject|4|||
126422092|NCT01156714|454840691|FG002|Overall Study|Withdrawal by Subject|3|||
126422093|NCT00165672|454840692|FG000|Overall Study|Adverse Event|0|||
126422094|NCT00165672|454840693|FG001|Overall Study|Adverse Event|1|||
126422095|NCT02360228|454840705|FG000|Overall Study|Withdrawal by Subject|1|||
126422096|NCT02360228|454840706|FG001|Overall Study|Withdrawal by Subject|0|||
126422097|NCT02360228|454840707|FG002|Overall Study|Withdrawal by Subject|0|||
126422098|NCT02360228|454840705|FG000|Overall Study|Self-discontinued medication|0|||
126422099|NCT02360228|454840706|FG001|Overall Study|Self-discontinued medication|1|||
126422100|NCT02360228|454840707|FG002|Overall Study|Self-discontinued medication|0|||
126422101|NCT02360228|454840705|FG000|Overall Study|Unstable symptoms during screening|0|||
126422102|NCT02360228|454840706|FG001|Overall Study|Unstable symptoms during screening|0|||
126422103|NCT02360228|454840707|FG002|Overall Study|Unstable symptoms during screening|1|||
126422104|NCT01059318|454840708|FG000|Core Study (26 Week)|Adverse Event|3|||
126422105|NCT01059318|454840708|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
126422106|NCT01059318|454840708|FG000|Extension (36 Week)|Adverse Event|3|||
126422107|NCT04186871|454840711|FG000|Overall Study|Lack of Efficacy|0|||
126422108|NCT04186871|454840712|FG001|Overall Study|Lack of Efficacy|1|||
126422109|NCT04186871|454840713|FG002|Overall Study|Lack of Efficacy|0|||
126422110|NCT04186871|454840714|FG003|Overall Study|Lack of Efficacy|0|||
126422111|NCT04186871|454840715|FG004|Overall Study|Lack of Efficacy|1|||
126422112|NCT04186871|454840716|FG005|Overall Study|Lack of Efficacy|1|||
126422113|NCT04186871|454840711|FG000|Overall Study|Adverse Event|1|||
126422114|NCT04186871|454840712|FG001|Overall Study|Adverse Event|1|||
126422115|NCT04186871|454840713|FG002|Overall Study|Adverse Event|0|||
126422116|NCT04186871|454840714|FG003|Overall Study|Adverse Event|0|||
126422117|NCT04186871|454840715|FG004|Overall Study|Adverse Event|0|||
126422118|NCT04186871|454840716|FG005|Overall Study|Adverse Event|2|||
126422119|NCT04186871|454840711|FG000|Overall Study|Study terminated by sponsor|1|||
126422120|NCT04186871|454840712|FG001|Overall Study|Study terminated by sponsor|2|||
126422121|NCT04186871|454840713|FG002|Overall Study|Study terminated by sponsor|0|||
126422122|NCT04186871|454840714|FG003|Overall Study|Study terminated by sponsor|1|||
126422123|NCT04186871|454840715|FG004|Overall Study|Study terminated by sponsor|0|||
126422124|NCT04186871|454840716|FG005|Overall Study|Study terminated by sponsor|0|||
126422125|NCT04186871|454840711|FG000|Overall Study|Other reasons|0|||
126422126|NCT04186871|454840712|FG001|Overall Study|Other reasons|0|||
126422127|NCT04186871|454840713|FG002|Overall Study|Other reasons|0|||
126422128|NCT04186871|454840714|FG003|Overall Study|Other reasons|0|||
126422129|NCT04186871|454840715|FG004|Overall Study|Other reasons|0|||
126422130|NCT04186871|454840716|FG005|Overall Study|Other reasons|1|||
126422131|NCT04186871|454840711|FG000|Overall Study|Withdrawal by Subject|0|||
126422132|NCT04186871|454840712|FG001|Overall Study|Withdrawal by Subject|0|||
126422133|NCT04186871|454840713|FG002|Overall Study|Withdrawal by Subject|0|||
126422134|NCT04186871|454840714|FG003|Overall Study|Withdrawal by Subject|0|||
126422135|NCT04186871|454840715|FG004|Overall Study|Withdrawal by Subject|0|||
126422136|NCT04186871|454840716|FG005|Overall Study|Withdrawal by Subject|1|||
126422137|NCT04186871|454840711|FG000|Overall Study|Lost to Follow-up|0|||
126422138|NCT04186871|454840712|FG001|Overall Study|Lost to Follow-up|0|||
126422139|NCT04186871|454840713|FG002|Overall Study|Lost to Follow-up|0|||
126422140|NCT04186871|454840714|FG003|Overall Study|Lost to Follow-up|0|||
126422141|NCT04186871|454840715|FG004|Overall Study|Lost to Follow-up|0|||
126422142|NCT04186871|454840716|FG005|Overall Study|Lost to Follow-up|1|||
126422143|NCT03790917|454840717|FG000|Overall Study|Death|1|||
126422144|NCT02464410|454840718|FG000|Overall Study|Death|3|||
126422145|NCT02464410|454840719|FG001|Overall Study|Death|4|||
126422146|NCT02464410|454840718|FG000|Overall Study|Lost to Follow-up|7|||
126422147|NCT02464410|454840719|FG001|Overall Study|Lost to Follow-up|9|||
126422148|NCT02464410|454840718|FG000|Overall Study|Withdrawal by Subject|12|||
126422149|NCT02464410|454840719|FG001|Overall Study|Withdrawal by Subject|3|||
126422150|NCT00176462|454840723|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
126422151|NCT00176462|454840724|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
126422152|NCT00176462|454840723|FG000|Induction (4 Weeks)|Death|1|||
126422153|NCT00176462|454840724|FG001|Induction (4 Weeks)|Death|2|||
126422154|NCT00176462|454840723|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
126422155|NCT00176462|454840724|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
126422156|NCT00176462|454840723|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
126422157|NCT00176462|454840724|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
126422158|NCT00176462|454840723|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
126422159|NCT00176462|454840724|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
126422160|NCT00176462|454840723|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
126422161|NCT00176462|454840724|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
126422162|NCT00176462|454840723|FG000|Consolidation (12 Weeks)|Not documented|0|||
126422163|NCT00176462|454840724|FG001|Consolidation (12 Weeks)|Not documented|1|||
126422164|NCT00176462|454840723|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
126422165|NCT00176462|454840724|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
126477499|NCT01817530|455048292|FG004|Overall Study|Subject Noncompliant|0|||
126477500|NCT01817530|455048293|FG005|Overall Study|Subject Noncompliant|1|||
126559130|NCT03704298|455340660|FG001|Overall Study|Withdrawal by Subject|0|||
126559131|NCT03704298|455340661|FG002|Overall Study|Withdrawal by Subject|0|||
126559132|NCT03704298|455340662|FG003|Overall Study|Withdrawal by Subject|0|||
126559133|NCT03704298|455340659|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
126559134|NCT03704298|455340660|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
126559135|NCT03704298|455340661|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
126559136|NCT03704298|455340662|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
126559137|NCT01027871|455340663|FG000|Overall Study|Physician Decision|1|||
126559138|NCT01027871|455340664|FG001|Overall Study|Physician Decision|5|||
126559139|NCT01027871|455340665|FG002|Overall Study|Physician Decision|0|||
126559140|NCT01027871|455340663|FG000|Overall Study|Protocol Violation|0|||
126559141|NCT01027871|455340664|FG001|Overall Study|Protocol Violation|2|||
126559142|NCT01027871|455340665|FG002|Overall Study|Protocol Violation|2|||
126559143|NCT01027871|455340663|FG000|Overall Study|Withdrawal by Subject|1|||
126559144|NCT01027871|455340664|FG001|Overall Study|Withdrawal by Subject|2|||
126559145|NCT01027871|455340665|FG002|Overall Study|Withdrawal by Subject|2|||
126559146|NCT01027871|455340663|FG000|Overall Study|Adverse Event|0|||
126559147|NCT01027871|455340664|FG001|Overall Study|Adverse Event|2|||
126559148|NCT01027871|455340665|FG002|Overall Study|Adverse Event|2|||
126559149|NCT01027871|455340663|FG000|Overall Study|Sponsor Decision|0|||
126559150|NCT01027871|455340664|FG001|Overall Study|Sponsor Decision|2|||
126559151|NCT01027871|455340665|FG002|Overall Study|Sponsor Decision|0|||
126559152|NCT01027871|455340663|FG000|Overall Study|Discontinued Prior to Treatment|0|||
126559153|NCT01027871|455340664|FG001|Overall Study|Discontinued Prior to Treatment|0|||
126559154|NCT01027871|455340665|FG002|Overall Study|Discontinued Prior to Treatment|1|||
126559155|NCT01414166|455340666|FG000|Overall Study|Adverse Event|10|||
126559156|NCT01414166|455340667|FG001|Overall Study|Adverse Event|2|||
126559157|NCT01414166|455340666|FG000|Overall Study|Lost to Follow-up|4|||
126559158|NCT01414166|455340667|FG001|Overall Study|Lost to Follow-up|1|||
126559159|NCT01414166|455340666|FG000|Overall Study|Non-compliance with study drug|2|||
126559160|NCT01414166|455340667|FG001|Overall Study|Non-compliance with study drug|0|||
126559161|NCT01414166|455340666|FG000|Overall Study|Physician Decision|2|||
126559162|NCT01414166|455340667|FG001|Overall Study|Physician Decision|0|||
126559163|NCT01414166|455340666|FG000|Overall Study|Protocol Violation|2|||
126559164|NCT01414166|455340667|FG001|Overall Study|Protocol Violation|0|||
126559165|NCT01414166|455340666|FG000|Overall Study|Study terminated by Sponsor|68|||
126559166|NCT01414166|455340667|FG001|Overall Study|Study terminated by Sponsor|75|||
126559167|NCT01414166|455340666|FG000|Overall Study|Withdrawal by Subject|3|||
126559168|NCT01414166|455340667|FG001|Overall Study|Withdrawal by Subject|5|||
126559169|NCT03782727|455340668|FG000|Overall Study|Lost to Follow-up|32|||
126559170|NCT04159896|455340674|FG000|Overall Study|Lack of Efficacy|7|||
126422166|NCT00176462|454840723|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
126422167|NCT00176462|454840724|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
126477501|NCT01817530|455048294|FG006|Overall Study|Subject Noncompliant|1|||
126477502|NCT01817530|455048295|FG007|Overall Study|Subject Noncompliant|1|||
126477503|NCT01817530|455048288|FG000|Overall Study|Lack of Efficacy|1|||
126477504|NCT01817530|455048289|FG001|Overall Study|Lack of Efficacy|0|||
126477505|NCT01817530|455048290|FG002|Overall Study|Lack of Efficacy|0|||
126477506|NCT01817530|455048291|FG003|Overall Study|Lack of Efficacy|0|||
126477507|NCT01817530|455048292|FG004|Overall Study|Lack of Efficacy|0|||
126477508|NCT01817530|455048293|FG005|Overall Study|Lack of Efficacy|1|||
126477509|NCT01817530|455048294|FG006|Overall Study|Lack of Efficacy|0|||
126477510|NCT01817530|455048295|FG007|Overall Study|Lack of Efficacy|1|||
126477511|NCT01817530|455048288|FG000|Overall Study|Pregnancy|0|||
126477512|NCT01817530|455048289|FG001|Overall Study|Pregnancy|0|||
126477513|NCT01817530|455048290|FG002|Overall Study|Pregnancy|0|||
126422168|NCT01408459|454840725|FG000|Overall Study|Withdrawal by Subject|1|||
126422169|NCT01408459|454840726|FG001|Overall Study|Withdrawal by Subject|1|||
126422170|NCT01657292|454840731|FG000|Overall Study|Adverse Event|6|||
126422171|NCT01657292|454840731|FG000|Overall Study|Withdrawal by Subject|2|||
126422172|NCT01657292|454840731|FG000|Overall Study|Violation of eligibility criteria|1|||
126422173|NCT01657292|454840731|FG000|Overall Study|Change of therapy|1|||
126422174|NCT00650845|454840732|FG000|Overall Study|Withdrawal by Subject|5|||
126422175|NCT00650845|454840733|FG001|Overall Study|Withdrawal by Subject|0|||
126422176|NCT00650845|454840732|FG000|Overall Study|Protocol Violation|0|||
126422177|NCT00650845|454840733|FG001|Overall Study|Protocol Violation|13|||
126422178|NCT03932760|454840734|FG000|Overall Study|Became Ineligible|2|||
126422179|NCT03932760|454840735|FG001|Overall Study|Became Ineligible|5|||
126422180|NCT03932760|454840734|FG000|Overall Study|Withdrawal by Subject|6|||
126422181|NCT03932760|454840735|FG001|Overall Study|Withdrawal by Subject|6|||
126422182|NCT01301833|454840736|FG000|Overall Study|Adverse Event|7|||
126422183|NCT01301833|454840737|FG001|Overall Study|Adverse Event|5|||
126422184|NCT01301833|454840738|FG002|Overall Study|Adverse Event|5|||
126422185|NCT01301833|454840739|FG003|Overall Study|Adverse Event|5|||
126422186|NCT01301833|454840736|FG000|Overall Study|Lack of Efficacy|1|||
126422187|NCT01301833|454840737|FG001|Overall Study|Lack of Efficacy|1|||
126422188|NCT01301833|454840738|FG002|Overall Study|Lack of Efficacy|0|||
126422189|NCT01301833|454840739|FG003|Overall Study|Lack of Efficacy|0|||
126422190|NCT01301833|454840736|FG000|Overall Study|Physician Decision|3|||
126422191|NCT01301833|454840737|FG001|Overall Study|Physician Decision|1|||
126422192|NCT01301833|454840738|FG002|Overall Study|Physician Decision|1|||
126422193|NCT01301833|454840739|FG003|Overall Study|Physician Decision|0|||
126422194|NCT01301833|454840736|FG000|Overall Study|Withdrawal by Subject|3|||
126422195|NCT01301833|454840737|FG001|Overall Study|Withdrawal by Subject|1|||
126422196|NCT01301833|454840738|FG002|Overall Study|Withdrawal by Subject|1|||
126422197|NCT01301833|454840739|FG003|Overall Study|Withdrawal by Subject|2|||
126422198|NCT01301833|454840736|FG000|Overall Study|Personal matter|1|||
126422199|NCT01301833|454840737|FG001|Overall Study|Personal matter|0|||
126422200|NCT01301833|454840738|FG002|Overall Study|Personal matter|0|||
126422201|NCT01301833|454840739|FG003|Overall Study|Personal matter|0|||
126422202|NCT03922620|454840740|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
126422203|NCT03922620|454840741|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
126422204|NCT03566082|454840742|FG000|Overall Study|Death|7|||
126422205|NCT03566082|454840742|FG000|Overall Study|Failures (revision required)|2|||
126422206|NCT03566082|454840742|FG000|Overall Study|Lost to Follow-up|8|||
126422207|NCT00983385|454840745|FG000|Observation Period|Not eligible to be dosed|20|||
126422208|NCT00983385|454840745|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
126422209|NCT01279681|454840747|FG000|Overall Study|Disease Progression|9|||
126422210|NCT01279681|454840748|FG001|Overall Study|Disease Progression|6|||
126422211|NCT01279681|454840747|FG000|Overall Study|Withdrawal by Subject|3|||
126422212|NCT01279681|454840748|FG001|Overall Study|Withdrawal by Subject|4|||
126422213|NCT01279681|454840747|FG000|Overall Study|Adverse Event|2|||
126422214|NCT01279681|454840748|FG001|Overall Study|Adverse Event|3|||
126422215|NCT01279681|454840747|FG000|Overall Study|Death|0|||
126422216|NCT01279681|454840748|FG001|Overall Study|Death|1|||
126422217|NCT01279681|454840747|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
126422218|NCT01279681|454840748|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
126422219|NCT01279681|454840747|FG000|Overall Study|Physician Decision|1|||
126422220|NCT01279681|454840748|FG001|Overall Study|Physician Decision|0|||
126422221|NCT01279681|454840747|FG000|Overall Study|Other Reason|0|||
126422222|NCT01279681|454840748|FG001|Overall Study|Other Reason|2|||
126477514|NCT01817530|455048291|FG003|Overall Study|Pregnancy|0|||
126477515|NCT01817530|455048292|FG004|Overall Study|Pregnancy|0|||
126477516|NCT01817530|455048293|FG005|Overall Study|Pregnancy|1|||
126477517|NCT01817530|455048294|FG006|Overall Study|Pregnancy|0|||
126477518|NCT01817530|455048295|FG007|Overall Study|Pregnancy|0|||
126477519|NCT01817530|455048288|FG000|Overall Study|Other|0|||
126477520|NCT01817530|455048289|FG001|Overall Study|Other|1|||
126477521|NCT01817530|455048290|FG002|Overall Study|Other|0|||
126477522|NCT01817530|455048291|FG003|Overall Study|Other|0|||
126477523|NCT01817530|455048292|FG004|Overall Study|Other|1|||
126477524|NCT01817530|455048293|FG005|Overall Study|Other|0|||
126477525|NCT01817530|455048294|FG006|Overall Study|Other|5|||
126477526|NCT01817530|455048295|FG007|Overall Study|Other|0|||
126477527|NCT01817530|455048288|FG000|Overall Study|Surgery or Invasive Intervention|1|||
126477528|NCT01817530|455048289|FG001|Overall Study|Surgery or Invasive Intervention|0|||
126477529|NCT01817530|455048290|FG002|Overall Study|Surgery or Invasive Intervention|0|||
126477530|NCT01817530|455048291|FG003|Overall Study|Surgery or Invasive Intervention|0|||
126477531|NCT01817530|455048292|FG004|Overall Study|Surgery or Invasive Intervention|1|||
126477532|NCT01817530|455048293|FG005|Overall Study|Surgery or Invasive Intervention|1|||
126477533|NCT01817530|455048294|FG006|Overall Study|Surgery or Invasive Intervention|1|||
126477534|NCT01817530|455048295|FG007|Overall Study|Surgery or Invasive Intervention|0|||
126477535|NCT01817530|455048288|FG000|Overall Study|Consent Withdrawn by Subject|3|||
126477536|NCT01817530|455048289|FG001|Overall Study|Consent Withdrawn by Subject|4|||
126477537|NCT01817530|455048290|FG002|Overall Study|Consent Withdrawn by Subject|7|||
126477538|NCT01817530|455048291|FG003|Overall Study|Consent Withdrawn by Subject|3|||
126477539|NCT01817530|455048292|FG004|Overall Study|Consent Withdrawn by Subject|5|||
126477540|NCT01817530|455048293|FG005|Overall Study|Consent Withdrawn by Subject|3|||
126477541|NCT01817530|455048294|FG006|Overall Study|Consent Withdrawn by Subject|3|||
126477542|NCT01817530|455048295|FG007|Overall Study|Consent Withdrawn by Subject|10|||
126477543|NCT01817530|455048288|FG000|Overall Study|Lost to Follow-up|1|||
126477544|NCT01817530|455048289|FG001|Overall Study|Lost to Follow-up|4|||
126477545|NCT01817530|455048290|FG002|Overall Study|Lost to Follow-up|2|||
126477546|NCT01817530|455048291|FG003|Overall Study|Lost to Follow-up|1|||
126477547|NCT01817530|455048292|FG004|Overall Study|Lost to Follow-up|3|||
126477548|NCT01817530|455048293|FG005|Overall Study|Lost to Follow-up|2|||
126477549|NCT01817530|455048294|FG006|Overall Study|Lost to Follow-up|8|||
126477550|NCT01817530|455048295|FG007|Overall Study|Lost to Follow-up|4|||
126477551|NCT03298867|455048296|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
126477552|NCT03298867|455048297|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
126477553|NCT03298867|455048296|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
126477554|NCT03298867|455048297|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
126477555|NCT03298867|455048296|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
126477556|NCT03298867|455048297|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
126477557|NCT03298867|455048296|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
126477558|NCT03298867|455048297|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
126477559|NCT03298867|455048296|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
126477560|NCT03298867|455048297|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
126477561|NCT03298867|455048296|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
126477562|NCT03298867|455048297|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
126477563|NCT03298867|455048296|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
126477564|NCT03298867|455048297|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
126477565|NCT03298867|455048296|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
126477566|NCT03298867|455048297|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
126477567|NCT03298867|455048296|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
126477568|NCT03298867|455048297|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
126477569|NCT01453361|455048298|FG000|Overall Study|Disease Progression|6|||
126477570|NCT01453361|455048298|FG000|Overall Study|Screen-Failures|10|||
126477571|NCT04560998|455048299|FG000|Overall Study|Withdrawal by Subject|18|||
126477572|NCT04560998|455048300|FG001|Overall Study|Withdrawal by Subject|12|||
126477573|NCT04560998|455048299|FG000|Overall Study|Lost to Follow-up|8|||
126477574|NCT04560998|455048300|FG001|Overall Study|Lost to Follow-up|5|||
126477575|NCT04560998|455048299|FG000|Overall Study|Physician Decision|4|||
126477576|NCT04560998|455048300|FG001|Overall Study|Physician Decision|0|||
126477577|NCT01798004|455049880|FG000|Overall Study|Death|2|||
126477578|NCT01798004|455049880|FG000|Overall Study|Lack of Efficacy|8|||
126477579|NCT01798004|455049880|FG000|Overall Study|Physician Decision|25|||
126477580|NCT01798004|455049880|FG000|Overall Study|Withdrawal by Subject|4|||
126477581|NCT01798004|455049880|FG000|Overall Study|Ineligible|4|||
126477582|NCT01798004|455049880|FG000|Overall Study|Patient/parent refusal|7|||
126477583|NCT01798004|455049880|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
126477584|NCT01798004|455049880|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
126477585|NCT03539081|455049888|FG000|Overall Study|Withdrawal by Subject|2|||
126477586|NCT03539081|455049889|FG001|Overall Study|Withdrawal by Subject|3|||
126477587|NCT03539081|455049890|FG002|Overall Study|Withdrawal by Subject|0|||
126477588|NCT03539081|455049888|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
126477589|NCT03539081|455049889|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
126477590|NCT03539081|455049890|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
126477591|NCT01673867|455049894|FG000|Randomization|Adverse event unrelated to study drug|1|||
126477592|NCT01673867|455049895|FG001|Randomization|Adverse event unrelated to study drug|0|||
126477593|NCT01673867|455049894|FG000|Randomization|Participant request to discontinue study treatment|0|||
126477594|NCT01673867|455049895|FG001|Randomization|Participant request to discontinue study treatment|4|||
126477595|NCT01673867|455049894|FG000|Randomization|Withdrawal by participant|0|||
126477596|NCT01673867|455049895|FG001|Randomization|Withdrawal by participant|12|||
126477597|NCT01673867|455049894|FG000|Randomization|Lost to Follow-up|0|||
126477598|NCT01673867|455049895|FG001|Randomization|Lost to Follow-up|1|||
126477599|NCT01673867|455049894|FG000|Randomization|Participant no longer meets study criteria|4|||
126477600|NCT01673867|455049895|FG001|Randomization|Participant no longer meets study criteria|5|||
126477601|NCT01673867|455049894|FG000|Treatment|Disease Progression|208|||
126477602|NCT01673867|455049895|FG001|Treatment|Disease Progression|178|||
126477603|NCT01673867|455049894|FG000|Treatment|Study Drug Toxicity|23|||
126477604|NCT01673867|455049895|FG001|Treatment|Study Drug Toxicity|43|||
126477605|NCT01673867|455049894|FG000|Treatment|Death|2|||
126477606|NCT01673867|455049895|FG001|Treatment|Death|3|||
126722040|NCT03987919|455933232|FG000|Overall Study|Protocol Violation|0|||
126722041|NCT03987919|455933233|FG001|Overall Study|Protocol Violation|1|||
126722042|NCT03987919|455933234|FG002|Overall Study|Protocol Violation|0|||
126722043|NCT03987919|455933235|FG003|Overall Study|Protocol Violation|0|||
126722044|NCT03987919|455933232|FG000|Overall Study|Site terminated by Sponsor|0|||
126722045|NCT03987919|455933233|FG001|Overall Study|Site terminated by Sponsor|0|||
126477607|NCT01673867|455049894|FG000|Treatment|Adverse event unrelated to study drug|23|||
126477608|NCT01673867|455049895|FG001|Treatment|Adverse event unrelated to study drug|10|||
126722046|NCT03987919|455933234|FG002|Overall Study|Site terminated by Sponsor|0|||
126722047|NCT03987919|455933235|FG003|Overall Study|Site terminated by Sponsor|1|||
126722048|NCT03987919|455933232|FG000|Overall Study|Withdrawal by Subject|7|||
126722049|NCT03987919|455933233|FG001|Overall Study|Withdrawal by Subject|7|||
126477609|NCT01673867|455049894|FG000|Treatment|Participant request to discontinue study treatment|7|||
126477610|NCT01673867|455049895|FG001|Treatment|Participant request to discontinue study treatment|17|||
126477611|NCT01673867|455049894|FG000|Treatment|Withdrawal by participant|5|||
126477612|NCT01673867|455049895|FG001|Treatment|Withdrawal by participant|5|||
126722050|NCT03987919|455933234|FG002|Overall Study|Withdrawal by Subject|8|||
126477613|NCT01673867|455049894|FG000|Treatment|Maximum clinical benefit|1|||
126477614|NCT01673867|455049895|FG001|Treatment|Maximum clinical benefit|10|||
126477615|NCT01673867|455049894|FG000|Treatment|Participant no longer meets study criteria|2|||
126477616|NCT01673867|455049895|FG001|Treatment|Participant no longer meets study criteria|0|||
126477617|NCT01673867|455049894|FG000|Treatment|Administrative reason by sponsor|3|||
126477618|NCT01673867|455049895|FG001|Treatment|Administrative reason by sponsor|0|||
126477619|NCT01673867|455049894|FG000|Treatment|Other reason|11|||
126477620|NCT01673867|455049895|FG001|Treatment|Other reason|2|||
126477621|NCT02550106|455049898|FG000|Overall Study|Adverse Event|1|||
126477622|NCT02550106|455049898|FG000|Overall Study|Lack of Efficacy|3|||
126477623|NCT02550106|455049898|FG000|Overall Study|Protocol Violation|6|||
126477624|NCT02550106|455049898|FG000|Overall Study|Withdrawal by Subject|2|||
126477625|NCT00926328|455049899|FG000|Overall Study|Lost to Follow-up|12|||
126477626|NCT00926328|455049900|FG001|Overall Study|Lost to Follow-up|14|||
126477627|NCT00289133|455049901|FG000|Overall Study|Non-study device implanted|12|||
126477628|NCT00289133|455049902|FG001|Overall Study|Non-study device implanted|0|||
126477629|NCT00289133|455049901|FG000|Overall Study|Protocol Violation|32|||
126477630|NCT00289133|455049902|FG001|Overall Study|Protocol Violation|38|||
126477631|NCT00289133|455049901|FG000|Overall Study|Withdrawal by Subject|9|||
126477632|NCT00289133|455049902|FG001|Overall Study|Withdrawal by Subject|10|||
126477633|NCT00289133|455049901|FG000|Overall Study|Death|5|||
126477634|NCT00289133|455049902|FG001|Overall Study|Death|10|||
126477635|NCT00289133|455049901|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
126477636|NCT00289133|455049902|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
126477637|NCT00289133|455049901|FG000|Overall Study|Physician Decision|41|||
126477638|NCT00289133|455049902|FG001|Overall Study|Physician Decision|45|||
126477639|NCT00289133|455049901|FG000|Overall Study|Revision|8|||
126477640|NCT00289133|455049902|FG001|Overall Study|Revision|6|||
126477641|NCT00289133|455049901|FG000|Overall Study|Lost to Follow-up|92|||
126477642|NCT00289133|455049902|FG001|Overall Study|Lost to Follow-up|115|||
126477643|NCT03094169|455049906|FG000|Overall Study|Lack of Efficacy|0|||
126477644|NCT03094169|455049907|FG001|Overall Study|Lack of Efficacy|0|||
126477645|NCT03094169|455049908|FG002|Overall Study|Lack of Efficacy|0|||
126477646|NCT03094169|455049909|FG003|Overall Study|Lack of Efficacy|0|||
126477647|NCT03094169|455049910|FG004|Overall Study|Lack of Efficacy|0|||
126477648|NCT03094169|455049911|FG005|Overall Study|Lack of Efficacy|0|||
126477649|NCT03094169|455049912|FG006|Overall Study|Lack of Efficacy|0|||
126477650|NCT03094169|455049913|FG007|Overall Study|Lack of Efficacy|21|||
126477651|NCT03094169|455049906|FG000|Overall Study|Adverse Event|0|||
126477652|NCT03094169|455049907|FG001|Overall Study|Adverse Event|0|||
126477653|NCT03094169|455049908|FG002|Overall Study|Adverse Event|0|||
126477654|NCT03094169|455049909|FG003|Overall Study|Adverse Event|0|||
126477655|NCT03094169|455049910|FG004|Overall Study|Adverse Event|0|||
126477656|NCT03094169|455049911|FG005|Overall Study|Adverse Event|0|||
126477657|NCT03094169|455049912|FG006|Overall Study|Adverse Event|0|||
126477658|NCT03094169|455049913|FG007|Overall Study|Adverse Event|2|||
126722051|NCT03987919|455933235|FG003|Overall Study|Withdrawal by Subject|4|||
126477659|NCT03094169|455049906|FG000|Overall Study|Withdrawal by Subject|0|||
126477660|NCT03094169|455049907|FG001|Overall Study|Withdrawal by Subject|0|||
126477661|NCT03094169|455049908|FG002|Overall Study|Withdrawal by Subject|0|||
126477662|NCT03094169|455049909|FG003|Overall Study|Withdrawal by Subject|0|||
126477663|NCT03094169|455049910|FG004|Overall Study|Withdrawal by Subject|0|||
126477664|NCT03094169|455049911|FG005|Overall Study|Withdrawal by Subject|0|||
126477665|NCT03094169|455049912|FG006|Overall Study|Withdrawal by Subject|1|||
126477666|NCT03094169|455049913|FG007|Overall Study|Withdrawal by Subject|1|||
126477667|NCT03094169|455049906|FG000|Overall Study|Trial Termination|0|||
126477668|NCT03094169|455049907|FG001|Overall Study|Trial Termination|0|||
126477669|NCT03094169|455049908|FG002|Overall Study|Trial Termination|0|||
126772338|NCT00854607|456122092|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
126477670|NCT03094169|455049909|FG003|Overall Study|Trial Termination|0|||
126477671|NCT03094169|455049910|FG004|Overall Study|Trial Termination|0|||
126477672|NCT03094169|455049911|FG005|Overall Study|Trial Termination|0|||
126477673|NCT03094169|455049912|FG006|Overall Study|Trial Termination|0|||
126477674|NCT03094169|455049913|FG007|Overall Study|Trial Termination|1|||
126477675|NCT04645953|455049914|FG000|Overall Study|Lost to Follow-up|2|||
126477676|NCT04645953|455049915|FG001|Overall Study|Lost to Follow-up|1|||
126477677|NCT04645953|455049916|FG002|Overall Study|Lost to Follow-up|1|||
126477678|NCT04645953|455049914|FG000|Overall Study|Withdrawal by Subject|0|||
126477679|NCT04645953|455049915|FG001|Overall Study|Withdrawal by Subject|1|||
126477680|NCT04645953|455049916|FG002|Overall Study|Withdrawal by Subject|0|||
126477681|NCT04645953|455049914|FG000|Overall Study|Physician Decision|0|||
126477682|NCT04645953|455049915|FG001|Overall Study|Physician Decision|1|||
126477683|NCT04645953|455049916|FG002|Overall Study|Physician Decision|0|||
126477684|NCT04645953|455049914|FG000|Overall Study|Discontinued Prior to Dosing|0|||
126477685|NCT04645953|455049915|FG001|Overall Study|Discontinued Prior to Dosing|0|||
126477686|NCT04645953|455049916|FG002|Overall Study|Discontinued Prior to Dosing|2|||
126477687|NCT04613375|455049917|FG000|Overall Study|Death|198|||
126477688|NCT04613375|455049917|FG000|Overall Study|Withdrawal by Subject|3|||
126477689|NCT00002651|455049918|FG000|Induction|Adverse Event|44|||
126477690|NCT00002651|455049919|FG001|Induction|Adverse Event|0|||
126477691|NCT00002651|455049920|FG002|Induction|Adverse Event|0|||
126477692|NCT00002651|455049918|FG000|Induction|Refusal unrelated to adverse event|50|||
126477693|NCT00002651|455049919|FG001|Induction|Refusal unrelated to adverse event|0|||
126477694|NCT00002651|455049920|FG002|Induction|Refusal unrelated to adverse event|0|||
126477695|NCT00002651|455049918|FG000|Induction|Progression/relapse|274|||
126477696|NCT00002651|455049919|FG001|Induction|Progression/relapse|0|||
126477697|NCT00002651|455049920|FG002|Induction|Progression/relapse|0|||
126477698|NCT00002651|455049918|FG000|Induction|Death|62|||
126477699|NCT00002651|455049919|FG001|Induction|Death|0|||
126477700|NCT00002651|455049920|FG002|Induction|Death|0|||
126477701|NCT00002651|455049918|FG000|Induction|Other|823|||
126477702|NCT00002651|455049919|FG001|Induction|Other|0|||
126477703|NCT00002651|455049920|FG002|Induction|Other|0|||
126477704|NCT00002651|455049918|FG000|Induction|not eligible|90|||
126477705|NCT00002651|455049919|FG001|Induction|not eligible|0|||
126477706|NCT00002651|455049920|FG002|Induction|not eligible|0|||
126477707|NCT00002651|455049918|FG000|Consolidation and Randomization|Adverse Event|0|||
126722052|NCT03987919|455933232|FG000|Overall Study|Other - as reported by the investigator|1|||
126722053|NCT03987919|455933233|FG001|Overall Study|Other - as reported by the investigator|3|||
126722054|NCT03987919|455933234|FG002|Overall Study|Other - as reported by the investigator|2|||
126722055|NCT03987919|455933235|FG003|Overall Study|Other - as reported by the investigator|0|||
126722056|NCT01194804|455933236|FG000|Overall Study|Withdrawal by Subject|1|||
126722057|NCT03621943|455933237|FG000|First Randomized Intervention|Lost to Follow-up|51|||
126722058|NCT03621943|455933238|FG001|First Randomized Intervention|Lost to Follow-up|54|||
126722059|NCT03621943|455933237|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
126722060|NCT03621943|455933238|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
126722061|NCT03621943|455933237|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
126722062|NCT03621943|455933238|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
126722063|NCT03621943|455933237|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
126722064|NCT03621943|455933238|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
126722065|NCT00748553|455933239|FG000|Overall Study|Adverse Event|0|||
126722066|NCT00748553|455933240|FG001|Overall Study|Adverse Event|1|||
126722067|NCT00748553|455933239|FG000|Overall Study|disease progression|2|||
126722068|NCT00748553|455933240|FG001|Overall Study|disease progression|0|||
126722069|NCT00748553|455933239|FG000|Overall Study|noncompliance|1|||
126722070|NCT00748553|455933240|FG001|Overall Study|noncompliance|0|||
126722071|NCT00315705|455933241|FG000|Phase 1|Refused further treatment|1|||
126477708|NCT00002651|455049919|FG001|Consolidation and Randomization|Adverse Event|36|||
126477709|NCT00002651|455049920|FG002|Consolidation and Randomization|Adverse Event|14|||
126477710|NCT00002651|455049918|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
126477711|NCT00002651|455049919|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
126477712|NCT00002651|455049920|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
126477713|NCT00002651|455049918|FG000|Consolidation and Randomization|Progression/relapse|0|||
126477714|NCT00002651|455049919|FG001|Consolidation and Randomization|Progression/relapse|295|||
126477715|NCT00002651|455049920|FG002|Consolidation and Randomization|Progression/relapse|298|||
126477716|NCT00002651|455049918|FG000|Consolidation and Randomization|Death|0|||
126477717|NCT00002651|455049919|FG001|Consolidation and Randomization|Death|38|||
126477718|NCT00002651|455049920|FG002|Consolidation and Randomization|Death|48|||
126477719|NCT00002651|455049918|FG000|Consolidation and Randomization|Other|0|||
126477720|NCT00002651|455049919|FG001|Consolidation and Randomization|Other|314|||
126477721|NCT00002651|455049920|FG002|Consolidation and Randomization|Other|313|||
126477722|NCT00002651|455049918|FG000|Consolidation and Randomization|not eligible|0|||
126477723|NCT00002651|455049919|FG001|Consolidation and Randomization|not eligible|102|||
126477724|NCT00002651|455049920|FG002|Consolidation and Randomization|not eligible|112|||
126477725|NCT02763462|455049926|FG000|Overall Study|Protocol Violation|6|||
126477726|NCT00261807|455049927|FG000|Overall Study|Lost to Follow-up|2|||
126477727|NCT00261807|455049927|FG000|Overall Study|Adverse Event|2|||
126477728|NCT00261807|455049927|FG000|Overall Study|Death|1|||
126477729|NCT00261807|455049927|FG000|Overall Study|Protocol Violation|2|||
126477730|NCT00675948|455049930|FG000|Overall Study|Adverse Event|23|||
126477731|NCT00675948|455049931|FG001|Overall Study|Adverse Event|1|||
126477732|NCT00675948|455049930|FG000|Overall Study|Lack of Efficacy|3|||
126722072|NCT00315705|455933241|FG000|Phase 1|Failure to achieve response|8|||
126722073|NCT00315705|455933241|FG000|Phase 1|Disease relapse|4|||
126722074|NCT00315705|455933241|FG000|Phase 1|Scheduled for transplant|9|||
126722075|NCT00315705|455933241|FG000|Phase 1|Death|3|||
126477733|NCT00675948|455049931|FG001|Overall Study|Lack of Efficacy|0|||
126477734|NCT00675948|455049930|FG000|Overall Study|Withdrawal by Subject|7|||
126477735|NCT00675948|455049931|FG001|Overall Study|Withdrawal by Subject|0|||
126477736|NCT00675948|455049930|FG000|Overall Study|Lost to Follow-up|2|||
126477737|NCT00675948|455049931|FG001|Overall Study|Lost to Follow-up|0|||
126477738|NCT00675948|455049930|FG000|Overall Study|Protocol Violation|1|||
126477739|NCT00675948|455049931|FG001|Overall Study|Protocol Violation|0|||
126477740|NCT00675948|455049930|FG000|Overall Study|Pain under control|1|||
126477741|NCT00675948|455049931|FG001|Overall Study|Pain under control|0|||
126477742|NCT00675948|455049930|FG000|Overall Study|Sponsor decision|0|||
126477743|NCT00675948|455049931|FG001|Overall Study|Sponsor decision|1|||
126477744|NCT00675948|455049930|FG000|Overall Study|Patient died|1|||
126477745|NCT00675948|455049931|FG001|Overall Study|Patient died|0|||
126477746|NCT00675948|455049930|FG000|Overall Study|Patient unable to comply with diaries|1|||
126477747|NCT00675948|455049931|FG001|Overall Study|Patient unable to comply with diaries|0|||
126477748|NCT00675948|455049930|FG000|Overall Study|Patient feels unable to take medication|0|||
126477749|NCT00675948|455049931|FG001|Overall Study|Patient feels unable to take medication|1|||
126477750|NCT05209360|455049932|FG000|Overall Study|Withdrawal by Subject|0|||
126477751|NCT05209360|455049933|FG001|Overall Study|Withdrawal by Subject|0|||
126477752|NCT05209360|455049934|FG002|Overall Study|Withdrawal by Subject|1|||
126477753|NCT05209360|455049935|FG003|Overall Study|Withdrawal by Subject|0|||
126477754|NCT05209360|455049936|FG004|Overall Study|Withdrawal by Subject|0|||
126477755|NCT05209360|455049937|FG005|Overall Study|Withdrawal by Subject|0|||
126477756|NCT02527161|455049938|FG000|Overall Study|Failed MRI|52|||
126477757|NCT02527161|455049938|FG000|Overall Study|Withdrawal by Subject|19|||
126477758|NCT02527161|455049938|FG000|Overall Study|Delay in or unfit for surgery|16|||
126477759|NCT02527161|455049938|FG000|Overall Study|MRI contraindication|6|||
126477760|NCT02527161|455049938|FG000|Overall Study|Consent violation|4|||
126477761|NCT02527161|455049938|FG000|Overall Study|Only Recruited to Part A|27|||
126477762|NCT02527161|455049938|FG000|Overall Study|Physician Decision|1|||
126477763|NCT02527161|455049938|FG000|Overall Study|Adverse Event|1|||
126477764|NCT02527161|455049938|FG000|Overall Study|Lost to Follow-up|6|||
126477765|NCT02100514|455049939|FG000|Treatment Period|Adverse Event|0|||
126477766|NCT02100514|455049940|FG001|Treatment Period|Adverse Event|5|||
126477767|NCT02100514|455049941|FG002|Treatment Period|Adverse Event|0|||
126477768|NCT02100514|455049942|FG003|Treatment Period|Adverse Event|0|||
126477769|NCT02100514|455049943|FG004|Treatment Period|Adverse Event|0|||
126477770|NCT02100514|455049939|FG000|Treatment Period|Death|2|||
126477771|NCT02100514|455049940|FG001|Treatment Period|Death|2|||
126477772|NCT02100514|455049941|FG002|Treatment Period|Death|0|||
126477773|NCT02100514|455049942|FG003|Treatment Period|Death|0|||
126477774|NCT02100514|455049943|FG004|Treatment Period|Death|0|||
126477775|NCT02100514|455049939|FG000|Treatment Period|Lost to Follow-up|5|||
126477776|NCT02100514|455049940|FG001|Treatment Period|Lost to Follow-up|17|||
126477777|NCT02100514|455049941|FG002|Treatment Period|Lost to Follow-up|0|||
126477778|NCT02100514|455049942|FG003|Treatment Period|Lost to Follow-up|0|||
126477779|NCT02100514|455049943|FG004|Treatment Period|Lost to Follow-up|0|||
126477780|NCT02100514|455049939|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
126722076|NCT00315705|455933241|FG000|Phase 2|Physician Decision|4|||
126477781|NCT02100514|455049940|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
126477782|NCT02100514|455049941|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
126477783|NCT02100514|455049942|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
126477784|NCT02100514|455049943|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
126477785|NCT02100514|455049939|FG000|Treatment Period|Protocol Violation|1|||
126477786|NCT02100514|455049940|FG001|Treatment Period|Protocol Violation|1|||
126477787|NCT02100514|455049941|FG002|Treatment Period|Protocol Violation|0|||
126477788|NCT02100514|455049942|FG003|Treatment Period|Protocol Violation|0|||
126477789|NCT02100514|455049943|FG004|Treatment Period|Protocol Violation|0|||
126477790|NCT02100514|455049939|FG000|Treatment Period|Withdrawal by Subject|12|||
126477791|NCT02100514|455049940|FG001|Treatment Period|Withdrawal by Subject|37|||
126477792|NCT02100514|455049941|FG002|Treatment Period|Withdrawal by Subject|0|||
126477793|NCT02100514|455049942|FG003|Treatment Period|Withdrawal by Subject|0|||
126477794|NCT02100514|455049943|FG004|Treatment Period|Withdrawal by Subject|0|||
126477795|NCT02100514|455049939|FG000|Treatment Period|Other|9|||
126477796|NCT02100514|455049940|FG001|Treatment Period|Other|11|||
126477797|NCT02100514|455049941|FG002|Treatment Period|Other|0|||
126722077|NCT00315705|455933241|FG000|Phase 2|Adverse Event|1|||
126477798|NCT02100514|455049942|FG003|Treatment Period|Other|0|||
126477799|NCT02100514|455049943|FG004|Treatment Period|Other|0|||
126477800|NCT02100514|455049939|FG000|Extension Period|Withdrew consent|0|||
126477801|NCT02100514|455049940|FG001|Extension Period|Withdrew consent|0|||
126477802|NCT02100514|455049941|FG002|Extension Period|Withdrew consent|2|||
126477803|NCT02100514|455049942|FG003|Extension Period|Withdrew consent|0|||
126477804|NCT02100514|455049943|FG004|Extension Period|Withdrew consent|0|||
126477805|NCT00724932|455049944|FG000|Overall Study|Lost to Follow-up|1|||
126477806|NCT00724932|455049945|FG001|Overall Study|Lost to Follow-up|0|||
126477807|NCT00724932|455049944|FG000|Overall Study|Not treated|4|||
126477808|NCT00724932|455049945|FG001|Overall Study|Not treated|3|||
126477809|NCT01081678|455049946|FG000|Overall Study|Ineligibility Determined|0|||
126477810|NCT01081678|455049947|FG001|Overall Study|Ineligibility Determined|0|||
126477811|NCT01081678|455049948|FG002|Overall Study|Ineligibility Determined|1|||
126477812|NCT01081678|455049949|FG003|Overall Study|Ineligibility Determined|1|||
126477813|NCT01081678|455049946|FG000|Overall Study|Noncompliance|3|||
126477814|NCT01081678|455049947|FG001|Overall Study|Noncompliance|4|||
126477815|NCT01081678|455049948|FG002|Overall Study|Noncompliance|5|||
126477816|NCT01081678|455049949|FG003|Overall Study|Noncompliance|2|||
126477817|NCT01081678|455049946|FG000|Overall Study|Adverse Event|2|||
126477818|NCT01081678|455049947|FG001|Overall Study|Adverse Event|1|||
126477819|NCT01081678|455049948|FG002|Overall Study|Adverse Event|2|||
126477820|NCT01081678|455049949|FG003|Overall Study|Adverse Event|2|||
126477821|NCT01081678|455049946|FG000|Overall Study|Withdrawal by Subject|15|||
126477822|NCT01081678|455049947|FG001|Overall Study|Withdrawal by Subject|7|||
126477823|NCT01081678|455049948|FG002|Overall Study|Withdrawal by Subject|17|||
126477824|NCT01081678|455049949|FG003|Overall Study|Withdrawal by Subject|14|||
126477825|NCT01081678|455049946|FG000|Overall Study|Administrative Decision|1|||
126477826|NCT01081678|455049947|FG001|Overall Study|Administrative Decision|0|||
126477827|NCT01081678|455049948|FG002|Overall Study|Administrative Decision|0|||
126477828|NCT01081678|455049949|FG003|Overall Study|Administrative Decision|1|||
126477829|NCT01081678|455049946|FG000|Overall Study|Lost to Follow-up|4|||
126477830|NCT01081678|455049947|FG001|Overall Study|Lost to Follow-up|1|||
126477831|NCT01081678|455049948|FG002|Overall Study|Lost to Follow-up|4|||
126477832|NCT01081678|455049949|FG003|Overall Study|Lost to Follow-up|3|||
126477833|NCT01081678|455049946|FG000|Overall Study|Death|2|||
126477834|NCT01081678|455049947|FG001|Overall Study|Death|2|||
126477835|NCT01081678|455049948|FG002|Overall Study|Death|2|||
126477836|NCT01081678|455049949|FG003|Overall Study|Death|6|||
126477837|NCT01081678|455049946|FG000|Overall Study|Other|0|||
126477838|NCT01081678|455049947|FG001|Overall Study|Other|1|||
126477839|NCT01081678|455049948|FG002|Overall Study|Other|0|||
126477840|NCT01081678|455049949|FG003|Overall Study|Other|0|||
126477841|NCT02499783|455049950|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
126477842|NCT02499783|455049951|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
126477843|NCT02499783|455049952|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
126477844|NCT02499783|455049950|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
126477845|NCT02499783|455049951|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
126477846|NCT02499783|455049952|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
126477847|NCT02499783|455049950|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
126477848|NCT02499783|455049951|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
126477849|NCT02499783|455049952|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
126477850|NCT02499783|455049950|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
126477851|NCT02499783|455049951|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
126559171|NCT04159896|455340674|FG000|Overall Study|Withdrawal by Subject|1|||
126559172|NCT04159896|455340674|FG000|Overall Study|Adverse Event|1|||
126559173|NCT04159896|455340674|FG000|Overall Study|A transient ischaemic attack|1|||
126722078|NCT00315705|455933241|FG000|Phase 2|Failure to achieve response|3|||
126722079|NCT00315705|455933241|FG000|Phase 2|Disease relapse|1|||
126722080|NCT00315705|455933241|FG000|Phase 2|Scheduled for transplant|8|||
126477852|NCT02499783|455049952|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
126477853|NCT02499783|455049950|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
126477854|NCT02499783|455049951|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
126477855|NCT02499783|455049952|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
126477856|NCT02499783|455049950|FG000|DB Period: Weeks 0-8|Other|1|||
126477857|NCT02499783|455049951|FG001|DB Period: Weeks 0-8|Other|1|||
126477858|NCT02499783|455049952|FG002|DB Period: Weeks 0-8|Other|0|||
126477859|NCT02499783|455049950|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
126477860|NCT02499783|455049951|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
126477861|NCT02499783|455049952|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
126477862|NCT02499783|455049950|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
126477863|NCT02499783|455049951|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
126477864|NCT02499783|455049952|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
126477865|NCT02499783|455049950|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
126477866|NCT02499783|455049951|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
126477867|NCT02499783|455049952|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
126559174|NCT02084082|455340675|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
126477868|NCT02499783|455049950|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
126477869|NCT02499783|455049951|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
126477870|NCT02499783|455049952|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
126477871|NCT01866293|455049953|FG000|Overall Study|Adverse Event|2|||
126477872|NCT04457336|455049954|FG000|Period 2: Part A|Withdrawal by Subject|0|||
126477873|NCT04457336|455049955|FG001|Period 2: Part A|Withdrawal by Subject|1|||
126477874|NCT04457336|455049956|FG002|Period 2: Part A|Withdrawal by Subject|1|||
126477875|NCT04457336|455049957|FG003|Period 2: Part A|Withdrawal by Subject|1|||
126477876|NCT04457336|455049958|FG004|Period 2: Part A|Withdrawal by Subject|0|||
126477877|NCT04457336|455049959|FG005|Period 2: Part A|Withdrawal by Subject|0|||
126477878|NCT04457336|455049960|FG006|Period 2: Part A|Withdrawal by Subject|0|||
126477879|NCT04457336|455049961|FG007|Period 2: Part A|Withdrawal by Subject|0|||
126477880|NCT04457336|455049954|FG000|Period 2: Part A|Adverse Event|0|||
126477881|NCT04457336|455049955|FG001|Period 2: Part A|Adverse Event|0|||
126722081|NCT00315705|455933241|FG000|Phase 2|Other|1|||
126722082|NCT00315705|455933241|FG000|Phase 2|Death|7|||
126722083|NCT00948818|455933243|FG000|Overall Study|Adverse Event|10|||
126722084|NCT00948818|455933244|FG001|Overall Study|Adverse Event|32|||
126477882|NCT04457336|455049956|FG002|Period 2: Part A|Adverse Event|1|||
126477883|NCT04457336|455049957|FG003|Period 2: Part A|Adverse Event|1|||
126477884|NCT04457336|455049958|FG004|Period 2: Part A|Adverse Event|0|||
126477885|NCT04457336|455049959|FG005|Period 2: Part A|Adverse Event|0|||
126477886|NCT04457336|455049960|FG006|Period 2: Part A|Adverse Event|0|||
126477887|NCT04457336|455049961|FG007|Period 2: Part A|Adverse Event|0|||
126722085|NCT00948818|455933243|FG000|Overall Study|Protocol Violation|9|||
126722086|NCT00948818|455933244|FG001|Overall Study|Protocol Violation|10|||
126722087|NCT00948818|455933243|FG000|Overall Study|Withdrawal by Subject|25|||
126722088|NCT00948818|455933244|FG001|Overall Study|Withdrawal by Subject|25|||
126722089|NCT00948818|455933243|FG000|Overall Study|Lost to Follow-up|10|||
126722090|NCT00948818|455933244|FG001|Overall Study|Lost to Follow-up|17|||
126722091|NCT00948818|455933243|FG000|Overall Study|Lack of Efficacy|4|||
126722092|NCT00948818|455933244|FG001|Overall Study|Lack of Efficacy|5|||
126722093|NCT00948818|455933243|FG000|Overall Study|Other Reason|4|||
126722094|NCT00948818|455933244|FG001|Overall Study|Other Reason|5|||
126722095|NCT02330549|455933245|FG000|Overall Study|Adverse Event|1|||
126722096|NCT02330549|455933246|FG001|Overall Study|Adverse Event|0|||
126722097|NCT02330549|455933245|FG000|Overall Study|Subject withdrew consent|2|||
126722098|NCT02330549|455933246|FG001|Overall Study|Subject withdrew consent|1|||
126722099|NCT02330549|455933245|FG000|Overall Study|Failure to meet randomization criteria|1|||
126722100|NCT02330549|455933246|FG001|Overall Study|Failure to meet randomization criteria|0|||
126722101|NCT02326467|455933250|FG000|Overall Study|Withdrawal by Subject|1|||
126722102|NCT00434512|455933251|FG000|Overall Study|Migrated/moved from study area|0|||
126722103|NCT00434512|455933252|FG001|Overall Study|Migrated/moved from study area|0|||
126722104|NCT00434512|455933253|FG002|Overall Study|Migrated/moved from study area|0|||
126722105|NCT00434512|455933254|FG003|Overall Study|Migrated/moved from study area|1|||
126722106|NCT00434512|455933255|FG004|Overall Study|Migrated/moved from study area|1|||
126722107|NCT00434512|455933256|FG005|Overall Study|Migrated/moved from study area|1|||
126722108|NCT00434512|455933251|FG000|Overall Study|Other|0|||
126722109|NCT00434512|455933252|FG001|Overall Study|Other|1|||
126722110|NCT00434512|455933253|FG002|Overall Study|Other|0|||
126722111|NCT00434512|455933254|FG003|Overall Study|Other|0|||
126722112|NCT00434512|455933255|FG004|Overall Study|Other|0|||
126722113|NCT00434512|455933256|FG005|Overall Study|Other|0|||
126722114|NCT01575197|455933259|FG000|Overall Study|Migration out of study area|1|||
126722115|NCT01575197|455933260|FG001|Overall Study|Migration out of study area|5|||
126722116|NCT01575197|455933261|FG002|Overall Study|Migration out of study area|4|||
126722117|NCT01575197|455933259|FG000|Overall Study|SAE|0|||
126722118|NCT01575197|455933260|FG001|Overall Study|SAE|1|||
126722119|NCT01575197|455933261|FG002|Overall Study|SAE|0|||
126722120|NCT01575197|455933259|FG000|Overall Study|Lost to Follow-up|0|||
126477888|NCT04457336|455049954|FG000|Period 2: Part A|Study Terminated|0|||
126477889|NCT04457336|455049955|FG001|Period 2: Part A|Study Terminated|0|||
126477890|NCT04457336|455049956|FG002|Period 2: Part A|Study Terminated|1|||
126477891|NCT04457336|455049957|FG003|Period 2: Part A|Study Terminated|0|||
126722121|NCT01575197|455933260|FG001|Overall Study|Lost to Follow-up|1|||
126722122|NCT01575197|455933261|FG002|Overall Study|Lost to Follow-up|0|||
126722123|NCT01575197|455933259|FG000|Overall Study|Withdrawal by Subject|0|||
126722124|NCT01575197|455933260|FG001|Overall Study|Withdrawal by Subject|1|||
126477892|NCT04457336|455049958|FG004|Period 2: Part A|Study Terminated|0|||
126477893|NCT04457336|455049959|FG005|Period 2: Part A|Study Terminated|0|||
126477894|NCT04457336|455049960|FG006|Period 2: Part A|Study Terminated|0|||
126477895|NCT04457336|455049961|FG007|Period 2: Part A|Study Terminated|0|||
126477896|NCT04457336|455049954|FG000|Period 2: Part A|Protocol Violation|0|||
126477897|NCT04457336|455049955|FG001|Period 2: Part A|Protocol Violation|1|||
126477898|NCT04457336|455049956|FG002|Period 2: Part A|Protocol Violation|0|||
126477899|NCT04457336|455049957|FG003|Period 2: Part A|Protocol Violation|0|||
126722125|NCT01575197|455933261|FG002|Overall Study|Withdrawal by Subject|1|||
126722126|NCT01575197|455933259|FG000|Overall Study|Protocol Violation|2|||
126477900|NCT04457336|455049958|FG004|Period 2: Part A|Protocol Violation|0|||
126722127|NCT01575197|455933260|FG001|Overall Study|Protocol Violation|1|||
126722128|NCT01575197|455933261|FG002|Overall Study|Protocol Violation|1|||
126722129|NCT00111475|455933265|FG000|Overall Study|Lost to Follow-up|0|||
126722130|NCT00111475|455933266|FG001|Overall Study|Lost to Follow-up|0|||
126722131|NCT00111475|455933267|FG002|Overall Study|Lost to Follow-up|0|||
126477901|NCT04457336|455049959|FG005|Period 2: Part A|Protocol Violation|0|||
126477902|NCT04457336|455049960|FG006|Period 2: Part A|Protocol Violation|0|||
126477903|NCT04457336|455049961|FG007|Period 2: Part A|Protocol Violation|0|||
126477904|NCT04457336|455049954|FG000|Period 2: Part A|Lost to Follow-up|0|||
126477905|NCT04457336|455049955|FG001|Period 2: Part A|Lost to Follow-up|1|||
126477906|NCT04457336|455049956|FG002|Period 2: Part A|Lost to Follow-up|0|||
126477907|NCT04457336|455049957|FG003|Period 2: Part A|Lost to Follow-up|0|||
126477908|NCT04457336|455049958|FG004|Period 2: Part A|Lost to Follow-up|0|||
126477909|NCT04457336|455049959|FG005|Period 2: Part A|Lost to Follow-up|0|||
126477910|NCT04457336|455049960|FG006|Period 2: Part A|Lost to Follow-up|0|||
126477911|NCT04457336|455049961|FG007|Period 2: Part A|Lost to Follow-up|0|||
126477912|NCT04457336|455049954|FG000|Period 2: Part A|Other|0|||
126477913|NCT04457336|455049955|FG001|Period 2: Part A|Other|1|||
126477914|NCT04457336|455049956|FG002|Period 2: Part A|Other|0|||
126477915|NCT04457336|455049957|FG003|Period 2: Part A|Other|0|||
126477916|NCT04457336|455049958|FG004|Period 2: Part A|Other|0|||
126477917|NCT04457336|455049959|FG005|Period 2: Part A|Other|0|||
126477918|NCT04457336|455049960|FG006|Period 2: Part A|Other|0|||
126477919|NCT04457336|455049961|FG007|Period 2: Part A|Other|0|||
126477920|NCT04457336|455049954|FG000|Period 2: Part A|Physician Decision|0|||
126477921|NCT04457336|455049955|FG001|Period 2: Part A|Physician Decision|0|||
126477922|NCT04457336|455049956|FG002|Period 2: Part A|Physician Decision|0|||
126477923|NCT04457336|455049957|FG003|Period 2: Part A|Physician Decision|1|||
126477924|NCT04457336|455049958|FG004|Period 2: Part A|Physician Decision|0|||
126477925|NCT04457336|455049959|FG005|Period 2: Part A|Physician Decision|0|||
126477926|NCT04457336|455049960|FG006|Period 2: Part A|Physician Decision|0|||
126477927|NCT04457336|455049961|FG007|Period 2: Part A|Physician Decision|0|||
126477928|NCT04457336|455049954|FG000|Period 3: Part B|Study Terminated|0|||
126477929|NCT04457336|455049955|FG001|Period 3: Part B|Study Terminated|0|||
126477930|NCT04457336|455049956|FG002|Period 3: Part B|Study Terminated|0|||
126477931|NCT04457336|455049957|FG003|Period 3: Part B|Study Terminated|0|||
126477932|NCT04457336|455049958|FG004|Period 3: Part B|Study Terminated|1|||
126477933|NCT04457336|455049959|FG005|Period 3: Part B|Study Terminated|10|||
126477934|NCT04457336|455049960|FG006|Period 3: Part B|Study Terminated|13|||
126477935|NCT04457336|455049961|FG007|Period 3: Part B|Study Terminated|0|||
126477936|NCT04457336|455049954|FG000|Period 3: Part B|Withdrawal by Subject|0|||
126477937|NCT04457336|455049955|FG001|Period 3: Part B|Withdrawal by Subject|0|||
126477938|NCT04457336|455049956|FG002|Period 3: Part B|Withdrawal by Subject|0|||
126477939|NCT04457336|455049957|FG003|Period 3: Part B|Withdrawal by Subject|0|||
126477940|NCT04457336|455049958|FG004|Period 3: Part B|Withdrawal by Subject|0|||
126477941|NCT04457336|455049959|FG005|Period 3: Part B|Withdrawal by Subject|1|||
126477942|NCT04457336|455049960|FG006|Period 3: Part B|Withdrawal by Subject|2|||
126477943|NCT04457336|455049961|FG007|Period 3: Part B|Withdrawal by Subject|0|||
126477944|NCT04457336|455049954|FG000|Period 4: Part C|Study Terminated|0|||
126477945|NCT04457336|455049955|FG001|Period 4: Part C|Study Terminated|0|||
126477946|NCT04457336|455049956|FG002|Period 4: Part C|Study Terminated|0|||
126477947|NCT04457336|455049957|FG003|Period 4: Part C|Study Terminated|0|||
126477948|NCT04457336|455049958|FG004|Period 4: Part C|Study Terminated|0|||
126477949|NCT04457336|455049959|FG005|Period 4: Part C|Study Terminated|0|||
126477950|NCT04457336|455049960|FG006|Period 4: Part C|Study Terminated|0|||
126477951|NCT04457336|455049961|FG007|Period 4: Part C|Study Terminated|30|||
126477952|NCT04457336|455049954|FG000|Period 4: Part C|Adverse Event|0|||
126722132|NCT00111475|455933268|FG003|Overall Study|Lost to Follow-up|0|||
126722133|NCT00111475|455933269|FG004|Overall Study|Lost to Follow-up|0|||
126722134|NCT00111475|455933270|FG005|Overall Study|Lost to Follow-up|1|||
126477953|NCT04457336|455049955|FG001|Period 4: Part C|Adverse Event|0|||
126477954|NCT04457336|455049956|FG002|Period 4: Part C|Adverse Event|0|||
126477955|NCT04457336|455049957|FG003|Period 4: Part C|Adverse Event|0|||
126477956|NCT04457336|455049958|FG004|Period 4: Part C|Adverse Event|0|||
126477957|NCT04457336|455049959|FG005|Period 4: Part C|Adverse Event|0|||
126477958|NCT04457336|455049960|FG006|Period 4: Part C|Adverse Event|0|||
126722135|NCT00111475|455933271|FG006|Overall Study|Lost to Follow-up|0|||
126722136|NCT00111475|455933272|FG007|Overall Study|Lost to Follow-up|0|||
126477959|NCT04457336|455049961|FG007|Period 4: Part C|Adverse Event|2|||
126722137|NCT00111475|455933273|FG008|Overall Study|Lost to Follow-up|0|||
126477960|NCT04457336|455049954|FG000|Period 4: Part C|Site Terminated|0|||
126477961|NCT04457336|455049955|FG001|Period 4: Part C|Site Terminated|0|||
126477962|NCT04457336|455049956|FG002|Period 4: Part C|Site Terminated|0|||
126477963|NCT04457336|455049957|FG003|Period 4: Part C|Site Terminated|0|||
126477964|NCT04457336|455049958|FG004|Period 4: Part C|Site Terminated|0|||
126477965|NCT04457336|455049959|FG005|Period 4: Part C|Site Terminated|0|||
126477966|NCT04457336|455049960|FG006|Period 4: Part C|Site Terminated|0|||
126477967|NCT04457336|455049961|FG007|Period 4: Part C|Site Terminated|1|||
126477968|NCT04457336|455049954|FG000|Period 4: Part C|Other|0|||
126477969|NCT04457336|455049955|FG001|Period 4: Part C|Other|0|||
126477970|NCT04457336|455049956|FG002|Period 4: Part C|Other|0|||
126477971|NCT04457336|455049957|FG003|Period 4: Part C|Other|0|||
126477972|NCT04457336|455049958|FG004|Period 4: Part C|Other|0|||
126477973|NCT04457336|455049959|FG005|Period 4: Part C|Other|0|||
126477974|NCT04457336|455049960|FG006|Period 4: Part C|Other|0|||
126477975|NCT04457336|455049961|FG007|Period 4: Part C|Other|2|||
126477976|NCT04457336|455049954|FG000|Period 4: Part C|Withdrawal by Subject|0|||
126477977|NCT04457336|455049955|FG001|Period 4: Part C|Withdrawal by Subject|0|||
126477978|NCT04457336|455049956|FG002|Period 4: Part C|Withdrawal by Subject|0|||
126477979|NCT04457336|455049957|FG003|Period 4: Part C|Withdrawal by Subject|0|||
126477980|NCT04457336|455049958|FG004|Period 4: Part C|Withdrawal by Subject|0|||
126477981|NCT04457336|455049959|FG005|Period 4: Part C|Withdrawal by Subject|0|||
126477982|NCT04457336|455049960|FG006|Period 4: Part C|Withdrawal by Subject|0|||
126477983|NCT04457336|455049961|FG007|Period 4: Part C|Withdrawal by Subject|3|||
126477984|NCT04447794|455049964|FG000|Overall Study|Lost to Follow-up|2|||
126477985|NCT04447794|455049965|FG001|Overall Study|Lost to Follow-up|3|||
126477986|NCT04447794|455049966|FG002|Overall Study|Lost to Follow-up|8|||
126477987|NCT04447794|455049964|FG000|Overall Study|Withdrawal by Subject|1|||
126477988|NCT04447794|455049965|FG001|Overall Study|Withdrawal by Subject|1|||
126477989|NCT04447794|455049966|FG002|Overall Study|Withdrawal by Subject|0|||
126477990|NCT02571075|455049967|FG000|Overall Study|Lost to Follow-up|20|||
126477991|NCT02571075|455049968|FG001|Overall Study|Lost to Follow-up|24|||
126477992|NCT02693119|455049971|FG000|Open-Label Period|Withdrawal by Subject|0|||
126477993|NCT02693119|455049972|FG001|Open-Label Period|Withdrawal by Subject|1|||
126477994|NCT00963937|455049975|FG000|Overall Study|Protocol Violation|1|||
126477995|NCT00963937|455049976|FG001|Overall Study|Protocol Violation|1|||
126477996|NCT00963937|455049977|FG002|Overall Study|Protocol Violation|0|||
126477997|NCT00963937|455049975|FG000|Overall Study|Physician Decision|18|||
126477998|NCT00963937|455049976|FG001|Overall Study|Physician Decision|10|||
126477999|NCT00963937|455049977|FG002|Overall Study|Physician Decision|4|||
126478000|NCT00205881|455049978|FG000|Overall Study|Withdrawal by Subject|16|||
126478001|NCT01235689|455049984|FG000|Overall Study|Adverse Event|12|||
126478002|NCT01235689|455049985|FG001|Overall Study|Adverse Event|16|||
126478003|NCT01235689|455049984|FG000|Overall Study|Lack of Efficacy|12|||
126478004|NCT01235689|455049985|FG001|Overall Study|Lack of Efficacy|5|||
126478005|NCT01235689|455049984|FG000|Overall Study|Withdrawal by Subject|3|||
126478006|NCT01235689|455049985|FG001|Overall Study|Withdrawal by Subject|4|||
126478007|NCT01235689|455049984|FG000|Overall Study|Lost to Follow-up|1|||
126478008|NCT01235689|455049985|FG001|Overall Study|Lost to Follow-up|2|||
126478009|NCT01235689|455049984|FG000|Overall Study|Miscellaneous|1|||
126478010|NCT01235689|455049985|FG001|Overall Study|Miscellaneous|5|||
126478011|NCT00389597|455049986|FG000|Overall Study|Lost to Follow-up|8|||
126478012|NCT00389597|455049987|FG001|Overall Study|Lost to Follow-up|6|||
126478013|NCT00389597|455049988|FG002|Overall Study|Lost to Follow-up|4|||
126478014|NCT00389597|455049989|FG003|Overall Study|Lost to Follow-up|6|||
126478015|NCT00005044|455049990|FG000|Overall Study|Protocol Violation|37|||
126478016|NCT00005044|455049991|FG001|Overall Study|Protocol Violation|46|||
126478017|NCT00005044|455049990|FG000|Overall Study|Withdrawal by Subject|1|||
126478018|NCT00005044|455049991|FG001|Overall Study|Withdrawal by Subject|5|||
126478019|NCT00005044|455049990|FG000|Overall Study|No protocol treatment|0|||
126478020|NCT00005044|455049991|FG001|Overall Study|No protocol treatment|1|||
126478021|NCT04431453|455049992|FG000|Overall Study|Withdrew Consent|0|||
126478022|NCT04431453|455049993|FG001|Overall Study|Withdrew Consent|1|||
126478023|NCT04431453|455049994|FG002|Overall Study|Withdrew Consent|0|||
126478024|NCT04431453|455049995|FG003|Overall Study|Withdrew Consent|2|||
126478025|NCT04431453|455049996|FG004|Overall Study|Withdrew Consent|0|||
126478026|NCT04431453|455049997|FG005|Overall Study|Withdrew Consent|0|||
126478027|NCT04431453|455049998|FG006|Overall Study|Withdrew Consent|0|||
126478028|NCT04431453|455049999|FG007|Overall Study|Withdrew Consent|0|||
126478029|NCT04431453|455049992|FG000|Overall Study|Death|1|||
126478030|NCT04431453|455049993|FG001|Overall Study|Death|0|||
126478031|NCT04431453|455049994|FG002|Overall Study|Death|0|||
126478032|NCT04431453|455049995|FG003|Overall Study|Death|0|||
126478033|NCT04431453|455049996|FG004|Overall Study|Death|0|||
126478034|NCT04431453|455049997|FG005|Overall Study|Death|0|||
126478035|NCT04431453|455049998|FG006|Overall Study|Death|0|||
126478036|NCT04431453|455049999|FG007|Overall Study|Death|1|||
126478037|NCT04431453|455049992|FG000|Overall Study|Lost to Follow-up|0|||
126478038|NCT04431453|455049993|FG001|Overall Study|Lost to Follow-up|0|||
126722138|NCT00111475|455933274|FG009|Overall Study|Lost to Follow-up|0|||
126478039|NCT04431453|455049994|FG002|Overall Study|Lost to Follow-up|1|||
126478040|NCT04431453|455049995|FG003|Overall Study|Lost to Follow-up|1|||
126478041|NCT04431453|455049996|FG004|Overall Study|Lost to Follow-up|0|||
126478042|NCT04431453|455049997|FG005|Overall Study|Lost to Follow-up|0|||
126478043|NCT04431453|455049998|FG006|Overall Study|Lost to Follow-up|0|||
126478044|NCT04431453|455049999|FG007|Overall Study|Lost to Follow-up|0|||
126478045|NCT04431453|455049992|FG000|Overall Study|Enrolled but Never Treated|0|||
126478046|NCT04431453|455049993|FG001|Overall Study|Enrolled but Never Treated|0|||
126478047|NCT04431453|455049994|FG002|Overall Study|Enrolled but Never Treated|0|||
126722139|NCT03303092|455933275|FG000|Overall Study|Adverse Event|1|||
126478048|NCT04431453|455049995|FG003|Overall Study|Enrolled but Never Treated|0|||
126478049|NCT04431453|455049996|FG004|Overall Study|Enrolled but Never Treated|1|||
126478050|NCT04431453|455049997|FG005|Overall Study|Enrolled but Never Treated|0|||
126478051|NCT04431453|455049998|FG006|Overall Study|Enrolled but Never Treated|0|||
126478052|NCT04431453|455049999|FG007|Overall Study|Enrolled but Never Treated|0|||
126478053|NCT03546062|455050000|FG000|Overall Study|Adverse Event|6|||
126478054|NCT03546062|455050001|FG001|Overall Study|Adverse Event|5|||
126478055|NCT03546062|455050002|FG002|Overall Study|Adverse Event|8|||
126478056|NCT02083965|455050004|FG000|Treatment Period|Other|1|||
126478057|NCT02083965|455050005|FG001|Treatment Period|Other|0|||
126478058|NCT04502433|455050007|FG000|Overall Study|Death|2|||
126478059|NCT04502433|455050008|FG001|Overall Study|Death|4|||
126478060|NCT04502433|455050007|FG000|Overall Study|Lost to Follow-up|1|||
126478061|NCT04502433|455050008|FG001|Overall Study|Lost to Follow-up|0|||
126478062|NCT04502433|455050007|FG000|Overall Study|Physician Decision|0|||
126478063|NCT04502433|455050008|FG001|Overall Study|Physician Decision|1|||
126478064|NCT02935842|455050009|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
126478065|NCT02935842|455050010|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
126478066|NCT02935842|455050011|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
126478067|NCT02935842|455050012|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
126478068|NCT02935842|455050009|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
126478069|NCT02935842|455050010|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
126478070|NCT02935842|455050011|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
126478071|NCT02935842|455050012|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
126478072|NCT02935842|455050009|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
126478073|NCT02935842|455050010|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
126478074|NCT02935842|455050011|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
126478075|NCT02935842|455050012|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
126478076|NCT02935842|455050009|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
126478077|NCT02935842|455050010|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
126478078|NCT02935842|455050011|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
126478079|NCT02935842|455050012|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
126478080|NCT02935842|455050009|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
126478081|NCT02935842|455050010|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
126478082|NCT02935842|455050011|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
126478083|NCT02935842|455050012|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
126478084|NCT01201785|455050015|FG000|Overall Study|Lost to Follow-up|16|||
126478085|NCT04545385|455050016|FG000|Overall Study|Withdrawal by Subject|2|||
126478086|NCT04545385|455050017|FG001|Overall Study|Withdrawal by Subject|0|||
126478087|NCT04545385|455050016|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
126478088|NCT04545385|455050017|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
126478089|NCT04545385|455050016|FG000|Overall Study|Study termination|10|||
126478090|NCT04545385|455050017|FG001|Overall Study|Study termination|10|||
126478091|NCT04545385|455050016|FG000|Overall Study|Sponsor decision|2|||
126478092|NCT04545385|455050017|FG001|Overall Study|Sponsor decision|2|||
126478093|NCT04545385|455050016|FG000|Overall Study|Other than specified|1|||
126478094|NCT04545385|455050017|FG001|Overall Study|Other than specified|0|||
126478095|NCT02369016|455050018|FG000|Overall Study|AE associated with clinical disease progression|2|||
126478096|NCT02369016|455050019|FG001|Overall Study|AE associated with clinical disease progression|1|||
126478097|NCT02369016|455050018|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
126478098|NCT02369016|455050019|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
126478099|NCT02369016|455050018|FG000|Overall Study|Progressive disease - clinical progression|1|||
126478100|NCT02369016|455050019|FG001|Overall Study|Progressive disease - clinical progression|4|||
126478101|NCT02369016|455050018|FG000|Overall Study|withdrawal by patient|4|||
126478102|NCT02369016|455050019|FG001|Overall Study|withdrawal by patient|0|||
126722140|NCT03303092|455933276|FG001|Overall Study|Adverse Event|0|||
126722141|NCT03303092|455933277|FG002|Overall Study|Adverse Event|1|||
126722142|NCT03303092|455933275|FG000|Overall Study|Protocol Violation|1|||
126722143|NCT03303092|455933276|FG001|Overall Study|Protocol Violation|5|||
126478103|NCT02369016|455050018|FG000|Overall Study|Progressive disease - radiological progression|6|||
126478104|NCT02369016|455050019|FG001|Overall Study|Progressive disease - radiological progression|2|||
126478105|NCT01702961|455050020|FG000|Overall Study|Additional treatment|3|||
126478106|NCT01702961|455050020|FG000|Overall Study|Progressive disease|5|||
126478107|NCT01702961|455050020|FG000|Overall Study|Relapse|20|||
126478108|NCT01702961|455050020|FG000|Overall Study|Death|6|||
126478109|NCT01702961|455050020|FG000|Overall Study|Lost to Follow-up|2|||
126478110|NCT01702961|455050020|FG000|Overall Study|Ongoing|11|||
126478111|NCT02229383|455050021|FG000|Overall Study|Adverse Event|7|||
126478112|NCT02229383|455050022|FG001|Overall Study|Adverse Event|4|||
126478113|NCT02229383|455050021|FG000|Overall Study|Death|0|||
126478114|NCT02229383|455050022|FG001|Overall Study|Death|1|||
126722144|NCT03303092|455933277|FG002|Overall Study|Protocol Violation|1|||
126722145|NCT03303092|455933275|FG000|Overall Study|Withdrawal by Subject|1|||
126478115|NCT02229383|455050021|FG000|Overall Study|Lost to Follow-up|5|||
126478116|NCT02229383|455050022|FG001|Overall Study|Lost to Follow-up|3|||
126478117|NCT02229383|455050021|FG000|Overall Study|Withdrawal by Subject|4|||
126478118|NCT02229383|455050022|FG001|Overall Study|Withdrawal by Subject|6|||
126478119|NCT02229383|455050021|FG000|Overall Study|Did not receive treatment|1|||
126478120|NCT02229383|455050022|FG001|Overall Study|Did not receive treatment|0|||
126478121|NCT02229383|455050021|FG000|Overall Study|Other|3|||
126478122|NCT02229383|455050022|FG001|Overall Study|Other|8|||
126478123|NCT00674362|455050023|FG000|Double Blind|Adverse Event|6|||
126478124|NCT00674362|455050024|FG001|Double Blind|Adverse Event|6|||
126478125|NCT00674362|455050023|FG000|Double Blind|Lack of Efficacy|2|||
126478126|NCT00674362|455050024|FG001|Double Blind|Lack of Efficacy|6|||
126478127|NCT00674362|455050023|FG000|Double Blind|Loss of efficacy|0|||
126478128|NCT00674362|455050024|FG001|Double Blind|Loss of efficacy|1|||
126478129|NCT00674362|455050023|FG000|Double Blind|Withdrawal by Subject|4|||
126478130|NCT00674362|455050024|FG001|Double Blind|Withdrawal by Subject|3|||
126478131|NCT00674362|455050023|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
126478132|NCT00674362|455050024|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
126478133|NCT00674362|455050023|FG000|Double Blind|Other: Surgery|0|||
126478134|NCT00674362|455050024|FG001|Double Blind|Other: Surgery|1|||
126478135|NCT00674362|455050023|FG000|Open Label|Adverse Event|1|||
126478136|NCT00674362|455050024|FG001|Open Label|Adverse Event|0|||
126478137|NCT00674362|455050023|FG000|Open Label|Other: Subject moved to extension study|1|||
126478138|NCT00674362|455050024|FG001|Open Label|Other: Subject moved to extension study|0|||
126478139|NCT01201850|455050026|FG000|Overall Study|Tumor progression|4|||
126478140|NCT00191139|455050027|FG000|Overall Study|Adverse Event|2|||
126478141|NCT00191139|455050028|FG001|Overall Study|Adverse Event|6|||
126478142|NCT00191139|455050027|FG000|Overall Study|Death|2|||
126478143|NCT00191139|455050028|FG001|Overall Study|Death|0|||
126478144|NCT00191139|455050027|FG000|Overall Study|Withdrawal by Subject|0|||
126478145|NCT00191139|455050028|FG001|Overall Study|Withdrawal by Subject|3|||
126478146|NCT00191139|455050027|FG000|Overall Study|Disease Progression|0|||
126478147|NCT00191139|455050028|FG001|Overall Study|Disease Progression|1|||
126478148|NCT00191139|455050027|FG000|Overall Study|Other|1|||
126478149|NCT00191139|455050028|FG001|Overall Study|Other|2|||
126478150|NCT03846804|455050029|FG000|Overall Study|Refused blood draw|1|||
126478151|NCT03846804|455050029|FG000|Overall Study|Protocol Violation|1|||
126478152|NCT00404235|455050030|FG000|Overall Study|Withdrawal by Subject|1|||
126478153|NCT00404235|455050031|FG001|Overall Study|Withdrawal by Subject|2|||
126478154|NCT00345839|455050032|FG000|Overall Study|Withdrawal by Subject|91|||
126478155|NCT00345839|455050033|FG001|Overall Study|Withdrawal by Subject|98|||
126478156|NCT00345839|455050032|FG000|Overall Study|Lost to Follow-up|58|||
126478157|NCT00345839|455050033|FG001|Overall Study|Lost to Follow-up|61|||
126478158|NCT00743483|455050036|FG000|Baseline Period|Physician Decision|1|||
126478159|NCT00743483|455050036|FG000|Treatment Period|Adverse Event|1|||
126478160|NCT01466153|455050037|FG000|Overall Study|Disease Progression|2|||
126478161|NCT01466153|455050038|FG001|Overall Study|Disease Progression|2|||
126478162|NCT01466153|455050039|FG002|Overall Study|Disease Progression|0|||
126478163|NCT01466153|455050037|FG000|Overall Study|Adverse Event|14|||
126478164|NCT01466153|455050038|FG001|Overall Study|Adverse Event|13|||
126478165|NCT01466153|455050039|FG002|Overall Study|Adverse Event|17|||
126478166|NCT01466153|455050037|FG000|Overall Study|Withdrawal of Consent|2|||
126478167|NCT01466153|455050038|FG001|Overall Study|Withdrawal of Consent|0|||
126478168|NCT01466153|455050039|FG002|Overall Study|Withdrawal of Consent|0|||
126478169|NCT01466153|455050037|FG000|Overall Study|Investigator Discretion|3|||
126478170|NCT01466153|455050038|FG001|Overall Study|Investigator Discretion|2|||
126478171|NCT01466153|455050039|FG002|Overall Study|Investigator Discretion|2|||
126478172|NCT01466153|455050037|FG000|Overall Study|Randomized-Not Treated|2|||
126478173|NCT01466153|455050038|FG001|Overall Study|Randomized-Not Treated|3|||
126478174|NCT01466153|455050039|FG002|Overall Study|Randomized-Not Treated|4|||
126478175|NCT01466153|455050037|FG000|Overall Study|Other-Unspecified|6|||
126478176|NCT01466153|455050038|FG001|Overall Study|Other-Unspecified|4|||
126478177|NCT01466153|455050039|FG002|Overall Study|Other-Unspecified|2|||
126478178|NCT02323113|455051762|FG000|Overall Study|Adverse Event|3|||
126478179|NCT02323113|455051763|FG001|Overall Study|Adverse Event|3|||
126478180|NCT02323113|455051764|FG002|Overall Study|Adverse Event|2|||
126478181|NCT02323113|455051765|FG003|Overall Study|Adverse Event|5|||
126478182|NCT02323113|455051766|FG004|Overall Study|Adverse Event|8|||
126478183|NCT02323113|455051767|FG005|Overall Study|Adverse Event|3|||
126478184|NCT02323113|455051768|FG006|Overall Study|Adverse Event|6|||
126478185|NCT02323113|455051769|FG007|Overall Study|Adverse Event|0|||
126478186|NCT02323113|455051762|FG000|Overall Study|Progressive Disease|0|||
126478187|NCT02323113|455051763|FG001|Overall Study|Progressive Disease|1|||
126478188|NCT02323113|455051764|FG002|Overall Study|Progressive Disease|1|||
126478189|NCT02323113|455051765|FG003|Overall Study|Progressive Disease|0|||
126478190|NCT02323113|455051766|FG004|Overall Study|Progressive Disease|0|||
126478191|NCT02323113|455051767|FG005|Overall Study|Progressive Disease|3|||
126478192|NCT02323113|455051768|FG006|Overall Study|Progressive Disease|0|||
126478193|NCT02323113|455051769|FG007|Overall Study|Progressive Disease|0|||
126478194|NCT02323113|455051762|FG000|Overall Study|Symptomatic Deterioration|0|||
126478195|NCT02323113|455051763|FG001|Overall Study|Symptomatic Deterioration|0|||
126478196|NCT02323113|455051764|FG002|Overall Study|Symptomatic Deterioration|1|||
126478197|NCT02323113|455051765|FG003|Overall Study|Symptomatic Deterioration|0|||
126478198|NCT02323113|455051766|FG004|Overall Study|Symptomatic Deterioration|1|||
126478199|NCT02323113|455051767|FG005|Overall Study|Symptomatic Deterioration|0|||
126478200|NCT02323113|455051768|FG006|Overall Study|Symptomatic Deterioration|0|||
126478201|NCT02323113|455051769|FG007|Overall Study|Symptomatic Deterioration|0|||
126478202|NCT02323113|455051762|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
126478203|NCT02323113|455051763|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
126478204|NCT02323113|455051764|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
126478205|NCT02323113|455051765|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
126478206|NCT02323113|455051766|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
126478207|NCT02323113|455051767|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
126478208|NCT02323113|455051768|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
126478209|NCT02323113|455051769|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
126478210|NCT02323113|455051762|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
126478211|NCT02323113|455051763|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
126478212|NCT02323113|455051764|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
126478213|NCT02323113|455051765|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
126478214|NCT02323113|455051766|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
126478215|NCT02323113|455051767|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
126478216|NCT02323113|455051768|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
126478217|NCT02323113|455051769|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
126478218|NCT03281577|455051770|FG000|Overall Study|Adverse Event|0|||
126478219|NCT03281577|455051771|FG001|Overall Study|Adverse Event|0|||
126478220|NCT03281577|455051772|FG002|Overall Study|Adverse Event|0|||
126478221|NCT03281577|455051773|FG003|Overall Study|Adverse Event|1|||
126478222|NCT03281577|455051770|FG000|Overall Study|Withdrawal by Subject|1|||
126478223|NCT03281577|455051771|FG001|Overall Study|Withdrawal by Subject|0|||
126478224|NCT03281577|455051772|FG002|Overall Study|Withdrawal by Subject|0|||
126478225|NCT03281577|455051773|FG003|Overall Study|Withdrawal by Subject|0|||
126478226|NCT00443261|455051774|FG000|Overall Study|Death|1|||
126478227|NCT01663532|455051775|FG000|Overall Study|Lost to Follow-up|9|||
126478228|NCT01663532|455051776|FG001|Overall Study|Lost to Follow-up|10|||
126478229|NCT01663532|455051775|FG000|Overall Study|Adverse Event|7|||
126478230|NCT01663532|455051776|FG001|Overall Study|Adverse Event|13|||
126478231|NCT01663532|455051775|FG000|Overall Study|Met Withdrawal Criteria|7|||
126478232|NCT01663532|455051776|FG001|Overall Study|Met Withdrawal Criteria|6|||
126478233|NCT01663532|455051775|FG000|Overall Study|Physician Decision|1|||
126478234|NCT01663532|455051776|FG001|Overall Study|Physician Decision|1|||
126478235|NCT01663532|455051775|FG000|Overall Study|Withdrawal by Subject|35|||
126478236|NCT01663532|455051776|FG001|Overall Study|Withdrawal by Subject|17|||
126478237|NCT01663532|455051775|FG000|Overall Study|Lack of Efficacy|15|||
126478238|NCT01663532|455051776|FG001|Overall Study|Lack of Efficacy|60|||
126478239|NCT01433991|455051778|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
126478240|NCT01433991|455051779|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
126478241|NCT01433991|455051780|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
126478242|NCT01433991|455051781|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
126478243|NCT01433991|455051778|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
126478244|NCT01433991|455051779|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
126478245|NCT01433991|455051780|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
126478246|NCT01433991|455051781|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
126478247|NCT01433991|455051778|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
126478248|NCT01433991|455051779|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
126478249|NCT01433991|455051780|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
126478250|NCT01433991|455051781|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
126478251|NCT01433991|455051778|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
126478252|NCT01433991|455051779|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
126478253|NCT01433991|455051780|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
126478254|NCT01433991|455051781|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
126478255|NCT01433991|455051778|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
126478256|NCT01433991|455051779|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
126478257|NCT01433991|455051780|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
126478258|NCT01433991|455051781|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
126478259|NCT01433991|455051778|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
126772339|NCT03959137|456122095|FG000|Overall Study|Protocol Violation|6|||
126478260|NCT01433991|455051779|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
126478261|NCT01433991|455051780|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
126478262|NCT01433991|455051781|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
126478263|NCT01433991|455051778|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
126478264|NCT01433991|455051779|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
126478265|NCT01433991|455051780|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
126478266|NCT01433991|455051781|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
126478267|NCT00354744|455051782|FG000|Overall Study|Adverse Event|2|||
126478268|NCT00354744|455051782|FG000|Overall Study|Death|2|||
126478269|NCT00354744|455051782|FG000|Overall Study|Lack of Efficacy|11|||
126478270|NCT00354744|455051782|FG000|Overall Study|Lost to Follow-up|2|||
126478271|NCT00354744|455051782|FG000|Overall Study|Physician Decision|11|||
126478272|NCT00354744|455051782|FG000|Overall Study|Withdrawal by Subject|14|||
126478273|NCT01193530|455051783|FG000|Overall Study|Withdrawal by Subject|2|||
126478274|NCT01193530|455051784|FG001|Overall Study|Withdrawal by Subject|2|||
126478275|NCT01193530|455051783|FG000|Overall Study|Began Contraindicated Therapy|1|||
126478276|NCT01193530|455051784|FG001|Overall Study|Began Contraindicated Therapy|0|||
126478277|NCT01193530|455051783|FG000|Overall Study|Lost Light Box|0|||
126478278|NCT01193530|455051784|FG001|Overall Study|Lost Light Box|1|||
126478279|NCT01193530|455051783|FG000|Overall Study|Returned home - out of state|0|||
126478280|NCT01193530|455051784|FG001|Overall Study|Returned home - out of state|1|||
126478281|NCT01193530|455051783|FG000|Overall Study|Non-Compliance|0|||
126478282|NCT01193530|455051784|FG001|Overall Study|Non-Compliance|1|||
126478283|NCT01513343|455051787|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
126478284|NCT01513343|455051788|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
126478285|NCT01513343|455051787|FG000|Post Data Collection|Dropped/withdrew from study|7|||
126478286|NCT01513343|455051788|FG001|Post Data Collection|Dropped/withdrew from study|1|||
126478287|NCT01513343|455051787|FG000|Post Data Collection|Lost to Follow-up|10|||
126478288|NCT01513343|455051788|FG001|Post Data Collection|Lost to Follow-up|23|||
126478289|NCT01513343|455051787|FG000|6-month Follow-up|Lost to Follow-up|28|||
126478290|NCT01513343|455051788|FG001|6-month Follow-up|Lost to Follow-up|17|||
126478291|NCT01513343|455051787|FG000|12-month Follow-up|Lost to Follow-up|10|||
126478292|NCT01513343|455051788|FG001|12-month Follow-up|Lost to Follow-up|3|||
126478293|NCT01921387|455051789|FG000|Overall Study|Adverse Event|1|||
126478294|NCT01706146|455051791|FG000|Overall Study|Withdrawal by Subject|1|||
126478295|NCT01706146|455051791|FG000|Overall Study|Adverse Event|3|||
126478296|NCT01706146|455051791|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
126478297|NCT02582983|455051792|FG000|Overall Study|Death|3|||
126478298|NCT02582983|455051792|FG000|Overall Study|Withdrawal by Subject|2|||
126478299|NCT02582983|455051792|FG000|Overall Study|Adverse Event|1|||
126478300|NCT01007812|455051797|FG000|Period 1, One Week|Lost to Follow-up|0|||
126478301|NCT01007812|455051798|FG001|Period 1, One Week|Lost to Follow-up|1|||
126478302|NCT01007812|455051797|FG000|Period 1, One Week|Discomfort|1|||
126478303|NCT01007812|455051798|FG001|Period 1, One Week|Discomfort|0|||
126478304|NCT01091974|455051799|FG000|Overall Study|Did not start intervention|3|||
126478305|NCT01091974|455051800|FG001|Overall Study|Did not start intervention|1|||
126478306|NCT01091974|455051801|FG002|Overall Study|Did not start intervention|3|||
126478307|NCT01091974|455051802|FG003|Overall Study|Did not start intervention|1|||
126478308|NCT01091974|455051799|FG000|Overall Study|resumed sleep medication|0|||
126478309|NCT01091974|455051800|FG001|Overall Study|resumed sleep medication|0|||
126478310|NCT01091974|455051801|FG002|Overall Study|resumed sleep medication|1|||
126478311|NCT01091974|455051802|FG003|Overall Study|resumed sleep medication|2|||
126478312|NCT01091974|455051799|FG000|Overall Study|Withdrawal by Subject|1|||
126478313|NCT01091974|455051800|FG001|Overall Study|Withdrawal by Subject|3|||
126478314|NCT01091974|455051801|FG002|Overall Study|Withdrawal by Subject|2|||
126478315|NCT01091974|455051802|FG003|Overall Study|Withdrawal by Subject|2|||
126478316|NCT01091974|455051799|FG000|Overall Study|side-effects|1|||
126478317|NCT01091974|455051800|FG001|Overall Study|side-effects|1|||
126478318|NCT01091974|455051801|FG002|Overall Study|side-effects|0|||
126478319|NCT01091974|455051802|FG003|Overall Study|side-effects|2|||
126478320|NCT00555971|455051804|FG000|Overall Study|Adverse Event|1|||
126478321|NCT00555971|455051805|FG001|Overall Study|Adverse Event|1|||
126478322|NCT00518284|455051806|FG000|Overall Study|Adverse Event|0|||
126478323|NCT00518284|455051807|FG001|Overall Study|Adverse Event|1|||
126478324|NCT00518284|455051808|FG002|Overall Study|Adverse Event|0|||
126478325|NCT00518284|455051809|FG003|Overall Study|Adverse Event|0|||
126478326|NCT00518284|455051806|FG000|Overall Study|Study Termination|0|||
126478327|NCT00518284|455051807|FG001|Overall Study|Study Termination|2|||
126478328|NCT00518284|455051808|FG002|Overall Study|Study Termination|1|||
126478329|NCT00518284|455051809|FG003|Overall Study|Study Termination|2|||
126478330|NCT02571777|455051810|FG000|Overall Study|Subject/guardian decision|34|||
126478331|NCT02571777|455051811|FG001|Overall Study|Subject/guardian decision|26|||
126478332|NCT02571777|455051812|FG002|Overall Study|Subject/guardian decision|26|||
126478333|NCT02571777|455051813|FG003|Overall Study|Subject/guardian decision|25|||
126478334|NCT02571777|455051814|FG004|Overall Study|Subject/guardian decision|27|||
126478335|NCT02571777|455051810|FG000|Overall Study|Protocol Deviation|2|||
126722146|NCT03303092|455933276|FG001|Overall Study|Withdrawal by Subject|1|||
126722147|NCT03303092|455933277|FG002|Overall Study|Withdrawal by Subject|3|||
126722148|NCT01995136|455933280|FG000|Overall Study|Change in residence|1|||
126722149|NCT00748540|455933281|FG000|Overall Study|Physician Decision|1|||
126722150|NCT01814800|455933282|FG000|Overall Study|Adverse Event|2|||
126722151|NCT01814800|455933282|FG000|Overall Study|Pregnancy|1|||
126478336|NCT02571777|455051811|FG001|Overall Study|Protocol Deviation|3|||
126478337|NCT02571777|455051812|FG002|Overall Study|Protocol Deviation|4|||
126478338|NCT02571777|455051813|FG003|Overall Study|Protocol Deviation|8|||
126478339|NCT02571777|455051814|FG004|Overall Study|Protocol Deviation|4|||
126478340|NCT02571777|455051810|FG000|Overall Study|Death|1|||
126478341|NCT02571777|455051811|FG001|Overall Study|Death|1|||
126478342|NCT02571777|455051812|FG002|Overall Study|Death|4|||
126478343|NCT02571777|455051813|FG003|Overall Study|Death|0|||
126478344|NCT02571777|455051814|FG004|Overall Study|Death|0|||
126478345|NCT02571777|455051810|FG000|Overall Study|Lost to Follow-up|1|||
126478346|NCT02571777|455051811|FG001|Overall Study|Lost to Follow-up|1|||
126478347|NCT02571777|455051812|FG002|Overall Study|Lost to Follow-up|2|||
126478348|NCT02571777|455051813|FG003|Overall Study|Lost to Follow-up|0|||
126478349|NCT02571777|455051814|FG004|Overall Study|Lost to Follow-up|1|||
126478350|NCT02571777|455051810|FG000|Overall Study|Physician Decision|1|||
126478351|NCT02571777|455051811|FG001|Overall Study|Physician Decision|7|||
126478352|NCT02571777|455051812|FG002|Overall Study|Physician Decision|5|||
126478353|NCT02571777|455051813|FG003|Overall Study|Physician Decision|2|||
126478354|NCT02571777|455051814|FG004|Overall Study|Physician Decision|4|||
126478355|NCT02571777|455051810|FG000|Overall Study|Pregnancy|0|||
126478356|NCT02571777|455051811|FG001|Overall Study|Pregnancy|0|||
126478357|NCT02571777|455051812|FG002|Overall Study|Pregnancy|0|||
126478358|NCT02571777|455051813|FG003|Overall Study|Pregnancy|2|||
126478359|NCT02571777|455051814|FG004|Overall Study|Pregnancy|0|||
126478360|NCT00801632|455051815|FG000|Overall Study|Re-transplant|1|||
126478361|NCT03095612|455051818|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
126478362|NCT03095612|455051819|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
126478363|NCT03095612|455051820|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
126478364|NCT03095612|455051821|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
126478365|NCT03095612|455051822|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
126478366|NCT03095612|455051823|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
126478367|NCT03095612|455051824|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
126478368|NCT00621582|455051825|FG000|Overall Study|Adverse Event|7|||
126478369|NCT00621582|455051825|FG000|Overall Study|Protocol Violation|57|||
126478370|NCT00621582|455051825|FG000|Overall Study|Lost to Follow-up|24|||
126478371|NCT00621582|455051825|FG000|Overall Study|issues not identified by investigators|18|||
126478372|NCT01387932|455051827|FG000|Randomized and Treated|Physician Decision|3|||
126478373|NCT01387932|455051828|FG001|Randomized and Treated|Physician Decision|2|||
126478374|NCT01387932|455051827|FG000|Randomized and Treated|Withdrawal by Subject|4|||
126478375|NCT01387932|455051828|FG001|Randomized and Treated|Withdrawal by Subject|2|||
126478376|NCT01387932|455051827|FG000|Survival Follow-up|Liver Transplant|24|||
126478377|NCT01387932|455051828|FG001|Survival Follow-up|Liver Transplant|28|||
126478378|NCT01387932|455051827|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
126478379|NCT01387932|455051828|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
126478380|NCT01387932|455051827|FG000|Survival Follow-up|Withdrawal by Subject|2|||
126478381|NCT01387932|455051828|FG001|Survival Follow-up|Withdrawal by Subject|4|||
126478382|NCT01387932|455051827|FG000|Survival Follow-up|Lost to Follow-up|6|||
126478383|NCT01387932|455051828|FG001|Survival Follow-up|Lost to Follow-up|5|||
126478384|NCT00781274|455051830|FG000|Overall Study|Withdrawal by Subject|2|||
126478385|NCT01534962|455051831|FG000|Overall Study|Randomized but did not start treatment|2|||
126478386|NCT01534962|455051832|FG001|Overall Study|Randomized but did not start treatment|0|||
126478387|NCT01534962|455051833|FG002|Overall Study|Randomized but did not start treatment|0|||
126478388|NCT01534962|455051834|FG003|Overall Study|Randomized but did not start treatment|1|||
126478389|NCT01534962|455051831|FG000|Overall Study|Discontinued at AF recurrence|35|||
126478390|NCT01534962|455051832|FG001|Overall Study|Discontinued at AF recurrence|26|||
126478391|NCT01534962|455051833|FG002|Overall Study|Discontinued at AF recurrence|24|||
126478392|NCT01534962|455051834|FG003|Overall Study|Discontinued at AF recurrence|31|||
126722152|NCT01814800|455933282|FG000|Overall Study|Sponsor decision|1|||
126478393|NCT00087607|455051835|FG000|Overall Study|Adverse Event|14|||
126478394|NCT00087607|455051836|FG001|Overall Study|Adverse Event|24|||
126478395|NCT00087607|455051835|FG000|Overall Study|Death|0|||
126478396|NCT00087607|455051836|FG001|Overall Study|Death|1|||
126478397|NCT00087607|455051835|FG000|Overall Study|Insufficient Therapeutic Response|53|||
126478398|NCT00087607|455051836|FG001|Overall Study|Insufficient Therapeutic Response|42|||
126478399|NCT00087607|455051835|FG000|Overall Study|Failure to return|21|||
126722153|NCT01814800|455933282|FG000|Overall Study|Subject relocation|1|||
126722154|NCT02371759|455933283|FG000|Overall Study|Protocol Violation|3|||
126478400|NCT00087607|455051836|FG001|Overall Study|Failure to return|17|||
126478401|NCT00087607|455051835|FG000|Overall Study|Withdrew Consent|12|||
126478402|NCT00087607|455051836|FG001|Overall Study|Withdrew Consent|16|||
126478403|NCT00087607|455051835|FG000|Overall Study|Administrative|12|||
126478404|NCT00087607|455051836|FG001|Overall Study|Administrative|12|||
126478405|NCT00087607|455051835|FG000|Overall Study|Refused Treatment|5|||
126478406|NCT00087607|455051836|FG001|Overall Study|Refused Treatment|7|||
126478407|NCT00087607|455051835|FG000|Overall Study|Other Protocol Violation|5|||
126478408|NCT00087607|455051836|FG001|Overall Study|Other Protocol Violation|2|||
126478409|NCT00087607|455051835|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
126478410|NCT00087607|455051836|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
126478411|NCT00190671|455051837|FG000|Overall Study|Satisfactory Response|4|||
126478412|NCT00190671|455051838|FG001|Overall Study|Satisfactory Response|7|||
126478413|NCT00190671|455051837|FG000|Overall Study|Lack of Efficacy|19|||
126478414|NCT00190671|455051838|FG001|Overall Study|Lack of Efficacy|24|||
126478415|NCT00190671|455051837|FG000|Overall Study|Death from Study Disease|1|||
126478416|NCT00190671|455051838|FG001|Overall Study|Death from Study Disease|1|||
126478417|NCT00190671|455051837|FG000|Overall Study|Adverse Event|3|||
126478418|NCT00190671|455051838|FG001|Overall Study|Adverse Event|2|||
126478419|NCT00190671|455051837|FG000|Overall Study|Clinical Relapse|0|||
126478420|NCT00190671|455051838|FG001|Overall Study|Clinical Relapse|1|||
126478421|NCT00190671|455051837|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
126478422|NCT00190671|455051838|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
126478423|NCT00190671|455051837|FG000|Overall Study|Death from Other Causes|0|||
126478424|NCT00190671|455051838|FG001|Overall Study|Death from Other Causes|2|||
126478425|NCT00190671|455051837|FG000|Overall Study|Protocol Violation|0|||
126478426|NCT00190671|455051838|FG001|Overall Study|Protocol Violation|1|||
126478427|NCT00190671|455051837|FG000|Overall Study|Withdrawal by Subject|0|||
126478428|NCT00190671|455051838|FG001|Overall Study|Withdrawal by Subject|2|||
126478429|NCT00191269|455051839|FG000|Overall Study|Protocol Violation|0|||
126478430|NCT00191269|455051840|FG001|Overall Study|Protocol Violation|2|||
126478431|NCT00191269|455051839|FG000|Overall Study|Adverse Event|1|||
126478432|NCT00191269|455051840|FG001|Overall Study|Adverse Event|4|||
126478433|NCT00191269|455051839|FG000|Overall Study|Progression of Disease|4|||
126478434|NCT00191269|455051840|FG001|Overall Study|Progression of Disease|42|||
126478435|NCT00191269|455051839|FG000|Overall Study|Lack of Efficacy|1|||
126478436|NCT00191269|455051840|FG001|Overall Study|Lack of Efficacy|5|||
126478437|NCT00191269|455051839|FG000|Overall Study|Withdrawal by Subject|0|||
126478438|NCT00191269|455051840|FG001|Overall Study|Withdrawal by Subject|1|||
126478439|NCT00191269|455051839|FG000|Overall Study|Pathologic Aggrevation|0|||
126478440|NCT00191269|455051840|FG001|Overall Study|Pathologic Aggrevation|1|||
126478441|NCT00191269|455051839|FG000|Overall Study|Physician Decision|0|||
126478442|NCT00191269|455051840|FG001|Overall Study|Physician Decision|3|||
126478443|NCT05399641|455051841|FG000|Overall Study|Adverse Event|0|||
126478444|NCT05399641|455051842|FG001|Overall Study|Adverse Event|1|||
126478445|NCT05399641|455051843|FG002|Overall Study|Adverse Event|1|||
126478446|NCT05399641|455051841|FG000|Overall Study|Lost to Follow-up|1|||
126478447|NCT05399641|455051842|FG001|Overall Study|Lost to Follow-up|2|||
126478448|NCT05399641|455051843|FG002|Overall Study|Lost to Follow-up|2|||
126478449|NCT05399641|455051841|FG000|Overall Study|Physician Decision|1|||
126478450|NCT05399641|455051842|FG001|Overall Study|Physician Decision|3|||
126478451|NCT05399641|455051843|FG002|Overall Study|Physician Decision|3|||
126478452|NCT05399641|455051841|FG000|Overall Study|Withdrawal by Subject|4|||
126478453|NCT05399641|455051842|FG001|Overall Study|Withdrawal by Subject|11|||
126478454|NCT05399641|455051843|FG002|Overall Study|Withdrawal by Subject|7|||
126478455|NCT05399641|455051841|FG000|Overall Study|Reason not defined|3|||
126478456|NCT05399641|455051842|FG001|Overall Study|Reason not defined|5|||
126478457|NCT05399641|455051843|FG002|Overall Study|Reason not defined|6|||
126478458|NCT02094677|455051844|FG000|Overall Study|Screening|3|||
126478459|NCT02094677|455051845|FG001|Overall Study|Screening|1|||
126478460|NCT01300650|455051846|FG000|Overall Study|Adverse Event|1|||
126478461|NCT00668707|455051855|FG000|Overall Study|Cancer Recurrence|58|||
126478462|NCT00668707|455051856|FG001|Overall Study|Cancer Recurrence|58|||
126478463|NCT00668707|455051855|FG000|Overall Study|Withdrawal by Subject|117|||
126478464|NCT00668707|455051856|FG001|Overall Study|Withdrawal by Subject|100|||
126478465|NCT00668707|455051855|FG000|Overall Study|Lost to Follow-up|3|||
126478466|NCT00668707|455051856|FG001|Overall Study|Lost to Follow-up|6|||
126478467|NCT00668707|455051855|FG000|Overall Study|Protocol Violation|10|||
126478468|NCT00668707|455051856|FG001|Overall Study|Protocol Violation|12|||
126478469|NCT00668707|455051855|FG000|Overall Study|Death|11|||
126478470|NCT00668707|455051856|FG001|Overall Study|Death|4|||
126478471|NCT00923156|455051857|FG000|Overall Study|Adverse Event|0|||
126478472|NCT00923156|455051858|FG001|Overall Study|Adverse Event|2|||
126478473|NCT00923156|455051859|FG002|Overall Study|Adverse Event|1|||
126478474|NCT00923156|455051857|FG000|Overall Study|Abnormal laboratory values|0|||
126478475|NCT00923156|455051858|FG001|Overall Study|Abnormal laboratory values|0|||
126478476|NCT00923156|455051859|FG002|Overall Study|Abnormal laboratory values|1|||
126478477|NCT00923156|455051857|FG000|Overall Study|Withdrawal by Subject|0|||
126478478|NCT00923156|455051858|FG001|Overall Study|Withdrawal by Subject|1|||
126478479|NCT00923156|455051859|FG002|Overall Study|Withdrawal by Subject|0|||
126478480|NCT00923156|455051857|FG000|Overall Study|Death|0|||
126478481|NCT00923156|455051858|FG001|Overall Study|Death|1|||
126478482|NCT00923156|455051859|FG002|Overall Study|Death|0|||
126478483|NCT00923156|455051857|FG000|Overall Study|Lack of Efficacy|0|||
126478484|NCT00923156|455051858|FG001|Overall Study|Lack of Efficacy|0|||
126478485|NCT00923156|455051859|FG002|Overall Study|Lack of Efficacy|1|||
126478486|NCT03137537|455051861|FG000|Overall Study|Adverse Event|0|||
126478487|NCT03137537|455051862|FG001|Overall Study|Adverse Event|1|||
126478488|NCT04066023|455051863|FG000|Overall Study|Adverse Event|0|||
126478489|NCT04066023|455051864|FG001|Overall Study|Adverse Event|0|||
126478490|NCT04066023|455051865|FG002|Overall Study|Adverse Event|1|||
126478491|NCT04066023|455051863|FG000|Overall Study|Sponsor decision|3|||
126478492|NCT04066023|455051864|FG001|Overall Study|Sponsor decision|6|||
126478493|NCT04066023|455051865|FG002|Overall Study|Sponsor decision|2|||
126478494|NCT04066023|455051863|FG000|Overall Study|Physician Decision|0|||
126478495|NCT04066023|455051864|FG001|Overall Study|Physician Decision|0|||
126478496|NCT04066023|455051865|FG002|Overall Study|Physician Decision|1|||
126478497|NCT04066023|455051863|FG000|Overall Study|Lost to Follow-up|0|||
126478498|NCT04066023|455051864|FG001|Overall Study|Lost to Follow-up|1|||
126478499|NCT04066023|455051865|FG002|Overall Study|Lost to Follow-up|1|||
126478500|NCT04066023|455051863|FG000|Overall Study|Noncompliance|0|||
126478501|NCT04066023|455051864|FG001|Overall Study|Noncompliance|1|||
126478502|NCT04066023|455051865|FG002|Overall Study|Noncompliance|1|||
126478503|NCT03386448|455051866|FG000|Overall Study|Adverse Event|0|||
126478504|NCT03386448|455051867|FG001|Overall Study|Adverse Event|2|||
126478505|NCT03338010|455051870|FG000|Overall Study|Withdrawal by Subject|14|||
126478506|NCT03338010|455051871|FG001|Overall Study|Withdrawal by Subject|8|||
126478507|NCT03338010|455051870|FG000|Overall Study|Lost to Follow-up|4|||
126478508|NCT03338010|455051871|FG001|Overall Study|Lost to Follow-up|2|||
126478509|NCT03338010|455051870|FG000|Overall Study|Adverse Event|3|||
126478510|NCT03338010|455051871|FG001|Overall Study|Adverse Event|2|||
126478511|NCT03338010|455051870|FG000|Overall Study|Physician Decision|2|||
126478512|NCT03338010|455051871|FG001|Overall Study|Physician Decision|2|||
126478513|NCT03338010|455051870|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126478514|NCT03338010|455051871|FG001|Overall Study|Non-Compliance with Study Drug|3|||
126478515|NCT03338010|455051870|FG000|Overall Study|Protocol Violation|0|||
126478516|NCT03338010|455051871|FG001|Overall Study|Protocol Violation|1|||
126478517|NCT01146665|455051872|FG000|Overall Study|Withdrawal by Subject|10|||
126478518|NCT01146665|455051873|FG001|Overall Study|Withdrawal by Subject|16|||
126478519|NCT02465515|455051874|FG000|Overall Study|Investigator site closed|4|||
126478520|NCT02465515|455051875|FG001|Overall Study|Investigator site closed|5|||
126478521|NCT02465515|455051874|FG000|Overall Study|Withdrawal by Subject|74|||
126478522|NCT02465515|455051875|FG001|Overall Study|Withdrawal by Subject|43|||
126478523|NCT02465515|455051874|FG000|Overall Study|Physician Decision|8|||
126478524|NCT02465515|455051875|FG001|Overall Study|Physician Decision|12|||
126478525|NCT02465515|455051874|FG000|Overall Study|Lost to Follow-up|68|||
126478526|NCT02465515|455051875|FG001|Overall Study|Lost to Follow-up|51|||
126478527|NCT00293033|455051876|FG000|Open-label Titration Period|Adverse Event|10|||
126478528|NCT00293033|455051876|FG000|Open-label Titration Period|Death|3|||
126478529|NCT00293033|455051876|FG000|Open-label Titration Period|Lack of Efficacy|5|||
126478530|NCT00293033|455051876|FG000|Open-label Titration Period|Protocol Violation|2|||
126478531|NCT00293033|455051876|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
126478532|NCT00293033|455051876|FG000|Open-label Titration Period|Noncompliance and other|27|||
126478533|NCT00293033|455051876|FG000|Double-blind Treatment Period|Adverse Event|3|||
126478534|NCT00293033|455051876|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
126478535|NCT00293033|455051876|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
126478536|NCT00293033|455051876|FG000|Double-blind Treatment Period|Noncompliance|4|||
126478537|NCT00816595|455051877|FG000|Overall Study|Withdrawal by Subject|2|||
126478538|NCT00816595|455051878|FG001|Overall Study|Withdrawal by Subject|0|||
126478539|NCT03583697|455051879|FG000|Overall Study|Withdrawal by Subject|0|||
126478540|NCT03583697|455051880|FG001|Overall Study|Withdrawal by Subject|0|||
126478541|NCT03583697|455051881|FG002|Overall Study|Withdrawal by Subject|1|||
126478542|NCT03583697|455051879|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
126478543|NCT03583697|455051880|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
126478544|NCT03583697|455051881|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
126478545|NCT00679432|455051884|FG000|Overall Study|Adverse Event|5|||
126478546|NCT00679432|455051885|FG001|Overall Study|Adverse Event|6|||
126478547|NCT00679432|455051886|FG002|Overall Study|Adverse Event|10|||
126478548|NCT00679432|455051887|FG003|Overall Study|Adverse Event|7|||
126478549|NCT00679432|455051884|FG000|Overall Study|Protocol Violation|1|||
126478550|NCT00679432|455051885|FG001|Overall Study|Protocol Violation|1|||
126478551|NCT00679432|455051886|FG002|Overall Study|Protocol Violation|2|||
126478552|NCT00679432|455051887|FG003|Overall Study|Protocol Violation|1|||
126478553|NCT00679432|455051884|FG000|Overall Study|Withdrawal by Subject|8|||
126478554|NCT00679432|455051885|FG001|Overall Study|Withdrawal by Subject|11|||
126478555|NCT00679432|455051886|FG002|Overall Study|Withdrawal by Subject|10|||
126478556|NCT00679432|455051887|FG003|Overall Study|Withdrawal by Subject|9|||
126478557|NCT00679432|455051884|FG000|Overall Study|Lost to Follow-up|1|||
126478558|NCT00679432|455051885|FG001|Overall Study|Lost to Follow-up|5|||
126478559|NCT00679432|455051886|FG002|Overall Study|Lost to Follow-up|4|||
126478560|NCT00679432|455051887|FG003|Overall Study|Lost to Follow-up|2|||
126478561|NCT00679432|455051884|FG000|Overall Study|Physician Decision|3|||
126722155|NCT02371759|455933284|FG001|Overall Study|Protocol Violation|1|||
126722156|NCT02371759|455933285|FG002|Overall Study|Protocol Violation|1|||
126722157|NCT02371759|455933286|FG003|Overall Study|Protocol Violation|0|||
126722158|NCT02371759|455933287|FG004|Overall Study|Protocol Violation|3|||
126722159|NCT02371759|455933288|FG005|Overall Study|Protocol Violation|1|||
126722160|NCT02371759|455933289|FG006|Overall Study|Protocol Violation|0|||
126478562|NCT00679432|455051885|FG001|Overall Study|Physician Decision|2|||
126478563|NCT00679432|455051886|FG002|Overall Study|Physician Decision|2|||
126478564|NCT00679432|455051887|FG003|Overall Study|Physician Decision|2|||
126478565|NCT00679432|455051884|FG000|Overall Study|Sponsor decision|1|||
126478566|NCT00679432|455051885|FG001|Overall Study|Sponsor decision|0|||
126478567|NCT00679432|455051886|FG002|Overall Study|Sponsor decision|0|||
126478568|NCT00679432|455051887|FG003|Overall Study|Sponsor decision|0|||
126478569|NCT00679432|455051884|FG000|Overall Study|Lack of Efficacy|13|||
126478570|NCT00679432|455051885|FG001|Overall Study|Lack of Efficacy|9|||
126478571|NCT00679432|455051886|FG002|Overall Study|Lack of Efficacy|14|||
126478572|NCT00679432|455051887|FG003|Overall Study|Lack of Efficacy|8|||
126478573|NCT00679432|455051884|FG000|Overall Study|Infectious colitis, normal histology|5|||
126478574|NCT00679432|455051885|FG001|Overall Study|Infectious colitis, normal histology|4|||
126478575|NCT00679432|455051886|FG002|Overall Study|Infectious colitis, normal histology|8|||
126478576|NCT00679432|455051887|FG003|Overall Study|Infectious colitis, normal histology|3|||
126478577|NCT00679432|455051884|FG000|Overall Study|Randomization error, return to prior Rx|0|||
126478578|NCT00679432|455051885|FG001|Overall Study|Randomization error, return to prior Rx|0|||
126478579|NCT00679432|455051886|FG002|Overall Study|Randomization error, return to prior Rx|3|||
126478580|NCT00679432|455051887|FG003|Overall Study|Randomization error, return to prior Rx|0|||
126478581|NCT02339584|455051888|FG000|Overall Study|Adverse Event|11|||
126478582|NCT02339584|455051889|FG001|Overall Study|Adverse Event|7|||
126478583|NCT02339584|455051888|FG000|Overall Study|Lack of Efficacy|0|||
126478584|NCT02339584|455051889|FG001|Overall Study|Lack of Efficacy|1|||
126478585|NCT02339584|455051888|FG000|Overall Study|Physician Decision|1|||
126478586|NCT02339584|455051889|FG001|Overall Study|Physician Decision|2|||
126478587|NCT02339584|455051888|FG000|Overall Study|Protocol Violation|1|||
126478588|NCT02339584|455051889|FG001|Overall Study|Protocol Violation|1|||
126478589|NCT02339584|455051888|FG000|Overall Study|Withdrawal by Subject|2|||
126478590|NCT02339584|455051889|FG001|Overall Study|Withdrawal by Subject|4|||
126478591|NCT00873912|455051890|FG000|Overall Study|Withdrawal by Subject|1|||
126478592|NCT00873912|455051891|FG001|Overall Study|Withdrawal by Subject|0|||
126478593|NCT00873912|455051890|FG000|Overall Study|Lost to Follow-up|2|||
126478594|NCT00873912|455051891|FG001|Overall Study|Lost to Follow-up|0|||
126478595|NCT01980940|455051895|FG000|Overall Study|Protocol Violation|0|||
126478596|NCT01980940|455051896|FG001|Overall Study|Protocol Violation|0|||
126478597|NCT01980940|455051897|FG002|Overall Study|Protocol Violation|0|||
126478598|NCT01980940|455051898|FG003|Overall Study|Protocol Violation|0|||
126478599|NCT01980940|455051899|FG004|Overall Study|Protocol Violation|0|||
126478600|NCT01980940|455051900|FG005|Overall Study|Protocol Violation|2|||
126478601|NCT01980940|455051901|FG006|Overall Study|Protocol Violation|0|||
126478602|NCT01980940|455051902|FG007|Overall Study|Protocol Violation|0|||
126559175|NCT02084082|455340676|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
126559176|NCT02084082|455340677|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
126559177|NCT02084082|455340678|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
126559178|NCT02084082|455340675|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
126559179|NCT02084082|455340676|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
126559180|NCT02084082|455340677|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
126559181|NCT02084082|455340678|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
126559182|NCT05705167|455340679|FG000|Overall Study|Randomised but not Treated|0|||
126559183|NCT05705167|455340680|FG001|Overall Study|Randomised but not Treated|2|||
126559184|NCT05705167|455340681|FG002|Overall Study|Randomised but not Treated|0|||
126559185|NCT05705167|455340682|FG003|Overall Study|Randomised but not Treated|7|||
126559186|NCT05705167|455340683|FG004|Overall Study|Randomised but not Treated|0|||
126559187|NCT05705167|455340684|FG005|Overall Study|Randomised but not Treated|0|||
126559188|NCT05705167|455340685|FG006|Overall Study|Randomised but not Treated|0|||
126559189|NCT05705167|455340679|FG000|Overall Study|Death|0|||
126559190|NCT05705167|455340680|FG001|Overall Study|Death|0|||
126722161|NCT02371759|455933290|FG007|Overall Study|Protocol Violation|3|||
126559191|NCT05705167|455340681|FG002|Overall Study|Death|3|||
126559192|NCT05705167|455340682|FG003|Overall Study|Death|0|||
126559193|NCT05705167|455340683|FG004|Overall Study|Death|1|||
126559194|NCT05705167|455340684|FG005|Overall Study|Death|1|||
126559195|NCT05705167|455340685|FG006|Overall Study|Death|1|||
126559196|NCT05705167|455340679|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
126722162|NCT02371759|455933283|FG000|Overall Study|Withdrawal by Subject|0|||
126722163|NCT02371759|455933284|FG001|Overall Study|Withdrawal by Subject|0|||
126478603|NCT00844831|455053678|FG000|Overall Study|Withdrawal by Subject|4|||
126478604|NCT00844831|455053678|FG000|Overall Study|Adverse Event|1|||
126478605|NCT00844831|455053678|FG000|Overall Study|Physician Decision|1|||
126478606|NCT03305575|455053685|FG000|Overall Study|Physician Decision|1|||
126478607|NCT03305575|455053686|FG001|Overall Study|Physician Decision|0|||
126478608|NCT03486223|455053699|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
126478609|NCT03486223|455053700|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
126478610|NCT01819831|455053701|FG000|Overall Study|Withdrawal by Subject|1|||
126478611|NCT01749137|455053702|FG000|Overall Study|Adverse Event|4|||
126478612|NCT01749137|455053703|FG001|Overall Study|Adverse Event|4|||
126478613|NCT01749137|455053702|FG000|Overall Study|Lost to Follow-up|2|||
126478614|NCT01749137|455053703|FG001|Overall Study|Lost to Follow-up|3|||
126478615|NCT01749137|455053702|FG000|Overall Study|Physician Decision|1|||
126478616|NCT01749137|455053703|FG001|Overall Study|Physician Decision|0|||
126478617|NCT01749137|455053702|FG000|Overall Study|Withdrawal by Subject|8|||
126478618|NCT01749137|455053703|FG001|Overall Study|Withdrawal by Subject|4|||
126478619|NCT02587234|455053719|FG000|Overall Study|Withdrawal by Subject|1|||
126478620|NCT02587234|455053720|FG001|Overall Study|Withdrawal by Subject|1|||
126478621|NCT02587234|455053719|FG000|Overall Study|Lost to Follow-up|0|||
126478622|NCT02587234|455053720|FG001|Overall Study|Lost to Follow-up|2|||
126478623|NCT03068130|455053725|FG000|Overall Study|Adverse Event|19|||
126478624|NCT03068130|455053725|FG000|Overall Study|Death|14|||
126478625|NCT03068130|455053725|FG000|Overall Study|Lost to Follow-up|4|||
126478626|NCT03068130|455053725|FG000|Overall Study|Withdrawal by Subject|26|||
126478627|NCT03068130|455053725|FG000|Overall Study|Administrative Reasons|3|||
126478628|NCT03068130|455053725|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
126478629|NCT03068130|455053725|FG000|Overall Study|Study terminated by sponsor|194|||
126478630|NCT01153347|455053728|FG000|Overall Study|Withdrawal by Subject|7|||
126478631|NCT01153347|455053729|FG001|Overall Study|Withdrawal by Subject|7|||
126478632|NCT01153347|455053730|FG002|Overall Study|Withdrawal by Subject|7|||
126478633|NCT01153347|455053731|FG003|Overall Study|Withdrawal by Subject|7|||
126478634|NCT01153347|455053728|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126478635|NCT01153347|455053729|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126478636|NCT01153347|455053730|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
126478637|NCT01153347|455053731|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
126478638|NCT01153347|455053728|FG000|Overall Study|Adverse Event|3|||
126478639|NCT01153347|455053729|FG001|Overall Study|Adverse Event|9|||
126478640|NCT01153347|455053730|FG002|Overall Study|Adverse Event|21|||
126478641|NCT01153347|455053731|FG003|Overall Study|Adverse Event|7|||
126478642|NCT01153347|455053728|FG000|Overall Study|Severe non-compliance to protocol|6|||
126478643|NCT01153347|455053729|FG001|Overall Study|Severe non-compliance to protocol|7|||
126478644|NCT01153347|455053730|FG002|Overall Study|Severe non-compliance to protocol|4|||
126478645|NCT01153347|455053731|FG003|Overall Study|Severe non-compliance to protocol|3|||
126478646|NCT01153347|455053728|FG000|Overall Study|Condition under investigation worsened|1|||
126478647|NCT01153347|455053729|FG001|Overall Study|Condition under investigation worsened|1|||
126478648|NCT01153347|455053730|FG002|Overall Study|Condition under investigation worsened|0|||
126478649|NCT01153347|455053731|FG003|Overall Study|Condition under investigation worsened|0|||
126478650|NCT01153347|455053728|FG000|Overall Study|Lack of Efficacy|2|||
126478651|NCT01153347|455053729|FG001|Overall Study|Lack of Efficacy|2|||
126478652|NCT01153347|455053730|FG002|Overall Study|Lack of Efficacy|0|||
126478653|NCT01153347|455053731|FG003|Overall Study|Lack of Efficacy|4|||
126478654|NCT01153347|455053728|FG000|Overall Study|Study-specific withdrawal criteria|4|||
126478655|NCT01153347|455053729|FG001|Overall Study|Study-specific withdrawal criteria|3|||
126478656|NCT01153347|455053730|FG002|Overall Study|Study-specific withdrawal criteria|1|||
126478657|NCT01153347|455053731|FG003|Overall Study|Study-specific withdrawal criteria|2|||
126478658|NCT01153347|455053728|FG000|Overall Study|Lost to Follow-up|4|||
126478659|NCT01153347|455053729|FG001|Overall Study|Lost to Follow-up|9|||
126478660|NCT01153347|455053730|FG002|Overall Study|Lost to Follow-up|11|||
126478661|NCT01153347|455053731|FG003|Overall Study|Lost to Follow-up|8|||
126478662|NCT01153347|455053728|FG000|Overall Study|Other|5|||
126478663|NCT01153347|455053729|FG001|Overall Study|Other|5|||
126478664|NCT01153347|455053730|FG002|Overall Study|Other|4|||
126478665|NCT01153347|455053731|FG003|Overall Study|Other|0|||
126478666|NCT01153347|455053728|FG000|Overall Study|Death|1|||
126478667|NCT01153347|455053729|FG001|Overall Study|Death|0|||
126478668|NCT01153347|455053730|FG002|Overall Study|Death|0|||
126478669|NCT01153347|455053731|FG003|Overall Study|Death|0|||
126478670|NCT03130257|455053732|FG000|Overall Study|Withdrawal by Subject|1|||
126478671|NCT03130257|455053733|FG001|Overall Study|Withdrawal by Subject|0|||
126478672|NCT03130257|455053734|FG002|Overall Study|Withdrawal by Subject|2|||
126478673|NCT00297830|455053735|FG000|6 Month Visit|Death|1|||
126478674|NCT00297830|455053736|FG001|6 Month Visit|Death|0|||
126478675|NCT00297830|455053737|FG002|6 Month Visit|Death|2|||
126478676|NCT00297830|455053735|FG000|6 Month Visit|Withdrawal by Subject|2|||
126478677|NCT00297830|455053736|FG001|6 Month Visit|Withdrawal by Subject|1|||
126478678|NCT00297830|455053737|FG002|6 Month Visit|Withdrawal by Subject|1|||
126478679|NCT00297830|455053735|FG000|6 Month Visit|Adverse Event|0|||
126478680|NCT00297830|455053736|FG001|6 Month Visit|Adverse Event|1|||
126478681|NCT00297830|455053737|FG002|6 Month Visit|Adverse Event|0|||
126478682|NCT00297830|455053735|FG000|12 Month Visit|Lost to Follow-up|1|||
126478683|NCT00297830|455053736|FG001|12 Month Visit|Lost to Follow-up|0|||
126478684|NCT00297830|455053737|FG002|12 Month Visit|Lost to Follow-up|0|||
126478685|NCT00297830|455053735|FG000|12 Month Visit|Adverse Event|0|||
126478686|NCT00297830|455053736|FG001|12 Month Visit|Adverse Event|3|||
126478687|NCT00297830|455053737|FG002|12 Month Visit|Adverse Event|0|||
126478688|NCT00297830|455053735|FG000|12 Month Visit|Withdrawal by Subject|0|||
126478689|NCT00297830|455053736|FG001|12 Month Visit|Withdrawal by Subject|3|||
126478690|NCT00297830|455053737|FG002|12 Month Visit|Withdrawal by Subject|0|||
126478691|NCT02835820|455053738|FG000|Overall Study|Baseline Screen Failure|0|||
126478692|NCT02835820|455053739|FG001|Overall Study|Baseline Screen Failure|3|||
126478693|NCT01751178|455053742|FG000|Overall Study|Adverse Event|2|||
126478694|NCT01751178|455053743|FG001|Overall Study|Adverse Event|0|||
126478695|NCT01751178|455053744|FG002|Overall Study|Adverse Event|0|||
126478696|NCT01751178|455053742|FG000|Overall Study|Other Reason (unknown)|1|||
126478697|NCT01751178|455053743|FG001|Overall Study|Other Reason (unknown)|0|||
126478698|NCT01751178|455053744|FG002|Overall Study|Other Reason (unknown)|2|||
126478699|NCT00288054|455053748|FG000|Overall Study|Protocol Violation|2|||
126478700|NCT00288054|455053748|FG000|Overall Study|Lack of Efficacy|16|||
126478701|NCT00288054|455053748|FG000|Overall Study|Adverse Event|3|||
126478702|NCT00288054|455053748|FG000|Overall Study|Withdrawal by Subject|1|||
126478703|NCT00288054|455053748|FG000|Overall Study|Not protocol specified|2|||
126478704|NCT00289991|455053749|FG000|Overall Study|Death|35|||
126478705|NCT00289991|455053750|FG001|Overall Study|Death|38|||
126478706|NCT00289991|455053749|FG000|Overall Study|Adverse Event|15|||
126478707|NCT00289991|455053750|FG001|Overall Study|Adverse Event|13|||
126478708|NCT00289991|455053749|FG000|Overall Study|Failure of prophylaxis|1|||
126478709|NCT00289991|455053750|FG001|Overall Study|Failure of prophylaxis|1|||
126478710|NCT00289991|455053749|FG000|Overall Study|Fungal breakthrough infection|0|||
126478711|NCT00289991|455053750|FG001|Overall Study|Fungal breakthrough infection|1|||
126478712|NCT00289991|455053749|FG000|Overall Study|Lost to Follow-up|0|||
126478713|NCT00289991|455053750|FG001|Overall Study|Lost to Follow-up|1|||
126478714|NCT00289991|455053749|FG000|Overall Study|Withdrawal by Subject|2|||
126478715|NCT00289991|455053750|FG001|Overall Study|Withdrawal by Subject|12|||
126478716|NCT00289991|455053749|FG000|Overall Study|Other|5|||
126478717|NCT00289991|455053750|FG001|Overall Study|Other|14|||
126478718|NCT01606007|455053761|FG000|Overall Study|Reason 'Other' in the protocol|0|||
126478719|NCT01606007|455053762|FG001|Overall Study|Reason 'Other' in the protocol|1|||
126478720|NCT01606007|455053763|FG002|Overall Study|Reason 'Other' in the protocol|1|||
126478721|NCT01606007|455053761|FG000|Overall Study|Pregnancy|0|||
126478722|NCT01606007|455053762|FG001|Overall Study|Pregnancy|1|||
126478723|NCT01606007|455053763|FG002|Overall Study|Pregnancy|1|||
126478724|NCT01606007|455053761|FG000|Overall Study|Withdrawal by Subject|8|||
126478725|NCT01606007|455053762|FG001|Overall Study|Withdrawal by Subject|6|||
126478726|NCT01606007|455053763|FG002|Overall Study|Withdrawal by Subject|1|||
126478727|NCT01606007|455053761|FG000|Overall Study|Adverse Event|0|||
126478728|NCT01606007|455053762|FG001|Overall Study|Adverse Event|1|||
126478729|NCT01606007|455053763|FG002|Overall Study|Adverse Event|1|||
126478730|NCT01606007|455053761|FG000|Overall Study|discontinue study treatment|0|||
126478731|NCT01606007|455053762|FG001|Overall Study|discontinue study treatment|2|||
126478732|NCT01606007|455053763|FG002|Overall Study|discontinue study treatment|1|||
126478733|NCT01606007|455053761|FG000|Overall Study|Lost to Follow-up|6|||
126478734|NCT01606007|455053762|FG001|Overall Study|Lost to Follow-up|8|||
126478735|NCT01606007|455053763|FG002|Overall Study|Lost to Follow-up|5|||
126478736|NCT01606007|455053761|FG000|Overall Study|Poor/Non-compliance|1|||
126478737|NCT01606007|455053762|FG001|Overall Study|Poor/Non-compliance|0|||
126478738|NCT01606007|455053763|FG002|Overall Study|Poor/Non-compliance|0|||
126478739|NCT03733470|455053768|FG000|Overall Study|PI Decision|1|||
126478740|NCT03733470|455053769|FG001|Overall Study|PI Decision|1|||
126478741|NCT01010061|455053770|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
126478742|NCT01010061|455053771|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
126478743|NCT01010061|455053770|FG000|Overall Study|Disease Progression|2|||
126478744|NCT01010061|455053771|FG001|Overall Study|Disease Progression|8|||
126478745|NCT01010061|455053770|FG000|Overall Study|Withdrew Consent|5|||
126478746|NCT01010061|455053771|FG001|Overall Study|Withdrew Consent|1|||
126478747|NCT01010061|455053770|FG000|Overall Study|Death|3|||
126478748|NCT01010061|455053771|FG001|Overall Study|Death|6|||
126722164|NCT02371759|455933285|FG002|Overall Study|Withdrawal by Subject|0|||
126722165|NCT02371759|455933286|FG003|Overall Study|Withdrawal by Subject|0|||
126722166|NCT02371759|455933287|FG004|Overall Study|Withdrawal by Subject|0|||
126478749|NCT01010061|455053770|FG000|Overall Study|Administrative/Other|0|||
126478750|NCT01010061|455053771|FG001|Overall Study|Administrative/Other|1|||
126478751|NCT01010061|455053770|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
126478752|NCT01010061|455053771|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
126478753|NCT01010061|455053770|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126478754|NCT01010061|455053771|FG001|Overall Study|Insufficient Therapeutic Response|5|||
126478755|NCT01010061|455053770|FG000|Overall Study|Violation of Selection Criteria|0|||
126478756|NCT01010061|455053771|FG001|Overall Study|Violation of Selection Criteria|1|||
126478757|NCT01010061|455053770|FG000|Overall Study|Did Not Receive Treatment|2|||
126478758|NCT01010061|455053771|FG001|Overall Study|Did Not Receive Treatment|2|||
126478759|NCT02217878|455053772|FG000|Overall Study|required morphine due to chest pain|1|||
126478760|NCT02217878|455053773|FG001|Overall Study|required morphine due to chest pain|2|||
126478761|NCT02217878|455053772|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
126478762|NCT02217878|455053773|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
126478763|NCT02021773|455053779|FG000|Overall Study|Adverse Event|1|||
126478764|NCT02021773|455053780|FG001|Overall Study|Adverse Event|4|||
126478765|NCT02021773|455053781|FG002|Overall Study|Adverse Event|3|||
126478766|NCT02021773|455053779|FG000|Overall Study|Lack of Efficacy|2|||
126478767|NCT02021773|455053780|FG001|Overall Study|Lack of Efficacy|2|||
126478768|NCT02021773|455053781|FG002|Overall Study|Lack of Efficacy|2|||
126478769|NCT02021773|455053779|FG000|Overall Study|Protocol Violation|2|||
126478770|NCT02021773|455053780|FG001|Overall Study|Protocol Violation|3|||
126478771|NCT02021773|455053781|FG002|Overall Study|Protocol Violation|1|||
126478772|NCT02021773|455053779|FG000|Overall Study|Withdrawal by Subject|3|||
126478773|NCT02021773|455053780|FG001|Overall Study|Withdrawal by Subject|4|||
126478774|NCT02021773|455053781|FG002|Overall Study|Withdrawal by Subject|5|||
126478775|NCT02021773|455053779|FG000|Overall Study|Lost to Follow-up|1|||
126478776|NCT02021773|455053780|FG001|Overall Study|Lost to Follow-up|3|||
126478777|NCT02021773|455053781|FG002|Overall Study|Lost to Follow-up|0|||
126478778|NCT02021773|455053779|FG000|Overall Study|Reason not specified|3|||
126478779|NCT02021773|455053780|FG001|Overall Study|Reason not specified|0|||
126478780|NCT02021773|455053781|FG002|Overall Study|Reason not specified|0|||
126478781|NCT02243696|455053782|FG000|Overall Study|Death|282|||
126478782|NCT02243696|455053782|FG000|Overall Study|Withdrawal by Subject|79|||
126478783|NCT02243696|455053782|FG000|Overall Study|Lost to Follow-up|57|||
126478784|NCT02243696|455053782|FG000|Overall Study|Subject No Longer has Study System|42|||
126478785|NCT02243696|455053782|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
126478786|NCT02243696|455053782|FG000|Overall Study|Study Terminated for EP PASSION|961|||
126478787|NCT00282984|455053783|FG000|Overall Study|Death|2|||
126478788|NCT00282984|455053784|FG001|Overall Study|Death|5|||
126478789|NCT00282984|455053783|FG000|Overall Study|Adverse Event|8|||
126478790|NCT00282984|455053784|FG001|Overall Study|Adverse Event|5|||
126478791|NCT00282984|455053783|FG000|Overall Study|Lack of Efficacy|0|||
126478792|NCT00282984|455053784|FG001|Overall Study|Lack of Efficacy|2|||
126478793|NCT00282984|455053783|FG000|Overall Study|Lost to Follow-up|14|||
126478794|NCT00282984|455053784|FG001|Overall Study|Lost to Follow-up|10|||
126478795|NCT00282984|455053783|FG000|Overall Study|Withdrawal by Participant|22|||
126478796|NCT00282984|455053784|FG001|Overall Study|Withdrawal by Participant|34|||
126478797|NCT00282984|455053783|FG000|Overall Study|Participant stopped study medication|2|||
126478798|NCT00282984|455053784|FG001|Overall Study|Participant stopped study medication|2|||
126478799|NCT00282984|455053783|FG000|Overall Study|Participant only allowed phone follow-up|0|||
126478800|NCT00282984|455053784|FG001|Overall Study|Participant only allowed phone follow-up|1|||
126478801|NCT00282984|455053783|FG000|Overall Study|Participant used antipsychosis meds|0|||
126478802|NCT00282984|455053784|FG001|Overall Study|Participant used antipsychosis meds|1|||
126478803|NCT00282984|455053783|FG000|Overall Study|lack of motivation|1|||
126478804|NCT00282984|455053784|FG001|Overall Study|lack of motivation|0|||
126478805|NCT00282984|455053783|FG000|Overall Study|in prison|0|||
126478806|NCT00282984|455053784|FG001|Overall Study|in prison|1|||
126478807|NCT00282984|455053783|FG000|Overall Study|Protocol Violation|2|||
126478808|NCT00282984|455053784|FG001|Overall Study|Protocol Violation|0|||
126478809|NCT02151110|455053790|FG000|Overall Study|Withdrawal by Subject|0|||
126478810|NCT02151110|455053791|FG001|Overall Study|Withdrawal by Subject|0|||
126478811|NCT02151110|455053792|FG002|Overall Study|Withdrawal by Subject|0|||
126478812|NCT02151110|455053793|FG003|Overall Study|Withdrawal by Subject|0|||
126478813|NCT02151110|455053794|FG004|Overall Study|Withdrawal by Subject|0|||
126478814|NCT02151110|455053795|FG005|Overall Study|Withdrawal by Subject|0|||
126478815|NCT02151110|455053796|FG006|Overall Study|Withdrawal by Subject|0|||
126478816|NCT02151110|455053797|FG007|Overall Study|Withdrawal by Subject|1|||
126478817|NCT02151110|455053790|FG000|Overall Study|Lost to Follow-up|0|||
126478818|NCT02151110|455053791|FG001|Overall Study|Lost to Follow-up|0|||
126478819|NCT02151110|455053792|FG002|Overall Study|Lost to Follow-up|0|||
126478820|NCT02151110|455053793|FG003|Overall Study|Lost to Follow-up|0|||
126478821|NCT02151110|455053794|FG004|Overall Study|Lost to Follow-up|0|||
126478822|NCT02151110|455053795|FG005|Overall Study|Lost to Follow-up|0|||
126478823|NCT02151110|455053796|FG006|Overall Study|Lost to Follow-up|0|||
126478824|NCT02151110|455053797|FG007|Overall Study|Lost to Follow-up|2|||
126478825|NCT02015754|455053798|FG000|Overall Study|Disease progression|5|||
126478826|NCT02015754|455053798|FG000|Overall Study|Change in treatment modality|5|||
126478827|NCT02015754|455053798|FG000|Overall Study|Lost to Follow-up|1|||
126478828|NCT01128842|455053799|FG000|Overall Study|Adverse Event|1|||
126478829|NCT01128842|455053799|FG000|Overall Study|Disease Progression|6|||
126478830|NCT04528732|455053800|FG000|Overall Study|Death|1|||
126478831|NCT04528732|455053801|FG001|Overall Study|Death|0|||
126478832|NCT04528732|455053802|FG002|Overall Study|Death|1|||
126478833|NCT04528732|455053800|FG000|Overall Study|Lost to Follow-up|0|||
126478834|NCT04528732|455053801|FG001|Overall Study|Lost to Follow-up|1|||
126478835|NCT04528732|455053802|FG002|Overall Study|Lost to Follow-up|2|||
126478836|NCT00114530|455053810|FG000|Overall Study|Death|3|||
126478837|NCT00114530|455053811|FG001|Overall Study|Death|11|||
126478838|NCT00114530|455053810|FG000|Overall Study|Lost to Follow-up|1|||
126478839|NCT00114530|455053811|FG001|Overall Study|Lost to Follow-up|1|||
126478840|NCT00114530|455053810|FG000|Overall Study|Physician Decision|1|||
126478841|NCT00114530|455053811|FG001|Overall Study|Physician Decision|1|||
126478842|NCT00114530|455053810|FG000|Overall Study|Withdrawal by Subject|2|||
126478843|NCT00114530|455053811|FG001|Overall Study|Withdrawal by Subject|6|||
126478844|NCT00114530|455053810|FG000|Overall Study|Breast Cancer|1|||
126478845|NCT00114530|455053811|FG001|Overall Study|Breast Cancer|0|||
126478846|NCT00114530|455053810|FG000|Overall Study|Subject decision after endpoint failure|0|||
126478847|NCT00114530|455053811|FG001|Overall Study|Subject decision after endpoint failure|1|||
126478848|NCT00114530|455053810|FG000|Overall Study|Ineligible|1|||
126478849|NCT00114530|455053811|FG001|Overall Study|Ineligible|0|||
126478850|NCT00365508|455053814|FG000|Overall Study|Lost to Follow-up|139|||
126478851|NCT00365508|455053815|FG001|Overall Study|Lost to Follow-up|154|||
126478852|NCT00751933|455053816|FG000|Overall Study|Withdrawal by Subject|0|||
126478853|NCT00751933|455053817|FG001|Overall Study|Withdrawal by Subject|1|||
126478854|NCT00751933|455053818|FG002|Overall Study|Withdrawal by Subject|0|||
126478855|NCT00751933|455053819|FG003|Overall Study|Withdrawal by Subject|0|||
126478856|NCT00751933|455053816|FG000|Overall Study|Physician Decision|0|||
126478857|NCT00751933|455053817|FG001|Overall Study|Physician Decision|0|||
126478858|NCT00751933|455053818|FG002|Overall Study|Physician Decision|1|||
126478859|NCT00751933|455053819|FG003|Overall Study|Physician Decision|1|||
126478860|NCT02538029|455053821|FG000|Overall Study|unable to complete cognitive assessments|1|||
126478861|NCT02538029|455053822|FG001|Overall Study|unable to complete cognitive assessments|0|||
126478862|NCT02538029|455053823|FG002|Overall Study|unable to complete cognitive assessments|1|||
126478863|NCT05248867|455053825|FG000|Double-blind Period|Lost to Follow-up|0|||
126478864|NCT05248867|455053826|FG001|Double-blind Period|Lost to Follow-up|3|||
126478865|NCT05248867|455053827|FG002|Double-blind Period|Lost to Follow-up|0|||
126478866|NCT05248867|455053828|FG003|Double-blind Period|Lost to Follow-up|0|||
126478867|NCT05248867|455053829|FG004|Double-blind Period|Lost to Follow-up|0|||
126478868|NCT05248867|455053830|FG005|Double-blind Period|Lost to Follow-up|0|||
126478869|NCT05248867|455053825|FG000|Double-blind Period|Withdrawal by Subject|5|||
126478870|NCT05248867|455053826|FG001|Double-blind Period|Withdrawal by Subject|14|||
126478871|NCT05248867|455053827|FG002|Double-blind Period|Withdrawal by Subject|0|||
126478872|NCT05248867|455053828|FG003|Double-blind Period|Withdrawal by Subject|0|||
126478873|NCT05248867|455053829|FG004|Double-blind Period|Withdrawal by Subject|0|||
126478874|NCT05248867|455053830|FG005|Double-blind Period|Withdrawal by Subject|0|||
126478875|NCT05248867|455053825|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
126478876|NCT05248867|455053826|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
126478877|NCT05248867|455053827|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
126722167|NCT02371759|455933288|FG005|Overall Study|Withdrawal by Subject|0|||
126722168|NCT02371759|455933289|FG006|Overall Study|Withdrawal by Subject|0|||
126722169|NCT02371759|455933290|FG007|Overall Study|Withdrawal by Subject|1|||
126722170|NCT00243230|455933293|FG000|Double-Blind Period|Adverse Event|0|||
126722171|NCT00243230|455933294|FG001|Double-Blind Period|Adverse Event|2|||
126478878|NCT05248867|455053828|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
126478879|NCT05248867|455053829|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
126478880|NCT05248867|455053830|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
126478881|NCT05248867|455053825|FG000|Double-blind Period|Other, not specified|3|||
126478882|NCT05248867|455053826|FG001|Double-blind Period|Other, not specified|8|||
126478883|NCT05248867|455053827|FG002|Double-blind Period|Other, not specified|0|||
126478884|NCT05248867|455053828|FG003|Double-blind Period|Other, not specified|0|||
126478885|NCT05248867|455053829|FG004|Double-blind Period|Other, not specified|0|||
126478886|NCT05248867|455053830|FG005|Double-blind Period|Other, not specified|0|||
126478887|NCT05248867|455053825|FG000|Open-label Period|Withdrawal by Subject|0|||
126478888|NCT05248867|455053826|FG001|Open-label Period|Withdrawal by Subject|0|||
126478889|NCT05248867|455053827|FG002|Open-label Period|Withdrawal by Subject|3|||
126478890|NCT05248867|455053828|FG003|Open-label Period|Withdrawal by Subject|1|||
126478891|NCT05248867|455053829|FG004|Open-label Period|Withdrawal by Subject|7|||
126478892|NCT05248867|455053830|FG005|Open-label Period|Withdrawal by Subject|9|||
126478893|NCT05248867|455053825|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
126478894|NCT05248867|455053826|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
126478895|NCT05248867|455053827|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
126478896|NCT05248867|455053828|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
126478897|NCT05248867|455053829|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
126478898|NCT05248867|455053830|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
126722172|NCT00243230|455933295|FG002|Double-Blind Period|Adverse Event|2|||
126478899|NCT05248867|455053825|FG000|Open-label Period|Lost to Follow-up|0|||
126478900|NCT05248867|455053826|FG001|Open-label Period|Lost to Follow-up|0|||
126478901|NCT05248867|455053827|FG002|Open-label Period|Lost to Follow-up|0|||
126478902|NCT05248867|455053828|FG003|Open-label Period|Lost to Follow-up|0|||
126478903|NCT05248867|455053829|FG004|Open-label Period|Lost to Follow-up|5|||
126478904|NCT05248867|455053830|FG005|Open-label Period|Lost to Follow-up|2|||
126478905|NCT05248867|455053825|FG000|Open-label Period|COVID-19 Infection|0|||
126478906|NCT05248867|455053826|FG001|Open-label Period|COVID-19 Infection|0|||
126478907|NCT05248867|455053827|FG002|Open-label Period|COVID-19 Infection|0|||
126478908|NCT05248867|455053828|FG003|Open-label Period|COVID-19 Infection|0|||
126478909|NCT05248867|455053829|FG004|Open-label Period|COVID-19 Infection|1|||
126478910|NCT05248867|455053830|FG005|Open-label Period|COVID-19 Infection|0|||
126478911|NCT05248867|455053825|FG000|Open-label Period|Other, not specified|0|||
126478912|NCT05248867|455053826|FG001|Open-label Period|Other, not specified|0|||
126478913|NCT05248867|455053827|FG002|Open-label Period|Other, not specified|0|||
126478914|NCT05248867|455053828|FG003|Open-label Period|Other, not specified|0|||
126478915|NCT05248867|455053829|FG004|Open-label Period|Other, not specified|4|||
126478916|NCT05248867|455053830|FG005|Open-label Period|Other, not specified|0|||
126478917|NCT01064310|455053831|FG000|Period 1|Adverse Event|7|||
126478918|NCT01064310|455053832|FG001|Period 1|Adverse Event|10|||
126478919|NCT01064310|455053833|FG002|Period 1|Adverse Event|0|||
126478920|NCT01064310|455053831|FG000|Period 1|Physician Decision|1|||
126478921|NCT01064310|455053832|FG001|Period 1|Physician Decision|0|||
126478922|NCT01064310|455053833|FG002|Period 1|Physician Decision|0|||
126478923|NCT01064310|455053831|FG000|Period 1|Withdrawal by Subject|2|||
126478924|NCT01064310|455053832|FG001|Period 1|Withdrawal by Subject|2|||
126478925|NCT01064310|455053833|FG002|Period 1|Withdrawal by Subject|0|||
126478926|NCT01064310|455053831|FG000|Period 1|Lack of Efficacy|3|||
126478927|NCT01064310|455053832|FG001|Period 1|Lack of Efficacy|5|||
126478928|NCT01064310|455053833|FG002|Period 1|Lack of Efficacy|0|||
126478929|NCT01064310|455053831|FG000|Period 1|Entered Open-label Period|1|||
126478930|NCT01064310|455053832|FG001|Period 1|Entered Open-label Period|1|||
126478931|NCT01064310|455053833|FG002|Period 1|Entered Open-label Period|0|||
126478932|NCT01064310|455053831|FG000|Period 2|Adverse Event|2|||
126478933|NCT01064310|455053832|FG001|Period 2|Adverse Event|1|||
126478934|NCT01064310|455053833|FG002|Period 2|Adverse Event|0|||
126478935|NCT01064310|455053831|FG000|Period 2|Physician Decision|0|||
126478936|NCT01064310|455053832|FG001|Period 2|Physician Decision|1|||
126478937|NCT01064310|455053833|FG002|Period 2|Physician Decision|0|||
126478938|NCT01064310|455053831|FG000|Period 2|Entered Open-label Period|1|||
126478939|NCT01064310|455053832|FG001|Period 2|Entered Open-label Period|0|||
126478940|NCT01064310|455053833|FG002|Period 2|Entered Open-label Period|0|||
126478941|NCT01064310|455053831|FG000|Period 2|Lack of Efficacy|1|||
126478942|NCT01064310|455053832|FG001|Period 2|Lack of Efficacy|4|||
126478943|NCT01064310|455053833|FG002|Period 2|Lack of Efficacy|0|||
126478944|NCT01064310|455053831|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
126478945|NCT01064310|455053832|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
126478946|NCT01064310|455053833|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
126478947|NCT01064310|455053831|FG000|Open Label Pazopinib|Adverse Event|0|||
126478948|NCT01064310|455053832|FG001|Open Label Pazopinib|Adverse Event|0|||
126478949|NCT01064310|455053833|FG002|Open Label Pazopinib|Adverse Event|12|||
126478950|NCT01064310|455053831|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
126478951|NCT01064310|455053832|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
126478952|NCT01064310|455053833|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
126478953|NCT01064310|455053831|FG000|Open Label Pazopinib|Physician Decision|0|||
126478954|NCT01064310|455053832|FG001|Open Label Pazopinib|Physician Decision|0|||
126478955|NCT01064310|455053833|FG002|Open Label Pazopinib|Physician Decision|20|||
126478956|NCT00873015|455053835|FG000|Overall Study|Withdrawal by Subject|0|||
126478957|NCT00873015|455053836|FG001|Overall Study|Withdrawal by Subject|1|||
126478958|NCT00873015|455053837|FG002|Overall Study|Withdrawal by Subject|0|||
126478959|NCT00873015|455053838|FG003|Overall Study|Withdrawal by Subject|0|||
126478960|NCT01382212|455053846|FG000|Overall Study|Kidney transplant|1|||
126478961|NCT01382212|455053846|FG000|Overall Study|Withdrew consent|1|||
126478962|NCT01084083|455053847|FG000|Overall Study|Adverse Event|5|||
126478963|NCT01084083|455053847|FG000|Overall Study|Death|1|||
126478964|NCT01084083|455053847|FG000|Overall Study|Withdrawal by Subject|2|||
126478965|NCT01084083|455053847|FG000|Overall Study|Complicating disease|1|||
126478966|NCT01084083|455053847|FG000|Overall Study|Other|2|||
126478967|NCT01084083|455053847|FG000|Overall Study|Never started assigned therapy|1|||
126478968|NCT01273597|455053848|FG000|Overall Study|Adverse Event|5|||
126478969|NCT01273597|455053848|FG000|Overall Study|Underwent Kidney Transplantation|2|||
126478970|NCT01273597|455053848|FG000|Overall Study|Reason Not Reported|1|||
126478971|NCT01088997|455053850|FG000|Overall Study|Physician Decision|1|||
126478972|NCT01088997|455053851|FG001|Overall Study|Physician Decision|1|||
126478973|NCT01088997|455053850|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
126478974|NCT01088997|455053851|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
126478975|NCT01088997|455053850|FG000|Overall Study|Excluded prior to receiving drug|1|||
126478976|NCT01088997|455053851|FG001|Overall Study|Excluded prior to receiving drug|1|||
126478977|NCT05695209|455053854|FG000|3-months|Withdrawal by Subject|2|||
126478978|NCT05695209|455053855|FG001|3-months|Withdrawal by Subject|0|||
126478979|NCT05695209|455053854|FG000|3-months|Unable to contact for 3-month data collection|0|||
126478980|NCT05695209|455053855|FG001|3-months|Unable to contact for 3-month data collection|1|||
126478981|NCT05695209|455053854|FG000|6-months|Lost to Follow-up|1|||
126478982|NCT05695209|455053855|FG001|6-months|Lost to Follow-up|1|||
126478983|NCT03749447|455055243|FG000|Overall Study|Adverse Event|11|||
126478984|NCT03749447|455055244|FG001|Overall Study|Adverse Event|3|||
126478985|NCT03749447|455055243|FG000|Overall Study|Death|1|||
126478986|NCT03749447|455055244|FG001|Overall Study|Death|1|||
126478987|NCT03749447|455055243|FG000|Overall Study|Lost to Follow-up|2|||
126478988|NCT03749447|455055244|FG001|Overall Study|Lost to Follow-up|2|||
126478989|NCT03749447|455055243|FG000|Overall Study|Reason Not Specified|0|||
126478990|NCT03749447|455055244|FG001|Overall Study|Reason Not Specified|3|||
126478991|NCT03749447|455055243|FG000|Overall Study|Physician Decision|4|||
126478992|NCT03749447|455055244|FG001|Overall Study|Physician Decision|3|||
126478993|NCT03749447|455055243|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
126478994|NCT03749447|455055244|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
126478995|NCT03749447|455055243|FG000|Overall Study|Study Terminated By Sponsor|112|||
126478996|NCT03749447|455055244|FG001|Overall Study|Study Terminated By Sponsor|105|||
126478997|NCT03749447|455055243|FG000|Overall Study|Withdrawal by Subject|12|||
126478998|NCT03749447|455055244|FG001|Overall Study|Withdrawal by Subject|6|||
126478999|NCT03749447|455055243|FG000|Overall Study|Non-compliance With Study Drug|0|||
126479000|NCT03749447|455055244|FG001|Overall Study|Non-compliance With Study Drug|1|||
126479001|NCT05996718|455055245|FG000|Overall Study|Lost to Follow-up|3|||
126479002|NCT01218113|455055246|FG000|Overall Study|Withdrawal by Subject|1|||
126479003|NCT01218113|455055247|FG001|Overall Study|Withdrawal by Subject|0|||
126479004|NCT01218113|455055248|FG002|Overall Study|Withdrawal by Subject|1|||
126479005|NCT01218113|455055246|FG000|Overall Study|Lost to Follow-up|4|||
126479006|NCT01218113|455055247|FG001|Overall Study|Lost to Follow-up|1|||
126479007|NCT01218113|455055248|FG002|Overall Study|Lost to Follow-up|4|||
126479008|NCT01218113|455055246|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
126479009|NCT01218113|455055247|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
126479010|NCT01218113|455055248|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
126479011|NCT01713686|455055249|FG000|Overall Study|Lost to Follow-up|9|||
126479012|NCT01713686|455055249|FG000|Overall Study|Withdrawal by Subject|6|||
126479013|NCT04840615|455055250|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
126479014|NCT04840615|455055251|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
126479015|NCT04840615|455055252|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
126479016|NCT00967668|455055253|FG000|Overall Study|Withdrawal by Subject|13|||
126479017|NCT00967668|455055254|FG001|Overall Study|Withdrawal by Subject|8|||
126479018|NCT00967668|455055255|FG002|Overall Study|Withdrawal by Subject|8|||
126479019|NCT00967668|455055253|FG000|Overall Study|Death|0|||
126479020|NCT00967668|455055254|FG001|Overall Study|Death|2|||
126479021|NCT00967668|455055255|FG002|Overall Study|Death|4|||
126479022|NCT00967668|455055253|FG000|Overall Study|Removed due to behavior|1|||
126479023|NCT00967668|455055254|FG001|Overall Study|Removed due to behavior|1|||
126479024|NCT00967668|455055255|FG002|Overall Study|Removed due to behavior|2|||
126479025|NCT00967668|455055253|FG000|Overall Study|Refused Year 2|11|||
126479026|NCT00967668|455055254|FG001|Overall Study|Refused Year 2|6|||
126479027|NCT00967668|455055255|FG002|Overall Study|Refused Year 2|4|||
126479028|NCT00967668|455055253|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
126479029|NCT00967668|455055254|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
126479030|NCT00967668|455055255|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
126479031|NCT00967668|455055253|FG000|Overall Study|Lost to Follow-up|15|||
126479032|NCT00967668|455055254|FG001|Overall Study|Lost to Follow-up|9|||
126479033|NCT00967668|455055255|FG002|Overall Study|Lost to Follow-up|16|||
126479034|NCT00967668|455055253|FG000|Overall Study|Refused 12-mo assessment|3|||
126479035|NCT00967668|455055254|FG001|Overall Study|Refused 12-mo assessment|1|||
126479036|NCT00967668|455055255|FG002|Overall Study|Refused 12-mo assessment|9|||
126479037|NCT00967668|455055253|FG000|Overall Study|Pregnancy|1|||
126479038|NCT00967668|455055254|FG001|Overall Study|Pregnancy|0|||
126479039|NCT00967668|455055255|FG002|Overall Study|Pregnancy|0|||
126479040|NCT00115739|455055257|FG000|Overall Study|Lost to Follow-up|3|||
126479041|NCT00709761|455055260|FG000|Overall Study|Withdrawal by Subject|8|||
126479042|NCT00709761|455055260|FG000|Overall Study|study closed/terminated|17|||
126479043|NCT00709761|455055260|FG000|Overall Study|Lost to Follow-up|2|||
126479044|NCT00259649|455055261|FG000|Overall Study|Lost to Follow-up|7|||
126479045|NCT00259649|455055261|FG000|Overall Study|irregular menses|3|||
126479046|NCT01918774|455055264|FG000|Overall Study|Lost prior to first CBTw session|4|||
126479047|NCT01918774|455055264|FG000|Overall Study|Lost to Follow-up|1|||
126479048|NCT01606800|455055265|FG000|Overall Study|Adverse Event|3|||
126479049|NCT01606800|455055266|FG001|Overall Study|Adverse Event|1|||
126479050|NCT01606800|455055265|FG000|Overall Study|Participant withdrew consent|0|||
126479051|NCT01606800|455055266|FG001|Overall Study|Participant withdrew consent|1|||
126479052|NCT01606800|455055265|FG000|Overall Study|Missing completion status|2|||
126479053|NCT01606800|455055266|FG001|Overall Study|Missing completion status|0|||
126479054|NCT00717197|455055273|FG000|Overall Study|Unable to purchase study drug|5|||
126479055|NCT00717197|455055273|FG000|Overall Study|Tumor Progression|1|||
126479056|NCT00717197|455055273|FG000|Overall Study|Physician Decision|1|||
126479057|NCT00982137|455055274|FG000|Overall Study|Lost to Follow-up|0|||
126479058|NCT00982137|455055275|FG001|Overall Study|Lost to Follow-up|0|||
126479059|NCT00982137|455055276|FG002|Overall Study|Lost to Follow-up|0|||
126479060|NCT00982137|455055277|FG003|Overall Study|Lost to Follow-up|1|||
126479061|NCT00982137|455055274|FG000|Overall Study|Withdrawal by Subject|0|||
126479062|NCT00982137|455055275|FG001|Overall Study|Withdrawal by Subject|1|||
126479063|NCT00982137|455055276|FG002|Overall Study|Withdrawal by Subject|0|||
126479064|NCT00982137|455055277|FG003|Overall Study|Withdrawal by Subject|0|||
126479065|NCT03311724|455055280|FG000|Overall Study|Physician Decision|0|||
126479066|NCT03311724|455055281|FG001|Overall Study|Physician Decision|0|||
126479067|NCT03311724|455055282|FG002|Overall Study|Physician Decision|0|||
126479068|NCT03311724|455055283|FG003|Overall Study|Physician Decision|1|||
126479069|NCT03311724|455055280|FG000|Overall Study|Protocol Violation|1|||
126479070|NCT03311724|455055281|FG001|Overall Study|Protocol Violation|0|||
126479071|NCT03311724|455055282|FG002|Overall Study|Protocol Violation|1|||
126479072|NCT03311724|455055283|FG003|Overall Study|Protocol Violation|0|||
126479073|NCT03311724|455055280|FG000|Overall Study|Withdrawal by Subject|1|||
126479074|NCT03311724|455055281|FG001|Overall Study|Withdrawal by Subject|1|||
126479075|NCT03311724|455055282|FG002|Overall Study|Withdrawal by Subject|0|||
126479076|NCT03311724|455055283|FG003|Overall Study|Withdrawal by Subject|0|||
126479077|NCT03311724|455055280|FG000|Overall Study|Lost to Follow-up|1|||
126479078|NCT03311724|455055281|FG001|Overall Study|Lost to Follow-up|0|||
126479079|NCT03311724|455055282|FG002|Overall Study|Lost to Follow-up|0|||
126479080|NCT03311724|455055283|FG003|Overall Study|Lost to Follow-up|0|||
126479081|NCT03311724|455055280|FG000|Overall Study|Sponsor Decision|0|||
126479082|NCT03311724|455055281|FG001|Overall Study|Sponsor Decision|0|||
126479083|NCT03311724|455055282|FG002|Overall Study|Sponsor Decision|1|||
126479084|NCT03311724|455055283|FG003|Overall Study|Sponsor Decision|0|||
126479085|NCT01575769|455055290|FG000|Overall Study|Adverse Event|1|||
126479086|NCT01575769|455055290|FG000|Overall Study|Study terminated by sponsor|40|||
126479087|NCT03156543|455055293|FG000|Overall Study|Withdrawal by Subject|1|||
126479088|NCT03156543|455055294|FG001|Overall Study|Withdrawal by Subject|0|||
126479089|NCT00674700|455055295|FG000|Year 1|Adverse Event|17|||
126479090|NCT00674700|455055296|FG001|Year 1|Adverse Event|20|||
126479091|NCT00674700|455055297|FG002|Year 1|Adverse Event|5|||
126479092|NCT00674700|455055295|FG000|Year 1|Withdrawal by Subject|7|||
126479093|NCT00674700|455055296|FG001|Year 1|Withdrawal by Subject|7|||
126479094|NCT00674700|455055297|FG002|Year 1|Withdrawal by Subject|6|||
126479095|NCT00674700|455055295|FG000|Year 1|Any other reason not above-mentioned|7|||
126479096|NCT00674700|455055296|FG001|Year 1|Any other reason not above-mentioned|7|||
126479097|NCT00674700|455055297|FG002|Year 1|Any other reason not above-mentioned|6|||
126479098|NCT00674700|455055295|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
126479099|NCT00674700|455055296|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
126479100|NCT00674700|455055297|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
126479101|NCT00674700|455055295|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
126479102|NCT00674700|455055296|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
126479103|NCT00674700|455055297|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
126479104|NCT00674700|455055295|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
126479105|NCT00674700|455055296|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
126479106|NCT00674700|455055297|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
126479107|NCT00691015|455055298|FG000|Overall Study|Refused further treatment|1|||
126479108|NCT03535844|455055301|FG000|Overall Study|Withdrawal by Subject|0|||
126479109|NCT03535844|455055302|FG001|Overall Study|Withdrawal by Subject|1|||
126479110|NCT00160693|455055306|FG000|Overall Study|Adverse Event|97|||
126479111|NCT00160693|455055306|FG000|Overall Study|Lack of Efficacy|30|||
126479112|NCT00160693|455055306|FG000|Overall Study|Protocol Violation|24|||
126479113|NCT00160693|455055306|FG000|Overall Study|Lost to Follow-up|15|||
126479114|NCT00160693|455055306|FG000|Overall Study|Withdrawal by Subject|54|||
126479115|NCT00160693|455055306|FG000|Overall Study|Study terminated by sponsor|15|||
126479116|NCT03039283|455055309|FG000|Overall Study|Protocol Violation|2|||
126479117|NCT01867424|455055310|FG000|Overall Study|Patient noncompliance|2|||
126479118|NCT01867424|455055311|FG001|Overall Study|Patient noncompliance|1|||
126479119|NCT01056653|455055312|FG000|Overall Study|Lost to Follow-up|0|||
126559197|NCT05705167|455340680|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
126479120|NCT01056653|455055313|FG001|Overall Study|Lost to Follow-up|0|||
126479121|NCT01056653|455055314|FG002|Overall Study|Lost to Follow-up|2|||
126479122|NCT01847274|455055315|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
126479123|NCT01847274|455055316|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
126479124|NCT01847274|455055317|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
126479125|NCT01847274|455055318|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
126479126|NCT01847274|455055319|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
126479127|NCT01847274|455055320|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
126479128|NCT01847274|455055321|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
126479129|NCT01847274|455055322|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
126479130|NCT01847274|455055323|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
126479131|NCT01847274|455055324|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
126479132|NCT01847274|455055325|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
126479133|NCT01847274|455055315|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
126479134|NCT01847274|455055316|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
126479135|NCT01847274|455055317|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
126479136|NCT01847274|455055318|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
126479137|NCT01847274|455055319|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
126479138|NCT01847274|455055320|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
126479139|NCT01847274|455055321|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
126479140|NCT01847274|455055322|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
126479141|NCT01847274|455055323|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
126479142|NCT01847274|455055324|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
126479143|NCT01847274|455055325|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
126479144|NCT01847274|455055315|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
126479145|NCT01847274|455055316|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
126479146|NCT01847274|455055317|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
126479147|NCT01847274|455055318|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
126479148|NCT01847274|455055319|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
126479149|NCT01847274|455055320|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
126479150|NCT01847274|455055321|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
126479151|NCT01847274|455055322|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
126479152|NCT01847274|455055323|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
126479153|NCT01847274|455055324|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
126479154|NCT01847274|455055325|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
126479155|NCT01847274|455055315|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
126479156|NCT01847274|455055316|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
126479157|NCT01847274|455055317|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
126479158|NCT01847274|455055318|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
126479159|NCT01847274|455055319|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
126479160|NCT01847274|455055320|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
126479161|NCT01847274|455055321|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
126479162|NCT01847274|455055322|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
126479163|NCT01847274|455055323|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
126479164|NCT01847274|455055324|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
126479165|NCT01847274|455055325|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
126479166|NCT01847274|455055315|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
126479167|NCT01847274|455055316|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
126479168|NCT01847274|455055317|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
126479169|NCT01847274|455055318|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
126479170|NCT01847274|455055319|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
126479171|NCT01847274|455055320|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
126479172|NCT01847274|455055321|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
126479173|NCT01847274|455055322|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
126479174|NCT01847274|455055323|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
126479175|NCT01847274|455055324|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
126479176|NCT01847274|455055325|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
126479177|NCT01847274|455055315|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
126479178|NCT01847274|455055316|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
126479179|NCT01847274|455055317|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
126479180|NCT01847274|455055318|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
126479181|NCT01847274|455055319|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
126479182|NCT01847274|455055320|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
126479183|NCT01847274|455055321|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
126479184|NCT01847274|455055322|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
126722173|NCT00243230|455933296|FG003|Double-Blind Period|Adverse Event|0|||
126722174|NCT00243230|455933293|FG000|Double-Blind Period|Withdrawal by Subject|1|||
126722175|NCT00243230|455933294|FG001|Double-Blind Period|Withdrawal by Subject|0|||
126722176|NCT00243230|455933295|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126722177|NCT00243230|455933296|FG003|Double-Blind Period|Withdrawal by Subject|0|||
126479185|NCT01847274|455055323|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
126479186|NCT01847274|455055324|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
126479187|NCT01847274|455055325|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
126479188|NCT01847274|455055315|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
126479189|NCT01847274|455055316|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
126479190|NCT01847274|455055317|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
126479191|NCT01847274|455055318|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
126479192|NCT01847274|455055319|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
126479193|NCT01847274|455055320|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
126479194|NCT01847274|455055321|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
126722178|NCT00243230|455933293|FG000|Double-Blind Period|Protocol Violation|0|||
126479195|NCT01847274|455055322|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
126479196|NCT01847274|455055323|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
126479197|NCT01847274|455055324|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
126479198|NCT01847274|455055325|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
126479199|NCT01847274|455055315|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
126479200|NCT01847274|455055316|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
126479201|NCT01847274|455055317|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
126479202|NCT01847274|455055318|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
126479203|NCT01847274|455055319|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
126479204|NCT01847274|455055320|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
126479205|NCT01847274|455055321|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
126479206|NCT01847274|455055322|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
126479207|NCT01847274|455055323|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
126479208|NCT01847274|455055324|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
126479209|NCT01847274|455055325|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
126479210|NCT01847274|455055315|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
126479211|NCT01847274|455055316|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
126479212|NCT01847274|455055317|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
126479213|NCT01847274|455055318|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
126479214|NCT01847274|455055319|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
126479215|NCT01847274|455055320|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
126479216|NCT01847274|455055321|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
126479217|NCT01847274|455055322|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
126479218|NCT01847274|455055323|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
126479219|NCT01847274|455055324|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
126479220|NCT01847274|455055325|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
126479221|NCT01847274|455055315|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
126479222|NCT01847274|455055316|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
126479223|NCT01847274|455055317|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
126479224|NCT01847274|455055318|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
126479225|NCT01847274|455055319|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
126479226|NCT01847274|455055320|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
126479227|NCT01847274|455055321|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
126479228|NCT01847274|455055322|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
126479229|NCT01847274|455055323|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
126479230|NCT01847274|455055324|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
126479231|NCT01847274|455055325|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
126479232|NCT01847274|455055315|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
126479233|NCT01847274|455055316|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
126479234|NCT01847274|455055317|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
126479235|NCT01847274|455055318|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
126479236|NCT01847274|455055319|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
126479237|NCT01847274|455055320|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
126479238|NCT01847274|455055321|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
126479239|NCT01847274|455055322|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
126479240|NCT01847274|455055323|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
126479241|NCT01847274|455055324|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
126722179|NCT00243230|455933294|FG001|Double-Blind Period|Protocol Violation|0|||
126722180|NCT00243230|455933295|FG002|Double-Blind Period|Protocol Violation|1|||
126722181|NCT00243230|455933296|FG003|Double-Blind Period|Protocol Violation|0|||
126722182|NCT00243230|455933293|FG000|Double-Blind Period|Randomized but Not Treated|0|||
126722183|NCT00243230|455933294|FG001|Double-Blind Period|Randomized but Not Treated|0|||
126722184|NCT00243230|455933295|FG002|Double-Blind Period|Randomized but Not Treated|2|||
126722185|NCT00243230|455933296|FG003|Double-Blind Period|Randomized but Not Treated|0|||
126756534|NCT01667731|456059465|FG000|Overall Study|Enrolled but not treated|0|||
126722186|NCT00243230|455933293|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
126722187|NCT00243230|455933294|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
126722188|NCT00243230|455933295|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
126722189|NCT00243230|455933296|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
126722190|NCT00243230|455933293|FG000|Open Label Period|Adverse Event|0|||
126722191|NCT00243230|455933294|FG001|Open Label Period|Adverse Event|0|||
126722192|NCT00243230|455933295|FG002|Open Label Period|Adverse Event|0|||
126722193|NCT00243230|455933296|FG003|Open Label Period|Adverse Event|2|||
126722194|NCT00243230|455933293|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
126722195|NCT00243230|455933294|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
126722196|NCT00243230|455933295|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
126722197|NCT00243230|455933296|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
126722198|NCT00243230|455933293|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
126722199|NCT00243230|455933294|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
126722200|NCT00243230|455933295|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
126722201|NCT00243230|455933296|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
126722202|NCT00243230|455933293|FG000|Open Label Period|Lost to Follow-up|0|||
126722203|NCT00243230|455933294|FG001|Open Label Period|Lost to Follow-up|0|||
126479242|NCT01847274|455055325|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
126479243|NCT01847274|455055315|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
126479244|NCT01847274|455055316|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
126479245|NCT01847274|455055317|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
126479246|NCT01847274|455055318|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
126479247|NCT01847274|455055319|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
126479248|NCT01847274|455055320|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
126479249|NCT01847274|455055321|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
126479250|NCT01847274|455055322|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
126479251|NCT01847274|455055323|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
126479252|NCT01847274|455055324|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
126479253|NCT01847274|455055325|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
126479254|NCT01847274|455055315|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
126479255|NCT01847274|455055316|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
126479256|NCT01847274|455055317|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
126479257|NCT01847274|455055318|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
126479258|NCT01847274|455055319|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
126479259|NCT01847274|455055320|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
126479260|NCT01847274|455055321|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
126479261|NCT01847274|455055322|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
126479262|NCT01847274|455055323|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
126479263|NCT01847274|455055324|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
126479264|NCT01847274|455055325|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
126479265|NCT01847274|455055315|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
126479266|NCT01847274|455055316|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
126479267|NCT01847274|455055317|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
126479268|NCT01847274|455055318|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
126479269|NCT01847274|455055319|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
126479270|NCT01847274|455055320|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
126479271|NCT01847274|455055321|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
126479272|NCT01847274|455055322|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
126479273|NCT01847274|455055323|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
126479274|NCT01847274|455055324|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
126479275|NCT01847274|455055325|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
126722204|NCT00243230|455933295|FG002|Open Label Period|Lost to Follow-up|0|||
126722205|NCT00243230|455933296|FG003|Open Label Period|Lost to Follow-up|2|||
126722206|NCT00243230|455933293|FG000|Open Label Period|Withdrawal by Subject|0|||
126722207|NCT00243230|455933294|FG001|Open Label Period|Withdrawal by Subject|0|||
126722208|NCT00243230|455933295|FG002|Open Label Period|Withdrawal by Subject|0|||
126722209|NCT00243230|455933296|FG003|Open Label Period|Withdrawal by Subject|2|||
126722210|NCT00243230|455933293|FG000|Open Label Period|Protocol Violation|0|||
126722211|NCT00243230|455933294|FG001|Open Label Period|Protocol Violation|0|||
126722212|NCT00243230|455933295|FG002|Open Label Period|Protocol Violation|0|||
126722213|NCT00243230|455933296|FG003|Open Label Period|Protocol Violation|2|||
126722214|NCT00243230|455933293|FG000|Open Label Period|Administrative Reason|0|||
126722215|NCT00243230|455933294|FG001|Open Label Period|Administrative Reason|0|||
126722216|NCT00243230|455933295|FG002|Open Label Period|Administrative Reason|0|||
126722217|NCT00243230|455933296|FG003|Open Label Period|Administrative Reason|63|||
126722218|NCT01689207|455933297|FG000|Overall Study|Adverse Event|0|||
126722219|NCT01689207|455933298|FG001|Overall Study|Adverse Event|1|||
126479276|NCT01847274|455055315|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
126479277|NCT01847274|455055316|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
126479278|NCT01847274|455055317|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
126479279|NCT01847274|455055318|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
126479280|NCT01847274|455055319|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
126479281|NCT01847274|455055320|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
126479282|NCT01847274|455055321|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
126479283|NCT01847274|455055322|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
126722220|NCT01689207|455933299|FG002|Overall Study|Adverse Event|0|||
126722221|NCT01689207|455933300|FG003|Overall Study|Adverse Event|0|||
126722222|NCT01689207|455933301|FG004|Overall Study|Adverse Event|2|||
126722223|NCT01689207|455933302|FG005|Overall Study|Adverse Event|1|||
126722224|NCT01689207|455933303|FG006|Overall Study|Adverse Event|0|||
126722225|NCT01689207|455933304|FG007|Overall Study|Adverse Event|0|||
126722226|NCT01689207|455933305|FG008|Overall Study|Adverse Event|1|||
126722227|NCT01689207|455933306|FG009|Overall Study|Adverse Event|0|||
126722228|NCT01689207|455933307|FG010|Overall Study|Adverse Event|0|||
126479284|NCT01847274|455055323|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
126479285|NCT01847274|455055324|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
126479286|NCT01847274|455055325|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
126479287|NCT01847274|455055315|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
126479288|NCT01847274|455055316|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
126479289|NCT01847274|455055317|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
126479290|NCT01847274|455055318|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
126479291|NCT01847274|455055319|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
126479292|NCT01847274|455055320|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
126479293|NCT01847274|455055321|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
126479294|NCT01847274|455055322|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
126479295|NCT01847274|455055323|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
126479296|NCT01847274|455055324|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
126479297|NCT01847274|455055325|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
126479298|NCT03727230|455055326|FG000|Overall Study|Lost to Follow-up|12|||
126479299|NCT04377620|455055327|FG000|Overall Study|Death|42|||
126479300|NCT04377620|455055328|FG001|Overall Study|Death|48|||
126479301|NCT04377620|455055329|FG002|Overall Study|Death|36|||
126479302|NCT04377620|455055327|FG000|Overall Study|Withdrawal by Subject|0|||
126479303|NCT04377620|455055328|FG001|Overall Study|Withdrawal by Subject|2|||
126479304|NCT04377620|455055329|FG002|Overall Study|Withdrawal by Subject|0|||
126479305|NCT03470441|455055330|FG000|Overall Study|Death|0|||
126479306|NCT03470441|455055331|FG001|Overall Study|Death|1|||
126479307|NCT03470441|455055332|FG002|Overall Study|Death|1|||
126479308|NCT03470441|455055333|FG003|Overall Study|Death|0|||
126479309|NCT03470441|455055330|FG000|Overall Study|Adverse Event|0|||
126479310|NCT03470441|455055331|FG001|Overall Study|Adverse Event|0|||
126479311|NCT03470441|455055332|FG002|Overall Study|Adverse Event|0|||
126479312|NCT03470441|455055333|FG003|Overall Study|Adverse Event|1|||
126479313|NCT03470441|455055330|FG000|Overall Study|Withdrawal by Subject|1|||
126479314|NCT03470441|455055331|FG001|Overall Study|Withdrawal by Subject|4|||
126479315|NCT03470441|455055332|FG002|Overall Study|Withdrawal by Subject|1|||
126479316|NCT03470441|455055333|FG003|Overall Study|Withdrawal by Subject|3|||
126479317|NCT03768414|455055334|FG000|Overall Study|Adverse Event or side effects|72|||
126479318|NCT03768414|455055335|FG001|Overall Study|Adverse Event or side effects|28|||
126479319|NCT03768414|455055334|FG000|Overall Study|Refusal unrelated to adverse event|33|||
126479320|NCT03768414|455055335|FG001|Overall Study|Refusal unrelated to adverse event|33|||
126479321|NCT03768414|455055334|FG000|Overall Study|Progression/relapse|132|||
126479322|NCT03768414|455055335|FG001|Overall Study|Progression/relapse|60|||
126479323|NCT03768414|455055334|FG000|Overall Study|Death|9|||
126479324|NCT03768414|455055335|FG001|Overall Study|Death|6|||
126479325|NCT03768414|455055334|FG000|Overall Study|Other - not protocol specified|45|||
126722229|NCT05118386|455933310|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
126479326|NCT03768414|455055335|FG001|Overall Study|Other - not protocol specified|18|||
126722230|NCT05118386|455933311|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
126722231|NCT05118386|455933312|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
126722232|NCT05118386|455933313|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
126722233|NCT05118386|455933314|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
126722234|NCT05118386|455933315|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
126722235|NCT05118386|455933310|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
126772340|NCT00190684|456122096|FG000|Overall Study|Adverse Event|86|||
126479327|NCT03768414|455055334|FG000|Overall Study|Reason under review|3|||
126479328|NCT03768414|455055335|FG001|Overall Study|Reason under review|2|||
126479329|NCT02197520|455055342|FG000|Period 1|Withdrawal by Subject|1|||
126479330|NCT02197520|455055343|FG001|Period 1|Withdrawal by Subject|0|||
126479331|NCT02197520|455055342|FG000|Period 2|Adverse Event|0|||
126479332|NCT02197520|455055343|FG001|Period 2|Adverse Event|2|||
126479333|NCT02197520|455055342|FG000|Period 2|Withdrawal by Subject|1|||
126479334|NCT02197520|455055343|FG001|Period 2|Withdrawal by Subject|0|||
126479335|NCT01306942|455055344|FG000|Phase I|Adverse Event|2|||
126479336|NCT01306942|455055345|FG001|Phase I|Adverse Event|2|||
126479337|NCT01306942|455055346|FG002|Phase I|Adverse Event|0|||
126479338|NCT01306942|455055347|FG003|Phase I|Adverse Event|0|||
126479339|NCT01306942|455055344|FG000|Phase I|Physician Decision|3|||
126479340|NCT01306942|455055345|FG001|Phase I|Physician Decision|1|||
126479341|NCT01306942|455055346|FG002|Phase I|Physician Decision|0|||
126479342|NCT01306942|455055347|FG003|Phase I|Physician Decision|0|||
126479343|NCT01306942|455055344|FG000|Phase II|Adverse Event|0|||
126479344|NCT01306942|455055345|FG001|Phase II|Adverse Event|0|||
126479345|NCT01306942|455055346|FG002|Phase II|Adverse Event|0|||
126479346|NCT01306942|455055347|FG003|Phase II|Adverse Event|6|||
126479347|NCT01306942|455055344|FG000|Phase II|Physician Decision|2|||
126479348|NCT01306942|455055345|FG001|Phase II|Physician Decision|0|||
126479349|NCT01306942|455055346|FG002|Phase II|Physician Decision|0|||
126479350|NCT01306942|455055347|FG003|Phase II|Physician Decision|5|||
126479351|NCT01306942|455055344|FG000|Phase II|Withdrawal by Subject|0|||
126479352|NCT01306942|455055345|FG001|Phase II|Withdrawal by Subject|0|||
126479353|NCT01306942|455055346|FG002|Phase II|Withdrawal by Subject|0|||
126479354|NCT01306942|455055347|FG003|Phase II|Withdrawal by Subject|2|||
126479355|NCT01306942|455055344|FG000|Phase II|Death|0|||
126479356|NCT01306942|455055345|FG001|Phase II|Death|0|||
126479357|NCT01306942|455055346|FG002|Phase II|Death|0|||
126479358|NCT01306942|455055347|FG003|Phase II|Death|1|||
126479359|NCT01306942|455055344|FG000|Phase II|Not finished treatment|0|||
126479360|NCT01306942|455055345|FG001|Phase II|Not finished treatment|0|||
126479361|NCT01306942|455055346|FG002|Phase II|Not finished treatment|0|||
126479362|NCT01306942|455055347|FG003|Phase II|Not finished treatment|1|||
126479363|NCT01306942|455055344|FG000|Phase II|Protocol Violation|0|||
126479364|NCT01306942|455055345|FG001|Phase II|Protocol Violation|0|||
126479365|NCT01306942|455055346|FG002|Phase II|Protocol Violation|0|||
126479366|NCT01306942|455055347|FG003|Phase II|Protocol Violation|1|||
126479367|NCT00334958|455055348|FG000|Overall Study|Medication Noncompliance|0|||
126479368|NCT00334958|455055349|FG001|Overall Study|Medication Noncompliance|3|||
126479369|NCT00334958|455055348|FG000|Overall Study|Protocol Violation|2|||
126479370|NCT00334958|455055349|FG001|Overall Study|Protocol Violation|2|||
126479371|NCT00334958|455055348|FG000|Overall Study|Request of the investigator or sponsor|0|||
126479372|NCT00334958|455055349|FG001|Overall Study|Request of the investigator or sponsor|1|||
126479373|NCT00334958|455055348|FG000|Overall Study|Withdrawal by Subject|7|||
126479374|NCT00334958|455055349|FG001|Overall Study|Withdrawal by Subject|4|||
126479375|NCT00334958|455055348|FG000|Overall Study|Adverse Event|27|||
126479376|NCT00334958|455055349|FG001|Overall Study|Adverse Event|12|||
126479377|NCT00334958|455055348|FG000|Overall Study|Other|1|||
126479378|NCT00334958|455055349|FG001|Overall Study|Other|2|||
126479379|NCT03408483|455055355|FG000|Overall Study|Physician Decision|3|||
126479380|NCT03408483|455055356|FG001|Overall Study|Physician Decision|3|||
126479381|NCT03408483|455055355|FG000|Overall Study|Lost to Follow-up|3|||
126479382|NCT03408483|455055356|FG001|Overall Study|Lost to Follow-up|0|||
126479383|NCT00478231|455055357|FG000|Overall Study|Death|7|||
126479384|NCT00478231|455055357|FG000|Overall Study|Lack of Efficacy|47|||
126479385|NCT00478231|455055357|FG000|Overall Study|Lost to Follow-up|7|||
126479386|NCT00478231|455055357|FG000|Overall Study|Withdrawal by Subject|6|||
126479387|NCT00478231|455055357|FG000|Overall Study|Other|9|||
126479388|NCT00478231|455055357|FG000|Overall Study|Adverse Event|5|||
126479389|NCT00478231|455055357|FG000|Overall Study|Randomized, not treated|3|||
126479390|NCT00824720|455055358|FG000|Overall Study|failed plug insertion|3|||
126479391|NCT00824720|455055359|FG001|Overall Study|failed plug insertion|1|||
126479392|NCT00824720|455055360|FG002|Overall Study|failed plug insertion|0|||
126479393|NCT00824720|455055358|FG000|Overall Study|Protocol Violation|0|||
126479394|NCT00824720|455055359|FG001|Overall Study|Protocol Violation|0|||
126479395|NCT00824720|455055360|FG002|Overall Study|Protocol Violation|1|||
126479396|NCT02777333|455055361|FG000|Overall Study|Withdrawal by Subject|0|||
126479397|NCT02777333|455055362|FG001|Overall Study|Withdrawal by Subject|1|||
126479398|NCT02777333|455055361|FG000|Overall Study|Lost to Follow-up|0|||
126479399|NCT02777333|455055362|FG001|Overall Study|Lost to Follow-up|1|||
126479400|NCT00837811|455055363|FG000|Overall Study|Adverse Event|4|||
126479401|NCT00837811|455055364|FG001|Overall Study|Adverse Event|6|||
126479402|NCT00837811|455055365|FG002|Overall Study|Adverse Event|0|||
126479403|NCT00837811|455055363|FG000|Overall Study|Death|1|||
126479404|NCT00837811|455055364|FG001|Overall Study|Death|1|||
126479405|NCT00837811|455055365|FG002|Overall Study|Death|0|||
126479406|NCT00837811|455055363|FG000|Overall Study|Lack of Efficacy|0|||
126479407|NCT00837811|455055364|FG001|Overall Study|Lack of Efficacy|11|||
126479408|NCT00837811|455055365|FG002|Overall Study|Lack of Efficacy|0|||
126479409|NCT00837811|455055363|FG000|Overall Study|Lost to Follow-up|1|||
126722236|NCT05118386|455933311|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
126722237|NCT05118386|455933312|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
126722238|NCT05118386|455933313|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
126722239|NCT05118386|455933314|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
126722240|NCT05118386|455933315|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
126722241|NCT01423617|455933316|FG000|Overall Study|Lost to Follow-up|0|||
126722242|NCT01423617|455933317|FG001|Overall Study|Lost to Follow-up|1|||
126722243|NCT01515306|455933318|FG000|Overall Study|Adverse Event|3|||
126722244|NCT01515306|455933319|FG001|Overall Study|Adverse Event|2|||
126722245|NCT01515306|455933318|FG000|Overall Study|Progressive Disease|19|||
126722246|NCT01515306|455933319|FG001|Overall Study|Progressive Disease|9|||
126722247|NCT01515306|455933318|FG000|Overall Study|Withdrawal by Subject|1|||
126722248|NCT01515306|455933319|FG001|Overall Study|Withdrawal by Subject|2|||
126722249|NCT01515306|455933318|FG000|Overall Study|Physician Decision|1|||
126722250|NCT01515306|455933319|FG001|Overall Study|Physician Decision|1|||
126722251|NCT00303108|455933320|FG000|Overall Study|Adverse Event|5|||
126722252|NCT00303108|455933321|FG001|Overall Study|Adverse Event|6|||
126722253|NCT00303108|455933322|FG002|Overall Study|Adverse Event|7|||
126479410|NCT00837811|455055364|FG001|Overall Study|Lost to Follow-up|3|||
126479411|NCT00837811|455055365|FG002|Overall Study|Lost to Follow-up|0|||
126479412|NCT00837811|455055363|FG000|Overall Study|Physician Decision|0|||
126479413|NCT00837811|455055364|FG001|Overall Study|Physician Decision|2|||
126479414|NCT00837811|455055365|FG002|Overall Study|Physician Decision|1|||
126479415|NCT00837811|455055363|FG000|Overall Study|Withdrawal by Subject|1|||
126479416|NCT00837811|455055364|FG001|Overall Study|Withdrawal by Subject|9|||
126479417|NCT00837811|455055365|FG002|Overall Study|Withdrawal by Subject|0|||
126479418|NCT00837811|455055363|FG000|Overall Study|Sponsor Decision|0|||
126479419|NCT00837811|455055364|FG001|Overall Study|Sponsor Decision|2|||
126479420|NCT00837811|455055365|FG002|Overall Study|Sponsor Decision|0|||
126479421|NCT04731363|455055366|FG000|Overall Study|Could not obtain samples|0|||
126479422|NCT04731363|455055367|FG001|Overall Study|Could not obtain samples|1|||
126479423|NCT04731363|455055368|FG002|Overall Study|Could not obtain samples|0|||
126479424|NCT04731363|455055369|FG003|Overall Study|Could not obtain samples|0|||
126479425|NCT04731363|455055366|FG000|Overall Study|Physician Decision|0|||
126479426|NCT04731363|455055367|FG001|Overall Study|Physician Decision|1|||
126479427|NCT04731363|455055368|FG002|Overall Study|Physician Decision|0|||
126479428|NCT04731363|455055369|FG003|Overall Study|Physician Decision|0|||
126479429|NCT02513394|455055370|FG000|Overall Study|Withdrawal by Subject|11|||
126479430|NCT02513394|455055371|FG001|Overall Study|Withdrawal by Subject|23|||
126479431|NCT02513394|455055370|FG000|Overall Study|Ineligible|1|||
126479432|NCT02513394|455055371|FG001|Overall Study|Ineligible|0|||
126479433|NCT04292743|455055372|FG000|Overall Study|Physician Decision|1|||
126479434|NCT04292743|455055373|FG001|Overall Study|Physician Decision|3|||
126479435|NCT04292743|455055374|FG002|Overall Study|Physician Decision|0|||
126479436|NCT04292743|455055375|FG003|Overall Study|Physician Decision|0|||
126479437|NCT04292743|455055372|FG000|Overall Study|Withdrawal by Subject|0|||
126479438|NCT04292743|455055373|FG001|Overall Study|Withdrawal by Subject|5|||
126479439|NCT04292743|455055374|FG002|Overall Study|Withdrawal by Subject|0|||
126479440|NCT04292743|455055375|FG003|Overall Study|Withdrawal by Subject|0|||
126479441|NCT04292743|455055372|FG000|Overall Study|Death|0|||
126479442|NCT04292743|455055373|FG001|Overall Study|Death|1|||
126479443|NCT04292743|455055374|FG002|Overall Study|Death|0|||
126479444|NCT04292743|455055375|FG003|Overall Study|Death|0|||
126479445|NCT04292743|455055372|FG000|Overall Study|Progression of Disease|2|||
126479446|NCT04292743|455055373|FG001|Overall Study|Progression of Disease|5|||
126479447|NCT04292743|455055374|FG002|Overall Study|Progression of Disease|0|||
126479448|NCT04292743|455055375|FG003|Overall Study|Progression of Disease|0|||
126479449|NCT04292743|455055372|FG000|Overall Study|No Treatment per protocol|0|||
126479450|NCT04292743|455055373|FG001|Overall Study|No Treatment per protocol|2|||
126479451|NCT04292743|455055374|FG002|Overall Study|No Treatment per protocol|0|||
126722254|NCT00303108|455933320|FG000|Overall Study|Patient Request|4|||
126722255|NCT00303108|455933321|FG001|Overall Study|Patient Request|2|||
126722256|NCT00303108|455933322|FG002|Overall Study|Patient Request|8|||
126722257|NCT00303108|455933320|FG000|Overall Study|Failed Entry|1|||
126722258|NCT00303108|455933321|FG001|Overall Study|Failed Entry|0|||
126722259|NCT00303108|455933322|FG002|Overall Study|Failed Entry|1|||
126722260|NCT00303108|455933320|FG000|Overall Study|ineligible|2|||
126479452|NCT04292743|455055375|FG003|Overall Study|No Treatment per protocol|0|||
126479453|NCT05766423|455055376|FG000|Overall Study|Withdrawal by Subject|1|||
126479454|NCT05766423|455055377|FG001|Overall Study|Withdrawal by Subject|0|||
126479455|NCT05766423|455055376|FG000|Overall Study|Consented, not scheduled|3|||
126479456|NCT05766423|455055377|FG001|Overall Study|Consented, not scheduled|5|||
126479457|NCT00688753|455057625|FG000|Overall Study|Disease progression|55|||
126479458|NCT00688753|455057625|FG000|Overall Study|Missing|1|||
126479459|NCT00688753|455057625|FG000|Overall Study|Death|9|||
126479460|NCT00688753|455057625|FG000|Overall Study|Withdrawal by Subject|3|||
126479461|NCT00688753|455057625|FG000|Overall Study|Adverse Event|20|||
126722261|NCT00303108|455933321|FG001|Overall Study|ineligible|1|||
126479462|NCT00688753|455057625|FG000|Overall Study|Protocol Violation|1|||
126479463|NCT00688753|455057625|FG000|Overall Study|Lost to Follow-up|3|||
126479464|NCT03187197|455057627|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
126479465|NCT03187197|455057628|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
126479466|NCT03187197|455057629|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
126479467|NCT03187197|455057627|FG000|Overall Study|Withdrawal by Subject|8|||
126479468|NCT03187197|455057628|FG001|Overall Study|Withdrawal by Subject|63|||
126479469|NCT03187197|455057629|FG002|Overall Study|Withdrawal by Subject|4|||
126479470|NCT03187197|455057627|FG000|Overall Study|Lost to Follow-up|1|||
126479471|NCT03187197|455057628|FG001|Overall Study|Lost to Follow-up|60|||
126479472|NCT03187197|455057629|FG002|Overall Study|Lost to Follow-up|7|||
126479473|NCT03187197|455057627|FG000|Overall Study|Adverse Event|6|||
126479474|NCT03187197|455057628|FG001|Overall Study|Adverse Event|29|||
126479475|NCT03187197|455057629|FG002|Overall Study|Adverse Event|0|||
126479476|NCT03187197|455057627|FG000|Overall Study|Death|0|||
126479477|NCT03187197|455057628|FG001|Overall Study|Death|11|||
126479478|NCT03187197|455057629|FG002|Overall Study|Death|0|||
126479479|NCT03187197|455057627|FG000|Overall Study|Administrative problem|1|||
126479480|NCT03187197|455057628|FG001|Overall Study|Administrative problem|1|||
126479481|NCT03187197|455057629|FG002|Overall Study|Administrative problem|0|||
126479482|NCT03187197|455057627|FG000|Overall Study|Reason not listed|2|||
126479483|NCT03187197|455057628|FG001|Overall Study|Reason not listed|54|||
126479484|NCT03187197|455057629|FG002|Overall Study|Reason not listed|1|||
126479485|NCT03187197|455057627|FG000|Overall Study|Missing|1|||
126479486|NCT03187197|455057628|FG001|Overall Study|Missing|32|||
126479487|NCT03187197|455057629|FG002|Overall Study|Missing|3|||
126479488|NCT03187197|455057627|FG000|Overall Study|Status missing|2|||
126479489|NCT03187197|455057628|FG001|Overall Study|Status missing|33|||
126479490|NCT03187197|455057629|FG002|Overall Study|Status missing|3|||
126479491|NCT03187197|455057627|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
126479492|NCT03187197|455057628|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
126479493|NCT03187197|455057629|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
126479494|NCT02385045|455057630|FG000|Overall Study|Endoscopy could not be completed|4|||
126479495|NCT02200211|455057631|FG000|Overall Study|Lost to Follow-up|7|||
126479496|NCT02200211|455057632|FG001|Overall Study|Lost to Follow-up|7|||
126479497|NCT02200211|455057633|FG002|Overall Study|Lost to Follow-up|1|||
126479498|NCT02200211|455057634|FG003|Overall Study|Lost to Follow-up|2|||
126479499|NCT02200211|455057631|FG000|Overall Study|Withdrawal by Subject|1|||
126479500|NCT02200211|455057632|FG001|Overall Study|Withdrawal by Subject|0|||
126722262|NCT00303108|455933322|FG002|Overall Study|ineligible|0|||
126722263|NCT03201198|455933325|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
126722264|NCT03201198|455933326|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
126722265|NCT03201198|455933325|FG000|Overall Study|Withdrawal by Subject|2|||
126722266|NCT03201198|455933326|FG001|Overall Study|Withdrawal by Subject|3|||
126722267|NCT03855137|455933327|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
126722268|NCT03855137|455933328|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
126722269|NCT03855137|455933329|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
126722270|NCT03855137|455933327|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
126722271|NCT03855137|455933328|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
126722272|NCT03855137|455933329|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
126722273|NCT03855137|455933327|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
126722274|NCT03855137|455933328|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
126722275|NCT03855137|455933329|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
126722276|NCT03855137|455933327|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
126722277|NCT03855137|455933328|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
126722278|NCT03855137|455933329|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
126722279|NCT03855137|455933327|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
126722280|NCT03855137|455933328|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
126722281|NCT03855137|455933329|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
126722282|NCT03855137|455933327|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
126722283|NCT03855137|455933328|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
126722284|NCT03855137|455933329|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
126722285|NCT03855137|455933327|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
126722286|NCT03855137|455933328|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
126722287|NCT03855137|455933329|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
126479501|NCT02200211|455057633|FG002|Overall Study|Withdrawal by Subject|0|||
126479502|NCT02200211|455057634|FG003|Overall Study|Withdrawal by Subject|0|||
126479503|NCT00042289|455057635|FG000|Overall Study|Lost to Follow-up|3|||
126479504|NCT00042289|455057636|FG001|Overall Study|Lost to Follow-up|0|||
126479505|NCT00042289|455057637|FG002|Overall Study|Lost to Follow-up|0|||
126479506|NCT00042289|455057638|FG003|Overall Study|Lost to Follow-up|1|||
126479507|NCT00042289|455057639|FG004|Overall Study|Lost to Follow-up|3|||
126722288|NCT03855137|455933327|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
126722289|NCT03855137|455933328|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
126722290|NCT03855137|455933329|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
126722291|NCT03855137|455933327|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
126722292|NCT03855137|455933328|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
126722293|NCT03855137|455933329|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
126479508|NCT00042289|455057640|FG005|Overall Study|Lost to Follow-up|3|||
126479509|NCT00042289|455057641|FG006|Overall Study|Lost to Follow-up|6|||
126479510|NCT00042289|455057642|FG007|Overall Study|Lost to Follow-up|1|||
126479511|NCT00042289|455057643|FG008|Overall Study|Lost to Follow-up|1|||
126479512|NCT00042289|455057644|FG009|Overall Study|Lost to Follow-up|0|||
126479513|NCT00042289|455057645|FG010|Overall Study|Lost to Follow-up|0|||
126479514|NCT00042289|455057646|FG011|Overall Study|Lost to Follow-up|0|||
126479515|NCT00042289|455057647|FG012|Overall Study|Lost to Follow-up|0|||
126479516|NCT00042289|455057648|FG013|Overall Study|Lost to Follow-up|0|||
126479517|NCT00042289|455057649|FG014|Overall Study|Lost to Follow-up|0|||
126479518|NCT00042289|455057650|FG015|Overall Study|Lost to Follow-up|1|||
126479519|NCT00042289|455057651|FG016|Overall Study|Lost to Follow-up|1|||
126479520|NCT00042289|455057652|FG017|Overall Study|Lost to Follow-up|0|||
126479521|NCT00042289|455057653|FG018|Overall Study|Lost to Follow-up|3|||
126479522|NCT00042289|455057654|FG019|Overall Study|Lost to Follow-up|2|||
126479523|NCT00042289|455057655|FG020|Overall Study|Lost to Follow-up|0|||
126479524|NCT00042289|455057656|FG021|Overall Study|Lost to Follow-up|0|||
126479525|NCT00042289|455057657|FG022|Overall Study|Lost to Follow-up|0|||
126479526|NCT00042289|455057658|FG023|Overall Study|Lost to Follow-up|0|||
126479527|NCT00042289|455057659|FG024|Overall Study|Lost to Follow-up|0|||
126479528|NCT00042289|455057660|FG025|Overall Study|Lost to Follow-up|0|||
126479529|NCT00042289|455057661|FG026|Overall Study|Lost to Follow-up|2|||
126479530|NCT00042289|455057662|FG027|Overall Study|Lost to Follow-up|2|||
126479531|NCT00042289|455057663|FG028|Overall Study|Lost to Follow-up|2|||
126479532|NCT00042289|455057664|FG029|Overall Study|Lost to Follow-up|0|||
126479533|NCT00042289|455057665|FG030|Overall Study|Lost to Follow-up|0|||
126479534|NCT00042289|455057666|FG031|Overall Study|Lost to Follow-up|2|||
126479535|NCT00042289|455057667|FG032|Overall Study|Lost to Follow-up|1|||
126479536|NCT00042289|455057668|FG033|Overall Study|Lost to Follow-up|1|||
126479537|NCT00042289|455057669|FG034|Overall Study|Lost to Follow-up|1|||
126479538|NCT00042289|455057670|FG035|Overall Study|Lost to Follow-up|2|||
126479539|NCT00042289|455057671|FG036|Overall Study|Lost to Follow-up|1|||
126479540|NCT00042289|455057672|FG037|Overall Study|Lost to Follow-up|1|||
126479541|NCT00042289|455057673|FG038|Overall Study|Lost to Follow-up|0|||
126479542|NCT00042289|455057674|FG039|Overall Study|Lost to Follow-up|5|||
126479543|NCT00042289|455057675|FG040|Overall Study|Lost to Follow-up|0|||
126479544|NCT00042289|455057676|FG041|Overall Study|Lost to Follow-up|2|||
126479545|NCT00042289|455057677|FG042|Overall Study|Lost to Follow-up|2|||
126479546|NCT00042289|455057678|FG043|Overall Study|Lost to Follow-up|0|||
126479547|NCT00042289|455057679|FG044|Overall Study|Lost to Follow-up|0|||
126479548|NCT00042289|455057680|FG045|Overall Study|Lost to Follow-up|1|||
126479549|NCT00042289|455057681|FG046|Overall Study|Lost to Follow-up|0|||
126722294|NCT03855137|455933327|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
126722295|NCT03855137|455933328|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
126722296|NCT03855137|455933329|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
126479550|NCT00042289|455057635|FG000|Overall Study|Other reason|0|||
126479551|NCT00042289|455057636|FG001|Overall Study|Other reason|0|||
126479552|NCT00042289|455057637|FG002|Overall Study|Other reason|0|||
126479553|NCT00042289|455057638|FG003|Overall Study|Other reason|2|||
126479554|NCT00042289|455057639|FG004|Overall Study|Other reason|0|||
126479555|NCT00042289|455057640|FG005|Overall Study|Other reason|0|||
126479556|NCT00042289|455057641|FG006|Overall Study|Other reason|0|||
126479557|NCT00042289|455057642|FG007|Overall Study|Other reason|0|||
126479558|NCT00042289|455057643|FG008|Overall Study|Other reason|0|||
126479559|NCT00042289|455057644|FG009|Overall Study|Other reason|0|||
126479560|NCT00042289|455057645|FG010|Overall Study|Other reason|0|||
126479561|NCT00042289|455057646|FG011|Overall Study|Other reason|0|||
126479562|NCT00042289|455057647|FG012|Overall Study|Other reason|0|||
126479563|NCT00042289|455057648|FG013|Overall Study|Other reason|0|||
126479564|NCT00042289|455057649|FG014|Overall Study|Other reason|0|||
126479565|NCT00042289|455057650|FG015|Overall Study|Other reason|0|||
126479566|NCT00042289|455057651|FG016|Overall Study|Other reason|0|||
126479567|NCT00042289|455057652|FG017|Overall Study|Other reason|0|||
126479568|NCT00042289|455057653|FG018|Overall Study|Other reason|1|||
126479569|NCT00042289|455057654|FG019|Overall Study|Other reason|0|||
126722297|NCT02427477|455933332|FG000|Period 1|Adverse Event|1|||
126479570|NCT00042289|455057655|FG020|Overall Study|Other reason|0|||
126479571|NCT00042289|455057656|FG021|Overall Study|Other reason|0|||
126479572|NCT00042289|455057657|FG022|Overall Study|Other reason|0|||
126479573|NCT00042289|455057658|FG023|Overall Study|Other reason|1|||
126479574|NCT00042289|455057659|FG024|Overall Study|Other reason|0|||
126479575|NCT00042289|455057660|FG025|Overall Study|Other reason|0|||
126479576|NCT00042289|455057661|FG026|Overall Study|Other reason|1|||
126479577|NCT00042289|455057662|FG027|Overall Study|Other reason|0|||
126479578|NCT00042289|455057663|FG028|Overall Study|Other reason|3|||
126479579|NCT00042289|455057664|FG029|Overall Study|Other reason|0|||
126479580|NCT00042289|455057665|FG030|Overall Study|Other reason|0|||
126479581|NCT00042289|455057666|FG031|Overall Study|Other reason|1|||
126479582|NCT00042289|455057667|FG032|Overall Study|Other reason|0|||
126479583|NCT00042289|455057668|FG033|Overall Study|Other reason|1|||
126479584|NCT00042289|455057669|FG034|Overall Study|Other reason|0|||
126479585|NCT00042289|455057670|FG035|Overall Study|Other reason|2|||
126479586|NCT00042289|455057671|FG036|Overall Study|Other reason|0|||
126479587|NCT00042289|455057672|FG037|Overall Study|Other reason|0|||
126479588|NCT00042289|455057673|FG038|Overall Study|Other reason|0|||
126479589|NCT00042289|455057674|FG039|Overall Study|Other reason|0|||
126479590|NCT00042289|455057675|FG040|Overall Study|Other reason|0|||
126479591|NCT00042289|455057676|FG041|Overall Study|Other reason|0|||
126479592|NCT00042289|455057677|FG042|Overall Study|Other reason|0|||
126479593|NCT00042289|455057678|FG043|Overall Study|Other reason|1|||
126479594|NCT00042289|455057679|FG044|Overall Study|Other reason|0|||
126479595|NCT00042289|455057680|FG045|Overall Study|Other reason|0|||
126479596|NCT00042289|455057681|FG046|Overall Study|Other reason|0|||
126479597|NCT00042289|455057635|FG000|Overall Study|Severe debilitation, unable to continue|0|||
126479598|NCT00042289|455057636|FG001|Overall Study|Severe debilitation, unable to continue|0|||
126559198|NCT05705167|455340681|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
126479599|NCT00042289|455057637|FG002|Overall Study|Severe debilitation, unable to continue|0|||
126479600|NCT00042289|455057638|FG003|Overall Study|Severe debilitation, unable to continue|0|||
126479601|NCT00042289|455057639|FG004|Overall Study|Severe debilitation, unable to continue|0|||
126479602|NCT00042289|455057640|FG005|Overall Study|Severe debilitation, unable to continue|0|||
126479603|NCT00042289|455057641|FG006|Overall Study|Severe debilitation, unable to continue|0|||
126479604|NCT00042289|455057642|FG007|Overall Study|Severe debilitation, unable to continue|0|||
126479605|NCT00042289|455057643|FG008|Overall Study|Severe debilitation, unable to continue|0|||
126479606|NCT00042289|455057644|FG009|Overall Study|Severe debilitation, unable to continue|0|||
126479607|NCT00042289|455057645|FG010|Overall Study|Severe debilitation, unable to continue|0|||
126479608|NCT00042289|455057646|FG011|Overall Study|Severe debilitation, unable to continue|0|||
126479609|NCT00042289|455057647|FG012|Overall Study|Severe debilitation, unable to continue|0|||
126479610|NCT00042289|455057648|FG013|Overall Study|Severe debilitation, unable to continue|0|||
126479611|NCT00042289|455057649|FG014|Overall Study|Severe debilitation, unable to continue|0|||
126479612|NCT00042289|455057650|FG015|Overall Study|Severe debilitation, unable to continue|0|||
126479613|NCT00042289|455057651|FG016|Overall Study|Severe debilitation, unable to continue|0|||
126479614|NCT00042289|455057652|FG017|Overall Study|Severe debilitation, unable to continue|0|||
126479615|NCT00042289|455057653|FG018|Overall Study|Severe debilitation, unable to continue|0|||
126479616|NCT00042289|455057654|FG019|Overall Study|Severe debilitation, unable to continue|0|||
126479617|NCT00042289|455057655|FG020|Overall Study|Severe debilitation, unable to continue|0|||
126479618|NCT00042289|455057656|FG021|Overall Study|Severe debilitation, unable to continue|1|||
126479619|NCT00042289|455057657|FG022|Overall Study|Severe debilitation, unable to continue|0|||
126479620|NCT00042289|455057658|FG023|Overall Study|Severe debilitation, unable to continue|1|||
126479621|NCT00042289|455057659|FG024|Overall Study|Severe debilitation, unable to continue|0|||
126479622|NCT00042289|455057660|FG025|Overall Study|Severe debilitation, unable to continue|0|||
126479623|NCT00042289|455057661|FG026|Overall Study|Severe debilitation, unable to continue|0|||
126479624|NCT00042289|455057662|FG027|Overall Study|Severe debilitation, unable to continue|1|||
126479625|NCT00042289|455057663|FG028|Overall Study|Severe debilitation, unable to continue|0|||
126479626|NCT00042289|455057664|FG029|Overall Study|Severe debilitation, unable to continue|0|||
126479627|NCT00042289|455057665|FG030|Overall Study|Severe debilitation, unable to continue|0|||
126479628|NCT00042289|455057666|FG031|Overall Study|Severe debilitation, unable to continue|1|||
126479629|NCT00042289|455057667|FG032|Overall Study|Severe debilitation, unable to continue|1|||
126479630|NCT00042289|455057668|FG033|Overall Study|Severe debilitation, unable to continue|0|||
126479631|NCT00042289|455057669|FG034|Overall Study|Severe debilitation, unable to continue|0|||
126479632|NCT00042289|455057670|FG035|Overall Study|Severe debilitation, unable to continue|0|||
126479633|NCT00042289|455057671|FG036|Overall Study|Severe debilitation, unable to continue|0|||
126479634|NCT00042289|455057672|FG037|Overall Study|Severe debilitation, unable to continue|0|||
126479635|NCT00042289|455057673|FG038|Overall Study|Severe debilitation, unable to continue|0|||
126479636|NCT00042289|455057674|FG039|Overall Study|Severe debilitation, unable to continue|0|||
126479637|NCT00042289|455057675|FG040|Overall Study|Severe debilitation, unable to continue|0|||
126479638|NCT00042289|455057676|FG041|Overall Study|Severe debilitation, unable to continue|0|||
126559199|NCT05705167|455340682|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
126559200|NCT05705167|455340683|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
126479639|NCT00042289|455057677|FG042|Overall Study|Severe debilitation, unable to continue|0|||
126479640|NCT00042289|455057678|FG043|Overall Study|Severe debilitation, unable to continue|0|||
126479641|NCT00042289|455057679|FG044|Overall Study|Severe debilitation, unable to continue|0|||
126479642|NCT00042289|455057680|FG045|Overall Study|Severe debilitation, unable to continue|0|||
126559201|NCT05705167|455340684|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
126479643|NCT00042289|455057681|FG046|Overall Study|Severe debilitation, unable to continue|0|||
126479644|NCT00042289|455057635|FG000|Overall Study|Site closed|0|||
126479645|NCT00042289|455057636|FG001|Overall Study|Site closed|0|||
126479646|NCT00042289|455057637|FG002|Overall Study|Site closed|0|||
126479647|NCT00042289|455057638|FG003|Overall Study|Site closed|0|||
126479648|NCT00042289|455057639|FG004|Overall Study|Site closed|0|||
126479649|NCT00042289|455057640|FG005|Overall Study|Site closed|0|||
126479650|NCT00042289|455057641|FG006|Overall Study|Site closed|0|||
126479651|NCT00042289|455057642|FG007|Overall Study|Site closed|0|||
126479652|NCT00042289|455057643|FG008|Overall Study|Site closed|0|||
126479653|NCT00042289|455057644|FG009|Overall Study|Site closed|0|||
126479654|NCT00042289|455057645|FG010|Overall Study|Site closed|0|||
126479655|NCT00042289|455057646|FG011|Overall Study|Site closed|0|||
126479656|NCT00042289|455057647|FG012|Overall Study|Site closed|0|||
126479657|NCT00042289|455057648|FG013|Overall Study|Site closed|0|||
126479658|NCT00042289|455057649|FG014|Overall Study|Site closed|0|||
126479659|NCT00042289|455057650|FG015|Overall Study|Site closed|0|||
126479660|NCT00042289|455057651|FG016|Overall Study|Site closed|0|||
126479661|NCT00042289|455057652|FG017|Overall Study|Site closed|0|||
126479662|NCT00042289|455057653|FG018|Overall Study|Site closed|0|||
126479663|NCT00042289|455057654|FG019|Overall Study|Site closed|0|||
126479664|NCT00042289|455057655|FG020|Overall Study|Site closed|0|||
126479665|NCT00042289|455057656|FG021|Overall Study|Site closed|0|||
126479666|NCT00042289|455057657|FG022|Overall Study|Site closed|0|||
126479667|NCT00042289|455057658|FG023|Overall Study|Site closed|0|||
126479668|NCT00042289|455057659|FG024|Overall Study|Site closed|0|||
126479669|NCT00042289|455057660|FG025|Overall Study|Site closed|0|||
126479670|NCT00042289|455057661|FG026|Overall Study|Site closed|0|||
126722298|NCT02427477|455933333|FG001|Period 1|Adverse Event|0|||
126722299|NCT04369430|455933338|FG000|Overall Study|Adverse Event|2|||
126722300|NCT04369430|455933339|FG001|Overall Study|Adverse Event|3|||
126479671|NCT00042289|455057662|FG027|Overall Study|Site closed|0|||
126479672|NCT00042289|455057663|FG028|Overall Study|Site closed|0|||
126479673|NCT00042289|455057664|FG029|Overall Study|Site closed|0|||
126479674|NCT00042289|455057665|FG030|Overall Study|Site closed|0|||
126479675|NCT00042289|455057666|FG031|Overall Study|Site closed|3|||
126479676|NCT00042289|455057667|FG032|Overall Study|Site closed|0|||
126479677|NCT00042289|455057668|FG033|Overall Study|Site closed|0|||
126479678|NCT00042289|455057669|FG034|Overall Study|Site closed|0|||
126479679|NCT00042289|455057670|FG035|Overall Study|Site closed|0|||
126479680|NCT00042289|455057671|FG036|Overall Study|Site closed|1|||
126479681|NCT00042289|455057672|FG037|Overall Study|Site closed|0|||
126479682|NCT00042289|455057673|FG038|Overall Study|Site closed|0|||
126479683|NCT00042289|455057674|FG039|Overall Study|Site closed|0|||
126479684|NCT00042289|455057675|FG040|Overall Study|Site closed|0|||
126479685|NCT00042289|455057676|FG041|Overall Study|Site closed|0|||
126479686|NCT00042289|455057677|FG042|Overall Study|Site closed|1|||
126479687|NCT00042289|455057678|FG043|Overall Study|Site closed|0|||
126479688|NCT00042289|455057679|FG044|Overall Study|Site closed|0|||
126479689|NCT00042289|455057680|FG045|Overall Study|Site closed|0|||
126479690|NCT00042289|455057681|FG046|Overall Study|Site closed|0|||
126479691|NCT00042289|455057635|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
126479692|NCT00042289|455057636|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
126479693|NCT00042289|455057637|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
126479694|NCT00042289|455057638|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
126479695|NCT00042289|455057639|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
126479696|NCT00042289|455057640|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
126479697|NCT00042289|455057641|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
126479698|NCT00042289|455057642|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
126479699|NCT00042289|455057643|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
126479700|NCT00042289|455057644|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
126479701|NCT00042289|455057645|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
126479702|NCT00042289|455057646|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
126479703|NCT00042289|455057647|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
126722301|NCT04369430|455933338|FG000|Overall Study|Death|1|||
126722302|NCT04369430|455933339|FG001|Overall Study|Death|0|||
126479704|NCT00042289|455057648|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
126479705|NCT00042289|455057649|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
126479706|NCT00042289|455057650|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
126479707|NCT00042289|455057651|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
126479708|NCT00042289|455057652|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
126479709|NCT00042289|455057653|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
126479710|NCT00042289|455057654|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
126479711|NCT00042289|455057655|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
126479712|NCT00042289|455057656|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
126479713|NCT00042289|455057657|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
126479714|NCT00042289|455057658|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
126479715|NCT00042289|455057659|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
126479716|NCT00042289|455057660|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
126479717|NCT00042289|455057661|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
126479718|NCT00042289|455057662|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
126479719|NCT00042289|455057663|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
126479720|NCT00042289|455057664|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
126479721|NCT00042289|455057665|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
126479722|NCT00042289|455057666|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
126479723|NCT00042289|455057667|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
126479724|NCT00042289|455057668|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
126479725|NCT00042289|455057669|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
126479726|NCT00042289|455057670|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
126479727|NCT00042289|455057671|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
126479728|NCT00042289|455057672|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
126479729|NCT00042289|455057673|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
126479730|NCT00042289|455057674|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
126479731|NCT00042289|455057675|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
126479732|NCT00042289|455057676|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
126479733|NCT00042289|455057677|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
126479734|NCT00042289|455057678|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
126479735|NCT00042289|455057679|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
126479736|NCT00042289|455057680|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
126479737|NCT00042289|455057681|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
126479738|NCT00042289|455057635|FG000|Overall Study|Protocol Violation|0|||
126479739|NCT00042289|455057636|FG001|Overall Study|Protocol Violation|0|||
126479740|NCT00042289|455057637|FG002|Overall Study|Protocol Violation|0|||
126479741|NCT00042289|455057638|FG003|Overall Study|Protocol Violation|0|||
126479742|NCT00042289|455057639|FG004|Overall Study|Protocol Violation|0|||
126479743|NCT00042289|455057640|FG005|Overall Study|Protocol Violation|1|||
126479744|NCT00042289|455057641|FG006|Overall Study|Protocol Violation|0|||
126479745|NCT00042289|455057642|FG007|Overall Study|Protocol Violation|1|||
126479746|NCT00042289|455057643|FG008|Overall Study|Protocol Violation|0|||
126479747|NCT00042289|455057644|FG009|Overall Study|Protocol Violation|0|||
126479748|NCT00042289|455057645|FG010|Overall Study|Protocol Violation|0|||
126479749|NCT00042289|455057646|FG011|Overall Study|Protocol Violation|0|||
126479750|NCT00042289|455057647|FG012|Overall Study|Protocol Violation|0|||
126479751|NCT00042289|455057648|FG013|Overall Study|Protocol Violation|0|||
126479752|NCT00042289|455057649|FG014|Overall Study|Protocol Violation|0|||
126479753|NCT00042289|455057650|FG015|Overall Study|Protocol Violation|0|||
126479754|NCT00042289|455057651|FG016|Overall Study|Protocol Violation|0|||
126479755|NCT00042289|455057652|FG017|Overall Study|Protocol Violation|0|||
126479756|NCT00042289|455057653|FG018|Overall Study|Protocol Violation|0|||
126479757|NCT00042289|455057654|FG019|Overall Study|Protocol Violation|0|||
126479758|NCT00042289|455057655|FG020|Overall Study|Protocol Violation|0|||
126479759|NCT00042289|455057656|FG021|Overall Study|Protocol Violation|0|||
126479760|NCT00042289|455057657|FG022|Overall Study|Protocol Violation|0|||
126479761|NCT00042289|455057658|FG023|Overall Study|Protocol Violation|1|||
126479762|NCT00042289|455057659|FG024|Overall Study|Protocol Violation|1|||
126479763|NCT00042289|455057660|FG025|Overall Study|Protocol Violation|0|||
126479764|NCT00042289|455057661|FG026|Overall Study|Protocol Violation|2|||
126479765|NCT00042289|455057662|FG027|Overall Study|Protocol Violation|0|||
126479766|NCT00042289|455057663|FG028|Overall Study|Protocol Violation|0|||
126479767|NCT00042289|455057664|FG029|Overall Study|Protocol Violation|0|||
126479768|NCT00042289|455057665|FG030|Overall Study|Protocol Violation|1|||
126479769|NCT00042289|455057666|FG031|Overall Study|Protocol Violation|0|||
126479770|NCT00042289|455057667|FG032|Overall Study|Protocol Violation|0|||
126479771|NCT00042289|455057668|FG033|Overall Study|Protocol Violation|0|||
126479772|NCT00042289|455057669|FG034|Overall Study|Protocol Violation|0|||
126479773|NCT00042289|455057670|FG035|Overall Study|Protocol Violation|0|||
126479774|NCT00042289|455057671|FG036|Overall Study|Protocol Violation|0|||
126479775|NCT00042289|455057672|FG037|Overall Study|Protocol Violation|0|||
126479776|NCT00042289|455057673|FG038|Overall Study|Protocol Violation|0|||
126479777|NCT00042289|455057674|FG039|Overall Study|Protocol Violation|0|||
126479778|NCT00042289|455057675|FG040|Overall Study|Protocol Violation|0|||
126479779|NCT00042289|455057676|FG041|Overall Study|Protocol Violation|1|||
126479780|NCT00042289|455057677|FG042|Overall Study|Protocol Violation|1|||
126479781|NCT00042289|455057678|FG043|Overall Study|Protocol Violation|1|||
126479782|NCT00042289|455057679|FG044|Overall Study|Protocol Violation|0|||
126479783|NCT00042289|455057680|FG045|Overall Study|Protocol Violation|0|||
126479784|NCT00042289|455057681|FG046|Overall Study|Protocol Violation|0|||
126479785|NCT00042289|455057635|FG000|Overall Study|Withdrawal by Subject|4|||
126479786|NCT00042289|455057636|FG001|Overall Study|Withdrawal by Subject|1|||
126479787|NCT00042289|455057637|FG002|Overall Study|Withdrawal by Subject|0|||
126479788|NCT00042289|455057638|FG003|Overall Study|Withdrawal by Subject|2|||
126722303|NCT04369430|455933338|FG000|Overall Study|Withdrawal by Subject|4|||
126722304|NCT04369430|455933339|FG001|Overall Study|Withdrawal by Subject|3|||
126722305|NCT04369430|455933338|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
126722306|NCT04369430|455933339|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
126722307|NCT04369430|455933338|FG000|Overall Study|Lost to Follow-up|0|||
126722308|NCT04369430|455933339|FG001|Overall Study|Lost to Follow-up|1|||
126722309|NCT02435277|455933340|FG000|Overall Study|Adverse Event|1|||
126722310|NCT02435277|455933341|FG001|Overall Study|Adverse Event|1|||
126722311|NCT02435277|455933342|FG002|Overall Study|Adverse Event|0|||
126722312|NCT02435277|455933343|FG003|Overall Study|Adverse Event|0|||
126722313|NCT02435277|455933340|FG000|Overall Study|Withdrawal by Subject|1|||
126479789|NCT00042289|455057639|FG004|Overall Study|Withdrawal by Subject|0|||
126479790|NCT00042289|455057640|FG005|Overall Study|Withdrawal by Subject|2|||
126479791|NCT00042289|455057641|FG006|Overall Study|Withdrawal by Subject|0|||
126479792|NCT00042289|455057642|FG007|Overall Study|Withdrawal by Subject|0|||
126479793|NCT00042289|455057643|FG008|Overall Study|Withdrawal by Subject|0|||
126479794|NCT00042289|455057644|FG009|Overall Study|Withdrawal by Subject|1|||
126479795|NCT00042289|455057645|FG010|Overall Study|Withdrawal by Subject|0|||
126479796|NCT00042289|455057646|FG011|Overall Study|Withdrawal by Subject|0|||
126479797|NCT00042289|455057647|FG012|Overall Study|Withdrawal by Subject|2|||
126479798|NCT00042289|455057648|FG013|Overall Study|Withdrawal by Subject|0|||
126479799|NCT00042289|455057649|FG014|Overall Study|Withdrawal by Subject|0|||
126479800|NCT00042289|455057650|FG015|Overall Study|Withdrawal by Subject|0|||
126479801|NCT00042289|455057651|FG016|Overall Study|Withdrawal by Subject|0|||
126479802|NCT00042289|455057652|FG017|Overall Study|Withdrawal by Subject|0|||
126479803|NCT00042289|455057653|FG018|Overall Study|Withdrawal by Subject|0|||
126479804|NCT00042289|455057654|FG019|Overall Study|Withdrawal by Subject|0|||
126479805|NCT00042289|455057655|FG020|Overall Study|Withdrawal by Subject|0|||
126479806|NCT00042289|455057656|FG021|Overall Study|Withdrawal by Subject|1|||
126479807|NCT00042289|455057657|FG022|Overall Study|Withdrawal by Subject|1|||
126479808|NCT00042289|455057658|FG023|Overall Study|Withdrawal by Subject|1|||
126479809|NCT00042289|455057659|FG024|Overall Study|Withdrawal by Subject|0|||
126479810|NCT00042289|455057660|FG025|Overall Study|Withdrawal by Subject|0|||
126479811|NCT00042289|455057661|FG026|Overall Study|Withdrawal by Subject|1|||
126479812|NCT00042289|455057662|FG027|Overall Study|Withdrawal by Subject|0|||
126479813|NCT00042289|455057663|FG028|Overall Study|Withdrawal by Subject|2|||
126479814|NCT00042289|455057664|FG029|Overall Study|Withdrawal by Subject|0|||
126479815|NCT00042289|455057665|FG030|Overall Study|Withdrawal by Subject|0|||
126479816|NCT00042289|455057666|FG031|Overall Study|Withdrawal by Subject|1|||
126479817|NCT00042289|455057667|FG032|Overall Study|Withdrawal by Subject|2|||
126479818|NCT00042289|455057668|FG033|Overall Study|Withdrawal by Subject|1|||
126479819|NCT00042289|455057669|FG034|Overall Study|Withdrawal by Subject|0|||
126479820|NCT00042289|455057670|FG035|Overall Study|Withdrawal by Subject|0|||
126479821|NCT00042289|455057671|FG036|Overall Study|Withdrawal by Subject|0|||
126479822|NCT00042289|455057672|FG037|Overall Study|Withdrawal by Subject|1|||
126479823|NCT00042289|455057673|FG038|Overall Study|Withdrawal by Subject|0|||
126479824|NCT00042289|455057674|FG039|Overall Study|Withdrawal by Subject|0|||
126479825|NCT00042289|455057675|FG040|Overall Study|Withdrawal by Subject|0|||
126479826|NCT00042289|455057676|FG041|Overall Study|Withdrawal by Subject|0|||
126479827|NCT00042289|455057677|FG042|Overall Study|Withdrawal by Subject|1|||
126479828|NCT00042289|455057678|FG043|Overall Study|Withdrawal by Subject|0|||
126479829|NCT00042289|455057679|FG044|Overall Study|Withdrawal by Subject|0|||
126479830|NCT00042289|455057680|FG045|Overall Study|Withdrawal by Subject|0|||
126722314|NCT02435277|455933341|FG001|Overall Study|Withdrawal by Subject|0|||
126722315|NCT02435277|455933342|FG002|Overall Study|Withdrawal by Subject|0|||
126722316|NCT02435277|455933343|FG003|Overall Study|Withdrawal by Subject|0|||
126479831|NCT00042289|455057681|FG046|Overall Study|Withdrawal by Subject|0|||
126479832|NCT00745823|455057682|FG000|Overall Study|Adverse Event|5|||
126479833|NCT00745823|455057683|FG001|Overall Study|Adverse Event|3|||
126479834|NCT00745823|455057682|FG000|Overall Study|Lack of Efficacy|20|||
126479835|NCT00745823|455057683|FG001|Overall Study|Lack of Efficacy|6|||
126479836|NCT00745823|455057682|FG000|Overall Study|Lost to Follow-up|10|||
126722317|NCT00008138|455933344|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
126722318|NCT00008138|455933344|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
126479837|NCT00745823|455057683|FG001|Overall Study|Lost to Follow-up|11|||
126479838|NCT00745823|455057682|FG000|Overall Study|Physician Decision|10|||
126479839|NCT00745823|455057683|FG001|Overall Study|Physician Decision|5|||
126479840|NCT00745823|455057682|FG000|Overall Study|Pregnancy|0|||
126479841|NCT00745823|455057683|FG001|Overall Study|Pregnancy|4|||
126479842|NCT00745823|455057682|FG000|Overall Study|Withdrawal by Subject|14|||
126479843|NCT00745823|455057683|FG001|Overall Study|Withdrawal by Subject|8|||
126479844|NCT00745823|455057682|FG000|Overall Study|Study Terminated by Sponsor|326|||
126479845|NCT00745823|455057683|FG001|Overall Study|Study Terminated by Sponsor|349|||
126479846|NCT01687998|455057684|FG000|Overall Study|Withdrawal by Subject|49|||
126479847|NCT01687998|455057685|FG001|Overall Study|Withdrawal by Subject|51|||
126479848|NCT01687998|455057684|FG000|Overall Study|Known to be Alive at Study End|54|||
126722319|NCT00008138|455933344|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
126722320|NCT00008138|455933344|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
126479849|NCT01687998|455057685|FG001|Overall Study|Known to be Alive at Study End|62|||
126479850|NCT01687998|455057684|FG000|Overall Study|Lost to Follow-up|9|||
126479851|NCT01687998|455057685|FG001|Overall Study|Lost to Follow-up|7|||
126479852|NCT00612690|455057686|FG000|Overall Study|Lost to Follow-up|72|||
126479853|NCT00612690|455057687|FG001|Overall Study|Lost to Follow-up|98|||
126479854|NCT00612690|455057686|FG000|Overall Study|Withdrawal by Subject|32|||
126479855|NCT00612690|455057687|FG001|Overall Study|Withdrawal by Subject|20|||
126479856|NCT00612690|455057686|FG000|Overall Study|Withdrawal by Site|11|||
126479857|NCT00612690|455057687|FG001|Overall Study|Withdrawal by Site|0|||
126479858|NCT00787891|455057689|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
126479859|NCT00787891|455057690|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
126479860|NCT00787891|455057689|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
126479861|NCT00787891|455057690|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
126479862|NCT00787891|455057689|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
126479863|NCT00787891|455057690|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
126479864|NCT00787891|455057689|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
126479865|NCT00787891|455057690|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
126479866|NCT00787891|455057689|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
126479867|NCT00787891|455057690|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
126479868|NCT00787891|455057689|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
126479869|NCT00787891|455057690|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
126479870|NCT00787891|455057689|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
126479871|NCT00787891|455057690|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
126479872|NCT00787891|455057689|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
126479873|NCT00787891|455057690|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
126479874|NCT00787891|455057689|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
126479875|NCT00787891|455057690|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
126479876|NCT00787891|455057689|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
126479877|NCT00787891|455057690|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
126479878|NCT02955602|455057691|FG000|Overall Study|Adverse Event|0|||
126479879|NCT02955602|455057692|FG001|Overall Study|Adverse Event|3|||
126479880|NCT02955602|455057693|FG002|Overall Study|Adverse Event|0|||
126479881|NCT02955602|455057691|FG000|Overall Study|Withdrawal of informed consent|1|||
126479882|NCT02955602|455057692|FG001|Overall Study|Withdrawal of informed consent|3|||
126479883|NCT02955602|455057693|FG002|Overall Study|Withdrawal of informed consent|2|||
126479884|NCT02955602|455057691|FG000|Overall Study|Lost to Follow-up|0|||
126479885|NCT02955602|455057692|FG001|Overall Study|Lost to Follow-up|0|||
126479886|NCT02955602|455057693|FG002|Overall Study|Lost to Follow-up|1|||
126479887|NCT02955602|455057691|FG000|Overall Study|Other|0|||
126479888|NCT02955602|455057692|FG001|Overall Study|Other|1|||
126479889|NCT02955602|455057693|FG002|Overall Study|Other|3|||
126479890|NCT02980601|455057696|FG000|Overall Study|Lost to Follow-up|2|||
126479891|NCT02980601|455057697|FG001|Overall Study|Lost to Follow-up|2|||
126479892|NCT02980601|455057696|FG000|Overall Study|Death|0|||
126479893|NCT02980601|455057697|FG001|Overall Study|Death|1|||
126479894|NCT02980601|455057696|FG000|Overall Study|Graft loss|1|||
126479895|NCT02980601|455057697|FG001|Overall Study|Graft loss|0|||
126479896|NCT02980601|455057696|FG000|Overall Study|Failed to sign consent|2|||
126479897|NCT02980601|455057697|FG001|Overall Study|Failed to sign consent|0|||
126479898|NCT00395304|455057698|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126479899|NCT00395304|455057699|FG001|Treatment Period 1|Withdrawal by Subject|3|||
126479900|NCT00395304|455057700|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126479901|NCT00395304|455057701|FG003|Treatment Period 1|Withdrawal by Subject|2|||
126479902|NCT00395304|455057702|FG004|Treatment Period 1|Withdrawal by Subject|1|||
126479903|NCT00395304|455057703|FG005|Treatment Period 1|Withdrawal by Subject|1|||
126479904|NCT00395304|455057698|FG000|Treatment Period 1|Lost to Follow-up|1|||
126479905|NCT00395304|455057699|FG001|Treatment Period 1|Lost to Follow-up|0|||
126722321|NCT00008138|455933344|FG000|Interval Debulking|Withdrawal by Subject|2|||
126722322|NCT00008138|455933344|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
126479906|NCT00395304|455057700|FG002|Treatment Period 1|Lost to Follow-up|0|||
126479907|NCT00395304|455057701|FG003|Treatment Period 1|Lost to Follow-up|1|||
126479908|NCT00395304|455057702|FG004|Treatment Period 1|Lost to Follow-up|0|||
126479909|NCT00395304|455057703|FG005|Treatment Period 1|Lost to Follow-up|1|||
126479910|NCT00395304|455057698|FG000|Treatment Period 1|Physician Decision|0|||
126479911|NCT00395304|455057699|FG001|Treatment Period 1|Physician Decision|1|||
126479912|NCT00395304|455057700|FG002|Treatment Period 1|Physician Decision|0|||
126722323|NCT00008138|455933344|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
126479913|NCT00395304|455057701|FG003|Treatment Period 1|Physician Decision|0|||
126479914|NCT00395304|455057702|FG004|Treatment Period 1|Physician Decision|0|||
126479915|NCT00395304|455057703|FG005|Treatment Period 1|Physician Decision|0|||
126479916|NCT00395304|455057698|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126479917|NCT00395304|455057699|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126479918|NCT00395304|455057700|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126479919|NCT00395304|455057701|FG003|Treatment Period 2|Withdrawal by Subject|1|||
126479920|NCT00395304|455057702|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126479921|NCT00395304|455057703|FG005|Treatment Period 2|Withdrawal by Subject|2|||
126479922|NCT00395304|455057698|FG000|Treatment Period 2|Lost to Follow-up|0|||
126479923|NCT00395304|455057699|FG001|Treatment Period 2|Lost to Follow-up|3|||
126479924|NCT00395304|455057700|FG002|Treatment Period 2|Lost to Follow-up|0|||
126479925|NCT00395304|455057701|FG003|Treatment Period 2|Lost to Follow-up|0|||
126479926|NCT00395304|455057702|FG004|Treatment Period 2|Lost to Follow-up|0|||
126479927|NCT00395304|455057703|FG005|Treatment Period 2|Lost to Follow-up|0|||
126479928|NCT00395304|455057698|FG000|Treatment Period 2|Physician Decision|0|||
126479929|NCT00395304|455057699|FG001|Treatment Period 2|Physician Decision|0|||
126479930|NCT00395304|455057700|FG002|Treatment Period 2|Physician Decision|1|||
126479931|NCT00395304|455057701|FG003|Treatment Period 2|Physician Decision|0|||
126479932|NCT00395304|455057702|FG004|Treatment Period 2|Physician Decision|0|||
126479933|NCT00395304|455057703|FG005|Treatment Period 2|Physician Decision|0|||
126479934|NCT00395304|455057698|FG000|Treatment Period 2|Other|0|||
126479935|NCT00395304|455057699|FG001|Treatment Period 2|Other|1|||
126479936|NCT00395304|455057700|FG002|Treatment Period 2|Other|0|||
126479937|NCT00395304|455057701|FG003|Treatment Period 2|Other|0|||
126479938|NCT00395304|455057702|FG004|Treatment Period 2|Other|0|||
126479939|NCT00395304|455057703|FG005|Treatment Period 2|Other|0|||
126479940|NCT00395304|455057698|FG000|Treatment Period 3|Withdrawal by Subject|0|||
126479941|NCT00395304|455057699|FG001|Treatment Period 3|Withdrawal by Subject|0|||
126479942|NCT00395304|455057700|FG002|Treatment Period 3|Withdrawal by Subject|0|||
126479943|NCT00395304|455057701|FG003|Treatment Period 3|Withdrawal by Subject|1|||
126479944|NCT00395304|455057702|FG004|Treatment Period 3|Withdrawal by Subject|0|||
126479945|NCT00395304|455057703|FG005|Treatment Period 3|Withdrawal by Subject|1|||
126479946|NCT00395304|455057698|FG000|Treatment Period 3|Lost to Follow-up|1|||
126479947|NCT00395304|455057699|FG001|Treatment Period 3|Lost to Follow-up|1|||
126479948|NCT00395304|455057700|FG002|Treatment Period 3|Lost to Follow-up|0|||
126479949|NCT00395304|455057701|FG003|Treatment Period 3|Lost to Follow-up|0|||
126479950|NCT00395304|455057702|FG004|Treatment Period 3|Lost to Follow-up|0|||
126479951|NCT00395304|455057703|FG005|Treatment Period 3|Lost to Follow-up|0|||
126479952|NCT00395304|455057698|FG000|Treatment Period 3|Physician Decision|0|||
126479953|NCT00395304|455057699|FG001|Treatment Period 3|Physician Decision|1|||
126479954|NCT00395304|455057700|FG002|Treatment Period 3|Physician Decision|0|||
126479955|NCT00395304|455057701|FG003|Treatment Period 3|Physician Decision|0|||
126479956|NCT00395304|455057702|FG004|Treatment Period 3|Physician Decision|0|||
126479957|NCT00395304|455057703|FG005|Treatment Period 3|Physician Decision|0|||
126479958|NCT00395304|455057698|FG000|Treatment Period 3|Other|0|||
126479959|NCT00395304|455057699|FG001|Treatment Period 3|Other|0|||
126479960|NCT00395304|455057700|FG002|Treatment Period 3|Other|0|||
126479961|NCT00395304|455057701|FG003|Treatment Period 3|Other|1|||
126479962|NCT00395304|455057702|FG004|Treatment Period 3|Other|0|||
126479963|NCT00395304|455057703|FG005|Treatment Period 3|Other|0|||
126479964|NCT03797014|455057705|FG000|Overall Study|Withdrawal by Subject|1|||
126479965|NCT03797014|455057705|FG000|Overall Study|Lost to Follow-up|1|||
126479966|NCT03797014|455057705|FG000|Overall Study|Protocol Violation|1|||
126479967|NCT01970397|455057706|FG000|Overall Study|Adverse Event|0|||
126479968|NCT01970397|455057707|FG001|Overall Study|Adverse Event|1|||
126479969|NCT01970397|455057706|FG000|Overall Study|Lost to Follow-up|0|||
126479970|NCT01970397|455057707|FG001|Overall Study|Lost to Follow-up|1|||
126479971|NCT01970397|455057706|FG000|Overall Study|Personal Reasons|1|||
126479972|NCT01970397|455057707|FG001|Overall Study|Personal Reasons|2|||
126479973|NCT01970397|455057706|FG000|Overall Study|Protocol Violation|1|||
126479974|NCT01970397|455057707|FG001|Overall Study|Protocol Violation|1|||
126479975|NCT01389817|455057710|FG000|Overall Study|Physician Decision|1|||
126479976|NCT01389817|455057711|FG001|Overall Study|Physician Decision|0|||
126479977|NCT01389817|455057710|FG000|Overall Study|Lost to Follow-up|1|||
126479978|NCT01389817|455057711|FG001|Overall Study|Lost to Follow-up|0|||
126479979|NCT01389817|455057710|FG000|Overall Study|Withdrawal by Subject|2|||
126479980|NCT01389817|455057711|FG001|Overall Study|Withdrawal by Subject|0|||
126479981|NCT02871297|455057714|FG000|Overall Study|Adverse Event|34|||
126479982|NCT02871297|455057714|FG000|Overall Study|Lack of Efficacy|10|||
126479983|NCT02871297|455057714|FG000|Overall Study|Non-compliance with study drug|15|||
126479984|NCT02871297|455057714|FG000|Overall Study|Protocol Violation|3|||
126479985|NCT02871297|455057714|FG000|Overall Study|Withdrawal by Subject|20|||
126479986|NCT02871297|455057714|FG000|Overall Study|Lost to Follow-up|13|||
126479987|NCT02871297|455057714|FG000|Overall Study|Rolled over to 13546A|2|||
126479988|NCT02871297|455057714|FG000|Overall Study|Other than specified|39|||
126479989|NCT01434667|455057718|FG000|Overall Study|Lost to Follow-up|5|||
126479990|NCT01434667|455057719|FG001|Overall Study|Lost to Follow-up|10|||
126479991|NCT04115839|455057720|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
126479992|NCT04115839|455057721|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
126479993|NCT04115839|455057722|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
126479994|NCT04115839|455057723|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
126479995|NCT04115839|455057724|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
126479996|NCT04115839|455057725|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
126479997|NCT04115839|455057726|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
126479998|NCT04115839|455057720|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
126479999|NCT04115839|455057721|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
126480000|NCT04115839|455057722|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
126480001|NCT04115839|455057723|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
126480002|NCT04115839|455057724|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
126480003|NCT04115839|455057725|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
126480004|NCT04115839|455057726|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
126480005|NCT04115839|455057720|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
126480006|NCT04115839|455057721|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
126480007|NCT04115839|455057722|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
126480008|NCT04115839|455057723|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
126480009|NCT04115839|455057724|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
126480010|NCT04115839|455057725|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
126480011|NCT04115839|455057726|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
126480012|NCT04115839|455057720|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
126722324|NCT00008138|455933344|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
126722325|NCT02065622|455933345|FG000|Induction Study|Adverse Event|13|||
126722326|NCT02065622|455933346|FG001|Induction Study|Adverse Event|19|||
126722327|NCT02065622|455933347|FG002|Induction Study|Adverse Event|0|||
126480013|NCT04115839|455057721|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
126480014|NCT04115839|455057722|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
126480015|NCT04115839|455057723|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
126480016|NCT04115839|455057724|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
126480017|NCT04115839|455057725|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
126480018|NCT04115839|455057726|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
126480019|NCT04115839|455057720|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
126480020|NCT04115839|455057721|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
126480021|NCT04115839|455057722|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
126480022|NCT04115839|455057723|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
126480023|NCT04115839|455057724|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
126480024|NCT04115839|455057725|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
126480025|NCT04115839|455057726|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
126480026|NCT04115839|455057720|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
126480027|NCT04115839|455057721|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
126480028|NCT04115839|455057722|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
126480029|NCT04115839|455057723|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
126480030|NCT04115839|455057724|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
126480031|NCT04115839|455057725|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
126480032|NCT04115839|455057726|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
126480033|NCT02966028|455057727|FG000|Overall Study|Adverse Event|7|||
126480034|NCT02966028|455057728|FG001|Overall Study|Adverse Event|13|||
126480035|NCT02966028|455057729|FG002|Overall Study|Adverse Event|10|||
126480036|NCT02966028|455057727|FG000|Overall Study|Physician Decision|1|||
126480037|NCT02966028|455057728|FG001|Overall Study|Physician Decision|0|||
126480038|NCT02966028|455057729|FG002|Overall Study|Physician Decision|2|||
126480039|NCT02966028|455057727|FG000|Overall Study|Withdrawal by Subject|7|||
126480040|NCT02966028|455057728|FG001|Overall Study|Withdrawal by Subject|5|||
126480041|NCT02966028|455057729|FG002|Overall Study|Withdrawal by Subject|5|||
126480042|NCT02966028|455057727|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
126480043|NCT02966028|455057728|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
126480044|NCT02966028|455057729|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
126480045|NCT02034110|455057730|FG000|Overall Study|Physician Decision|0|||
126480046|NCT02034110|455057731|FG001|Overall Study|Physician Decision|0|||
126480047|NCT02034110|455057732|FG002|Overall Study|Physician Decision|0|||
126480048|NCT02034110|455057733|FG003|Overall Study|Physician Decision|0|||
126480049|NCT02034110|455057734|FG004|Overall Study|Physician Decision|2|||
126480050|NCT02034110|455057735|FG005|Overall Study|Physician Decision|0|||
126480051|NCT02034110|455057736|FG006|Overall Study|Physician Decision|1|||
126480052|NCT02034110|455057737|FG007|Overall Study|Physician Decision|0|||
126480053|NCT02034110|455057730|FG000|Overall Study|Lost to Follow-up|1|||
126480054|NCT02034110|455057731|FG001|Overall Study|Lost to Follow-up|0|||
126480055|NCT02034110|455057732|FG002|Overall Study|Lost to Follow-up|0|||
126480056|NCT02034110|455057733|FG003|Overall Study|Lost to Follow-up|0|||
126480057|NCT02034110|455057734|FG004|Overall Study|Lost to Follow-up|1|||
126480058|NCT02034110|455057735|FG005|Overall Study|Lost to Follow-up|0|||
126480059|NCT02034110|455057736|FG006|Overall Study|Lost to Follow-up|1|||
126480060|NCT02034110|455057737|FG007|Overall Study|Lost to Follow-up|0|||
126480061|NCT02034110|455057730|FG000|Overall Study|Withdrawal by Subject|5|||
126480062|NCT02034110|455057731|FG001|Overall Study|Withdrawal by Subject|7|||
126480063|NCT02034110|455057732|FG002|Overall Study|Withdrawal by Subject|0|||
126480064|NCT02034110|455057733|FG003|Overall Study|Withdrawal by Subject|3|||
126480065|NCT02034110|455057734|FG004|Overall Study|Withdrawal by Subject|7|||
126480066|NCT02034110|455057735|FG005|Overall Study|Withdrawal by Subject|0|||
126480067|NCT02034110|455057736|FG006|Overall Study|Withdrawal by Subject|3|||
126480068|NCT02034110|455057737|FG007|Overall Study|Withdrawal by Subject|1|||
126480069|NCT02034110|455057730|FG000|Overall Study|Study closed by sponsor|6|||
126480070|NCT02034110|455057731|FG001|Overall Study|Study closed by sponsor|2|||
126480071|NCT02034110|455057732|FG002|Overall Study|Study closed by sponsor|0|||
126480072|NCT02034110|455057733|FG003|Overall Study|Study closed by sponsor|6|||
126480073|NCT02034110|455057734|FG004|Overall Study|Study closed by sponsor|7|||
126480074|NCT02034110|455057735|FG005|Overall Study|Study closed by sponsor|0|||
126480075|NCT02034110|455057736|FG006|Overall Study|Study closed by sponsor|42|||
126480076|NCT02034110|455057737|FG007|Overall Study|Study closed by sponsor|0|||
126480077|NCT00621985|455057738|FG000|Dexamethasone Admission|Adverse Event|1|||
126480078|NCT01877265|455057742|FG000|Treatment Period 1|Sponsor Decision|0|||
126480079|NCT01877265|455057743|FG001|Treatment Period 1|Sponsor Decision|0|||
126480080|NCT01877265|455057744|FG002|Treatment Period 1|Sponsor Decision|1|||
126480081|NCT01877265|455057745|FG003|Treatment Period 1|Sponsor Decision|0|||
126480082|NCT01877265|455057746|FG004|Treatment Period 1|Sponsor Decision|0|||
126480083|NCT01877265|455057747|FG005|Treatment Period 1|Sponsor Decision|0|||
126480084|NCT01877265|455057742|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
126480085|NCT01877265|455057743|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
126480086|NCT01877265|455057744|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
126480087|NCT01877265|455057745|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
126480088|NCT01877265|455057746|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
126480089|NCT01877265|455057747|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
126480090|NCT01877265|455057742|FG000|Treatment Period 3|Lost to Follow-up|1|||
126480091|NCT01877265|455057743|FG001|Treatment Period 3|Lost to Follow-up|0|||
126480092|NCT01877265|455057744|FG002|Treatment Period 3|Lost to Follow-up|0|||
126480093|NCT01877265|455057745|FG003|Treatment Period 3|Lost to Follow-up|0|||
126480094|NCT01877265|455057746|FG004|Treatment Period 3|Lost to Follow-up|0|||
126480095|NCT01877265|455057747|FG005|Treatment Period 3|Lost to Follow-up|0|||
126480096|NCT04160195|455057748|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
126480097|NCT04160195|455057749|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
126480098|NCT00684593|455057755|FG000|Overall Study|Adverse Event|0|||
126480099|NCT00684593|455057756|FG001|Overall Study|Adverse Event|2|||
126480100|NCT05386680|455057759|FG000|Overall Study|Guardian decision|2|||
126480101|NCT03706079|455057767|FG000|Predecessor Study|Death|0|||
126480102|NCT03706079|455057768|FG001|Predecessor Study|Death|2|||
126480103|NCT03706079|455057769|FG002|Predecessor Study|Death|0|||
126480104|NCT03706079|455057770|FG003|Predecessor Study|Death|1|||
126480105|NCT03706079|455057771|FG004|Predecessor Study|Death|0|||
126480106|NCT03706079|455057772|FG005|Predecessor Study|Death|0|||
126480107|NCT03706079|455057767|FG000|Predecessor Study|Lost to Follow-up|5|||
126480108|NCT03706079|455057768|FG001|Predecessor Study|Lost to Follow-up|2|||
126480109|NCT03706079|455057769|FG002|Predecessor Study|Lost to Follow-up|0|||
126480110|NCT03706079|455057770|FG003|Predecessor Study|Lost to Follow-up|0|||
126480111|NCT03706079|455057771|FG004|Predecessor Study|Lost to Follow-up|1|||
126480112|NCT03706079|455057772|FG005|Predecessor Study|Lost to Follow-up|0|||
126480113|NCT03706079|455057767|FG000|Predecessor Study|Withdrawal by Subject|8|||
126480114|NCT03706079|455057768|FG001|Predecessor Study|Withdrawal by Subject|15|||
126480115|NCT03706079|455057769|FG002|Predecessor Study|Withdrawal by Subject|0|||
126480116|NCT03706079|455057770|FG003|Predecessor Study|Withdrawal by Subject|5|||
126480117|NCT03706079|455057771|FG004|Predecessor Study|Withdrawal by Subject|2|||
126480118|NCT03706079|455057772|FG005|Predecessor Study|Withdrawal by Subject|0|||
126480119|NCT03706079|455057767|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
126480120|NCT03706079|455057768|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
126480121|NCT03706079|455057769|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
126480122|NCT03706079|455057770|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
126480123|NCT03706079|455057771|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
126480124|NCT03706079|455057772|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
126480125|NCT03706079|455057767|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
126480126|NCT03706079|455057768|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
126480127|NCT03706079|455057769|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
126480128|NCT03706079|455057770|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
126480129|NCT03706079|455057771|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
126480130|NCT03706079|455057772|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
126480131|NCT03706079|455057767|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
126480132|NCT03706079|455057768|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
126480133|NCT03706079|455057769|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
126480134|NCT03706079|455057770|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
126480135|NCT03706079|455057771|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
126480136|NCT03706079|455057772|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
126480137|NCT03706079|455057767|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
126480138|NCT03706079|455057768|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
126480139|NCT03706079|455057769|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
126480140|NCT03706079|455057770|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
126480141|NCT03706079|455057771|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
126480142|NCT03706079|455057772|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
126480143|NCT03706079|455057767|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
126480144|NCT03706079|455057768|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
126480145|NCT03706079|455057769|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
126480146|NCT03706079|455057770|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
126480147|NCT03706079|455057771|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
126480148|NCT03706079|455057772|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
126480149|NCT03706079|455057767|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
126480150|NCT03706079|455057768|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
126480151|NCT03706079|455057769|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
126480152|NCT03706079|455057770|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
126480153|NCT03706079|455057771|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
126480154|NCT03706079|455057772|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
126480155|NCT03706079|455057767|FG000|Long Term Extension (DESTINATION)|Death|8|||
126480156|NCT03706079|455057768|FG001|Long Term Extension (DESTINATION)|Death|2|||
126480157|NCT03706079|455057769|FG002|Long Term Extension (DESTINATION)|Death|2|||
126480158|NCT03706079|455057770|FG003|Long Term Extension (DESTINATION)|Death|1|||
126480159|NCT03706079|455057771|FG004|Long Term Extension (DESTINATION)|Death|0|||
126480160|NCT03706079|455057772|FG005|Long Term Extension (DESTINATION)|Death|0|||
126480161|NCT01203098|455057779|FG000|Overall Study|Adverse Event|3|||
126480162|NCT01203098|455057780|FG001|Overall Study|Adverse Event|1|||
126480163|NCT01203098|455057781|FG002|Overall Study|Adverse Event|7|||
126480164|NCT01203098|455057779|FG000|Overall Study|Lost to Follow-up|0|||
126480165|NCT01203098|455057780|FG001|Overall Study|Lost to Follow-up|0|||
126480166|NCT01203098|455057781|FG002|Overall Study|Lost to Follow-up|1|||
126480167|NCT01203098|455057779|FG000|Overall Study|Physician Decision|2|||
126480168|NCT01203098|455057780|FG001|Overall Study|Physician Decision|2|||
126480169|NCT01203098|455057781|FG002|Overall Study|Physician Decision|0|||
126480170|NCT01203098|455057779|FG000|Overall Study|Withdrawal by Subject|1|||
126480171|NCT01203098|455057780|FG001|Overall Study|Withdrawal by Subject|1|||
126480172|NCT01203098|455057781|FG002|Overall Study|Withdrawal by Subject|3|||
126480173|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
126480174|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
126722328|NCT02065622|455933348|FG003|Induction Study|Adverse Event|0|||
126722329|NCT02065622|455933349|FG004|Induction Study|Adverse Event|0|||
126722330|NCT02065622|455933345|FG000|Induction Study|Withdrawal by Subject|3|||
126722331|NCT02065622|455933346|FG001|Induction Study|Withdrawal by Subject|5|||
126722332|NCT02065622|455933347|FG002|Induction Study|Withdrawal by Subject|0|||
126480175|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
126480176|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
126480177|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
126480178|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
126480179|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
126480180|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
126480181|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
126480182|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
126480183|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
126480184|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
126480185|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
126480186|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
126480187|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
126480188|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
126480189|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
126480190|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
126722333|NCT02065622|455933348|FG003|Induction Study|Withdrawal by Subject|0|||
126722334|NCT02065622|455933349|FG004|Induction Study|Withdrawal by Subject|0|||
126722335|NCT02065622|455933345|FG000|Induction Study|Lost to Follow-up|1|||
126722336|NCT02065622|455933346|FG001|Induction Study|Lost to Follow-up|0|||
126722337|NCT02065622|455933347|FG002|Induction Study|Lost to Follow-up|0|||
126722338|NCT02065622|455933348|FG003|Induction Study|Lost to Follow-up|0|||
126722339|NCT02065622|455933349|FG004|Induction Study|Lost to Follow-up|0|||
126722340|NCT02065622|455933345|FG000|Induction Study|Lack of Efficacy|22|||
126722341|NCT02065622|455933346|FG001|Induction Study|Lack of Efficacy|27|||
126722342|NCT02065622|455933347|FG002|Induction Study|Lack of Efficacy|0|||
126722343|NCT02065622|455933348|FG003|Induction Study|Lack of Efficacy|0|||
126722344|NCT02065622|455933349|FG004|Induction Study|Lack of Efficacy|0|||
126722345|NCT02065622|455933345|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
126722346|NCT02065622|455933346|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
126722347|NCT02065622|455933347|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
126722348|NCT02065622|455933348|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
126722349|NCT02065622|455933349|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
126722350|NCT02065622|455933345|FG000|Induction Study|Subject Noncompliance|1|||
126722351|NCT02065622|455933346|FG001|Induction Study|Subject Noncompliance|1|||
126722352|NCT02065622|455933347|FG002|Induction Study|Subject Noncompliance|0|||
126722353|NCT02065622|455933348|FG003|Induction Study|Subject Noncompliance|0|||
126722354|NCT02065622|455933349|FG004|Induction Study|Subject Noncompliance|0|||
126722355|NCT02065622|455933345|FG000|Induction Study|Other, Not Specified|3|||
126722356|NCT02065622|455933346|FG001|Induction Study|Other, Not Specified|2|||
126722357|NCT02065622|455933347|FG002|Induction Study|Other, Not Specified|0|||
126722358|NCT02065622|455933348|FG003|Induction Study|Other, Not Specified|0|||
126722359|NCT02065622|455933349|FG004|Induction Study|Other, Not Specified|0|||
126722360|NCT02065622|455933345|FG000|Maintenance Study|Adverse Event|0|||
126722361|NCT02065622|455933346|FG001|Maintenance Study|Adverse Event|0|||
126722362|NCT02065622|455933347|FG002|Maintenance Study|Adverse Event|25|||
126722363|NCT02065622|455933348|FG003|Maintenance Study|Adverse Event|22|||
126722364|NCT02065622|455933349|FG004|Maintenance Study|Adverse Event|11|||
126722365|NCT02065622|455933345|FG000|Maintenance Study|Withdrawal by Subject|0|||
126722366|NCT02065622|455933346|FG001|Maintenance Study|Withdrawal by Subject|0|||
126722367|NCT02065622|455933347|FG002|Maintenance Study|Withdrawal by Subject|11|||
126722368|NCT02065622|455933348|FG003|Maintenance Study|Withdrawal by Subject|5|||
126722369|NCT02065622|455933349|FG004|Maintenance Study|Withdrawal by Subject|7|||
126722370|NCT02065622|455933345|FG000|Maintenance Study|Lost to Follow-up|0|||
126722371|NCT02065622|455933346|FG001|Maintenance Study|Lost to Follow-up|0|||
126722372|NCT02065622|455933347|FG002|Maintenance Study|Lost to Follow-up|4|||
126722373|NCT02065622|455933348|FG003|Maintenance Study|Lost to Follow-up|1|||
126722374|NCT02065622|455933349|FG004|Maintenance Study|Lost to Follow-up|1|||
126722375|NCT02065622|455933345|FG000|Maintenance Study|Lack of Efficacy|0|||
126480191|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
126480192|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
126480193|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
126480194|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
126480195|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
126480196|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
126480197|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
126480198|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
126480199|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
126480200|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
126480201|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
126480202|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
126480203|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
126480204|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
126480205|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
126480206|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
126480207|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
126480208|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
126480209|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
126480210|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
126480211|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
126480212|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
126480213|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
126480214|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
126480215|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
126480216|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
126722376|NCT02065622|455933346|FG001|Maintenance Study|Lack of Efficacy|0|||
126722377|NCT02065622|455933347|FG002|Maintenance Study|Lack of Efficacy|70|||
126722378|NCT02065622|455933348|FG003|Maintenance Study|Lack of Efficacy|55|||
126722379|NCT02065622|455933349|FG004|Maintenance Study|Lack of Efficacy|19|||
126722380|NCT02065622|455933345|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
126480217|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
126480218|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
126480219|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
126480220|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
126480221|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
126480222|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
126480223|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
126480224|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
126480225|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
126480226|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
126480227|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
126480228|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
126480229|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
126480230|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
126480231|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
126480232|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
126480233|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
126480234|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
126480235|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
126480236|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
126480237|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
126480238|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
126480239|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
126480240|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
126480241|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
126480242|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
126480243|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Change of location|0|||
126480244|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Change of location|0|||
126480245|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Change of location|0|||
126480246|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Change of location|1|||
126480247|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Change of location|0|||
126480248|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
126480249|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
126480250|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
126480251|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
126480252|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
126480253|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
126480254|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
126480255|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
126480256|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
126480257|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
126480258|NCT00730405|455057784|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
126480259|NCT00730405|455057785|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
126480260|NCT00730405|455057786|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
126480261|NCT00730405|455057787|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
126480262|NCT00730405|455057788|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
126480263|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
126480264|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
126480265|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
126480266|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
126480267|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
126480268|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
126480269|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
126480270|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
126480271|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
126480272|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
126480273|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
126480274|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
126480275|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
126480276|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
126480277|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
126480278|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Death|0|||
126480279|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Death|1|||
126480280|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Death|0|||
126480281|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Death|1|||
126480282|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Death|0|||
126480283|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Change of location|1|||
126480284|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Change of location|1|||
126480285|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Change of location|0|||
126480286|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Change of location|1|||
126480287|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Change of location|0|||
126480288|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
126480289|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
126480290|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
126480291|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
126480292|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
126480293|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
126480294|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
126480295|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
126480296|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
126480297|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
126480298|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
126480299|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
126480300|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
126480301|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
126480302|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
126480303|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
126480304|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
126480305|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
126480306|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
126480307|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
126480308|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
126480309|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
126480310|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
126480311|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
126480312|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
126480313|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
126480314|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
126480315|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
126480316|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
126480317|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
126480318|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
126480319|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
126480320|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
126480321|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
126480322|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
126480323|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
126480324|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
126480325|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
126480326|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
126480327|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
126480328|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
126480329|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
126480330|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
126480331|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
126480332|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
126480333|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
126480334|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
126480335|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
126480336|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
126480337|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
126480338|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Missing|0|||
126480339|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Missing|0|||
126480340|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Missing|2|||
126480341|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Missing|0|||
126480342|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Missing|0|||
126480343|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
126480344|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
126722381|NCT02065622|455933346|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
126722382|NCT02065622|455933347|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
126722383|NCT02065622|455933348|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
126722384|NCT02065622|455933349|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
126722385|NCT02065622|455933345|FG000|Maintenance Study|Subject Non-Compliance|0|||
126722386|NCT02065622|455933346|FG001|Maintenance Study|Subject Non-Compliance|0|||
126722387|NCT02065622|455933347|FG002|Maintenance Study|Subject Non-Compliance|1|||
126722388|NCT02065622|455933348|FG003|Maintenance Study|Subject Non-Compliance|3|||
126722389|NCT02065622|455933349|FG004|Maintenance Study|Subject Non-Compliance|2|||
126722390|NCT02065622|455933345|FG000|Maintenance Study|Other, Not Specified|0|||
126722391|NCT02065622|455933346|FG001|Maintenance Study|Other, Not Specified|0|||
126722392|NCT02065622|455933347|FG002|Maintenance Study|Other, Not Specified|6|||
126722393|NCT02065622|455933348|FG003|Maintenance Study|Other, Not Specified|14|||
126722394|NCT02065622|455933349|FG004|Maintenance Study|Other, Not Specified|2|||
126722395|NCT02065622|455933345|FG000|Maintenance Study|Unknown Reason|0|||
126480345|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
126480346|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
126480347|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
126480348|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
126480349|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
126480350|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
126480351|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
126480352|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
126480353|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
126480354|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
126480355|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
126480356|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
126480357|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
126480358|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
126480359|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
126480360|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
126480361|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
126480362|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
126480363|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
126480364|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
126480365|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
126480366|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
126480367|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
126480368|NCT00730405|455057784|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
126480369|NCT00730405|455057785|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
126480370|NCT00730405|455057786|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
126480371|NCT00730405|455057787|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
126480372|NCT00730405|455057788|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
126480373|NCT03851705|455057792|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
126480374|NCT03851705|455057793|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
126480375|NCT03851705|455057794|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
126480376|NCT03851705|455057795|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
126480377|NCT03851705|455057792|FG000|Part 1: Double-Blind Period|Other reason|1|||
126480378|NCT03851705|455057793|FG001|Part 1: Double-Blind Period|Other reason|0|||
126480379|NCT03851705|455057794|FG002|Part 1: Double-Blind Period|Other reason|0|||
126480380|NCT03851705|455057795|FG003|Part 1: Double-Blind Period|Other reason|0|||
126480381|NCT03851705|455057792|FG000|Part 2: Open-Label Period|Other reason|0|||
126480382|NCT03851705|455057793|FG001|Part 2: Open-Label Period|Other reason|0|||
126480383|NCT03851705|455057794|FG002|Part 2: Open-Label Period|Other reason|0|||
126480384|NCT03851705|455057795|FG003|Part 2: Open-Label Period|Other reason|1|||
126480385|NCT03851705|455057792|FG000|Part 2: Open-Label Period|Death|0|||
126480386|NCT03851705|455057793|FG001|Part 2: Open-Label Period|Death|0|||
126480387|NCT03851705|455057794|FG002|Part 2: Open-Label Period|Death|3|||
126480388|NCT03851705|455057795|FG003|Part 2: Open-Label Period|Death|0|||
126480389|NCT03851705|455057792|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
126480390|NCT03851705|455057793|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
126480391|NCT03851705|455057794|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
126480392|NCT03851705|455057795|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
126480393|NCT01496807|455057796|FG000|Overall Study|Progressive Disease|21|||
126722396|NCT02065622|455933346|FG001|Maintenance Study|Unknown Reason|0|||
126480394|NCT01496807|455057796|FG000|Overall Study|Participant preference/toxicity|8|||
126480395|NCT01496807|455057796|FG000|Overall Study|Change in diagnosis|1|||
126480396|NCT02591290|455057803|FG000|Overall Study|Withdrawal by Subject|2|||
126722397|NCT02065622|455933347|FG002|Maintenance Study|Unknown Reason|0|||
126722398|NCT02065622|455933348|FG003|Maintenance Study|Unknown Reason|1|||
126722399|NCT02065622|455933349|FG004|Maintenance Study|Unknown Reason|0|||
126722400|NCT01767194|455933350|FG000|Overall Study|Adverse Event|1|||
126722401|NCT01767194|455933351|FG001|Overall Study|Adverse Event|1|||
126722402|NCT01767194|455933350|FG000|Overall Study|Death|0|||
126480397|NCT00913497|455057804|FG000|Overall Study|Adverse Event|1|||
126480398|NCT00913497|455057804|FG000|Overall Study|Withdrawal by Subject|2|||
126480399|NCT02002091|455057811|FG000|Screening|Lost to Follow-up|10|||
126480400|NCT02002091|455057812|FG001|Screening|Lost to Follow-up|12|||
126480401|NCT02002091|455057811|FG000|Screening|Death|3|||
126480402|NCT02002091|455057812|FG001|Screening|Death|2|||
126480403|NCT00369824|455057813|FG000|Overall Study|Adverse Event|0|||
126480404|NCT00369824|455057814|FG001|Overall Study|Adverse Event|2|||
126480405|NCT00369824|455057815|FG002|Overall Study|Adverse Event|0|||
126480406|NCT00369824|455057816|FG003|Overall Study|Adverse Event|0|||
126480407|NCT00369824|455057817|FG004|Overall Study|Adverse Event|1|||
126480408|NCT00369824|455057818|FG005|Overall Study|Adverse Event|0|||
126480409|NCT00369824|455057813|FG000|Overall Study|Protocol Violation|0|||
126480410|NCT00369824|455057814|FG001|Overall Study|Protocol Violation|1|||
126480411|NCT00369824|455057815|FG002|Overall Study|Protocol Violation|0|||
126480412|NCT00369824|455057816|FG003|Overall Study|Protocol Violation|1|||
126480413|NCT00369824|455057817|FG004|Overall Study|Protocol Violation|1|||
126480414|NCT00369824|455057818|FG005|Overall Study|Protocol Violation|0|||
126480415|NCT00369824|455057813|FG000|Overall Study|Withdrawal by Subject|9|||
126480416|NCT00369824|455057814|FG001|Overall Study|Withdrawal by Subject|5|||
126480417|NCT00369824|455057815|FG002|Overall Study|Withdrawal by Subject|5|||
126480418|NCT00369824|455057816|FG003|Overall Study|Withdrawal by Subject|4|||
126480419|NCT00369824|455057817|FG004|Overall Study|Withdrawal by Subject|6|||
126480420|NCT00369824|455057818|FG005|Overall Study|Withdrawal by Subject|2|||
126480421|NCT00369824|455057813|FG000|Overall Study|Lost to Follow-up|6|||
126480422|NCT00369824|455057814|FG001|Overall Study|Lost to Follow-up|11|||
126480423|NCT00369824|455057815|FG002|Overall Study|Lost to Follow-up|7|||
126480424|NCT00369824|455057816|FG003|Overall Study|Lost to Follow-up|8|||
126480425|NCT00369824|455057817|FG004|Overall Study|Lost to Follow-up|9|||
126480426|NCT00369824|455057818|FG005|Overall Study|Lost to Follow-up|6|||
126480427|NCT00369824|455057813|FG000|Overall Study|Other|0|||
126480428|NCT00369824|455057814|FG001|Overall Study|Other|0|||
126480429|NCT00369824|455057815|FG002|Overall Study|Other|0|||
126480430|NCT00369824|455057816|FG003|Overall Study|Other|2|||
126480431|NCT00369824|455057817|FG004|Overall Study|Other|1|||
126480432|NCT00369824|455057818|FG005|Overall Study|Other|3|||
126480433|NCT01390649|455057819|FG000|Overall Study|Physician Decision|1|||
126480434|NCT03385564|455057821|FG000|Overall Study|Adverse Event|0|||
126480435|NCT03385564|455057822|FG001|Overall Study|Adverse Event|0|||
126480436|NCT03385564|455057823|FG002|Overall Study|Adverse Event|3|||
126480437|NCT03385564|455057824|FG003|Overall Study|Adverse Event|3|||
126480438|NCT03385564|455057821|FG000|Overall Study|Other than listed|0|||
126480439|NCT03385564|455057822|FG001|Overall Study|Other than listed|0|||
126480440|NCT03385564|455057823|FG002|Overall Study|Other than listed|0|||
126480441|NCT03385564|455057824|FG003|Overall Study|Other than listed|5|||
126480442|NCT03385564|455057821|FG000|Overall Study|Withdrawal by Subject|0|||
126480443|NCT03385564|455057822|FG001|Overall Study|Withdrawal by Subject|1|||
126480444|NCT03385564|455057823|FG002|Overall Study|Withdrawal by Subject|1|||
126480445|NCT03385564|455057824|FG003|Overall Study|Withdrawal by Subject|0|||
126480446|NCT03385564|455057821|FG000|Overall Study|Lack of Efficacy|0|||
126480447|NCT03385564|455057822|FG001|Overall Study|Lack of Efficacy|0|||
126480448|NCT03385564|455057823|FG002|Overall Study|Lack of Efficacy|0|||
126480449|NCT03385564|455057824|FG003|Overall Study|Lack of Efficacy|1|||
126480450|NCT03385564|455057821|FG000|Overall Study|Death|0|||
126480451|NCT03385564|455057822|FG001|Overall Study|Death|0|||
126480452|NCT03385564|455057823|FG002|Overall Study|Death|1|||
126480453|NCT03385564|455057824|FG003|Overall Study|Death|0|||
126722403|NCT01767194|455933351|FG001|Overall Study|Death|1|||
126722404|NCT01767194|455933350|FG000|Overall Study|Lack of Efficacy|12|||
126480454|NCT00622401|455057825|FG000|Overall Study|Disease progression prior to treatment|3|||
126480455|NCT00622401|455057826|FG001|Overall Study|Disease progression prior to treatment|2|||
126480456|NCT00622401|455057827|FG002|Overall Study|Disease progression prior to treatment|0|||
126480457|NCT03724032|455057831|FG000|Overall Study|Physician Decision|1|||
126480458|NCT03724032|455057832|FG001|Overall Study|Physician Decision|0|||
126480459|NCT03724032|455057833|FG002|Overall Study|Physician Decision|0|||
126480460|NCT03724032|455057831|FG000|Overall Study|Protocol Violation|2|||
126480461|NCT03724032|455057832|FG001|Overall Study|Protocol Violation|2|||
126480462|NCT03724032|455057833|FG002|Overall Study|Protocol Violation|1|||
126722405|NCT01767194|455933351|FG001|Overall Study|Lack of Efficacy|11|||
126480463|NCT00001880|455057836|FG000|Overall Study|Death|14|||
126480464|NCT02639065|455057837|FG000|Study Treatment|Disease Progression|13|||
126480465|NCT02639065|455057837|FG000|Study Treatment|Adverse Event|9|||
126480466|NCT02639065|455057837|FG000|Study Treatment|Withdrawal by Subject|1|||
126480467|NCT02639065|455057837|FG000|Follow up|Subject refused to follow up|1|||
126480468|NCT02639065|455057837|FG000|Follow up|Symptomatic Deterioration|2|||
126722406|NCT01767194|455933350|FG000|Overall Study|Physician Decision|2|||
126722407|NCT01767194|455933351|FG001|Overall Study|Physician Decision|23|||
126480469|NCT02639065|455057837|FG000|Follow up|Death|2|||
126480470|NCT02639065|455057837|FG000|Follow up|Study Terminated|1|||
126480471|NCT02639065|455057837|FG000|Follow up|Disease Progression|3|||
126480472|NCT01845831|455057838|FG000|Inpatient Phase|Withdrawal by Subject|1|||
126480473|NCT01845831|455057839|FG001|Inpatient Phase|Withdrawal by Subject|1|||
126480474|NCT01845831|455057840|FG002|Inpatient Phase|Withdrawal by Subject|0|||
126480475|NCT01845831|455057841|FG003|Inpatient Phase|Withdrawal by Subject|0|||
126480476|NCT01845831|455057842|FG004|Inpatient Phase|Withdrawal by Subject|0|||
126480477|NCT02610725|455057843|FG000|Overall Study|Lost to Follow-up|197|||
126480478|NCT02610725|455057843|FG000|Overall Study|self-reported contraindication|9|||
126480479|NCT04094883|455057844|FG000|Overall Study|Withdrawal by Subject|1|||
126480480|NCT00826943|455057845|FG000|Overall Study|Withdrawal by Subject|0|||
126480481|NCT00826943|455057846|FG001|Overall Study|Withdrawal by Subject|0|||
126480482|NCT00826943|455057847|FG002|Overall Study|Withdrawal by Subject|0|||
126480483|NCT00826943|455057848|FG003|Overall Study|Withdrawal by Subject|0|||
126480484|NCT00826943|455057849|FG004|Overall Study|Withdrawal by Subject|1|||
126480485|NCT00826943|455057850|FG005|Overall Study|Withdrawal by Subject|0|||
126480486|NCT01348165|455057851|FG000|Overall Study|Adverse Event|0|||
126480487|NCT01348165|455057852|FG001|Overall Study|Adverse Event|0|||
126480488|NCT01348165|455057853|FG002|Overall Study|Adverse Event|0|||
126480489|NCT01348165|455057854|FG003|Overall Study|Adverse Event|0|||
126480490|NCT01348165|455057855|FG004|Overall Study|Adverse Event|0|||
126480491|NCT01348165|455057856|FG005|Overall Study|Adverse Event|0|||
126480492|NCT01348165|455057857|FG006|Overall Study|Adverse Event|1|||
126480493|NCT01594762|455057858|FG000|Overall Study|Withdrawal by Subject|1|||
126480494|NCT01594762|455057859|FG001|Overall Study|Withdrawal by Subject|0|||
126480495|NCT01594762|455057858|FG000|Overall Study|Lost to Follow-up|10|||
126480496|NCT01594762|455057859|FG001|Overall Study|Lost to Follow-up|10|||
126480497|NCT02302807|455057860|FG000|Overall Study|Withdrawal by Subject|28|||
126480498|NCT02302807|455057861|FG001|Overall Study|Withdrawal by Subject|11|||
126480499|NCT02302807|455057860|FG000|Overall Study|Lost to Follow-up|4|||
126480500|NCT02302807|455057861|FG001|Overall Study|Lost to Follow-up|6|||
126480501|NCT02302807|455057860|FG000|Overall Study|Death|397|||
126480502|NCT02302807|455057861|FG001|Overall Study|Death|385|||
126480503|NCT02302807|455057860|FG000|Overall Study|Study Terminated By Sponsor|35|||
126480504|NCT02302807|455057861|FG001|Overall Study|Study Terminated By Sponsor|64|||
126480505|NCT02302807|455057860|FG000|Overall Study|Physician Decision|0|||
126480506|NCT02302807|455057861|FG001|Overall Study|Physician Decision|1|||
126480507|NCT03329573|455057862|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
126480508|NCT03329573|455057863|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
126480509|NCT03329573|455057864|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
126480510|NCT03329573|455057865|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
126480511|NCT03329573|455057862|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
126480512|NCT03329573|455057863|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
126480513|NCT03329573|455057864|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126480514|NCT03329573|455057865|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
126480515|NCT03329573|455057862|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
126480516|NCT03329573|455057863|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
126480517|NCT03329573|455057864|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
126480518|NCT03329573|455057865|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
126480519|NCT03329573|455057862|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
126480520|NCT03329573|455057863|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
126480521|NCT03329573|455057864|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
126480522|NCT03329573|455057865|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
126480523|NCT00590720|455059849|FG000|Overall Study|Lost to Follow-up|1|||
126480524|NCT00590720|455059850|FG001|Overall Study|Lost to Follow-up|0|||
126480525|NCT00590720|455059849|FG000|Overall Study|Withdrawal by Subject|0|||
126480526|NCT00590720|455059850|FG001|Overall Study|Withdrawal by Subject|1|||
126480527|NCT01001377|455059851|FG000|Overall Study|Ineligibility determined|2|||
126480528|NCT01001377|455059852|FG001|Overall Study|Ineligibility determined|0|||
126480529|NCT01001377|455059851|FG000|Overall Study|Withdrawal by Subject|19|||
126480530|NCT01001377|455059852|FG001|Overall Study|Withdrawal by Subject|20|||
126480531|NCT01001377|455059851|FG000|Overall Study|Lost to Follow-up|14|||
126480532|NCT01001377|455059852|FG001|Overall Study|Lost to Follow-up|17|||
126480533|NCT01001377|455059851|FG000|Overall Study|Death|391|||
126480534|NCT01001377|455059852|FG001|Overall Study|Death|384|||
126480535|NCT02193867|455059855|FG000|Overall Study|Death|2|||
126480536|NCT02193867|455059855|FG000|Overall Study|Sponsor Study Termination|2|||
126480537|NCT03616600|455059856|FG000|Overall Study|Withdrawal by Subject|1|||
126480538|NCT03616600|455059857|FG001|Overall Study|Withdrawal by Subject|0|||
126480539|NCT03600818|455059858|FG000|Overall Study|Adverse Event|4|||
126480540|NCT03600818|455059859|FG001|Overall Study|Adverse Event|7|||
126480541|NCT03600818|455059858|FG000|Overall Study|Lack of Efficacy|9|||
126480542|NCT03600818|455059859|FG001|Overall Study|Lack of Efficacy|4|||
126480543|NCT03600818|455059858|FG000|Overall Study|Withdrawal by Subject|4|||
126480544|NCT03600818|455059859|FG001|Overall Study|Withdrawal by Subject|3|||
126480545|NCT03600818|455059858|FG000|Overall Study|Other-unspecified|5|||
126480546|NCT03600818|455059859|FG001|Overall Study|Other-unspecified|3|||
126480547|NCT03600818|455059858|FG000|Overall Study|Randomized and not treated|0|||
126480548|NCT03600818|455059859|FG001|Overall Study|Randomized and not treated|1|||
126480549|NCT02059395|455059861|FG000|Overall Study|Lost to Follow-up|2|||
126480550|NCT02059395|455059862|FG001|Overall Study|Lost to Follow-up|4|||
126480551|NCT02849678|455059863|FG000|Overall Study|Protocol Violation|3|||
126480552|NCT02849678|455059864|FG001|Overall Study|Protocol Violation|6|||
126480553|NCT01488370|455059865|FG000|Overall Study|Protocol Violation|0|||
126480554|NCT01488370|455059866|FG001|Overall Study|Protocol Violation|1|||
126480555|NCT01488370|455059867|FG002|Overall Study|Protocol Violation|1|||
126480556|NCT01471171|455059868|FG000|Treatment Period 1|Adverse Event|4|||
126480557|NCT01471171|455059869|FG001|Treatment Period 1|Adverse Event|1|||
126480558|NCT01471171|455059868|FG000|Treatment Period 2|Adverse Event|1|||
126480559|NCT01471171|455059869|FG001|Treatment Period 2|Adverse Event|0|||
126480560|NCT03478930|455059871|FG000|Overall Study|Adverse Event|0|||
126480561|NCT03478930|455059872|FG001|Overall Study|Adverse Event|1|||
126480562|NCT03478930|455059871|FG000|Overall Study|Lack of Efficacy|3|||
126480563|NCT03478930|455059872|FG001|Overall Study|Lack of Efficacy|3|||
126480564|NCT03478930|455059871|FG000|Overall Study|Withdrawal by Subject|6|||
126480565|NCT03478930|455059872|FG001|Overall Study|Withdrawal by Subject|5|||
126480566|NCT04189081|455059873|FG000|Overall Study|Lost to Follow-up|1|||
126480567|NCT04189081|455059874|FG001|Overall Study|Lost to Follow-up|0|||
126480568|NCT04189081|455059875|FG002|Overall Study|Lost to Follow-up|0|||
126480569|NCT04189081|455059873|FG000|Overall Study|Withdrawal by Subject|0|||
126480570|NCT04189081|455059874|FG001|Overall Study|Withdrawal by Subject|0|||
126480571|NCT04189081|455059875|FG002|Overall Study|Withdrawal by Subject|1|||
126480572|NCT00705484|455059880|FG000|Overall Study|Adverse Event|28|||
126480573|NCT00705484|455059881|FG001|Overall Study|Adverse Event|27|||
126480574|NCT00705484|455059880|FG000|Overall Study|Lost to Follow-up|169|||
126480575|NCT00705484|455059881|FG001|Overall Study|Lost to Follow-up|250|||
126480576|NCT00705484|455059880|FG000|Overall Study|Withdrawal by Subject|96|||
126480577|NCT00705484|455059881|FG001|Overall Study|Withdrawal by Subject|72|||
126480578|NCT00705484|455059880|FG000|Overall Study|Administrative|89|||
126480579|NCT00705484|455059881|FG001|Overall Study|Administrative|59|||
126480580|NCT02228460|455059884|FG000|Overall Study|Adverse Event|1|||
126480581|NCT02228460|455059884|FG000|Overall Study|Lost to Follow-up|1|||
126480582|NCT01243892|455059885|FG000|Overall Study|Did not meet eligibility criteria|2|||
126480583|NCT01243892|455059886|FG001|Overall Study|Did not meet eligibility criteria|0|||
126480584|NCT03982368|455059891|FG000|Overall Study|Adverse Event|6|||
126480585|NCT03982368|455059892|FG001|Overall Study|Adverse Event|4|||
126480586|NCT03982368|455059893|FG002|Overall Study|Adverse Event|3|||
126480587|NCT03982368|455059891|FG000|Overall Study|Lost to Follow-up|2|||
126480588|NCT03982368|455059892|FG001|Overall Study|Lost to Follow-up|1|||
126480589|NCT03982368|455059893|FG002|Overall Study|Lost to Follow-up|0|||
126480590|NCT03982368|455059891|FG000|Overall Study|Withdrawal by Subject|1|||
126480591|NCT03982368|455059892|FG001|Overall Study|Withdrawal by Subject|2|||
126480592|NCT03982368|455059893|FG002|Overall Study|Withdrawal by Subject|0|||
126480593|NCT03982368|455059891|FG000|Overall Study|unknow|4|||
126480594|NCT03982368|455059892|FG001|Overall Study|unknow|0|||
126480595|NCT03982368|455059893|FG002|Overall Study|unknow|2|||
126480596|NCT00329238|455059894|FG000|Overall Study|Adverse Event|147|||
126480597|NCT00329238|455059895|FG001|Overall Study|Adverse Event|129|||
126480598|NCT00329238|455059894|FG000|Overall Study|Protocol Violation|23|||
126480599|NCT00329238|455059895|FG001|Overall Study|Protocol Violation|34|||
126480600|NCT00329238|455059894|FG000|Overall Study|Lost to Follow-up|2|||
126480601|NCT00329238|455059895|FG001|Overall Study|Lost to Follow-up|6|||
126480602|NCT00329238|455059894|FG000|Overall Study|Withdrawal by Subject|64|||
126480603|NCT00329238|455059895|FG001|Overall Study|Withdrawal by Subject|58|||
126480604|NCT00329238|455059894|FG000|Overall Study|Other reason (not specified)|40|||
126480605|NCT00329238|455059895|FG001|Overall Study|Other reason (not specified)|54|||
126480606|NCT05393895|455059898|FG000|Overall Study|Adverse Event|2|||
126480607|NCT05393895|455059899|FG001|Overall Study|Adverse Event|3|||
126480608|NCT05393895|455059898|FG000|Overall Study|Lost to Follow-up|4|||
126480609|NCT05393895|455059899|FG001|Overall Study|Lost to Follow-up|3|||
126480610|NCT05393895|455059898|FG000|Overall Study|Protocol Violation|1|||
126480611|NCT05393895|455059899|FG001|Overall Study|Protocol Violation|0|||
126480612|NCT05393895|455059898|FG000|Overall Study|Withdrawal by Subject|1|||
126480613|NCT05393895|455059899|FG001|Overall Study|Withdrawal by Subject|4|||
126480614|NCT00968513|455059902|FG000|Overall Study|Death|4|||
126480615|NCT00968513|455059903|FG001|Overall Study|Death|10|||
126480616|NCT00968513|455059904|FG002|Overall Study|Death|15|||
126480617|NCT05537883|455059905|FG000|Overall Study|revisional surgery|4|||
126480618|NCT05537883|455059906|FG001|Overall Study|revisional surgery|2|||
126480619|NCT05537883|455059905|FG000|Overall Study|surgeries were cancelled|0|||
126480620|NCT05537883|455059906|FG001|Overall Study|surgeries were cancelled|2|||
126480621|NCT05537883|455059905|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
126480622|NCT05537883|455059906|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
126480623|NCT01302834|455059907|FG000|Overall Study|Protocol Violation|17|||
126480624|NCT01302834|455059908|FG001|Overall Study|Protocol Violation|23|||
126480625|NCT01302834|455059907|FG000|Overall Study|HIV positive|1|||
126480626|NCT01302834|455059908|FG001|Overall Study|HIV positive|3|||
126480627|NCT01328431|455059909|FG000|Baseline|Protocol Violation|0|||
126480628|NCT01328431|455059910|FG001|Baseline|Protocol Violation|2|||
126480629|NCT01328431|455059909|FG000|1 Month (1M)|Lost to Follow-up|55|||
126480630|NCT01328431|455059910|FG001|1 Month (1M)|Lost to Follow-up|58|||
126480631|NCT01328431|455059909|FG000|3 Month (3M)|Death|2|||
126480632|NCT01328431|455059910|FG001|3 Month (3M)|Death|2|||
126480633|NCT01328431|455059909|FG000|3 Month (3M)|Lost to Follow-up|75|||
126480634|NCT01328431|455059910|FG001|3 Month (3M)|Lost to Follow-up|70|||
126480635|NCT01328431|455059909|FG000|12 Month (12M)|Death|2|||
126480636|NCT01328431|455059910|FG001|12 Month (12M)|Death|6|||
126480637|NCT01328431|455059909|FG000|12 Month (12M)|Lost to Follow-up|82|||
126480638|NCT01328431|455059910|FG001|12 Month (12M)|Lost to Follow-up|91|||
126480639|NCT05379231|455059911|FG000|Home Visit|Withdrawal by Subject|2|||
126480640|NCT05379231|455059911|FG000|In-lab Visit|Withdrawal by Subject|2|||
126480641|NCT02296320|455059918|FG000|Overall Study|Withdrawal by Subject|4|||
126480642|NCT02296320|455059919|FG001|Overall Study|Withdrawal by Subject|0|||
126480643|NCT02296320|455059920|FG002|Overall Study|Withdrawal by Subject|2|||
126480644|NCT02296320|455059918|FG000|Overall Study|Death|24|||
126480645|NCT02296320|455059919|FG001|Overall Study|Death|3|||
126480646|NCT02296320|455059920|FG002|Overall Study|Death|27|||
126480647|NCT02296320|455059918|FG000|Overall Study|Lost to Follow-up|5|||
126480648|NCT02296320|455059919|FG001|Overall Study|Lost to Follow-up|2|||
126480649|NCT02296320|455059920|FG002|Overall Study|Lost to Follow-up|7|||
126480650|NCT02296320|455059918|FG000|Overall Study|Not treated|2|||
126480651|NCT02296320|455059919|FG001|Overall Study|Not treated|0|||
126480652|NCT02296320|455059920|FG002|Overall Study|Not treated|0|||
126480653|NCT02296320|455059918|FG000|Overall Study|Not - specified|0|||
126480654|NCT02296320|455059919|FG001|Overall Study|Not - specified|0|||
126480655|NCT02296320|455059920|FG002|Overall Study|Not - specified|1|||
126480656|NCT01874054|455059923|FG000|Overall Study|Withdrawal by Subject|3|||
126480657|NCT01874054|455059923|FG000|Overall Study|Study Termination by Sponsor|42|||
126480658|NCT01874054|455059923|FG000|Overall Study|Lost to Follow-up|5|||
126480659|NCT01874054|455059923|FG000|Overall Study|Death|5|||
126480660|NCT00702923|455059924|FG000|Overall Study|Adverse Event|1|||
126480661|NCT03087643|455059929|FG000|Overall Study|Withdrawal by Subject|2|||
126480662|NCT03087643|455059930|FG001|Overall Study|Withdrawal by Subject|4|||
126480663|NCT03087643|455059929|FG000|Overall Study|Death|2|||
126480664|NCT03087643|455059930|FG001|Overall Study|Death|2|||
126480665|NCT02083783|455059934|FG000|Overall Study|Withdrawal by Subject|1|||
126480666|NCT02083783|455059935|FG001|Overall Study|Withdrawal by Subject|0|||
126480667|NCT01546883|455059938|FG000|Overall Study|Withdrawal by Subject|3|||
126480668|NCT01546883|455059938|FG000|Overall Study|Adverse Event|4|||
126480669|NCT01546883|455059938|FG000|Overall Study|Lost to Follow-up|2|||
126480670|NCT01546883|455059938|FG000|Overall Study|early closure of study|2|||
126480671|NCT01546883|455059938|FG000|Overall Study|other unrelated illness|1|||
126480672|NCT02256631|455059942|FG000|Overall Study|Lost to Follow-up|1|||
126480673|NCT02256631|455059943|FG001|Overall Study|Lost to Follow-up|1|||
126480674|NCT02256631|455059944|FG002|Overall Study|Lost to Follow-up|0|||
126480675|NCT02256631|455059945|FG003|Overall Study|Lost to Follow-up|2|||
126480676|NCT02256631|455059946|FG004|Overall Study|Lost to Follow-up|0|||
126480677|NCT02256631|455059947|FG005|Overall Study|Lost to Follow-up|4|||
126480678|NCT02256631|455059948|FG006|Overall Study|Lost to Follow-up|1|||
126480679|NCT02256631|455059942|FG000|Overall Study|Withdrawal by Subject|0|||
126480680|NCT02256631|455059943|FG001|Overall Study|Withdrawal by Subject|0|||
126480681|NCT02256631|455059944|FG002|Overall Study|Withdrawal by Subject|0|||
126480682|NCT02256631|455059945|FG003|Overall Study|Withdrawal by Subject|1|||
126480683|NCT02256631|455059946|FG004|Overall Study|Withdrawal by Subject|1|||
126480684|NCT02256631|455059947|FG005|Overall Study|Withdrawal by Subject|0|||
126480685|NCT02256631|455059948|FG006|Overall Study|Withdrawal by Subject|1|||
126480686|NCT02256631|455059942|FG000|Overall Study|Unable to get to clinic|0|||
126480687|NCT02256631|455059943|FG001|Overall Study|Unable to get to clinic|2|||
126480688|NCT02256631|455059944|FG002|Overall Study|Unable to get to clinic|0|||
126480689|NCT02256631|455059945|FG003|Overall Study|Unable to get to clinic|1|||
126480690|NCT02256631|455059946|FG004|Overall Study|Unable to get to clinic|0|||
126480691|NCT02256631|455059947|FG005|Overall Study|Unable to get to clinic|1|||
126480692|NCT02256631|455059948|FG006|Overall Study|Unable to get to clinic|2|||
126480693|NCT01427972|455059949|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126480694|NCT01427972|455059950|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126480695|NCT01427972|455059951|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126480696|NCT01427972|455059952|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126480697|NCT01427972|455059953|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126480698|NCT01427972|455059954|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126480699|NCT01427972|455059955|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126480700|NCT01427972|455059956|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
126480701|NCT01427972|455059957|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126480702|NCT01427972|455059958|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126480703|NCT01427972|455059959|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126480704|NCT01427972|455059960|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
126480705|NCT01427972|455059949|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
126480706|NCT01427972|455059950|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
126480707|NCT01427972|455059951|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
126480708|NCT01427972|455059952|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
126480709|NCT01427972|455059953|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
126480710|NCT01427972|455059954|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
126480711|NCT01427972|455059955|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
126480712|NCT01427972|455059956|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
126480713|NCT01427972|455059957|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
126480714|NCT01427972|455059958|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
126480715|NCT01427972|455059959|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
126480716|NCT01427972|455059960|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
126480717|NCT01427972|455059949|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
126480718|NCT01427972|455059950|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
126480719|NCT01427972|455059951|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
126480720|NCT01427972|455059952|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
126480721|NCT01427972|455059953|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
126480722|NCT01427972|455059954|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
126480723|NCT01427972|455059955|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
126480724|NCT01427972|455059956|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
126480725|NCT01427972|455059957|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
126480726|NCT01427972|455059958|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
126480727|NCT01427972|455059959|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
126480728|NCT01427972|455059960|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
126480729|NCT00530946|455059961|FG000|Overall Study|Adverse Event|1|||
126480730|NCT00530946|455059962|FG001|Overall Study|Adverse Event|2|||
126480731|NCT00530946|455059963|FG002|Overall Study|Adverse Event|1|||
126480732|NCT00530946|455059964|FG003|Overall Study|Adverse Event|1|||
126480733|NCT00530946|455059961|FG000|Overall Study|Protocol Violation|0|||
126480734|NCT00530946|455059962|FG001|Overall Study|Protocol Violation|0|||
126480735|NCT00530946|455059963|FG002|Overall Study|Protocol Violation|0|||
126480736|NCT00530946|455059964|FG003|Overall Study|Protocol Violation|1|||
126480737|NCT00530946|455059961|FG000|Overall Study|Noncompliance|1|||
126480738|NCT00530946|455059962|FG001|Overall Study|Noncompliance|0|||
126480739|NCT00530946|455059963|FG002|Overall Study|Noncompliance|0|||
126480740|NCT00530946|455059964|FG003|Overall Study|Noncompliance|0|||
126480741|NCT00880009|455059965|FG000|Overall Study|Study terminated by sponsor|14|||
126480742|NCT00880009|455059965|FG000|Overall Study|Withdrawal by Subject|1|||
126480743|NCT00880009|455059965|FG000|Overall Study|Protocol Violation|1|||
126480744|NCT00457301|455059966|FG000|Overall Study|Withdrawal by Subject|3|||
126480745|NCT00457301|455059967|FG001|Overall Study|Withdrawal by Subject|3|||
126480746|NCT00457301|455059966|FG000|Overall Study|Censored out of the study|15|||
126480747|NCT00457301|455059967|FG001|Overall Study|Censored out of the study|14|||
126480748|NCT00457301|455059966|FG000|Overall Study|Death|5|||
126480749|NCT00457301|455059967|FG001|Overall Study|Death|7|||
126480750|NCT02378961|455059968|FG000|Overall Study|Lack of Efficacy|4|||
126480751|NCT02378961|455059969|FG001|Overall Study|Lack of Efficacy|2|||
126480752|NCT02378961|455059970|FG002|Overall Study|Lack of Efficacy|0|||
126480753|NCT02378961|455059971|FG003|Overall Study|Lack of Efficacy|1|||
126480754|NCT02378961|455059968|FG000|Overall Study|Death|0|||
126480755|NCT02378961|455059969|FG001|Overall Study|Death|0|||
126480756|NCT02378961|455059970|FG002|Overall Study|Death|1|||
126480757|NCT02378961|455059971|FG003|Overall Study|Death|0|||
126480758|NCT01253408|455059972|FG000|Overall Study|Adverse Event|0|||
126480759|NCT01253408|455059973|FG001|Overall Study|Adverse Event|1|||
126722408|NCT01767194|455933350|FG000|Overall Study|Withdrawal by Subject|0|||
126722409|NCT01767194|455933351|FG001|Overall Study|Withdrawal by Subject|1|||
126722410|NCT01767194|455933350|FG000|Overall Study|Ineligible|1|||
126722411|NCT01767194|455933351|FG001|Overall Study|Ineligible|1|||
126722412|NCT01767194|455933350|FG000|Overall Study|Refusal by patient/parent|2|||
126480760|NCT01253408|455059974|FG002|Overall Study|Adverse Event|0|||
126480761|NCT03035409|455059976|FG000|Overall Study|Adverse Event|5|||
126480762|NCT03035409|455059976|FG000|Overall Study|Death|2|||
126480763|NCT03035409|455059976|FG000|Overall Study|Withdrawal by Subject|2|||
126480764|NCT03035409|455059976|FG000|Overall Study|Non compliance|4|||
126480765|NCT03035409|455059976|FG000|Overall Study|Patient was jittery|1|||
126722413|NCT01767194|455933351|FG001|Overall Study|Refusal by patient/parent|4|||
126722414|NCT01767194|455933350|FG000|Overall Study|Criteria not met on time for next cycle|0|||
126480766|NCT03035409|455059976|FG000|Overall Study|Did not like Questionnaire|1|||
126480767|NCT03035409|455059976|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
126480768|NCT03035409|455059976|FG000|Overall Study|Did not like taking drugs|1|||
126480769|NCT01552694|455059977|FG000|Overall Study|Lost to Follow-up|0|||
126480770|NCT01552694|455059978|FG001|Overall Study|Lost to Follow-up|1|||
126480771|NCT01552694|455059977|FG000|Overall Study|Protocol Violation|0|||
126480772|NCT01552694|455059978|FG001|Overall Study|Protocol Violation|1|||
126480773|NCT02657369|455059981|FG000|Overall Study|Death|27|||
126480774|NCT02657369|455059981|FG000|Overall Study|Study terminated by sponsor|7|||
126480775|NCT00361569|455059982|FG000|Overall Study|Protocol Violation|3|||
126480776|NCT00361569|455059983|FG001|Overall Study|Protocol Violation|2|||
126480777|NCT00361569|455059984|FG002|Overall Study|Protocol Violation|4|||
126480778|NCT00361569|455059985|FG003|Overall Study|Protocol Violation|2|||
126480779|NCT00361569|455059982|FG000|Overall Study|Withdrawal by Subject|2|||
126480780|NCT00361569|455059983|FG001|Overall Study|Withdrawal by Subject|1|||
126480781|NCT00361569|455059984|FG002|Overall Study|Withdrawal by Subject|9|||
126480782|NCT00361569|455059985|FG003|Overall Study|Withdrawal by Subject|14|||
126480783|NCT00361569|455059982|FG000|Overall Study|Adverse Event|3|||
126480784|NCT00361569|455059983|FG001|Overall Study|Adverse Event|5|||
126480785|NCT00361569|455059984|FG002|Overall Study|Adverse Event|2|||
126480786|NCT00361569|455059985|FG003|Overall Study|Adverse Event|2|||
126480787|NCT00361569|455059982|FG000|Overall Study|Lost to Follow-up|2|||
126480788|NCT00361569|455059983|FG001|Overall Study|Lost to Follow-up|3|||
126480789|NCT00361569|455059984|FG002|Overall Study|Lost to Follow-up|3|||
126480790|NCT00361569|455059985|FG003|Overall Study|Lost to Follow-up|2|||
126480791|NCT00361569|455059982|FG000|Overall Study|Not specified by investigator|2|||
126480792|NCT00361569|455059983|FG001|Overall Study|Not specified by investigator|0|||
126480793|NCT00361569|455059984|FG002|Overall Study|Not specified by investigator|0|||
126480794|NCT00361569|455059985|FG003|Overall Study|Not specified by investigator|1|||
126480795|NCT00481078|455059986|FG000|Overall Study|Progression of disease|11|||
126480796|NCT00481078|455059987|FG001|Overall Study|Progression of disease|11|||
126480797|NCT00481078|455059986|FG000|Overall Study|Adverse Event|15|||
126480798|NCT00481078|455059987|FG001|Overall Study|Adverse Event|3|||
126480799|NCT00481078|455059986|FG000|Overall Study|Death|5|||
126480800|NCT00481078|455059987|FG001|Overall Study|Death|3|||
126480801|NCT00481078|455059986|FG000|Overall Study|Intercurrent illness|1|||
126480802|NCT00481078|455059987|FG001|Overall Study|Intercurrent illness|0|||
126480803|NCT00481078|455059986|FG000|Overall Study|Withdrawal by Subject|7|||
126480804|NCT00481078|455059987|FG001|Overall Study|Withdrawal by Subject|1|||
126480805|NCT00481078|455059986|FG000|Overall Study|Information not available|1|||
126480806|NCT00481078|455059987|FG001|Overall Study|Information not available|0|||
126480807|NCT00481078|455059986|FG000|Overall Study|Received other treatment|2|||
126480808|NCT00481078|455059987|FG001|Overall Study|Received other treatment|1|||
126480809|NCT00481078|455059986|FG000|Overall Study|Brain metastasis|0|||
126480810|NCT00481078|455059987|FG001|Overall Study|Brain metastasis|1|||
126480811|NCT01558271|455059988|FG000|Overall Study|Adverse Event|6|||
126480812|NCT01558271|455059989|FG001|Overall Study|Adverse Event|3|||
126480813|NCT01558271|455059990|FG002|Overall Study|Adverse Event|4|||
126480814|NCT01558271|455059988|FG000|Overall Study|Lost to Follow-up|1|||
126480815|NCT01558271|455059989|FG001|Overall Study|Lost to Follow-up|0|||
126480816|NCT01558271|455059990|FG002|Overall Study|Lost to Follow-up|0|||
126480817|NCT01558271|455059988|FG000|Overall Study|Protocol Violation|1|||
126480818|NCT01558271|455059989|FG001|Overall Study|Protocol Violation|0|||
126480819|NCT01558271|455059990|FG002|Overall Study|Protocol Violation|0|||
126480820|NCT01558271|455059988|FG000|Overall Study|Withdrawal by Subject|10|||
126480821|NCT01558271|455059989|FG001|Overall Study|Withdrawal by Subject|6|||
126480822|NCT01558271|455059990|FG002|Overall Study|Withdrawal by Subject|12|||
126480823|NCT01558271|455059988|FG000|Overall Study|Physician Decision|0|||
126480824|NCT01558271|455059989|FG001|Overall Study|Physician Decision|2|||
126480825|NCT01558271|455059990|FG002|Overall Study|Physician Decision|1|||
126480826|NCT02612727|455059991|FG000|Overall Study|Parent request|4|||
126480827|NCT02612727|455059992|FG001|Overall Study|Parent request|1|||
126480828|NCT02612727|455059991|FG000|Overall Study|Needed treatment incompatible with PT|1|||
126480829|NCT02612727|455059992|FG001|Overall Study|Needed treatment incompatible with PT|1|||
126480830|NCT02612727|455059991|FG000|Overall Study|Direct hyperbilirubinemia|0|||
126480831|NCT02612727|455059992|FG001|Overall Study|Direct hyperbilirubinemia|2|||
126480832|NCT01063868|455059993|FG000|Overall Study|Adverse Event|9|||
126480833|NCT01063868|455059994|FG001|Overall Study|Adverse Event|7|||
126480834|NCT01063868|455059993|FG000|Overall Study|Withdrawal by Subject|3|||
126480835|NCT01063868|455059994|FG001|Overall Study|Withdrawal by Subject|1|||
126480836|NCT01063868|455059993|FG000|Overall Study|Study Terminated By Sponsor|23|||
126480837|NCT01063868|455059994|FG001|Overall Study|Study Terminated By Sponsor|4|||
126480838|NCT01446289|455059997|FG000|Overall Study|Withdrawal by Subject|1|||
126559202|NCT05705167|455340685|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
126480839|NCT01446289|455059998|FG001|Overall Study|Withdrawal by Subject|0|||
126480840|NCT01446289|455059999|FG002|Overall Study|Withdrawal by Subject|1|||
126480841|NCT01446289|455060000|FG003|Overall Study|Withdrawal by Subject|0|||
126480842|NCT03307967|455060001|FG000|Overall Study|Lost to Follow-up|4|||
126480843|NCT02578316|455060002|FG000|Extension Phase|Progression of disease|6|||
126480844|NCT02166905|455060003|FG000|Overall Study|Withdrawal by Subject|1|||
126480845|NCT02166905|455060004|FG001|Overall Study|Withdrawal by Subject|0|||
126722415|NCT01767194|455933351|FG001|Overall Study|Criteria not met on time for next cycle|1|||
126722416|NCT04973228|455933352|FG000|Overall Study|Adverse Event|2|||
126722417|NCT04973228|455933353|FG001|Overall Study|Adverse Event|3|||
126722418|NCT04973228|455933352|FG000|Overall Study|Lack of Efficacy|1|||
126722419|NCT04973228|455933353|FG001|Overall Study|Lack of Efficacy|3|||
126722420|NCT04973228|455933352|FG000|Overall Study|Lost to Follow-up|12|||
126722421|NCT04973228|455933353|FG001|Overall Study|Lost to Follow-up|4|||
126722422|NCT04973228|455933352|FG000|Overall Study|Withdrawal by Subject|11|||
126722423|NCT04973228|455933353|FG001|Overall Study|Withdrawal by Subject|4|||
126722424|NCT04973228|455933352|FG000|Overall Study|Did not tolerate application|1|||
126722425|NCT04973228|455933353|FG001|Overall Study|Did not tolerate application|0|||
126722426|NCT04973228|455933352|FG000|Overall Study|Wanted to early terminate and use own product|0|||
126722427|NCT04973228|455933353|FG001|Overall Study|Wanted to early terminate and use own product|1|||
126722428|NCT04973228|455933352|FG000|Overall Study|Missed visits due to new work schedule|1|||
126722429|NCT04973228|455933353|FG001|Overall Study|Missed visits due to new work schedule|0|||
126722430|NCT02678780|455933359|FG000|Overall Study|Adverse Event|11|||
126722431|NCT02678780|455933360|FG001|Overall Study|Adverse Event|14|||
126722432|NCT02678780|455933359|FG000|Overall Study|Withdrawal by Subject|2|||
126722433|NCT02678780|455933360|FG001|Overall Study|Withdrawal by Subject|1|||
126722434|NCT02678780|455933359|FG000|Overall Study|Sponsor discontinuation|7|||
126722435|NCT02678780|455933360|FG001|Overall Study|Sponsor discontinuation|4|||
126722436|NCT02678780|455933359|FG000|Overall Study|Death|1|||
126722437|NCT02678780|455933360|FG001|Overall Study|Death|1|||
126722438|NCT02678780|455933359|FG000|Overall Study|Other|6|||
126722439|NCT02678780|455933360|FG001|Overall Study|Other|8|||
126722440|NCT00992446|455933382|FG000|Overall Study|Disease Progression|1|||
126722441|NCT00992446|455933382|FG000|Overall Study|Withdrawal by Subject|2|||
126722442|NCT00992446|455933382|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
126722443|NCT02294318|455934422|FG000|Overall Study|Worsening of drinking|3|||
126722444|NCT02294318|455934423|FG001|Overall Study|Worsening of drinking|0|||
126722445|NCT02294318|455934422|FG000|Overall Study|Not exposed to intervention|0|||
126722446|NCT02294318|455934423|FG001|Overall Study|Not exposed to intervention|2|||
126722447|NCT03725202|455934425|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
126722448|NCT03725202|455934426|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
126722449|NCT03725202|455934427|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
126722450|NCT03725202|455934428|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
126722451|NCT03725202|455934429|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
126722452|NCT03725202|455934430|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
126722453|NCT03725202|455934431|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
126722454|NCT03725202|455934432|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
126722455|NCT03725202|455934425|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
126480846|NCT02166905|455060005|FG002|Overall Study|Withdrawal by Subject|0|||
126480847|NCT02166905|455060006|FG003|Overall Study|Withdrawal by Subject|0|||
126480848|NCT02617628|455060007|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
126480849|NCT02617628|455060008|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
126480850|NCT03278873|455060012|FG000|Overall Study|Withdrawal by Subject|0|||
126480851|NCT03278873|455060013|FG001|Overall Study|Withdrawal by Subject|1|||
126480852|NCT03278873|455060014|FG002|Overall Study|Withdrawal by Subject|0|||
126480853|NCT03278873|455060015|FG003|Overall Study|Withdrawal by Subject|0|||
126480854|NCT03278873|455060012|FG000|Overall Study|Sponsor's decision|0|||
126480855|NCT03278873|455060013|FG001|Overall Study|Sponsor's decision|1|||
126480856|NCT03278873|455060014|FG002|Overall Study|Sponsor's decision|0|||
126480857|NCT03278873|455060015|FG003|Overall Study|Sponsor's decision|0|||
126480858|NCT03278873|455060012|FG000|Overall Study|Early Termination|2|||
126480859|NCT03278873|455060013|FG001|Overall Study|Early Termination|6|||
126559203|NCT04736056|455340686|FG000|Overall Study|Death|0|||
126722456|NCT03725202|455934426|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
126722457|NCT03725202|455934427|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
126722458|NCT03725202|455934428|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
126480860|NCT03278873|455060014|FG002|Overall Study|Early Termination|0|||
126480861|NCT03278873|455060015|FG003|Overall Study|Early Termination|4|||
126559204|NCT04736056|455340687|FG001|Overall Study|Death|0|||
126559205|NCT04736056|455340688|FG002|Overall Study|Death|0|||
126559206|NCT04736056|455340689|FG003|Overall Study|Death|1|||
126559207|NCT04736056|455340686|FG000|Overall Study|Lost to Follow-up|1|||
126722459|NCT03725202|455934429|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
126722460|NCT03725202|455934430|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
126722461|NCT03725202|455934431|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
126722462|NCT03725202|455934432|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
126722463|NCT03725202|455934425|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
126722464|NCT03725202|455934426|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126722465|NCT03725202|455934427|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126722466|NCT03725202|455934428|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126722467|NCT03725202|455934429|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126480862|NCT03278873|455060012|FG000|Overall Study|Lost to Follow-up|0|||
126480863|NCT03278873|455060013|FG001|Overall Study|Lost to Follow-up|0|||
126480864|NCT03278873|455060014|FG002|Overall Study|Lost to Follow-up|2|||
126480865|NCT03278873|455060015|FG003|Overall Study|Lost to Follow-up|0|||
126480866|NCT03278873|455060012|FG000|Overall Study|The patient decided to withdraw via email|1|||
126480867|NCT03278873|455060013|FG001|Overall Study|The patient decided to withdraw via email|0|||
126480868|NCT03278873|455060014|FG002|Overall Study|The patient decided to withdraw via email|0|||
126480869|NCT03278873|455060015|FG003|Overall Study|The patient decided to withdraw via email|0|||
126480870|NCT03278873|455060012|FG000|Overall Study|The patient was unresponsive to contact|0|||
126480871|NCT03278873|455060013|FG001|Overall Study|The patient was unresponsive to contact|0|||
126480872|NCT03278873|455060014|FG002|Overall Study|The patient was unresponsive to contact|0|||
126480873|NCT03278873|455060015|FG003|Overall Study|The patient was unresponsive to contact|4|||
126480874|NCT03278873|455060012|FG000|Overall Study|The patient wished to participate no longer|0|||
126480875|NCT03278873|455060013|FG001|Overall Study|The patient wished to participate no longer|1|||
126480876|NCT03278873|455060014|FG002|Overall Study|The patient wished to participate no longer|0|||
126480877|NCT03278873|455060015|FG003|Overall Study|The patient wished to participate no longer|0|||
126480878|NCT03278873|455060012|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
126480879|NCT03278873|455060013|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
126480880|NCT03278873|455060014|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
126480881|NCT03278873|455060015|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
126480882|NCT05243641|455060016|FG000|Overall Study|Adverse Event|3|||
126480883|NCT05243641|455060017|FG001|Overall Study|Adverse Event|0|||
126480884|NCT05243641|455060018|FG002|Overall Study|Adverse Event|0|||
126480885|NCT05243641|455060019|FG003|Overall Study|Adverse Event|1|||
126480886|NCT05243641|455060020|FG004|Overall Study|Adverse Event|0|||
126480887|NCT05243641|455060021|FG005|Overall Study|Adverse Event|0|||
126480888|NCT05243641|455060016|FG000|Overall Study|Disease progression|4|||
126480889|NCT05243641|455060017|FG001|Overall Study|Disease progression|0|||
126480890|NCT05243641|455060018|FG002|Overall Study|Disease progression|0|||
126480891|NCT05243641|455060019|FG003|Overall Study|Disease progression|2|||
126480892|NCT05243641|455060020|FG004|Overall Study|Disease progression|0|||
126480893|NCT05243641|455060021|FG005|Overall Study|Disease progression|0|||
126480894|NCT04518306|455060022|FG000|Double-Blind Period|Run in failure|0|||
126480895|NCT04518306|455060023|FG001|Double-Blind Period|Run in failure|0|||
126480896|NCT04518306|455060024|FG002|Double-Blind Period|Run in failure|1|||
126480897|NCT04518306|455060022|FG000|Double-Blind Period|Adverse Event|0|||
126480898|NCT04518306|455060023|FG001|Double-Blind Period|Adverse Event|2|||
126480899|NCT04518306|455060024|FG002|Double-Blind Period|Adverse Event|2|||
126480900|NCT04518306|455060022|FG000|Double-Blind Period|Lost to Follow-up|1|||
126480901|NCT04518306|455060023|FG001|Double-Blind Period|Lost to Follow-up|2|||
126480902|NCT04518306|455060024|FG002|Double-Blind Period|Lost to Follow-up|2|||
126480903|NCT04518306|455060022|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
126480904|NCT04518306|455060023|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
126480905|NCT04518306|455060024|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
126480906|NCT04518306|455060022|FG000|Double-Blind Period|Other|0|||
126480907|NCT04518306|455060023|FG001|Double-Blind Period|Other|2|||
126480908|NCT04518306|455060024|FG002|Double-Blind Period|Other|0|||
126480909|NCT04518306|455060022|FG000|Double-Blind Period|Missing|0|||
126480910|NCT04518306|455060023|FG001|Double-Blind Period|Missing|1|||
126480911|NCT04518306|455060024|FG002|Double-Blind Period|Missing|0|||
126480912|NCT05372419|455060025|FG000|Overall Study|Protocol Deviation|1|||
126480913|NCT05372419|455060025|FG000|Overall Study|Withdrawal by Subject|5|||
126480914|NCT05372419|455060025|FG000|Overall Study|Lost to Follow-up|7|||
126480915|NCT02801331|455060026|FG000|Overall Study|Transferred to another hospital|8|||
126480916|NCT02801331|455060027|FG001|Overall Study|Transferred to another hospital|7|||
126480917|NCT02801331|455060026|FG000|Overall Study|Withdrawal by Subject|0|||
126480918|NCT02801331|455060027|FG001|Overall Study|Withdrawal by Subject|4|||
126480919|NCT02801331|455060026|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
126480920|NCT02801331|455060027|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
126480921|NCT03253744|455060029|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
126480922|NCT03253744|455060030|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
126480923|NCT03253744|455060031|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
126480924|NCT03253744|455060032|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
126480925|NCT04698187|455060038|FG000|Overall Study|Withdrawal by Subject|7|||
126480926|NCT04698187|455060038|FG000|Overall Study|Death|21|||
126480927|NCT04698187|455060038|FG000|Overall Study|Sponsor Decision|15|||
126480928|NCT04698187|455060038|FG000|Overall Study|In-transit Disease|1|||
126480929|NCT03904043|455060039|FG000|Overall Study|Adverse Event|1|||
126480930|NCT03904043|455060040|FG001|Overall Study|Adverse Event|1|||
126480931|NCT03904043|455060039|FG000|Overall Study|Withdrawal by Subject|1|||
126480932|NCT03904043|455060040|FG001|Overall Study|Withdrawal by Subject|0|||
126480933|NCT03904043|455060039|FG000|Overall Study|Non-compliance|1|||
126480934|NCT03904043|455060040|FG001|Overall Study|Non-compliance|0|||
126480935|NCT03904043|455060039|FG000|Overall Study|Did not start treatment|1|||
126480936|NCT03904043|455060040|FG001|Overall Study|Did not start treatment|0|||
126480937|NCT04362072|455060041|FG000|Treatment|Adverse Event|1|||
126480938|NCT04362072|455060041|FG000|Treatment|Death|9|||
126480939|NCT04362072|455060041|FG000|Treatment|Physician Decision|2|||
126480940|NCT04362072|455060041|FG000|Treatment|Progressive disease|27|||
126480941|NCT04362072|455060041|FG000|Treatment|Withdrawal by Subject|4|||
126480942|NCT04362072|455060041|FG000|Treatment|Global deterioration of health status|1|||
126480943|NCT04362072|455060041|FG000|Treatment|Switched to commercial Lorlatinib|13|||
126480944|NCT04362072|455060041|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
126480945|NCT04362072|455060041|FG000|Treatment|Other|3|||
126480946|NCT04362072|455060041|FG000|Follow up|Death|2|||
126480947|NCT04362072|455060041|FG000|Follow up|Other|2|||
126480948|NCT01133522|455060042|FG000|Overall Study|Withdrawal by Subject|0|||
126480949|NCT01133522|455060043|FG001|Overall Study|Withdrawal by Subject|1|||
126480950|NCT01133522|455060044|FG002|Overall Study|Withdrawal by Subject|0|||
126480951|NCT01133522|455060045|FG003|Overall Study|Withdrawal by Subject|1|||
126480952|NCT01133522|455060046|FG004|Overall Study|Withdrawal by Subject|0|||
126480953|NCT01133522|455060047|FG005|Overall Study|Withdrawal by Subject|0|||
126480954|NCT01133522|455060048|FG006|Overall Study|Withdrawal by Subject|0|||
126480955|NCT01133522|455060049|FG007|Overall Study|Withdrawal by Subject|0|||
126480956|NCT01133522|455060050|FG008|Overall Study|Withdrawal by Subject|0|||
126480957|NCT01133522|455060051|FG009|Overall Study|Withdrawal by Subject|0|||
126480958|NCT01133522|455060042|FG000|Overall Study|Physician Decision|0|||
126480959|NCT01133522|455060043|FG001|Overall Study|Physician Decision|0|||
126480960|NCT01133522|455060044|FG002|Overall Study|Physician Decision|0|||
126480961|NCT01133522|455060045|FG003|Overall Study|Physician Decision|0|||
126480962|NCT01133522|455060046|FG004|Overall Study|Physician Decision|1|||
126480963|NCT01133522|455060047|FG005|Overall Study|Physician Decision|0|||
126480964|NCT01133522|455060048|FG006|Overall Study|Physician Decision|0|||
126480965|NCT01133522|455060049|FG007|Overall Study|Physician Decision|0|||
126480966|NCT01133522|455060050|FG008|Overall Study|Physician Decision|0|||
126480967|NCT01133522|455060051|FG009|Overall Study|Physician Decision|0|||
126480968|NCT00381485|455061767|FG000|Open-Label Run-In Period|Adverse Event|9|||
126480969|NCT00381485|455061768|FG001|Open-Label Run-In Period|Adverse Event|0|||
126480970|NCT00381485|455061769|FG002|Open-Label Run-In Period|Adverse Event|0|||
126480971|NCT00381485|455061770|FG003|Open-Label Run-In Period|Adverse Event|0|||
126480972|NCT00381485|455061767|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
126480973|NCT00381485|455061768|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
126480974|NCT00381485|455061769|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
126480975|NCT00381485|455061770|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
126480976|NCT00381485|455061767|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
126480977|NCT00381485|455061768|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
126480978|NCT00381485|455061769|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
126480979|NCT00381485|455061770|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
126480980|NCT00381485|455061767|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
126480981|NCT00381485|455061768|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
126480982|NCT00381485|455061769|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
126480983|NCT00381485|455061770|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
126480984|NCT00381485|455061767|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
126480985|NCT00381485|455061768|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
126480986|NCT00381485|455061769|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
126480987|NCT00381485|455061770|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
126480988|NCT00381485|455061767|FG000|Open-Label Run-In Period|Treatment failure|1|||
126480989|NCT00381485|455061768|FG001|Open-Label Run-In Period|Treatment failure|0|||
126480990|NCT00381485|455061769|FG002|Open-Label Run-In Period|Treatment failure|0|||
126480991|NCT00381485|455061770|FG003|Open-Label Run-In Period|Treatment failure|0|||
126480992|NCT00381485|455061767|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126480993|NCT00381485|455061768|FG001|Double-Blind Treatment Period|Adverse Event|2|||
126480994|NCT00381485|455061769|FG002|Double-Blind Treatment Period|Adverse Event|2|||
126559208|NCT04736056|455340687|FG001|Overall Study|Lost to Follow-up|0|||
126480995|NCT00381485|455061770|FG003|Double-Blind Treatment Period|Adverse Event|5|||
126480996|NCT00381485|455061767|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
126480997|NCT00381485|455061768|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
126480998|NCT00381485|455061769|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
126480999|NCT00381485|455061770|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
126481000|NCT00381485|455061767|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126481001|NCT00381485|455061768|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
126481002|NCT00381485|455061769|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
126481003|NCT00381485|455061770|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
126722468|NCT03725202|455934430|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126559209|NCT04736056|455340688|FG002|Overall Study|Lost to Follow-up|1|||
126481004|NCT00381485|455061767|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
126481005|NCT00381485|455061768|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
126481006|NCT00381485|455061769|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
126481007|NCT00381485|455061770|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
126481008|NCT00381485|455061767|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
126481009|NCT00381485|455061768|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
126481010|NCT00381485|455061769|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
126481011|NCT00381485|455061770|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
126481012|NCT00381485|455061767|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
126481013|NCT00381485|455061768|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
126481014|NCT00381485|455061769|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
126481015|NCT00381485|455061770|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
126481016|NCT00381485|455061767|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
126481017|NCT00381485|455061768|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
126481018|NCT00381485|455061769|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
126481019|NCT00381485|455061770|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
126481020|NCT00381485|455061767|FG000|Double-Blind Treatment Period|Administrative|0|||
126481021|NCT00381485|455061768|FG001|Double-Blind Treatment Period|Administrative|1|||
126481022|NCT00381485|455061769|FG002|Double-Blind Treatment Period|Administrative|0|||
126481023|NCT00381485|455061770|FG003|Double-Blind Treatment Period|Administrative|1|||
126481024|NCT01235351|455061771|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
126481025|NCT01235351|455061772|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
126481026|NCT01898806|455061778|FG000|Overall Study|Withdrawal by Subject|2|||
126481027|NCT01898806|455061778|FG000|Overall Study|Physician Decision|1|||
126481028|NCT00126191|455061779|FG000|Overall Study|Physician Decision|0|||
126481029|NCT00126191|455061780|FG001|Overall Study|Physician Decision|1|||
126481030|NCT00126191|455061779|FG000|Overall Study|Death|0|||
126481031|NCT00126191|455061780|FG001|Overall Study|Death|1|||
126481032|NCT01648101|455061781|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
126481033|NCT01648101|455061782|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
126481034|NCT01648101|455061783|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
126481035|NCT01648101|455061781|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
126481036|NCT01648101|455061782|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
126481037|NCT01648101|455061783|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
126481038|NCT01648101|455061781|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
126481039|NCT01648101|455061782|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
126481040|NCT01648101|455061783|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
126481041|NCT01648101|455061781|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
126481042|NCT01648101|455061782|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
126481043|NCT01648101|455061783|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
126481044|NCT01648101|455061781|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
126481045|NCT01648101|455061782|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
126481046|NCT01648101|455061783|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
126481047|NCT01648101|455061781|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
126481048|NCT01648101|455061782|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
126481049|NCT01648101|455061783|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
126481050|NCT01648101|455061781|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
126481051|NCT01648101|455061782|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
126481052|NCT01648101|455061783|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
126481053|NCT01648101|455061781|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
126481054|NCT01648101|455061782|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
126481055|NCT01648101|455061783|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
126481056|NCT01648101|455061781|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
126481057|NCT01648101|455061782|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
126481058|NCT01648101|455061783|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
126481059|NCT01648101|455061781|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
126481060|NCT01648101|455061782|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
126481061|NCT01648101|455061783|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
126481062|NCT01648101|455061781|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
126481063|NCT01648101|455061782|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
126481064|NCT01648101|455061783|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
126481065|NCT03003390|455061784|FG000|Overall Study|Physician Decision|2|||
126481066|NCT03003390|455061785|FG001|Overall Study|Physician Decision|0|||
126481067|NCT03003390|455061784|FG000|Overall Study|Parent refused intervention|2|||
126722469|NCT03725202|455934431|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126481068|NCT03003390|455061785|FG001|Overall Study|Parent refused intervention|0|||
126481069|NCT02469298|455061799|FG000|Overall Study|Protocol Violation|0|||
126559210|NCT04736056|455340689|FG003|Overall Study|Lost to Follow-up|1|||
126559211|NCT04736056|455340686|FG000|Overall Study|Withdrawal by Subject|2|||
126559212|NCT04736056|455340687|FG001|Overall Study|Withdrawal by Subject|0|||
126481070|NCT02469298|455061800|FG001|Overall Study|Protocol Violation|1|||
126481071|NCT02469298|455061801|FG002|Overall Study|Protocol Violation|1|||
126481072|NCT02469298|455061802|FG003|Overall Study|Protocol Violation|0|||
126481073|NCT02469298|455061799|FG000|Overall Study|Lost to Follow-up|1|||
126481074|NCT02469298|455061800|FG001|Overall Study|Lost to Follow-up|0|||
126481075|NCT02469298|455061801|FG002|Overall Study|Lost to Follow-up|1|||
126481076|NCT02469298|455061802|FG003|Overall Study|Lost to Follow-up|0|||
126481077|NCT02469298|455061799|FG000|Overall Study|Physician Decision|0|||
126481078|NCT02469298|455061800|FG001|Overall Study|Physician Decision|0|||
126481079|NCT02469298|455061801|FG002|Overall Study|Physician Decision|0|||
126481080|NCT02469298|455061802|FG003|Overall Study|Physician Decision|1|||
126481081|NCT02469298|455061799|FG000|Overall Study|Withdrawal by Subject|0|||
126481082|NCT02469298|455061800|FG001|Overall Study|Withdrawal by Subject|0|||
126481083|NCT02469298|455061801|FG002|Overall Study|Withdrawal by Subject|0|||
126481084|NCT02469298|455061802|FG003|Overall Study|Withdrawal by Subject|1|||
126481085|NCT00307294|455061803|FG000|Overall Study|Withdrawal by Subject|1|||
126481086|NCT00290888|455061807|FG000|Overall Study|Physician Decision|3|||
126481087|NCT00290888|455061808|FG001|Overall Study|Physician Decision|1|||
126481088|NCT03000439|455061809|FG000|Open Label Part 1|Adverse Event|6|||
126481089|NCT03000439|455061810|FG001|Open Label Part 1|Adverse Event|0|||
126481090|NCT03000439|455061811|FG002|Open Label Part 1|Adverse Event|0|||
126481091|NCT03000439|455061812|FG003|Open Label Part 1|Adverse Event|0|||
126481092|NCT03000439|455061809|FG000|Open Label Part 1|Other|2|||
126481093|NCT03000439|455061810|FG001|Open Label Part 1|Other|0|||
126481094|NCT03000439|455061811|FG002|Open Label Part 1|Other|0|||
126481095|NCT03000439|455061812|FG003|Open Label Part 1|Other|0|||
126481096|NCT03000439|455061809|FG000|Open Label Part 1|Insufficient clinical response|16|||
126481097|NCT03000439|455061810|FG001|Open Label Part 1|Insufficient clinical response|0|||
126481098|NCT03000439|455061811|FG002|Open Label Part 1|Insufficient clinical response|0|||
126481099|NCT03000439|455061812|FG003|Open Label Part 1|Insufficient clinical response|0|||
126481100|NCT03000439|455061809|FG000|Open Label Part 2|Other|0|||
126481101|NCT03000439|455061810|FG001|Open Label Part 2|Other|5|||
126481102|NCT03000439|455061811|FG002|Open Label Part 2|Other|0|||
126481103|NCT03000439|455061812|FG003|Open Label Part 2|Other|0|||
126481104|NCT03000439|455061809|FG000|Open Label Part 2|Insufficient clinical response|0|||
126481105|NCT03000439|455061810|FG001|Open Label Part 2|Insufficient clinical response|12|||
126481106|NCT03000439|455061811|FG002|Open Label Part 2|Insufficient clinical response|0|||
126481107|NCT03000439|455061812|FG003|Open Label Part 2|Insufficient clinical response|0|||
126481108|NCT03000439|455061809|FG000|Double Blind Phase|Adverse Event|0|||
126481109|NCT03000439|455061810|FG001|Double Blind Phase|Adverse Event|0|||
126481110|NCT03000439|455061811|FG002|Double Blind Phase|Adverse Event|2|||
126481111|NCT03000439|455061812|FG003|Double Blind Phase|Adverse Event|1|||
126481112|NCT03000439|455061809|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
126481113|NCT03000439|455061810|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
126481114|NCT03000439|455061811|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
126481115|NCT03000439|455061812|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
126481116|NCT03000439|455061809|FG000|Double Blind Phase|Other|0|||
126481117|NCT03000439|455061810|FG001|Double Blind Phase|Other|0|||
126481118|NCT03000439|455061811|FG002|Double Blind Phase|Other|10|||
126481119|NCT03000439|455061812|FG003|Double Blind Phase|Other|11|||
126481120|NCT03000439|455061809|FG000|Double Blind Phase|Insufficient clinical response|0|||
126481121|NCT03000439|455061810|FG001|Double Blind Phase|Insufficient clinical response|0|||
126481122|NCT03000439|455061811|FG002|Double Blind Phase|Insufficient clinical response|0|||
126481123|NCT03000439|455061812|FG003|Double Blind Phase|Insufficient clinical response|2|||
126481124|NCT02370160|455061813|FG000|Overall Study|Death|3|||
126481125|NCT02370160|455061814|FG001|Overall Study|Death|4|||
126481126|NCT02370160|455061815|FG002|Overall Study|Death|1|||
126481127|NCT04487730|455061818|FG000|Overall Study|Withdrawal by Subject|3|||
126481128|NCT04487730|455061819|FG001|Overall Study|Withdrawal by Subject|1|||
126481129|NCT04487730|455061818|FG000|Overall Study|Lost to Follow-up|0|||
126481130|NCT04487730|455061819|FG001|Overall Study|Lost to Follow-up|1|||
126481131|NCT04487730|455061818|FG000|Overall Study|Physician Decision|0|||
126481132|NCT04487730|455061819|FG001|Overall Study|Physician Decision|1|||
126481133|NCT01581931|455061820|FG000|Washout|Adverse Event|0|||
126481134|NCT01581931|455061821|FG001|Washout|Adverse Event|1|||
126481135|NCT02954237|455061822|FG000|Overall Study|Withdrawal by Subject|25|||
126481136|NCT02954237|455061822|FG000|Overall Study|Missed visit|16|||
126481137|NCT02954237|455061822|FG000|Overall Study|Death|2|||
126481138|NCT02853604|455061823|FG000|Overall Study|Withdrawal by Subject|12|||
126481139|NCT02853604|455061824|FG001|Overall Study|Withdrawal by Subject|35|||
126481140|NCT02853604|455061823|FG000|Overall Study|Lost to Follow-up|4|||
126481141|NCT02853604|455061824|FG001|Overall Study|Lost to Follow-up|8|||
126481142|NCT02853604|455061823|FG000|Overall Study|Death|1|||
126481143|NCT02853604|455061824|FG001|Overall Study|Death|5|||
126481144|NCT02853604|455061823|FG000|Overall Study|Miscellaneous|11|||
126481145|NCT02853604|455061824|FG001|Overall Study|Miscellaneous|2|||
126481146|NCT02853604|455061823|FG000|Overall Study|Progressive Disease|0|||
126481147|NCT02853604|455061824|FG001|Overall Study|Progressive Disease|2|||
126481148|NCT00964860|455061825|FG000|Overall Study|Withdrawal by Subject|0|||
126481149|NCT00964860|455061826|FG001|Overall Study|Withdrawal by Subject|1|||
126481150|NCT03716024|455061827|FG000|Overall Study|Randomized, not Treated|7|||
126481151|NCT03716024|455061828|FG001|Overall Study|Randomized, not Treated|8|||
126481152|NCT03716024|455061827|FG000|Overall Study|Adverse Event|1|||
126481153|NCT03716024|455061828|FG001|Overall Study|Adverse Event|2|||
126481154|NCT03716024|455061827|FG000|Overall Study|Treatment Failure|1|||
126481155|NCT03716024|455061828|FG001|Overall Study|Treatment Failure|0|||
126481156|NCT03716024|455061827|FG000|Overall Study|Lost to Follow-up|2|||
126481157|NCT03716024|455061828|FG001|Overall Study|Lost to Follow-up|6|||
126481158|NCT03716024|455061827|FG000|Overall Study|Withdrawal by Subject|0|||
126481159|NCT03716024|455061828|FG001|Overall Study|Withdrawal by Subject|1|||
126481160|NCT03716024|455061827|FG000|Overall Study|Missing Reason|0|||
126481161|NCT03716024|455061828|FG001|Overall Study|Missing Reason|1|||
126481162|NCT00867568|455061829|FG000|Overall Study|Lack of Efficacy|10|||
126481163|NCT00867568|455061829|FG000|Overall Study|Adverse Event|4|||
126481164|NCT00867568|455061829|FG000|Overall Study|Withdrawal by Subject|1|||
126481165|NCT04343261|455061830|FG000|Overall Study|Adverse Event|1|||
126481166|NCT04343261|455061830|FG000|Overall Study|received inadequate amount of antibodies|7|||
126481167|NCT04623216|455061835|FG000|Overall Study|Death|5|||
126481168|NCT04623216|455061836|FG001|Overall Study|Death|2|||
126481169|NCT04623216|455061837|FG002|Overall Study|Death|0|||
126481170|NCT04623216|455061838|FG003|Overall Study|Death|0|||
126481171|NCT04623216|455061835|FG000|Overall Study|Terminated by Sponsor|3|||
126481172|NCT04623216|455061836|FG001|Overall Study|Terminated by Sponsor|2|||
126481173|NCT04623216|455061837|FG002|Overall Study|Terminated by Sponsor|2|||
126481174|NCT04623216|455061838|FG003|Overall Study|Terminated by Sponsor|0|||
126481175|NCT04623216|455061835|FG000|Overall Study|Physician Decision|1|||
126481176|NCT04623216|455061836|FG001|Overall Study|Physician Decision|0|||
126481177|NCT04623216|455061837|FG002|Overall Study|Physician Decision|0|||
126481178|NCT04623216|455061838|FG003|Overall Study|Physician Decision|0|||
126481179|NCT01651039|455061839|FG000|Overall Study|Non-evaluables|5|||
126481180|NCT01651039|455061839|FG000|Overall Study|Physician Decision|2|||
126481181|NCT01651039|455061839|FG000|Overall Study|Withdrawal by Subject|1|||
126481182|NCT01651039|455061839|FG000|Overall Study|Progressive Disease|22|||
126481183|NCT04930965|455061842|FG000|Overall Study|Lost to Follow-up|7|||
126481184|NCT04930965|455061843|FG001|Overall Study|Lost to Follow-up|5|||
126481185|NCT00134082|455061844|FG000|Overall Study|Adverse Event|2|||
126481186|NCT00134082|455061844|FG000|Overall Study|Death|1|||
126481187|NCT00044083|455061845|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
126481188|NCT00044083|455061846|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
126481189|NCT00044083|455061845|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
126481190|NCT00044083|455061846|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
126481191|NCT00044083|455061845|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
126481192|NCT00044083|455061846|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
126481193|NCT00044083|455061845|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
126481194|NCT00044083|455061846|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
126481195|NCT00044083|455061845|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
126481196|NCT00044083|455061846|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
126481197|NCT00044083|455061845|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
126481198|NCT00044083|455061846|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
126481199|NCT00044083|455061845|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
126481200|NCT00044083|455061846|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
126481201|NCT00044083|455061845|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
126481202|NCT00044083|455061846|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
126481203|NCT00044083|455061845|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
126481204|NCT00044083|455061846|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
126722470|NCT03725202|455934432|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
126722471|NCT03725202|455934425|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
126722472|NCT03725202|455934426|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126722473|NCT03725202|455934427|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126481205|NCT00044083|455061845|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
126481206|NCT00044083|455061846|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
126481207|NCT00119106|455061847|FG000|Overall Study|HIV infected at baseline|179|||
126559213|NCT04736056|455340688|FG002|Overall Study|Withdrawal by Subject|0|||
126481208|NCT00119106|455061848|FG001|Overall Study|HIV infected at baseline|178|||
126481209|NCT03066804|455061849|FG000|Overall Study|Physician Decision|0|||
126481210|NCT03066804|455061850|FG001|Overall Study|Physician Decision|4|||
126481211|NCT03066804|455061849|FG000|Overall Study|Death|23|||
126481212|NCT03066804|455061850|FG001|Overall Study|Death|17|||
126481213|NCT03066804|455061849|FG000|Overall Study|Withdrawal by Subject|19|||
126481214|NCT03066804|455061850|FG001|Overall Study|Withdrawal by Subject|25|||
126481215|NCT03066804|455061849|FG000|Overall Study|Lost to Follow-up|2|||
126481216|NCT03066804|455061850|FG001|Overall Study|Lost to Follow-up|0|||
126481217|NCT03066804|455061849|FG000|Overall Study|Adverse Event|2|||
126481218|NCT03066804|455061850|FG001|Overall Study|Adverse Event|3|||
126481219|NCT03066804|455061849|FG000|Overall Study|Technical problems|5|||
126722474|NCT03725202|455934428|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126722475|NCT03725202|455934429|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126722476|NCT03725202|455934430|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126722477|NCT03725202|455934431|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126722478|NCT03725202|455934432|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
126722479|NCT03725202|455934425|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
126722480|NCT03725202|455934426|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
126722481|NCT03725202|455934427|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
126722482|NCT03725202|455934428|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
126722483|NCT03725202|455934429|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
126722484|NCT03725202|455934430|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
126722485|NCT03725202|455934431|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
126722486|NCT03725202|455934432|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
126722487|NCT03725202|455934425|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126722488|NCT03725202|455934426|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126722489|NCT03725202|455934427|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
126722490|NCT03725202|455934428|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126722491|NCT03725202|455934429|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126722492|NCT03725202|455934430|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126722493|NCT03725202|455934431|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126722494|NCT03725202|455934432|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
126722495|NCT03725202|455934425|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
126722496|NCT03725202|455934426|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
126722497|NCT03725202|455934427|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
126722498|NCT03725202|455934428|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
126722499|NCT03725202|455934429|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
126722500|NCT03725202|455934430|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
126481220|NCT03066804|455061850|FG001|Overall Study|Technical problems|1|||
126481221|NCT03310021|455061852|FG000|Overall Study|Withdrawal by Subject|0|||
126481222|NCT03310021|455061853|FG001|Overall Study|Withdrawal by Subject|0|||
126481223|NCT03310021|455061854|FG002|Overall Study|Withdrawal by Subject|0|||
126481224|NCT03310021|455061855|FG003|Overall Study|Withdrawal by Subject|0|||
126481225|NCT03310021|455061856|FG004|Overall Study|Withdrawal by Subject|0|||
126481226|NCT03310021|455061857|FG005|Overall Study|Withdrawal by Subject|0|||
126481227|NCT03310021|455061858|FG006|Overall Study|Withdrawal by Subject|1|||
126481228|NCT03310021|455061859|FG007|Overall Study|Withdrawal by Subject|0|||
126481229|NCT03310021|455061860|FG008|Overall Study|Withdrawal by Subject|0|||
126481230|NCT03310021|455061861|FG009|Overall Study|Withdrawal by Subject|0|||
126481231|NCT03310021|455061862|FG010|Overall Study|Withdrawal by Subject|0|||
126481232|NCT03310021|455061863|FG011|Overall Study|Withdrawal by Subject|0|||
126481233|NCT03310021|455061864|FG012|Overall Study|Withdrawal by Subject|0|||
126481234|NCT03310021|455061865|FG013|Overall Study|Withdrawal by Subject|0|||
126481235|NCT03310021|455061866|FG014|Overall Study|Withdrawal by Subject|0|||
126481236|NCT03310021|455061867|FG015|Overall Study|Withdrawal by Subject|0|||
126481237|NCT03310021|455061868|FG016|Overall Study|Withdrawal by Subject|0|||
126481238|NCT03310021|455061869|FG017|Overall Study|Withdrawal by Subject|0|||
126481239|NCT03310021|455061870|FG018|Overall Study|Withdrawal by Subject|0|||
126481240|NCT03310021|455061871|FG019|Overall Study|Withdrawal by Subject|0|||
126481241|NCT03310021|455061852|FG000|Overall Study|Lost to Follow-up|0|||
126481242|NCT03310021|455061853|FG001|Overall Study|Lost to Follow-up|0|||
126481243|NCT03310021|455061854|FG002|Overall Study|Lost to Follow-up|0|||
126481244|NCT03310021|455061855|FG003|Overall Study|Lost to Follow-up|0|||
126481245|NCT03310021|455061856|FG004|Overall Study|Lost to Follow-up|0|||
126481246|NCT03310021|455061857|FG005|Overall Study|Lost to Follow-up|0|||
126481247|NCT03310021|455061858|FG006|Overall Study|Lost to Follow-up|0|||
126722501|NCT03725202|455934431|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
126722502|NCT03725202|455934432|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
126722503|NCT03725202|455934425|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
126722504|NCT03725202|455934426|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
126481248|NCT03310021|455061859|FG007|Overall Study|Lost to Follow-up|0|||
126481249|NCT03310021|455061860|FG008|Overall Study|Lost to Follow-up|0|||
126772341|NCT00190684|456122096|FG000|Overall Study|Satisfactory response|80|||
126481250|NCT03310021|455061861|FG009|Overall Study|Lost to Follow-up|0|||
126481251|NCT03310021|455061862|FG010|Overall Study|Lost to Follow-up|1|||
126481252|NCT03310021|455061863|FG011|Overall Study|Lost to Follow-up|0|||
126481253|NCT03310021|455061864|FG012|Overall Study|Lost to Follow-up|0|||
126481254|NCT03310021|455061865|FG013|Overall Study|Lost to Follow-up|0|||
126481255|NCT03310021|455061866|FG014|Overall Study|Lost to Follow-up|0|||
126481256|NCT03310021|455061867|FG015|Overall Study|Lost to Follow-up|0|||
126481257|NCT03310021|455061868|FG016|Overall Study|Lost to Follow-up|0|||
126481258|NCT03310021|455061869|FG017|Overall Study|Lost to Follow-up|0|||
126481259|NCT03310021|455061870|FG018|Overall Study|Lost to Follow-up|0|||
126481260|NCT03310021|455061871|FG019|Overall Study|Lost to Follow-up|0|||
126481261|NCT03953820|455061877|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
126481262|NCT03953820|455061878|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
126481263|NCT03953820|455061879|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
126481264|NCT03953820|455061877|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
126481265|NCT03953820|455061878|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
126481266|NCT03953820|455061879|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
126481267|NCT00799422|455061881|FG000|First Week of Wear|Lost to Follow-up|0|||
126481268|NCT00799422|455061882|FG001|First Week of Wear|Lost to Follow-up|0|||
126481269|NCT00799422|455061883|FG002|First Week of Wear|Lost to Follow-up|1|||
126481270|NCT00799422|455061884|FG003|First Week of Wear|Lost to Follow-up|0|||
126481271|NCT00799422|455061885|FG004|First Week of Wear|Lost to Follow-up|0|||
126481272|NCT00799422|455061886|FG005|First Week of Wear|Lost to Follow-up|0|||
126481273|NCT00799422|455061881|FG000|First Week of Wear|Adverse Event|0|||
126481274|NCT00799422|455061882|FG001|First Week of Wear|Adverse Event|0|||
126481275|NCT00799422|455061883|FG002|First Week of Wear|Adverse Event|0|||
126481276|NCT00799422|455061884|FG003|First Week of Wear|Adverse Event|1|||
126481277|NCT00799422|455061885|FG004|First Week of Wear|Adverse Event|0|||
126481278|NCT00799422|455061886|FG005|First Week of Wear|Adverse Event|0|||
126481279|NCT00622284|455061887|FG000|Overall Study|Lack of Efficacy|45|||
126481280|NCT00622284|455061888|FG001|Overall Study|Lack of Efficacy|15|||
126481281|NCT00622284|455061887|FG000|Overall Study|Adverse Event|61|||
126481282|NCT00622284|455061888|FG001|Overall Study|Adverse Event|90|||
126481283|NCT00622284|455061887|FG000|Overall Study|Protocol Violation|12|||
126481284|NCT00622284|455061888|FG001|Overall Study|Protocol Violation|5|||
126481285|NCT00622284|455061887|FG000|Overall Study|Lost to Follow-up|11|||
126481286|NCT00622284|455061888|FG001|Overall Study|Lost to Follow-up|13|||
126481287|NCT00622284|455061887|FG000|Overall Study|Withdrawal by Subject|27|||
126481288|NCT00622284|455061888|FG001|Overall Study|Withdrawal by Subject|24|||
126481289|NCT00622284|455061887|FG000|Overall Study|Other reason (not specified)|33|||
126481290|NCT00622284|455061888|FG001|Overall Study|Other reason (not specified)|24|||
126481291|NCT03322631|455061895|FG000|Overall Study|Withdrawal by Subject|0|||
126481292|NCT03322631|455061896|FG001|Overall Study|Withdrawal by Subject|1|||
126481293|NCT03322631|455061897|FG002|Overall Study|Withdrawal by Subject|0|||
126481294|NCT03322631|455061898|FG003|Overall Study|Withdrawal by Subject|0|||
126481295|NCT03322631|455061895|FG000|Overall Study|Adverse Event|0|||
126481296|NCT03322631|455061896|FG001|Overall Study|Adverse Event|0|||
126481297|NCT03322631|455061897|FG002|Overall Study|Adverse Event|1|||
126481298|NCT03322631|455061898|FG003|Overall Study|Adverse Event|0|||
126481299|NCT02412618|455061900|FG000|Overall Study|Withdrawal by Subject|1|||
126481300|NCT02412618|455061901|FG001|Overall Study|Withdrawal by Subject|1|||
126481301|NCT02412618|455061900|FG000|Overall Study|Expulsion|1|||
126481302|NCT02412618|455061901|FG001|Overall Study|Expulsion|1|||
126481303|NCT01217801|455061902|FG000|Period 1|Protocol Violation|1|||
126481304|NCT01217801|455061903|FG001|Period 1|Protocol Violation|1|||
126481305|NCT01217801|455061902|FG000|Period 1|Withdrawal by Subject|0|||
126481306|NCT01217801|455061903|FG001|Period 1|Withdrawal by Subject|1|||
126481307|NCT00291577|455061908|FG000|Overall Study|Adverse Event|1|||
126481308|NCT00291577|455061908|FG000|Overall Study|Other|4|||
126481309|NCT00291577|455061908|FG000|Overall Study|Withdrawal by Subject|2|||
126481310|NCT00291577|455061908|FG000|Overall Study|Lack of Efficacy|14|||
126481311|NCT04967443|455061912|FG000|Open Label Treatment|Death|1|||
126481312|NCT04967443|455061913|FG001|Open Label Treatment|Death|0|||
126481313|NCT04967443|455061914|FG002|Open Label Treatment|Death|0|||
126481314|NCT04967443|455061915|FG003|Open Label Treatment|Death|0|||
126481315|NCT04967443|455061916|FG004|Open Label Treatment|Death|0|||
126559214|NCT04736056|455340689|FG003|Overall Study|Withdrawal by Subject|0|||
126481316|NCT04967443|455061917|FG005|Open Label Treatment|Death|0|||
126481317|NCT04967443|455061918|FG006|Open Label Treatment|Death|0|||
126481318|NCT04967443|455061919|FG007|Open Label Treatment|Death|0|||
126481319|NCT04967443|455061912|FG000|Open Label Treatment|Lost to Follow-up|0|||
126481320|NCT04967443|455061913|FG001|Open Label Treatment|Lost to Follow-up|0|||
126481321|NCT04967443|455061914|FG002|Open Label Treatment|Lost to Follow-up|1|||
126481322|NCT04967443|455061915|FG003|Open Label Treatment|Lost to Follow-up|0|||
126481323|NCT04967443|455061916|FG004|Open Label Treatment|Lost to Follow-up|0|||
126481324|NCT04967443|455061917|FG005|Open Label Treatment|Lost to Follow-up|0|||
126481325|NCT04967443|455061918|FG006|Open Label Treatment|Lost to Follow-up|0|||
126481326|NCT04967443|455061919|FG007|Open Label Treatment|Lost to Follow-up|0|||
126481327|NCT04967443|455061912|FG000|Open Label Treatment|Withdrawal by Subject|0|||
126481328|NCT04967443|455061913|FG001|Open Label Treatment|Withdrawal by Subject|1|||
126481329|NCT04967443|455061914|FG002|Open Label Treatment|Withdrawal by Subject|0|||
126481330|NCT04967443|455061915|FG003|Open Label Treatment|Withdrawal by Subject|1|||
126481331|NCT04967443|455061916|FG004|Open Label Treatment|Withdrawal by Subject|0|||
126481332|NCT04967443|455061917|FG005|Open Label Treatment|Withdrawal by Subject|1|||
126481333|NCT04967443|455061918|FG006|Open Label Treatment|Withdrawal by Subject|2|||
126481334|NCT04967443|455061919|FG007|Open Label Treatment|Withdrawal by Subject|3|||
126481335|NCT04967443|455061912|FG000|Follow-Up|Death|1|||
126481336|NCT04967443|455061913|FG001|Follow-Up|Death|0|||
126481337|NCT04967443|455061914|FG002|Follow-Up|Death|0|||
126481338|NCT04967443|455061915|FG003|Follow-Up|Death|0|||
126481339|NCT04967443|455061916|FG004|Follow-Up|Death|0|||
126481340|NCT04967443|455061917|FG005|Follow-Up|Death|0|||
126481341|NCT04967443|455061918|FG006|Follow-Up|Death|0|||
126481342|NCT04967443|455061919|FG007|Follow-Up|Death|0|||
126481343|NCT04967443|455061912|FG000|Follow-Up|Lost to Follow-up|0|||
126481344|NCT04967443|455061913|FG001|Follow-Up|Lost to Follow-up|0|||
126481345|NCT04967443|455061914|FG002|Follow-Up|Lost to Follow-up|1|||
126481346|NCT04967443|455061915|FG003|Follow-Up|Lost to Follow-up|1|||
126481347|NCT04967443|455061916|FG004|Follow-Up|Lost to Follow-up|0|||
126481348|NCT04967443|455061917|FG005|Follow-Up|Lost to Follow-up|0|||
126481349|NCT04967443|455061918|FG006|Follow-Up|Lost to Follow-up|0|||
126481350|NCT04967443|455061919|FG007|Follow-Up|Lost to Follow-up|0|||
126481351|NCT04967443|455061912|FG000|Follow-Up|Withdrawal by Subject|0|||
126481352|NCT04967443|455061913|FG001|Follow-Up|Withdrawal by Subject|1|||
126481353|NCT04967443|455061914|FG002|Follow-Up|Withdrawal by Subject|0|||
126481354|NCT04967443|455061915|FG003|Follow-Up|Withdrawal by Subject|1|||
126481355|NCT04967443|455061916|FG004|Follow-Up|Withdrawal by Subject|0|||
126481356|NCT04967443|455061917|FG005|Follow-Up|Withdrawal by Subject|1|||
126481357|NCT04967443|455061918|FG006|Follow-Up|Withdrawal by Subject|2|||
126481358|NCT04967443|455061919|FG007|Follow-Up|Withdrawal by Subject|3|||
126481359|NCT04502693|455061920|FG000|Overall Study|Adverse Event|7|||
126481360|NCT04502693|455061921|FG001|Overall Study|Adverse Event|6|||
126481361|NCT04502693|455061922|FG002|Overall Study|Adverse Event|11|||
126481362|NCT04502693|455061923|FG003|Overall Study|Adverse Event|1|||
126481363|NCT04502693|455061920|FG000|Overall Study|Lost to Follow-up|32|||
126481364|NCT04502693|455061921|FG001|Overall Study|Lost to Follow-up|36|||
126481365|NCT04502693|455061922|FG002|Overall Study|Lost to Follow-up|69|||
126481366|NCT04502693|455061923|FG003|Overall Study|Lost to Follow-up|4|||
126481367|NCT04502693|455061920|FG000|Overall Study|Protocol Violation|8|||
126481368|NCT04502693|455061921|FG001|Overall Study|Protocol Violation|8|||
126481369|NCT04502693|455061922|FG002|Overall Study|Protocol Violation|16|||
126481370|NCT04502693|455061923|FG003|Overall Study|Protocol Violation|1|||
126481371|NCT04502693|455061920|FG000|Overall Study|Withdrawal by Subject|46|||
126481372|NCT04502693|455061921|FG001|Overall Study|Withdrawal by Subject|38|||
126481373|NCT04502693|455061922|FG002|Overall Study|Withdrawal by Subject|54|||
126481374|NCT04502693|455061923|FG003|Overall Study|Withdrawal by Subject|7|||
126481375|NCT04502693|455061920|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
126481376|NCT04502693|455061921|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
126481377|NCT04502693|455061922|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
126481378|NCT04502693|455061923|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126481379|NCT04502693|455061920|FG000|Overall Study|Other|1|||
126481380|NCT04502693|455061921|FG001|Overall Study|Other|0|||
126481381|NCT04502693|455061922|FG002|Overall Study|Other|1|||
126481382|NCT04502693|455061923|FG003|Overall Study|Other|1|||
126481383|NCT00602797|455061924|FG000|Overall Study|Adverse Event|1|||
126481384|NCT03943147|455061928|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
126481385|NCT03943147|455061929|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
126481386|NCT03943147|455061928|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
126481387|NCT03943147|455061929|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
126481388|NCT03943147|455061928|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
126481389|NCT03943147|455061929|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
126481390|NCT03943147|455061928|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
126481391|NCT03943147|455061929|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
126481392|NCT03943147|455061928|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
126481393|NCT03943147|455061929|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
126481394|NCT03943147|455061928|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
126481395|NCT03943147|455061929|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
126481396|NCT02756013|455061930|FG000|Overall Study|Adverse Event|1|||
126481397|NCT02756013|455061930|FG000|Overall Study|Hypersensitivity|1|||
126481398|NCT01318993|455061931|FG000|Overall Study|Adverse Event|53|||
126481399|NCT01318993|455061931|FG000|Overall Study|Lack of Efficacy|121|||
126481400|NCT01318993|455061931|FG000|Overall Study|Protocol Violation|3|||
126481401|NCT01318993|455061931|FG000|Overall Study|Protocol based stopping criteria|6|||
126481402|NCT01318993|455061931|FG000|Overall Study|Study closed or terminated|174|||
126481403|NCT01318993|455061931|FG000|Overall Study|Lost to Follow-up|4|||
126481404|NCT01318993|455061931|FG000|Overall Study|Physician Decision|13|||
126481405|NCT01318993|455061931|FG000|Overall Study|Withdrawal by Subject|24|||
126481406|NCT00629707|455061934|FG000|Overall Study|Withdrawal by Subject|0|||
126481407|NCT00629707|455061935|FG001|Overall Study|Withdrawal by Subject|1|||
126481408|NCT00629707|455061934|FG000|Overall Study|Physician Decision|0|||
126481409|NCT00629707|455061935|FG001|Overall Study|Physician Decision|1|||
126481410|NCT00074152|455061936|FG000|Overall Study|Death|21|||
126481411|NCT00074152|455061937|FG001|Overall Study|Death|9|||
126481412|NCT00074152|455061936|FG000|Overall Study|Lack of Efficacy|34|||
126481413|NCT00074152|455061937|FG001|Overall Study|Lack of Efficacy|24|||
126481414|NCT03547583|455061938|FG000|Overall Study|Adverse Event|16|||
126481415|NCT03547583|455061939|FG001|Overall Study|Adverse Event|11|||
126481416|NCT03547583|455061940|FG002|Overall Study|Adverse Event|10|||
126481417|NCT03547583|455061938|FG000|Overall Study|Death|11|||
126481418|NCT03547583|455061939|FG001|Overall Study|Death|7|||
126481419|NCT03547583|455061940|FG002|Overall Study|Death|4|||
126481420|NCT03547583|455061938|FG000|Overall Study|Lost to Follow-up|1|||
126772342|NCT00190684|456122096|FG000|Overall Study|Lack of efficacy|204|||
126481421|NCT03547583|455061939|FG001|Overall Study|Lost to Follow-up|0|||
126481422|NCT03547583|455061940|FG002|Overall Study|Lost to Follow-up|0|||
126481423|NCT03547583|455061938|FG000|Overall Study|Non-compliance with study drug|0|||
126481424|NCT03547583|455061939|FG001|Overall Study|Non-compliance with study drug|0|||
126481425|NCT03547583|455061940|FG002|Overall Study|Non-compliance with study drug|1|||
126481426|NCT03547583|455061938|FG000|Overall Study|Physician Decision|1|||
126481427|NCT03547583|455061939|FG001|Overall Study|Physician Decision|0|||
126481428|NCT03547583|455061940|FG002|Overall Study|Physician Decision|3|||
126481429|NCT03547583|455061938|FG000|Overall Study|Protocol Violation|2|||
126481430|NCT03547583|455061939|FG001|Overall Study|Protocol Violation|1|||
126481431|NCT03547583|455061940|FG002|Overall Study|Protocol Violation|1|||
126481432|NCT03547583|455061938|FG000|Overall Study|Withdrawal by Subject|12|||
126481433|NCT03547583|455061939|FG001|Overall Study|Withdrawal by Subject|19|||
126481434|NCT03547583|455061940|FG002|Overall Study|Withdrawal by Subject|10|||
126481435|NCT03547583|455061938|FG000|Overall Study|Other|2|||
126481436|NCT03547583|455061939|FG001|Overall Study|Other|2|||
126481437|NCT03547583|455061940|FG002|Overall Study|Other|3|||
126481438|NCT00382252|455061941|FG000|Overall Study|Death|4|||
126481439|NCT00382252|455061941|FG000|Overall Study|Protocol Violation|8|||
126481440|NCT00382252|455061941|FG000|Overall Study|Not treated by RFA|1|||
126481441|NCT05570500|455061946|FG000|Overall Study|Lost to Follow-up|7|||
126481442|NCT05570500|455061947|FG001|Overall Study|Lost to Follow-up|5|||
126481443|NCT04706091|455061948|FG000|Treatment 2|Withdrawal by Subject|1|||
126481444|NCT04706091|455061949|FG001|Treatment 2|Withdrawal by Subject|0|||
126481445|NCT01664533|455063679|FG000|Overall Study|Death|42|||
126481446|NCT01664533|455063679|FG000|Overall Study|Lost to Follow-up|3|||
126481447|NCT01664533|455063679|FG000|Overall Study|Study termination|9|||
126481448|NCT01664533|455063679|FG000|Overall Study|Protocol Violation|3|||
126481449|NCT03291808|455063684|FG000|Overall Study|Lost to Follow-up|6|||
126481450|NCT03291808|455063684|FG000|Overall Study|Research burden|4|||
126481451|NCT01892293|455063687|FG000|Overall Study|Apheresed but not treated|4|||
126481452|NCT03602482|455063688|FG000|Overall Study|Withdrawal by Subject|6|||
126481453|NCT03602482|455063689|FG001|Overall Study|Withdrawal by Subject|7|||
126481454|NCT03602482|455063690|FG002|Overall Study|Withdrawal by Subject|0|||
126481455|NCT03602482|455063691|FG003|Overall Study|Withdrawal by Subject|0|||
126481456|NCT02397278|455063692|FG000|Overall Study|Withdrawal by Subject|0|||
126481457|NCT02397278|455063693|FG001|Overall Study|Withdrawal by Subject|2|||
126481458|NCT02397278|455063692|FG000|Overall Study|Deemed ineligible following surgery|1|||
126481459|NCT02397278|455063693|FG001|Overall Study|Deemed ineligible following surgery|1|||
126481460|NCT01397084|455063694|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
126481461|NCT01397084|455063694|FG000|Overall Study|Protocol Violation|2|||
126481462|NCT01397084|455063694|FG000|Overall Study|Adverse Event|2|||
126481463|NCT01397084|455063694|FG000|Overall Study|Withdrawal by Subject|1|||
126481464|NCT01397084|455063694|FG000|Overall Study|Lost to Follow-up|1|||
126481465|NCT01397084|455063694|FG000|Overall Study|Used other proton pump inhibitor|1|||
126481466|NCT00618072|455063695|FG000|Overall Study|Lost to Follow-up|2|||
126481467|NCT00618072|455063696|FG001|Overall Study|Lost to Follow-up|0|||
126481468|NCT00618072|455063697|FG002|Overall Study|Lost to Follow-up|3|||
126481469|NCT00618072|455063695|FG000|Overall Study|Physician Decision|0|||
126481470|NCT00618072|455063696|FG001|Overall Study|Physician Decision|1|||
126481471|NCT00618072|455063697|FG002|Overall Study|Physician Decision|1|||
126481472|NCT03292588|455063698|FG000|Overall Study|Death|1|||
126481473|NCT03292588|455063699|FG001|Overall Study|Death|0|||
126481474|NCT03292588|455063698|FG000|Overall Study|Lost to Follow-up|12|||
126481475|NCT03292588|455063699|FG001|Overall Study|Lost to Follow-up|16|||
126481476|NCT03292588|455063698|FG000|Overall Study|Physician Decision|0|||
126481477|NCT03292588|455063699|FG001|Overall Study|Physician Decision|1|||
126481478|NCT03292588|455063698|FG000|Overall Study|Withdrawal by Subject|4|||
126481479|NCT03292588|455063699|FG001|Overall Study|Withdrawal by Subject|4|||
126481480|NCT03292588|455063698|FG000|Overall Study|Move out of town|1|||
126772343|NCT00190684|456122096|FG000|Overall Study|Lost to Follow-up|232|||
126481481|NCT03292588|455063699|FG001|Overall Study|Move out of town|0|||
126481482|NCT03292588|455063698|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
126481483|NCT03292588|455063699|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
126772344|NCT00190684|456122096|FG000|Overall Study|Patient moved|60|||
126772345|NCT00190684|456122096|FG000|Overall Study|Patient Decision|432|||
126772346|NCT00190684|456122096|FG000|Overall Study|Clinical relapse|67|||
126772347|NCT00190684|456122096|FG000|Overall Study|Sponsor's decision|17|||
126772348|NCT00190684|456122096|FG000|Overall Study|Physician Decision|84|||
126772349|NCT00190684|456122096|FG000|Overall Study|Protocol Violation|123|||
126772350|NCT00190684|456122096|FG000|Overall Study|Study Period III Completed|103|||
126772351|NCT00190684|456122096|FG000|Overall Study|Study Period V Completed|1|||
126772352|NCT00829439|456122102|FG000|Overall Study|Adverse Event|0|||
126772353|NCT00829439|456122103|FG001|Overall Study|Adverse Event|0|||
126772354|NCT00829439|456122104|FG002|Overall Study|Adverse Event|1|||
126772355|NCT00829439|456122105|FG003|Overall Study|Adverse Event|0|||
126772356|NCT00758706|456122114|FG000|Overall Study|Adverse Event|4|||
126772357|NCT00758706|456122115|FG001|Overall Study|Adverse Event|4|||
126772358|NCT01494649|456122116|FG000|Overall Study|Lost to Follow-up|0|||
126772359|NCT01494649|456122117|FG001|Overall Study|Lost to Follow-up|1|||
126772360|NCT03467971|456122118|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126772361|NCT03467971|456122119|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126772362|NCT01174368|456122122|FG000|Overall Study|Withdrawal by Subject|1|||
126772363|NCT04449354|456122123|FG000|Overall Study|Withdrawal by Subject|1|||
126772364|NCT05789420|456122124|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
126772365|NCT05789420|456122124|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
126772366|NCT02720094|456122125|FG000|Overall Study|Scheduled exit visit/end of study|2|||
126772367|NCT02720094|456122126|FG001|Overall Study|Scheduled exit visit/end of study|1|||
126772368|NCT02720094|456122125|FG000|Overall Study|Death|4|||
126772369|NCT02720094|456122126|FG001|Overall Study|Death|7|||
126772370|NCT02720094|456122125|FG000|Overall Study|Withdrawal by Subject|55|||
126772371|NCT02720094|456122126|FG001|Overall Study|Withdrawal by Subject|56|||
126772372|NCT02720094|456122125|FG000|Overall Study|Lost to Follow-up|2|||
126772373|NCT02720094|456122126|FG001|Overall Study|Lost to Follow-up|7|||
126772374|NCT02720094|456122125|FG000|Overall Study|Physician Decision|1|||
126772375|NCT02720094|456122126|FG001|Overall Study|Physician Decision|3|||
126772376|NCT02720094|456122125|FG000|Overall Study|Inappropriate enrollment|1|||
126772377|NCT02720094|456122126|FG001|Overall Study|Inappropriate enrollment|3|||
126772378|NCT02720094|456122125|FG000|Overall Study|Ongoing|2210|||
126772379|NCT02720094|456122126|FG001|Overall Study|Ongoing|2203|||
126772380|NCT02720094|456122125|FG000|Overall Study|Relocation|1|||
126772381|NCT02720094|456122126|FG001|Overall Study|Relocation|1|||
126772382|NCT02913261|456122127|FG000|Overall Study|Technical problems|0|||
126772383|NCT02913261|456122128|FG001|Overall Study|Technical problems|1|||
126772384|NCT02913261|456122127|FG000|Overall Study|Lack of Efficacy|32|||
126772385|NCT02913261|456122128|FG001|Overall Study|Lack of Efficacy|69|||
126772386|NCT02913261|456122127|FG000|Overall Study|Adverse Event|27|||
126772387|NCT02913261|456122128|FG001|Overall Study|Adverse Event|5|||
126772388|NCT02913261|456122127|FG000|Overall Study|Death|25|||
126772389|NCT02913261|456122128|FG001|Overall Study|Death|22|||
126772390|NCT02913261|456122127|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
126772391|NCT02913261|456122128|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
126772392|NCT02913261|456122127|FG000|Overall Study|Disease relapse|8|||
126772393|NCT02913261|456122128|FG001|Overall Study|Disease relapse|13|||
126481484|NCT00592384|455063700|FG000|Overall Study|Withdrawal by Subject|5|||
126481485|NCT00592384|455063701|FG001|Overall Study|Withdrawal by Subject|6|||
126481486|NCT02151591|455063702|FG000|Overall Study|Lost to Follow-up|6|||
126481487|NCT02151591|455063703|FG001|Overall Study|Lost to Follow-up|3|||
126481488|NCT03633695|455063709|FG000|Overall Study|Lost to Follow-up|4|||
126481489|NCT03633695|455063710|FG001|Overall Study|Lost to Follow-up|5|||
126481490|NCT03633695|455063709|FG000|Overall Study|Discontinued|8|||
126481491|NCT03633695|455063710|FG001|Overall Study|Discontinued|4|||
126481492|NCT02380677|455063718|FG000|Overall Study|Adverse Event|0|||
126481493|NCT02380677|455063719|FG001|Overall Study|Adverse Event|0|||
126481494|NCT02380677|455063720|FG002|Overall Study|Adverse Event|0|||
126481495|NCT02380677|455063721|FG003|Overall Study|Adverse Event|1|||
126481496|NCT02380677|455063722|FG004|Overall Study|Adverse Event|1|||
126481497|NCT02380677|455063723|FG005|Overall Study|Adverse Event|4|||
126481498|NCT02380677|455063724|FG006|Overall Study|Adverse Event|2|||
126481499|NCT02380677|455063725|FG007|Overall Study|Adverse Event|2|||
126481500|NCT02380677|455063726|FG008|Overall Study|Adverse Event|2|||
126481501|NCT02380677|455063727|FG009|Overall Study|Adverse Event|1|||
126481502|NCT02380677|455063728|FG010|Overall Study|Adverse Event|2|||
126772394|NCT02913261|456122127|FG000|Overall Study|Physician Decision|8|||
126772395|NCT02913261|456122128|FG001|Overall Study|Physician Decision|9|||
126772396|NCT02913261|456122127|FG000|Overall Study|Subject/guardian decision|4|||
126772397|NCT02913261|456122128|FG001|Overall Study|Subject/guardian decision|6|||
126772398|NCT02913261|456122127|FG000|Overall Study|Graft loss|2|||
126772399|NCT02913261|456122128|FG001|Overall Study|Graft loss|0|||
126772400|NCT00000135|456122151|FG000|Overall Study|Death|27|||
126481503|NCT02380677|455063729|FG011|Overall Study|Adverse Event|1|||
126481504|NCT02380677|455063718|FG000|Overall Study|Physician Decision|1|||
126481505|NCT02380677|455063719|FG001|Overall Study|Physician Decision|0|||
126481506|NCT02380677|455063720|FG002|Overall Study|Physician Decision|1|||
126481507|NCT02380677|455063721|FG003|Overall Study|Physician Decision|1|||
126481508|NCT02380677|455063722|FG004|Overall Study|Physician Decision|0|||
126481509|NCT02380677|455063723|FG005|Overall Study|Physician Decision|0|||
126481510|NCT02380677|455063724|FG006|Overall Study|Physician Decision|0|||
126481511|NCT02380677|455063725|FG007|Overall Study|Physician Decision|0|||
126481512|NCT02380677|455063726|FG008|Overall Study|Physician Decision|0|||
126481513|NCT02380677|455063727|FG009|Overall Study|Physician Decision|0|||
126481514|NCT02380677|455063728|FG010|Overall Study|Physician Decision|0|||
126481515|NCT02380677|455063729|FG011|Overall Study|Physician Decision|0|||
126481516|NCT02380677|455063718|FG000|Overall Study|Lack of Efficacy|0|||
126481517|NCT02380677|455063719|FG001|Overall Study|Lack of Efficacy|1|||
126481518|NCT02380677|455063720|FG002|Overall Study|Lack of Efficacy|2|||
126481519|NCT02380677|455063721|FG003|Overall Study|Lack of Efficacy|0|||
126481520|NCT02380677|455063722|FG004|Overall Study|Lack of Efficacy|4|||
126481521|NCT02380677|455063723|FG005|Overall Study|Lack of Efficacy|1|||
126481522|NCT02380677|455063724|FG006|Overall Study|Lack of Efficacy|1|||
126481523|NCT02380677|455063725|FG007|Overall Study|Lack of Efficacy|2|||
126481524|NCT02380677|455063726|FG008|Overall Study|Lack of Efficacy|2|||
126481525|NCT02380677|455063727|FG009|Overall Study|Lack of Efficacy|0|||
126481526|NCT02380677|455063728|FG010|Overall Study|Lack of Efficacy|2|||
126481527|NCT02380677|455063729|FG011|Overall Study|Lack of Efficacy|1|||
126481528|NCT02380677|455063718|FG000|Overall Study|Withdrawal by Subject|0|||
126481529|NCT02380677|455063719|FG001|Overall Study|Withdrawal by Subject|0|||
126481530|NCT02380677|455063720|FG002|Overall Study|Withdrawal by Subject|0|||
126481531|NCT02380677|455063721|FG003|Overall Study|Withdrawal by Subject|0|||
126481532|NCT02380677|455063722|FG004|Overall Study|Withdrawal by Subject|0|||
126481533|NCT02380677|455063723|FG005|Overall Study|Withdrawal by Subject|0|||
126481534|NCT02380677|455063724|FG006|Overall Study|Withdrawal by Subject|0|||
126481535|NCT02380677|455063725|FG007|Overall Study|Withdrawal by Subject|0|||
126481536|NCT02380677|455063726|FG008|Overall Study|Withdrawal by Subject|0|||
126481537|NCT02380677|455063727|FG009|Overall Study|Withdrawal by Subject|1|||
126481538|NCT02380677|455063728|FG010|Overall Study|Withdrawal by Subject|0|||
126481539|NCT02380677|455063729|FG011|Overall Study|Withdrawal by Subject|3|||
126481540|NCT02380677|455063718|FG000|Overall Study|Other|0|||
126481541|NCT02380677|455063719|FG001|Overall Study|Other|0|||
126481542|NCT02380677|455063720|FG002|Overall Study|Other|0|||
126481543|NCT02380677|455063721|FG003|Overall Study|Other|1|||
126481544|NCT02380677|455063722|FG004|Overall Study|Other|1|||
126481545|NCT02380677|455063723|FG005|Overall Study|Other|1|||
126481546|NCT02380677|455063724|FG006|Overall Study|Other|0|||
126481547|NCT02380677|455063725|FG007|Overall Study|Other|0|||
126481548|NCT02380677|455063726|FG008|Overall Study|Other|0|||
126481549|NCT02380677|455063727|FG009|Overall Study|Other|0|||
126481550|NCT02380677|455063728|FG010|Overall Study|Other|0|||
126481551|NCT02380677|455063729|FG011|Overall Study|Other|0|||
126481552|NCT04932096|455063730|FG000|Overall Study|Withdrawal by Subject|1|||
126481553|NCT04932096|455063731|FG001|Overall Study|Withdrawal by Subject|1|||
126481554|NCT04932096|455063730|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
126481555|NCT04932096|455063731|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
126481556|NCT01976338|455063733|FG000|Overall Study|Physician Decision|0|||
126481557|NCT01976338|455063734|FG001|Overall Study|Physician Decision|1|||
126481558|NCT01976338|455063733|FG000|Overall Study|Lost to Follow-up|3|||
126481559|NCT01976338|455063734|FG001|Overall Study|Lost to Follow-up|0|||
126481560|NCT01976338|455063733|FG000|Overall Study|Withdrawal by Subject|5|||
126481561|NCT01976338|455063734|FG001|Overall Study|Withdrawal by Subject|2|||
126481562|NCT01976338|455063733|FG000|Overall Study|Adverse Event|5|||
126481563|NCT01976338|455063734|FG001|Overall Study|Adverse Event|1|||
126481564|NCT00777608|455063735|FG000|Overall Study|Lost to Follow-up|1|||
126481565|NCT00777608|455063736|FG001|Overall Study|Lost to Follow-up|1|||
126481566|NCT00777608|455063735|FG000|Overall Study|Withdrawal by Subject|1|||
126481567|NCT00777608|455063736|FG001|Overall Study|Withdrawal by Subject|3|||
126481568|NCT00777608|455063735|FG000|Overall Study|Protocol Violation|1|||
126481569|NCT00777608|455063736|FG001|Overall Study|Protocol Violation|0|||
126481570|NCT00777608|455063735|FG000|Overall Study|Investigator Decision|1|||
126481571|NCT00777608|455063736|FG001|Overall Study|Investigator Decision|2|||
126481572|NCT04213079|455063737|FG000|Overall Study|Lost to Follow-up|0|||
126481573|NCT04213079|455063738|FG001|Overall Study|Lost to Follow-up|2|||
126481574|NCT03766581|455063741|FG000|Randomization|Other reasons|2|||
126481575|NCT03766581|455063742|FG001|Randomization|Other reasons|1|||
126481576|NCT03766581|455063743|FG002|Randomization|Other reasons|0|||
126481577|NCT03766581|455063744|FG003|Randomization|Other reasons|1|||
126481578|NCT03766581|455063745|FG004|Randomization|Other reasons|0|||
126481579|NCT03766581|455063746|FG005|Randomization|Other reasons|0|||
126481580|NCT03766581|455063747|FG006|Randomization|Other reasons|0|||
126481581|NCT03766581|455063748|FG007|Randomization|Other reasons|0|||
126481582|NCT03766581|455063741|FG000|Randomization|Participant no longer meets study criteria|5|||
126481583|NCT03766581|455063742|FG001|Randomization|Participant no longer meets study criteria|3|||
126481584|NCT03766581|455063743|FG002|Randomization|Participant no longer meets study criteria|4|||
126481585|NCT03766581|455063744|FG003|Randomization|Participant no longer meets study criteria|0|||
126481586|NCT03766581|455063745|FG004|Randomization|Participant no longer meets study criteria|2|||
126481587|NCT03766581|455063746|FG005|Randomization|Participant no longer meets study criteria|3|||
126481588|NCT03766581|455063747|FG006|Randomization|Participant no longer meets study criteria|0|||
126481589|NCT03766581|455063748|FG007|Randomization|Participant no longer meets study criteria|1|||
126481590|NCT03766581|455063741|FG000|Randomization|Participant request to discontinue study treatment|1|||
126481591|NCT03766581|455063742|FG001|Randomization|Participant request to discontinue study treatment|0|||
126481592|NCT03766581|455063743|FG002|Randomization|Participant request to discontinue study treatment|0|||
126481593|NCT03766581|455063744|FG003|Randomization|Participant request to discontinue study treatment|0|||
126481594|NCT03766581|455063745|FG004|Randomization|Participant request to discontinue study treatment|1|||
126481595|NCT03766581|455063746|FG005|Randomization|Participant request to discontinue study treatment|2|||
126481596|NCT03766581|455063747|FG006|Randomization|Participant request to discontinue study treatment|0|||
126481597|NCT03766581|455063748|FG007|Randomization|Participant request to discontinue study treatment|0|||
126481598|NCT03766581|455063741|FG000|Randomization|Participant withdrew consent|1|||
126481599|NCT03766581|455063742|FG001|Randomization|Participant withdrew consent|0|||
126481600|NCT03766581|455063743|FG002|Randomization|Participant withdrew consent|1|||
126481601|NCT03766581|455063744|FG003|Randomization|Participant withdrew consent|2|||
126481602|NCT03766581|455063745|FG004|Randomization|Participant withdrew consent|1|||
126481603|NCT03766581|455063746|FG005|Randomization|Participant withdrew consent|1|||
126481604|NCT03766581|455063747|FG006|Randomization|Participant withdrew consent|0|||
126481605|NCT03766581|455063748|FG007|Randomization|Participant withdrew consent|0|||
126481606|NCT03766581|455063741|FG000|Treatment|Adverse Event|82|||
126481607|NCT03766581|455063742|FG001|Treatment|Adverse Event|44|||
126481608|NCT03766581|455063743|FG002|Treatment|Adverse Event|47|||
126481609|NCT03766581|455063744|FG003|Treatment|Adverse Event|46|||
126481610|NCT03766581|455063745|FG004|Treatment|Adverse Event|50|||
126481611|NCT03766581|455063746|FG005|Treatment|Adverse Event|77|||
126481612|NCT03766581|455063747|FG006|Treatment|Adverse Event|5|||
126481613|NCT03766581|455063748|FG007|Treatment|Adverse Event|2|||
126481614|NCT03766581|455063741|FG000|Treatment|Participant request to discontinue treatment|34|||
126481615|NCT03766581|455063742|FG001|Treatment|Participant request to discontinue treatment|6|||
126481616|NCT03766581|455063743|FG002|Treatment|Participant request to discontinue treatment|10|||
126481617|NCT03766581|455063744|FG003|Treatment|Participant request to discontinue treatment|10|||
126481618|NCT03766581|455063745|FG004|Treatment|Participant request to discontinue treatment|14|||
126481619|NCT03766581|455063746|FG005|Treatment|Participant request to discontinue treatment|15|||
126481620|NCT03766581|455063747|FG006|Treatment|Participant request to discontinue treatment|0|||
126481621|NCT03766581|455063748|FG007|Treatment|Participant request to discontinue treatment|1|||
126481622|NCT03766581|455063741|FG000|Treatment|Participant withdrew consent|11|||
126481623|NCT03766581|455063742|FG001|Treatment|Participant withdrew consent|4|||
126481624|NCT03766581|455063743|FG002|Treatment|Participant withdrew consent|5|||
126481625|NCT03766581|455063744|FG003|Treatment|Participant withdrew consent|5|||
126481626|NCT03766581|455063745|FG004|Treatment|Participant withdrew consent|4|||
126481627|NCT03766581|455063746|FG005|Treatment|Participant withdrew consent|4|||
126481628|NCT03766581|455063747|FG006|Treatment|Participant withdrew consent|0|||
126481629|NCT03766581|455063748|FG007|Treatment|Participant withdrew consent|0|||
126481630|NCT03766581|455063741|FG000|Treatment|Death|1|||
126481631|NCT03766581|455063742|FG001|Treatment|Death|0|||
126481632|NCT03766581|455063743|FG002|Treatment|Death|0|||
126481633|NCT03766581|455063744|FG003|Treatment|Death|0|||
126481634|NCT03766581|455063745|FG004|Treatment|Death|0|||
126481635|NCT03766581|455063746|FG005|Treatment|Death|0|||
126481636|NCT03766581|455063747|FG006|Treatment|Death|0|||
126481637|NCT03766581|455063748|FG007|Treatment|Death|0|||
126481638|NCT03766581|455063741|FG000|Treatment|Lost to Follow-up|1|||
126481639|NCT03766581|455063742|FG001|Treatment|Lost to Follow-up|0|||
126481640|NCT03766581|455063743|FG002|Treatment|Lost to Follow-up|0|||
126481641|NCT03766581|455063744|FG003|Treatment|Lost to Follow-up|1|||
126481642|NCT03766581|455063745|FG004|Treatment|Lost to Follow-up|0|||
126481643|NCT03766581|455063746|FG005|Treatment|Lost to Follow-up|0|||
126481644|NCT03766581|455063747|FG006|Treatment|Lost to Follow-up|0|||
126481645|NCT03766581|455063748|FG007|Treatment|Lost to Follow-up|0|||
126481646|NCT03766581|455063741|FG000|Treatment|Poor/Non compliance|2|||
126481647|NCT03766581|455063742|FG001|Treatment|Poor/Non compliance|2|||
126481648|NCT03766581|455063743|FG002|Treatment|Poor/Non compliance|1|||
126481649|NCT03766581|455063744|FG003|Treatment|Poor/Non compliance|1|||
126481650|NCT03766581|455063745|FG004|Treatment|Poor/Non compliance|1|||
126481651|NCT03766581|455063746|FG005|Treatment|Poor/Non compliance|1|||
126481652|NCT03766581|455063747|FG006|Treatment|Poor/Non compliance|0|||
126481653|NCT03766581|455063748|FG007|Treatment|Poor/Non compliance|0|||
126481654|NCT03766581|455063741|FG000|Treatment|Participant no longer meets study criteria|9|||
126481655|NCT03766581|455063742|FG001|Treatment|Participant no longer meets study criteria|1|||
126481656|NCT03766581|455063743|FG002|Treatment|Participant no longer meets study criteria|5|||
126481657|NCT03766581|455063744|FG003|Treatment|Participant no longer meets study criteria|4|||
126481658|NCT03766581|455063745|FG004|Treatment|Participant no longer meets study criteria|4|||
126481659|NCT03766581|455063746|FG005|Treatment|Participant no longer meets study criteria|4|||
126481660|NCT03766581|455063747|FG006|Treatment|Participant no longer meets study criteria|2|||
126481661|NCT03766581|455063748|FG007|Treatment|Participant no longer meets study criteria|0|||
126481662|NCT03766581|455063741|FG000|Treatment|Other reasons|13|||
126481663|NCT03766581|455063742|FG001|Treatment|Other reasons|8|||
126481664|NCT03766581|455063743|FG002|Treatment|Other reasons|3|||
126481665|NCT03766581|455063744|FG003|Treatment|Other reasons|7|||
126481666|NCT03766581|455063745|FG004|Treatment|Other reasons|3|||
126481667|NCT03766581|455063746|FG005|Treatment|Other reasons|3|||
126481668|NCT03766581|455063747|FG006|Treatment|Other reasons|0|||
126481669|NCT03766581|455063748|FG007|Treatment|Other reasons|0|||
126481670|NCT02732119|455063749|FG000|Phase I|Adverse Event|1|||
126481671|NCT02732119|455063750|FG001|Phase I|Adverse Event|3|||
126481672|NCT02732119|455063751|FG002|Phase I|Adverse Event|1|||
126481673|NCT02732119|455063752|FG003|Phase I|Adverse Event|0|||
126481674|NCT02732119|455063753|FG004|Phase I|Adverse Event|0|||
126481675|NCT02732119|455063749|FG000|Phase I|Progressive disease|7|||
126481676|NCT02732119|455063750|FG001|Phase I|Progressive disease|3|||
126481677|NCT02732119|455063751|FG002|Phase I|Progressive disease|2|||
126481678|NCT02732119|455063752|FG003|Phase I|Progressive disease|0|||
126481679|NCT02732119|455063753|FG004|Phase I|Progressive disease|0|||
126481680|NCT02732119|455063749|FG000|Phase I|Protocol deviation|0|||
126481681|NCT02732119|455063750|FG001|Phase I|Protocol deviation|1|||
126481682|NCT02732119|455063751|FG002|Phase I|Protocol deviation|0|||
126481683|NCT02732119|455063752|FG003|Phase I|Protocol deviation|0|||
126481684|NCT02732119|455063753|FG004|Phase I|Protocol deviation|0|||
126481685|NCT02732119|455063749|FG000|Phase I|Physician Decision|0|||
126481686|NCT02732119|455063750|FG001|Phase I|Physician Decision|3|||
126481687|NCT02732119|455063751|FG002|Phase I|Physician Decision|4|||
126481688|NCT02732119|455063752|FG003|Phase I|Physician Decision|0|||
126481689|NCT02732119|455063753|FG004|Phase I|Physician Decision|0|||
126481690|NCT02732119|455063749|FG000|Phase II|Adverse Event|0|||
126481691|NCT02732119|455063750|FG001|Phase II|Adverse Event|0|||
126481692|NCT02732119|455063751|FG002|Phase II|Adverse Event|0|||
126481693|NCT02732119|455063752|FG003|Phase II|Adverse Event|3|||
126481694|NCT02732119|455063753|FG004|Phase II|Adverse Event|3|||
126481695|NCT02732119|455063749|FG000|Phase II|Death|0|||
126481696|NCT02732119|455063750|FG001|Phase II|Death|0|||
126481697|NCT02732119|455063751|FG002|Phase II|Death|0|||
126481698|NCT02732119|455063752|FG003|Phase II|Death|1|||
126481699|NCT02732119|455063753|FG004|Phase II|Death|0|||
126481700|NCT02732119|455063749|FG000|Phase II|Progressive dissease|0|||
126481701|NCT02732119|455063750|FG001|Phase II|Progressive dissease|0|||
126481702|NCT02732119|455063751|FG002|Phase II|Progressive dissease|0|||
126481703|NCT02732119|455063752|FG003|Phase II|Progressive dissease|30|||
126481704|NCT02732119|455063753|FG004|Phase II|Progressive dissease|23|||
126481705|NCT02732119|455063749|FG000|Phase II|Study terminated by sponsor|0|||
126481706|NCT02732119|455063750|FG001|Phase II|Study terminated by sponsor|0|||
126481707|NCT02732119|455063751|FG002|Phase II|Study terminated by sponsor|0|||
126481708|NCT02732119|455063752|FG003|Phase II|Study terminated by sponsor|2|||
126481709|NCT02732119|455063753|FG004|Phase II|Study terminated by sponsor|2|||
126481710|NCT02732119|455063749|FG000|Phase II|Other|0|||
126481711|NCT02732119|455063750|FG001|Phase II|Other|0|||
126481712|NCT02732119|455063751|FG002|Phase II|Other|0|||
126481713|NCT02732119|455063752|FG003|Phase II|Other|2|||
126481714|NCT02732119|455063753|FG004|Phase II|Other|0|||
126481715|NCT02732119|455063749|FG000|Phase II|Physician Decision|0|||
126481716|NCT02732119|455063750|FG001|Phase II|Physician Decision|0|||
126481717|NCT02732119|455063751|FG002|Phase II|Physician Decision|0|||
126481718|NCT02732119|455063752|FG003|Phase II|Physician Decision|8|||
126481719|NCT02732119|455063753|FG004|Phase II|Physician Decision|5|||
126481720|NCT00520936|455063754|FG000|Overall Study|Physician Decision|0|||
126481721|NCT00520936|455063755|FG001|Overall Study|Physician Decision|2|||
126481722|NCT00520936|455063756|FG002|Overall Study|Physician Decision|1|||
126481723|NCT00520936|455063757|FG003|Overall Study|Physician Decision|0|||
126481724|NCT00520936|455063758|FG004|Overall Study|Physician Decision|0|||
126481725|NCT00520936|455063759|FG005|Overall Study|Physician Decision|0|||
126481726|NCT00520936|455063760|FG006|Overall Study|Physician Decision|0|||
126481727|NCT00520936|455063761|FG007|Overall Study|Physician Decision|0|||
126481728|NCT00520936|455063754|FG000|Overall Study|Withdrawal by Subject|0|||
126481729|NCT00520936|455063755|FG001|Overall Study|Withdrawal by Subject|0|||
126481730|NCT00520936|455063756|FG002|Overall Study|Withdrawal by Subject|0|||
126481731|NCT00520936|455063757|FG003|Overall Study|Withdrawal by Subject|0|||
126559215|NCT04736056|455340686|FG000|Overall Study|Physician Decision|1|||
126559216|NCT04736056|455340687|FG001|Overall Study|Physician Decision|0|||
126481732|NCT00520936|455063758|FG004|Overall Study|Withdrawal by Subject|0|||
126481733|NCT00520936|455063759|FG005|Overall Study|Withdrawal by Subject|0|||
126481734|NCT00520936|455063760|FG006|Overall Study|Withdrawal by Subject|0|||
126481735|NCT00520936|455063761|FG007|Overall Study|Withdrawal by Subject|1|||
126481736|NCT00520936|455063754|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
126481737|NCT00520936|455063755|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
126481738|NCT00520936|455063756|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
126481739|NCT00520936|455063757|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
126481740|NCT00520936|455063758|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
126481741|NCT00520936|455063759|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
126481742|NCT00520936|455063760|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
126481743|NCT00520936|455063761|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
126481744|NCT00520936|455063754|FG000|Overall Study|Death|0|||
126481745|NCT00520936|455063755|FG001|Overall Study|Death|0|||
126481746|NCT00520936|455063756|FG002|Overall Study|Death|0|||
126481747|NCT00520936|455063757|FG003|Overall Study|Death|0|||
126481748|NCT00520936|455063758|FG004|Overall Study|Death|0|||
126481749|NCT00520936|455063759|FG005|Overall Study|Death|0|||
126481750|NCT00520936|455063760|FG006|Overall Study|Death|1|||
126481751|NCT00520936|455063761|FG007|Overall Study|Death|0|||
126481752|NCT00520936|455063754|FG000|Overall Study|Protocol Violation|0|||
126481753|NCT00520936|455063755|FG001|Overall Study|Protocol Violation|1|||
126481754|NCT00520936|455063756|FG002|Overall Study|Protocol Violation|1|||
126481755|NCT00520936|455063757|FG003|Overall Study|Protocol Violation|0|||
126481756|NCT00520936|455063758|FG004|Overall Study|Protocol Violation|1|||
126481757|NCT00520936|455063759|FG005|Overall Study|Protocol Violation|0|||
126481758|NCT00520936|455063760|FG006|Overall Study|Protocol Violation|1|||
126481759|NCT00520936|455063761|FG007|Overall Study|Protocol Violation|0|||
126481760|NCT05275400|455063766|FG000|Treatment Period|Adverse Event|7|||
126481761|NCT05275400|455063767|FG001|Treatment Period|Adverse Event|1|||
126481762|NCT05275400|455063766|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
126481763|NCT05275400|455063767|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
126481764|NCT05275400|455063766|FG000|Treatment Period|Death|5|||
126481765|NCT05275400|455063767|FG001|Treatment Period|Death|2|||
126481766|NCT05275400|455063766|FG000|Treatment Period|Protocol Violation|1|||
126481767|NCT05275400|455063767|FG001|Treatment Period|Protocol Violation|0|||
126481768|NCT05275400|455063766|FG000|Treatment Period|Physician Decision|5|||
126481769|NCT05275400|455063767|FG001|Treatment Period|Physician Decision|4|||
126481770|NCT05275400|455063766|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
126481771|NCT05275400|455063767|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
126481772|NCT05275400|455063766|FG000|Treatment Period|Withdrawal by Subject|30|||
126481773|NCT05275400|455063767|FG001|Treatment Period|Withdrawal by Subject|12|||
126481774|NCT05275400|455063766|FG000|Treatment Period|Lost to Follow-up|1|||
126481775|NCT05275400|455063767|FG001|Treatment Period|Lost to Follow-up|5|||
126481776|NCT05275400|455063766|FG000|Treatment Period|Lack of Efficacy|1|||
126481777|NCT05275400|455063767|FG001|Treatment Period|Lack of Efficacy|0|||
126481778|NCT05275400|455063766|FG000|Treatment Period|Sponsor Decision|1|||
126481779|NCT05275400|455063767|FG001|Treatment Period|Sponsor Decision|0|||
126481780|NCT05275400|455063766|FG000|Follow-Up Period|Death|2|||
126481781|NCT05275400|455063767|FG001|Follow-Up Period|Death|0|||
126481782|NCT05275400|455063766|FG000|Follow-Up Period|Protocol Violation|1|||
126481783|NCT05275400|455063767|FG001|Follow-Up Period|Protocol Violation|0|||
126481784|NCT05275400|455063766|FG000|Follow-Up Period|Withdrawal by Subject|3|||
126481785|NCT05275400|455063767|FG001|Follow-Up Period|Withdrawal by Subject|0|||
126481786|NCT02585960|455063768|FG000|PK/Safety Assessment Period|Physician Decision|0|||
126481787|NCT02585960|455063769|FG001|PK/Safety Assessment Period|Physician Decision|1|||
126481788|NCT02585960|455063770|FG002|PK/Safety Assessment Period|Physician Decision|0|||
126481789|NCT02585960|455063768|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
126481790|NCT02585960|455063769|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
126481791|NCT02585960|455063770|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
126481792|NCT02585960|455063768|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
126481793|NCT02585960|455063769|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
126481794|NCT02585960|455063770|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
126481795|NCT02585960|455063768|FG000|PK/Safety Assessment Period|Other|4|||
126481796|NCT02585960|455063769|FG001|PK/Safety Assessment Period|Other|4|||
126481797|NCT02585960|455063770|FG002|PK/Safety Assessment Period|Other|0|||
126481798|NCT02585960|455063768|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
126481799|NCT02585960|455063769|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
126559217|NCT04736056|455340688|FG002|Overall Study|Physician Decision|1|||
126559218|NCT04736056|455340689|FG003|Overall Study|Physician Decision|0|||
126481800|NCT02585960|455063770|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
126481801|NCT02585960|455063768|FG000|PK/Safety Assessment Period|Screen Failure|0|||
126481802|NCT02585960|455063769|FG001|PK/Safety Assessment Period|Screen Failure|0|||
126481803|NCT02585960|455063770|FG002|PK/Safety Assessment Period|Screen Failure|1|||
126481804|NCT02585960|455063768|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
126481805|NCT02585960|455063769|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
126481806|NCT02585960|455063770|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
126481807|NCT02585960|455063768|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
126481808|NCT02585960|455063769|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
126481809|NCT02585960|455063770|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
126481810|NCT03639935|455063771|FG000|Overall Study|Death|3|||
126481811|NCT03639935|455063771|FG000|Overall Study|Adverse Event|1|||
126481812|NCT06333613|455063772|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
126481813|NCT03648541|455063775|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
126481814|NCT03648541|455063776|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
126481815|NCT03648541|455063775|FG000|Re-induction Period Only|Lack of Efficacy|7|||
126481816|NCT03648541|455063776|FG001|Re-induction Period Only|Lack of Efficacy|0|||
126481817|NCT03648541|455063775|FG000|Maintenance Period Only|Missing|0|||
126481818|NCT03648541|455063776|FG001|Maintenance Period Only|Missing|1|||
126481819|NCT03648541|455063775|FG000|Maintenance Period Only|Other not listed below|0|||
126481820|NCT03648541|455063776|FG001|Maintenance Period Only|Other not listed below|4|||
126481821|NCT03648541|455063775|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
126481822|NCT03648541|455063776|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
126481823|NCT03648541|455063775|FG000|Maintenance Period Only|Protocol Violation|0|||
126481824|NCT03648541|455063776|FG001|Maintenance Period Only|Protocol Violation|1|||
126481825|NCT03648541|455063775|FG000|Maintenance Period Only|Lack of Efficacy|0|||
126481826|NCT03648541|455063776|FG001|Maintenance Period Only|Lack of Efficacy|18|||
126481827|NCT03648541|455063775|FG000|Maintenance Period Only|Adverse Event|0|||
126481828|NCT03648541|455063776|FG001|Maintenance Period Only|Adverse Event|4|||
126481829|NCT03648541|455063775|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
126481830|NCT03648541|455063776|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
126481831|NCT02197247|455063779|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
126481832|NCT02197247|455063779|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
126481833|NCT02197247|455063779|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
126481834|NCT02197247|455063779|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
126481835|NCT02197247|455063779|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
126481836|NCT02197247|455063779|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
126481837|NCT02197247|455063779|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
126481838|NCT02197247|455063779|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
126481839|NCT01619423|455063780|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
126481840|NCT01619423|455063781|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
126481841|NCT01619423|455063782|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
126481842|NCT01619423|455063783|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
126481843|NCT02340975|455063793|FG000|Overall Study|Death|6|||
126481844|NCT02340975|455063794|FG001|Overall Study|Death|23|||
126481845|NCT02340975|455063795|FG002|Overall Study|Death|21|||
126481846|NCT02340975|455063796|FG003|Overall Study|Death|7|||
126481847|NCT02340975|455063797|FG004|Overall Study|Death|21|||
126481848|NCT02340975|455063798|FG005|Overall Study|Death|13|||
126481849|NCT02340975|455063793|FG000|Overall Study|Lost to Follow-up|0|||
126481850|NCT02340975|455063794|FG001|Overall Study|Lost to Follow-up|0|||
126481851|NCT02340975|455063795|FG002|Overall Study|Lost to Follow-up|0|||
126481852|NCT02340975|455063796|FG003|Overall Study|Lost to Follow-up|0|||
126481853|NCT02340975|455063797|FG004|Overall Study|Lost to Follow-up|2|||
126481854|NCT02340975|455063798|FG005|Overall Study|Lost to Follow-up|0|||
126481855|NCT02340975|455063793|FG000|Overall Study|Withdrawal by Subject|0|||
126481856|NCT02340975|455063794|FG001|Overall Study|Withdrawal by Subject|0|||
126481857|NCT02340975|455063795|FG002|Overall Study|Withdrawal by Subject|3|||
126481858|NCT02340975|455063796|FG003|Overall Study|Withdrawal by Subject|3|||
126481859|NCT02340975|455063797|FG004|Overall Study|Withdrawal by Subject|2|||
126481860|NCT02340975|455063798|FG005|Overall Study|Withdrawal by Subject|0|||
126481861|NCT02340975|455063793|FG000|Overall Study|Other|0|||
126481862|NCT02340975|455063794|FG001|Overall Study|Other|4|||
126481863|NCT02340975|455063795|FG002|Overall Study|Other|0|||
126481864|NCT02340975|455063796|FG003|Overall Study|Other|2|||
126481865|NCT02340975|455063797|FG004|Overall Study|Other|0|||
126481866|NCT02340975|455063798|FG005|Overall Study|Other|6|||
126481867|NCT02099708|455063806|FG000|Overall Study|Data Not Available|30|||
126481868|NCT02099708|455063806|FG000|Overall Study|Lost to Follow-up|141|||
126481869|NCT02099708|455063806|FG000|Overall Study|Other|29|||
126481870|NCT05466682|455063810|FG000|Overall Study|Withdrawal by Subject|0|||
126481871|NCT05466682|455063811|FG001|Overall Study|Withdrawal by Subject|2|||
126481872|NCT05466682|455063810|FG000|Overall Study|Lost to Follow-up|2|||
126481873|NCT05466682|455063811|FG001|Overall Study|Lost to Follow-up|1|||
126481874|NCT01697566|455063812|FG000|Overall Study|Withdrawal by Subject|0|||
126481875|NCT01697566|455063813|FG001|Overall Study|Withdrawal by Subject|0|||
126481876|NCT01697566|455063814|FG002|Overall Study|Withdrawal by Subject|1|||
126481877|NCT01697566|455063815|FG003|Overall Study|Withdrawal by Subject|1|||
126481878|NCT01697566|455063812|FG000|Overall Study|Final biopsy not obtained|0|||
126481879|NCT01697566|455063813|FG001|Overall Study|Final biopsy not obtained|0|||
126481880|NCT01697566|455063814|FG002|Overall Study|Final biopsy not obtained|1|||
126481881|NCT01697566|455063815|FG003|Overall Study|Final biopsy not obtained|0|||
126481882|NCT01930123|455063816|FG000|Overall Study|Adverse Event|1|||
126481883|NCT01930123|455063817|FG001|Overall Study|Adverse Event|0|||
126481884|NCT01930123|455063816|FG000|Overall Study|Physician Decision|21|||
126481885|NCT01930123|455063817|FG001|Overall Study|Physician Decision|8|||
126481886|NCT01930123|455063816|FG000|Overall Study|Withdrawal by Subject|1|||
126772401|NCT00000135|456122152|FG001|Overall Study|Death|14|||
126481887|NCT01930123|455063817|FG001|Overall Study|Withdrawal by Subject|0|||
126481888|NCT01447433|455063820|FG000|Overall Study|Lost to Follow-up|0|||
126481889|NCT01447433|455063821|FG001|Overall Study|Lost to Follow-up|2|||
126481890|NCT01447433|455063820|FG000|Overall Study|Withdrawal by Subject|3|||
126481891|NCT01447433|455063821|FG001|Overall Study|Withdrawal by Subject|3|||
126481892|NCT01447433|455063820|FG000|Overall Study|Protocol Violation|1|||
126481893|NCT01447433|455063821|FG001|Overall Study|Protocol Violation|1|||
126481894|NCT00036270|455063822|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
126481895|NCT00036270|455063823|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
126481896|NCT00036270|455063822|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
126481897|NCT00036270|455063823|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
126481898|NCT00036270|455063822|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
126481899|NCT00036270|455063823|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
126481900|NCT00036270|455063822|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
126481901|NCT00036270|455063823|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
126481902|NCT00036270|455063822|FG000|Study Treatment to 5 Year Report|Other|277|||
126481903|NCT00036270|455063823|FG001|Study Treatment to 5 Year Report|Other|288|||
126481904|NCT00036270|455063822|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
126481905|NCT00036270|455063823|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
126481906|NCT00036270|455063822|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
126559219|NCT02099539|455340696|FG000|Overall Study|Progressive Disease|3|||
126559220|NCT02099539|455340697|FG001|Overall Study|Progressive Disease|2|||
126772402|NCT02340078|456122153|FG000|Overall Study|Protocol Violation|1|||
126772403|NCT01311505|456122154|FG000|First Intervention Period|Protocol Violation|0|||
126772404|NCT01311505|456122155|FG001|First Intervention Period|Protocol Violation|1|||
126772405|NCT00567996|456122156|FG000|Overall Study|Adverse Event|18|||
126772406|NCT00567996|456122157|FG001|Overall Study|Adverse Event|16|||
126772407|NCT00567996|456122158|FG002|Overall Study|Adverse Event|13|||
126772408|NCT00567996|456122156|FG000|Overall Study|Protocol Deviation|9|||
126772409|NCT00567996|456122157|FG001|Overall Study|Protocol Deviation|11|||
126772410|NCT00567996|456122158|FG002|Overall Study|Protocol Deviation|13|||
126772411|NCT00567996|456122156|FG000|Overall Study|Withdrawal by Subject|8|||
126772412|NCT00567996|456122157|FG001|Overall Study|Withdrawal by Subject|12|||
126772413|NCT00567996|456122158|FG002|Overall Study|Withdrawal by Subject|22|||
126772414|NCT00567996|456122156|FG000|Overall Study|Abnormal Lab value(s)|2|||
126772415|NCT00567996|456122157|FG001|Overall Study|Abnormal Lab value(s)|1|||
126772416|NCT00567996|456122158|FG002|Overall Study|Abnormal Lab value(s)|2|||
126772417|NCT00567996|456122156|FG000|Overall Study|Abnormal test procedure result(s)|2|||
126772418|NCT00567996|456122157|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126772419|NCT00567996|456122158|FG002|Overall Study|Abnormal test procedure result(s)|1|||
126772420|NCT00567996|456122156|FG000|Overall Study|Lost to Follow-up|2|||
126772421|NCT00567996|456122157|FG001|Overall Study|Lost to Follow-up|5|||
126772422|NCT00567996|456122158|FG002|Overall Study|Lost to Follow-up|2|||
126772423|NCT00567996|456122156|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126772424|NCT00567996|456122157|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126772425|NCT00567996|456122158|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
126772426|NCT00567996|456122156|FG000|Overall Study|Administrative problems|1|||
126772427|NCT00567996|456122157|FG001|Overall Study|Administrative problems|1|||
126772428|NCT00567996|456122158|FG002|Overall Study|Administrative problems|0|||
126772429|NCT00567996|456122156|FG000|Overall Study|Death|1|||
126772430|NCT00567996|456122157|FG001|Overall Study|Death|0|||
126772431|NCT00567996|456122158|FG002|Overall Study|Death|2|||
126772432|NCT00567996|456122156|FG000|Overall Study|Patient's inability to use the device|0|||
126772433|NCT00567996|456122157|FG001|Overall Study|Patient's inability to use the device|1|||
126772434|NCT00567996|456122158|FG002|Overall Study|Patient's inability to use the device|0|||
126772435|NCT03022799|456122161|FG000|Overall Study|Adverse Event|0|||
126772436|NCT03022799|456122162|FG001|Overall Study|Adverse Event|0|||
126772437|NCT03022799|456122163|FG002|Overall Study|Adverse Event|0|||
126772438|NCT03022799|456122164|FG003|Overall Study|Adverse Event|0|||
126772439|NCT03022799|456122165|FG004|Overall Study|Adverse Event|0|||
126772440|NCT03022799|456122166|FG005|Overall Study|Adverse Event|0|||
126772441|NCT03022799|456122167|FG006|Overall Study|Adverse Event|0|||
126772442|NCT03022799|456122168|FG007|Overall Study|Adverse Event|0|||
126772443|NCT03022799|456122169|FG008|Overall Study|Adverse Event|0|||
126559221|NCT02099539|455340698|FG002|Overall Study|Progressive Disease|2|||
126559222|NCT02099539|455340699|FG003|Overall Study|Progressive Disease|1|||
126772444|NCT03022799|456122170|FG009|Overall Study|Adverse Event|1|||
126772445|NCT03022799|456122171|FG010|Overall Study|Adverse Event|1|||
126772446|NCT03022799|456122172|FG011|Overall Study|Adverse Event|0|||
126772447|NCT03022799|456122173|FG012|Overall Study|Adverse Event|0|||
126772448|NCT00883129|456122174|FG000|Overall Study|Adverse Event|7|||
126772449|NCT00883129|456122175|FG001|Overall Study|Adverse Event|15|||
126772450|NCT00883129|456122174|FG000|Overall Study|Withdrawal by Subject|8|||
126772451|NCT00883129|456122175|FG001|Overall Study|Withdrawal by Subject|9|||
126772452|NCT00883129|456122174|FG000|Overall Study|Non-compliance|3|||
126481907|NCT00036270|455063823|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
126481908|NCT00036270|455063822|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
126481909|NCT00036270|455063823|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
126481910|NCT00036270|455063822|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
126481911|NCT00036270|455063823|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
126481912|NCT00036270|455063822|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
126481913|NCT00036270|455063823|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
126481914|NCT00036270|455063822|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
126481915|NCT00036270|455063823|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
126481916|NCT01578187|455063824|FG000|Usability Phase|Withdrawal by Subject|1|||
126481917|NCT01964430|455063825|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
126481918|NCT01964430|455063826|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
126481919|NCT01964430|455063825|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
126481920|NCT01964430|455063826|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
126481921|NCT01964430|455063825|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
126481922|NCT01964430|455063826|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
126481923|NCT01964430|455063825|FG000|Treatment Period|Adverse Event|71|||
126481924|NCT01964430|455063826|FG001|Treatment Period|Adverse Event|37|||
126481925|NCT01964430|455063825|FG000|Treatment Period|Withdrawal by Subject|36|||
126481926|NCT01964430|455063826|FG001|Treatment Period|Withdrawal by Subject|27|||
126481927|NCT01964430|455063825|FG000|Treatment Period|Death|1|||
126481928|NCT01964430|455063826|FG001|Treatment Period|Death|3|||
126481929|NCT01964430|455063825|FG000|Treatment Period|Protocol Deviation|0|||
126481930|NCT01964430|455063826|FG001|Treatment Period|Protocol Deviation|1|||
126481931|NCT01964430|455063825|FG000|Treatment Period|Physician Decision|5|||
126481932|NCT01964430|455063826|FG001|Treatment Period|Physician Decision|4|||
126481933|NCT01964430|455063825|FG000|Treatment Period|Disease Relapse|28|||
126481934|NCT01964430|455063826|FG001|Treatment Period|Disease Relapse|38|||
126481935|NCT01964430|455063825|FG000|Treatment Period|Other reasons|1|||
126481936|NCT01964430|455063826|FG001|Treatment Period|Other reasons|3|||
126481937|NCT02516163|455063827|FG000|Overall Study|Withdrawal by Subject|1|||
126481938|NCT02516163|455063827|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
126481939|NCT02516163|455063827|FG000|Overall Study|Unfit/delay in surgery|3|||
126481940|NCT02516163|455063827|FG000|Overall Study|Use of incorrect measurement technique|5|||
126481941|NCT02516163|455063827|FG000|Overall Study|Data not recorded|2|||
126481942|NCT02516163|455063827|FG000|Overall Study|MRI contraindication exclusion|6|||
126481943|NCT02801396|455063828|FG000|Period 1|Withdrawal by Subject|0|||
126481944|NCT02801396|455063829|FG001|Period 1|Withdrawal by Subject|0|||
126481945|NCT02801396|455063830|FG002|Period 1|Withdrawal by Subject|0|||
126481946|NCT02801396|455063831|FG003|Period 1|Withdrawal by Subject|0|||
126481947|NCT02801396|455063832|FG004|Period 1|Withdrawal by Subject|1|||
126481948|NCT02801396|455063833|FG005|Period 1|Withdrawal by Subject|0|||
126481949|NCT01658072|455063836|FG000|Overall Study|Protocol Violation|4|||
126481950|NCT01658072|455063837|FG001|Overall Study|Protocol Violation|2|||
126481951|NCT03208244|455063838|FG000|Overall Study|Death|1|||
126481952|NCT01709162|455063839|FG000|Overall Study|Disease progression|3|||
126481953|NCT01709162|455063840|FG001|Overall Study|Disease progression|3|||
126481954|NCT01709162|455063839|FG000|Overall Study|Study drug toxicity|2|||
126481955|NCT01709162|455063840|FG001|Overall Study|Study drug toxicity|0|||
126481956|NCT01709162|455063839|FG000|Overall Study|Administrative reason by sponsor|0|||
126481957|NCT01709162|455063840|FG001|Overall Study|Administrative reason by sponsor|1|||
126481958|NCT01709162|455063839|FG000|Overall Study|Other|1|||
126481959|NCT01709162|455063840|FG001|Overall Study|Other|0|||
126481960|NCT01709162|455063839|FG000|Overall Study|Withdrawal by Subject|0|||
126481961|NCT01709162|455063840|FG001|Overall Study|Withdrawal by Subject|1|||
126481962|NCT02405780|455063848|FG000|Period I|Adverse Event|8|||
126481963|NCT02405780|455063849|FG001|Period I|Adverse Event|0|||
126481964|NCT02405780|455063850|FG002|Period I|Adverse Event|3|||
126481965|NCT02405780|455063851|FG003|Period I|Adverse Event|7|||
126481966|NCT02405780|455063848|FG000|Period I|Medical reasons|1|||
126481967|NCT02405780|455063849|FG001|Period I|Medical reasons|1|||
126481968|NCT02405780|455063850|FG002|Period I|Medical reasons|0|||
126481969|NCT02405780|455063851|FG003|Period I|Medical reasons|1|||
126481970|NCT02405780|455063848|FG000|Period I|Screening Failure|1|||
126481971|NCT02405780|455063849|FG001|Period I|Screening Failure|0|||
126481972|NCT02405780|455063850|FG002|Period I|Screening Failure|1|||
126481973|NCT02405780|455063851|FG003|Period I|Screening Failure|0|||
126481974|NCT02405780|455063848|FG000|Period I|Withdrawal by Subject|9|||
126481975|NCT02405780|455063849|FG001|Period I|Withdrawal by Subject|1|||
126481976|NCT02405780|455063850|FG002|Period I|Withdrawal by Subject|3|||
126481977|NCT02405780|455063851|FG003|Period I|Withdrawal by Subject|4|||
126481978|NCT02405780|455063848|FG000|Period I|Non-compliance with study procedures|8|||
126481979|NCT02405780|455063849|FG001|Period I|Non-compliance with study procedures|6|||
126481980|NCT02405780|455063850|FG002|Period I|Non-compliance with study procedures|8|||
126481981|NCT02405780|455063851|FG003|Period I|Non-compliance with study procedures|11|||
126481982|NCT02405780|455063848|FG000|Period II|Adverse Event|3|||
126722505|NCT03725202|455934427|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
126722506|NCT03725202|455934428|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
126722507|NCT03725202|455934429|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
126722508|NCT03725202|455934430|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
126722509|NCT03725202|455934431|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
126722510|NCT03725202|455934432|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
126722511|NCT03725202|455934425|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
126722512|NCT03725202|455934426|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
126722513|NCT03725202|455934427|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
126722514|NCT03725202|455934428|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
126722515|NCT03725202|455934429|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
126722516|NCT03725202|455934430|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
126722517|NCT03725202|455934431|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
126722518|NCT03725202|455934432|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
126722519|NCT03725202|455934425|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126722520|NCT03725202|455934426|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126722521|NCT03725202|455934427|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126722522|NCT03725202|455934428|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126722523|NCT03725202|455934429|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126722524|NCT03725202|455934430|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126722525|NCT03725202|455934431|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
126722526|NCT03725202|455934432|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
126722527|NCT03725202|455934425|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126722528|NCT03725202|455934426|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126722529|NCT03725202|455934427|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126722530|NCT03725202|455934428|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126722531|NCT03725202|455934429|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126722532|NCT03725202|455934430|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
126722533|NCT03725202|455934431|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126722534|NCT03725202|455934432|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
126722535|NCT03725202|455934425|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
126722536|NCT03725202|455934426|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
126722537|NCT03725202|455934427|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
126722538|NCT03725202|455934428|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
126722539|NCT03725202|455934429|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
126722540|NCT03725202|455934430|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
126722541|NCT03725202|455934431|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
126722542|NCT03725202|455934432|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
126722543|NCT01328249|455934435|FG000|Overall Study|Adverse Event|3|||
126722544|NCT01328249|455934436|FG001|Overall Study|Adverse Event|0|||
126722545|NCT01328249|455934435|FG000|Overall Study|Disease progression|1|||
126722546|NCT01328249|455934436|FG001|Overall Study|Disease progression|0|||
126722547|NCT01328249|455934435|FG000|Overall Study|Withdrawal by Subject|1|||
126722548|NCT01328249|455934436|FG001|Overall Study|Withdrawal by Subject|1|||
126722549|NCT01328249|455934435|FG000|Overall Study|Moved before end of treatment visit|1|||
126722550|NCT01328249|455934436|FG001|Overall Study|Moved before end of treatment visit|0|||
126722551|NCT01328249|455934435|FG000|Overall Study|Subject choice|1|||
126722552|NCT01328249|455934436|FG001|Overall Study|Subject choice|1|||
126722553|NCT01328249|455934435|FG000|Overall Study|Protocol Violation|0|||
126722554|NCT01328249|455934436|FG001|Overall Study|Protocol Violation|1|||
126722555|NCT01215734|455934437|FG000|Overall Study|Death|0|||
126722556|NCT01215734|455934438|FG001|Overall Study|Death|1|||
126722557|NCT01716533|455934439|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
126722558|NCT01716533|455934440|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
126722559|NCT01716533|455934441|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
126722560|NCT01716533|455934442|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
126722561|NCT01716533|455934439|FG000|Overall Study|Withdrawal by Subject|0|||
126722562|NCT01716533|455934440|FG001|Overall Study|Withdrawal by Subject|0|||
126722563|NCT01716533|455934441|FG002|Overall Study|Withdrawal by Subject|0|||
126722564|NCT01716533|455934442|FG003|Overall Study|Withdrawal by Subject|5|||
126722565|NCT01716533|455934439|FG000|Overall Study|Death|0|||
126559223|NCT02099539|455340700|FG004|Overall Study|Progressive Disease|4|||
126722566|NCT01716533|455934440|FG001|Overall Study|Death|0|||
126722567|NCT01716533|455934441|FG002|Overall Study|Death|0|||
126722568|NCT01716533|455934442|FG003|Overall Study|Death|2|||
126722569|NCT01716533|455934439|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
126722570|NCT01716533|455934440|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
126722571|NCT01716533|455934441|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
126722572|NCT01716533|455934442|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
126722573|NCT00745368|455934445|FG000|Overall Study|Unable to provide sample|3|||
126481983|NCT02405780|455063849|FG001|Period II|Adverse Event|5|||
126481984|NCT02405780|455063850|FG002|Period II|Adverse Event|4|||
126481985|NCT02405780|455063851|FG003|Period II|Adverse Event|11|||
126481986|NCT02405780|455063848|FG000|Period II|Medical reason|0|||
126481987|NCT02405780|455063849|FG001|Period II|Medical reason|1|||
126481988|NCT02405780|455063850|FG002|Period II|Medical reason|0|||
126481989|NCT02405780|455063851|FG003|Period II|Medical reason|0|||
126481990|NCT02405780|455063848|FG000|Period II|Pregnancy|0|||
126481991|NCT02405780|455063849|FG001|Period II|Pregnancy|0|||
126481992|NCT02405780|455063850|FG002|Period II|Pregnancy|1|||
126481993|NCT02405780|455063851|FG003|Period II|Pregnancy|0|||
126481994|NCT02405780|455063848|FG000|Period II|Withdrawal by Subject|7|||
126481995|NCT02405780|455063849|FG001|Period II|Withdrawal by Subject|4|||
126481996|NCT02405780|455063850|FG002|Period II|Withdrawal by Subject|0|||
126481997|NCT02405780|455063851|FG003|Period II|Withdrawal by Subject|3|||
126481998|NCT02405780|455063848|FG000|Period II|Non-compliance with study procedures|5|||
126481999|NCT02405780|455063849|FG001|Period II|Non-compliance with study procedures|2|||
126482000|NCT02405780|455063850|FG002|Period II|Non-compliance with study procedures|7|||
126482001|NCT02405780|455063851|FG003|Period II|Non-compliance with study procedures|4|||
126482002|NCT01654536|455063852|FG000|Overall Study|Lost to Follow-up|5|||
126482003|NCT01654536|455063853|FG001|Overall Study|Lost to Follow-up|5|||
126482004|NCT01654536|455063852|FG000|Overall Study|Physician Decision|12|||
126482005|NCT01654536|455063853|FG001|Overall Study|Physician Decision|8|||
126482006|NCT01654536|455063852|FG000|Overall Study|Withdrawal by Subject|27|||
126482007|NCT01654536|455063853|FG001|Overall Study|Withdrawal by Subject|25|||
126482008|NCT03736447|455063860|FG000|Overall Study|Adverse Event|5|||
126482009|NCT03736447|455063861|FG001|Overall Study|Adverse Event|1|||
126482010|NCT03736447|455063860|FG000|Overall Study|Withdrawal by Subject|5|||
126482011|NCT03736447|455063861|FG001|Overall Study|Withdrawal by Subject|1|||
126482012|NCT03736447|455063860|FG000|Overall Study|Lost to Follow-up|1|||
126482013|NCT03736447|455063861|FG001|Overall Study|Lost to Follow-up|0|||
126482014|NCT03736447|455063860|FG000|Overall Study|Physician Decision|1|||
126482015|NCT03736447|455063861|FG001|Overall Study|Physician Decision|0|||
126482016|NCT03736447|455063860|FG000|Overall Study|Continued commitment to study treatment|3|||
126482017|NCT03736447|455063861|FG001|Overall Study|Continued commitment to study treatment|0|||
126482018|NCT03736447|455063860|FG000|Overall Study|Taste aversion to study product|0|||
126482019|NCT03736447|455063861|FG001|Overall Study|Taste aversion to study product|1|||
126482020|NCT02619175|455063862|FG000|Overall Study|Withdrawal by Subject|1|||
126482021|NCT02619175|455063863|FG001|Overall Study|Withdrawal by Subject|0|||
126482022|NCT02619175|455063862|FG000|Overall Study|foot pain|1|||
126482023|NCT02619175|455063863|FG001|Overall Study|foot pain|0|||
126482024|NCT01473836|455065606|FG000|Overall Study|Adverse Event|4|||
126482025|NCT01473836|455065606|FG000|Overall Study|Lack of Efficacy|1|||
126482026|NCT01473836|455065606|FG000|Overall Study|Does not meet entrance criteria|1|||
126482027|NCT03364023|455065607|FG000|Overall Study|Lost to Follow-up|3|||
126482028|NCT03364023|455065607|FG000|Overall Study|Death|14|||
126482029|NCT00105469|455065622|FG000|Overall Study|Adverse Event|9|||
126482030|NCT00105469|455065623|FG001|Overall Study|Adverse Event|8|||
126482031|NCT00105469|455065622|FG000|Overall Study|Protocol Violation|4|||
126482032|NCT00105469|455065623|FG001|Overall Study|Protocol Violation|0|||
126482033|NCT00105469|455065622|FG000|Overall Study|Withdrawal by Subject|2|||
126482034|NCT00105469|455065623|FG001|Overall Study|Withdrawal by Subject|3|||
126482035|NCT00105469|455065622|FG000|Overall Study|Lost to Follow-up|1|||
126482036|NCT00105469|455065623|FG001|Overall Study|Lost to Follow-up|0|||
126482037|NCT00105469|455065622|FG000|Overall Study|Lack of Efficacy|2|||
126482038|NCT00105469|455065623|FG001|Overall Study|Lack of Efficacy|0|||
126482039|NCT00105469|455065622|FG000|Overall Study|Other Reason|4|||
126482040|NCT00105469|455065623|FG001|Overall Study|Other Reason|0|||
126482041|NCT00599924|455065624|FG000|Overall Study|Lack of Efficacy|3|||
126482042|NCT00599924|455065625|FG001|Overall Study|Lack of Efficacy|5|||
126482043|NCT00599924|455065626|FG002|Overall Study|Lack of Efficacy|1|||
126482044|NCT00599924|455065627|FG003|Overall Study|Lack of Efficacy|2|||
126482045|NCT00599924|455065628|FG004|Overall Study|Lack of Efficacy|3|||
126482046|NCT00599924|455065629|FG005|Overall Study|Lack of Efficacy|2|||
126482047|NCT00599924|455065630|FG006|Overall Study|Lack of Efficacy|0|||
126482048|NCT00599924|455065624|FG000|Overall Study|Adverse Event|0|||
126482049|NCT00599924|455065625|FG001|Overall Study|Adverse Event|0|||
126482050|NCT00599924|455065626|FG002|Overall Study|Adverse Event|0|||
126482051|NCT00599924|455065627|FG003|Overall Study|Adverse Event|2|||
126482052|NCT00599924|455065628|FG004|Overall Study|Adverse Event|0|||
126482053|NCT00599924|455065629|FG005|Overall Study|Adverse Event|0|||
126482054|NCT00599924|455065630|FG006|Overall Study|Adverse Event|2|||
126482055|NCT00599924|455065624|FG000|Overall Study|Death|0|||
126482056|NCT00599924|455065625|FG001|Overall Study|Death|0|||
126482057|NCT00599924|455065626|FG002|Overall Study|Death|0|||
126482058|NCT00599924|455065627|FG003|Overall Study|Death|2|||
126482059|NCT00599924|455065628|FG004|Overall Study|Death|0|||
126482060|NCT00599924|455065629|FG005|Overall Study|Death|2|||
126482061|NCT00599924|455065630|FG006|Overall Study|Death|1|||
126482062|NCT00599924|455065624|FG000|Overall Study|Protocol Violation|0|||
126482063|NCT00599924|455065625|FG001|Overall Study|Protocol Violation|0|||
126482064|NCT00599924|455065626|FG002|Overall Study|Protocol Violation|0|||
126482065|NCT00599924|455065627|FG003|Overall Study|Protocol Violation|1|||
126482066|NCT00599924|455065628|FG004|Overall Study|Protocol Violation|0|||
126482067|NCT00599924|455065629|FG005|Overall Study|Protocol Violation|0|||
126482068|NCT00599924|455065630|FG006|Overall Study|Protocol Violation|0|||
126482069|NCT00599924|455065624|FG000|Overall Study|Withdrawal by Subject|0|||
126482070|NCT00599924|455065625|FG001|Overall Study|Withdrawal by Subject|0|||
126482071|NCT00599924|455065626|FG002|Overall Study|Withdrawal by Subject|1|||
126482072|NCT00599924|455065627|FG003|Overall Study|Withdrawal by Subject|0|||
126482073|NCT00599924|455065628|FG004|Overall Study|Withdrawal by Subject|1|||
126482074|NCT00599924|455065629|FG005|Overall Study|Withdrawal by Subject|0|||
126482075|NCT00599924|455065630|FG006|Overall Study|Withdrawal by Subject|0|||
126482076|NCT00599924|455065624|FG000|Overall Study|Other|0|||
126482077|NCT00599924|455065625|FG001|Overall Study|Other|0|||
126482078|NCT00599924|455065626|FG002|Overall Study|Other|0|||
126482079|NCT00599924|455065627|FG003|Overall Study|Other|1|||
126482080|NCT00599924|455065628|FG004|Overall Study|Other|2|||
126482081|NCT00599924|455065629|FG005|Overall Study|Other|0|||
126482082|NCT00599924|455065630|FG006|Overall Study|Other|2|||
126482083|NCT01806298|455065631|FG000|Overall Study|Adverse Event|3|||
126482084|NCT01806298|455065631|FG000|Overall Study|Protocol Non-compliance|1|||
126482085|NCT01806298|455065631|FG000|Overall Study|Withdrawal by Subject|1|||
126482086|NCT01806298|455065631|FG000|Overall Study|Other|5|||
126482087|NCT02601469|455065632|FG000|Overall Study|Enrolled in Error|1|||
126482088|NCT02601469|455065633|FG001|Overall Study|Enrolled in Error|0|||
126482089|NCT02820753|455065634|FG000|2 Month|Withdrawal by Subject|3|||
126482090|NCT02820753|455065635|FG001|2 Month|Withdrawal by Subject|3|||
126482091|NCT02820753|455065634|FG000|2 Month|Lost to Follow-up|24|||
126482092|NCT02820753|455065635|FG001|2 Month|Lost to Follow-up|26|||
126482093|NCT02820753|455065634|FG000|2 Month|Stopped per NIH Hold|51|||
126482094|NCT02820753|455065635|FG001|2 Month|Stopped per NIH Hold|13|||
126482095|NCT02820753|455065634|FG000|6 Month|Withdrawal by Subject|2|||
126482096|NCT02820753|455065635|FG001|6 Month|Withdrawal by Subject|2|||
126482097|NCT02820753|455065634|FG000|6 Month|Lost to Follow-up|20|||
126482098|NCT02820753|455065635|FG001|6 Month|Lost to Follow-up|27|||
126482099|NCT02820753|455065634|FG000|6 Month|Stopped per NIH Hold|81|||
126482100|NCT02820753|455065635|FG001|6 Month|Stopped per NIH Hold|81|||
126482101|NCT02820753|455065634|FG000|6 Month|Death|0|||
126482102|NCT02820753|455065635|FG001|6 Month|Death|1|||
126482103|NCT02161731|455065639|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
126482104|NCT02161731|455065640|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
126482105|NCT02161731|455065639|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
126482106|NCT02161731|455065640|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
126482107|NCT01408485|455065641|FG000|Overall Study|Withdrawal by Subject|21|||
126482108|NCT00062374|455065651|FG000|Overall Study|Not treated|12|||
126482109|NCT00840450|455065658|FG000|Overall Study|Adverse Event|1|||
126482110|NCT00840450|455065658|FG000|Overall Study|Lack of Efficacy|2|||
126482111|NCT00617123|455065659|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
126482112|NCT00617123|455065660|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
126482113|NCT00617123|455065659|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
126482114|NCT00617123|455065660|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
126482115|NCT00617123|455065659|FG000|Referral Screening Period|Adverse Event|0|||
126482116|NCT00617123|455065660|FG001|Referral Screening Period|Adverse Event|1|||
126482117|NCT00617123|455065659|FG000|Study Treatment Period|Withdrawal by Subject|8|||
126482118|NCT00617123|455065660|FG001|Study Treatment Period|Withdrawal by Subject|12|||
126482119|NCT00617123|455065659|FG000|Study Treatment Period|Adverse Event|7|||
126482120|NCT00617123|455065660|FG001|Study Treatment Period|Adverse Event|3|||
126482121|NCT00617123|455065659|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
126482122|NCT00617123|455065660|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
126482123|NCT00617123|455065659|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
126482124|NCT00617123|455065660|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
126482125|NCT00133952|455065662|FG000|Overall Study|Adverse Event|1|||
126482126|NCT00133952|455065663|FG001|Overall Study|Adverse Event|2|||
126482127|NCT00133952|455065662|FG000|Overall Study|Death|3|||
126482128|NCT00133952|455065663|FG001|Overall Study|Death|2|||
126482129|NCT00133952|455065662|FG000|Overall Study|Lost to Follow-up|9|||
126482130|NCT00133952|455065663|FG001|Overall Study|Lost to Follow-up|14|||
126482131|NCT00133952|455065662|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
126482132|NCT00133952|455065663|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
126482133|NCT00133952|455065662|FG000|Overall Study|Protocol Violation|1|||
126482134|NCT00133952|455065663|FG001|Overall Study|Protocol Violation|1|||
126482135|NCT00133952|455065662|FG000|Overall Study|Withdrawal by Subject|20|||
126482136|NCT00133952|455065663|FG001|Overall Study|Withdrawal by Subject|4|||
126482137|NCT00133952|455065662|FG000|Overall Study|Physician Decision|4|||
126482138|NCT00133952|455065663|FG001|Overall Study|Physician Decision|3|||
126482139|NCT00133952|455065662|FG000|Overall Study|Sponsor Decision|0|||
126482140|NCT00133952|455065663|FG001|Overall Study|Sponsor Decision|1|||
126482141|NCT02170298|455065664|FG000|Overall Study|Withdrawal by Subject|0|||
126482142|NCT02170298|455065665|FG001|Overall Study|Withdrawal by Subject|1|||
126482143|NCT02170298|455065664|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
126482144|NCT02170298|455065665|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
126482145|NCT00003479|455065668|FG000|Overall Study|Not evaluable|3|||
126482146|NCT02128113|455065669|FG000|Overall Study|Withdrawal by Subject|3|||
126482147|NCT02128113|455065670|FG001|Overall Study|Withdrawal by Subject|1|||
126482148|NCT02128113|455065671|FG002|Overall Study|Withdrawal by Subject|0|||
126482149|NCT02128113|455065669|FG000|Overall Study|Protocol Violation|0|||
126482150|NCT02128113|455065670|FG001|Overall Study|Protocol Violation|1|||
126482151|NCT02128113|455065671|FG002|Overall Study|Protocol Violation|0|||
126482152|NCT02128113|455065669|FG000|Overall Study|Surgery cancelled|0|||
126482153|NCT02128113|455065670|FG001|Overall Study|Surgery cancelled|1|||
126482154|NCT02128113|455065671|FG002|Overall Study|Surgery cancelled|0|||
126482155|NCT02128113|455065669|FG000|Overall Study|Adverse Event|0|||
126482156|NCT02128113|455065670|FG001|Overall Study|Adverse Event|0|||
126482157|NCT02128113|455065671|FG002|Overall Study|Adverse Event|1|||
126482158|NCT01061177|455065672|FG000|Overall Study|Adverse Event|117|||
126482159|NCT01061177|455065672|FG000|Overall Study|Withdrawal by Subject|27|||
126482160|NCT01061177|455065672|FG000|Overall Study|Disease progression|17|||
126482161|NCT01061177|455065672|FG000|Overall Study|Protocol Violation|11|||
126482162|NCT01061177|455065672|FG000|Overall Study|Lost to Follow-up|9|||
126482163|NCT01061177|455065672|FG000|Overall Study|New cancer therapy|9|||
126482164|NCT01061177|455065672|FG000|Overall Study|Abnormal laboratory values|6|||
126482165|NCT01061177|455065672|FG000|Overall Study|Abnormal test procedure results|4|||
126482166|NCT01061177|455065672|FG000|Overall Study|Administratie problems|4|||
126482167|NCT01061177|455065672|FG000|Overall Study|Death|4|||
126482168|NCT00299104|455065673|FG000|Treatment Period|Adverse Event|14|||
126482169|NCT00299104|455065674|FG001|Treatment Period|Adverse Event|9|||
126482170|NCT00299104|455065675|FG002|Treatment Period|Adverse Event|7|||
126482171|NCT00299104|455065673|FG000|Treatment Period|Death|1|||
126482172|NCT00299104|455065674|FG001|Treatment Period|Death|1|||
126482173|NCT00299104|455065675|FG002|Treatment Period|Death|1|||
126482174|NCT00299104|455065673|FG000|Treatment Period|Insufficient therapeutic response|34|||
126482175|NCT00299104|455065674|FG001|Treatment Period|Insufficient therapeutic response|13|||
126482176|NCT00299104|455065675|FG002|Treatment Period|Insufficient therapeutic response|8|||
126482177|NCT00299104|455065673|FG000|Treatment Period|Failure to return|9|||
126482178|NCT00299104|455065674|FG001|Treatment Period|Failure to return|8|||
126482179|NCT00299104|455065675|FG002|Treatment Period|Failure to return|8|||
126482180|NCT00299104|455065673|FG000|Treatment Period|Violation of selection criteria|1|||
126482181|NCT00299104|455065674|FG001|Treatment Period|Violation of selection criteria|2|||
126482182|NCT00299104|455065675|FG002|Treatment Period|Violation of selection criteria|0|||
126482183|NCT00299104|455065673|FG000|Treatment Period|Protocol Violation|1|||
126482184|NCT00299104|455065674|FG001|Treatment Period|Protocol Violation|1|||
126482185|NCT00299104|455065675|FG002|Treatment Period|Protocol Violation|0|||
126482186|NCT00299104|455065673|FG000|Treatment Period|Refused treatment|9|||
126482187|NCT00299104|455065674|FG001|Treatment Period|Refused treatment|2|||
126482188|NCT00299104|455065675|FG002|Treatment Period|Refused treatment|2|||
126482189|NCT00299104|455065673|FG000|Treatment Period|Withdrew consent|14|||
126482190|NCT00299104|455065674|FG001|Treatment Period|Withdrew consent|19|||
126482191|NCT00299104|455065675|FG002|Treatment Period|Withdrew consent|9|||
126482192|NCT00299104|455065673|FG000|Treatment Period|Administrative reasons|106|||
126482193|NCT00299104|455065674|FG001|Treatment Period|Administrative reasons|120|||
126482194|NCT00299104|455065675|FG002|Treatment Period|Administrative reasons|137|||
126482195|NCT00299104|455065673|FG000|Safety Follow-Up (SFU) Period|Death|3|||
126482196|NCT00299104|455065674|FG001|Safety Follow-Up (SFU) Period|Death|2|||
126482197|NCT00299104|455065675|FG002|Safety Follow-Up (SFU) Period|Death|1|||
126482198|NCT00299104|455065673|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
126482199|NCT00299104|455065674|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
126482200|NCT00299104|455065675|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
126482201|NCT00299104|455065673|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
126482202|NCT00299104|455065674|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
126482203|NCT00299104|455065675|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
126482204|NCT00299104|455065673|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
126482205|NCT00299104|455065674|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
126482206|NCT00299104|455065675|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
126482207|NCT00299104|455065673|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
126482208|NCT00299104|455065674|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
126482209|NCT00299104|455065675|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
126482210|NCT00299104|455065673|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
126482211|NCT00299104|455065674|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
126482212|NCT00299104|455065675|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
126482213|NCT00299104|455065673|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
126482214|NCT00299104|455065674|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
126482215|NCT00299104|455065675|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
126482216|NCT00299104|455065673|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
126482217|NCT00299104|455065674|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
126482218|NCT00299104|455065675|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
126482219|NCT00587054|455065685|FG000|Overall Study|Patient not treated|9|||
126482220|NCT00601458|455065692|FG000|Overall Study|Dosing Error|1|||
126482221|NCT00601458|455065693|FG001|Overall Study|Dosing Error|0|||
126482222|NCT00601458|455065694|FG002|Overall Study|Dosing Error|0|||
126482223|NCT00601458|455065692|FG000|Overall Study|Incomplete Data|0|||
126482224|NCT00601458|455065693|FG001|Overall Study|Incomplete Data|2|||
126482225|NCT00601458|455065694|FG002|Overall Study|Incomplete Data|0|||
126482226|NCT00601458|455065692|FG000|Overall Study|Protocol Violation|3|||
126482227|NCT00601458|455065693|FG001|Overall Study|Protocol Violation|2|||
126482228|NCT00601458|455065694|FG002|Overall Study|Protocol Violation|1|||
126482229|NCT00601458|455065692|FG000|Overall Study|Early Termination|0|||
126482230|NCT00601458|455065693|FG001|Overall Study|Early Termination|1|||
126482231|NCT00601458|455065694|FG002|Overall Study|Early Termination|1|||
126482232|NCT00370032|455065695|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
126482233|NCT00370032|455065696|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
126482234|NCT00370032|455065695|FG000|Washout Period|Withdrawal by Subject|0|||
126482235|NCT00370032|455065696|FG001|Washout Period|Withdrawal by Subject|1|||
126482236|NCT00370032|455065695|FG000|Washout Period|Lost to Follow-up|0|||
126482237|NCT00370032|455065696|FG001|Washout Period|Lost to Follow-up|1|||
126482238|NCT00370032|455065695|FG000|Washout Period|Adverse Event|1|||
126482239|NCT00370032|455065696|FG001|Washout Period|Adverse Event|0|||
126482240|NCT00370032|455065695|FG000|Follow-up Period|Withdrawal by Subject|1|||
126482241|NCT00370032|455065696|FG001|Follow-up Period|Withdrawal by Subject|0|||
126482242|NCT04584645|455065697|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
126482243|NCT04584645|455065698|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
126482244|NCT00390468|455065699|FG000|Overall Study|Protocol Violation|2|||
126482245|NCT00390468|455065699|FG000|Overall Study|Lack of Efficacy|1|||
126482246|NCT03129100|455065702|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
126482247|NCT03129100|455065703|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
126482248|NCT03129100|455065704|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
126482249|NCT03129100|455065705|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
126482250|NCT03129100|455065706|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
126482251|NCT03129100|455065707|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
126482252|NCT03129100|455065708|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
126482253|NCT03129100|455065709|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
126482254|NCT03129100|455065710|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
126482255|NCT03129100|455065711|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
126482256|NCT03129100|455065712|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
126482257|NCT03129100|455065713|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
126482258|NCT03129100|455065714|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
126482259|NCT03129100|455065715|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
126482260|NCT03129100|455065716|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
126482261|NCT03129100|455065717|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
126482262|NCT03129100|455065718|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
126482263|NCT03129100|455065719|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
126482264|NCT03129100|455065720|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
126482265|NCT03129100|455065721|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
126482266|NCT03129100|455065722|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
126482267|NCT03129100|455065723|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
126482268|NCT03129100|455065724|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
126482269|NCT03129100|455065725|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
126482270|NCT03129100|455065726|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
126482271|NCT03129100|455065727|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
126482272|NCT03129100|455065702|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
126482273|NCT03129100|455065703|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482274|NCT03129100|455065704|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482275|NCT03129100|455065705|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482276|NCT03129100|455065706|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482277|NCT03129100|455065707|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482278|NCT03129100|455065708|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482279|NCT03129100|455065709|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126559224|NCT02099539|455340701|FG005|Overall Study|Progressive Disease|2|||
126559225|NCT02099539|455340702|FG006|Overall Study|Progressive Disease|0|||
126482280|NCT03129100|455065710|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482281|NCT03129100|455065711|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482282|NCT03129100|455065712|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482283|NCT03129100|455065713|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482284|NCT03129100|455065714|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482285|NCT03129100|455065715|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482286|NCT03129100|455065716|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126772453|NCT00883129|456122175|FG001|Overall Study|Non-compliance|6|||
126772454|NCT00883129|456122174|FG000|Overall Study|Lost to Follow-up|1|||
126772455|NCT00883129|456122175|FG001|Overall Study|Lost to Follow-up|2|||
126772456|NCT00883129|456122174|FG000|Overall Study|Death|1|||
126772457|NCT00883129|456122175|FG001|Overall Study|Death|2|||
126772458|NCT00883129|456122174|FG000|Overall Study|Defined Treatment Failure|0|||
126772459|NCT00883129|456122175|FG001|Overall Study|Defined Treatment Failure|2|||
126772460|NCT03273257|456122176|FG000|Overall Study|Death|0|||
126772461|NCT03273257|456122177|FG001|Overall Study|Death|1|||
126772462|NCT03273257|456122176|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
126772463|NCT03273257|456122177|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
126772464|NCT03273257|456122176|FG000|Overall Study|Study terminated|3|||
126772465|NCT03273257|456122177|FG001|Overall Study|Study terminated|2|||
126772466|NCT01211613|456123550|FG000|Overall Study|Lost to Follow-up|2|||
126772467|NCT01211613|456123551|FG001|Overall Study|Lost to Follow-up|2|||
126772468|NCT01211613|456123552|FG002|Overall Study|Lost to Follow-up|2|||
126772469|NCT01211613|456123550|FG000|Overall Study|Withdrawal by Subject|1|||
126772470|NCT01211613|456123551|FG001|Overall Study|Withdrawal by Subject|0|||
126772471|NCT01211613|456123552|FG002|Overall Study|Withdrawal by Subject|0|||
126772472|NCT03853213|456123553|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
126772473|NCT03853213|456123554|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
126772474|NCT03853213|456123553|FG000|Overall Study|Other (e.g., too busy)|0|||
126772475|NCT03853213|456123554|FG001|Overall Study|Other (e.g., too busy)|2|||
126772476|NCT01458132|456123555|FG000|Overall Study|Other|15|||
126772477|NCT01458132|456123556|FG001|Overall Study|Other|3|||
126772478|NCT00833976|456123561|FG000|Overall Study|Withdrawal by Subject|5|||
126772479|NCT00833976|456123561|FG000|Overall Study|Lost to Follow-up|4|||
126772480|NCT00833976|456123561|FG000|Overall Study|Did not meet eligibility criteria|41|||
126772481|NCT00833976|456123561|FG000|Overall Study|Physician Decision|1|||
126772482|NCT03911960|456123562|FG000|Overall Study|Lost to Follow-up|5|||
126772483|NCT03911960|456123563|FG001|Overall Study|Lost to Follow-up|3|||
126772484|NCT02239692|456123564|FG000|Overall Study|Incomplete colonoscopy|1|||
126772485|NCT02239692|456123565|FG001|Overall Study|Incomplete colonoscopy|2|||
126772486|NCT02239692|456123564|FG000|Overall Study|Adverse Event|0|||
126772487|NCT02239692|456123565|FG001|Overall Study|Adverse Event|1|||
126772488|NCT02239692|456123564|FG000|Overall Study|Physician Decision|0|||
126772489|NCT02239692|456123565|FG001|Overall Study|Physician Decision|1|||
126772490|NCT02239692|456123564|FG000|Overall Study|Lost to Follow-up|1|||
126772491|NCT02239692|456123565|FG001|Overall Study|Lost to Follow-up|4|||
126772492|NCT02239692|456123564|FG000|Overall Study|Withdrawal by Subject|3|||
126772493|NCT02239692|456123565|FG001|Overall Study|Withdrawal by Subject|5|||
126772494|NCT02239692|456123564|FG000|Overall Study|Other reason|1|||
126772495|NCT02239692|456123565|FG001|Overall Study|Other reason|0|||
126772496|NCT00297492|456123566|FG000|Set Quit Date|Lost to Follow-up|7|||
126772497|NCT00297492|456123567|FG001|Set Quit Date|Lost to Follow-up|13|||
126772498|NCT00297492|456123568|FG002|Set Quit Date|Lost to Follow-up|5|||
126772499|NCT00297492|456123566|FG000|6 Month Follow-up|Lost to Follow-up|63|||
126772500|NCT00297492|456123567|FG001|6 Month Follow-up|Lost to Follow-up|49|||
126772501|NCT00297492|456123568|FG002|6 Month Follow-up|Lost to Follow-up|27|||
126772502|NCT01422720|456123571|FG000|Overall Study|Adverse Event|16|||
126772503|NCT01422720|456123571|FG000|Overall Study|Lack of Efficacy|1|||
126772504|NCT01422720|456123571|FG000|Overall Study|Withdrawal by Subject|4|||
126772505|NCT01422720|456123571|FG000|Overall Study|Ineligibility|1|||
126772506|NCT01074307|456123573|FG000|Overall Study|No primary endpoint evaluation|14|||
126772507|NCT01074307|456123574|FG001|Overall Study|No primary endpoint evaluation|6|||
126772508|NCT01074307|456123573|FG000|Overall Study|Exclusion criterion|0|||
126772509|NCT01074307|456123574|FG001|Overall Study|Exclusion criterion|1|||
126772510|NCT01074307|456123573|FG000|Overall Study|Protocol Violation|8|||
126772511|NCT01074307|456123574|FG001|Overall Study|Protocol Violation|5|||
126772512|NCT02162511|456123579|FG000|Overall Study|Lack of Efficacy|0|||
126772513|NCT02162511|456123580|FG001|Overall Study|Lack of Efficacy|0|||
126772514|NCT02162511|456123581|FG002|Overall Study|Lack of Efficacy|2|||
126772515|NCT00802529|456123582|FG000|Overall Study|Lost to Follow-up|0|||
126772516|NCT00802529|456123583|FG001|Overall Study|Lost to Follow-up|1|||
126772517|NCT00563524|456123591|FG000|Overall Study|Adverse Event|0|||
126772518|NCT00563524|456123592|FG001|Overall Study|Adverse Event|1|||
126772519|NCT00563524|456123593|FG002|Overall Study|Adverse Event|0|||
126482287|NCT03129100|455065717|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126772520|NCT00563524|456123594|FG003|Overall Study|Adverse Event|0|||
126772521|NCT00563524|456123595|FG004|Overall Study|Adverse Event|2|||
126772522|NCT00563524|456123596|FG005|Overall Study|Adverse Event|0|||
126772523|NCT00563524|456123591|FG000|Overall Study|Lost to Follow-up|1|||
126772524|NCT00563524|456123592|FG001|Overall Study|Lost to Follow-up|0|||
126772525|NCT00563524|456123593|FG002|Overall Study|Lost to Follow-up|0|||
126772526|NCT00563524|456123594|FG003|Overall Study|Lost to Follow-up|0|||
126772527|NCT00563524|456123595|FG004|Overall Study|Lost to Follow-up|0|||
126482288|NCT03129100|455065718|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126772528|NCT00563524|456123596|FG005|Overall Study|Lost to Follow-up|0|||
126482289|NCT03129100|455065719|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482290|NCT03129100|455065720|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482291|NCT03129100|455065721|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482292|NCT03129100|455065722|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482293|NCT03129100|455065723|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482294|NCT03129100|455065724|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482295|NCT03129100|455065725|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482296|NCT03129100|455065726|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482297|NCT03129100|455065727|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
126482298|NCT03129100|455065702|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
126482299|NCT03129100|455065703|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
126482300|NCT03129100|455065704|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482301|NCT03129100|455065705|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482302|NCT03129100|455065706|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482303|NCT03129100|455065707|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482304|NCT03129100|455065708|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482305|NCT03129100|455065709|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482306|NCT03129100|455065710|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482307|NCT03129100|455065711|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482308|NCT03129100|455065712|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482309|NCT03129100|455065713|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482310|NCT03129100|455065714|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482311|NCT03129100|455065715|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482312|NCT03129100|455065716|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482313|NCT03129100|455065717|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482314|NCT03129100|455065718|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482315|NCT03129100|455065719|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482316|NCT03129100|455065720|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482317|NCT03129100|455065721|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482318|NCT03129100|455065722|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482319|NCT03129100|455065723|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482320|NCT03129100|455065724|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482321|NCT03129100|455065725|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482322|NCT03129100|455065726|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482323|NCT03129100|455065727|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
126482324|NCT03129100|455065702|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
126482325|NCT03129100|455065703|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
126482326|NCT03129100|455065704|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482327|NCT03129100|455065705|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482328|NCT03129100|455065706|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482329|NCT03129100|455065707|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482330|NCT03129100|455065708|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482331|NCT03129100|455065709|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482332|NCT03129100|455065710|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482333|NCT03129100|455065711|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482334|NCT03129100|455065712|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482335|NCT03129100|455065713|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482336|NCT03129100|455065714|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482337|NCT03129100|455065715|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482338|NCT03129100|455065716|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482339|NCT03129100|455065717|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482340|NCT03129100|455065718|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482341|NCT03129100|455065719|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482342|NCT03129100|455065720|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482343|NCT03129100|455065721|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482344|NCT03129100|455065722|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482345|NCT03129100|455065723|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482346|NCT03129100|455065724|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482347|NCT03129100|455065725|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482348|NCT03129100|455065726|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482349|NCT03129100|455065727|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
126482350|NCT03129100|455065702|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482351|NCT03129100|455065703|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
126482352|NCT03129100|455065704|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482353|NCT03129100|455065705|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
126559226|NCT02099539|455340696|FG000|Overall Study|Adverse Event|0|||
126559227|NCT02099539|455340697|FG001|Overall Study|Adverse Event|0|||
126559228|NCT02099539|455340698|FG002|Overall Study|Adverse Event|1|||
126482354|NCT03129100|455065706|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
126559229|NCT02099539|455340699|FG003|Overall Study|Adverse Event|1|||
126559230|NCT02099539|455340700|FG004|Overall Study|Adverse Event|0|||
126482355|NCT03129100|455065707|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482356|NCT03129100|455065708|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482357|NCT03129100|455065709|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482358|NCT03129100|455065710|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482359|NCT03129100|455065711|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482360|NCT03129100|455065712|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482361|NCT03129100|455065713|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482362|NCT03129100|455065714|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482363|NCT03129100|455065715|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482364|NCT03129100|455065716|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482365|NCT03129100|455065717|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482366|NCT03129100|455065718|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482367|NCT03129100|455065719|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482368|NCT03129100|455065720|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482369|NCT03129100|455065721|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482370|NCT03129100|455065722|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482371|NCT03129100|455065723|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482372|NCT03129100|455065724|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482373|NCT03129100|455065725|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482374|NCT03129100|455065726|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482375|NCT03129100|455065727|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
126482376|NCT03129100|455065702|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482377|NCT03129100|455065703|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482378|NCT03129100|455065704|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
126482379|NCT03129100|455065705|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
126482380|NCT03129100|455065706|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482381|NCT03129100|455065707|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
126482382|NCT03129100|455065708|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482383|NCT03129100|455065709|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482384|NCT03129100|455065710|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482385|NCT03129100|455065711|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482386|NCT03129100|455065712|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482387|NCT03129100|455065713|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482388|NCT03129100|455065714|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482389|NCT03129100|455065715|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482390|NCT03129100|455065716|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482391|NCT03129100|455065717|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482392|NCT03129100|455065718|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482393|NCT03129100|455065719|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482394|NCT03129100|455065720|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482395|NCT03129100|455065721|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482396|NCT03129100|455065722|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482397|NCT03129100|455065723|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482398|NCT03129100|455065724|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482399|NCT03129100|455065725|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482400|NCT03129100|455065726|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482401|NCT03129100|455065727|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
126482402|NCT03129100|455065702|FG000|Period2 Extension Period (Group A and B)|Death|0|||
126482403|NCT03129100|455065703|FG001|Period2 Extension Period (Group A and B)|Death|0|||
126482404|NCT03129100|455065704|FG002|Period2 Extension Period (Group A and B)|Death|1|||
126482405|NCT03129100|455065705|FG003|Period2 Extension Period (Group A and B)|Death|0|||
126482406|NCT03129100|455065706|FG004|Period2 Extension Period (Group A and B)|Death|0|||
126482407|NCT03129100|455065707|FG005|Period2 Extension Period (Group A and B)|Death|0|||
126482408|NCT03129100|455065708|FG006|Period2 Extension Period (Group A and B)|Death|0|||
126482409|NCT03129100|455065709|FG007|Period2 Extension Period (Group A and B)|Death|0|||
126482410|NCT03129100|455065710|FG008|Period2 Extension Period (Group A and B)|Death|0|||
126722574|NCT00495495|455934446|FG000|Overall Study|Protocol Violation|99|||
126722575|NCT03331666|455934450|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
126722576|NCT03331666|455934451|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
126722577|NCT03137121|455934452|FG000|Overall Study|Withdrawal by Subject|0|||
126722578|NCT03137121|455934453|FG001|Overall Study|Withdrawal by Subject|1|||
126482411|NCT03129100|455065711|FG009|Period2 Extension Period (Group A and B)|Death|0|||
126482412|NCT03129100|455065712|FG010|Period2 Extension Period (Group A and B)|Death|0|||
126482413|NCT03129100|455065713|FG011|Period2 Extension Period (Group A and B)|Death|0|||
126482414|NCT03129100|455065714|FG012|Period2 Extension Period (Group A and B)|Death|0|||
126482415|NCT03129100|455065715|FG013|Period2 Extension Period (Group A and B)|Death|0|||
126482416|NCT03129100|455065716|FG014|Period2 Extension Period (Group A and B)|Death|0|||
126482417|NCT03129100|455065717|FG015|Period2 Extension Period (Group A and B)|Death|0|||
126482418|NCT03129100|455065718|FG016|Period2 Extension Period (Group A and B)|Death|0|||
126482419|NCT03129100|455065719|FG017|Period2 Extension Period (Group A and B)|Death|0|||
126482420|NCT03129100|455065720|FG018|Period2 Extension Period (Group A and B)|Death|0|||
126482421|NCT03129100|455065721|FG019|Period2 Extension Period (Group A and B)|Death|0|||
126482422|NCT03129100|455065722|FG020|Period2 Extension Period (Group A and B)|Death|0|||
126482423|NCT03129100|455065723|FG021|Period2 Extension Period (Group A and B)|Death|0|||
126482424|NCT03129100|455065724|FG022|Period2 Extension Period (Group A and B)|Death|0|||
126482425|NCT03129100|455065725|FG023|Period2 Extension Period (Group A and B)|Death|0|||
126482426|NCT03129100|455065726|FG024|Period2 Extension Period (Group A and B)|Death|0|||
126482427|NCT03129100|455065727|FG025|Period2 Extension Period (Group A and B)|Death|0|||
126482428|NCT03129100|455065702|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482429|NCT03129100|455065703|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482430|NCT03129100|455065704|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
126482431|NCT03129100|455065705|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
126482432|NCT03129100|455065706|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
126482433|NCT03129100|455065707|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
126482434|NCT03129100|455065708|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
126482435|NCT03129100|455065709|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482436|NCT03129100|455065710|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482437|NCT03129100|455065711|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482438|NCT03129100|455065712|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482439|NCT03129100|455065713|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482440|NCT03129100|455065714|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482441|NCT03129100|455065715|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482442|NCT03129100|455065716|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482443|NCT03129100|455065717|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482444|NCT03129100|455065718|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482445|NCT03129100|455065719|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482446|NCT03129100|455065720|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482447|NCT03129100|455065721|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482448|NCT03129100|455065722|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482449|NCT03129100|455065723|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482450|NCT03129100|455065724|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482451|NCT03129100|455065725|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482452|NCT03129100|455065726|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482453|NCT03129100|455065727|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
126482454|NCT03129100|455065702|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482455|NCT03129100|455065703|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482456|NCT03129100|455065704|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
126482457|NCT03129100|455065705|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482458|NCT03129100|455065706|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482459|NCT03129100|455065707|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482460|NCT03129100|455065708|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482461|NCT03129100|455065709|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482462|NCT03129100|455065710|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482463|NCT03129100|455065711|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482464|NCT03129100|455065712|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482465|NCT03129100|455065713|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482466|NCT03129100|455065714|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482467|NCT03129100|455065715|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482468|NCT03129100|455065716|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482469|NCT03129100|455065717|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482470|NCT03129100|455065718|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482471|NCT03129100|455065719|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482472|NCT03129100|455065720|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482473|NCT03129100|455065721|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482474|NCT03129100|455065722|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482475|NCT03129100|455065723|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482476|NCT03129100|455065724|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482477|NCT03129100|455065725|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482478|NCT03129100|455065726|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126559231|NCT02099539|455340701|FG005|Overall Study|Adverse Event|0|||
126559232|NCT02099539|455340702|FG006|Overall Study|Adverse Event|0|||
126772529|NCT00563524|456123591|FG000|Overall Study|Protocol Violation|0|||
126772530|NCT00563524|456123592|FG001|Overall Study|Protocol Violation|1|||
126482479|NCT03129100|455065727|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
126482480|NCT03129100|455065702|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482481|NCT03129100|455065703|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482482|NCT03129100|455065704|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
126482483|NCT03129100|455065705|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482484|NCT03129100|455065706|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482485|NCT03129100|455065707|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482486|NCT03129100|455065708|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482487|NCT03129100|455065709|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482488|NCT03129100|455065710|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482489|NCT03129100|455065711|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482490|NCT03129100|455065712|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482491|NCT03129100|455065713|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482492|NCT03129100|455065714|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482493|NCT03129100|455065715|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482494|NCT03129100|455065716|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482495|NCT03129100|455065717|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482496|NCT03129100|455065718|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482497|NCT03129100|455065719|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482498|NCT03129100|455065720|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482499|NCT03129100|455065721|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482500|NCT03129100|455065722|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482501|NCT03129100|455065723|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482502|NCT03129100|455065724|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482503|NCT03129100|455065725|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126772531|NCT00563524|456123593|FG002|Overall Study|Protocol Violation|0|||
126772532|NCT00563524|456123594|FG003|Overall Study|Protocol Violation|0|||
126772533|NCT00563524|456123595|FG004|Overall Study|Protocol Violation|0|||
126772534|NCT00563524|456123596|FG005|Overall Study|Protocol Violation|0|||
126772535|NCT00563524|456123591|FG000|Overall Study|Withdrawal by Subject|1|||
126772536|NCT00563524|456123592|FG001|Overall Study|Withdrawal by Subject|1|||
126772537|NCT00563524|456123593|FG002|Overall Study|Withdrawal by Subject|3|||
126772538|NCT00563524|456123594|FG003|Overall Study|Withdrawal by Subject|0|||
126772539|NCT00563524|456123595|FG004|Overall Study|Withdrawal by Subject|0|||
126772540|NCT00563524|456123596|FG005|Overall Study|Withdrawal by Subject|1|||
126772541|NCT00817778|456123600|FG000|Overall Study|Adverse Event|1|||
126772542|NCT00817778|456123601|FG001|Overall Study|Adverse Event|0|||
126772543|NCT00817778|456123600|FG000|Overall Study|Withdrawal by Subject|1|||
126772544|NCT00817778|456123601|FG001|Overall Study|Withdrawal by Subject|1|||
126772545|NCT00817778|456123600|FG000|Overall Study|Protocol Violation|0|||
126772546|NCT00817778|456123601|FG001|Overall Study|Protocol Violation|1|||
126772547|NCT00817778|456123600|FG000|Overall Study|Study-specific discontinuation criteria|0|||
126772548|NCT00817778|456123601|FG001|Overall Study|Study-specific discontinuation criteria|1|||
126772549|NCT00817778|456123600|FG000|Overall Study|Poor venous access|1|||
126772550|NCT00817778|456123601|FG001|Overall Study|Poor venous access|0|||
126772551|NCT02360397|456123603|FG000|Overall Study|Incomplete screening|3|||
126772552|NCT02360397|456123603|FG000|Overall Study|Adverse Event|1|||
126772553|NCT01537549|456123604|FG000|Overall Study|Lost to Follow-up|1|||
126772554|NCT01537549|456123604|FG000|Overall Study|Withdrawal by Subject|2|||
126772555|NCT02923115|456123612|FG000|Overall Study|Lost to Follow-up|0|||
126772556|NCT02923115|456123613|FG001|Overall Study|Lost to Follow-up|0|||
126772557|NCT02923115|456123614|FG002|Overall Study|Lost to Follow-up|0|||
126772558|NCT02923115|456123615|FG003|Overall Study|Lost to Follow-up|1|||
126772559|NCT02923115|456123616|FG004|Overall Study|Lost to Follow-up|0|||
126772560|NCT02923115|456123617|FG005|Overall Study|Lost to Follow-up|0|||
126772561|NCT02923115|456123612|FG000|Overall Study|Withdrawal by Subject|0|||
126772562|NCT02923115|456123613|FG001|Overall Study|Withdrawal by Subject|1|||
126772563|NCT02923115|456123614|FG002|Overall Study|Withdrawal by Subject|0|||
126772564|NCT02923115|456123615|FG003|Overall Study|Withdrawal by Subject|0|||
126772565|NCT02923115|456123616|FG004|Overall Study|Withdrawal by Subject|0|||
126772566|NCT02923115|456123617|FG005|Overall Study|Withdrawal by Subject|0|||
126772567|NCT02923115|456123612|FG000|Overall Study|Randomized, but not dosed|0|||
126772568|NCT02923115|456123613|FG001|Overall Study|Randomized, but not dosed|0|||
126772569|NCT02923115|456123614|FG002|Overall Study|Randomized, but not dosed|3|||
126772570|NCT02923115|456123615|FG003|Overall Study|Randomized, but not dosed|1|||
126772571|NCT02923115|456123616|FG004|Overall Study|Randomized, but not dosed|5|||
126772572|NCT02923115|456123617|FG005|Overall Study|Randomized, but not dosed|0|||
126772573|NCT04056299|456123618|FG000|Overall Study|Sponsor discontinued study|3|||
126772574|NCT04056299|456123619|FG001|Overall Study|Sponsor discontinued study|3|||
126482504|NCT03129100|455065726|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482505|NCT03129100|455065727|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
126482506|NCT03129100|455065702|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482507|NCT03129100|455065703|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482508|NCT03129100|455065704|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
126482509|NCT03129100|455065705|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482510|NCT03129100|455065706|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482511|NCT03129100|455065707|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482512|NCT03129100|455065708|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482513|NCT03129100|455065709|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482514|NCT03129100|455065710|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482515|NCT03129100|455065711|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482516|NCT03129100|455065712|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482517|NCT03129100|455065713|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482518|NCT03129100|455065714|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482519|NCT03129100|455065715|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482520|NCT03129100|455065716|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482521|NCT03129100|455065717|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482522|NCT03129100|455065718|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482523|NCT03129100|455065719|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482524|NCT03129100|455065720|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482525|NCT03129100|455065721|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482526|NCT03129100|455065722|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482527|NCT03129100|455065723|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482528|NCT03129100|455065724|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482529|NCT03129100|455065725|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482530|NCT03129100|455065726|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482531|NCT03129100|455065727|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
126482532|NCT03129100|455065702|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482533|NCT03129100|455065703|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482534|NCT03129100|455065704|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482535|NCT03129100|455065705|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126559233|NCT02099539|455340696|FG000|Overall Study|Physician Decision|0|||
126559234|NCT02099539|455340697|FG001|Overall Study|Physician Decision|0|||
126559235|NCT02099539|455340698|FG002|Overall Study|Physician Decision|0|||
126559236|NCT02099539|455340699|FG003|Overall Study|Physician Decision|0|||
126559237|NCT02099539|455340700|FG004|Overall Study|Physician Decision|0|||
126559238|NCT02099539|455340701|FG005|Overall Study|Physician Decision|1|||
126559239|NCT02099539|455340702|FG006|Overall Study|Physician Decision|0|||
126559240|NCT00819234|455340708|FG000|Overall Study|Withdrawal by Subject|8|||
126482536|NCT03129100|455065706|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
126482537|NCT03129100|455065707|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
126482538|NCT03129100|455065708|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
126482539|NCT03129100|455065709|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482540|NCT03129100|455065710|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482541|NCT03129100|455065711|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482542|NCT03129100|455065712|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482543|NCT03129100|455065713|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482544|NCT03129100|455065714|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482545|NCT03129100|455065715|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482546|NCT03129100|455065716|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482547|NCT03129100|455065717|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482548|NCT03129100|455065718|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482549|NCT03129100|455065719|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482550|NCT03129100|455065720|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482551|NCT03129100|455065721|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482552|NCT03129100|455065722|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482553|NCT03129100|455065723|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482554|NCT03129100|455065724|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126559241|NCT00819234|455340709|FG001|Overall Study|Withdrawal by Subject|13|||
126559242|NCT00819234|455340710|FG002|Overall Study|Withdrawal by Subject|6|||
126482555|NCT03129100|455065725|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126559243|NCT00819234|455340711|FG003|Overall Study|Withdrawal by Subject|3|||
126559244|NCT00819234|455340712|FG004|Overall Study|Withdrawal by Subject|0|||
126559245|NCT00819234|455340713|FG005|Overall Study|Withdrawal by Subject|4|||
126482556|NCT03129100|455065726|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482557|NCT03129100|455065727|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
126482558|NCT03129100|455065702|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482559|NCT03129100|455065703|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482560|NCT03129100|455065704|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482561|NCT03129100|455065705|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482562|NCT03129100|455065706|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482563|NCT03129100|455065707|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482564|NCT03129100|455065708|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482565|NCT03129100|455065709|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482566|NCT03129100|455065710|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482567|NCT03129100|455065711|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
126482568|NCT03129100|455065712|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482569|NCT03129100|455065713|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482570|NCT03129100|455065714|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482571|NCT03129100|455065715|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482572|NCT03129100|455065716|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482573|NCT03129100|455065717|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482574|NCT03129100|455065718|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482575|NCT03129100|455065719|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482576|NCT03129100|455065720|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482577|NCT03129100|455065721|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482578|NCT03129100|455065722|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482579|NCT03129100|455065723|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482580|NCT03129100|455065724|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482581|NCT03129100|455065725|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482582|NCT03129100|455065726|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482583|NCT03129100|455065727|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
126482584|NCT03129100|455065702|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482585|NCT03129100|455065703|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482586|NCT03129100|455065704|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482587|NCT03129100|455065705|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482588|NCT03129100|455065706|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482589|NCT03129100|455065707|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482590|NCT03129100|455065708|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482591|NCT03129100|455065709|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482592|NCT03129100|455065710|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482593|NCT03129100|455065711|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482594|NCT03129100|455065712|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482595|NCT03129100|455065713|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
126482596|NCT03129100|455065714|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482597|NCT03129100|455065715|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482598|NCT03129100|455065716|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482599|NCT03129100|455065717|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482600|NCT03129100|455065718|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482601|NCT03129100|455065719|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482602|NCT03129100|455065720|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482603|NCT03129100|455065721|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482604|NCT03129100|455065722|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482605|NCT03129100|455065723|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482606|NCT03129100|455065724|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482607|NCT03129100|455065725|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482608|NCT03129100|455065726|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482609|NCT03129100|455065727|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
126482610|NCT03129100|455065702|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482611|NCT03129100|455065703|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482612|NCT03129100|455065704|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482613|NCT03129100|455065705|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482614|NCT03129100|455065706|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482615|NCT03129100|455065707|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482616|NCT03129100|455065708|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482617|NCT03129100|455065709|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482618|NCT03129100|455065710|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482619|NCT03129100|455065711|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482620|NCT03129100|455065712|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482621|NCT03129100|455065713|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
126482622|NCT03129100|455065714|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
126482623|NCT03129100|455065715|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
126482624|NCT03129100|455065716|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
126482625|NCT03129100|455065717|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482626|NCT03129100|455065718|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482627|NCT03129100|455065719|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482628|NCT03129100|455065720|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482629|NCT03129100|455065721|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482630|NCT03129100|455065722|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482631|NCT03129100|455065723|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482632|NCT03129100|455065724|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482633|NCT03129100|455065725|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482634|NCT03129100|455065726|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482635|NCT03129100|455065727|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
126482636|NCT03129100|455065702|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482637|NCT03129100|455065703|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482638|NCT03129100|455065704|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482639|NCT03129100|455065705|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482640|NCT03129100|455065706|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482641|NCT03129100|455065707|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482642|NCT03129100|455065708|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482643|NCT03129100|455065709|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482644|NCT03129100|455065710|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482645|NCT03129100|455065711|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482646|NCT03129100|455065712|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482647|NCT03129100|455065713|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
126482648|NCT03129100|455065714|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482649|NCT03129100|455065715|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
126482650|NCT03129100|455065716|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
126482651|NCT03129100|455065717|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482652|NCT03129100|455065718|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482653|NCT03129100|455065719|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482654|NCT03129100|455065720|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482655|NCT03129100|455065721|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482656|NCT03129100|455065722|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482657|NCT03129100|455065723|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482658|NCT03129100|455065724|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482659|NCT03129100|455065725|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482660|NCT03129100|455065726|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482661|NCT03129100|455065727|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
126482662|NCT03129100|455065702|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482663|NCT03129100|455065703|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482664|NCT03129100|455065704|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482665|NCT03129100|455065705|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482666|NCT03129100|455065706|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482667|NCT03129100|455065707|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482668|NCT03129100|455065708|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482669|NCT03129100|455065709|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482670|NCT03129100|455065710|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482671|NCT03129100|455065711|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482672|NCT03129100|455065712|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482673|NCT03129100|455065713|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482674|NCT03129100|455065714|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482675|NCT03129100|455065715|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482676|NCT03129100|455065716|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482677|NCT03129100|455065717|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
126482678|NCT03129100|455065718|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482679|NCT03129100|455065719|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482680|NCT03129100|455065720|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482681|NCT03129100|455065721|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482682|NCT03129100|455065722|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482683|NCT03129100|455065723|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482684|NCT03129100|455065724|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482685|NCT03129100|455065725|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482686|NCT03129100|455065726|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482687|NCT03129100|455065727|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
126482688|NCT03129100|455065702|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482689|NCT03129100|455065703|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482690|NCT03129100|455065704|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482691|NCT03129100|455065705|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482692|NCT03129100|455065706|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482693|NCT03129100|455065707|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482694|NCT03129100|455065708|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482695|NCT03129100|455065709|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482696|NCT03129100|455065710|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482697|NCT03129100|455065711|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482698|NCT03129100|455065712|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482699|NCT03129100|455065713|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482700|NCT03129100|455065714|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
126482701|NCT03129100|455065715|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482702|NCT03129100|455065716|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
126482703|NCT03129100|455065717|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
126482704|NCT03129100|455065718|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482705|NCT03129100|455065719|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482706|NCT03129100|455065720|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482707|NCT03129100|455065721|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482708|NCT03129100|455065722|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482709|NCT03129100|455065723|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482710|NCT03129100|455065724|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482711|NCT03129100|455065725|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482712|NCT03129100|455065726|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482713|NCT03129100|455065727|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
126482714|NCT03129100|455065702|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482715|NCT03129100|455065703|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482716|NCT03129100|455065704|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482717|NCT03129100|455065705|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482718|NCT03129100|455065706|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482719|NCT03129100|455065707|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482720|NCT03129100|455065708|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482721|NCT03129100|455065709|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482722|NCT03129100|455065710|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482723|NCT03129100|455065711|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482724|NCT03129100|455065712|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482725|NCT03129100|455065713|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482726|NCT03129100|455065714|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482727|NCT03129100|455065715|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482728|NCT03129100|455065716|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482729|NCT03129100|455065717|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482730|NCT03129100|455065718|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482731|NCT03129100|455065719|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
126482732|NCT03129100|455065720|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482733|NCT03129100|455065721|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
126482734|NCT03129100|455065722|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126722579|NCT01026389|455934459|FG000|Overall Study|Withdrawal by Subject|1|||
126722580|NCT01026389|455934460|FG001|Overall Study|Withdrawal by Subject|3|||
126722581|NCT01026389|455934459|FG000|Overall Study|change of treatment, patient moved|4|||
126722582|NCT01026389|455934460|FG001|Overall Study|change of treatment, patient moved|2|||
126722583|NCT04410198|455934461|FG000|Overall Study|Death|10|||
126722584|NCT04410198|455934461|FG000|Overall Study|Withdrawal by Subject|7|||
126722585|NCT04410198|455934461|FG000|Overall Study|Transferred/Relocation|4|||
126722586|NCT04410198|455934461|FG000|Overall Study|Kidney Transplant|9|||
126722587|NCT04410198|455934461|FG000|Overall Study|Adverse Event|4|||
126722588|NCT04410198|455934461|FG000|Overall Study|Physician Decision|2|||
126722589|NCT04410198|455934461|FG000|Overall Study|Other than specified|1|||
126722590|NCT01830543|455934467|FG000|Overall Study|Subject Decision|19|||
126722591|NCT01830543|455934468|FG001|Overall Study|Subject Decision|21|||
126482735|NCT03129100|455065723|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482736|NCT03129100|455065724|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482737|NCT03129100|455065725|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482738|NCT03129100|455065726|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482739|NCT03129100|455065727|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
126482740|NCT03129100|455065702|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482741|NCT03129100|455065703|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482742|NCT03129100|455065704|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482743|NCT03129100|455065705|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482744|NCT03129100|455065706|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482745|NCT03129100|455065707|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482746|NCT03129100|455065708|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482747|NCT03129100|455065709|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482748|NCT03129100|455065710|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482749|NCT03129100|455065711|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482750|NCT03129100|455065712|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482751|NCT03129100|455065713|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482752|NCT03129100|455065714|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482753|NCT03129100|455065715|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482754|NCT03129100|455065716|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482755|NCT03129100|455065717|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482756|NCT03129100|455065718|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482757|NCT03129100|455065719|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482758|NCT03129100|455065720|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482759|NCT03129100|455065721|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482760|NCT03129100|455065722|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
126482761|NCT03129100|455065723|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482762|NCT03129100|455065724|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482763|NCT03129100|455065725|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482764|NCT03129100|455065726|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482765|NCT03129100|455065727|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
126482766|NCT03129100|455065702|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
126482767|NCT03129100|455065703|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
126482768|NCT03129100|455065704|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
126482769|NCT03129100|455065705|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
126482770|NCT03129100|455065706|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
126482771|NCT03129100|455065707|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
126482772|NCT03129100|455065708|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
126482773|NCT03129100|455065709|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
126482774|NCT03129100|455065710|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
126482775|NCT03129100|455065711|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
126482776|NCT03129100|455065712|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
126482777|NCT03129100|455065713|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
126482778|NCT03129100|455065714|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
126482779|NCT03129100|455065715|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
126482780|NCT03129100|455065716|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
126482781|NCT03129100|455065717|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
126482782|NCT03129100|455065718|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
126482783|NCT03129100|455065719|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
126482784|NCT03129100|455065720|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
126482785|NCT03129100|455065721|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
126482786|NCT03129100|455065722|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
126482787|NCT03129100|455065723|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
126482788|NCT03129100|455065724|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
126482789|NCT03129100|455065725|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
126482790|NCT03129100|455065726|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
126482791|NCT03129100|455065727|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
126722592|NCT01830543|455934469|FG002|Overall Study|Subject Decision|57|||
126482792|NCT03129100|455065702|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482793|NCT03129100|455065703|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482794|NCT03129100|455065704|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482795|NCT03129100|455065705|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482796|NCT03129100|455065706|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482797|NCT03129100|455065707|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482798|NCT03129100|455065708|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482799|NCT03129100|455065709|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482800|NCT03129100|455065710|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482801|NCT03129100|455065711|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482802|NCT03129100|455065712|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126722593|NCT01830543|455934467|FG000|Overall Study|Adverse Event|91|||
126722594|NCT01830543|455934468|FG001|Overall Study|Adverse Event|77|||
126722595|NCT01830543|455934469|FG002|Overall Study|Adverse Event|76|||
126722596|NCT01830543|455934467|FG000|Overall Study|Death|20|||
126722597|NCT01830543|455934468|FG001|Overall Study|Death|22|||
126482803|NCT03129100|455065713|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482804|NCT03129100|455065714|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482805|NCT03129100|455065715|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482806|NCT03129100|455065716|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482807|NCT03129100|455065717|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482808|NCT03129100|455065718|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482809|NCT03129100|455065719|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482810|NCT03129100|455065720|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482811|NCT03129100|455065721|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482812|NCT03129100|455065722|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
126482813|NCT03129100|455065723|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482814|NCT03129100|455065724|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482815|NCT03129100|455065725|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482816|NCT03129100|455065726|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482817|NCT03129100|455065727|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
126482818|NCT03129100|455065702|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
126482819|NCT03129100|455065703|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
126482820|NCT03129100|455065704|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
126482821|NCT03129100|455065705|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
126482822|NCT03129100|455065706|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
126482823|NCT03129100|455065707|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
126482824|NCT03129100|455065708|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
126482825|NCT03129100|455065709|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
126482826|NCT03129100|455065710|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
126482827|NCT03129100|455065711|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
126482828|NCT03129100|455065712|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
126482829|NCT03129100|455065713|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
126482830|NCT03129100|455065714|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
126482831|NCT03129100|455065715|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
126482832|NCT03129100|455065716|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
126482833|NCT03129100|455065717|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
126482834|NCT03129100|455065718|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
126482835|NCT03129100|455065719|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
126482836|NCT03129100|455065720|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
126482837|NCT03129100|455065721|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
126482838|NCT03129100|455065722|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
126482839|NCT03129100|455065723|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
126482840|NCT03129100|455065724|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
126482841|NCT03129100|455065725|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
126482842|NCT03129100|455065726|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
126482843|NCT03129100|455065727|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
126482844|NCT03129100|455065702|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482845|NCT03129100|455065703|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482846|NCT03129100|455065704|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482847|NCT03129100|455065705|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482848|NCT03129100|455065706|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482849|NCT03129100|455065707|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482850|NCT03129100|455065708|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482851|NCT03129100|455065709|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482852|NCT03129100|455065710|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482853|NCT03129100|455065711|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482854|NCT03129100|455065712|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482855|NCT03129100|455065713|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482856|NCT03129100|455065714|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482857|NCT03129100|455065715|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482858|NCT03129100|455065716|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482859|NCT03129100|455065717|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482860|NCT03129100|455065718|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482861|NCT03129100|455065719|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482862|NCT03129100|455065720|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482863|NCT03129100|455065721|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482864|NCT03129100|455065722|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482865|NCT03129100|455065723|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482866|NCT03129100|455065724|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482867|NCT03129100|455065725|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
126482868|NCT03129100|455065726|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
126482869|NCT03129100|455065727|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
126482870|NCT03129100|455065702|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482871|NCT03129100|455065703|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126722598|NCT01830543|455934469|FG002|Overall Study|Death|22|||
126482872|NCT03129100|455065704|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482873|NCT03129100|455065705|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482874|NCT03129100|455065706|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482875|NCT03129100|455065707|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482876|NCT03129100|455065708|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482877|NCT03129100|455065709|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482878|NCT03129100|455065710|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482879|NCT03129100|455065711|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482880|NCT03129100|455065712|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482881|NCT03129100|455065713|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482882|NCT03129100|455065714|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482883|NCT03129100|455065715|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482884|NCT03129100|455065716|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482885|NCT03129100|455065717|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482886|NCT03129100|455065718|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482887|NCT03129100|455065719|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126722599|NCT01830543|455934467|FG000|Overall Study|Protocol Violation|3|||
126722600|NCT01830543|455934468|FG001|Overall Study|Protocol Violation|7|||
126722601|NCT01830543|455934469|FG002|Overall Study|Protocol Violation|7|||
126722602|NCT01830543|455934467|FG000|Overall Study|Physician Decision|11|||
126722603|NCT01830543|455934468|FG001|Overall Study|Physician Decision|5|||
126722604|NCT01830543|455934469|FG002|Overall Study|Physician Decision|12|||
126722605|NCT01830543|455934467|FG000|Overall Study|Withdrawal by consent|3|||
126722606|NCT01830543|455934468|FG001|Overall Study|Withdrawal by consent|3|||
126722607|NCT01830543|455934469|FG002|Overall Study|Withdrawal by consent|3|||
126722608|NCT01830543|455934467|FG000|Overall Study|Other|12|||
126722609|NCT01830543|455934468|FG001|Overall Study|Other|17|||
126722610|NCT01830543|455934469|FG002|Overall Study|Other|37|||
126722611|NCT03583372|455934474|FG000|Overall Study|Withdrawal by Subject|6|||
126722612|NCT03583372|455934475|FG001|Overall Study|Withdrawal by Subject|11|||
126722613|NCT03583372|455934476|FG002|Overall Study|Withdrawal by Subject|7|||
126722614|NCT03583372|455934477|FG003|Overall Study|Withdrawal by Subject|8|||
126722615|NCT03583372|455934474|FG000|Overall Study|Lost to Follow-up|4|||
126722616|NCT03583372|455934475|FG001|Overall Study|Lost to Follow-up|6|||
126722617|NCT03583372|455934476|FG002|Overall Study|Lost to Follow-up|3|||
126722618|NCT03583372|455934477|FG003|Overall Study|Lost to Follow-up|2|||
126722619|NCT03583372|455934474|FG000|Overall Study|Adverse Event|1|||
126722620|NCT03583372|455934475|FG001|Overall Study|Adverse Event|3|||
126722621|NCT03583372|455934476|FG002|Overall Study|Adverse Event|4|||
126482888|NCT03129100|455065720|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482889|NCT03129100|455065721|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482890|NCT03129100|455065722|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482891|NCT03129100|455065723|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482892|NCT03129100|455065724|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
126482893|NCT03129100|455065725|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
126482894|NCT03129100|455065726|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
126482895|NCT03129100|455065727|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
126482896|NCT03129100|455065702|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482897|NCT03129100|455065703|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482898|NCT03129100|455065704|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482899|NCT03129100|455065705|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482900|NCT03129100|455065706|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482901|NCT03129100|455065707|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482902|NCT03129100|455065708|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482903|NCT03129100|455065709|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482904|NCT03129100|455065710|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482905|NCT03129100|455065711|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482906|NCT03129100|455065712|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482907|NCT03129100|455065713|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482908|NCT03129100|455065714|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482909|NCT03129100|455065715|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482910|NCT03129100|455065716|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482911|NCT03129100|455065717|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126722622|NCT03583372|455934477|FG003|Overall Study|Adverse Event|4|||
126722623|NCT03583372|455934474|FG000|Overall Study|Physician Decision|0|||
126722624|NCT03583372|455934475|FG001|Overall Study|Physician Decision|1|||
126722625|NCT03583372|455934476|FG002|Overall Study|Physician Decision|1|||
126722626|NCT03583372|455934477|FG003|Overall Study|Physician Decision|1|||
126722627|NCT03583372|455934474|FG000|Overall Study|Lack of Efficacy|0|||
126722628|NCT03583372|455934475|FG001|Overall Study|Lack of Efficacy|1|||
126722629|NCT03583372|455934476|FG002|Overall Study|Lack of Efficacy|0|||
126482912|NCT03129100|455065718|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482913|NCT03129100|455065719|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482914|NCT03129100|455065720|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482915|NCT03129100|455065721|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482916|NCT03129100|455065722|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482917|NCT03129100|455065723|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482918|NCT03129100|455065724|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482919|NCT03129100|455065725|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482920|NCT03129100|455065726|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
126482921|NCT03129100|455065727|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
126482922|NCT03129100|455065702|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482923|NCT03129100|455065703|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482924|NCT03129100|455065704|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482925|NCT03129100|455065705|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482926|NCT03129100|455065706|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482927|NCT03129100|455065707|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482928|NCT03129100|455065708|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482929|NCT03129100|455065709|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482930|NCT03129100|455065710|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482931|NCT03129100|455065711|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482932|NCT03129100|455065712|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482933|NCT03129100|455065713|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482934|NCT03129100|455065714|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482935|NCT03129100|455065715|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482936|NCT03129100|455065716|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482937|NCT03129100|455065717|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482938|NCT03129100|455065718|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482939|NCT03129100|455065719|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482940|NCT03129100|455065720|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482941|NCT03129100|455065721|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482942|NCT03129100|455065722|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482943|NCT03129100|455065723|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482944|NCT03129100|455065724|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482945|NCT03129100|455065725|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482946|NCT03129100|455065726|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
126482947|NCT03129100|455065727|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
126482948|NCT03129100|455065702|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
126482949|NCT03129100|455065703|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
126482950|NCT03129100|455065704|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
126482951|NCT03129100|455065705|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
126482952|NCT03129100|455065706|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
126482953|NCT03129100|455065707|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
126482954|NCT03129100|455065708|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
126482955|NCT03129100|455065709|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
126482956|NCT03129100|455065710|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
126482957|NCT03129100|455065711|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
126482958|NCT03129100|455065712|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
126482959|NCT03129100|455065713|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
126482960|NCT03129100|455065714|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
126482961|NCT03129100|455065715|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
126482962|NCT03129100|455065716|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
126482963|NCT03129100|455065717|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
126482964|NCT03129100|455065718|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
126482965|NCT03129100|455065719|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
126482966|NCT03129100|455065720|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
126482967|NCT03129100|455065721|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
126482968|NCT03129100|455065722|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
126482969|NCT03129100|455065723|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
126482970|NCT03129100|455065724|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
126482971|NCT03129100|455065725|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
126482972|NCT03129100|455065726|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
126482973|NCT03129100|455065727|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
126482974|NCT01587001|455065728|FG000|Overall Study|Lost to Follow-up|2|||
126482975|NCT01587001|455065729|FG001|Overall Study|Lost to Follow-up|0|||
126482976|NCT01587001|455065728|FG000|Overall Study|Insufficient samples to complete testing|4|||
126482977|NCT01587001|455065729|FG001|Overall Study|Insufficient samples to complete testing|1|||
126482978|NCT03845985|455065730|FG000|Overall Study|Lost to Follow-up|2|||
126482979|NCT03845985|455065731|FG001|Overall Study|Lost to Follow-up|1|||
126482980|NCT03845985|455065730|FG000|Overall Study|Physician Decision|1|||
126482981|NCT03845985|455065731|FG001|Overall Study|Physician Decision|0|||
126722630|NCT03583372|455934477|FG003|Overall Study|Lack of Efficacy|1|||
126722631|NCT03583372|455934474|FG000|Overall Study|Death|1|||
126722632|NCT03583372|455934475|FG001|Overall Study|Death|0|||
126722633|NCT03583372|455934476|FG002|Overall Study|Death|0|||
126722634|NCT03583372|455934477|FG003|Overall Study|Death|0|||
126722635|NCT03583372|455934474|FG000|Overall Study|Protocol Violation|0|||
126722636|NCT03583372|455934475|FG001|Overall Study|Protocol Violation|1|||
126722637|NCT03583372|455934476|FG002|Overall Study|Protocol Violation|0|||
126722638|NCT03583372|455934477|FG003|Overall Study|Protocol Violation|0|||
126722639|NCT03583372|455934474|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
126722640|NCT03583372|455934475|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
126722641|NCT03583372|455934476|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
126722642|NCT03583372|455934477|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
126722643|NCT03583372|455934474|FG000|Overall Study|Did Not Receive Study Drug|0|||
126722644|NCT03583372|455934475|FG001|Overall Study|Did Not Receive Study Drug|1|||
126722645|NCT03583372|455934476|FG002|Overall Study|Did Not Receive Study Drug|0|||
126722646|NCT03583372|455934477|FG003|Overall Study|Did Not Receive Study Drug|0|||
126722647|NCT03583372|455934474|FG000|Overall Study|Captured as Other in the Database|1|||
126722648|NCT03583372|455934475|FG001|Overall Study|Captured as Other in the Database|2|||
126722649|NCT03583372|455934476|FG002|Overall Study|Captured as Other in the Database|4|||
126722650|NCT03583372|455934477|FG003|Overall Study|Captured as Other in the Database|1|||
126722651|NCT03446651|455934485|FG000|Overall Study|Lost to Follow-up|4|||
126722652|NCT03446651|455934486|FG001|Overall Study|Lost to Follow-up|0|||
126722653|NCT03446651|455934485|FG000|Overall Study|Open Label Participants|5|||
126772575|NCT00068406|456123621|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
126482982|NCT03845985|455065730|FG000|Overall Study|Withdrawal by Subject|4|||
126482983|NCT03845985|455065731|FG001|Overall Study|Withdrawal by Subject|1|||
126482984|NCT03334539|455065734|FG000|Overall Study|Adverse Event|3|||
126482985|NCT03334539|455065735|FG001|Overall Study|Adverse Event|5|||
126482986|NCT03334539|455065736|FG002|Overall Study|Adverse Event|0|||
126482987|NCT03334539|455065734|FG000|Overall Study|Withdrawal by Subject|0|||
126482988|NCT03334539|455065735|FG001|Overall Study|Withdrawal by Subject|1|||
126482989|NCT03334539|455065736|FG002|Overall Study|Withdrawal by Subject|1|||
126482990|NCT03334539|455065734|FG000|Overall Study|Administrative Reasons|1|||
126482991|NCT03334539|455065735|FG001|Overall Study|Administrative Reasons|0|||
126482992|NCT03334539|455065736|FG002|Overall Study|Administrative Reasons|0|||
126482993|NCT03334539|455065734|FG000|Overall Study|Hypertension Not Controlled|0|||
126482994|NCT03334539|455065735|FG001|Overall Study|Hypertension Not Controlled|1|||
126482995|NCT03334539|455065736|FG002|Overall Study|Hypertension Not Controlled|0|||
126482996|NCT00968201|455065737|FG000|Base Study - (Period II)|Adverse Event|8|||
126482997|NCT00968201|455065738|FG001|Base Study - (Period II)|Adverse Event|0|||
126482998|NCT00968201|455065739|FG002|Base Study - (Period II)|Adverse Event|16|||
126482999|NCT00968201|455065737|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
126483000|NCT00968201|455065738|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
126483001|NCT00968201|455065739|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
126483002|NCT00968201|455065737|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
126483003|NCT00968201|455065738|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
126483004|NCT00968201|455065739|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
126483005|NCT00968201|455065737|FG000|Base Study - (Period II)|Protocol Violation|12|||
126559246|NCT00819234|455340714|FG006|Overall Study|Withdrawal by Subject|4|||
126559247|NCT00819234|455340715|FG007|Overall Study|Withdrawal by Subject|8|||
126559248|NCT00819234|455340716|FG008|Overall Study|Withdrawal by Subject|5|||
126559249|NCT00819234|455340717|FG009|Overall Study|Withdrawal by Subject|3|||
126559250|NCT00819234|455340708|FG000|Overall Study|Adverse Event|0|||
126559251|NCT00819234|455340709|FG001|Overall Study|Adverse Event|0|||
126559252|NCT00819234|455340710|FG002|Overall Study|Adverse Event|1|||
126559253|NCT00819234|455340711|FG003|Overall Study|Adverse Event|0|||
126559254|NCT00819234|455340712|FG004|Overall Study|Adverse Event|0|||
126559255|NCT00819234|455340713|FG005|Overall Study|Adverse Event|2|||
126559256|NCT00819234|455340714|FG006|Overall Study|Adverse Event|0|||
126559257|NCT00819234|455340715|FG007|Overall Study|Adverse Event|0|||
126559258|NCT00819234|455340716|FG008|Overall Study|Adverse Event|0|||
126559259|NCT00819234|455340717|FG009|Overall Study|Adverse Event|0|||
126559260|NCT00819234|455340708|FG000|Overall Study|Physician Decision|0|||
126559261|NCT00819234|455340709|FG001|Overall Study|Physician Decision|0|||
126559262|NCT00819234|455340710|FG002|Overall Study|Physician Decision|0|||
126722654|NCT03446651|455934486|FG001|Overall Study|Open Label Participants|0|||
126722655|NCT02420223|455934487|FG000|Overall Study|Adverse Event|1|||
126483006|NCT00968201|455065738|FG001|Base Study - (Period II)|Protocol Violation|0|||
126483007|NCT00968201|455065739|FG002|Base Study - (Period II)|Protocol Violation|12|||
126559263|NCT00819234|455340711|FG003|Overall Study|Physician Decision|1|||
126559264|NCT00819234|455340712|FG004|Overall Study|Physician Decision|0|||
126559265|NCT00819234|455340713|FG005|Overall Study|Physician Decision|0|||
126559266|NCT00819234|455340714|FG006|Overall Study|Physician Decision|0|||
126559267|NCT00819234|455340715|FG007|Overall Study|Physician Decision|0|||
126559268|NCT00819234|455340716|FG008|Overall Study|Physician Decision|0|||
126722656|NCT02420223|455934488|FG001|Overall Study|Adverse Event|0|||
126483008|NCT00968201|455065737|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
126483009|NCT00968201|455065738|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
126483010|NCT00968201|455065739|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
126483011|NCT00968201|455065737|FG000|Base Study - (Period II)|Site Error|0|||
126483012|NCT00968201|455065738|FG001|Base Study - (Period II)|Site Error|0|||
126483013|NCT00968201|455065739|FG002|Base Study - (Period II)|Site Error|1|||
126483014|NCT00968201|455065737|FG000|Extension Study - (Period III)|Adverse Event|0|||
126483015|NCT00968201|455065738|FG001|Extension Study - (Period III)|Adverse Event|5|||
126483016|NCT00968201|455065739|FG002|Extension Study - (Period III)|Adverse Event|22|||
126483017|NCT00968201|455065737|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
126483018|NCT00968201|455065738|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
126483019|NCT00968201|455065739|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
126483020|NCT00968201|455065737|FG000|Extension Study - (Period III)|Protocol Violation|0|||
126483021|NCT00968201|455065738|FG001|Extension Study - (Period III)|Protocol Violation|17|||
126483022|NCT00968201|455065739|FG002|Extension Study - (Period III)|Protocol Violation|14|||
126483023|NCT00968201|455065737|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
126483024|NCT00968201|455065738|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
126483025|NCT00968201|455065739|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
126483026|NCT00968201|455065737|FG000|Extension Study - (Period III)|Patient Relocated|0|||
126483027|NCT00968201|455065738|FG001|Extension Study - (Period III)|Patient Relocated|1|||
126483028|NCT00968201|455065739|FG002|Extension Study - (Period III)|Patient Relocated|1|||
126483029|NCT00968201|455065737|FG000|Extension Study - (Period III)|Noncompliance|0|||
126483030|NCT00968201|455065738|FG001|Extension Study - (Period III)|Noncompliance|0|||
126483031|NCT00968201|455065739|FG002|Extension Study - (Period III)|Noncompliance|3|||
126483032|NCT00968201|455065737|FG000|Extension Study - (Period III)|Other|0|||
126483033|NCT00968201|455065738|FG001|Extension Study - (Period III)|Other|0|||
126483034|NCT00968201|455065739|FG002|Extension Study - (Period III)|Other|2|||
126483035|NCT00968201|455065737|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
126483036|NCT00968201|455065738|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
126483037|NCT00968201|455065739|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
126483038|NCT04974697|455065740|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
126483039|NCT04974697|455065740|FG000|Overall Study|Lens discomfort|1|||
126483040|NCT03706456|455065742|FG000|Overall Study|Adverse Event|1|||
126483041|NCT03706456|455065742|FG000|Overall Study|Lack of Efficacy|2|||
126483042|NCT02784431|455065743|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
126483043|NCT02784431|455065743|FG000|Overall Study|Early Study Termination|19|||
126483044|NCT03302234|455065746|FG000|Overall Study|Death|191|||
126483045|NCT03302234|455065747|FG001|Overall Study|Death|192|||
126483046|NCT03302234|455065746|FG000|Overall Study|Withdrawal by Subject|2|||
126483047|NCT03302234|455065747|FG001|Overall Study|Withdrawal by Subject|2|||
126483048|NCT03302234|455065746|FG000|Overall Study|Sponsor Decision|90|||
126483049|NCT03302234|455065747|FG001|Overall Study|Sponsor Decision|89|||
126483050|NCT03302234|455065746|FG000|Overall Study|Laryngeal carcinoma|0|||
126483051|NCT03302234|455065747|FG001|Overall Study|Laryngeal carcinoma|1|||
126483052|NCT03302234|455065746|FG000|Overall Study|Not Reported|1|||
126483053|NCT03302234|455065747|FG001|Overall Study|Not Reported|0|||
126483054|NCT02795832|455065748|FG000|Overall Study|Adverse Event|0|||
126483055|NCT02795832|455065749|FG001|Overall Study|Adverse Event|0|||
126483056|NCT02795832|455065750|FG002|Overall Study|Adverse Event|0|||
126483057|NCT02795832|455065751|FG003|Overall Study|Adverse Event|0|||
126483058|NCT02795832|455065752|FG004|Overall Study|Adverse Event|0|||
126483059|NCT02795832|455065753|FG005|Overall Study|Adverse Event|3|||
126483060|NCT04523220|455065754|FG000|Main Treatment Period|Physician Decision|1|||
126483061|NCT04523220|455065755|FG001|Main Treatment Period|Physician Decision|1|||
126483062|NCT04523220|455065756|FG002|Main Treatment Period|Physician Decision|0|||
126722657|NCT02420223|455934487|FG000|Overall Study|Physician Decision|0|||
126483063|NCT04523220|455065754|FG000|Main Treatment Period|Other|5|||
126483064|NCT04523220|455065755|FG001|Main Treatment Period|Other|2|||
126483065|NCT04523220|455065756|FG002|Main Treatment Period|Other|4|||
126722658|NCT02420223|455934488|FG001|Overall Study|Physician Decision|2|||
126722659|NCT01894477|455934501|FG000|Overall Study|Protocol Violation|0|||
126722660|NCT01894477|455934502|FG001|Overall Study|Protocol Violation|1|||
126483066|NCT04523220|455065754|FG000|Main Treatment Period|Subject Decision|5|||
126483067|NCT04523220|455065755|FG001|Main Treatment Period|Subject Decision|7|||
126483068|NCT04523220|455065756|FG002|Main Treatment Period|Subject Decision|3|||
126483069|NCT04523220|455065754|FG000|Main Treatment Period|Death|5|||
126483070|NCT04523220|455065755|FG001|Main Treatment Period|Death|11|||
126483071|NCT04523220|455065756|FG002|Main Treatment Period|Death|4|||
126483072|NCT04523220|455065754|FG000|Main Treatment Period|Adverse Event|11|||
126483073|NCT04523220|455065755|FG001|Main Treatment Period|Adverse Event|9|||
126483074|NCT04523220|455065756|FG002|Main Treatment Period|Adverse Event|9|||
126483075|NCT04523220|455065754|FG000|Main Treatment Period|Withdrawal by Subject|3|||
126483076|NCT04523220|455065755|FG001|Main Treatment Period|Withdrawal by Subject|3|||
126483077|NCT04523220|455065756|FG002|Main Treatment Period|Withdrawal by Subject|4|||
126483078|NCT04523220|455065754|FG000|Main Treatment Period|Study drug never adminstered|10|||
126483079|NCT04523220|455065755|FG001|Main Treatment Period|Study drug never adminstered|3|||
126483080|NCT04523220|455065756|FG002|Main Treatment Period|Study drug never adminstered|5|||
126483081|NCT04523220|455065754|FG000|Extension Treatment Period|Physician Decision|1|||
126483082|NCT04523220|455065755|FG001|Extension Treatment Period|Physician Decision|0|||
126483083|NCT04523220|455065756|FG002|Extension Treatment Period|Physician Decision|3|||
126483084|NCT04523220|455065754|FG000|Extension Treatment Period|Other|2|||
126483085|NCT04523220|455065755|FG001|Extension Treatment Period|Other|6|||
126483086|NCT04523220|455065756|FG002|Extension Treatment Period|Other|6|||
126483087|NCT04523220|455065754|FG000|Extension Treatment Period|Subject Decision|5|||
126483088|NCT04523220|455065755|FG001|Extension Treatment Period|Subject Decision|2|||
126483089|NCT04523220|455065756|FG002|Extension Treatment Period|Subject Decision|4|||
126483090|NCT04523220|455065754|FG000|Extension Treatment Period|Death|6|||
126483091|NCT04523220|455065755|FG001|Extension Treatment Period|Death|4|||
126483092|NCT04523220|455065756|FG002|Extension Treatment Period|Death|7|||
126483093|NCT04523220|455065754|FG000|Extension Treatment Period|Adverse Event|6|||
126483094|NCT04523220|455065755|FG001|Extension Treatment Period|Adverse Event|7|||
126483095|NCT04523220|455065756|FG002|Extension Treatment Period|Adverse Event|9|||
126483096|NCT04523220|455065754|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
126483097|NCT04523220|455065755|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
126483098|NCT04523220|455065756|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
126483099|NCT04523220|455065754|FG000|Extension Treatment Period|Study drug never administered|0|||
126483100|NCT04523220|455065755|FG001|Extension Treatment Period|Study drug never administered|1|||
126483101|NCT04523220|455065756|FG002|Extension Treatment Period|Study drug never administered|0|||
126483102|NCT00221403|455065757|FG000|Overall Study|Protocol Violation|1|||
126483103|NCT00221403|455065758|FG001|Overall Study|Protocol Violation|0|||
126483104|NCT00221403|455065759|FG002|Overall Study|Protocol Violation|0|||
126483105|NCT00221403|455065757|FG000|Overall Study|Physician Decision|1|||
126483106|NCT00221403|455065758|FG001|Overall Study|Physician Decision|0|||
126483107|NCT00221403|455065759|FG002|Overall Study|Physician Decision|0|||
126483108|NCT00221403|455065757|FG000|Overall Study|Withdrawal by Subject|0|||
126483109|NCT00221403|455065758|FG001|Overall Study|Withdrawal by Subject|3|||
126483110|NCT00221403|455065759|FG002|Overall Study|Withdrawal by Subject|0|||
126483111|NCT00221403|455065757|FG000|Overall Study|Lack of Efficacy|0|||
126483112|NCT00221403|455065758|FG001|Overall Study|Lack of Efficacy|1|||
126483113|NCT00221403|455065759|FG002|Overall Study|Lack of Efficacy|0|||
126483114|NCT00221403|455065757|FG000|Overall Study|Adverse Event|0|||
126483115|NCT00221403|455065758|FG001|Overall Study|Adverse Event|1|||
126483116|NCT00221403|455065759|FG002|Overall Study|Adverse Event|0|||
126483117|NCT02010775|455065760|FG000|Overall Study|Adverse Event|0|||
126483118|NCT02010775|455065761|FG001|Overall Study|Adverse Event|0|||
126483119|NCT02010775|455065762|FG002|Overall Study|Adverse Event|0|||
126483120|NCT02010775|455065763|FG003|Overall Study|Adverse Event|0|||
126483121|NCT02010775|455065764|FG004|Overall Study|Adverse Event|1|||
126483122|NCT02010775|455065760|FG000|Overall Study|Pregnancy|0|||
126483123|NCT02010775|455065761|FG001|Overall Study|Pregnancy|0|||
126483124|NCT02010775|455065762|FG002|Overall Study|Pregnancy|2|||
126483125|NCT02010775|455065763|FG003|Overall Study|Pregnancy|0|||
126483126|NCT02010775|455065764|FG004|Overall Study|Pregnancy|0|||
126483127|NCT02010775|455065760|FG000|Overall Study|Lost to Follow-up|2|||
126483128|NCT02010775|455065761|FG001|Overall Study|Lost to Follow-up|0|||
126483129|NCT02010775|455065762|FG002|Overall Study|Lost to Follow-up|0|||
126483130|NCT02010775|455065763|FG003|Overall Study|Lost to Follow-up|1|||
126483131|NCT02010775|455065764|FG004|Overall Study|Lost to Follow-up|1|||
126483132|NCT02010775|455065760|FG000|Overall Study|Personal Reasons|3|||
126483133|NCT02010775|455065761|FG001|Overall Study|Personal Reasons|3|||
126483134|NCT02010775|455065762|FG002|Overall Study|Personal Reasons|1|||
126483135|NCT02010775|455065763|FG003|Overall Study|Personal Reasons|2|||
126483136|NCT02010775|455065764|FG004|Overall Study|Personal Reasons|4|||
126483137|NCT00256750|455065765|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
126483138|NCT00256750|455065766|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
126483139|NCT00256750|455065767|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
126483140|NCT00256750|455065765|FG000|Transplanted Pre-Treatment|Other|2|||
126483141|NCT00256750|455065766|FG001|Transplanted Pre-Treatment|Other|0|||
126483142|NCT00256750|455065767|FG002|Transplanted Pre-Treatment|Other|0|||
126483143|NCT00256750|455065765|FG000|Transplanted Pre-Treatment|Death|1|||
126483144|NCT00256750|455065766|FG001|Transplanted Pre-Treatment|Death|0|||
126559269|NCT00819234|455340717|FG009|Overall Study|Physician Decision|2|||
126483145|NCT00256750|455065767|FG002|Transplanted Pre-Treatment|Death|0|||
126483146|NCT00256750|455065765|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
126483147|NCT00256750|455065766|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
126559270|NCT00819234|455340708|FG000|Overall Study|Protocol Violation|0|||
126483148|NCT00256750|455065767|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
126483149|NCT00256750|455065765|FG000|Post-Transplant Treated (12 Months)|Death|3|||
126483150|NCT00256750|455065766|FG001|Post-Transplant Treated (12 Months)|Death|2|||
126483151|NCT00256750|455065767|FG002|Post-Transplant Treated (12 Months)|Death|4|||
126483152|NCT00256750|455065765|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
126483153|NCT00256750|455065766|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
126483154|NCT00256750|455065767|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
126483155|NCT00256750|455065765|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
126483156|NCT00256750|455065766|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
126483157|NCT00256750|455065767|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
126483158|NCT00256750|455065765|FG000|Post-Transplant Treated (12 Months)|Other|5|||
126483159|NCT00256750|455065766|FG001|Post-Transplant Treated (12 Months)|Other|4|||
126483160|NCT00256750|455065767|FG002|Post-Transplant Treated (12 Months)|Other|2|||
126483161|NCT00256750|455065765|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
126483162|NCT00256750|455065766|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
126483163|NCT00256750|455065767|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
126483164|NCT00256750|455065765|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
126483165|NCT00256750|455065766|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
126483166|NCT00256750|455065767|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
126483167|NCT00256750|455065765|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
126483168|NCT00256750|455065766|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
126483169|NCT00256750|455065767|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
126483170|NCT00256750|455065765|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
126483171|NCT00256750|455065766|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
126483172|NCT00256750|455065767|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
126483173|NCT00256750|455065765|FG000|Post-Transplant Treated (24 Months)|Death|3|||
126483174|NCT00256750|455065766|FG001|Post-Transplant Treated (24 Months)|Death|0|||
126483175|NCT00256750|455065767|FG002|Post-Transplant Treated (24 Months)|Death|0|||
126483176|NCT00256750|455065765|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
126483177|NCT00256750|455065766|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
126483178|NCT00256750|455065767|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
126483179|NCT00256750|455065765|FG000|Post-Transplant Treated (24 Months)|Other|2|||
126483180|NCT00256750|455065766|FG001|Post-Transplant Treated (24 Months)|Other|0|||
126483181|NCT00256750|455065767|FG002|Post-Transplant Treated (24 Months)|Other|1|||
126483182|NCT00256750|455065765|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
126483183|NCT00256750|455065766|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
126483184|NCT00256750|455065767|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
126483185|NCT00256750|455065765|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
126483186|NCT00256750|455065766|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
126483187|NCT00256750|455065767|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
126483188|NCT00256750|455065765|FG000|Post-Transplant Treated (36 Months)|Death|0|||
126483189|NCT00256750|455065766|FG001|Post-Transplant Treated (36 Months)|Death|2|||
126483190|NCT00256750|455065767|FG002|Post-Transplant Treated (36 Months)|Death|1|||
126483191|NCT00256750|455065765|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
126483192|NCT00256750|455065766|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
126483193|NCT00256750|455065767|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
126483194|NCT00256750|455065765|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
126483195|NCT00256750|455065766|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
126483196|NCT00256750|455065767|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
126483197|NCT00256750|455065765|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
126483198|NCT00256750|455065766|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
126483199|NCT00256750|455065767|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
126483200|NCT00256750|455065765|FG000|Post-Transplant Treated (36 Months)|Other|0|||
126483201|NCT00256750|455065766|FG001|Post-Transplant Treated (36 Months)|Other|1|||
126483202|NCT00256750|455065767|FG002|Post-Transplant Treated (36 Months)|Other|1|||
126483203|NCT00256750|455065765|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
126483204|NCT00256750|455065766|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
126483205|NCT00256750|455065767|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
126483206|NCT00256750|455065765|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
126483207|NCT00256750|455065766|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
126483208|NCT00256750|455065767|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
126483209|NCT00256750|455065765|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
126483210|NCT00256750|455065766|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
126483211|NCT00256750|455065767|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
126483212|NCT00256750|455065765|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
126483213|NCT00256750|455065766|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
126483214|NCT00256750|455065767|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
126559271|NCT00819234|455340709|FG001|Overall Study|Protocol Violation|0|||
126559272|NCT00819234|455340710|FG002|Overall Study|Protocol Violation|1|||
126559273|NCT00819234|455340711|FG003|Overall Study|Protocol Violation|0|||
126559274|NCT00819234|455340712|FG004|Overall Study|Protocol Violation|0|||
126559275|NCT00819234|455340713|FG005|Overall Study|Protocol Violation|0|||
126559276|NCT00819234|455340714|FG006|Overall Study|Protocol Violation|0|||
126483215|NCT00256750|455065765|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
126483216|NCT00256750|455065766|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
126483217|NCT00256750|455065767|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
126483218|NCT00256750|455065765|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
126483219|NCT00256750|455065766|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
126483220|NCT00256750|455065767|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
126483221|NCT00256750|455065765|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
126483222|NCT00256750|455065766|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
126483223|NCT00256750|455065767|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
126483224|NCT00256750|455065765|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
126483225|NCT00256750|455065766|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
126483226|NCT00256750|455065767|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
126483227|NCT00256750|455065765|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
126483228|NCT00256750|455065766|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
126483229|NCT00256750|455065767|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
126483230|NCT02030041|455065768|FG000|Overall Study|Withdrawal by Subject|2|||
126483231|NCT02030041|455065769|FG001|Overall Study|Withdrawal by Subject|2|||
126483232|NCT02030041|455065770|FG002|Overall Study|Withdrawal by Subject|1|||
126483233|NCT05201703|455065771|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
126483234|NCT05201703|455065772|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
126483235|NCT05201703|455065771|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
126483236|NCT05201703|455065772|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
126483237|NCT01197560|455065773|FG000|Overall Study|Adverse Event|6|||
126483238|NCT01197560|455065774|FG001|Overall Study|Adverse Event|8|||
126483239|NCT01197560|455065773|FG000|Overall Study|Death|3|||
126483240|NCT01197560|455065774|FG001|Overall Study|Death|5|||
126483241|NCT01197560|455065773|FG000|Overall Study|Withdrawal by Subject|1|||
126483242|NCT01197560|455065774|FG001|Overall Study|Withdrawal by Subject|1|||
126483243|NCT01197560|455065773|FG000|Overall Study|Disease progression|40|||
126483244|NCT01197560|455065774|FG001|Overall Study|Disease progression|35|||
126483245|NCT01197560|455065773|FG000|Overall Study|Miscellaneous|4|||
126483246|NCT01197560|455065774|FG001|Overall Study|Miscellaneous|3|||
126483247|NCT01197560|455065773|FG000|Overall Study|Missing|0|||
126483248|NCT01197560|455065774|FG001|Overall Study|Missing|1|||
126483249|NCT02006719|455065775|FG000|Overall Study|Withdrawal by Subject|10|||
126483250|NCT02006719|455065776|FG001|Overall Study|Withdrawal by Subject|2|||
126483251|NCT02006719|455065775|FG000|Overall Study|Lost to Follow-up|5|||
126483252|NCT02006719|455065776|FG001|Overall Study|Lost to Follow-up|1|||
126483253|NCT02006719|455065775|FG000|Overall Study|Protocol Violation|2|||
126483254|NCT02006719|455065776|FG001|Overall Study|Protocol Violation|0|||
126483255|NCT02006719|455065775|FG000|Overall Study|Adverse Event|1|||
126483256|NCT02006719|455065776|FG001|Overall Study|Adverse Event|1|||
126483257|NCT02006719|455065775|FG000|Overall Study|Other/Unknown|0|||
126483258|NCT02006719|455065776|FG001|Overall Study|Other/Unknown|1|||
126483259|NCT04659161|455065777|FG000|Overall Study|Adverse Event|10|||
126483260|NCT04659161|455065778|FG001|Overall Study|Adverse Event|6|||
126483261|NCT04659161|455065777|FG000|Overall Study|Withdrawal by Subject|13|||
126483262|NCT04659161|455065778|FG001|Overall Study|Withdrawal by Subject|12|||
126483263|NCT04659161|455065777|FG000|Overall Study|Other|9|||
126483264|NCT04659161|455065778|FG001|Overall Study|Other|8|||
126483265|NCT01929343|455065779|FG000|Overall Study|Physician Decision|0|||
126483266|NCT01929343|455065780|FG001|Overall Study|Physician Decision|2|||
126483267|NCT01929343|455065781|FG002|Overall Study|Physician Decision|0|||
126483268|NCT01929343|455065779|FG000|Overall Study|Withdrawal by Subject|1|||
126483269|NCT01929343|455065780|FG001|Overall Study|Withdrawal by Subject|0|||
126483270|NCT01929343|455065781|FG002|Overall Study|Withdrawal by Subject|0|||
126483271|NCT02197130|455065784|FG000|Overall Study|Adverse Event|13|||
126483272|NCT02197130|455065785|FG001|Overall Study|Adverse Event|4|||
126483273|NCT02197130|455065786|FG002|Overall Study|Adverse Event|23|||
126483274|NCT02197130|455065784|FG000|Overall Study|Death|0|||
126483275|NCT02197130|455065785|FG001|Overall Study|Death|1|||
126483276|NCT02197130|455065786|FG002|Overall Study|Death|0|||
126483277|NCT02197130|455065784|FG000|Overall Study|Lost to Follow-up|2|||
126483278|NCT02197130|455065785|FG001|Overall Study|Lost to Follow-up|0|||
126483279|NCT02197130|455065786|FG002|Overall Study|Lost to Follow-up|1|||
126483280|NCT02197130|455065784|FG000|Overall Study|Does not meet entrance criteria|0|||
126483281|NCT02197130|455065785|FG001|Overall Study|Does not meet entrance criteria|0|||
126483282|NCT02197130|455065786|FG002|Overall Study|Does not meet entrance criteria|1|||
126483283|NCT02197130|455065784|FG000|Overall Study|Withdrawal by Subject|0|||
126483284|NCT02197130|455065785|FG001|Overall Study|Withdrawal by Subject|3|||
126483285|NCT02197130|455065786|FG002|Overall Study|Withdrawal by Subject|4|||
126483286|NCT02197130|455065784|FG000|Overall Study|Other|1|||
126483287|NCT02197130|455065785|FG001|Overall Study|Other|0|||
126483288|NCT02197130|455065786|FG002|Overall Study|Other|3|||
126483289|NCT00211510|455065789|FG000|Overall Study|Physician Decision|3|||
126483290|NCT00211510|455065790|FG001|Overall Study|Physician Decision|1|||
126483291|NCT00211510|455065789|FG000|Overall Study|Withdrawal by Subject|3|||
126483292|NCT00211510|455065790|FG001|Overall Study|Withdrawal by Subject|1|||
126483293|NCT03338998|455065792|FG000|Treatment Period|Withdrawal by Subject|1|||
126483294|NCT03338998|455065793|FG001|Treatment Period|Withdrawal by Subject|1|||
126483295|NCT03338998|455065792|FG000|Treatment Period|Adverse Event|0|||
126483296|NCT03338998|455065793|FG001|Treatment Period|Adverse Event|2|||
126483297|NCT03338998|455065792|FG000|Treatment Period|Protocol deviation|1|||
126483298|NCT03338998|455065793|FG001|Treatment Period|Protocol deviation|0|||
126483299|NCT03338998|455065792|FG000|Treatment Period|Physician Decision|2|||
126483300|NCT03338998|455065793|FG001|Treatment Period|Physician Decision|0|||
126483301|NCT03338998|455065792|FG000|Treatment Period|Subject failed swallow test|4|||
126483302|NCT03338998|455065793|FG001|Treatment Period|Subject failed swallow test|0|||
126483303|NCT03338998|455065792|FG000|Safety Follow-Up Period|Adverse Event|0|||
126483304|NCT03338998|455065793|FG001|Safety Follow-Up Period|Adverse Event|1|||
126483305|NCT03338998|455065792|FG000|Safety Follow-Up Period|Protocol deviation|1|||
126483306|NCT03338998|455065793|FG001|Safety Follow-Up Period|Protocol deviation|0|||
126483307|NCT03338998|455065792|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
126483308|NCT03338998|455065793|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
126483309|NCT03288129|455065794|FG000|Overall Study|Adverse Event|10|||
126483310|NCT03288129|455065794|FG000|Overall Study|Lost to Follow-up|3|||
126483311|NCT03288129|455065794|FG000|Overall Study|Withdrawal by Subject|3|||
126483312|NCT03288129|455065794|FG000|Overall Study|Withdrawal of consent/assent|1|||
126483313|NCT03288129|455065794|FG000|Overall Study|Other|5|||
126483314|NCT00558558|455065799|FG000|Overall Study|Unable to swallow|1|||
126483315|NCT00558558|455065799|FG000|Overall Study|Withdrawal by Subject|1|||
126483316|NCT00558558|455065799|FG000|Overall Study|Lack of Efficacy|4|||
126483317|NCT03808545|455067570|FG000|Overall Study|Withdrawal by Subject|1|||
126483318|NCT03808545|455067571|FG001|Overall Study|Withdrawal by Subject|1|||
126483319|NCT00980057|455067576|FG000|Overall Study|Death|13|||
126483320|NCT00980057|455067577|FG001|Overall Study|Death|3|||
126483321|NCT00980057|455067576|FG000|Overall Study|Adverse Event|0|||
126483322|NCT00980057|455067577|FG001|Overall Study|Adverse Event|1|||
126483323|NCT00980057|455067576|FG000|Overall Study|Physician Decision|4|||
126483324|NCT00980057|455067577|FG001|Overall Study|Physician Decision|0|||
126483325|NCT00980057|455067576|FG000|Overall Study|Lost to Follow-up|1|||
126483326|NCT00980057|455067577|FG001|Overall Study|Lost to Follow-up|0|||
126483327|NCT00980057|455067576|FG000|Overall Study|Withdrawal by Subject|1|||
126483328|NCT00980057|455067577|FG001|Overall Study|Withdrawal by Subject|1|||
126483329|NCT04980040|455067578|FG000|Overall Study|Violated the Inclusion Criteria|260|||
126483330|NCT04980040|455067578|FG000|Overall Study|Violated the Administration & Dosage|225|||
126483331|NCT04980040|455067578|FG000|Overall Study|Lost to Safety-Follow-up|4|||
126483332|NCT04980040|455067578|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
126483333|NCT01315678|455067579|FG000|Overall Study|Withdrawal by Subject|7|||
126483334|NCT01315678|455067580|FG001|Overall Study|Withdrawal by Subject|3|||
126483335|NCT01315678|455067579|FG000|Overall Study|Adverse Event|3|||
126483336|NCT01315678|455067580|FG001|Overall Study|Adverse Event|1|||
126483337|NCT01315678|455067579|FG000|Overall Study|Lost to Follow-up|1|||
126483338|NCT01315678|455067580|FG001|Overall Study|Lost to Follow-up|0|||
126483339|NCT01315678|455067579|FG000|Overall Study|similar reason to those listed above|3|||
126483340|NCT01315678|455067580|FG001|Overall Study|similar reason to those listed above|2|||
126483341|NCT00573469|455067581|FG000|Overall Study|Adverse Event|1|||
126483342|NCT00573469|455067582|FG001|Overall Study|Adverse Event|1|||
126483343|NCT00573469|455067583|FG002|Overall Study|Adverse Event|1|||
126483344|NCT00573469|455067581|FG000|Overall Study|Withdrawal by Subject|0|||
126483345|NCT00573469|455067582|FG001|Overall Study|Withdrawal by Subject|2|||
126483346|NCT00573469|455067583|FG002|Overall Study|Withdrawal by Subject|0|||
126483347|NCT00573469|455067581|FG000|Overall Study|Other|5|||
126483348|NCT00573469|455067582|FG001|Overall Study|Other|1|||
126483349|NCT00573469|455067583|FG002|Overall Study|Other|3|||
126483350|NCT00004978|455067584|FG000|Overall Study|Death|107|||
126483351|NCT00004978|455067585|FG001|Overall Study|Death|116|||
126483352|NCT00004978|455067584|FG000|Overall Study|Lost to Follow-up|101|||
126483353|NCT00004978|455067585|FG001|Overall Study|Lost to Follow-up|108|||
126483354|NCT00004978|455067584|FG000|Overall Study|Withdrawal by Subject|17|||
126483355|NCT00004978|455067585|FG001|Overall Study|Withdrawal by Subject|26|||
126483356|NCT00004978|455067584|FG000|Overall Study|site closure - not in analysis cohort|19|||
126483357|NCT00004978|455067585|FG001|Overall Study|site closure - not in analysis cohort|20|||
126483358|NCT03761277|455067586|FG000|Enrollment to Implant|Screen Failure|17|||
126483359|NCT03761277|455067586|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
126483360|NCT03761277|455067586|FG000|Enrollment to Implant|Physician Decision|2|||
126483361|NCT03761277|455067586|FG000|Enrollment to Implant|Site Closure|3|||
126483362|NCT03761277|455067586|FG000|Enrollment to Implant|Sponsor Request|2|||
126483363|NCT03761277|455067586|FG000|Post-Implant to 6 Months|Adverse Event|2|||
126483364|NCT03761277|455067586|FG000|Post-Implant to 6 Months|Death|1|||
126722661|NCT01894477|455934501|FG000|Overall Study|protocol changed due SC changed to cord|0|||
126722662|NCT01894477|455934502|FG001|Overall Study|protocol changed due SC changed to cord|1|||
126722663|NCT01592409|455934503|FG000|Overall Study|Withdrawal by Subject|0|||
126722664|NCT01592409|455934504|FG001|Overall Study|Withdrawal by Subject|1|||
126722665|NCT01409031|455934505|FG000|Overall Study|transferred to other hosp|1|||
126483365|NCT03761277|455067586|FG000|Post-Implant to 6 Months|Site Closure|2|||
126483366|NCT03761277|455067586|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
126483367|NCT03761277|455067586|FG000|6 Months to 12 Months|Physician Decision|2|||
126483368|NCT03761277|455067586|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
126483369|NCT03555591|455067587|FG000|Overall Study|Protocol Violation|77|||
126483370|NCT01532414|455067588|FG000|Overall Study|Lost to Follow-up|3|||
126483371|NCT01532414|455067589|FG001|Overall Study|Lost to Follow-up|0|||
126483372|NCT01532414|455067590|FG002|Overall Study|Lost to Follow-up|1|||
126483373|NCT01532414|455067588|FG000|Overall Study|Withdrawal by Subject|3|||
126483374|NCT01532414|455067589|FG001|Overall Study|Withdrawal by Subject|0|||
126483375|NCT01532414|455067590|FG002|Overall Study|Withdrawal by Subject|0|||
126483376|NCT01532414|455067588|FG000|Overall Study|No V6 semen sample|0|||
126483377|NCT01532414|455067589|FG001|Overall Study|No V6 semen sample|1|||
126483378|NCT01532414|455067590|FG002|Overall Study|No V6 semen sample|0|||
126483379|NCT01532414|455067588|FG000|Overall Study|Adverse Event|0|||
126483380|NCT01532414|455067589|FG001|Overall Study|Adverse Event|1|||
126483381|NCT01532414|455067590|FG002|Overall Study|Adverse Event|1|||
126483382|NCT01532414|455067588|FG000|Overall Study|Unable to complete 24 hour PK|0|||
126483383|NCT01532414|455067589|FG001|Overall Study|Unable to complete 24 hour PK|0|||
126483384|NCT01532414|455067590|FG002|Overall Study|Unable to complete 24 hour PK|1|||
126483385|NCT01532414|455067588|FG000|Overall Study|Withdrawn by sponsor|1|||
126483386|NCT01532414|455067589|FG001|Overall Study|Withdrawn by sponsor|0|||
126483387|NCT01532414|455067590|FG002|Overall Study|Withdrawn by sponsor|0|||
126483388|NCT00187486|455067591|FG000|Overall Study|Protocol Violation|1|||
126483389|NCT00578812|455067595|FG000|Overall Study|Not treated|6|||
126483390|NCT00578812|455067596|FG001|Overall Study|Not treated|7|||
126483391|NCT00617773|455067597|FG000|Overall Study|Physician Decision|1|||
126483392|NCT00617773|455067597|FG000|Overall Study|Lack of compliance with the protocol|1|||
126483393|NCT00617773|455067597|FG000|Overall Study|Withdrawal by Subject|1|||
126483394|NCT00617773|455067597|FG000|Overall Study|Death|1|||
126483395|NCT00617773|455067597|FG000|Overall Study|Progressive disease|19|||
126483396|NCT00617773|455067597|FG000|Overall Study|Protocol Violation|1|||
126483397|NCT03217175|455067600|FG000|Overall Study|Physician Decision|4|||
126483398|NCT03217175|455067601|FG001|Overall Study|Physician Decision|1|||
126483399|NCT05035550|455067613|FG000|Overall Study|Withdrawal by Subject|3|||
126483400|NCT05035550|455067614|FG001|Overall Study|Withdrawal by Subject|0|||
126483401|NCT01751867|455067615|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
126483402|NCT01751867|455067616|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
126483403|NCT01751867|455067615|FG000|Overall Study|Diease Progression|4|||
126483404|NCT01751867|455067616|FG001|Overall Study|Diease Progression|18|||
126483405|NCT01751867|455067615|FG000|Overall Study|Adverse Event|8|||
126483406|NCT01751867|455067616|FG001|Overall Study|Adverse Event|15|||
126483407|NCT01751867|455067615|FG000|Overall Study|Poor Compliance|0|||
126483408|NCT01751867|455067616|FG001|Overall Study|Poor Compliance|5|||
126483409|NCT01751867|455067615|FG000|Overall Study|Withdrawal by Subject|3|||
126483410|NCT01751867|455067616|FG001|Overall Study|Withdrawal by Subject|1|||
126483411|NCT01751867|455067615|FG000|Overall Study|Physician Decision|4|||
126483412|NCT01751867|455067616|FG001|Overall Study|Physician Decision|7|||
126483413|NCT01751867|455067615|FG000|Overall Study|Protocol Violation|0|||
126483414|NCT01751867|455067616|FG001|Overall Study|Protocol Violation|2|||
126483415|NCT01751867|455067615|FG000|Overall Study|Death|0|||
126483416|NCT01751867|455067616|FG001|Overall Study|Death|5|||
126483417|NCT01751867|455067615|FG000|Overall Study|Other|11|||
126483418|NCT01751867|455067616|FG001|Overall Study|Other|37|||
126483419|NCT01751867|455067615|FG000|Overall Study|Randomized but not treated.|2|||
126483420|NCT01751867|455067616|FG001|Overall Study|Randomized but not treated.|1|||
126483421|NCT01806545|455067617|FG000|Overall Study|Adverse Event|2|||
126483422|NCT01806545|455067618|FG001|Overall Study|Adverse Event|3|||
126483423|NCT01806545|455067617|FG000|Overall Study|Lost to Follow-up|1|||
126483424|NCT01806545|455067618|FG001|Overall Study|Lost to Follow-up|0|||
126483425|NCT01806545|455067617|FG000|Overall Study|Withdrawal by Subject|3|||
126483426|NCT01806545|455067618|FG001|Overall Study|Withdrawal by Subject|2|||
126559277|NCT00819234|455340715|FG007|Overall Study|Protocol Violation|0|||
126722666|NCT01409031|455934506|FG001|Overall Study|transferred to other hosp|0|||
126483427|NCT01508650|455067619|FG000|Overall Study|Lost to Follow-up|0|||
126483428|NCT01508650|455067620|FG001|Overall Study|Lost to Follow-up|3|||
126483429|NCT02064894|455067621|FG000|Overall Study|Withdrawal by Subject|43|||
126483430|NCT02064894|455067622|FG001|Overall Study|Withdrawal by Subject|102|||
126483431|NCT02064894|455067623|FG002|Overall Study|Withdrawal by Subject|115|||
126483432|NCT01396148|455067624|FG000|Overall Study|Patient Decision|1|||
126483433|NCT00884312|455067627|FG000|Overall Study|Non-fatal Progressive Disease|0|||
126483434|NCT00884312|455067628|FG001|Overall Study|Non-fatal Progressive Disease|8|||
126483435|NCT00884312|455067627|FG000|Overall Study|Fatal Progressive Disease|0|||
126483436|NCT00884312|455067628|FG001|Overall Study|Fatal Progressive Disease|1|||
126483437|NCT00884312|455067627|FG000|Overall Study|Non-fatal Adverse Event|1|||
126483438|NCT00884312|455067628|FG001|Overall Study|Non-fatal Adverse Event|0|||
126483439|NCT00884312|455067627|FG000|Overall Study|Fatal Adverse Event|1|||
126483440|NCT00884312|455067628|FG001|Overall Study|Fatal Adverse Event|4|||
126483441|NCT00884312|455067627|FG000|Overall Study|Withdrawal by Subject|0|||
126483442|NCT00884312|455067628|FG001|Overall Study|Withdrawal by Subject|6|||
126483443|NCT00884312|455067627|FG000|Overall Study|Physician Decision|0|||
126483444|NCT00884312|455067628|FG001|Overall Study|Physician Decision|1|||
126483445|NCT00884312|455067627|FG000|Overall Study|Other|0|||
126483446|NCT00884312|455067628|FG001|Overall Study|Other|4|||
126483447|NCT00884312|455067627|FG000|Overall Study|Did Not Receive Study Drug|0|||
126483448|NCT00884312|455067628|FG001|Overall Study|Did Not Receive Study Drug|1|||
126483449|NCT00224042|455067629|FG000|Overall Study|Adverse Event|2|||
126483450|NCT00224042|455067630|FG001|Overall Study|Adverse Event|1|||
126483451|NCT00224042|455067629|FG000|Overall Study|Protocol Violation|0|||
126483452|NCT00224042|455067630|FG001|Overall Study|Protocol Violation|1|||
126483453|NCT00224042|455067629|FG000|Overall Study|Physician Decision|0|||
126483454|NCT00224042|455067630|FG001|Overall Study|Physician Decision|1|||
126483455|NCT00224042|455067629|FG000|Overall Study|Did not meet lab incusion criteria|2|||
126483456|NCT00224042|455067630|FG001|Overall Study|Did not meet lab incusion criteria|3|||
126483457|NCT00224042|455067629|FG000|Overall Study|Other|2|||
126483458|NCT00224042|455067630|FG001|Overall Study|Other|0|||
126483459|NCT03052725|455067631|FG000|Overall Study|Adverse Event|2|||
126483460|NCT03052725|455067632|FG001|Overall Study|Adverse Event|0|||
126483461|NCT03052725|455067631|FG000|Overall Study|Withdrawal by Subject|3|||
126483462|NCT03052725|455067632|FG001|Overall Study|Withdrawal by Subject|4|||
126483463|NCT03052725|455067631|FG000|Overall Study|Pregnancy|0|||
126483464|NCT03052725|455067632|FG001|Overall Study|Pregnancy|1|||
126483465|NCT03052725|455067631|FG000|Overall Study|Site closure|0|||
126483466|NCT03052725|455067632|FG001|Overall Study|Site closure|1|||
126483467|NCT03052725|455067631|FG000|Overall Study|Study terminated by sponsor|143|||
126483468|NCT03052725|455067632|FG001|Overall Study|Study terminated by sponsor|144|||
126483469|NCT00847379|455067639|FG000|Overall Study|Study terminated by Sponsor|59|||
126483470|NCT00847379|455067640|FG001|Overall Study|Study terminated by Sponsor|57|||
126483471|NCT00847379|455067641|FG002|Overall Study|Study terminated by Sponsor|57|||
126483472|NCT02969369|455067642|FG000|Study|Adverse Event|1|||
126722667|NCT02345252|455934511|FG000|Double-Blind Phase|Adverse Event|2|||
126722668|NCT02345252|455934512|FG001|Double-Blind Phase|Adverse Event|3|||
126722669|NCT02345252|455934511|FG000|Double-Blind Phase|Death|1|||
126722670|NCT02345252|455934512|FG001|Double-Blind Phase|Death|2|||
126722671|NCT02345252|455934511|FG000|Double-Blind Phase|Lack of Efficacy|1|||
126722672|NCT02345252|455934512|FG001|Double-Blind Phase|Lack of Efficacy|0|||
126722673|NCT02345252|455934511|FG000|Double-Blind Phase|Investigator's Discretion|4|||
126722674|NCT02345252|455934512|FG001|Double-Blind Phase|Investigator's Discretion|6|||
126722675|NCT02345252|455934511|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
126722676|NCT02345252|455934512|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
126483473|NCT02969369|455067643|FG001|Study|Adverse Event|6|||
126483474|NCT02969369|455067642|FG000|Study|Lack of Efficacy|0|||
126483475|NCT02969369|455067643|FG001|Study|Lack of Efficacy|1|||
126483476|NCT02969369|455067642|FG000|Study|Lost to Follow-up|0|||
126483477|NCT02969369|455067643|FG001|Study|Lost to Follow-up|1|||
126483478|NCT02969369|455067642|FG000|Study|Withdrawal by Subject|3|||
126483479|NCT02969369|455067643|FG001|Study|Withdrawal by Subject|5|||
126483480|NCT02969369|455067642|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
126722677|NCT02345252|455934511|FG000|Double-Blind Phase|Protocol Violation|2|||
126722678|NCT02345252|455934512|FG001|Double-Blind Phase|Protocol Violation|1|||
126483481|NCT02969369|455067643|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
126483482|NCT02969369|455067642|FG000|Double-blind Period|Adverse Event|1|||
126483483|NCT02969369|455067643|FG001|Double-blind Period|Adverse Event|5|||
126483484|NCT02969369|455067642|FG000|Double-blind Period|Lost to Follow-up|0|||
126483485|NCT02969369|455067643|FG001|Double-blind Period|Lost to Follow-up|1|||
126483486|NCT02969369|455067642|FG000|Double-blind Period|Withdrawal by Subject|2|||
126483487|NCT02969369|455067643|FG001|Double-blind Period|Withdrawal by Subject|3|||
126483488|NCT02969369|455067642|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
126483489|NCT02969369|455067643|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
126483490|NCT02969369|455067642|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
126483491|NCT02969369|455067643|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
126483492|NCT02969369|455067642|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
126483493|NCT02969369|455067643|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
126483494|NCT02969369|455067642|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
126483495|NCT02969369|455067643|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
126483496|NCT00521014|455067644|FG000|Overall Study|Inevaluable, not treated|1|||
126722679|NCT02345252|455934511|FG000|Double-Blind Phase|Withdrew Consent|21|||
126722680|NCT02345252|455934512|FG001|Double-Blind Phase|Withdrew Consent|23|||
126722681|NCT02345252|455934511|FG000|Double-Blind Phase|Lost to Follow-up|8|||
126483497|NCT02794883|455067645|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
126483498|NCT02794883|455067646|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
126483499|NCT02794883|455067647|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
126483500|NCT02794883|455067645|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
126483501|NCT02794883|455067646|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
126483502|NCT02794883|455067647|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
126483503|NCT02794883|455067645|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
126483504|NCT02794883|455067646|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
126483505|NCT02794883|455067647|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
126483506|NCT02794883|455067645|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
126483507|NCT02794883|455067646|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
126483508|NCT02794883|455067647|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
126483509|NCT02794883|455067645|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
126483510|NCT02794883|455067646|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
126483511|NCT02794883|455067647|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
126483512|NCT02794883|455067645|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
126483513|NCT02794883|455067646|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
126483514|NCT02794883|455067647|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
126483515|NCT02794883|455067645|FG000|Follow-up Period (up to 2 Years)|Death|12|||
126483516|NCT02794883|455067646|FG001|Follow-up Period (up to 2 Years)|Death|10|||
126483517|NCT02794883|455067647|FG002|Follow-up Period (up to 2 Years)|Death|10|||
126483518|NCT00003499|455067648|FG000|Overall Study|Not evaluable|8|||
126483519|NCT02864498|455067653|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
126483520|NCT02864498|455067654|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
126483521|NCT02864498|455067655|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
126483522|NCT02864498|455067653|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
126483523|NCT02864498|455067654|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
126483524|NCT02864498|455067655|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
126483525|NCT02864498|455067653|FG000|Overall Study|Investigator Discretion|0|||
126483526|NCT02864498|455067654|FG001|Overall Study|Investigator Discretion|2|||
126483527|NCT02864498|455067655|FG002|Overall Study|Investigator Discretion|1|||
126483528|NCT02864498|455067653|FG000|Overall Study|Lost to Follow-up|8|||
126483529|NCT02864498|455067654|FG001|Overall Study|Lost to Follow-up|6|||
126483530|NCT02864498|455067655|FG002|Overall Study|Lost to Follow-up|3|||
126483531|NCT02864498|455067653|FG000|Overall Study|Lack of Efficacy|5|||
126483532|NCT02864498|455067654|FG001|Overall Study|Lack of Efficacy|3|||
126483533|NCT02864498|455067655|FG002|Overall Study|Lack of Efficacy|3|||
126483534|NCT02864498|455067653|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
126483535|NCT02864498|455067654|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
126483536|NCT02864498|455067655|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
126483537|NCT02864498|455067653|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
126483538|NCT02864498|455067654|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
126483539|NCT02864498|455067655|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
126483540|NCT02864498|455067653|FG000|Overall Study|Subject moved out of the country.|0|||
126483541|NCT02864498|455067654|FG001|Overall Study|Subject moved out of the country.|0|||
126483542|NCT02864498|455067655|FG002|Overall Study|Subject moved out of the country.|1|||
126483543|NCT01812174|455067656|FG000|Overall Study|Death|1|||
126483544|NCT01812174|455067657|FG001|Overall Study|Death|0|||
126483545|NCT01812174|455067656|FG000|Overall Study|Protocol Violation|2|||
126483546|NCT01812174|455067657|FG001|Overall Study|Protocol Violation|0|||
126483547|NCT00851747|455067667|FG000|Overall Study|Physician Decision|6|||
126483548|NCT00851747|455067668|FG001|Overall Study|Physician Decision|6|||
126483549|NCT00851747|455067669|FG002|Overall Study|Physician Decision|6|||
126483550|NCT01854710|455067670|FG000|Overall Study|Withdrawal by Subject|2|||
126483551|NCT01854710|455067671|FG001|Overall Study|Withdrawal by Subject|1|||
126483552|NCT01854710|455067672|FG002|Overall Study|Withdrawal by Subject|0|||
126483553|NCT01854710|455067673|FG003|Overall Study|Withdrawal by Subject|0|||
126483554|NCT01854710|455067674|FG004|Overall Study|Withdrawal by Subject|0|||
126483555|NCT01854710|455067675|FG005|Overall Study|Withdrawal by Subject|0|||
126483556|NCT01854710|455067670|FG000|Overall Study|CRI procedural error|2|||
126483557|NCT01854710|455067671|FG001|Overall Study|CRI procedural error|2|||
126483558|NCT01854710|455067672|FG002|Overall Study|CRI procedural error|2|||
126483559|NCT01854710|455067673|FG003|Overall Study|CRI procedural error|2|||
126483560|NCT01854710|455067674|FG004|Overall Study|CRI procedural error|2|||
126483561|NCT01854710|455067675|FG005|Overall Study|CRI procedural error|2|||
126483562|NCT01844518|455067678|FG000|Overall Study|Adverse Event|7|||
126483563|NCT01844518|455067679|FG001|Overall Study|Adverse Event|1|||
126483564|NCT01844518|455067678|FG000|Overall Study|Lack of Efficacy|17|||
126483565|NCT01844518|455067679|FG001|Overall Study|Lack of Efficacy|5|||
126483566|NCT01844518|455067678|FG000|Overall Study|Participant's request to discontinue|4|||
126722682|NCT02345252|455934512|FG001|Double-Blind Phase|Lost to Follow-up|10|||
126483567|NCT01844518|455067679|FG001|Overall Study|Participant's request to discontinue|1|||
126483568|NCT01844518|455067678|FG000|Overall Study|Poor/Non-compliance|1|||
126483569|NCT01844518|455067679|FG001|Overall Study|Poor/Non-compliance|0|||
126483570|NCT01844518|455067678|FG000|Overall Study|No Longer Met Study Criteria|2|||
126483571|NCT01844518|455067679|FG001|Overall Study|No Longer Met Study Criteria|0|||
126483572|NCT01844518|455067678|FG000|Overall Study|Withdrawal by Subject|9|||
126483573|NCT01844518|455067679|FG001|Overall Study|Withdrawal by Subject|0|||
126483574|NCT01844518|455067678|FG000|Overall Study|Pregnancy|1|||
126483575|NCT01844518|455067679|FG001|Overall Study|Pregnancy|0|||
126483576|NCT00571948|455067681|FG000|Overall Study|Lost to Follow-up|2|||
126483577|NCT00571948|455067682|FG001|Overall Study|Lost to Follow-up|0|||
126483578|NCT00571948|455067681|FG000|Overall Study|Withdrawal by Subject|1|||
126483579|NCT00571948|455067682|FG001|Overall Study|Withdrawal by Subject|2|||
126483580|NCT00571948|455067681|FG000|Overall Study|Protocol Violation|3|||
126483581|NCT00571948|455067682|FG001|Overall Study|Protocol Violation|3|||
126483582|NCT00571948|455067681|FG000|Overall Study|infant refused study meal|3|||
126483583|NCT00571948|455067682|FG001|Overall Study|infant refused study meal|4|||
126483584|NCT00571948|455067681|FG000|Overall Study|Parent were afraid of blood colection|2|||
126722683|NCT02345252|455934511|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
126722684|NCT02345252|455934512|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
126722685|NCT01094730|455934513|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
126722686|NCT01094730|455934514|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
126722687|NCT01094730|455934513|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
126722688|NCT01094730|455934514|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
126722689|NCT01094730|455934513|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
126722690|NCT01094730|455934514|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
126722691|NCT01094730|455934513|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
126722692|NCT01094730|455934514|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
126722693|NCT01094730|455934513|FG000|Period 2 (14 Days)|Protocol Violation|2|||
126722694|NCT01094730|455934514|FG001|Period 2 (14 Days)|Protocol Violation|0|||
126722695|NCT01094730|455934513|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
126722696|NCT01094730|455934514|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
126722697|NCT01094730|455934513|FG000|Period 2 (14 Days)|Adverse Event|0|||
126722698|NCT01094730|455934514|FG001|Period 2 (14 Days)|Adverse Event|1|||
126483585|NCT00571948|455067682|FG001|Overall Study|Parent were afraid of blood colection|5|||
126483586|NCT04112784|455067683|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
126483587|NCT04112784|455067683|FG000|Overall Study|Screen Failures|4|||
126483588|NCT00393029|455067684|FG000|Overall Study|Not treated|0|||
126483589|NCT00393029|455067685|FG001|Overall Study|Not treated|1|||
126483590|NCT03715530|455067686|FG000|Overall Study|Lost to Follow-up|3|||
126483591|NCT03715530|455067687|FG001|Overall Study|Lost to Follow-up|1|||
126483592|NCT03715530|455067688|FG002|Overall Study|Lost to Follow-up|2|||
126483593|NCT01737697|455067691|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126483594|NCT01737697|455067692|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
126483595|NCT01737697|455067693|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126483596|NCT01737697|455067694|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
126483597|NCT01737697|455067695|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
126483598|NCT01737697|455067696|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126483599|NCT01737697|455067697|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126483600|NCT01737697|455067698|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126483601|NCT01737697|455067699|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126483602|NCT01737697|455067700|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126483603|NCT01737697|455067701|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126483604|NCT01737697|455067702|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126483605|NCT01737697|455067703|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126483606|NCT01737697|455067704|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126483607|NCT01737697|455067705|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
126483608|NCT01737697|455067691|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
126483609|NCT01737697|455067692|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
126483610|NCT01737697|455067693|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
126483611|NCT01737697|455067694|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
126483612|NCT01737697|455067695|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
126483613|NCT01737697|455067696|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
126483614|NCT01737697|455067697|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
126483615|NCT01737697|455067698|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
126483616|NCT01737697|455067699|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
126483617|NCT01737697|455067700|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
126483618|NCT01737697|455067701|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
126483619|NCT01737697|455067702|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
126483620|NCT01737697|455067703|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
126483621|NCT01737697|455067704|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
126722699|NCT01094730|455934513|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
126722700|NCT01094730|455934514|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
126483622|NCT01737697|455067705|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
126483623|NCT01737697|455067691|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483624|NCT01737697|455067692|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483625|NCT01737697|455067693|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483626|NCT01737697|455067694|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
126483627|NCT01737697|455067695|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483628|NCT01737697|455067696|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483629|NCT01737697|455067697|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483630|NCT01737697|455067698|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483631|NCT01737697|455067699|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483632|NCT01737697|455067700|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483633|NCT01737697|455067701|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483634|NCT01737697|455067702|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483635|NCT01737697|455067703|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483636|NCT01737697|455067704|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483637|NCT01737697|455067705|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
126483638|NCT01737697|455067691|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483639|NCT01737697|455067692|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
126483640|NCT01737697|455067693|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483641|NCT01737697|455067694|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483642|NCT01737697|455067695|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483643|NCT01737697|455067696|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483644|NCT01737697|455067697|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483645|NCT01737697|455067698|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483646|NCT01737697|455067699|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483647|NCT01737697|455067700|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483648|NCT01737697|455067701|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483649|NCT01737697|455067702|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483650|NCT01737697|455067703|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483651|NCT01737697|455067704|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483652|NCT01737697|455067705|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
126483653|NCT01737697|455067691|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483654|NCT01737697|455067692|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483655|NCT01737697|455067693|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483656|NCT01737697|455067694|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483657|NCT01737697|455067695|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
126483658|NCT01737697|455067696|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483659|NCT01737697|455067697|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483660|NCT01737697|455067698|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483661|NCT01737697|455067699|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483662|NCT01737697|455067700|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483663|NCT01737697|455067701|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483664|NCT01737697|455067702|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483665|NCT01737697|455067703|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483666|NCT01737697|455067704|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483667|NCT01737697|455067705|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
126483668|NCT01737697|455067691|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
126483669|NCT01737697|455067692|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
126483670|NCT01737697|455067693|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
126483671|NCT01737697|455067694|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
126483672|NCT01737697|455067695|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
126483673|NCT01737697|455067696|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
126483674|NCT01737697|455067697|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
126483675|NCT01737697|455067698|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
126483676|NCT01737697|455067699|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
126483677|NCT01737697|455067700|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
126483678|NCT01737697|455067701|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
126483679|NCT01737697|455067702|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
126483680|NCT01737697|455067703|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
126483681|NCT01737697|455067704|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
126483682|NCT01737697|455067705|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
126483683|NCT01737697|455067691|FG000|Subacute Phase|Adverse Event|0|||
126483684|NCT01737697|455067692|FG001|Subacute Phase|Adverse Event|0|||
126483685|NCT01737697|455067693|FG002|Subacute Phase|Adverse Event|0|||
126483686|NCT01737697|455067694|FG003|Subacute Phase|Adverse Event|0|||
126483687|NCT01737697|455067695|FG004|Subacute Phase|Adverse Event|0|||
126483688|NCT01737697|455067696|FG005|Subacute Phase|Adverse Event|1|||
126559278|NCT00819234|455340716|FG008|Overall Study|Protocol Violation|0|||
126483689|NCT01737697|455067697|FG006|Subacute Phase|Adverse Event|1|||
126483690|NCT01737697|455067698|FG007|Subacute Phase|Adverse Event|1|||
126483691|NCT01737697|455067699|FG008|Subacute Phase|Adverse Event|1|||
126483692|NCT01737697|455067700|FG009|Subacute Phase|Adverse Event|1|||
126483693|NCT01737697|455067701|FG010|Subacute Phase|Adverse Event|4|||
126483694|NCT01737697|455067702|FG011|Subacute Phase|Adverse Event|1|||
126483695|NCT01737697|455067703|FG012|Subacute Phase|Adverse Event|1|||
126483696|NCT01737697|455067704|FG013|Subacute Phase|Adverse Event|0|||
126483697|NCT01737697|455067705|FG014|Subacute Phase|Adverse Event|0|||
126483698|NCT01737697|455067691|FG000|Subacute Phase|Withdrawal by Subject|0|||
126483699|NCT01737697|455067692|FG001|Subacute Phase|Withdrawal by Subject|0|||
126483700|NCT01737697|455067693|FG002|Subacute Phase|Withdrawal by Subject|0|||
126483701|NCT01737697|455067694|FG003|Subacute Phase|Withdrawal by Subject|0|||
126722701|NCT04171037|455934515|FG000|Overall Study|Lost to Follow-up|1|||
126722702|NCT04171037|455934516|FG001|Overall Study|Lost to Follow-up|0|||
126722703|NCT04171037|455934515|FG000|Overall Study|Physician Decision|3|||
126722704|NCT04171037|455934516|FG001|Overall Study|Physician Decision|3|||
126722705|NCT00779324|455934517|FG000|Overall Study|Lost to Follow-up|2|||
126722706|NCT00779324|455934518|FG001|Overall Study|Lost to Follow-up|1|||
126722707|NCT00779324|455934517|FG000|Overall Study|Withdrawal by Subject|4|||
126722708|NCT00779324|455934518|FG001|Overall Study|Withdrawal by Subject|2|||
126722709|NCT00779324|455934517|FG000|Overall Study|Missed visit|1|||
126483702|NCT01737697|455067695|FG004|Subacute Phase|Withdrawal by Subject|0|||
126483703|NCT01737697|455067696|FG005|Subacute Phase|Withdrawal by Subject|1|||
126483704|NCT01737697|455067697|FG006|Subacute Phase|Withdrawal by Subject|0|||
126483705|NCT01737697|455067698|FG007|Subacute Phase|Withdrawal by Subject|2|||
126483706|NCT01737697|455067699|FG008|Subacute Phase|Withdrawal by Subject|0|||
126483707|NCT01737697|455067700|FG009|Subacute Phase|Withdrawal by Subject|1|||
126483708|NCT01737697|455067701|FG010|Subacute Phase|Withdrawal by Subject|0|||
126483709|NCT01737697|455067702|FG011|Subacute Phase|Withdrawal by Subject|1|||
126483710|NCT01737697|455067703|FG012|Subacute Phase|Withdrawal by Subject|1|||
126483711|NCT01737697|455067704|FG013|Subacute Phase|Withdrawal by Subject|1|||
126483712|NCT01737697|455067705|FG014|Subacute Phase|Withdrawal by Subject|0|||
126483713|NCT01737697|455067691|FG000|Subacute Phase|Lost to Follow-up|0|||
126483714|NCT01737697|455067692|FG001|Subacute Phase|Lost to Follow-up|0|||
126483715|NCT01737697|455067693|FG002|Subacute Phase|Lost to Follow-up|0|||
126483716|NCT01737697|455067694|FG003|Subacute Phase|Lost to Follow-up|0|||
126483717|NCT01737697|455067695|FG004|Subacute Phase|Lost to Follow-up|0|||
126483718|NCT01737697|455067696|FG005|Subacute Phase|Lost to Follow-up|0|||
126483719|NCT01737697|455067697|FG006|Subacute Phase|Lost to Follow-up|0|||
126483720|NCT01737697|455067698|FG007|Subacute Phase|Lost to Follow-up|0|||
126483721|NCT01737697|455067699|FG008|Subacute Phase|Lost to Follow-up|0|||
126483722|NCT01737697|455067700|FG009|Subacute Phase|Lost to Follow-up|0|||
126483723|NCT01737697|455067701|FG010|Subacute Phase|Lost to Follow-up|0|||
126722710|NCT00779324|455934518|FG001|Overall Study|Missed visit|1|||
126722711|NCT00617409|455934519|FG000|Overall Study|Withdrawal by Subject|4|||
126483724|NCT01737697|455067702|FG011|Subacute Phase|Lost to Follow-up|0|||
126483725|NCT01737697|455067703|FG012|Subacute Phase|Lost to Follow-up|0|||
126483726|NCT01737697|455067704|FG013|Subacute Phase|Lost to Follow-up|0|||
126483727|NCT01737697|455067705|FG014|Subacute Phase|Lost to Follow-up|1|||
126483728|NCT01737697|455067691|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
126483729|NCT01737697|455067692|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
126483730|NCT01737697|455067693|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
126483731|NCT01737697|455067694|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
126483732|NCT01737697|455067695|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
126483733|NCT01737697|455067696|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
126483734|NCT01737697|455067697|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
126483735|NCT01737697|455067698|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
126483736|NCT01737697|455067699|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
126483737|NCT01737697|455067700|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
126483738|NCT01737697|455067701|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
126483739|NCT01737697|455067702|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
126483740|NCT01737697|455067703|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
126483741|NCT01737697|455067704|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
126483742|NCT01737697|455067705|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
126483743|NCT01737697|455067691|FG000|Subacute Phase|Protocol Violation|0|||
126483744|NCT01737697|455067692|FG001|Subacute Phase|Protocol Violation|0|||
126483745|NCT01737697|455067693|FG002|Subacute Phase|Protocol Violation|0|||
126483746|NCT01737697|455067694|FG003|Subacute Phase|Protocol Violation|0|||
126483747|NCT01737697|455067695|FG004|Subacute Phase|Protocol Violation|0|||
126483748|NCT01737697|455067696|FG005|Subacute Phase|Protocol Violation|1|||
126559279|NCT00819234|455340717|FG009|Overall Study|Protocol Violation|0|||
126483749|NCT01737697|455067697|FG006|Subacute Phase|Protocol Violation|0|||
126483750|NCT01737697|455067698|FG007|Subacute Phase|Protocol Violation|0|||
126483751|NCT01737697|455067699|FG008|Subacute Phase|Protocol Violation|0|||
126483752|NCT01737697|455067700|FG009|Subacute Phase|Protocol Violation|0|||
126483753|NCT01737697|455067701|FG010|Subacute Phase|Protocol Violation|1|||
126483754|NCT01737697|455067702|FG011|Subacute Phase|Protocol Violation|0|||
126722712|NCT00617409|455934520|FG001|Overall Study|Withdrawal by Subject|1|||
126722713|NCT00617409|455934521|FG002|Overall Study|Withdrawal by Subject|2|||
126483755|NCT01737697|455067703|FG012|Subacute Phase|Protocol Violation|0|||
126483756|NCT01737697|455067704|FG013|Subacute Phase|Protocol Violation|0|||
126483757|NCT01737697|455067705|FG014|Subacute Phase|Protocol Violation|0|||
126483758|NCT01737697|455067691|FG000|Subacute Phase|Physician Decision|0|||
126483759|NCT01737697|455067692|FG001|Subacute Phase|Physician Decision|0|||
126483760|NCT01737697|455067693|FG002|Subacute Phase|Physician Decision|0|||
126483761|NCT01737697|455067694|FG003|Subacute Phase|Physician Decision|0|||
126483762|NCT01737697|455067695|FG004|Subacute Phase|Physician Decision|0|||
126483763|NCT01737697|455067696|FG005|Subacute Phase|Physician Decision|0|||
126483764|NCT01737697|455067697|FG006|Subacute Phase|Physician Decision|0|||
126483765|NCT01737697|455067698|FG007|Subacute Phase|Physician Decision|0|||
126483766|NCT01737697|455067699|FG008|Subacute Phase|Physician Decision|1|||
126483767|NCT01737697|455067700|FG009|Subacute Phase|Physician Decision|0|||
126483768|NCT01737697|455067701|FG010|Subacute Phase|Physician Decision|0|||
126483769|NCT01737697|455067702|FG011|Subacute Phase|Physician Decision|0|||
126483770|NCT01737697|455067703|FG012|Subacute Phase|Physician Decision|0|||
126483771|NCT01737697|455067704|FG013|Subacute Phase|Physician Decision|0|||
126483772|NCT01737697|455067705|FG014|Subacute Phase|Physician Decision|0|||
126483773|NCT01737697|455067691|FG000|Subacute Phase|Death|0|||
126483774|NCT01737697|455067692|FG001|Subacute Phase|Death|0|||
126483775|NCT01737697|455067693|FG002|Subacute Phase|Death|0|||
126483776|NCT01737697|455067694|FG003|Subacute Phase|Death|0|||
126483777|NCT01737697|455067695|FG004|Subacute Phase|Death|0|||
126483778|NCT01737697|455067696|FG005|Subacute Phase|Death|0|||
126483779|NCT01737697|455067697|FG006|Subacute Phase|Death|0|||
126483780|NCT01737697|455067698|FG007|Subacute Phase|Death|0|||
126483781|NCT01737697|455067699|FG008|Subacute Phase|Death|0|||
126483782|NCT01737697|455067700|FG009|Subacute Phase|Death|0|||
126483783|NCT01737697|455067701|FG010|Subacute Phase|Death|1|||
126483784|NCT01737697|455067702|FG011|Subacute Phase|Death|0|||
126483785|NCT01737697|455067703|FG012|Subacute Phase|Death|0|||
126483786|NCT01737697|455067704|FG013|Subacute Phase|Death|0|||
126483787|NCT01737697|455067705|FG014|Subacute Phase|Death|0|||
126483788|NCT03648983|455067710|FG000|Overall Study|Study was terminated due to PI departure|95|||
126483789|NCT01269463|455067711|FG000|First Intervention|Withdrawal by Subject|1|||
126483790|NCT01269463|455067712|FG001|First Intervention|Withdrawal by Subject|0|||
126483791|NCT01269463|455067711|FG000|First Intervention|Adverse Event|1|||
126483792|NCT01269463|455067712|FG001|First Intervention|Adverse Event|0|||
126483793|NCT01269463|455067711|FG000|First Intervention|Lack of Efficacy|0|||
126483794|NCT01269463|455067712|FG001|First Intervention|Lack of Efficacy|1|||
126483795|NCT01269463|455067711|FG000|First Intervention|Physician Decision|0|||
126483796|NCT01269463|455067712|FG001|First Intervention|Physician Decision|1|||
126483797|NCT04404361|455067716|FG000|Overall Study|Death|12|||
126483798|NCT04404361|455067717|FG001|Overall Study|Death|12|||
126483799|NCT04404361|455067716|FG000|Overall Study|Withdrawal by Subject|13|||
126483800|NCT04404361|455067717|FG001|Overall Study|Withdrawal by Subject|5|||
126483801|NCT04404361|455067716|FG000|Overall Study|Lost to Follow-up|6|||
126483802|NCT04404361|455067717|FG001|Overall Study|Lost to Follow-up|3|||
126483803|NCT04404361|455067716|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
126483804|NCT04404361|455067717|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
126722714|NCT00617409|455934519|FG000|Overall Study|Adverse Event|0|||
126483805|NCT02862171|455067718|FG000|Overall Study|Death|1|||
126483806|NCT02862171|455067718|FG000|Overall Study|Lost to Follow-up|13|||
126483807|NCT02862171|455067718|FG000|Overall Study|Withdrawal by Subject|57|||
126483808|NCT02862171|455067718|FG000|Overall Study|Non-compliance|4|||
126483809|NCT02862171|455067718|FG000|Overall Study|HIV-1 seroconversion|18|||
126483810|NCT02549937|455067720|FG000|Overall Study|Death|0|||
126483811|NCT02549937|455067721|FG001|Overall Study|Death|1|||
126483812|NCT02549937|455067722|FG002|Overall Study|Death|0|||
126483813|NCT02549937|455067723|FG003|Overall Study|Death|1|||
126483814|NCT02549937|455067724|FG004|Overall Study|Death|0|||
126483815|NCT02549937|455067725|FG005|Overall Study|Death|8|||
126483816|NCT02549937|455067726|FG006|Overall Study|Death|0|||
126483817|NCT02549937|455067727|FG007|Overall Study|Death|0|||
126483818|NCT02549937|455067728|FG008|Overall Study|Death|19|||
126483819|NCT02549937|455067720|FG000|Overall Study|No follow up required|3|||
126483820|NCT02549937|455067721|FG001|Overall Study|No follow up required|6|||
126483821|NCT02549937|455067722|FG002|Overall Study|No follow up required|3|||
126483822|NCT02549937|455067723|FG003|Overall Study|No follow up required|8|||
126483823|NCT02549937|455067724|FG004|Overall Study|No follow up required|12|||
126483824|NCT02549937|455067725|FG005|Overall Study|No follow up required|21|||
126483825|NCT02549937|455067726|FG006|Overall Study|No follow up required|9|||
126722715|NCT00617409|455934520|FG001|Overall Study|Adverse Event|2|||
126483826|NCT02549937|455067727|FG007|Overall Study|No follow up required|11|||
126483827|NCT02549937|455067728|FG008|Overall Study|No follow up required|0|||
126483828|NCT02549937|455067720|FG000|Overall Study|Other|0|||
126483829|NCT02549937|455067721|FG001|Overall Study|Other|0|||
126483830|NCT02549937|455067722|FG002|Overall Study|Other|0|||
126483831|NCT02549937|455067723|FG003|Overall Study|Other|0|||
126483832|NCT02549937|455067724|FG004|Overall Study|Other|1|||
126722716|NCT00617409|455934521|FG002|Overall Study|Adverse Event|3|||
126483833|NCT02549937|455067725|FG005|Overall Study|Other|0|||
126483834|NCT02549937|455067726|FG006|Overall Study|Other|3|||
126483835|NCT02549937|455067727|FG007|Overall Study|Other|2|||
126483836|NCT02549937|455067728|FG008|Overall Study|Other|3|||
126483837|NCT02549937|455067720|FG000|Overall Study|Lost to Follow-up|0|||
126483838|NCT02549937|455067721|FG001|Overall Study|Lost to Follow-up|0|||
126483839|NCT02549937|455067722|FG002|Overall Study|Lost to Follow-up|0|||
126483840|NCT02549937|455067723|FG003|Overall Study|Lost to Follow-up|0|||
126483841|NCT02549937|455067724|FG004|Overall Study|Lost to Follow-up|0|||
126483842|NCT02549937|455067725|FG005|Overall Study|Lost to Follow-up|0|||
126483843|NCT02549937|455067726|FG006|Overall Study|Lost to Follow-up|0|||
126483844|NCT02549937|455067727|FG007|Overall Study|Lost to Follow-up|0|||
126483845|NCT02549937|455067728|FG008|Overall Study|Lost to Follow-up|3|||
126483846|NCT02549937|455067720|FG000|Overall Study|Withdrawal by Subject|0|||
126483847|NCT02549937|455067721|FG001|Overall Study|Withdrawal by Subject|0|||
126483848|NCT02549937|455067722|FG002|Overall Study|Withdrawal by Subject|0|||
126483849|NCT02549937|455067723|FG003|Overall Study|Withdrawal by Subject|0|||
126483850|NCT02549937|455067724|FG004|Overall Study|Withdrawal by Subject|0|||
126483851|NCT02549937|455067725|FG005|Overall Study|Withdrawal by Subject|1|||
126483852|NCT02549937|455067726|FG006|Overall Study|Withdrawal by Subject|4|||
126483853|NCT02549937|455067727|FG007|Overall Study|Withdrawal by Subject|3|||
126483854|NCT02549937|455067728|FG008|Overall Study|Withdrawal by Subject|2|||
126483855|NCT02549937|455067720|FG000|Overall Study|Sponsor Decision|0|||
126483856|NCT02549937|455067721|FG001|Overall Study|Sponsor Decision|0|||
126483857|NCT02549937|455067722|FG002|Overall Study|Sponsor Decision|0|||
126483858|NCT02549937|455067723|FG003|Overall Study|Sponsor Decision|0|||
126483859|NCT02549937|455067724|FG004|Overall Study|Sponsor Decision|0|||
126483860|NCT02549937|455067725|FG005|Overall Study|Sponsor Decision|0|||
126483861|NCT02549937|455067726|FG006|Overall Study|Sponsor Decision|0|||
126483862|NCT02549937|455067727|FG007|Overall Study|Sponsor Decision|0|||
126483863|NCT02549937|455067728|FG008|Overall Study|Sponsor Decision|6|||
126483864|NCT03930797|455067729|FG000|Overall Study|Lost to Follow-up|3|||
126483865|NCT03930797|455067730|FG001|Overall Study|Lost to Follow-up|10|||
126483866|NCT00662012|455067731|FG000|Overall Study|Lost to Follow-up|85|||
126483867|NCT00662012|455067731|FG000|Overall Study|Death|1|||
126483868|NCT00662012|455067731|FG000|Overall Study|Withdrawal by Subject|1|||
126483869|NCT02144012|455067734|FG000|Overall Study|Adverse Event|1|||
126483870|NCT02144012|455067735|FG001|Overall Study|Adverse Event|0|||
126483871|NCT02144012|455067734|FG000|Overall Study|Death|1|||
126483872|NCT02144012|455067735|FG001|Overall Study|Death|0|||
126483873|NCT02144012|455067734|FG000|Overall Study|Withdrawal by Subject|11|||
126483874|NCT02144012|455067735|FG001|Overall Study|Withdrawal by Subject|3|||
126483875|NCT02144012|455067734|FG000|Overall Study|Study Terminated by Sponsor|18|||
126483876|NCT02144012|455067735|FG001|Overall Study|Study Terminated by Sponsor|12|||
126483877|NCT02144012|455067734|FG000|Overall Study|Other|3|||
126483878|NCT02144012|455067735|FG001|Overall Study|Other|0|||
126483879|NCT02915016|455067736|FG000|Overall Study|Lost to Follow-up|4|||
126483880|NCT02915016|455067737|FG001|Overall Study|Lost to Follow-up|2|||
126483881|NCT02915016|455067738|FG002|Overall Study|Lost to Follow-up|5|||
126483882|NCT02915016|455067739|FG003|Overall Study|Lost to Follow-up|3|||
126483883|NCT02915016|455067740|FG004|Overall Study|Lost to Follow-up|5|||
126483884|NCT02915016|455067741|FG005|Overall Study|Lost to Follow-up|2|||
126483885|NCT02915016|455067742|FG006|Overall Study|Lost to Follow-up|8|||
126483886|NCT02915016|455067743|FG007|Overall Study|Lost to Follow-up|2|||
126483887|NCT02915016|455067736|FG000|Overall Study|Physician Decision|0|||
126483888|NCT02915016|455067737|FG001|Overall Study|Physician Decision|0|||
126483889|NCT02915016|455067738|FG002|Overall Study|Physician Decision|1|||
126483890|NCT02915016|455067739|FG003|Overall Study|Physician Decision|0|||
126483891|NCT02915016|455067740|FG004|Overall Study|Physician Decision|0|||
126483892|NCT02915016|455067741|FG005|Overall Study|Physician Decision|1|||
126483893|NCT02915016|455067742|FG006|Overall Study|Physician Decision|2|||
126483894|NCT02915016|455067743|FG007|Overall Study|Physician Decision|0|||
126772576|NCT00068406|456123621|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
126483895|NCT02915016|455067736|FG000|Overall Study|Withdrawal by Subject|2|||
126483896|NCT02915016|455067737|FG001|Overall Study|Withdrawal by Subject|0|||
126483897|NCT02915016|455067738|FG002|Overall Study|Withdrawal by Subject|1|||
126483898|NCT02915016|455067739|FG003|Overall Study|Withdrawal by Subject|0|||
126483899|NCT02915016|455067740|FG004|Overall Study|Withdrawal by Subject|1|||
126483900|NCT02915016|455067741|FG005|Overall Study|Withdrawal by Subject|3|||
126483901|NCT02915016|455067742|FG006|Overall Study|Withdrawal by Subject|1|||
126483902|NCT02915016|455067743|FG007|Overall Study|Withdrawal by Subject|1|||
126483903|NCT02915016|455067736|FG000|Overall Study|Elected not to continue|0|||
126483904|NCT02915016|455067737|FG001|Overall Study|Elected not to continue|0|||
126483905|NCT02915016|455067738|FG002|Overall Study|Elected not to continue|0|||
126483906|NCT02915016|455067739|FG003|Overall Study|Elected not to continue|1|||
126483907|NCT02915016|455067740|FG004|Overall Study|Elected not to continue|0|||
126483908|NCT02915016|455067741|FG005|Overall Study|Elected not to continue|0|||
126483909|NCT02915016|455067742|FG006|Overall Study|Elected not to continue|1|||
126483910|NCT02915016|455067743|FG007|Overall Study|Elected not to continue|0|||
126483911|NCT02915016|455067736|FG000|Overall Study|HIV infection|1|||
126483912|NCT02915016|455067737|FG001|Overall Study|HIV infection|1|||
126483913|NCT02915016|455067738|FG002|Overall Study|HIV infection|1|||
126483914|NCT02915016|455067739|FG003|Overall Study|HIV infection|0|||
126483915|NCT02915016|455067740|FG004|Overall Study|HIV infection|1|||
126483916|NCT02915016|455067741|FG005|Overall Study|HIV infection|0|||
126483917|NCT02915016|455067742|FG006|Overall Study|HIV infection|0|||
126483918|NCT02915016|455067743|FG007|Overall Study|HIV infection|0|||
126483919|NCT02915016|455067736|FG000|Overall Study|Participant unable to adhere|0|||
126483920|NCT02915016|455067737|FG001|Overall Study|Participant unable to adhere|0|||
126483921|NCT02915016|455067738|FG002|Overall Study|Participant unable to adhere|0|||
126483922|NCT02915016|455067739|FG003|Overall Study|Participant unable to adhere|0|||
126483923|NCT02915016|455067740|FG004|Overall Study|Participant unable to adhere|0|||
126483924|NCT02915016|455067741|FG005|Overall Study|Participant unable to adhere|0|||
126483925|NCT02915016|455067742|FG006|Overall Study|Participant unable to adhere|0|||
126483926|NCT02915016|455067743|FG007|Overall Study|Participant unable to adhere|1|||
126483927|NCT05255068|455069010|FG000|Overall Study|Lost to Follow-up|0|||
126483928|NCT05255068|455069011|FG001|Overall Study|Lost to Follow-up|1|||
126483929|NCT00540514|455069014|FG000|Overall Study|Still on treatment|3|||
126483930|NCT00540514|455069015|FG001|Overall Study|Still on treatment|0|||
126483931|NCT00540514|455069014|FG000|Overall Study|Unacceptable Toxicity|61|||
126483932|NCT00540514|455069015|FG001|Overall Study|Unacceptable Toxicity|62|||
126483933|NCT00540514|455069014|FG000|Overall Study|Adverse Event|20|||
126483934|NCT00540514|455069015|FG001|Overall Study|Adverse Event|24|||
126483935|NCT00540514|455069014|FG000|Overall Study|Physician Decision|86|||
126483936|NCT00540514|455069015|FG001|Overall Study|Physician Decision|99|||
126483937|NCT00540514|455069014|FG000|Overall Study|Protocol Deviation|3|||
126722717|NCT00617409|455934519|FG000|Overall Study|Disease Progression|8|||
126722718|NCT00617409|455934520|FG001|Overall Study|Disease Progression|8|||
126722719|NCT00617409|455934521|FG002|Overall Study|Disease Progression|18|||
126722720|NCT00617409|455934519|FG000|Overall Study|Death|3|||
126722721|NCT00617409|455934520|FG001|Overall Study|Death|5|||
126722722|NCT00617409|455934521|FG002|Overall Study|Death|4|||
126722723|NCT00617409|455934519|FG000|Overall Study|Alternative Therapy|1|||
126722724|NCT00617409|455934520|FG001|Overall Study|Alternative Therapy|2|||
126722725|NCT00617409|455934521|FG002|Overall Study|Alternative Therapy|0|||
126722726|NCT01100307|455934527|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
126722727|NCT01100307|455934528|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
126722728|NCT01100307|455934527|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
126722729|NCT01100307|455934528|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
126722730|NCT01100307|455934527|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
126722731|NCT01100307|455934528|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
126722732|NCT01100307|455934527|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
126722733|NCT01100307|455934528|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
126722734|NCT01100307|455934527|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
126722735|NCT01100307|455934528|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
126722736|NCT01100307|455934527|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
126722737|NCT01100307|455934528|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
126722738|NCT00406640|455934532|FG000|Acute Phase|Adverse Event|18|||
126483938|NCT00540514|455069015|FG001|Overall Study|Protocol Deviation|4|||
126483939|NCT00540514|455069014|FG000|Overall Study|Lost to Follow-up|1|||
126483940|NCT00540514|455069015|FG001|Overall Study|Lost to Follow-up|1|||
126483941|NCT00540514|455069014|FG000|Overall Study|Withdrawal by Subject|65|||
126483942|NCT00540514|455069015|FG001|Overall Study|Withdrawal by Subject|67|||
126483943|NCT00540514|455069014|FG000|Overall Study|Excluded prior to treatment|7|||
126483944|NCT00540514|455069015|FG001|Overall Study|Excluded prior to treatment|7|||
126483945|NCT00540514|455069014|FG000|Overall Study|Paclitaxel not available|0|||
126483946|NCT00540514|455069015|FG001|Overall Study|Paclitaxel not available|2|||
126483947|NCT02501473|455069016|FG000|Overall Study|Study Terminated|2|||
126483948|NCT02501473|455069017|FG001|Overall Study|Study Terminated|3|||
126483949|NCT02501473|455069018|FG002|Overall Study|Study Terminated|7|||
126483950|NCT02501473|455069019|FG003|Overall Study|Study Terminated|9|||
126483951|NCT02501473|455069020|FG004|Overall Study|Study Terminated|2|||
126483952|NCT02501473|455069021|FG005|Overall Study|Study Terminated|10|||
126483953|NCT02501473|455069022|FG006|Overall Study|Study Terminated|1|||
126483954|NCT02501473|455069023|FG007|Overall Study|Study Terminated|0|||
126559280|NCT00819234|455340708|FG000|Overall Study|Lost to Follow-up|2|||
126559281|NCT00819234|455340709|FG001|Overall Study|Lost to Follow-up|2|||
126483955|NCT02501473|455069016|FG000|Overall Study|Withdrawal by Subject|0|||
126483956|NCT02501473|455069017|FG001|Overall Study|Withdrawal by Subject|0|||
126483957|NCT02501473|455069018|FG002|Overall Study|Withdrawal by Subject|3|||
126483958|NCT02501473|455069019|FG003|Overall Study|Withdrawal by Subject|3|||
126722739|NCT00406640|455934533|FG001|Acute Phase|Adverse Event|13|||
126722740|NCT00406640|455934532|FG000|Acute Phase|Failed to Return|5|||
126722741|NCT00406640|455934533|FG001|Acute Phase|Failed to Return|1|||
126722742|NCT00406640|455934532|FG000|Acute Phase|Physician Decision|0|||
126722743|NCT00406640|455934533|FG001|Acute Phase|Physician Decision|1|||
126483959|NCT02501473|455069020|FG004|Overall Study|Withdrawal by Subject|2|||
126483960|NCT02501473|455069021|FG005|Overall Study|Withdrawal by Subject|2|||
126483961|NCT02501473|455069022|FG006|Overall Study|Withdrawal by Subject|0|||
126483962|NCT02501473|455069023|FG007|Overall Study|Withdrawal by Subject|0|||
126483963|NCT02501473|455069016|FG000|Overall Study|Death|0|||
126483964|NCT02501473|455069017|FG001|Overall Study|Death|0|||
126483965|NCT02501473|455069018|FG002|Overall Study|Death|1|||
126483966|NCT02501473|455069019|FG003|Overall Study|Death|1|||
126483967|NCT02501473|455069020|FG004|Overall Study|Death|0|||
126483968|NCT02501473|455069021|FG005|Overall Study|Death|1|||
126483969|NCT02501473|455069022|FG006|Overall Study|Death|0|||
126483970|NCT02501473|455069023|FG007|Overall Study|Death|0|||
126483971|NCT02501473|455069016|FG000|Overall Study|Lost to Follow-up|1|||
126483972|NCT02501473|455069017|FG001|Overall Study|Lost to Follow-up|0|||
126483973|NCT02501473|455069018|FG002|Overall Study|Lost to Follow-up|1|||
126483974|NCT02501473|455069019|FG003|Overall Study|Lost to Follow-up|0|||
126483975|NCT02501473|455069020|FG004|Overall Study|Lost to Follow-up|0|||
126483976|NCT02501473|455069021|FG005|Overall Study|Lost to Follow-up|1|||
126483977|NCT02501473|455069022|FG006|Overall Study|Lost to Follow-up|0|||
126483978|NCT02501473|455069023|FG007|Overall Study|Lost to Follow-up|0|||
126483979|NCT02501473|455069016|FG000|Overall Study|Reason not specified|0|||
126483980|NCT02501473|455069017|FG001|Overall Study|Reason not specified|0|||
126483981|NCT02501473|455069018|FG002|Overall Study|Reason not specified|1|||
126483982|NCT02501473|455069019|FG003|Overall Study|Reason not specified|1|||
126483983|NCT02501473|455069020|FG004|Overall Study|Reason not specified|0|||
126483984|NCT02501473|455069021|FG005|Overall Study|Reason not specified|0|||
126483985|NCT02501473|455069022|FG006|Overall Study|Reason not specified|0|||
126483986|NCT02501473|455069023|FG007|Overall Study|Reason not specified|0|||
126483987|NCT00907777|455069024|FG000|Overall Study|Withdrawal by Subject|0|||
126483988|NCT00907777|455069025|FG001|Overall Study|Withdrawal by Subject|1|||
126483989|NCT02674529|455069026|FG000|Overall Study|Lost to Follow-up|1|||
126483990|NCT02674529|455069027|FG001|Overall Study|Lost to Follow-up|2|||
126483991|NCT02674529|455069026|FG000|Overall Study|Withdrawal by Subject|2|||
126483992|NCT02674529|455069027|FG001|Overall Study|Withdrawal by Subject|1|||
126483993|NCT02674529|455069026|FG000|Overall Study|Physician Decision|0|||
126483994|NCT02674529|455069027|FG001|Overall Study|Physician Decision|1|||
126483995|NCT02674529|455069026|FG000|Overall Study|Protocol Violation|0|||
126483996|NCT02674529|455069027|FG001|Overall Study|Protocol Violation|1|||
126483997|NCT02891850|455069028|FG000|Overall Study|Adverse Event|3|||
126483998|NCT02891850|455069029|FG001|Overall Study|Adverse Event|0|||
126483999|NCT02891850|455069028|FG000|Overall Study|Death|0|||
126484000|NCT02891850|455069029|FG001|Overall Study|Death|4|||
126484001|NCT02891850|455069028|FG000|Overall Study|Physician Decision|1|||
126484002|NCT02891850|455069029|FG001|Overall Study|Physician Decision|0|||
126484003|NCT02891850|455069028|FG000|Overall Study|Pregnancy|1|||
126484004|NCT02891850|455069029|FG001|Overall Study|Pregnancy|0|||
126484005|NCT02891850|455069028|FG000|Overall Study|Withdrawal by Subject|2|||
126484006|NCT02891850|455069029|FG001|Overall Study|Withdrawal by Subject|3|||
126484007|NCT00331682|455069032|FG000|Overall Study|Adverse Event|1|||
126484008|NCT02548650|455069037|FG000|Triple Therapy|Adverse Event|1|||
126484009|NCT02548650|455069038|FG001|Triple Therapy|Adverse Event|0|||
126484010|NCT02548650|455069037|FG000|Triple Therapy|Withdrawal by Subject|0|||
126484011|NCT02548650|455069038|FG001|Triple Therapy|Withdrawal by Subject|4|||
126484012|NCT02548650|455069037|FG000|Double Therapy|Adverse Event|1|||
126484013|NCT02548650|455069038|FG001|Double Therapy|Adverse Event|1|||
126484014|NCT02548650|455069037|FG000|Double Therapy|Withdrawal by Subject|0|||
126484015|NCT02548650|455069038|FG001|Double Therapy|Withdrawal by Subject|1|||
126484016|NCT01539538|455069039|FG000|Overall Study|Adverse Event|13|||
126484017|NCT01539538|455069040|FG001|Overall Study|Adverse Event|18|||
126484018|NCT01539538|455069039|FG000|Overall Study|Lack of Efficacy|13|||
126484019|NCT01539538|455069040|FG001|Overall Study|Lack of Efficacy|16|||
126484020|NCT01539538|455069039|FG000|Overall Study|Withdrawal by Subject|2|||
126484021|NCT01539538|455069040|FG001|Overall Study|Withdrawal by Subject|3|||
126484022|NCT01539538|455069039|FG000|Overall Study|PCA no longer required or PCA problem|3|||
126484023|NCT01539538|455069040|FG001|Overall Study|PCA no longer required or PCA problem|7|||
126484024|NCT01909674|455069041|FG000|Overall Study|Withdrawal by Subject|5|||
126484025|NCT01909674|455069042|FG001|Overall Study|Withdrawal by Subject|2|||
126484026|NCT00378378|455069043|FG000|Overall Study|Withdrawal by Subject|0|||
126484027|NCT00378378|455069044|FG001|Overall Study|Withdrawal by Subject|1|||
126484028|NCT00378378|455069045|FG002|Overall Study|Withdrawal by Subject|0|||
126484029|NCT00378378|455069043|FG000|Overall Study|Treatment Failure|0|||
126484030|NCT00378378|455069044|FG001|Overall Study|Treatment Failure|0|||
126484031|NCT00378378|455069045|FG002|Overall Study|Treatment Failure|1|||
126484032|NCT00378378|455069043|FG000|Overall Study|Non-compliance with protocol|0|||
126484033|NCT00378378|455069044|FG001|Overall Study|Non-compliance with protocol|0|||
126484034|NCT00378378|455069045|FG002|Overall Study|Non-compliance with protocol|1|||
126484035|NCT00407797|455069046|FG000|Overall Study|Lost to Follow-up|2|||
126484036|NCT00407797|455069046|FG000|Overall Study|Adverse Event|6|||
126484037|NCT00407797|455069046|FG000|Overall Study|Other|7|||
126484038|NCT00407797|455069046|FG000|Overall Study|Withdrawal by Subject|3|||
126484039|NCT00553644|455069047|FG000|Overall Study|Adverse Event|17|||
126484040|NCT00553644|455069047|FG000|Overall Study|Withdrawal by Subject|4|||
126484041|NCT00553644|455069047|FG000|Overall Study|Physician Decision|1|||
126484042|NCT00553644|455069047|FG000|Overall Study|Alternative therapy|6|||
126484043|NCT01051323|455069048|FG000|Overall Study|Discontinuation of treatment|103|||
126484044|NCT01051323|455069048|FG000|Overall Study|Transplantation|28|||
126484045|NCT01051323|455069048|FG000|Overall Study|Dialysis dependency|22|||
126484046|NCT01051323|455069048|FG000|Overall Study|Withdrawal by Subject|13|||
126484047|NCT01051323|455069048|FG000|Overall Study|Lost to Follow-up|31|||
126484048|NCT01051323|455069048|FG000|Overall Study|Death|129|||
126484049|NCT01051323|455069048|FG000|Overall Study|Hospitalization|28|||
126484050|NCT01051323|455069048|FG000|Overall Study|Other|148|||
126484051|NCT01051323|455069048|FG000|Overall Study|Missing|37|||
126484052|NCT01537393|455069049|FG000|Overall Study|Exclude prior to study|32|||
126484053|NCT01537393|455069050|FG001|Overall Study|Exclude prior to study|44|||
126484054|NCT01537393|455069049|FG000|Overall Study|Death|20|||
126484055|NCT01537393|455069050|FG001|Overall Study|Death|32|||
126484056|NCT01537393|455069049|FG000|Overall Study|Withdrawal by Subject|18|||
126484057|NCT01537393|455069050|FG001|Overall Study|Withdrawal by Subject|17|||
126484058|NCT01537393|455069049|FG000|Overall Study|Lost to Follow-up|53|||
126484059|NCT01537393|455069050|FG001|Overall Study|Lost to Follow-up|48|||
126484060|NCT01537393|455069049|FG000|Overall Study|Failure - Regrafted|28|||
126484061|NCT01537393|455069050|FG001|Overall Study|Failure - Regrafted|43|||
126484062|NCT01537393|455069049|FG000|Overall Study|Failure - Not regrafted|2|||
126484063|NCT01537393|455069050|FG001|Overall Study|Failure - Not regrafted|6|||
126484064|NCT01537393|455069049|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
126484065|NCT01537393|455069050|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
126484066|NCT01637272|455069055|FG000|Overall Study|Adverse Event|6|||
126484067|NCT01637272|455069055|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126484068|NCT01637272|455069055|FG000|Overall Study|Withdrawal by Subject|3|||
126484069|NCT01637272|455069055|FG000|Overall Study|Lost to Follow-up|2|||
126484070|NCT01637272|455069055|FG000|Overall Study|completed core, did not enter ext. phase|4|||
126484071|NCT01637272|455069055|FG000|Overall Study|Administrative problems|1|||
126484072|NCT01637272|455069055|FG000|Overall Study|Protocol Violation|2|||
126484073|NCT01496612|455069056|FG000|1st Intervention|Adverse Event|1|||
126484074|NCT01496612|455069057|FG001|1st Intervention|Adverse Event|0|||
126484075|NCT01496612|455069056|FG000|1st Intervention|Withdrawal by Subject|1|||
126484076|NCT01496612|455069057|FG001|1st Intervention|Withdrawal by Subject|0|||
126484077|NCT03708328|455069068|FG000|Overall Study|Death|3|||
126484078|NCT03708328|455069069|FG001|Overall Study|Death|3|||
126484079|NCT03708328|455069070|FG002|Overall Study|Death|4|||
126484080|NCT03708328|455069071|FG003|Overall Study|Death|2|||
126484081|NCT03708328|455069072|FG004|Overall Study|Death|2|||
126484082|NCT03708328|455069073|FG005|Overall Study|Death|13|||
126484083|NCT03708328|455069074|FG006|Overall Study|Death|26|||
126484084|NCT03708328|455069075|FG007|Overall Study|Death|18|||
126484085|NCT03708328|455069076|FG008|Overall Study|Death|13|||
126484086|NCT03708328|455069077|FG009|Overall Study|Death|8|||
126484087|NCT03708328|455069068|FG000|Overall Study|Lost to Follow-up|0|||
126484088|NCT03708328|455069069|FG001|Overall Study|Lost to Follow-up|1|||
126484089|NCT03708328|455069070|FG002|Overall Study|Lost to Follow-up|0|||
126484090|NCT03708328|455069071|FG003|Overall Study|Lost to Follow-up|1|||
126484091|NCT03708328|455069072|FG004|Overall Study|Lost to Follow-up|0|||
126484092|NCT03708328|455069073|FG005|Overall Study|Lost to Follow-up|3|||
126484093|NCT03708328|455069074|FG006|Overall Study|Lost to Follow-up|3|||
126484094|NCT03708328|455069075|FG007|Overall Study|Lost to Follow-up|0|||
126484095|NCT03708328|455069076|FG008|Overall Study|Lost to Follow-up|0|||
126484096|NCT03708328|455069077|FG009|Overall Study|Lost to Follow-up|1|||
126484097|NCT03708328|455069068|FG000|Overall Study|Physician Decision|0|||
126484098|NCT03708328|455069069|FG001|Overall Study|Physician Decision|0|||
126484099|NCT03708328|455069070|FG002|Overall Study|Physician Decision|0|||
126484100|NCT03708328|455069071|FG003|Overall Study|Physician Decision|0|||
126484101|NCT03708328|455069072|FG004|Overall Study|Physician Decision|0|||
126484102|NCT03708328|455069073|FG005|Overall Study|Physician Decision|1|||
126484103|NCT03708328|455069074|FG006|Overall Study|Physician Decision|0|||
126559282|NCT00819234|455340710|FG002|Overall Study|Lost to Follow-up|0|||
126559283|NCT00819234|455340711|FG003|Overall Study|Lost to Follow-up|2|||
126559284|NCT00819234|455340712|FG004|Overall Study|Lost to Follow-up|1|||
126484104|NCT03708328|455069075|FG007|Overall Study|Physician Decision|0|||
126484105|NCT03708328|455069076|FG008|Overall Study|Physician Decision|0|||
126484106|NCT03708328|455069077|FG009|Overall Study|Physician Decision|0|||
126484107|NCT03708328|455069068|FG000|Overall Study|Withdrawal by Subject|0|||
126484108|NCT03708328|455069069|FG001|Overall Study|Withdrawal by Subject|0|||
126484109|NCT03708328|455069070|FG002|Overall Study|Withdrawal by Subject|0|||
126484110|NCT03708328|455069071|FG003|Overall Study|Withdrawal by Subject|0|||
126484111|NCT03708328|455069072|FG004|Overall Study|Withdrawal by Subject|1|||
126484112|NCT03708328|455069073|FG005|Overall Study|Withdrawal by Subject|0|||
126484113|NCT03708328|455069074|FG006|Overall Study|Withdrawal by Subject|2|||
126559285|NCT00819234|455340713|FG005|Overall Study|Lost to Follow-up|1|||
126484114|NCT03708328|455069075|FG007|Overall Study|Withdrawal by Subject|4|||
126484115|NCT03708328|455069076|FG008|Overall Study|Withdrawal by Subject|1|||
126484116|NCT03708328|455069077|FG009|Overall Study|Withdrawal by Subject|5|||
126484117|NCT03708328|455069068|FG000|Overall Study|Study Closed Locally|0|||
126484118|NCT03708328|455069069|FG001|Overall Study|Study Closed Locally|0|||
126484119|NCT03708328|455069070|FG002|Overall Study|Study Closed Locally|0|||
126484120|NCT03708328|455069071|FG003|Overall Study|Study Closed Locally|0|||
126484121|NCT03708328|455069072|FG004|Overall Study|Study Closed Locally|0|||
126484122|NCT03708328|455069073|FG005|Overall Study|Study Closed Locally|0|||
126484123|NCT03708328|455069074|FG006|Overall Study|Study Closed Locally|0|||
126484124|NCT03708328|455069075|FG007|Overall Study|Study Closed Locally|1|||
126484125|NCT03708328|455069076|FG008|Overall Study|Study Closed Locally|0|||
126484126|NCT03708328|455069077|FG009|Overall Study|Study Closed Locally|0|||
126484127|NCT03708328|455069068|FG000|Overall Study|Study Ended By Sponsor|0|||
126484128|NCT03708328|455069069|FG001|Overall Study|Study Ended By Sponsor|0|||
126484129|NCT03708328|455069070|FG002|Overall Study|Study Ended By Sponsor|0|||
126484130|NCT03708328|455069071|FG003|Overall Study|Study Ended By Sponsor|0|||
126484131|NCT03708328|455069072|FG004|Overall Study|Study Ended By Sponsor|0|||
126484132|NCT03708328|455069073|FG005|Overall Study|Study Ended By Sponsor|1|||
126484133|NCT03708328|455069074|FG006|Overall Study|Study Ended By Sponsor|0|||
126484134|NCT03708328|455069075|FG007|Overall Study|Study Ended By Sponsor|1|||
126722744|NCT00406640|455934532|FG000|Acute Phase|Lost to Follow-up|7|||
126484135|NCT03708328|455069076|FG008|Overall Study|Study Ended By Sponsor|0|||
126484136|NCT03708328|455069077|FG009|Overall Study|Study Ended By Sponsor|0|||
126484137|NCT03708328|455069068|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
126484138|NCT03708328|455069069|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
126484139|NCT03708328|455069070|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
126484140|NCT03708328|455069071|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
126484141|NCT03708328|455069072|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
126484142|NCT03708328|455069073|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
126484143|NCT03708328|455069074|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
126484144|NCT03708328|455069075|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
126484145|NCT03708328|455069076|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
126484146|NCT03708328|455069077|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
126484147|NCT02605824|455069078|FG000|Overall Study|Physician Decision|1|||
126484148|NCT02605824|455069079|FG001|Overall Study|Physician Decision|0|||
126484149|NCT01962896|455069084|FG000|Overall Study|Lack of Efficacy|4|||
126484150|NCT00317356|455069087|FG000|Overall Study|Adverse Event|0|||
126484151|NCT00317356|455069088|FG001|Overall Study|Adverse Event|0|||
126484152|NCT00317356|455069089|FG002|Overall Study|Adverse Event|1|||
126484153|NCT00317356|455069090|FG003|Overall Study|Adverse Event|0|||
126484154|NCT00317356|455069087|FG000|Overall Study|Lack of Efficacy|1|||
126484155|NCT00317356|455069088|FG001|Overall Study|Lack of Efficacy|1|||
126484156|NCT00317356|455069089|FG002|Overall Study|Lack of Efficacy|0|||
126484157|NCT00317356|455069090|FG003|Overall Study|Lack of Efficacy|3|||
126484158|NCT00317356|455069087|FG000|Overall Study|Physician Decision|0|||
126484159|NCT00317356|455069088|FG001|Overall Study|Physician Decision|1|||
126484160|NCT00317356|455069089|FG002|Overall Study|Physician Decision|0|||
126484161|NCT00317356|455069090|FG003|Overall Study|Physician Decision|0|||
126484162|NCT01949506|455069091|FG000|Overall Study|Physician Decision|1|||
126484163|NCT04212650|455069093|FG000|Overall Study|Withdrawal by Subject|1|||
126484164|NCT04212650|455069094|FG001|Overall Study|Withdrawal by Subject|0|||
126484165|NCT05475236|455069096|FG000|Overall Study|Withdrawal by Subject|0|||
126484166|NCT05475236|455069097|FG001|Overall Study|Withdrawal by Subject|1|||
126484167|NCT05425745|455069100|FG000|Overall Study|Withdrawal of Consent|3|||
126484168|NCT05425745|455069101|FG001|Overall Study|Withdrawal of Consent|3|||
126484169|NCT05425745|455069100|FG000|Overall Study|Death|2|||
126484170|NCT05425745|455069101|FG001|Overall Study|Death|3|||
126484171|NCT05425745|455069100|FG000|Overall Study|Lost to Follow-up|1|||
126484172|NCT05425745|455069101|FG001|Overall Study|Lost to Follow-up|2|||
126484173|NCT05425745|455069100|FG000|Overall Study|Adverse Event|0|||
126484174|NCT05425745|455069101|FG001|Overall Study|Adverse Event|1|||
126484175|NCT05425745|455069100|FG000|Overall Study|Did not return for end of study visit|0|||
126722745|NCT00406640|455934533|FG001|Acute Phase|Lost to Follow-up|4|||
126484176|NCT05425745|455069101|FG001|Overall Study|Did not return for end of study visit|1|||
126484177|NCT05425745|455069100|FG000|Overall Study|End of study visit completed by phone|1|||
126484178|NCT05425745|455069101|FG001|Overall Study|End of study visit completed by phone|0|||
126484179|NCT05425745|455069100|FG000|Overall Study|Subject decision|1|||
126484180|NCT05425745|455069101|FG001|Overall Study|Subject decision|0|||
126484181|NCT00630396|455070869|FG000|Overall Study|Death|4|||
126484182|NCT00630396|455070869|FG000|Overall Study|Lost to Follow-up|3|||
126484183|NCT02990910|455070872|FG000|Overall Study|Lack of Efficacy|6|||
126484184|NCT02990910|455070873|FG001|Overall Study|Lack of Efficacy|10|||
126722746|NCT00406640|455934532|FG000|Acute Phase|Protocol deviation|4|||
126722747|NCT00406640|455934533|FG001|Acute Phase|Protocol deviation|10|||
126484185|NCT00790023|455070878|FG000|Overall Study|Adverse Event|2|||
126484186|NCT00790023|455070879|FG001|Overall Study|Adverse Event|1|||
126484187|NCT00790023|455070880|FG002|Overall Study|Adverse Event|4|||
126484188|NCT00790023|455070878|FG000|Overall Study|Protocol Violation|2|||
126484189|NCT00790023|455070879|FG001|Overall Study|Protocol Violation|4|||
126484190|NCT00790023|455070880|FG002|Overall Study|Protocol Violation|2|||
126484191|NCT00790023|455070878|FG000|Overall Study|Withdrawal by Subject|2|||
126484192|NCT00790023|455070879|FG001|Overall Study|Withdrawal by Subject|0|||
126484193|NCT00790023|455070880|FG002|Overall Study|Withdrawal by Subject|6|||
126484194|NCT00790023|455070878|FG000|Overall Study|Lost to Follow-up|0|||
126484195|NCT00790023|455070879|FG001|Overall Study|Lost to Follow-up|0|||
126484196|NCT00790023|455070880|FG002|Overall Study|Lost to Follow-up|1|||
126484197|NCT00790023|455070878|FG000|Overall Study|Other|5|||
126484198|NCT00790023|455070879|FG001|Overall Study|Other|5|||
126484199|NCT00790023|455070880|FG002|Overall Study|Other|8|||
126484200|NCT01338792|455070881|FG000|Overall Study|Adverse Event|2|||
126484201|NCT01338792|455070881|FG000|Overall Study|Death|1|||
126484202|NCT01338792|455070881|FG000|Overall Study|Withdrawal by Subject|1|||
126484203|NCT02468414|455070882|FG000|Overall Study|Early Study Termination by Sponsor|1|||
126484204|NCT02468414|455070883|FG001|Overall Study|Early Study Termination by Sponsor|0|||
126484205|NCT02468414|455070882|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
126484206|NCT02468414|455070883|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
126484207|NCT02468414|455070882|FG000|Overall Study|Screen Failure|1|||
126484208|NCT02468414|455070883|FG001|Overall Study|Screen Failure|0|||
126484209|NCT01652703|455070884|FG000|Overall Study|Withdrawal by Subject|0|||
126484210|NCT01652703|455070885|FG001|Overall Study|Withdrawal by Subject|1|||
126484211|NCT01652703|455070886|FG002|Overall Study|Withdrawal by Subject|3|||
126484212|NCT01652703|455070887|FG003|Overall Study|Withdrawal by Subject|1|||
126484213|NCT01652703|455070888|FG004|Overall Study|Withdrawal by Subject|0|||
126484214|NCT01652703|455070889|FG005|Overall Study|Withdrawal by Subject|1|||
126484215|NCT01652703|455070884|FG000|Overall Study|Other|0|||
126484216|NCT01652703|455070885|FG001|Overall Study|Other|0|||
126484217|NCT01652703|455070886|FG002|Overall Study|Other|0|||
126484218|NCT01652703|455070887|FG003|Overall Study|Other|1|||
126484219|NCT01652703|455070888|FG004|Overall Study|Other|1|||
126484220|NCT01652703|455070889|FG005|Overall Study|Other|1|||
126484221|NCT02155608|455070893|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
126484222|NCT02155608|455070894|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
126484223|NCT02155608|455070893|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
126484224|NCT02155608|455070894|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
126722748|NCT00406640|455934532|FG000|Acute Phase|Protocol Violation|3|||
126484225|NCT00543140|455070896|FG000|Overall Study|Lost to Follow-up|33|||
126484226|NCT00543140|455070896|FG000|Overall Study|Withdrawal by Subject|13|||
126484227|NCT00543140|455070896|FG000|Overall Study|Protocol Violation|10|||
126484228|NCT00543140|455070896|FG000|Overall Study|Insufficient weight loss|10|||
126484229|NCT00543140|455070896|FG000|Overall Study|SAE leading to explant of SAGB|3|||
126484230|NCT00543140|455070896|FG000|Overall Study|Death|1|||
126484231|NCT00543140|455070896|FG000|Overall Study|Subject moved|1|||
126484232|NCT00543140|455070896|FG000|Overall Study|Conversion to different procedure|1|||
126484233|NCT04532164|455070899|FG000|Overall Study|Adverse Event|1|||
126484234|NCT04532164|455070899|FG000|Overall Study|Protocol Violation|5|||
126484235|NCT04532164|455070899|FG000|Overall Study|Lost to Follow-up|1|||
126484236|NCT04532164|455070899|FG000|Overall Study|Found to be Ineligible|3|||
126484237|NCT04532164|455070899|FG000|Overall Study|Withdrawal by Subject|14|||
126484238|NCT02599129|455070900|FG000|Overall Study|Lack of Efficacy|2|||
126484239|NCT02599129|455070901|FG001|Overall Study|Lack of Efficacy|2|||
126484240|NCT02599129|455070900|FG000|Overall Study|Lost to Follow-up|1|||
126484241|NCT02599129|455070901|FG001|Overall Study|Lost to Follow-up|0|||
126484242|NCT02599129|455070900|FG000|Overall Study|Withdrawal by Subject|2|||
126484243|NCT02599129|455070901|FG001|Overall Study|Withdrawal by Subject|1|||
126484244|NCT01029795|455070909|FG000|Overall Study|Entry Criteria Not Met|2|||
126484245|NCT01029795|455070910|FG001|Overall Study|Entry Criteria Not Met|1|||
126484246|NCT01029795|455070909|FG000|Overall Study|Physician Decision|2|||
126722749|NCT00406640|455934533|FG001|Acute Phase|Protocol Violation|2|||
126722750|NCT00406640|455934532|FG000|Acute Phase|Withdrawal by Subject|11|||
126484247|NCT01029795|455070910|FG001|Overall Study|Physician Decision|1|||
126484248|NCT01029795|455070909|FG000|Overall Study|Sponsor Decision|11|||
126484249|NCT01029795|455070910|FG001|Overall Study|Sponsor Decision|17|||
126484250|NCT01029795|455070909|FG000|Overall Study|Withdrawal by Subject|1|||
126484251|NCT01029795|455070910|FG001|Overall Study|Withdrawal by Subject|3|||
126484252|NCT00429273|455070911|FG000|Overall Study|Lost to Follow-up|1|||
126484253|NCT00429273|455070912|FG001|Overall Study|Lost to Follow-up|2|||
126722751|NCT00406640|455934533|FG001|Acute Phase|Withdrawal by Subject|9|||
126484254|NCT00429273|455070913|FG002|Overall Study|Lost to Follow-up|2|||
126484255|NCT00429273|455070911|FG000|Overall Study|Physician Decision|6|||
126484256|NCT00429273|455070912|FG001|Overall Study|Physician Decision|5|||
126484257|NCT00429273|455070913|FG002|Overall Study|Physician Decision|5|||
126484258|NCT00429273|455070911|FG000|Overall Study|Adverse Event|1|||
126722752|NCT00406640|455934532|FG000|Acute Phase|Lack of Efficacy|3|||
126484259|NCT00429273|455070912|FG001|Overall Study|Adverse Event|1|||
126484260|NCT00429273|455070913|FG002|Overall Study|Adverse Event|2|||
126484261|NCT01438957|455070914|FG000|Overall Study|Physician Decision|1|||
126484262|NCT01438957|455070915|FG001|Overall Study|Physician Decision|1|||
126484263|NCT01438957|455070916|FG002|Overall Study|Physician Decision|0|||
126484264|NCT01438957|455070917|FG003|Overall Study|Physician Decision|1|||
126484265|NCT01438957|455070918|FG004|Overall Study|Physician Decision|0|||
126484266|NCT02495168|455070920|FG000|Overall Study|Other than Specified|18|||
126484267|NCT02495168|455070921|FG001|Overall Study|Other than Specified|22|||
126484268|NCT02495168|455070922|FG002|Overall Study|Other than Specified|5|||
126484269|NCT02495168|455070920|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
126484270|NCT02495168|455070921|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
126484271|NCT02495168|455070922|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
126484272|NCT02495168|455070920|FG000|Overall Study|Physician Decision|1|||
126484273|NCT02495168|455070921|FG001|Overall Study|Physician Decision|1|||
126484274|NCT02495168|455070922|FG002|Overall Study|Physician Decision|0|||
126484275|NCT02495168|455070920|FG000|Overall Study|Lost to Follow-up|10|||
126484276|NCT02495168|455070921|FG001|Overall Study|Lost to Follow-up|6|||
126484277|NCT02495168|455070922|FG002|Overall Study|Lost to Follow-up|1|||
126484278|NCT02495168|455070920|FG000|Overall Study|Withdrawal by Subject|1|||
126484279|NCT02495168|455070921|FG001|Overall Study|Withdrawal by Subject|4|||
126484280|NCT02495168|455070922|FG002|Overall Study|Withdrawal by Subject|2|||
126484281|NCT02495168|455070920|FG000|Overall Study|Protocol Violation|0|||
126484282|NCT02495168|455070921|FG001|Overall Study|Protocol Violation|10|||
126484283|NCT02495168|455070922|FG002|Overall Study|Protocol Violation|1|||
126484284|NCT02495168|455070920|FG000|Overall Study|Adverse Event|4|||
126484285|NCT02495168|455070921|FG001|Overall Study|Adverse Event|8|||
126484286|NCT02495168|455070922|FG002|Overall Study|Adverse Event|3|||
126484287|NCT02495168|455070920|FG000|Overall Study|Lack of Efficacy|0|||
126484288|NCT02495168|455070921|FG001|Overall Study|Lack of Efficacy|0|||
126484289|NCT02495168|455070922|FG002|Overall Study|Lack of Efficacy|3|||
126484290|NCT00727025|455070923|FG000|Overall Study|Physician Decision|23|||
126484291|NCT02270957|455070924|FG000|Overall Study|Lack of Efficacy|2|||
126484292|NCT02270957|455070925|FG001|Overall Study|Lack of Efficacy|4|||
126484293|NCT02270957|455070924|FG000|Overall Study|Adverse Event|2|||
126484294|NCT02270957|455070925|FG001|Overall Study|Adverse Event|0|||
126484295|NCT04390191|455070926|FG000|Overall Study|Withdrawal by Subject|1|||
126484296|NCT04390191|455070927|FG001|Overall Study|Withdrawal by Subject|0|||
126484297|NCT03978832|455070930|FG000|Overall Study|Adverse Event|1|||
126484298|NCT03978832|455070930|FG000|Overall Study|Lost to Follow-up|1|||
126484299|NCT03978832|455070930|FG000|Overall Study|Withdrawal by Subject|6|||
126484300|NCT03978832|455070930|FG000|Overall Study|Physician Decision|2|||
126484301|NCT03978832|455070930|FG000|Overall Study|did not pass screening criteria|44|||
126484302|NCT02042183|455070931|FG000|Overall Study|Physician Decision|7|||
126484303|NCT02042183|455070932|FG001|Overall Study|Physician Decision|2|||
126484304|NCT02042183|455070931|FG000|Overall Study|Lack of Efficacy|4|||
126484305|NCT02042183|455070932|FG001|Overall Study|Lack of Efficacy|3|||
126484306|NCT02042183|455070931|FG000|Overall Study|Non-compliance with Study Drug|2|||
126484307|NCT02042183|455070932|FG001|Overall Study|Non-compliance with Study Drug|3|||
126484308|NCT02042183|455070931|FG000|Overall Study|Adverse Event|17|||
126484309|NCT02042183|455070932|FG001|Overall Study|Adverse Event|6|||
126484310|NCT02042183|455070931|FG000|Overall Study|Other|3|||
126484311|NCT02042183|455070932|FG001|Overall Study|Other|3|||
126484312|NCT02042183|455070931|FG000|Overall Study|Withdrawal by Subject|21|||
126484313|NCT02042183|455070932|FG001|Overall Study|Withdrawal by Subject|16|||
126484314|NCT02042183|455070931|FG000|Overall Study|Site Terminated by Sponsor|2|||
126484315|NCT02042183|455070932|FG001|Overall Study|Site Terminated by Sponsor|1|||
126484316|NCT02042183|455070931|FG000|Overall Study|Lost to Follow-up|9|||
126484317|NCT02042183|455070932|FG001|Overall Study|Lost to Follow-up|2|||
126484318|NCT01727297|455070933|FG000|Overall Study|Death|13|||
126484319|NCT01727297|455070934|FG001|Overall Study|Death|0|||
126484320|NCT01727297|455070933|FG000|Overall Study|Protocol Violation|1|||
126484321|NCT01727297|455070934|FG001|Overall Study|Protocol Violation|10|||
126484322|NCT01727297|455070933|FG000|Overall Study|Adverse Event|3|||
126484323|NCT01727297|455070934|FG001|Overall Study|Adverse Event|1|||
126484324|NCT01727297|455070933|FG000|Overall Study|Lost to Follow-up|11|||
126484325|NCT01727297|455070934|FG001|Overall Study|Lost to Follow-up|0|||
126484326|NCT01727297|455070933|FG000|Overall Study|Withdrawal by Subject|26|||
126484327|NCT01727297|455070934|FG001|Overall Study|Withdrawal by Subject|27|||
126484328|NCT01727297|455070933|FG000|Overall Study|Physician Decision|19|||
126484329|NCT01727297|455070934|FG001|Overall Study|Physician Decision|5|||
126484330|NCT01727297|455070933|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
126484331|NCT01727297|455070934|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
126484332|NCT01192516|455070935|FG000|Overall Study|Lost to Follow-up|7|||
126484333|NCT01192516|455070936|FG001|Overall Study|Lost to Follow-up|10|||
126484334|NCT01192516|455070937|FG002|Overall Study|Lost to Follow-up|7|||
126484335|NCT01192516|455070935|FG000|Overall Study|Withdrawal by Subject|4|||
126484336|NCT01192516|455070936|FG001|Overall Study|Withdrawal by Subject|4|||
126484337|NCT01192516|455070937|FG002|Overall Study|Withdrawal by Subject|1|||
126484338|NCT01192516|455070935|FG000|Overall Study|started new treatment|5|||
126484339|NCT01192516|455070936|FG001|Overall Study|started new treatment|1|||
126484340|NCT01192516|455070937|FG002|Overall Study|started new treatment|0|||
126484341|NCT01192516|455070935|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
126484342|NCT01192516|455070936|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
126484343|NCT01192516|455070937|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
126484344|NCT02244606|455070938|FG000|Overall Study|Adverse Event|0|||
126484345|NCT02244606|455070939|FG001|Overall Study|Adverse Event|1|||
126484346|NCT02244606|455070940|FG002|Overall Study|Adverse Event|1|||
126484347|NCT02244606|455070941|FG003|Overall Study|Adverse Event|0|||
126484348|NCT02244606|455070938|FG000|Overall Study|Lost to Follow-up|2|||
126484349|NCT02244606|455070939|FG001|Overall Study|Lost to Follow-up|2|||
126484350|NCT02244606|455070940|FG002|Overall Study|Lost to Follow-up|1|||
126484351|NCT02244606|455070941|FG003|Overall Study|Lost to Follow-up|0|||
126484352|NCT02244606|455070938|FG000|Overall Study|Protocol Violation|0|||
126484353|NCT02244606|455070939|FG001|Overall Study|Protocol Violation|0|||
126484354|NCT02244606|455070940|FG002|Overall Study|Protocol Violation|0|||
126484355|NCT02244606|455070941|FG003|Overall Study|Protocol Violation|1|||
126484356|NCT02244606|455070938|FG000|Overall Study|Withdrawal by Subject|1|||
126484357|NCT02244606|455070939|FG001|Overall Study|Withdrawal by Subject|1|||
126484358|NCT02244606|455070940|FG002|Overall Study|Withdrawal by Subject|0|||
126484359|NCT02244606|455070941|FG003|Overall Study|Withdrawal by Subject|0|||
126484360|NCT02244606|455070938|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
126484361|NCT02244606|455070939|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
126484362|NCT02244606|455070940|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
126484363|NCT02244606|455070941|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
126484364|NCT03782792|455070944|FG000|Overall Study|Patient left the country|0|||
126484365|NCT03782792|455070945|FG001|Overall Study|Patient left the country|1|||
126484366|NCT03782792|455070944|FG000|Overall Study|Withdrawal by Subject|1|||
126484367|NCT03782792|455070945|FG001|Overall Study|Withdrawal by Subject|2|||
126484368|NCT02321800|455070947|FG000|Overall Study|Withdrawal by Subject|3|||
126484369|NCT02321800|455070948|FG001|Overall Study|Withdrawal by Subject|3|||
126484370|NCT02321800|455070947|FG000|Overall Study|Death|1|||
126484371|NCT02321800|455070948|FG001|Overall Study|Death|0|||
126484372|NCT02321800|455070947|FG000|Overall Study|Protocol Violation|1|||
126484373|NCT02321800|455070948|FG001|Overall Study|Protocol Violation|0|||
126484374|NCT02321800|455070947|FG000|Overall Study|Lost to Follow-up|10|||
126484375|NCT02321800|455070948|FG001|Overall Study|Lost to Follow-up|4|||
126484376|NCT02321800|455070947|FG000|Overall Study|Adverse Event|2|||
126484377|NCT02321800|455070948|FG001|Overall Study|Adverse Event|3|||
126484378|NCT02321800|455070947|FG000|Overall Study|Other, Miscellaneous|3|||
126484379|NCT02321800|455070948|FG001|Overall Study|Other, Miscellaneous|1|||
126484380|NCT03132220|455070954|FG000|Overall Study|Lost to Follow-up|17|||
126484381|NCT03132220|455070955|FG001|Overall Study|Lost to Follow-up|8|||
126484382|NCT03132220|455070954|FG000|Overall Study|Withdrawal by Subject|1|||
126484383|NCT03132220|455070955|FG001|Overall Study|Withdrawal by Subject|4|||
126484384|NCT01169493|455070956|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
126484385|NCT01169493|455070957|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
126484386|NCT01169493|455070958|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
126484387|NCT01169493|455070959|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
126484388|NCT01169493|455070960|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
126484389|NCT01169493|455070961|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
126484390|NCT01169493|455070956|FG000|Period 3 (6 Months)|Adverse Event|0|||
126484391|NCT01169493|455070957|FG001|Period 3 (6 Months)|Adverse Event|1|||
126484392|NCT01169493|455070958|FG002|Period 3 (6 Months)|Adverse Event|0|||
126484393|NCT01169493|455070959|FG003|Period 3 (6 Months)|Adverse Event|0|||
126484394|NCT01169493|455070960|FG004|Period 3 (6 Months)|Adverse Event|0|||
126484395|NCT01169493|455070961|FG005|Period 3 (6 Months)|Adverse Event|0|||
126484396|NCT01169493|455070956|FG000|Period 3 (6 Months)|Physician Decision|0|||
126484397|NCT01169493|455070957|FG001|Period 3 (6 Months)|Physician Decision|1|||
126484398|NCT01169493|455070958|FG002|Period 3 (6 Months)|Physician Decision|1|||
126484399|NCT01169493|455070959|FG003|Period 3 (6 Months)|Physician Decision|0|||
126484400|NCT01169493|455070960|FG004|Period 3 (6 Months)|Physician Decision|0|||
126484401|NCT01169493|455070961|FG005|Period 3 (6 Months)|Physician Decision|0|||
126484402|NCT05228132|455070962|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
126484403|NCT05228132|455070962|FG000|Overall Study|Adverse Event|3|||
126484404|NCT05228132|455070962|FG000|Overall Study|Lost to Follow-up|1|||
126484405|NCT05228132|455070962|FG000|Overall Study|Arteriovenous-fistula mature|1|||
126484406|NCT01336764|455070963|FG000|Overall Study|Withdrawal by Subject|5|||
126484407|NCT01336764|455070964|FG001|Overall Study|Withdrawal by Subject|5|||
126484408|NCT00730132|455070965|FG000|Overall Study|Protocol Violation|154|||
126772577|NCT03231709|456123622|FG000|Treatment Period 1|Reason not Specified|0|||
126484409|NCT00730132|455070965|FG000|Overall Study|Death|1|||
126484410|NCT01626391|455070966|FG000|Overall Study|Physician Decision|1|||
126484411|NCT01626391|455070967|FG001|Overall Study|Physician Decision|0|||
126772578|NCT03231709|456123623|FG001|Treatment Period 1|Reason not Specified|1|||
126484412|NCT01626391|455070966|FG000|Overall Study|Withdrawal by Subject|1|||
126484413|NCT01626391|455070967|FG001|Overall Study|Withdrawal by Subject|0|||
126484414|NCT01233258|455070972|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
126484415|NCT01233258|455070973|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
126484416|NCT01233258|455070974|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
126484417|NCT01233258|455070975|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
126484418|NCT01233258|455070976|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
126484419|NCT01233258|455070977|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
126484420|NCT01233258|455070972|FG000|First Intervention (6 Months)|Protocol Violation|0|||
126484421|NCT01233258|455070973|FG001|First Intervention (6 Months)|Protocol Violation|0|||
126484422|NCT01233258|455070974|FG002|First Intervention (6 Months)|Protocol Violation|1|||
126484423|NCT01233258|455070975|FG003|First Intervention (6 Months)|Protocol Violation|0|||
126484424|NCT01233258|455070976|FG004|First Intervention (6 Months)|Protocol Violation|0|||
126484425|NCT01233258|455070977|FG005|First Intervention (6 Months)|Protocol Violation|0|||
126484426|NCT01233258|455070972|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
126484427|NCT01233258|455070973|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
126484428|NCT01233258|455070974|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
126484429|NCT01233258|455070975|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
126484430|NCT01233258|455070976|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
126484431|NCT01233258|455070977|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
126484432|NCT02695329|455070980|FG000|Overall Study|Adverse Event|1|||
126484433|NCT02695329|455070981|FG001|Overall Study|Adverse Event|0|||
126484434|NCT02695329|455070980|FG000|Overall Study|Poor X-ray quality for measurement|4|||
126484435|NCT02695329|455070981|FG001|Overall Study|Poor X-ray quality for measurement|5|||
126484436|NCT00843024|455070982|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
126484437|NCT00843024|455070983|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
126484438|NCT00843024|455070984|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
126484439|NCT00843024|455070985|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
126484440|NCT00843024|455070986|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
126484441|NCT00843024|455070987|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
126484442|NCT00843024|455070982|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
126484443|NCT00843024|455070983|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
126484444|NCT00843024|455070984|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
126484445|NCT00843024|455070985|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
126484446|NCT00843024|455070986|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
126484447|NCT00843024|455070987|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
126484448|NCT00843024|455070982|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
126484449|NCT00843024|455070983|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
126484450|NCT00843024|455070984|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
126484451|NCT00843024|455070985|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
126484452|NCT00843024|455070986|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
126484453|NCT00843024|455070987|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
126484454|NCT00843024|455070982|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
126484455|NCT00843024|455070983|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
126484456|NCT00843024|455070984|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
126484457|NCT00843024|455070985|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
126484458|NCT00843024|455070986|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
126484459|NCT00843024|455070987|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
126484460|NCT00843024|455070982|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
126484461|NCT00843024|455070983|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
126484462|NCT00843024|455070984|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
126484463|NCT00843024|455070985|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
126484464|NCT00843024|455070986|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
126484465|NCT00843024|455070987|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
126484466|NCT00843024|455070982|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
126484467|NCT00843024|455070983|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
126484468|NCT00843024|455070984|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
126484469|NCT00843024|455070985|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
126484470|NCT00843024|455070986|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
126484471|NCT00843024|455070987|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
126559286|NCT00819234|455340714|FG006|Overall Study|Lost to Follow-up|1|||
126559287|NCT00819234|455340715|FG007|Overall Study|Lost to Follow-up|1|||
126559288|NCT00819234|455340716|FG008|Overall Study|Lost to Follow-up|1|||
126484472|NCT00843024|455070982|FG000|Single-blind Placebo Run-In Phase|Other|0|||
126484473|NCT00843024|455070983|FG001|Single-blind Placebo Run-In Phase|Other|1|||
126484474|NCT00843024|455070984|FG002|Single-blind Placebo Run-In Phase|Other|0|||
126559289|NCT00819234|455340717|FG009|Overall Study|Lost to Follow-up|2|||
126484475|NCT00843024|455070985|FG003|Single-blind Placebo Run-In Phase|Other|0|||
126484476|NCT00843024|455070986|FG004|Single-blind Placebo Run-In Phase|Other|0|||
126484477|NCT00843024|455070987|FG005|Single-blind Placebo Run-In Phase|Other|0|||
126484478|NCT00843024|455070982|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
126484479|NCT00843024|455070983|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
126484480|NCT00843024|455070984|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
126484481|NCT00843024|455070985|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
126484482|NCT00843024|455070986|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
126484483|NCT00843024|455070987|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
126484484|NCT00843024|455070982|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
126484485|NCT00843024|455070983|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
126484486|NCT00843024|455070984|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
126484487|NCT00843024|455070985|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
126484488|NCT00843024|455070986|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
126484489|NCT00843024|455070987|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
126484490|NCT00843024|455070982|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126484491|NCT00843024|455070983|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126484492|NCT00843024|455070984|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126484493|NCT00843024|455070985|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
126484494|NCT00843024|455070986|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126484495|NCT00843024|455070987|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
126484496|NCT00843024|455070982|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
126484497|NCT00843024|455070983|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
126484498|NCT00843024|455070984|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
126484499|NCT00843024|455070985|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
126484500|NCT00843024|455070986|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
126484501|NCT00843024|455070987|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
126484502|NCT00843024|455070982|FG000|Double-blind Treatment Phase|Physician Decision|0|||
126484503|NCT00843024|455070983|FG001|Double-blind Treatment Phase|Physician Decision|0|||
126484504|NCT00843024|455070984|FG002|Double-blind Treatment Phase|Physician Decision|0|||
126484505|NCT00843024|455070985|FG003|Double-blind Treatment Phase|Physician Decision|3|||
126484506|NCT00843024|455070986|FG004|Double-blind Treatment Phase|Physician Decision|1|||
126484507|NCT00843024|455070987|FG005|Double-blind Treatment Phase|Physician Decision|1|||
126484508|NCT00843024|455070982|FG000|Double-blind Treatment Phase|Adverse Event|0|||
126484509|NCT00843024|455070983|FG001|Double-blind Treatment Phase|Adverse Event|0|||
126484510|NCT00843024|455070984|FG002|Double-blind Treatment Phase|Adverse Event|0|||
126484511|NCT00843024|455070985|FG003|Double-blind Treatment Phase|Adverse Event|0|||
126484512|NCT00843024|455070986|FG004|Double-blind Treatment Phase|Adverse Event|1|||
126484513|NCT00843024|455070987|FG005|Double-blind Treatment Phase|Adverse Event|1|||
126484514|NCT00843024|455070982|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
126484515|NCT00843024|455070983|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
126484516|NCT00843024|455070984|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
126484517|NCT00843024|455070985|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
126484518|NCT00843024|455070986|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
126484519|NCT00843024|455070987|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
126484520|NCT01032837|455070988|FG000|Overall Study|Adverse event/internal illness|0|||
126484521|NCT01032837|455070989|FG001|Overall Study|Adverse event/internal illness|1|||
126484522|NCT01032837|455070990|FG002|Overall Study|Adverse event/internal illness|0|||
126484523|NCT01032837|455070991|FG003|Overall Study|Adverse event/internal illness|1|||
126484524|NCT01032837|455070988|FG000|Overall Study|Withdrew consent|0|||
126484525|NCT01032837|455070989|FG001|Overall Study|Withdrew consent|2|||
126484526|NCT01032837|455070990|FG002|Overall Study|Withdrew consent|0|||
126484527|NCT01032837|455070991|FG003|Overall Study|Withdrew consent|1|||
126484528|NCT01032837|455070988|FG000|Overall Study|Failed to return|0|||
126484529|NCT01032837|455070989|FG001|Overall Study|Failed to return|0|||
126484530|NCT01032837|455070990|FG002|Overall Study|Failed to return|1|||
126484531|NCT01032837|455070991|FG003|Overall Study|Failed to return|0|||
126484532|NCT01032837|455070988|FG000|Overall Study|Refused treatment|0|||
126484533|NCT01032837|455070989|FG001|Overall Study|Refused treatment|0|||
126484534|NCT01032837|455070990|FG002|Overall Study|Refused treatment|0|||
126484535|NCT01032837|455070991|FG003|Overall Study|Refused treatment|1|||
126484536|NCT02439138|455070993|FG000|Overall Study|Adverse Event|1|||
126484537|NCT02439138|455070993|FG000|Overall Study|PI decision to terminate the study|2|||
126484538|NCT00006237|455070998|FG000|Overall Study|Adverse Event|39|||
126484539|NCT00006237|455070999|FG001|Overall Study|Adverse Event|29|||
126484540|NCT00006237|455070998|FG000|Overall Study|Death|1|||
126484541|NCT00006237|455070999|FG001|Overall Study|Death|0|||
126484542|NCT00006237|455070998|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
126484543|NCT00006237|455070999|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
126484544|NCT00006237|455070998|FG000|Overall Study|Progression/relapse|54|||
126484545|NCT00006237|455070999|FG001|Overall Study|Progression/relapse|2|||
126484546|NCT00006237|455070998|FG000|Overall Study|Not eligible|9|||
126484547|NCT00006237|455070999|FG001|Overall Study|Not eligible|20|||
126484548|NCT00006237|455070998|FG000|Overall Study|Withdrawal by Subject|0|||
126484549|NCT00006237|455070999|FG001|Overall Study|Withdrawal by Subject|1|||
126484550|NCT00006237|455070998|FG000|Overall Study|Not protocol specified|14|||
126484551|NCT00006237|455070999|FG001|Overall Study|Not protocol specified|5|||
126484552|NCT01846416|455071002|FG000|Treatment Phase|Death|2|||
126484553|NCT01846416|455071003|FG001|Treatment Phase|Death|9|||
126484554|NCT01846416|455071004|FG002|Treatment Phase|Death|1|||
126484555|NCT01846416|455071002|FG000|Treatment Phase|Withdrawal by Subject|2|||
126484556|NCT01846416|455071003|FG001|Treatment Phase|Withdrawal by Subject|4|||
126484557|NCT01846416|455071004|FG002|Treatment Phase|Withdrawal by Subject|2|||
126484558|NCT01846416|455071002|FG000|Treatment Phase|Other|1|||
126484559|NCT01846416|455071003|FG001|Treatment Phase|Other|5|||
126484560|NCT01846416|455071004|FG002|Treatment Phase|Other|1|||
126484561|NCT01846416|455071002|FG000|Treatment Phase|Physician Decision|1|||
126484562|NCT01846416|455071003|FG001|Treatment Phase|Physician Decision|2|||
126484563|NCT01846416|455071004|FG002|Treatment Phase|Physician Decision|0|||
126484564|NCT01846416|455071002|FG000|Treatment Phase|Adverse Event|3|||
126484565|NCT01846416|455071003|FG001|Treatment Phase|Adverse Event|4|||
126484566|NCT01846416|455071004|FG002|Treatment Phase|Adverse Event|0|||
126484567|NCT01846416|455071002|FG000|Treatment Phase|Non-compliance|0|||
126484568|NCT01846416|455071003|FG001|Treatment Phase|Non-compliance|2|||
126484569|NCT01846416|455071004|FG002|Treatment Phase|Non-compliance|0|||
126484570|NCT01846416|455071002|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
126484571|NCT01846416|455071003|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
126484572|NCT01846416|455071004|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
126484573|NCT01846416|455071002|FG000|Treatment Phase|Progressive Disease|21|||
126484574|NCT01846416|455071003|FG001|Treatment Phase|Progressive Disease|63|||
126484575|NCT01846416|455071004|FG002|Treatment Phase|Progressive Disease|9|||
126484576|NCT01846416|455071002|FG000|Survival Follow-up|Death|21|||
126484577|NCT01846416|455071003|FG001|Survival Follow-up|Death|62|||
126484578|NCT01846416|455071004|FG002|Survival Follow-up|Death|9|||
126484579|NCT01846416|455071002|FG000|Survival Follow-up|Lost to Follow-up|0|||
126484580|NCT01846416|455071003|FG001|Survival Follow-up|Lost to Follow-up|2|||
126484581|NCT01846416|455071004|FG002|Survival Follow-up|Lost to Follow-up|2|||
126484582|NCT01846416|455071002|FG000|Survival Follow-up|Withdrawal by Subject|2|||
126484583|NCT01846416|455071003|FG001|Survival Follow-up|Withdrawal by Subject|7|||
126484584|NCT01846416|455071004|FG002|Survival Follow-up|Withdrawal by Subject|0|||
126484585|NCT01846416|455071002|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
126484586|NCT01846416|455071003|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
126484587|NCT01846416|455071004|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
126484588|NCT01846416|455071002|FG000|Survival Follow-up|Other|3|||
126484589|NCT01846416|455071003|FG001|Survival Follow-up|Other|1|||
126484590|NCT01846416|455071004|FG002|Survival Follow-up|Other|1|||
126484591|NCT01487200|455071007|FG000|Overall Study|Withdrawal by Subject|0|||
126484592|NCT01487200|455071008|FG001|Overall Study|Withdrawal by Subject|1|||
126484593|NCT01487200|455071009|FG002|Overall Study|Withdrawal by Subject|0|||
126484594|NCT01487200|455071010|FG003|Overall Study|Withdrawal by Subject|0|||
126484595|NCT02837783|455071011|FG000|Overall Study|Adverse Event|1|||
126484596|NCT02837783|455071012|FG001|Overall Study|Adverse Event|0|||
126484597|NCT02837783|455071011|FG000|Overall Study|Other, Not Specified|1|||
126484598|NCT02837783|455071012|FG001|Overall Study|Other, Not Specified|2|||
126484599|NCT02216591|455071013|FG000|Overall Study|Lost to Follow-up|0|||
126484600|NCT02216591|455071014|FG001|Overall Study|Lost to Follow-up|1|||
126484601|NCT02207244|455071015|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
126484602|NCT02207244|455071016|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
126484603|NCT02207244|455071017|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
126484604|NCT02207244|455071018|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
126484605|NCT02207244|455071019|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
126484606|NCT02207244|455071020|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
126484607|NCT02207244|455071021|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
126484608|NCT02207244|455071022|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
126484609|NCT02207244|455071023|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
126484610|NCT02207244|455071024|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
126484611|NCT02207244|455071025|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
126484612|NCT02207244|455071015|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
126484613|NCT02207244|455071016|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
126484614|NCT02207244|455071017|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
126484615|NCT02207244|455071018|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
126484616|NCT02207244|455071019|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
126484617|NCT02207244|455071020|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
126484618|NCT02207244|455071021|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
126484619|NCT02207244|455071022|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
126484620|NCT02207244|455071023|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
126484621|NCT02207244|455071024|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
126484622|NCT02207244|455071025|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
126484623|NCT02207244|455071015|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
126484624|NCT02207244|455071016|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
126484625|NCT02207244|455071017|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
126484626|NCT02207244|455071018|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
126484627|NCT02207244|455071019|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
126484628|NCT02207244|455071020|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
126484629|NCT02207244|455071021|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
126484630|NCT02207244|455071022|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
126484631|NCT02207244|455071023|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
126484632|NCT02207244|455071024|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
126484633|NCT02207244|455071025|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
126484634|NCT02207244|455071015|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
126484635|NCT02207244|455071016|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
126484636|NCT02207244|455071017|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
126484637|NCT02207244|455071018|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
126484638|NCT02207244|455071019|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
126484639|NCT02207244|455071020|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
126484640|NCT02207244|455071021|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
126484641|NCT02207244|455071022|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
126484642|NCT02207244|455071023|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
126484643|NCT02207244|455071024|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
126484644|NCT02207244|455071025|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
126484645|NCT02207244|455071015|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
126484646|NCT02207244|455071016|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
126484647|NCT02207244|455071017|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
126484648|NCT02207244|455071018|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
126484649|NCT02207244|455071019|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
126559290|NCT05174065|455340718|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
126559291|NCT05174065|455340719|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
126559292|NCT05174065|455340720|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
126559293|NCT05174065|455340718|FG000|Placebo-controlled Period|Other|0|||
126559294|NCT05174065|455340719|FG001|Placebo-controlled Period|Other|1|||
126559295|NCT05174065|455340720|FG002|Placebo-controlled Period|Other|0|||
126559296|NCT05174065|455340718|FG000|Placebo-controlled Period|Adverse Event|1|||
126559297|NCT05174065|455340719|FG001|Placebo-controlled Period|Adverse Event|1|||
126559298|NCT05174065|455340720|FG002|Placebo-controlled Period|Adverse Event|0|||
126559299|NCT05174065|455340718|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
126559300|NCT05174065|455340719|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
126559301|NCT05174065|455340720|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
126559302|NCT05174065|455340718|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
126559303|NCT05174065|455340719|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
126559304|NCT05174065|455340720|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
126559305|NCT05174065|455340718|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
126559306|NCT05174065|455340719|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
126559307|NCT05174065|455340720|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
126559308|NCT00097370|455340721|FG000|Stage 1|Adverse Event|3|||
126559309|NCT00097370|455340721|FG000|Stage 1|Withdrawal by Subject|1|||
126559310|NCT00097370|455340721|FG000|Stage 1|Lack of Efficacy|2|||
126559311|NCT00097370|455340721|FG000|Stage 2|Adverse Event|5|||
126484650|NCT02207244|455071020|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
126484651|NCT02207244|455071021|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
126484652|NCT02207244|455071022|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
126484653|NCT02207244|455071023|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
126484654|NCT02207244|455071024|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
126484655|NCT02207244|455071025|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
126484656|NCT02207244|455071015|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
126484657|NCT02207244|455071016|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
126484658|NCT02207244|455071017|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
126484659|NCT02207244|455071018|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
126484660|NCT02207244|455071019|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
126484661|NCT02207244|455071020|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
126559312|NCT00097370|455340721|FG000|Stage 2|Withdrawal by Subject|1|||
126559313|NCT00097370|455340721|FG000|Stage 2|Lack of Efficacy|3|||
126559314|NCT00097370|455340721|FG000|Stage 2|Pregnancy|1|||
126559315|NCT00097370|455340721|FG000|Stage 2|Sponsor Terminated Study|2|||
126559316|NCT00097370|455340721|FG000|Stage 2|Lost to Follow-up|1|||
126484662|NCT02207244|455071021|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
126484663|NCT02207244|455071022|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
126484664|NCT02207244|455071023|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
126484665|NCT02207244|455071024|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
126484666|NCT02207244|455071025|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
126484667|NCT02207244|455071015|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
126484668|NCT02207244|455071016|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
126484669|NCT02207244|455071017|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
126484670|NCT02207244|455071018|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
126484671|NCT02207244|455071019|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
126484672|NCT02207244|455071020|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
126484673|NCT02207244|455071021|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
126484674|NCT02207244|455071022|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
126484675|NCT02207244|455071023|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
126484676|NCT02207244|455071024|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
126484677|NCT02207244|455071025|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
126484678|NCT02207244|455071015|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
126484679|NCT02207244|455071016|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
126484680|NCT02207244|455071017|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
126484681|NCT02207244|455071018|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
126484682|NCT02207244|455071019|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
126484683|NCT02207244|455071020|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
126484684|NCT02207244|455071021|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
126484685|NCT02207244|455071022|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
126484686|NCT02207244|455071023|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
126484687|NCT02207244|455071024|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
126484688|NCT02207244|455071025|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
126484689|NCT02207244|455071015|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
126484690|NCT02207244|455071016|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
126484691|NCT02207244|455071017|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
126484692|NCT02207244|455071018|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
126484693|NCT02207244|455071019|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
126484694|NCT02207244|455071020|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
126484695|NCT02207244|455071021|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
126484696|NCT02207244|455071022|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
126484697|NCT02207244|455071023|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
126484698|NCT02207244|455071024|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
126484699|NCT02207244|455071025|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
126484700|NCT02207244|455071015|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
126484701|NCT02207244|455071016|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
126484702|NCT02207244|455071017|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
126484703|NCT02207244|455071018|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
126484704|NCT02207244|455071019|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
126484705|NCT02207244|455071020|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
126484706|NCT02207244|455071021|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
126484707|NCT02207244|455071022|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
126484708|NCT02207244|455071023|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
126484709|NCT02207244|455071024|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
126484710|NCT02207244|455071025|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
126559317|NCT00097370|455340721|FG000|Stage 3|Adverse Event|2|||
126559318|NCT00097370|455340721|FG000|Stage 3|Withdrawal by Subject|3|||
126559319|NCT00097370|455340721|FG000|Stage 3|Lack of Efficacy|1|||
126559320|NCT00097370|455340721|FG000|Stage 3|Sponsor Terminated Study|52|||
126559321|NCT00097370|455340721|FG000|Stage 3|Lost to Follow-up|1|||
126559322|NCT02419755|455340723|FG000|Overall Study|Death|1|||
126559323|NCT02419755|455340724|FG001|Overall Study|Death|3|||
126559324|NCT02419755|455340723|FG000|Overall Study|Relapse|0|||
126559325|NCT02419755|455340724|FG001|Overall Study|Relapse|1|||
126559326|NCT02419755|455340723|FG000|Overall Study|Ineligible|1|||
126559327|NCT02419755|455340724|FG001|Overall Study|Ineligible|0|||
126559328|NCT02419755|455340723|FG000|Overall Study|Withdrawal by Subject|1|||
126559329|NCT02419755|455340724|FG001|Overall Study|Withdrawal by Subject|0|||
126559330|NCT02337361|455340725|FG000|3-month Follow-up|Lost to Follow-up|19|||
126559331|NCT02337361|455340726|FG001|3-month Follow-up|Lost to Follow-up|14|||
126559332|NCT02337361|455340725|FG000|6-month Follow-up|Lost to Follow-up|2|||
126559333|NCT02337361|455340726|FG001|6-month Follow-up|Lost to Follow-up|4|||
126559334|NCT02427646|455340727|FG000|Overall Study|Lack of Efficacy|2|||
126722753|NCT00406640|455934533|FG001|Acute Phase|Lack of Efficacy|3|||
126559335|NCT02427646|455340728|FG001|Overall Study|Lack of Efficacy|3|||
126722754|NCT00406640|455934532|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
126484711|NCT02207244|455071015|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
126484712|NCT02207244|455071016|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
126484713|NCT02207244|455071017|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
126484714|NCT02207244|455071018|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
126484715|NCT02207244|455071019|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
126484716|NCT02207244|455071020|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
126484717|NCT02207244|455071021|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
126484718|NCT02207244|455071022|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
126484719|NCT02207244|455071023|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
126484720|NCT02207244|455071024|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
126484721|NCT02207244|455071025|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
126484722|NCT02207244|455071015|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
126484723|NCT02207244|455071016|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
126484724|NCT02207244|455071017|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
126484725|NCT02207244|455071018|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
126484726|NCT02207244|455071019|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
126484727|NCT02207244|455071020|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
126484728|NCT02207244|455071021|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
126484729|NCT02207244|455071022|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
126484730|NCT02207244|455071023|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
126484731|NCT02207244|455071024|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
126484732|NCT02207244|455071025|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
126484733|NCT02207244|455071015|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
126484734|NCT02207244|455071016|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
126484735|NCT02207244|455071017|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
126484736|NCT02207244|455071018|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
126484737|NCT02207244|455071019|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
126484738|NCT02207244|455071020|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
126484739|NCT02207244|455071021|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
126484740|NCT02207244|455071022|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
126484741|NCT02207244|455071023|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
126484742|NCT02207244|455071024|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
126484743|NCT02207244|455071025|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
126484744|NCT02207244|455071015|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
126484745|NCT02207244|455071016|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
126484746|NCT02207244|455071017|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
126484747|NCT02207244|455071018|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
126484748|NCT02207244|455071019|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
126484749|NCT02207244|455071020|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
126484750|NCT02207244|455071021|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
126484751|NCT02207244|455071022|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
126484752|NCT02207244|455071023|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
126484753|NCT02207244|455071024|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
126484754|NCT02207244|455071025|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
126484755|NCT02207244|455071015|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
126484756|NCT02207244|455071016|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
126484757|NCT02207244|455071017|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
126484758|NCT02207244|455071018|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
126484759|NCT02207244|455071019|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
126484760|NCT02207244|455071020|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
126484761|NCT02207244|455071021|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
126484762|NCT02207244|455071022|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
126484763|NCT02207244|455071023|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
126484764|NCT02207244|455071024|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
126484765|NCT02207244|455071025|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
126484766|NCT02207244|455071015|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
126484767|NCT02207244|455071016|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
126484768|NCT02207244|455071017|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
126484769|NCT02207244|455071018|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
126484770|NCT02207244|455071019|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
126484771|NCT02207244|455071020|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
126484772|NCT02207244|455071021|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
126559336|NCT02427646|455340727|FG000|Overall Study|Physician Decision|1|||
126559337|NCT02427646|455340728|FG001|Overall Study|Physician Decision|4|||
126559338|NCT02427646|455340727|FG000|Overall Study|Protocol Violation|3|||
126559339|NCT02427646|455340728|FG001|Overall Study|Protocol Violation|3|||
126559340|NCT02427646|455340727|FG000|Overall Study|Bothersome hand weakness|2|||
126484773|NCT02207244|455071022|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
126484774|NCT02207244|455071023|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
126484775|NCT02207244|455071024|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
126484776|NCT02207244|455071025|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
126484777|NCT02207244|455071015|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
126484778|NCT02207244|455071016|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
126484779|NCT02207244|455071017|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
126484780|NCT02207244|455071018|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
126484781|NCT02207244|455071019|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
126484782|NCT02207244|455071020|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
126484783|NCT02207244|455071021|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
126484784|NCT02207244|455071022|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
126484785|NCT02207244|455071023|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
126484786|NCT02207244|455071024|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
126484787|NCT02207244|455071025|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
126484788|NCT02207244|455071015|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
126484789|NCT02207244|455071016|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
126484790|NCT02207244|455071017|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
126484791|NCT02207244|455071018|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
126484792|NCT02207244|455071019|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
126484793|NCT02207244|455071020|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
126484794|NCT02207244|455071021|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
126484795|NCT02207244|455071022|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
126484796|NCT02207244|455071023|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
126484797|NCT02207244|455071024|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
126484798|NCT02207244|455071025|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
126484799|NCT02207244|455071015|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
126484800|NCT02207244|455071016|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
126484801|NCT02207244|455071017|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
126484802|NCT02207244|455071018|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
126484803|NCT02207244|455071019|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
126484804|NCT02207244|455071020|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
126484805|NCT02207244|455071021|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
126484806|NCT02207244|455071022|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
126484807|NCT02207244|455071023|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
126484808|NCT02207244|455071024|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
126484809|NCT02207244|455071025|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
126484810|NCT02207244|455071015|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
126484811|NCT02207244|455071016|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
126484812|NCT02207244|455071017|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
126484813|NCT02207244|455071018|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
126484814|NCT02207244|455071019|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
126484815|NCT02207244|455071020|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
126484816|NCT02207244|455071021|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
126484817|NCT02207244|455071022|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
126484818|NCT02207244|455071023|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
126484819|NCT02207244|455071024|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
126484820|NCT02207244|455071025|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
126484821|NCT02207244|455071015|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
126484822|NCT02207244|455071016|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
126484823|NCT02207244|455071017|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
126484824|NCT02207244|455071018|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
126484825|NCT02207244|455071019|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
126484826|NCT02207244|455071020|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
126484827|NCT02207244|455071021|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
126484828|NCT02207244|455071022|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
126484829|NCT02207244|455071023|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
126559341|NCT02427646|455340728|FG001|Overall Study|Bothersome hand weakness|4|||
126559342|NCT01101542|455340729|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
126559343|NCT01101542|455340729|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
126559344|NCT01101542|455340729|FG000|Year 4 Surveillance Period|Other|287|||
126559345|NCT01101542|455340729|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
126559346|NCT01101542|455340729|FG000|Year 5 Surveillance Period|Pregnancy|1|||
126559347|NCT01101542|455340729|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
126559348|NCT01101542|455340729|FG000|Year 6 Surveillance Period|Pregnancy|1|||
126484830|NCT02207244|455071024|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
126484831|NCT02207244|455071025|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
126484832|NCT02207244|455071015|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
126484833|NCT02207244|455071016|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
126484834|NCT02207244|455071017|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
126484835|NCT02207244|455071018|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
126484836|NCT02207244|455071019|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
126484837|NCT02207244|455071020|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
126484838|NCT02207244|455071021|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
126484839|NCT02207244|455071022|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
126484840|NCT02207244|455071023|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
126484841|NCT02207244|455071024|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
126484842|NCT02207244|455071025|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
126484843|NCT02207244|455071015|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
126484844|NCT02207244|455071016|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
126484845|NCT02207244|455071017|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
126484846|NCT02207244|455071018|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
126484847|NCT02207244|455071019|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
126484848|NCT02207244|455071020|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
126484849|NCT02207244|455071021|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
126484850|NCT02207244|455071022|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
126484851|NCT02207244|455071023|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
126484852|NCT02207244|455071024|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
126484853|NCT02207244|455071025|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
126484854|NCT02207244|455071015|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
126484855|NCT02207244|455071016|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
126484856|NCT02207244|455071017|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
126484857|NCT02207244|455071018|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
126484858|NCT02207244|455071019|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
126484859|NCT02207244|455071020|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
126484860|NCT02207244|455071021|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
126484861|NCT02207244|455071022|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
126484862|NCT02207244|455071023|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
126484863|NCT02207244|455071024|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
126484864|NCT02207244|455071025|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
126484865|NCT02207244|455071015|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
126484866|NCT02207244|455071016|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
126484867|NCT02207244|455071017|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
126484868|NCT02207244|455071018|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
126484869|NCT02207244|455071019|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
126484870|NCT02207244|455071020|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
126484871|NCT02207244|455071021|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
126484872|NCT02207244|455071022|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
126484873|NCT02207244|455071023|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
126484874|NCT02207244|455071024|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
126484875|NCT02207244|455071025|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
126484876|NCT02207244|455071015|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
126484877|NCT02207244|455071016|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
126484878|NCT02207244|455071017|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
126484879|NCT02207244|455071018|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
126484880|NCT02207244|455071019|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
126484881|NCT02207244|455071020|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
126484882|NCT02207244|455071021|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
126484883|NCT02207244|455071022|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
126484884|NCT02207244|455071023|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
126484885|NCT02207244|455071024|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
126484886|NCT02207244|455071025|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
126484887|NCT02207244|455071015|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
126484888|NCT02207244|455071016|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
126484889|NCT02207244|455071017|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
126484890|NCT02207244|455071018|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
126484891|NCT02207244|455071019|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
126484892|NCT02207244|455071020|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
126559349|NCT01101542|455340729|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
126484893|NCT02207244|455071021|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
126484894|NCT02207244|455071022|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
126484895|NCT02207244|455071023|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
126484896|NCT02207244|455071024|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
126484897|NCT02207244|455071025|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
126484898|NCT02207244|455071015|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
126484899|NCT02207244|455071016|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
126484900|NCT02207244|455071017|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
126484901|NCT02207244|455071018|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
126484902|NCT02207244|455071019|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
126484903|NCT02207244|455071020|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
126484904|NCT02207244|455071021|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
126484905|NCT02207244|455071022|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
126484906|NCT02207244|455071023|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
126484907|NCT02207244|455071024|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
126484908|NCT02207244|455071025|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
126484909|NCT02207244|455071015|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
126484910|NCT02207244|455071016|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
126484911|NCT02207244|455071017|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
126484912|NCT02207244|455071018|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
126484913|NCT02207244|455071019|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
126484914|NCT02207244|455071020|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
126484915|NCT02207244|455071021|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
126484916|NCT02207244|455071022|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
126484917|NCT02207244|455071023|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
126484918|NCT02207244|455071024|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
126484919|NCT02207244|455071025|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
126484920|NCT00039130|455071026|FG000|Overall Study|Adverse Event|11|||
126484921|NCT00039130|455071026|FG000|Overall Study|Death|9|||
126484922|NCT00039130|455071026|FG000|Overall Study|Withdrawal by Subject|3|||
126484923|NCT00039130|455071026|FG000|Overall Study|Progression|2|||
126484924|NCT00039130|455071026|FG000|Overall Study|Subsequent treatment|2|||
126484925|NCT00039130|455071026|FG000|Overall Study|Physician Decision|3|||
126484926|NCT01866930|455071027|FG000|Treatment Period|Other|1|||
126484927|NCT01866930|455071028|FG001|Treatment Period|Other|0|||
126484928|NCT01866930|455071027|FG000|Treatment Period|Death|0|||
126484929|NCT01866930|455071028|FG001|Treatment Period|Death|2|||
126484930|NCT01866930|455071027|FG000|Treatment Period|Poor/non compliance|0|||
126484931|NCT01866930|455071028|FG001|Treatment Period|Poor/non compliance|2|||
126484932|NCT01866930|455071027|FG000|Treatment Period|No longer meets study criteria|0|||
126484933|NCT01866930|455071028|FG001|Treatment Period|No longer meets study criteria|1|||
126484934|NCT01866930|455071027|FG000|Treatment Period|Withdrawal by Subject|2|||
126484935|NCT01866930|455071028|FG001|Treatment Period|Withdrawal by Subject|8|||
126484936|NCT01866930|455071027|FG000|Treatment Period|Lack of Efficacy|1|||
126484937|NCT01866930|455071028|FG001|Treatment Period|Lack of Efficacy|9|||
126484938|NCT01866930|455071027|FG000|Treatment Period|Adverse Event|4|||
126484939|NCT01866930|455071028|FG001|Treatment Period|Adverse Event|12|||
126484940|NCT01866930|455071027|FG000|Treatment Period|Lost to Follow-up|1|||
126484941|NCT01866930|455071028|FG001|Treatment Period|Lost to Follow-up|1|||
126484942|NCT01866930|455071027|FG000|Follow-up Period|Lost to Follow-up|1|||
126484943|NCT01866930|455071028|FG001|Follow-up Period|Lost to Follow-up|1|||
126484944|NCT01866930|455071027|FG000|Follow-up Period|Other|1|||
126484945|NCT01866930|455071028|FG001|Follow-up Period|Other|5|||
126484946|NCT01866930|455071027|FG000|Follow-up Period|No longer required per protocol|1|||
126484947|NCT01866930|455071028|FG001|Follow-up Period|No longer required per protocol|0|||
126484948|NCT01866930|455071027|FG000|Follow-up Period|Withdrawal by Subject|3|||
126484949|NCT01866930|455071028|FG001|Follow-up Period|Withdrawal by Subject|3|||
126484950|NCT00279305|455071031|FG000|Overall Study|Pregnancy|1|||
126722755|NCT00406640|455934533|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
126484951|NCT00279305|455071032|FG001|Overall Study|Pregnancy|0|||
126484952|NCT00279305|455071031|FG000|Overall Study|Withdrawal by Subject|2|||
126722756|NCT00406640|455934532|FG000|DB Continuation Phase for Responders|Death|1|||
126484953|NCT00279305|455071032|FG001|Overall Study|Withdrawal by Subject|0|||
126484954|NCT00279305|455071031|FG000|Overall Study|Dificulting establishing IV|1|||
126484955|NCT00279305|455071032|FG001|Overall Study|Dificulting establishing IV|0|||
126484956|NCT00279305|455071031|FG000|Overall Study|FDA Safety Alert|4|||
126484957|NCT00279305|455071032|FG001|Overall Study|FDA Safety Alert|1|||
126484958|NCT00621153|455071041|FG000|Overall Study|Safety Reason|8|||
126484959|NCT00621153|455071042|FG001|Overall Study|Safety Reason|7|||
126484960|NCT00621153|455071041|FG000|Overall Study|Adverse Event|3|||
126484961|NCT00621153|455071042|FG001|Overall Study|Adverse Event|2|||
126484962|NCT00621153|455071041|FG000|Overall Study|Lost to Follow-up|5|||
126559350|NCT00901485|455340730|FG000|Overall Study|Lack of Efficacy|0|||
126484963|NCT00621153|455071042|FG001|Overall Study|Lost to Follow-up|1|||
126484964|NCT00621153|455071041|FG000|Overall Study|Withdrawal by Subject|4|||
126484965|NCT00621153|455071042|FG001|Overall Study|Withdrawal by Subject|5|||
126722757|NCT00406640|455934533|FG001|DB Continuation Phase for Responders|Death|0|||
126722758|NCT00406640|455934532|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
126722759|NCT00406640|455934533|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
126722760|NCT00406640|455934532|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
126722761|NCT00406640|455934533|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
126722762|NCT00406640|455934532|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
126484966|NCT00753415|455071043|FG000|Part A|Disease progression|1|||
126722763|NCT00406640|455934533|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
126722764|NCT00406640|455934532|FG000|DB Continuation Phase for Responders|non-compliance|7|||
126722765|NCT00406640|455934533|FG001|DB Continuation Phase for Responders|non-compliance|5|||
126722766|NCT00406640|455934532|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
126722767|NCT00406640|455934533|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
126722768|NCT00406640|455934532|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
126722769|NCT00406640|455934533|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
126722770|NCT00406640|455934532|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
126722771|NCT00406640|455934533|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
126722772|NCT00406640|455934532|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
126722773|NCT00406640|455934533|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
126722774|NCT00406640|455934532|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
126722775|NCT00406640|455934533|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
126722776|NCT00406640|455934532|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
126722777|NCT00406640|455934533|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
126722778|NCT00406640|455934532|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
126722779|NCT00406640|455934533|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
126722780|NCT00406640|455934532|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
126722781|NCT00406640|455934533|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
126722782|NCT00406640|455934532|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
126722783|NCT00406640|455934533|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
126722784|NCT00406640|455934532|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
126722785|NCT00406640|455934533|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
126722786|NCT01454401|455934536|FG000|Overall Study|Death|1|||
126722787|NCT01454401|455934536|FG000|Overall Study|hospitalised|1|||
126484967|NCT00753415|455071044|FG001|Part A|Disease progression|0|||
126484968|NCT00753415|455071045|FG002|Part A|Disease progression|1|||
126484969|NCT00753415|455071046|FG003|Part A|Disease progression|2|||
126484970|NCT00753415|455071047|FG004|Part A|Disease progression|0|||
126484971|NCT00753415|455071048|FG005|Part A|Disease progression|0|||
126484972|NCT00753415|455071049|FG006|Part A|Disease progression|0|||
126484973|NCT00753415|455071050|FG007|Part A|Disease progression|0|||
126484974|NCT00753415|455071051|FG008|Part A|Disease progression|0|||
126484975|NCT00753415|455071052|FG009|Part A|Disease progression|0|||
126484976|NCT00753415|455071043|FG000|Part A|Withdrawal by Subject|0|||
126484977|NCT00753415|455071044|FG001|Part A|Withdrawal by Subject|0|||
126484978|NCT00753415|455071045|FG002|Part A|Withdrawal by Subject|1|||
126484979|NCT00753415|455071046|FG003|Part A|Withdrawal by Subject|0|||
126484980|NCT00753415|455071047|FG004|Part A|Withdrawal by Subject|0|||
126484981|NCT00753415|455071048|FG005|Part A|Withdrawal by Subject|0|||
126484982|NCT00753415|455071049|FG006|Part A|Withdrawal by Subject|0|||
126484983|NCT00753415|455071050|FG007|Part A|Withdrawal by Subject|0|||
126484984|NCT00753415|455071051|FG008|Part A|Withdrawal by Subject|0|||
126484985|NCT00753415|455071052|FG009|Part A|Withdrawal by Subject|0|||
126484986|NCT00753415|455071043|FG000|Part B|Lost to Follow-up|0|||
126484987|NCT00753415|455071044|FG001|Part B|Lost to Follow-up|0|||
126484988|NCT00753415|455071045|FG002|Part B|Lost to Follow-up|0|||
126484989|NCT00753415|455071046|FG003|Part B|Lost to Follow-up|0|||
126484990|NCT00753415|455071047|FG004|Part B|Lost to Follow-up|0|||
126484991|NCT00753415|455071048|FG005|Part B|Lost to Follow-up|0|||
126484992|NCT00753415|455071049|FG006|Part B|Lost to Follow-up|0|||
126484993|NCT00753415|455071050|FG007|Part B|Lost to Follow-up|1|||
126484994|NCT00753415|455071051|FG008|Part B|Lost to Follow-up|1|||
126484995|NCT00753415|455071052|FG009|Part B|Lost to Follow-up|0|||
126484996|NCT00753415|455071043|FG000|Part B|Disease progression|0|||
126484997|NCT00753415|455071044|FG001|Part B|Disease progression|0|||
126484998|NCT00753415|455071045|FG002|Part B|Disease progression|0|||
126722788|NCT01454401|455934536|FG000|Overall Study|osteomyelitis|2|||
126484999|NCT00753415|455071046|FG003|Part B|Disease progression|0|||
126485000|NCT00753415|455071047|FG004|Part B|Disease progression|0|||
126485001|NCT00753415|455071048|FG005|Part B|Disease progression|0|||
126485002|NCT00753415|455071049|FG006|Part B|Disease progression|0|||
126485003|NCT00753415|455071050|FG007|Part B|Disease progression|0|||
126485004|NCT00753415|455071051|FG008|Part B|Disease progression|2|||
126485005|NCT00753415|455071052|FG009|Part B|Disease progression|1|||
126485006|NCT03919799|455071053|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
126485007|NCT03919799|455071054|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
126485008|NCT03919799|455071055|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
126485009|NCT03919799|455071056|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
126485010|NCT03919799|455071057|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
126485011|NCT03919799|455071053|FG000|DB Period (28 Weeks)|Adverse Event|1|||
126485012|NCT03919799|455071054|FG001|DB Period (28 Weeks)|Adverse Event|1|||
126485013|NCT03919799|455071055|FG002|DB Period (28 Weeks)|Adverse Event|1|||
126485014|NCT03919799|455071056|FG003|DB Period (28 Weeks)|Adverse Event|0|||
126485015|NCT03919799|455071057|FG004|DB Period (28 Weeks)|Adverse Event|0|||
126485016|NCT03919799|455071053|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
126485017|NCT03919799|455071054|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
126485018|NCT03919799|455071055|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
126485019|NCT03919799|455071056|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
126485020|NCT03919799|455071057|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
126485021|NCT03919799|455071053|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
126485022|NCT03919799|455071054|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
126485023|NCT03919799|455071055|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
126485024|NCT03919799|455071056|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
126485025|NCT03919799|455071057|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
126485026|NCT03919799|455071053|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
126485027|NCT03919799|455071054|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
126485028|NCT03919799|455071055|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
126485029|NCT03919799|455071056|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
126485030|NCT03919799|455071057|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
126485031|NCT04023526|455073155|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
126485032|NCT04023526|455073156|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
126485033|NCT04023526|455073155|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
126485034|NCT04023526|455073156|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
126485035|NCT01411774|455073169|FG000|Overall Study|Withdrawal by Subject|0|||
126485036|NCT01411774|455073170|FG001|Overall Study|Withdrawal by Subject|3|||
126485037|NCT00056316|455073171|FG000|Overall Study|Withdrawal by Subject|2|||
126485038|NCT00056316|455073172|FG001|Overall Study|Withdrawal by Subject|2|||
126485039|NCT00056316|455073171|FG000|Overall Study|Death/NH placement of pt|1|||
126485040|NCT00056316|455073172|FG001|Overall Study|Death/NH placement of pt|1|||
126485041|NCT00903695|455073177|FG000|Overall Study|medical exclusion after 1st testing|1|||
126485042|NCT00903695|455073178|FG001|Overall Study|medical exclusion after 1st testing|0|||
126485043|NCT00903695|455073177|FG000|Overall Study|lung cancer|1|||
126485044|NCT00903695|455073178|FG001|Overall Study|lung cancer|0|||
126485045|NCT03902574|455073188|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
126485046|NCT03902574|455073189|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
126485047|NCT03902574|455073190|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
126485048|NCT02269241|455073195|FG000|Overall Study|Lost to Follow-up|269|||
126485049|NCT02269241|455073195|FG000|Overall Study|Withdrawal by Subject|155|||
126485050|NCT02269241|455073195|FG000|Overall Study|Protocol Violation|1|||
126485051|NCT02269241|455073195|FG000|Overall Study|Physician Decision|7|||
126485052|NCT02269241|455073195|FG000|Overall Study|Pregnancy|15|||
126485053|NCT02269241|455073195|FG000|Overall Study|Wish for pregnancy|5|||
126485054|NCT02269241|455073195|FG000|Overall Study|Development of an exclusion criteria|16|||
126485055|NCT02269241|455073195|FG000|Overall Study|Adverse Event|113|||
126485056|NCT02269241|455073195|FG000|Overall Study|At the specific request of the sponsor|20|||
126485057|NCT02269241|455073195|FG000|Overall Study|Several reasons not classified|53|||
126485058|NCT02269241|455073195|FG000|Overall Study|Screening failures|546|||
126485059|NCT00166114|455073201|FG000|Overall Study|Protocol Violation|2|||
126485060|NCT00166114|455073202|FG001|Overall Study|Protocol Violation|1|||
126485061|NCT00166114|455073201|FG000|Overall Study|Withdrawal by Subject|10|||
126485062|NCT00166114|455073202|FG001|Overall Study|Withdrawal by Subject|4|||
126485063|NCT00166114|455073201|FG000|Overall Study|Adverse Event|2|||
126485064|NCT00166114|455073202|FG001|Overall Study|Adverse Event|1|||
126485065|NCT01218204|455073209|FG000|Part B Washout|Adverse Event|0|||
126485066|NCT01218204|455073210|FG001|Part B Washout|Adverse Event|1|||
126485067|NCT01218204|455073211|FG002|Part B Washout|Adverse Event|0|||
126485068|NCT01218204|455073212|FG003|Part B Washout|Adverse Event|0|||
126485069|NCT01218204|455073209|FG000|Part B Washout|Lost to Follow-up|0|||
126485070|NCT01218204|455073210|FG001|Part B Washout|Lost to Follow-up|2|||
126485071|NCT01218204|455073211|FG002|Part B Washout|Lost to Follow-up|0|||
126485072|NCT01218204|455073212|FG003|Part B Washout|Lost to Follow-up|0|||
126485073|NCT01218204|455073209|FG000|Part B Washout|Physician Decision|0|||
126485074|NCT01218204|455073210|FG001|Part B Washout|Physician Decision|14|||
126485075|NCT01218204|455073211|FG002|Part B Washout|Physician Decision|0|||
126485076|NCT01218204|455073212|FG003|Part B Washout|Physician Decision|0|||
126485077|NCT01218204|455073209|FG000|Part B Washout|Withdrawal by Subject|0|||
126485078|NCT01218204|455073210|FG001|Part B Washout|Withdrawal by Subject|14|||
126485079|NCT01218204|455073211|FG002|Part B Washout|Withdrawal by Subject|0|||
126485080|NCT01218204|455073212|FG003|Part B Washout|Withdrawal by Subject|0|||
126485081|NCT01218204|455073209|FG000|Part B Washout|Reached defined stopping criteria|0|||
126485082|NCT01218204|455073210|FG001|Part B Washout|Reached defined stopping criteria|2|||
126485083|NCT01218204|455073211|FG002|Part B Washout|Reached defined stopping criteria|0|||
126485084|NCT01218204|455073212|FG003|Part B Washout|Reached defined stopping criteria|0|||
126485085|NCT01218204|455073209|FG000|Part B Washout|Did not meet continuation criteria|0|||
126485086|NCT01218204|455073210|FG001|Part B Washout|Did not meet continuation criteria|112|||
126485087|NCT01218204|455073211|FG002|Part B Washout|Did not meet continuation criteria|0|||
126485088|NCT01218204|455073212|FG003|Part B Washout|Did not meet continuation criteria|0|||
126485089|NCT01218204|455073209|FG000|Part B Run-in|Adverse Event|0|||
126485090|NCT01218204|455073210|FG001|Part B Run-in|Adverse Event|0|||
126485091|NCT01218204|455073211|FG002|Part B Run-in|Adverse Event|1|||
126485092|NCT01218204|455073212|FG003|Part B Run-in|Adverse Event|0|||
126485093|NCT01218204|455073209|FG000|Part B Run-in|Protocol Violation|0|||
126485094|NCT01218204|455073210|FG001|Part B Run-in|Protocol Violation|0|||
126485095|NCT01218204|455073211|FG002|Part B Run-in|Protocol Violation|2|||
126485096|NCT01218204|455073212|FG003|Part B Run-in|Protocol Violation|0|||
126485097|NCT01218204|455073209|FG000|Part B Run-in|Withdrawal by Subject|0|||
126485098|NCT01218204|455073210|FG001|Part B Run-in|Withdrawal by Subject|0|||
126485099|NCT01218204|455073211|FG002|Part B Run-in|Withdrawal by Subject|3|||
126485100|NCT01218204|455073212|FG003|Part B Run-in|Withdrawal by Subject|0|||
126485101|NCT01218204|455073209|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
126485102|NCT01218204|455073210|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
126485103|NCT01218204|455073211|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
126485104|NCT01218204|455073212|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
126485105|NCT01218204|455073209|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
126485106|NCT01218204|455073210|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
126485107|NCT01218204|455073211|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
126485108|NCT01218204|455073212|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
126485109|NCT00545168|455073213|FG000|Overall Study|Lost to Follow-up|5|||
126485110|NCT00545168|455073214|FG001|Overall Study|Lost to Follow-up|5|||
126485111|NCT00545168|455073215|FG002|Overall Study|Lost to Follow-up|5|||
126485112|NCT00545168|455073213|FG000|Overall Study|Withdrawal by Subject|9|||
126722789|NCT01454401|455934536|FG000|Overall Study|non-adherence|1|||
126485113|NCT00545168|455073214|FG001|Overall Study|Withdrawal by Subject|0|||
126485114|NCT00545168|455073215|FG002|Overall Study|Withdrawal by Subject|13|||
126485115|NCT00545168|455073213|FG000|Overall Study|Protocol Violation|1|||
126485116|NCT00545168|455073214|FG001|Overall Study|Protocol Violation|0|||
126485117|NCT00545168|455073215|FG002|Overall Study|Protocol Violation|1|||
126485118|NCT00545168|455073213|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
126485119|NCT00545168|455073214|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
126485120|NCT00545168|455073215|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
126485121|NCT00127660|455073216|FG000|Overall Study|Protocol Violation|3|||
126485122|NCT00127660|455073217|FG001|Overall Study|Protocol Violation|3|||
126485123|NCT00127660|455073218|FG002|Overall Study|Protocol Violation|5|||
126485124|NCT00127660|455073219|FG003|Overall Study|Protocol Violation|0|||
126485125|NCT01987505|455073220|FG000|Overall Study|Other|9|||
126485126|NCT01987505|455073220|FG000|Overall Study|Withdrawal by Subject|2|||
126485127|NCT01987505|455073220|FG000|Overall Study|Other Reason|2|||
126485128|NCT01987505|455073220|FG000|Overall Study|Lost to Follow-up|15|||
126485129|NCT01987505|455073220|FG000|Overall Study|Investigator Decision|2|||
126485130|NCT01987505|455073220|FG000|Overall Study|Death|4|||
126485131|NCT00489541|455073221|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
126485132|NCT00489541|455073222|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
126485133|NCT00489541|455073221|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
126485134|NCT00489541|455073222|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
126485135|NCT00489541|455073221|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
126485136|NCT00489541|455073222|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
126485137|NCT00489541|455073221|FG000|12-Month Clinical Follow-up|Death|3|||
126485138|NCT00489541|455073222|FG001|12-Month Clinical Follow-up|Death|2|||
126485139|NCT00489541|455073221|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
126485140|NCT00489541|455073222|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
126485141|NCT00489541|455073221|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
126485142|NCT00489541|455073222|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
126722790|NCT00755846|455936000|FG000|Overall Study|Adverse Event|0|||
126722791|NCT00755846|455936001|FG001|Overall Study|Adverse Event|0|||
126722792|NCT00755846|455936002|FG002|Overall Study|Adverse Event|0|||
126485143|NCT05131646|455073223|FG000|Overall Study|Withdrawal by Subject|1|||
126485144|NCT05131646|455073224|FG001|Overall Study|Withdrawal by Subject|0|||
126485145|NCT05131646|455073225|FG002|Overall Study|Withdrawal by Subject|0|||
126485146|NCT03266107|455073226|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
126485147|NCT03266107|455073226|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
126485148|NCT03266107|455073226|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
126485149|NCT03266107|455073226|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
126485150|NCT01191801|455073231|FG000|Overall Study|Death|36|||
126485151|NCT01191801|455073232|FG001|Overall Study|Death|12|||
126485152|NCT01191801|455073231|FG000|Overall Study|Lack of Efficacy|176|||
126485153|NCT01191801|455073232|FG001|Overall Study|Lack of Efficacy|258|||
126485154|NCT01191801|455073231|FG000|Overall Study|Adverse Event|9|||
126485155|NCT01191801|455073232|FG001|Overall Study|Adverse Event|8|||
126485156|NCT01191801|455073231|FG000|Overall Study|Protocol Violation|2|||
126485157|NCT01191801|455073232|FG001|Overall Study|Protocol Violation|4|||
126485158|NCT01191801|455073231|FG000|Overall Study|Physician Decision|47|||
126485159|NCT01191801|455073232|FG001|Overall Study|Physician Decision|24|||
126485160|NCT01191801|455073231|FG000|Overall Study|Withdrawal by Subject|1|||
126485161|NCT01191801|455073232|FG001|Overall Study|Withdrawal by Subject|4|||
126485162|NCT01191801|455073231|FG000|Overall Study|Not Provided|45|||
126485163|NCT01191801|455073232|FG001|Overall Study|Not Provided|27|||
126485164|NCT05147350|455073240|FG000|Overall Study|Death|2|||
126485165|NCT05147350|455073241|FG001|Overall Study|Death|3|||
126485166|NCT05147350|455073242|FG002|Overall Study|Death|3|||
126485167|NCT05147350|455073243|FG003|Overall Study|Death|2|||
126485168|NCT05147350|455073244|FG004|Overall Study|Death|2|||
126485169|NCT05147350|455073245|FG005|Overall Study|Death|1|||
126485170|NCT05147350|455073246|FG006|Overall Study|Death|1|||
126485171|NCT05147350|455073247|FG007|Overall Study|Death|3|||
126485172|NCT05147350|455073240|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
126485173|NCT05147350|455073241|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
126485174|NCT05147350|455073242|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
126485175|NCT05147350|455073243|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
126485176|NCT05147350|455073244|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
126485177|NCT05147350|455073245|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
126485178|NCT05147350|455073246|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
126485179|NCT05147350|455073247|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
126485180|NCT05147350|455073240|FG000|Overall Study|Withdrawal by Subject|0|||
126485181|NCT05147350|455073241|FG001|Overall Study|Withdrawal by Subject|0|||
126485182|NCT05147350|455073242|FG002|Overall Study|Withdrawal by Subject|3|||
126485183|NCT05147350|455073243|FG003|Overall Study|Withdrawal by Subject|1|||
126485184|NCT05147350|455073244|FG004|Overall Study|Withdrawal by Subject|1|||
126485185|NCT05147350|455073245|FG005|Overall Study|Withdrawal by Subject|0|||
126485186|NCT05147350|455073246|FG006|Overall Study|Withdrawal by Subject|1|||
126485187|NCT05147350|455073247|FG007|Overall Study|Withdrawal by Subject|0|||
126485188|NCT05147350|455073240|FG000|Overall Study|Other Reasons|0|||
126485189|NCT05147350|455073241|FG001|Overall Study|Other Reasons|0|||
126485190|NCT05147350|455073242|FG002|Overall Study|Other Reasons|2|||
126485191|NCT05147350|455073243|FG003|Overall Study|Other Reasons|0|||
126485192|NCT05147350|455073244|FG004|Overall Study|Other Reasons|0|||
126485193|NCT05147350|455073245|FG005|Overall Study|Other Reasons|2|||
126485194|NCT05147350|455073246|FG006|Overall Study|Other Reasons|1|||
126485195|NCT05147350|455073247|FG007|Overall Study|Other Reasons|1|||
126485196|NCT01256008|455073250|FG000|Overall Study|Lost to Follow-up|6|||
126485197|NCT01256008|455073251|FG001|Overall Study|Lost to Follow-up|4|||
126485198|NCT01256008|455073252|FG002|Overall Study|Lost to Follow-up|11|||
126485199|NCT01256008|455073250|FG000|Overall Study|Withdrawal by Subject|2|||
126485200|NCT01256008|455073251|FG001|Overall Study|Withdrawal by Subject|3|||
126485201|NCT01256008|455073252|FG002|Overall Study|Withdrawal by Subject|10|||
126485202|NCT00814164|455073255|FG000|Overall Study|Progression|7|||
126485203|NCT00814164|455073255|FG000|Overall Study|not stated|7|||
126485204|NCT00814164|455073255|FG000|Overall Study|Death|5|||
126485205|NCT00982878|455073259|FG000|Overall Study|Physician Decision|1|||
126485206|NCT02627144|455073262|FG000|Overall Study|Serious adverse event|32|||
126485207|NCT02627144|455073262|FG000|Overall Study|Cancer progression|171|||
126485208|NCT02627144|455073262|FG000|Overall Study|Death from cancer|20|||
126485209|NCT02627144|455073262|FG000|Overall Study|Death from other cause|8|||
126485210|NCT02627144|455073262|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
126485211|NCT02627144|455073262|FG000|Overall Study|Administrative reasons|65|||
126485212|NCT02627144|455073262|FG000|Overall Study|Lost to Follow-up|8|||
126485213|NCT02627144|455073262|FG000|Overall Study|Enrolled, not treated|6|||
126485214|NCT02627144|455073262|FG000|Overall Study|Other|17|||
126485215|NCT01906008|455073270|FG000|Overall Study|Lost to Follow-up|2|||
126485216|NCT01906008|455073271|FG001|Overall Study|Lost to Follow-up|0|||
126485217|NCT01906008|455073270|FG000|Overall Study|Oxaliplatin toxicity|2|||
126485218|NCT01906008|455073271|FG001|Overall Study|Oxaliplatin toxicity|0|||
126485219|NCT01906008|455073270|FG000|Overall Study|Protocol Violation|0|||
126485220|NCT01906008|455073271|FG001|Overall Study|Protocol Violation|1|||
126485221|NCT01906008|455073270|FG000|Overall Study|Withdrawal by Subject|1|||
126485222|NCT01906008|455073271|FG001|Overall Study|Withdrawal by Subject|5|||
126485223|NCT01906008|455073270|FG000|Overall Study|Did not start study med|3|||
126485224|NCT01906008|455073271|FG001|Overall Study|Did not start study med|4|||
126485225|NCT01906008|455073270|FG000|Overall Study|Oxaliplatin stops|10|||
126485226|NCT01906008|455073271|FG001|Overall Study|Oxaliplatin stops|8|||
126485227|NCT01906008|455073270|FG000|Overall Study|Hospice|1|||
126559351|NCT00901485|455340731|FG001|Overall Study|Lack of Efficacy|2|||
126485228|NCT01906008|455073271|FG001|Overall Study|Hospice|0|||
126485229|NCT01906008|455073270|FG000|Overall Study|Physician Decision|3|||
126485230|NCT01906008|455073271|FG001|Overall Study|Physician Decision|3|||
126485231|NCT01906008|455073270|FG000|Overall Study|Lack of compliance of study med|5|||
126485232|NCT01906008|455073271|FG001|Overall Study|Lack of compliance of study med|3|||
126485233|NCT01906008|455073270|FG000|Overall Study|Adverse Event|0|||
126485234|NCT01906008|455073271|FG001|Overall Study|Adverse Event|3|||
126485235|NCT02220205|455073272|FG000|Overall Study|Withdrawal by Subject|1|||
126485236|NCT02220205|455073273|FG001|Overall Study|Withdrawal by Subject|0|||
126485237|NCT00420927|455073274|FG000|Period 1|Adverse Event|19|||
126485238|NCT00420927|455073275|FG001|Period 1|Adverse Event|15|||
126485239|NCT00420927|455073276|FG002|Period 1|Adverse Event|0|||
126485240|NCT00420927|455073277|FG003|Period 1|Adverse Event|0|||
126485241|NCT00420927|455073278|FG004|Period 1|Adverse Event|0|||
126485242|NCT00420927|455073279|FG005|Period 1|Adverse Event|0|||
126485243|NCT00420927|455073280|FG006|Period 1|Adverse Event|0|||
126485244|NCT00420927|455073274|FG000|Period 1|Withdrawal by Subject|7|||
126485245|NCT00420927|455073275|FG001|Period 1|Withdrawal by Subject|12|||
126485246|NCT00420927|455073276|FG002|Period 1|Withdrawal by Subject|0|||
126485247|NCT00420927|455073277|FG003|Period 1|Withdrawal by Subject|0|||
126485248|NCT00420927|455073278|FG004|Period 1|Withdrawal by Subject|0|||
126485249|NCT00420927|455073279|FG005|Period 1|Withdrawal by Subject|0|||
126485250|NCT00420927|455073280|FG006|Period 1|Withdrawal by Subject|0|||
126485251|NCT00420927|455073274|FG000|Period 1|Lost to Follow-up|8|||
126485252|NCT00420927|455073275|FG001|Period 1|Lost to Follow-up|6|||
126485253|NCT00420927|455073276|FG002|Period 1|Lost to Follow-up|0|||
126485254|NCT00420927|455073277|FG003|Period 1|Lost to Follow-up|0|||
126485255|NCT00420927|455073278|FG004|Period 1|Lost to Follow-up|0|||
126485256|NCT00420927|455073279|FG005|Period 1|Lost to Follow-up|0|||
126485257|NCT00420927|455073280|FG006|Period 1|Lost to Follow-up|0|||
126485258|NCT00420927|455073274|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
126485259|NCT00420927|455073275|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
126485260|NCT00420927|455073276|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
126485261|NCT00420927|455073277|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
126485262|NCT00420927|455073278|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
126485263|NCT00420927|455073279|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
126485264|NCT00420927|455073280|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
126485265|NCT00420927|455073274|FG000|Period 1|Death|2|||
126485266|NCT00420927|455073275|FG001|Period 1|Death|0|||
126485267|NCT00420927|455073276|FG002|Period 1|Death|0|||
126485268|NCT00420927|455073277|FG003|Period 1|Death|0|||
126485269|NCT00420927|455073278|FG004|Period 1|Death|0|||
126485270|NCT00420927|455073279|FG005|Period 1|Death|0|||
126485271|NCT00420927|455073280|FG006|Period 1|Death|0|||
126485272|NCT00420927|455073274|FG000|Period 1|Subject moved/relocated|0|||
126485273|NCT00420927|455073275|FG001|Period 1|Subject moved/relocated|2|||
126485274|NCT00420927|455073276|FG002|Period 1|Subject moved/relocated|0|||
126485275|NCT00420927|455073277|FG003|Period 1|Subject moved/relocated|0|||
126485276|NCT00420927|455073278|FG004|Period 1|Subject moved/relocated|0|||
126485277|NCT00420927|455073279|FG005|Period 1|Subject moved/relocated|0|||
126485278|NCT00420927|455073280|FG006|Period 1|Subject moved/relocated|0|||
126485279|NCT00420927|455073274|FG000|Period 1|Noncompliant with study drug|1|||
126485280|NCT00420927|455073275|FG001|Period 1|Noncompliant with study drug|1|||
126485281|NCT00420927|455073276|FG002|Period 1|Noncompliant with study drug|0|||
126485282|NCT00420927|455073277|FG003|Period 1|Noncompliant with study drug|0|||
126485283|NCT00420927|455073278|FG004|Period 1|Noncompliant with study drug|0|||
126485284|NCT00420927|455073279|FG005|Period 1|Noncompliant with study drug|0|||
126485285|NCT00420927|455073280|FG006|Period 1|Noncompliant with study drug|0|||
126485286|NCT00420927|455073274|FG000|Period 1|Randomization error|1|||
126485287|NCT00420927|455073275|FG001|Period 1|Randomization error|0|||
126485288|NCT00420927|455073276|FG002|Period 1|Randomization error|0|||
126485289|NCT00420927|455073277|FG003|Period 1|Randomization error|0|||
126485290|NCT00420927|455073278|FG004|Period 1|Randomization error|0|||
126485291|NCT00420927|455073279|FG005|Period 1|Randomization error|0|||
126485292|NCT00420927|455073280|FG006|Period 1|Randomization error|0|||
126485293|NCT00420927|455073274|FG000|Period 1|Suspected tuberculosis/positive test|1|||
126485294|NCT00420927|455073275|FG001|Period 1|Suspected tuberculosis/positive test|1|||
126485295|NCT00420927|455073276|FG002|Period 1|Suspected tuberculosis/positive test|0|||
126485296|NCT00420927|455073277|FG003|Period 1|Suspected tuberculosis/positive test|0|||
126485297|NCT00420927|455073278|FG004|Period 1|Suspected tuberculosis/positive test|0|||
126485298|NCT00420927|455073279|FG005|Period 1|Suspected tuberculosis/positive test|0|||
126485299|NCT00420927|455073280|FG006|Period 1|Suspected tuberculosis/positive test|0|||
126485300|NCT00420927|455073274|FG000|Period 1|Study site closure|0|||
126485301|NCT00420927|455073275|FG001|Period 1|Study site closure|1|||
126485302|NCT00420927|455073276|FG002|Period 1|Study site closure|0|||
126485303|NCT00420927|455073277|FG003|Period 1|Study site closure|0|||
126485304|NCT00420927|455073278|FG004|Period 1|Study site closure|0|||
126485305|NCT00420927|455073279|FG005|Period 1|Study site closure|0|||
126485306|NCT00420927|455073280|FG006|Period 1|Study site closure|0|||
126485307|NCT00420927|455073274|FG000|Period 1|Subject received new diagnosis|0|||
126485308|NCT00420927|455073275|FG001|Period 1|Subject received new diagnosis|2|||
126485309|NCT00420927|455073276|FG002|Period 1|Subject received new diagnosis|0|||
126485310|NCT00420927|455073277|FG003|Period 1|Subject received new diagnosis|0|||
126722793|NCT00755846|455936003|FG003|Overall Study|Adverse Event|1|||
126722794|NCT00755846|455936004|FG004|Overall Study|Adverse Event|3|||
126722795|NCT00755846|455936005|FG005|Overall Study|Adverse Event|2|||
126485311|NCT00420927|455073278|FG004|Period 1|Subject received new diagnosis|0|||
126485312|NCT00420927|455073279|FG005|Period 1|Subject received new diagnosis|0|||
126485313|NCT00420927|455073280|FG006|Period 1|Subject received new diagnosis|0|||
126485314|NCT00420927|455073274|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
126485315|NCT00420927|455073275|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
126485316|NCT00420927|455073276|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
126485317|NCT00420927|455073277|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
126485318|NCT00420927|455073278|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
126485319|NCT00420927|455073279|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
126485320|NCT00420927|455073280|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
126485321|NCT00420927|455073274|FG000|Period 1|Failed to meet entry criteria|8|||
126485322|NCT00420927|455073275|FG001|Period 1|Failed to meet entry criteria|7|||
126485323|NCT00420927|455073276|FG002|Period 1|Failed to meet entry criteria|0|||
126485324|NCT00420927|455073277|FG003|Period 1|Failed to meet entry criteria|0|||
126485325|NCT00420927|455073278|FG004|Period 1|Failed to meet entry criteria|0|||
126485326|NCT00420927|455073279|FG005|Period 1|Failed to meet entry criteria|0|||
126485327|NCT00420927|455073280|FG006|Period 1|Failed to meet entry criteria|0|||
126485328|NCT00420927|455073274|FG000|Period 1|Took prohibited medication|1|||
126485329|NCT00420927|455073275|FG001|Period 1|Took prohibited medication|3|||
126485330|NCT00420927|455073276|FG002|Period 1|Took prohibited medication|0|||
126485331|NCT00420927|455073277|FG003|Period 1|Took prohibited medication|0|||
126485332|NCT00420927|455073278|FG004|Period 1|Took prohibited medication|0|||
126485333|NCT00420927|455073279|FG005|Period 1|Took prohibited medication|0|||
126485334|NCT00420927|455073280|FG006|Period 1|Took prohibited medication|0|||
126485335|NCT00420927|455073274|FG000|Period 2|Adverse Event|0|||
126485336|NCT00420927|455073275|FG001|Period 2|Adverse Event|0|||
126485337|NCT00420927|455073276|FG002|Period 2|Adverse Event|7|||
126485338|NCT00420927|455073277|FG003|Period 2|Adverse Event|3|||
126485339|NCT00420927|455073278|FG004|Period 2|Adverse Event|17|||
126485340|NCT00420927|455073279|FG005|Period 2|Adverse Event|6|||
126485341|NCT00420927|455073280|FG006|Period 2|Adverse Event|20|||
126485342|NCT00420927|455073274|FG000|Period 2|Withdrawal by Subject|0|||
126485343|NCT00420927|455073275|FG001|Period 2|Withdrawal by Subject|0|||
126485344|NCT00420927|455073276|FG002|Period 2|Withdrawal by Subject|1|||
126485345|NCT00420927|455073277|FG003|Period 2|Withdrawal by Subject|3|||
126485346|NCT00420927|455073278|FG004|Period 2|Withdrawal by Subject|11|||
126485347|NCT00420927|455073279|FG005|Period 2|Withdrawal by Subject|2|||
126485348|NCT00420927|455073280|FG006|Period 2|Withdrawal by Subject|12|||
126485349|NCT00420927|455073274|FG000|Period 2|Lost to Follow-up|0|||
126485350|NCT00420927|455073275|FG001|Period 2|Lost to Follow-up|0|||
126485351|NCT00420927|455073276|FG002|Period 2|Lost to Follow-up|2|||
126485352|NCT00420927|455073277|FG003|Period 2|Lost to Follow-up|2|||
126485353|NCT00420927|455073278|FG004|Period 2|Lost to Follow-up|6|||
126485354|NCT00420927|455073279|FG005|Period 2|Lost to Follow-up|3|||
126485355|NCT00420927|455073280|FG006|Period 2|Lost to Follow-up|9|||
126485356|NCT00420927|455073274|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
126485357|NCT00420927|455073275|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
126485358|NCT00420927|455073276|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
126485359|NCT00420927|455073277|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
126485360|NCT00420927|455073278|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
126485361|NCT00420927|455073279|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
126485362|NCT00420927|455073280|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
126485363|NCT00420927|455073274|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
126485364|NCT00420927|455073275|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
126485365|NCT00420927|455073276|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
126485366|NCT00420927|455073277|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
126485367|NCT00420927|455073278|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
126485368|NCT00420927|455073279|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
126485369|NCT00420927|455073280|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
126485370|NCT00420927|455073274|FG000|Period 2|Subject unable to find transportation|0|||
126722796|NCT00755846|455936000|FG000|Overall Study|Protocol Violation|1|||
126485371|NCT00420927|455073275|FG001|Period 2|Subject unable to find transportation|0|||
126722797|NCT00755846|455936001|FG001|Overall Study|Protocol Violation|1|||
126485372|NCT00420927|455073276|FG002|Period 2|Subject unable to find transportation|0|||
126485373|NCT00420927|455073277|FG003|Period 2|Subject unable to find transportation|0|||
126485374|NCT00420927|455073278|FG004|Period 2|Subject unable to find transportation|0|||
126485375|NCT00420927|455073279|FG005|Period 2|Subject unable to find transportation|0|||
126485376|NCT00420927|455073280|FG006|Period 2|Subject unable to find transportation|1|||
126485377|NCT00420927|455073274|FG000|Period 2|Physician Decision|0|||
126485378|NCT00420927|455073275|FG001|Period 2|Physician Decision|0|||
126485379|NCT00420927|455073276|FG002|Period 2|Physician Decision|0|||
126485380|NCT00420927|455073277|FG003|Period 2|Physician Decision|0|||
126722798|NCT00755846|455936002|FG002|Overall Study|Protocol Violation|1|||
126485381|NCT00420927|455073278|FG004|Period 2|Physician Decision|1|||
126485382|NCT00420927|455073279|FG005|Period 2|Physician Decision|1|||
126485383|NCT00420927|455073280|FG006|Period 2|Physician Decision|0|||
126485384|NCT00420927|455073274|FG000|Period 2|Sponsor decision|0|||
126485385|NCT00420927|455073275|FG001|Period 2|Sponsor decision|0|||
126485386|NCT00420927|455073276|FG002|Period 2|Sponsor decision|1|||
126485387|NCT00420927|455073277|FG003|Period 2|Sponsor decision|0|||
126485388|NCT00420927|455073278|FG004|Period 2|Sponsor decision|0|||
126485389|NCT00420927|455073279|FG005|Period 2|Sponsor decision|0|||
126485390|NCT00420927|455073280|FG006|Period 2|Sponsor decision|1|||
126485391|NCT00420927|455073274|FG000|Period 2|Randomization error|0|||
126485392|NCT00420927|455073275|FG001|Period 2|Randomization error|0|||
126485393|NCT00420927|455073276|FG002|Period 2|Randomization error|0|||
126485394|NCT00420927|455073277|FG003|Period 2|Randomization error|0|||
126485395|NCT00420927|455073278|FG004|Period 2|Randomization error|1|||
126485396|NCT00420927|455073279|FG005|Period 2|Randomization error|1|||
126485397|NCT00420927|455073280|FG006|Period 2|Randomization error|0|||
126485398|NCT00420927|455073274|FG000|Period 2|Noncompliant with study drug|0|||
126485399|NCT00420927|455073275|FG001|Period 2|Noncompliant with study drug|0|||
126485400|NCT00420927|455073276|FG002|Period 2|Noncompliant with study drug|0|||
126485401|NCT00420927|455073277|FG003|Period 2|Noncompliant with study drug|1|||
126485402|NCT00420927|455073278|FG004|Period 2|Noncompliant with study drug|0|||
126485403|NCT00420927|455073279|FG005|Period 2|Noncompliant with study drug|0|||
126485404|NCT00420927|455073280|FG006|Period 2|Noncompliant with study drug|2|||
126485405|NCT00420927|455073274|FG000|Period 2|Methotrexate intolerance|0|||
126485406|NCT00420927|455073275|FG001|Period 2|Methotrexate intolerance|0|||
126485407|NCT00420927|455073276|FG002|Period 2|Methotrexate intolerance|0|||
126485408|NCT00420927|455073277|FG003|Period 2|Methotrexate intolerance|0|||
126485409|NCT00420927|455073278|FG004|Period 2|Methotrexate intolerance|0|||
126485410|NCT00420927|455073279|FG005|Period 2|Methotrexate intolerance|0|||
126485411|NCT00420927|455073280|FG006|Period 2|Methotrexate intolerance|1|||
126485412|NCT00420927|455073274|FG000|Period 2|Took prohibited medication|0|||
126485413|NCT00420927|455073275|FG001|Period 2|Took prohibited medication|0|||
126485414|NCT00420927|455073276|FG002|Period 2|Took prohibited medication|0|||
126485415|NCT00420927|455073277|FG003|Period 2|Took prohibited medication|0|||
126485416|NCT00420927|455073278|FG004|Period 2|Took prohibited medication|1|||
126485417|NCT00420927|455073279|FG005|Period 2|Took prohibited medication|0|||
126485418|NCT00420927|455073280|FG006|Period 2|Took prohibited medication|0|||
126485419|NCT01465997|455073281|FG000|Overall Study|Adverse Event|12|||
126485420|NCT01465997|455073282|FG001|Overall Study|Adverse Event|22|||
126485421|NCT01465997|455073281|FG000|Overall Study|Lack of Efficacy|13|||
126485422|NCT01465997|455073282|FG001|Overall Study|Lack of Efficacy|1|||
126485423|NCT01465997|455073281|FG000|Overall Study|Protocol Violation|1|||
126485424|NCT01465997|455073282|FG001|Overall Study|Protocol Violation|4|||
126485425|NCT01465997|455073281|FG000|Overall Study|Lost to Follow-up|6|||
126485426|NCT01465997|455073282|FG001|Overall Study|Lost to Follow-up|9|||
126485427|NCT01465997|455073281|FG000|Overall Study|Withdrawal by Subject|32|||
126485428|NCT01465997|455073282|FG001|Overall Study|Withdrawal by Subject|35|||
126485429|NCT01465997|455073281|FG000|Overall Study|investigator's decision|1|||
126485430|NCT01465997|455073282|FG001|Overall Study|investigator's decision|1|||
126485431|NCT01465997|455073281|FG000|Overall Study|Death|0|||
126485432|NCT01465997|455073282|FG001|Overall Study|Death|1|||
126485433|NCT01465997|455073281|FG000|Overall Study|sponsor's decision|1|||
126485434|NCT01465997|455073282|FG001|Overall Study|sponsor's decision|1|||
126485435|NCT01465997|455073281|FG000|Overall Study|subject withdrew consent|1|||
126485436|NCT01465997|455073282|FG001|Overall Study|subject withdrew consent|0|||
126485437|NCT01465997|455073281|FG000|Overall Study|local lab unblinded site|1|||
126485438|NCT01465997|455073282|FG001|Overall Study|local lab unblinded site|0|||
126485439|NCT01465997|455073281|FG000|Overall Study|withdrew before follow-up|0|||
126485440|NCT01465997|455073282|FG001|Overall Study|withdrew before follow-up|13|||
126485441|NCT01465997|455073281|FG000|Overall Study|decision by site staff|0|||
126485442|NCT01465997|455073282|FG001|Overall Study|decision by site staff|1|||
126485443|NCT01465997|455073281|FG000|Overall Study|subject left participation SP0993|0|||
126722799|NCT00755846|455936003|FG003|Overall Study|Protocol Violation|1|||
126485444|NCT01465997|455073282|FG001|Overall Study|subject left participation SP0993|1|||
126485445|NCT02246660|455073283|FG000|Overall Study|Withdrawal by Subject|0|||
126485446|NCT02246660|455073284|FG001|Overall Study|Withdrawal by Subject|1|||
126485447|NCT02246660|455073285|FG002|Overall Study|Withdrawal by Subject|0|||
126722800|NCT00755846|455936004|FG004|Overall Study|Protocol Violation|1|||
126722801|NCT00755846|455936005|FG005|Overall Study|Protocol Violation|1|||
126485448|NCT02246660|455073283|FG000|Overall Study|Death|0|||
126485449|NCT02246660|455073284|FG001|Overall Study|Death|0|||
126485450|NCT02246660|455073285|FG002|Overall Study|Death|1|||
126485451|NCT03018704|455073286|FG000|Overall Study|Lost to Follow-up|1|||
126485452|NCT03018704|455073287|FG001|Overall Study|Lost to Follow-up|1|||
126485453|NCT00642460|455073288|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
126485454|NCT00642460|455073289|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
126485455|NCT00642460|455073290|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
126485456|NCT00642460|455073291|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
126485457|NCT00642460|455073292|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
126485458|NCT00642460|455073293|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
126485459|NCT00642460|455073288|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
126485460|NCT00642460|455073289|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
126485461|NCT00642460|455073290|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
126485462|NCT00642460|455073291|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
126485463|NCT00642460|455073292|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
126485464|NCT00642460|455073293|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
126485465|NCT00642460|455073288|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
126485466|NCT00642460|455073289|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
126485467|NCT00642460|455073290|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
126485468|NCT00642460|455073291|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
126485469|NCT00642460|455073292|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
126485470|NCT00642460|455073293|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
126485471|NCT00642460|455073288|FG000|Part II: Open-Label Up to Week 92|Death|0|||
126485472|NCT00642460|455073289|FG001|Part II: Open-Label Up to Week 92|Death|1|||
126485473|NCT00642460|455073290|FG002|Part II: Open-Label Up to Week 92|Death|0|||
126485474|NCT00642460|455073291|FG003|Part II: Open-Label Up to Week 92|Death|2|||
126485475|NCT00642460|455073292|FG004|Part II: Open-Label Up to Week 92|Death|0|||
126485476|NCT00642460|455073293|FG005|Part II: Open-Label Up to Week 92|Death|0|||
126485477|NCT00642460|455073288|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
126485478|NCT00642460|455073289|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
126485479|NCT00642460|455073290|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
126485480|NCT00642460|455073291|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
126485481|NCT00642460|455073292|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
126485482|NCT00642460|455073293|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
126485483|NCT00642460|455073288|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
126485484|NCT00642460|455073289|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
126485485|NCT00642460|455073290|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
126485486|NCT00642460|455073291|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
126485487|NCT00642460|455073292|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
126485488|NCT00642460|455073293|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
126722802|NCT00755846|455936000|FG000|Overall Study|Lost to Follow-up|0|||
126722803|NCT00755846|455936001|FG001|Overall Study|Lost to Follow-up|2|||
126722804|NCT00755846|455936002|FG002|Overall Study|Lost to Follow-up|1|||
126485489|NCT00642460|455073288|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
126485490|NCT00642460|455073289|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
126485491|NCT00642460|455073290|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
126485492|NCT00642460|455073291|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
126485493|NCT00642460|455073292|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
126485494|NCT00642460|455073293|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
126485495|NCT00642460|455073288|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
126485496|NCT00642460|455073289|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
126485497|NCT00642460|455073290|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
126485498|NCT00642460|455073291|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
126485499|NCT00642460|455073292|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
126485500|NCT00642460|455073293|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
126485501|NCT00642460|455073288|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
126485502|NCT00642460|455073289|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
126485503|NCT00642460|455073290|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
126485504|NCT00642460|455073291|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
126485505|NCT00642460|455073292|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
126485506|NCT00642460|455073293|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
126485507|NCT00642460|455073288|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
126485508|NCT00642460|455073289|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
126485509|NCT00642460|455073290|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
126485510|NCT00642460|455073291|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
126485511|NCT00642460|455073292|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
126485512|NCT00642460|455073293|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
126485513|NCT00642460|455073288|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
126485514|NCT00642460|455073289|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
126485515|NCT00642460|455073290|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
126485516|NCT00642460|455073291|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
126485517|NCT00642460|455073292|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
126485518|NCT00642460|455073293|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
126485519|NCT00642460|455073288|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
126722805|NCT00755846|455936003|FG003|Overall Study|Lost to Follow-up|0|||
126485520|NCT00642460|455073289|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
126485521|NCT00642460|455073290|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
126485522|NCT00642460|455073291|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
126485523|NCT00642460|455073292|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
126485524|NCT00642460|455073293|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
126485525|NCT00642460|455073288|FG000|Part III: Open-Label Up to Week 260|Other|0|||
126485526|NCT00642460|455073289|FG001|Part III: Open-Label Up to Week 260|Other|0|||
126485527|NCT00642460|455073290|FG002|Part III: Open-Label Up to Week 260|Other|0|||
126485528|NCT00642460|455073291|FG003|Part III: Open-Label Up to Week 260|Other|0|||
126485529|NCT00642460|455073292|FG004|Part III: Open-Label Up to Week 260|Other|2|||
126485530|NCT00642460|455073293|FG005|Part III: Open-Label Up to Week 260|Other|2|||
126485531|NCT00642460|455073288|FG000|Part III: Open-Label Up to Week 260|Death|0|||
126485532|NCT00642460|455073289|FG001|Part III: Open-Label Up to Week 260|Death|0|||
126485533|NCT00642460|455073290|FG002|Part III: Open-Label Up to Week 260|Death|0|||
126485534|NCT00642460|455073291|FG003|Part III: Open-Label Up to Week 260|Death|0|||
126485535|NCT00642460|455073292|FG004|Part III: Open-Label Up to Week 260|Death|0|||
126485536|NCT00642460|455073293|FG005|Part III: Open-Label Up to Week 260|Death|3|||
126485537|NCT00642460|455073288|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
126485538|NCT00642460|455073289|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
126485539|NCT00642460|455073290|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
126485540|NCT00642460|455073291|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
126485541|NCT00642460|455073292|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
126485542|NCT00642460|455073293|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
126485543|NCT00642460|455073288|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
126485544|NCT00642460|455073289|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
126485545|NCT00642460|455073290|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
126485546|NCT00642460|455073291|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
126485547|NCT00642460|455073292|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
126485548|NCT00642460|455073293|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
126485549|NCT00320411|455073295|FG000|Overall Study|No investigational product admin.|4|||
126485550|NCT02557646|455073300|FG000|Overall Study|Adverse Event|40|||
126485551|NCT02557646|455073300|FG000|Overall Study|Death|1|||
126485552|NCT02557646|455073300|FG000|Overall Study|Lack of Efficacy|186|||
126485553|NCT02557646|455073300|FG000|Overall Study|Withdrawal by Subject|18|||
126485554|NCT02557646|455073300|FG000|Overall Study|Lost to Follow-up|17|||
126485555|NCT02557646|455073300|FG000|Overall Study|Other|14|||
126485556|NCT00518986|455073301|FG000|Overall Study|Adverse Event|12|||
126485557|NCT00518986|455073302|FG001|Overall Study|Adverse Event|7|||
126485558|NCT00518986|455073301|FG000|Overall Study|Lack of Efficacy|0|||
126485559|NCT00518986|455073302|FG001|Overall Study|Lack of Efficacy|2|||
126485560|NCT00518986|455073301|FG000|Overall Study|Lost to Follow-up|3|||
126485561|NCT00518986|455073302|FG001|Overall Study|Lost to Follow-up|2|||
126485562|NCT00518986|455073301|FG000|Overall Study|Physician Decision|0|||
126485563|NCT00518986|455073302|FG001|Overall Study|Physician Decision|3|||
126485564|NCT00518986|455073301|FG000|Overall Study|Protocol Violation|5|||
126485565|NCT00518986|455073302|FG001|Overall Study|Protocol Violation|7|||
126485566|NCT00518986|455073301|FG000|Overall Study|Withdrawal by Subject|4|||
126485567|NCT00518986|455073302|FG001|Overall Study|Withdrawal by Subject|4|||
126485568|NCT00518986|455073301|FG000|Overall Study|Non-Specific|2|||
126485569|NCT00518986|455073302|FG001|Overall Study|Non-Specific|1|||
126485570|NCT02088047|455073303|FG000|Overall Study|Withdrawal by Subject|1|||
126485571|NCT02088047|455073304|FG001|Overall Study|Withdrawal by Subject|0|||
126485572|NCT04605484|455073307|FG000|Overall Study|Lost to Follow-up|0|||
126485573|NCT04605484|455073308|FG001|Overall Study|Lost to Follow-up|1|||
126485574|NCT04605484|455073309|FG002|Overall Study|Lost to Follow-up|1|||
126485575|NCT04605484|455073307|FG000|Overall Study|Other|0|||
126485576|NCT04605484|455073308|FG001|Overall Study|Other|1|||
126485577|NCT04605484|455073309|FG002|Overall Study|Other|0|||
126485578|NCT04171531|455073310|FG000|Overall Study|Lost to Follow-up|4|||
126485579|NCT04171531|455073311|FG001|Overall Study|Lost to Follow-up|5|||
126485580|NCT04171531|455073310|FG000|Overall Study|Consent only through 6 months|1|||
126485581|NCT04171531|455073311|FG001|Overall Study|Consent only through 6 months|1|||
126485582|NCT04171531|455073310|FG000|Overall Study|Insurance did not cover procedure|0|||
126485583|NCT04171531|455073311|FG001|Overall Study|Insurance did not cover procedure|1|||
126485584|NCT04171531|455073310|FG000|Overall Study|Physician Decision|0|||
126485585|NCT04171531|455073311|FG001|Overall Study|Physician Decision|3|||
126485586|NCT04171531|455073310|FG000|Overall Study|Withdrawal by Subject|1|||
126485587|NCT04171531|455073311|FG001|Overall Study|Withdrawal by Subject|5|||
126485588|NCT05683249|455073312|FG000|Overall Study|Adverse Event|3|||
126485589|NCT05683249|455073313|FG001|Overall Study|Adverse Event|1|||
126485590|NCT05683249|455073312|FG000|Overall Study|Lack of Efficacy|0|||
126485591|NCT05683249|455073313|FG001|Overall Study|Lack of Efficacy|2|||
126485592|NCT05683249|455073312|FG000|Overall Study|Lost to Follow-up|6|||
126485593|NCT05683249|455073313|FG001|Overall Study|Lost to Follow-up|5|||
126485594|NCT05683249|455073312|FG000|Overall Study|Non-compliance with Study Drug|2|||
126485595|NCT05683249|455073313|FG001|Overall Study|Non-compliance with Study Drug|0|||
126485596|NCT05683249|455073312|FG000|Overall Study|Protocol Violation|6|||
126485597|NCT05683249|455073313|FG001|Overall Study|Protocol Violation|3|||
126485598|NCT05683249|455073312|FG000|Overall Study|Withdrawal by Subject|9|||
126485599|NCT05683249|455073313|FG001|Overall Study|Withdrawal by Subject|8|||
126485600|NCT05683249|455073312|FG000|Overall Study|Other|0|||
126485601|NCT05683249|455073313|FG001|Overall Study|Other|2|||
126485602|NCT04862585|455073314|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
126485603|NCT04862585|455073315|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
126485604|NCT04862585|455073314|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
126485605|NCT04862585|455073315|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
126485606|NCT04862585|455073314|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
126485607|NCT04862585|455073315|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
126485608|NCT04862585|455073314|FG000|Overall Study|one withdrew without providing a reason|0|||
126485609|NCT04862585|455073315|FG001|Overall Study|one withdrew without providing a reason|1|||
126485610|NCT03366337|455073316|FG000|Overall Study|Lost to Follow-up|1|||
126485611|NCT03366337|455073317|FG001|Overall Study|Lost to Follow-up|0|||
126485612|NCT03366337|455073318|FG002|Overall Study|Lost to Follow-up|1|||
126485613|NCT03366337|455073319|FG003|Overall Study|Lost to Follow-up|0|||
126485614|NCT03366337|455073316|FG000|Overall Study|Withdrawal by Subject|2|||
126485615|NCT03366337|455073317|FG001|Overall Study|Withdrawal by Subject|0|||
126485616|NCT03366337|455073318|FG002|Overall Study|Withdrawal by Subject|1|||
126485617|NCT03366337|455073319|FG003|Overall Study|Withdrawal by Subject|1|||
126485618|NCT05229406|455073320|FG000|Overall Study|Withdrawal by Subject|1|||
126485619|NCT05229406|455073321|FG001|Overall Study|Withdrawal by Subject|2|||
126485620|NCT00459953|455073322|FG000|Overall Study|not analyzed-household member in study|1|||
126485621|NCT00459953|455073323|FG001|Overall Study|not analyzed-household member in study|1|||
126485622|NCT00496470|455073324|FG000|Overall Study|Adverse Event|8|||
126485623|NCT00496470|455073325|FG001|Overall Study|Adverse Event|10|||
126485624|NCT00496470|455073324|FG000|Overall Study|Withdrawal by Subject|5|||
126485625|NCT00496470|455073325|FG001|Overall Study|Withdrawal by Subject|12|||
126485626|NCT00496470|455073324|FG000|Overall Study|Incorrectly enrolled|13|||
126485627|NCT00496470|455073325|FG001|Overall Study|Incorrectly enrolled|5|||
126485628|NCT00496470|455073324|FG000|Overall Study|Other reason|0|||
126485629|NCT00496470|455073325|FG001|Overall Study|Other reason|2|||
126485630|NCT00040664|455073326|FG000|Overall Study|Adverse Event|12|||
126485631|NCT00040664|455073327|FG001|Overall Study|Adverse Event|3|||
126485632|NCT00040664|455073328|FG002|Overall Study|Adverse Event|2|||
126485633|NCT00040664|455073329|FG003|Overall Study|Adverse Event|7|||
126485634|NCT00040664|455073326|FG000|Overall Study|Lack of Efficacy|9|||
126485635|NCT00040664|455073327|FG001|Overall Study|Lack of Efficacy|2|||
126485636|NCT00040664|455073328|FG002|Overall Study|Lack of Efficacy|3|||
126485637|NCT00040664|455073329|FG003|Overall Study|Lack of Efficacy|4|||
126485638|NCT00040664|455073326|FG000|Overall Study|Insufficient CD4 response|1|||
126485639|NCT00040664|455073327|FG001|Overall Study|Insufficient CD4 response|0|||
126485640|NCT00040664|455073328|FG002|Overall Study|Insufficient CD4 response|1|||
126485641|NCT00040664|455073329|FG003|Overall Study|Insufficient CD4 response|0|||
126485642|NCT00040664|455073326|FG000|Overall Study|Lost to Follow-up|4|||
126485643|NCT00040664|455073327|FG001|Overall Study|Lost to Follow-up|2|||
126485644|NCT00040664|455073328|FG002|Overall Study|Lost to Follow-up|0|||
126485645|NCT00040664|455073329|FG003|Overall Study|Lost to Follow-up|2|||
126485646|NCT00040664|455073326|FG000|Overall Study|Protocol Violation|2|||
126485647|NCT00040664|455073327|FG001|Overall Study|Protocol Violation|1|||
126485648|NCT00040664|455073328|FG002|Overall Study|Protocol Violation|0|||
126485649|NCT00040664|455073329|FG003|Overall Study|Protocol Violation|1|||
126485650|NCT00040664|455073326|FG000|Overall Study|Withdrawal by Subject|7|||
126485651|NCT00040664|455073327|FG001|Overall Study|Withdrawal by Subject|0|||
126485652|NCT00040664|455073328|FG002|Overall Study|Withdrawal by Subject|3|||
126485653|NCT00040664|455073329|FG003|Overall Study|Withdrawal by Subject|4|||
126485654|NCT00040664|455073326|FG000|Overall Study|Pregnancy|3|||
126485655|NCT00040664|455073327|FG001|Overall Study|Pregnancy|0|||
126485656|NCT00040664|455073328|FG002|Overall Study|Pregnancy|0|||
126485657|NCT00040664|455073329|FG003|Overall Study|Pregnancy|3|||
126485658|NCT00040664|455073326|FG000|Overall Study|Medication adherence/compliance problems|8|||
126485659|NCT00040664|455073327|FG001|Overall Study|Medication adherence/compliance problems|2|||
126485660|NCT00040664|455073328|FG002|Overall Study|Medication adherence/compliance problems|1|||
126485661|NCT00040664|455073329|FG003|Overall Study|Medication adherence/compliance problems|5|||
126485662|NCT00040664|455073326|FG000|Overall Study|Poor taste|2|||
126485663|NCT00040664|455073327|FG001|Overall Study|Poor taste|0|||
126485664|NCT00040664|455073328|FG002|Overall Study|Poor taste|2|||
126722806|NCT00755846|455936004|FG004|Overall Study|Lost to Follow-up|4|||
126485665|NCT00040664|455073329|FG003|Overall Study|Poor taste|0|||
126485666|NCT00040664|455073326|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
126485667|NCT00040664|455073327|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
126722807|NCT00755846|455936005|FG005|Overall Study|Lost to Follow-up|2|||
126485668|NCT00040664|455073328|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
126485669|NCT00040664|455073329|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
126485670|NCT00040664|455073326|FG000|Overall Study|Change of formulation|2|||
126485671|NCT00040664|455073327|FG001|Overall Study|Change of formulation|2|||
126485672|NCT00040664|455073328|FG002|Overall Study|Change of formulation|0|||
126485673|NCT00040664|455073329|FG003|Overall Study|Change of formulation|0|||
126485674|NCT00040664|455073326|FG000|Overall Study|Non-viability of oral suspension|1|||
126485675|NCT00040664|455073327|FG001|Overall Study|Non-viability of oral suspension|0|||
126485676|NCT00040664|455073328|FG002|Overall Study|Non-viability of oral suspension|1|||
126485677|NCT00040664|455073329|FG003|Overall Study|Non-viability of oral suspension|0|||
126485678|NCT04419714|455073331|FG000|Overall Study|Technical Fault|5|||
126485679|NCT04419714|455073331|FG000|Overall Study|Protocol Deviation|2|||
126485680|NCT04419714|455073331|FG000|Overall Study|Withdrawal by Subject|1|||
126485681|NCT02324569|455074829|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
126485682|NCT02324569|455074830|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
126485683|NCT02324569|455074829|FG000|Overall Study|Voluntary Withdrawal|3|||
126485684|NCT02324569|455074830|FG001|Overall Study|Voluntary Withdrawal|6|||
126485685|NCT02324569|455074829|FG000|Overall Study|Lack of Efficacy|2|||
126485686|NCT02324569|455074830|FG001|Overall Study|Lack of Efficacy|3|||
126485687|NCT02324569|455074829|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
126485688|NCT02324569|455074830|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
126485689|NCT02324569|455074829|FG000|Overall Study|Inconvenient Schedule|2|||
126485690|NCT02324569|455074830|FG001|Overall Study|Inconvenient Schedule|0|||
126485691|NCT01943292|455074831|FG000|Overall Study|Withdrawal by Subject|1|||
126485692|NCT01943292|455074832|FG001|Overall Study|Withdrawal by Subject|0|||
126485693|NCT01943292|455074833|FG002|Overall Study|Withdrawal by Subject|0|||
126485694|NCT00911820|455074834|FG000|Overall Study|RECIST progression|12|||
126485695|NCT00911820|455074835|FG001|Overall Study|RECIST progression|8|||
126485696|NCT00911820|455074834|FG000|Overall Study|Adverse Event|8|||
126485697|NCT00911820|455074835|FG001|Overall Study|Adverse Event|8|||
126485698|NCT00911820|455074834|FG000|Overall Study|Clinical Progression|7|||
126485699|NCT00911820|455074835|FG001|Overall Study|Clinical Progression|5|||
126485700|NCT00911820|455074834|FG000|Overall Study|Physician Decision|5|||
126485701|NCT00911820|455074835|FG001|Overall Study|Physician Decision|9|||
126485702|NCT00911820|455074834|FG000|Overall Study|Decline in Performance Status|4|||
126485703|NCT00911820|455074835|FG001|Overall Study|Decline in Performance Status|2|||
126485704|NCT00911820|455074834|FG000|Overall Study|Withdrawal by Subject|3|||
126485705|NCT00911820|455074835|FG001|Overall Study|Withdrawal by Subject|4|||
126485706|NCT00911820|455074834|FG000|Overall Study|Death|1|||
126485707|NCT00911820|455074835|FG001|Overall Study|Death|2|||
126485708|NCT00911820|455074834|FG000|Overall Study|Pursue surgery|1|||
126485709|NCT00911820|455074835|FG001|Overall Study|Pursue surgery|1|||
126485710|NCT00911820|455074834|FG000|Overall Study|Pursue Radiation|1|||
126485711|NCT00911820|455074835|FG001|Overall Study|Pursue Radiation|0|||
126485712|NCT00911820|455074834|FG000|Overall Study|Still on Therapy|2|||
126485713|NCT00911820|455074835|FG001|Overall Study|Still on Therapy|2|||
126485714|NCT00911820|455074834|FG000|Overall Study|Pathology Not Confirmed|1|||
126485715|NCT00911820|455074835|FG001|Overall Study|Pathology Not Confirmed|0|||
126485716|NCT00911820|455074834|FG000|Overall Study|Withdraw before Receive Treatment|0|||
126485717|NCT00911820|455074835|FG001|Overall Study|Withdraw before Receive Treatment|2|||
126485718|NCT00638378|455074836|FG000|Overall Study|Death|2|||
126485719|NCT00638378|455074836|FG000|Overall Study|Adverse Event|1|||
126485720|NCT00638378|455074836|FG000|Overall Study|Disease progression|15|||
126485721|NCT00638378|455074836|FG000|Overall Study|Physician Decision|4|||
126485722|NCT03098550|455074843|FG000|Overall Study|Disease Progression|30|||
126485723|NCT03098550|455074844|FG001|Overall Study|Disease Progression|19|||
126485724|NCT03098550|455074845|FG002|Overall Study|Disease Progression|41|||
126485725|NCT03098550|455074843|FG000|Overall Study|Study Drug Toxicity|2|||
126485726|NCT03098550|455074844|FG001|Overall Study|Study Drug Toxicity|1|||
126485727|NCT03098550|455074845|FG002|Overall Study|Study Drug Toxicity|0|||
126485728|NCT03098550|455074843|FG000|Overall Study|Death|1|||
126485729|NCT03098550|455074844|FG001|Overall Study|Death|0|||
126485730|NCT03098550|455074845|FG002|Overall Study|Death|0|||
126485731|NCT03098550|455074843|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
126485732|NCT03098550|455074844|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
126485733|NCT03098550|455074845|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
126485734|NCT03098550|455074843|FG000|Overall Study|Administrative reason by sponsor|0|||
126485735|NCT03098550|455074844|FG001|Overall Study|Administrative reason by sponsor|0|||
126485736|NCT03098550|455074845|FG002|Overall Study|Administrative reason by sponsor|1|||
126559352|NCT00901485|455340730|FG000|Overall Study|Withdrawal by Subject|1|||
126559353|NCT00901485|455340731|FG001|Overall Study|Withdrawal by Subject|2|||
126485737|NCT03098550|455074843|FG000|Overall Study|Other reasons|2|||
126485738|NCT03098550|455074844|FG001|Overall Study|Other reasons|0|||
126485739|NCT03098550|455074845|FG002|Overall Study|Other reasons|0|||
126485740|NCT00759031|455074852|FG000|First Intervention (1 Day)|Physician Decision|1|||
126485741|NCT00759031|455074853|FG001|First Intervention (1 Day)|Physician Decision|0|||
126485742|NCT00759031|455074852|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
126485743|NCT00759031|455074853|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
126485744|NCT00759031|455074852|FG000|First Intervention (1 Day)|Screening failure|1|||
126485745|NCT00759031|455074853|FG001|First Intervention (1 Day)|Screening failure|0|||
126485746|NCT00309387|455074856|FG000|Overall Study|Death|72|||
126485747|NCT00309387|455074857|FG001|Overall Study|Death|73|||
126485748|NCT00309387|455074856|FG000|Overall Study|Lost to Follow-up|70|||
126485749|NCT00309387|455074857|FG001|Overall Study|Lost to Follow-up|86|||
126485750|NCT02483520|455074859|FG000|Overall Study|Lost to Follow-up|3|||
126485751|NCT02483520|455074860|FG001|Overall Study|Lost to Follow-up|4|||
126485752|NCT02483520|455074859|FG000|Overall Study|Withdrawal by Subject|4|||
126485753|NCT02483520|455074860|FG001|Overall Study|Withdrawal by Subject|14|||
126485754|NCT02483520|455074859|FG000|Overall Study|Hospitalized|2|||
126485755|NCT02483520|455074860|FG001|Overall Study|Hospitalized|3|||
126485756|NCT02483520|455074859|FG000|Overall Study|Moved to LTC|2|||
126485757|NCT02483520|455074860|FG001|Overall Study|Moved to LTC|3|||
126485758|NCT04492618|455074862|FG000|Overall Study|Withdrawal by Subject|1|||
126485759|NCT01401283|455074863|FG000|Overall Study|surgery cancelled|5|||
126485760|NCT01401283|455074864|FG001|Overall Study|surgery cancelled|8|||
126485761|NCT01401283|455074863|FG000|Overall Study|preoperative arrhythmia|5|||
126485762|NCT01401283|455074864|FG001|Overall Study|preoperative arrhythmia|0|||
126485763|NCT01401283|455074863|FG000|Overall Study|no central venous access|0|||
126485764|NCT01401283|455074864|FG001|Overall Study|no central venous access|1|||
126485765|NCT01401283|455074863|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
126485766|NCT01401283|455074864|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
126485767|NCT03489720|455074865|FG000|Overall Study|Withdrawal by Subject|2|||
126485768|NCT03489720|455074866|FG001|Overall Study|Withdrawal by Subject|0|||
126485769|NCT02101060|455074870|FG000|Overall Study|Adverse Event|1|||
126485770|NCT02101060|455074871|FG001|Overall Study|Adverse Event|0|||
126722808|NCT00755846|455936000|FG000|Overall Study|Withdrawal by Subject|2|||
126722809|NCT00755846|455936001|FG001|Overall Study|Withdrawal by Subject|3|||
126722810|NCT00755846|455936002|FG002|Overall Study|Withdrawal by Subject|5|||
126722811|NCT00755846|455936003|FG003|Overall Study|Withdrawal by Subject|2|||
126722812|NCT00755846|455936004|FG004|Overall Study|Withdrawal by Subject|0|||
126722813|NCT00755846|455936005|FG005|Overall Study|Withdrawal by Subject|1|||
126722814|NCT00755846|455936000|FG000|Overall Study|Hyperglycemic Rescue|21|||
126722815|NCT00755846|455936001|FG001|Overall Study|Hyperglycemic Rescue|7|||
126722816|NCT00755846|455936002|FG002|Overall Study|Hyperglycemic Rescue|5|||
126722817|NCT00755846|455936003|FG003|Overall Study|Hyperglycemic Rescue|8|||
126722818|NCT00755846|455936004|FG004|Overall Study|Hyperglycemic Rescue|8|||
126722819|NCT00755846|455936005|FG005|Overall Study|Hyperglycemic Rescue|7|||
126722820|NCT00755846|455936000|FG000|Overall Study|Physician Decision|1|||
126722821|NCT00755846|455936001|FG001|Overall Study|Physician Decision|3|||
126722822|NCT00755846|455936002|FG002|Overall Study|Physician Decision|0|||
126722823|NCT00755846|455936003|FG003|Overall Study|Physician Decision|1|||
126722824|NCT00755846|455936004|FG004|Overall Study|Physician Decision|0|||
126722825|NCT00755846|455936005|FG005|Overall Study|Physician Decision|1|||
126722826|NCT00755846|455936000|FG000|Overall Study|Administrative Error|0|||
126722827|NCT00755846|455936001|FG001|Overall Study|Administrative Error|1|||
126722828|NCT00755846|455936002|FG002|Overall Study|Administrative Error|0|||
126722829|NCT00755846|455936003|FG003|Overall Study|Administrative Error|0|||
126485771|NCT02101060|455074870|FG000|Overall Study|Withdrawal by Subject|1|||
126722830|NCT00755846|455936004|FG004|Overall Study|Administrative Error|0|||
126485772|NCT02101060|455074871|FG001|Overall Study|Withdrawal by Subject|1|||
126485773|NCT02101060|455074870|FG000|Overall Study|Lost to Follow-up|3|||
126485774|NCT02101060|455074871|FG001|Overall Study|Lost to Follow-up|3|||
126485775|NCT03462082|455074872|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
126485776|NCT03462082|455074873|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
126485777|NCT03462082|455074874|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
126722831|NCT00755846|455936005|FG005|Overall Study|Administrative Error|0|||
126485778|NCT03462082|455074875|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
126722832|NCT00755846|455936000|FG000|Overall Study|Participant Non-compliance|0|||
126722833|NCT00755846|455936001|FG001|Overall Study|Participant Non-compliance|0|||
126722834|NCT00755846|455936002|FG002|Overall Study|Participant Non-compliance|0|||
126722835|NCT00755846|455936003|FG003|Overall Study|Participant Non-compliance|0|||
126722836|NCT00755846|455936004|FG004|Overall Study|Participant Non-compliance|1|||
126722837|NCT00755846|455936005|FG005|Overall Study|Participant Non-compliance|0|||
126485779|NCT03462082|455074876|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
126485780|NCT03462082|455074877|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
126485781|NCT03462082|455074878|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
126485782|NCT03462082|455074879|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
126485783|NCT03454997|455074885|FG000|Overall Study|Staff Coach - Left Oranization|1|||
126485784|NCT03454997|455074886|FG001|Overall Study|Staff Coach - Left Oranization|1|||
126485785|NCT03454997|455074885|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
126772579|NCT03231709|456123622|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
126722838|NCT00786032|455936006|FG000|Overall Study|Death|4|||
126722839|NCT00786032|455936006|FG000|Overall Study|Withdrawal by Subject|14|||
126722840|NCT00786032|455936006|FG000|Overall Study|Did not complete in the timeframe|6|||
126722841|NCT02669862|455936007|FG000|Overall Study|Lost to Follow-up|0|||
126722842|NCT02669862|455936008|FG001|Overall Study|Lost to Follow-up|2|||
126722843|NCT02669862|455936009|FG002|Overall Study|Lost to Follow-up|1|||
126722844|NCT02669862|455936007|FG000|Overall Study|Withdrawal by Subject|2|||
126722845|NCT02669862|455936008|FG001|Overall Study|Withdrawal by Subject|2|||
126722846|NCT02669862|455936009|FG002|Overall Study|Withdrawal by Subject|3|||
126722847|NCT02669862|455936007|FG000|Overall Study|moved|0|||
126722848|NCT02669862|455936008|FG001|Overall Study|moved|1|||
126722849|NCT02669862|455936009|FG002|Overall Study|moved|0|||
126722850|NCT02669862|455936007|FG000|Overall Study|Protocol Violation|0|||
126722851|NCT02669862|455936008|FG001|Overall Study|Protocol Violation|0|||
126722852|NCT02669862|455936009|FG002|Overall Study|Protocol Violation|1|||
126722853|NCT00311181|455936010|FG000|Overall Study|Final DFTs were not obtained|96|||
126722854|NCT02429258|455936011|FG000|Overall Study|Withdrawal by Subject|2|||
126485786|NCT03454997|455074886|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
126485787|NCT03454997|455074885|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
126485788|NCT03454997|455074886|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
126485789|NCT03454997|455074885|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
126485790|NCT03454997|455074886|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
126485791|NCT03454997|455074885|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
126485792|NCT03454997|455074886|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
126722855|NCT02429258|455936012|FG001|Overall Study|Withdrawal by Subject|0|||
126722856|NCT02429258|455936011|FG000|Overall Study|Protocol Violation|0|||
126722857|NCT02429258|455936012|FG001|Overall Study|Protocol Violation|1|||
126722858|NCT02397694|455936013|FG000|Double-Blinded Phase|Adverse Event|1|||
126722859|NCT02397694|455936014|FG001|Double-Blinded Phase|Adverse Event|0|||
126722860|NCT02397694|455936013|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
126722861|NCT02397694|455936014|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
126722862|NCT02397694|455936013|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
126722863|NCT02397694|455936014|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
126722864|NCT02397694|455936013|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
126722865|NCT02397694|455936014|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
126485793|NCT03454997|455074885|FG000|Overall Study|Client with SMI - Left organization|0|||
126485794|NCT03454997|455074886|FG001|Overall Study|Client with SMI - Left organization|1|||
126485795|NCT03454997|455074885|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
126485796|NCT03454997|455074886|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
126722866|NCT02397694|455936013|FG000|Open Label Extension Phase|Protocol Violation|1|||
126722867|NCT02397694|455936014|FG001|Open Label Extension Phase|Protocol Violation|0|||
126722868|NCT02397694|455936013|FG000|Open Label Extension Phase|Withdrew Consent|3|||
126722869|NCT02397694|455936014|FG001|Open Label Extension Phase|Withdrew Consent|1|||
126722870|NCT02397694|455936013|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
126722871|NCT02397694|455936014|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
126722872|NCT02616185|455936016|FG000|Overall Study|Death|0|||
126722873|NCT02616185|455936017|FG001|Overall Study|Death|0|||
126722874|NCT02616185|455936018|FG002|Overall Study|Death|0|||
126722875|NCT02616185|455936019|FG003|Overall Study|Death|1|||
126722876|NCT02616185|455936020|FG004|Overall Study|Death|2|||
126722877|NCT02616185|455936021|FG005|Overall Study|Death|0|||
126722878|NCT02616185|455936022|FG006|Overall Study|Death|0|||
126722879|NCT02616185|455936023|FG007|Overall Study|Death|2|||
126722880|NCT02616185|455936024|FG008|Overall Study|Death|1|||
126722881|NCT02616185|455936016|FG000|Overall Study|Study terminated by sponsor|0|||
126722882|NCT02616185|455936017|FG001|Overall Study|Study terminated by sponsor|0|||
126722883|NCT02616185|455936018|FG002|Overall Study|Study terminated by sponsor|1|||
126722884|NCT02616185|455936019|FG003|Overall Study|Study terminated by sponsor|0|||
126722885|NCT02616185|455936020|FG004|Overall Study|Study terminated by sponsor|0|||
126722886|NCT02616185|455936021|FG005|Overall Study|Study terminated by sponsor|0|||
126772580|NCT03231709|456123623|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
126772581|NCT03451331|456123624|FG000|Overall Study|Withdrawal by Subject|1|||
126772582|NCT03451331|456123625|FG001|Overall Study|Withdrawal by Subject|0|||
126772583|NCT03451331|456123624|FG000|Overall Study|Unable to start treatment.|1|||
126772584|NCT03451331|456123625|FG001|Overall Study|Unable to start treatment.|1|||
126772585|NCT01875991|456123626|FG000|Overall Study|Withdrawal by Subject|6|||
126772586|NCT01875991|456123627|FG001|Overall Study|Withdrawal by Subject|6|||
126485797|NCT00299975|455074890|FG000|Overall Study|Adverse Event|1|||
126485798|NCT00299975|455074891|FG001|Overall Study|Adverse Event|0|||
126485799|NCT00299975|455074892|FG002|Overall Study|Adverse Event|2|||
126485800|NCT00299975|455074890|FG000|Overall Study|Pregnancy|0|||
126485801|NCT00299975|455074891|FG001|Overall Study|Pregnancy|0|||
126722887|NCT02616185|455936022|FG006|Overall Study|Study terminated by sponsor|5|||
126722888|NCT02616185|455936023|FG007|Overall Study|Study terminated by sponsor|2|||
126722889|NCT02616185|455936024|FG008|Overall Study|Study terminated by sponsor|0|||
126722890|NCT02616185|455936016|FG000|Overall Study|Participant refused further follow-up|1|||
126722891|NCT02616185|455936017|FG001|Overall Study|Participant refused further follow-up|1|||
126722892|NCT02616185|455936018|FG002|Overall Study|Participant refused further follow-up|2|||
126722893|NCT02616185|455936019|FG003|Overall Study|Participant refused further follow-up|3|||
126722894|NCT02616185|455936020|FG004|Overall Study|Participant refused further follow-up|4|||
126722895|NCT02616185|455936021|FG005|Overall Study|Participant refused further follow-up|0|||
126722896|NCT02616185|455936022|FG006|Overall Study|Participant refused further follow-up|3|||
126722897|NCT02616185|455936023|FG007|Overall Study|Participant refused further follow-up|4|||
126722898|NCT02616185|455936024|FG008|Overall Study|Participant refused further follow-up|3|||
126722899|NCT02616185|455936016|FG000|Overall Study|Not reported|0|||
126722900|NCT02616185|455936017|FG001|Overall Study|Not reported|0|||
126722901|NCT02616185|455936018|FG002|Overall Study|Not reported|0|||
126722902|NCT02616185|455936019|FG003|Overall Study|Not reported|1|||
126722903|NCT02616185|455936020|FG004|Overall Study|Not reported|3|||
126722904|NCT02616185|455936021|FG005|Overall Study|Not reported|1|||
126485802|NCT00299975|455074892|FG002|Overall Study|Pregnancy|1|||
126485803|NCT00299975|455074890|FG000|Overall Study|Lack of Efficacy|1|||
126485804|NCT00299975|455074891|FG001|Overall Study|Lack of Efficacy|0|||
126485805|NCT00299975|455074892|FG002|Overall Study|Lack of Efficacy|1|||
126485806|NCT00299975|455074890|FG000|Overall Study|Lost to Follow-up|1|||
126485807|NCT00299975|455074891|FG001|Overall Study|Lost to Follow-up|0|||
126485808|NCT00299975|455074892|FG002|Overall Study|Lost to Follow-up|0|||
126485809|NCT00299975|455074890|FG000|Overall Study|Withdrawal by Subject|0|||
126485810|NCT00299975|455074891|FG001|Overall Study|Withdrawal by Subject|1|||
126485811|NCT00299975|455074892|FG002|Overall Study|Withdrawal by Subject|3|||
126485812|NCT00299975|455074890|FG000|Overall Study|Physician Decision|0|||
126485813|NCT00299975|455074891|FG001|Overall Study|Physician Decision|0|||
126485814|NCT00299975|455074892|FG002|Overall Study|Physician Decision|1|||
126485815|NCT04448171|455074894|FG000|Overall Study|Procedure Cancelled|1|||
126485816|NCT04448171|455074895|FG001|Overall Study|Procedure Cancelled|0|||
126485817|NCT04448171|455074894|FG000|Overall Study|Protocol Violation|1|||
126485818|NCT04448171|455074895|FG001|Overall Study|Protocol Violation|0|||
126485819|NCT00660309|455074898|FG000|Overall Study|Adverse Event|2|||
126485820|NCT00660309|455074899|FG001|Overall Study|Adverse Event|0|||
126485821|NCT00660309|455074898|FG000|Overall Study|Withdrawal by Subject|0|||
126485822|NCT00660309|455074899|FG001|Overall Study|Withdrawal by Subject|3|||
126485823|NCT02573311|455074902|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
126485824|NCT02573311|455074903|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
126485825|NCT02573311|455074902|FG000|Disposition for Part 2|Physician Decision|25|||
126485826|NCT02573311|455074903|FG001|Disposition for Part 2|Physician Decision|7|||
126485827|NCT02573311|455074902|FG000|Disposition for Part 2|Adverse Event|36|||
126485828|NCT02573311|455074903|FG001|Disposition for Part 2|Adverse Event|5|||
126485829|NCT02573311|455074902|FG000|Disposition for Part 2|Lost to Follow-up|76|||
126485830|NCT02573311|455074903|FG001|Disposition for Part 2|Lost to Follow-up|7|||
126485831|NCT02573311|455074902|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
126485832|NCT02573311|455074903|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
126485833|NCT02573311|455074902|FG000|Disposition for Part 2|Investigator decision|0|||
126485834|NCT02573311|455074903|FG001|Disposition for Part 2|Investigator decision|1|||
126485835|NCT02573311|455074902|FG000|Disposition for Part 2|Other than specified above|13|||
126485836|NCT02573311|455074903|FG001|Disposition for Part 2|Other than specified above|3|||
126485837|NCT05288062|455074909|FG000|Overall Study|Ineligible|0|||
126485838|NCT05288062|455074910|FG001|Overall Study|Ineligible|0|||
126485839|NCT05288062|455074911|FG002|Overall Study|Ineligible|1|||
126485840|NCT05288062|455074912|FG003|Overall Study|Ineligible|0|||
126485841|NCT05288062|455074909|FG000|Overall Study|Withdrawal by Subject|0|||
126485842|NCT05288062|455074910|FG001|Overall Study|Withdrawal by Subject|0|||
126485843|NCT05288062|455074911|FG002|Overall Study|Withdrawal by Subject|1|||
126485844|NCT05288062|455074912|FG003|Overall Study|Withdrawal by Subject|0|||
126485845|NCT01217814|455074913|FG000|Overall Study|Adverse Event|1|||
126485846|NCT01217814|455074914|FG001|Overall Study|Adverse Event|1|||
126485847|NCT01217814|455074915|FG002|Overall Study|Adverse Event|0|||
126485848|NCT01217814|455074913|FG000|Overall Study|Lack of Efficacy|0|||
126485849|NCT01217814|455074914|FG001|Overall Study|Lack of Efficacy|0|||
126722905|NCT02616185|455936022|FG006|Overall Study|Not reported|0|||
126485850|NCT01217814|455074915|FG002|Overall Study|Lack of Efficacy|1|||
126485851|NCT01370356|455074916|FG000|Overall Study|Death|1|||
126485852|NCT01370356|455074917|FG001|Overall Study|Death|0|||
126485853|NCT01370356|455074916|FG000|Overall Study|Lack of Efficacy|6|||
126485854|NCT01370356|455074917|FG001|Overall Study|Lack of Efficacy|28|||
126485855|NCT01370356|455074916|FG000|Overall Study|Lost to Follow-up|76|||
126485856|NCT01370356|455074917|FG001|Overall Study|Lost to Follow-up|81|||
126722906|NCT02616185|455936023|FG007|Overall Study|Not reported|5|||
126722907|NCT02616185|455936024|FG008|Overall Study|Not reported|2|||
126722908|NCT01303380|455936025|FG000|Overall Study|Lack of compliance to study procedures|1|||
126485857|NCT01370356|455074916|FG000|Overall Study|Withdrawal by Subject|54|||
126485858|NCT01370356|455074917|FG001|Overall Study|Withdrawal by Subject|59|||
126485859|NCT01370356|455074916|FG000|Overall Study|Reason not specified|39|||
126485860|NCT01370356|455074917|FG001|Overall Study|Reason not specified|43|||
126485861|NCT01370356|455074916|FG000|Overall Study|Protocol Violation|3|||
126485862|NCT01370356|455074917|FG001|Overall Study|Protocol Violation|3|||
126485863|NCT01370356|455074916|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
126485864|NCT01370356|455074917|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
126485865|NCT01370356|455074916|FG000|Overall Study|AE Not Related to Study Drug|1|||
126485866|NCT01370356|455074917|FG001|Overall Study|AE Not Related to Study Drug|4|||
126485867|NCT00729651|455074918|FG000|Overall Study|Withdrawal by Subject|5|||
126485868|NCT00729651|455074919|FG001|Overall Study|Withdrawal by Subject|6|||
126485869|NCT00729651|455074918|FG000|Overall Study|Lost to Follow-up|5|||
126485870|NCT00729651|455074919|FG001|Overall Study|Lost to Follow-up|4|||
126485871|NCT00729651|455074918|FG000|Overall Study|Protocol Violation|0|||
126485872|NCT00729651|455074919|FG001|Overall Study|Protocol Violation|1|||
126485873|NCT00729651|455074918|FG000|Overall Study|Adverse Event|7|||
126485874|NCT00729651|455074919|FG001|Overall Study|Adverse Event|3|||
126485875|NCT00729651|455074918|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
126485876|NCT00729651|455074919|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
126485877|NCT00729651|455074918|FG000|Overall Study|Subject's private reason|2|||
126485878|NCT00729651|455074919|FG001|Overall Study|Subject's private reason|0|||
126485879|NCT02925494|455074920|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
126485880|NCT02925494|455074921|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
126485881|NCT02925494|455074922|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
126485882|NCT02925494|455074923|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
126485883|NCT02925494|455074920|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
126485884|NCT02925494|455074921|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
126485885|NCT02925494|455074922|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
126485886|NCT02925494|455074923|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
126485887|NCT02925494|455074920|FG000|Post-Treatment Follow-Up Period|Other|1|||
126485888|NCT02925494|455074921|FG001|Post-Treatment Follow-Up Period|Other|4|||
126485889|NCT02925494|455074922|FG002|Post-Treatment Follow-Up Period|Other|3|||
126485890|NCT02925494|455074923|FG003|Post-Treatment Follow-Up Period|Other|6|||
126485891|NCT02925494|455074920|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
126485892|NCT02925494|455074921|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
126485893|NCT02925494|455074922|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
126485894|NCT02925494|455074923|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
126485895|NCT02925494|455074920|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
126485896|NCT02925494|455074921|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
126485897|NCT02925494|455074922|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
126485898|NCT02925494|455074923|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
126485899|NCT02925494|455074920|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
126485900|NCT02925494|455074921|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
126485901|NCT02925494|455074922|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
126485902|NCT02925494|455074923|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
126485903|NCT02925494|455074920|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
126485904|NCT02925494|455074921|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
126485905|NCT02925494|455074922|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
126485906|NCT02925494|455074923|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
126485907|NCT06149247|455074928|FG000|Overall Study|Adverse Event|0|||
126485908|NCT06149247|455074929|FG001|Overall Study|Adverse Event|1|||
126485909|NCT05182125|455074930|FG000|Overall Study|Withdrawal by Subject|0|||
126485910|NCT05182125|455074931|FG001|Overall Study|Withdrawal by Subject|0|||
126485911|NCT05182125|455074932|FG002|Overall Study|Withdrawal by Subject|0|||
126485912|NCT05182125|455074933|FG003|Overall Study|Withdrawal by Subject|0|||
126485913|NCT05182125|455074934|FG004|Overall Study|Withdrawal by Subject|2|||
126485914|NCT05182125|455074935|FG005|Overall Study|Withdrawal by Subject|0|||
126485915|NCT05182125|455074930|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
126485916|NCT05182125|455074931|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
126485917|NCT05182125|455074932|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
126485918|NCT05182125|455074933|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
126485919|NCT05182125|455074934|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
126485920|NCT05182125|455074935|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
126485921|NCT05182125|455074930|FG000|Overall Study|Death|0|||
126485922|NCT05182125|455074931|FG001|Overall Study|Death|0|||
126485923|NCT05182125|455074932|FG002|Overall Study|Death|0|||
126722909|NCT01346371|455936026|FG000|Overall Study|Lost to Follow-up|2|||
126722910|NCT01346371|455936027|FG001|Overall Study|Lost to Follow-up|0|||
126485924|NCT05182125|455074933|FG003|Overall Study|Death|0|||
126485925|NCT05182125|455074934|FG004|Overall Study|Death|1|||
126485926|NCT05182125|455074935|FG005|Overall Study|Death|0|||
126485927|NCT05182125|455074930|FG000|Overall Study|Health Contact Follow-up|5|||
126485928|NCT05182125|455074931|FG001|Overall Study|Health Contact Follow-up|5|||
126485929|NCT05182125|455074932|FG002|Overall Study|Health Contact Follow-up|2|||
126485930|NCT05182125|455074933|FG003|Overall Study|Health Contact Follow-up|9|||
126485931|NCT05182125|455074934|FG004|Overall Study|Health Contact Follow-up|7|||
126485932|NCT05182125|455074935|FG005|Overall Study|Health Contact Follow-up|2|||
126485933|NCT01218243|455074936|FG000|Overall Study|Lack of Efficacy|1|||
126485934|NCT01218243|455074937|FG001|Overall Study|Lack of Efficacy|1|||
126485935|NCT01218243|455074936|FG000|Overall Study|Lost to Follow-up|3|||
126485936|NCT01218243|455074937|FG001|Overall Study|Lost to Follow-up|3|||
126485937|NCT01218243|455074936|FG000|Overall Study|Protocol Violation|5|||
126485938|NCT01218243|455074937|FG001|Overall Study|Protocol Violation|10|||
126485939|NCT01049308|455074938|FG000|Pill Counts|Withdrawal by Subject|83|||
126485940|NCT03926169|455074943|FG000|Period A|Adverse Event|2|||
126485941|NCT03926169|455074944|FG001|Period A|Adverse Event|2|||
126485942|NCT03926169|455074945|FG002|Period A|Adverse Event|1|||
126485943|NCT03926169|455074943|FG000|Period A|Withdrawal by Subject|2|||
126485944|NCT03926169|455074944|FG001|Period A|Withdrawal by Subject|2|||
126485945|NCT03926169|455074945|FG002|Period A|Withdrawal by Subject|2|||
126485946|NCT03926169|455074943|FG000|Period A|Lost to Follow-up|3|||
126485947|NCT03926169|455074944|FG001|Period A|Lost to Follow-up|1|||
126485948|NCT03926169|455074945|FG002|Period A|Lost to Follow-up|0|||
126485949|NCT03926169|455074943|FG000|Period A|Lack of Efficacy|0|||
126485950|NCT03926169|455074944|FG001|Period A|Lack of Efficacy|2|||
126485951|NCT03926169|455074945|FG002|Period A|Lack of Efficacy|2|||
126485952|NCT03926169|455074943|FG000|Period A|COVID-19 Infection|0|||
126485953|NCT03926169|455074944|FG001|Period A|COVID-19 Infection|1|||
126485954|NCT03926169|455074945|FG002|Period A|COVID-19 Infection|0|||
126485955|NCT03926169|455074943|FG000|Period A|COVID-19 Logistical Restrictions|0|||
126485956|NCT03926169|455074944|FG001|Period A|COVID-19 Logistical Restrictions|2|||
126485957|NCT03926169|455074945|FG002|Period A|COVID-19 Logistical Restrictions|1|||
126485958|NCT03926169|455074943|FG000|Period A|Other, Not Specified|1|||
126485959|NCT03926169|455074944|FG001|Period A|Other, Not Specified|0|||
126485960|NCT03926169|455074945|FG002|Period A|Other, Not Specified|0|||
126485961|NCT03926169|455074943|FG000|Period B|Adverse Event|3|||
126485962|NCT03926169|455074944|FG001|Period B|Adverse Event|1|||
126485963|NCT03926169|455074945|FG002|Period B|Adverse Event|1|||
126485964|NCT03926169|455074943|FG000|Period B|Withdrawal by Subject|1|||
126485965|NCT03926169|455074944|FG001|Period B|Withdrawal by Subject|3|||
126485966|NCT03926169|455074945|FG002|Period B|Withdrawal by Subject|0|||
126485967|NCT03926169|455074943|FG000|Period B|Lack of Efficacy|3|||
126485968|NCT03926169|455074944|FG001|Period B|Lack of Efficacy|1|||
126485969|NCT03926169|455074945|FG002|Period B|Lack of Efficacy|1|||
126485970|NCT03926169|455074943|FG000|Period B|Lost to Follow-up|1|||
126485971|NCT03926169|455074944|FG001|Period B|Lost to Follow-up|1|||
126485972|NCT03926169|455074945|FG002|Period B|Lost to Follow-up|4|||
126485973|NCT03926169|455074943|FG000|Period B|Other, Not Specified|62|||
126485974|NCT03926169|455074944|FG001|Period B|Other, Not Specified|57|||
126485975|NCT03926169|455074945|FG002|Period B|Other, Not Specified|65|||
126485976|NCT02615145|455074947|FG000|Overall Study|Did Not Start Treatment|0|||
126485977|NCT02615145|455074948|FG001|Overall Study|Did Not Start Treatment|0|||
126485978|NCT02615145|455074949|FG002|Overall Study|Did Not Start Treatment|1|||
126485979|NCT02615145|455074950|FG003|Overall Study|Did Not Start Treatment|1|||
126485980|NCT02615145|455074947|FG000|Overall Study|Failure to Return|20|||
126485981|NCT02615145|455074948|FG001|Overall Study|Failure to Return|10|||
126485982|NCT02615145|455074949|FG002|Overall Study|Failure to Return|7|||
126485983|NCT02615145|455074950|FG003|Overall Study|Failure to Return|0|||
126485984|NCT02615145|455074947|FG000|Overall Study|Death|2|||
126485985|NCT02615145|455074948|FG001|Overall Study|Death|3|||
126485986|NCT02615145|455074949|FG002|Overall Study|Death|0|||
126485987|NCT02615145|455074950|FG003|Overall Study|Death|0|||
126485988|NCT02615145|455074947|FG000|Overall Study|Other, Not Specified|5|||
126485989|NCT02615145|455074948|FG001|Overall Study|Other, Not Specified|2|||
126485990|NCT02615145|455074949|FG002|Overall Study|Other, Not Specified|0|||
126485991|NCT02615145|455074950|FG003|Overall Study|Other, Not Specified|0|||
126485992|NCT03727347|455074951|FG000|Overall Study|Withdrawal by Subject|2|||
126485993|NCT03727347|455074951|FG000|Overall Study|Lost to Follow-up|1|||
126485994|NCT03200860|455074952|FG000|Overall Study|Withdrawal by Subject|1|||
126485995|NCT03200860|455074953|FG001|Overall Study|Withdrawal by Subject|0|||
126485996|NCT01744197|455074955|FG000|Overall Study|Received 1 patch|2|||
126485997|NCT01744197|455074956|FG001|Overall Study|Received 1 patch|1|||
126485998|NCT01744197|455074955|FG000|Overall Study|No patch received|2|||
126485999|NCT01744197|455074956|FG001|Overall Study|No patch received|2|||
126486000|NCT04342897|455074957|FG000|Overall Study|Death|7|||
126486001|NCT04342897|455074958|FG001|Overall Study|Death|4|||
126486002|NCT04342897|455074957|FG000|Overall Study|Lost to Follow-up|6|||
126486003|NCT04342897|455074958|FG001|Overall Study|Lost to Follow-up|6|||
126486004|NCT04342897|455074957|FG000|Overall Study|Withdrawal by Subject|1|||
126486005|NCT04342897|455074958|FG001|Overall Study|Withdrawal by Subject|2|||
126486006|NCT02634320|455074960|FG000|Overall Study|Adverse Event|2|||
126486007|NCT02634320|455074960|FG000|Overall Study|Lost to Follow-up|3|||
126486008|NCT02634320|455074960|FG000|Overall Study|Moved out of area|2|||
126722911|NCT01670656|455936029|FG000|Overall Study|Non-compliance with study drug|0|||
126486009|NCT02634320|455074960|FG000|Overall Study|Out of window for study visits|1|||
126486010|NCT02634320|455074960|FG000|Overall Study|Protocol Violation|1|||
126486011|NCT02634320|455074960|FG000|Overall Study|Withdrawal by Subject|5|||
126486012|NCT02634320|455074960|FG000|Overall Study|Lack of Efficacy|2|||
126486013|NCT04656691|455074967|FG000|Overall Study|Adverse Event|1|||
126486014|NCT03199274|455074968|FG000|Overall Study|Withdrawal by Subject|4|||
126486015|NCT03199274|455074969|FG001|Overall Study|Withdrawal by Subject|0|||
126486016|NCT03199274|455074968|FG000|Overall Study|Lost to Follow-up|0|||
126486017|NCT03199274|455074969|FG001|Overall Study|Lost to Follow-up|1|||
126486018|NCT03199274|455074968|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
126486019|NCT03199274|455074969|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
126486020|NCT02846779|455074972|FG000|Overall Study|Lost Enrollment|83|||
126486021|NCT02846779|455074973|FG001|Overall Study|Lost Enrollment|82|||
126486022|NCT02846779|455074974|FG002|Overall Study|Lost Enrollment|86|||
126486023|NCT02846779|455074972|FG000|Overall Study|Less than 31 days of follow-up|56|||
126486024|NCT02846779|455074973|FG001|Overall Study|Less than 31 days of follow-up|45|||
126486025|NCT02846779|455074974|FG002|Overall Study|Less than 31 days of follow-up|52|||
126486026|NCT01325584|455074979|FG000|Overall Study|Death|1|||
126486027|NCT00887978|455074980|FG000|Overall Study|Adverse Event|18|||
126486028|NCT00887978|455074981|FG001|Overall Study|Adverse Event|5|||
126486029|NCT00887978|455074980|FG000|Overall Study|Clinical Worsening|4|||
126486030|NCT00887978|455074981|FG001|Overall Study|Clinical Worsening|4|||
126486031|NCT00887978|455074980|FG000|Overall Study|Death|2|||
126486032|NCT00887978|455074981|FG001|Overall Study|Death|3|||
126486033|NCT00887978|455074980|FG000|Overall Study|Withdrawal by Subject|1|||
126486034|NCT00887978|455074981|FG001|Overall Study|Withdrawal by Subject|2|||
126486035|NCT00887978|455074980|FG000|Overall Study|Lost to Follow-up|0|||
126486036|NCT00887978|455074981|FG001|Overall Study|Lost to Follow-up|1|||
126486037|NCT02239978|455076106|FG000|Overall Study|Withdrawal by Subject|2|||
126486038|NCT02239978|455076107|FG001|Overall Study|Withdrawal by Subject|0|||
126486039|NCT01852110|455076119|FG000|Overall Study|Adverse Event|12|||
126486040|NCT01852110|455076120|FG001|Overall Study|Adverse Event|5|||
126486041|NCT01852110|455076121|FG002|Overall Study|Adverse Event|0|||
126486042|NCT01852110|455076122|FG003|Overall Study|Adverse Event|0|||
126486043|NCT01852110|455076123|FG004|Overall Study|Adverse Event|0|||
126486044|NCT01852110|455076124|FG005|Overall Study|Adverse Event|0|||
126486045|NCT01852110|455076119|FG000|Overall Study|Lost to Follow-up|1|||
126486046|NCT01852110|455076120|FG001|Overall Study|Lost to Follow-up|3|||
126486047|NCT01852110|455076121|FG002|Overall Study|Lost to Follow-up|0|||
126722912|NCT01670656|455936030|FG001|Overall Study|Non-compliance with study drug|0|||
126722913|NCT01670656|455936031|FG002|Overall Study|Non-compliance with study drug|3|||
126722914|NCT01670656|455936032|FG003|Overall Study|Non-compliance with study drug|0|||
126722915|NCT01670656|455936033|FG004|Overall Study|Non-compliance with study drug|1|||
126722916|NCT01670656|455936029|FG000|Overall Study|Pregnancy|0|||
126722917|NCT01670656|455936030|FG001|Overall Study|Pregnancy|0|||
126722918|NCT01670656|455936031|FG002|Overall Study|Pregnancy|0|||
126722919|NCT01670656|455936032|FG003|Overall Study|Pregnancy|0|||
126722920|NCT01670656|455936033|FG004|Overall Study|Pregnancy|1|||
126722921|NCT01670656|455936029|FG000|Overall Study|Withdrawal by Subject|1|||
126722922|NCT01670656|455936030|FG001|Overall Study|Withdrawal by Subject|1|||
126722923|NCT01670656|455936031|FG002|Overall Study|Withdrawal by Subject|0|||
126722924|NCT01670656|455936032|FG003|Overall Study|Withdrawal by Subject|0|||
126722925|NCT01670656|455936033|FG004|Overall Study|Withdrawal by Subject|0|||
126722926|NCT01670656|455936029|FG000|Overall Study|Non-compliance with protocol|0|||
126722927|NCT01670656|455936030|FG001|Overall Study|Non-compliance with protocol|3|||
126722928|NCT01670656|455936031|FG002|Overall Study|Non-compliance with protocol|1|||
126722929|NCT01670656|455936032|FG003|Overall Study|Non-compliance with protocol|1|||
126722930|NCT01670656|455936033|FG004|Overall Study|Non-compliance with protocol|2|||
126722931|NCT01670656|455936029|FG000|Overall Study|Adverse Event|2|||
126486048|NCT01852110|455076122|FG003|Overall Study|Lost to Follow-up|0|||
126486049|NCT01852110|455076123|FG004|Overall Study|Lost to Follow-up|0|||
126486050|NCT01852110|455076124|FG005|Overall Study|Lost to Follow-up|0|||
126559354|NCT01929993|455342476|FG000|Overall Study|Protocol Violation|4|||
126559355|NCT01929993|455342477|FG001|Overall Study|Protocol Violation|6|||
126722932|NCT01670656|455936030|FG001|Overall Study|Adverse Event|2|||
126722933|NCT01670656|455936031|FG002|Overall Study|Adverse Event|2|||
126722934|NCT01670656|455936032|FG003|Overall Study|Adverse Event|3|||
126722935|NCT01670656|455936033|FG004|Overall Study|Adverse Event|3|||
126722936|NCT01670656|455936029|FG000|Overall Study|Subject withdrew consent|0|||
126722937|NCT01670656|455936030|FG001|Overall Study|Subject withdrew consent|1|||
126722938|NCT01670656|455936031|FG002|Overall Study|Subject withdrew consent|2|||
126722939|NCT01670656|455936032|FG003|Overall Study|Subject withdrew consent|1|||
126486051|NCT01852110|455076119|FG000|Overall Study|Non-compliance with Study Drug|2|||
126486052|NCT01852110|455076120|FG001|Overall Study|Non-compliance with Study Drug|1|||
126486053|NCT01852110|455076121|FG002|Overall Study|Non-compliance with Study Drug|0|||
126486054|NCT01852110|455076122|FG003|Overall Study|Non-compliance with Study Drug|0|||
126486055|NCT01852110|455076123|FG004|Overall Study|Non-compliance with Study Drug|0|||
126486056|NCT01852110|455076124|FG005|Overall Study|Non-compliance with Study Drug|0|||
126486057|NCT01852110|455076119|FG000|Overall Study|Physician Decision|1|||
126722940|NCT01670656|455936033|FG004|Overall Study|Subject withdrew consent|1|||
126722941|NCT01670656|455936029|FG000|Overall Study|Lost to Follow-up|0|||
126722942|NCT01670656|455936030|FG001|Overall Study|Lost to Follow-up|0|||
126722943|NCT01670656|455936031|FG002|Overall Study|Lost to Follow-up|0|||
126486058|NCT01852110|455076120|FG001|Overall Study|Physician Decision|0|||
126486059|NCT01852110|455076121|FG002|Overall Study|Physician Decision|0|||
126486060|NCT01852110|455076122|FG003|Overall Study|Physician Decision|0|||
126486061|NCT01852110|455076123|FG004|Overall Study|Physician Decision|0|||
126486062|NCT01852110|455076124|FG005|Overall Study|Physician Decision|0|||
126486063|NCT01852110|455076119|FG000|Overall Study|Protocol Violation|0|||
126486064|NCT01852110|455076120|FG001|Overall Study|Protocol Violation|1|||
126486065|NCT01852110|455076121|FG002|Overall Study|Protocol Violation|0|||
126486066|NCT01852110|455076122|FG003|Overall Study|Protocol Violation|0|||
126486067|NCT01852110|455076123|FG004|Overall Study|Protocol Violation|0|||
126486068|NCT01852110|455076124|FG005|Overall Study|Protocol Violation|0|||
126486069|NCT01852110|455076119|FG000|Overall Study|Study Terminated by Sponsor|30|||
126486070|NCT01852110|455076120|FG001|Overall Study|Study Terminated by Sponsor|32|||
126486071|NCT01852110|455076121|FG002|Overall Study|Study Terminated by Sponsor|0|||
126486072|NCT01852110|455076122|FG003|Overall Study|Study Terminated by Sponsor|0|||
126486073|NCT01852110|455076123|FG004|Overall Study|Study Terminated by Sponsor|0|||
126486074|NCT01852110|455076124|FG005|Overall Study|Study Terminated by Sponsor|0|||
126486075|NCT01852110|455076119|FG000|Overall Study|Withdrawal by Subject|4|||
126486076|NCT01852110|455076120|FG001|Overall Study|Withdrawal by Subject|4|||
126486077|NCT01852110|455076121|FG002|Overall Study|Withdrawal by Subject|0|||
126486078|NCT01852110|455076122|FG003|Overall Study|Withdrawal by Subject|0|||
126486079|NCT01852110|455076123|FG004|Overall Study|Withdrawal by Subject|0|||
126486080|NCT01852110|455076124|FG005|Overall Study|Withdrawal by Subject|0|||
126486081|NCT00381095|455076127|FG000|Overall Study|Death|3|||
126486082|NCT00381095|455076128|FG001|Overall Study|Death|4|||
126486083|NCT00381095|455076127|FG000|Overall Study|Lack of Efficacy|2|||
126486084|NCT00381095|455076128|FG001|Overall Study|Lack of Efficacy|4|||
126486085|NCT00381095|455076127|FG000|Overall Study|Other|2|||
126486086|NCT00381095|455076128|FG001|Overall Study|Other|2|||
126486087|NCT00381095|455076127|FG000|Overall Study|Protocol Violation|1|||
126486088|NCT00381095|455076128|FG001|Overall Study|Protocol Violation|1|||
126486089|NCT00381095|455076127|FG000|Overall Study|Withdrawal by Subject|3|||
126486090|NCT00381095|455076128|FG001|Overall Study|Withdrawal by Subject|3|||
126486091|NCT00381095|455076127|FG000|Overall Study|Adverse Event|2|||
126486092|NCT00381095|455076128|FG001|Overall Study|Adverse Event|7|||
126486093|NCT01342796|455076130|FG000|Overall Study|Withdrawal by Subject|2|||
126486094|NCT01342796|455076131|FG001|Overall Study|Withdrawal by Subject|0|||
126486095|NCT01342796|455076130|FG000|Overall Study|Lost to Follow-up|0|||
126486096|NCT01342796|455076131|FG001|Overall Study|Lost to Follow-up|3|||
126486097|NCT01342796|455076130|FG000|Overall Study|Inappropriate enrollment|1|||
126486098|NCT01342796|455076131|FG001|Overall Study|Inappropriate enrollment|0|||
126486099|NCT01599234|455076137|FG000|Overall Study|Adverse Event|9|||
126486100|NCT01599234|455076138|FG001|Overall Study|Adverse Event|5|||
126486101|NCT01599234|455076137|FG000|Overall Study|Withdrawal by Subject|2|||
126486102|NCT01599234|455076138|FG001|Overall Study|Withdrawal by Subject|1|||
126486103|NCT01599234|455076137|FG000|Overall Study|Lost to Follow-up|1|||
126486104|NCT01599234|455076138|FG001|Overall Study|Lost to Follow-up|2|||
126486105|NCT01599234|455076137|FG000|Overall Study|Lack of Efficacy|2|||
126486106|NCT01599234|455076138|FG001|Overall Study|Lack of Efficacy|4|||
126486107|NCT01599234|455076137|FG000|Overall Study|Unable to operate spray|1|||
126486108|NCT01599234|455076138|FG001|Overall Study|Unable to operate spray|0|||
126486109|NCT01599234|455076137|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
126486110|NCT01599234|455076138|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
126486111|NCT01599234|455076137|FG000|Overall Study|Death|1|||
126486112|NCT01599234|455076138|FG001|Overall Study|Death|0|||
126486113|NCT01599234|455076137|FG000|Overall Study|Patient would not stop driving|1|||
126722944|NCT01670656|455936032|FG003|Overall Study|Lost to Follow-up|0|||
126722945|NCT01670656|455936033|FG004|Overall Study|Lost to Follow-up|3|||
126722946|NCT01670656|455936029|FG000|Overall Study|Subject moved|0|||
126722947|NCT01670656|455936030|FG001|Overall Study|Subject moved|0|||
126722948|NCT01670656|455936031|FG002|Overall Study|Subject moved|0|||
126486114|NCT01599234|455076138|FG001|Overall Study|Patient would not stop driving|0|||
126486115|NCT01599234|455076137|FG000|Overall Study|Contra-indication discovered|0|||
126486116|NCT01599234|455076138|FG001|Overall Study|Contra-indication discovered|1|||
126486117|NCT01599234|455076137|FG000|Overall Study|Pregnancy|0|||
126486118|NCT01599234|455076138|FG001|Overall Study|Pregnancy|1|||
126486119|NCT02899988|455076143|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
126486120|NCT02899988|455076144|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
126486121|NCT02899988|455076145|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126486122|NCT02899988|455076146|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126486123|NCT02899988|455076147|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126486124|NCT02899988|455076148|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126486125|NCT02899988|455076149|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126486126|NCT02899988|455076150|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126722949|NCT01670656|455936032|FG003|Overall Study|Subject moved|1|||
126486127|NCT02899988|455076151|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126486128|NCT02899988|455076152|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126486129|NCT02899988|455076153|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126486130|NCT02899988|455076143|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
126486131|NCT02899988|455076144|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
126486132|NCT02899988|455076145|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
126486133|NCT02899988|455076146|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
126486134|NCT02899988|455076147|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
126486135|NCT02899988|455076148|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
126486136|NCT02899988|455076149|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
126486137|NCT02899988|455076150|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
126486138|NCT02899988|455076151|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
126486139|NCT02899988|455076152|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
126486140|NCT02899988|455076153|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
126486141|NCT02899988|455076143|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
126486142|NCT02899988|455076144|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
126486143|NCT02899988|455076145|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
126486144|NCT02899988|455076146|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
126486145|NCT02899988|455076147|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
126486146|NCT02899988|455076148|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
126486147|NCT02899988|455076149|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
126486148|NCT02899988|455076150|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
126486149|NCT02899988|455076151|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
126486150|NCT02899988|455076152|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
126486151|NCT02899988|455076153|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
126486152|NCT02899988|455076143|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
126486153|NCT02899988|455076144|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
126486154|NCT02899988|455076145|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
126486155|NCT02899988|455076146|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
126486156|NCT02899988|455076147|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
126486157|NCT02899988|455076148|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
126486158|NCT02899988|455076149|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
126486159|NCT02899988|455076150|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
126486160|NCT02899988|455076151|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
126486161|NCT02899988|455076152|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
126486162|NCT02899988|455076153|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
126486163|NCT02899988|455076143|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
126486164|NCT02899988|455076144|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
126486165|NCT02899988|455076145|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
126486166|NCT02899988|455076146|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
126486167|NCT02899988|455076147|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
126486168|NCT02899988|455076148|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
126486169|NCT02899988|455076149|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
126486170|NCT02899988|455076150|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
126486171|NCT02899988|455076151|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
126486172|NCT02899988|455076152|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
126486173|NCT02899988|455076153|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
126486174|NCT02899988|455076143|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
126486175|NCT02899988|455076144|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
126486176|NCT02899988|455076145|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
126486177|NCT02899988|455076146|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
126486178|NCT02899988|455076147|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
126486179|NCT02899988|455076148|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
126486180|NCT02899988|455076149|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
126486181|NCT02899988|455076150|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
126486182|NCT02899988|455076151|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
126486183|NCT02899988|455076152|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
126486184|NCT02899988|455076153|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
126486185|NCT04271605|455076154|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
126486186|NCT00171730|455076158|FG000|Overall Study|Adverse Event|3|||
126486187|NCT00171730|455076158|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
126486188|NCT00171730|455076158|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
126486189|NCT00171730|455076158|FG000|Overall Study|Withdrawal by Subject|3|||
126486190|NCT05025241|455076159|FG000|Screening|Failed Screening|5|||
126486191|NCT05025241|455076159|FG000|Treatment and Follow Up|Adverse Event|3|||
126486192|NCT01053221|455076160|FG000|Overall Study|The study was closed prematurely|5|||
126486193|NCT01053221|455076161|FG001|Overall Study|The study was closed prematurely|9|||
126486194|NCT02266225|455076162|FG000|Overall Study|Lost to Follow-up|2|||
126486195|NCT02266225|455076162|FG000|Overall Study|Death|1|||
126486196|NCT02266225|455076162|FG000|Overall Study|Withdrawal by Subject|13|||
126486197|NCT01950741|455076173|FG000|Overall Study|Lost to Follow-up|1|||
126486198|NCT01950741|455076173|FG000|Overall Study|Death|1|||
126486199|NCT01950741|455076173|FG000|Overall Study|Withdrawal by Subject|1|||
126486200|NCT02521870|455076174|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126486201|NCT02521870|455076175|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
126486202|NCT02521870|455076176|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126486203|NCT02521870|455076177|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126486204|NCT02521870|455076178|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126486205|NCT02521870|455076179|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126486206|NCT02521870|455076180|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126486207|NCT02521870|455076181|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126486208|NCT02521870|455076182|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126486209|NCT02521870|455076183|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126486210|NCT02521870|455076184|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126486211|NCT02521870|455076185|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
126486212|NCT02521870|455076174|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
126486213|NCT02521870|455076175|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
126486214|NCT02521870|455076176|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
126486215|NCT02521870|455076177|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
126486216|NCT02521870|455076178|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
126486217|NCT02521870|455076179|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
126486218|NCT02521870|455076180|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
126486219|NCT02521870|455076181|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
126486220|NCT02521870|455076182|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
126486221|NCT02521870|455076183|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
126486222|NCT02521870|455076184|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
126486223|NCT02521870|455076185|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
126486224|NCT02521870|455076174|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
126486225|NCT02521870|455076175|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
126486226|NCT02521870|455076176|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
126486227|NCT02521870|455076177|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
126486228|NCT02521870|455076178|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
126486229|NCT02521870|455076179|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
126486230|NCT02521870|455076180|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
126486231|NCT02521870|455076181|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
126486232|NCT02521870|455076182|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
126486233|NCT02521870|455076183|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
126486234|NCT02521870|455076184|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
126486235|NCT02521870|455076185|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
126486236|NCT02521870|455076174|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
126486237|NCT02521870|455076175|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
126486238|NCT02521870|455076176|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
126486239|NCT02521870|455076177|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
126486240|NCT02521870|455076178|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
126486241|NCT02521870|455076179|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
126486242|NCT02521870|455076180|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
126486243|NCT02521870|455076181|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
126486244|NCT02521870|455076182|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
126486245|NCT02521870|455076183|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
126486246|NCT02521870|455076184|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
126486247|NCT02521870|455076185|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
126486248|NCT02521870|455076174|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
126486249|NCT02521870|455076175|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
126486250|NCT02521870|455076176|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
126486251|NCT02521870|455076177|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
126486252|NCT02521870|455076178|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
126486253|NCT02521870|455076179|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
126486254|NCT02521870|455076180|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
126486255|NCT02521870|455076181|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
126486256|NCT02521870|455076182|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
126486257|NCT02521870|455076183|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
126486258|NCT02521870|455076184|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
126772587|NCT01875991|456123626|FG000|Overall Study|Sponsor Decision|1|||
126772588|NCT01875991|456123627|FG001|Overall Study|Sponsor Decision|0|||
126772589|NCT02419469|456123628|FG000|Overall Study|Withdrawal by Subject|1|||
126772590|NCT02454972|456123629|FG000|Overall Study|Progressive disease|17|||
126772591|NCT02454972|456123630|FG001|Overall Study|Progressive disease|16|||
126772592|NCT02454972|456123631|FG002|Overall Study|Progressive disease|59|||
126486259|NCT02521870|455076185|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
126486260|NCT02521870|455076174|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
126486261|NCT02521870|455076175|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
126486262|NCT02521870|455076176|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
126772593|NCT02454972|456123632|FG003|Overall Study|Progressive disease|23|||
126722950|NCT01670656|455936033|FG004|Overall Study|Subject moved|0|||
126722951|NCT00789958|455936034|FG000|Overall Study|Adverse Event|3|||
126722952|NCT00789958|455936034|FG000|Overall Study|Withdrawal by Subject|4|||
126722953|NCT00789958|455936034|FG000|Overall Study|Progression|3|||
126722954|NCT00789958|455936034|FG000|Overall Study|not protocol specified|1|||
126722955|NCT00789958|455936034|FG000|Overall Study|Not eligible/not analyzable|26|||
126722956|NCT00836277|455936037|FG000|Overall Study|Not evaluable for response|6|||
126722957|NCT01354353|455936038|FG000|Overall Study|Adverse Event|1|||
126722958|NCT01354353|455936039|FG001|Overall Study|Adverse Event|0|||
126722959|NCT01354353|455936040|FG002|Overall Study|Adverse Event|0|||
126722960|NCT01354353|455936041|FG003|Overall Study|Adverse Event|4|||
126722961|NCT01354353|455936042|FG004|Overall Study|Adverse Event|0|||
126722962|NCT01354353|455936043|FG005|Overall Study|Adverse Event|5|||
126722963|NCT01354353|455936038|FG000|Overall Study|Entry Criteria Not Met|0|||
126722964|NCT01354353|455936039|FG001|Overall Study|Entry Criteria Not Met|0|||
126722965|NCT01354353|455936040|FG002|Overall Study|Entry Criteria Not Met|0|||
126722966|NCT01354353|455936041|FG003|Overall Study|Entry Criteria Not Met|1|||
126722967|NCT01354353|455936042|FG004|Overall Study|Entry Criteria Not Met|1|||
126722968|NCT01354353|455936043|FG005|Overall Study|Entry Criteria Not Met|0|||
126722969|NCT01354353|455936038|FG000|Overall Study|Physician Decision|0|||
126722970|NCT01354353|455936039|FG001|Overall Study|Physician Decision|1|||
126486263|NCT02521870|455076177|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
126486264|NCT02521870|455076178|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
126486265|NCT02521870|455076179|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
126486266|NCT02521870|455076180|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
126486267|NCT02521870|455076181|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
126486268|NCT02521870|455076182|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
126486269|NCT02521870|455076183|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
126486270|NCT02521870|455076184|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
126486271|NCT02521870|455076185|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
126486272|NCT02521870|455076174|FG000|Phase 2: Dose Expansion|Death|0|||
126486273|NCT02521870|455076175|FG001|Phase 2: Dose Expansion|Death|0|||
126486274|NCT02521870|455076176|FG002|Phase 2: Dose Expansion|Death|0|||
126486275|NCT02521870|455076177|FG003|Phase 2: Dose Expansion|Death|0|||
126486276|NCT02521870|455076178|FG004|Phase 2: Dose Expansion|Death|1|||
126486277|NCT02521870|455076179|FG005|Phase 2: Dose Expansion|Death|1|||
126486278|NCT02521870|455076180|FG006|Phase 2: Dose Expansion|Death|3|||
126486279|NCT02521870|455076181|FG007|Phase 2: Dose Expansion|Death|1|||
126486280|NCT02521870|455076182|FG008|Phase 2: Dose Expansion|Death|1|||
126486281|NCT02521870|455076183|FG009|Phase 2: Dose Expansion|Death|5|||
126486282|NCT02521870|455076184|FG010|Phase 2: Dose Expansion|Death|2|||
126486283|NCT02521870|455076185|FG011|Phase 2: Dose Expansion|Death|2|||
126486284|NCT02521870|455076174|FG000|Phase 2: Dose Expansion|Other|0|||
126486285|NCT02521870|455076175|FG001|Phase 2: Dose Expansion|Other|0|||
126486286|NCT02521870|455076176|FG002|Phase 2: Dose Expansion|Other|0|||
126486287|NCT02521870|455076177|FG003|Phase 2: Dose Expansion|Other|0|||
126486288|NCT02521870|455076178|FG004|Phase 2: Dose Expansion|Other|10|||
126486289|NCT02521870|455076179|FG005|Phase 2: Dose Expansion|Other|3|||
126486290|NCT02521870|455076180|FG006|Phase 2: Dose Expansion|Other|2|||
126486291|NCT02521870|455076181|FG007|Phase 2: Dose Expansion|Other|0|||
126486292|NCT02521870|455076182|FG008|Phase 2: Dose Expansion|Other|10|||
126486293|NCT02521870|455076183|FG009|Phase 2: Dose Expansion|Other|5|||
126486294|NCT02521870|455076184|FG010|Phase 2: Dose Expansion|Other|1|||
126486295|NCT02521870|455076185|FG011|Phase 2: Dose Expansion|Other|7|||
126486296|NCT02521870|455076174|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126486297|NCT02521870|455076175|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126486298|NCT02521870|455076176|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126486299|NCT02521870|455076177|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126486300|NCT02521870|455076178|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
126486301|NCT02521870|455076179|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126486302|NCT02521870|455076180|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126486303|NCT02521870|455076181|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126486304|NCT02521870|455076182|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126486305|NCT02521870|455076183|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126486306|NCT02521870|455076184|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126486307|NCT02521870|455076185|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
126486308|NCT02521870|455076174|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
126486309|NCT02521870|455076175|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
126486310|NCT02521870|455076176|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
126559356|NCT01929993|455342476|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
126722971|NCT01354353|455936040|FG002|Overall Study|Physician Decision|1|||
126486311|NCT02521870|455076177|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
126486312|NCT02521870|455076178|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
126559357|NCT01929993|455342477|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
126486313|NCT02521870|455076179|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
126722972|NCT01354353|455936041|FG003|Overall Study|Physician Decision|0|||
126486314|NCT02521870|455076180|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
126486315|NCT02521870|455076181|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
126486316|NCT02521870|455076182|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
126486317|NCT02521870|455076183|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
126486318|NCT02521870|455076184|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
126486319|NCT02521870|455076185|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
126486320|NCT00519831|455076186|FG000|Overall Study|Adverse Event|3|||
126486321|NCT02854631|455076187|FG000|Overall Study|Adverse Event|1|||
126486322|NCT02854631|455076188|FG001|Overall Study|Adverse Event|2|||
126486323|NCT02854631|455076187|FG000|Overall Study|Withdrew Consent|3|||
126722973|NCT01354353|455936042|FG004|Overall Study|Physician Decision|0|||
126486324|NCT02854631|455076188|FG001|Overall Study|Withdrew Consent|2|||
126486325|NCT02854631|455076187|FG000|Overall Study|Investigator's Discretion|2|||
126486326|NCT02854631|455076188|FG001|Overall Study|Investigator's Discretion|0|||
126486327|NCT02854631|455076187|FG000|Overall Study|Death|12|||
126486328|NCT02854631|455076188|FG001|Overall Study|Death|8|||
126486329|NCT02854631|455076187|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
126486330|NCT02854631|455076188|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
126486331|NCT02854631|455076187|FG000|Overall Study|Protocol Violation|0|||
126486332|NCT02854631|455076188|FG001|Overall Study|Protocol Violation|1|||
126486333|NCT02854631|455076187|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
126486334|NCT02854631|455076188|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
126486335|NCT02854631|455076187|FG000|Overall Study|Lost to Follow-up|4|||
126486336|NCT02854631|455076188|FG001|Overall Study|Lost to Follow-up|2|||
126486337|NCT00844896|455076189|FG000|Overall Study|Lost to Follow-up|12|||
126486338|NCT00844896|455076190|FG001|Overall Study|Lost to Follow-up|16|||
126486339|NCT00844896|455076189|FG000|Overall Study|Parents did not have time to complete|0|||
126486340|NCT00844896|455076190|FG001|Overall Study|Parents did not have time to complete|1|||
126486341|NCT02233647|455076191|FG000|Overall Study|Adverse Event|1|||
126486342|NCT01835587|455076195|FG000|Overall Study|Disease Recurrence or Relapse|0|||
126486343|NCT01835587|455076196|FG001|Overall Study|Disease Recurrence or Relapse|3|||
126486344|NCT01835587|455076197|FG002|Overall Study|Disease Recurrence or Relapse|0|||
126486345|NCT01835587|455076198|FG003|Overall Study|Disease Recurrence or Relapse|3|||
126486346|NCT01835587|455076195|FG000|Overall Study|Withdrawal by Subject|2|||
126486347|NCT01835587|455076196|FG001|Overall Study|Withdrawal by Subject|0|||
126486348|NCT01835587|455076197|FG002|Overall Study|Withdrawal by Subject|0|||
126486349|NCT01835587|455076198|FG003|Overall Study|Withdrawal by Subject|3|||
126486350|NCT01835587|455076195|FG000|Overall Study|Adverse Event|0|||
126486351|NCT01835587|455076196|FG001|Overall Study|Adverse Event|0|||
126486352|NCT01835587|455076197|FG002|Overall Study|Adverse Event|2|||
126486353|NCT01835587|455076198|FG003|Overall Study|Adverse Event|2|||
126486354|NCT01835587|455076195|FG000|Overall Study|Death|0|||
126486355|NCT01835587|455076196|FG001|Overall Study|Death|0|||
126486356|NCT01835587|455076197|FG002|Overall Study|Death|0|||
126486357|NCT01835587|455076198|FG003|Overall Study|Death|1|||
126486358|NCT01835587|455076195|FG000|Overall Study|Miscellaneous|0|||
126486359|NCT01835587|455076196|FG001|Overall Study|Miscellaneous|1|||
126486360|NCT01835587|455076197|FG002|Overall Study|Miscellaneous|0|||
126486361|NCT01835587|455076198|FG003|Overall Study|Miscellaneous|0|||
126486362|NCT00357968|455076199|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
126486363|NCT00357968|455076200|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
126486364|NCT00357968|455076199|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
126486365|NCT00357968|455076200|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
126722974|NCT01354353|455936043|FG005|Overall Study|Physician Decision|0|||
126722975|NCT01354353|455936038|FG000|Overall Study|Withdrawal by Subject|2|||
126486366|NCT00600483|455076201|FG000|Overall Study|Lost to Follow-up|26|||
126486367|NCT00600483|455076202|FG001|Overall Study|Lost to Follow-up|47|||
126486368|NCT00600483|455076201|FG000|Overall Study|Randomized but not treated|10|||
126486369|NCT00600483|455076202|FG001|Overall Study|Randomized but not treated|0|||
126486370|NCT04102020|455076217|FG000|Overall Study|Adverse Event|1|||
126486371|NCT04102020|455076218|FG001|Overall Study|Adverse Event|0|||
126722976|NCT01354353|455936039|FG001|Overall Study|Withdrawal by Subject|0|||
126722977|NCT01354353|455936040|FG002|Overall Study|Withdrawal by Subject|1|||
126486372|NCT04102020|455076219|FG002|Overall Study|Adverse Event|0|||
126486373|NCT04102020|455076220|FG003|Overall Study|Adverse Event|1|||
126486374|NCT04102020|455076221|FG004|Overall Study|Adverse Event|0|||
126486375|NCT04102020|455076217|FG000|Overall Study|Withdrawal by Subject|0|||
126486376|NCT04102020|455076218|FG001|Overall Study|Withdrawal by Subject|1|||
126486377|NCT04102020|455076219|FG002|Overall Study|Withdrawal by Subject|1|||
126486378|NCT04102020|455076220|FG003|Overall Study|Withdrawal by Subject|1|||
126486379|NCT04102020|455076221|FG004|Overall Study|Withdrawal by Subject|1|||
126486380|NCT04102020|455076217|FG000|Overall Study|Death|1|||
126486381|NCT04102020|455076218|FG001|Overall Study|Death|4|||
126486382|NCT04102020|455076219|FG002|Overall Study|Death|1|||
126486383|NCT04102020|455076220|FG003|Overall Study|Death|1|||
126486384|NCT04102020|455076221|FG004|Overall Study|Death|0|||
126722978|NCT01354353|455936041|FG003|Overall Study|Withdrawal by Subject|0|||
126722979|NCT01354353|455936042|FG004|Overall Study|Withdrawal by Subject|0|||
126722980|NCT01354353|455936043|FG005|Overall Study|Withdrawal by Subject|1|||
126722981|NCT04831515|455936046|FG000|First Intervention|Adverse Event|0|||
126722982|NCT04831515|455936047|FG001|First Intervention|Adverse Event|1|||
126722983|NCT01640925|455936050|FG000|Overall Study|Withdrawal by Subject|1|||
126722984|NCT01640925|455936051|FG001|Overall Study|Withdrawal by Subject|0|||
126722985|NCT01640925|455936050|FG000|Overall Study|Previously enrolled in this trial|13|||
126722986|NCT01640925|455936051|FG001|Overall Study|Previously enrolled in this trial|11|||
126722987|NCT01030458|455936065|FG000|Overall Study|Lost to Follow-up|9|||
126722988|NCT01030458|455936066|FG001|Overall Study|Lost to Follow-up|10|||
126722989|NCT01030458|455936065|FG000|Overall Study|Withdrawal by Subject|2|||
126722990|NCT01030458|455936066|FG001|Overall Study|Withdrawal by Subject|3|||
126722991|NCT01030458|455936065|FG000|Overall Study|Logistical reasons|9|||
126722992|NCT01030458|455936066|FG001|Overall Study|Logistical reasons|5|||
126722993|NCT01030458|455936065|FG000|Overall Study|Moved or changed job|6|||
126722994|NCT01030458|455936066|FG001|Overall Study|Moved or changed job|13|||
126722995|NCT01030458|455936065|FG000|Overall Study|Side effect of medication|1|||
126722996|NCT01030458|455936066|FG001|Overall Study|Side effect of medication|1|||
126722997|NCT01332019|455936067|FG000|Overall Study|Was Not Dosed|1|||
126722998|NCT01332019|455936068|FG001|Overall Study|Was Not Dosed|0|||
126722999|NCT01332019|455936067|FG000|Overall Study|Other|16|||
126723000|NCT01332019|455936068|FG001|Overall Study|Other|18|||
126723001|NCT01332019|455936067|FG000|Overall Study|Death|2|||
126723002|NCT01332019|455936068|FG001|Overall Study|Death|1|||
126723003|NCT01332019|455936067|FG000|Overall Study|Physician Decision|4|||
126486385|NCT04102020|455076217|FG000|Overall Study|Physician Decision|1|||
126486386|NCT04102020|455076218|FG001|Overall Study|Physician Decision|2|||
126486387|NCT04102020|455076219|FG002|Overall Study|Physician Decision|2|||
126486388|NCT04102020|455076220|FG003|Overall Study|Physician Decision|0|||
126486389|NCT04102020|455076221|FG004|Overall Study|Physician Decision|1|||
126486390|NCT04102020|455076217|FG000|Overall Study|COVID-19 Infection|1|||
126486391|NCT04102020|455076218|FG001|Overall Study|COVID-19 Infection|0|||
126486392|NCT04102020|455076219|FG002|Overall Study|COVID-19 Infection|0|||
126486393|NCT04102020|455076220|FG003|Overall Study|COVID-19 Infection|0|||
126486394|NCT04102020|455076221|FG004|Overall Study|COVID-19 Infection|0|||
126486395|NCT04102020|455076217|FG000|Overall Study|Not disclosed|5|||
126486396|NCT04102020|455076218|FG001|Overall Study|Not disclosed|3|||
126486397|NCT04102020|455076219|FG002|Overall Study|Not disclosed|8|||
126486398|NCT04102020|455076220|FG003|Overall Study|Not disclosed|0|||
126486399|NCT04102020|455076221|FG004|Overall Study|Not disclosed|1|||
126486400|NCT04102020|455076217|FG000|Overall Study|MIssing|1|||
126486401|NCT04102020|455076218|FG001|Overall Study|MIssing|0|||
126486402|NCT04102020|455076219|FG002|Overall Study|MIssing|1|||
126486403|NCT04102020|455076220|FG003|Overall Study|MIssing|1|||
126486404|NCT04102020|455076221|FG004|Overall Study|MIssing|1|||
126486405|NCT04102020|455076217|FG000|Overall Study|Continuing in ongoing study|13|||
126486406|NCT04102020|455076218|FG001|Overall Study|Continuing in ongoing study|13|||
126486407|NCT04102020|455076219|FG002|Overall Study|Continuing in ongoing study|7|||
126486408|NCT04102020|455076220|FG003|Overall Study|Continuing in ongoing study|26|||
126486409|NCT04102020|455076221|FG004|Overall Study|Continuing in ongoing study|12|||
126486410|NCT05980182|455076233|FG000|Overall Study|Lost to Follow-up|10|||
126486411|NCT04600921|455076234|FG000|Overall Study|Withdrawal by Subject|3|||
126486412|NCT04600921|455076235|FG001|Overall Study|Withdrawal by Subject|5|||
126486413|NCT04600921|455076234|FG000|Overall Study|Death|0|||
126486414|NCT04600921|455076235|FG001|Overall Study|Death|1|||
126486415|NCT00410046|455078213|FG000|Overall Study|Adverse Event|3|||
126486416|NCT00410046|455078213|FG000|Overall Study|Withdrawal by Subject|1|||
126486417|NCT00410046|455078213|FG000|Overall Study|Lost to Follow-up|1|||
126486418|NCT01384760|455078215|FG000|Overall Study|Lost to Follow-up|0|||
126723004|NCT01332019|455936068|FG001|Overall Study|Physician Decision|3|||
126723005|NCT01332019|455936067|FG000|Overall Study|Withdrawal by Subject|73|||
126772594|NCT02454972|456123633|FG004|Overall Study|Progressive disease|16|||
126486419|NCT01384760|455078216|FG001|Overall Study|Lost to Follow-up|6|||
126723006|NCT01332019|455936068|FG001|Overall Study|Withdrawal by Subject|71|||
126723007|NCT01332019|455936067|FG000|Overall Study|Lost to Follow-up|4|||
126723008|NCT01332019|455936068|FG001|Overall Study|Lost to Follow-up|7|||
126723009|NCT01332019|455936067|FG000|Overall Study|Adverse Event|13|||
126486420|NCT01384760|455078215|FG000|Overall Study|Protocol Violation|16|||
126486421|NCT01384760|455078216|FG001|Overall Study|Protocol Violation|0|||
126486422|NCT00963547|455078217|FG000|Overall Study|Adverse Event|0|||
126486423|NCT00963547|455078218|FG001|Overall Study|Adverse Event|1|||
126486424|NCT00963547|455078219|FG002|Overall Study|Adverse Event|0|||
126486425|NCT00963547|455078220|FG003|Overall Study|Adverse Event|1|||
126486426|NCT00963547|455078221|FG004|Overall Study|Adverse Event|0|||
126486427|NCT00963547|455078222|FG005|Overall Study|Adverse Event|0|||
126723010|NCT01332019|455936068|FG001|Overall Study|Adverse Event|22|||
126723011|NCT05142332|455936073|FG000|Overall Study|Withdrawal by Subject|0|||
126486428|NCT00963547|455078223|FG006|Overall Study|Adverse Event|0|||
126723012|NCT05142332|455936074|FG001|Overall Study|Withdrawal by Subject|1|||
126486429|NCT00963547|455078217|FG000|Overall Study|Physician Decision|1|||
126486430|NCT00963547|455078218|FG001|Overall Study|Physician Decision|1|||
126486431|NCT00963547|455078219|FG002|Overall Study|Physician Decision|0|||
126486432|NCT00963547|455078220|FG003|Overall Study|Physician Decision|0|||
126486433|NCT00963547|455078221|FG004|Overall Study|Physician Decision|0|||
126486434|NCT00963547|455078222|FG005|Overall Study|Physician Decision|0|||
126486435|NCT00963547|455078223|FG006|Overall Study|Physician Decision|0|||
126486436|NCT00963547|455078217|FG000|Overall Study|Progressive Disease|3|||
126486437|NCT00963547|455078218|FG001|Overall Study|Progressive Disease|8|||
126486438|NCT00963547|455078219|FG002|Overall Study|Progressive Disease|9|||
126486439|NCT00963547|455078220|FG003|Overall Study|Progressive Disease|5|||
126486440|NCT00963547|455078221|FG004|Overall Study|Progressive Disease|0|||
126486441|NCT00963547|455078222|FG005|Overall Study|Progressive Disease|0|||
126486442|NCT00963547|455078223|FG006|Overall Study|Progressive Disease|0|||
126486443|NCT00963547|455078217|FG000|Overall Study|Withdrawal by Subject|0|||
126486444|NCT00963547|455078218|FG001|Overall Study|Withdrawal by Subject|0|||
126486445|NCT00963547|455078219|FG002|Overall Study|Withdrawal by Subject|3|||
126486446|NCT00963547|455078220|FG003|Overall Study|Withdrawal by Subject|0|||
126486447|NCT00963547|455078221|FG004|Overall Study|Withdrawal by Subject|0|||
126486448|NCT00963547|455078222|FG005|Overall Study|Withdrawal by Subject|0|||
126486449|NCT00963547|455078223|FG006|Overall Study|Withdrawal by Subject|0|||
126486450|NCT00963547|455078217|FG000|Overall Study|Reason Unknown|0|||
126486451|NCT00963547|455078218|FG001|Overall Study|Reason Unknown|1|||
126486452|NCT00963547|455078219|FG002|Overall Study|Reason Unknown|0|||
126486453|NCT00963547|455078220|FG003|Overall Study|Reason Unknown|0|||
126486454|NCT00963547|455078221|FG004|Overall Study|Reason Unknown|0|||
126486455|NCT00963547|455078222|FG005|Overall Study|Reason Unknown|0|||
126486456|NCT00963547|455078223|FG006|Overall Study|Reason Unknown|0|||
126486457|NCT00482612|455078230|FG000|In-treatment Period|No study medication administered|0|||
126486458|NCT00482612|455078231|FG001|In-treatment Period|No study medication administered|0|||
126486459|NCT00482612|455078232|FG002|In-treatment Period|No study medication administered|1|||
126486460|NCT00482612|455078233|FG003|In-treatment Period|No study medication administered|0|||
126486461|NCT00482612|455078230|FG000|Follow-up Period|Other|4|||
126486462|NCT00482612|455078231|FG001|Follow-up Period|Other|2|||
126486463|NCT00482612|455078232|FG002|Follow-up Period|Other|1|||
126486464|NCT00482612|455078233|FG003|Follow-up Period|Other|2|||
126486465|NCT00482612|455078230|FG000|Follow-up Period|Lack of compliance|0|||
126486466|NCT00482612|455078231|FG001|Follow-up Period|Lack of compliance|0|||
126486467|NCT00482612|455078232|FG002|Follow-up Period|Lack of compliance|1|||
126486468|NCT00482612|455078233|FG003|Follow-up Period|Lack of compliance|0|||
126486469|NCT00482612|455078230|FG000|Follow-up Period|Lost to Follow-up|0|||
126486470|NCT00482612|455078231|FG001|Follow-up Period|Lost to Follow-up|4|||
126486471|NCT00482612|455078232|FG002|Follow-up Period|Lost to Follow-up|2|||
126486472|NCT00482612|455078233|FG003|Follow-up Period|Lost to Follow-up|1|||
126486473|NCT00482612|455078230|FG000|Follow-up Period|Adverse Event|4|||
126486474|NCT00482612|455078231|FG001|Follow-up Period|Adverse Event|7|||
126486475|NCT00482612|455078232|FG002|Follow-up Period|Adverse Event|9|||
126486476|NCT00482612|455078233|FG003|Follow-up Period|Adverse Event|0|||
126486477|NCT00482612|455078230|FG000|Follow-up Period|Lack of Efficacy|2|||
126486478|NCT00482612|455078231|FG001|Follow-up Period|Lack of Efficacy|0|||
126486479|NCT00482612|455078232|FG002|Follow-up Period|Lack of Efficacy|1|||
126486480|NCT00482612|455078233|FG003|Follow-up Period|Lack of Efficacy|0|||
126486481|NCT00482612|455078230|FG000|Follow-up Period|Withdrawal by Subject|3|||
126486482|NCT00482612|455078231|FG001|Follow-up Period|Withdrawal by Subject|5|||
126486483|NCT00482612|455078232|FG002|Follow-up Period|Withdrawal by Subject|7|||
126486484|NCT00482612|455078233|FG003|Follow-up Period|Withdrawal by Subject|2|||
126486485|NCT00482612|455078230|FG000|Follow-up Period|Reasons not related to trial|1|||
126486486|NCT00482612|455078231|FG001|Follow-up Period|Reasons not related to trial|0|||
126486487|NCT00482612|455078232|FG002|Follow-up Period|Reasons not related to trial|1|||
126486488|NCT00482612|455078233|FG003|Follow-up Period|Reasons not related to trial|3|||
126486489|NCT01366521|455078234|FG000|Overall Study|Adverse Event|1|||
126486490|NCT01366521|455078235|FG001|Overall Study|Adverse Event|0|||
126486491|NCT01366521|455078236|FG002|Overall Study|Adverse Event|0|||
126559358|NCT01256476|455342478|FG000|Overall Study|Adverse Event|2|||
126486492|NCT01366521|455078237|FG003|Overall Study|Adverse Event|0|||
126486493|NCT01366521|455078234|FG000|Overall Study|Protocol Violation|0|||
126486494|NCT01366521|455078235|FG001|Overall Study|Protocol Violation|0|||
126486495|NCT01366521|455078236|FG002|Overall Study|Protocol Violation|1|||
126486496|NCT01366521|455078237|FG003|Overall Study|Protocol Violation|0|||
126486497|NCT01366521|455078234|FG000|Overall Study|Physician Decision|0|||
126486498|NCT01366521|455078235|FG001|Overall Study|Physician Decision|0|||
126486499|NCT01366521|455078236|FG002|Overall Study|Physician Decision|1|||
126486500|NCT01366521|455078237|FG003|Overall Study|Physician Decision|0|||
126486501|NCT01366521|455078234|FG000|Overall Study|Withdrawal by Subject|0|||
126486502|NCT01366521|455078235|FG001|Overall Study|Withdrawal by Subject|1|||
126486503|NCT01366521|455078236|FG002|Overall Study|Withdrawal by Subject|0|||
126486504|NCT01366521|455078237|FG003|Overall Study|Withdrawal by Subject|0|||
126486505|NCT00684307|455078238|FG000|Overall Study|Adverse Event|11|||
126486506|NCT00684307|455078239|FG001|Overall Study|Adverse Event|6|||
126486507|NCT00684307|455078240|FG002|Overall Study|Adverse Event|15|||
126486508|NCT00684307|455078241|FG003|Overall Study|Adverse Event|16|||
126486509|NCT00684307|455078242|FG004|Overall Study|Adverse Event|8|||
126486510|NCT00684307|455078238|FG000|Overall Study|Development of increasing Liver Function|0|||
126486511|NCT00684307|455078239|FG001|Overall Study|Development of increasing Liver Function|2|||
126486512|NCT00684307|455078240|FG002|Overall Study|Development of increasing Liver Function|0|||
126486513|NCT00684307|455078241|FG003|Overall Study|Development of increasing Liver Function|1|||
126486514|NCT00684307|455078242|FG004|Overall Study|Development of increasing Liver Function|0|||
126486515|NCT00684307|455078238|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
126486516|NCT00684307|455078239|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
126486517|NCT00684307|455078240|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
126486518|NCT00684307|455078241|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
126486519|NCT00684307|455078242|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
126486520|NCT00684307|455078238|FG000|Overall Study|Incorrect enrolment or randomization|4|||
126486521|NCT00684307|455078239|FG001|Overall Study|Incorrect enrolment or randomization|0|||
126486522|NCT00684307|455078240|FG002|Overall Study|Incorrect enrolment or randomization|0|||
126486523|NCT00684307|455078241|FG003|Overall Study|Incorrect enrolment or randomization|0|||
126486524|NCT00684307|455078242|FG004|Overall Study|Incorrect enrolment or randomization|0|||
126486525|NCT00684307|455078238|FG000|Overall Study|Interupted IP for more than 7 days|0|||
126486526|NCT00684307|455078239|FG001|Overall Study|Interupted IP for more than 7 days|4|||
126486527|NCT00684307|455078240|FG002|Overall Study|Interupted IP for more than 7 days|1|||
126486528|NCT00684307|455078241|FG003|Overall Study|Interupted IP for more than 7 days|3|||
126486529|NCT00684307|455078242|FG004|Overall Study|Interupted IP for more than 7 days|3|||
126486530|NCT00684307|455078238|FG000|Overall Study|Severe non compliance to protocol|1|||
126486531|NCT00684307|455078239|FG001|Overall Study|Severe non compliance to protocol|0|||
126486532|NCT00684307|455078240|FG002|Overall Study|Severe non compliance to protocol|0|||
126486533|NCT00684307|455078241|FG003|Overall Study|Severe non compliance to protocol|1|||
126486534|NCT00684307|455078242|FG004|Overall Study|Severe non compliance to protocol|2|||
126486535|NCT00684307|455078238|FG000|Overall Study|Participant not willing to continue|7|||
126486536|NCT00684307|455078239|FG001|Overall Study|Participant not willing to continue|10|||
126486537|NCT00684307|455078240|FG002|Overall Study|Participant not willing to continue|11|||
126486538|NCT00684307|455078241|FG003|Overall Study|Participant not willing to continue|5|||
126486539|NCT00684307|455078242|FG004|Overall Study|Participant not willing to continue|8|||
126486540|NCT00684307|455078238|FG000|Overall Study|Criteria from the CSR|0|||
126486541|NCT00684307|455078239|FG001|Overall Study|Criteria from the CSR|0|||
126486542|NCT00684307|455078240|FG002|Overall Study|Criteria from the CSR|1|||
126486543|NCT00684307|455078241|FG003|Overall Study|Criteria from the CSR|3|||
126486544|NCT00684307|455078242|FG004|Overall Study|Criteria from the CSR|3|||
126486545|NCT00660023|455078243|FG000|Overall Study|Adverse Event|2|||
126486546|NCT00660023|455078243|FG000|Overall Study|Death|8|||
126486547|NCT00660023|455078243|FG000|Overall Study|Blood Transfusion|5|||
126486548|NCT00660023|455078243|FG000|Overall Study|Renal Transplantation|3|||
126486549|NCT00660023|455078243|FG000|Overall Study|Withdrawal by Subject|1|||
126486550|NCT00660023|455078243|FG000|Overall Study|Missed Pregnancy Test|1|||
126486551|NCT00660023|455078243|FG000|Overall Study|Other Screening Failure|9|||
126486552|NCT02430311|455078244|FG000|Part A|Adverse Event|0|||
126486553|NCT02430311|455078245|FG001|Part A|Adverse Event|1|||
126486554|NCT02430311|455078244|FG000|Part A|Withdrawal by Subject|1|||
126486555|NCT02430311|455078245|FG001|Part A|Withdrawal by Subject|0|||
126486556|NCT02430311|455078244|FG000|Part B|Meet study-specific withdrawal criteria|6|||
126486557|NCT02430311|455078245|FG001|Part B|Meet study-specific withdrawal criteria|6|||
126486558|NCT02430311|455078244|FG000|Part B|Withdrawal by Subject|2|||
126486559|NCT02430311|455078245|FG001|Part B|Withdrawal by Subject|2|||
126486560|NCT02430311|455078244|FG000|Part B|Adverse Event|1|||
126486561|NCT02430311|455078245|FG001|Part B|Adverse Event|0|||
126486562|NCT02430311|455078244|FG000|Part B|Death|1|||
126486563|NCT02430311|455078245|FG001|Part B|Death|0|||
126486564|NCT04180488|455078246|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
126486565|NCT04180488|455078247|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
126486566|NCT04180488|455078248|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
126486567|NCT04180488|455078249|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
126486568|NCT04180488|455078250|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
126486569|NCT04180488|455078251|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
126486570|NCT04180488|455078246|FG000|Overall Study|Withdrawal by Subject|8|||
126486571|NCT04180488|455078247|FG001|Overall Study|Withdrawal by Subject|4|||
126486572|NCT04180488|455078248|FG002|Overall Study|Withdrawal by Subject|5|||
126486573|NCT04180488|455078249|FG003|Overall Study|Withdrawal by Subject|2|||
126486574|NCT04180488|455078250|FG004|Overall Study|Withdrawal by Subject|8|||
126486575|NCT04180488|455078251|FG005|Overall Study|Withdrawal by Subject|6|||
126486576|NCT04180488|455078246|FG000|Overall Study|Adverse Event|3|||
126486577|NCT04180488|455078247|FG001|Overall Study|Adverse Event|2|||
126486578|NCT04180488|455078248|FG002|Overall Study|Adverse Event|0|||
126486579|NCT04180488|455078249|FG003|Overall Study|Adverse Event|0|||
126486580|NCT04180488|455078250|FG004|Overall Study|Adverse Event|0|||
126486581|NCT04180488|455078251|FG005|Overall Study|Adverse Event|0|||
126486582|NCT04180488|455078246|FG000|Overall Study|Poor compliance to protocol|0|||
126486583|NCT04180488|455078247|FG001|Overall Study|Poor compliance to protocol|0|||
126486584|NCT04180488|455078248|FG002|Overall Study|Poor compliance to protocol|1|||
126486585|NCT04180488|455078249|FG003|Overall Study|Poor compliance to protocol|0|||
126486586|NCT04180488|455078250|FG004|Overall Study|Poor compliance to protocol|0|||
126486587|NCT04180488|455078251|FG005|Overall Study|Poor compliance to protocol|0|||
126486588|NCT03506815|455078252|FG000|Overall Study|Adverse Event|8|||
126486589|NCT03506815|455078253|FG001|Overall Study|Adverse Event|0|||
126486590|NCT03506815|455078252|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
126486591|NCT03506815|455078253|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
126486592|NCT03506815|455078252|FG000|Overall Study|Protocol Violation|1|||
126486593|NCT03506815|455078253|FG001|Overall Study|Protocol Violation|0|||
126486594|NCT03506815|455078252|FG000|Overall Study|Elective Surgery|1|||
126486595|NCT03506815|455078253|FG001|Overall Study|Elective Surgery|0|||
126486596|NCT04160091|455078256|FG000|Overall Study|Terminated by Sponsor|7|||
126486597|NCT04160091|455078257|FG001|Overall Study|Terminated by Sponsor|3|||
126486598|NCT04160091|455078258|FG002|Overall Study|Terminated by Sponsor|5|||
126486599|NCT04160091|455078259|FG003|Overall Study|Terminated by Sponsor|2|||
126486600|NCT04160091|455078256|FG000|Overall Study|Noncompliance|0|||
126486601|NCT04160091|455078257|FG001|Overall Study|Noncompliance|0|||
126486602|NCT04160091|455078258|FG002|Overall Study|Noncompliance|0|||
126486603|NCT04160091|455078259|FG003|Overall Study|Noncompliance|1|||
126486604|NCT04160091|455078256|FG000|Overall Study|Withdrawal by Subject|0|||
126486605|NCT04160091|455078257|FG001|Overall Study|Withdrawal by Subject|0|||
126486606|NCT04160091|455078258|FG002|Overall Study|Withdrawal by Subject|0|||
126486607|NCT04160091|455078259|FG003|Overall Study|Withdrawal by Subject|1|||
126486608|NCT01104493|455078263|FG000|Overall Study|Lost to Follow-up|0|||
126486609|NCT01104493|455078264|FG001|Overall Study|Lost to Follow-up|2|||
126486610|NCT02433483|455078265|FG000|Overall Study|Unacceptable toxicity|1|||
126486611|NCT02433483|455078265|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
126486612|NCT02485301|455078269|FG000|Overall Study|Serious Adverse Events|2|||
126486613|NCT02485301|455078270|FG001|Overall Study|Serious Adverse Events|1|||
126486614|NCT02485301|455078269|FG000|Overall Study|Protocol Violation|0|||
126486615|NCT02485301|455078270|FG001|Overall Study|Protocol Violation|1|||
126486616|NCT02485301|455078269|FG000|Overall Study|Withdrawal by Subject|6|||
126486617|NCT02485301|455078270|FG001|Overall Study|Withdrawal by Subject|7|||
126486618|NCT02485301|455078269|FG000|Overall Study|Migrated/moved from study area|10|||
126486619|NCT02485301|455078270|FG001|Overall Study|Migrated/moved from study area|19|||
126486620|NCT02485301|455078269|FG000|Overall Study|Lost to Follow-up|17|||
126486621|NCT02485301|455078270|FG001|Overall Study|Lost to Follow-up|17|||
126486622|NCT02485301|455078269|FG000|Overall Study|Other|3|||
126486623|NCT02485301|455078270|FG001|Overall Study|Other|4|||
126486624|NCT01059825|455078271|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
126486625|NCT01059825|455078272|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
126486626|NCT01059825|455078273|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
126486627|NCT01059825|455078274|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
126486628|NCT01059825|455078275|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
126486629|NCT01059825|455078276|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
126486630|NCT01059825|455078277|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
126486631|NCT01059825|455078271|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
126486632|NCT01059825|455078272|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
126486633|NCT01059825|455078273|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
126486634|NCT01059825|455078274|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
126486635|NCT01059825|455078275|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
126486636|NCT01059825|455078276|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
126486637|NCT01059825|455078277|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
126723013|NCT05142332|455936075|FG002|Overall Study|Withdrawal by Subject|2|||
126723014|NCT05142332|455936076|FG003|Overall Study|Withdrawal by Subject|0|||
126723015|NCT05142332|455936077|FG004|Overall Study|Withdrawal by Subject|0|||
126723016|NCT05142332|455936078|FG005|Overall Study|Withdrawal by Subject|2|||
126723017|NCT05142332|455936079|FG006|Overall Study|Withdrawal by Subject|6|||
126723018|NCT05142332|455936073|FG000|Overall Study|Left ED|3|||
126486638|NCT01059825|455078271|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
126486639|NCT01059825|455078272|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
126486640|NCT01059825|455078273|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
126486641|NCT01059825|455078274|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
126486642|NCT01059825|455078275|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
126486643|NCT01059825|455078276|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
126486644|NCT01059825|455078277|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
126486645|NCT01059825|455078271|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
126486646|NCT01059825|455078272|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
126486647|NCT01059825|455078273|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
126486648|NCT01059825|455078274|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
126486649|NCT01059825|455078275|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
126486650|NCT01059825|455078276|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
126486651|NCT01059825|455078277|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
126486652|NCT01059825|455078271|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
126486653|NCT01059825|455078272|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
126486654|NCT01059825|455078273|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
126486655|NCT01059825|455078274|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
126486656|NCT01059825|455078275|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
126486657|NCT01059825|455078276|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
126486658|NCT01059825|455078277|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
126486659|NCT01059825|455078271|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
126486660|NCT01059825|455078272|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
126486661|NCT01059825|455078273|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
126486662|NCT01059825|455078274|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
126486663|NCT01059825|455078275|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
126486664|NCT01059825|455078276|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
126486665|NCT01059825|455078277|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
126486666|NCT01059825|455078271|FG000|Treatment Period|Lost to Follow-up|2|||
126486667|NCT01059825|455078272|FG001|Treatment Period|Lost to Follow-up|1|||
126486668|NCT01059825|455078273|FG002|Treatment Period|Lost to Follow-up|0|||
126486669|NCT01059825|455078274|FG003|Treatment Period|Lost to Follow-up|1|||
126486670|NCT01059825|455078275|FG004|Treatment Period|Lost to Follow-up|2|||
126486671|NCT01059825|455078276|FG005|Treatment Period|Lost to Follow-up|0|||
126486672|NCT01059825|455078277|FG006|Treatment Period|Lost to Follow-up|0|||
126486673|NCT01059825|455078271|FG000|Treatment Period|Withdrawal by Subject|3|||
126486674|NCT01059825|455078272|FG001|Treatment Period|Withdrawal by Subject|0|||
126486675|NCT01059825|455078273|FG002|Treatment Period|Withdrawal by Subject|1|||
126486676|NCT01059825|455078274|FG003|Treatment Period|Withdrawal by Subject|5|||
126486677|NCT01059825|455078275|FG004|Treatment Period|Withdrawal by Subject|4|||
126486678|NCT01059825|455078276|FG005|Treatment Period|Withdrawal by Subject|1|||
126486679|NCT01059825|455078277|FG006|Treatment Period|Withdrawal by Subject|0|||
126486680|NCT01059825|455078271|FG000|Treatment Period|Other reason not specified|1|||
126486681|NCT01059825|455078272|FG001|Treatment Period|Other reason not specified|2|||
126486682|NCT01059825|455078273|FG002|Treatment Period|Other reason not specified|1|||
126486683|NCT01059825|455078274|FG003|Treatment Period|Other reason not specified|2|||
126486684|NCT01059825|455078275|FG004|Treatment Period|Other reason not specified|0|||
126486685|NCT01059825|455078276|FG005|Treatment Period|Other reason not specified|0|||
126486686|NCT01059825|455078277|FG006|Treatment Period|Other reason not specified|0|||
126486687|NCT01059825|455078271|FG000|Treatment Period|Protocol Violation|0|||
126486688|NCT01059825|455078272|FG001|Treatment Period|Protocol Violation|0|||
126486689|NCT01059825|455078273|FG002|Treatment Period|Protocol Violation|1|||
126486690|NCT01059825|455078274|FG003|Treatment Period|Protocol Violation|1|||
126486691|NCT01059825|455078275|FG004|Treatment Period|Protocol Violation|1|||
126486692|NCT01059825|455078276|FG005|Treatment Period|Protocol Violation|1|||
126486693|NCT01059825|455078277|FG006|Treatment Period|Protocol Violation|0|||
126486694|NCT01059825|455078271|FG000|Treatment Period|Adverse event related to study drug|1|||
126486695|NCT01059825|455078272|FG001|Treatment Period|Adverse event related to study drug|0|||
126486696|NCT01059825|455078273|FG002|Treatment Period|Adverse event related to study drug|1|||
126486697|NCT01059825|455078274|FG003|Treatment Period|Adverse event related to study drug|1|||
126486698|NCT01059825|455078275|FG004|Treatment Period|Adverse event related to study drug|0|||
126486699|NCT01059825|455078276|FG005|Treatment Period|Adverse event related to study drug|0|||
126486700|NCT01059825|455078277|FG006|Treatment Period|Adverse event related to study drug|0|||
126486701|NCT01059825|455078271|FG000|Treatment Period|Insufficient clinical response|3|||
126486702|NCT01059825|455078272|FG001|Treatment Period|Insufficient clinical response|0|||
126486703|NCT01059825|455078273|FG002|Treatment Period|Insufficient clinical response|0|||
126486704|NCT01059825|455078274|FG003|Treatment Period|Insufficient clinical response|0|||
126486705|NCT01059825|455078275|FG004|Treatment Period|Insufficient clinical response|0|||
126486706|NCT01059825|455078276|FG005|Treatment Period|Insufficient clinical response|0|||
126486707|NCT01059825|455078277|FG006|Treatment Period|Insufficient clinical response|0|||
126486708|NCT01059825|455078271|FG000|Treatment Period|Adverse event not related to study drug|0|||
126486709|NCT01059825|455078272|FG001|Treatment Period|Adverse event not related to study drug|1|||
126486710|NCT01059825|455078273|FG002|Treatment Period|Adverse event not related to study drug|2|||
126486711|NCT01059825|455078274|FG003|Treatment Period|Adverse event not related to study drug|1|||
126486712|NCT01059825|455078275|FG004|Treatment Period|Adverse event not related to study drug|1|||
126486713|NCT01059825|455078276|FG005|Treatment Period|Adverse event not related to study drug|1|||
126486714|NCT01059825|455078277|FG006|Treatment Period|Adverse event not related to study drug|0|||
126559359|NCT01256476|455342479|FG001|Overall Study|Adverse Event|1|||
126486715|NCT03342690|455078278|FG000|Overall Study|Missing Information|9|||
126486716|NCT03342690|455078278|FG000|Overall Study|Protocol Violation|16|||
126486717|NCT00549302|455078281|FG000|Double-Blind|Death|2|||
126486718|NCT00549302|455078282|FG001|Double-Blind|Death|9|||
126486719|NCT00549302|455078283|FG002|Double-Blind|Death|0|||
126486720|NCT00549302|455078281|FG000|Double-Blind|Adverse Event|3|||
126486721|NCT00549302|455078282|FG001|Double-Blind|Adverse Event|16|||
126486722|NCT00549302|455078283|FG002|Double-Blind|Adverse Event|0|||
126486723|NCT00549302|455078281|FG000|Double-Blind|Withdrawal by Subject|3|||
126486724|NCT00549302|455078282|FG001|Double-Blind|Withdrawal by Subject|8|||
126486725|NCT00549302|455078283|FG002|Double-Blind|Withdrawal by Subject|0|||
126486726|NCT00549302|455078281|FG000|Double-Blind|Investigator Decision|1|||
126486727|NCT00549302|455078282|FG001|Double-Blind|Investigator Decision|5|||
126486728|NCT00549302|455078283|FG002|Double-Blind|Investigator Decision|0|||
126486729|NCT00549302|455078281|FG000|Double-Blind|Sponsor Decision|0|||
126486730|NCT00549302|455078282|FG001|Double-Blind|Sponsor Decision|1|||
126486731|NCT00549302|455078283|FG002|Double-Blind|Sponsor Decision|0|||
126486732|NCT00549302|455078281|FG000|Double-Blind|Lost to Follow-up|1|||
126486733|NCT00549302|455078282|FG001|Double-Blind|Lost to Follow-up|2|||
126486734|NCT00549302|455078283|FG002|Double-Blind|Lost to Follow-up|0|||
126486735|NCT00549302|455078281|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
126486736|NCT00549302|455078282|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
126486737|NCT00549302|455078283|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
126486738|NCT00549302|455078281|FG000|Double-Blind|New condition or starts new therapy|0|||
126486739|NCT00549302|455078282|FG001|Double-Blind|New condition or starts new therapy|2|||
126486740|NCT00549302|455078283|FG002|Double-Blind|New condition or starts new therapy|0|||
126486741|NCT00549302|455078281|FG000|Open-Label|Adverse Event|0|||
126486742|NCT00549302|455078282|FG001|Open-Label|Adverse Event|0|||
126486743|NCT00549302|455078283|FG002|Open-Label|Adverse Event|11|||
126486744|NCT00549302|455078281|FG000|Open-Label|Death|0|||
126486745|NCT00549302|455078282|FG001|Open-Label|Death|0|||
126486746|NCT00549302|455078283|FG002|Open-Label|Death|40|||
126486747|NCT00549302|455078281|FG000|Open-Label|Investigator Decision|0|||
126486748|NCT00549302|455078282|FG001|Open-Label|Investigator Decision|0|||
126486749|NCT00549302|455078283|FG002|Open-Label|Investigator Decision|5|||
126486750|NCT00549302|455078281|FG000|Open-Label|Lost to Follow-up|0|||
126486751|NCT00549302|455078282|FG001|Open-Label|Lost to Follow-up|0|||
126486752|NCT00549302|455078283|FG002|Open-Label|Lost to Follow-up|2|||
126486753|NCT00549302|455078281|FG000|Open-Label|Other|0|||
126486754|NCT00549302|455078282|FG001|Open-Label|Other|0|||
126486755|NCT00549302|455078283|FG002|Open-Label|Other|3|||
126486756|NCT00549302|455078281|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
126486757|NCT00549302|455078282|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
126486758|NCT00549302|455078283|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
126486759|NCT00549302|455078281|FG000|Open-Label|Withdrawal by Subject|0|||
126486760|NCT00549302|455078282|FG001|Open-Label|Withdrawal by Subject|0|||
126486761|NCT00549302|455078283|FG002|Open-Label|Withdrawal by Subject|6|||
126486762|NCT03585504|455078284|FG000|Overall Study|Lost to Follow-up|26|||
126486763|NCT03585504|455078285|FG001|Overall Study|Lost to Follow-up|29|||
126486764|NCT01414114|455078286|FG000|Overall Study|Adverse Event|2|||
126486765|NCT01414114|455078286|FG000|Overall Study|Withdrawal by Subject|1|||
126486766|NCT01414114|455078286|FG000|Overall Study|Other|2|||
126486767|NCT00105482|455078287|FG000|Overall Study|Adverse Event|1|||
126486768|NCT00105482|455078288|FG001|Overall Study|Adverse Event|1|||
126486769|NCT00105482|455078287|FG000|Overall Study|Lost to Follow-up|26|||
126486770|NCT00105482|455078288|FG001|Overall Study|Lost to Follow-up|17|||
126486771|NCT00105482|455078287|FG000|Overall Study|Withdrawal by Subject|0|||
126486772|NCT00105482|455078288|FG001|Overall Study|Withdrawal by Subject|1|||
126486773|NCT00105482|455078287|FG000|Overall Study|Lost Interest|29|||
126486774|NCT00105482|455078288|FG001|Overall Study|Lost Interest|32|||
126486775|NCT00105482|455078287|FG000|Overall Study|Scheduling Conflict|2|||
126486776|NCT00105482|455078288|FG001|Overall Study|Scheduling Conflict|3|||
126486777|NCT00105482|455078287|FG000|Overall Study|Withdrawn by PI|1|||
126486778|NCT00105482|455078288|FG001|Overall Study|Withdrawn by PI|1|||
126486779|NCT05620563|455078289|FG000|Overall Study|Adverse Event|3|||
126486780|NCT05620563|455078290|FG001|Overall Study|Adverse Event|1|||
126559360|NCT01256476|455342478|FG000|Overall Study|Withdrawal by Subject|2|||
126486781|NCT05620563|455078289|FG000|Overall Study|Lost to Follow-up|0|||
126486782|NCT05620563|455078290|FG001|Overall Study|Lost to Follow-up|2|||
126486783|NCT05620563|455078289|FG000|Overall Study|Protocol Deviation|1|||
126486784|NCT05620563|455078290|FG001|Overall Study|Protocol Deviation|2|||
126486785|NCT05620563|455078289|FG000|Overall Study|Withdrawal by Subject|3|||
126486786|NCT05620563|455078290|FG001|Overall Study|Withdrawal by Subject|3|||
126486787|NCT05620563|455078289|FG000|Overall Study|Physician Decision|0|||
126486788|NCT05620563|455078290|FG001|Overall Study|Physician Decision|1|||
126486789|NCT00411645|455078296|FG000|Overall Study|Consent Withdrawn|13|||
126559361|NCT01256476|455342479|FG001|Overall Study|Withdrawal by Subject|1|||
126486790|NCT00411645|455078297|FG001|Overall Study|Consent Withdrawn|22|||
126486791|NCT00411645|455078296|FG000|Overall Study|Death|56|||
126486792|NCT00411645|455078297|FG001|Overall Study|Death|135|||
126486793|NCT00411645|455078296|FG000|Overall Study|Investigator/Sponsor Decision|10|||
126486794|NCT00411645|455078297|FG001|Overall Study|Investigator/Sponsor Decision|7|||
126486795|NCT00411645|455078296|FG000|Overall Study|Lost to Follow-up|2|||
126486796|NCT00411645|455078297|FG001|Overall Study|Lost to Follow-up|0|||
126486797|NCT04626297|455078298|FG000|Overall Study|Adverse Event|5|||
126486798|NCT04626297|455078299|FG001|Overall Study|Adverse Event|3|||
126486799|NCT04626297|455078298|FG000|Overall Study|Lost to Follow-up|7|||
126486800|NCT04626297|455078299|FG001|Overall Study|Lost to Follow-up|3|||
126486801|NCT04626297|455078298|FG000|Overall Study|Protocol Violation|5|||
126486802|NCT04626297|455078299|FG001|Overall Study|Protocol Violation|1|||
126486803|NCT04626297|455078298|FG000|Overall Study|Withdrawal by Subject|20|||
126486804|NCT04626297|455078299|FG001|Overall Study|Withdrawal by Subject|6|||
126486805|NCT04626297|455078298|FG000|Overall Study|Sponsor decision|2|||
126486806|NCT04626297|455078299|FG001|Overall Study|Sponsor decision|1|||
126486807|NCT00743340|455078302|FG000|Overall Study|Study medication non-compliance|1|||
126486808|NCT00743340|455078302|FG000|Overall Study|Lost to Follow-up|1|||
126486809|NCT00743340|455078302|FG000|Overall Study|Withdrawal from the Study|5|||
126486810|NCT00743340|455078302|FG000|Overall Study|Protocol Violation|1|||
126486811|NCT00743340|455078302|FG000|Overall Study|Virologic failure|8|||
126486812|NCT00743340|455078302|FG000|Overall Study|Pregnancy|1|||
126486813|NCT00743340|455078302|FG000|Overall Study|Rolled over to other Gilead Study|23|||
126486814|NCT00743340|455078302|FG000|Overall Study|Participant Relocated|1|||
126486815|NCT01425281|455078303|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
126486816|NCT01425281|455078304|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
126486817|NCT01425281|455078303|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
126486818|NCT01425281|455078304|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
126486819|NCT01425281|455078303|FG000|At 180-day Clinical Follow-up|Death|0|||
126486820|NCT01425281|455078304|FG001|At 180-day Clinical Follow-up|Death|1|||
126486821|NCT01425281|455078303|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
126486822|NCT01425281|455078304|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
126486823|NCT01425281|455078303|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
126486824|NCT01425281|455078304|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
126486825|NCT01425281|455078303|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
126486826|NCT01425281|455078304|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
126486827|NCT01425281|455078303|FG000|At 2-year Clinical Follow-up|Death|2|||
126486828|NCT01425281|455078304|FG001|At 2-year Clinical Follow-up|Death|0|||
126486829|NCT01425281|455078303|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
126486830|NCT01425281|455078304|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
126486831|NCT01425281|455078303|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
126486832|NCT01425281|455078304|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
126486833|NCT01425281|455078303|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
126486834|NCT01425281|455078304|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
126486835|NCT01425281|455078303|FG000|At 3-year Clinical Follow-up|Death|2|||
126486836|NCT01425281|455078304|FG001|At 3-year Clinical Follow-up|Death|3|||
126486837|NCT01425281|455078303|FG000|At 4-year Clinical Follow-up|Death|7|||
126486838|NCT01425281|455078304|FG001|At 4-year Clinical Follow-up|Death|3|||
126486839|NCT01425281|455078303|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
126486840|NCT01425281|455078304|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
126486841|NCT01425281|455078303|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
126486842|NCT01425281|455078304|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
126486843|NCT01425281|455078303|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
126486844|NCT01425281|455078304|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
126486845|NCT01425281|455078303|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
126486846|NCT01425281|455078304|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
126486847|NCT01425281|455078303|FG000|At 5-year Clinical Follow-up|Death|2|||
126486848|NCT01425281|455078304|FG001|At 5-year Clinical Follow-up|Death|0|||
126486849|NCT01425281|455078303|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
126486850|NCT01425281|455078304|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
126486851|NCT01425281|455078303|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
126486852|NCT01425281|455078304|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
126486853|NCT01425281|455078303|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
126486854|NCT01425281|455078304|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
126486855|NCT02706691|455078306|FG000|Overall Study|Adverse Event|1|||
126486856|NCT01402492|455078307|FG000|Overall Study|Withdrawal by Subject|17|||
126486857|NCT01402492|455078308|FG001|Overall Study|Withdrawal by Subject|11|||
126486858|NCT01402492|455078309|FG002|Overall Study|Withdrawal by Subject|11|||
126486859|NCT01402492|455078307|FG000|Overall Study|Adverse Event|2|||
126486860|NCT01402492|455078308|FG001|Overall Study|Adverse Event|3|||
126559362|NCT01256476|455342478|FG000|Overall Study|Lost to Follow-up|1|||
126559363|NCT01256476|455342479|FG001|Overall Study|Lost to Follow-up|2|||
126559364|NCT01256476|455342478|FG000|Overall Study|Persistent ALT or AST elevation|1|||
126723019|NCT05142332|455936074|FG001|Overall Study|Left ED|0|||
126723020|NCT05142332|455936075|FG002|Overall Study|Left ED|4|||
126723021|NCT05142332|455936076|FG003|Overall Study|Left ED|6|||
126723022|NCT05142332|455936077|FG004|Overall Study|Left ED|1|||
126486861|NCT01402492|455078309|FG002|Overall Study|Adverse Event|4|||
126486862|NCT01402492|455078307|FG000|Overall Study|Physician Decision|0|||
126486863|NCT01402492|455078308|FG001|Overall Study|Physician Decision|3|||
126486864|NCT01402492|455078309|FG002|Overall Study|Physician Decision|0|||
126486865|NCT01402492|455078307|FG000|Overall Study|Incarcerated (N=3)|2|||
126486866|NCT01402492|455078308|FG001|Overall Study|Incarcerated (N=3)|0|||
126486867|NCT01402492|455078309|FG002|Overall Study|Incarcerated (N=3)|1|||
126486868|NCT03167411|455078310|FG000|Overall Study|Adverse Event|0|||
126486869|NCT03167411|455078311|FG001|Overall Study|Adverse Event|1|||
126486870|NCT02651922|455078315|FG000|Overall Study|due to exclusion criteria|2|||
126486871|NCT00211809|455078318|FG000|Overall Study|Lack of Efficacy|1|||
126486872|NCT00211809|455078318|FG000|Overall Study|Lost to Follow-up|2|||
126486873|NCT00211809|455078318|FG000|Overall Study|Pregnancy|1|||
126486874|NCT00211809|455078318|FG000|Overall Study|side effects|2|||
126486875|NCT04294472|455078319|FG000|Overall Study|Adverse Event|0|||
126486876|NCT04294472|455078320|FG001|Overall Study|Adverse Event|1|||
126486877|NCT04294472|455078321|FG002|Overall Study|Adverse Event|1|||
126486878|NCT04294472|455078319|FG000|Overall Study|Randomized but not treated|0|||
126486879|NCT04294472|455078320|FG001|Overall Study|Randomized but not treated|1|||
126486880|NCT04294472|455078321|FG002|Overall Study|Randomized but not treated|1|||
126486881|NCT01756898|455078325|FG000|Overall Study|Adverse Event|7|||
126723023|NCT05142332|455936078|FG005|Overall Study|Left ED|2|||
126723024|NCT05142332|455936079|FG006|Overall Study|Left ED|6|||
126723025|NCT05142332|455936073|FG000|Overall Study|Physician Decision|0|||
126723026|NCT05142332|455936074|FG001|Overall Study|Physician Decision|0|||
126723027|NCT05142332|455936075|FG002|Overall Study|Physician Decision|2|||
126723028|NCT05142332|455936076|FG003|Overall Study|Physician Decision|1|||
126723029|NCT05142332|455936077|FG004|Overall Study|Physician Decision|0|||
126723030|NCT05142332|455936078|FG005|Overall Study|Physician Decision|0|||
126723031|NCT05142332|455936079|FG006|Overall Study|Physician Decision|3|||
126723032|NCT05142332|455936073|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
126723033|NCT05142332|455936074|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
126723034|NCT05142332|455936075|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
126723035|NCT05142332|455936076|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
126723036|NCT05142332|455936077|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
126723037|NCT05142332|455936078|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
126723038|NCT05142332|455936079|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
126723039|NCT02052778|455936082|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
126723040|NCT02052778|455936083|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
126723041|NCT02052778|455936084|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
126723042|NCT02052778|455936085|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
126723043|NCT02052778|455936086|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
126723044|NCT02052778|455936087|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
126723045|NCT02052778|455936088|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126723046|NCT02052778|455936089|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
126723047|NCT02052778|455936090|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
126723048|NCT02052778|455936091|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
126723049|NCT02052778|455936092|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
126723050|NCT02052778|455936093|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
126723051|NCT02052778|455936094|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
126723052|NCT02052778|455936095|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
126723053|NCT02052778|455936096|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126723054|NCT02052778|455936097|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126723055|NCT02052778|455936098|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126723056|NCT02052778|455936099|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126723057|NCT02052778|455936100|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126723058|NCT02052778|455936101|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126723059|NCT02052778|455936102|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126723060|NCT02052778|455936103|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126723061|NCT02052778|455936104|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
126723062|NCT02052778|455936082|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
126486882|NCT01756898|455078326|FG001|Overall Study|Adverse Event|1|||
126486883|NCT01756898|455078327|FG002|Overall Study|Adverse Event|0|||
126486884|NCT01756898|455078328|FG003|Overall Study|Adverse Event|0|||
126486885|NCT01756898|455078325|FG000|Overall Study|Lack of Efficacy|4|||
126486886|NCT01756898|455078326|FG001|Overall Study|Lack of Efficacy|7|||
126486887|NCT01756898|455078327|FG002|Overall Study|Lack of Efficacy|6|||
126723063|NCT02052778|455936083|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
126723064|NCT02052778|455936084|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
126723065|NCT02052778|455936085|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
126486888|NCT01756898|455078328|FG003|Overall Study|Lack of Efficacy|6|||
126486889|NCT01756898|455078325|FG000|Overall Study|Lost to Follow-up|2|||
126486890|NCT01756898|455078326|FG001|Overall Study|Lost to Follow-up|4|||
126486891|NCT01756898|455078327|FG002|Overall Study|Lost to Follow-up|2|||
126486892|NCT01756898|455078328|FG003|Overall Study|Lost to Follow-up|3|||
126486893|NCT01756898|455078325|FG000|Overall Study|Protocol Violation|1|||
126486894|NCT01756898|455078326|FG001|Overall Study|Protocol Violation|2|||
126486895|NCT01756898|455078327|FG002|Overall Study|Protocol Violation|2|||
126486896|NCT01756898|455078328|FG003|Overall Study|Protocol Violation|1|||
126486897|NCT01756898|455078325|FG000|Overall Study|Withdrew Consent|5|||
126486898|NCT01756898|455078326|FG001|Overall Study|Withdrew Consent|3|||
126486899|NCT01756898|455078327|FG002|Overall Study|Withdrew Consent|5|||
126486900|NCT01756898|455078328|FG003|Overall Study|Withdrew Consent|6|||
126486901|NCT01756898|455078325|FG000|Overall Study|Other|0|||
126486902|NCT01756898|455078326|FG001|Overall Study|Other|2|||
126486903|NCT01756898|455078327|FG002|Overall Study|Other|2|||
126486904|NCT01756898|455078328|FG003|Overall Study|Other|0|||
126486905|NCT01500694|455078329|FG000|Overall Study|Adverse Event|4|||
126486906|NCT01500694|455078330|FG001|Overall Study|Adverse Event|3|||
126486907|NCT01500694|455078329|FG000|Overall Study|Protocol Violation|0|||
126486908|NCT01500694|455078330|FG001|Overall Study|Protocol Violation|1|||
126486909|NCT01500694|455078329|FG000|Overall Study|Withdrawal by Subject|23|||
126486910|NCT01500694|455078330|FG001|Overall Study|Withdrawal by Subject|14|||
126486911|NCT01500694|455078329|FG000|Overall Study|Lost to Follow-up|2|||
126486912|NCT01500694|455078330|FG001|Overall Study|Lost to Follow-up|3|||
126486913|NCT01500694|455078329|FG000|Overall Study|Lack of Efficacy|14|||
126486914|NCT01500694|455078330|FG001|Overall Study|Lack of Efficacy|5|||
126486915|NCT01500694|455078329|FG000|Overall Study|Other|9|||
126486916|NCT01500694|455078330|FG001|Overall Study|Other|3|||
126486917|NCT00496054|455078333|FG000|Overall Study|Adverse Event|1|||
126486918|NCT00496054|455078333|FG000|Overall Study|Lost to Follow-up|7|||
126486919|NCT00471328|455078336|FG000|Core Phase|Adverse Event|18|||
126486920|NCT00471328|455078337|FG001|Core Phase|Adverse Event|6|||
126486921|NCT00471328|455078336|FG000|Core Phase|Death|8|||
126486922|NCT00471328|455078337|FG001|Core Phase|Death|4|||
126486923|NCT00471328|455078336|FG000|Core Phase|Withdrawal by Subject|2|||
126486924|NCT00471328|455078337|FG001|Core Phase|Withdrawal by Subject|2|||
126486925|NCT00471328|455078336|FG000|Core Phase|Abnormal laboratory value|1|||
126486926|NCT00471328|455078337|FG001|Core Phase|Abnormal laboratory value|0|||
126486927|NCT00471328|455078336|FG000|Core Phase|Disease Progression|78|||
126486928|NCT00471328|455078337|FG001|Core Phase|Disease Progression|53|||
126486929|NCT00471328|455078336|FG000|Core Phase|Administrative Problem|0|||
126486930|NCT00471328|455078337|FG001|Core Phase|Administrative Problem|1|||
126486931|NCT00471328|455078336|FG000|Core Phase|Protocol Deviation|0|||
126486932|NCT00471328|455078337|FG001|Core Phase|Protocol Deviation|1|||
126486933|NCT00471328|455078336|FG000|Extension Phase|Adverse Event|3|||
126486934|NCT00471328|455078337|FG001|Extension Phase|Adverse Event|12|||
126486935|NCT00471328|455078336|FG000|Extension Phase|Withdrawal by Subject|0|||
126486936|NCT00471328|455078337|FG001|Extension Phase|Withdrawal by Subject|2|||
126486937|NCT00471328|455078336|FG000|Extension Phase|Death|1|||
126723066|NCT02052778|455936086|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
126723067|NCT02052778|455936087|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
126486938|NCT00471328|455078337|FG001|Extension Phase|Death|7|||
126486939|NCT00471328|455078336|FG000|Extension Phase|Protocol Deviation|3|||
126486940|NCT00471328|455078337|FG001|Extension Phase|Protocol Deviation|1|||
126486941|NCT00471328|455078336|FG000|Extension Phase|Treatment duration as per protocol|0|||
126486942|NCT00471328|455078337|FG001|Extension Phase|Treatment duration as per protocol|1|||
126486943|NCT00471328|455078336|FG000|Extension Phase|Disease Progression|32|||
126486944|NCT00471328|455078337|FG001|Extension Phase|Disease Progression|44|||
126486945|NCT00471328|455078336|FG000|Extension Phase|New cancer Therapy|1|||
126486946|NCT00471328|455078337|FG001|Extension Phase|New cancer Therapy|0|||
126486947|NCT00471328|455078336|FG000|Extension Phase|Administrative Problem|1|||
126486948|NCT00471328|455078337|FG001|Extension Phase|Administrative Problem|0|||
126486949|NCT04051008|455078338|FG000|Overall Study|Withdrawal by Subject|2|||
126486950|NCT04051008|455078339|FG001|Overall Study|Withdrawal by Subject|0|||
126486951|NCT04051008|455078340|FG002|Overall Study|Withdrawal by Subject|1|||
126486952|NCT01605877|455078341|FG000|Overall Study|Withdrawal by Subject|1|||
126486953|NCT00458211|455078342|FG000|Overall Study|Lack of Efficacy|12|||
126486954|NCT00458211|455078342|FG000|Overall Study|Withdrawal by Subject|2|||
126486955|NCT00458211|455078342|FG000|Overall Study|Protocol Violation|2|||
126486956|NCT01482884|455078353|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
126486957|NCT01482884|455078354|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
126486958|NCT01482884|455078353|FG000|Overall Study|Protocol Violation|1|||
126486959|NCT01482884|455078354|FG001|Overall Study|Protocol Violation|0|||
126486960|NCT01482884|455078353|FG000|Overall Study|Lost to Follow-up|2|||
126486961|NCT01482884|455078354|FG001|Overall Study|Lost to Follow-up|2|||
126486962|NCT01482884|455078353|FG000|Overall Study|Lack of Efficacy|0|||
126486963|NCT01482884|455078354|FG001|Overall Study|Lack of Efficacy|1|||
126486964|NCT01482884|455078353|FG000|Overall Study|Adverse Event|2|||
126486965|NCT01482884|455078354|FG001|Overall Study|Adverse Event|1|||
126486966|NCT01482884|455078353|FG000|Overall Study|Withdrawal by Subject|8|||
126486967|NCT01482884|455078354|FG001|Overall Study|Withdrawal by Subject|13|||
126486968|NCT05353985|455078355|FG000|Overall Study|Adverse Event|5|||
126486969|NCT05353985|455078356|FG001|Overall Study|Adverse Event|7|||
126486970|NCT05353985|455078355|FG000|Overall Study|Lost to Follow-up|1|||
126486971|NCT05353985|455078356|FG001|Overall Study|Lost to Follow-up|1|||
126486972|NCT05353985|455078355|FG000|Overall Study|Protocol Violation|1|||
126486973|NCT05353985|455078356|FG001|Overall Study|Protocol Violation|0|||
126486974|NCT05353985|455078355|FG000|Overall Study|Withdrawal by Subject|13|||
126486975|NCT05353985|455078356|FG001|Overall Study|Withdrawal by Subject|17|||
126486976|NCT05353985|455078355|FG000|Overall Study|Reason Not Specified|1|||
126486977|NCT05353985|455078356|FG001|Overall Study|Reason Not Specified|0|||
126486978|NCT05353985|455078355|FG000|Overall Study|Randomized in Error & Not Treated|0|||
126486979|NCT05353985|455078356|FG001|Overall Study|Randomized in Error & Not Treated|1|||
126486980|NCT00996216|455080461|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
126486981|NCT00996216|455080461|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
126486982|NCT00996216|455080461|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
126486983|NCT00793403|455080462|FG000|Overall Study|Other|73|||
126486984|NCT00842712|455080465|FG000|Safety Run-in Part|Adverse Event|0|||
126486985|NCT00842712|455080466|FG001|Safety Run-in Part|Adverse Event|1|||
126486986|NCT00842712|455080467|FG002|Safety Run-in Part|Adverse Event|0|||
126486987|NCT00842712|455080468|FG003|Safety Run-in Part|Adverse Event|0|||
126486988|NCT00842712|455080469|FG004|Safety Run-in Part|Adverse Event|0|||
126559365|NCT01256476|455342479|FG001|Overall Study|Persistent ALT or AST elevation|0|||
126559366|NCT01256476|455342478|FG000|Overall Study|Physician Decision|0|||
126559367|NCT01256476|455342479|FG001|Overall Study|Physician Decision|1|||
126559368|NCT01256476|455342478|FG000|Overall Study|Subject non-compliance|0|||
126559369|NCT01256476|455342479|FG001|Overall Study|Subject non-compliance|1|||
126559370|NCT01256476|455342478|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
126559371|NCT01256476|455342479|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
126559372|NCT02268396|455342483|FG000|Overall Study|Adverse Event|3|||
126559373|NCT02268396|455342483|FG000|Overall Study|Administrative|2|||
126559374|NCT02268396|455342483|FG000|Overall Study|Withdrawal by Subject|1|||
126559375|NCT02268396|455342483|FG000|Overall Study|Lost to Follow-up|2|||
126559376|NCT02268396|455342483|FG000|Overall Study|Protocol-Specified Criteria|2|||
126559377|NCT02268396|455342483|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
126559378|NCT03660943|455342484|FG000|Overall Study|Adverse Event|5|||
126559379|NCT03660943|455342485|FG001|Overall Study|Adverse Event|3|||
126559380|NCT03660943|455342484|FG000|Overall Study|Death|0|||
126559381|NCT03660943|455342485|FG001|Overall Study|Death|2|||
126559382|NCT03660943|455342484|FG000|Overall Study|Lost to Follow-up|7|||
126559383|NCT03660943|455342485|FG001|Overall Study|Lost to Follow-up|3|||
126559384|NCT03660943|455342484|FG000|Overall Study|Protocol Violation|3|||
126559385|NCT03660943|455342485|FG001|Overall Study|Protocol Violation|5|||
126559386|NCT03660943|455342484|FG000|Overall Study|Withdrawal by Subject|8|||
126559387|NCT03660943|455342485|FG001|Overall Study|Withdrawal by Subject|15|||
126559388|NCT03660943|455342484|FG000|Overall Study|Lack of Efficacy|9|||
126559389|NCT03660943|455342485|FG001|Overall Study|Lack of Efficacy|12|||
126559390|NCT03660943|455342484|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
126559391|NCT03660943|455342485|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
126559392|NCT02491411|455342488|FG000|Overall Study|Physician Decision|4|||
126559393|NCT01939158|455342489|FG000|Overall Study|Adverse Event|1|||
126559394|NCT01939158|455342490|FG001|Overall Study|Adverse Event|0|||
126559395|NCT01939158|455342491|FG002|Overall Study|Adverse Event|0|||
126559396|NCT01939158|455342492|FG003|Overall Study|Adverse Event|0|||
126559397|NCT01939158|455342489|FG000|Overall Study|Withdrawal by Subject|22|||
126559398|NCT01939158|455342490|FG001|Overall Study|Withdrawal by Subject|25|||
126559399|NCT01939158|455342491|FG002|Overall Study|Withdrawal by Subject|15|||
126559400|NCT01939158|455342492|FG003|Overall Study|Withdrawal by Subject|17|||
126723068|NCT02052778|455936088|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
126723069|NCT02052778|455936089|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
126723070|NCT02052778|455936090|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
126486989|NCT00842712|455080470|FG005|Safety Run-in Part|Adverse Event|0|||
126486990|NCT00842712|455080471|FG006|Safety Run-in Part|Adverse Event|0|||
126486991|NCT00842712|455080465|FG000|Safety Run-in Part|Progressive disease|3|||
126486992|NCT00842712|455080466|FG001|Safety Run-in Part|Progressive disease|1|||
126486993|NCT00842712|455080467|FG002|Safety Run-in Part|Progressive disease|0|||
126559401|NCT01939158|455342489|FG000|Overall Study|Migrated/moved from study area|5|||
126559402|NCT01939158|455342490|FG001|Overall Study|Migrated/moved from study area|7|||
126486994|NCT00842712|455080468|FG003|Safety Run-in Part|Progressive disease|1|||
126723071|NCT02052778|455936091|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126723072|NCT02052778|455936092|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126723073|NCT02052778|455936093|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
126723074|NCT02052778|455936094|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
126723075|NCT02052778|455936095|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
126723076|NCT02052778|455936096|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126723077|NCT02052778|455936097|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126486995|NCT00842712|455080469|FG004|Safety Run-in Part|Progressive disease|0|||
126723078|NCT02052778|455936098|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126723079|NCT02052778|455936099|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126723080|NCT02052778|455936100|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126723081|NCT02052778|455936101|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126723082|NCT02052778|455936102|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126723083|NCT02052778|455936103|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126723084|NCT02052778|455936104|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
126723085|NCT02052778|455936082|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126772595|NCT02454972|456123634|FG005|Overall Study|Progressive disease|12|||
126486996|NCT00842712|455080470|FG005|Safety Run-in Part|Progressive disease|0|||
126486997|NCT00842712|455080471|FG006|Safety Run-in Part|Progressive disease|0|||
126486998|NCT00842712|455080465|FG000|Randomized Part|Randomized but not treated|0|||
126486999|NCT00842712|455080466|FG001|Randomized Part|Randomized but not treated|0|||
126487000|NCT00842712|455080467|FG002|Randomized Part|Randomized but not treated|0|||
126487001|NCT00842712|455080468|FG003|Randomized Part|Randomized but not treated|0|||
126487002|NCT00842712|455080469|FG004|Randomized Part|Randomized but not treated|0|||
126487003|NCT00842712|455080470|FG005|Randomized Part|Randomized but not treated|1|||
126487004|NCT00842712|455080471|FG006|Randomized Part|Randomized but not treated|4|||
126487005|NCT00842712|455080465|FG000|Randomized Part|Ongoing at cut-off date|0|||
126487006|NCT00842712|455080466|FG001|Randomized Part|Ongoing at cut-off date|0|||
126487007|NCT00842712|455080467|FG002|Randomized Part|Ongoing at cut-off date|0|||
126487008|NCT00842712|455080468|FG003|Randomized Part|Ongoing at cut-off date|0|||
126487009|NCT00842712|455080469|FG004|Randomized Part|Ongoing at cut-off date|0|||
126487010|NCT00842712|455080470|FG005|Randomized Part|Ongoing at cut-off date|0|||
126487011|NCT00842712|455080471|FG006|Randomized Part|Ongoing at cut-off date|2|||
126487012|NCT00085631|455080475|FG000|Overall Study|Missing Data|4|||
126487013|NCT00085631|455080476|FG001|Overall Study|Missing Data|11|||
126487014|NCT00085631|455080477|FG002|Overall Study|Missing Data|7|||
126487015|NCT00779467|455080478|FG000|Overall Study|Lack of Efficacy|11|||
126487016|NCT00779467|455080479|FG001|Overall Study|Lack of Efficacy|2|||
126487017|NCT00779467|455080480|FG002|Overall Study|Lack of Efficacy|6|||
126487018|NCT00779467|455080481|FG003|Overall Study|Lack of Efficacy|11|||
126487019|NCT00779467|455080478|FG000|Overall Study|failed inclusion criteria|3|||
126487020|NCT00779467|455080479|FG001|Overall Study|failed inclusion criteria|3|||
126487021|NCT00779467|455080480|FG002|Overall Study|failed inclusion criteria|1|||
126487022|NCT00779467|455080481|FG003|Overall Study|failed inclusion criteria|2|||
126487023|NCT00779467|455080478|FG000|Overall Study|missing data|1|||
126487024|NCT00779467|455080479|FG001|Overall Study|missing data|0|||
126487025|NCT00779467|455080480|FG002|Overall Study|missing data|1|||
126487026|NCT00779467|455080481|FG003|Overall Study|missing data|4|||
126487027|NCT00779467|455080478|FG000|Overall Study|technical issue|0|||
126487028|NCT00779467|455080479|FG001|Overall Study|technical issue|0|||
126487029|NCT00779467|455080480|FG002|Overall Study|technical issue|2|||
126487030|NCT00779467|455080481|FG003|Overall Study|technical issue|1|||
126487031|NCT00779467|455080478|FG000|Overall Study|unavailable research staff|0|||
126487032|NCT00779467|455080479|FG001|Overall Study|unavailable research staff|0|||
126487033|NCT00779467|455080480|FG002|Overall Study|unavailable research staff|0|||
126487034|NCT00779467|455080481|FG003|Overall Study|unavailable research staff|1|||
126487035|NCT04118166|455080484|FG000|Overall Study|Adverse Event|1|||
126487036|NCT03521934|455080491|FG000|Overall Study|Death|65|||
126487037|NCT03521934|455080492|FG001|Overall Study|Death|73|||
126487038|NCT03521934|455080491|FG000|Overall Study|Withdrawal by Subject|18|||
126487039|NCT03521934|455080492|FG001|Overall Study|Withdrawal by Subject|23|||
126487040|NCT03521934|455080491|FG000|Overall Study|Site Terminated by Sponsor|39|||
126487041|NCT03521934|455080492|FG001|Overall Study|Site Terminated by Sponsor|35|||
126487042|NCT03521934|455080491|FG000|Overall Study|Study Terminated by Sponsor|483|||
126487043|NCT03521934|455080492|FG001|Overall Study|Study Terminated by Sponsor|477|||
126487044|NCT03521934|455080491|FG000|Overall Study|Reason not Specified|3|||
126487045|NCT03521934|455080492|FG001|Overall Study|Reason not Specified|6|||
126487046|NCT05048784|455080493|FG000|Period 1|Adverse Event|3|||
126487047|NCT05048784|455080494|FG001|Period 1|Adverse Event|1|||
126487048|NCT05048784|455080495|FG002|Period 1|Adverse Event|0|||
126487049|NCT05048784|455080496|FG003|Period 1|Adverse Event|0|||
126487050|NCT05048784|455080493|FG000|Period 2|Lost to Follow-up|0|||
126723086|NCT02052778|455936083|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723087|NCT02052778|455936084|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723088|NCT02052778|455936085|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723089|NCT02052778|455936086|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723090|NCT02052778|455936087|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723091|NCT02052778|455936088|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723092|NCT02052778|455936089|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126487051|NCT05048784|455080494|FG001|Period 2|Lost to Follow-up|1|||
126487052|NCT05048784|455080495|FG002|Period 2|Lost to Follow-up|0|||
126487053|NCT05048784|455080496|FG003|Period 2|Lost to Follow-up|0|||
126487054|NCT00885105|455080497|FG000|Overall Study|Withdrawal by Subject|0|||
126723093|NCT02052778|455936090|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126487055|NCT00885105|455080498|FG001|Overall Study|Withdrawal by Subject|8|||
126487056|NCT00885105|455080497|FG000|Overall Study|Adverse Event|1|||
126487057|NCT00885105|455080498|FG001|Overall Study|Adverse Event|0|||
126487058|NCT00885105|455080497|FG000|Overall Study|Protocol Violation|0|||
126487059|NCT00885105|455080498|FG001|Overall Study|Protocol Violation|2|||
126487060|NCT03020160|455080499|FG000|Overall Study|Withdrawal by Subject|1|||
126487061|NCT03020160|455080500|FG001|Overall Study|Withdrawal by Subject|0|||
126487062|NCT01513473|455080501|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
126487063|NCT01513473|455080502|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
126487064|NCT01513473|455080501|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
126487065|NCT01513473|455080502|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
126487066|NCT01513473|455080501|FG000|Main Trial (26 Weeks)|Unclassified|0|||
126487067|NCT01513473|455080502|FG001|Main Trial (26 Weeks)|Unclassified|2|||
126487068|NCT01513473|455080501|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
126487069|NCT01513473|455080502|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
126487070|NCT01513473|455080501|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
126487071|NCT01513473|455080502|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
126487072|NCT00284050|455080503|FG000|Overall Study|Adverse Event|1|||
126487073|NCT00284050|455080504|FG001|Overall Study|Adverse Event|1|||
126487074|NCT00284050|455080505|FG002|Overall Study|Adverse Event|1|||
126487075|NCT00284050|455080503|FG000|Overall Study|Lack of Efficacy|0|||
126487076|NCT00284050|455080504|FG001|Overall Study|Lack of Efficacy|1|||
126487077|NCT00284050|455080505|FG002|Overall Study|Lack of Efficacy|3|||
126487078|NCT00284050|455080503|FG000|Overall Study|Protocol Violation|0|||
126487079|NCT00284050|455080504|FG001|Overall Study|Protocol Violation|1|||
126487080|NCT00284050|455080505|FG002|Overall Study|Protocol Violation|2|||
126487081|NCT00284050|455080503|FG000|Overall Study|Withdrawal by Subject|2|||
126487082|NCT00284050|455080504|FG001|Overall Study|Withdrawal by Subject|2|||
126487083|NCT00284050|455080505|FG002|Overall Study|Withdrawal by Subject|2|||
126487084|NCT00284050|455080503|FG000|Overall Study|Lost to Follow-up|1|||
126487085|NCT00284050|455080504|FG001|Overall Study|Lost to Follow-up|0|||
126487086|NCT00284050|455080505|FG002|Overall Study|Lost to Follow-up|1|||
126487087|NCT00284050|455080503|FG000|Overall Study|Death|1|||
126487088|NCT00284050|455080504|FG001|Overall Study|Death|0|||
126487089|NCT00284050|455080505|FG002|Overall Study|Death|0|||
126487090|NCT02708121|455080506|FG000|Overall Study|Withdrawn by Study Team|1|||
126487091|NCT02708121|455080507|FG001|Overall Study|Withdrawn by Study Team|1|||
126487092|NCT02708121|455080506|FG000|Overall Study|Withdrawal by Subject|0|||
126487093|NCT02708121|455080507|FG001|Overall Study|Withdrawal by Subject|4|||
126487094|NCT01833520|455080512|FG000|Overall Study|Lack of Efficacy|3|||
126487095|NCT01833520|455080513|FG001|Overall Study|Lack of Efficacy|3|||
126487096|NCT01833520|455080514|FG002|Overall Study|Lack of Efficacy|8|||
126487097|NCT01833520|455080515|FG003|Overall Study|Lack of Efficacy|3|||
126487098|NCT02743520|455080516|FG000|Overall Study|Withdrawal by Subject|1|||
126487099|NCT01749514|455080517|FG000|Overall Study|Lost to Follow-up|0|||
126487100|NCT01749514|455080518|FG001|Overall Study|Lost to Follow-up|0|||
126487101|NCT01749514|455080519|FG002|Overall Study|Lost to Follow-up|0|||
126487102|NCT01749514|455080520|FG003|Overall Study|Lost to Follow-up|0|||
126487103|NCT01749514|455080521|FG004|Overall Study|Lost to Follow-up|0|||
126487104|NCT01749514|455080522|FG005|Overall Study|Lost to Follow-up|0|||
126487105|NCT01749514|455080523|FG006|Overall Study|Lost to Follow-up|0|||
126723094|NCT02052778|455936091|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126487106|NCT01749514|455080524|FG007|Overall Study|Lost to Follow-up|1|||
126487107|NCT01749514|455080517|FG000|Overall Study|Withdrawal by Subject|0|||
126487108|NCT01749514|455080518|FG001|Overall Study|Withdrawal by Subject|0|||
126487109|NCT01749514|455080519|FG002|Overall Study|Withdrawal by Subject|0|||
126487110|NCT01749514|455080520|FG003|Overall Study|Withdrawal by Subject|0|||
126487111|NCT01749514|455080521|FG004|Overall Study|Withdrawal by Subject|0|||
126487112|NCT01749514|455080522|FG005|Overall Study|Withdrawal by Subject|1|||
126487113|NCT01749514|455080523|FG006|Overall Study|Withdrawal by Subject|0|||
126487114|NCT01749514|455080524|FG007|Overall Study|Withdrawal by Subject|1|||
126487115|NCT01749514|455080517|FG000|Overall Study|Not Reported|0|||
126487116|NCT01749514|455080518|FG001|Overall Study|Not Reported|0|||
126487117|NCT01749514|455080519|FG002|Overall Study|Not Reported|0|||
126487118|NCT01749514|455080520|FG003|Overall Study|Not Reported|0|||
126487119|NCT01749514|455080521|FG004|Overall Study|Not Reported|0|||
126487120|NCT01749514|455080522|FG005|Overall Study|Not Reported|0|||
126487121|NCT01749514|455080523|FG006|Overall Study|Not Reported|0|||
126487122|NCT01749514|455080524|FG007|Overall Study|Not Reported|5|||
126487123|NCT00938639|455080526|FG000|Overall Study|Moved away from study area|0|||
126487124|NCT00938639|455080527|FG001|Overall Study|Moved away from study area|1|||
126487125|NCT00938639|455080526|FG000|Overall Study|Lost to Follow-up|1|||
126487126|NCT00938639|455080527|FG001|Overall Study|Lost to Follow-up|2|||
126487127|NCT00938639|455080526|FG000|Overall Study|Family issues|1|||
126487128|NCT00938639|455080527|FG001|Overall Study|Family issues|1|||
126487129|NCT00938639|455080526|FG000|Overall Study|Participant noncompliance|1|||
126487130|NCT00938639|455080527|FG001|Overall Study|Participant noncompliance|0|||
126487131|NCT02509156|455080530|FG000|Randomized Phase|Death|1|||
126487132|NCT02509156|455080531|FG001|Randomized Phase|Death|0|||
126487133|NCT02509156|455080530|FG000|Randomized Phase|Withdrawal by Subject|1|||
126487134|NCT02509156|455080531|FG001|Randomized Phase|Withdrawal by Subject|1|||
126487135|NCT02547649|455080532|FG000|Overall Study|Lost to Follow-up|3|||
126487136|NCT02547649|455080533|FG001|Overall Study|Lost to Follow-up|1|||
126487137|NCT02547649|455080534|FG002|Overall Study|Lost to Follow-up|1|||
126487138|NCT02547649|455080532|FG000|Overall Study|Not vaccinated|0|||
126487139|NCT02547649|455080533|FG001|Overall Study|Not vaccinated|0|||
126487140|NCT02547649|455080534|FG002|Overall Study|Not vaccinated|1|||
126487141|NCT02547649|455080532|FG000|Overall Study|Withdrawal by Subject|0|||
126487142|NCT02547649|455080533|FG001|Overall Study|Withdrawal by Subject|4|||
126487143|NCT02547649|455080534|FG002|Overall Study|Withdrawal by Subject|2|||
126487144|NCT04326231|455080535|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
126487145|NCT01750242|455080540|FG000|Overall Study|Unreadable Images|3|||
126487146|NCT01484197|455080543|FG000|Treatment Period 1|Adverse Event|1|||
126487147|NCT01484197|455080544|FG001|Treatment Period 1|Adverse Event|0|||
126487148|NCT01484197|455080545|FG002|Treatment Period 1|Adverse Event|0|||
126487149|NCT01484197|455080546|FG003|Treatment Period 1|Adverse Event|0|||
126487150|NCT01484197|455080543|FG000|Treatment Period 2|Subject withdrew consent|0|||
126487151|NCT01484197|455080544|FG001|Treatment Period 2|Subject withdrew consent|0|||
126487152|NCT01484197|455080545|FG002|Treatment Period 2|Subject withdrew consent|0|||
126487153|NCT01484197|455080546|FG003|Treatment Period 2|Subject withdrew consent|1|||
126487154|NCT01678911|455080556|FG000|Second Intervention|Lost to Follow-up|2|||
126487155|NCT01678911|455080557|FG001|Second Intervention|Lost to Follow-up|0|||
126487156|NCT01980992|455080558|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
126487157|NCT01980992|455080559|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
126487158|NCT01980992|455080558|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
126487159|NCT01980992|455080559|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
126487160|NCT01980992|455080558|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
126487161|NCT01980992|455080559|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
126487162|NCT01980992|455080558|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
126487163|NCT01980992|455080559|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
126487164|NCT01980992|455080558|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
126487165|NCT01980992|455080559|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
126487166|NCT01980992|455080558|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
126487167|NCT01980992|455080559|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
126487168|NCT01366209|455080564|FG000|Overall Study|Adverse Event|6|||
126487169|NCT01366209|455080565|FG001|Overall Study|Adverse Event|7|||
126487170|NCT01366209|455080564|FG000|Overall Study|Withdrawal by Subject|4|||
126487171|NCT01366209|455080565|FG001|Overall Study|Withdrawal by Subject|4|||
126487172|NCT01366209|455080564|FG000|Overall Study|Death|12|||
126487173|NCT01366209|455080565|FG001|Overall Study|Death|19|||
126487174|NCT01366209|455080564|FG000|Overall Study|Lung transplantation|6|||
126487175|NCT01366209|455080565|FG001|Overall Study|Lung transplantation|1|||
126487176|NCT01366209|455080564|FG000|Overall Study|Lost to Follow-up|2|||
126487177|NCT01366209|455080565|FG001|Overall Study|Lost to Follow-up|1|||
126487178|NCT01366209|455080564|FG000|Overall Study|Physician Decision|1|||
126487179|NCT01366209|455080565|FG001|Overall Study|Physician Decision|0|||
126487180|NCT01366209|455080564|FG000|Overall Study|Sponsors decision|0|||
126487181|NCT01366209|455080565|FG001|Overall Study|Sponsors decision|1|||
126487182|NCT01366209|455080564|FG000|Overall Study|Withdrew consent|4|||
126487183|NCT01366209|455080565|FG001|Overall Study|Withdrew consent|3|||
126487184|NCT02670837|455080566|FG000|Overall Study|Death|2|||
126487185|NCT02670837|455080567|FG001|Overall Study|Death|0|||
126487186|NCT02670837|455080568|FG002|Overall Study|Death|0|||
126487187|NCT01985867|455080569|FG000|Overall Study|Lost to Follow-up|3|||
126487188|NCT01985867|455080570|FG001|Overall Study|Lost to Follow-up|4|||
126487189|NCT01985867|455080569|FG000|Overall Study|Adverse Event|3|||
126487190|NCT01985867|455080570|FG001|Overall Study|Adverse Event|2|||
126487191|NCT01985867|455080569|FG000|Overall Study|Lack of Efficacy|1|||
126487192|NCT01985867|455080570|FG001|Overall Study|Lack of Efficacy|0|||
126487193|NCT02859454|455080573|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
126487194|NCT01025752|455080574|FG000|Overall Study|Lost to Follow-up|7|||
126487195|NCT01025752|455080575|FG001|Overall Study|Lost to Follow-up|10|||
126487196|NCT01025752|455080574|FG000|Overall Study|Physician Decision|1|||
126487197|NCT01025752|455080575|FG001|Overall Study|Physician Decision|3|||
126487198|NCT01417234|455080578|FG000|Overall Study|Subject non-compliant|3|||
126487199|NCT00023764|455080579|FG000|Overall Study|Other|1|||
126487200|NCT00023764|455080579|FG000|Overall Study|Adverse Event|4|||
126487201|NCT00023764|455080579|FG000|Overall Study|Withdrawal by Subject|1|||
126487202|NCT00023764|455080579|FG000|Overall Study|Progression of disease|6|||
126487203|NCT00023764|455080579|FG000|Overall Study|patient received other treatment|1|||
126487204|NCT00023764|455080579|FG000|Overall Study|delay in obtaining staging images|1|||
126487205|NCT02603419|455080584|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
126487206|NCT02603419|455080585|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
126487207|NCT02603419|455080586|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
126487208|NCT02603419|455080587|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
126487209|NCT02603419|455080588|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
126487210|NCT02603419|455080589|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
126487211|NCT02603419|455080584|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
126487212|NCT02603419|455080585|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
126487213|NCT02603419|455080586|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
126487214|NCT02603419|455080587|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
126487215|NCT02603419|455080588|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
126487216|NCT02603419|455080589|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
126487217|NCT02603419|455080584|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
126487218|NCT02603419|455080585|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
126487219|NCT02603419|455080586|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
126487220|NCT02603419|455080587|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
126487221|NCT02603419|455080588|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
126487222|NCT02603419|455080589|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
126487223|NCT02603419|455080584|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
126487224|NCT02603419|455080585|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
126487225|NCT02603419|455080586|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
126487226|NCT02603419|455080587|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
126487227|NCT02603419|455080588|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
126487228|NCT02603419|455080589|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
126487229|NCT02603419|455080584|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
126487230|NCT02603419|455080585|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
126487231|NCT02603419|455080586|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
126487232|NCT02603419|455080587|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
126487233|NCT02603419|455080588|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
126487234|NCT02603419|455080589|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
126559403|NCT01939158|455342491|FG002|Overall Study|Migrated/moved from study area|3|||
126559404|NCT01939158|455342492|FG003|Overall Study|Migrated/moved from study area|6|||
126559405|NCT01939158|455342489|FG000|Overall Study|Lost to Follow-up|18|||
126559406|NCT01939158|455342490|FG001|Overall Study|Lost to Follow-up|17|||
126559407|NCT01939158|455342491|FG002|Overall Study|Lost to Follow-up|17|||
126487235|NCT02603419|455080584|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
126487236|NCT02603419|455080585|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
126487237|NCT02603419|455080586|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
126487238|NCT02603419|455080587|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
126487239|NCT02603419|455080588|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
126487240|NCT02603419|455080589|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
126487241|NCT02603419|455080584|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
126487242|NCT02603419|455080585|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
126487243|NCT02603419|455080586|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
126487244|NCT02603419|455080587|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
126487245|NCT02603419|455080588|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
126487246|NCT02603419|455080589|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
126487247|NCT02603419|455080584|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
126487248|NCT02603419|455080585|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
126487249|NCT02603419|455080586|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
126487250|NCT02603419|455080587|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
126487251|NCT02603419|455080588|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
126559408|NCT01939158|455342492|FG003|Overall Study|Lost to Follow-up|17|||
126723095|NCT02052778|455936092|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126487252|NCT02603419|455080589|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
126487253|NCT02603419|455080584|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
126487254|NCT02603419|455080585|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
126487255|NCT02603419|455080586|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
126487256|NCT02603419|455080587|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
126487257|NCT02603419|455080588|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
126487258|NCT02603419|455080589|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
126487259|NCT02603419|455080584|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
126487260|NCT02603419|455080585|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
126487261|NCT02603419|455080586|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
126487262|NCT02603419|455080587|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
126487263|NCT02603419|455080588|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
126487264|NCT02603419|455080589|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
126487265|NCT02289417|455080591|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
126487266|NCT02289417|455080592|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
126487267|NCT02289417|455080593|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
126487268|NCT02289417|455080594|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
126487269|NCT02289417|455080595|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
126487270|NCT02289417|455080596|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
126487271|NCT02289417|455080597|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
126487272|NCT02289417|455080598|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
126487273|NCT02289417|455080599|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
126487274|NCT02289417|455080591|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
126487275|NCT02289417|455080592|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
126487276|NCT02289417|455080593|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
126487277|NCT02289417|455080594|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
126487278|NCT02289417|455080595|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
126487279|NCT02289417|455080596|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
126487280|NCT02289417|455080597|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
126487281|NCT02289417|455080598|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
126487282|NCT02289417|455080599|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
126487283|NCT02289417|455080591|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
126487284|NCT02289417|455080592|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
126487285|NCT02289417|455080593|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
126487286|NCT02289417|455080594|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
126487287|NCT02289417|455080595|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
126487288|NCT02289417|455080596|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
126487289|NCT02289417|455080597|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
126487290|NCT02289417|455080598|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
126487291|NCT02289417|455080599|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
126487292|NCT02289417|455080591|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
126487293|NCT02289417|455080592|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
126487294|NCT02289417|455080593|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
126487295|NCT02289417|455080594|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
126487296|NCT02289417|455080595|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
126487297|NCT02289417|455080596|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
126487298|NCT02289417|455080597|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
126487299|NCT02289417|455080598|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
126487300|NCT02289417|455080599|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
126487301|NCT02289417|455080591|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
126487302|NCT02289417|455080592|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
126487303|NCT02289417|455080593|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
126487304|NCT02289417|455080594|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
126487305|NCT02289417|455080595|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
126487306|NCT02289417|455080596|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
126487307|NCT02289417|455080597|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
126487308|NCT02289417|455080598|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
126487309|NCT02289417|455080599|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
126487310|NCT02289417|455080591|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
126559409|NCT01939158|455342489|FG000|Overall Study|Death|0|||
126487311|NCT02289417|455080592|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
126487312|NCT02289417|455080593|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
126487313|NCT02289417|455080594|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
126487314|NCT02289417|455080595|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
126487315|NCT02289417|455080596|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
126487316|NCT02289417|455080597|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
126487317|NCT02289417|455080598|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
126487318|NCT02289417|455080599|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
126487319|NCT02289417|455080591|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
126559410|NCT01939158|455342490|FG001|Overall Study|Death|0|||
126487320|NCT02289417|455080592|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
126487321|NCT02289417|455080593|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
126487322|NCT02289417|455080594|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
126487323|NCT02289417|455080595|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
126487324|NCT02289417|455080596|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
126487325|NCT02289417|455080597|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
126487326|NCT02289417|455080598|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
126487327|NCT02289417|455080599|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
126487328|NCT02289417|455080591|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
126487329|NCT02289417|455080592|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
126487330|NCT02289417|455080593|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
126487331|NCT02289417|455080594|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
126487332|NCT02289417|455080595|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
126487333|NCT02289417|455080596|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
126487334|NCT02289417|455080597|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
126487335|NCT02289417|455080598|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
126487336|NCT02289417|455080599|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
126487337|NCT02289417|455080591|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
126487338|NCT02289417|455080592|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
126487339|NCT02289417|455080593|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
126487340|NCT02289417|455080594|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
126487341|NCT02289417|455080595|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
126487342|NCT02289417|455080596|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
126487343|NCT02289417|455080597|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
126487344|NCT02289417|455080598|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
126487345|NCT02289417|455080599|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
126487346|NCT02289417|455080591|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
126487347|NCT02289417|455080592|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
126487348|NCT02289417|455080593|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
126487349|NCT02289417|455080594|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
126487350|NCT02289417|455080595|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
126487351|NCT02289417|455080596|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
126487352|NCT02289417|455080597|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
126487353|NCT02289417|455080598|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
126487354|NCT02289417|455080599|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
126487355|NCT02289417|455080591|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
126487356|NCT02289417|455080592|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
126487357|NCT02289417|455080593|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
126487358|NCT02289417|455080594|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
126487359|NCT02289417|455080595|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
126487360|NCT02289417|455080596|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
126487361|NCT02289417|455080597|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
126487362|NCT02289417|455080598|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
126487363|NCT02289417|455080599|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
126487364|NCT02289417|455080591|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
126487365|NCT02289417|455080592|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
126487366|NCT02289417|455080593|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
126487367|NCT02289417|455080594|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
126487368|NCT02289417|455080595|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
126487369|NCT02289417|455080596|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
126487370|NCT02289417|455080597|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
126487371|NCT02289417|455080598|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
126487372|NCT02289417|455080599|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
126487373|NCT02289417|455080591|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
126487374|NCT02289417|455080592|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
126487375|NCT02289417|455080593|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
126487376|NCT02289417|455080594|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
126487377|NCT02289417|455080595|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
126487378|NCT02289417|455080596|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
126487379|NCT02289417|455080597|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
126487380|NCT02289417|455080598|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
126487381|NCT02289417|455080599|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
126487382|NCT02289417|455080591|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
126487383|NCT02289417|455080592|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
126487384|NCT02289417|455080593|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
126487385|NCT02289417|455080594|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
126487386|NCT02289417|455080595|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
126487387|NCT02289417|455080596|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
126487388|NCT02289417|455080597|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
126487389|NCT02289417|455080598|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
126487390|NCT02289417|455080599|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
126487391|NCT04786990|455080600|FG000|Overall Study|Withdrawal by Subject|1|||
126487392|NCT04786990|455080600|FG000|Overall Study|Adverse Event|1|||
126487393|NCT04786990|455080600|FG000|Overall Study|Lost to Follow-up|1|||
126487394|NCT04786990|455080600|FG000|Overall Study|Noncompliance|1|||
126487395|NCT04786990|455080600|FG000|Overall Study|Unable to complete site visits|1|||
126487396|NCT04786990|455080600|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
126487397|NCT01782222|455080603|FG000|Overall Study|Adverse Event|4|||
126487398|NCT01782222|455080604|FG001|Overall Study|Adverse Event|5|||
126487399|NCT01782222|455080605|FG002|Overall Study|Adverse Event|3|||
126487400|NCT01782222|455080603|FG000|Overall Study|Lack of Efficacy|2|||
126487401|NCT01782222|455080604|FG001|Overall Study|Lack of Efficacy|1|||
126487402|NCT01782222|455080605|FG002|Overall Study|Lack of Efficacy|0|||
126487403|NCT01782222|455080603|FG000|Overall Study|Protocol Violation|1|||
126487404|NCT01782222|455080604|FG001|Overall Study|Protocol Violation|0|||
126487405|NCT01782222|455080605|FG002|Overall Study|Protocol Violation|0|||
126487406|NCT01782222|455080603|FG000|Overall Study|Withdrawal by Subject|1|||
126487407|NCT01782222|455080604|FG001|Overall Study|Withdrawal by Subject|4|||
126487408|NCT01782222|455080605|FG002|Overall Study|Withdrawal by Subject|1|||
126487409|NCT01782222|455080603|FG000|Overall Study|Moved to other state|0|||
126487410|NCT01782222|455080604|FG001|Overall Study|Moved to other state|1|||
126487411|NCT01782222|455080605|FG002|Overall Study|Moved to other state|0|||
126487412|NCT03572062|455080609|FG000|Overall Study|Adverse Event|0|||
126487413|NCT03572062|455080610|FG001|Overall Study|Adverse Event|0|||
126487414|NCT03572062|455080611|FG002|Overall Study|Adverse Event|0|||
126487415|NCT03572062|455080612|FG003|Overall Study|Adverse Event|0|||
126487416|NCT03572062|455080613|FG004|Overall Study|Adverse Event|0|||
126487417|NCT03572062|455080614|FG005|Overall Study|Adverse Event|0|||
126487418|NCT03572062|455080615|FG006|Overall Study|Adverse Event|0|||
126487419|NCT03572062|455080616|FG007|Overall Study|Adverse Event|0|||
126487420|NCT03572062|455080617|FG008|Overall Study|Adverse Event|1|||
126487421|NCT03572062|455080618|FG009|Overall Study|Adverse Event|3|||
126487422|NCT03572062|455080609|FG000|Overall Study|Death|0|||
126487423|NCT03572062|455080610|FG001|Overall Study|Death|0|||
126487424|NCT03572062|455080611|FG002|Overall Study|Death|0|||
126487425|NCT03572062|455080612|FG003|Overall Study|Death|0|||
126487426|NCT03572062|455080613|FG004|Overall Study|Death|0|||
126487427|NCT03572062|455080614|FG005|Overall Study|Death|1|||
126487428|NCT03572062|455080615|FG006|Overall Study|Death|0|||
126487429|NCT03572062|455080616|FG007|Overall Study|Death|0|||
126487430|NCT03572062|455080617|FG008|Overall Study|Death|0|||
126487431|NCT03572062|455080618|FG009|Overall Study|Death|0|||
126487432|NCT03572062|455080609|FG000|Overall Study|Lost to Follow-up|0|||
126487433|NCT03572062|455080610|FG001|Overall Study|Lost to Follow-up|0|||
126487434|NCT03572062|455080611|FG002|Overall Study|Lost to Follow-up|0|||
126487435|NCT03572062|455080612|FG003|Overall Study|Lost to Follow-up|0|||
126487436|NCT03572062|455080613|FG004|Overall Study|Lost to Follow-up|0|||
126487437|NCT03572062|455080614|FG005|Overall Study|Lost to Follow-up|1|||
126487438|NCT03572062|455080615|FG006|Overall Study|Lost to Follow-up|1|||
126487439|NCT03572062|455080616|FG007|Overall Study|Lost to Follow-up|0|||
126487440|NCT03572062|455080617|FG008|Overall Study|Lost to Follow-up|0|||
126487441|NCT03572062|455080618|FG009|Overall Study|Lost to Follow-up|0|||
126487442|NCT03572062|455080609|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
126487443|NCT03572062|455080610|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126487444|NCT03572062|455080611|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
126487445|NCT03572062|455080612|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
126487446|NCT03572062|455080613|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
126487447|NCT03572062|455080614|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
126487448|NCT03572062|455080615|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
126487449|NCT03572062|455080616|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
126487450|NCT03572062|455080617|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
126487451|NCT03572062|455080618|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
126487452|NCT03572062|455080609|FG000|Overall Study|Study Terminated By Sponsor|0|||
126487453|NCT03572062|455080610|FG001|Overall Study|Study Terminated By Sponsor|0|||
126487454|NCT03572062|455080611|FG002|Overall Study|Study Terminated By Sponsor|0|||
126487455|NCT03572062|455080612|FG003|Overall Study|Study Terminated By Sponsor|0|||
126487456|NCT03572062|455080613|FG004|Overall Study|Study Terminated By Sponsor|0|||
126487457|NCT03572062|455080614|FG005|Overall Study|Study Terminated By Sponsor|0|||
126487458|NCT03572062|455080615|FG006|Overall Study|Study Terminated By Sponsor|0|||
126487459|NCT03572062|455080616|FG007|Overall Study|Study Terminated By Sponsor|0|||
126487460|NCT03572062|455080617|FG008|Overall Study|Study Terminated By Sponsor|29|||
126487461|NCT03572062|455080618|FG009|Overall Study|Study Terminated By Sponsor|27|||
126487462|NCT03572062|455080609|FG000|Overall Study|Physician Decision|0|||
126487463|NCT03572062|455080610|FG001|Overall Study|Physician Decision|0|||
126487464|NCT03572062|455080611|FG002|Overall Study|Physician Decision|0|||
126487465|NCT03572062|455080612|FG003|Overall Study|Physician Decision|0|||
126487466|NCT03572062|455080613|FG004|Overall Study|Physician Decision|0|||
126487467|NCT03572062|455080614|FG005|Overall Study|Physician Decision|0|||
126487468|NCT03572062|455080615|FG006|Overall Study|Physician Decision|0|||
126487469|NCT03572062|455080616|FG007|Overall Study|Physician Decision|0|||
126487470|NCT03572062|455080617|FG008|Overall Study|Physician Decision|1|||
126487471|NCT03572062|455080618|FG009|Overall Study|Physician Decision|0|||
126487472|NCT03572062|455080609|FG000|Overall Study|Withdrawal by Subject|0|||
126487473|NCT03572062|455080610|FG001|Overall Study|Withdrawal by Subject|0|||
126487474|NCT03572062|455080611|FG002|Overall Study|Withdrawal by Subject|0|||
126487475|NCT03572062|455080612|FG003|Overall Study|Withdrawal by Subject|0|||
126487476|NCT03572062|455080613|FG004|Overall Study|Withdrawal by Subject|0|||
126487477|NCT03572062|455080614|FG005|Overall Study|Withdrawal by Subject|0|||
126487478|NCT03572062|455080615|FG006|Overall Study|Withdrawal by Subject|0|||
126487479|NCT03572062|455080616|FG007|Overall Study|Withdrawal by Subject|0|||
126487480|NCT03572062|455080617|FG008|Overall Study|Withdrawal by Subject|0|||
126487481|NCT03572062|455080618|FG009|Overall Study|Withdrawal by Subject|1|||
126487482|NCT03572062|455080609|FG000|Overall Study|Randomized But Not Treated|0|||
126487483|NCT03572062|455080610|FG001|Overall Study|Randomized But Not Treated|0|||
126487484|NCT03572062|455080611|FG002|Overall Study|Randomized But Not Treated|0|||
126487485|NCT03572062|455080612|FG003|Overall Study|Randomized But Not Treated|0|||
126487486|NCT03572062|455080613|FG004|Overall Study|Randomized But Not Treated|1|||
126487487|NCT03572062|455080614|FG005|Overall Study|Randomized But Not Treated|2|||
126487488|NCT03572062|455080615|FG006|Overall Study|Randomized But Not Treated|0|||
126487489|NCT03572062|455080616|FG007|Overall Study|Randomized But Not Treated|1|||
126487490|NCT03572062|455080617|FG008|Overall Study|Randomized But Not Treated|0|||
126487491|NCT03572062|455080618|FG009|Overall Study|Randomized But Not Treated|0|||
126487492|NCT01858389|455080619|FG000|Overall Study|Death|1|||
126487493|NCT01858389|455080620|FG001|Overall Study|Death|3|||
126487494|NCT01858389|455080619|FG000|Overall Study|Study terminated by sponsor|0|||
126487495|NCT01858389|455080620|FG001|Overall Study|Study terminated by sponsor|2|||
126487496|NCT01858389|455080619|FG000|Overall Study|Withdrawal by Subject|0|||
126487497|NCT01858389|455080620|FG001|Overall Study|Withdrawal by Subject|1|||
126487498|NCT01858389|455080619|FG000|Overall Study|Progressive disease|10|||
126487499|NCT01858389|455080620|FG001|Overall Study|Progressive disease|11|||
126487500|NCT01858389|455080619|FG000|Overall Study|Other|2|||
126487501|NCT01858389|455080620|FG001|Overall Study|Other|4|||
126487502|NCT01858389|455080619|FG000|Overall Study|Adverse Event|3|||
126487503|NCT01858389|455080620|FG001|Overall Study|Adverse Event|1|||
126487504|NCT01858389|455080619|FG000|Overall Study|Did not receive treatment|0|||
126487505|NCT01858389|455080620|FG001|Overall Study|Did not receive treatment|3|||
126487506|NCT00687323|455080621|FG000|Overall Study|Death|25|||
126487507|NCT00687323|455080621|FG000|Overall Study|Withdrawal by Subject|1|||
126487508|NCT00687323|455080621|FG000|Overall Study|Excluded from efficacy evaluations|6|||
126487509|NCT00687323|455080621|FG000|Overall Study|Screen failure|148|||
126487510|NCT02132130|455080625|FG000|Overall Study|Lost to Follow-up|0|||
126487511|NCT02132130|455080626|FG001|Overall Study|Lost to Follow-up|2|||
126487512|NCT02132130|455080627|FG002|Overall Study|Lost to Follow-up|0|||
126487513|NCT02132130|455080628|FG003|Overall Study|Lost to Follow-up|0|||
126487514|NCT02132130|455080625|FG000|Overall Study|Withdrawal by Subject|0|||
126487515|NCT02132130|455080626|FG001|Overall Study|Withdrawal by Subject|0|||
126487516|NCT02132130|455080627|FG002|Overall Study|Withdrawal by Subject|0|||
126487517|NCT02132130|455080628|FG003|Overall Study|Withdrawal by Subject|1|||
126487518|NCT03310775|455080631|FG000|Overall Study|Lost to Follow-up|2|||
126487519|NCT03310775|455080632|FG001|Overall Study|Lost to Follow-up|3|||
126487520|NCT03310775|455080631|FG000|Overall Study|aggravation of depression|0|||
126487521|NCT03310775|455080632|FG001|Overall Study|aggravation of depression|1|||
126487522|NCT00838578|455080637|FG000|Overall Study|Protocol Violation|2|||
126723096|NCT02052778|455936093|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126487523|NCT00646776|455080638|FG000|Overall Study|Adverse Event|1|||
126487524|NCT00646776|455080639|FG001|Overall Study|Adverse Event|9|||
126487525|NCT00646776|455080638|FG000|Overall Study|Investigator discretion|0|||
126487526|NCT00646776|455080639|FG001|Overall Study|Investigator discretion|4|||
126487527|NCT00126568|455080640|FG000|Overall Study|Death|2|||
126487528|NCT00580606|455080644|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
126723097|NCT02052778|455936094|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126487529|NCT00580606|455080645|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
126487530|NCT00580606|455080644|FG000|Open Label (OL)|Withdrawal by Subject|4|||
126487531|NCT00580606|455080645|FG001|Open Label (OL)|Withdrawal by Subject|6|||
126487532|NCT00580606|455080644|FG000|Open Label (OL)|Dosing Symptoms|0|||
126487533|NCT00580606|455080645|FG001|Open Label (OL)|Dosing Symptoms|1|||
126487534|NCT00580606|455080644|FG000|Open Label (OL)|Lost to Follow-up|0|||
126487535|NCT00580606|455080645|FG001|Open Label (OL)|Lost to Follow-up|1|||
126487536|NCT00580606|455080644|FG000|Open Label (OL)|Pregnancy|0|||
126487537|NCT00580606|455080645|FG001|Open Label (OL)|Pregnancy|1|||
126487538|NCT00580606|455080644|FG000|Open Label (OL)|Non-compliance|2|||
126487539|NCT00580606|455080645|FG001|Open Label (OL)|Non-compliance|0|||
126487540|NCT00580606|455080644|FG000|Open Label (OL)|Physician Decision|1|||
126559411|NCT01939158|455342491|FG002|Overall Study|Death|1|||
126487541|NCT00580606|455080645|FG001|Open Label (OL)|Physician Decision|1|||
126487542|NCT00580606|455080644|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
126487543|NCT00580606|455080645|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
126487544|NCT00439244|455080648|FG000|Overall Study|Adverse Event|5|||
126487545|NCT00439244|455080649|FG001|Overall Study|Adverse Event|2|||
126487546|NCT00439244|455080650|FG002|Overall Study|Adverse Event|3|||
126487547|NCT00439244|455080648|FG000|Overall Study|Withdrawal by Subject|3|||
126487548|NCT00439244|455080649|FG001|Overall Study|Withdrawal by Subject|1|||
126487549|NCT00439244|455080650|FG002|Overall Study|Withdrawal by Subject|2|||
126487550|NCT00439244|455080648|FG000|Overall Study|Lost to Follow-up|2|||
126487551|NCT00439244|455080649|FG001|Overall Study|Lost to Follow-up|1|||
126487552|NCT00439244|455080650|FG002|Overall Study|Lost to Follow-up|2|||
126487553|NCT00439244|455080648|FG000|Overall Study|Death|0|||
126487554|NCT00439244|455080649|FG001|Overall Study|Death|1|||
126487555|NCT00439244|455080650|FG002|Overall Study|Death|0|||
126487556|NCT00439244|455080648|FG000|Overall Study|Protocol Violation|0|||
126487557|NCT00439244|455080649|FG001|Overall Study|Protocol Violation|1|||
126487558|NCT00439244|455080650|FG002|Overall Study|Protocol Violation|0|||
126487559|NCT00439244|455080648|FG000|Overall Study|Administrative problems|1|||
126487560|NCT00439244|455080649|FG001|Overall Study|Administrative problems|0|||
126487561|NCT00439244|455080650|FG002|Overall Study|Administrative problems|0|||
126487562|NCT03655691|455080651|FG000|Overall Study|Adverse Event|0|||
126487563|NCT03655691|455080652|FG001|Overall Study|Adverse Event|0|||
126487564|NCT03655691|455080653|FG002|Overall Study|Adverse Event|1|||
126487565|NCT03655691|455080651|FG000|Overall Study|Lost to Follow-up|1|||
126487566|NCT03655691|455080652|FG001|Overall Study|Lost to Follow-up|1|||
126487567|NCT03655691|455080653|FG002|Overall Study|Lost to Follow-up|2|||
126487568|NCT03655691|455080651|FG000|Overall Study|Protocol Violation|0|||
126487569|NCT03655691|455080652|FG001|Overall Study|Protocol Violation|1|||
126487570|NCT03655691|455080653|FG002|Overall Study|Protocol Violation|0|||
126487571|NCT03655691|455080651|FG000|Overall Study|Withdrawal by Subject|1|||
126487572|NCT03655691|455080652|FG001|Overall Study|Withdrawal by Subject|1|||
126487573|NCT03655691|455080653|FG002|Overall Study|Withdrawal by Subject|0|||
126487574|NCT04847557|455080654|FG000|Overall Study|Adverse Event|1|||
126487575|NCT04847557|455080655|FG001|Overall Study|Adverse Event|0|||
126487576|NCT04847557|455080654|FG000|Overall Study|Death|19|||
126487577|NCT04847557|455080655|FG001|Overall Study|Death|15|||
126487578|NCT04847557|455080654|FG000|Overall Study|Lost to Follow-up|3|||
126487579|NCT04847557|455080655|FG001|Overall Study|Lost to Follow-up|6|||
126487580|NCT04847557|455080654|FG000|Overall Study|Physician Decision|1|||
126487581|NCT04847557|455080655|FG001|Overall Study|Physician Decision|0|||
126487582|NCT04847557|455080654|FG000|Overall Study|Protocol Violation|0|||
126487583|NCT04847557|455080655|FG001|Overall Study|Protocol Violation|1|||
126487584|NCT04847557|455080654|FG000|Overall Study|Withdrawal by Subject|8|||
126487585|NCT04847557|455080655|FG001|Overall Study|Withdrawal by Subject|14|||
126487586|NCT01549860|455082735|FG000|Overall Study|Withdrawal by Subject|1|||
126487587|NCT01549860|455082736|FG001|Overall Study|Withdrawal by Subject|0|||
126487588|NCT01549860|455082735|FG000|Overall Study|Physician Decision|1|||
126487589|NCT01549860|455082736|FG001|Overall Study|Physician Decision|1|||
126487590|NCT01327885|455082737|FG000|Overall Study|Disease progression-according to RECIST|173|||
126487591|NCT01327885|455082738|FG001|Overall Study|Disease progression-according to RECIST|165|||
126487592|NCT01327885|455082737|FG000|Overall Study|Clinical progression|24|||
126487593|NCT01327885|455082738|FG001|Overall Study|Clinical progression|27|||
126487594|NCT01327885|455082737|FG000|Overall Study|Adverse Event|14|||
126487595|NCT01327885|455082738|FG001|Overall Study|Adverse Event|10|||
126487596|NCT01327885|455082737|FG000|Overall Study|Subject choice|5|||
126487597|NCT01327885|455082738|FG001|Overall Study|Subject choice|10|||
126487598|NCT01327885|455082737|FG000|Overall Study|Other|8|||
126487599|NCT01327885|455082738|FG001|Overall Study|Other|6|||
126487600|NCT01327885|455082737|FG000|Overall Study|Withdrawal of consent from study|3|||
126487601|NCT01327885|455082738|FG001|Overall Study|Withdrawal of consent from study|4|||
126487602|NCT01327885|455082737|FG000|Overall Study|Not treated|1|||
126487603|NCT01327885|455082738|FG001|Overall Study|Not treated|1|||
126487604|NCT01327885|455082737|FG000|Overall Study|Administrative decision|0|||
126487605|NCT01327885|455082738|FG001|Overall Study|Administrative decision|1|||
126487606|NCT02041286|455082739|FG000|Overall Study|Adverse Event|1|||
126487607|NCT01349790|455082742|FG000|Overall Study|Investigator Judgement|3|||
126487608|NCT01349790|455082742|FG000|Overall Study|Death|2|||
126487609|NCT01349790|455082742|FG000|Overall Study|Withdrawal by Patient|2|||
126559412|NCT01939158|455342492|FG003|Overall Study|Death|1|||
126487610|NCT01349790|455082742|FG000|Overall Study|Adverse Event|1|||
126487611|NCT01349790|455082742|FG000|Overall Study|Lost to Follow-up|1|||
126487612|NCT02085785|455082745|FG000|Overall Study|Withdrawal by Subject|2|||
126487613|NCT02085785|455082746|FG001|Overall Study|Withdrawal by Subject|1|||
126487614|NCT02085785|455082745|FG000|Overall Study|Lost to Follow-up|0|||
126487615|NCT02085785|455082746|FG001|Overall Study|Lost to Follow-up|1|||
126487616|NCT02692703|455082747|FG000|Overall Study|Lost to Follow-up|1|||
126559413|NCT01939158|455342489|FG000|Overall Study|No longer meets eligibility criteria|0|||
126487617|NCT02692703|455082747|FG000|Overall Study|Other|1|||
126487618|NCT03519932|455082748|FG000|First Intervention|Adverse Event|1|||
126487619|NCT03519932|455082749|FG001|First Intervention|Adverse Event|3|||
126487620|NCT02573350|455082752|FG000|Overall Study|Lost to Follow-up|2|||
126487621|NCT02573350|455082753|FG001|Overall Study|Lost to Follow-up|1|||
126487622|NCT02573350|455082752|FG000|Overall Study|Adverse Event|3|||
126487623|NCT02573350|455082753|FG001|Overall Study|Adverse Event|4|||
126487624|NCT02573350|455082752|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
126487625|NCT02573350|455082753|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
126487626|NCT02573350|455082752|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
126487627|NCT02573350|455082753|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
126487628|NCT02573350|455082752|FG000|Overall Study|Subject withdrew consent to participate|6|||
126487629|NCT02573350|455082753|FG001|Overall Study|Subject withdrew consent to participate|1|||
126487630|NCT02573350|455082752|FG000|Overall Study|Protocol Deviation|1|||
126487631|NCT02573350|455082753|FG001|Overall Study|Protocol Deviation|1|||
126487632|NCT01979016|455082754|FG000|Overall Study|Withdrawal by Subject|2|||
126487633|NCT01979016|455082755|FG001|Overall Study|Withdrawal by Subject|0|||
126559414|NCT01939158|455342490|FG001|Overall Study|No longer meets eligibility criteria|0|||
126559415|NCT01939158|455342491|FG002|Overall Study|No longer meets eligibility criteria|1|||
126559416|NCT01939158|455342492|FG003|Overall Study|No longer meets eligibility criteria|0|||
126559417|NCT01939158|455342489|FG000|Overall Study|Other|1|||
126559418|NCT01939158|455342490|FG001|Overall Study|Other|3|||
126559419|NCT01939158|455342491|FG002|Overall Study|Other|4|||
126559420|NCT01939158|455342492|FG003|Overall Study|Other|3|||
126559421|NCT02065245|455342493|FG000|Infusion 1|Lost to Follow-up|0|||
126559422|NCT02065245|455342494|FG001|Infusion 1|Lost to Follow-up|0|||
126559423|NCT02065245|455342495|FG002|Infusion 1|Lost to Follow-up|0|||
126559424|NCT02065245|455342496|FG003|Infusion 1|Lost to Follow-up|0|||
126559425|NCT02065245|455342497|FG004|Infusion 1|Lost to Follow-up|0|||
126559426|NCT02065245|455342498|FG005|Infusion 1|Lost to Follow-up|0|||
126559427|NCT02065245|455342499|FG006|Infusion 1|Lost to Follow-up|1|||
126559428|NCT02065245|455342493|FG000|Infusion 1|Death|0|||
126559429|NCT02065245|455342494|FG001|Infusion 1|Death|0|||
126559430|NCT02065245|455342495|FG002|Infusion 1|Death|1|||
126559431|NCT02065245|455342496|FG003|Infusion 1|Death|0|||
126559432|NCT02065245|455342497|FG004|Infusion 1|Death|1|||
126559433|NCT02065245|455342498|FG005|Infusion 1|Death|0|||
126559434|NCT02065245|455342499|FG006|Infusion 1|Death|0|||
126559435|NCT02065245|455342493|FG000|Infusion 2|Death|0|||
126559436|NCT02065245|455342494|FG001|Infusion 2|Death|0|||
126559437|NCT02065245|455342495|FG002|Infusion 2|Death|0|||
126559438|NCT02065245|455342496|FG003|Infusion 2|Death|0|||
126559439|NCT02065245|455342497|FG004|Infusion 2|Death|0|||
126559440|NCT02065245|455342498|FG005|Infusion 2|Death|0|||
126559441|NCT02065245|455342499|FG006|Infusion 2|Death|1|||
126559442|NCT02065245|455342493|FG000|Infusion 3|Lost to Follow-up|1|||
126559443|NCT02065245|455342494|FG001|Infusion 3|Lost to Follow-up|1|||
126559444|NCT02065245|455342495|FG002|Infusion 3|Lost to Follow-up|0|||
126559445|NCT02065245|455342496|FG003|Infusion 3|Lost to Follow-up|0|||
126559446|NCT02065245|455342497|FG004|Infusion 3|Lost to Follow-up|0|||
126559447|NCT02065245|455342498|FG005|Infusion 3|Lost to Follow-up|0|||
126559448|NCT02065245|455342499|FG006|Infusion 3|Lost to Follow-up|0|||
126559449|NCT01304706|455342500|FG000|Overall Study|Adverse Event|2|||
126559450|NCT01304706|455342500|FG000|Overall Study|Lack of Efficacy|1|||
126559451|NCT01304706|455342500|FG000|Overall Study|Death|3|||
126559452|NCT01304706|455342500|FG000|Overall Study|Withdrawal by Subject|3|||
126559453|NCT01304706|455342500|FG000|Overall Study|Lost to Follow-up|7|||
126559454|NCT01304706|455342500|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
126559455|NCT02892409|455342501|FG000|Overall Study|Adverse Event|1|||
126559456|NCT02892409|455342502|FG001|Overall Study|Adverse Event|0|||
126559457|NCT02892409|455342501|FG000|Overall Study|Withdrawal by Subject|2|||
126487634|NCT01979016|455082754|FG000|Overall Study|Adverse Event|0|||
126559458|NCT02892409|455342502|FG001|Overall Study|Withdrawal by Subject|1|||
126559459|NCT01345292|455342507|FG000|Overall Study|Withdrawal by Subject|2|||
126559460|NCT01345292|455342508|FG001|Overall Study|Withdrawal by Subject|0|||
126487635|NCT01979016|455082755|FG001|Overall Study|Adverse Event|1|||
126487636|NCT04983264|455082756|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
126487637|NCT04983264|455082757|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
126559461|NCT01345292|455342509|FG002|Overall Study|Withdrawal by Subject|1|||
126772596|NCT02454972|456123635|FG006|Overall Study|Progressive disease|19|||
126487638|NCT04983264|455082758|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
126487639|NCT04983264|455082756|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
126487640|NCT04983264|455082757|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
126559462|NCT01033643|455342512|FG000|Overall Study|Withdrew Consent|0|||
126559463|NCT01033643|455342513|FG001|Overall Study|Withdrew Consent|3|||
126559464|NCT01033643|455342514|FG002|Overall Study|Withdrew Consent|0|||
126559465|NCT01033643|455342515|FG003|Overall Study|Withdrew Consent|0|||
126559466|NCT01033643|455342516|FG004|Overall Study|Withdrew Consent|0|||
126559467|NCT01033643|455342517|FG005|Overall Study|Withdrew Consent|1|||
126559468|NCT04822298|455342518|FG000|Overall Study|Death|3|||
126559469|NCT01789203|455342521|FG000|Overall Study|Adverse Event|2|||
126559470|NCT01789203|455342522|FG001|Overall Study|Adverse Event|2|||
126559471|NCT01789203|455342521|FG000|Overall Study|Withdrawal by Subject|1|||
126559472|NCT01789203|455342522|FG001|Overall Study|Withdrawal by Subject|0|||
126559473|NCT01789203|455342521|FG000|Overall Study|Death|1|||
126559474|NCT01789203|455342522|FG001|Overall Study|Death|0|||
126559475|NCT01789203|455342521|FG000|Overall Study|Protocol Violation|2|||
126559476|NCT01789203|455342522|FG001|Overall Study|Protocol Violation|1|||
126559477|NCT01789203|455342521|FG000|Overall Study|Other|1|||
126559478|NCT01789203|455342522|FG001|Overall Study|Other|1|||
126559479|NCT01789203|455342521|FG000|Overall Study|patient non-adherent|2|||
126559480|NCT01789203|455342522|FG001|Overall Study|patient non-adherent|0|||
126559481|NCT00852475|455342529|FG000|Overall Study|Lost to Follow-up|3|||
126559482|NCT00852475|455342530|FG001|Overall Study|Lost to Follow-up|4|||
126559483|NCT00515086|455342531|FG000|Overall Study|Adverse Event|1|||
126559484|NCT00515086|455342532|FG001|Overall Study|Adverse Event|1|||
126559485|NCT00515086|455342533|FG002|Overall Study|Adverse Event|2|||
126559486|NCT00515086|455342534|FG003|Overall Study|Adverse Event|3|||
126559487|NCT00515086|455342531|FG000|Overall Study|Administrative|1|||
126559488|NCT00515086|455342532|FG001|Overall Study|Administrative|1|||
126559489|NCT00515086|455342533|FG002|Overall Study|Administrative|0|||
126559490|NCT00515086|455342534|FG003|Overall Study|Administrative|0|||
126559491|NCT00515086|455342531|FG000|Overall Study|Withdrawal by Subject|1|||
126559492|NCT00515086|455342532|FG001|Overall Study|Withdrawal by Subject|0|||
126559493|NCT00515086|455342533|FG002|Overall Study|Withdrawal by Subject|0|||
126559494|NCT00515086|455342534|FG003|Overall Study|Withdrawal by Subject|1|||
126559495|NCT00515086|455342531|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
126559496|NCT00515086|455342532|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126559497|NCT00515086|455342533|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
126559498|NCT00515086|455342534|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
126559499|NCT00515086|455342531|FG000|Overall Study|Lost to Follow-up|1|||
126559500|NCT00515086|455342532|FG001|Overall Study|Lost to Follow-up|0|||
126559501|NCT00515086|455342533|FG002|Overall Study|Lost to Follow-up|0|||
126559502|NCT00515086|455342534|FG003|Overall Study|Lost to Follow-up|0|||
126559503|NCT00515086|455342531|FG000|Overall Study|Study drug no longer required|0|||
126559504|NCT00515086|455342532|FG001|Overall Study|Study drug no longer required|1|||
126559505|NCT00515086|455342533|FG002|Overall Study|Study drug no longer required|0|||
126559506|NCT00515086|455342534|FG003|Overall Study|Study drug no longer required|0|||
126559507|NCT00515086|455342531|FG000|Overall Study|Death|2|||
126559508|NCT00515086|455342532|FG001|Overall Study|Death|0|||
126559509|NCT00515086|455342533|FG002|Overall Study|Death|0|||
126487641|NCT04983264|455082758|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
126487642|NCT02551731|455082761|FG000|Overall Study|Withdrawal by Subject|2|||
126487643|NCT03765918|455082770|FG000|Overall Study|Death|109|||
126487644|NCT03765918|455082771|FG001|Overall Study|Death|127|||
126487645|NCT03765918|455082770|FG000|Overall Study|Lost to Follow-up|2|||
126487646|NCT03765918|455082771|FG001|Overall Study|Lost to Follow-up|3|||
126487647|NCT03765918|455082770|FG000|Overall Study|Withdrawal by Subject|12|||
126487648|NCT03765918|455082771|FG001|Overall Study|Withdrawal by Subject|16|||
126487649|NCT03765918|455082770|FG000|Overall Study|Participants Ongoing|240|||
126487650|NCT03765918|455082771|FG001|Overall Study|Participants Ongoing|205|||
126487651|NCT04202965|455082772|FG000|Overall Study|Adverse Event|3|||
126487652|NCT04202965|455082772|FG000|Overall Study|Did not meet inclusion criteria|1|||
126487653|NCT00006903|455082773|FG000|Overall Study|Still receiving treatment|0|||
126487654|NCT00006903|455082774|FG001|Overall Study|Still receiving treatment|0|||
126487655|NCT00006903|455082775|FG002|Overall Study|Still receiving treatment|1|||
126487656|NCT00006903|455082773|FG000|Overall Study|Refused further treatment|0|||
126487657|NCT00006903|455082774|FG001|Overall Study|Refused further treatment|2|||
126487658|NCT00006903|455082775|FG002|Overall Study|Refused further treatment|1|||
126487659|NCT00006903|455082773|FG000|Overall Study|Adverse Event|0|||
126487660|NCT00006903|455082774|FG001|Overall Study|Adverse Event|0|||
126487661|NCT00006903|455082775|FG002|Overall Study|Adverse Event|1|||
126487662|NCT00006903|455082773|FG000|Overall Study|Death|0|||
126487663|NCT00006903|455082774|FG001|Overall Study|Death|1|||
126487664|NCT00006903|455082775|FG002|Overall Study|Death|0|||
126487665|NCT00006903|455082773|FG000|Overall Study|Patient never treated|0|||
126487666|NCT00006903|455082774|FG001|Overall Study|Patient never treated|0|||
126487667|NCT00006903|455082775|FG002|Overall Study|Patient never treated|1|||
126487668|NCT00006903|455082773|FG000|Overall Study|Ineligible|10|||
126487669|NCT00006903|455082774|FG001|Overall Study|Ineligible|1|||
126487670|NCT00006903|455082775|FG002|Overall Study|Ineligible|2|||
126487671|NCT02117648|455082778|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
126487672|NCT02117648|455082778|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
126559510|NCT00515086|455342534|FG003|Overall Study|Death|0|||
126559511|NCT02373813|455342535|FG000|Run-In Period|Other, Not Specified|5|||
126559512|NCT02373813|455342536|FG001|Run-In Period|Other, Not Specified|0|||
126559513|NCT02373813|455342537|FG002|Run-In Period|Other, Not Specified|0|||
126559514|NCT02373813|455342538|FG003|Run-In Period|Other, Not Specified|0|||
126487673|NCT02117648|455082778|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
126487674|NCT02117648|455082778|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
126487675|NCT02117648|455082778|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
126487676|NCT02117648|455082778|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
126487677|NCT02117648|455082778|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
126487678|NCT02117648|455082778|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
126487679|NCT02117648|455082778|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
126487680|NCT02117648|455082778|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
126487681|NCT02117648|455082778|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
126487682|NCT00553514|455082779|FG000|Overall Study|Protocol deviation|0|||
126487683|NCT00553514|455082780|FG001|Overall Study|Protocol deviation|0|||
126487684|NCT00553514|455082781|FG002|Overall Study|Protocol deviation|0|||
126487685|NCT00553514|455082782|FG003|Overall Study|Protocol deviation|1|||
126487686|NCT00553514|455082783|FG004|Overall Study|Protocol deviation|0|||
126487687|NCT00553514|455082779|FG000|Overall Study|Lack of ovarian response|4|||
126487688|NCT00553514|455082780|FG001|Overall Study|Lack of ovarian response|5|||
126487689|NCT00553514|455082781|FG002|Overall Study|Lack of ovarian response|5|||
126487690|NCT00553514|455082782|FG003|Overall Study|Lack of ovarian response|5|||
126487691|NCT00553514|455082783|FG004|Overall Study|Lack of ovarian response|6|||
126487692|NCT00553514|455082779|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
126487693|NCT00553514|455082780|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
126487694|NCT00553514|455082781|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
126487695|NCT00553514|455082782|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
126487696|NCT00553514|455082783|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
126487697|NCT00553514|455082779|FG000|Overall Study|Risk of multiple pregnancy|0|||
126487698|NCT00553514|455082780|FG001|Overall Study|Risk of multiple pregnancy|2|||
126487699|NCT00553514|455082781|FG002|Overall Study|Risk of multiple pregnancy|0|||
126487700|NCT00553514|455082782|FG003|Overall Study|Risk of multiple pregnancy|1|||
126487701|NCT00553514|455082783|FG004|Overall Study|Risk of multiple pregnancy|0|||
126487702|NCT00553514|455082779|FG000|Overall Study|Other|1|||
126487703|NCT00553514|455082780|FG001|Overall Study|Other|1|||
126487704|NCT00553514|455082781|FG002|Overall Study|Other|0|||
126487705|NCT00553514|455082782|FG003|Overall Study|Other|0|||
126487706|NCT00553514|455082783|FG004|Overall Study|Other|1|||
126487707|NCT01442675|455082786|FG000|Overall Study|Protocol Violation|6|||
126487708|NCT01442675|455082786|FG000|Overall Study|Lost to Follow-up|2|||
126487709|NCT01442675|455082786|FG000|Overall Study|Withdrawal by Subject|4|||
126559515|NCT02373813|455342535|FG000|Run-In Period|Withdrawal by Subject|16|||
126559516|NCT02373813|455342536|FG001|Run-In Period|Withdrawal by Subject|0|||
126559517|NCT02373813|455342537|FG002|Run-In Period|Withdrawal by Subject|0|||
126559518|NCT02373813|455342538|FG003|Run-In Period|Withdrawal by Subject|0|||
126559519|NCT02373813|455342535|FG000|Run-In Period|Decision by Sponsor|11|||
126559520|NCT02373813|455342536|FG001|Run-In Period|Decision by Sponsor|0|||
126559521|NCT02373813|455342537|FG002|Run-In Period|Decision by Sponsor|0|||
126559522|NCT02373813|455342538|FG003|Run-In Period|Decision by Sponsor|0|||
126559523|NCT02373813|455342535|FG000|Run-In Period|Protocol Violation|75|||
126559524|NCT02373813|455342536|FG001|Run-In Period|Protocol Violation|0|||
126559525|NCT02373813|455342537|FG002|Run-In Period|Protocol Violation|0|||
126559526|NCT02373813|455342538|FG003|Run-In Period|Protocol Violation|0|||
126559527|NCT02373813|455342535|FG000|Run-In Period|Lost to Follow-up|2|||
126559528|NCT02373813|455342536|FG001|Run-In Period|Lost to Follow-up|0|||
126559529|NCT02373813|455342537|FG002|Run-In Period|Lost to Follow-up|0|||
126559530|NCT02373813|455342538|FG003|Run-In Period|Lost to Follow-up|0|||
126559531|NCT02373813|455342535|FG000|Run-In Period|Adverse Event|3|||
126559532|NCT02373813|455342536|FG001|Run-In Period|Adverse Event|0|||
126487710|NCT01919723|455082787|FG000|Overall Study|Blood Samples Hemolyzed|2|||
126487711|NCT01919723|455082788|FG001|Overall Study|Blood Samples Hemolyzed|2|||
126487712|NCT00752232|455082789|FG000|Overall Study|Protocol Violation|0|||
126487713|NCT00752232|455082790|FG001|Overall Study|Protocol Violation|0|||
126487714|NCT00752232|455082791|FG002|Overall Study|Protocol Violation|0|||
126487715|NCT00752232|455082792|FG003|Overall Study|Protocol Violation|0|||
126487716|NCT00752232|455082793|FG004|Overall Study|Protocol Violation|0|||
126487717|NCT00752232|455082794|FG005|Overall Study|Protocol Violation|1|||
126487718|NCT00752232|455082795|FG006|Overall Study|Protocol Violation|0|||
126487719|NCT00752232|455082789|FG000|Overall Study|Caregiver request|2|||
126487720|NCT00752232|455082790|FG001|Overall Study|Caregiver request|0|||
126487721|NCT00752232|455082791|FG002|Overall Study|Caregiver request|0|||
126487722|NCT00752232|455082792|FG003|Overall Study|Caregiver request|0|||
126487723|NCT00752232|455082793|FG004|Overall Study|Caregiver request|1|||
126487724|NCT00752232|455082794|FG005|Overall Study|Caregiver request|0|||
126487725|NCT00752232|455082795|FG006|Overall Study|Caregiver request|0|||
126487726|NCT00752232|455082789|FG000|Overall Study|Investigator request|0|||
126487727|NCT00752232|455082790|FG001|Overall Study|Investigator request|0|||
126487728|NCT00752232|455082791|FG002|Overall Study|Investigator request|0|||
126487729|NCT00752232|455082792|FG003|Overall Study|Investigator request|0|||
126559533|NCT02373813|455342537|FG002|Run-In Period|Adverse Event|0|||
126559534|NCT02373813|455342538|FG003|Run-In Period|Adverse Event|0|||
126487730|NCT00752232|455082793|FG004|Overall Study|Investigator request|1|||
126487731|NCT00752232|455082794|FG005|Overall Study|Investigator request|0|||
126487732|NCT00752232|455082795|FG006|Overall Study|Investigator request|0|||
126487733|NCT00752232|455082789|FG000|Overall Study|Subject request|0|||
126487734|NCT00752232|455082790|FG001|Overall Study|Subject request|0|||
126487735|NCT00752232|455082791|FG002|Overall Study|Subject request|1|||
126487736|NCT00752232|455082792|FG003|Overall Study|Subject request|0|||
126487737|NCT00752232|455082793|FG004|Overall Study|Subject request|0|||
126487738|NCT00752232|455082794|FG005|Overall Study|Subject request|0|||
126487739|NCT00752232|455082795|FG006|Overall Study|Subject request|0|||
126487740|NCT00752232|455082789|FG000|Overall Study|Group home admission|0|||
126487741|NCT00752232|455082790|FG001|Overall Study|Group home admission|0|||
126487742|NCT00752232|455082791|FG002|Overall Study|Group home admission|0|||
126487743|NCT00752232|455082792|FG003|Overall Study|Group home admission|1|||
126487744|NCT00752232|455082793|FG004|Overall Study|Group home admission|0|||
126487745|NCT00752232|455082794|FG005|Overall Study|Group home admission|0|||
126487746|NCT00752232|455082795|FG006|Overall Study|Group home admission|0|||
126487747|NCT00752232|455082789|FG000|Overall Study|Caregiver could not attend the subject|0|||
126487748|NCT00752232|455082790|FG001|Overall Study|Caregiver could not attend the subject|0|||
126487749|NCT00752232|455082791|FG002|Overall Study|Caregiver could not attend the subject|0|||
126487750|NCT00752232|455082792|FG003|Overall Study|Caregiver could not attend the subject|0|||
126487751|NCT00752232|455082793|FG004|Overall Study|Caregiver could not attend the subject|1|||
126487752|NCT00752232|455082794|FG005|Overall Study|Caregiver could not attend the subject|0|||
126487753|NCT00752232|455082795|FG006|Overall Study|Caregiver could not attend the subject|0|||
126487754|NCT04502589|455082796|FG000|Overall Study|Physician Decision|1|||
126487755|NCT04502589|455082797|FG001|Overall Study|Physician Decision|0|||
126487756|NCT00555321|455082798|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
126487757|NCT00555321|455082799|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
126487758|NCT00555321|455082800|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
126487759|NCT00555321|455082801|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
126487760|NCT00555321|455082802|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
126487761|NCT00555321|455082798|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
126487762|NCT00555321|455082799|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
126487763|NCT00555321|455082800|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
126487764|NCT00555321|455082801|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
126487765|NCT00555321|455082802|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
126487766|NCT00555321|455082798|FG000|Treatment Phase up to 12-months|Death|2|||
126487767|NCT00555321|455082799|FG001|Treatment Phase up to 12-months|Death|1|||
126487768|NCT00555321|455082800|FG002|Treatment Phase up to 12-months|Death|4|||
126487769|NCT00555321|455082801|FG003|Treatment Phase up to 12-months|Death|0|||
126487770|NCT00555321|455082802|FG004|Treatment Phase up to 12-months|Death|0|||
126487771|NCT00555321|455082798|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
126487772|NCT00555321|455082799|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
126487773|NCT00555321|455082800|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
126487774|NCT00555321|455082801|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
126487775|NCT00555321|455082802|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
126487776|NCT00555321|455082798|FG000|Treatment Phase up to 12-months|Other Reason|1|||
126487777|NCT00555321|455082799|FG001|Treatment Phase up to 12-months|Other Reason|3|||
126487778|NCT00555321|455082800|FG002|Treatment Phase up to 12-months|Other Reason|2|||
126487779|NCT00555321|455082801|FG003|Treatment Phase up to 12-months|Other Reason|0|||
126487780|NCT00555321|455082802|FG004|Treatment Phase up to 12-months|Other Reason|0|||
126487781|NCT00555321|455082798|FG000|Treatment Phase up to 12-months|Never treated|2|||
126487782|NCT00555321|455082799|FG001|Treatment Phase up to 12-months|Never treated|3|||
126487783|NCT00555321|455082800|FG002|Treatment Phase up to 12-months|Never treated|1|||
126487784|NCT00555321|455082801|FG003|Treatment Phase up to 12-months|Never treated|0|||
126487785|NCT00555321|455082802|FG004|Treatment Phase up to 12-months|Never treated|4|||
126487786|NCT00555321|455082798|FG000|Long-term Extension Phase|Adverse Event|2|||
126487787|NCT00555321|455082799|FG001|Long-term Extension Phase|Adverse Event|5|||
126487788|NCT00555321|455082800|FG002|Long-term Extension Phase|Adverse Event|2|||
126487789|NCT00555321|455082801|FG003|Long-term Extension Phase|Adverse Event|1|||
126487790|NCT00555321|455082802|FG004|Long-term Extension Phase|Adverse Event|0|||
126487791|NCT00555321|455082798|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
126487792|NCT00555321|455082799|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
126487793|NCT00555321|455082800|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
126487794|NCT00555321|455082801|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
126487795|NCT00555321|455082802|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
126487796|NCT00555321|455082798|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
126487797|NCT00555321|455082799|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
126487798|NCT00555321|455082800|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
126487799|NCT00555321|455082801|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
126487800|NCT00555321|455082802|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
126723098|NCT02052778|455936095|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
126723099|NCT02052778|455936096|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723100|NCT02052778|455936097|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723101|NCT02052778|455936098|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723102|NCT02052778|455936099|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723103|NCT02052778|455936100|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723104|NCT02052778|455936101|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723105|NCT02052778|455936102|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723106|NCT02052778|455936103|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126723107|NCT02052778|455936104|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
126487801|NCT00555321|455082798|FG000|Long-term Extension Phase|Death|2|||
126723108|NCT02052778|455936082|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
126723109|NCT02052778|455936083|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
126723110|NCT02052778|455936084|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
126723111|NCT02052778|455936085|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
126723112|NCT02052778|455936086|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
126723113|NCT02052778|455936087|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
126723114|NCT02052778|455936088|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
126723115|NCT02052778|455936089|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
126723116|NCT02052778|455936090|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
126723117|NCT02052778|455936091|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
126723118|NCT02052778|455936092|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
126723119|NCT02052778|455936093|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
126723120|NCT02052778|455936094|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
126723121|NCT02052778|455936095|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
126723122|NCT02052778|455936096|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
126723123|NCT02052778|455936097|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
126723124|NCT02052778|455936098|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
126723125|NCT02052778|455936099|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
126723126|NCT02052778|455936100|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
126723127|NCT02052778|455936101|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
126723128|NCT02052778|455936102|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
126723129|NCT02052778|455936103|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
126723130|NCT02052778|455936104|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
126723131|NCT02052778|455936082|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723132|NCT02052778|455936083|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723133|NCT02052778|455936084|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723134|NCT02052778|455936085|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723135|NCT02052778|455936086|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723136|NCT02052778|455936087|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723137|NCT02052778|455936088|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723138|NCT02052778|455936089|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723139|NCT02052778|455936090|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
126723140|NCT02052778|455936091|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723141|NCT02052778|455936092|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723142|NCT02052778|455936093|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723143|NCT02052778|455936094|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723144|NCT02052778|455936095|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
126723145|NCT02052778|455936096|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723146|NCT02052778|455936097|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723147|NCT02052778|455936098|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723148|NCT02052778|455936099|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723149|NCT02052778|455936100|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723150|NCT02052778|455936101|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723151|NCT02052778|455936102|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723152|NCT02052778|455936103|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723153|NCT02052778|455936104|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
126723154|NCT02052778|455936082|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723155|NCT02052778|455936083|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723156|NCT02052778|455936084|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126772597|NCT02454972|456123636|FG007|Overall Study|Progressive disease|27|||
126487802|NCT00555321|455082799|FG001|Long-term Extension Phase|Death|0|||
126487803|NCT00555321|455082800|FG002|Long-term Extension Phase|Death|0|||
126487804|NCT00555321|455082801|FG003|Long-term Extension Phase|Death|3|||
126487805|NCT00555321|455082802|FG004|Long-term Extension Phase|Death|0|||
126487806|NCT00555321|455082798|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
126487807|NCT00555321|455082799|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
126487808|NCT00555321|455082800|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
126487809|NCT00555321|455082801|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
126487810|NCT00555321|455082802|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
126487811|NCT00555321|455082798|FG000|Long-term Extension Phase|Other Reason|1|||
126487812|NCT00555321|455082799|FG001|Long-term Extension Phase|Other Reason|0|||
126487813|NCT00555321|455082800|FG002|Long-term Extension Phase|Other Reason|2|||
126487814|NCT00555321|455082801|FG003|Long-term Extension Phase|Other Reason|0|||
126487815|NCT00555321|455082802|FG004|Long-term Extension Phase|Other Reason|0|||
126487816|NCT00160251|455082803|FG000|Prior to Amendment 2|Adverse Event|2|||
126487817|NCT00160251|455082804|FG001|Prior to Amendment 2|Adverse Event|1|||
126487818|NCT00160251|455082805|FG002|Prior to Amendment 2|Adverse Event|3|||
126487819|NCT00160251|455082806|FG003|Prior to Amendment 2|Adverse Event|1|||
126487820|NCT00160251|455082807|FG004|Prior to Amendment 2|Adverse Event|1|||
126487821|NCT00160251|455082808|FG005|Prior to Amendment 2|Adverse Event|1|||
126487822|NCT00160251|455082809|FG006|Prior to Amendment 2|Adverse Event|1|||
126487823|NCT00160251|455082810|FG007|Prior to Amendment 2|Adverse Event|0|||
126487824|NCT00160251|455082803|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
126487825|NCT00160251|455082804|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
126487826|NCT00160251|455082805|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
126487827|NCT00160251|455082806|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
126487828|NCT00160251|455082807|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
126487829|NCT00160251|455082808|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
126487830|NCT00160251|455082809|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
126487831|NCT00160251|455082810|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
126487832|NCT00160251|455082803|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
126487833|NCT00160251|455082804|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
126487834|NCT00160251|455082805|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
126487835|NCT00160251|455082806|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
126487836|NCT00160251|455082807|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
126487837|NCT00160251|455082808|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
126487838|NCT00160251|455082809|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
126487839|NCT00160251|455082810|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
126487840|NCT00160251|455082803|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
126487841|NCT00160251|455082804|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
126487842|NCT00160251|455082805|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
126487843|NCT00160251|455082806|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
126487844|NCT00160251|455082807|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
126487845|NCT00160251|455082808|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
126487846|NCT00160251|455082809|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
126487847|NCT00160251|455082810|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
126487848|NCT00160251|455082803|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
126487849|NCT00160251|455082804|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
126487850|NCT00160251|455082805|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
126487851|NCT00160251|455082806|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
126487852|NCT00160251|455082807|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
126487853|NCT00160251|455082808|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
126487854|NCT00160251|455082809|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
126487855|NCT00160251|455082810|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
126487856|NCT00160251|455082803|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
126487857|NCT00160251|455082804|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
126487858|NCT00160251|455082805|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
126487859|NCT00160251|455082806|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
126487860|NCT00160251|455082807|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
126487861|NCT00160251|455082808|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
126487862|NCT00160251|455082809|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
126487863|NCT00160251|455082810|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
126487864|NCT00160251|455082803|FG000|Post-amendment 2|Adverse Event|0|||
126487865|NCT00160251|455082804|FG001|Post-amendment 2|Adverse Event|0|||
126487866|NCT00160251|455082805|FG002|Post-amendment 2|Adverse Event|0|||
126487867|NCT00160251|455082806|FG003|Post-amendment 2|Adverse Event|0|||
126487868|NCT00160251|455082807|FG004|Post-amendment 2|Adverse Event|0|||
126723157|NCT02052778|455936085|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126487869|NCT00160251|455082808|FG005|Post-amendment 2|Adverse Event|0|||
126487870|NCT00160251|455082809|FG006|Post-amendment 2|Adverse Event|0|||
126487871|NCT00160251|455082810|FG007|Post-amendment 2|Adverse Event|20|||
126487872|NCT00160251|455082803|FG000|Post-amendment 2|Lack of Efficacy|0|||
126487873|NCT00160251|455082804|FG001|Post-amendment 2|Lack of Efficacy|0|||
126487874|NCT00160251|455082805|FG002|Post-amendment 2|Lack of Efficacy|0|||
126487875|NCT00160251|455082806|FG003|Post-amendment 2|Lack of Efficacy|0|||
126487876|NCT00160251|455082807|FG004|Post-amendment 2|Lack of Efficacy|0|||
126487877|NCT00160251|455082808|FG005|Post-amendment 2|Lack of Efficacy|0|||
126487878|NCT00160251|455082809|FG006|Post-amendment 2|Lack of Efficacy|0|||
126487879|NCT00160251|455082810|FG007|Post-amendment 2|Lack of Efficacy|24|||
126487880|NCT00160251|455082803|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
126487881|NCT00160251|455082804|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
126487882|NCT00160251|455082805|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
126487883|NCT00160251|455082806|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
126487884|NCT00160251|455082807|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
126487885|NCT00160251|455082808|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
126487886|NCT00160251|455082809|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
126487887|NCT00160251|455082810|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
126487888|NCT00582166|455082813|FG000|Overall Study|Death|1|||
126487889|NCT00582166|455082813|FG000|Overall Study|Ineligible pathology|1|||
126487890|NCT02532972|455082814|FG000|Overall Study|Withdrawal by Subject|1|||
126487891|NCT01606436|455082815|FG000|Overall Study|Withdrawal by Subject|0|||
126487892|NCT01606436|455082816|FG001|Overall Study|Withdrawal by Subject|0|||
126487893|NCT01606436|455082817|FG002|Overall Study|Withdrawal by Subject|1|||
126487894|NCT01606436|455082818|FG003|Overall Study|Withdrawal by Subject|1|||
126487895|NCT01606436|455082819|FG004|Overall Study|Withdrawal by Subject|1|||
126487896|NCT01606436|455082820|FG005|Overall Study|Withdrawal by Subject|0|||
126487897|NCT01606436|455082815|FG000|Overall Study|Adverse Event|0|||
126487898|NCT01606436|455082816|FG001|Overall Study|Adverse Event|0|||
126487899|NCT01606436|455082817|FG002|Overall Study|Adverse Event|1|||
126487900|NCT01606436|455082818|FG003|Overall Study|Adverse Event|0|||
126487901|NCT01606436|455082819|FG004|Overall Study|Adverse Event|0|||
126487902|NCT01606436|455082820|FG005|Overall Study|Adverse Event|0|||
126487903|NCT01606436|455082815|FG000|Overall Study|Sponsor Decision|0|||
126487904|NCT01606436|455082816|FG001|Overall Study|Sponsor Decision|0|||
126487905|NCT01606436|455082817|FG002|Overall Study|Sponsor Decision|0|||
126487906|NCT01606436|455082818|FG003|Overall Study|Sponsor Decision|1|||
126487907|NCT01606436|455082819|FG004|Overall Study|Sponsor Decision|0|||
126487908|NCT01606436|455082820|FG005|Overall Study|Sponsor Decision|0|||
126487909|NCT03334448|455082824|FG000|Washout|Personal Reason|0|||
126487910|NCT03334448|455082825|FG001|Washout|Personal Reason|1|||
126487911|NCT03334448|455082826|FG002|Washout|Personal Reason|0|||
126487912|NCT03334448|455082827|FG003|Washout|Personal Reason|0|||
126487913|NCT03334448|455082824|FG000|Washout|Protocol Violation|0|||
126487914|NCT03334448|455082825|FG001|Washout|Protocol Violation|0|||
126487915|NCT03334448|455082826|FG002|Washout|Protocol Violation|0|||
126487916|NCT03334448|455082827|FG003|Washout|Protocol Violation|1|||
126487917|NCT02496611|455082830|FG000|Overall Study|Lost to Follow-up|2|||
126487918|NCT02496611|455082831|FG001|Overall Study|Lost to Follow-up|1|||
126487919|NCT02496611|455082830|FG000|Overall Study|Withdrawal by Subject|5|||
126487920|NCT02496611|455082831|FG001|Overall Study|Withdrawal by Subject|2|||
126487921|NCT02850965|455082832|FG000|Overall Study|Other than listed|3|||
126487922|NCT02850965|455082833|FG001|Overall Study|Other than listed|4|||
126487923|NCT02850965|455082832|FG000|Overall Study|Protocol Violation|0|||
126487924|NCT02850965|455082833|FG001|Overall Study|Protocol Violation|2|||
126487925|NCT02850965|455082832|FG000|Overall Study|Lost to Follow-up|5|||
126487926|NCT02850965|455082833|FG001|Overall Study|Lost to Follow-up|3|||
126487927|NCT02850965|455082832|FG000|Overall Study|Lack of Efficacy|4|||
126487928|NCT02850965|455082833|FG001|Overall Study|Lack of Efficacy|8|||
126487929|NCT02850965|455082832|FG000|Overall Study|Adverse Event|3|||
126487930|NCT02850965|455082833|FG001|Overall Study|Adverse Event|2|||
126487931|NCT02850965|455082832|FG000|Overall Study|Withdrawal by Subject|3|||
126487932|NCT02850965|455082833|FG001|Overall Study|Withdrawal by Subject|4|||
126487933|NCT02850965|455082832|FG000|Overall Study|Physician Decision|0|||
126487934|NCT02850965|455082833|FG001|Overall Study|Physician Decision|1|||
126487935|NCT02850965|455082832|FG000|Overall Study|Randomized but not treated|0|||
126487936|NCT02850965|455082833|FG001|Overall Study|Randomized but not treated|1|||
126487937|NCT02788357|455082836|FG000|Overall Study|Lost to Follow-up|3|||
126487938|NCT02788357|455082837|FG001|Overall Study|Lost to Follow-up|0|||
126487939|NCT00371137|455082838|FG000|Overall Study|Adverse Event|20|||
126487940|NCT00371137|455082839|FG001|Overall Study|Adverse Event|35|||
126487941|NCT00371137|455082840|FG002|Overall Study|Adverse Event|42|||
126487942|NCT00371137|455082838|FG000|Overall Study|Withdrawal by Subject|11|||
126723158|NCT02052778|455936086|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126487943|NCT00371137|455082839|FG001|Overall Study|Withdrawal by Subject|10|||
126487944|NCT00371137|455082840|FG002|Overall Study|Withdrawal by Subject|15|||
126487945|NCT00371137|455082838|FG000|Overall Study|Lost to Follow-up|6|||
126487946|NCT00371137|455082839|FG001|Overall Study|Lost to Follow-up|3|||
126487947|NCT00371137|455082840|FG002|Overall Study|Lost to Follow-up|5|||
126487948|NCT00371137|455082838|FG000|Overall Study|Lack of Efficacy|30|||
126487949|NCT00371137|455082839|FG001|Overall Study|Lack of Efficacy|12|||
126487950|NCT00371137|455082840|FG002|Overall Study|Lack of Efficacy|13|||
126487951|NCT00371137|455082838|FG000|Overall Study|Sponsor Decision|2|||
126487952|NCT00371137|455082839|FG001|Overall Study|Sponsor Decision|1|||
126487953|NCT00371137|455082840|FG002|Overall Study|Sponsor Decision|2|||
126487954|NCT00371137|455082838|FG000|Overall Study|Physician Decision|1|||
126723159|NCT02052778|455936087|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
126487955|NCT00371137|455082839|FG001|Overall Study|Physician Decision|1|||
126487956|NCT00371137|455082840|FG002|Overall Study|Physician Decision|1|||
126487957|NCT00371137|455082838|FG000|Overall Study|Protocol Violation|2|||
126487958|NCT00371137|455082839|FG001|Overall Study|Protocol Violation|1|||
126487959|NCT00371137|455082840|FG002|Overall Study|Protocol Violation|1|||
126487960|NCT00833794|455082841|FG000|Open-label Phase|Adverse Event|225|||
126487961|NCT00833794|455082842|FG001|Open-label Phase|Adverse Event|0|||
126487962|NCT00833794|455082841|FG000|Open-label Phase|Lack of Efficacy|28|||
126487963|NCT00833794|455082842|FG001|Open-label Phase|Lack of Efficacy|0|||
126487964|NCT00833794|455082841|FG000|Open-label Phase|Withdrawal by Subject|48|||
126487965|NCT00833794|455082842|FG001|Open-label Phase|Withdrawal by Subject|0|||
126487966|NCT00833794|455082841|FG000|Open-label Phase|Physician Decision|20|||
126487967|NCT00833794|455082842|FG001|Open-label Phase|Physician Decision|0|||
126487968|NCT00833794|455082841|FG000|Open-label Phase|Administrative reason|1|||
126487969|NCT00833794|455082842|FG001|Open-label Phase|Administrative reason|0|||
126487970|NCT00833794|455082841|FG000|Open-label Phase|Protocol Violation|47|||
126487971|NCT00833794|455082842|FG001|Open-label Phase|Protocol Violation|0|||
126487972|NCT00833794|455082841|FG000|Open-label Phase|Did not complete wash-out period|12|||
126487973|NCT00833794|455082842|FG001|Open-label Phase|Did not complete wash-out period|0|||
126487974|NCT00833794|455082841|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
126487975|NCT00833794|455082842|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
126487976|NCT00833794|455082841|FG000|Double-blind Phase|Adverse Event|44|||
126487977|NCT00833794|455082842|FG001|Double-blind Phase|Adverse Event|11|||
126487978|NCT00833794|455082841|FG000|Double-blind Phase|Lack of Efficacy|34|||
126487979|NCT00833794|455082842|FG001|Double-blind Phase|Lack of Efficacy|22|||
126487980|NCT00833794|455082841|FG000|Double-blind Phase|Withdrawal by Subject|23|||
126487981|NCT00833794|455082842|FG001|Double-blind Phase|Withdrawal by Subject|6|||
126487982|NCT00833794|455082841|FG000|Double-blind Phase|Physician Decision|4|||
126487983|NCT00833794|455082842|FG001|Double-blind Phase|Physician Decision|7|||
126487984|NCT00833794|455082841|FG000|Double-blind Phase|Administrative reason|1|||
126487985|NCT00833794|455082842|FG001|Double-blind Phase|Administrative reason|3|||
126487986|NCT02007109|455082843|FG000|Overall Study|Diary not returned or excluded|102|||
126487987|NCT02007109|455082843|FG000|Overall Study|Excluded - Age<7yo|9|||
126487988|NCT01918085|455082844|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
126487989|NCT01918085|455082845|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
126487990|NCT00598832|455082848|FG000|Overall Study|Lack of Efficacy|3|||
126487991|NCT00598832|455082849|FG001|Overall Study|Lack of Efficacy|7|||
126487992|NCT00598832|455082848|FG000|Overall Study|Adverse Event|6|||
126487993|NCT00598832|455082849|FG001|Overall Study|Adverse Event|2|||
126487994|NCT00598832|455082848|FG000|Overall Study|Withdrawal by Subject|25|||
126487995|NCT00598832|455082849|FG001|Overall Study|Withdrawal by Subject|36|||
126487996|NCT00598832|455082848|FG000|Overall Study|Protocol Violation|0|||
126487997|NCT00598832|455082849|FG001|Overall Study|Protocol Violation|2|||
126487998|NCT00598832|455082848|FG000|Overall Study|Lost to Follow-up|24|||
126487999|NCT00598832|455082849|FG001|Overall Study|Lost to Follow-up|29|||
126488000|NCT00598832|455082848|FG000|Overall Study|Pregnancy|2|||
126488001|NCT00598832|455082849|FG001|Overall Study|Pregnancy|2|||
126488002|NCT00598832|455082848|FG000|Overall Study|Physician Decision|1|||
126488003|NCT00598832|455082849|FG001|Overall Study|Physician Decision|4|||
126488004|NCT00598832|455082848|FG000|Overall Study|Non compliance|1|||
126488005|NCT00598832|455082849|FG001|Overall Study|Non compliance|0|||
126488006|NCT02760069|455082850|FG000|Overall Study|Withdrawal by Subject|0|||
126488007|NCT02760069|455082851|FG001|Overall Study|Withdrawal by Subject|1|||
126488008|NCT02760069|455082852|FG002|Overall Study|Withdrawal by Subject|1|||
126488009|NCT00679302|455082853|FG000|Overall Study|Lost to Follow-up|8|||
126488010|NCT00679302|455082854|FG001|Overall Study|Lost to Follow-up|4|||
126488011|NCT03031678|455082855|FG000|Overall Study|Study closed prior to completion|1|||
126488012|NCT01753856|455082856|FG000|Overall Study|Adverse Event|1|||
126488013|NCT01753856|455082857|FG001|Overall Study|Adverse Event|0|||
126488014|NCT01753856|455082856|FG000|Overall Study|Withdrawal by Subject|0|||
126488015|NCT01753856|455082857|FG001|Overall Study|Withdrawal by Subject|2|||
126488016|NCT01753856|455082856|FG000|Overall Study|Sponsor Decision|2|||
126723160|NCT02052778|455936088|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723161|NCT02052778|455936089|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126772598|NCT02454972|456123637|FG008|Overall Study|Progressive disease|0|||
126488017|NCT01753856|455082857|FG001|Overall Study|Sponsor Decision|0|||
126488018|NCT00434330|455082862|FG000|Overall Study|Adverse Event|0|||
126488019|NCT00434330|455082863|FG001|Overall Study|Adverse Event|0|||
126488020|NCT00434330|455082864|FG002|Overall Study|Adverse Event|1|||
126488021|NCT00434330|455082865|FG003|Overall Study|Adverse Event|0|||
126488022|NCT00434330|455082866|FG004|Overall Study|Adverse Event|0|||
126488023|NCT00434330|455082867|FG005|Overall Study|Adverse Event|0|||
126488024|NCT00434330|455082862|FG000|Overall Study|Death|1|||
126488025|NCT00434330|455082863|FG001|Overall Study|Death|0|||
126488026|NCT00434330|455082864|FG002|Overall Study|Death|0|||
126488027|NCT00434330|455082865|FG003|Overall Study|Death|0|||
126488028|NCT00434330|455082866|FG004|Overall Study|Death|1|||
126488029|NCT00434330|455082867|FG005|Overall Study|Death|1|||
126488030|NCT00434330|455082862|FG000|Overall Study|Withdrawal by Subject|0|||
126488031|NCT00434330|455082863|FG001|Overall Study|Withdrawal by Subject|0|||
126488032|NCT00434330|455082864|FG002|Overall Study|Withdrawal by Subject|1|||
126488033|NCT00434330|455082865|FG003|Overall Study|Withdrawal by Subject|1|||
126488034|NCT00434330|455082866|FG004|Overall Study|Withdrawal by Subject|0|||
126488035|NCT00434330|455082867|FG005|Overall Study|Withdrawal by Subject|0|||
126488036|NCT00434330|455082862|FG000|Overall Study|Renal transplant|0|||
126488037|NCT00434330|455082863|FG001|Overall Study|Renal transplant|0|||
126488038|NCT00434330|455082864|FG002|Overall Study|Renal transplant|0|||
126488039|NCT00434330|455082865|FG003|Overall Study|Renal transplant|1|||
126488040|NCT00434330|455082866|FG004|Overall Study|Renal transplant|0|||
126488041|NCT00434330|455082867|FG005|Overall Study|Renal transplant|0|||
126488042|NCT00434330|455082862|FG000|Overall Study|Subject Not Compliant With Study|0|||
126488043|NCT00434330|455082863|FG001|Overall Study|Subject Not Compliant With Study|0|||
126488044|NCT00434330|455082864|FG002|Overall Study|Subject Not Compliant With Study|1|||
126488045|NCT00434330|455082865|FG003|Overall Study|Subject Not Compliant With Study|0|||
126488046|NCT00434330|455082866|FG004|Overall Study|Subject Not Compliant With Study|0|||
126488047|NCT00434330|455082867|FG005|Overall Study|Subject Not Compliant With Study|0|||
126488048|NCT05109442|455082870|FG000|Overall Study|Withdrawal by Subject|0|||
126488049|NCT05109442|455082871|FG001|Overall Study|Withdrawal by Subject|0|||
126488050|NCT05109442|455082872|FG002|Overall Study|Withdrawal by Subject|1|||
126488051|NCT05109442|455082873|FG003|Overall Study|Withdrawal by Subject|0|||
126488052|NCT05109442|455082874|FG004|Overall Study|Withdrawal by Subject|0|||
126488053|NCT05109442|455082875|FG005|Overall Study|Withdrawal by Subject|0|||
126488054|NCT05109442|455082870|FG000|Overall Study|Adverse Event|0|||
126488055|NCT05109442|455082871|FG001|Overall Study|Adverse Event|1|||
126488056|NCT05109442|455082872|FG002|Overall Study|Adverse Event|5|||
126488057|NCT05109442|455082873|FG003|Overall Study|Adverse Event|0|||
126488058|NCT05109442|455082874|FG004|Overall Study|Adverse Event|0|||
126488059|NCT05109442|455082875|FG005|Overall Study|Adverse Event|2|||
126488060|NCT05109442|455082870|FG000|Overall Study|Death|0|||
126488061|NCT05109442|455082871|FG001|Overall Study|Death|0|||
126488062|NCT05109442|455082872|FG002|Overall Study|Death|4|||
126488063|NCT05109442|455082873|FG003|Overall Study|Death|0|||
126488064|NCT05109442|455082874|FG004|Overall Study|Death|0|||
126488065|NCT05109442|455082875|FG005|Overall Study|Death|1|||
126488066|NCT05109442|455082870|FG000|Overall Study|Physician Decision|1|||
126488067|NCT05109442|455082871|FG001|Overall Study|Physician Decision|0|||
126488068|NCT05109442|455082872|FG002|Overall Study|Physician Decision|1|||
126488069|NCT05109442|455082873|FG003|Overall Study|Physician Decision|0|||
126488070|NCT05109442|455082874|FG004|Overall Study|Physician Decision|0|||
126488071|NCT05109442|455082875|FG005|Overall Study|Physician Decision|2|||
126488072|NCT05109442|455082870|FG000|Overall Study|Other than listed|0|||
126488073|NCT05109442|455082871|FG001|Overall Study|Other than listed|0|||
126488074|NCT05109442|455082872|FG002|Overall Study|Other than listed|9|||
126488075|NCT05109442|455082873|FG003|Overall Study|Other than listed|2|||
126488076|NCT05109442|455082874|FG004|Overall Study|Other than listed|0|||
126488077|NCT05109442|455082875|FG005|Overall Study|Other than listed|8|||
126488078|NCT05109442|455082870|FG000|Overall Study|Lack of Efficacy|3|||
126488079|NCT05109442|455082871|FG001|Overall Study|Lack of Efficacy|5|||
126488080|NCT05109442|455082872|FG002|Overall Study|Lack of Efficacy|29|||
126488081|NCT05109442|455082873|FG003|Overall Study|Lack of Efficacy|10|||
126488082|NCT05109442|455082874|FG004|Overall Study|Lack of Efficacy|11|||
126488083|NCT05109442|455082875|FG005|Overall Study|Lack of Efficacy|17|||
126488084|NCT04853225|455082876|FG000|Overall Study|Withdrawal by Subject|81|||
126488085|NCT04853225|455082877|FG001|Overall Study|Withdrawal by Subject|4|||
126488086|NCT04853225|455082878|FG002|Overall Study|Withdrawal by Subject|1|||
126488087|NCT04853225|455082876|FG000|Overall Study|Physician Decision|12|||
126488088|NCT04853225|455082877|FG001|Overall Study|Physician Decision|4|||
126488089|NCT04853225|455082878|FG002|Overall Study|Physician Decision|1|||
126488090|NCT04853225|455082876|FG000|Overall Study|Lost to Follow-up|50|||
126488091|NCT04853225|455082877|FG001|Overall Study|Lost to Follow-up|0|||
126488092|NCT04853225|455082878|FG002|Overall Study|Lost to Follow-up|0|||
126488093|NCT04853225|455082876|FG000|Overall Study|Other|102|||
126488094|NCT04853225|455082877|FG001|Overall Study|Other|11|||
126488095|NCT04853225|455082878|FG002|Overall Study|Other|5|||
126488096|NCT04853225|455082876|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
126488097|NCT04853225|455082877|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
126488098|NCT04853225|455082878|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
126488099|NCT04853225|455082876|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
126488100|NCT04853225|455082877|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
126488101|NCT04853225|455082878|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
126488102|NCT03918447|455082879|FG000|Overall Study|Death|1|||
126488103|NCT03918447|455082880|FG001|Overall Study|Death|0|||
126488104|NCT03918447|455082879|FG000|Overall Study|Lost to Follow-up|13|||
126488105|NCT03918447|455082880|FG001|Overall Study|Lost to Follow-up|6|||
126488106|NCT03918447|455082879|FG000|Overall Study|Withdrawal by Subject|19|||
126488107|NCT03918447|455082880|FG001|Overall Study|Withdrawal by Subject|17|||
126488108|NCT03918447|455082879|FG000|Overall Study|Study Terminated by Sponsor|195|||
126488109|NCT03918447|455082880|FG001|Overall Study|Study Terminated by Sponsor|197|||
126488110|NCT03918447|455082879|FG000|Overall Study|Reason not Specified|0|||
126488111|NCT03918447|455082880|FG001|Overall Study|Reason not Specified|1|||
126488112|NCT03278613|455082881|FG000|Overall Study|Lost to Follow-up|3|||
126488113|NCT03278613|455082882|FG001|Overall Study|Lost to Follow-up|1|||
126488114|NCT01405456|455082883|FG000|Overall Study|Lost to Follow-up|2|||
126488115|NCT01405456|455082884|FG001|Overall Study|Lost to Follow-up|1|||
126488116|NCT01405456|455082883|FG000|Overall Study|Physician Decision|1|||
126488117|NCT01405456|455082884|FG001|Overall Study|Physician Decision|0|||
126488118|NCT05355805|455082885|FG000|Overall Study|Lost to Follow-up|6|||
126488119|NCT05355805|455082886|FG001|Overall Study|Lost to Follow-up|11|||
126488120|NCT05355805|455082887|FG002|Overall Study|Lost to Follow-up|10|||
126488121|NCT05355805|455082888|FG003|Overall Study|Lost to Follow-up|6|||
126488122|NCT05355805|455082885|FG000|Overall Study|Decision by Sponsor|0|||
126488123|NCT05355805|455082886|FG001|Overall Study|Decision by Sponsor|0|||
126488124|NCT05355805|455082887|FG002|Overall Study|Decision by Sponsor|1|||
126488125|NCT05355805|455082888|FG003|Overall Study|Decision by Sponsor|0|||
126488126|NCT05355805|455082885|FG000|Overall Study|Withdrawal by Subject|7|||
126488127|NCT05355805|455082886|FG001|Overall Study|Withdrawal by Subject|14|||
126488128|NCT05355805|455082887|FG002|Overall Study|Withdrawal by Subject|15|||
126488129|NCT05355805|455082888|FG003|Overall Study|Withdrawal by Subject|13|||
126488130|NCT02167893|455082889|FG000|Overall Study|Investigator transferred|85|||
126488131|NCT02167893|455082889|FG000|Overall Study|Investigator health reasons|10|||
126488132|NCT02167893|455082889|FG000|Overall Study|Case report forms not collected|68|||
126488133|NCT04818840|455082890|FG000|Overall Study|Lost to Follow-up|0|||
126488134|NCT04818840|455082891|FG001|Overall Study|Lost to Follow-up|5|||
126488135|NCT04818840|455082890|FG000|Overall Study|Physician Decision|1|||
126488136|NCT04818840|455082891|FG001|Overall Study|Physician Decision|0|||
126488137|NCT04818840|455082890|FG000|Overall Study|Site Terminated by Sponsor|0|||
126488138|NCT04818840|455082891|FG001|Overall Study|Site Terminated by Sponsor|3|||
126488139|NCT04818840|455082890|FG000|Overall Study|Study Terminated by Sponsor|43|||
126488140|NCT04818840|455082891|FG001|Overall Study|Study Terminated by Sponsor|7|||
126488141|NCT04818840|455082890|FG000|Overall Study|Withdrawal by Subject|0|||
126488142|NCT04818840|455082891|FG001|Overall Study|Withdrawal by Subject|1|||
126488143|NCT00793598|455084486|FG000|Overall Study|Patient Request|0|||
126488144|NCT00793598|455084487|FG001|Overall Study|Patient Request|1|||
126488145|NCT00793598|455084488|FG002|Overall Study|Patient Request|0|||
126488146|NCT00793598|455084489|FG003|Overall Study|Patient Request|0|||
126488147|NCT00793598|455084490|FG004|Overall Study|Patient Request|0|||
126488148|NCT00793598|455084491|FG005|Overall Study|Patient Request|0|||
126488149|NCT00793598|455084492|FG006|Overall Study|Patient Request|0|||
126488150|NCT00793598|455084493|FG007|Overall Study|Patient Request|0|||
126488151|NCT00793598|455084486|FG000|Overall Study|Protocol Violation|0|||
126488152|NCT00793598|455084487|FG001|Overall Study|Protocol Violation|0|||
126488153|NCT00793598|455084488|FG002|Overall Study|Protocol Violation|0|||
126488154|NCT00793598|455084489|FG003|Overall Study|Protocol Violation|0|||
126488155|NCT00793598|455084490|FG004|Overall Study|Protocol Violation|0|||
126488156|NCT00793598|455084491|FG005|Overall Study|Protocol Violation|0|||
126488157|NCT00793598|455084492|FG006|Overall Study|Protocol Violation|0|||
126488158|NCT00793598|455084493|FG007|Overall Study|Protocol Violation|1|||
126488159|NCT00793598|455084486|FG000|Overall Study|Subject not dosed|0|||
126488160|NCT00793598|455084487|FG001|Overall Study|Subject not dosed|0|||
126488161|NCT00793598|455084488|FG002|Overall Study|Subject not dosed|0|||
126488162|NCT00793598|455084489|FG003|Overall Study|Subject not dosed|0|||
126488163|NCT00793598|455084490|FG004|Overall Study|Subject not dosed|0|||
126488164|NCT00793598|455084491|FG005|Overall Study|Subject not dosed|1|||
126488165|NCT00793598|455084492|FG006|Overall Study|Subject not dosed|0|||
126488166|NCT00793598|455084493|FG007|Overall Study|Subject not dosed|0|||
126488167|NCT02310568|455084496|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
126488168|NCT02310568|455084497|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
126488169|NCT02310568|455084498|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
126488170|NCT02310568|455084499|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
126488171|NCT02310568|455084500|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
126488172|NCT02310568|455084496|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
126488173|NCT02310568|455084497|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
126488174|NCT02310568|455084498|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
126488175|NCT02310568|455084499|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
126488176|NCT02310568|455084500|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
126488177|NCT02310568|455084496|FG000|Stage 1 ( 4 Weeks)|Other|1|||
126772599|NCT02454972|456123629|FG000|Overall Study|Death|0|||
126488178|NCT02310568|455084497|FG001|Stage 1 ( 4 Weeks)|Other|1|||
126488179|NCT02310568|455084498|FG002|Stage 1 ( 4 Weeks)|Other|0|||
126488180|NCT02310568|455084499|FG003|Stage 1 ( 4 Weeks)|Other|0|||
126488181|NCT02310568|455084500|FG004|Stage 1 ( 4 Weeks)|Other|0|||
126488182|NCT02310568|455084496|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
126488183|NCT02310568|455084497|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
126488184|NCT02310568|455084498|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
126488185|NCT02310568|455084499|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
126488186|NCT02310568|455084500|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
126488187|NCT02310568|455084496|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
126488188|NCT02310568|455084497|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
126488189|NCT02310568|455084498|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
126488190|NCT02310568|455084499|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
126488191|NCT02310568|455084500|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
126488192|NCT02310568|455084496|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
126488193|NCT02310568|455084497|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
126488194|NCT02310568|455084498|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
126488195|NCT02310568|455084499|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
126488196|NCT02310568|455084500|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
126488197|NCT02310568|455084496|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
126488198|NCT02310568|455084497|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
126488199|NCT02310568|455084498|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
126488200|NCT02310568|455084499|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
126488201|NCT02310568|455084500|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
126488202|NCT02310568|455084496|FG000|Stage 2 (4 Weeks)|Other|0|||
126488203|NCT02310568|455084497|FG001|Stage 2 (4 Weeks)|Other|1|||
126488204|NCT02310568|455084498|FG002|Stage 2 (4 Weeks)|Other|1|||
126488205|NCT02310568|455084499|FG003|Stage 2 (4 Weeks)|Other|0|||
126488206|NCT02310568|455084500|FG004|Stage 2 (4 Weeks)|Other|0|||
126488207|NCT02310568|455084496|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
126488208|NCT02310568|455084497|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
126488209|NCT02310568|455084498|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
126488210|NCT02310568|455084499|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
126488211|NCT02310568|455084500|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
126488212|NCT02310568|455084496|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
126488213|NCT02310568|455084497|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
126488214|NCT02310568|455084498|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
126488215|NCT02310568|455084499|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
126488216|NCT02310568|455084500|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
126488217|NCT02310568|455084496|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
126488218|NCT02310568|455084497|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
126488219|NCT02310568|455084498|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
126488220|NCT02310568|455084499|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
126488221|NCT02310568|455084500|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
126488222|NCT02989194|455084506|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
126488223|NCT02989194|455084507|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
126488224|NCT02989194|455084508|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
126488225|NCT02989194|455084506|FG000|Overall Study|Lost to Follow-up|0|||
126488226|NCT02989194|455084507|FG001|Overall Study|Lost to Follow-up|1|||
126488227|NCT02989194|455084508|FG002|Overall Study|Lost to Follow-up|0|||
126488228|NCT02989194|455084506|FG000|Overall Study|Withdrawal by Subject|0|||
126488229|NCT02989194|455084507|FG001|Overall Study|Withdrawal by Subject|1|||
126488230|NCT02989194|455084508|FG002|Overall Study|Withdrawal by Subject|0|||
126488231|NCT01224431|455084511|FG000|Overall Study|not randomized|0|||
126488232|NCT01224431|455084512|FG001|Overall Study|not randomized|4|||
126488233|NCT01224431|455084511|FG000|Overall Study|no video record|0|||
126488234|NCT01224431|455084512|FG001|Overall Study|no video record|1|||
126488235|NCT03824912|455084519|FG000|Overall Study|Lost to Follow-up|18|||
126488236|NCT03824912|455084520|FG001|Overall Study|Lost to Follow-up|15|||
126488237|NCT03824912|455084521|FG002|Overall Study|Lost to Follow-up|8|||
126488238|NCT03824912|455084519|FG000|Overall Study|Negative Baseline Culture Result|118|||
126488239|NCT03824912|455084520|FG001|Overall Study|Negative Baseline Culture Result|112|||
126488240|NCT03824912|455084521|FG002|Overall Study|Negative Baseline Culture Result|57|||
126488241|NCT03824912|455084519|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126488242|NCT03824912|455084520|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126488243|NCT03824912|455084521|FG002|Overall Study|Non-Compliance with Study Drug|1|||
126488244|NCT03824912|455084519|FG000|Overall Study|Protocol Violation|1|||
126488245|NCT03824912|455084520|FG001|Overall Study|Protocol Violation|4|||
126488246|NCT03824912|455084521|FG002|Overall Study|Protocol Violation|1|||
126488247|NCT03824912|455084519|FG000|Overall Study|Withdrawal by Subject|3|||
126488248|NCT03824912|455084520|FG001|Overall Study|Withdrawal by Subject|2|||
126488249|NCT03824912|455084521|FG002|Overall Study|Withdrawal by Subject|1|||
126488250|NCT03824912|455084519|FG000|Overall Study|Participation in another study|0|||
126488251|NCT03824912|455084520|FG001|Overall Study|Participation in another study|1|||
126488252|NCT03824912|455084521|FG002|Overall Study|Participation in another study|0|||
126488253|NCT02511184|455084522|FG000|Overall Study|Death|1|||
126488254|NCT02511184|455084523|FG001|Overall Study|Death|0|||
126488255|NCT02511184|455084522|FG000|Overall Study|Lost to Follow-up|0|||
126488256|NCT02511184|455084523|FG001|Overall Study|Lost to Follow-up|1|||
126488257|NCT02511184|455084522|FG000|Overall Study|Study terminated by sponsor|1|||
126488258|NCT02511184|455084523|FG001|Overall Study|Study terminated by sponsor|5|||
126488259|NCT02511184|455084522|FG000|Overall Study|Withdrawal by Subject|0|||
126488260|NCT02511184|455084523|FG001|Overall Study|Withdrawal by Subject|1|||
126488261|NCT03138889|455084534|FG000|Overall Study|Withdrawal by Subject|5|||
126488262|NCT03138889|455084535|FG001|Overall Study|Withdrawal by Subject|5|||
126723162|NCT02052778|455936090|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723163|NCT02052778|455936091|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126488263|NCT03138889|455084536|FG002|Overall Study|Withdrawal by Subject|0|||
126488264|NCT03138889|455084537|FG003|Overall Study|Withdrawal by Subject|2|||
126488265|NCT03138889|455084538|FG004|Overall Study|Withdrawal by Subject|1|||
126488266|NCT03138889|455084539|FG005|Overall Study|Withdrawal by Subject|3|||
126488267|NCT03138889|455084540|FG006|Overall Study|Withdrawal by Subject|0|||
126488268|NCT03138889|455084541|FG007|Overall Study|Withdrawal by Subject|1|||
126488269|NCT01963403|455084546|FG000|Overall Study|Lost to Follow-up|2|||
126488270|NCT01963403|455084547|FG001|Overall Study|Lost to Follow-up|3|||
126488271|NCT01963403|455084546|FG000|Overall Study|Implant removal|0|||
126488272|NCT01963403|455084547|FG001|Overall Study|Implant removal|1|||
126488273|NCT02289690|455084554|FG000|Overall Study|Adverse Event Related to Progression|0|||
126488274|NCT02289690|455084555|FG001|Overall Study|Adverse Event Related to Progression|1|||
126488275|NCT02289690|455084556|FG002|Overall Study|Adverse Event Related to Progression|1|||
126488276|NCT02289690|455084557|FG003|Overall Study|Adverse Event Related to Progression|0|||
126488277|NCT02289690|455084558|FG004|Overall Study|Adverse Event Related to Progression|1|||
126488278|NCT02289690|455084559|FG005|Overall Study|Adverse Event Related to Progression|0|||
126488279|NCT02289690|455084560|FG006|Overall Study|Adverse Event Related to Progression|1|||
126488280|NCT02289690|455084561|FG007|Overall Study|Adverse Event Related to Progression|0|||
126488281|NCT02289690|455084562|FG008|Overall Study|Adverse Event Related to Progression|0|||
126488282|NCT02289690|455084563|FG009|Overall Study|Adverse Event Related to Progression|0|||
126488283|NCT02289690|455084554|FG000|Overall Study|Withdrawal by Subject|1|||
126488284|NCT02289690|455084555|FG001|Overall Study|Withdrawal by Subject|0|||
126488285|NCT02289690|455084556|FG002|Overall Study|Withdrawal by Subject|0|||
126488286|NCT02289690|455084557|FG003|Overall Study|Withdrawal by Subject|0|||
126488287|NCT02289690|455084558|FG004|Overall Study|Withdrawal by Subject|1|||
126488288|NCT02289690|455084559|FG005|Overall Study|Withdrawal by Subject|1|||
126488289|NCT02289690|455084560|FG006|Overall Study|Withdrawal by Subject|0|||
126488290|NCT02289690|455084561|FG007|Overall Study|Withdrawal by Subject|0|||
126488291|NCT02289690|455084562|FG008|Overall Study|Withdrawal by Subject|4|||
126488292|NCT02289690|455084563|FG009|Overall Study|Withdrawal by Subject|2|||
126488293|NCT02289690|455084554|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
126488294|NCT02289690|455084555|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
126488295|NCT02289690|455084556|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
126488296|NCT02289690|455084557|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
126488297|NCT02289690|455084558|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
126488298|NCT02289690|455084559|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
126488299|NCT02289690|455084560|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
126488300|NCT02289690|455084561|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
126488301|NCT02289690|455084562|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
126488302|NCT02289690|455084563|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
126488303|NCT02289690|455084554|FG000|Overall Study|Lost to Follow-up|0|||
126488304|NCT02289690|455084555|FG001|Overall Study|Lost to Follow-up|0|||
126488305|NCT02289690|455084556|FG002|Overall Study|Lost to Follow-up|0|||
126488306|NCT02289690|455084557|FG003|Overall Study|Lost to Follow-up|0|||
126488307|NCT02289690|455084558|FG004|Overall Study|Lost to Follow-up|0|||
126488308|NCT02289690|455084559|FG005|Overall Study|Lost to Follow-up|0|||
126488309|NCT02289690|455084560|FG006|Overall Study|Lost to Follow-up|0|||
126488310|NCT02289690|455084561|FG007|Overall Study|Lost to Follow-up|1|||
126488311|NCT02289690|455084562|FG008|Overall Study|Lost to Follow-up|0|||
126488312|NCT02289690|455084563|FG009|Overall Study|Lost to Follow-up|2|||
126723164|NCT02052778|455936092|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723165|NCT02052778|455936093|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723166|NCT02052778|455936094|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
126723167|NCT02052778|455936095|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723168|NCT02052778|455936096|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723169|NCT02052778|455936097|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723170|NCT02052778|455936098|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126772600|NCT02454972|456123630|FG001|Overall Study|Death|0|||
126488313|NCT02289690|455084554|FG000|Overall Study|Death|0|||
126488314|NCT02289690|455084555|FG001|Overall Study|Death|0|||
126488315|NCT02289690|455084556|FG002|Overall Study|Death|0|||
126488316|NCT02289690|455084557|FG003|Overall Study|Death|0|||
126488317|NCT02289690|455084558|FG004|Overall Study|Death|0|||
126723171|NCT02052778|455936099|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126772601|NCT02454972|456123631|FG002|Overall Study|Death|5|||
126488318|NCT02289690|455084559|FG005|Overall Study|Death|0|||
126488319|NCT02289690|455084560|FG006|Overall Study|Death|0|||
126488320|NCT02289690|455084561|FG007|Overall Study|Death|49|||
126488321|NCT02289690|455084562|FG008|Overall Study|Death|45|||
126488322|NCT02289690|455084563|FG009|Overall Study|Death|41|||
126488323|NCT02289690|455084554|FG000|Overall Study|Sponsor Discontinued Study|0|||
126488324|NCT02289690|455084555|FG001|Overall Study|Sponsor Discontinued Study|0|||
126488325|NCT02289690|455084556|FG002|Overall Study|Sponsor Discontinued Study|0|||
126488326|NCT02289690|455084557|FG003|Overall Study|Sponsor Discontinued Study|0|||
126488327|NCT02289690|455084558|FG004|Overall Study|Sponsor Discontinued Study|0|||
126488328|NCT02289690|455084559|FG005|Overall Study|Sponsor Discontinued Study|0|||
126488329|NCT02289690|455084560|FG006|Overall Study|Sponsor Discontinued Study|0|||
126488330|NCT02289690|455084561|FG007|Overall Study|Sponsor Discontinued Study|9|||
126488331|NCT02289690|455084562|FG008|Overall Study|Sponsor Discontinued Study|7|||
126488332|NCT02289690|455084563|FG009|Overall Study|Sponsor Discontinued Study|15|||
126488333|NCT02289690|455084554|FG000|Overall Study|Other|0|||
126488334|NCT02289690|455084555|FG001|Overall Study|Other|0|||
126488335|NCT02289690|455084556|FG002|Overall Study|Other|0|||
126488336|NCT02289690|455084557|FG003|Overall Study|Other|1|||
126488337|NCT02289690|455084558|FG004|Overall Study|Other|1|||
126488338|NCT02289690|455084559|FG005|Overall Study|Other|0|||
126488339|NCT02289690|455084560|FG006|Overall Study|Other|1|||
126488340|NCT02289690|455084561|FG007|Overall Study|Other|2|||
126488341|NCT02289690|455084562|FG008|Overall Study|Other|3|||
126488342|NCT02289690|455084563|FG009|Overall Study|Other|1|||
126488343|NCT02254486|455084566|FG000|Overall Study|Adverse Event|1|||
126488344|NCT02254486|455084567|FG001|Overall Study|Adverse Event|1|||
126488345|NCT02254486|455084566|FG000|Overall Study|Lack of Efficacy|1|||
126488346|NCT02254486|455084567|FG001|Overall Study|Lack of Efficacy|0|||
126488347|NCT02254486|455084566|FG000|Overall Study|Lost to Follow-up|2|||
126488348|NCT02254486|455084567|FG001|Overall Study|Lost to Follow-up|4|||
126488349|NCT02254486|455084566|FG000|Overall Study|Protocol Violation|1|||
126488350|NCT02254486|455084567|FG001|Overall Study|Protocol Violation|2|||
126488351|NCT02254486|455084566|FG000|Overall Study|Withdrawal by Subject|17|||
126488352|NCT02254486|455084567|FG001|Overall Study|Withdrawal by Subject|15|||
126488353|NCT02254486|455084566|FG000|Overall Study|GFR<60mL/min|16|||
126488354|NCT02254486|455084567|FG001|Overall Study|GFR<60mL/min|21|||
126488355|NCT02254486|455084566|FG000|Overall Study|Various|12|||
126488356|NCT02254486|455084567|FG001|Overall Study|Various|12|||
126488357|NCT01350414|455084574|FG000|Overall Study|Lost to Follow-up|13|||
126488358|NCT01350414|455084574|FG000|Overall Study|Withdrawal by Subject|4|||
126488359|NCT01350414|455084574|FG000|Overall Study|Physician Decision|2|||
126488360|NCT04016285|455084575|FG000|Overall Study|Did not progress to surgery|2|||
126488361|NCT04016285|455084576|FG001|Overall Study|Did not progress to surgery|5|||
126488362|NCT04016285|455084575|FG000|Overall Study|Failed to collect outcome data|5|||
126488363|NCT04016285|455084576|FG001|Overall Study|Failed to collect outcome data|3|||
126488364|NCT04166435|455084577|FG000|Overall Study|2 patients ineligible for response|2|||
126488365|NCT03033394|455084581|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
126488366|NCT03033394|455084581|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
126488367|NCT03033394|455084581|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
126488368|NCT03033394|455084581|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
126488369|NCT03033394|455084581|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
126488370|NCT02036294|455084582|FG000|Overall Study|Death|7|||
126488371|NCT02036294|455084583|FG001|Overall Study|Death|8|||
126488372|NCT02036294|455084582|FG000|Overall Study|Withdrawal by Subject|2|||
126488373|NCT02036294|455084583|FG001|Overall Study|Withdrawal by Subject|3|||
126488374|NCT00356369|455084584|FG000|Active Phase|Withdrawal by Subject|2|||
126488375|NCT00356369|455084585|FG001|Active Phase|Withdrawal by Subject|1|||
126488376|NCT02407704|455084602|FG000|Overall Study|Lost to Follow-up|0|||
126488377|NCT02407704|455084603|FG001|Overall Study|Lost to Follow-up|0|||
126488378|NCT02407704|455084604|FG002|Overall Study|Lost to Follow-up|0|||
126559535|NCT02373813|455342535|FG000|Run-In Period|Noncompliance|1|||
126559536|NCT02373813|455342536|FG001|Run-In Period|Noncompliance|0|||
126559537|NCT02373813|455342537|FG002|Run-In Period|Noncompliance|0|||
126772602|NCT02454972|456123632|FG003|Overall Study|Death|1|||
126559538|NCT02373813|455342538|FG003|Run-In Period|Noncompliance|0|||
126559539|NCT02373813|455342535|FG000|Run-In Period|Ineligibility Determined|3|||
126772603|NCT02454972|456123633|FG004|Overall Study|Death|0|||
126488379|NCT02407704|455084605|FG003|Overall Study|Lost to Follow-up|2|||
126488380|NCT02407704|455084602|FG000|Overall Study|Protocol Violation|0|||
126488381|NCT02407704|455084603|FG001|Overall Study|Protocol Violation|0|||
126488382|NCT02407704|455084604|FG002|Overall Study|Protocol Violation|0|||
126488383|NCT02407704|455084605|FG003|Overall Study|Protocol Violation|1|||
126488384|NCT02407704|455084602|FG000|Overall Study|Withdrawal by Subject|0|||
126488385|NCT02407704|455084603|FG001|Overall Study|Withdrawal by Subject|0|||
126488386|NCT02407704|455084604|FG002|Overall Study|Withdrawal by Subject|1|||
126488387|NCT02407704|455084605|FG003|Overall Study|Withdrawal by Subject|0|||
126488388|NCT03944954|455084606|FG000|Overall Study|Withdrawal by Subject|22|||
126488389|NCT03944954|455084607|FG001|Overall Study|Withdrawal by Subject|4|||
126772604|NCT02454972|456123634|FG005|Overall Study|Death|0|||
126559540|NCT02373813|455342536|FG001|Run-In Period|Ineligibility Determined|0|||
126559541|NCT02373813|455342537|FG002|Run-In Period|Ineligibility Determined|0|||
126559542|NCT02373813|455342538|FG003|Run-In Period|Ineligibility Determined|0|||
126559543|NCT02373813|455342535|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
126488390|NCT03944954|455084606|FG000|Overall Study|Lost to Follow-up|18|||
126488391|NCT03944954|455084607|FG001|Overall Study|Lost to Follow-up|0|||
126488392|NCT03944954|455084606|FG000|Overall Study|Failed Medical Screening|7|||
126488393|NCT03944954|455084607|FG001|Overall Study|Failed Medical Screening|0|||
126488394|NCT02730455|455084610|FG000|Overall Study|Death|5|||
126488395|NCT02730455|455084611|FG001|Overall Study|Death|6|||
126488396|NCT02730455|455084612|FG002|Overall Study|Death|4|||
126488397|NCT02730455|455084610|FG000|Overall Study|Consent withdrawn|2|||
126488398|NCT02730455|455084611|FG001|Overall Study|Consent withdrawn|4|||
126488399|NCT02730455|455084612|FG002|Overall Study|Consent withdrawn|1|||
126488400|NCT02730455|455084610|FG000|Overall Study|Lost to Follow-up|3|||
126488401|NCT02730455|455084611|FG001|Overall Study|Lost to Follow-up|1|||
126488402|NCT02730455|455084612|FG002|Overall Study|Lost to Follow-up|4|||
126488403|NCT02730455|455084610|FG000|Overall Study|Other|1|||
126488404|NCT02730455|455084611|FG001|Overall Study|Other|1|||
126488405|NCT02730455|455084612|FG002|Overall Study|Other|2|||
126488406|NCT02730455|455084610|FG000|Overall Study|Other|2|||
126488407|NCT02730455|455084611|FG001|Overall Study|Other|2|||
126488408|NCT02730455|455084612|FG002|Overall Study|Other|0|||
126488409|NCT02268084|455084619|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
126488410|NCT02268084|455084620|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
126488411|NCT02268084|455084619|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
126488412|NCT02268084|455084620|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
126488413|NCT05227027|455084621|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
126488414|NCT05227027|455084622|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
126488415|NCT01683383|455084623|FG000|Overall Study|Infant was not transported|1|||
126488416|NCT01683383|455084624|FG001|Overall Study|Infant was not transported|0|||
126488417|NCT00855920|455084625|FG000|Overall Study|Protocol Violation|0|||
126488418|NCT00855920|455084626|FG001|Overall Study|Protocol Violation|0|||
126488419|NCT00855920|455084627|FG002|Overall Study|Protocol Violation|2|||
126488420|NCT00855920|455084625|FG000|Overall Study|Adverse Event|2|||
126488421|NCT00855920|455084626|FG001|Overall Study|Adverse Event|1|||
126488422|NCT00855920|455084627|FG002|Overall Study|Adverse Event|1|||
126488423|NCT00855920|455084625|FG000|Overall Study|Lack of Efficacy|2|||
126488424|NCT00855920|455084626|FG001|Overall Study|Lack of Efficacy|2|||
126488425|NCT00855920|455084627|FG002|Overall Study|Lack of Efficacy|2|||
126488426|NCT00855920|455084625|FG000|Overall Study|Withdrawal by Subject|2|||
126488427|NCT00855920|455084626|FG001|Overall Study|Withdrawal by Subject|3|||
126488428|NCT00855920|455084627|FG002|Overall Study|Withdrawal by Subject|2|||
126488429|NCT00855920|455084625|FG000|Overall Study|Lost to Follow-up|1|||
126488430|NCT00855920|455084626|FG001|Overall Study|Lost to Follow-up|0|||
126488431|NCT00855920|455084627|FG002|Overall Study|Lost to Follow-up|2|||
126488432|NCT00855920|455084625|FG000|Overall Study|Death|0|||
126488433|NCT00855920|455084626|FG001|Overall Study|Death|1|||
126488434|NCT00855920|455084627|FG002|Overall Study|Death|0|||
126488435|NCT00855920|455084625|FG000|Overall Study|Decision by the sponsor|0|||
126488436|NCT00855920|455084626|FG001|Overall Study|Decision by the sponsor|1|||
126488437|NCT00855920|455084627|FG002|Overall Study|Decision by the sponsor|1|||
126488438|NCT00855920|455084625|FG000|Overall Study|Other than specified above|1|||
126488439|NCT00855920|455084626|FG001|Overall Study|Other than specified above|1|||
126488440|NCT00855920|455084627|FG002|Overall Study|Other than specified above|1|||
126488441|NCT00996307|455084628|FG000|Overall Study|Adverse Event|0|||
126488442|NCT00996307|455084629|FG001|Overall Study|Adverse Event|1|||
126488443|NCT00996307|455084630|FG002|Overall Study|Adverse Event|0|||
126488444|NCT00996307|455084631|FG003|Overall Study|Adverse Event|0|||
126488445|NCT00996307|455084628|FG000|Overall Study|Withdrawal by Subject|3|||
126488446|NCT00996307|455084629|FG001|Overall Study|Withdrawal by Subject|2|||
126488447|NCT00996307|455084630|FG002|Overall Study|Withdrawal by Subject|5|||
126488448|NCT00996307|455084631|FG003|Overall Study|Withdrawal by Subject|5|||
126488449|NCT00996307|455084628|FG000|Overall Study|Lost to Follow-up|13|||
126488450|NCT00996307|455084629|FG001|Overall Study|Lost to Follow-up|13|||
126488451|NCT00996307|455084630|FG002|Overall Study|Lost to Follow-up|7|||
126488452|NCT00996307|455084631|FG003|Overall Study|Lost to Follow-up|15|||
126488453|NCT00996307|455084628|FG000|Overall Study|Administrative reason|0|||
126488454|NCT00996307|455084629|FG001|Overall Study|Administrative reason|1|||
126488455|NCT00996307|455084630|FG002|Overall Study|Administrative reason|0|||
126488456|NCT00996307|455084631|FG003|Overall Study|Administrative reason|0|||
126488457|NCT00996307|455084628|FG000|Overall Study|Unable to classify|4|||
126488458|NCT00996307|455084629|FG001|Overall Study|Unable to classify|0|||
126488459|NCT00996307|455084630|FG002|Overall Study|Unable to classify|2|||
126723172|NCT02052778|455936100|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723173|NCT02052778|455936101|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723174|NCT02052778|455936102|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723175|NCT02052778|455936103|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723176|NCT02052778|455936104|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
126723177|NCT02052778|455936082|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126723178|NCT02052778|455936083|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126723179|NCT02052778|455936084|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126723180|NCT02052778|455936085|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126488460|NCT00996307|455084631|FG003|Overall Study|Unable to classify|1|||
126488461|NCT01365910|455084633|FG000|Overall Study|Withdrawal by Subject|7|||
126488462|NCT01365910|455084633|FG000|Overall Study|disease progression|18|||
126488463|NCT01365910|455084633|FG000|Overall Study|Adverse Event|3|||
126488464|NCT01365910|455084633|FG000|Overall Study|other complicating disease|1|||
126488465|NCT01365910|455084633|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
126488466|NCT00536198|455084634|FG000|Overall Study|Lost to Follow-up|15|||
126488467|NCT00536198|455084635|FG001|Overall Study|Lost to Follow-up|14|||
126488468|NCT00536198|455084634|FG000|Overall Study|Withdrawal by Subject|16|||
126488469|NCT00536198|455084635|FG001|Overall Study|Withdrawal by Subject|12|||
126488470|NCT00536198|455084634|FG000|Overall Study|Adverse Event|2|||
126488471|NCT00536198|455084635|FG001|Overall Study|Adverse Event|2|||
126488472|NCT00536198|455084634|FG000|Overall Study|Rescue|3|||
126488473|NCT00536198|455084635|FG001|Overall Study|Rescue|9|||
126488474|NCT00536198|455084634|FG000|Overall Study|Pregnancy|1|||
126488475|NCT00536198|455084635|FG001|Overall Study|Pregnancy|1|||
126488476|NCT00536198|455084634|FG000|Overall Study|Protocol Violation|0|||
126488477|NCT00536198|455084635|FG001|Overall Study|Protocol Violation|1|||
126488478|NCT02013791|455084636|FG000|Period 1|Lost to Follow-up|0|||
126488479|NCT02013791|455084637|FG001|Period 1|Lost to Follow-up|0|||
126488480|NCT02013791|455084638|FG002|Period 1|Lost to Follow-up|0|||
126488481|NCT02013791|455084639|FG003|Period 1|Lost to Follow-up|1|||
126488482|NCT02013791|455084640|FG004|Period 1|Lost to Follow-up|0|||
126488483|NCT02013791|455084641|FG005|Period 1|Lost to Follow-up|0|||
126488484|NCT02013791|455084642|FG006|Period 1|Lost to Follow-up|1|||
126488485|NCT02013791|455084643|FG007|Period 1|Lost to Follow-up|1|||
126488486|NCT02013791|455084644|FG008|Period 1|Lost to Follow-up|0|||
126488487|NCT02013791|455084636|FG000|Period 1|Other Miscellaneous Reasons|0|||
126488488|NCT02013791|455084637|FG001|Period 1|Other Miscellaneous Reasons|2|||
126488489|NCT02013791|455084638|FG002|Period 1|Other Miscellaneous Reasons|0|||
126488490|NCT02013791|455084639|FG003|Period 1|Other Miscellaneous Reasons|0|||
126488491|NCT02013791|455084640|FG004|Period 1|Other Miscellaneous Reasons|0|||
126488492|NCT02013791|455084641|FG005|Period 1|Other Miscellaneous Reasons|0|||
126488493|NCT02013791|455084642|FG006|Period 1|Other Miscellaneous Reasons|0|||
126488494|NCT02013791|455084643|FG007|Period 1|Other Miscellaneous Reasons|0|||
126723181|NCT02052778|455936086|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126723182|NCT02052778|455936087|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126723183|NCT02052778|455936088|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126488495|NCT02013791|455084644|FG008|Period 1|Other Miscellaneous Reasons|0|||
126488496|NCT03798483|455084645|FG000|Overall Study|Lost to Follow-up|2|||
126488497|NCT00640601|455084647|FG000|Overall Study|Adverse Event|43|||
126488498|NCT00640601|455084647|FG000|Overall Study|Withdrawal by Subject|20|||
126488499|NCT00640601|455084647|FG000|Overall Study|Protocol Violation|6|||
126488500|NCT00640601|455084647|FG000|Overall Study|Lack of Efficacy|16|||
126488501|NCT00640601|455084647|FG000|Overall Study|Lost to Follow-up|9|||
126488502|NCT00640601|455084647|FG000|Overall Study|Physician Decision|8|||
126488503|NCT00640601|455084647|FG000|Overall Study|treatment naive, combination therapy|10|||
126488504|NCT01691781|455084664|FG000|Overall Study|Withdrawal by Subject|4|||
126488505|NCT01691781|455084665|FG001|Overall Study|Withdrawal by Subject|3|||
126488506|NCT01691781|455084664|FG000|Overall Study|Physician Decision|1|||
126488507|NCT01691781|455084665|FG001|Overall Study|Physician Decision|1|||
126488508|NCT01691781|455084664|FG000|Overall Study|Protocol Violation|2|||
126488509|NCT01691781|455084665|FG001|Overall Study|Protocol Violation|2|||
126723184|NCT02052778|455936089|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126723185|NCT02052778|455936090|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126723186|NCT02052778|455936091|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126723187|NCT02052778|455936092|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126772605|NCT02454972|456123635|FG006|Overall Study|Death|0|||
126488510|NCT01691781|455084664|FG000|Overall Study|Adverse Event|0|||
126488511|NCT01691781|455084665|FG001|Overall Study|Adverse Event|1|||
126488512|NCT01927367|455084666|FG000|Overall Study|Withdrawal by Subject|7|||
126488513|NCT01927367|455084667|FG001|Overall Study|Withdrawal by Subject|4|||
126488514|NCT01927367|455084666|FG000|Overall Study|No baseline data|0|||
126488515|NCT01927367|455084667|FG001|Overall Study|No baseline data|1|||
126488516|NCT03064451|455084675|FG000|Overall Study|Lost to Follow-up|1|||
126488517|NCT03064451|455084675|FG000|Overall Study|Mapping Failure|4|||
126488518|NCT03064451|455084675|FG000|Overall Study|Exited prior to procedure|8|||
126723188|NCT02052778|455936093|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126488519|NCT03064451|455084675|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
126488520|NCT00850564|455084676|FG000|Overall Study|Withdrawal by Subject|2|||
126488521|NCT02700815|455086533|FG000|Overall Study|Adverse Event|0|||
126488522|NCT02700815|455086534|FG001|Overall Study|Adverse Event|6|||
126488523|NCT02700815|455086535|FG002|Overall Study|Adverse Event|2|||
126488524|NCT02700815|455086536|FG003|Overall Study|Adverse Event|3|||
126488525|NCT02700815|455086533|FG000|Overall Study|Lack of Efficacy|0|||
126488526|NCT02700815|455086534|FG001|Overall Study|Lack of Efficacy|0|||
126488527|NCT02700815|455086535|FG002|Overall Study|Lack of Efficacy|1|||
126488528|NCT02700815|455086536|FG003|Overall Study|Lack of Efficacy|2|||
126488529|NCT02700815|455086533|FG000|Overall Study|Lost to Follow-up|1|||
126488530|NCT02700815|455086534|FG001|Overall Study|Lost to Follow-up|0|||
126488531|NCT02700815|455086535|FG002|Overall Study|Lost to Follow-up|0|||
126488532|NCT02700815|455086536|FG003|Overall Study|Lost to Follow-up|1|||
126488533|NCT02700815|455086533|FG000|Overall Study|Refusal to continue medication|0|||
126488534|NCT02700815|455086534|FG001|Overall Study|Refusal to continue medication|1|||
126488535|NCT02700815|455086535|FG002|Overall Study|Refusal to continue medication|0|||
126488536|NCT02700815|455086536|FG003|Overall Study|Refusal to continue medication|1|||
126488537|NCT02700815|455086533|FG000|Overall Study|Withdrawal by Subject|0|||
126488538|NCT02700815|455086534|FG001|Overall Study|Withdrawal by Subject|0|||
126488539|NCT02700815|455086535|FG002|Overall Study|Withdrawal by Subject|1|||
126488540|NCT02700815|455086536|FG003|Overall Study|Withdrawal by Subject|0|||
126488541|NCT00524368|455086537|FG000|Overall Study|Adverse Event|10|||
126488542|NCT00524368|455086538|FG001|Overall Study|Adverse Event|12|||
126488543|NCT00524368|455086537|FG000|Overall Study|Lost to Follow-up|9|||
126488544|NCT00524368|455086538|FG001|Overall Study|Lost to Follow-up|13|||
126488545|NCT00524368|455086537|FG000|Overall Study|Withdrawal by Subject|4|||
126723189|NCT02052778|455936094|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126723190|NCT02052778|455936095|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126723191|NCT02052778|455936096|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
126723192|NCT02052778|455936097|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
126723193|NCT02052778|455936098|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
126723194|NCT02052778|455936099|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
126723195|NCT02052778|455936100|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
126723196|NCT02052778|455936101|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
126723197|NCT02052778|455936102|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
126723198|NCT02052778|455936103|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
126723199|NCT02052778|455936104|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
126723200|NCT02052778|455936082|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723201|NCT02052778|455936083|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723202|NCT02052778|455936084|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723203|NCT02052778|455936085|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723204|NCT02052778|455936086|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723205|NCT02052778|455936087|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723206|NCT02052778|455936088|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723207|NCT02052778|455936089|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723208|NCT02052778|455936090|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723209|NCT02052778|455936091|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723210|NCT02052778|455936092|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723211|NCT02052778|455936093|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723212|NCT02052778|455936094|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723213|NCT02052778|455936095|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723214|NCT02052778|455936096|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
126723215|NCT02052778|455936097|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
126488546|NCT00524368|455086538|FG001|Overall Study|Withdrawal by Subject|5|||
126488547|NCT00524368|455086537|FG000|Overall Study|Non-compliant|8|||
126488548|NCT00524368|455086538|FG001|Overall Study|Non-compliant|9|||
126488549|NCT00524368|455086537|FG000|Overall Study|Reached a Virologic Endpoint|3|||
126488550|NCT00524368|455086538|FG001|Overall Study|Reached a Virologic Endpoint|2|||
126488551|NCT00524368|455086537|FG000|Overall Study|Sponsor's Decision|2|||
126488552|NCT00524368|455086538|FG001|Overall Study|Sponsor's Decision|0|||
126488553|NCT00524368|455086537|FG000|Overall Study|Ineligible to Continue the study|2|||
126488554|NCT00524368|455086538|FG001|Overall Study|Ineligible to Continue the study|5|||
126488555|NCT00524368|455086537|FG000|Overall Study|Other|3|||
126488556|NCT00524368|455086538|FG001|Overall Study|Other|2|||
126488557|NCT00531232|455086539|FG000|Overall Study|Investigator decision|0|||
126488558|NCT00531232|455086540|FG001|Overall Study|Investigator decision|0|||
126488559|NCT00531232|455086541|FG002|Overall Study|Investigator decision|4|||
126488560|NCT00531232|455086539|FG000|Overall Study|Participants refused further treatment|0|||
126488561|NCT00531232|455086540|FG001|Overall Study|Participants refused further treatment|1|||
126488562|NCT00531232|455086541|FG002|Overall Study|Participants refused further treatment|2|||
126488563|NCT00531232|455086539|FG000|Overall Study|Adverse events (AEs)|1|||
126488564|NCT00531232|455086540|FG001|Overall Study|Adverse events (AEs)|2|||
126488565|NCT00531232|455086541|FG002|Overall Study|Adverse events (AEs)|2|||
126488566|NCT00531232|455086539|FG000|Overall Study|Treatment failure|1|||
126488567|NCT00531232|455086540|FG001|Overall Study|Treatment failure|3|||
126488568|NCT00531232|455086541|FG002|Overall Study|Treatment failure|7|||
126723216|NCT02052778|455936098|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723217|NCT02052778|455936099|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
126723218|NCT02052778|455936100|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
126723219|NCT02052778|455936101|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
126723220|NCT02052778|455936102|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
126723221|NCT02052778|455936103|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
126723222|NCT02052778|455936104|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
126723223|NCT02052778|455936082|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723224|NCT02052778|455936083|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723225|NCT02052778|455936084|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723226|NCT02052778|455936085|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723227|NCT02052778|455936086|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723228|NCT02052778|455936087|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723229|NCT02052778|455936088|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723230|NCT02052778|455936089|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723231|NCT02052778|455936090|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126488569|NCT00531232|455086539|FG000|Overall Study|Disease recurrence|0|||
126488570|NCT00531232|455086540|FG001|Overall Study|Disease recurrence|0|||
126488571|NCT00531232|455086541|FG002|Overall Study|Disease recurrence|1|||
126488572|NCT00531232|455086539|FG000|Overall Study|Deceased|2|||
126488573|NCT00531232|455086540|FG001|Overall Study|Deceased|2|||
126488574|NCT00531232|455086541|FG002|Overall Study|Deceased|2|||
126488575|NCT00531232|455086539|FG000|Overall Study|Withdrawal by Subject|0|||
126488576|NCT00531232|455086540|FG001|Overall Study|Withdrawal by Subject|1|||
126488577|NCT00531232|455086541|FG002|Overall Study|Withdrawal by Subject|2|||
126488578|NCT00531232|455086539|FG000|Overall Study|Other|0|||
126488579|NCT00531232|455086540|FG001|Overall Study|Other|0|||
126488580|NCT00531232|455086541|FG002|Overall Study|Other|5|||
126488581|NCT02154490|455086547|FG000|Overall Study|No tissue submitted|23|||
126488582|NCT02154490|455086547|FG000|Overall Study|No biomarker results|167|||
126488583|NCT02154490|455086547|FG000|Overall Study|Not assigned to a sub-study|270|||
126488584|NCT02154490|455086547|FG000|Overall Study|Did not register to a sub-study|749|||
126488585|NCT02961751|455086556|FG000|Overall Study|Lost to Follow-up|11|||
126488586|NCT02961751|455086556|FG000|Overall Study|Physician Decision|2|||
126488587|NCT02961751|455086556|FG000|Overall Study|Not Eligible at Enrollment|1|||
126488588|NCT02961751|455086556|FG000|Overall Study|Protocol Violation|1|||
126488589|NCT02373202|455086557|FG000|Overall Study|Adverse Event|2|||
126488590|NCT02373202|455086558|FG001|Overall Study|Adverse Event|5|||
126488591|NCT02373202|455086559|FG002|Overall Study|Adverse Event|2|||
126488592|NCT02373202|455086560|FG003|Overall Study|Adverse Event|1|||
126488593|NCT02373202|455086557|FG000|Overall Study|Lack of Efficacy|0|||
126488594|NCT02373202|455086558|FG001|Overall Study|Lack of Efficacy|0|||
126488595|NCT02373202|455086559|FG002|Overall Study|Lack of Efficacy|1|||
126488596|NCT02373202|455086560|FG003|Overall Study|Lack of Efficacy|0|||
126488597|NCT02373202|455086557|FG000|Overall Study|Other|0|||
126488598|NCT02373202|455086558|FG001|Overall Study|Other|1|||
126488599|NCT02373202|455086559|FG002|Overall Study|Other|0|||
126488600|NCT02373202|455086560|FG003|Overall Study|Other|0|||
126488601|NCT01411228|455086562|FG000|Overall Study|Lost to Follow-up|0|||
126488602|NCT01411228|455086563|FG001|Overall Study|Lost to Follow-up|0|||
126488603|NCT01411228|455086564|FG002|Overall Study|Lost to Follow-up|1|||
126488604|NCT01411228|455086562|FG000|Overall Study|Withdrawal by Subject|1|||
126488605|NCT01411228|455086563|FG001|Overall Study|Withdrawal by Subject|0|||
126488606|NCT01411228|455086564|FG002|Overall Study|Withdrawal by Subject|0|||
126488607|NCT03909295|455086565|FG000|Overall Study|Adverse Event|2|||
126488608|NCT03909295|455086565|FG000|Overall Study|Study terminated by sponsor|50|||
126488609|NCT01752907|455086569|FG000|Overall Study|Withdrawal by Subject|4|||
126488610|NCT01752907|455086570|FG001|Overall Study|Withdrawal by Subject|10|||
126488611|NCT01752907|455086569|FG000|Overall Study|Lost to Follow-up|2|||
126488612|NCT01752907|455086570|FG001|Overall Study|Lost to Follow-up|1|||
126488613|NCT01752907|455086569|FG000|Overall Study|Decision by Sponsor|6|||
126488614|NCT01752907|455086570|FG001|Overall Study|Decision by Sponsor|9|||
126488615|NCT00609492|455086577|FG000|Overall Study|Withdrawal by Subject|0|||
126488616|NCT00609492|455086578|FG001|Overall Study|Withdrawal by Subject|2|||
126488617|NCT00609492|455086579|FG002|Overall Study|Withdrawal by Subject|3|||
126723232|NCT02052778|455936091|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723233|NCT02052778|455936092|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723234|NCT02052778|455936093|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126488618|NCT00609492|455086577|FG000|Overall Study|Lost to Follow-up|1|||
126488619|NCT00609492|455086578|FG001|Overall Study|Lost to Follow-up|1|||
126488620|NCT00609492|455086579|FG002|Overall Study|Lost to Follow-up|4|||
126488621|NCT00720434|455086580|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
126488622|NCT00720434|455086581|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
126488623|NCT00720434|455086582|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
126488624|NCT00720434|455086583|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
126488625|NCT00720434|455086580|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
126723235|NCT02052778|455936094|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723236|NCT02052778|455936095|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723237|NCT02052778|455936096|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
126723238|NCT02052778|455936097|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
126723239|NCT02052778|455936098|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
126723240|NCT02052778|455936099|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723241|NCT02052778|455936100|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
126723242|NCT02052778|455936101|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
126723243|NCT02052778|455936102|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723244|NCT02052778|455936103|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126723245|NCT02052778|455936104|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
126488626|NCT00720434|455086581|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
126488627|NCT00720434|455086582|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
126488628|NCT00720434|455086583|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
126488629|NCT00720434|455086580|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
126488630|NCT00720434|455086581|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
126488631|NCT00720434|455086582|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
126488632|NCT00720434|455086583|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
126488633|NCT00720434|455086580|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
126723246|NCT02052778|455936082|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723247|NCT02052778|455936083|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723248|NCT02052778|455936084|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723249|NCT02052778|455936085|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723250|NCT02052778|455936086|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723251|NCT02052778|455936087|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723252|NCT02052778|455936088|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723253|NCT02052778|455936089|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723254|NCT02052778|455936090|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723255|NCT02052778|455936091|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723256|NCT02052778|455936092|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723257|NCT02052778|455936093|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723258|NCT02052778|455936094|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723259|NCT02052778|455936095|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723260|NCT02052778|455936096|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
126723261|NCT02052778|455936097|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
126723262|NCT02052778|455936098|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723263|NCT02052778|455936099|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723264|NCT02052778|455936100|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723265|NCT02052778|455936101|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723266|NCT02052778|455936102|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723267|NCT02052778|455936103|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723268|NCT02052778|455936104|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
126723269|NCT02052778|455936082|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126723270|NCT02052778|455936083|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126723271|NCT02052778|455936084|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126488634|NCT00720434|455086581|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
126488635|NCT00720434|455086582|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
126488636|NCT00720434|455086583|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
126488637|NCT00720434|455086580|FG000|Open-Label Period (Week 5-72)|Other|4|||
126488638|NCT00720434|455086581|FG001|Open-Label Period (Week 5-72)|Other|3|||
126488639|NCT00720434|455086582|FG002|Open-Label Period (Week 5-72)|Other|3|||
126488640|NCT00720434|455086583|FG003|Open-Label Period (Week 5-72)|Other|2|||
126723272|NCT02052778|455936085|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126723273|NCT02052778|455936086|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126488641|NCT02782780|455086584|FG000|Overall Study|dropped out after randomization.|7|||
126488642|NCT02782780|455086585|FG001|Overall Study|dropped out after randomization.|5|||
126488643|NCT02782780|455086584|FG000|Overall Study|Protocol Violation|0|||
126488644|NCT02782780|455086585|FG001|Overall Study|Protocol Violation|2|||
126488645|NCT03510884|455086588|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
126488646|NCT03510884|455086589|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
126488647|NCT03510884|455086590|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
126488648|NCT03510884|455086591|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
126488649|NCT03510884|455086588|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
126488650|NCT03510884|455086589|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
126488651|NCT03510884|455086590|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
126488652|NCT03510884|455086591|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
126488653|NCT03510884|455086588|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
126488654|NCT03510884|455086589|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
126488655|NCT03510884|455086590|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
126488656|NCT03510884|455086591|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
126488657|NCT03510884|455086588|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
126488658|NCT03510884|455086589|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
126488659|NCT03510884|455086590|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
126488660|NCT03510884|455086591|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
126488661|NCT03510884|455086588|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
126488662|NCT03510884|455086589|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
126488663|NCT03510884|455086590|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
126488664|NCT03510884|455086591|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
126488665|NCT03510884|455086588|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
126488666|NCT03510884|455086589|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
126488667|NCT03510884|455086590|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
126488668|NCT03510884|455086591|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
126488669|NCT03510884|455086588|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
126488670|NCT03510884|455086589|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
126488671|NCT03510884|455086590|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
126488672|NCT03510884|455086591|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
126488673|NCT03510884|455086588|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
126488674|NCT03510884|455086589|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
126488675|NCT03510884|455086590|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
126488676|NCT03510884|455086591|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
126488677|NCT03510884|455086588|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
126488678|NCT03510884|455086589|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
126488679|NCT03510884|455086590|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
126488680|NCT03510884|455086591|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
126488681|NCT03510884|455086588|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
126488682|NCT03510884|455086589|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
126488683|NCT03510884|455086590|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
126488684|NCT03510884|455086591|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
126488685|NCT00856284|455086592|FG000|Overall Study|Hyperglycemic rescue|231|||
126488686|NCT00856284|455086593|FG001|Overall Study|Hyperglycemic rescue|201|||
126488687|NCT00856284|455086594|FG002|Overall Study|Hyperglycemic rescue|235|||
126488688|NCT00856284|455086592|FG000|Overall Study|Adverse Event|60|||
126488689|NCT00856284|455086593|FG001|Overall Study|Adverse Event|74|||
126488690|NCT00856284|455086594|FG002|Overall Study|Adverse Event|82|||
126488691|NCT00856284|455086592|FG000|Overall Study|Major protocol deviation|24|||
126488692|NCT00856284|455086593|FG001|Overall Study|Major protocol deviation|16|||
126488693|NCT00856284|455086594|FG002|Overall Study|Major protocol deviation|15|||
126488694|NCT00856284|455086592|FG000|Overall Study|Lost to Follow-up|20|||
126488695|NCT00856284|455086593|FG001|Overall Study|Lost to Follow-up|22|||
126488696|NCT00856284|455086594|FG002|Overall Study|Lost to Follow-up|28|||
126488697|NCT00856284|455086592|FG000|Overall Study|Voluntary withdrawal|48|||
126488698|NCT00856284|455086593|FG001|Overall Study|Voluntary withdrawal|52|||
126488699|NCT00856284|455086594|FG002|Overall Study|Voluntary withdrawal|62|||
126488700|NCT00856284|455086592|FG000|Overall Study|Pregnancy|1|||
126488701|NCT00856284|455086593|FG001|Overall Study|Pregnancy|2|||
126488702|NCT00856284|455086594|FG002|Overall Study|Pregnancy|0|||
126488703|NCT00856284|455086592|FG000|Overall Study|Investigator discretion|9|||
126488704|NCT00856284|455086593|FG001|Overall Study|Investigator discretion|8|||
126488705|NCT00856284|455086594|FG002|Overall Study|Investigator discretion|10|||
126488706|NCT00856284|455086592|FG000|Overall Study|Other|15|||
126488707|NCT00856284|455086593|FG001|Overall Study|Other|17|||
126488708|NCT00856284|455086594|FG002|Overall Study|Other|14|||
126488709|NCT00856284|455086592|FG000|Overall Study|Randomized in error|0|||
126488710|NCT00856284|455086593|FG001|Overall Study|Randomized in error|0|||
126488711|NCT00856284|455086594|FG002|Overall Study|Randomized in error|1|||
126488712|NCT02904512|455086597|FG000|Overall Study|Withdrawal by Subject|1|||
126488713|NCT02904512|455086598|FG001|Overall Study|Withdrawal by Subject|0|||
126488714|NCT02904512|455086597|FG000|Overall Study|Transferred to ICU|1|||
126488715|NCT02904512|455086598|FG001|Overall Study|Transferred to ICU|0|||
126488716|NCT02904512|455086597|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
126488717|NCT02904512|455086598|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
126488718|NCT00267046|455086603|FG000|Overall Study|Disease progression|4|||
126488719|NCT00267046|455086604|FG001|Overall Study|Disease progression|2|||
126488720|NCT00267046|455086603|FG000|Overall Study|Chemotoxicity|2|||
126488721|NCT00267046|455086604|FG001|Overall Study|Chemotoxicity|0|||
126488722|NCT00267046|455086603|FG000|Overall Study|Open-label palifermin|2|||
126488723|NCT00267046|455086604|FG001|Overall Study|Open-label palifermin|7|||
126488724|NCT00267046|455086603|FG000|Overall Study|Surgery|3|||
126488725|NCT00267046|455086604|FG001|Overall Study|Surgery|1|||
126488726|NCT00267046|455086603|FG000|Overall Study|Withdrawal by Subject|1|||
126488727|NCT00267046|455086604|FG001|Overall Study|Withdrawal by Subject|0|||
126488728|NCT00267046|455086603|FG000|Overall Study|Radiation|0|||
126488729|NCT00267046|455086604|FG001|Overall Study|Radiation|1|||
126488730|NCT00460408|455086605|FG000|Overall Study|Adverse Event|1|||
126488731|NCT00460408|455086606|FG001|Overall Study|Adverse Event|0|||
126488732|NCT00460408|455086607|FG002|Overall Study|Adverse Event|0|||
126488733|NCT00460408|455086608|FG003|Overall Study|Adverse Event|0|||
126488734|NCT00460408|455086605|FG000|Overall Study|Death|7|||
126488735|NCT00460408|455086606|FG001|Overall Study|Death|0|||
126488736|NCT00460408|455086607|FG002|Overall Study|Death|0|||
126488737|NCT00460408|455086608|FG003|Overall Study|Death|0|||
126488738|NCT00460408|455086605|FG000|Overall Study|Lost to Follow-up|11|||
126488739|NCT00460408|455086606|FG001|Overall Study|Lost to Follow-up|0|||
126488740|NCT00460408|455086607|FG002|Overall Study|Lost to Follow-up|1|||
126488741|NCT00460408|455086608|FG003|Overall Study|Lost to Follow-up|0|||
126488742|NCT00460408|455086605|FG000|Overall Study|Withdrawal by Subject|31|||
126488743|NCT00460408|455086606|FG001|Overall Study|Withdrawal by Subject|0|||
126488744|NCT00460408|455086607|FG002|Overall Study|Withdrawal by Subject|0|||
126488745|NCT00460408|455086608|FG003|Overall Study|Withdrawal by Subject|0|||
126488746|NCT00460408|455086605|FG000|Overall Study|Insufficient clinical response|5|||
126488747|NCT00460408|455086606|FG001|Overall Study|Insufficient clinical response|1|||
126488748|NCT00460408|455086607|FG002|Overall Study|Insufficient clinical response|5|||
126488749|NCT00460408|455086608|FG003|Overall Study|Insufficient clinical response|0|||
126488750|NCT00460408|455086605|FG000|Overall Study|Other|12|||
126488751|NCT00460408|455086606|FG001|Overall Study|Other|2|||
126488752|NCT00460408|455086607|FG002|Overall Study|Other|0|||
126488753|NCT00460408|455086608|FG003|Overall Study|Other|0|||
126488754|NCT00865124|455086609|FG000|Overall Study|Physician Decision|2|||
126488755|NCT00865124|455086610|FG001|Overall Study|Physician Decision|1|||
126488756|NCT00865124|455086611|FG002|Overall Study|Physician Decision|0|||
126488757|NCT00865124|455086609|FG000|Overall Study|Withdrawn consent|2|||
126488758|NCT00865124|455086610|FG001|Overall Study|Withdrawn consent|0|||
126488759|NCT00865124|455086611|FG002|Overall Study|Withdrawn consent|0|||
126488760|NCT01442493|455086619|FG000|Overall Study|withdrawn from study|3|||
126488761|NCT01442493|455086620|FG001|Overall Study|withdrawn from study|2|||
126488762|NCT01986985|455086625|FG000|Overall Study|Withdrawal by Subject|4|||
126488763|NCT01986985|455086625|FG000|Overall Study|Scan not completed due to malfunction|3|||
126488764|NCT03042533|455086626|FG000|Overall Study|MD left program|1|||
126488765|NCT03042533|455086627|FG001|Overall Study|MD left program|4|||
126488766|NCT03042533|455086628|FG002|Overall Study|MD left program|1|||
126488767|NCT01111149|455086634|FG000|Overall Study|Protocol Violation|1|||
126488768|NCT01111149|455086635|FG001|Overall Study|Protocol Violation|1|||
126488769|NCT01111149|455086636|FG002|Overall Study|Protocol Violation|2|||
126488770|NCT01111149|455086634|FG000|Overall Study|Withdrawal by Subject|1|||
126488771|NCT01111149|455086635|FG001|Overall Study|Withdrawal by Subject|0|||
126488772|NCT01111149|455086636|FG002|Overall Study|Withdrawal by Subject|2|||
126488773|NCT00759954|455086637|FG000|Overall Study|Personal reason|1|||
126488774|NCT00759954|455086638|FG001|Overall Study|Personal reason|0|||
126488775|NCT00759954|455086637|FG000|Overall Study|Adverse Event|1|||
126488776|NCT00759954|455086638|FG001|Overall Study|Adverse Event|2|||
126488777|NCT00137046|455086639|FG000|Overall Study|Death|2|||
126488778|NCT00137046|455086640|FG001|Overall Study|Death|1|||
126488779|NCT00137046|455086639|FG000|Overall Study|Adverse Event|16|||
126488780|NCT00137046|455086640|FG001|Overall Study|Adverse Event|5|||
126488781|NCT00137046|455086639|FG000|Overall Study|Laboratory Abnormality|2|||
126488782|NCT00137046|455086640|FG001|Overall Study|Laboratory Abnormality|0|||
126488783|NCT00137046|455086639|FG000|Overall Study|Lack of Efficacy|13|||
126488784|NCT00137046|455086640|FG001|Overall Study|Lack of Efficacy|1|||
126488785|NCT00137046|455086639|FG000|Overall Study|Lost to Follow-up|8|||
126488786|NCT00137046|455086640|FG001|Overall Study|Lost to Follow-up|24|||
126488787|NCT00137046|455086639|FG000|Overall Study|Other|23|||
126488788|NCT00137046|455086640|FG001|Overall Study|Other|19|||
126488789|NCT00137046|455086639|FG000|Overall Study|Withdrawal by Subject|33|||
126488790|NCT00137046|455086640|FG001|Overall Study|Withdrawal by Subject|42|||
126488791|NCT00137046|455086639|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
126488792|NCT00137046|455086640|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
126488793|NCT00137046|455086639|FG000|Overall Study|Withdrew prior to study treatment|1|||
126488794|NCT00137046|455086640|FG001|Overall Study|Withdrew prior to study treatment|1|||
126488795|NCT02725710|455086642|FG000|Overall Study|Lost to Follow-up|1|||
126488796|NCT02725710|455086643|FG001|Overall Study|Lost to Follow-up|0|||
126488797|NCT01666782|455086646|FG000|Overall Study|Received 2 doses of vaccine|0|||
126488798|NCT01666782|455086647|FG001|Overall Study|Received 2 doses of vaccine|1|||
126488799|NCT01666782|455086646|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
126488800|NCT01666782|455086647|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
126488801|NCT03681405|455086648|FG000|Overall Study|Found to be ineligible after randomized|1|||
126488802|NCT03681405|455086649|FG001|Overall Study|Found to be ineligible after randomized|0|||
126488803|NCT03978520|455086650|FG000|Overall Study|Adverse Event|2|||
126488804|NCT03978520|455086651|FG001|Overall Study|Adverse Event|5|||
126488805|NCT03978520|455086652|FG002|Overall Study|Adverse Event|3|||
126488806|NCT03978520|455086653|FG003|Overall Study|Adverse Event|5|||
126488807|NCT03978520|455086654|FG004|Overall Study|Adverse Event|6|||
126488808|NCT03978520|455086650|FG000|Overall Study|Withdrawal by Subject|10|||
126488809|NCT03978520|455086651|FG001|Overall Study|Withdrawal by Subject|4|||
126488810|NCT03978520|455086652|FG002|Overall Study|Withdrawal by Subject|5|||
126488811|NCT03978520|455086653|FG003|Overall Study|Withdrawal by Subject|6|||
126488812|NCT03978520|455086654|FG004|Overall Study|Withdrawal by Subject|5|||
126488813|NCT03978520|455086650|FG000|Overall Study|Lost to Follow-up|2|||
126488814|NCT03978520|455086651|FG001|Overall Study|Lost to Follow-up|2|||
126488815|NCT03978520|455086652|FG002|Overall Study|Lost to Follow-up|2|||
126488816|NCT03978520|455086653|FG003|Overall Study|Lost to Follow-up|0|||
126488817|NCT03978520|455086654|FG004|Overall Study|Lost to Follow-up|1|||
126488818|NCT03978520|455086650|FG000|Overall Study|COVID-19 infection|0|||
126488819|NCT03978520|455086651|FG001|Overall Study|COVID-19 infection|1|||
126488820|NCT03978520|455086652|FG002|Overall Study|COVID-19 infection|0|||
126488821|NCT03978520|455086653|FG003|Overall Study|COVID-19 infection|0|||
126488822|NCT03978520|455086654|FG004|Overall Study|COVID-19 infection|0|||
126488823|NCT03978520|455086650|FG000|Overall Study|Other, not specified|9|||
126488824|NCT03978520|455086651|FG001|Overall Study|Other, not specified|4|||
126488825|NCT03978520|455086652|FG002|Overall Study|Other, not specified|1|||
126488826|NCT03978520|455086653|FG003|Overall Study|Other, not specified|1|||
126488827|NCT03978520|455086654|FG004|Overall Study|Other, not specified|2|||
126488828|NCT03978520|455086650|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
126488829|NCT03978520|455086651|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
126488830|NCT03978520|455086652|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
126488831|NCT03978520|455086653|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
126488832|NCT03978520|455086654|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
126488833|NCT01648205|455086657|FG000|Placebo|Pregnancy|1|||
126488834|NCT01648205|455086657|FG000|Placebo|Withdrawal by Subject|1|||
126488835|NCT01648205|455086657|FG000|Placebo|Protocol Violation|2|||
126488836|NCT01648205|455086657|FG000|Ranolazine|Death|1|||
126488837|NCT01648205|455086657|FG000|Ranolazine|Withdrawal by Subject|1|||
126488838|NCT01648205|455086657|FG000|Ranolazine|Protocol Violation|3|||
126488839|NCT02142959|455086664|FG000|Overall Study|Adverse Event|1|||
126488840|NCT02142959|455086665|FG001|Overall Study|Adverse Event|0|||
126488841|NCT02142959|455086666|FG002|Overall Study|Adverse Event|0|||
126488842|NCT02142959|455086664|FG000|Overall Study|Death|0|||
126488843|NCT02142959|455086665|FG001|Overall Study|Death|1|||
126488844|NCT02142959|455086666|FG002|Overall Study|Death|0|||
126488845|NCT02142959|455086664|FG000|Overall Study|Withdrawal by Subject|3|||
126488846|NCT02142959|455086665|FG001|Overall Study|Withdrawal by Subject|1|||
126488847|NCT02142959|455086666|FG002|Overall Study|Withdrawal by Subject|3|||
126488848|NCT02142959|455086664|FG000|Overall Study|Administrative Reasons|1|||
126488849|NCT02142959|455086665|FG001|Overall Study|Administrative Reasons|0|||
126488850|NCT02142959|455086666|FG002|Overall Study|Administrative Reasons|1|||
126488851|NCT02142959|455086664|FG000|Overall Study|Missing|0|||
126488852|NCT02142959|455086665|FG001|Overall Study|Missing|1|||
126488853|NCT02142959|455086666|FG002|Overall Study|Missing|0|||
126488854|NCT02142959|455086664|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
126488855|NCT02142959|455086665|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
126488856|NCT02142959|455086666|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
126488857|NCT02142959|455086664|FG000|Overall Study|Patient didn't complete end of study visit|0|||
126488858|NCT02142959|455086665|FG001|Overall Study|Patient didn't complete end of study visit|0|||
126488859|NCT02142959|455086666|FG002|Overall Study|Patient didn't complete end of study visit|1|||
126488860|NCT03547687|455086667|FG000|Overall Study|Withdrawal by Subject|1|||
126488861|NCT03547687|455086667|FG000|Overall Study|Death|1|||
126488862|NCT02547454|455086671|FG000|Overall Study|Due to hemodialysis|53|||
126488863|NCT02547454|455086671|FG000|Overall Study|Due to transplantation|1|||
126488864|NCT02547454|455086671|FG000|Overall Study|Due to no further need to treat|4|||
126488865|NCT02547454|455086671|FG000|Overall Study|Death|38|||
126488866|NCT02547454|455086671|FG000|Overall Study|Lost to Follow-up|26|||
126488867|NCT02547454|455086671|FG000|Overall Study|Other|39|||
126488868|NCT02547454|455086671|FG000|Overall Study|No data|11|||
126488869|NCT04557371|455086675|FG000|Overall Study|Covid-19-related|0|||
126488870|NCT04557371|455086676|FG001|Overall Study|Covid-19-related|1|||
126488871|NCT04557371|455086677|FG002|Overall Study|Covid-19-related|0|||
126488872|NCT04557371|455086675|FG000|Overall Study|Withdrawal by Subject|0|||
126488873|NCT04557371|455086676|FG001|Overall Study|Withdrawal by Subject|1|||
126488874|NCT04557371|455086677|FG002|Overall Study|Withdrawal by Subject|0|||
126488875|NCT04557371|455086675|FG000|Overall Study|Adverse Event|1|||
126488876|NCT04557371|455086676|FG001|Overall Study|Adverse Event|0|||
126488877|NCT04557371|455086677|FG002|Overall Study|Adverse Event|0|||
126488878|NCT03694821|455086678|FG000|Overall Study|Study terminated|4|||
126488879|NCT03694821|455086679|FG001|Overall Study|Study terminated|8|||
126488880|NCT03694821|455086680|FG002|Overall Study|Study terminated|4|||
126488881|NCT00203996|455086681|FG000|Overall Study|Lost to Follow-up|0|||
126488882|NCT00203996|455086682|FG001|Overall Study|Lost to Follow-up|0|||
126488883|NCT00203996|455086683|FG002|Overall Study|Lost to Follow-up|0|||
126488884|NCT00203996|455086684|FG003|Overall Study|Lost to Follow-up|1|||
126488885|NCT00203996|455086685|FG004|Overall Study|Lost to Follow-up|0|||
126488886|NCT00203996|455086686|FG005|Overall Study|Lost to Follow-up|0|||
126488887|NCT00203996|455086687|FG006|Overall Study|Lost to Follow-up|0|||
126488888|NCT00203996|455086688|FG007|Overall Study|Lost to Follow-up|0|||
126488889|NCT00203996|455086689|FG008|Overall Study|Lost to Follow-up|0|||
126488890|NCT00203996|455086690|FG009|Overall Study|Lost to Follow-up|0|||
126488891|NCT00203996|455086681|FG000|Overall Study|Protocol Violation|0|||
126488892|NCT00203996|455086682|FG001|Overall Study|Protocol Violation|0|||
126488893|NCT00203996|455086683|FG002|Overall Study|Protocol Violation|0|||
126488894|NCT00203996|455086684|FG003|Overall Study|Protocol Violation|6|||
126488895|NCT00203996|455086685|FG004|Overall Study|Protocol Violation|1|||
126488896|NCT00203996|455086686|FG005|Overall Study|Protocol Violation|0|||
126488897|NCT00203996|455086687|FG006|Overall Study|Protocol Violation|0|||
126488898|NCT00203996|455086688|FG007|Overall Study|Protocol Violation|0|||
126488899|NCT00203996|455086689|FG008|Overall Study|Protocol Violation|0|||
126488900|NCT00203996|455086690|FG009|Overall Study|Protocol Violation|0|||
126488901|NCT00203996|455086681|FG000|Overall Study|Physician Decision|0|||
126488902|NCT00203996|455086682|FG001|Overall Study|Physician Decision|0|||
126488903|NCT00203996|455086683|FG002|Overall Study|Physician Decision|0|||
126488904|NCT00203996|455086684|FG003|Overall Study|Physician Decision|2|||
126488905|NCT00203996|455086685|FG004|Overall Study|Physician Decision|0|||
126488906|NCT00203996|455086686|FG005|Overall Study|Physician Decision|0|||
126488907|NCT00203996|455086687|FG006|Overall Study|Physician Decision|0|||
126488908|NCT00203996|455086688|FG007|Overall Study|Physician Decision|0|||
126488909|NCT00203996|455086689|FG008|Overall Study|Physician Decision|0|||
126488910|NCT00203996|455086690|FG009|Overall Study|Physician Decision|1|||
126488911|NCT00203996|455086681|FG000|Overall Study|CPAP machine malfunction|0|||
126488912|NCT00203996|455086682|FG001|Overall Study|CPAP machine malfunction|0|||
126488913|NCT00203996|455086683|FG002|Overall Study|CPAP machine malfunction|0|||
126488914|NCT00203996|455086684|FG003|Overall Study|CPAP machine malfunction|1|||
126488915|NCT00203996|455086685|FG004|Overall Study|CPAP machine malfunction|0|||
126488916|NCT00203996|455086686|FG005|Overall Study|CPAP machine malfunction|0|||
126488917|NCT00203996|455086687|FG006|Overall Study|CPAP machine malfunction|0|||
126488918|NCT00203996|455086688|FG007|Overall Study|CPAP machine malfunction|0|||
126488919|NCT00203996|455086689|FG008|Overall Study|CPAP machine malfunction|0|||
126488920|NCT00203996|455086690|FG009|Overall Study|CPAP machine malfunction|0|||
126488921|NCT00203996|455086681|FG000|Overall Study|Scheduling issue|0|||
126488922|NCT00203996|455086682|FG001|Overall Study|Scheduling issue|0|||
126488923|NCT00203996|455086683|FG002|Overall Study|Scheduling issue|0|||
126488924|NCT00203996|455086684|FG003|Overall Study|Scheduling issue|0|||
126488925|NCT00203996|455086685|FG004|Overall Study|Scheduling issue|0|||
126488926|NCT00203996|455086686|FG005|Overall Study|Scheduling issue|0|||
126488927|NCT00203996|455086687|FG006|Overall Study|Scheduling issue|0|||
126488928|NCT00203996|455086688|FG007|Overall Study|Scheduling issue|2|||
126488929|NCT00203996|455086689|FG008|Overall Study|Scheduling issue|0|||
126488930|NCT00203996|455086690|FG009|Overall Study|Scheduling issue|0|||
126488931|NCT03789318|455086693|FG000|Overall Study|Adverse Event|0|||
126488932|NCT03789318|455086694|FG001|Overall Study|Adverse Event|0|||
126488933|NCT03789318|455086695|FG002|Overall Study|Adverse Event|1|||
126488934|NCT03789318|455086696|FG003|Overall Study|Adverse Event|1|||
126488935|NCT03789318|455086697|FG004|Overall Study|Adverse Event|0|||
126488936|NCT03789318|455086693|FG000|Overall Study|Lost to Follow-up|0|||
126488937|NCT03789318|455086694|FG001|Overall Study|Lost to Follow-up|0|||
126488938|NCT03789318|455086695|FG002|Overall Study|Lost to Follow-up|1|||
126488939|NCT03789318|455086696|FG003|Overall Study|Lost to Follow-up|0|||
126488940|NCT03789318|455086697|FG004|Overall Study|Lost to Follow-up|0|||
126488941|NCT03789318|455086693|FG000|Overall Study|Withdrawal by Subject|0|||
126488942|NCT03789318|455086694|FG001|Overall Study|Withdrawal by Subject|0|||
126488943|NCT03789318|455086695|FG002|Overall Study|Withdrawal by Subject|1|||
126488944|NCT03789318|455086696|FG003|Overall Study|Withdrawal by Subject|0|||
126488945|NCT03789318|455086697|FG004|Overall Study|Withdrawal by Subject|0|||
126488946|NCT03700671|455086698|FG000|Overall Study|Lack of Efficacy|1|||
126488947|NCT03700671|455086699|FG001|Overall Study|Lack of Efficacy|2|||
126488948|NCT01774968|455086700|FG000|Overall Study|Adverse Event|4|||
126488949|NCT01774968|455086701|FG001|Overall Study|Adverse Event|4|||
126488950|NCT01774968|455086700|FG000|Overall Study|Death|0|||
126488951|NCT01774968|455086701|FG001|Overall Study|Death|1|||
126488952|NCT01774968|455086700|FG000|Overall Study|Lost to Follow-up|1|||
126488953|NCT01774968|455086701|FG001|Overall Study|Lost to Follow-up|3|||
126488954|NCT01774968|455086700|FG000|Overall Study|Physician Decision|5|||
126488955|NCT01774968|455086701|FG001|Overall Study|Physician Decision|1|||
126488956|NCT01774968|455086700|FG000|Overall Study|Protocol Violation|14|||
126488957|NCT01774968|455086701|FG001|Overall Study|Protocol Violation|13|||
126488958|NCT01774968|455086700|FG000|Overall Study|Sponsor Decision|0|||
126488959|NCT01774968|455086701|FG001|Overall Study|Sponsor Decision|2|||
126488960|NCT01774968|455086700|FG000|Overall Study|Withdrawal by Subject|6|||
126488961|NCT01774968|455086701|FG001|Overall Study|Withdrawal by Subject|11|||
126488962|NCT01937559|455086704|FG000|Overall Study|Physician Decision|3|||
126488963|NCT01937559|455086705|FG001|Overall Study|Physician Decision|3|||
126488964|NCT01937559|455086706|FG002|Overall Study|Physician Decision|0|||
126488965|NCT01937559|455086704|FG000|Overall Study|Withdrawal by Subject|6|||
126488966|NCT01937559|455086705|FG001|Overall Study|Withdrawal by Subject|4|||
126488967|NCT01937559|455086706|FG002|Overall Study|Withdrawal by Subject|0|||
126488968|NCT01937559|455086704|FG000|Overall Study|screen fail|2|||
126488969|NCT01937559|455086705|FG001|Overall Study|screen fail|4|||
126488970|NCT01937559|455086706|FG002|Overall Study|screen fail|0|||
126488971|NCT02345850|455088413|FG000|Overall Study|Not transplanted|10|||
126488972|NCT02345850|455088414|FG001|Overall Study|Not transplanted|5|||
126488973|NCT02345850|455088415|FG002|Overall Study|Not transplanted|4|||
126488974|NCT02345850|455088413|FG000|Overall Study|Lost to Follow-up|2|||
126488975|NCT02345850|455088414|FG001|Overall Study|Lost to Follow-up|3|||
126488976|NCT02345850|455088415|FG002|Overall Study|Lost to Follow-up|2|||
126488977|NCT02345850|455088413|FG000|Overall Study|Withdrawal by Subject|1|||
126488978|NCT02345850|455088414|FG001|Overall Study|Withdrawal by Subject|0|||
126488979|NCT02345850|455088415|FG002|Overall Study|Withdrawal by Subject|0|||
126488980|NCT01991067|455088417|FG000|Overall Study|Lost to Follow-up|6|||
126488981|NCT01991067|455088418|FG001|Overall Study|Lost to Follow-up|5|||
126488982|NCT02670083|455088420|FG000|Overall Study|Adverse Event|16|||
126488983|NCT02670083|455088421|FG001|Overall Study|Adverse Event|13|||
126488984|NCT02670083|455088420|FG000|Overall Study|Death|4|||
126488985|NCT02670083|455088421|FG001|Overall Study|Death|6|||
126488986|NCT02670083|455088420|FG000|Overall Study|Lost to Follow-up|2|||
126488987|NCT02670083|455088421|FG001|Overall Study|Lost to Follow-up|2|||
126488988|NCT02670083|455088420|FG000|Overall Study|Multiple Reasons|9|||
126488989|NCT02670083|455088421|FG001|Overall Study|Multiple Reasons|9|||
126488990|NCT02670083|455088420|FG000|Overall Study|Physician Decision|0|||
126488991|NCT02670083|455088421|FG001|Overall Study|Physician Decision|2|||
126488992|NCT02670083|455088420|FG000|Overall Study|Study Terminated By Sponsor|257|||
126488993|NCT02670083|455088421|FG001|Overall Study|Study Terminated By Sponsor|254|||
126488994|NCT02670083|455088420|FG000|Overall Study|Symptomatic Deterioration|0|||
126488995|NCT02670083|455088421|FG001|Overall Study|Symptomatic Deterioration|2|||
126488996|NCT02670083|455088420|FG000|Overall Study|Withdrawal by Subject|32|||
126488997|NCT02670083|455088421|FG001|Overall Study|Withdrawal by Subject|31|||
126488998|NCT02670083|455088420|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126488999|NCT02670083|455088421|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126489000|NCT02014597|455088422|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
126489001|NCT02014597|455088423|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
126489002|NCT00464087|455088426|FG000|Overall Study|No PCI per inclusion criteria|0|||
126489003|NCT00464087|455088427|FG001|Overall Study|No PCI per inclusion criteria|0|||
126723274|NCT02052778|455936087|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126489004|NCT00464087|455088428|FG002|Overall Study|No PCI per inclusion criteria|29|||
126723275|NCT02052778|455936088|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126489005|NCT02057406|455088429|FG000|Overall Study|Physician Decision|0|||
126489006|NCT02057406|455088430|FG001|Overall Study|Physician Decision|0|||
126489007|NCT02057406|455088431|FG002|Overall Study|Physician Decision|2|||
126489008|NCT02057406|455088429|FG000|Overall Study|Withdrawal by Subject|0|||
126489009|NCT02057406|455088430|FG001|Overall Study|Withdrawal by Subject|2|||
126489010|NCT02057406|455088431|FG002|Overall Study|Withdrawal by Subject|0|||
126723276|NCT02052778|455936089|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126489011|NCT02057406|455088429|FG000|Overall Study|Lost to Follow-up|0|||
126489012|NCT02057406|455088430|FG001|Overall Study|Lost to Follow-up|0|||
126489013|NCT02057406|455088431|FG002|Overall Study|Lost to Follow-up|1|||
126489014|NCT02057406|455088429|FG000|Overall Study|Death|1|||
126489015|NCT02057406|455088430|FG001|Overall Study|Death|0|||
126489016|NCT02057406|455088431|FG002|Overall Study|Death|0|||
126489017|NCT02057406|455088429|FG000|Overall Study|Protocol Violation|0|||
126489018|NCT02057406|455088430|FG001|Overall Study|Protocol Violation|1|||
126489019|NCT02057406|455088431|FG002|Overall Study|Protocol Violation|0|||
126489020|NCT02057406|455088429|FG000|Overall Study|Patient transportation issues|0|||
126489021|NCT02057406|455088430|FG001|Overall Study|Patient transportation issues|0|||
126489022|NCT02057406|455088431|FG002|Overall Study|Patient transportation issues|1|||
126489023|NCT02425046|455088432|FG000|Overall Study|Lost to Follow-up|52|||
126489024|NCT02425046|455088433|FG001|Overall Study|Lost to Follow-up|50|||
126489025|NCT02425046|455088434|FG002|Overall Study|Lost to Follow-up|56|||
126489026|NCT02425046|455088432|FG000|Overall Study|Withdrawal by Subject|16|||
126489027|NCT02425046|455088433|FG001|Overall Study|Withdrawal by Subject|12|||
126489028|NCT02425046|455088434|FG002|Overall Study|Withdrawal by Subject|0|||
126489029|NCT00931762|455088435|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
126489030|NCT00931762|455088435|FG000|Overall Study|Administrative Problems|5|||
126489031|NCT00931762|455088435|FG000|Overall Study|Death|1|||
126489032|NCT00931762|455088435|FG000|Overall Study|Disease Progression|3|||
126489033|NCT00931762|455088435|FG000|Overall Study|Adverse Event (s)|11|||
126489034|NCT00931762|455088435|FG000|Overall Study|Subject withdrew consent|13|||
126489035|NCT02692716|455088438|FG000|Overall Study|Lost to Follow-up|2|||
126489036|NCT02692716|455088439|FG001|Overall Study|Lost to Follow-up|5|||
126489037|NCT02692716|455088438|FG000|Overall Study|Withdrawal by Subject|3|||
126489038|NCT02692716|455088439|FG001|Overall Study|Withdrawal by Subject|1|||
126489039|NCT03562481|455088444|FG000|First Intervention|Lost to Follow-up|1|||
126489040|NCT03562481|455088445|FG001|First Intervention|Lost to Follow-up|0|||
126489041|NCT02664441|455088446|FG000|Randomization|Withdrawal by Subject|0|||
126489042|NCT02664441|455088447|FG001|Randomization|Withdrawal by Subject|1|||
126489043|NCT02664441|455088446|FG000|36-week Randomized Trial|Adverse Event|2|||
126489044|NCT02664441|455088447|FG001|36-week Randomized Trial|Adverse Event|0|||
126489045|NCT02664441|455088446|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
126489046|NCT02664441|455088447|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
126489047|NCT02664441|455088446|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
126489048|NCT02664441|455088447|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
126489049|NCT02664441|455088446|FG000|18-week Open Label Extension|Adverse Event|1|||
126489050|NCT02664441|455088447|FG001|18-week Open Label Extension|Adverse Event|0|||
126489051|NCT02664441|455088446|FG000|18-week Open Label Extension|Physician Decision|1|||
126489052|NCT02664441|455088447|FG001|18-week Open Label Extension|Physician Decision|0|||
126489053|NCT02664441|455088446|FG000|18-week Open Label Extension|Death|1|||
126489054|NCT02664441|455088447|FG001|18-week Open Label Extension|Death|0|||
126489055|NCT02664441|455088446|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
126489056|NCT02664441|455088447|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
126489057|NCT01413191|455088448|FG000|Overall Study|Lost to Follow-up|5|||
126489058|NCT01413191|455088448|FG000|Overall Study|Disease Progression|5|||
126489059|NCT01413191|455088448|FG000|Overall Study|Death|1|||
126489060|NCT03654651|455088449|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
126489061|NCT03654651|455088450|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
126489062|NCT01702454|455088451|FG000|Overall Study|Consent withdrawal|0|||
126489063|NCT01702454|455088452|FG001|Overall Study|Consent withdrawal|1|||
126489064|NCT01702454|455088451|FG000|Overall Study|Migrated/moved from study area|0|||
126489065|NCT01702454|455088452|FG001|Overall Study|Migrated/moved from study area|1|||
126489066|NCT01702454|455088451|FG000|Overall Study|Lost to Follow-up|3|||
126489067|NCT01702454|455088452|FG001|Overall Study|Lost to Follow-up|6|||
126489068|NCT03247530|455088457|FG000|Overall Study|Withdrawal by caregiver|19|||
126489069|NCT03247530|455088458|FG001|Overall Study|Withdrawal by caregiver|8|||
126489070|NCT03247530|455088459|FG002|Overall Study|Withdrawal by caregiver|10|||
126489071|NCT03247530|455088457|FG000|Overall Study|Lost to Follow-up|3|||
126489072|NCT03247530|455088458|FG001|Overall Study|Lost to Follow-up|9|||
126489073|NCT03247530|455088459|FG002|Overall Study|Lost to Follow-up|6|||
126489074|NCT03247530|455088457|FG000|Overall Study|Adverse Event|2|||
126489075|NCT03247530|455088458|FG001|Overall Study|Adverse Event|5|||
126489076|NCT03247530|455088459|FG002|Overall Study|Adverse Event|2|||
126489077|NCT03247530|455088457|FG000|Overall Study|Failure to follow procedure|1|||
126489078|NCT03247530|455088458|FG001|Overall Study|Failure to follow procedure|1|||
126489079|NCT03247530|455088459|FG002|Overall Study|Failure to follow procedure|1|||
126489080|NCT03247530|455088457|FG000|Overall Study|Withdrawal by Subject|1|||
126489081|NCT03247530|455088458|FG001|Overall Study|Withdrawal by Subject|1|||
126489082|NCT03247530|455088459|FG002|Overall Study|Withdrawal by Subject|0|||
126489083|NCT03247530|455088457|FG000|Overall Study|Study medication misuse|0|||
126489084|NCT03247530|455088458|FG001|Overall Study|Study medication misuse|1|||
126489085|NCT03247530|455088459|FG002|Overall Study|Study medication misuse|0|||
126489086|NCT03247530|455088457|FG000|Overall Study|Other, multiple categories|1|||
126489087|NCT03247530|455088458|FG001|Overall Study|Other, multiple categories|3|||
126489088|NCT03247530|455088459|FG002|Overall Study|Other, multiple categories|1|||
126489089|NCT01124422|455088460|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
126489090|NCT01124422|455088461|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
126489091|NCT01124422|455088462|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
126489092|NCT01124422|455088460|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
126489093|NCT01124422|455088461|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
126489094|NCT01124422|455088462|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
126489095|NCT01124422|455088460|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
126489096|NCT01124422|455088461|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
126489097|NCT01124422|455088462|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
126489098|NCT01124422|455088460|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
126489099|NCT01124422|455088461|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
126489100|NCT01124422|455088462|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
126489101|NCT01124422|455088460|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
126489102|NCT01124422|455088461|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
126489103|NCT01124422|455088462|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
126489104|NCT01124422|455088460|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
126489105|NCT01124422|455088461|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
126489106|NCT01124422|455088462|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
126489107|NCT01124422|455088460|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
126489108|NCT01124422|455088461|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
126489109|NCT01124422|455088462|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
126489110|NCT01124422|455088460|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
126489111|NCT01124422|455088461|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
126489112|NCT01124422|455088462|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
126489113|NCT01124422|455088460|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
126489114|NCT01124422|455088461|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
126489115|NCT01124422|455088462|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
126489116|NCT01124422|455088460|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
126489117|NCT01124422|455088461|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
126489118|NCT01124422|455088462|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
126489119|NCT03454893|455088467|FG000|Overall Study|Study Terminated by the Sponsor|5|||
126489120|NCT03454893|455088467|FG000|Overall Study|Did not pass screening|4|||
126489121|NCT02288559|455088468|FG000|Overall Study|Adverse Event|1|||
126489122|NCT02288559|455088469|FG001|Overall Study|Adverse Event|1|||
126489123|NCT02288559|455088470|FG002|Overall Study|Adverse Event|5|||
126489124|NCT02288559|455088471|FG003|Overall Study|Adverse Event|0|||
126489125|NCT02288559|455088468|FG000|Overall Study|Death|0|||
126489126|NCT02288559|455088469|FG001|Overall Study|Death|0|||
126489127|NCT02288559|455088470|FG002|Overall Study|Death|1|||
126489128|NCT02288559|455088471|FG003|Overall Study|Death|0|||
126489129|NCT02288559|455088468|FG000|Overall Study|Lost to Follow-up|0|||
126489130|NCT02288559|455088469|FG001|Overall Study|Lost to Follow-up|0|||
126489131|NCT02288559|455088470|FG002|Overall Study|Lost to Follow-up|0|||
126489132|NCT02288559|455088471|FG003|Overall Study|Lost to Follow-up|1|||
126489133|NCT02288559|455088468|FG000|Overall Study|Withdrawal by Subject|0|||
126489134|NCT02288559|455088469|FG001|Overall Study|Withdrawal by Subject|0|||
126489135|NCT02288559|455088470|FG002|Overall Study|Withdrawal by Subject|2|||
126489136|NCT02288559|455088471|FG003|Overall Study|Withdrawal by Subject|1|||
126489137|NCT02288559|455088468|FG000|Overall Study|Reason Not Specified|0|||
126489138|NCT02288559|455088469|FG001|Overall Study|Reason Not Specified|0|||
126489139|NCT02288559|455088470|FG002|Overall Study|Reason Not Specified|3|||
126489140|NCT02288559|455088471|FG003|Overall Study|Reason Not Specified|0|||
126489141|NCT02320149|455088472|FG000|Overall Study|Adverse Event|3|||
126489142|NCT02320149|455088473|FG001|Overall Study|Adverse Event|7|||
126489143|NCT02320149|455088472|FG000|Overall Study|Withdrawal of Consent|28|||
126489144|NCT02320149|455088473|FG001|Overall Study|Withdrawal of Consent|32|||
126489145|NCT02320149|455088472|FG000|Overall Study|Lost to Follow-up|21|||
126489146|NCT02320149|455088473|FG001|Overall Study|Lost to Follow-up|34|||
126489147|NCT02320149|455088472|FG000|Overall Study|Protocol Violation|2|||
126489148|NCT02320149|455088473|FG001|Overall Study|Protocol Violation|1|||
126489149|NCT02320149|455088472|FG000|Overall Study|Noncompliance with Study Treatment|7|||
126489150|NCT02320149|455088473|FG001|Overall Study|Noncompliance with Study Treatment|2|||
126489151|NCT02320149|455088472|FG000|Overall Study|Lack of Efficacy|0|||
126489152|NCT02320149|455088473|FG001|Overall Study|Lack of Efficacy|1|||
126489153|NCT02320149|455088472|FG000|Overall Study|Other Miscellaneous Reasons|2|||
126489154|NCT02320149|455088473|FG001|Overall Study|Other Miscellaneous Reasons|3|||
126489155|NCT01156311|455088477|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
126489156|NCT01156311|455088478|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
126489157|NCT01156311|455088479|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
126489158|NCT01156311|455088480|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
126489159|NCT01156311|455088477|FG000|2-Month Monotherapy Period|Physician Decision|0|||
126489160|NCT01156311|455088478|FG001|2-Month Monotherapy Period|Physician Decision|1|||
126489161|NCT01156311|455088479|FG002|2-Month Monotherapy Period|Physician Decision|0|||
126489162|NCT01156311|455088480|FG003|2-Month Monotherapy Period|Physician Decision|0|||
126489163|NCT01156311|455088477|FG000|2-Month Monotherapy Period|Other|1|||
126489164|NCT01156311|455088478|FG001|2-Month Monotherapy Period|Other|0|||
126489165|NCT01156311|455088479|FG002|2-Month Monotherapy Period|Other|0|||
126489166|NCT01156311|455088480|FG003|2-Month Monotherapy Period|Other|0|||
126489167|NCT01156311|455088477|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
126489168|NCT01156311|455088478|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
126489169|NCT01156311|455088479|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
126489170|NCT01156311|455088480|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
126489171|NCT01156311|455088477|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
126489172|NCT01156311|455088478|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
126489173|NCT01156311|455088479|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
126489174|NCT01156311|455088480|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
126489175|NCT01156311|455088477|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
126489176|NCT01156311|455088478|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
126489177|NCT01156311|455088479|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
126489178|NCT01156311|455088480|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
126489179|NCT01156311|455088477|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
126489180|NCT01156311|455088478|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
126489181|NCT01156311|455088479|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
126489182|NCT01156311|455088480|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
126489183|NCT01156311|455088477|FG000|6-month Add-on Therapy Period|Other|0|||
126489184|NCT01156311|455088478|FG001|6-month Add-on Therapy Period|Other|0|||
126489185|NCT01156311|455088479|FG002|6-month Add-on Therapy Period|Other|1|||
126489186|NCT01156311|455088480|FG003|6-month Add-on Therapy Period|Other|2|||
126489187|NCT01741701|455088481|FG000|Overall Study|Adverse Event|5|||
126489188|NCT01741701|455088482|FG001|Overall Study|Adverse Event|1|||
126489189|NCT01741701|455088481|FG000|Overall Study|Withdrawal by Subject|0|||
126489190|NCT01741701|455088482|FG001|Overall Study|Withdrawal by Subject|1|||
126489191|NCT00372112|455088487|FG000|Overall Study|Adverse Event|0|||
126489192|NCT00372112|455088488|FG001|Overall Study|Adverse Event|1|||
126489193|NCT00372112|455088489|FG002|Overall Study|Adverse Event|1|||
126489194|NCT00372112|455088490|FG003|Overall Study|Adverse Event|1|||
126489195|NCT00372112|455088487|FG000|Overall Study|Withdrawal by Subject|0|||
126489196|NCT00372112|455088488|FG001|Overall Study|Withdrawal by Subject|0|||
126489197|NCT00372112|455088489|FG002|Overall Study|Withdrawal by Subject|2|||
126489198|NCT00372112|455088490|FG003|Overall Study|Withdrawal by Subject|1|||
126489199|NCT00372112|455088487|FG000|Overall Study|Exacerbation|0|||
126489200|NCT00372112|455088488|FG001|Overall Study|Exacerbation|0|||
126489201|NCT00372112|455088489|FG002|Overall Study|Exacerbation|0|||
126489202|NCT00372112|455088490|FG003|Overall Study|Exacerbation|1|||
126489203|NCT00372112|455088487|FG000|Overall Study|PR >240 at Visit 3|0|||
126489204|NCT00372112|455088488|FG001|Overall Study|PR >240 at Visit 3|0|||
126489205|NCT00372112|455088489|FG002|Overall Study|PR >240 at Visit 3|0|||
126489206|NCT00372112|455088490|FG003|Overall Study|PR >240 at Visit 3|1|||
126489207|NCT00372112|455088487|FG000|Overall Study|Hepatitis B|1|||
126489208|NCT00372112|455088488|FG001|Overall Study|Hepatitis B|0|||
126489209|NCT00372112|455088489|FG002|Overall Study|Hepatitis B|0|||
126723277|NCT02052778|455936090|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126723278|NCT02052778|455936091|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126723279|NCT02052778|455936092|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126723280|NCT02052778|455936093|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126723281|NCT02052778|455936094|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126723282|NCT02052778|455936095|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126489210|NCT00372112|455088490|FG003|Overall Study|Hepatitis B|0|||
126489211|NCT00372112|455088487|FG000|Overall Study|Other-protocol violation|0|||
126723283|NCT02052778|455936096|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
126723284|NCT02052778|455936097|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
126723285|NCT02052778|455936098|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126723286|NCT02052778|455936099|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126489212|NCT00372112|455088488|FG001|Overall Study|Other-protocol violation|0|||
126489213|NCT00372112|455088489|FG002|Overall Study|Other-protocol violation|1|||
126489214|NCT00372112|455088490|FG003|Overall Study|Other-protocol violation|0|||
126489215|NCT04649060|455088505|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
126489216|NCT04649060|455088506|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
126489217|NCT04649060|455088505|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
126723287|NCT02052778|455936100|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126489218|NCT04649060|455088506|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
126489219|NCT04649060|455088505|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
126489220|NCT04649060|455088506|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
126489221|NCT04649060|455088505|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
126489222|NCT04649060|455088506|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
126489223|NCT04649060|455088505|FG000|Arm A/Arm B Treatment|Patient Request|1|||
126489224|NCT04649060|455088506|FG001|Arm A/Arm B Treatment|Patient Request|0|||
126489225|NCT04649060|455088505|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
126489226|NCT04649060|455088506|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
126489227|NCT04649060|455088505|FG000|Arm A/Arm B Treatment|Other|1|||
126489228|NCT04649060|455088506|FG001|Arm A/Arm B Treatment|Other|0|||
126489229|NCT04649060|455088505|FG000|Crossover (Arm B)|Adverse Event|0|||
126489230|NCT04649060|455088506|FG001|Crossover (Arm B)|Adverse Event|1|||
126489231|NCT04649060|455088505|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
126489232|NCT04649060|455088506|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
126489233|NCT04997161|455088507|FG000|Overall Study|Study terminated by sponsor|3|||
126489234|NCT04044716|455088508|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
126489235|NCT04044716|455088509|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
126489236|NCT04044716|455088510|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
126489237|NCT04044716|455088508|FG000|Overall Study|Lost to Follow-up|2|||
126489238|NCT04044716|455088509|FG001|Overall Study|Lost to Follow-up|3|||
126489239|NCT04044716|455088510|FG002|Overall Study|Lost to Follow-up|0|||
126489240|NCT01018186|455088511|FG000|2-week Run-in Period|Protocol Violation|1|||
126489241|NCT01018186|455088512|FG001|2-week Run-in Period|Protocol Violation|0|||
126489242|NCT01018186|455088513|FG002|2-week Run-in Period|Protocol Violation|0|||
126489243|NCT01018186|455088514|FG003|2-week Run-in Period|Protocol Violation|0|||
126489244|NCT01018186|455088511|FG000|2-week Run-in Period|Lost to Follow-up|2|||
126489245|NCT01018186|455088512|FG001|2-week Run-in Period|Lost to Follow-up|0|||
126489246|NCT01018186|455088513|FG002|2-week Run-in Period|Lost to Follow-up|0|||
126489247|NCT01018186|455088514|FG003|2-week Run-in Period|Lost to Follow-up|0|||
126489248|NCT01018186|455088511|FG000|2-week Run-in Period|Physician Decision|3|||
126489249|NCT01018186|455088512|FG001|2-week Run-in Period|Physician Decision|0|||
126489250|NCT01018186|455088513|FG002|2-week Run-in Period|Physician Decision|0|||
126489251|NCT01018186|455088514|FG003|2-week Run-in Period|Physician Decision|0|||
126489252|NCT01018186|455088511|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
126489253|NCT01018186|455088512|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126489254|NCT01018186|455088513|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126489255|NCT01018186|455088514|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
126489256|NCT01018186|455088511|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
126489257|NCT01018186|455088512|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
126489258|NCT01018186|455088513|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
126489259|NCT01018186|455088514|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
126489260|NCT01018186|455088511|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
126489261|NCT01018186|455088512|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
126489262|NCT01018186|455088513|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
126489263|NCT01018186|455088514|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
126489264|NCT01018186|455088511|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
126489265|NCT01018186|455088512|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
126489266|NCT01018186|455088513|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
126489267|NCT01018186|455088514|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
126489268|NCT01018186|455088511|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
126489269|NCT01018186|455088512|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
126489270|NCT01018186|455088513|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
126489271|NCT01018186|455088514|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
126489272|NCT01018186|455088511|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
126489273|NCT01018186|455088512|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
126489274|NCT01018186|455088513|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
126489275|NCT01018186|455088514|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
126489276|NCT01018186|455088511|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
126489277|NCT01018186|455088512|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
126489278|NCT01018186|455088513|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
126489279|NCT01018186|455088514|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
126489280|NCT01018186|455088511|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
126489281|NCT01018186|455088512|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
126489282|NCT01018186|455088513|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
126489283|NCT01018186|455088514|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
126489284|NCT01018186|455088511|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
126489285|NCT01018186|455088512|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
126489286|NCT01018186|455088513|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
126489287|NCT01018186|455088514|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
126489288|NCT03049280|455088515|FG000|Overall Study|Physician Decision|1|||
126489289|NCT03552198|455088516|FG000|Overall Study|Lost to Follow-up|42|||
126489290|NCT03552198|455088517|FG001|Overall Study|Lost to Follow-up|48|||
126489291|NCT03552198|455088518|FG002|Overall Study|Lost to Follow-up|15|||
126489292|NCT03552198|455088519|FG003|Overall Study|Lost to Follow-up|19|||
126489293|NCT03552198|455088516|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
126489294|NCT03552198|455088517|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
126489295|NCT03552198|455088518|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
126723288|NCT02052778|455936101|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
126489296|NCT03552198|455088519|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
126489297|NCT03552198|455088516|FG000|Overall Study|Did not receive air alerts|1|||
126489298|NCT03552198|455088517|FG001|Overall Study|Did not receive air alerts|0|||
126489299|NCT03552198|455088518|FG002|Overall Study|Did not receive air alerts|0|||
126489300|NCT03552198|455088519|FG003|Overall Study|Did not receive air alerts|1|||
126489301|NCT03235154|455088520|FG000|Overall Study|Withdrawal by Subject|1|||
126489302|NCT03235154|455088520|FG000|Overall Study|Adverse Event|1|||
126489303|NCT03235154|455088520|FG000|Overall Study|Lost to Follow-up|2|||
126489304|NCT02326025|455088521|FG000|Overall Study|Adverse Event|3|||
126489305|NCT02326025|455088522|FG001|Overall Study|Adverse Event|0|||
126489306|NCT02326025|455088521|FG000|Overall Study|Physician Decision|1|||
126489307|NCT02326025|455088522|FG001|Overall Study|Physician Decision|2|||
126489308|NCT02326025|455088521|FG000|Overall Study|Physician and Participant Decision|1|||
126489309|NCT02326025|455088522|FG001|Overall Study|Physician and Participant Decision|0|||
126489310|NCT02326025|455088521|FG000|Overall Study|Withdrawal by Subject|0|||
126489311|NCT02326025|455088522|FG001|Overall Study|Withdrawal by Subject|2|||
126489312|NCT02326025|455088521|FG000|Overall Study|Protocol Violation|0|||
126489313|NCT02326025|455088522|FG001|Overall Study|Protocol Violation|1|||
126489314|NCT00001723|455088523|FG000|Overall Study|Lack of Efficacy|6|||
126489315|NCT00001723|455088524|FG001|Overall Study|Lack of Efficacy|7|||
126489316|NCT00001723|455088523|FG000|Overall Study|Lack of family interest|4|||
126489317|NCT00001723|455088524|FG001|Overall Study|Lack of family interest|5|||
126489318|NCT00001723|455088523|FG000|Overall Study|Lost to Follow-up|2|||
126489319|NCT00001723|455088524|FG001|Overall Study|Lost to Follow-up|2|||
126489320|NCT00001723|455088523|FG000|Overall Study|medication intolerance|1|||
126489321|NCT00001723|455088524|FG001|Overall Study|medication intolerance|2|||
126489322|NCT02643082|455088525|FG000|Period 1|Adverse Event|1|||
126489323|NCT02643082|455088526|FG001|Period 1|Adverse Event|0|||
126489324|NCT01324999|455088527|FG000|Overall Study|Adverse Event|3|||
126489325|NCT01324999|455088527|FG000|Overall Study|Withdrawal by Subject|2|||
126489326|NCT00276744|455088528|FG000|PART A|Reason unknown|98|||
126489327|NCT01714635|455088531|FG000|Overall Study|Discontinued|1|||
126489328|NCT01714635|455088532|FG001|Overall Study|Discontinued|0|||
126489329|NCT01714635|455088533|FG002|Overall Study|Discontinued|2|||
126489330|NCT01714635|455088531|FG000|Overall Study|Missed 6-month exam|1|||
126489331|NCT01714635|455088532|FG001|Overall Study|Missed 6-month exam|0|||
126489332|NCT01714635|455088533|FG002|Overall Study|Missed 6-month exam|0|||
126489333|NCT00230607|455088534|FG000|Overall Study|Other|3|||
126489334|NCT02860169|455088535|FG000|Part A|Withdrawal by Subject|1|||
126489335|NCT02860169|455088535|FG000|Part A|Other (Screening failure)|6|||
126489336|NCT02860169|455088535|FG000|Part A|Other (Survey not completed)|3|||
126489337|NCT02860169|455088535|FG000|Part A|Other (did not completed consent)|1|||
126489338|NCT02860169|455088535|FG000|Part B|Other (Screening failure)|10|||
126489339|NCT02860169|455088535|FG000|Part B|Withdrawal by Subject|1|||
126489340|NCT02860169|455088535|FG000|Part C|Other (Screening failure)|1|||
126489341|NCT03667924|455088536|FG000|Baseline Completed|Lost to Follow-up|0|||
126489342|NCT03667924|455088537|FG001|Baseline Completed|Lost to Follow-up|2|||
126489343|NCT03667924|455088538|FG002|Baseline Completed|Lost to Follow-up|0|||
126489344|NCT03667924|455088536|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
126489345|NCT03667924|455088537|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
126489346|NCT03667924|455088538|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
126489347|NCT03667924|455088536|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
126489348|NCT03667924|455088537|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
126489349|NCT03667924|455088538|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
126489350|NCT03667924|455088536|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
126489351|NCT03667924|455088537|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
126489352|NCT03667924|455088538|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
126489353|NCT03667924|455088536|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
126489354|NCT03667924|455088537|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
126489355|NCT03667924|455088538|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
126489356|NCT03667924|455088536|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
126489357|NCT03667924|455088537|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
126489358|NCT03667924|455088538|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
126489359|NCT03667924|455088536|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
126489360|NCT03667924|455088537|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
126489361|NCT03667924|455088538|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
126489362|NCT00897104|455088543|FG000|Overall Study|Lost to Follow-up|12|||
126489363|NCT00897104|455088544|FG001|Overall Study|Lost to Follow-up|17|||
126489364|NCT00897104|455088545|FG002|Overall Study|Lost to Follow-up|2|||
126489365|NCT00897104|455088543|FG000|Overall Study|Pregnancy|0|||
126489366|NCT00897104|455088544|FG001|Overall Study|Pregnancy|1|||
126489367|NCT00897104|455088545|FG002|Overall Study|Pregnancy|0|||
126489368|NCT00897104|455088543|FG000|Overall Study|Protocol Violation|0|||
126489369|NCT00897104|455088544|FG001|Overall Study|Protocol Violation|1|||
126489370|NCT00897104|455088545|FG002|Overall Study|Protocol Violation|0|||
126489371|NCT00897104|455088543|FG000|Overall Study|Withdrawal by Subject|23|||
126489372|NCT00897104|455088544|FG001|Overall Study|Withdrawal by Subject|27|||
126489373|NCT00897104|455088545|FG002|Overall Study|Withdrawal by Subject|3|||
126489374|NCT00897104|455088543|FG000|Overall Study|Abnormal Prestudy Labs|2|||
126489375|NCT00897104|455088544|FG001|Overall Study|Abnormal Prestudy Labs|0|||
126489376|NCT00897104|455088545|FG002|Overall Study|Abnormal Prestudy Labs|0|||
126489377|NCT00897104|455088543|FG000|Overall Study|Abnormal Baseline ECG|2|||
126489378|NCT00897104|455088544|FG001|Overall Study|Abnormal Baseline ECG|2|||
126489379|NCT00897104|455088545|FG002|Overall Study|Abnormal Baseline ECG|0|||
126489380|NCT00897104|455088543|FG000|Overall Study|Need for Concom. Med.|0|||
126489381|NCT00897104|455088544|FG001|Overall Study|Need for Concom. Med.|1|||
126489382|NCT00897104|455088545|FG002|Overall Study|Need for Concom. Med.|1|||
126489383|NCT00897104|455088543|FG000|Overall Study|Lack of Migraine Attack|20|||
126489384|NCT00897104|455088544|FG001|Overall Study|Lack of Migraine Attack|22|||
126489385|NCT00897104|455088545|FG002|Overall Study|Lack of Migraine Attack|1|||
126489386|NCT00897104|455088543|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
126489387|NCT00897104|455088544|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126489388|NCT00897104|455088545|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126489389|NCT00897104|455088543|FG000|Overall Study|Other|3|||
126489390|NCT00897104|455088544|FG001|Overall Study|Other|0|||
126489391|NCT00897104|455088545|FG002|Overall Study|Other|0|||
126489392|NCT00897104|455088543|FG000|Overall Study|Protocol Violation|1|||
126489393|NCT00897104|455088544|FG001|Overall Study|Protocol Violation|0|||
126489394|NCT00897104|455088545|FG002|Overall Study|Protocol Violation|0|||
126489395|NCT00897104|455088543|FG000|Overall Study|Withdrawal by Subject|0|||
126489396|NCT00897104|455088544|FG001|Overall Study|Withdrawal by Subject|0|||
126489397|NCT00897104|455088545|FG002|Overall Study|Withdrawal by Subject|1|||
126489398|NCT01059799|455088548|FG000|Overall Study|Adverse Event|2|||
126489399|NCT01059799|455088549|FG001|Overall Study|Adverse Event|3|||
126489400|NCT01059799|455088548|FG000|Overall Study|Lack of Efficacy|1|||
126489401|NCT01059799|455088549|FG001|Overall Study|Lack of Efficacy|0|||
126489402|NCT01059799|455088548|FG000|Overall Study|Protocol Violation|3|||
126489403|NCT01059799|455088549|FG001|Overall Study|Protocol Violation|2|||
126489404|NCT01059799|455088548|FG000|Overall Study|Withdrawal criteria|13|||
126489405|NCT01059799|455088549|FG001|Overall Study|Withdrawal criteria|2|||
126489406|NCT01059799|455088548|FG000|Overall Study|Other|12|||
126489407|NCT01059799|455088549|FG001|Overall Study|Other|3|||
126489408|NCT00750204|455088550|FG000|Overall Study|study halted prematurely|1|||
126489409|NCT00750204|455088551|FG001|Overall Study|study halted prematurely|1|||
126489410|NCT00477971|455088552|FG000|Overall Study|Disease progression|6|||
126489411|NCT00477971|455088553|FG001|Overall Study|Disease progression|0|||
126489412|NCT00477971|455088552|FG000|Overall Study|Withdrawal by Subject|3|||
126489413|NCT00477971|455088553|FG001|Overall Study|Withdrawal by Subject|1|||
126489414|NCT00477971|455088552|FG000|Overall Study|Adverse Event|3|||
126489415|NCT00477971|455088553|FG001|Overall Study|Adverse Event|0|||
126489416|NCT00477971|455088552|FG000|Overall Study|Death|2|||
126489417|NCT00477971|455088553|FG001|Overall Study|Death|4|||
126489418|NCT00477971|455088552|FG000|Overall Study|Alternative treatment|3|||
126489419|NCT00477971|455088553|FG001|Overall Study|Alternative treatment|1|||
126489420|NCT01317160|455088554|FG000|Overall Study|Incorrect inclusion|1|||
126489421|NCT01317160|455088555|FG001|Overall Study|Incorrect inclusion|1|||
126489422|NCT01317160|455088554|FG000|Overall Study|Lost to Follow-up|3|||
126489423|NCT01317160|455088555|FG001|Overall Study|Lost to Follow-up|3|||
126489424|NCT01317160|455088554|FG000|Overall Study|Withdrawal by Subject|0|||
126489425|NCT01317160|455088555|FG001|Overall Study|Withdrawal by Subject|2|||
126489426|NCT02141282|455090262|FG000|Overall Study|Adverse event, not related to progression|8|||
126489427|NCT02141282|455090263|FG001|Overall Study|Adverse event, not related to progression|1|||
126489428|NCT02141282|455090264|FG002|Overall Study|Adverse event, not related to progression|3|||
126489429|NCT02141282|455090265|FG003|Overall Study|Adverse event, not related to progression|1|||
126489430|NCT02141282|455090262|FG000|Overall Study|Adverse event, related to progression|1|||
126489431|NCT02141282|455090263|FG001|Overall Study|Adverse event, related to progression|0|||
126489432|NCT02141282|455090264|FG002|Overall Study|Adverse event, related to progression|2|||
126489433|NCT02141282|455090265|FG003|Overall Study|Adverse event, related to progression|0|||
126489434|NCT02141282|455090262|FG000|Overall Study|COVID-19 infection|1|||
126489435|NCT02141282|455090263|FG001|Overall Study|COVID-19 infection|0|||
126489436|NCT02141282|455090264|FG002|Overall Study|COVID-19 infection|0|||
126489437|NCT02141282|455090265|FG003|Overall Study|COVID-19 infection|0|||
126489438|NCT02141282|455090262|FG000|Overall Study|Lost to Follow-up|0|||
126489439|NCT02141282|455090263|FG001|Overall Study|Lost to Follow-up|0|||
126489440|NCT02141282|455090264|FG002|Overall Study|Lost to Follow-up|4|||
126489441|NCT02141282|455090265|FG003|Overall Study|Lost to Follow-up|2|||
126489442|NCT02141282|455090262|FG000|Overall Study|Other, not specified|14|||
126489443|NCT02141282|455090263|FG001|Overall Study|Other, not specified|11|||
126489444|NCT02141282|455090264|FG002|Overall Study|Other, not specified|23|||
126489445|NCT02141282|455090265|FG003|Overall Study|Other, not specified|9|||
126723289|NCT02052778|455936102|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126723290|NCT02052778|455936103|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126723291|NCT02052778|455936104|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
126489446|NCT02141282|455090262|FG000|Overall Study|Progressive disease, Richter's|4|||
126489447|NCT02141282|455090263|FG001|Overall Study|Progressive disease, Richter's|1|||
126489448|NCT02141282|455090264|FG002|Overall Study|Progressive disease, Richter's|1|||
126489449|NCT02141282|455090265|FG003|Overall Study|Progressive disease, Richter's|1|||
126489450|NCT02141282|455090262|FG000|Overall Study|Progressive disease per protocol|12|||
126489451|NCT02141282|455090263|FG001|Overall Study|Progressive disease per protocol|7|||
126489452|NCT02141282|455090264|FG002|Overall Study|Progressive disease per protocol|9|||
126489453|NCT02141282|455090265|FG003|Overall Study|Progressive disease per protocol|2|||
126489454|NCT02141282|455090262|FG000|Overall Study|Stem cell transplant|1|||
126489455|NCT02141282|455090263|FG001|Overall Study|Stem cell transplant|0|||
126489456|NCT02141282|455090264|FG002|Overall Study|Stem cell transplant|1|||
126489457|NCT02141282|455090265|FG003|Overall Study|Stem cell transplant|0|||
126489458|NCT02141282|455090262|FG000|Overall Study|Study terminated by Sponsor|0|||
126489459|NCT02141282|455090263|FG001|Overall Study|Study terminated by Sponsor|1|||
126489460|NCT02141282|455090264|FG002|Overall Study|Study terminated by Sponsor|0|||
126489461|NCT02141282|455090265|FG003|Overall Study|Study terminated by Sponsor|0|||
126489462|NCT02141282|455090262|FG000|Overall Study|Subject non-compliance|0|||
126489463|NCT02141282|455090263|FG001|Overall Study|Subject non-compliance|0|||
126489464|NCT02141282|455090264|FG002|Overall Study|Subject non-compliance|1|||
126489465|NCT02141282|455090265|FG003|Overall Study|Subject non-compliance|0|||
126489466|NCT02141282|455090262|FG000|Overall Study|Withdrew consent|2|||
126489467|NCT02141282|455090263|FG001|Overall Study|Withdrew consent|0|||
126489468|NCT02141282|455090264|FG002|Overall Study|Withdrew consent|4|||
126489469|NCT02141282|455090265|FG003|Overall Study|Withdrew consent|0|||
126489470|NCT03312933|455090266|FG000|Overall Study|Protocol Violation|15|||
126489471|NCT03312933|455090266|FG000|Overall Study|Lost to Follow-up|36|||
126489472|NCT03312933|455090266|FG000|Overall Study|Withdrawal by Subject|3|||
126489473|NCT00224055|455090272|FG000|Overall Study|Adverse Event|9|||
126489474|NCT00224055|455090273|FG001|Overall Study|Adverse Event|3|||
126489475|NCT00224055|455090272|FG000|Overall Study|Lost to Follow-up|1|||
126489476|NCT00224055|455090273|FG001|Overall Study|Lost to Follow-up|2|||
126489477|NCT00224055|455090272|FG000|Overall Study|Protocol Violation|1|||
126489478|NCT00224055|455090273|FG001|Overall Study|Protocol Violation|1|||
126489479|NCT00224055|455090272|FG000|Overall Study|Inclusion Violation|3|||
126489480|NCT00224055|455090273|FG001|Overall Study|Inclusion Violation|6|||
126489481|NCT00224055|455090272|FG000|Overall Study|Withdrawal by Subject|0|||
126489482|NCT00224055|455090273|FG001|Overall Study|Withdrawal by Subject|2|||
126489483|NCT00224055|455090272|FG000|Overall Study|Other|1|||
126489484|NCT00224055|455090273|FG001|Overall Study|Other|0|||
126489485|NCT04317066|455090274|FG000|Overall Study|Sponsor decision|5|||
126489486|NCT04317066|455090274|FG000|Overall Study|Death|2|||
126489487|NCT00848081|455090277|FG000|Overall Study|Adverse Event|6|||
126489488|NCT00848081|455090278|FG001|Overall Study|Adverse Event|7|||
126489489|NCT00848081|455090277|FG000|Overall Study|Protocol Violation|8|||
126489490|NCT00848081|455090278|FG001|Overall Study|Protocol Violation|5|||
126489491|NCT00848081|455090277|FG000|Overall Study|Lost to Follow-up|1|||
126489492|NCT00848081|455090278|FG001|Overall Study|Lost to Follow-up|0|||
126489493|NCT00848081|455090277|FG000|Overall Study|Physician Decision|0|||
126489494|NCT00848081|455090278|FG001|Overall Study|Physician Decision|3|||
126489495|NCT00848081|455090277|FG000|Overall Study|Withdrawal by Subject|5|||
126489496|NCT00848081|455090278|FG001|Overall Study|Withdrawal by Subject|3|||
126489497|NCT02064868|455090279|FG000|Overall Study|Lost to Follow-up|14|||
126489498|NCT02064868|455090280|FG001|Overall Study|Lost to Follow-up|8|||
126489499|NCT02064868|455090279|FG000|Overall Study|Physician Decision|1|||
126489500|NCT02064868|455090280|FG001|Overall Study|Physician Decision|0|||
126489501|NCT02064868|455090279|FG000|Overall Study|Withdrawal by Subject|14|||
126489502|NCT02064868|455090280|FG001|Overall Study|Withdrawal by Subject|3|||
126489503|NCT02064868|455090279|FG000|Overall Study|Technical Problems or Missing|5|||
126489504|NCT02064868|455090280|FG001|Overall Study|Technical Problems or Missing|2|||
126489505|NCT00754624|455090284|FG000|Overall Study|Adverse Event|16|||
126489506|NCT00754624|455090284|FG000|Overall Study|Death|1|||
126489507|NCT00754624|455090284|FG000|Overall Study|Physician Decision|8|||
126489508|NCT00754624|455090284|FG000|Overall Study|Protocol Violation|1|||
126489509|NCT00754624|455090284|FG000|Overall Study|Withdrawal by Subject|28|||
126489510|NCT00754624|455090284|FG000|Overall Study|Various|12|||
126489511|NCT00754624|455090284|FG000|Overall Study|Lost to Follow-up|3|||
126489512|NCT00418314|455090285|FG000|Overall Study|Withdrawal by Subject|1|||
126489513|NCT00418314|455090286|FG001|Overall Study|Withdrawal by Subject|2|||
126489514|NCT00589914|455090289|FG000|Overall Study|Adverse Event|19|||
126489515|NCT00589914|455090290|FG001|Overall Study|Adverse Event|10|||
126489516|NCT00589914|455090289|FG000|Overall Study|Death|2|||
126489517|NCT00589914|455090290|FG001|Overall Study|Death|0|||
126489518|NCT00589914|455090289|FG000|Overall Study|Lack of Efficacy|40|||
126489519|NCT00589914|455090290|FG001|Overall Study|Lack of Efficacy|43|||
126489520|NCT00589914|455090289|FG000|Overall Study|Lost to Follow-up|11|||
126559544|NCT02373813|455342536|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
126559545|NCT02373813|455342537|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
126489521|NCT00589914|455090290|FG001|Overall Study|Lost to Follow-up|18|||
126489522|NCT00589914|455090289|FG000|Overall Study|Pregnancy|1|||
126489523|NCT00589914|455090290|FG001|Overall Study|Pregnancy|0|||
126489524|NCT00589914|455090289|FG000|Overall Study|Withdrawal by Subject|55|||
126489525|NCT00589914|455090290|FG001|Overall Study|Withdrawal by Subject|49|||
126489526|NCT00589914|455090289|FG000|Overall Study|Other|22|||
126489527|NCT00589914|455090290|FG001|Overall Study|Other|17|||
126489528|NCT01402544|455090296|FG000|Overall Study|Withdrawal by Subject|6|||
126489529|NCT02051608|455090297|FG000|Part 1: Double Blind Treatment|Death|3|||
126489530|NCT02051608|455090298|FG001|Part 1: Double Blind Treatment|Death|3|||
126489531|NCT02051608|455090299|FG002|Part 1: Double Blind Treatment|Death|0|||
126489532|NCT02051608|455090300|FG003|Part 1: Double Blind Treatment|Death|0|||
126489533|NCT02051608|455090297|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
126489534|NCT02051608|455090298|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
126489535|NCT02051608|455090299|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
126489536|NCT02051608|455090300|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
126489537|NCT02051608|455090297|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
126489538|NCT02051608|455090298|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
126489539|NCT02051608|455090299|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
126489540|NCT02051608|455090300|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
126489541|NCT02051608|455090297|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
126489542|NCT02051608|455090298|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
126489543|NCT02051608|455090299|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
126489544|NCT02051608|455090300|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
126489545|NCT02051608|455090297|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
126489546|NCT02051608|455090298|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
126489547|NCT02051608|455090299|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
126489548|NCT02051608|455090300|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
126489549|NCT02051608|455090297|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
126489550|NCT02051608|455090298|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
126489551|NCT02051608|455090299|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
126489552|NCT02051608|455090300|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
126489553|NCT02051608|455090297|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
126489554|NCT02051608|455090298|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
126489555|NCT02051608|455090299|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
126489556|NCT02051608|455090300|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
126489557|NCT02051608|455090297|FG000|Part 1: Double Blind Treatment|Other|6|||
126489558|NCT02051608|455090298|FG001|Part 1: Double Blind Treatment|Other|3|||
126489559|NCT02051608|455090299|FG002|Part 1: Double Blind Treatment|Other|0|||
126489560|NCT02051608|455090300|FG003|Part 1: Double Blind Treatment|Other|0|||
126489561|NCT02051608|455090297|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
126489562|NCT02051608|455090298|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
126489563|NCT02051608|455090299|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
126489564|NCT02051608|455090300|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
126489565|NCT02051608|455090297|FG000|Part 2: Open-label Extension|Adverse Event|0|||
126489566|NCT02051608|455090298|FG001|Part 2: Open-label Extension|Adverse Event|0|||
126489567|NCT02051608|455090299|FG002|Part 2: Open-label Extension|Adverse Event|6|||
126489568|NCT02051608|455090300|FG003|Part 2: Open-label Extension|Adverse Event|8|||
126489569|NCT02051608|455090297|FG000|Part 2: Open-label Extension|Death|0|||
126489570|NCT02051608|455090298|FG001|Part 2: Open-label Extension|Death|0|||
126489571|NCT02051608|455090299|FG002|Part 2: Open-label Extension|Death|7|||
126489572|NCT02051608|455090300|FG003|Part 2: Open-label Extension|Death|4|||
126489573|NCT02051608|455090297|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
126489574|NCT02051608|455090298|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
126489575|NCT02051608|455090299|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
126489576|NCT02051608|455090300|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
126489577|NCT02051608|455090297|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
126489578|NCT02051608|455090298|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
126489579|NCT02051608|455090299|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
126489580|NCT02051608|455090300|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
126489581|NCT02051608|455090297|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
126489582|NCT02051608|455090298|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
126489583|NCT02051608|455090299|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
126489584|NCT02051608|455090300|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
126489585|NCT02051608|455090297|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
126489586|NCT02051608|455090298|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
126489587|NCT02051608|455090299|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
126489588|NCT02051608|455090300|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
126723292|NCT02052778|455936082|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
126723293|NCT02052778|455936083|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
126723294|NCT02052778|455936084|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
126723295|NCT02052778|455936085|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
126723296|NCT02052778|455936086|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
126723297|NCT02052778|455936087|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
126723298|NCT02052778|455936088|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
126723299|NCT02052778|455936089|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
126723300|NCT02052778|455936090|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
126723301|NCT02052778|455936091|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
126489589|NCT02051608|455090297|FG000|Part 2: Open-label Extension|Physician Decision|0|||
126489590|NCT02051608|455090298|FG001|Part 2: Open-label Extension|Physician Decision|0|||
126489591|NCT02051608|455090299|FG002|Part 2: Open-label Extension|Physician Decision|8|||
126489592|NCT02051608|455090300|FG003|Part 2: Open-label Extension|Physician Decision|5|||
126489593|NCT02051608|455090297|FG000|Part 2: Open-label Extension|Other|0|||
126489594|NCT02051608|455090298|FG001|Part 2: Open-label Extension|Other|0|||
126489595|NCT02051608|455090299|FG002|Part 2: Open-label Extension|Other|9|||
126489596|NCT02051608|455090300|FG003|Part 2: Open-label Extension|Other|9|||
126489597|NCT04876274|455090301|FG000|Overall Study|Lost to Follow-up|9|||
126489598|NCT04876274|455090302|FG001|Overall Study|Lost to Follow-up|12|||
126489599|NCT01948050|455090303|FG000|Overall Study|Withdrawal by Subject|0|||
126489600|NCT01948050|455090304|FG001|Overall Study|Withdrawal by Subject|1|||
126489601|NCT03303079|455090305|FG000|Overall Study|Adverse Event|0|||
126489602|NCT03303079|455090306|FG001|Overall Study|Adverse Event|1|||
126489603|NCT03303079|455090307|FG002|Overall Study|Adverse Event|3|||
126489604|NCT03303079|455090305|FG000|Overall Study|Protocol Violation|5|||
126489605|NCT03303079|455090306|FG001|Overall Study|Protocol Violation|4|||
126489606|NCT03303079|455090307|FG002|Overall Study|Protocol Violation|7|||
126489607|NCT03303079|455090305|FG000|Overall Study|Withdrawal by Subject|2|||
126489608|NCT03303079|455090306|FG001|Overall Study|Withdrawal by Subject|4|||
126489609|NCT03303079|455090307|FG002|Overall Study|Withdrawal by Subject|2|||
126489610|NCT03303079|455090305|FG000|Overall Study|Other than specified|0|||
126489611|NCT03303079|455090306|FG001|Overall Study|Other than specified|2|||
126489612|NCT03303079|455090307|FG002|Overall Study|Other than specified|0|||
126489613|NCT02005445|455090308|FG000|Overall Study|Dual study enrollment|0|||
126489614|NCT02005445|455090309|FG001|Overall Study|Dual study enrollment|1|||
126489615|NCT01314443|455090310|FG000|Overall Study|Withdrawal by Subject|2|||
126489616|NCT01314443|455090311|FG001|Overall Study|Withdrawal by Subject|1|||
126489617|NCT01314443|455090312|FG002|Overall Study|Withdrawal by Subject|1|||
126489618|NCT01314443|455090313|FG003|Overall Study|Withdrawal by Subject|1|||
126489619|NCT01314443|455090310|FG000|Overall Study|Protocol Violation|2|||
126489620|NCT01314443|455090311|FG001|Overall Study|Protocol Violation|2|||
126489621|NCT01314443|455090312|FG002|Overall Study|Protocol Violation|1|||
126489622|NCT01314443|455090313|FG003|Overall Study|Protocol Violation|1|||
126489623|NCT00449540|455090315|FG000|Pretreatment Phase|No migraine experienced|66|||
126489624|NCT00449540|455090316|FG001|Pretreatment Phase|No migraine experienced|0|||
126489625|NCT00449540|455090317|FG002|Pretreatment Phase|No migraine experienced|0|||
126489626|NCT00449540|455090315|FG000|Treatment Phase|did not experience or treat migraine|0|||
126489627|NCT00449540|455090316|FG001|Treatment Phase|did not experience or treat migraine|20|||
126489628|NCT00449540|455090317|FG002|Treatment Phase|did not experience or treat migraine|17|||
126489629|NCT02709785|455090318|FG000|Overall Study|Withdrawal by Subject|1|||
126489630|NCT02709785|455090319|FG001|Overall Study|Withdrawal by Subject|2|||
126489631|NCT02709785|455090320|FG002|Overall Study|Withdrawal by Subject|1|||
126489632|NCT00010374|455090321|FG000|Overall Study|False positive phrenic nerve test|1|||
126489633|NCT01961323|455090322|FG000|Overall Study|Withdrawal by Subject|7|||
126489634|NCT01961323|455090322|FG000|Overall Study|Lost to Follow-up|8|||
126489635|NCT01961323|455090322|FG000|Overall Study|screen failure|34|||
126489636|NCT02875860|455090325|FG000|Overall Study|Withdrawal by Subject|0|||
126489637|NCT02875860|455090326|FG001|Overall Study|Withdrawal by Subject|1|||
126489638|NCT02746874|455090327|FG000|Overall Study|Withdrawal by Subject|0|||
126489639|NCT02746874|455090328|FG001|Overall Study|Withdrawal by Subject|1|||
126489640|NCT02746874|455090327|FG000|Overall Study|Surgery Date Changed|0|||
126489641|NCT02746874|455090328|FG001|Overall Study|Surgery Date Changed|2|||
126489642|NCT00487747|455090331|FG000|Overall Study|Adverse Event|1|||
126489643|NCT00487747|455090331|FG000|Overall Study|Lost to Follow-up|9|||
126489644|NCT00487747|455090331|FG000|Overall Study|Lack of Efficacy|1|||
126489645|NCT01830972|455090332|FG000|Part II|Withdrawal by Subject|2|||
126489646|NCT01830972|455090333|FG001|Part II|Withdrawal by Subject|2|||
126489647|NCT01830972|455090332|FG000|Part III|Withdrawal by Subject|1|||
126489648|NCT01830972|455090333|FG001|Part III|Withdrawal by Subject|0|||
126489649|NCT01830972|455090332|FG000|Part III|Noncompliance|1|||
126489650|NCT01830972|455090333|FG001|Part III|Noncompliance|0|||
126489651|NCT01830972|455090332|FG000|Part IV|Withdrawal by Subject|2|||
126489652|NCT01830972|455090333|FG001|Part IV|Withdrawal by Subject|1|||
126559546|NCT02373813|455342538|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
126489653|NCT01830972|455090332|FG000|Part IV|Non-Compliance|1|||
126489654|NCT01830972|455090333|FG001|Part IV|Non-Compliance|0|||
126489655|NCT01907815|455090336|FG000|Overall Study|Withdrawal by Subject|1|||
126489656|NCT01907815|455090337|FG001|Overall Study|Withdrawal by Subject|0|||
126489657|NCT02205814|455090338|FG000|Overall Study|Lost to Follow-up|0|||
126489658|NCT02205814|455090339|FG001|Overall Study|Lost to Follow-up|0|||
126489659|NCT02205814|455090340|FG002|Overall Study|Lost to Follow-up|0|||
126489660|NCT02205814|455090341|FG003|Overall Study|Lost to Follow-up|1|||
126489661|NCT02205814|455090338|FG000|Overall Study|Lack of Efficacy|1|||
126489662|NCT02205814|455090339|FG001|Overall Study|Lack of Efficacy|0|||
126489663|NCT02205814|455090340|FG002|Overall Study|Lack of Efficacy|1|||
126489664|NCT02205814|455090341|FG003|Overall Study|Lack of Efficacy|1|||
126489665|NCT02205814|455090338|FG000|Overall Study|Physician Decision|0|||
126489666|NCT02205814|455090339|FG001|Overall Study|Physician Decision|0|||
126489667|NCT02205814|455090340|FG002|Overall Study|Physician Decision|1|||
126489668|NCT02205814|455090341|FG003|Overall Study|Physician Decision|0|||
126489669|NCT02205814|455090338|FG000|Overall Study|Protocol Violation|1|||
126489670|NCT02205814|455090339|FG001|Overall Study|Protocol Violation|0|||
126489671|NCT02205814|455090340|FG002|Overall Study|Protocol Violation|0|||
126489672|NCT02205814|455090341|FG003|Overall Study|Protocol Violation|1|||
126489673|NCT02205814|455090338|FG000|Overall Study|Withdrawal by Subject|0|||
126489674|NCT02205814|455090339|FG001|Overall Study|Withdrawal by Subject|1|||
126489675|NCT02205814|455090340|FG002|Overall Study|Withdrawal by Subject|2|||
126489676|NCT02205814|455090341|FG003|Overall Study|Withdrawal by Subject|1|||
126489677|NCT02205814|455090338|FG000|Overall Study|not compliant with study procedures|0|||
126489678|NCT02205814|455090339|FG001|Overall Study|not compliant with study procedures|0|||
126489679|NCT02205814|455090340|FG002|Overall Study|not compliant with study procedures|1|||
126489680|NCT02205814|455090341|FG003|Overall Study|not compliant with study procedures|0|||
126489681|NCT01426373|455090342|FG000|Overall Study|Adverse Event|6|||
126489682|NCT01426373|455090342|FG000|Overall Study|Lost to Follow-up|14|||
126489683|NCT01426373|455090342|FG000|Overall Study|Participant Convenience|10|||
126489684|NCT01426373|455090342|FG000|Overall Study|Miscellaneous Reasons|4|||
126489685|NCT04952402|455090343|FG000|Overall Study|Lost to Follow-up|1|||
126489686|NCT04952402|455090344|FG001|Overall Study|Lost to Follow-up|3|||
126489687|NCT04952402|455090343|FG000|Overall Study|Lack Of Venous Access|0|||
126489688|NCT04952402|455090344|FG001|Overall Study|Lack Of Venous Access|1|||
126489689|NCT00726661|455090345|FG000|Overall Study|Lost to Follow-up|36|||
126489690|NCT00726661|455090346|FG001|Overall Study|Lost to Follow-up|11|||
126489691|NCT00726661|455090345|FG000|Overall Study|Withdrawal by Subject|17|||
126489692|NCT00726661|455090346|FG001|Overall Study|Withdrawal by Subject|13|||
126489693|NCT00726661|455090345|FG000|Overall Study|Trial terminated by sponsor|214|||
126489694|NCT00726661|455090346|FG001|Overall Study|Trial terminated by sponsor|187|||
126489695|NCT00726661|455090345|FG000|Overall Study|Death|475|||
126489696|NCT00726661|455090346|FG001|Overall Study|Death|159|||
126489697|NCT00726661|455090345|FG000|Overall Study|Physician Decision|25|||
126489698|NCT00726661|455090346|FG001|Overall Study|Physician Decision|13|||
126489699|NCT00726661|455090345|FG000|Overall Study|Other|47|||
126489700|NCT00726661|455090346|FG001|Overall Study|Other|35|||
126489701|NCT01996982|455090351|FG000|Overall Study|PI/team left institution|7|||
126489702|NCT01574326|455090352|FG000|Overall Study|Randomized but not treated|0|||
126489703|NCT01574326|455090353|FG001|Overall Study|Randomized but not treated|1|||
126489704|NCT01574326|455090352|FG000|Overall Study|Withdrawal by Participant|2|||
126489705|NCT01574326|455090353|FG001|Overall Study|Withdrawal by Participant|4|||
126489706|NCT01574326|455090352|FG000|Overall Study|Physician Decision|5|||
126489707|NCT01574326|455090353|FG001|Overall Study|Physician Decision|3|||
126489708|NCT01574326|455090352|FG000|Overall Study|Adverse Event|1|||
126489709|NCT01574326|455090353|FG001|Overall Study|Adverse Event|3|||
126489710|NCT01574326|455090352|FG000|Overall Study|Other: Mainly kidney transplant|8|||
126489711|NCT01574326|455090353|FG001|Overall Study|Other: Mainly kidney transplant|8|||
126489712|NCT01195415|455090372|FG000|Overall Study|No repeat biopsy due to progression|2|||
126489713|NCT03060629|455090382|FG000|Overall Study|Death|4|||
126489714|NCT03060629|455090383|FG001|Overall Study|Death|5|||
126489715|NCT03060629|455090382|FG000|Overall Study|Withdrawal by Subject|50|||
126489716|NCT03060629|455090383|FG001|Overall Study|Withdrawal by Subject|35|||
126489717|NCT03060629|455090382|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
126489718|NCT03060629|455090383|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
126489719|NCT03060629|455090382|FG000|Overall Study|Participant Relocate|15|||
126489720|NCT03060629|455090383|FG001|Overall Study|Participant Relocate|15|||
126489721|NCT03060629|455090382|FG000|Overall Study|Unable to Contact Participant|34|||
126489722|NCT03060629|455090383|FG001|Overall Study|Unable to Contact Participant|23|||
126489723|NCT03060629|455090382|FG000|Overall Study|Investigator Decision|7|||
126489724|NCT03060629|455090383|FG001|Overall Study|Investigator Decision|7|||
126489725|NCT03060629|455090382|FG000|Overall Study|Study Terminated by Sponsor|1100|||
126489726|NCT03060629|455090383|FG001|Overall Study|Study Terminated by Sponsor|1123|||
126489727|NCT03060629|455090382|FG000|Overall Study|Other|4|||
126489728|NCT03060629|455090383|FG001|Overall Study|Other|4|||
126489729|NCT02505867|455090384|FG000|Overall Study|Lack of Efficacy|6|||
126489730|NCT02505867|455090385|FG001|Overall Study|Lack of Efficacy|6|||
126723302|NCT02052778|455936092|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
126723303|NCT02052778|455936093|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
126723304|NCT02052778|455936094|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
126723305|NCT02052778|455936095|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
126723306|NCT02052778|455936096|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
126723307|NCT02052778|455936097|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
126489731|NCT01862874|455090386|FG000|Overall Study|Randomized not treated|1|||
126489732|NCT01862874|455090387|FG001|Overall Study|Randomized not treated|0|||
126489733|NCT01862874|455090386|FG000|Overall Study|Adverse Event|0|||
126489734|NCT01862874|455090387|FG001|Overall Study|Adverse Event|3|||
126489735|NCT01862874|455090386|FG000|Overall Study|Lost to Follow-up|26|||
126489736|NCT01862874|455090387|FG001|Overall Study|Lost to Follow-up|29|||
126489737|NCT01862874|455090386|FG000|Overall Study|Physician Decision|5|||
126489738|NCT01862874|455090387|FG001|Overall Study|Physician Decision|3|||
126489739|NCT01862874|455090386|FG000|Overall Study|Withdrawn by parent/guardian|1|||
126489740|NCT01862874|455090387|FG001|Overall Study|Withdrawn by parent/guardian|1|||
126489741|NCT01862874|455090386|FG000|Overall Study|Withdrawal by Subject|46|||
126489742|NCT01862874|455090387|FG001|Overall Study|Withdrawal by Subject|40|||
126489743|NCT01862874|455090386|FG000|Overall Study|Death|0|||
126489744|NCT01862874|455090387|FG001|Overall Study|Death|1|||
126489745|NCT02743871|455090391|FG000|Overall Study|Lost to Follow-up|0|||
126489746|NCT02743871|455090392|FG001|Overall Study|Lost to Follow-up|0|||
126489747|NCT02743871|455090393|FG002|Overall Study|Lost to Follow-up|0|||
126489748|NCT02743871|455090394|FG003|Overall Study|Lost to Follow-up|1|||
126489749|NCT02743871|455090395|FG004|Overall Study|Lost to Follow-up|0|||
126489750|NCT02743871|455090396|FG005|Overall Study|Lost to Follow-up|0|||
126489751|NCT02743871|455090397|FG006|Overall Study|Lost to Follow-up|1|||
126489752|NCT02743871|455090398|FG007|Overall Study|Lost to Follow-up|0|||
126489753|NCT02743871|455090399|FG008|Overall Study|Lost to Follow-up|0|||
126489754|NCT02743871|455090400|FG009|Overall Study|Lost to Follow-up|0|||
126489755|NCT02743871|455090401|FG010|Overall Study|Lost to Follow-up|0|||
126489756|NCT02743871|455090402|FG011|Overall Study|Lost to Follow-up|2|||
126489757|NCT02743871|455090403|FG012|Overall Study|Lost to Follow-up|0|||
126489758|NCT02743871|455090404|FG013|Overall Study|Lost to Follow-up|0|||
126489759|NCT02743871|455090391|FG000|Overall Study|Withdrawal by Subject|0|||
126489760|NCT02743871|455090392|FG001|Overall Study|Withdrawal by Subject|0|||
126489761|NCT02743871|455090393|FG002|Overall Study|Withdrawal by Subject|0|||
126489762|NCT02743871|455090394|FG003|Overall Study|Withdrawal by Subject|0|||
126489763|NCT02743871|455090395|FG004|Overall Study|Withdrawal by Subject|0|||
126489764|NCT02743871|455090396|FG005|Overall Study|Withdrawal by Subject|0|||
126489765|NCT02743871|455090397|FG006|Overall Study|Withdrawal by Subject|0|||
126489766|NCT02743871|455090398|FG007|Overall Study|Withdrawal by Subject|0|||
126489767|NCT02743871|455090399|FG008|Overall Study|Withdrawal by Subject|0|||
126489768|NCT02743871|455090400|FG009|Overall Study|Withdrawal by Subject|0|||
126489769|NCT02743871|455090401|FG010|Overall Study|Withdrawal by Subject|1|||
126489770|NCT02743871|455090402|FG011|Overall Study|Withdrawal by Subject|0|||
126489771|NCT02743871|455090403|FG012|Overall Study|Withdrawal by Subject|12|||
126489772|NCT02743871|455090404|FG013|Overall Study|Withdrawal by Subject|6|||
126489773|NCT02743871|455090391|FG000|Overall Study|Adverse Event|1|||
126489774|NCT02743871|455090392|FG001|Overall Study|Adverse Event|0|||
126489775|NCT02743871|455090393|FG002|Overall Study|Adverse Event|0|||
126489776|NCT02743871|455090394|FG003|Overall Study|Adverse Event|0|||
126489777|NCT02743871|455090395|FG004|Overall Study|Adverse Event|0|||
126489778|NCT02743871|455090396|FG005|Overall Study|Adverse Event|0|||
126489779|NCT02743871|455090397|FG006|Overall Study|Adverse Event|0|||
126489780|NCT02743871|455090398|FG007|Overall Study|Adverse Event|0|||
126489781|NCT02743871|455090399|FG008|Overall Study|Adverse Event|0|||
126489782|NCT02743871|455090400|FG009|Overall Study|Adverse Event|0|||
126489783|NCT02743871|455090401|FG010|Overall Study|Adverse Event|0|||
126489784|NCT02743871|455090402|FG011|Overall Study|Adverse Event|0|||
126489785|NCT02743871|455090403|FG012|Overall Study|Adverse Event|0|||
126489786|NCT02743871|455090404|FG013|Overall Study|Adverse Event|0|||
126489787|NCT02743871|455090391|FG000|Overall Study|Other|0|||
126489788|NCT02743871|455090392|FG001|Overall Study|Other|0|||
126489789|NCT02743871|455090393|FG002|Overall Study|Other|0|||
126723308|NCT02052778|455936098|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
126489790|NCT02743871|455090394|FG003|Overall Study|Other|0|||
126489791|NCT02743871|455090395|FG004|Overall Study|Other|0|||
126489792|NCT02743871|455090396|FG005|Overall Study|Other|0|||
126489793|NCT02743871|455090397|FG006|Overall Study|Other|0|||
126489794|NCT02743871|455090398|FG007|Overall Study|Other|0|||
126489795|NCT02743871|455090399|FG008|Overall Study|Other|0|||
126489796|NCT02743871|455090400|FG009|Overall Study|Other|0|||
126489797|NCT02743871|455090401|FG010|Overall Study|Other|0|||
126489798|NCT02743871|455090402|FG011|Overall Study|Other|1|||
126489799|NCT02743871|455090403|FG012|Overall Study|Other|1|||
126489800|NCT02743871|455090404|FG013|Overall Study|Other|1|||
126489801|NCT02743871|455090391|FG000|Overall Study|Protocol Violation|0|||
126489802|NCT02743871|455090392|FG001|Overall Study|Protocol Violation|0|||
126489803|NCT02743871|455090393|FG002|Overall Study|Protocol Violation|0|||
126489804|NCT02743871|455090394|FG003|Overall Study|Protocol Violation|0|||
126489805|NCT02743871|455090395|FG004|Overall Study|Protocol Violation|0|||
126489806|NCT02743871|455090396|FG005|Overall Study|Protocol Violation|0|||
126489807|NCT02743871|455090397|FG006|Overall Study|Protocol Violation|0|||
126489808|NCT02743871|455090398|FG007|Overall Study|Protocol Violation|0|||
126489809|NCT02743871|455090399|FG008|Overall Study|Protocol Violation|0|||
126489810|NCT02743871|455090400|FG009|Overall Study|Protocol Violation|0|||
126489811|NCT02743871|455090401|FG010|Overall Study|Protocol Violation|0|||
126489812|NCT02743871|455090402|FG011|Overall Study|Protocol Violation|0|||
126489813|NCT02743871|455090403|FG012|Overall Study|Protocol Violation|2|||
126489814|NCT02743871|455090404|FG013|Overall Study|Protocol Violation|0|||
126489815|NCT02848651|455090409|FG000|Overall Study|Death|85|||
126489816|NCT02848651|455090409|FG000|Overall Study|Lost to Follow-up|1|||
126489817|NCT02848651|455090409|FG000|Overall Study|Non-Compliance|1|||
126489818|NCT02848651|455090409|FG000|Overall Study|Symptomatic Deterioration|1|||
126489819|NCT02848651|455090409|FG000|Overall Study|Physician Decision|4|||
126489820|NCT02848651|455090409|FG000|Overall Study|Withdrawal by Subject|14|||
126489821|NCT00662363|455090412|FG000|Overall Study|Withdrawal by Subject|6|||
126489822|NCT00662363|455090413|FG001|Overall Study|Withdrawal by Subject|5|||
126489823|NCT00662363|455090412|FG000|Overall Study|Adverse Event|0|||
126489824|NCT00662363|455090413|FG001|Overall Study|Adverse Event|3|||
126489825|NCT00662363|455090412|FG000|Overall Study|Discharged early from rehab|4|||
126489826|NCT00662363|455090413|FG001|Overall Study|Discharged early from rehab|1|||
126489827|NCT00662363|455090412|FG000|Overall Study|Protocol Violation|1|||
126489828|NCT00662363|455090413|FG001|Overall Study|Protocol Violation|1|||
126489829|NCT01428453|455090414|FG000|Overall Study|Adverse Event|2|||
126489830|NCT01428453|455090415|FG001|Overall Study|Adverse Event|7|||
126489831|NCT01428453|455090414|FG000|Overall Study|Protocol Violation|1|||
126489832|NCT01428453|455090415|FG001|Overall Study|Protocol Violation|0|||
126489833|NCT01428453|455090414|FG000|Overall Study|Lost to Follow-up|0|||
126489834|NCT01428453|455090415|FG001|Overall Study|Lost to Follow-up|1|||
126489835|NCT01428453|455090414|FG000|Overall Study|Withdrawal by Subject|3|||
126489836|NCT01428453|455090415|FG001|Overall Study|Withdrawal by Subject|1|||
126489837|NCT04203238|455092558|FG000|Overall Study|Withdrawal by Subject|1|||
126489838|NCT04203238|455092559|FG001|Overall Study|Withdrawal by Subject|1|||
126489839|NCT04203238|455092558|FG000|Overall Study|Covid-19|3|||
126489840|NCT04203238|455092559|FG001|Overall Study|Covid-19|0|||
126489841|NCT01955733|455092560|FG000|Period 1|Lost to Follow-up|1|||
126489842|NCT01955733|455092561|FG001|Period 1|Lost to Follow-up|0|||
126489843|NCT01955733|455092562|FG002|Period 1|Lost to Follow-up|0|||
126489844|NCT01955733|455092560|FG000|Period 2|Adverse Event|1|||
126489845|NCT01955733|455092561|FG001|Period 2|Adverse Event|0|||
126489846|NCT01955733|455092562|FG002|Period 2|Adverse Event|0|||
126489847|NCT01955733|455092560|FG000|Period 2|Physician Decision|0|||
126489848|NCT01955733|455092561|FG001|Period 2|Physician Decision|0|||
126489849|NCT01955733|455092562|FG002|Period 2|Physician Decision|1|||
126489850|NCT01955733|455092560|FG000|Period 2|Withdrawal by Subject|1|||
126489851|NCT01955733|455092561|FG001|Period 2|Withdrawal by Subject|3|||
126489852|NCT01955733|455092562|FG002|Period 2|Withdrawal by Subject|2|||
126489853|NCT01955733|455092560|FG000|Period 2|Study terminated by sponsor|8|||
126489854|NCT01955733|455092561|FG001|Period 2|Study terminated by sponsor|14|||
126489855|NCT01955733|455092562|FG002|Period 2|Study terminated by sponsor|16|||
126489856|NCT01955733|455092560|FG000|Period 2|Lost to Follow-up|2|||
126489857|NCT01955733|455092561|FG001|Period 2|Lost to Follow-up|0|||
126489858|NCT01955733|455092562|FG002|Period 2|Lost to Follow-up|0|||
126489859|NCT01955733|455092560|FG000|Period 2|Other not defined above|0|||
126489860|NCT01955733|455092561|FG001|Period 2|Other not defined above|2|||
126489861|NCT01955733|455092562|FG002|Period 2|Other not defined above|2|||
126489862|NCT00733408|455092563|FG000|Overall Study|Adverse Event|4|||
126489863|NCT01134783|455092564|FG000|Overall Study|Pregnancy|16|||
126489864|NCT01134783|455092565|FG001|Overall Study|Pregnancy|8|||
126489865|NCT01134783|455092564|FG000|Overall Study|Withdrawal by Subject|15|||
126489866|NCT01134783|455092565|FG001|Overall Study|Withdrawal by Subject|9|||
126489867|NCT01134783|455092564|FG000|Overall Study|Lost to Follow-up|5|||
126489868|NCT01134783|455092565|FG001|Overall Study|Lost to Follow-up|20|||
126489869|NCT04221009|455092567|FG000|Overall Study|Withdrawal by Subject|4|||
126489870|NCT02762266|455092568|FG000|Overall Study|Physician Decision|2|||
126772606|NCT02454972|456123636|FG007|Overall Study|Death|0|||
126489871|NCT02762266|455092569|FG001|Overall Study|Physician Decision|0|||
126489872|NCT01438424|455092570|FG000|Overall Study|Continuing treatment|29|||
126489873|NCT01438424|455092570|FG000|Overall Study|Minimal virologic response|95|||
126489874|NCT01438424|455092570|FG000|Overall Study|Not identified|55|||
126489875|NCT01438424|455092570|FG000|Overall Study|Withdrawal by Subject|104|||
126489876|NCT01438424|455092570|FG000|Overall Study|Progression of chronic hepatitis B|22|||
126489877|NCT01438424|455092570|FG000|Overall Study|Death|22|||
126489878|NCT01438424|455092570|FG000|Overall Study|Adverse Event|17|||
126489879|NCT01438424|455092570|FG000|Overall Study|Lost to Follow-up|17|||
126489880|NCT01438424|455092570|FG000|Overall Study|Abnormal laboratory test result|14|||
126489881|NCT01438424|455092570|FG000|Overall Study|Need for drug prohibited by protocol|14|||
126489882|NCT01438424|455092570|FG000|Overall Study|Pregnancy|7|||
126489883|NCT01438424|455092570|FG000|Overall Study|No longer met inclusion criteria|1|||
126489884|NCT01438424|455092570|FG000|Overall Study|Participant noncompliance|20|||
126489885|NCT04232124|455092571|FG000|Overall Study|Lost to Follow-up|3|||
126489886|NCT02329730|455092572|FG000|Overall Study|Protocol Violation|0|||
126489887|NCT02329730|455092573|FG001|Overall Study|Protocol Violation|0|||
126489888|NCT02329730|455092574|FG002|Overall Study|Protocol Violation|0|||
126489889|NCT02329730|455092575|FG003|Overall Study|Protocol Violation|0|||
126489890|NCT02329730|455092576|FG004|Overall Study|Protocol Violation|2|||
126489891|NCT02329730|455092577|FG005|Overall Study|Protocol Violation|2|||
126489892|NCT02329730|455092578|FG006|Overall Study|Protocol Violation|0|||
126489893|NCT02329730|455092579|FG007|Overall Study|Protocol Violation|0|||
126489894|NCT02329730|455092580|FG008|Overall Study|Protocol Violation|0|||
126489895|NCT02329730|455092581|FG009|Overall Study|Protocol Violation|0|||
126489896|NCT02329730|455092582|FG010|Overall Study|Protocol Violation|0|||
126489897|NCT02329730|455092583|FG011|Overall Study|Protocol Violation|0|||
126489898|NCT02329730|455092572|FG000|Overall Study|Withdrawal by Subject|0|||
126489899|NCT02329730|455092573|FG001|Overall Study|Withdrawal by Subject|0|||
126489900|NCT02329730|455092574|FG002|Overall Study|Withdrawal by Subject|0|||
126489901|NCT02329730|455092575|FG003|Overall Study|Withdrawal by Subject|0|||
126489902|NCT02329730|455092576|FG004|Overall Study|Withdrawal by Subject|1|||
126489903|NCT02329730|455092577|FG005|Overall Study|Withdrawal by Subject|0|||
126489904|NCT02329730|455092578|FG006|Overall Study|Withdrawal by Subject|1|||
126489905|NCT02329730|455092579|FG007|Overall Study|Withdrawal by Subject|1|||
126489906|NCT02329730|455092580|FG008|Overall Study|Withdrawal by Subject|1|||
126489907|NCT02329730|455092581|FG009|Overall Study|Withdrawal by Subject|1|||
126489908|NCT02329730|455092582|FG010|Overall Study|Withdrawal by Subject|0|||
126489909|NCT02329730|455092583|FG011|Overall Study|Withdrawal by Subject|0|||
126489910|NCT02392247|455092586|FG000|Overall Study|Withdrawal by Subject|1|||
126489911|NCT02392247|455092586|FG000|Overall Study|Surgery cancelled; no data|1|||
126489912|NCT03010254|455092587|FG000|Overall Study|Adverse Event|0|||
126489913|NCT03010254|455092588|FG001|Overall Study|Adverse Event|1|||
126489914|NCT03010254|455092587|FG000|Overall Study|Lost to Follow-up|4|||
126489915|NCT03010254|455092588|FG001|Overall Study|Lost to Follow-up|0|||
126489916|NCT03010254|455092587|FG000|Overall Study|Withdrawal by Subject|1|||
126489917|NCT03010254|455092588|FG001|Overall Study|Withdrawal by Subject|1|||
126489918|NCT03010254|455092587|FG000|Overall Study|Other|2|||
126489919|NCT03010254|455092588|FG001|Overall Study|Other|3|||
126489920|NCT01404325|455092589|FG000|Overall Study|Lost to Follow-up|1|||
126489921|NCT01404325|455092590|FG001|Overall Study|Lost to Follow-up|0|||
126489922|NCT01404325|455092589|FG000|Overall Study|Death|2|||
126489923|NCT01404325|455092590|FG001|Overall Study|Death|0|||
126489924|NCT01404325|455092589|FG000|Overall Study|Graft loss/Retransplantation|1|||
126489925|NCT01404325|455092590|FG001|Overall Study|Graft loss/Retransplantation|0|||
126489926|NCT01404325|455092589|FG000|Overall Study|non-specified reason|0|||
126489927|NCT01404325|455092590|FG001|Overall Study|non-specified reason|2|||
126489928|NCT01529346|455092596|FG000|Overall Study|Lost to Follow-up|2|||
126489929|NCT01529346|455092597|FG001|Overall Study|Lost to Follow-up|0|||
126489930|NCT01529346|455092598|FG002|Overall Study|Lost to Follow-up|1|||
126489931|NCT01529346|455092599|FG003|Overall Study|Lost to Follow-up|0|||
126489932|NCT01529346|455092600|FG004|Overall Study|Lost to Follow-up|0|||
126489933|NCT01529346|455092596|FG000|Overall Study|Other|0|||
126489934|NCT01529346|455092597|FG001|Overall Study|Other|1|||
126489935|NCT01529346|455092598|FG002|Overall Study|Other|1|||
126489936|NCT01529346|455092599|FG003|Overall Study|Other|0|||
126489937|NCT01529346|455092600|FG004|Overall Study|Other|0|||
126489938|NCT00386776|455092601|FG000|Overall Study|Withdrawal by Subject|8|||
126489939|NCT01500629|455092602|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
126489940|NCT01500629|455092603|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
126489941|NCT00588848|455092604|FG000|Overall Study|Physician Decision|0|||
126489942|NCT00588848|455092605|FG001|Overall Study|Physician Decision|3|||
126489943|NCT01499667|455092606|FG000|Overall Study|administrative problems|4|||
126489944|NCT01499667|455092607|FG001|Overall Study|administrative problems|5|||
126489945|NCT01499667|455092608|FG002|Overall Study|administrative problems|5|||
126489946|NCT01499667|455092606|FG000|Overall Study|Protocol Violation|1|||
126489947|NCT01499667|455092607|FG001|Overall Study|Protocol Violation|3|||
126489948|NCT01499667|455092608|FG002|Overall Study|Protocol Violation|2|||
126489949|NCT01499667|455092606|FG000|Overall Study|Adverse Event|0|||
126489950|NCT01499667|455092607|FG001|Overall Study|Adverse Event|2|||
126489951|NCT01499667|455092608|FG002|Overall Study|Adverse Event|2|||
126489952|NCT01499667|455092606|FG000|Overall Study|Withdrawal by Subject|2|||
126489953|NCT01499667|455092607|FG001|Overall Study|Withdrawal by Subject|1|||
126489954|NCT01499667|455092608|FG002|Overall Study|Withdrawal by Subject|1|||
126489955|NCT01499667|455092606|FG000|Overall Study|Lack of Efficacy|2|||
126489956|NCT01499667|455092607|FG001|Overall Study|Lack of Efficacy|0|||
126489957|NCT01499667|455092608|FG002|Overall Study|Lack of Efficacy|0|||
126489958|NCT02902965|455092612|FG000|Overall Study|Withdrawal by Subject|10|||
126489959|NCT00531050|455092613|FG000|Part 1: Period 1|Adverse Event|0|||
126489960|NCT00531050|455092614|FG001|Part 1: Period 1|Adverse Event|1|||
126489961|NCT00531050|455092615|FG002|Part 1: Period 1|Adverse Event|0|||
126489962|NCT00531050|455092616|FG003|Part 1: Period 1|Adverse Event|0|||
126489963|NCT00531050|455092617|FG004|Part 1: Period 1|Adverse Event|0|||
126489964|NCT00531050|455092618|FG005|Part 1: Period 1|Adverse Event|0|||
126489965|NCT00531050|455092613|FG000|Part 1: Period 1|Protocol Deviation|0|||
126489966|NCT00531050|455092614|FG001|Part 1: Period 1|Protocol Deviation|0|||
126489967|NCT00531050|455092615|FG002|Part 1: Period 1|Protocol Deviation|0|||
126489968|NCT00531050|455092616|FG003|Part 1: Period 1|Protocol Deviation|1|||
126489969|NCT00531050|455092617|FG004|Part 1: Period 1|Protocol Deviation|0|||
126489970|NCT00531050|455092618|FG005|Part 1: Period 1|Protocol Deviation|0|||
126489971|NCT00531050|455092613|FG000|Part 1: Period 3|Adverse Event|1|||
126489972|NCT00531050|455092614|FG001|Part 1: Period 3|Adverse Event|0|||
126489973|NCT00531050|455092615|FG002|Part 1: Period 3|Adverse Event|0|||
126489974|NCT00531050|455092616|FG003|Part 1: Period 3|Adverse Event|0|||
126489975|NCT00531050|455092617|FG004|Part 1: Period 3|Adverse Event|0|||
126489976|NCT00531050|455092618|FG005|Part 1: Period 3|Adverse Event|0|||
126489977|NCT00531050|455092613|FG000|Part 2: Period 1|Adverse Event|0|||
126489978|NCT00531050|455092614|FG001|Part 2: Period 1|Adverse Event|0|||
126489979|NCT00531050|455092615|FG002|Part 2: Period 1|Adverse Event|0|||
126489980|NCT00531050|455092616|FG003|Part 2: Period 1|Adverse Event|0|||
126489981|NCT00531050|455092617|FG004|Part 2: Period 1|Adverse Event|0|||
126489982|NCT00531050|455092618|FG005|Part 2: Period 1|Adverse Event|1|||
126489983|NCT00531050|455092613|FG000|Part 2: Period 3|Abnormal test procedure|1|||
126489984|NCT00531050|455092614|FG001|Part 2: Period 3|Abnormal test procedure|0|||
126489985|NCT00531050|455092615|FG002|Part 2: Period 3|Abnormal test procedure|0|||
126489986|NCT00531050|455092616|FG003|Part 2: Period 3|Abnormal test procedure|0|||
126489987|NCT00531050|455092617|FG004|Part 2: Period 3|Abnormal test procedure|0|||
126489988|NCT00531050|455092618|FG005|Part 2: Period 3|Abnormal test procedure|1|||
126489989|NCT02233309|455092622|FG000|Overall Study|Physician Decision|5|||
126489990|NCT00799487|455092623|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
126489991|NCT00799487|455092624|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
126489992|NCT00799487|455092625|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
126489993|NCT00799487|455092623|FG000|Dose Adjustment Period|Adverse Event|2|||
126489994|NCT00799487|455092624|FG001|Dose Adjustment Period|Adverse Event|0|||
126489995|NCT00799487|455092625|FG002|Dose Adjustment Period|Adverse Event|0|||
126489996|NCT00799487|455092623|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
126489997|NCT00799487|455092624|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
126489998|NCT00799487|455092625|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
126489999|NCT00799487|455092623|FG000|Dose Adjustment Period|Investigator Discretion|2|||
126490000|NCT00799487|455092624|FG001|Dose Adjustment Period|Investigator Discretion|0|||
126490001|NCT00799487|455092625|FG002|Dose Adjustment Period|Investigator Discretion|0|||
126490002|NCT00799487|455092623|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
126490003|NCT00799487|455092624|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
126490004|NCT00799487|455092625|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
126490005|NCT00799487|455092623|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
126490006|NCT00799487|455092624|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
126490007|NCT00799487|455092625|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
126490008|NCT00799487|455092623|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
126490009|NCT00799487|455092624|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
126490010|NCT00799487|455092625|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
126490011|NCT00799487|455092623|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
126490012|NCT00799487|455092624|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
126490013|NCT00799487|455092625|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
126490014|NCT00799487|455092623|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
126490015|NCT00799487|455092624|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
126490016|NCT00799487|455092625|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
126490017|NCT00799487|455092623|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
126490018|NCT00799487|455092624|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
126490019|NCT00799487|455092625|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
126490020|NCT00799487|455092623|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
126490021|NCT00799487|455092624|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
126490022|NCT00799487|455092625|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
126490023|NCT00799487|455092623|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
126490024|NCT00799487|455092624|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
126490025|NCT00799487|455092625|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
126490026|NCT01828281|455092626|FG000|Overall Study|Withdrawal by Subject|1|||
126490027|NCT01828281|455092627|FG001|Overall Study|Withdrawal by Subject|0|||
126490028|NCT00142584|455092628|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
126490029|NCT00142584|455092629|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
126490030|NCT00142584|455092628|FG000|Overall Study|Withdrawal by Subject|30|||
126490031|NCT00142584|455092629|FG001|Overall Study|Withdrawal by Subject|16|||
126490032|NCT00142584|455092628|FG000|Overall Study|Lost to Follow-up|22|||
126490033|NCT00142584|455092629|FG001|Overall Study|Lost to Follow-up|12|||
126490034|NCT00142584|455092628|FG000|Overall Study|Adverse Event|14|||
126490035|NCT00142584|455092629|FG001|Overall Study|Adverse Event|5|||
126490036|NCT00142584|455092628|FG000|Overall Study|Protocol Violation|4|||
126490037|NCT00142584|455092629|FG001|Overall Study|Protocol Violation|7|||
126490038|NCT00142584|455092628|FG000|Overall Study|Treatment Failure|2|||
126490039|NCT00142584|455092629|FG001|Overall Study|Treatment Failure|0|||
126490040|NCT03070782|455092631|FG000|Overall Study|Adverse Event|3|||
126490041|NCT03070782|455092632|FG001|Overall Study|Adverse Event|0|||
126490042|NCT03070782|455092633|FG002|Overall Study|Adverse Event|3|||
126490043|NCT03070782|455092634|FG003|Overall Study|Adverse Event|1|||
126490044|NCT03070782|455092635|FG004|Overall Study|Adverse Event|6|||
126490045|NCT03070782|455092636|FG005|Overall Study|Adverse Event|2|||
126490046|NCT03070782|455092631|FG000|Overall Study|Withdrawal by Subject|2|||
126490047|NCT03070782|455092632|FG001|Overall Study|Withdrawal by Subject|1|||
126490048|NCT03070782|455092633|FG002|Overall Study|Withdrawal by Subject|1|||
126490049|NCT03070782|455092634|FG003|Overall Study|Withdrawal by Subject|0|||
126490050|NCT03070782|455092635|FG004|Overall Study|Withdrawal by Subject|4|||
126490051|NCT03070782|455092636|FG005|Overall Study|Withdrawal by Subject|3|||
126490052|NCT03070782|455092631|FG000|Overall Study|Reason Not Specified|2|||
126490053|NCT03070782|455092632|FG001|Overall Study|Reason Not Specified|0|||
126490054|NCT03070782|455092633|FG002|Overall Study|Reason Not Specified|0|||
126490055|NCT03070782|455092634|FG003|Overall Study|Reason Not Specified|1|||
126490056|NCT03070782|455092635|FG004|Overall Study|Reason Not Specified|2|||
126490057|NCT03070782|455092636|FG005|Overall Study|Reason Not Specified|1|||
126490058|NCT03070782|455092631|FG000|Overall Study|Ineligibility|0|||
126490059|NCT03070782|455092632|FG001|Overall Study|Ineligibility|0|||
126490060|NCT03070782|455092633|FG002|Overall Study|Ineligibility|0|||
126490061|NCT03070782|455092634|FG003|Overall Study|Ineligibility|1|||
126490062|NCT03070782|455092635|FG004|Overall Study|Ineligibility|0|||
126490063|NCT03070782|455092636|FG005|Overall Study|Ineligibility|1|||
126490064|NCT03070782|455092631|FG000|Overall Study|Pregnancy|0|||
126490065|NCT03070782|455092632|FG001|Overall Study|Pregnancy|0|||
126490066|NCT03070782|455092633|FG002|Overall Study|Pregnancy|0|||
126490067|NCT03070782|455092634|FG003|Overall Study|Pregnancy|1|||
126490068|NCT03070782|455092635|FG004|Overall Study|Pregnancy|0|||
126490069|NCT03070782|455092636|FG005|Overall Study|Pregnancy|0|||
126490070|NCT03070782|455092631|FG000|Overall Study|Investigator Judgement|0|||
126490071|NCT03070782|455092632|FG001|Overall Study|Investigator Judgement|0|||
126490072|NCT03070782|455092633|FG002|Overall Study|Investigator Judgement|0|||
126490073|NCT03070782|455092634|FG003|Overall Study|Investigator Judgement|1|||
126490074|NCT03070782|455092635|FG004|Overall Study|Investigator Judgement|0|||
126490075|NCT03070782|455092636|FG005|Overall Study|Investigator Judgement|0|||
126490076|NCT01083576|455092637|FG000|Overall Study|Treatment Failure|6|||
126490077|NCT01083576|455092638|FG001|Overall Study|Treatment Failure|1|||
126490078|NCT03527966|455092639|FG000|Overall Study|Lost to Follow-up|3|||
126490079|NCT03527966|455092640|FG001|Overall Study|Lost to Follow-up|0|||
126490080|NCT00558025|455092641|FG000|Overall Study|Adverse Event|1|||
126490081|NCT00558025|455092642|FG001|Overall Study|Adverse Event|1|||
126490082|NCT00558025|455092641|FG000|Overall Study|Withdrawal by Subject|2|||
126490083|NCT00558025|455092642|FG001|Overall Study|Withdrawal by Subject|2|||
126490084|NCT00558025|455092641|FG000|Overall Study|Protocol Violation|1|||
126490085|NCT00558025|455092642|FG001|Overall Study|Protocol Violation|0|||
126490086|NCT01881776|455092646|FG000|Overall Study|Lost to Follow-up|1|||
126490087|NCT01881776|455092647|FG001|Overall Study|Lost to Follow-up|2|||
126490088|NCT01881776|455092648|FG002|Overall Study|Lost to Follow-up|1|||
126490089|NCT01881776|455092646|FG000|Overall Study|Protocol Violation|0|||
126490090|NCT01881776|455092647|FG001|Overall Study|Protocol Violation|2|||
126490091|NCT01881776|455092648|FG002|Overall Study|Protocol Violation|1|||
126490092|NCT00276159|455092651|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
126490093|NCT00333866|455092652|FG000|Overall Study|Adverse Event|23|||
126490094|NCT00333866|455092653|FG001|Overall Study|Adverse Event|37|||
126490095|NCT00333866|455092654|FG002|Overall Study|Adverse Event|38|||
126490096|NCT00333866|455092655|FG003|Overall Study|Adverse Event|47|||
126490097|NCT00333866|455092652|FG000|Overall Study|Other|3|||
126490098|NCT00333866|455092653|FG001|Overall Study|Other|2|||
126490099|NCT00333866|455092654|FG002|Overall Study|Other|2|||
126490100|NCT00333866|455092655|FG003|Overall Study|Other|2|||
126490101|NCT00333866|455092652|FG000|Overall Study|Lack of Efficacy|8|||
126490102|NCT00333866|455092653|FG001|Overall Study|Lack of Efficacy|6|||
126490103|NCT00333866|455092654|FG002|Overall Study|Lack of Efficacy|3|||
126490104|NCT00333866|455092655|FG003|Overall Study|Lack of Efficacy|5|||
126490105|NCT00333866|455092652|FG000|Overall Study|Lost to Follow-up|1|||
126490106|NCT00333866|455092653|FG001|Overall Study|Lost to Follow-up|2|||
126490107|NCT00333866|455092654|FG002|Overall Study|Lost to Follow-up|2|||
126490108|NCT00333866|455092655|FG003|Overall Study|Lost to Follow-up|2|||
126490109|NCT00333866|455092652|FG000|Overall Study|Withdrawal by Subject|8|||
126490110|NCT00333866|455092653|FG001|Overall Study|Withdrawal by Subject|14|||
126490111|NCT00333866|455092654|FG002|Overall Study|Withdrawal by Subject|4|||
126490112|NCT00333866|455092655|FG003|Overall Study|Withdrawal by Subject|9|||
126490113|NCT00333866|455092652|FG000|Overall Study|Randomized but not Treated|5|||
126723309|NCT02052778|455936099|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
126723310|NCT02052778|455936100|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
126723311|NCT02052778|455936101|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
126723312|NCT02052778|455936102|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
126723313|NCT02052778|455936103|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
126723314|NCT02052778|455936104|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
126723315|NCT02052778|455936082|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723316|NCT02052778|455936083|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723317|NCT02052778|455936084|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723318|NCT02052778|455936085|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723319|NCT02052778|455936086|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723320|NCT02052778|455936087|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723321|NCT02052778|455936088|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723322|NCT02052778|455936089|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723323|NCT02052778|455936090|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723324|NCT02052778|455936091|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723325|NCT02052778|455936092|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723326|NCT02052778|455936093|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723327|NCT02052778|455936094|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723328|NCT02052778|455936095|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723329|NCT02052778|455936096|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
126723330|NCT02052778|455936097|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
126723331|NCT02052778|455936098|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
126723332|NCT02052778|455936099|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723333|NCT02052778|455936100|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
126723334|NCT02052778|455936101|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723335|NCT02052778|455936102|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723336|NCT02052778|455936103|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723337|NCT02052778|455936104|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
126723338|NCT02052778|455936082|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723339|NCT02052778|455936083|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723340|NCT02052778|455936084|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723341|NCT02052778|455936085|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723342|NCT02052778|455936086|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723343|NCT02052778|455936087|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723344|NCT02052778|455936088|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723345|NCT02052778|455936089|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723346|NCT02052778|455936090|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723347|NCT02052778|455936091|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723348|NCT02052778|455936092|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723349|NCT02052778|455936093|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126490114|NCT00333866|455092653|FG001|Overall Study|Randomized but not Treated|3|||
126490115|NCT00333866|455092654|FG002|Overall Study|Randomized but not Treated|2|||
126490116|NCT00333866|455092655|FG003|Overall Study|Randomized but not Treated|1|||
126490117|NCT00673465|455092666|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
126490118|NCT00673465|455092667|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
126490119|NCT00673465|455092668|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
126490120|NCT00673465|455092669|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
126490121|NCT00673465|455092670|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
126490122|NCT00673465|455092671|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
126490123|NCT00673465|455092672|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
126490124|NCT00673465|455092673|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
126490125|NCT00673465|455092674|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
126490126|NCT00673465|455092675|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
126490127|NCT00673465|455092676|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
126490128|NCT00673465|455092677|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
126490129|NCT00673465|455092666|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
126490130|NCT00673465|455092667|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
126490131|NCT00673465|455092668|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
126490132|NCT00673465|455092669|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
126490133|NCT00673465|455092670|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
126490134|NCT00673465|455092671|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
126490135|NCT00673465|455092672|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
126490136|NCT00673465|455092673|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
126723350|NCT02052778|455936094|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723351|NCT02052778|455936095|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723352|NCT02052778|455936096|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723353|NCT02052778|455936097|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723354|NCT02052778|455936098|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723355|NCT02052778|455936099|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723356|NCT02052778|455936100|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723357|NCT02052778|455936101|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723358|NCT02052778|455936102|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723359|NCT02052778|455936103|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
126723360|NCT02052778|455936104|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
126723361|NCT02052778|455936082|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723362|NCT02052778|455936083|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723363|NCT02052778|455936084|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723364|NCT02052778|455936085|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723365|NCT02052778|455936086|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723366|NCT02052778|455936087|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723367|NCT02052778|455936088|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723368|NCT02052778|455936089|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723369|NCT02052778|455936090|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723370|NCT02052778|455936091|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723371|NCT02052778|455936092|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723372|NCT02052778|455936093|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723373|NCT02052778|455936094|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723374|NCT02052778|455936095|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723375|NCT02052778|455936096|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723376|NCT02052778|455936097|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723377|NCT02052778|455936098|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723378|NCT02052778|455936099|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723379|NCT02052778|455936100|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723380|NCT02052778|455936101|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723381|NCT02052778|455936102|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723382|NCT02052778|455936103|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
126723383|NCT02052778|455936104|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
126723384|NCT02052778|455936082|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723385|NCT02052778|455936083|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723386|NCT02052778|455936084|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723387|NCT02052778|455936085|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723388|NCT02052778|455936086|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126490137|NCT00673465|455092674|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
126490138|NCT00673465|455092675|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
126490139|NCT00673465|455092676|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
126490140|NCT00673465|455092677|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
126490141|NCT01829191|455092678|FG000|Overall Study|Relocation|0|||
126490142|NCT01829191|455092679|FG001|Overall Study|Relocation|1|||
126490143|NCT01829191|455092678|FG000|Overall Study|Lens discomfort|0|||
126490144|NCT01829191|455092679|FG001|Overall Study|Lens discomfort|3|||
126490145|NCT01829191|455092678|FG000|Overall Study|Lens handling difficulty|1|||
126490146|NCT01829191|455092679|FG001|Overall Study|Lens handling difficulty|4|||
126490147|NCT01829191|455092678|FG000|Overall Study|Protocol Violation|4|||
126490148|NCT01829191|455092679|FG001|Overall Study|Protocol Violation|1|||
126490149|NCT01829191|455092678|FG000|Overall Study|Withdrawal by Subject|2|||
126490150|NCT01829191|455092679|FG001|Overall Study|Withdrawal by Subject|3|||
126490151|NCT01829191|455092678|FG000|Overall Study|Lost to Follow-up|0|||
126490152|NCT01829191|455092679|FG001|Overall Study|Lost to Follow-up|1|||
126490153|NCT01829191|455092678|FG000|Overall Study|Subject was fit for ortho - k|0|||
126490154|NCT01829191|455092679|FG001|Overall Study|Subject was fit for ortho - k|1|||
126490155|NCT00429104|455092680|FG000|Overall Study|Protocol Violation|1|||
126490156|NCT01276353|455092681|FG000|Double-blind|Adverse Event|2|||
126490157|NCT01276353|455092682|FG001|Double-blind|Adverse Event|0|||
126490158|NCT01276353|455092681|FG000|Double-blind|Withdrawal by Subject|1|||
126490159|NCT01276353|455092682|FG001|Double-blind|Withdrawal by Subject|0|||
126490160|NCT01276353|455092681|FG000|Extension|Adverse Event|2|||
126490161|NCT01276353|455092682|FG001|Extension|Adverse Event|5|||
126490162|NCT01276353|455092681|FG000|Extension|Withdrawal by Subject|1|||
126490163|NCT01276353|455092682|FG001|Extension|Withdrawal by Subject|2|||
126490164|NCT01276353|455092681|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
126490165|NCT01276353|455092682|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
126490166|NCT01276353|455092681|FG000|Extension|Physician Decision|1|||
126490167|NCT01276353|455092682|FG001|Extension|Physician Decision|0|||
126490168|NCT01276353|455092681|FG000|Extension|Prohibited concomitant medications|0|||
126490169|NCT01276353|455092682|FG001|Extension|Prohibited concomitant medications|1|||
126490170|NCT01285310|455092684|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
126490171|NCT01285310|455092685|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
126490172|NCT01285310|455092686|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
126490173|NCT01285310|455092687|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
126490174|NCT01285310|455092688|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
126490175|NCT01285310|455092684|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
126490176|NCT01285310|455092685|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
126490177|NCT01285310|455092686|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
126490178|NCT01285310|455092687|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
126490179|NCT01285310|455092688|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
126490180|NCT01285310|455092684|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
126490181|NCT01285310|455092685|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
126490182|NCT01285310|455092686|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
126490183|NCT01285310|455092687|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
126490184|NCT01285310|455092688|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
126490185|NCT01285310|455092684|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
126490186|NCT01285310|455092685|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
126490187|NCT01285310|455092686|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
126490188|NCT01285310|455092687|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
126490189|NCT01285310|455092688|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
126490190|NCT01285310|455092684|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
126490191|NCT01285310|455092685|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
126490192|NCT01285310|455092686|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
126490193|NCT01285310|455092687|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
126490194|NCT01285310|455092688|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
126490195|NCT01285310|455092684|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
126490196|NCT01285310|455092685|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
126490197|NCT01285310|455092686|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
126490198|NCT01285310|455092687|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
126490199|NCT01285310|455092688|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
126490200|NCT01285310|455092684|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
126490201|NCT01285310|455092685|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
126490202|NCT01285310|455092686|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
126490203|NCT01285310|455092687|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
126490204|NCT01285310|455092688|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
126490205|NCT01285310|455092684|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
126490206|NCT01285310|455092685|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
126490207|NCT01285310|455092686|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
126490208|NCT01285310|455092687|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
126490209|NCT01285310|455092688|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
126490210|NCT01285310|455092684|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
126490211|NCT01285310|455092685|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
126490212|NCT01285310|455092686|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
126490213|NCT01285310|455092687|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
126490214|NCT01285310|455092688|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
126490215|NCT01285310|455092684|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
126490216|NCT01285310|455092685|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
126490217|NCT01285310|455092686|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
126490218|NCT01285310|455092687|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
126490219|NCT01285310|455092688|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
126490220|NCT01285310|455092684|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
126490221|NCT01285310|455092685|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
126490222|NCT01285310|455092686|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
126490223|NCT01285310|455092687|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
126490224|NCT01285310|455092688|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
126490225|NCT01285310|455092684|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
126490226|NCT01285310|455092685|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
126490227|NCT01285310|455092686|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
126490228|NCT01285310|455092687|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
126490229|NCT01285310|455092688|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
126490230|NCT00143403|455092689|FG000|Overall Study|Adverse Event|3|||
126490231|NCT00143403|455092690|FG001|Overall Study|Adverse Event|8|||
126490232|NCT00143403|455092689|FG000|Overall Study|Death|1|||
126490233|NCT00143403|455092690|FG001|Overall Study|Death|0|||
126490234|NCT00143403|455092689|FG000|Overall Study|Withdrawal by Subject|3|||
126490235|NCT00143403|455092690|FG001|Overall Study|Withdrawal by Subject|12|||
126490236|NCT00143403|455092689|FG000|Overall Study|Relapse|15|||
126490237|NCT00143403|455092690|FG001|Overall Study|Relapse|7|||
126490238|NCT00143403|455092689|FG000|Overall Study|Protocol Violation|2|||
126490239|NCT00143403|455092690|FG001|Overall Study|Protocol Violation|2|||
126490240|NCT00143403|455092689|FG000|Overall Study|specified by site|4|||
126490241|NCT00143403|455092690|FG001|Overall Study|specified by site|9|||
126490242|NCT00143403|455092689|FG000|Overall Study|Randomized Not Treated|7|||
126490243|NCT00143403|455092690|FG001|Overall Study|Randomized Not Treated|8|||
126490244|NCT00514540|455092691|FG000|First-Line Chemo|Withdrawal by Subject|1|||
126723389|NCT02052778|455936087|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723390|NCT02052778|455936088|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723391|NCT02052778|455936089|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723392|NCT02052778|455936090|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723393|NCT02052778|455936091|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723394|NCT02052778|455936092|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723395|NCT02052778|455936093|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723396|NCT02052778|455936094|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723397|NCT02052778|455936095|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723398|NCT02052778|455936096|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723399|NCT02052778|455936097|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723400|NCT02052778|455936098|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126490245|NCT00514540|455092691|FG000|First-Line Chemo|Protocol Violation|7|||
126490246|NCT00514540|455092691|FG000|Second-Line|Physician/Patient Decision|31|||
126490247|NCT00587639|455092692|FG000|Overall Study|Withdrawal by Subject|1|||
126490248|NCT03402386|455092693|FG000|Overall Study|Adverse Event|3|||
126490249|NCT03402386|455092693|FG000|Overall Study|Physician Decision|1|||
126490250|NCT03402386|455092693|FG000|Overall Study|Difficult to control Hb|2|||
126490251|NCT00533845|455092694|FG000|Overall Study|Physician Decision|1|||
126490252|NCT00533845|455092695|FG001|Overall Study|Physician Decision|0|||
126490253|NCT00005937|455092698|FG000|Overall Study|Lack of Efficacy|5|||
126490254|NCT01288469|455092699|FG000|Overall Study|Adverse Event|4|||
126490255|NCT01288469|455092700|FG001|Overall Study|Adverse Event|1|||
126490256|NCT01288469|455092701|FG002|Overall Study|Adverse Event|1|||
126490257|NCT01288469|455092699|FG000|Overall Study|Poor compliance to protocol|0|||
126490258|NCT01288469|455092700|FG001|Overall Study|Poor compliance to protocol|1|||
126490259|NCT01288469|455092701|FG002|Overall Study|Poor compliance to protocol|0|||
126490260|NCT01288469|455092699|FG000|Overall Study|Participant Moved|1|||
126490261|NCT01288469|455092700|FG001|Overall Study|Participant Moved|0|||
126490262|NCT01288469|455092701|FG002|Overall Study|Participant Moved|0|||
126490263|NCT01288469|455092699|FG000|Overall Study|Consent withdrawn by subject|1|||
126490264|NCT01288469|455092700|FG001|Overall Study|Consent withdrawn by subject|1|||
126490265|NCT01288469|455092701|FG002|Overall Study|Consent withdrawn by subject|1|||
126490266|NCT01288469|455092699|FG000|Overall Study|Exclusion criteria finally met|1|||
126490267|NCT01288469|455092700|FG001|Overall Study|Exclusion criteria finally met|0|||
126490268|NCT01288469|455092701|FG002|Overall Study|Exclusion criteria finally met|0|||
126490269|NCT00255047|455092702|FG000|Overall Study|Serious Adverse Events|2|||
126490270|NCT00255047|455092703|FG001|Overall Study|Serious Adverse Events|1|||
126490271|NCT00255047|455092704|FG002|Overall Study|Serious Adverse Events|2|||
126490272|NCT00255047|455092705|FG003|Overall Study|Serious Adverse Events|1|||
126490273|NCT00255047|455092702|FG000|Overall Study|Adverse Event|0|||
126490274|NCT00255047|455092703|FG001|Overall Study|Adverse Event|3|||
126490275|NCT00255047|455092704|FG002|Overall Study|Adverse Event|2|||
126490276|NCT00255047|455092705|FG003|Overall Study|Adverse Event|1|||
126490277|NCT00255047|455092702|FG000|Overall Study|Protocol Violation|13|||
126490278|NCT00255047|455092703|FG001|Overall Study|Protocol Violation|13|||
126490279|NCT00255047|455092704|FG002|Overall Study|Protocol Violation|16|||
126490280|NCT00255047|455092705|FG003|Overall Study|Protocol Violation|20|||
126490281|NCT00255047|455092702|FG000|Overall Study|Lost to Follow-up|9|||
126490282|NCT00255047|455092703|FG001|Overall Study|Lost to Follow-up|8|||
126490283|NCT00255047|455092704|FG002|Overall Study|Lost to Follow-up|5|||
126490284|NCT00255047|455092705|FG003|Overall Study|Lost to Follow-up|6|||
126490285|NCT00255047|455092702|FG000|Overall Study|Withdrawal by Subject|24|||
126723401|NCT02052778|455936099|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723402|NCT02052778|455936100|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126772607|NCT02454972|456123637|FG008|Overall Study|Death|95|||
126490286|NCT00255047|455092703|FG001|Overall Study|Withdrawal by Subject|23|||
126490287|NCT00255047|455092704|FG002|Overall Study|Withdrawal by Subject|25|||
126772608|NCT02454972|456123629|FG000|Overall Study|Physician Decision|0|||
126772609|NCT02454972|456123630|FG001|Overall Study|Physician Decision|1|||
126490288|NCT00255047|455092705|FG003|Overall Study|Withdrawal by Subject|18|||
126490289|NCT01574612|455092706|FG000|Overall Study|Adverse Event|3|||
126490290|NCT01574612|455092706|FG000|Overall Study|non compliant with drug|2|||
126490291|NCT01574612|455092706|FG000|Overall Study|Withdrawal by Subject|1|||
126490292|NCT01574612|455092706|FG000|Overall Study|Lost to Follow-up|2|||
126490293|NCT02452398|455092707|FG000|Overall Study|Adverse Event|1|||
126490294|NCT02452398|455092707|FG000|Overall Study|Lost to Follow-up|28|||
126490295|NCT02452398|455092707|FG000|Overall Study|Physician Decision|2|||
126490296|NCT02452398|455092707|FG000|Overall Study|Withdrawal by Subject|6|||
126490297|NCT02452398|455092707|FG000|Overall Study|Moved away|4|||
126490298|NCT01957644|455092710|FG000|Overall Study|Adverse Event|4|||
126490299|NCT01957644|455092711|FG001|Overall Study|Adverse Event|2|||
126490300|NCT01957644|455092712|FG002|Overall Study|Adverse Event|0|||
126490301|NCT01957644|455092713|FG003|Overall Study|Adverse Event|0|||
126490302|NCT01957644|455092714|FG004|Overall Study|Adverse Event|1|||
126490303|NCT01957644|455092710|FG000|Overall Study|Progressive disease / relapse|0|||
126490304|NCT01957644|455092711|FG001|Overall Study|Progressive disease / relapse|1|||
126490305|NCT01957644|455092712|FG002|Overall Study|Progressive disease / relapse|0|||
126490306|NCT01957644|455092713|FG003|Overall Study|Progressive disease / relapse|1|||
126490307|NCT01957644|455092714|FG004|Overall Study|Progressive disease / relapse|0|||
126490308|NCT01957644|455092710|FG000|Overall Study|Other reason|1|||
126490309|NCT01957644|455092711|FG001|Overall Study|Other reason|2|||
126490310|NCT01957644|455092712|FG002|Overall Study|Other reason|1|||
126490311|NCT01957644|455092713|FG003|Overall Study|Other reason|1|||
126490312|NCT01957644|455092714|FG004|Overall Study|Other reason|0|||
126490313|NCT01957644|455092710|FG000|Overall Study|Withdrawal by Subject|1|||
126490314|NCT01957644|455092711|FG001|Overall Study|Withdrawal by Subject|0|||
126490315|NCT01957644|455092712|FG002|Overall Study|Withdrawal by Subject|0|||
126490316|NCT01957644|455092713|FG003|Overall Study|Withdrawal by Subject|0|||
126490317|NCT01957644|455092714|FG004|Overall Study|Withdrawal by Subject|0|||
126490318|NCT01957644|455092710|FG000|Overall Study|Protocol Violation|0|||
126490319|NCT01957644|455092711|FG001|Overall Study|Protocol Violation|1|||
126490320|NCT01957644|455092712|FG002|Overall Study|Protocol Violation|0|||
126490321|NCT01957644|455092713|FG003|Overall Study|Protocol Violation|0|||
126490322|NCT01957644|455092714|FG004|Overall Study|Protocol Violation|0|||
126490323|NCT00927784|455092715|FG000|Overall Study|Death|1|||
126490324|NCT00927784|455092716|FG001|Overall Study|Death|0|||
126490325|NCT00927784|455092715|FG000|Overall Study|Withdrawal by Subject|1|||
126490326|NCT00927784|455092716|FG001|Overall Study|Withdrawal by Subject|0|||
126490327|NCT02170051|455092717|FG000|Overall Study|Withdrawal by Subject|10|||
126490328|NCT02170051|455092718|FG001|Overall Study|Withdrawal by Subject|10|||
126490329|NCT02170051|455092717|FG000|Overall Study|Lost to Follow-up|1|||
126490330|NCT02170051|455092718|FG001|Overall Study|Lost to Follow-up|3|||
126490331|NCT01867021|455092719|FG000|Overall Study|Adverse Event|0|||
126490332|NCT01867021|455092720|FG001|Overall Study|Adverse Event|1|||
126490333|NCT01867021|455092719|FG000|Overall Study|Not Eligible|0|||
126490334|NCT01867021|455092720|FG001|Overall Study|Not Eligible|1|||
126490335|NCT01867021|455092719|FG000|Overall Study|Death|1|||
126490336|NCT01867021|455092720|FG001|Overall Study|Death|0|||
126490337|NCT01867021|455092719|FG000|Overall Study|Lost to Follow-up|0|||
126490338|NCT01867021|455092720|FG001|Overall Study|Lost to Follow-up|2|||
126490339|NCT01867021|455092719|FG000|Overall Study|Withdrawal by Subject|1|||
126490340|NCT01867021|455092720|FG001|Overall Study|Withdrawal by Subject|6|||
126490341|NCT00881712|455092721|FG000|Overall Study|Death|1|||
126490342|NCT00881712|455092722|FG001|Overall Study|Death|0|||
126490343|NCT00881712|455092723|FG002|Overall Study|Death|0|||
126772610|NCT02454972|456123631|FG002|Overall Study|Physician Decision|2|||
126772611|NCT02454972|456123632|FG003|Overall Study|Physician Decision|1|||
126772612|NCT02454972|456123633|FG004|Overall Study|Physician Decision|2|||
126772613|NCT02454972|456123634|FG005|Overall Study|Physician Decision|0|||
126772614|NCT02454972|456123635|FG006|Overall Study|Physician Decision|0|||
126772615|NCT02454972|456123636|FG007|Overall Study|Physician Decision|1|||
126772616|NCT02454972|456123637|FG008|Overall Study|Physician Decision|0|||
126772617|NCT02454972|456123629|FG000|Overall Study|Non treatment-related adverse event|2|||
126772618|NCT02454972|456123630|FG001|Overall Study|Non treatment-related adverse event|0|||
126772619|NCT02454972|456123631|FG002|Overall Study|Non treatment-related adverse event|1|||
126772620|NCT02454972|456123632|FG003|Overall Study|Non treatment-related adverse event|0|||
126490344|NCT00881712|455092721|FG000|Overall Study|Withdrawal by Subject|1|||
126490345|NCT00881712|455092722|FG001|Overall Study|Withdrawal by Subject|0|||
126490346|NCT00881712|455092723|FG002|Overall Study|Withdrawal by Subject|0|||
126490347|NCT01782495|455092731|FG000|Overall Study|Adverse Event|0|||
126772621|NCT02454972|456123633|FG004|Overall Study|Non treatment-related adverse event|0|||
126772622|NCT02454972|456123634|FG005|Overall Study|Non treatment-related adverse event|1|||
126772623|NCT02454972|456123635|FG006|Overall Study|Non treatment-related adverse event|0|||
126490348|NCT01782495|455092732|FG001|Overall Study|Adverse Event|0|||
126490349|NCT01782495|455092733|FG002|Overall Study|Adverse Event|0|||
126490350|NCT01782495|455092734|FG003|Overall Study|Adverse Event|0|||
126490351|NCT01782495|455092735|FG004|Overall Study|Adverse Event|0|||
126490352|NCT01782495|455092736|FG005|Overall Study|Adverse Event|0|||
126490353|NCT01782495|455092737|FG006|Overall Study|Adverse Event|0|||
126490354|NCT01782495|455092738|FG007|Overall Study|Adverse Event|2|||
126490355|NCT01782495|455092739|FG008|Overall Study|Adverse Event|0|||
126490356|NCT01782495|455092740|FG009|Overall Study|Adverse Event|0|||
126490357|NCT01782495|455092741|FG010|Overall Study|Adverse Event|0|||
126490358|NCT01782495|455092731|FG000|Overall Study|Withdrew Consent|0|||
126772624|NCT02454972|456123636|FG007|Overall Study|Non treatment-related adverse event|1|||
126490359|NCT01782495|455092732|FG001|Overall Study|Withdrew Consent|1|||
126490360|NCT01782495|455092733|FG002|Overall Study|Withdrew Consent|0|||
126490361|NCT01782495|455092734|FG003|Overall Study|Withdrew Consent|0|||
126490362|NCT01782495|455092735|FG004|Overall Study|Withdrew Consent|0|||
126490363|NCT01782495|455092736|FG005|Overall Study|Withdrew Consent|0|||
126490364|NCT01782495|455092737|FG006|Overall Study|Withdrew Consent|0|||
126490365|NCT01782495|455092738|FG007|Overall Study|Withdrew Consent|1|||
126490366|NCT01782495|455092739|FG008|Overall Study|Withdrew Consent|0|||
126490367|NCT01782495|455092740|FG009|Overall Study|Withdrew Consent|0|||
126490368|NCT01782495|455092741|FG010|Overall Study|Withdrew Consent|0|||
126490369|NCT00071513|455092742|FG000|Intervention Component|Withdrawal by Subject|2|||
126490370|NCT00071513|455092743|FG001|Intervention Component|Withdrawal by Subject|3|||
126490371|NCT00071513|455092742|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
126490372|NCT00071513|455092743|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
126490373|NCT02260921|455092744|FG000|Overall Study|Adverse Event|1|||
126490374|NCT02260921|455092745|FG001|Overall Study|Adverse Event|0|||
126490375|NCT02260921|455092744|FG000|Overall Study|Lost to Follow-up|4|||
126490376|NCT02260921|455092745|FG001|Overall Study|Lost to Follow-up|3|||
126490377|NCT02260921|455092744|FG000|Overall Study|Withdraw Consent|4|||
126490378|NCT02260921|455092745|FG001|Overall Study|Withdraw Consent|1|||
126490379|NCT02260921|455092744|FG000|Overall Study|Death|1|||
126490380|NCT02260921|455092745|FG001|Overall Study|Death|0|||
126490381|NCT02260921|455092744|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
126490382|NCT02260921|455092745|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
126490383|NCT01244425|455092746|FG000|Overall Study|Withdrawal by Subject|2|||
126490384|NCT01244425|455092747|FG001|Overall Study|Withdrawal by Subject|2|||
126490385|NCT01244425|455092746|FG000|Overall Study|Adverse Event|1|||
126490386|NCT01244425|455092747|FG001|Overall Study|Adverse Event|1|||
126490387|NCT02744391|455092748|FG000|Overall Study|Lost to Follow-up|9|||
126490388|NCT02744391|455092748|FG000|Overall Study|Physician Decision|2|||
126490389|NCT02744391|455092748|FG000|Overall Study|Withdrawal by Subject|3|||
126490390|NCT01996709|455092749|FG000|Overall Study|Withdrawal by Subject|1|||
126490391|NCT01996709|455092750|FG001|Overall Study|Withdrawal by Subject|0|||
126490392|NCT01996709|455092749|FG000|Overall Study|Lost to Follow-up|3|||
126490393|NCT01996709|455092750|FG001|Overall Study|Lost to Follow-up|0|||
126490394|NCT01996709|455092749|FG000|Overall Study|Subject Non-Compliant|1|||
126490395|NCT01996709|455092750|FG001|Overall Study|Subject Non-Compliant|0|||
126490396|NCT01996709|455092749|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
126490397|NCT01996709|455092750|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
126490398|NCT02480114|455092755|FG000|Overall Study|Not completing surveys|3|||
126490399|NCT02480114|455092756|FG001|Overall Study|Not completing surveys|2|||
126490400|NCT02480114|455092755|FG000|Overall Study|Withdrawal by Subject|2|||
126490401|NCT02480114|455092756|FG001|Overall Study|Withdrawal by Subject|4|||
126490402|NCT02480114|455092755|FG000|Overall Study|Disease progression|3|||
126490403|NCT02480114|455092756|FG001|Overall Study|Disease progression|0|||
126490404|NCT02480114|455092755|FG000|Overall Study|Improper completion of survey|1|||
126490405|NCT02480114|455092756|FG001|Overall Study|Improper completion of survey|1|||
126490406|NCT02480114|455092755|FG000|Overall Study|Not eligible|0|||
126490407|NCT02480114|455092756|FG001|Overall Study|Not eligible|1|||
126490408|NCT01535053|455092757|FG000|Overall Study|Ineligible|1|||
126490409|NCT01535053|455092758|FG001|Overall Study|Ineligible|2|||
126490410|NCT00512707|455092759|FG000|Overall Study|Lost to Follow-up|5|||
126490411|NCT00512707|455092760|FG001|Overall Study|Lost to Follow-up|11|||
126490412|NCT00512707|455092759|FG000|Overall Study|Developed skin irritation|2|||
126490413|NCT00512707|455092760|FG001|Overall Study|Developed skin irritation|1|||
126490414|NCT00512707|455092759|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
126490415|NCT00512707|455092760|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
126490416|NCT00512707|455092759|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
126490417|NCT00512707|455092760|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
126490418|NCT04405037|455092761|FG000|Overall Study|Withdrawal by Subject|1|||
126490419|NCT04405037|455092762|FG001|Overall Study|Withdrawal by Subject|0|||
126490420|NCT04405037|455092761|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
126490421|NCT04405037|455092762|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
126490422|NCT02759471|455092763|FG000|Overall Study|discomfort|2|||
126490423|NCT02879305|455092764|FG000|Overall Study|Investigator Site Closed|55|||
126490424|NCT02879305|455092765|FG001|Overall Study|Investigator Site Closed|57|||
126490425|NCT02879305|455092764|FG000|Overall Study|Withdrawal by Subject|44|||
126490426|NCT02879305|455092765|FG001|Overall Study|Withdrawal by Subject|42|||
126490427|NCT02879305|455092764|FG000|Overall Study|Lost to Follow-up|17|||
126490428|NCT02879305|455092765|FG001|Overall Study|Lost to Follow-up|12|||
126490429|NCT02879305|455092764|FG000|Overall Study|Other|1|||
126490430|NCT02879305|455092765|FG001|Overall Study|Other|0|||
126490431|NCT02068443|455094214|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126490432|NCT02068443|455094215|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
126490433|NCT02068443|455094216|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
126490434|NCT02068443|455094214|FG000|Overall Study|Voluntary Withdrawal|4|||
126490435|NCT02068443|455094215|FG001|Overall Study|Voluntary Withdrawal|0|||
126490436|NCT02068443|455094216|FG002|Overall Study|Voluntary Withdrawal|1|||
126490437|NCT02068443|455094214|FG000|Overall Study|Lack of Efficacy|2|||
126490438|NCT02068443|455094215|FG001|Overall Study|Lack of Efficacy|1|||
126490439|NCT02068443|455094216|FG002|Overall Study|Lack of Efficacy|0|||
126490440|NCT02068443|455094214|FG000|Overall Study|Other Reason Not Specified|1|||
126490441|NCT02068443|455094215|FG001|Overall Study|Other Reason Not Specified|0|||
126490442|NCT02068443|455094216|FG002|Overall Study|Other Reason Not Specified|0|||
126490443|NCT00664742|455094217|FG000|Overall Study|Withdrawn due to adverse events|3|||
126490444|NCT00664742|455094217|FG000|Overall Study|Withdrawal by Subject|31|||
126490445|NCT00664742|455094217|FG000|Overall Study|Lost to Follow-up|92|||
126490446|NCT01986855|455094218|FG000|Overall Study|Adverse Event|1|||
126490447|NCT01986855|455094219|FG001|Overall Study|Adverse Event|0|||
126490448|NCT01986855|455094220|FG002|Overall Study|Adverse Event|0|||
126490449|NCT01986855|455094218|FG000|Overall Study|Death|3|||
126490450|NCT01986855|455094219|FG001|Overall Study|Death|4|||
126490451|NCT01986855|455094220|FG002|Overall Study|Death|4|||
126490452|NCT01986855|455094218|FG000|Overall Study|Lost to Follow-up|2|||
126490453|NCT01986855|455094219|FG001|Overall Study|Lost to Follow-up|1|||
126490454|NCT01986855|455094220|FG002|Overall Study|Lost to Follow-up|0|||
126490455|NCT01986855|455094218|FG000|Overall Study|Screen Failure|0|||
126490456|NCT01986855|455094219|FG001|Overall Study|Screen Failure|1|||
126490457|NCT01986855|455094220|FG002|Overall Study|Screen Failure|0|||
126490458|NCT01986855|455094218|FG000|Overall Study|Participant Moved|0|||
126490459|NCT01986855|455094219|FG001|Overall Study|Participant Moved|0|||
126490460|NCT01986855|455094220|FG002|Overall Study|Participant Moved|2|||
126490461|NCT01986855|455094218|FG000|Overall Study|Withdrawal by Subject|7|||
126490462|NCT01986855|455094219|FG001|Overall Study|Withdrawal by Subject|8|||
126490463|NCT01986855|455094220|FG002|Overall Study|Withdrawal by Subject|5|||
126490464|NCT02825992|455094221|FG000|Overall Study|Withdrawal by Subject|4|||
126490465|NCT02825992|455094221|FG000|Overall Study|Lost to Follow-up|2|||
126490466|NCT02825992|455094221|FG000|Overall Study|Procedure terminated|2|||
126490467|NCT00710710|455094222|FG000|Overall Study|Consent withdrawn|2|||
126490468|NCT00710710|455094223|FG001|Overall Study|Consent withdrawn|2|||
126490469|NCT00710710|455094222|FG000|Overall Study|Protocol Violation|0|||
126490470|NCT00710710|455094223|FG001|Overall Study|Protocol Violation|1|||
126490471|NCT00710710|455094222|FG000|Overall Study|Adverse Event|3|||
126490472|NCT00710710|455094223|FG001|Overall Study|Adverse Event|3|||
126490473|NCT00710710|455094222|FG000|Overall Study|Progressive disease|40|||
126490474|NCT00710710|455094223|FG001|Overall Study|Progressive disease|38|||
126490475|NCT00715078|455094224|FG000|Overall Study|Death|29|||
126490476|NCT00715078|455094225|FG001|Overall Study|Death|36|||
126490477|NCT00715078|455094226|FG002|Overall Study|Death|36|||
126490478|NCT00715078|455094224|FG000|Overall Study|Withdrawal by Subject|1|||
126490479|NCT00715078|455094225|FG001|Overall Study|Withdrawal by Subject|0|||
126490480|NCT00715078|455094226|FG002|Overall Study|Withdrawal by Subject|1|||
126490481|NCT00715078|455094224|FG000|Overall Study|Unable to start due to disease prog.|0|||
126490482|NCT00715078|455094225|FG001|Overall Study|Unable to start due to disease prog.|0|||
126490483|NCT00715078|455094226|FG002|Overall Study|Unable to start due to disease prog.|1|||
126490484|NCT02892760|455094227|FG000|Overall Study|Withdrawal by Subject|3|||
126490485|NCT02673489|455094232|FG000|Treatment Period|Lost to Follow-up|3|||
126490486|NCT02673489|455094233|FG001|Treatment Period|Lost to Follow-up|0|||
126490487|NCT02673489|455094232|FG000|Treatment Period|Participant request to discontinue|1|||
126490488|NCT02673489|455094233|FG001|Treatment Period|Participant request to discontinue|1|||
126490489|NCT02673489|455094232|FG000|Treatment Period|Participant moved to another province|1|||
126490490|NCT02673489|455094233|FG001|Treatment Period|Participant moved to another province|0|||
126490491|NCT02673489|455094232|FG000|Treatment Period|Participant was incarcerated|0|||
126490492|NCT02673489|455094233|FG001|Treatment Period|Participant was incarcerated|1|||
126490493|NCT02673489|455094232|FG000|Treatment Period|Adverse Event|0|||
126490494|NCT02673489|455094233|FG001|Treatment Period|Adverse Event|1|||
126490495|NCT02673489|455094232|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
126490496|NCT02673489|455094233|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
126490497|NCT02673489|455094232|FG000|Follow Up Period|Unable to return for follow-up|0|||
126490498|NCT02673489|455094233|FG001|Follow Up Period|Unable to return for follow-up|1|||
126490499|NCT02259582|455094234|FG000|Overall Study|Physician Decision|0|||
126490500|NCT02259582|455094235|FG001|Overall Study|Physician Decision|1|||
126490501|NCT02259582|455094236|FG002|Overall Study|Physician Decision|0|||
126490502|NCT02259582|455094234|FG000|Overall Study|Death|0|||
126490503|NCT02259582|455094235|FG001|Overall Study|Death|0|||
126490504|NCT02259582|455094236|FG002|Overall Study|Death|1|||
126490505|NCT02259582|455094234|FG000|Overall Study|Adverse Event|1|||
126490506|NCT02259582|455094235|FG001|Overall Study|Adverse Event|0|||
126490507|NCT02259582|455094236|FG002|Overall Study|Adverse Event|1|||
126490508|NCT02259582|455094234|FG000|Overall Study|Withdrawal by Subject|0|||
126490509|NCT02259582|455094235|FG001|Overall Study|Withdrawal by Subject|0|||
126490510|NCT02259582|455094236|FG002|Overall Study|Withdrawal by Subject|1|||
126490511|NCT02259582|455094234|FG000|Overall Study|Disease progression|14|||
126490512|NCT02259582|455094235|FG001|Overall Study|Disease progression|15|||
126490513|NCT02259582|455094236|FG002|Overall Study|Disease progression|17|||
126490514|NCT02259582|455094234|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
126490515|NCT02259582|455094235|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
126490516|NCT02259582|455094236|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
126490517|NCT00232817|455094237|FG000|Overall Study|Protocol Violation|2|||
126490518|NCT00232817|455094238|FG001|Overall Study|Protocol Violation|1|||
126490519|NCT04481750|455094239|FG000|Period 1 (Fasted)|Adverse Event|0|||
126490520|NCT04481750|455094240|FG001|Period 1 (Fasted)|Adverse Event|0|||
126490521|NCT04481750|455094241|FG002|Period 1 (Fasted)|Adverse Event|1|||
126490522|NCT04481750|455094242|FG003|Period 1 (Fasted)|Adverse Event|0|||
126490523|NCT04481750|455094243|FG004|Period 1 (Fasted)|Adverse Event|0|||
126490524|NCT04481750|455094244|FG005|Period 1 (Fasted)|Adverse Event|0|||
126490525|NCT04481750|455094245|FG006|Period 1 (Fasted)|Adverse Event|0|||
126490526|NCT04481750|455094246|FG007|Period 1 (Fasted)|Adverse Event|0|||
126490527|NCT04481750|455094247|FG008|Period 1 (Fasted)|Adverse Event|0|||
126490528|NCT04481750|455094248|FG009|Period 1 (Fasted)|Adverse Event|0|||
126490529|NCT04481750|455094249|FG010|Period 1 (Fasted)|Adverse Event|0|||
126490530|NCT03263442|455094250|FG000|Inpatient Phase|Death|1|||
126490531|NCT03263442|455094251|FG001|Inpatient Phase|Death|0|||
126490532|NCT03263442|455094250|FG000|Inpatient Phase|Withdrawal by Subject|1|||
126490533|NCT03263442|455094251|FG001|Inpatient Phase|Withdrawal by Subject|0|||
126490534|NCT03263442|455094250|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
126490535|NCT03263442|455094251|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
126490536|NCT03263442|455094250|FG000|1-month Follow-Up|Lost to Follow-up|1|||
126490537|NCT03263442|455094251|FG001|1-month Follow-Up|Lost to Follow-up|0|||
126490538|NCT03263442|455094250|FG000|3-month Follow-Up|Lost to Follow-up|1|||
126490539|NCT03263442|455094251|FG001|3-month Follow-Up|Lost to Follow-up|3|||
126490540|NCT03263442|455094250|FG000|6-month Follow-Up|Lost to Follow-up|2|||
126490541|NCT03263442|455094251|FG001|6-month Follow-Up|Lost to Follow-up|2|||
126490542|NCT00475176|455094252|FG000|Overall Study|Adverse Event|2|||
126490543|NCT00475176|455094252|FG000|Overall Study|Withdrawal by Subject|1|||
126490544|NCT00475176|455094252|FG000|Overall Study|Protocol Violation|1|||
126490545|NCT01463878|455094253|FG000|Overall Study|no longer met criteria for tube feed|2|||
126490546|NCT01463878|455094254|FG001|Overall Study|no longer met criteria for tube feed|2|||
126490547|NCT03804879|455094255|FG000|Overall Study|Adverse Event|3|||
126490548|NCT03804879|455094256|FG001|Overall Study|Adverse Event|0|||
126490549|NCT03804879|455094255|FG000|Overall Study|Study Terminated By Sponsor|10|||
126490550|NCT03804879|455094256|FG001|Overall Study|Study Terminated By Sponsor|12|||
126490551|NCT03804879|455094255|FG000|Overall Study|Withdrawal by Subject|3|||
126490552|NCT03804879|455094256|FG001|Overall Study|Withdrawal by Subject|1|||
126490553|NCT02436889|455094257|FG000|Overall Study|No improvement in symptoms|1|||
126490554|NCT02436889|455094258|FG001|Overall Study|No improvement in symptoms|0|||
126490555|NCT02436889|455094257|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
126490556|NCT02436889|455094258|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
126490557|NCT01585428|455094259|FG000|Overall Study|Death during treatment|1|||
126490558|NCT01585428|455094260|FG001|Overall Study|Death during treatment|0|||
126490559|NCT01084174|455094261|FG000|Overall Study|gastrointestinal symptoms|1|||
126490560|NCT01084174|455094262|FG001|Overall Study|gastrointestinal symptoms|1|||
126490561|NCT01084174|455094261|FG000|Overall Study|Eosinophilic esophagitis|0|||
126490562|NCT01084174|455094262|FG001|Overall Study|Eosinophilic esophagitis|1|||
126490563|NCT01084174|455094261|FG000|Overall Study|Anaphylaxis|0|||
126490564|NCT01084174|455094262|FG001|Overall Study|Anaphylaxis|1|||
126490565|NCT01084174|455094261|FG000|Overall Study|Participant noncompliance|0|||
126490566|NCT01084174|455094262|FG001|Overall Study|Participant noncompliance|1|||
126490567|NCT01034462|455094263|FG000|Overall Study|Adverse Event|7|||
126490568|NCT01034462|455094264|FG001|Overall Study|Adverse Event|17|||
126490569|NCT01034462|455094263|FG000|Overall Study|Lack of Efficacy|4|||
126490570|NCT01034462|455094264|FG001|Overall Study|Lack of Efficacy|4|||
126490571|NCT01034462|455094263|FG000|Overall Study|Protocol Violation|10|||
126490572|NCT01034462|455094264|FG001|Overall Study|Protocol Violation|7|||
126490573|NCT01034462|455094263|FG000|Overall Study|Withdrawal by Subject|9|||
126490574|NCT01034462|455094264|FG001|Overall Study|Withdrawal by Subject|8|||
126490575|NCT01034462|455094263|FG000|Overall Study|Lost to Follow-up|14|||
126490576|NCT01034462|455094264|FG001|Overall Study|Lost to Follow-up|16|||
126490577|NCT01034462|455094263|FG000|Overall Study|Other reasons|1|||
126490578|NCT01034462|455094264|FG001|Overall Study|Other reasons|2|||
126490579|NCT01594125|455094265|FG000|Overall Study|Withdrawal by Subject|1|||
126772625|NCT02454972|456123637|FG008|Overall Study|Non treatment-related adverse event|0|||
126490580|NCT01594125|455094266|FG001|Overall Study|Withdrawal by Subject|0|||
126490581|NCT01594125|455094267|FG002|Overall Study|Withdrawal by Subject|0|||
126490582|NCT01594125|455094268|FG003|Overall Study|Withdrawal by Subject|1|||
126490583|NCT01594125|455094269|FG004|Overall Study|Withdrawal by Subject|0|||
126490584|NCT01594125|455094265|FG000|Overall Study|Progressive Disease|3|||
126559547|NCT02373813|455342535|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
126490585|NCT01594125|455094266|FG001|Overall Study|Progressive Disease|12|||
126490586|NCT01594125|455094267|FG002|Overall Study|Progressive Disease|3|||
126772626|NCT02454972|456123629|FG000|Overall Study|Treatment-related adverse events|0|||
126772627|NCT02454972|456123630|FG001|Overall Study|Treatment-related adverse events|1|||
126490587|NCT01594125|455094268|FG003|Overall Study|Progressive Disease|3|||
126490588|NCT01594125|455094269|FG004|Overall Study|Progressive Disease|7|||
126490589|NCT01484873|455094270|FG000|Overall Study|Withdrawal by Subject|2|||
126490590|NCT02618434|455094272|FG000|Overall Study|Withdrawal by Subject|0|||
126490591|NCT02618434|455094273|FG001|Overall Study|Withdrawal by Subject|2|||
126490592|NCT02618434|455094274|FG002|Overall Study|Withdrawal by Subject|3|||
126490593|NCT02618434|455094272|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
126490594|NCT02618434|455094273|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
126490595|NCT02618434|455094274|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
126490596|NCT02618434|455094272|FG000|Overall Study|Lost to Follow-up|3|||
126490597|NCT02618434|455094273|FG001|Overall Study|Lost to Follow-up|1|||
126490598|NCT02618434|455094274|FG002|Overall Study|Lost to Follow-up|3|||
126490599|NCT02618434|455094272|FG000|Overall Study|Adverse Event|1|||
126490600|NCT02618434|455094273|FG001|Overall Study|Adverse Event|0|||
126490601|NCT02618434|455094274|FG002|Overall Study|Adverse Event|12|||
126490602|NCT02618434|455094272|FG000|Overall Study|Physician Decision|0|||
126490603|NCT02618434|455094273|FG001|Overall Study|Physician Decision|1|||
126490604|NCT02618434|455094274|FG002|Overall Study|Physician Decision|0|||
126490605|NCT02618434|455094272|FG000|Overall Study|Protocol Violation|0|||
126490606|NCT02618434|455094273|FG001|Overall Study|Protocol Violation|0|||
126490607|NCT02618434|455094274|FG002|Overall Study|Protocol Violation|1|||
126490608|NCT02618434|455094272|FG000|Overall Study|Other, Multiple categories|1|||
126490609|NCT02618434|455094273|FG001|Overall Study|Other, Multiple categories|1|||
126490610|NCT02618434|455094274|FG002|Overall Study|Other, Multiple categories|1|||
126490611|NCT01988103|455094275|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
126490612|NCT01988103|455094276|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
126490613|NCT01988103|455094277|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
126490614|NCT01988103|455094278|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
126490615|NCT01988103|455094279|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
126490616|NCT01988103|455094275|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
126490617|NCT01988103|455094276|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
126490618|NCT01988103|455094277|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
126490619|NCT01988103|455094278|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
126490620|NCT01988103|455094279|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
126490621|NCT01988103|455094275|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
126490622|NCT01988103|455094276|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
126490623|NCT01988103|455094277|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
126490624|NCT01988103|455094278|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
126490625|NCT01988103|455094279|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
126490626|NCT01988103|455094275|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
126490627|NCT01988103|455094276|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
126490628|NCT01988103|455094277|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
126490629|NCT01988103|455094278|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
126490630|NCT01988103|455094279|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
126490631|NCT01988103|455094275|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
126490632|NCT01988103|455094276|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
126490633|NCT01988103|455094277|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
126490634|NCT01988103|455094278|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
126490635|NCT01988103|455094279|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
126490636|NCT01988103|455094275|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
126490637|NCT01988103|455094276|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
126490638|NCT01988103|455094277|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
126490639|NCT01988103|455094278|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
126490640|NCT01988103|455094279|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
126490641|NCT01988103|455094275|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
126490642|NCT01988103|455094276|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
126490643|NCT01988103|455094277|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
126490644|NCT01988103|455094278|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
126490645|NCT01988103|455094279|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
126490646|NCT03590041|455094280|FG000|Overall Study|Protocol Violation|4|||
126490647|NCT03590041|455094281|FG001|Overall Study|Protocol Violation|3|||
126772628|NCT02454972|456123631|FG002|Overall Study|Treatment-related adverse events|1|||
126490648|NCT03590041|455094280|FG000|Overall Study|No session data recorded|14|||
126490649|NCT03590041|455094281|FG001|Overall Study|No session data recorded|2|||
126490650|NCT03315208|455094282|FG000|Overall Study|Lost to Follow-up|11|||
126490651|NCT03315208|455094283|FG001|Overall Study|Lost to Follow-up|6|||
126490652|NCT03315208|455094282|FG000|Overall Study|Withdrawal by Subject|2|||
126772629|NCT02454972|456123632|FG003|Overall Study|Treatment-related adverse events|0|||
126490653|NCT03315208|455094283|FG001|Overall Study|Withdrawal by Subject|0|||
126490654|NCT01359449|455094289|FG000|Overall Study|Lost to Follow-up|1|||
126490655|NCT01359449|455094290|FG001|Overall Study|Lost to Follow-up|0|||
126490656|NCT01359449|455094289|FG000|Overall Study|Protocol Violation|0|||
126490657|NCT01359449|455094290|FG001|Overall Study|Protocol Violation|2|||
126490658|NCT01359449|455094289|FG000|Overall Study|Withdrawal by Subject|3|||
126490659|NCT01359449|455094290|FG001|Overall Study|Withdrawal by Subject|2|||
126490660|NCT02393547|455094297|FG000|Overall Study|Adverse Event|2|||
126490661|NCT02393547|455094297|FG000|Overall Study|Withdrawal by Subject|3|||
126490662|NCT02393547|455094297|FG000|Overall Study|Lost to Follow-up|1|||
126490663|NCT02927431|455094298|FG000|Overall Study|Withdrawal by Subject|0|||
126490664|NCT02927431|455094299|FG001|Overall Study|Withdrawal by Subject|0|||
126490665|NCT02927431|455094300|FG002|Overall Study|Withdrawal by Subject|1|||
126490666|NCT01896531|455094301|FG000|Overall Study|Death|57|||
126490667|NCT01896531|455094302|FG001|Overall Study|Death|59|||
126490668|NCT01896531|455094301|FG000|Overall Study|Lost to Follow-up|3|||
126490669|NCT01896531|455094302|FG001|Overall Study|Lost to Follow-up|0|||
126490670|NCT01896531|455094301|FG000|Overall Study|Non-compliance|0|||
126490671|NCT01896531|455094302|FG001|Overall Study|Non-compliance|1|||
126490672|NCT01896531|455094301|FG000|Overall Study|Study Ended by Sponsor|7|||
126490673|NCT01896531|455094302|FG001|Overall Study|Study Ended by Sponsor|20|||
126490674|NCT01896531|455094301|FG000|Overall Study|Withdrawal by Subject|3|||
126490675|NCT01896531|455094302|FG001|Overall Study|Withdrawal by Subject|2|||
126490676|NCT01896531|455094301|FG000|Overall Study|Death Prior to Treatment|1|||
126490677|NCT01896531|455094302|FG001|Overall Study|Death Prior to Treatment|0|||
126490678|NCT00563381|455094315|FG000|Overall Study|Adverse Event|264|||
126490679|NCT00563381|455094316|FG001|Overall Study|Adverse Event|292|||
126490680|NCT00563381|455094315|FG000|Overall Study|Protocol Violation|66|||
126490681|NCT00563381|455094316|FG001|Overall Study|Protocol Violation|74|||
126490682|NCT00563381|455094315|FG000|Overall Study|Lost to Follow-up|7|||
126490683|NCT00563381|455094316|FG001|Overall Study|Lost to Follow-up|15|||
126490684|NCT00563381|455094315|FG000|Overall Study|Withdrawal by Subject|192|||
126490685|NCT00563381|455094316|FG001|Overall Study|Withdrawal by Subject|209|||
126490686|NCT00563381|455094315|FG000|Overall Study|Lack of Efficacy|32|||
126490687|NCT00563381|455094316|FG001|Overall Study|Lack of Efficacy|24|||
126490688|NCT00563381|455094315|FG000|Overall Study|Individual different reasons|24|||
126490689|NCT00563381|455094316|FG001|Overall Study|Individual different reasons|34|||
126490690|NCT00110149|455094317|FG000|Overall Study|Physician Decision|3|||
126490691|NCT00667368|455094320|FG000|Overall Study|Lost to Follow-up|176|||
126490692|NCT00667368|455094321|FG001|Overall Study|Lost to Follow-up|155|||
126490693|NCT00667368|455094320|FG000|Overall Study|Discontinued early|24|||
126490694|NCT00667368|455094321|FG001|Overall Study|Discontinued early|17|||
126490695|NCT01405742|455094329|FG000|Overall Study|Lost to Follow-up|1|||
126490696|NCT01405742|455094330|FG001|Overall Study|Lost to Follow-up|0|||
126490697|NCT03672747|455094332|FG000|Overall Study|Lost to Follow-up|1|||
126490698|NCT03672747|455094333|FG001|Overall Study|Lost to Follow-up|1|||
126490699|NCT03672747|455094334|FG002|Overall Study|Lost to Follow-up|2|||
126490700|NCT03672747|455094335|FG003|Overall Study|Lost to Follow-up|2|||
126490701|NCT03672747|455094336|FG004|Overall Study|Lost to Follow-up|2|||
126490702|NCT03672747|455094337|FG005|Overall Study|Lost to Follow-up|1|||
126490703|NCT03428360|455094338|FG000|Overall Study|Informed consent withdrawn|5|||
126490704|NCT03428360|455094338|FG000|Overall Study|Withdrawal by Subject|4|||
126490705|NCT03428360|455094338|FG000|Overall Study|Lost to Follow-up|5|||
126490706|NCT03428360|455094338|FG000|Overall Study|Physician Decision|2|||
126490707|NCT03428360|455094338|FG000|Overall Study|Informed consent withdrawn|5|||
126490708|NCT03428360|455094338|FG000|Overall Study|Study terminated by sponsor|10|||
126490709|NCT03428360|455094338|FG000|Overall Study|Non-compliant with study|1|||
126490710|NCT03428360|455094338|FG000|Overall Study|Non-compliant with study drug|3|||
126490711|NCT03428360|455094338|FG000|Overall Study|Death|3|||
126490712|NCT03428360|455094338|FG000|Overall Study|Adverse Event|1|||
126490713|NCT03428360|455094338|FG000|Overall Study|Not on antiepileptic drug|1|||
126490714|NCT03241342|455094344|FG000|Overall Study|Adverse Event|5|||
126490715|NCT03241342|455094345|FG001|Overall Study|Adverse Event|8|||
126490716|NCT03241342|455094346|FG002|Overall Study|Adverse Event|4|||
126490717|NCT03241342|455094344|FG000|Overall Study|Lack of Efficacy|0|||
126490718|NCT03241342|455094345|FG001|Overall Study|Lack of Efficacy|0|||
126490719|NCT03241342|455094346|FG002|Overall Study|Lack of Efficacy|1|||
126490720|NCT03241342|455094344|FG000|Overall Study|noncompliance with study drug|2|||
126490721|NCT03241342|455094345|FG001|Overall Study|noncompliance with study drug|1|||
126490722|NCT03241342|455094346|FG002|Overall Study|noncompliance with study drug|1|||
126490723|NCT03241342|455094344|FG000|Overall Study|sponsor decision|0|||
126490724|NCT03241342|455094345|FG001|Overall Study|sponsor decision|1|||
126490725|NCT03241342|455094346|FG002|Overall Study|sponsor decision|2|||
126490726|NCT03241342|455094344|FG000|Overall Study|not reported|15|||
126490727|NCT03241342|455094345|FG001|Overall Study|not reported|21|||
126490728|NCT03241342|455094346|FG002|Overall Study|not reported|19|||
126490729|NCT01846611|455094348|FG000|Overall Study|Lost to Follow-up|4|||
126490730|NCT01846611|455094349|FG001|Overall Study|Lost to Follow-up|6|||
126490731|NCT01846611|455094348|FG000|Overall Study|Withdrawal by Subject|15|||
126490732|NCT01846611|455094349|FG001|Overall Study|Withdrawal by Subject|19|||
126490733|NCT01846611|455094348|FG000|Overall Study|Other|19|||
126490734|NCT01846611|455094349|FG001|Overall Study|Other|18|||
126490735|NCT04772755|455094350|FG000|Overall Study|Withdrawal by Subject|1|||
126490736|NCT04772755|455094351|FG001|Overall Study|Withdrawal by Subject|0|||
126490737|NCT04772755|455094350|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
126490738|NCT04772755|455094351|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
126490739|NCT01905657|455094352|FG000|Overall Study|Adverse Event|23|||
126490740|NCT01905657|455094353|FG001|Overall Study|Adverse Event|17|||
126490741|NCT01905657|455094354|FG002|Overall Study|Adverse Event|18|||
126490742|NCT01905657|455094352|FG000|Overall Study|Clinical Progression|103|||
126490743|NCT01905657|455094353|FG001|Overall Study|Clinical Progression|78|||
126490744|NCT01905657|455094354|FG002|Overall Study|Clinical Progression|59|||
126490745|NCT01905657|455094352|FG000|Overall Study|Death|40|||
126490746|NCT01905657|455094353|FG001|Overall Study|Death|43|||
126490747|NCT01905657|455094354|FG002|Overall Study|Death|47|||
126490748|NCT01905657|455094352|FG000|Overall Study|Excluded Medication|13|||
126490749|NCT01905657|455094353|FG001|Overall Study|Excluded Medication|16|||
126490750|NCT01905657|455094354|FG002|Overall Study|Excluded Medication|9|||
126490751|NCT01905657|455094352|FG000|Overall Study|Lost to Follow-up|1|||
126490752|NCT01905657|455094353|FG001|Overall Study|Lost to Follow-up|2|||
126490753|NCT01905657|455094354|FG002|Overall Study|Lost to Follow-up|1|||
126490754|NCT01905657|455094352|FG000|Overall Study|Physician Decision|5|||
126490755|NCT01905657|455094353|FG001|Overall Study|Physician Decision|8|||
126490756|NCT01905657|455094354|FG002|Overall Study|Physician Decision|12|||
126490757|NCT01905657|455094352|FG000|Overall Study|Protocol Violation|2|||
126490758|NCT01905657|455094353|FG001|Overall Study|Protocol Violation|1|||
126490759|NCT01905657|455094354|FG002|Overall Study|Protocol Violation|1|||
126490760|NCT01905657|455094352|FG000|Overall Study|Screen Failure|0|||
126490761|NCT01905657|455094353|FG001|Overall Study|Screen Failure|1|||
126490762|NCT01905657|455094354|FG002|Overall Study|Screen Failure|0|||
126490763|NCT01905657|455094352|FG000|Overall Study|Withdrawal by Subject|15|||
126490764|NCT01905657|455094353|FG001|Overall Study|Withdrawal by Subject|21|||
126490765|NCT01905657|455094354|FG002|Overall Study|Withdrawal by Subject|53|||
126490766|NCT01905657|455094352|FG000|Overall Study|Sponsor Decision|1|||
126772630|NCT02454972|456123633|FG004|Overall Study|Treatment-related adverse events|2|||
126490767|NCT01905657|455094353|FG001|Overall Study|Sponsor Decision|0|||
126490768|NCT01905657|455094354|FG002|Overall Study|Sponsor Decision|0|||
126490769|NCT03032705|455094359|FG000|Overall Study|Lost to Follow-up|16|||
126490770|NCT03032705|455094360|FG001|Overall Study|Lost to Follow-up|17|||
126490771|NCT03032705|455094359|FG000|Overall Study|did not quality|6|||
126490772|NCT03032705|455094360|FG001|Overall Study|did not quality|6|||
126490773|NCT02279173|455096244|FG000|Overall Study|Protocol-specified Criteria|67|||
126490774|NCT02279173|455096244|FG000|Overall Study|Withdrawal by Subject|20|||
126490775|NCT02279173|455096244|FG000|Overall Study|Decision by Sponsor|4|||
126490776|NCT02279173|455096244|FG000|Overall Study|Lost to Follow-up|3|||
126490777|NCT00157950|455096245|FG000|Overall Study|Death|1|||
126490778|NCT00157950|455096246|FG001|Overall Study|Death|0|||
126490779|NCT00293254|455096247|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
126490780|NCT00293254|455096248|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
126490781|NCT00293254|455096247|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
126490782|NCT00293254|455096248|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
126490783|NCT00293254|455096247|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
126490784|NCT00293254|455096248|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
126490785|NCT00293254|455096247|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
126490786|NCT00293254|455096248|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
126490787|NCT00293254|455096247|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
126490788|NCT00293254|455096248|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
126490789|NCT00293254|455096247|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
126490790|NCT00293254|455096248|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
126490791|NCT00293254|455096247|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
126490792|NCT00293254|455096248|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
126490793|NCT00293254|455096247|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
126490794|NCT00293254|455096248|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
126490795|NCT00293254|455096247|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
126490796|NCT00293254|455096248|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
126490797|NCT00293254|455096247|FG000|Extension - Double-Blind Week 49-156|Death|4|||
126490798|NCT00293254|455096248|FG001|Extension - Double-Blind Week 49-156|Death|1|||
126490799|NCT00293254|455096247|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
126490800|NCT00293254|455096248|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
126490801|NCT00293254|455096247|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
126490802|NCT00293254|455096248|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
126772631|NCT02454972|456123634|FG005|Overall Study|Treatment-related adverse events|0|||
126723403|NCT02052778|455936101|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723404|NCT02052778|455936102|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126490803|NCT00293254|455096247|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
126490804|NCT00293254|455096248|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
126490805|NCT00293254|455096247|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
126490806|NCT00293254|455096248|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
126490807|NCT00293254|455096247|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
126490808|NCT00293254|455096248|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
126490809|NCT00293254|455096247|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
126490810|NCT00293254|455096248|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
126490811|NCT00293254|455096247|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
126490812|NCT00293254|455096248|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
126490813|NCT00293254|455096247|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
126490814|NCT00293254|455096248|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
126490815|NCT00293254|455096247|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
126490816|NCT00293254|455096248|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
126490817|NCT00293254|455096247|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
126490818|NCT00293254|455096248|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
126490819|NCT00293254|455096247|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
126490820|NCT00293254|455096248|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
126490821|NCT00293254|455096247|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
126490822|NCT00293254|455096248|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
126490823|NCT00293254|455096247|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
126490824|NCT00293254|455096248|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
126490825|NCT00293254|455096247|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
126490826|NCT00293254|455096248|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
126490827|NCT00293254|455096247|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
126490828|NCT00293254|455096248|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
126490829|NCT00293254|455096247|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
126490830|NCT00293254|455096248|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
126490831|NCT00293254|455096247|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
126490832|NCT00293254|455096248|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
126490833|NCT02335489|455096249|FG000|Overall Study|Sponsor terminated study|4|||
126490834|NCT02335489|455096249|FG000|Overall Study|Lost to Follow-up|1|||
126490835|NCT02335489|455096249|FG000|Overall Study|Withdrawal by Subject|2|||
126490836|NCT02335489|455096249|FG000|Overall Study|Physician Decision|2|||
126490837|NCT02335489|455096249|FG000|Overall Study|Lack of Efficacy|1|||
126490838|NCT02564042|455096250|FG000|Overall Study|Adverse Event|4|||
126490839|NCT02564042|455096251|FG001|Overall Study|Adverse Event|4|||
126490840|NCT02564042|455096252|FG002|Overall Study|Adverse Event|3|||
126490841|NCT02564042|455096253|FG003|Overall Study|Adverse Event|0|||
126490842|NCT02564042|455096254|FG004|Overall Study|Adverse Event|0|||
126490843|NCT02564042|455096255|FG005|Overall Study|Adverse Event|1|||
126490844|NCT02564042|455096250|FG000|Overall Study|Lost to Follow-up|1|||
126490845|NCT02564042|455096251|FG001|Overall Study|Lost to Follow-up|1|||
126490846|NCT02564042|455096252|FG002|Overall Study|Lost to Follow-up|1|||
126490847|NCT02564042|455096253|FG003|Overall Study|Lost to Follow-up|0|||
126490848|NCT02564042|455096254|FG004|Overall Study|Lost to Follow-up|1|||
126490849|NCT02564042|455096255|FG005|Overall Study|Lost to Follow-up|1|||
126490850|NCT02564042|455096250|FG000|Overall Study|Physician Decision|1|||
126490851|NCT02564042|455096251|FG001|Overall Study|Physician Decision|0|||
126490852|NCT02564042|455096252|FG002|Overall Study|Physician Decision|0|||
126490853|NCT02564042|455096253|FG003|Overall Study|Physician Decision|1|||
126490854|NCT02564042|455096254|FG004|Overall Study|Physician Decision|0|||
126490855|NCT02564042|455096255|FG005|Overall Study|Physician Decision|0|||
126490856|NCT02564042|455096250|FG000|Overall Study|Withdrawal by Subject|5|||
126490857|NCT02564042|455096251|FG001|Overall Study|Withdrawal by Subject|3|||
126490858|NCT02564042|455096252|FG002|Overall Study|Withdrawal by Subject|2|||
126490859|NCT02564042|455096253|FG003|Overall Study|Withdrawal by Subject|2|||
126490860|NCT02564042|455096254|FG004|Overall Study|Withdrawal by Subject|10|||
126490861|NCT02564042|455096255|FG005|Overall Study|Withdrawal by Subject|12|||
126490862|NCT01356966|455096256|FG000|Overall Study|Withdrawal by Subject|1|||
126490863|NCT01356966|455096257|FG001|Overall Study|Withdrawal by Subject|2|||
126490864|NCT01356966|455096256|FG000|Overall Study|Physician Decision|1|||
126490865|NCT01356966|455096257|FG001|Overall Study|Physician Decision|0|||
126490866|NCT01549392|455096258|FG000|Overall Study|Withdrawal by Subject|1|||
126490867|NCT01549392|455096259|FG001|Overall Study|Withdrawal by Subject|0|||
126490868|NCT02743806|455096260|FG000|Overall Study|Adverse Event|9|||
126490869|NCT02743806|455096260|FG000|Overall Study|Lost to Follow-up|8|||
126490870|NCT02743806|455096260|FG000|Overall Study|Voluntary Withdrawal|54|||
126490871|NCT02743806|455096260|FG000|Overall Study|Study Termination|65|||
126490872|NCT02743806|455096260|FG000|Overall Study|Pregnancy|6|||
126490873|NCT02743806|455096260|FG000|Overall Study|No Longer Clinically Benefiting|27|||
126490874|NCT02743806|455096260|FG000|Overall Study|Reason Not Specified|12|||
126490875|NCT04273217|455096262|FG000|Overall Study|Lost to Follow-up|0|||
126490876|NCT04273217|455096263|FG001|Overall Study|Lost to Follow-up|0|||
126490877|NCT04273217|455096264|FG002|Overall Study|Lost to Follow-up|0|||
126490878|NCT04273217|455096265|FG003|Overall Study|Lost to Follow-up|0|||
126490879|NCT04273217|455096266|FG004|Overall Study|Lost to Follow-up|0|||
126490880|NCT04273217|455096267|FG005|Overall Study|Lost to Follow-up|1|||
126490881|NCT04273217|455096262|FG000|Overall Study|Participant non-compliance|0|||
126490882|NCT04273217|455096263|FG001|Overall Study|Participant non-compliance|0|||
126490883|NCT04273217|455096264|FG002|Overall Study|Participant non-compliance|0|||
126490884|NCT04273217|455096265|FG003|Overall Study|Participant non-compliance|0|||
126490885|NCT04273217|455096266|FG004|Overall Study|Participant non-compliance|1|||
126490886|NCT04273217|455096267|FG005|Overall Study|Participant non-compliance|0|||
126490887|NCT04273217|455096262|FG000|Overall Study|Positive urine drug screen|1|||
126490888|NCT04273217|455096263|FG001|Overall Study|Positive urine drug screen|0|||
126490889|NCT04273217|455096264|FG002|Overall Study|Positive urine drug screen|1|||
126490890|NCT04273217|455096265|FG003|Overall Study|Positive urine drug screen|0|||
126490891|NCT04273217|455096266|FG004|Overall Study|Positive urine drug screen|0|||
126490892|NCT04273217|455096267|FG005|Overall Study|Positive urine drug screen|1|||
126490893|NCT00849381|455096268|FG000|Overall Study|Adverse Event|1|||
126490894|NCT00849381|455096268|FG000|Overall Study|Lost to Follow-up|129|||
126490895|NCT00849381|455096268|FG000|Overall Study|Protocol Violation|5|||
126490896|NCT00849381|455096268|FG000|Overall Study|Withdrawal by Subject|6|||
126490897|NCT00849381|455096268|FG000|Overall Study|Other|4|||
126490898|NCT00303498|455096269|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
126490899|NCT00303498|455096270|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
126490900|NCT00303498|455096269|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
126490901|NCT00303498|455096270|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
126490902|NCT00303498|455096269|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
126490903|NCT00303498|455096270|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
126490904|NCT00303498|455096269|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
126490905|NCT00303498|455096270|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
126490906|NCT00303498|455096269|FG000|Run-In-Phase (10 Weeks)|Other|4|||
126490907|NCT00303498|455096270|FG001|Run-In-Phase (10 Weeks)|Other|1|||
126490908|NCT00303498|455096269|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
126490909|NCT00303498|455096270|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
126490910|NCT00303498|455096269|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
126490911|NCT00303498|455096270|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
126490912|NCT00303498|455096269|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
126490913|NCT00303498|455096270|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
126490914|NCT00303498|455096269|FG000|Maintenance Phase (24 Weeks)|Death|1|||
126490915|NCT00303498|455096270|FG001|Maintenance Phase (24 Weeks)|Death|0|||
126490916|NCT00303498|455096269|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
126490917|NCT00303498|455096270|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
126490918|NCT00303498|455096269|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
126490919|NCT00303498|455096270|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
126490920|NCT00303498|455096269|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
126490921|NCT00303498|455096270|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
126490922|NCT00303498|455096269|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
126490923|NCT00303498|455096270|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
126490924|NCT00303498|455096269|FG000|Maintenance Phase (24 Weeks)|Other|1|||
126490925|NCT00303498|455096270|FG001|Maintenance Phase (24 Weeks)|Other|0|||
126490926|NCT00303498|455096269|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
126490927|NCT00303498|455096270|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
126490928|NCT00303498|455096269|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
126490929|NCT00303498|455096270|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
126490930|NCT02289898|455096278|FG000|Overall Study|Death|5|||
126490931|NCT02289898|455096279|FG001|Overall Study|Death|4|||
126490932|NCT02289898|455096280|FG002|Overall Study|Death|3|||
126490933|NCT02289898|455096278|FG000|Overall Study|Physician Decision|2|||
126490934|NCT02289898|455096279|FG001|Overall Study|Physician Decision|5|||
126723405|NCT02052778|455936103|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
126723406|NCT02052778|455936104|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
126723407|NCT02052778|455936082|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723408|NCT02052778|455936083|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723409|NCT02052778|455936084|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723410|NCT02052778|455936085|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723411|NCT02052778|455936086|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723412|NCT02052778|455936087|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723413|NCT02052778|455936088|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723414|NCT02052778|455936089|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126490935|NCT02289898|455096280|FG002|Overall Study|Physician Decision|2|||
126490936|NCT02289898|455096278|FG000|Overall Study|Withdrawal by Subject|0|||
126490937|NCT02289898|455096279|FG001|Overall Study|Withdrawal by Subject|4|||
126490938|NCT02289898|455096280|FG002|Overall Study|Withdrawal by Subject|1|||
126490939|NCT02289898|455096278|FG000|Overall Study|Adverse Event|3|||
126490940|NCT02289898|455096279|FG001|Overall Study|Adverse Event|5|||
126490941|NCT02289898|455096280|FG002|Overall Study|Adverse Event|5|||
126490942|NCT02289898|455096278|FG000|Overall Study|Disease progression|34|||
126490943|NCT02289898|455096279|FG001|Overall Study|Disease progression|28|||
126490944|NCT02289898|455096280|FG002|Overall Study|Disease progression|34|||
126490945|NCT02289898|455096278|FG000|Overall Study|Use of another anticancer therapy|0|||
126490946|NCT02289898|455096279|FG001|Overall Study|Use of another anticancer therapy|0|||
126490947|NCT02289898|455096280|FG002|Overall Study|Use of another anticancer therapy|1|||
126490948|NCT02289898|455096278|FG000|Overall Study|Other|8|||
126490949|NCT02289898|455096279|FG001|Overall Study|Other|7|||
126490950|NCT02289898|455096280|FG002|Overall Study|Other|10|||
126490951|NCT00103142|455096286|FG000|Overall Study|Adverse Event|1|||
126490952|NCT00103142|455096287|FG001|Overall Study|Adverse Event|0|||
126490953|NCT00103142|455096286|FG000|Overall Study|Progression of disease|2|||
126490954|NCT00103142|455096287|FG001|Overall Study|Progression of disease|1|||
126490955|NCT02598076|455096289|FG000|Overall Study|Lost to Follow-up|2|||
126490956|NCT02598076|455096290|FG001|Overall Study|Lost to Follow-up|3|||
126490957|NCT01946425|455096291|FG000|Overall Study|Protocol Violation|1|||
126490958|NCT01946425|455096292|FG001|Overall Study|Protocol Violation|0|||
126490959|NCT01946425|455096291|FG000|Overall Study|Withdrawal by Subject|1|||
126490960|NCT01946425|455096292|FG001|Overall Study|Withdrawal by Subject|0|||
126490961|NCT02611778|455096293|FG000|Overall Study|Withdrawal by Subject|2|||
126490962|NCT02611778|455096294|FG001|Overall Study|Withdrawal by Subject|8|||
126490963|NCT02611778|455096293|FG000|Overall Study|Adverse Event|1|||
126490964|NCT02611778|455096294|FG001|Overall Study|Adverse Event|2|||
126490965|NCT02611778|455096293|FG000|Overall Study|Death|2|||
126490966|NCT02611778|455096294|FG001|Overall Study|Death|1|||
126490967|NCT02611778|455096293|FG000|Overall Study|Protocol Violation|1|||
126490968|NCT02611778|455096294|FG001|Overall Study|Protocol Violation|0|||
126490969|NCT02611778|455096293|FG000|Overall Study|Lost to Follow-up|3|||
126490970|NCT02611778|455096294|FG001|Overall Study|Lost to Follow-up|1|||
126490971|NCT02611778|455096293|FG000|Overall Study|Need for alternative treatment|1|||
126490972|NCT02611778|455096294|FG001|Overall Study|Need for alternative treatment|0|||
126490973|NCT02611778|455096293|FG000|Overall Study|Other Reason|2|||
126490974|NCT02611778|455096294|FG001|Overall Study|Other Reason|1|||
126490975|NCT00022633|455096295|FG000|Overall Study|Adverse Event|11|||
126490976|NCT00022633|455096296|FG001|Overall Study|Adverse Event|1|||
126490977|NCT00022633|455096295|FG000|Overall Study|Refusal unrelated to adverse event|1|||
126490978|NCT00022633|455096296|FG001|Overall Study|Refusal unrelated to adverse event|0|||
126490979|NCT00022633|455096295|FG000|Overall Study|Progression/relapse|9|||
126490980|NCT00022633|455096296|FG001|Overall Study|Progression/relapse|2|||
126490981|NCT00022633|455096295|FG000|Overall Study|Death|4|||
126490982|NCT00022633|455096296|FG001|Overall Study|Death|0|||
126490983|NCT00022633|455096295|FG000|Overall Study|Other - not protocol specified|3|||
126490984|NCT00022633|455096296|FG001|Overall Study|Other - not protocol specified|2|||
126490985|NCT00022633|455096295|FG000|Overall Study|Ineligible|4|||
126490986|NCT00022633|455096296|FG001|Overall Study|Ineligible|0|||
126490987|NCT00770289|455096305|FG000|Overall Study|Other|6|||
126490988|NCT02956486|455096306|FG000|Core Phase|Adverse Event|51|||
126490989|NCT02956486|455096307|FG001|Core Phase|Adverse Event|88|||
126490990|NCT02956486|455096308|FG002|Core Phase|Adverse Event|0|||
126490991|NCT02956486|455096306|FG000|Core Phase|Lost to Follow-up|8|||
126490992|NCT02956486|455096307|FG001|Core Phase|Lost to Follow-up|6|||
126490993|NCT02956486|455096308|FG002|Core Phase|Lost to Follow-up|0|||
126490994|NCT02956486|455096306|FG000|Core Phase|Inadequate therapeutic effect|4|||
126490995|NCT02956486|455096307|FG001|Core Phase|Inadequate therapeutic effect|5|||
126490996|NCT02956486|455096308|FG002|Core Phase|Inadequate therapeutic effect|0|||
126490997|NCT02956486|455096306|FG000|Core Phase|Withdrawal by Subject|101|||
126490998|NCT02956486|455096307|FG001|Core Phase|Withdrawal by Subject|104|||
126490999|NCT02956486|455096308|FG002|Core Phase|Withdrawal by Subject|0|||
126491000|NCT02956486|455096306|FG000|Core Phase|Study terminated by sponsor|888|||
126491001|NCT02956486|455096307|FG001|Core Phase|Study terminated by sponsor|848|||
126491002|NCT02956486|455096308|FG002|Core Phase|Study terminated by sponsor|0|||
126491003|NCT02956486|455096306|FG000|Core Phase|Other|27|||
126559548|NCT02373813|455342536|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
126491004|NCT02956486|455096307|FG001|Core Phase|Other|18|||
126491005|NCT02956486|455096308|FG002|Core Phase|Other|0|||
126491006|NCT02956486|455096306|FG000|Core Phase|Not treated|0|||
126491007|NCT02956486|455096307|FG001|Core Phase|Not treated|3|||
126491008|NCT02956486|455096308|FG002|Core Phase|Not treated|0|||
126491009|NCT02956486|455096306|FG000|Extension Phase|Adverse Event|0|||
126491010|NCT02956486|455096307|FG001|Extension Phase|Adverse Event|0|||
126491011|NCT02956486|455096308|FG002|Extension Phase|Adverse Event|2|||
126491012|NCT02956486|455096306|FG000|Extension Phase|Study terminated by sponsor|0|||
126491013|NCT02956486|455096307|FG001|Extension Phase|Study terminated by sponsor|0|||
126491014|NCT02956486|455096308|FG002|Extension Phase|Study terminated by sponsor|16|||
126491015|NCT02956486|455096306|FG000|Extension Phase|Not Treated|0|||
126491016|NCT02956486|455096307|FG001|Extension Phase|Not Treated|0|||
126491017|NCT02956486|455096308|FG002|Extension Phase|Not Treated|1|||
126491018|NCT03325075|455096311|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
126491019|NCT03325075|455096312|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
126491020|NCT03325075|455096313|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
126491021|NCT03325075|455096314|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
126491022|NCT03325075|455096311|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
126491023|NCT03325075|455096312|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
126491024|NCT03325075|455096313|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
126491025|NCT03325075|455096314|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
126491026|NCT03325075|455096311|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
126491027|NCT03325075|455096312|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
126491028|NCT03325075|455096313|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
126491029|NCT03325075|455096314|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
126491030|NCT00422591|455096315|FG000|Overall Study|Physician Decision|4|||
126491031|NCT00422591|455096315|FG000|Overall Study|Withdrawal by Subject|2|||
126491032|NCT02659631|455096318|FG000|Overall Study|Lost to Follow-up|0|||
126491033|NCT02659631|455096319|FG001|Overall Study|Lost to Follow-up|0|||
126491034|NCT02659631|455096320|FG002|Overall Study|Lost to Follow-up|2|||
126491035|NCT02659631|455096321|FG003|Overall Study|Lost to Follow-up|0|||
126491036|NCT02659631|455096322|FG004|Overall Study|Lost to Follow-up|0|||
126491037|NCT02659631|455096323|FG005|Overall Study|Lost to Follow-up|1|||
126491038|NCT02659631|455096324|FG006|Overall Study|Lost to Follow-up|0|||
126491039|NCT02659631|455096325|FG007|Overall Study|Lost to Follow-up|0|||
126491040|NCT02659631|455096326|FG008|Overall Study|Lost to Follow-up|0|||
126491041|NCT02659631|455096327|FG009|Overall Study|Lost to Follow-up|0|||
126491042|NCT02659631|455096318|FG000|Overall Study|Withdrawal prior to treatment|0|||
126491043|NCT02659631|455096319|FG001|Overall Study|Withdrawal prior to treatment|0|||
126491044|NCT02659631|455096320|FG002|Overall Study|Withdrawal prior to treatment|0|||
126491045|NCT02659631|455096321|FG003|Overall Study|Withdrawal prior to treatment|0|||
126491046|NCT02659631|455096322|FG004|Overall Study|Withdrawal prior to treatment|1|||
126491047|NCT02659631|455096323|FG005|Overall Study|Withdrawal prior to treatment|0|||
126491048|NCT02659631|455096324|FG006|Overall Study|Withdrawal prior to treatment|0|||
126491049|NCT02659631|455096325|FG007|Overall Study|Withdrawal prior to treatment|0|||
126491050|NCT02659631|455096326|FG008|Overall Study|Withdrawal prior to treatment|0|||
126491051|NCT02659631|455096327|FG009|Overall Study|Withdrawal prior to treatment|0|||
126491052|NCT02659631|455096318|FG000|Overall Study|Participant refused further follow-up|0|||
126491053|NCT02659631|455096319|FG001|Overall Study|Participant refused further follow-up|0|||
126491054|NCT02659631|455096320|FG002|Overall Study|Participant refused further follow-up|0|||
126491055|NCT02659631|455096321|FG003|Overall Study|Participant refused further follow-up|1|||
126491056|NCT02659631|455096322|FG004|Overall Study|Participant refused further follow-up|0|||
126491057|NCT02659631|455096323|FG005|Overall Study|Participant refused further follow-up|0|||
126491058|NCT02659631|455096324|FG006|Overall Study|Participant refused further follow-up|0|||
126491059|NCT02659631|455096325|FG007|Overall Study|Participant refused further follow-up|0|||
126491060|NCT02659631|455096326|FG008|Overall Study|Participant refused further follow-up|1|||
126491061|NCT02659631|455096327|FG009|Overall Study|Participant refused further follow-up|0|||
126491062|NCT02659631|455096318|FG000|Overall Study|Death (follow-up phase)|1|||
126491063|NCT02659631|455096319|FG001|Overall Study|Death (follow-up phase)|2|||
126491064|NCT02659631|455096320|FG002|Overall Study|Death (follow-up phase)|1|||
126491065|NCT02659631|455096321|FG003|Overall Study|Death (follow-up phase)|1|||
126491066|NCT02659631|455096322|FG004|Overall Study|Death (follow-up phase)|3|||
126491067|NCT02659631|455096323|FG005|Overall Study|Death (follow-up phase)|2|||
126491068|NCT02659631|455096324|FG006|Overall Study|Death (follow-up phase)|0|||
126491069|NCT02659631|455096325|FG007|Overall Study|Death (follow-up phase)|3|||
126491070|NCT02659631|455096326|FG008|Overall Study|Death (follow-up phase)|1|||
126491071|NCT02659631|455096327|FG009|Overall Study|Death (follow-up phase)|0|||
126491072|NCT02659631|455096318|FG000|Overall Study|Death (treatment phase)|0|||
126491073|NCT02659631|455096319|FG001|Overall Study|Death (treatment phase)|0|||
126491074|NCT02659631|455096320|FG002|Overall Study|Death (treatment phase)|0|||
126491075|NCT02659631|455096321|FG003|Overall Study|Death (treatment phase)|0|||
126491076|NCT02659631|455096322|FG004|Overall Study|Death (treatment phase)|1|||
126491077|NCT02659631|455096323|FG005|Overall Study|Death (treatment phase)|0|||
126491078|NCT02659631|455096324|FG006|Overall Study|Death (treatment phase)|1|||
126491079|NCT02659631|455096325|FG007|Overall Study|Death (treatment phase)|0|||
126491080|NCT02659631|455096326|FG008|Overall Study|Death (treatment phase)|0|||
126491081|NCT02659631|455096327|FG009|Overall Study|Death (treatment phase)|0|||
126491082|NCT02377466|455096328|FG000|Overall Study|Other: Randomized and not treated|0|||
126491083|NCT02377466|455096329|FG001|Overall Study|Other: Randomized and not treated|2|||
126491084|NCT00495170|455096330|FG000|Overall Study|Lost to Follow-up|9|||
126491085|NCT00495170|455096330|FG000|Overall Study|Withdrawal by Subject|3|||
126491086|NCT00495170|455096330|FG000|Overall Study|Inappropriate staging|8|||
126491087|NCT02485574|455096334|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
126491088|NCT01408914|455096335|FG000|Overall Study|Could not complete tx in protocol period|5|||
126491089|NCT01408914|455096336|FG001|Overall Study|Could not complete tx in protocol period|5|||
126491090|NCT01408914|455096337|FG002|Overall Study|Could not complete tx in protocol period|6|||
126491091|NCT01408914|455096335|FG000|Overall Study|Lost to Follow-up|4|||
126723415|NCT02052778|455936090|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723416|NCT02052778|455936091|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723417|NCT02052778|455936092|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723418|NCT02052778|455936093|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723419|NCT02052778|455936094|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126491092|NCT01408914|455096336|FG001|Overall Study|Lost to Follow-up|1|||
126491093|NCT01408914|455096337|FG002|Overall Study|Lost to Follow-up|2|||
126491094|NCT01408914|455096335|FG000|Overall Study|Physician Decision|1|||
126491095|NCT01408914|455096336|FG001|Overall Study|Physician Decision|1|||
126491096|NCT01408914|455096337|FG002|Overall Study|Physician Decision|0|||
126491097|NCT01408914|455096335|FG000|Overall Study|Withdrawal by Subject|1|||
126491098|NCT01408914|455096336|FG001|Overall Study|Withdrawal by Subject|0|||
126491099|NCT01408914|455096337|FG002|Overall Study|Withdrawal by Subject|1|||
126491100|NCT01408914|455096335|FG000|Overall Study|Moved out of study jurisdiction|1|||
126491101|NCT01408914|455096336|FG001|Overall Study|Moved out of study jurisdiction|1|||
126491102|NCT01408914|455096337|FG002|Overall Study|Moved out of study jurisdiction|0|||
126491103|NCT01408914|455096335|FG000|Overall Study|Late exclusion|0|||
126491104|NCT01408914|455096336|FG001|Overall Study|Late exclusion|3|||
126491105|NCT01408914|455096337|FG002|Overall Study|Late exclusion|3|||
126491106|NCT01408914|455096335|FG000|Overall Study|Change in local TB/HIV norms|0|||
126491107|NCT01408914|455096336|FG001|Overall Study|Change in local TB/HIV norms|1|||
126491108|NCT01408914|455096337|FG002|Overall Study|Change in local TB/HIV norms|1|||
126491109|NCT00330616|455096338|FG000|Overall Study|Adverse Event|13|||
126491110|NCT00330616|455096338|FG000|Overall Study|Lack of Efficacy|1|||
126491111|NCT00330616|455096338|FG000|Overall Study|Lost to Follow-up|2|||
126491112|NCT00330616|455096338|FG000|Overall Study|Withdrawal by Subject|4|||
126491113|NCT00330616|455096338|FG000|Overall Study|Other|1|||
126491114|NCT01957553|455096343|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
126491115|NCT01957553|455096344|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
126491116|NCT01957553|455096343|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
126491117|NCT01957553|455096344|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
126491118|NCT01957553|455096343|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
126491119|NCT01957553|455096344|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
126491120|NCT01957553|455096343|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
126491121|NCT01957553|455096344|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
126491122|NCT01957553|455096343|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
126491123|NCT01957553|455096344|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
126491124|NCT01957553|455096343|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
126491125|NCT01957553|455096344|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
126491126|NCT01957553|455096343|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
126491127|NCT01957553|455096344|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
126491128|NCT01957553|455096343|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
126491129|NCT01957553|455096344|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
126491130|NCT01957553|455096343|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
126491131|NCT01957553|455096344|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
126491132|NCT00732615|455096345|FG000|Overall Study|Withdrawal by Subject|3|||
126491133|NCT00732615|455096346|FG001|Overall Study|Withdrawal by Subject|1|||
126491134|NCT00732615|455096345|FG000|Overall Study|Lost to Follow-up|0|||
126491135|NCT00732615|455096346|FG001|Overall Study|Lost to Follow-up|1|||
126491136|NCT00732615|455096345|FG000|Overall Study|Adverse Event|0|||
126491137|NCT00732615|455096346|FG001|Overall Study|Adverse Event|2|||
126491138|NCT00732615|455096345|FG000|Overall Study|Physician Decision|3|||
126491139|NCT00732615|455096346|FG001|Overall Study|Physician Decision|0|||
126491140|NCT00732615|455096345|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
126491141|NCT00732615|455096346|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
126491142|NCT01333059|455096349|FG000|Overall Study|Physician Decision|3|||
126491143|NCT01333059|455096350|FG001|Overall Study|Physician Decision|3|||
126491144|NCT01333059|455096349|FG000|Overall Study|Protocol Violation|3|||
126491145|NCT01333059|455096350|FG001|Overall Study|Protocol Violation|0|||
126491146|NCT03566823|455096351|FG000|Overall Study|Lack of Efficacy|0|||
126491147|NCT03566823|455096352|FG001|Overall Study|Lack of Efficacy|1|||
126491148|NCT03566823|455096353|FG002|Overall Study|Lack of Efficacy|0|||
126491149|NCT03566823|455096351|FG000|Overall Study|Withdrawal by Subject|1|||
126491150|NCT03566823|455096352|FG001|Overall Study|Withdrawal by Subject|2|||
126491151|NCT03566823|455096353|FG002|Overall Study|Withdrawal by Subject|0|||
126491152|NCT03566823|455096351|FG000|Overall Study|Adverse Event|1|||
126491153|NCT03566823|455096352|FG001|Overall Study|Adverse Event|0|||
126491154|NCT03566823|455096353|FG002|Overall Study|Adverse Event|2|||
126491155|NCT02733367|455096354|FG000|Overall Study|Withdrawal by Subject|6|||
126491156|NCT01348347|455096355|FG000|Overall Study|Withdrawal by Subject|1|||
126491157|NCT01348347|455096356|FG001|Overall Study|Withdrawal by Subject|1|||
126491158|NCT01348347|455096357|FG002|Overall Study|Withdrawal by Subject|1|||
126491159|NCT01348347|455096355|FG000|Overall Study|Progressive disease|2|||
126491160|NCT01348347|455096356|FG001|Overall Study|Progressive disease|5|||
126491161|NCT01348347|455096357|FG002|Overall Study|Progressive disease|5|||
126491162|NCT00748033|455096361|FG000|Overall Study|Adverse Event|0|||
126491163|NCT00748033|455096362|FG001|Overall Study|Adverse Event|1|||
126491164|NCT00191789|455096363|FG000|Overall Study|Adverse Event|5|||
126491165|NCT00191789|455096363|FG000|Overall Study|Patient: Satisfactory Response|5|||
126491166|NCT00191789|455096363|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
126491167|NCT00191789|455096363|FG000|Overall Study|Withdrawal by Subject|4|||
126491168|NCT00191789|455096363|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
126491169|NCT00191789|455096363|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
126491170|NCT00191789|455096363|FG000|Overall Study|Death - Not Study-Drug Related|1|||
126491171|NCT02999854|455096366|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
126491172|NCT02999854|455096367|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
126491173|NCT02999854|455096366|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
126491174|NCT02999854|455096367|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
126491175|NCT02999854|455096366|FG000|Active Study Phase (up to 18 Months)|Death|7|||
126491176|NCT02999854|455096367|FG001|Active Study Phase (up to 18 Months)|Death|5|||
126491177|NCT02999854|455096366|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
126491178|NCT02999854|455096367|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
126491179|NCT02999854|455096366|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
126491180|NCT02999854|455096367|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
126491181|NCT02999854|455096366|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
126491182|NCT02999854|455096367|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
126491183|NCT02999854|455096366|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
126491184|NCT02999854|455096367|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
126491185|NCT02999854|455096366|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
126491186|NCT02999854|455096367|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
126491187|NCT04140292|455096368|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
126491188|NCT04140292|455096369|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
126491189|NCT00459667|455096370|FG000|Overall Study|Adverse Event|9|||
126491190|NCT00459667|455096371|FG001|Overall Study|Adverse Event|12|||
126491191|NCT00459667|455096372|FG002|Overall Study|Adverse Event|8|||
126491192|NCT00459667|455096370|FG000|Overall Study|Lost to Follow-up|5|||
126491193|NCT00459667|455096371|FG001|Overall Study|Lost to Follow-up|9|||
126491194|NCT00459667|455096372|FG002|Overall Study|Lost to Follow-up|3|||
126491195|NCT00459667|455096370|FG000|Overall Study|Pregnancy|1|||
126491196|NCT00459667|455096371|FG001|Overall Study|Pregnancy|1|||
126491197|NCT00459667|455096372|FG002|Overall Study|Pregnancy|1|||
126491198|NCT00459667|455096370|FG000|Overall Study|Protocol Violation|1|||
126491199|NCT00459667|455096371|FG001|Overall Study|Protocol Violation|0|||
126491200|NCT00459667|455096372|FG002|Overall Study|Protocol Violation|0|||
126491201|NCT00459667|455096370|FG000|Overall Study|Withdrawal by Subject|3|||
126491202|NCT00459667|455096371|FG001|Overall Study|Withdrawal by Subject|5|||
126491203|NCT00459667|455096372|FG002|Overall Study|Withdrawal by Subject|5|||
126491204|NCT00459667|455096370|FG000|Overall Study|Other disease modifying treatment|1|||
126491205|NCT00459667|455096371|FG001|Overall Study|Other disease modifying treatment|2|||
126491206|NCT00459667|455096372|FG002|Overall Study|Other disease modifying treatment|1|||
126491207|NCT00459667|455096370|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
126491208|NCT00459667|455096371|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
126491209|NCT00459667|455096372|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
126491210|NCT00459667|455096370|FG000|Overall Study|No treatment administered|6|||
126491211|NCT00459667|455096371|FG001|Overall Study|No treatment administered|3|||
126491212|NCT00459667|455096372|FG002|Overall Study|No treatment administered|1|||
126491213|NCT01013701|455096373|FG000|Overall Study|study prematurely terminated|7|||
126491214|NCT02671422|455096377|FG000|Overall Study|Lost to Follow-up|1|||
126491215|NCT02671422|455096377|FG000|Overall Study|Adverse Event|68|||
126491216|NCT02671422|455096377|FG000|Overall Study|Lack of Efficacy|1|||
126772632|NCT02454972|456123635|FG006|Overall Study|Treatment-related adverse events|0|||
126491217|NCT02671422|455096377|FG000|Overall Study|Lost to Follow-up|4|||
126491218|NCT02671422|455096377|FG000|Overall Study|Withdrawal by Subject|7|||
126491219|NCT02671422|455096377|FG000|Overall Study|Progressive Disease|156|||
126491220|NCT02671422|455096377|FG000|Overall Study|Worsening of Disease|4|||
126491221|NCT02671422|455096377|FG000|Overall Study|Sponsor decision|5|||
126772633|NCT02454972|456123636|FG007|Overall Study|Treatment-related adverse events|2|||
126491222|NCT02671422|455096377|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
126491223|NCT02671422|455096377|FG000|Overall Study|Not treated with Vargatef®|3|||
126491224|NCT02671422|455096377|FG000|Overall Study|Other not defined above|3|||
126491225|NCT04080297|455096378|FG000|Overall Study|Adverse Event|1|||
126491226|NCT04080297|455096379|FG001|Overall Study|Adverse Event|3|||
126491227|NCT04080297|455096378|FG000|Overall Study|concurrent illness|1|||
126491228|NCT04080297|455096379|FG001|Overall Study|concurrent illness|0|||
126491229|NCT02626520|455096380|FG000|Overall Study|Physician Decision|1|||
126491230|NCT02626520|455096381|FG001|Overall Study|Physician Decision|1|||
126491231|NCT02626520|455096380|FG000|Overall Study|Adverse Event|0|||
126491232|NCT02626520|455096381|FG001|Overall Study|Adverse Event|4|||
126491233|NCT02626520|455096380|FG000|Overall Study|Lack of Efficacy|0|||
126491234|NCT02626520|455096381|FG001|Overall Study|Lack of Efficacy|2|||
126491235|NCT02626520|455096380|FG000|Overall Study|Did not start protocol therapy|0|||
126491236|NCT02626520|455096381|FG001|Overall Study|Did not start protocol therapy|2|||
126491237|NCT02626520|455096380|FG000|Overall Study|Study terminated|0|||
126491238|NCT02626520|455096381|FG001|Overall Study|Study terminated|1|||
126491239|NCT04702997|455096382|FG000|Overall Study|Withdrawal by Subject|1|||
126491240|NCT04702997|455096383|FG001|Overall Study|Withdrawal by Subject|1|||
126491241|NCT03915496|455096384|FG000|Overall Study|Adverse Event|2|||
126491242|NCT03915496|455096385|FG001|Overall Study|Adverse Event|1|||
126491243|NCT03915496|455096386|FG002|Overall Study|Adverse Event|2|||
126491244|NCT02200445|455096389|FG000|Overall Study|Lack of Efficacy|1|||
126491245|NCT02200445|455096390|FG001|Overall Study|Lack of Efficacy|2|||
126491246|NCT02200445|455096391|FG002|Overall Study|Lack of Efficacy|2|||
126491247|NCT02200445|455096389|FG000|Overall Study|Adverse Event|0|||
126491248|NCT02200445|455096390|FG001|Overall Study|Adverse Event|2|||
126491249|NCT02200445|455096391|FG002|Overall Study|Adverse Event|0|||
126491250|NCT01386554|455096395|FG000|Overall Study|Lost to Follow-up|0|||
126491251|NCT01386554|455096396|FG001|Overall Study|Lost to Follow-up|0|||
126491252|NCT01386554|455096397|FG002|Overall Study|Lost to Follow-up|1|||
126491253|NCT01386554|455096395|FG000|Overall Study|Adverse Event|2|||
126491254|NCT01386554|455096396|FG001|Overall Study|Adverse Event|5|||
126491255|NCT01386554|455096397|FG002|Overall Study|Adverse Event|2|||
126491256|NCT01386554|455096395|FG000|Overall Study|Progressive disease|1|||
126491257|NCT01386554|455096396|FG001|Overall Study|Progressive disease|2|||
126491258|NCT01386554|455096397|FG002|Overall Study|Progressive disease|2|||
126491259|NCT01386554|455096395|FG000|Overall Study|Administration of live vaccines|0|||
126491260|NCT01386554|455096396|FG001|Overall Study|Administration of live vaccines|1|||
126491261|NCT01386554|455096397|FG002|Overall Study|Administration of live vaccines|0|||
126491262|NCT01386554|455096395|FG000|Overall Study|Investigator discretion|0|||
126491263|NCT01386554|455096396|FG001|Overall Study|Investigator discretion|0|||
126491264|NCT01386554|455096397|FG002|Overall Study|Investigator discretion|1|||
126491265|NCT01386554|455096395|FG000|Overall Study|Reason not collected|0|||
126491266|NCT01386554|455096396|FG001|Overall Study|Reason not collected|1|||
126491267|NCT01386554|455096397|FG002|Overall Study|Reason not collected|0|||
126491268|NCT03334903|455096398|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
126491269|NCT03334903|455096399|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
126491270|NCT03334903|455096398|FG000|Overall Study|Protocol Violation|1|||
126491271|NCT03334903|455096399|FG001|Overall Study|Protocol Violation|3|||
126491272|NCT03334903|455096398|FG000|Overall Study|Surgery postponed|1|||
126491273|NCT03334903|455096399|FG001|Overall Study|Surgery postponed|0|||
126491274|NCT03334903|455096398|FG000|Overall Study|Adverse Event|1|||
126491275|NCT03334903|455096399|FG001|Overall Study|Adverse Event|1|||
126491276|NCT03334903|455096398|FG000|Overall Study|Withdrawal by Subject|0|||
126491277|NCT03334903|455096399|FG001|Overall Study|Withdrawal by Subject|1|||
126491278|NCT00353262|455096400|FG000|Overall Study|Adverse Event|8|||
126491279|NCT00353262|455096400|FG000|Overall Study|Withdrawal by Subject|2|||
126491280|NCT00353262|455096400|FG000|Overall Study|Insufficient Therapeutic Response|13|||
126491281|NCT00353262|455096400|FG000|Overall Study|Progression|1|||
126491282|NCT00353262|455096400|FG000|Overall Study|Surgery|4|||
126491283|NCT00353262|455096400|FG000|Overall Study|Break from Chemotherapy|1|||
126491284|NCT00001596|455097958|FG000|Overall Study|Death|1|||
126491285|NCT00001596|455097959|FG001|Overall Study|Death|0|||
126491286|NCT00001596|455097958|FG000|Overall Study|Withdrawal by Subject|3|||
126491287|NCT00001596|455097959|FG001|Overall Study|Withdrawal by Subject|1|||
126491288|NCT00001596|455097958|FG000|Overall Study|Study Termination|12|||
126491289|NCT00001596|455097959|FG001|Overall Study|Study Termination|9|||
126491290|NCT00001596|455097958|FG000|Overall Study|Adverse Event|1|||
126491291|NCT00001596|455097959|FG001|Overall Study|Adverse Event|0|||
126491292|NCT00180414|455097965|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
126491293|NCT00180414|455097966|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
126491294|NCT02927080|455097967|FG000|Overall Study|Withdrawal by Subject|0|||
126491295|NCT02927080|455097968|FG001|Overall Study|Withdrawal by Subject|0|||
126491296|NCT02927080|455097969|FG002|Overall Study|Withdrawal by Subject|0|||
126491297|NCT02927080|455097970|FG003|Overall Study|Withdrawal by Subject|0|||
126491298|NCT02927080|455097971|FG004|Overall Study|Withdrawal by Subject|1|||
126723420|NCT02052778|455936095|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723421|NCT02052778|455936096|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723422|NCT02052778|455936097|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126491299|NCT02927080|455097972|FG005|Overall Study|Withdrawal by Subject|0|||
126491300|NCT02927080|455097973|FG006|Overall Study|Withdrawal by Subject|1|||
126491301|NCT02927080|455097974|FG007|Overall Study|Withdrawal by Subject|1|||
126491302|NCT02927080|455097975|FG008|Overall Study|Withdrawal by Subject|0|||
126491303|NCT02927080|455097976|FG009|Overall Study|Withdrawal by Subject|2|||
126491304|NCT02927080|455097967|FG000|Overall Study|Willingness to comply with protocol|0|||
126491305|NCT02927080|455097968|FG001|Overall Study|Willingness to comply with protocol|0|||
126491306|NCT02927080|455097969|FG002|Overall Study|Willingness to comply with protocol|0|||
126491307|NCT02927080|455097970|FG003|Overall Study|Willingness to comply with protocol|0|||
126491308|NCT02927080|455097971|FG004|Overall Study|Willingness to comply with protocol|0|||
126491309|NCT02927080|455097972|FG005|Overall Study|Willingness to comply with protocol|0|||
126491310|NCT02927080|455097973|FG006|Overall Study|Willingness to comply with protocol|0|||
126491311|NCT02927080|455097974|FG007|Overall Study|Willingness to comply with protocol|0|||
126491312|NCT02927080|455097975|FG008|Overall Study|Willingness to comply with protocol|0|||
126491313|NCT02927080|455097976|FG009|Overall Study|Willingness to comply with protocol|1|||
126491314|NCT02927080|455097967|FG000|Overall Study|Study terminated by Sponsor|0|||
126491315|NCT02927080|455097968|FG001|Overall Study|Study terminated by Sponsor|0|||
126491316|NCT02927080|455097969|FG002|Overall Study|Study terminated by Sponsor|0|||
126491317|NCT02927080|455097970|FG003|Overall Study|Study terminated by Sponsor|0|||
126491318|NCT02927080|455097971|FG004|Overall Study|Study terminated by Sponsor|0|||
126491319|NCT02927080|455097972|FG005|Overall Study|Study terminated by Sponsor|0|||
126491320|NCT02927080|455097973|FG006|Overall Study|Study terminated by Sponsor|6|||
126491321|NCT02927080|455097974|FG007|Overall Study|Study terminated by Sponsor|7|||
126491322|NCT02927080|455097975|FG008|Overall Study|Study terminated by Sponsor|2|||
126491323|NCT02927080|455097976|FG009|Overall Study|Study terminated by Sponsor|3|||
126491324|NCT02927080|455097967|FG000|Overall Study|Adverse Event|0|||
126491325|NCT02927080|455097968|FG001|Overall Study|Adverse Event|1|||
126491326|NCT02927080|455097969|FG002|Overall Study|Adverse Event|0|||
126491327|NCT02927080|455097970|FG003|Overall Study|Adverse Event|0|||
126491328|NCT02927080|455097971|FG004|Overall Study|Adverse Event|0|||
126491329|NCT02927080|455097972|FG005|Overall Study|Adverse Event|0|||
126491330|NCT02927080|455097973|FG006|Overall Study|Adverse Event|0|||
126491331|NCT02927080|455097974|FG007|Overall Study|Adverse Event|1|||
126491332|NCT02927080|455097975|FG008|Overall Study|Adverse Event|0|||
126491333|NCT02927080|455097976|FG009|Overall Study|Adverse Event|1|||
126491334|NCT02927080|455097967|FG000|Overall Study|Other|0|||
126491335|NCT02927080|455097968|FG001|Overall Study|Other|0|||
126491336|NCT02927080|455097969|FG002|Overall Study|Other|0|||
126491337|NCT02927080|455097970|FG003|Overall Study|Other|0|||
126491338|NCT02927080|455097971|FG004|Overall Study|Other|0|||
126491339|NCT02927080|455097972|FG005|Overall Study|Other|0|||
126491340|NCT02927080|455097973|FG006|Overall Study|Other|1|||
126491341|NCT02927080|455097974|FG007|Overall Study|Other|0|||
126491342|NCT02927080|455097975|FG008|Overall Study|Other|1|||
126491343|NCT02927080|455097976|FG009|Overall Study|Other|0|||
126491344|NCT01199289|455097977|FG000|Overall Study|Ineligibility determined|2|||
126491345|NCT01199289|455097978|FG001|Overall Study|Ineligibility determined|1|||
126491346|NCT01199289|455097979|FG002|Overall Study|Ineligibility determined|0|||
126491347|NCT01199289|455097980|FG003|Overall Study|Ineligibility determined|0|||
126491348|NCT01199289|455097977|FG000|Overall Study|Protocol Violation|1|||
126491349|NCT01199289|455097978|FG001|Overall Study|Protocol Violation|0|||
126491350|NCT01199289|455097979|FG002|Overall Study|Protocol Violation|0|||
126491351|NCT01199289|455097980|FG003|Overall Study|Protocol Violation|1|||
126491352|NCT01199289|455097977|FG000|Overall Study|Noncompliance|1|||
126491353|NCT01199289|455097978|FG001|Overall Study|Noncompliance|0|||
126491354|NCT01199289|455097979|FG002|Overall Study|Noncompliance|2|||
126491355|NCT01199289|455097980|FG003|Overall Study|Noncompliance|0|||
126491356|NCT01199289|455097977|FG000|Overall Study|Adverse Event|0|||
126491357|NCT01199289|455097978|FG001|Overall Study|Adverse Event|3|||
126491358|NCT01199289|455097979|FG002|Overall Study|Adverse Event|1|||
126491359|NCT01199289|455097980|FG003|Overall Study|Adverse Event|4|||
126559549|NCT02373813|455342537|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
126491360|NCT01199289|455097977|FG000|Overall Study|Full consent withdrawn|2|||
126491361|NCT01199289|455097978|FG001|Overall Study|Full consent withdrawn|2|||
126491362|NCT01199289|455097979|FG002|Overall Study|Full consent withdrawn|2|||
126491363|NCT01199289|455097980|FG003|Overall Study|Full consent withdrawn|3|||
126491364|NCT01199289|455097977|FG000|Overall Study|Administrative decision|0|||
126491365|NCT01199289|455097978|FG001|Overall Study|Administrative decision|0|||
126491366|NCT01199289|455097979|FG002|Overall Study|Administrative decision|0|||
126491367|NCT01199289|455097980|FG003|Overall Study|Administrative decision|1|||
126491368|NCT01199289|455097977|FG000|Overall Study|Lost to Follow-up|0|||
126491369|NCT01199289|455097978|FG001|Overall Study|Lost to Follow-up|0|||
126491370|NCT01199289|455097979|FG002|Overall Study|Lost to Follow-up|0|||
126491371|NCT01199289|455097980|FG003|Overall Study|Lost to Follow-up|1|||
126491372|NCT01199289|455097977|FG000|Overall Study|Protocol-specified criteria|3|||
126491373|NCT01199289|455097978|FG001|Overall Study|Protocol-specified criteria|0|||
126491374|NCT01199289|455097979|FG002|Overall Study|Protocol-specified criteria|0|||
126491375|NCT01199289|455097980|FG003|Overall Study|Protocol-specified criteria|1|||
126491376|NCT01199289|455097977|FG000|Overall Study|Pregnancy|0|||
126491377|NCT01199289|455097978|FG001|Overall Study|Pregnancy|1|||
126491378|NCT01199289|455097979|FG002|Overall Study|Pregnancy|0|||
126491379|NCT01199289|455097980|FG003|Overall Study|Pregnancy|1|||
126491380|NCT00127712|455097985|FG000|Overall Study|Adverse Event|3|||
126491381|NCT00127712|455097986|FG001|Overall Study|Adverse Event|0|||
126491382|NCT00127712|455097985|FG000|Overall Study|Lack of GI access to continue|2|||
126491383|NCT00127712|455097986|FG001|Overall Study|Lack of GI access to continue|0|||
126491384|NCT02642614|455097987|FG000|Overall Study|Adverse Event|1|||
126491385|NCT02642614|455097988|FG001|Overall Study|Adverse Event|1|||
126491386|NCT02642614|455097989|FG002|Overall Study|Adverse Event|2|||
126491387|NCT02642614|455097990|FG003|Overall Study|Adverse Event|2|||
126491388|NCT02642614|455097987|FG000|Overall Study|Lost to Follow-up|1|||
126491389|NCT02642614|455097988|FG001|Overall Study|Lost to Follow-up|0|||
126491390|NCT02642614|455097989|FG002|Overall Study|Lost to Follow-up|0|||
126491391|NCT02642614|455097990|FG003|Overall Study|Lost to Follow-up|0|||
126491392|NCT02642614|455097987|FG000|Overall Study|Withdrawal by Subject|1|||
126491393|NCT02642614|455097988|FG001|Overall Study|Withdrawal by Subject|1|||
126491394|NCT02642614|455097989|FG002|Overall Study|Withdrawal by Subject|0|||
126491395|NCT02642614|455097990|FG003|Overall Study|Withdrawal by Subject|0|||
126491396|NCT02282020|455097996|FG000|Overall Study|Objective Disease Progression|128|||
126491397|NCT02282020|455097997|FG001|Overall Study|Objective Disease Progression|30|||
126491398|NCT02282020|455097996|FG000|Overall Study|Adverse Event|18|||
126491399|NCT02282020|455097997|FG001|Overall Study|Adverse Event|15|||
126491400|NCT02282020|455097996|FG000|Overall Study|Withdrawal by Subject|7|||
126491401|NCT02282020|455097997|FG001|Overall Study|Withdrawal by Subject|10|||
126491402|NCT02282020|455097996|FG000|Overall Study|Miscellaneous|5|||
126491403|NCT02282020|455097997|FG001|Overall Study|Miscellaneous|19|||
126491404|NCT02282020|455097996|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
126491405|NCT02282020|455097997|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
126491406|NCT02282020|455097996|FG000|Overall Study|Developed Discontinuation Criteria|0|||
126491407|NCT02282020|455097997|FG001|Overall Study|Developed Discontinuation Criteria|2|||
126491408|NCT02282020|455097996|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
126491409|NCT02282020|455097997|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
126491410|NCT00759863|455097998|FG000|Overall Study|Death, moved, or lost contact|20|||
126491411|NCT00759863|455097999|FG001|Overall Study|Death, moved, or lost contact|18|||
126491412|NCT00503308|455098003|FG000|Overall Study|Protocol Violation|2|||
126491413|NCT00503308|455098004|FG001|Overall Study|Protocol Violation|1|||
126491414|NCT00311623|455098011|FG000|Overall Study|Physician Decision|0|||
126491415|NCT00311623|455098012|FG001|Overall Study|Physician Decision|0|||
126491416|NCT00311623|455098013|FG002|Overall Study|Physician Decision|2|||
126491417|NCT03998189|455098014|FG000|Overall Study|Lack of Efficacy|0|||
126491418|NCT03998189|455098015|FG001|Overall Study|Lack of Efficacy|1|||
126491419|NCT03227029|455098016|FG000|Overall Study|Child Wheezed (no treatment)|0|||
126491420|NCT03227029|455098017|FG001|Overall Study|Child Wheezed (no treatment)|1|||
126491421|NCT03227029|455098018|FG002|Overall Study|Child Wheezed (no treatment)|0|||
126491422|NCT03227029|455098016|FG000|Overall Study|No post RSV season visit due to COVID|3|||
126491423|NCT03227029|455098017|FG001|Overall Study|No post RSV season visit due to COVID|3|||
126491424|NCT03227029|455098018|FG002|Overall Study|No post RSV season visit due to COVID|2|||
126491425|NCT03227029|455098016|FG000|Overall Study|Not able to get to clinic|0|||
126491426|NCT03227029|455098017|FG001|Overall Study|Not able to get to clinic|0|||
126491427|NCT03227029|455098018|FG002|Overall Study|Not able to get to clinic|1|||
126491428|NCT03227029|455098016|FG000|Overall Study|Withdrawal by Subject|1|||
126491429|NCT03227029|455098017|FG001|Overall Study|Withdrawal by Subject|0|||
126491430|NCT03227029|455098018|FG002|Overall Study|Withdrawal by Subject|0|||
126491431|NCT03227029|455098016|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
126491432|NCT03227029|455098017|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
126491433|NCT03227029|455098018|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
126491434|NCT03414424|455098019|FG000|Overall Study|Screened out after consent|0|||
126491435|NCT03414424|455098020|FG001|Overall Study|Screened out after consent|2|||
126491436|NCT03414424|455098019|FG000|Overall Study|Lost to Follow-up|0|||
126772634|NCT02454972|456123637|FG008|Overall Study|Treatment-related adverse events|0|||
126491437|NCT03414424|455098020|FG001|Overall Study|Lost to Follow-up|1|||
126491438|NCT01949051|455098026|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
126491439|NCT01949051|455098027|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
126491440|NCT01949051|455098028|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
126491441|NCT01949051|455098029|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
126491442|NCT01949051|455098030|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
126491443|NCT01949051|455098031|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
126491444|NCT01949051|455098026|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
126772635|NCT02454972|456123629|FG000|Overall Study|Patient moves to compassionate use|0|||
126491445|NCT01949051|455098027|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126491446|NCT01949051|455098028|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126491447|NCT01949051|455098029|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126491448|NCT01949051|455098030|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126491449|NCT01949051|455098031|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
126491450|NCT01949051|455098026|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
126491451|NCT01949051|455098027|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
126491452|NCT01949051|455098028|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
126491453|NCT01949051|455098029|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
126491454|NCT01949051|455098030|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
126491455|NCT01949051|455098031|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
126491456|NCT01949051|455098026|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
126491457|NCT01949051|455098027|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
126491458|NCT01949051|455098028|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
126491459|NCT01949051|455098029|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
126491460|NCT01949051|455098030|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
126491461|NCT01949051|455098031|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
126491462|NCT01949051|455098026|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
126491463|NCT01949051|455098027|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
126491464|NCT01949051|455098028|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
126491465|NCT01949051|455098029|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
126491466|NCT01949051|455098030|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
126491467|NCT01949051|455098031|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
126491468|NCT01782859|455098033|FG000|Overall Study|Protocol Violation|6|||
126491469|NCT01782859|455098034|FG001|Overall Study|Protocol Violation|6|||
126491470|NCT01782859|455098033|FG000|Overall Study|Withdrawal by Subject|0|||
126491471|NCT01782859|455098034|FG001|Overall Study|Withdrawal by Subject|1|||
126491472|NCT00811473|455098037|FG000|Overall Study|Adverse Event|3|||
126491473|NCT00811473|455098038|FG001|Overall Study|Adverse Event|12|||
126491474|NCT00811473|455098037|FG000|Overall Study|Lost to Follow-up|5|||
126491475|NCT00811473|455098038|FG001|Overall Study|Lost to Follow-up|1|||
126491476|NCT00811473|455098037|FG000|Overall Study|Withdrawal by Subject|2|||
126491477|NCT00811473|455098038|FG001|Overall Study|Withdrawal by Subject|4|||
126491478|NCT00811473|455098037|FG000|Overall Study|Severe non-compliance to protocol|2|||
126491479|NCT00811473|455098038|FG001|Overall Study|Severe non-compliance to protocol|4|||
126491480|NCT00811473|455098037|FG000|Overall Study|Lack of therapeutic response|4|||
126491481|NCT00811473|455098038|FG001|Overall Study|Lack of therapeutic response|1|||
126491482|NCT00811473|455098037|FG000|Overall Study|Condition under investigation worsened|1|||
126491483|NCT00811473|455098038|FG001|Overall Study|Condition under investigation worsened|3|||
126491484|NCT00811473|455098037|FG000|Overall Study|Other 2|4|||
126491485|NCT00811473|455098038|FG001|Overall Study|Other 2|1|||
126491486|NCT00811473|455098037|FG000|Overall Study|Incorrect Enrollment|1|||
126491487|NCT00811473|455098038|FG001|Overall Study|Incorrect Enrollment|0|||
126491488|NCT00811473|455098037|FG000|Overall Study|Safety Reasons|1|||
126491489|NCT00811473|455098038|FG001|Overall Study|Safety Reasons|0|||
126491490|NCT01585194|455098042|FG000|Overall Study|Withdrawal by Subject|1|||
126491491|NCT01585194|455098042|FG000|Overall Study|Physician Decision|2|||
126491492|NCT01585194|455098042|FG000|Overall Study|Lack of insurance|1|||
126491493|NCT00993291|455098043|FG000|Overall Study|Withdrawal by Subject|1|||
126491494|NCT01922089|455098046|FG000|Overall Study|Adverse Event|18|||
126491495|NCT01922089|455098047|FG001|Overall Study|Adverse Event|13|||
126491496|NCT01922089|455098046|FG000|Overall Study|Protocol Deviation|10|||
126491497|NCT01922089|455098047|FG001|Overall Study|Protocol Deviation|7|||
126491498|NCT01922089|455098046|FG000|Overall Study|Withdrawal by Subject|3|||
126491499|NCT01922089|455098047|FG001|Overall Study|Withdrawal by Subject|4|||
126491500|NCT01922089|455098046|FG000|Overall Study|administrative problems|4|||
126491501|NCT01922089|455098047|FG001|Overall Study|administrative problems|1|||
126491502|NCT01922089|455098046|FG000|Overall Study|Physician Decision|2|||
126491503|NCT01922089|455098047|FG001|Overall Study|Physician Decision|3|||
126491504|NCT01922089|455098046|FG000|Overall Study|Death|2|||
126491505|NCT01922089|455098047|FG001|Overall Study|Death|1|||
126491506|NCT01922089|455098046|FG000|Overall Study|Lost to Follow-up|0|||
126491507|NCT01922089|455098047|FG001|Overall Study|Lost to Follow-up|1|||
126491508|NCT04903626|455098051|FG000|Overall Study|Lost to Follow-up|6|||
126491509|NCT04903626|455098051|FG000|Overall Study|Withdrawal by Subject|1|||
126491510|NCT04903626|455098051|FG000|Overall Study|Other, Not Specified|1|||
126491511|NCT00573534|455098052|FG000|Overall Study|oppositional behavior|3|||
126491512|NCT01129960|455098066|FG000|Overall Study|Withdrawal by Subject|3|||
126491513|NCT01129960|455098067|FG001|Overall Study|Withdrawal by Subject|0|||
126723423|NCT02052778|455936098|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126491514|NCT01129960|455098068|FG002|Overall Study|Withdrawal by Subject|3|||
126491515|NCT01129960|455098069|FG003|Overall Study|Withdrawal by Subject|2|||
126491516|NCT01129960|455098066|FG000|Overall Study|Lack of Efficacy|1|||
126491517|NCT01129960|455098067|FG001|Overall Study|Lack of Efficacy|1|||
126491518|NCT01129960|455098068|FG002|Overall Study|Lack of Efficacy|1|||
126559550|NCT02373813|455342538|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
126559551|NCT02373813|455342535|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126559552|NCT02373813|455342536|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
126772636|NCT02454972|456123630|FG001|Overall Study|Patient moves to compassionate use|0|||
126491519|NCT01129960|455098069|FG003|Overall Study|Lack of Efficacy|1|||
126491520|NCT01129960|455098066|FG000|Overall Study|Adverse Event|23|||
126491521|NCT01129960|455098067|FG001|Overall Study|Adverse Event|16|||
126491522|NCT01129960|455098068|FG002|Overall Study|Adverse Event|16|||
126491523|NCT01129960|455098069|FG003|Overall Study|Adverse Event|7|||
126491524|NCT01129960|455098066|FG000|Overall Study|Protocol Violation|1|||
126491525|NCT01129960|455098067|FG001|Overall Study|Protocol Violation|2|||
126491526|NCT01129960|455098068|FG002|Overall Study|Protocol Violation|3|||
126491527|NCT01129960|455098069|FG003|Overall Study|Protocol Violation|0|||
126491528|NCT01129960|455098066|FG000|Overall Study|Lost to Follow-up|0|||
126491529|NCT01129960|455098067|FG001|Overall Study|Lost to Follow-up|2|||
126491530|NCT01129960|455098068|FG002|Overall Study|Lost to Follow-up|3|||
126491531|NCT01129960|455098069|FG003|Overall Study|Lost to Follow-up|3|||
126491532|NCT01129960|455098066|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
126491533|NCT01129960|455098067|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
126491534|NCT01129960|455098068|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
126491535|NCT01129960|455098069|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
126491536|NCT01129960|455098066|FG000|Overall Study|Physician Decision|1|||
126491537|NCT01129960|455098067|FG001|Overall Study|Physician Decision|0|||
126491538|NCT01129960|455098068|FG002|Overall Study|Physician Decision|0|||
126491539|NCT01129960|455098069|FG003|Overall Study|Physician Decision|0|||
126491540|NCT01129960|455098066|FG000|Overall Study|Pregnancy|1|||
126491541|NCT01129960|455098067|FG001|Overall Study|Pregnancy|0|||
126491542|NCT01129960|455098068|FG002|Overall Study|Pregnancy|0|||
126491543|NCT01129960|455098069|FG003|Overall Study|Pregnancy|0|||
126491544|NCT00165776|455098070|FG000|Overall Study|Lack of Efficacy|0|||
126491545|NCT00165776|455098071|FG001|Overall Study|Lack of Efficacy|0|||
126491546|NCT00165776|455098072|FG002|Overall Study|Lack of Efficacy|0|||
126491547|NCT00165776|455098073|FG003|Overall Study|Lack of Efficacy|1|||
126491548|NCT00165776|455098070|FG000|Overall Study|Withdrawal by Subject|4|||
126491549|NCT00165776|455098071|FG001|Overall Study|Withdrawal by Subject|1|||
126491550|NCT00165776|455098072|FG002|Overall Study|Withdrawal by Subject|2|||
126491551|NCT00165776|455098073|FG003|Overall Study|Withdrawal by Subject|0|||
126491552|NCT00165776|455098070|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
126491553|NCT00165776|455098071|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
126491554|NCT00165776|455098072|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
126491555|NCT00165776|455098073|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
126491556|NCT02622321|455098076|FG000|Overall Study|Withdrawal by Subject|2|||
126491557|NCT02622321|455098077|FG001|Overall Study|Withdrawal by Subject|0|||
126491558|NCT02622321|455098078|FG002|Overall Study|Withdrawal by Subject|0|||
126491559|NCT02622321|455098079|FG003|Overall Study|Withdrawal by Subject|0|||
126491560|NCT02622321|455098076|FG000|Overall Study|Death|0|||
126491561|NCT02622321|455098077|FG001|Overall Study|Death|0|||
126491562|NCT02622321|455098078|FG002|Overall Study|Death|1|||
126491563|NCT02622321|455098079|FG003|Overall Study|Death|0|||
126491564|NCT02622321|455098076|FG000|Overall Study|Physician Decision|1|||
126491565|NCT02622321|455098077|FG001|Overall Study|Physician Decision|0|||
126491566|NCT02622321|455098078|FG002|Overall Study|Physician Decision|0|||
126491567|NCT02622321|455098079|FG003|Overall Study|Physician Decision|0|||
126491568|NCT00241280|455098081|FG000|Overall Study|Adverse Event|2|||
126491569|NCT00241280|455098082|FG001|Overall Study|Adverse Event|6|||
126491570|NCT00241280|455098081|FG000|Overall Study|Discomfort|11|||
126491571|NCT00241280|455098082|FG001|Overall Study|Discomfort|16|||
126491572|NCT00241280|455098081|FG000|Overall Study|Pregnancy|1|||
126491573|NCT00241280|455098082|FG001|Overall Study|Pregnancy|5|||
126491574|NCT00241280|455098081|FG000|Overall Study|Lost to Follow-up|5|||
126491575|NCT00241280|455098082|FG001|Overall Study|Lost to Follow-up|8|||
126491576|NCT00241280|455098081|FG000|Overall Study|Withdrawal by Subject|7|||
126491577|NCT00241280|455098082|FG001|Overall Study|Withdrawal by Subject|4|||
126491578|NCT00241280|455098081|FG000|Overall Study|Protocol Violation|4|||
126491579|NCT00241280|455098082|FG001|Overall Study|Protocol Violation|10|||
126491580|NCT00241280|455098081|FG000|Overall Study|Relocation|4|||
126491581|NCT00241280|455098082|FG001|Overall Study|Relocation|4|||
126491582|NCT00241280|455098081|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
126491583|NCT00241280|455098082|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
126491584|NCT00241280|455098081|FG000|Overall Study|Unsatisfactory Visual Response|1|||
126491585|NCT00241280|455098082|FG001|Overall Study|Unsatisfactory Visual Response|1|||
126491586|NCT00241280|455098081|FG000|Overall Study|Diabetic|1|||
126491587|NCT00241280|455098082|FG001|Overall Study|Diabetic|0|||
126491588|NCT00241280|455098081|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
126491589|NCT00241280|455098082|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
126491590|NCT00241280|455098081|FG000|Overall Study|Dispensed incorrect test article|1|||
126491591|NCT00241280|455098082|FG001|Overall Study|Dispensed incorrect test article|2|||
126491592|NCT00241280|455098081|FG000|Overall Study|Unacceptable Fit|0|||
126491593|NCT00241280|455098082|FG001|Overall Study|Unacceptable Fit|1|||
126491594|NCT00241280|455098081|FG000|Overall Study|Scheduling Conflict|0|||
126491595|NCT00241280|455098082|FG001|Overall Study|Scheduling Conflict|2|||
126491596|NCT00241280|455098081|FG000|Overall Study|History of Ocular Surgery|0|||
126491597|NCT00241280|455098082|FG001|Overall Study|History of Ocular Surgery|1|||
126491598|NCT00241280|455098081|FG000|Overall Study|Coating on Lens|1|||
126491599|NCT00241280|455098082|FG001|Overall Study|Coating on Lens|0|||
126491600|NCT00241280|455098081|FG000|Overall Study|Excessive Dryness|0|||
126491601|NCT00241280|455098082|FG001|Overall Study|Excessive Dryness|1|||
126491602|NCT00965718|455098083|FG000|Overall Study|Withdrawal by Subject|4|||
126491603|NCT01958008|455098085|FG000|Overall Study|Worsening of disease under study|0|||
126491604|NCT01958008|455098086|FG001|Overall Study|Worsening of disease under study|0|||
126491605|NCT01958008|455098087|FG002|Overall Study|Worsening of disease under study|1|||
126491606|NCT01958008|455098088|FG003|Overall Study|Worsening of disease under study|0|||
126491607|NCT01958008|455098085|FG000|Overall Study|Other adverse event|1|||
126491608|NCT01958008|455098086|FG001|Overall Study|Other adverse event|0|||
126491609|NCT01958008|455098087|FG002|Overall Study|Other adverse event|0|||
126491610|NCT01958008|455098088|FG003|Overall Study|Other adverse event|0|||
126491611|NCT01634360|455098089|FG000|Overall Study|Adverse Event|10|||
126491612|NCT01634360|455098090|FG001|Overall Study|Adverse Event|34|||
126491613|NCT01634360|455098089|FG000|Overall Study|subject withdrew consent|13|||
126491614|NCT01634360|455098090|FG001|Overall Study|subject withdrew consent|23|||
126491615|NCT01634360|455098089|FG000|Overall Study|Protocol Violation|1|||
126491616|NCT01634360|455098090|FG001|Overall Study|Protocol Violation|1|||
126491617|NCT01634360|455098089|FG000|Overall Study|Lack of Efficacy|4|||
126491618|NCT01634360|455098090|FG001|Overall Study|Lack of Efficacy|14|||
126491619|NCT01634360|455098089|FG000|Overall Study|Other|3|||
126491620|NCT01634360|455098090|FG001|Overall Study|Other|20|||
126491621|NCT01634360|455098089|FG000|Overall Study|Study termination by sponsor|18|||
126491622|NCT01634360|455098090|FG001|Overall Study|Study termination by sponsor|44|||
126491623|NCT02028065|455098091|FG000|Randomization Through Start Treatment|Not treated|1|||
126491624|NCT02028065|455098092|FG001|Randomization Through Start Treatment|Not treated|3|||
126491625|NCT02028065|455098093|FG002|Randomization Through Start Treatment|Not treated|3|||
126491626|NCT02028065|455098091|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
126491627|NCT02028065|455098092|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
126491628|NCT02028065|455098093|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
126491629|NCT02028065|455098091|FG000|Treatment Through Study Completion|Physician Decision|1|||
126491630|NCT02028065|455098092|FG001|Treatment Through Study Completion|Physician Decision|0|||
126491631|NCT02028065|455098093|FG002|Treatment Through Study Completion|Physician Decision|0|||
126491632|NCT02028065|455098091|FG000|Treatment Through Study Completion|Protocol Violation|1|||
126491633|NCT02028065|455098092|FG001|Treatment Through Study Completion|Protocol Violation|4|||
126491634|NCT02028065|455098093|FG002|Treatment Through Study Completion|Protocol Violation|0|||
126491635|NCT02028065|455098091|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
126491636|NCT02028065|455098092|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
126491637|NCT02028065|455098093|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
126491638|NCT02028065|455098091|FG000|Treatment Through Study Completion|Adverse Event|3|||
126491639|NCT02028065|455098092|FG001|Treatment Through Study Completion|Adverse Event|3|||
126491640|NCT02028065|455098093|FG002|Treatment Through Study Completion|Adverse Event|5|||
126491641|NCT01414855|455098096|FG000|Overall Study|Death|17|||
126491642|NCT01414855|455098096|FG000|Overall Study|Lost to Follow-up|5|||
126491643|NCT01414855|455098096|FG000|Overall Study|Withdrawal by Subject|7|||
126491644|NCT04851314|455098100|FG000|Overall Study|Unable to complete research set-up procedures|0|||
126491645|NCT04851314|455098101|FG001|Overall Study|Unable to complete research set-up procedures|2|||
126491646|NCT04851314|455098100|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
126491647|NCT04851314|455098101|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
126491648|NCT00877383|455098102|FG000|Overall Study|Adverse Event|13|||
126491649|NCT00877383|455098103|FG001|Overall Study|Adverse Event|14|||
126491650|NCT00877383|455098102|FG000|Overall Study|Lost to Follow-up|5|||
126491651|NCT00877383|455098103|FG001|Overall Study|Lost to Follow-up|3|||
126491652|NCT00877383|455098102|FG000|Overall Study|Subject withdrew consent|3|||
126491653|NCT00877383|455098103|FG001|Overall Study|Subject withdrew consent|12|||
126491654|NCT00877383|455098102|FG000|Overall Study|Subject no longer requires study drug|2|||
126491655|NCT00877383|455098103|FG001|Overall Study|Subject no longer requires study drug|0|||
126491656|NCT00877383|455098102|FG000|Overall Study|Administrative problems|2|||
126491657|NCT00877383|455098103|FG001|Overall Study|Administrative problems|0|||
126491658|NCT00877383|455098102|FG000|Overall Study|Protocol deviation|2|||
126491659|NCT00877383|455098103|FG001|Overall Study|Protocol deviation|6|||
126491660|NCT00877383|455098102|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126491661|NCT00877383|455098103|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126491662|NCT00877383|455098102|FG000|Overall Study|Death|1|||
126491663|NCT00877383|455098103|FG001|Overall Study|Death|2|||
126491664|NCT02107482|455098104|FG000|Overall Study|inconveinence|2|||
126491665|NCT02107482|455098104|FG000|Overall Study|Lost to Follow-up|1|||
126491666|NCT02107482|455098104|FG000|Overall Study|Lack of Efficacy|1|||
126491667|NCT04868890|455098111|FG000|Overall Study|Death|2|||
126491668|NCT04868890|455098112|FG001|Overall Study|Death|1|||
126491669|NCT04868890|455098111|FG000|Overall Study|Withdrawal by Subject|1|||
126772637|NCT02454972|456123631|FG002|Overall Study|Patient moves to compassionate use|0|||
126491670|NCT04868890|455098112|FG001|Overall Study|Withdrawal by Subject|5|||
126491671|NCT00867009|455098113|FG000|Induction Period|Nonserious Adverse Event|5|||
126491672|NCT00867009|455098113|FG000|Induction Period|Serious Adverse Event|10|||
126491673|NCT00867009|455098113|FG000|Induction Period|Death due to serious adverse event|6|||
126491674|NCT00867009|455098113|FG000|Induction Period|Death due to Study Disease|4|||
126491675|NCT00867009|455098113|FG000|Induction Period|Protocol Violation|1|||
126491676|NCT00867009|455098113|FG000|Induction Period|Withdrawal by Subject|8|||
126491677|NCT00867009|455098113|FG000|Induction Period|Physician Decision|3|||
126491678|NCT00867009|455098113|FG000|Induction Period|Progressive Disease (PD)|25|||
126491679|NCT00867009|455098113|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
126491680|NCT01850524|455098118|FG000|Overall Study|Lost to Follow-up|5|||
126491681|NCT01850524|455098119|FG001|Overall Study|Lost to Follow-up|10|||
126491682|NCT01850524|455098118|FG000|Overall Study|Withdrawal by Subject|24|||
126491683|NCT01850524|455098119|FG001|Overall Study|Withdrawal by Subject|22|||
126491684|NCT01850524|455098118|FG000|Overall Study|Reason not Specified|142|||
126491685|NCT01850524|455098119|FG001|Overall Study|Reason not Specified|141|||
126491686|NCT00368355|455098120|FG000|Overall Study|Adverse Event|1|||
126491687|NCT00368355|455098121|FG001|Overall Study|Adverse Event|0|||
126491688|NCT00368355|455098120|FG000|Overall Study|Death|2|||
126491689|NCT00368355|455098121|FG001|Overall Study|Death|4|||
126491690|NCT00368355|455098120|FG000|Overall Study|Relapse|6|||
126491691|NCT00368355|455098121|FG001|Overall Study|Relapse|10|||
126491692|NCT00368355|455098120|FG000|Overall Study|Subsequent transplant|0|||
126491693|NCT00368355|455098121|FG001|Overall Study|Subsequent transplant|3|||
126491694|NCT00368355|455098120|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
126491695|NCT00368355|455098121|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
126491696|NCT03358290|455098123|FG000|Overall Study|Study discontinued by Sponsor|0|||
126491697|NCT03358290|455098124|FG001|Overall Study|Study discontinued by Sponsor|1|||
126491698|NCT03358290|455098125|FG002|Overall Study|Study discontinued by Sponsor|1|||
126491699|NCT03358290|455098126|FG003|Overall Study|Study discontinued by Sponsor|0|||
126491700|NCT03358290|455098127|FG004|Overall Study|Study discontinued by Sponsor|0|||
126491701|NCT03358290|455098123|FG000|Overall Study|Adverse Event|0|||
126491702|NCT03358290|455098124|FG001|Overall Study|Adverse Event|0|||
126491703|NCT03358290|455098125|FG002|Overall Study|Adverse Event|1|||
126491704|NCT03358290|455098126|FG003|Overall Study|Adverse Event|2|||
126491705|NCT03358290|455098127|FG004|Overall Study|Adverse Event|0|||
126491706|NCT03358290|455098123|FG000|Overall Study|Withdrawal by Subject|0|||
126491707|NCT03358290|455098124|FG001|Overall Study|Withdrawal by Subject|0|||
126491708|NCT03358290|455098125|FG002|Overall Study|Withdrawal by Subject|0|||
126491709|NCT03358290|455098126|FG003|Overall Study|Withdrawal by Subject|0|||
126491710|NCT03358290|455098127|FG004|Overall Study|Withdrawal by Subject|1|||
126491711|NCT01339429|455098135|FG000|Overall Study|Withdrawal by Subject|1|||
126491712|NCT01339429|455098135|FG000|Overall Study|Physician Decision|3|||
126491713|NCT01085591|455098136|FG000|Overall Study|Adverse Event|0|||
126491714|NCT01085591|455098137|FG001|Overall Study|Adverse Event|1|||
126491715|NCT01085591|455098138|FG002|Overall Study|Adverse Event|3|||
126491716|NCT01085591|455098136|FG000|Overall Study|Physician Decision|1|||
126491717|NCT01085591|455098137|FG001|Overall Study|Physician Decision|0|||
126491718|NCT01085591|455098138|FG002|Overall Study|Physician Decision|1|||
126491719|NCT01085591|455098136|FG000|Overall Study|Withdrawal by Subject|0|||
126491720|NCT01085591|455098137|FG001|Overall Study|Withdrawal by Subject|2|||
126491721|NCT01085591|455098138|FG002|Overall Study|Withdrawal by Subject|1|||
126491722|NCT01085591|455098136|FG000|Overall Study|Lost to Follow-up|0|||
126491723|NCT01085591|455098137|FG001|Overall Study|Lost to Follow-up|1|||
126491724|NCT01085591|455098138|FG002|Overall Study|Lost to Follow-up|1|||
126491725|NCT01085591|455098136|FG000|Overall Study|Protocol Violation|1|||
126491726|NCT01085591|455098137|FG001|Overall Study|Protocol Violation|1|||
126491727|NCT01085591|455098138|FG002|Overall Study|Protocol Violation|1|||
126491728|NCT01085591|455098136|FG000|Overall Study|Other|0|||
126491729|NCT01085591|455098137|FG001|Overall Study|Other|1|||
126491730|NCT01085591|455098138|FG002|Overall Study|Other|0|||
126491731|NCT01085591|455098136|FG000|Overall Study|Not Properly Consented|1|||
126491732|NCT01085591|455098137|FG001|Overall Study|Not Properly Consented|0|||
126491733|NCT01085591|455098138|FG002|Overall Study|Not Properly Consented|0|||
126491734|NCT00556712|455098139|FG000|Overall Study|Adverse Event|7|||
126491735|NCT00556712|455098140|FG001|Overall Study|Adverse Event|19|||
126491736|NCT00556712|455098139|FG000|Overall Study|Death|5|||
126491737|NCT00556712|455098140|FG001|Overall Study|Death|10|||
126491738|NCT00556712|455098139|FG000|Overall Study|Progressive Disease|383|||
126491739|NCT00556712|455098140|FG001|Overall Study|Progressive Disease|320|||
126491740|NCT00556712|455098139|FG000|Overall Study|Protocol Violation|3|||
126491741|NCT00556712|455098140|FG001|Overall Study|Protocol Violation|2|||
126491742|NCT00556712|455098139|FG000|Overall Study|Refused Treatment|17|||
126491743|NCT00556712|455098140|FG001|Overall Study|Refused Treatment|16|||
126491744|NCT00556712|455098139|FG000|Overall Study|Failure to Return|2|||
126491745|NCT00556712|455098140|FG001|Overall Study|Failure to Return|3|||
126491746|NCT00556712|455098139|FG000|Overall Study|Other|2|||
126491747|NCT00556712|455098140|FG001|Overall Study|Other|2|||
126491748|NCT00556712|455098139|FG000|Overall Study|Ongoing at Data Cutoff|32|||
126491749|NCT00556712|455098140|FG001|Overall Study|Ongoing at Data Cutoff|66|||
126491750|NCT00463346|455099927|FG000|Overall Study|Withdrawal by Subject|3|||
126491751|NCT00463346|455099928|FG001|Overall Study|Withdrawal by Subject|3|||
126491752|NCT00501293|455099929|FG000|Optimization Period|Enrolled in error|1|||
126491753|NCT00501293|455099930|FG001|Optimization Period|Enrolled in error|0|||
126491754|NCT00501293|455099929|FG000|Maintenance Period|Withdrawal by Subject|14|||
126491755|NCT00501293|455099930|FG001|Maintenance Period|Withdrawal by Subject|13|||
126491756|NCT00501293|455099929|FG000|Maintenance Period|Lost to Follow-up|12|||
126491757|NCT00501293|455099930|FG001|Maintenance Period|Lost to Follow-up|7|||
126491758|NCT00501293|455099929|FG000|Maintenance Period|Adverse Event|6|||
126491759|NCT00501293|455099930|FG001|Maintenance Period|Adverse Event|6|||
126491760|NCT00501293|455099929|FG000|Maintenance Period|Protocol Violation|2|||
126491761|NCT00501293|455099930|FG001|Maintenance Period|Protocol Violation|1|||
126491762|NCT00501293|455099929|FG000|Maintenance Period|Lack of Efficacy|4|||
126491763|NCT00501293|455099930|FG001|Maintenance Period|Lack of Efficacy|1|||
126491764|NCT00501293|455099929|FG000|Maintenance Period|Noncompliant with study medication|5|||
126491765|NCT00501293|455099930|FG001|Maintenance Period|Noncompliant with study medication|0|||
126491766|NCT00501293|455099929|FG000|Maintenance Period|Went into rehabilitation|1|||
126491767|NCT00501293|455099930|FG001|Maintenance Period|Went into rehabilitation|0|||
126491768|NCT00501293|455099929|FG000|Maintenance Period|Would not wear patch|1|||
126491769|NCT00501293|455099930|FG001|Maintenance Period|Would not wear patch|0|||
126491770|NCT00501293|455099929|FG000|Maintenance Period|Application site reaction|1|||
126491771|NCT00501293|455099930|FG001|Maintenance Period|Application site reaction|0|||
126491772|NCT04067544|455099931|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
126491773|NCT00967798|455099932|FG000|Overall Study|Withdrawal by Subject|5|||
126491774|NCT00967798|455099933|FG001|Overall Study|Withdrawal by Subject|2|||
126491775|NCT00967798|455099932|FG000|Overall Study|Lost to Follow-up|4|||
126491776|NCT00967798|455099933|FG001|Overall Study|Lost to Follow-up|1|||
126491777|NCT01320085|455099934|FG000|Overall Study|Disease Progression|26|||
126491778|NCT01320085|455099935|FG001|Overall Study|Disease Progression|93|||
126491779|NCT01320085|455099936|FG002|Overall Study|Disease Progression|17|||
126491780|NCT01320085|455099934|FG000|Overall Study|Adverse Event|12|||
126491781|NCT01320085|455099935|FG001|Overall Study|Adverse Event|20|||
126491782|NCT01320085|455099936|FG002|Overall Study|Adverse Event|5|||
126491783|NCT01320085|455099934|FG000|Overall Study|Withdrawal by Subject|2|||
126491784|NCT01320085|455099935|FG001|Overall Study|Withdrawal by Subject|4|||
126491785|NCT01320085|455099936|FG002|Overall Study|Withdrawal by Subject|1|||
126491786|NCT01320085|455099934|FG000|Overall Study|Protocol Deviation|1|||
126491787|NCT01320085|455099935|FG001|Overall Study|Protocol Deviation|0|||
126491788|NCT01320085|455099936|FG002|Overall Study|Protocol Deviation|1|||
126491789|NCT01320085|455099934|FG000|Overall Study|Administrative problems|0|||
126491790|NCT01320085|455099935|FG001|Overall Study|Administrative problems|0|||
126491791|NCT01320085|455099936|FG002|Overall Study|Administrative problems|1|||
126491792|NCT03316131|455099937|FG000|Treatment Period 2|Protocol deviation|1|||
126491793|NCT03316131|455099938|FG001|Treatment Period 2|Protocol deviation|0|||
126491794|NCT00082355|455099941|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
126491795|NCT00082355|455099941|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
126491796|NCT00082355|455099941|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
126491797|NCT00708162|455099949|FG000|Randomized Phase|Randomized but Not Treated|7|||
126491798|NCT00708162|455099950|FG001|Randomized Phase|Randomized but Not Treated|5|||
126491799|NCT00708162|455099949|FG000|Randomized Phase|Participant Noncompliance|40|||
126491800|NCT00708162|455099950|FG001|Randomized Phase|Participant Noncompliance|32|||
126491801|NCT00708162|455099949|FG000|Randomized Phase|Lost to Follow-up|34|||
126491802|NCT00708162|455099950|FG001|Randomized Phase|Lost to Follow-up|34|||
126491803|NCT00708162|455099949|FG000|Randomized Phase|Withdrew Consent|31|||
126491804|NCT00708162|455099950|FG001|Randomized Phase|Withdrew Consent|22|||
126491805|NCT00708162|455099949|FG000|Randomized Phase|Lack of Efficacy|14|||
126491806|NCT00708162|455099950|FG001|Randomized Phase|Lack of Efficacy|19|||
126491807|NCT00708162|455099949|FG000|Randomized Phase|Protocol Violation|10|||
126491808|NCT00708162|455099950|FG001|Randomized Phase|Protocol Violation|11|||
126491809|NCT00708162|455099949|FG000|Randomized Phase|Adverse Event|8|||
126491810|NCT00708162|455099950|FG001|Randomized Phase|Adverse Event|12|||
126491811|NCT00708162|455099949|FG000|Randomized Phase|Investigator's Discretion|7|||
126491812|NCT00708162|455099950|FG001|Randomized Phase|Investigator's Discretion|10|||
126491813|NCT00708162|455099949|FG000|Randomized Phase|Death|2|||
126491814|NCT00708162|455099950|FG001|Randomized Phase|Death|9|||
126491815|NCT00708162|455099949|FG000|Randomized Phase|Pregnancy|3|||
126491816|NCT00708162|455099950|FG001|Randomized Phase|Pregnancy|0|||
126491817|NCT00708162|455099949|FG000|Open-Label Phase|Lost to Follow-up|10|||
126491818|NCT00708162|455099950|FG001|Open-Label Phase|Lost to Follow-up|8|||
126491819|NCT00708162|455099949|FG000|Open-Label Phase|Withdrew Consent|12|||
126491820|NCT00708162|455099950|FG001|Open-Label Phase|Withdrew Consent|6|||
126491821|NCT00708162|455099949|FG000|Open-Label Phase|Participant Noncompliance|7|||
126491822|NCT00708162|455099950|FG001|Open-Label Phase|Participant Noncompliance|7|||
126491823|NCT00708162|455099949|FG000|Open-Label Phase|Lack of Efficacy|7|||
126491824|NCT00708162|455099950|FG001|Open-Label Phase|Lack of Efficacy|4|||
126491825|NCT00708162|455099949|FG000|Open-Label Phase|Investigator's Discretion|3|||
126491826|NCT00708162|455099950|FG001|Open-Label Phase|Investigator's Discretion|2|||
126491827|NCT00708162|455099949|FG000|Open-Label Phase|Death|3|||
126491828|NCT00708162|455099950|FG001|Open-Label Phase|Death|1|||
126491829|NCT00708162|455099949|FG000|Open-Label Phase|Adverse Event|1|||
126491830|NCT00708162|455099950|FG001|Open-Label Phase|Adverse Event|2|||
126491831|NCT00708162|455099949|FG000|Open-Label Phase|Other|1|||
126491832|NCT00708162|455099950|FG001|Open-Label Phase|Other|0|||
126491833|NCT00708643|455099951|FG000|Overall Study|Adverse Event|0|||
126491834|NCT00708643|455099952|FG001|Overall Study|Adverse Event|1|||
126491835|NCT00503009|455099953|FG000|Overall Study|Protocol Violation|1|||
126491836|NCT00503009|455099954|FG001|Overall Study|Protocol Violation|0|||
126491837|NCT00503009|455099955|FG002|Overall Study|Protocol Violation|1|||
126491838|NCT00503009|455099953|FG000|Overall Study|Withdrawal by Subject|0|||
126491839|NCT00503009|455099954|FG001|Overall Study|Withdrawal by Subject|1|||
126491840|NCT00503009|455099955|FG002|Overall Study|Withdrawal by Subject|1|||
126491841|NCT00503009|455099953|FG000|Overall Study|Physician Decision|0|||
126491842|NCT00503009|455099954|FG001|Overall Study|Physician Decision|1|||
126491843|NCT00503009|455099955|FG002|Overall Study|Physician Decision|1|||
126491844|NCT01349803|455099956|FG000|Overall Study|Adverse Event|0|||
126491845|NCT01349803|455099957|FG001|Overall Study|Adverse Event|0|||
126491846|NCT01349803|455099958|FG002|Overall Study|Adverse Event|0|||
126491847|NCT01349803|455099959|FG003|Overall Study|Adverse Event|2|||
126491848|NCT01349803|455099956|FG000|Overall Study|Withdrawal by Subject|1|||
126491849|NCT01349803|455099957|FG001|Overall Study|Withdrawal by Subject|0|||
126491850|NCT01349803|455099958|FG002|Overall Study|Withdrawal by Subject|0|||
126491851|NCT01349803|455099959|FG003|Overall Study|Withdrawal by Subject|0|||
126491852|NCT01349803|455099956|FG000|Overall Study|Protocol-specified criteria|0|||
126491853|NCT01349803|455099957|FG001|Overall Study|Protocol-specified criteria|1|||
126491854|NCT01349803|455099958|FG002|Overall Study|Protocol-specified criteria|3|||
126491855|NCT01349803|455099959|FG003|Overall Study|Protocol-specified criteria|0|||
126491856|NCT01710033|455099960|FG000|Stage 2|Adverse Event|0|||
126491857|NCT01710033|455099961|FG001|Stage 2|Adverse Event|0|||
126491858|NCT01710033|455099962|FG002|Stage 2|Adverse Event|0|||
126491859|NCT01710033|455099963|FG003|Stage 2|Adverse Event|0|||
126491860|NCT01710033|455099964|FG004|Stage 2|Adverse Event|1|||
126491861|NCT00100815|455099965|FG000|Overall Study|Progression|24|||
126491862|NCT00100815|455099965|FG000|Overall Study|Adverse Event|18|||
126491863|NCT00100815|455099965|FG000|Overall Study|Death|4|||
126491864|NCT00100815|455099965|FG000|Overall Study|Other|3|||
126491865|NCT01647282|455099967|FG000|Overall Study|Physician Decision|7|||
126491866|NCT01647282|455099968|FG001|Overall Study|Physician Decision|5|||
126491867|NCT01244906|455099970|FG000|Overall Study|Death|2|||
126491868|NCT01244906|455099970|FG000|Overall Study|Progression of disease post treatment|6|||
126491869|NCT03720470|455099975|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
126491870|NCT03720470|455099976|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
126491871|NCT03720470|455099977|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
126491872|NCT03720470|455099978|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
126491873|NCT03720470|455099979|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
126491874|NCT03720470|455099980|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
126491875|NCT03720470|455099975|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
126491876|NCT03720470|455099976|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
126491877|NCT03720470|455099977|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
126491878|NCT03720470|455099978|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
126491879|NCT03720470|455099979|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
126491880|NCT03720470|455099980|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
126491881|NCT03720470|455099975|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
126491882|NCT03720470|455099976|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
126491883|NCT03720470|455099977|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
126491884|NCT03720470|455099978|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
126491885|NCT03720470|455099979|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
126491886|NCT03720470|455099980|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
126491887|NCT03720470|455099975|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
126491888|NCT03720470|455099976|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
126491889|NCT03720470|455099977|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
126491890|NCT03720470|455099978|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
126491891|NCT03720470|455099979|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
126491892|NCT03720470|455099980|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
126491893|NCT03720470|455099975|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
126491894|NCT03720470|455099976|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
126491895|NCT03720470|455099977|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
126491896|NCT03720470|455099978|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
126491897|NCT03720470|455099979|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
126491898|NCT03720470|455099980|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
126491899|NCT03720470|455099975|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
126491900|NCT03720470|455099976|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
126491901|NCT03720470|455099977|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
126491902|NCT03720470|455099978|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
126491903|NCT03720470|455099979|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
126491904|NCT03720470|455099980|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
126491905|NCT03720470|455099975|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
126491906|NCT03720470|455099976|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
126491907|NCT03720470|455099977|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
126491908|NCT03720470|455099978|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
126491909|NCT03720470|455099979|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
126491910|NCT03720470|455099980|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
126491911|NCT03720470|455099975|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
126491912|NCT03720470|455099976|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
126491913|NCT03720470|455099977|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
126491914|NCT03720470|455099978|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
126491915|NCT03720470|455099979|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
126491916|NCT03720470|455099980|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
126491917|NCT03720470|455099975|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
126491918|NCT03720470|455099976|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
126491919|NCT03720470|455099977|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
126491920|NCT03720470|455099978|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
126491921|NCT03720470|455099979|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
126491922|NCT03720470|455099980|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
126491923|NCT03720470|455099975|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
126491924|NCT03720470|455099976|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
126491925|NCT03720470|455099977|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
126491926|NCT03720470|455099978|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
126491927|NCT03720470|455099979|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
126491928|NCT03720470|455099980|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
126491929|NCT03720470|455099975|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
126491930|NCT03720470|455099976|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
126491931|NCT03720470|455099977|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
126491932|NCT03720470|455099978|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
126491933|NCT03720470|455099979|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
126491934|NCT03720470|455099980|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
126491935|NCT03720470|455099975|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
126491936|NCT03720470|455099976|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
126491937|NCT03720470|455099977|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
126491938|NCT03720470|455099978|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
126491939|NCT03720470|455099979|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
126491940|NCT03720470|455099980|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
126491941|NCT03720470|455099975|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
126491942|NCT03720470|455099976|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
126491943|NCT03720470|455099977|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
126491944|NCT03720470|455099978|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
126491945|NCT03720470|455099979|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
126491946|NCT03720470|455099980|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
126491947|NCT03720470|455099975|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
126491948|NCT03720470|455099976|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
126491949|NCT03720470|455099977|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
126491950|NCT03720470|455099978|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
126491951|NCT03720470|455099979|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
126491952|NCT03720470|455099980|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
126491953|NCT03720470|455099975|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
126491954|NCT03720470|455099976|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
126491955|NCT03720470|455099977|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
126491956|NCT03720470|455099978|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
126491957|NCT03720470|455099979|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
126491958|NCT03720470|455099980|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
126491959|NCT03720470|455099975|FG000|Treatment Period: Final 4 Weeks|Other|0|||
126491960|NCT03720470|455099976|FG001|Treatment Period: Final 4 Weeks|Other|1|||
126491961|NCT03720470|455099977|FG002|Treatment Period: Final 4 Weeks|Other|0|||
126491962|NCT03720470|455099978|FG003|Treatment Period: Final 4 Weeks|Other|2|||
126491963|NCT03720470|455099979|FG004|Treatment Period: Final 4 Weeks|Other|1|||
126491964|NCT03720470|455099980|FG005|Treatment Period: Final 4 Weeks|Other|0|||
126491965|NCT00460031|455099981|FG000|Overall Study|Adverse Event|5|||
126491966|NCT00460031|455099981|FG000|Overall Study|Withdrawal by Subject|5|||
126491967|NCT00460031|455099981|FG000|Overall Study|Death|1|||
126491968|NCT04532099|455099982|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
126491969|NCT04532099|455099983|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
126491970|NCT04532099|455099984|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
126491971|NCT00644995|455099989|FG000|Overall Study|Lost to Follow-up|1|||
126491972|NCT00644995|455099990|FG001|Overall Study|Lost to Follow-up|4|||
126491973|NCT00644995|455099989|FG000|Overall Study|Refused|1|||
126491974|NCT00644995|455099990|FG001|Overall Study|Refused|0|||
126491975|NCT02066233|455099991|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
126491976|NCT02066233|455099992|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
126491977|NCT02772081|455099993|FG000|Overall Study|Physician Decision|1|||
126491978|NCT02772081|455099994|FG001|Overall Study|Physician Decision|1|||
126491979|NCT02772081|455099993|FG000|Overall Study|Death|1|||
126491980|NCT02772081|455099994|FG001|Overall Study|Death|1|||
126491981|NCT01291173|455099998|FG000|Overall Study|Adverse Event|0|||
126491982|NCT01291173|455099999|FG001|Overall Study|Adverse Event|3|||
126491983|NCT01291173|455100000|FG002|Overall Study|Adverse Event|1|||
126491984|NCT01291173|455100001|FG003|Overall Study|Adverse Event|3|||
126491985|NCT01291173|455099998|FG000|Overall Study|Protocol Violation|7|||
126491986|NCT01291173|455099999|FG001|Overall Study|Protocol Violation|2|||
126491987|NCT01291173|455100000|FG002|Overall Study|Protocol Violation|2|||
126491988|NCT01291173|455100001|FG003|Overall Study|Protocol Violation|5|||
126491989|NCT01291173|455099998|FG000|Overall Study|Withdrawal by Subject|6|||
126491990|NCT01291173|455099999|FG001|Overall Study|Withdrawal by Subject|4|||
126491991|NCT01291173|455100000|FG002|Overall Study|Withdrawal by Subject|4|||
126491992|NCT01291173|455100001|FG003|Overall Study|Withdrawal by Subject|2|||
126491993|NCT01291173|455099998|FG000|Overall Study|Lost to Follow-up|4|||
126491994|NCT01291173|455099999|FG001|Overall Study|Lost to Follow-up|6|||
126491995|NCT01291173|455100000|FG002|Overall Study|Lost to Follow-up|3|||
126491996|NCT01291173|455100001|FG003|Overall Study|Lost to Follow-up|2|||
126491997|NCT01291173|455099998|FG000|Overall Study|Unable to meet visit schedule|0|||
126491998|NCT01291173|455099999|FG001|Overall Study|Unable to meet visit schedule|0|||
126491999|NCT01291173|455100000|FG002|Overall Study|Unable to meet visit schedule|1|||
126492000|NCT01291173|455100001|FG003|Overall Study|Unable to meet visit schedule|0|||
126492001|NCT01291173|455099998|FG000|Overall Study|Lack of compliance|0|||
126492002|NCT01291173|455099999|FG001|Overall Study|Lack of compliance|0|||
126492003|NCT01291173|455100000|FG002|Overall Study|Lack of compliance|0|||
126492004|NCT01291173|455100001|FG003|Overall Study|Lack of compliance|1|||
126492005|NCT01291173|455099998|FG000|Overall Study|Subject was unblinded|0|||
126492006|NCT01291173|455099999|FG001|Overall Study|Subject was unblinded|0|||
126492007|NCT01291173|455100000|FG002|Overall Study|Subject was unblinded|1|||
126492008|NCT01291173|455100001|FG003|Overall Study|Subject was unblinded|0|||
126492009|NCT01291173|455099998|FG000|Overall Study|Excluded therapy|0|||
126492010|NCT01291173|455099999|FG001|Overall Study|Excluded therapy|0|||
126492011|NCT01291173|455100000|FG002|Overall Study|Excluded therapy|1|||
126492012|NCT01291173|455100001|FG003|Overall Study|Excluded therapy|0|||
126492013|NCT00390858|455100002|FG000|Overall Study|Adverse Event|6|||
126492014|NCT00390858|455100003|FG001|Overall Study|Adverse Event|2|||
126492015|NCT00390858|455100002|FG000|Overall Study|Lack of Efficacy|0|||
126492016|NCT00390858|455100003|FG001|Overall Study|Lack of Efficacy|1|||
126492017|NCT00390858|455100002|FG000|Overall Study|Withdrawal by Subject|3|||
126492018|NCT00390858|455100003|FG001|Overall Study|Withdrawal by Subject|4|||
126492019|NCT01113801|455100004|FG000|Overall Study|Adverse Event|4|||
126492020|NCT01113801|455100005|FG001|Overall Study|Adverse Event|0|||
126492021|NCT01113801|455100006|FG002|Overall Study|Adverse Event|2|||
126492022|NCT01113801|455100007|FG003|Overall Study|Adverse Event|6|||
126492023|NCT01113801|455100004|FG000|Overall Study|Death|4|||
126492024|NCT01113801|455100005|FG001|Overall Study|Death|5|||
126492025|NCT01113801|455100006|FG002|Overall Study|Death|3|||
126492026|NCT01113801|455100007|FG003|Overall Study|Death|4|||
126492027|NCT01113801|455100004|FG000|Overall Study|Protocol Violation|0|||
126492028|NCT01113801|455100005|FG001|Overall Study|Protocol Violation|1|||
126492029|NCT01113801|455100006|FG002|Overall Study|Protocol Violation|0|||
126492030|NCT01113801|455100007|FG003|Overall Study|Protocol Violation|0|||
126492031|NCT01113801|455100004|FG000|Overall Study|Withdrawal by Subject|9|||
126492032|NCT01113801|455100005|FG001|Overall Study|Withdrawal by Subject|7|||
126492033|NCT01113801|455100006|FG002|Overall Study|Withdrawal by Subject|7|||
126492034|NCT01113801|455100007|FG003|Overall Study|Withdrawal by Subject|8|||
126492035|NCT01113801|455100004|FG000|Overall Study|Physician Decision|2|||
126492036|NCT01113801|455100005|FG001|Overall Study|Physician Decision|2|||
126492037|NCT01113801|455100006|FG002|Overall Study|Physician Decision|3|||
126492038|NCT01113801|455100007|FG003|Overall Study|Physician Decision|3|||
126492039|NCT01113801|455100004|FG000|Overall Study|Sponsor Decision|15|||
126492040|NCT01113801|455100005|FG001|Overall Study|Sponsor Decision|21|||
126492041|NCT01113801|455100006|FG002|Overall Study|Sponsor Decision|20|||
126492042|NCT01113801|455100007|FG003|Overall Study|Sponsor Decision|15|||
126492043|NCT01113801|455100004|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
126492044|NCT01113801|455100005|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
126492045|NCT01113801|455100006|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
126492046|NCT01113801|455100007|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
126492047|NCT02728895|455100008|FG000|Overall Study|Other|1|||
126492048|NCT02728895|455100009|FG001|Overall Study|Other|2|||
126492049|NCT02728895|455100008|FG000|Overall Study|Withdrawal by Subject|0|||
126492050|NCT02728895|455100009|FG001|Overall Study|Withdrawal by Subject|3|||
126492051|NCT01506479|455100010|FG000|Overall Study|Lost to Follow-up|1|||
126492052|NCT01506479|455100011|FG001|Overall Study|Lost to Follow-up|2|||
126492053|NCT01506479|455100012|FG002|Overall Study|Lost to Follow-up|2|||
126492054|NCT01506479|455100010|FG000|Overall Study|Withdrawal by Subject|1|||
126492055|NCT01506479|455100011|FG001|Overall Study|Withdrawal by Subject|2|||
126492056|NCT01506479|455100012|FG002|Overall Study|Withdrawal by Subject|1|||
126492057|NCT01506479|455100010|FG000|Overall Study|Missing assessment|1|||
126492058|NCT01506479|455100011|FG001|Overall Study|Missing assessment|0|||
126492059|NCT01506479|455100012|FG002|Overall Study|Missing assessment|0|||
126492060|NCT01506479|455100010|FG000|Overall Study|Adverse Event|0|||
126492061|NCT01506479|455100011|FG001|Overall Study|Adverse Event|1|||
126492062|NCT01506479|455100012|FG002|Overall Study|Adverse Event|0|||
126492063|NCT00810407|455100013|FG000|Overall Study|Protocol Violation|3|||
126492064|NCT00810407|455100013|FG000|Overall Study|No Visit After First Day of Treatment|3|||
126492065|NCT02426892|455100016|FG000|Overall Study|Adverse Event|2|||
126492066|NCT02426892|455100016|FG000|Overall Study|Lack of Efficacy|17|||
126492067|NCT02426892|455100016|FG000|Overall Study|Withdrawal by Subject|1|||
126492068|NCT02763189|455100019|FG000|Overall Study|Device failure|0|||
126492069|NCT02763189|455100020|FG001|Overall Study|Device failure|2|||
126492070|NCT02049957|455100025|FG000|Overall Study|Progressive Disease|5|||
126492071|NCT02049957|455100026|FG001|Overall Study|Progressive Disease|4|||
126492072|NCT02049957|455100027|FG002|Overall Study|Progressive Disease|2|||
126492073|NCT02049957|455100028|FG003|Overall Study|Progressive Disease|2|||
126492074|NCT02049957|455100029|FG004|Overall Study|Progressive Disease|6|||
126492075|NCT02049957|455100030|FG005|Overall Study|Progressive Disease|35|||
126492076|NCT02049957|455100031|FG006|Overall Study|Progressive Disease|7|||
126492077|NCT02049957|455100032|FG007|Overall Study|Progressive Disease|26|||
126492078|NCT02049957|455100033|FG008|Overall Study|Progressive Disease|6|||
126492079|NCT02049957|455100025|FG000|Overall Study|Adverse Event|1|||
126492080|NCT02049957|455100026|FG001|Overall Study|Adverse Event|1|||
126492081|NCT02049957|455100027|FG002|Overall Study|Adverse Event|1|||
126492082|NCT02049957|455100028|FG003|Overall Study|Adverse Event|0|||
126492083|NCT02049957|455100029|FG004|Overall Study|Adverse Event|0|||
126492084|NCT02049957|455100030|FG005|Overall Study|Adverse Event|5|||
126492085|NCT02049957|455100031|FG006|Overall Study|Adverse Event|0|||
126492086|NCT02049957|455100032|FG007|Overall Study|Adverse Event|6|||
126492087|NCT02049957|455100033|FG008|Overall Study|Adverse Event|1|||
126492088|NCT02049957|455100025|FG000|Overall Study|Study Terminated by Sponsor|0|||
126492089|NCT02049957|455100026|FG001|Overall Study|Study Terminated by Sponsor|1|||
126492090|NCT02049957|455100027|FG002|Overall Study|Study Terminated by Sponsor|0|||
126492091|NCT02049957|455100028|FG003|Overall Study|Study Terminated by Sponsor|0|||
126492092|NCT02049957|455100029|FG004|Overall Study|Study Terminated by Sponsor|0|||
126492093|NCT02049957|455100030|FG005|Overall Study|Study Terminated by Sponsor|0|||
126492094|NCT02049957|455100031|FG006|Overall Study|Study Terminated by Sponsor|1|||
126492095|NCT02049957|455100032|FG007|Overall Study|Study Terminated by Sponsor|0|||
126492096|NCT02049957|455100033|FG008|Overall Study|Study Terminated by Sponsor|0|||
126492097|NCT02049957|455100025|FG000|Overall Study|Withdrawal by Subject|0|||
126492098|NCT02049957|455100026|FG001|Overall Study|Withdrawal by Subject|0|||
126492099|NCT02049957|455100027|FG002|Overall Study|Withdrawal by Subject|0|||
126492100|NCT02049957|455100028|FG003|Overall Study|Withdrawal by Subject|1|||
126492101|NCT02049957|455100029|FG004|Overall Study|Withdrawal by Subject|0|||
126492102|NCT02049957|455100030|FG005|Overall Study|Withdrawal by Subject|2|||
126492103|NCT02049957|455100031|FG006|Overall Study|Withdrawal by Subject|0|||
126492104|NCT02049957|455100032|FG007|Overall Study|Withdrawal by Subject|3|||
126492105|NCT02049957|455100033|FG008|Overall Study|Withdrawal by Subject|1|||
126492106|NCT02049957|455100025|FG000|Overall Study|Physician Decision|0|||
126492107|NCT02049957|455100026|FG001|Overall Study|Physician Decision|0|||
126492108|NCT02049957|455100027|FG002|Overall Study|Physician Decision|0|||
126492109|NCT02049957|455100028|FG003|Overall Study|Physician Decision|0|||
126492110|NCT02049957|455100029|FG004|Overall Study|Physician Decision|0|||
126492111|NCT02049957|455100030|FG005|Overall Study|Physician Decision|1|||
126492112|NCT02049957|455100031|FG006|Overall Study|Physician Decision|0|||
126492113|NCT02049957|455100032|FG007|Overall Study|Physician Decision|0|||
126492114|NCT02049957|455100033|FG008|Overall Study|Physician Decision|0|||
126492115|NCT03557151|455100034|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
126492116|NCT03557151|455100035|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
126492117|NCT03557151|455100034|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
126492118|NCT03557151|455100035|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
126492119|NCT03557151|455100034|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
126492120|NCT03557151|455100035|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
126492121|NCT01414075|455100036|FG000|Overall Study|Adverse Event|1|||
126492122|NCT01414075|455100037|FG001|Overall Study|Adverse Event|0|||
126492123|NCT01414075|455100038|FG002|Overall Study|Adverse Event|1|||
126492124|NCT01414075|455100039|FG003|Overall Study|Adverse Event|0|||
126492125|NCT01414075|455100036|FG000|Overall Study|Death|1|||
126492126|NCT01414075|455100037|FG001|Overall Study|Death|0|||
126723424|NCT02052778|455936099|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126492127|NCT01414075|455100038|FG002|Overall Study|Death|0|||
126492128|NCT01414075|455100039|FG003|Overall Study|Death|1|||
126492129|NCT01414075|455100036|FG000|Overall Study|Withdrawal by Subject|0|||
126492130|NCT01414075|455100037|FG001|Overall Study|Withdrawal by Subject|0|||
126492131|NCT01414075|455100038|FG002|Overall Study|Withdrawal by Subject|0|||
126492132|NCT01414075|455100039|FG003|Overall Study|Withdrawal by Subject|1|||
126492133|NCT01414075|455100036|FG000|Overall Study|Other than specified|1|||
126492134|NCT01414075|455100037|FG001|Overall Study|Other than specified|0|||
126492135|NCT01414075|455100038|FG002|Overall Study|Other than specified|1|||
126492136|NCT01414075|455100039|FG003|Overall Study|Other than specified|0|||
126492137|NCT00467259|455100043|FG000|Overall Study|Adverse Event|24|||
126492138|NCT00467259|455100044|FG001|Overall Study|Adverse Event|90|||
126492139|NCT00467259|455100043|FG000|Overall Study|Protocol Violation|1|||
126492140|NCT00467259|455100044|FG001|Overall Study|Protocol Violation|7|||
126492141|NCT00467259|455100043|FG000|Overall Study|Withdrawal by Subject|34|||
126492142|NCT00467259|455100044|FG001|Overall Study|Withdrawal by Subject|108|||
126492143|NCT00467259|455100043|FG000|Overall Study|Physician Decision|0|||
126492144|NCT00467259|455100044|FG001|Overall Study|Physician Decision|2|||
126492145|NCT00467259|455100043|FG000|Overall Study|Lost to Follow-up|14|||
126492146|NCT00467259|455100044|FG001|Overall Study|Lost to Follow-up|34|||
126492147|NCT00467259|455100043|FG000|Overall Study|Site Closed|2|||
126492148|NCT00467259|455100044|FG001|Overall Study|Site Closed|1|||
126492149|NCT04285879|455100047|FG000|Overall Study|Lost to Follow-up|1|||
126492150|NCT04285879|455100048|FG001|Overall Study|Lost to Follow-up|8|||
126492151|NCT04285879|455100047|FG000|Overall Study|medical/surgical exclusion|16|||
126492152|NCT04285879|455100048|FG001|Overall Study|medical/surgical exclusion|0|||
126492153|NCT00459108|455100050|FG000|Overall Study|Withdrawal by Subject|5|||
126492154|NCT00459108|455100050|FG000|Overall Study|Adverse Event|3|||
126492155|NCT00459108|455100050|FG000|Overall Study|Death|2|||
126492156|NCT00459108|455100050|FG000|Overall Study|Progression|1|||
126492157|NCT00396591|455100053|FG000|Overall Study|Disease Progression|13|||
126492158|NCT00396591|455100053|FG000|Overall Study|Adverse Event|2|||
126492159|NCT00396591|455100053|FG000|Overall Study|Participant request|1|||
126492160|NCT00818662|455100055|FG000|Overall Study|Adverse Event|5|||
126492161|NCT00818662|455100056|FG001|Overall Study|Adverse Event|14|||
126492162|NCT00818662|455100057|FG002|Overall Study|Adverse Event|4|||
126723425|NCT02052778|455936100|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723426|NCT02052778|455936101|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723427|NCT02052778|455936102|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723428|NCT02052778|455936103|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
126723429|NCT02052778|455936104|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
126723430|NCT02052778|455936082|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723431|NCT02052778|455936083|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723432|NCT02052778|455936084|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723433|NCT02052778|455936085|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723434|NCT02052778|455936086|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723435|NCT02052778|455936087|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723436|NCT02052778|455936088|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723437|NCT02052778|455936089|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723438|NCT02052778|455936090|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723439|NCT02052778|455936091|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723440|NCT02052778|455936092|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723441|NCT02052778|455936093|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723442|NCT02052778|455936094|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126772638|NCT02454972|456123632|FG003|Overall Study|Patient moves to compassionate use|0|||
126772639|NCT02454972|456123633|FG004|Overall Study|Patient moves to compassionate use|0|||
126492163|NCT00818662|455100058|FG003|Overall Study|Adverse Event|3|||
126492164|NCT00818662|455100055|FG000|Overall Study|Withdrawal by Subject|5|||
126492165|NCT00818662|455100056|FG001|Overall Study|Withdrawal by Subject|4|||
126492166|NCT00818662|455100057|FG002|Overall Study|Withdrawal by Subject|2|||
126492167|NCT00818662|455100058|FG003|Overall Study|Withdrawal by Subject|2|||
126492168|NCT00818662|455100055|FG000|Overall Study|Death|1|||
126492169|NCT00818662|455100056|FG001|Overall Study|Death|3|||
126492170|NCT00818662|455100057|FG002|Overall Study|Death|0|||
126492171|NCT00818662|455100058|FG003|Overall Study|Death|0|||
126492172|NCT00818662|455100055|FG000|Overall Study|Physician Decision|1|||
126492173|NCT00818662|455100056|FG001|Overall Study|Physician Decision|0|||
126492174|NCT00818662|455100057|FG002|Overall Study|Physician Decision|0|||
126492175|NCT00818662|455100058|FG003|Overall Study|Physician Decision|0|||
126492176|NCT00818662|455100055|FG000|Overall Study|Lost to Follow-up|0|||
126492177|NCT00818662|455100056|FG001|Overall Study|Lost to Follow-up|0|||
126492178|NCT00818662|455100057|FG002|Overall Study|Lost to Follow-up|0|||
126492179|NCT00818662|455100058|FG003|Overall Study|Lost to Follow-up|1|||
126492180|NCT00818662|455100055|FG000|Overall Study|Unwilling or Unable to Participate|4|||
126492181|NCT00818662|455100056|FG001|Overall Study|Unwilling or Unable to Participate|6|||
126492182|NCT00818662|455100057|FG002|Overall Study|Unwilling or Unable to Participate|2|||
126492183|NCT00818662|455100058|FG003|Overall Study|Unwilling or Unable to Participate|4|||
126492184|NCT00818662|455100055|FG000|Overall Study|Protocol Violation|1|||
126492185|NCT00818662|455100056|FG001|Overall Study|Protocol Violation|1|||
126492186|NCT00818662|455100057|FG002|Overall Study|Protocol Violation|0|||
126492187|NCT00818662|455100058|FG003|Overall Study|Protocol Violation|0|||
126492188|NCT00818662|455100055|FG000|Overall Study|Requires a Prohibited Medication|1|||
126492189|NCT00818662|455100056|FG001|Overall Study|Requires a Prohibited Medication|0|||
126492190|NCT00818662|455100057|FG002|Overall Study|Requires a Prohibited Medication|0|||
126492191|NCT00818662|455100058|FG003|Overall Study|Requires a Prohibited Medication|0|||
126492192|NCT00818662|455100055|FG000|Overall Study|Safety Risk|1|||
126492193|NCT00818662|455100056|FG001|Overall Study|Safety Risk|1|||
126492194|NCT00818662|455100057|FG002|Overall Study|Safety Risk|0|||
126492195|NCT00818662|455100058|FG003|Overall Study|Safety Risk|1|||
126492196|NCT00818662|455100055|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
126492197|NCT00818662|455100056|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
126492198|NCT00818662|455100057|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
126492199|NCT00818662|455100058|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
126492200|NCT00818662|455100055|FG000|Overall Study|Participant's health declined|0|||
126492201|NCT00818662|455100056|FG001|Overall Study|Participant's health declined|0|||
126492202|NCT00818662|455100057|FG002|Overall Study|Participant's health declined|0|||
126492203|NCT00818662|455100058|FG003|Overall Study|Participant's health declined|1|||
126492204|NCT00818662|455100055|FG000|Overall Study|Caregiver to pursue other treatment|0|||
126492205|NCT00818662|455100056|FG001|Overall Study|Caregiver to pursue other treatment|1|||
126492206|NCT00818662|455100057|FG002|Overall Study|Caregiver to pursue other treatment|0|||
126492207|NCT00818662|455100058|FG003|Overall Study|Caregiver to pursue other treatment|0|||
126492208|NCT00818662|455100055|FG000|Overall Study|Moving out of state|0|||
126492209|NCT00818662|455100056|FG001|Overall Study|Moving out of state|0|||
126492210|NCT00818662|455100057|FG002|Overall Study|Moving out of state|0|||
126492211|NCT00818662|455100058|FG003|Overall Study|Moving out of state|1|||
126492212|NCT00818662|455100055|FG000|Overall Study|Declined move to another study site|1|||
126492213|NCT00818662|455100056|FG001|Overall Study|Declined move to another study site|0|||
126492214|NCT00818662|455100057|FG002|Overall Study|Declined move to another study site|0|||
126492215|NCT00818662|455100058|FG003|Overall Study|Declined move to another study site|0|||
126492216|NCT00818662|455100055|FG000|Overall Study|Change in living situation|0|||
126492217|NCT00818662|455100056|FG001|Overall Study|Change in living situation|0|||
126492218|NCT00818662|455100057|FG002|Overall Study|Change in living situation|0|||
126492219|NCT00818662|455100058|FG003|Overall Study|Change in living situation|1|||
126492220|NCT00818662|455100055|FG000|Overall Study|Study partner decision|0|||
126492221|NCT00818662|455100056|FG001|Overall Study|Study partner decision|0|||
126492222|NCT00818662|455100057|FG002|Overall Study|Study partner decision|0|||
126492223|NCT00818662|455100058|FG003|Overall Study|Study partner decision|1|||
126492224|NCT00818662|455100055|FG000|Overall Study|Admitted to long term nursing care|0|||
126492225|NCT00818662|455100056|FG001|Overall Study|Admitted to long term nursing care|1|||
126492226|NCT00818662|455100057|FG002|Overall Study|Admitted to long term nursing care|0|||
126723443|NCT02052778|455936095|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723444|NCT02052778|455936096|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723445|NCT02052778|455936097|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723446|NCT02052778|455936098|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723447|NCT02052778|455936099|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126492227|NCT00818662|455100058|FG003|Overall Study|Admitted to long term nursing care|0|||
126492228|NCT01472081|455100059|FG000|Overall Study|Continuing treatment at time of analysis|1|||
126492229|NCT01472081|455100060|FG001|Overall Study|Continuing treatment at time of analysis|4|||
126492230|NCT01472081|455100061|FG002|Overall Study|Continuing treatment at time of analysis|1|||
126492231|NCT01472081|455100062|FG003|Overall Study|Continuing treatment at time of analysis|8|||
126492232|NCT01472081|455100063|FG004|Overall Study|Continuing treatment at time of analysis|9|||
126492233|NCT01472081|455100064|FG005|Overall Study|Continuing treatment at time of analysis|0|||
126492234|NCT01472081|455100059|FG000|Overall Study|Disease Progression|4|||
126492235|NCT01472081|455100060|FG001|Overall Study|Disease Progression|10|||
126492236|NCT01472081|455100061|FG002|Overall Study|Disease Progression|12|||
126492237|NCT01472081|455100062|FG003|Overall Study|Disease Progression|31|||
126492238|NCT01472081|455100063|FG004|Overall Study|Disease Progression|22|||
126492239|NCT01472081|455100064|FG005|Overall Study|Disease Progression|3|||
126492240|NCT01472081|455100059|FG000|Overall Study|Study drug toxicity|2|||
126492241|NCT01472081|455100060|FG001|Overall Study|Study drug toxicity|9|||
126492242|NCT01472081|455100061|FG002|Overall Study|Study drug toxicity|4|||
126492243|NCT01472081|455100062|FG003|Overall Study|Study drug toxicity|6|||
126492244|NCT01472081|455100063|FG004|Overall Study|Study drug toxicity|13|||
126492245|NCT01472081|455100064|FG005|Overall Study|Study drug toxicity|2|||
126492246|NCT01472081|455100059|FG000|Overall Study|Death|0|||
126492247|NCT01472081|455100060|FG001|Overall Study|Death|0|||
126492248|NCT01472081|455100061|FG002|Overall Study|Death|0|||
126492249|NCT01472081|455100062|FG003|Overall Study|Death|0|||
126492250|NCT01472081|455100063|FG004|Overall Study|Death|1|||
126492251|NCT01472081|455100064|FG005|Overall Study|Death|0|||
126492252|NCT01472081|455100059|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
126492253|NCT01472081|455100060|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
126492254|NCT01472081|455100061|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
126492255|NCT01472081|455100062|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
126492256|NCT01472081|455100063|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
126492257|NCT01472081|455100064|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
126492258|NCT01472081|455100059|FG000|Overall Study|Withdrawal by Subject|0|||
126492259|NCT01472081|455100060|FG001|Overall Study|Withdrawal by Subject|0|||
126492260|NCT01472081|455100061|FG002|Overall Study|Withdrawal by Subject|0|||
126492261|NCT01472081|455100062|FG003|Overall Study|Withdrawal by Subject|0|||
126492262|NCT01472081|455100063|FG004|Overall Study|Withdrawal by Subject|0|||
126492263|NCT01472081|455100064|FG005|Overall Study|Withdrawal by Subject|1|||
126492264|NCT01472081|455100059|FG000|Overall Study|Poor/non-compliance|0|||
126492265|NCT01472081|455100060|FG001|Overall Study|Poor/non-compliance|0|||
126492266|NCT01472081|455100061|FG002|Overall Study|Poor/non-compliance|1|||
126492267|NCT01472081|455100062|FG003|Overall Study|Poor/non-compliance|0|||
126492268|NCT01472081|455100063|FG004|Overall Study|Poor/non-compliance|1|||
126492269|NCT01472081|455100064|FG005|Overall Study|Poor/non-compliance|0|||
126492270|NCT01472081|455100059|FG000|Overall Study|No longer meets study criteria|0|||
126492271|NCT01472081|455100060|FG001|Overall Study|No longer meets study criteria|0|||
126492272|NCT01472081|455100061|FG002|Overall Study|No longer meets study criteria|1|||
126492273|NCT01472081|455100062|FG003|Overall Study|No longer meets study criteria|0|||
126492274|NCT01472081|455100063|FG004|Overall Study|No longer meets study criteria|0|||
126492275|NCT01472081|455100064|FG005|Overall Study|No longer meets study criteria|0|||
126492276|NCT01472081|455100059|FG000|Overall Study|Subject request to discontinue treatment|0|||
126492277|NCT01472081|455100060|FG001|Overall Study|Subject request to discontinue treatment|3|||
126492278|NCT01472081|455100061|FG002|Overall Study|Subject request to discontinue treatment|1|||
126492279|NCT01472081|455100062|FG003|Overall Study|Subject request to discontinue treatment|1|||
126492280|NCT01472081|455100063|FG004|Overall Study|Subject request to discontinue treatment|0|||
126492281|NCT01472081|455100064|FG005|Overall Study|Subject request to discontinue treatment|0|||
126492282|NCT03605303|455100065|FG000|Period 1|Study Terminated|2|||
126492283|NCT03605303|455100066|FG001|Period 1|Study Terminated|1|||
126492284|NCT01572909|455101784|FG000|Overall Study|Adverse Event|7|||
126492285|NCT01572909|455101785|FG001|Overall Study|Adverse Event|2|||
126492286|NCT01572909|455101784|FG000|Overall Study|Death|3|||
126492287|NCT01572909|455101785|FG001|Overall Study|Death|1|||
126492288|NCT01572909|455101784|FG000|Overall Study|Lost to Follow-up|8|||
126492289|NCT01572909|455101785|FG001|Overall Study|Lost to Follow-up|7|||
126492290|NCT01572909|455101784|FG000|Overall Study|Physician Decision|1|||
126492291|NCT01572909|455101785|FG001|Overall Study|Physician Decision|1|||
126492292|NCT01572909|455101784|FG000|Overall Study|Technical Issues|1|||
126492293|NCT01572909|455101785|FG001|Overall Study|Technical Issues|0|||
126492294|NCT01572909|455101784|FG000|Overall Study|Withdrawal by Subject|12|||
126492295|NCT01572909|455101785|FG001|Overall Study|Withdrawal by Subject|11|||
126492296|NCT01572909|455101784|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
126492297|NCT01572909|455101785|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
126492298|NCT03641651|455101786|FG000|Overall Study|organizational issues at one study site|1|||
126492299|NCT04779489|455101787|FG000|Overall Study|Physician Decision|1|||
126492300|NCT00623727|455101788|FG000|Double Blind (DB)|Adverse Event|1|||
126492301|NCT00623727|455101789|FG001|Double Blind (DB)|Adverse Event|3|||
126492302|NCT00623727|455101788|FG000|Double Blind (DB)|Physician Decision|0|||
126492303|NCT00623727|455101789|FG001|Double Blind (DB)|Physician Decision|1|||
126492304|NCT00623727|455101788|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
126492305|NCT00623727|455101789|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
126492306|NCT00623727|455101788|FG000|Double Blind (DB)|Lack of Efficacy|2|||
126492307|NCT00623727|455101789|FG001|Double Blind (DB)|Lack of Efficacy|2|||
126492308|NCT00623727|455101788|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
126492309|NCT00623727|455101789|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
126492310|NCT00623727|455101788|FG000|Double Blind (DB)|Lost to Follow-up|1|||
126492311|NCT00623727|455101789|FG001|Double Blind (DB)|Lost to Follow-up|1|||
126492312|NCT00623727|455101788|FG000|Double Blind (DB)|Protocol Violation|2|||
126492313|NCT00623727|455101789|FG001|Double Blind (DB)|Protocol Violation|2|||
126492314|NCT00623727|455101788|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
126492315|NCT00623727|455101789|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
126772640|NCT02454972|456123634|FG005|Overall Study|Patient moves to compassionate use|0|||
126772641|NCT02454972|456123635|FG006|Overall Study|Patient moves to compassionate use|2|||
126772642|NCT02454972|456123636|FG007|Overall Study|Patient moves to compassionate use|0|||
126772643|NCT02454972|456123637|FG008|Overall Study|Patient moves to compassionate use|0|||
126772644|NCT02454972|456123629|FG000|Overall Study|Withdrawal by Subject|0|||
126492316|NCT00623727|455101788|FG000|Open Label Follow-up|Study termination|0|||
126492317|NCT00623727|455101789|FG001|Open Label Follow-up|Study termination|6|||
126492318|NCT00623727|455101788|FG000|Open Label Follow-up|Participant convenience|0|||
126492319|NCT00623727|455101789|FG001|Open Label Follow-up|Participant convenience|1|||
126492320|NCT00951665|455101790|FG000|Phase 1b|Adverse Event|2|||
126492321|NCT00951665|455101791|FG001|Phase 1b|Adverse Event|1|||
126492322|NCT00951665|455101792|FG002|Phase 1b|Adverse Event|0|||
126492323|NCT00951665|455101793|FG003|Phase 1b|Adverse Event|1|||
126492324|NCT00951665|455101794|FG004|Phase 1b|Adverse Event|0|||
126492325|NCT00951665|455101795|FG005|Phase 1b|Adverse Event|0|||
126492326|NCT00951665|455101790|FG000|Phase 1b|Death|1|||
126492327|NCT00951665|455101791|FG001|Phase 1b|Death|0|||
126492328|NCT00951665|455101792|FG002|Phase 1b|Death|2|||
126492329|NCT00951665|455101793|FG003|Phase 1b|Death|0|||
126492330|NCT00951665|455101794|FG004|Phase 1b|Death|0|||
126492331|NCT00951665|455101795|FG005|Phase 1b|Death|0|||
126492332|NCT00951665|455101790|FG000|Phase 1b|Physician Decision|4|||
126492333|NCT00951665|455101791|FG001|Phase 1b|Physician Decision|0|||
126492334|NCT00951665|455101792|FG002|Phase 1b|Physician Decision|1|||
126492335|NCT00951665|455101793|FG003|Phase 1b|Physician Decision|0|||
126492336|NCT00951665|455101794|FG004|Phase 1b|Physician Decision|0|||
126492337|NCT00951665|455101795|FG005|Phase 1b|Physician Decision|0|||
126492338|NCT00951665|455101790|FG000|Phase 1b|Withdrawal by Subject|0|||
126492339|NCT00951665|455101791|FG001|Phase 1b|Withdrawal by Subject|1|||
126492340|NCT00951665|455101792|FG002|Phase 1b|Withdrawal by Subject|0|||
126492341|NCT00951665|455101793|FG003|Phase 1b|Withdrawal by Subject|0|||
126492342|NCT00951665|455101794|FG004|Phase 1b|Withdrawal by Subject|0|||
126492343|NCT00951665|455101795|FG005|Phase 1b|Withdrawal by Subject|0|||
126492344|NCT00951665|455101790|FG000|Phase 1b|Disease Progression|13|||
126492345|NCT00951665|455101791|FG001|Phase 1b|Disease Progression|2|||
126492346|NCT00951665|455101792|FG002|Phase 1b|Disease Progression|14|||
126492347|NCT00951665|455101793|FG003|Phase 1b|Disease Progression|0|||
126492348|NCT00951665|455101794|FG004|Phase 1b|Disease Progression|0|||
126492349|NCT00951665|455101795|FG005|Phase 1b|Disease Progression|0|||
126492350|NCT00951665|455101790|FG000|Phase 1b|Protocol Violation|2|||
126492351|NCT00951665|455101791|FG001|Phase 1b|Protocol Violation|0|||
126492352|NCT00951665|455101792|FG002|Phase 1b|Protocol Violation|0|||
126492353|NCT00951665|455101793|FG003|Phase 1b|Protocol Violation|0|||
126492354|NCT00951665|455101794|FG004|Phase 1b|Protocol Violation|0|||
126492355|NCT00951665|455101795|FG005|Phase 1b|Protocol Violation|0|||
126492356|NCT00951665|455101790|FG000|Phase 2a|Adverse Event|0|||
126492357|NCT00951665|455101791|FG001|Phase 2a|Adverse Event|0|||
126492358|NCT00951665|455101792|FG002|Phase 2a|Adverse Event|0|||
126492359|NCT00951665|455101793|FG003|Phase 2a|Adverse Event|0|||
126492360|NCT00951665|455101794|FG004|Phase 2a|Adverse Event|2|||
126492361|NCT00951665|455101795|FG005|Phase 2a|Adverse Event|0|||
126492362|NCT00951665|455101790|FG000|Phase 2a|Death|0|||
126492363|NCT00951665|455101791|FG001|Phase 2a|Death|0|||
126492364|NCT00951665|455101792|FG002|Phase 2a|Death|0|||
126492365|NCT00951665|455101793|FG003|Phase 2a|Death|0|||
126492366|NCT00951665|455101794|FG004|Phase 2a|Death|1|||
126492367|NCT00951665|455101795|FG005|Phase 2a|Death|1|||
126492368|NCT00951665|455101790|FG000|Phase 2a|Lost to Follow-up|0|||
126492369|NCT00951665|455101791|FG001|Phase 2a|Lost to Follow-up|0|||
126492370|NCT00951665|455101792|FG002|Phase 2a|Lost to Follow-up|0|||
126492371|NCT00951665|455101793|FG003|Phase 2a|Lost to Follow-up|0|||
126492372|NCT00951665|455101794|FG004|Phase 2a|Lost to Follow-up|1|||
126772645|NCT02454972|456123630|FG001|Overall Study|Withdrawal by Subject|1|||
126772646|NCT02454972|456123631|FG002|Overall Study|Withdrawal by Subject|5|||
126492373|NCT00951665|455101795|FG005|Phase 2a|Lost to Follow-up|0|||
126492374|NCT00951665|455101790|FG000|Phase 2a|Physician Decision|0|||
126492375|NCT00951665|455101791|FG001|Phase 2a|Physician Decision|0|||
126492376|NCT00951665|455101792|FG002|Phase 2a|Physician Decision|0|||
126492377|NCT00951665|455101793|FG003|Phase 2a|Physician Decision|0|||
126492378|NCT00951665|455101794|FG004|Phase 2a|Physician Decision|0|||
126492379|NCT00951665|455101795|FG005|Phase 2a|Physician Decision|1|||
126492380|NCT00951665|455101790|FG000|Phase 2a|Withdrawal by Subject|0|||
126492381|NCT00951665|455101791|FG001|Phase 2a|Withdrawal by Subject|0|||
126492382|NCT00951665|455101792|FG002|Phase 2a|Withdrawal by Subject|0|||
126492383|NCT00951665|455101793|FG003|Phase 2a|Withdrawal by Subject|0|||
126492384|NCT00951665|455101794|FG004|Phase 2a|Withdrawal by Subject|2|||
126492385|NCT00951665|455101795|FG005|Phase 2a|Withdrawal by Subject|0|||
126492386|NCT00951665|455101790|FG000|Phase 2a|Disease Progression|0|||
126492387|NCT00951665|455101791|FG001|Phase 2a|Disease Progression|0|||
126492388|NCT00951665|455101792|FG002|Phase 2a|Disease Progression|0|||
126492389|NCT00951665|455101793|FG003|Phase 2a|Disease Progression|0|||
126492390|NCT00951665|455101794|FG004|Phase 2a|Disease Progression|6|||
126492391|NCT00951665|455101795|FG005|Phase 2a|Disease Progression|5|||
126492392|NCT02723084|455101796|FG000|Overall Study|Withdrawal by Subject|1|||
126492393|NCT02723084|455101797|FG001|Overall Study|Withdrawal by Subject|1|||
126492394|NCT02723084|455101796|FG000|Overall Study|Lost to Follow-up|3|||
126492395|NCT02723084|455101797|FG001|Overall Study|Lost to Follow-up|0|||
126492396|NCT02450903|455101799|FG000|Overall Study|Adverse Event|3|||
126492397|NCT02450903|455101799|FG000|Overall Study|Progressive disease|15|||
126492398|NCT02450903|455101799|FG000|Overall Study|Switched to commercial drug|1|||
126492399|NCT02450903|455101799|FG000|Overall Study|Subject/guardian decision|1|||
126492400|NCT01164956|455101800|FG000|Overall Study|Side Effects|1|||
126492401|NCT01164956|455101801|FG001|Overall Study|Side Effects|0|||
126492402|NCT01164956|455101802|FG002|Overall Study|Side Effects|1|||
126492403|NCT01409564|455101803|FG000|Overall Study|low medication compliance|4|||
126492404|NCT01409564|455101804|FG001|Overall Study|low medication compliance|3|||
126492405|NCT01409564|455101803|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
126492406|NCT01409564|455101804|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
126492407|NCT03020407|455101805|FG000|Overall Study|Withdrawal by Subject|2|||
126492408|NCT03020407|455101806|FG001|Overall Study|Withdrawal by Subject|1|||
126492409|NCT03020407|455101805|FG000|Overall Study|Lost to Follow-up|2|||
126492410|NCT03020407|455101806|FG001|Overall Study|Lost to Follow-up|3|||
126492411|NCT03020407|455101805|FG000|Overall Study|Protocol Violation|0|||
126492412|NCT03020407|455101806|FG001|Overall Study|Protocol Violation|1|||
126492413|NCT02699554|455101807|FG000|Overall Study|Lost to Follow-up|9|||
126492414|NCT00788151|455101808|FG000|Overall Study|Other adverse event|0|||
126492415|NCT00788151|455101809|FG001|Overall Study|Other adverse event|2|||
126492416|NCT00788151|455101808|FG000|Overall Study|Protocol Violation|0|||
126492417|NCT00788151|455101809|FG001|Overall Study|Protocol Violation|1|||
126492418|NCT00788151|455101808|FG000|Overall Study|Withdrawal by Subject|13|||
126492419|NCT00788151|455101809|FG001|Overall Study|Withdrawal by Subject|6|||
126492420|NCT00788151|455101808|FG000|Overall Study|Enrolled but not treated|1|||
126492421|NCT00788151|455101809|FG001|Overall Study|Enrolled but not treated|1|||
126492422|NCT02169739|455101810|FG000|Overall Study|Lost to Follow-up|0|||
126492423|NCT02169739|455101811|FG001|Overall Study|Lost to Follow-up|4|||
126492424|NCT03635957|455101812|FG000|Run-In Period|Lost to Follow-up|1|||
126492425|NCT03635957|455101812|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
126492426|NCT00350636|455101813|FG000|Overall Study|Adverse Event|19|||
126492427|NCT00350636|455101814|FG001|Overall Study|Adverse Event|13|||
126492428|NCT00350636|455101813|FG000|Overall Study|Protocol Violation|1|||
126492429|NCT00350636|455101814|FG001|Overall Study|Protocol Violation|3|||
126492430|NCT00350636|455101813|FG000|Overall Study|Withdrawal by Subject|13|||
126492431|NCT00350636|455101814|FG001|Overall Study|Withdrawal by Subject|17|||
126492432|NCT00350636|455101813|FG000|Overall Study|Lost to Follow-up|9|||
126492433|NCT00350636|455101814|FG001|Overall Study|Lost to Follow-up|8|||
126492434|NCT00350636|455101813|FG000|Overall Study|Physician Decision|0|||
126492435|NCT00350636|455101814|FG001|Overall Study|Physician Decision|2|||
126492436|NCT00350636|455101813|FG000|Overall Study|Other|1|||
126492437|NCT00350636|455101814|FG001|Overall Study|Other|2|||
126492438|NCT01042236|455101819|FG000|Treatment Period 1|Adverse Event|0|||
126492439|NCT01042236|455101820|FG001|Treatment Period 1|Adverse Event|1|||
126492440|NCT01042236|455101821|FG002|Treatment Period 1|Adverse Event|0|||
126492441|NCT01042236|455101822|FG003|Treatment Period 1|Adverse Event|0|||
126492442|NCT01042236|455101823|FG004|Treatment Period 1|Adverse Event|1|||
126492443|NCT01042236|455101824|FG005|Treatment Period 1|Adverse Event|0|||
126492444|NCT01042236|455101819|FG000|Treatment Period 3|Adverse Event|0|||
126492445|NCT01042236|455101820|FG001|Treatment Period 3|Adverse Event|0|||
126492446|NCT01042236|455101821|FG002|Treatment Period 3|Adverse Event|0|||
126492447|NCT01042236|455101822|FG003|Treatment Period 3|Adverse Event|1|||
126492448|NCT01042236|455101823|FG004|Treatment Period 3|Adverse Event|0|||
126492449|NCT01042236|455101824|FG005|Treatment Period 3|Adverse Event|0|||
126492450|NCT01042236|455101819|FG000|Treatment Period 3|Protocol Violation|0|||
126492451|NCT01042236|455101820|FG001|Treatment Period 3|Protocol Violation|0|||
126492452|NCT01042236|455101821|FG002|Treatment Period 3|Protocol Violation|0|||
126492453|NCT01042236|455101822|FG003|Treatment Period 3|Protocol Violation|1|||
126492454|NCT01042236|455101823|FG004|Treatment Period 3|Protocol Violation|0|||
126492455|NCT01042236|455101824|FG005|Treatment Period 3|Protocol Violation|0|||
126492456|NCT00227903|455101825|FG000|Overall Study|Withdrawal by Subject|2|||
126492457|NCT00227903|455101826|FG001|Overall Study|Withdrawal by Subject|5|||
126492458|NCT00227903|455101825|FG000|Overall Study|Subject moved out of area|1|||
126492459|NCT00227903|455101826|FG001|Overall Study|Subject moved out of area|2|||
126492460|NCT00227903|455101825|FG000|Overall Study|Lost to Follow-up|1|||
126492461|NCT00227903|455101826|FG001|Overall Study|Lost to Follow-up|3|||
126492462|NCT00227903|455101825|FG000|Overall Study|Miscarriage|1|||
126492463|NCT00227903|455101826|FG001|Overall Study|Miscarriage|0|||
126492464|NCT01475331|455101827|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
126492465|NCT01475331|455101828|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
126492466|NCT01475331|455101827|FG000|Overall Study|excessive main duct communication|1|||
126492467|NCT01475331|455101828|FG001|Overall Study|excessive main duct communication|1|||
126492468|NCT01475331|455101827|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
126492469|NCT01475331|455101828|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
126492470|NCT01475331|455101827|FG000|Overall Study|Sign of malignancy during the procedure|2|||
126492471|NCT01475331|455101828|FG001|Overall Study|Sign of malignancy during the procedure|0|||
126492472|NCT01475331|455101827|FG000|Overall Study|cyst found to be prohibitively small|0|||
126492473|NCT01475331|455101828|FG001|Overall Study|cyst found to be prohibitively small|1|||
126492474|NCT01525550|455101829|FG000|Overall Study|Lost to Follow-up|8|||
126492475|NCT01525550|455101830|FG001|Overall Study|Lost to Follow-up|2|||
126492476|NCT01525550|455101829|FG000|Overall Study|Death|19|||
126492477|NCT01525550|455101830|FG001|Overall Study|Death|28|||
126492478|NCT01525550|455101829|FG000|Overall Study|Other|0|||
126492479|NCT01525550|455101830|FG001|Overall Study|Other|4|||
126492480|NCT01525550|455101829|FG000|Overall Study|Sponsor's Decision|30|||
126492481|NCT01525550|455101830|FG001|Overall Study|Sponsor's Decision|11|||
126492482|NCT01525550|455101829|FG000|Overall Study|Withdrawal by Subject|4|||
126492483|NCT01525550|455101830|FG001|Overall Study|Withdrawal by Subject|0|||
126492484|NCT00453921|455101837|FG000|Overall Study|Withdrawal by Subject|1|||
126492485|NCT00453921|455101838|FG001|Overall Study|Withdrawal by Subject|1|||
126492486|NCT00453921|455101839|FG002|Overall Study|Withdrawal by Subject|1|||
126492487|NCT00453921|455101840|FG003|Overall Study|Withdrawal by Subject|1|||
126492488|NCT00453921|455101837|FG000|Overall Study|Lost to Follow-up|0|||
126492489|NCT00453921|455101838|FG001|Overall Study|Lost to Follow-up|0|||
126492490|NCT00453921|455101839|FG002|Overall Study|Lost to Follow-up|1|||
126492491|NCT00453921|455101840|FG003|Overall Study|Lost to Follow-up|0|||
126492492|NCT03103919|455101842|FG000|Overall Study|Adverse Event|2|||
126492493|NCT03103919|455101843|FG001|Overall Study|Adverse Event|2|||
126492494|NCT02436356|455101844|FG000|Overall Study|Excluded by MRI Screening|0|||
126492495|NCT02436356|455101845|FG001|Overall Study|Excluded by MRI Screening|0|||
126492496|NCT02436356|455101846|FG002|Overall Study|Excluded by MRI Screening|2|||
126492497|NCT02436356|455101844|FG000|Overall Study|Lost to Follow-up|0|||
126492498|NCT02436356|455101845|FG001|Overall Study|Lost to Follow-up|1|||
126492499|NCT02436356|455101846|FG002|Overall Study|Lost to Follow-up|0|||
126492500|NCT02436356|455101844|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
126492501|NCT02436356|455101845|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
126492502|NCT02436356|455101846|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
126492503|NCT02436356|455101844|FG000|Overall Study|Excluded due to other medical conditions|3|||
126492504|NCT02436356|455101845|FG001|Overall Study|Excluded due to other medical conditions|0|||
126492505|NCT02436356|455101846|FG002|Overall Study|Excluded due to other medical conditions|0|||
126492506|NCT02436356|455101844|FG000|Overall Study|Withdrawal by Subject|1|||
126492507|NCT02436356|455101845|FG001|Overall Study|Withdrawal by Subject|0|||
126492508|NCT02436356|455101846|FG002|Overall Study|Withdrawal by Subject|0|||
126492509|NCT04577118|455101847|FG000|Overall Study|Withdrawal by Subject|4|||
126492510|NCT00674661|455101848|FG000|Overall Study|Other|5|||
126492511|NCT00674661|455101849|FG001|Overall Study|Other|7|||
126492512|NCT00674661|455101848|FG000|Overall Study|Lost to Follow-up|6|||
126492513|NCT00674661|455101849|FG001|Overall Study|Lost to Follow-up|3|||
126492514|NCT00674661|455101848|FG000|Overall Study|Withdrawal by Subject|0|||
126492515|NCT00674661|455101849|FG001|Overall Study|Withdrawal by Subject|5|||
126492516|NCT03108027|455101851|FG000|Period 1|Subject/Guardian Decision|0|||
126492517|NCT03108027|455101852|FG001|Period 1|Subject/Guardian Decision|0|||
126492518|NCT03108027|455101853|FG002|Period 1|Subject/Guardian Decision|0|||
126492519|NCT03108027|455101854|FG003|Period 1|Subject/Guardian Decision|2|||
126492520|NCT03108027|455101855|FG004|Period 1|Subject/Guardian Decision|0|||
126492521|NCT03108027|455101856|FG005|Period 1|Subject/Guardian Decision|0|||
126492522|NCT03108027|455101851|FG000|Period 3|Adverse Event|0|||
126492523|NCT03108027|455101852|FG001|Period 3|Adverse Event|1|||
126492524|NCT03108027|455101853|FG002|Period 3|Adverse Event|0|||
126492525|NCT03108027|455101854|FG003|Period 3|Adverse Event|0|||
126492526|NCT03108027|455101855|FG004|Period 3|Adverse Event|0|||
126492527|NCT03108027|455101856|FG005|Period 3|Adverse Event|0|||
126492528|NCT02574247|455101857|FG000|Overall Study|Withdrawal by Subject|1|||
126492529|NCT02574247|455101858|FG001|Overall Study|Withdrawal by Subject|0|||
126492530|NCT02574247|455101859|FG002|Overall Study|Withdrawal by Subject|0|||
126492531|NCT02574247|455101857|FG000|Overall Study|Did not meet inclusion criteria|4|||
126492532|NCT02574247|455101858|FG001|Overall Study|Did not meet inclusion criteria|3|||
126492533|NCT02574247|455101859|FG002|Overall Study|Did not meet inclusion criteria|5|||
126492534|NCT00268996|455101860|FG000|Overall Study|Adverse Event|11|||
126492535|NCT00268996|455101861|FG001|Overall Study|Adverse Event|7|||
126492536|NCT00268996|455101860|FG000|Overall Study|Lost to Follow-up|3|||
126492537|NCT00268996|455101861|FG001|Overall Study|Lost to Follow-up|1|||
126492538|NCT00268996|455101860|FG000|Overall Study|Withdrawal by Subject|5|||
126492539|NCT00268996|455101861|FG001|Overall Study|Withdrawal by Subject|11|||
126492540|NCT00268996|455101860|FG000|Overall Study|Non-compliance|1|||
126492541|NCT00268996|455101861|FG001|Overall Study|Non-compliance|0|||
126492542|NCT00268996|455101860|FG000|Overall Study|Other|1|||
126492543|NCT00268996|455101861|FG001|Overall Study|Other|1|||
126492544|NCT04210310|455101862|FG000|Overall Study|Lost to Follow-up|32|||
126492545|NCT04210310|455101863|FG001|Overall Study|Lost to Follow-up|1|||
126492546|NCT03198234|455101864|FG000|Overall Study|Relapse of primary disease|0|||
126492547|NCT03198234|455101865|FG001|Overall Study|Relapse of primary disease|1|||
126492548|NCT03198234|455101866|FG002|Overall Study|Relapse of primary disease|0|||
126492549|NCT01340898|455101867|FG000|Primary Phase|Serious Adverse Events|0|||
126492550|NCT01340898|455101868|FG001|Primary Phase|Serious Adverse Events|0|||
126492551|NCT01340898|455101869|FG002|Primary Phase|Serious Adverse Events|1|||
126492552|NCT01340898|455101867|FG000|Primary Phase|Withdrawal by Subject|8|||
126492553|NCT01340898|455101868|FG001|Primary Phase|Withdrawal by Subject|7|||
126492554|NCT01340898|455101869|FG002|Primary Phase|Withdrawal by Subject|5|||
126492555|NCT01340898|455101867|FG000|Primary Phase|Migrated/moved from study area|4|||
126492556|NCT01340898|455101868|FG001|Primary Phase|Migrated/moved from study area|1|||
126492557|NCT01340898|455101869|FG002|Primary Phase|Migrated/moved from study area|0|||
126492558|NCT01340898|455101867|FG000|Primary Phase|Lost to Follow-up|4|||
126492559|NCT01340898|455101868|FG001|Primary Phase|Lost to Follow-up|1|||
126492560|NCT01340898|455101869|FG002|Primary Phase|Lost to Follow-up|0|||
126492561|NCT01340898|455101867|FG000|Booster Phase|Withdrawal by Subject|3|||
126492562|NCT01340898|455101868|FG001|Booster Phase|Withdrawal by Subject|0|||
126492563|NCT01340898|455101869|FG002|Booster Phase|Withdrawal by Subject|4|||
126492564|NCT01340898|455101867|FG000|Booster Phase|Migrated/moved from study area|3|||
126492565|NCT01340898|455101868|FG001|Booster Phase|Migrated/moved from study area|0|||
126492566|NCT01340898|455101869|FG002|Booster Phase|Migrated/moved from study area|0|||
126492567|NCT01340898|455101867|FG000|Booster Phase|Lost to Follow-up|4|||
126492568|NCT01340898|455101868|FG001|Booster Phase|Lost to Follow-up|2|||
126492569|NCT01340898|455101869|FG002|Booster Phase|Lost to Follow-up|3|||
126492570|NCT02056340|455101870|FG000|Overall Study|Lost to Follow-up|5|||
126492571|NCT02056340|455101871|FG001|Overall Study|Lost to Follow-up|5|||
126492572|NCT02056340|455101870|FG000|Overall Study|Withdrawal by Subject|2|||
126492573|NCT02056340|455101871|FG001|Overall Study|Withdrawal by Subject|6|||
126492574|NCT04900220|455101872|FG000|Overall Study|Lost to Follow-up|1|||
126492575|NCT04900220|455101873|FG001|Overall Study|Lost to Follow-up|1|||
126492576|NCT02196558|455101874|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
126492577|NCT02196558|455101875|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
126492578|NCT02196558|455101876|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
126492579|NCT02196558|455101874|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
126492580|NCT02196558|455101875|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
126492581|NCT02196558|455101876|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
126492582|NCT02196558|455101874|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
126492583|NCT02196558|455101875|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
126492584|NCT02196558|455101876|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
126492585|NCT02196558|455101874|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
126492586|NCT02196558|455101875|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
126492587|NCT02196558|455101876|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
126492588|NCT02196558|455101874|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
126492589|NCT02196558|455101875|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
126492590|NCT02196558|455101876|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
126492591|NCT01214629|455101878|FG000|Overall Study|Progressive Disease|1|||
126492592|NCT01214629|455101879|FG001|Overall Study|Progressive Disease|1|||
126492593|NCT01214629|455101880|FG002|Overall Study|Progressive Disease|0|||
126492594|NCT01214629|455101881|FG003|Overall Study|Progressive Disease|1|||
126492595|NCT01214629|455101882|FG004|Overall Study|Progressive Disease|2|||
126492596|NCT01214629|455101883|FG005|Overall Study|Progressive Disease|3|||
126492597|NCT01214629|455101884|FG006|Overall Study|Progressive Disease|1|||
126492598|NCT01214629|455101885|FG007|Overall Study|Progressive Disease|1|||
126492599|NCT01214629|455101886|FG008|Overall Study|Progressive Disease|1|||
126492600|NCT01214629|455101887|FG009|Overall Study|Progressive Disease|5|||
126492601|NCT01214629|455101888|FG010|Overall Study|Progressive Disease|1|||
126492602|NCT01214629|455101878|FG000|Overall Study|Adverse Event|0|||
126492603|NCT01214629|455101879|FG001|Overall Study|Adverse Event|0|||
126492604|NCT01214629|455101880|FG002|Overall Study|Adverse Event|0|||
126492605|NCT01214629|455101881|FG003|Overall Study|Adverse Event|1|||
126492606|NCT01214629|455101882|FG004|Overall Study|Adverse Event|0|||
126492607|NCT01214629|455101883|FG005|Overall Study|Adverse Event|1|||
126492608|NCT01214629|455101884|FG006|Overall Study|Adverse Event|0|||
126492609|NCT01214629|455101885|FG007|Overall Study|Adverse Event|0|||
126492610|NCT01214629|455101886|FG008|Overall Study|Adverse Event|0|||
126492611|NCT01214629|455101887|FG009|Overall Study|Adverse Event|1|||
126492612|NCT01214629|455101888|FG010|Overall Study|Adverse Event|0|||
126492613|NCT01214629|455101878|FG000|Overall Study|Physician Decision|0|||
126492614|NCT01214629|455101879|FG001|Overall Study|Physician Decision|0|||
126492615|NCT01214629|455101880|FG002|Overall Study|Physician Decision|0|||
126492616|NCT01214629|455101881|FG003|Overall Study|Physician Decision|0|||
126492617|NCT01214629|455101882|FG004|Overall Study|Physician Decision|0|||
126492618|NCT01214629|455101883|FG005|Overall Study|Physician Decision|0|||
126492619|NCT01214629|455101884|FG006|Overall Study|Physician Decision|0|||
126492620|NCT01214629|455101885|FG007|Overall Study|Physician Decision|0|||
126492621|NCT01214629|455101886|FG008|Overall Study|Physician Decision|0|||
126492622|NCT01214629|455101887|FG009|Overall Study|Physician Decision|0|||
126492623|NCT01214629|455101888|FG010|Overall Study|Physician Decision|1|||
126492624|NCT01214629|455101878|FG000|Overall Study|Withdrawal by Subject|0|||
126492625|NCT01214629|455101879|FG001|Overall Study|Withdrawal by Subject|0|||
126492626|NCT01214629|455101880|FG002|Overall Study|Withdrawal by Subject|0|||
126492627|NCT01214629|455101881|FG003|Overall Study|Withdrawal by Subject|0|||
126492628|NCT01214629|455101882|FG004|Overall Study|Withdrawal by Subject|0|||
126492629|NCT01214629|455101883|FG005|Overall Study|Withdrawal by Subject|0|||
126492630|NCT01214629|455101884|FG006|Overall Study|Withdrawal by Subject|0|||
126492631|NCT01214629|455101885|FG007|Overall Study|Withdrawal by Subject|0|||
126492632|NCT01214629|455101886|FG008|Overall Study|Withdrawal by Subject|0|||
126492633|NCT01214629|455101887|FG009|Overall Study|Withdrawal by Subject|1|||
126492634|NCT01214629|455101888|FG010|Overall Study|Withdrawal by Subject|0|||
126492635|NCT02669433|455101892|FG000|Overall Study|Protocol Violation|0|||
126492636|NCT02669433|455101893|FG001|Overall Study|Protocol Violation|4|||
126492637|NCT02669433|455101894|FG002|Overall Study|Protocol Violation|1|||
126492638|NCT02669433|455101892|FG000|Overall Study|Disease Progression|1|||
126492639|NCT02669433|455101893|FG001|Overall Study|Disease Progression|0|||
126492640|NCT02669433|455101894|FG002|Overall Study|Disease Progression|0|||
126492641|NCT02669433|455101892|FG000|Overall Study|Physician Decision|1|||
126492642|NCT02669433|455101893|FG001|Overall Study|Physician Decision|1|||
126492643|NCT02669433|455101894|FG002|Overall Study|Physician Decision|0|||
126492644|NCT02669433|455101892|FG000|Overall Study|Adverse Event|6|||
126492645|NCT02669433|455101893|FG001|Overall Study|Adverse Event|7|||
126492646|NCT02669433|455101894|FG002|Overall Study|Adverse Event|10|||
126492647|NCT02669433|455101892|FG000|Overall Study|Sponsor Termination|1|||
126492648|NCT02669433|455101893|FG001|Overall Study|Sponsor Termination|0|||
126492649|NCT02669433|455101894|FG002|Overall Study|Sponsor Termination|1|||
126492650|NCT02669433|455101892|FG000|Overall Study|Withdrawal by Subject|5|||
126492651|NCT02669433|455101893|FG001|Overall Study|Withdrawal by Subject|1|||
126492652|NCT02669433|455101894|FG002|Overall Study|Withdrawal by Subject|0|||
126492653|NCT02669433|455101892|FG000|Overall Study|Withdrawal by Caregiver|1|||
126492654|NCT02669433|455101893|FG001|Overall Study|Withdrawal by Caregiver|0|||
126492655|NCT02669433|455101894|FG002|Overall Study|Withdrawal by Caregiver|2|||
126492656|NCT02669433|455101892|FG000|Overall Study|Death|0|||
126492657|NCT02669433|455101893|FG001|Overall Study|Death|1|||
126492658|NCT02669433|455101894|FG002|Overall Study|Death|1|||
126492659|NCT00576927|455101895|FG000|Clinical Assessment|Lack of Efficacy|24|||
126492660|NCT00576927|455101895|FG000|Clinical Assessment|Death|1|||
126492661|NCT00576927|455101895|FG000|Clinical Assessment|Withdrawal by Subject|10|||
126492662|NCT00576927|455101895|FG000|Clinical Assessment|Physician Decision|1|||
126492663|NCT00576927|455101895|FG000|Baseline|Physician Decision|9|||
126492664|NCT00576927|455101895|FG000|Baseline|Medication Change by PCP of subject|1|||
126492665|NCT00576927|455101895|FG000|Baseline|Withdrawal by Subject|3|||
126492666|NCT00576927|455101895|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
126492667|NCT00576927|455101895|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
126492668|NCT00576927|455101895|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
126492669|NCT00576927|455101895|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
126492670|NCT00576927|455101895|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
126492671|NCT03266094|455101896|FG000|Overall Study|Lost to Follow-up|1|||
126492672|NCT03266094|455101896|FG000|Overall Study|Withdrawal by Subject|1|||
126492673|NCT03128892|455101897|FG000|Overall Study|Withdrawal by Subject|2|||
126492674|NCT03128892|455101897|FG000|Overall Study|Physician Decision|1|||
126492675|NCT03473808|455101903|FG000|Overall Study|Withdrawal by Subject|1|||
126492676|NCT02157298|455101904|FG000|Overall Study|Adverse Event|1|||
126492677|NCT02157298|455101905|FG001|Overall Study|Adverse Event|0|||
126492678|NCT02157298|455101904|FG000|Overall Study|Subject no longer meets study criteria|1|||
126492679|NCT02157298|455101905|FG001|Overall Study|Subject no longer meets study criteria|2|||
126492680|NCT02157298|455101904|FG000|Overall Study|Poor/Non-compliance|1|||
126492681|NCT02157298|455101905|FG001|Overall Study|Poor/Non-compliance|0|||
126492682|NCT02157298|455101904|FG000|Overall Study|Withdrawal by Subject|1|||
126492683|NCT02157298|455101905|FG001|Overall Study|Withdrawal by Subject|0|||
126492684|NCT03171415|455101906|FG000|Overall Study|Lost to Follow-up|0|||
126492685|NCT03171415|455101907|FG001|Overall Study|Lost to Follow-up|0|||
126492686|NCT03171415|455101908|FG002|Overall Study|Lost to Follow-up|0|||
126492687|NCT03171415|455101909|FG003|Overall Study|Lost to Follow-up|0|||
126492688|NCT03171415|455101910|FG004|Overall Study|Lost to Follow-up|2|||
126492689|NCT04059094|455101911|FG000|Overall Study|Adverse Event|0|||
126492690|NCT04059094|455101912|FG001|Overall Study|Adverse Event|0|||
126492691|NCT04059094|455101913|FG002|Overall Study|Adverse Event|0|||
126492692|NCT04059094|455101914|FG003|Overall Study|Adverse Event|0|||
126492693|NCT04059094|455101915|FG004|Overall Study|Adverse Event|1|||
126492694|NCT04059094|455101911|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
126492695|NCT04059094|455101912|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
126492696|NCT04059094|455101913|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
126492697|NCT04059094|455101914|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
126492698|NCT04059094|455101915|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
126723448|NCT02052778|455936100|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723449|NCT02052778|455936101|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723450|NCT02052778|455936102|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723451|NCT02052778|455936103|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
126723452|NCT02052778|455936104|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
126723453|NCT02052778|455936082|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
126723454|NCT02052778|455936083|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
126723455|NCT02052778|455936084|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
126723456|NCT02052778|455936085|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
126723457|NCT02052778|455936086|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
126723458|NCT02052778|455936087|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
126723459|NCT02052778|455936088|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
126723460|NCT02052778|455936089|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
126723461|NCT02052778|455936090|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
126723462|NCT02052778|455936091|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
126723463|NCT02052778|455936092|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
126723464|NCT02052778|455936093|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
126723465|NCT02052778|455936094|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
126723466|NCT02052778|455936095|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
126723467|NCT02052778|455936096|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
126723468|NCT02052778|455936097|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
126723469|NCT02052778|455936098|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
126723470|NCT02052778|455936099|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
126723471|NCT02052778|455936100|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
126723472|NCT02052778|455936101|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
126723473|NCT02052778|455936102|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
126723474|NCT02052778|455936103|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
126723475|NCT02052778|455936104|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
126723476|NCT02052778|455936082|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723477|NCT02052778|455936083|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723478|NCT02052778|455936084|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723479|NCT02052778|455936085|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
126492699|NCT03715764|455101918|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
126492700|NCT03715764|455101919|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
126492701|NCT03715764|455101918|FG000|3 Month Follow-up|Lost to Follow-up|2|||
126492702|NCT03715764|455101919|FG001|3 Month Follow-up|Lost to Follow-up|2|||
126492703|NCT03715764|455101918|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
126492704|NCT03715764|455101919|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
126492705|NCT03715764|455101918|FG000|6 Month Follow-up|Lost to Follow-up|3|||
126492706|NCT03715764|455101919|FG001|6 Month Follow-up|Lost to Follow-up|0|||
126492707|NCT03715764|455101918|FG000|12 Month Follow-up|Lost to Follow-up|2|||
126492708|NCT03715764|455101919|FG001|12 Month Follow-up|Lost to Follow-up|3|||
126492709|NCT03715764|455101918|FG000|12 Month Follow-up|Pregnancy|0|||
126492710|NCT03715764|455101919|FG001|12 Month Follow-up|Pregnancy|1|||
126492711|NCT03715764|455101918|FG000|12 Month Follow-up|Surgery|2|||
126492712|NCT03715764|455101919|FG001|12 Month Follow-up|Surgery|0|||
126492713|NCT03715764|455101918|FG000|12 Month Follow-up|Wrong address|1|||
126492714|NCT03715764|455101919|FG001|12 Month Follow-up|Wrong address|0|||
126492715|NCT03715764|455101918|FG000|12 Month Follow-up|No symptoms|1|||
126492716|NCT03715764|455101919|FG001|12 Month Follow-up|No symptoms|0|||
126492717|NCT03715764|455101918|FG000|12 Month Follow-up|Changed primary care centre|0|||
126492718|NCT03715764|455101919|FG001|12 Month Follow-up|Changed primary care centre|1|||
126492719|NCT01338493|455101926|FG000|Enrolled|Withdrawal by Subject|1|||
126492720|NCT01338493|455101926|FG000|Enrolled|Patient not implanted|4|||
126723480|NCT02052778|455936086|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723481|NCT02052778|455936087|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723482|NCT02052778|455936088|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
126492721|NCT01338493|455101926|FG000|Discharge|Death|1|||
126492722|NCT01338493|455101926|FG000|Discharge|Missed visit|1|||
126492723|NCT01338493|455101926|FG000|6 Months Follow up|Lost to Follow-up|11|||
126492724|NCT01338493|455101926|FG000|6 Months Follow up|Missed visit|8|||
126723483|NCT02052778|455936089|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723484|NCT02052778|455936090|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
126492725|NCT01338493|455101926|FG000|12 Months Follow up|Lost to Follow-up|9|||
126492726|NCT01705652|455101928|FG000|Overall Study|Adverse Event|1|||
126492727|NCT01705652|455101929|FG001|Overall Study|Adverse Event|0|||
126492728|NCT01705652|455101928|FG000|Overall Study|Withdrawal by Subject|1|||
126723485|NCT02052778|455936091|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723486|NCT02052778|455936092|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
126492729|NCT01705652|455101929|FG001|Overall Study|Withdrawal by Subject|2|||
126492730|NCT01705652|455101928|FG000|Overall Study|non-compliance|1|||
126492731|NCT01705652|455101929|FG001|Overall Study|non-compliance|1|||
126492732|NCT00541034|455101930|FG000|Overall Study|Non-Compliance|3|||
126492733|NCT00656474|455101931|FG000|Overall Study|Other Reason|1|||
126492734|NCT01962207|455101932|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
126492735|NCT01962207|455101933|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
126492736|NCT01962207|455101934|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
126492737|NCT01962207|455101935|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
126492738|NCT01962207|455101932|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
126492739|NCT01962207|455101933|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
126492740|NCT01962207|455101934|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
126492741|NCT01962207|455101935|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
126492742|NCT01962207|455101932|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
126492743|NCT01962207|455101933|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
126492744|NCT01962207|455101934|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
126492745|NCT01962207|455101935|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
126492746|NCT01962207|455101932|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
126492747|NCT01962207|455101933|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
126492748|NCT01962207|455101934|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
126492749|NCT01962207|455101935|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
126492750|NCT01962207|455101932|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
126492751|NCT01962207|455101933|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
126492752|NCT01962207|455101934|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
126492753|NCT01962207|455101935|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
126492754|NCT01962207|455101932|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
126492755|NCT01962207|455101933|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
126492756|NCT01962207|455101934|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
126492757|NCT01962207|455101935|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
126492758|NCT00847704|455101936|FG000|Overall Study|Withdrawal by Subject|1|||
126492759|NCT03036072|455101939|FG000|Overall Study|Death|0|||
126492760|NCT03036072|455101940|FG001|Overall Study|Death|1|||
126492761|NCT03036072|455101939|FG000|Overall Study|Withdrawal by Subject|0|||
126492762|NCT03036072|455101940|FG001|Overall Study|Withdrawal by Subject|1|||
126492763|NCT03036072|455101939|FG000|Overall Study|Physician Decision|0|||
126492764|NCT03036072|455101940|FG001|Overall Study|Physician Decision|1|||
126492765|NCT00492115|455101945|FG000|Overall Study|Withdrawal by Subject|3|||
126492766|NCT00492115|455101946|FG001|Overall Study|Withdrawal by Subject|4|||
126492767|NCT03564145|455101947|FG000|Overall Study|Adverse Event|4|||
126492768|NCT03564145|455101947|FG000|Overall Study|Lost to Follow-up|21|||
126492769|NCT03564145|455101947|FG000|Overall Study|Protocol Violation|2|||
126492770|NCT03564145|455101947|FG000|Overall Study|Withdrawal by Subject|48|||
126492771|NCT03564145|455101947|FG000|Overall Study|Study Terminated by Sponsor|146|||
126492772|NCT03564145|455101947|FG000|Overall Study|Physician Decision|1|||
126492773|NCT03564145|455101947|FG000|Overall Study|Other Than Specified|1|||
126492774|NCT03564145|455101947|FG000|Overall Study|Pregnancy|1|||
126492775|NCT01031069|455101950|FG000|Overall Study|Serious Adverse Event|0|||
126492776|NCT01031069|455101951|FG001|Overall Study|Serious Adverse Event|1|||
126492777|NCT01031069|455101952|FG002|Overall Study|Serious Adverse Event|0|||
126492778|NCT01031069|455101953|FG003|Overall Study|Serious Adverse Event|0|||
126492779|NCT01031069|455101950|FG000|Overall Study|Withdrawal by Subject|2|||
126492780|NCT01031069|455101951|FG001|Overall Study|Withdrawal by Subject|3|||
126492781|NCT01031069|455101952|FG002|Overall Study|Withdrawal by Subject|18|||
126492782|NCT01031069|455101953|FG003|Overall Study|Withdrawal by Subject|18|||
126492783|NCT01031069|455101950|FG000|Overall Study|Migrated/moved from study area|1|||
126492784|NCT01031069|455101951|FG001|Overall Study|Migrated/moved from study area|2|||
126492785|NCT01031069|455101952|FG002|Overall Study|Migrated/moved from study area|1|||
126492786|NCT01031069|455101953|FG003|Overall Study|Migrated/moved from study area|1|||
126492787|NCT01031069|455101950|FG000|Overall Study|Lost to Follow-up|9|||
126492788|NCT01031069|455101951|FG001|Overall Study|Lost to Follow-up|5|||
126492789|NCT01031069|455101952|FG002|Overall Study|Lost to Follow-up|21|||
126492790|NCT01031069|455101953|FG003|Overall Study|Lost to Follow-up|15|||
126492791|NCT01031069|455101950|FG000|Overall Study|Other|0|||
126492792|NCT01031069|455101951|FG001|Overall Study|Other|0|||
126492793|NCT01031069|455101952|FG002|Overall Study|Other|1|||
126492794|NCT01031069|455101953|FG003|Overall Study|Other|0|||
126492795|NCT05286307|455101954|FG000|Overall Study|Incomplete outcome assessments|2|||
126492796|NCT05286307|455101955|FG001|Overall Study|Incomplete outcome assessments|1|||
126492797|NCT05286307|455101954|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
126492798|NCT05286307|455101955|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
126492799|NCT05286307|455101954|FG000|Overall Study|Lost to follow up at 6 months|25|||
126492800|NCT05286307|455101955|FG001|Overall Study|Lost to follow up at 6 months|35|||
126492801|NCT05286307|455101954|FG000|Overall Study|Study medication not available|1|||
126492802|NCT05286307|455101955|FG001|Overall Study|Study medication not available|1|||
126492803|NCT01103284|455101956|FG000|Overall Study|Death|2|||
126492804|NCT01103284|455101957|FG001|Overall Study|Death|0|||
126492805|NCT01103284|455101956|FG000|Overall Study|Lost to Follow-up|9|||
126492806|NCT01103284|455101957|FG001|Overall Study|Lost to Follow-up|10|||
126492807|NCT01103284|455101956|FG000|Overall Study|Pregnancy|3|||
126492808|NCT01103284|455101957|FG001|Overall Study|Pregnancy|1|||
126492809|NCT01103284|455101956|FG000|Overall Study|Protocol Violation|12|||
126492810|NCT01103284|455101957|FG001|Overall Study|Protocol Violation|5|||
126492811|NCT01103284|455101956|FG000|Overall Study|Adverse Event|0|||
126492812|NCT01103284|455101957|FG001|Overall Study|Adverse Event|5|||
126492813|NCT01103284|455101956|FG000|Overall Study|Withdrawal by Subject|14|||
126492814|NCT01103284|455101957|FG001|Overall Study|Withdrawal by Subject|18|||
126492815|NCT01103284|455101956|FG000|Overall Study|Dermal Hypersensitivity|0|||
126492816|NCT01103284|455101957|FG001|Overall Study|Dermal Hypersensitivity|1|||
126492817|NCT01103284|455101956|FG000|Overall Study|Termination by the Sponsor|0|||
126492818|NCT01103284|455101957|FG001|Overall Study|Termination by the Sponsor|1|||
126492819|NCT01103284|455101956|FG000|Overall Study|Not described|2|||
126492820|NCT01103284|455101957|FG001|Overall Study|Not described|1|||
126492821|NCT01103284|455101956|FG000|Overall Study|Missing CRF entries for study completion|0|||
126492822|NCT01103284|455101957|FG001|Overall Study|Missing CRF entries for study completion|2|||
126492823|NCT05024058|455104080|FG000|Treatment|Study terminated by sponsor|5|||
126492824|NCT05024058|455104081|FG001|Treatment|Study terminated by sponsor|6|||
126492825|NCT05024058|455104082|FG002|Treatment|Study terminated by sponsor|4|||
126492826|NCT05024058|455104083|FG003|Treatment|Study terminated by sponsor|2|||
126492827|NCT05024058|455104084|FG004|Treatment|Study terminated by sponsor|3|||
126492828|NCT05024058|455104085|FG005|Treatment|Study terminated by sponsor|3|||
126492829|NCT05024058|455104086|FG006|Treatment|Study terminated by sponsor|1|||
126492830|NCT05024058|455104087|FG007|Treatment|Study terminated by sponsor|3|||
126492831|NCT05024058|455104088|FG008|Treatment|Study terminated by sponsor|6|||
126492832|NCT05024058|455104089|FG009|Treatment|Study terminated by sponsor|6|||
126492833|NCT05024058|455104080|FG000|Follow-up|Withdrawal by Subject|1|||
126492834|NCT05024058|455104081|FG001|Follow-up|Withdrawal by Subject|0|||
126492835|NCT05024058|455104082|FG002|Follow-up|Withdrawal by Subject|1|||
126492836|NCT05024058|455104083|FG003|Follow-up|Withdrawal by Subject|0|||
126492837|NCT05024058|455104084|FG004|Follow-up|Withdrawal by Subject|0|||
126492838|NCT05024058|455104085|FG005|Follow-up|Withdrawal by Subject|0|||
126492839|NCT05024058|455104086|FG006|Follow-up|Withdrawal by Subject|0|||
126492840|NCT05024058|455104087|FG007|Follow-up|Withdrawal by Subject|1|||
126492841|NCT05024058|455104088|FG008|Follow-up|Withdrawal by Subject|0|||
126492842|NCT05024058|455104089|FG009|Follow-up|Withdrawal by Subject|1|||
126492843|NCT02734810|455104093|FG000|Overall Study|Adverse Event|1|||
126492844|NCT02734810|455104094|FG001|Overall Study|Adverse Event|0|||
126492845|NCT02734810|455104093|FG000|Overall Study|Lack of Efficacy|1|||
126492846|NCT02734810|455104094|FG001|Overall Study|Lack of Efficacy|0|||
126492847|NCT01104636|455104100|FG000|Overall Study|Lack of Efficacy|43|||
126492848|NCT01104636|455104100|FG000|Overall Study|Lost to Follow-up|24|||
126492849|NCT01104636|455104100|FG000|Overall Study|Withdrawal by Subject|4|||
126492850|NCT01104636|455104100|FG000|Overall Study|Other|43|||
126492851|NCT01104636|455104100|FG000|Overall Study|Study terminated by sponsor|1|||
126492852|NCT01104636|455104100|FG000|Overall Study|Pregnancy|2|||
126492853|NCT01104636|455104100|FG000|Overall Study|Adverse Event|40|||
126492854|NCT01104636|455104100|FG000|Overall Study|Ongoing|21|||
126492855|NCT01706003|455104101|FG000|Overall Study|Withdrawal by Subject|2|||
126492856|NCT01706003|455104102|FG001|Overall Study|Withdrawal by Subject|0|||
126492857|NCT01706003|455104101|FG000|Overall Study|Not scheduled|3|||
126492858|NCT01706003|455104102|FG001|Overall Study|Not scheduled|0|||
126492859|NCT01706003|455104101|FG000|Overall Study|Lost to Follow-up|6|||
126492860|NCT01706003|455104102|FG001|Overall Study|Lost to Follow-up|4|||
126492861|NCT00407563|455104105|FG000|Overall Study|Patient continues on treatment|1|||
126492862|NCT00696696|455104106|FG000|Overall Study|Adverse Event|5|||
126492863|NCT00696696|455104106|FG000|Overall Study|Withdrawal by Subject|8|||
126492864|NCT00696696|455104106|FG000|Overall Study|Physician Decision|2|||
126492865|NCT00696696|455104106|FG000|Overall Study|Death|3|||
126492866|NCT03055260|455104107|FG000|Overall Study|Withdrawal by Subject|1|||
126492867|NCT03055260|455104108|FG001|Overall Study|Withdrawal by Subject|0|||
126492868|NCT02507505|455104109|FG000|Overall Study|Withdrawal by Subject|13|||
126772647|NCT02454972|456123632|FG003|Overall Study|Withdrawal by Subject|2|||
126772648|NCT02454972|456123633|FG004|Overall Study|Withdrawal by Subject|3|||
126492869|NCT02507505|455104110|FG001|Overall Study|Withdrawal by Subject|11|||
126492870|NCT02507505|455104109|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
126559553|NCT02373813|455342537|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
126492871|NCT02507505|455104110|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
126492872|NCT02507505|455104109|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
126492873|NCT02507505|455104110|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
126492874|NCT02507505|455104109|FG000|Overall Study|Death before receipt of anesthesia|0|||
126492875|NCT02507505|455104110|FG001|Overall Study|Death before receipt of anesthesia|1|||
126492876|NCT03182829|455104111|FG000|Overall Study|Protocol Violation|12|||
126492877|NCT03182829|455104112|FG001|Overall Study|Protocol Violation|12|||
126492878|NCT03182829|455104111|FG000|Overall Study|Other|4|||
126492879|NCT03182829|455104112|FG001|Overall Study|Other|3|||
126492880|NCT00254540|455104113|FG000|Overall Study|Adverse Event|6|||
126492881|NCT00254540|455104114|FG001|Overall Study|Adverse Event|7|||
126492882|NCT00254540|455104113|FG000|Overall Study|Lack of Efficacy|13|||
126492883|NCT00254540|455104114|FG001|Overall Study|Lack of Efficacy|13|||
126492884|NCT00254540|455104113|FG000|Overall Study|Death|0|||
126492885|NCT00254540|455104114|FG001|Overall Study|Death|1|||
126492886|NCT00254540|455104113|FG000|Overall Study|Laboratory Test Abnormality|0|||
126492887|NCT00254540|455104114|FG001|Overall Study|Laboratory Test Abnormality|1|||
126492888|NCT00225251|455104115|FG000|Overall Study|Withdrawal by Subject|1|||
126492889|NCT00225251|455104116|FG001|Overall Study|Withdrawal by Subject|1|||
126492890|NCT03045328|455104122|FG000|Overall Study|Withdrawal by Subject|2|||
126723487|NCT02052778|455936093|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723488|NCT02052778|455936094|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723489|NCT02052778|455936095|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723490|NCT02052778|455936096|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723491|NCT02052778|455936097|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723492|NCT02052778|455936098|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723493|NCT02052778|455936099|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723494|NCT02052778|455936100|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723495|NCT02052778|455936101|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723496|NCT02052778|455936102|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723497|NCT02052778|455936103|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
126723498|NCT02052778|455936104|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
126723499|NCT01358877|455936109|FG000|Overall Study|Death|80|||
126723500|NCT01358877|455936110|FG001|Overall Study|Death|89|||
126723501|NCT01358877|455936109|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
126723502|NCT01358877|455936110|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
126723503|NCT01358877|455936109|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
126723504|NCT01358877|455936110|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
126723505|NCT01358877|455936109|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
126723506|NCT01358877|455936110|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
126723507|NCT01358877|455936109|FG000|Overall Study|Other|142|||
126723508|NCT01358877|455936110|FG001|Overall Study|Other|129|||
126723509|NCT01911845|455936115|FG000|Overall Study|Adverse Event|2|||
126723510|NCT01911845|455936115|FG000|Overall Study|Lost to Follow-up|1|||
126723511|NCT01911845|455936115|FG000|Overall Study|Other (not specified)|3|||
126723512|NCT01994226|455936116|FG000|Overall Study|Protocol Violation|13|||
126723513|NCT01994226|455936117|FG001|Overall Study|Protocol Violation|10|||
126723514|NCT01994226|455936116|FG000|Overall Study|Early Cessation of treatment|6|||
126723515|NCT01994226|455936117|FG001|Overall Study|Early Cessation of treatment|11|||
126723516|NCT00501046|455936122|FG000|Overall Study|Adverse Event|21|||
126723517|NCT00501046|455936123|FG001|Overall Study|Adverse Event|25|||
126723518|NCT00501046|455936122|FG000|Overall Study|Death|23|||
126723519|NCT00501046|455936123|FG001|Overall Study|Death|30|||
126723520|NCT00501046|455936122|FG000|Overall Study|Lost to Follow-up|14|||
126723521|NCT00501046|455936123|FG001|Overall Study|Lost to Follow-up|13|||
126723522|NCT00501046|455936122|FG000|Overall Study|Physician Decision|7|||
126492891|NCT00592839|455104123|FG000|Overall Study|Withdrawal by Subject|1|||
126492892|NCT00592839|455104124|FG001|Overall Study|Withdrawal by Subject|1|||
126492893|NCT00592839|455104125|FG002|Overall Study|Withdrawal by Subject|3|||
126492894|NCT00592839|455104123|FG000|Overall Study|Protocol Violation|1|||
126492895|NCT00592839|455104124|FG001|Overall Study|Protocol Violation|1|||
126492896|NCT00592839|455104125|FG002|Overall Study|Protocol Violation|2|||
126492897|NCT00592839|455104123|FG000|Overall Study|Adverse Event|0|||
126492898|NCT00592839|455104124|FG001|Overall Study|Adverse Event|1|||
126492899|NCT00592839|455104125|FG002|Overall Study|Adverse Event|0|||
126492900|NCT00592839|455104123|FG000|Overall Study|Lost to Follow-up|0|||
126492901|NCT00592839|455104124|FG001|Overall Study|Lost to Follow-up|1|||
126723523|NCT00501046|455936123|FG001|Overall Study|Physician Decision|2|||
126723524|NCT00501046|455936122|FG000|Overall Study|Pregnancy|0|||
126723525|NCT00501046|455936123|FG001|Overall Study|Pregnancy|3|||
126492902|NCT00592839|455104125|FG002|Overall Study|Lost to Follow-up|1|||
126723526|NCT00501046|455936122|FG000|Overall Study|Protocol Violation|2|||
126723527|NCT00501046|455936123|FG001|Overall Study|Protocol Violation|1|||
126723528|NCT00501046|455936122|FG000|Overall Study|Withdrawal by Subject|84|||
126723529|NCT00501046|455936123|FG001|Overall Study|Withdrawal by Subject|83|||
126723530|NCT00501046|455936122|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
126723531|NCT00501046|455936123|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
126723532|NCT01980706|455936128|FG000|Overall Study|Withdrawal by Subject|9|||
126492903|NCT01313767|455104126|FG000|Overall Study|Adverse Event|1|||
126492904|NCT01313767|455104127|FG001|Overall Study|Adverse Event|0|||
126492905|NCT01313767|455104126|FG000|Overall Study|Lost to Follow-up|1|||
126723533|NCT01980706|455936129|FG001|Overall Study|Withdrawal by Subject|6|||
126492906|NCT01313767|455104127|FG001|Overall Study|Lost to Follow-up|0|||
126492907|NCT01313767|455104126|FG000|Overall Study|Withdrawal by Subject|2|||
126492908|NCT01313767|455104127|FG001|Overall Study|Withdrawal by Subject|1|||
126492909|NCT01313767|455104126|FG000|Overall Study|Protocol Violation|3|||
126492910|NCT01313767|455104127|FG001|Overall Study|Protocol Violation|1|||
126492911|NCT01287897|455104133|FG000|Overall Study|Adverse Event|5|||
126492912|NCT01287897|455104134|FG001|Overall Study|Adverse Event|3|||
126492913|NCT01287897|455104135|FG002|Overall Study|Adverse Event|6|||
126492914|NCT01287897|455104136|FG003|Overall Study|Adverse Event|4|||
126492915|NCT01287897|455104133|FG000|Overall Study|Lack of Efficacy|2|||
126492916|NCT01287897|455104134|FG001|Overall Study|Lack of Efficacy|0|||
126492917|NCT01287897|455104135|FG002|Overall Study|Lack of Efficacy|0|||
126492918|NCT01287897|455104136|FG003|Overall Study|Lack of Efficacy|0|||
126492919|NCT01287897|455104133|FG000|Overall Study|Protocol Violation|1|||
126492920|NCT01287897|455104134|FG001|Overall Study|Protocol Violation|1|||
126492921|NCT01287897|455104135|FG002|Overall Study|Protocol Violation|0|||
126492922|NCT01287897|455104136|FG003|Overall Study|Protocol Violation|1|||
126492923|NCT01287897|455104133|FG000|Overall Study|Lost to Follow-up|0|||
126492924|NCT01287897|455104134|FG001|Overall Study|Lost to Follow-up|0|||
126492925|NCT01287897|455104135|FG002|Overall Study|Lost to Follow-up|2|||
126492926|NCT01287897|455104136|FG003|Overall Study|Lost to Follow-up|0|||
126492927|NCT01287897|455104133|FG000|Overall Study|Withdrawal by Subject|1|||
126492928|NCT01287897|455104134|FG001|Overall Study|Withdrawal by Subject|5|||
126492929|NCT01287897|455104135|FG002|Overall Study|Withdrawal by Subject|3|||
126492930|NCT01287897|455104136|FG003|Overall Study|Withdrawal by Subject|2|||
126492931|NCT01287897|455104133|FG000|Overall Study|Not consented properly|0|||
126492932|NCT01287897|455104134|FG001|Overall Study|Not consented properly|1|||
126492933|NCT01287897|455104135|FG002|Overall Study|Not consented properly|0|||
126492934|NCT01287897|455104136|FG003|Overall Study|Not consented properly|0|||
126492935|NCT01287897|455104133|FG000|Overall Study|Not meeting entrance criteria|1|||
126492936|NCT01287897|455104134|FG001|Overall Study|Not meeting entrance criteria|1|||
126492937|NCT01287897|455104135|FG002|Overall Study|Not meeting entrance criteria|0|||
126492938|NCT01287897|455104136|FG003|Overall Study|Not meeting entrance criteria|0|||
126492939|NCT01287897|455104133|FG000|Overall Study|Other|1|||
126492940|NCT01287897|455104134|FG001|Overall Study|Other|0|||
126492941|NCT01287897|455104135|FG002|Overall Study|Other|1|||
126492942|NCT01287897|455104136|FG003|Overall Study|Other|0|||
126492943|NCT00249444|455104137|FG000|Overall Study|Lost to Follow-up|2|||
126492944|NCT00249444|455104138|FG001|Overall Study|Lost to Follow-up|2|||
126492945|NCT00249444|455104137|FG000|Overall Study|non-compliant|9|||
126492946|NCT00249444|455104138|FG001|Overall Study|non-compliant|11|||
126492947|NCT00249444|455104137|FG000|Overall Study|Adverse Event|1|||
126492948|NCT00249444|455104138|FG001|Overall Study|Adverse Event|1|||
126492949|NCT00249444|455104137|FG000|Overall Study|life event|0|||
126492950|NCT00249444|455104138|FG001|Overall Study|life event|1|||
126492951|NCT00936910|455104141|FG000|Overall Study|Lack of Efficacy|3|||
126492952|NCT00412854|455104142|FG000|Overall Study|Withdrawn due to adverse events|1|||
126492953|NCT00412854|455104143|FG001|Overall Study|Withdrawn due to adverse events|5|||
126492954|NCT00412854|455104142|FG000|Overall Study|Withdrawn for other reasons|13|||
126492955|NCT00412854|455104143|FG001|Overall Study|Withdrawn for other reasons|11|||
126492956|NCT04483011|455104147|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
126492957|NCT04483011|455104148|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
126492958|NCT03518073|455104149|FG000|Overall Study|Adverse Event|2|||
126492959|NCT03518073|455104150|FG001|Overall Study|Adverse Event|4|||
126492960|NCT03518073|455104151|FG002|Overall Study|Adverse Event|2|||
126492961|NCT03518073|455104149|FG000|Overall Study|Death|2|||
126492962|NCT03518073|455104150|FG001|Overall Study|Death|1|||
126492963|NCT03518073|455104151|FG002|Overall Study|Death|3|||
126492964|NCT03518073|455104149|FG000|Overall Study|Lost to Follow-up|1|||
126492965|NCT03518073|455104150|FG001|Overall Study|Lost to Follow-up|0|||
126492966|NCT03518073|455104151|FG002|Overall Study|Lost to Follow-up|1|||
126492967|NCT03518073|455104149|FG000|Overall Study|Physician Decision|5|||
126492968|NCT03518073|455104150|FG001|Overall Study|Physician Decision|0|||
126492969|NCT03518073|455104151|FG002|Overall Study|Physician Decision|2|||
126492970|NCT03518073|455104149|FG000|Overall Study|Progressive disease|1|||
126492971|NCT03518073|455104150|FG001|Overall Study|Progressive disease|1|||
126492972|NCT03518073|455104151|FG002|Overall Study|Progressive disease|1|||
126492973|NCT03518073|455104149|FG000|Overall Study|Protocol Violation|1|||
126492974|NCT03518073|455104150|FG001|Overall Study|Protocol Violation|0|||
126492975|NCT03518073|455104151|FG002|Overall Study|Protocol Violation|0|||
126492976|NCT03518073|455104149|FG000|Overall Study|Withdrawal by Subject|30|||
126492977|NCT03518073|455104150|FG001|Overall Study|Withdrawal by Subject|34|||
126492978|NCT03518073|455104151|FG002|Overall Study|Withdrawal by Subject|29|||
126492979|NCT03518073|455104149|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
126492980|NCT03518073|455104150|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
126492981|NCT03518073|455104151|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
126492982|NCT03518073|455104149|FG000|Overall Study|Covid-19|1|||
126492983|NCT03518073|455104150|FG001|Overall Study|Covid-19|2|||
126492984|NCT03518073|455104151|FG002|Overall Study|Covid-19|1|||
126492985|NCT03045081|455104152|FG000|Overall Study|Withdrawal by Subject|6|||
126492986|NCT03045081|455104153|FG001|Overall Study|Withdrawal by Subject|11|||
126492987|NCT01853046|455104154|FG000|Overall Study|Withdrawal by Subject|1|||
126492988|NCT01853046|455104155|FG001|Overall Study|Withdrawal by Subject|1|||
126492989|NCT01853046|455104154|FG000|Overall Study|Adverse Event|4|||
126492990|NCT01853046|455104155|FG001|Overall Study|Adverse Event|2|||
126492991|NCT01853046|455104154|FG000|Overall Study|Disease progression|13|||
126492992|NCT01853046|455104155|FG001|Overall Study|Disease progression|3|||
126492993|NCT01485640|455104156|FG000|Overall Study|Adverse Event|10|||
126492994|NCT01485640|455104156|FG000|Overall Study|Lack of Efficacy|2|||
126492995|NCT01485640|455104156|FG000|Overall Study|Protocol Violation|1|||
126492996|NCT01485640|455104156|FG000|Overall Study|Withdrawal by Subject|14|||
126492997|NCT01485640|455104156|FG000|Overall Study|Terminated by Sponsor|95|||
126492998|NCT00065507|455104160|FG000|Overall Study|Death|16|||
126492999|NCT00065507|455104161|FG001|Overall Study|Death|17|||
126493000|NCT00065507|455104160|FG000|Overall Study|Adverse Event|4|||
126493001|NCT00065507|455104161|FG001|Overall Study|Adverse Event|3|||
126493002|NCT00065507|455104160|FG000|Overall Study|Lack of Efficacy|0|||
126493003|NCT00065507|455104161|FG001|Overall Study|Lack of Efficacy|6|||
126493004|NCT00065507|455104160|FG000|Overall Study|Poor/Non-compliance|3|||
126493005|NCT00065507|455104161|FG001|Overall Study|Poor/Non-compliance|2|||
126493006|NCT00065507|455104160|FG000|Overall Study|Lost to Follow-up|3|||
126493007|NCT00065507|455104161|FG001|Overall Study|Lost to Follow-up|0|||
126493008|NCT00065507|455104160|FG000|Overall Study|Subject Withdrew Consent|2|||
126493009|NCT00065507|455104161|FG001|Overall Study|Subject Withdrew Consent|1|||
126493010|NCT00065507|455104160|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
126493011|NCT00065507|455104161|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
126493012|NCT02411292|455104162|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
126493013|NCT02411292|455104162|FG000|Overall Study|Death|2|||
126493014|NCT02411292|455104162|FG000|Overall Study|Lost to Follow-up|3|||
126493015|NCT02232425|455104165|FG000|Overall Study|Lost to Follow-up|6|||
126493016|NCT02232425|455104166|FG001|Overall Study|Lost to Follow-up|2|||
126493017|NCT02232425|455104165|FG000|Overall Study|Adverse Event|2|||
126493018|NCT02232425|455104166|FG001|Overall Study|Adverse Event|0|||
126493019|NCT02232425|455104165|FG000|Overall Study|Withdrawal by Subject|5|||
126493020|NCT02232425|455104166|FG001|Overall Study|Withdrawal by Subject|6|||
126493021|NCT02232425|455104165|FG000|Overall Study|Lack of Efficacy|1|||
126493022|NCT02232425|455104166|FG001|Overall Study|Lack of Efficacy|0|||
126493023|NCT00665353|455104167|FG000|Study Step 1|Adverse Event|1|||
126493024|NCT00665353|455104167|FG000|Study Step 1|Withdrawal by Subject|2|||
126493025|NCT00665353|455104167|FG000|Study Step 2|Lost to Follow-up|2|||
126493026|NCT00665353|455104167|FG000|Study Step 2|Lack of Efficacy|12|||
126493027|NCT00498602|455104168|FG000|Overall Study|Death|0|||
126493028|NCT00498602|455104169|FG001|Overall Study|Death|0|||
126493029|NCT00498602|455104170|FG002|Overall Study|Death|0|||
126493030|NCT00498602|455104171|FG003|Overall Study|Death|0|||
126493031|NCT00498602|455104172|FG004|Overall Study|Death|0|||
126493032|NCT00498602|455104173|FG005|Overall Study|Death|1|||
126493033|NCT00498602|455104174|FG006|Overall Study|Death|0|||
126493034|NCT00498602|455104168|FG000|Overall Study|Lack of Efficacy|1|||
126493035|NCT00498602|455104169|FG001|Overall Study|Lack of Efficacy|0|||
126493036|NCT00498602|455104170|FG002|Overall Study|Lack of Efficacy|0|||
126493037|NCT00498602|455104171|FG003|Overall Study|Lack of Efficacy|0|||
126493038|NCT00498602|455104172|FG004|Overall Study|Lack of Efficacy|0|||
126493039|NCT00498602|455104173|FG005|Overall Study|Lack of Efficacy|0|||
126493040|NCT00498602|455104174|FG006|Overall Study|Lack of Efficacy|0|||
126493041|NCT00498602|455104168|FG000|Overall Study|Lost to Follow-up|0|||
126493042|NCT00498602|455104169|FG001|Overall Study|Lost to Follow-up|2|||
126493043|NCT00498602|455104170|FG002|Overall Study|Lost to Follow-up|0|||
126493044|NCT00498602|455104171|FG003|Overall Study|Lost to Follow-up|2|||
126493045|NCT00498602|455104172|FG004|Overall Study|Lost to Follow-up|0|||
126493046|NCT00498602|455104173|FG005|Overall Study|Lost to Follow-up|0|||
126493047|NCT00498602|455104174|FG006|Overall Study|Lost to Follow-up|0|||
126493048|NCT00498602|455104168|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
126493049|NCT00498602|455104169|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
126493050|NCT00498602|455104170|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
126493051|NCT00498602|455104171|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
126493052|NCT00498602|455104172|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
126493053|NCT00498602|455104173|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
126493054|NCT00498602|455104174|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
126493055|NCT00498602|455104168|FG000|Overall Study|AE not related to Study Drug|1|||
126493056|NCT00498602|455104169|FG001|Overall Study|AE not related to Study Drug|3|||
126493057|NCT00498602|455104170|FG002|Overall Study|AE not related to Study Drug|0|||
126493058|NCT00498602|455104171|FG003|Overall Study|AE not related to Study Drug|0|||
126493059|NCT00498602|455104172|FG004|Overall Study|AE not related to Study Drug|2|||
126493060|NCT00498602|455104173|FG005|Overall Study|AE not related to Study Drug|2|||
126493061|NCT00498602|455104174|FG006|Overall Study|AE not related to Study Drug|1|||
126493062|NCT00498602|455104168|FG000|Overall Study|Caregiver Request|2|||
126493063|NCT00498602|455104169|FG001|Overall Study|Caregiver Request|2|||
126493064|NCT00498602|455104170|FG002|Overall Study|Caregiver Request|2|||
126493065|NCT00498602|455104171|FG003|Overall Study|Caregiver Request|0|||
126493066|NCT00498602|455104172|FG004|Overall Study|Caregiver Request|1|||
126493067|NCT00498602|455104173|FG005|Overall Study|Caregiver Request|2|||
126493068|NCT00498602|455104174|FG006|Overall Study|Caregiver Request|0|||
126493069|NCT00498602|455104168|FG000|Overall Study|Investigator Request|0|||
126493070|NCT00498602|455104169|FG001|Overall Study|Investigator Request|0|||
126493071|NCT00498602|455104170|FG002|Overall Study|Investigator Request|1|||
126493072|NCT00498602|455104171|FG003|Overall Study|Investigator Request|0|||
126493073|NCT00498602|455104172|FG004|Overall Study|Investigator Request|0|||
126493074|NCT00498602|455104173|FG005|Overall Study|Investigator Request|0|||
126493075|NCT00498602|455104174|FG006|Overall Study|Investigator Request|0|||
126493076|NCT00498602|455104168|FG000|Overall Study|Subject Request|3|||
126493077|NCT00498602|455104169|FG001|Overall Study|Subject Request|0|||
126493078|NCT00498602|455104170|FG002|Overall Study|Subject Request|1|||
126493079|NCT00498602|455104171|FG003|Overall Study|Subject Request|1|||
126493080|NCT00498602|455104172|FG004|Overall Study|Subject Request|1|||
126493081|NCT00498602|455104173|FG005|Overall Study|Subject Request|4|||
126493082|NCT00498602|455104174|FG006|Overall Study|Subject Request|1|||
126493083|NCT00498602|455104168|FG000|Overall Study|Other|2|||
126493084|NCT00498602|455104169|FG001|Overall Study|Other|3|||
126493085|NCT00498602|455104170|FG002|Overall Study|Other|1|||
126493086|NCT00498602|455104171|FG003|Overall Study|Other|0|||
126493087|NCT00498602|455104172|FG004|Overall Study|Other|0|||
126493088|NCT00498602|455104173|FG005|Overall Study|Other|3|||
126493089|NCT00498602|455104174|FG006|Overall Study|Other|0|||
126493090|NCT02632552|455104175|FG000|Overall Study|Lost to Follow-up|14|||
126493091|NCT02632552|455104176|FG001|Overall Study|Lost to Follow-up|8|||
126493092|NCT02632552|455104175|FG000|Overall Study|Withdrawal by Subject|2|||
126493093|NCT02632552|455104176|FG001|Overall Study|Withdrawal by Subject|0|||
126559554|NCT02373813|455342538|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
126559555|NCT02373813|455342535|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126493094|NCT02632552|455104175|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
126493095|NCT02632552|455104176|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
126493096|NCT01846507|455104177|FG000|Overall Study|Lost to Follow-up|4|||
126493097|NCT01846507|455104177|FG000|Overall Study|Protocol Violation|1|||
126493098|NCT01846507|455104177|FG000|Overall Study|Missing data|2|||
126493099|NCT00450450|455104178|FG000|Overall Study|Death|1|||
126493100|NCT00450450|455104179|FG001|Overall Study|Death|3|||
126493101|NCT00450450|455104178|FG000|Overall Study|Relapse|2|||
126493102|NCT00450450|455104179|FG001|Overall Study|Relapse|0|||
126493103|NCT00450450|455104178|FG000|Overall Study|Missing Data|2|||
126493104|NCT00450450|455104179|FG001|Overall Study|Missing Data|0|||
126493105|NCT03318315|455104180|FG000|Overall Study|Lost to Follow-up|3|||
126493106|NCT03318315|455104181|FG001|Overall Study|Lost to Follow-up|2|||
126493107|NCT03318315|455104182|FG002|Overall Study|Lost to Follow-up|1|||
126493108|NCT03318315|455104180|FG000|Overall Study|Protocol Violation|1|||
126493109|NCT03318315|455104181|FG001|Overall Study|Protocol Violation|1|||
126723534|NCT01980706|455936130|FG002|Overall Study|Withdrawal by Subject|2|||
126723535|NCT01980706|455936128|FG000|Overall Study|Adverse Event|1|||
126723536|NCT01980706|455936129|FG001|Overall Study|Adverse Event|2|||
126723537|NCT01980706|455936130|FG002|Overall Study|Adverse Event|5|||
126723538|NCT01980706|455936128|FG000|Overall Study|Lost to Follow-up|3|||
126723539|NCT01980706|455936129|FG001|Overall Study|Lost to Follow-up|4|||
126493110|NCT03318315|455104182|FG002|Overall Study|Protocol Violation|1|||
126493111|NCT03318315|455104180|FG000|Overall Study|Withdrawal by Subject|0|||
126493112|NCT03318315|455104181|FG001|Overall Study|Withdrawal by Subject|0|||
126493113|NCT03318315|455104182|FG002|Overall Study|Withdrawal by Subject|2|||
126493114|NCT02707991|455104183|FG000|Overall Study|Protocol Violation|1|||
126493115|NCT02707991|455104184|FG001|Overall Study|Protocol Violation|0|||
126493116|NCT02707991|455104183|FG000|Overall Study|Became ineligible|0|||
126493117|NCT02707991|455104184|FG001|Overall Study|Became ineligible|1|||
126493118|NCT00451321|455104189|FG000|Overall Study|Lost to Follow-up|3|||
126493119|NCT00451321|455104190|FG001|Overall Study|Lost to Follow-up|3|||
126493120|NCT00451321|455104191|FG002|Overall Study|Lost to Follow-up|1|||
126493121|NCT00451321|455104192|FG003|Overall Study|Lost to Follow-up|3|||
126493122|NCT00451321|455104193|FG004|Overall Study|Lost to Follow-up|0|||
126493123|NCT00451321|455104194|FG005|Overall Study|Lost to Follow-up|1|||
126493124|NCT00451321|455104195|FG006|Overall Study|Lost to Follow-up|0|||
126493125|NCT00451321|455104196|FG007|Overall Study|Lost to Follow-up|0|||
126493126|NCT00451321|455104189|FG000|Overall Study|Withdrawal by Subject|3|||
126559556|NCT02373813|455342536|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
126723540|NCT01980706|455936130|FG002|Overall Study|Lost to Follow-up|3|||
126723541|NCT01980706|455936128|FG000|Overall Study|miscellaneous|4|||
126493127|NCT00451321|455104190|FG001|Overall Study|Withdrawal by Subject|1|||
126493128|NCT00451321|455104191|FG002|Overall Study|Withdrawal by Subject|0|||
126493129|NCT00451321|455104192|FG003|Overall Study|Withdrawal by Subject|4|||
126493130|NCT00451321|455104193|FG004|Overall Study|Withdrawal by Subject|0|||
126723542|NCT01980706|455936129|FG001|Overall Study|miscellaneous|5|||
126493131|NCT00451321|455104194|FG005|Overall Study|Withdrawal by Subject|0|||
126493132|NCT00451321|455104195|FG006|Overall Study|Withdrawal by Subject|0|||
126493133|NCT00451321|455104196|FG007|Overall Study|Withdrawal by Subject|0|||
126493134|NCT00451321|455104189|FG000|Overall Study|Study closed/terminated|1|||
126493135|NCT00451321|455104190|FG001|Overall Study|Study closed/terminated|1|||
126493136|NCT00451321|455104191|FG002|Overall Study|Study closed/terminated|17|||
126493137|NCT00451321|455104192|FG003|Overall Study|Study closed/terminated|5|||
126493138|NCT00451321|455104193|FG004|Overall Study|Study closed/terminated|7|||
126493139|NCT00451321|455104194|FG005|Overall Study|Study closed/terminated|7|||
126493140|NCT00451321|455104195|FG006|Overall Study|Study closed/terminated|5|||
126723543|NCT01980706|455936130|FG002|Overall Study|miscellaneous|3|||
126723544|NCT01934894|455936133|FG000|Overall Study|Adverse Event|1|||
126493141|NCT00451321|455104196|FG007|Overall Study|Study closed/terminated|3|||
126493142|NCT00451321|455104189|FG000|Overall Study|Sponsor decision to amend protocol|0|||
126493143|NCT00451321|455104190|FG001|Overall Study|Sponsor decision to amend protocol|0|||
126493144|NCT00451321|455104191|FG002|Overall Study|Sponsor decision to amend protocol|0|||
126493145|NCT00451321|455104192|FG003|Overall Study|Sponsor decision to amend protocol|0|||
126493146|NCT00451321|455104193|FG004|Overall Study|Sponsor decision to amend protocol|0|||
126493147|NCT00451321|455104194|FG005|Overall Study|Sponsor decision to amend protocol|1|||
126493148|NCT00451321|455104195|FG006|Overall Study|Sponsor decision to amend protocol|1|||
126493149|NCT00451321|455104196|FG007|Overall Study|Sponsor decision to amend protocol|3|||
126493150|NCT01166763|455104200|FG000|Overall Study|Withdrawal by Subject|3|||
126493151|NCT01528254|455104201|FG000|Overall Study|Administrative problems|96|||
126493152|NCT01528254|455104202|FG001|Overall Study|Administrative problems|94|||
126493153|NCT01528254|455104201|FG000|Overall Study|Adverse Event|28|||
126493154|NCT01528254|455104202|FG001|Overall Study|Adverse Event|44|||
126493155|NCT01528254|455104201|FG000|Overall Study|Lost to Follow-up|17|||
126493156|NCT01528254|455104202|FG001|Overall Study|Lost to Follow-up|24|||
126493157|NCT01528254|455104201|FG000|Overall Study|Death|13|||
126493158|NCT01528254|455104202|FG001|Overall Study|Death|9|||
126493159|NCT01528254|455104201|FG000|Overall Study|Protocol deviation|9|||
126493160|NCT01528254|455104202|FG001|Overall Study|Protocol deviation|19|||
126493161|NCT01528254|455104201|FG000|Overall Study|New therapy for study indication|8|||
126493162|NCT01528254|455104202|FG001|Overall Study|New therapy for study indication|6|||
126493163|NCT01528254|455104201|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
126493164|NCT01528254|455104202|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
126493165|NCT01528254|455104201|FG000|Overall Study|Withdrawal by Subject|5|||
126493166|NCT01528254|455104202|FG001|Overall Study|Withdrawal by Subject|4|||
126493167|NCT01528254|455104201|FG000|Overall Study|Abnormal laboratory value(s)|3|||
126493168|NCT01528254|455104202|FG001|Overall Study|Abnormal laboratory value(s)|7|||
126493169|NCT01528254|455104201|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126493170|NCT01528254|455104202|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126493171|NCT01528254|455104201|FG000|Overall Study|No longer requires study drug|1|||
126493172|NCT01528254|455104202|FG001|Overall Study|No longer requires study drug|1|||
126493173|NCT04339296|455104203|FG000|Overall Study|Refuse to participate after allocation|1|||
126493174|NCT04339296|455104204|FG001|Overall Study|Refuse to participate after allocation|1|||
126493175|NCT04339296|455104203|FG000|Overall Study|Withdrew after completion of baseline|2|||
126493176|NCT04339296|455104204|FG001|Overall Study|Withdrew after completion of baseline|1|||
126493177|NCT04339296|455104203|FG000|Overall Study|Lost to Follow-up|0|||
126493178|NCT04339296|455104204|FG001|Overall Study|Lost to Follow-up|4|||
126493179|NCT04339296|455104203|FG000|Overall Study|Discontinued intervention|5|||
126493180|NCT04339296|455104204|FG001|Overall Study|Discontinued intervention|3|||
126493181|NCT01909479|455104205|FG000|From Baseline to Week 26|Adverse Event|3|||
126493182|NCT01909479|455104206|FG001|From Baseline to Week 26|Adverse Event|2|||
126493183|NCT01909479|455104205|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
126493184|NCT01909479|455104206|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
126493185|NCT01909479|455104205|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
126493186|NCT01909479|455104206|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
126493187|NCT01909479|455104205|FG000|26 - 52 Weeks|Adverse Event|0|||
126493188|NCT01909479|455104206|FG001|26 - 52 Weeks|Adverse Event|1|||
126493189|NCT01909479|455104205|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
126493190|NCT01909479|455104206|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
126493191|NCT01909479|455104205|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
126493192|NCT01909479|455104206|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
126493193|NCT01909479|455104205|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
126493194|NCT01909479|455104206|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
126493195|NCT01909479|455104205|FG000|52 Weeks to End of Study|Adverse Event|2|||
126493196|NCT01909479|455104206|FG001|52 Weeks to End of Study|Adverse Event|1|||
126493197|NCT01909479|455104205|FG000|52 Weeks to End of Study|Death|0|||
126493198|NCT01909479|455104206|FG001|52 Weeks to End of Study|Death|1|||
126493199|NCT01909479|455104205|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
126493200|NCT01909479|455104206|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
126493201|NCT01909479|455104205|FG000|52 Weeks to End of Study|Protocol Violation|1|||
126723545|NCT01934894|455936134|FG001|Overall Study|Adverse Event|2|||
126493202|NCT01909479|455104206|FG001|52 Weeks to End of Study|Protocol Violation|0|||
126493203|NCT01909479|455104205|FG000|52 Weeks to End of Study|Progressive disease|1|||
126493204|NCT01909479|455104206|FG001|52 Weeks to End of Study|Progressive disease|1|||
126493205|NCT01909479|455104205|FG000|52 Weeks to End of Study|Personal reasons|2|||
126493206|NCT01909479|455104206|FG001|52 Weeks to End of Study|Personal reasons|1|||
126493207|NCT01909479|455104205|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
126493208|NCT01909479|455104206|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
126493209|NCT01909479|455104205|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
126493210|NCT01909479|455104206|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
126493211|NCT01909479|455104205|FG000|52 Weeks to End of Study|Lack of contact|1|||
126493212|NCT01909479|455104206|FG001|52 Weeks to End of Study|Lack of contact|0|||
126493213|NCT01909479|455104205|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
126493214|NCT01909479|455104206|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
126493215|NCT01909479|455104205|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
126493216|NCT01909479|455104206|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
126493217|NCT04446377|455104207|FG000|Overall Study|Withdrawal by Subject|6|||
126493218|NCT04446377|455104208|FG001|Overall Study|Withdrawal by Subject|1|||
126493219|NCT04446377|455104207|FG000|Overall Study|Physician Decision|1|||
126493220|NCT04446377|455104208|FG001|Overall Study|Physician Decision|1|||
126493221|NCT04446377|455104207|FG000|Overall Study|Lost to Follow-up|0|||
126493222|NCT04446377|455104208|FG001|Overall Study|Lost to Follow-up|2|||
126493223|NCT04446377|455104207|FG000|Overall Study|Not eligible|0|||
126493224|NCT04446377|455104208|FG001|Overall Study|Not eligible|1|||
126493225|NCT00737282|455104211|FG000|Overall Study|Study prematurely terminated|175|||
126493226|NCT01187043|455104212|FG000|Overall Study|Adverse Event|0|||
126493227|NCT01187043|455104213|FG001|Overall Study|Adverse Event|0|||
126493228|NCT01187043|455104214|FG002|Overall Study|Adverse Event|0|||
126493229|NCT01187043|455104215|FG003|Overall Study|Adverse Event|0|||
126493230|NCT01187043|455104216|FG004|Overall Study|Adverse Event|1|||
126493231|NCT01187043|455104212|FG000|Overall Study|Unable to make scheduled visits|1|||
126493232|NCT01187043|455104213|FG001|Overall Study|Unable to make scheduled visits|0|||
126493233|NCT01187043|455104214|FG002|Overall Study|Unable to make scheduled visits|4|||
126493234|NCT01187043|455104215|FG003|Overall Study|Unable to make scheduled visits|0|||
126493235|NCT01187043|455104216|FG004|Overall Study|Unable to make scheduled visits|1|||
126493236|NCT02484729|455104220|FG000|Overall Study|Failure of IntelliCap Error|0|||
126493237|NCT02484729|455104221|FG001|Overall Study|Failure of IntelliCap Error|0|||
126493238|NCT02484729|455104222|FG002|Overall Study|Failure of IntelliCap Error|0|||
126493239|NCT02484729|455104223|FG003|Overall Study|Failure of IntelliCap Error|0|||
126493240|NCT02484729|455104224|FG004|Overall Study|Failure of IntelliCap Error|0|||
126493241|NCT02484729|455104225|FG005|Overall Study|Failure of IntelliCap Error|0|||
126493242|NCT02484729|455104226|FG006|Overall Study|Failure of IntelliCap Error|0|||
126493243|NCT02484729|455104227|FG007|Overall Study|Failure of IntelliCap Error|0|||
126493244|NCT02484729|455104228|FG008|Overall Study|Failure of IntelliCap Error|0|||
126493245|NCT02484729|455104229|FG009|Overall Study|Failure of IntelliCap Error|1|||
126493246|NCT02111850|455104230|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
126493247|NCT02111850|455104231|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
126493248|NCT02111850|455104232|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
126493249|NCT02111850|455104233|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
126493250|NCT02111850|455104234|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
126493251|NCT02111850|455104235|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
126493252|NCT02111850|455104236|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
126493253|NCT02111850|455104237|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
126493254|NCT02111850|455104238|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
126559557|NCT02373813|455342537|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
126559558|NCT02373813|455342538|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
126559559|NCT02403674|455342539|FG000|Base Study|Death|1|||
126559560|NCT02403674|455342540|FG001|Base Study|Death|4|||
126559561|NCT02403674|455342539|FG000|Base Study|Adverse Event|11|||
126493255|NCT02111850|455104239|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
126493256|NCT02111850|455104240|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
126493257|NCT02625259|455104243|FG000|First Intervention (Day 1)|Other|0|||
126493258|NCT02625259|455104244|FG001|First Intervention (Day 1)|Other|0|||
126559562|NCT02403674|455342540|FG001|Base Study|Adverse Event|26|||
126559563|NCT02403674|455342539|FG000|Base Study|Lack of Efficacy|31|||
126559564|NCT02403674|455342540|FG001|Base Study|Lack of Efficacy|23|||
126559565|NCT02403674|455342539|FG000|Base Study|Lost to Follow-up|6|||
126559566|NCT02403674|455342540|FG001|Base Study|Lost to Follow-up|8|||
126559567|NCT02403674|455342539|FG000|Base Study|Withdrawal by Subject|10|||
126559568|NCT02403674|455342540|FG001|Base Study|Withdrawal by Subject|17|||
126559569|NCT02403674|455342539|FG000|Base Study|Physician Decision|2|||
126493259|NCT02625259|455104245|FG002|First Intervention (Day 1)|Other|1|||
126559570|NCT02403674|455342540|FG001|Base Study|Physician Decision|2|||
126723546|NCT01934894|455936133|FG000|Overall Study|Death|2|||
126723547|NCT01934894|455936134|FG001|Overall Study|Death|0|||
126723548|NCT01934894|455936133|FG000|Overall Study|Withdrawal by Subject|0|||
126723549|NCT01934894|455936134|FG001|Overall Study|Withdrawal by Subject|1|||
126723550|NCT01934894|455936133|FG000|Overall Study|Progressive Disease|3|||
126723551|NCT01934894|455936134|FG001|Overall Study|Progressive Disease|2|||
126723552|NCT01842308|455936135|FG000|Overall Study|Withdrawal by Subject|0|||
126723553|NCT01842308|455936136|FG001|Overall Study|Withdrawal by Subject|0|||
126723554|NCT01842308|455936137|FG002|Overall Study|Withdrawal by Subject|0|||
126723555|NCT01842308|455936138|FG003|Overall Study|Withdrawal by Subject|0|||
126723556|NCT01842308|455936139|FG004|Overall Study|Withdrawal by Subject|1|||
126723557|NCT00987623|455936140|FG000|Overall Study|Lost to Follow-up|2|||
126723558|NCT00987623|455936141|FG001|Overall Study|Lost to Follow-up|1|||
126723559|NCT00987623|455936140|FG000|Overall Study|Time/job conflict|2|||
126723560|NCT00987623|455936141|FG001|Overall Study|Time/job conflict|0|||
126723561|NCT00987623|455936140|FG000|Overall Study|Discomfort|1|||
126723562|NCT00987623|455936141|FG001|Overall Study|Discomfort|0|||
126723563|NCT00987623|455936140|FG000|Overall Study|Biomicroscopy|0|||
126723564|NCT00987623|455936141|FG001|Overall Study|Biomicroscopy|1|||
126723565|NCT00987623|455936140|FG000|Overall Study|Influenza|0|||
126723566|NCT00987623|455936141|FG001|Overall Study|Influenza|1|||
126723567|NCT02509598|455936142|FG000|Overall Study|Withdrawal by Subject|1|||
126723568|NCT02196038|455936143|FG000|Overall Study|Death|16|||
126723569|NCT02196038|455936144|FG001|Overall Study|Death|21|||
126723570|NCT02196038|455936143|FG000|Overall Study|Withdrawal by Subject|0|||
126723571|NCT02196038|455936144|FG001|Overall Study|Withdrawal by Subject|1|||
126723572|NCT02196038|455936143|FG000|Overall Study|Lost to Follow-up|1|||
126723573|NCT02196038|455936144|FG001|Overall Study|Lost to Follow-up|0|||
126723574|NCT04056455|455936145|FG000|Overall Study|Adverse Event|1|||
126723575|NCT04056455|455936146|FG001|Overall Study|Adverse Event|0|||
126723576|NCT03135028|455936151|FG000|Overall Study|Death|6|||
126723577|NCT03135028|455936151|FG000|Overall Study|Study Terminated by Sponsor|2|||
126723578|NCT03135028|455936151|FG000|Overall Study|Withdrew Consent|1|||
126723579|NCT02065869|455936153|FG000|Overall Study|Death|7|||
126723580|NCT02065869|455936153|FG000|Overall Study|Disease relapse|16|||
126723581|NCT02065869|455936153|FG000|Overall Study|Lost to Follow-up|4|||
126723582|NCT02065869|455936153|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
126723583|NCT02065869|455936153|FG000|Overall Study|Withdrawal by Subject|1|||
126723584|NCT04436822|455936154|FG000|Overall Study|Physician Decision|2|||
126493260|NCT02625259|455104246|FG003|First Intervention (Day 1)|Other|0|||
126493261|NCT02625259|455104247|FG004|First Intervention (Day 1)|Other|0|||
126493262|NCT02625259|455104243|FG000|First Intervention (Day 1)|Adverse Event|2|||
126493263|NCT02625259|455104244|FG001|First Intervention (Day 1)|Adverse Event|1|||
126493264|NCT02625259|455104245|FG002|First Intervention (Day 1)|Adverse Event|0|||
126493265|NCT02625259|455104246|FG003|First Intervention (Day 1)|Adverse Event|0|||
126493266|NCT02625259|455104247|FG004|First Intervention (Day 1)|Adverse Event|0|||
126493267|NCT02625259|455104243|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
126493268|NCT02625259|455104244|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
126493269|NCT02625259|455104245|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
126493270|NCT02625259|455104246|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
126493271|NCT02625259|455104247|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
126493272|NCT01980875|455104248|FG000|Overall Study|Withdrew Consent|1|||
126493273|NCT01980875|455104249|FG001|Overall Study|Withdrew Consent|1|||
126493274|NCT01980875|455104250|FG002|Overall Study|Withdrew Consent|1|||
126493275|NCT01980875|455104248|FG000|Overall Study|Study Terminated by Sponsor|7|||
126493276|NCT01980875|455104249|FG001|Overall Study|Study Terminated by Sponsor|24|||
126493277|NCT01980875|455104250|FG002|Overall Study|Study Terminated by Sponsor|22|||
126493278|NCT01980875|455104248|FG000|Overall Study|Lost to Follow-up|0|||
126493279|NCT01980875|455104249|FG001|Overall Study|Lost to Follow-up|0|||
126493280|NCT01980875|455104250|FG002|Overall Study|Lost to Follow-up|1|||
126493281|NCT00513474|455104251|FG000|Overall Study|Death|6|||
126493282|NCT00513474|455104252|FG001|Overall Study|Death|9|||
126493283|NCT00513474|455104251|FG000|Overall Study|Participant Withdrew Consent|1|||
126493284|NCT00513474|455104252|FG001|Overall Study|Participant Withdrew Consent|0|||
126493285|NCT00665847|455104253|FG000|Overall Study|Adverse Event|8|||
126723585|NCT04436822|455936155|FG001|Overall Study|Physician Decision|0|||
126723586|NCT04436822|455936154|FG000|Overall Study|Sponsor request|1|||
126723587|NCT04436822|455936155|FG001|Overall Study|Sponsor request|0|||
126723588|NCT04436822|455936154|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126723589|NCT04436822|455936155|FG001|Overall Study|Withdrawal by parent/guardian|3|||
126723590|NCT04436822|455936154|FG000|Overall Study|Unsuccessful procedure|0|||
126723591|NCT04436822|455936155|FG001|Overall Study|Unsuccessful procedure|1|||
126723592|NCT04436822|455936154|FG000|Overall Study|Withdrawal due to Covid-19|8|||
126493286|NCT00665847|455104253|FG000|Overall Study|Withdrawal by Subject|2|||
126723593|NCT04436822|455936155|FG001|Overall Study|Withdrawal due to Covid-19|1|||
126493287|NCT00665847|455104253|FG000|Overall Study|Subject non-compliant|8|||
126493288|NCT00665847|455104253|FG000|Overall Study|Subject reached a virologic endpoint|4|||
126493289|NCT00665847|455104253|FG000|Overall Study|Resistance to TMC125|1|||
126723594|NCT04436822|455936154|FG000|Overall Study|Withdrawal by Subject|1|||
126723595|NCT04436822|455936155|FG001|Overall Study|Withdrawal by Subject|0|||
126723596|NCT04436822|455936154|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
126723597|NCT04436822|455936155|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
126723598|NCT03375112|455936156|FG000|Overall Study|Withdrawal by Subject|3|||
126723599|NCT03375112|455936157|FG001|Overall Study|Withdrawal by Subject|0|||
126723600|NCT00369668|455936158|FG000|Overall Study|Lack of Efficacy|4|||
126723601|NCT00369668|455936159|FG001|Overall Study|Lack of Efficacy|5|||
126723602|NCT00369668|455936160|FG002|Overall Study|Lack of Efficacy|7|||
126723603|NCT00894413|455936163|FG000|Overall Study|Physician Decision|0|||
126723604|NCT00894413|455936164|FG001|Overall Study|Physician Decision|2|||
126723605|NCT00894413|455936163|FG000|Overall Study|Adverse Event|0|||
126723606|NCT00894413|455936164|FG001|Overall Study|Adverse Event|2|||
126723607|NCT00894413|455936163|FG000|Overall Study|Withdrawal by Subject|0|||
126723608|NCT00894413|455936164|FG001|Overall Study|Withdrawal by Subject|4|||
126723609|NCT03213626|455936167|FG000|Overall Study|Adverse Event|1|||
126723610|NCT03213626|455936167|FG000|Overall Study|Progressive Disease|6|||
126723611|NCT02457182|455938643|FG000|Overall Study|Lost to Follow-up|1|||
126723612|NCT02457182|455938644|FG001|Overall Study|Lost to Follow-up|0|||
126723613|NCT00789191|455938649|FG000|Overall Study|Adverse Event|2|||
126723614|NCT00789191|455938650|FG001|Overall Study|Adverse Event|4|||
126723615|NCT00789191|455938649|FG000|Overall Study|Lack of Efficacy|0|||
126493290|NCT00665847|455104253|FG000|Overall Study|Subject ineligible to continue the trial|1|||
126493291|NCT00665847|455104253|FG000|Overall Study|Switch to Commercial Medication|1|||
126493292|NCT02663674|455104259|FG000|Overall Study|Lost to Follow-up|5|||
126493293|NCT02663674|455104260|FG001|Overall Study|Lost to Follow-up|4|||
126493294|NCT02663674|455104259|FG000|Overall Study|Withdrawal by Subject|1|||
126493295|NCT02663674|455104260|FG001|Overall Study|Withdrawal by Subject|4|||
126493296|NCT02663674|455104259|FG000|Overall Study|Physician Decision|1|||
126493297|NCT02663674|455104260|FG001|Overall Study|Physician Decision|1|||
126493298|NCT02663674|455104259|FG000|Overall Study|Other Event (Health Related)|0|||
126493299|NCT02663674|455104260|FG001|Overall Study|Other Event (Health Related)|1|||
126493300|NCT01853826|455105919|FG000|Overall Study|Patients who switched to commercial drug|11|||
126493301|NCT01853826|455105919|FG000|Overall Study|Patient refused to continue medication|21|||
126493302|NCT01853826|455105919|FG000|Overall Study|Lost to Follow-up|2|||
126493303|NCT01853826|455105919|FG000|Overall Study|Non-compliant with protocol|4|||
126493304|NCT01853826|455105919|FG000|Overall Study|Other adverse events (AE)|62|||
126493305|NCT01853826|455105919|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
126493306|NCT01853826|455105919|FG000|Overall Study|Progressive disease|342|||
126493307|NCT01853826|455105919|FG000|Overall Study|Other than listed|13|||
126493308|NCT01853826|455105919|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
126493309|NCT02081690|455105921|FG000|Overall Study|Death|3|||
126493310|NCT02081690|455105921|FG000|Overall Study|Physician Decision|3|||
126493311|NCT02081690|455105921|FG000|Overall Study|Withdrawal by Subject|1|||
126493312|NCT03204981|455105923|FG000|Overall Study|Physician Decision|2|||
126493313|NCT03204981|455105923|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
126493314|NCT00982488|455105924|FG000|Overall Study|Administrative reason by sponsor|81|||
126493315|NCT00982488|455105925|FG001|Overall Study|Administrative reason by sponsor|3|||
126493316|NCT00982488|455105926|FG002|Overall Study|Administrative reason by sponsor|11|||
126493317|NCT00982488|455105927|FG003|Overall Study|Administrative reason by sponsor|0|||
126493318|NCT00982488|455105928|FG004|Overall Study|Administrative reason by sponsor|0|||
126493319|NCT00982488|455105924|FG000|Overall Study|Adverse event unrelated to study drug|5|||
126493320|NCT00982488|455105925|FG001|Overall Study|Adverse event unrelated to study drug|1|||
126493321|NCT00982488|455105926|FG002|Overall Study|Adverse event unrelated to study drug|0|||
126493322|NCT00982488|455105927|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126493323|NCT00982488|455105928|FG004|Overall Study|Adverse event unrelated to study drug|0|||
126493324|NCT00982488|455105924|FG000|Overall Study|Death|11|||
126493325|NCT00982488|455105925|FG001|Overall Study|Death|0|||
126723616|NCT00789191|455938650|FG001|Overall Study|Lack of Efficacy|5|||
126723617|NCT00789191|455938649|FG000|Overall Study|Protocol Violation|5|||
126723618|NCT00789191|455938650|FG001|Overall Study|Protocol Violation|3|||
126723619|NCT00789191|455938649|FG000|Overall Study|Withdrawal Criteria|2|||
126723620|NCT00789191|455938650|FG001|Overall Study|Withdrawal Criteria|4|||
126723621|NCT00789191|455938649|FG000|Overall Study|Unclassified|5|||
126723622|NCT00789191|455938650|FG001|Overall Study|Unclassified|3|||
126723623|NCT01009983|455938651|FG000|Overall Study|necessary scans not completed|1|||
126493326|NCT00982488|455105926|FG002|Overall Study|Death|2|||
126493327|NCT00982488|455105927|FG003|Overall Study|Death|0|||
126493328|NCT00982488|455105928|FG004|Overall Study|Death|0|||
126493329|NCT00982488|455105924|FG000|Overall Study|Disease progression|30|||
126493330|NCT00982488|455105925|FG001|Overall Study|Disease progression|5|||
126493331|NCT00982488|455105926|FG002|Overall Study|Disease progression|10|||
126493332|NCT00982488|455105927|FG003|Overall Study|Disease progression|1|||
126493333|NCT00982488|455105928|FG004|Overall Study|Disease progression|1|||
126723624|NCT03497429|455938652|FG000|Overall Study|Progressive disease|3|||
126772649|NCT02454972|456123634|FG005|Overall Study|Withdrawal by Subject|2|||
126772650|NCT02454972|456123635|FG006|Overall Study|Withdrawal by Subject|0|||
126772651|NCT02454972|456123636|FG007|Overall Study|Withdrawal by Subject|1|||
126772652|NCT02454972|456123637|FG008|Overall Study|Withdrawal by Subject|2|||
126772653|NCT02454972|456123629|FG000|Overall Study|Multiple delay/holds on treatment|0|||
126772654|NCT02454972|456123630|FG001|Overall Study|Multiple delay/holds on treatment|0|||
126772655|NCT02454972|456123631|FG002|Overall Study|Multiple delay/holds on treatment|0|||
126772656|NCT02454972|456123632|FG003|Overall Study|Multiple delay/holds on treatment|1|||
126772657|NCT02454972|456123633|FG004|Overall Study|Multiple delay/holds on treatment|0|||
126772658|NCT02454972|456123634|FG005|Overall Study|Multiple delay/holds on treatment|0|||
126772659|NCT02454972|456123635|FG006|Overall Study|Multiple delay/holds on treatment|0|||
126772660|NCT02454972|456123636|FG007|Overall Study|Multiple delay/holds on treatment|0|||
126493334|NCT00982488|455105924|FG000|Overall Study|Lost to Follow-up|1|||
126493335|NCT00982488|455105925|FG001|Overall Study|Lost to Follow-up|0|||
126493336|NCT00982488|455105926|FG002|Overall Study|Lost to Follow-up|0|||
126493337|NCT00982488|455105927|FG003|Overall Study|Lost to Follow-up|0|||
126493338|NCT00982488|455105928|FG004|Overall Study|Lost to Follow-up|0|||
126493339|NCT00982488|455105924|FG000|Overall Study|Maximum clinical benefit|1|||
126493340|NCT00982488|455105925|FG001|Overall Study|Maximum clinical benefit|1|||
126493341|NCT00982488|455105926|FG002|Overall Study|Maximum clinical benefit|1|||
126493342|NCT00982488|455105927|FG003|Overall Study|Maximum clinical benefit|0|||
126493343|NCT00982488|455105928|FG004|Overall Study|Maximum clinical benefit|0|||
126493344|NCT00982488|455105924|FG000|Overall Study|Other|15|||
126493345|NCT00982488|455105925|FG001|Overall Study|Other|1|||
126493346|NCT00982488|455105926|FG002|Overall Study|Other|3|||
126493347|NCT00982488|455105927|FG003|Overall Study|Other|1|||
126493348|NCT00982488|455105928|FG004|Overall Study|Other|0|||
126493349|NCT00982488|455105924|FG000|Overall Study|Poor compliance/noncompliance|0|||
126493350|NCT00982488|455105925|FG001|Overall Study|Poor compliance/noncompliance|1|||
126493351|NCT00982488|455105926|FG002|Overall Study|Poor compliance/noncompliance|0|||
126493352|NCT00982488|455105927|FG003|Overall Study|Poor compliance/noncompliance|0|||
126493353|NCT00982488|455105928|FG004|Overall Study|Poor compliance/noncompliance|0|||
126493354|NCT00982488|455105924|FG000|Overall Study|Stem cell transplant|2|||
126493355|NCT00982488|455105925|FG001|Overall Study|Stem cell transplant|0|||
126493356|NCT00982488|455105926|FG002|Overall Study|Stem cell transplant|0|||
126493357|NCT00982488|455105927|FG003|Overall Study|Stem cell transplant|1|||
126493358|NCT00982488|455105928|FG004|Overall Study|Stem cell transplant|0|||
126493359|NCT00982488|455105924|FG000|Overall Study|Study drug toxicity|34|||
126493360|NCT00982488|455105925|FG001|Overall Study|Study drug toxicity|1|||
126493361|NCT00982488|455105926|FG002|Overall Study|Study drug toxicity|6|||
126493362|NCT00982488|455105927|FG003|Overall Study|Study drug toxicity|0|||
126493363|NCT00982488|455105928|FG004|Overall Study|Study drug toxicity|0|||
126493364|NCT00982488|455105924|FG000|Overall Study|Withdrawal by Subject|5|||
126493365|NCT00982488|455105925|FG001|Overall Study|Withdrawal by Subject|1|||
126493366|NCT00982488|455105926|FG002|Overall Study|Withdrawal by Subject|1|||
126493367|NCT00982488|455105927|FG003|Overall Study|Withdrawal by Subject|0|||
126493368|NCT00982488|455105928|FG004|Overall Study|Withdrawal by Subject|0|||
126493369|NCT00397982|455105932|FG000|Overall Study|Withdrawal by Subject|1|||
126493370|NCT00397982|455105932|FG000|Overall Study|Adverse Event|1|||
126493371|NCT00397982|455105932|FG000|Overall Study|noncompliance|1|||
126493372|NCT00397982|455105932|FG000|Overall Study|Unrelated health issues|1|||
126493373|NCT04244786|455105933|FG000|Overall Study|Adverse Event|0|||
126493374|NCT04244786|455105934|FG001|Overall Study|Adverse Event|0|||
126493375|NCT04244786|455105935|FG002|Overall Study|Adverse Event|2|||
126493376|NCT04244786|455105933|FG000|Overall Study|Withdrawal by Subject|0|||
126493377|NCT04244786|455105934|FG001|Overall Study|Withdrawal by Subject|0|||
126493378|NCT04244786|455105935|FG002|Overall Study|Withdrawal by Subject|5|||
126493379|NCT00613938|455105942|FG000|Overall Study|Withdrawal by Subject|2|||
126493380|NCT00613938|455105943|FG001|Overall Study|Withdrawal by Subject|4|||
126772661|NCT02454972|456123637|FG008|Overall Study|Multiple delay/holds on treatment|0|||
126772662|NCT02454972|456123629|FG000|Overall Study|Never treated|0|||
126772663|NCT02454972|456123630|FG001|Overall Study|Never treated|0|||
126772664|NCT02454972|456123631|FG002|Overall Study|Never treated|3|||
126493381|NCT00613938|455105944|FG002|Overall Study|Withdrawal by Subject|9|||
126493382|NCT00613938|455105945|FG003|Overall Study|Withdrawal by Subject|9|||
126493383|NCT00613938|455105942|FG000|Overall Study|Adverse Event|1|||
126493384|NCT00613938|455105943|FG001|Overall Study|Adverse Event|4|||
126493385|NCT00613938|455105944|FG002|Overall Study|Adverse Event|8|||
126493386|NCT00613938|455105945|FG003|Overall Study|Adverse Event|5|||
126493387|NCT00613938|455105942|FG000|Overall Study|Lack of Efficacy|16|||
126493388|NCT00613938|455105943|FG001|Overall Study|Lack of Efficacy|18|||
126493389|NCT00613938|455105944|FG002|Overall Study|Lack of Efficacy|5|||
126493390|NCT00613938|455105945|FG003|Overall Study|Lack of Efficacy|9|||
126493391|NCT00613938|455105942|FG000|Overall Study|Other|1|||
126493392|NCT00613938|455105943|FG001|Overall Study|Other|2|||
126493393|NCT00613938|455105944|FG002|Overall Study|Other|1|||
126493394|NCT00613938|455105945|FG003|Overall Study|Other|3|||
126493395|NCT02636868|455105946|FG000|Overall Study|Death|0|||
126493396|NCT02636868|455105947|FG001|Overall Study|Death|1|||
126493397|NCT02636868|455105948|FG002|Overall Study|Death|2|||
126493398|NCT03220217|455105949|FG000|Overall Study|Withdrawal by Subject|0|||
126493399|NCT03220217|455105950|FG001|Overall Study|Withdrawal by Subject|1|||
126493400|NCT03220217|455105951|FG002|Overall Study|Withdrawal by Subject|0|||
126493401|NCT03220217|455105949|FG000|Overall Study|Subject Missed Procedure|0|||
126493402|NCT03220217|455105950|FG001|Overall Study|Subject Missed Procedure|0|||
126493403|NCT03220217|455105951|FG002|Overall Study|Subject Missed Procedure|1|||
126493404|NCT03025542|455105952|FG000|Overall Study|Adverse Event|0|||
126493405|NCT03025542|455105953|FG001|Overall Study|Adverse Event|2|||
126493406|NCT03025542|455105952|FG000|Overall Study|Lost to Follow-up|1|||
126493407|NCT03025542|455105953|FG001|Overall Study|Lost to Follow-up|0|||
126493408|NCT03025542|455105952|FG000|Overall Study|Withdrawal by Subject|1|||
126493409|NCT03025542|455105953|FG001|Overall Study|Withdrawal by Subject|0|||
126493410|NCT03745937|455105954|FG000|Overall Study|Withdrawal by Subject|0|||
126493411|NCT03745937|455105955|FG001|Overall Study|Withdrawal by Subject|0|||
126493412|NCT03745937|455105956|FG002|Overall Study|Withdrawal by Subject|0|||
126493413|NCT03745937|455105957|FG003|Overall Study|Withdrawal by Subject|1|||
126493414|NCT03745937|455105954|FG000|Overall Study|Not-specifed|0|||
126493415|NCT03745937|455105955|FG001|Overall Study|Not-specifed|1|||
126493416|NCT03745937|455105956|FG002|Overall Study|Not-specifed|0|||
126493417|NCT03745937|455105957|FG003|Overall Study|Not-specifed|1|||
126493418|NCT00488345|455105960|FG000|Overall Study|Adverse Event|0|||
126559571|NCT02403674|455342539|FG000|Base Study|Pregnancy|2|||
126559572|NCT02403674|455342540|FG001|Base Study|Pregnancy|2|||
126559573|NCT02403674|455342539|FG000|Base Study|Protocol Violation|8|||
126559574|NCT02403674|455342540|FG001|Base Study|Protocol Violation|4|||
126493419|NCT00488345|455105961|FG001|Overall Study|Adverse Event|1|||
126493420|NCT00488345|455105962|FG002|Overall Study|Adverse Event|1|||
126493421|NCT00488345|455105960|FG000|Overall Study|Unable to administer antibiotics at home|0|||
126493422|NCT00488345|455105961|FG001|Overall Study|Unable to administer antibiotics at home|1|||
126493423|NCT00488345|455105962|FG002|Overall Study|Unable to administer antibiotics at home|0|||
126493424|NCT00488345|455105960|FG000|Overall Study|Institutional Review Board review|0|||
126493425|NCT00488345|455105961|FG001|Overall Study|Institutional Review Board review|0|||
126493426|NCT00488345|455105962|FG002|Overall Study|Institutional Review Board review|1|||
126493427|NCT00488345|455105960|FG000|Overall Study|Surgical team recommendation|0|||
126493428|NCT00488345|455105961|FG001|Overall Study|Surgical team recommendation|1|||
126493429|NCT00488345|455105962|FG002|Overall Study|Surgical team recommendation|0|||
126493430|NCT00488345|455105960|FG000|Overall Study|Parent/legal guardian request|0|||
126493431|NCT00488345|455105961|FG001|Overall Study|Parent/legal guardian request|1|||
126493432|NCT00488345|455105962|FG002|Overall Study|Parent/legal guardian request|1|||
126493433|NCT02057198|455105972|FG000|Overall Study|Death|0|||
126493434|NCT02057198|455105973|FG001|Overall Study|Death|0|||
126493435|NCT02057198|455105974|FG002|Overall Study|Death|1|||
126493436|NCT02057198|455105972|FG000|Overall Study|Discharged early; lost to followup|0|||
126493437|NCT02057198|455105973|FG001|Overall Study|Discharged early; lost to followup|1|||
126493438|NCT02057198|455105974|FG002|Overall Study|Discharged early; lost to followup|0|||
126493439|NCT02345811|455105980|FG000|First Intervention|Withdrawal by Subject|1|||
126493440|NCT02345811|455105981|FG001|First Intervention|Withdrawal by Subject|1|||
126493441|NCT02877082|455105982|FG000|Overall Study|Trial was closed early|5|||
126493442|NCT02489344|455105983|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
126493443|NCT02489344|455105983|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
126493444|NCT02489344|455105983|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
126493445|NCT02489344|455105983|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
126493446|NCT03480750|455105984|FG000|Overall Study|Withdrawal by Subject|0|||
126493447|NCT03480750|455105985|FG001|Overall Study|Withdrawal by Subject|1|||
126493448|NCT03480750|455105986|FG002|Overall Study|Withdrawal by Subject|0|||
126493449|NCT03480750|455105987|FG003|Overall Study|Withdrawal by Subject|0|||
126493450|NCT03480750|455105988|FG004|Overall Study|Withdrawal by Subject|0|||
126493451|NCT03480750|455105989|FG005|Overall Study|Withdrawal by Subject|0|||
126493452|NCT03480750|455105984|FG000|Overall Study|The interruption in Trientine shippment|0|||
126493453|NCT03480750|455105985|FG001|Overall Study|The interruption in Trientine shippment|0|||
126493454|NCT03480750|455105986|FG002|Overall Study|The interruption in Trientine shippment|0|||
126493455|NCT03480750|455105987|FG003|Overall Study|The interruption in Trientine shippment|0|||
126493456|NCT03480750|455105988|FG004|Overall Study|The interruption in Trientine shippment|0|||
126723625|NCT03497429|455938653|FG001|Overall Study|Progressive disease|4|||
126723626|NCT03497429|455938652|FG000|Overall Study|Adverse Event|0|||
126723627|NCT03497429|455938653|FG001|Overall Study|Adverse Event|2|||
126723628|NCT00506948|455938654|FG000|Overall Study|Death|4|||
126723629|NCT00506948|455938654|FG000|Overall Study|Adverse Event|5|||
126723630|NCT00506948|455938654|FG000|Overall Study|Physician Decision|1|||
126723631|NCT00762372|455938656|FG000|Overall Study|Adverse Event|1|||
126723632|NCT00762372|455938657|FG001|Overall Study|Adverse Event|0|||
126723633|NCT00762372|455938658|FG002|Overall Study|Adverse Event|0|||
126493457|NCT03480750|455105989|FG005|Overall Study|The interruption in Trientine shippment|1|||
126493458|NCT01132482|455105990|FG000|Overall Study|Adverse Event|1|||
126493459|NCT01132482|455105991|FG001|Overall Study|Adverse Event|0|||
126493460|NCT03683758|455105992|FG000|Overall Study|Non-study commitment conflict|1|||
126493461|NCT03683758|455105993|FG001|Overall Study|Non-study commitment conflict|3|||
126493462|NCT03683758|455105992|FG000|Overall Study|Illness preventing participation|1|||
126493463|NCT03683758|455105993|FG001|Overall Study|Illness preventing participation|0|||
126493464|NCT03683758|455105992|FG000|Overall Study|Adverse Event|1|||
126493465|NCT03683758|455105993|FG001|Overall Study|Adverse Event|0|||
126493466|NCT00723892|455105994|FG000|Overall Study|Participant not tracked|33|||
126493467|NCT00723892|455105995|FG001|Overall Study|Participant not tracked|35|||
126493468|NCT00723892|455105994|FG000|Overall Study|Virological criterion|24|||
126493469|NCT00723892|455105995|FG001|Overall Study|Virological criterion|9|||
126493470|NCT00723892|455105994|FG000|Overall Study|Withdrawal by Subject|6|||
126493471|NCT00723892|455105995|FG001|Overall Study|Withdrawal by Subject|9|||
126493472|NCT00723892|455105994|FG000|Overall Study|End planned|11|||
126493473|NCT00723892|455105995|FG001|Overall Study|End planned|7|||
126493474|NCT00723892|455105994|FG000|Overall Study|Bad tolerance|5|||
126493475|NCT00723892|455105995|FG001|Overall Study|Bad tolerance|5|||
126493476|NCT00723892|455105994|FG000|Overall Study|Multiple reasons|17|||
126493477|NCT00723892|455105995|FG001|Overall Study|Multiple reasons|12|||
126493478|NCT00723892|455105994|FG000|Overall Study|Other|6|||
126493479|NCT00723892|455105995|FG001|Overall Study|Other|3|||
126493480|NCT00723892|455105994|FG000|Overall Study|Study end|1|||
126493481|NCT00723892|455105995|FG001|Overall Study|Study end|3|||
126493482|NCT00723892|455105994|FG000|Overall Study|Weight loss|1|||
126493483|NCT00723892|455105995|FG001|Overall Study|Weight loss|3|||
126493484|NCT00723892|455105994|FG000|Overall Study|Alcohol abuse|0|||
126493485|NCT00723892|455105995|FG001|Overall Study|Alcohol abuse|1|||
126493486|NCT00723892|455105994|FG000|Overall Study|Intercurrent infection|2|||
126493487|NCT00723892|455105995|FG001|Overall Study|Intercurrent infection|0|||
126493488|NCT00723892|455105994|FG000|Overall Study|Drug addiction|1|||
126493489|NCT00723892|455105995|FG001|Overall Study|Drug addiction|0|||
126493490|NCT01172847|455106000|FG000|Overall Study|Withdrawal by Subject|3|||
126493491|NCT01163279|455106002|FG000|Overall Study|Withdrawal by Subject|2|||
126493492|NCT01163279|455106003|FG001|Overall Study|Withdrawal by Subject|0|||
126493493|NCT01601626|455106006|FG000|Overall Study|Death|1|||
126493494|NCT01601626|455106007|FG001|Overall Study|Death|1|||
126493495|NCT01601626|455106008|FG002|Overall Study|Death|1|||
126493496|NCT01601626|455106006|FG000|Overall Study|Lost to Follow-up|1|||
126493497|NCT01601626|455106007|FG001|Overall Study|Lost to Follow-up|2|||
126493498|NCT01601626|455106008|FG002|Overall Study|Lost to Follow-up|0|||
126493499|NCT01601626|455106006|FG000|Overall Study|Unable to Get to Clinic|0|||
126493500|NCT01601626|455106007|FG001|Overall Study|Unable to Get to Clinic|1|||
126493501|NCT01601626|455106008|FG002|Overall Study|Unable to Get to Clinic|0|||
126493502|NCT01601626|455106006|FG000|Overall Study|Withdrawal by Subject|0|||
126493503|NCT01601626|455106007|FG001|Overall Study|Withdrawal by Subject|1|||
126493504|NCT01601626|455106008|FG002|Overall Study|Withdrawal by Subject|1|||
126493505|NCT01601626|455106006|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
126493506|NCT01601626|455106007|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
126493507|NCT01601626|455106008|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
126493508|NCT00546637|455106012|FG000|Overall Study|Adverse Event|46|||
126493509|NCT00546637|455106013|FG001|Overall Study|Adverse Event|20|||
126493510|NCT00546637|455106012|FG000|Overall Study|Lack of Efficacy|5|||
126493511|NCT00546637|455106013|FG001|Overall Study|Lack of Efficacy|5|||
126723634|NCT03364335|455938659|FG000|Overall Study|Adverse Event|3|||
126723635|NCT03364335|455938660|FG001|Overall Study|Adverse Event|4|||
126493512|NCT00546637|455106012|FG000|Overall Study|Lost to Follow-up|2|||
126493513|NCT00546637|455106013|FG001|Overall Study|Lost to Follow-up|2|||
126493514|NCT00546637|455106012|FG000|Overall Study|Other|10|||
126493515|NCT00546637|455106013|FG001|Overall Study|Other|12|||
126493516|NCT00546637|455106012|FG000|Overall Study|Withdrawal by Subject|7|||
126493517|NCT00546637|455106013|FG001|Overall Study|Withdrawal by Subject|9|||
126493518|NCT00546637|455106012|FG000|Overall Study|Randomized, but not treated|3|||
126723636|NCT03364335|455938661|FG002|Overall Study|Adverse Event|1|||
126493519|NCT00546637|455106013|FG001|Overall Study|Randomized, but not treated|1|||
126493520|NCT03274440|455106014|FG000|Overall Study|Time commitment too great|1|||
126493521|NCT03274440|455106015|FG001|Overall Study|Time commitment too great|0|||
126493522|NCT03274440|455106016|FG002|Overall Study|Time commitment too great|0|||
126493523|NCT03274440|455106017|FG003|Overall Study|Time commitment too great|1|||
126493524|NCT03274440|455106018|FG004|Overall Study|Time commitment too great|0|||
126493525|NCT03274440|455106019|FG005|Overall Study|Time commitment too great|0|||
126493526|NCT01074450|455106020|FG000|First Intervention|Emesis in Dosing Interval|0|||
126493527|NCT01074450|455106021|FG001|First Intervention|Emesis in Dosing Interval|2|||
126493528|NCT01074450|455106020|FG000|Second Intervention|Protocol Violation|1|||
126493529|NCT01074450|455106021|FG001|Second Intervention|Protocol Violation|0|||
126723637|NCT03364335|455938662|FG003|Overall Study|Adverse Event|2|||
126723638|NCT03364335|455938663|FG004|Overall Study|Adverse Event|0|||
126493530|NCT01074450|455106020|FG000|Second Intervention|Physician Decision|0|||
126493531|NCT01074450|455106021|FG001|Second Intervention|Physician Decision|1|||
126493532|NCT04984993|455106022|FG000|Overall Study|Withdrawal by Subject|8|||
126493533|NCT04984993|455106023|FG001|Overall Study|Withdrawal by Subject|2|||
126493534|NCT04984993|455106022|FG000|Overall Study|Lost to Follow-up|2|||
126493535|NCT04984993|455106023|FG001|Overall Study|Lost to Follow-up|2|||
126493536|NCT04984993|455106022|FG000|Overall Study|Both patients moved to another country|4|||
126493537|NCT04984993|455106023|FG001|Overall Study|Both patients moved to another country|0|||
126493538|NCT02865187|455106026|FG000|Overall Study|Lost to Follow-up|12|||
126493539|NCT02865187|455106027|FG001|Overall Study|Lost to Follow-up|7|||
126493540|NCT02865187|455106026|FG000|Overall Study|Adverse Event|1|||
126493541|NCT02865187|455106027|FG001|Overall Study|Adverse Event|0|||
126493542|NCT01110707|455106028|FG000|Overall Study|Protocol Violation|0|||
126493543|NCT01110707|455106029|FG001|Overall Study|Protocol Violation|3|||
126493544|NCT02968563|455106034|FG000|Overall Study|Adverse Event|0|||
126493545|NCT02968563|455106035|FG001|Overall Study|Adverse Event|6|||
126493546|NCT02968563|455106034|FG000|Overall Study|Death|1|||
126493547|NCT02968563|455106035|FG001|Overall Study|Death|1|||
126493548|NCT02968563|455106034|FG000|Overall Study|Lost to Follow-up|0|||
126493549|NCT02968563|455106035|FG001|Overall Study|Lost to Follow-up|1|||
126493550|NCT02369341|455106036|FG000|Overall Study|Migrated/moved from study area|1|||
126493551|NCT02369341|455106037|FG001|Overall Study|Migrated/moved from study area|0|||
126493552|NCT03287804|455106038|FG000|Overall Study|Death|1|||
126493553|NCT03287804|455106038|FG000|Overall Study|Physician Decision|2|||
126493554|NCT03287804|455106038|FG000|Overall Study|Progressive disease|8|||
126493555|NCT02710045|455106042|FG000|Overall Study|Death|1|||
126493556|NCT02710045|455106043|FG001|Overall Study|Death|2|||
126493557|NCT02710045|455106044|FG002|Overall Study|Death|0|||
126493558|NCT02710045|455106042|FG000|Overall Study|Withdrawal by Subject|6|||
126493559|NCT02710045|455106043|FG001|Overall Study|Withdrawal by Subject|6|||
126493560|NCT02710045|455106044|FG002|Overall Study|Withdrawal by Subject|2|||
126493561|NCT02710045|455106042|FG000|Overall Study|Protocol Violation|1|||
126493562|NCT02710045|455106043|FG001|Overall Study|Protocol Violation|2|||
126493563|NCT02710045|455106044|FG002|Overall Study|Protocol Violation|3|||
126493564|NCT02710045|455106042|FG000|Overall Study|Lost to Follow-up|3|||
126493565|NCT02710045|455106043|FG001|Overall Study|Lost to Follow-up|6|||
126493566|NCT02710045|455106044|FG002|Overall Study|Lost to Follow-up|7|||
126493567|NCT02710045|455106042|FG000|Overall Study|Physician Decision|0|||
126493568|NCT02710045|455106043|FG001|Overall Study|Physician Decision|0|||
126493569|NCT02710045|455106044|FG002|Overall Study|Physician Decision|1|||
126493570|NCT02710045|455106042|FG000|Overall Study|Poor Attendance|0|||
126493571|NCT02710045|455106043|FG001|Overall Study|Poor Attendance|1|||
126493572|NCT02710045|455106044|FG002|Overall Study|Poor Attendance|0|||
126493573|NCT03178773|455106045|FG000|Overall Study|Death|0|||
126493574|NCT03178773|455106046|FG001|Overall Study|Death|1|||
126493575|NCT03178773|455106045|FG000|Overall Study|Lost to Follow-up|29|||
126493576|NCT03178773|455106046|FG001|Overall Study|Lost to Follow-up|25|||
126493577|NCT03178773|455106045|FG000|Overall Study|Withdrawal by Subject|10|||
126493578|NCT03178773|455106046|FG001|Overall Study|Withdrawal by Subject|14|||
126493579|NCT01382446|455106047|FG000|Overall Study|Withdrawal by Subject|0|||
126493580|NCT01382446|455106048|FG001|Overall Study|Withdrawal by Subject|1|||
126493581|NCT01382446|455106047|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
126493582|NCT01382446|455106048|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
126493583|NCT00597766|455106049|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
126493584|NCT00597766|455106050|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
126493585|NCT00597766|455106051|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
126493586|NCT00597766|455106049|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
126493587|NCT00597766|455106050|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
126493588|NCT00597766|455106051|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
126493589|NCT02810392|455106053|FG000|Overall Study|Subject too ill to continue|1|||
126493590|NCT02810392|455106054|FG001|Overall Study|Subject too ill to continue|0|||
126493591|NCT02810392|455106053|FG000|Overall Study|COVID 19 research restrictions|0|||
126493592|NCT02810392|455106054|FG001|Overall Study|COVID 19 research restrictions|1|||
126493593|NCT00840294|455106055|FG000|Overall Study|Withdrawal by Subject|2|||
126493594|NCT00840294|455106056|FG001|Overall Study|Withdrawal by Subject|1|||
126493595|NCT00840294|455106055|FG000|Overall Study|Protocol Violation|1|||
126493596|NCT00840294|455106056|FG001|Overall Study|Protocol Violation|3|||
126493597|NCT00840294|455106055|FG000|Overall Study|Illness|0|||
126493598|NCT00840294|455106056|FG001|Overall Study|Illness|1|||
126493599|NCT04387435|455106057|FG000|Overall Study|Physician Decision|1|||
126493600|NCT03855280|455106058|FG000|Treatment Phase|Adverse Event|1|||
126493601|NCT03855280|455106058|FG000|Treatment Phase|Withdrawal by Subject|1|||
126493602|NCT03855280|455106058|FG000|Continuation Phase|Protocol Violation|1|||
126493603|NCT03855280|455106058|FG000|Continuation Phase|Adverse Event|1|||
126723639|NCT03364335|455938659|FG000|Overall Study|Lost to Follow-up|7|||
126493604|NCT03855280|455106058|FG000|Continuation Phase|Sponsor Concluded Study|1|||
126493605|NCT00969150|455106066|FG000|Overall Study|Adverse Event|4|||
126493606|NCT00969150|455106067|FG001|Overall Study|Adverse Event|14|||
126493607|NCT00969150|455106066|FG000|Overall Study|Lack of Efficacy|1|||
126493608|NCT00969150|455106067|FG001|Overall Study|Lack of Efficacy|1|||
126493609|NCT00969150|455106066|FG000|Overall Study|Protocol Violation|9|||
126493610|NCT00969150|455106067|FG001|Overall Study|Protocol Violation|12|||
126493611|NCT00969150|455106066|FG000|Overall Study|Withdrawal by Subject|13|||
126493612|NCT00969150|455106067|FG001|Overall Study|Withdrawal by Subject|9|||
126493613|NCT00969150|455106066|FG000|Overall Study|Lost to Follow-up|5|||
126493614|NCT00969150|455106067|FG001|Overall Study|Lost to Follow-up|4|||
126493615|NCT00969150|455106066|FG000|Overall Study|Other reasons|1|||
126493616|NCT00969150|455106067|FG001|Overall Study|Other reasons|0|||
126493617|NCT00461682|455106070|FG000|Overall Study|Protocol Violation|1|||
126493618|NCT00883116|455106071|FG000|Overall Study|Adverse event unrelated to study drug|5|||
126493619|NCT00883116|455106072|FG001|Overall Study|Adverse event unrelated to study drug|10|||
126493620|NCT00883116|455106071|FG000|Overall Study|Death|6|||
126493621|NCT00883116|455106072|FG001|Overall Study|Death|2|||
126493622|NCT00883116|455106071|FG000|Overall Study|Disease progression|130|||
126493623|NCT00883116|455106072|FG001|Overall Study|Disease progression|128|||
126493624|NCT00883116|455106071|FG000|Overall Study|Lost to Follow-up|0|||
126493625|NCT00883116|455106072|FG001|Overall Study|Lost to Follow-up|1|||
126493626|NCT00883116|455106071|FG000|Overall Study|Maximum clinical benefit|13|||
126493627|NCT00883116|455106072|FG001|Overall Study|Maximum clinical benefit|46|||
126493628|NCT00883116|455106071|FG000|Overall Study|Not identified|3|||
126723640|NCT03364335|455938660|FG001|Overall Study|Lost to Follow-up|7|||
126493629|NCT00883116|455106072|FG001|Overall Study|Not identified|6|||
126723641|NCT03364335|455938661|FG002|Overall Study|Lost to Follow-up|10|||
126723642|NCT03364335|455938662|FG003|Overall Study|Lost to Follow-up|11|||
126723643|NCT03364335|455938663|FG004|Overall Study|Lost to Follow-up|11|||
126723644|NCT02670915|455938664|FG000|Overall Study|Withdrawal by Subject|0|||
126723645|NCT02670915|455938665|FG001|Overall Study|Withdrawal by Subject|1|||
126723646|NCT02670915|455938666|FG002|Overall Study|Withdrawal by Subject|4|||
126723647|NCT02670915|455938664|FG000|Overall Study|Withdrawal by parent/guardian|4|||
126723648|NCT02670915|455938665|FG001|Overall Study|Withdrawal by parent/guardian|4|||
126723649|NCT02670915|455938666|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126723650|NCT02670915|455938664|FG000|Overall Study|Unclassified|0|||
126723651|NCT02670915|455938665|FG001|Overall Study|Unclassified|3|||
126723652|NCT02670915|455938666|FG002|Overall Study|Unclassified|0|||
126723653|NCT00818207|455938667|FG000|Overall Study|Adverse Event|6|||
126493630|NCT00883116|455106071|FG000|Overall Study|Study drug toxicity|36|||
126493631|NCT00883116|455106072|FG001|Overall Study|Study drug toxicity|16|||
126493632|NCT00883116|455106071|FG000|Overall Study|Withdrawal by Subject|14|||
126493633|NCT00883116|455106072|FG001|Overall Study|Withdrawal by Subject|8|||
126723654|NCT00818207|455938668|FG001|Overall Study|Adverse Event|0|||
126723655|NCT00818207|455938667|FG000|Overall Study|Lost to Follow-up|160|||
126723656|NCT00818207|455938668|FG001|Overall Study|Lost to Follow-up|146|||
126493634|NCT00883116|455106071|FG000|Overall Study|No longer meets study criteria|2|||
126493635|NCT00883116|455106072|FG001|Overall Study|No longer meets study criteria|2|||
126493636|NCT01361464|455106073|FG000|Overall Study|Death|1|||
126493637|NCT01361464|455106073|FG000|Overall Study|Withdrawal by Subject|2|||
126493638|NCT00903617|455108094|FG000|Overall Study|Adverse Event|0|||
126493639|NCT00903617|455108095|FG001|Overall Study|Adverse Event|1|||
126493640|NCT00903617|455108096|FG002|Overall Study|Adverse Event|1|||
126493641|NCT00903617|455108097|FG003|Overall Study|Adverse Event|0|||
126493642|NCT00903617|455108094|FG000|Overall Study|Protocol-defined stopping criteria|0|||
126493643|NCT00903617|455108095|FG001|Overall Study|Protocol-defined stopping criteria|2|||
126493644|NCT00903617|455108096|FG002|Overall Study|Protocol-defined stopping criteria|0|||
126493645|NCT00903617|455108097|FG003|Overall Study|Protocol-defined stopping criteria|0|||
126493646|NCT00903617|455108094|FG000|Overall Study|Lost to Follow-up|2|||
126493647|NCT00903617|455108095|FG001|Overall Study|Lost to Follow-up|0|||
126723657|NCT00818207|455938667|FG000|Overall Study|Multiple reasons|11|||
126493648|NCT00903617|455108096|FG002|Overall Study|Lost to Follow-up|1|||
126493649|NCT00903617|455108097|FG003|Overall Study|Lost to Follow-up|1|||
126493650|NCT00903617|455108094|FG000|Overall Study|Withdrawal by Subject|1|||
126493651|NCT00903617|455108095|FG001|Overall Study|Withdrawal by Subject|2|||
126723658|NCT00818207|455938668|FG001|Overall Study|Multiple reasons|12|||
126723659|NCT00818207|455938667|FG000|Overall Study|Withdrawal by Subject|42|||
126723660|NCT00818207|455938668|FG001|Overall Study|Withdrawal by Subject|104|||
126723661|NCT00818207|455938667|FG000|Overall Study|Death|3|||
126723662|NCT00818207|455938668|FG001|Overall Study|Death|5|||
126723663|NCT02494778|455938669|FG000|Overall Study|Death|3|||
126723664|NCT02494778|455938669|FG000|Overall Study|Other|173|||
126493652|NCT00903617|455108096|FG002|Overall Study|Withdrawal by Subject|3|||
126493653|NCT00903617|455108097|FG003|Overall Study|Withdrawal by Subject|0|||
126493654|NCT02355691|455108098|FG000|Overall Study|Loss of Research Personnel|7|||
126493655|NCT02355691|455108099|FG001|Overall Study|Loss of Research Personnel|9|||
126493656|NCT00462761|455108100|FG000|Overall Study|Adverse Event|6|||
126493657|NCT00462761|455108100|FG000|Overall Study|Withdrawal by Subject|9|||
126493658|NCT00462761|455108100|FG000|Overall Study|Physician Decision|5|||
126493659|NCT00462761|455108100|FG000|Overall Study|Disease progression|43|||
126723665|NCT02494778|455938669|FG000|Overall Study|Lack of Efficacy|4|||
126493660|NCT00462761|455108100|FG000|Overall Study|Death|12|||
126493661|NCT00462761|455108100|FG000|Overall Study|Other|1|||
126493662|NCT03060447|455108101|FG000|Overall Study|Withdrawal by Subject|2|||
126493663|NCT03060447|455108102|FG001|Overall Study|Withdrawal by Subject|0|||
126493664|NCT00573755|455108103|FG000|Overall Study|Still receiving treatment|1|||
126493665|NCT00573755|455108104|FG001|Overall Study|Still receiving treatment|0|||
126723666|NCT02494778|455938669|FG000|Overall Study|Adverse Event|18|||
126723667|NCT02494778|455938669|FG000|Overall Study|Withdrawal by Subject|20|||
126723668|NCT02494778|455938669|FG000|Overall Study|Lost to Follow-up|2|||
126723669|NCT02494778|455938669|FG000|Overall Study|Noncompliant with study drug admin.|1|||
126723670|NCT02174861|455938670|FG000|Overall Study|Decision by sponsor|8|||
126723671|NCT02174861|455938670|FG000|Overall Study|Withdrawal by Subject|124|||
126493666|NCT02733991|455108110|FG000|Overall Study|Adverse Event|1|||
126493667|NCT02733991|455108111|FG001|Overall Study|Adverse Event|0|||
126493668|NCT02733991|455108110|FG000|Overall Study|Withdrawal by Subject|0|||
126493669|NCT02733991|455108111|FG001|Overall Study|Withdrawal by Subject|5|||
126493670|NCT02612428|455108114|FG000|VTL-308|Death|14|||
126493671|NCT02612428|455108115|FG001|VTL-308|Death|16|||
126493672|NCT02612428|455108114|FG000|VTL-308|Withdrawal by Subject|0|||
126493673|NCT02612428|455108115|FG001|VTL-308|Withdrawal by Subject|1|||
126493674|NCT02612428|455108114|FG000|VTL-308E|Death|9|||
126493675|NCT02612428|455108115|FG001|VTL-308E|Death|7|||
126493676|NCT02612428|455108114|FG000|VTL-308E|Lost to Follow-up|2|||
126493677|NCT02612428|455108115|FG001|VTL-308E|Lost to Follow-up|0|||
126493678|NCT01928329|455108116|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
126493679|NCT01928329|455108117|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
126493680|NCT01928329|455108116|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
126493681|NCT01928329|455108117|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
126493682|NCT01928329|455108116|FG000|Overall Study|Adverse Event|5|||
126493683|NCT01928329|455108117|FG001|Overall Study|Adverse Event|3|||
126493684|NCT01928329|455108116|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
126493685|NCT01928329|455108117|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
126493686|NCT01928329|455108116|FG000|Overall Study|Withdrawal by Subject|1|||
126493687|NCT01928329|455108117|FG001|Overall Study|Withdrawal by Subject|5|||
126493688|NCT01928329|455108116|FG000|Overall Study|Physician Decision|1|||
126493689|NCT01928329|455108117|FG001|Overall Study|Physician Decision|1|||
126493690|NCT03187262|455108118|FG000|Induction|Lack of Efficacy|2|||
126493691|NCT03187262|455108118|FG000|Induction|Progressive Disease|4|||
126493692|NCT03187262|455108118|FG000|Consolidation|Progressive Disease|5|||
126493693|NCT02604212|455108121|FG000|Overall Study|Study Terminated by Sponsor|2|||
126493694|NCT02604212|455108122|FG001|Overall Study|Study Terminated by Sponsor|1|||
126493695|NCT02604212|455108123|FG002|Overall Study|Study Terminated by Sponsor|3|||
126493696|NCT02604212|455108124|FG003|Overall Study|Study Terminated by Sponsor|3|||
126493697|NCT02604212|455108121|FG000|Overall Study|Withdrawal by Subject|0|||
126493698|NCT02604212|455108122|FG001|Overall Study|Withdrawal by Subject|0|||
126493699|NCT02604212|455108123|FG002|Overall Study|Withdrawal by Subject|1|||
126493700|NCT02604212|455108124|FG003|Overall Study|Withdrawal by Subject|0|||
126493701|NCT01119131|455108127|FG000|Overall Study|Adverse Event|1|||
126493702|NCT01119131|455108128|FG001|Overall Study|Adverse Event|1|||
126493703|NCT01119131|455108129|FG002|Overall Study|Adverse Event|1|||
126493704|NCT01119131|455108127|FG000|Overall Study|Non-Compliance|1|||
126493705|NCT01119131|455108128|FG001|Overall Study|Non-Compliance|0|||
126493706|NCT01119131|455108129|FG002|Overall Study|Non-Compliance|4|||
126493707|NCT01119131|455108127|FG000|Overall Study|Physician Decision|0|||
126493708|NCT01119131|455108128|FG001|Overall Study|Physician Decision|0|||
126493709|NCT01119131|455108129|FG002|Overall Study|Physician Decision|1|||
126493710|NCT00909389|455108132|FG000|Overall Study|Adverse Event|6|||
126493711|NCT00909389|455108132|FG000|Overall Study|Death|4|||
126493712|NCT00909389|455108132|FG000|Overall Study|Poor Compliance|16|||
126493713|NCT00909389|455108132|FG000|Overall Study|Lost to Follow-up|4|||
126493714|NCT00909389|455108132|FG000|Overall Study|No Information|103|||
126493715|NCT00003492|455108133|FG000|Overall Study|Not evaluable|6|||
126493716|NCT00383149|455108147|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
126493717|NCT00383149|455108147|FG000|Overall Study|Death|2|||
126493718|NCT00383149|455108147|FG000|Overall Study|Disease Progression|38|||
126493719|NCT00383149|455108147|FG000|Overall Study|Lost to Follow-up|1|||
126493720|NCT00383149|455108147|FG000|Overall Study|Other|1|||
126493721|NCT00383149|455108147|FG000|Overall Study|Study Drug Toxicity|4|||
126493722|NCT00383149|455108147|FG000|Overall Study|Request to Discontinue Treatment|4|||
126493723|NCT00383149|455108147|FG000|Overall Study|Participant Withdrew Consent|1|||
126493724|NCT00453544|455108148|FG000|Overall Study|Withdrawal by Subject|1|||
126493725|NCT00453544|455108149|FG001|Overall Study|Withdrawal by Subject|0|||
126493726|NCT00453544|455108150|FG002|Overall Study|Withdrawal by Subject|0|||
126493727|NCT00453544|455108151|FG003|Overall Study|Withdrawal by Subject|0|||
126493728|NCT00453544|455108148|FG000|Overall Study|Primary outcome measure not completed|1|||
126493729|NCT00453544|455108149|FG001|Overall Study|Primary outcome measure not completed|1|||
126723672|NCT02174861|455938670|FG000|Overall Study|Lost to Follow-up|26|||
126723673|NCT01000727|455938676|FG000|Overall Study|Lost to Follow-up|41|||
126493730|NCT00453544|455108150|FG002|Overall Study|Primary outcome measure not completed|0|||
126493731|NCT00453544|455108151|FG003|Overall Study|Primary outcome measure not completed|1|||
126493732|NCT02457910|455108152|FG000|Overall Study|Withdrawal by Subject|0|||
126493733|NCT02457910|455108153|FG001|Overall Study|Withdrawal by Subject|0|||
126493734|NCT02457910|455108154|FG002|Overall Study|Withdrawal by Subject|0|||
126493735|NCT02457910|455108155|FG003|Overall Study|Withdrawal by Subject|0|||
126493736|NCT02457910|455108156|FG004|Overall Study|Withdrawal by Subject|0|||
126493737|NCT02457910|455108157|FG005|Overall Study|Withdrawal by Subject|1|||
126493738|NCT02457910|455108152|FG000|Overall Study|Adverse Event|0|||
126493739|NCT02457910|455108153|FG001|Overall Study|Adverse Event|2|||
126493740|NCT02457910|455108154|FG002|Overall Study|Adverse Event|1|||
126493741|NCT02457910|455108155|FG003|Overall Study|Adverse Event|1|||
126493742|NCT02457910|455108156|FG004|Overall Study|Adverse Event|1|||
126493743|NCT02457910|455108157|FG005|Overall Study|Adverse Event|3|||
126493744|NCT02457910|455108152|FG000|Overall Study|Disease progression|3|||
126493745|NCT02457910|455108153|FG001|Overall Study|Disease progression|3|||
126493746|NCT02457910|455108154|FG002|Overall Study|Disease progression|1|||
126493747|NCT02457910|455108155|FG003|Overall Study|Disease progression|1|||
126493748|NCT02457910|455108156|FG004|Overall Study|Disease progression|4|||
126493749|NCT02457910|455108157|FG005|Overall Study|Disease progression|6|||
126493750|NCT02457910|455108152|FG000|Overall Study|Other complicating illness|0|||
126493751|NCT02457910|455108153|FG001|Overall Study|Other complicating illness|0|||
126493752|NCT02457910|455108154|FG002|Overall Study|Other complicating illness|0|||
126493753|NCT02457910|455108155|FG003|Overall Study|Other complicating illness|0|||
126493754|NCT02457910|455108156|FG004|Overall Study|Other complicating illness|0|||
126493755|NCT02457910|455108157|FG005|Overall Study|Other complicating illness|1|||
126493756|NCT02457910|455108152|FG000|Overall Study|Death|0|||
126493757|NCT02457910|455108153|FG001|Overall Study|Death|0|||
126493758|NCT02457910|455108154|FG002|Overall Study|Death|1|||
126493759|NCT02457910|455108155|FG003|Overall Study|Death|0|||
126493760|NCT02457910|455108156|FG004|Overall Study|Death|0|||
126493761|NCT02457910|455108157|FG005|Overall Study|Death|0|||
126493762|NCT00619801|455108158|FG000|Overall Study|Lack of Efficacy|0|||
126493763|NCT00619801|455108159|FG001|Overall Study|Lack of Efficacy|1|||
126493764|NCT00619801|455108158|FG000|Overall Study|Withdrawal by Subject|1|||
126493765|NCT00619801|455108159|FG001|Overall Study|Withdrawal by Subject|1|||
126493766|NCT00619801|455108158|FG000|Overall Study|Loss of efficacy|0|||
126493767|NCT00619801|455108159|FG001|Overall Study|Loss of efficacy|1|||
126493768|NCT03721276|455108162|FG000|Overall Study|Lost to Follow-up|5|||
126493769|NCT03721276|455108163|FG001|Overall Study|Lost to Follow-up|3|||
126493770|NCT03721276|455108162|FG000|Overall Study|Adverse Event|0|||
126493771|NCT03721276|455108163|FG001|Overall Study|Adverse Event|1|||
126493772|NCT01829230|455108168|FG000|Overall Study|Protocol Violation|0|||
126493773|NCT01829230|455108169|FG001|Overall Study|Protocol Violation|2|||
126493774|NCT01829230|455108168|FG000|Overall Study|Withdrawal by Subject|0|||
126493775|NCT01829230|455108169|FG001|Overall Study|Withdrawal by Subject|1|||
126493776|NCT01829230|455108168|FG000|Overall Study|Lost to Follow-up|1|||
126493777|NCT01829230|455108169|FG001|Overall Study|Lost to Follow-up|1|||
126493778|NCT04501666|455108175|FG000|Overall Study|Physician Decision|0|||
126493779|NCT04501666|455108176|FG001|Overall Study|Physician Decision|1|||
126493780|NCT04501666|455108175|FG000|Overall Study|Adverse Event|12|||
126493781|NCT04501666|455108176|FG001|Overall Study|Adverse Event|4|||
126493782|NCT04501666|455108175|FG000|Overall Study|Subject's request|10|||
126493783|NCT04501666|455108176|FG001|Overall Study|Subject's request|6|||
126493784|NCT04501666|455108175|FG000|Overall Study|Protocol Deviation|2|||
126493785|NCT04501666|455108176|FG001|Overall Study|Protocol Deviation|1|||
126493786|NCT04501666|455108175|FG000|Overall Study|Other-- site permanently closing|0|||
126493787|NCT04501666|455108176|FG001|Overall Study|Other-- site permanently closing|1|||
126493788|NCT04128267|455108177|FG000|Overall Study|Withdrawal by Subject|6|||
126493789|NCT04128267|455108177|FG000|Overall Study|Death|2|||
126493790|NCT04128267|455108177|FG000|Overall Study|Disease progression|1|||
126493791|NCT04128267|455108177|FG000|Overall Study|Participant had other medical issues|4|||
126493792|NCT04128267|455108177|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
126493793|NCT01722071|455108178|FG000|Overall Study|Protocol Violation|1|||
126493794|NCT01722071|455108179|FG001|Overall Study|Protocol Violation|0|||
126493795|NCT01106898|455108180|FG000|Overall Study|Adverse Event|6|||
126493796|NCT03021265|455108181|FG000|Overall Study|Adverse Event|29|||
126493797|NCT03021265|455108181|FG000|Overall Study|Lack of Efficacy|3|||
126493798|NCT03021265|455108181|FG000|Overall Study|Improved|17|||
126493799|NCT03021265|455108181|FG000|Overall Study|Lost to Follow-up|67|||
126493800|NCT03021265|455108181|FG000|Overall Study|No reason given|2|||
126493801|NCT03021265|455108181|FG000|Overall Study|No visit since the first visit|4|||
126493802|NCT00642941|455108182|FG000|Overall Study|Physician Decision|3|||
126493803|NCT00642941|455108183|FG001|Overall Study|Physician Decision|1|||
126493804|NCT00642941|455108184|FG002|Overall Study|Physician Decision|0|||
126493805|NCT00642941|455108185|FG003|Overall Study|Physician Decision|0|||
126493806|NCT00642941|455108186|FG004|Overall Study|Physician Decision|0|||
126493807|NCT00642941|455108187|FG005|Overall Study|Physician Decision|0|||
126493808|NCT00642941|455108188|FG006|Overall Study|Physician Decision|1|||
126723674|NCT01000727|455938677|FG001|Overall Study|Lost to Follow-up|43|||
126723675|NCT01000727|455938676|FG000|Overall Study|Withdrawal by Subject|111|||
126723676|NCT01000727|455938677|FG001|Overall Study|Withdrawal by Subject|109|||
126493809|NCT00642941|455108189|FG007|Overall Study|Physician Decision|0|||
126493810|NCT00642941|455108190|FG008|Overall Study|Physician Decision|0|||
126493811|NCT00642941|455108191|FG009|Overall Study|Physician Decision|1|||
126493812|NCT00642941|455108192|FG010|Overall Study|Physician Decision|0|||
126493813|NCT00642941|455108193|FG011|Overall Study|Physician Decision|1|||
126493814|NCT00642941|455108182|FG000|Overall Study|Death|4|||
126493815|NCT00642941|455108183|FG001|Overall Study|Death|0|||
126493816|NCT00642941|455108184|FG002|Overall Study|Death|1|||
126493817|NCT00642941|455108185|FG003|Overall Study|Death|1|||
126493818|NCT00642941|455108186|FG004|Overall Study|Death|2|||
126493819|NCT00642941|455108187|FG005|Overall Study|Death|1|||
126493820|NCT00642941|455108188|FG006|Overall Study|Death|0|||
126493821|NCT00642941|455108189|FG007|Overall Study|Death|0|||
126493822|NCT00642941|455108190|FG008|Overall Study|Death|0|||
126493823|NCT00642941|455108191|FG009|Overall Study|Death|0|||
126493824|NCT00642941|455108192|FG010|Overall Study|Death|0|||
126493825|NCT00642941|455108193|FG011|Overall Study|Death|1|||
126493826|NCT00642941|455108182|FG000|Overall Study|Study closed by Sponsor|0|||
126493827|NCT00642941|455108183|FG001|Overall Study|Study closed by Sponsor|1|||
126493828|NCT00642941|455108184|FG002|Overall Study|Study closed by Sponsor|0|||
126493829|NCT00642941|455108185|FG003|Overall Study|Study closed by Sponsor|0|||
126493830|NCT00642941|455108186|FG004|Overall Study|Study closed by Sponsor|0|||
126493831|NCT00642941|455108187|FG005|Overall Study|Study closed by Sponsor|0|||
126493832|NCT00642941|455108188|FG006|Overall Study|Study closed by Sponsor|0|||
126493833|NCT00642941|455108189|FG007|Overall Study|Study closed by Sponsor|0|||
126493834|NCT00642941|455108190|FG008|Overall Study|Study closed by Sponsor|0|||
126493835|NCT00642941|455108191|FG009|Overall Study|Study closed by Sponsor|0|||
126493836|NCT00642941|455108192|FG010|Overall Study|Study closed by Sponsor|0|||
126493837|NCT00642941|455108193|FG011|Overall Study|Study closed by Sponsor|0|||
126493838|NCT00642941|455108182|FG000|Overall Study|Withdrawal by Subject|1|||
126493839|NCT00642941|455108183|FG001|Overall Study|Withdrawal by Subject|0|||
126493840|NCT00642941|455108184|FG002|Overall Study|Withdrawal by Subject|0|||
126493841|NCT00642941|455108185|FG003|Overall Study|Withdrawal by Subject|2|||
126493842|NCT00642941|455108186|FG004|Overall Study|Withdrawal by Subject|0|||
126493843|NCT00642941|455108187|FG005|Overall Study|Withdrawal by Subject|0|||
126493844|NCT00642941|455108188|FG006|Overall Study|Withdrawal by Subject|2|||
126493845|NCT00642941|455108189|FG007|Overall Study|Withdrawal by Subject|0|||
126493846|NCT00642941|455108190|FG008|Overall Study|Withdrawal by Subject|1|||
126493847|NCT00642941|455108191|FG009|Overall Study|Withdrawal by Subject|0|||
126493848|NCT00642941|455108192|FG010|Overall Study|Withdrawal by Subject|0|||
126493849|NCT00642941|455108193|FG011|Overall Study|Withdrawal by Subject|1|||
126493850|NCT00642941|455108182|FG000|Overall Study|Protocol Violation|0|||
126493851|NCT00642941|455108183|FG001|Overall Study|Protocol Violation|0|||
126493852|NCT00642941|455108184|FG002|Overall Study|Protocol Violation|0|||
126493853|NCT00642941|455108185|FG003|Overall Study|Protocol Violation|0|||
126493854|NCT00642941|455108186|FG004|Overall Study|Protocol Violation|0|||
126493855|NCT00642941|455108187|FG005|Overall Study|Protocol Violation|0|||
126493856|NCT00642941|455108188|FG006|Overall Study|Protocol Violation|1|||
126493857|NCT00642941|455108189|FG007|Overall Study|Protocol Violation|0|||
126493858|NCT00642941|455108190|FG008|Overall Study|Protocol Violation|0|||
126493859|NCT00642941|455108191|FG009|Overall Study|Protocol Violation|0|||
126493860|NCT00642941|455108192|FG010|Overall Study|Protocol Violation|0|||
126493861|NCT00642941|455108193|FG011|Overall Study|Protocol Violation|0|||
126493862|NCT00642941|455108182|FG000|Overall Study|Adverse Event|1|||
126493863|NCT00642941|455108183|FG001|Overall Study|Adverse Event|1|||
126493864|NCT00642941|455108184|FG002|Overall Study|Adverse Event|0|||
126493865|NCT00642941|455108185|FG003|Overall Study|Adverse Event|0|||
126493866|NCT00642941|455108186|FG004|Overall Study|Adverse Event|0|||
126493867|NCT00642941|455108187|FG005|Overall Study|Adverse Event|0|||
126493868|NCT00642941|455108188|FG006|Overall Study|Adverse Event|1|||
126493869|NCT00642941|455108189|FG007|Overall Study|Adverse Event|1|||
126493870|NCT00642941|455108190|FG008|Overall Study|Adverse Event|0|||
126493871|NCT00642941|455108191|FG009|Overall Study|Adverse Event|1|||
126493872|NCT00642941|455108192|FG010|Overall Study|Adverse Event|0|||
126493873|NCT00642941|455108193|FG011|Overall Study|Adverse Event|0|||
126493874|NCT00642941|455108182|FG000|Overall Study|Other|1|||
126493875|NCT00642941|455108183|FG001|Overall Study|Other|1|||
126493876|NCT00642941|455108184|FG002|Overall Study|Other|1|||
126493877|NCT00642941|455108185|FG003|Overall Study|Other|1|||
126493878|NCT00642941|455108186|FG004|Overall Study|Other|0|||
126493879|NCT00642941|455108187|FG005|Overall Study|Other|1|||
126493880|NCT00642941|455108188|FG006|Overall Study|Other|0|||
126493881|NCT00642941|455108189|FG007|Overall Study|Other|1|||
126493882|NCT00642941|455108190|FG008|Overall Study|Other|0|||
126493883|NCT00642941|455108191|FG009|Overall Study|Other|0|||
126493884|NCT00642941|455108192|FG010|Overall Study|Other|0|||
126493885|NCT00642941|455108193|FG011|Overall Study|Other|1|||
126493886|NCT00642941|455108182|FG000|Overall Study|Disease progression|60|||
126493887|NCT00642941|455108183|FG001|Overall Study|Disease progression|50|||
126493888|NCT00642941|455108184|FG002|Overall Study|Disease progression|5|||
126493889|NCT00642941|455108185|FG003|Overall Study|Disease progression|36|||
126493890|NCT00642941|455108186|FG004|Overall Study|Disease progression|23|||
126493891|NCT00642941|455108187|FG005|Overall Study|Disease progression|39|||
126493892|NCT00642941|455108188|FG006|Overall Study|Disease progression|18|||
126493893|NCT00642941|455108189|FG007|Overall Study|Disease progression|12|||
126493894|NCT00642941|455108190|FG008|Overall Study|Disease progression|10|||
126493895|NCT00642941|455108191|FG009|Overall Study|Disease progression|7|||
126493896|NCT00642941|455108192|FG010|Overall Study|Disease progression|12|||
126493897|NCT00642941|455108193|FG011|Overall Study|Disease progression|7|||
126493898|NCT01698801|455108194|FG000|Treatment Phase|Adverse Event|4|||
126493899|NCT01698801|455108194|FG000|Treatment Phase|Protocol Violation|1|||
126493900|NCT01698801|455108194|FG000|Treatment Phase|Other|4|||
126493901|NCT01698801|455108194|FG000|Treatment Phase|Withdrawal by Subject|1|||
126493902|NCT01698801|455108194|FG000|Treatment Phase|Disease progression|1|||
126493903|NCT01698801|455108194|FG000|Follow Up Phase|Withdrawal by Subject|1|||
126493904|NCT01698801|455108194|FG000|Follow Up Phase|Death|4|||
126493905|NCT01614067|455108195|FG000|Overall Study|Pregnancy|1|||
126493906|NCT01614067|455108196|FG001|Overall Study|Pregnancy|0|||
126493907|NCT01614067|455108195|FG000|Overall Study|Physician Decision|6|||
126493908|NCT01614067|455108196|FG001|Overall Study|Physician Decision|5|||
126493909|NCT01614067|455108195|FG000|Overall Study|Withdrawal by Subject|0|||
126493910|NCT01614067|455108196|FG001|Overall Study|Withdrawal by Subject|1|||
126493911|NCT01614067|455108195|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
126493912|NCT01614067|455108196|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
126493913|NCT01505868|455108197|FG000|Overall Study|Withdrawal by Subject|1|||
126493914|NCT01505868|455108198|FG001|Overall Study|Withdrawal by Subject|0|||
126493915|NCT01505868|455108199|FG002|Overall Study|Withdrawal by Subject|0|||
126493916|NCT01505868|455108200|FG003|Overall Study|Withdrawal by Subject|0|||
126493917|NCT01505868|455108201|FG004|Overall Study|Withdrawal by Subject|0|||
126493918|NCT02062879|455108202|FG000|Overall Study|Withdrawal by Subject|4|||
126493919|NCT02062879|455108203|FG001|Overall Study|Withdrawal by Subject|1|||
126493920|NCT02289079|455108204|FG000|Overall Study|Physician Decision|2|||
126493921|NCT02289079|455108205|FG001|Overall Study|Physician Decision|0|||
126493922|NCT02289079|455108204|FG000|Overall Study|Lost to Follow-up|0|||
126493923|NCT02289079|455108205|FG001|Overall Study|Lost to Follow-up|1|||
126493924|NCT00680043|455108206|FG000|Overall Study|Withdrawal by Subject|1|||
126493925|NCT00680043|455108207|FG001|Overall Study|Withdrawal by Subject|0|||
126493926|NCT00680043|455108208|FG002|Overall Study|Withdrawal by Subject|0|||
126493927|NCT00680043|455108206|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
126493928|NCT00680043|455108207|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
126493929|NCT00680043|455108208|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
126493930|NCT00680043|455108206|FG000|Overall Study|Renal Transplant|1|||
126493931|NCT00680043|455108207|FG001|Overall Study|Renal Transplant|0|||
126493932|NCT00680043|455108208|FG002|Overall Study|Renal Transplant|4|||
126493933|NCT00553150|455108209|FG000|Overall Study|Withdrawal by Subject|0|||
126493934|NCT00553150|455108210|FG001|Overall Study|Withdrawal by Subject|0|||
126493935|NCT00553150|455108211|FG002|Overall Study|Withdrawal by Subject|0|||
126493936|NCT00553150|455108212|FG003|Overall Study|Withdrawal by Subject|2|||
126493937|NCT00553150|455108209|FG000|Overall Study|Protocol Violation|0|||
126493938|NCT00553150|455108210|FG001|Overall Study|Protocol Violation|0|||
126493939|NCT00553150|455108211|FG002|Overall Study|Protocol Violation|0|||
126493940|NCT00553150|455108212|FG003|Overall Study|Protocol Violation|1|||
126493941|NCT00553150|455108209|FG000|Overall Study|Ineligible|0|||
126493942|NCT00553150|455108210|FG001|Overall Study|Ineligible|0|||
126493943|NCT00553150|455108211|FG002|Overall Study|Ineligible|0|||
126493944|NCT00553150|455108212|FG003|Overall Study|Ineligible|1|||
126493945|NCT03061331|455108213|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
126493946|NCT03061331|455108214|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
126493947|NCT02998840|455108218|FG000|Overall Study|Lost to Follow-up|1|||
126493948|NCT02998840|455108219|FG001|Overall Study|Lost to Follow-up|1|||
126493949|NCT02998840|455108220|FG002|Overall Study|Lost to Follow-up|2|||
126493950|NCT02998840|455108221|FG003|Overall Study|Lost to Follow-up|3|||
126493951|NCT02998840|455108218|FG000|Overall Study|Withdrawal by Subject|1|||
126493952|NCT02998840|455108219|FG001|Overall Study|Withdrawal by Subject|1|||
126493953|NCT02998840|455108220|FG002|Overall Study|Withdrawal by Subject|0|||
126493954|NCT02998840|455108221|FG003|Overall Study|Withdrawal by Subject|1|||
126493955|NCT02998840|455108218|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
126493956|NCT02998840|455108219|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
126493957|NCT02998840|455108220|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
126493958|NCT02998840|455108221|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
126493959|NCT01686633|455108222|FG000|Overall Study|Lack of Efficacy|33|||
126493960|NCT01686633|455108223|FG001|Overall Study|Lack of Efficacy|13|||
126493961|NCT01686633|455108224|FG002|Overall Study|Lack of Efficacy|11|||
126493962|NCT01686633|455108222|FG000|Overall Study|Withdrawal by Subject|8|||
126493963|NCT01686633|455108223|FG001|Overall Study|Withdrawal by Subject|8|||
126493964|NCT01686633|455108224|FG002|Overall Study|Withdrawal by Subject|5|||
126493965|NCT01686633|455108222|FG000|Overall Study|Physician Decision|3|||
126493966|NCT01686633|455108223|FG001|Overall Study|Physician Decision|4|||
126493967|NCT01686633|455108224|FG002|Overall Study|Physician Decision|4|||
126493968|NCT01686633|455108222|FG000|Overall Study|Adverse Event|4|||
126493969|NCT01686633|455108223|FG001|Overall Study|Adverse Event|3|||
126493970|NCT01686633|455108224|FG002|Overall Study|Adverse Event|3|||
126493971|NCT01686633|455108222|FG000|Overall Study|Protocol Violation|2|||
126493972|NCT01686633|455108223|FG001|Overall Study|Protocol Violation|3|||
126493973|NCT01686633|455108224|FG002|Overall Study|Protocol Violation|0|||
126493974|NCT01686633|455108222|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
126493975|NCT01686633|455108223|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
126493976|NCT01686633|455108224|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
126493977|NCT01686633|455108222|FG000|Overall Study|Lost to Follow-up|0|||
126493978|NCT01686633|455108223|FG001|Overall Study|Lost to Follow-up|1|||
126493979|NCT01686633|455108224|FG002|Overall Study|Lost to Follow-up|1|||
126493980|NCT00195676|455108226|FG000|Period O - Open-label Treatment|Adverse Event|82|||
126493981|NCT00195676|455108226|FG000|Period O - Open-label Treatment|Death|6|||
126493982|NCT00195676|455108226|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
126493983|NCT00195676|455108226|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
126493984|NCT00195676|455108226|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
126493985|NCT00195676|455108226|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
126493986|NCT00195676|455108226|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
126493987|NCT00195676|455108226|FG000|Period O - Open-label Treatment|Other reasons|68|||
126493988|NCT00195676|455108226|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
126493989|NCT00195676|455108226|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
126493990|NCT00195676|455108226|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
126493991|NCT00195676|455108226|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
126493992|NCT00195676|455108226|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
126493993|NCT00195676|455108226|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
126493994|NCT00195676|455108226|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
126493995|NCT00195676|455108226|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
126493996|NCT00195676|455108226|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
126493997|NCT00195676|455108226|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
126493998|NCT00195676|455108226|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
126493999|NCT00195676|455108226|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
126494000|NCT00195676|455108226|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
126494001|NCT01189812|455108227|FG000|Overall Study|Withdrawal by Subject|2|||
126494002|NCT01189812|455108228|FG001|Overall Study|Withdrawal by Subject|3|||
126494003|NCT01189812|455108227|FG000|Overall Study|Adverse Event|1|||
126494004|NCT01189812|455108228|FG001|Overall Study|Adverse Event|0|||
126494005|NCT01189812|455108227|FG000|Overall Study|Out of Window|4|||
126494006|NCT01189812|455108228|FG001|Overall Study|Out of Window|3|||
126494007|NCT01189812|455108227|FG000|Overall Study|Moved out of State|1|||
126494008|NCT01189812|455108228|FG001|Overall Study|Moved out of State|2|||
126494009|NCT00616655|455108229|FG000|Overall Study|Adverse Event|10|||
126494010|NCT00616655|455108230|FG001|Overall Study|Adverse Event|7|||
126494011|NCT00616655|455108231|FG002|Overall Study|Adverse Event|12|||
126494012|NCT00616655|455108229|FG000|Overall Study|Lack of Efficacy|5|||
126494013|NCT00616655|455108230|FG001|Overall Study|Lack of Efficacy|5|||
126494014|NCT00616655|455108231|FG002|Overall Study|Lack of Efficacy|5|||
126494015|NCT00616655|455108229|FG000|Overall Study|Lost to Follow-up|3|||
126494016|NCT00616655|455108230|FG001|Overall Study|Lost to Follow-up|12|||
126494017|NCT00616655|455108231|FG002|Overall Study|Lost to Follow-up|10|||
126494018|NCT00616655|455108229|FG000|Overall Study|Protocol Violation|2|||
126494019|NCT00616655|455108230|FG001|Overall Study|Protocol Violation|4|||
126494020|NCT00616655|455108231|FG002|Overall Study|Protocol Violation|3|||
126494021|NCT00616655|455108229|FG000|Overall Study|Withdrawal by Subject|9|||
126494022|NCT00616655|455108230|FG001|Overall Study|Withdrawal by Subject|7|||
126494023|NCT00616655|455108231|FG002|Overall Study|Withdrawal by Subject|11|||
126494024|NCT00616655|455108229|FG000|Overall Study|Does not meet in/ex criteria|0|||
126494025|NCT00616655|455108230|FG001|Overall Study|Does not meet in/ex criteria|0|||
126494026|NCT00616655|455108231|FG002|Overall Study|Does not meet in/ex criteria|2|||
126494027|NCT00616655|455108229|FG000|Overall Study|Other|6|||
126494028|NCT00616655|455108230|FG001|Overall Study|Other|6|||
126494029|NCT00616655|455108231|FG002|Overall Study|Other|5|||
126494030|NCT03761147|455108232|FG000|Overall Study|Withdrawal by Subject|6|||
126494031|NCT03761147|455108233|FG001|Overall Study|Withdrawal by Subject|1|||
126494032|NCT03761147|455108232|FG000|Overall Study|Adverse Event|1|||
126494033|NCT03761147|455108233|FG001|Overall Study|Adverse Event|3|||
126494034|NCT01026792|455108235|FG000|Overall Study|Protocol Violation|1|||
126494035|NCT00309842|455108236|FG000|Overall Study|Lost to Follow-up|1|||
126494036|NCT00423150|455108237|FG000|Overall Study|Adverse Event|11|||
126494037|NCT00423150|455108237|FG000|Overall Study|Progression of disease being studied|69|||
126494038|NCT00423150|455108237|FG000|Overall Study|Withdrawal by Subject|1|||
126494039|NCT00423150|455108237|FG000|Overall Study|Non-compliance with protocol|1|||
126494040|NCT00423150|455108237|FG000|Overall Study|Administrative|4|||
126494041|NCT03204305|455108238|FG000|Overall Study|Lost to Follow-up|6|||
126494042|NCT03204305|455108239|FG001|Overall Study|Lost to Follow-up|4|||
126494043|NCT03204305|455108240|FG002|Overall Study|Lost to Follow-up|0|||
126494044|NCT03204305|455108241|FG003|Overall Study|Lost to Follow-up|0|||
126494045|NCT03204305|455108238|FG000|Overall Study|Physician Decision|1|||
126494046|NCT03204305|455108239|FG001|Overall Study|Physician Decision|0|||
126494047|NCT03204305|455108240|FG002|Overall Study|Physician Decision|0|||
126494048|NCT03204305|455108241|FG003|Overall Study|Physician Decision|0|||
126494049|NCT03204305|455108238|FG000|Overall Study|failure to place arterial line|2|||
126494050|NCT03204305|455108239|FG001|Overall Study|failure to place arterial line|1|||
126494051|NCT03204305|455108240|FG002|Overall Study|failure to place arterial line|0|||
126494052|NCT03204305|455108241|FG003|Overall Study|failure to place arterial line|0|||
126494053|NCT03204305|455108238|FG000|Overall Study|Withdrawal by Subject|2|||
126494054|NCT03204305|455108239|FG001|Overall Study|Withdrawal by Subject|0|||
126494055|NCT03204305|455108240|FG002|Overall Study|Withdrawal by Subject|0|||
126494056|NCT03204305|455108241|FG003|Overall Study|Withdrawal by Subject|0|||
126494057|NCT02953314|455108242|FG000|Overall Study|Adverse Event|0|||
126494058|NCT02953314|455108243|FG001|Overall Study|Adverse Event|1|||
126494059|NCT02953314|455108242|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
126494060|NCT02953314|455108243|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
126494061|NCT00535223|455108244|FG000|Overall Study|Withdrawal by Subject|4|||
126494062|NCT00535223|455108245|FG001|Overall Study|Withdrawal by Subject|1|||
126494063|NCT02045797|455108246|FG000|Overall Study|Adverse Event|3|||
126494064|NCT02045797|455108247|FG001|Overall Study|Adverse Event|1|||
126494065|NCT02045797|455108248|FG002|Overall Study|Adverse Event|0|||
126494066|NCT02045797|455108246|FG000|Overall Study|Lack of Efficacy|1|||
126494067|NCT02045797|455108247|FG001|Overall Study|Lack of Efficacy|0|||
126494068|NCT02045797|455108248|FG002|Overall Study|Lack of Efficacy|0|||
126494069|NCT02045797|455108246|FG000|Overall Study|Lost to Follow-up|2|||
126494070|NCT02045797|455108247|FG001|Overall Study|Lost to Follow-up|3|||
126494071|NCT02045797|455108248|FG002|Overall Study|Lost to Follow-up|1|||
126494072|NCT02045797|455108246|FG000|Overall Study|Physician Decision|0|||
126494073|NCT02045797|455108247|FG001|Overall Study|Physician Decision|1|||
126494074|NCT02045797|455108248|FG002|Overall Study|Physician Decision|0|||
126494075|NCT02045797|455108246|FG000|Overall Study|Withdrawal by Subject|1|||
126494076|NCT02045797|455108247|FG001|Overall Study|Withdrawal by Subject|2|||
126494077|NCT02045797|455108248|FG002|Overall Study|Withdrawal by Subject|0|||
126494078|NCT01765153|455108249|FG000|Training Phase 1|Format of intervention differed|1|||
126494079|NCT01765153|455108250|FG001|Training Phase 1|Format of intervention differed|0|||
126494080|NCT01765153|455108249|FG000|Training Phase 1|Poor participation in intervention|0|||
126494081|NCT01765153|455108250|FG001|Training Phase 1|Poor participation in intervention|1|||
126494082|NCT01765153|455108249|FG000|Rest Phase 1|Withdrawal by Subject|0|||
126494083|NCT01765153|455108250|FG001|Rest Phase 1|Withdrawal by Subject|1|||
126494084|NCT01765153|455108249|FG000|Training Phase 2|Withdrawal by Subject|0|||
126494085|NCT01765153|455108250|FG001|Training Phase 2|Withdrawal by Subject|1|||
126494086|NCT01765153|455108249|FG000|Rest Phase 2|Lost to Follow-up|2|||
126494087|NCT01765153|455108250|FG001|Rest Phase 2|Lost to Follow-up|1|||
126494088|NCT02554812|455108255|FG000|Overall Study|Adverse Event|2|||
126494089|NCT02554812|455108256|FG001|Overall Study|Adverse Event|5|||
126494090|NCT02554812|455108257|FG002|Overall Study|Adverse Event|3|||
126772665|NCT02454972|456123632|FG003|Overall Study|Never treated|1|||
126772666|NCT02454972|456123633|FG004|Overall Study|Never treated|1|||
126772667|NCT02454972|456123634|FG005|Overall Study|Never treated|0|||
126772668|NCT02454972|456123635|FG006|Overall Study|Never treated|0|||
126772669|NCT02454972|456123636|FG007|Overall Study|Never treated|0|||
126772670|NCT02454972|456123637|FG008|Overall Study|Never treated|5|||
126772671|NCT02454972|456123629|FG000|Overall Study|Lost to Follow-up|0|||
126772672|NCT02454972|456123630|FG001|Overall Study|Lost to Follow-up|0|||
126772673|NCT02454972|456123631|FG002|Overall Study|Lost to Follow-up|0|||
126772674|NCT02454972|456123632|FG003|Overall Study|Lost to Follow-up|0|||
126772675|NCT02454972|456123633|FG004|Overall Study|Lost to Follow-up|0|||
126772676|NCT02454972|456123634|FG005|Overall Study|Lost to Follow-up|0|||
126772677|NCT02454972|456123635|FG006|Overall Study|Lost to Follow-up|0|||
126772678|NCT02454972|456123636|FG007|Overall Study|Lost to Follow-up|0|||
126772679|NCT02454972|456123637|FG008|Overall Study|Lost to Follow-up|2|||
126772680|NCT02454972|456123629|FG000|Overall Study|Study termination|0|||
126772681|NCT02454972|456123630|FG001|Overall Study|Study termination|0|||
126772682|NCT02454972|456123631|FG002|Overall Study|Study termination|0|||
126772683|NCT02454972|456123632|FG003|Overall Study|Study termination|0|||
126772684|NCT02454972|456123633|FG004|Overall Study|Study termination|0|||
126772685|NCT02454972|456123634|FG005|Overall Study|Study termination|0|||
126494091|NCT02554812|455108258|FG003|Overall Study|Adverse Event|0|||
126494092|NCT02554812|455108259|FG004|Overall Study|Adverse Event|5|||
126494093|NCT02554812|455108260|FG005|Overall Study|Adverse Event|0|||
126772686|NCT02454972|456123635|FG006|Overall Study|Study termination|0|||
126559575|NCT02403674|455342539|FG000|Base Study|Non-Compliance with study drug|1|||
126559576|NCT02403674|455342540|FG001|Base Study|Non-Compliance with study drug|4|||
126559577|NCT02403674|455342539|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
126559578|NCT02403674|455342540|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
126559579|NCT02403674|455342539|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
126559580|NCT02403674|455342540|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
126559581|NCT02403674|455342539|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
126559582|NCT02403674|455342540|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
126559583|NCT02403674|455342539|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
126559584|NCT02403674|455342540|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
126559585|NCT02403674|455342539|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
126559586|NCT02403674|455342540|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
126559587|NCT02403674|455342539|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
126559588|NCT02403674|455342540|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
126559589|NCT02403674|455342539|FG000|Study Extension 1 (Open-Label)|Death|1|||
126559590|NCT02403674|455342540|FG001|Study Extension 1 (Open-Label)|Death|0|||
126559591|NCT02403674|455342539|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
126559592|NCT02403674|455342540|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
126559593|NCT02403674|455342539|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
126559594|NCT02403674|455342540|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
126559595|NCT02403674|455342539|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
126559596|NCT02403674|455342540|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
126559597|NCT02403674|455342539|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
126559598|NCT02403674|455342540|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
126559599|NCT02403674|455342539|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
126559600|NCT02403674|455342540|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
126559601|NCT02403674|455342539|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
126559602|NCT02403674|455342540|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
126559603|NCT02403674|455342539|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
126559604|NCT02403674|455342540|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
126559605|NCT02403674|455342539|FG000|Study Extension 2 (Open-Label)|Death|2|||
126559606|NCT02403674|455342540|FG001|Study Extension 2 (Open-Label)|Death|2|||
126559607|NCT02403674|455342539|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
126559608|NCT02403674|455342540|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
126559609|NCT02403674|455342539|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
126559610|NCT02403674|455342540|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
126559611|NCT02403674|455342539|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
126559612|NCT02403674|455342540|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
126559613|NCT02403674|455342539|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
126559614|NCT02403674|455342540|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
126559615|NCT02403674|455342539|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
126559616|NCT02403674|455342540|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
126559617|NCT02403674|455342539|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
126559618|NCT02403674|455342540|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
126559619|NCT02403674|455342539|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
126723677|NCT01000727|455938676|FG000|Overall Study|Study closed/terminated|23|||
126723678|NCT01000727|455938677|FG001|Overall Study|Study closed/terminated|24|||
126723679|NCT03544268|455938680|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
126756535|NCT01667731|456059466|FG001|Overall Study|Enrolled but not treated|0|||
126494094|NCT02554812|455108261|FG006|Overall Study|Adverse Event|1|||
126494095|NCT02554812|455108262|FG007|Overall Study|Adverse Event|6|||
126494096|NCT02554812|455108263|FG008|Overall Study|Adverse Event|2|||
126494097|NCT02554812|455108264|FG009|Overall Study|Adverse Event|2|||
126494098|NCT02554812|455108265|FG010|Overall Study|Adverse Event|1|||
126494099|NCT02554812|455108266|FG011|Overall Study|Adverse Event|2|||
126494100|NCT02554812|455108267|FG012|Overall Study|Adverse Event|0|||
126494101|NCT02554812|455108268|FG013|Overall Study|Adverse Event|3|||
126494102|NCT02554812|455108269|FG014|Overall Study|Adverse Event|2|||
126494103|NCT02554812|455108270|FG015|Overall Study|Adverse Event|1|||
126494104|NCT02554812|455108271|FG016|Overall Study|Adverse Event|0|||
126494105|NCT02554812|455108272|FG017|Overall Study|Adverse Event|1|||
126494106|NCT02554812|455108273|FG018|Overall Study|Adverse Event|0|||
126494107|NCT02554812|455108274|FG019|Overall Study|Adverse Event|0|||
126494108|NCT02554812|455108275|FG020|Overall Study|Adverse Event|0|||
126494109|NCT02554812|455108276|FG021|Overall Study|Adverse Event|2|||
126494110|NCT02554812|455108277|FG022|Overall Study|Adverse Event|1|||
126494111|NCT02554812|455108278|FG023|Overall Study|Adverse Event|1|||
126494112|NCT02554812|455108279|FG024|Overall Study|Adverse Event|1|||
126494113|NCT02554812|455108280|FG025|Overall Study|Adverse Event|2|||
126494114|NCT02554812|455108281|FG026|Overall Study|Adverse Event|1|||
126494115|NCT02554812|455108255|FG000|Overall Study|Death|1|||
126494116|NCT02554812|455108256|FG001|Overall Study|Death|2|||
126494117|NCT02554812|455108257|FG002|Overall Study|Death|2|||
126494118|NCT02554812|455108258|FG003|Overall Study|Death|2|||
126494119|NCT02554812|455108259|FG004|Overall Study|Death|0|||
126723680|NCT03544268|455938681|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
126723681|NCT00568958|455938683|FG000|Allocation|Withdrawal by Subject|7|||
126723682|NCT00568958|455938684|FG001|Allocation|Withdrawal by Subject|3|||
126494120|NCT02554812|455108260|FG005|Overall Study|Death|1|||
126494121|NCT02554812|455108261|FG006|Overall Study|Death|1|||
126494122|NCT02554812|455108262|FG007|Overall Study|Death|1|||
126494123|NCT02554812|455108263|FG008|Overall Study|Death|0|||
126494124|NCT02554812|455108264|FG009|Overall Study|Death|0|||
126494125|NCT02554812|455108265|FG010|Overall Study|Death|0|||
126494126|NCT02554812|455108266|FG011|Overall Study|Death|0|||
126494127|NCT02554812|455108267|FG012|Overall Study|Death|0|||
126494128|NCT02554812|455108268|FG013|Overall Study|Death|0|||
126494129|NCT02554812|455108269|FG014|Overall Study|Death|1|||
126494130|NCT02554812|455108270|FG015|Overall Study|Death|1|||
126494131|NCT02554812|455108271|FG016|Overall Study|Death|1|||
126494132|NCT02554812|455108272|FG017|Overall Study|Death|0|||
126494133|NCT02554812|455108273|FG018|Overall Study|Death|1|||
126494134|NCT02554812|455108274|FG019|Overall Study|Death|2|||
126494135|NCT02554812|455108275|FG020|Overall Study|Death|0|||
126494136|NCT02554812|455108276|FG021|Overall Study|Death|1|||
126494137|NCT02554812|455108277|FG022|Overall Study|Death|1|||
126494138|NCT02554812|455108278|FG023|Overall Study|Death|0|||
126494139|NCT02554812|455108279|FG024|Overall Study|Death|0|||
126494140|NCT02554812|455108280|FG025|Overall Study|Death|0|||
126494141|NCT02554812|455108281|FG026|Overall Study|Death|0|||
126494142|NCT02554812|455108255|FG000|Overall Study|Lost to Follow-up|0|||
126494143|NCT02554812|455108256|FG001|Overall Study|Lost to Follow-up|1|||
126494144|NCT02554812|455108257|FG002|Overall Study|Lost to Follow-up|0|||
126494145|NCT02554812|455108258|FG003|Overall Study|Lost to Follow-up|0|||
126494146|NCT02554812|455108259|FG004|Overall Study|Lost to Follow-up|0|||
126494147|NCT02554812|455108260|FG005|Overall Study|Lost to Follow-up|0|||
126494148|NCT02554812|455108261|FG006|Overall Study|Lost to Follow-up|0|||
126494149|NCT02554812|455108262|FG007|Overall Study|Lost to Follow-up|0|||
126494150|NCT02554812|455108263|FG008|Overall Study|Lost to Follow-up|0|||
126494151|NCT02554812|455108264|FG009|Overall Study|Lost to Follow-up|0|||
126494152|NCT02554812|455108265|FG010|Overall Study|Lost to Follow-up|0|||
126494153|NCT02554812|455108266|FG011|Overall Study|Lost to Follow-up|0|||
126494154|NCT02554812|455108267|FG012|Overall Study|Lost to Follow-up|0|||
126494155|NCT02554812|455108268|FG013|Overall Study|Lost to Follow-up|0|||
126494156|NCT02554812|455108269|FG014|Overall Study|Lost to Follow-up|0|||
126494157|NCT02554812|455108270|FG015|Overall Study|Lost to Follow-up|0|||
126494158|NCT02554812|455108271|FG016|Overall Study|Lost to Follow-up|0|||
126494159|NCT02554812|455108272|FG017|Overall Study|Lost to Follow-up|0|||
126494160|NCT02554812|455108273|FG018|Overall Study|Lost to Follow-up|0|||
126494161|NCT02554812|455108274|FG019|Overall Study|Lost to Follow-up|0|||
126494162|NCT02554812|455108275|FG020|Overall Study|Lost to Follow-up|0|||
126494163|NCT02554812|455108276|FG021|Overall Study|Lost to Follow-up|0|||
126494164|NCT02554812|455108277|FG022|Overall Study|Lost to Follow-up|0|||
126494165|NCT02554812|455108278|FG023|Overall Study|Lost to Follow-up|0|||
126494166|NCT02554812|455108279|FG024|Overall Study|Lost to Follow-up|0|||
126494167|NCT02554812|455108280|FG025|Overall Study|Lost to Follow-up|0|||
126494168|NCT02554812|455108281|FG026|Overall Study|Lost to Follow-up|0|||
126494169|NCT02554812|455108255|FG000|Overall Study|Global deterioration of health status|4|||
126494170|NCT02554812|455108256|FG001|Overall Study|Global deterioration of health status|3|||
126494171|NCT02554812|455108257|FG002|Overall Study|Global deterioration of health status|3|||
126494172|NCT02554812|455108258|FG003|Overall Study|Global deterioration of health status|2|||
126494173|NCT02554812|455108259|FG004|Overall Study|Global deterioration of health status|5|||
126494174|NCT02554812|455108260|FG005|Overall Study|Global deterioration of health status|0|||
126494175|NCT02554812|455108261|FG006|Overall Study|Global deterioration of health status|2|||
126494176|NCT02554812|455108262|FG007|Overall Study|Global deterioration of health status|1|||
126494177|NCT02554812|455108263|FG008|Overall Study|Global deterioration of health status|1|||
126494178|NCT02554812|455108264|FG009|Overall Study|Global deterioration of health status|1|||
126494179|NCT02554812|455108265|FG010|Overall Study|Global deterioration of health status|2|||
126494180|NCT02554812|455108266|FG011|Overall Study|Global deterioration of health status|1|||
126494181|NCT02554812|455108267|FG012|Overall Study|Global deterioration of health status|0|||
126494182|NCT02554812|455108268|FG013|Overall Study|Global deterioration of health status|0|||
126494183|NCT02554812|455108269|FG014|Overall Study|Global deterioration of health status|0|||
126494184|NCT02554812|455108270|FG015|Overall Study|Global deterioration of health status|1|||
126494185|NCT02554812|455108271|FG016|Overall Study|Global deterioration of health status|0|||
126723683|NCT00568958|455938683|FG000|Allocation|Physician Decision|2|||
126494186|NCT02554812|455108272|FG017|Overall Study|Global deterioration of health status|0|||
126494187|NCT02554812|455108273|FG018|Overall Study|Global deterioration of health status|0|||
126494188|NCT02554812|455108274|FG019|Overall Study|Global deterioration of health status|0|||
126494189|NCT02554812|455108275|FG020|Overall Study|Global deterioration of health status|0|||
126494190|NCT02554812|455108276|FG021|Overall Study|Global deterioration of health status|0|||
126723684|NCT00568958|455938684|FG001|Allocation|Physician Decision|0|||
126723685|NCT00568958|455938683|FG000|Follow-Up|Withdrawal by Subject|6|||
126723686|NCT00568958|455938684|FG001|Follow-Up|Withdrawal by Subject|6|||
126723687|NCT00568958|455938683|FG000|Follow-Up|Physician Decision|1|||
126723688|NCT00568958|455938684|FG001|Follow-Up|Physician Decision|1|||
126723689|NCT00568958|455938683|FG000|Follow-Up|Family Emergency|1|||
126723690|NCT00568958|455938684|FG001|Follow-Up|Family Emergency|0|||
126723691|NCT00568958|455938683|FG000|Follow-Up|Adverse Event|1|||
126723692|NCT00568958|455938684|FG001|Follow-Up|Adverse Event|0|||
126723693|NCT00377611|455938689|FG000|Overall Study|Adverse Event|2|||
126723694|NCT00377611|455938690|FG001|Overall Study|Adverse Event|9|||
126723695|NCT00377611|455938689|FG000|Overall Study|Protocol Violation|2|||
126723696|NCT00377611|455938690|FG001|Overall Study|Protocol Violation|0|||
126723697|NCT00377611|455938689|FG000|Overall Study|Withdrawal by Subject|0|||
126723698|NCT00377611|455938690|FG001|Overall Study|Withdrawal by Subject|5|||
126723699|NCT00377611|455938689|FG000|Overall Study|Lost to Follow-up|18|||
126723700|NCT00377611|455938690|FG001|Overall Study|Lost to Follow-up|16|||
126723701|NCT00377611|455938689|FG000|Overall Study|Other|0|||
126723702|NCT00377611|455938690|FG001|Overall Study|Other|3|||
126723703|NCT00871377|455938693|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
126723704|NCT00871377|455938694|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
126723705|NCT00871377|455938695|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
126723706|NCT00871377|455938696|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
126723707|NCT00871377|455938697|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
126723708|NCT00871377|455938698|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
126723709|NCT00871377|455938693|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
126723710|NCT00871377|455938694|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
126723711|NCT00871377|455938695|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
126723712|NCT00871377|455938696|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
126723713|NCT00871377|455938697|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
126723714|NCT00871377|455938698|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
126723715|NCT00871377|455938693|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
126723716|NCT00871377|455938694|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
126723717|NCT00871377|455938695|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
126723718|NCT00871377|455938696|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
126723719|NCT00871377|455938697|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
126723720|NCT00871377|455938698|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
126723721|NCT00871377|455938693|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
126723722|NCT00871377|455938694|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
126723723|NCT00871377|455938695|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
126723724|NCT00871377|455938696|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
126723725|NCT00871377|455938697|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
126723726|NCT00871377|455938698|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
126723727|NCT00871377|455938693|FG000|Third Intervention (10 Weeks)|Death|0|||
126723728|NCT00871377|455938694|FG001|Third Intervention (10 Weeks)|Death|0|||
126723729|NCT00871377|455938695|FG002|Third Intervention (10 Weeks)|Death|0|||
126723730|NCT00871377|455938696|FG003|Third Intervention (10 Weeks)|Death|1|||
126723731|NCT00871377|455938697|FG004|Third Intervention (10 Weeks)|Death|0|||
126723732|NCT00871377|455938698|FG005|Third Intervention (10 Weeks)|Death|0|||
126723733|NCT01395368|455938700|FG000|Overall Study|Physician Decision|14|||
126723734|NCT01395368|455938700|FG000|Overall Study|Withdrawal by Subject|2|||
126723735|NCT00288860|455938703|FG000|Overall Study|Did not complete intake|4|||
126723736|NCT00288860|455938704|FG001|Overall Study|Did not complete intake|8|||
126723737|NCT00288860|455938703|FG000|Overall Study|Death|4|||
126723738|NCT00288860|455938704|FG001|Overall Study|Death|3|||
126494191|NCT02554812|455108277|FG022|Overall Study|Global deterioration of health status|0|||
126723739|NCT00288860|455938703|FG000|Overall Study|Withdrawal by Subject|20|||
126772687|NCT02454972|456123636|FG007|Overall Study|Study termination|0|||
126772688|NCT02454972|456123637|FG008|Overall Study|Study termination|6|||
126494192|NCT02554812|455108278|FG023|Overall Study|Global deterioration of health status|0|||
126494193|NCT02554812|455108279|FG024|Overall Study|Global deterioration of health status|0|||
126494194|NCT02554812|455108280|FG025|Overall Study|Global deterioration of health status|0|||
126723740|NCT00288860|455938704|FG001|Overall Study|Withdrawal by Subject|15|||
126723741|NCT00288860|455938703|FG000|Overall Study|Lost to Follow-up|74|||
126723742|NCT00288860|455938704|FG001|Overall Study|Lost to Follow-up|71|||
126723743|NCT03072719|455938709|FG000|Overall Study|Adverse Event|1|||
126723744|NCT03072719|455938710|FG001|Overall Study|Adverse Event|1|||
126723745|NCT00882999|455938712|FG000|Overall Study|Adverse Event|0|||
126723746|NCT00882999|455938713|FG001|Overall Study|Adverse Event|0|||
126723747|NCT00882999|455938714|FG002|Overall Study|Adverse Event|0|||
126723748|NCT00882999|455938715|FG003|Overall Study|Adverse Event|0|||
126772689|NCT01377233|456123638|FG000|Open-label|Adverse Event|1|||
126723749|NCT00882999|455938716|FG004|Overall Study|Adverse Event|1|||
126723750|NCT00882999|455938717|FG005|Overall Study|Adverse Event|0|||
126723751|NCT00882999|455938718|FG006|Overall Study|Adverse Event|0|||
126723752|NCT00882999|455938712|FG000|Overall Study|Death|0|||
126772690|NCT01377233|456123639|FG001|Open-label|Adverse Event|0|||
126494195|NCT02554812|455108281|FG026|Overall Study|Global deterioration of health status|0|||
126494196|NCT02554812|455108255|FG000|Overall Study|Progressive disease|20|||
126494197|NCT02554812|455108256|FG001|Overall Study|Progressive disease|16|||
126494198|NCT02554812|455108257|FG002|Overall Study|Progressive disease|19|||
126494199|NCT02554812|455108258|FG003|Overall Study|Progressive disease|18|||
126494200|NCT02554812|455108259|FG004|Overall Study|Progressive disease|21|||
126494201|NCT02554812|455108260|FG005|Overall Study|Progressive disease|15|||
126494202|NCT02554812|455108261|FG006|Overall Study|Progressive disease|6|||
126494203|NCT02554812|455108262|FG007|Overall Study|Progressive disease|13|||
126494204|NCT02554812|455108263|FG008|Overall Study|Progressive disease|6|||
126494205|NCT02554812|455108264|FG009|Overall Study|Progressive disease|6|||
126494206|NCT02554812|455108265|FG010|Overall Study|Progressive disease|8|||
126494207|NCT02554812|455108266|FG011|Overall Study|Progressive disease|8|||
126494208|NCT02554812|455108267|FG012|Overall Study|Progressive disease|6|||
126494209|NCT02554812|455108268|FG013|Overall Study|Progressive disease|10|||
126494210|NCT02554812|455108269|FG014|Overall Study|Progressive disease|20|||
126494211|NCT02554812|455108270|FG015|Overall Study|Progressive disease|6|||
126494212|NCT02554812|455108271|FG016|Overall Study|Progressive disease|3|||
126494213|NCT02554812|455108272|FG017|Overall Study|Progressive disease|3|||
126494214|NCT02554812|455108273|FG018|Overall Study|Progressive disease|11|||
126494215|NCT02554812|455108274|FG019|Overall Study|Progressive disease|7|||
126494216|NCT02554812|455108275|FG020|Overall Study|Progressive disease|11|||
126494217|NCT02554812|455108276|FG021|Overall Study|Progressive disease|6|||
126494218|NCT02554812|455108277|FG022|Overall Study|Progressive disease|9|||
126494219|NCT02554812|455108278|FG023|Overall Study|Progressive disease|9|||
126494220|NCT02554812|455108279|FG024|Overall Study|Progressive disease|4|||
126494221|NCT02554812|455108280|FG025|Overall Study|Progressive disease|5|||
126494222|NCT02554812|455108281|FG026|Overall Study|Progressive disease|5|||
126494223|NCT02554812|455108255|FG000|Overall Study|Other|0|||
126494224|NCT02554812|455108256|FG001|Overall Study|Other|0|||
126494225|NCT02554812|455108257|FG002|Overall Study|Other|2|||
126494226|NCT02554812|455108258|FG003|Overall Study|Other|3|||
126494227|NCT02554812|455108259|FG004|Overall Study|Other|2|||
126494228|NCT02554812|455108260|FG005|Overall Study|Other|1|||
126494229|NCT02554812|455108261|FG006|Overall Study|Other|0|||
126494230|NCT02554812|455108262|FG007|Overall Study|Other|0|||
126494231|NCT02554812|455108263|FG008|Overall Study|Other|1|||
126494232|NCT02554812|455108264|FG009|Overall Study|Other|1|||
126494233|NCT02554812|455108265|FG010|Overall Study|Other|0|||
126494234|NCT02554812|455108266|FG011|Overall Study|Other|0|||
126494235|NCT02554812|455108267|FG012|Overall Study|Other|1|||
126494236|NCT02554812|455108268|FG013|Overall Study|Other|0|||
126494237|NCT02554812|455108269|FG014|Overall Study|Other|1|||
126494238|NCT02554812|455108270|FG015|Overall Study|Other|0|||
126494239|NCT02554812|455108271|FG016|Overall Study|Other|0|||
126494240|NCT02554812|455108272|FG017|Overall Study|Other|0|||
126494241|NCT02554812|455108273|FG018|Overall Study|Other|0|||
126494242|NCT02554812|455108274|FG019|Overall Study|Other|0|||
126494243|NCT02554812|455108275|FG020|Overall Study|Other|0|||
126494244|NCT02554812|455108276|FG021|Overall Study|Other|2|||
126494245|NCT02554812|455108277|FG022|Overall Study|Other|0|||
126494246|NCT02554812|455108278|FG023|Overall Study|Other|0|||
126494247|NCT02554812|455108279|FG024|Overall Study|Other|0|||
126494248|NCT02554812|455108280|FG025|Overall Study|Other|0|||
126494249|NCT02554812|455108281|FG026|Overall Study|Other|0|||
126494250|NCT02554812|455108255|FG000|Overall Study|Withdrawal by Subject|1|||
126494251|NCT02554812|455108256|FG001|Overall Study|Withdrawal by Subject|0|||
126494252|NCT02554812|455108257|FG002|Overall Study|Withdrawal by Subject|0|||
126494253|NCT02554812|455108258|FG003|Overall Study|Withdrawal by Subject|2|||
126494254|NCT02554812|455108259|FG004|Overall Study|Withdrawal by Subject|2|||
126494255|NCT02554812|455108260|FG005|Overall Study|Withdrawal by Subject|3|||
126494256|NCT02554812|455108261|FG006|Overall Study|Withdrawal by Subject|0|||
126494257|NCT02554812|455108262|FG007|Overall Study|Withdrawal by Subject|0|||
126494258|NCT02554812|455108263|FG008|Overall Study|Withdrawal by Subject|1|||
126494259|NCT02554812|455108264|FG009|Overall Study|Withdrawal by Subject|1|||
126494260|NCT02554812|455108265|FG010|Overall Study|Withdrawal by Subject|0|||
126494261|NCT02554812|455108266|FG011|Overall Study|Withdrawal by Subject|1|||
126494262|NCT02554812|455108267|FG012|Overall Study|Withdrawal by Subject|1|||
126494263|NCT02554812|455108268|FG013|Overall Study|Withdrawal by Subject|1|||
126494264|NCT02554812|455108269|FG014|Overall Study|Withdrawal by Subject|1|||
126494265|NCT02554812|455108270|FG015|Overall Study|Withdrawal by Subject|1|||
126494266|NCT02554812|455108271|FG016|Overall Study|Withdrawal by Subject|3|||
126494267|NCT02554812|455108272|FG017|Overall Study|Withdrawal by Subject|1|||
126494268|NCT02554812|455108273|FG018|Overall Study|Withdrawal by Subject|0|||
126494269|NCT02554812|455108274|FG019|Overall Study|Withdrawal by Subject|2|||
126494270|NCT02554812|455108275|FG020|Overall Study|Withdrawal by Subject|0|||
126494271|NCT02554812|455108276|FG021|Overall Study|Withdrawal by Subject|1|||
126494272|NCT02554812|455108277|FG022|Overall Study|Withdrawal by Subject|0|||
126494273|NCT02554812|455108278|FG023|Overall Study|Withdrawal by Subject|1|||
126494274|NCT02554812|455108279|FG024|Overall Study|Withdrawal by Subject|0|||
126494275|NCT02554812|455108280|FG025|Overall Study|Withdrawal by Subject|0|||
126494276|NCT02554812|455108281|FG026|Overall Study|Withdrawal by Subject|1|||
126494277|NCT02554812|455108255|FG000|Overall Study|Physician Decision|1|||
126494278|NCT02554812|455108256|FG001|Overall Study|Physician Decision|0|||
126494279|NCT02554812|455108257|FG002|Overall Study|Physician Decision|0|||
126494280|NCT02554812|455108258|FG003|Overall Study|Physician Decision|1|||
126494281|NCT02554812|455108259|FG004|Overall Study|Physician Decision|0|||
126494282|NCT02554812|455108260|FG005|Overall Study|Physician Decision|1|||
126494283|NCT02554812|455108261|FG006|Overall Study|Physician Decision|0|||
126494284|NCT02554812|455108262|FG007|Overall Study|Physician Decision|0|||
126494285|NCT02554812|455108263|FG008|Overall Study|Physician Decision|0|||
126494286|NCT02554812|455108264|FG009|Overall Study|Physician Decision|0|||
126494287|NCT02554812|455108265|FG010|Overall Study|Physician Decision|1|||
126494288|NCT02554812|455108266|FG011|Overall Study|Physician Decision|0|||
126494289|NCT02554812|455108267|FG012|Overall Study|Physician Decision|0|||
126494290|NCT02554812|455108268|FG013|Overall Study|Physician Decision|0|||
126494291|NCT02554812|455108269|FG014|Overall Study|Physician Decision|0|||
126494292|NCT02554812|455108270|FG015|Overall Study|Physician Decision|0|||
126494293|NCT02554812|455108271|FG016|Overall Study|Physician Decision|1|||
126494294|NCT02554812|455108272|FG017|Overall Study|Physician Decision|1|||
126494295|NCT02554812|455108273|FG018|Overall Study|Physician Decision|0|||
126494296|NCT02554812|455108274|FG019|Overall Study|Physician Decision|1|||
126494297|NCT02554812|455108275|FG020|Overall Study|Physician Decision|1|||
126494298|NCT02554812|455108276|FG021|Overall Study|Physician Decision|0|||
126494299|NCT02554812|455108277|FG022|Overall Study|Physician Decision|1|||
126494300|NCT02554812|455108278|FG023|Overall Study|Physician Decision|0|||
126494301|NCT02554812|455108279|FG024|Overall Study|Physician Decision|0|||
126494302|NCT02554812|455108280|FG025|Overall Study|Physician Decision|0|||
126494303|NCT02554812|455108281|FG026|Overall Study|Physician Decision|0|||
126494304|NCT02554812|455108255|FG000|Overall Study|Study terminated by sponsor|0|||
126494305|NCT02554812|455108256|FG001|Overall Study|Study terminated by sponsor|0|||
126494306|NCT02554812|455108257|FG002|Overall Study|Study terminated by sponsor|0|||
126494307|NCT02554812|455108258|FG003|Overall Study|Study terminated by sponsor|0|||
126494308|NCT02554812|455108259|FG004|Overall Study|Study terminated by sponsor|0|||
126494309|NCT02554812|455108260|FG005|Overall Study|Study terminated by sponsor|0|||
126494310|NCT02554812|455108261|FG006|Overall Study|Study terminated by sponsor|0|||
126494311|NCT02554812|455108262|FG007|Overall Study|Study terminated by sponsor|0|||
126494312|NCT02554812|455108263|FG008|Overall Study|Study terminated by sponsor|0|||
126494313|NCT02554812|455108264|FG009|Overall Study|Study terminated by sponsor|0|||
126494314|NCT02554812|455108265|FG010|Overall Study|Study terminated by sponsor|0|||
126494315|NCT02554812|455108266|FG011|Overall Study|Study terminated by sponsor|0|||
126494316|NCT02554812|455108267|FG012|Overall Study|Study terminated by sponsor|0|||
126494317|NCT02554812|455108268|FG013|Overall Study|Study terminated by sponsor|0|||
126494318|NCT02554812|455108269|FG014|Overall Study|Study terminated by sponsor|0|||
126494319|NCT02554812|455108270|FG015|Overall Study|Study terminated by sponsor|0|||
126494320|NCT02554812|455108271|FG016|Overall Study|Study terminated by sponsor|0|||
126494321|NCT02554812|455108272|FG017|Overall Study|Study terminated by sponsor|0|||
126494322|NCT02554812|455108273|FG018|Overall Study|Study terminated by sponsor|0|||
126494323|NCT02554812|455108274|FG019|Overall Study|Study terminated by sponsor|0|||
126494324|NCT02554812|455108275|FG020|Overall Study|Study terminated by sponsor|0|||
126494325|NCT02554812|455108276|FG021|Overall Study|Study terminated by sponsor|0|||
126494326|NCT02554812|455108277|FG022|Overall Study|Study terminated by sponsor|0|||
126494327|NCT02554812|455108278|FG023|Overall Study|Study terminated by sponsor|0|||
126494328|NCT02554812|455108279|FG024|Overall Study|Study terminated by sponsor|1|||
126494329|NCT02554812|455108280|FG025|Overall Study|Study terminated by sponsor|0|||
126494330|NCT02554812|455108281|FG026|Overall Study|Study terminated by sponsor|0|||
126494331|NCT02554812|455108255|FG000|Overall Study|No longer meets eligibility criteria|0|||
126494332|NCT02554812|455108256|FG001|Overall Study|No longer meets eligibility criteria|1|||
126494333|NCT02554812|455108257|FG002|Overall Study|No longer meets eligibility criteria|0|||
126494334|NCT02554812|455108258|FG003|Overall Study|No longer meets eligibility criteria|0|||
126494335|NCT02554812|455108259|FG004|Overall Study|No longer meets eligibility criteria|0|||
126494336|NCT02554812|455108260|FG005|Overall Study|No longer meets eligibility criteria|0|||
126494337|NCT02554812|455108261|FG006|Overall Study|No longer meets eligibility criteria|0|||
126494338|NCT02554812|455108262|FG007|Overall Study|No longer meets eligibility criteria|0|||
126494339|NCT02554812|455108263|FG008|Overall Study|No longer meets eligibility criteria|0|||
126494340|NCT02554812|455108264|FG009|Overall Study|No longer meets eligibility criteria|0|||
126494341|NCT02554812|455108265|FG010|Overall Study|No longer meets eligibility criteria|0|||
126494342|NCT02554812|455108266|FG011|Overall Study|No longer meets eligibility criteria|0|||
126494343|NCT02554812|455108267|FG012|Overall Study|No longer meets eligibility criteria|0|||
126494344|NCT02554812|455108268|FG013|Overall Study|No longer meets eligibility criteria|0|||
126494345|NCT02554812|455108269|FG014|Overall Study|No longer meets eligibility criteria|0|||
126494346|NCT02554812|455108270|FG015|Overall Study|No longer meets eligibility criteria|0|||
126494347|NCT02554812|455108271|FG016|Overall Study|No longer meets eligibility criteria|0|||
126494348|NCT02554812|455108272|FG017|Overall Study|No longer meets eligibility criteria|0|||
126723753|NCT00882999|455938713|FG001|Overall Study|Death|1|||
126723754|NCT00882999|455938714|FG002|Overall Study|Death|0|||
126772691|NCT01377233|456123640|FG002|Open-label|Adverse Event|0|||
126772692|NCT01377233|456123641|FG003|Open-label|Adverse Event|0|||
126494349|NCT02554812|455108273|FG018|Overall Study|No longer meets eligibility criteria|0|||
126494350|NCT02554812|455108274|FG019|Overall Study|No longer meets eligibility criteria|0|||
126494351|NCT02554812|455108275|FG020|Overall Study|No longer meets eligibility criteria|0|||
126494352|NCT02554812|455108276|FG021|Overall Study|No longer meets eligibility criteria|0|||
126494353|NCT02554812|455108277|FG022|Overall Study|No longer meets eligibility criteria|0|||
126494354|NCT02554812|455108278|FG023|Overall Study|No longer meets eligibility criteria|0|||
126494355|NCT02554812|455108279|FG024|Overall Study|No longer meets eligibility criteria|0|||
126494356|NCT02554812|455108280|FG025|Overall Study|No longer meets eligibility criteria|0|||
126494357|NCT02554812|455108281|FG026|Overall Study|No longer meets eligibility criteria|0|||
126494358|NCT00415909|455109605|FG000|Overall Study|Withdrawal by Subject|2|||
126494359|NCT00415909|455109605|FG000|Overall Study|Death|1|||
126494360|NCT00312494|455109606|FG000|Overall Study|Randomized; not treated with study drug|9|||
126494361|NCT00312494|455109607|FG001|Overall Study|Randomized; not treated with study drug|10|||
126494362|NCT00312494|455109608|FG002|Overall Study|Randomized; not treated with study drug|5|||
126494363|NCT00312494|455109606|FG000|Overall Study|Adverse Event|33|||
126494364|NCT00312494|455109607|FG001|Overall Study|Adverse Event|15|||
126494365|NCT00312494|455109608|FG002|Overall Study|Adverse Event|11|||
126494366|NCT00312494|455109606|FG000|Overall Study|Lack of Efficacy|4|||
126494367|NCT00312494|455109607|FG001|Overall Study|Lack of Efficacy|6|||
126494368|NCT00312494|455109608|FG002|Overall Study|Lack of Efficacy|8|||
126494369|NCT00312494|455109606|FG000|Overall Study|Laboratory abnormality|1|||
126494370|NCT00312494|455109607|FG001|Overall Study|Laboratory abnormality|0|||
126494371|NCT00312494|455109608|FG002|Overall Study|Laboratory abnormality|0|||
126494372|NCT00312494|455109606|FG000|Overall Study|Lost to Follow-up|8|||
126494373|NCT00312494|455109607|FG001|Overall Study|Lost to Follow-up|8|||
126494374|NCT00312494|455109608|FG002|Overall Study|Lost to Follow-up|8|||
126494375|NCT00312494|455109606|FG000|Overall Study|Withdrawal by Subject|6|||
126494376|NCT00312494|455109607|FG001|Overall Study|Withdrawal by Subject|9|||
126494377|NCT00312494|455109608|FG002|Overall Study|Withdrawal by Subject|10|||
126494378|NCT00312494|455109606|FG000|Overall Study|Other|10|||
126494379|NCT00312494|455109607|FG001|Overall Study|Other|10|||
126494380|NCT00312494|455109608|FG002|Overall Study|Other|1|||
126494381|NCT03232281|455109609|FG000|Overall Study|Adverse Event|1|||
126494382|NCT03232281|455109610|FG001|Overall Study|Adverse Event|1|||
126494383|NCT03232281|455109609|FG000|Overall Study|Withdrawal by Subject|5|||
126494384|NCT03232281|455109610|FG001|Overall Study|Withdrawal by Subject|4|||
126494385|NCT03232281|455109609|FG000|Overall Study|Protocol Deviation|1|||
126494386|NCT03232281|455109610|FG001|Overall Study|Protocol Deviation|1|||
126494387|NCT02522286|455109612|FG000|Overall Study|Withdrawal by Subject|3|||
126494388|NCT02522286|455109613|FG001|Overall Study|Withdrawal by Subject|0|||
126494389|NCT02522286|455109614|FG002|Overall Study|Withdrawal by Subject|0|||
126494390|NCT02522286|455109615|FG003|Overall Study|Withdrawal by Subject|3|||
126494391|NCT00605813|455109616|FG000|Overall Study|Protocol Violation|25|||
126494392|NCT00174915|455109617|FG000|Overall Study|Lost to Follow-up|19|||
126494393|NCT00174915|455109618|FG001|Overall Study|Lost to Follow-up|17|||
126494394|NCT00174915|455109619|FG002|Overall Study|Lost to Follow-up|9|||
126494395|NCT00174915|455109620|FG003|Overall Study|Lost to Follow-up|17|||
126494396|NCT00174915|455109621|FG004|Overall Study|Lost to Follow-up|10|||
126494397|NCT00174915|455109617|FG000|Overall Study|Adverse Event|18|||
126494398|NCT00174915|455109618|FG001|Overall Study|Adverse Event|16|||
126494399|NCT00174915|455109619|FG002|Overall Study|Adverse Event|11|||
126494400|NCT00174915|455109620|FG003|Overall Study|Adverse Event|18|||
126494401|NCT00174915|455109621|FG004|Overall Study|Adverse Event|5|||
126494402|NCT00174915|455109617|FG000|Overall Study|Personal Reason(s)|16|||
126494403|NCT00174915|455109618|FG001|Overall Study|Personal Reason(s)|16|||
126494404|NCT00174915|455109619|FG002|Overall Study|Personal Reason(s)|9|||
126494405|NCT00174915|455109620|FG003|Overall Study|Personal Reason(s)|9|||
126494406|NCT00174915|455109621|FG004|Overall Study|Personal Reason(s)|9|||
126494407|NCT00174915|455109617|FG000|Overall Study|Other|15|||
126494408|NCT00174915|455109618|FG001|Overall Study|Other|8|||
126494409|NCT00174915|455109619|FG002|Overall Study|Other|6|||
126494410|NCT00174915|455109620|FG003|Overall Study|Other|5|||
126494411|NCT00174915|455109621|FG004|Overall Study|Other|3|||
126494412|NCT00174915|455109617|FG000|Overall Study|Gout Flare|13|||
126494413|NCT00174915|455109618|FG001|Overall Study|Gout Flare|6|||
126494414|NCT00174915|455109619|FG002|Overall Study|Gout Flare|8|||
126494415|NCT00174915|455109620|FG003|Overall Study|Gout Flare|1|||
126494416|NCT00174915|455109621|FG004|Overall Study|Gout Flare|0|||
126494417|NCT00174915|455109617|FG000|Overall Study|Protocol Violation|6|||
126494418|NCT00174915|455109618|FG001|Overall Study|Protocol Violation|3|||
126494419|NCT00174915|455109619|FG002|Overall Study|Protocol Violation|3|||
126494420|NCT00174915|455109620|FG003|Overall Study|Protocol Violation|6|||
126494421|NCT00174915|455109621|FG004|Overall Study|Protocol Violation|3|||
126494422|NCT00174915|455109617|FG000|Overall Study|Therapeutic Failure|6|||
126494423|NCT00174915|455109618|FG001|Overall Study|Therapeutic Failure|3|||
126494424|NCT00174915|455109619|FG002|Overall Study|Therapeutic Failure|2|||
126772693|NCT01377233|456123642|FG004|Open-label|Adverse Event|0|||
126723755|NCT00882999|455938715|FG003|Overall Study|Death|0|||
126723756|NCT00882999|455938716|FG004|Overall Study|Death|0|||
126723757|NCT00882999|455938717|FG005|Overall Study|Death|0|||
126723758|NCT00882999|455938718|FG006|Overall Study|Death|0|||
126723759|NCT00882999|455938712|FG000|Overall Study|Withdrawal by Subject|7|||
126494425|NCT00174915|455109620|FG003|Overall Study|Therapeutic Failure|1|||
126494426|NCT00174915|455109621|FG004|Overall Study|Therapeutic Failure|3|||
126494427|NCT02132767|455109626|FG000|Overall Study|Death|3|||
126494428|NCT02132767|455109627|FG001|Overall Study|Death|2|||
126494429|NCT02132767|455109626|FG000|Overall Study|Withdrawal by Subject|10|||
126494430|NCT02132767|455109627|FG001|Overall Study|Withdrawal by Subject|9|||
126494431|NCT02132767|455109626|FG000|Overall Study|Lost to Follow-up|4|||
126494432|NCT02132767|455109627|FG001|Overall Study|Lost to Follow-up|4|||
126494433|NCT00778700|455109630|FG000|Overall Study|Adverse Event|6|||
126494434|NCT00778700|455109631|FG001|Overall Study|Adverse Event|1|||
126494435|NCT00778700|455109632|FG002|Overall Study|Adverse Event|3|||
126494436|NCT00778700|455109633|FG003|Overall Study|Adverse Event|5|||
126494437|NCT00778700|455109630|FG000|Overall Study|Protocol Violation|1|||
126494438|NCT00778700|455109631|FG001|Overall Study|Protocol Violation|1|||
126494439|NCT00778700|455109632|FG002|Overall Study|Protocol Violation|0|||
126494440|NCT00778700|455109633|FG003|Overall Study|Protocol Violation|0|||
126494441|NCT00778700|455109630|FG000|Overall Study|Subject Withdrew Consent|6|||
126494442|NCT00778700|455109631|FG001|Overall Study|Subject Withdrew Consent|4|||
126494443|NCT00778700|455109632|FG002|Overall Study|Subject Withdrew Consent|1|||
126494444|NCT00778700|455109633|FG003|Overall Study|Subject Withdrew Consent|4|||
126494445|NCT00778700|455109630|FG000|Overall Study|Lost to Follow-up|3|||
126494446|NCT00778700|455109631|FG001|Overall Study|Lost to Follow-up|1|||
126494447|NCT00778700|455109632|FG002|Overall Study|Lost to Follow-up|0|||
126494448|NCT00778700|455109633|FG003|Overall Study|Lost to Follow-up|1|||
126494449|NCT00778700|455109630|FG000|Overall Study|Reason not Specified|2|||
126494450|NCT00778700|455109631|FG001|Overall Study|Reason not Specified|0|||
126494451|NCT00778700|455109632|FG002|Overall Study|Reason not Specified|1|||
126494452|NCT00778700|455109633|FG003|Overall Study|Reason not Specified|3|||
126494453|NCT00778700|455109630|FG000|Overall Study|Other|0|||
126494454|NCT00778700|455109631|FG001|Overall Study|Other|0|||
126494455|NCT00778700|455109632|FG002|Overall Study|Other|1|||
126494456|NCT00778700|455109633|FG003|Overall Study|Other|0|||
126494457|NCT04267133|455109637|FG000|Overall Study|Withdrawal by Subject|1|||
126494458|NCT04267133|455109637|FG000|Overall Study|Adverse Event|4|||
126494459|NCT01275833|455109639|FG000|Overall Study|Study terminated|1|||
126494460|NCT01275833|455109640|FG001|Overall Study|Study terminated|1|||
126494461|NCT00003901|455109643|FG000|Overall Study|Adverse Event|1|||
126494462|NCT00003901|455109643|FG000|Overall Study|Withdrawal by Subject|1|||
126494463|NCT00003901|455109643|FG000|Overall Study|Ineligible|6|||
126494464|NCT00003901|455109643|FG000|Overall Study|CT Scan not within protocol requirement|2|||
126494465|NCT00003901|455109643|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
126494466|NCT00003901|455109643|FG000|Overall Study|Medical problems|6|||
126494467|NCT00857220|455109646|FG000|Overall Study|Adverse Event|35|||
126494468|NCT00857220|455109646|FG000|Overall Study|Death|1|||
126494469|NCT00857220|455109646|FG000|Overall Study|Lack of Efficacy|11|||
126494470|NCT00857220|455109646|FG000|Overall Study|Lost to Follow-up|30|||
126494471|NCT00857220|455109646|FG000|Overall Study|Physician Decision|4|||
126494472|NCT00857220|455109646|FG000|Overall Study|Protocol Violation|16|||
126494473|NCT00857220|455109646|FG000|Overall Study|Withdrawal by Subject|67|||
126494474|NCT00857220|455109646|FG000|Overall Study|Clinical Hold|6|||
126494475|NCT00857220|455109646|FG000|Overall Study|Site Closed|5|||
126494476|NCT00857220|455109646|FG000|Overall Study|Miscellaneous|8|||
126494477|NCT00680745|455109647|FG000|Overall Study|Withdrawal by Subject|8|||
126494478|NCT00680745|455109648|FG001|Overall Study|Withdrawal by Subject|3|||
126494479|NCT00680745|455109649|FG002|Overall Study|Withdrawal by Subject|2|||
126494480|NCT00680745|455109650|FG003|Overall Study|Withdrawal by Subject|8|||
126723760|NCT00882999|455938713|FG001|Overall Study|Withdrawal by Subject|6|||
126494481|NCT00680745|455109647|FG000|Overall Study|Lost to Follow-up|0|||
126494482|NCT00680745|455109648|FG001|Overall Study|Lost to Follow-up|1|||
126494483|NCT00680745|455109649|FG002|Overall Study|Lost to Follow-up|1|||
126494484|NCT00680745|455109650|FG003|Overall Study|Lost to Follow-up|0|||
126494485|NCT00680745|455109647|FG000|Overall Study|Death|1|||
126494486|NCT00680745|455109648|FG001|Overall Study|Death|0|||
126494487|NCT00680745|455109649|FG002|Overall Study|Death|1|||
126494488|NCT00680745|455109650|FG003|Overall Study|Death|0|||
126723761|NCT00882999|455938714|FG002|Overall Study|Withdrawal by Subject|3|||
126723762|NCT00882999|455938715|FG003|Overall Study|Withdrawal by Subject|3|||
126494489|NCT00680745|455109647|FG000|Overall Study|Adverse Event|5|||
126494490|NCT00680745|455109648|FG001|Overall Study|Adverse Event|3|||
126494491|NCT00680745|455109649|FG002|Overall Study|Adverse Event|3|||
126494492|NCT00680745|455109650|FG003|Overall Study|Adverse Event|3|||
126494493|NCT00680745|455109647|FG000|Overall Study|Poor/Non-compliance|0|||
126494494|NCT00680745|455109648|FG001|Overall Study|Poor/Non-compliance|3|||
126494495|NCT00680745|455109649|FG002|Overall Study|Poor/Non-compliance|0|||
126494496|NCT00680745|455109650|FG003|Overall Study|Poor/Non-compliance|0|||
126772694|NCT01377233|456123638|FG000|Open-label|Withdrawal by Subject|3|||
126772695|NCT01377233|456123639|FG001|Open-label|Withdrawal by Subject|0|||
126772696|NCT01377233|456123640|FG002|Open-label|Withdrawal by Subject|0|||
126772697|NCT01377233|456123641|FG003|Open-label|Withdrawal by Subject|0|||
126494497|NCT00680745|455109647|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
126494498|NCT00680745|455109648|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
126772698|NCT01377233|456123642|FG004|Open-label|Withdrawal by Subject|0|||
126494499|NCT00680745|455109649|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
126494500|NCT00680745|455109650|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
126494501|NCT00680745|455109647|FG000|Overall Study|False Treatment|0|||
126494502|NCT00680745|455109648|FG001|Overall Study|False Treatment|1|||
126494503|NCT00680745|455109649|FG002|Overall Study|False Treatment|3|||
126494504|NCT00680745|455109650|FG003|Overall Study|False Treatment|0|||
126494505|NCT00742001|455109651|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
126494506|NCT00742001|455109652|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
126494507|NCT00742001|455109653|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
126494508|NCT00137423|455109654|FG000|Overall Study|Adverse Event|7|||
126494509|NCT00137423|455109655|FG001|Overall Study|Adverse Event|9|||
126494510|NCT00137423|455109654|FG000|Overall Study|consent withdrawn|1|||
126494511|NCT00137423|455109655|FG001|Overall Study|consent withdrawn|1|||
126494512|NCT00137423|455109654|FG000|Overall Study|Lack of Efficacy|31|||
126494513|NCT00137423|455109655|FG001|Overall Study|Lack of Efficacy|33|||
126494514|NCT00137423|455109654|FG000|Overall Study|Death|0|||
126494515|NCT00137423|455109655|FG001|Overall Study|Death|1|||
126494516|NCT02617511|455109657|FG000|Overall Study|Withdrawal by Subject|1|||
126494517|NCT02617511|455109658|FG001|Overall Study|Withdrawal by Subject|0|||
126494518|NCT02141997|455109659|FG000|Overall Study|Adverse Event|0|||
126494519|NCT02141997|455109660|FG001|Overall Study|Adverse Event|2|||
126494520|NCT02141997|455109661|FG002|Overall Study|Adverse Event|0|||
126494521|NCT02141997|455109662|FG003|Overall Study|Adverse Event|1|||
126494522|NCT02141997|455109659|FG000|Overall Study|Participant noncompliance|1|||
126494523|NCT02141997|455109660|FG001|Overall Study|Participant noncompliance|0|||
126494524|NCT02141997|455109661|FG002|Overall Study|Participant noncompliance|0|||
126494525|NCT02141997|455109662|FG003|Overall Study|Participant noncompliance|0|||
126494526|NCT02141997|455109659|FG000|Overall Study|Withdrew consent|1|||
126494527|NCT02141997|455109660|FG001|Overall Study|Withdrew consent|0|||
126494528|NCT02141997|455109661|FG002|Overall Study|Withdrew consent|3|||
126494529|NCT02141997|455109662|FG003|Overall Study|Withdrew consent|0|||
126494530|NCT02141997|455109659|FG000|Overall Study|Other|1|||
126494531|NCT02141997|455109660|FG001|Overall Study|Other|4|||
126494532|NCT02141997|455109661|FG002|Overall Study|Other|0|||
126494533|NCT02141997|455109662|FG003|Overall Study|Other|0|||
126494534|NCT04105998|455109665|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
126494535|NCT04105998|455109666|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
126494536|NCT01050257|455109669|FG000|Overall Study|Adverse Event|4|||
126494537|NCT01050257|455109670|FG001|Overall Study|Adverse Event|4|||
126494538|NCT01050257|455109671|FG002|Overall Study|Adverse Event|2|||
126494539|NCT01050257|455109669|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
126494540|NCT01050257|455109670|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
126494541|NCT01050257|455109671|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
126494542|NCT01050257|455109669|FG000|Overall Study|Withdrawal by Subject|0|||
126494543|NCT01050257|455109670|FG001|Overall Study|Withdrawal by Subject|3|||
126494544|NCT01050257|455109671|FG002|Overall Study|Withdrawal by Subject|0|||
126494545|NCT01050257|455109669|FG000|Overall Study|No reason specified|0|||
126494546|NCT01050257|455109670|FG001|Overall Study|No reason specified|0|||
126494547|NCT01050257|455109671|FG002|Overall Study|No reason specified|2|||
126494548|NCT01050257|455109669|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
126494549|NCT01050257|455109670|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
126772699|NCT01377233|456123638|FG000|Double-blind|Adverse Event|0|||
126772700|NCT01377233|456123639|FG001|Double-blind|Adverse Event|1|||
126494550|NCT01050257|455109671|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
126772701|NCT01377233|456123640|FG002|Double-blind|Adverse Event|2|||
126772702|NCT01377233|456123641|FG003|Double-blind|Adverse Event|2|||
126494551|NCT01050257|455109669|FG000|Overall Study|Violation criteria|0|||
126494552|NCT01050257|455109670|FG001|Overall Study|Violation criteria|1|||
126494553|NCT01050257|455109671|FG002|Overall Study|Violation criteria|0|||
126494554|NCT01050257|455109669|FG000|Overall Study|Failure to return|0|||
126494555|NCT01050257|455109670|FG001|Overall Study|Failure to return|2|||
126494556|NCT01050257|455109671|FG002|Overall Study|Failure to return|0|||
126494557|NCT01050257|455109669|FG000|Overall Study|Death|0|||
126494558|NCT01050257|455109670|FG001|Overall Study|Death|0|||
126494559|NCT01050257|455109671|FG002|Overall Study|Death|1|||
126494560|NCT00171223|455109672|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
126494561|NCT00171223|455109673|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
126494562|NCT00171223|455109674|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
126494563|NCT00171223|455109672|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
126772703|NCT01377233|456123642|FG004|Double-blind|Adverse Event|0|||
126494564|NCT00171223|455109673|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
126494565|NCT00171223|455109674|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
126494566|NCT00171223|455109672|FG000|Overall Study|Abnormal Procedure|1|||
126494567|NCT00171223|455109673|FG001|Overall Study|Abnormal Procedure|0|||
126494568|NCT00171223|455109674|FG002|Overall Study|Abnormal Procedure|0|||
126494569|NCT00171223|455109672|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
126494570|NCT00171223|455109673|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
126723763|NCT00882999|455938716|FG004|Overall Study|Withdrawal by Subject|6|||
126723764|NCT00882999|455938717|FG005|Overall Study|Withdrawal by Subject|5|||
126723765|NCT00882999|455938718|FG006|Overall Study|Withdrawal by Subject|5|||
126494571|NCT00171223|455109674|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
126494572|NCT00171223|455109672|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
126494573|NCT00171223|455109673|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
126494574|NCT00171223|455109674|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
126494575|NCT00171223|455109672|FG000|Overall Study|Protocol Violation|2|||
126494576|NCT00171223|455109673|FG001|Overall Study|Protocol Violation|2|||
126494577|NCT00171223|455109674|FG002|Overall Study|Protocol Violation|3|||
126494578|NCT00171223|455109672|FG000|Overall Study|Participant Withdrew Consent|12|||
126494579|NCT00171223|455109673|FG001|Overall Study|Participant Withdrew Consent|21|||
126494580|NCT00171223|455109674|FG002|Overall Study|Participant Withdrew Consent|15|||
126494581|NCT00171223|455109672|FG000|Overall Study|Lost to Follow-up|5|||
126494582|NCT00171223|455109673|FG001|Overall Study|Lost to Follow-up|2|||
126494583|NCT00171223|455109674|FG002|Overall Study|Lost to Follow-up|3|||
126494584|NCT00171223|455109672|FG000|Overall Study|Administrative Problems|4|||
126494585|NCT00171223|455109673|FG001|Overall Study|Administrative Problems|7|||
126494586|NCT00171223|455109674|FG002|Overall Study|Administrative Problems|6|||
126494587|NCT00171223|455109672|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
126494588|NCT00171223|455109673|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
126494589|NCT00171223|455109674|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
126494590|NCT00171223|455109672|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
126494591|NCT00171223|455109673|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
126494592|NCT00171223|455109674|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
126494593|NCT00278109|455109676|FG000|Overall Study|Adverse Event|3|||
126494594|NCT00278109|455109676|FG000|Overall Study|social circumstances|1|||
126494595|NCT02580357|455109677|FG000|Overall Study|Lost to Follow-up|2|||
126494596|NCT02580357|455109678|FG001|Overall Study|Lost to Follow-up|0|||
126494597|NCT02580357|455109679|FG002|Overall Study|Lost to Follow-up|0|||
126494598|NCT02580357|455109677|FG000|Overall Study|Protocol Violation|1|||
126494599|NCT02580357|455109678|FG001|Overall Study|Protocol Violation|0|||
126494600|NCT02580357|455109679|FG002|Overall Study|Protocol Violation|0|||
126494601|NCT02064166|455109680|FG000|Overall Study|Adverse Event|1|||
126494602|NCT02064166|455109681|FG001|Overall Study|Adverse Event|0|||
126494603|NCT00450333|455109682|FG000|Overall Study|Study terminated|47|||
126494604|NCT00450333|455109683|FG001|Overall Study|Study terminated|54|||
126494605|NCT00450333|455109684|FG002|Overall Study|Study terminated|16|||
126494606|NCT00450333|455109685|FG003|Overall Study|Study terminated|21|||
126494607|NCT00450333|455109682|FG000|Overall Study|Adverse Event|1|||
126494608|NCT00450333|455109683|FG001|Overall Study|Adverse Event|7|||
126494609|NCT00450333|455109684|FG002|Overall Study|Adverse Event|2|||
126494610|NCT00450333|455109685|FG003|Overall Study|Adverse Event|2|||
126494611|NCT00450333|455109682|FG000|Overall Study|Protocol Violation|1|||
126494612|NCT00450333|455109683|FG001|Overall Study|Protocol Violation|0|||
126494613|NCT00450333|455109684|FG002|Overall Study|Protocol Violation|1|||
126494614|NCT00450333|455109685|FG003|Overall Study|Protocol Violation|0|||
126494615|NCT00450333|455109682|FG000|Overall Study|Withdrawal by Subject|1|||
126494616|NCT00450333|455109683|FG001|Overall Study|Withdrawal by Subject|0|||
126494617|NCT00450333|455109684|FG002|Overall Study|Withdrawal by Subject|3|||
126494618|NCT00450333|455109685|FG003|Overall Study|Withdrawal by Subject|0|||
126494619|NCT00450333|455109682|FG000|Overall Study|Kidney transplant|1|||
126494620|NCT00450333|455109683|FG001|Overall Study|Kidney transplant|0|||
126494621|NCT00450333|455109684|FG002|Overall Study|Kidney transplant|1|||
126723766|NCT00882999|455938712|FG000|Overall Study|Lost to Follow-up|0|||
126723767|NCT00882999|455938713|FG001|Overall Study|Lost to Follow-up|1|||
126723768|NCT00882999|455938714|FG002|Overall Study|Lost to Follow-up|1|||
126494622|NCT00450333|455109685|FG003|Overall Study|Kidney transplant|3|||
126494623|NCT00450333|455109682|FG000|Overall Study|Death|3|||
126494624|NCT00450333|455109683|FG001|Overall Study|Death|2|||
126494625|NCT00450333|455109684|FG002|Overall Study|Death|2|||
126723769|NCT00882999|455938715|FG003|Overall Study|Lost to Follow-up|2|||
126494626|NCT00450333|455109685|FG003|Overall Study|Death|2|||
126494627|NCT02375113|455109688|FG000|Overall Study|Undisclosed Reason(s).|1|||
126494628|NCT02375113|455109689|FG001|Overall Study|Undisclosed Reason(s).|1|||
126494629|NCT02375113|455109688|FG000|Overall Study|Poor adherence (<70%).|1|||
126494630|NCT02375113|455109689|FG001|Overall Study|Poor adherence (<70%).|0|||
126494631|NCT02375113|455109688|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
126494632|NCT02375113|455109689|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
126723770|NCT00882999|455938716|FG004|Overall Study|Lost to Follow-up|1|||
126723771|NCT00882999|455938717|FG005|Overall Study|Lost to Follow-up|1|||
126723772|NCT00882999|455938718|FG006|Overall Study|Lost to Follow-up|2|||
126723773|NCT00882999|455938712|FG000|Overall Study|Physician Decision|1|||
126723774|NCT00882999|455938713|FG001|Overall Study|Physician Decision|0|||
126723775|NCT00882999|455938714|FG002|Overall Study|Physician Decision|0|||
126723776|NCT00882999|455938715|FG003|Overall Study|Physician Decision|0|||
126723777|NCT00882999|455938716|FG004|Overall Study|Physician Decision|0|||
126723778|NCT00882999|455938717|FG005|Overall Study|Physician Decision|1|||
126723779|NCT00882999|455938718|FG006|Overall Study|Physician Decision|1|||
126723780|NCT01104584|455938719|FG000|Overall Study|Study drug never administered|21|||
126772704|NCT01377233|456123638|FG000|Double-blind|Protocol Violation|0|||
126772705|NCT01377233|456123639|FG001|Double-blind|Protocol Violation|0|||
126772706|NCT01377233|456123640|FG002|Double-blind|Protocol Violation|0|||
126772707|NCT01377233|456123641|FG003|Double-blind|Protocol Violation|0|||
126772708|NCT01377233|456123642|FG004|Double-blind|Protocol Violation|1|||
126772709|NCT01377233|456123638|FG000|Double-blind|Withdrawal by Subject|0|||
126772710|NCT01377233|456123639|FG001|Double-blind|Withdrawal by Subject|0|||
126772711|NCT01377233|456123640|FG002|Double-blind|Withdrawal by Subject|0|||
126772712|NCT01377233|456123641|FG003|Double-blind|Withdrawal by Subject|1|||
126772713|NCT01377233|456123642|FG004|Double-blind|Withdrawal by Subject|0|||
126772714|NCT01377233|456123638|FG000|Double-blind|Administrative or other|0|||
126772715|NCT01377233|456123639|FG001|Double-blind|Administrative or other|0|||
126772716|NCT01377233|456123640|FG002|Double-blind|Administrative or other|0|||
126772717|NCT01377233|456123641|FG003|Double-blind|Administrative or other|1|||
126772718|NCT01377233|456123642|FG004|Double-blind|Administrative or other|1|||
126772719|NCT01785875|456123643|FG000|Overall Study|Withdrawal by Subject|41|||
126772720|NCT01785875|456123644|FG001|Overall Study|Withdrawal by Subject|34|||
126772721|NCT01785875|456123645|FG002|Overall Study|Withdrawal by Subject|36|||
126772722|NCT01785875|456123643|FG000|Overall Study|Lost to Follow-up|19|||
126772723|NCT01785875|456123644|FG001|Overall Study|Lost to Follow-up|22|||
126772724|NCT01785875|456123645|FG002|Overall Study|Lost to Follow-up|6|||
126772725|NCT01785875|456123643|FG000|Overall Study|Death|27|||
126772726|NCT01785875|456123644|FG001|Overall Study|Death|16|||
126772727|NCT01785875|456123645|FG002|Overall Study|Death|7|||
126494633|NCT00416078|455109702|FG000|Overall Study|Death|3|||
126494634|NCT00416078|455109703|FG001|Overall Study|Death|4|||
126494635|NCT00416078|455109702|FG000|Overall Study|Withdrawal by Subject|3|||
126494636|NCT00416078|455109703|FG001|Overall Study|Withdrawal by Subject|2|||
126494637|NCT00416078|455109702|FG000|Overall Study|Physician Decision|1|||
126494638|NCT00416078|455109703|FG001|Overall Study|Physician Decision|0|||
126494639|NCT00416078|455109702|FG000|Overall Study|Lost to Follow-up|4|||
126723781|NCT01104584|455938719|FG000|Overall Study|Study prematurely discontinued|2|||
126494640|NCT00416078|455109703|FG001|Overall Study|Lost to Follow-up|2|||
126494641|NCT02335099|455109707|FG000|Treatment|Withdrawal by Subject|1|||
126494642|NCT02335099|455109708|FG001|Treatment|Withdrawal by Subject|3|||
126494643|NCT02335099|455109707|FG000|Treatment|Lost to Follow-up|2|||
126494644|NCT02335099|455109708|FG001|Treatment|Lost to Follow-up|0|||
126494645|NCT02335099|455109707|FG000|Treatment|Death|1|||
126494646|NCT02335099|455109708|FG001|Treatment|Death|0|||
126494647|NCT02335099|455109707|FG000|Treatment|Adverse Event|1|||
126494648|NCT02335099|455109708|FG001|Treatment|Adverse Event|2|||
126494649|NCT02335099|455109707|FG000|Follow-up|Death|0|||
126494650|NCT02335099|455109708|FG001|Follow-up|Death|1|||
126494651|NCT00484939|455109711|FG000|Overall Study|Death|9|||
126494652|NCT00484939|455109712|FG001|Overall Study|Death|13|||
126494653|NCT00484939|455109711|FG000|Overall Study|Adverse Event|22|||
126494654|NCT00484939|455109712|FG001|Overall Study|Adverse Event|12|||
126723782|NCT04017442|455938720|FG000|Overall Study|Withdrawal by Subject|0|||
126723783|NCT04017442|455938721|FG001|Overall Study|Withdrawal by Subject|3|||
126772728|NCT01785875|456123643|FG000|Overall Study|Sponsor Decision|0|||
126772729|NCT01785875|456123644|FG001|Overall Study|Sponsor Decision|2|||
126772730|NCT01785875|456123645|FG002|Overall Study|Sponsor Decision|0|||
126772731|NCT01785875|456123643|FG000|Overall Study|Protocol Specified Criteria|207|||
126772732|NCT01785875|456123644|FG001|Overall Study|Protocol Specified Criteria|214|||
126772733|NCT01785875|456123645|FG002|Overall Study|Protocol Specified Criteria|55|||
126772734|NCT01785875|456123643|FG000|Overall Study|Missing|0|||
126494655|NCT00484939|455109711|FG000|Overall Study|Patient Withdrew Consent|19|||
126494656|NCT00484939|455109712|FG001|Overall Study|Patient Withdrew Consent|10|||
126494657|NCT00484939|455109711|FG000|Overall Study|Protocol Violation|3|||
126772735|NCT01785875|456123644|FG001|Overall Study|Missing|1|||
126494658|NCT00484939|455109712|FG001|Overall Study|Protocol Violation|3|||
126494659|NCT00484939|455109711|FG000|Overall Study|Lost to Follow-up|0|||
126494660|NCT00484939|455109712|FG001|Overall Study|Lost to Follow-up|3|||
126494661|NCT00484939|455109711|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
126494662|NCT00484939|455109712|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
126772736|NCT01785875|456123645|FG002|Overall Study|Missing|3|||
126772737|NCT04991311|456123648|FG000|Overall Study|Adverse Event|1|||
126772738|NCT00755937|456123649|FG000|Recruitment|Unknown if infliximab received|164|||
126494663|NCT00484939|455109711|FG000|Overall Study|Disease progression|67|||
126494664|NCT00484939|455109712|FG001|Overall Study|Disease progression|88|||
126494665|NCT00484939|455109711|FG000|Overall Study|Screen Failure|2|||
126494666|NCT00484939|455109712|FG001|Overall Study|Screen Failure|2|||
126494667|NCT00484939|455109711|FG000|Overall Study|Reason Not Specified|11|||
126494668|NCT00484939|455109712|FG001|Overall Study|Reason Not Specified|6|||
126494669|NCT01367158|455109713|FG000|Overall Study|Withdrew consent|0|||
126494670|NCT01367158|455109714|FG001|Overall Study|Withdrew consent|2|||
126494671|NCT01367158|455109715|FG002|Overall Study|Withdrew consent|1|||
126494672|NCT01367158|455109716|FG003|Overall Study|Withdrew consent|0|||
126494673|NCT01367158|455109717|FG004|Overall Study|Withdrew consent|2|||
126494674|NCT01367158|455109718|FG005|Overall Study|Withdrew consent|0|||
126494675|NCT01367158|455109719|FG006|Overall Study|Withdrew consent|0|||
126494676|NCT01367158|455109720|FG007|Overall Study|Withdrew consent|1|||
126494677|NCT01367158|455109721|FG008|Overall Study|Withdrew consent|0|||
126494678|NCT01367158|455109722|FG009|Overall Study|Withdrew consent|0|||
126494679|NCT01367158|455109723|FG010|Overall Study|Withdrew consent|0|||
126494680|NCT01367158|455109713|FG000|Overall Study|Lost to Follow-up|0|||
126494681|NCT01367158|455109714|FG001|Overall Study|Lost to Follow-up|0|||
126494682|NCT01367158|455109715|FG002|Overall Study|Lost to Follow-up|0|||
126494683|NCT01367158|455109716|FG003|Overall Study|Lost to Follow-up|1|||
126494684|NCT01367158|455109717|FG004|Overall Study|Lost to Follow-up|0|||
126723784|NCT04017442|455938720|FG000|Overall Study|Lost to Follow-up|21|||
126723785|NCT04017442|455938721|FG001|Overall Study|Lost to Follow-up|19|||
126723786|NCT02586233|455938724|FG000|Overall Study|Randomized but did not receive treatment|0|||
126723787|NCT02586233|455938725|FG001|Overall Study|Randomized but did not receive treatment|1|||
126723788|NCT02586233|455938726|FG002|Overall Study|Randomized but did not receive treatment|0|||
126723789|NCT02586233|455938727|FG003|Overall Study|Randomized but did not receive treatment|0|||
126723790|NCT02586233|455938728|FG004|Overall Study|Randomized but did not receive treatment|0|||
126723791|NCT02586233|455938729|FG005|Overall Study|Randomized but did not receive treatment|2|||
126723792|NCT02586233|455938730|FG006|Overall Study|Randomized but did not receive treatment|2|||
126723793|NCT02586233|455938724|FG000|Overall Study|Death|0|||
126723794|NCT02586233|455938725|FG001|Overall Study|Death|1|||
126723795|NCT02586233|455938726|FG002|Overall Study|Death|0|||
126723796|NCT02586233|455938727|FG003|Overall Study|Death|0|||
126723797|NCT02586233|455938728|FG004|Overall Study|Death|2|||
126723798|NCT02586233|455938729|FG005|Overall Study|Death|0|||
126723799|NCT02586233|455938730|FG006|Overall Study|Death|0|||
126723800|NCT00082758|455938731|FG000|Overall Study|Adverse Event|0|||
126723801|NCT00082758|455938732|FG001|Overall Study|Adverse Event|2|||
126723802|NCT00082758|455938733|FG002|Overall Study|Adverse Event|0|||
126723803|NCT00082758|455938731|FG000|Overall Study|Lack of Efficacy|12|||
126723804|NCT00082758|455938732|FG001|Overall Study|Lack of Efficacy|13|||
126723805|NCT00082758|455938733|FG002|Overall Study|Lack of Efficacy|0|||
126723806|NCT00082758|455938731|FG000|Overall Study|Physician Decision|0|||
126723807|NCT00082758|455938732|FG001|Overall Study|Physician Decision|1|||
126723808|NCT00082758|455938733|FG002|Overall Study|Physician Decision|0|||
126723809|NCT00082758|455938731|FG000|Overall Study|Withdrawal by Subject|3|||
126723810|NCT00082758|455938732|FG001|Overall Study|Withdrawal by Subject|0|||
126723811|NCT00082758|455938733|FG002|Overall Study|Withdrawal by Subject|0|||
126723812|NCT00082758|455938731|FG000|Overall Study|Protocol Violation|0|||
126723813|NCT00082758|455938732|FG001|Overall Study|Protocol Violation|1|||
126723814|NCT00082758|455938733|FG002|Overall Study|Protocol Violation|0|||
126723815|NCT02561299|455938737|FG000|Overall Study|Death|2|||
126723816|NCT02561299|455938738|FG001|Overall Study|Death|4|||
126723817|NCT02561299|455938737|FG000|Overall Study|Lost to Follow-up|1|||
126723818|NCT02561299|455938738|FG001|Overall Study|Lost to Follow-up|0|||
126723819|NCT02561299|455938737|FG000|Overall Study|Withdrawal by Subject|2|||
126723820|NCT02561299|455938738|FG001|Overall Study|Withdrawal by Subject|2|||
126723821|NCT04507867|455938739|FG000|Overall Study|Death|7|||
126723822|NCT04507867|455938740|FG001|Overall Study|Death|1|||
126723823|NCT01106625|455938744|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
126494685|NCT01367158|455109718|FG005|Overall Study|Lost to Follow-up|2|||
126494686|NCT01367158|455109719|FG006|Overall Study|Lost to Follow-up|0|||
126494687|NCT01367158|455109720|FG007|Overall Study|Lost to Follow-up|1|||
126723824|NCT01106625|455938745|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
126723825|NCT01106625|455938746|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
126723826|NCT01106625|455938744|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
126723827|NCT01106625|455938745|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
126723828|NCT01106625|455938746|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
126723829|NCT01106625|455938744|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
126723830|NCT01106625|455938745|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
126494688|NCT01367158|455109721|FG008|Overall Study|Lost to Follow-up|0|||
126494689|NCT01367158|455109722|FG009|Overall Study|Lost to Follow-up|0|||
126494690|NCT01367158|455109723|FG010|Overall Study|Lost to Follow-up|1|||
126494691|NCT01367158|455109713|FG000|Overall Study|Protocol Violation|0|||
126723831|NCT01106625|455938746|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
126723832|NCT01106625|455938744|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
126494692|NCT01367158|455109714|FG001|Overall Study|Protocol Violation|1|||
126494693|NCT01367158|455109715|FG002|Overall Study|Protocol Violation|0|||
126494694|NCT01367158|455109716|FG003|Overall Study|Protocol Violation|0|||
126494695|NCT01367158|455109717|FG004|Overall Study|Protocol Violation|0|||
126494696|NCT01367158|455109718|FG005|Overall Study|Protocol Violation|0|||
126494697|NCT01367158|455109719|FG006|Overall Study|Protocol Violation|0|||
126494698|NCT01367158|455109720|FG007|Overall Study|Protocol Violation|0|||
126494699|NCT01367158|455109721|FG008|Overall Study|Protocol Violation|0|||
126494700|NCT01367158|455109722|FG009|Overall Study|Protocol Violation|0|||
126494701|NCT01367158|455109723|FG010|Overall Study|Protocol Violation|0|||
126494702|NCT01870583|455111380|FG000|Overall Study|Protocol Violation|0|||
126494703|NCT01870583|455111381|FG001|Overall Study|Protocol Violation|5|||
126494704|NCT01870583|455111382|FG002|Overall Study|Protocol Violation|3|||
126494705|NCT01870583|455111380|FG000|Overall Study|Lost to Follow-up|11|||
126494706|NCT01870583|455111381|FG001|Overall Study|Lost to Follow-up|13|||
126494707|NCT01870583|455111382|FG002|Overall Study|Lost to Follow-up|5|||
126494708|NCT00937157|455111383|FG000|Overall Study|Pregnancy|1|||
126494709|NCT00937157|455111383|FG000|Overall Study|Lost to Follow-up|3|||
126494710|NCT00469092|455111384|FG000|Overall Study|Adverse Event|5|||
126494711|NCT00469092|455111385|FG001|Overall Study|Adverse Event|4|||
126494712|NCT00469092|455111384|FG000|Overall Study|Lack of Efficacy|1|||
126494713|NCT00469092|455111385|FG001|Overall Study|Lack of Efficacy|0|||
126494714|NCT00469092|455111384|FG000|Overall Study|Lost to Follow-up|1|||
126494715|NCT00469092|455111385|FG001|Overall Study|Lost to Follow-up|2|||
126494716|NCT00469092|455111384|FG000|Overall Study|Protocol Violation|3|||
126494717|NCT00469092|455111385|FG001|Overall Study|Protocol Violation|3|||
126494718|NCT00469092|455111384|FG000|Overall Study|Withdrawal by Subject|4|||
126494719|NCT00469092|455111385|FG001|Overall Study|Withdrawal by Subject|4|||
126494720|NCT00469092|455111384|FG000|Overall Study|Withdrawal Criteria|3|||
126494721|NCT00469092|455111385|FG001|Overall Study|Withdrawal Criteria|4|||
126494722|NCT00469092|455111384|FG000|Overall Study|Incorrectly Randomised|4|||
126494723|NCT00469092|455111385|FG001|Overall Study|Incorrectly Randomised|3|||
126494724|NCT00469092|455111384|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
126494725|NCT00469092|455111385|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
126494726|NCT00469092|455111384|FG000|Overall Study|Use of lipid lowering drug|1|||
126494727|NCT00469092|455111385|FG001|Overall Study|Use of lipid lowering drug|0|||
126494728|NCT00469092|455111384|FG000|Overall Study|Hypoglycaemic Episodes|1|||
126494729|NCT00469092|455111385|FG001|Overall Study|Hypoglycaemic Episodes|1|||
126494730|NCT00469092|455111384|FG000|Overall Study|Abnormal lab value|1|||
126494731|NCT00469092|455111385|FG001|Overall Study|Abnormal lab value|0|||
126494732|NCT00469092|455111384|FG000|Overall Study|Use of Corticosteroid|1|||
126494733|NCT00469092|455111385|FG001|Overall Study|Use of Corticosteroid|0|||
126494734|NCT02024867|455111386|FG000|Overall Study|Protocol Violation|3|||
126494735|NCT02024867|455111387|FG001|Overall Study|Protocol Violation|3|||
126494736|NCT02024867|455111386|FG000|Overall Study|Lost to Follow-up|6|||
126494737|NCT02024867|455111387|FG001|Overall Study|Lost to Follow-up|4|||
126494738|NCT01998633|455111389|FG000|Overall Study|Death|1|||
126494739|NCT00413192|455111390|FG000|Overall Study|Disease progression|26|||
126494740|NCT00413192|455111391|FG001|Overall Study|Disease progression|31|||
126494741|NCT00413192|455111392|FG002|Overall Study|Disease progression|16|||
126494742|NCT00413192|455111393|FG003|Overall Study|Disease progression|25|||
126494743|NCT00413192|455111390|FG000|Overall Study|Toxicity|3|||
126494744|NCT00413192|455111391|FG001|Overall Study|Toxicity|2|||
126494745|NCT00413192|455111392|FG002|Overall Study|Toxicity|2|||
126494746|NCT00413192|455111393|FG003|Overall Study|Toxicity|2|||
126494747|NCT00413192|455111390|FG000|Overall Study|Withdrawal by Subject|3|||
126494748|NCT00413192|455111391|FG001|Overall Study|Withdrawal by Subject|5|||
126494749|NCT00413192|455111392|FG002|Overall Study|Withdrawal by Subject|0|||
126494750|NCT00413192|455111393|FG003|Overall Study|Withdrawal by Subject|1|||
126494751|NCT00413192|455111390|FG000|Overall Study|Intercurrent illness|0|||
126494752|NCT00413192|455111391|FG001|Overall Study|Intercurrent illness|0|||
126494753|NCT00413192|455111392|FG002|Overall Study|Intercurrent illness|0|||
126494754|NCT00413192|455111393|FG003|Overall Study|Intercurrent illness|1|||
126494755|NCT00413192|455111390|FG000|Overall Study|Intercurrent death|0|||
126494756|NCT00413192|455111391|FG001|Overall Study|Intercurrent death|1|||
126494757|NCT00413192|455111392|FG002|Overall Study|Intercurrent death|0|||
126494758|NCT00413192|455111393|FG003|Overall Study|Intercurrent death|0|||
126494759|NCT00413192|455111390|FG000|Overall Study|Other|5|||
126494760|NCT00413192|455111391|FG001|Overall Study|Other|1|||
126494761|NCT00413192|455111392|FG002|Overall Study|Other|1|||
126494762|NCT00413192|455111393|FG003|Overall Study|Other|2|||
126494763|NCT00413192|455111390|FG000|Overall Study|Not treated|0|||
126494764|NCT00413192|455111391|FG001|Overall Study|Not treated|0|||
126494765|NCT00413192|455111392|FG002|Overall Study|Not treated|0|||
126494766|NCT00413192|455111393|FG003|Overall Study|Not treated|1|||
126494767|NCT03992781|455111401|FG000|Overall Study|Lost to Follow-up|5|||
126494768|NCT03992781|455111401|FG000|Overall Study|Adverse Event|1|||
126494769|NCT03992781|455111401|FG000|Overall Study|Lack of Efficacy|5|||
126494770|NCT02268864|455111402|FG000|Overall Study|Withdrawal by Subject|2|||
126494771|NCT02268864|455111403|FG001|Overall Study|Withdrawal by Subject|0|||
126494772|NCT02268864|455111404|FG002|Overall Study|Withdrawal by Subject|0|||
126494773|NCT02268864|455111402|FG000|Overall Study|Death|0|||
126494774|NCT02268864|455111403|FG001|Overall Study|Death|1|||
126494775|NCT02268864|455111404|FG002|Overall Study|Death|0|||
126494776|NCT00730912|455111411|FG000|Overall Study|Discontinued|0|||
126494777|NCT00730912|455111412|FG001|Overall Study|Discontinued|0|||
126494778|NCT00730912|455111413|FG002|Overall Study|Discontinued|1|||
126494779|NCT03311659|455111418|FG000|Overall Study|Protocol Violation|1|||
126494780|NCT04053023|455111419|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
126494781|NCT04053023|455111420|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
126494782|NCT00071760|455111421|FG000|Overall Study|Adverse Event|2|||
126494783|NCT00071760|455111422|FG001|Overall Study|Adverse Event|1|||
126494784|NCT00071760|455111421|FG000|Overall Study|Lost to Follow-up|0|||
126494785|NCT00071760|455111422|FG001|Overall Study|Lost to Follow-up|3|||
126494786|NCT00071760|455111421|FG000|Overall Study|Protocol Violation|1|||
126494787|NCT00071760|455111422|FG001|Overall Study|Protocol Violation|0|||
126494788|NCT00071760|455111421|FG000|Overall Study|Withdrawal by Subject|0|||
126494789|NCT00071760|455111422|FG001|Overall Study|Withdrawal by Subject|1|||
126494790|NCT00071760|455111421|FG000|Overall Study|Insufficient Viral Load Response|1|||
126494791|NCT00071760|455111422|FG001|Overall Study|Insufficient Viral Load Response|1|||
126494792|NCT00071760|455111421|FG000|Overall Study|Lack of availability of RTV|1|||
126494793|NCT00071760|455111422|FG001|Overall Study|Lack of availability of RTV|0|||
126494794|NCT00071760|455111421|FG000|Overall Study|Physician Decision|2|||
126494795|NCT00071760|455111422|FG001|Overall Study|Physician Decision|1|||
126494796|NCT00071760|455111421|FG000|Overall Study|Relocation|0|||
126494797|NCT00071760|455111422|FG001|Overall Study|Relocation|1|||
126494798|NCT03338855|455111427|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
126494799|NCT03338855|455111428|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
126494800|NCT00511667|455111429|FG000|Overall Study|Adverse Event|1|||
126494801|NCT00511667|455111430|FG001|Overall Study|Adverse Event|0|||
126494802|NCT00511667|455111429|FG000|Overall Study|Protocol Violation|1|||
126494803|NCT00511667|455111430|FG001|Overall Study|Protocol Violation|1|||
126494804|NCT00511667|455111429|FG000|Overall Study|Withdrawal by Subject|2|||
126494805|NCT00511667|455111430|FG001|Overall Study|Withdrawal by Subject|0|||
126494806|NCT00511667|455111429|FG000|Overall Study|Site terminated|6|||
126494807|NCT00511667|455111430|FG001|Overall Study|Site terminated|1|||
126494808|NCT00511667|455111429|FG000|Overall Study|Other|2|||
126494809|NCT00511667|455111430|FG001|Overall Study|Other|1|||
126494810|NCT00056407|455111431|FG000|Overall Study|Adverse Event|282|||
126494811|NCT00056407|455111432|FG001|Overall Study|Adverse Event|364|||
126494812|NCT00056407|455111431|FG000|Overall Study|Withdrawal by Subject|377|||
126494813|NCT00056407|455111432|FG001|Overall Study|Withdrawal by Subject|361|||
126494814|NCT00056407|455111431|FG000|Overall Study|Lost to Follow-up|123|||
126494815|NCT00056407|455111432|FG001|Overall Study|Lost to Follow-up|113|||
126494816|NCT00056407|455111431|FG000|Overall Study|Protocol Violation|104|||
126494817|NCT00056407|455111432|FG001|Overall Study|Protocol Violation|95|||
126494818|NCT00056407|455111431|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
126494819|NCT00056407|455111432|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
126494820|NCT00056407|455111431|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
126494821|NCT00056407|455111432|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
126494822|NCT00056407|455111431|FG000|Overall Study|Missing|25|||
126494823|NCT00056407|455111432|FG001|Overall Study|Missing|34|||
126494824|NCT03251079|455111433|FG000|Overall Study|Withdrawal by Subject|1|||
126494825|NCT00455429|455111439|FG000|Overall Study|Study Terminated by Sponsor|0|||
126494826|NCT00455429|455111440|FG001|Overall Study|Study Terminated by Sponsor|0|||
126494827|NCT00455429|455111441|FG002|Overall Study|Study Terminated by Sponsor|0|||
126494828|NCT00455429|455111442|FG003|Overall Study|Study Terminated by Sponsor|3|||
126494829|NCT00455429|455111439|FG000|Overall Study|Lost to Follow-up|1|||
126494830|NCT00455429|455111440|FG001|Overall Study|Lost to Follow-up|0|||
126494831|NCT00455429|455111441|FG002|Overall Study|Lost to Follow-up|0|||
126494832|NCT00455429|455111442|FG003|Overall Study|Lost to Follow-up|3|||
126494833|NCT00455429|455111439|FG000|Overall Study|Withdrawal by Subject|0|||
126494834|NCT00455429|455111440|FG001|Overall Study|Withdrawal by Subject|1|||
126494835|NCT00455429|455111441|FG002|Overall Study|Withdrawal by Subject|1|||
126494836|NCT00455429|455111442|FG003|Overall Study|Withdrawal by Subject|0|||
126494837|NCT00455429|455111439|FG000|Overall Study|Lack of Efficacy|0|||
126494838|NCT00455429|455111440|FG001|Overall Study|Lack of Efficacy|1|||
126494839|NCT00455429|455111441|FG002|Overall Study|Lack of Efficacy|0|||
126494840|NCT00455429|455111442|FG003|Overall Study|Lack of Efficacy|1|||
126723833|NCT01106625|455938745|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
126723834|NCT01106625|455938746|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
126494841|NCT00455429|455111439|FG000|Overall Study|Adverse Event|0|||
126494842|NCT00455429|455111440|FG001|Overall Study|Adverse Event|1|||
126723835|NCT01106625|455938744|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
126494843|NCT00455429|455111441|FG002|Overall Study|Adverse Event|0|||
126494844|NCT00455429|455111442|FG003|Overall Study|Adverse Event|3|||
126494845|NCT00455429|455111439|FG000|Overall Study|Randomly assigned but not treated|0|||
126494846|NCT00455429|455111440|FG001|Overall Study|Randomly assigned but not treated|0|||
126494847|NCT00455429|455111441|FG002|Overall Study|Randomly assigned but not treated|0|||
126494848|NCT00455429|455111442|FG003|Overall Study|Randomly assigned but not treated|2|||
126494849|NCT00455429|455111439|FG000|Overall Study|Personal Reason|1|||
126494850|NCT00455429|455111440|FG001|Overall Study|Personal Reason|0|||
126494851|NCT00455429|455111441|FG002|Overall Study|Personal Reason|0|||
126494852|NCT00455429|455111442|FG003|Overall Study|Personal Reason|0|||
126494853|NCT00455429|455111439|FG000|Overall Study|Non-compliance|0|||
126494854|NCT00455429|455111440|FG001|Overall Study|Non-compliance|0|||
126494855|NCT00455429|455111441|FG002|Overall Study|Non-compliance|0|||
126494856|NCT00455429|455111442|FG003|Overall Study|Non-compliance|1|||
126494857|NCT00455429|455111439|FG000|Overall Study|Other|0|||
126494858|NCT00455429|455111440|FG001|Overall Study|Other|2|||
126494859|NCT00455429|455111441|FG002|Overall Study|Other|0|||
126494860|NCT00455429|455111442|FG003|Overall Study|Other|1|||
126494861|NCT01165554|455111449|FG000|Overall Study|Withdrawal by Subject|23|||
126494862|NCT02951156|455111450|FG000|Overall Study|Death|3|||
126494863|NCT02951156|455111451|FG001|Overall Study|Death|8|||
126494864|NCT02951156|455111452|FG002|Overall Study|Death|5|||
126494865|NCT02951156|455111450|FG000|Overall Study|Progressive disease|1|||
126494866|NCT02951156|455111451|FG001|Overall Study|Progressive disease|0|||
126494867|NCT02951156|455111452|FG002|Overall Study|Progressive disease|1|||
126494868|NCT02951156|455111450|FG000|Overall Study|Withdrawal by Subject|0|||
126494869|NCT02951156|455111451|FG001|Overall Study|Withdrawal by Subject|0|||
126494870|NCT02951156|455111452|FG002|Overall Study|Withdrawal by Subject|1|||
126494871|NCT02951156|455111450|FG000|Overall Study|Study terminated by sponsor|0|||
126494872|NCT02951156|455111451|FG001|Overall Study|Study terminated by sponsor|0|||
126494873|NCT02951156|455111452|FG002|Overall Study|Study terminated by sponsor|1|||
126494874|NCT02951156|455111450|FG000|Overall Study|Other|5|||
126494875|NCT02951156|455111451|FG001|Overall Study|Other|1|||
126494876|NCT02951156|455111452|FG002|Overall Study|Other|2|||
126494877|NCT04351087|455111453|FG000|Overall Study|Lost to Follow-up|7|||
126494878|NCT04351087|455111454|FG001|Overall Study|Lost to Follow-up|3|||
126494879|NCT04351087|455111453|FG000|Overall Study|Withdrawal by Subject|3|||
126494880|NCT04351087|455111454|FG001|Overall Study|Withdrawal by Subject|4|||
126494881|NCT04351087|455111453|FG000|Overall Study|Lack of Efficacy|3|||
126494882|NCT04351087|455111454|FG001|Overall Study|Lack of Efficacy|2|||
126494883|NCT03519347|455111457|FG000|Interventional Crossover Period 1|Death|0|||
126494884|NCT03519347|455111458|FG001|Interventional Crossover Period 1|Death|0|||
126494885|NCT03519347|455111459|FG002|Interventional Crossover Period 1|Death|0|||
126494886|NCT03519347|455111460|FG003|Interventional Crossover Period 1|Death|1|||
126494887|NCT05517382|455111461|FG000|Overall Study|Lost to Follow-up|0|||
126494888|NCT05517382|455111462|FG001|Overall Study|Lost to Follow-up|1|||
126494889|NCT01641692|455111463|FG000|Treatment Period 1|Adverse Event|1|||
126494890|NCT01641692|455111464|FG001|Treatment Period 1|Adverse Event|0|||
126494891|NCT01641692|455111465|FG002|Treatment Period 1|Adverse Event|0|||
126494892|NCT01641692|455111466|FG003|Treatment Period 1|Adverse Event|0|||
126494893|NCT01641692|455111467|FG004|Treatment Period 1|Adverse Event|0|||
126494894|NCT01641692|455111468|FG005|Treatment Period 1|Adverse Event|0|||
126494895|NCT01641692|455111469|FG006|Treatment Period 1|Adverse Event|0|||
126494896|NCT01641692|455111470|FG007|Treatment Period 1|Adverse Event|0|||
126494897|NCT01641692|455111463|FG000|Treatment Period 1|Lack of Efficacy|0|||
126494898|NCT01641692|455111464|FG001|Treatment Period 1|Lack of Efficacy|0|||
126494899|NCT01641692|455111465|FG002|Treatment Period 1|Lack of Efficacy|0|||
126494900|NCT01641692|455111466|FG003|Treatment Period 1|Lack of Efficacy|0|||
126494901|NCT01641692|455111467|FG004|Treatment Period 1|Lack of Efficacy|0|||
126494902|NCT01641692|455111468|FG005|Treatment Period 1|Lack of Efficacy|0|||
126494903|NCT01641692|455111469|FG006|Treatment Period 1|Lack of Efficacy|0|||
126494904|NCT01641692|455111470|FG007|Treatment Period 1|Lack of Efficacy|1|||
126723836|NCT01106625|455938745|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
126723837|NCT01106625|455938746|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
126723838|NCT01106625|455938744|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
126723839|NCT01106625|455938745|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
126494905|NCT01641692|455111463|FG000|Treatment Period 1|Protocol Violation|1|||
126494906|NCT01641692|455111464|FG001|Treatment Period 1|Protocol Violation|0|||
126494907|NCT01641692|455111465|FG002|Treatment Period 1|Protocol Violation|0|||
126494908|NCT01641692|455111466|FG003|Treatment Period 1|Protocol Violation|0|||
126494909|NCT01641692|455111467|FG004|Treatment Period 1|Protocol Violation|2|||
126723840|NCT01106625|455938746|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
126494910|NCT01641692|455111468|FG005|Treatment Period 1|Protocol Violation|0|||
126494911|NCT01641692|455111469|FG006|Treatment Period 1|Protocol Violation|0|||
126494912|NCT01641692|455111470|FG007|Treatment Period 1|Protocol Violation|0|||
126494913|NCT01641692|455111463|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
126494914|NCT01641692|455111464|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
126494915|NCT01641692|455111465|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
126494916|NCT01641692|455111466|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
126494917|NCT01641692|455111467|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
126494918|NCT01641692|455111468|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
126494919|NCT01641692|455111469|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
126494920|NCT01641692|455111470|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
126494921|NCT01641692|455111463|FG000|Treatment Period 1|Lost to Follow-up|0|||
126494922|NCT01641692|455111464|FG001|Treatment Period 1|Lost to Follow-up|0|||
126494923|NCT01641692|455111465|FG002|Treatment Period 1|Lost to Follow-up|1|||
126494924|NCT01641692|455111466|FG003|Treatment Period 1|Lost to Follow-up|0|||
126494925|NCT01641692|455111467|FG004|Treatment Period 1|Lost to Follow-up|0|||
126494926|NCT01641692|455111468|FG005|Treatment Period 1|Lost to Follow-up|0|||
126772739|NCT00755937|456123649|FG000|Observational Follow-up|Lost to Follow-up|148|||
126772740|NCT01440595|456123652|FG000|Overall Study|Lost to Follow-up|0|||
126772741|NCT01440595|456123653|FG001|Overall Study|Lost to Follow-up|1|||
126772742|NCT01440595|456123654|FG002|Overall Study|Lost to Follow-up|0|||
126772743|NCT01440595|456123652|FG000|Overall Study|Study terminated by sponsor.|1|||
126772744|NCT01440595|456123653|FG001|Overall Study|Study terminated by sponsor.|2|||
126772745|NCT01440595|456123654|FG002|Overall Study|Study terminated by sponsor.|1|||
126772746|NCT01347879|456123655|FG000|Overall Study|Adverse Event|0|||
126772747|NCT01347879|456123656|FG001|Overall Study|Adverse Event|12|||
126772748|NCT01347879|456123655|FG000|Overall Study|Lost to Follow-up|2|||
126772749|NCT01347879|456123656|FG001|Overall Study|Lost to Follow-up|0|||
126772750|NCT01347879|456123655|FG000|Overall Study|Withdrawal by Subject|3|||
126772751|NCT01347879|456123656|FG001|Overall Study|Withdrawal by Subject|2|||
126772752|NCT01347879|456123655|FG000|Overall Study|Other|2|||
126772753|NCT01347879|456123656|FG001|Overall Study|Other|3|||
126772754|NCT01223196|456123657|FG000|Overall Study|Lost to Follow-up|2|||
126772755|NCT01223196|456123658|FG001|Overall Study|Lost to Follow-up|0|||
126772756|NCT01223196|456123657|FG000|Overall Study|Physician Decision|1|||
126772757|NCT01223196|456123658|FG001|Overall Study|Physician Decision|0|||
126772758|NCT01223196|456123657|FG000|Overall Study|Withdrawal by Subject|1|||
126772759|NCT01223196|456123658|FG001|Overall Study|Withdrawal by Subject|0|||
126772760|NCT01238822|456123663|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
126772761|NCT02725671|456123672|FG000|Overall Study|Lost to Follow-up|1|||
126772762|NCT00965263|456123673|FG000|Overall Study|Physician Decision|2|||
126772763|NCT00965263|456123674|FG001|Overall Study|Physician Decision|0|||
126772764|NCT00965263|456123673|FG000|Overall Study|Family emergency|0|||
126772765|NCT00965263|456123674|FG001|Overall Study|Family emergency|1|||
126772766|NCT00965263|456123673|FG000|Overall Study|Protocol Violation|0|||
126772767|NCT00965263|456123674|FG001|Overall Study|Protocol Violation|2|||
126772768|NCT00963599|456123675|FG000|Overall Study|Adverse Event|2|||
126772769|NCT00963599|456123676|FG001|Overall Study|Adverse Event|0|||
126772770|NCT00963599|456123677|FG002|Overall Study|Adverse Event|1|||
126772771|NCT00963599|456123678|FG003|Overall Study|Adverse Event|2|||
126772772|NCT00963599|456123675|FG000|Overall Study|Lack of Efficacy|0|||
126772773|NCT00963599|456123676|FG001|Overall Study|Lack of Efficacy|2|||
126772774|NCT00963599|456123677|FG002|Overall Study|Lack of Efficacy|1|||
126772775|NCT00963599|456123678|FG003|Overall Study|Lack of Efficacy|4|||
126494927|NCT01641692|455111469|FG006|Treatment Period 1|Lost to Follow-up|0|||
126494928|NCT01641692|455111470|FG007|Treatment Period 1|Lost to Follow-up|0|||
126494929|NCT01641692|455111463|FG000|Treatment Period 1|Physician Decision|0|||
126494930|NCT01641692|455111464|FG001|Treatment Period 1|Physician Decision|0|||
126494931|NCT01641692|455111465|FG002|Treatment Period 1|Physician Decision|0|||
126494932|NCT01641692|455111466|FG003|Treatment Period 1|Physician Decision|0|||
126494933|NCT01641692|455111467|FG004|Treatment Period 1|Physician Decision|1|||
126494934|NCT01641692|455111468|FG005|Treatment Period 1|Physician Decision|0|||
126494935|NCT01641692|455111469|FG006|Treatment Period 1|Physician Decision|0|||
126494936|NCT01641692|455111470|FG007|Treatment Period 1|Physician Decision|0|||
126494937|NCT01641692|455111463|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126494938|NCT01641692|455111464|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126494939|NCT01641692|455111465|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126494940|NCT01641692|455111466|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126494941|NCT01641692|455111467|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126494942|NCT01641692|455111468|FG005|Treatment Period 1|Withdrawal by Subject|2|||
126494943|NCT01641692|455111469|FG006|Treatment Period 1|Withdrawal by Subject|0|||
126772776|NCT00963599|456123675|FG000|Overall Study|Lost to Follow-up|0|||
126772777|NCT00963599|456123676|FG001|Overall Study|Lost to Follow-up|1|||
126772778|NCT00963599|456123677|FG002|Overall Study|Lost to Follow-up|1|||
126772779|NCT00963599|456123678|FG003|Overall Study|Lost to Follow-up|1|||
126772780|NCT00963599|456123675|FG000|Overall Study|Protocol Violation|2|||
126772781|NCT00963599|456123676|FG001|Overall Study|Protocol Violation|2|||
126772782|NCT00963599|456123677|FG002|Overall Study|Protocol Violation|3|||
126494944|NCT01641692|455111470|FG007|Treatment Period 1|Withdrawal by Subject|1|||
126494945|NCT01641692|455111463|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
126494946|NCT01641692|455111464|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
126772783|NCT00963599|456123678|FG003|Overall Study|Protocol Violation|4|||
126772784|NCT00963599|456123675|FG000|Overall Study|Withdrawal by Subject|2|||
126772785|NCT00963599|456123676|FG001|Overall Study|Withdrawal by Subject|1|||
126494947|NCT01641692|455111465|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
126494948|NCT01641692|455111466|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
126494949|NCT01641692|455111467|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
126494950|NCT01641692|455111468|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
126494951|NCT01641692|455111469|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
126494952|NCT01641692|455111470|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
126494953|NCT01641692|455111463|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
126494954|NCT01641692|455111464|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
126494955|NCT01641692|455111465|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
126494956|NCT01641692|455111466|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
126494957|NCT01641692|455111467|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
126494958|NCT01641692|455111468|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
126494959|NCT01641692|455111469|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
126494960|NCT01641692|455111470|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
126494961|NCT01641692|455111463|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
126494962|NCT01641692|455111464|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
126494963|NCT01641692|455111465|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
126494964|NCT01641692|455111466|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
126494965|NCT01641692|455111467|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
126494966|NCT01641692|455111468|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
126494967|NCT01641692|455111469|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
126494968|NCT01641692|455111470|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
126494969|NCT01641692|455111463|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
126494970|NCT01641692|455111464|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
126494971|NCT01641692|455111465|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
126494972|NCT01641692|455111466|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
126494973|NCT01641692|455111467|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
126494974|NCT01641692|455111468|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
126494975|NCT01641692|455111469|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
126494976|NCT01641692|455111470|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
126494977|NCT01641692|455111463|FG000|Treatment Period 2|Lack of Efficacy|1|||
126494978|NCT01641692|455111464|FG001|Treatment Period 2|Lack of Efficacy|0|||
126494979|NCT01641692|455111465|FG002|Treatment Period 2|Lack of Efficacy|0|||
126494980|NCT01641692|455111466|FG003|Treatment Period 2|Lack of Efficacy|0|||
126494981|NCT01641692|455111467|FG004|Treatment Period 2|Lack of Efficacy|0|||
126494982|NCT01641692|455111468|FG005|Treatment Period 2|Lack of Efficacy|0|||
126494983|NCT01641692|455111469|FG006|Treatment Period 2|Lack of Efficacy|0|||
126494984|NCT01641692|455111470|FG007|Treatment Period 2|Lack of Efficacy|0|||
126494985|NCT01641692|455111463|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
126494986|NCT01641692|455111464|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126494987|NCT01641692|455111465|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126494988|NCT01641692|455111466|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126494989|NCT01641692|455111467|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126494990|NCT01641692|455111468|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126494991|NCT01641692|455111469|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126494992|NCT01641692|455111470|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126494993|NCT01641692|455111463|FG000|Treatment Period 2|Lost to Follow-up|0|||
126494994|NCT01641692|455111464|FG001|Treatment Period 2|Lost to Follow-up|0|||
126494995|NCT01641692|455111465|FG002|Treatment Period 2|Lost to Follow-up|0|||
126494996|NCT01641692|455111466|FG003|Treatment Period 2|Lost to Follow-up|0|||
126494997|NCT01641692|455111467|FG004|Treatment Period 2|Lost to Follow-up|0|||
126494998|NCT01641692|455111468|FG005|Treatment Period 2|Lost to Follow-up|1|||
126494999|NCT01641692|455111469|FG006|Treatment Period 2|Lost to Follow-up|0|||
126495000|NCT01641692|455111470|FG007|Treatment Period 2|Lost to Follow-up|0|||
126495001|NCT01641692|455111463|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126495002|NCT01641692|455111464|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126495003|NCT01641692|455111465|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126495004|NCT01641692|455111466|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126723841|NCT01106625|455938744|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
126723842|NCT01106625|455938745|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
126723843|NCT01106625|455938746|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
126495005|NCT01641692|455111467|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126495006|NCT01641692|455111468|FG005|Treatment Period 2|Withdrawal by Subject|1|||
126495007|NCT01641692|455111469|FG006|Treatment Period 2|Withdrawal by Subject|0|||
126495008|NCT01641692|455111470|FG007|Treatment Period 2|Withdrawal by Subject|1|||
126495009|NCT01641692|455111463|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
126495010|NCT01641692|455111464|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
126495011|NCT01641692|455111465|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
126495012|NCT01641692|455111466|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
126495013|NCT01641692|455111467|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
126495014|NCT01641692|455111468|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
126495015|NCT01641692|455111469|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
126495016|NCT01641692|455111470|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
126495017|NCT01641692|455111463|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
126495018|NCT01641692|455111464|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
126495019|NCT01641692|455111465|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
126495020|NCT01641692|455111466|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
126495021|NCT01641692|455111467|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
126495022|NCT01641692|455111468|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
126495023|NCT01641692|455111469|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
126495024|NCT01641692|455111470|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
126495025|NCT01641692|455111463|FG000|Treatment Period 3|Adverse Event|0|||
126495026|NCT01641692|455111464|FG001|Treatment Period 3|Adverse Event|0|||
126495027|NCT01641692|455111465|FG002|Treatment Period 3|Adverse Event|0|||
126495028|NCT01641692|455111466|FG003|Treatment Period 3|Adverse Event|0|||
126495029|NCT01641692|455111467|FG004|Treatment Period 3|Adverse Event|0|||
126495030|NCT01641692|455111468|FG005|Treatment Period 3|Adverse Event|0|||
126495031|NCT01641692|455111469|FG006|Treatment Period 3|Adverse Event|1|||
126495032|NCT01641692|455111470|FG007|Treatment Period 3|Adverse Event|0|||
126495033|NCT01641692|455111463|FG000|Treatment Period 3|Protocol Violation|0|||
126495034|NCT01641692|455111464|FG001|Treatment Period 3|Protocol Violation|0|||
126495035|NCT01641692|455111465|FG002|Treatment Period 3|Protocol Violation|1|||
126495036|NCT01641692|455111466|FG003|Treatment Period 3|Protocol Violation|0|||
126495037|NCT01641692|455111467|FG004|Treatment Period 3|Protocol Violation|0|||
126495038|NCT01641692|455111468|FG005|Treatment Period 3|Protocol Violation|0|||
126495039|NCT01641692|455111469|FG006|Treatment Period 3|Protocol Violation|0|||
126495040|NCT01641692|455111470|FG007|Treatment Period 3|Protocol Violation|0|||
126495041|NCT01641692|455111463|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126495042|NCT01641692|455111464|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126495043|NCT01641692|455111465|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126495044|NCT01641692|455111466|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126495045|NCT01641692|455111467|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126495046|NCT01641692|455111468|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126495047|NCT01641692|455111469|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
126495048|NCT01641692|455111470|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126495049|NCT01641692|455111463|FG000|Treatment Period 3|Lost to Follow-up|0|||
126495050|NCT01641692|455111464|FG001|Treatment Period 3|Lost to Follow-up|1|||
126495051|NCT01641692|455111465|FG002|Treatment Period 3|Lost to Follow-up|0|||
126495052|NCT01641692|455111466|FG003|Treatment Period 3|Lost to Follow-up|0|||
126495053|NCT01641692|455111467|FG004|Treatment Period 3|Lost to Follow-up|0|||
126495054|NCT01641692|455111468|FG005|Treatment Period 3|Lost to Follow-up|0|||
126495055|NCT01641692|455111469|FG006|Treatment Period 3|Lost to Follow-up|0|||
126495056|NCT01641692|455111470|FG007|Treatment Period 3|Lost to Follow-up|0|||
126495057|NCT01641692|455111463|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
126495058|NCT01641692|455111464|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
126495059|NCT01641692|455111465|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
126495060|NCT01641692|455111466|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
126723844|NCT01106625|455938744|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
126723845|NCT01106625|455938745|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
126723846|NCT01106625|455938746|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
126723847|NCT01106625|455938744|FG000|Core Period: Baseline to Week 26|Other|8|||
126723848|NCT01106625|455938745|FG001|Core Period: Baseline to Week 26|Other|7|||
126495061|NCT01641692|455111467|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
126495062|NCT01641692|455111468|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
126495063|NCT01641692|455111469|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
126495064|NCT01641692|455111470|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
126559620|NCT02403674|455342540|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
126559621|NCT03738241|455342545|FG000|Overall Study|Withdrawal by Subject|0|||
126559622|NCT03738241|455342546|FG001|Overall Study|Withdrawal by Subject|0|||
126559623|NCT03738241|455342547|FG002|Overall Study|Withdrawal by Subject|0|||
126559624|NCT03738241|455342548|FG003|Overall Study|Withdrawal by Subject|0|||
126559625|NCT03738241|455342549|FG004|Overall Study|Withdrawal by Subject|0|||
126559626|NCT03738241|455342550|FG005|Overall Study|Withdrawal by Subject|0|||
126559627|NCT03738241|455342551|FG006|Overall Study|Withdrawal by Subject|0|||
126559628|NCT03738241|455342552|FG007|Overall Study|Withdrawal by Subject|0|||
126559629|NCT03738241|455342553|FG008|Overall Study|Withdrawal by Subject|0|||
126559630|NCT03738241|455342554|FG009|Overall Study|Withdrawal by Subject|1|||
126559631|NCT03738241|455342545|FG000|Overall Study|Physician Decision|0|||
126495065|NCT01641692|455111463|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
126723849|NCT01106625|455938746|FG002|Core Period: Baseline to Week 26|Other|4|||
126723850|NCT01106625|455938744|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
126723851|NCT01106625|455938745|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
126723852|NCT01106625|455938746|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
126723853|NCT01106625|455938744|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
126723854|NCT01106625|455938745|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
126723855|NCT01106625|455938746|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
126723856|NCT01106625|455938744|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
126723857|NCT01106625|455938745|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
126723858|NCT01106625|455938746|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
126723859|NCT01106625|455938744|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126723860|NCT01106625|455938745|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
126723861|NCT01106625|455938746|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
126495066|NCT01641692|455111464|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
126495067|NCT01641692|455111465|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
126495068|NCT01641692|455111466|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
126559632|NCT03738241|455342546|FG001|Overall Study|Physician Decision|0|||
126559633|NCT03738241|455342547|FG002|Overall Study|Physician Decision|0|||
126559634|NCT03738241|455342548|FG003|Overall Study|Physician Decision|0|||
126559635|NCT03738241|455342549|FG004|Overall Study|Physician Decision|0|||
126559636|NCT03738241|455342550|FG005|Overall Study|Physician Decision|0|||
126559637|NCT03738241|455342551|FG006|Overall Study|Physician Decision|0|||
126559638|NCT03738241|455342552|FG007|Overall Study|Physician Decision|0|||
126559639|NCT03738241|455342553|FG008|Overall Study|Physician Decision|1|||
126559640|NCT03738241|455342554|FG009|Overall Study|Physician Decision|0|||
126559641|NCT03738241|455342545|FG000|Overall Study|Adverse Event|1|||
126559642|NCT03738241|455342546|FG001|Overall Study|Adverse Event|0|||
126559643|NCT03738241|455342547|FG002|Overall Study|Adverse Event|0|||
126559644|NCT03738241|455342548|FG003|Overall Study|Adverse Event|0|||
126559645|NCT03738241|455342549|FG004|Overall Study|Adverse Event|0|||
126559646|NCT03738241|455342550|FG005|Overall Study|Adverse Event|0|||
126559647|NCT03738241|455342551|FG006|Overall Study|Adverse Event|0|||
126559648|NCT03738241|455342552|FG007|Overall Study|Adverse Event|0|||
126559649|NCT03738241|455342553|FG008|Overall Study|Adverse Event|0|||
126559650|NCT03738241|455342554|FG009|Overall Study|Adverse Event|0|||
126559651|NCT02788656|455342555|FG000|Overall Study|Withdrawal by Subject|1|||
126559652|NCT02788656|455342556|FG001|Overall Study|Withdrawal by Subject|0|||
126559653|NCT03169361|455342557|FG000|Overall Study|Protocol Violation|32|||
126559654|NCT02271594|455342558|FG000|Overall Study|Study closed; recruiting failure|19|||
126559655|NCT02271594|455342559|FG001|Overall Study|Study closed; recruiting failure|12|||
126559656|NCT00088465|455342564|FG000|Overall Study|Withdrawal by Subject|290|||
126559657|NCT00088465|455342564|FG000|Overall Study|Adverse Event|77|||
126559658|NCT00088465|455342564|FG000|Overall Study|Lost to Follow-up|57|||
126559659|NCT00088465|455342564|FG000|Overall Study|Physician Decision|45|||
126723862|NCT01106625|455938744|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
126772786|NCT00963599|456123677|FG002|Overall Study|Withdrawal by Subject|3|||
126495069|NCT01641692|455111467|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
126772787|NCT00963599|456123678|FG003|Overall Study|Withdrawal by Subject|3|||
126495070|NCT01641692|455111468|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
126495071|NCT01641692|455111469|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
126495072|NCT01641692|455111470|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
126495073|NCT04948450|455111475|FG000|Overall Study|Return home|1|||
126495074|NCT04948450|455111476|FG001|Overall Study|Return home|3|||
126495075|NCT00101907|455111480|FG000|Overall Study|Adverse Event|1|||
126495076|NCT00101907|455111481|FG001|Overall Study|Adverse Event|0|||
126495077|NCT00101907|455111482|FG002|Overall Study|Adverse Event|0|||
126495078|NCT00101907|455111483|FG003|Overall Study|Adverse Event|0|||
126495079|NCT00101907|455111484|FG004|Overall Study|Adverse Event|0|||
126495080|NCT00101907|455111485|FG005|Overall Study|Adverse Event|0|||
126495081|NCT00101907|455111480|FG000|Overall Study|Death|0|||
126495082|NCT00101907|455111481|FG001|Overall Study|Death|1|||
126495083|NCT00101907|455111482|FG002|Overall Study|Death|0|||
126495084|NCT00101907|455111483|FG003|Overall Study|Death|0|||
126495085|NCT00101907|455111484|FG004|Overall Study|Death|3|||
126495086|NCT00101907|455111485|FG005|Overall Study|Death|0|||
126559660|NCT00088465|455342564|FG000|Overall Study|Sponsor Decision|37|||
126495087|NCT00101907|455111480|FG000|Overall Study|Physician Decision|0|||
126559661|NCT00088465|455342564|FG000|Overall Study|Lack of Efficacy|27|||
126559662|NCT00088465|455342564|FG000|Overall Study|Protocol Violation|17|||
126559663|NCT00088465|455342564|FG000|Overall Study|Death|11|||
126559664|NCT00495469|455342565|FG000|Overall Study|Adverse Event|0|||
126559665|NCT00495469|455342566|FG001|Overall Study|Adverse Event|1|||
126559666|NCT00495469|455342567|FG002|Overall Study|Adverse Event|3|||
126559667|NCT00495469|455342568|FG003|Overall Study|Adverse Event|0|||
126559668|NCT00495469|455342569|FG004|Overall Study|Adverse Event|1|||
126495088|NCT00101907|455111481|FG001|Overall Study|Physician Decision|0|||
126495089|NCT00101907|455111482|FG002|Overall Study|Physician Decision|0|||
126495090|NCT00101907|455111483|FG003|Overall Study|Physician Decision|1|||
126495091|NCT00101907|455111484|FG004|Overall Study|Physician Decision|1|||
126495092|NCT00101907|455111485|FG005|Overall Study|Physician Decision|0|||
126495093|NCT00101907|455111480|FG000|Overall Study|Withdrawal by Subject|1|||
126495094|NCT00101907|455111481|FG001|Overall Study|Withdrawal by Subject|0|||
126495095|NCT00101907|455111482|FG002|Overall Study|Withdrawal by Subject|1|||
126495096|NCT00101907|455111483|FG003|Overall Study|Withdrawal by Subject|0|||
126495097|NCT00101907|455111484|FG004|Overall Study|Withdrawal by Subject|1|||
126495098|NCT00101907|455111485|FG005|Overall Study|Withdrawal by Subject|0|||
126495099|NCT01474876|455111490|FG000|Overall Study|Adverse Event|11|||
126495100|NCT01474876|455111491|FG001|Overall Study|Adverse Event|5|||
126495101|NCT01474876|455111492|FG002|Overall Study|Adverse Event|0|||
126495102|NCT01474876|455111490|FG000|Overall Study|Serious Adverse Event|2|||
126495103|NCT01474876|455111491|FG001|Overall Study|Serious Adverse Event|3|||
126495104|NCT01474876|455111492|FG002|Overall Study|Serious Adverse Event|0|||
126495105|NCT01474876|455111490|FG000|Overall Study|Lost to Follow-up|5|||
126495106|NCT01474876|455111491|FG001|Overall Study|Lost to Follow-up|4|||
126495107|NCT01474876|455111492|FG002|Overall Study|Lost to Follow-up|0|||
126495108|NCT01474876|455111490|FG000|Overall Study|Investigator's decision|28|||
126495109|NCT01474876|455111491|FG001|Overall Study|Investigator's decision|6|||
126495110|NCT01474876|455111492|FG002|Overall Study|Investigator's decision|0|||
126495111|NCT01474876|455111490|FG000|Overall Study|Patient's request|19|||
126495112|NCT01474876|455111491|FG001|Overall Study|Patient's request|5|||
126495113|NCT01474876|455111492|FG002|Overall Study|Patient's request|0|||
126495114|NCT01474876|455111490|FG000|Overall Study|Investigator's decision and pt request|1|||
126495115|NCT01474876|455111491|FG001|Overall Study|Investigator's decision and pt request|0|||
126495116|NCT01474876|455111492|FG002|Overall Study|Investigator's decision and pt request|0|||
126495117|NCT01523886|455111493|FG000|Overall Study|surgery cancelled|0|||
126495118|NCT01523886|455111494|FG001|Overall Study|surgery cancelled|1|||
126495119|NCT01173718|455111509|FG000|Overall Study|Death|17|||
126495120|NCT01173718|455111509|FG000|Overall Study|Abandonment of study graft|27|||
126495121|NCT02226003|455111511|FG000|Overall Study|Lost to Follow-up|2|||
126495122|NCT02226003|455111512|FG001|Overall Study|Lost to Follow-up|1|||
126495123|NCT02226003|455111513|FG002|Overall Study|Lost to Follow-up|3|||
126495124|NCT02226003|455111511|FG000|Overall Study|Withdrawal by Subject|0|||
126495125|NCT02226003|455111512|FG001|Overall Study|Withdrawal by Subject|0|||
126495126|NCT02226003|455111513|FG002|Overall Study|Withdrawal by Subject|3|||
126495127|NCT04219891|455111518|FG000|Overall Study|Lost to Follow-up|3|||
126495128|NCT04219891|455111518|FG000|Overall Study|Withdrawal by Subject|2|||
126495129|NCT00670800|455112945|FG000|Overall Study|2 controls were insulin resistant|0|||
126495130|NCT00670800|455112946|FG001|Overall Study|2 controls were insulin resistant|2|||
126495131|NCT01786629|455112947|FG000|Overall Study|Lack of Efficacy|0|||
126495132|NCT01786629|455112948|FG001|Overall Study|Lack of Efficacy|4|||
126495133|NCT01786629|455112947|FG000|Overall Study|Adverse Event|0|||
126495134|NCT01786629|455112948|FG001|Overall Study|Adverse Event|1|||
126495135|NCT04736199|455112949|FG000|Overall Study|Adverse Event|28|||
126495136|NCT04736199|455112950|FG001|Overall Study|Adverse Event|22|||
126495137|NCT04736199|455112949|FG000|Overall Study|Death|9|||
126495138|NCT04736199|455112950|FG001|Overall Study|Death|3|||
126495139|NCT04736199|455112949|FG000|Overall Study|Lost to Follow-up|4|||
126495140|NCT04736199|455112950|FG001|Overall Study|Lost to Follow-up|1|||
126495141|NCT04736199|455112949|FG000|Overall Study|Physician Decision|5|||
126495142|NCT04736199|455112950|FG001|Overall Study|Physician Decision|9|||
126495143|NCT04736199|455112949|FG000|Overall Study|Withdrawal by Subject|21|||
126495144|NCT04736199|455112950|FG001|Overall Study|Withdrawal by Subject|9|||
126495145|NCT04736199|455112949|FG000|Overall Study|Progressive disease|120|||
126495146|NCT04736199|455112950|FG001|Overall Study|Progressive disease|101|||
126495147|NCT04736199|455112949|FG000|Overall Study|Subject decision|13|||
126495148|NCT04736199|455112950|FG001|Overall Study|Subject decision|13|||
126495149|NCT04736199|455112949|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
126495150|NCT04736199|455112950|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
126495151|NCT04736199|455112949|FG000|Overall Study|Additional primary malignancy|1|||
126495152|NCT04736199|455112950|FG001|Overall Study|Additional primary malignancy|0|||
126495153|NCT04736199|455112949|FG000|Overall Study|Non-compliance with study drug|0|||
126495154|NCT04736199|455112950|FG001|Overall Study|Non-compliance with study drug|1|||
126495155|NCT04736199|455112949|FG000|Overall Study|Other reason|0|||
126495156|NCT04736199|455112950|FG001|Overall Study|Other reason|1|||
126495157|NCT04736199|455112949|FG000|Overall Study|Ongoing with study drug|240|||
126723863|NCT01106625|455938745|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126723864|NCT01106625|455938746|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
126495158|NCT04736199|455112950|FG001|Overall Study|Ongoing with study drug|63|||
126495159|NCT04736199|455112949|FG000|Overall Study|Study drug never administered|3|||
126495160|NCT04736199|455112950|FG001|Overall Study|Study drug never administered|0|||
126559669|NCT00495469|455342570|FG005|Overall Study|Adverse Event|1|||
126495161|NCT04318080|455112951|FG000|Overall Study|Study closed by sponsor|10|||
126495162|NCT04318080|455112952|FG001|Overall Study|Study closed by sponsor|22|||
126495163|NCT04318080|455112951|FG000|Overall Study|Death|3|||
126495164|NCT04318080|455112952|FG001|Overall Study|Death|9|||
126495165|NCT04318080|455112951|FG000|Overall Study|Withdrawal by Subject|1|||
126495166|NCT04318080|455112952|FG001|Overall Study|Withdrawal by Subject|0|||
126495167|NCT04318080|455112951|FG000|Overall Study|Protocol Deviation|1|||
126495168|NCT04318080|455112952|FG001|Overall Study|Protocol Deviation|0|||
126495169|NCT00410761|455112953|FG000|Randomized Treatment Period|Adverse Event|34|||
126495170|NCT00410761|455112954|FG001|Randomized Treatment Period|Adverse Event|3|||
126495171|NCT00410761|455112953|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
126495172|NCT00410761|455112954|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
126495173|NCT00410761|455112953|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
126495174|NCT00410761|455112954|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
126495175|NCT00410761|455112953|FG000|Randomized Treatment Period|Other|69|||
126495176|NCT00410761|455112954|FG001|Randomized Treatment Period|Other|21|||
126495177|NCT00410761|455112953|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
126495178|NCT00410761|455112954|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
126495179|NCT00410761|455112953|FG000|Open-Label Treatment Period|Adverse Event|13|||
126495180|NCT00410761|455112954|FG001|Open-Label Treatment Period|Adverse Event|15|||
126495181|NCT00410761|455112953|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
126495182|NCT00410761|455112954|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
126495183|NCT00410761|455112953|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
126495184|NCT00410761|455112954|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
126495185|NCT00410761|455112953|FG000|Open-Label Treatment Period|Other|18|||
126495186|NCT00410761|455112954|FG001|Open-Label Treatment Period|Other|9|||
126495187|NCT02926924|455112955|FG000|Overall Study|withdrawal - reason unknown|0|||
126495188|NCT02926924|455112956|FG001|Overall Study|withdrawal - reason unknown|1|||
126495189|NCT03712904|455112958|FG000|Overall Study|Death|0|||
126495190|NCT03712904|455112959|FG001|Overall Study|Death|1|||
126495191|NCT03712904|455112958|FG000|Overall Study|Withdrawal by Subject|0|||
126495192|NCT03712904|455112959|FG001|Overall Study|Withdrawal by Subject|1|||
126495193|NCT03712904|455112958|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
126495194|NCT03712904|455112959|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
126495195|NCT01852942|455112961|FG000|Overall Study|Physician Decision|1|||
126495196|NCT01852942|455112962|FG001|Overall Study|Physician Decision|0|||
126495197|NCT01852942|455112961|FG000|Overall Study|Death|1|||
126495198|NCT01852942|455112962|FG001|Overall Study|Death|1|||
126495199|NCT01852942|455112961|FG000|Overall Study|Withdrawal by Subject|2|||
126495200|NCT01852942|455112962|FG001|Overall Study|Withdrawal by Subject|3|||
126495201|NCT01852942|455112961|FG000|Overall Study|Lost to Follow-up|1|||
126495202|NCT01852942|455112962|FG001|Overall Study|Lost to Follow-up|2|||
126495203|NCT01921179|455112963|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
126495204|NCT01921179|455112964|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
126495205|NCT01921179|455112963|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
126495206|NCT01921179|455112964|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
126495207|NCT04568590|455112965|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
126495208|NCT00858442|455112970|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
126495209|NCT00858442|455112971|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
126495210|NCT00202644|455112974|FG000|Overall Study|Adverse Event|12|||
126495211|NCT00202644|455112975|FG001|Overall Study|Adverse Event|13|||
126495212|NCT00202644|455112974|FG000|Overall Study|Withdrawal by Subject|8|||
126495213|NCT00202644|455112975|FG001|Overall Study|Withdrawal by Subject|6|||
126495214|NCT00202644|455112974|FG000|Overall Study|Lack of Efficacy|6|||
126495215|NCT00202644|455112975|FG001|Overall Study|Lack of Efficacy|6|||
126495216|NCT00202644|455112974|FG000|Overall Study|Lost to Follow-up|0|||
126495217|NCT00202644|455112975|FG001|Overall Study|Lost to Follow-up|1|||
126495218|NCT00202644|455112974|FG000|Overall Study|Other|9|||
126495219|NCT00202644|455112975|FG001|Overall Study|Other|1|||
126495220|NCT02750592|455112981|FG000|Overall Study|Adverse Event|3|||
126495221|NCT02750592|455112981|FG000|Overall Study|Lack of Efficacy|2|||
126495222|NCT02981342|455112984|FG000|Overall Study|Adverse Event|0|||
126495223|NCT02981342|455112985|FG001|Overall Study|Adverse Event|0|||
126495224|NCT02981342|455112986|FG002|Overall Study|Adverse Event|0|||
126495225|NCT02981342|455112987|FG003|Overall Study|Adverse Event|1|||
126495226|NCT02981342|455112984|FG000|Overall Study|Death|0|||
126495227|NCT02981342|455112985|FG001|Overall Study|Death|9|||
126495228|NCT02981342|455112986|FG002|Overall Study|Death|9|||
126495229|NCT02981342|455112987|FG003|Overall Study|Death|4|||
126495230|NCT02981342|455112984|FG000|Overall Study|Withdrawal by Subject|0|||
126559670|NCT00495469|455342571|FG006|Overall Study|Adverse Event|1|||
126723865|NCT01106625|455938744|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
126495231|NCT02981342|455112985|FG001|Overall Study|Withdrawal by Subject|0|||
126495232|NCT02981342|455112986|FG002|Overall Study|Withdrawal by Subject|3|||
126495233|NCT02981342|455112987|FG003|Overall Study|Withdrawal by Subject|1|||
126495234|NCT02981342|455112984|FG000|Overall Study|Study closed by sponsor|0|||
126495235|NCT02981342|455112985|FG001|Overall Study|Study closed by sponsor|0|||
126495236|NCT02981342|455112986|FG002|Overall Study|Study closed by sponsor|1|||
126495237|NCT02981342|455112987|FG003|Overall Study|Study closed by sponsor|1|||
126495238|NCT02981342|455112984|FG000|Overall Study|Randomized, Never Treated|0|||
126495239|NCT02981342|455112985|FG001|Overall Study|Randomized, Never Treated|1|||
126495240|NCT02981342|455112986|FG002|Overall Study|Randomized, Never Treated|0|||
126495241|NCT02981342|455112987|FG003|Overall Study|Randomized, Never Treated|7|||
126495242|NCT02981342|455112984|FG000|Overall Study|Lost to Follow-up|0|||
126495243|NCT02981342|455112985|FG001|Overall Study|Lost to Follow-up|1|||
126495244|NCT02981342|455112986|FG002|Overall Study|Lost to Follow-up|0|||
126495245|NCT02981342|455112987|FG003|Overall Study|Lost to Follow-up|0|||
126495246|NCT05333900|455112988|FG000|Overall Study|Protocol Violation|0|||
126495247|NCT05333900|455112989|FG001|Overall Study|Protocol Violation|1|||
126495248|NCT05333900|455112988|FG000|Overall Study|Withdrawal by Subject|0|||
126495249|NCT05333900|455112989|FG001|Overall Study|Withdrawal by Subject|1|||
126495250|NCT05333900|455112988|FG000|Overall Study|COVID-19 Pandemic|1|||
126495251|NCT05333900|455112989|FG001|Overall Study|COVID-19 Pandemic|1|||
126495252|NCT03724812|455112992|FG000|Overall Study|Missed Visit|1|||
126495253|NCT03724812|455112992|FG000|Overall Study|Death|2|||
126495254|NCT03724812|455112992|FG000|Overall Study|Withdrawal by Subject|1|||
126495255|NCT01851720|455112993|FG000|Overall Study|Lost to Follow-up|0|||
126495256|NCT01851720|455112994|FG001|Overall Study|Lost to Follow-up|1|||
126495257|NCT03525574|455112995|FG000|Overall Study|Adverse Event|15|||
126495258|NCT03525574|455112996|FG001|Overall Study|Adverse Event|0|||
126495259|NCT03525574|455112995|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
126495260|NCT03525574|455112996|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
126495261|NCT03525574|455112995|FG000|Overall Study|Lost to Follow-up|4|||
126495262|NCT03525574|455112996|FG001|Overall Study|Lost to Follow-up|0|||
126495263|NCT03525574|455112995|FG000|Overall Study|Commercial drug is Available for participant|48|||
126495264|NCT03525574|455112996|FG001|Overall Study|Commercial drug is Available for participant|0|||
126495265|NCT03525574|455112995|FG000|Overall Study|Death|1|||
126495266|NCT03525574|455112996|FG001|Overall Study|Death|0|||
126495267|NCT03525574|455112995|FG000|Overall Study|Other non-compliance|2|||
126495268|NCT03525574|455112996|FG001|Overall Study|Other non-compliance|0|||
126495269|NCT03525574|455112995|FG000|Overall Study|Physician Decision|6|||
126495270|NCT03525574|455112996|FG001|Overall Study|Physician Decision|0|||
126495271|NCT03525574|455112995|FG000|Overall Study|Other|58|||
126495272|NCT03525574|455112996|FG001|Overall Study|Other|0|||
126495273|NCT03525574|455112995|FG000|Overall Study|Enrolled but never dosed|1|||
126495274|NCT03525574|455112996|FG001|Overall Study|Enrolled but never dosed|0|||
126495275|NCT03525574|455112995|FG000|Overall Study|Not enrolled in 105 study|0|||
126495276|NCT03525574|455112996|FG001|Overall Study|Not enrolled in 105 study|3|||
126495277|NCT03045887|455112999|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
126495278|NCT03045887|455113000|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
126495279|NCT03045887|455113001|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
126495280|NCT03045887|455113002|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
126495281|NCT03045887|455113003|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
126495282|NCT03045887|455113004|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
126495283|NCT03045887|455113005|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
126495284|NCT03045887|455113006|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
126495285|NCT03045887|455113007|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
126495286|NCT03045887|455113008|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
126495287|NCT03045887|455112999|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
126495288|NCT03045887|455113000|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
126495289|NCT03045887|455113001|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
126495290|NCT03045887|455113002|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
126559671|NCT00495469|455342565|FG000|Overall Study|Lost to Follow-up|1|||
126559672|NCT00495469|455342566|FG001|Overall Study|Lost to Follow-up|1|||
126495291|NCT03045887|455113003|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
126495292|NCT03045887|455113004|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
126495293|NCT03045887|455113005|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
126495294|NCT03045887|455113006|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
126495295|NCT03045887|455113007|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
126495296|NCT03045887|455113008|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
126495297|NCT03045887|455112999|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
126495298|NCT03045887|455113000|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
126495299|NCT03045887|455113001|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
126495300|NCT03045887|455113002|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
126495301|NCT03045887|455113003|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
126495302|NCT03045887|455113004|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
126495303|NCT03045887|455113005|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
126495304|NCT03045887|455113006|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
126495305|NCT03045887|455113007|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
126559673|NCT00495469|455342567|FG002|Overall Study|Lost to Follow-up|3|||
126559674|NCT00495469|455342568|FG003|Overall Study|Lost to Follow-up|1|||
126559675|NCT00495469|455342569|FG004|Overall Study|Lost to Follow-up|0|||
126559676|NCT00495469|455342570|FG005|Overall Study|Lost to Follow-up|0|||
126559677|NCT00495469|455342571|FG006|Overall Study|Lost to Follow-up|0|||
126559678|NCT00495469|455342565|FG000|Overall Study|Protocol Violation|0|||
126559679|NCT00495469|455342566|FG001|Overall Study|Protocol Violation|0|||
126559680|NCT00495469|455342567|FG002|Overall Study|Protocol Violation|0|||
126559681|NCT00495469|455342568|FG003|Overall Study|Protocol Violation|0|||
126772788|NCT00123487|456123681|FG000|Randomized|Death prior to starting treatment|0|||
126772789|NCT00123487|456123682|FG001|Randomized|Death prior to starting treatment|1|||
126772790|NCT00123487|456123681|FG000|Randomized|SAE prior to starting treatment|1|||
126495306|NCT03045887|455113008|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
126495307|NCT03045887|455112999|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
126495308|NCT03045887|455113000|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
126495309|NCT03045887|455113001|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
126495310|NCT03045887|455113002|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
126495311|NCT03045887|455113003|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
126495312|NCT03045887|455113004|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
126495313|NCT03045887|455113005|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
126495314|NCT03045887|455113006|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
126495315|NCT03045887|455113007|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
126495316|NCT03045887|455113008|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
126495317|NCT03045887|455112999|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126495318|NCT03045887|455113000|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126495319|NCT03045887|455113001|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126495320|NCT03045887|455113002|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
126495321|NCT03045887|455113003|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126495322|NCT03045887|455113004|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126495323|NCT03045887|455113005|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126495324|NCT03045887|455113006|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126495325|NCT03045887|455113007|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126495326|NCT03045887|455113008|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
126495327|NCT03226392|455113009|FG000|Overall Study|Protocol Deviation|1|||
126495328|NCT03226392|455113010|FG001|Overall Study|Protocol Deviation|0|||
126495329|NCT03226392|455113009|FG000|Overall Study|Physician Decision|1|||
126495330|NCT03226392|455113010|FG001|Overall Study|Physician Decision|0|||
126495331|NCT03226392|455113009|FG000|Overall Study|Lost to Follow-up|1|||
126495332|NCT03226392|455113010|FG001|Overall Study|Lost to Follow-up|0|||
126495333|NCT03226392|455113009|FG000|Overall Study|Adverse Event|1|||
126495334|NCT03226392|455113010|FG001|Overall Study|Adverse Event|0|||
126495335|NCT03226392|455113009|FG000|Overall Study|Technical Problems|0|||
126495336|NCT03226392|455113010|FG001|Overall Study|Technical Problems|2|||
126495337|NCT03226392|455113009|FG000|Overall Study|Subject/Guardian Decision|7|||
126495338|NCT03226392|455113010|FG001|Overall Study|Subject/Guardian Decision|6|||
126495339|NCT02631850|455113011|FG000|Treatment Period|Lost to Follow-up|0|||
126495340|NCT02631850|455113012|FG001|Treatment Period|Lost to Follow-up|1|||
126495341|NCT02631850|455113013|FG002|Treatment Period|Lost to Follow-up|0|||
126495342|NCT02631850|455113014|FG003|Treatment Period|Lost to Follow-up|0|||
126495343|NCT02631850|455113011|FG000|Treatment Period|Protocol Violation|1|||
126495344|NCT02631850|455113012|FG001|Treatment Period|Protocol Violation|0|||
126495345|NCT02631850|455113013|FG002|Treatment Period|Protocol Violation|0|||
126495346|NCT02631850|455113014|FG003|Treatment Period|Protocol Violation|0|||
126495347|NCT02631850|455113011|FG000|Treatment Period|Withdrawal by Subject|0|||
126495348|NCT02631850|455113012|FG001|Treatment Period|Withdrawal by Subject|5|||
126495349|NCT02631850|455113013|FG002|Treatment Period|Withdrawal by Subject|2|||
126495350|NCT02631850|455113014|FG003|Treatment Period|Withdrawal by Subject|2|||
126495351|NCT02631850|455113011|FG000|Treatment Period|Adverse Event|1|||
126495352|NCT02631850|455113012|FG001|Treatment Period|Adverse Event|0|||
126495353|NCT02631850|455113013|FG002|Treatment Period|Adverse Event|2|||
126495354|NCT02631850|455113014|FG003|Treatment Period|Adverse Event|3|||
126495355|NCT02631850|455113011|FG000|Treatment Period|Family medical issue|1|||
126495356|NCT02631850|455113012|FG001|Treatment Period|Family medical issue|0|||
126495357|NCT02631850|455113013|FG002|Treatment Period|Family medical issue|0|||
126495358|NCT02631850|455113014|FG003|Treatment Period|Family medical issue|0|||
126495359|NCT02631850|455113011|FG000|6 Month Follow up|Lost to Follow-up|5|||
126559682|NCT00495469|455342569|FG004|Overall Study|Protocol Violation|1|||
126495360|NCT02631850|455113012|FG001|6 Month Follow up|Lost to Follow-up|8|||
126559683|NCT00495469|455342570|FG005|Overall Study|Protocol Violation|2|||
126559684|NCT00495469|455342571|FG006|Overall Study|Protocol Violation|0|||
126559685|NCT00495469|455342565|FG000|Overall Study|Withdrawal by Subject|5|||
126495361|NCT02631850|455113013|FG002|6 Month Follow up|Lost to Follow-up|3|||
126495362|NCT02631850|455113014|FG003|6 Month Follow up|Lost to Follow-up|5|||
126495363|NCT02631850|455113011|FG000|6 Month Follow up|Withdrawal by Subject|1|||
126495364|NCT02631850|455113012|FG001|6 Month Follow up|Withdrawal by Subject|0|||
126495365|NCT02631850|455113013|FG002|6 Month Follow up|Withdrawal by Subject|0|||
126495366|NCT02631850|455113014|FG003|6 Month Follow up|Withdrawal by Subject|2|||
126495367|NCT02631850|455113011|FG000|6 Month Follow up|Adverse Event|1|||
126495368|NCT02631850|455113012|FG001|6 Month Follow up|Adverse Event|4|||
126495369|NCT02631850|455113013|FG002|6 Month Follow up|Adverse Event|1|||
126495370|NCT02631850|455113014|FG003|6 Month Follow up|Adverse Event|3|||
126495371|NCT02631850|455113011|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
126495372|NCT02631850|455113012|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
126495373|NCT02631850|455113013|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
126495374|NCT02631850|455113014|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
126495375|NCT01086540|455113015|FG000|Overall Study|Death|3|||
126495376|NCT01086540|455113016|FG001|Overall Study|Death|1|||
126495377|NCT01086540|455113015|FG000|Overall Study|Physician Decision|2|||
126495378|NCT01086540|455113016|FG001|Overall Study|Physician Decision|1|||
126495379|NCT01086540|455113015|FG000|Overall Study|Addition of new therapy for PAH|1|||
126495380|NCT01086540|455113016|FG001|Overall Study|Addition of new therapy for PAH|0|||
126495381|NCT03164928|455113017|FG000|Overall Study|Lost to Follow-up|1|||
126495382|NCT03164928|455113018|FG001|Overall Study|Lost to Follow-up|0|||
126495383|NCT01998737|455113019|FG000|Overall Study|Corrupted database|23|||
126495384|NCT01998737|455113020|FG001|Overall Study|Corrupted database|0|||
126495385|NCT02118012|455113023|FG000|Overall Study|Adverse Event|0|||
126495386|NCT02118012|455113024|FG001|Overall Study|Adverse Event|1|||
126495387|NCT02118012|455113023|FG000|Overall Study|Physician Decision|0|||
126495388|NCT02118012|455113024|FG001|Overall Study|Physician Decision|1|||
126495389|NCT03698994|455113025|FG000|Overall Study|Adverse Event|2|||
126495390|NCT03698994|455113025|FG000|Overall Study|Death|1|||
126495391|NCT03698994|455113025|FG000|Overall Study|Physician Decision|1|||
126495392|NCT03698994|455113025|FG000|Overall Study|Withdrawal by Subject|3|||
126495393|NCT03698994|455113025|FG000|Overall Study|Progressive Disease|12|||
126495394|NCT01994629|455113033|FG000|Overall Study|Withdrawal by Subject|1|||
126495395|NCT01994629|455113034|FG001|Overall Study|Withdrawal by Subject|0|||
126495396|NCT01994629|455113033|FG000|Overall Study|Lost to Follow-up|0|||
126495397|NCT01994629|455113034|FG001|Overall Study|Lost to Follow-up|3|||
126495398|NCT03424265|455113035|FG000|Overall Study|screening failure|1|||
126495399|NCT03424265|455113036|FG001|Overall Study|screening failure|0|||
126495400|NCT03424265|455113035|FG000|Overall Study|Withdrawal by Subject|0|||
126495401|NCT03424265|455113036|FG001|Overall Study|Withdrawal by Subject|2|||
126495402|NCT01558752|455113037|FG000|Overall Study|Physician Decision|2|||
126495403|NCT01558752|455113038|FG001|Overall Study|Physician Decision|0|||
126495404|NCT00894322|455113044|FG000|Overall Study|Withdrawal by Subject|1|||
126495405|NCT00894322|455113045|FG001|Overall Study|Withdrawal by Subject|0|||
126495406|NCT00894322|455113046|FG002|Overall Study|Withdrawal by Subject|0|||
126495407|NCT02738450|455113048|FG000|Overall Study|Withdrawal by Subject|0|||
126495408|NCT02738450|455113049|FG001|Overall Study|Withdrawal by Subject|2|||
126495409|NCT02738450|455113050|FG002|Overall Study|Withdrawal by Subject|0|||
126495410|NCT00296374|455113057|FG000|Overall Study|Adverse Event|14|||
126495411|NCT00296374|455113058|FG001|Overall Study|Adverse Event|10|||
126495412|NCT00296374|455113059|FG002|Overall Study|Adverse Event|7|||
126495413|NCT00296374|455113057|FG000|Overall Study|Withdrawal by Subject|3|||
126495414|NCT00296374|455113058|FG001|Overall Study|Withdrawal by Subject|5|||
126495415|NCT00296374|455113059|FG002|Overall Study|Withdrawal by Subject|11|||
126495416|NCT00296374|455113057|FG000|Overall Study|Incorrect enrollment|3|||
126495417|NCT00296374|455113058|FG001|Overall Study|Incorrect enrollment|3|||
126495418|NCT00296374|455113059|FG002|Overall Study|Incorrect enrollment|4|||
126495419|NCT00296374|455113057|FG000|Overall Study|Protocol Violation|1|||
126495420|NCT00296374|455113058|FG001|Overall Study|Protocol Violation|2|||
126495421|NCT00296374|455113059|FG002|Overall Study|Protocol Violation|3|||
126495422|NCT00296374|455113057|FG000|Overall Study|Lost to Follow-up|3|||
126495423|NCT00296374|455113058|FG001|Overall Study|Lost to Follow-up|1|||
126495424|NCT00296374|455113059|FG002|Overall Study|Lost to Follow-up|1|||
126495425|NCT00296374|455113057|FG000|Overall Study|Relocated to another state|1|||
126495426|NCT00296374|455113058|FG001|Overall Study|Relocated to another state|0|||
126495427|NCT00296374|455113059|FG002|Overall Study|Relocated to another state|0|||
126495428|NCT00296374|455113057|FG000|Overall Study|Stopped drug before end of study visit|0|||
126559686|NCT00495469|455342566|FG001|Overall Study|Withdrawal by Subject|3|||
126559687|NCT00495469|455342567|FG002|Overall Study|Withdrawal by Subject|1|||
126495429|NCT00296374|455113058|FG001|Overall Study|Stopped drug before end of study visit|1|||
126495430|NCT00296374|455113059|FG002|Overall Study|Stopped drug before end of study visit|0|||
126495431|NCT00296374|455113057|FG000|Overall Study|Nephrologist introduced ACE|0|||
126495432|NCT00296374|455113058|FG001|Overall Study|Nephrologist introduced ACE|1|||
126495433|NCT00296374|455113059|FG002|Overall Study|Nephrologist introduced ACE|0|||
126495434|NCT00296374|455113057|FG000|Overall Study|Pregnancy|0|||
126495435|NCT00296374|455113058|FG001|Overall Study|Pregnancy|0|||
126495436|NCT00296374|455113059|FG002|Overall Study|Pregnancy|2|||
126495437|NCT00296374|455113057|FG000|Overall Study|Other|0|||
126772791|NCT00123487|456123682|FG001|Randomized|SAE prior to starting treatment|0|||
126772792|NCT00123487|456123681|FG000|Treated With Study Drug|Adverse Event|23|||
126772793|NCT00123487|456123682|FG001|Treated With Study Drug|Adverse Event|22|||
126772794|NCT00123487|456123681|FG000|Treated With Study Drug|Disease Progression|141|||
126772795|NCT00123487|456123682|FG001|Treated With Study Drug|Disease Progression|122|||
126772796|NCT00123487|456123681|FG000|Treated With Study Drug|Physician Decision|8|||
126772797|NCT00123487|456123682|FG001|Treated With Study Drug|Physician Decision|9|||
126772798|NCT00123487|456123681|FG000|Treated With Study Drug|Other|59|||
126772799|NCT00123487|456123682|FG001|Treated With Study Drug|Other|58|||
126772800|NCT00123487|456123681|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
126772801|NCT00123487|456123682|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
126772802|NCT00123487|456123681|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
126772803|NCT00123487|456123682|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
126772804|NCT00123487|456123681|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
126772805|NCT00123487|456123682|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
126772806|NCT00995488|456123683|FG000|Overall Study|Withdrawal by Subject|1|||
126772807|NCT01039584|456123684|FG000|Overall Study|Withdrawal by Subject|4|||
126772808|NCT01039584|456123685|FG001|Overall Study|Withdrawal by Subject|2|||
126772809|NCT01039584|456123686|FG002|Overall Study|Withdrawal by Subject|1|||
126772810|NCT01039584|456123684|FG000|Overall Study|Protocol Violation|10|||
126772811|NCT01039584|456123685|FG001|Overall Study|Protocol Violation|4|||
126772812|NCT01039584|456123686|FG002|Overall Study|Protocol Violation|6|||
126772813|NCT01039584|456123684|FG000|Overall Study|Lost to Follow-up|5|||
126772814|NCT01039584|456123685|FG001|Overall Study|Lost to Follow-up|3|||
126772815|NCT01039584|456123686|FG002|Overall Study|Lost to Follow-up|4|||
126772816|NCT01039584|456123684|FG000|Overall Study|Negative Baseline culture for Candida|59|||
126772817|NCT01039584|456123685|FG001|Overall Study|Negative Baseline culture for Candida|59|||
126772818|NCT01039584|456123686|FG002|Overall Study|Negative Baseline culture for Candida|24|||
126772819|NCT01039584|456123684|FG000|Overall Study|Lack of Efficacy|7|||
126772820|NCT01039584|456123685|FG001|Overall Study|Lack of Efficacy|6|||
126772821|NCT01039584|456123686|FG002|Overall Study|Lack of Efficacy|10|||
126772822|NCT01039584|456123684|FG000|Overall Study|other|1|||
126772823|NCT01039584|456123685|FG001|Overall Study|other|3|||
126772824|NCT01039584|456123686|FG002|Overall Study|other|1|||
126772825|NCT01039584|456123684|FG000|Overall Study|Pap smear with significant pathology|10|||
126772826|NCT01039584|456123685|FG001|Overall Study|Pap smear with significant pathology|10|||
126772827|NCT01039584|456123686|FG002|Overall Study|Pap smear with significant pathology|3|||
126772828|NCT01039584|456123684|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
126772829|NCT01039584|456123685|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
126772830|NCT01039584|456123686|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
126772831|NCT04639310|456123689|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
126772832|NCT04639310|456123690|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
126772833|NCT02082262|456125272|FG000|Overall Study|Withdrawal by Subject|3|||
126772834|NCT02082262|456125272|FG000|Overall Study|Adverse Event|48|||
126772835|NCT01408576|456125273|FG000|Overall Study|Lack of Efficacy|17|||
126772836|NCT01408576|456125274|FG001|Overall Study|Lack of Efficacy|30|||
126772837|NCT01408576|456125275|FG002|Overall Study|Lack of Efficacy|48|||
126495438|NCT00296374|455113058|FG001|Overall Study|Other|0|||
126495439|NCT00296374|455113059|FG002|Overall Study|Other|1|||
126495440|NCT06308822|455114682|FG000|Overall Study|Mutation Status Not Confirmed|17|||
126495441|NCT06308822|455114682|FG000|Overall Study|Adverse Event|1|||
126495442|NCT06308822|455114682|FG000|Overall Study|Death|5|||
126495443|NCT06308822|455114682|FG000|Overall Study|Disease progression|8|||
126495444|NCT06308822|455114682|FG000|Overall Study|Withdrawal by Subject|1|||
126495445|NCT06308822|455114682|FG000|Overall Study|Physician Decision|3|||
126495446|NCT04708886|455114683|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
126495447|NCT04708886|455114683|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
126495448|NCT01372501|455114684|FG000|Overall Study|Adverse Event|4|||
126495449|NCT01372501|455114684|FG000|Overall Study|Device migration|1|||
126495450|NCT01466348|455114685|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
126495451|NCT01466348|455114686|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
126495452|NCT03989440|455114687|FG000|Overall Study|COVID-19 travel restrictions|0|||
126495453|NCT03989440|455114688|FG001|Overall Study|COVID-19 travel restrictions|0|||
126559688|NCT00495469|455342568|FG003|Overall Study|Withdrawal by Subject|3|||
126772838|NCT01408576|456125273|FG000|Overall Study|Protocol Violation|1|||
126495454|NCT03989440|455114689|FG002|Overall Study|COVID-19 travel restrictions|1|||
126495455|NCT03989440|455114690|FG003|Overall Study|COVID-19 travel restrictions|0|||
126495456|NCT03989440|455114691|FG004|Overall Study|COVID-19 travel restrictions|0|||
126495457|NCT03989440|455114692|FG005|Overall Study|COVID-19 travel restrictions|0|||
126772839|NCT01408576|456125274|FG001|Overall Study|Protocol Violation|2|||
126772840|NCT01408576|456125275|FG002|Overall Study|Protocol Violation|2|||
126772841|NCT01408576|456125273|FG000|Overall Study|Lost to Follow-up|10|||
126772842|NCT01408576|456125274|FG001|Overall Study|Lost to Follow-up|9|||
126772843|NCT01408576|456125275|FG002|Overall Study|Lost to Follow-up|17|||
126495458|NCT03989440|455114687|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
126495459|NCT03989440|455114688|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
126495460|NCT03989440|455114689|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
126495461|NCT03989440|455114690|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
126495462|NCT03989440|455114691|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
126495463|NCT03989440|455114692|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
126495464|NCT03970733|455114695|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
126495465|NCT03970733|455114696|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
126495466|NCT03970733|455114697|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
126495467|NCT03970733|455114698|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
126495468|NCT03970733|455114699|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
126495469|NCT03970733|455114695|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
126495470|NCT03970733|455114696|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
126495471|NCT03970733|455114697|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
126495472|NCT03970733|455114698|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
126495473|NCT03970733|455114699|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
126495474|NCT03970733|455114695|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
126495475|NCT03970733|455114696|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
126495476|NCT03970733|455114697|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
126495477|NCT03970733|455114698|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
126495478|NCT03970733|455114699|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
126495479|NCT03970733|455114695|FG000|Main Study Phase (18 Months)|Other|1|||
126495480|NCT03970733|455114696|FG001|Main Study Phase (18 Months)|Other|1|||
126495481|NCT03970733|455114697|FG002|Main Study Phase (18 Months)|Other|0|||
126495482|NCT03970733|455114698|FG003|Main Study Phase (18 Months)|Other|0|||
126495483|NCT03970733|455114699|FG004|Main Study Phase (18 Months)|Other|0|||
126495484|NCT03970733|455114695|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
126495485|NCT03970733|455114696|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
126495486|NCT03970733|455114697|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
126495487|NCT03970733|455114698|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
126495488|NCT03970733|455114699|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
126495489|NCT02189473|455114703|FG000|Overall Study|Death|22|||
126495490|NCT02189473|455114704|FG001|Overall Study|Death|23|||
126495491|NCT02189473|455114703|FG000|Overall Study|Lost to Follow-up|1|||
126495492|NCT02189473|455114704|FG001|Overall Study|Lost to Follow-up|2|||
126495493|NCT01955161|455114705|FG000|Overall Study|Withdrawal before treatment|2|||
126495494|NCT01955161|455114706|FG001|Overall Study|Withdrawal before treatment|0|||
126495495|NCT01955161|455114707|FG002|Overall Study|Withdrawal before treatment|1|||
126495496|NCT01955161|455114705|FG000|Overall Study|Adverse Event|10|||
126495497|NCT01955161|455114706|FG001|Overall Study|Adverse Event|14|||
126495498|NCT01955161|455114707|FG002|Overall Study|Adverse Event|15|||
126495499|NCT01955161|455114705|FG000|Overall Study|Death|1|||
126495500|NCT01955161|455114706|FG001|Overall Study|Death|1|||
126495501|NCT01955161|455114707|FG002|Overall Study|Death|3|||
126495502|NCT01955161|455114705|FG000|Overall Study|Withdrawal by Subject|9|||
126495503|NCT01955161|455114706|FG001|Overall Study|Withdrawal by Subject|8|||
126495504|NCT01955161|455114707|FG002|Overall Study|Withdrawal by Subject|12|||
126559689|NCT00495469|455342569|FG004|Overall Study|Withdrawal by Subject|3|||
126559690|NCT00495469|455342570|FG005|Overall Study|Withdrawal by Subject|2|||
126559691|NCT00495469|455342571|FG006|Overall Study|Withdrawal by Subject|3|||
126559692|NCT00495469|455342565|FG000|Overall Study|Lack of Efficacy|0|||
126559693|NCT00495469|455342566|FG001|Overall Study|Lack of Efficacy|0|||
126559694|NCT00495469|455342567|FG002|Overall Study|Lack of Efficacy|0|||
126559695|NCT00495469|455342568|FG003|Overall Study|Lack of Efficacy|0|||
126495505|NCT01955161|455114705|FG000|Overall Study|Protocol Violation|2|||
126495506|NCT01955161|455114706|FG001|Overall Study|Protocol Violation|0|||
126495507|NCT01955161|455114707|FG002|Overall Study|Protocol Violation|0|||
126495508|NCT01955161|455114705|FG000|Overall Study|Other reason: physician decision|0|||
126495509|NCT01955161|455114706|FG001|Overall Study|Other reason: physician decision|1|||
126495510|NCT01955161|455114707|FG002|Overall Study|Other reason: physician decision|1|||
126495511|NCT01955161|455114705|FG000|Overall Study|Other reason: disallowed medication|1|||
126495512|NCT01955161|455114706|FG001|Overall Study|Other reason: disallowed medication|0|||
126495513|NCT01955161|455114707|FG002|Overall Study|Other reason: disallowed medication|1|||
126559696|NCT00495469|455342569|FG004|Overall Study|Lack of Efficacy|0|||
126495514|NCT01955161|455114705|FG000|Overall Study|Other reason: caregiver unavailable|1|||
126559697|NCT00495469|455342570|FG005|Overall Study|Lack of Efficacy|0|||
126559698|NCT00495469|455342571|FG006|Overall Study|Lack of Efficacy|1|||
126559699|NCT00495469|455342565|FG000|Overall Study|Liver function test abnormality|0|||
126495515|NCT01955161|455114706|FG001|Overall Study|Other reason: caregiver unavailable|0|||
126495516|NCT01955161|455114707|FG002|Overall Study|Other reason: caregiver unavailable|0|||
126495517|NCT01955161|455114705|FG000|Overall Study|Other reason: moved to nursing home|0|||
126495518|NCT01955161|455114706|FG001|Overall Study|Other reason: moved to nursing home|1|||
126495519|NCT01955161|455114707|FG002|Overall Study|Other reason: moved to nursing home|0|||
126772844|NCT01408576|456125273|FG000|Overall Study|Withdrawal by Subject|34|||
126772845|NCT01408576|456125274|FG001|Overall Study|Withdrawal by Subject|60|||
126772846|NCT01408576|456125275|FG002|Overall Study|Withdrawal by Subject|66|||
126772847|NCT01408576|456125273|FG000|Overall Study|Sponsor terminated study|89|||
126772848|NCT01408576|456125274|FG001|Overall Study|Sponsor terminated study|333|||
126772849|NCT01408576|456125275|FG002|Overall Study|Sponsor terminated study|330|||
126772850|NCT01408576|456125273|FG000|Overall Study|AE, serious fatal|4|||
126772851|NCT01408576|456125274|FG001|Overall Study|AE, serious fatal|4|||
126772852|NCT01408576|456125275|FG002|Overall Study|AE, serious fatal|1|||
126772853|NCT01408576|456125273|FG000|Overall Study|SAE, non-fatal|11|||
126772854|NCT01408576|456125274|FG001|Overall Study|SAE, non-fatal|23|||
126772855|NCT01408576|456125275|FG002|Overall Study|SAE, non-fatal|14|||
126772856|NCT01408576|456125273|FG000|Overall Study|AE, non-serious non-fatal|12|||
126772857|NCT01408576|456125274|FG001|Overall Study|AE, non-serious non-fatal|19|||
126772858|NCT01408576|456125275|FG002|Overall Study|AE, non-serious non-fatal|11|||
126772859|NCT01408576|456125273|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
126772860|NCT01408576|456125274|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126772861|NCT01408576|456125275|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126772862|NCT01408576|456125273|FG000|Overall Study|AE, unknown type|0|||
126772863|NCT01408576|456125274|FG001|Overall Study|AE, unknown type|1|||
126772864|NCT01408576|456125275|FG002|Overall Study|AE, unknown type|0|||
126772865|NCT01408576|456125273|FG000|Overall Study|Other|10|||
126772866|NCT01408576|456125274|FG001|Overall Study|Other|16|||
126772867|NCT01408576|456125275|FG002|Overall Study|Other|18|||
126772868|NCT01791127|456125276|FG000|Overall Study|Death|356|||
126772869|NCT01791127|456125276|FG000|Overall Study|Patient has withdrawn from study|293|||
126772870|NCT01791127|456125276|FG000|Overall Study|Lost to Follow-up|42|||
126772871|NCT01791127|456125276|FG000|Overall Study|All Siello leads are explanted|31|||
126772872|NCT01791127|456125276|FG000|Overall Study|Completion of 30 day safety registry|1|||
126772873|NCT01791127|456125276|FG000|Overall Study|Study terminated for EP Passion|749|||
126772874|NCT00520494|456125277|FG000|Overall Study|Withdrawal by Subject|1|||
126772875|NCT03471182|456125281|FG000|Overall Study|Withdrawal by Subject|1|||
126772876|NCT03471182|456125282|FG001|Overall Study|Withdrawal by Subject|1|||
126772877|NCT03471182|456125283|FG002|Overall Study|Withdrawal by Subject|0|||
126495520|NCT01955161|455114705|FG000|Overall Study|Other reason: insufficient compliance|0|||
126495521|NCT01955161|455114706|FG001|Overall Study|Other reason: insufficient compliance|0|||
126495522|NCT01955161|455114707|FG002|Overall Study|Other reason: insufficient compliance|1|||
126495523|NCT01955161|455114705|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
126495524|NCT01955161|455114706|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
126495525|NCT01955161|455114707|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
126495526|NCT01955161|455114705|FG000|Overall Study|Other reason: patient's will|0|||
126495527|NCT01955161|455114706|FG001|Overall Study|Other reason: patient's will|0|||
126495528|NCT01955161|455114707|FG002|Overall Study|Other reason: patient's will|1|||
126495529|NCT02784821|455114710|FG000|Overall Study|Death|0|||
126495530|NCT02784821|455114711|FG001|Overall Study|Death|5|||
126495531|NCT02784821|455114712|FG002|Overall Study|Death|4|||
126495532|NCT02784821|455114713|FG003|Overall Study|Death|5|||
126495533|NCT01394523|455114714|FG000|Overall Study|Unable to place block|1|||
126495534|NCT01394523|455114715|FG001|Overall Study|Unable to place block|0|||
126495535|NCT01394523|455114716|FG002|Overall Study|Unable to place block|0|||
126495536|NCT04741074|455114717|FG000|Overall Study|Withdrawal by Subject|1|||
126495537|NCT04741074|455114718|FG001|Overall Study|Withdrawal by Subject|1|||
126495538|NCT04741074|455114717|FG000|Overall Study|Study terminated prematurely|1|||
126495539|NCT04741074|455114718|FG001|Overall Study|Study terminated prematurely|0|||
126495540|NCT02432846|455114719|FG000|Overall Study (4 Arms/Strata)|Death|3|||
126495541|NCT02432846|455114720|FG001|Overall Study (4 Arms/Strata)|Death|2|||
126495542|NCT02432846|455114721|FG002|Overall Study (4 Arms/Strata)|Death|4|||
126495543|NCT02432846|455114722|FG003|Overall Study (4 Arms/Strata)|Death|3|||
126495544|NCT02432846|455114723|FG004|Overall Study (4 Arms/Strata)|Death|0|||
126495545|NCT02432846|455114724|FG005|Overall Study (4 Arms/Strata)|Death|0|||
126495546|NCT02432846|455114719|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
126495547|NCT02432846|455114720|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
126495548|NCT02432846|455114721|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
126495549|NCT02432846|455114722|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
126495550|NCT02432846|455114723|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
126772878|NCT03471182|456125281|FG000|Overall Study|Technical failure|2|||
126772879|NCT03471182|456125282|FG001|Overall Study|Technical failure|0|||
126772880|NCT03471182|456125283|FG002|Overall Study|Technical failure|0|||
126772881|NCT04440163|456125284|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
126772882|NCT04440163|456125285|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
126772883|NCT04440163|456125286|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
126772884|NCT04440163|456125287|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
126495551|NCT02432846|455114724|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
126495552|NCT02432846|455114719|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
126495553|NCT02432846|455114720|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
126495554|NCT02432846|455114721|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
126495555|NCT02432846|455114722|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
126495556|NCT02432846|455114723|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
126495557|NCT02432846|455114724|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
126495558|NCT02432846|455114719|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
126495559|NCT02432846|455114720|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
126495560|NCT02432846|455114721|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
126495561|NCT02432846|455114722|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
126495562|NCT02432846|455114723|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
126495563|NCT02432846|455114724|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
126495564|NCT02432846|455114719|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
126495565|NCT02432846|455114720|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
126495566|NCT02432846|455114721|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
126495567|NCT02432846|455114722|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
126495568|NCT02432846|455114723|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
126495569|NCT02432846|455114724|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
126495570|NCT02432846|455114719|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
126495571|NCT02432846|455114720|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
126495572|NCT02432846|455114721|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
126495573|NCT02432846|455114722|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
126495574|NCT02432846|455114723|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
126495575|NCT02432846|455114724|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
126495576|NCT02432846|455114719|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
126495577|NCT02432846|455114720|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
126495578|NCT02432846|455114721|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
126495579|NCT02432846|455114722|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
126495580|NCT02432846|455114723|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
126495581|NCT02432846|455114724|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
126495582|NCT02432846|455114719|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
126495583|NCT02432846|455114720|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
126495584|NCT02432846|455114721|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
126495585|NCT02432846|455114722|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
126495586|NCT02432846|455114723|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
126495587|NCT02432846|455114724|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
126495588|NCT02432846|455114719|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
126495589|NCT02432846|455114720|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
126495590|NCT02432846|455114721|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
126495591|NCT02432846|455114722|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
126495592|NCT02432846|455114723|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
126495593|NCT02432846|455114724|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
126495594|NCT02432846|455114719|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
126495595|NCT02432846|455114720|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
126495596|NCT02432846|455114721|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
126495597|NCT02432846|455114722|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
126495598|NCT02432846|455114723|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
126495599|NCT02432846|455114724|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
126495600|NCT02432846|455114719|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
126495601|NCT02432846|455114720|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
126495602|NCT02432846|455114721|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
126495603|NCT02432846|455114722|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
126495604|NCT02432846|455114723|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
126495605|NCT02432846|455114724|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
126495606|NCT02432846|455114719|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
126495607|NCT02432846|455114720|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
126495608|NCT02432846|455114721|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
126495609|NCT02432846|455114722|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
126495610|NCT02432846|455114723|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
126495611|NCT02432846|455114724|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
126495612|NCT02432846|455114719|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
126495613|NCT02432846|455114720|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
126495614|NCT02432846|455114721|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
126495615|NCT02432846|455114722|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
126495616|NCT02432846|455114723|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
126495617|NCT02432846|455114724|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
126495618|NCT02432846|455114719|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
126495619|NCT02432846|455114720|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
126495620|NCT02432846|455114721|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
126495621|NCT02432846|455114722|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
126495622|NCT02432846|455114723|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
126495623|NCT02432846|455114724|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
126495624|NCT01770379|455114725|FG000|Overall Study|Technical issues|1|||
126495625|NCT01770379|455114726|FG001|Overall Study|Technical issues|0|||
126495626|NCT01770379|455114727|FG002|Overall Study|Technical issues|0|||
126495627|NCT01770379|455114725|FG000|Overall Study|Withdrawal by Subject|7|||
126495628|NCT01770379|455114726|FG001|Overall Study|Withdrawal by Subject|10|||
126495629|NCT01770379|455114727|FG002|Overall Study|Withdrawal by Subject|7|||
126495630|NCT01770379|455114725|FG000|Overall Study|study terminated by sponsor|22|||
126495631|NCT01770379|455114726|FG001|Overall Study|study terminated by sponsor|23|||
126495632|NCT01770379|455114727|FG002|Overall Study|study terminated by sponsor|22|||
126495633|NCT01770379|455114725|FG000|Overall Study|Protocol Violation|0|||
126495634|NCT01770379|455114726|FG001|Overall Study|Protocol Violation|1|||
126495635|NCT01770379|455114727|FG002|Overall Study|Protocol Violation|1|||
126495636|NCT01770379|455114725|FG000|Overall Study|Physician Decision|0|||
126495637|NCT01770379|455114726|FG001|Overall Study|Physician Decision|1|||
126495638|NCT01770379|455114727|FG002|Overall Study|Physician Decision|2|||
126495639|NCT01770379|455114725|FG000|Overall Study|Lost to Follow-up|0|||
126495640|NCT01770379|455114726|FG001|Overall Study|Lost to Follow-up|0|||
126495641|NCT01770379|455114727|FG002|Overall Study|Lost to Follow-up|2|||
126495642|NCT01770379|455114725|FG000|Overall Study|Lack of Efficacy|8|||
126772885|NCT04440163|456125288|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
126772886|NCT04440163|456125289|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
126772887|NCT04440163|456125290|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
126772888|NCT04440163|456125291|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
126772889|NCT04440163|456125284|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
126495643|NCT01770379|455114726|FG001|Overall Study|Lack of Efficacy|6|||
126495644|NCT01770379|455114727|FG002|Overall Study|Lack of Efficacy|6|||
126495645|NCT01770379|455114725|FG000|Overall Study|Adverse Event|1|||
126495646|NCT01770379|455114726|FG001|Overall Study|Adverse Event|3|||
126495647|NCT01770379|455114727|FG002|Overall Study|Adverse Event|2|||
126495648|NCT01912287|455114729|FG000|Overall Study|Ineligible|1|||
126495649|NCT01912287|455114730|FG001|Overall Study|Ineligible|0|||
126495650|NCT01912287|455114731|FG002|Overall Study|Ineligible|1|||
126495651|NCT01912287|455114729|FG000|Overall Study|No-show|0|||
126495652|NCT01912287|455114730|FG001|Overall Study|No-show|0|||
126495653|NCT01912287|455114731|FG002|Overall Study|No-show|1|||
126495654|NCT01912287|455114729|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
126495655|NCT01912287|455114730|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
126495656|NCT01912287|455114731|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
126495657|NCT01912287|455114729|FG000|Overall Study|Felt treatment no longer needed|0|||
126495658|NCT01912287|455114730|FG001|Overall Study|Felt treatment no longer needed|1|||
126495659|NCT01912287|455114731|FG002|Overall Study|Felt treatment no longer needed|0|||
126495660|NCT01912287|455114729|FG000|Overall Study|Life circumstances|4|||
126559700|NCT00495469|455342566|FG001|Overall Study|Liver function test abnormality|1|||
126559701|NCT00495469|455342567|FG002|Overall Study|Liver function test abnormality|0|||
126559702|NCT00495469|455342568|FG003|Overall Study|Liver function test abnormality|0|||
126559703|NCT00495469|455342569|FG004|Overall Study|Liver function test abnormality|0|||
126559704|NCT00495469|455342570|FG005|Overall Study|Liver function test abnormality|0|||
126559705|NCT00495469|455342571|FG006|Overall Study|Liver function test abnormality|0|||
126559706|NCT00495469|455342565|FG000|Overall Study|ST depression at randomisation in ECG|0|||
126559707|NCT00495469|455342566|FG001|Overall Study|ST depression at randomisation in ECG|1|||
126559708|NCT00495469|455342567|FG002|Overall Study|ST depression at randomisation in ECG|0|||
126559709|NCT00495469|455342568|FG003|Overall Study|ST depression at randomisation in ECG|0|||
126559710|NCT00495469|455342569|FG004|Overall Study|ST depression at randomisation in ECG|0|||
126559711|NCT00495469|455342570|FG005|Overall Study|ST depression at randomisation in ECG|0|||
126559712|NCT00495469|455342571|FG006|Overall Study|ST depression at randomisation in ECG|0|||
126495661|NCT01912287|455114730|FG001|Overall Study|Life circumstances|2|||
126559713|NCT04531540|455342576|FG000|Overall Study|Adverse Event|1|||
126495662|NCT01912287|455114731|FG002|Overall Study|Life circumstances|0|||
126495663|NCT01912287|455114729|FG000|Overall Study|Lost Interest|1|||
126495664|NCT01912287|455114730|FG001|Overall Study|Lost Interest|0|||
126495665|NCT01912287|455114731|FG002|Overall Study|Lost Interest|0|||
126495666|NCT01912287|455114729|FG000|Overall Study|Uknown reason - subject drop out|5|||
126495667|NCT01912287|455114730|FG001|Overall Study|Uknown reason - subject drop out|7|||
126559714|NCT04531540|455342576|FG000|Overall Study|Protocol Violation|3|||
126559715|NCT04531540|455342576|FG000|Overall Study|Withdrawal by Subject|4|||
126495668|NCT01912287|455114731|FG002|Overall Study|Uknown reason - subject drop out|3|||
126495669|NCT01912287|455114729|FG000|Overall Study|Missed Assesment|1|||
126495670|NCT01912287|455114730|FG001|Overall Study|Missed Assesment|1|||
126495671|NCT01912287|455114731|FG002|Overall Study|Missed Assesment|1|||
126495672|NCT01912287|455114729|FG000|Overall Study|Scheduling/change in availability|17|||
126495673|NCT01912287|455114730|FG001|Overall Study|Scheduling/change in availability|10|||
126495674|NCT01912287|455114731|FG002|Overall Study|Scheduling/change in availability|8|||
126495675|NCT03914326|455114734|FG000|Overall Study|Withdrawal by Subject|27|||
126495676|NCT03914326|455114735|FG001|Overall Study|Withdrawal by Subject|34|||
126495677|NCT03914326|455114734|FG000|Overall Study|Lost to Follow-up|43|||
126495678|NCT03914326|455114735|FG001|Overall Study|Lost to Follow-up|51|||
126495679|NCT03914326|455114734|FG000|Overall Study|Randomised more than once|0|||
126495680|NCT03914326|455114735|FG001|Overall Study|Randomised more than once|1|||
126495681|NCT02357901|455114740|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
126495682|NCT02357901|455114741|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
126495683|NCT02357901|455114742|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
126495684|NCT02357901|455114743|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
126495685|NCT02357901|455114740|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
126495686|NCT02357901|455114741|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
126495687|NCT02357901|455114742|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
126495688|NCT02357901|455114743|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
126495689|NCT02357901|455114740|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
126495690|NCT02357901|455114741|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
126495691|NCT02357901|455114742|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
126495692|NCT02357901|455114743|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
126495693|NCT02357901|455114740|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
126495694|NCT02357901|455114741|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
126495695|NCT02357901|455114742|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
126495696|NCT02357901|455114743|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
126495697|NCT02357901|455114740|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
126495698|NCT02357901|455114741|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
126495699|NCT02357901|455114742|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
126495700|NCT02357901|455114743|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
126495701|NCT02357901|455114740|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
126495702|NCT02357901|455114741|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
126495703|NCT02357901|455114742|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
126495704|NCT02357901|455114743|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
126495705|NCT02357901|455114740|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
126495706|NCT02357901|455114741|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
126495707|NCT02357901|455114742|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
126495708|NCT02357901|455114743|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
126495709|NCT02357901|455114740|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
126495710|NCT02357901|455114741|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
126495711|NCT02357901|455114742|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
126495712|NCT02357901|455114743|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
126495713|NCT02357901|455114740|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
126495714|NCT02357901|455114741|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
126495715|NCT02357901|455114742|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
126495716|NCT02357901|455114743|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
126495717|NCT02357901|455114740|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
126495718|NCT02357901|455114741|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
126495719|NCT02357901|455114742|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
126495720|NCT02357901|455114743|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
126495721|NCT02357901|455114740|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
126495722|NCT02357901|455114741|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
126495723|NCT02357901|455114742|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
126495724|NCT02357901|455114743|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
126495725|NCT04788953|455114744|FG000|Overall Study|Adverse Event|1|||
126495726|NCT04788953|455114745|FG001|Overall Study|Adverse Event|1|||
126495727|NCT04788953|455114744|FG000|Overall Study|Withdrawal by Subject|1|||
126495728|NCT04788953|455114745|FG001|Overall Study|Withdrawal by Subject|0|||
126495729|NCT04788953|455114744|FG000|Overall Study|Protocol Violation|0|||
126495730|NCT04788953|455114745|FG001|Overall Study|Protocol Violation|1|||
126495731|NCT00491387|455114746|FG000|Overall Study|study terminated|20|||
126495732|NCT02150954|455114749|FG000|Overall Study|Protocol Violation|1|||
126495733|NCT02150954|455114750|FG001|Overall Study|Protocol Violation|0|||
126495734|NCT03814746|455114751|FG000|Overall Study|Participant decision|9|||
126495735|NCT03814746|455114752|FG001|Overall Study|Participant decision|6|||
126495736|NCT03814746|455114753|FG002|Overall Study|Participant decision|15|||
126495737|NCT03814746|455114751|FG000|Overall Study|Physician Decision|2|||
126495738|NCT03814746|455114752|FG001|Overall Study|Physician Decision|2|||
126495739|NCT03814746|455114753|FG002|Overall Study|Physician Decision|4|||
126495740|NCT03814746|455114751|FG000|Overall Study|Death|2|||
126495741|NCT03814746|455114752|FG001|Overall Study|Death|2|||
126495742|NCT03814746|455114753|FG002|Overall Study|Death|2|||
126495743|NCT03814746|455114751|FG000|Overall Study|Adverse Event|2|||
126495744|NCT03814746|455114752|FG001|Overall Study|Adverse Event|2|||
126495745|NCT03814746|455114753|FG002|Overall Study|Adverse Event|1|||
126495746|NCT03814746|455114751|FG000|Overall Study|Lost to Follow-up|2|||
126495747|NCT03814746|455114752|FG001|Overall Study|Lost to Follow-up|1|||
126495748|NCT03814746|455114753|FG002|Overall Study|Lost to Follow-up|2|||
126495749|NCT03814746|455114751|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126495750|NCT03814746|455114752|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126495751|NCT03814746|455114753|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126495752|NCT03814746|455114751|FG000|Overall Study|Pregnancy|0|||
126495753|NCT03814746|455114752|FG001|Overall Study|Pregnancy|1|||
126495754|NCT03814746|455114753|FG002|Overall Study|Pregnancy|1|||
126495755|NCT03814746|455114751|FG000|Overall Study|Protocol Violation|1|||
126495756|NCT03814746|455114752|FG001|Overall Study|Protocol Violation|0|||
126495757|NCT03814746|455114753|FG002|Overall Study|Protocol Violation|0|||
126495758|NCT02278263|455114755|FG000|Overall Study|Protocol Violation|7|||
126495759|NCT02278263|455114756|FG001|Overall Study|Protocol Violation|0|||
126495760|NCT02278263|455114757|FG002|Overall Study|Protocol Violation|9|||
126495761|NCT03997383|455114758|FG000|Double-blind Treatment Period|Adverse Event|4|||
126495762|NCT03997383|455114759|FG001|Double-blind Treatment Period|Adverse Event|3|||
126495763|NCT03997383|455114758|FG000|Double-blind Treatment Period|Death|4|||
126495764|NCT03997383|455114759|FG001|Double-blind Treatment Period|Death|4|||
126495765|NCT03997383|455114758|FG000|Double-blind Treatment Period|Physician Decision|2|||
126495766|NCT03997383|455114759|FG001|Double-blind Treatment Period|Physician Decision|0|||
126495767|NCT03997383|455114758|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
126495768|NCT03997383|455114759|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
126495769|NCT03997383|455114758|FG000|Open-label Extension Period|Ongoing|148|||
126495770|NCT03997383|455114759|FG001|Open-label Extension Period|Ongoing|151|||
126495771|NCT03997383|455114758|FG000|Open-label Extension Period|Adverse Event|4|||
126495772|NCT03997383|455114759|FG001|Open-label Extension Period|Adverse Event|1|||
126495773|NCT03997383|455114758|FG000|Open-label Extension Period|Death|8|||
126495774|NCT03997383|455114759|FG001|Open-label Extension Period|Death|9|||
126495775|NCT03997383|455114758|FG000|Open-label Extension Period|Physician Decision|1|||
126495776|NCT03997383|455114759|FG001|Open-label Extension Period|Physician Decision|1|||
126495777|NCT03997383|455114758|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
126495778|NCT03997383|455114759|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
126495779|NCT03997383|455114758|FG000|Open-label Extension Period|Reason Not Specified|2|||
126495780|NCT03997383|455114759|FG001|Open-label Extension Period|Reason Not Specified|0|||
126495781|NCT03880019|455114760|FG000|Overall Study|Competing disease|1|||
126495782|NCT00326950|455114761|FG000|Overall Study|Progressive Disease|1|||
126495783|NCT05811234|455114767|FG000|Overall Study|Loss of Effectiveness|2|||
126495784|NCT05811234|455114767|FG000|Overall Study|Adverse Event|4|||
126495785|NCT05811234|455114767|FG000|Overall Study|Pregnancy|1|||
126495786|NCT05811234|455114767|FG000|Overall Study|Disease progression|1|||
126495787|NCT05811234|455114767|FG000|Overall Study|Withdrawal by Subject|4|||
126495788|NCT05811234|455114767|FG000|Overall Study|Lost to Follow-up|13|||
126495789|NCT05811234|455114767|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
126495790|NCT04499781|455114768|FG000|Overall Study|Lost to Follow-up|2|||
126495791|NCT04499781|455114769|FG001|Overall Study|Lost to Follow-up|3|||
126495792|NCT04499781|455114768|FG000|Overall Study|Withdrawal by Subject|2|||
126495793|NCT04499781|455114769|FG001|Overall Study|Withdrawal by Subject|0|||
126495794|NCT00227305|455114772|FG000|Overall Study|Adverse Event|40|||
126495795|NCT00227305|455114772|FG000|Overall Study|Withdrawal by Subject|42|||
126495796|NCT00227305|455114772|FG000|Overall Study|Lost to Follow-up|33|||
126495797|NCT00227305|455114772|FG000|Overall Study|Study specific discontinuation|13|||
126495798|NCT00227305|455114772|FG000|Overall Study|MOVED OUT OF AREA|3|||
126495799|NCT00227305|455114772|FG000|Overall Study|Lack of Efficacy|7|||
126495800|NCT00227305|455114772|FG000|Overall Study|Physician Decision|3|||
126495801|NCT00227305|455114772|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
126495802|NCT00227305|455114772|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
126495803|NCT00227305|455114772|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
126495804|NCT04103892|455114777|FG000|Overall Study|Adverse Event|0|||
126495805|NCT04103892|455114778|FG001|Overall Study|Adverse Event|0|||
126495806|NCT04103892|455114779|FG002|Overall Study|Adverse Event|0|||
126495807|NCT04103892|455114780|FG003|Overall Study|Adverse Event|3|||
126495808|NCT04103892|455114777|FG000|Overall Study|Lost to Follow-up|0|||
126495809|NCT04103892|455114778|FG001|Overall Study|Lost to Follow-up|0|||
126495810|NCT04103892|455114779|FG002|Overall Study|Lost to Follow-up|2|||
126495811|NCT04103892|455114780|FG003|Overall Study|Lost to Follow-up|0|||
126495812|NCT04103892|455114777|FG000|Overall Study|Protocol Violation|0|||
126495813|NCT04103892|455114778|FG001|Overall Study|Protocol Violation|0|||
126495814|NCT04103892|455114779|FG002|Overall Study|Protocol Violation|1|||
126495815|NCT04103892|455114780|FG003|Overall Study|Protocol Violation|1|||
126495816|NCT04103892|455114777|FG000|Overall Study|Withdrawal by Subject|1|||
126495817|NCT04103892|455114778|FG001|Overall Study|Withdrawal by Subject|0|||
126495818|NCT04103892|455114779|FG002|Overall Study|Withdrawal by Subject|2|||
126495819|NCT04103892|455114780|FG003|Overall Study|Withdrawal by Subject|5|||
126495820|NCT04103892|455114777|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
126495821|NCT04103892|455114778|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
126495822|NCT04103892|455114779|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
126495823|NCT04103892|455114780|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
126495824|NCT03051607|455114787|FG000|Overall Study|Adverse Event|66|||
126495825|NCT03341533|455114788|FG000|Overall Study|Withdrawal by Subject|1|||
126495826|NCT03341533|455114789|FG001|Overall Study|Withdrawal by Subject|1|||
126495827|NCT03341533|455114788|FG000|Overall Study|Not eligible after randomization|2|||
126495828|NCT03341533|455114789|FG001|Overall Study|Not eligible after randomization|1|||
126495829|NCT01603459|455114799|FG000|Overall Study|Adverse Event|5|||
126495830|NCT01603459|455114799|FG000|Overall Study|Withdrawal by Subject|5|||
126495831|NCT01603459|455114799|FG000|Overall Study|Lost to Follow-up|3|||
126495832|NCT01603459|455114799|FG000|Overall Study|Predefined discontinuation criteria|3|||
126495833|NCT01603459|455114799|FG000|Overall Study|Non-compliance|1|||
126495834|NCT01603459|455114799|FG000|Overall Study|Administrative reason|1|||
126495835|NCT00399360|455114801|FG000|Overall Study|Lost to Follow-up|2|||
126495836|NCT00399360|455114802|FG001|Overall Study|Lost to Follow-up|1|||
126495837|NCT00399360|455114803|FG002|Overall Study|Lost to Follow-up|2|||
126495838|NCT00399360|455114804|FG003|Overall Study|Lost to Follow-up|4|||
126495839|NCT00399360|455114801|FG000|Overall Study|Adverse Event|0|||
126495840|NCT00399360|455114802|FG001|Overall Study|Adverse Event|0|||
126495841|NCT00399360|455114803|FG002|Overall Study|Adverse Event|1|||
126495842|NCT00399360|455114804|FG003|Overall Study|Adverse Event|0|||
126495843|NCT00399360|455114801|FG000|Overall Study|Withdrawal by Subject|0|||
126495844|NCT00399360|455114802|FG001|Overall Study|Withdrawal by Subject|2|||
126495845|NCT00399360|455114803|FG002|Overall Study|Withdrawal by Subject|0|||
126495846|NCT00399360|455114804|FG003|Overall Study|Withdrawal by Subject|2|||
126495847|NCT01412021|455114805|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
126495848|NCT01412021|455114805|FG000|Overall Study|Treatment Prior to Approval|3|||
126495849|NCT01412021|455114805|FG000|Overall Study|Transferred to Other Hospital|9|||
126495850|NCT01166178|455114806|FG000|Overall Study|Withdrawal by Subject|1|||
126495851|NCT01166178|455114807|FG001|Overall Study|Withdrawal by Subject|0|||
126495852|NCT01166178|455114806|FG000|Overall Study|Study was terminated|20|||
126495853|NCT01166178|455114807|FG001|Overall Study|Study was terminated|8|||
126495854|NCT03658538|455114813|FG000|Overall Study|Death|2|||
126495855|NCT03658538|455114814|FG001|Overall Study|Death|1|||
126495856|NCT03658538|455114813|FG000|Overall Study|Cancer diagnosis|1|||
126495857|NCT03658538|455114814|FG001|Overall Study|Cancer diagnosis|0|||
126495858|NCT03658538|455114813|FG000|Overall Study|Change residence|1|||
126495859|NCT03658538|455114814|FG001|Overall Study|Change residence|2|||
126495860|NCT03658538|455114813|FG000|Overall Study|Lost to Follow-up|3|||
126495861|NCT03658538|455114814|FG001|Overall Study|Lost to Follow-up|3|||
126495862|NCT03658538|455114813|FG000|Overall Study|Unblinded|2|||
126495863|NCT03658538|455114814|FG001|Overall Study|Unblinded|3|||
126495864|NCT03658538|455114813|FG000|Overall Study|Physician Decision|0|||
126495865|NCT03658538|455114814|FG001|Overall Study|Physician Decision|1|||
126495866|NCT03658538|455114813|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
126495867|NCT03658538|455114814|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
126772890|NCT04440163|456125285|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
126772891|NCT04440163|456125286|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
126772892|NCT04440163|456125287|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
126772893|NCT04440163|456125288|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
126772894|NCT04440163|456125289|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
126495868|NCT03658538|455114813|FG000|Overall Study|Evicted from home|1|||
126495869|NCT03658538|455114814|FG001|Overall Study|Evicted from home|0|||
126495870|NCT04537234|455114818|FG000|Overall Study|Withdrawal by Subject|2|||
126495871|NCT04537234|455114819|FG001|Overall Study|Withdrawal by Subject|0|||
126495872|NCT07114198|455114822|FG000|Overall Study|Protocol Violation|1|||
126495873|NCT07114198|455114823|FG001|Overall Study|Protocol Violation|1|||
126495874|NCT01721330|455114824|FG000|Overall Study|Withdrawal by Subject|0|||
126495875|NCT01721330|455114825|FG001|Overall Study|Withdrawal by Subject|1|||
126495876|NCT05608005|455116284|FG000|Overall Study|Adverse Event|2|||
126495877|NCT05608005|455116285|FG001|Overall Study|Adverse Event|1|||
126495878|NCT05608005|455116286|FG002|Overall Study|Adverse Event|3|||
126495879|NCT05608005|455116284|FG000|Overall Study|Protocol Violation|2|||
126495880|NCT05608005|455116285|FG001|Overall Study|Protocol Violation|3|||
126495881|NCT05608005|455116286|FG002|Overall Study|Protocol Violation|0|||
126495882|NCT05608005|455116284|FG000|Overall Study|Withdrawal by Subject|10|||
126495883|NCT05608005|455116285|FG001|Overall Study|Withdrawal by Subject|12|||
126495884|NCT05608005|455116286|FG002|Overall Study|Withdrawal by Subject|4|||
126559716|NCT04531540|455342576|FG000|Overall Study|Found to be Ineligible|1|||
126723866|NCT01106625|455938745|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
126495885|NCT05608005|455116284|FG000|Overall Study|Lost to Follow-up|25|||
126495886|NCT05608005|455116285|FG001|Overall Study|Lost to Follow-up|27|||
126495887|NCT05608005|455116286|FG002|Overall Study|Lost to Follow-up|15|||
126495888|NCT05608005|455116284|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
126495889|NCT05608005|455116285|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
126495890|NCT05608005|455116286|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
126495891|NCT01277523|455116287|FG000|Overall Study|Adverse Event|1|||
126495892|NCT01277523|455116288|FG001|Overall Study|Adverse Event|0|||
126495893|NCT01277523|455116289|FG002|Overall Study|Adverse Event|0|||
126495894|NCT01277523|455116287|FG000|Overall Study|Protocol Violation|2|||
126495895|NCT01277523|455116288|FG001|Overall Study|Protocol Violation|0|||
126495896|NCT01277523|455116289|FG002|Overall Study|Protocol Violation|0|||
126495897|NCT01277523|455116287|FG000|Overall Study|Other Reason not Defined|0|||
126495898|NCT01277523|455116288|FG001|Overall Study|Other Reason not Defined|1|||
126495899|NCT01277523|455116289|FG002|Overall Study|Other Reason not Defined|0|||
126495900|NCT01030523|455116290|FG000|Initial Study (5 Years)|Death|1|||
126495901|NCT01030523|455116291|FG001|Initial Study (5 Years)|Death|0|||
126495902|NCT01030523|455116290|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
126495903|NCT01030523|455116291|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
126495904|NCT01030523|455116290|FG000|Initial Study (5 Years)|Implant failure|1|||
126495905|NCT01030523|455116291|FG001|Initial Study (5 Years)|Implant failure|0|||
126495906|NCT01030523|455116290|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
126495907|NCT01030523|455116291|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
126495908|NCT01030523|455116290|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
126495909|NCT01030523|455116291|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
126495910|NCT01030523|455116290|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
126495911|NCT01030523|455116291|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
126495912|NCT01859494|455116296|FG000|Overall Study|Adverse Event|1|||
126495913|NCT02389998|455116299|FG000|Overall Study|car accident|1|||
126495914|NCT02389998|455116300|FG001|Overall Study|car accident|0|||
126495915|NCT02769247|455116306|FG000|Overall Study|Withdrawal by Subject|1|||
126495916|NCT02769247|455116307|FG001|Overall Study|Withdrawal by Subject|0|||
126495917|NCT02769247|455116308|FG002|Overall Study|Withdrawal by Subject|0|||
126495918|NCT02769247|455116309|FG003|Overall Study|Withdrawal by Subject|1|||
126495919|NCT02769247|455116306|FG000|Overall Study|Protocol Violation|0|||
126495920|NCT02769247|455116307|FG001|Overall Study|Protocol Violation|0|||
126495921|NCT02769247|455116308|FG002|Overall Study|Protocol Violation|1|||
126495922|NCT02769247|455116309|FG003|Overall Study|Protocol Violation|0|||
126495923|NCT02769247|455116306|FG000|Overall Study|Physician Decision|1|||
126495924|NCT02769247|455116307|FG001|Overall Study|Physician Decision|0|||
126495925|NCT02769247|455116308|FG002|Overall Study|Physician Decision|0|||
126495926|NCT02769247|455116309|FG003|Overall Study|Physician Decision|0|||
126495927|NCT05089682|455116314|FG000|Overall Study|Withdrawal by Subject|2|||
126495928|NCT01996826|455116317|FG000|Overall Study|Lost to Follow-up|6|||
126495929|NCT01996826|455116318|FG001|Overall Study|Lost to Follow-up|2|||
126495930|NCT01996826|455116317|FG000|Overall Study|Physician Decision|1|||
126495931|NCT01996826|455116318|FG001|Overall Study|Physician Decision|1|||
126495932|NCT01266460|455116325|FG000|Overall Study|Adverse Event|3|||
126495933|NCT01266460|455116325|FG000|Overall Study|Withdrawal by Subject|5|||
126495934|NCT01266460|455116325|FG000|Overall Study|Disease Progression|18|||
126495935|NCT01266460|455116325|FG000|Overall Study|Not otherwise specified|8|||
126495936|NCT01132547|455116326|FG000|Overall Study|Withdrawal by Subject|3|||
126495937|NCT01132547|455116327|FG001|Overall Study|Withdrawal by Subject|1|||
126495938|NCT01132547|455116326|FG000|Overall Study|Death|1|||
126495939|NCT01132547|455116327|FG001|Overall Study|Death|0|||
126495940|NCT00483379|455116330|FG000|Treatment Period|Adverse Event|1|||
126495941|NCT00483379|455116331|FG001|Treatment Period|Adverse Event|0|||
126495942|NCT00483379|455116330|FG000|Treatment Period|Withdrawal by Subject|1|||
126495943|NCT00483379|455116331|FG001|Treatment Period|Withdrawal by Subject|0|||
126495944|NCT02809677|455116332|FG000|Overall Study|Withdrawal by Subject|8|||
126723867|NCT01106625|455938746|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
126723868|NCT01106625|455938744|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
126723869|NCT01106625|455938745|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
126723870|NCT01106625|455938746|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
126723871|NCT01106625|455938744|FG000|Extension Period: Week 26 to Week 52|Other|5|||
126723872|NCT01106625|455938745|FG001|Extension Period: Week 26 to Week 52|Other|5|||
126723873|NCT01106625|455938746|FG002|Extension Period: Week 26 to Week 52|Other|4|||
126495945|NCT04969224|455116333|FG000|Overall Study|Adverse Event|1|||
126495946|NCT04969224|455116333|FG000|Overall Study|Enrolled but never dosed|1|||
126495947|NCT03165110|455116334|FG000|Overall Study|Anroid phone software incompatibility|1|||
126559717|NCT01575860|455342579|FG000|Overall Study|Withdrawal by Subject|1|||
126559718|NCT01575860|455342579|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
126495948|NCT05533632|455116335|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
126495949|NCT05533632|455116335|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
126495950|NCT05533632|455116335|FG000|Overall Study|Lost to Follow-up|1|||
126495951|NCT05533632|455116335|FG000|Overall Study|Withdrawal by Subject|4|||
126495952|NCT05533632|455116335|FG000|Overall Study|Adverse Event|4|||
126495953|NCT04327388|455116338|FG000|Overall Study|Adverse Event|17|||
126495954|NCT04327388|455116339|FG001|Overall Study|Adverse Event|18|||
126495955|NCT04327388|455116340|FG002|Overall Study|Adverse Event|9|||
126495956|NCT04327388|455116338|FG000|Overall Study|Other|1|||
126495957|NCT04327388|455116339|FG001|Overall Study|Other|2|||
126495958|NCT04327388|455116340|FG002|Overall Study|Other|0|||
126495959|NCT04327388|455116338|FG000|Overall Study|Randomized and not treated|2|||
126495960|NCT04327388|455116339|FG001|Overall Study|Randomized and not treated|0|||
126495961|NCT04327388|455116340|FG002|Overall Study|Randomized and not treated|2|||
126495962|NCT04340362|455116343|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
126495963|NCT01675128|455116346|FG000|Overall Study|Disease progression on study|1|||
126495964|NCT01675128|455116347|FG001|Overall Study|Disease progression on study|1|||
126495965|NCT01675128|455116348|FG002|Overall Study|Disease progression on study|1|||
126495966|NCT01675128|455116346|FG000|Overall Study|Refused further treatment|1|||
126495967|NCT01675128|455116347|FG001|Overall Study|Refused further treatment|0|||
126495968|NCT01675128|455116348|FG002|Overall Study|Refused further treatment|0|||
126495969|NCT01675128|455116346|FG000|Overall Study|Pulmonary complication; off study|0|||
126495970|NCT01675128|455116347|FG001|Overall Study|Pulmonary complication; off study|1|||
126495971|NCT01675128|455116348|FG002|Overall Study|Pulmonary complication; off study|0|||
126495972|NCT00529542|455116349|FG000|Overall Study|Withdrawal by Subject|1|||
126495973|NCT00529542|455116350|FG001|Overall Study|Withdrawal by Subject|0|||
126495974|NCT00529542|455116349|FG000|Overall Study|Lost to Follow-up|0|||
126495975|NCT00529542|455116350|FG001|Overall Study|Lost to Follow-up|1|||
126495976|NCT05104567|455116352|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
126495977|NCT05104567|455116353|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
126495978|NCT05104567|455116354|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
126495979|NCT05104567|455116355|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
126495980|NCT05104567|455116356|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
126495981|NCT05104567|455116357|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
126495982|NCT05104567|455116358|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
126495983|NCT05104567|455116352|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
126495984|NCT05104567|455116353|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
126495985|NCT05104567|455116354|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
126495986|NCT05104567|455116355|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
126495987|NCT05104567|455116356|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
126495988|NCT05104567|455116357|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
126495989|NCT05104567|455116358|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
126495990|NCT05104567|455116352|FG000|Overall Study|Progressive disease|3|||
126495991|NCT05104567|455116353|FG001|Overall Study|Progressive disease|13|||
126495992|NCT05104567|455116354|FG002|Overall Study|Progressive disease|13|||
126559719|NCT00180674|455342581|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
126559720|NCT00180674|455342581|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
126559721|NCT01106976|455342582|FG000|Overall Study|Lost to Follow-up|8|||
126559722|NCT02956967|455342584|FG000|Overall Study|Adverse Event|3|||
126559723|NCT02956967|455342584|FG000|Overall Study|Reason non-related to neutropenia|10|||
126559724|NCT02956967|455342584|FG000|Overall Study|Lost to Follow-up|5|||
126559725|NCT02956967|455342584|FG000|Overall Study|Missing|1|||
126559726|NCT02956967|455342584|FG000|Overall Study|Termination of Nivestim administration|29|||
126559727|NCT01823341|455342585|FG000|Overall Study|Failed run-in|7|||
126559728|NCT01823341|455342585|FG000|Overall Study|Withdrawal by Subject|7|||
126559729|NCT01823341|455342585|FG000|Overall Study|Adverse Event|1|||
126559730|NCT00924560|455342586|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
126559731|NCT00924560|455342587|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
126495993|NCT05104567|455116355|FG003|Overall Study|Progressive disease|17|||
126495994|NCT05104567|455116356|FG004|Overall Study|Progressive disease|17|||
126495995|NCT05104567|455116357|FG005|Overall Study|Progressive disease|28|||
126495996|NCT05104567|455116358|FG006|Overall Study|Progressive disease|24|||
126495997|NCT05104567|455116352|FG000|Overall Study|Withdrawal by Subject|1|||
126723874|NCT01088438|455938755|FG000|Overall Study|Withdrawal by Subject|11|||
126495998|NCT05104567|455116353|FG001|Overall Study|Withdrawal by Subject|1|||
126559732|NCT00924560|455342588|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
126559733|NCT00924560|455342586|FG000|Overall Study|Non Compliance with the Protocol|20|||
126559734|NCT00924560|455342587|FG001|Overall Study|Non Compliance with the Protocol|15|||
126559735|NCT00924560|455342588|FG002|Overall Study|Non Compliance with the Protocol|4|||
126723875|NCT01088438|455938756|FG001|Overall Study|Withdrawal by Subject|6|||
126495999|NCT05104567|455116354|FG002|Overall Study|Withdrawal by Subject|2|||
126496000|NCT05104567|455116355|FG003|Overall Study|Withdrawal by Subject|0|||
126496001|NCT05104567|455116356|FG004|Overall Study|Withdrawal by Subject|0|||
126496002|NCT05104567|455116357|FG005|Overall Study|Withdrawal by Subject|0|||
126496003|NCT05104567|455116358|FG006|Overall Study|Withdrawal by Subject|0|||
126496004|NCT05104567|455116352|FG000|Overall Study|Other|1|||
126496005|NCT05104567|455116353|FG001|Overall Study|Other|1|||
126496006|NCT05104567|455116354|FG002|Overall Study|Other|1|||
126496007|NCT05104567|455116355|FG003|Overall Study|Other|0|||
126496008|NCT05104567|455116356|FG004|Overall Study|Other|0|||
126496009|NCT05104567|455116357|FG005|Overall Study|Other|0|||
126496010|NCT05104567|455116358|FG006|Overall Study|Other|0|||
126496011|NCT05778786|455116366|FG000|Period 1|COVID-19 Related|3|||
126496012|NCT05778786|455116367|FG001|Period 1|COVID-19 Related|3|||
126496013|NCT05778786|455116366|FG000|Period 1|Withdrew Consent during Study|1|||
126496014|NCT05778786|455116367|FG001|Period 1|Withdrew Consent during Study|0|||
126496015|NCT05778786|455116366|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
126496016|NCT05778786|455116367|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
126496017|NCT05778786|455116366|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
126496018|NCT05778786|455116367|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
126496019|NCT02446990|455116368|FG000|Overall Study|Death|485|||
126496020|NCT02446990|455116369|FG001|Overall Study|Death|458|||
126496021|NCT02446990|455116368|FG000|Overall Study|Lost to Follow-up|3|||
126496022|NCT02446990|455116369|FG001|Overall Study|Lost to Follow-up|1|||
126496023|NCT02446990|455116368|FG000|Overall Study|Physician Decision|1|||
126496024|NCT02446990|455116369|FG001|Overall Study|Physician Decision|0|||
126496025|NCT02446990|455116368|FG000|Overall Study|Withdrawal by Subject|231|||
126496026|NCT02446990|455116369|FG001|Overall Study|Withdrawal by Subject|199|||
126723876|NCT01088438|455938755|FG000|Overall Study|Lost to Follow-up|18|||
126723877|NCT01088438|455938756|FG001|Overall Study|Lost to Follow-up|30|||
126723878|NCT00511342|455938757|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
126723879|NCT00511342|455938758|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
126723880|NCT00511342|455938757|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
126723881|NCT00511342|455938758|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
126723882|NCT00511342|455938757|FG000|Overall Study|Pregnancy|0|||
126723883|NCT00511342|455938758|FG001|Overall Study|Pregnancy|1|||
126723884|NCT00511342|455938757|FG000|Overall Study|Pregnancy wish|0|||
126723885|NCT00511342|455938758|FG001|Overall Study|Pregnancy wish|1|||
126723886|NCT00511342|455938757|FG000|Overall Study|Lost to Follow-up|1|||
126723887|NCT00511342|455938758|FG001|Overall Study|Lost to Follow-up|5|||
126723888|NCT00511342|455938757|FG000|Overall Study|Other Reason|2|||
126723889|NCT00511342|455938758|FG001|Overall Study|Other Reason|2|||
126723890|NCT01496430|455938759|FG000|Overall Study|Adverse Event|0|||
126723891|NCT01496430|455938760|FG001|Overall Study|Adverse Event|0|||
126723892|NCT01496430|455938761|FG002|Overall Study|Adverse Event|1|||
126723893|NCT01496430|455938759|FG000|Overall Study|Major Protocol Deviation|0|||
126723894|NCT01496430|455938760|FG001|Overall Study|Major Protocol Deviation|0|||
126723895|NCT01496430|455938761|FG002|Overall Study|Major Protocol Deviation|1|||
126723896|NCT01496430|455938759|FG000|Overall Study|Lost to Follow-up|2|||
126723897|NCT01496430|455938760|FG001|Overall Study|Lost to Follow-up|3|||
126723898|NCT01496430|455938761|FG002|Overall Study|Lost to Follow-up|1|||
126723899|NCT01496430|455938759|FG000|Overall Study|Voluntary Withdrawal|2|||
126723900|NCT01496430|455938760|FG001|Overall Study|Voluntary Withdrawal|1|||
126723901|NCT01496430|455938761|FG002|Overall Study|Voluntary Withdrawal|6|||
126723902|NCT01496430|455938759|FG000|Overall Study|Principal Investigator Discretion|0|||
126723903|NCT01496430|455938760|FG001|Overall Study|Principal Investigator Discretion|1|||
126723904|NCT01496430|455938761|FG002|Overall Study|Principal Investigator Discretion|1|||
126723905|NCT01496430|455938759|FG000|Overall Study|Other|2|||
126723906|NCT01496430|455938760|FG001|Overall Study|Other|0|||
126723907|NCT01496430|455938761|FG002|Overall Study|Other|0|||
126723908|NCT00997321|455938762|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
126723909|NCT00997321|455938763|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
126723910|NCT01276457|455938773|FG000|Core Study|Adverse Event|6|||
126723911|NCT01276457|455938774|FG001|Core Study|Adverse Event|3|||
126723912|NCT01276457|455938773|FG000|Core Study|Lost to Follow-up|1|||
126723913|NCT01276457|455938774|FG001|Core Study|Lost to Follow-up|2|||
126723914|NCT01276457|455938773|FG000|Core Study|Administrative problems|1|||
126723915|NCT01276457|455938774|FG001|Core Study|Administrative problems|1|||
126723916|NCT01276457|455938773|FG000|Core Study|Death|2|||
126723917|NCT01276457|455938774|FG001|Core Study|Death|2|||
126723918|NCT01276457|455938773|FG000|Core Study|Lack of Efficacy|3|||
126496027|NCT03333044|455116370|FG000|Overall Study|Pregnancy|1|||
126496028|NCT03333044|455116371|FG001|Overall Study|Pregnancy|0|||
126496029|NCT03333044|455116372|FG002|Overall Study|Pregnancy|0|||
126496030|NCT03333044|455116370|FG000|Overall Study|Lost to Follow-up|0|||
126496031|NCT03333044|455116371|FG001|Overall Study|Lost to Follow-up|14|||
126496032|NCT03333044|455116372|FG002|Overall Study|Lost to Follow-up|6|||
126496033|NCT03188094|455116373|FG000|Overall Study|Screen failure|1|||
126723919|NCT01276457|455938774|FG001|Core Study|Lack of Efficacy|12|||
126723920|NCT01276457|455938773|FG000|Extension Study|Lost to Follow-up|3|||
126559736|NCT00924560|455342586|FG000|Overall Study|Physician Decision|2|||
126559737|NCT00924560|455342587|FG001|Overall Study|Physician Decision|3|||
126559738|NCT00924560|455342588|FG002|Overall Study|Physician Decision|4|||
126559739|NCT00924560|455342586|FG000|Overall Study|Withdrawal by Subject|50|||
126559740|NCT00924560|455342587|FG001|Overall Study|Withdrawal by Subject|44|||
126559741|NCT00924560|455342588|FG002|Overall Study|Withdrawal by Subject|18|||
126559742|NCT00924560|455342586|FG000|Overall Study|Adverse Event|39|||
126496034|NCT03188094|455116374|FG001|Overall Study|Screen failure|0|||
126496035|NCT03188094|455116375|FG002|Overall Study|Screen failure|0|||
126496036|NCT03188094|455116373|FG000|Overall Study|Pregnancy|3|||
126496037|NCT03188094|455116374|FG001|Overall Study|Pregnancy|0|||
126496038|NCT03188094|455116375|FG002|Overall Study|Pregnancy|0|||
126496039|NCT03188094|455116373|FG000|Overall Study|Ineligible|1|||
126496040|NCT03188094|455116374|FG001|Overall Study|Ineligible|0|||
126496041|NCT03188094|455116375|FG002|Overall Study|Ineligible|0|||
126496042|NCT03188094|455116373|FG000|Overall Study|Lost to Follow-up|0|||
126496043|NCT03188094|455116374|FG001|Overall Study|Lost to Follow-up|0|||
126496044|NCT03188094|455116375|FG002|Overall Study|Lost to Follow-up|17|||
126496045|NCT02921776|455116376|FG000|Overall Study|patient deterioration, fatigue|2|||
126496046|NCT02921776|455116377|FG001|Overall Study|patient deterioration, fatigue|6|||
126496047|NCT02921776|455116378|FG002|Overall Study|patient deterioration, fatigue|0|||
126496048|NCT02921776|455116379|FG003|Overall Study|patient deterioration, fatigue|0|||
126496049|NCT02921776|455116380|FG004|Overall Study|patient deterioration, fatigue|0|||
126496050|NCT02921776|455116381|FG005|Overall Study|patient deterioration, fatigue|0|||
126496051|NCT02921776|455116382|FG006|Overall Study|patient deterioration, fatigue|0|||
126496052|NCT02921776|455116383|FG007|Overall Study|patient deterioration, fatigue|0|||
126496053|NCT02921776|455116376|FG000|Overall Study|Withdrawal by Subject|0|||
126496054|NCT02921776|455116377|FG001|Overall Study|Withdrawal by Subject|2|||
126496055|NCT02921776|455116378|FG002|Overall Study|Withdrawal by Subject|0|||
126496056|NCT02921776|455116379|FG003|Overall Study|Withdrawal by Subject|1|||
126496057|NCT02921776|455116380|FG004|Overall Study|Withdrawal by Subject|1|||
126496058|NCT02921776|455116381|FG005|Overall Study|Withdrawal by Subject|0|||
126496059|NCT02921776|455116382|FG006|Overall Study|Withdrawal by Subject|8|||
126496060|NCT02921776|455116383|FG007|Overall Study|Withdrawal by Subject|1|||
126496061|NCT02921776|455116376|FG000|Overall Study|Death|0|||
126496062|NCT02921776|455116377|FG001|Overall Study|Death|0|||
126496063|NCT02921776|455116378|FG002|Overall Study|Death|0|||
126496064|NCT02921776|455116379|FG003|Overall Study|Death|2|||
126496065|NCT02921776|455116380|FG004|Overall Study|Death|0|||
126496066|NCT02921776|455116381|FG005|Overall Study|Death|0|||
126496067|NCT02921776|455116382|FG006|Overall Study|Death|0|||
126496068|NCT02921776|455116383|FG007|Overall Study|Death|0|||
126496069|NCT02921776|455116376|FG000|Overall Study|extubation or early discharge|0|||
126496070|NCT02921776|455116377|FG001|Overall Study|extubation or early discharge|0|||
126496071|NCT02921776|455116378|FG002|Overall Study|extubation or early discharge|0|||
126496072|NCT02921776|455116379|FG003|Overall Study|extubation or early discharge|5|||
126496073|NCT02921776|455116380|FG004|Overall Study|extubation or early discharge|5|||
126496074|NCT02921776|455116381|FG005|Overall Study|extubation or early discharge|0|||
126496075|NCT02921776|455116382|FG006|Overall Study|extubation or early discharge|0|||
126496076|NCT02921776|455116383|FG007|Overall Study|extubation or early discharge|0|||
126496077|NCT02921776|455116376|FG000|Overall Study|Lost to Follow-up|0|||
126496078|NCT02921776|455116377|FG001|Overall Study|Lost to Follow-up|0|||
126496079|NCT02921776|455116378|FG002|Overall Study|Lost to Follow-up|0|||
126496080|NCT02921776|455116379|FG003|Overall Study|Lost to Follow-up|0|||
126496081|NCT02921776|455116380|FG004|Overall Study|Lost to Follow-up|0|||
126496082|NCT02921776|455116381|FG005|Overall Study|Lost to Follow-up|2|||
126496083|NCT02921776|455116382|FG006|Overall Study|Lost to Follow-up|3|||
126496084|NCT02921776|455116383|FG007|Overall Study|Lost to Follow-up|6|||
126496085|NCT02070744|455116384|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
126496086|NCT02070744|455116385|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
126496087|NCT02070744|455116386|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
126496088|NCT02070744|455116387|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
126496089|NCT02070744|455116388|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
126496090|NCT02070744|455116384|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
126496091|NCT02070744|455116385|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
126496092|NCT02070744|455116386|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
126496093|NCT02070744|455116387|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
126496094|NCT02070744|455116388|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
126496095|NCT02070744|455116384|FG000|OLE Phase (48 Weeks)|Other|0|||
126496096|NCT02070744|455116385|FG001|OLE Phase (48 Weeks)|Other|0|||
126723921|NCT01276457|455938774|FG001|Extension Study|Lost to Follow-up|0|||
126723922|NCT01276457|455938773|FG000|Extension Study|Death|0|||
126496097|NCT02070744|455116386|FG002|OLE Phase (48 Weeks)|Other|0|||
126496098|NCT02070744|455116387|FG003|OLE Phase (48 Weeks)|Other|0|||
126496099|NCT02070744|455116388|FG004|OLE Phase (48 Weeks)|Other|1|||
126559743|NCT00924560|455342587|FG001|Overall Study|Adverse Event|33|||
126559744|NCT00924560|455342588|FG002|Overall Study|Adverse Event|0|||
126772895|NCT04440163|456125290|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
126772896|NCT04440163|456125291|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
126772897|NCT04440163|456125284|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
126772898|NCT04440163|456125285|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
126772899|NCT04440163|456125286|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
126772900|NCT04440163|456125287|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
126772901|NCT04440163|456125288|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
126772902|NCT04440163|456125289|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
126772903|NCT04440163|456125290|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
126772904|NCT04440163|456125291|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
126772905|NCT04440163|456125284|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
126772906|NCT04440163|456125285|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
126772907|NCT04440163|456125286|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
126772908|NCT04440163|456125287|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
126772909|NCT04440163|456125288|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
126772910|NCT04440163|456125289|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
126772911|NCT04440163|456125290|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
126772912|NCT04440163|456125291|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
126772913|NCT04440163|456125284|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
126772914|NCT04440163|456125285|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
126772915|NCT04440163|456125286|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
126772916|NCT04440163|456125287|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
126772917|NCT04440163|456125288|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
126772918|NCT04440163|456125289|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
126772919|NCT04440163|456125290|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
126772920|NCT04440163|456125291|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
126772921|NCT04440163|456125284|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
126772922|NCT04440163|456125285|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
126772923|NCT04440163|456125286|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
126772924|NCT04440163|456125287|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
126772925|NCT04440163|456125288|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
126772926|NCT04440163|456125289|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
126772927|NCT04440163|456125290|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
126772928|NCT04440163|456125291|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
126772929|NCT04440163|456125284|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
126772930|NCT04440163|456125285|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
126772931|NCT04440163|456125286|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
126772932|NCT04440163|456125287|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
126772933|NCT04440163|456125288|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
126772934|NCT04440163|456125289|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
126772935|NCT04440163|456125290|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
126772936|NCT04440163|456125291|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
126772937|NCT04440163|456125284|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
126496100|NCT04199117|455116389|FG000|Overall Study|Withdrawal by Subject|3|||
126496101|NCT04199117|455116390|FG001|Overall Study|Withdrawal by Subject|0|||
126496102|NCT04199117|455116391|FG002|Overall Study|Withdrawal by Subject|0|||
126496103|NCT04199117|455116392|FG003|Overall Study|Withdrawal by Subject|1|||
126496104|NCT04199117|455116393|FG004|Overall Study|Withdrawal by Subject|1|||
126496105|NCT04199117|455116394|FG005|Overall Study|Withdrawal by Subject|0|||
126496106|NCT04199117|455116395|FG006|Overall Study|Withdrawal by Subject|0|||
126496107|NCT04199117|455116396|FG007|Overall Study|Withdrawal by Subject|2|||
126496108|NCT04199117|455116397|FG008|Overall Study|Withdrawal by Subject|0|||
126496109|NCT04199117|455116398|FG009|Overall Study|Withdrawal by Subject|0|||
126496110|NCT04199117|455116399|FG010|Overall Study|Withdrawal by Subject|1|||
126496111|NCT04199117|455116400|FG011|Overall Study|Withdrawal by Subject|1|||
126496112|NCT04199117|455116401|FG012|Overall Study|Withdrawal by Subject|2|||
126496113|NCT04199117|455116402|FG013|Overall Study|Withdrawal by Subject|1|||
126496114|NCT04199117|455116403|FG014|Overall Study|Withdrawal by Subject|1|||
126496115|NCT04199117|455116404|FG015|Overall Study|Withdrawal by Subject|1|||
126496116|NCT04199117|455116389|FG000|Overall Study|Death|1|||
126496117|NCT04199117|455116390|FG001|Overall Study|Death|1|||
126496118|NCT04199117|455116391|FG002|Overall Study|Death|0|||
126496119|NCT04199117|455116392|FG003|Overall Study|Death|0|||
126496120|NCT04199117|455116393|FG004|Overall Study|Death|0|||
126496121|NCT04199117|455116394|FG005|Overall Study|Death|0|||
126496122|NCT04199117|455116395|FG006|Overall Study|Death|0|||
126496123|NCT04199117|455116396|FG007|Overall Study|Death|0|||
126559745|NCT00924560|455342586|FG000|Overall Study|Pregnancy|5|||
126496124|NCT04199117|455116397|FG008|Overall Study|Death|0|||
126496125|NCT04199117|455116398|FG009|Overall Study|Death|0|||
126496126|NCT04199117|455116399|FG010|Overall Study|Death|0|||
126496127|NCT04199117|455116400|FG011|Overall Study|Death|1|||
126496128|NCT04199117|455116401|FG012|Overall Study|Death|0|||
126496129|NCT04199117|455116402|FG013|Overall Study|Death|1|||
126496130|NCT04199117|455116403|FG014|Overall Study|Death|0|||
126496131|NCT04199117|455116404|FG015|Overall Study|Death|0|||
126496132|NCT04199117|455116389|FG000|Overall Study|Withdrawal by PI|0|||
126496133|NCT04199117|455116390|FG001|Overall Study|Withdrawal by PI|0|||
126496134|NCT04199117|455116391|FG002|Overall Study|Withdrawal by PI|0|||
126496135|NCT04199117|455116392|FG003|Overall Study|Withdrawal by PI|0|||
126496136|NCT04199117|455116393|FG004|Overall Study|Withdrawal by PI|0|||
126496137|NCT04199117|455116394|FG005|Overall Study|Withdrawal by PI|0|||
126496138|NCT04199117|455116395|FG006|Overall Study|Withdrawal by PI|0|||
126496139|NCT04199117|455116396|FG007|Overall Study|Withdrawal by PI|0|||
126496140|NCT04199117|455116397|FG008|Overall Study|Withdrawal by PI|0|||
126496141|NCT04199117|455116398|FG009|Overall Study|Withdrawal by PI|0|||
126496142|NCT04199117|455116399|FG010|Overall Study|Withdrawal by PI|0|||
126496143|NCT04199117|455116400|FG011|Overall Study|Withdrawal by PI|0|||
126496144|NCT04199117|455116401|FG012|Overall Study|Withdrawal by PI|1|||
126496145|NCT04199117|455116402|FG013|Overall Study|Withdrawal by PI|0|||
126496146|NCT04199117|455116403|FG014|Overall Study|Withdrawal by PI|0|||
126496147|NCT04199117|455116404|FG015|Overall Study|Withdrawal by PI|0|||
126496148|NCT05478252|455116405|FG000|Overall Study|Withdrawal by Subject|2|||
126496149|NCT05478252|455116406|FG001|Overall Study|Withdrawal by Subject|3|||
126496150|NCT05478252|455116405|FG000|Overall Study|Lost to Follow-up|4|||
126496151|NCT05478252|455116406|FG001|Overall Study|Lost to Follow-up|2|||
126496152|NCT05478252|455116405|FG000|Overall Study|Physician Decision|1|||
126496153|NCT05478252|455116406|FG001|Overall Study|Physician Decision|1|||
126496154|NCT05478252|455116405|FG000|Overall Study|Death|1|||
126496155|NCT05478252|455116406|FG001|Overall Study|Death|0|||
126496156|NCT01881230|455117889|FG000|Overall Study|Death|2|||
126496157|NCT01881230|455117890|FG001|Overall Study|Death|0|||
126496158|NCT01881230|455117891|FG002|Overall Study|Death|1|||
126496159|NCT01881230|455117889|FG000|Overall Study|Adverse Event|9|||
126496160|NCT01881230|455117890|FG001|Overall Study|Adverse Event|13|||
126496161|NCT01881230|455117891|FG002|Overall Study|Adverse Event|12|||
126496162|NCT01881230|455117889|FG000|Overall Study|Progressive Disease|31|||
126496163|NCT01881230|455117890|FG001|Overall Study|Progressive Disease|35|||
126496164|NCT01881230|455117891|FG002|Overall Study|Progressive Disease|36|||
126496165|NCT01881230|455117889|FG000|Overall Study|Symptomatic Deterioration|3|||
126496166|NCT01881230|455117890|FG001|Overall Study|Symptomatic Deterioration|3|||
126496167|NCT01881230|455117891|FG002|Overall Study|Symptomatic Deterioration|1|||
126496168|NCT01881230|455117889|FG000|Overall Study|Withdrawal by Subject|6|||
126496169|NCT01881230|455117890|FG001|Overall Study|Withdrawal by Subject|4|||
126496170|NCT01881230|455117891|FG002|Overall Study|Withdrawal by Subject|6|||
126496171|NCT01881230|455117889|FG000|Overall Study|Physician Decision|4|||
126496172|NCT01881230|455117890|FG001|Overall Study|Physician Decision|3|||
126496173|NCT01881230|455117891|FG002|Overall Study|Physician Decision|6|||
126496174|NCT01881230|455117889|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126496175|NCT01881230|455117890|FG001|Overall Study|Non-Compliance with Study Drug|2|||
126496176|NCT01881230|455117891|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126496177|NCT01881230|455117889|FG000|Overall Study|Given Commercially Available Drug|0|||
126496178|NCT01881230|455117890|FG001|Overall Study|Given Commercially Available Drug|0|||
126496179|NCT01881230|455117891|FG002|Overall Study|Given Commercially Available Drug|2|||
126496180|NCT01881230|455117889|FG000|Overall Study|Protocol Violation|1|||
126496181|NCT01881230|455117890|FG001|Overall Study|Protocol Violation|1|||
126496182|NCT01881230|455117891|FG002|Overall Study|Protocol Violation|0|||
126496183|NCT01881230|455117889|FG000|Overall Study|Miscellaneous|3|||
126496184|NCT01881230|455117890|FG001|Overall Study|Miscellaneous|3|||
126496185|NCT01881230|455117891|FG002|Overall Study|Miscellaneous|0|||
126496186|NCT01881230|455117889|FG000|Overall Study|Untreated: Other|0|||
126496187|NCT01881230|455117890|FG001|Overall Study|Untreated: Other|0|||
126496188|NCT01881230|455117891|FG002|Overall Study|Untreated: Other|1|||
126496189|NCT01881230|455117889|FG000|Overall Study|Untreated: Death|0|||
126496190|NCT01881230|455117890|FG001|Overall Study|Untreated: Death|0|||
126496191|NCT01881230|455117891|FG002|Overall Study|Untreated: Death|1|||
126496192|NCT01881230|455117889|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
126496193|NCT01881230|455117890|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
126496194|NCT01881230|455117891|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
126496195|NCT02385266|455117892|FG000|Overall Study|Withdrawal by Subject|1|||
126496196|NCT02385266|455117893|FG001|Overall Study|Withdrawal by Subject|3|||
126496197|NCT00518323|455117894|FG000|Overall Study|Lack of Efficacy|14|||
126496198|NCT00518323|455117895|FG001|Overall Study|Lack of Efficacy|2|||
126496199|NCT00518323|455117896|FG002|Overall Study|Lack of Efficacy|4|||
126496200|NCT00518323|455117897|FG003|Overall Study|Lack of Efficacy|20|||
126496201|NCT00518323|455117894|FG000|Overall Study|Withdrawal by Subject|1|||
126496202|NCT00518323|455117895|FG001|Overall Study|Withdrawal by Subject|2|||
126496203|NCT00518323|455117896|FG002|Overall Study|Withdrawal by Subject|4|||
126772938|NCT04440163|456125285|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
126772939|NCT04440163|456125286|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
126772940|NCT04440163|456125287|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
126772941|NCT04440163|456125288|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
126772942|NCT04440163|456125289|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
126772943|NCT04440163|456125290|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
126772944|NCT04440163|456125291|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
126772945|NCT04440163|456125284|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
126772946|NCT04440163|456125285|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
126772947|NCT04440163|456125286|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
126772948|NCT04440163|456125287|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
126772949|NCT04440163|456125288|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
126772950|NCT04440163|456125289|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
126772951|NCT04440163|456125290|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
126772952|NCT04440163|456125291|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
126772953|NCT04440163|456125284|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
126772954|NCT04440163|456125285|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
126772955|NCT04440163|456125286|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
126772956|NCT04440163|456125287|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
126772957|NCT04440163|456125288|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
126772958|NCT04440163|456125289|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
126772959|NCT04440163|456125290|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
126772960|NCT04440163|456125291|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
126772961|NCT04440163|456125284|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
126772962|NCT04440163|456125285|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
126772963|NCT04440163|456125286|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
126772964|NCT04440163|456125287|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
126772965|NCT04440163|456125288|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
126772966|NCT04440163|456125289|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
126772967|NCT04440163|456125290|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
126772968|NCT04440163|456125291|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
126772969|NCT04440163|456125284|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126772970|NCT04440163|456125285|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126772971|NCT04440163|456125286|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126772972|NCT04440163|456125287|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
126772973|NCT04440163|456125288|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126772974|NCT04440163|456125289|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126772975|NCT04440163|456125290|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126772976|NCT04440163|456125291|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
126772977|NCT02018042|456125294|FG000|Overall Study|Withdrawal by Subject|1|||
126772978|NCT01954082|456125295|FG000|Overall Study|Study Suspension|42|||
126772979|NCT01954082|456125296|FG001|Overall Study|Study Suspension|36|||
126772980|NCT01954082|456125295|FG000|Overall Study|Adverse Event|10|||
126772981|NCT01954082|456125296|FG001|Overall Study|Adverse Event|4|||
126772982|NCT01954082|456125295|FG000|Overall Study|Intolerance|0|||
126772983|NCT01954082|456125296|FG001|Overall Study|Intolerance|1|||
126772984|NCT01954082|456125295|FG000|Overall Study|Non-compliance|6|||
126496204|NCT00518323|455117897|FG003|Overall Study|Withdrawal by Subject|2|||
126496205|NCT00518323|455117894|FG000|Overall Study|Lost to Follow-up|0|||
126496206|NCT00518323|455117895|FG001|Overall Study|Lost to Follow-up|2|||
126496207|NCT00518323|455117896|FG002|Overall Study|Lost to Follow-up|1|||
126496208|NCT00518323|455117897|FG003|Overall Study|Lost to Follow-up|3|||
126496209|NCT00518323|455117894|FG000|Overall Study|Adverse Event|1|||
126496210|NCT00518323|455117895|FG001|Overall Study|Adverse Event|1|||
126496211|NCT00518323|455117896|FG002|Overall Study|Adverse Event|1|||
126496212|NCT00518323|455117897|FG003|Overall Study|Adverse Event|0|||
126496213|NCT00518323|455117894|FG000|Overall Study|Prohibited medication and others|3|||
126496214|NCT00518323|455117895|FG001|Overall Study|Prohibited medication and others|1|||
126496215|NCT00518323|455117896|FG002|Overall Study|Prohibited medication and others|1|||
126496216|NCT00518323|455117897|FG003|Overall Study|Prohibited medication and others|0|||
126496217|NCT01514760|455117898|FG000|Overall Study|Lost to Follow-up|2|||
126496218|NCT02092662|455117899|FG000|Overall Study|Lost to Follow-up|13|||
126496219|NCT02092662|455117900|FG001|Overall Study|Lost to Follow-up|0|||
126496220|NCT03329690|455117902|FG000|Overall Study|Progressive disease per RECIST|85|||
126496221|NCT03329690|455117903|FG001|Overall Study|Progressive disease per RECIST|44|||
126496222|NCT03329690|455117904|FG002|Overall Study|Progressive disease per RECIST|6|||
126496223|NCT03329690|455117905|FG003|Overall Study|Progressive disease per RECIST|16|||
126496224|NCT03329690|455117906|FG004|Overall Study|Progressive disease per RECIST|20|||
126496225|NCT03329690|455117902|FG000|Overall Study|Clinical progression|7|||
126496226|NCT03329690|455117903|FG001|Overall Study|Clinical progression|4|||
126496227|NCT03329690|455117904|FG002|Overall Study|Clinical progression|1|||
126496228|NCT03329690|455117905|FG003|Overall Study|Clinical progression|1|||
126496229|NCT03329690|455117906|FG004|Overall Study|Clinical progression|1|||
126496230|NCT03329690|455117902|FG000|Overall Study|Adverse Event|22|||
126496231|NCT03329690|455117903|FG001|Overall Study|Adverse Event|4|||
126496232|NCT03329690|455117904|FG002|Overall Study|Adverse Event|0|||
126496233|NCT03329690|455117905|FG003|Overall Study|Adverse Event|1|||
126496234|NCT03329690|455117906|FG004|Overall Study|Adverse Event|2|||
126496235|NCT03329690|455117902|FG000|Overall Study|Death|2|||
126496236|NCT03329690|455117903|FG001|Overall Study|Death|0|||
126496237|NCT03329690|455117904|FG002|Overall Study|Death|0|||
126496238|NCT03329690|455117905|FG003|Overall Study|Death|1|||
126496239|NCT03329690|455117906|FG004|Overall Study|Death|0|||
126496240|NCT03329690|455117902|FG000|Overall Study|Withdrawal by Subject|2|||
126496241|NCT03329690|455117903|FG001|Overall Study|Withdrawal by Subject|3|||
126496242|NCT03329690|455117904|FG002|Overall Study|Withdrawal by Subject|0|||
126496243|NCT03329690|455117905|FG003|Overall Study|Withdrawal by Subject|1|||
126496244|NCT03329690|455117906|FG004|Overall Study|Withdrawal by Subject|0|||
126496245|NCT03329690|455117902|FG000|Overall Study|Physician Decision|1|||
126496246|NCT03329690|455117903|FG001|Overall Study|Physician Decision|0|||
126496247|NCT03329690|455117904|FG002|Overall Study|Physician Decision|0|||
126496248|NCT03329690|455117905|FG003|Overall Study|Physician Decision|0|||
126496249|NCT03329690|455117906|FG004|Overall Study|Physician Decision|1|||
126496250|NCT03329690|455117902|FG000|Overall Study|Miscellaneous|6|||
126496251|NCT03329690|455117903|FG001|Overall Study|Miscellaneous|0|||
126496252|NCT03329690|455117904|FG002|Overall Study|Miscellaneous|0|||
126496253|NCT03329690|455117905|FG003|Overall Study|Miscellaneous|0|||
126496254|NCT03329690|455117906|FG004|Overall Study|Miscellaneous|0|||
126496255|NCT03329690|455117902|FG000|Overall Study|Did not receive treatment|1|||
126496256|NCT03329690|455117903|FG001|Overall Study|Did not receive treatment|0|||
126496257|NCT03329690|455117904|FG002|Overall Study|Did not receive treatment|0|||
126496258|NCT03329690|455117905|FG003|Overall Study|Did not receive treatment|1|||
126496259|NCT03329690|455117906|FG004|Overall Study|Did not receive treatment|0|||
126496260|NCT02418468|455117908|FG000|Overall Study|Adverse Event|1|||
126496261|NCT02418468|455117909|FG001|Overall Study|Adverse Event|0|||
126496262|NCT02418468|455117908|FG000|Overall Study|Withdrawal of informed consent|1|||
126496263|NCT02418468|455117909|FG001|Overall Study|Withdrawal of informed consent|1|||
126496264|NCT02914769|455117910|FG000|Overall Study|Protocol Violation|3|||
126496265|NCT02914769|455117911|FG001|Overall Study|Protocol Violation|2|||
126496266|NCT02914769|455117910|FG000|Overall Study|Withdrawal by Subject|0|||
126496267|NCT02914769|455117911|FG001|Overall Study|Withdrawal by Subject|1|||
126496268|NCT02337907|455117912|FG000|Overall Study|Other than listed|1|||
126496269|NCT02337907|455117913|FG001|Overall Study|Other than listed|0|||
126496270|NCT02337907|455117914|FG002|Overall Study|Other than listed|0|||
126496271|NCT02337907|455117915|FG003|Overall Study|Other than listed|1|||
126496272|NCT02337907|455117916|FG004|Overall Study|Other than listed|1|||
126496273|NCT02337907|455117917|FG005|Overall Study|Other than listed|0|||
126496274|NCT02337907|455117912|FG000|Overall Study|Withdrawal by Subject|2|||
126496275|NCT02337907|455117913|FG001|Overall Study|Withdrawal by Subject|3|||
126496276|NCT02337907|455117914|FG002|Overall Study|Withdrawal by Subject|0|||
126496277|NCT02337907|455117915|FG003|Overall Study|Withdrawal by Subject|2|||
126496278|NCT02337907|455117916|FG004|Overall Study|Withdrawal by Subject|5|||
126496279|NCT02337907|455117917|FG005|Overall Study|Withdrawal by Subject|0|||
126496280|NCT02337907|455117912|FG000|Overall Study|Lost to Follow-up|0|||
126496281|NCT02337907|455117913|FG001|Overall Study|Lost to Follow-up|0|||
126496282|NCT02337907|455117914|FG002|Overall Study|Lost to Follow-up|0|||
126496283|NCT02337907|455117915|FG003|Overall Study|Lost to Follow-up|0|||
126496284|NCT02337907|455117916|FG004|Overall Study|Lost to Follow-up|0|||
126496285|NCT02337907|455117917|FG005|Overall Study|Lost to Follow-up|1|||
126496286|NCT02337907|455117912|FG000|Overall Study|Adverse Event|1|||
126496287|NCT02337907|455117913|FG001|Overall Study|Adverse Event|1|||
126496288|NCT02337907|455117914|FG002|Overall Study|Adverse Event|1|||
126496289|NCT02337907|455117915|FG003|Overall Study|Adverse Event|1|||
126496290|NCT02337907|455117916|FG004|Overall Study|Adverse Event|4|||
126496291|NCT02337907|455117917|FG005|Overall Study|Adverse Event|0|||
126496292|NCT01592344|455117921|FG000|Overall Study|Adverse Event|1|||
126496293|NCT01592344|455117922|FG001|Overall Study|Adverse Event|1|||
126496294|NCT01592344|455117921|FG000|Overall Study|Lack of Efficacy|1|||
126496295|NCT01592344|455117922|FG001|Overall Study|Lack of Efficacy|0|||
126496296|NCT01592344|455117921|FG000|Overall Study|not available at primary outcome visit|2|||
126496297|NCT01592344|455117922|FG001|Overall Study|not available at primary outcome visit|4|||
126496298|NCT00099437|455117924|FG000|Overall Study|Lost to Follow-up|30|||
126496299|NCT00099437|455117925|FG001|Overall Study|Lost to Follow-up|33|||
126496300|NCT00099437|455117924|FG000|Overall Study|Death|293|||
126496301|NCT00099437|455117925|FG001|Overall Study|Death|261|||
126496302|NCT00099437|455117924|FG000|Overall Study|Withdrawal by Subject|6|||
126496303|NCT00099437|455117925|FG001|Overall Study|Withdrawal by Subject|10|||
126559746|NCT00924560|455342587|FG001|Overall Study|Pregnancy|7|||
126559747|NCT00924560|455342588|FG002|Overall Study|Pregnancy|1|||
126559748|NCT00924560|455342586|FG000|Overall Study|Lost to Follow-up|78|||
126559749|NCT00924560|455342587|FG001|Overall Study|Lost to Follow-up|94|||
126559750|NCT00924560|455342588|FG002|Overall Study|Lost to Follow-up|45|||
126559751|NCT00924560|455342586|FG000|Overall Study|Miscellaneous Reasons|13|||
126559752|NCT00924560|455342587|FG001|Overall Study|Miscellaneous Reasons|10|||
126559753|NCT00924560|455342588|FG002|Overall Study|Miscellaneous Reasons|10|||
126559754|NCT03590743|455342590|FG000|Overall Study|Withdrawal by Subject|0|||
126559755|NCT03590743|455342591|FG001|Overall Study|Withdrawal by Subject|1|||
126559756|NCT02696226|455342592|FG000|Overall Study|Study terminated - lack of enrollment|1|||
126559757|NCT02696226|455342593|FG001|Overall Study|Study terminated - lack of enrollment|0|||
126559758|NCT02696226|455342594|FG002|Overall Study|Study terminated - lack of enrollment|2|||
126559759|NCT02696226|455342595|FG003|Overall Study|Study terminated - lack of enrollment|0|||
126559760|NCT02909101|455342603|FG000|Overall Study|Lost to Follow-up|1|||
126559761|NCT02909101|455342604|FG001|Overall Study|Lost to Follow-up|1|||
126559762|NCT00604786|455342605|FG000|Overall Study|Lost to Follow-up|2|||
126559763|NCT00604786|455342606|FG001|Overall Study|Lost to Follow-up|0|||
126559764|NCT01221181|455342607|FG000|Overall Study|Lost to Follow-up|1|||
126559765|NCT02698436|455342608|FG000|Overall Study|Adverse Event|1|||
126559766|NCT02698436|455342609|FG001|Overall Study|Adverse Event|0|||
126559767|NCT02698436|455342608|FG000|Overall Study|Withdrawal by Subject|3|||
126559768|NCT02698436|455342609|FG001|Overall Study|Withdrawal by Subject|3|||
126559769|NCT02698436|455342608|FG000|Overall Study|Lost to Follow-up|2|||
126559770|NCT02698436|455342609|FG001|Overall Study|Lost to Follow-up|4|||
126559771|NCT02698436|455342608|FG000|Overall Study|Non-compliance with study regimen|1|||
126559772|NCT02698436|455342609|FG001|Overall Study|Non-compliance with study regimen|0|||
126559773|NCT03073005|455342610|FG000|Overall Study|Death|6|||
126559774|NCT03073005|455342611|FG001|Overall Study|Death|0|||
126559775|NCT03073005|455342612|FG002|Overall Study|Death|7|||
126559776|NCT03073005|455342613|FG003|Overall Study|Death|0|||
126559777|NCT03073005|455342610|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
126559778|NCT03073005|455342611|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
126559779|NCT03073005|455342612|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
126559780|NCT03073005|455342613|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
126559781|NCT03073005|455342610|FG000|Overall Study|Lost to Follow-up|2|||
126559782|NCT03073005|455342611|FG001|Overall Study|Lost to Follow-up|2|||
126559783|NCT03073005|455342612|FG002|Overall Study|Lost to Follow-up|1|||
126723923|NCT01276457|455938774|FG001|Extension Study|Death|1|||
126496304|NCT00099437|455117924|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
126496305|NCT00099437|455117925|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
126496306|NCT02488681|455117928|FG000|Overall Study|Implant unsuccessful|7|||
126496307|NCT05413369|455117929|FG000|Overall Study|Adverse Event|1|||
126496308|NCT05413369|455117930|FG001|Overall Study|Adverse Event|1|||
126496309|NCT05413369|455117929|FG000|Overall Study|Withdrawal by Subject|13|||
126496310|NCT05413369|455117930|FG001|Overall Study|Withdrawal by Subject|4|||
126496311|NCT05413369|455117929|FG000|Overall Study|Non-compliance with study schedule|2|||
126496312|NCT05413369|455117930|FG001|Overall Study|Non-compliance with study schedule|1|||
126496313|NCT05413369|455117929|FG000|Overall Study|Other|1|||
126496314|NCT05413369|455117930|FG001|Overall Study|Other|1|||
126496315|NCT00720057|455117931|FG000|Overall Study|Lost to Follow-up|0|||
126496316|NCT00720057|455117932|FG001|Overall Study|Lost to Follow-up|2|||
126496317|NCT00720057|455117931|FG000|Overall Study|Protocol Violation|1|||
126496318|NCT00720057|455117932|FG001|Overall Study|Protocol Violation|0|||
126723924|NCT01276457|455938773|FG000|Extension Study|Lack of Efficacy|3|||
126723925|NCT01276457|455938774|FG001|Extension Study|Lack of Efficacy|1|||
126723926|NCT02402218|455938779|FG000|Overall Study|Did not pickup study medication|12|||
126723927|NCT02402218|455938780|FG001|Overall Study|Did not pickup study medication|9|||
126496319|NCT00720057|455117931|FG000|Overall Study|Withdrawal by Subject|0|||
126723928|NCT02402218|455938781|FG002|Overall Study|Did not pickup study medication|13|||
126723929|NCT02402218|455938779|FG000|Overall Study|Lack of Efficacy|0|||
126723930|NCT02402218|455938780|FG001|Overall Study|Lack of Efficacy|1|||
126723931|NCT02402218|455938781|FG002|Overall Study|Lack of Efficacy|1|||
126723932|NCT02402218|455938779|FG000|Overall Study|Death|1|||
126723933|NCT02402218|455938780|FG001|Overall Study|Death|0|||
126723934|NCT02402218|455938781|FG002|Overall Study|Death|0|||
126496320|NCT00720057|455117932|FG001|Overall Study|Withdrawal by Subject|1|||
126496321|NCT04120974|455117936|FG000|Overall Study|Death|1|||
126559784|NCT03073005|455342613|FG003|Overall Study|Lost to Follow-up|2|||
126559785|NCT03073005|455342610|FG000|Overall Study|Withdrawal by Subject|0|||
126723935|NCT02402218|455938779|FG000|Overall Study|Reinfection|0|||
126723936|NCT02402218|455938780|FG001|Overall Study|Reinfection|0|||
126496322|NCT04120974|455117936|FG000|Overall Study|Physician Decision|1|||
126559786|NCT03073005|455342611|FG001|Overall Study|Withdrawal by Subject|4|||
126559787|NCT03073005|455342612|FG002|Overall Study|Withdrawal by Subject|4|||
126559788|NCT03073005|455342613|FG003|Overall Study|Withdrawal by Subject|4|||
126559789|NCT01290094|455342614|FG000|Overall Study|Withdrawal by Subject|1|||
126723937|NCT02402218|455938781|FG002|Overall Study|Reinfection|1|||
126723938|NCT02402218|455938779|FG000|Overall Study|Adverse Event|0|||
126723939|NCT02402218|455938780|FG001|Overall Study|Adverse Event|2|||
126723940|NCT02402218|455938781|FG002|Overall Study|Adverse Event|1|||
126723941|NCT02402218|455938779|FG000|Overall Study|Withdrawal by Subject|1|||
126723942|NCT02402218|455938780|FG001|Overall Study|Withdrawal by Subject|1|||
126723943|NCT02402218|455938781|FG002|Overall Study|Withdrawal by Subject|1|||
126723944|NCT03807739|455938782|FG000|Overall Study|Adverse Event|1|||
126723945|NCT03807739|455938783|FG001|Overall Study|Adverse Event|0|||
126723946|NCT03807739|455938784|FG002|Overall Study|Adverse Event|0|||
126723947|NCT03807739|455938785|FG003|Overall Study|Adverse Event|0|||
126723948|NCT03807739|455938782|FG000|Overall Study|Withdrawal by Subject|1|||
126723949|NCT03807739|455938783|FG001|Overall Study|Withdrawal by Subject|0|||
126723950|NCT03807739|455938784|FG002|Overall Study|Withdrawal by Subject|0|||
126723951|NCT03807739|455938785|FG003|Overall Study|Withdrawal by Subject|0|||
126723952|NCT03126539|455938796|FG000|Overall Study|Lost to Follow-up|1|||
126723953|NCT03126539|455938797|FG001|Overall Study|Lost to Follow-up|1|||
126723954|NCT03126539|455938798|FG002|Overall Study|Lost to Follow-up|1|||
126723955|NCT03126539|455938799|FG003|Overall Study|Lost to Follow-up|0|||
126723956|NCT03126539|455938800|FG004|Overall Study|Lost to Follow-up|0|||
126723957|NCT02632110|455938801|FG000|Overall Study|Withdrawal by Subject|1|||
126723958|NCT02632110|455938802|FG001|Overall Study|Withdrawal by Subject|1|||
126723959|NCT02632110|455938803|FG002|Overall Study|Withdrawal by Subject|0|||
126723960|NCT02632110|455938804|FG003|Overall Study|Withdrawal by Subject|0|||
126723961|NCT02632110|455938805|FG004|Overall Study|Withdrawal by Subject|1|||
126723962|NCT02632110|455938806|FG005|Overall Study|Withdrawal by Subject|1|||
126723963|NCT02632110|455938807|FG006|Overall Study|Withdrawal by Subject|3|||
126723964|NCT02632110|455938808|FG007|Overall Study|Withdrawal by Subject|3|||
126723965|NCT02632110|455938809|FG008|Overall Study|Withdrawal by Subject|1|||
126723966|NCT02632110|455938810|FG009|Overall Study|Withdrawal by Subject|1|||
126723967|NCT03352414|455938811|FG000|Overall Study|Ineligible by operative criteria|12|||
126723968|NCT03352414|455938812|FG001|Overall Study|Ineligible by operative criteria|10|||
126723969|NCT00516269|455938815|FG000|Overall Study|Adverse Event|2|||
126723970|NCT00516269|455938816|FG001|Overall Study|Adverse Event|1|||
126723971|NCT00516269|455938815|FG000|Overall Study|Lost to Follow-up|0|||
126723972|NCT00516269|455938816|FG001|Overall Study|Lost to Follow-up|1|||
126723973|NCT00516269|455938815|FG000|Overall Study|Protocol Violation|0|||
126723974|NCT00516269|455938816|FG001|Overall Study|Protocol Violation|1|||
126723975|NCT00142519|455938817|FG000|Overall Study|Not Treated|7|||
126723976|NCT00142519|455938818|FG001|Overall Study|Not Treated|9|||
126723977|NCT00142519|455938817|FG000|Overall Study|Protocol Violation|1|||
126723978|NCT00142519|455938818|FG001|Overall Study|Protocol Violation|0|||
126723979|NCT00142519|455938817|FG000|Overall Study|Withdrawal by Subject|10|||
126723980|NCT00142519|455938818|FG001|Overall Study|Withdrawal by Subject|7|||
126723981|NCT02596711|455938819|FG000|Overall Study|Lost to Follow-up|1|||
126723982|NCT02596711|455938820|FG001|Overall Study|Lost to Follow-up|2|||
126723983|NCT02596711|455938821|FG002|Overall Study|Lost to Follow-up|3|||
126723984|NCT01005732|455938822|FG000|Overall Study|Lost to Follow-up|10|||
126723985|NCT01005732|455938822|FG000|Overall Study|Death|1|||
126723986|NCT01552928|455938823|FG000|Period 3|Adverse Event|0|||
126723987|NCT01552928|455938824|FG001|Period 3|Adverse Event|0|||
126723988|NCT01552928|455938825|FG002|Period 3|Adverse Event|1|||
126723989|NCT01552928|455938826|FG003|Period 3|Adverse Event|0|||
126723990|NCT01079962|455938828|FG000|Overall Study|Adverse Event|2|||
126723991|NCT01079962|455938829|FG001|Overall Study|Adverse Event|2|||
126723992|NCT01079962|455938828|FG000|Overall Study|Withdrawal by Subject|5|||
126723993|NCT01079962|455938829|FG001|Overall Study|Withdrawal by Subject|7|||
126723994|NCT01079962|455938828|FG000|Overall Study|Protocol Violation|2|||
126723995|NCT01079962|455938829|FG001|Overall Study|Protocol Violation|2|||
126723996|NCT01079962|455938828|FG000|Overall Study|No blood pressure (BP) control|3|||
126723997|NCT01079962|455938829|FG001|Overall Study|No blood pressure (BP) control|0|||
126723998|NCT01079962|455938828|FG000|Overall Study|Inclusion/exclusion criteria|1|||
126723999|NCT01079962|455938829|FG001|Overall Study|Inclusion/exclusion criteria|3|||
126724000|NCT01079962|455938828|FG000|Overall Study|Participant not returning for next visit|1|||
126724001|NCT01079962|455938829|FG001|Overall Study|Participant not returning for next visit|0|||
126724002|NCT01079962|455938828|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
126724003|NCT01079962|455938829|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
126724004|NCT01331239|455938830|FG000|Part II: Core Study|Adverse Event|0|||
126724005|NCT01331239|455938831|FG001|Part II: Core Study|Adverse Event|3|||
126724006|NCT01331239|455938832|FG002|Part II: Core Study|Adverse Event|0|||
126724007|NCT01331239|455938830|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
126724008|NCT01331239|455938831|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
126724009|NCT01331239|455938832|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
126724010|NCT01331239|455938830|FG000|Part II: Core Study|Withdrawal by Subject|0|||
126724011|NCT01331239|455938831|FG001|Part II: Core Study|Withdrawal by Subject|2|||
126724012|NCT01331239|455938832|FG002|Part II: Core Study|Withdrawal by Subject|0|||
126724013|NCT01331239|455938830|FG000|Part II: Core Study|Administrative problems|0|||
126724014|NCT01331239|455938831|FG001|Part II: Core Study|Administrative problems|1|||
126496323|NCT04120974|455117936|FG000|Overall Study|Lost to Follow-up|6|||
126496324|NCT04256785|455117937|FG000|Overall Study|Adverse Event|8|||
126496325|NCT04256785|455117938|FG001|Overall Study|Adverse Event|6|||
126772985|NCT01954082|456125296|FG001|Overall Study|Non-compliance|4|||
126772986|NCT01954082|456125295|FG000|Overall Study|Physician Decision|2|||
126772987|NCT01954082|456125296|FG001|Overall Study|Physician Decision|0|||
126772988|NCT01954082|456125295|FG000|Overall Study|Parent Decision|1|||
126772989|NCT01954082|456125296|FG001|Overall Study|Parent Decision|0|||
126772990|NCT01954082|456125295|FG000|Overall Study|Withdrawal by Subject|0|||
126772991|NCT01954082|456125296|FG001|Overall Study|Withdrawal by Subject|1|||
126772992|NCT01954082|456125295|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
126772993|NCT01954082|456125296|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
126772994|NCT01954082|456125295|FG000|Overall Study|Redirection of Care|0|||
126772995|NCT01954082|456125296|FG001|Overall Study|Redirection of Care|2|||
126772996|NCT01954082|456125295|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
126772997|NCT01954082|456125296|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
126772998|NCT01954082|456125295|FG000|Overall Study|Comfort Care|0|||
126772999|NCT01954082|456125296|FG001|Overall Study|Comfort Care|1|||
126773000|NCT01954082|456125295|FG000|Overall Study|Infant Moved|0|||
126773001|NCT01954082|456125296|FG001|Overall Study|Infant Moved|1|||
126773002|NCT01954082|456125295|FG000|Overall Study|Randomized not Treated|4|||
126773003|NCT01954082|456125296|FG001|Overall Study|Randomized not Treated|2|||
126773004|NCT00707174|456125299|FG000|Overall Study|Adverse Event|1|||
126773005|NCT00707174|456125300|FG001|Overall Study|Adverse Event|6|||
126773006|NCT00707174|456125299|FG000|Overall Study|Withdrawal by Subject|4|||
126773007|NCT00707174|456125300|FG001|Overall Study|Withdrawal by Subject|1|||
126773008|NCT00572156|456125301|FG000|Overall Study|Adverse Event|3|||
126496326|NCT04256785|455117937|FG000|Overall Study|Lack of Efficacy|3|||
126496327|NCT04256785|455117938|FG001|Overall Study|Lack of Efficacy|4|||
126496328|NCT04256785|455117937|FG000|Overall Study|Lost to Follow-up|7|||
126496329|NCT04256785|455117938|FG001|Overall Study|Lost to Follow-up|7|||
126496330|NCT04256785|455117937|FG000|Overall Study|Protocol Violation|1|||
126496331|NCT04256785|455117938|FG001|Overall Study|Protocol Violation|0|||
126496332|NCT04256785|455117937|FG000|Overall Study|Withdrawal by Subject|4|||
126724015|NCT01331239|455938832|FG002|Part II: Core Study|Administrative problems|0|||
126724016|NCT00946530|455938833|FG000|Overall Study|Withdrawal by Subject|0|||
126724017|NCT00946530|455938834|FG001|Overall Study|Withdrawal by Subject|3|||
126724018|NCT00946530|455938835|FG002|Overall Study|Withdrawal by Subject|0|||
126724019|NCT00946530|455938836|FG003|Overall Study|Withdrawal by Subject|3|||
126724020|NCT00946530|455938833|FG000|Overall Study|Physician Decision|1|||
126724021|NCT00946530|455938834|FG001|Overall Study|Physician Decision|1|||
126724022|NCT00946530|455938835|FG002|Overall Study|Physician Decision|1|||
126724023|NCT00946530|455938836|FG003|Overall Study|Physician Decision|1|||
126724024|NCT01008995|455938839|FG000|Controlled Period|Adverse Event|1|||
126724025|NCT01008995|455938840|FG001|Controlled Period|Adverse Event|2|||
126724026|NCT01008995|455938841|FG002|Controlled Period|Adverse Event|0|||
126724027|NCT01008995|455938842|FG003|Controlled Period|Adverse Event|0|||
126724028|NCT01008995|455938839|FG000|Controlled Period|Other|2|||
126724029|NCT01008995|455938840|FG001|Controlled Period|Other|1|||
126724030|NCT01008995|455938841|FG002|Controlled Period|Other|0|||
126724031|NCT01008995|455938842|FG003|Controlled Period|Other|0|||
126724032|NCT01008995|455938839|FG000|After Controlled Period|Adverse Event|0|||
126724033|NCT01008995|455938840|FG001|After Controlled Period|Adverse Event|0|||
126724034|NCT01008995|455938841|FG002|After Controlled Period|Adverse Event|1|||
126724035|NCT01008995|455938842|FG003|After Controlled Period|Adverse Event|1|||
126724036|NCT01008995|455938839|FG000|After Controlled Period|Other|0|||
126724037|NCT01008995|455938840|FG001|After Controlled Period|Other|0|||
126724038|NCT01008995|455938841|FG002|After Controlled Period|Other|1|||
126724039|NCT01008995|455938842|FG003|After Controlled Period|Other|0|||
126724040|NCT02702518|455940274|FG000|Overall Study|Lost to Follow-up|3|||
126724041|NCT02702518|455940275|FG001|Overall Study|Lost to Follow-up|4|||
126724042|NCT00165841|455940276|FG000|Overall Study|Adverse Event|2|||
126724043|NCT00165841|455940277|FG001|Overall Study|Adverse Event|3|||
126724044|NCT00165841|455940276|FG000|Overall Study|Lack of Efficacy|6|||
126773009|NCT00572156|456125302|FG001|Overall Study|Adverse Event|1|||
126773010|NCT00572156|456125303|FG002|Overall Study|Adverse Event|5|||
126496333|NCT04256785|455117938|FG001|Overall Study|Withdrawal by Subject|1|||
126496334|NCT04256785|455117937|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
126496335|NCT04256785|455117938|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
126724045|NCT00165841|455940277|FG001|Overall Study|Lack of Efficacy|33|||
126724046|NCT00165841|455940276|FG000|Overall Study|Lost to Follow-up|4|||
126724047|NCT00165841|455940277|FG001|Overall Study|Lost to Follow-up|4|||
126724048|NCT00165841|455940276|FG000|Overall Study|Withdrawal by Subject|7|||
126724049|NCT00165841|455940277|FG001|Overall Study|Withdrawal by Subject|8|||
126724050|NCT00165841|455940276|FG000|Overall Study|Physician Decision|1|||
126724051|NCT00165841|455940277|FG001|Overall Study|Physician Decision|0|||
126724052|NCT00165841|455940276|FG000|Overall Study|Protocol Violation|6|||
126773011|NCT00572156|456125304|FG003|Overall Study|Adverse Event|1|||
126773012|NCT00572156|456125301|FG000|Overall Study|Lost to Follow-up|1|||
126773013|NCT00572156|456125302|FG001|Overall Study|Lost to Follow-up|1|||
126773014|NCT00572156|456125303|FG002|Overall Study|Lost to Follow-up|1|||
126773015|NCT00572156|456125304|FG003|Overall Study|Lost to Follow-up|0|||
126773016|NCT00572156|456125301|FG000|Overall Study|Protocol Violation|1|||
126773017|NCT00572156|456125302|FG001|Overall Study|Protocol Violation|2|||
126773018|NCT00572156|456125303|FG002|Overall Study|Protocol Violation|0|||
126773019|NCT00572156|456125304|FG003|Overall Study|Protocol Violation|2|||
126773020|NCT00572156|456125301|FG000|Overall Study|Patient/Parent Decision|1|||
126773021|NCT00572156|456125302|FG001|Overall Study|Patient/Parent Decision|6|||
126773022|NCT00572156|456125303|FG002|Overall Study|Patient/Parent Decision|4|||
126773023|NCT00572156|456125304|FG003|Overall Study|Patient/Parent Decision|3|||
126773024|NCT00572156|456125301|FG000|Overall Study|Sponsor Decision|20|||
126773025|NCT00572156|456125302|FG001|Overall Study|Sponsor Decision|16|||
126496336|NCT01170091|455117939|FG000|Overall Study|Missing efficacy evaluation|3|||
126773026|NCT00572156|456125303|FG002|Overall Study|Sponsor Decision|17|||
126773027|NCT00572156|456125304|FG003|Overall Study|Sponsor Decision|19|||
126773028|NCT02261974|456125305|FG000|Overall Study|Withdrawal by Subject|3|||
126773029|NCT02261974|456125306|FG001|Overall Study|Withdrawal by Subject|2|||
126773030|NCT02261974|456125305|FG000|Overall Study|Pregnancy|0|||
126773031|NCT02261974|456125306|FG001|Overall Study|Pregnancy|1|||
126773032|NCT02261974|456125305|FG000|Overall Study|Missed treatment cut-off date|6|||
126773033|NCT02261974|456125306|FG001|Overall Study|Missed treatment cut-off date|3|||
126773034|NCT02261974|456125305|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
126773035|NCT02261974|456125306|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
126773036|NCT02261974|456125305|FG000|Overall Study|Lost to Follow-up|2|||
126773037|NCT02261974|456125306|FG001|Overall Study|Lost to Follow-up|0|||
126773038|NCT02261974|456125305|FG000|Overall Study|Adverse Event|1|||
126773039|NCT02261974|456125306|FG001|Overall Study|Adverse Event|0|||
126773040|NCT01453374|456125307|FG000|Overall Study|Adverse Event|7|||
126773041|NCT01453374|456125307|FG000|Overall Study|Lack of Efficacy|1|||
126773042|NCT01453374|456125307|FG000|Overall Study|Lost to Follow-up|3|||
126773043|NCT01453374|456125307|FG000|Overall Study|Withdrawal by Subject|5|||
126773044|NCT01453374|456125307|FG000|Overall Study|Incarcerated|2|||
126773045|NCT05180630|456125308|FG000|First Intervention|Physician Decision|0|||
126773046|NCT05180630|456125309|FG001|First Intervention|Physician Decision|0|||
126773047|NCT05180630|456125310|FG002|First Intervention|Physician Decision|3|||
126773048|NCT00709735|456125318|FG000|Overall Study|Lost to Follow-up|1|||
126773049|NCT00709735|456125319|FG001|Overall Study|Lost to Follow-up|1|||
126773050|NCT00709735|456125318|FG000|Overall Study|Relapse into Opioid Abuse|0|||
126773051|NCT00709735|456125319|FG001|Overall Study|Relapse into Opioid Abuse|1|||
126773052|NCT00709735|456125318|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
126773053|NCT00709735|456125319|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
126773054|NCT00666718|456125320|FG000|Overall Study|Adverse Event|0|||
126773055|NCT00666718|456125321|FG001|Overall Study|Adverse Event|1|||
126773056|NCT00666718|456125320|FG000|Overall Study|Death|1|||
126773057|NCT00666718|456125321|FG001|Overall Study|Death|0|||
126773058|NCT00666718|456125320|FG000|Overall Study|Lost to Follow-up|1|||
126773059|NCT00666718|456125321|FG001|Overall Study|Lost to Follow-up|0|||
126773060|NCT00666718|456125320|FG000|Overall Study|Entry Criteria Not Met|2|||
126773061|NCT00666718|456125321|FG001|Overall Study|Entry Criteria Not Met|0|||
126773062|NCT00666718|456125320|FG000|Overall Study|Protocol Violation|1|||
126773063|NCT00666718|456125321|FG001|Overall Study|Protocol Violation|3|||
126773064|NCT00666718|456125320|FG000|Overall Study|Withdrawal by Subject|7|||
126773065|NCT00666718|456125321|FG001|Overall Study|Withdrawal by Subject|12|||
126773066|NCT00666718|456125320|FG000|Overall Study|Physician Decision|0|||
126773067|NCT00666718|456125321|FG001|Overall Study|Physician Decision|2|||
126773068|NCT03496207|456125322|FG000|Base Study|Adverse Event|0|||
126773069|NCT03496207|456125323|FG001|Base Study|Adverse Event|0|||
126773070|NCT03496207|456125324|FG002|Base Study|Adverse Event|1|||
126773071|NCT03496207|456125325|FG003|Base Study|Adverse Event|1|||
126773072|NCT03496207|456125326|FG004|Base Study|Adverse Event|4|||
126496337|NCT01170091|455117939|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
126773073|NCT03496207|456125322|FG000|Base Study|Death|0|||
126773074|NCT03496207|456125323|FG001|Base Study|Death|0|||
126773075|NCT03496207|456125324|FG002|Base Study|Death|0|||
126773076|NCT03496207|456125325|FG003|Base Study|Death|0|||
126773077|NCT03496207|456125326|FG004|Base Study|Death|1|||
126773078|NCT03496207|456125322|FG000|Base Study|Withdrawal by Subject|0|||
126773079|NCT03496207|456125323|FG001|Base Study|Withdrawal by Subject|0|||
126773080|NCT03496207|456125324|FG002|Base Study|Withdrawal by Subject|1|||
126773081|NCT03496207|456125325|FG003|Base Study|Withdrawal by Subject|0|||
126773082|NCT03496207|456125326|FG004|Base Study|Withdrawal by Subject|1|||
126773083|NCT03496207|456125322|FG000|Extension Period|Adverse Event|0|||
126773084|NCT03496207|456125323|FG001|Extension Period|Adverse Event|0|||
126559790|NCT01290094|455342614|FG000|Overall Study|Lost to Follow-up|5|||
126773085|NCT03496207|456125324|FG002|Extension Period|Adverse Event|0|||
126773086|NCT03496207|456125325|FG003|Extension Period|Adverse Event|1|||
126773087|NCT03496207|456125326|FG004|Extension Period|Adverse Event|1|||
126773088|NCT03496207|456125322|FG000|Extension Period|Death|1|||
126773089|NCT03496207|456125323|FG001|Extension Period|Death|0|||
126559791|NCT04091672|455344433|FG000|Overall Study|Death|6|||
126559792|NCT04091672|455344434|FG001|Overall Study|Death|6|||
126559793|NCT04091672|455344433|FG000|Overall Study|Lost to Follow-up|7|||
126559794|NCT04091672|455344434|FG001|Overall Study|Lost to Follow-up|7|||
126559795|NCT04091672|455344433|FG000|Overall Study|Withdrawal by Subject|3|||
126559796|NCT04091672|455344434|FG001|Overall Study|Withdrawal by Subject|3|||
126559797|NCT04091672|455344433|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
126559798|NCT04091672|455344434|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
126559799|NCT05296629|455344435|FG000|Overall Study|Withdrawal by Subject|3|||
126559800|NCT05296629|455344436|FG001|Overall Study|Withdrawal by Subject|10|||
126559801|NCT05296629|455344437|FG002|Overall Study|Withdrawal by Subject|4|||
126559802|NCT05296629|455344435|FG000|Overall Study|Lost to Follow-up|2|||
126559803|NCT05296629|455344436|FG001|Overall Study|Lost to Follow-up|7|||
126559804|NCT05296629|455344437|FG002|Overall Study|Lost to Follow-up|1|||
126559805|NCT05296629|455344435|FG000|Overall Study|Adverse Event|0|||
126559806|NCT05296629|455344436|FG001|Overall Study|Adverse Event|4|||
126559807|NCT05296629|455344437|FG002|Overall Study|Adverse Event|2|||
126559808|NCT05296629|455344435|FG000|Overall Study|Protocol Violation|0|||
126559809|NCT05296629|455344436|FG001|Overall Study|Protocol Violation|2|||
126559810|NCT05296629|455344437|FG002|Overall Study|Protocol Violation|0|||
126559811|NCT02401529|455344440|FG000|Overall Study|Lost to Follow-up|2|||
126559812|NCT02401529|455344441|FG001|Overall Study|Lost to Follow-up|1|||
126559813|NCT02401529|455344440|FG000|Overall Study|Physician Decision|2|||
126559814|NCT02401529|455344441|FG001|Overall Study|Physician Decision|6|||
126559815|NCT02401529|455344440|FG000|Overall Study|Protocol Violation|5|||
126559816|NCT02401529|455344441|FG001|Overall Study|Protocol Violation|0|||
126559817|NCT01518257|455344444|FG000|Overall Study|Lost to Follow-up|1|||
126559818|NCT01518257|455344445|FG001|Overall Study|Lost to Follow-up|0|||
126559819|NCT01518257|455344444|FG000|Overall Study|Other Miscellaneous Reason|1|||
126559820|NCT01518257|455344445|FG001|Overall Study|Other Miscellaneous Reason|0|||
126559821|NCT00924664|455344446|FG000|Overall Study|Adverse Event|23|||
126559822|NCT00924664|455344447|FG001|Overall Study|Adverse Event|39|||
126559823|NCT00924664|455344446|FG000|Overall Study|Lack of Efficacy|10|||
126559824|NCT00924664|455344447|FG001|Overall Study|Lack of Efficacy|15|||
126559825|NCT00924664|455344446|FG000|Overall Study|Lost to Follow-up|10|||
126559826|NCT00924664|455344447|FG001|Overall Study|Lost to Follow-up|12|||
126559827|NCT00924664|455344446|FG000|Overall Study|Withdrawal by Subject|47|||
126559828|NCT00924664|455344447|FG001|Overall Study|Withdrawal by Subject|71|||
126559829|NCT00924664|455344446|FG000|Overall Study|Protocol Violation|2|||
126559830|NCT00924664|455344447|FG001|Overall Study|Protocol Violation|5|||
126559831|NCT00924664|455344446|FG000|Overall Study|Pregnancy|1|||
126559832|NCT00924664|455344447|FG001|Overall Study|Pregnancy|1|||
126559833|NCT00924664|455344446|FG000|Overall Study|Death|0|||
126559834|NCT00924664|455344447|FG001|Overall Study|Death|2|||
126559835|NCT00924664|455344446|FG000|Overall Study|Study terminated by sponsor|199|||
126559836|NCT00924664|455344447|FG001|Overall Study|Study terminated by sponsor|330|||
126559837|NCT00924664|455344446|FG000|Overall Study|Other|29|||
126559838|NCT00924664|455344447|FG001|Overall Study|Other|52|||
126496338|NCT00391274|455117947|FG000|Overall Study|Death Due to Study Disease|55|||
126496339|NCT00391274|455117948|FG001|Overall Study|Death Due to Study Disease|45|||
126496340|NCT00391274|455117947|FG000|Overall Study|Lost to Follow-up|0|||
126496341|NCT00391274|455117948|FG001|Overall Study|Lost to Follow-up|3|||
126496342|NCT00391274|455117947|FG000|Overall Study|Physician Decision|4|||
126496343|NCT00391274|455117948|FG001|Overall Study|Physician Decision|2|||
126496344|NCT00391274|455117947|FG000|Overall Study|Withdrawal by Subject|0|||
126496345|NCT00391274|455117948|FG001|Overall Study|Withdrawal by Subject|3|||
126496346|NCT00391274|455117947|FG000|Overall Study|Death Due to Adverse Event|1|||
126496347|NCT00391274|455117948|FG001|Overall Study|Death Due to Adverse Event|3|||
126496348|NCT00391274|455117947|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
126496349|NCT00391274|455117948|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
126496350|NCT00391274|455117947|FG000|Overall Study|Death Not Study Related|0|||
126496351|NCT00391274|455117948|FG001|Overall Study|Death Not Study Related|1|||
126496352|NCT03447990|455117950|FG000|Overall Study|Withdrawal by Subject|0|||
126496353|NCT03447990|455117951|FG001|Overall Study|Withdrawal by Subject|0|||
126496354|NCT03447990|455117952|FG002|Overall Study|Withdrawal by Subject|0|||
126496355|NCT03447990|455117953|FG003|Overall Study|Withdrawal by Subject|0|||
126496356|NCT03447990|455117954|FG004|Overall Study|Withdrawal by Subject|0|||
126496357|NCT03447990|455117955|FG005|Overall Study|Withdrawal by Subject|0|||
126496358|NCT03447990|455117956|FG006|Overall Study|Withdrawal by Subject|1|||
126559839|NCT00924664|455344446|FG000|Overall Study|Randomized but not Treated|1|||
126559840|NCT00924664|455344447|FG001|Overall Study|Randomized but not Treated|0|||
126496359|NCT03559257|455117957|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
126559841|NCT03158948|455344449|FG000|Overall Study|Death|1|||
126559842|NCT03158948|455344450|FG001|Overall Study|Death|1|||
126559843|NCT03158948|455344451|FG002|Overall Study|Death|3|||
126724053|NCT00165841|455940277|FG001|Overall Study|Protocol Violation|8|||
126559844|NCT03158948|455344452|FG003|Overall Study|Death|2|||
126559845|NCT03158948|455344449|FG000|Overall Study|Physician Decision|0|||
126559846|NCT03158948|455344450|FG001|Overall Study|Physician Decision|0|||
126724054|NCT00165841|455940276|FG000|Overall Study|Other|3|||
126724055|NCT00165841|455940277|FG001|Overall Study|Other|5|||
126724056|NCT00165841|455940276|FG000|Overall Study|Medication Noncompliance|1|||
126724057|NCT00165841|455940277|FG001|Overall Study|Medication Noncompliance|1|||
126724058|NCT03196193|455940284|FG000|Overall Study|Adverse Event|1|||
126724059|NCT03196193|455940285|FG001|Overall Study|Adverse Event|0|||
126724060|NCT03196193|455940284|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
126724061|NCT03196193|455940285|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
126724062|NCT02709083|455940286|FG000|Overall Study|Original PI left institution|7|||
126724063|NCT01697267|455940287|FG000|Overall Study|Death|3|||
126496360|NCT03559257|455117958|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
126496361|NCT03559257|455117957|FG000|Double Blind Treatment Period|Protocol Violation|1|||
126496362|NCT03559257|455117958|FG001|Double Blind Treatment Period|Protocol Violation|4|||
126496363|NCT03559257|455117957|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
126496364|NCT03559257|455117958|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
126496365|NCT03559257|455117957|FG000|Double Blind Treatment Period|Adverse Event|0|||
126496366|NCT03559257|455117958|FG001|Double Blind Treatment Period|Adverse Event|1|||
126496367|NCT03559257|455117957|FG000|Double Blind Treatment Period|Screen Failure|0|||
126496368|NCT03559257|455117958|FG001|Double Blind Treatment Period|Screen Failure|1|||
126496369|NCT03559257|455117957|FG000|Open-label Treatment Period|Adverse Event|1|||
126496370|NCT03559257|455117958|FG001|Open-label Treatment Period|Adverse Event|4|||
126496371|NCT03559257|455117957|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
126496372|NCT03559257|455117958|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
126496373|NCT03559257|455117957|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
126496374|NCT03559257|455117958|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
126496375|NCT03559257|455117957|FG000|Open-label Treatment Period|Protocol Violation|2|||
126496376|NCT03559257|455117958|FG001|Open-label Treatment Period|Protocol Violation|0|||
126496377|NCT03559257|455117957|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
126496378|NCT03559257|455117958|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
126496379|NCT03559257|455117957|FG000|Open-label Treatment Period|Physician Decision|0|||
126496380|NCT03559257|455117958|FG001|Open-label Treatment Period|Physician Decision|1|||
126496381|NCT03630120|455117959|FG000|Overall Study|Disease progression|0|||
126496382|NCT03630120|455117960|FG001|Overall Study|Disease progression|1|||
126559847|NCT03158948|455344451|FG002|Overall Study|Physician Decision|0|||
126559848|NCT03158948|455344452|FG003|Overall Study|Physician Decision|1|||
126559849|NCT01876043|455344453|FG000|Overall Study|Death|1|||
126559850|NCT01876043|455344453|FG000|Overall Study|Withdrawal by Subject|1|||
126559851|NCT02206685|455344455|FG000|Overall Study|Surgery cancelled/changed|2|||
126559852|NCT02206685|455344456|FG001|Overall Study|Surgery cancelled/changed|3|||
126559853|NCT02206685|455344455|FG000|Overall Study|Withdrawal by Subject|1|||
126559854|NCT02206685|455344456|FG001|Overall Study|Withdrawal by Subject|2|||
126559855|NCT02206685|455344455|FG000|Overall Study|Protocol Violation|2|||
126559856|NCT02206685|455344456|FG001|Overall Study|Protocol Violation|2|||
126559857|NCT00079937|455344457|FG000|Overall Study|Adverse Event|2|||
126559858|NCT00079937|455344458|FG001|Overall Study|Adverse Event|1|||
126559859|NCT00079937|455344457|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126559860|NCT00079937|455344458|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126559861|NCT00079937|455344457|FG000|Overall Study|Subject no longer requires study drug|3|||
126559862|NCT00079937|455344458|FG001|Overall Study|Subject no longer requires study drug|0|||
126559863|NCT00079937|455344457|FG000|Overall Study|Protocol Violation|8|||
126559864|NCT00079937|455344458|FG001|Overall Study|Protocol Violation|6|||
126559865|NCT00079937|455344457|FG000|Overall Study|Withdrawal by Subject|21|||
126559866|NCT00079937|455344458|FG001|Overall Study|Withdrawal by Subject|7|||
126559867|NCT00079937|455344457|FG000|Overall Study|Lost to Follow-up|12|||
126559868|NCT00079937|455344458|FG001|Overall Study|Lost to Follow-up|5|||
126559869|NCT00079937|455344457|FG000|Overall Study|Administrative problems|22|||
126559870|NCT00079937|455344458|FG001|Overall Study|Administrative problems|11|||
126559871|NCT01616563|455344459|FG000|Overall Study|Lost to Follow-up|40|||
126559872|NCT00093795|455344460|FG000|Overall Study|No follow up data|20|||
126559873|NCT00093795|455344461|FG001|Overall Study|No follow up data|16|||
126559874|NCT00093795|455344462|FG002|Overall Study|No follow up data|17|||
126559875|NCT01195675|455344466|FG000|Overall Study|Adverse Event|1|||
126559876|NCT01195675|455344466|FG000|Overall Study|Withdrawal by Subject|2|||
126559877|NCT01106287|455344467|FG000|Overall Study|Adverse Event|1|||
126559878|NCT01106287|455344468|FG001|Overall Study|Adverse Event|0|||
126724064|NCT01697267|455940288|FG001|Overall Study|Death|1|||
126724065|NCT01697267|455940287|FG000|Overall Study|Withdrawal by Subject|5|||
126724066|NCT01697267|455940288|FG001|Overall Study|Withdrawal by Subject|5|||
126496383|NCT03630120|455117961|FG002|Overall Study|Disease progression|1|||
126496384|NCT03630120|455117962|FG003|Overall Study|Disease progression|1|||
126559879|NCT01106287|455344469|FG002|Overall Study|Adverse Event|0|||
126559880|NCT01106287|455344470|FG003|Overall Study|Adverse Event|0|||
126559881|NCT00072475|455344471|FG000|Overall Study|Adverse Event|44|||
126559882|NCT00072475|455344471|FG000|Overall Study|Death|3|||
126724067|NCT01697267|455940287|FG000|Overall Study|Adverse Event|2|||
126559883|NCT00072475|455344471|FG000|Overall Study|Withdrawal by Subject|46|||
126773090|NCT03496207|456125324|FG002|Extension Period|Death|0|||
126773091|NCT03496207|456125325|FG003|Extension Period|Death|1|||
126773092|NCT03496207|456125326|FG004|Extension Period|Death|2|||
126773093|NCT03496207|456125322|FG000|Extension Period|Withdrawal by Subject|1|||
126773094|NCT03496207|456125323|FG001|Extension Period|Withdrawal by Subject|0|||
126773095|NCT03496207|456125324|FG002|Extension Period|Withdrawal by Subject|0|||
126773096|NCT03496207|456125325|FG003|Extension Period|Withdrawal by Subject|1|||
126773097|NCT03496207|456125326|FG004|Extension Period|Withdrawal by Subject|1|||
126773098|NCT03496207|456125322|FG000|Extension Period|Elevated hemoglobin levels|0|||
126773099|NCT03496207|456125323|FG001|Extension Period|Elevated hemoglobin levels|0|||
126773100|NCT03496207|456125324|FG002|Extension Period|Elevated hemoglobin levels|0|||
126773101|NCT03496207|456125325|FG003|Extension Period|Elevated hemoglobin levels|0|||
126773102|NCT03496207|456125326|FG004|Extension Period|Elevated hemoglobin levels|1|||
126773103|NCT00810615|456125329|FG000|Overall Study|Withdrawal by Subject|1|||
126773104|NCT00810615|456125330|FG001|Overall Study|Withdrawal by Subject|1|||
126773105|NCT02525562|456125331|FG000|Overall Study|Death|9|||
126773106|NCT02525562|456125332|FG001|Overall Study|Death|0|||
126773107|NCT02525562|456125333|FG002|Overall Study|Death|0|||
126773108|NCT02525562|456125331|FG000|Overall Study|Lost to Follow-up|19|||
126773109|NCT02525562|456125332|FG001|Overall Study|Lost to Follow-up|0|||
126773110|NCT02525562|456125333|FG002|Overall Study|Lost to Follow-up|0|||
126773111|NCT02525562|456125331|FG000|Overall Study|Withdrawal by Subject|37|||
126773112|NCT02525562|456125332|FG001|Overall Study|Withdrawal by Subject|0|||
126773113|NCT02525562|456125333|FG002|Overall Study|Withdrawal by Subject|0|||
126773114|NCT02525562|456125331|FG000|Overall Study|Revision/Removal of Study Device|4|||
126773115|NCT02525562|456125332|FG001|Overall Study|Revision/Removal of Study Device|0|||
126773116|NCT02525562|456125333|FG002|Overall Study|Revision/Removal of Study Device|0|||
126773117|NCT02525562|456125331|FG000|Overall Study|Study Closed by Sponsor|154|||
126773118|NCT02525562|456125332|FG001|Overall Study|Study Closed by Sponsor|0|||
126773119|NCT02525562|456125333|FG002|Overall Study|Study Closed by Sponsor|0|||
126773120|NCT02567266|456125334|FG000|Overall Study|Withdrawal by Subject|10|||
126773121|NCT02567266|456125335|FG001|Overall Study|Withdrawal by Subject|7|||
126773122|NCT02567266|456125336|FG002|Overall Study|Withdrawal by Subject|6|||
126773123|NCT02567266|456125334|FG000|Overall Study|Lost to Follow-up|13|||
126773124|NCT02567266|456125335|FG001|Overall Study|Lost to Follow-up|8|||
126773125|NCT02567266|456125336|FG002|Overall Study|Lost to Follow-up|10|||
126773126|NCT01255722|456125337|FG000|Overall Study|Adverse Event|0|||
126773127|NCT01255722|456125338|FG001|Overall Study|Adverse Event|1|||
126773128|NCT01255722|456125339|FG002|Overall Study|Adverse Event|1|||
126773129|NCT01255722|456125337|FG000|Overall Study|asymptomatic patient|1|||
126773130|NCT01255722|456125338|FG001|Overall Study|asymptomatic patient|0|||
126773131|NCT01255722|456125339|FG002|Overall Study|asymptomatic patient|0|||
126773132|NCT01255722|456125337|FG000|Overall Study|beta-blocker contraindicated|2|||
126773133|NCT01255722|456125338|FG001|Overall Study|beta-blocker contraindicated|0|||
126773134|NCT01255722|456125339|FG002|Overall Study|beta-blocker contraindicated|0|||
126773135|NCT02164539|456125340|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
126773136|NCT02164539|456125341|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
126773137|NCT02164539|456125342|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
126773138|NCT02164539|456125343|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
126773139|NCT02164539|456125344|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
126773140|NCT02164539|456125345|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
126773141|NCT02164539|456125346|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
126773142|NCT02164539|456125340|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
126773143|NCT02164539|456125341|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
126773144|NCT02164539|456125342|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
126496385|NCT01387347|455117963|FG000|Overall Study|Lost to Follow-up|2|||
126496386|NCT01387347|455117964|FG001|Overall Study|Lost to Follow-up|1|||
126496387|NCT01519960|455117965|FG000|Overall Study|Withdrawal from the study|26|||
126496388|NCT01519960|455117966|FG001|Overall Study|Withdrawal from the study|22|||
126496389|NCT01519960|455117967|FG002|Overall Study|Withdrawal from the study|5|||
126496390|NCT00561080|455117970|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
126496391|NCT00561080|455117971|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
126773145|NCT02164539|456125343|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
126773146|NCT02164539|456125344|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
126773147|NCT02164539|456125345|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
126773148|NCT02164539|456125346|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
126773149|NCT02164539|456125340|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
126773150|NCT02164539|456125341|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
126773151|NCT02164539|456125342|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
126773152|NCT02164539|456125343|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
126773153|NCT02164539|456125344|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
126773154|NCT02164539|456125345|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
126496392|NCT00561080|455117972|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
126496393|NCT00561080|455117970|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
126773155|NCT02164539|456125346|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
126724068|NCT01697267|455940288|FG001|Overall Study|Adverse Event|1|||
126724069|NCT01697267|455940287|FG000|Overall Study|Lost to Follow-up|2|||
126724070|NCT01697267|455940288|FG001|Overall Study|Lost to Follow-up|4|||
126496394|NCT00561080|455117971|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
126496395|NCT00561080|455117972|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
126496396|NCT00561080|455117970|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
126496397|NCT00561080|455117971|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
126496398|NCT00561080|455117972|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
126496399|NCT00561080|455117970|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
126496400|NCT00561080|455117971|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
126496401|NCT00561080|455117972|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
126496402|NCT00561080|455117970|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
126496403|NCT00561080|455117971|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
126496404|NCT00561080|455117972|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
126496405|NCT00561080|455117970|FG000|Vaccination Period (up to Month 4)|Other|0|||
126496406|NCT00561080|455117971|FG001|Vaccination Period (up to Month 4)|Other|2|||
126496407|NCT00561080|455117972|FG002|Vaccination Period (up to Month 4)|Other|1|||
126496408|NCT00561080|455117970|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
126496409|NCT00561080|455117971|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
126496410|NCT00561080|455117972|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
126496411|NCT00561080|455117970|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
126496412|NCT00561080|455117971|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
126496413|NCT00561080|455117972|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
126496414|NCT00561080|455117970|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
126496415|NCT00561080|455117971|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
126496416|NCT00561080|455117972|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
126496417|NCT00561080|455117970|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
126496418|NCT00561080|455117971|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
126496419|NCT00561080|455117972|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
126496420|NCT00238121|455117973|FG000|Overall Study|Withdrawal by Subject|1|||
126496421|NCT00238121|455117974|FG001|Overall Study|Withdrawal by Subject|1|||
126496422|NCT00238121|455117973|FG000|Overall Study|Adverse Event|2|||
126496423|NCT00238121|455117974|FG001|Overall Study|Adverse Event|1|||
126496424|NCT02221284|455117975|FG000|Overall Study|Case Report Forms Uncollected|56|||
126496425|NCT02221284|455117975|FG000|Overall Study|Protocol Deviation|5|||
126496426|NCT00832585|455117986|FG000|Overall Study|Withdrawal by Subject|1|||
126496427|NCT00832585|455117986|FG000|Overall Study|Lost to Follow-up|1|||
126496428|NCT01374087|455117988|FG000|Overall Study|Adverse Event|1|||
126496429|NCT01374087|455117989|FG001|Overall Study|Adverse Event|0|||
126496430|NCT01374087|455117988|FG000|Overall Study|Disease progression|2|||
126496431|NCT01374087|455117989|FG001|Overall Study|Disease progression|2|||
126496432|NCT01374087|455117988|FG000|Overall Study|Study discontinued|13|||
126496433|NCT01374087|455117989|FG001|Overall Study|Study discontinued|13|||
126496434|NCT03526458|455117990|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
126496435|NCT03526458|455117991|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
126496436|NCT03526458|455117990|FG000|Overall Study|Stone passed, surgery cancelled|2|||
126496437|NCT03526458|455117991|FG001|Overall Study|Stone passed, surgery cancelled|1|||
126496438|NCT03526458|455117990|FG000|Overall Study|Withdrawal by Subject|1|||
126496439|NCT03526458|455117991|FG001|Overall Study|Withdrawal by Subject|0|||
126496440|NCT03526458|455117990|FG000|Overall Study|Physician Decision|2|||
126496441|NCT03526458|455117991|FG001|Overall Study|Physician Decision|1|||
126496442|NCT03526458|455117990|FG000|Overall Study|Lack of equipment|1|||
126496443|NCT03526458|455117991|FG001|Overall Study|Lack of equipment|1|||
126496444|NCT04170348|455117992|FG000|Overall Study|Lost to Follow-up|2|||
126496445|NCT04170348|455117993|FG001|Overall Study|Lost to Follow-up|2|||
126496446|NCT04170348|455117992|FG000|Overall Study|Withdrawal by Subject|1|||
126496447|NCT04170348|455117993|FG001|Overall Study|Withdrawal by Subject|5|||
126496448|NCT04170348|455117992|FG000|Overall Study|Non-adherence|1|||
126496449|NCT04170348|455117993|FG001|Overall Study|Non-adherence|1|||
126496450|NCT04170348|455117992|FG000|Overall Study|Adverse Event|1|||
126496451|NCT04170348|455117993|FG001|Overall Study|Adverse Event|0|||
126496452|NCT01082965|455117994|FG000|Overall Study|Protocol Violation|0|||
126496453|NCT01082965|455117995|FG001|Overall Study|Protocol Violation|1|||
126496454|NCT01082965|455117994|FG000|Overall Study|Other|1|||
126496455|NCT01082965|455117995|FG001|Overall Study|Other|1|||
126496456|NCT02587065|455117996|FG000|Overall Study|Adverse Event|14|||
126496457|NCT02587065|455117996|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
126496458|NCT02587065|455117996|FG000|Overall Study|Non-adherence to the Protocol|3|||
126724071|NCT01697267|455940287|FG000|Overall Study|Physician Decision|2|||
126496459|NCT02587065|455117996|FG000|Overall Study|Discontinuation of Study Medication|2|||
126496460|NCT02587065|455117996|FG000|Overall Study|Reason not Specified|3|||
126724072|NCT01697267|455940288|FG001|Overall Study|Physician Decision|4|||
126724073|NCT00333619|455940289|FG000|Overall Study|Death|12|||
126724074|NCT00333619|455940290|FG001|Overall Study|Death|6|||
126496461|NCT00445965|455117999|FG000|Overall Study|Adverse Event|2|||
126496462|NCT00445965|455117999|FG000|Overall Study|Physician Decision|1|||
126496463|NCT00445965|455117999|FG000|Overall Study|Enrolled but not treated|1|||
126496464|NCT00445965|455117999|FG000|Overall Study|Removed due to progressive disease|29|||
126496465|NCT02406651|455118002|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
126496466|NCT01602380|455118006|FG000|Overall Study|Death|147|||
126496467|NCT01602380|455118007|FG001|Overall Study|Death|145|||
126496468|NCT01602380|455118006|FG000|Overall Study|Withdrawal by Subject|39|||
126496469|NCT01602380|455118007|FG001|Overall Study|Withdrawal by Subject|41|||
126496470|NCT01602380|455118006|FG000|Overall Study|Lost to Follow-up|15|||
126496471|NCT01602380|455118007|FG001|Overall Study|Lost to Follow-up|12|||
126496472|NCT01602380|455118006|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
126496473|NCT01602380|455118007|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
126496474|NCT01602380|455118006|FG000|Overall Study|Other|2|||
126496475|NCT01602380|455118007|FG001|Overall Study|Other|0|||
126496476|NCT01064401|455118009|FG000|Overall Study|Adverse Event|47|||
126496477|NCT01064401|455118010|FG001|Overall Study|Adverse Event|56|||
126496478|NCT01064401|455118009|FG000|Overall Study|Lack of Efficacy|46|||
126496479|NCT01064401|455118010|FG001|Overall Study|Lack of Efficacy|23|||
126496480|NCT01064401|455118009|FG000|Overall Study|Lost to Follow-up|12|||
126496481|NCT01064401|455118010|FG001|Overall Study|Lost to Follow-up|9|||
126496482|NCT01064401|455118009|FG000|Overall Study|Consent Withdrawn|98|||
126496483|NCT01064401|455118010|FG001|Overall Study|Consent Withdrawn|80|||
126496484|NCT01064401|455118009|FG000|Overall Study|Investigator Decision|4|||
126496485|NCT01064401|455118010|FG001|Overall Study|Investigator Decision|6|||
126496486|NCT01064401|455118009|FG000|Overall Study|Death|4|||
126496487|NCT01064401|455118010|FG001|Overall Study|Death|0|||
126496488|NCT01064401|455118009|FG000|Overall Study|Pregnancy|4|||
126496489|NCT01064401|455118010|FG001|Overall Study|Pregnancy|7|||
126496490|NCT01064401|455118009|FG000|Overall Study|Noncompliance|7|||
126496491|NCT01064401|455118010|FG001|Overall Study|Noncompliance|8|||
126496492|NCT01064401|455118009|FG000|Overall Study|Site Closure|4|||
126496493|NCT01064401|455118010|FG001|Overall Study|Site Closure|5|||
126496494|NCT01064401|455118009|FG000|Overall Study|Other|2|||
126496495|NCT01064401|455118010|FG001|Overall Study|Other|1|||
126496496|NCT03158051|455118011|FG000|Overall Study|Lost to Follow-up|41|||
126496497|NCT03158051|455118012|FG001|Overall Study|Lost to Follow-up|47|||
126496498|NCT03158051|455118011|FG000|Overall Study|Physician Decision|6|||
126496499|NCT03158051|455118012|FG001|Overall Study|Physician Decision|7|||
126496500|NCT03158051|455118011|FG000|Overall Study|Withdrawal by Subject|24|||
126496501|NCT03158051|455118012|FG001|Overall Study|Withdrawal by Subject|15|||
126496502|NCT03158051|455118011|FG000|Overall Study|Death|0|||
126496503|NCT03158051|455118012|FG001|Overall Study|Death|1|||
126496504|NCT02738151|455118013|FG000|Overall Study|Randomized but not treated|4|||
126496505|NCT02738151|455118014|FG001|Overall Study|Randomized but not treated|1|||
126496506|NCT02738151|455118013|FG000|Overall Study|Adverse Event|4|||
126496507|NCT02738151|455118014|FG001|Overall Study|Adverse Event|5|||
126496508|NCT02738151|455118013|FG000|Overall Study|Hypoglycemia|0|||
126496509|NCT02738151|455118014|FG001|Overall Study|Hypoglycemia|1|||
126496510|NCT02738151|455118013|FG000|Overall Study|Poor Compliance to Protocol|4|||
126496511|NCT02738151|455118014|FG001|Overall Study|Poor Compliance to Protocol|3|||
126496512|NCT02738151|455118013|FG000|Overall Study|Other than specified above|11|||
126496513|NCT02738151|455118014|FG001|Overall Study|Other than specified above|21|||
126496514|NCT02005250|455118015|FG000|Overall Study|Lost to Follow-up|15|||
126496515|NCT02005250|455118016|FG001|Overall Study|Lost to Follow-up|5|||
126496516|NCT02588833|455118017|FG000|Part 1|Withdrawal by Subject|1|||
126496517|NCT02588833|455118018|FG001|Part 1|Withdrawal by Subject|0|||
126496518|NCT02588833|455118017|FG000|Part 2A|Physician Decision|0|||
126496519|NCT02588833|455118018|FG001|Part 2A|Physician Decision|1|||
126496520|NCT02588833|455118017|FG000|Part 2A|Withdrawal by Subject|0|||
126496521|NCT02588833|455118018|FG001|Part 2A|Withdrawal by Subject|1|||
126496522|NCT02588833|455118017|FG000|Part 2B|Adverse Event|0|||
126496523|NCT02588833|455118018|FG001|Part 2B|Adverse Event|1|||
126496524|NCT02588833|455118017|FG000|Part 2C|Adverse Event|0|||
126496525|NCT02588833|455118018|FG001|Part 2C|Adverse Event|1|||
126496526|NCT02588833|455118017|FG000|Part 2C|Withdrawal by Subject|0|||
126496527|NCT02588833|455118018|FG001|Part 2C|Withdrawal by Subject|1|||
126496528|NCT02588833|455118017|FG000|Part 3 (Safety Follow-up)|Other|0|||
126496529|NCT02588833|455118018|FG001|Part 3 (Safety Follow-up)|Other|2|||
126496530|NCT03649711|455118020|FG000|Overall Study|Adverse Event|0|||
126496531|NCT03649711|455118021|FG001|Overall Study|Adverse Event|1|||
126496532|NCT03649711|455118022|FG002|Overall Study|Adverse Event|0|||
126496533|NCT03649711|455118020|FG000|Overall Study|Kidney Transplant|1|||
126496534|NCT03649711|455118021|FG001|Overall Study|Kidney Transplant|0|||
126496535|NCT03649711|455118022|FG002|Overall Study|Kidney Transplant|0|||
126496536|NCT04007094|455118027|FG000|Overall Study|Lost to Follow-up|1|||
126496537|NCT04007094|455118028|FG001|Overall Study|Lost to Follow-up|1|||
126496538|NCT02946047|455118029|FG000|Overall Study|Adverse Event|1|||
126496539|NCT02946047|455118030|FG001|Overall Study|Adverse Event|0|||
126724075|NCT00333619|455940289|FG000|Overall Study|Withdrawal by Subject|6|||
126724076|NCT00333619|455940290|FG001|Overall Study|Withdrawal by Subject|1|||
126496540|NCT02946047|455118031|FG002|Overall Study|Adverse Event|0|||
126496541|NCT02946047|455118032|FG003|Overall Study|Adverse Event|0|||
126496542|NCT01581307|455118033|FG000|Overall Study|Withdrawal by Subject|1|||
126496543|NCT01816893|455118036|FG000|Washout Period|Withdrawal by Subject|2|||
126496544|NCT01816893|455118037|FG001|Washout Period|Withdrawal by Subject|0|||
126496545|NCT00939809|455119699|FG000|Overall Study|Adverse Event|2|||
126496546|NCT00939809|455119699|FG000|Overall Study|Death|1|||
126496547|NCT00702403|455119700|FG000|From Consent to Engraftment|Progressive leukemia|6|||
126496548|NCT00702403|455119700|FG000|From Consent to Engraftment|Critically ill|2|||
126496549|NCT00702403|455119700|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
126496550|NCT00702403|455119700|FG000|From Consent to Engraftment|Myocardial infarction|1|||
126496551|NCT00702403|455119700|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
126496552|NCT00702403|455119700|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
126496553|NCT00702403|455119700|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
126496554|NCT00702403|455119700|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
126496555|NCT00702403|455119700|FG000|From Engraftment to Study Completion|Non-compliance|2|||
126496556|NCT00702403|455119700|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
126496557|NCT00702403|455119700|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
126496558|NCT00702403|455119700|FG000|From Engraftment to Study Completion|Suicide|1|||
126496559|NCT00702403|455119700|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
126496560|NCT00702403|455119700|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
126496561|NCT00702403|455119700|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
126496562|NCT00380978|455119702|FG000|Overall Study|Refused allocated intervention|0|||
126496563|NCT00380978|455119703|FG001|Overall Study|Refused allocated intervention|6|||
126496564|NCT00380978|455119702|FG000|Overall Study|Wrong study envelope|0|||
126496565|NCT00380978|455119703|FG001|Overall Study|Wrong study envelope|2|||
126496566|NCT00380978|455119702|FG000|Overall Study|Allocation prior to analgesia request|1|||
126496567|NCT00380978|455119703|FG001|Overall Study|Allocation prior to analgesia request|2|||
126496568|NCT00380978|455119702|FG000|Overall Study|Parous patient|1|||
126496569|NCT00380978|455119703|FG001|Overall Study|Parous patient|0|||
126496570|NCT04146545|455119704|FG000|Overall Study|deemed ineligible after randomization|1|||
126496571|NCT04146545|455119705|FG001|Overall Study|deemed ineligible after randomization|0|||
126496572|NCT01729754|455119706|FG000|Part 1|Adverse Event|2|||
126496573|NCT01729754|455119707|FG001|Part 1|Adverse Event|0|||
126496574|NCT01729754|455119708|FG002|Part 1|Adverse Event|0|||
126496575|NCT01729754|455119709|FG003|Part 1|Adverse Event|1|||
126496576|NCT01729754|455119710|FG004|Part 1|Adverse Event|0|||
126496577|NCT01729754|455119711|FG005|Part 1|Adverse Event|0|||
126496578|NCT01729754|455119712|FG006|Part 1|Adverse Event|2|||
126496579|NCT01729754|455119713|FG007|Part 1|Adverse Event|0|||
126496580|NCT01729754|455119714|FG008|Part 1|Adverse Event|0|||
126496581|NCT01729754|455119715|FG009|Part 1|Adverse Event|5|||
126496582|NCT01729754|455119706|FG000|Part 1|Lack of Efficacy|1|||
126496583|NCT01729754|455119707|FG001|Part 1|Lack of Efficacy|0|||
126496584|NCT01729754|455119708|FG002|Part 1|Lack of Efficacy|0|||
126496585|NCT01729754|455119709|FG003|Part 1|Lack of Efficacy|0|||
126496586|NCT01729754|455119710|FG004|Part 1|Lack of Efficacy|0|||
126496587|NCT01729754|455119711|FG005|Part 1|Lack of Efficacy|0|||
126496588|NCT01729754|455119712|FG006|Part 1|Lack of Efficacy|2|||
126496589|NCT01729754|455119713|FG007|Part 1|Lack of Efficacy|0|||
126496590|NCT01729754|455119714|FG008|Part 1|Lack of Efficacy|0|||
126496591|NCT01729754|455119715|FG009|Part 1|Lack of Efficacy|0|||
126496592|NCT01729754|455119706|FG000|Part 1|Lost to Follow-up|1|||
126496593|NCT01729754|455119707|FG001|Part 1|Lost to Follow-up|0|||
126496594|NCT01729754|455119708|FG002|Part 1|Lost to Follow-up|0|||
126496595|NCT01729754|455119709|FG003|Part 1|Lost to Follow-up|2|||
126496596|NCT01729754|455119710|FG004|Part 1|Lost to Follow-up|0|||
126496597|NCT01729754|455119711|FG005|Part 1|Lost to Follow-up|0|||
126496598|NCT01729754|455119712|FG006|Part 1|Lost to Follow-up|3|||
126496599|NCT01729754|455119713|FG007|Part 1|Lost to Follow-up|0|||
126496600|NCT01729754|455119714|FG008|Part 1|Lost to Follow-up|0|||
126496601|NCT01729754|455119715|FG009|Part 1|Lost to Follow-up|3|||
126496602|NCT01729754|455119706|FG000|Part 1|Non-compliance with Study Drug|1|||
126496603|NCT01729754|455119707|FG001|Part 1|Non-compliance with Study Drug|0|||
126496604|NCT01729754|455119708|FG002|Part 1|Non-compliance with Study Drug|0|||
126496605|NCT01729754|455119709|FG003|Part 1|Non-compliance with Study Drug|0|||
126496606|NCT01729754|455119710|FG004|Part 1|Non-compliance with Study Drug|0|||
126496607|NCT01729754|455119711|FG005|Part 1|Non-compliance with Study Drug|0|||
126496608|NCT01729754|455119712|FG006|Part 1|Non-compliance with Study Drug|0|||
126496609|NCT01729754|455119713|FG007|Part 1|Non-compliance with Study Drug|0|||
126559884|NCT00072475|455344471|FG000|Overall Study|Patient/Investigator Decision|4|||
126496610|NCT01729754|455119714|FG008|Part 1|Non-compliance with Study Drug|0|||
126496611|NCT01729754|455119715|FG009|Part 1|Non-compliance with Study Drug|0|||
126496612|NCT01729754|455119706|FG000|Part 1|Physician Decision|0|||
126496613|NCT01729754|455119707|FG001|Part 1|Physician Decision|0|||
126496614|NCT01729754|455119708|FG002|Part 1|Physician Decision|0|||
126496615|NCT01729754|455119709|FG003|Part 1|Physician Decision|0|||
126496616|NCT01729754|455119710|FG004|Part 1|Physician Decision|0|||
126496617|NCT01729754|455119711|FG005|Part 1|Physician Decision|0|||
126496618|NCT01729754|455119712|FG006|Part 1|Physician Decision|0|||
126496619|NCT01729754|455119713|FG007|Part 1|Physician Decision|0|||
126496620|NCT01729754|455119714|FG008|Part 1|Physician Decision|0|||
126724077|NCT00333619|455940289|FG000|Overall Study|Lost to Follow-up|3|||
126724078|NCT00333619|455940290|FG001|Overall Study|Lost to Follow-up|3|||
126724079|NCT04031404|455940291|FG000|Baseline|Lost to Follow-up|0|||
126724080|NCT04031404|455940292|FG001|Baseline|Lost to Follow-up|1|||
126496621|NCT01729754|455119715|FG009|Part 1|Physician Decision|4|||
126496622|NCT01729754|455119706|FG000|Part 1|Pregnancy|0|||
126496623|NCT01729754|455119707|FG001|Part 1|Pregnancy|0|||
126496624|NCT01729754|455119708|FG002|Part 1|Pregnancy|0|||
126724081|NCT04031404|455940291|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
126724082|NCT04031404|455940292|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
126724083|NCT04031404|455940291|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
126724084|NCT04031404|455940292|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
126724085|NCT04031404|455940291|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
126724086|NCT04031404|455940292|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
126724087|NCT04031404|455940291|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
126724088|NCT04031404|455940292|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
126724089|NCT02796391|455940295|FG000|Overall Study|Lost to Follow-up|2|||
126724090|NCT02796391|455940296|FG001|Overall Study|Lost to Follow-up|2|||
126724091|NCT02796391|455940297|FG002|Overall Study|Lost to Follow-up|13|||
126724092|NCT02796391|455940298|FG003|Overall Study|Lost to Follow-up|8|||
126724093|NCT02796391|455940299|FG004|Overall Study|Lost to Follow-up|14|||
126724094|NCT02796391|455940300|FG005|Overall Study|Lost to Follow-up|13|||
126724095|NCT02796391|455940295|FG000|Overall Study|COVID|0|||
126724096|NCT02796391|455940296|FG001|Overall Study|COVID|0|||
126724097|NCT02796391|455940297|FG002|Overall Study|COVID|5|||
126724098|NCT02796391|455940298|FG003|Overall Study|COVID|5|||
126724099|NCT02796391|455940299|FG004|Overall Study|COVID|2|||
126724100|NCT02796391|455940300|FG005|Overall Study|COVID|4|||
126724101|NCT02796391|455940295|FG000|Overall Study|Participant did not like study cigarettes|0|||
126724102|NCT02796391|455940296|FG001|Overall Study|Participant did not like study cigarettes|0|||
126724103|NCT02796391|455940297|FG002|Overall Study|Participant did not like study cigarettes|3|||
126724104|NCT02796391|455940298|FG003|Overall Study|Participant did not like study cigarettes|0|||
126724105|NCT02796391|455940299|FG004|Overall Study|Participant did not like study cigarettes|0|||
126724106|NCT02796391|455940300|FG005|Overall Study|Participant did not like study cigarettes|0|||
126724107|NCT02796391|455940295|FG000|Overall Study|Withdrawal by Subject|1|||
126496625|NCT01729754|455119709|FG003|Part 1|Pregnancy|1|||
126496626|NCT01729754|455119710|FG004|Part 1|Pregnancy|0|||
126496627|NCT01729754|455119711|FG005|Part 1|Pregnancy|0|||
126496628|NCT01729754|455119712|FG006|Part 1|Pregnancy|0|||
126496629|NCT01729754|455119713|FG007|Part 1|Pregnancy|0|||
126496630|NCT01729754|455119714|FG008|Part 1|Pregnancy|0|||
126496631|NCT01729754|455119715|FG009|Part 1|Pregnancy|1|||
126496632|NCT01729754|455119706|FG000|Part 1|Progressive Disease|0|||
126496633|NCT01729754|455119707|FG001|Part 1|Progressive Disease|0|||
126496634|NCT01729754|455119708|FG002|Part 1|Progressive Disease|0|||
126496635|NCT01729754|455119709|FG003|Part 1|Progressive Disease|0|||
126496636|NCT01729754|455119710|FG004|Part 1|Progressive Disease|0|||
126496637|NCT01729754|455119711|FG005|Part 1|Progressive Disease|0|||
126496638|NCT01729754|455119712|FG006|Part 1|Progressive Disease|0|||
126496639|NCT01729754|455119713|FG007|Part 1|Progressive Disease|0|||
126496640|NCT01729754|455119714|FG008|Part 1|Progressive Disease|0|||
126496641|NCT01729754|455119715|FG009|Part 1|Progressive Disease|1|||
126496642|NCT01729754|455119706|FG000|Part 1|Protocol Violation|2|||
126496643|NCT01729754|455119707|FG001|Part 1|Protocol Violation|0|||
126496644|NCT01729754|455119708|FG002|Part 1|Protocol Violation|0|||
126496645|NCT01729754|455119709|FG003|Part 1|Protocol Violation|1|||
126496646|NCT01729754|455119710|FG004|Part 1|Protocol Violation|0|||
126496647|NCT01729754|455119711|FG005|Part 1|Protocol Violation|0|||
126496648|NCT01729754|455119712|FG006|Part 1|Protocol Violation|1|||
126496649|NCT01729754|455119713|FG007|Part 1|Protocol Violation|0|||
126496650|NCT01729754|455119714|FG008|Part 1|Protocol Violation|0|||
126496651|NCT01729754|455119715|FG009|Part 1|Protocol Violation|0|||
126496652|NCT01729754|455119706|FG000|Part 1|Withdrawal by Subject|5|||
126724108|NCT02796391|455940296|FG001|Overall Study|Withdrawal by Subject|1|||
126724109|NCT02796391|455940297|FG002|Overall Study|Withdrawal by Subject|4|||
126724110|NCT02796391|455940298|FG003|Overall Study|Withdrawal by Subject|3|||
126724111|NCT02796391|455940299|FG004|Overall Study|Withdrawal by Subject|4|||
126724112|NCT02796391|455940300|FG005|Overall Study|Withdrawal by Subject|3|||
126724113|NCT02796391|455940295|FG000|Overall Study|Adverse Event|0|||
126496653|NCT01729754|455119707|FG001|Part 1|Withdrawal by Subject|0|||
126496654|NCT01729754|455119708|FG002|Part 1|Withdrawal by Subject|0|||
126496655|NCT01729754|455119709|FG003|Part 1|Withdrawal by Subject|7|||
126496656|NCT01729754|455119710|FG004|Part 1|Withdrawal by Subject|0|||
126496657|NCT01729754|455119711|FG005|Part 1|Withdrawal by Subject|0|||
126496658|NCT01729754|455119712|FG006|Part 1|Withdrawal by Subject|5|||
126496659|NCT01729754|455119713|FG007|Part 1|Withdrawal by Subject|0|||
126496660|NCT01729754|455119714|FG008|Part 1|Withdrawal by Subject|0|||
126496661|NCT01729754|455119715|FG009|Part 1|Withdrawal by Subject|6|||
126496662|NCT01729754|455119706|FG000|Part 1|Other Protocol Specified Criteria|2|||
126496663|NCT01729754|455119707|FG001|Part 1|Other Protocol Specified Criteria|0|||
126496664|NCT01729754|455119708|FG002|Part 1|Other Protocol Specified Criteria|0|||
126496665|NCT01729754|455119709|FG003|Part 1|Other Protocol Specified Criteria|0|||
126496666|NCT01729754|455119710|FG004|Part 1|Other Protocol Specified Criteria|0|||
126496667|NCT01729754|455119711|FG005|Part 1|Other Protocol Specified Criteria|0|||
126496668|NCT01729754|455119712|FG006|Part 1|Other Protocol Specified Criteria|1|||
126496669|NCT01729754|455119713|FG007|Part 1|Other Protocol Specified Criteria|0|||
126496670|NCT01729754|455119714|FG008|Part 1|Other Protocol Specified Criteria|0|||
126496671|NCT01729754|455119715|FG009|Part 1|Other Protocol Specified Criteria|4|||
126496672|NCT01729754|455119706|FG000|Part 2|Adverse Event|2|||
126496673|NCT01729754|455119707|FG001|Part 2|Adverse Event|0|||
126496674|NCT01729754|455119708|FG002|Part 2|Adverse Event|0|||
126496675|NCT01729754|455119709|FG003|Part 2|Adverse Event|0|||
126496676|NCT01729754|455119710|FG004|Part 2|Adverse Event|0|||
126496677|NCT01729754|455119711|FG005|Part 2|Adverse Event|0|||
126496678|NCT01729754|455119712|FG006|Part 2|Adverse Event|0|||
126496679|NCT01729754|455119713|FG007|Part 2|Adverse Event|0|||
126496680|NCT01729754|455119714|FG008|Part 2|Adverse Event|1|||
126496681|NCT01729754|455119715|FG009|Part 2|Adverse Event|2|||
126496682|NCT01729754|455119706|FG000|Part 2|Lack of Efficacy|0|||
126496683|NCT01729754|455119707|FG001|Part 2|Lack of Efficacy|0|||
126496684|NCT01729754|455119708|FG002|Part 2|Lack of Efficacy|0|||
126496685|NCT01729754|455119709|FG003|Part 2|Lack of Efficacy|0|||
126496686|NCT01729754|455119710|FG004|Part 2|Lack of Efficacy|0|||
126496687|NCT01729754|455119711|FG005|Part 2|Lack of Efficacy|0|||
126496688|NCT01729754|455119712|FG006|Part 2|Lack of Efficacy|0|||
126496689|NCT01729754|455119713|FG007|Part 2|Lack of Efficacy|0|||
126496690|NCT01729754|455119714|FG008|Part 2|Lack of Efficacy|2|||
126496691|NCT01729754|455119715|FG009|Part 2|Lack of Efficacy|2|||
126496692|NCT01729754|455119706|FG000|Part 2|Lost to Follow-up|0|||
126496693|NCT01729754|455119707|FG001|Part 2|Lost to Follow-up|0|||
126496694|NCT01729754|455119708|FG002|Part 2|Lost to Follow-up|0|||
126496695|NCT01729754|455119709|FG003|Part 2|Lost to Follow-up|2|||
126496696|NCT01729754|455119710|FG004|Part 2|Lost to Follow-up|0|||
126496697|NCT01729754|455119711|FG005|Part 2|Lost to Follow-up|0|||
126496698|NCT01729754|455119712|FG006|Part 2|Lost to Follow-up|0|||
126496699|NCT01729754|455119713|FG007|Part 2|Lost to Follow-up|1|||
126496700|NCT01729754|455119714|FG008|Part 2|Lost to Follow-up|0|||
126496701|NCT01729754|455119715|FG009|Part 2|Lost to Follow-up|2|||
126496702|NCT01729754|455119706|FG000|Part 2|Non-Compliance with Study Drug|0|||
126496703|NCT01729754|455119707|FG001|Part 2|Non-Compliance with Study Drug|0|||
126496704|NCT01729754|455119708|FG002|Part 2|Non-Compliance with Study Drug|0|||
126496705|NCT01729754|455119709|FG003|Part 2|Non-Compliance with Study Drug|0|||
126496706|NCT01729754|455119710|FG004|Part 2|Non-Compliance with Study Drug|0|||
126496707|NCT01729754|455119711|FG005|Part 2|Non-Compliance with Study Drug|0|||
126496708|NCT01729754|455119712|FG006|Part 2|Non-Compliance with Study Drug|0|||
126496709|NCT01729754|455119713|FG007|Part 2|Non-Compliance with Study Drug|0|||
126496710|NCT01729754|455119714|FG008|Part 2|Non-Compliance with Study Drug|0|||
126496711|NCT01729754|455119715|FG009|Part 2|Non-Compliance with Study Drug|1|||
126496712|NCT01729754|455119706|FG000|Part 2|Pregnancy|0|||
126496713|NCT01729754|455119707|FG001|Part 2|Pregnancy|0|||
126496714|NCT01729754|455119708|FG002|Part 2|Pregnancy|0|||
126496715|NCT01729754|455119709|FG003|Part 2|Pregnancy|1|||
126496716|NCT01729754|455119710|FG004|Part 2|Pregnancy|0|||
126496717|NCT01729754|455119711|FG005|Part 2|Pregnancy|0|||
126496718|NCT01729754|455119712|FG006|Part 2|Pregnancy|0|||
126496719|NCT01729754|455119713|FG007|Part 2|Pregnancy|0|||
126496720|NCT01729754|455119714|FG008|Part 2|Pregnancy|0|||
126496721|NCT01729754|455119715|FG009|Part 2|Pregnancy|1|||
126496722|NCT01729754|455119706|FG000|Part 2|Withdrawal by Subject|3|||
126496723|NCT01729754|455119707|FG001|Part 2|Withdrawal by Subject|0|||
126496724|NCT01729754|455119708|FG002|Part 2|Withdrawal by Subject|0|||
126496725|NCT01729754|455119709|FG003|Part 2|Withdrawal by Subject|2|||
126496726|NCT01729754|455119710|FG004|Part 2|Withdrawal by Subject|0|||
126559885|NCT04730947|455344472|FG000|Overall Study|Withdrawal by Subject|0|||
126496727|NCT01729754|455119711|FG005|Part 2|Withdrawal by Subject|0|||
126496728|NCT01729754|455119712|FG006|Part 2|Withdrawal by Subject|0|||
126496729|NCT01729754|455119713|FG007|Part 2|Withdrawal by Subject|1|||
126496730|NCT01729754|455119714|FG008|Part 2|Withdrawal by Subject|1|||
126496731|NCT01729754|455119715|FG009|Part 2|Withdrawal by Subject|4|||
126496732|NCT01729754|455119706|FG000|Part 2|Other Protocol Specified Criteria|1|||
126496733|NCT01729754|455119707|FG001|Part 2|Other Protocol Specified Criteria|0|||
126496734|NCT01729754|455119708|FG002|Part 2|Other Protocol Specified Criteria|0|||
126496735|NCT01729754|455119709|FG003|Part 2|Other Protocol Specified Criteria|0|||
126496736|NCT01729754|455119710|FG004|Part 2|Other Protocol Specified Criteria|0|||
126496737|NCT01729754|455119711|FG005|Part 2|Other Protocol Specified Criteria|0|||
126496738|NCT01729754|455119712|FG006|Part 2|Other Protocol Specified Criteria|0|||
126496739|NCT01729754|455119713|FG007|Part 2|Other Protocol Specified Criteria|1|||
126496740|NCT01729754|455119714|FG008|Part 2|Other Protocol Specified Criteria|0|||
126773156|NCT02164539|456125340|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
126773157|NCT02164539|456125341|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
126773158|NCT02164539|456125342|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
126773159|NCT02164539|456125343|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
126773160|NCT02164539|456125344|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
126773161|NCT02164539|456125345|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
126773162|NCT02164539|456125346|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
126773163|NCT02164539|456125340|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
126773164|NCT02164539|456125341|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
126773165|NCT02164539|456125342|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
126773166|NCT02164539|456125343|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
126773167|NCT02164539|456125344|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
126773168|NCT02164539|456125345|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
126773169|NCT02164539|456125346|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
126773170|NCT02164539|456125340|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
126773171|NCT02164539|456125341|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
126773172|NCT02164539|456125342|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
126773173|NCT02164539|456125343|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
126773174|NCT02164539|456125344|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
126773175|NCT02164539|456125345|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
126773176|NCT02164539|456125346|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
126773177|NCT02643966|456125347|FG000|First Screening Round|ineligible|1|||
126773178|NCT02643966|456125347|FG000|First Screening Round|excluded from analysis|2|||
126773179|NCT02643966|456125347|FG000|First Screening Round|Lost to Follow-up|56|||
126773180|NCT02643966|456125347|FG000|First Screening Round|Withdrawal by Subject|28|||
126773181|NCT02643966|456125347|FG000|First Screening Round|Death|1|||
126773182|NCT02643966|456125347|FG000|Between First and Second Screening|Lost to Follow-up|65|||
126773183|NCT02643966|456125347|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
126773184|NCT02643966|456125347|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
126773185|NCT02643966|456125347|FG000|Second Screening Round|Withdrawal by Subject|20|||
126773186|NCT02643966|456125347|FG000|Second Screening Round|Lost to Follow-up|57|||
126773187|NCT02643966|456125347|FG000|Second Screening Round|Physician Decision|2|||
126773188|NCT02643966|456125347|FG000|Second Screening Round|Death|4|||
126773189|NCT02643966|456125347|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
126773190|NCT02643966|456125347|FG000|Between Second and Third Screening|Death|1|||
126773191|NCT02643966|456125347|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
126773192|NCT02643966|456125347|FG000|Third Screening Round|PI excluded|2|||
126773193|NCT02643966|456125347|FG000|Third Screening Round|Lost to Follow-up|241|||
126773194|NCT03835975|456125350|FG000|Overall Study|Lost to Follow-up|1|||
126773195|NCT03835975|456125351|FG001|Overall Study|Lost to Follow-up|1|||
126773196|NCT03835975|456125352|FG002|Overall Study|Lost to Follow-up|0|||
126773197|NCT03835975|456125353|FG003|Overall Study|Lost to Follow-up|0|||
126773198|NCT03835975|456125354|FG004|Overall Study|Lost to Follow-up|0|||
126773199|NCT03835975|456125350|FG000|Overall Study|No longer met eligibility criteria|0|||
126773200|NCT03835975|456125351|FG001|Overall Study|No longer met eligibility criteria|1|||
126773201|NCT03835975|456125352|FG002|Overall Study|No longer met eligibility criteria|0|||
126773202|NCT03835975|456125353|FG003|Overall Study|No longer met eligibility criteria|0|||
126773203|NCT03835975|456125354|FG004|Overall Study|No longer met eligibility criteria|0|||
126773204|NCT03835975|456125350|FG000|Overall Study|Protocol Violation|1|||
126773205|NCT03835975|456125351|FG001|Overall Study|Protocol Violation|1|||
126773206|NCT03835975|456125352|FG002|Overall Study|Protocol Violation|2|||
126773207|NCT03835975|456125353|FG003|Overall Study|Protocol Violation|0|||
126773208|NCT03835975|456125354|FG004|Overall Study|Protocol Violation|0|||
126773209|NCT03835975|456125350|FG000|Overall Study|Withdrawal by Subject|1|||
126773210|NCT03835975|456125351|FG001|Overall Study|Withdrawal by Subject|0|||
126773211|NCT03835975|456125352|FG002|Overall Study|Withdrawal by Subject|1|||
126773212|NCT03835975|456125353|FG003|Overall Study|Withdrawal by Subject|1|||
126773213|NCT03835975|456125354|FG004|Overall Study|Withdrawal by Subject|0|||
126773214|NCT00061945|456125359|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
126773215|NCT00061945|456125360|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
126773216|NCT00061945|456125359|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
126496741|NCT01729754|455119715|FG009|Part 2|Other Protocol Specified Criteria|0|||
126773217|NCT00061945|456125360|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
126773218|NCT00061945|456125359|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
126773219|NCT00061945|456125360|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
126773220|NCT00061945|456125359|FG000|Course IV: Alemtuzumab|Early exits|6|||
126773221|NCT00061945|456125360|FG001|Course IV: Alemtuzumab|Early exits|15|||
126773222|NCT03611751|456125361|FG000|Pre-treatment|Randomized but not treated|1|||
126773223|NCT03611751|456125362|FG001|Pre-treatment|Randomized but not treated|1|||
126773224|NCT03611751|456125363|FG002|Pre-treatment|Randomized but not treated|0|||
126496742|NCT01729754|455119706|FG000|Part 3|Adverse Event|0|||
126496743|NCT01729754|455119707|FG001|Part 3|Adverse Event|0|||
126496744|NCT01729754|455119708|FG002|Part 3|Adverse Event|1|||
126773225|NCT03611751|456125361|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
126773226|NCT03611751|456125362|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
126773227|NCT03611751|456125363|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
126773228|NCT03611751|456125361|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
126773229|NCT03611751|456125362|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
126773230|NCT03611751|456125363|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
126773231|NCT03611751|456125361|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
126773232|NCT03611751|456125362|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
126773233|NCT03611751|456125363|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
126773234|NCT03611751|456125361|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
126773235|NCT03611751|456125362|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
126773236|NCT03611751|456125363|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
126773237|NCT03611751|456125361|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
126773238|NCT03611751|456125362|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
126773239|NCT03611751|456125363|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
126773240|NCT03611751|456125361|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
126773241|NCT03611751|456125362|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
126773242|NCT03611751|456125363|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
126773243|NCT03611751|456125361|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
126773244|NCT03611751|456125362|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
126773245|NCT03611751|456125363|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
126773246|NCT03611751|456125361|FG000|Treatment Week 0 - Week 16|Death|0|||
126773247|NCT03611751|456125362|FG001|Treatment Week 0 - Week 16|Death|0|||
126773248|NCT03611751|456125363|FG002|Treatment Week 0 - Week 16|Death|1|||
126773249|NCT03611751|456125361|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
126773250|NCT03611751|456125362|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
126773251|NCT03611751|456125363|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
126773252|NCT03611751|456125361|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
126773253|NCT03611751|456125362|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
126773254|NCT03611751|456125363|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
126773255|NCT03611751|456125361|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
126773256|NCT03611751|456125362|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
126773257|NCT03611751|456125363|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
126773258|NCT03611751|456125361|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
126773259|NCT03611751|456125362|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
126773260|NCT03611751|456125363|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
126773261|NCT03611751|456125361|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
126773262|NCT03611751|456125362|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
126773263|NCT03611751|456125363|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
126773264|NCT03611751|456125361|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
126773265|NCT03611751|456125362|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
126773266|NCT03611751|456125363|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
126773267|NCT03611751|456125361|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
126773268|NCT03611751|456125362|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
126773269|NCT03611751|456125363|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
126773270|NCT03611751|456125361|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
126773271|NCT03611751|456125362|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
126773272|NCT03611751|456125363|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
126773273|NCT03611751|456125361|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
126773274|NCT03611751|456125362|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
126773275|NCT03611751|456125363|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
126773276|NCT03611751|456125361|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
126773277|NCT03611751|456125362|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
126773278|NCT03611751|456125363|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
126773279|NCT03611751|456125361|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
126773280|NCT03611751|456125362|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
126496745|NCT01729754|455119709|FG003|Part 3|Adverse Event|0|||
126496746|NCT01729754|455119710|FG004|Part 3|Adverse Event|0|||
126496747|NCT01729754|455119711|FG005|Part 3|Adverse Event|5|||
126773281|NCT03611751|456125363|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
126773282|NCT03611751|456125361|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
126773283|NCT03611751|456125362|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
126773284|NCT03611751|456125363|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
126773285|NCT03611751|456125361|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
126773286|NCT03611751|456125362|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
126773287|NCT03611751|456125363|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
126773288|NCT03611751|456125361|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
126773289|NCT03611751|456125362|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
126773290|NCT03611751|456125363|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
126773291|NCT03672396|456125364|FG000|Overall Study|Withdrawal by Subject|4|||
126773292|NCT03672396|456125364|FG000|Overall Study|Physician Decision|1|||
126773293|NCT03672396|456125364|FG000|Overall Study|Adverse Event|1|||
126496748|NCT01729754|455119712|FG006|Part 3|Adverse Event|0|||
126773294|NCT02441179|456125366|FG000|Overall Study|Withdrawal by Subject|1|||
126773295|NCT02441179|456125367|FG001|Overall Study|Withdrawal by Subject|1|||
126773296|NCT02702271|456125368|FG000|Overall Study|Death|36|||
126773297|NCT02702271|456125369|FG001|Overall Study|Death|7|||
126773298|NCT02702271|456125368|FG000|Overall Study|Lost to Follow-up|12|||
126773299|NCT02702271|456125369|FG001|Overall Study|Lost to Follow-up|0|||
126773300|NCT02702271|456125368|FG000|Overall Study|Withdrawal by Subject|8|||
126773301|NCT02702271|456125369|FG001|Overall Study|Withdrawal by Subject|1|||
126773302|NCT02702271|456125368|FG000|Overall Study|Physician Decision|2|||
126773303|NCT02702271|456125369|FG001|Overall Study|Physician Decision|0|||
126773304|NCT02702271|456125368|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
126773305|NCT02702271|456125369|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
126496749|NCT01729754|455119713|FG007|Part 3|Adverse Event|0|||
126496750|NCT01729754|455119714|FG008|Part 3|Adverse Event|0|||
126496751|NCT01729754|455119715|FG009|Part 3|Adverse Event|3|||
126496752|NCT01729754|455119706|FG000|Part 3|Death|0|||
126496753|NCT01729754|455119707|FG001|Part 3|Death|0|||
126496754|NCT01729754|455119708|FG002|Part 3|Death|0|||
126496755|NCT01729754|455119709|FG003|Part 3|Death|0|||
126496756|NCT01729754|455119710|FG004|Part 3|Death|0|||
126496757|NCT01729754|455119711|FG005|Part 3|Death|2|||
126496758|NCT01729754|455119712|FG006|Part 3|Death|0|||
126496759|NCT01729754|455119713|FG007|Part 3|Death|0|||
126496760|NCT01729754|455119714|FG008|Part 3|Death|0|||
126496761|NCT01729754|455119715|FG009|Part 3|Death|0|||
126496762|NCT01729754|455119706|FG000|Part 3|Lack of Efficacy|0|||
126496763|NCT01729754|455119707|FG001|Part 3|Lack of Efficacy|0|||
126496764|NCT01729754|455119708|FG002|Part 3|Lack of Efficacy|0|||
126496765|NCT01729754|455119709|FG003|Part 3|Lack of Efficacy|0|||
126496766|NCT01729754|455119710|FG004|Part 3|Lack of Efficacy|2|||
126496767|NCT01729754|455119711|FG005|Part 3|Lack of Efficacy|0|||
126496768|NCT01729754|455119712|FG006|Part 3|Lack of Efficacy|0|||
126496769|NCT01729754|455119713|FG007|Part 3|Lack of Efficacy|0|||
126496770|NCT01729754|455119714|FG008|Part 3|Lack of Efficacy|0|||
126496771|NCT01729754|455119715|FG009|Part 3|Lack of Efficacy|4|||
126496772|NCT01729754|455119706|FG000|Part 3|Lost to Follow-up|0|||
126496773|NCT01729754|455119707|FG001|Part 3|Lost to Follow-up|1|||
126496774|NCT01729754|455119708|FG002|Part 3|Lost to Follow-up|2|||
126496775|NCT01729754|455119709|FG003|Part 3|Lost to Follow-up|0|||
126496776|NCT01729754|455119710|FG004|Part 3|Lost to Follow-up|0|||
126496777|NCT01729754|455119711|FG005|Part 3|Lost to Follow-up|3|||
126496778|NCT01729754|455119712|FG006|Part 3|Lost to Follow-up|0|||
126496779|NCT01729754|455119713|FG007|Part 3|Lost to Follow-up|0|||
126496780|NCT01729754|455119714|FG008|Part 3|Lost to Follow-up|1|||
126496781|NCT01729754|455119715|FG009|Part 3|Lost to Follow-up|0|||
126496782|NCT01729754|455119706|FG000|Part 3|Physician Decision|0|||
126496783|NCT01729754|455119707|FG001|Part 3|Physician Decision|0|||
126496784|NCT01729754|455119708|FG002|Part 3|Physician Decision|1|||
126496785|NCT01729754|455119709|FG003|Part 3|Physician Decision|0|||
126496786|NCT01729754|455119710|FG004|Part 3|Physician Decision|0|||
126559886|NCT04730947|455344473|FG001|Overall Study|Withdrawal by Subject|1|||
126559887|NCT00940017|455344474|FG000|Overall Study|did not meet entrance criteria|3|||
126559888|NCT00940017|455344474|FG000|Overall Study|Adverse Event|1|||
126559889|NCT01450943|455344475|FG000|Overall Study|Screen failure, loss to follow-up|2|||
126559890|NCT01450943|455344476|FG001|Overall Study|Screen failure, loss to follow-up|7|||
126559891|NCT01450943|455344477|FG002|Overall Study|Screen failure, loss to follow-up|6|||
126559892|NCT02949271|455344482|FG000|Overall Study|Lack of Efficacy|5|||
126559893|NCT02949271|455344483|FG001|Overall Study|Lack of Efficacy|4|||
126559894|NCT02949271|455344482|FG000|Overall Study|Lost to Follow-up|3|||
126559895|NCT02949271|455344483|FG001|Overall Study|Lost to Follow-up|6|||
126559896|NCT02949271|455344482|FG000|Overall Study|Physician Decision|5|||
126559897|NCT02949271|455344483|FG001|Overall Study|Physician Decision|5|||
126559898|NCT02949271|455344482|FG000|Overall Study|Protocol Violation|6|||
126559899|NCT02949271|455344483|FG001|Overall Study|Protocol Violation|3|||
126559900|NCT02949271|455344482|FG000|Overall Study|Withdrawal by Subject|1|||
126559901|NCT02949271|455344483|FG001|Overall Study|Withdrawal by Subject|0|||
126559902|NCT02949271|455344482|FG000|Overall Study|Delivered prior to intervention|7|||
126559903|NCT02949271|455344483|FG001|Overall Study|Delivered prior to intervention|9|||
126496787|NCT01729754|455119711|FG005|Part 3|Physician Decision|0|||
126496788|NCT01729754|455119712|FG006|Part 3|Physician Decision|0|||
126496789|NCT01729754|455119713|FG007|Part 3|Physician Decision|0|||
126496790|NCT01729754|455119714|FG008|Part 3|Physician Decision|0|||
126496791|NCT01729754|455119715|FG009|Part 3|Physician Decision|0|||
126496792|NCT01729754|455119706|FG000|Part 3|Withdrawal by Subject|0|||
126496793|NCT01729754|455119707|FG001|Part 3|Withdrawal by Subject|4|||
126496794|NCT01729754|455119708|FG002|Part 3|Withdrawal by Subject|1|||
126496795|NCT01729754|455119709|FG003|Part 3|Withdrawal by Subject|0|||
126559904|NCT02949271|455344482|FG000|Overall Study|Outside the window for cervical dilation|2|||
126773306|NCT03091400|456125370|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
126496796|NCT01729754|455119710|FG004|Part 3|Withdrawal by Subject|2|||
126496797|NCT01729754|455119711|FG005|Part 3|Withdrawal by Subject|1|||
126496798|NCT01729754|455119712|FG006|Part 3|Withdrawal by Subject|0|||
126496799|NCT01729754|455119713|FG007|Part 3|Withdrawal by Subject|2|||
126496800|NCT01729754|455119714|FG008|Part 3|Withdrawal by Subject|0|||
126496801|NCT01729754|455119715|FG009|Part 3|Withdrawal by Subject|0|||
126496802|NCT01729754|455119706|FG000|Part 3|Other Protocol Specified Criteria|0|||
126496803|NCT01729754|455119707|FG001|Part 3|Other Protocol Specified Criteria|0|||
126496804|NCT01729754|455119708|FG002|Part 3|Other Protocol Specified Criteria|0|||
126496805|NCT01729754|455119709|FG003|Part 3|Other Protocol Specified Criteria|0|||
126724114|NCT02796391|455940296|FG001|Overall Study|Adverse Event|0|||
126724115|NCT02796391|455940297|FG002|Overall Study|Adverse Event|0|||
126724116|NCT02796391|455940298|FG003|Overall Study|Adverse Event|1|||
126724117|NCT02796391|455940299|FG004|Overall Study|Adverse Event|0|||
126724118|NCT02796391|455940300|FG005|Overall Study|Adverse Event|0|||
126724119|NCT02796391|455940295|FG000|Overall Study|Protocol Violation|0|||
126724120|NCT02796391|455940296|FG001|Overall Study|Protocol Violation|0|||
126724121|NCT02796391|455940297|FG002|Overall Study|Protocol Violation|0|||
126724122|NCT02796391|455940298|FG003|Overall Study|Protocol Violation|1|||
126724123|NCT02796391|455940299|FG004|Overall Study|Protocol Violation|0|||
126724124|NCT02796391|455940300|FG005|Overall Study|Protocol Violation|0|||
126724125|NCT02681055|455940301|FG000|Weeks 5-12|Adverse Event|1|||
126724126|NCT02695524|455940302|FG000|Overall Study|Lost to Follow-up|3|||
126724127|NCT02695524|455940303|FG001|Overall Study|Lost to Follow-up|2|||
126724128|NCT02695524|455940302|FG000|Overall Study|Death|0|||
126724129|NCT02695524|455940303|FG001|Overall Study|Death|1|||
126724130|NCT00831441|455940304|FG000|Randomized|Death|82|||
126724131|NCT00831441|455940305|FG001|Randomized|Death|81|||
126724132|NCT00831441|455940304|FG000|Randomized|Adverse Event|248|||
126724133|NCT00831441|455940305|FG001|Randomized|Adverse Event|321|||
126724134|NCT00831441|455940304|FG000|Randomized|Emergency procedure|2|||
126724135|NCT00831441|455940305|FG001|Randomized|Emergency procedure|2|||
126724136|NCT00831441|455940304|FG000|Randomized|Elective procedure|26|||
126724137|NCT00831441|455940305|FG001|Randomized|Elective procedure|25|||
126724138|NCT00831441|455940304|FG000|Randomized|Physician Decision|26|||
126724139|NCT00831441|455940305|FG001|Randomized|Physician Decision|35|||
126724140|NCT00831441|455940304|FG000|Randomized|No longer met criteria|13|||
126724141|NCT00831441|455940305|FG001|Randomized|No longer met criteria|19|||
126724142|NCT00831441|455940304|FG000|Randomized|Withdrawal by Subject|178|||
126724143|NCT00831441|455940305|FG001|Randomized|Withdrawal by Subject|212|||
126724144|NCT00831441|455940304|FG000|Randomized|Lost to Follow-up|26|||
126724145|NCT00831441|455940305|FG001|Randomized|Lost to Follow-up|35|||
126724146|NCT00831441|455940304|FG000|Randomized|Administrative reason by sponsor|2780|||
126724147|NCT00831441|455940305|FG001|Randomized|Administrative reason by sponsor|2671|||
126724148|NCT00831441|455940304|FG000|Randomized|poor/non-compliance|30|||
126724149|NCT00831441|455940305|FG001|Randomized|poor/non-compliance|38|||
126724150|NCT00831441|455940304|FG000|Randomized|non-specified|276|||
126724151|NCT00831441|455940305|FG001|Randomized|non-specified|266|||
126724152|NCT00831441|455940304|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
126724153|NCT00831441|455940305|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
126724154|NCT00831441|455940304|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
126724155|NCT00831441|455940305|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
126724156|NCT00831441|455940304|FG000|Follow Up (30 Days)|Death|63|||
126724157|NCT00831441|455940305|FG001|Follow Up (30 Days)|Death|86|||
126724158|NCT00831441|455940304|FG000|Follow Up (30 Days)|non-specified|16|||
126724159|NCT00831441|455940305|FG001|Follow Up (30 Days)|non-specified|26|||
126724160|NCT00831441|455940304|FG000|Follow Up (30 Days)|missing end of study status|0|||
126724161|NCT00831441|455940305|FG001|Follow Up (30 Days)|missing end of study status|1|||
126724162|NCT05674344|455940306|FG000|Overall Study|Screen Fail|21|||
126724163|NCT05674344|455940306|FG000|Overall Study|Incomplete study procedures|3|||
126724164|NCT00111917|455940307|FG000|Overall Study|Withdrawal by Subject|1|||
126724165|NCT00111917|455940308|FG001|Overall Study|Withdrawal by Subject|1|||
126724166|NCT00798655|455940309|FG000|Overall Study|Did not receive at least one dose of pan|2|||
126724167|NCT00960934|455940310|FG000|Overall Study|Adverse Event|2|||
126724168|NCT00960934|455940311|FG001|Overall Study|Adverse Event|3|||
126724169|NCT00960934|455940312|FG002|Overall Study|Adverse Event|3|||
126724170|NCT00960934|455940313|FG003|Overall Study|Adverse Event|2|||
126724171|NCT00960934|455940314|FG004|Overall Study|Adverse Event|4|||
126773307|NCT03091400|456125371|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
126773308|NCT00051636|456125372|FG000|Period 1 - Core|Adverse Event|2|||
126724172|NCT00960934|455940315|FG005|Overall Study|Adverse Event|3|||
126724173|NCT00960934|455940310|FG000|Overall Study|Lack of Efficacy|1|||
126724174|NCT00960934|455940311|FG001|Overall Study|Lack of Efficacy|0|||
126724175|NCT00960934|455940312|FG002|Overall Study|Lack of Efficacy|0|||
126724176|NCT00960934|455940313|FG003|Overall Study|Lack of Efficacy|0|||
126724177|NCT00960934|455940314|FG004|Overall Study|Lack of Efficacy|0|||
126724178|NCT00960934|455940315|FG005|Overall Study|Lack of Efficacy|0|||
126496806|NCT01729754|455119710|FG004|Part 3|Other Protocol Specified Criteria|0|||
126724179|NCT00960934|455940310|FG000|Overall Study|Lost to Follow-up|0|||
126724180|NCT00960934|455940311|FG001|Overall Study|Lost to Follow-up|1|||
126724181|NCT00960934|455940312|FG002|Overall Study|Lost to Follow-up|0|||
126724182|NCT00960934|455940313|FG003|Overall Study|Lost to Follow-up|0|||
126724183|NCT00960934|455940314|FG004|Overall Study|Lost to Follow-up|0|||
126724184|NCT00960934|455940315|FG005|Overall Study|Lost to Follow-up|0|||
126496807|NCT01729754|455119711|FG005|Part 3|Other Protocol Specified Criteria|2|||
126496808|NCT01729754|455119712|FG006|Part 3|Other Protocol Specified Criteria|0|||
126496809|NCT01729754|455119713|FG007|Part 3|Other Protocol Specified Criteria|1|||
126496810|NCT01729754|455119714|FG008|Part 3|Other Protocol Specified Criteria|0|||
126496811|NCT01729754|455119715|FG009|Part 3|Other Protocol Specified Criteria|0|||
126496812|NCT00773292|455119716|FG000|Treatment 48 Weeks|Adverse Event|1|||
126496813|NCT00773292|455119716|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
126496814|NCT00542919|455119717|FG000|Overall Study|Adverse Event|1|||
126496815|NCT00542919|455119718|FG001|Overall Study|Adverse Event|5|||
126496816|NCT00542919|455119719|FG002|Overall Study|Adverse Event|1|||
126496817|NCT00542919|455119717|FG000|Overall Study|Withdrawal by Subject|1|||
126496818|NCT00542919|455119718|FG001|Overall Study|Withdrawal by Subject|0|||
126496819|NCT00542919|455119719|FG002|Overall Study|Withdrawal by Subject|3|||
126496820|NCT00542919|455119717|FG000|Overall Study|Physician Decision|2|||
126496821|NCT00542919|455119718|FG001|Overall Study|Physician Decision|2|||
126496822|NCT00542919|455119719|FG002|Overall Study|Physician Decision|1|||
126496823|NCT00542919|455119717|FG000|Overall Study|Sponsor Decision|1|||
126496824|NCT00542919|455119718|FG001|Overall Study|Sponsor Decision|0|||
126496825|NCT00542919|455119719|FG002|Overall Study|Sponsor Decision|0|||
126496826|NCT00542919|455119717|FG000|Overall Study|Lost to Follow-up|2|||
126496827|NCT00542919|455119718|FG001|Overall Study|Lost to Follow-up|0|||
126496828|NCT00542919|455119719|FG002|Overall Study|Lost to Follow-up|1|||
126496829|NCT00112502|455119720|FG000|Overall Study|Withdrawal by Subject|0|||
126496830|NCT00112502|455119721|FG001|Overall Study|Withdrawal by Subject|1|||
126496831|NCT00112502|455119722|FG002|Overall Study|Withdrawal by Subject|1|||
126496832|NCT00112502|455119723|FG003|Overall Study|Withdrawal by Subject|4|||
126496833|NCT00112502|455119724|FG004|Overall Study|Withdrawal by Subject|2|||
126496834|NCT00112502|455119725|FG005|Overall Study|Withdrawal by Subject|5|||
126496835|NCT00112502|455119726|FG006|Overall Study|Withdrawal by Subject|3|||
126496836|NCT00112502|455119727|FG007|Overall Study|Withdrawal by Subject|7|||
126496837|NCT02747420|455119728|FG000|Overall Study|Lost to Follow-up|4|||
126496838|NCT02747420|455119729|FG001|Overall Study|Lost to Follow-up|2|||
126496839|NCT02747420|455119728|FG000|Overall Study|Withdrawal by Subject|3|||
126496840|NCT02747420|455119729|FG001|Overall Study|Withdrawal by Subject|2|||
126496841|NCT03662542|455119734|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
126496842|NCT03662542|455119735|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
126496843|NCT03662542|455119736|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
126496844|NCT03662542|455119737|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
126496845|NCT03662542|455119738|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
126496846|NCT03662542|455119739|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
126496847|NCT03662542|455119740|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
126496848|NCT03662542|455119741|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
126496849|NCT03662542|455119742|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
126496850|NCT03662542|455119734|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
126496851|NCT03662542|455119735|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
126496852|NCT03662542|455119736|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
126496853|NCT03662542|455119737|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
126496854|NCT03662542|455119738|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
126496855|NCT03662542|455119739|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
126496856|NCT03662542|455119740|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
126496857|NCT03662542|455119741|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
126496858|NCT03662542|455119742|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
126496859|NCT03662542|455119734|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
126496860|NCT03662542|455119735|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
126496861|NCT03662542|455119736|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
126496862|NCT03662542|455119737|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
126496863|NCT03662542|455119738|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
126496864|NCT03662542|455119739|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
126496865|NCT03662542|455119740|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
126496866|NCT03662542|455119741|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
126496867|NCT03662542|455119742|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
126496868|NCT03662542|455119734|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
126496869|NCT03662542|455119735|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
126496870|NCT03662542|455119736|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
126496871|NCT03662542|455119737|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
126496872|NCT03662542|455119738|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
126496873|NCT03662542|455119739|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
126496874|NCT03662542|455119740|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
126496875|NCT03662542|455119741|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
126496876|NCT03662542|455119742|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
126496877|NCT03662542|455119734|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
126496878|NCT03662542|455119735|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
126496879|NCT03662542|455119736|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
126496880|NCT03662542|455119737|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
126496881|NCT03662542|455119738|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
126496882|NCT03662542|455119739|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
126496883|NCT03662542|455119740|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
126496884|NCT03662542|455119741|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
126496885|NCT03662542|455119742|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
126496886|NCT03662542|455119734|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
126724185|NCT00960934|455940310|FG000|Overall Study|Other|2|||
126724186|NCT00960934|455940311|FG001|Overall Study|Other|1|||
126724187|NCT00960934|455940312|FG002|Overall Study|Other|5|||
126724188|NCT00960934|455940313|FG003|Overall Study|Other|4|||
126724189|NCT00960934|455940314|FG004|Overall Study|Other|2|||
126724190|NCT00960934|455940315|FG005|Overall Study|Other|2|||
126724191|NCT00960934|455940310|FG000|Overall Study|Physician Decision|0|||
126724192|NCT00960934|455940311|FG001|Overall Study|Physician Decision|1|||
126724193|NCT00960934|455940312|FG002|Overall Study|Physician Decision|0|||
126724194|NCT00960934|455940313|FG003|Overall Study|Physician Decision|0|||
126724195|NCT00960934|455940314|FG004|Overall Study|Physician Decision|0|||
126724196|NCT00960934|455940315|FG005|Overall Study|Physician Decision|0|||
126724197|NCT00960934|455940310|FG000|Overall Study|Progressive Disease|1|||
126724198|NCT00960934|455940311|FG001|Overall Study|Progressive Disease|1|||
126724199|NCT00960934|455940312|FG002|Overall Study|Progressive Disease|0|||
126724200|NCT00960934|455940313|FG003|Overall Study|Progressive Disease|0|||
126724201|NCT00960934|455940314|FG004|Overall Study|Progressive Disease|1|||
126724202|NCT00960934|455940315|FG005|Overall Study|Progressive Disease|1|||
126724203|NCT00960934|455940310|FG000|Overall Study|Protocol Violation|3|||
126724204|NCT00960934|455940311|FG001|Overall Study|Protocol Violation|4|||
126724205|NCT00960934|455940312|FG002|Overall Study|Protocol Violation|0|||
126724206|NCT00960934|455940313|FG003|Overall Study|Protocol Violation|3|||
126724207|NCT00960934|455940314|FG004|Overall Study|Protocol Violation|3|||
126724208|NCT00960934|455940315|FG005|Overall Study|Protocol Violation|2|||
126724209|NCT00960934|455940310|FG000|Overall Study|Withdrawal by Subject|5|||
126724210|NCT00960934|455940311|FG001|Overall Study|Withdrawal by Subject|6|||
126724211|NCT00960934|455940312|FG002|Overall Study|Withdrawal by Subject|4|||
126724212|NCT00960934|455940313|FG003|Overall Study|Withdrawal by Subject|5|||
126724213|NCT00960934|455940314|FG004|Overall Study|Withdrawal by Subject|5|||
126724214|NCT00960934|455940315|FG005|Overall Study|Withdrawal by Subject|7|||
126724215|NCT00960934|455940310|FG000|Overall Study|Study Terminated by Sponsor|50|||
126724216|NCT00960934|455940311|FG001|Overall Study|Study Terminated by Sponsor|46|||
126724217|NCT00960934|455940312|FG002|Overall Study|Study Terminated by Sponsor|52|||
126724218|NCT00960934|455940313|FG003|Overall Study|Study Terminated by Sponsor|50|||
126724219|NCT00960934|455940314|FG004|Overall Study|Study Terminated by Sponsor|49|||
126724220|NCT00960934|455940315|FG005|Overall Study|Study Terminated by Sponsor|49|||
126724221|NCT02156492|455940316|FG000|Period 1|No Reason Given|0|||
126773309|NCT00051636|456125373|FG001|Period 1 - Core|Adverse Event|2|||
126773310|NCT00051636|456125372|FG000|Period 1 - Core|Protocol Violation|1|||
126773311|NCT00051636|456125373|FG001|Period 1 - Core|Protocol Violation|0|||
126773312|NCT00051636|456125372|FG000|Period 1 - Core|Withdrawal by Subject|1|||
126773313|NCT00051636|456125373|FG001|Period 1 - Core|Withdrawal by Subject|2|||
126773314|NCT00051636|456125372|FG000|Period 1 - Core|Lost to Follow-up|0|||
126773315|NCT00051636|456125373|FG001|Period 1 - Core|Lost to Follow-up|2|||
126773316|NCT00051636|456125372|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
126773317|NCT00051636|456125373|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
126773318|NCT00051636|456125372|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
126773319|NCT00051636|456125373|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
126773320|NCT00051636|456125372|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
126773321|NCT00051636|456125373|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
126773322|NCT00051636|456125372|FG000|Period 2- Extended Observation Period|Death|4|||
126773323|NCT00051636|456125373|FG001|Period 2- Extended Observation Period|Death|5|||
126773324|NCT00051636|456125372|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
126773325|NCT00051636|456125373|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
126496887|NCT03662542|455119735|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
126496888|NCT03662542|455119736|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
126724222|NCT02156492|455940317|FG001|Period 1|No Reason Given|1|||
126724223|NCT02156492|455940318|FG002|Period 1|No Reason Given|0|||
126724224|NCT02156492|455940316|FG000|Period 3|Adverse Event|0|||
126724225|NCT02156492|455940317|FG001|Period 3|Adverse Event|1|||
126724226|NCT02156492|455940318|FG002|Period 3|Adverse Event|0|||
126724227|NCT05254613|455940325|FG000|Overall Study|Lost to Follow-up|0|||
126773326|NCT01656967|456125374|FG000|Overall Study|faulty monitor|1|||
126496889|NCT03662542|455119737|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
126724228|NCT05254613|455940326|FG001|Overall Study|Lost to Follow-up|0|||
126724229|NCT05254613|455940327|FG002|Overall Study|Lost to Follow-up|1|||
126724230|NCT02338492|455940328|FG000|Overall Study|Death|32|||
126724231|NCT02338492|455940328|FG000|Overall Study|Adverse Event|3|||
126496890|NCT03662542|455119738|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
126496891|NCT03662542|455119739|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
126496892|NCT03662542|455119740|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
126496893|NCT03662542|455119741|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
126496894|NCT03662542|455119742|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
126496895|NCT03662542|455119734|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
126496896|NCT03662542|455119735|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
126496897|NCT03662542|455119736|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
126496898|NCT03662542|455119737|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
126496899|NCT03662542|455119738|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
126496900|NCT03662542|455119739|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
126724232|NCT02338492|455940328|FG000|Overall Study|Lost to Follow-up|4|||
126724233|NCT02338492|455940328|FG000|Overall Study|Reason not captured above|6|||
126724234|NCT01757405|455940329|FG000|Overall Study|Lost to Follow-up|1|||
126724235|NCT01757405|455940330|FG001|Overall Study|Lost to Follow-up|1|||
126724236|NCT01757405|455940329|FG000|Overall Study|Withdrawal by Subject|0|||
126724237|NCT01757405|455940330|FG001|Overall Study|Withdrawal by Subject|1|||
126724238|NCT02387372|455940331|FG000|Overall Study|Not Treated|1|||
126724239|NCT02387372|455940332|FG001|Overall Study|Not Treated|0|||
126724240|NCT00238303|455940334|FG000|Overall Study|Withdrawal by Subject|11|||
126724241|NCT00238303|455940335|FG001|Overall Study|Withdrawal by Subject|1|||
126724242|NCT00238303|455940336|FG002|Overall Study|Withdrawal by Subject|2|||
126724243|NCT00238303|455940334|FG000|Overall Study|Death|1|||
126724244|NCT00238303|455940335|FG001|Overall Study|Death|0|||
126724245|NCT00238303|455940336|FG002|Overall Study|Death|1|||
126724246|NCT00238303|455940334|FG000|Overall Study|Other Medical Problems|2|||
126724247|NCT00238303|455940335|FG001|Overall Study|Other Medical Problems|0|||
126724248|NCT00238303|455940336|FG002|Overall Study|Other Medical Problems|2|||
126724249|NCT00238303|455940334|FG000|Overall Study|Poor tolerance of study treatment|1|||
126724250|NCT00238303|455940335|FG001|Overall Study|Poor tolerance of study treatment|0|||
126724251|NCT00238303|455940336|FG002|Overall Study|Poor tolerance of study treatment|1|||
126724252|NCT00238303|455940334|FG000|Overall Study|Adverse Event|0|||
126724253|NCT00238303|455940335|FG001|Overall Study|Adverse Event|1|||
126724254|NCT00238303|455940336|FG002|Overall Study|Adverse Event|3|||
126724255|NCT00848549|455940337|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
126724256|NCT00848549|455940338|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
126724257|NCT00848549|455940337|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
126724258|NCT00848549|455940338|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
126724259|NCT00848549|455940337|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
126724260|NCT00848549|455940338|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
126724261|NCT00848549|455940337|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
126724262|NCT00848549|455940338|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
126724263|NCT00848549|455940337|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
126724264|NCT00848549|455940338|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
126724265|NCT00848549|455940337|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
126724266|NCT00848549|455940338|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
126724267|NCT00848549|455940337|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
126724268|NCT00848549|455940338|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
126724269|NCT00848549|455940337|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
126724270|NCT00848549|455940338|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
126724271|NCT00848549|455940337|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
126724272|NCT00848549|455940338|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
126724273|NCT00848549|455940337|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
126724274|NCT00848549|455940338|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
126724275|NCT00848549|455940337|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
126724276|NCT00848549|455940338|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
126724277|NCT00848549|455940337|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
126724278|NCT00848549|455940338|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
126496901|NCT03662542|455119740|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
126496902|NCT03662542|455119741|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
126496903|NCT03662542|455119742|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
126496904|NCT03662542|455119734|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
126496905|NCT03662542|455119735|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
126496906|NCT03662542|455119736|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
126496907|NCT03662542|455119737|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
126496908|NCT03662542|455119738|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
126496909|NCT03662542|455119739|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
126496910|NCT03662542|455119740|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
126724279|NCT00848549|455940337|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
126724280|NCT00848549|455940338|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
126773327|NCT01656967|456125375|FG001|Overall Study|faulty monitor|0|||
126773328|NCT01656967|456125374|FG000|Overall Study|unsuccessful ETT insertion|3|||
126773329|NCT01656967|456125375|FG001|Overall Study|unsuccessful ETT insertion|2|||
126773330|NCT00975884|456125376|FG000|Overall Study|Adverse Event|1|||
126773331|NCT00975884|456125377|FG001|Overall Study|Adverse Event|0|||
126773332|NCT00975884|456125376|FG000|Overall Study|Lost to Follow-up|5|||
126773333|NCT00975884|456125377|FG001|Overall Study|Lost to Follow-up|3|||
126496911|NCT03662542|455119741|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
126496912|NCT03662542|455119742|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
126496913|NCT03662542|455119734|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
126496914|NCT03662542|455119735|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
126496915|NCT03662542|455119736|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
126496916|NCT03662542|455119737|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
126496917|NCT03662542|455119738|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
126496918|NCT03662542|455119739|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
126496919|NCT03662542|455119740|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
126496920|NCT03662542|455119741|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
126496921|NCT03662542|455119742|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
126724281|NCT00848549|455940337|FG000|E2090-E044-314 (Extension Study)|Other|5|||
126724282|NCT00848549|455940338|FG001|E2090-E044-314 (Extension Study)|Other|6|||
126724283|NCT01248130|455940341|FG000|Overall Study|Protocol Violation|1|||
126724284|NCT01248130|455940342|FG001|Overall Study|Protocol Violation|0|||
126724285|NCT01248130|455940341|FG000|Overall Study|Ineligible|1|||
126724286|NCT01248130|455940342|FG001|Overall Study|Ineligible|0|||
126724287|NCT02106455|455940347|FG000|Overall Study|Case Report Form Uncollected|6|||
126724288|NCT02106455|455940347|FG000|Overall Study|Protocol Deviation|2|||
126724289|NCT00229203|455940348|FG000|Overall Study|Progressive disease|18|||
126724290|NCT00229203|455940349|FG001|Overall Study|Progressive disease|9|||
126724291|NCT00229203|455940348|FG000|Overall Study|Toxicity|6|||
126724292|NCT00229203|455940349|FG001|Overall Study|Toxicity|1|||
126724293|NCT00229203|455940348|FG000|Overall Study|Death|4|||
126724294|NCT00229203|455940349|FG001|Overall Study|Death|2|||
126724295|NCT00229203|455940348|FG000|Overall Study|Other|3|||
126724296|NCT00229203|455940349|FG001|Overall Study|Other|3|||
126496922|NCT03662542|455119734|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
126496923|NCT03662542|455119735|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
126496924|NCT03662542|455119736|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
126496925|NCT03662542|455119737|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
126496926|NCT03662542|455119738|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
126496927|NCT03662542|455119739|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
126496928|NCT03662542|455119740|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
126496929|NCT03662542|455119741|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
126496930|NCT03662542|455119742|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
126496931|NCT03662542|455119734|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
126496932|NCT03662542|455119735|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
126496933|NCT03662542|455119736|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
126496934|NCT03662542|455119737|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
126496935|NCT03662542|455119738|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
126496936|NCT03662542|455119739|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
126496937|NCT03662542|455119740|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
126496938|NCT03662542|455119741|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
126496939|NCT03662542|455119742|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
126496940|NCT03662542|455119734|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
126496941|NCT03662542|455119735|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
126496942|NCT03662542|455119736|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
126496943|NCT03662542|455119737|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
126496944|NCT03662542|455119738|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
126496945|NCT03662542|455119739|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
126496946|NCT03662542|455119740|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
126496947|NCT03662542|455119741|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
126496948|NCT03662542|455119742|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
126496949|NCT03662542|455119734|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
126496950|NCT03662542|455119735|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
126496951|NCT03662542|455119736|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
126496952|NCT03662542|455119737|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
126496953|NCT03662542|455119738|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
126496954|NCT03662542|455119739|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
126724297|NCT00229203|455940348|FG000|Overall Study|Withdrawal by Subject|1|||
126724298|NCT00229203|455940349|FG001|Overall Study|Withdrawal by Subject|4|||
126724299|NCT00436566|455940357|FG000|Overall Study|Withdrawal by Subject|2|||
126724300|NCT00436566|455940357|FG000|Overall Study|Protocol Violation|1|||
126724301|NCT01188564|455940358|FG000|Double-blind Phase|randomized not treated|1|||
126773334|NCT00975884|456125376|FG000|Overall Study|Withdrawal by Subject|9|||
126773335|NCT00975884|456125377|FG001|Overall Study|Withdrawal by Subject|9|||
126773336|NCT00975884|456125376|FG000|Overall Study|Other|1|||
126773337|NCT00975884|456125377|FG001|Overall Study|Other|3|||
126773338|NCT00479765|456125378|FG000|Overall Study|study terminated|4|||
126773339|NCT05166512|456125379|FG000|Randomized|Lost to Follow-up|2|||
126773340|NCT05166512|456125380|FG001|Randomized|Lost to Follow-up|0|||
126773341|NCT05166512|456125379|FG000|Randomized|Withdrawal by Subject|1|||
126773342|NCT05166512|456125380|FG001|Randomized|Withdrawal by Subject|0|||
126773343|NCT05166512|456125379|FG000|Baseline Data Collection|Lost to Follow-up|0|||
126773344|NCT05166512|456125380|FG001|Baseline Data Collection|Lost to Follow-up|3|||
126773345|NCT05166512|456125379|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
126773346|NCT05166512|456125380|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
126773347|NCT05166512|456125379|FG000|Baseline Data Collection|Protocol Violation|2|||
126773348|NCT05166512|456125380|FG001|Baseline Data Collection|Protocol Violation|0|||
126773349|NCT05166512|456125379|FG000|4 Month Data Collection|Lost to Follow-up|1|||
126773350|NCT05166512|456125380|FG001|4 Month Data Collection|Lost to Follow-up|0|||
126773351|NCT05166512|456125379|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
126773352|NCT05166512|456125380|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
126773353|NCT05166512|456125379|FG000|12 Month Data Collection|Lost to Follow-up|3|||
126773354|NCT05166512|456125380|FG001|12 Month Data Collection|Lost to Follow-up|1|||
126773355|NCT05166512|456125379|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
126773356|NCT05166512|456125380|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
126773357|NCT02139306|456125383|FG000|Overall Study|Withdrawal by Subject|4|||
126773358|NCT02139306|456125384|FG001|Overall Study|Withdrawal by Subject|6|||
126773359|NCT02139306|456125383|FG000|Overall Study|Adverse Event|3|||
126773360|NCT02139306|456125384|FG001|Overall Study|Adverse Event|4|||
126773361|NCT02139306|456125383|FG000|Overall Study|Physician Decision|0|||
126773362|NCT02139306|456125384|FG001|Overall Study|Physician Decision|1|||
126773363|NCT02139306|456125383|FG000|Overall Study|Other Unspecified|2|||
126773364|NCT02139306|456125384|FG001|Overall Study|Other Unspecified|3|||
126773365|NCT02139306|456125383|FG000|Overall Study|Protocol Violation|4|||
126773366|NCT02139306|456125384|FG001|Overall Study|Protocol Violation|0|||
126773367|NCT02956005|456125385|FG000|Overall Study|Not eligible|1|||
126773368|NCT02956005|456125385|FG000|Overall Study|Withdrawal by Subject|3|||
126773369|NCT02956005|456125385|FG000|Overall Study|Physician Decision|12|||
126773370|NCT01185639|456125386|FG000|Overall Study|Progressed and didn't receive therapy|2|||
126773371|NCT01861717|456125387|FG000|Overall Study|Lost to Follow-up|1|||
126773372|NCT01861717|456125387|FG000|Overall Study|Withdrawal by Subject|1|||
126773373|NCT03033069|456125388|FG000|Overall Study|Adverse Event|6|||
126773374|NCT03033069|456125389|FG001|Overall Study|Adverse Event|7|||
126773375|NCT03033069|456125390|FG002|Overall Study|Adverse Event|4|||
126773376|NCT03033069|456125391|FG003|Overall Study|Adverse Event|6|||
126773377|NCT03033069|456125388|FG000|Overall Study|Lack of Efficacy|0|||
126496955|NCT03662542|455119740|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
126496956|NCT03662542|455119741|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
126496957|NCT03662542|455119742|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
126496958|NCT01217060|455119744|FG000|Overall Study|Withdrawal by Subject|1|||
126496959|NCT03388138|455119747|FG000|Overall Study|Protocol Violation|1|||
126496960|NCT03388138|455119748|FG001|Overall Study|Protocol Violation|0|||
126496961|NCT01528072|455119751|FG000|Overall Study|Withdrawal by Subject|5|||
126496962|NCT01528072|455119751|FG000|Overall Study|Physician Decision|1|||
126496963|NCT01528072|455119751|FG000|Overall Study|Determined not eligible by AEAC|1|||
126496964|NCT01528072|455119751|FG000|Overall Study|Missed Visit|2|||
126496965|NCT01528072|455119751|FG000|Overall Study|Lost to Follow-up|5|||
126496966|NCT01528072|455119751|FG000|Overall Study|Explanted|2|||
126496967|NCT01528072|455119751|FG000|Overall Study|Site Closure|4|||
126496968|NCT01528072|455119751|FG000|Overall Study|Death|2|||
126496969|NCT01528072|455119751|FG000|Overall Study|Early Termination of Study|52|||
126496970|NCT01290666|455119760|FG000|Overall Study|Lost to Follow-up|11|||
126496971|NCT01290666|455119760|FG000|Overall Study|Withdrawal by Subject|23|||
126496972|NCT01290666|455119760|FG000|Overall Study|Early Termination of Study|4|||
126496973|NCT02063854|455119766|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
126496974|NCT02063854|455119767|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
126496975|NCT02063854|455119768|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
126496976|NCT02063854|455119769|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
126496977|NCT02063854|455119770|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
126496978|NCT02063854|455119771|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
126496979|NCT02063854|455119772|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
126496980|NCT02063854|455119766|FG000|Overall Study|Major Protocol Deviation|0|||
126496981|NCT02063854|455119767|FG001|Overall Study|Major Protocol Deviation|0|||
126496982|NCT02063854|455119768|FG002|Overall Study|Major Protocol Deviation|3|||
126773378|NCT03033069|456125389|FG001|Overall Study|Lack of Efficacy|0|||
126773379|NCT03033069|456125390|FG002|Overall Study|Lack of Efficacy|1|||
126773380|NCT03033069|456125391|FG003|Overall Study|Lack of Efficacy|0|||
126773381|NCT03033069|456125388|FG000|Overall Study|Lost to Follow-up|6|||
126773382|NCT03033069|456125389|FG001|Overall Study|Lost to Follow-up|5|||
126773383|NCT03033069|456125390|FG002|Overall Study|Lost to Follow-up|5|||
126773384|NCT03033069|456125391|FG003|Overall Study|Lost to Follow-up|6|||
126559905|NCT02949271|455344483|FG001|Overall Study|Outside the window for cervical dilation|3|||
126559906|NCT01684046|455344484|FG000|Period 1, First 30 Days|Adverse Event|0|||
126724302|NCT01188564|455940359|FG001|Double-blind Phase|randomized not treated|0|||
126724303|NCT00781599|455940373|FG000|Overall Study|Lost to Follow-up|7|||
126724304|NCT00781599|455940374|FG001|Overall Study|Lost to Follow-up|4|||
126724305|NCT00089479|455940379|FG000|Overall Study|Death|108|||
126724306|NCT00089479|455940380|FG001|Overall Study|Death|75|||
126724307|NCT00089479|455940379|FG000|Overall Study|Withdrawal by Subject|86|||
126724308|NCT00089479|455940380|FG001|Overall Study|Withdrawal by Subject|107|||
126724309|NCT00089479|455940379|FG000|Overall Study|Lost to Follow-up|137|||
126724310|NCT00089479|455940380|FG001|Overall Study|Lost to Follow-up|107|||
126724311|NCT01124448|455940381|FG000|Overall Study|Lost to Follow-up|0|||
126724312|NCT01124448|455940382|FG001|Overall Study|Lost to Follow-up|3|||
126724313|NCT01124448|455940381|FG000|Overall Study|Protocol Violation|2|||
126724314|NCT01124448|455940382|FG001|Overall Study|Protocol Violation|0|||
126724315|NCT03198754|455940383|FG000|Overall Study|Withdrawal by Subject|5|||
126724316|NCT03198754|455940384|FG001|Overall Study|Withdrawal by Subject|4|||
126724317|NCT03198754|455940383|FG000|Overall Study|Lost to Follow-up|4|||
126724318|NCT03198754|455940384|FG001|Overall Study|Lost to Follow-up|3|||
126724319|NCT03198754|455940383|FG000|Overall Study|Ineligible|2|||
126724320|NCT03198754|455940384|FG001|Overall Study|Ineligible|1|||
126724321|NCT02512068|455940390|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
126724322|NCT02512068|455940391|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
126724323|NCT02512068|455940390|FG000|Overall Study|Major Protocol Deviation|1|||
126724324|NCT02512068|455940391|FG001|Overall Study|Major Protocol Deviation|0|||
126724325|NCT02512068|455940390|FG000|Overall Study|Voluntary Withdrawal|0|||
126724326|NCT02512068|455940391|FG001|Overall Study|Voluntary Withdrawal|1|||
126724327|NCT02512068|455940390|FG000|Overall Study|Lack of Efficacy|0|||
126724328|NCT02512068|455940391|FG001|Overall Study|Lack of Efficacy|1|||
126724329|NCT02512068|455940390|FG000|Overall Study|Reason Not Specified|3|||
126724330|NCT02512068|455940391|FG001|Overall Study|Reason Not Specified|5|||
126724331|NCT03521687|455940394|FG000|Overall Study|Adverse Event|4|||
126724332|NCT03521687|455940394|FG000|Overall Study|Physician Decision|1|||
126724333|NCT01151579|455940397|FG000|Overall Study|Physician Decision|3|||
126724334|NCT01151579|455940398|FG001|Overall Study|Physician Decision|1|||
126724335|NCT01151579|455940397|FG000|Overall Study|Withdrawal by Subject|3|||
126724336|NCT01151579|455940398|FG001|Overall Study|Withdrawal by Subject|2|||
126724337|NCT01151579|455940397|FG000|Overall Study|Not meet inclusion criteria|6|||
126724338|NCT01151579|455940398|FG001|Overall Study|Not meet inclusion criteria|4|||
126724339|NCT01153763|455940403|FG000|Overall Study|Study Closed|16|||
126724340|NCT01153763|455940403|FG000|Overall Study|Lost to Follow-up|1|||
126724341|NCT01153763|455940403|FG000|Overall Study|Physician Decision|2|||
126724342|NCT01153763|455940403|FG000|Overall Study|Withdrawal by Subject|2|||
126724343|NCT01474746|455940404|FG000|Overall Study|Lost to Follow-up|1|||
126724344|NCT01474746|455940405|FG001|Overall Study|Lost to Follow-up|1|||
126724345|NCT01474746|455940404|FG000|Overall Study|Withdrawal by Subject|2|||
126724346|NCT01474746|455940405|FG001|Overall Study|Withdrawal by Subject|1|||
126724347|NCT01766336|455940407|FG000|Overall Study|Adverse Event|11|||
126724348|NCT01766336|455940408|FG001|Overall Study|Adverse Event|8|||
126724349|NCT01766336|455940407|FG000|Overall Study|Death|4|||
126724350|NCT01766336|455940408|FG001|Overall Study|Death|3|||
126724351|NCT01766336|455940407|FG000|Overall Study|Lost to Follow-up|1|||
126724352|NCT01766336|455940408|FG001|Overall Study|Lost to Follow-up|3|||
126724353|NCT01766336|455940407|FG000|Overall Study|Physician Decision|4|||
126724354|NCT01766336|455940408|FG001|Overall Study|Physician Decision|2|||
126724355|NCT01766336|455940407|FG000|Overall Study|Protocol Violation|0|||
126724356|NCT01766336|455940408|FG001|Overall Study|Protocol Violation|1|||
126724357|NCT01766336|455940407|FG000|Overall Study|Sponsor Decision|52|||
126724358|NCT01766336|455940408|FG001|Overall Study|Sponsor Decision|43|||
126724359|NCT01766336|455940407|FG000|Overall Study|Withdrawal by Subject|18|||
126724360|NCT01766336|455940408|FG001|Overall Study|Withdrawal by Subject|15|||
126724361|NCT02605447|455940409|FG000|Overall Study|Death|66|||
126724362|NCT02605447|455940409|FG000|Overall Study|Physician Decision|1|||
126724363|NCT02605447|455940409|FG000|Overall Study|Lost to Follow-up|24|||
126724364|NCT02605447|455940409|FG000|Overall Study|Withdrawal by Subject|10|||
126724365|NCT02605447|455940409|FG000|Overall Study|Not disclosed|1|||
126724366|NCT04544709|455940412|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
126724367|NCT03628508|455940413|FG000|Overall Study|Lost to Follow-up|1|||
126724368|NCT02045212|455940414|FG000|Overall Study|Adverse Event|0|||
126724369|NCT02045212|455940415|FG001|Overall Study|Adverse Event|1|||
126724370|NCT02045212|455940414|FG000|Overall Study|Withdrawal by Subject|1|||
126724371|NCT02045212|455940415|FG001|Overall Study|Withdrawal by Subject|0|||
126724372|NCT02045212|455940414|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
126724373|NCT02045212|455940415|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
126724374|NCT04570657|455940419|FG000|Overall Study|Adverse Event|0|||
126724375|NCT04570657|455940420|FG001|Overall Study|Adverse Event|0|||
126724376|NCT04570657|455940421|FG002|Overall Study|Adverse Event|1|||
126724377|NCT04570657|455940419|FG000|Overall Study|Lost to Follow-up|0|||
126559907|NCT01684046|455344485|FG001|Period 1, First 30 Days|Adverse Event|2|||
126559908|NCT01097655|455344486|FG000|Overall Study|Withdrawal by Subject|1|||
126496983|NCT02063854|455119769|FG003|Overall Study|Major Protocol Deviation|0|||
126496984|NCT02063854|455119770|FG004|Overall Study|Major Protocol Deviation|0|||
126496985|NCT02063854|455119771|FG005|Overall Study|Major Protocol Deviation|0|||
126496986|NCT02063854|455119772|FG006|Overall Study|Major Protocol Deviation|0|||
126496987|NCT02063854|455119766|FG000|Overall Study|Voluntary Withdrawal|2|||
126496988|NCT02063854|455119767|FG001|Overall Study|Voluntary Withdrawal|0|||
126496989|NCT02063854|455119768|FG002|Overall Study|Voluntary Withdrawal|8|||
126496990|NCT02063854|455119769|FG003|Overall Study|Voluntary Withdrawal|1|||
126496991|NCT02063854|455119770|FG004|Overall Study|Voluntary Withdrawal|3|||
126496992|NCT02063854|455119771|FG005|Overall Study|Voluntary Withdrawal|6|||
126496993|NCT02063854|455119772|FG006|Overall Study|Voluntary Withdrawal|1|||
126496994|NCT02063854|455119766|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
126496995|NCT02063854|455119767|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
126496996|NCT02063854|455119768|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
126496997|NCT02063854|455119769|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
126496998|NCT02063854|455119770|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
126496999|NCT02063854|455119771|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
126497000|NCT02063854|455119772|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
126497001|NCT02063854|455119766|FG000|Overall Study|Reason Not Specified|1|||
126497002|NCT02063854|455119767|FG001|Overall Study|Reason Not Specified|0|||
126497003|NCT02063854|455119768|FG002|Overall Study|Reason Not Specified|0|||
126497004|NCT02063854|455119769|FG003|Overall Study|Reason Not Specified|0|||
126497005|NCT02063854|455119770|FG004|Overall Study|Reason Not Specified|0|||
126497006|NCT02063854|455119771|FG005|Overall Study|Reason Not Specified|0|||
126497007|NCT02063854|455119772|FG006|Overall Study|Reason Not Specified|0|||
126497008|NCT02063854|455119766|FG000|Overall Study|Did Not Receive Study Drug|0|||
126497009|NCT02063854|455119767|FG001|Overall Study|Did Not Receive Study Drug|0|||
126497010|NCT02063854|455119768|FG002|Overall Study|Did Not Receive Study Drug|0|||
126497011|NCT02063854|455119769|FG003|Overall Study|Did Not Receive Study Drug|0|||
126497012|NCT02063854|455119770|FG004|Overall Study|Did Not Receive Study Drug|0|||
126497013|NCT02063854|455119771|FG005|Overall Study|Did Not Receive Study Drug|1|||
126497014|NCT02063854|455119772|FG006|Overall Study|Did Not Receive Study Drug|0|||
126497015|NCT01462084|455119773|FG000|Overall Study|Withdrawal by Subject|1|||
126497016|NCT01462084|455119774|FG001|Overall Study|Withdrawal by Subject|0|||
126497017|NCT01462084|455119773|FG000|Overall Study|Protocol Violation|1|||
126497018|NCT01462084|455119774|FG001|Overall Study|Protocol Violation|1|||
126497019|NCT03538158|455119775|FG000|Overall Study|Lost to Follow-up|13|||
126497020|NCT03538158|455119776|FG001|Overall Study|Lost to Follow-up|7|||
126497021|NCT03538158|455119775|FG000|Overall Study|Withdrawal by Subject|2|||
126497022|NCT03538158|455119776|FG001|Overall Study|Withdrawal by Subject|1|||
126497023|NCT00930579|455119777|FG000|Overall Study|Withdrawal by Subject|1|||
126497024|NCT00930579|455119777|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
126497025|NCT00695396|455119778|FG000|Overall Study|Study Closed Prematurely|5|||
126497026|NCT00695396|455119779|FG001|Overall Study|Study Closed Prematurely|6|||
126497027|NCT00695396|455119780|FG002|Overall Study|Study Closed Prematurely|8|||
126497028|NCT00695396|455119778|FG000|Overall Study|Withdrawal by Subject|2|||
126497029|NCT00695396|455119779|FG001|Overall Study|Withdrawal by Subject|2|||
126497030|NCT00695396|455119780|FG002|Overall Study|Withdrawal by Subject|0|||
126497031|NCT02255981|455119782|FG000|Overall Study|Lost to Follow-up|3|||
126497032|NCT02255981|455119782|FG000|Overall Study|Withdrawal by Subject|1|||
126497033|NCT00772707|455119783|FG000|Overall Study|Withdrawn|3|||
126497034|NCT04356963|455119787|FG000|First Session|Withdrawal by Subject|1|||
126497035|NCT04356963|455119787|FG000|Second Session|Withdrawal by Subject|3|||
126497036|NCT04356963|455119787|FG000|Second Session|Lost to Follow-up|1|||
126497037|NCT04356963|455119787|FG000|Third Session|Lost to Follow-up|6|||
126497038|NCT04356963|455119787|FG000|Third Session|Withdrawal by Subject|1|||
126497039|NCT02726074|455119796|FG000|Overall Study|Withdrawal by Subject|4|||
126497040|NCT02726074|455119796|FG000|Overall Study|Adverse Event|14|||
126497041|NCT02726074|455119796|FG000|Overall Study|Protocol Violation|3|||
126497042|NCT02726074|455119796|FG000|Overall Study|Lost to Follow-up|2|||
126497043|NCT02726074|455119796|FG000|Overall Study|Others|3|||
126497044|NCT00613015|455119799|FG000|Overall Study|Lost to Follow-up|0|||
126497045|NCT00613015|455119800|FG001|Overall Study|Lost to Follow-up|1|||
126497046|NCT00613015|455119801|FG002|Overall Study|Lost to Follow-up|3|||
126497047|NCT00613015|455119802|FG003|Overall Study|Lost to Follow-up|3|||
126497048|NCT00613015|455119803|FG004|Overall Study|Lost to Follow-up|2|||
126497049|NCT00613015|455119804|FG005|Overall Study|Lost to Follow-up|3|||
126497050|NCT03338062|455119805|FG000|Overall Study|Alternative Therapy|1|||
126497051|NCT03338062|455119806|FG001|Overall Study|Alternative Therapy|0|||
126497052|NCT02153112|455119807|FG000|Overall Study|Adverse Event|0|||
126559909|NCT01097655|455344486|FG000|Overall Study|Subject Documented Twice|1|||
126497053|NCT02153112|455119808|FG001|Overall Study|Adverse Event|0|||
126497054|NCT02153112|455119809|FG002|Overall Study|Adverse Event|1|||
126497055|NCT02153112|455119810|FG003|Overall Study|Adverse Event|0|||
126773385|NCT03033069|456125388|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126773386|NCT03033069|456125389|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126773387|NCT03033069|456125390|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126773388|NCT03033069|456125391|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126773389|NCT03033069|456125388|FG000|Overall Study|Protocol Deviation|0|||
126773390|NCT03033069|456125389|FG001|Overall Study|Protocol Deviation|1|||
126773391|NCT03033069|456125390|FG002|Overall Study|Protocol Deviation|0|||
126773392|NCT03033069|456125391|FG003|Overall Study|Protocol Deviation|0|||
126773393|NCT03033069|456125388|FG000|Overall Study|Withdrawal by Subject|10|||
126773394|NCT03033069|456125389|FG001|Overall Study|Withdrawal by Subject|10|||
126773395|NCT03033069|456125390|FG002|Overall Study|Withdrawal by Subject|11|||
126773396|NCT03033069|456125391|FG003|Overall Study|Withdrawal by Subject|6|||
126773397|NCT03033069|456125388|FG000|Overall Study|Withdrawal By Caregiver|1|||
126773398|NCT03033069|456125389|FG001|Overall Study|Withdrawal By Caregiver|0|||
126773399|NCT03033069|456125390|FG002|Overall Study|Withdrawal By Caregiver|0|||
126773400|NCT03033069|456125391|FG003|Overall Study|Withdrawal By Caregiver|0|||
126773401|NCT03033069|456125388|FG000|Overall Study|Reason not Specified|0|||
126773402|NCT03033069|456125389|FG001|Overall Study|Reason not Specified|1|||
126773403|NCT03033069|456125390|FG002|Overall Study|Reason not Specified|0|||
126773404|NCT03033069|456125391|FG003|Overall Study|Reason not Specified|1|||
126773405|NCT00430638|456125392|FG000|Overall Study|Adverse Event|15|||
126773406|NCT00430638|456125393|FG001|Overall Study|Adverse Event|15|||
126773407|NCT00430638|456125392|FG000|Overall Study|Uncontrolled blood pressure|48|||
126773408|NCT00430638|456125393|FG001|Overall Study|Uncontrolled blood pressure|13|||
126773409|NCT00430638|456125392|FG000|Overall Study|Lost to Follow-up|1|||
126773410|NCT00430638|456125393|FG001|Overall Study|Lost to Follow-up|7|||
126773411|NCT00430638|456125392|FG000|Overall Study|Protocol Violation|6|||
126773412|NCT00430638|456125393|FG001|Overall Study|Protocol Violation|4|||
126497056|NCT02153112|455119811|FG004|Overall Study|Adverse Event|0|||
126497057|NCT02153112|455119812|FG005|Overall Study|Adverse Event|0|||
126497058|NCT02153112|455119813|FG006|Overall Study|Adverse Event|0|||
126497059|NCT02153112|455119814|FG007|Overall Study|Adverse Event|0|||
126497060|NCT02153112|455119815|FG008|Overall Study|Adverse Event|0|||
126497061|NCT02153112|455119816|FG009|Overall Study|Adverse Event|0|||
126497062|NCT02153112|455119807|FG000|Overall Study|Lost to Follow-up|1|||
126497063|NCT02153112|455119808|FG001|Overall Study|Lost to Follow-up|1|||
126497064|NCT02153112|455119809|FG002|Overall Study|Lost to Follow-up|0|||
126497065|NCT02153112|455119810|FG003|Overall Study|Lost to Follow-up|0|||
126497066|NCT02153112|455119811|FG004|Overall Study|Lost to Follow-up|2|||
126497067|NCT02153112|455119812|FG005|Overall Study|Lost to Follow-up|1|||
126497068|NCT02153112|455119813|FG006|Overall Study|Lost to Follow-up|1|||
126497069|NCT02153112|455119814|FG007|Overall Study|Lost to Follow-up|0|||
126497070|NCT02153112|455119815|FG008|Overall Study|Lost to Follow-up|1|||
126497071|NCT02153112|455119816|FG009|Overall Study|Lost to Follow-up|1|||
126497072|NCT02153112|455119807|FG000|Overall Study|Withdrawal by Subject|3|||
126497073|NCT02153112|455119808|FG001|Overall Study|Withdrawal by Subject|1|||
126497074|NCT02153112|455119809|FG002|Overall Study|Withdrawal by Subject|2|||
126497075|NCT02153112|455119810|FG003|Overall Study|Withdrawal by Subject|2|||
126497076|NCT02153112|455119811|FG004|Overall Study|Withdrawal by Subject|1|||
126497077|NCT02153112|455119812|FG005|Overall Study|Withdrawal by Subject|1|||
126497078|NCT02153112|455119813|FG006|Overall Study|Withdrawal by Subject|7|||
126497079|NCT02153112|455119814|FG007|Overall Study|Withdrawal by Subject|2|||
126497080|NCT02153112|455119815|FG008|Overall Study|Withdrawal by Subject|13|||
126497081|NCT02153112|455119816|FG009|Overall Study|Withdrawal by Subject|12|||
126773413|NCT00430638|456125392|FG000|Overall Study|Withdrawal by Subject|4|||
126773414|NCT00430638|456125393|FG001|Overall Study|Withdrawal by Subject|6|||
126773415|NCT00430638|456125392|FG000|Overall Study|Non-compliant|2|||
126497082|NCT02153112|455119807|FG000|Overall Study|Reason not Specified|0|||
126497083|NCT02153112|455119808|FG001|Overall Study|Reason not Specified|0|||
126497084|NCT02153112|455119809|FG002|Overall Study|Reason not Specified|0|||
126497085|NCT02153112|455119810|FG003|Overall Study|Reason not Specified|0|||
126497086|NCT02153112|455119811|FG004|Overall Study|Reason not Specified|0|||
126497087|NCT02153112|455119812|FG005|Overall Study|Reason not Specified|0|||
126497088|NCT02153112|455119813|FG006|Overall Study|Reason not Specified|0|||
126497089|NCT02153112|455119814|FG007|Overall Study|Reason not Specified|0|||
126497090|NCT02153112|455119815|FG008|Overall Study|Reason not Specified|1|||
126497091|NCT02153112|455119816|FG009|Overall Study|Reason not Specified|1|||
126497092|NCT01288287|455119817|FG000|Overall Study|Lost to Follow-up|8|||
126497093|NCT01288287|455119817|FG000|Overall Study|Withdrawal by Subject|4|||
126773416|NCT00430638|456125393|FG001|Overall Study|Non-compliant|1|||
126773417|NCT00430638|456125392|FG000|Overall Study|Other|2|||
126497094|NCT01288287|455119817|FG000|Overall Study|Lack of Efficacy|13|||
126497095|NCT01288287|455119817|FG000|Overall Study|Other Reason|13|||
126773418|NCT00430638|456125393|FG001|Overall Study|Other|2|||
126773419|NCT05458895|456125395|FG000|Overall Study|Withdrawal by Subject|8|||
126497096|NCT01288287|455119817|FG000|Overall Study|Unknown Reason|1|||
126497097|NCT01288287|455119817|FG000|Overall Study|Unknown Status|7|||
126497098|NCT03255382|455119821|FG000|Overall Study|Adverse Event|3|||
126497099|NCT03255382|455119822|FG001|Overall Study|Adverse Event|0|||
126724378|NCT04570657|455940420|FG001|Overall Study|Lost to Follow-up|0|||
126724379|NCT04570657|455940421|FG002|Overall Study|Lost to Follow-up|1|||
126724380|NCT04570657|455940419|FG000|Overall Study|Physician Decision|0|||
126724381|NCT04570657|455940420|FG001|Overall Study|Physician Decision|1|||
126724382|NCT04570657|455940421|FG002|Overall Study|Physician Decision|0|||
126724383|NCT04570657|455940419|FG000|Overall Study|Withdrawal by Subject|1|||
126724384|NCT04570657|455940420|FG001|Overall Study|Withdrawal by Subject|2|||
126724385|NCT04570657|455940421|FG002|Overall Study|Withdrawal by Subject|2|||
126724386|NCT01072539|455940422|FG000|Overall Study|Treated prior to the Site Initiation|1|||
126724387|NCT01072539|455940422|FG000|Overall Study|Protocol Violation|2|||
126724388|NCT00115804|455940425|FG000|Overall Study|Adverse Event|2|||
126724389|NCT01752842|455940426|FG000|Overall Study|Adverse Event|3|||
126724390|NCT01752842|455940427|FG001|Overall Study|Adverse Event|0|||
126497100|NCT03255382|455119821|FG000|Overall Study|Lost to Follow-up|2|||
126497101|NCT03255382|455119822|FG001|Overall Study|Lost to Follow-up|0|||
126497102|NCT03255382|455119821|FG000|Overall Study|Withdrawal by Subject|2|||
126497103|NCT03255382|455119822|FG001|Overall Study|Withdrawal by Subject|0|||
126497104|NCT03255382|455119821|FG000|Overall Study|Other|6|||
126497105|NCT03255382|455119822|FG001|Overall Study|Other|0|||
126497106|NCT03011307|455119827|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
126497107|NCT03011307|455119828|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
126497108|NCT03011307|455119827|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
126497109|NCT03011307|455119828|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
126497110|NCT03011307|455119827|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
126497111|NCT03011307|455119828|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
126497112|NCT00271947|455119829|FG000|Overall Study|Lost to Follow-up|1|||
126497113|NCT02466555|455119830|FG000|Overall Study|Lost to Follow-up|2|||
126497114|NCT03839212|455119831|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
126497115|NCT00679263|455119832|FG000|Visit 2/Dose 1|Adverse Event|1|||
126497116|NCT00679263|455119833|FG001|Visit 2/Dose 1|Adverse Event|0|||
126497117|NCT00679263|455119834|FG002|Visit 2/Dose 1|Adverse Event|0|||
126497118|NCT00679263|455119832|FG000|Visit 2/Dose 1|subject not compliance|1|||
126497119|NCT00679263|455119833|FG001|Visit 2/Dose 1|subject not compliance|1|||
126497120|NCT00679263|455119834|FG002|Visit 2/Dose 1|subject not compliance|0|||
126497121|NCT01464346|455119835|FG000|Overall Study|Withdrawal by Subject|0|||
126497122|NCT01464346|455119836|FG001|Overall Study|Withdrawal by Subject|0|||
126497123|NCT01464346|455119837|FG002|Overall Study|Withdrawal by Subject|1|||
126497124|NCT00733746|455119838|FG000|Overall Study|Ineligible|5|||
126497125|NCT03999892|455119839|FG000|Overall Study|Lost to Follow-up|1|||
126497126|NCT02295995|455119840|FG000|Overall Study|Lost to Follow-up|5|||
126497127|NCT02295995|455119841|FG001|Overall Study|Lost to Follow-up|1|||
126497128|NCT02447081|455119842|FG000|Overall Study|Death|161|||
126497129|NCT02447081|455119842|FG000|Overall Study|Lost to Follow-up|36|||
126497130|NCT02447081|455119842|FG000|Overall Study|Visit not completed|17|||
126497131|NCT02447081|455119842|FG000|Overall Study|unsuccessful implant procedure|10|||
126497132|NCT02113956|455119846|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
126497133|NCT02113956|455119847|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
126497134|NCT02113956|455119846|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
126497135|NCT02113956|455119847|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
126497136|NCT02113956|455119846|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
126497137|NCT02113956|455119847|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
126497138|NCT01498458|455119848|FG000|Overall Study|Adverse Event|4|||
126497139|NCT01498458|455119848|FG000|Overall Study|Physician Decision|3|||
126497140|NCT00718328|455119849|FG000|Overall Study|Lost to Follow-up|1|||
126497141|NCT00718328|455119850|FG001|Overall Study|Lost to Follow-up|0|||
126497142|NCT00378209|455119855|FG000|Overall Study|Progressive disease|11|||
126497143|NCT00378209|455119855|FG000|Overall Study|Adverse Event|3|||
126497144|NCT00378209|455119855|FG000|Overall Study|Initiation of non-protocol therapy|3|||
126497145|NCT00378209|455119855|FG000|Overall Study|Physician Decision|3|||
126497146|NCT00378209|455119855|FG000|Overall Study|Death|1|||
126497147|NCT00378209|455119855|FG000|Overall Study|Treatment delay|1|||
126497148|NCT04814433|455119861|FG000|Overall Study|Survey not returned|4|||
126559910|NCT01097655|455344486|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
126559911|NCT05458102|455344488|FG000|Overall Study|Withdrew consent|2|||
126724391|NCT01752842|455940426|FG000|Overall Study|Withdrawal by Subject|0|||
126724392|NCT01752842|455940427|FG001|Overall Study|Withdrawal by Subject|2|||
126724393|NCT01683071|455940428|FG000|Part 1|Lack of Efficacy|1|||
126724394|NCT01683071|455940429|FG001|Part 1|Lack of Efficacy|0|||
126724395|NCT01683071|455940430|FG002|Part 1|Lack of Efficacy|0|||
126497149|NCT04814433|455119862|FG001|Overall Study|Survey not returned|8|||
126497150|NCT04814433|455119863|FG002|Overall Study|Survey not returned|4|||
126559912|NCT05458102|455344489|FG001|Overall Study|Withdrew consent|0|||
126724396|NCT01683071|455940431|FG003|Part 1|Lack of Efficacy|3|||
126724397|NCT01683071|455940432|FG004|Part 1|Lack of Efficacy|0|||
126773420|NCT05458895|456125395|FG000|Overall Study|Lost to Follow-up|17|||
126773421|NCT05458895|456125395|FG000|Overall Study|Pregnancy|2|||
126773422|NCT05458895|456125395|FG000|Overall Study|Withdrawal by Study Team|1|||
126773423|NCT03724968|456127001|FG000|Overall Study|Insurance issues|0|||
126773424|NCT03724968|456127002|FG001|Overall Study|Insurance issues|1|||
126773425|NCT03724968|456127001|FG000|Overall Study|Study closed|0|||
126773426|NCT03724968|456127002|FG001|Overall Study|Study closed|1|||
126773427|NCT01142466|456127003|FG000|Overall Study|Adverse Event|2|||
126773428|NCT01142466|456127004|FG001|Overall Study|Adverse Event|1|||
126773429|NCT01142466|456127003|FG000|Overall Study|Withdrawal by Subject|1|||
126773430|NCT01142466|456127004|FG001|Overall Study|Withdrawal by Subject|1|||
126773431|NCT03724916|456127005|FG000|Overall Study|Withdrawal by Subject|0|||
126773432|NCT03724916|456127006|FG001|Overall Study|Withdrawal by Subject|1|||
126773433|NCT03724916|456127007|FG002|Overall Study|Withdrawal by Subject|1|||
126773434|NCT03724916|456127008|FG003|Overall Study|Withdrawal by Subject|2|||
126773435|NCT03724916|456127005|FG000|Overall Study|Randomized but not Treated|1|||
126773436|NCT03724916|456127006|FG001|Overall Study|Randomized but not Treated|0|||
126773437|NCT03724916|456127007|FG002|Overall Study|Randomized but not Treated|0|||
126773438|NCT03724916|456127008|FG003|Overall Study|Randomized but not Treated|0|||
126773439|NCT03591107|456127013|FG000|Overall Study|Same patient in both arms|1|||
126773440|NCT03591107|456127014|FG001|Overall Study|Same patient in both arms|1|||
126773441|NCT03591107|456127013|FG000|Overall Study|Sought care at other clinics|0|||
126773442|NCT03591107|456127014|FG001|Overall Study|Sought care at other clinics|2|||
126773443|NCT03591107|456127013|FG000|Overall Study|Discharged from clinic|0|||
126773444|NCT03591107|456127014|FG001|Overall Study|Discharged from clinic|1|||
126773445|NCT03591107|456127013|FG000|Overall Study|Withdrawal by Subject|0|||
126773446|NCT03591107|456127014|FG001|Overall Study|Withdrawal by Subject|1|||
126773447|NCT01084603|456127028|FG000|Baseline|Withdrawal by Subject|2|||
126773448|NCT01084603|456127028|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
126773449|NCT01084603|456127028|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
126773450|NCT01084603|456127028|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
126773451|NCT01084603|456127028|FG000|Washout Period 4|Adverse Event|1|||
126773452|NCT03836729|456127030|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
126773453|NCT03862625|456127031|FG000|Overall Study|Lost to Follow-up|0|||
126773454|NCT03862625|456127032|FG001|Overall Study|Lost to Follow-up|1|||
126773455|NCT01270841|456127033|FG000|Overall Study|Adverse Event|0|||
126773456|NCT01270841|456127034|FG001|Overall Study|Adverse Event|1|||
126773457|NCT01270841|456127035|FG002|Overall Study|Adverse Event|0|||
126773458|NCT01270841|456127036|FG003|Overall Study|Adverse Event|3|||
126773459|NCT01270841|456127033|FG000|Overall Study|Withdrawal by Subject|3|||
126773460|NCT01270841|456127034|FG001|Overall Study|Withdrawal by Subject|2|||
126773461|NCT01270841|456127035|FG002|Overall Study|Withdrawal by Subject|3|||
126773462|NCT01270841|456127036|FG003|Overall Study|Withdrawal by Subject|3|||
126773463|NCT01270841|456127033|FG000|Overall Study|Lost to Follow-up|3|||
126773464|NCT01270841|456127034|FG001|Overall Study|Lost to Follow-up|1|||
126773465|NCT01270841|456127035|FG002|Overall Study|Lost to Follow-up|4|||
126773466|NCT01270841|456127036|FG003|Overall Study|Lost to Follow-up|2|||
126773467|NCT01270841|456127033|FG000|Overall Study|Physician Decision|0|||
126773468|NCT01270841|456127034|FG001|Overall Study|Physician Decision|1|||
126773469|NCT01270841|456127035|FG002|Overall Study|Physician Decision|0|||
126773470|NCT01270841|456127036|FG003|Overall Study|Physician Decision|0|||
126773471|NCT01270841|456127033|FG000|Overall Study|Did not qualify|6|||
126773472|NCT01270841|456127034|FG001|Overall Study|Did not qualify|3|||
126773473|NCT01270841|456127035|FG002|Overall Study|Did not qualify|4|||
126773474|NCT01270841|456127036|FG003|Overall Study|Did not qualify|5|||
126773475|NCT01270841|456127033|FG000|Overall Study|Protocol Violation|1|||
126773476|NCT01270841|456127034|FG001|Overall Study|Protocol Violation|5|||
126773477|NCT01270841|456127035|FG002|Overall Study|Protocol Violation|0|||
126773478|NCT01270841|456127036|FG003|Overall Study|Protocol Violation|0|||
126773479|NCT01270841|456127033|FG000|Overall Study|Enrolled in error|0|||
126773480|NCT01270841|456127034|FG001|Overall Study|Enrolled in error|1|||
126773481|NCT01270841|456127035|FG002|Overall Study|Enrolled in error|0|||
126497151|NCT04814433|455119864|FG003|Overall Study|Survey not returned|5|||
126497152|NCT02496533|455119865|FG000|Overall Study|Lack of data on outcome|3|||
126497153|NCT02496533|455119866|FG001|Overall Study|Lack of data on outcome|0|||
126497154|NCT02496533|455119865|FG000|Overall Study|Patient did not complete all measures|0|||
126497155|NCT02496533|455119866|FG001|Overall Study|Patient did not complete all measures|4|||
126497156|NCT02496533|455119865|FG000|Overall Study|Late for radiologic testing|0|||
126497157|NCT02496533|455119866|FG001|Overall Study|Late for radiologic testing|2|||
126497158|NCT04439253|455121835|FG000|Overall Study|Adverse Event|1|||
126773482|NCT01270841|456127036|FG003|Overall Study|Enrolled in error|0|||
126773483|NCT04388527|456127037|FG000|Overall Study|Death|14|||
126773484|NCT04388527|456127037|FG000|Overall Study|Withdrawal by Subject|2|||
126773485|NCT04388527|456127037|FG000|Overall Study|Lost to Follow-up|1|||
126497159|NCT04439253|455121835|FG000|Overall Study|Disease progression|2|||
126497160|NCT04439253|455121835|FG000|Overall Study|Complicating disease|1|||
126773486|NCT01612702|456127038|FG000|Overall Study|Protocol Violation|11|||
126773487|NCT01612702|456127039|FG001|Overall Study|Protocol Violation|11|||
126773488|NCT01542736|456127040|FG000|Overall Study|Death|1|||
126773489|NCT00370396|456127043|FG000|Overall Study|Withdrawal by Subject|0|||
126773490|NCT00370396|456127044|FG001|Overall Study|Withdrawal by Subject|0|||
126497161|NCT03971695|455121836|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
126497162|NCT03971695|455121837|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
126773491|NCT00370396|456127045|FG002|Overall Study|Withdrawal by Subject|1|||
126773492|NCT00370396|456127043|FG000|Overall Study|Lost to Follow-up|11|||
126773493|NCT00370396|456127044|FG001|Overall Study|Lost to Follow-up|1|||
126773494|NCT00370396|456127045|FG002|Overall Study|Lost to Follow-up|0|||
126773495|NCT02400905|456127046|FG000|Overall Study|Death|24|||
126773496|NCT02400905|456127046|FG000|Overall Study|Lost to Follow-up|18|||
126773497|NCT02400905|456127046|FG000|Overall Study|Withdrawal by Subject|16|||
126773498|NCT02400905|456127046|FG000|Overall Study|Physician Decision|4|||
126773499|NCT02400905|456127046|FG000|Overall Study|Other|1|||
126773500|NCT01364298|456127053|FG000|Overall Study|Adverse Event|3|||
126773501|NCT01364298|456127054|FG001|Overall Study|Adverse Event|4|||
126773502|NCT01364298|456127053|FG000|Overall Study|Lack of adherence to treatment|1|||
126773503|NCT01364298|456127054|FG001|Overall Study|Lack of adherence to treatment|3|||
126773504|NCT01364298|456127053|FG000|Overall Study|Lack of Efficacy|1|||
126773505|NCT01364298|456127054|FG001|Overall Study|Lack of Efficacy|0|||
126773506|NCT01364298|456127053|FG000|Overall Study|Lost to Follow-up|5|||
126773507|NCT01364298|456127054|FG001|Overall Study|Lost to Follow-up|10|||
126773508|NCT01364298|456127053|FG000|Overall Study|Withdrawal by Subject|3|||
126773509|NCT01364298|456127054|FG001|Overall Study|Withdrawal by Subject|3|||
126773510|NCT01364298|456127053|FG000|Overall Study|Other|1|||
126773511|NCT01364298|456127054|FG001|Overall Study|Other|3|||
126773512|NCT00420849|456127055|FG000|Overall Study|Lack of Efficacy|154|||
126773513|NCT00420849|456127055|FG000|Overall Study|Adverse Event|107|||
126773514|NCT00420849|456127055|FG000|Overall Study|Withdrawal by Subject|28|||
126773515|NCT00420849|456127055|FG000|Overall Study|Death|18|||
126773516|NCT00420849|456127055|FG000|Overall Study|Other|14|||
126773517|NCT00420849|456127055|FG000|Overall Study|Transplant|8|||
126773518|NCT00420849|456127055|FG000|Overall Study|Protocol Violation|1|||
126773519|NCT00420849|456127055|FG000|Overall Study|Lost to Follow-up|1|||
126773520|NCT00659581|456127056|FG000|Overall Study|Adverse Event|1006|||
126773521|NCT00659581|456127056|FG000|Overall Study|Lack of Efficacy|1183|||
126773522|NCT00659581|456127056|FG000|Overall Study|Other|6393|||
126773523|NCT00944125|456127062|FG000|3 to 6 Months|Withdrawal by Subject|0|||
126773524|NCT00944125|456127063|FG001|3 to 6 Months|Withdrawal by Subject|2|||
126773525|NCT00944125|456127062|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
126773526|NCT00944125|456127063|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
126773527|NCT00446134|456127064|FG000|Overall Study|Adverse Event|7|||
126773528|NCT00446134|456127065|FG001|Overall Study|Adverse Event|17|||
126773529|NCT00446134|456127066|FG002|Overall Study|Adverse Event|13|||
126773530|NCT00446134|456127067|FG003|Overall Study|Adverse Event|18|||
126773531|NCT00446134|456127064|FG000|Overall Study|Lack of Efficacy|19|||
126773532|NCT00446134|456127065|FG001|Overall Study|Lack of Efficacy|19|||
126773533|NCT00446134|456127066|FG002|Overall Study|Lack of Efficacy|24|||
126773534|NCT00446134|456127067|FG003|Overall Study|Lack of Efficacy|19|||
126773535|NCT00446134|456127064|FG000|Overall Study|Protocol Violation|0|||
126773536|NCT00446134|456127065|FG001|Overall Study|Protocol Violation|2|||
126773537|NCT00446134|456127066|FG002|Overall Study|Protocol Violation|1|||
126497163|NCT03971695|455121838|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
126497164|NCT03971695|455121839|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
126497165|NCT03971695|455121840|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
126497166|NCT03971695|455121841|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
126497167|NCT03971695|455121842|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
126497168|NCT03971695|455121843|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
126497169|NCT03971695|455121844|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
126497170|NCT03971695|455121845|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
126773538|NCT00446134|456127067|FG003|Overall Study|Protocol Violation|0|||
126773539|NCT00446134|456127064|FG000|Overall Study|Lost to Follow-up|1|||
126773540|NCT00446134|456127065|FG001|Overall Study|Lost to Follow-up|3|||
126773541|NCT00446134|456127066|FG002|Overall Study|Lost to Follow-up|1|||
126773542|NCT00446134|456127067|FG003|Overall Study|Lost to Follow-up|1|||
126773543|NCT00446134|456127064|FG000|Overall Study|Withdrawal by Subject|3|||
126773544|NCT00446134|456127065|FG001|Overall Study|Withdrawal by Subject|3|||
126773545|NCT00446134|456127066|FG002|Overall Study|Withdrawal by Subject|1|||
126773546|NCT00446134|456127067|FG003|Overall Study|Withdrawal by Subject|3|||
126773547|NCT00446134|456127064|FG000|Overall Study|Physician Decision|0|||
126773548|NCT00446134|456127065|FG001|Overall Study|Physician Decision|0|||
126773549|NCT00446134|456127066|FG002|Overall Study|Physician Decision|0|||
126773550|NCT00446134|456127067|FG003|Overall Study|Physician Decision|2|||
126773551|NCT00446134|456127064|FG000|Overall Study|Adverse Event-Diarrhea|1|||
126773552|NCT00446134|456127065|FG001|Overall Study|Adverse Event-Diarrhea|1|||
126497171|NCT03971695|455121846|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
126497172|NCT03971695|455121847|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
126497173|NCT03971695|455121848|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
126497174|NCT04447417|455121849|FG000|Overall Study|Withdrawal by Subject|1|||
126497175|NCT04447417|455121850|FG001|Overall Study|Withdrawal by Subject|0|||
126497176|NCT04447417|455121849|FG000|Overall Study|Failure to meet inclusion criteria|1|||
126497177|NCT04447417|455121850|FG001|Overall Study|Failure to meet inclusion criteria|0|||
126497178|NCT04447417|455121849|FG000|Overall Study|Lost to Follow-up|1|||
126497179|NCT04447417|455121850|FG001|Overall Study|Lost to Follow-up|0|||
126497180|NCT02155738|455121854|FG000|Overall Study|Missing critical information|1|||
126497181|NCT02155738|455121855|FG001|Overall Study|Missing critical information|0|||
126497182|NCT02155738|455121856|FG002|Overall Study|Missing critical information|0|||
126497183|NCT02155738|455121857|FG003|Overall Study|Missing critical information|1|||
126497184|NCT02016625|455121858|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
126497185|NCT02016625|455121859|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
126497186|NCT02016625|455121858|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
126497187|NCT02016625|455121859|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
126497188|NCT02016625|455121858|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
126497189|NCT02016625|455121859|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
126497190|NCT01190254|455121860|FG000|Overall Study|Adverse Event|3|||
126497191|NCT01190254|455121861|FG001|Overall Study|Adverse Event|6|||
126497192|NCT01190254|455121862|FG002|Overall Study|Adverse Event|8|||
126497193|NCT01190254|455121860|FG000|Overall Study|Lack of Efficacy|7|||
126497194|NCT01190254|455121861|FG001|Overall Study|Lack of Efficacy|4|||
126497195|NCT01190254|455121862|FG002|Overall Study|Lack of Efficacy|5|||
126497196|NCT01190254|455121860|FG000|Overall Study|Lost to Follow-up|4|||
126497197|NCT01190254|455121861|FG001|Overall Study|Lost to Follow-up|2|||
126497198|NCT01190254|455121862|FG002|Overall Study|Lost to Follow-up|0|||
126497199|NCT01190254|455121860|FG000|Overall Study|Withdrawal by Subject|4|||
126497200|NCT01190254|455121861|FG001|Overall Study|Withdrawal by Subject|5|||
126497201|NCT01190254|455121862|FG002|Overall Study|Withdrawal by Subject|7|||
126497202|NCT01190254|455121860|FG000|Overall Study|Protocol Violation|2|||
126497203|NCT01190254|455121861|FG001|Overall Study|Protocol Violation|0|||
126497204|NCT01190254|455121862|FG002|Overall Study|Protocol Violation|2|||
126497205|NCT01190254|455121860|FG000|Overall Study|Did not meet protocol eligibility|1|||
126497206|NCT01190254|455121861|FG001|Overall Study|Did not meet protocol eligibility|0|||
126497207|NCT01190254|455121862|FG002|Overall Study|Did not meet protocol eligibility|0|||
126497208|NCT02356783|455121863|FG000|Overall Study|Lost to Follow-up|1|||
126497209|NCT02356783|455121864|FG001|Overall Study|Lost to Follow-up|3|||
126724398|NCT01683071|455940433|FG005|Part 1|Lack of Efficacy|0|||
126724399|NCT01683071|455940428|FG000|Part 1|Withdrawal by Subject|1|||
126724400|NCT01683071|455940429|FG001|Part 1|Withdrawal by Subject|2|||
126724401|NCT01683071|455940430|FG002|Part 1|Withdrawal by Subject|2|||
126724402|NCT01683071|455940431|FG003|Part 1|Withdrawal by Subject|1|||
126724403|NCT01683071|455940432|FG004|Part 1|Withdrawal by Subject|0|||
126724404|NCT01683071|455940433|FG005|Part 1|Withdrawal by Subject|0|||
126724405|NCT01683071|455940428|FG000|Part 1|Surgery Cancelled|1|||
126724406|NCT01683071|455940429|FG001|Part 1|Surgery Cancelled|0|||
126724407|NCT01683071|455940430|FG002|Part 1|Surgery Cancelled|0|||
126724408|NCT01683071|455940431|FG003|Part 1|Surgery Cancelled|0|||
126724409|NCT01683071|455940432|FG004|Part 1|Surgery Cancelled|0|||
126724410|NCT01683071|455940433|FG005|Part 1|Surgery Cancelled|0|||
126724411|NCT01683071|455940428|FG000|Part 1|Did not receive study drug|1|||
126724412|NCT01683071|455940429|FG001|Part 1|Did not receive study drug|0|||
126724413|NCT01683071|455940430|FG002|Part 1|Did not receive study drug|0|||
126724414|NCT01683071|455940431|FG003|Part 1|Did not receive study drug|1|||
126724415|NCT01683071|455940432|FG004|Part 1|Did not receive study drug|0|||
126724416|NCT01683071|455940433|FG005|Part 1|Did not receive study drug|0|||
126724417|NCT01683071|455940428|FG000|Part 1|Early termination; met exclusion criteria|0|||
126724418|NCT01683071|455940429|FG001|Part 1|Early termination; met exclusion criteria|2|||
126724419|NCT01683071|455940430|FG002|Part 1|Early termination; met exclusion criteria|1|||
126724420|NCT01683071|455940431|FG003|Part 1|Early termination; met exclusion criteria|0|||
126724421|NCT01683071|455940432|FG004|Part 1|Early termination; met exclusion criteria|0|||
126724422|NCT01683071|455940433|FG005|Part 1|Early termination; met exclusion criteria|0|||
126724423|NCT01683071|455940428|FG000|Part 2|Lack of Efficacy|0|||
126497210|NCT04729127|455121865|FG000|Overall Study|Suspended/Terminated EI Services|4|||
126497211|NCT04729127|455121866|FG001|Overall Study|Suspended/Terminated EI Services|0|||
126497212|NCT04729127|455121867|FG002|Overall Study|Suspended/Terminated EI Services|4|||
126497213|NCT04729127|455121868|FG003|Overall Study|Suspended/Terminated EI Services|6|||
126497214|NCT04729127|455121869|FG004|Overall Study|Suspended/Terminated EI Services|0|||
126724424|NCT01683071|455940429|FG001|Part 2|Lack of Efficacy|0|||
126497215|NCT04729127|455121870|FG005|Overall Study|Suspended/Terminated EI Services|6|||
126497216|NCT04729127|455121871|FG006|Overall Study|Suspended/Terminated EI Services|2|||
126497217|NCT04729127|455121872|FG007|Overall Study|Suspended/Terminated EI Services|0|||
126559913|NCT05458102|455344488|FG000|Overall Study|Adverse Event|1|||
126559914|NCT05458102|455344489|FG001|Overall Study|Adverse Event|0|||
126559915|NCT05458102|455344488|FG000|Overall Study|Enrolled but never treated|1|||
126559916|NCT05458102|455344489|FG001|Overall Study|Enrolled but never treated|0|||
126559917|NCT05458102|455344488|FG000|Overall Study|Protocol Violation|1|||
126559918|NCT05458102|455344489|FG001|Overall Study|Protocol Violation|0|||
126724425|NCT01683071|455940430|FG002|Part 2|Lack of Efficacy|0|||
126724426|NCT01683071|455940431|FG003|Part 2|Lack of Efficacy|0|||
126724427|NCT01683071|455940432|FG004|Part 2|Lack of Efficacy|3|||
126724428|NCT01683071|455940433|FG005|Part 2|Lack of Efficacy|4|||
126724429|NCT01683071|455940428|FG000|Part 2|Lost to Follow-up|0|||
126724430|NCT01683071|455940429|FG001|Part 2|Lost to Follow-up|0|||
126724431|NCT01683071|455940430|FG002|Part 2|Lost to Follow-up|0|||
126724432|NCT01683071|455940431|FG003|Part 2|Lost to Follow-up|0|||
126724433|NCT01683071|455940432|FG004|Part 2|Lost to Follow-up|2|||
126724434|NCT01683071|455940433|FG005|Part 2|Lost to Follow-up|0|||
126724435|NCT01683071|455940428|FG000|Part 2|Withdrawal by Subject|0|||
126724436|NCT01683071|455940429|FG001|Part 2|Withdrawal by Subject|0|||
126724437|NCT01683071|455940430|FG002|Part 2|Withdrawal by Subject|0|||
126724438|NCT01683071|455940431|FG003|Part 2|Withdrawal by Subject|0|||
126724439|NCT01683071|455940432|FG004|Part 2|Withdrawal by Subject|3|||
126724440|NCT01683071|455940433|FG005|Part 2|Withdrawal by Subject|3|||
126724441|NCT01683071|455940428|FG000|Part 2|Surgery cancelled|0|||
126724442|NCT01683071|455940429|FG001|Part 2|Surgery cancelled|0|||
126724443|NCT01683071|455940430|FG002|Part 2|Surgery cancelled|0|||
126724444|NCT01683071|455940431|FG003|Part 2|Surgery cancelled|0|||
126724445|NCT01683071|455940432|FG004|Part 2|Surgery cancelled|4|||
126724446|NCT01683071|455940433|FG005|Part 2|Surgery cancelled|2|||
126724447|NCT01683071|455940428|FG000|Part 2|Did not receive study drug|0|||
126724448|NCT01683071|455940429|FG001|Part 2|Did not receive study drug|0|||
126724449|NCT01683071|455940430|FG002|Part 2|Did not receive study drug|0|||
126724450|NCT01683071|455940431|FG003|Part 2|Did not receive study drug|0|||
126724451|NCT01683071|455940432|FG004|Part 2|Did not receive study drug|2|||
126724452|NCT01683071|455940433|FG005|Part 2|Did not receive study drug|1|||
126724453|NCT01683071|455940428|FG000|Part 2|Met exclusion criterion|0|||
126724454|NCT01683071|455940429|FG001|Part 2|Met exclusion criterion|0|||
126724455|NCT01683071|455940430|FG002|Part 2|Met exclusion criterion|0|||
126724456|NCT01683071|455940431|FG003|Part 2|Met exclusion criterion|0|||
126724457|NCT01683071|455940432|FG004|Part 2|Met exclusion criterion|1|||
126724458|NCT01683071|455940433|FG005|Part 2|Met exclusion criterion|1|||
126724459|NCT01683071|455940428|FG000|Part 2|Protocol deviation|0|||
126724460|NCT01683071|455940429|FG001|Part 2|Protocol deviation|0|||
126724461|NCT01683071|455940430|FG002|Part 2|Protocol deviation|0|||
126724462|NCT01683071|455940431|FG003|Part 2|Protocol deviation|0|||
126724463|NCT01683071|455940432|FG004|Part 2|Protocol deviation|1|||
126724464|NCT01683071|455940433|FG005|Part 2|Protocol deviation|2|||
126724465|NCT01683071|455940428|FG000|Part 2|Withdrawal by investigator decision|0|||
126724466|NCT01683071|455940429|FG001|Part 2|Withdrawal by investigator decision|0|||
126724467|NCT01683071|455940430|FG002|Part 2|Withdrawal by investigator decision|0|||
126724468|NCT01683071|455940431|FG003|Part 2|Withdrawal by investigator decision|0|||
126724469|NCT01683071|455940432|FG004|Part 2|Withdrawal by investigator decision|1|||
126724470|NCT01683071|455940433|FG005|Part 2|Withdrawal by investigator decision|2|||
126724471|NCT02020031|455942248|FG000|Overall Study|Physician Decision|1|||
126724472|NCT02020031|455942249|FG001|Overall Study|Physician Decision|1|||
126724473|NCT02625324|455942262|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
126724474|NCT02625324|455942262|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
126724475|NCT02625324|455942262|FG000|6-Month Follow-up Subject Accountability|Death|5|||
126724476|NCT02625324|455942262|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
126773553|NCT00446134|456127066|FG002|Overall Study|Adverse Event-Diarrhea|2|||
126773554|NCT00446134|456127067|FG003|Overall Study|Adverse Event-Diarrhea|0|||
126773555|NCT00446134|456127064|FG000|Overall Study|Reason Not Completed|3|||
126773556|NCT00446134|456127065|FG001|Overall Study|Reason Not Completed|0|||
126773557|NCT00446134|456127066|FG002|Overall Study|Reason Not Completed|1|||
126773558|NCT00446134|456127067|FG003|Overall Study|Reason Not Completed|2|||
126773559|NCT03125629|456127068|FG000|Overall Study|Withdrawal by Subject|2|||
126773560|NCT03125629|456127068|FG000|Overall Study|Equipment malfunction|1|||
126773561|NCT00743119|456127069|FG000|Overall Study|unreliable|3|||
126773562|NCT00743119|456127069|FG000|Overall Study|Withdrawal by Subject|1|||
126773563|NCT03909971|456127070|FG000|Overall Study|Other Reasons Not Specified|0|||
126773564|NCT03909971|456127071|FG001|Overall Study|Other Reasons Not Specified|1|||
126773565|NCT03909971|456127070|FG000|Overall Study|Global Deterioration of Health Status|2|||
126773566|NCT03909971|456127071|FG001|Overall Study|Global Deterioration of Health Status|1|||
126773567|NCT03909971|456127070|FG000|Overall Study|Progressive Disease|6|||
126724477|NCT02625324|455942262|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
126724478|NCT02625324|455942262|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
126724479|NCT02625324|455942262|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
126724480|NCT02625324|455942262|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
126773568|NCT03909971|456127071|FG001|Overall Study|Progressive Disease|14|||
126773569|NCT03909971|456127070|FG000|Overall Study|Death|2|||
126773570|NCT03909971|456127071|FG001|Overall Study|Death|6|||
126773571|NCT04816877|456127072|FG000|Overall Study|Withdrawal by Subject|1|||
126773572|NCT04816877|456127073|FG001|Overall Study|Withdrawal by Subject|0|||
126773573|NCT02176642|456127077|FG000|Overall Study|Withdrawal by Subject|0|||
126773574|NCT02176642|456127078|FG001|Overall Study|Withdrawal by Subject|1|||
126773575|NCT00295620|456127079|FG000|Overall Study|Lost to Follow-up|9|||
126773576|NCT00295620|456127080|FG001|Overall Study|Lost to Follow-up|5|||
126773577|NCT00295620|456127079|FG000|Overall Study|Withdrawal by Subject|37|||
126773578|NCT00295620|456127080|FG001|Overall Study|Withdrawal by Subject|50|||
126773579|NCT00295620|456127079|FG000|Overall Study|Death|206|||
126773580|NCT00295620|456127080|FG001|Overall Study|Death|207|||
126773581|NCT00295620|456127079|FG000|Overall Study|Other reasons|10|||
126773582|NCT00295620|456127080|FG001|Overall Study|Other reasons|9|||
126773583|NCT00295620|456127079|FG000|Overall Study|Discontinuation by sponsor|580|||
126773584|NCT00295620|456127080|FG001|Overall Study|Discontinuation by sponsor|593|||
126773585|NCT00295620|456127079|FG000|Overall Study|Protocol Violation|30|||
126773586|NCT00295620|456127080|FG001|Overall Study|Protocol Violation|32|||
126773587|NCT01309828|456127081|FG000|Overall Study|Adverse Event|10|||
126773588|NCT01309828|456127082|FG001|Overall Study|Adverse Event|11|||
126773589|NCT01309828|456127081|FG000|Overall Study|Voluntary Withdrawal|5|||
126773590|NCT01309828|456127082|FG001|Overall Study|Voluntary Withdrawal|4|||
126773591|NCT01309828|456127081|FG000|Overall Study|Major Protocol Deviation|0|||
126773592|NCT01309828|456127082|FG001|Overall Study|Major Protocol Deviation|1|||
126773593|NCT01309828|456127081|FG000|Overall Study|Other|1|||
126773594|NCT01309828|456127082|FG001|Overall Study|Other|0|||
126773595|NCT00217971|456127083|FG000|Overall Study|Adverse Event|1|||
126773596|NCT00217971|456127084|FG001|Overall Study|Adverse Event|1|||
126773597|NCT00217971|456127083|FG000|Overall Study|Lost to Follow-up|15|||
126773598|NCT00217971|456127084|FG001|Overall Study|Lost to Follow-up|19|||
126773599|NCT00217971|456127083|FG000|Overall Study|Physician Decision|0|||
126773600|NCT00217971|456127084|FG001|Overall Study|Physician Decision|1|||
126773601|NCT00217971|456127083|FG000|Overall Study|Withdrawal by Subject|7|||
126773602|NCT00217971|456127084|FG001|Overall Study|Withdrawal by Subject|12|||
126773603|NCT00217971|456127083|FG000|Overall Study|non compliant|1|||
126773604|NCT00217971|456127084|FG001|Overall Study|non compliant|0|||
126773605|NCT02989610|456127085|FG000|Overall Study|Withdrawal by Subject|20|||
126773606|NCT02989610|456127085|FG000|Overall Study|Departure of PI from Site|8|||
126773607|NCT02989610|456127085|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
126773608|NCT02989610|456127085|FG000|Overall Study|Lost to Follow-up|3|||
126773609|NCT02989610|456127085|FG000|Overall Study|Death|3|||
126773610|NCT02989610|456127085|FG000|Overall Study|System Explant|3|||
126773611|NCT02989610|456127085|FG000|Overall Study|Subject Non-Compliance|2|||
126773612|NCT02989610|456127085|FG000|Overall Study|System Revision|2|||
126773613|NCT02989610|456127085|FG000|Overall Study|PI Left, Study Closing|1|||
126773614|NCT02989610|456127085|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
126773615|NCT02989610|456127085|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
126773616|NCT02556632|456127090|FG000|Overall Study|Lost to Follow-up|1|||
126773617|NCT02556632|456127091|FG001|Overall Study|Lost to Follow-up|0|||
126773618|NCT02556632|456127092|FG002|Overall Study|Lost to Follow-up|0|||
126773619|NCT02556632|456127090|FG000|Overall Study|Disliked Intervention|1|||
126773620|NCT02556632|456127091|FG001|Overall Study|Disliked Intervention|1|||
126773621|NCT02556632|456127092|FG002|Overall Study|Disliked Intervention|1|||
126773622|NCT02556632|456127090|FG000|Overall Study|No Reason|1|||
126773623|NCT02556632|456127091|FG001|Overall Study|No Reason|0|||
126773624|NCT02556632|456127092|FG002|Overall Study|No Reason|1|||
126773625|NCT02556632|456127090|FG000|Overall Study|Personal Issues|0|||
126773626|NCT02556632|456127091|FG001|Overall Study|Personal Issues|1|||
126773627|NCT02556632|456127092|FG002|Overall Study|Personal Issues|1|||
126773628|NCT02556632|456127090|FG000|Overall Study|Changed Mind|0|||
126773629|NCT02556632|456127091|FG001|Overall Study|Changed Mind|1|||
126773630|NCT02556632|456127092|FG002|Overall Study|Changed Mind|0|||
126773631|NCT02556632|456127090|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
126773632|NCT02556632|456127091|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
126773633|NCT02556632|456127092|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
126773634|NCT02556632|456127090|FG000|Overall Study|Unrelated Adverse Event|1|||
126773635|NCT02556632|456127091|FG001|Overall Study|Unrelated Adverse Event|0|||
126773636|NCT02556632|456127092|FG002|Overall Study|Unrelated Adverse Event|3|||
126773637|NCT02556632|456127090|FG000|Overall Study|Related Adverse Event|0|||
126497218|NCT04729127|455121873|FG008|Overall Study|Suspended/Terminated EI Services|2|||
126773638|NCT02556632|456127091|FG001|Overall Study|Related Adverse Event|1|||
126773639|NCT02556632|456127092|FG002|Overall Study|Related Adverse Event|0|||
126773640|NCT02556632|456127090|FG000|Overall Study|Possibly Related Adverse Event|0|||
126773641|NCT02556632|456127091|FG001|Overall Study|Possibly Related Adverse Event|0|||
126773642|NCT02556632|456127092|FG002|Overall Study|Possibly Related Adverse Event|1|||
126773643|NCT02556632|456127090|FG000|Overall Study|Did Not Start RT|0|||
126497219|NCT04729127|455121865|FG000|Overall Study|Withdrawal by Subject|1|||
126773644|NCT02556632|456127091|FG001|Overall Study|Did Not Start RT|1|||
126773645|NCT02556632|456127092|FG002|Overall Study|Did Not Start RT|0|||
126773646|NCT02556632|456127090|FG000|Overall Study|Ineligible|0|||
126559919|NCT03303105|455344490|FG000|Overall Study|Adverse Event|0|||
126559920|NCT03303105|455344491|FG001|Overall Study|Adverse Event|2|||
126559921|NCT03303105|455344490|FG000|Overall Study|Lack of Efficacy|1|||
126559922|NCT03303105|455344491|FG001|Overall Study|Lack of Efficacy|0|||
126559923|NCT03303105|455344490|FG000|Overall Study|Protocol Violation|1|||
126559924|NCT03303105|455344491|FG001|Overall Study|Protocol Violation|0|||
126559925|NCT03303105|455344490|FG000|Overall Study|Withdrawal by Subject|0|||
126559926|NCT03303105|455344491|FG001|Overall Study|Withdrawal by Subject|2|||
126559927|NCT00448864|455344497|FG000|Overall Study|Death|1|||
126559928|NCT00448864|455344498|FG001|Overall Study|Death|0|||
126559929|NCT00448864|455344499|FG002|Overall Study|Death|0|||
126559930|NCT00448864|455344497|FG000|Overall Study|Lost to Follow-up|3|||
126559931|NCT00448864|455344498|FG001|Overall Study|Lost to Follow-up|1|||
126559932|NCT00448864|455344499|FG002|Overall Study|Lost to Follow-up|0|||
126559933|NCT00448864|455344497|FG000|Overall Study|Physician Decision|1|||
126559934|NCT00448864|455344498|FG001|Overall Study|Physician Decision|0|||
126559935|NCT00448864|455344499|FG002|Overall Study|Physician Decision|1|||
126559936|NCT00448864|455344497|FG000|Overall Study|Withdrawal by Subject|0|||
126559937|NCT00448864|455344498|FG001|Overall Study|Withdrawal by Subject|2|||
126559938|NCT00448864|455344499|FG002|Overall Study|Withdrawal by Subject|0|||
126559939|NCT00448864|455344497|FG000|Overall Study|Protocol Violation|0|||
126559940|NCT00448864|455344498|FG001|Overall Study|Protocol Violation|2|||
126559941|NCT00448864|455344499|FG002|Overall Study|Protocol Violation|0|||
126559942|NCT01323660|455344500|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
126559943|NCT01323660|455344501|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
126559944|NCT01323660|455344502|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
126559945|NCT01323660|455344503|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
126559946|NCT01323660|455344504|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
126559947|NCT01323660|455344505|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
126559948|NCT01323660|455344500|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
126559949|NCT01323660|455344501|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
126559950|NCT01323660|455344502|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
126559951|NCT01323660|455344503|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
126559952|NCT01323660|455344504|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
126559953|NCT01323660|455344505|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
126559954|NCT01323660|455344500|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
126559955|NCT01323660|455344501|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
126559956|NCT01323660|455344502|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
126559957|NCT01323660|455344503|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
126559958|NCT01323660|455344504|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
126559959|NCT01323660|455344505|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
126559960|NCT01323660|455344500|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126559961|NCT01323660|455344501|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126559962|NCT01323660|455344502|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126559963|NCT01323660|455344503|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126559964|NCT01323660|455344504|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
126559965|NCT01323660|455344505|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126559966|NCT01323660|455344500|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126559967|NCT01323660|455344501|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126559968|NCT01323660|455344502|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126559969|NCT01323660|455344503|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126559970|NCT01323660|455344504|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
126559971|NCT01323660|455344505|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126724481|NCT02625324|455942262|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
126724482|NCT02625324|455942262|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
126724483|NCT02625324|455942262|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
126724484|NCT02625324|455942262|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
126724485|NCT02625324|455942262|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
126724486|NCT02625324|455942262|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
126724487|NCT02625324|455942262|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
126724488|NCT02625324|455942262|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
126724489|NCT02625324|455942262|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
126724490|NCT04092816|455942263|FG000|Overall Study|Lost to Follow-up|1|||
126724491|NCT04092816|455942264|FG001|Overall Study|Lost to Follow-up|2|||
126724492|NCT01116687|455942265|FG000|Overall Study|Withdrawal by Subject|4|||
126559972|NCT01323660|455344500|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
126559973|NCT01323660|455344501|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126559974|NCT01323660|455344502|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
126559975|NCT01323660|455344503|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
126559976|NCT01323660|455344504|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
126559977|NCT01323660|455344505|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126497220|NCT04729127|455121866|FG001|Overall Study|Withdrawal by Subject|0|||
126497221|NCT04729127|455121867|FG002|Overall Study|Withdrawal by Subject|1|||
126497222|NCT04729127|455121868|FG003|Overall Study|Withdrawal by Subject|0|||
126497223|NCT04729127|455121869|FG004|Overall Study|Withdrawal by Subject|0|||
126497224|NCT04729127|455121870|FG005|Overall Study|Withdrawal by Subject|0|||
126497225|NCT04729127|455121871|FG006|Overall Study|Withdrawal by Subject|0|||
126497226|NCT04729127|455121872|FG007|Overall Study|Withdrawal by Subject|0|||
126497227|NCT04729127|455121873|FG008|Overall Study|Withdrawal by Subject|0|||
126497228|NCT04729127|455121865|FG000|Overall Study|Switched Agency/Setting|1|||
126497229|NCT04729127|455121866|FG001|Overall Study|Switched Agency/Setting|0|||
126497230|NCT04729127|455121867|FG002|Overall Study|Switched Agency/Setting|1|||
126497231|NCT04729127|455121868|FG003|Overall Study|Switched Agency/Setting|1|||
126497232|NCT04729127|455121869|FG004|Overall Study|Switched Agency/Setting|0|||
126497233|NCT04729127|455121870|FG005|Overall Study|Switched Agency/Setting|1|||
126497234|NCT04729127|455121871|FG006|Overall Study|Switched Agency/Setting|1|||
126497235|NCT04729127|455121872|FG007|Overall Study|Switched Agency/Setting|0|||
126497236|NCT04729127|455121873|FG008|Overall Study|Switched Agency/Setting|1|||
126497237|NCT00887354|455121874|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
126497238|NCT00887354|455121875|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
126497239|NCT00887354|455121874|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
126497240|NCT00887354|455121875|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
126497241|NCT00887354|455121874|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
126497242|NCT00887354|455121875|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
126497243|NCT00887354|455121874|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
126497244|NCT00887354|455121875|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
126497245|NCT00887354|455121874|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
126497246|NCT00887354|455121875|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
126497247|NCT00887354|455121874|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
126497248|NCT00887354|455121875|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
126497249|NCT00887354|455121874|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
126497250|NCT00887354|455121875|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
126497251|NCT00887354|455121874|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
126497252|NCT00887354|455121875|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
126497253|NCT00887354|455121874|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
126497254|NCT00887354|455121875|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
126497255|NCT00887354|455121874|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
126497256|NCT00887354|455121875|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
126497257|NCT00887354|455121874|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
126497258|NCT00887354|455121875|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
126497259|NCT00887354|455121874|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
126497260|NCT00887354|455121875|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
126497261|NCT00887354|455121874|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
126497262|NCT00887354|455121875|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
126497263|NCT00887354|455121874|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
126497264|NCT00887354|455121875|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
126497265|NCT00887354|455121874|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
126497266|NCT00887354|455121875|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
126497267|NCT01365507|455121878|FG000|Overall Study|Withdrawal Criteria|8|||
126497268|NCT01365507|455121879|FG001|Overall Study|Withdrawal Criteria|5|||
126497269|NCT01365507|455121878|FG000|Overall Study|Unclassified|1|||
126497270|NCT01365507|455121879|FG001|Overall Study|Unclassified|4|||
126497271|NCT00192504|455121882|FG000|Overall Study|Lost to Follow-up|1|||
126497272|NCT00192504|455121883|FG001|Overall Study|Lost to Follow-up|0|||
126724493|NCT00424528|455942266|FG000|Overall Study|Adverse Event|2|||
126724494|NCT00424528|455942267|FG001|Overall Study|Adverse Event|1|||
126724495|NCT00424528|455942268|FG002|Overall Study|Adverse Event|2|||
126724496|NCT00424528|455942266|FG000|Overall Study|Protocol Violation|1|||
126724497|NCT00424528|455942267|FG001|Overall Study|Protocol Violation|1|||
126724498|NCT00424528|455942268|FG002|Overall Study|Protocol Violation|0|||
126724499|NCT00424528|455942266|FG000|Overall Study|Lost to Follow-up|0|||
126724500|NCT00424528|455942267|FG001|Overall Study|Lost to Follow-up|1|||
126724501|NCT00424528|455942268|FG002|Overall Study|Lost to Follow-up|0|||
126497273|NCT00192504|455121884|FG002|Overall Study|Lost to Follow-up|0|||
126497274|NCT00192504|455121885|FG003|Overall Study|Lost to Follow-up|0|||
126724502|NCT00424528|455942266|FG000|Overall Study|noncompliance with study requirements|2|||
126724503|NCT00424528|455942267|FG001|Overall Study|noncompliance with study requirements|1|||
126497275|NCT00192504|455121882|FG000|Overall Study|Dosing window missed|0|||
126497276|NCT00192504|455121883|FG001|Overall Study|Dosing window missed|0|||
126497277|NCT00192504|455121884|FG002|Overall Study|Dosing window missed|1|||
126497278|NCT00192504|455121885|FG003|Overall Study|Dosing window missed|0|||
126497279|NCT02794103|455121886|FG000|Overall Study|Loss to follow up due to high sedation|3|||
126724504|NCT00424528|455942268|FG002|Overall Study|noncompliance with study requirements|2|||
126497280|NCT01139450|455121887|FG000|Overall Study|Withdrawal by Subject|7|||
126497281|NCT01139450|455121888|FG001|Overall Study|Withdrawal by Subject|10|||
126724505|NCT02395653|455942272|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
126724506|NCT02395653|455942272|FG000|Overall Study|Consent Withdrawn at Screening|1|||
126724507|NCT02395653|455942272|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
126724508|NCT02395653|455942272|FG000|Overall Study|Investigator Decision at Screening|1|||
126724509|NCT02395653|455942272|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
126724510|NCT02395653|455942272|FG000|Overall Study|Withdrawal by Subject|1|||
126724511|NCT02395653|455942272|FG000|Overall Study|Lost to Follow-up|1|||
126724512|NCT00967226|455942276|FG000|Overall Study|Adverse Event|0|||
126724513|NCT00967226|455942277|FG001|Overall Study|Adverse Event|5|||
126724514|NCT00967226|455942276|FG000|Overall Study|Protocol Violation|2|||
126724515|NCT00967226|455942277|FG001|Overall Study|Protocol Violation|0|||
126724516|NCT00967226|455942276|FG000|Overall Study|Physician Decision|0|||
126724517|NCT00967226|455942277|FG001|Overall Study|Physician Decision|1|||
126724518|NCT00605722|455942278|FG000|Overall Study|Adverse Event|6|||
126724519|NCT00605722|455942278|FG000|Overall Study|Insufficient therapeutic response|44|||
126724520|NCT00605722|455942278|FG000|Overall Study|Failure to return|1|||
126724521|NCT00487084|455942281|FG000|Overall Study|Did not receive intervention|4|||
126724522|NCT00487084|455942282|FG001|Overall Study|Did not receive intervention|3|||
126724523|NCT00487084|455942283|FG002|Overall Study|Did not receive intervention|5|||
126724524|NCT02690207|455942291|FG000|Overall Study|Lost to Follow-up|48|||
126724525|NCT02690207|455942291|FG000|Overall Study|Withdrawal by Subject|46|||
126724526|NCT02690207|455942291|FG000|Overall Study|Protocol Violation|2|||
126724527|NCT02690207|455942291|FG000|Overall Study|Serious adverse event|110|||
126724528|NCT02690207|455942291|FG000|Overall Study|Non-serious Adverse Event|18|||
126724529|NCT02690207|455942291|FG000|Overall Study|Migrated/moved from study area|5|||
126724530|NCT02690207|455942291|FG000|Overall Study|Suspected HZ Episode|1|||
126724531|NCT02690207|455942291|FG000|Overall Study|Other reasons for withdrawal|23|||
126724532|NCT01626352|455942292|FG000|Overall Study|Disease Progression|3|||
126724533|NCT01626352|455942292|FG000|Overall Study|Intercurrent Illness|2|||
126724534|NCT01626352|455942292|FG000|Overall Study|Death|2|||
126724535|NCT01626352|455942292|FG000|Overall Study|Withdrawal by Subject|1|||
126724536|NCT01626352|455942292|FG000|Overall Study|Non-Compliance|1|||
126724537|NCT01626352|455942292|FG000|Overall Study|Never Treated|1|||
126724538|NCT04348656|455942295|FG000|Overall Study|Withdrawal by Subject|2|||
126724539|NCT04348656|455942296|FG001|Overall Study|Withdrawal by Subject|0|||
126724540|NCT04348656|455942295|FG000|Overall Study|Lost to Follow-up|11|||
126724541|NCT04348656|455942296|FG001|Overall Study|Lost to Follow-up|6|||
126724542|NCT00937560|455942300|FG000|Initial Treatment|Death|6|||
126724543|NCT00937560|455942300|FG000|Initial Treatment|Withdraw consent|3|||
126724544|NCT00937560|455942300|FG000|Initial Treatment|Adverse Event|1|||
126724545|NCT00937560|455942300|FG000|Initial Treatment|Lost to Follow-up|1|||
126724546|NCT00937560|455942300|FG000|Initial Treatment|No end of study page|10|||
126724547|NCT00937560|455942300|FG000|Maintenance Treatment|Death|12|||
126724548|NCT00937560|455942300|FG000|Maintenance Treatment|Withdraw consent|5|||
126724549|NCT00937560|455942300|FG000|Maintenance Treatment|According to protocol|1|||
126724550|NCT03607838|455942303|FG000|Overall Study|Lack of Efficacy|14|||
126724551|NCT03607838|455942304|FG001|Overall Study|Lack of Efficacy|20|||
126724552|NCT03607838|455942303|FG000|Overall Study|Withdrawal by Subject|13|||
126724553|NCT03607838|455942304|FG001|Overall Study|Withdrawal by Subject|8|||
126724554|NCT03607838|455942303|FG000|Overall Study|Lost to Follow-up|6|||
126724555|NCT03607838|455942304|FG001|Overall Study|Lost to Follow-up|11|||
126724556|NCT03607838|455942303|FG000|Overall Study|Adverse Event|2|||
126724557|NCT03607838|455942304|FG001|Overall Study|Adverse Event|2|||
126724558|NCT03607838|455942303|FG000|Overall Study|Physician Decision|2|||
126724559|NCT03607838|455942304|FG001|Overall Study|Physician Decision|0|||
126724560|NCT03607838|455942303|FG000|Overall Study|Failure to meet randomization criteria|1|||
126724561|NCT03607838|455942304|FG001|Overall Study|Failure to meet randomization criteria|2|||
126724562|NCT03607838|455942303|FG000|Overall Study|Pregnancy|1|||
126724563|NCT03607838|455942304|FG001|Overall Study|Pregnancy|0|||
126724564|NCT03607838|455942303|FG000|Overall Study|Protocol Violation|1|||
126724565|NCT03607838|455942304|FG001|Overall Study|Protocol Violation|0|||
126724566|NCT03607838|455942303|FG000|Overall Study|Due to work|1|||
126724567|NCT03607838|455942304|FG001|Overall Study|Due to work|0|||
126724568|NCT03607838|455942303|FG000|Overall Study|Litigation|0|||
126724569|NCT03607838|455942304|FG001|Overall Study|Litigation|1|||
126724570|NCT03607838|455942303|FG000|Overall Study|Temperature excursion for study drug|0|||
126724571|NCT03607838|455942304|FG001|Overall Study|Temperature excursion for study drug|1|||
126724572|NCT03607838|455942303|FG000|Overall Study|Change of mind|0|||
126724573|NCT03607838|455942304|FG001|Overall Study|Change of mind|1|||
126724574|NCT01576016|455942305|FG000|Lead Safety|Death|132|||
126724575|NCT01576016|455942306|FG001|Lead Safety|Death|0|||
126724576|NCT01576016|455942305|FG000|Lead Safety|Withdrawal by Subject|81|||
126724577|NCT01576016|455942306|FG001|Lead Safety|Withdrawal by Subject|0|||
126724578|NCT01576016|455942305|FG000|Lead Safety|System Explanted without Replacement|24|||
126497282|NCT01139450|455121889|FG002|Overall Study|Withdrawal by Subject|13|||
126773647|NCT02556632|456127091|FG001|Overall Study|Ineligible|1|||
126497283|NCT01139450|455121887|FG000|Overall Study|Lack of Efficacy|3|||
126497284|NCT01139450|455121888|FG001|Overall Study|Lack of Efficacy|1|||
126497285|NCT01139450|455121889|FG002|Overall Study|Lack of Efficacy|8|||
126497286|NCT01139450|455121887|FG000|Overall Study|Protocol Violation|6|||
126497287|NCT01139450|455121888|FG001|Overall Study|Protocol Violation|5|||
126497288|NCT01139450|455121889|FG002|Overall Study|Protocol Violation|2|||
126497289|NCT01139450|455121887|FG000|Overall Study|Lost to Follow-up|9|||
126497290|NCT01139450|455121888|FG001|Overall Study|Lost to Follow-up|7|||
126497291|NCT01139450|455121889|FG002|Overall Study|Lost to Follow-up|11|||
126497292|NCT01139450|455121887|FG000|Overall Study|Administrative|0|||
126497293|NCT01139450|455121888|FG001|Overall Study|Administrative|0|||
126497294|NCT01139450|455121889|FG002|Overall Study|Administrative|1|||
126497295|NCT01139450|455121887|FG000|Overall Study|Adverse Event|2|||
126497296|NCT01139450|455121888|FG001|Overall Study|Adverse Event|2|||
126497297|NCT01139450|455121889|FG002|Overall Study|Adverse Event|3|||
126497298|NCT04608500|455121890|FG000|Overall Study|Adverse Event|2|||
126497299|NCT04608500|455121891|FG001|Overall Study|Adverse Event|0|||
126497300|NCT04608500|455121890|FG000|Overall Study|Lost to Follow-up|15|||
126497301|NCT04608500|455121891|FG001|Overall Study|Lost to Follow-up|9|||
126497302|NCT04608500|455121890|FG000|Overall Study|Participant request|11|||
126497303|NCT04608500|455121891|FG001|Overall Study|Participant request|7|||
126497304|NCT04608500|455121890|FG000|Overall Study|Protocol Violation|1|||
126497305|NCT04608500|455121891|FG001|Overall Study|Protocol Violation|0|||
126497306|NCT04608500|455121890|FG000|Overall Study|Other|6|||
126497307|NCT04608500|455121891|FG001|Overall Study|Other|2|||
126497308|NCT00914810|455121900|FG000|Overall Study|Withdrawal by Subject|1|||
126497309|NCT00914810|455121901|FG001|Overall Study|Withdrawal by Subject|0|||
126724579|NCT01576016|455942306|FG001|Lead Safety|System Explanted without Replacement|0|||
126724580|NCT01576016|455942305|FG000|Lead Safety|Physician Decision|14|||
126724581|NCT01576016|455942306|FG001|Lead Safety|Physician Decision|0|||
126724582|NCT01576016|455942305|FG000|Lead Safety|Lost to Follow-up|13|||
126724583|NCT01576016|455942306|FG001|Lead Safety|Lost to Follow-up|0|||
126724584|NCT01576016|455942305|FG000|Lead Safety|Unsuccessful implant|2|||
126724585|NCT01576016|455942306|FG001|Lead Safety|Unsuccessful implant|0|||
126724586|NCT01576016|455942305|FG000|Lead Safety|Sponsor request|1|||
126724587|NCT01576016|455942306|FG001|Lead Safety|Sponsor request|0|||
126724588|NCT01576016|455942305|FG000|Lead Safety|Device replaced with CRT-D|1|||
126724589|NCT01576016|455942306|FG001|Lead Safety|Device replaced with CRT-D|0|||
126724590|NCT01576016|455942305|FG000|Lead Safety|Patient on Palliative Care|1|||
126724591|NCT01576016|455942306|FG001|Lead Safety|Patient on Palliative Care|0|||
126724592|NCT01576016|455942305|FG000|Lead Safety|Patient noncompliance|1|||
126724593|NCT01576016|455942306|FG001|Lead Safety|Patient noncompliance|0|||
126724594|NCT01576016|455942305|FG000|Lead Safety|Too far from study site|1|||
126724595|NCT01576016|455942306|FG001|Lead Safety|Too far from study site|0|||
126724596|NCT01576016|455942305|FG000|Lead Safety|System deactivated|1|||
126724597|NCT01576016|455942306|FG001|Lead Safety|System deactivated|0|||
126724598|NCT01576016|455942305|FG000|Lead Safety|Patient no longer followed by study PI|1|||
126724599|NCT01576016|455942306|FG001|Lead Safety|Patient no longer followed by study PI|0|||
126724600|NCT01576016|455942305|FG000|MRI Safety|Withdrawal by Subject|0|||
126724601|NCT01576016|455942306|FG001|MRI Safety|Withdrawal by Subject|10|||
126724602|NCT01576016|455942305|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
126724603|NCT01576016|455942306|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
126724604|NCT01576016|455942305|FG000|MRI Safety|Has not yet completed MRI scan|0|||
126724605|NCT01576016|455942306|FG001|MRI Safety|Has not yet completed MRI scan|56|||
126724606|NCT01576016|455942305|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
126724607|NCT01576016|455942306|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
126724608|NCT02488551|455942309|FG000|Overall Study|Lost to Follow-up|4|||
126724609|NCT02488551|455942310|FG001|Overall Study|Lost to Follow-up|7|||
126724610|NCT02488551|455942311|FG002|Overall Study|Lost to Follow-up|0|||
126724611|NCT02488551|455942312|FG003|Overall Study|Lost to Follow-up|0|||
126724612|NCT02488551|455942309|FG000|Overall Study|Military Deployment|1|||
126724613|NCT02488551|455942310|FG001|Overall Study|Military Deployment|1|||
126724614|NCT02488551|455942311|FG002|Overall Study|Military Deployment|0|||
126724615|NCT02488551|455942312|FG003|Overall Study|Military Deployment|0|||
126724616|NCT03364608|455942313|FG000|Overall Study|Withdrawal by Subject|4|||
126724617|NCT03364608|455942313|FG000|Overall Study|Protocol Violation|2|||
126497310|NCT00914810|455121900|FG000|Overall Study|Relocated out of state|1|||
126497311|NCT00914810|455121901|FG001|Overall Study|Relocated out of state|0|||
126497312|NCT00914810|455121900|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
126497313|NCT00914810|455121901|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
126497314|NCT04782856|455121902|FG000|Overall Study|Withdrawal by Subject|0|||
126497315|NCT04782856|455121903|FG001|Overall Study|Withdrawal by Subject|1|||
126724618|NCT03364608|455942313|FG000|Overall Study|Lost to Follow-up|2|||
126724619|NCT02546674|455942320|FG000|Overall Study|Adverse Event|19|||
126724620|NCT02546674|455942320|FG000|Overall Study|Death|1|||
126724621|NCT02546674|455942320|FG000|Overall Study|Lost to Follow-up|1|||
126724622|NCT02546674|455942320|FG000|Overall Study|Physician Decision|13|||
126724623|NCT02546674|455942320|FG000|Overall Study|Pregnancy|1|||
126497316|NCT01465022|455121904|FG000|Overall Study|Lost to Follow-up|15|||
126773648|NCT02556632|456127092|FG002|Overall Study|Ineligible|0|||
126773649|NCT02556632|456127090|FG000|Overall Study|Disliked Study Procedures|0|||
126773650|NCT02556632|456127091|FG001|Overall Study|Disliked Study Procedures|0|||
126773651|NCT02556632|456127092|FG002|Overall Study|Disliked Study Procedures|1|||
126773652|NCT02556632|456127090|FG000|Overall Study|Treatment or Change Delay|0|||
126773653|NCT02556632|456127091|FG001|Overall Study|Treatment or Change Delay|0|||
126773654|NCT02556632|456127092|FG002|Overall Study|Treatment or Change Delay|1|||
126773655|NCT01066039|456127095|FG000|Overall Study|Adverse Event|6|||
126773656|NCT01066039|456127095|FG000|Overall Study|Withdrawal by Subject|17|||
126773657|NCT01066039|456127095|FG000|Overall Study|Protocol Violation|2|||
126773658|NCT01066039|456127095|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
126773659|NCT01066039|456127095|FG000|Overall Study|Investigator's Request|1|||
126773660|NCT01066039|456127095|FG000|Overall Study|Dropout due to Insulin Administration|1|||
126773661|NCT01066039|456127095|FG000|Overall Study|Additional Antihypertensive Required|4|||
126773662|NCT01066039|456127095|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
126773663|NCT01066039|456127095|FG000|Overall Study|Failure to Control Blood Pressure|1|||
126773664|NCT01066039|456127095|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
126773665|NCT02574260|456127096|FG000|Overall Study|Disease Progression|1|||
126773666|NCT04508621|456127098|FG000|Overall Study|Adverse Event|39|||
126773667|NCT04508621|456127099|FG001|Overall Study|Adverse Event|16|||
126773668|NCT04508621|456127098|FG000|Overall Study|Lack of Efficacy|2|||
126773669|NCT04508621|456127099|FG001|Overall Study|Lack of Efficacy|8|||
126773670|NCT04508621|456127098|FG000|Overall Study|Physician Decision|0|||
126773671|NCT04508621|456127099|FG001|Overall Study|Physician Decision|1|||
126773672|NCT04508621|456127098|FG000|Overall Study|Withdrawal by Subject|10|||
126773673|NCT04508621|456127099|FG001|Overall Study|Withdrawal by Subject|14|||
126773674|NCT04508621|456127098|FG000|Overall Study|Lost to Follow-up|12|||
126773675|NCT04508621|456127099|FG001|Overall Study|Lost to Follow-up|9|||
126559978|NCT01323660|455344500|FG000|Washout Period (14 Days)|Adverse Event|0|||
126559979|NCT01323660|455344501|FG001|Washout Period (14 Days)|Adverse Event|0|||
126559980|NCT01323660|455344502|FG002|Washout Period (14 Days)|Adverse Event|0|||
126559981|NCT01323660|455344503|FG003|Washout Period (14 Days)|Adverse Event|0|||
126559982|NCT01323660|455344504|FG004|Washout Period (14 Days)|Adverse Event|1|||
126559983|NCT01323660|455344505|FG005|Washout Period (14 Days)|Adverse Event|0|||
126559984|NCT01323660|455344500|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
126559985|NCT01323660|455344501|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
126559986|NCT01323660|455344502|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
126559987|NCT01323660|455344503|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
126559988|NCT01323660|455344504|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
126559989|NCT01323660|455344505|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
126559990|NCT01323660|455344500|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
126559991|NCT01323660|455344501|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
126559992|NCT01323660|455344502|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
126559993|NCT01323660|455344503|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
126559994|NCT01323660|455344504|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
126559995|NCT01323660|455344505|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
126559996|NCT01323660|455344500|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
126559997|NCT01323660|455344501|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
126559998|NCT01323660|455344502|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
126559999|NCT01323660|455344503|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
126560000|NCT01323660|455344504|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
126724624|NCT02546674|455942320|FG000|Overall Study|Progressive Disease|2|||
126724625|NCT02546674|455942320|FG000|Overall Study|Protocol Deviation|2|||
126724626|NCT02546674|455942320|FG000|Overall Study|Subject/Guardian Decision|6|||
126724627|NCT02546674|455942320|FG000|Overall Study|Withdrawal of Informed Consent|3|||
126724628|NCT01163253|455942321|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
126724629|NCT01163253|455942322|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
126724630|NCT01163253|455942321|FG000|Overall Study|Study Terminated by Sponsor|978|||
126724631|NCT01163253|455942322|FG001|Overall Study|Study Terminated by Sponsor|349|||
126724632|NCT01163253|455942321|FG000|Overall Study|Protocol Violation|43|||
126724633|NCT01163253|455942322|FG001|Overall Study|Protocol Violation|12|||
126724634|NCT01163253|455942321|FG000|Overall Study|Withdrawal by Subject|199|||
126724635|NCT01163253|455942322|FG001|Overall Study|Withdrawal by Subject|50|||
126724636|NCT01163253|455942321|FG000|Overall Study|Medication Error|1|||
126724637|NCT01163253|455942322|FG001|Overall Study|Medication Error|0|||
126724638|NCT01163253|455942321|FG000|Overall Study|Lost to Follow-up|125|||
126724639|NCT01163253|455942322|FG001|Overall Study|Lost to Follow-up|23|||
126724640|NCT01163253|455942321|FG000|Overall Study|Insufficient Clinical Response|423|||
126724641|NCT01163253|455942322|FG001|Overall Study|Insufficient Clinical Response|29|||
126724642|NCT01163253|455942321|FG000|Overall Study|Adverse Event|300|||
126724643|NCT01163253|455942322|FG001|Overall Study|Adverse Event|78|||
126724644|NCT01163253|455942321|FG000|Overall Study|Death|17|||
126724645|NCT01163253|455942322|FG001|Overall Study|Death|5|||
126724646|NCT01163253|455942321|FG000|Overall Study|Ongoing|13|||
126724647|NCT01163253|455942322|FG001|Overall Study|Ongoing|4|||
126724648|NCT01163253|455942321|FG000|Overall Study|Other Unspecified|170|||
126724649|NCT01163253|455942322|FG001|Overall Study|Other Unspecified|34|||
126724650|NCT02492997|455942323|FG000|Overall Study|Withdrawal by Subject|1|||
126724651|NCT02492997|455942324|FG001|Overall Study|Withdrawal by Subject|0|||
126724652|NCT02492997|455942323|FG000|Overall Study|Gained Weight|1|||
126724653|NCT02492997|455942324|FG001|Overall Study|Gained Weight|0|||
126724654|NCT02492997|455942323|FG000|Overall Study|Lost to Follow-up|0|||
126724655|NCT02492997|455942324|FG001|Overall Study|Lost to Follow-up|1|||
126724656|NCT03888391|455942331|FG000|Overall Study|Lost to Follow-up|15|||
126724657|NCT01954251|455942333|FG000|Overall Study|Adverse Event|5|||
126724658|NCT01954251|455942334|FG001|Overall Study|Adverse Event|7|||
126724659|NCT01954251|455942333|FG000|Overall Study|Lost to Follow-up|6|||
126724660|NCT01954251|455942334|FG001|Overall Study|Lost to Follow-up|6|||
126724661|NCT01954251|455942333|FG000|Overall Study|Withdrawal by Subject|2|||
126724662|NCT01954251|455942334|FG001|Overall Study|Withdrawal by Subject|6|||
126724663|NCT02864940|455942335|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
126724664|NCT02864940|455942336|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
126724665|NCT02175771|455942339|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
126724666|NCT02175771|455942340|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126724667|NCT02175771|455942341|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126724668|NCT02175771|455942342|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126724669|NCT02175771|455942343|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126724670|NCT02175771|455942344|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126724671|NCT02175771|455942345|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126724672|NCT02175771|455942346|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126724673|NCT02175771|455942347|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126724674|NCT02175771|455942339|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
126724675|NCT02175771|455942340|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126724676|NCT02175771|455942341|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126724677|NCT02175771|455942342|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126724678|NCT02175771|455942343|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126724679|NCT02175771|455942344|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126724680|NCT02175771|455942345|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126724681|NCT02175771|455942346|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126724682|NCT02175771|455942347|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126724683|NCT02175771|455942339|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
126724684|NCT02175771|455942340|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126724685|NCT02175771|455942341|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126724686|NCT02175771|455942342|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126724687|NCT02175771|455942343|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126724688|NCT02175771|455942344|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126724689|NCT02175771|455942345|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126724690|NCT02175771|455942346|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126724691|NCT02175771|455942347|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126724692|NCT02175771|455942339|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
126724693|NCT02175771|455942340|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
126724694|NCT02175771|455942341|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
126724695|NCT02175771|455942342|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
126724696|NCT02175771|455942343|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
126724697|NCT02175771|455942344|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
126724698|NCT02175771|455942345|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
126724699|NCT02175771|455942346|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
126724700|NCT02175771|455942347|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
126724701|NCT02175771|455942339|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
126724702|NCT02175771|455942340|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126724703|NCT02175771|455942341|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126724704|NCT02175771|455942342|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126724705|NCT02175771|455942343|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126724706|NCT02175771|455942344|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126724707|NCT02175771|455942345|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126724708|NCT02175771|455942346|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126773676|NCT04508621|456127098|FG000|Overall Study|COVID-19 related crisis|3|||
126773677|NCT04508621|456127099|FG001|Overall Study|COVID-19 related crisis|0|||
126724709|NCT02175771|455942347|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126724710|NCT02175771|455942339|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
126724711|NCT02175771|455942340|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126724712|NCT02175771|455942341|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126724713|NCT02175771|455942342|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126560001|NCT01323660|455344505|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
126560002|NCT01323660|455344500|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
126560003|NCT01323660|455344501|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
126560004|NCT01323660|455344502|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
126560005|NCT01323660|455344503|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
126560006|NCT01323660|455344504|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
126560007|NCT01323660|455344505|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
126560008|NCT01323660|455344500|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
126560009|NCT01323660|455344501|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
126560010|NCT01323660|455344502|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
126560011|NCT01323660|455344503|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
126560012|NCT01323660|455344504|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
126560013|NCT01323660|455344505|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
126560014|NCT01323660|455344500|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126560015|NCT01323660|455344501|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126560016|NCT01323660|455344502|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126560017|NCT01323660|455344503|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126560018|NCT01323660|455344504|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
126560019|NCT01323660|455344505|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126560020|NCT00278564|455344506|FG000|Overall Study|Lack of Efficacy|4|||
126560021|NCT01094743|455344507|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
126560022|NCT02851511|455344508|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
126560023|NCT02851511|455344509|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
126560024|NCT02851511|455344510|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
126560025|NCT02851511|455344511|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
126560026|NCT02851511|455344508|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
126560027|NCT02851511|455344509|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
126560028|NCT02851511|455344510|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
126560029|NCT02851511|455344511|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
126724714|NCT02175771|455942343|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126724715|NCT02175771|455942344|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126724716|NCT02175771|455942345|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126724717|NCT02175771|455942346|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126724718|NCT02175771|455942347|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126724719|NCT02175771|455942339|FG000|Run-In Period (Pre-assignment)|Other|8|||
126724720|NCT02175771|455942340|FG001|Run-In Period (Pre-assignment)|Other|0|||
126724721|NCT02175771|455942341|FG002|Run-In Period (Pre-assignment)|Other|0|||
126724722|NCT02175771|455942342|FG003|Run-In Period (Pre-assignment)|Other|0|||
126724723|NCT02175771|455942343|FG004|Run-In Period (Pre-assignment)|Other|0|||
126724724|NCT02175771|455942344|FG005|Run-In Period (Pre-assignment)|Other|0|||
126724725|NCT02175771|455942345|FG006|Run-In Period (Pre-assignment)|Other|0|||
126724726|NCT02175771|455942346|FG007|Run-In Period (Pre-assignment)|Other|0|||
126724727|NCT02175771|455942347|FG008|Run-In Period (Pre-assignment)|Other|0|||
126724728|NCT02175771|455942339|FG000|Treatment Period|Adverse Event|0|||
126724729|NCT02175771|455942340|FG001|Treatment Period|Adverse Event|2|||
126724730|NCT02175771|455942341|FG002|Treatment Period|Adverse Event|1|||
126724731|NCT02175771|455942342|FG003|Treatment Period|Adverse Event|1|||
126724732|NCT02175771|455942343|FG004|Treatment Period|Adverse Event|1|||
126724733|NCT02175771|455942344|FG005|Treatment Period|Adverse Event|3|||
126724734|NCT02175771|455942345|FG006|Treatment Period|Adverse Event|2|||
126724735|NCT02175771|455942346|FG007|Treatment Period|Adverse Event|0|||
126724736|NCT02175771|455942347|FG008|Treatment Period|Adverse Event|1|||
126724737|NCT02175771|455942339|FG000|Treatment Period|Withdrawal by Subject|0|||
126724738|NCT02175771|455942340|FG001|Treatment Period|Withdrawal by Subject|9|||
126724739|NCT02175771|455942341|FG002|Treatment Period|Withdrawal by Subject|3|||
126724740|NCT02175771|455942342|FG003|Treatment Period|Withdrawal by Subject|6|||
126724741|NCT02175771|455942343|FG004|Treatment Period|Withdrawal by Subject|2|||
126724742|NCT02175771|455942344|FG005|Treatment Period|Withdrawal by Subject|4|||
126724743|NCT02175771|455942345|FG006|Treatment Period|Withdrawal by Subject|2|||
126724744|NCT02175771|455942346|FG007|Treatment Period|Withdrawal by Subject|9|||
126724745|NCT02175771|455942347|FG008|Treatment Period|Withdrawal by Subject|2|||
126724746|NCT02175771|455942339|FG000|Treatment Period|Noncompliance|0|||
126724747|NCT02175771|455942340|FG001|Treatment Period|Noncompliance|1|||
126724748|NCT02175771|455942341|FG002|Treatment Period|Noncompliance|2|||
126773678|NCT04508621|456127098|FG000|Overall Study|Subject non-compliance|1|||
126724749|NCT02175771|455942342|FG003|Treatment Period|Noncompliance|0|||
126724750|NCT02175771|455942343|FG004|Treatment Period|Noncompliance|0|||
126724751|NCT02175771|455942344|FG005|Treatment Period|Noncompliance|0|||
126724752|NCT02175771|455942345|FG006|Treatment Period|Noncompliance|0|||
126724753|NCT02175771|455942346|FG007|Treatment Period|Noncompliance|0|||
126724754|NCT02175771|455942347|FG008|Treatment Period|Noncompliance|1|||
126724755|NCT02175771|455942339|FG000|Treatment Period|Protocol Violation|0|||
126773679|NCT04508621|456127099|FG001|Overall Study|Subject non-compliance|0|||
126773680|NCT00808015|456127100|FG000|Overall Study|Death|1|||
126773681|NCT00808015|456127100|FG000|Overall Study|Lack of Efficacy|58|||
126773682|NCT00808015|456127100|FG000|Overall Study|Lost to Follow-up|76|||
126773683|NCT00808015|456127100|FG000|Overall Study|Participants not willing to participate|158|||
126497317|NCT01465022|455121905|FG001|Overall Study|Lost to Follow-up|14|||
126497318|NCT01465022|455121906|FG002|Overall Study|Lost to Follow-up|0|||
126724756|NCT02175771|455942340|FG001|Treatment Period|Protocol Violation|0|||
126724757|NCT02175771|455942341|FG002|Treatment Period|Protocol Violation|0|||
126724758|NCT02175771|455942342|FG003|Treatment Period|Protocol Violation|0|||
126724759|NCT02175771|455942343|FG004|Treatment Period|Protocol Violation|0|||
126724760|NCT02175771|455942344|FG005|Treatment Period|Protocol Violation|0|||
126724761|NCT02175771|455942345|FG006|Treatment Period|Protocol Violation|0|||
126724762|NCT02175771|455942346|FG007|Treatment Period|Protocol Violation|1|||
126497319|NCT01465022|455121904|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
126724763|NCT02175771|455942347|FG008|Treatment Period|Protocol Violation|0|||
126724764|NCT02175771|455942339|FG000|Treatment Period|Disease progression|0|||
126724765|NCT02175771|455942340|FG001|Treatment Period|Disease progression|0|||
126724766|NCT02175771|455942341|FG002|Treatment Period|Disease progression|0|||
126724767|NCT02175771|455942342|FG003|Treatment Period|Disease progression|0|||
126724768|NCT02175771|455942343|FG004|Treatment Period|Disease progression|0|||
126724769|NCT02175771|455942344|FG005|Treatment Period|Disease progression|0|||
126724770|NCT02175771|455942345|FG006|Treatment Period|Disease progression|0|||
126724771|NCT02175771|455942346|FG007|Treatment Period|Disease progression|2|||
126724772|NCT02175771|455942347|FG008|Treatment Period|Disease progression|0|||
126724773|NCT02175771|455942339|FG000|Treatment Period|Lost to Follow-up|0|||
126724774|NCT02175771|455942340|FG001|Treatment Period|Lost to Follow-up|3|||
126724775|NCT02175771|455942341|FG002|Treatment Period|Lost to Follow-up|1|||
126724776|NCT02175771|455942342|FG003|Treatment Period|Lost to Follow-up|3|||
126724777|NCT02175771|455942343|FG004|Treatment Period|Lost to Follow-up|1|||
126724778|NCT02175771|455942344|FG005|Treatment Period|Lost to Follow-up|2|||
126724779|NCT02175771|455942345|FG006|Treatment Period|Lost to Follow-up|1|||
126724780|NCT02175771|455942346|FG007|Treatment Period|Lost to Follow-up|2|||
126724781|NCT02175771|455942347|FG008|Treatment Period|Lost to Follow-up|2|||
126724782|NCT02175771|455942339|FG000|Treatment Period|Lack of Efficacy|0|||
126724783|NCT02175771|455942340|FG001|Treatment Period|Lack of Efficacy|0|||
126724784|NCT02175771|455942341|FG002|Treatment Period|Lack of Efficacy|0|||
126724785|NCT02175771|455942342|FG003|Treatment Period|Lack of Efficacy|0|||
126724786|NCT02175771|455942343|FG004|Treatment Period|Lack of Efficacy|0|||
126724787|NCT02175771|455942344|FG005|Treatment Period|Lack of Efficacy|1|||
126724788|NCT02175771|455942345|FG006|Treatment Period|Lack of Efficacy|0|||
126724789|NCT02175771|455942346|FG007|Treatment Period|Lack of Efficacy|1|||
126724790|NCT02175771|455942347|FG008|Treatment Period|Lack of Efficacy|0|||
126724791|NCT02175771|455942339|FG000|Treatment Period|Other|0|||
126724792|NCT02175771|455942340|FG001|Treatment Period|Other|1|||
126724793|NCT02175771|455942341|FG002|Treatment Period|Other|0|||
126724794|NCT02175771|455942342|FG003|Treatment Period|Other|3|||
126724795|NCT02175771|455942343|FG004|Treatment Period|Other|1|||
126724796|NCT02175771|455942344|FG005|Treatment Period|Other|0|||
126724797|NCT02175771|455942345|FG006|Treatment Period|Other|0|||
126724798|NCT02175771|455942346|FG007|Treatment Period|Other|2|||
126724799|NCT02175771|455942347|FG008|Treatment Period|Other|0|||
126724800|NCT00579501|455942350|FG000|Overall Study|Death|1|||
126724801|NCT00579501|455942350|FG000|Overall Study|End of neoadjuvant therapy|25|||
126724802|NCT00579501|455942350|FG000|Overall Study|toxicity|1|||
126724803|NCT00579501|455942350|FG000|Overall Study|Secondary lesion|1|||
126724804|NCT00579501|455942350|FG000|Overall Study|Radiation therapy before surgery|1|||
126724805|NCT03364673|455942351|FG000|Overall Study|Withdrawal by Subject|2|||
126724806|NCT03364673|455942351|FG000|Overall Study|Injury unrelated to study|3|||
126724807|NCT02232087|455942352|FG000|Overall Study|Withdrawal by Subject|2|||
126724808|NCT02232087|455942353|FG001|Overall Study|Withdrawal by Subject|0|||
126497320|NCT01465022|455121905|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
126497321|NCT01465022|455121906|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
126497322|NCT01465022|455121904|FG000|Overall Study|Not Randomized|0|||
126497323|NCT01465022|455121905|FG001|Overall Study|Not Randomized|0|||
126724809|NCT02232087|455942354|FG002|Overall Study|Withdrawal by Subject|0|||
126724810|NCT02232087|455942355|FG003|Overall Study|Withdrawal by Subject|0|||
126724811|NCT02232087|455942356|FG004|Overall Study|Withdrawal by Subject|0|||
126773684|NCT00808015|456127100|FG000|Overall Study|Adverse Event|22|||
126724812|NCT02232087|455942357|FG005|Overall Study|Withdrawal by Subject|1|||
126724813|NCT02232087|455942352|FG000|Overall Study|poor inhalation technique|0|||
126724814|NCT02232087|455942353|FG001|Overall Study|poor inhalation technique|1|||
126724815|NCT02232087|455942354|FG002|Overall Study|poor inhalation technique|0|||
126724816|NCT02232087|455942355|FG003|Overall Study|poor inhalation technique|0|||
126724817|NCT02232087|455942356|FG004|Overall Study|poor inhalation technique|0|||
126724818|NCT02232087|455942357|FG005|Overall Study|poor inhalation technique|2|||
126773685|NCT00808015|456127100|FG000|Overall Study|Other|25|||
126497324|NCT01465022|455121906|FG002|Overall Study|Not Randomized|70|||
126497325|NCT01327300|455121907|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
126724819|NCT02232087|455942352|FG000|Overall Study|protocol stop criteria|0|||
126724820|NCT02232087|455942353|FG001|Overall Study|protocol stop criteria|1|||
126724821|NCT02232087|455942354|FG002|Overall Study|protocol stop criteria|0|||
126724822|NCT02232087|455942355|FG003|Overall Study|protocol stop criteria|1|||
126724823|NCT02232087|455942356|FG004|Overall Study|protocol stop criteria|0|||
126724824|NCT02232087|455942357|FG005|Overall Study|protocol stop criteria|0|||
126724825|NCT02232087|455942352|FG000|Overall Study|Adverse Event|0|||
126724826|NCT02232087|455942353|FG001|Overall Study|Adverse Event|0|||
126724827|NCT02232087|455942354|FG002|Overall Study|Adverse Event|0|||
126724828|NCT02232087|455942355|FG003|Overall Study|Adverse Event|0|||
126724829|NCT02232087|455942356|FG004|Overall Study|Adverse Event|1|||
126724830|NCT02232087|455942357|FG005|Overall Study|Adverse Event|0|||
126724831|NCT04069156|455942358|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
126724832|NCT04069156|455942359|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
126724833|NCT04069156|455942358|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
126724834|NCT04069156|455942359|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
126724835|NCT04069156|455942358|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
126724836|NCT04069156|455942359|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
126724837|NCT04069156|455942358|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
126724838|NCT04069156|455942359|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
126724839|NCT02208024|455942360|FG000|Overall Study|Withdrawal by Subject|1|||
126724840|NCT02207556|455942361|FG000|Overall Study|Physician Decision|1|||
126724841|NCT02207556|455942362|FG001|Overall Study|Physician Decision|0|||
126724842|NCT02207556|455942361|FG000|Overall Study|Withdrawal by Subject|1|||
126724843|NCT02207556|455942362|FG001|Overall Study|Withdrawal by Subject|0|||
126724844|NCT02207556|455942361|FG000|Overall Study|Death|0|||
126724845|NCT02207556|455942362|FG001|Overall Study|Death|5|||
126724846|NCT03558555|455942363|FG000|Overall Study|Lost to Follow-up|2|||
126724847|NCT03558555|455942364|FG001|Overall Study|Lost to Follow-up|1|||
126724848|NCT01958125|455942365|FG000|Overall Study|Missing diary data|2|||
126724849|NCT01958125|455942366|FG001|Overall Study|Missing diary data|6|||
126724850|NCT01958125|455942365|FG000|Overall Study|No headache attacks|0|||
126724851|NCT01958125|455942366|FG001|Overall Study|No headache attacks|2|||
126724852|NCT04096326|455942367|FG000|Overall Study|Withdrawal by Subject|0|||
126724853|NCT04096326|455942368|FG001|Overall Study|Withdrawal by Subject|0|||
126724854|NCT04096326|455942369|FG002|Overall Study|Withdrawal by Subject|0|||
126724855|NCT04096326|455942370|FG003|Overall Study|Withdrawal by Subject|0|||
126724856|NCT04096326|455942371|FG004|Overall Study|Withdrawal by Subject|0|||
126724857|NCT04096326|455942372|FG005|Overall Study|Withdrawal by Subject|0|||
126724858|NCT04096326|455942373|FG006|Overall Study|Withdrawal by Subject|1|||
126724859|NCT04096326|455942374|FG007|Overall Study|Withdrawal by Subject|0|||
126724860|NCT04096326|455942375|FG008|Overall Study|Withdrawal by Subject|0|||
126724861|NCT04096326|455942376|FG009|Overall Study|Withdrawal by Subject|0|||
126724862|NCT04096326|455942367|FG000|Overall Study|Lost to Follow-up|0|||
126724863|NCT04096326|455942368|FG001|Overall Study|Lost to Follow-up|1|||
126724864|NCT04096326|455942369|FG002|Overall Study|Lost to Follow-up|0|||
126724865|NCT04096326|455942370|FG003|Overall Study|Lost to Follow-up|0|||
126724866|NCT04096326|455942371|FG004|Overall Study|Lost to Follow-up|0|||
126724867|NCT04096326|455942372|FG005|Overall Study|Lost to Follow-up|0|||
126724868|NCT04096326|455942373|FG006|Overall Study|Lost to Follow-up|0|||
126724869|NCT04096326|455942374|FG007|Overall Study|Lost to Follow-up|0|||
126724870|NCT04096326|455942375|FG008|Overall Study|Lost to Follow-up|0|||
126724871|NCT04096326|455942376|FG009|Overall Study|Lost to Follow-up|0|||
126724872|NCT04096326|455942367|FG000|Overall Study|COVID-19-related reasons|0|||
126724873|NCT04096326|455942368|FG001|Overall Study|COVID-19-related reasons|0|||
126724874|NCT04096326|455942369|FG002|Overall Study|COVID-19-related reasons|0|||
126724875|NCT04096326|455942370|FG003|Overall Study|COVID-19-related reasons|0|||
126724876|NCT04096326|455942371|FG004|Overall Study|COVID-19-related reasons|1|||
126724877|NCT04096326|455942372|FG005|Overall Study|COVID-19-related reasons|5|||
126724878|NCT04096326|455942373|FG006|Overall Study|COVID-19-related reasons|0|||
126724879|NCT04096326|455942374|FG007|Overall Study|COVID-19-related reasons|0|||
126724880|NCT04096326|455942375|FG008|Overall Study|COVID-19-related reasons|0|||
126724881|NCT04096326|455942376|FG009|Overall Study|COVID-19-related reasons|0|||
126497326|NCT01327300|455121908|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
126497327|NCT03020823|455121911|FG000|Overall Study|Physician Decision|4|||
126497328|NCT03020823|455121911|FG000|Overall Study|Lack of Efficacy|4|||
126497329|NCT03020823|455121911|FG000|Overall Study|Adverse Event|2|||
126497330|NCT03739112|455121913|FG000|Overall Study|Adverse Event|2|||
126724882|NCT02130427|455942378|FG000|Overall Study|Imaging results not interpretable|30|||
126724883|NCT00543569|455942383|FG000|Overall Study|Death|2|||
126724884|NCT00543569|455942384|FG001|Overall Study|Death|2|||
126724885|NCT00543569|455942385|FG002|Overall Study|Death|3|||
126724886|NCT00543569|455942386|FG003|Overall Study|Death|1|||
126724887|NCT00543569|455942383|FG000|Overall Study|Lost to Follow-up|0|||
126497331|NCT03739112|455121914|FG001|Overall Study|Adverse Event|2|||
126724888|NCT00543569|455942384|FG001|Overall Study|Lost to Follow-up|0|||
126724889|NCT00543569|455942385|FG002|Overall Study|Lost to Follow-up|1|||
126497332|NCT03739112|455121913|FG000|Overall Study|Withdrawal by Subject|38|||
126497333|NCT03739112|455121914|FG001|Overall Study|Withdrawal by Subject|19|||
126497334|NCT03739112|455121913|FG000|Overall Study|Lost to Follow-up|31|||
126497335|NCT03739112|455121914|FG001|Overall Study|Lost to Follow-up|33|||
126497336|NCT03739112|455121913|FG000|Overall Study|Protocol Deviation|12|||
126724890|NCT00543569|455942386|FG003|Overall Study|Lost to Follow-up|1|||
126724891|NCT00543569|455942383|FG000|Overall Study|Miscellaneous Reasons|7|||
126724892|NCT00543569|455942384|FG001|Overall Study|Miscellaneous Reasons|3|||
126724893|NCT00543569|455942385|FG002|Overall Study|Miscellaneous Reasons|11|||
126724894|NCT00543569|455942386|FG003|Overall Study|Miscellaneous Reasons|4|||
126724895|NCT00543569|455942383|FG000|Overall Study|Randomized but never received study drug|3|||
126724896|NCT00543569|455942384|FG001|Overall Study|Randomized but never received study drug|3|||
126724897|NCT00543569|455942385|FG002|Overall Study|Randomized but never received study drug|5|||
126724898|NCT00543569|455942386|FG003|Overall Study|Randomized but never received study drug|3|||
126724899|NCT03150095|455942387|FG000|Overall Study|Death|0|||
126724900|NCT03150095|455942388|FG001|Overall Study|Death|1|||
126724901|NCT03150095|455942387|FG000|Overall Study|Lost to Follow-up|1|||
126724902|NCT03150095|455942388|FG001|Overall Study|Lost to Follow-up|1|||
126724903|NCT03150095|455942387|FG000|Overall Study|Withdrawal by Subject|4|||
126724904|NCT03150095|455942388|FG001|Overall Study|Withdrawal by Subject|0|||
126724905|NCT03150095|455942387|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
126724906|NCT03150095|455942388|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
126724907|NCT04032171|455942389|FG000|Overall Study|Study Termination|1|||
126724908|NCT04032171|455942390|FG001|Overall Study|Study Termination|0|||
126724909|NCT02124707|455942391|FG000|Overall Study|Adverse Event|5|||
126724910|NCT02124707|455942391|FG000|Overall Study|Physician Decision|1|||
126724911|NCT02124707|455942391|FG000|Overall Study|Death|1|||
126724912|NCT00668200|455942401|FG000|Overall Study|Withdrawal by Subject|2|||
126724913|NCT00668200|455942401|FG000|Overall Study|Lost to Follow-up|1|||
126724914|NCT01098461|455942403|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
126724915|NCT01098461|455942404|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
126724916|NCT01098461|455942405|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
126724917|NCT01098461|455942406|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
126724918|NCT01098461|455942403|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
126724919|NCT01098461|455942404|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
126724920|NCT01098461|455942405|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
126724921|NCT01098461|455942406|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
126724922|NCT01098461|455942403|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
126724923|NCT01098461|455942404|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
126724924|NCT01098461|455942405|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
126724925|NCT01098461|455942406|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
126724926|NCT01098461|455942403|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
126724927|NCT01098461|455942404|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
126724928|NCT01098461|455942405|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
126724929|NCT01098461|455942406|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
126497337|NCT03739112|455121914|FG001|Overall Study|Protocol Deviation|9|||
126497338|NCT03739112|455121913|FG000|Overall Study|Physician Decision|1|||
126497339|NCT03739112|455121914|FG001|Overall Study|Physician Decision|0|||
126497340|NCT03739112|455121913|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
126497341|NCT03739112|455121914|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
126497342|NCT03739112|455121913|FG000|Overall Study|Site went on hold|65|||
126497343|NCT03739112|455121914|FG001|Overall Study|Site went on hold|67|||
126497344|NCT03739112|455121913|FG000|Overall Study|Other than specified|8|||
126497345|NCT03739112|455121914|FG001|Overall Study|Other than specified|5|||
126497346|NCT03739112|455121913|FG000|Overall Study|Randomized but not vaccinated|31|||
126497347|NCT03739112|455121914|FG001|Overall Study|Randomized but not vaccinated|25|||
126497348|NCT04307446|455121925|FG000|Overall Study|Lost to Follow-up|2|||
126497349|NCT04307446|455121926|FG001|Overall Study|Lost to Follow-up|0|||
126497350|NCT03257631|455121929|FG000|Overall Study|Death|1|||
126497351|NCT03257631|455121930|FG001|Overall Study|Death|0|||
126497352|NCT03257631|455121931|FG002|Overall Study|Death|1|||
126497353|NCT03257631|455121932|FG003|Overall Study|Death|1|||
126497354|NCT03257631|455121929|FG000|Overall Study|Progressive Disease|10|||
126497355|NCT03257631|455121930|FG001|Overall Study|Progressive Disease|9|||
126497356|NCT03257631|455121931|FG002|Overall Study|Progressive Disease|17|||
126497357|NCT03257631|455121932|FG003|Overall Study|Progressive Disease|8|||
126724930|NCT01098461|455942403|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
126724931|NCT01098461|455942404|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
126497358|NCT03257631|455121929|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126497359|NCT03257631|455121930|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126497360|NCT03257631|455121931|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
126497361|NCT03257631|455121932|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
126724932|NCT01098461|455942405|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
126724933|NCT01098461|455942406|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
126724934|NCT01098461|455942403|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
126724935|NCT01098461|455942404|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
126724936|NCT01098461|455942405|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
126724937|NCT01098461|455942406|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
126724938|NCT01098461|455942403|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
126724939|NCT01098461|455942404|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
126724940|NCT01098461|455942405|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
126724941|NCT01098461|455942406|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
126724942|NCT01968187|455942408|FG000|Overall Study|Adverse Event|0|||
126724943|NCT01968187|455942409|FG001|Overall Study|Adverse Event|1|||
126724944|NCT01968187|455942408|FG000|Overall Study|Randomized but not treated|1|||
126724945|NCT01968187|455942409|FG001|Overall Study|Randomized but not treated|0|||
126724946|NCT04095286|455942410|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126724947|NCT04095286|455942411|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
126724948|NCT04095286|455942412|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126724949|NCT04095286|455942413|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126724950|NCT04095286|455942414|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126724951|NCT04095286|455942415|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126724952|NCT04095286|455942410|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
126724953|NCT04095286|455942411|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
126724954|NCT04095286|455942412|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
126724955|NCT04095286|455942413|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
126724956|NCT04095286|455942414|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
126724957|NCT04095286|455942415|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
126724958|NCT04095286|455942410|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
126724959|NCT04095286|455942411|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
126724960|NCT04095286|455942412|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
126724961|NCT04095286|455942413|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
126724962|NCT04095286|455942414|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
126773686|NCT00808015|456127100|FG000|Overall Study|Enrolled but not treated|4|||
126497362|NCT03257631|455121929|FG000|Overall Study|Adverse Event|0|||
126497363|NCT03257631|455121930|FG001|Overall Study|Adverse Event|0|||
126497364|NCT03257631|455121931|FG002|Overall Study|Adverse Event|2|||
126497365|NCT03257631|455121932|FG003|Overall Study|Adverse Event|0|||
126497366|NCT02529137|455121933|FG000|Overall Study|Discontinuation for different reasons|8|||
126497367|NCT01454570|455121937|FG000|Overall Study|Withdrawal by Subject|2|||
126497368|NCT01454570|455121937|FG000|Overall Study|Screen Failure|7|||
126497369|NCT00536107|455121938|FG000|Overall Study|Death|5|||
126497370|NCT00536107|455121939|FG001|Overall Study|Death|1|||
126497371|NCT00536107|455121938|FG000|Overall Study|Incorrect enrolment|1|||
126497372|NCT00536107|455121939|FG001|Overall Study|Incorrect enrolment|0|||
126497373|NCT00536107|455121938|FG000|Overall Study|Withdrawal by Subject|0|||
126497374|NCT00536107|455121939|FG001|Overall Study|Withdrawal by Subject|1|||
126497375|NCT00536107|455121938|FG000|Overall Study|Study Termination|2|||
126497376|NCT00536107|455121939|FG001|Overall Study|Study Termination|4|||
126497377|NCT00371254|455121940|FG000|Overall Study|Disease progression|13|||
126497378|NCT00371254|455121941|FG001|Overall Study|Disease progression|13|||
126497379|NCT00371254|455121940|FG000|Overall Study|Study drug toxicity|3|||
126497380|NCT00371254|455121941|FG001|Overall Study|Study drug toxicity|5|||
126497381|NCT00371254|455121940|FG000|Overall Study|Subject request|5|||
126497382|NCT00371254|455121941|FG001|Overall Study|Subject request|0|||
126497383|NCT00371254|455121940|FG000|Overall Study|Investigator Decision|2|||
126497384|NCT00371254|455121941|FG001|Overall Study|Investigator Decision|0|||
126497385|NCT00371254|455121940|FG000|Overall Study|Adverse event unrelated to study drug|0|||
126497386|NCT00371254|455121941|FG001|Overall Study|Adverse event unrelated to study drug|1|||
126497387|NCT00371254|455121940|FG000|Overall Study|Lost to Follow-up|0|||
126497388|NCT00371254|455121941|FG001|Overall Study|Lost to Follow-up|1|||
126497389|NCT00371254|455121940|FG000|Overall Study|Withdrawal by Subject|0|||
126497390|NCT00371254|455121941|FG001|Overall Study|Withdrawal by Subject|1|||
126497391|NCT02246673|455121944|FG000|Overall Study|Sponsor Decision|1|||
126497392|NCT02246673|455121945|FG001|Overall Study|Sponsor Decision|0|||
126497393|NCT02246673|455121946|FG002|Overall Study|Sponsor Decision|0|||
126497394|NCT02246673|455121947|FG003|Overall Study|Sponsor Decision|0|||
126497395|NCT02246673|455121948|FG004|Overall Study|Sponsor Decision|0|||
126497396|NCT02246673|455121944|FG000|Overall Study|Withdrawal by Subject|0|||
126497397|NCT02246673|455121945|FG001|Overall Study|Withdrawal by Subject|0|||
126497398|NCT02246673|455121946|FG002|Overall Study|Withdrawal by Subject|0|||
126497399|NCT02246673|455121947|FG003|Overall Study|Withdrawal by Subject|0|||
126497400|NCT02246673|455121948|FG004|Overall Study|Withdrawal by Subject|1|||
126560030|NCT02851511|455344508|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
126560031|NCT02851511|455344509|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
126560032|NCT02851511|455344510|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
126560033|NCT02851511|455344511|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
126560034|NCT02851511|455344508|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
126560035|NCT02851511|455344509|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
126560036|NCT02851511|455344510|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
126560037|NCT02851511|455344511|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
126560038|NCT02851511|455344508|FG000|Phase I|Physician Decision|0|||
126560039|NCT02851511|455344509|FG001|Phase I|Physician Decision|0|||
126560040|NCT02851511|455344510|FG002|Phase I|Physician Decision|0|||
126560041|NCT02851511|455344511|FG003|Phase I|Physician Decision|1|||
126560042|NCT02851511|455344508|FG000|Phase I|Withdrawal by Subject|2|||
126560043|NCT02851511|455344509|FG001|Phase I|Withdrawal by Subject|1|||
126560044|NCT02851511|455344510|FG002|Phase I|Withdrawal by Subject|0|||
126560045|NCT02851511|455344511|FG003|Phase I|Withdrawal by Subject|3|||
126560046|NCT02851511|455344508|FG000|Phase II|Physician Decision|18|||
126560047|NCT02851511|455344509|FG001|Phase II|Physician Decision|16|||
126560048|NCT02851511|455344510|FG002|Phase II|Physician Decision|0|||
126560049|NCT02851511|455344511|FG003|Phase II|Physician Decision|0|||
126560050|NCT02851511|455344508|FG000|Phase II|Withdrawal by Subject|18|||
126560051|NCT02851511|455344509|FG001|Phase II|Withdrawal by Subject|16|||
126560052|NCT02851511|455344510|FG002|Phase II|Withdrawal by Subject|0|||
126560053|NCT02851511|455344511|FG003|Phase II|Withdrawal by Subject|0|||
126560054|NCT02851511|455344508|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
126560055|NCT02851511|455344509|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
126560056|NCT02851511|455344510|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
126560057|NCT02851511|455344511|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
126560058|NCT02851511|455344508|FG000|Phase II|Lost to Follow-up|0|||
126560059|NCT02851511|455344509|FG001|Phase II|Lost to Follow-up|1|||
126560060|NCT02851511|455344510|FG002|Phase II|Lost to Follow-up|0|||
126560061|NCT02851511|455344511|FG003|Phase II|Lost to Follow-up|0|||
126560062|NCT00051311|455344512|FG000|Overall Study|Starting new study|0|||
126560063|NCT00051311|455344513|FG001|Overall Study|Starting new study|1|||
126560064|NCT00051311|455344512|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
126560065|NCT00051311|455344513|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
126560066|NCT00051311|455344512|FG000|Overall Study|Death of recipient|8|||
126560067|NCT00051311|455344513|FG001|Overall Study|Death of recipient|8|||
126560068|NCT00051311|455344512|FG000|Overall Study|Recipient taken off study|4|||
126560069|NCT00051311|455344513|FG001|Overall Study|Recipient taken off study|4|||
126560070|NCT00372567|455344523|FG000|Phase 3 Study|Adverse Event|5|||
126560071|NCT00372567|455344524|FG001|Phase 3 Study|Adverse Event|1|||
126560072|NCT00372567|455344525|FG002|Phase 3 Study|Adverse Event|1|||
126560073|NCT00372567|455344523|FG000|Phase 3 Study|Death|1|||
126560074|NCT00372567|455344524|FG001|Phase 3 Study|Death|1|||
126560075|NCT00372567|455344525|FG002|Phase 3 Study|Death|0|||
126560076|NCT00372567|455344523|FG000|Phase 3 Study|Protocol Violation|0|||
126560077|NCT00372567|455344524|FG001|Phase 3 Study|Protocol Violation|0|||
126560078|NCT00372567|455344525|FG002|Phase 3 Study|Protocol Violation|1|||
126560079|NCT00372567|455344523|FG000|Phase 3 Study|Objective progression or relapse|10|||
126560080|NCT00372567|455344524|FG001|Phase 3 Study|Objective progression or relapse|13|||
126724963|NCT04095286|455942415|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
126724964|NCT04095286|455942410|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126724965|NCT04095286|455942411|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126724966|NCT04095286|455942412|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
126724967|NCT04095286|455942413|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126724968|NCT04095286|455942414|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126724969|NCT04095286|455942415|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
126724970|NCT04095286|455942410|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
126724971|NCT04095286|455942411|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
126724972|NCT04095286|455942412|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
126724973|NCT04095286|455942413|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
126724974|NCT04095286|455942414|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
126724975|NCT04095286|455942415|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
126560081|NCT00372567|455344525|FG002|Phase 3 Study|Objective progression or relapse|4|||
126560082|NCT00372567|455344523|FG000|Phase 3 Study|Global deterioration of health status|0|||
126560083|NCT00372567|455344524|FG001|Phase 3 Study|Global deterioration of health status|1|||
126560084|NCT00372567|455344525|FG002|Phase 3 Study|Global deterioration of health status|0|||
126560085|NCT00372567|455344523|FG000|Phase 3 Study|Other|2|||
126560086|NCT00372567|455344524|FG001|Phase 3 Study|Other|2|||
126560087|NCT00372567|455344525|FG002|Phase 3 Study|Other|1|||
126560088|NCT00372567|455344523|FG000|Phase 3 Study|study terminated by sponsor|13|||
126560089|NCT00372567|455344524|FG001|Phase 3 Study|study terminated by sponsor|8|||
126560090|NCT00372567|455344525|FG002|Phase 3 Study|study terminated by sponsor|5|||
126560091|NCT00303303|455344527|FG000|Overall Study|Withdrawal by Subject|0|||
126560092|NCT00303303|455344528|FG001|Overall Study|Withdrawal by Subject|0|||
126560093|NCT00303303|455344529|FG002|Overall Study|Withdrawal by Subject|1|||
126560094|NCT00582790|455344532|FG000|Overall Study|Rapid progression of disease|1|||
126560095|NCT00480441|455344533|FG000|Screening|Not Eligible|37|||
126560096|NCT00480441|455344534|FG001|Screening|Not Eligible|0|||
126560097|NCT00480441|455344535|FG002|Screening|Not Eligible|0|||
126560098|NCT00480441|455344533|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
126560099|NCT00480441|455344534|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
126560100|NCT00480441|455344535|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
126560101|NCT00480441|455344533|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
126560102|NCT00480441|455344534|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
126560103|NCT00480441|455344535|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
126560104|NCT00480441|455344533|FG000|Baseline Functional MRI|physical contraindication|4|||
126560105|NCT00480441|455344534|FG001|Baseline Functional MRI|physical contraindication|0|||
126560106|NCT00480441|455344535|FG002|Baseline Functional MRI|physical contraindication|0|||
126560107|NCT00480441|455344533|FG000|Randomization|Lost to Follow-up|0|||
126560108|NCT00480441|455344534|FG001|Randomization|Lost to Follow-up|7|||
126560109|NCT00480441|455344535|FG002|Randomization|Lost to Follow-up|2|||
126773687|NCT00084617|456127115|FG000|Overall Study|Withdrawal by Subject|7|||
126773688|NCT00084617|456127115|FG000|Overall Study|Lack of Efficacy|1|||
126560110|NCT01004263|455344547|FG000|Overall Study|Adverse Event|15|||
126560111|NCT01004263|455344547|FG000|Overall Study|Withdrawal by Subject|58|||
126560112|NCT01004263|455344547|FG000|Overall Study|Protocol Violation|10|||
126560113|NCT01004263|455344547|FG000|Overall Study|Lost to Follow-up|64|||
126560114|NCT01004263|455344547|FG000|Overall Study|Lack of Efficacy|13|||
126560115|NCT01004263|455344547|FG000|Overall Study|Pregnancy|2|||
126560116|NCT01004263|455344547|FG000|Overall Study|Physician Decision|15|||
126560117|NCT01004263|455344547|FG000|Overall Study|Lack of Qualifying Event|2|||
126560118|NCT00958009|455344549|FG000|Overall Study|Adverse Event|1|||
126560119|NCT00958009|455344549|FG000|Overall Study|Subject found device difficult to use|1|||
126560120|NCT00558753|455344550|FG000|Overall Study|Lost to Follow-up|5|||
126560121|NCT00558753|455344551|FG001|Overall Study|Lost to Follow-up|7|||
126560122|NCT00821236|455344552|FG000|Overall Study|Lost to Follow-up|3|||
126560123|NCT00578227|455344555|FG000|Overall Study|Lost to Follow-up|0|||
126560124|NCT00578227|455344556|FG001|Overall Study|Lost to Follow-up|1|||
126560125|NCT00578227|455344557|FG002|Overall Study|Lost to Follow-up|1|||
126560126|NCT00578227|455344555|FG000|Overall Study|Withdrawal by Subject|5|||
126560127|NCT00578227|455344556|FG001|Overall Study|Withdrawal by Subject|1|||
126773689|NCT00084617|456127115|FG000|Overall Study|Protocol Violation|1|||
126773690|NCT01625286|456127116|FG000|Overall Study|Adverse Event|0|||
126773691|NCT01625286|456127117|FG001|Overall Study|Adverse Event|0|||
126773692|NCT01625286|456127118|FG002|Overall Study|Adverse Event|0|||
126497401|NCT02246673|455121944|FG000|Overall Study|Lost to Follow-up|0|||
126497402|NCT02246673|455121945|FG001|Overall Study|Lost to Follow-up|0|||
126497403|NCT02246673|455121946|FG002|Overall Study|Lost to Follow-up|0|||
126497404|NCT02246673|455121947|FG003|Overall Study|Lost to Follow-up|1|||
126497405|NCT02246673|455121948|FG004|Overall Study|Lost to Follow-up|0|||
126497406|NCT02246673|455121944|FG000|Overall Study|Protocol Violation|0|||
126497407|NCT02246673|455121945|FG001|Overall Study|Protocol Violation|0|||
126497408|NCT02246673|455121946|FG002|Overall Study|Protocol Violation|0|||
126497409|NCT02246673|455121947|FG003|Overall Study|Protocol Violation|1|||
126497410|NCT02246673|455121948|FG004|Overall Study|Protocol Violation|0|||
126497411|NCT01679002|455121950|FG000|Overall Study|Adverse Event|1|||
126497412|NCT01679002|455121951|FG001|Overall Study|Adverse Event|1|||
126497413|NCT01679002|455121952|FG002|Overall Study|Adverse Event|0|||
126497414|NCT01176266|455121953|FG000|Overall Study|Death|6|||
126497415|NCT01176266|455121953|FG000|Overall Study|Withdrawal by Subject|3|||
126497416|NCT01179477|455121954|FG000|Overall Study|Death|542|||
126497417|NCT01179477|455121954|FG000|Overall Study|Unsuccessful implant|80|||
126497418|NCT01179477|455121954|FG000|Overall Study|Non-death withdrawal|438|||
126497419|NCT01179477|455121954|FG000|Overall Study|Did not complete final visit|27|||
126497420|NCT05075850|455121962|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
126497421|NCT03194321|455121963|FG000|Overall Study|Withdrawal by Subject|1|||
126497422|NCT03194321|455121963|FG000|Overall Study|Lost to Follow-up|1|||
126497423|NCT03194321|455121963|FG000|Overall Study|Travel for Follow-up|1|||
126560128|NCT00578227|455344557|FG002|Overall Study|Withdrawal by Subject|3|||
126560129|NCT04668144|455344558|FG000|Overall Study|Protocol Violation|0|||
126560130|NCT04668144|455344559|FG001|Overall Study|Protocol Violation|1|||
126560131|NCT04668144|455344560|FG002|Overall Study|Protocol Violation|2|||
126560132|NCT00577629|455344561|FG000|Treatment Period|Death|1|||
126560133|NCT00577629|455344561|FG000|Long Term Follow-Up|Death|15|||
126497424|NCT01092182|455121967|FG000|Overall Study|Death|0|||
126497425|NCT01092182|455121968|FG001|Overall Study|Death|5|||
126497426|NCT01092182|455121969|FG002|Overall Study|Death|3|||
126497427|NCT01092182|455121967|FG000|Overall Study|participant safety|1|||
126560134|NCT00577629|455344561|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
126773693|NCT01625286|456127119|FG003|Overall Study|Adverse Event|0|||
126773694|NCT01625286|456127120|FG004|Overall Study|Adverse Event|1|||
126773695|NCT01625286|456127121|FG005|Overall Study|Adverse Event|2|||
126773696|NCT01625286|456127122|FG006|Overall Study|Adverse Event|1|||
126773697|NCT01625286|456127116|FG000|Overall Study|Death|0|||
126773698|NCT01625286|456127117|FG001|Overall Study|Death|0|||
126773699|NCT01625286|456127118|FG002|Overall Study|Death|1|||
126773700|NCT01625286|456127119|FG003|Overall Study|Death|1|||
126773701|NCT01625286|456127120|FG004|Overall Study|Death|0|||
126773702|NCT01625286|456127121|FG005|Overall Study|Death|11|||
126773703|NCT01625286|456127122|FG006|Overall Study|Death|16|||
126773704|NCT01625286|456127116|FG000|Overall Study|Withdrawal by Subject|0|||
126773705|NCT01625286|456127117|FG001|Overall Study|Withdrawal by Subject|1|||
126773706|NCT01625286|456127118|FG002|Overall Study|Withdrawal by Subject|0|||
126773707|NCT01625286|456127119|FG003|Overall Study|Withdrawal by Subject|1|||
126773708|NCT01625286|456127120|FG004|Overall Study|Withdrawal by Subject|0|||
126773709|NCT01625286|456127121|FG005|Overall Study|Withdrawal by Subject|0|||
126773710|NCT01625286|456127122|FG006|Overall Study|Withdrawal by Subject|1|||
126773711|NCT01625286|456127116|FG000|Overall Study|Any reason not specifically recorded|0|||
126773712|NCT01625286|456127117|FG001|Overall Study|Any reason not specifically recorded|0|||
126773713|NCT01625286|456127118|FG002|Overall Study|Any reason not specifically recorded|0|||
126773714|NCT01625286|456127119|FG003|Overall Study|Any reason not specifically recorded|0|||
126773715|NCT01625286|456127120|FG004|Overall Study|Any reason not specifically recorded|0|||
126773716|NCT01625286|456127121|FG005|Overall Study|Any reason not specifically recorded|1|||
126773717|NCT01625286|456127122|FG006|Overall Study|Any reason not specifically recorded|0|||
126773718|NCT01625286|456127116|FG000|Overall Study|Progressive disease|6|||
126773719|NCT01625286|456127117|FG001|Overall Study|Progressive disease|3|||
126773720|NCT01625286|456127118|FG002|Overall Study|Progressive disease|4|||
126773721|NCT01625286|456127119|FG003|Overall Study|Progressive disease|5|||
126773722|NCT01625286|456127120|FG004|Overall Study|Progressive disease|5|||
126773723|NCT01625286|456127121|FG005|Overall Study|Progressive disease|0|||
126773724|NCT01625286|456127122|FG006|Overall Study|Progressive disease|0|||
126773725|NCT01625286|456127116|FG000|Overall Study|Lost to Follow-up|0|||
126773726|NCT01625286|456127117|FG001|Overall Study|Lost to Follow-up|0|||
126773727|NCT01625286|456127118|FG002|Overall Study|Lost to Follow-up|0|||
126773728|NCT01625286|456127119|FG003|Overall Study|Lost to Follow-up|0|||
126773729|NCT01625286|456127120|FG004|Overall Study|Lost to Follow-up|0|||
126773730|NCT01625286|456127121|FG005|Overall Study|Lost to Follow-up|0|||
126773731|NCT01625286|456127122|FG006|Overall Study|Lost to Follow-up|1|||
126773732|NCT00928135|456127123|FG000|Overall Study|Withdrawal by Subject|1|||
126773733|NCT00928135|456127124|FG001|Overall Study|Withdrawal by Subject|0|||
126773734|NCT03338673|456127127|FG000|Overall Study|Lost to Follow-up|1|||
126773735|NCT03338673|456127128|FG001|Overall Study|Lost to Follow-up|1|||
126773736|NCT00434148|456127129|FG000|Overall Study|Adverse Event|18|||
126773737|NCT00434148|456127130|FG001|Overall Study|Adverse Event|18|||
126773738|NCT00434148|456127129|FG000|Overall Study|Lack of Efficacy|25|||
126773739|NCT00434148|456127130|FG001|Overall Study|Lack of Efficacy|28|||
126773740|NCT00434148|456127129|FG000|Overall Study|Withdrawal by Subject|15|||
126773741|NCT00434148|456127130|FG001|Overall Study|Withdrawal by Subject|15|||
126773742|NCT00434148|456127129|FG000|Overall Study|Protocol Violation|4|||
126773743|NCT00434148|456127130|FG001|Overall Study|Protocol Violation|0|||
126773744|NCT00434148|456127129|FG000|Overall Study|Administrative problems|6|||
126773745|NCT00434148|456127130|FG001|Overall Study|Administrative problems|10|||
126773746|NCT00434148|456127129|FG000|Overall Study|Lost to Follow-up|0|||
126773747|NCT00434148|456127130|FG001|Overall Study|Lost to Follow-up|1|||
126773748|NCT00434148|456127129|FG000|Overall Study|Condition no longer requires study drug|1|||
126773749|NCT00434148|456127130|FG001|Overall Study|Condition no longer requires study drug|0|||
126773750|NCT00434148|456127129|FG000|Overall Study|Abnormal test procedure result|0|||
126773751|NCT00434148|456127130|FG001|Overall Study|Abnormal test procedure result|1|||
126773752|NCT00828516|456127134|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
126773753|NCT04523831|456127144|FG000|Overall Study|Lost to Follow-up|15|||
126773754|NCT04523831|456127145|FG001|Overall Study|Lost to Follow-up|17|||
126497428|NCT01092182|455121968|FG001|Overall Study|participant safety|2|||
126497429|NCT01092182|455121969|FG002|Overall Study|participant safety|0|||
126497430|NCT01092182|455121967|FG000|Overall Study|Physician Decision|0|||
126773755|NCT04523831|456127144|FG000|Overall Study|Death|0|||
126773756|NCT04523831|456127145|FG001|Overall Study|Death|3|||
126773757|NCT04523831|456127144|FG000|Overall Study|Adverse Event|2|||
126773758|NCT04523831|456127145|FG001|Overall Study|Adverse Event|0|||
126773759|NCT02367781|456127152|FG000|Overall Study|Withdrawal by Subject|20|||
126773760|NCT02367781|456127153|FG001|Overall Study|Withdrawal by Subject|13|||
126497431|NCT01092182|455121968|FG001|Overall Study|Physician Decision|6|||
126773761|NCT02367781|456127152|FG000|Overall Study|Protocol Violation|0|||
126497432|NCT01092182|455121969|FG002|Overall Study|Physician Decision|0|||
126497433|NCT01092182|455121967|FG000|Overall Study|Did not meet criteria|0|||
126773762|NCT02367781|456127153|FG001|Overall Study|Protocol Violation|1|||
126773763|NCT02367781|456127152|FG000|Overall Study|Physician Decision|7|||
126773764|NCT02367781|456127153|FG001|Overall Study|Physician Decision|0|||
126773765|NCT02367781|456127152|FG000|Overall Study|Randomized in Error|5|||
126724976|NCT00254293|455944513|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
126724977|NCT00254293|455944514|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
126724978|NCT00254293|455944515|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
126497434|NCT01092182|455121968|FG001|Overall Study|Did not meet criteria|0|||
126497435|NCT01092182|455121969|FG002|Overall Study|Did not meet criteria|25|||
126497436|NCT01092182|455121967|FG000|Overall Study|Non-compliance|0|||
126497437|NCT01092182|455121968|FG001|Overall Study|Non-compliance|3|||
126497438|NCT01092182|455121969|FG002|Overall Study|Non-compliance|0|||
126497439|NCT01092182|455121967|FG000|Overall Study|Participant refused follow-up|0|||
126497440|NCT01092182|455121968|FG001|Overall Study|Participant refused follow-up|2|||
126497441|NCT01092182|455121969|FG002|Overall Study|Participant refused follow-up|0|||
126497442|NCT02515045|455121977|FG000|Overall Study|Adverse Event|0|||
126497443|NCT02515045|455121978|FG001|Overall Study|Adverse Event|3|||
126497444|NCT02515045|455121979|FG002|Overall Study|Adverse Event|3|||
126497445|NCT02515045|455121977|FG000|Overall Study|Lost to Follow-up|0|||
126497446|NCT02515045|455121978|FG001|Overall Study|Lost to Follow-up|1|||
126497447|NCT02515045|455121979|FG002|Overall Study|Lost to Follow-up|1|||
126497448|NCT01782664|455121982|FG000|Overall Study|Adverse Event|2|||
126497449|NCT01782664|455121983|FG001|Overall Study|Adverse Event|2|||
126497450|NCT01782664|455121984|FG002|Overall Study|Adverse Event|2|||
126497451|NCT01782664|455121985|FG003|Overall Study|Adverse Event|2|||
126497452|NCT01782664|455121986|FG004|Overall Study|Adverse Event|0|||
126497453|NCT01782664|455121987|FG005|Overall Study|Adverse Event|0|||
126497454|NCT01782664|455121982|FG000|Overall Study|Lack of Efficacy|2|||
126497455|NCT01782664|455121983|FG001|Overall Study|Lack of Efficacy|0|||
126497456|NCT01782664|455121984|FG002|Overall Study|Lack of Efficacy|2|||
126497457|NCT01782664|455121985|FG003|Overall Study|Lack of Efficacy|2|||
126497458|NCT01782664|455121986|FG004|Overall Study|Lack of Efficacy|0|||
126497459|NCT01782664|455121987|FG005|Overall Study|Lack of Efficacy|0|||
126497460|NCT01782664|455121982|FG000|Overall Study|Protocol Violation|0|||
126497461|NCT01782664|455121983|FG001|Overall Study|Protocol Violation|1|||
126497462|NCT01782664|455121984|FG002|Overall Study|Protocol Violation|0|||
126497463|NCT01782664|455121985|FG003|Overall Study|Protocol Violation|1|||
126497464|NCT01782664|455121986|FG004|Overall Study|Protocol Violation|0|||
126497465|NCT01782664|455121987|FG005|Overall Study|Protocol Violation|0|||
126497466|NCT01782664|455121982|FG000|Overall Study|Withdrawal by Subject|2|||
126497467|NCT01782664|455121983|FG001|Overall Study|Withdrawal by Subject|2|||
126497468|NCT01782664|455121984|FG002|Overall Study|Withdrawal by Subject|0|||
126497469|NCT01782664|455121985|FG003|Overall Study|Withdrawal by Subject|0|||
126497470|NCT01782664|455121986|FG004|Overall Study|Withdrawal by Subject|0|||
126497471|NCT01782664|455121987|FG005|Overall Study|Withdrawal by Subject|0|||
126497472|NCT02677987|455121989|FG000|Overall Study|Withdrawal by Subject|3|||
126497473|NCT02677987|455121990|FG001|Overall Study|Withdrawal by Subject|0|||
126497474|NCT02677987|455121989|FG000|Overall Study|Lost to Follow-up|1|||
126497475|NCT02677987|455121990|FG001|Overall Study|Lost to Follow-up|0|||
126497476|NCT00673179|455121993|FG000|Overall Study|Toxicity/Complications|3|||
126497477|NCT00673179|455121994|FG001|Overall Study|Toxicity/Complications|0|||
126497478|NCT01522365|455121995|FG000|Overall Study|Withdrawal by Subject|1|||
126497479|NCT01522365|455121996|FG001|Overall Study|Withdrawal by Subject|1|||
126497480|NCT01522365|455121995|FG000|Overall Study|Lost to Follow-up|1|||
126724979|NCT00254293|455944516|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
126724980|NCT00254293|455944517|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
126724981|NCT00254293|455944518|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
126724982|NCT00254293|455944519|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
126724983|NCT00254293|455944513|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
126724984|NCT00254293|455944514|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
126724985|NCT00254293|455944515|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
126724986|NCT00254293|455944516|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
126724987|NCT00254293|455944517|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
126724988|NCT00254293|455944518|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
126497481|NCT01522365|455121996|FG001|Overall Study|Lost to Follow-up|1|||
126497482|NCT00651755|455121997|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
126497483|NCT00651755|455121998|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
126497484|NCT00651755|455121997|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
126497485|NCT00651755|455121998|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
126497486|NCT00624052|455121999|FG000|Overall Study|Adverse Event|7|||
126497487|NCT00624052|455122000|FG001|Overall Study|Adverse Event|6|||
126497488|NCT00624052|455122001|FG002|Overall Study|Adverse Event|0|||
126497489|NCT00624052|455122002|FG003|Overall Study|Adverse Event|3|||
126497490|NCT00624052|455121999|FG000|Overall Study|Lack of Efficacy|1|||
126497491|NCT00624052|455122000|FG001|Overall Study|Lack of Efficacy|1|||
126497492|NCT00624052|455122001|FG002|Overall Study|Lack of Efficacy|0|||
126497493|NCT00624052|455122002|FG003|Overall Study|Lack of Efficacy|0|||
126497494|NCT00624052|455121999|FG000|Overall Study|Lost to Follow-up|2|||
126497495|NCT00624052|455122000|FG001|Overall Study|Lost to Follow-up|3|||
126497496|NCT00624052|455122001|FG002|Overall Study|Lost to Follow-up|1|||
126724989|NCT00254293|455944519|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
126724990|NCT00254293|455944513|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
126724991|NCT00254293|455944514|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
126724992|NCT00254293|455944515|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
126724993|NCT00254293|455944516|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
126724994|NCT00254293|455944517|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
126724995|NCT00254293|455944518|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
126724996|NCT00254293|455944519|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
126724997|NCT00254293|455944513|FG000|LTE Open Label Variable SC Dosing|Death|0|||
126724998|NCT00254293|455944514|FG001|LTE Open Label Variable SC Dosing|Death|0|||
126724999|NCT00254293|455944515|FG002|LTE Open Label Variable SC Dosing|Death|1|||
126725000|NCT00254293|455944516|FG003|LTE Open Label Variable SC Dosing|Death|0|||
126725001|NCT00254293|455944517|FG004|LTE Open Label Variable SC Dosing|Death|0|||
126725002|NCT00254293|455944518|FG005|LTE Open Label Variable SC Dosing|Death|0|||
126725003|NCT00254293|455944519|FG006|LTE Open Label Variable SC Dosing|Death|0|||
126725004|NCT00254293|455944513|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
126725005|NCT00254293|455944514|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
126725006|NCT00254293|455944515|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
126725007|NCT00254293|455944516|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
126725008|NCT00254293|455944517|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
126725009|NCT00254293|455944518|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
126725010|NCT00254293|455944519|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
126725011|NCT00254293|455944513|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
126725012|NCT00254293|455944514|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
126725013|NCT00254293|455944515|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
126725014|NCT00254293|455944516|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
126725015|NCT00254293|455944517|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
126725016|NCT00254293|455944518|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
126725017|NCT00254293|455944519|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
126725018|NCT00254293|455944513|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
126725019|NCT00254293|455944514|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
126725020|NCT00254293|455944515|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
126725021|NCT00254293|455944516|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
126725022|NCT00254293|455944517|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
126725023|NCT00254293|455944518|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
126725024|NCT00254293|455944519|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
126725025|NCT00254293|455944513|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
126725026|NCT00254293|455944514|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
126725027|NCT00254293|455944515|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
126725028|NCT00254293|455944516|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
126725029|NCT00254293|455944517|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
126725030|NCT00254293|455944518|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
126725031|NCT00254293|455944519|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
126725032|NCT00254293|455944513|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
126725033|NCT00254293|455944514|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
126725034|NCT00254293|455944515|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
126725035|NCT00254293|455944516|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
126725036|NCT00254293|455944517|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
126725037|NCT00254293|455944518|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
126725038|NCT00254293|455944519|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
126725039|NCT00254293|455944513|FG000|LTE Open Label Variable SC Dosing|Other|0|||
126725040|NCT00254293|455944514|FG001|LTE Open Label Variable SC Dosing|Other|0|||
126725041|NCT00254293|455944515|FG002|LTE Open Label Variable SC Dosing|Other|2|||
126725042|NCT00254293|455944516|FG003|LTE Open Label Variable SC Dosing|Other|0|||
126725043|NCT00254293|455944517|FG004|LTE Open Label Variable SC Dosing|Other|0|||
126725044|NCT00254293|455944518|FG005|LTE Open Label Variable SC Dosing|Other|0|||
126725045|NCT00254293|455944519|FG006|LTE Open Label Variable SC Dosing|Other|0|||
126725046|NCT00254293|455944513|FG000|LTE Open Label Fixed Dosing|Death|0|||
126725047|NCT00254293|455944514|FG001|LTE Open Label Fixed Dosing|Death|0|||
126725048|NCT00254293|455944515|FG002|LTE Open Label Fixed Dosing|Death|0|||
126725049|NCT00254293|455944516|FG003|LTE Open Label Fixed Dosing|Death|0|||
126497497|NCT00624052|455122002|FG003|Overall Study|Lost to Follow-up|0|||
126497498|NCT00624052|455121999|FG000|Overall Study|Non compliant with the protocol|2|||
126725050|NCT00254293|455944517|FG004|LTE Open Label Fixed Dosing|Death|0|||
126725051|NCT00254293|455944518|FG005|LTE Open Label Fixed Dosing|Death|0|||
126725052|NCT00254293|455944519|FG006|LTE Open Label Fixed Dosing|Death|3|||
126725053|NCT00254293|455944513|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
126725054|NCT00254293|455944514|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
126497499|NCT00624052|455122000|FG001|Overall Study|Non compliant with the protocol|1|||
126725055|NCT00254293|455944515|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
126725056|NCT00254293|455944516|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
126725057|NCT00254293|455944517|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
126725058|NCT00254293|455944518|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
126725059|NCT00254293|455944519|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
126725060|NCT00254293|455944513|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
126725061|NCT00254293|455944514|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
126725062|NCT00254293|455944515|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
126725063|NCT00254293|455944516|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
126725064|NCT00254293|455944517|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
126725065|NCT00254293|455944518|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
126725066|NCT00254293|455944519|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
126725067|NCT00254293|455944513|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
126725068|NCT00254293|455944514|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
126725069|NCT00254293|455944515|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
126725070|NCT00254293|455944516|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
126725071|NCT00254293|455944517|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
126725072|NCT00254293|455944518|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
126725073|NCT00254293|455944519|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
126725074|NCT00254293|455944513|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
126725075|NCT00254293|455944514|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
126725076|NCT00254293|455944515|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
126725077|NCT00254293|455944516|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
126725078|NCT00254293|455944517|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
126725079|NCT00254293|455944518|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
126725080|NCT00254293|455944519|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
126725081|NCT00254293|455944513|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
126725082|NCT00254293|455944514|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
126725083|NCT00254293|455944515|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
126725084|NCT00254293|455944516|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
126725085|NCT00254293|455944517|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
126725086|NCT00254293|455944518|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
126725087|NCT00254293|455944519|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
126725088|NCT00254293|455944513|FG000|LTE Open Label Fixed Dosing|Other|0|||
126725089|NCT00254293|455944514|FG001|LTE Open Label Fixed Dosing|Other|0|||
126725090|NCT00254293|455944515|FG002|LTE Open Label Fixed Dosing|Other|0|||
126725091|NCT00254293|455944516|FG003|LTE Open Label Fixed Dosing|Other|0|||
126725092|NCT00254293|455944517|FG004|LTE Open Label Fixed Dosing|Other|0|||
126725093|NCT00254293|455944518|FG005|LTE Open Label Fixed Dosing|Other|0|||
126725094|NCT00254293|455944519|FG006|LTE Open Label Fixed Dosing|Other|1|||
126725095|NCT00839423|455944524|FG000|Overall Study|Adverse Event|4|||
126725096|NCT00839423|455944525|FG001|Overall Study|Adverse Event|3|||
126725097|NCT00839423|455944526|FG002|Overall Study|Adverse Event|7|||
126725098|NCT00839423|455944527|FG003|Overall Study|Adverse Event|16|||
126725099|NCT00839423|455944524|FG000|Overall Study|Lack of Efficacy|6|||
126725100|NCT00839423|455944525|FG001|Overall Study|Lack of Efficacy|6|||
126725101|NCT00839423|455944526|FG002|Overall Study|Lack of Efficacy|3|||
126725102|NCT00839423|455944527|FG003|Overall Study|Lack of Efficacy|2|||
126725103|NCT00839423|455944524|FG000|Overall Study|Non-compliance|0|||
126725104|NCT00839423|455944525|FG001|Overall Study|Non-compliance|0|||
126725105|NCT00839423|455944526|FG002|Overall Study|Non-compliance|0|||
126725106|NCT00839423|455944527|FG003|Overall Study|Non-compliance|1|||
126725107|NCT00839423|455944524|FG000|Overall Study|Protocol Violation|0|||
126725108|NCT00839423|455944525|FG001|Overall Study|Protocol Violation|1|||
126725109|NCT00839423|455944526|FG002|Overall Study|Protocol Violation|2|||
126725110|NCT00839423|455944527|FG003|Overall Study|Protocol Violation|0|||
126725111|NCT00839423|455944524|FG000|Overall Study|Withdrawal of consent|4|||
126725112|NCT00839423|455944525|FG001|Overall Study|Withdrawal of consent|0|||
126725113|NCT00839423|455944526|FG002|Overall Study|Withdrawal of consent|4|||
126725114|NCT00839423|455944527|FG003|Overall Study|Withdrawal of consent|1|||
126725115|NCT00839423|455944524|FG000|Overall Study|Lost to Follow-up|1|||
126725116|NCT00839423|455944525|FG001|Overall Study|Lost to Follow-up|0|||
126725117|NCT00839423|455944526|FG002|Overall Study|Lost to Follow-up|1|||
126725118|NCT00839423|455944527|FG003|Overall Study|Lost to Follow-up|0|||
126725119|NCT00839423|455944524|FG000|Overall Study|Administrative or other reasons|3|||
126725120|NCT00839423|455944525|FG001|Overall Study|Administrative or other reasons|0|||
126725121|NCT00839423|455944526|FG002|Overall Study|Administrative or other reasons|1|||
126725122|NCT00839423|455944527|FG003|Overall Study|Administrative or other reasons|0|||
126725123|NCT01071096|455944528|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
126725124|NCT01071096|455944529|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
126773766|NCT02367781|456127153|FG001|Overall Study|Randomized in Error|4|||
126725125|NCT00756886|455944530|FG000|Overall Study|Lost to Follow-up|1|||
126725126|NCT00756886|455944531|FG001|Overall Study|Lost to Follow-up|0|||
126773767|NCT02367781|456127152|FG000|Overall Study|Non-Compliance|1|||
126725127|NCT00756886|455944530|FG000|Overall Study|Adverse Event|0|||
126725128|NCT00756886|455944531|FG001|Overall Study|Adverse Event|3|||
126725129|NCT00756886|455944530|FG000|Overall Study|Lack of Efficacy|1|||
126725130|NCT00756886|455944531|FG001|Overall Study|Lack of Efficacy|0|||
126725131|NCT00756886|455944530|FG000|Overall Study|Ineligible|9|||
126725132|NCT00756886|455944531|FG001|Overall Study|Ineligible|4|||
126725133|NCT03421964|455944535|FG000|Overall Study|Lost to Follow-up|11|||
126725134|NCT03421964|455944536|FG001|Overall Study|Lost to Follow-up|21|||
126725135|NCT03421964|455944535|FG000|Overall Study|Withdrawal by Subject|9|||
126725136|NCT03421964|455944536|FG001|Overall Study|Withdrawal by Subject|3|||
126725137|NCT03421964|455944535|FG000|Overall Study|Incarcerated|1|||
126725138|NCT03421964|455944536|FG001|Overall Study|Incarcerated|0|||
126725139|NCT03421964|455944535|FG000|Overall Study|Inpt Treatment Facility|1|||
126725140|NCT03421964|455944536|FG001|Overall Study|Inpt Treatment Facility|1|||
126725141|NCT03421964|455944535|FG000|Overall Study|Virtual Platform Issues|1|||
126725142|NCT03421964|455944536|FG001|Overall Study|Virtual Platform Issues|1|||
126725143|NCT00423735|455944537|FG000|Overall Study|Ineligible / No protocol treatment|8|||
126725144|NCT00423735|455944538|FG001|Overall Study|Ineligible / No protocol treatment|6|||
126725145|NCT00423735|455944539|FG002|Overall Study|Ineligible / No protocol treatment|0|||
126725146|NCT02504268|455944543|FG000|Overall Study|Adverse Event|18|||
126725147|NCT02504268|455944544|FG001|Overall Study|Adverse Event|8|||
126725148|NCT02504268|455944545|FG002|Overall Study|Adverse Event|14|||
126725149|NCT02504268|455944546|FG003|Overall Study|Adverse Event|0|||
126725150|NCT02504268|455944547|FG004|Overall Study|Adverse Event|0|||
126725151|NCT02504268|455944548|FG005|Overall Study|Adverse Event|0|||
126725152|NCT02504268|455944549|FG006|Overall Study|Adverse Event|0|||
126725153|NCT02504268|455944550|FG007|Overall Study|Adverse Event|0|||
126725154|NCT02504268|455944551|FG008|Overall Study|Adverse Event|0|||
126725155|NCT02504268|455944543|FG000|Overall Study|Withdrawal of Consent|11|||
126725156|NCT02504268|455944544|FG001|Overall Study|Withdrawal of Consent|10|||
126725157|NCT02504268|455944545|FG002|Overall Study|Withdrawal of Consent|3|||
126725158|NCT02504268|455944546|FG003|Overall Study|Withdrawal of Consent|0|||
126725159|NCT02504268|455944547|FG004|Overall Study|Withdrawal of Consent|0|||
126725160|NCT02504268|455944548|FG005|Overall Study|Withdrawal of Consent|0|||
126725161|NCT02504268|455944549|FG006|Overall Study|Withdrawal of Consent|0|||
126725162|NCT02504268|455944550|FG007|Overall Study|Withdrawal of Consent|0|||
126725163|NCT02504268|455944551|FG008|Overall Study|Withdrawal of Consent|0|||
126725164|NCT02504268|455944543|FG000|Overall Study|Pregnancy|2|||
126725165|NCT02504268|455944544|FG001|Overall Study|Pregnancy|0|||
126725166|NCT02504268|455944545|FG002|Overall Study|Pregnancy|0|||
126725167|NCT02504268|455944546|FG003|Overall Study|Pregnancy|0|||
126725168|NCT02504268|455944547|FG004|Overall Study|Pregnancy|0|||
126725169|NCT02504268|455944548|FG005|Overall Study|Pregnancy|0|||
126725170|NCT02504268|455944549|FG006|Overall Study|Pregnancy|0|||
126725171|NCT02504268|455944550|FG007|Overall Study|Pregnancy|0|||
126725172|NCT02504268|455944551|FG008|Overall Study|Pregnancy|0|||
126725173|NCT02504268|455944543|FG000|Overall Study|Lost to Follow-up|3|||
126725174|NCT02504268|455944544|FG001|Overall Study|Lost to Follow-up|6|||
126725175|NCT02504268|455944545|FG002|Overall Study|Lost to Follow-up|4|||
126725176|NCT02504268|455944546|FG003|Overall Study|Lost to Follow-up|0|||
126725177|NCT02504268|455944547|FG004|Overall Study|Lost to Follow-up|0|||
126725178|NCT02504268|455944548|FG005|Overall Study|Lost to Follow-up|0|||
126725179|NCT02504268|455944549|FG006|Overall Study|Lost to Follow-up|0|||
126725180|NCT02504268|455944550|FG007|Overall Study|Lost to Follow-up|0|||
126725181|NCT02504268|455944551|FG008|Overall Study|Lost to Follow-up|0|||
126725182|NCT02504268|455944543|FG000|Overall Study|Death|1|||
126725183|NCT02504268|455944544|FG001|Overall Study|Death|1|||
126725184|NCT02504268|455944545|FG002|Overall Study|Death|0|||
126725185|NCT02504268|455944546|FG003|Overall Study|Death|0|||
126725186|NCT02504268|455944547|FG004|Overall Study|Death|0|||
126725187|NCT02504268|455944548|FG005|Overall Study|Death|0|||
126725188|NCT02504268|455944549|FG006|Overall Study|Death|0|||
126725189|NCT02504268|455944550|FG007|Overall Study|Death|0|||
126725190|NCT02504268|455944551|FG008|Overall Study|Death|0|||
126725191|NCT02504268|455944543|FG000|Overall Study|Subject Request to Discontinue|11|||
126725192|NCT02504268|455944544|FG001|Overall Study|Subject Request to Discontinue|3|||
126725193|NCT02504268|455944545|FG002|Overall Study|Subject Request to Discontinue|6|||
126725194|NCT02504268|455944546|FG003|Overall Study|Subject Request to Discontinue|0|||
126725195|NCT02504268|455944547|FG004|Overall Study|Subject Request to Discontinue|0|||
126725196|NCT02504268|455944548|FG005|Overall Study|Subject Request to Discontinue|0|||
126725197|NCT02504268|455944549|FG006|Overall Study|Subject Request to Discontinue|0|||
126725198|NCT02504268|455944550|FG007|Overall Study|Subject Request to Discontinue|0|||
126725199|NCT02504268|455944551|FG008|Overall Study|Subject Request to Discontinue|0|||
126725200|NCT02504268|455944543|FG000|Overall Study|No Longer Meets Study Criteria|2|||
126725201|NCT02504268|455944544|FG001|Overall Study|No Longer Meets Study Criteria|3|||
126725202|NCT02504268|455944545|FG002|Overall Study|No Longer Meets Study Criteria|0|||
126725203|NCT02504268|455944546|FG003|Overall Study|No Longer Meets Study Criteria|0|||
126725204|NCT02504268|455944547|FG004|Overall Study|No Longer Meets Study Criteria|0|||
126725205|NCT02504268|455944548|FG005|Overall Study|No Longer Meets Study Criteria|0|||
126773768|NCT02367781|456127153|FG001|Overall Study|Non-Compliance|0|||
126773769|NCT02367781|456127152|FG000|Overall Study|Lost to Follow-up|1|||
126773770|NCT02367781|456127153|FG001|Overall Study|Lost to Follow-up|2|||
126773771|NCT02367781|456127152|FG000|Overall Study|Death|330|||
126773772|NCT02367781|456127153|FG001|Overall Study|Death|176|||
126773773|NCT02367781|456127152|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
126773774|NCT02367781|456127153|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
126773775|NCT02367781|456127152|FG000|Overall Study|Prolonged Hospitalization|1|||
126773776|NCT02367781|456127153|FG001|Overall Study|Prolonged Hospitalization|0|||
126773777|NCT02367781|456127152|FG000|Overall Study|Death Prior First Dose|1|||
126773778|NCT02367781|456127153|FG001|Overall Study|Death Prior First Dose|0|||
126773779|NCT02367781|456127152|FG000|Overall Study|Administrative-Change Facility|1|||
126773780|NCT02367781|456127153|FG001|Overall Study|Administrative-Change Facility|0|||
126773781|NCT02367781|456127152|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
126773782|NCT02367781|456127153|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
126773783|NCT02367781|456127152|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
126773784|NCT02367781|456127153|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
126773785|NCT02367781|456127152|FG000|Overall Study|Study Terminated by Sponsor|3|||
126773786|NCT02367781|456127153|FG001|Overall Study|Study Terminated by Sponsor|1|||
126773787|NCT02367781|456127152|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
126773788|NCT02367781|456127153|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
126773789|NCT02367781|456127152|FG000|Overall Study|Sponsor Decision|2|||
126773790|NCT02367781|456127153|FG001|Overall Study|Sponsor Decision|0|||
126773791|NCT02367781|456127152|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
126773792|NCT02367781|456127153|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
126773793|NCT02623426|456127154|FG000|Overall Study|Lost to Follow-up|0|||
126773794|NCT02623426|456127155|FG001|Overall Study|Lost to Follow-up|0|||
126773795|NCT02623426|456127156|FG002|Overall Study|Lost to Follow-up|1|||
126497500|NCT00624052|455122001|FG002|Overall Study|Non compliant with the protocol|1|||
126497501|NCT00624052|455122002|FG003|Overall Study|Non compliant with the protocol|1|||
126497502|NCT00624052|455121999|FG000|Overall Study|Consent withdrawn|3|||
126497503|NCT00624052|455122000|FG001|Overall Study|Consent withdrawn|1|||
126497504|NCT00624052|455122001|FG002|Overall Study|Consent withdrawn|1|||
126497505|NCT00624052|455122002|FG003|Overall Study|Consent withdrawn|0|||
126497506|NCT00624052|455121999|FG000|Overall Study|Changed job/ran out if meds|0|||
126497507|NCT00624052|455122000|FG001|Overall Study|Changed job/ran out if meds|2|||
126497508|NCT00624052|455122001|FG002|Overall Study|Changed job/ran out if meds|0|||
126497509|NCT00624052|455122002|FG003|Overall Study|Changed job/ran out if meds|0|||
126497510|NCT00281684|455122005|FG000|Overall Study|Lost to Follow-up|0|||
126497511|NCT00281684|455122006|FG001|Overall Study|Lost to Follow-up|0|||
126497512|NCT00281684|455122007|FG002|Overall Study|Lost to Follow-up|1|||
126497513|NCT00281684|455122008|FG003|Overall Study|Lost to Follow-up|0|||
126497514|NCT00281684|455122005|FG000|Overall Study|Withdrawal by Subject|1|||
126497515|NCT00281684|455122006|FG001|Overall Study|Withdrawal by Subject|0|||
126497516|NCT00281684|455122007|FG002|Overall Study|Withdrawal by Subject|0|||
126497517|NCT00281684|455122008|FG003|Overall Study|Withdrawal by Subject|0|||
126497518|NCT01120756|455122009|FG000|Overall Study|Withdrawal by Subject|1|||
126497519|NCT01120756|455122010|FG001|Overall Study|Withdrawal by Subject|1|||
126497520|NCT03760146|455122018|FG000|Overall Study|Adverse Event|11|||
126497521|NCT03760146|455122019|FG001|Overall Study|Adverse Event|8|||
126497522|NCT03760146|455122020|FG002|Overall Study|Adverse Event|0|||
126497523|NCT03760146|455122021|FG003|Overall Study|Adverse Event|0|||
126497524|NCT03760146|455122022|FG004|Overall Study|Adverse Event|0|||
126497525|NCT03760146|455122023|FG005|Overall Study|Adverse Event|0|||
126497526|NCT03760146|455122018|FG000|Overall Study|Death|1|||
126773796|NCT02623426|456127154|FG000|Overall Study|Withdrawal by Subject|1|||
126497527|NCT03760146|455122019|FG001|Overall Study|Death|0|||
126497528|NCT03760146|455122020|FG002|Overall Study|Death|0|||
126497529|NCT03760146|455122021|FG003|Overall Study|Death|0|||
126497530|NCT03760146|455122022|FG004|Overall Study|Death|0|||
126497531|NCT03760146|455122023|FG005|Overall Study|Death|0|||
126497532|NCT03760146|455122018|FG000|Overall Study|Lost to Follow-up|41|||
126497533|NCT03760146|455122019|FG001|Overall Study|Lost to Follow-up|28|||
126773797|NCT02623426|456127155|FG001|Overall Study|Withdrawal by Subject|2|||
126773798|NCT02623426|456127156|FG002|Overall Study|Withdrawal by Subject|2|||
126773799|NCT03185949|456127159|FG000|ITT Analysis|Withdrawal by Subject|4|||
126497534|NCT03760146|455122020|FG002|Overall Study|Lost to Follow-up|9|||
126497535|NCT03760146|455122021|FG003|Overall Study|Lost to Follow-up|2|||
126497536|NCT03760146|455122022|FG004|Overall Study|Lost to Follow-up|14|||
126497537|NCT03760146|455122023|FG005|Overall Study|Lost to Follow-up|8|||
126497538|NCT03760146|455122018|FG000|Overall Study|No longer met eligibility criteria|3|||
126497539|NCT03760146|455122019|FG001|Overall Study|No longer met eligibility criteria|9|||
126497540|NCT03760146|455122020|FG002|Overall Study|No longer met eligibility criteria|0|||
126497541|NCT03760146|455122021|FG003|Overall Study|No longer met eligibility criteria|0|||
126497542|NCT03760146|455122022|FG004|Overall Study|No longer met eligibility criteria|1|||
126773800|NCT03185949|456127160|FG001|ITT Analysis|Withdrawal by Subject|3|||
126773801|NCT03185949|456127159|FG000|PP Analysis|Protocol Violation|2|||
126773802|NCT03185949|456127160|FG001|PP Analysis|Protocol Violation|2|||
126773803|NCT03185949|456127159|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
126773804|NCT03185949|456127160|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
126560135|NCT00577629|455344561|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
126560136|NCT00577629|455344561|FG000|Long Term Follow-Up|Physician Decision|1|||
126560137|NCT01605136|455344564|FG000|Study Period|Withdrawal by Subject|2|||
126560138|NCT01605136|455344565|FG001|Study Period|Withdrawal by Subject|0|||
126560139|NCT01605136|455344564|FG000|Study Period|Physician Decision|1|||
126560140|NCT01605136|455344565|FG001|Study Period|Physician Decision|1|||
126560141|NCT01605136|455344564|FG000|Study Period|Lost to Follow-up|0|||
126560142|NCT01605136|455344565|FG001|Study Period|Lost to Follow-up|2|||
126560143|NCT01605136|455344564|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
126560144|NCT01605136|455344565|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
126560145|NCT01072929|455344566|FG000|Overall Study|Adverse Event|8|||
126560146|NCT01072929|455344567|FG001|Overall Study|Adverse Event|11|||
126560147|NCT01072929|455344568|FG002|Overall Study|Adverse Event|2|||
126560148|NCT01072929|455344566|FG000|Overall Study|Lack of Efficacy|7|||
126560149|NCT01072929|455344567|FG001|Overall Study|Lack of Efficacy|4|||
126560150|NCT01072929|455344568|FG002|Overall Study|Lack of Efficacy|0|||
126560151|NCT01072929|455344566|FG000|Overall Study|Withdrawal by Subject|7|||
126560152|NCT01072929|455344567|FG001|Overall Study|Withdrawal by Subject|15|||
126560153|NCT01072929|455344568|FG002|Overall Study|Withdrawal by Subject|3|||
126560154|NCT01072929|455344566|FG000|Overall Study|Protocol Violation|13|||
126560155|NCT01072929|455344567|FG001|Overall Study|Protocol Violation|11|||
126560156|NCT01072929|455344568|FG002|Overall Study|Protocol Violation|2|||
126560157|NCT01072929|455344566|FG000|Overall Study|Lost to Follow-up|8|||
126560158|NCT01072929|455344567|FG001|Overall Study|Lost to Follow-up|4|||
126560159|NCT01072929|455344568|FG002|Overall Study|Lost to Follow-up|1|||
126560160|NCT01072929|455344566|FG000|Overall Study|Noncompliance with study medication|0|||
126560161|NCT01072929|455344567|FG001|Overall Study|Noncompliance with study medication|3|||
126560162|NCT01072929|455344568|FG002|Overall Study|Noncompliance with study medication|0|||
126560163|NCT01072929|455344566|FG000|Overall Study|Noncompliance with study procedures|1|||
126560164|NCT01072929|455344567|FG001|Overall Study|Noncompliance with study procedures|0|||
126560165|NCT01072929|455344568|FG002|Overall Study|Noncompliance with study procedures|1|||
126560166|NCT01072929|455344566|FG000|Overall Study|Other|0|||
126560167|NCT01072929|455344567|FG001|Overall Study|Other|3|||
126560168|NCT01072929|455344568|FG002|Overall Study|Other|0|||
126560169|NCT02929108|455344571|FG000|Overall Study|Hospice patient death|100|||
126560170|NCT02929108|455344572|FG001|Overall Study|Hospice patient death|64|||
126560171|NCT02929108|455344573|FG002|Overall Study|Hospice patient death|28|||
126560172|NCT02929108|455344574|FG003|Overall Study|Hospice patient death|46|||
126560173|NCT02929108|455344575|FG004|Overall Study|Hospice patient death|55|||
126560174|NCT02929108|455344576|FG005|Overall Study|Hospice patient death|28|||
126560175|NCT02929108|455344577|FG006|Overall Study|Hospice patient death|78|||
126560176|NCT00052962|455344578|FG000|Overall Study|Not evaluable|0|||
126560177|NCT00052962|455344579|FG001|Overall Study|Not evaluable|2|||
126560178|NCT00052962|455344578|FG000|Overall Study|Not randomized/not evaluable|1|||
126560179|NCT00052962|455344579|FG001|Overall Study|Not randomized/not evaluable|0|||
126560180|NCT01723774|455344583|FG000|Neoadjuvant|Ki67 > 10%|4|||
126560181|NCT01723774|455344584|FG001|Neoadjuvant|Ki67 > 10%|0|||
126560182|NCT01723774|455344585|FG002|Neoadjuvant|Ki67 > 10%|10|||
126560183|NCT01723774|455344586|FG003|Neoadjuvant|Ki67 > 10%|0|||
126560184|NCT01723774|455344583|FG000|Neoadjuvant|Withdrawal by Subject|3|||
126560185|NCT01723774|455344584|FG001|Neoadjuvant|Withdrawal by Subject|1|||
126560186|NCT01723774|455344585|FG002|Neoadjuvant|Withdrawal by Subject|0|||
126773805|NCT05166421|456127169|FG000|Overall Study|Other|3|||
126773806|NCT05166421|456127170|FG001|Overall Study|Other|1|||
126773807|NCT05166421|456127171|FG002|Overall Study|Other|1|||
126773808|NCT05166421|456127169|FG000|Overall Study|Withdrawal by Subject|5|||
126773809|NCT05166421|456127170|FG001|Overall Study|Withdrawal by Subject|3|||
126560187|NCT01723774|455344586|FG003|Neoadjuvant|Withdrawal by Subject|0|||
126560188|NCT01723774|455344583|FG000|Neoadjuvant|Disease progression|0|||
126560189|NCT01723774|455344584|FG001|Neoadjuvant|Disease progression|1|||
126560190|NCT01723774|455344585|FG002|Neoadjuvant|Disease progression|1|||
126560191|NCT01723774|455344586|FG003|Neoadjuvant|Disease progression|0|||
126560192|NCT01723774|455344583|FG000|Neoadjuvant|Adverse Event|0|||
126560193|NCT01723774|455344584|FG001|Neoadjuvant|Adverse Event|1|||
126773810|NCT05166421|456127171|FG002|Overall Study|Withdrawal by Subject|6|||
126560194|NCT01723774|455344585|FG002|Neoadjuvant|Adverse Event|2|||
126560195|NCT01723774|455344586|FG003|Neoadjuvant|Adverse Event|0|||
126560196|NCT01723774|455344583|FG000|Neoadjuvant|High estradiol|0|||
126560197|NCT01723774|455344584|FG001|Neoadjuvant|High estradiol|1|||
126773811|NCT05166421|456127169|FG000|Overall Study|Lost to Follow-up|4|||
126560198|NCT01723774|455344585|FG002|Neoadjuvant|High estradiol|0|||
126560199|NCT01723774|455344586|FG003|Neoadjuvant|High estradiol|0|||
126560200|NCT02487446|455344590|FG000|Period 1|Physician Decision|0|||
126560201|NCT02487446|455344591|FG001|Period 1|Physician Decision|1|||
126725206|NCT02504268|455944549|FG006|Overall Study|No Longer Meets Study Criteria|0|||
126725207|NCT02504268|455944550|FG007|Overall Study|No Longer Meets Study Criteria|0|||
126725208|NCT02504268|455944551|FG008|Overall Study|No Longer Meets Study Criteria|0|||
126725209|NCT02504268|455944543|FG000|Overall Study|Lack of Efficacy|11|||
126725210|NCT02504268|455944544|FG001|Overall Study|Lack of Efficacy|35|||
126725211|NCT02504268|455944545|FG002|Overall Study|Lack of Efficacy|9|||
126725212|NCT02504268|455944546|FG003|Overall Study|Lack of Efficacy|0|||
126725213|NCT02504268|455944547|FG004|Overall Study|Lack of Efficacy|0|||
126725214|NCT02504268|455944548|FG005|Overall Study|Lack of Efficacy|0|||
126725215|NCT02504268|455944549|FG006|Overall Study|Lack of Efficacy|0|||
126725216|NCT02504268|455944550|FG007|Overall Study|Lack of Efficacy|0|||
126725217|NCT02504268|455944551|FG008|Overall Study|Lack of Efficacy|0|||
126725218|NCT02504268|455944543|FG000|Overall Study|Poor/Non-Compliance|3|||
126560202|NCT02487446|455344590|FG000|Period 1|Lack of Efficacy|1|||
126560203|NCT02487446|455344591|FG001|Period 1|Lack of Efficacy|0|||
126560204|NCT02487446|455344590|FG000|Period 1|Protocol deviation|3|||
126560205|NCT02487446|455344591|FG001|Period 1|Protocol deviation|2|||
126560206|NCT02487446|455344590|FG000|Period 1|Lost to Follow-up|2|||
126560207|NCT02487446|455344591|FG001|Period 1|Lost to Follow-up|0|||
126560208|NCT02487446|455344590|FG000|Period 1|Withdrawal by Subject|2|||
126560209|NCT02487446|455344591|FG001|Period 1|Withdrawal by Subject|0|||
126725219|NCT02504268|455944544|FG001|Overall Study|Poor/Non-Compliance|2|||
126497543|NCT03760146|455122023|FG005|Overall Study|No longer met eligibility criteria|0|||
126497544|NCT03760146|455122018|FG000|Overall Study|Protocol Violation|21|||
126497545|NCT03760146|455122019|FG001|Overall Study|Protocol Violation|13|||
126497546|NCT03760146|455122020|FG002|Overall Study|Protocol Violation|1|||
126497547|NCT03760146|455122021|FG003|Overall Study|Protocol Violation|0|||
126497548|NCT03760146|455122022|FG004|Overall Study|Protocol Violation|1|||
126497549|NCT03760146|455122023|FG005|Overall Study|Protocol Violation|0|||
126497550|NCT03760146|455122018|FG000|Overall Study|Withdrawal by Subject|19|||
126497551|NCT03760146|455122019|FG001|Overall Study|Withdrawal by Subject|20|||
126497552|NCT03760146|455122020|FG002|Overall Study|Withdrawal by Subject|1|||
126497553|NCT03760146|455122021|FG003|Overall Study|Withdrawal by Subject|0|||
126497554|NCT03760146|455122022|FG004|Overall Study|Withdrawal by Subject|1|||
126497555|NCT03760146|455122023|FG005|Overall Study|Withdrawal by Subject|0|||
126497556|NCT00449644|455122024|FG000|Overall Study|Adverse Event|0|||
126497557|NCT00449644|455122025|FG001|Overall Study|Adverse Event|0|||
126497558|NCT00449644|455122026|FG002|Overall Study|Adverse Event|3|||
126497559|NCT00449644|455122027|FG003|Overall Study|Adverse Event|5|||
126497560|NCT00449644|455122024|FG000|Overall Study|Death|1|||
126497561|NCT00449644|455122025|FG001|Overall Study|Death|0|||
126497562|NCT00449644|455122026|FG002|Overall Study|Death|6|||
126497563|NCT00449644|455122027|FG003|Overall Study|Death|1|||
126497564|NCT00449644|455122024|FG000|Overall Study|Lost to Follow-up|1|||
126497565|NCT00449644|455122025|FG001|Overall Study|Lost to Follow-up|1|||
126560210|NCT02487446|455344590|FG000|Period 1|Adverse Event|5|||
126560211|NCT02487446|455344591|FG001|Period 1|Adverse Event|5|||
126560212|NCT02487446|455344590|FG000|Washout|Lost to Follow-up|0|||
126560213|NCT02487446|455344591|FG001|Washout|Lost to Follow-up|2|||
126725220|NCT02504268|455944545|FG002|Overall Study|Poor/Non-Compliance|3|||
126725221|NCT02504268|455944546|FG003|Overall Study|Poor/Non-Compliance|0|||
126725222|NCT02504268|455944547|FG004|Overall Study|Poor/Non-Compliance|0|||
126725223|NCT02504268|455944548|FG005|Overall Study|Poor/Non-Compliance|0|||
126725224|NCT02504268|455944549|FG006|Overall Study|Poor/Non-Compliance|0|||
126725225|NCT02504268|455944550|FG007|Overall Study|Poor/Non-Compliance|0|||
126725226|NCT02504268|455944551|FG008|Overall Study|Poor/Non-Compliance|0|||
126725227|NCT02504268|455944543|FG000|Overall Study|Not Disclosed|1|||
126725228|NCT02504268|455944544|FG001|Overall Study|Not Disclosed|0|||
126725229|NCT02504268|455944545|FG002|Overall Study|Not Disclosed|2|||
126725230|NCT02504268|455944546|FG003|Overall Study|Not Disclosed|0|||
126725231|NCT02504268|455944547|FG004|Overall Study|Not Disclosed|0|||
126725232|NCT02504268|455944548|FG005|Overall Study|Not Disclosed|0|||
126725233|NCT02504268|455944549|FG006|Overall Study|Not Disclosed|0|||
126725234|NCT02504268|455944550|FG007|Overall Study|Not Disclosed|0|||
126497566|NCT00449644|455122026|FG002|Overall Study|Lost to Follow-up|5|||
126497567|NCT00449644|455122027|FG003|Overall Study|Lost to Follow-up|3|||
126497568|NCT00449644|455122024|FG000|Overall Study|Pregnancy|0|||
126497569|NCT00449644|455122025|FG001|Overall Study|Pregnancy|0|||
126497570|NCT00449644|455122026|FG002|Overall Study|Pregnancy|3|||
126497571|NCT00449644|455122027|FG003|Overall Study|Pregnancy|2|||
126497572|NCT00449644|455122024|FG000|Overall Study|Protocol Violation|4|||
126497573|NCT00449644|455122025|FG001|Overall Study|Protocol Violation|4|||
126497574|NCT00449644|455122026|FG002|Overall Study|Protocol Violation|3|||
126560214|NCT02487446|455344590|FG000|Washout|Withdrawal by Subject|1|||
126560215|NCT02487446|455344591|FG001|Washout|Withdrawal by Subject|4|||
126725235|NCT02504268|455944551|FG008|Overall Study|Not Disclosed|0|||
126725236|NCT03025217|455944552|FG000|Overall Study|Pregnancy|1|||
126725237|NCT03025217|455944552|FG000|Overall Study|Lost to Follow-up|1|||
126725238|NCT03025217|455944552|FG000|Overall Study|Not eligible, poor English|2|||
126725239|NCT00194025|455944553|FG000|Overall Study|Adverse Event|1|||
126725240|NCT00194025|455944553|FG000|Overall Study|non-adherence with study medication|4|||
126725241|NCT04804033|455944556|FG000|Period 1: DBT Phase|Adverse Event|1|||
126725242|NCT04804033|455944557|FG001|Period 1: DBT Phase|Adverse Event|5|||
126725243|NCT04804033|455944558|FG002|Period 1: DBT Phase|Adverse Event|3|||
126725244|NCT04804033|455944559|FG003|Period 1: DBT Phase|Adverse Event|4|||
126725245|NCT04804033|455944556|FG000|Period 1: DBT Phase|Death|1|||
126725246|NCT04804033|455944557|FG001|Period 1: DBT Phase|Death|0|||
126725247|NCT04804033|455944558|FG002|Period 1: DBT Phase|Death|0|||
126725248|NCT04804033|455944559|FG003|Period 1: DBT Phase|Death|0|||
126725249|NCT04804033|455944556|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
126725250|NCT04804033|455944557|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
126725251|NCT04804033|455944558|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
126725252|NCT04804033|455944559|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
126725253|NCT04804033|455944556|FG000|Period 1: DBT Phase|Non-compliance|1|||
126725254|NCT04804033|455944557|FG001|Period 1: DBT Phase|Non-compliance|0|||
126773812|NCT05166421|456127170|FG001|Overall Study|Lost to Follow-up|1|||
126497575|NCT00449644|455122027|FG003|Overall Study|Protocol Violation|7|||
126497576|NCT00449644|455122024|FG000|Overall Study|Withdrawal by Subject|3|||
126497577|NCT00449644|455122025|FG001|Overall Study|Withdrawal by Subject|4|||
126497578|NCT00449644|455122026|FG002|Overall Study|Withdrawal by Subject|6|||
126497579|NCT00449644|455122027|FG003|Overall Study|Withdrawal by Subject|7|||
126497580|NCT00449644|455122024|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
126497581|NCT00449644|455122025|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
126497582|NCT00449644|455122026|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
126497583|NCT00449644|455122027|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
126497584|NCT00449644|455122024|FG000|Overall Study|Other|1|||
126497585|NCT00449644|455122025|FG001|Overall Study|Other|4|||
126497586|NCT00449644|455122026|FG002|Overall Study|Other|1|||
126497587|NCT00449644|455122027|FG003|Overall Study|Other|0|||
126497588|NCT00449644|455122024|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
126497589|NCT00449644|455122025|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
126497590|NCT00449644|455122026|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
126497591|NCT00449644|455122027|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
126497592|NCT03642717|455122028|FG000|Overall Study|Lost to Follow-up|2|||
126497593|NCT03642717|455122028|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
126497594|NCT03642717|455122028|FG000|Overall Study|Taken study drug prior to contract date|3|||
126497595|NCT01559012|455122031|FG000|Overall Study|Withdrawal by Subject|0|||
126497596|NCT01559012|455122032|FG001|Overall Study|Withdrawal by Subject|1|||
126497597|NCT00946712|455122033|FG000|Overall Study|Adverse Event|118|||
126497598|NCT00946712|455122034|FG001|Overall Study|Adverse Event|124|||
126497599|NCT00946712|455122033|FG000|Overall Study|Disease progression|308|||
126497600|NCT00946712|455122034|FG001|Overall Study|Disease progression|404|||
126497601|NCT00946712|455122033|FG000|Overall Study|Death|21|||
126497602|NCT00946712|455122034|FG001|Overall Study|Death|22|||
126497603|NCT00946712|455122033|FG000|Overall Study|No treatment given|25|||
126497604|NCT00946712|455122034|FG001|Overall Study|No treatment given|29|||
126497605|NCT00946712|455122033|FG000|Overall Study|Other reasons|61|||
126497606|NCT00946712|455122034|FG001|Overall Study|Other reasons|73|||
126497607|NCT00946712|455122033|FG000|Overall Study|On Treatment|0|||
126497608|NCT00946712|455122034|FG001|Overall Study|On Treatment|4|||
126497609|NCT00946712|455122033|FG000|Overall Study|Ineligible|14|||
126497610|NCT00946712|455122034|FG001|Overall Study|Ineligible|6|||
126497611|NCT02291055|455122035|FG000|Overall Study|Death|2|||
126497612|NCT02291055|455122036|FG001|Overall Study|Death|2|||
126497613|NCT02291055|455122037|FG002|Overall Study|Death|5|||
126497614|NCT02291055|455122038|FG003|Overall Study|Death|8|||
126497615|NCT02291055|455122039|FG004|Overall Study|Death|12|||
126497616|NCT02291055|455122035|FG000|Overall Study|Lost to Follow-up|0|||
126497617|NCT02291055|455122036|FG001|Overall Study|Lost to Follow-up|0|||
126497618|NCT02291055|455122037|FG002|Overall Study|Lost to Follow-up|0|||
126497619|NCT02291055|455122038|FG003|Overall Study|Lost to Follow-up|1|||
126497620|NCT02291055|455122039|FG004|Overall Study|Lost to Follow-up|2|||
126497621|NCT02291055|455122035|FG000|Overall Study|Withdrawal by Subject|3|||
126497622|NCT02291055|455122036|FG001|Overall Study|Withdrawal by Subject|1|||
126497623|NCT02291055|455122037|FG002|Overall Study|Withdrawal by Subject|1|||
126497624|NCT02291055|455122038|FG003|Overall Study|Withdrawal by Subject|5|||
126497625|NCT02291055|455122039|FG004|Overall Study|Withdrawal by Subject|10|||
126497626|NCT02291055|455122035|FG000|Overall Study|Progressive Disease|0|||
126497627|NCT02291055|455122036|FG001|Overall Study|Progressive Disease|0|||
126497628|NCT02291055|455122037|FG002|Overall Study|Progressive Disease|1|||
126497629|NCT02291055|455122038|FG003|Overall Study|Progressive Disease|4|||
126497630|NCT02291055|455122039|FG004|Overall Study|Progressive Disease|2|||
126497631|NCT02291055|455122035|FG000|Overall Study|Study Terminated by Sponsor|0|||
126497632|NCT02291055|455122036|FG001|Overall Study|Study Terminated by Sponsor|0|||
126497633|NCT02291055|455122037|FG002|Overall Study|Study Terminated by Sponsor|0|||
126497634|NCT02291055|455122038|FG003|Overall Study|Study Terminated by Sponsor|5|||
126497635|NCT02291055|455122039|FG004|Overall Study|Study Terminated by Sponsor|1|||
126725255|NCT04804033|455944558|FG002|Period 1: DBT Phase|Non-compliance|1|||
126725256|NCT04804033|455944559|FG003|Period 1: DBT Phase|Non-compliance|2|||
126773813|NCT05166421|456127171|FG002|Overall Study|Lost to Follow-up|7|||
126773814|NCT00569231|456128976|FG000|Overall Study|Study unrelated surgery|1|||
126773815|NCT00569231|456128976|FG000|Overall Study|Airfare expense|2|||
126773816|NCT00569231|456128976|FG000|Overall Study|Withdrawal by Subject|1|||
126773817|NCT00569231|456128976|FG000|Overall Study|Car accident injury|1|||
126773818|NCT00569231|456128976|FG000|Overall Study|Non-compliance|2|||
126773819|NCT00700310|456128979|FG000|Overall Study|Adverse Event|6|||
126773820|NCT00700310|456128980|FG001|Overall Study|Adverse Event|10|||
126773821|NCT00700310|456128981|FG002|Overall Study|Adverse Event|5|||
126773822|NCT00700310|456128982|FG003|Overall Study|Adverse Event|11|||
126773823|NCT00700310|456128979|FG000|Overall Study|Lost to Follow-up|4|||
126773824|NCT00700310|456128980|FG001|Overall Study|Lost to Follow-up|1|||
126773825|NCT00700310|456128981|FG002|Overall Study|Lost to Follow-up|0|||
126773826|NCT00700310|456128982|FG003|Overall Study|Lost to Follow-up|1|||
126773827|NCT00700310|456128979|FG000|Overall Study|Withdrawal by Subject|8|||
126773828|NCT00700310|456128980|FG001|Overall Study|Withdrawal by Subject|9|||
126773829|NCT00700310|456128981|FG002|Overall Study|Withdrawal by Subject|8|||
126773830|NCT00700310|456128982|FG003|Overall Study|Withdrawal by Subject|8|||
126560216|NCT02487446|455344590|FG000|Washout|Adverse Event|2|||
126560217|NCT02487446|455344591|FG001|Washout|Adverse Event|2|||
126560218|NCT02487446|455344590|FG000|Period 2|Protocol deviation|0|||
126560219|NCT02487446|455344591|FG001|Period 2|Protocol deviation|1|||
126560220|NCT02487446|455344590|FG000|Period 2|Lost to Follow-up|1|||
126560221|NCT02487446|455344591|FG001|Period 2|Lost to Follow-up|1|||
126560222|NCT02487446|455344590|FG000|Period 2|Withdrawal by Subject|1|||
126560223|NCT02487446|455344591|FG001|Period 2|Withdrawal by Subject|1|||
126560224|NCT02487446|455344590|FG000|Period 2|Adverse Event|6|||
126560225|NCT02487446|455344591|FG001|Period 2|Adverse Event|2|||
126560226|NCT04438785|455344596|FG000|Overall Study|change of weight, give up intervention|2|||
126560227|NCT04438785|455344597|FG001|Overall Study|change of weight, give up intervention|10|||
126560228|NCT04011033|455344598|FG000|Overall Study|Physician Decision|2|||
126560229|NCT04011033|455344599|FG001|Overall Study|Physician Decision|3|||
126560230|NCT04011033|455344598|FG000|Overall Study|Withdrawal by Subject|1|||
126560231|NCT04011033|455344599|FG001|Overall Study|Withdrawal by Subject|0|||
126560232|NCT02027935|455344600|FG000|Overall Study|Death|1|||
126560233|NCT02027935|455344600|FG000|Overall Study|Lack of Efficacy|5|||
126560234|NCT02027935|455344600|FG000|Overall Study|Study Closure|1|||
126560235|NCT00689104|455344601|FG000|Overall Study|Eligibility criterion not met|5|||
126560236|NCT00689104|455344602|FG001|Overall Study|Eligibility criterion not met|8|||
126560237|NCT00689104|455344603|FG002|Overall Study|Eligibility criterion not met|0|||
126560238|NCT00689104|455344604|FG003|Overall Study|Eligibility criterion not met|4|||
126560239|NCT00689104|455344601|FG000|Overall Study|Adverse Event|13|||
126560240|NCT00689104|455344602|FG001|Overall Study|Adverse Event|25|||
126560241|NCT00689104|455344603|FG002|Overall Study|Adverse Event|16|||
126560242|NCT00689104|455344604|FG003|Overall Study|Adverse Event|24|||
126560243|NCT00689104|455344601|FG000|Overall Study|Lack of Efficacy|5|||
126560244|NCT00689104|455344602|FG001|Overall Study|Lack of Efficacy|6|||
126560245|NCT00689104|455344603|FG002|Overall Study|Lack of Efficacy|2|||
126560246|NCT00689104|455344604|FG003|Overall Study|Lack of Efficacy|3|||
126560247|NCT00689104|455344601|FG000|Overall Study|Withdrawal by Subject|12|||
126560248|NCT00689104|455344602|FG001|Overall Study|Withdrawal by Subject|11|||
126560249|NCT00689104|455344603|FG002|Overall Study|Withdrawal by Subject|18|||
126560250|NCT00689104|455344604|FG003|Overall Study|Withdrawal by Subject|11|||
126560251|NCT00689104|455344601|FG000|Overall Study|Lost to Follow-up|4|||
126560252|NCT00689104|455344602|FG001|Overall Study|Lost to Follow-up|3|||
126560253|NCT00689104|455344603|FG002|Overall Study|Lost to Follow-up|2|||
126560254|NCT00689104|455344604|FG003|Overall Study|Lost to Follow-up|5|||
126560255|NCT00689104|455344601|FG000|Overall Study|Protocol Violation|2|||
126560256|NCT00689104|455344602|FG001|Overall Study|Protocol Violation|3|||
126560257|NCT00689104|455344603|FG002|Overall Study|Protocol Violation|5|||
126560258|NCT00689104|455344604|FG003|Overall Study|Protocol Violation|3|||
126560259|NCT00689104|455344601|FG000|Overall Study|Randomized but never received study drug|2|||
126773831|NCT00700310|456128979|FG000|Overall Study|Lack of Efficacy|0|||
126773832|NCT00700310|456128980|FG001|Overall Study|Lack of Efficacy|3|||
126773833|NCT00700310|456128981|FG002|Overall Study|Lack of Efficacy|0|||
126560260|NCT00689104|455344602|FG001|Overall Study|Randomized but never received study drug|1|||
126560261|NCT00689104|455344603|FG002|Overall Study|Randomized but never received study drug|1|||
126560262|NCT00689104|455344604|FG003|Overall Study|Randomized but never received study drug|0|||
126560263|NCT00689104|455344601|FG000|Overall Study|Physician Decision|1|||
126560264|NCT00689104|455344602|FG001|Overall Study|Physician Decision|0|||
126560265|NCT00689104|455344603|FG002|Overall Study|Physician Decision|0|||
126773834|NCT00700310|456128982|FG003|Overall Study|Lack of Efficacy|1|||
126773835|NCT00700310|456128979|FG000|Overall Study|Administrative/Other|1|||
126773836|NCT00700310|456128980|FG001|Overall Study|Administrative/Other|3|||
126560266|NCT00689104|455344604|FG003|Overall Study|Physician Decision|0|||
126560267|NCT00689104|455344601|FG000|Overall Study|Non-compliance with study procedures|0|||
126560268|NCT00689104|455344602|FG001|Overall Study|Non-compliance with study procedures|0|||
126560269|NCT00689104|455344603|FG002|Overall Study|Non-compliance with study procedures|1|||
126773837|NCT00700310|456128981|FG002|Overall Study|Administrative/Other|1|||
126773838|NCT00700310|456128982|FG003|Overall Study|Administrative/Other|3|||
126773839|NCT00700310|456128979|FG000|Overall Study|Randomized, Not Treated|2|||
126773840|NCT00700310|456128980|FG001|Overall Study|Randomized, Not Treated|0|||
126773841|NCT00700310|456128981|FG002|Overall Study|Randomized, Not Treated|2|||
126773842|NCT00700310|456128982|FG003|Overall Study|Randomized, Not Treated|2|||
126773843|NCT00681824|456128987|FG000|Overall Study|withdrawn by investigator|0|||
126773844|NCT00681824|456128988|FG001|Overall Study|withdrawn by investigator|0|||
126773845|NCT00681824|456128989|FG002|Overall Study|withdrawn by investigator|1|||
126773846|NCT00681824|456128987|FG000|Overall Study|scheduling conflict|1|||
126773847|NCT00681824|456128988|FG001|Overall Study|scheduling conflict|0|||
126773848|NCT00681824|456128989|FG002|Overall Study|scheduling conflict|0|||
126773849|NCT00681824|456128987|FG000|Overall Study|Death|0|||
126773850|NCT00681824|456128988|FG001|Overall Study|Death|1|||
126773851|NCT00681824|456128989|FG002|Overall Study|Death|0|||
126773852|NCT04575038|456128990|FG000|Overall Study|Withdrawal by Subject|1|||
126773853|NCT04575038|456128991|FG001|Overall Study|Withdrawal by Subject|1|||
126773854|NCT01902134|456128993|FG000|Overall Study|Adverse Event|3|||
126773855|NCT01902134|456128994|FG001|Overall Study|Adverse Event|1|||
126773856|NCT01902134|456128995|FG002|Overall Study|Adverse Event|2|||
126773857|NCT01902134|456128996|FG003|Overall Study|Adverse Event|1|||
126773858|NCT01902134|456128997|FG004|Overall Study|Adverse Event|1|||
126773859|NCT01902134|456128998|FG005|Overall Study|Adverse Event|3|||
126773860|NCT01902134|456128993|FG000|Overall Study|Lack of Efficacy|0|||
126773861|NCT01902134|456128994|FG001|Overall Study|Lack of Efficacy|0|||
126773862|NCT01902134|456128995|FG002|Overall Study|Lack of Efficacy|2|||
126773863|NCT01902134|456128996|FG003|Overall Study|Lack of Efficacy|0|||
126773864|NCT01902134|456128997|FG004|Overall Study|Lack of Efficacy|0|||
126773865|NCT01902134|456128998|FG005|Overall Study|Lack of Efficacy|1|||
126773866|NCT01902134|456128993|FG000|Overall Study|Physician Decision|0|||
126773867|NCT01902134|456128994|FG001|Overall Study|Physician Decision|1|||
126773868|NCT01902134|456128995|FG002|Overall Study|Physician Decision|0|||
126773869|NCT01902134|456128996|FG003|Overall Study|Physician Decision|0|||
126773870|NCT01902134|456128997|FG004|Overall Study|Physician Decision|0|||
126773871|NCT01902134|456128998|FG005|Overall Study|Physician Decision|0|||
126773872|NCT01902134|456128993|FG000|Overall Study|Protocol Violation|0|||
126773873|NCT01902134|456128994|FG001|Overall Study|Protocol Violation|0|||
126773874|NCT01902134|456128995|FG002|Overall Study|Protocol Violation|0|||
126773875|NCT01902134|456128996|FG003|Overall Study|Protocol Violation|0|||
126773876|NCT01902134|456128997|FG004|Overall Study|Protocol Violation|0|||
126773877|NCT01902134|456128998|FG005|Overall Study|Protocol Violation|1|||
126773878|NCT01902134|456128993|FG000|Overall Study|Withdrawal by Subject|4|||
126773879|NCT01902134|456128994|FG001|Overall Study|Withdrawal by Subject|8|||
126773880|NCT01902134|456128995|FG002|Overall Study|Withdrawal by Subject|9|||
126773881|NCT01902134|456128996|FG003|Overall Study|Withdrawal by Subject|1|||
126773882|NCT01902134|456128997|FG004|Overall Study|Withdrawal by Subject|5|||
126773883|NCT01902134|456128998|FG005|Overall Study|Withdrawal by Subject|4|||
126773884|NCT01902134|456128993|FG000|Overall Study|no compliance|1|||
126773885|NCT01902134|456128994|FG001|Overall Study|no compliance|0|||
126773886|NCT01902134|456128995|FG002|Overall Study|no compliance|0|||
126773887|NCT01902134|456128996|FG003|Overall Study|no compliance|0|||
126773888|NCT01902134|456128997|FG004|Overall Study|no compliance|0|||
126773889|NCT01902134|456128998|FG005|Overall Study|no compliance|0|||
126773890|NCT01902134|456128993|FG000|Overall Study|Other|0|||
126773891|NCT01902134|456128994|FG001|Overall Study|Other|1|||
126773892|NCT01902134|456128995|FG002|Overall Study|Other|2|||
126773893|NCT01902134|456128996|FG003|Overall Study|Other|0|||
126773894|NCT01902134|456128997|FG004|Overall Study|Other|1|||
126773895|NCT01902134|456128998|FG005|Overall Study|Other|0|||
126773896|NCT00305110|456128999|FG000|Overall Study|Missing data|29|||
126773897|NCT00678379|456129000|FG000|Overall Study|Injection performed after tonsillectomy|2|||
126773898|NCT00678379|456129001|FG001|Overall Study|Injection performed after tonsillectomy|0|||
126497636|NCT02291055|455122035|FG000|Overall Study|Other|0|||
126497637|NCT02291055|455122036|FG001|Overall Study|Other|2|||
126497638|NCT02291055|455122037|FG002|Overall Study|Other|1|||
126497639|NCT02291055|455122038|FG003|Overall Study|Other|4|||
126773899|NCT00678379|456129002|FG002|Overall Study|Injection performed after tonsillectomy|1|||
126773900|NCT00678379|456129000|FG000|Overall Study|Incomplete Data|4|||
126773901|NCT00678379|456129001|FG001|Overall Study|Incomplete Data|3|||
126773902|NCT00678379|456129002|FG002|Overall Study|Incomplete Data|3|||
126773903|NCT00350519|456129003|FG000|Overall Study|Death|0|||
126497640|NCT02291055|455122039|FG004|Overall Study|Other|0|||
126497641|NCT03759379|455123492|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
126773904|NCT00350519|456129004|FG001|Overall Study|Death|1|||
126773905|NCT00350519|456129003|FG000|Overall Study|Physician Decision|0|||
126773906|NCT00350519|456129004|FG001|Overall Study|Physician Decision|1|||
126773907|NCT00350519|456129003|FG000|Overall Study|Protocol Violation|1|||
126773908|NCT00350519|456129004|FG001|Overall Study|Protocol Violation|2|||
126773909|NCT00350519|456129003|FG000|Overall Study|Withdrawal by Subject|3|||
126773910|NCT00350519|456129004|FG001|Overall Study|Withdrawal by Subject|2|||
126560270|NCT00689104|455344604|FG003|Overall Study|Non-compliance with study procedures|0|||
126560271|NCT01394991|455344607|FG000|Overall Study|Adverse Event|0|||
126560272|NCT01394991|455344608|FG001|Overall Study|Adverse Event|4|||
126560273|NCT01394991|455344607|FG000|Overall Study|Lack of Efficacy|5|||
126560274|NCT01394991|455344608|FG001|Overall Study|Lack of Efficacy|7|||
126560275|NCT01394991|455344607|FG000|Overall Study|Lost to Follow-up|6|||
126560276|NCT01394991|455344608|FG001|Overall Study|Lost to Follow-up|8|||
126560277|NCT01394991|455344607|FG000|Overall Study|Physician Decision|1|||
126560278|NCT01394991|455344608|FG001|Overall Study|Physician Decision|3|||
126560279|NCT01394991|455344607|FG000|Overall Study|Protocol Violation|1|||
126560280|NCT01394991|455344608|FG001|Overall Study|Protocol Violation|1|||
126560281|NCT01394991|455344607|FG000|Overall Study|Withdrawal by Subject|20|||
126560282|NCT01394991|455344608|FG001|Overall Study|Withdrawal by Subject|17|||
126560283|NCT01394991|455344607|FG000|Overall Study|Chemotherapy Termination|10|||
126560284|NCT01394991|455344608|FG001|Overall Study|Chemotherapy Termination|15|||
126560285|NCT01394991|455344607|FG000|Overall Study|Disease Progression|7|||
126560286|NCT01394991|455344608|FG001|Overall Study|Disease Progression|7|||
126560287|NCT01394991|455344607|FG000|Overall Study|Prematurely Termination of Trial|9|||
126560288|NCT01394991|455344608|FG001|Overall Study|Prematurely Termination of Trial|10|||
126560289|NCT00725010|455344618|FG000|Overall Study|Toxicity|9|||
126560290|NCT00725010|455344618|FG000|Overall Study|Tumor Progression|7|||
126560291|NCT00725010|455344618|FG000|Overall Study|Withdrawal by Subject|2|||
126560292|NCT00725010|455344618|FG000|Overall Study|Death|1|||
126560293|NCT00725010|455344618|FG000|Overall Study|Lost to Follow-up|1|||
126560294|NCT00725010|455344618|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
126560295|NCT00725010|455344618|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
126560296|NCT00725010|455344618|FG000|Overall Study|No further documentation|1|||
126560297|NCT00725010|455344618|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
126560298|NCT04610684|455346585|FG000|Study Treatment|Withdrawal by Subject|1|||
126560299|NCT04610684|455346585|FG000|Study Treatment|Disease Progression|2|||
126560300|NCT04610684|455346585|FG000|Follow up|Death|2|||
126560301|NCT04610684|455346585|FG000|Follow up|Withdrawal by Subject|1|||
126560302|NCT04978363|455346589|FG000|Overall Study|Other medical issues unrelated to the study|0|||
126560303|NCT04978363|455346590|FG001|Overall Study|Other medical issues unrelated to the study|0|||
126560304|NCT04978363|455346591|FG002|Overall Study|Other medical issues unrelated to the study|0|||
126560305|NCT04978363|455346592|FG003|Overall Study|Other medical issues unrelated to the study|0|||
126560306|NCT04978363|455346593|FG004|Overall Study|Other medical issues unrelated to the study|1|||
126560307|NCT04978363|455346594|FG005|Overall Study|Other medical issues unrelated to the study|0|||
126560308|NCT04978363|455346595|FG006|Overall Study|Other medical issues unrelated to the study|0|||
126560309|NCT04978363|455346596|FG007|Overall Study|Other medical issues unrelated to the study|0|||
126560310|NCT04978363|455346597|FG008|Overall Study|Other medical issues unrelated to the study|0|||
126560311|NCT04978363|455346598|FG009|Overall Study|Other medical issues unrelated to the study|0|||
126560312|NCT04978363|455346599|FG010|Overall Study|Other medical issues unrelated to the study|0|||
126560313|NCT04978363|455346589|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
126560314|NCT04978363|455346590|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
126560315|NCT04978363|455346591|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
126560316|NCT04978363|455346592|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
126560317|NCT04978363|455346593|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
126560318|NCT04978363|455346594|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
126560319|NCT04978363|455346595|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
126560320|NCT04978363|455346596|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
126560321|NCT04978363|455346597|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
126560322|NCT04978363|455346598|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
126560323|NCT04978363|455346599|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
126560324|NCT04978363|455346589|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126560325|NCT04978363|455346590|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
126560326|NCT04978363|455346591|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126560327|NCT04978363|455346592|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126560328|NCT04978363|455346593|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126560329|NCT04978363|455346594|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126560330|NCT04978363|455346595|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126560331|NCT04978363|455346596|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126560332|NCT04978363|455346597|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126560333|NCT04978363|455346598|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126560334|NCT04978363|455346599|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
126560335|NCT01251614|455346600|FG000|Overall Study|Adverse Event|1|||
126560336|NCT01251614|455346601|FG001|Overall Study|Adverse Event|0|||
126560337|NCT01251614|455346602|FG002|Overall Study|Adverse Event|1|||
126560338|NCT01251614|455346600|FG000|Overall Study|Lack of Efficacy|1|||
126497642|NCT03759379|455123493|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
126497643|NCT03759379|455123492|FG000|Treatment Period|Death|2|||
126497644|NCT03759379|455123493|FG001|Treatment Period|Death|3|||
126497645|NCT03759379|455123492|FG000|Treatment Period|Lost to Follow-up|1|||
126497646|NCT03759379|455123493|FG001|Treatment Period|Lost to Follow-up|0|||
126497647|NCT03759379|455123492|FG000|Treatment Period|Physician Decision|0|||
126497648|NCT03759379|455123493|FG001|Treatment Period|Physician Decision|1|||
126497649|NCT01536379|455123495|FG000|Overall Study|Adverse Event|1|||
126497650|NCT01536379|455123496|FG001|Overall Study|Adverse Event|2|||
126497651|NCT01536379|455123495|FG000|Overall Study|Withdrawal by Subject|1|||
126497652|NCT01536379|455123496|FG001|Overall Study|Withdrawal by Subject|1|||
126497653|NCT02603809|455123501|FG000|Overall Study|Withdrawal by Subject|4|||
126497654|NCT02603809|455123502|FG001|Overall Study|Withdrawal by Subject|1|||
126497655|NCT02603809|455123503|FG002|Overall Study|Withdrawal by Subject|2|||
126497656|NCT02603809|455123504|FG003|Overall Study|Withdrawal by Subject|3|||
126497657|NCT02603809|455123505|FG004|Overall Study|Withdrawal by Subject|3|||
126497658|NCT02603809|455123506|FG005|Overall Study|Withdrawal by Subject|4|||
126497659|NCT02603809|455123501|FG000|Overall Study|Lost to Follow-up|2|||
126497660|NCT02603809|455123502|FG001|Overall Study|Lost to Follow-up|3|||
126497661|NCT02603809|455123503|FG002|Overall Study|Lost to Follow-up|1|||
126497662|NCT02603809|455123504|FG003|Overall Study|Lost to Follow-up|4|||
126497663|NCT02603809|455123505|FG004|Overall Study|Lost to Follow-up|2|||
126497664|NCT02603809|455123506|FG005|Overall Study|Lost to Follow-up|2|||
126497665|NCT02603809|455123501|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
126497666|NCT02603809|455123502|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
126497667|NCT02603809|455123503|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
126497668|NCT02603809|455123504|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
126497669|NCT02603809|455123505|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
126497670|NCT02603809|455123506|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
126497671|NCT02603809|455123501|FG000|Overall Study|Physician Decision|0|||
126497672|NCT02603809|455123502|FG001|Overall Study|Physician Decision|0|||
126497673|NCT02603809|455123503|FG002|Overall Study|Physician Decision|0|||
126497674|NCT02603809|455123504|FG003|Overall Study|Physician Decision|1|||
126497675|NCT02603809|455123505|FG004|Overall Study|Physician Decision|2|||
126497676|NCT02603809|455123506|FG005|Overall Study|Physician Decision|1|||
126497677|NCT02603809|455123501|FG000|Overall Study|Adverse Event|3|||
126497678|NCT02603809|455123502|FG001|Overall Study|Adverse Event|0|||
126497679|NCT02603809|455123503|FG002|Overall Study|Adverse Event|2|||
126497680|NCT02603809|455123504|FG003|Overall Study|Adverse Event|2|||
126497681|NCT02603809|455123505|FG004|Overall Study|Adverse Event|1|||
126497682|NCT02603809|455123506|FG005|Overall Study|Adverse Event|1|||
126497683|NCT02603809|455123501|FG000|Overall Study|Lack of Efficacy|0|||
126497684|NCT02603809|455123502|FG001|Overall Study|Lack of Efficacy|1|||
126497685|NCT02603809|455123503|FG002|Overall Study|Lack of Efficacy|0|||
126497686|NCT02603809|455123504|FG003|Overall Study|Lack of Efficacy|0|||
126497687|NCT02603809|455123505|FG004|Overall Study|Lack of Efficacy|0|||
126497688|NCT02603809|455123506|FG005|Overall Study|Lack of Efficacy|1|||
126497689|NCT03446040|455123507|FG000|Overall Study|Disease progression|3|||
126497690|NCT03446040|455123508|FG001|Overall Study|Disease progression|3|||
126497691|NCT03446040|455123509|FG002|Overall Study|Disease progression|3|||
126497692|NCT03446040|455123510|FG003|Overall Study|Disease progression|4|||
126497693|NCT03446040|455123511|FG004|Overall Study|Disease progression|4|||
126497694|NCT03446040|455123512|FG005|Overall Study|Disease progression|6|||
126497695|NCT03446040|455123513|FG006|Overall Study|Disease progression|3|||
126497696|NCT03446040|455123514|FG007|Overall Study|Disease progression|4|||
126497697|NCT03446040|455123515|FG008|Overall Study|Disease progression|2|||
126497698|NCT03446040|455123516|FG009|Overall Study|Disease progression|4|||
126497699|NCT03446040|455123517|FG010|Overall Study|Disease progression|9|||
126497700|NCT03446040|455123518|FG011|Overall Study|Disease progression|3|||
126497701|NCT03446040|455123519|FG012|Overall Study|Disease progression|7|||
126497702|NCT03446040|455123520|FG013|Overall Study|Disease progression|7|||
126497703|NCT03446040|455123507|FG000|Overall Study|Study drug toxicity|0|||
126497704|NCT03446040|455123508|FG001|Overall Study|Study drug toxicity|0|||
126497705|NCT03446040|455123509|FG002|Overall Study|Study drug toxicity|0|||
126497706|NCT03446040|455123510|FG003|Overall Study|Study drug toxicity|0|||
126497707|NCT03446040|455123511|FG004|Overall Study|Study drug toxicity|0|||
126497708|NCT03446040|455123512|FG005|Overall Study|Study drug toxicity|0|||
126497709|NCT03446040|455123513|FG006|Overall Study|Study drug toxicity|0|||
126497710|NCT03446040|455123514|FG007|Overall Study|Study drug toxicity|0|||
126497711|NCT03446040|455123515|FG008|Overall Study|Study drug toxicity|1|||
126497712|NCT03446040|455123516|FG009|Overall Study|Study drug toxicity|0|||
126497713|NCT03446040|455123517|FG010|Overall Study|Study drug toxicity|0|||
126497714|NCT03446040|455123518|FG011|Overall Study|Study drug toxicity|0|||
126497715|NCT03446040|455123519|FG012|Overall Study|Study drug toxicity|0|||
126497716|NCT03446040|455123520|FG013|Overall Study|Study drug toxicity|0|||
126497717|NCT03446040|455123507|FG000|Overall Study|Adverse Event|0|||
126497718|NCT03446040|455123508|FG001|Overall Study|Adverse Event|0|||
126497719|NCT03446040|455123509|FG002|Overall Study|Adverse Event|0|||
126497720|NCT03446040|455123510|FG003|Overall Study|Adverse Event|0|||
126773911|NCT02595528|456129005|FG000|Overall Study|Withdrawal by Subject|1|||
126773912|NCT02595528|456129006|FG001|Overall Study|Withdrawal by Subject|2|||
126773913|NCT02595528|456129007|FG002|Overall Study|Withdrawal by Subject|1|||
126773914|NCT02595528|456129008|FG003|Overall Study|Withdrawal by Subject|3|||
126773915|NCT02595528|456129005|FG000|Overall Study|Lost to Follow-up|1|||
126773916|NCT02595528|456129006|FG001|Overall Study|Lost to Follow-up|1|||
126773917|NCT02595528|456129007|FG002|Overall Study|Lost to Follow-up|0|||
126773918|NCT02595528|456129008|FG003|Overall Study|Lost to Follow-up|1|||
126773919|NCT03101293|456129012|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
126773920|NCT03101293|456129013|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
126773921|NCT03333382|456129015|FG000|Overall Study|Lost to Follow-up|1|||
126773922|NCT03333382|456129016|FG001|Overall Study|Lost to Follow-up|0|||
126773923|NCT00550420|456129017|FG000|Overall Study|Adverse Event|28|||
126773924|NCT00550420|456129017|FG000|Overall Study|Lost to Follow-up|8|||
126773925|NCT00550420|456129017|FG000|Overall Study|Protocol Violation|11|||
126773926|NCT00550420|456129017|FG000|Overall Study|Withdrawal by Subject|30|||
126773927|NCT00550420|456129017|FG000|Overall Study|Still in study at termination|206|||
126773928|NCT00550420|456129017|FG000|Overall Study|Missing|2|||
126773929|NCT00550420|456129017|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
126773930|NCT00550420|456129017|FG000|Overall Study|Investigators opinion|1|||
126773931|NCT00550420|456129017|FG000|Overall Study|Lack of curative effect|1|||
126773932|NCT00550420|456129017|FG000|Overall Study|Unethical stop of enrollment|2|||
126773933|NCT00550420|456129017|FG000|Overall Study|Caregiver's decision to withdraw|1|||
126773934|NCT00550420|456129017|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
126773935|NCT00550420|456129017|FG000|Overall Study|Exclusion criteria|1|||
126773936|NCT00550420|456129017|FG000|Overall Study|Prohibited medicine|1|||
126773937|NCT02773446|456129022|FG000|First Admission|Withdrawal by Subject|0|||
126773938|NCT02773446|456129023|FG001|First Admission|Withdrawal by Subject|0|||
126773939|NCT02773446|456129024|FG002|First Admission|Withdrawal by Subject|0|||
126773940|NCT02773446|456129025|FG003|First Admission|Withdrawal by Subject|1|||
126773941|NCT02773446|456129026|FG004|First Admission|Withdrawal by Subject|0|||
126773942|NCT02773446|456129027|FG005|First Admission|Withdrawal by Subject|0|||
126773943|NCT02773446|456129022|FG000|First Admission|Lost to Follow-up|1|||
126773944|NCT02773446|456129023|FG001|First Admission|Lost to Follow-up|0|||
126773945|NCT02773446|456129024|FG002|First Admission|Lost to Follow-up|0|||
126773946|NCT02773446|456129025|FG003|First Admission|Lost to Follow-up|0|||
126773947|NCT02773446|456129026|FG004|First Admission|Lost to Follow-up|0|||
126773948|NCT02773446|456129027|FG005|First Admission|Lost to Follow-up|0|||
126773949|NCT03237611|456129028|FG000|Overall Study|Withdrawal by Subject|1|||
126773950|NCT03237611|456129028|FG000|Overall Study|Ineligible|1|||
126773951|NCT01613131|456129029|FG000|Overall Study|Withdrawal by Subject|3|||
126773952|NCT01613131|456129030|FG001|Overall Study|Withdrawal by Subject|5|||
126773953|NCT00787566|456129033|FG000|Overall Study|AE related to chemotherapy|0|||
126773954|NCT00787566|456129034|FG001|Overall Study|AE related to chemotherapy|1|||
126773955|NCT00787566|456129035|FG002|Overall Study|AE related to chemotherapy|0|||
126773956|NCT01814761|456129036|FG000|Overall Study|Other Reasons|1|||
126773957|NCT01814761|456129037|FG001|Overall Study|Other Reasons|10|||
126773958|NCT01814761|456129036|FG000|Overall Study|Ocular Adverse Event|6|||
126773959|NCT01814761|456129037|FG001|Overall Study|Ocular Adverse Event|15|||
126773960|NCT01814761|456129036|FG000|Overall Study|Lost to Follow-up|1|||
126773961|NCT01814761|456129037|FG001|Overall Study|Lost to Follow-up|5|||
126773962|NCT03137082|456129038|FG000|Overall Study|Withdrawal by Subject|1|||
126773963|NCT03137082|456129039|FG001|Overall Study|Withdrawal by Subject|1|||
126773964|NCT03137082|456129038|FG000|Overall Study|Lost to Follow-up|1|||
126773965|NCT03137082|456129039|FG001|Overall Study|Lost to Follow-up|0|||
126773966|NCT00417027|456129040|FG000|Overall Study|Protocol Violation|0|||
126773967|NCT00417027|456129041|FG001|Overall Study|Protocol Violation|5|||
126773968|NCT00417027|456129042|FG002|Overall Study|Protocol Violation|5|||
126773969|NCT00544557|456129043|FG000|Overall Study|Adverse Event|140|||
126773970|NCT00544557|456129043|FG000|Overall Study|Lack of Efficacy|196|||
126773971|NCT00544557|456129043|FG000|Overall Study|Other|98|||
126773972|NCT01020305|456129051|FG000|Overall Study|Adverse Event|2|||
126773973|NCT01017029|456129055|FG000|Overall Study|Lost to Follow-up|1|||
126773974|NCT01017029|456129056|FG001|Overall Study|Lost to Follow-up|0|||
126773975|NCT01017029|456129055|FG000|Overall Study|Administrative problem|0|||
126773976|NCT01017029|456129056|FG001|Overall Study|Administrative problem|1|||
126773977|NCT01017029|456129055|FG000|Overall Study|Death|3|||
126773978|NCT01017029|456129056|FG001|Overall Study|Death|1|||
126773979|NCT00618774|456129057|FG000|Overall Study|Adverse Event|5|||
126773980|NCT00618774|456129058|FG001|Overall Study|Adverse Event|3|||
126773981|NCT00618774|456129057|FG000|Overall Study|Withdrawal by Subject|1|||
126773982|NCT00618774|456129058|FG001|Overall Study|Withdrawal by Subject|0|||
126773983|NCT02753400|456129060|FG000|Overall Study|Adverse Event|3|||
126773984|NCT02753400|456129061|FG001|Overall Study|Adverse Event|0|||
126773985|NCT02753400|456129060|FG000|Overall Study|Withdrawal by Subject|2|||
126773986|NCT02753400|456129061|FG001|Overall Study|Withdrawal by Subject|1|||
126773987|NCT01415921|456129062|FG000|Overall Study|Adverse Event|0|||
126773988|NCT01415921|456129063|FG001|Overall Study|Adverse Event|1|||
126497721|NCT03446040|455123511|FG004|Overall Study|Adverse Event|0|||
126497722|NCT03446040|455123512|FG005|Overall Study|Adverse Event|2|||
126497723|NCT03446040|455123513|FG006|Overall Study|Adverse Event|0|||
126497724|NCT03446040|455123514|FG007|Overall Study|Adverse Event|0|||
126497725|NCT03446040|455123515|FG008|Overall Study|Adverse Event|1|||
126497726|NCT03446040|455123516|FG009|Overall Study|Adverse Event|0|||
126497727|NCT03446040|455123517|FG010|Overall Study|Adverse Event|0|||
126497728|NCT03446040|455123518|FG011|Overall Study|Adverse Event|0|||
126497729|NCT03446040|455123519|FG012|Overall Study|Adverse Event|0|||
126497730|NCT03446040|455123520|FG013|Overall Study|Adverse Event|0|||
126497731|NCT03446040|455123507|FG000|Overall Study|Death|0|||
126497732|NCT03446040|455123508|FG001|Overall Study|Death|0|||
126497733|NCT03446040|455123509|FG002|Overall Study|Death|0|||
126497734|NCT03446040|455123510|FG003|Overall Study|Death|0|||
126497735|NCT03446040|455123511|FG004|Overall Study|Death|0|||
126497736|NCT03446040|455123512|FG005|Overall Study|Death|0|||
126725257|NCT04804033|455944556|FG000|Period 1: DBT Phase|Other|0|||
126725258|NCT04804033|455944557|FG001|Period 1: DBT Phase|Other|1|||
126725259|NCT04804033|455944558|FG002|Period 1: DBT Phase|Other|0|||
126725260|NCT04804033|455944559|FG003|Period 1: DBT Phase|Other|0|||
126725261|NCT04804033|455944556|FG000|Period 1: DBT Phase|Pregnancy|2|||
126725262|NCT04804033|455944557|FG001|Period 1: DBT Phase|Pregnancy|0|||
126725263|NCT04804033|455944558|FG002|Period 1: DBT Phase|Pregnancy|0|||
126725264|NCT04804033|455944559|FG003|Period 1: DBT Phase|Pregnancy|0|||
126725265|NCT04804033|455944556|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
126725266|NCT04804033|455944557|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
126725267|NCT04804033|455944558|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
126725268|NCT04804033|455944559|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
126725269|NCT04804033|455944556|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
126725270|NCT04804033|455944557|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
126725271|NCT04804033|455944558|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
126725272|NCT04804033|455944559|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
126725273|NCT04804033|455944556|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
126725274|NCT04804033|455944557|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
126725275|NCT04804033|455944558|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
126725276|NCT04804033|455944559|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
126725277|NCT04804033|455944556|FG000|Period 2: OLE Phase|Adverse Event|3|||
126725278|NCT04804033|455944557|FG001|Period 2: OLE Phase|Adverse Event|4|||
126725279|NCT04804033|455944558|FG002|Period 2: OLE Phase|Adverse Event|2|||
126725280|NCT04804033|455944559|FG003|Period 2: OLE Phase|Adverse Event|0|||
126725281|NCT04804033|455944556|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
126725282|NCT04804033|455944557|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
126725283|NCT04804033|455944558|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
126725284|NCT04804033|455944559|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
126725285|NCT04804033|455944556|FG000|Period 2: OLE Phase|Non-compliance|2|||
126725286|NCT04804033|455944557|FG001|Period 2: OLE Phase|Non-compliance|2|||
126725287|NCT04804033|455944558|FG002|Period 2: OLE Phase|Non-compliance|0|||
126725288|NCT04804033|455944559|FG003|Period 2: OLE Phase|Non-compliance|1|||
126725289|NCT04804033|455944556|FG000|Period 2: OLE Phase|Other|0|||
126725290|NCT04804033|455944557|FG001|Period 2: OLE Phase|Other|2|||
126725291|NCT04804033|455944558|FG002|Period 2: OLE Phase|Other|0|||
126725292|NCT04804033|455944559|FG003|Period 2: OLE Phase|Other|0|||
126725293|NCT04804033|455944556|FG000|Period 2: OLE Phase|Physician Decision|1|||
126725294|NCT04804033|455944557|FG001|Period 2: OLE Phase|Physician Decision|1|||
126725295|NCT04804033|455944558|FG002|Period 2: OLE Phase|Physician Decision|0|||
126725296|NCT04804033|455944559|FG003|Period 2: OLE Phase|Physician Decision|0|||
126725297|NCT04804033|455944556|FG000|Period 2: OLE Phase|Pregnancy|0|||
126725298|NCT04804033|455944557|FG001|Period 2: OLE Phase|Pregnancy|0|||
126725299|NCT04804033|455944558|FG002|Period 2: OLE Phase|Pregnancy|2|||
126725300|NCT04804033|455944559|FG003|Period 2: OLE Phase|Pregnancy|0|||
126725301|NCT04804033|455944556|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
126725302|NCT04804033|455944557|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
126725303|NCT04804033|455944558|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
126725304|NCT04804033|455944559|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
126725305|NCT04804033|455944556|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
126725306|NCT04804033|455944557|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
126725307|NCT04804033|455944558|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
126725308|NCT04804033|455944559|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
126725309|NCT04804033|455944556|FG000|Period 2: OLE Phase|Not reported|0|||
126725310|NCT04804033|455944557|FG001|Period 2: OLE Phase|Not reported|2|||
126725311|NCT04804033|455944558|FG002|Period 2: OLE Phase|Not reported|0|||
126725312|NCT04804033|455944559|FG003|Period 2: OLE Phase|Not reported|0|||
126725313|NCT04804033|455944556|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
126497737|NCT03446040|455123513|FG006|Overall Study|Death|0|||
126497738|NCT03446040|455123514|FG007|Overall Study|Death|0|||
126497739|NCT03446040|455123515|FG008|Overall Study|Death|0|||
126560339|NCT01251614|455346601|FG001|Overall Study|Lack of Efficacy|9|||
126497740|NCT03446040|455123516|FG009|Overall Study|Death|0|||
126497741|NCT03446040|455123517|FG010|Overall Study|Death|1|||
126773989|NCT01415921|456129062|FG000|Overall Study|Physician Decision|1|||
126773990|NCT01415921|456129063|FG001|Overall Study|Physician Decision|1|||
126773991|NCT01415921|456129062|FG000|Overall Study|Withdrawal by Subject|0|||
126773992|NCT01415921|456129063|FG001|Overall Study|Withdrawal by Subject|1|||
126773993|NCT01415921|456129062|FG000|Overall Study|Other|2|||
126773994|NCT01415921|456129063|FG001|Overall Study|Other|0|||
126773995|NCT01830920|456129068|FG000|Overall Study|Adverse Event|1|||
126773996|NCT01830920|456129069|FG001|Overall Study|Adverse Event|0|||
126773997|NCT01830920|456129070|FG002|Overall Study|Adverse Event|1|||
126773998|NCT01830920|456129071|FG003|Overall Study|Adverse Event|0|||
126773999|NCT01830920|456129072|FG004|Overall Study|Adverse Event|0|||
126774000|NCT01830920|456129068|FG000|Overall Study|Withdrawal by Subject|2|||
126497742|NCT03446040|455123518|FG011|Overall Study|Death|0|||
126497743|NCT03446040|455123519|FG012|Overall Study|Death|0|||
126497744|NCT03446040|455123520|FG013|Overall Study|Death|2|||
126497745|NCT03446040|455123507|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
126497746|NCT03446040|455123508|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
126497747|NCT03446040|455123509|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
126497748|NCT03446040|455123510|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
126497749|NCT03446040|455123511|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
126497750|NCT03446040|455123512|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
126497751|NCT03446040|455123513|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
126497752|NCT03446040|455123514|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
126497753|NCT03446040|455123515|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
126497754|NCT03446040|455123516|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
126497755|NCT03446040|455123517|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
126497756|NCT03446040|455123518|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
126497757|NCT03446040|455123519|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
126497758|NCT03446040|455123520|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
126497759|NCT03446040|455123507|FG000|Overall Study|Participant withdrew consent|0|||
126497760|NCT03446040|455123508|FG001|Overall Study|Participant withdrew consent|0|||
126497761|NCT03446040|455123509|FG002|Overall Study|Participant withdrew consent|0|||
126497762|NCT03446040|455123510|FG003|Overall Study|Participant withdrew consent|0|||
126497763|NCT03446040|455123511|FG004|Overall Study|Participant withdrew consent|0|||
126497764|NCT03446040|455123512|FG005|Overall Study|Participant withdrew consent|1|||
126497765|NCT03446040|455123513|FG006|Overall Study|Participant withdrew consent|0|||
126497766|NCT03446040|455123514|FG007|Overall Study|Participant withdrew consent|1|||
126497767|NCT03446040|455123515|FG008|Overall Study|Participant withdrew consent|0|||
126497768|NCT03446040|455123516|FG009|Overall Study|Participant withdrew consent|0|||
126497769|NCT03446040|455123517|FG010|Overall Study|Participant withdrew consent|0|||
126497770|NCT03446040|455123518|FG011|Overall Study|Participant withdrew consent|0|||
126497771|NCT03446040|455123519|FG012|Overall Study|Participant withdrew consent|0|||
126497772|NCT03446040|455123520|FG013|Overall Study|Participant withdrew consent|0|||
126497773|NCT03446040|455123507|FG000|Overall Study|Not reported|0|||
126497774|NCT03446040|455123508|FG001|Overall Study|Not reported|0|||
126497775|NCT03446040|455123509|FG002|Overall Study|Not reported|1|||
126497776|NCT03446040|455123510|FG003|Overall Study|Not reported|0|||
126497777|NCT03446040|455123511|FG004|Overall Study|Not reported|0|||
126497778|NCT03446040|455123512|FG005|Overall Study|Not reported|0|||
126497779|NCT03446040|455123513|FG006|Overall Study|Not reported|0|||
126497780|NCT03446040|455123514|FG007|Overall Study|Not reported|0|||
126497781|NCT03446040|455123515|FG008|Overall Study|Not reported|0|||
126497782|NCT03446040|455123516|FG009|Overall Study|Not reported|0|||
126497783|NCT03446040|455123517|FG010|Overall Study|Not reported|0|||
126497784|NCT03446040|455123518|FG011|Overall Study|Not reported|0|||
126774001|NCT01830920|456129069|FG001|Overall Study|Withdrawal by Subject|2|||
126774002|NCT01830920|456129070|FG002|Overall Study|Withdrawal by Subject|1|||
126497785|NCT03446040|455123519|FG012|Overall Study|Not reported|0|||
126497786|NCT03446040|455123520|FG013|Overall Study|Not reported|0|||
126497787|NCT03036098|455123521|FG000|Pre-Treatment|Other Reasons|1|||
126497788|NCT03036098|455123522|FG001|Pre-Treatment|Other Reasons|2|||
126497789|NCT03036098|455123523|FG002|Pre-Treatment|Other Reasons|0|||
126497790|NCT03036098|455123524|FG003|Pre-Treatment|Other Reasons|5|||
126497791|NCT03036098|455123521|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
126497792|NCT03036098|455123522|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
126497793|NCT03036098|455123523|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
126497794|NCT03036098|455123524|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
126774003|NCT01830920|456129071|FG003|Overall Study|Withdrawal by Subject|7|||
126497795|NCT03036098|455123521|FG000|Pre-Treatment|Withdrawal by Subject|1|||
126774004|NCT01830920|456129072|FG004|Overall Study|Withdrawal by Subject|1|||
126774005|NCT01830920|456129068|FG000|Overall Study|Death|3|||
126774006|NCT01830920|456129069|FG001|Overall Study|Death|3|||
126497796|NCT03036098|455123522|FG001|Pre-Treatment|Withdrawal by Subject|14|||
126497797|NCT03036098|455123523|FG002|Pre-Treatment|Withdrawal by Subject|0|||
126497798|NCT03036098|455123524|FG003|Pre-Treatment|Withdrawal by Subject|5|||
126497799|NCT03036098|455123521|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
126497800|NCT03036098|455123522|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
126497801|NCT03036098|455123523|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
126497802|NCT03036098|455123524|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
126497803|NCT03036098|455123521|FG000|Treatment|Disease Progression|130|||
126497804|NCT03036098|455123522|FG001|Treatment|Disease Progression|77|||
126497805|NCT03036098|455123523|FG002|Treatment|Disease Progression|168|||
126497806|NCT03036098|455123524|FG003|Treatment|Disease Progression|50|||
126497807|NCT03036098|455123521|FG000|Treatment|Study Drug Toxicity|95|||
126497808|NCT03036098|455123522|FG001|Treatment|Study Drug Toxicity|45|||
126497809|NCT03036098|455123523|FG002|Treatment|Study Drug Toxicity|26|||
126497810|NCT03036098|455123524|FG003|Treatment|Study Drug Toxicity|22|||
126497811|NCT03036098|455123521|FG000|Treatment|Death|9|||
126497812|NCT03036098|455123522|FG001|Treatment|Death|3|||
126497813|NCT03036098|455123523|FG002|Treatment|Death|1|||
126497814|NCT03036098|455123524|FG003|Treatment|Death|2|||
126497815|NCT03036098|455123521|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
126497816|NCT03036098|455123522|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
126497817|NCT03036098|455123523|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
126497818|NCT03036098|455123524|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
126497819|NCT03036098|455123521|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
126497820|NCT03036098|455123522|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
126497821|NCT03036098|455123523|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
126497822|NCT03036098|455123524|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
126497823|NCT03036098|455123521|FG000|Treatment|Withdrawal by Subject|2|||
126497824|NCT03036098|455123522|FG001|Treatment|Withdrawal by Subject|9|||
126497825|NCT03036098|455123523|FG002|Treatment|Withdrawal by Subject|2|||
126497826|NCT03036098|455123524|FG003|Treatment|Withdrawal by Subject|4|||
126497827|NCT03036098|455123521|FG000|Treatment|Maximum Clinical Benefit|6|||
126497828|NCT03036098|455123522|FG001|Treatment|Maximum Clinical Benefit|1|||
126497829|NCT03036098|455123523|FG002|Treatment|Maximum Clinical Benefit|6|||
126497830|NCT03036098|455123524|FG003|Treatment|Maximum Clinical Benefit|10|||
126497831|NCT03036098|455123521|FG000|Treatment|Poor/Non Compliance|1|||
126497832|NCT03036098|455123522|FG001|Treatment|Poor/Non Compliance|2|||
126497833|NCT03036098|455123523|FG002|Treatment|Poor/Non Compliance|0|||
126497834|NCT03036098|455123524|FG003|Treatment|Poor/Non Compliance|1|||
126497835|NCT03036098|455123521|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
126497836|NCT03036098|455123522|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
126497837|NCT03036098|455123523|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
126497838|NCT03036098|455123524|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
126497839|NCT03036098|455123521|FG000|Treatment|Administrative Reason by Sponsor|1|||
126497840|NCT03036098|455123522|FG001|Treatment|Administrative Reason by Sponsor|0|||
126497841|NCT03036098|455123523|FG002|Treatment|Administrative Reason by Sponsor|2|||
126497842|NCT03036098|455123524|FG003|Treatment|Administrative Reason by Sponsor|1|||
126497843|NCT03036098|455123521|FG000|Treatment|Other Reasons|31|||
126497844|NCT03036098|455123522|FG001|Treatment|Other Reasons|5|||
126497845|NCT03036098|455123523|FG002|Treatment|Other Reasons|21|||
126497846|NCT03036098|455123524|FG003|Treatment|Other Reasons|8|||
126497847|NCT03036098|455123521|FG000|Treatment|Ongoing Treatment|0|||
126497848|NCT03036098|455123522|FG001|Treatment|Ongoing Treatment|0|||
126497849|NCT03036098|455123523|FG002|Treatment|Ongoing Treatment|23|||
126497850|NCT03036098|455123524|FG003|Treatment|Ongoing Treatment|0|||
126497851|NCT02672423|455123527|FG000|Period 1|Adverse Event|0|||
126497852|NCT02672423|455123528|FG001|Period 1|Adverse Event|0|||
126497853|NCT02672423|455123529|FG002|Period 1|Adverse Event|0|||
126497854|NCT02672423|455123530|FG003|Period 1|Adverse Event|0|||
126497855|NCT02672423|455123531|FG004|Period 1|Adverse Event|1|||
126497856|NCT02672423|455123532|FG005|Period 1|Adverse Event|0|||
126497857|NCT02672423|455123533|FG006|Period 1|Adverse Event|0|||
126497858|NCT02672423|455123534|FG007|Period 1|Adverse Event|0|||
126497859|NCT02672423|455123535|FG008|Period 1|Adverse Event|0|||
126497860|NCT02672423|455123536|FG009|Period 1|Adverse Event|0|||
126497861|NCT02672423|455123527|FG000|Period 2|Withdrawal by Subject|0|||
126497862|NCT02672423|455123528|FG001|Period 2|Withdrawal by Subject|0|||
126497863|NCT02672423|455123529|FG002|Period 2|Withdrawal by Subject|1|||
126497864|NCT02672423|455123530|FG003|Period 2|Withdrawal by Subject|0|||
126497865|NCT02672423|455123531|FG004|Period 2|Withdrawal by Subject|0|||
126497866|NCT02672423|455123532|FG005|Period 2|Withdrawal by Subject|0|||
126497867|NCT02672423|455123533|FG006|Period 2|Withdrawal by Subject|0|||
126497868|NCT02672423|455123534|FG007|Period 2|Withdrawal by Subject|0|||
126497869|NCT02672423|455123535|FG008|Period 2|Withdrawal by Subject|0|||
126497870|NCT02672423|455123536|FG009|Period 2|Withdrawal by Subject|0|||
126497871|NCT02672423|455123527|FG000|Period 3|Withdrawal by Subject|0|||
126497872|NCT02672423|455123528|FG001|Period 3|Withdrawal by Subject|0|||
126497873|NCT02672423|455123529|FG002|Period 3|Withdrawal by Subject|0|||
126497874|NCT02672423|455123530|FG003|Period 3|Withdrawal by Subject|0|||
126497875|NCT02672423|455123531|FG004|Period 3|Withdrawal by Subject|0|||
126497876|NCT02672423|455123532|FG005|Period 3|Withdrawal by Subject|0|||
126497877|NCT02672423|455123533|FG006|Period 3|Withdrawal by Subject|0|||
126497878|NCT02672423|455123534|FG007|Period 3|Withdrawal by Subject|1|||
126497879|NCT02672423|455123535|FG008|Period 3|Withdrawal by Subject|0|||
126497880|NCT02672423|455123536|FG009|Period 3|Withdrawal by Subject|0|||
126497881|NCT02672423|455123527|FG000|Period 3|Physician Decision|0|||
126497882|NCT02672423|455123528|FG001|Period 3|Physician Decision|0|||
126497883|NCT02672423|455123529|FG002|Period 3|Physician Decision|0|||
126497884|NCT02672423|455123530|FG003|Period 3|Physician Decision|0|||
126497885|NCT02672423|455123531|FG004|Period 3|Physician Decision|0|||
126497886|NCT02672423|455123532|FG005|Period 3|Physician Decision|1|||
126497887|NCT02672423|455123533|FG006|Period 3|Physician Decision|0|||
126497888|NCT02672423|455123534|FG007|Period 3|Physician Decision|0|||
126497889|NCT02672423|455123535|FG008|Period 3|Physician Decision|0|||
126497890|NCT02672423|455123536|FG009|Period 3|Physician Decision|0|||
126497891|NCT01046682|455123540|FG000|Overall Study|Adverse Event|2|||
126497892|NCT01046682|455123541|FG001|Overall Study|Adverse Event|0|||
126497893|NCT01265849|455123544|FG000|Overall Study|Randomized//Treatment not initiated|1|||
126497894|NCT01265849|455123545|FG001|Overall Study|Randomized//Treatment not initiated|4|||
126497895|NCT01265849|455123546|FG002|Overall Study|Randomized//Treatment not initiated|0|||
126497896|NCT01265849|455123544|FG000|Overall Study|Physician Decision|1|||
126497897|NCT01265849|455123545|FG001|Overall Study|Physician Decision|2|||
126497898|NCT01265849|455123546|FG002|Overall Study|Physician Decision|0|||
126497899|NCT01265849|455123544|FG000|Overall Study|Lost to Follow-up|18|||
126497900|NCT01265849|455123545|FG001|Overall Study|Lost to Follow-up|15|||
126497901|NCT01265849|455123546|FG002|Overall Study|Lost to Follow-up|5|||
126497902|NCT01265849|455123544|FG000|Overall Study|Not otherwise specified|1|||
126497903|NCT01265849|455123545|FG001|Overall Study|Not otherwise specified|6|||
126497904|NCT01265849|455123546|FG002|Overall Study|Not otherwise specified|1|||
126497905|NCT01265849|455123544|FG000|Overall Study|Withdrawal by Subject|25|||
126497906|NCT01265849|455123545|FG001|Overall Study|Withdrawal by Subject|34|||
126497907|NCT01265849|455123546|FG002|Overall Study|Withdrawal by Subject|13|||
126497908|NCT00271609|455123548|FG000|Overall Study|Adverse Event|11|||
126497909|NCT00271609|455123549|FG001|Overall Study|Adverse Event|3|||
126497910|NCT00271609|455123548|FG000|Overall Study|Withdrawal by Subject|2|||
126497911|NCT00271609|455123549|FG001|Overall Study|Withdrawal by Subject|0|||
126497912|NCT02188589|455123550|FG000|Overall Study|Withdrawal by Subject|5|||
126497913|NCT00975481|455123553|FG000|Second Intervention Period|Adverse Event|2|||
126497914|NCT00975481|455123554|FG001|Second Intervention Period|Adverse Event|1|||
126497915|NCT00975481|455123555|FG002|Second Intervention Period|Adverse Event|0|||
126497916|NCT00975481|455123556|FG003|Second Intervention Period|Adverse Event|0|||
126497917|NCT00975481|455123557|FG004|Second Intervention Period|Adverse Event|0|||
126497918|NCT00975481|455123558|FG005|Second Intervention Period|Adverse Event|0|||
126497919|NCT00975481|455123553|FG000|Second Intervention Period|Withdrawal by Subject|0|||
126497920|NCT00975481|455123554|FG001|Second Intervention Period|Withdrawal by Subject|0|||
126497921|NCT00975481|455123555|FG002|Second Intervention Period|Withdrawal by Subject|1|||
126497922|NCT00975481|455123556|FG003|Second Intervention Period|Withdrawal by Subject|0|||
126497923|NCT00975481|455123557|FG004|Second Intervention Period|Withdrawal by Subject|0|||
126497924|NCT00975481|455123558|FG005|Second Intervention Period|Withdrawal by Subject|0|||
126497925|NCT00975481|455123553|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
126497926|NCT00975481|455123554|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
126497927|NCT00975481|455123555|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
126497928|NCT00975481|455123556|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
126497929|NCT00975481|455123557|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
126497930|NCT00975481|455123558|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
126497931|NCT00975481|455123553|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
126497932|NCT00975481|455123554|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
126497933|NCT00975481|455123555|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
126497934|NCT00975481|455123556|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
126497935|NCT00975481|455123557|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
126725314|NCT04804033|455944557|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
126725315|NCT04804033|455944558|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
126725316|NCT04804033|455944559|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
126725317|NCT04804033|455944556|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
126725318|NCT04804033|455944557|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
126725319|NCT04804033|455944558|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
126725320|NCT04804033|455944559|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
126725321|NCT04804033|455944556|FG000|Period 3: Follow-up Phase|Other|0|||
126725322|NCT04804033|455944557|FG001|Period 3: Follow-up Phase|Other|1|||
126725323|NCT04804033|455944558|FG002|Period 3: Follow-up Phase|Other|2|||
126725324|NCT04804033|455944559|FG003|Period 3: Follow-up Phase|Other|1|||
126725325|NCT04804033|455944556|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
126725326|NCT04804033|455944557|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
126497936|NCT00975481|455123558|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
126497937|NCT00643682|455123559|FG000|Overall Study|did not keep appointment|522|||
126497938|NCT00643682|455123560|FG001|Overall Study|did not keep appointment|509|||
126497939|NCT03755414|455123566|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
126497940|NCT03755414|455123567|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
126497941|NCT03755414|455123568|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
126497942|NCT03755414|455123566|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
126497943|NCT03755414|455123567|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
126497944|NCT03755414|455123568|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
126497945|NCT03755414|455123566|FG000|Overall Study|Non-compliance|0|||
126560340|NCT01251614|455346602|FG002|Overall Study|Lack of Efficacy|4|||
126725327|NCT04804033|455944558|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
126725328|NCT04804033|455944559|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
126725329|NCT04804033|455944556|FG000|Period 3: Follow-up Phase|Not reported|18|||
126725330|NCT04804033|455944557|FG001|Period 3: Follow-up Phase|Not reported|15|||
126725331|NCT04804033|455944558|FG002|Period 3: Follow-up Phase|Not reported|1|||
126725332|NCT04804033|455944559|FG003|Period 3: Follow-up Phase|Not reported|4|||
126725333|NCT00209170|455944560|FG000|Overall Study|Adverse Event|0|||
126725334|NCT00209170|455944561|FG001|Overall Study|Adverse Event|1|||
126725335|NCT00209170|455944560|FG000|Overall Study|Withdrawal by Subject|2|||
126725336|NCT00209170|455944561|FG001|Overall Study|Withdrawal by Subject|1|||
126725337|NCT00209170|455944560|FG000|Overall Study|Lack of Efficacy|0|||
126725338|NCT00209170|455944561|FG001|Overall Study|Lack of Efficacy|1|||
126725339|NCT02108600|455944562|FG000|Overall Study|Withdrawal by Subject|2|||
126725340|NCT02108600|455944563|FG001|Overall Study|Withdrawal by Subject|0|||
126725341|NCT02108600|455944562|FG000|Overall Study|Lost to Follow-up|1|||
126725342|NCT02108600|455944563|FG001|Overall Study|Lost to Follow-up|1|||
126725343|NCT02108951|455944567|FG000|Overall Study|Lost to Follow-up|1|||
126725344|NCT02108951|455944567|FG000|Overall Study|Patient's/guardian's decision|1|||
126725345|NCT02108951|455944567|FG000|Overall Study|Study Terminated by Sponsor|14|||
126725346|NCT00718666|455944568|FG000|Booster Phase Year 5|No active participation request|0|||
126725347|NCT00718666|455944569|FG001|Booster Phase Year 5|No active participation request|0|||
126725348|NCT00718666|455944570|FG002|Booster Phase Year 5|No active participation request|1|||
126725349|NCT00718666|455944568|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
126725350|NCT00718666|455944569|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
126725351|NCT00718666|455944570|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
126725352|NCT00718666|455944568|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
126725353|NCT00718666|455944569|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
126725354|NCT00718666|455944570|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
126725355|NCT00718666|455944568|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
126725356|NCT00718666|455944569|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
126725357|NCT00718666|455944570|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
126725358|NCT00421343|455944573|FG000|Overall Study|Death|1|||
126725359|NCT00421343|455944573|FG000|Overall Study|Withdrawal by Subject|2|||
126725360|NCT00421343|455944573|FG000|Overall Study|Lost to Follow-up|3|||
126725361|NCT03471767|455944579|FG000|Overall Study|Withdrawal by Subject|3|||
126725362|NCT03471767|455944580|FG001|Overall Study|Withdrawal by Subject|1|||
126725363|NCT03471767|455944579|FG000|Overall Study|Adverse Event|1|||
126725364|NCT03471767|455944580|FG001|Overall Study|Adverse Event|0|||
126725365|NCT03471767|455944579|FG000|Overall Study|Lost to Follow-up|1|||
126725366|NCT03471767|455944580|FG001|Overall Study|Lost to Follow-up|0|||
126725367|NCT03471767|455944579|FG000|Overall Study|PI Withdrawal|1|||
126725368|NCT03471767|455944580|FG001|Overall Study|PI Withdrawal|3|||
126725369|NCT00678587|455944581|FG000|Overall Study|Adverse Event|3|||
126725370|NCT00678587|455944582|FG001|Overall Study|Adverse Event|3|||
126725371|NCT00678587|455944581|FG000|Overall Study|Lack of Efficacy|1|||
126725372|NCT00678587|455944582|FG001|Overall Study|Lack of Efficacy|0|||
126725373|NCT00678587|455944581|FG000|Overall Study|Protocol Violation|2|||
126725374|NCT00678587|455944582|FG001|Overall Study|Protocol Violation|1|||
126725375|NCT00678587|455944581|FG000|Overall Study|Study Closed/Terminated|1|||
126725376|NCT00678587|455944582|FG001|Overall Study|Study Closed/Terminated|0|||
126725377|NCT00678587|455944581|FG000|Overall Study|Lost to Follow-up|3|||
126725378|NCT00678587|455944582|FG001|Overall Study|Lost to Follow-up|5|||
126725379|NCT00678587|455944581|FG000|Overall Study|Investigator Discretion|2|||
126725380|NCT00678587|455944582|FG001|Overall Study|Investigator Discretion|6|||
126725381|NCT00678587|455944581|FG000|Overall Study|Withdrew Consent|8|||
126725382|NCT00678587|455944582|FG001|Overall Study|Withdrew Consent|3|||
126774007|NCT01830920|456129070|FG002|Overall Study|Death|5|||
126774008|NCT01830920|456129071|FG003|Overall Study|Death|4|||
126497946|NCT03755414|455123567|FG001|Overall Study|Non-compliance|1|||
126725383|NCT03806179|455944583|FG000|Overall Study|Progressive disease|0|||
126725384|NCT03806179|455944584|FG001|Overall Study|Progressive disease|2|||
126725385|NCT01952730|455944587|FG000|Overall Study|FDA shut down core lab used by study|1|||
126725386|NCT01357915|455944592|FG000|Overall Study|Lost to Follow-up|3|||
126497947|NCT03755414|455123568|FG002|Overall Study|Non-compliance|0|||
126497948|NCT02154581|455123576|FG000|Overall Study|Lost to Follow-up|7|||
126497949|NCT02154581|455123577|FG001|Overall Study|Lost to Follow-up|8|||
126497950|NCT00741039|455123578|FG000|Overall Study|Patient non-compliance|2|||
126497951|NCT00741039|455123579|FG001|Overall Study|Patient non-compliance|0|||
126497952|NCT00853723|455123584|FG000|Overall Study|Adverse Event|3|||
126497953|NCT00853723|455123585|FG001|Overall Study|Adverse Event|4|||
126497954|NCT00853723|455123586|FG002|Overall Study|Adverse Event|1|||
126497955|NCT00853723|455123584|FG000|Overall Study|Withdrawal by Subject|2|||
126497956|NCT00853723|455123585|FG001|Overall Study|Withdrawal by Subject|1|||
126497957|NCT00853723|455123586|FG002|Overall Study|Withdrawal by Subject|0|||
126497958|NCT00853723|455123584|FG000|Overall Study|Protocol Violation|1|||
126497959|NCT00853723|455123585|FG001|Overall Study|Protocol Violation|2|||
126497960|NCT00853723|455123586|FG002|Overall Study|Protocol Violation|1|||
126497961|NCT01531387|455123587|FG000|Overall Study|Early termination of study|11|||
126497962|NCT01531387|455123588|FG001|Overall Study|Early termination of study|11|||
126497963|NCT02642432|455123591|FG000|Overall Study|Adverse Event|2|||
126497964|NCT02642432|455123591|FG000|Overall Study|Withdrew Consent|1|||
126497965|NCT02642432|455123591|FG000|Overall Study|Lost to Follow-up|2|||
126497966|NCT02642432|455123591|FG000|Overall Study|Other|3|||
126497967|NCT01848756|455123592|FG000|Overall Study|Adverse Event|1|||
126497968|NCT01848756|455123592|FG000|Overall Study|Withdrawal by Subject|1|||
126497969|NCT01848756|455123592|FG000|Overall Study|Enrolled in Error|1|||
126497970|NCT03245008|455123593|FG000|Overall Study|Adverse Event|15|||
126497971|NCT03245008|455123594|FG001|Overall Study|Adverse Event|18|||
126497972|NCT03245008|455123595|FG002|Overall Study|Adverse Event|15|||
126497973|NCT03245008|455123596|FG003|Overall Study|Adverse Event|0|||
126497974|NCT03245008|455123597|FG004|Overall Study|Adverse Event|1|||
126497975|NCT03245008|455123593|FG000|Overall Study|Lack of Efficacy|0|||
126497976|NCT03245008|455123594|FG001|Overall Study|Lack of Efficacy|1|||
126497977|NCT03245008|455123595|FG002|Overall Study|Lack of Efficacy|0|||
126497978|NCT03245008|455123596|FG003|Overall Study|Lack of Efficacy|0|||
126497979|NCT03245008|455123597|FG004|Overall Study|Lack of Efficacy|0|||
126497980|NCT03245008|455123593|FG000|Overall Study|Lost to Follow-up|4|||
126497981|NCT03245008|455123594|FG001|Overall Study|Lost to Follow-up|1|||
126497982|NCT03245008|455123595|FG002|Overall Study|Lost to Follow-up|0|||
126497983|NCT03245008|455123596|FG003|Overall Study|Lost to Follow-up|0|||
126497984|NCT03245008|455123597|FG004|Overall Study|Lost to Follow-up|1|||
126497985|NCT03245008|455123593|FG000|Overall Study|Physician Decision|1|||
126497986|NCT03245008|455123594|FG001|Overall Study|Physician Decision|3|||
126497987|NCT03245008|455123595|FG002|Overall Study|Physician Decision|4|||
126497988|NCT03245008|455123596|FG003|Overall Study|Physician Decision|0|||
126497989|NCT03245008|455123597|FG004|Overall Study|Physician Decision|0|||
126497990|NCT03245008|455123593|FG000|Overall Study|Protocol Violation|0|||
126497991|NCT03245008|455123594|FG001|Overall Study|Protocol Violation|1|||
126497992|NCT03245008|455123595|FG002|Overall Study|Protocol Violation|0|||
126497993|NCT03245008|455123596|FG003|Overall Study|Protocol Violation|0|||
126497994|NCT03245008|455123597|FG004|Overall Study|Protocol Violation|0|||
126497995|NCT03245008|455123593|FG000|Overall Study|Withdrawal by Subject|20|||
126497996|NCT03245008|455123594|FG001|Overall Study|Withdrawal by Subject|19|||
126497997|NCT03245008|455123595|FG002|Overall Study|Withdrawal by Subject|11|||
126725387|NCT01357915|455944593|FG001|Overall Study|Lost to Follow-up|0|||
126497998|NCT03245008|455123596|FG003|Overall Study|Withdrawal by Subject|0|||
126497999|NCT03245008|455123597|FG004|Overall Study|Withdrawal by Subject|0|||
126498000|NCT03245008|455123593|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
126498001|NCT03245008|455123594|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
126498002|NCT03245008|455123595|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
126498003|NCT03245008|455123596|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
126725388|NCT00305253|455944594|FG000|Overall Study|Withdrawal by Subject|0|||
126725389|NCT00305253|455944595|FG001|Overall Study|Withdrawal by Subject|1|||
126725390|NCT05373706|455944599|FG000|Overall Study|Lost to Follow-up|2|||
126725391|NCT05373706|455944600|FG001|Overall Study|Lost to Follow-up|2|||
126725392|NCT01479374|455944605|FG000|Overall Study|Adverse Event|2|||
126725393|NCT01479374|455944606|FG001|Overall Study|Adverse Event|1|||
126725394|NCT01479374|455944607|FG002|Overall Study|Adverse Event|0|||
126725395|NCT01479374|455944605|FG000|Overall Study|Lost to Follow-up|1|||
126725396|NCT01479374|455944606|FG001|Overall Study|Lost to Follow-up|2|||
126725397|NCT01479374|455944607|FG002|Overall Study|Lost to Follow-up|0|||
126725398|NCT01479374|455944605|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
126725399|NCT01479374|455944606|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
126725400|NCT01479374|455944607|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
126725401|NCT01479374|455944605|FG000|Overall Study|Other|0|||
126725402|NCT01479374|455944606|FG001|Overall Study|Other|4|||
126725403|NCT01479374|455944607|FG002|Overall Study|Other|5|||
126725404|NCT01606761|455944608|FG000|Prior to Week 24|Lost to Follow-up|0|||
126725405|NCT01606761|455944609|FG001|Prior to Week 24|Lost to Follow-up|3|||
126725406|NCT01606761|455944610|FG002|Prior to Week 24|Lost to Follow-up|2|||
126498004|NCT03245008|455123597|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
126498005|NCT03245008|455123593|FG000|Overall Study|Failure to meet randomization criteria|0|||
126498006|NCT03245008|455123594|FG001|Overall Study|Failure to meet randomization criteria|1|||
126498007|NCT03245008|455123595|FG002|Overall Study|Failure to meet randomization criteria|0|||
126498008|NCT03245008|455123596|FG003|Overall Study|Failure to meet randomization criteria|1|||
126498009|NCT03245008|455123597|FG004|Overall Study|Failure to meet randomization criteria|0|||
126498010|NCT02075658|455123598|FG000|Overall Study|Physician Decision|2|||
126498011|NCT02075658|455123599|FG001|Overall Study|Physician Decision|2|||
126498012|NCT01286012|455123600|FG000|Overall Study|Adverse Event|3|||
126498013|NCT01286012|455123601|FG001|Overall Study|Adverse Event|3|||
126498014|NCT01286012|455123600|FG000|Overall Study|Death|2|||
126498015|NCT01286012|455123601|FG001|Overall Study|Death|3|||
126498016|NCT01286012|455123600|FG000|Overall Study|Protocol Violation|1|||
126498017|NCT01286012|455123601|FG001|Overall Study|Protocol Violation|1|||
126498018|NCT01286012|455123600|FG000|Overall Study|Withdrawal by Subject|4|||
126498019|NCT01286012|455123601|FG001|Overall Study|Withdrawal by Subject|4|||
126498020|NCT01286012|455123600|FG000|Overall Study|Physician Decision|2|||
126498021|NCT01286012|455123601|FG001|Overall Study|Physician Decision|0|||
126498022|NCT01286012|455123600|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
126498023|NCT01286012|455123601|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
126498024|NCT02865915|455123605|FG000|Overall Study|Pregnancy|1|||
126498025|NCT02865915|455123606|FG001|Overall Study|Pregnancy|0|||
126498026|NCT02865915|455123605|FG000|Overall Study|Withdrawal by Subject|1|||
126498027|NCT02865915|455123606|FG001|Overall Study|Withdrawal by Subject|1|||
126498028|NCT02865915|455123605|FG000|Overall Study|Adverse Event|0|||
126498029|NCT02865915|455123606|FG001|Overall Study|Adverse Event|4|||
126498030|NCT02865915|455123605|FG000|Overall Study|Lost to Follow-up|0|||
126498031|NCT02865915|455123606|FG001|Overall Study|Lost to Follow-up|1|||
126498032|NCT02865915|455123605|FG000|Overall Study|Protocol Violation|0|||
126498033|NCT02865915|455123606|FG001|Overall Study|Protocol Violation|1|||
126498034|NCT02865915|455123605|FG000|Overall Study|Study terminated by sponsor|23|||
126498035|NCT02865915|455123606|FG001|Overall Study|Study terminated by sponsor|18|||
126498036|NCT02865915|455123605|FG000|Overall Study|Dosing group discontinued|0|||
126498037|NCT02865915|455123606|FG001|Overall Study|Dosing group discontinued|5|||
126498038|NCT00663052|455123607|FG000|Overall Study|Adverse Event|6|||
126498039|NCT00663052|455123608|FG001|Overall Study|Adverse Event|3|||
126498040|NCT00663052|455123607|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
126498041|NCT00663052|455123608|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
126498042|NCT00663052|455123607|FG000|Overall Study|Protocol Violation|1|||
126498043|NCT00663052|455123608|FG001|Overall Study|Protocol Violation|0|||
126498044|NCT00663052|455123607|FG000|Overall Study|Withdrawal by Subject|2|||
126498045|NCT00663052|455123608|FG001|Overall Study|Withdrawal by Subject|5|||
126498046|NCT00663052|455123607|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
126498047|NCT00663052|455123608|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
126498048|NCT00663052|455123607|FG000|Overall Study|Other|0|||
126498049|NCT00663052|455123608|FG001|Overall Study|Other|1|||
126498050|NCT05760300|455123609|FG000|Overall Study|Adverse Event|0|||
126498051|NCT05760300|455123610|FG001|Overall Study|Adverse Event|0|||
126498052|NCT05760300|455123611|FG002|Overall Study|Adverse Event|1|||
126498053|NCT05760300|455123612|FG003|Overall Study|Adverse Event|0|||
126498054|NCT05760300|455123609|FG000|Overall Study|Participant Decision|1|||
126498055|NCT05760300|455123610|FG001|Overall Study|Participant Decision|0|||
126498056|NCT05760300|455123611|FG002|Overall Study|Participant Decision|0|||
126498057|NCT05760300|455123612|FG003|Overall Study|Participant Decision|0|||
126498058|NCT04350788|455123626|FG000|Overall Study|Lost to Follow-up|6|||
126498059|NCT04350788|455123627|FG001|Overall Study|Lost to Follow-up|2|||
126498060|NCT04350788|455123626|FG000|Overall Study|Withdrawal by Subject|2|||
126498061|NCT04350788|455123627|FG001|Overall Study|Withdrawal by Subject|4|||
126498062|NCT04350788|455123626|FG000|Overall Study|Protocol Violation|4|||
126498063|NCT04350788|455123627|FG001|Overall Study|Protocol Violation|0|||
126498064|NCT01894581|455123628|FG000|Overall Study|Withdrawal by Subject|2|||
126498065|NCT01894581|455123629|FG001|Overall Study|Withdrawal by Subject|3|||
126498066|NCT01894581|455123628|FG000|Overall Study|Screen Failure|3|||
126498067|NCT01894581|455123629|FG001|Overall Study|Screen Failure|4|||
126498068|NCT03313804|455123630|FG000|Treatment|Death|5|||
126498069|NCT03313804|455123630|FG000|Treatment|still on treatment|2|||
126498070|NCT03313804|455123630|FG000|Follow Up|still on follow up|3|||
126498071|NCT01252940|455123631|FG000|Main Study Phase|Randomized but not treated|4|||
126498072|NCT01252940|455123632|FG001|Main Study Phase|Randomized but not treated|2|||
126498073|NCT01252940|455123631|FG000|Main Study Phase|Adverse Event|3|||
126498074|NCT01252940|455123632|FG001|Main Study Phase|Adverse Event|1|||
126498075|NCT01252940|455123631|FG000|Main Study Phase|Lack of Efficacy|1|||
126498076|NCT01252940|455123632|FG001|Main Study Phase|Lack of Efficacy|0|||
126498077|NCT01252940|455123631|FG000|Main Study Phase|Lost to Follow-up|6|||
126498078|NCT01252940|455123632|FG001|Main Study Phase|Lost to Follow-up|1|||
126498079|NCT01252940|455123631|FG000|Main Study Phase|Physician Decision|1|||
126498080|NCT01252940|455123632|FG001|Main Study Phase|Physician Decision|0|||
126774009|NCT01830920|456129072|FG004|Overall Study|Death|4|||
126774010|NCT01830920|456129068|FG000|Overall Study|Other|15|||
126774011|NCT01830920|456129069|FG001|Overall Study|Other|1|||
126774012|NCT01830920|456129070|FG002|Overall Study|Other|1|||
126774013|NCT01830920|456129071|FG003|Overall Study|Other|5|||
126774014|NCT01830920|456129072|FG004|Overall Study|Other|3|||
126774015|NCT03876873|456129073|FG000|Overall Study|Physician Decision|0|||
126774016|NCT03876873|456129074|FG001|Overall Study|Physician Decision|1|||
126774017|NCT03547531|456129075|FG000|Overall Study|not coming in data collection : sick|2|||
126774018|NCT03547531|456129076|FG001|Overall Study|not coming in data collection : sick|2|||
126774019|NCT03547531|456129075|FG000|Overall Study|having family occasion|0|||
126774020|NCT03547531|456129076|FG001|Overall Study|having family occasion|2|||
126498081|NCT01252940|455123631|FG000|Main Study Phase|Protocol Violation|4|||
126498082|NCT01252940|455123632|FG001|Main Study Phase|Protocol Violation|2|||
126498083|NCT01252940|455123631|FG000|Main Study Phase|Withdrawal by Subject|6|||
126498084|NCT01252940|455123632|FG001|Main Study Phase|Withdrawal by Subject|5|||
126498085|NCT01252940|455123631|FG000|Main Study Phase|Subject Non-compliance|1|||
126498086|NCT01252940|455123632|FG001|Main Study Phase|Subject Non-compliance|1|||
126498087|NCT01252940|455123631|FG000|Extension Phase|Adverse Event|2|||
126498088|NCT01252940|455123632|FG001|Extension Phase|Adverse Event|1|||
126498089|NCT01252940|455123631|FG000|Extension Phase|Lack of Efficacy|1|||
126498090|NCT01252940|455123632|FG001|Extension Phase|Lack of Efficacy|0|||
126498091|NCT01252940|455123631|FG000|Extension Phase|Lost to Follow-up|5|||
126498092|NCT01252940|455123632|FG001|Extension Phase|Lost to Follow-up|0|||
126498093|NCT01252940|455123631|FG000|Extension Phase|Physician Decision|0|||
126498094|NCT01252940|455123632|FG001|Extension Phase|Physician Decision|1|||
126498095|NCT01252940|455123631|FG000|Extension Phase|Subject Non-compliance|1|||
126498096|NCT01252940|455123632|FG001|Extension Phase|Subject Non-compliance|0|||
126498097|NCT01252940|455123631|FG000|Extension Phase|Withdrawal by Subject|1|||
126498098|NCT01252940|455123632|FG001|Extension Phase|Withdrawal by Subject|1|||
126498099|NCT04690751|455123636|FG000|Overall Study|Protocol Violation|0|||
126498100|NCT04690751|455123637|FG001|Overall Study|Protocol Violation|1|||
126498101|NCT04690751|455123638|FG002|Overall Study|Protocol Violation|0|||
126498102|NCT04690751|455123639|FG003|Overall Study|Protocol Violation|1|||
126498103|NCT04690751|455123640|FG004|Overall Study|Protocol Violation|2|||
126498104|NCT04690751|455123641|FG005|Overall Study|Protocol Violation|0|||
126498105|NCT04690751|455123636|FG000|Overall Study|Adverse Event|0|||
126498106|NCT04690751|455123637|FG001|Overall Study|Adverse Event|0|||
126498107|NCT04690751|455123638|FG002|Overall Study|Adverse Event|1|||
126498108|NCT04690751|455123639|FG003|Overall Study|Adverse Event|0|||
126498109|NCT04690751|455123640|FG004|Overall Study|Adverse Event|0|||
126498110|NCT04690751|455123641|FG005|Overall Study|Adverse Event|0|||
126498111|NCT04690751|455123636|FG000|Overall Study|Positive urine drug screen test|0|||
126498112|NCT04690751|455123637|FG001|Overall Study|Positive urine drug screen test|0|||
126498113|NCT04690751|455123638|FG002|Overall Study|Positive urine drug screen test|0|||
126498114|NCT04690751|455123639|FG003|Overall Study|Positive urine drug screen test|0|||
126498115|NCT04690751|455123640|FG004|Overall Study|Positive urine drug screen test|1|||
126498116|NCT04690751|455123641|FG005|Overall Study|Positive urine drug screen test|0|||
126498117|NCT04364620|455123642|FG000|Overall Study|Disease Progression|20|||
126498118|NCT04364620|455123642|FG000|Overall Study|Adverse Event|5|||
126498119|NCT04364620|455123642|FG000|Overall Study|Physician Decision|4|||
126498120|NCT04364620|455123642|FG000|Overall Study|Death|3|||
126498121|NCT04364620|455123642|FG000|Overall Study|Other|2|||
126498122|NCT04364620|455123642|FG000|Overall Study|Withdrawal by Subject|1|||
126498123|NCT00156533|455124889|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
126498124|NCT00156533|455124890|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
126498125|NCT00156533|455124891|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
126498126|NCT00156533|455124892|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
126498127|NCT00156533|455124889|FG000|Overall Study|Withdrawal by Subject|1|||
126498128|NCT00156533|455124890|FG001|Overall Study|Withdrawal by Subject|0|||
126498129|NCT00156533|455124891|FG002|Overall Study|Withdrawal by Subject|0|||
126774021|NCT03402126|456129085|FG000|Overall Study|Lost to Follow-up|6|||
126498130|NCT00156533|455124892|FG003|Overall Study|Withdrawal by Subject|1|||
126498131|NCT00156533|455124889|FG000|Overall Study|Failed Screening|1|||
126498132|NCT00156533|455124890|FG001|Overall Study|Failed Screening|0|||
126498133|NCT00156533|455124891|FG002|Overall Study|Failed Screening|1|||
126498134|NCT00156533|455124892|FG003|Overall Study|Failed Screening|1|||
126774022|NCT03402126|456129085|FG000|Overall Study|Protocol Violation|10|||
126498135|NCT01254227|455124895|FG000|Overall Study|Withdrawal by Subject|6|||
126498136|NCT01254227|455124895|FG000|Overall Study|Lost to Follow-up|6|||
126498137|NCT01254227|455124895|FG000|Overall Study|Adverse Event|5|||
126498138|NCT01254227|455124895|FG000|Overall Study|Abnormal test procedure result|5|||
126498139|NCT01254227|455124895|FG000|Overall Study|Administrative problems|2|||
126498140|NCT01254227|455124895|FG000|Overall Study|Death|1|||
126498141|NCT01254227|455124895|FG000|Overall Study|Protocol deviation|1|||
126498142|NCT03265249|455124898|FG000|Overall Study|Withdrawal by Subject|0|||
126498143|NCT03265249|455124899|FG001|Overall Study|Withdrawal by Subject|1|||
126774023|NCT03402126|456129085|FG000|Overall Study|Sponsor request/Study termination|29|||
126560341|NCT01251614|455346600|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
126560342|NCT01251614|455346601|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
126560343|NCT01251614|455346602|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
126560344|NCT01251614|455346600|FG000|Overall Study|Pregnancy|0|||
126560345|NCT01251614|455346601|FG001|Overall Study|Pregnancy|0|||
126560346|NCT01251614|455346602|FG002|Overall Study|Pregnancy|2|||
126560347|NCT01251614|455346600|FG000|Overall Study|Loss of Disease Control|0|||
126560348|NCT01251614|455346601|FG001|Overall Study|Loss of Disease Control|1|||
126560349|NCT01251614|455346602|FG002|Overall Study|Loss of Disease Control|0|||
126560350|NCT01251614|455346600|FG000|Overall Study|Withdrawal by Subject|0|||
126560351|NCT01251614|455346601|FG001|Overall Study|Withdrawal by Subject|2|||
126560352|NCT01251614|455346602|FG002|Overall Study|Withdrawal by Subject|1|||
126560353|NCT01251614|455346600|FG000|Overall Study|Lost to Follow-up|0|||
126560354|NCT01251614|455346601|FG001|Overall Study|Lost to Follow-up|1|||
126560355|NCT01251614|455346602|FG002|Overall Study|Lost to Follow-up|0|||
126560356|NCT02153788|455346603|FG000|Overall Study|Physician Decision|2|||
126560357|NCT02153788|455346604|FG001|Overall Study|Physician Decision|1|||
126560358|NCT04672460|455346605|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
126560359|NCT04672460|455346606|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
126560360|NCT04672460|455346605|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
126560361|NCT04672460|455346606|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
126560362|NCT04672460|455346605|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
126560363|NCT04672460|455346606|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
126560364|NCT04672460|455346605|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
126560365|NCT04672460|455346606|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
126725407|NCT01606761|455944611|FG003|Prior to Week 24|Lost to Follow-up|0|||
126725408|NCT01606761|455944612|FG004|Prior to Week 24|Lost to Follow-up|0|||
126498144|NCT03873987|455124905|FG000|Overall Study|Adverse Event|1|||
126498145|NCT03873987|455124906|FG001|Overall Study|Adverse Event|0|||
126498146|NCT03873987|455124905|FG000|Overall Study|staff was unable to start a new IV line|1|||
126498147|NCT03873987|455124906|FG001|Overall Study|staff was unable to start a new IV line|0|||
126498148|NCT03873987|455124905|FG000|Overall Study|Lost to Follow-up|0|||
126498149|NCT03873987|455124906|FG001|Overall Study|Lost to Follow-up|1|||
126498150|NCT02535741|455124907|FG000|Overall Study|Adverse Event|3|||
126498151|NCT02535741|455124907|FG000|Overall Study|Withdrawal by Subject|9|||
126498152|NCT02535741|455124907|FG000|Overall Study|Lost to Follow-up|10|||
126498153|NCT02535741|455124907|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
126498154|NCT02535741|455124907|FG000|Overall Study|Missing data|6|||
126498155|NCT00798369|455124908|FG000|Overall Study|Subject withdrew consent|0|||
126498156|NCT00798369|455124909|FG001|Overall Study|Subject withdrew consent|0|||
126498157|NCT00798369|455124910|FG002|Overall Study|Subject withdrew consent|1|||
126498158|NCT00798369|455124911|FG003|Overall Study|Subject withdrew consent|1|||
126498159|NCT00798369|455124912|FG004|Overall Study|Subject withdrew consent|0|||
126498160|NCT00798369|455124913|FG005|Overall Study|Subject withdrew consent|2|||
126498161|NCT00798369|455124908|FG000|Overall Study|Lost to Follow-up|1|||
126498162|NCT00798369|455124909|FG001|Overall Study|Lost to Follow-up|1|||
126498163|NCT00798369|455124910|FG002|Overall Study|Lost to Follow-up|1|||
126498164|NCT00798369|455124911|FG003|Overall Study|Lost to Follow-up|0|||
126498165|NCT00798369|455124912|FG004|Overall Study|Lost to Follow-up|1|||
126498166|NCT00798369|455124913|FG005|Overall Study|Lost to Follow-up|0|||
126498167|NCT00798369|455124908|FG000|Overall Study|Adminstrative problems|0|||
126498168|NCT00798369|455124909|FG001|Overall Study|Adminstrative problems|0|||
126498169|NCT00798369|455124910|FG002|Overall Study|Adminstrative problems|0|||
126498170|NCT00798369|455124911|FG003|Overall Study|Adminstrative problems|0|||
126498171|NCT00798369|455124912|FG004|Overall Study|Adminstrative problems|0|||
126498172|NCT00798369|455124913|FG005|Overall Study|Adminstrative problems|1|||
126498173|NCT04475588|455124914|FG000|Overall Study|Adverse Event|2|||
126498174|NCT04475588|455124915|FG001|Overall Study|Adverse Event|0|||
126498175|NCT04014075|455124918|FG000|Overall Study|Progressive Disease|53|||
126498176|NCT04014075|455124918|FG000|Overall Study|Adverse Event|15|||
126498177|NCT04014075|455124918|FG000|Overall Study|Clinical Progression|4|||
126498178|NCT04014075|455124918|FG000|Overall Study|Death|2|||
126498179|NCT04014075|455124918|FG000|Overall Study|Withdrawal by Subject|2|||
126498180|NCT04014075|455124918|FG000|Overall Study|Miscellaneous|2|||
126498181|NCT04014075|455124918|FG000|Overall Study|Physician Decision|1|||
126498182|NCT02584504|455124919|FG000|Double-blind Treatment|Participant withdrew consent|0|||
126560366|NCT04672460|455346605|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
126560367|NCT04672460|455346606|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
126725409|NCT01606761|455944608|FG000|Prior to Week 24|Withdrawal by Subject|12|||
126498183|NCT02584504|455124920|FG001|Double-blind Treatment|Participant withdrew consent|0|||
126498184|NCT02584504|455124921|FG002|Double-blind Treatment|Participant withdrew consent|1|||
126498185|NCT02584504|455124919|FG000|Double-blind Treatment|Adverse Event|0|||
126498186|NCT02584504|455124920|FG001|Double-blind Treatment|Adverse Event|1|||
126498187|NCT02584504|455124921|FG002|Double-blind Treatment|Adverse Event|0|||
126498188|NCT02584504|455124919|FG000|Double-blind Treatment|Family Matter|0|||
126498189|NCT02584504|455124920|FG001|Double-blind Treatment|Family Matter|1|||
126498190|NCT02584504|455124921|FG002|Double-blind Treatment|Family Matter|0|||
126498191|NCT02584504|455124919|FG000|Open-label Treatment|Participant withdrew consent|0|||
126498192|NCT02584504|455124920|FG001|Open-label Treatment|Participant withdrew consent|0|||
126498193|NCT02584504|455124921|FG002|Open-label Treatment|Participant withdrew consent|4|||
126498194|NCT02584504|455124919|FG000|Open-label Treatment|Adverse Event|2|||
126498195|NCT02584504|455124920|FG001|Open-label Treatment|Adverse Event|2|||
126498196|NCT02584504|455124921|FG002|Open-label Treatment|Adverse Event|3|||
126498197|NCT02584504|455124919|FG000|Open-label Treatment|Physician Decision|0|||
126498198|NCT02584504|455124920|FG001|Open-label Treatment|Physician Decision|1|||
126498199|NCT02584504|455124921|FG002|Open-label Treatment|Physician Decision|0|||
126498200|NCT02584504|455124919|FG000|Open-label Treatment|Entered but not treated|0|||
126498201|NCT02584504|455124920|FG001|Open-label Treatment|Entered but not treated|1|||
126498202|NCT02584504|455124921|FG002|Open-label Treatment|Entered but not treated|1|||
126498203|NCT03102918|455124922|FG000|Overall Study|Protocol Violation|1|||
126498204|NCT03102918|455124923|FG001|Overall Study|Protocol Violation|0|||
126498205|NCT01316276|455124928|FG000|Overall Study|Death|1|||
126498206|NCT01316276|455124928|FG000|Overall Study|Adverse Event|19|||
126498207|NCT01316276|455124928|FG000|Overall Study|Withdrawal of consent|24|||
126498208|NCT01316276|455124928|FG000|Overall Study|Lost to Follow-up|1|||
126498209|NCT01316276|455124928|FG000|Overall Study|Other|22|||
126498210|NCT01652664|455124929|FG000|Overall Study|Treatment Failure|5|||
126498211|NCT01652664|455124930|FG001|Overall Study|Treatment Failure|1|||
126498212|NCT01652664|455124929|FG000|Overall Study|Inadequate IOP control|1|||
126498213|NCT01652664|455124930|FG001|Overall Study|Inadequate IOP control|0|||
126498214|NCT00507442|455124936|FG000|Overall Study|Adverse Event|8|||
126498215|NCT00507442|455124937|FG001|Overall Study|Adverse Event|11|||
126498216|NCT00507442|455124938|FG002|Overall Study|Adverse Event|4|||
126498217|NCT00507442|455124939|FG003|Overall Study|Adverse Event|1|||
126725410|NCT01606761|455944609|FG001|Prior to Week 24|Withdrawal by Subject|10|||
126498218|NCT00507442|455124936|FG000|Overall Study|Protocol Violation|0|||
126498219|NCT00507442|455124937|FG001|Overall Study|Protocol Violation|1|||
126498220|NCT00507442|455124938|FG002|Overall Study|Protocol Violation|0|||
126498221|NCT00507442|455124939|FG003|Overall Study|Protocol Violation|0|||
126498222|NCT00507442|455124936|FG000|Overall Study|Lost to Follow-up|0|||
126498223|NCT00507442|455124937|FG001|Overall Study|Lost to Follow-up|0|||
126498224|NCT00507442|455124938|FG002|Overall Study|Lost to Follow-up|1|||
126498225|NCT00507442|455124939|FG003|Overall Study|Lost to Follow-up|0|||
126498226|NCT00507442|455124936|FG000|Overall Study|Physician Decision|0|||
126498227|NCT00507442|455124937|FG001|Overall Study|Physician Decision|2|||
126498228|NCT00507442|455124938|FG002|Overall Study|Physician Decision|4|||
126498229|NCT00507442|455124939|FG003|Overall Study|Physician Decision|1|||
126498230|NCT00507442|455124936|FG000|Overall Study|Progressive Disease|2|||
126498231|NCT00507442|455124937|FG001|Overall Study|Progressive Disease|4|||
126498232|NCT00507442|455124938|FG002|Overall Study|Progressive Disease|2|||
126498233|NCT00507442|455124939|FG003|Overall Study|Progressive Disease|0|||
126498234|NCT00507442|455124936|FG000|Overall Study|Withdrawal by Subject|4|||
126498235|NCT00507442|455124937|FG001|Overall Study|Withdrawal by Subject|4|||
126498236|NCT00507442|455124938|FG002|Overall Study|Withdrawal by Subject|2|||
126498237|NCT00507442|455124939|FG003|Overall Study|Withdrawal by Subject|1|||
126498238|NCT00507442|455124936|FG000|Overall Study|Other|2|||
126498239|NCT00507442|455124937|FG001|Overall Study|Other|5|||
126498240|NCT00507442|455124938|FG002|Overall Study|Other|2|||
126498241|NCT00507442|455124939|FG003|Overall Study|Other|2|||
126498242|NCT02410954|455124944|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
126498243|NCT02410954|455124945|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
126498244|NCT02410954|455124944|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
126498245|NCT02410954|455124945|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
126498246|NCT00751348|455124946|FG000|Overall Study|Withdrawal by Subject|5|||
126725411|NCT01606761|455944610|FG002|Prior to Week 24|Withdrawal by Subject|9|||
126725412|NCT01606761|455944611|FG003|Prior to Week 24|Withdrawal by Subject|0|||
126725413|NCT01606761|455944612|FG004|Prior to Week 24|Withdrawal by Subject|0|||
126498247|NCT00751348|455124947|FG001|Overall Study|Withdrawal by Subject|2|||
126498248|NCT00751348|455124946|FG000|Overall Study|Migration from study area|1|||
126498249|NCT00751348|455124947|FG001|Overall Study|Migration from study area|0|||
126498250|NCT04829318|455124948|FG000|Overall Study|Adverse Event|6|||
126498251|NCT04829318|455124948|FG000|Overall Study|Death|1|||
126498252|NCT04829318|455124948|FG000|Overall Study|Lost to Follow-up|1|||
126498253|NCT04829318|455124948|FG000|Overall Study|Physician Decision|1|||
126498254|NCT04829318|455124948|FG000|Overall Study|Withdrawal by Subject|19|||
126498255|NCT04829318|455124948|FG000|Overall Study|Site terminated by sponsor|1|||
126498256|NCT04829318|455124948|FG000|Overall Study|Sponsor decision|5|||
126498257|NCT04829318|455124948|FG000|Overall Study|Other|1|||
126498258|NCT03803774|455124951|FG000|Dose Escalation|Withdrawal by Subject|0|||
126498259|NCT03803774|455124952|FG001|Dose Escalation|Withdrawal by Subject|0|||
126725414|NCT01606761|455944608|FG000|Prior to Week 24|Adverse Event|11|||
126560368|NCT04672460|455346605|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
126560369|NCT04672460|455346606|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
126560370|NCT04672460|455346605|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
126560371|NCT04672460|455346606|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
126560372|NCT04672460|455346605|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
126560373|NCT04672460|455346606|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
126560374|NCT04672460|455346605|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
126560375|NCT04672460|455346606|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
126498260|NCT03803774|455124953|FG002|Dose Escalation|Withdrawal by Subject|0|||
126498261|NCT03803774|455124954|FG003|Dose Escalation|Withdrawal by Subject|1|||
126498262|NCT03803774|455124955|FG004|Dose Escalation|Withdrawal by Subject|0|||
126498263|NCT01826487|455124956|FG000|Overall Study|Adverse Event|1|||
126560376|NCT04672460|455346605|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
126498264|NCT01826487|455124957|FG001|Overall Study|Adverse Event|1|||
126498265|NCT01826487|455124956|FG000|Overall Study|Lost to Follow-up|1|||
126498266|NCT01826487|455124957|FG001|Overall Study|Lost to Follow-up|0|||
126498267|NCT01826487|455124956|FG000|Overall Study|Withdrawal by Subject|1|||
126498268|NCT01826487|455124957|FG001|Overall Study|Withdrawal by Subject|3|||
126498269|NCT01826487|455124956|FG000|Overall Study|Protocol Violation|1|||
126498270|NCT01826487|455124957|FG001|Overall Study|Protocol Violation|1|||
126498271|NCT01408030|455124958|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
126498272|NCT01408030|455124959|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
126498273|NCT01408030|455124960|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
126498274|NCT01408030|455124961|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
126498275|NCT01408030|455124958|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
126498276|NCT01408030|455124959|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
126498277|NCT01408030|455124960|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
126498278|NCT01408030|455124961|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
126498279|NCT01408030|455124958|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
126498280|NCT01408030|455124959|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
126498281|NCT01408030|455124960|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
126498282|NCT01408030|455124961|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
126498283|NCT01408030|455124958|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
126498284|NCT01408030|455124959|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
126498285|NCT01408030|455124960|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
126498286|NCT01408030|455124961|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
126498287|NCT01408030|455124958|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
126498288|NCT01408030|455124959|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
126498289|NCT01408030|455124960|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
126498290|NCT01408030|455124961|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
126498291|NCT01408030|455124958|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
126498292|NCT01408030|455124959|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
126498293|NCT01408030|455124960|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
126498294|NCT01408030|455124961|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
126498295|NCT01408030|455124958|FG000|Observation Phase (Off Drug)|Other|1|||
126498296|NCT01408030|455124959|FG001|Observation Phase (Off Drug)|Other|1|||
126498297|NCT01408030|455124960|FG002|Observation Phase (Off Drug)|Other|1|||
126498298|NCT01408030|455124961|FG003|Observation Phase (Off Drug)|Other|1|||
126498299|NCT00003641|455124963|FG000|Overall Study|Withdrawal by Subject|0|||
126498300|NCT00003641|455124964|FG001|Overall Study|Withdrawal by Subject|100|||
126498301|NCT00003641|455124963|FG000|Overall Study|Adverse Event|0|||
126498302|NCT00003641|455124964|FG001|Overall Study|Adverse Event|38|||
126498303|NCT00003641|455124963|FG000|Overall Study|Disease progression|0|||
126498304|NCT00003641|455124964|FG001|Overall Study|Disease progression|2|||
126498305|NCT00003641|455124963|FG000|Overall Study|Unknown/missing|0|||
126498306|NCT00003641|455124964|FG001|Overall Study|Unknown/missing|22|||
126498307|NCT00003641|455124963|FG000|Overall Study|Should not receive interferon therapy|2|||
126498308|NCT00003641|455124964|FG001|Overall Study|Should not receive interferon therapy|0|||
126498309|NCT00003641|455124963|FG000|Overall Study|Never started interferon|567|||
126560377|NCT04672460|455346606|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
126725415|NCT01606761|455944609|FG001|Prior to Week 24|Adverse Event|18|||
126725416|NCT01606761|455944610|FG002|Prior to Week 24|Adverse Event|22|||
126725417|NCT01606761|455944611|FG003|Prior to Week 24|Adverse Event|0|||
126498310|NCT00003641|455124964|FG001|Overall Study|Never started interferon|12|||
126498311|NCT02081079|455124965|FG000|Overall Study|Lack of Efficacy|3|||
126498312|NCT02081079|455124966|FG001|Overall Study|Lack of Efficacy|2|||
126498313|NCT02081079|455124965|FG000|Overall Study|Lost to Follow-up|1|||
126498314|NCT02081079|455124966|FG001|Overall Study|Lost to Follow-up|0|||
126725418|NCT01606761|455944612|FG004|Prior to Week 24|Adverse Event|0|||
126498315|NCT03659916|455124967|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
126498316|NCT03659916|455124968|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
126498317|NCT03659916|455124969|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
126498318|NCT03659916|455124967|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
126498319|NCT03659916|455124968|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
126498320|NCT03659916|455124969|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
126498321|NCT03659916|455124967|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
126498322|NCT03659916|455124968|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
126498323|NCT03659916|455124969|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
126498324|NCT03659916|455124967|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
126498325|NCT03659916|455124968|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
126498326|NCT03659916|455124969|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
126498327|NCT03659916|455124967|FG000|Treatment Period (72 Weeks)|Other|1|||
126498328|NCT03659916|455124968|FG001|Treatment Period (72 Weeks)|Other|3|||
126498329|NCT03659916|455124969|FG002|Treatment Period (72 Weeks)|Other|9|||
126498330|NCT03659916|455124967|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
126498331|NCT03659916|455124968|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
126498332|NCT03659916|455124969|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
126498333|NCT03659916|455124967|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
126498334|NCT03659916|455124968|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
126498335|NCT03659916|455124969|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
126498336|NCT03659916|455124967|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
126498337|NCT03659916|455124968|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
126498338|NCT03659916|455124969|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
126498339|NCT03659916|455124967|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
126498340|NCT03659916|455124968|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
126498341|NCT03659916|455124969|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
126498342|NCT03659916|455124967|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
126498343|NCT03659916|455124968|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
126498344|NCT03659916|455124969|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
126498345|NCT03659916|455124967|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
126498346|NCT03659916|455124968|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
126498347|NCT03659916|455124969|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
126498348|NCT00878709|455124970|FG000|Overall Study|Withdrawal by Subject|197|||
126498349|NCT00878709|455124971|FG001|Overall Study|Withdrawal by Subject|120|||
126498350|NCT00878709|455124970|FG000|Overall Study|Lost to Follow-up|35|||
126498351|NCT00878709|455124971|FG001|Overall Study|Lost to Follow-up|33|||
126498352|NCT00878709|455124970|FG000|Overall Study|Other Reasons|93|||
126498353|NCT00878709|455124971|FG001|Overall Study|Other Reasons|84|||
126498354|NCT01712854|455124972|FG000|Overall Study|Physician Decision|1|||
126498355|NCT02225743|455124973|FG000|Overall Study|Withdrawal by Subject|18|||
126498356|NCT03886220|455124974|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
126498357|NCT03886220|455124975|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
126498358|NCT03886220|455124974|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
126498359|NCT03886220|455124975|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126498360|NCT03886220|455124974|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
126498361|NCT03886220|455124975|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
126498362|NCT00768300|455124976|FG000|Overall Study|Randomized but not treated|1|||
126498363|NCT00768300|455124977|FG001|Overall Study|Randomized but not treated|1|||
126498364|NCT00768300|455124976|FG000|Overall Study|Adverse Event|10|||
126498365|NCT00768300|455124977|FG001|Overall Study|Adverse Event|2|||
126498366|NCT00768300|455124976|FG000|Overall Study|Protocol Violation|6|||
126498367|NCT00768300|455124977|FG001|Overall Study|Protocol Violation|1|||
126498368|NCT00768300|455124976|FG000|Overall Study|Withdrawal by Subject|13|||
126498369|NCT00768300|455124977|FG001|Overall Study|Withdrawal by Subject|7|||
126498370|NCT00768300|455124976|FG000|Overall Study|Physician Decision|2|||
126498371|NCT00768300|455124977|FG001|Overall Study|Physician Decision|3|||
126498372|NCT00768300|455124976|FG000|Overall Study|Study discontinued by Sponsor|271|||
126498373|NCT00768300|455124977|FG001|Overall Study|Study discontinued by Sponsor|140|||
126498374|NCT00768300|455124976|FG000|Overall Study|Death|21|||
126498375|NCT00768300|455124977|FG001|Overall Study|Death|5|||
126498376|NCT00768300|455124976|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
126498377|NCT00768300|455124977|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
126725419|NCT01606761|455944608|FG000|Prior to Week 24|Lack of Efficacy|15|||
126725420|NCT01606761|455944609|FG001|Prior to Week 24|Lack of Efficacy|14|||
126498378|NCT00768300|455124976|FG000|Overall Study|Screen failure following randomization|1|||
126498379|NCT00768300|455124977|FG001|Overall Study|Screen failure following randomization|0|||
126498380|NCT00768300|455124976|FG000|Overall Study|Received lung transplant|1|||
126498381|NCT00768300|455124977|FG001|Overall Study|Received lung transplant|1|||
126498382|NCT00768300|455124976|FG000|Overall Study|Lost to Follow-up|0|||
126498383|NCT00768300|455124977|FG001|Overall Study|Lost to Follow-up|1|||
126498384|NCT00768300|455124976|FG000|Overall Study|Began prohibited concomitant medication|0|||
126498385|NCT00768300|455124977|FG001|Overall Study|Began prohibited concomitant medication|1|||
126498386|NCT00768300|455124976|FG000|Overall Study|Treated but never dosed with Study drug|1|||
126560378|NCT04672460|455346605|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
126560379|NCT04672460|455346606|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
126560380|NCT04672460|455346605|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
126560381|NCT04672460|455346606|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
126560382|NCT04672460|455346605|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
126560383|NCT04672460|455346606|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
126560384|NCT04672460|455346605|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
126560385|NCT04672460|455346606|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
126560386|NCT04672460|455346605|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
126560387|NCT04672460|455346606|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
126560388|NCT04672460|455346605|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
126560389|NCT04672460|455346606|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
126560390|NCT04672460|455346605|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
126725421|NCT01606761|455944610|FG002|Prior to Week 24|Lack of Efficacy|8|||
126725422|NCT01606761|455944611|FG003|Prior to Week 24|Lack of Efficacy|0|||
126725423|NCT01606761|455944612|FG004|Prior to Week 24|Lack of Efficacy|0|||
126725424|NCT01606761|455944608|FG000|Prior to Week 24|Physician Decision|0|||
126725425|NCT01606761|455944609|FG001|Prior to Week 24|Physician Decision|3|||
126725426|NCT01606761|455944610|FG002|Prior to Week 24|Physician Decision|1|||
126725427|NCT01606761|455944611|FG003|Prior to Week 24|Physician Decision|0|||
126725428|NCT01606761|455944612|FG004|Prior to Week 24|Physician Decision|0|||
126725429|NCT01606761|455944608|FG000|Prior to Week 24|Other|4|||
126725430|NCT01606761|455944609|FG001|Prior to Week 24|Other|7|||
126725431|NCT01606761|455944610|FG002|Prior to Week 24|Other|5|||
126725432|NCT01606761|455944611|FG003|Prior to Week 24|Other|0|||
126725433|NCT01606761|455944612|FG004|Prior to Week 24|Other|0|||
126725434|NCT01606761|455944608|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
126725435|NCT01606761|455944609|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
126725436|NCT01606761|455944610|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
126725437|NCT01606761|455944611|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
126725438|NCT01606761|455944612|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
126725439|NCT01606761|455944608|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
126725440|NCT01606761|455944609|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
126725441|NCT01606761|455944610|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
126725442|NCT01606761|455944611|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
126725443|NCT01606761|455944612|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
126725444|NCT01606761|455944608|FG000|Week 24 to Week 52|Adverse Event|0|||
126725445|NCT01606761|455944609|FG001|Week 24 to Week 52|Adverse Event|11|||
126725446|NCT01606761|455944610|FG002|Week 24 to Week 52|Adverse Event|14|||
126725447|NCT01606761|455944611|FG003|Week 24 to Week 52|Adverse Event|3|||
126725448|NCT01606761|455944612|FG004|Week 24 to Week 52|Adverse Event|15|||
126725449|NCT01606761|455944608|FG000|Week 24 to Week 52|Death|0|||
126725450|NCT01606761|455944609|FG001|Week 24 to Week 52|Death|0|||
126725451|NCT01606761|455944610|FG002|Week 24 to Week 52|Death|2|||
126725452|NCT01606761|455944611|FG003|Week 24 to Week 52|Death|1|||
126725453|NCT01606761|455944612|FG004|Week 24 to Week 52|Death|0|||
126725454|NCT01606761|455944608|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
126725455|NCT01606761|455944609|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
126725456|NCT01606761|455944610|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
126725457|NCT01606761|455944611|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
126725458|NCT01606761|455944612|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
126725459|NCT01606761|455944608|FG000|Week 24 to Week 52|Physician Decision|0|||
126725460|NCT01606761|455944609|FG001|Week 24 to Week 52|Physician Decision|1|||
126725461|NCT01606761|455944610|FG002|Week 24 to Week 52|Physician Decision|1|||
126725462|NCT01606761|455944611|FG003|Week 24 to Week 52|Physician Decision|0|||
126725463|NCT01606761|455944612|FG004|Week 24 to Week 52|Physician Decision|0|||
126725464|NCT01606761|455944608|FG000|Week 24 to Week 52|Other|0|||
126725465|NCT01606761|455944609|FG001|Week 24 to Week 52|Other|1|||
126725466|NCT01606761|455944610|FG002|Week 24 to Week 52|Other|5|||
126725467|NCT01606761|455944611|FG003|Week 24 to Week 52|Other|2|||
126725468|NCT01606761|455944612|FG004|Week 24 to Week 52|Other|2|||
126725469|NCT01606761|455944608|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
126725470|NCT01606761|455944609|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
126725471|NCT01606761|455944610|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
126725472|NCT01606761|455944611|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
126725473|NCT01606761|455944612|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
126725474|NCT01606761|455944608|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
126725475|NCT01606761|455944609|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
126725476|NCT01606761|455944610|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
126725477|NCT01606761|455944611|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
126725478|NCT01606761|455944612|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
126725479|NCT01606761|455944608|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
126725480|NCT01606761|455944609|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
126725481|NCT01606761|455944610|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
126498387|NCT00768300|455124977|FG001|Overall Study|Treated but never dosed with Study drug|0|||
126498388|NCT00768300|455124976|FG000|Overall Study|Missing data|1|||
126498389|NCT00768300|455124977|FG001|Overall Study|Missing data|0|||
126498390|NCT00322842|455124982|FG000|Overall Study|Withdrawal by Subject|0|||
126498391|NCT00322842|455124983|FG001|Overall Study|Withdrawal by Subject|1|||
126498392|NCT00322842|455124982|FG000|Overall Study|Lost to Follow-up|0|||
126498393|NCT00322842|455124983|FG001|Overall Study|Lost to Follow-up|1|||
126498394|NCT00322842|455124982|FG000|Overall Study|Refused transplant|1|||
126498395|NCT00322842|455124983|FG001|Overall Study|Refused transplant|0|||
126498396|NCT00322842|455124982|FG000|Overall Study|Death|1|||
126498397|NCT00322842|455124983|FG001|Overall Study|Death|0|||
126498398|NCT02068222|455124984|FG000|Overall Study|Lost to Follow-up|1|||
126498399|NCT00698581|455124988|FG000|Overall Study|Lack of Efficacy|23|||
126498400|NCT00698581|455124989|FG001|Overall Study|Lack of Efficacy|11|||
126498401|NCT00698581|455124988|FG000|Overall Study|Withdrawal by Subject|6|||
126498402|NCT00698581|455124989|FG001|Overall Study|Withdrawal by Subject|0|||
126498403|NCT00698581|455124988|FG000|Overall Study|Other reason|9|||
126498404|NCT00698581|455124989|FG001|Overall Study|Other reason|1|||
126498405|NCT00698581|455124988|FG000|Overall Study|SAE, non-fatal|1|||
126498406|NCT00698581|455124989|FG001|Overall Study|SAE, non-fatal|0|||
126498407|NCT00698581|455124988|FG000|Overall Study|AE, non-serious non-fatal|4|||
126498408|NCT00698581|455124989|FG001|Overall Study|AE, non-serious non-fatal|0|||
126498409|NCT00698581|455124988|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126498410|NCT00698581|455124989|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
126498411|NCT00698581|455124988|FG000|Overall Study|AE of unknown type|1|||
126498412|NCT00698581|455124989|FG001|Overall Study|AE of unknown type|0|||
126498413|NCT00302458|455124992|FG000|Overall Study|Lost to Follow-up|1|||
126498414|NCT00302458|455124992|FG000|Overall Study|Ineligible after screening|1|||
126498415|NCT00302458|455124992|FG000|Overall Study|Withdrawal by Subject|1|||
126498416|NCT02867709|455124993|FG000|Treatment Period|Adverse Event|1|||
126498417|NCT02867709|455124994|FG001|Treatment Period|Adverse Event|1|||
126498418|NCT02867709|455124995|FG002|Treatment Period|Adverse Event|2|||
126498419|NCT02867709|455124993|FG000|Treatment Period|Withdrawal of Consent|7|||
126498420|NCT02867709|455124994|FG001|Treatment Period|Withdrawal of Consent|9|||
126498421|NCT02867709|455124995|FG002|Treatment Period|Withdrawal of Consent|8|||
126498422|NCT02867709|455124993|FG000|Treatment Period|Lost to Follow-up|17|||
126498423|NCT02867709|455124994|FG001|Treatment Period|Lost to Follow-up|20|||
126498424|NCT02867709|455124995|FG002|Treatment Period|Lost to Follow-up|20|||
126498425|NCT02867709|455124993|FG000|Treatment Period|Lack of Qualifying Event|42|||
126498426|NCT02867709|455124994|FG001|Treatment Period|Lack of Qualifying Event|55|||
126498427|NCT02867709|455124995|FG002|Treatment Period|Lack of Qualifying Event|42|||
126498428|NCT02867709|455124993|FG000|Treatment Period|Protocol Violation|3|||
126498429|NCT02867709|455124994|FG001|Treatment Period|Protocol Violation|2|||
126498430|NCT02867709|455124995|FG002|Treatment Period|Protocol Violation|3|||
126498431|NCT02867709|455124993|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
126498432|NCT02867709|455124994|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
126498433|NCT02867709|455124995|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
126498434|NCT02867709|455124993|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
126498435|NCT02867709|455124994|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
126498436|NCT02867709|455124995|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
126560391|NCT04672460|455346606|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
126498437|NCT02867709|455124993|FG000|Safety Follow-up Period|Pregnancy|0|||
126498438|NCT02867709|455124994|FG001|Safety Follow-up Period|Pregnancy|1|||
126498439|NCT02867709|455124995|FG002|Safety Follow-up Period|Pregnancy|0|||
126498440|NCT02867709|455124993|FG000|Safety Follow-up Period|Protocol Violation|0|||
126498441|NCT02867709|455124994|FG001|Safety Follow-up Period|Protocol Violation|1|||
126560392|NCT00049517|455346609|FG000|Induction|Disease progression|0|||
126498442|NCT02867709|455124995|FG002|Safety Follow-up Period|Protocol Violation|1|||
126498443|NCT03615105|455125002|FG000|Overall Study|Protocol Violation|1|||
126498444|NCT03615105|455125003|FG001|Overall Study|Protocol Violation|0|||
126498445|NCT03615105|455125004|FG002|Overall Study|Protocol Violation|0|||
126498446|NCT03615105|455125002|FG000|Overall Study|Death|0|||
126725482|NCT01606761|455944611|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
126498447|NCT03615105|455125003|FG001|Overall Study|Death|2|||
126498448|NCT03615105|455125004|FG002|Overall Study|Death|0|||
126498449|NCT05214768|455125005|FG000|Induction Period|Withdrawal by Subject|1|||
126498450|NCT05214768|455125006|FG001|Induction Period|Withdrawal by Subject|0|||
126498451|NCT05214768|455125007|FG002|Induction Period|Withdrawal by Subject|0|||
126560393|NCT00049517|455346610|FG001|Induction|Disease progression|0|||
126498452|NCT05214768|455125008|FG003|Induction Period|Withdrawal by Subject|0|||
126498453|NCT05214768|455125009|FG004|Induction Period|Withdrawal by Subject|0|||
126498454|NCT05214768|455125010|FG005|Induction Period|Withdrawal by Subject|0|||
126498455|NCT05214768|455125005|FG000|Induction Period|Physician Decision|1|||
126498456|NCT05214768|455125006|FG001|Induction Period|Physician Decision|0|||
126498457|NCT05214768|455125007|FG002|Induction Period|Physician Decision|0|||
126498458|NCT05214768|455125008|FG003|Induction Period|Physician Decision|0|||
126560394|NCT00049517|455346611|FG002|Induction|Disease progression|0|||
126560395|NCT00049517|455346612|FG003|Induction|Disease progression|0|||
126560396|NCT00049517|455346613|FG004|Induction|Disease progression|18|||
126560397|NCT00049517|455346614|FG005|Induction|Disease progression|11|||
126560398|NCT00049517|455346609|FG000|Induction|Adverse Event|0|||
126560399|NCT00049517|455346610|FG001|Induction|Adverse Event|0|||
126560400|NCT00049517|455346611|FG002|Induction|Adverse Event|0|||
126560401|NCT00049517|455346612|FG003|Induction|Adverse Event|0|||
126560402|NCT00049517|455346613|FG004|Induction|Adverse Event|5|||
126560403|NCT00049517|455346614|FG005|Induction|Adverse Event|7|||
126560404|NCT00049517|455346609|FG000|Induction|Death|0|||
126560405|NCT00049517|455346610|FG001|Induction|Death|0|||
126560406|NCT00049517|455346611|FG002|Induction|Death|0|||
126560407|NCT00049517|455346612|FG003|Induction|Death|0|||
126498459|NCT05214768|455125009|FG004|Induction Period|Physician Decision|0|||
126498460|NCT05214768|455125010|FG005|Induction Period|Physician Decision|0|||
126498461|NCT05214768|455125005|FG000|Maintenance Period|Other Reasons|0|||
126498462|NCT05214768|455125006|FG001|Maintenance Period|Other Reasons|0|||
126498463|NCT05214768|455125007|FG002|Maintenance Period|Other Reasons|1|||
126498464|NCT05214768|455125008|FG003|Maintenance Period|Other Reasons|1|||
126498465|NCT05214768|455125009|FG004|Maintenance Period|Other Reasons|0|||
126498466|NCT05214768|455125010|FG005|Maintenance Period|Other Reasons|0|||
126498467|NCT05214768|455125005|FG000|Maintenance Period|Withdrawal by Subject|0|||
126498468|NCT05214768|455125006|FG001|Maintenance Period|Withdrawal by Subject|0|||
126498469|NCT05214768|455125007|FG002|Maintenance Period|Withdrawal by Subject|0|||
126498470|NCT05214768|455125008|FG003|Maintenance Period|Withdrawal by Subject|1|||
126498471|NCT05214768|455125009|FG004|Maintenance Period|Withdrawal by Subject|0|||
126498472|NCT05214768|455125010|FG005|Maintenance Period|Withdrawal by Subject|0|||
126498473|NCT05214768|455125005|FG000|Maintenance Period|Lack of Efficacy|0|||
126498474|NCT05214768|455125006|FG001|Maintenance Period|Lack of Efficacy|0|||
126498475|NCT05214768|455125007|FG002|Maintenance Period|Lack of Efficacy|1|||
126560408|NCT00049517|455346613|FG004|Induction|Death|9|||
126560409|NCT00049517|455346614|FG005|Induction|Death|6|||
126560410|NCT00049517|455346609|FG000|Induction|Withdrawal by Subject|0|||
126725483|NCT01606761|455944612|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
126725484|NCT01606761|455944608|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
126725485|NCT01606761|455944609|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
126725486|NCT01606761|455944610|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
126725487|NCT01606761|455944611|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
126725488|NCT01606761|455944612|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
126725489|NCT05086289|455944613|FG000|Overall Study|Adverse Event|4|||
126725490|NCT05086289|455944614|FG001|Overall Study|Adverse Event|2|||
126725491|NCT05086289|455944613|FG000|Overall Study|Lost to Follow-up|2|||
126725492|NCT05086289|455944614|FG001|Overall Study|Lost to Follow-up|0|||
126725493|NCT05086289|455944613|FG000|Overall Study|Non-compliance with study drug|2|||
126725494|NCT05086289|455944614|FG001|Overall Study|Non-compliance with study drug|1|||
126725495|NCT05086289|455944613|FG000|Overall Study|Physician Decision|2|||
126725496|NCT05086289|455944614|FG001|Overall Study|Physician Decision|0|||
126725497|NCT05086289|455944613|FG000|Overall Study|Withdrawal by Subject|5|||
126725498|NCT05086289|455944614|FG001|Overall Study|Withdrawal by Subject|2|||
126725499|NCT02237157|455944615|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
126725500|NCT02237157|455944616|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
126725501|NCT02237157|455944617|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
126725502|NCT02237157|455944618|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
126725503|NCT02237157|455944615|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
126725504|NCT02237157|455944616|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
126725505|NCT02237157|455944617|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
126725506|NCT02237157|455944618|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
126725507|NCT01996748|455944619|FG000|Overall Study|Personal reason|1|||
126725508|NCT01996748|455944620|FG001|Overall Study|Personal reason|0|||
126725509|NCT01996748|455944619|FG000|Overall Study|Physician Decision|2|||
126725510|NCT01996748|455944620|FG001|Overall Study|Physician Decision|0|||
126725511|NCT01996748|455944619|FG000|Overall Study|Adverse Event|1|||
126725512|NCT01996748|455944620|FG001|Overall Study|Adverse Event|4|||
126725513|NCT01996748|455944619|FG000|Overall Study|Withdrawal by Subject|0|||
126725514|NCT01996748|455944620|FG001|Overall Study|Withdrawal by Subject|1|||
126498476|NCT05214768|455125008|FG003|Maintenance Period|Lack of Efficacy|0|||
126498477|NCT05214768|455125009|FG004|Maintenance Period|Lack of Efficacy|1|||
126560411|NCT00049517|455346610|FG001|Induction|Withdrawal by Subject|0|||
126560412|NCT00049517|455346611|FG002|Induction|Withdrawal by Subject|0|||
126498478|NCT05214768|455125010|FG005|Maintenance Period|Lack of Efficacy|0|||
126498479|NCT05214768|455125005|FG000|Open Label Extension Period|Physician Decision|0|||
126498480|NCT05214768|455125006|FG001|Open Label Extension Period|Physician Decision|0|||
126560413|NCT00049517|455346612|FG003|Induction|Withdrawal by Subject|0|||
126560414|NCT00049517|455346613|FG004|Induction|Withdrawal by Subject|1|||
126560415|NCT00049517|455346614|FG005|Induction|Withdrawal by Subject|3|||
126560416|NCT00049517|455346609|FG000|Induction|Alternative therapy|0|||
126560417|NCT00049517|455346610|FG001|Induction|Alternative therapy|0|||
126774024|NCT03402126|456129085|FG000|Overall Study|Study product no longer in use|1|||
126774025|NCT03402126|456129085|FG000|Overall Study|Technical problems|1|||
126774026|NCT03402126|456129085|FG000|Overall Study|Withdrawal by Subject|6|||
126774027|NCT03402126|456129085|FG000|Overall Study|Physician Decision|2|||
126774028|NCT03402126|456129085|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
126774029|NCT03402126|456129085|FG000|Overall Study|Death|4|||
126774030|NCT02117479|456129086|FG000|Overall Study|Death|13|||
126774031|NCT02117479|456129087|FG001|Overall Study|Death|8|||
126774032|NCT02117479|456129086|FG000|Overall Study|Adverse Event|8|||
126774033|NCT02117479|456129087|FG001|Overall Study|Adverse Event|16|||
126774034|NCT02117479|456129086|FG000|Overall Study|Subject decision|8|||
126774035|NCT02117479|456129087|FG001|Overall Study|Subject decision|9|||
126774036|NCT02117479|456129086|FG000|Overall Study|Disease progression|104|||
126774037|NCT02117479|456129087|FG001|Overall Study|Disease progression|108|||
126774038|NCT02117479|456129086|FG000|Overall Study|Noncompliance with study treatment|1|||
126774039|NCT02117479|456129087|FG001|Overall Study|Noncompliance with study treatment|0|||
126774040|NCT02117479|456129086|FG000|Overall Study|Study terminated by the sponsor|4|||
126774041|NCT02117479|456129087|FG001|Overall Study|Study terminated by the sponsor|6|||
126774042|NCT02117479|456129086|FG000|Overall Study|Physician Decision|7|||
126774043|NCT02117479|456129087|FG001|Overall Study|Physician Decision|2|||
126774044|NCT02117479|456129086|FG000|Overall Study|Other unspecified|11|||
126774045|NCT02117479|456129087|FG001|Overall Study|Other unspecified|7|||
126774046|NCT01959230|456129088|FG000|Overall Study|Failure to follow study procedures|0|||
126774047|NCT01959230|456129089|FG001|Overall Study|Failure to follow study procedures|1|||
126774048|NCT01959230|456129088|FG000|Overall Study|Administrative reasons|2|||
126774049|NCT01959230|456129089|FG001|Overall Study|Administrative reasons|0|||
126774050|NCT01959230|456129088|FG000|Overall Study|Withdrawal by Subject|2|||
126774051|NCT01959230|456129089|FG001|Overall Study|Withdrawal by Subject|0|||
126774052|NCT00720304|456129090|FG000|Overall Study|Withdrawal by Subject|14|||
126774053|NCT00720304|456129091|FG001|Overall Study|Withdrawal by Subject|1|||
126774054|NCT00720304|456129090|FG000|Overall Study|Death|1|||
126774055|NCT00720304|456129091|FG001|Overall Study|Death|0|||
126774056|NCT00720304|456129090|FG000|Overall Study|Physician Decision|5|||
126774057|NCT00720304|456129091|FG001|Overall Study|Physician Decision|2|||
126774058|NCT00720304|456129090|FG000|Overall Study|Adverse Event|3|||
126774059|NCT00720304|456129091|FG001|Overall Study|Adverse Event|1|||
126774060|NCT00720304|456129090|FG000|Overall Study|Disease progression|6|||
126774061|NCT00720304|456129091|FG001|Overall Study|Disease progression|1|||
126774062|NCT01333475|456129092|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
126774063|NCT01333475|456129093|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
126774064|NCT01333475|456129092|FG000|Overall Study|Toxicity|1|||
126774065|NCT01333475|456129093|FG001|Overall Study|Toxicity|3|||
126774066|NCT02981602|456129094|FG000|Overall Study|Adverse Event|0|||
126774067|NCT02981602|456129095|FG001|Overall Study|Adverse Event|0|||
126774068|NCT02981602|456129096|FG002|Overall Study|Adverse Event|0|||
126774069|NCT02981602|456129097|FG003|Overall Study|Adverse Event|1|||
126774070|NCT02981602|456129098|FG004|Overall Study|Adverse Event|0|||
126774071|NCT01169987|456129099|FG000|Overall Study|Withdrawal by Subject|3|||
126774072|NCT01169987|456129099|FG000|Overall Study|Lost to Follow-up|24|||
126774073|NCT01169987|456129099|FG000|Overall Study|Other|4|||
126774074|NCT00386100|456129100|FG000|Overall Study|Did not receive study medication|6|||
126774075|NCT00386100|456129101|FG001|Overall Study|Did not receive study medication|4|||
126774076|NCT00386100|456129100|FG000|Overall Study|Adverse Event|15|||
126774077|NCT00386100|456129101|FG001|Overall Study|Adverse Event|25|||
126774078|NCT00386100|456129100|FG000|Overall Study|Death|0|||
126774079|NCT00386100|456129101|FG001|Overall Study|Death|1|||
126774080|NCT00386100|456129100|FG000|Overall Study|Insufficient therapeutic effect|30|||
126774081|NCT00386100|456129101|FG001|Overall Study|Insufficient therapeutic effect|6|||
126774082|NCT00386100|456129100|FG000|Overall Study|Lost to Follow-up|29|||
126774083|NCT00386100|456129101|FG001|Overall Study|Lost to Follow-up|29|||
126774084|NCT00386100|456129100|FG000|Overall Study|Non-compliance|18|||
126774085|NCT00386100|456129101|FG001|Overall Study|Non-compliance|19|||
126774086|NCT00386100|456129100|FG000|Overall Study|Protocol Violation|5|||
126774087|NCT00386100|456129101|FG001|Overall Study|Protocol Violation|3|||
126774088|NCT00386100|456129100|FG000|Overall Study|Withdrawal by Subject|32|||
126774089|NCT00386100|456129101|FG001|Overall Study|Withdrawal by Subject|31|||
126774090|NCT00386100|456129100|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
126774091|NCT00386100|456129101|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
126774092|NCT00386100|456129100|FG000|Overall Study|BMD <2.5|1|||
126774093|NCT00386100|456129101|FG001|Overall Study|BMD <2.5|0|||
126498481|NCT05214768|455125007|FG002|Open Label Extension Period|Physician Decision|0|||
126498482|NCT05214768|455125008|FG003|Open Label Extension Period|Physician Decision|0|||
126774094|NCT00386100|456129100|FG000|Overall Study|Consecutive elevated Hba1C|1|||
126774095|NCT00386100|456129101|FG001|Overall Study|Consecutive elevated Hba1C|0|||
126774096|NCT00386100|456129100|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
126774097|NCT00386100|456129101|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
126774098|NCT00386100|456129100|FG000|Overall Study|Laboratory findings|1|||
126498483|NCT05214768|455125009|FG004|Open Label Extension Period|Physician Decision|0|||
126498484|NCT05214768|455125010|FG005|Open Label Extension Period|Physician Decision|1|||
126498485|NCT05214768|455125005|FG000|Open Label Extension Period|Lack of Efficacy|0|||
126498486|NCT05214768|455125006|FG001|Open Label Extension Period|Lack of Efficacy|0|||
126498487|NCT05214768|455125007|FG002|Open Label Extension Period|Lack of Efficacy|0|||
126498488|NCT05214768|455125008|FG003|Open Label Extension Period|Lack of Efficacy|0|||
126498489|NCT05214768|455125009|FG004|Open Label Extension Period|Lack of Efficacy|0|||
126498490|NCT05214768|455125010|FG005|Open Label Extension Period|Lack of Efficacy|1|||
126498491|NCT05214768|455125005|FG000|Open Label Extension Period|Ongoing Study|0|||
126498492|NCT05214768|455125006|FG001|Open Label Extension Period|Ongoing Study|0|||
126498493|NCT05214768|455125007|FG002|Open Label Extension Period|Ongoing Study|0|||
126498494|NCT05214768|455125008|FG003|Open Label Extension Period|Ongoing Study|0|||
126498495|NCT05214768|455125009|FG004|Open Label Extension Period|Ongoing Study|0|||
126498496|NCT05214768|455125010|FG005|Open Label Extension Period|Ongoing Study|42|||
126498497|NCT05041322|455125011|FG000|Baseline|Withdrawal by Subject|1|||
126498498|NCT05041322|455125012|FG001|Baseline|Withdrawal by Subject|0|||
126498499|NCT05041322|455125011|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
126498500|NCT05041322|455125012|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
126498501|NCT05041322|455125011|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
126498502|NCT05041322|455125012|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
126498503|NCT03795298|455125013|FG000|Overall Study|Death|34|||
126498504|NCT03795298|455125014|FG001|Overall Study|Death|29|||
126498505|NCT03795298|455125013|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
126498506|NCT03795298|455125014|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
126498507|NCT03795298|455125013|FG000|Overall Study|Lost to Follow-up|28|||
126498508|NCT03795298|455125014|FG001|Overall Study|Lost to Follow-up|17|||
126498509|NCT03795298|455125013|FG000|Overall Study|Physician Decision|5|||
126498510|NCT03795298|455125014|FG001|Overall Study|Physician Decision|4|||
126498511|NCT03795298|455125013|FG000|Overall Study|Withdrawal by Subject|43|||
126498512|NCT03795298|455125014|FG001|Overall Study|Withdrawal by Subject|28|||
126498513|NCT03795298|455125013|FG000|Overall Study|Reason not reported|7|||
126498514|NCT03795298|455125014|FG001|Overall Study|Reason not reported|9|||
126498515|NCT04383743|455125015|FG000|Overall Study|Withdrawal by Subject|1|||
126498516|NCT04383743|455125015|FG000|Overall Study|Adverse Event|1|||
126498517|NCT04837131|455125016|FG000|Overall Study|Death|1|||
126498518|NCT04837131|455125016|FG000|Overall Study|Withdrawal by Subject|1|||
126498519|NCT04837131|455125016|FG000|Overall Study|Adverse Event|1|||
126498520|NCT04837131|455125016|FG000|Overall Study|Protocol Violation|1|||
126498521|NCT04303780|455125017|FG000|Overall Study|Death|104|||
126498522|NCT04303780|455125018|FG001|Overall Study|Death|85|||
126498523|NCT04303780|455125017|FG000|Overall Study|Lost to Follow-up|5|||
126498524|NCT04303780|455125018|FG001|Overall Study|Lost to Follow-up|2|||
126498525|NCT04303780|455125017|FG000|Overall Study|Withdrawal by Subject|12|||
126498526|NCT04303780|455125018|FG001|Overall Study|Withdrawal by Subject|39|||
126498527|NCT04303780|455125017|FG000|Overall Study|Ongoing in study|50|||
126498528|NCT04303780|455125018|FG001|Overall Study|Ongoing in study|45|||
126498529|NCT03482791|455125019|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
126498530|NCT03482791|455125020|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
126498531|NCT01239368|455128064|FG000|Overall Study|Principal investigator discretion|1|||
126498532|NCT01239368|455128065|FG001|Overall Study|Principal investigator discretion|0|||
126498533|NCT01239368|455128066|FG002|Overall Study|Principal investigator discretion|0|||
126498534|NCT01239368|455128067|FG003|Overall Study|Principal investigator discretion|0|||
126498535|NCT01239368|455128068|FG004|Overall Study|Principal investigator discretion|1|||
126498536|NCT01239368|455128069|FG005|Overall Study|Principal investigator discretion|2|||
126498537|NCT01239368|455128070|FG006|Overall Study|Principal investigator discretion|0|||
126498538|NCT01239368|455128071|FG007|Overall Study|Principal investigator discretion|0|||
126498539|NCT01239368|455128072|FG008|Overall Study|Principal investigator discretion|0|||
126498540|NCT01239368|455128073|FG009|Overall Study|Principal investigator discretion|1|||
126498541|NCT01239368|455128064|FG000|Overall Study|Disease progression on study|1|||
126498542|NCT01239368|455128065|FG001|Overall Study|Disease progression on study|1|||
126498543|NCT01239368|455128066|FG002|Overall Study|Disease progression on study|1|||
126498544|NCT01239368|455128067|FG003|Overall Study|Disease progression on study|1|||
126498545|NCT01239368|455128068|FG004|Overall Study|Disease progression on study|4|||
126498546|NCT01239368|455128069|FG005|Overall Study|Disease progression on study|2|||
126560418|NCT00049517|455346611|FG002|Induction|Alternative therapy|0|||
126774099|NCT00386100|456129101|FG001|Overall Study|Laboratory findings|0|||
126498547|NCT01239368|455128070|FG006|Overall Study|Disease progression on study|5|||
126498548|NCT01239368|455128071|FG007|Overall Study|Disease progression on study|0|||
126498549|NCT01239368|455128072|FG008|Overall Study|Disease progression on study|0|||
126498550|NCT01239368|455128073|FG009|Overall Study|Disease progression on study|2|||
126498551|NCT01239368|455128064|FG000|Overall Study|Refused further treatment|0|||
126498552|NCT01239368|455128065|FG001|Overall Study|Refused further treatment|0|||
126498553|NCT01239368|455128066|FG002|Overall Study|Refused further treatment|0|||
126498554|NCT01239368|455128067|FG003|Overall Study|Refused further treatment|0|||
126774100|NCT00386100|456129100|FG000|Overall Study|Participant's concern due to CPK levels|1|||
126774101|NCT00386100|456129101|FG001|Overall Study|Participant's concern due to CPK levels|0|||
126774102|NCT00386100|456129100|FG000|Overall Study|Participant moving out of state|2|||
126774103|NCT00386100|456129101|FG001|Overall Study|Participant moving out of state|0|||
126774104|NCT00386100|456129100|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
126774105|NCT00386100|456129101|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
126774106|NCT00386100|456129100|FG000|Overall Study|Didn't meet entry criteria|1|||
126774107|NCT00386100|456129101|FG001|Overall Study|Didn't meet entry criteria|1|||
126774108|NCT00386100|456129100|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
126774109|NCT00386100|456129101|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
126774110|NCT00386100|456129100|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
126774111|NCT00386100|456129101|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
126774112|NCT00386100|456129100|FG000|Overall Study|Bad metabolic control & patient security|1|||
126774113|NCT00386100|456129101|FG001|Overall Study|Bad metabolic control & patient security|0|||
126774114|NCT00386100|456129100|FG000|Overall Study|Bone loss by DXA bone scan|1|||
126774115|NCT00386100|456129101|FG001|Overall Study|Bone loss by DXA bone scan|0|||
126774116|NCT00386100|456129100|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
126498555|NCT01239368|455128068|FG004|Overall Study|Refused further treatment|0|||
126498556|NCT01239368|455128069|FG005|Overall Study|Refused further treatment|0|||
126498557|NCT01239368|455128070|FG006|Overall Study|Refused further treatment|0|||
126498558|NCT01239368|455128071|FG007|Overall Study|Refused further treatment|0|||
126498559|NCT01239368|455128072|FG008|Overall Study|Refused further treatment|0|||
126498560|NCT01239368|455128073|FG009|Overall Study|Refused further treatment|1|||
126498561|NCT01239368|455128064|FG000|Overall Study|Death|0|||
126498562|NCT01239368|455128065|FG001|Overall Study|Death|0|||
126498563|NCT01239368|455128066|FG002|Overall Study|Death|0|||
126498564|NCT01239368|455128067|FG003|Overall Study|Death|0|||
126498565|NCT01239368|455128068|FG004|Overall Study|Death|0|||
126498566|NCT01239368|455128069|FG005|Overall Study|Death|0|||
126498567|NCT01239368|455128070|FG006|Overall Study|Death|1|||
126498568|NCT01239368|455128071|FG007|Overall Study|Death|0|||
126498569|NCT01239368|455128072|FG008|Overall Study|Death|0|||
126498570|NCT01239368|455128073|FG009|Overall Study|Death|0|||
126498571|NCT04579380|455128074|FG000|Overall Study|Death|9|||
126498572|NCT04579380|455128075|FG001|Overall Study|Death|22|||
126498573|NCT04579380|455128076|FG002|Overall Study|Death|22|||
126498574|NCT04579380|455128077|FG003|Overall Study|Death|17|||
126498575|NCT04579380|455128078|FG004|Overall Study|Death|6|||
126498576|NCT04579380|455128079|FG005|Overall Study|Death|21|||
126498577|NCT04579380|455128080|FG006|Overall Study|Death|10|||
126498578|NCT04579380|455128081|FG007|Overall Study|Death|11|||
126498579|NCT04579380|455128082|FG008|Overall Study|Death|25|||
126498580|NCT04579380|455128074|FG000|Overall Study|Withdrawal by Subject|0|||
126498581|NCT04579380|455128075|FG001|Overall Study|Withdrawal by Subject|3|||
126498582|NCT04579380|455128076|FG002|Overall Study|Withdrawal by Subject|4|||
126498583|NCT04579380|455128077|FG003|Overall Study|Withdrawal by Subject|0|||
126498584|NCT04579380|455128078|FG004|Overall Study|Withdrawal by Subject|1|||
126498585|NCT04579380|455128079|FG005|Overall Study|Withdrawal by Subject|2|||
126498586|NCT04579380|455128080|FG006|Overall Study|Withdrawal by Subject|0|||
126498587|NCT04579380|455128081|FG007|Overall Study|Withdrawal by Subject|1|||
126498588|NCT04579380|455128082|FG008|Overall Study|Withdrawal by Subject|2|||
126498589|NCT04579380|455128074|FG000|Overall Study|Ongoing|2|||
126498590|NCT04579380|455128075|FG001|Overall Study|Ongoing|6|||
126498591|NCT04579380|455128076|FG002|Overall Study|Ongoing|4|||
126498592|NCT04579380|455128077|FG003|Overall Study|Ongoing|8|||
126498593|NCT04579380|455128078|FG004|Overall Study|Ongoing|5|||
126498594|NCT04579380|455128079|FG005|Overall Study|Ongoing|8|||
126498595|NCT04579380|455128080|FG006|Overall Study|Ongoing|3|||
126498596|NCT04579380|455128081|FG007|Overall Study|Ongoing|19|||
126498597|NCT04579380|455128082|FG008|Overall Study|Ongoing|6|||
126498598|NCT02967692|455128083|FG000|Overall Study|Progressive disease|3|||
126498599|NCT02967692|455128084|FG001|Overall Study|Progressive disease|15|||
126498600|NCT02967692|455128085|FG002|Overall Study|Progressive disease|114|||
126774117|NCT00386100|456129101|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
126498601|NCT02967692|455128086|FG003|Overall Study|Progressive disease|151|||
126498602|NCT02967692|455128083|FG000|Overall Study|Subject/guardian decision|1|||
126498603|NCT02967692|455128084|FG001|Overall Study|Subject/guardian decision|1|||
126498604|NCT02967692|455128085|FG002|Overall Study|Subject/guardian decision|14|||
126498605|NCT02967692|455128086|FG003|Overall Study|Subject/guardian decision|22|||
126498606|NCT02967692|455128083|FG000|Overall Study|Death|0|||
126498607|NCT02967692|455128084|FG001|Overall Study|Death|1|||
126774118|NCT00386100|456129100|FG000|Overall Study|7.6% bone loss|1|||
126498608|NCT02967692|455128085|FG002|Overall Study|Death|13|||
126498609|NCT02967692|455128086|FG003|Overall Study|Death|13|||
126498610|NCT02967692|455128083|FG000|Overall Study|Protocol deviation|1|||
126498611|NCT02967692|455128084|FG001|Overall Study|Protocol deviation|0|||
126498612|NCT02967692|455128085|FG002|Overall Study|Protocol deviation|1|||
126498613|NCT02967692|455128086|FG003|Overall Study|Protocol deviation|1|||
126498614|NCT02967692|455128083|FG000|Overall Study|Lost to Follow-up|0|||
126725515|NCT01996748|455944619|FG000|Overall Study|Lost to Follow-up|4|||
126725516|NCT01996748|455944620|FG001|Overall Study|Lost to Follow-up|1|||
126725517|NCT04533815|455944622|FG000|Overall Study|Adverse Event|2|||
126725518|NCT04533815|455944622|FG000|Overall Study|Site withdrew|5|||
126725519|NCT03599141|455944627|FG000|Overall Study|Lost to Follow-up|3|||
126725520|NCT03599141|455944628|FG001|Overall Study|Lost to Follow-up|1|||
126725521|NCT00807846|455944629|FG000|Overall Study|Adverse Event|5|||
126725522|NCT00807846|455944630|FG001|Overall Study|Adverse Event|0|||
126725523|NCT00807846|455944629|FG000|Overall Study|Lack of Efficacy|2|||
126725524|NCT00807846|455944630|FG001|Overall Study|Lack of Efficacy|0|||
126725525|NCT00807846|455944629|FG000|Overall Study|Protocol Violation|2|||
126725526|NCT00807846|455944630|FG001|Overall Study|Protocol Violation|1|||
126725527|NCT00807846|455944629|FG000|Overall Study|Withdrawal by Subject|2|||
126725528|NCT00807846|455944630|FG001|Overall Study|Withdrawal by Subject|1|||
126725529|NCT00807846|455944629|FG000|Overall Study|Other|1|||
126725530|NCT00807846|455944630|FG001|Overall Study|Other|2|||
126725531|NCT01081873|455944631|FG000|Overall Study|Death|86|||
126725532|NCT01081873|455944631|FG000|Overall Study|Withdrawal by Subject|10|||
126725533|NCT01081873|455944631|FG000|Overall Study|Lost to Follow-up|142|||
126725534|NCT01081873|455944631|FG000|Overall Study|Progression of prostate cancer|13|||
126725535|NCT01081873|455944631|FG000|Overall Study|Other|47|||
126725536|NCT03011840|455944632|FG000|Overall Study|Not received PIL in post PIL phase|0|||
126725537|NCT03011840|455944633|FG001|Overall Study|Not received PIL in post PIL phase|21|||
126725538|NCT01165021|455944634|FG000|Overall Study|Death|1|||
126725539|NCT02491073|455944635|FG000|Overall Study|screen failure|1|||
126725540|NCT02491073|455944636|FG001|Overall Study|screen failure|0|||
126725541|NCT01419665|455944637|FG000|Combination Treatment|Adverse Event|7|||
126725542|NCT01419665|455944638|FG001|Combination Treatment|Adverse Event|10|||
126725543|NCT01419665|455944637|FG000|Combination Treatment|Physician Decision|5|||
126725544|NCT01419665|455944638|FG001|Combination Treatment|Physician Decision|8|||
126725545|NCT01419665|455944637|FG000|Combination Treatment|Protocol Violation|6|||
126725546|NCT01419665|455944638|FG001|Combination Treatment|Protocol Violation|2|||
126725547|NCT01419665|455944637|FG000|Combination Treatment|disease progression|10|||
126725548|NCT01419665|455944638|FG001|Combination Treatment|disease progression|9|||
126725549|NCT01419665|455944637|FG000|Combination Treatment|Death|5|||
126725550|NCT01419665|455944638|FG001|Combination Treatment|Death|7|||
126725551|NCT01419665|455944637|FG000|Combination Treatment|administrative problems|0|||
126725552|NCT01419665|455944638|FG001|Combination Treatment|administrative problems|1|||
126725553|NCT01419665|455944637|FG000|Combination Treatment|Withdrawal by Subject|5|||
126725554|NCT01419665|455944638|FG001|Combination Treatment|Withdrawal by Subject|4|||
126725555|NCT01419665|455944637|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
126725556|NCT01419665|455944638|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
126725557|NCT01419665|455944637|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
126725558|NCT01419665|455944638|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
126725559|NCT01419665|455944637|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
126725560|NCT01419665|455944638|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
126725561|NCT01419665|455944637|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
126725562|NCT01419665|455944638|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
126725563|NCT01419665|455944637|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
126725564|NCT01419665|455944638|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
126725565|NCT01419665|455944637|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
126725566|NCT01419665|455944638|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
126725567|NCT01419665|455944637|FG000|Maintenance Treatment and/or Follow up|Death|1|||
126725568|NCT01419665|455944638|FG001|Maintenance Treatment and/or Follow up|Death|2|||
126725569|NCT01419665|455944637|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
126725570|NCT01419665|455944638|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
126725571|NCT01419665|455944637|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
126725572|NCT01419665|455944638|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
126725573|NCT01419665|455944637|FG000|Open Label Phase|Death|1|||
126725574|NCT01419665|455944638|FG001|Open Label Phase|Death|0|||
126725575|NCT01419665|455944637|FG000|Open Label Phase|disease progression|0|||
126498615|NCT02967692|455128084|FG001|Overall Study|Lost to Follow-up|0|||
126498616|NCT02967692|455128085|FG002|Overall Study|Lost to Follow-up|1|||
126498617|NCT02967692|455128086|FG003|Overall Study|Lost to Follow-up|0|||
126498618|NCT02967692|455128083|FG000|Overall Study|Physician Decision|0|||
126498619|NCT02967692|455128084|FG001|Overall Study|Physician Decision|0|||
126498620|NCT02967692|455128085|FG002|Overall Study|Physician Decision|22|||
126498621|NCT02967692|455128086|FG003|Overall Study|Physician Decision|13|||
126498622|NCT02967692|455128083|FG000|Overall Study|Adverse Event|2|||
126498623|NCT02967692|455128084|FG001|Overall Study|Adverse Event|9|||
126498624|NCT02967692|455128085|FG002|Overall Study|Adverse Event|60|||
126725576|NCT01419665|455944638|FG001|Open Label Phase|disease progression|1|||
126725577|NCT03738566|455944639|FG000|Initial Study Phase|Withdrawal by Subject|1|||
126725578|NCT03738566|455944640|FG001|Initial Study Phase|Withdrawal by Subject|1|||
126725579|NCT03738566|455944641|FG002|Initial Study Phase|Withdrawal by Subject|2|||
126498625|NCT02967692|455128086|FG003|Overall Study|Adverse Event|28|||
126498626|NCT02967692|455128083|FG000|Overall Study|Study terminated by sponsor|2|||
126498627|NCT02967692|455128084|FG001|Overall Study|Study terminated by sponsor|1|||
126498628|NCT02967692|455128085|FG002|Overall Study|Study terminated by sponsor|42|||
126498629|NCT02967692|455128086|FG003|Overall Study|Study terminated by sponsor|37|||
126498630|NCT00066066|455128089|FG000|Overall Study|Lost to Follow-up|6|||
126498631|NCT00066066|455128090|FG001|Overall Study|Lost to Follow-up|4|||
126498632|NCT00066066|455128091|FG002|Overall Study|Lost to Follow-up|7|||
126498633|NCT00066066|455128092|FG003|Overall Study|Lost to Follow-up|4|||
126498634|NCT00066066|455128093|FG004|Overall Study|Lost to Follow-up|3|||
126498635|NCT00066066|455128094|FG005|Overall Study|Lost to Follow-up|5|||
126498636|NCT02268409|455128095|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
126498637|NCT02268409|455128095|FG000|Overall Study|Death|1|||
126498638|NCT02268409|455128095|FG000|Overall Study|Lost to Follow-up|1|||
126498639|NCT02268409|455128095|FG000|Overall Study|Protocol Violation|3|||
126498640|NCT02268409|455128095|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
126498641|NCT02268409|455128095|FG000|Overall Study|Withdrawal by Subject|5|||
126498642|NCT00489853|455128100|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
126498643|NCT00489853|455128101|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
126498644|NCT00489853|455128102|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
126498645|NCT00489853|455128100|FG000|Wash-out Period 1|Adverse Event|0|||
126498646|NCT00489853|455128101|FG001|Wash-out Period 1|Adverse Event|1|||
126498647|NCT00489853|455128102|FG002|Wash-out Period 1|Adverse Event|1|||
126498648|NCT00489853|455128100|FG000|Wash-out Period 1|Protocol Violation|0|||
126498649|NCT00489853|455128101|FG001|Wash-out Period 1|Protocol Violation|1|||
126498650|NCT00489853|455128102|FG002|Wash-out Period 1|Protocol Violation|1|||
126498651|NCT00489853|455128100|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
126498652|NCT00489853|455128101|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
126498653|NCT00489853|455128102|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
126498654|NCT00489853|455128100|FG000|Wash-out Period 2|Adverse Event|1|||
126498655|NCT00489853|455128101|FG001|Wash-out Period 2|Adverse Event|1|||
126498656|NCT00489853|455128102|FG002|Wash-out Period 2|Adverse Event|0|||
126498657|NCT00489853|455128100|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
126498658|NCT00489853|455128101|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
126498659|NCT00489853|455128102|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
126498660|NCT00489853|455128100|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
126498661|NCT00489853|455128101|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
126498662|NCT00489853|455128102|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
126498663|NCT01541969|455128106|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
126498664|NCT01541969|455128107|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
126498665|NCT01541969|455128106|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
126498666|NCT01541969|455128107|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
126498667|NCT01541969|455128106|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
126498668|NCT01541969|455128107|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
126498669|NCT01541969|455128106|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
126498670|NCT01541969|455128107|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
126498671|NCT01541969|455128106|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
126498672|NCT01541969|455128107|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
126498673|NCT01541969|455128106|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
126498674|NCT01541969|455128107|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
126498675|NCT01541969|455128106|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
126498676|NCT01541969|455128107|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
126498677|NCT01541969|455128106|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
126498678|NCT01541969|455128107|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
126498679|NCT01541969|455128106|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
126498680|NCT01541969|455128107|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
126498681|NCT01541969|455128106|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
126498682|NCT01541969|455128107|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
126498683|NCT01614990|455128108|FG000|Overall Study|Protocol Violation|1|||
126498684|NCT01614990|455128109|FG001|Overall Study|Protocol Violation|1|||
126498685|NCT05129488|455128110|FG000|Overall Study|Protocol Violation|3|||
126498686|NCT02608268|455128111|FG000|Overall Study|Adverse Event|0|||
126498687|NCT02608268|455128112|FG001|Overall Study|Adverse Event|0|||
126498688|NCT02608268|455128113|FG002|Overall Study|Adverse Event|1|||
126498689|NCT02608268|455128114|FG003|Overall Study|Adverse Event|0|||
126498690|NCT02608268|455128115|FG004|Overall Study|Adverse Event|0|||
126498691|NCT02608268|455128116|FG005|Overall Study|Adverse Event|0|||
126498692|NCT02608268|455128117|FG006|Overall Study|Adverse Event|0|||
126498693|NCT02608268|455128118|FG007|Overall Study|Adverse Event|0|||
126498694|NCT02608268|455128119|FG008|Overall Study|Adverse Event|0|||
126498695|NCT02608268|455128120|FG009|Overall Study|Adverse Event|0|||
126498696|NCT02608268|455128121|FG010|Overall Study|Adverse Event|0|||
126774119|NCT00386100|456129101|FG001|Overall Study|7.6% bone loss|0|||
126774120|NCT00386100|456129100|FG000|Overall Study|Osteoporosis|0|||
126774121|NCT00386100|456129101|FG001|Overall Study|Osteoporosis|1|||
126774122|NCT00386100|456129100|FG000|Overall Study|Positive pregnancy test|1|||
126774123|NCT00386100|456129101|FG001|Overall Study|Positive pregnancy test|3|||
126774124|NCT00386100|456129100|FG000|Overall Study|Out of country for 5 months|1|||
126498697|NCT02608268|455128122|FG011|Overall Study|Adverse Event|0|||
126498698|NCT02608268|455128123|FG012|Overall Study|Adverse Event|2|||
126498699|NCT02608268|455128124|FG013|Overall Study|Adverse Event|0|||
126498700|NCT02608268|455128125|FG014|Overall Study|Adverse Event|0|||
126498701|NCT02608268|455128126|FG015|Overall Study|Adverse Event|0|||
126498702|NCT02608268|455128127|FG016|Overall Study|Adverse Event|0|||
126498703|NCT02608268|455128128|FG017|Overall Study|Adverse Event|0|||
126498704|NCT02608268|455128129|FG018|Overall Study|Adverse Event|0|||
126498705|NCT02608268|455128130|FG019|Overall Study|Adverse Event|0|||
126498706|NCT02608268|455128131|FG020|Overall Study|Adverse Event|1|||
126498707|NCT02608268|455128132|FG021|Overall Study|Adverse Event|1|||
126498708|NCT02608268|455128133|FG022|Overall Study|Adverse Event|0|||
126498709|NCT02608268|455128134|FG023|Overall Study|Adverse Event|0|||
126498710|NCT02608268|455128135|FG024|Overall Study|Adverse Event|1|||
126498711|NCT02608268|455128136|FG025|Overall Study|Adverse Event|0|||
126498712|NCT02608268|455128137|FG026|Overall Study|Adverse Event|0|||
126498713|NCT02608268|455128138|FG027|Overall Study|Adverse Event|0|||
126498714|NCT02608268|455128139|FG028|Overall Study|Adverse Event|1|||
126498715|NCT02608268|455128140|FG029|Overall Study|Adverse Event|0|||
126498716|NCT02608268|455128111|FG000|Overall Study|Death|1|||
126498717|NCT02608268|455128112|FG001|Overall Study|Death|0|||
126498718|NCT02608268|455128113|FG002|Overall Study|Death|0|||
126498719|NCT02608268|455128114|FG003|Overall Study|Death|0|||
126498720|NCT02608268|455128115|FG004|Overall Study|Death|0|||
126498721|NCT02608268|455128116|FG005|Overall Study|Death|0|||
126498722|NCT02608268|455128117|FG006|Overall Study|Death|0|||
126498723|NCT02608268|455128118|FG007|Overall Study|Death|0|||
126498724|NCT02608268|455128119|FG008|Overall Study|Death|1|||
126498725|NCT02608268|455128120|FG009|Overall Study|Death|1|||
126498726|NCT02608268|455128121|FG010|Overall Study|Death|0|||
126498727|NCT02608268|455128122|FG011|Overall Study|Death|0|||
126498728|NCT02608268|455128123|FG012|Overall Study|Death|0|||
126498729|NCT02608268|455128124|FG013|Overall Study|Death|0|||
126498730|NCT02608268|455128125|FG014|Overall Study|Death|0|||
126498731|NCT02608268|455128126|FG015|Overall Study|Death|1|||
126498732|NCT02608268|455128127|FG016|Overall Study|Death|0|||
126498733|NCT02608268|455128128|FG017|Overall Study|Death|1|||
126498734|NCT02608268|455128129|FG018|Overall Study|Death|0|||
126498735|NCT02608268|455128130|FG019|Overall Study|Death|1|||
126498736|NCT02608268|455128131|FG020|Overall Study|Death|1|||
126498737|NCT02608268|455128132|FG021|Overall Study|Death|0|||
126498738|NCT02608268|455128133|FG022|Overall Study|Death|0|||
126498739|NCT02608268|455128134|FG023|Overall Study|Death|0|||
126498740|NCT02608268|455128135|FG024|Overall Study|Death|1|||
126498741|NCT02608268|455128136|FG025|Overall Study|Death|2|||
126498742|NCT02608268|455128137|FG026|Overall Study|Death|0|||
126498743|NCT02608268|455128138|FG027|Overall Study|Death|1|||
126498744|NCT02608268|455128139|FG028|Overall Study|Death|4|||
126498745|NCT02608268|455128140|FG029|Overall Study|Death|0|||
126498746|NCT02608268|455128111|FG000|Overall Study|Physician Decision|0|||
126498747|NCT02608268|455128112|FG001|Overall Study|Physician Decision|0|||
126498748|NCT02608268|455128113|FG002|Overall Study|Physician Decision|0|||
126498749|NCT02608268|455128114|FG003|Overall Study|Physician Decision|0|||
126498750|NCT02608268|455128115|FG004|Overall Study|Physician Decision|0|||
126498751|NCT02608268|455128116|FG005|Overall Study|Physician Decision|0|||
126498752|NCT02608268|455128117|FG006|Overall Study|Physician Decision|0|||
126774125|NCT00386100|456129101|FG001|Overall Study|Out of country for 5 months|0|||
126774126|NCT00386100|456129100|FG000|Overall Study|Hb1Ac >8%|0|||
126774127|NCT00386100|456129101|FG001|Overall Study|Hb1Ac >8%|1|||
126498753|NCT02608268|455128118|FG007|Overall Study|Physician Decision|0|||
126498754|NCT02608268|455128119|FG008|Overall Study|Physician Decision|0|||
126498755|NCT02608268|455128120|FG009|Overall Study|Physician Decision|0|||
126498756|NCT02608268|455128121|FG010|Overall Study|Physician Decision|1|||
126498757|NCT02608268|455128122|FG011|Overall Study|Physician Decision|0|||
126498758|NCT02608268|455128123|FG012|Overall Study|Physician Decision|0|||
126498759|NCT02608268|455128124|FG013|Overall Study|Physician Decision|1|||
126498760|NCT02608268|455128125|FG014|Overall Study|Physician Decision|0|||
126498761|NCT02608268|455128126|FG015|Overall Study|Physician Decision|0|||
126498762|NCT02608268|455128127|FG016|Overall Study|Physician Decision|0|||
126498763|NCT02608268|455128128|FG017|Overall Study|Physician Decision|0|||
126498764|NCT02608268|455128129|FG018|Overall Study|Physician Decision|0|||
126498765|NCT02608268|455128130|FG019|Overall Study|Physician Decision|0|||
126498766|NCT02608268|455128131|FG020|Overall Study|Physician Decision|0|||
126498767|NCT02608268|455128132|FG021|Overall Study|Physician Decision|0|||
126498768|NCT02608268|455128133|FG022|Overall Study|Physician Decision|1|||
126774128|NCT00386100|456129100|FG000|Overall Study|Participant randomized in error|1|||
126774129|NCT00386100|456129101|FG001|Overall Study|Participant randomized in error|0|||
126560419|NCT00049517|455346612|FG003|Induction|Alternative therapy|0|||
126498769|NCT02608268|455128134|FG023|Overall Study|Physician Decision|1|||
126498770|NCT02608268|455128135|FG024|Overall Study|Physician Decision|1|||
126498771|NCT02608268|455128136|FG025|Overall Study|Physician Decision|0|||
126498772|NCT02608268|455128137|FG026|Overall Study|Physician Decision|0|||
126498773|NCT02608268|455128138|FG027|Overall Study|Physician Decision|2|||
126498774|NCT02608268|455128139|FG028|Overall Study|Physician Decision|1|||
126498775|NCT02608268|455128140|FG029|Overall Study|Physician Decision|1|||
126498776|NCT02608268|455128111|FG000|Overall Study|Progressive disease|12|||
126498777|NCT02608268|455128112|FG001|Overall Study|Progressive disease|8|||
126498778|NCT02608268|455128113|FG002|Overall Study|Progressive disease|13|||
126498779|NCT02608268|455128114|FG003|Overall Study|Progressive disease|5|||
126498780|NCT02608268|455128115|FG004|Overall Study|Progressive disease|2|||
126498781|NCT02608268|455128116|FG005|Overall Study|Progressive disease|4|||
126498782|NCT02608268|455128117|FG006|Overall Study|Progressive disease|6|||
126498783|NCT02608268|455128118|FG007|Overall Study|Progressive disease|2|||
126498784|NCT02608268|455128119|FG008|Overall Study|Progressive disease|5|||
126498785|NCT02608268|455128120|FG009|Overall Study|Progressive disease|6|||
126498786|NCT02608268|455128121|FG010|Overall Study|Progressive disease|5|||
126498787|NCT02608268|455128122|FG011|Overall Study|Progressive disease|5|||
126498788|NCT02608268|455128123|FG012|Overall Study|Progressive disease|4|||
126498789|NCT02608268|455128124|FG013|Overall Study|Progressive disease|11|||
126560420|NCT00049517|455346613|FG004|Induction|Alternative therapy|2|||
126560421|NCT00049517|455346614|FG005|Induction|Alternative therapy|2|||
126560422|NCT00049517|455346609|FG000|Induction|Other complicating disease|0|||
126560423|NCT00049517|455346610|FG001|Induction|Other complicating disease|0|||
126560424|NCT00049517|455346611|FG002|Induction|Other complicating disease|0|||
126560425|NCT00049517|455346612|FG003|Induction|Other complicating disease|0|||
126560426|NCT00049517|455346613|FG004|Induction|Other complicating disease|3|||
126560427|NCT00049517|455346614|FG005|Induction|Other complicating disease|0|||
126560428|NCT00049517|455346609|FG000|Induction|Reasons not reported|0|||
126560429|NCT00049517|455346610|FG001|Induction|Reasons not reported|0|||
126560430|NCT00049517|455346611|FG002|Induction|Reasons not reported|0|||
126560431|NCT00049517|455346612|FG003|Induction|Reasons not reported|0|||
126560432|NCT00049517|455346613|FG004|Induction|Reasons not reported|22|||
126560433|NCT00049517|455346614|FG005|Induction|Reasons not reported|25|||
126560434|NCT00049517|455346609|FG000|Conditioning/Transplant|Disease progression|14|||
126560435|NCT00049517|455346610|FG001|Conditioning/Transplant|Disease progression|6|||
126560436|NCT00049517|455346611|FG002|Conditioning/Transplant|Disease progression|10|||
126560437|NCT00049517|455346612|FG003|Conditioning/Transplant|Disease progression|6|||
126560438|NCT00049517|455346613|FG004|Conditioning/Transplant|Disease progression|0|||
126560439|NCT00049517|455346614|FG005|Conditioning/Transplant|Disease progression|0|||
126560440|NCT00049517|455346609|FG000|Conditioning/Transplant|Adverse Event|2|||
126560441|NCT00049517|455346610|FG001|Conditioning/Transplant|Adverse Event|1|||
126560442|NCT00049517|455346611|FG002|Conditioning/Transplant|Adverse Event|4|||
126560443|NCT00049517|455346612|FG003|Conditioning/Transplant|Adverse Event|8|||
126560444|NCT00049517|455346613|FG004|Conditioning/Transplant|Adverse Event|0|||
126560445|NCT00049517|455346614|FG005|Conditioning/Transplant|Adverse Event|0|||
126560446|NCT00049517|455346609|FG000|Conditioning/Transplant|Death|1|||
126560447|NCT00049517|455346610|FG001|Conditioning/Transplant|Death|0|||
126560448|NCT00049517|455346611|FG002|Conditioning/Transplant|Death|0|||
126560449|NCT00049517|455346612|FG003|Conditioning/Transplant|Death|2|||
126560450|NCT00049517|455346613|FG004|Conditioning/Transplant|Death|0|||
126560451|NCT00049517|455346614|FG005|Conditioning/Transplant|Death|0|||
126560452|NCT00049517|455346609|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
126560453|NCT00049517|455346610|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
126560454|NCT00049517|455346611|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
126560455|NCT00049517|455346612|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
126560456|NCT00049517|455346613|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
126560457|NCT00049517|455346614|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
126560458|NCT00049517|455346609|FG000|Conditioning/Transplant|Alternative therapy|4|||
126560459|NCT00049517|455346610|FG001|Conditioning/Transplant|Alternative therapy|4|||
126560460|NCT00049517|455346611|FG002|Conditioning/Transplant|Alternative therapy|2|||
126560461|NCT00049517|455346612|FG003|Conditioning/Transplant|Alternative therapy|1|||
126560462|NCT00049517|455346613|FG004|Conditioning/Transplant|Alternative therapy|1|||
126560463|NCT00049517|455346614|FG005|Conditioning/Transplant|Alternative therapy|0|||
126560464|NCT00049517|455346609|FG000|Conditioning/Transplant|Other complicating disease|2|||
126725580|NCT03738566|455944642|FG003|Initial Study Phase|Withdrawal by Subject|0|||
126498790|NCT02608268|455128125|FG014|Overall Study|Progressive disease|6|||
126498791|NCT02608268|455128126|FG015|Overall Study|Progressive disease|3|||
126725581|NCT03738566|455944639|FG000|Initial Study Phase|Death|0|||
126725582|NCT03738566|455944640|FG001|Initial Study Phase|Death|1|||
126560465|NCT00049517|455346610|FG001|Conditioning/Transplant|Other complicating disease|0|||
126560466|NCT00049517|455346611|FG002|Conditioning/Transplant|Other complicating disease|0|||
126498792|NCT02608268|455128127|FG016|Overall Study|Progressive disease|5|||
126498793|NCT02608268|455128128|FG017|Overall Study|Progressive disease|5|||
126725583|NCT03738566|455944641|FG002|Initial Study Phase|Death|0|||
126560467|NCT00049517|455346612|FG003|Conditioning/Transplant|Other complicating disease|4|||
126774130|NCT01706770|456129104|FG000|Overall Study|Lost to Follow-up|1|||
126774131|NCT01706770|456129105|FG001|Overall Study|Lost to Follow-up|0|||
126774132|NCT01706770|456129104|FG000|Overall Study|Physician Decision|1|||
126774133|NCT01706770|456129105|FG001|Overall Study|Physician Decision|0|||
126774134|NCT00886782|456129111|FG000|Overall Study|Disease progression|3|||
126774135|NCT00886782|456129112|FG001|Overall Study|Disease progression|3|||
126774136|NCT00886782|456129113|FG002|Overall Study|Disease progression|3|||
126774137|NCT00886782|456129111|FG000|Overall Study|Study drug toxicity|0|||
126774138|NCT00886782|456129112|FG001|Overall Study|Study drug toxicity|0|||
126774139|NCT00886782|456129113|FG002|Overall Study|Study drug toxicity|1|||
126774140|NCT00886782|456129111|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
126774141|NCT00886782|456129112|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
126774142|NCT00886782|456129113|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
126774143|NCT03636542|456129114|FG000|Overall Study|Lost to Follow-up|1|||
126774144|NCT03636542|456129115|FG001|Overall Study|Lost to Follow-up|1|||
126774145|NCT03636542|456129114|FG000|Overall Study|Physician Decision|0|||
126774146|NCT03636542|456129115|FG001|Overall Study|Physician Decision|1|||
126774147|NCT03636542|456129114|FG000|Overall Study|Withdrawal by Subject|1|||
126774148|NCT03636542|456129115|FG001|Overall Study|Withdrawal by Subject|0|||
126774149|NCT03674827|456129118|FG000|Treatment Phase|Adverse Event|0|||
126774150|NCT03674827|456129119|FG001|Treatment Phase|Adverse Event|0|||
126774151|NCT03674827|456129120|FG002|Treatment Phase|Adverse Event|0|||
126774152|NCT03674827|456129121|FG003|Treatment Phase|Adverse Event|0|||
126774153|NCT03674827|456129122|FG004|Treatment Phase|Adverse Event|0|||
126498794|NCT02608268|455128129|FG018|Overall Study|Progressive disease|5|||
126498795|NCT02608268|455128130|FG019|Overall Study|Progressive disease|2|||
126498796|NCT02608268|455128131|FG020|Overall Study|Progressive disease|10|||
126498797|NCT02608268|455128132|FG021|Overall Study|Progressive disease|4|||
126498798|NCT02608268|455128133|FG022|Overall Study|Progressive disease|5|||
126498799|NCT02608268|455128134|FG023|Overall Study|Progressive disease|5|||
126498800|NCT02608268|455128135|FG024|Overall Study|Progressive disease|3|||
126498801|NCT02608268|455128136|FG025|Overall Study|Progressive disease|11|||
126498802|NCT02608268|455128137|FG026|Overall Study|Progressive disease|16|||
126498803|NCT02608268|455128138|FG027|Overall Study|Progressive disease|11|||
126498804|NCT02608268|455128139|FG028|Overall Study|Progressive disease|10|||
126498805|NCT02608268|455128140|FG029|Overall Study|Progressive disease|15|||
126498806|NCT02608268|455128111|FG000|Overall Study|Subject/guardian decision|1|||
126498807|NCT02608268|455128112|FG001|Overall Study|Subject/guardian decision|1|||
126498808|NCT02608268|455128113|FG002|Overall Study|Subject/guardian decision|2|||
126498809|NCT02608268|455128114|FG003|Overall Study|Subject/guardian decision|0|||
126498810|NCT02608268|455128115|FG004|Overall Study|Subject/guardian decision|0|||
126498811|NCT02608268|455128116|FG005|Overall Study|Subject/guardian decision|0|||
126498812|NCT02608268|455128117|FG006|Overall Study|Subject/guardian decision|0|||
126498813|NCT02608268|455128118|FG007|Overall Study|Subject/guardian decision|0|||
126498814|NCT02608268|455128119|FG008|Overall Study|Subject/guardian decision|2|||
126498815|NCT02608268|455128120|FG009|Overall Study|Subject/guardian decision|2|||
126498816|NCT02608268|455128121|FG010|Overall Study|Subject/guardian decision|0|||
126498817|NCT02608268|455128122|FG011|Overall Study|Subject/guardian decision|1|||
126498818|NCT02608268|455128123|FG012|Overall Study|Subject/guardian decision|0|||
126498819|NCT02608268|455128124|FG013|Overall Study|Subject/guardian decision|1|||
126498820|NCT02608268|455128125|FG014|Overall Study|Subject/guardian decision|0|||
126498821|NCT02608268|455128126|FG015|Overall Study|Subject/guardian decision|1|||
126498822|NCT02608268|455128127|FG016|Overall Study|Subject/guardian decision|0|||
126498823|NCT02608268|455128128|FG017|Overall Study|Subject/guardian decision|0|||
126498824|NCT02608268|455128129|FG018|Overall Study|Subject/guardian decision|1|||
126498825|NCT02608268|455128130|FG019|Overall Study|Subject/guardian decision|0|||
126498826|NCT02608268|455128131|FG020|Overall Study|Subject/guardian decision|0|||
126498827|NCT02608268|455128132|FG021|Overall Study|Subject/guardian decision|0|||
126498828|NCT02608268|455128133|FG022|Overall Study|Subject/guardian decision|1|||
126498829|NCT02608268|455128134|FG023|Overall Study|Subject/guardian decision|0|||
126498830|NCT02608268|455128135|FG024|Overall Study|Subject/guardian decision|0|||
126498831|NCT02608268|455128136|FG025|Overall Study|Subject/guardian decision|1|||
126498832|NCT02608268|455128137|FG026|Overall Study|Subject/guardian decision|1|||
126498833|NCT02608268|455128138|FG027|Overall Study|Subject/guardian decision|1|||
126498834|NCT02608268|455128139|FG028|Overall Study|Subject/guardian decision|1|||
126498835|NCT02608268|455128140|FG029|Overall Study|Subject/guardian decision|0|||
126498836|NCT01012622|455128141|FG000|Overall Study|Withdrawal by Subject|6|||
126498837|NCT01012622|455128141|FG000|Overall Study|Lost to Follow-up|5|||
126498838|NCT01012622|455128141|FG000|Overall Study|Adverse Event|7|||
126498839|NCT01012622|455128141|FG000|Overall Study|non-compliance with the drug|9|||
126498840|NCT01012622|455128141|FG000|Overall Study|Other|1|||
126774154|NCT03674827|456129123|FG005|Treatment Phase|Adverse Event|2|||
126774155|NCT03674827|456129118|FG000|Treatment Phase|Death|2|||
126774156|NCT03674827|456129119|FG001|Treatment Phase|Death|0|||
126774157|NCT03674827|456129120|FG002|Treatment Phase|Death|0|||
126774158|NCT03674827|456129121|FG003|Treatment Phase|Death|0|||
126774159|NCT03674827|456129122|FG004|Treatment Phase|Death|1|||
126774160|NCT03674827|456129123|FG005|Treatment Phase|Death|0|||
126774161|NCT03674827|456129118|FG000|Treatment Phase|Progressive Disease|0|||
126774162|NCT03674827|456129119|FG001|Treatment Phase|Progressive Disease|4|||
126774163|NCT03674827|456129120|FG002|Treatment Phase|Progressive Disease|3|||
126774164|NCT03674827|456129121|FG003|Treatment Phase|Progressive Disease|4|||
126774165|NCT03674827|456129122|FG004|Treatment Phase|Progressive Disease|4|||
126774166|NCT03674827|456129123|FG005|Treatment Phase|Progressive Disease|9|||
126774167|NCT03674827|456129118|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
126774168|NCT03674827|456129119|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
126774169|NCT03674827|456129120|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
126774170|NCT03674827|456129121|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
126774171|NCT03674827|456129122|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
126774172|NCT03674827|456129123|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
126774173|NCT03674827|456129118|FG000|Treatment Phase|Withdrawal by Subject|0|||
126774174|NCT03674827|456129119|FG001|Treatment Phase|Withdrawal by Subject|0|||
126774175|NCT03674827|456129120|FG002|Treatment Phase|Withdrawal by Subject|0|||
126774176|NCT03674827|456129121|FG003|Treatment Phase|Withdrawal by Subject|0|||
126774177|NCT03674827|456129122|FG004|Treatment Phase|Withdrawal by Subject|0|||
126774178|NCT03674827|456129123|FG005|Treatment Phase|Withdrawal by Subject|1|||
126774179|NCT03674827|456129118|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
126774180|NCT03674827|456129119|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
126774181|NCT03674827|456129120|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
126560468|NCT00049517|455346613|FG004|Conditioning/Transplant|Other complicating disease|0|||
126725584|NCT03738566|455944642|FG003|Initial Study Phase|Death|0|||
126725585|NCT03738566|455944639|FG000|Initial Study Phase|Treatment failure|5|||
126725586|NCT03738566|455944640|FG001|Initial Study Phase|Treatment failure|0|||
126725587|NCT03738566|455944641|FG002|Initial Study Phase|Treatment failure|0|||
126725588|NCT03738566|455944642|FG003|Initial Study Phase|Treatment failure|0|||
126725589|NCT03738566|455944639|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
126725590|NCT03738566|455944640|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
126725591|NCT03738566|455944641|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
126725592|NCT03738566|455944642|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
126725593|NCT01655823|455944643|FG000|Overall Study|Lost to Follow-up|0|||
126725594|NCT01655823|455944644|FG001|Overall Study|Lost to Follow-up|1|||
126725595|NCT01655823|455944645|FG002|Overall Study|Lost to Follow-up|0|||
126725596|NCT01655823|455944646|FG003|Overall Study|Lost to Follow-up|0|||
126725597|NCT01655823|455944647|FG004|Overall Study|Lost to Follow-up|1|||
126725598|NCT01655823|455944643|FG000|Overall Study|Withdrawal by Subject|0|||
126725599|NCT01655823|455944644|FG001|Overall Study|Withdrawal by Subject|1|||
126725600|NCT01655823|455944645|FG002|Overall Study|Withdrawal by Subject|0|||
126725601|NCT01655823|455944646|FG003|Overall Study|Withdrawal by Subject|1|||
126725602|NCT01655823|455944647|FG004|Overall Study|Withdrawal by Subject|0|||
126725603|NCT02998554|455944650|FG000|Overall Study|Adverse Event|8|||
126725604|NCT02998554|455944651|FG001|Overall Study|Adverse Event|3|||
126725605|NCT02998554|455944650|FG000|Overall Study|Protocol deviation|1|||
126725606|NCT02998554|455944651|FG001|Overall Study|Protocol deviation|0|||
126725607|NCT02998554|455944650|FG000|Overall Study|Withdrawal by Subject|2|||
126725608|NCT02998554|455944651|FG001|Overall Study|Withdrawal by Subject|6|||
126725609|NCT02998554|455944650|FG000|Overall Study|Lost to Follow-up|0|||
126725610|NCT02998554|455944651|FG001|Overall Study|Lost to Follow-up|1|||
126725611|NCT02998554|455944650|FG000|Overall Study|Lack of Efficacy|0|||
126725612|NCT02998554|455944651|FG001|Overall Study|Lack of Efficacy|1|||
126725613|NCT03731364|455944656|FG000|Overall Study|Adverse Event|0|||
126725614|NCT03731364|455944657|FG001|Overall Study|Adverse Event|0|||
126725615|NCT03731364|455944658|FG002|Overall Study|Adverse Event|1|||
126725616|NCT03731364|455944659|FG003|Overall Study|Adverse Event|2|||
126725617|NCT03731364|455944660|FG004|Overall Study|Adverse Event|1|||
126725618|NCT01934192|455944661|FG000|Overall Study|Protocol Violation|0|||
126725619|NCT01934192|455944662|FG001|Overall Study|Protocol Violation|0|||
126725620|NCT01934192|455944663|FG002|Overall Study|Protocol Violation|0|||
126725621|NCT01934192|455944664|FG003|Overall Study|Protocol Violation|1|||
126774182|NCT03674827|456129121|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
126774183|NCT03674827|456129122|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
126774184|NCT03674827|456129123|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
126774185|NCT03674827|456129118|FG000|Treatment Phase|Other|0|||
126774186|NCT03674827|456129119|FG001|Treatment Phase|Other|1|||
126774187|NCT03674827|456129120|FG002|Treatment Phase|Other|0|||
126774188|NCT03674827|456129121|FG003|Treatment Phase|Other|0|||
126774189|NCT03674827|456129122|FG004|Treatment Phase|Other|0|||
126560469|NCT00049517|455346614|FG005|Conditioning/Transplant|Other complicating disease|1|||
126725622|NCT01934192|455944661|FG000|Overall Study|Other: reached stopping criteria|6|||
126725623|NCT01934192|455944662|FG001|Overall Study|Other: reached stopping criteria|5|||
126725624|NCT01934192|455944663|FG002|Overall Study|Other: reached stopping criteria|1|||
126725625|NCT01934192|455944664|FG003|Overall Study|Other: reached stopping criteria|0|||
126725626|NCT01934192|455944661|FG000|Overall Study|Physician Decision|3|||
126560470|NCT00049517|455346609|FG000|Conditioning/Transplant|Reasons not reported|25|||
126560471|NCT00049517|455346610|FG001|Conditioning/Transplant|Reasons not reported|31|||
126560472|NCT00049517|455346611|FG002|Conditioning/Transplant|Reasons not reported|18|||
126560473|NCT00049517|455346612|FG003|Conditioning/Transplant|Reasons not reported|15|||
126560474|NCT00049517|455346613|FG004|Conditioning/Transplant|Reasons not reported|5|||
126560475|NCT00049517|455346614|FG005|Conditioning/Transplant|Reasons not reported|5|||
126560476|NCT02790606|455346625|FG000|Overall Study|Death|27|||
126560477|NCT02790606|455346625|FG000|Overall Study|Lost to Follow-up|4|||
126560478|NCT02790606|455346625|FG000|Overall Study|Physician Decision|3|||
126560479|NCT02790606|455346625|FG000|Overall Study|Withdrawal by Subject|1|||
126560480|NCT02735915|455346626|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
126560481|NCT02735915|455346626|FG000|Overall Study|Withdrawal following SAE|2|||
126560482|NCT02735915|455346626|FG000|Overall Study|Withdrawal by Subject|1|||
126560483|NCT05328973|455346627|FG000|Overall Study|Withdrawal by Subject|0|||
126560484|NCT05328973|455346628|FG001|Overall Study|Withdrawal by Subject|1|||
126560485|NCT00946114|455346629|FG000|Overall Study|Death|5|||
126560486|NCT00946114|455346630|FG001|Overall Study|Death|2|||
126560487|NCT00946114|455346629|FG000|Overall Study|Other|1|||
126560488|NCT00946114|455346630|FG001|Overall Study|Other|0|||
126560489|NCT00946114|455346629|FG000|Overall Study|Withdrawal by Subject|2|||
126560490|NCT00946114|455346630|FG001|Overall Study|Withdrawal by Subject|0|||
126560491|NCT01764386|455346634|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
126560492|NCT01764386|455346635|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
126560493|NCT01764386|455346634|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
126560494|NCT01764386|455346635|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
126560495|NCT01764386|455346634|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
126560496|NCT01764386|455346635|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
126560497|NCT01764386|455346634|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
126560498|NCT01764386|455346635|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
126560499|NCT01764386|455346634|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
126560500|NCT01764386|455346635|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
126560501|NCT01764386|455346634|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
126560502|NCT01764386|455346635|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
126560503|NCT01764386|455346634|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
126560504|NCT01764386|455346635|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
126560505|NCT01764386|455346634|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
126560506|NCT01764386|455346635|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
126560507|NCT03929302|455346638|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
126560508|NCT03929302|455346639|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
126560509|NCT03929302|455346640|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
126498841|NCT01012622|455128141|FG000|Overall Study|screening failure|1|||
126498842|NCT01012622|455128141|FG000|Overall Study|withdrawal of consent by a parent|2|||
126498843|NCT00588822|455128142|FG000|Overall Study|progression of disease|8|||
126498844|NCT02082210|455128144|FG000|Overall Study|Death|0|||
126498845|NCT02082210|455128145|FG001|Overall Study|Death|0|||
126498846|NCT02082210|455128146|FG002|Overall Study|Death|1|||
126498847|NCT02082210|455128147|FG003|Overall Study|Death|1|||
126498848|NCT02082210|455128148|FG004|Overall Study|Death|1|||
126498849|NCT02082210|455128149|FG005|Overall Study|Death|0|||
126498850|NCT02082210|455128144|FG000|Overall Study|Withdrawal by Subject|0|||
126498851|NCT02082210|455128145|FG001|Overall Study|Withdrawal by Subject|0|||
126498852|NCT02082210|455128146|FG002|Overall Study|Withdrawal by Subject|0|||
126498853|NCT02082210|455128147|FG003|Overall Study|Withdrawal by Subject|1|||
126498854|NCT02082210|455128148|FG004|Overall Study|Withdrawal by Subject|2|||
126498855|NCT02082210|455128149|FG005|Overall Study|Withdrawal by Subject|2|||
126498856|NCT02082210|455128144|FG000|Overall Study|Clinical Progression|0|||
126498857|NCT02082210|455128145|FG001|Overall Study|Clinical Progression|0|||
126498858|NCT02082210|455128146|FG002|Overall Study|Clinical Progression|0|||
126560510|NCT03929302|455346638|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
126560511|NCT03929302|455346639|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
126560512|NCT03929302|455346640|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
126560513|NCT03929302|455346638|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
126560514|NCT03929302|455346639|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
126560515|NCT03929302|455346640|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
126560516|NCT04454567|455346642|FG000|Overall Study|Study Terminated by Sponsor|1|||
126560517|NCT04454567|455346643|FG001|Overall Study|Study Terminated by Sponsor|1|||
126560518|NCT01123161|455346646|FG000|Overall Study|Lost to Follow-up|1|||
126498859|NCT02082210|455128147|FG003|Overall Study|Clinical Progression|1|||
126498860|NCT02082210|455128148|FG004|Overall Study|Clinical Progression|0|||
126498861|NCT02082210|455128149|FG005|Overall Study|Clinical Progression|0|||
126498862|NCT02082210|455128144|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
126560519|NCT01123161|455346647|FG001|Overall Study|Lost to Follow-up|0|||
126560520|NCT01123161|455346646|FG000|Overall Study|Withdrawal by Subject|1|||
126560521|NCT01123161|455346647|FG001|Overall Study|Withdrawal by Subject|0|||
126560522|NCT02757885|455346648|FG000|Overall Study|Screen Failures|4|||
126560523|NCT01175707|455346649|FG000|Overall Study|Adverse Event|4|||
126560524|NCT01175707|455346650|FG001|Overall Study|Adverse Event|6|||
126560525|NCT00003377|455346654|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
126498863|NCT02082210|455128145|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
126498864|NCT02082210|455128146|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
126498865|NCT02082210|455128147|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
126498866|NCT02082210|455128148|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
126498867|NCT02082210|455128149|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
126498868|NCT02082210|455128144|FG000|Overall Study|Physician Decision|0|||
126498869|NCT02082210|455128145|FG001|Overall Study|Physician Decision|0|||
126498870|NCT02082210|455128146|FG002|Overall Study|Physician Decision|1|||
126498871|NCT02082210|455128147|FG003|Overall Study|Physician Decision|1|||
126498872|NCT02082210|455128148|FG004|Overall Study|Physician Decision|0|||
126498873|NCT02082210|455128149|FG005|Overall Study|Physician Decision|0|||
126498874|NCT04762680|455128150|FG000|Phase 2|Adverse Event|0|||
126498875|NCT04762680|455128151|FG001|Phase 2|Adverse Event|1|||
126498876|NCT04762680|455128152|FG002|Phase 2|Adverse Event|0|||
126498877|NCT04762680|455128153|FG003|Phase 2|Adverse Event|0|||
126498878|NCT04762680|455128154|FG004|Phase 2|Adverse Event|0|||
126498879|NCT04762680|455128155|FG005|Phase 2|Adverse Event|0|||
126498880|NCT04762680|455128156|FG006|Phase 2|Adverse Event|0|||
126498881|NCT04762680|455128157|FG007|Phase 2|Adverse Event|0|||
126498882|NCT04762680|455128158|FG008|Phase 2|Adverse Event|0|||
126498883|NCT04762680|455128159|FG009|Phase 2|Adverse Event|0|||
126498884|NCT04762680|455128160|FG010|Phase 2|Adverse Event|0|||
126498885|NCT04762680|455128161|FG011|Phase 2|Adverse Event|0|||
126498886|NCT04762680|455128162|FG012|Phase 2|Adverse Event|0|||
126498887|NCT04762680|455128163|FG013|Phase 2|Adverse Event|0|||
126498888|NCT04762680|455128164|FG014|Phase 2|Adverse Event|0|||
126498889|NCT04762680|455128165|FG015|Phase 2|Adverse Event|0|||
126498890|NCT04762680|455128166|FG016|Phase 2|Adverse Event|0|||
126498891|NCT04762680|455128167|FG017|Phase 2|Adverse Event|0|||
126498892|NCT04762680|455128168|FG018|Phase 2|Adverse Event|0|||
126498893|NCT04762680|455128169|FG019|Phase 2|Adverse Event|0|||
126498894|NCT04762680|455128170|FG020|Phase 2|Adverse Event|0|||
126498895|NCT04762680|455128171|FG021|Phase 2|Adverse Event|0|||
126498896|NCT04762680|455128150|FG000|Phase 2|Protocol Violation|5|||
126498897|NCT04762680|455128151|FG001|Phase 2|Protocol Violation|5|||
126498898|NCT04762680|455128152|FG002|Phase 2|Protocol Violation|1|||
126498899|NCT04762680|455128153|FG003|Phase 2|Protocol Violation|0|||
126498900|NCT04762680|455128154|FG004|Phase 2|Protocol Violation|0|||
126498901|NCT04762680|455128155|FG005|Phase 2|Protocol Violation|0|||
126498902|NCT04762680|455128156|FG006|Phase 2|Protocol Violation|0|||
126498903|NCT04762680|455128157|FG007|Phase 2|Protocol Violation|0|||
126498904|NCT04762680|455128158|FG008|Phase 2|Protocol Violation|0|||
126498905|NCT04762680|455128159|FG009|Phase 2|Protocol Violation|0|||
126498906|NCT04762680|455128160|FG010|Phase 2|Protocol Violation|0|||
126498907|NCT04762680|455128161|FG011|Phase 2|Protocol Violation|0|||
126498908|NCT04762680|455128162|FG012|Phase 2|Protocol Violation|0|||
126498909|NCT04762680|455128163|FG013|Phase 2|Protocol Violation|0|||
126498910|NCT04762680|455128164|FG014|Phase 2|Protocol Violation|0|||
126498911|NCT04762680|455128165|FG015|Phase 2|Protocol Violation|0|||
126498912|NCT04762680|455128166|FG016|Phase 2|Protocol Violation|0|||
126498913|NCT04762680|455128167|FG017|Phase 2|Protocol Violation|0|||
126498914|NCT04762680|455128168|FG018|Phase 2|Protocol Violation|0|||
126498915|NCT04762680|455128169|FG019|Phase 2|Protocol Violation|0|||
126498916|NCT04762680|455128170|FG020|Phase 2|Protocol Violation|0|||
126498917|NCT04762680|455128171|FG021|Phase 2|Protocol Violation|0|||
126498918|NCT04762680|455128150|FG000|Phase 2|Withdrawal by Subject|23|||
126498919|NCT04762680|455128151|FG001|Phase 2|Withdrawal by Subject|21|||
126498920|NCT04762680|455128152|FG002|Phase 2|Withdrawal by Subject|28|||
126498921|NCT04762680|455128153|FG003|Phase 2|Withdrawal by Subject|0|||
126725627|NCT01934192|455944662|FG001|Overall Study|Physician Decision|2|||
126725628|NCT01934192|455944663|FG002|Overall Study|Physician Decision|0|||
126725629|NCT01934192|455944664|FG003|Overall Study|Physician Decision|0|||
126725630|NCT02357849|455944665|FG000|Overall Study|Withdrawal by Subject|2|||
126725631|NCT02357849|455944666|FG001|Overall Study|Withdrawal by Subject|3|||
126725632|NCT03095521|455944667|FG000|Overall Study|Withdrawal by Subject|0|||
126725633|NCT03095521|455944668|FG001|Overall Study|Withdrawal by Subject|1|||
126725634|NCT03095521|455944667|FG000|Overall Study|Lost to Follow-up|0|||
126725635|NCT03095521|455944668|FG001|Overall Study|Lost to Follow-up|1|||
126725636|NCT01536119|455944669|FG000|Overall Study|Lost to Follow-up|17|||
126498922|NCT04762680|455128154|FG004|Phase 2|Withdrawal by Subject|0|||
126498923|NCT04762680|455128155|FG005|Phase 2|Withdrawal by Subject|0|||
126498924|NCT04762680|455128156|FG006|Phase 2|Withdrawal by Subject|0|||
126498925|NCT04762680|455128157|FG007|Phase 2|Withdrawal by Subject|0|||
126498926|NCT04762680|455128158|FG008|Phase 2|Withdrawal by Subject|0|||
126498927|NCT04762680|455128159|FG009|Phase 2|Withdrawal by Subject|0|||
126725637|NCT01536119|455944670|FG001|Overall Study|Lost to Follow-up|14|||
126498928|NCT04762680|455128160|FG010|Phase 2|Withdrawal by Subject|0|||
126498929|NCT04762680|455128161|FG011|Phase 2|Withdrawal by Subject|0|||
126498930|NCT04762680|455128162|FG012|Phase 2|Withdrawal by Subject|0|||
126498931|NCT04762680|455128163|FG013|Phase 2|Withdrawal by Subject|0|||
126498932|NCT04762680|455128164|FG014|Phase 2|Withdrawal by Subject|0|||
126498933|NCT04762680|455128165|FG015|Phase 2|Withdrawal by Subject|0|||
126498934|NCT04762680|455128166|FG016|Phase 2|Withdrawal by Subject|0|||
126498935|NCT04762680|455128167|FG017|Phase 2|Withdrawal by Subject|0|||
126498936|NCT04762680|455128168|FG018|Phase 2|Withdrawal by Subject|0|||
126498937|NCT04762680|455128169|FG019|Phase 2|Withdrawal by Subject|0|||
126498938|NCT04762680|455128170|FG020|Phase 2|Withdrawal by Subject|0|||
126498939|NCT04762680|455128171|FG021|Phase 2|Withdrawal by Subject|0|||
126498940|NCT04762680|455128150|FG000|Phase 2|Lost to Follow-up|14|||
126498941|NCT04762680|455128151|FG001|Phase 2|Lost to Follow-up|8|||
126498942|NCT04762680|455128152|FG002|Phase 2|Lost to Follow-up|9|||
126498943|NCT04762680|455128153|FG003|Phase 2|Lost to Follow-up|0|||
126498944|NCT04762680|455128154|FG004|Phase 2|Lost to Follow-up|0|||
126498945|NCT04762680|455128155|FG005|Phase 2|Lost to Follow-up|0|||
126498946|NCT04762680|455128156|FG006|Phase 2|Lost to Follow-up|0|||
126498947|NCT04762680|455128157|FG007|Phase 2|Lost to Follow-up|0|||
126498948|NCT04762680|455128158|FG008|Phase 2|Lost to Follow-up|0|||
126498949|NCT04762680|455128159|FG009|Phase 2|Lost to Follow-up|0|||
126498950|NCT04762680|455128160|FG010|Phase 2|Lost to Follow-up|0|||
126498951|NCT04762680|455128161|FG011|Phase 2|Lost to Follow-up|0|||
126498952|NCT04762680|455128162|FG012|Phase 2|Lost to Follow-up|0|||
126498953|NCT04762680|455128163|FG013|Phase 2|Lost to Follow-up|0|||
126498954|NCT04762680|455128164|FG014|Phase 2|Lost to Follow-up|0|||
126498955|NCT04762680|455128165|FG015|Phase 2|Lost to Follow-up|0|||
126498956|NCT04762680|455128166|FG016|Phase 2|Lost to Follow-up|0|||
126498957|NCT04762680|455128167|FG017|Phase 2|Lost to Follow-up|0|||
126498958|NCT04762680|455128168|FG018|Phase 2|Lost to Follow-up|0|||
126498959|NCT04762680|455128169|FG019|Phase 2|Lost to Follow-up|0|||
126498960|NCT04762680|455128170|FG020|Phase 2|Lost to Follow-up|0|||
126498961|NCT04762680|455128171|FG021|Phase 2|Lost to Follow-up|0|||
126498962|NCT04762680|455128150|FG000|Phase 3|Adverse Event|0|||
126498963|NCT04762680|455128151|FG001|Phase 3|Adverse Event|0|||
126498964|NCT04762680|455128152|FG002|Phase 3|Adverse Event|0|||
126498965|NCT04762680|455128153|FG003|Phase 3|Adverse Event|1|||
126498966|NCT04762680|455128154|FG004|Phase 3|Adverse Event|0|||
126498967|NCT04762680|455128155|FG005|Phase 3|Adverse Event|0|||
126498968|NCT04762680|455128156|FG006|Phase 3|Adverse Event|0|||
126498969|NCT04762680|455128157|FG007|Phase 3|Adverse Event|0|||
126498970|NCT04762680|455128158|FG008|Phase 3|Adverse Event|0|||
126498971|NCT04762680|455128159|FG009|Phase 3|Adverse Event|0|||
126498972|NCT04762680|455128160|FG010|Phase 3|Adverse Event|0|||
126498973|NCT04762680|455128161|FG011|Phase 3|Adverse Event|0|||
126498974|NCT04762680|455128162|FG012|Phase 3|Adverse Event|0|||
126725638|NCT01810042|455944671|FG000|Overall Study|Lost to Follow-up|10|||
126725639|NCT02773238|455944673|FG000|Overall Study|Lack of Efficacy|4|||
126725640|NCT05301322|455944676|FG000|Overall Study|Adverse Event|7|||
126725641|NCT05301322|455944677|FG001|Overall Study|Adverse Event|3|||
126725642|NCT05301322|455944676|FG000|Overall Study|Death|0|||
126725643|NCT05301322|455944677|FG001|Overall Study|Death|1|||
126725644|NCT05301322|455944676|FG000|Overall Study|Lost to Follow-up|2|||
126725645|NCT05301322|455944677|FG001|Overall Study|Lost to Follow-up|1|||
126725646|NCT05301322|455944676|FG000|Overall Study|Protocol Violation|3|||
126725647|NCT05301322|455944677|FG001|Overall Study|Protocol Violation|1|||
126725648|NCT05301322|455944676|FG000|Overall Study|Withdrawal by Subject|3|||
126725649|NCT05301322|455944677|FG001|Overall Study|Withdrawal by Subject|0|||
126725650|NCT05301322|455944676|FG000|Overall Study|Other|4|||
126725651|NCT05301322|455944677|FG001|Overall Study|Other|0|||
126725652|NCT01877382|455944681|FG000|Dose Escalation|Progressive disease|2|||
126725653|NCT01877382|455944682|FG001|Dose Escalation|Progressive disease|0|||
126725654|NCT01877382|455944683|FG002|Dose Escalation|Progressive disease|1|||
126725655|NCT01877382|455944684|FG003|Dose Escalation|Progressive disease|6|||
126725656|NCT01877382|455944685|FG004|Dose Escalation|Progressive disease|1|||
126725657|NCT01877382|455944686|FG005|Dose Escalation|Progressive disease|0|||
126725658|NCT01877382|455944687|FG006|Dose Escalation|Progressive disease|3|||
126498975|NCT04762680|455128163|FG013|Phase 3|Adverse Event|0|||
126498976|NCT04762680|455128164|FG014|Phase 3|Adverse Event|0|||
126498977|NCT04762680|455128165|FG015|Phase 3|Adverse Event|0|||
126498978|NCT04762680|455128166|FG016|Phase 3|Adverse Event|0|||
126498979|NCT04762680|455128167|FG017|Phase 3|Adverse Event|3|||
126498980|NCT04762680|455128168|FG018|Phase 3|Adverse Event|0|||
126498981|NCT04762680|455128169|FG019|Phase 3|Adverse Event|0|||
126725659|NCT01877382|455944688|FG007|Dose Escalation|Progressive disease|10|||
126725660|NCT01877382|455944689|FG008|Dose Escalation|Progressive disease|4|||
126725661|NCT01877382|455944690|FG009|Dose Escalation|Progressive disease|2|||
126725662|NCT01877382|455944691|FG010|Dose Escalation|Progressive disease|3|||
126498982|NCT04762680|455128170|FG020|Phase 3|Adverse Event|0|||
126498983|NCT04762680|455128171|FG021|Phase 3|Adverse Event|0|||
126498984|NCT04762680|455128150|FG000|Phase 3|Protocol Violation|0|||
126498985|NCT04762680|455128151|FG001|Phase 3|Protocol Violation|0|||
126498986|NCT04762680|455128152|FG002|Phase 3|Protocol Violation|0|||
126498987|NCT04762680|455128153|FG003|Phase 3|Protocol Violation|4|||
126498988|NCT04762680|455128154|FG004|Phase 3|Protocol Violation|1|||
126498989|NCT04762680|455128155|FG005|Phase 3|Protocol Violation|5|||
126498990|NCT04762680|455128156|FG006|Phase 3|Protocol Violation|1|||
126498991|NCT04762680|455128157|FG007|Phase 3|Protocol Violation|0|||
126498992|NCT04762680|455128158|FG008|Phase 3|Protocol Violation|0|||
126498993|NCT04762680|455128159|FG009|Phase 3|Protocol Violation|0|||
126498994|NCT04762680|455128160|FG010|Phase 3|Protocol Violation|0|||
126498995|NCT04762680|455128161|FG011|Phase 3|Protocol Violation|2|||
126498996|NCT04762680|455128162|FG012|Phase 3|Protocol Violation|3|||
126498997|NCT04762680|455128163|FG013|Phase 3|Protocol Violation|0|||
126498998|NCT04762680|455128164|FG014|Phase 3|Protocol Violation|0|||
126498999|NCT04762680|455128165|FG015|Phase 3|Protocol Violation|1|||
126499000|NCT04762680|455128166|FG016|Phase 3|Protocol Violation|0|||
126499001|NCT04762680|455128167|FG017|Phase 3|Protocol Violation|10|||
126499002|NCT04762680|455128168|FG018|Phase 3|Protocol Violation|0|||
126499003|NCT04762680|455128169|FG019|Phase 3|Protocol Violation|0|||
126499004|NCT04762680|455128170|FG020|Phase 3|Protocol Violation|0|||
126499005|NCT04762680|455128171|FG021|Phase 3|Protocol Violation|0|||
126499006|NCT04762680|455128150|FG000|Phase 3|Withdrawal by Subject|0|||
126499007|NCT04762680|455128151|FG001|Phase 3|Withdrawal by Subject|0|||
126499008|NCT04762680|455128152|FG002|Phase 3|Withdrawal by Subject|0|||
126499009|NCT04762680|455128153|FG003|Phase 3|Withdrawal by Subject|13|||
126499010|NCT04762680|455128154|FG004|Phase 3|Withdrawal by Subject|17|||
126499011|NCT04762680|455128155|FG005|Phase 3|Withdrawal by Subject|12|||
126499012|NCT04762680|455128156|FG006|Phase 3|Withdrawal by Subject|8|||
126499013|NCT04762680|455128157|FG007|Phase 3|Withdrawal by Subject|3|||
126499014|NCT04762680|455128158|FG008|Phase 3|Withdrawal by Subject|2|||
126774190|NCT03674827|456129123|FG005|Treatment Phase|Other|1|||
126774191|NCT03674827|456129118|FG000|Long-Term Follow-up Phase|Death|2|||
126774192|NCT03674827|456129119|FG001|Long-Term Follow-up Phase|Death|4|||
126774193|NCT03674827|456129120|FG002|Long-Term Follow-up Phase|Death|2|||
126774194|NCT03674827|456129121|FG003|Long-Term Follow-up Phase|Death|3|||
126774195|NCT03674827|456129122|FG004|Long-Term Follow-up Phase|Death|2|||
126774196|NCT03674827|456129123|FG005|Long-Term Follow-up Phase|Death|6|||
126774197|NCT03674827|456129118|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
126774198|NCT03674827|456129119|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
126774199|NCT03674827|456129120|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
126774200|NCT03674827|456129121|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
126774201|NCT03674827|456129122|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
126774202|NCT03674827|456129123|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
126774203|NCT03674827|456129118|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
126774204|NCT03674827|456129119|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
126774205|NCT03674827|456129120|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
126774206|NCT03674827|456129121|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
126774207|NCT03674827|456129122|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
126774208|NCT03674827|456129123|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
126774209|NCT01783483|456129124|FG000|Overall Study|Death|3|||
126774210|NCT01783483|456129125|FG001|Overall Study|Death|3|||
126774211|NCT01783483|456129124|FG000|Overall Study|Lost to Follow-up|14|||
126774212|NCT01783483|456129125|FG001|Overall Study|Lost to Follow-up|10|||
126499015|NCT04762680|455128159|FG009|Phase 3|Withdrawal by Subject|4|||
126499016|NCT04762680|455128160|FG010|Phase 3|Withdrawal by Subject|3|||
126499017|NCT04762680|455128161|FG011|Phase 3|Withdrawal by Subject|1|||
126499018|NCT04762680|455128162|FG012|Phase 3|Withdrawal by Subject|3|||
126499019|NCT04762680|455128163|FG013|Phase 3|Withdrawal by Subject|2|||
126499020|NCT04762680|455128164|FG014|Phase 3|Withdrawal by Subject|1|||
126499021|NCT04762680|455128165|FG015|Phase 3|Withdrawal by Subject|4|||
126499022|NCT04762680|455128166|FG016|Phase 3|Withdrawal by Subject|6|||
126499023|NCT04762680|455128167|FG017|Phase 3|Withdrawal by Subject|32|||
126499024|NCT04762680|455128168|FG018|Phase 3|Withdrawal by Subject|0|||
126499025|NCT04762680|455128169|FG019|Phase 3|Withdrawal by Subject|0|||
126499026|NCT04762680|455128170|FG020|Phase 3|Withdrawal by Subject|0|||
126499027|NCT04762680|455128171|FG021|Phase 3|Withdrawal by Subject|0|||
126499028|NCT04762680|455128150|FG000|Phase 3|Lost to Follow-up|0|||
126499029|NCT04762680|455128151|FG001|Phase 3|Lost to Follow-up|0|||
126774213|NCT01783483|456129124|FG000|Overall Study|Withdrawal by Subject|2|||
126774214|NCT01783483|456129125|FG001|Overall Study|Withdrawal by Subject|1|||
126774215|NCT01783483|456129124|FG000|Overall Study|Physician Decision|1|||
126499030|NCT04762680|455128152|FG002|Phase 3|Lost to Follow-up|0|||
126499031|NCT04762680|455128153|FG003|Phase 3|Lost to Follow-up|9|||
126499032|NCT04762680|455128154|FG004|Phase 3|Lost to Follow-up|22|||
126499033|NCT04762680|455128155|FG005|Phase 3|Lost to Follow-up|24|||
126774216|NCT01783483|456129125|FG001|Overall Study|Physician Decision|1|||
126499034|NCT04762680|455128156|FG006|Phase 3|Lost to Follow-up|2|||
126499035|NCT04762680|455128157|FG007|Phase 3|Lost to Follow-up|4|||
126499036|NCT04762680|455128158|FG008|Phase 3|Lost to Follow-up|6|||
126499037|NCT04762680|455128159|FG009|Phase 3|Lost to Follow-up|4|||
126499038|NCT04762680|455128160|FG010|Phase 3|Lost to Follow-up|3|||
126499039|NCT04762680|455128161|FG011|Phase 3|Lost to Follow-up|0|||
126774217|NCT04130919|456129126|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
126774218|NCT04130919|456129127|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
126499040|NCT04762680|455128162|FG012|Phase 3|Lost to Follow-up|5|||
126499041|NCT04762680|455128163|FG013|Phase 3|Lost to Follow-up|4|||
126499042|NCT04762680|455128164|FG014|Phase 3|Lost to Follow-up|6|||
126499043|NCT04762680|455128165|FG015|Phase 3|Lost to Follow-up|1|||
126499044|NCT04762680|455128166|FG016|Phase 3|Lost to Follow-up|1|||
126499045|NCT04762680|455128167|FG017|Phase 3|Lost to Follow-up|66|||
126499046|NCT04762680|455128168|FG018|Phase 3|Lost to Follow-up|0|||
126499047|NCT04762680|455128169|FG019|Phase 3|Lost to Follow-up|0|||
126499048|NCT04762680|455128170|FG020|Phase 3|Lost to Follow-up|0|||
126499049|NCT04762680|455128171|FG021|Phase 3|Lost to Follow-up|0|||
126499050|NCT04762680|455128150|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499051|NCT04762680|455128151|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499052|NCT04762680|455128152|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499053|NCT04762680|455128153|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499054|NCT04762680|455128154|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499055|NCT04762680|455128155|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499056|NCT04762680|455128156|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499057|NCT04762680|455128157|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499058|NCT04762680|455128158|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499059|NCT04762680|455128159|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499060|NCT04762680|455128160|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499061|NCT04762680|455128161|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499062|NCT04762680|455128162|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499063|NCT04762680|455128163|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499064|NCT04762680|455128164|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499065|NCT04762680|455128165|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499066|NCT04762680|455128166|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499067|NCT04762680|455128167|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499068|NCT04762680|455128168|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499069|NCT04762680|455128169|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499070|NCT04762680|455128170|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
126499071|NCT04762680|455128171|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
126499072|NCT04762680|455128150|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499073|NCT04762680|455128151|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499074|NCT04762680|455128152|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499075|NCT04762680|455128153|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499076|NCT04762680|455128154|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499077|NCT04762680|455128155|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499078|NCT04762680|455128156|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499079|NCT04762680|455128157|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499080|NCT04762680|455128158|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499081|NCT04762680|455128159|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499082|NCT04762680|455128160|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499083|NCT04762680|455128161|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499084|NCT04762680|455128162|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499085|NCT04762680|455128163|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499086|NCT04762680|455128164|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499087|NCT04762680|455128165|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499088|NCT04762680|455128166|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499089|NCT04762680|455128167|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499090|NCT04762680|455128168|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499091|NCT04762680|455128169|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
126499092|NCT04762680|455128170|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
126774219|NCT04130919|456129128|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
126774220|NCT04130919|456129129|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
126774221|NCT04130919|456129130|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
126774222|NCT04130919|456129131|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
126774223|NCT04130919|456129126|FG000|Blinded Treatment Phase|Adverse Event|0|||
126774224|NCT04130919|456129127|FG001|Blinded Treatment Phase|Adverse Event|0|||
126774225|NCT04130919|456129128|FG002|Blinded Treatment Phase|Adverse Event|1|||
126774226|NCT04130919|456129129|FG003|Blinded Treatment Phase|Adverse Event|0|||
126774227|NCT04130919|456129130|FG004|Blinded Treatment Phase|Adverse Event|0|||
126499093|NCT04762680|455128171|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
126499094|NCT02520011|455128172|FG000|Overall Study|Adverse Event|0|||
126499095|NCT02520011|455128173|FG001|Overall Study|Adverse Event|1|||
126499096|NCT02520011|455128174|FG002|Overall Study|Adverse Event|2|||
126499097|NCT02520011|455128172|FG000|Overall Study|Death|0|||
126499098|NCT02520011|455128173|FG001|Overall Study|Death|8|||
126774228|NCT04130919|456129131|FG005|Blinded Treatment Phase|Adverse Event|0|||
126774229|NCT04130919|456129126|FG000|Blinded Treatment Phase|Disease worsening|0|||
126499099|NCT02520011|455128174|FG002|Overall Study|Death|1|||
126499100|NCT02520011|455128172|FG000|Overall Study|Lack of Efficacy|4|||
126499101|NCT02520011|455128173|FG001|Overall Study|Lack of Efficacy|26|||
126499102|NCT02520011|455128174|FG002|Overall Study|Lack of Efficacy|4|||
126499103|NCT02520011|455128172|FG000|Overall Study|Physician Decision|0|||
126499104|NCT02520011|455128173|FG001|Overall Study|Physician Decision|2|||
126499105|NCT02520011|455128174|FG002|Overall Study|Physician Decision|0|||
126499106|NCT02520011|455128172|FG000|Overall Study|Withdrawal by Subject|1|||
126499107|NCT02520011|455128173|FG001|Overall Study|Withdrawal by Subject|3|||
126499108|NCT02520011|455128174|FG002|Overall Study|Withdrawal by Subject|0|||
126499109|NCT02520011|455128172|FG000|Overall Study|Protocol Deviation|0|||
126499110|NCT02520011|455128173|FG001|Overall Study|Protocol Deviation|1|||
126499111|NCT02520011|455128174|FG002|Overall Study|Protocol Deviation|0|||
126499112|NCT02520011|455128172|FG000|Overall Study|Patient went to hospice|0|||
126499113|NCT02520011|455128173|FG001|Overall Study|Patient went to hospice|1|||
126499114|NCT02520011|455128174|FG002|Overall Study|Patient went to hospice|0|||
126499115|NCT02520011|455128172|FG000|Overall Study|Progressive disease following response|0|||
126499116|NCT02520011|455128173|FG001|Overall Study|Progressive disease following response|4|||
126499117|NCT02520011|455128174|FG002|Overall Study|Progressive disease following response|2|||
126499118|NCT01063764|455128178|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
126499119|NCT01063764|455128178|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
126499120|NCT01063764|455128178|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
126499121|NCT01063764|455128178|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
126499122|NCT01063764|455128178|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
126499123|NCT01063764|455128178|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
126499124|NCT01063764|455128178|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
126499125|NCT02436759|455128179|FG000|Overall Study|Adverse Event|3|||
126499126|NCT02436759|455128180|FG001|Overall Study|Adverse Event|0|||
126499127|NCT02436759|455128179|FG000|Overall Study|Protocol Violation|1|||
126499128|NCT02436759|455128180|FG001|Overall Study|Protocol Violation|0|||
126499129|NCT02436759|455128179|FG000|Overall Study|Withdrawal by Subject|0|||
126499130|NCT02436759|455128180|FG001|Overall Study|Withdrawal by Subject|1|||
126499131|NCT01727141|455128181|FG000|Overall Study|Physician Decision|0|||
126499132|NCT01727141|455128182|FG001|Overall Study|Physician Decision|1|||
126499133|NCT01727141|455128183|FG002|Overall Study|Physician Decision|0|||
126499134|NCT01727141|455128184|FG003|Overall Study|Physician Decision|2|||
126499135|NCT01727141|455128181|FG000|Overall Study|Lost to Follow-up|0|||
126725663|NCT01877382|455944692|FG011|Dose Escalation|Progressive disease|3|||
126725664|NCT01877382|455944693|FG012|Dose Escalation|Progressive disease|13|||
126725665|NCT01877382|455944694|FG013|Dose Escalation|Progressive disease|1|||
126725666|NCT01877382|455944695|FG014|Dose Escalation|Progressive disease|0|||
126725667|NCT01877382|455944681|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
126725668|NCT01877382|455944682|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725669|NCT01877382|455944683|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725670|NCT01877382|455944684|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
126725671|NCT01877382|455944685|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725672|NCT01877382|455944686|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725673|NCT01877382|455944687|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
126725674|NCT01877382|455944688|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725675|NCT01877382|455944689|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725676|NCT01877382|455944690|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725677|NCT01877382|455944691|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725678|NCT01877382|455944692|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725679|NCT01877382|455944693|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725680|NCT01877382|455944694|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725681|NCT01877382|455944695|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725682|NCT01877382|455944681|FG000|Dose Escalation|Clinical progression|0|||
126725683|NCT01877382|455944682|FG001|Dose Escalation|Clinical progression|1|||
126725684|NCT01877382|455944683|FG002|Dose Escalation|Clinical progression|0|||
126725685|NCT01877382|455944684|FG003|Dose Escalation|Clinical progression|2|||
126725686|NCT01877382|455944685|FG004|Dose Escalation|Clinical progression|0|||
126725687|NCT01877382|455944686|FG005|Dose Escalation|Clinical progression|0|||
126725688|NCT01877382|455944687|FG006|Dose Escalation|Clinical progression|1|||
126725689|NCT01877382|455944688|FG007|Dose Escalation|Clinical progression|0|||
126725690|NCT01877382|455944689|FG008|Dose Escalation|Clinical progression|0|||
126725691|NCT01877382|455944690|FG009|Dose Escalation|Clinical progression|1|||
126725692|NCT01877382|455944691|FG010|Dose Escalation|Clinical progression|0|||
126725693|NCT01877382|455944692|FG011|Dose Escalation|Clinical progression|0|||
126499136|NCT01727141|455128182|FG001|Overall Study|Lost to Follow-up|2|||
126499137|NCT01727141|455128183|FG002|Overall Study|Lost to Follow-up|0|||
126499138|NCT01727141|455128184|FG003|Overall Study|Lost to Follow-up|0|||
126499139|NCT01727141|455128181|FG000|Overall Study|Death|0|||
126774230|NCT04130919|456129127|FG001|Blinded Treatment Phase|Disease worsening|0|||
126774231|NCT04130919|456129128|FG002|Blinded Treatment Phase|Disease worsening|1|||
126774232|NCT04130919|456129129|FG003|Blinded Treatment Phase|Disease worsening|0|||
126774233|NCT04130919|456129130|FG004|Blinded Treatment Phase|Disease worsening|0|||
126774234|NCT04130919|456129131|FG005|Blinded Treatment Phase|Disease worsening|0|||
126774235|NCT04130919|456129126|FG000|Blinded Treatment Phase|Investigator's decision|0|||
126774236|NCT04130919|456129127|FG001|Blinded Treatment Phase|Investigator's decision|1|||
126774237|NCT04130919|456129128|FG002|Blinded Treatment Phase|Investigator's decision|0|||
126774238|NCT04130919|456129129|FG003|Blinded Treatment Phase|Investigator's decision|0|||
126774239|NCT04130919|456129130|FG004|Blinded Treatment Phase|Investigator's decision|0|||
126774240|NCT04130919|456129131|FG005|Blinded Treatment Phase|Investigator's decision|0|||
126774241|NCT04130919|456129126|FG000|Blinded Treatment Phase|Withdrew consent|1|||
126774242|NCT04130919|456129127|FG001|Blinded Treatment Phase|Withdrew consent|0|||
126774243|NCT04130919|456129128|FG002|Blinded Treatment Phase|Withdrew consent|0|||
126774244|NCT04130919|456129129|FG003|Blinded Treatment Phase|Withdrew consent|0|||
126774245|NCT04130919|456129130|FG004|Blinded Treatment Phase|Withdrew consent|0|||
126774246|NCT04130919|456129131|FG005|Blinded Treatment Phase|Withdrew consent|0|||
126774247|NCT04130919|456129126|FG000|Open-label Treatment Phase|Withdrew consent|0|||
126774248|NCT04130919|456129127|FG001|Open-label Treatment Phase|Withdrew consent|0|||
126774249|NCT04130919|456129128|FG002|Open-label Treatment Phase|Withdrew consent|0|||
126774250|NCT04130919|456129129|FG003|Open-label Treatment Phase|Withdrew consent|1|||
126774251|NCT04130919|456129130|FG004|Open-label Treatment Phase|Withdrew consent|1|||
126774252|NCT04130919|456129131|FG005|Open-label Treatment Phase|Withdrew consent|1|||
126774253|NCT04130919|456129126|FG000|Open-label Treatment Phase|Disease worsening|0|||
126774254|NCT04130919|456129127|FG001|Open-label Treatment Phase|Disease worsening|0|||
126774255|NCT04130919|456129128|FG002|Open-label Treatment Phase|Disease worsening|0|||
126774256|NCT04130919|456129129|FG003|Open-label Treatment Phase|Disease worsening|1|||
126774257|NCT04130919|456129130|FG004|Open-label Treatment Phase|Disease worsening|0|||
126774258|NCT04130919|456129131|FG005|Open-label Treatment Phase|Disease worsening|1|||
126774259|NCT04130919|456129126|FG000|Open-label Treatment Phase|Investigator's decision|0|||
126774260|NCT04130919|456129127|FG001|Open-label Treatment Phase|Investigator's decision|0|||
126774261|NCT04130919|456129128|FG002|Open-label Treatment Phase|Investigator's decision|0|||
126774262|NCT04130919|456129129|FG003|Open-label Treatment Phase|Investigator's decision|1|||
126774263|NCT04130919|456129130|FG004|Open-label Treatment Phase|Investigator's decision|0|||
126774264|NCT04130919|456129131|FG005|Open-label Treatment Phase|Investigator's decision|0|||
126774265|NCT04130919|456129126|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
126774266|NCT04130919|456129127|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
126774267|NCT04130919|456129128|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
126774268|NCT04130919|456129129|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
126774269|NCT04130919|456129130|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
126774270|NCT04130919|456129131|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
126774271|NCT04130919|456129126|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
126774272|NCT04130919|456129127|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
126774273|NCT04130919|456129128|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
126774274|NCT04130919|456129129|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
126774275|NCT04130919|456129130|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
126774276|NCT04130919|456129131|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
126774277|NCT02624518|456129132|FG000|Overall Study|Physician Decision|1|||
126774278|NCT01462695|456129133|FG000|Overall Study|Adverse Event|1|||
126774279|NCT01462695|456129134|FG001|Overall Study|Adverse Event|1|||
126774280|NCT01462695|456129133|FG000|Overall Study|Death|2|||
126774281|NCT01462695|456129134|FG001|Overall Study|Death|0|||
126774282|NCT01462695|456129133|FG000|Overall Study|Lack of Efficacy|6|||
126774283|NCT01462695|456129134|FG001|Overall Study|Lack of Efficacy|12|||
126774284|NCT01462695|456129133|FG000|Overall Study|Physician Decision|5|||
126774285|NCT01462695|456129134|FG001|Overall Study|Physician Decision|0|||
126774286|NCT01462695|456129133|FG000|Overall Study|Withdrawal by Subject|2|||
126774287|NCT01462695|456129134|FG001|Overall Study|Withdrawal by Subject|0|||
126774288|NCT01462695|456129133|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
126774289|NCT01462695|456129134|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
126774290|NCT01358708|456129135|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
126774291|NCT01358708|456129136|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126774292|NCT01358708|456129135|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
126774293|NCT01358708|456129136|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
126774294|NCT03056001|456129137|FG000|Overall Study|Death|24|||
126774295|NCT03707522|456129140|FG000|Overall Study|Lost to Follow-up|24|||
126774296|NCT03707522|456129141|FG001|Overall Study|Lost to Follow-up|27|||
126774297|NCT03707522|456129142|FG002|Overall Study|Lost to Follow-up|41|||
126774298|NCT03707522|456129143|FG003|Overall Study|Lost to Follow-up|36|||
126499140|NCT01727141|455128182|FG001|Overall Study|Death|1|||
126499141|NCT01727141|455128183|FG002|Overall Study|Death|1|||
126560526|NCT00003377|455346655|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
126499142|NCT01727141|455128184|FG003|Overall Study|Death|1|||
126499143|NCT01727141|455128181|FG000|Overall Study|Protocol deviation|1|||
126499144|NCT01727141|455128182|FG001|Overall Study|Protocol deviation|1|||
126499145|NCT01727141|455128183|FG002|Overall Study|Protocol deviation|0|||
126499146|NCT01727141|455128184|FG003|Overall Study|Protocol deviation|1|||
126499147|NCT01727141|455128181|FG000|Overall Study|Withdrawal by Subject|4|||
126499148|NCT01727141|455128182|FG001|Overall Study|Withdrawal by Subject|4|||
126499149|NCT01727141|455128183|FG002|Overall Study|Withdrawal by Subject|2|||
126499150|NCT01727141|455128184|FG003|Overall Study|Withdrawal by Subject|11|||
126499151|NCT02603432|455128185|FG000|Overall Study|Adverse Event|1|||
126499152|NCT02603432|455128186|FG001|Overall Study|Adverse Event|0|||
126499153|NCT02603432|455128185|FG000|Overall Study|Death|221|||
126499154|NCT02603432|455128186|FG001|Overall Study|Death|242|||
126499155|NCT02603432|455128185|FG000|Overall Study|Lost to Follow-up|3|||
126499156|NCT02603432|455128186|FG001|Overall Study|Lost to Follow-up|9|||
126499157|NCT02603432|455128185|FG000|Overall Study|Progressive Disease|7|||
126499158|NCT02603432|455128186|FG001|Overall Study|Progressive Disease|5|||
126499159|NCT02603432|455128185|FG000|Overall Study|Withdrawal by Subject|12|||
126499160|NCT02603432|455128186|FG001|Overall Study|Withdrawal by Subject|18|||
126499161|NCT02603432|455128185|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
126499162|NCT02603432|455128186|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126499163|NCT02603432|455128185|FG000|Overall Study|Study terminated by sponsor|74|||
126499164|NCT02603432|455128186|FG001|Overall Study|Study terminated by sponsor|75|||
126499165|NCT02603432|455128185|FG000|Overall Study|Other|13|||
126499166|NCT02603432|455128186|FG001|Overall Study|Other|0|||
126499167|NCT01957462|455128190|FG000|Test Period 1|Withdrawal by Subject|1|||
126499168|NCT01957462|455128191|FG001|Test Period 1|Withdrawal by Subject|0|||
126499169|NCT01957462|455128190|FG000|Test Period 1|Adverse Event|1|||
126499170|NCT01957462|455128191|FG001|Test Period 1|Adverse Event|0|||
126499171|NCT05954052|455128192|FG000|Overall Study|Adverse Event|1|||
126499172|NCT03616912|455128193|FG000|Overall Study|Adverse Event|17|||
126499173|NCT03616912|455128194|FG001|Overall Study|Adverse Event|21|||
126499174|NCT03616912|455128195|FG002|Overall Study|Adverse Event|9|||
126499175|NCT03616912|455128196|FG003|Overall Study|Adverse Event|0|||
126499176|NCT03616912|455128197|FG004|Overall Study|Adverse Event|0|||
126499177|NCT03616912|455128198|FG005|Overall Study|Adverse Event|0|||
126499178|NCT03616912|455128193|FG000|Overall Study|Death|1|||
126499179|NCT03616912|455128194|FG001|Overall Study|Death|1|||
126499180|NCT03616912|455128195|FG002|Overall Study|Death|0|||
126499181|NCT03616912|455128196|FG003|Overall Study|Death|0|||
126499182|NCT03616912|455128197|FG004|Overall Study|Death|0|||
126499183|NCT03616912|455128198|FG005|Overall Study|Death|0|||
126499184|NCT03616912|455128193|FG000|Overall Study|Lack of Efficacy|13|||
126499185|NCT03616912|455128194|FG001|Overall Study|Lack of Efficacy|6|||
126499186|NCT03616912|455128195|FG002|Overall Study|Lack of Efficacy|8|||
126499187|NCT03616912|455128196|FG003|Overall Study|Lack of Efficacy|4|||
126499188|NCT03616912|455128197|FG004|Overall Study|Lack of Efficacy|5|||
126499189|NCT03616912|455128198|FG005|Overall Study|Lack of Efficacy|1|||
126499190|NCT03616912|455128193|FG000|Overall Study|Lost to Follow-up|1|||
126499191|NCT03616912|455128194|FG001|Overall Study|Lost to Follow-up|2|||
126499192|NCT03616912|455128195|FG002|Overall Study|Lost to Follow-up|3|||
126499193|NCT03616912|455128196|FG003|Overall Study|Lost to Follow-up|0|||
126499194|NCT03616912|455128197|FG004|Overall Study|Lost to Follow-up|0|||
126499195|NCT03616912|455128198|FG005|Overall Study|Lost to Follow-up|0|||
126499196|NCT03616912|455128193|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
126499197|NCT03616912|455128194|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
126499198|NCT03616912|455128195|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
126499199|NCT03616912|455128196|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
126499200|NCT03616912|455128197|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
126499201|NCT03616912|455128198|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
126499202|NCT03616912|455128193|FG000|Overall Study|Withdrawal by Subject|12|||
126499203|NCT03616912|455128194|FG001|Overall Study|Withdrawal by Subject|12|||
126499204|NCT03616912|455128195|FG002|Overall Study|Withdrawal by Subject|15|||
126499205|NCT03616912|455128196|FG003|Overall Study|Withdrawal by Subject|2|||
126499206|NCT03616912|455128197|FG004|Overall Study|Withdrawal by Subject|0|||
126499207|NCT03616912|455128198|FG005|Overall Study|Withdrawal by Subject|2|||
126499208|NCT03616912|455128193|FG000|Overall Study|Study Terminated by Sponsor|0|||
126499209|NCT03616912|455128194|FG001|Overall Study|Study Terminated by Sponsor|0|||
126499210|NCT03616912|455128195|FG002|Overall Study|Study Terminated by Sponsor|0|||
126499211|NCT03616912|455128196|FG003|Overall Study|Study Terminated by Sponsor|10|||
126499212|NCT03616912|455128197|FG004|Overall Study|Study Terminated by Sponsor|9|||
126499213|NCT03616912|455128198|FG005|Overall Study|Study Terminated by Sponsor|11|||
126499214|NCT03616912|455128193|FG000|Overall Study|Protocol Deviation|1|||
126499215|NCT03616912|455128194|FG001|Overall Study|Protocol Deviation|1|||
126499216|NCT03616912|455128195|FG002|Overall Study|Protocol Deviation|0|||
126499217|NCT03616912|455128196|FG003|Overall Study|Protocol Deviation|0|||
126499218|NCT03616912|455128197|FG004|Overall Study|Protocol Deviation|0|||
126499219|NCT03616912|455128198|FG005|Overall Study|Protocol Deviation|0|||
126499220|NCT03616912|455128193|FG000|Overall Study|Pregnancy|1|||
126499221|NCT03616912|455128194|FG001|Overall Study|Pregnancy|0|||
126499222|NCT03616912|455128195|FG002|Overall Study|Pregnancy|4|||
126499223|NCT03616912|455128196|FG003|Overall Study|Pregnancy|0|||
126499224|NCT03616912|455128197|FG004|Overall Study|Pregnancy|0|||
126499225|NCT03616912|455128198|FG005|Overall Study|Pregnancy|0|||
126499226|NCT03616912|455128193|FG000|Overall Study|Protocol Violation|1|||
126499227|NCT03616912|455128194|FG001|Overall Study|Protocol Violation|0|||
126499228|NCT03616912|455128195|FG002|Overall Study|Protocol Violation|2|||
126499229|NCT03616912|455128196|FG003|Overall Study|Protocol Violation|0|||
126499230|NCT03616912|455128197|FG004|Overall Study|Protocol Violation|0|||
126499231|NCT03616912|455128198|FG005|Overall Study|Protocol Violation|0|||
126499232|NCT03616912|455128193|FG000|Overall Study|Physician Decision|2|||
126499233|NCT03616912|455128194|FG001|Overall Study|Physician Decision|0|||
126499234|NCT03616912|455128195|FG002|Overall Study|Physician Decision|0|||
126499235|NCT03616912|455128196|FG003|Overall Study|Physician Decision|0|||
126499236|NCT03616912|455128197|FG004|Overall Study|Physician Decision|1|||
126499237|NCT03616912|455128198|FG005|Overall Study|Physician Decision|0|||
126499238|NCT03616912|455128193|FG000|Overall Study|Randomized But Never Treated|0|||
126499239|NCT03616912|455128194|FG001|Overall Study|Randomized But Never Treated|2|||
126499240|NCT03616912|455128195|FG002|Overall Study|Randomized But Never Treated|0|||
126499241|NCT03616912|455128196|FG003|Overall Study|Randomized But Never Treated|0|||
126499242|NCT03616912|455128197|FG004|Overall Study|Randomized But Never Treated|0|||
126499243|NCT03616912|455128198|FG005|Overall Study|Randomized But Never Treated|0|||
126499244|NCT01856790|455128199|FG000|Closed Loop Control|Withdrawal by Subject|2|||
126499245|NCT01856790|455128199|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
126499246|NCT01124604|455128200|FG000|Overall Study|Adverse Event|10|||
126499247|NCT01124604|455128201|FG001|Overall Study|Adverse Event|1|||
126499248|NCT01124604|455128200|FG000|Overall Study|Lack of Efficacy|1|||
126499249|NCT01124604|455128201|FG001|Overall Study|Lack of Efficacy|0|||
126725694|NCT01877382|455944693|FG012|Dose Escalation|Clinical progression|2|||
126725695|NCT01877382|455944694|FG013|Dose Escalation|Clinical progression|1|||
126725696|NCT01877382|455944695|FG014|Dose Escalation|Clinical progression|0|||
126725697|NCT01877382|455944681|FG000|Dose Escalation|Adverse Event|0|||
126725698|NCT01877382|455944682|FG001|Dose Escalation|Adverse Event|0|||
126725699|NCT01877382|455944683|FG002|Dose Escalation|Adverse Event|0|||
126725700|NCT01877382|455944684|FG003|Dose Escalation|Adverse Event|4|||
126725701|NCT01877382|455944685|FG004|Dose Escalation|Adverse Event|1|||
126725702|NCT01877382|455944686|FG005|Dose Escalation|Adverse Event|2|||
126725703|NCT01877382|455944687|FG006|Dose Escalation|Adverse Event|1|||
126725704|NCT01877382|455944688|FG007|Dose Escalation|Adverse Event|2|||
126725705|NCT01877382|455944689|FG008|Dose Escalation|Adverse Event|0|||
126725706|NCT01877382|455944690|FG009|Dose Escalation|Adverse Event|0|||
126725707|NCT01877382|455944691|FG010|Dose Escalation|Adverse Event|0|||
126725708|NCT01877382|455944692|FG011|Dose Escalation|Adverse Event|0|||
126725709|NCT01877382|455944693|FG012|Dose Escalation|Adverse Event|1|||
126725710|NCT01877382|455944694|FG013|Dose Escalation|Adverse Event|0|||
126725711|NCT01877382|455944695|FG014|Dose Escalation|Adverse Event|0|||
126725712|NCT01877382|455944681|FG000|Dose Escalation|Withdrawal by Subject|0|||
126725713|NCT01877382|455944682|FG001|Dose Escalation|Withdrawal by Subject|0|||
126725714|NCT01877382|455944683|FG002|Dose Escalation|Withdrawal by Subject|0|||
126725715|NCT01877382|455944684|FG003|Dose Escalation|Withdrawal by Subject|0|||
126725716|NCT01877382|455944685|FG004|Dose Escalation|Withdrawal by Subject|0|||
126725717|NCT01877382|455944686|FG005|Dose Escalation|Withdrawal by Subject|3|||
126725718|NCT01877382|455944687|FG006|Dose Escalation|Withdrawal by Subject|2|||
126725719|NCT01877382|455944688|FG007|Dose Escalation|Withdrawal by Subject|1|||
126725720|NCT01877382|455944689|FG008|Dose Escalation|Withdrawal by Subject|1|||
126725721|NCT01877382|455944690|FG009|Dose Escalation|Withdrawal by Subject|0|||
126725722|NCT01877382|455944691|FG010|Dose Escalation|Withdrawal by Subject|0|||
126725723|NCT01877382|455944692|FG011|Dose Escalation|Withdrawal by Subject|0|||
126725724|NCT01877382|455944693|FG012|Dose Escalation|Withdrawal by Subject|0|||
126725725|NCT01877382|455944694|FG013|Dose Escalation|Withdrawal by Subject|0|||
126725726|NCT01877382|455944695|FG014|Dose Escalation|Withdrawal by Subject|0|||
126725727|NCT01877382|455944681|FG000|Dose Escalation|Protocol Violation|0|||
126725728|NCT01877382|455944682|FG001|Dose Escalation|Protocol Violation|0|||
126725729|NCT01877382|455944683|FG002|Dose Escalation|Protocol Violation|0|||
126725730|NCT01877382|455944684|FG003|Dose Escalation|Protocol Violation|0|||
126499250|NCT01124604|455128200|FG000|Overall Study|Withdrawal by Subject|4|||
126499251|NCT01124604|455128201|FG001|Overall Study|Withdrawal by Subject|0|||
126499252|NCT01124604|455128200|FG000|Overall Study|Disease Progression|0|||
126499253|NCT01124604|455128201|FG001|Overall Study|Disease Progression|1|||
126499254|NCT04091646|455128202|FG000|Overall Study|Adverse Event|2|||
126499255|NCT04091646|455128203|FG001|Overall Study|Adverse Event|1|||
126499256|NCT04091646|455128202|FG000|Overall Study|Lost to Follow-up|6|||
126725731|NCT01877382|455944685|FG004|Dose Escalation|Protocol Violation|0|||
126725732|NCT01877382|455944686|FG005|Dose Escalation|Protocol Violation|0|||
126725733|NCT01877382|455944687|FG006|Dose Escalation|Protocol Violation|1|||
126499257|NCT04091646|455128203|FG001|Overall Study|Lost to Follow-up|2|||
126499258|NCT04091646|455128202|FG000|Overall Study|Protocol Violation|0|||
126499259|NCT04091646|455128203|FG001|Overall Study|Protocol Violation|1|||
126499260|NCT04091646|455128202|FG000|Overall Study|Withdrawal by Subject|4|||
126499261|NCT04091646|455128203|FG001|Overall Study|Withdrawal by Subject|1|||
126499262|NCT04091646|455128202|FG000|Overall Study|Participant Incarcerated|1|||
126499263|NCT04091646|455128203|FG001|Overall Study|Participant Incarcerated|0|||
126774299|NCT04363736|456129144|FG000|Overall Study|Withdrawal by Subject|1|||
126774300|NCT04363736|456129145|FG001|Overall Study|Withdrawal by Subject|0|||
126774301|NCT04363736|456129144|FG000|Overall Study|Lost to Follow-up|10|||
126774302|NCT04363736|456129145|FG001|Overall Study|Lost to Follow-up|7|||
126774303|NCT04363736|456129144|FG000|Overall Study|Death|8|||
126774304|NCT04363736|456129145|FG001|Overall Study|Death|6|||
126774305|NCT00990093|456129147|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
126774306|NCT00990093|456129148|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
126499264|NCT02066467|455128206|FG000|Overall Study|Did not undergo implant procedure|24|||
126499265|NCT02066467|455128206|FG000|Overall Study|Attempted to implant withoput success|43|||
126499266|NCT02066467|455128206|FG000|Overall Study|Consent ineligible|1|||
126499267|NCT02066467|455128206|FG000|Overall Study|Death|54|||
126499268|NCT02066467|455128206|FG000|Overall Study|Lost to Follow-up|51|||
126499269|NCT02066467|455128206|FG000|Overall Study|Adverse Event|20|||
126499270|NCT02066467|455128206|FG000|Overall Study|Withdrawal by Subject|16|||
126499271|NCT02066467|455128206|FG000|Overall Study|Physician Decision|2|||
126499272|NCT02066467|455128206|FG000|Overall Study|Not defined|4|||
126499273|NCT00456521|455128207|FG000|Overall Study|Adverse Event|150|||
126499274|NCT00456521|455128208|FG001|Overall Study|Adverse Event|25|||
126499275|NCT00456521|455128207|FG000|Overall Study|Withdrawal by Subject|43|||
126499276|NCT00456521|455128208|FG001|Overall Study|Withdrawal by Subject|24|||
126499277|NCT00456521|455128207|FG000|Overall Study|Lost to Follow-up|22|||
126499278|NCT00456521|455128208|FG001|Overall Study|Lost to Follow-up|17|||
126560527|NCT00003377|455346656|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
126560528|NCT00003377|455346657|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
126560529|NCT00003377|455346658|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
126560530|NCT00003377|455346654|FG000|Period II|Ureteral stent complications|0|||
126560531|NCT00003377|455346655|FG001|Period II|Ureteral stent complications|0|||
126560532|NCT00003377|455346656|FG002|Period II|Ureteral stent complications|0|||
126560533|NCT00003377|455346657|FG003|Period II|Ureteral stent complications|0|||
126560534|NCT00003377|455346658|FG004|Period II|Ureteral stent complications|1|||
126560535|NCT02256969|455346659|FG000|Overall Study|Screenfailed or withdrew|2|||
126560536|NCT02256969|455346660|FG001|Overall Study|Screenfailed or withdrew|1|||
126560537|NCT02256969|455346661|FG002|Overall Study|Screenfailed or withdrew|1|||
126560538|NCT02347943|455346662|FG000|Overall Study|Study was cancelled|140|||
126560539|NCT02347943|455346663|FG001|Overall Study|Study was cancelled|67|||
126560540|NCT02347943|455346664|FG002|Overall Study|Study was cancelled|45|||
126560541|NCT03566680|455346668|FG000|Overall Study|Pregnancy|1|||
126560542|NCT03566680|455346668|FG000|Overall Study|Lost to Follow-up|13|||
126560543|NCT03566680|455346668|FG000|Overall Study|Withdrawal by Subject|3|||
126560544|NCT02374957|455346677|FG000|Overall Study|Patient did not complete forms correctly|1|||
126560545|NCT02374957|455346678|FG001|Overall Study|Patient did not complete forms correctly|0|||
126560546|NCT00748969|455346679|FG000|Overall Study|Withdrawal by Subject|1|||
126560547|NCT00748969|455346680|FG001|Overall Study|Withdrawal by Subject|0|||
126560548|NCT00748969|455346679|FG000|Overall Study|Withdrawal by Subject|0|||
126560549|NCT00748969|455346680|FG001|Overall Study|Withdrawal by Subject|1|||
126560550|NCT02334306|455346681|FG000|Double-blind Period|Adverse Event|0|||
126560551|NCT02334306|455346682|FG001|Double-blind Period|Adverse Event|1|||
126560552|NCT02334306|455346681|FG000|Double-blind Period|Withdrawal by Subject|1|||
126560553|NCT02334306|455346682|FG001|Double-blind Period|Withdrawal by Subject|1|||
126560554|NCT01687270|455346683|FG000|Overall Study|Lack of Efficacy|11|||
126560555|NCT01687270|455346683|FG000|Overall Study|Lost to Follow-up|1|||
126560556|NCT00465985|455346684|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
126560557|NCT00465985|455346685|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
126560558|NCT00465985|455346684|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
126560559|NCT00465985|455346685|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
126560560|NCT00465985|455346684|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
126560561|NCT00465985|455346685|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
126560562|NCT00465985|455346684|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
126560563|NCT00465985|455346685|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
126560564|NCT05349084|455346686|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
126560565|NCT05124899|455346687|FG000|Overall Study|Lost to Follow-up|3|||
126560566|NCT01417000|455346689|FG000|Overall Study|Death|59|||
126560567|NCT01417000|455346690|FG001|Overall Study|Death|28|||
126560568|NCT01417000|455346689|FG000|Overall Study|Lost to Follow-up|1|||
126560569|NCT01417000|455346690|FG001|Overall Study|Lost to Follow-up|0|||
126774307|NCT00990093|456129147|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
126499279|NCT00456521|455128207|FG000|Overall Study|Lack of Efficacy|3|||
126560570|NCT01417000|455346689|FG000|Overall Study|Study Terminated by Sponsor|1|||
126499280|NCT00456521|455128208|FG001|Overall Study|Lack of Efficacy|6|||
126499281|NCT00456521|455128207|FG000|Overall Study|Protocol Violation|4|||
126499282|NCT00456521|455128208|FG001|Overall Study|Protocol Violation|0|||
126499283|NCT00456521|455128207|FG000|Overall Study|Pregnancy|1|||
126499284|NCT00456521|455128208|FG001|Overall Study|Pregnancy|1|||
126499285|NCT00456521|455128207|FG000|Overall Study|Drug non-compliance, moved, other|26|||
126499286|NCT00456521|455128208|FG001|Overall Study|Drug non-compliance, moved, other|11|||
126499287|NCT00605475|455128209|FG000|Overall Study|Abnormal Laboratory Values|0|||
126499288|NCT00605475|455128210|FG001|Overall Study|Abnormal Laboratory Values|0|||
126499289|NCT00605475|455128211|FG002|Overall Study|Abnormal Laboratory Values|0|||
126499290|NCT00605475|455128212|FG003|Overall Study|Abnormal Laboratory Values|0|||
126499291|NCT00605475|455128213|FG004|Overall Study|Abnormal Laboratory Values|0|||
126499292|NCT00605475|455128214|FG005|Overall Study|Abnormal Laboratory Values|0|||
126499293|NCT00605475|455128215|FG006|Overall Study|Abnormal Laboratory Values|0|||
126499294|NCT00605475|455128216|FG007|Overall Study|Abnormal Laboratory Values|0|||
126499295|NCT00605475|455128217|FG008|Overall Study|Abnormal Laboratory Values|1|||
126499296|NCT00605475|455128218|FG009|Overall Study|Abnormal Laboratory Values|0|||
126499297|NCT00605475|455128209|FG000|Overall Study|Administrative problems|0|||
126499298|NCT00605475|455128210|FG001|Overall Study|Administrative problems|0|||
126499299|NCT00605475|455128211|FG002|Overall Study|Administrative problems|0|||
126499300|NCT00605475|455128212|FG003|Overall Study|Administrative problems|0|||
126499301|NCT00605475|455128213|FG004|Overall Study|Administrative problems|0|||
126499302|NCT00605475|455128214|FG005|Overall Study|Administrative problems|0|||
126499303|NCT00605475|455128215|FG006|Overall Study|Administrative problems|1|||
126499304|NCT00605475|455128216|FG007|Overall Study|Administrative problems|0|||
126499305|NCT00605475|455128217|FG008|Overall Study|Administrative problems|0|||
126499306|NCT00605475|455128218|FG009|Overall Study|Administrative problems|0|||
126499307|NCT00605475|455128209|FG000|Overall Study|Lost to Follow-up|0|||
126499308|NCT00605475|455128210|FG001|Overall Study|Lost to Follow-up|0|||
126499309|NCT00605475|455128211|FG002|Overall Study|Lost to Follow-up|0|||
126499310|NCT00605475|455128212|FG003|Overall Study|Lost to Follow-up|0|||
126499311|NCT00605475|455128213|FG004|Overall Study|Lost to Follow-up|0|||
126499312|NCT00605475|455128214|FG005|Overall Study|Lost to Follow-up|0|||
126499313|NCT00605475|455128215|FG006|Overall Study|Lost to Follow-up|0|||
126499314|NCT00605475|455128216|FG007|Overall Study|Lost to Follow-up|0|||
126499315|NCT00605475|455128217|FG008|Overall Study|Lost to Follow-up|1|||
126499316|NCT00605475|455128218|FG009|Overall Study|Lost to Follow-up|1|||
126499317|NCT00605475|455128209|FG000|Overall Study|Protocol Violation|0|||
126499318|NCT00605475|455128210|FG001|Overall Study|Protocol Violation|0|||
126499319|NCT00605475|455128211|FG002|Overall Study|Protocol Violation|0|||
126499320|NCT00605475|455128212|FG003|Overall Study|Protocol Violation|0|||
126499321|NCT00605475|455128213|FG004|Overall Study|Protocol Violation|1|||
126499322|NCT00605475|455128214|FG005|Overall Study|Protocol Violation|0|||
126560571|NCT01417000|455346690|FG001|Overall Study|Study Terminated by Sponsor|1|||
126560572|NCT00647348|455346697|FG000|Overall Study|Lost to Follow-up|3|||
126725734|NCT01877382|455944688|FG007|Dose Escalation|Protocol Violation|0|||
126725735|NCT01877382|455944689|FG008|Dose Escalation|Protocol Violation|0|||
126725736|NCT01877382|455944690|FG009|Dose Escalation|Protocol Violation|0|||
126725737|NCT01877382|455944691|FG010|Dose Escalation|Protocol Violation|0|||
126725738|NCT01877382|455944692|FG011|Dose Escalation|Protocol Violation|0|||
126725739|NCT01877382|455944693|FG012|Dose Escalation|Protocol Violation|0|||
126725740|NCT01877382|455944694|FG013|Dose Escalation|Protocol Violation|0|||
126725741|NCT01877382|455944695|FG014|Dose Escalation|Protocol Violation|0|||
126725742|NCT01877382|455944681|FG000|Dose Escalation|Study terminated by sponsor|0|||
126725743|NCT01877382|455944682|FG001|Dose Escalation|Study terminated by sponsor|0|||
126725744|NCT01877382|455944683|FG002|Dose Escalation|Study terminated by sponsor|0|||
126725745|NCT01877382|455944684|FG003|Dose Escalation|Study terminated by sponsor|0|||
126725746|NCT01877382|455944685|FG004|Dose Escalation|Study terminated by sponsor|0|||
126725747|NCT01877382|455944686|FG005|Dose Escalation|Study terminated by sponsor|0|||
126725748|NCT01877382|455944687|FG006|Dose Escalation|Study terminated by sponsor|0|||
126725749|NCT01877382|455944688|FG007|Dose Escalation|Study terminated by sponsor|1|||
126725750|NCT01877382|455944689|FG008|Dose Escalation|Study terminated by sponsor|1|||
126725751|NCT01877382|455944690|FG009|Dose Escalation|Study terminated by sponsor|0|||
126725752|NCT01877382|455944691|FG010|Dose Escalation|Study terminated by sponsor|0|||
126725753|NCT01877382|455944692|FG011|Dose Escalation|Study terminated by sponsor|0|||
126725754|NCT01877382|455944693|FG012|Dose Escalation|Study terminated by sponsor|3|||
126725755|NCT01877382|455944694|FG013|Dose Escalation|Study terminated by sponsor|0|||
126725756|NCT01877382|455944695|FG014|Dose Escalation|Study terminated by sponsor|0|||
126725757|NCT01877382|455944681|FG000|Dose Escalation|Death|0|||
126725758|NCT01877382|455944682|FG001|Dose Escalation|Death|0|||
126725759|NCT01877382|455944683|FG002|Dose Escalation|Death|0|||
126725760|NCT01877382|455944684|FG003|Dose Escalation|Death|0|||
126725761|NCT01877382|455944685|FG004|Dose Escalation|Death|0|||
126725762|NCT01877382|455944686|FG005|Dose Escalation|Death|0|||
126725763|NCT01877382|455944687|FG006|Dose Escalation|Death|0|||
126725764|NCT01877382|455944688|FG007|Dose Escalation|Death|1|||
126499323|NCT00605475|455128215|FG006|Overall Study|Protocol Violation|0|||
126499324|NCT00605475|455128216|FG007|Overall Study|Protocol Violation|0|||
126499325|NCT00605475|455128217|FG008|Overall Study|Protocol Violation|0|||
126499326|NCT00605475|455128218|FG009|Overall Study|Protocol Violation|0|||
126499327|NCT00605475|455128209|FG000|Overall Study|Withdrawal by Subject|0|||
126499328|NCT00605475|455128210|FG001|Overall Study|Withdrawal by Subject|0|||
126499329|NCT00605475|455128211|FG002|Overall Study|Withdrawal by Subject|0|||
126499330|NCT00605475|455128212|FG003|Overall Study|Withdrawal by Subject|0|||
126499331|NCT00605475|455128213|FG004|Overall Study|Withdrawal by Subject|0|||
126499332|NCT00605475|455128214|FG005|Overall Study|Withdrawal by Subject|2|||
126499333|NCT00605475|455128215|FG006|Overall Study|Withdrawal by Subject|0|||
126499334|NCT00605475|455128216|FG007|Overall Study|Withdrawal by Subject|0|||
126499335|NCT00605475|455128217|FG008|Overall Study|Withdrawal by Subject|0|||
126499336|NCT00605475|455128218|FG009|Overall Study|Withdrawal by Subject|1|||
126499337|NCT02596854|455128221|FG000|Overall Study|Withdrawn|8|||
126499338|NCT00464568|455128230|FG000|Overall Study|Adverse Event|2|||
126499339|NCT03615326|455128231|FG000|Overall Study|Death|266|||
126499340|NCT03615326|455128232|FG001|Overall Study|Death|286|||
126499341|NCT03615326|455128233|FG002|Overall Study|Death|14|||
126499342|NCT03615326|455128234|FG003|Overall Study|Death|17|||
126499343|NCT03615326|455128231|FG000|Overall Study|Lost to Follow-up|0|||
126499344|NCT03615326|455128232|FG001|Overall Study|Lost to Follow-up|1|||
126499345|NCT03615326|455128233|FG002|Overall Study|Lost to Follow-up|0|||
126499346|NCT03615326|455128234|FG003|Overall Study|Lost to Follow-up|0|||
126499347|NCT03615326|455128231|FG000|Overall Study|Withdrawal by Subject|1|||
126499348|NCT03615326|455128232|FG001|Overall Study|Withdrawal by Subject|3|||
126499349|NCT03615326|455128233|FG002|Overall Study|Withdrawal by Subject|0|||
126499350|NCT03615326|455128234|FG003|Overall Study|Withdrawal by Subject|0|||
126499351|NCT03615326|455128231|FG000|Overall Study|Participants Ongoing|83|||
126499352|NCT03615326|455128232|FG001|Overall Study|Participants Ongoing|58|||
126499353|NCT03615326|455128233|FG002|Overall Study|Participants Ongoing|6|||
126499354|NCT03615326|455128234|FG003|Overall Study|Participants Ongoing|3|||
126499355|NCT00405587|455128237|FG000|Overall Study|Death|0|||
126499356|NCT00405587|455128238|FG001|Overall Study|Death|0|||
126499357|NCT00405587|455128239|FG002|Overall Study|Death|0|||
126499358|NCT00405587|455128240|FG003|Overall Study|Death|1|||
126499359|NCT00405587|455128237|FG000|Overall Study|Disease Progression|22|||
126499360|NCT00405587|455128238|FG001|Overall Study|Disease Progression|23|||
126499361|NCT00405587|455128239|FG002|Overall Study|Disease Progression|21|||
126499362|NCT00405587|455128240|FG003|Overall Study|Disease Progression|17|||
126499363|NCT00405587|455128237|FG000|Overall Study|Physician Decision|3|||
126499364|NCT00405587|455128238|FG001|Overall Study|Physician Decision|2|||
126499365|NCT00405587|455128239|FG002|Overall Study|Physician Decision|0|||
126499366|NCT00405587|455128240|FG003|Overall Study|Physician Decision|0|||
126499367|NCT00405587|455128237|FG000|Overall Study|Adverse Event|1|||
126499368|NCT00405587|455128238|FG001|Overall Study|Adverse Event|0|||
126499369|NCT00405587|455128239|FG002|Overall Study|Adverse Event|0|||
126499370|NCT00405587|455128240|FG003|Overall Study|Adverse Event|0|||
126499371|NCT00405587|455128237|FG000|Overall Study|Lost to Follow-up|0|||
126499372|NCT00405587|455128238|FG001|Overall Study|Lost to Follow-up|1|||
126499373|NCT00405587|455128239|FG002|Overall Study|Lost to Follow-up|1|||
126499374|NCT00405587|455128240|FG003|Overall Study|Lost to Follow-up|0|||
126499375|NCT00405587|455128237|FG000|Overall Study|Radiation induced necrosis|0|||
126499376|NCT00405587|455128238|FG001|Overall Study|Radiation induced necrosis|1|||
126499377|NCT00405587|455128239|FG002|Overall Study|Radiation induced necrosis|0|||
126499378|NCT00405587|455128240|FG003|Overall Study|Radiation induced necrosis|0|||
126499379|NCT00405587|455128237|FG000|Overall Study|Withdrawal by Subject|0|||
126499380|NCT00405587|455128238|FG001|Overall Study|Withdrawal by Subject|0|||
126499381|NCT00405587|455128239|FG002|Overall Study|Withdrawal by Subject|0|||
126499382|NCT00405587|455128240|FG003|Overall Study|Withdrawal by Subject|2|||
126499383|NCT00405587|455128237|FG000|Overall Study|Participant not dosed|0|||
126499384|NCT00405587|455128238|FG001|Overall Study|Participant not dosed|1|||
126499385|NCT00405587|455128239|FG002|Overall Study|Participant not dosed|0|||
126499386|NCT00405587|455128240|FG003|Overall Study|Participant not dosed|0|||
126499387|NCT06027866|455128241|FG000|Overall Study|Withdrawal by Subject|2|||
126499388|NCT03425331|455128244|FG000|Overall Study|Withdrawal by Subject|1|||
126499389|NCT03425331|455128244|FG000|Overall Study|Death|1|||
126499390|NCT03425331|455128244|FG000|Overall Study|Adverse Event|1|||
126499391|NCT03425331|455128244|FG000|Overall Study|Disease Progression|2|||
126499392|NCT02864251|455128246|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
126499393|NCT02864251|455128247|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
126499394|NCT02864251|455128248|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
126499395|NCT02864251|455128246|FG000|Pre-Treatment|Withdrawal by Participant|0|||
126499396|NCT02864251|455128247|FG001|Pre-Treatment|Withdrawal by Participant|0|||
126499397|NCT02864251|455128248|FG002|Pre-Treatment|Withdrawal by Participant|4|||
126499398|NCT02864251|455128246|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
126499399|NCT02864251|455128247|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
126499400|NCT02864251|455128248|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
126499401|NCT02864251|455128246|FG000|Pre-Treatment|Other Reasons|0|||
126499402|NCT02864251|455128247|FG001|Pre-Treatment|Other Reasons|1|||
126499403|NCT02864251|455128248|FG002|Pre-Treatment|Other Reasons|1|||
126725765|NCT01877382|455944689|FG008|Dose Escalation|Death|0|||
126725766|NCT01877382|455944690|FG009|Dose Escalation|Death|0|||
126725767|NCT01877382|455944691|FG010|Dose Escalation|Death|0|||
126725768|NCT01877382|455944692|FG011|Dose Escalation|Death|0|||
126725769|NCT01877382|455944693|FG012|Dose Escalation|Death|1|||
126725770|NCT01877382|455944694|FG013|Dose Escalation|Death|1|||
126725771|NCT01877382|455944695|FG014|Dose Escalation|Death|0|||
126725772|NCT01877382|455944681|FG000|Dose Expansion|Progressive disease|0|||
126725773|NCT01877382|455944682|FG001|Dose Expansion|Progressive disease|0|||
126725774|NCT01877382|455944683|FG002|Dose Expansion|Progressive disease|0|||
126725775|NCT01877382|455944684|FG003|Dose Expansion|Progressive disease|0|||
126725776|NCT01877382|455944685|FG004|Dose Expansion|Progressive disease|0|||
126725777|NCT01877382|455944686|FG005|Dose Expansion|Progressive disease|0|||
126725778|NCT01877382|455944687|FG006|Dose Expansion|Progressive disease|0|||
126725779|NCT01877382|455944688|FG007|Dose Expansion|Progressive disease|0|||
126725780|NCT01877382|455944689|FG008|Dose Expansion|Progressive disease|0|||
126725781|NCT01877382|455944690|FG009|Dose Expansion|Progressive disease|0|||
126725782|NCT01877382|455944691|FG010|Dose Expansion|Progressive disease|0|||
126725783|NCT01877382|455944692|FG011|Dose Expansion|Progressive disease|0|||
126725784|NCT01877382|455944693|FG012|Dose Expansion|Progressive disease|0|||
126725785|NCT01877382|455944694|FG013|Dose Expansion|Progressive disease|0|||
126725786|NCT01877382|455944695|FG014|Dose Expansion|Progressive disease|11|||
126725787|NCT01877382|455944681|FG000|Dose Expansion|Clinical progression|0|||
126725788|NCT01877382|455944682|FG001|Dose Expansion|Clinical progression|0|||
126725789|NCT01877382|455944683|FG002|Dose Expansion|Clinical progression|0|||
126725790|NCT01877382|455944684|FG003|Dose Expansion|Clinical progression|0|||
126725791|NCT01877382|455944685|FG004|Dose Expansion|Clinical progression|0|||
126725792|NCT01877382|455944686|FG005|Dose Expansion|Clinical progression|0|||
126725793|NCT01877382|455944687|FG006|Dose Expansion|Clinical progression|0|||
126725794|NCT01877382|455944688|FG007|Dose Expansion|Clinical progression|0|||
126725795|NCT01877382|455944689|FG008|Dose Expansion|Clinical progression|0|||
126725796|NCT01877382|455944690|FG009|Dose Expansion|Clinical progression|0|||
126725797|NCT01877382|455944691|FG010|Dose Expansion|Clinical progression|0|||
126725798|NCT01877382|455944692|FG011|Dose Expansion|Clinical progression|0|||
126725799|NCT01877382|455944693|FG012|Dose Expansion|Clinical progression|0|||
126725800|NCT01877382|455944694|FG013|Dose Expansion|Clinical progression|0|||
126725801|NCT01877382|455944695|FG014|Dose Expansion|Clinical progression|6|||
126725802|NCT01877382|455944681|FG000|Dose Expansion|Adverse Event|0|||
126725803|NCT01877382|455944682|FG001|Dose Expansion|Adverse Event|0|||
126725804|NCT01877382|455944683|FG002|Dose Expansion|Adverse Event|0|||
126725805|NCT01877382|455944684|FG003|Dose Expansion|Adverse Event|0|||
126725806|NCT01877382|455944685|FG004|Dose Expansion|Adverse Event|0|||
126725807|NCT01877382|455944686|FG005|Dose Expansion|Adverse Event|0|||
126725808|NCT01877382|455944687|FG006|Dose Expansion|Adverse Event|0|||
126725809|NCT01877382|455944688|FG007|Dose Expansion|Adverse Event|0|||
126725810|NCT01877382|455944689|FG008|Dose Expansion|Adverse Event|0|||
126725811|NCT01877382|455944690|FG009|Dose Expansion|Adverse Event|0|||
126725812|NCT01877382|455944691|FG010|Dose Expansion|Adverse Event|0|||
126725813|NCT01877382|455944692|FG011|Dose Expansion|Adverse Event|0|||
126725814|NCT01877382|455944693|FG012|Dose Expansion|Adverse Event|0|||
126725815|NCT01877382|455944694|FG013|Dose Expansion|Adverse Event|0|||
126725816|NCT01877382|455944695|FG014|Dose Expansion|Adverse Event|1|||
126725817|NCT01877382|455944681|FG000|Dose Expansion|Death|0|||
126725818|NCT01877382|455944682|FG001|Dose Expansion|Death|0|||
126725819|NCT01877382|455944683|FG002|Dose Expansion|Death|0|||
126725820|NCT01877382|455944684|FG003|Dose Expansion|Death|0|||
126725821|NCT01877382|455944685|FG004|Dose Expansion|Death|0|||
126725822|NCT01877382|455944686|FG005|Dose Expansion|Death|0|||
126725823|NCT01877382|455944687|FG006|Dose Expansion|Death|0|||
126725824|NCT01877382|455944688|FG007|Dose Expansion|Death|0|||
126725825|NCT01877382|455944689|FG008|Dose Expansion|Death|0|||
126725826|NCT01877382|455944690|FG009|Dose Expansion|Death|0|||
126725827|NCT01877382|455944691|FG010|Dose Expansion|Death|0|||
126725828|NCT01877382|455944692|FG011|Dose Expansion|Death|0|||
126725829|NCT01877382|455944693|FG012|Dose Expansion|Death|0|||
126725830|NCT01877382|455944694|FG013|Dose Expansion|Death|0|||
126725831|NCT01877382|455944695|FG014|Dose Expansion|Death|1|||
126725832|NCT01877382|455944681|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725833|NCT01877382|455944682|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725834|NCT01877382|455944683|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725835|NCT01877382|455944684|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725836|NCT01877382|455944685|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725837|NCT01877382|455944686|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725838|NCT01877382|455944687|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725839|NCT01877382|455944688|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126774308|NCT00990093|456129148|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
126774309|NCT00990093|456129147|FG000|Test Period 1 (1-14 Days)|Other|1|||
126774310|NCT00990093|456129148|FG001|Test Period 1 (1-14 Days)|Other|0|||
126774311|NCT00990093|456129147|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
126774312|NCT00990093|456129148|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
126774313|NCT00990093|456129147|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
126774314|NCT00990093|456129148|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
126774315|NCT00990093|456129147|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
126774316|NCT00990093|456129148|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
126774317|NCT00990093|456129147|FG000|Test Period 2 (15-28 Days)|Other|0|||
126774318|NCT00990093|456129148|FG001|Test Period 2 (15-28 Days)|Other|1|||
126774319|NCT04556838|456129149|FG000|Overall Study|Withdrawal by Subject|3|||
126774320|NCT04556838|456129150|FG001|Overall Study|Withdrawal by Subject|1|||
126774321|NCT04556838|456129151|FG002|Overall Study|Withdrawal by Subject|2|||
126774322|NCT04556838|456129149|FG000|Overall Study|Adverse Event|0|||
126774323|NCT04556838|456129150|FG001|Overall Study|Adverse Event|1|||
126774324|NCT04556838|456129151|FG002|Overall Study|Adverse Event|1|||
126774325|NCT04556838|456129149|FG000|Overall Study|Lost to Follow-up|0|||
126774326|NCT04556838|456129150|FG001|Overall Study|Lost to Follow-up|0|||
126774327|NCT04556838|456129151|FG002|Overall Study|Lost to Follow-up|2|||
126774328|NCT04556838|456129149|FG000|Overall Study|Subject travel|0|||
126774329|NCT04556838|456129150|FG001|Overall Study|Subject travel|1|||
126774330|NCT04556838|456129151|FG002|Overall Study|Subject travel|0|||
126774331|NCT04556838|456129149|FG000|Overall Study|Physician Decision|1|||
126774332|NCT04556838|456129150|FG001|Overall Study|Physician Decision|0|||
126774333|NCT04556838|456129151|FG002|Overall Study|Physician Decision|0|||
126774334|NCT00995930|456129152|FG000|Overall Study|Protocol deviation|2|||
126774335|NCT00995930|456129153|FG001|Overall Study|Protocol deviation|5|||
126774336|NCT00995930|456129152|FG000|Overall Study|Death|0|||
126774337|NCT00995930|456129153|FG001|Overall Study|Death|1|||
126774338|NCT00995930|456129152|FG000|Overall Study|Administrative problems|4|||
126774339|NCT00995930|456129153|FG001|Overall Study|Administrative problems|2|||
126774340|NCT00995930|456129152|FG000|Overall Study|Lost to Follow-up|1|||
126774341|NCT00995930|456129153|FG001|Overall Study|Lost to Follow-up|2|||
126774342|NCT00995930|456129152|FG000|Overall Study|Withdrawal by Subject|3|||
126774343|NCT00995930|456129153|FG001|Overall Study|Withdrawal by Subject|4|||
126774344|NCT00995930|456129152|FG000|Overall Study|Adverse Event|11|||
126774345|NCT00995930|456129153|FG001|Overall Study|Adverse Event|14|||
126774346|NCT05003167|456129154|FG000|Overall Study|Withdrawal by Subject|1|||
126774347|NCT01858558|456130983|FG000|Overall Study|Death|1|||
126774348|NCT01858558|456130984|FG001|Overall Study|Death|1|||
126774349|NCT01858558|456130983|FG000|Overall Study|Lost to Follow-up|1|||
126774350|NCT01858558|456130984|FG001|Overall Study|Lost to Follow-up|0|||
126774351|NCT01858558|456130983|FG000|Overall Study|Disease progression|3|||
126774352|NCT01858558|456130984|FG001|Overall Study|Disease progression|1|||
126774353|NCT01858558|456130983|FG000|Overall Study|Product contamination|2|||
126774354|NCT01858558|456130984|FG001|Overall Study|Product contamination|0|||
126774355|NCT01858558|456130983|FG000|Overall Study|Failed expansion of cell product|2|||
126499404|NCT02864251|455128246|FG000|Treatment|Disease Progression|109|||
126499405|NCT02864251|455128247|FG001|Treatment|Disease Progression|52|||
126499406|NCT02864251|455128248|FG002|Treatment|Disease Progression|101|||
126499407|NCT02864251|455128246|FG000|Treatment|Study Drug Toxicity|9|||
126499408|NCT02864251|455128247|FG001|Treatment|Study Drug Toxicity|4|||
126499409|NCT02864251|455128248|FG002|Treatment|Study Drug Toxicity|10|||
126499410|NCT02864251|455128246|FG000|Treatment|Death|0|||
126499411|NCT02864251|455128247|FG001|Treatment|Death|2|||
126725840|NCT01877382|455944689|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725841|NCT01877382|455944690|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725842|NCT01877382|455944691|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725843|NCT01877382|455944692|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725844|NCT01877382|455944693|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725845|NCT01877382|455944694|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
126725846|NCT01877382|455944695|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
126725847|NCT03829332|455944696|FG000|Overall Study|Death|225|||
126725848|NCT03829332|455944697|FG001|Overall Study|Death|230|||
126725849|NCT03829332|455944696|FG000|Overall Study|Lost to Follow-up|1|||
126725850|NCT03829332|455944697|FG001|Overall Study|Lost to Follow-up|3|||
126725851|NCT03829332|455944696|FG000|Overall Study|Physician Decision|1|||
126725852|NCT03829332|455944697|FG001|Overall Study|Physician Decision|0|||
126725853|NCT03829332|455944696|FG000|Overall Study|Sponsor Decision|71|||
126725854|NCT03829332|455944697|FG001|Overall Study|Sponsor Decision|72|||
126499412|NCT02864251|455128248|FG002|Treatment|Death|3|||
126499413|NCT02864251|455128246|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
126774356|NCT01858558|456130984|FG001|Overall Study|Failed expansion of cell product|0|||
126774357|NCT02598622|456130986|FG000|Overall Study|Withdrawal by Subject|3|||
126774358|NCT02598622|456130987|FG001|Overall Study|Withdrawal by Subject|0|||
126499414|NCT02864251|455128247|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
126499415|NCT02864251|455128248|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
126499416|NCT02864251|455128246|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
126499417|NCT02864251|455128247|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
126499418|NCT02864251|455128248|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
126499419|NCT02864251|455128246|FG000|Treatment|Withdrawal by Participant|8|||
126499420|NCT02864251|455128247|FG001|Treatment|Withdrawal by Participant|5|||
126499421|NCT02864251|455128248|FG002|Treatment|Withdrawal by Participant|13|||
126499422|NCT02864251|455128246|FG000|Treatment|Maximum Clinical Benefit|1|||
126499423|NCT02864251|455128247|FG001|Treatment|Maximum Clinical Benefit|0|||
126499424|NCT02864251|455128248|FG002|Treatment|Maximum Clinical Benefit|1|||
126499425|NCT02864251|455128246|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
126499426|NCT02864251|455128247|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
126499427|NCT02864251|455128248|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
126499428|NCT02864251|455128246|FG000|Treatment|Other Reasons|1|||
126499429|NCT02864251|455128247|FG001|Treatment|Other Reasons|1|||
126499430|NCT02864251|455128248|FG002|Treatment|Other Reasons|4|||
126560573|NCT00647348|455346698|FG001|Overall Study|Lost to Follow-up|6|||
126560574|NCT04319094|455346703|FG000|Baseline|Lost to Follow-up|4|||
126560575|NCT04319094|455346704|FG001|Baseline|Lost to Follow-up|5|||
126560576|NCT04319094|455346703|FG000|Baseline|Protocol Violation|0|||
126560577|NCT04319094|455346704|FG001|Baseline|Protocol Violation|3|||
126560578|NCT04319094|455346703|FG000|Baseline|Withdrawal by Subject|2|||
126560579|NCT04319094|455346704|FG001|Baseline|Withdrawal by Subject|1|||
126560580|NCT04319094|455346703|FG000|Post-Intervention|Death|0|||
126560581|NCT04319094|455346704|FG001|Post-Intervention|Death|1|||
126560582|NCT04319094|455346703|FG000|Post-Intervention|Lost to Follow-up|4|||
126499431|NCT02864251|455128246|FG000|Treatment|Administrative Reason by Sponsor|1|||
126499432|NCT02864251|455128247|FG001|Treatment|Administrative Reason by Sponsor|0|||
126499433|NCT02864251|455128248|FG002|Treatment|Administrative Reason by Sponsor|0|||
126499434|NCT03506373|455128249|FG000|Overall Study|Adverse Event|6|||
126560583|NCT04319094|455346704|FG001|Post-Intervention|Lost to Follow-up|4|||
126560584|NCT04319094|455346703|FG000|Post-Intervention|Withdrawal by Subject|8|||
126499435|NCT03506373|455128249|FG000|Overall Study|Withdrawal by Subject|2|||
126499436|NCT03506373|455128249|FG000|Overall Study|Disease progression|5|||
126499437|NCT03506373|455128249|FG000|Overall Study|Other|3|||
126499438|NCT00885755|455128250|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
126499439|NCT00885755|455128251|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
126499440|NCT00885755|455128252|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
126499441|NCT00885755|455128250|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
126499442|NCT00885755|455128251|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
126499443|NCT00885755|455128252|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
126499444|NCT00885755|455128250|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
126499445|NCT00885755|455128251|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
126499446|NCT00885755|455128252|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
126499447|NCT00885755|455128250|FG000|Part I: Trastuzumab+Taxane|Death|0|||
126499448|NCT00885755|455128251|FG001|Part I: Trastuzumab+Taxane|Death|0|||
126499449|NCT00885755|455128252|FG002|Part I: Trastuzumab+Taxane|Death|1|||
126499450|NCT00885755|455128250|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
126499451|NCT00885755|455128251|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
126499452|NCT00885755|455128252|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
126499453|NCT04343521|455128253|FG000|Overall Study|Adverse Event|0|||
126499454|NCT04343521|455128254|FG001|Overall Study|Adverse Event|2|||
126499455|NCT04343521|455128253|FG000|Overall Study|Death|1|||
126499456|NCT04343521|455128254|FG001|Overall Study|Death|2|||
126560585|NCT04319094|455346704|FG001|Post-Intervention|Withdrawal by Subject|5|||
126560586|NCT04319094|455346703|FG000|Post-Intervention|Incomplete Data Collection|1|||
126560587|NCT04319094|455346704|FG001|Post-Intervention|Incomplete Data Collection|3|||
126560588|NCT04319094|455346703|FG000|3-month|Death|1|||
126560589|NCT04319094|455346704|FG001|3-month|Death|0|||
126560590|NCT04319094|455346703|FG000|3-month|Lost to Follow-up|2|||
126560591|NCT04319094|455346704|FG001|3-month|Lost to Follow-up|2|||
126499457|NCT04343521|455128253|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
126560592|NCT04319094|455346703|FG000|3-month|Withdrawal by Subject|0|||
126499458|NCT04343521|455128254|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
126499459|NCT04343521|455128253|FG000|Overall Study|Withdrawal by Subject|70|||
126499460|NCT04343521|455128254|FG001|Overall Study|Withdrawal by Subject|95|||
126499461|NCT04343521|455128253|FG000|Overall Study|Withdrawal by study team|6|||
126499462|NCT04343521|455128254|FG001|Overall Study|Withdrawal by study team|12|||
126499463|NCT00107198|455128255|FG000|Overall Study|Lack of Efficacy|28|||
126560593|NCT04319094|455346704|FG001|3-month|Withdrawal by Subject|3|||
126560594|NCT04319094|455346703|FG000|3-month|Incomplete data collection|9|||
126560595|NCT04319094|455346704|FG001|3-month|Incomplete data collection|7|||
126560596|NCT04319094|455346703|FG000|6-month|Lost to Follow-up|1|||
126560597|NCT04319094|455346704|FG001|6-month|Lost to Follow-up|1|||
126560598|NCT04319094|455346703|FG000|6-month|Withdrawal by Subject|0|||
126560599|NCT04319094|455346704|FG001|6-month|Withdrawal by Subject|3|||
126774359|NCT02598622|456130986|FG000|Overall Study|Physician Decision|3|||
126774360|NCT02598622|456130987|FG001|Overall Study|Physician Decision|0|||
126774361|NCT01835470|456130988|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
126774362|NCT01835470|456130988|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
126774363|NCT04335110|456131006|FG000|Overall Study|Withdrawal by Subject|1|||
126774364|NCT04335110|456131007|FG001|Overall Study|Withdrawal by Subject|1|||
126774365|NCT04335110|456131006|FG000|Overall Study|Death|0|||
126774366|NCT04335110|456131007|FG001|Overall Study|Death|1|||
126774367|NCT00948025|456131008|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
126774368|NCT00948025|456131009|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
126774369|NCT00948025|456131008|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
126774370|NCT00948025|456131009|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
126774371|NCT00948025|456131008|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
126774372|NCT00948025|456131009|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
126774373|NCT01637961|456131010|FG000|Overall Study|Ineligible: wrong primary|1|||
126774374|NCT01637961|456131010|FG000|Overall Study|Ineligible: inadequate pathology|1|||
126774375|NCT00782275|456131017|FG000|Overall Study|Adverse Event|11|||
126774376|NCT00782275|456131017|FG000|Overall Study|Withdrawal by Subject|1|||
126774377|NCT00782275|456131017|FG000|Overall Study|Progressive Disease|21|||
126774378|NCT00782275|456131017|FG000|Overall Study|Physician Decision|4|||
126774379|NCT00782275|456131017|FG000|Overall Study|Not started treatment|1|||
126774380|NCT00782275|456131017|FG000|Overall Study|Other|3|||
126774381|NCT00289731|456131023|FG000|Overall Study|Adverse Event|1|||
126774382|NCT00289731|456131024|FG001|Overall Study|Adverse Event|2|||
126774383|NCT00289731|456131025|FG002|Overall Study|Adverse Event|2|||
126774384|NCT00289731|456131023|FG000|Overall Study|Other|1|||
126774385|NCT00289731|456131024|FG001|Overall Study|Other|0|||
126774386|NCT00289731|456131025|FG002|Overall Study|Other|0|||
126774387|NCT04378010|456131026|FG000|Overall Study|Adverse Event|8|||
126774388|NCT04378010|456131027|FG001|Overall Study|Adverse Event|14|||
126774389|NCT04378010|456131028|FG002|Overall Study|Adverse Event|4|||
126774390|NCT04378010|456131026|FG000|Overall Study|Withdrawal by Subject|0|||
126774391|NCT04378010|456131027|FG001|Overall Study|Withdrawal by Subject|2|||
126774392|NCT04378010|456131028|FG002|Overall Study|Withdrawal by Subject|1|||
126774393|NCT04378010|456131026|FG000|Overall Study|Protocol Violation|2|||
126774394|NCT04378010|456131027|FG001|Overall Study|Protocol Violation|1|||
126774395|NCT04378010|456131028|FG002|Overall Study|Protocol Violation|4|||
126774396|NCT04378010|456131026|FG000|Overall Study|Study terminated by Sponsor|22|||
126774397|NCT04378010|456131027|FG001|Overall Study|Study terminated by Sponsor|16|||
126774398|NCT04378010|456131028|FG002|Overall Study|Study terminated by Sponsor|22|||
126774399|NCT04378010|456131026|FG000|Overall Study|Subject inability to complete study visit|0|||
126774400|NCT04378010|456131027|FG001|Overall Study|Subject inability to complete study visit|0|||
126774401|NCT04378010|456131028|FG002|Overall Study|Subject inability to complete study visit|1|||
126774402|NCT04378010|456131026|FG000|Overall Study|Subject never dosed|0|||
126774403|NCT04378010|456131027|FG001|Overall Study|Subject never dosed|1|||
126774404|NCT04378010|456131028|FG002|Overall Study|Subject never dosed|0|||
126774405|NCT02019979|456131029|FG000|Overall Study|study terminated|14|||
126774406|NCT02513459|456131030|FG000|Overall Study|Adverse Event|7|||
126774407|NCT02513459|456131030|FG000|Overall Study|Withdrew consent|5|||
126774408|NCT02513459|456131030|FG000|Overall Study|Loss of efficacy|2|||
126774409|NCT02513459|456131030|FG000|Overall Study|Pregnancy|2|||
126774410|NCT02513459|456131030|FG000|Overall Study|Subject decision|2|||
126774411|NCT02513459|456131030|FG000|Overall Study|Lack of response|1|||
126774412|NCT02513459|456131030|FG000|Overall Study|Reproductive plans|1|||
126499464|NCT00107198|455128255|FG000|Overall Study|Lost to Follow-up|12|||
126499465|NCT00107198|455128255|FG000|Overall Study|Protocol Violation|1|||
126499466|NCT00107198|455128255|FG000|Overall Study|Withdrawal by Subject|6|||
126499467|NCT00107198|455128255|FG000|Overall Study|Ineligible|5|||
126499468|NCT05442554|455128256|FG000|Overall Study|Adverse Event|1|||
126499469|NCT04191382|455128261|FG000|Overall Study|Withdrawal by Subject|1|||
126499470|NCT04191382|455128262|FG001|Overall Study|Withdrawal by Subject|0|||
126499471|NCT04191382|455128263|FG002|Overall Study|Withdrawal by Subject|0|||
126499472|NCT05237206|455128264|FG000|Overall Study|screen failure-did not receive treatment|8|||
126499473|NCT05237206|455128264|FG000|Overall Study|did not receive treatment|3|||
126560600|NCT04319094|455346703|FG000|6-month|Incomplete data collection|14|||
126560601|NCT04319094|455346704|FG001|6-month|Incomplete data collection|9|||
126774413|NCT02513459|456131030|FG000|Overall Study|Surgery planned-- not done|1|||
126774414|NCT04023994|456131034|FG000|Overall Study|Lost to Follow-up|0|||
126774415|NCT04023994|456131035|FG001|Overall Study|Lost to Follow-up|1|||
126774416|NCT04023994|456131036|FG002|Overall Study|Lost to Follow-up|2|||
126774417|NCT04023994|456131037|FG003|Overall Study|Lost to Follow-up|0|||
126774418|NCT04023994|456131038|FG004|Overall Study|Lost to Follow-up|0|||
126774419|NCT04023994|456131039|FG005|Overall Study|Lost to Follow-up|0|||
126774420|NCT04023994|456131034|FG000|Overall Study|Withdrawal by Subject|0|||
126774421|NCT04023994|456131035|FG001|Overall Study|Withdrawal by Subject|0|||
126774422|NCT04023994|456131036|FG002|Overall Study|Withdrawal by Subject|0|||
126774423|NCT04023994|456131037|FG003|Overall Study|Withdrawal by Subject|1|||
126499474|NCT05172544|455128265|FG000|Overall Study|Withdrawal by Subject|1|||
126774424|NCT04023994|456131038|FG004|Overall Study|Withdrawal by Subject|0|||
126774425|NCT04023994|456131039|FG005|Overall Study|Withdrawal by Subject|0|||
126774426|NCT00923195|456131040|FG000|Overall Study|Death|0|||
126774427|NCT00923195|456131041|FG001|Overall Study|Death|1|||
126774428|NCT00467818|456131044|FG000|Overall Study|Adverse Event|1|||
126774429|NCT00467818|456131045|FG001|Overall Study|Adverse Event|0|||
126774430|NCT00467818|456131044|FG000|Overall Study|Lost to Follow-up|2|||
126774431|NCT00467818|456131045|FG001|Overall Study|Lost to Follow-up|2|||
126774432|NCT02143947|456131049|FG000|Overall Study|Lost to Follow-up|4|||
126774433|NCT02143947|456131050|FG001|Overall Study|Lost to Follow-up|2|||
126774434|NCT01244815|456131051|FG000|Overall Study|Not Treated|0|||
126774435|NCT01244815|456131052|FG001|Overall Study|Not Treated|1|||
126774436|NCT01244815|456131053|FG002|Overall Study|Not Treated|0|||
126774437|NCT01244815|456131054|FG003|Overall Study|Not Treated|0|||
126774438|NCT01244815|456131051|FG000|Overall Study|Adverse Event|4|||
126774439|NCT01244815|456131052|FG001|Overall Study|Adverse Event|7|||
126774440|NCT01244815|456131053|FG002|Overall Study|Adverse Event|5|||
126774441|NCT01244815|456131054|FG003|Overall Study|Adverse Event|5|||
126774442|NCT01244815|456131051|FG000|Overall Study|Treatment Failure|0|||
126774443|NCT01244815|456131052|FG001|Overall Study|Treatment Failure|0|||
126774444|NCT01244815|456131053|FG002|Overall Study|Treatment Failure|0|||
126774445|NCT01244815|456131054|FG003|Overall Study|Treatment Failure|1|||
126499475|NCT05172544|455128266|FG001|Overall Study|Withdrawal by Subject|0|||
126499476|NCT05172544|455128267|FG002|Overall Study|Withdrawal by Subject|0|||
126499477|NCT05172544|455128265|FG000|Overall Study|Physician Decision|0|||
126499478|NCT05172544|455128266|FG001|Overall Study|Physician Decision|0|||
126499479|NCT05172544|455128267|FG002|Overall Study|Physician Decision|1|||
126499480|NCT00362115|455128268|FG000|Overall Study|Adverse Event|0|||
126499481|NCT00362115|455128269|FG001|Overall Study|Adverse Event|1|||
126499482|NCT00362115|455128270|FG002|Overall Study|Adverse Event|1|||
126499483|NCT00362115|455128271|FG003|Overall Study|Adverse Event|1|||
126499484|NCT00362115|455128272|FG004|Overall Study|Adverse Event|2|||
126499485|NCT00362115|455128273|FG005|Overall Study|Adverse Event|2|||
126499486|NCT00362115|455128274|FG006|Overall Study|Adverse Event|1|||
126499487|NCT00362115|455128268|FG000|Overall Study|Protocol Violation|0|||
126499488|NCT00362115|455128269|FG001|Overall Study|Protocol Violation|0|||
126499489|NCT00362115|455128270|FG002|Overall Study|Protocol Violation|0|||
126499490|NCT00362115|455128271|FG003|Overall Study|Protocol Violation|0|||
126499491|NCT00362115|455128272|FG004|Overall Study|Protocol Violation|0|||
126499492|NCT00362115|455128273|FG005|Overall Study|Protocol Violation|1|||
126499493|NCT00362115|455128274|FG006|Overall Study|Protocol Violation|0|||
126499494|NCT00362115|455128268|FG000|Overall Study|Lost to Follow-up|0|||
126499495|NCT00362115|455128269|FG001|Overall Study|Lost to Follow-up|1|||
126499496|NCT00362115|455128270|FG002|Overall Study|Lost to Follow-up|0|||
126499497|NCT00362115|455128271|FG003|Overall Study|Lost to Follow-up|0|||
126499498|NCT00362115|455128272|FG004|Overall Study|Lost to Follow-up|2|||
126499499|NCT00362115|455128273|FG005|Overall Study|Lost to Follow-up|0|||
126499500|NCT00362115|455128274|FG006|Overall Study|Lost to Follow-up|1|||
126499501|NCT00362115|455128268|FG000|Overall Study|Withdrawal by Subject|1|||
126499502|NCT00362115|455128269|FG001|Overall Study|Withdrawal by Subject|3|||
126499503|NCT00362115|455128270|FG002|Overall Study|Withdrawal by Subject|1|||
126499504|NCT00362115|455128271|FG003|Overall Study|Withdrawal by Subject|0|||
126499505|NCT00362115|455128272|FG004|Overall Study|Withdrawal by Subject|1|||
126499506|NCT00362115|455128273|FG005|Overall Study|Withdrawal by Subject|3|||
126499507|NCT00362115|455128274|FG006|Overall Study|Withdrawal by Subject|4|||
126499508|NCT00362115|455128268|FG000|Overall Study|Lack of Efficacy|1|||
126499509|NCT00362115|455128269|FG001|Overall Study|Lack of Efficacy|0|||
126499510|NCT00362115|455128270|FG002|Overall Study|Lack of Efficacy|5|||
126499511|NCT00362115|455128271|FG003|Overall Study|Lack of Efficacy|2|||
126499512|NCT00362115|455128272|FG004|Overall Study|Lack of Efficacy|2|||
126499513|NCT00362115|455128273|FG005|Overall Study|Lack of Efficacy|0|||
126499514|NCT00362115|455128274|FG006|Overall Study|Lack of Efficacy|3|||
126499515|NCT00362115|455128268|FG000|Overall Study|Physician Decision|0|||
126499516|NCT00362115|455128269|FG001|Overall Study|Physician Decision|0|||
126499517|NCT00362115|455128270|FG002|Overall Study|Physician Decision|0|||
126499518|NCT00362115|455128271|FG003|Overall Study|Physician Decision|0|||
126499519|NCT00362115|455128272|FG004|Overall Study|Physician Decision|0|||
126499520|NCT00362115|455128273|FG005|Overall Study|Physician Decision|0|||
126499521|NCT00362115|455128274|FG006|Overall Study|Physician Decision|3|||
126499522|NCT00362115|455128268|FG000|Overall Study|Other|0|||
126499523|NCT00362115|455128269|FG001|Overall Study|Other|1|||
126774446|NCT01244815|456131051|FG000|Overall Study|Lost to Follow-up|3|||
126774447|NCT01244815|456131052|FG001|Overall Study|Lost to Follow-up|2|||
126499524|NCT00362115|455128270|FG002|Overall Study|Other|0|||
126774448|NCT01244815|456131053|FG002|Overall Study|Lost to Follow-up|3|||
126774449|NCT01244815|456131054|FG003|Overall Study|Lost to Follow-up|2|||
126774450|NCT01244815|456131051|FG000|Overall Study|Withdrawal by Subject|0|||
126774451|NCT01244815|456131052|FG001|Overall Study|Withdrawal by Subject|2|||
126774452|NCT01244815|456131053|FG002|Overall Study|Withdrawal by Subject|0|||
126774453|NCT01244815|456131054|FG003|Overall Study|Withdrawal by Subject|3|||
126499525|NCT00362115|455128271|FG003|Overall Study|Other|1|||
126499526|NCT00362115|455128272|FG004|Overall Study|Other|0|||
126499527|NCT00362115|455128273|FG005|Overall Study|Other|1|||
126499528|NCT00362115|455128274|FG006|Overall Study|Other|0|||
126499529|NCT01344161|455128275|FG000|Overall Study|Lost to Follow-up|4|||
126499530|NCT01344161|455128276|FG001|Overall Study|Lost to Follow-up|1|||
126499531|NCT01344161|455128275|FG000|Overall Study|Pregnancy|0|||
126499532|NCT01344161|455128276|FG001|Overall Study|Pregnancy|1|||
126499533|NCT01344161|455128275|FG000|Overall Study|Protocol Violation|1|||
126499534|NCT01344161|455128276|FG001|Overall Study|Protocol Violation|1|||
126499535|NCT00697515|455129531|FG000|Dose Optimization Period|Adverse Event|4|||
126499536|NCT00697515|455129532|FG001|Dose Optimization Period|Adverse Event|0|||
126499537|NCT00697515|455129531|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
126499538|NCT00697515|455129532|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
126499539|NCT00697515|455129531|FG000|Dose Optimization Period|Lost to Follow-up|2|||
126499540|NCT00697515|455129532|FG001|Dose Optimization Period|Lost to Follow-up|0|||
126499541|NCT00697515|455129531|FG000|Dose Optimization Period|sponsor request|2|||
126499542|NCT00697515|455129532|FG001|Dose Optimization Period|sponsor request|0|||
126499543|NCT00697515|455129531|FG000|Dose Optimization Period|called to active duty|1|||
126499544|NCT00697515|455129532|FG001|Dose Optimization Period|called to active duty|0|||
126499545|NCT00697515|455129531|FG000|Dose Optimization Period|elevated QTc|1|||
126499546|NCT00697515|455129532|FG001|Dose Optimization Period|elevated QTc|0|||
126499547|NCT00697515|455129531|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
126499548|NCT00697515|455129532|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
126499549|NCT00697515|455129531|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
126499550|NCT00697515|455129532|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
126499551|NCT00697515|455129531|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
126499552|NCT00697515|455129532|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
126499553|NCT00697515|455129531|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
126499554|NCT00697515|455129532|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
126499555|NCT00902564|455129536|FG000|Overall Study|Withdrawal by Subject|2|||
126499556|NCT02474199|455129537|FG000|Overall Study|Lost to Follow-up|1|||
126499557|NCT02474199|455129538|FG001|Overall Study|Lost to Follow-up|0|||
126499558|NCT02474199|455129539|FG002|Overall Study|Lost to Follow-up|0|||
126499559|NCT02474199|455129540|FG003|Overall Study|Lost to Follow-up|0|||
126499560|NCT02474199|455129537|FG000|Overall Study|Withdrawal by Subject|1|||
126499561|NCT02474199|455129538|FG001|Overall Study|Withdrawal by Subject|2|||
126499562|NCT02474199|455129539|FG002|Overall Study|Withdrawal by Subject|0|||
126499563|NCT02474199|455129540|FG003|Overall Study|Withdrawal by Subject|1|||
126499564|NCT02474199|455129537|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
126499565|NCT02474199|455129538|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
126499566|NCT02474199|455129539|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
126499567|NCT02474199|455129540|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
126499568|NCT02474199|455129537|FG000|Overall Study|Did not meet eligibility criteria|0|||
126499569|NCT02474199|455129538|FG001|Overall Study|Did not meet eligibility criteria|0|||
126499570|NCT02474199|455129539|FG002|Overall Study|Did not meet eligibility criteria|2|||
126499571|NCT02474199|455129540|FG003|Overall Study|Did not meet eligibility criteria|2|||
126499572|NCT04765358|455129541|FG000|Overall Study|Withdrawal by Subject|1|||
126499573|NCT02731729|455129542|FG000|Overall Study|Death|2|||
126499574|NCT02731729|455129543|FG001|Overall Study|Death|2|||
126499575|NCT02731729|455129542|FG000|Overall Study|Study terminated by Sponsor|6|||
126499576|NCT02731729|455129543|FG001|Overall Study|Study terminated by Sponsor|6|||
126499577|NCT02731729|455129542|FG000|Overall Study|Withdrawal by Subject|1|||
126499578|NCT02731729|455129543|FG001|Overall Study|Withdrawal by Subject|0|||
126499579|NCT00297037|455129544|FG000|Overall Study|Withdrawal by Subject|2|||
126499580|NCT00297037|455129545|FG001|Overall Study|Withdrawal by Subject|0|||
126499581|NCT00076011|455129546|FG000|Overall Study|Death|1|||
126499582|NCT00076011|455129546|FG000|Overall Study|Adverse Event|10|||
126499583|NCT00076011|455129546|FG000|Overall Study|Lack of Efficacy|25|||
126499584|NCT00076011|455129546|FG000|Overall Study|Withdrawal by Subject|1|||
126499585|NCT00076011|455129546|FG000|Overall Study|Study terminated by sponsor|3|||
126499586|NCT00076011|455129546|FG000|Overall Study|Other|11|||
126499587|NCT00076011|455129546|FG000|Overall Study|Ongoing|1|||
126499588|NCT00581776|455129547|FG000|Overall Study|Disease progression or no response|3|||
126499589|NCT04461015|455129550|FG000|Overall Study|IV access lost during the study|0|||
126499590|NCT04461015|455129551|FG001|Overall Study|IV access lost during the study|1|||
126499591|NCT04461015|455129550|FG000|Overall Study|Withdrawal by Subject|0|||
126499592|NCT04461015|455129551|FG001|Overall Study|Withdrawal by Subject|1|||
126499593|NCT01852812|455129561|FG000|Overall Study|Adverse Event|0|||
126499594|NCT01852812|455129562|FG001|Overall Study|Adverse Event|0|||
126499595|NCT01852812|455129563|FG002|Overall Study|Adverse Event|1|||
126499596|NCT01852812|455129561|FG000|Overall Study|Non-compliance With Study Drug|0|||
126499597|NCT01852812|455129562|FG001|Overall Study|Non-compliance With Study Drug|1|||
126499598|NCT01852812|455129563|FG002|Overall Study|Non-compliance With Study Drug|0|||
126774454|NCT01244815|456131051|FG000|Overall Study|Protocol Violation|7|||
126774455|NCT01244815|456131052|FG001|Overall Study|Protocol Violation|4|||
126774456|NCT01244815|456131053|FG002|Overall Study|Protocol Violation|3|||
126774457|NCT01244815|456131054|FG003|Overall Study|Protocol Violation|1|||
126774458|NCT01244815|456131051|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
126774459|NCT01244815|456131052|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
126774460|NCT01244815|456131053|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
126774461|NCT01244815|456131054|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
126774462|NCT01313728|456131056|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
126774463|NCT02444182|456131062|FG000|Overall Study|non-compliance|2|||
126774464|NCT02444182|456131063|FG001|Overall Study|non-compliance|1|||
126774465|NCT02444182|456131062|FG000|Overall Study|Lost to Follow-up|0|||
126774466|NCT02444182|456131063|FG001|Overall Study|Lost to Follow-up|4|||
126774467|NCT02487979|456131068|FG000|Overall Study|Physician Decision|2|||
126774468|NCT02487979|456131068|FG000|Overall Study|Withdrawal by Subject|2|||
126774469|NCT02487979|456131068|FG000|Overall Study|Progressive Disease|17|||
126774470|NCT00447694|456131069|FG000|Overall Study|Adverse Event|2|||
126774471|NCT00447694|456131069|FG000|Overall Study|Abnormal laboratory value|1|||
126774472|NCT00447694|456131069|FG000|Overall Study|Abnormal test procedure result|1|||
126774473|NCT00447694|456131069|FG000|Overall Study|Withdrawal by Subject|2|||
126774474|NCT00423488|456131071|FG000|Overall Study|No evidence of study drug intake|2|||
126774475|NCT00423488|456131072|FG001|Overall Study|No evidence of study drug intake|1|||
126774476|NCT00423488|456131071|FG000|Overall Study|No post baseline data|3|||
126774477|NCT00423488|456131072|FG001|Overall Study|No post baseline data|0|||
126774478|NCT00527397|456131073|FG000|Overall Study|Adverse Event|3|||
126774479|NCT00527397|456131073|FG000|Overall Study|Lack of Efficacy|1|||
126774480|NCT00527397|456131073|FG000|Overall Study|Protocol Violation|1|||
126774481|NCT00527397|456131073|FG000|Overall Study|Withdrawal by Subject|6|||
126774482|NCT00527397|456131073|FG000|Overall Study|Study terminated by sponsor|13|||
126774483|NCT01749033|456131076|FG000|Overall Study|Did not receive allocated intervention|3|||
126774484|NCT01749033|456131077|FG001|Overall Study|Did not receive allocated intervention|3|||
126774485|NCT01749033|456131078|FG002|Overall Study|Did not receive allocated intervention|0|||
126774486|NCT01749033|456131076|FG000|Overall Study|Lost to Follow-up|0|||
126774487|NCT01749033|456131077|FG001|Overall Study|Lost to Follow-up|2|||
126774488|NCT01749033|456131078|FG002|Overall Study|Lost to Follow-up|1|||
126774489|NCT00068237|456131079|FG000|Overall Study|Ineligible|3|||
126774490|NCT00068237|456131079|FG000|Overall Study|No protocol treatment received|2|||
126774491|NCT04380701|456131080|FG000|Overall Study|Pregnancy|0|||
126499599|NCT02250443|455129564|FG000|Overall Study|Administrative problems|7|||
126499600|NCT02250443|455129564|FG000|Overall Study|Adverse Event|3|||
126499601|NCT01549964|455129565|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
126499602|NCT01549964|455129566|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
126499603|NCT01549964|455129567|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
126499604|NCT01549964|455129568|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
126499605|NCT01549964|455129565|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
126499606|NCT01549964|455129566|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
126499607|NCT01549964|455129567|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
126499608|NCT01549964|455129568|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
126499609|NCT01549964|455129565|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
126499610|NCT01549964|455129566|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
126499611|NCT01549964|455129567|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
126499612|NCT01549964|455129568|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
126499613|NCT01549964|455129565|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
126499614|NCT01549964|455129566|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
126499615|NCT01549964|455129567|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
126499616|NCT01549964|455129568|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
126499617|NCT01549964|455129565|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
126499618|NCT01549964|455129566|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
126499619|NCT01549964|455129567|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
126499620|NCT01549964|455129568|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
126499621|NCT01549964|455129565|FG000|24-Week Treatment Period|Other|1|||
126499622|NCT01549964|455129566|FG001|24-Week Treatment Period|Other|0|||
126499623|NCT01549964|455129567|FG002|24-Week Treatment Period|Other|1|||
126499624|NCT01549964|455129568|FG003|24-Week Treatment Period|Other|0|||
126499625|NCT01549964|455129565|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
126499626|NCT01549964|455129566|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
126499627|NCT01549964|455129567|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
126499628|NCT01549964|455129568|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
126499629|NCT01549964|455129565|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
126774492|NCT04380701|456131081|FG001|Overall Study|Pregnancy|0|||
126774493|NCT04380701|456131082|FG002|Overall Study|Pregnancy|0|||
126774494|NCT04380701|456131083|FG003|Overall Study|Pregnancy|0|||
126774495|NCT04380701|456131084|FG004|Overall Study|Pregnancy|0|||
126774496|NCT04380701|456131085|FG005|Overall Study|Pregnancy|0|||
126499630|NCT01549964|455129566|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
126499631|NCT01549964|455129567|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
126499632|NCT01549964|455129568|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
126499633|NCT01549964|455129565|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
126499634|NCT01549964|455129566|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
126499635|NCT01549964|455129567|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
126499636|NCT01549964|455129568|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
126499637|NCT01549964|455129565|FG000|80-Week Extension Period|Pregnancy|0|||
126499638|NCT01549964|455129566|FG001|80-Week Extension Period|Pregnancy|0|||
126499639|NCT01549964|455129567|FG002|80-Week Extension Period|Pregnancy|1|||
126499640|NCT01549964|455129568|FG003|80-Week Extension Period|Pregnancy|0|||
126499641|NCT01549964|455129565|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
126499642|NCT01549964|455129566|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
126499643|NCT01549964|455129567|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
126499644|NCT01549964|455129568|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
126499645|NCT01549964|455129565|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
126499646|NCT01549964|455129566|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
126499647|NCT01549964|455129567|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
126499648|NCT01549964|455129568|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
126499649|NCT01549964|455129565|FG000|80-Week Extension Period|Lost to Follow-up|1|||
126499650|NCT01549964|455129566|FG001|80-Week Extension Period|Lost to Follow-up|0|||
126499651|NCT01549964|455129567|FG002|80-Week Extension Period|Lost to Follow-up|2|||
126560602|NCT04319094|455346703|FG000|9-month|Lost to Follow-up|8|||
126560603|NCT04319094|455346704|FG001|9-month|Lost to Follow-up|4|||
126560604|NCT04319094|455346703|FG000|9-month|Withdrawal by Subject|0|||
126560605|NCT04319094|455346704|FG001|9-month|Withdrawal by Subject|1|||
126560606|NCT04319094|455346703|FG000|9-month|Incomplete data collection|8|||
126560607|NCT04319094|455346704|FG001|9-month|Incomplete data collection|5|||
126560608|NCT04319094|455346703|FG000|12-month|Lost to Follow-up|11|||
126560609|NCT04319094|455346704|FG001|12-month|Lost to Follow-up|8|||
126560610|NCT04956692|455346705|FG000|Overall Study|Death|115|||
126560611|NCT04956692|455346706|FG001|Overall Study|Death|47|||
126560612|NCT04956692|455346705|FG000|Overall Study|Lost to Follow-up|0|||
126560613|NCT04956692|455346706|FG001|Overall Study|Lost to Follow-up|1|||
126560614|NCT04956692|455346705|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126560615|NCT04956692|455346706|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126560616|NCT04956692|455346705|FG000|Overall Study|Withdrawal by Subject|5|||
126560617|NCT04956692|455346706|FG001|Overall Study|Withdrawal by Subject|2|||
126560618|NCT04956692|455346705|FG000|Overall Study|Ongoing in Study|236|||
126560619|NCT04956692|455346706|FG001|Overall Study|Ongoing in Study|123|||
126560620|NCT01822821|455346710|FG000|Overall Study|Eligible surgery cancelled|1|||
126560621|NCT01822821|455346711|FG001|Overall Study|Eligible surgery cancelled|1|||
126560622|NCT01822821|455346710|FG000|Overall Study|Other reasons|1|||
126560623|NCT01822821|455346711|FG001|Overall Study|Other reasons|0|||
126560624|NCT05780047|455346712|FG000|Overall Study|Did not submit baseline urine test kit|226|||
126560625|NCT05780047|455346712|FG000|Overall Study|Lost to Follow-up|34|||
126560626|NCT05780047|455346712|FG000|Overall Study|Did not submit second urine test kit|124|||
126560627|NCT04873817|455346715|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
126560628|NCT04873817|455346715|FG000|Overall Study|Lost to Follow-up|4|||
126560629|NCT04873817|455346715|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
126560630|NCT04873817|455346715|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
126560631|NCT04873817|455346715|FG000|Overall Study|Other Reasons|3|||
126560632|NCT00665561|455346716|FG000|Overall Study|Death recorded on subject summary pages|75|||
126560633|NCT00665561|455346717|FG001|Overall Study|Death recorded on subject summary pages|75|||
126560634|NCT00665561|455346716|FG000|Overall Study|Does not meet entrance criteria|19|||
126560635|NCT00665561|455346717|FG001|Overall Study|Does not meet entrance criteria|21|||
126560636|NCT00665561|455346716|FG000|Overall Study|Lost to Follow-up|203|||
126499652|NCT01549964|455129568|FG003|80-Week Extension Period|Lost to Follow-up|1|||
126499653|NCT01549964|455129565|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
126560637|NCT00665561|455346717|FG001|Overall Study|Lost to Follow-up|264|||
126560638|NCT00665561|455346716|FG000|Overall Study|Withdrawal by Subject|74|||
126560639|NCT00665561|455346717|FG001|Overall Study|Withdrawal by Subject|65|||
126560640|NCT00665561|455346716|FG000|Overall Study|Other|123|||
126560641|NCT00665561|455346717|FG001|Overall Study|Other|108|||
126560642|NCT00665561|455346716|FG000|Overall Study|Site closed|8|||
126560643|NCT00665561|455346717|FG001|Overall Study|Site closed|0|||
126560644|NCT00665561|455346716|FG000|Overall Study|Withdrawn due to pregnancy|0|||
126774497|NCT04380701|456131086|FG006|Overall Study|Pregnancy|0|||
126499654|NCT01549964|455129566|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
126499655|NCT01549964|455129567|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
126499656|NCT01549964|455129568|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
126499657|NCT02290821|455129569|FG000|Overall Study|Withdrawal by Subject|1|||
126499658|NCT02290821|455129570|FG001|Overall Study|Withdrawal by Subject|1|||
126499659|NCT02290821|455129569|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
126499660|NCT02290821|455129570|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
126499661|NCT02290821|455129569|FG000|Overall Study|Lost to Follow-up|3|||
126499662|NCT02290821|455129570|FG001|Overall Study|Lost to Follow-up|2|||
126499663|NCT02438722|455129571|FG000|Overall Study|Adverse Event|12|||
126499664|NCT02438722|455129572|FG001|Overall Study|Adverse Event|9|||
126499665|NCT02438722|455129571|FG000|Overall Study|Refusal unrelated to AE|2|||
126499666|NCT02438722|455129572|FG001|Overall Study|Refusal unrelated to AE|5|||
126499667|NCT02438722|455129571|FG000|Overall Study|Disease progression/relapse|46|||
126499668|NCT02438722|455129572|FG001|Overall Study|Disease progression/relapse|51|||
126499669|NCT02438722|455129571|FG000|Overall Study|Death|0|||
126499670|NCT02438722|455129572|FG001|Overall Study|Death|3|||
126499671|NCT02438722|455129571|FG000|Overall Study|Physician Decision|2|||
126499672|NCT02438722|455129572|FG001|Overall Study|Physician Decision|2|||
126499673|NCT02438722|455129571|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
126499674|NCT02438722|455129572|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
126499675|NCT02438722|455129571|FG000|Overall Study|Withdrawal by Subject|0|||
126499676|NCT02438722|455129572|FG001|Overall Study|Withdrawal by Subject|1|||
126499677|NCT02438722|455129571|FG000|Overall Study|On protocol treatment|15|||
126499678|NCT02438722|455129572|FG001|Overall Study|On protocol treatment|14|||
126499679|NCT02438722|455129571|FG000|Overall Study|Did not receive protocol treatment|5|||
126499680|NCT02438722|455129572|FG001|Overall Study|Did not receive protocol treatment|0|||
126499681|NCT00909779|455129573|FG000|Overall Study|Adverse Event|53|||
126499682|NCT00909779|455129574|FG001|Overall Study|Adverse Event|55|||
126499683|NCT00909779|455129573|FG000|Overall Study|Lack of Efficacy|7|||
126499684|NCT00909779|455129574|FG001|Overall Study|Lack of Efficacy|4|||
126499685|NCT00909779|455129573|FG000|Overall Study|Lost to Follow-up|19|||
126499686|NCT00909779|455129574|FG001|Overall Study|Lost to Follow-up|15|||
126499687|NCT00909779|455129573|FG000|Overall Study|Physician Decision|8|||
126499688|NCT00909779|455129574|FG001|Overall Study|Physician Decision|2|||
126499689|NCT00909779|455129573|FG000|Overall Study|Protocol Violation|2|||
126499690|NCT00909779|455129574|FG001|Overall Study|Protocol Violation|5|||
126499691|NCT00909779|455129573|FG000|Overall Study|Withdrawal by Subject|116|||
126499692|NCT00909779|455129574|FG001|Overall Study|Withdrawal by Subject|80|||
126499693|NCT00909779|455129573|FG000|Overall Study|Site Ceasing Operation|2|||
126499694|NCT00909779|455129574|FG001|Overall Study|Site Ceasing Operation|2|||
126499695|NCT00909779|455129573|FG000|Overall Study|Medical Monitor Decision|1|||
126499696|NCT00909779|455129574|FG001|Overall Study|Medical Monitor Decision|0|||
126499697|NCT00909779|455129573|FG000|Overall Study|Noncompliance|1|||
126560645|NCT00665561|455346717|FG001|Overall Study|Withdrawn due to pregnancy|1|||
126560646|NCT00062868|455346720|FG000|Dose Level 1|Death|2|||
126560647|NCT00062868|455346721|FG001|Dose Level 1|Death|0|||
126560648|NCT00062868|455346722|FG002|Dose Level 1|Death|0|||
126560649|NCT00062868|455346723|FG003|Dose Level 1|Death|2|||
126560650|NCT00062868|455346724|FG004|Dose Level 1|Death|0|||
126560651|NCT00062868|455346725|FG005|Dose Level 1|Death|0|||
126560652|NCT00062868|455346726|FG006|Dose Level 1|Death|3|||
126560653|NCT00062868|455346727|FG007|Dose Level 1|Death|0|||
126560654|NCT00062868|455346728|FG008|Dose Level 1|Death|0|||
126560655|NCT00062868|455346729|FG009|Dose Level 1|Death|0|||
126560656|NCT00062868|455346730|FG010|Dose Level 1|Death|0|||
126774498|NCT04380701|456131087|FG007|Overall Study|Pregnancy|0|||
126774499|NCT04380701|456131088|FG008|Overall Study|Pregnancy|0|||
126774500|NCT04380701|456131089|FG009|Overall Study|Pregnancy|0|||
126774501|NCT04380701|456131090|FG010|Overall Study|Pregnancy|0|||
126774502|NCT04380701|456131091|FG011|Overall Study|Pregnancy|0|||
126774503|NCT04380701|456131092|FG012|Overall Study|Pregnancy|0|||
126774504|NCT04380701|456131093|FG013|Overall Study|Pregnancy|0|||
126774505|NCT04380701|456131094|FG014|Overall Study|Pregnancy|0|||
126774506|NCT04380701|456131095|FG015|Overall Study|Pregnancy|0|||
126560657|NCT00062868|455346731|FG011|Dose Level 1|Death|0|||
126560658|NCT00062868|455346732|FG012|Dose Level 1|Death|0|||
126560659|NCT00062868|455346733|FG013|Dose Level 1|Death|0|||
126774507|NCT04380701|456131096|FG016|Overall Study|Pregnancy|0|||
126774508|NCT04380701|456131097|FG017|Overall Study|Pregnancy|0|||
126499698|NCT00909779|455129574|FG001|Overall Study|Noncompliance|1|||
126560660|NCT00062868|455346734|FG014|Dose Level 1|Death|0|||
126499699|NCT00909779|455129573|FG000|Overall Study|Randomized in error|1|||
126499700|NCT00909779|455129574|FG001|Overall Study|Randomized in error|1|||
126774509|NCT04380701|456131098|FG018|Overall Study|Pregnancy|0|||
126774510|NCT04380701|456131099|FG019|Overall Study|Pregnancy|0|||
126499701|NCT00949325|455129575|FG000|Overall Study|Adverse Event|0|||
126499702|NCT00949325|455129576|FG001|Overall Study|Adverse Event|2|||
126499703|NCT00949325|455129577|FG002|Overall Study|Adverse Event|0|||
126499704|NCT01520363|455129578|FG000|Overall Study|Withdrawal by Subject|2|||
126560661|NCT00062868|455346735|FG015|Dose Level 1|Death|0|||
126560662|NCT00062868|455346736|FG016|Dose Level 1|Death|0|||
126560663|NCT00062868|455346737|FG017|Dose Level 1|Death|0|||
126774511|NCT04380701|456131100|FG020|Overall Study|Pregnancy|0|||
126774512|NCT04380701|456131101|FG021|Overall Study|Pregnancy|0|||
126774513|NCT04380701|456131102|FG022|Overall Study|Pregnancy|0|||
126560664|NCT00062868|455346738|FG018|Dose Level 1|Death|7|||
126560665|NCT00062868|455346739|FG019|Dose Level 1|Death|0|||
126560666|NCT00062868|455346740|FG020|Dose Level 1|Death|1|||
126560667|NCT00062868|455346720|FG000|Dose Level 1|Lost to Follow-up|0|||
126560668|NCT00062868|455346721|FG001|Dose Level 1|Lost to Follow-up|0|||
126560669|NCT00062868|455346722|FG002|Dose Level 1|Lost to Follow-up|0|||
126560670|NCT00062868|455346723|FG003|Dose Level 1|Lost to Follow-up|0|||
126560671|NCT00062868|455346724|FG004|Dose Level 1|Lost to Follow-up|0|||
126560672|NCT00062868|455346725|FG005|Dose Level 1|Lost to Follow-up|0|||
126560673|NCT00062868|455346726|FG006|Dose Level 1|Lost to Follow-up|0|||
126560674|NCT00062868|455346727|FG007|Dose Level 1|Lost to Follow-up|0|||
126560675|NCT00062868|455346728|FG008|Dose Level 1|Lost to Follow-up|0|||
126560676|NCT00062868|455346729|FG009|Dose Level 1|Lost to Follow-up|0|||
126560677|NCT00062868|455346730|FG010|Dose Level 1|Lost to Follow-up|0|||
126560678|NCT00062868|455346731|FG011|Dose Level 1|Lost to Follow-up|0|||
126560679|NCT00062868|455346732|FG012|Dose Level 1|Lost to Follow-up|1|||
126560680|NCT00062868|455346733|FG013|Dose Level 1|Lost to Follow-up|0|||
126560681|NCT00062868|455346734|FG014|Dose Level 1|Lost to Follow-up|0|||
126560682|NCT00062868|455346735|FG015|Dose Level 1|Lost to Follow-up|0|||
126560683|NCT00062868|455346736|FG016|Dose Level 1|Lost to Follow-up|0|||
126560684|NCT00062868|455346737|FG017|Dose Level 1|Lost to Follow-up|0|||
126560685|NCT00062868|455346738|FG018|Dose Level 1|Lost to Follow-up|2|||
126560686|NCT00062868|455346739|FG019|Dose Level 1|Lost to Follow-up|0|||
126499705|NCT01520363|455129579|FG001|Overall Study|Withdrawal by Subject|0|||
126499706|NCT01498952|455129583|FG000|Overall Study|Death|2|||
126499707|NCT01498952|455129584|FG001|Overall Study|Death|2|||
126499708|NCT01498952|455129585|FG002|Overall Study|Death|0|||
126499709|NCT01498952|455129586|FG003|Overall Study|Death|0|||
126499710|NCT01498952|455129587|FG004|Overall Study|Death|0|||
126499711|NCT00579826|455129588|FG000|Overall Study|Withdrawal by Subject|5|||
126499712|NCT00579826|455129589|FG001|Overall Study|Withdrawal by Subject|3|||
126499713|NCT02205333|455129595|FG000|Overall Study|Death|5|||
126499714|NCT02205333|455129596|FG001|Overall Study|Death|6|||
126499715|NCT02205333|455129597|FG002|Overall Study|Death|2|||
126499716|NCT02205333|455129598|FG003|Overall Study|Death|6|||
126499717|NCT02205333|455129599|FG004|Overall Study|Death|5|||
126499718|NCT02205333|455129600|FG005|Overall Study|Death|3|||
126499719|NCT02205333|455129601|FG006|Overall Study|Death|3|||
126499720|NCT02205333|455129602|FG007|Overall Study|Death|2|||
126499721|NCT02205333|455129603|FG008|Overall Study|Death|0|||
126560687|NCT00062868|455346740|FG020|Dose Level 1|Lost to Follow-up|1|||
126560688|NCT00062868|455346720|FG000|Dose Level 2|Death|0|||
126560689|NCT00062868|455346721|FG001|Dose Level 2|Death|3|||
126560690|NCT00062868|455346722|FG002|Dose Level 2|Death|0|||
126560691|NCT00062868|455346723|FG003|Dose Level 2|Death|0|||
126499722|NCT02205333|455129595|FG000|Overall Study|Withdrawal by Subject|1|||
126499723|NCT02205333|455129596|FG001|Overall Study|Withdrawal by Subject|0|||
126499724|NCT02205333|455129597|FG002|Overall Study|Withdrawal by Subject|0|||
126499725|NCT02205333|455129598|FG003|Overall Study|Withdrawal by Subject|1|||
126499726|NCT02205333|455129599|FG004|Overall Study|Withdrawal by Subject|0|||
126560692|NCT00062868|455346724|FG004|Dose Level 2|Death|2|||
126560693|NCT00062868|455346725|FG005|Dose Level 2|Death|0|||
126560694|NCT00062868|455346726|FG006|Dose Level 2|Death|0|||
126560695|NCT00062868|455346727|FG007|Dose Level 2|Death|0|||
126560696|NCT00062868|455346728|FG008|Dose Level 2|Death|0|||
126560697|NCT00062868|455346729|FG009|Dose Level 2|Death|0|||
126560698|NCT00062868|455346730|FG010|Dose Level 2|Death|1|||
126560699|NCT00062868|455346731|FG011|Dose Level 2|Death|0|||
126560700|NCT00062868|455346732|FG012|Dose Level 2|Death|0|||
126560701|NCT00062868|455346733|FG013|Dose Level 2|Death|0|||
126560702|NCT00062868|455346734|FG014|Dose Level 2|Death|0|||
126560703|NCT00062868|455346735|FG015|Dose Level 2|Death|0|||
126725855|NCT03829332|455944696|FG000|Overall Study|Withdrawal by Subject|11|||
126725856|NCT03829332|455944697|FG001|Overall Study|Withdrawal by Subject|9|||
126725857|NCT00430521|455944698|FG000|Overall Study|Adverse Event|0|||
126725858|NCT00430521|455944699|FG001|Overall Study|Adverse Event|0|||
126725859|NCT00430521|455944700|FG002|Overall Study|Adverse Event|0|||
126499727|NCT02205333|455129600|FG005|Overall Study|Withdrawal by Subject|0|||
126499728|NCT02205333|455129601|FG006|Overall Study|Withdrawal by Subject|2|||
126499729|NCT02205333|455129602|FG007|Overall Study|Withdrawal by Subject|0|||
126499730|NCT02205333|455129603|FG008|Overall Study|Withdrawal by Subject|0|||
126499731|NCT00454987|455129604|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
126499732|NCT00454987|455129605|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
126560704|NCT00062868|455346736|FG016|Dose Level 2|Death|2|||
126560705|NCT00062868|455346737|FG017|Dose Level 2|Death|0|||
126499733|NCT00454987|455129606|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
126499734|NCT00454987|455129604|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
126560706|NCT00062868|455346738|FG018|Dose Level 2|Death|0|||
126560707|NCT00062868|455346739|FG019|Dose Level 2|Death|0|||
126560708|NCT00062868|455346740|FG020|Dose Level 2|Death|0|||
126560709|NCT00062868|455346720|FG000|Dose Level 2|Lost to Follow-up|0|||
126560710|NCT00062868|455346721|FG001|Dose Level 2|Lost to Follow-up|0|||
126499735|NCT00454987|455129605|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
126499736|NCT00454987|455129606|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
126499737|NCT00454987|455129604|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
126499738|NCT00454987|455129605|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
126499739|NCT00454987|455129606|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
126499740|NCT01476696|455129607|FG000|Overall Study|Sponsor decision|2|||
126499741|NCT01476696|455129608|FG001|Overall Study|Sponsor decision|1|||
126499742|NCT01476696|455129609|FG002|Overall Study|Sponsor decision|0|||
126499743|NCT01476696|455129607|FG000|Overall Study|Withdrawal by Subject|1|||
126499744|NCT01476696|455129608|FG001|Overall Study|Withdrawal by Subject|0|||
126499745|NCT01476696|455129609|FG002|Overall Study|Withdrawal by Subject|0|||
126499746|NCT00728130|455129610|FG000|Overall Study|Withdrawal by Subject|1|||
126499747|NCT00728130|455129610|FG000|Overall Study|Paperwork not completed in time|1|||
126499748|NCT00728130|455129610|FG000|Overall Study|Physician Decision|1|||
126499749|NCT01737047|455129615|FG000|Overall Study|Death|10|||
126499750|NCT01737047|455129616|FG001|Overall Study|Death|0|||
126499751|NCT01737047|455129617|FG002|Overall Study|Death|1|||
126499752|NCT01737047|455129615|FG000|Overall Study|Withdrawal by Subject|17|||
126499753|NCT01737047|455129616|FG001|Overall Study|Withdrawal by Subject|11|||
126499754|NCT01737047|455129617|FG002|Overall Study|Withdrawal by Subject|4|||
126499755|NCT01154218|455129618|FG000|Third Intervention Period|Adverse Event|0|||
126499756|NCT01154218|455129619|FG001|Third Intervention Period|Adverse Event|1|||
126499757|NCT01154218|455129620|FG002|Third Intervention Period|Adverse Event|0|||
126499758|NCT01154218|455129621|FG003|Third Intervention Period|Adverse Event|0|||
126499759|NCT01154218|455129618|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
126499760|NCT01154218|455129619|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
126499761|NCT01154218|455129620|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
126499762|NCT01154218|455129621|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
126499763|NCT01154218|455129618|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
126499764|NCT01154218|455129619|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
126499765|NCT01154218|455129620|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
126499766|NCT01154218|455129621|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
126499767|NCT03965962|455129624|FG000|Overall Study|Adverse Event|1|||
126499768|NCT03965962|455129625|FG001|Overall Study|Adverse Event|0|||
126499769|NCT03965962|455129626|FG002|Overall Study|Adverse Event|0|||
126499770|NCT03965962|455129627|FG003|Overall Study|Adverse Event|0|||
126499771|NCT03965962|455129624|FG000|Overall Study|Protocol Violation|21|||
126499772|NCT03965962|455129625|FG001|Overall Study|Protocol Violation|4|||
126499773|NCT03965962|455129626|FG002|Overall Study|Protocol Violation|10|||
126499774|NCT03965962|455129627|FG003|Overall Study|Protocol Violation|5|||
126499775|NCT03965962|455129624|FG000|Overall Study|Lost to Follow-up|0|||
126499776|NCT03965962|455129625|FG001|Overall Study|Lost to Follow-up|1|||
126499777|NCT03965962|455129626|FG002|Overall Study|Lost to Follow-up|0|||
126499778|NCT03965962|455129627|FG003|Overall Study|Lost to Follow-up|0|||
126499779|NCT03965962|455129624|FG000|Overall Study|Withdrawal by Subject|3|||
126499780|NCT03965962|455129625|FG001|Overall Study|Withdrawal by Subject|0|||
126499781|NCT03965962|455129626|FG002|Overall Study|Withdrawal by Subject|0|||
126499782|NCT03965962|455129627|FG003|Overall Study|Withdrawal by Subject|1|||
126499783|NCT00729183|455129628|FG000|Overall Study|Adverse Event|11|||
126499784|NCT00729183|455129629|FG001|Overall Study|Adverse Event|5|||
126499785|NCT00729183|455129628|FG000|Overall Study|Lack of Efficacy|0|||
126499786|NCT00729183|455129629|FG001|Overall Study|Lack of Efficacy|1|||
126499787|NCT00729183|455129628|FG000|Overall Study|Lost to Follow-up|3|||
126499788|NCT00729183|455129629|FG001|Overall Study|Lost to Follow-up|1|||
126499789|NCT00729183|455129628|FG000|Overall Study|Physician Decision|1|||
126499790|NCT00729183|455129629|FG001|Overall Study|Physician Decision|1|||
126499791|NCT00729183|455129628|FG000|Overall Study|Protocol Violation|1|||
126499792|NCT00729183|455129629|FG001|Overall Study|Protocol Violation|0|||
126499793|NCT00729183|455129628|FG000|Overall Study|Withdrawal by Subject|9|||
126499794|NCT00729183|455129629|FG001|Overall Study|Withdrawal by Subject|7|||
126499795|NCT05497284|455129632|FG000|Overall Study|Adverse Event|1|||
126499796|NCT05497284|455129633|FG001|Overall Study|Adverse Event|0|||
126499797|NCT05497284|455129632|FG000|Overall Study|Physician Decision|0|||
126499798|NCT05497284|455129633|FG001|Overall Study|Physician Decision|1|||
126499799|NCT05497284|455129632|FG000|Overall Study|Study terminated by sponsor|7|||
126499800|NCT05497284|455129633|FG001|Overall Study|Study terminated by sponsor|4|||
126499801|NCT05497284|455129632|FG000|Overall Study|Subject Decision|0|||
126499802|NCT05497284|455129633|FG001|Overall Study|Subject Decision|1|||
126499803|NCT03878446|455129634|FG000|Overall Study|Withdrawn by parent or guardian|1|||
126499804|NCT03878446|455129635|FG001|Overall Study|Withdrawn by parent or guardian|0|||
126499805|NCT03878446|455129636|FG002|Overall Study|Withdrawn by parent or guardian|0|||
126499806|NCT03878446|455129637|FG003|Overall Study|Withdrawn by parent or guardian|0|||
126499807|NCT03878446|455129638|FG004|Overall Study|Withdrawn by parent or guardian|0|||
126499808|NCT01502423|455129639|FG000|Overall Study|Withdrawal by Subject|0|||
126499809|NCT01502423|455129640|FG001|Overall Study|Withdrawal by Subject|1|||
126499810|NCT05123222|455131689|FG000|Overall Study|Lost to Follow-up|2|||
126774514|NCT04380701|456131103|FG023|Overall Study|Pregnancy|0|||
126774515|NCT04380701|456131104|FG024|Overall Study|Pregnancy|0|||
126774516|NCT04380701|456131105|FG025|Overall Study|Pregnancy|0|||
126774517|NCT04380701|456131106|FG026|Overall Study|Pregnancy|0|||
126774518|NCT04380701|456131107|FG027|Overall Study|Pregnancy|0|||
126774519|NCT04380701|456131108|FG028|Overall Study|Pregnancy|0|||
126774520|NCT04380701|456131109|FG029|Overall Study|Pregnancy|0|||
126774521|NCT04380701|456131110|FG030|Overall Study|Pregnancy|0|||
126774522|NCT04380701|456131111|FG031|Overall Study|Pregnancy|0|||
126774523|NCT04380701|456131112|FG032|Overall Study|Pregnancy|1|||
126774524|NCT04380701|456131113|FG033|Overall Study|Pregnancy|0|||
126774525|NCT04380701|456131080|FG000|Overall Study|Lost to Follow-up|0|||
126774526|NCT04380701|456131081|FG001|Overall Study|Lost to Follow-up|0|||
126774527|NCT04380701|456131082|FG002|Overall Study|Lost to Follow-up|0|||
126774528|NCT04380701|456131083|FG003|Overall Study|Lost to Follow-up|0|||
126774529|NCT04380701|456131084|FG004|Overall Study|Lost to Follow-up|0|||
126774530|NCT04380701|456131085|FG005|Overall Study|Lost to Follow-up|0|||
126774531|NCT04380701|456131086|FG006|Overall Study|Lost to Follow-up|0|||
126774532|NCT04380701|456131087|FG007|Overall Study|Lost to Follow-up|0|||
126774533|NCT04380701|456131088|FG008|Overall Study|Lost to Follow-up|0|||
126774534|NCT04380701|456131089|FG009|Overall Study|Lost to Follow-up|0|||
126499811|NCT05123222|455131690|FG001|Overall Study|Lost to Follow-up|0|||
126499812|NCT05123222|455131691|FG002|Overall Study|Lost to Follow-up|0|||
126499813|NCT05123222|455131692|FG003|Overall Study|Lost to Follow-up|0|||
126499814|NCT05123222|455131689|FG000|Overall Study|Protocol Violation|0|||
126499815|NCT05123222|455131690|FG001|Overall Study|Protocol Violation|0|||
126499816|NCT05123222|455131691|FG002|Overall Study|Protocol Violation|1|||
126499817|NCT05123222|455131692|FG003|Overall Study|Protocol Violation|0|||
126499818|NCT02255500|455131697|FG000|Overall Study|Withdrawal by Subject|1|||
126499819|NCT02255500|455131698|FG001|Overall Study|Withdrawal by Subject|0|||
126499820|NCT00265343|455131699|FG000|Overall Study|Adverse Event|10|||
126499821|NCT00265343|455131700|FG001|Overall Study|Adverse Event|7|||
126499822|NCT00265343|455131699|FG000|Overall Study|Withdrawal by Subject|3|||
126560711|NCT00062868|455346722|FG002|Dose Level 2|Lost to Follow-up|0|||
126774535|NCT04380701|456131090|FG010|Overall Study|Lost to Follow-up|0|||
126499823|NCT00265343|455131700|FG001|Overall Study|Withdrawal by Subject|9|||
126499824|NCT00265343|455131699|FG000|Overall Study|Other|8|||
126499825|NCT00265343|455131700|FG001|Overall Study|Other|3|||
126499826|NCT04865354|455131701|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
126499827|NCT04865354|455131702|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
126499828|NCT04865354|455131701|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
126499829|NCT04865354|455131702|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
126499830|NCT04865354|455131701|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
126499831|NCT04865354|455131702|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
126499832|NCT00706641|455131707|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
126499833|NCT00706641|455131707|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
126499834|NCT00706641|455131707|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
126499835|NCT00004888|455131708|FG000|Overall Study|Adverse Event|5|||
126499836|NCT00004888|455131709|FG001|Overall Study|Adverse Event|10|||
126499837|NCT00004888|455131708|FG000|Overall Study|Withdrawal by Subject|0|||
126499838|NCT00004888|455131709|FG001|Overall Study|Withdrawal by Subject|3|||
126499839|NCT00004888|455131708|FG000|Overall Study|Physician Decision|1|||
126499840|NCT00004888|455131709|FG001|Overall Study|Physician Decision|1|||
126499841|NCT00004888|455131708|FG000|Overall Study|Progressive Disease|4|||
126499842|NCT00004888|455131709|FG001|Overall Study|Progressive Disease|9|||
126499843|NCT00004888|455131708|FG000|Overall Study|Death without progressive disease|0|||
126499844|NCT00004888|455131709|FG001|Overall Study|Death without progressive disease|1|||
126499845|NCT00004888|455131708|FG000|Overall Study|Toxic death|1|||
126499846|NCT00004888|455131709|FG001|Overall Study|Toxic death|0|||
126499847|NCT02579265|455131710|FG000|Overall Study|Weaned off earlier than 28 days|44|||
126499848|NCT02579265|455131711|FG001|Overall Study|Weaned off earlier than 28 days|43|||
126499849|NCT02579265|455131710|FG000|Overall Study|Adverse Event|2|||
126499850|NCT02579265|455131711|FG001|Overall Study|Adverse Event|0|||
126499851|NCT02579265|455131710|FG000|Overall Study|Any other reason not specified|0|||
126499852|NCT02579265|455131711|FG001|Overall Study|Any other reason not specified|2|||
126499853|NCT02579265|455131710|FG000|Overall Study|Withdrawal by Subject|2|||
126499854|NCT02579265|455131711|FG001|Overall Study|Withdrawal by Subject|0|||
126499855|NCT02579265|455131710|FG000|Overall Study|Physician Decision|1|||
126774536|NCT04380701|456131091|FG011|Overall Study|Lost to Follow-up|0|||
126774537|NCT04380701|456131092|FG012|Overall Study|Lost to Follow-up|0|||
126774538|NCT04380701|456131093|FG013|Overall Study|Lost to Follow-up|0|||
126774539|NCT04380701|456131094|FG014|Overall Study|Lost to Follow-up|0|||
126499856|NCT02579265|455131711|FG001|Overall Study|Physician Decision|0|||
126499857|NCT02579265|455131710|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
126499858|NCT02579265|455131711|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
126774540|NCT04380701|456131095|FG015|Overall Study|Lost to Follow-up|0|||
126774541|NCT04380701|456131096|FG016|Overall Study|Lost to Follow-up|0|||
126774542|NCT04380701|456131097|FG017|Overall Study|Lost to Follow-up|0|||
126499859|NCT02174848|455131715|FG000|Overall Study|Adverse Event|2|||
126499860|NCT02174848|455131716|FG001|Overall Study|Adverse Event|1|||
126499861|NCT02174848|455131715|FG000|Overall Study|Withdrawal by Subject|3|||
126499862|NCT02174848|455131716|FG001|Overall Study|Withdrawal by Subject|3|||
126499863|NCT02174848|455131715|FG000|Overall Study|Lost to Follow-up|0|||
126499864|NCT02174848|455131716|FG001|Overall Study|Lost to Follow-up|1|||
126499865|NCT02174848|455131715|FG000|Overall Study|Worsening of disease|1|||
126499866|NCT02174848|455131716|FG001|Overall Study|Worsening of disease|1|||
126499867|NCT02174848|455131715|FG000|Overall Study|Unable to comply with study requirements|1|||
126499868|NCT02174848|455131716|FG001|Overall Study|Unable to comply with study requirements|0|||
126499869|NCT00644969|455131718|FG000|Treatment Phase|Randomized, not treated|1|||
126499870|NCT00644969|455131719|FG001|Treatment Phase|Randomized, not treated|0|||
126499871|NCT00644969|455131718|FG000|Treatment Phase|Adverse Event|3|||
126499872|NCT00644969|455131719|FG001|Treatment Phase|Adverse Event|0|||
126499873|NCT00644969|455131718|FG000|Treatment Phase|Withdrawal by Subject|4|||
126499874|NCT00644969|455131719|FG001|Treatment Phase|Withdrawal by Subject|0|||
126499875|NCT00644969|455131718|FG000|Treatment Phase|Lost to Follow-up|2|||
126499876|NCT00644969|455131719|FG001|Treatment Phase|Lost to Follow-up|2|||
126499877|NCT00644969|455131718|FG000|Treatment Phase|Other|4|||
126499878|NCT00644969|455131719|FG001|Treatment Phase|Other|1|||
126499879|NCT00644969|455131718|FG000|Post Treatment Phase|Death|1|||
126499880|NCT00644969|455131719|FG001|Post Treatment Phase|Death|0|||
126499881|NCT00644969|455131718|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
126499882|NCT00644969|455131719|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
126499883|NCT00644969|455131718|FG000|Post Treatment Phase|Lost to Follow-up|4|||
126499884|NCT00644969|455131719|FG001|Post Treatment Phase|Lost to Follow-up|1|||
126499885|NCT00644969|455131718|FG000|Post Treatment Phase|Other|1|||
126499886|NCT00644969|455131719|FG001|Post Treatment Phase|Other|0|||
126499887|NCT02515942|455131720|FG000|Overall Study|Adverse Event|5|||
126499888|NCT02515942|455131721|FG001|Overall Study|Adverse Event|0|||
126499889|NCT02515942|455131722|FG002|Overall Study|Adverse Event|0|||
126499890|NCT02515942|455131720|FG000|Overall Study|Death|0|||
126499891|NCT02515942|455131721|FG001|Overall Study|Death|0|||
126499892|NCT02515942|455131722|FG002|Overall Study|Death|1|||
126499893|NCT02515942|455131720|FG000|Overall Study|Lack of Efficacy|0|||
126499894|NCT02515942|455131721|FG001|Overall Study|Lack of Efficacy|0|||
126499895|NCT02515942|455131722|FG002|Overall Study|Lack of Efficacy|1|||
126499896|NCT02515942|455131720|FG000|Overall Study|Lost to Follow-up|2|||
126499897|NCT02515942|455131721|FG001|Overall Study|Lost to Follow-up|0|||
126499898|NCT02515942|455131722|FG002|Overall Study|Lost to Follow-up|0|||
126499899|NCT02515942|455131720|FG000|Overall Study|Withdrawal by Subject|0|||
126499900|NCT02515942|455131721|FG001|Overall Study|Withdrawal by Subject|3|||
126499901|NCT02515942|455131722|FG002|Overall Study|Withdrawal by Subject|2|||
126499902|NCT00922766|455131723|FG000|Overall Study|Death|3|||
126499903|NCT00922766|455131723|FG000|Overall Study|Withdrawal by Subject|2|||
126499904|NCT00922766|455131723|FG000|Overall Study|Other|1|||
126499905|NCT00922766|455131723|FG000|Overall Study|Adverse Event|1|||
126499906|NCT00666757|455131726|FG000|Overall Study|Lost to Follow-up|39|||
126499907|NCT00666757|455131727|FG001|Overall Study|Lost to Follow-up|35|||
126499908|NCT00666757|455131726|FG000|Overall Study|Protocol Violation|23|||
126499909|NCT00666757|455131727|FG001|Overall Study|Protocol Violation|24|||
126499910|NCT00666757|455131726|FG000|Overall Study|Adverse Event|22|||
126499911|NCT00666757|455131727|FG001|Overall Study|Adverse Event|12|||
126499912|NCT00666757|455131726|FG000|Overall Study|Withdrawal by Subject|13|||
126499913|NCT00666757|455131727|FG001|Overall Study|Withdrawal by Subject|17|||
126499914|NCT00666757|455131726|FG000|Overall Study|Lack of Efficacy|3|||
126499915|NCT00666757|455131727|FG001|Overall Study|Lack of Efficacy|6|||
126499916|NCT00666757|455131726|FG000|Overall Study|Physician Decision|0|||
126499917|NCT00666757|455131727|FG001|Overall Study|Physician Decision|2|||
126499918|NCT00666757|455131726|FG000|Overall Study|Sponsor decision|0|||
126499919|NCT00666757|455131727|FG001|Overall Study|Sponsor decision|1|||
126499920|NCT01231581|455131728|FG000|Overall Study|Lost to Follow-up|2|||
126499921|NCT01231581|455131729|FG001|Overall Study|Lost to Follow-up|2|||
126725860|NCT00430521|455944701|FG003|Overall Study|Adverse Event|0|||
126499922|NCT01231581|455131728|FG000|Overall Study|Withdrawal by Subject|6|||
126499923|NCT01231581|455131729|FG001|Overall Study|Withdrawal by Subject|9|||
126499924|NCT01231581|455131728|FG000|Overall Study|Study Closed/Terminated|6|||
126499925|NCT01231581|455131729|FG001|Overall Study|Study Closed/Terminated|5|||
126499926|NCT01231581|455131728|FG000|Overall Study|Death|65|||
126499927|NCT01231581|455131729|FG001|Overall Study|Death|64|||
126499928|NCT01231581|455131728|FG000|Overall Study|Ongoing|1|||
126499929|NCT01231581|455131729|FG001|Overall Study|Ongoing|0|||
126499930|NCT02510794|455131730|FG000|Overall Study|Adverse Event|0|||
126499931|NCT02510794|455131731|FG001|Overall Study|Adverse Event|1|||
126499932|NCT02510794|455131732|FG002|Overall Study|Adverse Event|0|||
126499933|NCT02510794|455131733|FG003|Overall Study|Adverse Event|0|||
126725861|NCT00430521|455944702|FG004|Overall Study|Adverse Event|0|||
126499934|NCT02510794|455131730|FG000|Overall Study|Death|1|||
126499935|NCT02510794|455131731|FG001|Overall Study|Death|2|||
126499936|NCT02510794|455131732|FG002|Overall Study|Death|1|||
126499937|NCT02510794|455131733|FG003|Overall Study|Death|1|||
126499938|NCT02510794|455131730|FG000|Overall Study|Lack of Efficacy|3|||
126499939|NCT02510794|455131731|FG001|Overall Study|Lack of Efficacy|1|||
126499940|NCT02510794|455131732|FG002|Overall Study|Lack of Efficacy|1|||
126499941|NCT02510794|455131733|FG003|Overall Study|Lack of Efficacy|0|||
126499942|NCT02510794|455131730|FG000|Overall Study|Participant moved out of the area|0|||
126499943|NCT02510794|455131731|FG001|Overall Study|Participant moved out of the area|0|||
126499944|NCT02510794|455131732|FG002|Overall Study|Participant moved out of the area|0|||
126499945|NCT02510794|455131733|FG003|Overall Study|Participant moved out of the area|1|||
126499946|NCT02510794|455131730|FG000|Overall Study|Physician Decision|3|||
126499947|NCT02510794|455131731|FG001|Overall Study|Physician Decision|0|||
126499948|NCT02510794|455131732|FG002|Overall Study|Physician Decision|0|||
126499949|NCT02510794|455131733|FG003|Overall Study|Physician Decision|0|||
126499950|NCT02510794|455131730|FG000|Overall Study|Protocol Violation|0|||
126499951|NCT02510794|455131731|FG001|Overall Study|Protocol Violation|0|||
126499952|NCT02510794|455131732|FG002|Overall Study|Protocol Violation|1|||
126499953|NCT02510794|455131733|FG003|Overall Study|Protocol Violation|0|||
126499954|NCT02510794|455131730|FG000|Overall Study|Withdrawal by Subject|1|||
126499955|NCT02510794|455131731|FG001|Overall Study|Withdrawal by Subject|2|||
126499956|NCT02510794|455131732|FG002|Overall Study|Withdrawal by Subject|4|||
126499957|NCT02510794|455131733|FG003|Overall Study|Withdrawal by Subject|3|||
126499958|NCT01649375|455131734|FG000|Up to Week 16|Adverse Event|2|||
126499959|NCT01649375|455131735|FG001|Up to Week 16|Adverse Event|5|||
126499960|NCT01649375|455131736|FG002|Up to Week 16|Adverse Event|4|||
126499961|NCT01649375|455131737|FG003|Up to Week 16|Adverse Event|0|||
126499962|NCT01649375|455131738|FG004|Up to Week 16|Adverse Event|0|||
126499963|NCT01649375|455131734|FG000|Up to Week 16|Lack of Efficacy|0|||
126499964|NCT01649375|455131735|FG001|Up to Week 16|Lack of Efficacy|0|||
126499965|NCT01649375|455131736|FG002|Up to Week 16|Lack of Efficacy|1|||
126499966|NCT01649375|455131737|FG003|Up to Week 16|Lack of Efficacy|0|||
126499967|NCT01649375|455131738|FG004|Up to Week 16|Lack of Efficacy|0|||
126499968|NCT01649375|455131734|FG000|Up to Week 16|Physician Decision|0|||
126499969|NCT01649375|455131735|FG001|Up to Week 16|Physician Decision|0|||
126499970|NCT01649375|455131736|FG002|Up to Week 16|Physician Decision|1|||
126499971|NCT01649375|455131737|FG003|Up to Week 16|Physician Decision|0|||
126499972|NCT01649375|455131738|FG004|Up to Week 16|Physician Decision|0|||
126499973|NCT01649375|455131734|FG000|Up to Week 16|Withdrawal by Subject|2|||
126499974|NCT01649375|455131735|FG001|Up to Week 16|Withdrawal by Subject|1|||
126499975|NCT01649375|455131736|FG002|Up to Week 16|Withdrawal by Subject|2|||
126499976|NCT01649375|455131737|FG003|Up to Week 16|Withdrawal by Subject|0|||
126499977|NCT01649375|455131738|FG004|Up to Week 16|Withdrawal by Subject|0|||
126499978|NCT01649375|455131734|FG000|Up to Week 16|Death|1|||
126499979|NCT01649375|455131735|FG001|Up to Week 16|Death|0|||
126499980|NCT01649375|455131736|FG002|Up to Week 16|Death|0|||
126499981|NCT01649375|455131737|FG003|Up to Week 16|Death|0|||
126725862|NCT00430521|455944703|FG005|Overall Study|Adverse Event|2|||
126725863|NCT00430521|455944704|FG006|Overall Study|Adverse Event|1|||
126725864|NCT00430521|455944705|FG007|Overall Study|Adverse Event|0|||
126725865|NCT00430521|455944698|FG000|Overall Study|Lost to Follow-up|7|||
126725866|NCT00430521|455944699|FG001|Overall Study|Lost to Follow-up|8|||
126725867|NCT00430521|455944700|FG002|Overall Study|Lost to Follow-up|3|||
126725868|NCT00430521|455944701|FG003|Overall Study|Lost to Follow-up|5|||
126725869|NCT00430521|455944702|FG004|Overall Study|Lost to Follow-up|5|||
126725870|NCT00430521|455944703|FG005|Overall Study|Lost to Follow-up|2|||
126725871|NCT00430521|455944704|FG006|Overall Study|Lost to Follow-up|8|||
126725872|NCT00430521|455944705|FG007|Overall Study|Lost to Follow-up|10|||
126725873|NCT00430521|455944698|FG000|Overall Study|Pregnancy|0|||
126725874|NCT00430521|455944699|FG001|Overall Study|Pregnancy|0|||
126725875|NCT00430521|455944700|FG002|Overall Study|Pregnancy|0|||
126725876|NCT00430521|455944701|FG003|Overall Study|Pregnancy|0|||
126774543|NCT04380701|456131098|FG018|Overall Study|Lost to Follow-up|0|||
126774544|NCT04380701|456131099|FG019|Overall Study|Lost to Follow-up|0|||
126774545|NCT04380701|456131100|FG020|Overall Study|Lost to Follow-up|1|||
126499982|NCT01649375|455131738|FG004|Up to Week 16|Death|0|||
126499983|NCT01649375|455131734|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
126499984|NCT01649375|455131735|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
126499985|NCT01649375|455131736|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
126499986|NCT01649375|455131737|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
126499987|NCT01649375|455131738|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
126499988|NCT01649375|455131734|FG000|Week 16 up to Week 260|Non-compliance|0|||
126499989|NCT01649375|455131735|FG001|Week 16 up to Week 260|Non-compliance|1|||
126560712|NCT00062868|455346723|FG003|Dose Level 2|Lost to Follow-up|0|||
126725877|NCT00430521|455944702|FG004|Overall Study|Pregnancy|0|||
126499990|NCT01649375|455131736|FG002|Week 16 up to Week 260|Non-compliance|0|||
126499991|NCT01649375|455131737|FG003|Week 16 up to Week 260|Non-compliance|1|||
126499992|NCT01649375|455131738|FG004|Week 16 up to Week 260|Non-compliance|0|||
126499993|NCT01649375|455131734|FG000|Week 16 up to Week 260|Physician Decision|0|||
126499994|NCT01649375|455131735|FG001|Week 16 up to Week 260|Physician Decision|2|||
126499995|NCT01649375|455131736|FG002|Week 16 up to Week 260|Physician Decision|0|||
126725878|NCT00430521|455944703|FG005|Overall Study|Pregnancy|0|||
126499996|NCT01649375|455131737|FG003|Week 16 up to Week 260|Physician Decision|0|||
126499997|NCT01649375|455131738|FG004|Week 16 up to Week 260|Physician Decision|0|||
126499998|NCT01649375|455131734|FG000|Week 16 up to Week 260|Technical issues|0|||
126499999|NCT01649375|455131735|FG001|Week 16 up to Week 260|Technical issues|1|||
126500000|NCT01649375|455131736|FG002|Week 16 up to Week 260|Technical issues|0|||
126500001|NCT01649375|455131737|FG003|Week 16 up to Week 260|Technical issues|1|||
126500002|NCT01649375|455131738|FG004|Week 16 up to Week 260|Technical issues|0|||
126500003|NCT01649375|455131734|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
126500004|NCT01649375|455131735|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
126500005|NCT01649375|455131736|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
126500006|NCT01649375|455131737|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
126500007|NCT01649375|455131738|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
126500008|NCT01649375|455131734|FG000|Week 16 up to Week 260|Death|1|||
126500009|NCT01649375|455131735|FG001|Week 16 up to Week 260|Death|1|||
126500010|NCT01649375|455131736|FG002|Week 16 up to Week 260|Death|0|||
126500011|NCT01649375|455131737|FG003|Week 16 up to Week 260|Death|0|||
126500012|NCT01649375|455131738|FG004|Week 16 up to Week 260|Death|0|||
126500013|NCT01649375|455131734|FG000|Week 16 up to Week 260|Adverse Event|5|||
126500014|NCT01649375|455131735|FG001|Week 16 up to Week 260|Adverse Event|2|||
126500015|NCT01649375|455131736|FG002|Week 16 up to Week 260|Adverse Event|0|||
126500016|NCT01649375|455131737|FG003|Week 16 up to Week 260|Adverse Event|3|||
126500017|NCT01649375|455131738|FG004|Week 16 up to Week 260|Adverse Event|2|||
126500018|NCT01762943|455131741|FG000|Overall Study|Physician Decision|1|||
126500019|NCT01762943|455131742|FG001|Overall Study|Physician Decision|1|||
126500020|NCT01762943|455131741|FG000|Overall Study|Protocol Violation|1|||
126500021|NCT01762943|455131742|FG001|Overall Study|Protocol Violation|0|||
126500022|NCT01762943|455131741|FG000|Overall Study|Withdrawal by Subject|2|||
126500023|NCT01762943|455131742|FG001|Overall Study|Withdrawal by Subject|1|||
126500024|NCT02658890|455131743|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500025|NCT02658890|455131744|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500026|NCT02658890|455131745|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500027|NCT02658890|455131746|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500028|NCT02658890|455131747|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500029|NCT02658890|455131748|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500030|NCT02658890|455131749|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500031|NCT02658890|455131750|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500032|NCT02658890|455131751|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
126500033|NCT02658890|455131752|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500034|NCT02658890|455131753|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500035|NCT02658890|455131754|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500036|NCT02658890|455131755|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500037|NCT02658890|455131756|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500038|NCT02658890|455131757|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500039|NCT02658890|455131758|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500040|NCT02658890|455131759|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500041|NCT02658890|455131760|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500042|NCT02658890|455131761|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500043|NCT02658890|455131762|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500044|NCT02658890|455131763|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500045|NCT02658890|455131764|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500046|NCT02658890|455131765|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500047|NCT02658890|455131766|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500048|NCT02658890|455131767|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500049|NCT02658890|455131768|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500050|NCT02658890|455131769|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500051|NCT02658890|455131743|FG000|Treatment Phase|Adverse Event|0|||
126500052|NCT02658890|455131744|FG001|Treatment Phase|Adverse Event|1|||
126500053|NCT02658890|455131745|FG002|Treatment Phase|Adverse Event|2|||
126500054|NCT02658890|455131746|FG003|Treatment Phase|Adverse Event|2|||
126500055|NCT02658890|455131747|FG004|Treatment Phase|Adverse Event|1|||
126500056|NCT02658890|455131748|FG005|Treatment Phase|Adverse Event|0|||
126500057|NCT02658890|455131749|FG006|Treatment Phase|Adverse Event|0|||
126500058|NCT02658890|455131750|FG007|Treatment Phase|Adverse Event|2|||
126500059|NCT02658890|455131751|FG008|Treatment Phase|Adverse Event|1|||
126500060|NCT02658890|455131752|FG009|Treatment Phase|Adverse Event|2|||
126500061|NCT02658890|455131753|FG010|Treatment Phase|Adverse Event|3|||
126500062|NCT02658890|455131754|FG011|Treatment Phase|Adverse Event|0|||
126500063|NCT02658890|455131755|FG012|Treatment Phase|Adverse Event|1|||
126500064|NCT02658890|455131756|FG013|Treatment Phase|Adverse Event|4|||
126500065|NCT02658890|455131757|FG014|Treatment Phase|Adverse Event|0|||
126500066|NCT02658890|455131758|FG015|Treatment Phase|Adverse Event|0|||
126560713|NCT00062868|455346724|FG004|Dose Level 2|Lost to Follow-up|0|||
126725879|NCT00430521|455944704|FG006|Overall Study|Pregnancy|1|||
126725880|NCT00430521|455944705|FG007|Overall Study|Pregnancy|0|||
126725881|NCT00430521|455944698|FG000|Overall Study|Vaccine Expired|0|||
126725882|NCT00430521|455944699|FG001|Overall Study|Vaccine Expired|0|||
126725883|NCT00430521|455944700|FG002|Overall Study|Vaccine Expired|0|||
126725884|NCT00430521|455944701|FG003|Overall Study|Vaccine Expired|0|||
126725885|NCT00430521|455944702|FG004|Overall Study|Vaccine Expired|0|||
126725886|NCT00430521|455944703|FG005|Overall Study|Vaccine Expired|1|||
126725887|NCT00430521|455944704|FG006|Overall Study|Vaccine Expired|0|||
126725888|NCT00430521|455944705|FG007|Overall Study|Vaccine Expired|0|||
126725889|NCT00430521|455944698|FG000|Overall Study|Protocol Violation|1|||
126725890|NCT00430521|455944699|FG001|Overall Study|Protocol Violation|0|||
126725891|NCT00430521|455944700|FG002|Overall Study|Protocol Violation|0|||
126725892|NCT00430521|455944701|FG003|Overall Study|Protocol Violation|0|||
126725893|NCT00430521|455944702|FG004|Overall Study|Protocol Violation|0|||
126725894|NCT00430521|455944703|FG005|Overall Study|Protocol Violation|0|||
126725895|NCT00430521|455944704|FG006|Overall Study|Protocol Violation|0|||
126725896|NCT00430521|455944705|FG007|Overall Study|Protocol Violation|0|||
126725897|NCT00430521|455944698|FG000|Overall Study|Withdrawal by Subject|3|||
126725898|NCT00430521|455944699|FG001|Overall Study|Withdrawal by Subject|1|||
126725899|NCT00430521|455944700|FG002|Overall Study|Withdrawal by Subject|0|||
126725900|NCT00430521|455944701|FG003|Overall Study|Withdrawal by Subject|3|||
126725901|NCT00430521|455944702|FG004|Overall Study|Withdrawal by Subject|0|||
126725902|NCT00430521|455944703|FG005|Overall Study|Withdrawal by Subject|0|||
126725903|NCT00430521|455944704|FG006|Overall Study|Withdrawal by Subject|0|||
126725904|NCT00430521|455944705|FG007|Overall Study|Withdrawal by Subject|2|||
126725905|NCT02115113|455946373|FG000|Participants in Run-in Period|Death|0|||
126725906|NCT02115113|455946374|FG001|Participants in Run-in Period|Death|0|||
126725907|NCT02115113|455946375|FG002|Participants in Run-in Period|Death|1|||
126725908|NCT02115113|455946373|FG000|Participants in Run-in Period|Administrative problems|0|||
126725909|NCT02115113|455946374|FG001|Participants in Run-in Period|Administrative problems|0|||
126725910|NCT02115113|455946375|FG002|Participants in Run-in Period|Administrative problems|1|||
126725911|NCT02115113|455946373|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
126725912|NCT02115113|455946374|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
126725913|NCT02115113|455946375|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
126725914|NCT02115113|455946373|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
126725915|NCT02115113|455946374|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
126725916|NCT02115113|455946375|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
126725917|NCT02115113|455946373|FG000|Participants Randomized|Lost to Follow-up|1|||
126725918|NCT02115113|455946374|FG001|Participants Randomized|Lost to Follow-up|0|||
126725919|NCT02115113|455946375|FG002|Participants Randomized|Lost to Follow-up|0|||
126725920|NCT02115113|455946373|FG000|Participants Randomized|Death|1|||
126725921|NCT02115113|455946374|FG001|Participants Randomized|Death|0|||
126725922|NCT02115113|455946375|FG002|Participants Randomized|Death|0|||
126725923|NCT00296725|455946376|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
126500067|NCT02658890|455131759|FG016|Treatment Phase|Adverse Event|0|||
126500068|NCT02658890|455131760|FG017|Treatment Phase|Adverse Event|0|||
126500069|NCT02658890|455131761|FG018|Treatment Phase|Adverse Event|5|||
126500070|NCT02658890|455131762|FG019|Treatment Phase|Adverse Event|1|||
126500071|NCT02658890|455131763|FG020|Treatment Phase|Adverse Event|3|||
126500072|NCT02658890|455131764|FG021|Treatment Phase|Adverse Event|0|||
126500073|NCT02658890|455131765|FG022|Treatment Phase|Adverse Event|5|||
126500074|NCT02658890|455131766|FG023|Treatment Phase|Adverse Event|0|||
126500075|NCT02658890|455131767|FG024|Treatment Phase|Adverse Event|0|||
126500076|NCT02658890|455131768|FG025|Treatment Phase|Adverse Event|2|||
126500077|NCT02658890|455131769|FG026|Treatment Phase|Adverse Event|1|||
126500078|NCT02658890|455131743|FG000|Treatment Phase|Death|0|||
126500079|NCT02658890|455131744|FG001|Treatment Phase|Death|0|||
126500080|NCT02658890|455131745|FG002|Treatment Phase|Death|0|||
126500081|NCT02658890|455131746|FG003|Treatment Phase|Death|0|||
126500082|NCT02658890|455131747|FG004|Treatment Phase|Death|0|||
126560714|NCT00062868|455346725|FG005|Dose Level 2|Lost to Follow-up|0|||
126725924|NCT00296725|455946376|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
126500083|NCT02658890|455131748|FG005|Treatment Phase|Death|0|||
126725925|NCT00296725|455946376|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
126725926|NCT02622724|455946377|FG000|Overall Study|Death|51|||
126725927|NCT02622724|455946378|FG001|Overall Study|Death|53|||
126725928|NCT02622724|455946377|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
126725929|NCT02622724|455946378|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
126725930|NCT02622724|455946377|FG000|Overall Study|Early termination of study|38|||
126725931|NCT02622724|455946378|FG001|Overall Study|Early termination of study|43|||
126500084|NCT02658890|455131749|FG006|Treatment Phase|Death|0|||
126500085|NCT02658890|455131750|FG007|Treatment Phase|Death|0|||
126500086|NCT02658890|455131751|FG008|Treatment Phase|Death|0|||
126500087|NCT02658890|455131752|FG009|Treatment Phase|Death|0|||
126500088|NCT02658890|455131753|FG010|Treatment Phase|Death|0|||
126500089|NCT02658890|455131754|FG011|Treatment Phase|Death|0|||
126500090|NCT02658890|455131755|FG012|Treatment Phase|Death|0|||
126500091|NCT02658890|455131756|FG013|Treatment Phase|Death|0|||
126500092|NCT02658890|455131757|FG014|Treatment Phase|Death|0|||
126500093|NCT02658890|455131758|FG015|Treatment Phase|Death|0|||
126500094|NCT02658890|455131759|FG016|Treatment Phase|Death|0|||
126500095|NCT02658890|455131760|FG017|Treatment Phase|Death|0|||
126500096|NCT02658890|455131761|FG018|Treatment Phase|Death|1|||
126500097|NCT02658890|455131762|FG019|Treatment Phase|Death|0|||
126500098|NCT02658890|455131763|FG020|Treatment Phase|Death|0|||
126500099|NCT02658890|455131764|FG021|Treatment Phase|Death|0|||
126500100|NCT02658890|455131765|FG022|Treatment Phase|Death|0|||
126500101|NCT02658890|455131766|FG023|Treatment Phase|Death|0|||
126500102|NCT02658890|455131767|FG024|Treatment Phase|Death|0|||
126500103|NCT02658890|455131768|FG025|Treatment Phase|Death|0|||
126500104|NCT02658890|455131769|FG026|Treatment Phase|Death|0|||
126500105|NCT02658890|455131743|FG000|Treatment Phase|Lost to Follow-up|0|||
126500106|NCT02658890|455131744|FG001|Treatment Phase|Lost to Follow-up|0|||
126500107|NCT02658890|455131745|FG002|Treatment Phase|Lost to Follow-up|0|||
126500108|NCT02658890|455131746|FG003|Treatment Phase|Lost to Follow-up|0|||
126500109|NCT02658890|455131747|FG004|Treatment Phase|Lost to Follow-up|0|||
126500110|NCT02658890|455131748|FG005|Treatment Phase|Lost to Follow-up|0|||
126500111|NCT02658890|455131749|FG006|Treatment Phase|Lost to Follow-up|1|||
126500112|NCT02658890|455131750|FG007|Treatment Phase|Lost to Follow-up|0|||
126500113|NCT02658890|455131751|FG008|Treatment Phase|Lost to Follow-up|0|||
126500114|NCT02658890|455131752|FG009|Treatment Phase|Lost to Follow-up|0|||
126500115|NCT02658890|455131753|FG010|Treatment Phase|Lost to Follow-up|0|||
126500116|NCT02658890|455131754|FG011|Treatment Phase|Lost to Follow-up|0|||
126500117|NCT02658890|455131755|FG012|Treatment Phase|Lost to Follow-up|0|||
126500118|NCT02658890|455131756|FG013|Treatment Phase|Lost to Follow-up|0|||
126500119|NCT02658890|455131757|FG014|Treatment Phase|Lost to Follow-up|0|||
126500120|NCT02658890|455131758|FG015|Treatment Phase|Lost to Follow-up|0|||
126500121|NCT02658890|455131759|FG016|Treatment Phase|Lost to Follow-up|0|||
126500122|NCT02658890|455131760|FG017|Treatment Phase|Lost to Follow-up|0|||
126500123|NCT02658890|455131761|FG018|Treatment Phase|Lost to Follow-up|0|||
126500124|NCT02658890|455131762|FG019|Treatment Phase|Lost to Follow-up|0|||
126500125|NCT02658890|455131763|FG020|Treatment Phase|Lost to Follow-up|0|||
126500126|NCT02658890|455131764|FG021|Treatment Phase|Lost to Follow-up|0|||
126500127|NCT02658890|455131765|FG022|Treatment Phase|Lost to Follow-up|0|||
126500128|NCT02658890|455131766|FG023|Treatment Phase|Lost to Follow-up|0|||
126500129|NCT02658890|455131767|FG024|Treatment Phase|Lost to Follow-up|0|||
126500130|NCT02658890|455131768|FG025|Treatment Phase|Lost to Follow-up|0|||
126500131|NCT02658890|455131769|FG026|Treatment Phase|Lost to Follow-up|0|||
126500132|NCT02658890|455131743|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
126500133|NCT02658890|455131744|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
126500134|NCT02658890|455131745|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
126500135|NCT02658890|455131746|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
126500136|NCT02658890|455131747|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
126500137|NCT02658890|455131748|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
126500138|NCT02658890|455131749|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
126500139|NCT02658890|455131750|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
126500140|NCT02658890|455131751|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
126560715|NCT00062868|455346726|FG006|Dose Level 2|Lost to Follow-up|0|||
126560716|NCT00062868|455346727|FG007|Dose Level 2|Lost to Follow-up|0|||
126560717|NCT00062868|455346728|FG008|Dose Level 2|Lost to Follow-up|0|||
126560718|NCT00062868|455346729|FG009|Dose Level 2|Lost to Follow-up|0|||
126560719|NCT00062868|455346730|FG010|Dose Level 2|Lost to Follow-up|0|||
126560720|NCT00062868|455346731|FG011|Dose Level 2|Lost to Follow-up|0|||
126560721|NCT00062868|455346732|FG012|Dose Level 2|Lost to Follow-up|0|||
126560722|NCT00062868|455346733|FG013|Dose Level 2|Lost to Follow-up|1|||
126560723|NCT00062868|455346734|FG014|Dose Level 2|Lost to Follow-up|0|||
126560724|NCT00062868|455346735|FG015|Dose Level 2|Lost to Follow-up|0|||
126725932|NCT00356863|455946379|FG000|Overall Study|Death|16|||
126500141|NCT02658890|455131752|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
126500142|NCT02658890|455131753|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
126500143|NCT02658890|455131754|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
126500144|NCT02658890|455131755|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
126500145|NCT02658890|455131756|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
126500146|NCT02658890|455131757|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
126500147|NCT02658890|455131758|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
126500148|NCT02658890|455131759|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
126500149|NCT02658890|455131760|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
126500150|NCT02658890|455131761|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
126725933|NCT00356863|455946380|FG001|Overall Study|Death|32|||
126725934|NCT00356863|455946379|FG000|Overall Study|Lost to Follow-up|76|||
126500151|NCT02658890|455131762|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
126725935|NCT00356863|455946380|FG001|Overall Study|Lost to Follow-up|43|||
126500152|NCT02658890|455131763|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
126500153|NCT02658890|455131764|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
126500154|NCT02658890|455131765|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
126500155|NCT02658890|455131766|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
126500156|NCT02658890|455131767|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
126725936|NCT00343291|455946383|FG000|Overall Study|Adverse Event|13|||
126725937|NCT00343291|455946384|FG001|Overall Study|Adverse Event|13|||
126725938|NCT00343291|455946383|FG000|Overall Study|Death|3|||
126725939|NCT00343291|455946384|FG001|Overall Study|Death|2|||
126725940|NCT00343291|455946383|FG000|Overall Study|Progressive disease|33|||
126725941|NCT00343291|455946384|FG001|Overall Study|Progressive disease|34|||
126725942|NCT00343291|455946383|FG000|Overall Study|Withdrawal by Subject|0|||
126725943|NCT00343291|455946384|FG001|Overall Study|Withdrawal by Subject|2|||
126725944|NCT00343291|455946383|FG000|Overall Study|Other|8|||
126725945|NCT00343291|455946384|FG001|Overall Study|Other|5|||
126725946|NCT03712345|455946385|FG000|Overall Study|Failure to meet randomization criteria|0|||
126725947|NCT03712345|455946386|FG001|Overall Study|Failure to meet randomization criteria|0|||
126725948|NCT03712345|455946387|FG002|Overall Study|Failure to meet randomization criteria|1|||
126725949|NCT00485589|455946391|FG000|Overall Study|Death|2|||
126725950|NCT00485589|455946392|FG001|Overall Study|Death|2|||
126725951|NCT00485589|455946393|FG002|Overall Study|Death|0|||
126725952|NCT00485589|455946391|FG000|Overall Study|Failure to return|6|||
126725953|NCT00485589|455946392|FG001|Overall Study|Failure to return|5|||
126725954|NCT00485589|455946393|FG002|Overall Study|Failure to return|1|||
126725955|NCT00485589|455946391|FG000|Overall Study|Protocol Violation|1|||
126725956|NCT00485589|455946392|FG001|Overall Study|Protocol Violation|0|||
126725957|NCT00485589|455946393|FG002|Overall Study|Protocol Violation|0|||
126725958|NCT00485589|455946391|FG000|Overall Study|Violation of selection criteria at entry|0|||
126725959|NCT00485589|455946392|FG001|Overall Study|Violation of selection criteria at entry|3|||
126725960|NCT00485589|455946393|FG002|Overall Study|Violation of selection criteria at entry|1|||
126725961|NCT00485589|455946391|FG000|Overall Study|Administrative/Other|1|||
126725962|NCT00485589|455946392|FG001|Overall Study|Administrative/Other|2|||
126725963|NCT00485589|455946393|FG002|Overall Study|Administrative/Other|1|||
126725964|NCT00485589|455946391|FG000|Overall Study|Insufficient therapeutic response|10|||
126725965|NCT00485589|455946392|FG001|Overall Study|Insufficient therapeutic response|3|||
126725966|NCT00485589|455946393|FG002|Overall Study|Insufficient therapeutic response|1|||
126725967|NCT00485589|455946391|FG000|Overall Study|Refused treatment/did not cooperate|1|||
126725968|NCT00485589|455946392|FG001|Overall Study|Refused treatment/did not cooperate|0|||
126725969|NCT00485589|455946393|FG002|Overall Study|Refused treatment/did not cooperate|2|||
126725970|NCT00485589|455946391|FG000|Overall Study|Withdrawal by Subject|3|||
126725971|NCT00485589|455946392|FG001|Overall Study|Withdrawal by Subject|2|||
126725972|NCT00485589|455946393|FG002|Overall Study|Withdrawal by Subject|2|||
126725973|NCT00485589|455946391|FG000|Overall Study|Adverse Event|3|||
126725974|NCT00485589|455946392|FG001|Overall Study|Adverse Event|3|||
126725975|NCT00485589|455946393|FG002|Overall Study|Adverse Event|10|||
126725976|NCT02585999|455946394|FG000|Overall Study|Lost to Follow-up|1|||
126725977|NCT02585999|455946394|FG000|Overall Study|Protocol Violation|1|||
126725978|NCT01369849|455946395|FG000|Overall Study|Ineligible prior to treatment|0|||
126725979|NCT01369849|455946396|FG001|Overall Study|Ineligible prior to treatment|0|||
126725980|NCT01369849|455946397|FG002|Overall Study|Ineligible prior to treatment|1|||
126725981|NCT01369849|455946395|FG000|Overall Study|Ineligible after receiving treatment|0|||
126725982|NCT01369849|455946396|FG001|Overall Study|Ineligible after receiving treatment|1|||
126725983|NCT01369849|455946397|FG002|Overall Study|Ineligible after receiving treatment|0|||
126725984|NCT02924688|455946398|FG000|Overall Study|Adverse Event|9|||
126725985|NCT02924688|455946399|FG001|Overall Study|Adverse Event|3|||
126725986|NCT02924688|455946400|FG002|Overall Study|Adverse Event|2|||
126725987|NCT02924688|455946401|FG003|Overall Study|Adverse Event|2|||
126725988|NCT02924688|455946402|FG004|Overall Study|Adverse Event|3|||
126725989|NCT02924688|455946403|FG005|Overall Study|Adverse Event|2|||
126725990|NCT02924688|455946398|FG000|Overall Study|Lack of Efficacy|2|||
126725991|NCT02924688|455946399|FG001|Overall Study|Lack of Efficacy|3|||
126725992|NCT02924688|455946400|FG002|Overall Study|Lack of Efficacy|4|||
126725993|NCT02924688|455946401|FG003|Overall Study|Lack of Efficacy|2|||
126725994|NCT02924688|455946402|FG004|Overall Study|Lack of Efficacy|1|||
126725995|NCT02924688|455946403|FG005|Overall Study|Lack of Efficacy|1|||
126725996|NCT02924688|455946398|FG000|Overall Study|Protocol Violation|3|||
126725997|NCT02924688|455946399|FG001|Overall Study|Protocol Violation|7|||
126725998|NCT02924688|455946400|FG002|Overall Study|Protocol Violation|5|||
126725999|NCT02924688|455946401|FG003|Overall Study|Protocol Violation|6|||
126726000|NCT02924688|455946402|FG004|Overall Study|Protocol Violation|2|||
126726001|NCT02924688|455946403|FG005|Overall Study|Protocol Violation|2|||
126726002|NCT02924688|455946398|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
126726003|NCT02924688|455946399|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
126726004|NCT02924688|455946400|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
126726005|NCT02924688|455946401|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
126726006|NCT02924688|455946402|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
126726007|NCT02924688|455946403|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
126726008|NCT02924688|455946398|FG000|Overall Study|Lost to Follow-up|2|||
126726009|NCT02924688|455946399|FG001|Overall Study|Lost to Follow-up|4|||
126726010|NCT02924688|455946400|FG002|Overall Study|Lost to Follow-up|2|||
126726011|NCT02924688|455946401|FG003|Overall Study|Lost to Follow-up|4|||
126560725|NCT00062868|455346736|FG016|Dose Level 2|Lost to Follow-up|1|||
126560726|NCT00062868|455346737|FG017|Dose Level 2|Lost to Follow-up|0|||
126560727|NCT00062868|455346738|FG018|Dose Level 2|Lost to Follow-up|0|||
126560728|NCT00062868|455346739|FG019|Dose Level 2|Lost to Follow-up|0|||
126560729|NCT00062868|455346740|FG020|Dose Level 2|Lost to Follow-up|0|||
126560730|NCT00062868|455346720|FG000|Dose Level 3|Death|0|||
126560731|NCT00062868|455346721|FG001|Dose Level 3|Death|0|||
126560732|NCT00062868|455346722|FG002|Dose Level 3|Death|0|||
126560733|NCT00062868|455346723|FG003|Dose Level 3|Death|0|||
126560734|NCT00062868|455346724|FG004|Dose Level 3|Death|0|||
126560735|NCT00062868|455346725|FG005|Dose Level 3|Death|0|||
126560736|NCT00062868|455346726|FG006|Dose Level 3|Death|0|||
126560737|NCT00062868|455346727|FG007|Dose Level 3|Death|0|||
126560738|NCT00062868|455346728|FG008|Dose Level 3|Death|0|||
126560739|NCT00062868|455346729|FG009|Dose Level 3|Death|0|||
126560740|NCT00062868|455346730|FG010|Dose Level 3|Death|0|||
126560741|NCT00062868|455346731|FG011|Dose Level 3|Death|1|||
126560742|NCT00062868|455346732|FG012|Dose Level 3|Death|0|||
126560743|NCT00062868|455346733|FG013|Dose Level 3|Death|0|||
126560744|NCT00062868|455346734|FG014|Dose Level 3|Death|0|||
126560745|NCT00062868|455346735|FG015|Dose Level 3|Death|0|||
126560746|NCT00062868|455346736|FG016|Dose Level 3|Death|0|||
126560747|NCT00062868|455346737|FG017|Dose Level 3|Death|1|||
126560748|NCT00062868|455346738|FG018|Dose Level 3|Death|0|||
126560749|NCT00062868|455346739|FG019|Dose Level 3|Death|0|||
126560750|NCT00062868|455346740|FG020|Dose Level 3|Death|0|||
126560751|NCT00062868|455346720|FG000|Dose Level 3|Lost to Follow-up|0|||
126560752|NCT00062868|455346721|FG001|Dose Level 3|Lost to Follow-up|0|||
126560753|NCT00062868|455346722|FG002|Dose Level 3|Lost to Follow-up|0|||
126560754|NCT00062868|455346723|FG003|Dose Level 3|Lost to Follow-up|0|||
126560755|NCT00062868|455346724|FG004|Dose Level 3|Lost to Follow-up|0|||
126560756|NCT00062868|455346725|FG005|Dose Level 3|Lost to Follow-up|0|||
126560757|NCT00062868|455346726|FG006|Dose Level 3|Lost to Follow-up|0|||
126560758|NCT00062868|455346727|FG007|Dose Level 3|Lost to Follow-up|0|||
126560759|NCT00062868|455346728|FG008|Dose Level 3|Lost to Follow-up|0|||
126560760|NCT00062868|455346729|FG009|Dose Level 3|Lost to Follow-up|0|||
126560761|NCT00062868|455346730|FG010|Dose Level 3|Lost to Follow-up|0|||
126560762|NCT00062868|455346731|FG011|Dose Level 3|Lost to Follow-up|0|||
126560763|NCT00062868|455346732|FG012|Dose Level 3|Lost to Follow-up|0|||
126560764|NCT00062868|455346733|FG013|Dose Level 3|Lost to Follow-up|0|||
126560765|NCT00062868|455346734|FG014|Dose Level 3|Lost to Follow-up|1|||
126560766|NCT00062868|455346735|FG015|Dose Level 3|Lost to Follow-up|0|||
126774546|NCT04380701|456131101|FG021|Overall Study|Lost to Follow-up|0|||
126774547|NCT04380701|456131102|FG022|Overall Study|Lost to Follow-up|0|||
126500157|NCT02658890|455131768|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
126500158|NCT02658890|455131769|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
126500159|NCT02658890|455131743|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
126500160|NCT02658890|455131744|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
126500161|NCT02658890|455131745|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
126500162|NCT02658890|455131746|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
126500163|NCT02658890|455131747|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
126500164|NCT02658890|455131748|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
126500165|NCT02658890|455131749|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
126500166|NCT02658890|455131750|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
126500167|NCT02658890|455131751|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
126500168|NCT02658890|455131752|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
126500169|NCT02658890|455131753|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
126500170|NCT02658890|455131754|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
126500171|NCT02658890|455131755|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
126500172|NCT02658890|455131756|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
126500173|NCT02658890|455131757|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
126500174|NCT02658890|455131758|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
126500175|NCT02658890|455131759|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
126500176|NCT02658890|455131760|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
126500177|NCT02658890|455131761|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
126560767|NCT00062868|455346736|FG016|Dose Level 3|Lost to Follow-up|0|||
126560768|NCT00062868|455346737|FG017|Dose Level 3|Lost to Follow-up|0|||
126560769|NCT00062868|455346738|FG018|Dose Level 3|Lost to Follow-up|0|||
126560770|NCT00062868|455346739|FG019|Dose Level 3|Lost to Follow-up|0|||
126560771|NCT00062868|455346740|FG020|Dose Level 3|Lost to Follow-up|0|||
126560772|NCT00062868|455346720|FG000|Dose Level 3|Withdrew|0|||
126560773|NCT00062868|455346721|FG001|Dose Level 3|Withdrew|0|||
126560774|NCT00062868|455346722|FG002|Dose Level 3|Withdrew|2|||
126560775|NCT00062868|455346723|FG003|Dose Level 3|Withdrew|0|||
126500178|NCT02658890|455131762|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
126560776|NCT00062868|455346724|FG004|Dose Level 3|Withdrew|0|||
126560777|NCT00062868|455346725|FG005|Dose Level 3|Withdrew|0|||
126560778|NCT00062868|455346726|FG006|Dose Level 3|Withdrew|0|||
126560779|NCT00062868|455346727|FG007|Dose Level 3|Withdrew|0|||
126560780|NCT00062868|455346728|FG008|Dose Level 3|Withdrew|0|||
126774548|NCT04380701|456131103|FG023|Overall Study|Lost to Follow-up|1|||
126774549|NCT04380701|456131104|FG024|Overall Study|Lost to Follow-up|0|||
126774550|NCT04380701|456131105|FG025|Overall Study|Lost to Follow-up|0|||
126774551|NCT04380701|456131106|FG026|Overall Study|Lost to Follow-up|0|||
126774552|NCT04380701|456131107|FG027|Overall Study|Lost to Follow-up|0|||
126774553|NCT04380701|456131108|FG028|Overall Study|Lost to Follow-up|0|||
126774554|NCT04380701|456131109|FG029|Overall Study|Lost to Follow-up|1|||
126774555|NCT04380701|456131110|FG030|Overall Study|Lost to Follow-up|0|||
126774556|NCT04380701|456131111|FG031|Overall Study|Lost to Follow-up|0|||
126774557|NCT04380701|456131112|FG032|Overall Study|Lost to Follow-up|0|||
126774558|NCT04380701|456131113|FG033|Overall Study|Lost to Follow-up|1|||
126774559|NCT04380701|456131080|FG000|Overall Study|Private reason(s)|0|||
126774560|NCT04380701|456131081|FG001|Overall Study|Private reason(s)|0|||
126774561|NCT04380701|456131082|FG002|Overall Study|Private reason(s)|0|||
126774562|NCT04380701|456131083|FG003|Overall Study|Private reason(s)|0|||
126774563|NCT04380701|456131084|FG004|Overall Study|Private reason(s)|0|||
126774564|NCT04380701|456131085|FG005|Overall Study|Private reason(s)|0|||
126774565|NCT04380701|456131086|FG006|Overall Study|Private reason(s)|1|||
126774566|NCT04380701|456131087|FG007|Overall Study|Private reason(s)|0|||
126774567|NCT04380701|456131088|FG008|Overall Study|Private reason(s)|1|||
126774568|NCT04380701|456131089|FG009|Overall Study|Private reason(s)|1|||
126774569|NCT04380701|456131090|FG010|Overall Study|Private reason(s)|0|||
126774570|NCT04380701|456131091|FG011|Overall Study|Private reason(s)|0|||
126774571|NCT04380701|456131092|FG012|Overall Study|Private reason(s)|0|||
126774572|NCT04380701|456131093|FG013|Overall Study|Private reason(s)|0|||
126774573|NCT04380701|456131094|FG014|Overall Study|Private reason(s)|0|||
126774574|NCT04380701|456131095|FG015|Overall Study|Private reason(s)|0|||
126774575|NCT04380701|456131096|FG016|Overall Study|Private reason(s)|0|||
126774576|NCT04380701|456131097|FG017|Overall Study|Private reason(s)|0|||
126774577|NCT04380701|456131098|FG018|Overall Study|Private reason(s)|0|||
126774578|NCT04380701|456131099|FG019|Overall Study|Private reason(s)|0|||
126774579|NCT04380701|456131100|FG020|Overall Study|Private reason(s)|0|||
126774580|NCT04380701|456131101|FG021|Overall Study|Private reason(s)|0|||
126774581|NCT04380701|456131102|FG022|Overall Study|Private reason(s)|0|||
126774582|NCT04380701|456131103|FG023|Overall Study|Private reason(s)|1|||
126774583|NCT04380701|456131104|FG024|Overall Study|Private reason(s)|0|||
126774584|NCT04380701|456131105|FG025|Overall Study|Private reason(s)|0|||
126774585|NCT04380701|456131106|FG026|Overall Study|Private reason(s)|0|||
126774586|NCT04380701|456131107|FG027|Overall Study|Private reason(s)|0|||
126774587|NCT04380701|456131108|FG028|Overall Study|Private reason(s)|0|||
126774588|NCT04380701|456131109|FG029|Overall Study|Private reason(s)|1|||
126774589|NCT04380701|456131110|FG030|Overall Study|Private reason(s)|0|||
126774590|NCT04380701|456131111|FG031|Overall Study|Private reason(s)|0|||
126774591|NCT04380701|456131112|FG032|Overall Study|Private reason(s)|0|||
126774592|NCT04380701|456131113|FG033|Overall Study|Private reason(s)|0|||
126774593|NCT04380701|456131080|FG000|Overall Study|Withdrawal by Subject|0|||
126774594|NCT04380701|456131081|FG001|Overall Study|Withdrawal by Subject|0|||
126774595|NCT04380701|456131082|FG002|Overall Study|Withdrawal by Subject|0|||
126726012|NCT02924688|455946402|FG004|Overall Study|Lost to Follow-up|2|||
126726013|NCT02924688|455946403|FG005|Overall Study|Lost to Follow-up|4|||
126726014|NCT02924688|455946398|FG000|Overall Study|Physician Decision|2|||
126726015|NCT02924688|455946399|FG001|Overall Study|Physician Decision|1|||
126726016|NCT02924688|455946400|FG002|Overall Study|Physician Decision|0|||
126726017|NCT02924688|455946401|FG003|Overall Study|Physician Decision|1|||
126726018|NCT02924688|455946402|FG004|Overall Study|Physician Decision|1|||
126726019|NCT02924688|455946403|FG005|Overall Study|Physician Decision|1|||
126726020|NCT02924688|455946398|FG000|Overall Study|Withdrawal by Subject|14|||
126726021|NCT02924688|455946399|FG001|Overall Study|Withdrawal by Subject|13|||
126726022|NCT02924688|455946400|FG002|Overall Study|Withdrawal by Subject|9|||
126726023|NCT02924688|455946401|FG003|Overall Study|Withdrawal by Subject|12|||
126726024|NCT02924688|455946402|FG004|Overall Study|Withdrawal by Subject|13|||
126726025|NCT02924688|455946403|FG005|Overall Study|Withdrawal by Subject|14|||
126726026|NCT00174785|455946407|FG000|Overall Study|Adverse Event|293|||
126726027|NCT00174785|455946408|FG001|Overall Study|Adverse Event|191|||
126726028|NCT00174785|455946407|FG000|Overall Study|Protocol Violation|14|||
126726029|NCT00174785|455946408|FG001|Overall Study|Protocol Violation|14|||
126774596|NCT04380701|456131083|FG003|Overall Study|Withdrawal by Subject|0|||
126774597|NCT04380701|456131084|FG004|Overall Study|Withdrawal by Subject|0|||
126726030|NCT00174785|455946407|FG000|Overall Study|Withdrawal by Subject|173|||
126726031|NCT00174785|455946408|FG001|Overall Study|Withdrawal by Subject|175|||
126774598|NCT04380701|456131085|FG005|Overall Study|Withdrawal by Subject|0|||
126774599|NCT04380701|456131086|FG006|Overall Study|Withdrawal by Subject|1|||
126774600|NCT04380701|456131087|FG007|Overall Study|Withdrawal by Subject|1|||
126774601|NCT04380701|456131088|FG008|Overall Study|Withdrawal by Subject|0|||
126774602|NCT04380701|456131089|FG009|Overall Study|Withdrawal by Subject|0|||
126774603|NCT04380701|456131090|FG010|Overall Study|Withdrawal by Subject|0|||
126726032|NCT00174785|455946407|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
126774604|NCT04380701|456131091|FG011|Overall Study|Withdrawal by Subject|1|||
126774605|NCT04380701|456131092|FG012|Overall Study|Withdrawal by Subject|0|||
126500179|NCT02658890|455131763|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
126500180|NCT02658890|455131764|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
126500181|NCT02658890|455131765|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
126500182|NCT02658890|455131766|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
126500183|NCT02658890|455131767|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
126500184|NCT02658890|455131768|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
126500185|NCT02658890|455131769|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
126500186|NCT02658890|455131743|FG000|Treatment Phase|Other Reasons|0|||
126560781|NCT00062868|455346729|FG009|Dose Level 3|Withdrew|0|||
126560782|NCT00062868|455346730|FG010|Dose Level 3|Withdrew|0|||
126560783|NCT00062868|455346731|FG011|Dose Level 3|Withdrew|0|||
126560784|NCT00062868|455346732|FG012|Dose Level 3|Withdrew|0|||
126560785|NCT00062868|455346733|FG013|Dose Level 3|Withdrew|0|||
126560786|NCT00062868|455346734|FG014|Dose Level 3|Withdrew|0|||
126560787|NCT00062868|455346735|FG015|Dose Level 3|Withdrew|0|||
126560788|NCT00062868|455346736|FG016|Dose Level 3|Withdrew|0|||
126560789|NCT00062868|455346737|FG017|Dose Level 3|Withdrew|0|||
126560790|NCT00062868|455346738|FG018|Dose Level 3|Withdrew|0|||
126560791|NCT00062868|455346739|FG019|Dose Level 3|Withdrew|0|||
126560792|NCT00062868|455346740|FG020|Dose Level 3|Withdrew|0|||
126560793|NCT01734811|455346741|FG000|Overall Study|Lost to Follow-up|2|||
126560794|NCT01734811|455346742|FG001|Overall Study|Lost to Follow-up|3|||
126560795|NCT01734811|455346741|FG000|Overall Study|Withdrawal by Subject|2|||
126560796|NCT01734811|455346742|FG001|Overall Study|Withdrawal by Subject|0|||
126560797|NCT02414828|455346743|FG000|Overall Study|Lost to Follow-up|0|||
126560798|NCT02414828|455346744|FG001|Overall Study|Lost to Follow-up|1|||
126560799|NCT02414828|455346745|FG002|Overall Study|Lost to Follow-up|1|||
126560800|NCT02414828|455346746|FG003|Overall Study|Lost to Follow-up|2|||
126560801|NCT04949399|455346751|FG000|Overall Study|Lost to Follow-up|11|||
126560802|NCT04949399|455346752|FG001|Overall Study|Lost to Follow-up|6|||
126560803|NCT04949399|455346751|FG000|Overall Study|Withdrawal by Subject|2|||
126560804|NCT04949399|455346752|FG001|Overall Study|Withdrawal by Subject|3|||
126560805|NCT00814489|455346778|FG000|Overall Study|Other|2|||
126560806|NCT00814489|455346779|FG001|Overall Study|Other|0|||
126560807|NCT00814489|455346780|FG002|Overall Study|Other|1|||
126560808|NCT01712685|455346784|FG000|Overall Study|pt declined to participate before trmt|1|||
126560809|NCT01866917|455346785|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
126560810|NCT01866917|455346786|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
126560811|NCT00662909|455346790|FG000|Overall Study|Adverse Event|17|||
126560812|NCT00662909|455346791|FG001|Overall Study|Adverse Event|18|||
126560813|NCT00662909|455346792|FG002|Overall Study|Adverse Event|19|||
126560814|NCT00662909|455346790|FG000|Overall Study|Lack of Efficacy|9|||
126560815|NCT00662909|455346791|FG001|Overall Study|Lack of Efficacy|1|||
126560816|NCT00662909|455346792|FG002|Overall Study|Lack of Efficacy|5|||
126560817|NCT00662909|455346790|FG000|Overall Study|Withdrawal by Subject|29|||
126560818|NCT00662909|455346791|FG001|Overall Study|Withdrawal by Subject|22|||
126560819|NCT00662909|455346792|FG002|Overall Study|Withdrawal by Subject|16|||
126560820|NCT00662909|455346790|FG000|Overall Study|Lost to Follow-up|2|||
126560821|NCT00662909|455346791|FG001|Overall Study|Lost to Follow-up|9|||
126560822|NCT00662909|455346792|FG002|Overall Study|Lost to Follow-up|3|||
126560823|NCT00662909|455346790|FG000|Overall Study|Protocol Violation|7|||
126560824|NCT00662909|455346791|FG001|Overall Study|Protocol Violation|4|||
126560825|NCT00662909|455346792|FG002|Overall Study|Protocol Violation|5|||
126560826|NCT00662909|455346790|FG000|Overall Study|Randomized- never received study drug|1|||
126560827|NCT00662909|455346791|FG001|Overall Study|Randomized- never received study drug|0|||
126560828|NCT00662909|455346792|FG002|Overall Study|Randomized- never received study drug|0|||
126560829|NCT00662909|455346790|FG000|Overall Study|Non-compliance with study procedures|3|||
126560830|NCT00662909|455346791|FG001|Overall Study|Non-compliance with study procedures|3|||
126560831|NCT00662909|455346792|FG002|Overall Study|Non-compliance with study procedures|2|||
126560832|NCT00662909|455346790|FG000|Overall Study|Physician Decision|1|||
126560833|NCT00662909|455346791|FG001|Overall Study|Physician Decision|1|||
126560834|NCT00662909|455346792|FG002|Overall Study|Physician Decision|2|||
126560835|NCT00662909|455346790|FG000|Overall Study|Eligibility criterion not met|0|||
126726033|NCT00174785|455946408|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
126726034|NCT00174785|455946407|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
126560836|NCT00662909|455346791|FG001|Overall Study|Eligibility criterion not met|1|||
126560837|NCT00662909|455346792|FG002|Overall Study|Eligibility criterion not met|1|||
126560838|NCT03532178|455348342|FG000|First Period|Withdrawal by Subject|1|||
126560839|NCT03532178|455348343|FG001|First Period|Withdrawal by Subject|3|||
126726035|NCT00174785|455946408|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
126726036|NCT00174785|455946407|FG000|Overall Study|Other prohibited medication|5|||
126500187|NCT02658890|455131744|FG001|Treatment Phase|Other Reasons|0|||
126560840|NCT03532178|455348342|FG000|First Period|technical issues in data collection Technical issues|0|||
126560841|NCT03532178|455348343|FG001|First Period|technical issues in data collection Technical issues|1|||
126560842|NCT03532178|455348342|FG000|Second Period|Withdrawal by Subject|1|||
126560843|NCT03532178|455348343|FG001|Second Period|Withdrawal by Subject|1|||
126500188|NCT02658890|455131745|FG002|Treatment Phase|Other Reasons|0|||
126560844|NCT03532178|455348342|FG000|Second Period|Technical issues|0|||
126560845|NCT03532178|455348343|FG001|Second Period|Technical issues|1|||
126560846|NCT03302156|455348344|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
126560847|NCT03302156|455348345|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
126560848|NCT03302156|455348346|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
126560849|NCT02390557|455348347|FG000|Wave 2|Survey non-respondent|72|||
126560850|NCT02390557|455348348|FG001|Wave 2|Survey non-respondent|41|||
126560851|NCT02390557|455348349|FG002|Wave 2|Survey non-respondent|23|||
126500189|NCT02658890|455131746|FG003|Treatment Phase|Other Reasons|0|||
126500190|NCT02658890|455131747|FG004|Treatment Phase|Other Reasons|0|||
126774606|NCT04380701|456131093|FG013|Overall Study|Withdrawal by Subject|1|||
126774607|NCT04380701|456131094|FG014|Overall Study|Withdrawal by Subject|0|||
126500191|NCT02658890|455131748|FG005|Treatment Phase|Other Reasons|0|||
126500192|NCT02658890|455131749|FG006|Treatment Phase|Other Reasons|1|||
126500193|NCT02658890|455131750|FG007|Treatment Phase|Other Reasons|0|||
126500194|NCT02658890|455131751|FG008|Treatment Phase|Other Reasons|1|||
126500195|NCT02658890|455131752|FG009|Treatment Phase|Other Reasons|0|||
126500196|NCT02658890|455131753|FG010|Treatment Phase|Other Reasons|0|||
126500197|NCT02658890|455131754|FG011|Treatment Phase|Other Reasons|0|||
126500198|NCT02658890|455131755|FG012|Treatment Phase|Other Reasons|0|||
126500199|NCT02658890|455131756|FG013|Treatment Phase|Other Reasons|2|||
126500200|NCT02658890|455131757|FG014|Treatment Phase|Other Reasons|0|||
126500201|NCT02658890|455131758|FG015|Treatment Phase|Other Reasons|0|||
126560852|NCT03278028|455348353|FG000|Overall Study|Lost to Follow-up|1|||
126560853|NCT03278028|455348354|FG001|Overall Study|Lost to Follow-up|0|||
126774608|NCT04380701|456131095|FG015|Overall Study|Withdrawal by Subject|0|||
126500202|NCT02658890|455131759|FG016|Treatment Phase|Other Reasons|0|||
126774609|NCT04380701|456131096|FG016|Overall Study|Withdrawal by Subject|1|||
126774610|NCT04380701|456131097|FG017|Overall Study|Withdrawal by Subject|0|||
126774611|NCT04380701|456131098|FG018|Overall Study|Withdrawal by Subject|0|||
126774612|NCT04380701|456131099|FG019|Overall Study|Withdrawal by Subject|0|||
126774613|NCT04380701|456131100|FG020|Overall Study|Withdrawal by Subject|0|||
126774614|NCT04380701|456131101|FG021|Overall Study|Withdrawal by Subject|0|||
126774615|NCT04380701|456131102|FG022|Overall Study|Withdrawal by Subject|2|||
126774616|NCT04380701|456131103|FG023|Overall Study|Withdrawal by Subject|2|||
126774617|NCT04380701|456131104|FG024|Overall Study|Withdrawal by Subject|1|||
126774618|NCT04380701|456131105|FG025|Overall Study|Withdrawal by Subject|1|||
126774619|NCT04380701|456131106|FG026|Overall Study|Withdrawal by Subject|0|||
126774620|NCT04380701|456131107|FG027|Overall Study|Withdrawal by Subject|0|||
126774621|NCT04380701|456131108|FG028|Overall Study|Withdrawal by Subject|0|||
126774622|NCT04380701|456131109|FG029|Overall Study|Withdrawal by Subject|0|||
126774623|NCT04380701|456131110|FG030|Overall Study|Withdrawal by Subject|0|||
126774624|NCT04380701|456131111|FG031|Overall Study|Withdrawal by Subject|0|||
126774625|NCT04380701|456131112|FG032|Overall Study|Withdrawal by Subject|0|||
126774626|NCT04380701|456131113|FG033|Overall Study|Withdrawal by Subject|0|||
126774627|NCT04380701|456131080|FG000|Overall Study|Adverse Event|0|||
126774628|NCT04380701|456131081|FG001|Overall Study|Adverse Event|0|||
126774629|NCT04380701|456131082|FG002|Overall Study|Adverse Event|0|||
126774630|NCT04380701|456131083|FG003|Overall Study|Adverse Event|0|||
126774631|NCT04380701|456131084|FG004|Overall Study|Adverse Event|0|||
126774632|NCT04380701|456131085|FG005|Overall Study|Adverse Event|1|||
126774633|NCT04380701|456131086|FG006|Overall Study|Adverse Event|0|||
126774634|NCT04380701|456131087|FG007|Overall Study|Adverse Event|0|||
126774635|NCT04380701|456131088|FG008|Overall Study|Adverse Event|0|||
126774636|NCT04380701|456131089|FG009|Overall Study|Adverse Event|0|||
126774637|NCT04380701|456131090|FG010|Overall Study|Adverse Event|0|||
126774638|NCT04380701|456131091|FG011|Overall Study|Adverse Event|0|||
126774639|NCT04380701|456131092|FG012|Overall Study|Adverse Event|0|||
126774640|NCT04380701|456131093|FG013|Overall Study|Adverse Event|0|||
126500203|NCT02658890|455131760|FG017|Treatment Phase|Other Reasons|0|||
126560854|NCT03278028|455348353|FG000|Overall Study|Withdrawal by Subject|3|||
126560855|NCT03278028|455348354|FG001|Overall Study|Withdrawal by Subject|1|||
126560856|NCT03278028|455348353|FG000|Overall Study|Pregnancy|0|||
126560857|NCT03278028|455348354|FG001|Overall Study|Pregnancy|1|||
126560858|NCT01360840|455348355|FG000|Overall Study|Ongoing at data cut-off|10|||
126774641|NCT04380701|456131094|FG014|Overall Study|Adverse Event|0|||
126500204|NCT02658890|455131761|FG018|Treatment Phase|Other Reasons|1|||
126500205|NCT02658890|455131762|FG019|Treatment Phase|Other Reasons|0|||
126560859|NCT01360840|455348356|FG001|Overall Study|Ongoing at data cut-off|10|||
126560860|NCT01360840|455348357|FG002|Overall Study|Ongoing at data cut-off|9|||
126774642|NCT04380701|456131095|FG015|Overall Study|Adverse Event|1|||
126774643|NCT04380701|456131096|FG016|Overall Study|Adverse Event|0|||
126774644|NCT04380701|456131097|FG017|Overall Study|Adverse Event|0|||
126774645|NCT04380701|456131098|FG018|Overall Study|Adverse Event|0|||
126774646|NCT04380701|456131099|FG019|Overall Study|Adverse Event|1|||
126774647|NCT04380701|456131100|FG020|Overall Study|Adverse Event|0|||
126500206|NCT02658890|455131763|FG020|Treatment Phase|Other Reasons|0|||
126500207|NCT02658890|455131764|FG021|Treatment Phase|Other Reasons|0|||
126774648|NCT04380701|456131101|FG021|Overall Study|Adverse Event|0|||
126774649|NCT04380701|456131102|FG022|Overall Study|Adverse Event|0|||
126774650|NCT04380701|456131103|FG023|Overall Study|Adverse Event|0|||
126774651|NCT04380701|456131104|FG024|Overall Study|Adverse Event|0|||
126774652|NCT04380701|456131105|FG025|Overall Study|Adverse Event|0|||
126774653|NCT04380701|456131106|FG026|Overall Study|Adverse Event|0|||
126774654|NCT04380701|456131107|FG027|Overall Study|Adverse Event|0|||
126774655|NCT04380701|456131108|FG028|Overall Study|Adverse Event|0|||
126774656|NCT04380701|456131109|FG029|Overall Study|Adverse Event|0|||
126774657|NCT04380701|456131110|FG030|Overall Study|Adverse Event|0|||
126774658|NCT04380701|456131111|FG031|Overall Study|Adverse Event|0|||
126774659|NCT04380701|456131112|FG032|Overall Study|Adverse Event|0|||
126774660|NCT04380701|456131113|FG033|Overall Study|Adverse Event|0|||
126774661|NCT04380701|456131080|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
126774662|NCT04380701|456131081|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
126774663|NCT04380701|456131082|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
126774664|NCT04380701|456131083|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
126774665|NCT04380701|456131084|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
126774666|NCT04380701|456131085|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
126774667|NCT04380701|456131086|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
126774668|NCT04380701|456131087|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
126774669|NCT04380701|456131088|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
126774670|NCT04380701|456131089|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
126774671|NCT04380701|456131090|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
126774672|NCT04380701|456131091|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
126774673|NCT04380701|456131092|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
126774674|NCT04380701|456131093|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
126774675|NCT04380701|456131094|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
126774676|NCT04380701|456131095|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
126774677|NCT04380701|456131096|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
126774678|NCT04380701|456131097|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
126774679|NCT04380701|456131098|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
126774680|NCT04380701|456131099|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
126774681|NCT04380701|456131100|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
126774682|NCT04380701|456131101|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
126774683|NCT04380701|456131102|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
126774684|NCT04380701|456131103|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
126774685|NCT04380701|456131104|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
126774686|NCT04380701|456131105|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
126774687|NCT04380701|456131106|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
126774688|NCT04380701|456131107|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
126774689|NCT04380701|456131108|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
126774690|NCT04380701|456131109|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
126774691|NCT04380701|456131110|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
126774692|NCT04380701|456131111|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
126774693|NCT04380701|456131112|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
126774694|NCT04380701|456131113|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
126774695|NCT04380701|456131080|FG000|Overall Study|Physician Decision|0|||
126774696|NCT04380701|456131081|FG001|Overall Study|Physician Decision|0|||
126774697|NCT04380701|456131082|FG002|Overall Study|Physician Decision|0|||
126774698|NCT04380701|456131083|FG003|Overall Study|Physician Decision|0|||
126774699|NCT04380701|456131084|FG004|Overall Study|Physician Decision|0|||
126774700|NCT04380701|456131085|FG005|Overall Study|Physician Decision|0|||
126774701|NCT04380701|456131086|FG006|Overall Study|Physician Decision|0|||
126500208|NCT02658890|455131765|FG022|Treatment Phase|Other Reasons|0|||
126500209|NCT02658890|455131766|FG023|Treatment Phase|Other Reasons|0|||
126500210|NCT02658890|455131767|FG024|Treatment Phase|Other Reasons|1|||
126500211|NCT02658890|455131768|FG025|Treatment Phase|Other Reasons|0|||
126500212|NCT02658890|455131769|FG026|Treatment Phase|Other Reasons|1|||
126500213|NCT02658890|455131743|FG000|Treatment Phase|Progressive Disease|6|||
126500214|NCT02658890|455131744|FG001|Treatment Phase|Progressive Disease|7|||
126500215|NCT02658890|455131745|FG002|Treatment Phase|Progressive Disease|6|||
126500216|NCT02658890|455131746|FG003|Treatment Phase|Progressive Disease|12|||
126500217|NCT02658890|455131747|FG004|Treatment Phase|Progressive Disease|6|||
126774702|NCT04380701|456131087|FG007|Overall Study|Physician Decision|0|||
126774703|NCT04380701|456131088|FG008|Overall Study|Physician Decision|0|||
126500218|NCT02658890|455131748|FG005|Treatment Phase|Progressive Disease|18|||
126560861|NCT00463151|455348359|FG000|Overall Study|Adverse Event|0|||
126774704|NCT04380701|456131089|FG009|Overall Study|Physician Decision|0|||
126774705|NCT04380701|456131090|FG010|Overall Study|Physician Decision|0|||
126774706|NCT04380701|456131091|FG011|Overall Study|Physician Decision|0|||
126774707|NCT04380701|456131092|FG012|Overall Study|Physician Decision|0|||
126774708|NCT04380701|456131093|FG013|Overall Study|Physician Decision|0|||
126774709|NCT04380701|456131094|FG014|Overall Study|Physician Decision|0|||
126774710|NCT04380701|456131095|FG015|Overall Study|Physician Decision|0|||
126774711|NCT04380701|456131096|FG016|Overall Study|Physician Decision|0|||
126774712|NCT04380701|456131097|FG017|Overall Study|Physician Decision|0|||
126774713|NCT04380701|456131098|FG018|Overall Study|Physician Decision|0|||
126774714|NCT04380701|456131099|FG019|Overall Study|Physician Decision|0|||
126560862|NCT00463151|455348360|FG001|Overall Study|Adverse Event|0|||
126774715|NCT04380701|456131100|FG020|Overall Study|Physician Decision|0|||
126774716|NCT04380701|456131101|FG021|Overall Study|Physician Decision|0|||
126774717|NCT04380701|456131102|FG022|Overall Study|Physician Decision|0|||
126774718|NCT04380701|456131103|FG023|Overall Study|Physician Decision|0|||
126774719|NCT04380701|456131104|FG024|Overall Study|Physician Decision|2|||
126774720|NCT04380701|456131105|FG025|Overall Study|Physician Decision|0|||
126774721|NCT04380701|456131106|FG026|Overall Study|Physician Decision|0|||
126774722|NCT04380701|456131107|FG027|Overall Study|Physician Decision|0|||
126774723|NCT04380701|456131108|FG028|Overall Study|Physician Decision|0|||
126774724|NCT04380701|456131109|FG029|Overall Study|Physician Decision|0|||
126774725|NCT04380701|456131110|FG030|Overall Study|Physician Decision|0|||
126774726|NCT04380701|456131111|FG031|Overall Study|Physician Decision|0|||
126774727|NCT04380701|456131112|FG032|Overall Study|Physician Decision|0|||
126774728|NCT04380701|456131113|FG033|Overall Study|Physician Decision|0|||
126774729|NCT04380701|456131080|FG000|Overall Study|Death|0|||
126774730|NCT04380701|456131081|FG001|Overall Study|Death|0|||
126774731|NCT04380701|456131082|FG002|Overall Study|Death|0|||
126774732|NCT04380701|456131083|FG003|Overall Study|Death|0|||
126774733|NCT04380701|456131084|FG004|Overall Study|Death|0|||
126774734|NCT04380701|456131085|FG005|Overall Study|Death|0|||
126774735|NCT04380701|456131086|FG006|Overall Study|Death|0|||
126774736|NCT04380701|456131087|FG007|Overall Study|Death|0|||
126774737|NCT04380701|456131088|FG008|Overall Study|Death|0|||
126774738|NCT04380701|456131089|FG009|Overall Study|Death|0|||
126774739|NCT04380701|456131090|FG010|Overall Study|Death|0|||
126774740|NCT04380701|456131091|FG011|Overall Study|Death|0|||
126774741|NCT04380701|456131092|FG012|Overall Study|Death|0|||
126774742|NCT04380701|456131093|FG013|Overall Study|Death|0|||
126774743|NCT04380701|456131094|FG014|Overall Study|Death|0|||
126774744|NCT04380701|456131095|FG015|Overall Study|Death|0|||
126774745|NCT04380701|456131096|FG016|Overall Study|Death|0|||
126774746|NCT04380701|456131097|FG017|Overall Study|Death|0|||
126774747|NCT04380701|456131098|FG018|Overall Study|Death|0|||
126774748|NCT04380701|456131099|FG019|Overall Study|Death|0|||
126774749|NCT04380701|456131100|FG020|Overall Study|Death|0|||
126774750|NCT04380701|456131101|FG021|Overall Study|Death|0|||
126774751|NCT04380701|456131102|FG022|Overall Study|Death|0|||
126774752|NCT04380701|456131103|FG023|Overall Study|Death|0|||
126774753|NCT04380701|456131104|FG024|Overall Study|Death|1|||
126774754|NCT04380701|456131105|FG025|Overall Study|Death|0|||
126774755|NCT04380701|456131106|FG026|Overall Study|Death|0|||
126774756|NCT04380701|456131107|FG027|Overall Study|Death|0|||
126774757|NCT04380701|456131108|FG028|Overall Study|Death|0|||
126774758|NCT04380701|456131109|FG029|Overall Study|Death|0|||
126774759|NCT04380701|456131110|FG030|Overall Study|Death|0|||
126774760|NCT04380701|456131111|FG031|Overall Study|Death|0|||
126774761|NCT04380701|456131112|FG032|Overall Study|Death|0|||
126774762|NCT04380701|456131113|FG033|Overall Study|Death|0|||
126774763|NCT04380701|456131080|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774764|NCT04380701|456131081|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774765|NCT04380701|456131082|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774766|NCT04380701|456131083|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774767|NCT04380701|456131084|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126500219|NCT02658890|455131749|FG006|Treatment Phase|Progressive Disease|12|||
126500220|NCT02658890|455131750|FG007|Treatment Phase|Progressive Disease|19|||
126500221|NCT02658890|455131751|FG008|Treatment Phase|Progressive Disease|26|||
126500222|NCT02658890|455131752|FG009|Treatment Phase|Progressive Disease|8|||
126500223|NCT02658890|455131753|FG010|Treatment Phase|Progressive Disease|7|||
126500224|NCT02658890|455131754|FG011|Treatment Phase|Progressive Disease|9|||
126500225|NCT02658890|455131755|FG012|Treatment Phase|Progressive Disease|8|||
126500226|NCT02658890|455131756|FG013|Treatment Phase|Progressive Disease|29|||
126774768|NCT04380701|456131085|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126500227|NCT02658890|455131757|FG014|Treatment Phase|Progressive Disease|6|||
126500228|NCT02658890|455131758|FG015|Treatment Phase|Progressive Disease|2|||
126774769|NCT04380701|456131086|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774770|NCT04380701|456131087|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774771|NCT04380701|456131088|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774772|NCT04380701|456131089|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774773|NCT04380701|456131090|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774774|NCT04380701|456131091|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774775|NCT04380701|456131092|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774776|NCT04380701|456131093|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774777|NCT04380701|456131094|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774778|NCT04380701|456131095|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774779|NCT04380701|456131096|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774780|NCT04380701|456131097|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774781|NCT04380701|456131098|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774782|NCT04380701|456131099|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774783|NCT04380701|456131100|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774784|NCT04380701|456131101|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
126774785|NCT04380701|456131102|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
126774786|NCT04380701|456131103|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
126774787|NCT04380701|456131104|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
126774788|NCT04380701|456131105|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774789|NCT04380701|456131106|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774790|NCT04380701|456131107|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774791|NCT04380701|456131108|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774792|NCT04380701|456131109|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774793|NCT04380701|456131110|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774794|NCT04380701|456131111|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774795|NCT04380701|456131112|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774796|NCT04380701|456131113|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
126774797|NCT00363129|456131114|FG000|Overall Study|Withdrawal by Subject|11|||
126774798|NCT00363129|456131115|FG001|Overall Study|Withdrawal by Subject|18|||
126774799|NCT00363129|456131114|FG000|Overall Study|Adverse Event|8|||
126774800|NCT00363129|456131115|FG001|Overall Study|Adverse Event|3|||
126774801|NCT00363129|456131114|FG000|Overall Study|Alternate Treatment|2|||
126774802|NCT00363129|456131115|FG001|Overall Study|Alternate Treatment|4|||
126774803|NCT00363129|456131114|FG000|Overall Study|Other Medical Problems|2|||
126774804|NCT00363129|456131115|FG001|Overall Study|Other Medical Problems|4|||
126500229|NCT02658890|455131759|FG016|Treatment Phase|Progressive Disease|32|||
126500230|NCT02658890|455131760|FG017|Treatment Phase|Progressive Disease|14|||
126500231|NCT02658890|455131761|FG018|Treatment Phase|Progressive Disease|40|||
126500232|NCT02658890|455131762|FG019|Treatment Phase|Progressive Disease|32|||
126500233|NCT02658890|455131763|FG020|Treatment Phase|Progressive Disease|19|||
126500234|NCT02658890|455131764|FG021|Treatment Phase|Progressive Disease|30|||
126500235|NCT02658890|455131765|FG022|Treatment Phase|Progressive Disease|15|||
126500236|NCT02658890|455131766|FG023|Treatment Phase|Progressive Disease|0|||
126500237|NCT02658890|455131767|FG024|Treatment Phase|Progressive Disease|0|||
126500238|NCT02658890|455131768|FG025|Treatment Phase|Progressive Disease|14|||
126500239|NCT02658890|455131769|FG026|Treatment Phase|Progressive Disease|11|||
126500240|NCT02658890|455131743|FG000|Treatment Phase|Study Drug Toxicity|0|||
126500241|NCT02658890|455131744|FG001|Treatment Phase|Study Drug Toxicity|0|||
126500242|NCT02658890|455131745|FG002|Treatment Phase|Study Drug Toxicity|2|||
126500243|NCT02658890|455131746|FG003|Treatment Phase|Study Drug Toxicity|0|||
126500244|NCT02658890|455131747|FG004|Treatment Phase|Study Drug Toxicity|0|||
126500245|NCT02658890|455131748|FG005|Treatment Phase|Study Drug Toxicity|0|||
126500246|NCT02658890|455131749|FG006|Treatment Phase|Study Drug Toxicity|0|||
126500247|NCT02658890|455131750|FG007|Treatment Phase|Study Drug Toxicity|0|||
126500248|NCT02658890|455131751|FG008|Treatment Phase|Study Drug Toxicity|3|||
126500249|NCT02658890|455131752|FG009|Treatment Phase|Study Drug Toxicity|0|||
126500250|NCT02658890|455131753|FG010|Treatment Phase|Study Drug Toxicity|1|||
126500251|NCT02658890|455131754|FG011|Treatment Phase|Study Drug Toxicity|1|||
126500252|NCT02658890|455131755|FG012|Treatment Phase|Study Drug Toxicity|2|||
126500253|NCT02658890|455131756|FG013|Treatment Phase|Study Drug Toxicity|9|||
126500254|NCT02658890|455131757|FG014|Treatment Phase|Study Drug Toxicity|0|||
126500255|NCT02658890|455131758|FG015|Treatment Phase|Study Drug Toxicity|1|||
126500256|NCT02658890|455131759|FG016|Treatment Phase|Study Drug Toxicity|1|||
126500257|NCT02658890|455131760|FG017|Treatment Phase|Study Drug Toxicity|0|||
126500258|NCT02658890|455131761|FG018|Treatment Phase|Study Drug Toxicity|8|||
126500259|NCT02658890|455131762|FG019|Treatment Phase|Study Drug Toxicity|3|||
126500260|NCT02658890|455131763|FG020|Treatment Phase|Study Drug Toxicity|2|||
126500261|NCT02658890|455131764|FG021|Treatment Phase|Study Drug Toxicity|0|||
126500262|NCT02658890|455131765|FG022|Treatment Phase|Study Drug Toxicity|8|||
126500263|NCT02658890|455131766|FG023|Treatment Phase|Study Drug Toxicity|0|||
126500264|NCT02658890|455131767|FG024|Treatment Phase|Study Drug Toxicity|0|||
126500265|NCT02658890|455131768|FG025|Treatment Phase|Study Drug Toxicity|2|||
126500266|NCT02658890|455131769|FG026|Treatment Phase|Study Drug Toxicity|0|||
126500267|NCT02658890|455131743|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500268|NCT02658890|455131744|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500269|NCT02658890|455131745|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500270|NCT02658890|455131746|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
126500271|NCT02658890|455131747|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500272|NCT02658890|455131748|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500273|NCT02658890|455131749|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500274|NCT02658890|455131750|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500275|NCT02658890|455131751|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500276|NCT02658890|455131752|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
126500277|NCT02658890|455131753|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500278|NCT02658890|455131754|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500279|NCT02658890|455131755|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126726037|NCT00174785|455946408|FG001|Overall Study|Other prohibited medication|3|||
126726038|NCT00174785|455946407|FG000|Overall Study|Family request|6|||
126726039|NCT00174785|455946408|FG001|Overall Study|Family request|8|||
126726040|NCT00174785|455946407|FG000|Overall Study|Not pre-specified/Not coded|56|||
126726041|NCT00174785|455946408|FG001|Overall Study|Not pre-specified/Not coded|70|||
126726042|NCT00120289|455946410|FG000|Overall Study|Death|96|||
126726043|NCT00120289|455946411|FG001|Overall Study|Death|82|||
126726044|NCT00120289|455946410|FG000|Overall Study|Lost to Follow-up|11|||
126726045|NCT00120289|455946411|FG001|Overall Study|Lost to Follow-up|14|||
126726046|NCT00120289|455946410|FG000|Overall Study|Withdrawal by Subject|14|||
126726047|NCT00120289|455946411|FG001|Overall Study|Withdrawal by Subject|13|||
126726048|NCT01944969|455946412|FG000|Overall Study|Adverse Event|1|||
126726049|NCT01944969|455946412|FG000|Overall Study|Lack of Efficacy|1|||
126726050|NCT01944969|455946412|FG000|Overall Study|Non-compliance with IMP|1|||
126726051|NCT01944969|455946412|FG000|Overall Study|Administrative or other reasons|23|||
126726052|NCT00848250|455946414|FG000|Overall Study|surgery was completed without cardiopulm|0|||
126726053|NCT00848250|455946415|FG001|Overall Study|surgery was completed without cardiopulm|1|||
126726054|NCT02938585|455946418|FG000|Overall Study|Withdrawal by parent or guardian|0|||
126726055|NCT02938585|455946419|FG001|Overall Study|Withdrawal by parent or guardian|1|||
126726056|NCT02938585|455946420|FG002|Overall Study|Withdrawal by parent or guardian|0|||
126726057|NCT02938585|455946421|FG003|Overall Study|Withdrawal by parent or guardian|0|||
126726058|NCT02938585|455946418|FG000|Overall Study|Withdrawal by Subject|0|||
126726059|NCT02938585|455946419|FG001|Overall Study|Withdrawal by Subject|0|||
126726060|NCT02938585|455946420|FG002|Overall Study|Withdrawal by Subject|0|||
126726061|NCT02938585|455946421|FG003|Overall Study|Withdrawal by Subject|5|||
126726062|NCT02411201|455946425|FG000|Overall Study|Adverse Event|2|||
126726063|NCT02411201|455946425|FG000|Overall Study|Withdrawal by Subject|2|||
126726064|NCT02411201|455946425|FG000|Overall Study|Age group completed|2|||
126726065|NCT01260467|455946426|FG000|Overall Study|Withdrawal by Subject|2|||
126726066|NCT01774344|455946427|FG000|Overall Study|Withdrawal by Subject|3|||
126726067|NCT01774344|455946428|FG001|Overall Study|Withdrawal by Subject|10|||
126726068|NCT01774344|455946427|FG000|Overall Study|Protocol Violation|0|||
126726069|NCT01774344|455946428|FG001|Overall Study|Protocol Violation|1|||
126726070|NCT01774344|455946427|FG000|Overall Study|Lost to Follow-up|4|||
126726071|NCT01774344|455946428|FG001|Overall Study|Lost to Follow-up|10|||
126726072|NCT01774344|455946427|FG000|Overall Study|End of survival follow-up not available|2|||
126726073|NCT01774344|455946428|FG001|Overall Study|End of survival follow-up not available|2|||
126726074|NCT01774344|455946427|FG000|Overall Study|Data collection finished|4|||
126726075|NCT01774344|455946428|FG001|Overall Study|Data collection finished|14|||
126726076|NCT01774344|455946427|FG000|Overall Study|Other|0|||
126726077|NCT01774344|455946428|FG001|Overall Study|Other|1|||
126726078|NCT01774344|455946427|FG000|Overall Study|Did not enter Survival Follow up|49|||
126726079|NCT01774344|455946428|FG001|Overall Study|Did not enter Survival Follow up|83|||
126726080|NCT01397552|455946429|FG000|Overall Study|Adverse Event|1|||
126726081|NCT01397552|455946430|FG001|Overall Study|Adverse Event|0|||
126726082|NCT01397552|455946429|FG000|Overall Study|Withdrawal by Subject|2|||
126726083|NCT01397552|455946430|FG001|Overall Study|Withdrawal by Subject|1|||
126726084|NCT00992784|455946437|FG000|Overall Study|Adverse Event|2|||
126726085|NCT00992784|455946438|FG001|Overall Study|Adverse Event|1|||
126726086|NCT00992784|455946439|FG002|Overall Study|Adverse Event|0|||
126726087|NCT00992784|455946437|FG000|Overall Study|Withdrawal by Subject|1|||
126726088|NCT00992784|455946438|FG001|Overall Study|Withdrawal by Subject|1|||
126726089|NCT00992784|455946439|FG002|Overall Study|Withdrawal by Subject|1|||
126726090|NCT01363713|455946440|FG000|Overall Study|Adverse Event|1|||
126726091|NCT01363713|455946440|FG000|Overall Study|Protocol Violation|3|||
126726092|NCT01363713|455946440|FG000|Overall Study|Withdrawal by Subject|2|||
126726093|NCT01658579|455946441|FG000|Treatment Period A|Other|0|||
126774805|NCT00363129|456131114|FG000|Overall Study|Death|0|||
126726094|NCT01658579|455946442|FG001|Treatment Period A|Other|0|||
126726095|NCT01658579|455946443|FG002|Treatment Period A|Other|1|||
126726096|NCT01658579|455946444|FG003|Treatment Period A|Other|1|||
126726097|NCT01658579|455946441|FG000|Treatment Period A|Adverse Event|1|||
126726098|NCT01658579|455946442|FG001|Treatment Period A|Adverse Event|0|||
126726099|NCT01658579|455946443|FG002|Treatment Period A|Adverse Event|0|||
126726100|NCT01658579|455946444|FG003|Treatment Period A|Adverse Event|0|||
126726101|NCT01658579|455946441|FG000|Treatment Period B|Other|0|||
126726102|NCT01658579|455946442|FG001|Treatment Period B|Other|0|||
126726103|NCT01658579|455946443|FG002|Treatment Period B|Other|0|||
126774806|NCT00363129|456131115|FG001|Overall Study|Death|1|||
126774807|NCT00363129|456131114|FG000|Overall Study|Other Reasons|6|||
126774808|NCT00363129|456131115|FG001|Overall Study|Other Reasons|3|||
126774809|NCT00383019|456131116|FG000|Overall Study|Adverse Event|5|||
126774810|NCT00383019|456131117|FG001|Overall Study|Adverse Event|1|||
126774811|NCT00383019|456131116|FG000|Overall Study|Withdrawal by Subject|0|||
126774812|NCT00383019|456131117|FG001|Overall Study|Withdrawal by Subject|1|||
126774813|NCT03797222|456131118|FG000|Overall Study|Withdrawal by Subject|1|||
126774814|NCT00725725|456131120|FG000|Overall Study|Adverse Event|1|||
126500280|NCT02658890|455131756|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500281|NCT02658890|455131757|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500282|NCT02658890|455131758|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500283|NCT02658890|455131759|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500284|NCT02658890|455131760|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500285|NCT02658890|455131761|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
126500286|NCT02658890|455131762|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500287|NCT02658890|455131763|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500288|NCT02658890|455131764|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126774815|NCT00725725|456131121|FG001|Overall Study|Adverse Event|3|||
126774816|NCT00725725|456131122|FG002|Overall Study|Adverse Event|2|||
126500289|NCT02658890|455131765|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
126500290|NCT02658890|455131766|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500291|NCT02658890|455131767|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126774817|NCT00725725|456131120|FG000|Overall Study|Lost to Follow-up|2|||
126774818|NCT00725725|456131121|FG001|Overall Study|Lost to Follow-up|0|||
126774819|NCT00725725|456131122|FG002|Overall Study|Lost to Follow-up|2|||
126774820|NCT00725725|456131120|FG000|Overall Study|Withdrawal by Subject|1|||
126774821|NCT00725725|456131121|FG001|Overall Study|Withdrawal by Subject|0|||
126774822|NCT00725725|456131122|FG002|Overall Study|Withdrawal by Subject|1|||
126774823|NCT00725725|456131120|FG000|Overall Study|Protocol Violation|0|||
126774824|NCT00725725|456131121|FG001|Overall Study|Protocol Violation|1|||
126774825|NCT00725725|456131122|FG002|Overall Study|Protocol Violation|0|||
126774826|NCT01619085|456131123|FG000|Overall Study|Adverse Event|231|||
126774827|NCT01619085|456131123|FG000|Overall Study|Protocol Violation|4|||
126774828|NCT01619085|456131123|FG000|Overall Study|Lost to Follow-up|3|||
126774829|NCT01619085|456131123|FG000|Overall Study|Withdrawal by Subject|45|||
126774830|NCT01619085|456131123|FG000|Overall Study|Other than specified|96|||
126774831|NCT01619085|456131123|FG000|Overall Study|Not treated|1|||
126774832|NCT01619085|456131123|FG000|Overall Study|Death|145|||
126774833|NCT03125915|456131126|FG000|1 Month Follow up|Lost to Follow-up|3|||
126774834|NCT03125915|456131127|FG001|1 Month Follow up|Lost to Follow-up|3|||
126774835|NCT03125915|456131128|FG002|1 Month Follow up|Lost to Follow-up|2|||
126774836|NCT03125915|456131129|FG003|1 Month Follow up|Lost to Follow-up|3|||
126774837|NCT03125915|456131126|FG000|3 Month Follow-up|Lost to Follow-up|6|||
126774838|NCT03125915|456131127|FG001|3 Month Follow-up|Lost to Follow-up|4|||
126774839|NCT03125915|456131128|FG002|3 Month Follow-up|Lost to Follow-up|4|||
126774840|NCT03125915|456131129|FG003|3 Month Follow-up|Lost to Follow-up|2|||
126774841|NCT03125915|456131126|FG000|6 Month Follow-up|Lost to Follow-up|7|||
126774842|NCT03125915|456131127|FG001|6 Month Follow-up|Lost to Follow-up|3|||
126500292|NCT02658890|455131768|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500293|NCT02658890|455131769|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
126500294|NCT02658890|455131743|FG000|Treatment Phase|Withdrawal by Subject|0|||
126500295|NCT02658890|455131744|FG001|Treatment Phase|Withdrawal by Subject|1|||
126500296|NCT02658890|455131745|FG002|Treatment Phase|Withdrawal by Subject|0|||
126500297|NCT02658890|455131746|FG003|Treatment Phase|Withdrawal by Subject|0|||
126500298|NCT02658890|455131747|FG004|Treatment Phase|Withdrawal by Subject|0|||
126500299|NCT02658890|455131748|FG005|Treatment Phase|Withdrawal by Subject|0|||
126500300|NCT02658890|455131749|FG006|Treatment Phase|Withdrawal by Subject|1|||
126500301|NCT02658890|455131750|FG007|Treatment Phase|Withdrawal by Subject|0|||
126500302|NCT02658890|455131751|FG008|Treatment Phase|Withdrawal by Subject|0|||
126500303|NCT02658890|455131752|FG009|Treatment Phase|Withdrawal by Subject|1|||
126500304|NCT02658890|455131753|FG010|Treatment Phase|Withdrawal by Subject|0|||
126500305|NCT02658890|455131754|FG011|Treatment Phase|Withdrawal by Subject|0|||
126500306|NCT02658890|455131755|FG012|Treatment Phase|Withdrawal by Subject|1|||
126500307|NCT02658890|455131756|FG013|Treatment Phase|Withdrawal by Subject|3|||
126774843|NCT03125915|456131128|FG002|6 Month Follow-up|Lost to Follow-up|6|||
126774844|NCT03125915|456131129|FG003|6 Month Follow-up|Lost to Follow-up|3|||
126774845|NCT01458119|456131130|FG000|Overall Study|Physician Decision|4|||
126774846|NCT01458119|456131130|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
126774847|NCT01458119|456131130|FG000|Overall Study|Pregnancy|1|||
126774848|NCT01458119|456131130|FG000|Overall Study|Death|2|||
126774849|NCT01458119|456131130|FG000|Overall Study|Adverse Event|1|||
126774850|NCT01458119|456131130|FG000|Overall Study|Consent Withdrawn by Participant|8|||
126774851|NCT01458119|456131130|FG000|Overall Study|Non-compliance With Study Drug|3|||
126774852|NCT01123980|456131133|FG000|Overall Study|Adverse Event|1|||
126774853|NCT01123980|456131134|FG001|Overall Study|Adverse Event|1|||
126774854|NCT01123980|456131133|FG000|Overall Study|Lack of Efficacy|1|||
126774855|NCT01123980|456131134|FG001|Overall Study|Lack of Efficacy|0|||
126774856|NCT01123980|456131133|FG000|Overall Study|Physician Decision|0|||
126774857|NCT01123980|456131134|FG001|Overall Study|Physician Decision|1|||
126774858|NCT01123980|456131133|FG000|Overall Study|Lost to Follow-up|0|||
126774859|NCT01123980|456131134|FG001|Overall Study|Lost to Follow-up|6|||
126774860|NCT01123980|456131133|FG000|Overall Study|Protocol Violation|6|||
126774861|NCT01123980|456131134|FG001|Overall Study|Protocol Violation|6|||
126774862|NCT01123980|456131133|FG000|Overall Study|Withdrawal by Subject|5|||
126774863|NCT01123980|456131134|FG001|Overall Study|Withdrawal by Subject|3|||
126774864|NCT01123980|456131133|FG000|Overall Study|Unclassified|6|||
126774865|NCT01123980|456131134|FG001|Overall Study|Unclassified|7|||
126774866|NCT01225991|456131135|FG000|Overall Study|Withdrawal by Subject|6|||
126774867|NCT00789828|456131136|FG000|Core Period (48 Weeks)|Administrative problems|0|||
126774868|NCT00789828|456131137|FG001|Core Period (48 Weeks)|Administrative problems|1|||
126774869|NCT00789828|456131136|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
126774870|NCT00789828|456131137|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
126774871|NCT00789828|456131136|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
126774872|NCT00789828|456131137|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
126774873|NCT00789828|456131136|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
126774874|NCT00789828|456131137|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
126774875|NCT00789828|456131136|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
126774876|NCT00789828|456131137|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
126774877|NCT00789828|456131136|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
126774878|NCT00789828|456131137|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
126774879|NCT00789828|456131136|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
126774880|NCT00789828|456131137|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
126774881|NCT00789828|456131136|FG000|Open-label Extension Period (4 Years)|Death|1|||
126774882|NCT00789828|456131137|FG001|Open-label Extension Period (4 Years)|Death|0|||
126774883|NCT00789828|456131136|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
126774884|NCT00789828|456131137|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
126774885|NCT00789828|456131136|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
126774886|NCT00789828|456131137|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
126774887|NCT02094937|456131138|FG000|8 Weeks in Period 1|Adverse Event|9|||
126560863|NCT00463151|455348361|FG002|Overall Study|Adverse Event|1|||
126560864|NCT00463151|455348362|FG003|Overall Study|Adverse Event|0|||
126560865|NCT00463151|455348359|FG000|Overall Study|Lack of Efficacy|2|||
126560866|NCT00463151|455348360|FG001|Overall Study|Lack of Efficacy|5|||
126560867|NCT00463151|455348361|FG002|Overall Study|Lack of Efficacy|2|||
126560868|NCT00463151|455348362|FG003|Overall Study|Lack of Efficacy|5|||
126560869|NCT00463151|455348359|FG000|Overall Study|Protocol Violation|0|||
126560870|NCT00463151|455348360|FG001|Overall Study|Protocol Violation|0|||
126560871|NCT00463151|455348361|FG002|Overall Study|Protocol Violation|0|||
126560872|NCT00463151|455348362|FG003|Overall Study|Protocol Violation|1|||
126560873|NCT00463151|455348359|FG000|Overall Study|Withdrawal by Subject|0|||
126560874|NCT00463151|455348360|FG001|Overall Study|Withdrawal by Subject|0|||
126774888|NCT02094937|456131139|FG001|8 Weeks in Period 1|Adverse Event|0|||
126774889|NCT02094937|456131140|FG002|8 Weeks in Period 1|Adverse Event|0|||
126774890|NCT02094937|456131141|FG003|8 Weeks in Period 1|Adverse Event|0|||
126774891|NCT02094937|456131138|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
126500308|NCT02658890|455131757|FG014|Treatment Phase|Withdrawal by Subject|0|||
126500309|NCT02658890|455131758|FG015|Treatment Phase|Withdrawal by Subject|0|||
126500310|NCT02658890|455131759|FG016|Treatment Phase|Withdrawal by Subject|1|||
126500311|NCT02658890|455131760|FG017|Treatment Phase|Withdrawal by Subject|0|||
126500312|NCT02658890|455131761|FG018|Treatment Phase|Withdrawal by Subject|4|||
126500313|NCT02658890|455131762|FG019|Treatment Phase|Withdrawal by Subject|3|||
126500314|NCT02658890|455131763|FG020|Treatment Phase|Withdrawal by Subject|0|||
126500315|NCT02658890|455131764|FG021|Treatment Phase|Withdrawal by Subject|4|||
126500316|NCT02658890|455131765|FG022|Treatment Phase|Withdrawal by Subject|1|||
126500317|NCT02658890|455131766|FG023|Treatment Phase|Withdrawal by Subject|1|||
126500318|NCT02658890|455131767|FG024|Treatment Phase|Withdrawal by Subject|0|||
126500319|NCT02658890|455131768|FG025|Treatment Phase|Withdrawal by Subject|0|||
126774892|NCT02094937|456131139|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
126774893|NCT02094937|456131140|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
126774894|NCT02094937|456131141|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
126500320|NCT02658890|455131769|FG026|Treatment Phase|Withdrawal by Subject|0|||
126500321|NCT00159588|455131773|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
126560875|NCT00463151|455348361|FG002|Overall Study|Withdrawal by Subject|0|||
126560876|NCT00463151|455348362|FG003|Overall Study|Withdrawal by Subject|1|||
126560877|NCT00293462|455348363|FG000|Overall Study|Withdrawal by Subject|4|||
126560878|NCT00293462|455348364|FG001|Overall Study|Withdrawal by Subject|3|||
126560879|NCT00293462|455348365|FG002|Overall Study|Withdrawal by Subject|8|||
126500322|NCT00159588|455131774|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
126500323|NCT00159588|455131775|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
126500324|NCT03056755|455131777|FG000|Treatment- Core Phase|Progressive disease|89|||
126500325|NCT03056755|455131778|FG001|Treatment- Core Phase|Progressive disease|88|||
126500326|NCT03056755|455131779|FG002|Treatment- Core Phase|Progressive disease|90|||
126500327|NCT03056755|455131777|FG000|Treatment- Core Phase|Adverse Event|20|||
126500328|NCT03056755|455131778|FG001|Treatment- Core Phase|Adverse Event|14|||
126500329|NCT03056755|455131779|FG002|Treatment- Core Phase|Adverse Event|13|||
126500330|NCT03056755|455131777|FG000|Treatment- Core Phase|Physician Decision|7|||
126500331|NCT03056755|455131778|FG001|Treatment- Core Phase|Physician Decision|13|||
126500332|NCT03056755|455131779|FG002|Treatment- Core Phase|Physician Decision|5|||
126500333|NCT03056755|455131777|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
126500334|NCT03056755|455131778|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
126500335|NCT03056755|455131779|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
126500336|NCT03056755|455131777|FG000|Treatment- Core Phase|Death|3|||
126500337|NCT03056755|455131778|FG001|Treatment- Core Phase|Death|2|||
126500338|NCT03056755|455131779|FG002|Treatment- Core Phase|Death|4|||
126500339|NCT03056755|455131777|FG000|Treatment- Core Phase|Protocol deviation|1|||
126500340|NCT03056755|455131778|FG001|Treatment- Core Phase|Protocol deviation|1|||
126726104|NCT01658579|455946444|FG003|Treatment Period B|Other|1|||
126726105|NCT00608530|455946447|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
126726106|NCT00608530|455946448|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
126726107|NCT00608530|455946449|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
126726108|NCT00608530|455946450|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
126726109|NCT00608530|455946447|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
126726110|NCT00608530|455946448|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
126726111|NCT00608530|455946449|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
126726112|NCT00608530|455946450|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
126726113|NCT00608530|455946447|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
126726114|NCT00608530|455946448|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
126726115|NCT00608530|455946449|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
126726116|NCT00608530|455946450|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
126726117|NCT00608530|455946447|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
126726118|NCT00608530|455946448|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
126726119|NCT00608530|455946449|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
126726120|NCT00608530|455946450|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
126726121|NCT00608530|455946447|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
126726122|NCT00608530|455946448|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
126726123|NCT00608530|455946449|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
126726124|NCT00608530|455946450|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
126726125|NCT00608530|455946447|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
126726126|NCT00608530|455946448|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
126726127|NCT00608530|455946449|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
126726128|NCT00608530|455946450|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
126726129|NCT01514188|455946451|FG000|Overall Study|Adverse Event|3|||
126726130|NCT01514188|455946452|FG001|Overall Study|Adverse Event|5|||
126726131|NCT01514188|455946451|FG000|Overall Study|Withdrawal by Subject|2|||
126726132|NCT01514188|455946452|FG001|Overall Study|Withdrawal by Subject|4|||
126726133|NCT01514188|455946451|FG000|Overall Study|Protocol Violation|2|||
126726134|NCT01514188|455946452|FG001|Overall Study|Protocol Violation|4|||
126726135|NCT01514188|455946451|FG000|Overall Study|Physician Decision|0|||
126726136|NCT01514188|455946452|FG001|Overall Study|Physician Decision|2|||
126726137|NCT01514188|455946451|FG000|Overall Study|Disease Progression|13|||
126726138|NCT01514188|455946452|FG001|Overall Study|Disease Progression|14|||
126726139|NCT01514188|455946451|FG000|Overall Study|Death|1|||
126726140|NCT01514188|455946452|FG001|Overall Study|Death|3|||
126726141|NCT01514188|455946451|FG000|Overall Study|Other|2|||
126726142|NCT01514188|455946452|FG001|Overall Study|Other|1|||
126726143|NCT01019486|455946453|FG000|Overall Study|Withdrawal by Subject|1|||
126726144|NCT01019486|455946454|FG001|Overall Study|Withdrawal by Subject|1|||
126726145|NCT01019486|455946455|FG002|Overall Study|Withdrawal by Subject|1|||
126726146|NCT03029650|455946460|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
126726147|NCT03029650|455946461|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
126726148|NCT03029650|455946460|FG000|Washout (1 Week)|Physician Decision|0|||
126726149|NCT03029650|455946461|FG001|Washout (1 Week)|Physician Decision|1|||
126500341|NCT03056755|455131779|FG002|Treatment- Core Phase|Protocol deviation|0|||
126500342|NCT03056755|455131777|FG000|Treatment- Core Phase|Technical problems|1|||
126500343|NCT03056755|455131778|FG001|Treatment- Core Phase|Technical problems|0|||
126726150|NCT01875367|455946462|FG000|Overall Study|Not complete at least 2 questionaries|4|||
126726151|NCT01875367|455946463|FG001|Overall Study|Not complete at least 2 questionaries|2|||
126726152|NCT01875367|455946462|FG000|Overall Study|Not receive study treatment|1|||
126726153|NCT01875367|455946463|FG001|Overall Study|Not receive study treatment|0|||
126726154|NCT03977727|455946467|FG000|Second Treatment|Lost to Follow-up|0|||
126726155|NCT03977727|455946468|FG001|Second Treatment|Lost to Follow-up|3|||
126726156|NCT04799405|455946469|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
126726157|NCT00603980|455946470|FG000|Study Qualification|Protocol Violation|3|||
126726158|NCT00603980|455946470|FG000|Study Qualification|Inconsistent data reporting|13|||
126726159|NCT00603980|455946470|FG000|Main Study|14th subject completed trial|1|||
126726160|NCT02683525|455946471|FG000|Overall Study|Lost to Follow-up|1|||
126726161|NCT02683525|455946471|FG000|Overall Study|Physician Decision|1|||
126726162|NCT02683525|455946471|FG000|Overall Study|Disease Progression|6|||
126726163|NCT01627067|455946472|FG000|Overall Study|Screen Failure|1|||
126726164|NCT00926796|455946480|FG000|Overall Study|Did not receive randomized treatment|4|||
126726165|NCT00926796|455946481|FG001|Overall Study|Did not receive randomized treatment|7|||
126726166|NCT00926796|455946480|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
126726167|NCT00926796|455946481|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
126726168|NCT00926796|455946480|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
126726169|NCT00926796|455946481|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
126726170|NCT00926796|455946480|FG000|Overall Study|Adverse Event|7|||
126726171|NCT00926796|455946481|FG001|Overall Study|Adverse Event|14|||
126726172|NCT00926796|455946480|FG000|Overall Study|Lost to Follow-up|22|||
126726173|NCT00926796|455946481|FG001|Overall Study|Lost to Follow-up|13|||
126726174|NCT00926796|455946480|FG000|Overall Study|Protocol Violation|15|||
126726175|NCT00926796|455946481|FG001|Overall Study|Protocol Violation|11|||
126726176|NCT00926796|455946480|FG000|Overall Study|Withdrawal by Subject|1|||
126726177|NCT00926796|455946481|FG001|Overall Study|Withdrawal by Subject|0|||
126726178|NCT01341652|455946485|FG000|Overall Study|Incorrect Random Assignment|0|||
126726179|NCT01341652|455946486|FG001|Overall Study|Incorrect Random Assignment|1|||
126726180|NCT01341652|455946485|FG000|Overall Study|ineligible; presence metastatic disease|0|||
126726181|NCT01341652|455946486|FG001|Overall Study|ineligible; presence metastatic disease|1|||
126726182|NCT00632463|455946488|FG000|Overall Study|Adverse Event|0|||
126726183|NCT00632463|455946489|FG001|Overall Study|Adverse Event|1|||
126726184|NCT00632463|455946490|FG002|Overall Study|Adverse Event|0|||
126726185|NCT04167306|455946495|FG000|Overall Study|Lost to Follow-up|2|||
126726186|NCT04167306|455946496|FG001|Overall Study|Lost to Follow-up|2|||
126726187|NCT04167306|455946497|FG002|Overall Study|Lost to Follow-up|5|||
126726188|NCT04167306|455946498|FG003|Overall Study|Lost to Follow-up|5|||
126726189|NCT04167306|455946495|FG000|Overall Study|Adverse Event|13|||
126726190|NCT04167306|455946496|FG001|Overall Study|Adverse Event|14|||
126726191|NCT04167306|455946497|FG002|Overall Study|Adverse Event|5|||
126726192|NCT04167306|455946498|FG003|Overall Study|Adverse Event|4|||
126726193|NCT04167306|455946495|FG000|Overall Study|Withdrawal by Subject|4|||
126726194|NCT04167306|455946496|FG001|Overall Study|Withdrawal by Subject|6|||
126726195|NCT04167306|455946497|FG002|Overall Study|Withdrawal by Subject|8|||
126726196|NCT04167306|455946498|FG003|Overall Study|Withdrawal by Subject|3|||
126726197|NCT04167306|455946495|FG000|Overall Study|covid|1|||
126726198|NCT04167306|455946496|FG001|Overall Study|covid|1|||
126726199|NCT04167306|455946497|FG002|Overall Study|covid|2|||
126726200|NCT04167306|455946498|FG003|Overall Study|covid|1|||
126726201|NCT04167306|455946495|FG000|Overall Study|concomitant medication|0|||
126726202|NCT04167306|455946496|FG001|Overall Study|concomitant medication|0|||
126726203|NCT04167306|455946497|FG002|Overall Study|concomitant medication|0|||
126726204|NCT04167306|455946498|FG003|Overall Study|concomitant medication|1|||
126726205|NCT04167306|455946495|FG000|Overall Study|Alcohol treatment|0|||
126726206|NCT04167306|455946496|FG001|Overall Study|Alcohol treatment|4|||
126726207|NCT04167306|455946497|FG002|Overall Study|Alcohol treatment|3|||
126726208|NCT04167306|455946498|FG003|Overall Study|Alcohol treatment|2|||
126726209|NCT04167306|455946495|FG000|Overall Study|non-compliance|0|||
126726210|NCT04167306|455946496|FG001|Overall Study|non-compliance|0|||
126726211|NCT04167306|455946497|FG002|Overall Study|non-compliance|1|||
126726212|NCT04167306|455946498|FG003|Overall Study|non-compliance|0|||
126500344|NCT03056755|455131779|FG002|Treatment- Core Phase|Technical problems|0|||
126500345|NCT03056755|455131777|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
126500346|NCT03056755|455131778|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
126500347|NCT03056755|455131779|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
126726213|NCT04167306|455946495|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
126726214|NCT04167306|455946496|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
126726215|NCT04167306|455946497|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
126726216|NCT04167306|455946498|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
126726217|NCT04146467|455946500|FG000|Overall Study|Adverse Event|0|||
126726218|NCT04146467|455946501|FG001|Overall Study|Adverse Event|1|||
126726219|NCT04146467|455946500|FG000|Overall Study|Lost to Follow-up|0|||
126726220|NCT04146467|455946501|FG001|Overall Study|Lost to Follow-up|2|||
126726221|NCT02953782|455946502|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
126726222|NCT02953782|455946503|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
126726223|NCT02953782|455946504|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
126560880|NCT00293462|455348363|FG000|Overall Study|Death|1|||
126560881|NCT00293462|455348364|FG001|Overall Study|Death|0|||
126560882|NCT00293462|455348365|FG002|Overall Study|Death|0|||
126560883|NCT00293462|455348363|FG000|Overall Study|Lost to Follow-up|0|||
126560884|NCT00293462|455348364|FG001|Overall Study|Lost to Follow-up|1|||
126560885|NCT00293462|455348365|FG002|Overall Study|Lost to Follow-up|0|||
126560886|NCT00293462|455348363|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
126560887|NCT00293462|455348364|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
126560888|NCT00293462|455348365|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
126560889|NCT00293462|455348363|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
126560890|NCT00293462|455348364|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
126560891|NCT00293462|455348365|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
126560892|NCT00293462|455348363|FG000|Overall Study|Refuse Radiation Treatment|1|||
126560893|NCT00293462|455348364|FG001|Overall Study|Refuse Radiation Treatment|0|||
126560894|NCT00293462|455348365|FG002|Overall Study|Refuse Radiation Treatment|0|||
126560895|NCT00293462|455348363|FG000|Overall Study|No Show|0|||
126560896|NCT00293462|455348364|FG001|Overall Study|No Show|0|||
126560897|NCT00293462|455348365|FG002|Overall Study|No Show|1|||
126560898|NCT00293462|455348363|FG000|Overall Study|Went back to his home country|0|||
126560899|NCT00293462|455348364|FG001|Overall Study|Went back to his home country|0|||
126560900|NCT00293462|455348365|FG002|Overall Study|Went back to his home country|1|||
126560901|NCT00293462|455348363|FG000|Overall Study|Blood clot after chemotherapy|0|||
126560902|NCT00293462|455348364|FG001|Overall Study|Blood clot after chemotherapy|0|||
126560903|NCT00293462|455348365|FG002|Overall Study|Blood clot after chemotherapy|1|||
126560904|NCT00293462|455348363|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
126560905|NCT00293462|455348364|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
126560906|NCT00293462|455348365|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
126560907|NCT00293462|455348363|FG000|Overall Study|Possible Tracheostomy leakage|0|||
126560908|NCT00293462|455348364|FG001|Overall Study|Possible Tracheostomy leakage|1|||
126560909|NCT00293462|455348365|FG002|Overall Study|Possible Tracheostomy leakage|0|||
126560910|NCT00293462|455348363|FG000|Overall Study|Low radiation dose in oral cavity|0|||
126560911|NCT00293462|455348364|FG001|Overall Study|Low radiation dose in oral cavity|1|||
126560912|NCT00293462|455348365|FG002|Overall Study|Low radiation dose in oral cavity|0|||
126560913|NCT00293462|455348363|FG000|Overall Study|Physician Decision|0|||
126560914|NCT00293462|455348364|FG001|Overall Study|Physician Decision|1|||
126560915|NCT00293462|455348365|FG002|Overall Study|Physician Decision|0|||
126560916|NCT00688688|455348366|FG000|Overall Study|Eligibility criterion not met|7|||
126560917|NCT00688688|455348367|FG001|Overall Study|Eligibility criterion not met|7|||
126560918|NCT00688688|455348368|FG002|Overall Study|Eligibility criterion not met|10|||
126560919|NCT00688688|455348366|FG000|Overall Study|Adverse Event|52|||
126500348|NCT03056755|455131777|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
126500349|NCT03056755|455131778|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
126500350|NCT03056755|455131779|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
126500351|NCT03056755|455131777|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
126500352|NCT03056755|455131778|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
126500353|NCT03056755|455131779|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
126500354|NCT03056755|455131777|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
126500355|NCT03056755|455131778|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
126500356|NCT03056755|455131779|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
126500357|NCT02419742|455131782|FG000|Overall Study|Adverse Event|2|||
126500358|NCT02419742|455131783|FG001|Overall Study|Adverse Event|0|||
126500359|NCT02419742|455131782|FG000|Overall Study|Disease Progression|0|||
126500360|NCT02419742|455131783|FG001|Overall Study|Disease Progression|1|||
126500361|NCT02419742|455131782|FG000|Overall Study|Withdrew Consent|2|||
126500362|NCT02419742|455131783|FG001|Overall Study|Withdrew Consent|1|||
126500363|NCT02419742|455131782|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
126500364|NCT02419742|455131783|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
126500365|NCT02211131|455131789|FG000|Overall Study|Death|26|||
126500366|NCT02211131|455131790|FG001|Overall Study|Death|16|||
126500367|NCT02211131|455131789|FG000|Overall Study|Lost to Follow-up|4|||
126500368|NCT02211131|455131790|FG001|Overall Study|Lost to Follow-up|3|||
126500369|NCT02211131|455131789|FG000|Overall Study|Decision by Sponsor|1|||
126500370|NCT02211131|455131790|FG001|Overall Study|Decision by Sponsor|1|||
126500371|NCT02211131|455131789|FG000|Overall Study|Withdrawal by Subject|3|||
126500372|NCT02211131|455131790|FG001|Overall Study|Withdrawal by Subject|8|||
126500373|NCT03340025|455131791|FG000|Overall Study|Lost to Follow-up|2|||
126500374|NCT03340025|455131792|FG001|Overall Study|Lost to Follow-up|2|||
126500375|NCT03897179|455131795|FG000|Overall Study|Withdrawal by Subject|1|||
126500376|NCT02120950|455131796|FG000|Overall Study|Adverse Event|5|||
126560920|NCT00688688|455348367|FG001|Overall Study|Adverse Event|51|||
126560921|NCT00688688|455348368|FG002|Overall Study|Adverse Event|50|||
126560922|NCT00688688|455348366|FG000|Overall Study|Lack of Efficacy|34|||
126560923|NCT00688688|455348367|FG001|Overall Study|Lack of Efficacy|25|||
126500377|NCT02120950|455131797|FG001|Overall Study|Adverse Event|4|||
126500378|NCT02120950|455131798|FG002|Overall Study|Adverse Event|3|||
126500379|NCT02120950|455131796|FG000|Overall Study|Death|3|||
126500380|NCT02120950|455131797|FG001|Overall Study|Death|0|||
126500381|NCT02120950|455131798|FG002|Overall Study|Death|1|||
126500382|NCT02120950|455131796|FG000|Overall Study|Withdrawal by Subject|6|||
126500383|NCT02120950|455131797|FG001|Overall Study|Withdrawal by Subject|3|||
126500384|NCT02120950|455131798|FG002|Overall Study|Withdrawal by Subject|2|||
126500385|NCT02120950|455131796|FG000|Overall Study|Protocol Violation|1|||
126500386|NCT02120950|455131797|FG001|Overall Study|Protocol Violation|1|||
126500387|NCT02120950|455131798|FG002|Overall Study|Protocol Violation|7|||
126500388|NCT02120950|455131796|FG000|Overall Study|Other reasons|5|||
126500389|NCT02120950|455131797|FG001|Overall Study|Other reasons|4|||
126500390|NCT02120950|455131798|FG002|Overall Study|Other reasons|1|||
126500391|NCT02120950|455131796|FG000|Overall Study|Lost to Follow-up|0|||
126500392|NCT02120950|455131797|FG001|Overall Study|Lost to Follow-up|2|||
126500393|NCT02120950|455131798|FG002|Overall Study|Lost to Follow-up|1|||
126500394|NCT02424383|455131799|FG000|Overall Study|Withdrawal by Subject|32|||
126500395|NCT02424383|455131799|FG000|Overall Study|Death|170|||
126500396|NCT02424383|455131799|FG000|Overall Study|Sponsor's decision|3|||
126500397|NCT02424383|455131799|FG000|Overall Study|Investigator's decision|44|||
126500398|NCT02424383|455131799|FG000|Overall Study|Lost to Follow-up|81|||
126500399|NCT02424383|455131799|FG000|Overall Study|Other|7|||
126500400|NCT02424383|455131799|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
126500401|NCT02016482|455131802|FG000|Period A|Adverse Event|3|||
126500402|NCT02016482|455131803|FG001|Period A|Adverse Event|5|||
126500403|NCT02016482|455131802|FG000|Period A|Withdrawal by Subject|3|||
126500404|NCT02016482|455131803|FG001|Period A|Withdrawal by Subject|4|||
126500405|NCT02016482|455131802|FG000|Period A|Lost to Follow-up|3|||
126500406|NCT02016482|455131803|FG001|Period A|Lost to Follow-up|3|||
126500407|NCT02016482|455131802|FG000|Period A|Lack of Efficacy|2|||
126500408|NCT02016482|455131803|FG001|Period A|Lack of Efficacy|1|||
126500409|NCT02016482|455131802|FG000|Period A|Other|3|||
126500410|NCT02016482|455131803|FG001|Period A|Other|0|||
126500411|NCT02016482|455131802|FG000|Period A|Protocol Violation|0|||
126500412|NCT02016482|455131803|FG001|Period A|Protocol Violation|1|||
126500413|NCT02016482|455131802|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
126500414|NCT02016482|455131803|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
126726224|NCT02953782|455946505|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
126726225|NCT02953782|455946506|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
126726226|NCT02953782|455946507|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
126726227|NCT02953782|455946508|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
126726228|NCT02953782|455946509|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
126726229|NCT02953782|455946502|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
126726230|NCT02953782|455946503|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
126726231|NCT02953782|455946504|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
126726232|NCT02953782|455946505|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
126726233|NCT02953782|455946506|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
126726234|NCT02953782|455946507|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
126726235|NCT02953782|455946508|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
126500415|NCT02016482|455131802|FG000|Period B|Withdrawal by Subject|1|||
126500416|NCT02016482|455131803|FG001|Period B|Withdrawal by Subject|1|||
126500417|NCT02016482|455131802|FG000|Period B|Lost to Follow-up|2|||
126500418|NCT02016482|455131803|FG001|Period B|Lost to Follow-up|0|||
126500419|NCT02016482|455131802|FG000|Period B|Lack of Efficacy|6|||
126500420|NCT02016482|455131803|FG001|Period B|Lack of Efficacy|4|||
126500421|NCT02016482|455131802|FG000|Period B|Other|4|||
126500422|NCT02016482|455131803|FG001|Period B|Other|0|||
126500423|NCT02016482|455131802|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
126500424|NCT02016482|455131803|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
126500425|NCT02738333|455131815|FG000|Overall Study|Death|1|||
126500426|NCT02738333|455131816|FG001|Overall Study|Death|0|||
126500427|NCT02738333|455131817|FG002|Overall Study|Death|0|||
126500428|NCT02738333|455131815|FG000|Overall Study|Lost to Follow-up|1|||
126500429|NCT02738333|455131816|FG001|Overall Study|Lost to Follow-up|0|||
126560924|NCT00688688|455348368|FG002|Overall Study|Lack of Efficacy|45|||
126560925|NCT00688688|455348366|FG000|Overall Study|Withdrawal by Subject|66|||
126726236|NCT02953782|455946509|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
126726237|NCT02953782|455946502|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
126726238|NCT02953782|455946503|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
126726239|NCT02953782|455946504|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
126500430|NCT02738333|455131817|FG002|Overall Study|Lost to Follow-up|0|||
126500431|NCT00791518|455131818|FG000|Overall Study|Protocol Violation|93|||
126500432|NCT01251380|455131819|FG000|Overall Study|Other (Not otherwise specified)|12|||
126500433|NCT01251380|455131819|FG000|Overall Study|Withdrawal by Subject|6|||
126500434|NCT01251380|455131819|FG000|Overall Study|Lack of Efficacy|1|||
126500435|NCT01251380|455131819|FG000|Overall Study|Adverse Event|1|||
126560926|NCT00688688|455348367|FG001|Overall Study|Withdrawal by Subject|75|||
126560927|NCT00688688|455348368|FG002|Overall Study|Withdrawal by Subject|65|||
126560928|NCT00688688|455348366|FG000|Overall Study|Lost to Follow-up|14|||
126560929|NCT00688688|455348367|FG001|Overall Study|Lost to Follow-up|7|||
126560930|NCT00688688|455348368|FG002|Overall Study|Lost to Follow-up|7|||
126560931|NCT00688688|455348366|FG000|Overall Study|Protocol Violation|6|||
126560932|NCT00688688|455348367|FG001|Overall Study|Protocol Violation|9|||
126560933|NCT00688688|455348368|FG002|Overall Study|Protocol Violation|11|||
126560934|NCT00688688|455348366|FG000|Overall Study|Randomized but never received study drug|1|||
126560935|NCT00688688|455348367|FG001|Overall Study|Randomized but never received study drug|0|||
126560936|NCT00688688|455348368|FG002|Overall Study|Randomized but never received study drug|0|||
126560937|NCT00688688|455348366|FG000|Overall Study|Non-compliance with study procedures|5|||
126560938|NCT00688688|455348367|FG001|Overall Study|Non-compliance with study procedures|3|||
126560939|NCT00688688|455348368|FG002|Overall Study|Non-compliance with study procedures|4|||
126560940|NCT00688688|455348366|FG000|Overall Study|Taking exclusionary medications|1|||
126560941|NCT00688688|455348367|FG001|Overall Study|Taking exclusionary medications|0|||
126560942|NCT00688688|455348368|FG002|Overall Study|Taking exclusionary medications|0|||
126560943|NCT00688688|455348366|FG000|Overall Study|Site closure|0|||
126560944|NCT00688688|455348367|FG001|Overall Study|Site closure|1|||
126560945|NCT00688688|455348368|FG002|Overall Study|Site closure|0|||
126500436|NCT01251380|455131819|FG000|Overall Study|Lost to Follow-up|2|||
126500437|NCT02009046|455131820|FG000|Overall Study|Lost to Follow-up|256|||
126500438|NCT02009046|455131821|FG001|Overall Study|Lost to Follow-up|206|||
126500439|NCT02073279|455131827|FG000|Double-blind Period|Adverse Event|1|||
126500440|NCT02073279|455131828|FG001|Double-blind Period|Adverse Event|1|||
126500441|NCT02073279|455131827|FG000|Double-blind Period|Switched to another treatment|1|||
126500442|NCT02073279|455131828|FG001|Double-blind Period|Switched to another treatment|2|||
126500443|NCT02073279|455131827|FG000|Double-blind Period|Protocol Violation|0|||
126500444|NCT02073279|455131828|FG001|Double-blind Period|Protocol Violation|1|||
126500445|NCT02073279|455131827|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
126500446|NCT02073279|455131828|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
126500447|NCT02073279|455131827|FG000|Double-blind Period|Withdrawal by Subject|2|||
126500448|NCT02073279|455131828|FG001|Double-blind Period|Withdrawal by Subject|2|||
126500449|NCT02073279|455131827|FG000|Open-label Extension Period|Adverse Event|1|||
126500450|NCT02073279|455131828|FG001|Open-label Extension Period|Adverse Event|0|||
126500451|NCT02073279|455131827|FG000|Open-label Extension Period|Lack of Efficacy|1|||
126500452|NCT02073279|455131828|FG001|Open-label Extension Period|Lack of Efficacy|0|||
126500453|NCT02073279|455131827|FG000|Open-label Extension Period|Lost to Follow-up|0|||
126500454|NCT02073279|455131828|FG001|Open-label Extension Period|Lost to Follow-up|4|||
126500455|NCT02073279|455131827|FG000|Open-label Extension Period|Switched to another treatment|1|||
126500456|NCT02073279|455131828|FG001|Open-label Extension Period|Switched to another treatment|4|||
126500457|NCT02073279|455131827|FG000|Open-label Extension Period|Protocol Violation|0|||
126500458|NCT02073279|455131828|FG001|Open-label Extension Period|Protocol Violation|1|||
126500459|NCT02073279|455131827|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
126500460|NCT02073279|455131828|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
126500461|NCT02073279|455131827|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
126500462|NCT02073279|455131828|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
126500463|NCT00304356|455131829|FG000|Nitazoxanide|Physician Decision|5|||
126500464|NCT00304356|455131829|FG000|Nitazoxanide|Physician Decision|1|||
126500465|NCT00304356|455131829|FG000|Nitazoxanide|number is 0|1|||
126500466|NCT00304356|455131829|FG000|Nitazoxanide|Physician Decision|1|||
126500467|NCT00304356|455131829|FG000|Nitazoxanide|Physician Decision|1|||
126500468|NCT00304356|455131829|FG000|Nitazoxanide|Physician Decision|1|||
126500469|NCT00973479|455131830|FG000|Overall Study|Lost to Follow-up|0|||
126500470|NCT00973479|455131831|FG001|Overall Study|Lost to Follow-up|3|||
126500471|NCT00973479|455131830|FG000|Overall Study|Death|2|||
126500472|NCT00973479|455131831|FG001|Overall Study|Death|2|||
126500473|NCT00973479|455131830|FG000|Overall Study|Withdrawal by Subject|15|||
126500474|NCT00973479|455131831|FG001|Overall Study|Withdrawal by Subject|16|||
126500475|NCT00973479|455131830|FG000|Overall Study|Lack of Efficacy|5|||
126500476|NCT00973479|455131831|FG001|Overall Study|Lack of Efficacy|7|||
126500477|NCT00973479|455131830|FG000|Overall Study|Adverse Event|12|||
126500478|NCT00973479|455131831|FG001|Overall Study|Adverse Event|32|||
126500479|NCT00973479|455131830|FG000|Overall Study|Protocol Violation|2|||
126500480|NCT00973479|455131831|FG001|Overall Study|Protocol Violation|2|||
126500481|NCT00973479|455131830|FG000|Overall Study|Other|1|||
126500482|NCT00973479|455131831|FG001|Overall Study|Other|7|||
126500483|NCT00335972|455131832|FG000|Overall Study|not given treatments|0|||
126500484|NCT00335972|455131833|FG001|Overall Study|not given treatments|3|||
126500485|NCT02882854|455131836|FG000|Overall Study|Lost to Follow-up|1|||
126500486|NCT02882854|455131837|FG001|Overall Study|Lost to Follow-up|2|||
126500487|NCT02882854|455131836|FG000|Overall Study|Physician Decision|0|||
126500488|NCT02882854|455131837|FG001|Overall Study|Physician Decision|1|||
126560946|NCT00688688|455348366|FG000|Overall Study|Violation of exclusion criterion|0|||
126560947|NCT00688688|455348367|FG001|Overall Study|Violation of exclusion criterion|1|||
126560948|NCT00688688|455348368|FG002|Overall Study|Violation of exclusion criterion|0|||
126774895|NCT02094937|456131138|FG000|8 Weeks in Period 1|Protocol Violation|2|||
126774896|NCT02094937|456131139|FG001|8 Weeks in Period 1|Protocol Violation|0|||
126774897|NCT02094937|456131140|FG002|8 Weeks in Period 1|Protocol Violation|0|||
126774898|NCT02094937|456131141|FG003|8 Weeks in Period 1|Protocol Violation|0|||
126774899|NCT02094937|456131138|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
126774900|NCT02094937|456131139|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
126774901|NCT02094937|456131140|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
126774902|NCT02094937|456131141|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
126774903|NCT02094937|456131138|FG000|8 Weeks in Period 1|Physician Decision|1|||
126774904|NCT02094937|456131139|FG001|8 Weeks in Period 1|Physician Decision|0|||
126774905|NCT02094937|456131140|FG002|8 Weeks in Period 1|Physician Decision|0|||
126774906|NCT02094937|456131141|FG003|8 Weeks in Period 1|Physician Decision|0|||
126774907|NCT02094937|456131138|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
126774908|NCT02094937|456131139|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
126774909|NCT02094937|456131140|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
126774910|NCT02094937|456131141|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
126774911|NCT02094937|456131138|FG000|12 Weeks in Period 2|Adverse Event|0|||
126774912|NCT02094937|456131139|FG001|12 Weeks in Period 2|Adverse Event|2|||
126774913|NCT02094937|456131140|FG002|12 Weeks in Period 2|Adverse Event|4|||
126500489|NCT02039674|455131841|FG000|Overall Study|Adverse Event|0|||
126500490|NCT02039674|455131842|FG001|Overall Study|Adverse Event|0|||
126500491|NCT02039674|455131843|FG002|Overall Study|Adverse Event|0|||
126500492|NCT02039674|455131844|FG003|Overall Study|Adverse Event|1|||
126500493|NCT02039674|455131845|FG004|Overall Study|Adverse Event|0|||
126500494|NCT02039674|455131846|FG005|Overall Study|Adverse Event|0|||
126500495|NCT02039674|455131847|FG006|Overall Study|Adverse Event|0|||
126500496|NCT02039674|455131848|FG007|Overall Study|Adverse Event|0|||
126500497|NCT02039674|455131849|FG008|Overall Study|Adverse Event|2|||
126500498|NCT02039674|455131850|FG009|Overall Study|Adverse Event|1|||
126500499|NCT02039674|455131851|FG010|Overall Study|Adverse Event|0|||
126500500|NCT02039674|455131852|FG011|Overall Study|Adverse Event|2|||
126500501|NCT02039674|455131853|FG012|Overall Study|Adverse Event|3|||
126500502|NCT02039674|455131854|FG013|Overall Study|Adverse Event|1|||
126500503|NCT02039674|455131841|FG000|Overall Study|Death|2|||
126500504|NCT02039674|455131842|FG001|Overall Study|Death|0|||
126500505|NCT02039674|455131843|FG002|Overall Study|Death|2|||
126500506|NCT02039674|455131844|FG003|Overall Study|Death|3|||
126500507|NCT02039674|455131845|FG004|Overall Study|Death|0|||
126500508|NCT02039674|455131846|FG005|Overall Study|Death|0|||
126500509|NCT02039674|455131847|FG006|Overall Study|Death|1|||
126500510|NCT02039674|455131848|FG007|Overall Study|Death|0|||
126500511|NCT02039674|455131849|FG008|Overall Study|Death|2|||
126500512|NCT02039674|455131850|FG009|Overall Study|Death|0|||
126500513|NCT02039674|455131851|FG010|Overall Study|Death|1|||
126500514|NCT02039674|455131852|FG011|Overall Study|Death|3|||
126500515|NCT02039674|455131853|FG012|Overall Study|Death|2|||
126500516|NCT02039674|455131854|FG013|Overall Study|Death|8|||
126500517|NCT02039674|455131841|FG000|Overall Study|Excluded Medication|1|||
126500518|NCT02039674|455131842|FG001|Overall Study|Excluded Medication|1|||
126500519|NCT02039674|455131843|FG002|Overall Study|Excluded Medication|0|||
126560949|NCT03283553|455348371|FG000|Patient Participant Flow|Death|5|||
126500520|NCT02039674|455131844|FG003|Overall Study|Excluded Medication|1|||
126500521|NCT02039674|455131845|FG004|Overall Study|Excluded Medication|0|||
126500522|NCT02039674|455131846|FG005|Overall Study|Excluded Medication|1|||
126500523|NCT02039674|455131847|FG006|Overall Study|Excluded Medication|0|||
126500524|NCT02039674|455131848|FG007|Overall Study|Excluded Medication|0|||
126726240|NCT02953782|455946505|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
126726241|NCT02953782|455946506|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
126726242|NCT02953782|455946507|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
126726243|NCT02953782|455946508|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
126726244|NCT02953782|455946509|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
126726245|NCT02953782|455946502|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
126726246|NCT02953782|455946503|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
126726247|NCT02953782|455946504|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
126726248|NCT02953782|455946505|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
126726249|NCT02953782|455946506|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
126726250|NCT02953782|455946507|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
126726251|NCT02953782|455946508|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
126726252|NCT02953782|455946509|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
126726253|NCT02953782|455946502|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
126726254|NCT02953782|455946503|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
126726255|NCT02953782|455946504|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
126726256|NCT02953782|455946505|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
126774914|NCT02094937|456131141|FG003|12 Weeks in Period 2|Adverse Event|1|||
126774915|NCT02094937|456131138|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
126774916|NCT02094937|456131139|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
126774917|NCT02094937|456131140|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
126774918|NCT02094937|456131141|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
126774919|NCT02094937|456131138|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
126774920|NCT02094937|456131139|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
126774921|NCT02094937|456131140|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
126774922|NCT02094937|456131141|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
126774923|NCT02094937|456131138|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
126774924|NCT02094937|456131139|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
126774925|NCT02094937|456131140|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
126774926|NCT02094937|456131141|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
126774927|NCT02094937|456131138|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
126774928|NCT02094937|456131139|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
126774929|NCT02094937|456131140|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
126774930|NCT02094937|456131141|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
126774931|NCT01133392|456131142|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
126774932|NCT01133392|456131143|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
126774933|NCT01133392|456131142|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
126774934|NCT01133392|456131143|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
126774935|NCT02842086|456131144|FG000|Overall Study|Randomized but Never Treated|6|||
126774936|NCT02842086|456131145|FG001|Overall Study|Randomized but Never Treated|6|||
126774937|NCT02842086|456131144|FG000|Overall Study|Still in Double-Blind Phase|7|||
126774938|NCT02842086|456131145|FG001|Overall Study|Still in Double-Blind Phase|3|||
126774939|NCT02842086|456131144|FG000|Overall Study|Adverse Event|18|||
126774940|NCT02842086|456131145|FG001|Overall Study|Adverse Event|20|||
126774941|NCT02842086|456131144|FG000|Overall Study|Death|3|||
126774942|NCT02842086|456131145|FG001|Overall Study|Death|3|||
126774943|NCT02842086|456131144|FG000|Overall Study|Investigator's Discretion|9|||
126774944|NCT02842086|456131145|FG001|Overall Study|Investigator's Discretion|13|||
126774945|NCT02842086|456131144|FG000|Overall Study|Non-Compliance with Study Drug|9|||
126500525|NCT02039674|455131849|FG008|Overall Study|Excluded Medication|2|||
126726257|NCT02953782|455946506|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
126726258|NCT02953782|455946507|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
126726259|NCT02953782|455946508|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
126726260|NCT02953782|455946509|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
126726261|NCT02953782|455946502|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
126726262|NCT02953782|455946503|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
126726263|NCT02953782|455946504|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
126726264|NCT02953782|455946505|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
126726265|NCT02953782|455946506|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
126726266|NCT02953782|455946507|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
126726267|NCT02953782|455946508|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
126726268|NCT02953782|455946509|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
126726269|NCT02953782|455946502|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
126726270|NCT02953782|455946503|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
126726271|NCT02953782|455946504|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
126726272|NCT02953782|455946505|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
126726273|NCT02953782|455946506|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
126726274|NCT02953782|455946507|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
126726275|NCT02953782|455946508|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
126726276|NCT02953782|455946509|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
126726277|NCT02953782|455946502|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126726278|NCT02953782|455946503|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126726279|NCT02953782|455946504|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126726280|NCT02953782|455946505|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126726281|NCT02953782|455946506|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126726282|NCT02953782|455946507|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126726283|NCT02953782|455946508|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
126726284|NCT02953782|455946509|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
126774946|NCT02842086|456131145|FG001|Overall Study|Non-Compliance with Study Drug|8|||
126500526|NCT02039674|455131850|FG009|Overall Study|Excluded Medication|3|||
126500527|NCT02039674|455131851|FG010|Overall Study|Excluded Medication|5|||
126500528|NCT02039674|455131852|FG011|Overall Study|Excluded Medication|6|||
126774947|NCT02842086|456131144|FG000|Overall Study|Protocol Violation|8|||
126774948|NCT02842086|456131145|FG001|Overall Study|Protocol Violation|4|||
126774949|NCT02842086|456131144|FG000|Overall Study|Withdrew Consent|205|||
126500529|NCT02039674|455131853|FG012|Overall Study|Excluded Medication|8|||
126774950|NCT02842086|456131145|FG001|Overall Study|Withdrew Consent|194|||
126774951|NCT02842086|456131144|FG000|Overall Study|Lost to Follow-up|274|||
126774952|NCT02842086|456131145|FG001|Overall Study|Lost to Follow-up|236|||
126774953|NCT02842086|456131144|FG000|Overall Study|HIV-1 Infection|5|||
126774954|NCT02842086|456131145|FG001|Overall Study|HIV-1 Infection|6|||
126774955|NCT03751124|456131146|FG000|Overall Study|Adverse Event|4|||
126774956|NCT03751124|456131147|FG001|Overall Study|Adverse Event|3|||
126774957|NCT03751124|456131146|FG000|Overall Study|Protocol Deviation|0|||
126774958|NCT03751124|456131147|FG001|Overall Study|Protocol Deviation|1|||
126774959|NCT03751124|456131146|FG000|Overall Study|Lost to Follow-up|6|||
126774960|NCT03751124|456131147|FG001|Overall Study|Lost to Follow-up|4|||
126774961|NCT03751124|456131146|FG000|Overall Study|Withdrawal by Subject|6|||
126774962|NCT03751124|456131147|FG001|Overall Study|Withdrawal by Subject|8|||
126774963|NCT03751124|456131146|FG000|Overall Study|Lack of Efficacy|1|||
126774964|NCT03751124|456131147|FG001|Overall Study|Lack of Efficacy|1|||
126774965|NCT03751124|456131146|FG000|Overall Study|Pregnancy|0|||
126774966|NCT03751124|456131147|FG001|Overall Study|Pregnancy|1|||
126774967|NCT03751124|456131146|FG000|Overall Study|Other|9|||
126774968|NCT03751124|456131147|FG001|Overall Study|Other|9|||
126774969|NCT03751124|456131146|FG000|Overall Study|Participants who did not receive any study drug|0|||
126774970|NCT03751124|456131147|FG001|Overall Study|Participants who did not receive any study drug|1|||
126774971|NCT00555399|456131150|FG000|Overall Study|Withdrawal by Subject|0|||
126774972|NCT00555399|456131151|FG001|Overall Study|Withdrawal by Subject|0|||
126774973|NCT00555399|456131152|FG002|Overall Study|Withdrawal by Subject|1|||
126500530|NCT02039674|455131854|FG013|Overall Study|Excluded Medication|3|||
126500531|NCT02039674|455131841|FG000|Overall Study|Lost to Follow-up|0|||
126500532|NCT02039674|455131842|FG001|Overall Study|Lost to Follow-up|0|||
126500533|NCT02039674|455131843|FG002|Overall Study|Lost to Follow-up|0|||
126500534|NCT02039674|455131844|FG003|Overall Study|Lost to Follow-up|0|||
126500535|NCT02039674|455131845|FG004|Overall Study|Lost to Follow-up|1|||
126500536|NCT02039674|455131846|FG005|Overall Study|Lost to Follow-up|1|||
126500537|NCT02039674|455131847|FG006|Overall Study|Lost to Follow-up|0|||
126500538|NCT02039674|455131848|FG007|Overall Study|Lost to Follow-up|0|||
126500539|NCT02039674|455131849|FG008|Overall Study|Lost to Follow-up|0|||
126500540|NCT02039674|455131850|FG009|Overall Study|Lost to Follow-up|0|||
126500541|NCT02039674|455131851|FG010|Overall Study|Lost to Follow-up|0|||
126500542|NCT02039674|455131852|FG011|Overall Study|Lost to Follow-up|2|||
126500543|NCT02039674|455131853|FG012|Overall Study|Lost to Follow-up|2|||
126500544|NCT02039674|455131854|FG013|Overall Study|Lost to Follow-up|1|||
126500545|NCT02039674|455131841|FG000|Overall Study|Physician Decision|0|||
126500546|NCT02039674|455131842|FG001|Overall Study|Physician Decision|0|||
126500547|NCT02039674|455131843|FG002|Overall Study|Physician Decision|0|||
126500548|NCT02039674|455131844|FG003|Overall Study|Physician Decision|0|||
126500549|NCT02039674|455131845|FG004|Overall Study|Physician Decision|0|||
126500550|NCT02039674|455131846|FG005|Overall Study|Physician Decision|0|||
126500551|NCT02039674|455131847|FG006|Overall Study|Physician Decision|0|||
126500552|NCT02039674|455131848|FG007|Overall Study|Physician Decision|0|||
126500553|NCT02039674|455131849|FG008|Overall Study|Physician Decision|0|||
126500554|NCT02039674|455131850|FG009|Overall Study|Physician Decision|0|||
126500555|NCT02039674|455131851|FG010|Overall Study|Physician Decision|0|||
126500556|NCT02039674|455131852|FG011|Overall Study|Physician Decision|1|||
126500557|NCT02039674|455131853|FG012|Overall Study|Physician Decision|1|||
126500558|NCT02039674|455131854|FG013|Overall Study|Physician Decision|0|||
126500559|NCT02039674|455131841|FG000|Overall Study|Progressive Disease|8|||
126500560|NCT02039674|455131842|FG001|Overall Study|Progressive Disease|8|||
126500561|NCT02039674|455131843|FG002|Overall Study|Progressive Disease|6|||
126500562|NCT02039674|455131844|FG003|Overall Study|Progressive Disease|7|||
126560950|NCT03283553|455348372|FG001|Patient Participant Flow|Death|10|||
126560951|NCT03283553|455348371|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
126560952|NCT03283553|455348372|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
126560953|NCT03283553|455348371|FG000|Patient Participant Flow|Lost to Follow-up|1|||
126560954|NCT03283553|455348372|FG001|Patient Participant Flow|Lost to Follow-up|1|||
126560955|NCT03283553|455348371|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
126560956|NCT03283553|455348372|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
126500563|NCT02039674|455131845|FG004|Overall Study|Progressive Disease|9|||
126500564|NCT02039674|455131846|FG005|Overall Study|Progressive Disease|10|||
126500565|NCT02039674|455131847|FG006|Overall Study|Progressive Disease|1|||
126500566|NCT02039674|455131848|FG007|Overall Study|Progressive Disease|3|||
126560957|NCT03283553|455348371|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
126500567|NCT02039674|455131849|FG008|Overall Study|Progressive Disease|6|||
126500568|NCT02039674|455131850|FG009|Overall Study|Progressive Disease|4|||
126500569|NCT02039674|455131851|FG010|Overall Study|Progressive Disease|0|||
126500570|NCT02039674|455131852|FG011|Overall Study|Progressive Disease|34|||
126774974|NCT00555399|456131153|FG003|Overall Study|Withdrawal by Subject|0|||
126774975|NCT00555399|456131154|FG004|Overall Study|Withdrawal by Subject|0|||
126774976|NCT00555399|456131155|FG005|Overall Study|Withdrawal by Subject|0|||
126774977|NCT00555399|456131156|FG006|Overall Study|Withdrawal by Subject|0|||
126774978|NCT00555399|456131157|FG007|Overall Study|Withdrawal by Subject|0|||
126774979|NCT00555399|456131158|FG008|Overall Study|Withdrawal by Subject|0|||
126500571|NCT02039674|455131853|FG012|Overall Study|Progressive Disease|34|||
126500572|NCT02039674|455131854|FG013|Overall Study|Progressive Disease|18|||
126500573|NCT02039674|455131841|FG000|Overall Study|Withdrawal by Subject|1|||
126500574|NCT02039674|455131842|FG001|Overall Study|Withdrawal by Subject|2|||
126500575|NCT02039674|455131843|FG002|Overall Study|Withdrawal by Subject|3|||
126500576|NCT02039674|455131844|FG003|Overall Study|Withdrawal by Subject|0|||
126500577|NCT02039674|455131845|FG004|Overall Study|Withdrawal by Subject|1|||
126500578|NCT02039674|455131846|FG005|Overall Study|Withdrawal by Subject|0|||
126500579|NCT02039674|455131847|FG006|Overall Study|Withdrawal by Subject|0|||
126500580|NCT02039674|455131848|FG007|Overall Study|Withdrawal by Subject|0|||
126500581|NCT02039674|455131849|FG008|Overall Study|Withdrawal by Subject|0|||
126560958|NCT03283553|455348372|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
126560959|NCT03283553|455348371|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
126560960|NCT03283553|455348372|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
126726285|NCT01737840|455946510|FG000|Overall Study|Diagnosed with an other pathology|2|||
126726286|NCT01737840|455946511|FG001|Overall Study|Diagnosed with an other pathology|2|||
126726287|NCT01189435|455946512|FG000|Overall Study|Withdrawal by Subject|1|||
126726288|NCT01189435|455946512|FG000|Overall Study|Physician Decision|1|||
126726289|NCT03259490|455946515|FG000|Period 1|Withdrawal by Subject|0|||
126726290|NCT03259490|455946516|FG001|Period 1|Withdrawal by Subject|1|||
126726291|NCT03259490|455946515|FG000|Period 2|Protocol Violation|1|||
126726292|NCT03259490|455946516|FG001|Period 2|Protocol Violation|0|||
126726293|NCT01963208|455946517|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
126726294|NCT01963208|455946518|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
126726295|NCT01963208|455946519|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
126726296|NCT01963208|455946520|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
126726297|NCT01963208|455946521|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
126726298|NCT01963208|455946522|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
126726299|NCT01963208|455946517|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
126726300|NCT01963208|455946518|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
126726301|NCT01963208|455946519|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
126726302|NCT01963208|455946520|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
126726303|NCT01963208|455946521|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
126726304|NCT01963208|455946522|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
126726305|NCT01963208|455946517|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
126726306|NCT01963208|455946518|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
126726307|NCT01963208|455946519|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
126726308|NCT01963208|455946520|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
126726309|NCT01963208|455946521|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
126726310|NCT01963208|455946522|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
126500582|NCT02039674|455131850|FG009|Overall Study|Withdrawal by Subject|1|||
126500583|NCT02039674|455131851|FG010|Overall Study|Withdrawal by Subject|1|||
126500584|NCT02039674|455131852|FG011|Overall Study|Withdrawal by Subject|4|||
126500585|NCT02039674|455131853|FG012|Overall Study|Withdrawal by Subject|6|||
126500586|NCT02039674|455131854|FG013|Overall Study|Withdrawal by Subject|2|||
126500587|NCT02039674|455131841|FG000|Overall Study|Clinical Progression|0|||
126500588|NCT02039674|455131842|FG001|Overall Study|Clinical Progression|0|||
126500589|NCT02039674|455131843|FG002|Overall Study|Clinical Progression|0|||
126500590|NCT02039674|455131844|FG003|Overall Study|Clinical Progression|0|||
126500591|NCT02039674|455131845|FG004|Overall Study|Clinical Progression|0|||
126500592|NCT02039674|455131846|FG005|Overall Study|Clinical Progression|0|||
126500593|NCT02039674|455131847|FG006|Overall Study|Clinical Progression|1|||
126500594|NCT02039674|455131848|FG007|Overall Study|Clinical Progression|0|||
126500595|NCT02039674|455131849|FG008|Overall Study|Clinical Progression|0|||
126500596|NCT02039674|455131850|FG009|Overall Study|Clinical Progression|0|||
126500597|NCT02039674|455131851|FG010|Overall Study|Clinical Progression|0|||
126500598|NCT02039674|455131852|FG011|Overall Study|Clinical Progression|0|||
126500599|NCT02039674|455131853|FG012|Overall Study|Clinical Progression|1|||
126500600|NCT02039674|455131854|FG013|Overall Study|Clinical Progression|0|||
126500601|NCT02039674|455131841|FG000|Overall Study|Sponsor Decision|1|||
126500602|NCT02039674|455131842|FG001|Overall Study|Sponsor Decision|1|||
126500603|NCT02039674|455131843|FG002|Overall Study|Sponsor Decision|1|||
126500604|NCT02039674|455131844|FG003|Overall Study|Sponsor Decision|1|||
126500605|NCT02039674|455131845|FG004|Overall Study|Sponsor Decision|1|||
126500606|NCT02039674|455131846|FG005|Overall Study|Sponsor Decision|0|||
126500607|NCT02039674|455131847|FG006|Overall Study|Sponsor Decision|0|||
126500608|NCT02039674|455131848|FG007|Overall Study|Sponsor Decision|0|||
126500609|NCT02039674|455131849|FG008|Overall Study|Sponsor Decision|0|||
126500610|NCT02039674|455131850|FG009|Overall Study|Sponsor Decision|3|||
126500611|NCT02039674|455131851|FG010|Overall Study|Sponsor Decision|0|||
126500612|NCT02039674|455131852|FG011|Overall Study|Sponsor Decision|8|||
126500613|NCT02039674|455131853|FG012|Overall Study|Sponsor Decision|5|||
126500614|NCT02039674|455131854|FG013|Overall Study|Sponsor Decision|0|||
126500615|NCT02039674|455131841|FG000|Overall Study|Other|0|||
126500616|NCT02039674|455131842|FG001|Overall Study|Other|0|||
126500617|NCT02039674|455131843|FG002|Overall Study|Other|0|||
126500618|NCT02039674|455131844|FG003|Overall Study|Other|0|||
126500619|NCT02039674|455131845|FG004|Overall Study|Other|0|||
126500620|NCT02039674|455131846|FG005|Overall Study|Other|0|||
126500621|NCT02039674|455131847|FG006|Overall Study|Other|0|||
126500622|NCT02039674|455131848|FG007|Overall Study|Other|0|||
126500623|NCT02039674|455131849|FG008|Overall Study|Other|0|||
126500624|NCT02039674|455131850|FG009|Overall Study|Other|0|||
126500625|NCT02039674|455131851|FG010|Overall Study|Other|0|||
126500626|NCT02039674|455131852|FG011|Overall Study|Other|0|||
126500627|NCT02039674|455131853|FG012|Overall Study|Other|1|||
126500628|NCT02039674|455131854|FG013|Overall Study|Other|0|||
126500629|NCT01358357|455131855|FG000|Open Label Phase|Adverse Event|0|||
126500630|NCT01358357|455131856|FG001|Open Label Phase|Adverse Event|0|||
126500631|NCT01358357|455131857|FG002|Open Label Phase|Adverse Event|59|||
126500632|NCT01358357|455131855|FG000|Open Label Phase|Lack of Efficacy|0|||
126500633|NCT01358357|455131856|FG001|Open Label Phase|Lack of Efficacy|0|||
126500634|NCT01358357|455131857|FG002|Open Label Phase|Lack of Efficacy|107|||
126500635|NCT01358357|455131855|FG000|Open Label Phase|Lost to Follow-up|0|||
126500636|NCT01358357|455131856|FG001|Open Label Phase|Lost to Follow-up|0|||
126500637|NCT01358357|455131857|FG002|Open Label Phase|Lost to Follow-up|76|||
126500638|NCT01358357|455131855|FG000|Open Label Phase|Protocol Violation|0|||
126500639|NCT01358357|455131856|FG001|Open Label Phase|Protocol Violation|0|||
126500640|NCT01358357|455131857|FG002|Open Label Phase|Protocol Violation|45|||
126500641|NCT01358357|455131855|FG000|Open Label Phase|Withdrawal by Subject|0|||
126500642|NCT01358357|455131856|FG001|Open Label Phase|Withdrawal by Subject|0|||
126500643|NCT01358357|455131857|FG002|Open Label Phase|Withdrawal by Subject|112|||
126500644|NCT01358357|455131855|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
126500645|NCT01358357|455131856|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
126500646|NCT01358357|455131857|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
126500647|NCT01358357|455131855|FG000|Open Label Phase|Terminated at study completion|0|||
126500648|NCT01358357|455131856|FG001|Open Label Phase|Terminated at study completion|0|||
126500649|NCT01358357|455131857|FG002|Open Label Phase|Terminated at study completion|5|||
126500650|NCT01358357|455131855|FG000|Open Label Phase|Mood episode|0|||
126500651|NCT01358357|455131856|FG001|Open Label Phase|Mood episode|0|||
126500652|NCT01358357|455131857|FG002|Open Label Phase|Mood episode|42|||
126500653|NCT01358357|455131855|FG000|Double-Blind Phase|Adverse Event|8|||
126500654|NCT01358357|455131856|FG001|Double-Blind Phase|Adverse Event|5|||
126500655|NCT01358357|455131857|FG002|Double-Blind Phase|Adverse Event|0|||
126500656|NCT01358357|455131855|FG000|Double-Blind Phase|Lost to Follow-up|5|||
126500657|NCT01358357|455131856|FG001|Double-Blind Phase|Lost to Follow-up|7|||
126500658|NCT01358357|455131857|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126500659|NCT01358357|455131855|FG000|Double-Blind Phase|Protocol Violation|1|||
126500660|NCT01358357|455131856|FG001|Double-Blind Phase|Protocol Violation|11|||
126500661|NCT01358357|455131857|FG002|Double-Blind Phase|Protocol Violation|0|||
126500662|NCT01358357|455131855|FG000|Double-Blind Phase|Protocol Violation|16|||
126500663|NCT01358357|455131856|FG001|Double-Blind Phase|Protocol Violation|12|||
126500664|NCT01358357|455131857|FG002|Double-Blind Phase|Protocol Violation|0|||
126500665|NCT01358357|455131855|FG000|Double-Blind Phase|Terminated at study completion|2|||
126500666|NCT01358357|455131856|FG001|Double-Blind Phase|Terminated at study completion|0|||
126500667|NCT01358357|455131857|FG002|Double-Blind Phase|Terminated at study completion|0|||
126500668|NCT01358357|455131855|FG000|Double-Blind Phase|Recurrence of mood event|48|||
126500669|NCT01358357|455131856|FG001|Double-Blind Phase|Recurrence of mood event|64|||
126500670|NCT01358357|455131857|FG002|Double-Blind Phase|Recurrence of mood event|0|||
126500671|NCT01358357|455131855|FG000|Double-Blind Phase|Administrative|0|||
126500672|NCT01358357|455131856|FG001|Double-Blind Phase|Administrative|1|||
126500673|NCT01358357|455131857|FG002|Double-Blind Phase|Administrative|0|||
126500674|NCT02136576|455131858|FG000|Overall Study|Lost to Follow-up|2|||
126500675|NCT02136576|455131859|FG001|Overall Study|Lost to Follow-up|0|||
126500676|NCT02136576|455131860|FG002|Overall Study|Lost to Follow-up|0|||
126500677|NCT00537381|455131861|FG000|Overall Study|Adverse Event|13|||
126500678|NCT00537381|455131862|FG001|Overall Study|Adverse Event|9|||
126500679|NCT00537381|455131861|FG000|Overall Study|Death|3|||
126500680|NCT00537381|455131862|FG001|Overall Study|Death|3|||
126500681|NCT00537381|455131861|FG000|Overall Study|Withdrawal by Subject|5|||
126500682|NCT00537381|455131862|FG001|Overall Study|Withdrawal by Subject|14|||
126500683|NCT00537381|455131861|FG000|Overall Study|Physician Decision|7|||
126500684|NCT00537381|455131862|FG001|Overall Study|Physician Decision|6|||
126500685|NCT00537381|455131861|FG000|Overall Study|Disease Progression|9|||
126500686|NCT00537381|455131862|FG001|Overall Study|Disease Progression|18|||
126500687|NCT00537381|455131861|FG000|Overall Study|Sponsor decision|14|||
126500688|NCT00537381|455131862|FG001|Overall Study|Sponsor decision|9|||
126500689|NCT00537381|455131861|FG000|Overall Study|Other|5|||
126500690|NCT00537381|455131862|FG001|Overall Study|Other|3|||
126500691|NCT00549562|455131864|FG000|Overall Study|Adverse Event|1|||
126500692|NCT00549562|455131864|FG000|Overall Study|Lack of Efficacy|1|||
126500693|NCT00323115|455131867|FG000|Vaccine Administration|Adverse Event|1|||
126500694|NCT00323115|455131867|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
126774980|NCT00555399|456131159|FG009|Overall Study|Withdrawal by Subject|0|||
126774981|NCT00555399|456131160|FG010|Overall Study|Withdrawal by Subject|0|||
126774982|NCT00555399|456131161|FG011|Overall Study|Withdrawal by Subject|1|||
126774983|NCT00555399|456131150|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
126774984|NCT00555399|456131151|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
126774985|NCT00555399|456131152|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
126774986|NCT00555399|456131153|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
126774987|NCT00555399|456131154|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
126500695|NCT04365556|455131868|FG000|Overall Study|No longer eligible due to treatment plan|1|||
126500696|NCT04365556|455131869|FG001|Overall Study|No longer eligible due to treatment plan|0|||
126500697|NCT04365556|455131868|FG000|Overall Study|Lost to Follow-up|3|||
126500698|NCT04365556|455131869|FG001|Overall Study|Lost to Follow-up|2|||
126500699|NCT00567892|455131871|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
126500700|NCT00567892|455131872|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
126500701|NCT00567892|455131873|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
126500702|NCT00567892|455131874|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
126500703|NCT00567892|455131871|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
126500704|NCT00567892|455131872|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
126500705|NCT00567892|455131873|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
126500706|NCT00567892|455131874|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
126500707|NCT04709575|455133135|FG000|Overall Study|Withdrawal by Subject|6|||
126500708|NCT04709575|455133136|FG001|Overall Study|Withdrawal by Subject|2|||
126500709|NCT04709575|455133135|FG000|Overall Study|Lost to Follow-up|2|||
126500710|NCT04709575|455133136|FG001|Overall Study|Lost to Follow-up|2|||
126500711|NCT04709575|455133135|FG000|Overall Study|Adverse Event|1|||
126500712|NCT04709575|455133136|FG001|Overall Study|Adverse Event|0|||
126500713|NCT04709575|455133135|FG000|Overall Study|Protocol Violation|1|||
126500714|NCT04709575|455133136|FG001|Overall Study|Protocol Violation|1|||
126500715|NCT03181399|455133137|FG000|6 Months on Treatment|Protocol non-compliance|7|||
126500716|NCT03181399|455133137|FG000|6 Months on Treatment|Adverse Event|4|||
126500717|NCT03181399|455133137|FG000|6 Months on Treatment|Tried alternative treatment|2|||
126500718|NCT03181399|455133137|FG000|6 Months on Treatment|Lost to Follow-up|2|||
126500719|NCT03181399|455133137|FG000|6 Months on Treatment|Personal reasons|1|||
126500720|NCT03181399|455133137|FG000|3 Months Off-treatment|Parent unable to travel|1|||
126500721|NCT00539838|455133138|FG000|Overall Study|Fail to return|2|||
126500722|NCT00539838|455133139|FG001|Overall Study|Fail to return|0|||
126500723|NCT00539838|455133140|FG002|Overall Study|Fail to return|0|||
126500724|NCT00539838|455133138|FG000|Overall Study|Withdrawal by Subject|0|||
126500725|NCT00539838|455133139|FG001|Overall Study|Withdrawal by Subject|4|||
126500726|NCT00539838|455133140|FG002|Overall Study|Withdrawal by Subject|0|||
126500727|NCT00539838|455133138|FG000|Overall Study|Death|0|||
126500728|NCT00539838|455133139|FG001|Overall Study|Death|2|||
126500729|NCT00539838|455133140|FG002|Overall Study|Death|0|||
126500730|NCT00539838|455133138|FG000|Overall Study|Did not cooperate|1|||
126500731|NCT00539838|455133139|FG001|Overall Study|Did not cooperate|0|||
126500732|NCT00539838|455133140|FG002|Overall Study|Did not cooperate|1|||
126500733|NCT00539838|455133138|FG000|Overall Study|Administrative|4|||
126500734|NCT00539838|455133139|FG001|Overall Study|Administrative|0|||
126500735|NCT00539838|455133140|FG002|Overall Study|Administrative|8|||
126500736|NCT03090100|455133141|FG000|Overall Study|Adverse Event|9|||
126500737|NCT03090100|455133142|FG001|Overall Study|Adverse Event|11|||
126500738|NCT03090100|455133141|FG000|Overall Study|Pregnancy|1|||
126500739|NCT03090100|455133142|FG001|Overall Study|Pregnancy|1|||
126500740|NCT03090100|455133141|FG000|Overall Study|Lack of Efficacy|2|||
126500741|NCT03090100|455133142|FG001|Overall Study|Lack of Efficacy|7|||
126500742|NCT03090100|455133141|FG000|Overall Study|Lost to Follow-up|2|||
126500743|NCT03090100|455133142|FG001|Overall Study|Lost to Follow-up|2|||
126500744|NCT03090100|455133141|FG000|Overall Study|Withdrawal by Subject|7|||
126500745|NCT03090100|455133142|FG001|Overall Study|Withdrawal by Subject|19|||
126500746|NCT03090100|455133141|FG000|Overall Study|Protocol Violation|2|||
126500747|NCT03090100|455133142|FG001|Overall Study|Protocol Violation|6|||
126500748|NCT03090100|455133141|FG000|Overall Study|Non-compliance|2|||
126500749|NCT03090100|455133142|FG001|Overall Study|Non-compliance|0|||
126500750|NCT03090100|455133141|FG000|Overall Study|Other|2|||
126500751|NCT03090100|455133142|FG001|Overall Study|Other|2|||
126500752|NCT01660711|455133143|FG000|Overall Study|Adverse Event|7|||
126500753|NCT01660711|455133143|FG000|Overall Study|Withdrawal by Subject|1|||
126500754|NCT00952341|455133144|FG000|Cycle 1|Adverse Event|4|||
126500755|NCT00952341|455133145|FG001|Cycle 1|Adverse Event|1|||
126500756|NCT00952341|455133144|FG000|Cycle 1|Withdrawal by Subject|3|||
126500757|NCT00952341|455133145|FG001|Cycle 1|Withdrawal by Subject|8|||
126500758|NCT00952341|455133144|FG000|Cycle 1|Protocol Violation|2|||
126500759|NCT00952341|455133145|FG001|Cycle 1|Protocol Violation|1|||
126500760|NCT00952341|455133144|FG000|Cycle 1|Lost to Follow-up|11|||
126500761|NCT00952341|455133145|FG001|Cycle 1|Lost to Follow-up|2|||
126500762|NCT00952341|455133144|FG000|Cycle 1|Physician Decision|0|||
126560961|NCT03686683|455348373|FG000|Overall Study|Withdrawal by Subject|52|||
126560962|NCT03686683|455348374|FG001|Overall Study|Withdrawal by Subject|32|||
126774988|NCT00555399|456131155|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
126774989|NCT00555399|456131156|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
126774990|NCT00555399|456131157|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
126774991|NCT00555399|456131158|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
126774992|NCT00555399|456131159|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
126774993|NCT00555399|456131160|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
126774994|NCT00555399|456131161|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
126774995|NCT00343642|456132321|FG000|Overall Study|Lost to Follow-up|0|||
126774996|NCT00343642|456132322|FG001|Overall Study|Lost to Follow-up|1|||
126774997|NCT00343642|456132323|FG002|Overall Study|Lost to Follow-up|0|||
126774998|NCT00343642|456132321|FG000|Overall Study|Pregnancy|1|||
126774999|NCT00343642|456132322|FG001|Overall Study|Pregnancy|0|||
126775000|NCT00343642|456132323|FG002|Overall Study|Pregnancy|2|||
126775001|NCT00343642|456132321|FG000|Overall Study|Withdrawal by Subject|2|||
126775002|NCT00343642|456132322|FG001|Overall Study|Withdrawal by Subject|3|||
126775003|NCT00343642|456132323|FG002|Overall Study|Withdrawal by Subject|4|||
126775004|NCT00343642|456132321|FG000|Overall Study|Adverse Event|0|||
126775005|NCT00343642|456132322|FG001|Overall Study|Adverse Event|0|||
126775006|NCT00343642|456132323|FG002|Overall Study|Adverse Event|1|||
126775007|NCT00343642|456132321|FG000|Overall Study|Flare up|6|||
126775008|NCT00343642|456132322|FG001|Overall Study|Flare up|4|||
126775009|NCT00343642|456132323|FG002|Overall Study|Flare up|0|||
126775010|NCT03053622|456132328|FG000|Overall Study|Lost to Follow-up|0|||
126775011|NCT03053622|456132329|FG001|Overall Study|Lost to Follow-up|0|||
126775012|NCT03053622|456132330|FG002|Overall Study|Lost to Follow-up|0|||
126775013|NCT03053622|456132331|FG003|Overall Study|Lost to Follow-up|1|||
126775014|NCT01355523|456132335|FG000|Overall Study|Withdrawal by Subject|1|||
126775015|NCT01355523|456132336|FG001|Overall Study|Withdrawal by Subject|4|||
126775016|NCT01355523|456132335|FG000|Overall Study|Lost to Follow-up|0|||
126775017|NCT01355523|456132336|FG001|Overall Study|Lost to Follow-up|2|||
126775018|NCT01355523|456132335|FG000|Overall Study|Protocol Violation|0|||
126775019|NCT01355523|456132336|FG001|Overall Study|Protocol Violation|2|||
126500763|NCT00952341|455133145|FG001|Cycle 1|Physician Decision|1|||
126500764|NCT00952341|455133144|FG000|Cycle 2|Withdrawal by Subject|1|||
126500765|NCT00952341|455133145|FG001|Cycle 2|Withdrawal by Subject|1|||
126500766|NCT00952341|455133144|FG000|Cycle 2|Protocol Violation|1|||
126560963|NCT03686683|455348373|FG000|Overall Study|Lost to Follow-up|23|||
126500767|NCT00952341|455133145|FG001|Cycle 2|Protocol Violation|0|||
126500768|NCT00952341|455133144|FG000|Cycle 2|Lost to Follow-up|6|||
126500769|NCT00952341|455133145|FG001|Cycle 2|Lost to Follow-up|9|||
126500770|NCT00952341|455133144|FG000|Cycle 2|Physician Decision|1|||
126500771|NCT00952341|455133145|FG001|Cycle 2|Physician Decision|1|||
126500772|NCT00952341|455133144|FG000|Cycle 2|Progressive Disease|0|||
126500773|NCT00952341|455133145|FG001|Cycle 2|Progressive Disease|1|||
126500774|NCT03253848|455133148|FG000|Overall Study|Adverse Event|7|||
126500775|NCT03253848|455133148|FG000|Overall Study|Death|5|||
126500776|NCT03253848|455133148|FG000|Overall Study|initiation of other treatments|3|||
126500777|NCT03253848|455133148|FG000|Overall Study|Other complicating disease|1|||
126500778|NCT03253848|455133148|FG000|Overall Study|Withdrawal by Subject|1|||
126500779|NCT03253848|455133148|FG000|Overall Study|Declining health|1|||
126500780|NCT05352815|455133149|FG000|Overall Study|Withdrawal by Subject|28|||
126500781|NCT05352815|455133150|FG001|Overall Study|Withdrawal by Subject|24|||
126500782|NCT05352815|455133149|FG000|Overall Study|Lost to Follow-up|4|||
126500783|NCT05352815|455133150|FG001|Overall Study|Lost to Follow-up|7|||
126500784|NCT05352815|455133149|FG000|Overall Study|Death|2|||
126500785|NCT05352815|455133150|FG001|Overall Study|Death|3|||
126500786|NCT05352815|455133149|FG000|Overall Study|Site closure|1|||
126500787|NCT05352815|455133150|FG001|Overall Study|Site closure|0|||
126500788|NCT02759120|455133151|FG000|Overall Study|Death|34|||
126500789|NCT02759120|455133152|FG001|Overall Study|Death|36|||
126500790|NCT02759120|455133151|FG000|Overall Study|Lost to Follow-up|4|||
126500791|NCT02759120|455133152|FG001|Overall Study|Lost to Follow-up|7|||
126500792|NCT02759120|455133151|FG000|Overall Study|Physician Decision|3|||
126560964|NCT03686683|455348374|FG001|Overall Study|Lost to Follow-up|19|||
126775020|NCT01355523|456132335|FG000|Overall Study|Adverse Event|0|||
126775021|NCT01355523|456132336|FG001|Overall Study|Adverse Event|2|||
126775022|NCT01011907|456132337|FG000|Overall Study|Withdrawal by Subject|13|||
126775023|NCT01011907|456132338|FG001|Overall Study|Withdrawal by Subject|11|||
126775024|NCT01011907|456132337|FG000|Overall Study|Adverse Event|1|||
126775025|NCT01011907|456132338|FG001|Overall Study|Adverse Event|4|||
126775026|NCT01272193|456132339|FG000|Overall Study|Adverse Event|1|||
126500793|NCT02759120|455133152|FG001|Overall Study|Physician Decision|0|||
126500794|NCT02759120|455133151|FG000|Overall Study|Withdrawal by Subject|28|||
126500795|NCT02759120|455133152|FG001|Overall Study|Withdrawal by Subject|15|||
126500796|NCT02759120|455133151|FG000|Overall Study|Moved out of area|3|||
126500797|NCT02759120|455133152|FG001|Overall Study|Moved out of area|4|||
126500798|NCT02759120|455133151|FG000|Overall Study|Lung transplant|3|||
126560965|NCT03686683|455348373|FG000|Overall Study|Adverse Event|1|||
126560966|NCT03686683|455348374|FG001|Overall Study|Adverse Event|0|||
126560967|NCT03686683|455348373|FG000|Overall Study|Death|10|||
126560968|NCT03686683|455348374|FG001|Overall Study|Death|5|||
126560969|NCT03686683|455348373|FG000|Overall Study|Progressive Disease|1|||
126560970|NCT03686683|455348374|FG001|Overall Study|Progressive Disease|1|||
126560971|NCT03686683|455348373|FG000|Overall Study|Noncompliance|1|||
126560972|NCT03686683|455348374|FG001|Overall Study|Noncompliance|0|||
126560973|NCT03686683|455348373|FG000|Overall Study|Physician Decision|1|||
126560974|NCT03686683|455348374|FG001|Overall Study|Physician Decision|1|||
126560975|NCT03686683|455348373|FG000|Overall Study|Screen fail post-randomization|1|||
126560976|NCT03686683|455348374|FG001|Overall Study|Screen fail post-randomization|0|||
126560977|NCT03686683|455348373|FG000|Overall Study|Protocol Violation|3|||
126560978|NCT03686683|455348374|FG001|Overall Study|Protocol Violation|0|||
126560979|NCT03686683|455348373|FG000|Overall Study|No data available|1|||
126560980|NCT03686683|455348374|FG001|Overall Study|No data available|0|||
126560981|NCT03255941|455348375|FG000|Overall Study|Not eligible or refused injection|37|||
126560982|NCT03255941|455348376|FG001|Overall Study|Not eligible or refused injection|44|||
126560983|NCT03255941|455348377|FG002|Overall Study|Not eligible or refused injection|5|||
126560984|NCT03255941|455348378|FG003|Overall Study|Not eligible or refused injection|6|||
126560985|NCT03255941|455348375|FG000|Overall Study|Did not complete exit interview|1|||
126560986|NCT03255941|455348376|FG001|Overall Study|Did not complete exit interview|2|||
126560987|NCT03255941|455348377|FG002|Overall Study|Did not complete exit interview|0|||
126560988|NCT03255941|455348378|FG003|Overall Study|Did not complete exit interview|0|||
126560989|NCT00372060|455348379|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
126560990|NCT00372060|455348380|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
126560991|NCT00372060|455348379|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
126560992|NCT00372060|455348380|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
126560993|NCT00372060|455348379|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
126560994|NCT00372060|455348380|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
126560995|NCT00372060|455348379|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
126560996|NCT00372060|455348380|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
126560997|NCT00372060|455348379|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
126560998|NCT00372060|455348380|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
126500799|NCT02759120|455133152|FG001|Overall Study|Lung transplant|5|||
126500800|NCT02759120|455133151|FG000|Overall Study|Other reason not completed|10|||
126500801|NCT02759120|455133152|FG001|Overall Study|Other reason not completed|12|||
126500802|NCT05071183|455133157|FG000|Overall Study|Death|1|||
126500803|NCT05071183|455133158|FG001|Overall Study|Death|2|||
126500804|NCT05071183|455133159|FG002|Overall Study|Death|0|||
126500805|NCT05071183|455133157|FG000|Overall Study|Other Reasons|1|||
126500806|NCT05071183|455133158|FG001|Overall Study|Other Reasons|3|||
126560999|NCT00372060|455348379|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
126561000|NCT00372060|455348380|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
126561001|NCT01579578|455348381|FG000|Overall Study|Death|4|||
126500807|NCT05071183|455133159|FG002|Overall Study|Other Reasons|2|||
126500808|NCT02939560|455133169|FG000|Overall Study|Withdrawal by Subject|2|||
126500809|NCT02939560|455133169|FG000|Overall Study|Protocol Violation|1|||
126500810|NCT02420691|455133172|FG000|Overall Study|Adverse Event|3|||
126500811|NCT02420691|455133172|FG000|Overall Study|Withdrawal by Subject|3|||
126500812|NCT00704535|455133178|FG000|Overall Study|Adverse Event|2|||
126500813|NCT00704535|455133178|FG000|Overall Study|Death|2|||
126500814|NCT00704535|455133178|FG000|Overall Study|Lost to Follow-up|8|||
126500815|NCT00704535|455133178|FG000|Overall Study|Protocol Violation|10|||
126500816|NCT00704535|455133178|FG000|Overall Study|Completed status not on Case Report Form|124|||
126775027|NCT01272193|456132340|FG001|Overall Study|Adverse Event|1|||
126500817|NCT01480076|455133179|FG000|Overall Study|Run-in Failure|52|||
126561002|NCT01579578|455348382|FG001|Overall Study|Death|1|||
126561003|NCT01579578|455348381|FG000|Overall Study|Lost to Follow-up|1|||
126561004|NCT01579578|455348382|FG001|Overall Study|Lost to Follow-up|1|||
126775028|NCT01272193|456132339|FG000|Overall Study|Lack of Efficacy|0|||
126500818|NCT01480076|455133179|FG000|Overall Study|Adverse Event|39|||
126500819|NCT01480076|455133179|FG000|Overall Study|Death|2|||
126500820|NCT01480076|455133179|FG000|Overall Study|Disease Progression|5|||
126500821|NCT01480076|455133179|FG000|Overall Study|Non-compliance With Study Protocol|15|||
126561005|NCT01579578|455348381|FG000|Overall Study|Withdrawal by Subject|2|||
126561006|NCT01579578|455348382|FG001|Overall Study|Withdrawal by Subject|1|||
126561007|NCT01579578|455348381|FG000|Overall Study|Eligibility criteria|3|||
126561008|NCT01579578|455348382|FG001|Overall Study|Eligibility criteria|9|||
126561009|NCT01579578|455348381|FG000|Overall Study|Ongoing|3|||
126561010|NCT01579578|455348382|FG001|Overall Study|Ongoing|0|||
126775029|NCT01272193|456132340|FG001|Overall Study|Lack of Efficacy|3|||
126775030|NCT01272193|456132339|FG000|Overall Study|Withdrawal Criteria|1|||
126500822|NCT01480076|455133179|FG000|Overall Study|Withdrawal by Subject|105|||
126500823|NCT01480076|455133179|FG000|Overall Study|Lost to Follow-up|7|||
126500824|NCT01480076|455133179|FG000|Overall Study|Investigator Decision|13|||
126775031|NCT01272193|456132340|FG001|Overall Study|Withdrawal Criteria|1|||
126775032|NCT01272193|456132339|FG000|Overall Study|Unclassified|8|||
126775033|NCT01272193|456132340|FG001|Overall Study|Unclassified|7|||
126775034|NCT01440647|456132343|FG000|Overall Study|Death|2|||
126775035|NCT01440647|456132344|FG001|Overall Study|Death|3|||
126775036|NCT01406873|456132353|FG000|Overall Study|Withdrawal by Subject|1|||
126775037|NCT01406873|456132354|FG001|Overall Study|Withdrawal by Subject|1|||
126775038|NCT00207714|456132355|FG000|Overall Study|Adverse Event|6|||
126775039|NCT00207714|456132356|FG001|Overall Study|Adverse Event|2|||
126775040|NCT00207714|456132357|FG002|Overall Study|Adverse Event|4|||
126775041|NCT00207714|456132358|FG003|Overall Study|Adverse Event|3|||
126775042|NCT00207714|456132359|FG004|Overall Study|Adverse Event|1|||
126775043|NCT00207714|456132355|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
126775044|NCT00207714|456132356|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126775045|NCT00207714|456132357|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
126775046|NCT00207714|456132358|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
126775047|NCT00207714|456132359|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
126775048|NCT00207714|456132355|FG000|Overall Study|Other|3|||
126775049|NCT00207714|456132356|FG001|Overall Study|Other|2|||
126775050|NCT00207714|456132357|FG002|Overall Study|Other|5|||
126775051|NCT00207714|456132358|FG003|Overall Study|Other|1|||
126775052|NCT00207714|456132359|FG004|Overall Study|Other|0|||
126500825|NCT01480076|455133179|FG000|Overall Study|Other|52|||
126500826|NCT02503332|455133180|FG000|Overall Study|Adverse Event|17|||
126500827|NCT02503332|455133181|FG001|Overall Study|Adverse Event|5|||
126500828|NCT02503332|455133182|FG002|Overall Study|Adverse Event|3|||
126500829|NCT02503332|455133183|FG003|Overall Study|Adverse Event|1|||
126500830|NCT02503332|455133180|FG000|Overall Study|Investigator's Decision|5|||
126500831|NCT02503332|455133181|FG001|Overall Study|Investigator's Decision|1|||
126500832|NCT02503332|455133182|FG002|Overall Study|Investigator's Decision|0|||
126500833|NCT02503332|455133183|FG003|Overall Study|Investigator's Decision|0|||
126500834|NCT02503332|455133180|FG000|Overall Study|Sponsor's Decision|1|||
126500835|NCT02503332|455133181|FG001|Overall Study|Sponsor's Decision|0|||
126500836|NCT02503332|455133182|FG002|Overall Study|Sponsor's Decision|0|||
126500837|NCT02503332|455133183|FG003|Overall Study|Sponsor's Decision|1|||
126500838|NCT02503332|455133180|FG000|Overall Study|Subject Request|6|||
126500839|NCT02503332|455133181|FG001|Overall Study|Subject Request|5|||
126500840|NCT02503332|455133182|FG002|Overall Study|Subject Request|2|||
126500841|NCT02503332|455133183|FG003|Overall Study|Subject Request|1|||
126500842|NCT02503332|455133180|FG000|Overall Study|Death|0|||
126500843|NCT02503332|455133181|FG001|Overall Study|Death|2|||
126500844|NCT02503332|455133182|FG002|Overall Study|Death|2|||
126500845|NCT02503332|455133183|FG003|Overall Study|Death|0|||
126500846|NCT02503332|455133180|FG000|Overall Study|Other|5|||
126500847|NCT02503332|455133181|FG001|Overall Study|Other|6|||
126500848|NCT02503332|455133182|FG002|Overall Study|Other|1|||
126500849|NCT02503332|455133183|FG003|Overall Study|Other|1|||
126500850|NCT01413360|455133184|FG000|Overall Study|Lost to Follow-up|2|||
126500851|NCT01413360|455133184|FG000|Overall Study|Adverse Event|1|||
126500852|NCT05694546|455133187|FG000|Overall Study|Lost to Follow-up|11|||
126500853|NCT01589445|455133188|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
126500854|NCT01589445|455133188|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
126500855|NCT01589445|455133188|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
126500856|NCT01589445|455133188|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
126500857|NCT01589445|455133188|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
126500858|NCT01589445|455133188|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
126500859|NCT01589445|455133188|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
126500860|NCT01589445|455133188|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
126500861|NCT01589445|455133188|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
126500862|NCT01589445|455133188|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
126500863|NCT00325754|455133192|FG000|Overall Study|Adverse Event|4|||
126500864|NCT00325754|455133193|FG001|Overall Study|Adverse Event|1|||
126500865|NCT02625090|455133205|FG000|Overall Study|Participant wants to be pregnant|2|||
126500866|NCT02625090|455133205|FG000|Overall Study|For the Promoter|1|||
126500867|NCT02625090|455133205|FG000|Overall Study|Sponsor's Decision|9|||
126500868|NCT02625090|455133205|FG000|Overall Study|Somnolence|1|||
126500869|NCT02625090|455133205|FG000|Overall Study|Study terminated by Sponsor|7|||
126775053|NCT03627195|456132360|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
126775054|NCT03627195|456132361|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
126775055|NCT03627195|456132362|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
126775056|NCT03627195|456132363|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
126775057|NCT03627195|456132364|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
126775058|NCT03627195|456132365|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
126775059|NCT00736099|456132368|FG000|Overall Study|Adverse Event|61|||
126775060|NCT00736099|456132369|FG001|Overall Study|Adverse Event|18|||
126775061|NCT00736099|456132368|FG000|Overall Study|Protocol Violation|10|||
126500870|NCT02625090|455133205|FG000|Overall Study|Negative Benefit/Risk|1|||
126500871|NCT02625090|455133205|FG000|Overall Study|Protocol Deviation|2|||
126775062|NCT00736099|456132369|FG001|Overall Study|Protocol Violation|4|||
126500872|NCT02625090|455133205|FG000|Overall Study|Lack of Efficacy|16|||
126500873|NCT02625090|455133205|FG000|Overall Study|Adverse Event|3|||
126500874|NCT02439320|455133210|FG000|Overall Study|Adverse Event|0|||
126500875|NCT02439320|455133211|FG001|Overall Study|Adverse Event|2|||
126500876|NCT02439320|455133212|FG002|Overall Study|Adverse Event|0|||
126500877|NCT02439320|455133210|FG000|Overall Study|Lost to Follow-up|37|||
126500878|NCT02439320|455133211|FG001|Overall Study|Lost to Follow-up|34|||
126500879|NCT02439320|455133212|FG002|Overall Study|Lost to Follow-up|42|||
126561011|NCT01528709|455348383|FG000|Overall Study|Death|2|||
126561012|NCT01528709|455348384|FG001|Overall Study|Death|0|||
126561013|NCT01528709|455348383|FG000|Overall Study|Withdrawal by Subject|10|||
126561014|NCT01528709|455348384|FG001|Overall Study|Withdrawal by Subject|15|||
126561015|NCT01528709|455348383|FG000|Overall Study|allergy|1|||
126561016|NCT01528709|455348384|FG001|Overall Study|allergy|0|||
126561017|NCT01813422|455348395|FG000|Overall Study|Withdrawal by Subject|14|||
126561018|NCT01813422|455348396|FG001|Overall Study|Withdrawal by Subject|8|||
126561019|NCT01813422|455348395|FG000|Overall Study|Death|2|||
126561020|NCT01813422|455348396|FG001|Overall Study|Death|3|||
126561021|NCT01813422|455348395|FG000|Overall Study|Sponsor Decision|2|||
126561022|NCT01813422|455348396|FG001|Overall Study|Sponsor Decision|1|||
126775063|NCT00736099|456132368|FG000|Overall Study|Lost to Follow-up|12|||
126775064|NCT00736099|456132369|FG001|Overall Study|Lost to Follow-up|5|||
126500880|NCT02439320|455133210|FG000|Overall Study|Death|0|||
126500881|NCT02439320|455133211|FG001|Overall Study|Death|1|||
126500882|NCT02439320|455133212|FG002|Overall Study|Death|0|||
126500883|NCT02439320|455133210|FG000|Overall Study|Noncompliance with Protocol|10|||
126500884|NCT02439320|455133211|FG001|Overall Study|Noncompliance with Protocol|11|||
126500885|NCT02439320|455133212|FG002|Overall Study|Noncompliance with Protocol|7|||
126500886|NCT02439320|455133210|FG000|Overall Study|Pregnancy|0|||
126500887|NCT02439320|455133211|FG001|Overall Study|Pregnancy|1|||
126500888|NCT02439320|455133212|FG002|Overall Study|Pregnancy|1|||
126500889|NCT02439320|455133210|FG000|Overall Study|Withdrawal by Subject|12|||
126500890|NCT02439320|455133211|FG001|Overall Study|Withdrawal by Subject|16|||
126500891|NCT02439320|455133212|FG002|Overall Study|Withdrawal by Subject|14|||
126500892|NCT02439320|455133210|FG000|Overall Study|Physician Decision|2|||
126500893|NCT02439320|455133211|FG001|Overall Study|Physician Decision|1|||
126500894|NCT02439320|455133212|FG002|Overall Study|Physician Decision|0|||
126500895|NCT02439320|455133210|FG000|Overall Study|Sponsor Request|0|||
126500896|NCT02439320|455133211|FG001|Overall Study|Sponsor Request|2|||
126500897|NCT02439320|455133212|FG002|Overall Study|Sponsor Request|1|||
126500898|NCT02439320|455133210|FG000|Overall Study|Randomization Failure|35|||
126500899|NCT02439320|455133211|FG001|Overall Study|Randomization Failure|46|||
126500900|NCT02439320|455133212|FG002|Overall Study|Randomization Failure|34|||
126500901|NCT02972632|455133213|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
126500902|NCT02972632|455133213|FG000|Overall Study|Lost to Follow-up|4|||
126500903|NCT02972632|455133213|FG000|Overall Study|Voluntary Withdrawal|10|||
126500904|NCT01488097|455133223|FG000|Overall Study|Lost to Follow-up|1|||
126500905|NCT03054870|455133234|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
126500906|NCT03054870|455133234|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
126500907|NCT02140567|455133236|FG000|Overall Study|Problems with recording equipment|6|||
126500908|NCT01709695|455133238|FG000|Overall Study|Withdrawal by Subject|1|||
126500909|NCT01709695|455133239|FG001|Overall Study|Withdrawal by Subject|1|||
126500910|NCT02802592|455133240|FG000|Overall Study|Study terminated due to loss of funding|4|||
126500911|NCT02590939|455133241|FG000|Overall Study|Withdrawal by Subject|3|||
126500912|NCT02590939|455133242|FG001|Overall Study|Withdrawal by Subject|1|||
126500913|NCT02590939|455133241|FG000|Overall Study|Failed the nociceptive test|2|||
126500914|NCT02590939|455133242|FG001|Overall Study|Failed the nociceptive test|1|||
126500915|NCT03774433|455133243|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
126500916|NCT00108160|455133248|FG000|Overall Study|Lost to Follow-up|25|||
126500917|NCT00108160|455133249|FG001|Overall Study|Lost to Follow-up|12|||
126500918|NCT00108160|455133248|FG000|Overall Study|Death|1|||
126500919|NCT00108160|455133249|FG001|Overall Study|Death|2|||
126500920|NCT00108160|455133248|FG000|Overall Study|Withdrawal by Subject|4|||
126500921|NCT00108160|455133249|FG001|Overall Study|Withdrawal by Subject|2|||
126500922|NCT00108160|455133248|FG000|Overall Study|Protocol Violation|9|||
126500923|NCT00108160|455133249|FG001|Overall Study|Protocol Violation|5|||
126500924|NCT03082599|455133252|FG000|Overall Study|Lost to Follow-up|1|||
126500925|NCT03082599|455133253|FG001|Overall Study|Lost to Follow-up|0|||
126500926|NCT02347189|455133254|FG000|Overall Study|No implant attempted of study device|9|||
126500927|NCT02347189|455133254|FG000|Overall Study|No primary outcome data available|2|||
126500928|NCT00735878|455133255|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
126500929|NCT00735878|455133256|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
126500930|NCT00735878|455133257|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
126500931|NCT00994240|455133258|FG000|Overall Study|Lost to Follow-up|3|||
126500932|NCT00994240|455133259|FG001|Overall Study|Lost to Follow-up|2|||
126561023|NCT01813422|455348395|FG000|Overall Study|Lost to Follow-up|2|||
126561024|NCT01813422|455348396|FG001|Overall Study|Lost to Follow-up|4|||
126561025|NCT01653743|455348397|FG000|Overall Study|Withdrawal by Subject|1|||
126775065|NCT00736099|456132368|FG000|Overall Study|Withdrawal by Subject|42|||
126775066|NCT00736099|456132369|FG001|Overall Study|Withdrawal by Subject|13|||
126775067|NCT00736099|456132368|FG000|Overall Study|Lack of Efficacy|15|||
126775068|NCT00736099|456132369|FG001|Overall Study|Lack of Efficacy|8|||
126775069|NCT00736099|456132368|FG000|Overall Study|Other reason|43|||
126775070|NCT00736099|456132369|FG001|Overall Study|Other reason|10|||
126775071|NCT00686790|456132375|FG000|Overall Study|Adverse Event|2|||
126775072|NCT00686790|456132375|FG000|Overall Study|Withdrawal by Subject|1|||
126775073|NCT00686790|456132375|FG000|Overall Study|Death|1|||
126775074|NCT00686790|456132375|FG000|Overall Study|Lost to Follow-up|12|||
126775075|NCT00096382|456132376|FG000|Overall Study|Not treated|1|||
126775076|NCT00096382|456132377|FG001|Overall Study|Not treated|0|||
126775077|NCT00096382|456132376|FG000|Overall Study|Death during treatment|1|||
126775078|NCT00096382|456132377|FG001|Overall Study|Death during treatment|0|||
126775079|NCT02082912|456132381|FG000|Overall Study|Physician Decision|0|||
126775080|NCT02082912|456132382|FG001|Overall Study|Physician Decision|1|||
126775081|NCT00697112|456132399|FG000|Overall Study|Adverse Event|8|||
126500933|NCT00994240|455133258|FG000|Overall Study|Withdrawal by Subject|1|||
126500934|NCT00994240|455133259|FG001|Overall Study|Withdrawal by Subject|0|||
126500935|NCT00994240|455133258|FG000|Overall Study|study termination|2|||
126500936|NCT00994240|455133259|FG001|Overall Study|study termination|3|||
126500937|NCT00352846|455133260|FG000|Overall Study|Disease progression|0|||
126500938|NCT00352846|455133261|FG001|Overall Study|Disease progression|2|||
126500939|NCT00352846|455133260|FG000|Overall Study|Withdrawal by Subject|3|||
126500940|NCT00352846|455133261|FG001|Overall Study|Withdrawal by Subject|8|||
126500941|NCT00352846|455133260|FG000|Overall Study|Ineligible|3|||
126500942|NCT00352846|455133261|FG001|Overall Study|Ineligible|2|||
126500943|NCT00352846|455133260|FG000|Overall Study|Non-compliance|2|||
126500944|NCT00352846|455133261|FG001|Overall Study|Non-compliance|0|||
126500945|NCT00352846|455133260|FG000|Overall Study|Death|0|||
126500946|NCT00352846|455133261|FG001|Overall Study|Death|1|||
126500947|NCT01527682|455133262|FG000|Overall Study|Protocol Violation|8|||
126500948|NCT04254978|455134859|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
126500949|NCT04254978|455134859|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
126500950|NCT04254978|455134859|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
126500951|NCT04254978|455134859|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
126500952|NCT04254978|455134859|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
126500953|NCT04254978|455134859|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
126500954|NCT00277212|455134860|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
126500955|NCT00277212|455134861|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
126500956|NCT00277212|455134862|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
126500957|NCT00277212|455134860|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
126500958|NCT00277212|455134861|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
126500959|NCT00277212|455134862|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
126500960|NCT00277212|455134860|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
126500961|NCT00277212|455134861|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
126500962|NCT00277212|455134862|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
126500963|NCT00277212|455134860|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
126500964|NCT00277212|455134861|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
126500965|NCT00277212|455134862|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
126500966|NCT00277212|455134860|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
126500967|NCT00277212|455134861|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
126500968|NCT00277212|455134862|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
126500969|NCT00277212|455134860|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
126500970|NCT00277212|455134861|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
126500971|NCT00277212|455134862|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
126500972|NCT00277212|455134860|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
126500973|NCT00277212|455134861|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
126500974|NCT00277212|455134862|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
126500975|NCT00277212|455134860|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
126775082|NCT00697112|456132399|FG000|Overall Study|Lost to Follow-up|1|||
126775083|NCT00697112|456132399|FG000|Overall Study|Did not meet inclusion criteria|1|||
126775084|NCT00736333|456132400|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
126775085|NCT00736333|456132400|FG000|Overall Study|Data Missing|2|||
126775086|NCT00736333|456132400|FG000|Overall Study|Tumor Progression|75|||
126775087|NCT00736333|456132400|FG000|Overall Study|Toxicity|6|||
126500976|NCT00277212|455134861|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
126500977|NCT00277212|455134862|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
126500978|NCT00277212|455134860|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
126500979|NCT00277212|455134861|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
126500980|NCT00277212|455134862|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
126775088|NCT00736333|456132400|FG000|Overall Study|Withdrawal by Subject|10|||
126775089|NCT00736333|456132400|FG000|Overall Study|Death|7|||
126500981|NCT00277212|455134860|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
126500982|NCT00277212|455134861|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
126500983|NCT00277212|455134862|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
126561026|NCT01653743|455348398|FG001|Overall Study|Withdrawal by Subject|0|||
126561027|NCT01653743|455348397|FG000|Overall Study|Investigator discretion|3|||
126561028|NCT01653743|455348398|FG001|Overall Study|Investigator discretion|0|||
126500984|NCT00277212|455134860|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
126500985|NCT00277212|455134861|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
126500986|NCT00277212|455134862|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
126500987|NCT00277212|455134860|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
126500988|NCT00277212|455134861|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
126500989|NCT00277212|455134862|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
126500990|NCT00277212|455134860|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
126500991|NCT00277212|455134861|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
126500992|NCT00277212|455134862|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
126500993|NCT00277212|455134860|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
126500994|NCT00277212|455134861|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
126500995|NCT00277212|455134862|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
126561029|NCT04889118|455348400|FG000|Overall Study|Death|33|||
126561030|NCT04889118|455348401|FG001|Overall Study|Death|37|||
126561031|NCT04889118|455348400|FG000|Overall Study|Ongoing in Study|31|||
126561032|NCT04889118|455348401|FG001|Overall Study|Ongoing in Study|30|||
126561033|NCT02397889|455348406|FG000|Overall Study|Physician Decision|1|||
126561034|NCT02397889|455348407|FG001|Overall Study|Physician Decision|0|||
126561035|NCT00797225|455348415|FG000|Weeks 1 to 12|Adverse Event|0|||
126561036|NCT00797225|455348416|FG001|Weeks 1 to 12|Adverse Event|0|||
126561037|NCT00797225|455348417|FG002|Weeks 1 to 12|Adverse Event|1|||
126561038|NCT00797225|455348418|FG003|Weeks 1 to 12|Adverse Event|0|||
126561039|NCT00797225|455348419|FG004|Weeks 1 to 12|Adverse Event|0|||
126561040|NCT00797225|455348420|FG005|Weeks 1 to 12|Adverse Event|0|||
126561041|NCT00797225|455348421|FG006|Weeks 1 to 12|Adverse Event|0|||
126500996|NCT00277212|455134860|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
126500997|NCT00277212|455134861|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
126500998|NCT00277212|455134862|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
126500999|NCT00277212|455134860|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
126501000|NCT00277212|455134861|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
126501001|NCT00277212|455134862|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
126501002|NCT00277212|455134860|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
126501003|NCT00277212|455134861|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
126501004|NCT00277212|455134862|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
126501005|NCT00277212|455134860|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
126501006|NCT00277212|455134861|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
126501007|NCT00277212|455134862|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
126501008|NCT03336216|455134868|FG000|Randomization|Not reported|2|||
126501009|NCT03336216|455134869|FG001|Randomization|Not reported|0|||
126501010|NCT03336216|455134870|FG002|Randomization|Not reported|1|||
126501011|NCT03336216|455134871|FG003|Randomization|Not reported|0|||
126501012|NCT03336216|455134868|FG000|Randomization|Other reasons|1|||
126501013|NCT03336216|455134869|FG001|Randomization|Other reasons|1|||
126501014|NCT03336216|455134870|FG002|Randomization|Other reasons|1|||
126501015|NCT03336216|455134871|FG003|Randomization|Other reasons|0|||
126501016|NCT03336216|455134868|FG000|Randomization|Participant no longer meets study criteria|0|||
126501017|NCT03336216|455134869|FG001|Randomization|Participant no longer meets study criteria|2|||
126501018|NCT03336216|455134870|FG002|Randomization|Participant no longer meets study criteria|4|||
126501019|NCT03336216|455134871|FG003|Randomization|Participant no longer meets study criteria|1|||
126501020|NCT03336216|455134868|FG000|Randomization|Lost to Follow-up|1|||
126501021|NCT03336216|455134869|FG001|Randomization|Lost to Follow-up|0|||
126501022|NCT03336216|455134870|FG002|Randomization|Lost to Follow-up|0|||
126501023|NCT03336216|455134871|FG003|Randomization|Lost to Follow-up|0|||
126501024|NCT03336216|455134868|FG000|Randomization|Participant withdrew consent|9|||
126501025|NCT03336216|455134869|FG001|Randomization|Participant withdrew consent|1|||
126501026|NCT03336216|455134870|FG002|Randomization|Participant withdrew consent|0|||
126501027|NCT03336216|455134871|FG003|Randomization|Participant withdrew consent|0|||
126501028|NCT03336216|455134868|FG000|Randomization|Adverse Event|1|||
126501029|NCT03336216|455134869|FG001|Randomization|Adverse Event|1|||
126561042|NCT00797225|455348422|FG007|Weeks 1 to 12|Adverse Event|0|||
126501030|NCT03336216|455134870|FG002|Randomization|Adverse Event|0|||
126501031|NCT03336216|455134871|FG003|Randomization|Adverse Event|0|||
126501032|NCT03336216|455134868|FG000|Treatment|Adverse Event|2|||
126501033|NCT03336216|455134869|FG001|Treatment|Adverse Event|3|||
126501034|NCT03336216|455134870|FG002|Treatment|Adverse Event|4|||
126501035|NCT03336216|455134871|FG003|Treatment|Adverse Event|4|||
126561043|NCT00797225|455348415|FG000|Weeks 1 to 12|Non-compliance|0|||
126775090|NCT00736333|456132400|FG000|Overall Study|Other|4|||
126775091|NCT04126733|456132401|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
126775092|NCT04126733|456132401|FG000|Treatment Period|Adverse Event|8|||
126775093|NCT04126733|456132401|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
126775094|NCT04126733|456132401|FG000|Treatment Period|Physician Decision|5|||
126775095|NCT04126733|456132401|FG000|Treatment Period|Death|1|||
126775096|NCT04126733|456132401|FG000|Treatment Period|Other Reasons|2|||
126501036|NCT03336216|455134868|FG000|Treatment|Participant request to discontinue treatment|2|||
126561044|NCT00797225|455348416|FG001|Weeks 1 to 12|Non-compliance|1|||
126775097|NCT04126733|456132401|FG000|Active Follow-up Period|Death|13|||
126775098|NCT04126733|456132401|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
126775099|NCT04126733|456132401|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
126775100|NCT04126733|456132401|FG000|Active Follow-up Period|Other Reasons|1|||
126775101|NCT04126733|456132401|FG000|Long-term Follow-up Period|Death|22|||
126775102|NCT04126733|456132401|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
126775103|NCT04126733|456132401|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
126775104|NCT02629133|456132403|FG000|Overall Study|Lost to Follow-up|3|||
126775105|NCT02629133|456132404|FG001|Overall Study|Lost to Follow-up|1|||
126775106|NCT02629133|456132403|FG000|Overall Study|Withdrawal by Subject|1|||
126775107|NCT02629133|456132404|FG001|Overall Study|Withdrawal by Subject|1|||
126775108|NCT03216954|456132405|FG000|Overall Study|Adverse Event|0|||
126775109|NCT03216954|456132406|FG001|Overall Study|Adverse Event|0|||
126775110|NCT03216954|456132407|FG002|Overall Study|Adverse Event|1|||
126775111|NCT03216954|456132408|FG003|Overall Study|Adverse Event|0|||
126775112|NCT03216954|456132409|FG004|Overall Study|Adverse Event|1|||
126775113|NCT03216954|456132405|FG000|Overall Study|Withdrawal by Subject|2|||
126775114|NCT03216954|456132406|FG001|Overall Study|Withdrawal by Subject|0|||
126775115|NCT03216954|456132407|FG002|Overall Study|Withdrawal by Subject|0|||
126775116|NCT03216954|456132408|FG003|Overall Study|Withdrawal by Subject|0|||
126775117|NCT03216954|456132409|FG004|Overall Study|Withdrawal by Subject|0|||
126775118|NCT03216954|456132405|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
126775119|NCT03216954|456132406|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
126775120|NCT03216954|456132407|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
126775121|NCT03216954|456132408|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
126775122|NCT03216954|456132409|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
126775123|NCT02598193|456132410|FG000|Overall Study|Adverse Event|13|||
126775124|NCT02598193|456132410|FG000|Overall Study|Withdrawal by Subject|1|||
126775125|NCT02598193|456132410|FG000|Overall Study|Listed in active lung transplant list|1|||
126775126|NCT02598193|456132410|FG000|Overall Study|Does not want to take Nintedanib|1|||
126775127|NCT02354976|456132416|FG000|Overall Study|Other - reason not specified|1|||
126775128|NCT02354976|456132417|FG001|Overall Study|Other - reason not specified|0|||
126775129|NCT02354976|456132418|FG002|Overall Study|Other - reason not specified|1|||
126775130|NCT02354976|456132416|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
126501037|NCT03336216|455134869|FG001|Treatment|Participant request to discontinue treatment|1|||
126501038|NCT03336216|455134870|FG002|Treatment|Participant request to discontinue treatment|2|||
126501039|NCT03336216|455134871|FG003|Treatment|Participant request to discontinue treatment|2|||
126501040|NCT03336216|455134868|FG000|Treatment|Participant withdrew consent|7|||
126501041|NCT03336216|455134869|FG001|Treatment|Participant withdrew consent|2|||
126501042|NCT03336216|455134870|FG002|Treatment|Participant withdrew consent|3|||
126501043|NCT03336216|455134871|FG003|Treatment|Participant withdrew consent|2|||
126501044|NCT03336216|455134868|FG000|Treatment|Death|2|||
126501045|NCT03336216|455134869|FG001|Treatment|Death|3|||
126501046|NCT03336216|455134870|FG002|Treatment|Death|3|||
126501047|NCT03336216|455134871|FG003|Treatment|Death|4|||
126501048|NCT03336216|455134868|FG000|Treatment|Participant no longer meets study criteria|0|||
126501049|NCT03336216|455134869|FG001|Treatment|Participant no longer meets study criteria|1|||
126501050|NCT03336216|455134870|FG002|Treatment|Participant no longer meets study criteria|0|||
126501051|NCT03336216|455134871|FG003|Treatment|Participant no longer meets study criteria|0|||
126501052|NCT03336216|455134868|FG000|Treatment|Other reasons|2|||
126501053|NCT03336216|455134869|FG001|Treatment|Other reasons|0|||
126501054|NCT03336216|455134870|FG002|Treatment|Other reasons|0|||
126561045|NCT00797225|455348417|FG002|Weeks 1 to 12|Non-compliance|0|||
126561046|NCT00797225|455348418|FG003|Weeks 1 to 12|Non-compliance|0|||
126775131|NCT02354976|456132417|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
126775132|NCT02354976|456132418|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
126775133|NCT02354976|456132416|FG000|Overall Study|Adverse Event|1|||
126775134|NCT02354976|456132417|FG001|Overall Study|Adverse Event|0|||
126501055|NCT03336216|455134871|FG003|Treatment|Other reasons|3|||
126501056|NCT03336216|455134868|FG000|Treatment|Disease progression|23|||
126501057|NCT03336216|455134869|FG001|Treatment|Disease progression|34|||
126501058|NCT03336216|455134870|FG002|Treatment|Disease progression|33|||
126501059|NCT03336216|455134871|FG003|Treatment|Disease progression|26|||
126501060|NCT03336216|455134868|FG000|Treatment|Study drug toxicity|0|||
126501061|NCT03336216|455134869|FG001|Treatment|Study drug toxicity|3|||
126501062|NCT03336216|455134870|FG002|Treatment|Study drug toxicity|2|||
126501063|NCT03336216|455134871|FG003|Treatment|Study drug toxicity|0|||
126501064|NCT03336216|455134868|FG000|Treatment|Adverse Event unrelated to study drug|1|||
126501065|NCT03336216|455134869|FG001|Treatment|Adverse Event unrelated to study drug|1|||
126501066|NCT03336216|455134870|FG002|Treatment|Adverse Event unrelated to study drug|1|||
126501067|NCT03336216|455134871|FG003|Treatment|Adverse Event unrelated to study drug|0|||
126501068|NCT03336216|455134868|FG000|Treatment|Disease Recurrence|1|||
126501069|NCT03336216|455134869|FG001|Treatment|Disease Recurrence|0|||
126501070|NCT03336216|455134870|FG002|Treatment|Disease Recurrence|0|||
126501071|NCT03336216|455134871|FG003|Treatment|Disease Recurrence|0|||
126501072|NCT03239470|455134872|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
126501073|NCT03239470|455134873|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
126501074|NCT01023581|455134876|FG000|Overall Study|Adverse Event|4|||
126501075|NCT01023581|455134877|FG001|Overall Study|Adverse Event|4|||
126501076|NCT01023581|455134878|FG002|Overall Study|Adverse Event|7|||
126501077|NCT01023581|455134879|FG003|Overall Study|Adverse Event|3|||
126501078|NCT01023581|455134880|FG004|Overall Study|Adverse Event|2|||
126501079|NCT01023581|455134881|FG005|Overall Study|Adverse Event|5|||
126501080|NCT01023581|455134882|FG006|Overall Study|Adverse Event|11|||
126501081|NCT01023581|455134876|FG000|Overall Study|Major protocol deviation|2|||
126501082|NCT01023581|455134877|FG001|Overall Study|Major protocol deviation|0|||
126501083|NCT01023581|455134878|FG002|Overall Study|Major protocol deviation|3|||
126501084|NCT01023581|455134879|FG003|Overall Study|Major protocol deviation|0|||
126501085|NCT01023581|455134880|FG004|Overall Study|Major protocol deviation|0|||
126501086|NCT01023581|455134881|FG005|Overall Study|Major protocol deviation|0|||
126501087|NCT01023581|455134882|FG006|Overall Study|Major protocol deviation|0|||
126501088|NCT01023581|455134876|FG000|Overall Study|Lost to Follow-up|4|||
126501089|NCT01023581|455134877|FG001|Overall Study|Lost to Follow-up|8|||
126501090|NCT01023581|455134878|FG002|Overall Study|Lost to Follow-up|7|||
126501091|NCT01023581|455134879|FG003|Overall Study|Lost to Follow-up|2|||
126501092|NCT01023581|455134880|FG004|Overall Study|Lost to Follow-up|5|||
126501093|NCT01023581|455134881|FG005|Overall Study|Lost to Follow-up|2|||
126501094|NCT01023581|455134882|FG006|Overall Study|Lost to Follow-up|2|||
126501095|NCT01023581|455134876|FG000|Overall Study|Withdrawal by Subject|13|||
126501096|NCT01023581|455134877|FG001|Overall Study|Withdrawal by Subject|8|||
126501097|NCT01023581|455134878|FG002|Overall Study|Withdrawal by Subject|16|||
126501098|NCT01023581|455134879|FG003|Overall Study|Withdrawal by Subject|10|||
126501099|NCT01023581|455134880|FG004|Overall Study|Withdrawal by Subject|6|||
126501100|NCT01023581|455134881|FG005|Overall Study|Withdrawal by Subject|8|||
126501101|NCT01023581|455134882|FG006|Overall Study|Withdrawal by Subject|5|||
126501102|NCT01023581|455134876|FG000|Overall Study|Pregnancy|0|||
126501103|NCT01023581|455134877|FG001|Overall Study|Pregnancy|0|||
126501104|NCT01023581|455134878|FG002|Overall Study|Pregnancy|0|||
126501105|NCT01023581|455134879|FG003|Overall Study|Pregnancy|2|||
126501106|NCT01023581|455134880|FG004|Overall Study|Pregnancy|0|||
126501107|NCT01023581|455134881|FG005|Overall Study|Pregnancy|1|||
126501108|NCT01023581|455134882|FG006|Overall Study|Pregnancy|0|||
126501109|NCT01023581|455134876|FG000|Overall Study|Lack of Efficacy|9|||
126501110|NCT01023581|455134877|FG001|Overall Study|Lack of Efficacy|3|||
126501111|NCT01023581|455134878|FG002|Overall Study|Lack of Efficacy|6|||
126501112|NCT01023581|455134879|FG003|Overall Study|Lack of Efficacy|2|||
126501113|NCT01023581|455134880|FG004|Overall Study|Lack of Efficacy|1|||
126501114|NCT01023581|455134881|FG005|Overall Study|Lack of Efficacy|2|||
126501115|NCT01023581|455134882|FG006|Overall Study|Lack of Efficacy|1|||
126501116|NCT01023581|455134876|FG000|Overall Study|Physician Decision|2|||
126501117|NCT01023581|455134877|FG001|Overall Study|Physician Decision|0|||
126501118|NCT01023581|455134878|FG002|Overall Study|Physician Decision|2|||
126501119|NCT01023581|455134879|FG003|Overall Study|Physician Decision|1|||
126501120|NCT01023581|455134880|FG004|Overall Study|Physician Decision|1|||
126501121|NCT01023581|455134881|FG005|Overall Study|Physician Decision|1|||
126501122|NCT01023581|455134882|FG006|Overall Study|Physician Decision|1|||
126501123|NCT01023581|455134876|FG000|Overall Study|Other|1|||
126501124|NCT01023581|455134877|FG001|Overall Study|Other|0|||
126501125|NCT01023581|455134878|FG002|Overall Study|Other|1|||
126501126|NCT01023581|455134879|FG003|Overall Study|Other|0|||
126501127|NCT01023581|455134880|FG004|Overall Study|Other|1|||
126501128|NCT01023581|455134881|FG005|Overall Study|Other|0|||
126501129|NCT01023581|455134882|FG006|Overall Study|Other|0|||
126501130|NCT00278954|455134883|FG000|Overall Study|Adverse Event|3|||
126501131|NCT00278954|455134883|FG000|Overall Study|Lost to Follow-up|1|||
126501132|NCT00278954|455134883|FG000|Overall Study|Withdrawal by Subject|1|||
126501133|NCT03406858|455134884|FG000|Overall Study|Failure to receive treatment drug.|1|||
126501134|NCT03406858|455134884|FG000|Overall Study|ineligible|1|||
126501135|NCT02532647|455134894|FG000|Overall Study|Did not receive trial medication|1|||
126501136|NCT02532647|455134895|FG001|Overall Study|Did not receive trial medication|0|||
126501137|NCT02532647|455134896|FG002|Overall Study|Did not receive trial medication|1|||
126501138|NCT05664490|455134902|FG000|Overall Study|Withdrawal by Subject|0|||
126775135|NCT02354976|456132418|FG002|Overall Study|Adverse Event|2|||
126775136|NCT00986154|456132419|FG000|Overall Study|Death|136|||
126775137|NCT00986154|456132420|FG001|Overall Study|Death|127|||
126775138|NCT00986154|456132419|FG000|Overall Study|Lost to Follow-up|7|||
126775139|NCT00986154|456132420|FG001|Overall Study|Lost to Follow-up|4|||
126775140|NCT00986154|456132419|FG000|Overall Study|Withdrawal by Subject|32|||
126775141|NCT00986154|456132420|FG001|Overall Study|Withdrawal by Subject|33|||
126775142|NCT00986154|456132419|FG000|Overall Study|investigator/subject decide not continue|6|||
126775143|NCT00986154|456132420|FG001|Overall Study|investigator/subject decide not continue|3|||
126775144|NCT00986154|456132419|FG000|Overall Study|never received study drug|25|||
126775145|NCT00986154|456132420|FG001|Overall Study|never received study drug|27|||
126775146|NCT03726437|456132421|FG000|Overall Study|Lost to Follow-up|85|||
126775147|NCT03726437|456132422|FG001|Overall Study|Lost to Follow-up|76|||
126775148|NCT00068445|456132423|FG000|Randomization|Cancel|1|||
126775149|NCT00068445|456132424|FG001|Randomization|Cancel|3|||
126775150|NCT00068445|456132423|FG000|Randomization|Ineligible|1|||
126775151|NCT00068445|456132424|FG001|Randomization|Ineligible|1|||
126775152|NCT00068445|456132423|FG000|Treatment|Refused Further Treatment|13|||
126775153|NCT00068445|456132424|FG001|Treatment|Refused Further Treatment|10|||
126775154|NCT00068445|456132423|FG000|Treatment|Adverse Event|7|||
126775155|NCT00068445|456132424|FG001|Treatment|Adverse Event|1|||
126775156|NCT00068445|456132423|FG000|Treatment|Other (Specifics not available)|9|||
126775157|NCT00068445|456132424|FG001|Treatment|Other (Specifics not available)|5|||
126775158|NCT01896700|456132425|FG000|Overall Study|Adverse Event|4|||
126775159|NCT01896700|456132426|FG001|Overall Study|Adverse Event|5|||
126775160|NCT01896700|456132425|FG000|Overall Study|Withdrawal by Subject|0|||
126775161|NCT01896700|456132426|FG001|Overall Study|Withdrawal by Subject|1|||
126775162|NCT03118765|456132428|FG000|Overall Study|Withdrawal by Subject|0|||
126775163|NCT03118765|456132429|FG001|Overall Study|Withdrawal by Subject|0|||
126775164|NCT03118765|456132430|FG002|Overall Study|Withdrawal by Subject|1|||
126775165|NCT03118765|456132431|FG003|Overall Study|Withdrawal by Subject|0|||
126775166|NCT03118765|456132432|FG004|Overall Study|Withdrawal by Subject|0|||
126775167|NCT03118765|456132428|FG000|Overall Study|Adverse Event|1|||
126775168|NCT03118765|456132429|FG001|Overall Study|Adverse Event|1|||
126775169|NCT03118765|456132430|FG002|Overall Study|Adverse Event|1|||
126775170|NCT03118765|456132431|FG003|Overall Study|Adverse Event|1|||
126775171|NCT03118765|456132432|FG004|Overall Study|Adverse Event|1|||
126775172|NCT03118765|456132428|FG000|Overall Study|Non compliance with Study Procedures|0|||
126775173|NCT03118765|456132429|FG001|Overall Study|Non compliance with Study Procedures|0|||
126775174|NCT03118765|456132430|FG002|Overall Study|Non compliance with Study Procedures|0|||
126775175|NCT03118765|456132431|FG003|Overall Study|Non compliance with Study Procedures|1|||
126775176|NCT03118765|456132432|FG004|Overall Study|Non compliance with Study Procedures|0|||
126775177|NCT03118765|456132428|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
126775178|NCT03118765|456132429|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
126775179|NCT03118765|456132430|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
126775180|NCT03118765|456132431|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
126775181|NCT03118765|456132432|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
126775182|NCT03118765|456132428|FG000|Overall Study|COPD Exacerbation|1|||
126775183|NCT03118765|456132429|FG001|Overall Study|COPD Exacerbation|0|||
126775184|NCT03118765|456132430|FG002|Overall Study|COPD Exacerbation|0|||
126775185|NCT03118765|456132431|FG003|Overall Study|COPD Exacerbation|1|||
126775186|NCT03118765|456132432|FG004|Overall Study|COPD Exacerbation|0|||
126775187|NCT03118765|456132428|FG000|Overall Study|Lost to Follow-up|1|||
126775188|NCT03118765|456132429|FG001|Overall Study|Lost to Follow-up|0|||
126775189|NCT03118765|456132430|FG002|Overall Study|Lost to Follow-up|1|||
126775190|NCT03118765|456132431|FG003|Overall Study|Lost to Follow-up|0|||
126775191|NCT03118765|456132432|FG004|Overall Study|Lost to Follow-up|0|||
126775192|NCT03118765|456132428|FG000|Overall Study|Sponsor Decision|1|||
126775193|NCT03118765|456132429|FG001|Overall Study|Sponsor Decision|0|||
126775194|NCT03118765|456132430|FG002|Overall Study|Sponsor Decision|1|||
126775195|NCT03118765|456132431|FG003|Overall Study|Sponsor Decision|0|||
126775196|NCT03118765|456132432|FG004|Overall Study|Sponsor Decision|1|||
126775197|NCT00849524|456132433|FG000|Overall Study|Lack of Efficacy|3|||
126775198|NCT00879970|456132439|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
126775199|NCT00879970|456132440|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
126561047|NCT00797225|455348419|FG004|Weeks 1 to 12|Non-compliance|0|||
126561048|NCT00797225|455348420|FG005|Weeks 1 to 12|Non-compliance|0|||
126775200|NCT00879970|456132441|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
126775201|NCT00879970|456132442|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
126775202|NCT00879970|456132443|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
126775203|NCT00879970|456132439|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
126561049|NCT00797225|455348421|FG006|Weeks 1 to 12|Non-compliance|0|||
126561050|NCT00797225|455348422|FG007|Weeks 1 to 12|Non-compliance|0|||
126775204|NCT00879970|456132440|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
126775205|NCT00879970|456132441|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
126775206|NCT00879970|456132442|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
126561051|NCT00797225|455348415|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
126561052|NCT00797225|455348416|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
126561053|NCT00797225|455348417|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
126561054|NCT00797225|455348418|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
126561055|NCT00797225|455348419|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
126561056|NCT00797225|455348420|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
126561057|NCT00797225|455348421|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
126561058|NCT00797225|455348422|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
126561059|NCT00797225|455348415|FG000|Weeks 1 to 12|Sponsor Decision|1|||
126561060|NCT00797225|455348416|FG001|Weeks 1 to 12|Sponsor Decision|0|||
126561061|NCT00797225|455348417|FG002|Weeks 1 to 12|Sponsor Decision|0|||
126561062|NCT00797225|455348418|FG003|Weeks 1 to 12|Sponsor Decision|0|||
126561063|NCT00797225|455348419|FG004|Weeks 1 to 12|Sponsor Decision|0|||
126561064|NCT00797225|455348420|FG005|Weeks 1 to 12|Sponsor Decision|0|||
126561065|NCT00797225|455348421|FG006|Weeks 1 to 12|Sponsor Decision|0|||
126561066|NCT00797225|455348422|FG007|Weeks 1 to 12|Sponsor Decision|0|||
126561067|NCT00797225|455348415|FG000|Weeks 13 to 24|Non-compliance|0|||
126561068|NCT00797225|455348416|FG001|Weeks 13 to 24|Non-compliance|2|||
126561069|NCT00797225|455348417|FG002|Weeks 13 to 24|Non-compliance|0|||
126561070|NCT00797225|455348418|FG003|Weeks 13 to 24|Non-compliance|0|||
126561071|NCT00797225|455348419|FG004|Weeks 13 to 24|Non-compliance|0|||
126561072|NCT00797225|455348420|FG005|Weeks 13 to 24|Non-compliance|0|||
126561073|NCT00797225|455348421|FG006|Weeks 13 to 24|Non-compliance|0|||
126561074|NCT00797225|455348422|FG007|Weeks 13 to 24|Non-compliance|0|||
126561075|NCT00797225|455348415|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
126561076|NCT00797225|455348416|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
126561077|NCT00797225|455348417|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
126561078|NCT00797225|455348418|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
126561079|NCT00797225|455348419|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
126561080|NCT00797225|455348420|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
126561081|NCT00797225|455348421|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
126561082|NCT00797225|455348422|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
126561083|NCT00797225|455348415|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
126561084|NCT00797225|455348416|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
126561085|NCT00797225|455348417|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
126561086|NCT00797225|455348418|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
126561087|NCT00797225|455348419|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
126561088|NCT00797225|455348420|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
126561089|NCT00797225|455348421|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
126561090|NCT00797225|455348422|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
126561091|NCT00797225|455348415|FG000|Weeks 13 to 24|Adverse Event|0|||
126561092|NCT00797225|455348416|FG001|Weeks 13 to 24|Adverse Event|1|||
126561093|NCT00797225|455348417|FG002|Weeks 13 to 24|Adverse Event|0|||
126561094|NCT00797225|455348418|FG003|Weeks 13 to 24|Adverse Event|0|||
126561095|NCT00797225|455348419|FG004|Weeks 13 to 24|Adverse Event|0|||
126561096|NCT00797225|455348420|FG005|Weeks 13 to 24|Adverse Event|0|||
126561097|NCT00797225|455348421|FG006|Weeks 13 to 24|Adverse Event|1|||
126561098|NCT00797225|455348422|FG007|Weeks 13 to 24|Adverse Event|0|||
126561099|NCT00797225|455348415|FG000|Weeks 13 to 24|Sponsor Decision|0|||
126561100|NCT00797225|455348416|FG001|Weeks 13 to 24|Sponsor Decision|0|||
126561101|NCT00797225|455348417|FG002|Weeks 13 to 24|Sponsor Decision|0|||
126561102|NCT00797225|455348418|FG003|Weeks 13 to 24|Sponsor Decision|0|||
126561103|NCT00797225|455348419|FG004|Weeks 13 to 24|Sponsor Decision|0|||
126561104|NCT00797225|455348420|FG005|Weeks 13 to 24|Sponsor Decision|0|||
126561105|NCT00797225|455348421|FG006|Weeks 13 to 24|Sponsor Decision|1|||
126561106|NCT00797225|455348422|FG007|Weeks 13 to 24|Sponsor Decision|0|||
126561107|NCT01928940|455348423|FG000|Overall Study|Adverse Event|0|||
126561108|NCT01928940|455348424|FG001|Overall Study|Adverse Event|1|||
126561109|NCT02954055|455348425|FG000|Overall Study|Did not initiate therapy|6|||
126561110|NCT02954055|455348426|FG001|Overall Study|Did not initiate therapy|1|||
126561111|NCT01352507|455348431|FG000|Treatment Period 1|Adverse Event|3|||
126561112|NCT01352507|455348432|FG001|Treatment Period 1|Adverse Event|0|||
126561113|NCT01352507|455348431|FG000|Treatment Period 1|Lost to Follow-up|3|||
126561114|NCT01352507|455348432|FG001|Treatment Period 1|Lost to Follow-up|4|||
126561115|NCT01352507|455348431|FG000|Treatment Period 1|Withdrawal by Subject|7|||
126561116|NCT01352507|455348432|FG001|Treatment Period 1|Withdrawal by Subject|5|||
126561117|NCT01352507|455348431|FG000|Treatment Period 1|Physician Decision|1|||
126561118|NCT01352507|455348432|FG001|Treatment Period 1|Physician Decision|0|||
126561119|NCT01352507|455348431|FG000|Washout Period|Withdrawal by Subject|0|||
126561120|NCT01352507|455348432|FG001|Washout Period|Withdrawal by Subject|1|||
126561121|NCT01352507|455348431|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
126561122|NCT01352507|455348432|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
126561123|NCT01352507|455348431|FG000|Treatment Period 2|Withdrawal by Subject|4|||
126561124|NCT01352507|455348432|FG001|Treatment Period 2|Withdrawal by Subject|3|||
126561125|NCT01352507|455348431|FG000|Treatment Period 2|Lack of Efficacy|1|||
126561126|NCT01352507|455348432|FG001|Treatment Period 2|Lack of Efficacy|0|||
126561127|NCT02096003|455348433|FG000|Overall Study|Protocol Violation|0|||
126561128|NCT02096003|455348434|FG001|Overall Study|Protocol Violation|2|||
126561129|NCT02096003|455348433|FG000|Overall Study|additional surgery|2|||
126561130|NCT02096003|455348434|FG001|Overall Study|additional surgery|1|||
126561131|NCT01511250|455348435|FG000|Overall Study|Withdrawal of Consent|1|||
126561132|NCT01511250|455348436|FG001|Overall Study|Withdrawal of Consent|0|||
126561133|NCT01511250|455348437|FG002|Overall Study|Withdrawal of Consent|0|||
126561134|NCT01511250|455348438|FG003|Overall Study|Withdrawal of Consent|0|||
126561135|NCT01511250|455348439|FG004|Overall Study|Withdrawal of Consent|0|||
126561136|NCT01511250|455348440|FG005|Overall Study|Withdrawal of Consent|0|||
126561137|NCT01511250|455348441|FG006|Overall Study|Withdrawal of Consent|0|||
126561138|NCT01511250|455348442|FG007|Overall Study|Withdrawal of Consent|1|||
126561139|NCT01511250|455348443|FG008|Overall Study|Withdrawal of Consent|1|||
126561140|NCT01511250|455348444|FG009|Overall Study|Withdrawal of Consent|0|||
126561141|NCT01511250|455348435|FG000|Overall Study|Sponsor/Investigator Decision|1|||
126561142|NCT01511250|455348436|FG001|Overall Study|Sponsor/Investigator Decision|0|||
126561143|NCT01511250|455348437|FG002|Overall Study|Sponsor/Investigator Decision|0|||
126561144|NCT01511250|455348438|FG003|Overall Study|Sponsor/Investigator Decision|0|||
126561145|NCT01511250|455348439|FG004|Overall Study|Sponsor/Investigator Decision|0|||
126561146|NCT01511250|455348440|FG005|Overall Study|Sponsor/Investigator Decision|0|||
126561147|NCT01511250|455348441|FG006|Overall Study|Sponsor/Investigator Decision|0|||
126561148|NCT01511250|455348442|FG007|Overall Study|Sponsor/Investigator Decision|0|||
126561149|NCT01511250|455348443|FG008|Overall Study|Sponsor/Investigator Decision|0|||
126561150|NCT01511250|455348444|FG009|Overall Study|Sponsor/Investigator Decision|0|||
126561151|NCT01511250|455348435|FG000|Overall Study|Lost to Follow-up|7|||
126561152|NCT01511250|455348436|FG001|Overall Study|Lost to Follow-up|3|||
126561153|NCT01511250|455348437|FG002|Overall Study|Lost to Follow-up|3|||
126561154|NCT01511250|455348438|FG003|Overall Study|Lost to Follow-up|3|||
126561155|NCT01511250|455348439|FG004|Overall Study|Lost to Follow-up|0|||
126561156|NCT01511250|455348440|FG005|Overall Study|Lost to Follow-up|0|||
126561157|NCT01511250|455348441|FG006|Overall Study|Lost to Follow-up|2|||
126561158|NCT01511250|455348442|FG007|Overall Study|Lost to Follow-up|3|||
126561159|NCT01511250|455348443|FG008|Overall Study|Lost to Follow-up|13|||
126561160|NCT01511250|455348444|FG009|Overall Study|Lost to Follow-up|5|||
126561161|NCT01511250|455348435|FG000|Overall Study|Protocol Violation|0|||
126561162|NCT01511250|455348436|FG001|Overall Study|Protocol Violation|2|||
126561163|NCT01511250|455348437|FG002|Overall Study|Protocol Violation|1|||
126561164|NCT01511250|455348438|FG003|Overall Study|Protocol Violation|0|||
126561165|NCT01511250|455348439|FG004|Overall Study|Protocol Violation|0|||
126561166|NCT01511250|455348440|FG005|Overall Study|Protocol Violation|0|||
126561167|NCT01511250|455348441|FG006|Overall Study|Protocol Violation|0|||
126561168|NCT01511250|455348442|FG007|Overall Study|Protocol Violation|0|||
126561169|NCT01511250|455348443|FG008|Overall Study|Protocol Violation|0|||
126561170|NCT01511250|455348444|FG009|Overall Study|Protocol Violation|0|||
126561171|NCT00916006|455348450|FG000|Overall Study|Adverse Event|1|||
126561172|NCT00916006|455348451|FG001|Overall Study|Adverse Event|1|||
126561173|NCT00916006|455348450|FG000|Overall Study|Withdrawal by Subject|2|||
126561174|NCT00916006|455348451|FG001|Overall Study|Withdrawal by Subject|5|||
126561175|NCT00916006|455348450|FG000|Overall Study|Protocol Violation|0|||
126561176|NCT00916006|455348451|FG001|Overall Study|Protocol Violation|1|||
126561177|NCT05487703|455348452|FG000|Overall Study|Other|19|||
126501139|NCT05664490|455134903|FG001|Overall Study|Withdrawal by Subject|1|||
126501140|NCT05664490|455134902|FG000|Overall Study|Lost to Follow-up|14|||
126501141|NCT05664490|455134903|FG001|Overall Study|Lost to Follow-up|22|||
126501142|NCT01817725|455134904|FG000|Overall Study|Withdrawal by Subject|1|||
126501143|NCT01324388|455134905|FG000|Part 1 of Study|Adverse Event|2|||
126501144|NCT01324388|455134906|FG001|Part 1 of Study|Adverse Event|0|||
126501145|NCT01324388|455134907|FG002|Part 1 of Study|Adverse Event|0|||
126501146|NCT01324388|455134908|FG003|Part 1 of Study|Adverse Event|0|||
126501147|NCT01324388|455134905|FG000|Part 1 of Study|Protocol Violation|1|||
126501148|NCT01324388|455134906|FG001|Part 1 of Study|Protocol Violation|2|||
126501149|NCT01324388|455134907|FG002|Part 1 of Study|Protocol Violation|0|||
126501150|NCT01324388|455134908|FG003|Part 1 of Study|Protocol Violation|0|||
126501151|NCT01324388|455134905|FG000|Part 1 of Study|Physician Decision|1|||
126726311|NCT01963208|455946517|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
126501152|NCT01324388|455134906|FG001|Part 1 of Study|Physician Decision|0|||
126501153|NCT01324388|455134907|FG002|Part 1 of Study|Physician Decision|0|||
126561178|NCT05487703|455348452|FG000|Overall Study|Participant not well|5|||
126561179|NCT05487703|455348452|FG000|Overall Study|Insurance Reasons|6|||
126561180|NCT05487703|455348452|FG000|Overall Study|Physician Decision|19|||
126501154|NCT01324388|455134908|FG003|Part 1 of Study|Physician Decision|0|||
126501155|NCT01324388|455134905|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
126561181|NCT05487703|455348452|FG000|Overall Study|Lack of Efficacy|60|||
126561182|NCT04824131|455348453|FG000|CAB LA Oral Phase|Adverse Event|1|||
126726312|NCT01963208|455946518|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
126561183|NCT04824131|455348453|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
126561184|NCT04824131|455348453|FG000|Step 3|Withdrawal by Subject|2|||
126561185|NCT05489224|455348454|FG000|Treatment Period I|Withdrawal by Subject|6|||
126561186|NCT05489224|455348455|FG001|Treatment Period I|Withdrawal by Subject|5|||
126561187|NCT05489224|455348456|FG002|Treatment Period I|Withdrawal by Subject|0|||
126775207|NCT00879970|456132443|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
126775208|NCT00879970|456132439|FG000|Period 1 TZD Randomization|Death|2|||
126775209|NCT00879970|456132440|FG001|Period 1 TZD Randomization|Death|1|||
126775210|NCT00879970|456132441|FG002|Period 1 TZD Randomization|Death|0|||
126775211|NCT00879970|456132442|FG003|Period 1 TZD Randomization|Death|0|||
126775212|NCT00879970|456132443|FG004|Period 1 TZD Randomization|Death|0|||
126775213|NCT00879970|456132439|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
126775214|NCT00879970|456132440|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
126775215|NCT00879970|456132441|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
126775216|NCT00879970|456132442|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
126775217|NCT00879970|456132443|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
126775218|NCT00879970|456132439|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
126775219|NCT00879970|456132440|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
126775220|NCT00879970|456132441|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
126775221|NCT00879970|456132442|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
126775222|NCT00879970|456132443|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
126775223|NCT00879970|456132439|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
126775224|NCT00879970|456132440|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
126775225|NCT00879970|456132441|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
126775226|NCT00879970|456132442|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
126775227|NCT00879970|456132443|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
126775228|NCT00879970|456132439|FG000|Period 2 Vitamin D Randomization|Death|0|||
126775229|NCT00879970|456132440|FG001|Period 2 Vitamin D Randomization|Death|0|||
126775230|NCT00879970|456132441|FG002|Period 2 Vitamin D Randomization|Death|0|||
126775231|NCT00879970|456132442|FG003|Period 2 Vitamin D Randomization|Death|2|||
126775232|NCT00879970|456132443|FG004|Period 2 Vitamin D Randomization|Death|0|||
126775233|NCT01610167|456132445|FG000|Overall Study|Scheduling conflict.|0|||
126775234|NCT01610167|456132446|FG001|Overall Study|Scheduling conflict.|0|||
126775235|NCT01610167|456132447|FG002|Overall Study|Scheduling conflict.|2|||
126775236|NCT03296553|456132448|FG000|Overall Study|Withdrawal by Subject|1|||
126501156|NCT01324388|455134906|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
126501157|NCT01324388|455134907|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
126501158|NCT01324388|455134908|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
126501159|NCT01324388|455134905|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
126501160|NCT01324388|455134906|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
126501161|NCT01324388|455134907|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
126501162|NCT01324388|455134908|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
126501163|NCT00129129|455134911|FG000|Primary Phase|Adverse Event|2|||
126501164|NCT00129129|455134912|FG001|Primary Phase|Adverse Event|1|||
126501165|NCT00129129|455134913|FG002|Primary Phase|Adverse Event|0|||
126501166|NCT00129129|455134914|FG003|Primary Phase|Adverse Event|0|||
126501167|NCT00129129|455134915|FG004|Primary Phase|Adverse Event|0|||
126501168|NCT00129129|455134911|FG000|Primary Phase|Withdrawal by Subject|12|||
126501169|NCT00129129|455134912|FG001|Primary Phase|Withdrawal by Subject|10|||
126501170|NCT00129129|455134913|FG002|Primary Phase|Withdrawal by Subject|0|||
126501171|NCT00129129|455134914|FG003|Primary Phase|Withdrawal by Subject|0|||
126501172|NCT00129129|455134915|FG004|Primary Phase|Withdrawal by Subject|0|||
126501173|NCT00129129|455134911|FG000|Primary Phase|Migration from study area|1|||
126501174|NCT00129129|455134912|FG001|Primary Phase|Migration from study area|3|||
126501175|NCT00129129|455134913|FG002|Primary Phase|Migration from study area|0|||
126501176|NCT00129129|455134914|FG003|Primary Phase|Migration from study area|0|||
126501177|NCT00129129|455134915|FG004|Primary Phase|Migration from study area|0|||
126501178|NCT00129129|455134911|FG000|Primary Phase|Lost to Follow-up|8|||
126501179|NCT00129129|455134912|FG001|Primary Phase|Lost to Follow-up|6|||
126501180|NCT00129129|455134913|FG002|Primary Phase|Lost to Follow-up|0|||
126501181|NCT00129129|455134914|FG003|Primary Phase|Lost to Follow-up|0|||
126501182|NCT00129129|455134915|FG004|Primary Phase|Lost to Follow-up|0|||
126501183|NCT00129129|455134911|FG000|Primary Phase|Other|2|||
126501184|NCT00129129|455134912|FG001|Primary Phase|Other|5|||
126501185|NCT00129129|455134913|FG002|Primary Phase|Other|0|||
126501186|NCT00129129|455134914|FG003|Primary Phase|Other|0|||
126501187|NCT00129129|455134915|FG004|Primary Phase|Other|0|||
126501188|NCT00129129|455134911|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
126501189|NCT00129129|455134912|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
126501190|NCT00129129|455134913|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
126501191|NCT00129129|455134914|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
126501192|NCT00129129|455134915|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
126501193|NCT00129129|455134911|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
126775237|NCT03296553|456132449|FG001|Overall Study|Withdrawal by Subject|1|||
126775238|NCT03296553|456132448|FG000|Overall Study|Death|1|||
126501194|NCT00129129|455134912|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
126501195|NCT00129129|455134913|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
126501196|NCT00129129|455134914|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
126501197|NCT00129129|455134915|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
126501198|NCT00129129|455134911|FG000|Fourth Dose Phase|Migration from study area|0|||
126501199|NCT00129129|455134912|FG001|Fourth Dose Phase|Migration from study area|0|||
126501200|NCT00129129|455134913|FG002|Fourth Dose Phase|Migration from study area|0|||
126501201|NCT00129129|455134914|FG003|Fourth Dose Phase|Migration from study area|0|||
126501202|NCT00129129|455134915|FG004|Fourth Dose Phase|Migration from study area|2|||
126501203|NCT00129129|455134911|FG000|Fourth Dose Phase|Other|0|||
126501204|NCT00129129|455134912|FG001|Fourth Dose Phase|Other|0|||
126501205|NCT00129129|455134913|FG002|Fourth Dose Phase|Other|0|||
126501206|NCT00129129|455134914|FG003|Fourth Dose Phase|Other|1|||
126501207|NCT00129129|455134915|FG004|Fourth Dose Phase|Other|1|||
126501208|NCT00129129|455134911|FG000|Fourth Dose Phase|Protocol Violation|0|||
126501209|NCT00129129|455134912|FG001|Fourth Dose Phase|Protocol Violation|0|||
126501210|NCT00129129|455134913|FG002|Fourth Dose Phase|Protocol Violation|0|||
126501211|NCT00129129|455134914|FG003|Fourth Dose Phase|Protocol Violation|1|||
126501212|NCT00129129|455134915|FG004|Fourth Dose Phase|Protocol Violation|0|||
126501213|NCT03089606|455134916|FG000|Overall Study|Progression after Cycle 1|1|||
126501214|NCT01150123|455134918|FG000|Overall Study|Withdrawal by Subject|1|||
126501215|NCT01150123|455134919|FG001|Overall Study|Withdrawal by Subject|1|||
126501216|NCT01150123|455134920|FG002|Overall Study|Withdrawal by Subject|2|||
126501217|NCT01150123|455134921|FG003|Overall Study|Withdrawal by Subject|1|||
126501218|NCT01150123|455134922|FG004|Overall Study|Withdrawal by Subject|1|||
126501219|NCT01150123|455134923|FG005|Overall Study|Withdrawal by Subject|1|||
126501220|NCT01150123|455134924|FG006|Overall Study|Withdrawal by Subject|0|||
126501221|NCT01150123|455134925|FG007|Overall Study|Withdrawal by Subject|3|||
126501222|NCT01150123|455134926|FG008|Overall Study|Withdrawal by Subject|2|||
126501223|NCT01150123|455134927|FG009|Overall Study|Withdrawal by Subject|0|||
126501224|NCT01150123|455134928|FG010|Overall Study|Withdrawal by Subject|1|||
126501225|NCT01150123|455134929|FG011|Overall Study|Withdrawal by Subject|0|||
126501226|NCT01150123|455134930|FG012|Overall Study|Withdrawal by Subject|1|||
126501227|NCT01150123|455134931|FG013|Overall Study|Withdrawal by Subject|0|||
126501228|NCT01150123|455134932|FG014|Overall Study|Withdrawal by Subject|0|||
126501229|NCT01150123|455134933|FG015|Overall Study|Withdrawal by Subject|1|||
126501230|NCT01150123|455134934|FG016|Overall Study|Withdrawal by Subject|0|||
126501231|NCT01150123|455134935|FG017|Overall Study|Withdrawal by Subject|1|||
126501232|NCT01150123|455134918|FG000|Overall Study|Lost to Follow-up|2|||
126501233|NCT01150123|455134919|FG001|Overall Study|Lost to Follow-up|1|||
126501234|NCT01150123|455134920|FG002|Overall Study|Lost to Follow-up|2|||
126501235|NCT01150123|455134921|FG003|Overall Study|Lost to Follow-up|2|||
126501236|NCT01150123|455134922|FG004|Overall Study|Lost to Follow-up|2|||
126501237|NCT01150123|455134923|FG005|Overall Study|Lost to Follow-up|5|||
126501238|NCT01150123|455134924|FG006|Overall Study|Lost to Follow-up|0|||
126501239|NCT01150123|455134925|FG007|Overall Study|Lost to Follow-up|0|||
126501240|NCT01150123|455134926|FG008|Overall Study|Lost to Follow-up|3|||
126501241|NCT01150123|455134927|FG009|Overall Study|Lost to Follow-up|1|||
126501242|NCT01150123|455134928|FG010|Overall Study|Lost to Follow-up|1|||
126501243|NCT01150123|455134929|FG011|Overall Study|Lost to Follow-up|1|||
126501244|NCT01150123|455134930|FG012|Overall Study|Lost to Follow-up|2|||
126501245|NCT01150123|455134931|FG013|Overall Study|Lost to Follow-up|0|||
126501246|NCT01150123|455134932|FG014|Overall Study|Lost to Follow-up|0|||
126501247|NCT01150123|455134933|FG015|Overall Study|Lost to Follow-up|0|||
126501248|NCT01150123|455134934|FG016|Overall Study|Lost to Follow-up|0|||
126501249|NCT01150123|455134935|FG017|Overall Study|Lost to Follow-up|0|||
126501250|NCT02968979|455134942|FG000|Overall Study|Protocol Violation|7|||
126501251|NCT02968979|455134942|FG000|Overall Study|Withdrawal by Subject|1|||
126501252|NCT04404855|455134944|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
126501253|NCT04404855|455134945|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
126501254|NCT03320564|455134946|FG000|Overall Study|Protocol Violation|1|||
126501255|NCT00788827|455134947|FG000|Overall Study|Lack of Efficacy|2|||
126501256|NCT03979638|455134955|FG000|Period 1|Physician Decision|1|||
126501257|NCT03979638|455134956|FG001|Period 1|Physician Decision|1|||
126501258|NCT03979638|455134955|FG000|Period 1|Withdrawal by Subject|4|||
126501259|NCT03979638|455134956|FG001|Period 1|Withdrawal by Subject|3|||
126501260|NCT03979638|455134955|FG000|Period 1|Study terminated by Sponsor|1|||
126501261|NCT03979638|455134956|FG001|Period 1|Study terminated by Sponsor|3|||
126501262|NCT03979638|455134955|FG000|Period 1|Protocol Violation|1|||
126501263|NCT03979638|455134956|FG001|Period 1|Protocol Violation|0|||
126501264|NCT03979638|455134955|FG000|Period 2|Study terminated by Sponsor|1|||
126501265|NCT03979638|455134956|FG001|Period 2|Study terminated by Sponsor|1|||
126501266|NCT04248933|455134957|FG000|Overall Study|Lost to Follow-up|9|||
126501267|NCT04248933|455134957|FG000|Overall Study|Withdrawal by Subject|2|||
126501268|NCT00578942|455134960|FG000|Overall Study|Lost to Follow-up|1|||
126501269|NCT00600938|455134969|FG000|Core Study|Abnormal test procedure result(s)|3|||
126501270|NCT00600938|455134970|FG001|Core Study|Abnormal test procedure result(s)|2|||
126501271|NCT00600938|455134971|FG002|Core Study|Abnormal test procedure result(s)|0|||
126501272|NCT00600938|455134972|FG003|Core Study|Abnormal test procedure result(s)|0|||
126501273|NCT00600938|455134969|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
126501274|NCT00600938|455134970|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
126501275|NCT00600938|455134971|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
126501276|NCT00600938|455134972|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
126501277|NCT00600938|455134969|FG000|Core Study|Patient withdrew consent|7|||
126501278|NCT00600938|455134970|FG001|Core Study|Patient withdrew consent|12|||
126501279|NCT00600938|455134971|FG002|Core Study|Patient withdrew consent|0|||
126501280|NCT00600938|455134972|FG003|Core Study|Patient withdrew consent|0|||
126501281|NCT00600938|455134969|FG000|Core Study|Lost to Follow-up|3|||
126501282|NCT00600938|455134970|FG001|Core Study|Lost to Follow-up|2|||
126501283|NCT00600938|455134971|FG002|Core Study|Lost to Follow-up|0|||
126501284|NCT00600938|455134972|FG003|Core Study|Lost to Follow-up|0|||
126501285|NCT00600938|455134969|FG000|Core Study|Death|1|||
126501286|NCT00600938|455134970|FG001|Core Study|Death|1|||
126501287|NCT00600938|455134971|FG002|Core Study|Death|0|||
126501288|NCT00600938|455134972|FG003|Core Study|Death|0|||
126501289|NCT00600938|455134969|FG000|Core Study|Protocol Violation|1|||
126501290|NCT00600938|455134970|FG001|Core Study|Protocol Violation|2|||
126501291|NCT00600938|455134971|FG002|Core Study|Protocol Violation|0|||
126501292|NCT00600938|455134972|FG003|Core Study|Protocol Violation|0|||
126501293|NCT00600938|455134969|FG000|Extension Study|Adverse Event|1|||
126501294|NCT00600938|455134970|FG001|Extension Study|Adverse Event|0|||
126501295|NCT00600938|455134971|FG002|Extension Study|Adverse Event|2|||
126501296|NCT00600938|455134972|FG003|Extension Study|Adverse Event|0|||
126501297|NCT00600938|455134969|FG000|Extension Study|Abnormal test procedure results|0|||
126501298|NCT00600938|455134970|FG001|Extension Study|Abnormal test procedure results|1|||
126501299|NCT00600938|455134971|FG002|Extension Study|Abnormal test procedure results|1|||
126501300|NCT00600938|455134972|FG003|Extension Study|Abnormal test procedure results|1|||
126501301|NCT00600938|455134969|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
126501302|NCT00600938|455134970|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
126501303|NCT00600938|455134971|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
126501304|NCT00600938|455134972|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
126501305|NCT00600938|455134969|FG000|Extension Study|Withdrawal by Subject|2|||
126501306|NCT00600938|455134970|FG001|Extension Study|Withdrawal by Subject|2|||
126501307|NCT00600938|455134971|FG002|Extension Study|Withdrawal by Subject|3|||
126501308|NCT00600938|455134972|FG003|Extension Study|Withdrawal by Subject|0|||
126501309|NCT00600938|455134969|FG000|Extension Study|Lost to Follow-up|1|||
126501310|NCT00600938|455134970|FG001|Extension Study|Lost to Follow-up|1|||
126501311|NCT00600938|455134971|FG002|Extension Study|Lost to Follow-up|2|||
126501312|NCT00600938|455134972|FG003|Extension Study|Lost to Follow-up|0|||
126501313|NCT00600938|455134969|FG000|Extension Study|Death|1|||
126501314|NCT00600938|455134970|FG001|Extension Study|Death|0|||
126501315|NCT00600938|455134971|FG002|Extension Study|Death|0|||
126501316|NCT00600938|455134972|FG003|Extension Study|Death|0|||
126501317|NCT04220411|455134973|FG000|Overall Study|Adverse Event|0|||
126501318|NCT04220411|455134974|FG001|Overall Study|Adverse Event|0|||
126501319|NCT04220411|455134975|FG002|Overall Study|Adverse Event|0|||
126501320|NCT04220411|455134976|FG003|Overall Study|Adverse Event|1|||
126501321|NCT02680639|455134977|FG000|Screening Period|Screen Failure|7|||
126501322|NCT02680639|455134978|FG001|Screening Period|Screen Failure|0|||
126501323|NCT02680639|455134979|FG002|Screening Period|Screen Failure|0|||
126501324|NCT02678676|455134980|FG000|Overall Study|Death|619|||
126501325|NCT02678676|455134981|FG001|Overall Study|Death|649|||
126501326|NCT02678676|455134980|FG000|Overall Study|Withdrawal by Subject|13|||
126501327|NCT02678676|455134981|FG001|Overall Study|Withdrawal by Subject|5|||
126501328|NCT02678676|455134980|FG000|Overall Study|Lost to Follow-up|171|||
126501329|NCT02678676|455134981|FG001|Overall Study|Lost to Follow-up|151|||
126501330|NCT02678676|455134980|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
126501331|NCT02678676|455134981|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
126501332|NCT00747435|455134982|FG000|Overall Study|Lost to Follow-up|2|||
126501333|NCT00747435|455134982|FG000|Overall Study|Withdrawal by Subject|3|||
126501334|NCT00747435|455134982|FG000|Overall Study|Still undergoing follow up|1|||
126501335|NCT04059146|455134983|FG000|Overall Study|Withdrawal by Subject|0|||
126501336|NCT04059146|455134984|FG001|Overall Study|Withdrawal by Subject|1|||
126501337|NCT00851799|455134985|FG000|Overall Study|Death|1|||
126501338|NCT00851799|455134986|FG001|Overall Study|Death|0|||
126501339|NCT00851799|455134987|FG002|Overall Study|Death|1|||
126726313|NCT01963208|455946519|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
126501340|NCT00851799|455134985|FG000|Overall Study|Lost to Follow-up|5|||
126726314|NCT01963208|455946520|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
126726315|NCT01963208|455946521|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
126501341|NCT00851799|455134986|FG001|Overall Study|Lost to Follow-up|3|||
126501342|NCT00851799|455134987|FG002|Overall Study|Lost to Follow-up|10|||
126501343|NCT00851799|455134985|FG000|Overall Study|Not able to get to clinic|8|||
126501344|NCT00851799|455134986|FG001|Overall Study|Not able to get to clinic|5|||
126501345|NCT00851799|455134987|FG002|Overall Study|Not able to get to clinic|9|||
126561188|NCT05489224|455348454|FG000|Treatment Period I|Adverse Event|3|||
126775239|NCT03296553|456132449|FG001|Overall Study|Death|0|||
126775240|NCT02713243|456132451|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
126775241|NCT02713243|456132452|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
126775242|NCT02713243|456132451|FG000|Overall Study|Administrative problems|0|||
126775243|NCT02713243|456132452|FG001|Overall Study|Administrative problems|1|||
126775244|NCT02713243|456132451|FG000|Overall Study|Protocol deviation|0|||
126775245|NCT02713243|456132452|FG001|Overall Study|Protocol deviation|1|||
126775246|NCT00435825|456132457|FG000|Overall Study|Abnormality of Laboratory Test|0|||
126775247|NCT00435825|456132458|FG001|Overall Study|Abnormality of Laboratory Test|1|||
126775248|NCT00435825|456132459|FG002|Overall Study|Abnormality of Laboratory Test|0|||
126775249|NCT00435825|456132460|FG003|Overall Study|Abnormality of Laboratory Test|0|||
126775250|NCT00435825|456132457|FG000|Overall Study|Insufficient Therapeutic Response|3|||
126775251|NCT00435825|456132458|FG001|Overall Study|Insufficient Therapeutic Response|1|||
126775252|NCT00435825|456132459|FG002|Overall Study|Insufficient Therapeutic Response|0|||
126775253|NCT00435825|456132460|FG003|Overall Study|Insufficient Therapeutic Response|3|||
126775254|NCT00435825|456132457|FG000|Overall Study|Other Protocol Violation|1|||
126775255|NCT00435825|456132458|FG001|Overall Study|Other Protocol Violation|0|||
126775256|NCT00435825|456132459|FG002|Overall Study|Other Protocol Violation|0|||
126501346|NCT00851799|455134985|FG000|Overall Study|Not willing to adhere to requirements|1|||
126501347|NCT00851799|455134986|FG001|Overall Study|Not willing to adhere to requirements|2|||
126501348|NCT00851799|455134987|FG002|Overall Study|Not willing to adhere to requirements|2|||
126501349|NCT00851799|455134985|FG000|Overall Study|Withdrew consent prior study completion|1|||
126501350|NCT00851799|455134986|FG001|Overall Study|Withdrew consent prior study completion|2|||
126726316|NCT01963208|455946522|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
126726317|NCT01963208|455946517|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
126726318|NCT01963208|455946518|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
126726319|NCT01963208|455946519|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
126726320|NCT01963208|455946520|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
126726321|NCT01963208|455946521|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
126726322|NCT01963208|455946522|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
126726323|NCT01963208|455946517|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
126726324|NCT01963208|455946518|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
126726325|NCT01963208|455946519|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
126726326|NCT01963208|455946520|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
126726327|NCT01963208|455946521|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
126726328|NCT01963208|455946522|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
126726329|NCT01963208|455946517|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
126726330|NCT01963208|455946518|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
126726331|NCT01963208|455946519|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
126726332|NCT01963208|455946520|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
126726333|NCT01963208|455946521|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
126726334|NCT01963208|455946522|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
126726335|NCT01963208|455946517|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
126726336|NCT01963208|455946518|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
126726337|NCT01963208|455946519|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
126726338|NCT01963208|455946520|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
126726339|NCT01963208|455946521|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
126726340|NCT01963208|455946522|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
126726341|NCT01963208|455946517|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
126726342|NCT01963208|455946518|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
126726343|NCT01963208|455946519|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
126726344|NCT01963208|455946520|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
126726345|NCT01963208|455946521|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
126726346|NCT01963208|455946522|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
126726347|NCT01963208|455946517|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
126726348|NCT01963208|455946518|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
126726349|NCT01963208|455946519|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
126726350|NCT01963208|455946520|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
126726351|NCT01963208|455946521|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
126726352|NCT01963208|455946522|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
126726353|NCT01963208|455946517|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
126726354|NCT01963208|455946518|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
126726355|NCT01963208|455946519|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
126726356|NCT01963208|455946520|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
126726357|NCT01963208|455946521|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
126726358|NCT01963208|455946522|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
126775257|NCT00435825|456132460|FG003|Overall Study|Other Protocol Violation|0|||
126775258|NCT00435825|456132457|FG000|Overall Study|Refused treatment|2|||
126501351|NCT00851799|455134987|FG002|Overall Study|Withdrew consent prior study completion|1|||
126561189|NCT05489224|455348455|FG001|Treatment Period I|Adverse Event|11|||
126561190|NCT05489224|455348456|FG002|Treatment Period I|Adverse Event|0|||
126561191|NCT05489224|455348454|FG000|Treatment Period I|Lost to Follow-up|0|||
126561192|NCT05489224|455348455|FG001|Treatment Period I|Lost to Follow-up|1|||
126561193|NCT05489224|455348456|FG002|Treatment Period I|Lost to Follow-up|0|||
126561194|NCT05489224|455348454|FG000|Treatment Period I|Physician Decision|0|||
126561195|NCT05489224|455348455|FG001|Treatment Period I|Physician Decision|1|||
126561196|NCT05489224|455348456|FG002|Treatment Period I|Physician Decision|0|||
126561197|NCT05489224|455348454|FG000|Treatment Period II up to Week 32|Ongoing|222|||
126561198|NCT05489224|455348455|FG001|Treatment Period II up to Week 32|Ongoing|107|||
126561199|NCT05489224|455348456|FG002|Treatment Period II up to Week 32|Ongoing|107|||
126561200|NCT05489224|455348454|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
126561201|NCT05489224|455348455|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
126561202|NCT05489224|455348456|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
126561203|NCT05489224|455348454|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
126561204|NCT05489224|455348455|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
126561205|NCT05489224|455348456|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
126561206|NCT04887285|455348457|FG000|Overall Study|Lost to Follow-up|0|||
126561207|NCT04887285|455348458|FG001|Overall Study|Lost to Follow-up|2|||
126561208|NCT04887285|455348459|FG002|Overall Study|Lost to Follow-up|3|||
126561209|NCT04640571|455348460|FG000|Overall Study|Withdrawal by Subject|0|||
126561210|NCT04640571|455348461|FG001|Overall Study|Withdrawal by Subject|0|||
126561211|NCT04640571|455348462|FG002|Overall Study|Withdrawal by Subject|0|||
126561212|NCT04640571|455348463|FG003|Overall Study|Withdrawal by Subject|0|||
126561213|NCT04640571|455348464|FG004|Overall Study|Withdrawal by Subject|0|||
126561214|NCT04640571|455348465|FG005|Overall Study|Withdrawal by Subject|2|||
126561215|NCT00832780|455348470|FG000|Overall Study|Death|16|||
126501352|NCT00851799|455134985|FG000|Overall Study|Severe Debilitation|0|||
126501353|NCT00851799|455134986|FG001|Overall Study|Severe Debilitation|1|||
126501354|NCT00851799|455134987|FG002|Overall Study|Severe Debilitation|0|||
126501355|NCT00851799|455134985|FG000|Overall Study|Completed protocol due to pregnancy|0|||
126501356|NCT00851799|455134986|FG001|Overall Study|Completed protocol due to pregnancy|0|||
126501357|NCT00851799|455134987|FG002|Overall Study|Completed protocol due to pregnancy|1|||
126501358|NCT04056195|455134990|FG000|Overall Study|Adverse Event|1|||
126501359|NCT04056195|455134991|FG001|Overall Study|Adverse Event|0|||
126501360|NCT04056195|455134992|FG002|Overall Study|Adverse Event|0|||
126501361|NCT04056195|455134990|FG000|Overall Study|Withdrawal by Subject|0|||
126501362|NCT04056195|455134991|FG001|Overall Study|Withdrawal by Subject|1|||
126501363|NCT04056195|455134992|FG002|Overall Study|Withdrawal by Subject|1|||
126501364|NCT04056195|455134990|FG000|Overall Study|Physician Decision|1|||
126501365|NCT04056195|455134991|FG001|Overall Study|Physician Decision|1|||
126501366|NCT04056195|455134992|FG002|Overall Study|Physician Decision|1|||
126501367|NCT04439318|455135006|FG000|Overall Study|Ineligible|1|||
126501368|NCT04439318|455135006|FG000|Overall Study|Never Started Treatment|3|||
126501369|NCT04439318|455135006|FG000|Overall Study|Adverse Event|10|||
126501370|NCT04439318|455135006|FG000|Overall Study|Death|2|||
126501371|NCT04439318|455135006|FG000|Overall Study|Disease Progression|25|||
126501372|NCT04439318|455135006|FG000|Overall Study|Other Complicating Disease|2|||
126501373|NCT04439318|455135006|FG000|Overall Study|Withdrawal by Subject|4|||
126501374|NCT04439318|455135006|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
126501375|NCT04439318|455135006|FG000|Overall Study|Non-Compliance|1|||
126501376|NCT04439318|455135006|FG000|Overall Study|Still on Treatment|1|||
126501377|NCT00699972|455136461|FG000|Overall Study|Adverse Event|7|||
126501378|NCT00699972|455136462|FG001|Overall Study|Adverse Event|9|||
126501379|NCT00699972|455136463|FG002|Overall Study|Adverse Event|24|||
126501380|NCT00699972|455136461|FG000|Overall Study|Lost to Follow-up|0|||
126501381|NCT00699972|455136462|FG001|Overall Study|Lost to Follow-up|2|||
126501382|NCT00699972|455136463|FG002|Overall Study|Lost to Follow-up|0|||
126501383|NCT00699972|455136461|FG000|Overall Study|Withdrawal by Subject|3|||
126501384|NCT00699972|455136462|FG001|Overall Study|Withdrawal by Subject|7|||
126501385|NCT00699972|455136463|FG002|Overall Study|Withdrawal by Subject|4|||
126501386|NCT00699972|455136461|FG000|Overall Study|Lack of Efficacy|2|||
126501387|NCT00699972|455136462|FG001|Overall Study|Lack of Efficacy|0|||
126501388|NCT00699972|455136463|FG002|Overall Study|Lack of Efficacy|2|||
126501389|NCT00699972|455136461|FG000|Overall Study|Administrative/Other|3|||
126501390|NCT00699972|455136462|FG001|Overall Study|Administrative/Other|1|||
126561216|NCT00832780|455348470|FG000|Overall Study|Lost to Follow-up|4|||
126561217|NCT00832780|455348470|FG000|Overall Study|no reason given|2|||
126561218|NCT00832780|455348470|FG000|Overall Study|other complicating condition|2|||
126561219|NCT00832780|455348470|FG000|Overall Study|Physician Decision|1|||
126775259|NCT00435825|456132458|FG001|Overall Study|Refused treatment|0|||
126501391|NCT00699972|455136463|FG002|Overall Study|Administrative/Other|4|||
126501392|NCT00699972|455136461|FG000|Overall Study|Randomized, Not Treated|1|||
126501393|NCT00699972|455136462|FG001|Overall Study|Randomized, Not Treated|0|||
126501394|NCT00699972|455136463|FG002|Overall Study|Randomized, Not Treated|1|||
126501395|NCT03509675|455136467|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
126501396|NCT03509675|455136468|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
126775260|NCT00435825|456132459|FG002|Overall Study|Refused treatment|0|||
126775261|NCT00435825|456132460|FG003|Overall Study|Refused treatment|5|||
126775262|NCT00435825|456132457|FG000|Overall Study|Failure to return|5|||
126775263|NCT00435825|456132458|FG001|Overall Study|Failure to return|0|||
126775264|NCT00435825|456132459|FG002|Overall Study|Failure to return|4|||
126775265|NCT00435825|456132460|FG003|Overall Study|Failure to return|0|||
126775266|NCT00435825|456132457|FG000|Overall Study|Did not receive study drug|1|||
126775267|NCT00435825|456132458|FG001|Overall Study|Did not receive study drug|0|||
126775268|NCT00435825|456132459|FG002|Overall Study|Did not receive study drug|2|||
126775269|NCT00435825|456132460|FG003|Overall Study|Did not receive study drug|0|||
126775270|NCT00435825|456132457|FG000|Overall Study|Did not enter follow-up|0|||
126775271|NCT00435825|456132458|FG001|Overall Study|Did not enter follow-up|4|||
126775272|NCT00435825|456132459|FG002|Overall Study|Did not enter follow-up|1|||
126775273|NCT00435825|456132460|FG003|Overall Study|Did not enter follow-up|3|||
126775274|NCT00435825|456132457|FG000|Overall Study|Did not complete full follow-up period|6|||
126775275|NCT00435825|456132458|FG001|Overall Study|Did not complete full follow-up period|6|||
126775276|NCT00435825|456132459|FG002|Overall Study|Did not complete full follow-up period|4|||
126775277|NCT00435825|456132460|FG003|Overall Study|Did not complete full follow-up period|5|||
126775278|NCT00378482|456132461|FG000|Overall Study|Lost to Follow-up|1|||
126775279|NCT00378482|456132461|FG000|Overall Study|Lack of Efficacy|8|||
126775280|NCT00378482|456132461|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
126775281|NCT00378482|456132461|FG000|Overall Study|Withdrawal by Subject|4|||
126775282|NCT00378482|456132461|FG000|Overall Study|Adverse Event|9|||
126775283|NCT05788237|456132462|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
126775284|NCT05788237|456132463|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
126775285|NCT05788237|456132464|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
126775286|NCT05788237|456132465|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
126775287|NCT05788237|456132462|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
126775288|NCT05788237|456132463|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
126775289|NCT05788237|456132464|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
126775290|NCT05788237|456132465|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
126775291|NCT05788237|456132462|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
126775292|NCT05788237|456132463|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
126775293|NCT05788237|456132464|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
126775294|NCT05788237|456132465|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
126775295|NCT05788237|456132462|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
126775296|NCT05788237|456132463|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
126775297|NCT05788237|456132464|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
126775298|NCT05788237|456132465|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
126775299|NCT05788237|456132462|FG000|SSA (Approximately 2 Months)|Death|0|||
126775300|NCT05788237|456132463|FG001|SSA (Approximately 2 Months)|Death|1|||
126775301|NCT05788237|456132464|FG002|SSA (Approximately 2 Months)|Death|0|||
126775302|NCT05788237|456132465|FG003|SSA (Approximately 2 Months)|Death|0|||
126775303|NCT05788237|456132462|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
126775304|NCT05788237|456132463|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
126775305|NCT05788237|456132464|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
126775306|NCT05788237|456132465|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
126775307|NCT05788237|456132462|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
126775308|NCT05788237|456132463|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
126775309|NCT05788237|456132464|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
126775310|NCT05788237|456132465|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
126775311|NCT05788237|456132462|FG000|SSB (Approximately 1 Month)|Other|0|||
126775312|NCT05788237|456132463|FG001|SSB (Approximately 1 Month)|Other|0|||
126775313|NCT05788237|456132464|FG002|SSB (Approximately 1 Month)|Other|0|||
126775314|NCT05788237|456132465|FG003|SSB (Approximately 1 Month)|Other|1|||
126775315|NCT00860574|456134024|FG000|Overall Study|Death|2|||
126775316|NCT00860574|456134024|FG000|Overall Study|Relapse|1|||
126775317|NCT01246986|456134025|FG000|Overall Study|Lost to Follow-up|0|||
126775318|NCT01246986|456134026|FG001|Overall Study|Lost to Follow-up|1|||
126775319|NCT01246986|456134027|FG002|Overall Study|Lost to Follow-up|3|||
126775320|NCT01246986|456134028|FG003|Overall Study|Lost to Follow-up|0|||
126775321|NCT01246986|456134029|FG004|Overall Study|Lost to Follow-up|0|||
126775322|NCT01246986|456134030|FG005|Overall Study|Lost to Follow-up|1|||
126775323|NCT01246986|456134031|FG006|Overall Study|Lost to Follow-up|0|||
126775324|NCT01246986|456134025|FG000|Overall Study|Withdrawal by Subject|3|||
126775325|NCT01246986|456134026|FG001|Overall Study|Withdrawal by Subject|4|||
126775326|NCT01246986|456134027|FG002|Overall Study|Withdrawal by Subject|3|||
126775327|NCT01246986|456134028|FG003|Overall Study|Withdrawal by Subject|0|||
126775328|NCT01246986|456134029|FG004|Overall Study|Withdrawal by Subject|4|||
126775329|NCT01246986|456134030|FG005|Overall Study|Withdrawal by Subject|0|||
126775330|NCT01246986|456134031|FG006|Overall Study|Withdrawal by Subject|0|||
126775331|NCT01416142|456134035|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
126501397|NCT03509675|455136467|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
126501398|NCT03509675|455136468|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
126501399|NCT03509675|455136467|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
126501400|NCT03509675|455136468|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
126501401|NCT03509675|455136467|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
126501402|NCT03509675|455136468|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
126501403|NCT04920123|455136476|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
126501404|NCT04920123|455136477|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
126501405|NCT04920123|455136478|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
126501406|NCT03412084|455136479|FG000|Overall Study|Withdrawal by Subject|2|||
126501407|NCT03412084|455136480|FG001|Overall Study|Withdrawal by Subject|0|||
126501408|NCT03412084|455136479|FG000|Overall Study|Participant moved|1|||
126501409|NCT03412084|455136480|FG001|Overall Study|Participant moved|0|||
126501410|NCT03412084|455136479|FG000|Overall Study|Lost to Follow-up|1|||
126501411|NCT03412084|455136480|FG001|Overall Study|Lost to Follow-up|1|||
126501412|NCT02023151|455136487|FG000|Overall Study|Lost to Follow-up|4|||
126501413|NCT04064294|455136488|FG000|Overall Study|Adverse Event|1|||
126501414|NCT04064294|455136489|FG001|Overall Study|Adverse Event|0|||
126501415|NCT04064294|455136490|FG002|Overall Study|Adverse Event|0|||
126501416|NCT03450707|455136491|FG000|Overall Study|Outside enrollment window|4|||
126501417|NCT03450707|455136492|FG001|Overall Study|Outside enrollment window|1|||
126501418|NCT03450707|455136491|FG000|Overall Study|Death|1|||
126501419|NCT03450707|455136492|FG001|Overall Study|Death|0|||
126501420|NCT03450707|455136491|FG000|Overall Study|Indication for thiamine|1|||
126501421|NCT03450707|455136492|FG001|Overall Study|Indication for thiamine|1|||
126501422|NCT03450707|455136491|FG000|Overall Study|Evidence of traumatic brain injury|1|||
126501423|NCT03450707|455136492|FG001|Overall Study|Evidence of traumatic brain injury|0|||
126501424|NCT03450707|455136491|FG000|Overall Study|Following commands|0|||
126501425|NCT03450707|455136492|FG001|Overall Study|Following commands|3|||
126501426|NCT03450707|455136491|FG000|Overall Study|Lactate < 3.5|0|||
126501427|NCT03450707|455136492|FG001|Overall Study|Lactate < 3.5|2|||
126501428|NCT03450707|455136491|FG000|Overall Study|Rearrest with ECMO|0|||
126501429|NCT03450707|455136492|FG001|Overall Study|Rearrest with ECMO|1|||
126501430|NCT03450707|455136491|FG000|Overall Study|Indication for thiamine + head CT results|0|||
126501431|NCT03450707|455136492|FG001|Overall Study|Indication for thiamine + head CT results|1|||
126501432|NCT03450707|455136491|FG000|Overall Study|Family/patient goals of care|0|||
126501433|NCT03450707|455136492|FG001|Overall Study|Family/patient goals of care|1|||
126501434|NCT00481195|455136493|FG000|Overall Study|Adverse Event|16|||
126501435|NCT00481195|455136494|FG001|Overall Study|Adverse Event|11|||
126501436|NCT00481195|455136493|FG000|Overall Study|Lack of Efficacy|1|||
126501437|NCT00481195|455136494|FG001|Overall Study|Lack of Efficacy|3|||
126501438|NCT00481195|455136493|FG000|Overall Study|Lost to Follow-up|4|||
126501439|NCT00481195|455136494|FG001|Overall Study|Lost to Follow-up|6|||
126501440|NCT00481195|455136493|FG000|Overall Study|Physician Decision|3|||
126501441|NCT00481195|455136494|FG001|Overall Study|Physician Decision|1|||
126501442|NCT00481195|455136493|FG000|Overall Study|Protocol Violation|10|||
126501443|NCT00481195|455136494|FG001|Overall Study|Protocol Violation|7|||
126501444|NCT00481195|455136493|FG000|Overall Study|Withdrawal by Subject|3|||
126501445|NCT00481195|455136494|FG001|Overall Study|Withdrawal by Subject|9|||
126501446|NCT00481195|455136493|FG000|Overall Study|Miscellaneous|2|||
126501447|NCT00481195|455136494|FG001|Overall Study|Miscellaneous|2|||
126501448|NCT03343483|455136495|FG000|Overall Study|Death|0|||
126501449|NCT03343483|455136496|FG001|Overall Study|Death|3|||
126501450|NCT03343483|455136495|FG000|Overall Study|Lost to Follow-up|9|||
126501451|NCT03343483|455136496|FG001|Overall Study|Lost to Follow-up|13|||
126501452|NCT03343483|455136495|FG000|Overall Study|Withdrawal by Subject|8|||
126501453|NCT03343483|455136496|FG001|Overall Study|Withdrawal by Subject|17|||
126501454|NCT01505608|455136497|FG000|Phase I|Lack of Efficacy|0|||
126501455|NCT01505608|455136498|FG001|Phase I|Lack of Efficacy|4|||
126726359|NCT01963208|455946517|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
126726360|NCT01963208|455946518|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
126726361|NCT01963208|455946519|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
126726362|NCT01963208|455946520|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
126726363|NCT01963208|455946521|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
126726364|NCT01963208|455946522|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
126726365|NCT01963208|455946517|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
126726366|NCT01963208|455946518|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
126726367|NCT01963208|455946519|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
126726368|NCT01963208|455946520|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
126726369|NCT01963208|455946521|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
126726370|NCT01963208|455946522|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
126726371|NCT01963208|455946517|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
126726372|NCT01963208|455946518|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
126726373|NCT01963208|455946519|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
126501456|NCT01505608|455136497|FG000|Phase I|Adverse Event|0|||
126501457|NCT01505608|455136498|FG001|Phase I|Adverse Event|1|||
126501458|NCT01505608|455136497|FG000|Phase I|Withdrawal by Subject|0|||
126501459|NCT01505608|455136498|FG001|Phase I|Withdrawal by Subject|1|||
126501460|NCT01505608|455136497|FG000|Phase II|Lack of Efficacy|2|||
126501461|NCT01505608|455136498|FG001|Phase II|Lack of Efficacy|1|||
126501462|NCT01505608|455136497|FG000|Phase II|Protocol Violation|0|||
126501463|NCT01505608|455136498|FG001|Phase II|Protocol Violation|1|||
126501464|NCT02932904|455136499|FG000|Overall Study|Reason not Specified|1|||
126501465|NCT02932904|455136500|FG001|Overall Study|Reason not Specified|0|||
126501466|NCT02932904|455136501|FG002|Overall Study|Reason not Specified|2|||
126501467|NCT02932904|455136502|FG003|Overall Study|Reason not Specified|2|||
126501468|NCT02932904|455136499|FG000|Overall Study|Noncompliance with Study Drug|2|||
126501469|NCT02932904|455136500|FG001|Overall Study|Noncompliance with Study Drug|3|||
126501470|NCT02932904|455136501|FG002|Overall Study|Noncompliance with Study Drug|3|||
126501471|NCT02932904|455136502|FG003|Overall Study|Noncompliance with Study Drug|4|||
126501472|NCT02932904|455136499|FG000|Overall Study|Pregnancy|0|||
126501473|NCT02932904|455136500|FG001|Overall Study|Pregnancy|1|||
126501474|NCT02932904|455136501|FG002|Overall Study|Pregnancy|1|||
126501475|NCT02932904|455136502|FG003|Overall Study|Pregnancy|0|||
126501476|NCT02932904|455136499|FG000|Overall Study|Study Termination|0|||
126501477|NCT02932904|455136500|FG001|Overall Study|Study Termination|1|||
126726374|NCT01963208|455946520|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
126726375|NCT01963208|455946521|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
126726376|NCT01963208|455946522|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
126726377|NCT00448916|455946523|FG000|Overall Study|Adverse Event|2|||
126726378|NCT00448916|455946524|FG001|Overall Study|Adverse Event|2|||
126726379|NCT00448916|455946525|FG002|Overall Study|Adverse Event|3|||
126501478|NCT02932904|455136501|FG002|Overall Study|Study Termination|0|||
126501479|NCT02932904|455136502|FG003|Overall Study|Study Termination|0|||
126501480|NCT02932904|455136499|FG000|Overall Study|Voluntary Withdrawal|2|||
126501481|NCT02932904|455136500|FG001|Overall Study|Voluntary Withdrawal|1|||
126501482|NCT02932904|455136501|FG002|Overall Study|Voluntary Withdrawal|4|||
126501483|NCT02932904|455136502|FG003|Overall Study|Voluntary Withdrawal|2|||
126501484|NCT02932904|455136499|FG000|Overall Study|Lost to Follow-up|5|||
126501485|NCT02932904|455136500|FG001|Overall Study|Lost to Follow-up|3|||
126501486|NCT02932904|455136501|FG002|Overall Study|Lost to Follow-up|6|||
126501487|NCT02932904|455136502|FG003|Overall Study|Lost to Follow-up|0|||
126501488|NCT02932904|455136499|FG000|Overall Study|Significant Protocol Deviation|2|||
126501489|NCT02932904|455136500|FG001|Overall Study|Significant Protocol Deviation|3|||
126501490|NCT02932904|455136501|FG002|Overall Study|Significant Protocol Deviation|6|||
126501491|NCT02932904|455136502|FG003|Overall Study|Significant Protocol Deviation|1|||
126501492|NCT02932904|455136499|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
126501493|NCT02932904|455136500|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
126501494|NCT02932904|455136501|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
126501495|NCT02932904|455136502|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
126501496|NCT02932904|455136499|FG000|Overall Study|Randomized But Not Treated|1|||
126501497|NCT02932904|455136500|FG001|Overall Study|Randomized But Not Treated|1|||
126501498|NCT02932904|455136501|FG002|Overall Study|Randomized But Not Treated|0|||
126501499|NCT02932904|455136502|FG003|Overall Study|Randomized But Not Treated|2|||
126501500|NCT00337103|455136503|FG000|Overall Study|Progressive Disease|414|||
126501501|NCT00337103|455136504|FG001|Overall Study|Progressive Disease|410|||
126501502|NCT00337103|455136503|FG000|Overall Study|Adverse Event|45|||
126501503|NCT00337103|455136504|FG001|Overall Study|Adverse Event|59|||
126501504|NCT00337103|455136503|FG000|Overall Study|Subject Choice|34|||
126501505|NCT00337103|455136504|FG001|Overall Study|Subject Choice|27|||
126501506|NCT00337103|455136503|FG000|Overall Study|Clinical Progression|27|||
126501507|NCT00337103|455136504|FG001|Overall Study|Clinical Progression|24|||
126501508|NCT00337103|455136503|FG000|Overall Study|Physician Decision|15|||
126501509|NCT00337103|455136504|FG001|Overall Study|Physician Decision|14|||
126501510|NCT00337103|455136503|FG000|Overall Study|Withdrawal by Subject|8|||
126501511|NCT00337103|455136504|FG001|Overall Study|Withdrawal by Subject|5|||
126501512|NCT00337103|455136503|FG000|Overall Study|Other|5|||
126501513|NCT00337103|455136504|FG001|Overall Study|Other|6|||
126501514|NCT00337103|455136503|FG000|Overall Study|Entry Criteria Not Met|4|||
126501515|NCT00337103|455136504|FG001|Overall Study|Entry Criteria Not Met|1|||
126501516|NCT00337103|455136503|FG000|Overall Study|Lost to Follow-up|1|||
126501517|NCT00337103|455136504|FG001|Overall Study|Lost to Follow-up|2|||
126726380|NCT00448916|455946526|FG003|Overall Study|Adverse Event|2|||
126726381|NCT00448916|455946523|FG000|Overall Study|Lack of Efficacy|1|||
126726382|NCT00448916|455946524|FG001|Overall Study|Lack of Efficacy|0|||
126726383|NCT00448916|455946525|FG002|Overall Study|Lack of Efficacy|2|||
126726384|NCT00448916|455946526|FG003|Overall Study|Lack of Efficacy|1|||
126726385|NCT00448916|455946523|FG000|Overall Study|Withdrawal by Subject|3|||
126501518|NCT00337103|455136503|FG000|Overall Study|Death|1|||
126501519|NCT00337103|455136504|FG001|Overall Study|Death|0|||
126501520|NCT01577758|455136505|FG000|Dose Escalation Phase|Adverse Event|0|||
126501521|NCT01577758|455136506|FG001|Dose Escalation Phase|Adverse Event|0|||
126501522|NCT01577758|455136507|FG002|Dose Escalation Phase|Adverse Event|0|||
126726386|NCT00448916|455946524|FG001|Overall Study|Withdrawal by Subject|3|||
126726387|NCT00448916|455946525|FG002|Overall Study|Withdrawal by Subject|1|||
126726388|NCT00448916|455946526|FG003|Overall Study|Withdrawal by Subject|1|||
126726389|NCT00448916|455946523|FG000|Overall Study|Other|1|||
126726390|NCT00448916|455946524|FG001|Overall Study|Other|0|||
126726391|NCT00448916|455946525|FG002|Overall Study|Other|0|||
126726392|NCT00448916|455946526|FG003|Overall Study|Other|0|||
126726393|NCT00448916|455946523|FG000|Overall Study|Lost to Follow-up|0|||
126726394|NCT00448916|455946524|FG001|Overall Study|Lost to Follow-up|1|||
126726395|NCT00448916|455946525|FG002|Overall Study|Lost to Follow-up|0|||
126726396|NCT00448916|455946526|FG003|Overall Study|Lost to Follow-up|1|||
126726397|NCT00448916|455946523|FG000|Overall Study|Protocol Violation|0|||
126726398|NCT00448916|455946524|FG001|Overall Study|Protocol Violation|0|||
126726399|NCT00448916|455946525|FG002|Overall Study|Protocol Violation|0|||
126726400|NCT00448916|455946526|FG003|Overall Study|Protocol Violation|1|||
126726401|NCT03521193|455946527|FG000|Overall Study|Withdrawal by Subject|8|||
126726402|NCT03521193|455946528|FG001|Overall Study|Withdrawal by Subject|0|||
126775332|NCT01416142|456134036|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
126775333|NCT01416142|456134037|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
126775334|NCT01335399|456134038|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
126775335|NCT01335399|456134039|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
126775336|NCT01335399|456134038|FG000|Pre-treatment Period|Participant request to discontinue|0|||
126775337|NCT01335399|456134039|FG001|Pre-treatment Period|Participant request to discontinue|1|||
126775338|NCT01335399|456134038|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
126775339|NCT01335399|456134039|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
126775340|NCT01335399|456134038|FG000|Pre-treatment Period|Consent withdrawal|3|||
126501523|NCT01577758|455136508|FG003|Dose Escalation Phase|Adverse Event|0|||
126501524|NCT01577758|455136509|FG004|Dose Escalation Phase|Adverse Event|0|||
126501525|NCT01577758|455136510|FG005|Dose Escalation Phase|Adverse Event|2|||
126501526|NCT01577758|455136511|FG006|Dose Escalation Phase|Adverse Event|1|||
126501527|NCT01577758|455136512|FG007|Dose Escalation Phase|Adverse Event|0|||
126501528|NCT01577758|455136505|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
126501529|NCT01577758|455136506|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
126501530|NCT01577758|455136507|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
126501531|NCT01577758|455136508|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
126501532|NCT01577758|455136509|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
126501533|NCT01577758|455136510|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
126501534|NCT01577758|455136511|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
126501535|NCT01577758|455136512|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
126501536|NCT01577758|455136505|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
126501537|NCT01577758|455136506|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
126501538|NCT01577758|455136507|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
126501539|NCT01577758|455136508|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126501540|NCT01577758|455136509|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
126501541|NCT01577758|455136510|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
126501542|NCT01577758|455136511|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
126501543|NCT01577758|455136512|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
126501544|NCT01577758|455136505|FG000|Dose Escalation Phase|Progression Disease|2|||
126501545|NCT01577758|455136506|FG001|Dose Escalation Phase|Progression Disease|2|||
126501546|NCT01577758|455136507|FG002|Dose Escalation Phase|Progression Disease|1|||
126501547|NCT01577758|455136508|FG003|Dose Escalation Phase|Progression Disease|2|||
126501548|NCT01577758|455136509|FG004|Dose Escalation Phase|Progression Disease|5|||
126501549|NCT01577758|455136510|FG005|Dose Escalation Phase|Progression Disease|0|||
126501550|NCT01577758|455136511|FG006|Dose Escalation Phase|Progression Disease|0|||
126501551|NCT01577758|455136512|FG007|Dose Escalation Phase|Progression Disease|0|||
126501552|NCT01577758|455136505|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
126501553|NCT01577758|455136506|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
126501554|NCT01577758|455136507|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
126501555|NCT01577758|455136508|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
126501556|NCT01577758|455136509|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
126501557|NCT01577758|455136510|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
126501558|NCT01577758|455136511|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
126501559|NCT01577758|455136512|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
126501560|NCT01577758|455136505|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
126501561|NCT01577758|455136506|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
126501562|NCT01577758|455136507|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
126501563|NCT01577758|455136508|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
126501564|NCT01577758|455136509|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
126501565|NCT01577758|455136510|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
126501566|NCT01577758|455136511|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
126501567|NCT01577758|455136512|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
126726403|NCT03521193|455946527|FG000|Overall Study|non compliant to ASA treatment|8|||
126726404|NCT03521193|455946528|FG001|Overall Study|non compliant to ASA treatment|0|||
126501568|NCT01577758|455136505|FG000|mCRC Expansion Phase|Progression Disease|0|||
126501569|NCT01577758|455136506|FG001|mCRC Expansion Phase|Progression Disease|0|||
126501570|NCT01577758|455136507|FG002|mCRC Expansion Phase|Progression Disease|0|||
126501571|NCT01577758|455136508|FG003|mCRC Expansion Phase|Progression Disease|0|||
126501572|NCT01577758|455136509|FG004|mCRC Expansion Phase|Progression Disease|0|||
126501573|NCT01577758|455136510|FG005|mCRC Expansion Phase|Progression Disease|0|||
126501574|NCT01577758|455136511|FG006|mCRC Expansion Phase|Progression Disease|0|||
126501575|NCT01577758|455136512|FG007|mCRC Expansion Phase|Progression Disease|19|||
126501576|NCT01289847|455136515|FG000|Overall Study|Patient could not comply with visits|1|||
126501577|NCT03975647|455136518|FG000|Overall Study|Death|71|||
126501578|NCT03975647|455136519|FG001|Overall Study|Death|63|||
126501579|NCT03975647|455136518|FG000|Overall Study|Lost to Follow-up|2|||
126501580|NCT03975647|455136519|FG001|Overall Study|Lost to Follow-up|2|||
126501581|NCT03975647|455136518|FG000|Overall Study|Subject withdrawal of consent|7|||
126501582|NCT03975647|455136519|FG001|Overall Study|Subject withdrawal of consent|11|||
126501583|NCT02872116|455136520|FG000|Pre-Treatment|Disease Progression|0|||
126501584|NCT02872116|455136521|FG001|Pre-Treatment|Disease Progression|1|||
126501585|NCT02872116|455136522|FG002|Pre-Treatment|Disease Progression|0|||
126501586|NCT02872116|455136520|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
126501587|NCT02872116|455136521|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
126501588|NCT02872116|455136522|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
126501589|NCT02872116|455136520|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
126501590|NCT02872116|455136521|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
126501591|NCT02872116|455136522|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
126501592|NCT02872116|455136520|FG000|Pre-Treatment|Participant withdrew consent|2|||
126501593|NCT02872116|455136521|FG001|Pre-Treatment|Participant withdrew consent|20|||
126501594|NCT02872116|455136522|FG002|Pre-Treatment|Participant withdrew consent|3|||
126501595|NCT02872116|455136520|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
126501596|NCT02872116|455136521|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
126501597|NCT02872116|455136522|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
126501598|NCT02872116|455136520|FG000|Pre-Treatment|Other reasons|1|||
126501599|NCT02872116|455136521|FG001|Pre-Treatment|Other reasons|2|||
126501600|NCT02872116|455136522|FG002|Pre-Treatment|Other reasons|2|||
126501601|NCT02872116|455136520|FG000|Treatment|Death|121|||
126501602|NCT02872116|455136521|FG001|Treatment|Death|94|||
126501603|NCT02872116|455136522|FG002|Treatment|Death|68|||
126501604|NCT02872116|455136520|FG000|Treatment|Lost to Follow-up|5|||
126501605|NCT02872116|455136521|FG001|Treatment|Lost to Follow-up|7|||
126501606|NCT02872116|455136522|FG002|Treatment|Lost to Follow-up|3|||
126501607|NCT02872116|455136520|FG000|Treatment|Participant withdrew consent|20|||
126501608|NCT02872116|455136521|FG001|Treatment|Participant withdrew consent|40|||
126501609|NCT02872116|455136522|FG002|Treatment|Participant withdrew consent|8|||
126501610|NCT02872116|455136520|FG000|Treatment|Other reasons|13|||
126501611|NCT02872116|455136521|FG001|Treatment|Other reasons|12|||
126501612|NCT02872116|455136522|FG002|Treatment|Other reasons|5|||
126501613|NCT03792672|455136527|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
126501614|NCT03792672|455136528|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
126501615|NCT03792672|455136529|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
126501616|NCT03792672|455136530|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
126501617|NCT03792672|455136531|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
126501618|NCT03792672|455136532|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
126501619|NCT03792672|455136527|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
126501620|NCT03792672|455136528|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
126501621|NCT03792672|455136529|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
126501622|NCT03792672|455136530|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
126501623|NCT03792672|455136531|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
126501624|NCT03792672|455136532|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
126501625|NCT03792672|455136527|FG000|Treatment Period 4 (2 Days)|Other|1|||
126501626|NCT03792672|455136528|FG001|Treatment Period 4 (2 Days)|Other|0|||
126501627|NCT03792672|455136529|FG002|Treatment Period 4 (2 Days)|Other|0|||
126501628|NCT03792672|455136530|FG003|Treatment Period 4 (2 Days)|Other|0|||
126501629|NCT03792672|455136531|FG004|Treatment Period 4 (2 Days)|Other|0|||
126501630|NCT03792672|455136532|FG005|Treatment Period 4 (2 Days)|Other|0|||
126501631|NCT02319031|455136539|FG000|Treatment Period|Death|1|||
126501632|NCT02319031|455136540|FG001|Treatment Period|Death|0|||
126501633|NCT01085097|455136543|FG000|Overall Study|Adverse Event|0|||
126501634|NCT01085097|455136544|FG001|Overall Study|Adverse Event|0|||
126501635|NCT01085097|455136545|FG002|Overall Study|Adverse Event|2|||
126501636|NCT01085097|455136543|FG000|Overall Study|Treatment failure|2|||
126501637|NCT01085097|455136544|FG001|Overall Study|Treatment failure|0|||
126501638|NCT01085097|455136545|FG002|Overall Study|Treatment failure|0|||
126501639|NCT01498640|455136546|FG000|Overall Study|Lost to Follow-up|1|||
126501640|NCT01498640|455136546|FG000|Overall Study|Death|1|||
126501641|NCT01498640|455136546|FG000|Overall Study|Other|3|||
126501642|NCT03519971|455136547|FG000|Overall Study|Death|142|||
126501643|NCT03519971|455136548|FG001|Overall Study|Death|69|||
126561220|NCT04863898|455348471|FG000|Overall Study|Away from study clinic during intervention training period|2|||
126561221|NCT04863898|455348471|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
126561222|NCT04863898|455348471|FG000|Overall Study|Lost to Follow-up|3|||
126561223|NCT04863898|455348471|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
126561224|NCT04863898|455348471|FG000|Overall Study|No longer employed at clinic|3|||
126561225|NCT00770211|455348472|FG000|Overall Study|Lost to Follow-up|1|||
126561226|NCT00770211|455348473|FG001|Overall Study|Lost to Follow-up|0|||
126561227|NCT00770211|455348472|FG000|Overall Study|Withdrawal by Subject|0|||
126561228|NCT00770211|455348473|FG001|Overall Study|Withdrawal by Subject|2|||
126561229|NCT00764868|455348476|FG000|Overall Study|Adverse Event|18|||
126561230|NCT00764868|455348476|FG000|Overall Study|Withdrawal by Subject|31|||
126561231|NCT00764868|455348476|FG000|Overall Study|Non-compliance|16|||
126561232|NCT00764868|455348476|FG000|Overall Study|Lost to Follow-up|25|||
126561233|NCT00764868|455348476|FG000|Overall Study|Lack of Efficacy|5|||
126561234|NCT00764868|455348476|FG000|Overall Study|Subject moved|7|||
126561235|NCT00764868|455348476|FG000|Overall Study|Pregnancy|3|||
126561236|NCT00764868|455348476|FG000|Overall Study|Prohibited medication|1|||
126561237|NCT00764868|455348476|FG000|Overall Study|Out of town|1|||
126561238|NCT00764868|455348476|FG000|Overall Study|Misuse and compliance of study drug|1|||
126561239|NCT00764868|455348476|FG000|Overall Study|Subject sent to boarding school|1|||
126561240|NCT00764868|455348476|FG000|Overall Study|Met an exclusion criteria|1|||
126561241|NCT00764868|455348476|FG000|Overall Study|Positive drug screen|2|||
126561242|NCT00764868|455348476|FG000|Overall Study|Sponsor requested withdrawal|1|||
126561243|NCT03005288|455348479|FG000|Overall Study|Withdrawal by Subject|7|||
126561244|NCT03005288|455348480|FG001|Overall Study|Withdrawal by Subject|5|||
126561245|NCT03005288|455348479|FG000|Overall Study|Lost to Follow-up|0|||
126561246|NCT03005288|455348480|FG001|Overall Study|Lost to Follow-up|1|||
126561247|NCT03005288|455348479|FG000|Overall Study|Adverse Event|5|||
126561248|NCT03005288|455348480|FG001|Overall Study|Adverse Event|0|||
126561249|NCT03005288|455348479|FG000|Overall Study|Protocol deviation|0|||
126561250|NCT03005288|455348480|FG001|Overall Study|Protocol deviation|1|||
126561251|NCT03005288|455348479|FG000|Overall Study|Physician Decision|0|||
126561252|NCT03005288|455348480|FG001|Overall Study|Physician Decision|1|||
126561253|NCT01515319|455348481|FG000|Overall Study|Withdrawal by Subject|0|||
126561254|NCT01515319|455348482|FG001|Overall Study|Withdrawal by Subject|0|||
126561255|NCT01515319|455348483|FG002|Overall Study|Withdrawal by Subject|0|||
126561256|NCT01515319|455348484|FG003|Overall Study|Withdrawal by Subject|0|||
126561257|NCT01515319|455348485|FG004|Overall Study|Withdrawal by Subject|0|||
126561258|NCT01515319|455348486|FG005|Overall Study|Withdrawal by Subject|0|||
126561259|NCT01515319|455348487|FG006|Overall Study|Withdrawal by Subject|1|||
126561260|NCT01515319|455348488|FG007|Overall Study|Withdrawal by Subject|0|||
126561261|NCT01515319|455348489|FG008|Overall Study|Withdrawal by Subject|0|||
126561262|NCT01515319|455348490|FG009|Overall Study|Withdrawal by Subject|0|||
126561263|NCT01515319|455348481|FG000|Overall Study|Adverse Event|0|||
126561264|NCT01515319|455348482|FG001|Overall Study|Adverse Event|0|||
126561265|NCT01515319|455348483|FG002|Overall Study|Adverse Event|0|||
126561266|NCT01515319|455348484|FG003|Overall Study|Adverse Event|0|||
126561267|NCT01515319|455348485|FG004|Overall Study|Adverse Event|0|||
126561268|NCT01515319|455348486|FG005|Overall Study|Adverse Event|0|||
126561269|NCT01515319|455348487|FG006|Overall Study|Adverse Event|0|||
126561270|NCT01515319|455348488|FG007|Overall Study|Adverse Event|0|||
126561271|NCT01515319|455348489|FG008|Overall Study|Adverse Event|3|||
126561272|NCT01515319|455348490|FG009|Overall Study|Adverse Event|0|||
126561273|NCT01515319|455348481|FG000|Overall Study|Protocol Violation|0|||
126561274|NCT01515319|455348482|FG001|Overall Study|Protocol Violation|0|||
126561275|NCT01515319|455348483|FG002|Overall Study|Protocol Violation|0|||
126561276|NCT01515319|455348484|FG003|Overall Study|Protocol Violation|0|||
126561277|NCT01515319|455348485|FG004|Overall Study|Protocol Violation|0|||
126775341|NCT01335399|456134039|FG001|Pre-treatment Period|Consent withdrawal|0|||
126775342|NCT01335399|456134038|FG000|Treatment Period|Disease progression|117|||
126775343|NCT01335399|456134039|FG001|Treatment Period|Disease progression|145|||
126561278|NCT01515319|455348486|FG005|Overall Study|Protocol Violation|0|||
126561279|NCT01515319|455348487|FG006|Overall Study|Protocol Violation|0|||
126561280|NCT01515319|455348488|FG007|Overall Study|Protocol Violation|0|||
126561281|NCT01515319|455348489|FG008|Overall Study|Protocol Violation|2|||
126561282|NCT01515319|455348490|FG009|Overall Study|Protocol Violation|0|||
126561283|NCT01959880|455348491|FG000|Overall Study|Withdrawal by Subject|11|||
126561284|NCT01959880|455348492|FG001|Overall Study|Withdrawal by Subject|13|||
126561285|NCT01959880|455348493|FG002|Overall Study|Withdrawal by Subject|8|||
126561286|NCT01959880|455348494|FG003|Overall Study|Withdrawal by Subject|7|||
126561287|NCT01959880|455348491|FG000|Overall Study|Death|1|||
126561288|NCT01959880|455348492|FG001|Overall Study|Death|10|||
126561289|NCT01959880|455348493|FG002|Overall Study|Death|1|||
126775344|NCT01335399|456134038|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
126561290|NCT01959880|455348494|FG003|Overall Study|Death|2|||
126561291|NCT01959880|455348491|FG000|Overall Study|Lost to Follow-up|95|||
126561292|NCT01959880|455348492|FG001|Overall Study|Lost to Follow-up|18|||
126775345|NCT01335399|456134039|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
126775346|NCT01335399|456134038|FG000|Treatment Period|Study drug toxicity|52|||
126775347|NCT01335399|456134039|FG001|Treatment Period|Study drug toxicity|64|||
126775348|NCT01335399|456134038|FG000|Treatment Period|Participant request to discontinue|30|||
126775349|NCT01335399|456134039|FG001|Treatment Period|Participant request to discontinue|22|||
126775350|NCT01335399|456134038|FG000|Treatment Period|Other reasons|30|||
126775351|NCT01335399|456134039|FG001|Treatment Period|Other reasons|30|||
126775352|NCT01335399|456134038|FG000|Treatment Period|Consent withdrawal|10|||
126775353|NCT01335399|456134039|FG001|Treatment Period|Consent withdrawal|7|||
126775354|NCT01335399|456134038|FG000|Treatment Period|Death|7|||
126775355|NCT01335399|456134039|FG001|Treatment Period|Death|6|||
126775356|NCT01335399|456134038|FG000|Treatment Period|Poor/Non-compliance|3|||
126775357|NCT01335399|456134039|FG001|Treatment Period|Poor/Non-compliance|4|||
126775358|NCT01335399|456134038|FG000|Treatment Period|Lost to Follow-up|2|||
126775359|NCT01335399|456134039|FG001|Treatment Period|Lost to Follow-up|2|||
126775360|NCT01335399|456134038|FG000|Treatment Period|Maximum clinical benefit|1|||
126775361|NCT01335399|456134039|FG001|Treatment Period|Maximum clinical benefit|1|||
126775362|NCT01335399|456134038|FG000|Treatment Period|No longer meet study criteria|1|||
126775363|NCT01335399|456134039|FG001|Treatment Period|No longer meet study criteria|1|||
126775364|NCT01335399|456134038|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
126775365|NCT01335399|456134039|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
126775366|NCT02464059|456134040|FG000|Overall Study|Lost to Follow-up|6|||
126775367|NCT00304954|456134043|FG000|Overall Study|Withdrawal by Subject|0|||
126775368|NCT00304954|456134044|FG001|Overall Study|Withdrawal by Subject|0|||
126775369|NCT00304954|456134045|FG002|Overall Study|Withdrawal by Subject|1|||
126775370|NCT00304954|456134046|FG003|Overall Study|Withdrawal by Subject|0|||
126775371|NCT00304954|456134043|FG000|Overall Study|Adverse Event|1|||
126775372|NCT00304954|456134044|FG001|Overall Study|Adverse Event|0|||
126501644|NCT03519971|455136547|FG000|Overall Study|Lost to Follow-up|0|||
126501645|NCT03519971|455136548|FG001|Overall Study|Lost to Follow-up|1|||
126501646|NCT03519971|455136547|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
126501647|NCT03519971|455136548|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
126501648|NCT03519971|455136547|FG000|Overall Study|Withdrawal by Subject|3|||
126501649|NCT03519971|455136548|FG001|Overall Study|Withdrawal by Subject|2|||
126501650|NCT03519971|455136547|FG000|Overall Study|Other|1|||
126501651|NCT03519971|455136548|FG001|Overall Study|Other|0|||
126501652|NCT01524692|455136553|FG000|Overall Study|Withdrawal by Subject|3|||
126501653|NCT04007523|455136555|FG000|Overall Study|Withdrawal by Subject|0|||
126501654|NCT04007523|455136556|FG001|Overall Study|Withdrawal by Subject|1|||
126501655|NCT04007523|455136557|FG002|Overall Study|Withdrawal by Subject|1|||
126501656|NCT04007523|455136558|FG003|Overall Study|Withdrawal by Subject|0|||
126501657|NCT04007523|455136555|FG000|Overall Study|ICU Transfer|0|||
126501658|NCT04007523|455136556|FG001|Overall Study|ICU Transfer|1|||
126501659|NCT04007523|455136557|FG002|Overall Study|ICU Transfer|0|||
126501660|NCT04007523|455136558|FG003|Overall Study|ICU Transfer|0|||
126501661|NCT04007523|455136555|FG000|Overall Study|COVID hospital closure|0|||
126501662|NCT04007523|455136556|FG001|Overall Study|COVID hospital closure|0|||
126501663|NCT04007523|455136557|FG002|Overall Study|COVID hospital closure|1|||
126501664|NCT04007523|455136558|FG003|Overall Study|COVID hospital closure|2|||
126501665|NCT04007523|455136555|FG000|Overall Study|Surgery cancelled|0|||
126501666|NCT04007523|455136556|FG001|Overall Study|Surgery cancelled|0|||
126501667|NCT04007523|455136557|FG002|Overall Study|Surgery cancelled|1|||
126501668|NCT04007523|455136558|FG003|Overall Study|Surgery cancelled|1|||
126501669|NCT02197806|455136564|FG000|Overall Study|Adverse Event|0|||
126501670|NCT02197806|455136565|FG001|Overall Study|Adverse Event|1|||
126501671|NCT02197806|455136566|FG002|Overall Study|Adverse Event|0|||
126501672|NCT02197806|455136567|FG003|Overall Study|Adverse Event|1|||
126501673|NCT01708174|455136570|FG000|Treatment Period|Withdrawal by Subject|1|||
126501674|NCT01708174|455136571|FG001|Treatment Period|Withdrawal by Subject|0|||
126501675|NCT01708174|455136572|FG002|Treatment Period|Withdrawal by Subject|0|||
126501676|NCT01708174|455136570|FG000|Treatment Period|Progressive disease|0|||
126501677|NCT01708174|455136571|FG001|Treatment Period|Progressive disease|1|||
126501678|NCT01708174|455136572|FG002|Treatment Period|Progressive disease|0|||
126501679|NCT01708174|455136570|FG000|Treatment Period|Death|0|||
126501680|NCT01708174|455136571|FG001|Treatment Period|Death|0|||
126501681|NCT01708174|455136572|FG002|Treatment Period|Death|1|||
126501682|NCT01708174|455136570|FG000|Treatment Period|Adverse Event|0|||
126501683|NCT01708174|455136571|FG001|Treatment Period|Adverse Event|1|||
126501684|NCT01708174|455136572|FG002|Treatment Period|Adverse Event|0|||
126501685|NCT01894152|455136573|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
126501686|NCT02268812|455136574|FG000|Overall Study|Adverse Event|8|||
126501687|NCT02268812|455136575|FG001|Overall Study|Adverse Event|26|||
126501688|NCT02268812|455136576|FG002|Overall Study|Adverse Event|7|||
126501689|NCT02268812|455136577|FG003|Overall Study|Adverse Event|10|||
126501690|NCT02268812|455136574|FG000|Overall Study|Protocol deviation|0|||
126501691|NCT02268812|455136575|FG001|Overall Study|Protocol deviation|0|||
126501692|NCT02268812|455136576|FG002|Overall Study|Protocol deviation|1|||
126501693|NCT02268812|455136577|FG003|Overall Study|Protocol deviation|0|||
126501694|NCT02268812|455136574|FG000|Overall Study|Withdrawal by Subject|0|||
126501695|NCT02268812|455136575|FG001|Overall Study|Withdrawal by Subject|1|||
126501696|NCT02268812|455136576|FG002|Overall Study|Withdrawal by Subject|0|||
126501697|NCT02268812|455136577|FG003|Overall Study|Withdrawal by Subject|0|||
126501698|NCT02268812|455136574|FG000|Overall Study|Physician Decision|3|||
126501699|NCT02268812|455136575|FG001|Overall Study|Physician Decision|1|||
126501700|NCT02268812|455136576|FG002|Overall Study|Physician Decision|0|||
126501701|NCT02268812|455136577|FG003|Overall Study|Physician Decision|1|||
126501702|NCT02268812|455136574|FG000|Overall Study|Other|5|||
126501703|NCT02268812|455136575|FG001|Overall Study|Other|4|||
126501704|NCT02268812|455136576|FG002|Overall Study|Other|1|||
126501705|NCT02268812|455136577|FG003|Overall Study|Other|3|||
126501706|NCT00075582|455136578|FG000|Overall Study|Adverse Event|3|||
126501707|NCT00075582|455136579|FG001|Overall Study|Adverse Event|1|||
126501708|NCT00075582|455136578|FG000|Overall Study|Lack of Efficacy|4|||
126501709|NCT00075582|455136579|FG001|Overall Study|Lack of Efficacy|8|||
126501710|NCT00075582|455136578|FG000|Overall Study|Physician Decision|5|||
126501711|NCT00075582|455136579|FG001|Overall Study|Physician Decision|8|||
126501712|NCT00075582|455136578|FG000|Overall Study|Withdrawal by Subject|2|||
126501713|NCT00075582|455136579|FG001|Overall Study|Withdrawal by Subject|2|||
126501714|NCT00075582|455136578|FG000|Overall Study|Ineligible for study|36|||
126501715|NCT00075582|455136579|FG001|Overall Study|Ineligible for study|16|||
126501716|NCT05045144|455136580|FG000|Overall Study|Lost to Follow-up|3|||
126501717|NCT05045144|455136581|FG001|Overall Study|Lost to Follow-up|2|||
126501718|NCT05045144|455136582|FG002|Overall Study|Lost to Follow-up|3|||
126501719|NCT05045144|455136583|FG003|Overall Study|Lost to Follow-up|5|||
126501720|NCT05045144|455136584|FG004|Overall Study|Lost to Follow-up|13|||
126501721|NCT05045144|455136580|FG000|Overall Study|Withdrawal by Subject|0|||
126501722|NCT05045144|455136581|FG001|Overall Study|Withdrawal by Subject|1|||
126501723|NCT05045144|455136582|FG002|Overall Study|Withdrawal by Subject|0|||
126501724|NCT05045144|455136583|FG003|Overall Study|Withdrawal by Subject|0|||
126501725|NCT05045144|455136584|FG004|Overall Study|Withdrawal by Subject|0|||
126501726|NCT05045144|455136580|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126501727|NCT05045144|455136581|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126501728|NCT05045144|455136582|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126501729|NCT05045144|455136583|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126501730|NCT05045144|455136584|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126501731|NCT02486042|455136585|FG000|Overall Study|Physician Decision|1|||
126501732|NCT02486042|455136586|FG001|Overall Study|Physician Decision|7|||
126501733|NCT02486042|455136585|FG000|Overall Study|Hospital transfer|2|||
126501734|NCT02486042|455136586|FG001|Overall Study|Hospital transfer|2|||
126501735|NCT02486042|455136585|FG000|Overall Study|Withdrawal by Subject|0|||
126501736|NCT02486042|455136586|FG001|Overall Study|Withdrawal by Subject|2|||
126501737|NCT01466387|455136587|FG000|Overall Study|Adverse Event|0|||
126501738|NCT01466387|455136588|FG001|Overall Study|Adverse Event|0|||
126501739|NCT01466387|455136589|FG002|Overall Study|Adverse Event|1|||
126501740|NCT01466387|455136590|FG003|Overall Study|Adverse Event|1|||
126501741|NCT01466387|455136591|FG004|Overall Study|Adverse Event|0|||
126501742|NCT01466387|455136592|FG005|Overall Study|Adverse Event|0|||
126501743|NCT01466387|455136587|FG000|Overall Study|Lost to Follow-up|0|||
126501744|NCT01466387|455136588|FG001|Overall Study|Lost to Follow-up|0|||
126501745|NCT01466387|455136589|FG002|Overall Study|Lost to Follow-up|0|||
126501746|NCT01466387|455136590|FG003|Overall Study|Lost to Follow-up|0|||
126501747|NCT01466387|455136591|FG004|Overall Study|Lost to Follow-up|0|||
126501748|NCT01466387|455136592|FG005|Overall Study|Lost to Follow-up|1|||
126501749|NCT01466387|455136587|FG000|Overall Study|Protocol Violation|1|||
126501750|NCT01466387|455136588|FG001|Overall Study|Protocol Violation|0|||
126501751|NCT01466387|455136589|FG002|Overall Study|Protocol Violation|0|||
126501752|NCT01466387|455136590|FG003|Overall Study|Protocol Violation|1|||
126501753|NCT01466387|455136591|FG004|Overall Study|Protocol Violation|0|||
126501754|NCT01466387|455136592|FG005|Overall Study|Protocol Violation|0|||
126501755|NCT03745144|455136593|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
126501756|NCT03745144|455136594|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
126501757|NCT03745144|455136595|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
126501758|NCT03745144|455136593|FG000|Period 1|Other|0|||
126501759|NCT03745144|455136594|FG001|Period 1|Other|0|||
126501760|NCT03745144|455136595|FG002|Period 1|Other|1|||
126501761|NCT00896337|455136596|FG000|Overall Study|Death|7|||
126501762|NCT00896337|455136596|FG000|Overall Study|Withdrawal by Subject|7|||
126726405|NCT03707158|455946529|FG000|Midtreatment|Lost to Follow-up|16|||
126501763|NCT00896337|455136596|FG000|Overall Study|Lost to Follow-up|11|||
126501764|NCT01586819|455136597|FG000|Overall Study|Withdrawal by Subject|1|||
126501765|NCT01586819|455136598|FG001|Overall Study|Withdrawal by Subject|0|||
126501766|NCT01359254|455136599|FG000|Overall Study|Death|1|||
126501767|NCT01359254|455136600|FG001|Overall Study|Death|0|||
126561293|NCT01959880|455348493|FG002|Overall Study|Lost to Follow-up|15|||
126561294|NCT01959880|455348494|FG003|Overall Study|Lost to Follow-up|8|||
126561295|NCT01959880|455348491|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
126561296|NCT01959880|455348492|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
126726406|NCT03707158|455946530|FG001|Midtreatment|Lost to Follow-up|7|||
126501768|NCT04668950|455136601|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
126501769|NCT04668950|455136602|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
126501770|NCT04668950|455136601|FG000|Overall Study|Could not confirm started study medication|15|||
126501771|NCT04668950|455136602|FG001|Overall Study|Could not confirm started study medication|15|||
126501772|NCT04668950|455136601|FG000|Overall Study|Could not confirm baseline status|6|||
126501773|NCT04668950|455136602|FG001|Overall Study|Could not confirm baseline status|2|||
126501774|NCT04668950|455136601|FG000|Overall Study|Drop out and did not start medication|15|||
126501775|NCT04668950|455136602|FG001|Overall Study|Drop out and did not start medication|17|||
126501776|NCT04668950|455136601|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
126501777|NCT04668950|455136602|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
126501778|NCT04668950|455136601|FG000|Overall Study|Other|2|||
126501779|NCT04668950|455136602|FG001|Overall Study|Other|4|||
126501780|NCT01124643|455136608|FG000|Overall Study|Death|1|||
126501781|NCT02910167|455136609|FG000|Overall Study|Adverse Event|1|||
126501782|NCT02910167|455136609|FG000|Overall Study|Lost to Follow-up|18|||
126501783|NCT02028988|455136610|FG000|Overall Study|Withdrawal by Subject|2|||
126501784|NCT01063595|455136613|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
126501785|NCT01063595|455136614|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
126501786|NCT01063595|455136613|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
126501787|NCT01063595|455136614|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
126501788|NCT01063595|455136613|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
126501789|NCT01063595|455136614|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
126501790|NCT01063595|455136613|FG000|First Intervention|Adverse Event|1|||
126501791|NCT01063595|455136614|FG001|First Intervention|Adverse Event|4|||
126501792|NCT01063595|455136613|FG000|First Intervention|Withdrawal by Subject|1|||
126501793|NCT01063595|455136614|FG001|First Intervention|Withdrawal by Subject|0|||
126501794|NCT01063595|455136613|FG000|First Intervention|Reason not Specified|0|||
126501795|NCT01063595|455136614|FG001|First Intervention|Reason not Specified|1|||
126501796|NCT01796197|455136618|FG000|Overall Study|Lost to Follow-up|1|||
126501797|NCT01796197|455136618|FG000|Overall Study|Lack of Efficacy|1|||
126501798|NCT01380184|455136619|FG000|Part 1 (19 Days)|Adverse Event|1|||
126501799|NCT01380184|455136619|FG000|Part 2|Adverse Event|5|||
126501800|NCT01380184|455136619|FG000|Part 2|Disease Progression|8|||
126501801|NCT01380184|455136619|FG000|Part 2|Lost to Follow-up|1|||
126501802|NCT04243538|455136620|FG000|Overall Study|Withdrawal by Subject|0|||
126501803|NCT04243538|455136621|FG001|Overall Study|Withdrawal by Subject|2|||
126501804|NCT04243538|455136620|FG000|Overall Study|Lost to Follow-up|0|||
126501805|NCT04243538|455136621|FG001|Overall Study|Lost to Follow-up|3|||
126501806|NCT03532295|455136622|FG000|Overall Study|Did not start treatment|0|||
126501807|NCT03532295|455136623|FG001|Overall Study|Did not start treatment|2|||
126501808|NCT02776917|455136624|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
126501809|NCT05620576|455138230|FG000|Overall Study|Adverse Event|1|||
126501810|NCT05620576|455138231|FG001|Overall Study|Adverse Event|1|||
126501811|NCT05620576|455138230|FG000|Overall Study|Lost to Follow-up|3|||
126501812|NCT05620576|455138231|FG001|Overall Study|Lost to Follow-up|1|||
126501813|NCT05620576|455138230|FG000|Overall Study|Physician Decision|0|||
126501814|NCT05620576|455138231|FG001|Overall Study|Physician Decision|1|||
126501815|NCT05620576|455138230|FG000|Overall Study|Protocol Deviation|1|||
126501816|NCT05620576|455138231|FG001|Overall Study|Protocol Deviation|1|||
126501817|NCT05620576|455138230|FG000|Overall Study|Withdrawal by Subject|2|||
126501818|NCT05620576|455138231|FG001|Overall Study|Withdrawal by Subject|3|||
126501819|NCT02622828|455138232|FG000|Overall Study|participant withdrew|3|||
126501820|NCT04214288|455138237|FG000|Overall Study|Ongoing in the study|41|||
126501821|NCT04214288|455138238|FG001|Overall Study|Ongoing in the study|51|||
126501822|NCT04214288|455138239|FG002|Overall Study|Ongoing in the study|12|||
126501823|NCT04214288|455138240|FG003|Overall Study|Ongoing in the study|39|||
126501824|NCT04214288|455138237|FG000|Overall Study|Adverse Event|1|||
126501825|NCT04214288|455138238|FG001|Overall Study|Adverse Event|0|||
126501826|NCT04214288|455138239|FG002|Overall Study|Adverse Event|0|||
126501827|NCT04214288|455138240|FG003|Overall Study|Adverse Event|0|||
126501828|NCT04214288|455138237|FG000|Overall Study|Death|22|||
126501829|NCT04214288|455138238|FG001|Overall Study|Death|13|||
126501830|NCT04214288|455138239|FG002|Overall Study|Death|7|||
126501831|NCT04214288|455138240|FG003|Overall Study|Death|19|||
126501832|NCT04214288|455138237|FG000|Overall Study|Lost to Follow-up|1|||
126501833|NCT04214288|455138238|FG001|Overall Study|Lost to Follow-up|2|||
126501834|NCT04214288|455138239|FG002|Overall Study|Lost to Follow-up|1|||
126501835|NCT04214288|455138240|FG003|Overall Study|Lost to Follow-up|0|||
126501836|NCT04214288|455138237|FG000|Overall Study|Other|1|||
126501837|NCT04214288|455138238|FG001|Overall Study|Other|2|||
126501838|NCT04214288|455138239|FG002|Overall Study|Other|0|||
126501839|NCT04214288|455138240|FG003|Overall Study|Other|6|||
126501840|NCT04214288|455138237|FG000|Overall Study|Protocol Violation|0|||
126501841|NCT04214288|455138238|FG001|Overall Study|Protocol Violation|1|||
126501842|NCT04214288|455138239|FG002|Overall Study|Protocol Violation|0|||
126501843|NCT04214288|455138240|FG003|Overall Study|Protocol Violation|0|||
126501844|NCT04214288|455138237|FG000|Overall Study|Withdrawal by Subject|8|||
126501845|NCT04214288|455138238|FG001|Overall Study|Withdrawal by Subject|4|||
126501846|NCT04214288|455138239|FG002|Overall Study|Withdrawal by Subject|0|||
126501847|NCT04214288|455138240|FG003|Overall Study|Withdrawal by Subject|9|||
126501848|NCT01203072|455138250|FG000|Overall Study|Adverse Event|5|||
126501849|NCT01203072|455138251|FG001|Overall Study|Adverse Event|3|||
126501850|NCT01203072|455138252|FG002|Overall Study|Adverse Event|2|||
126501851|NCT01203072|455138253|FG003|Overall Study|Adverse Event|4|||
126501852|NCT01203072|455138254|FG004|Overall Study|Adverse Event|2|||
126501853|NCT01203072|455138250|FG000|Overall Study|Lack of Efficacy|1|||
126501854|NCT01203072|455138251|FG001|Overall Study|Lack of Efficacy|0|||
126501855|NCT01203072|455138252|FG002|Overall Study|Lack of Efficacy|0|||
126501856|NCT01203072|455138253|FG003|Overall Study|Lack of Efficacy|0|||
126501857|NCT01203072|455138254|FG004|Overall Study|Lack of Efficacy|0|||
126501858|NCT01203072|455138250|FG000|Overall Study|Lost to Follow-up|0|||
126501859|NCT01203072|455138251|FG001|Overall Study|Lost to Follow-up|1|||
126501860|NCT01203072|455138252|FG002|Overall Study|Lost to Follow-up|0|||
126501861|NCT01203072|455138253|FG003|Overall Study|Lost to Follow-up|0|||
126501862|NCT01203072|455138254|FG004|Overall Study|Lost to Follow-up|0|||
126501863|NCT01203072|455138250|FG000|Overall Study|Protocol Violation|2|||
126501864|NCT01203072|455138251|FG001|Overall Study|Protocol Violation|0|||
126501865|NCT01203072|455138252|FG002|Overall Study|Protocol Violation|0|||
126501866|NCT01203072|455138253|FG003|Overall Study|Protocol Violation|0|||
126501867|NCT01203072|455138254|FG004|Overall Study|Protocol Violation|1|||
126501868|NCT01203072|455138250|FG000|Overall Study|Withdrawal by Subject|2|||
126501869|NCT01203072|455138251|FG001|Overall Study|Withdrawal by Subject|2|||
126501870|NCT01203072|455138252|FG002|Overall Study|Withdrawal by Subject|1|||
126501871|NCT01203072|455138253|FG003|Overall Study|Withdrawal by Subject|2|||
126501872|NCT01203072|455138254|FG004|Overall Study|Withdrawal by Subject|3|||
126501873|NCT02286193|455138260|FG000|Overall Study|Referred: CRS unable to make contact|62|||
126501874|NCT02286193|455138260|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
126501875|NCT02286193|455138260|FG000|Overall Study|Referred: Declined service|38|||
126501876|NCT03387813|455138261|FG000|Overall Study|Death|40|||
126501877|NCT03387813|455138262|FG001|Overall Study|Death|37|||
126501878|NCT03387813|455138263|FG002|Overall Study|Death|190|||
126501879|NCT03387813|455138261|FG000|Overall Study|Withdrawal by Subject|9|||
126501880|NCT03387813|455138262|FG001|Overall Study|Withdrawal by Subject|19|||
126501881|NCT03387813|455138263|FG002|Overall Study|Withdrawal by Subject|32|||
126501882|NCT03387813|455138261|FG000|Overall Study|Lost to Follow-up|3|||
126501883|NCT03387813|455138262|FG001|Overall Study|Lost to Follow-up|9|||
126501884|NCT03387813|455138263|FG002|Overall Study|Lost to Follow-up|15|||
126501885|NCT03387813|455138261|FG000|Overall Study|Non-Compliance|6|||
126501886|NCT03387813|455138262|FG001|Overall Study|Non-Compliance|6|||
126501887|NCT03387813|455138263|FG002|Overall Study|Non-Compliance|31|||
126501888|NCT03387813|455138261|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
126501889|NCT03387813|455138262|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
126501890|NCT03387813|455138263|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
126501891|NCT03161483|455138269|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
126501892|NCT03161483|455138270|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
126501893|NCT03161483|455138271|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
126501894|NCT03161483|455138272|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
126501895|NCT03161483|455138269|FG000|Treatment Period|Death|1|||
126501896|NCT03161483|455138270|FG001|Treatment Period|Death|0|||
126501897|NCT03161483|455138271|FG002|Treatment Period|Death|0|||
126501898|NCT03161483|455138272|FG003|Treatment Period|Death|0|||
126501899|NCT03161483|455138269|FG000|Treatment Period|Adverse Event|5|||
126501900|NCT03161483|455138270|FG001|Treatment Period|Adverse Event|2|||
126501901|NCT03161483|455138271|FG002|Treatment Period|Adverse Event|1|||
126501902|NCT03161483|455138272|FG003|Treatment Period|Adverse Event|11|||
126501903|NCT03161483|455138269|FG000|Treatment Period|Pregnancy|1|||
126501904|NCT03161483|455138270|FG001|Treatment Period|Pregnancy|0|||
126501905|NCT03161483|455138271|FG002|Treatment Period|Pregnancy|0|||
126501906|NCT03161483|455138272|FG003|Treatment Period|Pregnancy|0|||
126501907|NCT03161483|455138269|FG000|Treatment Period|Lack of Efficacy|0|||
126501908|NCT03161483|455138270|FG001|Treatment Period|Lack of Efficacy|0|||
126501909|NCT03161483|455138271|FG002|Treatment Period|Lack of Efficacy|0|||
126501910|NCT03161483|455138272|FG003|Treatment Period|Lack of Efficacy|1|||
126775373|NCT00304954|456134045|FG002|Overall Study|Adverse Event|0|||
126501911|NCT03161483|455138269|FG000|Treatment Period|Withdrawal by Subject|2|||
126501912|NCT03161483|455138270|FG001|Treatment Period|Withdrawal by Subject|5|||
126501913|NCT03161483|455138271|FG002|Treatment Period|Withdrawal by Subject|2|||
126501914|NCT03161483|455138272|FG003|Treatment Period|Withdrawal by Subject|6|||
126501915|NCT03161483|455138269|FG000|Treatment Period|Lost to Follow-up|0|||
126501916|NCT03161483|455138270|FG001|Treatment Period|Lost to Follow-up|0|||
126501917|NCT03161483|455138271|FG002|Treatment Period|Lost to Follow-up|0|||
126501918|NCT03161483|455138272|FG003|Treatment Period|Lost to Follow-up|1|||
126501919|NCT03161483|455138269|FG000|Treatment Period|Protocol Violation|0|||
126501920|NCT03161483|455138270|FG001|Treatment Period|Protocol Violation|0|||
126501921|NCT03161483|455138271|FG002|Treatment Period|Protocol Violation|0|||
126501922|NCT03161483|455138272|FG003|Treatment Period|Protocol Violation|1|||
126501923|NCT03161483|455138269|FG000|Treatment Period|Other reasons|1|||
126501924|NCT03161483|455138270|FG001|Treatment Period|Other reasons|1|||
126726407|NCT03707158|455946529|FG000|Midtreatment|Withdrawal by Subject|28|||
126726408|NCT03707158|455946530|FG001|Midtreatment|Withdrawal by Subject|19|||
126726409|NCT03707158|455946529|FG000|Posttreatment|Lost to Follow-up|0|||
126726410|NCT03707158|455946530|FG001|Posttreatment|Lost to Follow-up|5|||
126726411|NCT03707158|455946529|FG000|Follow-up|Lost to Follow-up|19|||
126726412|NCT03707158|455946530|FG001|Follow-up|Lost to Follow-up|18|||
126726413|NCT03707158|455946529|FG000|Follow-up|Withdrawal by Subject|13|||
126726414|NCT03707158|455946530|FG001|Follow-up|Withdrawal by Subject|6|||
126726415|NCT05108805|455946531|FG000|Overall Study|T-cell expansion was not successful.|5|||
126726416|NCT01754922|455948926|FG000|Overall Study|Adverse Event|0|||
126726417|NCT01754922|455948927|FG001|Overall Study|Adverse Event|1|||
126726418|NCT00310388|455948929|FG000|Primary Reporting Phase|Adverse Event|101|||
126726419|NCT00310388|455948930|FG001|Primary Reporting Phase|Adverse Event|0|||
126726420|NCT00310388|455948929|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
126501925|NCT03161483|455138271|FG002|Treatment Period|Other reasons|0|||
126726421|NCT00310388|455948930|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
126726422|NCT00310388|455948929|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
126726423|NCT00310388|455948930|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
126726424|NCT00310388|455948929|FG000|Primary Reporting Phase|Protocol Violation|10|||
126726425|NCT00310388|455948930|FG001|Primary Reporting Phase|Protocol Violation|0|||
126726426|NCT00310388|455948929|FG000|Primary Reporting Phase|Pregnancy|3|||
126726427|NCT00310388|455948930|FG001|Primary Reporting Phase|Pregnancy|0|||
126726428|NCT00310388|455948929|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
126726429|NCT00310388|455948930|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
126726430|NCT00310388|455948929|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
126726431|NCT00310388|455948930|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
126726432|NCT00310388|455948929|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
126726433|NCT00310388|455948930|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
126726434|NCT00310388|455948929|FG000|Primary Reporting Phase|Physician Decision|2|||
126726435|NCT00310388|455948930|FG001|Primary Reporting Phase|Physician Decision|0|||
126726436|NCT00310388|455948929|FG000|Primary Reporting Phase|Request of the sponsor|19|||
126726437|NCT00310388|455948930|FG001|Primary Reporting Phase|Request of the sponsor|0|||
126726438|NCT00310388|455948929|FG000|Primary Reporting Phase|Failed to return|8|||
126726439|NCT00310388|455948930|FG001|Primary Reporting Phase|Failed to return|0|||
126726440|NCT00310388|455948929|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
126726441|NCT00310388|455948930|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
126726442|NCT00310388|455948929|FG000|Primary Reporting Phase|Participant request|2|||
126726443|NCT00310388|455948930|FG001|Primary Reporting Phase|Participant request|0|||
126726444|NCT00310388|455948929|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
126726445|NCT00310388|455948930|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
126726446|NCT00310388|455948929|FG000|Primary Reporting Phase|Discontinuation of study|1|||
126726447|NCT00310388|455948930|FG001|Primary Reporting Phase|Discontinuation of study|0|||
126726448|NCT00310388|455948929|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
126726449|NCT00310388|455948930|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
126726450|NCT00310388|455948929|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
126726451|NCT00310388|455948930|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
126726452|NCT00310388|455948929|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
126726453|NCT00310388|455948930|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
126726454|NCT00310388|455948929|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
126726455|NCT00310388|455948930|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
126726456|NCT00310388|455948929|FG000|Primary Reporting Phase|Participant passed away|1|||
126726457|NCT00310388|455948930|FG001|Primary Reporting Phase|Participant passed away|0|||
126726458|NCT00310388|455948929|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
126726459|NCT00310388|455948930|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
126726460|NCT00310388|455948929|FG000|Primary Reporting Phase|Missing|1|||
126726461|NCT00310388|455948930|FG001|Primary Reporting Phase|Missing|0|||
126726462|NCT00310388|455948929|FG000|Primary Reporting Phase|Other|1|||
126726463|NCT00310388|455948930|FG001|Primary Reporting Phase|Other|0|||
126726464|NCT00310388|455948929|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
126726465|NCT00310388|455948930|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
126775374|NCT00304954|456134046|FG003|Overall Study|Adverse Event|0|||
126775375|NCT03990389|456134049|FG000|Overall Study|Lost to Follow-up|3|||
126775376|NCT03990389|456134050|FG001|Overall Study|Lost to Follow-up|0|||
126775377|NCT02290028|456134051|FG000|Overall Study|Death|217|||
126775378|NCT02290028|456134051|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
126775379|NCT02290028|456134051|FG000|Overall Study|No longer under care of study physician|76|||
126775380|NCT02290028|456134051|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
126775381|NCT02290028|456134051|FG000|Overall Study|Withdrawal by Subject|52|||
126775382|NCT02290028|456134051|FG000|Overall Study|Study site closure|44|||
126775383|NCT02290028|456134051|FG000|Overall Study|Lost to Follow-up|34|||
126775384|NCT02290028|456134051|FG000|Overall Study|Miscellaneous|10|||
126775385|NCT02290028|456134051|FG000|Overall Study|Transition to EP PASSION|1295|||
126775386|NCT02290028|456134051|FG000|Overall Study|Planned study completion at 12 months|257|||
126775387|NCT03202511|456134052|FG000|Overall Study|Withdrawal by Subject|1|||
126775388|NCT03202511|456134053|FG001|Overall Study|Withdrawal by Subject|0|||
126775389|NCT00833547|456134054|FG000|Overall Study|Withdrawal by Subject|2|||
126775390|NCT00833547|456134055|FG001|Overall Study|Withdrawal by Subject|2|||
126775391|NCT01326702|456134058|FG000|Overall Study|Other|1|||
126775392|NCT01326702|456134059|FG001|Overall Study|Other|0|||
126775393|NCT01326702|456134060|FG002|Overall Study|Other|0|||
126775394|NCT01326702|456134061|FG003|Overall Study|Other|0|||
126775395|NCT01326702|456134062|FG004|Overall Study|Other|0|||
126775396|NCT01326702|456134063|FG005|Overall Study|Other|1|||
126775397|NCT01326702|456134064|FG006|Overall Study|Other|0|||
126775398|NCT01326702|456134058|FG000|Overall Study|progressive disease|1|||
126775399|NCT01326702|456134059|FG001|Overall Study|progressive disease|1|||
126775400|NCT01326702|456134060|FG002|Overall Study|progressive disease|3|||
126775401|NCT01326702|456134061|FG003|Overall Study|progressive disease|1|||
126775402|NCT01326702|456134062|FG004|Overall Study|progressive disease|3|||
126775403|NCT01326702|456134063|FG005|Overall Study|progressive disease|2|||
126775404|NCT01326702|456134064|FG006|Overall Study|progressive disease|3|||
126775405|NCT01326702|456134058|FG000|Overall Study|Death|0|||
126775406|NCT01326702|456134059|FG001|Overall Study|Death|1|||
126775407|NCT01326702|456134060|FG002|Overall Study|Death|0|||
126775408|NCT01326702|456134061|FG003|Overall Study|Death|0|||
126501926|NCT03161483|455138272|FG003|Treatment Period|Other reasons|0|||
126501927|NCT02404350|455138281|FG000|Overall Study|Adverse Event|2|||
126501928|NCT02404350|455138282|FG001|Overall Study|Adverse Event|2|||
126501929|NCT02404350|455138283|FG002|Overall Study|Adverse Event|3|||
126501930|NCT02404350|455138284|FG003|Overall Study|Adverse Event|9|||
126501931|NCT02404350|455138281|FG000|Overall Study|Lack of Efficacy|3|||
126501932|NCT02404350|455138282|FG001|Overall Study|Lack of Efficacy|1|||
126501933|NCT02404350|455138283|FG002|Overall Study|Lack of Efficacy|0|||
126501934|NCT02404350|455138284|FG003|Overall Study|Lack of Efficacy|3|||
126501935|NCT02404350|455138281|FG000|Overall Study|Lost to Follow-up|2|||
126501936|NCT02404350|455138282|FG001|Overall Study|Lost to Follow-up|0|||
126501937|NCT02404350|455138283|FG002|Overall Study|Lost to Follow-up|0|||
126501938|NCT02404350|455138284|FG003|Overall Study|Lost to Follow-up|1|||
126501939|NCT02404350|455138281|FG000|Overall Study|Physician Decision|1|||
126501940|NCT02404350|455138282|FG001|Overall Study|Physician Decision|0|||
126501941|NCT02404350|455138283|FG002|Overall Study|Physician Decision|0|||
126501942|NCT02404350|455138284|FG003|Overall Study|Physician Decision|2|||
126501943|NCT02404350|455138281|FG000|Overall Study|Pregnancy|0|||
126501944|NCT02404350|455138282|FG001|Overall Study|Pregnancy|0|||
126501945|NCT02404350|455138283|FG002|Overall Study|Pregnancy|0|||
126501946|NCT02404350|455138284|FG003|Overall Study|Pregnancy|1|||
126501947|NCT02404350|455138281|FG000|Overall Study|Withdrawal by Subject|7|||
126501948|NCT02404350|455138282|FG001|Overall Study|Withdrawal by Subject|3|||
126501949|NCT02404350|455138283|FG002|Overall Study|Withdrawal by Subject|3|||
126501950|NCT02404350|455138284|FG003|Overall Study|Withdrawal by Subject|19|||
126501951|NCT02404350|455138281|FG000|Overall Study|Due to Non-compliance with treatment|0|||
126501952|NCT02404350|455138282|FG001|Overall Study|Due to Non-compliance with treatment|0|||
126501953|NCT02404350|455138283|FG002|Overall Study|Due to Non-compliance with treatment|0|||
126501954|NCT02404350|455138284|FG003|Overall Study|Due to Non-compliance with treatment|1|||
126501955|NCT02404350|455138281|FG000|Overall Study|Due to Technical problems|0|||
126501956|NCT02404350|455138282|FG001|Overall Study|Due to Technical problems|0|||
126501957|NCT02404350|455138283|FG002|Overall Study|Due to Technical problems|0|||
126501958|NCT02404350|455138284|FG003|Overall Study|Due to Technical problems|1|||
126501959|NCT04238728|455138285|FG000|Overall Study|Withdrawal by Subject|1|||
126501960|NCT04238728|455138285|FG000|Overall Study|Lost to Follow-up|2|||
126501961|NCT05389657|455138287|FG000|Overall Study|Lost to Follow-up|7|||
126501962|NCT05389657|455138288|FG001|Overall Study|Lost to Follow-up|8|||
126501963|NCT01907828|455138289|FG000|Overall Study|Exclusion criteria not met|0|||
126501964|NCT01907828|455138290|FG001|Overall Study|Exclusion criteria not met|1|||
126501965|NCT01907828|455138289|FG000|Overall Study|Withdrawal by Subject|3|||
126501966|NCT01907828|455138290|FG001|Overall Study|Withdrawal by Subject|4|||
126501967|NCT01907828|455138289|FG000|Overall Study|Lost to Follow-up|3|||
126501968|NCT01907828|455138290|FG001|Overall Study|Lost to Follow-up|0|||
126775409|NCT01326702|456134062|FG004|Overall Study|Death|0|||
126561297|NCT01959880|455348493|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
126561298|NCT01959880|455348494|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
126561299|NCT01959880|455348491|FG000|Overall Study|Study completed early-FDA approved|1003|||
126561300|NCT01959880|455348492|FG001|Overall Study|Study completed early-FDA approved|311|||
126561301|NCT01959880|455348493|FG002|Overall Study|Study completed early-FDA approved|179|||
126561302|NCT01959880|455348494|FG003|Overall Study|Study completed early-FDA approved|152|||
126561303|NCT01919619|455348495|FG000|Overall Study|Physician Decision|1|||
126561304|NCT01919619|455348496|FG001|Overall Study|Physician Decision|1|||
126561305|NCT03253653|455348497|FG000|Overall Study|Withdrawal by Subject|4|||
126561306|NCT03253653|455348498|FG001|Overall Study|Withdrawal by Subject|1|||
126561307|NCT03253653|455348497|FG000|Overall Study|Protocol Violation|0|||
126561308|NCT03253653|455348498|FG001|Overall Study|Protocol Violation|5|||
126561309|NCT01211665|455349883|FG000|Overall Study|Withdrawal by Subject|1|||
126561310|NCT01211665|455349884|FG001|Overall Study|Withdrawal by Subject|0|||
126561311|NCT01211665|455349883|FG000|Overall Study|Death|1|||
126561312|NCT01211665|455349884|FG001|Overall Study|Death|0|||
126561313|NCT00498186|455349887|FG000|Overall Study|Protocol Violation|10|||
126561314|NCT00498186|455349887|FG000|Overall Study|Lack of Efficacy|31|||
126561315|NCT00498186|455349887|FG000|Overall Study|Adverse Event|89|||
126561316|NCT00498186|455349887|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
126561317|NCT00498186|455349887|FG000|Overall Study|Withdrawal by Subject|18|||
126561318|NCT00498186|455349887|FG000|Overall Study|Lost to Follow-up|3|||
126561319|NCT00498186|455349887|FG000|Overall Study|Other|10|||
126561320|NCT01390857|455349888|FG000|Overall Study|Protocol Violation|2|||
126561321|NCT01390857|455349888|FG000|Overall Study|Lost to Follow-up|1|||
126561322|NCT01390857|455349888|FG000|Overall Study|No Visit after the First Visit|7|||
126561323|NCT00886613|455349894|FG000|Overall Study|Protocol deviation (Part B)|1|||
126561324|NCT00886613|455349895|FG001|Overall Study|Protocol deviation (Part B)|0|||
126561325|NCT00886613|455349896|FG002|Overall Study|Protocol deviation (Part B)|0|||
126561326|NCT00886613|455349894|FG000|Overall Study|Lost to follow-up (Part B)|1|||
126561327|NCT00886613|455349895|FG001|Overall Study|Lost to follow-up (Part B)|0|||
126561328|NCT00886613|455349896|FG002|Overall Study|Lost to follow-up (Part B)|1|||
126561329|NCT00886613|455349894|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
126561330|NCT00886613|455349895|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
126561331|NCT00886613|455349896|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
126561332|NCT04541186|455349899|FG000|Main Study|Adverse Event|0|||
126561333|NCT04541186|455349900|FG001|Main Study|Adverse Event|0|||
126561334|NCT04541186|455349901|FG002|Main Study|Adverse Event|4|||
126561335|NCT04541186|455349902|FG003|Main Study|Adverse Event|0|||
126561336|NCT04541186|455349903|FG004|Main Study|Adverse Event|0|||
126561337|NCT04541186|455349899|FG000|Main Study|Investigator Decision|0|||
126561338|NCT04541186|455349900|FG001|Main Study|Investigator Decision|0|||
126561339|NCT04541186|455349901|FG002|Main Study|Investigator Decision|1|||
126561340|NCT04541186|455349902|FG003|Main Study|Investigator Decision|1|||
126561341|NCT04541186|455349903|FG004|Main Study|Investigator Decision|0|||
126561342|NCT04541186|455349899|FG000|Main Study|Withdrawal by Subject|1|||
126561343|NCT04541186|455349900|FG001|Main Study|Withdrawal by Subject|1|||
126561344|NCT04541186|455349901|FG002|Main Study|Withdrawal by Subject|0|||
126561345|NCT04541186|455349902|FG003|Main Study|Withdrawal by Subject|0|||
126561346|NCT04541186|455349903|FG004|Main Study|Withdrawal by Subject|0|||
126561347|NCT04541186|455349899|FG000|Main Study|COVID-19-related Dose Interruption|0|||
126561348|NCT04541186|455349900|FG001|Main Study|COVID-19-related Dose Interruption|0|||
126561349|NCT04541186|455349901|FG002|Main Study|COVID-19-related Dose Interruption|0|||
126561350|NCT04541186|455349902|FG003|Main Study|COVID-19-related Dose Interruption|0|||
126561351|NCT04541186|455349903|FG004|Main Study|COVID-19-related Dose Interruption|1|||
126561352|NCT04541186|455349899|FG000|Main Study|Randomized in Error Not Treated|0|||
126561353|NCT04541186|455349900|FG001|Main Study|Randomized in Error Not Treated|0|||
126561354|NCT04541186|455349901|FG002|Main Study|Randomized in Error Not Treated|1|||
126561355|NCT04541186|455349902|FG003|Main Study|Randomized in Error Not Treated|0|||
126561356|NCT04541186|455349903|FG004|Main Study|Randomized in Error Not Treated|0|||
126561357|NCT04541186|455349899|FG000|Fibrate Expansion Study|Other than Specified|0|||
126561358|NCT04541186|455349900|FG001|Fibrate Expansion Study|Other than Specified|0|||
126561359|NCT04541186|455349901|FG002|Fibrate Expansion Study|Other than Specified|0|||
126561360|NCT04541186|455349902|FG003|Fibrate Expansion Study|Other than Specified|0|||
126561361|NCT04541186|455349903|FG004|Fibrate Expansion Study|Other than Specified|1|||
126561362|NCT00691028|455349904|FG000|Open-label Period|Adverse Event|0|||
126561363|NCT00691028|455349905|FG001|Open-label Period|Adverse Event|0|||
126561364|NCT00691028|455349906|FG002|Open-label Period|Adverse Event|0|||
126561365|NCT00691028|455349907|FG003|Open-label Period|Adverse Event|16|||
126561366|NCT00691028|455349904|FG000|Open-label Period|Withdrawal by Subject|0|||
126561367|NCT00691028|455349905|FG001|Open-label Period|Withdrawal by Subject|0|||
126561368|NCT00691028|455349906|FG002|Open-label Period|Withdrawal by Subject|0|||
126561369|NCT00691028|455349907|FG003|Open-label Period|Withdrawal by Subject|3|||
126561370|NCT00691028|455349904|FG000|Open-label Period|not come to a hospital|0|||
126561371|NCT00691028|455349905|FG001|Open-label Period|not come to a hospital|0|||
126561372|NCT00691028|455349906|FG002|Open-label Period|not come to a hospital|0|||
126501969|NCT01907828|455138289|FG000|Overall Study|Participant refused 24-month follow-up|1|||
126501970|NCT01907828|455138290|FG001|Overall Study|Participant refused 24-month follow-up|0|||
126501971|NCT01907828|455138289|FG000|Overall Study|Participant met exclusion criteria|0|||
126501972|NCT01907828|455138290|FG001|Overall Study|Participant met exclusion criteria|1|||
126501973|NCT01256593|455138292|FG000|Overall Study|Protocol Violation|26|||
126501974|NCT01256593|455138292|FG000|Overall Study|No Drug Administration Information|2|||
126501975|NCT01256593|455138292|FG000|Overall Study|No Visit After Treatment|186|||
126501976|NCT04414553|455138293|FG000|Overall Study|Lost to Follow-up|20|||
126501977|NCT03065244|455138302|FG000|Overall Study|Lost to Follow-up|1|||
126501978|NCT03065244|455138303|FG001|Overall Study|Lost to Follow-up|1|||
126501979|NCT03065244|455138302|FG000|Overall Study|Diagnosed with a different disease|1|||
126501980|NCT03065244|455138303|FG001|Overall Study|Diagnosed with a different disease|1|||
126501981|NCT03065244|455138302|FG000|Overall Study|Protocol Violation|0|||
126501982|NCT03065244|455138303|FG001|Overall Study|Protocol Violation|1|||
126501983|NCT03065244|455138302|FG000|Overall Study|Withdrawal by Subject|1|||
126501984|NCT03065244|455138303|FG001|Overall Study|Withdrawal by Subject|1|||
126501985|NCT03717480|455138304|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
126501986|NCT01774786|455138305|FG000|Overall Study|Death|300|||
126501987|NCT01774786|455138306|FG001|Overall Study|Death|319|||
126501988|NCT01774786|455138305|FG000|Overall Study|Lost to Follow-up|6|||
126501989|NCT01774786|455138306|FG001|Overall Study|Lost to Follow-up|7|||
126501990|NCT01774786|455138305|FG000|Overall Study|Withdrawal by Subject|18|||
126501991|NCT01774786|455138306|FG001|Overall Study|Withdrawal by Subject|14|||
126501992|NCT01774786|455138305|FG000|Overall Study|Physician Decision|2|||
126501993|NCT01774786|455138306|FG001|Overall Study|Physician Decision|0|||
126501994|NCT01774786|455138305|FG000|Overall Study|Non-compliance|0|||
126501995|NCT01774786|455138306|FG001|Overall Study|Non-compliance|1|||
126501996|NCT01774786|455138305|FG000|Overall Study|Reason Not Specified|2|||
126501997|NCT01774786|455138306|FG001|Overall Study|Reason Not Specified|5|||
126501998|NCT02385084|455138307|FG000|Period 2|Protocol Violation|0|||
126501999|NCT02385084|455138308|FG001|Period 2|Protocol Violation|0|||
126502000|NCT02385084|455138309|FG002|Period 2|Protocol Violation|1|||
126502001|NCT02385084|455138310|FG003|Period 2|Protocol Violation|0|||
126502002|NCT02385084|455138311|FG004|Period 2|Protocol Violation|0|||
126502003|NCT02385084|455138312|FG005|Period 2|Protocol Violation|0|||
126502004|NCT02965703|455138318|FG000|Overall Study|Withdrawal by Subject|6|||
126502005|NCT02965703|455138319|FG001|Overall Study|Withdrawal by Subject|3|||
126502006|NCT02965703|455138320|FG002|Overall Study|Withdrawal by Subject|1|||
126502007|NCT02965703|455138318|FG000|Overall Study|Protocol Violation|1|||
126502008|NCT02965703|455138319|FG001|Overall Study|Protocol Violation|0|||
126502009|NCT02965703|455138320|FG002|Overall Study|Protocol Violation|0|||
126502010|NCT02965703|455138318|FG000|Overall Study|Adverse Event|1|||
126502011|NCT02965703|455138319|FG001|Overall Study|Adverse Event|1|||
126502012|NCT02965703|455138320|FG002|Overall Study|Adverse Event|0|||
126502013|NCT02965703|455138318|FG000|Overall Study|Lost to Follow-up|2|||
126502014|NCT02965703|455138319|FG001|Overall Study|Lost to Follow-up|1|||
126502015|NCT02965703|455138320|FG002|Overall Study|Lost to Follow-up|1|||
126502016|NCT00744627|455138321|FG000|Overall Study|Adverse Event|6|||
126502017|NCT00744627|455138322|FG001|Overall Study|Adverse Event|9|||
126502018|NCT00744627|455138321|FG000|Overall Study|Lack of Efficacy|7|||
126502019|NCT00744627|455138322|FG001|Overall Study|Lack of Efficacy|3|||
126502020|NCT00744627|455138321|FG000|Overall Study|Noncompliance|0|||
126502021|NCT00744627|455138322|FG001|Overall Study|Noncompliance|1|||
126502022|NCT00744627|455138321|FG000|Overall Study|Protocol Deviations|0|||
126502023|NCT00744627|455138322|FG001|Overall Study|Protocol Deviations|2|||
126502024|NCT00744627|455138321|FG000|Overall Study|Voluntary Withdrawal|9|||
126502025|NCT00744627|455138322|FG001|Overall Study|Voluntary Withdrawal|6|||
126502026|NCT00744627|455138321|FG000|Overall Study|Lost to Follow-up|2|||
126502027|NCT00744627|455138322|FG001|Overall Study|Lost to Follow-up|1|||
126502028|NCT00744627|455138321|FG000|Overall Study|Other|1|||
126502029|NCT00744627|455138322|FG001|Overall Study|Other|0|||
126502030|NCT02268786|455138323|FG000|Overall Study|No Euploid Embryos available|42|||
126502031|NCT02268786|455138324|FG001|Overall Study|No Euploid Embryos available|0|||
126502032|NCT02268786|455138323|FG000|Overall Study|Withdrawal by Subject|7|||
126502033|NCT02268786|455138324|FG001|Overall Study|Withdrawal by Subject|14|||
126502034|NCT02268786|455138323|FG000|Overall Study|Thaw Failure|6|||
126502035|NCT02268786|455138324|FG001|Overall Study|Thaw Failure|4|||
126502036|NCT02268786|455138323|FG000|Overall Study|Protocol Violation|1|||
126502037|NCT02268786|455138324|FG001|Overall Study|Protocol Violation|0|||
126561373|NCT00691028|455349907|FG003|Open-label Period|not come to a hospital|1|||
126502038|NCT00768144|455138325|FG000|Overall Study|Adverse Event|13|||
126502039|NCT00768144|455138325|FG000|Overall Study|Progressive Disease|21|||
126502040|NCT00768144|455138325|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
126502041|NCT00768144|455138325|FG000|Overall Study|Pt Withdrew Consent|1|||
126502042|NCT04251221|455138326|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
126502043|NCT04251221|455138327|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
126502044|NCT02171260|455138328|FG000|Overall Study|Death|0|||
126775410|NCT01326702|456134063|FG005|Overall Study|Death|0|||
126775411|NCT01326702|456134064|FG006|Overall Study|Death|0|||
126775412|NCT01326702|456134058|FG000|Overall Study|Adverse Event|0|||
126775413|NCT01326702|456134059|FG001|Overall Study|Adverse Event|0|||
126775414|NCT01326702|456134060|FG002|Overall Study|Adverse Event|1|||
126775415|NCT01326702|456134061|FG003|Overall Study|Adverse Event|1|||
126775416|NCT01326702|456134062|FG004|Overall Study|Adverse Event|0|||
126775417|NCT01326702|456134063|FG005|Overall Study|Adverse Event|3|||
126775418|NCT01326702|456134064|FG006|Overall Study|Adverse Event|1|||
126775419|NCT01326702|456134058|FG000|Overall Study|Withdrawal by Subject|0|||
126775420|NCT01326702|456134059|FG001|Overall Study|Withdrawal by Subject|0|||
126775421|NCT01326702|456134060|FG002|Overall Study|Withdrawal by Subject|1|||
126775422|NCT01326702|456134061|FG003|Overall Study|Withdrawal by Subject|0|||
126775423|NCT01326702|456134062|FG004|Overall Study|Withdrawal by Subject|1|||
126775424|NCT01326702|456134063|FG005|Overall Study|Withdrawal by Subject|1|||
126775425|NCT01326702|456134064|FG006|Overall Study|Withdrawal by Subject|3|||
126775426|NCT01326702|456134058|FG000|Overall Study|Not Treated|0|||
126775427|NCT01326702|456134059|FG001|Overall Study|Not Treated|0|||
126775428|NCT01326702|456134060|FG002|Overall Study|Not Treated|0|||
126775429|NCT01326702|456134061|FG003|Overall Study|Not Treated|1|||
126775430|NCT01326702|456134062|FG004|Overall Study|Not Treated|0|||
126775431|NCT01326702|456134063|FG005|Overall Study|Not Treated|1|||
126775432|NCT01326702|456134064|FG006|Overall Study|Not Treated|0|||
126775433|NCT01835132|456134066|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
126775434|NCT00856778|456134067|FG000|Overall Study|Adverse Event|7|||
126775435|NCT00856778|456134067|FG000|Overall Study|Withdrawal by Subject|10|||
126775436|NCT00856778|456134067|FG000|Overall Study|Study deviation|2|||
126775437|NCT00856778|456134067|FG000|Overall Study|Lost to Follow-up|5|||
126775438|NCT03208933|456134068|FG000|Overall Study|Death|3|||
126775439|NCT03208933|456134068|FG000|Overall Study|Withdrawal by Subject|3|||
126775440|NCT03208933|456134068|FG000|Overall Study|Adverse Event|1|||
126775441|NCT03208933|456134068|FG000|Overall Study|Lost to Follow-up|2|||
126775442|NCT03208933|456134068|FG000|Overall Study|Physician Decision|3|||
126775443|NCT03208933|456134068|FG000|Overall Study|Protocol Violation|1|||
126775444|NCT00331773|456134069|FG000|Overall Study|Withdrawal by Subject|6|||
126775445|NCT00331773|456134070|FG001|Overall Study|Withdrawal by Subject|4|||
126775446|NCT00331773|456134069|FG000|Overall Study|Protocol Violation|10|||
126775447|NCT00331773|456134070|FG001|Overall Study|Protocol Violation|3|||
126775448|NCT00525031|456134075|FG000|Overall Study|Disease Progression|1|||
126775449|NCT00525031|456134076|FG001|Overall Study|Disease Progression|1|||
126775450|NCT00830063|456134077|FG000|Overall Study|Adverse Event|7|||
126775451|NCT00830063|456134078|FG001|Overall Study|Adverse Event|13|||
126775452|NCT00830063|456134079|FG002|Overall Study|Adverse Event|16|||
126775453|NCT00830063|456134080|FG003|Overall Study|Adverse Event|13|||
126775454|NCT00830063|456134077|FG000|Overall Study|Death|1|||
126775455|NCT00830063|456134078|FG001|Overall Study|Death|0|||
126775456|NCT00830063|456134079|FG002|Overall Study|Death|0|||
126775457|NCT00830063|456134080|FG003|Overall Study|Death|0|||
126775458|NCT00830063|456134077|FG000|Overall Study|Lost to Follow-up|0|||
126775459|NCT00830063|456134078|FG001|Overall Study|Lost to Follow-up|0|||
126775460|NCT00830063|456134079|FG002|Overall Study|Lost to Follow-up|3|||
126502045|NCT02171260|455138329|FG001|Overall Study|Death|0|||
126502046|NCT02171260|455138330|FG002|Overall Study|Death|0|||
126502047|NCT02171260|455138331|FG003|Overall Study|Death|1|||
126502048|NCT02171260|455138328|FG000|Overall Study|Physician Decision|1|||
126502049|NCT02171260|455138329|FG001|Overall Study|Physician Decision|0|||
126502050|NCT02171260|455138330|FG002|Overall Study|Physician Decision|1|||
126502051|NCT02171260|455138331|FG003|Overall Study|Physician Decision|0|||
126502052|NCT02171260|455138328|FG000|Overall Study|Withdrawal by Subject|1|||
126502053|NCT02171260|455138329|FG001|Overall Study|Withdrawal by Subject|0|||
126502054|NCT02171260|455138330|FG002|Overall Study|Withdrawal by Subject|0|||
126502055|NCT02171260|455138331|FG003|Overall Study|Withdrawal by Subject|0|||
126502056|NCT02171260|455138328|FG000|Overall Study|Evidence of progressive disease|4|||
126502057|NCT02171260|455138329|FG001|Overall Study|Evidence of progressive disease|6|||
126502058|NCT02171260|455138330|FG002|Overall Study|Evidence of progressive disease|4|||
126502059|NCT02171260|455138331|FG003|Overall Study|Evidence of progressive disease|4|||
126502060|NCT00323492|455138332|FG000|Study Phase 1|Adverse Event|2|||
126561374|NCT00691028|455349904|FG000|Double-blind Period|Adverse Event|8|||
126775461|NCT00830063|456134080|FG003|Overall Study|Lost to Follow-up|1|||
126775462|NCT00830063|456134077|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
126775463|NCT00830063|456134078|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
126775464|NCT00830063|456134079|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
126775465|NCT00830063|456134080|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
126775466|NCT00830063|456134077|FG000|Overall Study|Lack of Efficacy|51|||
126775467|NCT00830063|456134078|FG001|Overall Study|Lack of Efficacy|23|||
126502061|NCT00323492|455138333|FG001|Study Phase 1|Adverse Event|0|||
126502062|NCT00323492|455138334|FG002|Study Phase 1|Adverse Event|0|||
126502063|NCT00323492|455138332|FG000|Study Phase 2|Adverse Event|1|||
126775468|NCT00830063|456134079|FG002|Overall Study|Lack of Efficacy|25|||
126775469|NCT00830063|456134080|FG003|Overall Study|Lack of Efficacy|32|||
126775470|NCT00830063|456134077|FG000|Overall Study|Other|5|||
126775471|NCT00830063|456134078|FG001|Overall Study|Other|5|||
126775472|NCT00830063|456134079|FG002|Overall Study|Other|8|||
126775473|NCT00830063|456134080|FG003|Overall Study|Other|6|||
126775474|NCT00830063|456134077|FG000|Overall Study|Withdrawal by Subject|16|||
126775475|NCT00830063|456134078|FG001|Overall Study|Withdrawal by Subject|10|||
126775476|NCT00830063|456134079|FG002|Overall Study|Withdrawal by Subject|16|||
126775477|NCT00830063|456134080|FG003|Overall Study|Withdrawal by Subject|13|||
126775478|NCT00830063|456134077|FG000|Overall Study|Protocol Violation|1|||
126775479|NCT00830063|456134078|FG001|Overall Study|Protocol Violation|0|||
126775480|NCT00830063|456134079|FG002|Overall Study|Protocol Violation|3|||
126775481|NCT00830063|456134080|FG003|Overall Study|Protocol Violation|2|||
126775482|NCT00830063|456134077|FG000|Overall Study|Randomized But Not Treated|0|||
126775483|NCT00830063|456134078|FG001|Overall Study|Randomized But Not Treated|2|||
126775484|NCT00830063|456134079|FG002|Overall Study|Randomized But Not Treated|0|||
126775485|NCT00830063|456134080|FG003|Overall Study|Randomized But Not Treated|2|||
126775486|NCT02140164|456134081|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
126775487|NCT01872689|456134092|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
126775488|NCT01872689|456134093|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
126775489|NCT01872689|456134094|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
126775490|NCT01872689|456134095|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
126775491|NCT01872689|456134092|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
126775492|NCT01872689|456134093|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
126775493|NCT01872689|456134094|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
126775494|NCT01872689|456134095|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
126775495|NCT01872689|456134092|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
126775496|NCT01872689|456134093|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
126775497|NCT01872689|456134094|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
126775498|NCT01872689|456134095|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
126775499|NCT01872689|456134092|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
126775500|NCT01872689|456134093|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
126775501|NCT01872689|456134094|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
126775502|NCT01872689|456134095|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
126775503|NCT01872689|456134092|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
126775504|NCT01872689|456134093|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
126775505|NCT01872689|456134094|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
126775506|NCT01872689|456134095|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
126775507|NCT01872689|456134092|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
126775508|NCT01872689|456134093|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
126775509|NCT01872689|456134094|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
126775510|NCT01872689|456134095|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
126775511|NCT01872689|456134092|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
126775512|NCT01872689|456134093|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
126775513|NCT01872689|456134094|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
126775514|NCT01872689|456134095|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
126775515|NCT01872689|456134092|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
126775516|NCT01872689|456134093|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
126775517|NCT01872689|456134094|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
126775518|NCT01872689|456134095|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
126775519|NCT01872689|456134092|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
126775520|NCT01872689|456134093|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
126775521|NCT01872689|456134094|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
126775522|NCT01872689|456134095|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
126775523|NCT01872689|456134092|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
126775524|NCT01872689|456134093|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
126775525|NCT01872689|456134094|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
126775526|NCT01872689|456134095|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
126775527|NCT01872689|456134092|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
126775528|NCT01872689|456134093|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
126775529|NCT01872689|456134094|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
126775530|NCT01872689|456134095|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
126775531|NCT01872689|456134092|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
126775532|NCT01872689|456134093|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
126775533|NCT01872689|456134094|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
126775534|NCT01872689|456134095|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
126775535|NCT01872689|456134092|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
126561375|NCT00691028|455349905|FG001|Double-blind Period|Adverse Event|9|||
126775536|NCT01872689|456134093|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
126775537|NCT01872689|456134094|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
126775538|NCT01872689|456134095|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
126775539|NCT01872689|456134092|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
126775540|NCT01872689|456134093|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
126775541|NCT01872689|456134094|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
126775542|NCT01872689|456134095|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
126775543|NCT00881959|456134098|FG000|Overall Study|Lost to Follow-up|2|||
126775544|NCT00881959|456134099|FG001|Overall Study|Lost to Follow-up|4|||
126775545|NCT00686374|456134101|FG000|Overall Study|Lack of Efficacy|10|||
126775546|NCT00686374|456134101|FG000|Overall Study|Adverse Event|8|||
126775547|NCT00686374|456134101|FG000|Overall Study|Withdrew consent|5|||
126775548|NCT00686374|456134101|FG000|Overall Study|Lost to Follow-up|1|||
126775549|NCT00686374|456134101|FG000|Overall Study|Missing reason|33|||
126775550|NCT00686374|456134101|FG000|Overall Study|Other, not specified|4|||
126775551|NCT01808209|456134102|FG000|Overall Study|Lost to Follow-up|0|||
126775552|NCT01808209|456134103|FG001|Overall Study|Lost to Follow-up|1|||
126775553|NCT03066440|456134104|FG000|Overall Study|Physician Decision|1|||
126775554|NCT03066440|456134105|FG001|Overall Study|Physician Decision|1|||
126775555|NCT03066440|456134104|FG000|Overall Study|Protocol Violation|0|||
126775556|NCT03066440|456134105|FG001|Overall Study|Protocol Violation|2|||
126775557|NCT01106352|456134113|FG000|Overall Study|Subjects untreated|0|||
126775558|NCT01106352|456134114|FG001|Overall Study|Subjects untreated|0|||
126775559|NCT01106352|456134115|FG002|Overall Study|Subjects untreated|0|||
126775560|NCT01106352|456134116|FG003|Overall Study|Subjects untreated|3|||
126775561|NCT01106352|456134117|FG004|Overall Study|Subjects untreated|4|||
126775562|NCT01106352|456134113|FG000|Overall Study|Sponsor Decision|1|||
126775563|NCT01106352|456134114|FG001|Overall Study|Sponsor Decision|0|||
126775564|NCT01106352|456134115|FG002|Overall Study|Sponsor Decision|0|||
126775565|NCT01106352|456134116|FG003|Overall Study|Sponsor Decision|0|||
126775566|NCT01106352|456134117|FG004|Overall Study|Sponsor Decision|0|||
126775567|NCT01106352|456134113|FG000|Overall Study|Too ill to come in for the visit|0|||
126775568|NCT01106352|456134114|FG001|Overall Study|Too ill to come in for the visit|0|||
126775569|NCT01106352|456134115|FG002|Overall Study|Too ill to come in for the visit|1|||
126775570|NCT01106352|456134116|FG003|Overall Study|Too ill to come in for the visit|0|||
126775571|NCT01106352|456134117|FG004|Overall Study|Too ill to come in for the visit|0|||
126502064|NCT00323492|455138333|FG001|Study Phase 2|Adverse Event|0|||
126502065|NCT00323492|455138334|FG002|Study Phase 2|Adverse Event|0|||
126502066|NCT00323492|455138332|FG000|Study Phase 2|Physician Decision|1|||
126502067|NCT00323492|455138333|FG001|Study Phase 2|Physician Decision|0|||
126502068|NCT00323492|455138334|FG002|Study Phase 2|Physician Decision|0|||
126502069|NCT00323492|455138332|FG000|Study Phase 2|Lost to Follow-up|1|||
126502070|NCT00323492|455138333|FG001|Study Phase 2|Lost to Follow-up|0|||
126502071|NCT00323492|455138334|FG002|Study Phase 2|Lost to Follow-up|0|||
126502072|NCT00323492|455138332|FG000|Study Phase 2|Withdrawal by Subject|0|||
126502073|NCT00323492|455138333|FG001|Study Phase 2|Withdrawal by Subject|1|||
126502074|NCT00323492|455138334|FG002|Study Phase 2|Withdrawal by Subject|0|||
126502075|NCT00323492|455138332|FG000|Study Phase 2|Noncompliance with study schedule|0|||
126502076|NCT00323492|455138333|FG001|Study Phase 2|Noncompliance with study schedule|0|||
126502077|NCT00323492|455138334|FG002|Study Phase 2|Noncompliance with study schedule|1|||
126502078|NCT00323492|455138332|FG000|Study Phase 2|Protocol Violation|1|||
126502079|NCT00323492|455138333|FG001|Study Phase 2|Protocol Violation|0|||
126502080|NCT00323492|455138334|FG002|Study Phase 2|Protocol Violation|0|||
126502081|NCT01319877|455138337|FG000|Overall Study|Lost to Follow-up|100|||
126502082|NCT01319877|455138338|FG001|Overall Study|Lost to Follow-up|37|||
126502083|NCT01319877|455138337|FG000|Overall Study|Physician Decision|2|||
126502084|NCT01319877|455138338|FG001|Overall Study|Physician Decision|0|||
126502085|NCT01319877|455138337|FG000|Overall Study|Disease Progression|2|||
126502086|NCT01319877|455138338|FG001|Overall Study|Disease Progression|2|||
126502087|NCT01319877|455138337|FG000|Overall Study|Withdrawal by Subject|0|||
126502088|NCT01319877|455138338|FG001|Overall Study|Withdrawal by Subject|1|||
126502089|NCT01319877|455138337|FG000|Overall Study|Reason Not Specified|4|||
126502090|NCT01319877|455138338|FG001|Overall Study|Reason Not Specified|5|||
126502091|NCT01342510|455138341|FG000|Overall Study|Protocol Violation|12|||
126502092|NCT01342510|455138342|FG001|Overall Study|Protocol Violation|6|||
126775572|NCT01106352|456134113|FG000|Overall Study|Lost to Follow-up|0|||
126775573|NCT01106352|456134114|FG001|Overall Study|Lost to Follow-up|0|||
126775574|NCT01106352|456134115|FG002|Overall Study|Lost to Follow-up|0|||
126775575|NCT01106352|456134116|FG003|Overall Study|Lost to Follow-up|0|||
126775576|NCT01106352|456134117|FG004|Overall Study|Lost to Follow-up|1|||
126775577|NCT01106352|456134113|FG000|Overall Study|Death|0|||
126775578|NCT01106352|456134114|FG001|Overall Study|Death|0|||
126775579|NCT01106352|456134115|FG002|Overall Study|Death|1|||
126502093|NCT01342510|455138343|FG002|Overall Study|Protocol Violation|13|||
126502094|NCT01342510|455138344|FG003|Overall Study|Protocol Violation|11|||
126502095|NCT01400516|455138346|FG000|Primary Trial|Withdrawal by Subject|0|||
126502096|NCT01400516|455138347|FG001|Primary Trial|Withdrawal by Subject|2|||
126502097|NCT05756790|455138355|FG000|Overall Study|Withdrawal by Subject|1|||
126775580|NCT01106352|456134116|FG003|Overall Study|Death|3|||
126775581|NCT01106352|456134117|FG004|Overall Study|Death|1|||
126775582|NCT01106352|456134113|FG000|Overall Study|Disease progression|0|||
126775583|NCT01106352|456134114|FG001|Overall Study|Disease progression|0|||
126775584|NCT01106352|456134115|FG002|Overall Study|Disease progression|0|||
126775585|NCT01106352|456134116|FG003|Overall Study|Disease progression|1|||
126775586|NCT01106352|456134117|FG004|Overall Study|Disease progression|0|||
126775587|NCT01106352|456134113|FG000|Overall Study|Withdrawal by Subject|0|||
126775588|NCT01106352|456134114|FG001|Overall Study|Withdrawal by Subject|0|||
126775589|NCT01106352|456134115|FG002|Overall Study|Withdrawal by Subject|0|||
126775590|NCT01106352|456134116|FG003|Overall Study|Withdrawal by Subject|3|||
126775591|NCT01106352|456134117|FG004|Overall Study|Withdrawal by Subject|2|||
126775592|NCT01106352|456134113|FG000|Overall Study|Went on hospice|0|||
126775593|NCT01106352|456134114|FG001|Overall Study|Went on hospice|0|||
126775594|NCT01106352|456134115|FG002|Overall Study|Went on hospice|0|||
126775595|NCT01106352|456134116|FG003|Overall Study|Went on hospice|1|||
126775596|NCT01106352|456134117|FG004|Overall Study|Went on hospice|0|||
126775597|NCT01106352|456134113|FG000|Overall Study|Subject entered hospice|0|||
126775598|NCT01106352|456134114|FG001|Overall Study|Subject entered hospice|0|||
126775599|NCT01106352|456134115|FG002|Overall Study|Subject entered hospice|0|||
126775600|NCT01106352|456134116|FG003|Overall Study|Subject entered hospice|1|||
126502098|NCT05756790|455138356|FG001|Overall Study|Withdrawal by Subject|1|||
126775601|NCT01106352|456134117|FG004|Overall Study|Subject entered hospice|0|||
126775602|NCT01106352|456134113|FG000|Overall Study|Home hospice since July 2013|0|||
126775603|NCT01106352|456134114|FG001|Overall Study|Home hospice since July 2013|0|||
126775604|NCT01106352|456134115|FG002|Overall Study|Home hospice since July 2013|0|||
126775605|NCT01106352|456134116|FG003|Overall Study|Home hospice since July 2013|1|||
126775606|NCT01106352|456134117|FG004|Overall Study|Home hospice since July 2013|0|||
126775607|NCT03944707|456134118|FG000|Overall Study|Adverse Event|0|||
126775608|NCT03944707|456134119|FG001|Overall Study|Adverse Event|2|||
126775609|NCT03944707|456134118|FG000|Overall Study|Study terminated by sponsor|12|||
126775610|NCT03944707|456134119|FG001|Overall Study|Study terminated by sponsor|7|||
126775611|NCT03944707|456134118|FG000|Overall Study|Subject decision|0|||
126775612|NCT03944707|456134119|FG001|Overall Study|Subject decision|1|||
126775613|NCT00751998|456134125|FG000|Overall Study|Lost to Follow-up|7|||
126775614|NCT00751998|456134125|FG000|Overall Study|Death|11|||
126775615|NCT00751998|456134125|FG000|Overall Study|Withdrawal by Subject|2|||
126775616|NCT02983227|456134126|FG000|Overall Study|Adverse Event|21|||
126775617|NCT02983227|456134127|FG001|Overall Study|Adverse Event|3|||
126775618|NCT02983227|456134126|FG000|Overall Study|Death|3|||
126775619|NCT02983227|456134127|FG001|Overall Study|Death|0|||
126775620|NCT02983227|456134126|FG000|Overall Study|Lack of Efficacy|8|||
126775621|NCT02983227|456134127|FG001|Overall Study|Lack of Efficacy|1|||
126775622|NCT02983227|456134126|FG000|Overall Study|Lost to Follow-up|3|||
126775623|NCT02983227|456134127|FG001|Overall Study|Lost to Follow-up|0|||
126775624|NCT02983227|456134126|FG000|Overall Study|Multiple Reasons|2|||
126775625|NCT02983227|456134127|FG001|Overall Study|Multiple Reasons|1|||
126775626|NCT02983227|456134126|FG000|Overall Study|Physician Decision|3|||
126775627|NCT02983227|456134127|FG001|Overall Study|Physician Decision|1|||
126775628|NCT02983227|456134126|FG000|Overall Study|Withdrawal by Subject|19|||
126775629|NCT02983227|456134127|FG001|Overall Study|Withdrawal by Subject|8|||
126775630|NCT01946282|456134128|FG000|Year 1|Did not return FIT kit|4186|||
126775631|NCT01946282|456134129|FG001|Year 1|Did not return FIT kit|608|||
126775632|NCT01946282|456134130|FG002|Year 1|Did not return FIT kit|654|||
126775633|NCT01946282|456134128|FG000|Year 2|Did not return FIT kit|803|||
126775634|NCT01946282|456134129|FG001|Year 2|Did not return FIT kit|131|||
126775635|NCT01946282|456134130|FG002|Year 2|Did not return FIT kit|115|||
126775636|NCT01946282|456134128|FG000|Year 3|Did not return FIT kit|288|||
126775637|NCT01946282|456134129|FG001|Year 3|Did not return FIT kit|43|||
126775638|NCT01946282|456134130|FG002|Year 3|Did not return FIT kit|30|||
126775639|NCT01507831|456134131|FG000|Overall Study|Randomized but not treated|0|||
126775640|NCT01507831|456134132|FG001|Overall Study|Randomized but not treated|3|||
126775641|NCT01507831|456134131|FG000|Overall Study|Adverse Event|48|||
126775642|NCT01507831|456134132|FG001|Overall Study|Adverse Event|113|||
126775643|NCT01507831|456134131|FG000|Overall Study|Death|6|||
126775644|NCT01507831|456134132|FG001|Overall Study|Death|2|||
126775645|NCT01507831|456134131|FG000|Overall Study|Poor compliance to protocol|38|||
126775646|NCT01507831|456134132|FG001|Overall Study|Poor compliance to protocol|60|||
126775647|NCT01507831|456134131|FG000|Overall Study|Physician Decision|0|||
126775648|NCT01507831|456134132|FG001|Overall Study|Physician Decision|4|||
126775649|NCT01507831|456134131|FG000|Overall Study|Participant moved|5|||
126775650|NCT01507831|456134132|FG001|Overall Study|Participant moved|19|||
126775651|NCT01507831|456134131|FG000|Overall Study|Consent withdrawn by participant|34|||
126775652|NCT01507831|456134132|FG001|Overall Study|Consent withdrawn by participant|72|||
126775653|NCT01507831|456134131|FG000|Overall Study|Related to study drug administration|5|||
126502099|NCT05756790|455138357|FG002|Overall Study|Withdrawal by Subject|1|||
126502100|NCT05756790|455138358|FG003|Overall Study|Withdrawal by Subject|1|||
126775654|NCT01507831|456134132|FG001|Overall Study|Related to study drug administration|14|||
126775655|NCT01507831|456134131|FG000|Overall Study|Last visit outside protocol visit window|51|||
126775656|NCT01507831|456134132|FG001|Overall Study|Last visit outside protocol visit window|143|||
126775657|NCT01507831|456134131|FG000|Overall Study|Selection criteria finally not met|0|||
126775658|NCT01507831|456134132|FG001|Overall Study|Selection criteria finally not met|1|||
126775659|NCT01507831|456134131|FG000|Overall Study|Site closure|0|||
126775660|NCT01507831|456134132|FG001|Overall Study|Site closure|3|||
126775661|NCT01507831|456134131|FG000|Overall Study|Potential lost to follow-up|3|||
126775662|NCT01507831|456134132|FG001|Overall Study|Potential lost to follow-up|0|||
126775663|NCT01507831|456134131|FG000|Overall Study|Other|3|||
126775664|NCT01507831|456134132|FG001|Overall Study|Other|6|||
126775665|NCT01021137|456134133|FG000|Overall Study|Lost to Follow-up|9|||
126775666|NCT01021137|456134134|FG001|Overall Study|Lost to Follow-up|4|||
126775667|NCT01021137|456134135|FG002|Overall Study|Lost to Follow-up|2|||
126775668|NCT01021137|456134136|FG003|Overall Study|Lost to Follow-up|6|||
126775669|NCT01021137|456134133|FG000|Overall Study|Withdrawal by Subject|1|||
126775670|NCT01021137|456134134|FG001|Overall Study|Withdrawal by Subject|0|||
126775671|NCT01021137|456134135|FG002|Overall Study|Withdrawal by Subject|0|||
126775672|NCT01021137|456134136|FG003|Overall Study|Withdrawal by Subject|3|||
126775673|NCT03439293|456134137|FG000|Overall Study|Death|22|||
126775674|NCT03439293|456134137|FG000|Overall Study|Withdrawal by Subject|8|||
126775675|NCT03439293|456134137|FG000|Overall Study|Lost to Follow-up|2|||
126775676|NCT03439293|456134137|FG000|Overall Study|Reason Not Specified|28|||
126775677|NCT03439293|456134137|FG000|Overall Study|Missing|1|||
126775678|NCT02766400|456134139|FG000|Overall Study|Death|1|||
126775679|NCT02766400|456134140|FG001|Overall Study|Death|2|||
126775680|NCT02766400|456134139|FG000|Overall Study|Withdrawal by Subject|1|||
126775681|NCT02766400|456134140|FG001|Overall Study|Withdrawal by Subject|0|||
126775682|NCT03499249|456134145|FG000|Overall Study|Physician Decision|1|||
126775683|NCT01559818|456134149|FG000|Overall Study|Physician Decision|1|||
126775684|NCT01559818|456134149|FG000|Overall Study|Pregnancy|1|||
126775685|NCT01559818|456134149|FG000|Overall Study|Study terminated by Sponsor|4|||
126775686|NCT01559818|456134149|FG000|Overall Study|Withdrawal by Subject|1|||
126775687|NCT04071626|456134153|FG000|Overall Study|Withdrawal by Subject|1|||
126775688|NCT04071626|456134154|FG001|Overall Study|Withdrawal by Subject|1|||
126775689|NCT04071626|456134153|FG000|Overall Study|Protocol Violation|0|||
126775690|NCT04071626|456134154|FG001|Overall Study|Protocol Violation|1|||
126775691|NCT01374906|456134155|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126775692|NCT01374906|456134156|FG001|Overall Study|Abnormal laboratory value(s)|3|||
126775693|NCT01374906|456134155|FG000|Overall Study|Administrative problems|2|||
126775694|NCT01374906|456134156|FG001|Overall Study|Administrative problems|2|||
126775695|NCT01374906|456134155|FG000|Overall Study|Adverse Event|10|||
126775696|NCT01374906|456134156|FG001|Overall Study|Adverse Event|11|||
126775697|NCT01374906|456134155|FG000|Overall Study|Death|0|||
126775698|NCT01374906|456134156|FG001|Overall Study|Death|2|||
126775699|NCT01374906|456134155|FG000|Overall Study|Protocol Violation|2|||
126775700|NCT01374906|456134156|FG001|Overall Study|Protocol Violation|2|||
126775701|NCT01374906|456134155|FG000|Overall Study|Withdrawal by Subject|15|||
126775702|NCT01374906|456134156|FG001|Overall Study|Withdrawal by Subject|9|||
126775703|NCT01374906|456134155|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
126775704|NCT01374906|456134156|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
126775705|NCT02475980|456134157|FG000|Overall Study|Lost to Follow-up|4|||
126775706|NCT02475980|456134157|FG000|Overall Study|Withdrawal by Subject|1|||
126775707|NCT00665626|456134161|FG000|Overall Study|Lack of Efficacy|8|||
126775708|NCT00665626|456134162|FG001|Overall Study|Lack of Efficacy|5|||
126775709|NCT00665626|456134161|FG000|Overall Study|Lost to Follow-up|0|||
126775710|NCT00665626|456134162|FG001|Overall Study|Lost to Follow-up|2|||
126775711|NCT00665626|456134161|FG000|Overall Study|Withdrawal by Subject|0|||
126775712|NCT00665626|456134162|FG001|Overall Study|Withdrawal by Subject|1|||
126775713|NCT00665626|456134161|FG000|Overall Study|Protocol Violation|0|||
126775714|NCT00665626|456134162|FG001|Overall Study|Protocol Violation|2|||
126775715|NCT00665626|456134161|FG000|Overall Study|Adverse Event|1|||
126775716|NCT00665626|456134162|FG001|Overall Study|Adverse Event|9|||
126775717|NCT00665626|456134161|FG000|Overall Study|Due to exclusion criteria|0|||
126775718|NCT00665626|456134162|FG001|Overall Study|Due to exclusion criteria|1|||
126775719|NCT00665626|456134161|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
126775720|NCT00665626|456134162|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
126775721|NCT00665626|456134161|FG000|Overall Study|Unably to comply with dosing regimen|0|||
126775722|NCT00665626|456134162|FG001|Overall Study|Unably to comply with dosing regimen|1|||
126775723|NCT00665626|456134161|FG000|Overall Study|Death|1|||
126775724|NCT00665626|456134162|FG001|Overall Study|Death|0|||
126502101|NCT05756790|455138359|FG004|Overall Study|Withdrawal by Subject|0|||
126502102|NCT05756790|455138360|FG005|Overall Study|Withdrawal by Subject|0|||
126502103|NCT05756790|455138355|FG000|Overall Study|Protocol Violation|0|||
126775725|NCT04147611|456134163|FG000|Overall Study|Physician Decision|0|||
126775726|NCT04147611|456134164|FG001|Overall Study|Physician Decision|1|||
126775727|NCT01629693|456134167|FG000|Overall Study|Lost to Follow-up|2|||
126775728|NCT01629693|456134168|FG001|Overall Study|Lost to Follow-up|4|||
126775729|NCT01629693|456134167|FG000|Overall Study|Withdrawal by Subject|2|||
126775730|NCT01629693|456134168|FG001|Overall Study|Withdrawal by Subject|2|||
126502104|NCT05756790|455138356|FG001|Overall Study|Protocol Violation|0|||
126502105|NCT05756790|455138357|FG002|Overall Study|Protocol Violation|1|||
126502106|NCT05756790|455138358|FG003|Overall Study|Protocol Violation|1|||
126502107|NCT05756790|455138359|FG004|Overall Study|Protocol Violation|0|||
126502108|NCT05756790|455138360|FG005|Overall Study|Protocol Violation|0|||
126502109|NCT05756790|455138355|FG000|Overall Study|Ineligible|0|||
126502110|NCT05756790|455138356|FG001|Overall Study|Ineligible|0|||
126502111|NCT05756790|455138357|FG002|Overall Study|Ineligible|0|||
126502112|NCT05756790|455138358|FG003|Overall Study|Ineligible|0|||
126502113|NCT05756790|455138359|FG004|Overall Study|Ineligible|2|||
126502114|NCT05756790|455138360|FG005|Overall Study|Ineligible|2|||
126502115|NCT00502697|455139868|FG000|Overall Study|Withdrawal by Subject|3|||
126502116|NCT00502697|455139869|FG001|Overall Study|Withdrawal by Subject|1|||
126502117|NCT00502697|455139868|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
126502118|NCT00502697|455139869|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
126502119|NCT00502697|455139868|FG000|Overall Study|found not to meet eligibility criteria|3|||
126502120|NCT00502697|455139869|FG001|Overall Study|found not to meet eligibility criteria|4|||
126502121|NCT00502697|455139868|FG000|Overall Study|did not meet assignment criteria|4|||
126502122|NCT00502697|455139869|FG001|Overall Study|did not meet assignment criteria|2|||
126502123|NCT01545817|455139870|FG000|Pazopanib|Disease progression|51|||
126502124|NCT01545817|455139871|FG001|Pazopanib|Disease progression|0|||
126502125|NCT01545817|455139870|FG000|Pazopanib|Adverse Event|19|||
126502126|NCT01545817|455139871|FG001|Pazopanib|Adverse Event|0|||
126502127|NCT01545817|455139870|FG000|Pazopanib|Other reason|4|||
126502128|NCT01545817|455139871|FG001|Pazopanib|Other reason|0|||
126502129|NCT01545817|455139870|FG000|Everolimus|Other reason|0|||
126502130|NCT01545817|455139871|FG001|Everolimus|Other reason|7|||
126502131|NCT01545817|455139870|FG000|Everolimus|Disease progression|0|||
126502132|NCT01545817|455139871|FG001|Everolimus|Disease progression|25|||
126502133|NCT01545817|455139870|FG000|Everolimus|Adverse Event|0|||
126502134|NCT01545817|455139871|FG001|Everolimus|Adverse Event|6|||
126502135|NCT00589108|455139875|FG000|Overall Study|Lost to Follow-up|1|||
126502136|NCT00589108|455139876|FG001|Overall Study|Lost to Follow-up|1|||
126502137|NCT00589108|455139877|FG002|Overall Study|Lost to Follow-up|1|||
126502138|NCT00589108|455139875|FG000|Overall Study|Death|3|||
126502139|NCT00589108|455139876|FG001|Overall Study|Death|3|||
126502140|NCT00589108|455139877|FG002|Overall Study|Death|4|||
126502141|NCT03026257|455139878|FG000|Overall Study|Adverse Event|3|||
126502142|NCT03026257|455139879|FG001|Overall Study|Adverse Event|0|||
126502143|NCT03026257|455139880|FG002|Overall Study|Adverse Event|0|||
126502144|NCT03026257|455139881|FG003|Overall Study|Adverse Event|0|||
126502145|NCT03026257|455139882|FG004|Overall Study|Adverse Event|0|||
126502146|NCT03026257|455139883|FG005|Overall Study|Adverse Event|0|||
126502147|NCT03026257|455139878|FG000|Overall Study|Lost to Follow-up|1|||
126502148|NCT03026257|455139879|FG001|Overall Study|Lost to Follow-up|0|||
126502149|NCT03026257|455139880|FG002|Overall Study|Lost to Follow-up|0|||
126502150|NCT03026257|455139881|FG003|Overall Study|Lost to Follow-up|0|||
126502151|NCT03026257|455139882|FG004|Overall Study|Lost to Follow-up|0|||
126502152|NCT03026257|455139883|FG005|Overall Study|Lost to Follow-up|0|||
126502153|NCT03026257|455139878|FG000|Overall Study|Protocol Violation|1|||
126502154|NCT03026257|455139879|FG001|Overall Study|Protocol Violation|0|||
126502155|NCT03026257|455139880|FG002|Overall Study|Protocol Violation|0|||
126502156|NCT03026257|455139881|FG003|Overall Study|Protocol Violation|1|||
126502157|NCT03026257|455139882|FG004|Overall Study|Protocol Violation|1|||
126502158|NCT03026257|455139883|FG005|Overall Study|Protocol Violation|0|||
126502159|NCT03026257|455139878|FG000|Overall Study|Withdrawal by Subject|1|||
126726466|NCT00310388|455948929|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
126726467|NCT00310388|455948930|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
126726468|NCT00310388|455948929|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
126726469|NCT00310388|455948930|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
126726470|NCT00310388|455948929|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
126726471|NCT00310388|455948930|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
126726472|NCT03457103|455948934|FG000|Overall Study|illness/hospitalization|4|||
126726473|NCT03457103|455948935|FG001|Overall Study|illness/hospitalization|2|||
126726474|NCT03457103|455948934|FG000|Overall Study|Lost to Follow-up|2|||
126726475|NCT03457103|455948935|FG001|Overall Study|Lost to Follow-up|1|||
126726476|NCT03457103|455948934|FG000|Overall Study|Withdrawal by Subject|1|||
126726477|NCT03457103|455948935|FG001|Overall Study|Withdrawal by Subject|2|||
126726478|NCT03457103|455948934|FG000|Overall Study|financial/ insurance issues|1|||
126726479|NCT03457103|455948935|FG001|Overall Study|financial/ insurance issues|1|||
126726480|NCT00213980|455948936|FG000|Overall Study|Withdrawal by Subject|3|||
126726481|NCT00213980|455948937|FG001|Overall Study|Withdrawal by Subject|1|||
126726482|NCT00213980|455948936|FG000|Overall Study|Adverse Event|1|||
126726483|NCT00213980|455948937|FG001|Overall Study|Adverse Event|1|||
126726484|NCT00213980|455948936|FG000|Overall Study|Disease progression|0|||
126726485|NCT00213980|455948937|FG001|Overall Study|Disease progression|2|||
126726486|NCT00213980|455948936|FG000|Overall Study|Developed ovarian cancer|1|||
126726487|NCT00213980|455948937|FG001|Overall Study|Developed ovarian cancer|0|||
126726488|NCT00213980|455948936|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
126775731|NCT01629693|456134167|FG000|Overall Study|Adverse Event|1|||
126775732|NCT01629693|456134168|FG001|Overall Study|Adverse Event|0|||
126775733|NCT01629693|456134167|FG000|Overall Study|Investigator decision|0|||
126775734|NCT01629693|456134168|FG001|Overall Study|Investigator decision|1|||
126775735|NCT01629693|456134167|FG000|Overall Study|Poor comfort of study lenses|0|||
126775736|NCT01629693|456134168|FG001|Overall Study|Poor comfort of study lenses|2|||
126775737|NCT01629693|456134167|FG000|Overall Study|Subject decision unrelated to AE|0|||
126775738|NCT01629693|456134168|FG001|Overall Study|Subject decision unrelated to AE|1|||
126775739|NCT01529749|456134169|FG000|Overall Study|Lost to Follow-up|0|||
126775740|NCT01529749|456134170|FG001|Overall Study|Lost to Follow-up|1|||
126775741|NCT01529749|456134171|FG002|Overall Study|Lost to Follow-up|1|||
126775742|NCT01529749|456134172|FG003|Overall Study|Lost to Follow-up|0|||
126775743|NCT01529749|456134169|FG000|Overall Study|Physician Decision|0|||
126775744|NCT01529749|456134170|FG001|Overall Study|Physician Decision|0|||
126775745|NCT01529749|456134171|FG002|Overall Study|Physician Decision|0|||
126775746|NCT01529749|456134172|FG003|Overall Study|Physician Decision|1|||
126775747|NCT01529749|456134169|FG000|Overall Study|Withdrawal by Subject|0|||
126775748|NCT01529749|456134170|FG001|Overall Study|Withdrawal by Subject|1|||
126502160|NCT03026257|455139879|FG001|Overall Study|Withdrawal by Subject|1|||
126502161|NCT03026257|455139880|FG002|Overall Study|Withdrawal by Subject|0|||
126726489|NCT00213980|455948937|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
126726490|NCT00798694|455948938|FG000|Overall Study|Lost to Follow-up|1|||
126726491|NCT00798694|455948939|FG001|Overall Study|Lost to Follow-up|1|||
126726492|NCT00798694|455948938|FG000|Overall Study|Physician Decision|1|||
126726493|NCT00798694|455948939|FG001|Overall Study|Physician Decision|0|||
126726494|NCT01089582|455948953|FG000|Overall Study|Death|2|||
126726495|NCT01089582|455948953|FG000|Overall Study|Adverse Event|15|||
126726496|NCT01089582|455948953|FG000|Overall Study|Lost to Follow-up|8|||
126726497|NCT01089582|455948953|FG000|Overall Study|Other|4|||
126726498|NCT01089582|455948953|FG000|Overall Study|Withdrawal by Subject|1|||
126726499|NCT00862849|455948954|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
126502162|NCT03026257|455139881|FG003|Overall Study|Withdrawal by Subject|0|||
126502163|NCT03026257|455139882|FG004|Overall Study|Withdrawal by Subject|0|||
126502164|NCT03026257|455139883|FG005|Overall Study|Withdrawal by Subject|0|||
126502165|NCT04380857|455139884|FG000|Overall Study|Lost to Follow-up|3|||
126502166|NCT04380857|455139885|FG001|Overall Study|Lost to Follow-up|3|||
126502167|NCT02558790|455139886|FG000|Overall Study|Lost to Follow-up|2|||
126502168|NCT02558790|455139886|FG000|Overall Study|Physician Decision|1|||
126726500|NCT00862849|455948955|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
126726501|NCT00862849|455948956|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
126726502|NCT00862849|455948957|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
126726503|NCT00862849|455948958|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
126726504|NCT00862849|455948959|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
126726505|NCT00862849|455948954|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
126726506|NCT00862849|455948955|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
126726507|NCT00862849|455948956|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
126726508|NCT00862849|455948957|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
126726509|NCT00862849|455948958|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
126726510|NCT00862849|455948959|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
126726511|NCT00289185|455948966|FG000|Overall Study|Withdrawal by Subject|4|||
126726512|NCT00289185|455948967|FG001|Overall Study|Withdrawal by Subject|8|||
126726513|NCT00289185|455948966|FG000|Overall Study|Lost to Follow-up|23|||
126726514|NCT00289185|455948967|FG001|Overall Study|Lost to Follow-up|17|||
126726515|NCT00289185|455948966|FG000|Overall Study|Death|1|||
126502169|NCT02558790|455139886|FG000|Overall Study|Withdrawal by Subject|1|||
126502170|NCT02558790|455139886|FG000|Overall Study|Screen Fail|3|||
126502171|NCT00838201|455139887|FG000|Overall Study|Investigator decision, or other reasons|2|||
126502172|NCT00838201|455139888|FG001|Overall Study|Investigator decision, or other reasons|3|||
126502173|NCT00838201|455139887|FG000|Overall Study|Noncompliance|0|||
126502174|NCT00838201|455139888|FG001|Overall Study|Noncompliance|1|||
126502175|NCT00838201|455139887|FG000|Overall Study|Administrative decision|1|||
126502176|NCT00838201|455139888|FG001|Overall Study|Administrative decision|2|||
126726516|NCT00289185|455948967|FG001|Overall Study|Death|1|||
126726517|NCT02432040|455948968|FG000|Overall Study|Lack of Efficacy|3|||
126726518|NCT02432040|455948969|FG001|Overall Study|Lack of Efficacy|0|||
126775749|NCT01529749|456134171|FG002|Overall Study|Withdrawal by Subject|1|||
126775750|NCT01529749|456134172|FG003|Overall Study|Withdrawal by Subject|0|||
126775751|NCT01529749|456134169|FG000|Overall Study|Protocol Violation|0|||
126775752|NCT01529749|456134170|FG001|Overall Study|Protocol Violation|0|||
126775753|NCT01529749|456134171|FG002|Overall Study|Protocol Violation|0|||
126502177|NCT00838201|455139887|FG000|Overall Study|Disease progression|3|||
126502178|NCT00838201|455139888|FG001|Overall Study|Disease progression|3|||
126502179|NCT00838201|455139887|FG000|Overall Study|Consent withdrawn|16|||
126726519|NCT02432040|455948968|FG000|Overall Study|Lost to Follow-up|4|||
126726520|NCT02432040|455948969|FG001|Overall Study|Lost to Follow-up|5|||
126726521|NCT02432040|455948968|FG000|Overall Study|Physician Decision|1|||
126726522|NCT02432040|455948969|FG001|Overall Study|Physician Decision|1|||
126775754|NCT01529749|456134172|FG003|Overall Study|Protocol Violation|1|||
126775755|NCT04385199|456134173|FG000|Overall Study|Withdrawal by Subject|1|||
126775756|NCT04385199|456134174|FG001|Overall Study|Withdrawal by Subject|0|||
126775757|NCT00265083|456135721|FG000|Overall Study|Adverse Event|5|||
126775758|NCT00265083|456135722|FG001|Overall Study|Adverse Event|13|||
126775759|NCT00265083|456135723|FG002|Overall Study|Adverse Event|15|||
126775760|NCT00265083|456135721|FG000|Overall Study|Lost to Follow-up|3|||
126775761|NCT00265083|456135722|FG001|Overall Study|Lost to Follow-up|4|||
126775762|NCT00265083|456135723|FG002|Overall Study|Lost to Follow-up|4|||
126775763|NCT00265083|456135721|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
126561376|NCT00691028|455349906|FG002|Double-blind Period|Adverse Event|6|||
126561377|NCT00691028|455349907|FG003|Double-blind Period|Adverse Event|0|||
126561378|NCT00691028|455349904|FG000|Double-blind Period|Lack of Efficacy|4|||
126561379|NCT00691028|455349905|FG001|Double-blind Period|Lack of Efficacy|3|||
126775764|NCT00265083|456135722|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
126775765|NCT00265083|456135723|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
126775766|NCT00265083|456135721|FG000|Overall Study|Other|1|||
126502180|NCT00838201|455139888|FG001|Overall Study|Consent withdrawn|19|||
126502181|NCT00838201|455139887|FG000|Overall Study|Lost to Follow-up|4|||
126502182|NCT00838201|455139888|FG001|Overall Study|Lost to Follow-up|3|||
126502183|NCT00838201|455139887|FG000|Overall Study|Adverse Event|5|||
126502184|NCT00838201|455139888|FG001|Overall Study|Adverse Event|9|||
126502185|NCT00838201|455139887|FG000|Overall Study|Death|11|||
126502186|NCT00838201|455139888|FG001|Overall Study|Death|13|||
126502187|NCT05228470|455139892|FG000|Overall Study|Death|6|||
126502188|NCT05228470|455139893|FG001|Overall Study|Death|11|||
126502189|NCT05228470|455139892|FG000|Overall Study|Withdrawal by Subject|1|||
126502190|NCT05228470|455139893|FG001|Overall Study|Withdrawal by Subject|8|||
126502191|NCT05228470|455139892|FG000|Overall Study|Ongoing|1|||
126502192|NCT05228470|455139893|FG001|Overall Study|Ongoing|11|||
126502193|NCT00136084|455139894|FG000|Overall Study|Death|12|||
126502194|NCT00136084|455139895|FG001|Overall Study|Death|5|||
126502195|NCT00136084|455139894|FG000|Overall Study|Unacceptable toxicity|8|||
126502196|NCT00136084|455139895|FG001|Overall Study|Unacceptable toxicity|11|||
126502197|NCT00136084|455139894|FG000|Overall Study|Relapse|20|||
126502198|NCT00136084|455139895|FG001|Overall Study|Relapse|23|||
126502199|NCT00136084|455139894|FG000|Overall Study|Lost to Follow-up|2|||
126502200|NCT00136084|455139895|FG001|Overall Study|Lost to Follow-up|0|||
126502201|NCT00136084|455139894|FG000|Overall Study|No Response|1|||
126502202|NCT00136084|455139895|FG001|Overall Study|No Response|2|||
126502203|NCT00136084|455139894|FG000|Overall Study|Withdrawal by Subject|5|||
126502204|NCT00136084|455139895|FG001|Overall Study|Withdrawal by Subject|1|||
126502205|NCT02449239|455139896|FG000|Induction Phase|Lack of Efficacy|64|||
126502206|NCT02449239|455139896|FG000|Induction Phase|Adverse Event|1|||
126502207|NCT02449239|455139896|FG000|Induction Phase|Lost to Follow-up|1|||
126502208|NCT02449239|455139896|FG000|Induction Phase|Protocol Violation|1|||
126502209|NCT02449239|455139896|FG000|Induction Phase|Physician Decision|1|||
126502210|NCT02449239|455139896|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
126502211|NCT02449239|455139896|FG000|Induction Phase|Withdrawal by Subject|1|||
126502212|NCT02449239|455139896|FG000|Maintenance Month 3|Lack of Efficacy|14|||
126502213|NCT02449239|455139896|FG000|Maintenance Month 6|Lack of Efficacy|10|||
126502214|NCT02449239|455139896|FG000|Maintenance Month 6|Adverse Event|2|||
126502215|NCT02449239|455139896|FG000|Maintenance Month 6|Physician Decision|1|||
126502216|NCT02449239|455139896|FG000|Maintenance Month 9|Lack of Efficacy|2|||
126502217|NCT02449239|455139896|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
126502218|NCT02449239|455139896|FG000|Maintenance Month 12|Lack of Efficacy|5|||
126502219|NCT02449239|455139896|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
126502220|NCT02449239|455139896|FG000|Maintenance Month 12|Subject moved from area|1|||
126502221|NCT02449239|455139896|FG000|Maintenance Month 15|Lack of Efficacy|1|||
126502222|NCT02449239|455139896|FG000|Maintenance Month 21|Lack of Efficacy|1|||
126502223|NCT02449239|455139896|FG000|Maintenance Month 21|Sponsor decision|1|||
126502224|NCT02476968|455139898|FG000|Overall Study|Other|0|||
126502225|NCT02476968|455139899|FG001|Overall Study|Other|2|||
126502226|NCT02476968|455139900|FG002|Overall Study|Other|0|||
126502227|NCT02476968|455139898|FG000|Overall Study|Lost to Follow-up|10|||
126502228|NCT02476968|455139899|FG001|Overall Study|Lost to Follow-up|0|||
126502229|NCT02476968|455139900|FG002|Overall Study|Lost to Follow-up|1|||
126775767|NCT00265083|456135722|FG001|Overall Study|Other|12|||
126775768|NCT00265083|456135723|FG002|Overall Study|Other|9|||
126502230|NCT02476968|455139898|FG000|Overall Study|Death|48|||
126502231|NCT02476968|455139899|FG001|Overall Study|Death|8|||
126502232|NCT02476968|455139900|FG002|Overall Study|Death|1|||
126502233|NCT02476968|455139898|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126502234|NCT02476968|455139899|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126502235|NCT02476968|455139900|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
126502236|NCT02476968|455139898|FG000|Overall Study|Patient decision|37|||
126502237|NCT02476968|455139899|FG001|Overall Study|Patient decision|8|||
126502238|NCT02476968|455139900|FG002|Overall Study|Patient decision|0|||
126502239|NCT01723163|455139901|FG000|Treatment Phase|Withdrawal by Subject|14|||
126775769|NCT04242186|456135724|FG000|Overall Study|Death|5|||
126775770|NCT00379587|456135725|FG000|Overall Study|Lost to Follow-up|2|||
126775771|NCT00534092|456135726|FG000|Overall Study|Lost to Follow-up|1|||
126775772|NCT00534092|456135727|FG001|Overall Study|Lost to Follow-up|0|||
126775773|NCT00534092|456135726|FG000|Overall Study|personal reasons/family concerns|1|||
126775774|NCT00534092|456135727|FG001|Overall Study|personal reasons/family concerns|0|||
126775775|NCT02323295|456135728|FG000|Overall Study|Adverse Event|0|||
126775776|NCT02323295|456135729|FG001|Overall Study|Adverse Event|1|||
126775777|NCT02323295|456135728|FG000|Overall Study|Withdrawal by Subject|0|||
126775778|NCT02323295|456135729|FG001|Overall Study|Withdrawal by Subject|1|||
126775779|NCT02323295|456135728|FG000|Overall Study|Patient did not have surgery as planned.|0|||
126775780|NCT02323295|456135729|FG001|Overall Study|Patient did not have surgery as planned.|1|||
126775781|NCT01155063|456135730|FG000|Overall Study|Adverse Event|1|||
126775782|NCT01155063|456135730|FG000|Overall Study|Withdrawal by Subject|1|||
126775783|NCT01155063|456135730|FG000|Overall Study|Study terminated by sponsor|87|||
126775784|NCT01314703|456135731|FG000|Overall Study|screen failure and closed enrollment|8|||
126775785|NCT01070966|456135738|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
126775786|NCT01070966|456135738|FG000|Participants for Safety Evaluation|Off-label use|9|||
126775787|NCT01070966|456135738|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
126775788|NCT01070966|456135738|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
126775789|NCT01070966|456135738|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
126775790|NCT01070966|456135738|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
126775791|NCT01070966|456135738|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
126775792|NCT01070966|456135738|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
126775793|NCT02770716|456135739|FG000|Overall Study|Death|101|||
126775794|NCT02770716|456135740|FG001|Overall Study|Death|45|||
126775795|NCT02770716|456135739|FG000|Overall Study|Withdrawal by Subject|4|||
126775796|NCT02770716|456135740|FG001|Overall Study|Withdrawal by Subject|2|||
126775797|NCT02770716|456135739|FG000|Overall Study|Lost to Follow-up|1|||
126775798|NCT02770716|456135740|FG001|Overall Study|Lost to Follow-up|0|||
126775799|NCT02770716|456135739|FG000|Overall Study|Various reasons|6|||
126775800|NCT02770716|456135740|FG001|Overall Study|Various reasons|2|||
126775801|NCT01725113|456135741|FG000|Overall Study|Kidney Transplant|1|||
126775802|NCT01725113|456135742|FG001|Overall Study|Kidney Transplant|1|||
126775803|NCT01725113|456135741|FG000|Overall Study|Withdrawal by Subject|0|||
126775804|NCT01725113|456135742|FG001|Overall Study|Withdrawal by Subject|1|||
126775805|NCT03989115|456135743|FG000|Overall Study|Withdrawal by Subject|2|||
126775806|NCT03989115|456135744|FG001|Overall Study|Withdrawal by Subject|1|||
126775807|NCT03989115|456135745|FG002|Overall Study|Withdrawal by Subject|3|||
126775808|NCT03989115|456135746|FG003|Overall Study|Withdrawal by Subject|0|||
126775809|NCT03989115|456135747|FG004|Overall Study|Withdrawal by Subject|17|||
126775810|NCT03989115|456135748|FG005|Overall Study|Withdrawal by Subject|1|||
126775811|NCT03989115|456135749|FG006|Overall Study|Withdrawal by Subject|0|||
126775812|NCT03989115|456135750|FG007|Overall Study|Withdrawal by Subject|0|||
126775813|NCT03989115|456135743|FG000|Overall Study|Sponsor decision to terminate the study|1|||
126775814|NCT03989115|456135744|FG001|Overall Study|Sponsor decision to terminate the study|1|||
126775815|NCT03989115|456135745|FG002|Overall Study|Sponsor decision to terminate the study|0|||
126775816|NCT03989115|456135746|FG003|Overall Study|Sponsor decision to terminate the study|1|||
126775817|NCT03989115|456135747|FG004|Overall Study|Sponsor decision to terminate the study|11|||
126775818|NCT03989115|456135748|FG005|Overall Study|Sponsor decision to terminate the study|0|||
126775819|NCT03989115|456135749|FG006|Overall Study|Sponsor decision to terminate the study|2|||
126775820|NCT03989115|456135750|FG007|Overall Study|Sponsor decision to terminate the study|1|||
126775821|NCT03989115|456135743|FG000|Overall Study|Lost to Follow-up|2|||
126775822|NCT03989115|456135744|FG001|Overall Study|Lost to Follow-up|0|||
126775823|NCT03989115|456135745|FG002|Overall Study|Lost to Follow-up|0|||
126775824|NCT03989115|456135746|FG003|Overall Study|Lost to Follow-up|0|||
126775825|NCT03989115|456135747|FG004|Overall Study|Lost to Follow-up|1|||
126775826|NCT03989115|456135748|FG005|Overall Study|Lost to Follow-up|0|||
126775827|NCT03989115|456135749|FG006|Overall Study|Lost to Follow-up|0|||
126775828|NCT03989115|456135750|FG007|Overall Study|Lost to Follow-up|0|||
126775829|NCT03989115|456135743|FG000|Overall Study|Death|2|||
126775830|NCT03989115|456135744|FG001|Overall Study|Death|2|||
126775831|NCT03989115|456135745|FG002|Overall Study|Death|9|||
126775832|NCT03989115|456135746|FG003|Overall Study|Death|6|||
126775833|NCT03989115|456135747|FG004|Overall Study|Death|31|||
126775834|NCT03989115|456135748|FG005|Overall Study|Death|6|||
126775835|NCT03989115|456135749|FG006|Overall Study|Death|2|||
126502240|NCT01723163|455139902|FG001|Treatment Phase|Withdrawal by Subject|6|||
126502241|NCT01723163|455139901|FG000|Treatment Phase|Withdrawal by PI|5|||
126502242|NCT01723163|455139902|FG001|Treatment Phase|Withdrawal by PI|1|||
126775836|NCT03989115|456135750|FG007|Overall Study|Death|3|||
126775837|NCT03989115|456135743|FG000|Overall Study|Other|1|||
126775838|NCT03989115|456135744|FG001|Overall Study|Other|2|||
126775839|NCT03989115|456135745|FG002|Overall Study|Other|0|||
126775840|NCT03989115|456135746|FG003|Overall Study|Other|0|||
126502243|NCT01723163|455139901|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
126726523|NCT02932332|455948970|FG000|Overall Study|Withdrawal by Subject|1|||
126726524|NCT02932332|455948971|FG001|Overall Study|Withdrawal by Subject|1|||
126726525|NCT02932332|455948972|FG002|Overall Study|Withdrawal by Subject|0|||
126726526|NCT02932332|455948973|FG003|Overall Study|Withdrawal by Subject|1|||
126726527|NCT02932332|455948970|FG000|Overall Study|Chest pain|0|||
126726528|NCT02932332|455948971|FG001|Overall Study|Chest pain|0|||
126726529|NCT02932332|455948972|FG002|Overall Study|Chest pain|0|||
126726530|NCT02932332|455948973|FG003|Overall Study|Chest pain|1|||
126726531|NCT02932332|455948970|FG000|Overall Study|Not Dyspneic cough|1|||
126726532|NCT02932332|455948971|FG001|Overall Study|Not Dyspneic cough|2|||
126726533|NCT02932332|455948972|FG002|Overall Study|Not Dyspneic cough|1|||
126726534|NCT02932332|455948973|FG003|Overall Study|Not Dyspneic cough|0|||
126726535|NCT02841787|455948974|FG000|Overall Study|Lost to Follow-up|1|||
126726536|NCT02841787|455948975|FG001|Overall Study|Lost to Follow-up|0|||
126726537|NCT02841787|455948976|FG002|Overall Study|Lost to Follow-up|0|||
126726538|NCT02841787|455948974|FG000|Overall Study|Symptoms dropped below threshold|1|||
126726539|NCT02841787|455948975|FG001|Overall Study|Symptoms dropped below threshold|0|||
126726540|NCT02841787|455948976|FG002|Overall Study|Symptoms dropped below threshold|0|||
126726541|NCT02841787|455948974|FG000|Overall Study|Withdrawal by Subject|1|||
126726542|NCT02841787|455948975|FG001|Overall Study|Withdrawal by Subject|4|||
126726543|NCT02841787|455948976|FG002|Overall Study|Withdrawal by Subject|0|||
126726544|NCT03633227|455948977|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
126726545|NCT03633227|455948978|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
126726546|NCT03633227|455948977|FG000|Double Blind (DB), up to Week 48|Death|2|||
126726547|NCT03633227|455948978|FG001|Double Blind (DB), up to Week 48|Death|1|||
126726548|NCT03633227|455948977|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
126726549|NCT03633227|455948978|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
126726550|NCT03633227|455948977|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
126726551|NCT03633227|455948978|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
126726552|NCT03633227|455948977|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
126726553|NCT03633227|455948978|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
126726554|NCT03633227|455948977|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
126726555|NCT03633227|455948978|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
126726556|NCT03633227|455948977|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
126726557|NCT03633227|455948978|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
126726558|NCT03633227|455948977|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
126726559|NCT03633227|455948978|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
126726560|NCT03633227|455948977|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
126726561|NCT03633227|455948978|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
126726562|NCT03633227|455948977|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
126726563|NCT03633227|455948978|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
126726564|NCT03633227|455948977|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
126726565|NCT03633227|455948978|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
126726566|NCT03633227|455948977|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
126726567|NCT03633227|455948978|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
126726568|NCT01069523|455948979|FG000|Overall Study|Withdrawal by Subject|4|||
126726569|NCT01069523|455948980|FG001|Overall Study|Withdrawal by Subject|7|||
126726570|NCT02951988|455948999|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
126726571|NCT02951988|455949000|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
126726572|NCT02951988|455949001|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
126726573|NCT02951988|455949002|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
126726574|NCT02951988|455948999|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
126726575|NCT02951988|455949000|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
126726576|NCT02951988|455949001|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
126726577|NCT02951988|455949002|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
126726578|NCT02951988|455948999|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
126726579|NCT02951988|455949000|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
126726580|NCT02951988|455949001|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
126726581|NCT02951988|455949002|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
126726582|NCT02951988|455948999|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
126726583|NCT02951988|455949000|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
126726584|NCT02951988|455949001|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
126726585|NCT02951988|455949002|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
126726586|NCT02951988|455948999|FG000|Open-Label Treatment Period|Protocol Violation|22|||
126726587|NCT02951988|455949000|FG001|Open-Label Treatment Period|Protocol Violation|0|||
126726588|NCT02951988|455949001|FG002|Open-Label Treatment Period|Protocol Violation|0|||
126726589|NCT02951988|455949002|FG003|Open-Label Treatment Period|Protocol Violation|0|||
126726590|NCT02951988|455948999|FG000|Open-Label Treatment Period|Pregnancy|2|||
126561380|NCT00691028|455349906|FG002|Double-blind Period|Lack of Efficacy|2|||
126561381|NCT00691028|455349907|FG003|Double-blind Period|Lack of Efficacy|0|||
126561382|NCT00691028|455349904|FG000|Double-blind Period|Withdrawal by Subject|1|||
126561383|NCT00691028|455349905|FG001|Double-blind Period|Withdrawal by Subject|0|||
126561384|NCT00691028|455349906|FG002|Double-blind Period|Withdrawal by Subject|1|||
126561385|NCT00691028|455349907|FG003|Double-blind Period|Withdrawal by Subject|0|||
126561386|NCT00691028|455349904|FG000|Double-blind Period|not come to a hospital.|0|||
126561387|NCT00691028|455349905|FG001|Double-blind Period|not come to a hospital.|1|||
126561388|NCT00691028|455349906|FG002|Double-blind Period|not come to a hospital.|0|||
126561389|NCT00691028|455349907|FG003|Double-blind Period|not come to a hospital.|0|||
126561390|NCT00058058|455349908|FG000|Overall Study|Withdrawal by Subject|4|||
126561391|NCT00058058|455349908|FG000|Overall Study|Ineligible|20|||
126561392|NCT00058058|455349908|FG000|Overall Study|Claustrophobic|5|||
126561393|NCT00058058|455349908|FG000|Overall Study|technical issues|6|||
126561394|NCT00058058|455349908|FG000|Overall Study|Poor positioning, illness,pain|3|||
126561395|NCT03255018|455349912|FG000|Overall Study|Death on study|0|||
126561396|NCT03255018|455349913|FG001|Overall Study|Death on study|5|||
126561397|NCT03255018|455349912|FG000|Overall Study|Withdrawal by Subject|0|||
126561398|NCT03255018|455349913|FG001|Overall Study|Withdrawal by Subject|2|||
126561399|NCT01119703|455349925|FG000|Overall Study|Adverse Event|0|||
126561400|NCT01119703|455349926|FG001|Overall Study|Adverse Event|1|||
126502244|NCT01723163|455139902|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
126502245|NCT01723163|455139901|FG000|3-Month Follow-up|Unable to Contact|12|||
126502246|NCT01723163|455139902|FG001|3-Month Follow-up|Unable to Contact|19|||
126502247|NCT01723163|455139901|FG000|6-Month Follow-up|Death|1|||
126502248|NCT01723163|455139902|FG001|6-Month Follow-up|Death|0|||
126502249|NCT01723163|455139901|FG000|6-Month Follow-up|Unable to Contact|17|||
126502250|NCT01723163|455139902|FG001|6-Month Follow-up|Unable to Contact|15|||
126502251|NCT01723163|455139901|FG000|12-Month Follow-up|Death|1|||
126502252|NCT01723163|455139902|FG001|12-Month Follow-up|Death|0|||
126502253|NCT01723163|455139901|FG000|12-Month Follow-up|Unable to Contact|23|||
126502254|NCT01723163|455139902|FG001|12-Month Follow-up|Unable to Contact|28|||
126502255|NCT03314584|455139921|FG000|Overall Study|Withdrawal by Subject|3|||
126502256|NCT03314584|455139922|FG001|Overall Study|Withdrawal by Subject|3|||
126502257|NCT03314584|455139921|FG000|Overall Study|Lost to Follow-up|4|||
126502258|NCT03314584|455139922|FG001|Overall Study|Lost to Follow-up|0|||
126502259|NCT06134817|455139923|FG000|Overall Study|Physician Departure - termination of study|1|||
126502260|NCT01990495|455139931|FG000|Overall Study|Physician Decision|5|||
126502261|NCT01990495|455139932|FG001|Overall Study|Physician Decision|4|||
126502262|NCT01928862|455139933|FG000|Overall Study|Lost to Follow-up|1|||
126502263|NCT01928862|455139934|FG001|Overall Study|Lost to Follow-up|0|||
126502264|NCT01928862|455139935|FG002|Overall Study|Lost to Follow-up|0|||
126502265|NCT01928862|455139936|FG003|Overall Study|Lost to Follow-up|0|||
126502266|NCT01928862|455139937|FG004|Overall Study|Lost to Follow-up|1|||
126502267|NCT01478321|455139938|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
126502268|NCT01478321|455139938|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
126502269|NCT01478321|455139938|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
126502270|NCT01478321|455139938|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
126502271|NCT01478321|455139938|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
126502272|NCT01478321|455139938|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
126502273|NCT01478321|455139938|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
126502274|NCT01478321|455139938|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
126502275|NCT04649164|455139939|FG000|Overall Study|Withdrawal by Subject|1|||
126502276|NCT04649164|455139940|FG001|Overall Study|Withdrawal by Subject|1|||
126502277|NCT04649164|455139941|FG002|Overall Study|Withdrawal by Subject|2|||
126502278|NCT04649164|455139939|FG000|Overall Study|Participant's care recipient expired|0|||
126502279|NCT04649164|455139940|FG001|Overall Study|Participant's care recipient expired|0|||
126502280|NCT04649164|455139941|FG002|Overall Study|Participant's care recipient expired|2|||
126502281|NCT03168464|455139942|FG000|Overall Study|Death|9|||
126502282|NCT03168464|455139942|FG000|Overall Study|Progression of disease|6|||
126502283|NCT02053753|455139945|FG000|Overall Study|Withdrawal by Subject|2|||
126561401|NCT03178201|455349927|FG000|Overall Study|Off study|5|||
126561402|NCT01763047|455349928|FG000|Period 1|Test Article Not Available|4|||
126561403|NCT01763047|455349929|FG001|Period 1|Test Article Not Available|1|||
126561404|NCT01763047|455349928|FG000|Period 1|Protocol Violation|4|||
126561405|NCT01763047|455349929|FG001|Period 1|Protocol Violation|4|||
126561406|NCT01763047|455349928|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
126502284|NCT02053753|455139946|FG001|Overall Study|Withdrawal by Subject|4|||
126502285|NCT02053753|455139945|FG000|Overall Study|Decision by Sponsor|1|||
126502286|NCT02053753|455139946|FG001|Overall Study|Decision by Sponsor|1|||
126502287|NCT02053753|455139945|FG000|Overall Study|Lost to Follow-up|4|||
126502288|NCT02053753|455139946|FG001|Overall Study|Lost to Follow-up|3|||
126502289|NCT00634088|455139949|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
126502290|NCT00634088|455139950|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
126502291|NCT00634088|455139951|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
126502292|NCT00634088|455139952|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
126561407|NCT01763047|455349929|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
126561408|NCT01763047|455349928|FG000|Period 1|Adverse Event|0|||
126502293|NCT00634088|455139949|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
126502294|NCT00634088|455139950|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
126502295|NCT00634088|455139951|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
126502296|NCT00634088|455139952|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
126502297|NCT00634088|455139949|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
126502298|NCT00634088|455139950|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
126502299|NCT00634088|455139951|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
126502300|NCT00634088|455139952|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
126502301|NCT00634088|455139949|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
126502302|NCT00634088|455139950|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
126502303|NCT00634088|455139951|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
126502304|NCT00634088|455139952|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
126502305|NCT00634088|455139949|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
126502306|NCT00634088|455139950|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
126502307|NCT00634088|455139951|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
126502308|NCT00634088|455139952|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
126502309|NCT00634088|455139949|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
126502310|NCT00634088|455139950|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
126502311|NCT00634088|455139951|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
126502312|NCT00634088|455139952|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
126502313|NCT04327999|455139962|FG000|Overall Study|Protocol Violation|1|||
126502314|NCT03735667|455139965|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
126502315|NCT03735667|455139966|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
126502316|NCT03735667|455139967|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
126502317|NCT03735667|455139965|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
126502318|NCT03735667|455139966|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
126502319|NCT03735667|455139967|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
126502320|NCT03735667|455139965|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
126502321|NCT03735667|455139966|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
126502322|NCT03735667|455139967|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
126502323|NCT03735667|455139965|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
126502324|NCT03735667|455139966|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
126502325|NCT03735667|455139967|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
126502326|NCT03735667|455139965|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
126502327|NCT03735667|455139966|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
126502328|NCT03735667|455139967|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
126502329|NCT03735667|455139965|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
126502330|NCT03735667|455139966|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
126502331|NCT03735667|455139967|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
126502332|NCT03735667|455139965|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
126502333|NCT03735667|455139966|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
126502334|NCT03735667|455139967|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
126502335|NCT03735667|455139965|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
126502336|NCT03735667|455139966|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
126502337|NCT03735667|455139967|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
126502338|NCT03735667|455139965|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
126502339|NCT03735667|455139966|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
126502340|NCT03735667|455139967|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
126502341|NCT03735667|455139965|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
126502342|NCT03735667|455139966|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
126502343|NCT03735667|455139967|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
126502344|NCT03735667|455139965|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
126502345|NCT03735667|455139966|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
126502346|NCT03735667|455139967|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
126502347|NCT03735667|455139965|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
126502348|NCT03735667|455139966|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
126502349|NCT03735667|455139967|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
126502350|NCT00006478|455139968|FG000|Overall Study|Vaccine could not be produced|1|||
126502351|NCT00006478|455139968|FG000|Overall Study|Physician Decision|6|||
126502352|NCT01987427|455139976|FG000|Overall Study|Adverse Event|4|||
126561409|NCT01763047|455349929|FG001|Period 1|Adverse Event|1|||
126775841|NCT03989115|456135747|FG004|Overall Study|Other|5|||
126775842|NCT03989115|456135748|FG005|Overall Study|Other|0|||
126502353|NCT01987427|455139977|FG001|Overall Study|Adverse Event|2|||
126561410|NCT01763047|455349928|FG000|Period 1|Unsatisfactory Visual Response|0|||
126502354|NCT01987427|455139978|FG002|Overall Study|Adverse Event|8|||
126502355|NCT01987427|455139976|FG000|Overall Study|Lost to Follow-up|6|||
126502356|NCT01987427|455139977|FG001|Overall Study|Lost to Follow-up|6|||
126502357|NCT01987427|455139978|FG002|Overall Study|Lost to Follow-up|9|||
126726591|NCT02951988|455949000|FG001|Open-Label Treatment Period|Pregnancy|0|||
126726592|NCT02951988|455949001|FG002|Open-Label Treatment Period|Pregnancy|0|||
126726593|NCT02951988|455949002|FG003|Open-Label Treatment Period|Pregnancy|0|||
126726594|NCT02951988|455948999|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
126726595|NCT02951988|455949000|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
126726596|NCT02951988|455949001|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
126726597|NCT02951988|455949002|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
126726598|NCT02951988|455948999|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
126726599|NCT02951988|455949000|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
126726600|NCT02951988|455949001|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
126726601|NCT02951988|455949002|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
126726602|NCT02951988|455948999|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
126726603|NCT02951988|455949000|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
126726604|NCT02951988|455949001|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
126726605|NCT02951988|455949002|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
126726606|NCT02951988|455948999|FG000|Open-Label Treatment Period|Adverse Event|45|||
126726607|NCT02951988|455949000|FG001|Open-Label Treatment Period|Adverse Event|0|||
126726608|NCT02951988|455949001|FG002|Open-Label Treatment Period|Adverse Event|0|||
126726609|NCT02951988|455949002|FG003|Open-Label Treatment Period|Adverse Event|0|||
126726610|NCT02951988|455948999|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
126726611|NCT02951988|455949000|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
126726612|NCT02951988|455949001|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
126726613|NCT02951988|455949002|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
126726614|NCT02951988|455948999|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
126726615|NCT02951988|455949000|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
126726616|NCT02951988|455949001|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
126726617|NCT02951988|455949002|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
126726618|NCT02951988|455948999|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
126726619|NCT02951988|455949000|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
126726620|NCT02951988|455949001|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
126726621|NCT02951988|455949002|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
126726622|NCT02951988|455948999|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
126726623|NCT02951988|455949000|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
126726624|NCT02951988|455949001|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
126726625|NCT02951988|455949002|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
126726626|NCT02951988|455948999|FG000|Double-Blind Treatment Period|Pregnancy|0|||
126726627|NCT02951988|455949000|FG001|Double-Blind Treatment Period|Pregnancy|1|||
126726628|NCT02951988|455949001|FG002|Double-Blind Treatment Period|Pregnancy|1|||
126726629|NCT02951988|455949002|FG003|Double-Blind Treatment Period|Pregnancy|0|||
126726630|NCT02951988|455948999|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126726631|NCT02951988|455949000|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
126726632|NCT02951988|455949001|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
126726633|NCT02951988|455949002|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
126726634|NCT02951988|455948999|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126726635|NCT02951988|455949000|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
126726636|NCT02951988|455949001|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
126726637|NCT02951988|455949002|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
126726638|NCT02951988|455948999|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126726639|NCT02951988|455949000|FG001|Double-Blind Treatment Period|Adverse Event|8|||
126726640|NCT02951988|455949001|FG002|Double-Blind Treatment Period|Adverse Event|3|||
126726641|NCT02951988|455949002|FG003|Double-Blind Treatment Period|Adverse Event|6|||
126726642|NCT02951988|455948999|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
126726643|NCT02951988|455949000|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
126726644|NCT02951988|455949001|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
126726645|NCT02951988|455949002|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
126726646|NCT05836818|455949003|FG000|Overall Study|Physician Decision|1|||
126726647|NCT05836818|455949004|FG001|Overall Study|Physician Decision|1|||
126502358|NCT01987427|455139976|FG000|Overall Study|Withdrawal by Subject|2|||
126502359|NCT01987427|455139977|FG001|Overall Study|Withdrawal by Subject|1|||
126502360|NCT01987427|455139978|FG002|Overall Study|Withdrawal by Subject|3|||
126726648|NCT05836818|455949005|FG002|Overall Study|Physician Decision|0|||
126726649|NCT05836818|455949003|FG000|Overall Study|Withdrawal by Subject|0|||
126726650|NCT05836818|455949004|FG001|Overall Study|Withdrawal by Subject|0|||
126726651|NCT05836818|455949005|FG002|Overall Study|Withdrawal by Subject|1|||
126726652|NCT05836818|455949003|FG000|Overall Study|Later found to be previously vaccinated|0|||
126726653|NCT05836818|455949004|FG001|Overall Study|Later found to be previously vaccinated|1|||
126726654|NCT05836818|455949005|FG002|Overall Study|Later found to be previously vaccinated|3|||
126726655|NCT05836818|455949003|FG000|Overall Study|Pregnancy|0|||
126726656|NCT05836818|455949004|FG001|Overall Study|Pregnancy|1|||
126502361|NCT01987427|455139976|FG000|Overall Study|Lack of Efficacy|1|||
126726657|NCT05836818|455949005|FG002|Overall Study|Pregnancy|0|||
126726658|NCT05836818|455949003|FG000|Overall Study|Allergic to vaccines|0|||
126726659|NCT05836818|455949004|FG001|Overall Study|Allergic to vaccines|1|||
126726660|NCT05836818|455949005|FG002|Overall Study|Allergic to vaccines|0|||
126726661|NCT00586924|455949011|FG000|Overall Study|Adverse event/serious adverse event|0|||
126502362|NCT01987427|455139977|FG001|Overall Study|Lack of Efficacy|0|||
126502363|NCT01987427|455139978|FG002|Overall Study|Lack of Efficacy|0|||
126502364|NCT01987427|455139976|FG000|Overall Study|Other|1|||
126502365|NCT01987427|455139977|FG001|Overall Study|Other|1|||
126502366|NCT01987427|455139978|FG002|Overall Study|Other|0|||
126502367|NCT01073865|455139979|FG000|Overall Study|Reasons other than below|19|||
126502368|NCT01073865|455139980|FG001|Overall Study|Reasons other than below|31|||
126502369|NCT01073865|455139979|FG000|Overall Study|Lost to Follow-up|1|||
126502370|NCT01073865|455139980|FG001|Overall Study|Lost to Follow-up|1|||
126502371|NCT01073865|455139979|FG000|Overall Study|Death|3|||
126502372|NCT01073865|455139980|FG001|Overall Study|Death|2|||
126502373|NCT01073865|455139979|FG000|Overall Study|Withdrawal by Subject|5|||
126502374|NCT01073865|455139980|FG001|Overall Study|Withdrawal by Subject|5|||
126502375|NCT00805766|455139981|FG000|Screening Period|Adverse Event|1|||
126502376|NCT00805766|455139981|FG000|Screening Period|Lack of Efficacy|2|||
126502377|NCT00805766|455139981|FG000|Screening Period|Pregnancy|1|||
126502378|NCT00805766|455139981|FG000|Screening Period|Responder|2|||
126502379|NCT00805766|455139981|FG000|Increased Dose Period|Adverse Event|4|||
126502380|NCT00805766|455139981|FG000|Increased Dose Period|Lack of Efficacy|7|||
126502381|NCT00805766|455139981|FG000|Increased Dose Period|Pregnancy|1|||
126502382|NCT00805766|455139981|FG000|Increased Dose Period|Withdrawal by Subject|1|||
126502383|NCT00600756|455139982|FG000|Analysis After 6 Months|Adverse Event|43|||
126502384|NCT00600756|455139983|FG001|Analysis After 6 Months|Adverse Event|33|||
126502385|NCT00600756|455139982|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
126502386|NCT00600756|455139983|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
126502387|NCT00600756|455139982|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
126502388|NCT00600756|455139983|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
126502389|NCT00600756|455139982|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
126502390|NCT00600756|455139983|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
126502391|NCT00600756|455139982|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
126502392|NCT00600756|455139983|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
126502393|NCT00600756|455139982|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
126502394|NCT00600756|455139983|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
126502395|NCT00600756|455139982|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
126502396|NCT00600756|455139983|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
126502397|NCT00600756|455139982|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
126502398|NCT00600756|455139983|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
126502399|NCT00600756|455139982|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
126502400|NCT00600756|455139983|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
126502401|NCT00600756|455139982|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
126502402|NCT00600756|455139983|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
126502403|NCT00600756|455139982|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
126502404|NCT00600756|455139983|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
126502405|NCT00600756|455139982|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
126502406|NCT00600756|455139983|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
126502407|NCT00600756|455139982|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
126502408|NCT00600756|455139983|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
126502409|NCT00600756|455139982|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
126502410|NCT00600756|455139983|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
126502411|NCT03560531|455139987|FG000|Overall Study|Death|4|||
126502412|NCT03560531|455139988|FG001|Overall Study|Death|1|||
126502413|NCT03560531|455139989|FG002|Overall Study|Death|1|||
126502414|NCT03560531|455139990|FG003|Overall Study|Death|2|||
126502415|NCT03560531|455139991|FG004|Overall Study|Death|6|||
126502416|NCT03560531|455139992|FG005|Overall Study|Death|1|||
126502417|NCT03560531|455139993|FG006|Overall Study|Death|4|||
126502418|NCT03560531|455139994|FG007|Overall Study|Death|8|||
126502419|NCT03560531|455139995|FG008|Overall Study|Death|1|||
126561411|NCT01763047|455349929|FG001|Period 1|Unsatisfactory Visual Response|3|||
126561412|NCT01763047|455349928|FG000|Period 1|Lens Power Not Available|0|||
126726662|NCT00586924|455949012|FG001|Overall Study|Adverse event/serious adverse event|0|||
126726663|NCT00586924|455949013|FG002|Overall Study|Adverse event/serious adverse event|0|||
126502420|NCT03560531|455139996|FG009|Overall Study|Death|3|||
126502421|NCT03560531|455139997|FG010|Overall Study|Death|2|||
126502422|NCT03560531|455139998|FG011|Overall Study|Death|0|||
126502423|NCT03560531|455139999|FG012|Overall Study|Death|4|||
126502424|NCT03560531|455140000|FG013|Overall Study|Death|1|||
126502425|NCT03560531|455139987|FG000|Overall Study|Lost to Follow-up|1|||
126502426|NCT03560531|455139988|FG001|Overall Study|Lost to Follow-up|1|||
126726664|NCT00586924|455949014|FG003|Overall Study|Adverse event/serious adverse event|1|||
126726665|NCT00586924|455949015|FG004|Overall Study|Adverse event/serious adverse event|0|||
126726666|NCT00586924|455949016|FG005|Overall Study|Adverse event/serious adverse event|2|||
126726667|NCT00586924|455949011|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
126726668|NCT00586924|455949012|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
126726669|NCT00586924|455949013|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
126726670|NCT00586924|455949014|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
126726671|NCT00586924|455949015|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
126726672|NCT00586924|455949016|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
126726673|NCT00586924|455949011|FG000|Overall Study|Disease progression|0|||
126726674|NCT00586924|455949012|FG001|Overall Study|Disease progression|0|||
126726675|NCT00586924|455949013|FG002|Overall Study|Disease progression|0|||
126726676|NCT00586924|455949014|FG003|Overall Study|Disease progression|1|||
126726677|NCT00586924|455949015|FG004|Overall Study|Disease progression|1|||
126726678|NCT00586924|455949016|FG005|Overall Study|Disease progression|0|||
126726679|NCT00586924|455949011|FG000|Overall Study|Development of neutralizing antibodies|2|||
126726680|NCT00586924|455949012|FG001|Overall Study|Development of neutralizing antibodies|2|||
126726681|NCT00586924|455949013|FG002|Overall Study|Development of neutralizing antibodies|2|||
126726682|NCT00586924|455949014|FG003|Overall Study|Development of neutralizing antibodies|0|||
126726683|NCT00586924|455949015|FG004|Overall Study|Development of neutralizing antibodies|0|||
126726684|NCT00586924|455949016|FG005|Overall Study|Development of neutralizing antibodies|22|||
126726685|NCT00586924|455949011|FG000|Overall Study|Complete response|0|||
126726686|NCT00586924|455949012|FG001|Overall Study|Complete response|1|||
126726687|NCT00586924|455949013|FG002|Overall Study|Complete response|0|||
126726688|NCT00586924|455949014|FG003|Overall Study|Complete response|0|||
126726689|NCT00586924|455949015|FG004|Overall Study|Complete response|2|||
126726690|NCT00586924|455949016|FG005|Overall Study|Complete response|2|||
126726691|NCT00586924|455949011|FG000|Overall Study|Other|1|||
126726692|NCT00586924|455949012|FG001|Overall Study|Other|0|||
126502427|NCT03560531|455139989|FG002|Overall Study|Lost to Follow-up|0|||
126726693|NCT00586924|455949013|FG002|Overall Study|Other|1|||
126502428|NCT03560531|455139990|FG003|Overall Study|Lost to Follow-up|0|||
126502429|NCT03560531|455139991|FG004|Overall Study|Lost to Follow-up|0|||
126502430|NCT03560531|455139992|FG005|Overall Study|Lost to Follow-up|0|||
126502431|NCT03560531|455139993|FG006|Overall Study|Lost to Follow-up|1|||
126502432|NCT03560531|455139994|FG007|Overall Study|Lost to Follow-up|0|||
126502433|NCT03560531|455139995|FG008|Overall Study|Lost to Follow-up|0|||
126502434|NCT03560531|455139996|FG009|Overall Study|Lost to Follow-up|0|||
126502435|NCT03560531|455139997|FG010|Overall Study|Lost to Follow-up|0|||
126502436|NCT03560531|455139998|FG011|Overall Study|Lost to Follow-up|0|||
126502437|NCT03560531|455139999|FG012|Overall Study|Lost to Follow-up|0|||
126502438|NCT03560531|455140000|FG013|Overall Study|Lost to Follow-up|0|||
126502439|NCT03560531|455139987|FG000|Overall Study|Withdrawal by Subject|1|||
126502440|NCT03560531|455139988|FG001|Overall Study|Withdrawal by Subject|0|||
126502441|NCT03560531|455139989|FG002|Overall Study|Withdrawal by Subject|0|||
126502442|NCT03560531|455139990|FG003|Overall Study|Withdrawal by Subject|0|||
126502443|NCT03560531|455139991|FG004|Overall Study|Withdrawal by Subject|0|||
126502444|NCT03560531|455139992|FG005|Overall Study|Withdrawal by Subject|0|||
126502445|NCT03560531|455139993|FG006|Overall Study|Withdrawal by Subject|0|||
126502446|NCT03560531|455139994|FG007|Overall Study|Withdrawal by Subject|3|||
126502447|NCT03560531|455139995|FG008|Overall Study|Withdrawal by Subject|2|||
126561413|NCT01763047|455349929|FG001|Period 1|Lens Power Not Available|1|||
126726694|NCT00586924|455949014|FG003|Overall Study|Other|1|||
126726695|NCT00586924|455949015|FG004|Overall Study|Other|1|||
126726696|NCT00586924|455949016|FG005|Overall Study|Other|6|||
126726697|NCT00621855|455949019|FG000|Overall Study|Adverse Event|32|||
126726698|NCT00621855|455949020|FG001|Overall Study|Adverse Event|31|||
126726699|NCT00621855|455949021|FG002|Overall Study|Adverse Event|48|||
126726700|NCT00621855|455949022|FG003|Overall Study|Adverse Event|34|||
126726701|NCT00621855|455949023|FG004|Overall Study|Adverse Event|31|||
126726702|NCT00621855|455949019|FG000|Overall Study|Lost to Follow-up|0|||
126726703|NCT00621855|455949020|FG001|Overall Study|Lost to Follow-up|1|||
126726704|NCT00621855|455949021|FG002|Overall Study|Lost to Follow-up|3|||
126726705|NCT00621855|455949022|FG003|Overall Study|Lost to Follow-up|4|||
126726706|NCT00621855|455949023|FG004|Overall Study|Lost to Follow-up|1|||
126726707|NCT00621855|455949019|FG000|Overall Study|Protocol Violation|16|||
126726708|NCT00621855|455949020|FG001|Overall Study|Protocol Violation|8|||
126726709|NCT00621855|455949021|FG002|Overall Study|Protocol Violation|6|||
126502448|NCT03560531|455139996|FG009|Overall Study|Withdrawal by Subject|0|||
126502449|NCT03560531|455139997|FG010|Overall Study|Withdrawal by Subject|0|||
126502450|NCT03560531|455139998|FG011|Overall Study|Withdrawal by Subject|0|||
126502451|NCT03560531|455139999|FG012|Overall Study|Withdrawal by Subject|2|||
126726710|NCT00621855|455949022|FG003|Overall Study|Protocol Violation|7|||
126726711|NCT00621855|455949023|FG004|Overall Study|Protocol Violation|8|||
126726712|NCT00621855|455949019|FG000|Overall Study|Withdrawal by Subject|16|||
126726713|NCT00621855|455949020|FG001|Overall Study|Withdrawal by Subject|11|||
126726714|NCT00621855|455949021|FG002|Overall Study|Withdrawal by Subject|13|||
126775843|NCT03989115|456135749|FG006|Overall Study|Other|0|||
126775844|NCT03989115|456135750|FG007|Overall Study|Other|0|||
126775845|NCT01759381|456135754|FG000|Overall Study|Death|1|||
126775846|NCT01759381|456135755|FG001|Overall Study|Death|0|||
126775847|NCT01965535|456135762|FG000|Overall Study|Lack of Efficacy|2|||
126775848|NCT01965535|456135763|FG001|Overall Study|Lack of Efficacy|1|||
126775849|NCT01493531|456135766|FG000|Overall Study|Adverse Event|4|||
126775850|NCT01493531|456135767|FG001|Overall Study|Adverse Event|12|||
126775851|NCT01493531|456135768|FG002|Overall Study|Adverse Event|9|||
126775852|NCT01493531|456135766|FG000|Overall Study|Gout flare|3|||
126775853|NCT01493531|456135767|FG001|Overall Study|Gout flare|0|||
126775854|NCT01493531|456135768|FG002|Overall Study|Gout flare|2|||
126775855|NCT01493531|456135766|FG000|Overall Study|Protocol Violation|8|||
126775856|NCT01493531|456135767|FG001|Overall Study|Protocol Violation|15|||
126775857|NCT01493531|456135768|FG002|Overall Study|Protocol Violation|12|||
126775858|NCT01493531|456135766|FG000|Overall Study|Sponsor terminated study|5|||
126775859|NCT01493531|456135767|FG001|Overall Study|Sponsor terminated study|2|||
126775860|NCT01493531|456135768|FG002|Overall Study|Sponsor terminated study|3|||
126775861|NCT01493531|456135766|FG000|Overall Study|Lost to Follow-up|5|||
126775862|NCT01493531|456135767|FG001|Overall Study|Lost to Follow-up|7|||
126775863|NCT01493531|456135768|FG002|Overall Study|Lost to Follow-up|11|||
126775864|NCT01493531|456135766|FG000|Overall Study|Withdrawal by Subject|16|||
126775865|NCT01493531|456135767|FG001|Overall Study|Withdrawal by Subject|13|||
126775866|NCT01493531|456135768|FG002|Overall Study|Withdrawal by Subject|11|||
126775867|NCT01493531|456135766|FG000|Overall Study|Death|0|||
126775868|NCT01493531|456135767|FG001|Overall Study|Death|1|||
126775869|NCT01493531|456135768|FG002|Overall Study|Death|0|||
126775870|NCT03031431|456135771|FG000|Overall Study|Infant removed by maternal request|1|||
126775871|NCT01205529|456135772|FG000|Overall Study|Procedure Cancelled|4|||
126775872|NCT01205529|456135772|FG000|Overall Study|Withdrawal by Subject|2|||
126775873|NCT01205529|456135772|FG000|Overall Study|Physician Decision|4|||
126775874|NCT01205529|456135772|FG000|Overall Study|Unstable post op|15|||
126775875|NCT01205529|456135772|FG000|Overall Study|No longer met criteria|30|||
126775876|NCT01027884|456135777|FG000|Overall Study|Adverse Event|2|||
126775877|NCT01027884|456135778|FG001|Overall Study|Adverse Event|1|||
126775878|NCT01027884|456135777|FG000|Overall Study|Protocol Violation|1|||
126775879|NCT01027884|456135778|FG001|Overall Study|Protocol Violation|0|||
126775880|NCT01027884|456135777|FG000|Overall Study|Non-compliance|1|||
126775881|NCT01027884|456135778|FG001|Overall Study|Non-compliance|1|||
126775882|NCT01027884|456135777|FG000|Overall Study|Withdrawal by Subject|0|||
126775883|NCT01027884|456135778|FG001|Overall Study|Withdrawal by Subject|1|||
126775884|NCT01027884|456135777|FG000|Overall Study|Lost to Follow-up|0|||
126775885|NCT01027884|456135778|FG001|Overall Study|Lost to Follow-up|1|||
126775886|NCT01027884|456135777|FG000|Overall Study|Spinal fixation surgery|0|||
126775887|NCT01027884|456135778|FG001|Overall Study|Spinal fixation surgery|3|||
126775888|NCT03670537|456135779|FG000|Overall Study|Protocol Violation|1|||
126775889|NCT02059187|456135780|FG000|Overall Study|Adverse Event|0|||
126775890|NCT02059187|456135781|FG001|Overall Study|Adverse Event|3|||
126775891|NCT02059187|456135780|FG000|Overall Study|Death|1|||
126775892|NCT02059187|456135781|FG001|Overall Study|Death|1|||
126775893|NCT02059187|456135780|FG000|Overall Study|Lost to Follow-up|9|||
126775894|NCT02059187|456135781|FG001|Overall Study|Lost to Follow-up|8|||
126775895|NCT02059187|456135780|FG000|Overall Study|Non-compliance with study drug|1|||
126775896|NCT02059187|456135781|FG001|Overall Study|Non-compliance with study drug|0|||
126775897|NCT02059187|456135780|FG000|Overall Study|Physician Decision|1|||
126561414|NCT01763047|455349928|FG000|Period 1|Study Site office Closed|0|||
126561415|NCT01763047|455349929|FG001|Period 1|Study Site office Closed|1|||
126561416|NCT01763047|455349928|FG000|Period 2|Lens Discomfort|1|||
126561417|NCT01763047|455349929|FG001|Period 2|Lens Discomfort|0|||
126561418|NCT01763047|455349928|FG000|Period 2|No longer meets Eligibility Criteria|1|||
126561419|NCT01763047|455349929|FG001|Period 2|No longer meets Eligibility Criteria|0|||
126561420|NCT01763047|455349928|FG000|Period 2|Study Site office Closed|1|||
126561421|NCT01763047|455349929|FG001|Period 2|Study Site office Closed|1|||
126561422|NCT01763047|455349928|FG000|Period 2|Unsatisfactory Visual Response|1|||
126775898|NCT02059187|456135781|FG001|Overall Study|Physician Decision|2|||
126775899|NCT02059187|456135780|FG000|Overall Study|Protocol Violation|1|||
126561423|NCT01763047|455349929|FG001|Period 2|Unsatisfactory Visual Response|1|||
126775900|NCT02059187|456135781|FG001|Overall Study|Protocol Violation|0|||
126775901|NCT02059187|456135780|FG000|Overall Study|Withdrawal by Subject|12|||
126775902|NCT02059187|456135781|FG001|Overall Study|Withdrawal by Subject|8|||
126775903|NCT03070431|456135782|FG000|Overall Study|Withdrawal by Subject|2|||
126775904|NCT03070431|456135782|FG000|Overall Study|Lost to Follow-up|2|||
126775905|NCT01889862|456135783|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
126775906|NCT01889862|456135784|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
126775907|NCT01889862|456135785|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
126775908|NCT01889862|456135786|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
126775909|NCT01889862|456135787|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
126775910|NCT01889862|456135783|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
126775911|NCT01889862|456135784|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
126561424|NCT01763047|455349928|FG000|Period 2|Protocol Violation|0|||
126561425|NCT01763047|455349929|FG001|Period 2|Protocol Violation|2|||
126561426|NCT01763047|455349928|FG000|Period 2|Unsatisfactory lens Fitting|0|||
126561427|NCT01763047|455349929|FG001|Period 2|Unsatisfactory lens Fitting|1|||
126561428|NCT03124108|455349933|FG000|Overall Study|Adverse Event|0|||
126561429|NCT03124108|455349934|FG001|Overall Study|Adverse Event|1|||
126561430|NCT03124108|455349935|FG002|Overall Study|Adverse Event|0|||
126561431|NCT05650333|455349936|FG000|Treatment Period (7 Days)|Adverse Event|1|||
126561432|NCT02616263|455349937|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
126561433|NCT02616263|455349938|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
126561434|NCT02616263|455349937|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
126561435|NCT02616263|455349938|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
126561436|NCT02616263|455349937|FG000|6 Month to 1.5 Year|Death|1|||
126561437|NCT02616263|455349938|FG001|6 Month to 1.5 Year|Death|0|||
126561438|NCT02616263|455349937|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
126561439|NCT02616263|455349938|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
126561440|NCT02616263|455349937|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
126561441|NCT02616263|455349938|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
126561442|NCT02616263|455349937|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
126561443|NCT02616263|455349938|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
126561444|NCT03686384|455349939|FG000|Overall Study|Lack of Efficacy|4|||
126561445|NCT03686384|455349940|FG001|Overall Study|Lack of Efficacy|13|||
126561446|NCT03686384|455349939|FG000|Overall Study|Lost to Follow-up|3|||
126561447|NCT03686384|455349940|FG001|Overall Study|Lost to Follow-up|0|||
126561448|NCT03686384|455349939|FG000|Overall Study|Physician Decision|0|||
126561449|NCT03686384|455349940|FG001|Overall Study|Physician Decision|1|||
126561450|NCT03686384|455349939|FG000|Overall Study|Took prohibited medication|0|||
126561451|NCT03686384|455349940|FG001|Overall Study|Took prohibited medication|1|||
126561452|NCT02820051|455349943|FG000|Overall Study|Lost to Follow-up|7|||
126561453|NCT02820051|455349944|FG001|Overall Study|Lost to Follow-up|4|||
126561454|NCT01222247|455349945|FG000|Overall Study|Lost to Follow-up|2|||
126561455|NCT01222247|455349946|FG001|Overall Study|Lost to Follow-up|2|||
126561456|NCT01767909|455349947|FG000|Overall Study|Withdrawal by Subject|4|||
126561457|NCT01767909|455349948|FG001|Overall Study|Withdrawal by Subject|7|||
126561458|NCT01767909|455349947|FG000|Overall Study|Adverse Event|3|||
126561459|NCT01767909|455349948|FG001|Overall Study|Adverse Event|1|||
126561460|NCT01767909|455349947|FG000|Overall Study|Withdrawal by Study Partner|3|||
126561461|NCT01767909|455349948|FG001|Overall Study|Withdrawal by Study Partner|1|||
126561462|NCT01767909|455349947|FG000|Overall Study|Non-Compliance|2|||
126561463|NCT01767909|455349948|FG001|Overall Study|Non-Compliance|0|||
126561464|NCT01767909|455349947|FG000|Overall Study|Perceived Lack of Efficacy|1|||
126561465|NCT01767909|455349948|FG001|Overall Study|Perceived Lack of Efficacy|0|||
126561466|NCT01767909|455349947|FG000|Overall Study|Investigator Recommendation|0|||
126561467|NCT01767909|455349948|FG001|Overall Study|Investigator Recommendation|1|||
126561468|NCT01767909|455349947|FG000|Overall Study|Lost to Follow-up|0|||
126561469|NCT01767909|455349948|FG001|Overall Study|Lost to Follow-up|1|||
126561470|NCT01767909|455349947|FG000|Overall Study|LP uncessessful|0|||
126561471|NCT01767909|455349948|FG001|Overall Study|LP uncessessful|1|||
126561472|NCT04939428|455349949|FG000|Overall Study|Death|0|||
126561473|NCT04939428|455349950|FG001|Overall Study|Death|1|||
126561474|NCT04939428|455349951|FG002|Overall Study|Death|0|||
126561475|NCT04939428|455349949|FG000|Overall Study|Lost to Follow-up|0|||
126561476|NCT04939428|455349950|FG001|Overall Study|Lost to Follow-up|5|||
126561477|NCT04939428|455349951|FG002|Overall Study|Lost to Follow-up|0|||
126561478|NCT04939428|455349949|FG000|Overall Study|Physician Decision|1|||
126561479|NCT04939428|455349950|FG001|Overall Study|Physician Decision|0|||
126561480|NCT04939428|455349951|FG002|Overall Study|Physician Decision|0|||
126561481|NCT04939428|455349949|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126561482|NCT04939428|455349950|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126561483|NCT04939428|455349951|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126561484|NCT04939428|455349949|FG000|Overall Study|Withdrawal by Subject|10|||
126561485|NCT04939428|455349950|FG001|Overall Study|Withdrawal by Subject|11|||
126561486|NCT04939428|455349951|FG002|Overall Study|Withdrawal by Subject|0|||
126561487|NCT04939428|455349949|FG000|Overall Study|Unkown|6|||
126561488|NCT04939428|455349950|FG001|Overall Study|Unkown|3|||
126561489|NCT04939428|455349951|FG002|Overall Study|Unkown|0|||
126561490|NCT04939428|455349949|FG000|Overall Study|Discotinued per protocol|0|||
126561491|NCT04939428|455349950|FG001|Overall Study|Discotinued per protocol|0|||
126561492|NCT04939428|455349951|FG002|Overall Study|Discotinued per protocol|902|||
126561493|NCT04639947|455349954|FG000|Overall Study|Screen fail|1|||
126561494|NCT02696785|455349957|FG000|Blinded Treatment Period|Adverse Event|0|||
126726715|NCT00621855|455949022|FG003|Overall Study|Withdrawal by Subject|13|||
126561495|NCT02696785|455349958|FG001|Blinded Treatment Period|Adverse Event|1|||
126561496|NCT02696785|455349959|FG002|Blinded Treatment Period|Adverse Event|3|||
126726716|NCT00621855|455949023|FG004|Overall Study|Withdrawal by Subject|9|||
126561497|NCT02696785|455349960|FG003|Blinded Treatment Period|Adverse Event|0|||
126561498|NCT02696785|455349957|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
126561499|NCT02696785|455349958|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
126561500|NCT02696785|455349959|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
126561501|NCT02696785|455349960|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
126561502|NCT02696785|455349957|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
126561503|NCT02696785|455349958|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
126561504|NCT02696785|455349959|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
126561505|NCT02696785|455349960|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
126561506|NCT02696785|455349957|FG000|Blinded Treatment Period|Screen Failure|1|||
126561507|NCT02696785|455349958|FG001|Blinded Treatment Period|Screen Failure|0|||
126561508|NCT02696785|455349959|FG002|Blinded Treatment Period|Screen Failure|0|||
126561509|NCT02696785|455349960|FG003|Blinded Treatment Period|Screen Failure|0|||
126561510|NCT02696785|455349957|FG000|Washout Period|Withdrawal by Subject|0|||
126561511|NCT02696785|455349958|FG001|Washout Period|Withdrawal by Subject|1|||
126561512|NCT02696785|455349959|FG002|Washout Period|Withdrawal by Subject|0|||
126561513|NCT02696785|455349960|FG003|Washout Period|Withdrawal by Subject|0|||
126561514|NCT02696785|455349957|FG000|Washout Period|Lack of Efficacy|0|||
126561515|NCT02696785|455349958|FG001|Washout Period|Lack of Efficacy|1|||
126561516|NCT02696785|455349959|FG002|Washout Period|Lack of Efficacy|0|||
126561517|NCT02696785|455349960|FG003|Washout Period|Lack of Efficacy|0|||
126561518|NCT02696785|455349957|FG000|Extended Treatment Period|Adverse Event|2|||
126561519|NCT02696785|455349958|FG001|Extended Treatment Period|Adverse Event|3|||
126561520|NCT02696785|455349959|FG002|Extended Treatment Period|Adverse Event|2|||
126561521|NCT02696785|455349960|FG003|Extended Treatment Period|Adverse Event|1|||
126561522|NCT02696785|455349957|FG000|Extended Treatment Period|Lack of Efficacy|0|||
126561523|NCT02696785|455349958|FG001|Extended Treatment Period|Lack of Efficacy|1|||
126561524|NCT02696785|455349959|FG002|Extended Treatment Period|Lack of Efficacy|0|||
126561525|NCT02696785|455349960|FG003|Extended Treatment Period|Lack of Efficacy|0|||
126561526|NCT02696785|455349957|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
126561527|NCT02696785|455349958|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
126561528|NCT02696785|455349959|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
126561529|NCT02696785|455349960|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
126561530|NCT02696785|455349957|FG000|Follow-up Period|Adverse Event|0|||
126561531|NCT02696785|455349958|FG001|Follow-up Period|Adverse Event|0|||
126561532|NCT02696785|455349959|FG002|Follow-up Period|Adverse Event|8|||
126561533|NCT02696785|455349960|FG003|Follow-up Period|Adverse Event|2|||
126561534|NCT02696785|455349957|FG000|Follow-up Period|Lost to Follow-up|0|||
126561535|NCT02696785|455349958|FG001|Follow-up Period|Lost to Follow-up|0|||
126561536|NCT02696785|455349959|FG002|Follow-up Period|Lost to Follow-up|0|||
126561537|NCT02696785|455349960|FG003|Follow-up Period|Lost to Follow-up|1|||
126561538|NCT02696785|455349957|FG000|Follow-up Period|Lack of Efficacy|0|||
126561539|NCT02696785|455349958|FG001|Follow-up Period|Lack of Efficacy|0|||
126561540|NCT02696785|455349959|FG002|Follow-up Period|Lack of Efficacy|0|||
126561541|NCT02696785|455349960|FG003|Follow-up Period|Lack of Efficacy|1|||
126561542|NCT02696785|455349957|FG000|Follow-up Period|Withdrawal by Subject|1|||
126561543|NCT02696785|455349958|FG001|Follow-up Period|Withdrawal by Subject|0|||
126561544|NCT02696785|455349959|FG002|Follow-up Period|Withdrawal by Subject|5|||
126561545|NCT02696785|455349960|FG003|Follow-up Period|Withdrawal by Subject|4|||
126561546|NCT00614744|455349962|FG000|Overall Study|Lost to Follow-up|5|||
126561547|NCT00614744|455349963|FG001|Overall Study|Lost to Follow-up|4|||
126561548|NCT00614744|455349962|FG000|Overall Study|Incomplete for Behavior Issues|0|||
126561549|NCT00614744|455349963|FG001|Overall Study|Incomplete for Behavior Issues|2|||
126561550|NCT00877851|455349964|FG000|Overall Study|Lost to Follow-up|5|||
126561551|NCT00877851|455349965|FG001|Overall Study|Lost to Follow-up|5|||
126561552|NCT00877851|455349964|FG000|Overall Study|computer problem|3|||
126561553|NCT00877851|455349965|FG001|Overall Study|computer problem|0|||
126561554|NCT00877851|455349964|FG000|Overall Study|no longer interested in participating|1|||
126561555|NCT00877851|455349965|FG001|Overall Study|no longer interested in participating|0|||
126561556|NCT03424239|455349973|FG000|Overall Study|Withdrawal by Subject|2|||
126561557|NCT03824236|455349976|FG000|Overall Study|Lost to Follow-up|0|||
126561558|NCT03824236|455349977|FG001|Overall Study|Lost to Follow-up|0|||
126561559|NCT03824236|455349978|FG002|Overall Study|Lost to Follow-up|1|||
126561560|NCT00701311|455349979|FG000|Overall Study|Lack of Efficacy|3|||
126561561|NCT00701311|455349979|FG000|Overall Study|Adverse Event|3|||
126561562|NCT00701311|455349979|FG000|Overall Study|Withdrawal by Subject|2|||
126561563|NCT00670540|455349982|FG000|Overall Study|ineligible|17|||
126561564|NCT00670540|455349982|FG000|Overall Study|not living in France|348|||
126561565|NCT00670540|455349982|FG000|Overall Study|refused to participate|189|||
126561566|NCT00670540|455349982|FG000|Overall Study|controls randomised for no follow up|2770|||
126561567|NCT00670540|455349982|FG000|Overall Study|missing information inclusion criteria|1|||
126561568|NCT01140347|455349983|FG000|Overall Study|Lost to Follow-up|5|||
126561569|NCT01140347|455349984|FG001|Overall Study|Lost to Follow-up|6|||
126561570|NCT01140347|455349983|FG000|Overall Study|Withdrawal by Subject|13|||
126561571|NCT01140347|455349984|FG001|Overall Study|Withdrawal by Subject|8|||
126561572|NCT00828919|455349985|FG000|Overall Study|Death|0|||
126561573|NCT00828919|455349986|FG001|Overall Study|Death|1|||
126561574|NCT00828919|455349987|FG002|Overall Study|Death|2|||
126561575|NCT00828919|455349988|FG003|Overall Study|Death|0|||
126561576|NCT00828919|455349989|FG004|Overall Study|Death|0|||
126561577|NCT00828919|455349985|FG000|Overall Study|Adverse Event|2|||
126561578|NCT00828919|455349986|FG001|Overall Study|Adverse Event|2|||
126561579|NCT00828919|455349987|FG002|Overall Study|Adverse Event|2|||
126561580|NCT00828919|455349988|FG003|Overall Study|Adverse Event|1|||
126561581|NCT00828919|455349989|FG004|Overall Study|Adverse Event|3|||
126561582|NCT00828919|455349985|FG000|Overall Study|Objective progression or relapse|4|||
126561583|NCT00828919|455349986|FG001|Overall Study|Objective progression or relapse|4|||
126561584|NCT00828919|455349987|FG002|Overall Study|Objective progression or relapse|11|||
126561585|NCT00828919|455349988|FG003|Overall Study|Objective progression or relapse|0|||
126561586|NCT00828919|455349989|FG004|Overall Study|Objective progression or relapse|5|||
126561587|NCT00828919|455349985|FG000|Overall Study|No longer willing to participate in study|0|||
126561588|NCT00828919|455349986|FG001|Overall Study|No longer willing to participate in study|0|||
126561589|NCT00828919|455349987|FG002|Overall Study|No longer willing to participate in study|2|||
126561590|NCT00828919|455349988|FG003|Overall Study|No longer willing to participate in study|0|||
126561591|NCT00828919|455349989|FG004|Overall Study|No longer willing to participate in study|0|||
126561592|NCT00828919|455349985|FG000|Overall Study|Insufficient Clinical Response|0|||
126561593|NCT00828919|455349986|FG001|Overall Study|Insufficient Clinical Response|1|||
126561594|NCT00828919|455349987|FG002|Overall Study|Insufficient Clinical Response|2|||
126561595|NCT00828919|455349988|FG003|Overall Study|Insufficient Clinical Response|0|||
126561596|NCT00828919|455349989|FG004|Overall Study|Insufficient Clinical Response|0|||
126561597|NCT00828919|455349985|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
126561598|NCT00828919|455349986|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
126561599|NCT00828919|455349987|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
126561600|NCT00828919|455349988|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
126561601|NCT00828919|455349989|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
126561602|NCT00828919|455349985|FG000|Overall Study|Other|1|||
126561603|NCT00828919|455349986|FG001|Overall Study|Other|0|||
126561604|NCT00828919|455349987|FG002|Overall Study|Other|1|||
126561605|NCT00828919|455349988|FG003|Overall Study|Other|1|||
126561606|NCT00828919|455349989|FG004|Overall Study|Other|0|||
126561607|NCT00828919|455349985|FG000|Overall Study|Lost to Follow-up|0|||
126561608|NCT00828919|455349986|FG001|Overall Study|Lost to Follow-up|1|||
126561609|NCT00828919|455349987|FG002|Overall Study|Lost to Follow-up|0|||
126561610|NCT00828919|455349988|FG003|Overall Study|Lost to Follow-up|0|||
126561611|NCT00828919|455349989|FG004|Overall Study|Lost to Follow-up|0|||
126561612|NCT01449929|455349991|FG000|Randomization Phase 96 Week|Adverse Event|5|||
126561613|NCT01449929|455349992|FG001|Randomization Phase 96 Week|Adverse Event|13|||
126561614|NCT01449929|455349993|FG002|Randomization Phase 96 Week|Adverse Event|0|||
126561615|NCT01449929|455349991|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
126561616|NCT01449929|455349992|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
126561617|NCT01449929|455349993|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
126561618|NCT01449929|455349991|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
126561619|NCT01449929|455349992|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
126561620|NCT01449929|455349993|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
126561621|NCT01449929|455349991|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
126561622|NCT01449929|455349992|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
126561623|NCT01449929|455349993|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
126561624|NCT01449929|455349991|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
126561625|NCT01449929|455349992|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
126561626|NCT01449929|455349993|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
126561627|NCT01449929|455349991|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
126561628|NCT01449929|455349992|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
126561629|NCT01449929|455349993|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
126561630|NCT01449929|455349991|FG000|Randomization Phase 96 Week|Physician Decision|2|||
126561631|NCT01449929|455349992|FG001|Randomization Phase 96 Week|Physician Decision|3|||
126561632|NCT01449929|455349993|FG002|Randomization Phase 96 Week|Physician Decision|0|||
126561633|NCT01449929|455349991|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
126561634|NCT01449929|455349992|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
126561635|NCT01449929|455349993|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
126561636|NCT01449929|455349991|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
126561637|NCT01449929|455349992|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
126561638|NCT01449929|455349993|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
126561639|NCT01449929|455349991|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
126561640|NCT01449929|455349992|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
126561641|NCT01449929|455349993|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
126726717|NCT00621855|455949019|FG000|Overall Study|Other|9|||
126561642|NCT01449929|455349991|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
126726718|NCT00621855|455949020|FG001|Overall Study|Other|7|||
126561643|NCT01449929|455349992|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
126561644|NCT01449929|455349993|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
126561645|NCT01871285|455349994|FG000|First Intervention (1 Day)|Adverse Event|1|||
126561646|NCT01871285|455349995|FG001|First Intervention (1 Day)|Adverse Event|0|||
126561647|NCT01871285|455349996|FG002|First Intervention (1 Day)|Adverse Event|0|||
126561648|NCT01871285|455349997|FG003|First Intervention (1 Day)|Adverse Event|0|||
126561649|NCT01871285|455349994|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
126561650|NCT01871285|455349995|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
126561651|NCT01871285|455349996|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
126561652|NCT01871285|455349997|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
126561653|NCT02501811|455349999|FG000|Overall Study|Death|1|||
126561654|NCT02501811|455350000|FG001|Overall Study|Death|3|||
126561655|NCT02501811|455350001|FG002|Overall Study|Death|2|||
126561656|NCT02501811|455350002|FG003|Overall Study|Death|3|||
126561657|NCT02501811|455349999|FG000|Overall Study|Withdrawal by Subject|3|||
126561658|NCT02501811|455350000|FG001|Overall Study|Withdrawal by Subject|3|||
126561659|NCT02501811|455350001|FG002|Overall Study|Withdrawal by Subject|2|||
126561660|NCT02501811|455350002|FG003|Overall Study|Withdrawal by Subject|3|||
126561661|NCT02501811|455349999|FG000|Overall Study|Lost to Follow-up|0|||
126561662|NCT02501811|455350000|FG001|Overall Study|Lost to Follow-up|0|||
126561663|NCT02501811|455350001|FG002|Overall Study|Lost to Follow-up|2|||
126561664|NCT02501811|455350002|FG003|Overall Study|Lost to Follow-up|1|||
126561665|NCT00359619|455351927|FG000|Overall Study|Adverse Event|0|||
126561666|NCT00359619|455351928|FG001|Overall Study|Adverse Event|0|||
126561667|NCT00359619|455351929|FG002|Overall Study|Adverse Event|1|||
126561668|NCT00359619|455351930|FG003|Overall Study|Adverse Event|0|||
126561669|NCT00359619|455351931|FG004|Overall Study|Adverse Event|0|||
126561670|NCT00359619|455351932|FG005|Overall Study|Adverse Event|0|||
126561671|NCT00359619|455351933|FG006|Overall Study|Adverse Event|1|||
126561672|NCT00359619|455351927|FG000|Overall Study|Withdrawal by Subject|3|||
126561673|NCT00359619|455351928|FG001|Overall Study|Withdrawal by Subject|1|||
126561674|NCT00359619|455351929|FG002|Overall Study|Withdrawal by Subject|4|||
126561675|NCT00359619|455351930|FG003|Overall Study|Withdrawal by Subject|2|||
126561676|NCT00359619|455351931|FG004|Overall Study|Withdrawal by Subject|2|||
126561677|NCT00359619|455351932|FG005|Overall Study|Withdrawal by Subject|0|||
126561678|NCT00359619|455351933|FG006|Overall Study|Withdrawal by Subject|3|||
126561679|NCT00359619|455351927|FG000|Overall Study|Other|1|||
126561680|NCT00359619|455351928|FG001|Overall Study|Other|0|||
126561681|NCT00359619|455351929|FG002|Overall Study|Other|0|||
126561682|NCT00359619|455351930|FG003|Overall Study|Other|0|||
126561683|NCT00359619|455351931|FG004|Overall Study|Other|0|||
126561684|NCT00359619|455351932|FG005|Overall Study|Other|0|||
126561685|NCT00359619|455351933|FG006|Overall Study|Other|0|||
126561686|NCT00359619|455351927|FG000|Overall Study|Lost to Follow-up|4|||
126561687|NCT00359619|455351928|FG001|Overall Study|Lost to Follow-up|4|||
126561688|NCT00359619|455351929|FG002|Overall Study|Lost to Follow-up|2|||
126561689|NCT00359619|455351930|FG003|Overall Study|Lost to Follow-up|1|||
126561690|NCT00359619|455351931|FG004|Overall Study|Lost to Follow-up|1|||
126561691|NCT00359619|455351932|FG005|Overall Study|Lost to Follow-up|5|||
126561692|NCT00359619|455351933|FG006|Overall Study|Lost to Follow-up|0|||
126561693|NCT00256308|455351934|FG000|Overall Study|Death|2|||
126561694|NCT01419717|455351935|FG000|Overall Study|Protocol-specified Criteria|62|||
126561695|NCT01419717|455351935|FG000|Overall Study|Adverse Event|19|||
126561696|NCT01419717|455351935|FG000|Overall Study|Death|17|||
126561697|NCT01419717|455351935|FG000|Overall Study|Withdrawal by Subject|10|||
126561698|NCT01419717|455351935|FG000|Overall Study|Disease Progression|9|||
126561699|NCT01419717|455351935|FG000|Overall Study|Other|4|||
126561700|NCT01419717|455351935|FG000|Overall Study|Lost to Follow-up|2|||
126561701|NCT01419717|455351935|FG000|Overall Study|Administrative Decision|1|||
126561702|NCT01419717|455351935|FG000|Overall Study|Noncompliance|1|||
126561703|NCT02857283|455351936|FG000|First Exposure|Withdrawal by Subject|1|||
126726719|NCT00621855|455949021|FG002|Overall Study|Other|6|||
126726720|NCT00621855|455949022|FG003|Overall Study|Other|5|||
126726721|NCT00621855|455949023|FG004|Overall Study|Other|4|||
126726722|NCT00621855|455949019|FG000|Overall Study|Patients did not receive study drug|3|||
126726723|NCT00621855|455949020|FG001|Overall Study|Patients did not receive study drug|3|||
126726724|NCT00621855|455949021|FG002|Overall Study|Patients did not receive study drug|5|||
126726725|NCT00621855|455949022|FG003|Overall Study|Patients did not receive study drug|4|||
126561704|NCT02857283|455351937|FG001|First Exposure|Withdrawal by Subject|0|||
126561705|NCT05074498|455351942|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
126726726|NCT00621855|455949023|FG004|Overall Study|Patients did not receive study drug|2|||
126561706|NCT05074498|455351943|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
126561707|NCT05074498|455351944|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
126561708|NCT05074498|455351945|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
126561709|NCT05074498|455351946|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
126561710|NCT05074498|455351947|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
126561711|NCT05074498|455351942|FG000|Part 1 (Upto Day 104)|Other|1|||
126561712|NCT05074498|455351943|FG001|Part 1 (Upto Day 104)|Other|0|||
126726727|NCT00403559|455949024|FG000|Overall Study|Adverse Event|0|||
126561713|NCT05074498|455351944|FG002|Part 1 (Upto Day 104)|Other|0|||
126561714|NCT05074498|455351945|FG003|Part 1 (Upto Day 104)|Other|0|||
126561715|NCT05074498|455351946|FG004|Part 1 (Upto Day 104)|Other|0|||
126561716|NCT05074498|455351947|FG005|Part 1 (Upto Day 104)|Other|0|||
126561717|NCT05074498|455351942|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
126561718|NCT05074498|455351943|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
126561719|NCT05074498|455351944|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
126561720|NCT05074498|455351945|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
126561721|NCT05074498|455351946|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
126561722|NCT05074498|455351947|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
126561723|NCT05074498|455351942|FG000|Part 2 (Upto Day 104)|Death|0|||
126561724|NCT05074498|455351943|FG001|Part 2 (Upto Day 104)|Death|0|||
126561725|NCT05074498|455351944|FG002|Part 2 (Upto Day 104)|Death|0|||
126561726|NCT05074498|455351945|FG003|Part 2 (Upto Day 104)|Death|0|||
126561727|NCT05074498|455351946|FG004|Part 2 (Upto Day 104)|Death|1|||
126561728|NCT05074498|455351947|FG005|Part 2 (Upto Day 104)|Death|0|||
126561729|NCT05074498|455351942|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
126561730|NCT05074498|455351943|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
126561731|NCT05074498|455351944|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
126561732|NCT05074498|455351945|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
126561733|NCT05074498|455351946|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
126561734|NCT05074498|455351947|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
126561735|NCT05074498|455351942|FG000|Part 2 (Upto Day 104)|Other|0|||
126561736|NCT05074498|455351943|FG001|Part 2 (Upto Day 104)|Other|0|||
126561737|NCT05074498|455351944|FG002|Part 2 (Upto Day 104)|Other|0|||
126561738|NCT05074498|455351945|FG003|Part 2 (Upto Day 104)|Other|0|||
126561739|NCT05074498|455351946|FG004|Part 2 (Upto Day 104)|Other|1|||
126561740|NCT05074498|455351947|FG005|Part 2 (Upto Day 104)|Other|0|||
126561741|NCT01240356|455351949|FG000|Overall Study|Withdrawal by Subject|2|||
126561742|NCT01240356|455351950|FG001|Overall Study|Withdrawal by Subject|0|||
126561743|NCT01240356|455351949|FG000|Overall Study|MRI contraindication|1|||
126561744|NCT01240356|455351950|FG001|Overall Study|MRI contraindication|0|||
126561745|NCT03085017|455351956|FG000|Overall Study|Death|0|||
126561746|NCT03085017|455351957|FG001|Overall Study|Death|3|||
126561747|NCT03681691|455351965|FG000|Overall Study|COVID|1|||
126561748|NCT03681691|455351966|FG001|Overall Study|COVID|0|||
126561749|NCT03681691|455351965|FG000|Overall Study|prolonged bleeding|1|||
126561750|NCT03681691|455351966|FG001|Overall Study|prolonged bleeding|0|||
126561751|NCT03681691|455351965|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
126561752|NCT03681691|455351966|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
126561753|NCT03613129|455351967|FG000|Pre-treatment Assessment|Protocol Violation|2|||
126561754|NCT03613129|455351968|FG001|Pre-treatment Assessment|Protocol Violation|0|||
126561755|NCT03613129|455351969|FG002|Pre-treatment Assessment|Protocol Violation|0|||
126561756|NCT03613129|455351970|FG003|Pre-treatment Assessment|Protocol Violation|0|||
126561757|NCT03613129|455351971|FG004|Pre-treatment Assessment|Protocol Violation|0|||
126561758|NCT03613129|455351967|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
126561759|NCT03613129|455351968|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
126561760|NCT03613129|455351969|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
126561761|NCT03613129|455351970|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
126561762|NCT03613129|455351971|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
126561763|NCT03432533|455351974|FG000|Overall Study|Lost to Follow-up|1|||
126561764|NCT03432533|455351975|FG001|Overall Study|Lost to Follow-up|2|||
126561765|NCT03432533|455351974|FG000|Overall Study|Withdrawal by Subject|14|||
126561766|NCT03432533|455351975|FG001|Overall Study|Withdrawal by Subject|9|||
126561767|NCT01582243|455351978|FG000|Overall Study|Withdrawal by Subject|1|||
126561768|NCT01582243|455351978|FG000|Overall Study|Adverse Event|1|||
126561769|NCT01582243|455351978|FG000|Overall Study|Lost to Follow-up|1|||
126561770|NCT02282527|455351980|FG000|Overall Study|Lost to Follow-up|0|||
126775912|NCT01889862|456135785|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
126775913|NCT01889862|456135786|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
126775914|NCT01889862|456135787|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
126561771|NCT02282527|455351981|FG001|Overall Study|Lost to Follow-up|1|||
126561772|NCT02282527|455351980|FG000|Overall Study|Lack of home health aid|1|||
126561773|NCT02282527|455351981|FG001|Overall Study|Lack of home health aid|0|||
126561774|NCT00941031|455351982|FG000|Induction Period|Lack of Efficacy|2|||
126561775|NCT00941031|455351983|FG001|Induction Period|Lack of Efficacy|1|||
126561776|NCT00941031|455351984|FG002|Induction Period|Lack of Efficacy|0|||
126561777|NCT00941031|455351985|FG003|Induction Period|Lack of Efficacy|5|||
126561778|NCT00941031|455351986|FG004|Induction Period|Lack of Efficacy|0|||
126561779|NCT00941031|455351987|FG005|Induction Period|Lack of Efficacy|0|||
126561780|NCT00941031|455351988|FG006|Induction Period|Lack of Efficacy|0|||
126775915|NCT01889862|456135783|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
126561781|NCT00941031|455351982|FG000|Induction Period|Withdrawal by Subject|1|||
126561782|NCT00941031|455351983|FG001|Induction Period|Withdrawal by Subject|2|||
126561783|NCT00941031|455351984|FG002|Induction Period|Withdrawal by Subject|2|||
126561784|NCT00941031|455351985|FG003|Induction Period|Withdrawal by Subject|2|||
126775916|NCT01889862|456135784|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
126775917|NCT01889862|456135785|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
126775918|NCT01889862|456135786|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
126775919|NCT01889862|456135787|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
126775920|NCT01889862|456135783|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
126775921|NCT01889862|456135784|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
126775922|NCT01889862|456135785|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
126775923|NCT01889862|456135786|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
126775924|NCT01889862|456135787|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
126775925|NCT01889862|456135783|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
126775926|NCT01889862|456135784|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
126775927|NCT01889862|456135785|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
126775928|NCT01889862|456135786|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
126775929|NCT01889862|456135787|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
126775930|NCT01889862|456135783|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
126775931|NCT01889862|456135784|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
126775932|NCT01889862|456135785|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
126775933|NCT01889862|456135786|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
126775934|NCT01889862|456135787|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
126775935|NCT01889862|456135783|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
126775936|NCT01889862|456135784|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
126775937|NCT01889862|456135785|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
126775938|NCT01889862|456135786|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
126775939|NCT01889862|456135787|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
126775940|NCT01889862|456135783|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
126775941|NCT01889862|456135784|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
126775942|NCT01889862|456135785|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
126775943|NCT01889862|456135786|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
126775944|NCT01889862|456135787|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
126775945|NCT01889862|456135783|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
126775946|NCT01889862|456135784|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
126775947|NCT01889862|456135785|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
126775948|NCT01889862|456135786|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
126775949|NCT01889862|456135787|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
126775950|NCT01889862|456135783|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
126775951|NCT01889862|456135784|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
126775952|NCT01889862|456135785|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
126775953|NCT01889862|456135786|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
126775954|NCT01889862|456135787|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
126775955|NCT00845026|456135788|FG000|Study Period III|Adverse Event|23|||
126775956|NCT00845026|456135789|FG001|Study Period III|Adverse Event|19|||
126775957|NCT00845026|456135788|FG000|Study Period III|Perceived lack of efficacy|27|||
126775958|NCT00845026|456135789|FG001|Study Period III|Perceived lack of efficacy|15|||
126775959|NCT00845026|456135788|FG000|Study Period III|Withdrawal by Subject|19|||
126775960|NCT00845026|456135789|FG001|Study Period III|Withdrawal by Subject|15|||
126775961|NCT00845026|456135788|FG000|Study Period III|Entry Criteria not met|8|||
126775962|NCT00845026|456135789|FG001|Study Period III|Entry Criteria not met|11|||
126775963|NCT00845026|456135788|FG000|Study Period III|Lost to Follow-up|4|||
126775964|NCT00845026|456135789|FG001|Study Period III|Lost to Follow-up|5|||
126775965|NCT00845026|456135788|FG000|Study Period III|Protocol Violation|8|||
126775966|NCT00845026|456135789|FG001|Study Period III|Protocol Violation|1|||
126775967|NCT00845026|456135788|FG000|Study Period III|Scheduled conflict|3|||
126775968|NCT00845026|456135789|FG001|Study Period III|Scheduled conflict|1|||
126775969|NCT00845026|456135788|FG000|Study Period III|Subject is moving or has moved|2|||
126775970|NCT00845026|456135789|FG001|Study Period III|Subject is moving or has moved|4|||
126775971|NCT00845026|456135788|FG000|Study Period III|Transportation issues|1|||
126775972|NCT00845026|456135789|FG001|Study Period III|Transportation issues|1|||
126775973|NCT00845026|456135788|FG000|Study Period IV|Adverse Event|4|||
126775974|NCT00845026|456135789|FG001|Study Period IV|Adverse Event|0|||
126775975|NCT00845026|456135788|FG000|Study Period IV|Perceived lack of efficacy|2|||
126502452|NCT03560531|455140000|FG013|Overall Study|Withdrawal by Subject|0|||
126502453|NCT03560531|455139987|FG000|Overall Study|Study end per-protocol|1|||
126502454|NCT03560531|455139988|FG001|Overall Study|Study end per-protocol|1|||
126775976|NCT00845026|456135789|FG001|Study Period IV|Perceived lack of efficacy|1|||
126775977|NCT00845026|456135788|FG000|Study Period IV|Protocol Violation|3|||
126775978|NCT00845026|456135789|FG001|Study Period IV|Protocol Violation|1|||
126502455|NCT03560531|455139989|FG002|Overall Study|Study end per-protocol|2|||
126775979|NCT00845026|456135788|FG000|Study Period IV|Lost to Follow-up|1|||
126775980|NCT00845026|456135789|FG001|Study Period IV|Lost to Follow-up|0|||
126775981|NCT00845026|456135788|FG000|Study Period IV|Withdrawal by Subject|4|||
126775982|NCT00845026|456135789|FG001|Study Period IV|Withdrawal by Subject|1|||
126775983|NCT00845026|456135788|FG000|Study Period IV|Entry Criteria Not Met|1|||
126775984|NCT00845026|456135789|FG001|Study Period IV|Entry Criteria Not Met|0|||
126561785|NCT00941031|455351986|FG004|Induction Period|Withdrawal by Subject|0|||
126561786|NCT00941031|455351987|FG005|Induction Period|Withdrawal by Subject|0|||
126561787|NCT00941031|455351988|FG006|Induction Period|Withdrawal by Subject|0|||
126561788|NCT00941031|455351982|FG000|Induction Period|Adminstative Problems|1|||
126561789|NCT00941031|455351983|FG001|Induction Period|Adminstative Problems|1|||
126561790|NCT00941031|455351984|FG002|Induction Period|Adminstative Problems|1|||
126561791|NCT00941031|455351985|FG003|Induction Period|Adminstative Problems|0|||
126561792|NCT00941031|455351986|FG004|Induction Period|Adminstative Problems|0|||
126561793|NCT00941031|455351987|FG005|Induction Period|Adminstative Problems|0|||
126561794|NCT00941031|455351988|FG006|Induction Period|Adminstative Problems|0|||
126561795|NCT00941031|455351982|FG000|Induction Period|Adverse Event|1|||
126561796|NCT00941031|455351983|FG001|Induction Period|Adverse Event|0|||
126561797|NCT00941031|455351984|FG002|Induction Period|Adverse Event|3|||
126561798|NCT00941031|455351985|FG003|Induction Period|Adverse Event|2|||
126561799|NCT00941031|455351986|FG004|Induction Period|Adverse Event|0|||
126561800|NCT00941031|455351987|FG005|Induction Period|Adverse Event|0|||
126561801|NCT00941031|455351988|FG006|Induction Period|Adverse Event|0|||
126561802|NCT00941031|455351982|FG000|Maintenance Period|Withdrawal by Subject|0|||
126561803|NCT00941031|455351983|FG001|Maintenance Period|Withdrawal by Subject|0|||
126561804|NCT00941031|455351984|FG002|Maintenance Period|Withdrawal by Subject|0|||
126561805|NCT00941031|455351985|FG003|Maintenance Period|Withdrawal by Subject|0|||
126561806|NCT00941031|455351986|FG004|Maintenance Period|Withdrawal by Subject|6|||
126561807|NCT00941031|455351987|FG005|Maintenance Period|Withdrawal by Subject|2|||
126561808|NCT00941031|455351988|FG006|Maintenance Period|Withdrawal by Subject|13|||
126561809|NCT00941031|455351982|FG000|Maintenance Period|Administrative Problems|0|||
126561810|NCT00941031|455351983|FG001|Maintenance Period|Administrative Problems|0|||
126561811|NCT00941031|455351984|FG002|Maintenance Period|Administrative Problems|0|||
126561812|NCT00941031|455351985|FG003|Maintenance Period|Administrative Problems|0|||
126561813|NCT00941031|455351986|FG004|Maintenance Period|Administrative Problems|1|||
126561814|NCT00941031|455351987|FG005|Maintenance Period|Administrative Problems|0|||
126561815|NCT00941031|455351988|FG006|Maintenance Period|Administrative Problems|1|||
126561816|NCT00941031|455351982|FG000|Maintenance Period|Protocol Violation|0|||
126561817|NCT00941031|455351983|FG001|Maintenance Period|Protocol Violation|0|||
126561818|NCT00941031|455351984|FG002|Maintenance Period|Protocol Violation|0|||
126561819|NCT00941031|455351985|FG003|Maintenance Period|Protocol Violation|0|||
126561820|NCT00941031|455351986|FG004|Maintenance Period|Protocol Violation|0|||
126561821|NCT00941031|455351987|FG005|Maintenance Period|Protocol Violation|0|||
126561822|NCT00941031|455351988|FG006|Maintenance Period|Protocol Violation|1|||
126561823|NCT00941031|455351982|FG000|Maintenance Period|Adverse Event|0|||
126561824|NCT00941031|455351983|FG001|Maintenance Period|Adverse Event|0|||
126561825|NCT00941031|455351984|FG002|Maintenance Period|Adverse Event|0|||
126561826|NCT00941031|455351985|FG003|Maintenance Period|Adverse Event|0|||
126561827|NCT00941031|455351986|FG004|Maintenance Period|Adverse Event|0|||
126561828|NCT00941031|455351987|FG005|Maintenance Period|Adverse Event|2|||
126561829|NCT00941031|455351988|FG006|Maintenance Period|Adverse Event|8|||
126561830|NCT00941031|455351982|FG000|Maintenance Period|Lost to Follow-up|0|||
126561831|NCT00941031|455351983|FG001|Maintenance Period|Lost to Follow-up|0|||
126561832|NCT00941031|455351984|FG002|Maintenance Period|Lost to Follow-up|0|||
126561833|NCT00941031|455351985|FG003|Maintenance Period|Lost to Follow-up|0|||
126561834|NCT00941031|455351986|FG004|Maintenance Period|Lost to Follow-up|2|||
126561835|NCT00941031|455351987|FG005|Maintenance Period|Lost to Follow-up|2|||
126561836|NCT00941031|455351988|FG006|Maintenance Period|Lost to Follow-up|7|||
126561837|NCT00941031|455351982|FG000|Maintenance Period|Lack of Efficacy|0|||
126561838|NCT00941031|455351983|FG001|Maintenance Period|Lack of Efficacy|0|||
126561839|NCT00941031|455351984|FG002|Maintenance Period|Lack of Efficacy|0|||
126561840|NCT00941031|455351985|FG003|Maintenance Period|Lack of Efficacy|0|||
126561841|NCT00941031|455351986|FG004|Maintenance Period|Lack of Efficacy|0|||
126561842|NCT00941031|455351987|FG005|Maintenance Period|Lack of Efficacy|0|||
126561843|NCT00941031|455351988|FG006|Maintenance Period|Lack of Efficacy|13|||
126561844|NCT01872611|455351989|FG000|Overall Study|Adverse Event|3|||
126561845|NCT01872611|455351990|FG001|Overall Study|Adverse Event|1|||
126561846|NCT01872611|455351989|FG000|Overall Study|Adverse Event, prior to treatment|0|||
126561847|NCT01872611|455351990|FG001|Overall Study|Adverse Event, prior to treatment|1|||
126561848|NCT01872611|455351989|FG000|Overall Study|Death|0|||
126561849|NCT01872611|455351990|FG001|Overall Study|Death|1|||
126561850|NCT01872611|455351989|FG000|Overall Study|Death, prior to treatment|0|||
126561851|NCT01872611|455351990|FG001|Overall Study|Death, prior to treatment|1|||
126561852|NCT01872611|455351989|FG000|Overall Study|Lost to Follow-up|8|||
126561853|NCT01872611|455351990|FG001|Overall Study|Lost to Follow-up|1|||
126561854|NCT01872611|455351989|FG000|Overall Study|Physician Decision|1|||
126561855|NCT01872611|455351990|FG001|Overall Study|Physician Decision|0|||
126561856|NCT01872611|455351989|FG000|Overall Study|Withdrawal by Subject|6|||
126561857|NCT01872611|455351990|FG001|Overall Study|Withdrawal by Subject|1|||
126561858|NCT01872611|455351989|FG000|Overall Study|Reason not provided|6|||
126561859|NCT01872611|455351990|FG001|Overall Study|Reason not provided|6|||
126561860|NCT00631917|455351991|FG000|Overall Study|Adverse Event|34|||
126561861|NCT00631917|455351992|FG001|Overall Study|Adverse Event|45|||
126502456|NCT03560531|455139990|FG003|Overall Study|Study end per-protocol|0|||
126502457|NCT03560531|455139991|FG004|Overall Study|Study end per-protocol|1|||
126502458|NCT03560531|455139992|FG005|Overall Study|Study end per-protocol|0|||
126502459|NCT03560531|455139993|FG006|Overall Study|Study end per-protocol|0|||
126502460|NCT03560531|455139994|FG007|Overall Study|Study end per-protocol|0|||
126502461|NCT03560531|455139995|FG008|Overall Study|Study end per-protocol|0|||
126502462|NCT03560531|455139996|FG009|Overall Study|Study end per-protocol|0|||
126502463|NCT03560531|455139997|FG010|Overall Study|Study end per-protocol|0|||
126502464|NCT03560531|455139998|FG011|Overall Study|Study end per-protocol|0|||
126502465|NCT03560531|455139999|FG012|Overall Study|Study end per-protocol|0|||
126502466|NCT03560531|455140000|FG013|Overall Study|Study end per-protocol|0|||
126502467|NCT03560531|455139987|FG000|Overall Study|Early study termination by sponsor|9|||
126502468|NCT03560531|455139988|FG001|Overall Study|Early study termination by sponsor|0|||
126502469|NCT03560531|455139989|FG002|Overall Study|Early study termination by sponsor|0|||
126502470|NCT03560531|455139990|FG003|Overall Study|Early study termination by sponsor|4|||
126502471|NCT03560531|455139991|FG004|Overall Study|Early study termination by sponsor|8|||
126502472|NCT03560531|455139992|FG005|Overall Study|Early study termination by sponsor|2|||
126502473|NCT03560531|455139993|FG006|Overall Study|Early study termination by sponsor|5|||
126502474|NCT03560531|455139994|FG007|Overall Study|Early study termination by sponsor|64|||
126502475|NCT03560531|455139995|FG008|Overall Study|Early study termination by sponsor|7|||
126502476|NCT03560531|455139996|FG009|Overall Study|Early study termination by sponsor|2|||
126502477|NCT03560531|455139997|FG010|Overall Study|Early study termination by sponsor|16|||
126502478|NCT03560531|455139998|FG011|Overall Study|Early study termination by sponsor|2|||
126502479|NCT03560531|455139999|FG012|Overall Study|Early study termination by sponsor|6|||
126502480|NCT03560531|455140000|FG013|Overall Study|Early study termination by sponsor|2|||
126502481|NCT01200797|455140003|FG000|Overall Study|symptomatic deterioration|2|||
126502482|NCT01200797|455140003|FG000|Overall Study|Adverse Event|4|||
126502483|NCT01200797|455140003|FG000|Overall Study|Disease Progression|13|||
126502484|NCT00642668|455140008|FG000|Overall Study|Lost to Follow-up|1|||
126502485|NCT00642668|455140008|FG000|Overall Study|Adverse Event|2|||
126502486|NCT00642668|455140008|FG000|Overall Study|Death|2|||
126502487|NCT00642668|455140008|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126502488|NCT00642668|455140008|FG000|Overall Study|Failure to Return|1|||
126502489|NCT00642668|455140008|FG000|Overall Study|Dialysis Initiation|5|||
126502490|NCT00642668|455140008|FG000|Overall Study|Blood Transfusion|2|||
126502491|NCT03608774|455140009|FG000|Overall Study|Lost to Follow-up|5|||
126502492|NCT03608774|455140010|FG001|Overall Study|Lost to Follow-up|5|||
126502493|NCT03608774|455140009|FG000|Overall Study|Withdrawal by Subject|1|||
126502494|NCT03608774|455140010|FG001|Overall Study|Withdrawal by Subject|0|||
126502495|NCT03608774|455140009|FG000|Overall Study|Protocol Violation|1|||
126502496|NCT03608774|455140010|FG001|Overall Study|Protocol Violation|0|||
126502497|NCT03608774|455140009|FG000|Overall Study|Not eligible at enrollment|0|||
126502498|NCT03608774|455140010|FG001|Overall Study|Not eligible at enrollment|1|||
126502499|NCT03608774|455140009|FG000|Overall Study|Health related event|0|||
126502500|NCT03608774|455140010|FG001|Overall Study|Health related event|1|||
126502501|NCT01177540|455140011|FG000|Overall Study|Adverse Event|1|||
126502502|NCT01177540|455140012|FG001|Overall Study|Adverse Event|0|||
126502503|NCT01623596|455140016|FG000|Overall Study|Abnormal laboratory values|2|||
126502504|NCT01623596|455140017|FG001|Overall Study|Abnormal laboratory values|0|||
126502505|NCT01623596|455140016|FG000|Overall Study|Administrative problems|9|||
126502506|NCT01623596|455140017|FG001|Overall Study|Administrative problems|13|||
126502507|NCT01623596|455140016|FG000|Overall Study|Adverse Event|20|||
126502508|NCT01623596|455140017|FG001|Overall Study|Adverse Event|29|||
126502509|NCT01623596|455140016|FG000|Overall Study|Death|0|||
126502510|NCT01623596|455140017|FG001|Overall Study|Death|2|||
126502511|NCT01623596|455140016|FG000|Overall Study|Lost to Follow-up|12|||
126502512|NCT01623596|455140017|FG001|Overall Study|Lost to Follow-up|16|||
126502513|NCT01623596|455140016|FG000|Overall Study|Withdrawal by Subject|13|||
126502514|NCT01623596|455140017|FG001|Overall Study|Withdrawal by Subject|31|||
126502515|NCT01623596|455140016|FG000|Overall Study|Patient no longer requires study drug|1|||
126502516|NCT01623596|455140017|FG001|Overall Study|Patient no longer requires study drug|0|||
126502517|NCT01623596|455140016|FG000|Overall Study|Protocol Violation|0|||
126502518|NCT01623596|455140017|FG001|Overall Study|Protocol Violation|6|||
126502519|NCT01623596|455140016|FG000|Overall Study|Lack of Efficacy|5|||
126502520|NCT01623596|455140017|FG001|Overall Study|Lack of Efficacy|3|||
126561862|NCT00631917|455351991|FG000|Overall Study|Abnormal laboratory value(s)|2|||
126502521|NCT01070316|455140018|FG000|Extension Phase|Lack of Efficacy|3|||
126502522|NCT01070316|455140018|FG000|Extension Phase|Withdrawal by Subject|1|||
126502523|NCT03200899|455140021|FG000|Overall Study|Lost to Follow-up|10|||
126502524|NCT03200899|455140022|FG001|Overall Study|Lost to Follow-up|23|||
126502525|NCT01449526|455140023|FG000|Overall Study|Lost to Follow-up|1|||
126502526|NCT01449526|455140024|FG001|Overall Study|Lost to Follow-up|2|||
126502527|NCT01449526|455140023|FG000|Overall Study|Withdrawal by Subject|1|||
126502528|NCT01449526|455140024|FG001|Overall Study|Withdrawal by Subject|1|||
126502529|NCT01449526|455140023|FG000|Overall Study|Symptoms/complaints|0|||
126502530|NCT01449526|455140024|FG001|Overall Study|Symptoms/complaints|1|||
126561863|NCT00631917|455351992|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126561864|NCT00631917|455351991|FG000|Overall Study|Abnormal test procedure result(s)|3|||
126561865|NCT00631917|455351992|FG001|Overall Study|Abnormal test procedure result(s)|2|||
126561866|NCT00631917|455351991|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
126561867|NCT00631917|455351992|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
126561868|NCT00631917|455351991|FG000|Overall Study|No longer required study drug|0|||
126561869|NCT00631917|455351992|FG001|Overall Study|No longer required study drug|1|||
126561870|NCT00631917|455351991|FG000|Overall Study|Protocol deviation|6|||
126561871|NCT00631917|455351992|FG001|Overall Study|Protocol deviation|5|||
126561872|NCT00631917|455351991|FG000|Overall Study|Subject withdrew consent|25|||
126561873|NCT00631917|455351992|FG001|Overall Study|Subject withdrew consent|33|||
126561874|NCT00631917|455351991|FG000|Overall Study|Lost to Follow-up|7|||
126561875|NCT00631917|455351992|FG001|Overall Study|Lost to Follow-up|7|||
126561876|NCT00631917|455351991|FG000|Overall Study|Administrative problems|2|||
126561877|NCT00631917|455351992|FG001|Overall Study|Administrative problems|0|||
126561878|NCT00631917|455351991|FG000|Overall Study|Death|1|||
126561879|NCT00631917|455351992|FG001|Overall Study|Death|0|||
126561880|NCT02939183|455351995|FG000|Overall Study|Death|0|||
126561881|NCT02939183|455351996|FG001|Overall Study|Death|0|||
126561882|NCT02939183|455351997|FG002|Overall Study|Death|1|||
126561883|NCT02939183|455351998|FG003|Overall Study|Death|0|||
126561884|NCT02939183|455351999|FG004|Overall Study|Death|0|||
126561885|NCT02939183|455352000|FG005|Overall Study|Death|2|||
126561886|NCT02939183|455352001|FG006|Overall Study|Death|1|||
126561887|NCT02939183|455352002|FG007|Overall Study|Death|0|||
126561888|NCT02939183|455352003|FG008|Overall Study|Death|0|||
126561889|NCT02939183|455351995|FG000|Overall Study|Sponsor decision|0|||
126561890|NCT02939183|455351996|FG001|Overall Study|Sponsor decision|1|||
126561891|NCT02939183|455351997|FG002|Overall Study|Sponsor decision|0|||
126561892|NCT02939183|455351998|FG003|Overall Study|Sponsor decision|1|||
126561893|NCT02939183|455351999|FG004|Overall Study|Sponsor decision|2|||
126561894|NCT02939183|455352000|FG005|Overall Study|Sponsor decision|0|||
126561895|NCT02939183|455352001|FG006|Overall Study|Sponsor decision|3|||
126561896|NCT02939183|455352002|FG007|Overall Study|Sponsor decision|1|||
126561897|NCT02939183|455352003|FG008|Overall Study|Sponsor decision|4|||
126561898|NCT02939183|455351995|FG000|Overall Study|Withdrawal by Subject|0|||
126561899|NCT02939183|455351996|FG001|Overall Study|Withdrawal by Subject|2|||
126561900|NCT02939183|455351997|FG002|Overall Study|Withdrawal by Subject|0|||
126561901|NCT02939183|455351998|FG003|Overall Study|Withdrawal by Subject|1|||
126561902|NCT02939183|455351999|FG004|Overall Study|Withdrawal by Subject|0|||
126561903|NCT02939183|455352000|FG005|Overall Study|Withdrawal by Subject|0|||
126561904|NCT02939183|455352001|FG006|Overall Study|Withdrawal by Subject|2|||
126561905|NCT02939183|455352002|FG007|Overall Study|Withdrawal by Subject|2|||
126561906|NCT02939183|455352003|FG008|Overall Study|Withdrawal by Subject|2|||
126561907|NCT02939183|455351995|FG000|Overall Study|Not treated due to adverse event|0|||
126561908|NCT02939183|455351996|FG001|Overall Study|Not treated due to adverse event|0|||
126561909|NCT02939183|455351997|FG002|Overall Study|Not treated due to adverse event|0|||
126561910|NCT02939183|455351998|FG003|Overall Study|Not treated due to adverse event|1|||
126561911|NCT02939183|455351999|FG004|Overall Study|Not treated due to adverse event|0|||
126561912|NCT02939183|455352000|FG005|Overall Study|Not treated due to adverse event|0|||
126561913|NCT02939183|455352001|FG006|Overall Study|Not treated due to adverse event|1|||
126561914|NCT02939183|455352002|FG007|Overall Study|Not treated due to adverse event|0|||
126561915|NCT02939183|455352003|FG008|Overall Study|Not treated due to adverse event|0|||
126561916|NCT01446003|455352008|FG000|Period 1|Protocol Violation|2|||
126561917|NCT01446003|455352009|FG001|Period 1|Protocol Violation|0|||
126561918|NCT01446003|455352008|FG000|Period 2|Adverse Event|1|||
126561919|NCT01446003|455352009|FG001|Period 2|Adverse Event|0|||
126561920|NCT00318656|455352010|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
126561921|NCT00318656|455352011|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
126561922|NCT00318656|455352010|FG000|Overall Study|Did not receive any treatment|0|||
126561923|NCT00318656|455352011|FG001|Overall Study|Did not receive any treatment|1|||
126561924|NCT03905135|455352012|FG000|Dose Escalation|Adverse Event|1|||
126726728|NCT00403559|455949025|FG001|Overall Study|Adverse Event|1|||
126726729|NCT00403559|455949024|FG000|Overall Study|Lost to Follow-up|3|||
126561925|NCT03905135|455352013|FG001|Dose Escalation|Adverse Event|1|||
126726730|NCT00403559|455949025|FG001|Overall Study|Lost to Follow-up|3|||
126726731|NCT00403559|455949024|FG000|Overall Study|Withdrawal by Subject|1|||
126726732|NCT00403559|455949025|FG001|Overall Study|Withdrawal by Subject|0|||
126726733|NCT03105700|455949026|FG000|Overall Study|screen fail|3|||
126561926|NCT03905135|455352012|FG000|Dose Escalation|Progressive disease|3|||
126561927|NCT03905135|455352013|FG001|Dose Escalation|Progressive disease|1|||
126561928|NCT03905135|455352012|FG000|Dose Escalation|Intercurrent illness|1|||
126561929|NCT03905135|455352013|FG001|Dose Escalation|Intercurrent illness|0|||
126561930|NCT01740557|455352016|FG000|Overall Study|Ineligible|1|||
126561931|NCT01740557|455352016|FG000|Overall Study|Screen failure|1|||
126561932|NCT00490555|455352019|FG000|Overall Study|noncompliant with drug administration|0|||
126561933|NCT00490555|455352020|FG001|Overall Study|noncompliant with drug administration|0|||
126561934|NCT00490555|455352021|FG002|Overall Study|noncompliant with drug administration|2|||
126561935|NCT00490555|455352022|FG003|Overall Study|noncompliant with drug administration|0|||
126561936|NCT01268566|455352025|FG000|Overall Study|Lost to Follow-up|1|||
126561937|NCT01268566|455352025|FG000|Overall Study|Withdrawal by Subject|12|||
126561938|NCT01268566|455352025|FG000|Overall Study|Death|30|||
126561939|NCT02042443|455352026|FG000|Overall Study|Adverse Event|2|||
126561940|NCT02042443|455352027|FG001|Overall Study|Adverse Event|1|||
126561941|NCT02042443|455352026|FG000|Overall Study|Withdrawal by Subject|0|||
126561942|NCT02042443|455352027|FG001|Overall Study|Withdrawal by Subject|1|||
126561943|NCT02042443|455352026|FG000|Overall Study|Progression|21|||
126561944|NCT02042443|455352027|FG001|Overall Study|Progression|17|||
126561945|NCT02042443|455352026|FG000|Overall Study|not protocol specified|1|||
126561946|NCT02042443|455352027|FG001|Overall Study|not protocol specified|1|||
126561947|NCT02042443|455352026|FG000|Overall Study|Not eligible/not analyzable|3|||
126561948|NCT02042443|455352027|FG001|Overall Study|Not eligible/not analyzable|6|||
126561949|NCT01007149|455352030|FG000|Overall Study|Administrative problems|0|||
126561950|NCT01007149|455352031|FG001|Overall Study|Administrative problems|1|||
126561951|NCT01913340|455352032|FG000|Overall Study|Death|2|||
126561952|NCT01913340|455352033|FG001|Overall Study|Death|5|||
126561953|NCT01913340|455352032|FG000|Overall Study|Lost to Follow-up|1|||
126561954|NCT01913340|455352033|FG001|Overall Study|Lost to Follow-up|1|||
126561955|NCT02784704|455352034|FG000|Overall Study|Adverse Event|4|||
126561956|NCT02784704|455352035|FG001|Overall Study|Adverse Event|2|||
126561957|NCT02784704|455352034|FG000|Overall Study|Lost to Follow-up|6|||
126561958|NCT02784704|455352035|FG001|Overall Study|Lost to Follow-up|4|||
126561959|NCT02784704|455352034|FG000|Overall Study|Withdrawal by Subject|1|||
126561960|NCT02784704|455352035|FG001|Overall Study|Withdrawal by Subject|3|||
126561961|NCT02784704|455352034|FG000|Overall Study|Subject Non Compliance|2|||
126561962|NCT02784704|455352035|FG001|Overall Study|Subject Non Compliance|0|||
126561963|NCT02320253|455352036|FG000|Overall Study|Withdrawal by Subject|3|||
126561964|NCT02320253|455352037|FG001|Overall Study|Withdrawal by Subject|0|||
126561965|NCT02320253|455352038|FG002|Overall Study|Withdrawal by Subject|0|||
126561966|NCT02320253|455352036|FG000|Overall Study|Lost to Follow-up|2|||
126561967|NCT02320253|455352037|FG001|Overall Study|Lost to Follow-up|2|||
126561968|NCT02320253|455352038|FG002|Overall Study|Lost to Follow-up|1|||
126561969|NCT02320253|455352036|FG000|Overall Study|Death|1|||
126561970|NCT02320253|455352037|FG001|Overall Study|Death|0|||
126561971|NCT02320253|455352038|FG002|Overall Study|Death|1|||
126561972|NCT00603538|455352039|FG000|Overall Study|Adverse Event|0|||
126561973|NCT00603538|455352040|FG001|Overall Study|Adverse Event|4|||
126561974|NCT00603538|455352041|FG002|Overall Study|Adverse Event|2|||
126561975|NCT00603538|455352039|FG000|Overall Study|Objective progression or relapse|3|||
126561976|NCT00603538|455352040|FG001|Overall Study|Objective progression or relapse|0|||
126561977|NCT00603538|455352041|FG002|Overall Study|Objective progression or relapse|0|||
126561978|NCT05750745|455352043|FG000|Overall Study|Adverse Event|1|||
126561979|NCT05750745|455352044|FG001|Overall Study|Adverse Event|0|||
126561980|NCT05750745|455352045|FG002|Overall Study|Adverse Event|0|||
126561981|NCT05750745|455352043|FG000|Overall Study|Protocol Violation|1|||
126561982|NCT05750745|455352044|FG001|Overall Study|Protocol Violation|0|||
126561983|NCT05750745|455352045|FG002|Overall Study|Protocol Violation|0|||
126561984|NCT05750745|455352043|FG000|Overall Study|Withdrawal by Subject|0|||
126561985|NCT05750745|455352044|FG001|Overall Study|Withdrawal by Subject|1|||
126561986|NCT05750745|455352045|FG002|Overall Study|Withdrawal by Subject|0|||
126561987|NCT04794179|455352047|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
126561988|NCT04794179|455352048|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
126561989|NCT00783692|455352053|FG000|Induction Phase|Adverse Event|7|||
126561990|NCT00783692|455352054|FG001|Induction Phase|Adverse Event|9|||
126561991|NCT00783692|455352055|FG002|Induction Phase|Adverse Event|24|||
126561992|NCT00783692|455352056|FG003|Induction Phase|Adverse Event|0|||
126561993|NCT00783692|455352057|FG004|Induction Phase|Adverse Event|0|||
126561994|NCT00783692|455352058|FG005|Induction Phase|Adverse Event|0|||
126561995|NCT00783692|455352059|FG006|Induction Phase|Adverse Event|0|||
126561996|NCT00783692|455352053|FG000|Induction Phase|Protocol Violation|0|||
126561997|NCT00783692|455352054|FG001|Induction Phase|Protocol Violation|0|||
126561998|NCT00783692|455352055|FG002|Induction Phase|Protocol Violation|1|||
126561999|NCT00783692|455352056|FG003|Induction Phase|Protocol Violation|0|||
126562000|NCT00783692|455352057|FG004|Induction Phase|Protocol Violation|0|||
126562001|NCT00783692|455352058|FG005|Induction Phase|Protocol Violation|0|||
126562002|NCT00783692|455352059|FG006|Induction Phase|Protocol Violation|0|||
126562003|NCT00783692|455352053|FG000|Induction Phase|Lack of Efficacy|1|||
126562004|NCT00783692|455352054|FG001|Induction Phase|Lack of Efficacy|3|||
126562005|NCT00783692|455352055|FG002|Induction Phase|Lack of Efficacy|28|||
126562006|NCT00783692|455352056|FG003|Induction Phase|Lack of Efficacy|0|||
126562007|NCT00783692|455352057|FG004|Induction Phase|Lack of Efficacy|0|||
126562008|NCT00783692|455352058|FG005|Induction Phase|Lack of Efficacy|0|||
126562009|NCT00783692|455352059|FG006|Induction Phase|Lack of Efficacy|0|||
126562010|NCT00783692|455352053|FG000|Induction Phase|Withdrawal by Subject|3|||
126562011|NCT00783692|455352054|FG001|Induction Phase|Withdrawal by Subject|9|||
126562012|NCT00783692|455352055|FG002|Induction Phase|Withdrawal by Subject|16|||
126562013|NCT00783692|455352056|FG003|Induction Phase|Withdrawal by Subject|0|||
126562014|NCT00783692|455352057|FG004|Induction Phase|Withdrawal by Subject|0|||
126562015|NCT00783692|455352058|FG005|Induction Phase|Withdrawal by Subject|0|||
126562016|NCT00783692|455352059|FG006|Induction Phase|Withdrawal by Subject|0|||
126562017|NCT00783692|455352053|FG000|Induction Phase|Lost to Follow-up|0|||
126562018|NCT00783692|455352054|FG001|Induction Phase|Lost to Follow-up|0|||
126562019|NCT00783692|455352055|FG002|Induction Phase|Lost to Follow-up|3|||
126562020|NCT00783692|455352056|FG003|Induction Phase|Lost to Follow-up|0|||
126562021|NCT00783692|455352057|FG004|Induction Phase|Lost to Follow-up|0|||
126562022|NCT00783692|455352058|FG005|Induction Phase|Lost to Follow-up|0|||
126562023|NCT00783692|455352059|FG006|Induction Phase|Lost to Follow-up|0|||
126562024|NCT00783692|455352053|FG000|Induction Phase|Other|0|||
126562025|NCT00783692|455352054|FG001|Induction Phase|Other|0|||
126562026|NCT00783692|455352055|FG002|Induction Phase|Other|2|||
126562027|NCT00783692|455352056|FG003|Induction Phase|Other|0|||
126562028|NCT00783692|455352057|FG004|Induction Phase|Other|0|||
126562029|NCT00783692|455352058|FG005|Induction Phase|Other|0|||
126562030|NCT00783692|455352059|FG006|Induction Phase|Other|0|||
126562031|NCT00783692|455352053|FG000|Maintenance Phase|Adverse Event|7|||
126562032|NCT00783692|455352054|FG001|Maintenance Phase|Adverse Event|0|||
126562033|NCT00783692|455352055|FG002|Maintenance Phase|Adverse Event|0|||
126562034|NCT00783692|455352056|FG003|Maintenance Phase|Adverse Event|15|||
126562035|NCT00783692|455352057|FG004|Maintenance Phase|Adverse Event|12|||
126562036|NCT00783692|455352058|FG005|Maintenance Phase|Adverse Event|9|||
126562037|NCT00783692|455352059|FG006|Maintenance Phase|Adverse Event|38|||
126562038|NCT00783692|455352053|FG000|Maintenance Phase|Protocol Violation|0|||
126562039|NCT00783692|455352054|FG001|Maintenance Phase|Protocol Violation|0|||
126562040|NCT00783692|455352055|FG002|Maintenance Phase|Protocol Violation|0|||
126562041|NCT00783692|455352056|FG003|Maintenance Phase|Protocol Violation|1|||
126562042|NCT00783692|455352057|FG004|Maintenance Phase|Protocol Violation|2|||
126562043|NCT00783692|455352058|FG005|Maintenance Phase|Protocol Violation|3|||
126562044|NCT00783692|455352059|FG006|Maintenance Phase|Protocol Violation|4|||
126562045|NCT00783692|455352053|FG000|Maintenance Phase|Lack of Efficacy|79|||
126562046|NCT00783692|455352054|FG001|Maintenance Phase|Lack of Efficacy|0|||
126562047|NCT00783692|455352055|FG002|Maintenance Phase|Lack of Efficacy|0|||
126562048|NCT00783692|455352056|FG003|Maintenance Phase|Lack of Efficacy|64|||
126562049|NCT00783692|455352057|FG004|Maintenance Phase|Lack of Efficacy|58|||
126562050|NCT00783692|455352058|FG005|Maintenance Phase|Lack of Efficacy|48|||
126562051|NCT00783692|455352059|FG006|Maintenance Phase|Lack of Efficacy|177|||
126562052|NCT00783692|455352053|FG000|Maintenance Phase|Withdrawal by Subject|7|||
126562053|NCT00783692|455352054|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126562054|NCT00783692|455352055|FG002|Maintenance Phase|Withdrawal by Subject|0|||
126562055|NCT00783692|455352056|FG003|Maintenance Phase|Withdrawal by Subject|7|||
126562056|NCT00783692|455352057|FG004|Maintenance Phase|Withdrawal by Subject|6|||
126562057|NCT00783692|455352058|FG005|Maintenance Phase|Withdrawal by Subject|9|||
126562058|NCT00783692|455352059|FG006|Maintenance Phase|Withdrawal by Subject|24|||
126562059|NCT00783692|455352053|FG000|Maintenance Phase|Lost to Follow-up|2|||
126562060|NCT00783692|455352054|FG001|Maintenance Phase|Lost to Follow-up|0|||
126562061|NCT00783692|455352055|FG002|Maintenance Phase|Lost to Follow-up|0|||
126562062|NCT00783692|455352056|FG003|Maintenance Phase|Lost to Follow-up|1|||
126562063|NCT00783692|455352057|FG004|Maintenance Phase|Lost to Follow-up|3|||
126562064|NCT00783692|455352058|FG005|Maintenance Phase|Lost to Follow-up|2|||
126562065|NCT00783692|455352059|FG006|Maintenance Phase|Lost to Follow-up|5|||
126562066|NCT00783692|455352053|FG000|Maintenance Phase|Other|0|||
126562067|NCT00783692|455352054|FG001|Maintenance Phase|Other|0|||
126562068|NCT00783692|455352055|FG002|Maintenance Phase|Other|0|||
126562069|NCT00783692|455352056|FG003|Maintenance Phase|Other|1|||
126562070|NCT00783692|455352057|FG004|Maintenance Phase|Other|0|||
126562071|NCT00783692|455352058|FG005|Maintenance Phase|Other|1|||
126562072|NCT00783692|455352059|FG006|Maintenance Phase|Other|1|||
126562073|NCT00768066|455352062|FG000|Overall Study|Did not receive study product injection.|3|||
126562074|NCT00768066|455352063|FG001|Overall Study|Did not receive study product injection.|3|||
126562075|NCT00768066|455352064|FG002|Overall Study|Did not receive study product injection.|0|||
126562076|NCT04831775|455352065|FG000|Overall Study|Lost to Follow-up|11|||
126562077|NCT04831775|455352066|FG001|Overall Study|Lost to Follow-up|13|||
126726734|NCT03105700|455949026|FG000|Overall Study|Lost to Follow-up|4|||
126562078|NCT05550337|455352069|FG000|Overall Study|Lack of Efficacy|0|||
126562079|NCT05550337|455352070|FG001|Overall Study|Lack of Efficacy|0|||
126562080|NCT05550337|455352071|FG002|Overall Study|Lack of Efficacy|1|||
126562081|NCT05550337|455352069|FG000|Overall Study|Adverse Event|1|||
126562082|NCT05550337|455352070|FG001|Overall Study|Adverse Event|5|||
126562083|NCT05550337|455352071|FG002|Overall Study|Adverse Event|0|||
126562084|NCT05550337|455352069|FG000|Overall Study|Withdrawal by Subject|8|||
126562085|NCT05550337|455352070|FG001|Overall Study|Withdrawal by Subject|14|||
126562086|NCT05550337|455352071|FG002|Overall Study|Withdrawal by Subject|10|||
126562087|NCT05550337|455352069|FG000|Overall Study|Pregnancy|0|||
126562088|NCT05550337|455352070|FG001|Overall Study|Pregnancy|0|||
126562089|NCT05550337|455352071|FG002|Overall Study|Pregnancy|1|||
126775985|NCT00845026|456135788|FG000|Study Period IV|Subject is moving or has moved|0|||
126775986|NCT00845026|456135789|FG001|Study Period IV|Subject is moving or has moved|1|||
126775987|NCT00845026|456135788|FG000|Study Period IV|Scheduling conflict|1|||
126775988|NCT00845026|456135789|FG001|Study Period IV|Scheduling conflict|0|||
126775989|NCT01325532|456135790|FG000|Overall Study|Withdrawal by Subject|2|||
126775990|NCT01325532|456135791|FG001|Overall Study|Withdrawal by Subject|0|||
126775991|NCT03012815|456135792|FG000|Overall Study|Lost to Follow-up|1|||
126775992|NCT03012815|456135793|FG001|Overall Study|Lost to Follow-up|0|||
126775993|NCT03012815|456135792|FG000|Overall Study|Physician Decision|3|||
126775994|NCT03012815|456135793|FG001|Overall Study|Physician Decision|2|||
126775995|NCT03012815|456135792|FG000|Overall Study|Adverse Event|1|||
126775996|NCT03012815|456135793|FG001|Overall Study|Adverse Event|0|||
126775997|NCT01252238|456135794|FG000|Overall Study|Sponsor terminated study|4|||
126775998|NCT01252238|456135795|FG001|Overall Study|Sponsor terminated study|4|||
126775999|NCT01252238|456135796|FG002|Overall Study|Sponsor terminated study|4|||
126776000|NCT00106028|456135806|FG000|Overall Study|Adverse Event|3|||
126776001|NCT00106028|456135807|FG001|Overall Study|Adverse Event|2|||
126776002|NCT00106028|456135806|FG000|Overall Study|Protocol Violation|1|||
126776003|NCT00106028|456135807|FG001|Overall Study|Protocol Violation|1|||
126776004|NCT00106028|456135806|FG000|Overall Study|Withdrawal by Subject|2|||
126776005|NCT00106028|456135807|FG001|Overall Study|Withdrawal by Subject|8|||
126776006|NCT00106028|456135806|FG000|Overall Study|Lost to Follow-up|0|||
126776007|NCT00106028|456135807|FG001|Overall Study|Lost to Follow-up|1|||
126776008|NCT01280981|456135808|FG000|Overall Study|Withdrawal by Subject|11|||
126776009|NCT01280981|456135808|FG000|Overall Study|Protocol Violation|2|||
126776010|NCT01280981|456135808|FG000|Overall Study|Lack of Efficacy|13|||
126776011|NCT01280981|456135808|FG000|Overall Study|Lost to Follow-up|3|||
126776012|NCT01280981|456135808|FG000|Overall Study|Adverse Event|6|||
126776013|NCT01280981|456135808|FG000|Overall Study|Irregular or discontinued menses|3|||
126776014|NCT01280981|456135808|FG000|Overall Study|Failed to return|45|||
126776015|NCT01280981|456135808|FG000|Overall Study|Non-compliance with protocol|3|||
126776016|NCT01280981|456135808|FG000|Overall Study|Withdrawal of consent|3|||
126776017|NCT01280981|456135808|FG000|Overall Study|Elective surgery|2|||
126776018|NCT01280981|456135808|FG000|Overall Study|Study site closure|1|||
126776019|NCT06371079|456135810|FG000|Overall Study|Missing data|88|||
126776020|NCT06371079|456135811|FG001|Overall Study|Missing data|247|||
126776021|NCT01256398|456135812|FG000|Overall Study|Withdrawal by Subject|1|||
126776022|NCT00411762|456135814|FG000|Overall Study|Withdrawal by Subject|5|||
126776023|NCT03276962|456135815|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
126776024|NCT03276962|456135816|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
126776025|NCT03276962|456135817|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
126776026|NCT03276962|456135818|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
126776027|NCT03276962|456135819|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
126776028|NCT03276962|456135815|FG000|Overall Study|Protocol Deviation|2|||
126776029|NCT03276962|456135816|FG001|Overall Study|Protocol Deviation|0|||
126776030|NCT03276962|456135817|FG002|Overall Study|Protocol Deviation|1|||
126776031|NCT03276962|456135818|FG003|Overall Study|Protocol Deviation|2|||
126776032|NCT03276962|456135819|FG004|Overall Study|Protocol Deviation|1|||
126776033|NCT03276962|456135815|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
126776034|NCT03276962|456135816|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
126776035|NCT03276962|456135817|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
126776036|NCT03276962|456135818|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
126776037|NCT03276962|456135819|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
126776038|NCT03276962|456135815|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
126776039|NCT03276962|456135816|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
126776040|NCT03276962|456135817|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
126776041|NCT03276962|456135818|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
126776042|NCT03276962|456135819|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
126776043|NCT03276962|456135815|FG000|Overall Study|Lost to Follow-up|10|||
126776044|NCT03276962|456135816|FG001|Overall Study|Lost to Follow-up|10|||
126776045|NCT03276962|456135817|FG002|Overall Study|Lost to Follow-up|4|||
126776046|NCT03276962|456135818|FG003|Overall Study|Lost to Follow-up|6|||
126776047|NCT03276962|456135819|FG004|Overall Study|Lost to Follow-up|10|||
126776048|NCT03276962|456135815|FG000|Overall Study|Other|0|||
126776049|NCT03276962|456135816|FG001|Overall Study|Other|2|||
126776050|NCT03276962|456135817|FG002|Overall Study|Other|0|||
126776051|NCT03276962|456135818|FG003|Overall Study|Other|2|||
126776052|NCT03276962|456135819|FG004|Overall Study|Other|1|||
126776053|NCT00449930|456135825|FG000|Overall Study|Adverse Event|9|||
126776054|NCT00449930|456135826|FG001|Overall Study|Adverse Event|19|||
126776055|NCT00449930|456135825|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
126776056|NCT00449930|456135826|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
126776057|NCT00449930|456135825|FG000|Overall Study|Lack of Efficacy|10|||
126776058|NCT00449930|456135826|FG001|Overall Study|Lack of Efficacy|1|||
126776059|NCT00449930|456135825|FG000|Overall Study|Lost to Follow-up|9|||
126726735|NCT00929734|455949029|FG000|Overall Study|Lost to Follow-up|2|||
126502531|NCT01449526|455140023|FG000|Overall Study|Lack of Motivation|0|||
126502532|NCT01449526|455140024|FG001|Overall Study|Lack of Motivation|1|||
126502533|NCT01449526|455140023|FG000|Overall Study|Cannot maintain visits|0|||
126502534|NCT01449526|455140024|FG001|Overall Study|Cannot maintain visits|1|||
126502535|NCT01132495|455140025|FG000|Overall Study|Various reasons|40|||
126502536|NCT01132495|455140026|FG001|Overall Study|Various reasons|38|||
126502537|NCT01132495|455140027|FG002|Overall Study|Various reasons|20|||
126502538|NCT01132495|455140028|FG003|Overall Study|Various reasons|12|||
126502539|NCT00082433|455140032|FG000|Overall Study|Adverse Event|12|||
126502540|NCT00082433|455140033|FG001|Overall Study|Adverse Event|17|||
126502541|NCT00082433|455140032|FG000|Overall Study|Death|8|||
126502542|NCT00082433|455140033|FG001|Overall Study|Death|18|||
126502543|NCT00082433|455140032|FG000|Overall Study|Disease Progression/Relapse|270|||
126502544|NCT00082433|455140033|FG001|Overall Study|Disease Progression/Relapse|388|||
126502545|NCT00082433|455140032|FG000|Overall Study|Physician Decision|50|||
126502546|NCT00082433|455140033|FG001|Overall Study|Physician Decision|61|||
126502547|NCT00082433|455140032|FG000|Overall Study|Lost to Follow-up|1|||
126502548|NCT00082433|455140033|FG001|Overall Study|Lost to Follow-up|2|||
126502549|NCT00082433|455140032|FG000|Overall Study|Study Drug Toxicity|179|||
126502550|NCT00082433|455140033|FG001|Overall Study|Study Drug Toxicity|66|||
126502551|NCT00082433|455140032|FG000|Overall Study|Withdrawal by Subject|55|||
126502552|NCT00082433|455140033|FG001|Overall Study|Withdrawal by Subject|30|||
126502553|NCT00082433|455140032|FG000|Overall Study|Still On Treatment|2|||
126502554|NCT00082433|455140033|FG001|Overall Study|Still On Treatment|1|||
126502555|NCT00082433|455140032|FG000|Overall Study|Not Treated|12|||
126502556|NCT00082433|455140033|FG001|Overall Study|Not Treated|11|||
126502557|NCT00082433|455140032|FG000|Overall Study|Ineligible|2|||
126502558|NCT00082433|455140033|FG001|Overall Study|Ineligible|1|||
126502559|NCT00082433|455140032|FG000|Overall Study|Noncompliance|2|||
126502560|NCT00082433|455140033|FG001|Overall Study|Noncompliance|1|||
126502561|NCT00082433|455140032|FG000|Overall Study|New primary cancer|1|||
126502562|NCT00082433|455140033|FG001|Overall Study|New primary cancer|0|||
126502563|NCT00082433|455140032|FG000|Overall Study|Impending surgery|0|||
126502564|NCT00082433|455140033|FG001|Overall Study|Impending surgery|1|||
126502565|NCT04097821|455140034|FG000|Overall Study|Subject Decision|0|||
126502566|NCT04097821|455140035|FG001|Overall Study|Subject Decision|0|||
126502567|NCT04097821|455140036|FG002|Overall Study|Subject Decision|0|||
126502568|NCT04097821|455140037|FG003|Overall Study|Subject Decision|1|||
126502569|NCT04097821|455140038|FG004|Overall Study|Subject Decision|2|||
126502570|NCT04097821|455140039|FG005|Overall Study|Subject Decision|2|||
126502571|NCT04097821|455140040|FG006|Overall Study|Subject Decision|0|||
126502572|NCT04097821|455140041|FG007|Overall Study|Subject Decision|1|||
126502573|NCT04097821|455140034|FG000|Overall Study|Death|0|||
126502574|NCT04097821|455140035|FG001|Overall Study|Death|0|||
126502575|NCT04097821|455140036|FG002|Overall Study|Death|3|||
126502576|NCT04097821|455140037|FG003|Overall Study|Death|1|||
126502577|NCT04097821|455140038|FG004|Overall Study|Death|0|||
126502578|NCT04097821|455140039|FG005|Overall Study|Death|0|||
126502579|NCT04097821|455140040|FG006|Overall Study|Death|0|||
126502580|NCT04097821|455140041|FG007|Overall Study|Death|0|||
126502581|NCT04097821|455140034|FG000|Overall Study|Physician Decision|1|||
126502582|NCT04097821|455140035|FG001|Overall Study|Physician Decision|2|||
126502583|NCT04097821|455140036|FG002|Overall Study|Physician Decision|0|||
126502584|NCT04097821|455140037|FG003|Overall Study|Physician Decision|0|||
126502585|NCT04097821|455140038|FG004|Overall Study|Physician Decision|0|||
126502586|NCT04097821|455140039|FG005|Overall Study|Physician Decision|0|||
126502587|NCT04097821|455140040|FG006|Overall Study|Physician Decision|0|||
126502588|NCT04097821|455140041|FG007|Overall Study|Physician Decision|0|||
126502589|NCT04097821|455140034|FG000|Overall Study|Adverse Event|0|||
126502590|NCT04097821|455140035|FG001|Overall Study|Adverse Event|0|||
126502591|NCT04097821|455140036|FG002|Overall Study|Adverse Event|1|||
126502592|NCT04097821|455140037|FG003|Overall Study|Adverse Event|1|||
126502593|NCT04097821|455140038|FG004|Overall Study|Adverse Event|0|||
126502594|NCT04097821|455140039|FG005|Overall Study|Adverse Event|0|||
126502595|NCT04097821|455140040|FG006|Overall Study|Adverse Event|0|||
126502596|NCT04097821|455140041|FG007|Overall Study|Adverse Event|0|||
126502597|NCT04097821|455140034|FG000|Overall Study|New Therapy For Study Indication|0|||
126502598|NCT04097821|455140035|FG001|Overall Study|New Therapy For Study Indication|0|||
126502599|NCT04097821|455140036|FG002|Overall Study|New Therapy For Study Indication|0|||
126502600|NCT04097821|455140037|FG003|Overall Study|New Therapy For Study Indication|0|||
126502601|NCT04097821|455140038|FG004|Overall Study|New Therapy For Study Indication|0|||
126502602|NCT04097821|455140039|FG005|Overall Study|New Therapy For Study Indication|0|||
126502603|NCT04097821|455140040|FG006|Overall Study|New Therapy For Study Indication|1|||
126502604|NCT04097821|455140041|FG007|Overall Study|New Therapy For Study Indication|0|||
126502605|NCT04477304|455140042|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
126502606|NCT04477304|455140043|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
126502607|NCT03256552|455141637|FG000|Overall Study|Protocol Violation|1|||
126502608|NCT03256552|455141637|FG000|Overall Study|Physician Decision|1|||
126502609|NCT03256552|455141637|FG000|Overall Study|Adverse Event|1|||
126502610|NCT03256552|455141637|FG000|Overall Study|Withdrawal by Subject|2|||
126502611|NCT05083442|455141638|FG000|Overall Study|Lost to Follow-up|1|||
126502612|NCT05083442|455141639|FG001|Overall Study|Lost to Follow-up|0|||
126502613|NCT05083442|455141638|FG000|Overall Study|Lack of Efficacy|0|||
126502614|NCT05083442|455141639|FG001|Overall Study|Lack of Efficacy|1|||
126502615|NCT05083442|455141638|FG000|Overall Study|Withdrawal by Subject|1|||
126502616|NCT05083442|455141639|FG001|Overall Study|Withdrawal by Subject|3|||
126502617|NCT05083442|455141638|FG000|Overall Study|scheduling difficulties|1|||
126502618|NCT05083442|455141639|FG001|Overall Study|scheduling difficulties|2|||
126502619|NCT02256891|455141642|FG000|Overall Study|Death|0|||
126502620|NCT02256891|455141643|FG001|Overall Study|Death|2|||
126502621|NCT02256891|455141642|FG000|Overall Study|Lost to Follow-up|0|||
126502622|NCT02256891|455141643|FG001|Overall Study|Lost to Follow-up|3|||
126726736|NCT00929734|455949030|FG001|Overall Study|Lost to Follow-up|1|||
126726737|NCT00929734|455949029|FG000|Overall Study|Withdrawal by Subject|0|||
126726738|NCT00929734|455949030|FG001|Overall Study|Withdrawal by Subject|2|||
126726739|NCT01253421|455949031|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
126726740|NCT01253421|455949032|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
126726741|NCT01253421|455949033|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
126726742|NCT01253421|455949034|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
126726743|NCT01253421|455949035|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
126726744|NCT01253421|455949031|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
126726745|NCT01253421|455949032|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
126726746|NCT01253421|455949033|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
126726747|NCT01253421|455949034|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
126726748|NCT01253421|455949035|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
126726749|NCT01253421|455949031|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
126726750|NCT01253421|455949032|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
126726751|NCT01253421|455949033|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
126726752|NCT01253421|455949034|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
126726753|NCT01253421|455949035|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
126726754|NCT01253421|455949031|FG000|Assessment and Scheduling|Physician Decision|1|||
126726755|NCT01253421|455949032|FG001|Assessment and Scheduling|Physician Decision|0|||
126726756|NCT01253421|455949033|FG002|Assessment and Scheduling|Physician Decision|0|||
126726757|NCT01253421|455949034|FG003|Assessment and Scheduling|Physician Decision|0|||
126726758|NCT01253421|455949035|FG004|Assessment and Scheduling|Physician Decision|0|||
126726759|NCT01253421|455949031|FG000|Drug+Scanning Visit|Physician Decision|0|||
126726760|NCT01253421|455949032|FG001|Drug+Scanning Visit|Physician Decision|0|||
126726761|NCT01253421|455949033|FG002|Drug+Scanning Visit|Physician Decision|0|||
126726762|NCT01253421|455949034|FG003|Drug+Scanning Visit|Physician Decision|0|||
126726763|NCT01253421|455949035|FG004|Drug+Scanning Visit|Physician Decision|1|||
126726764|NCT00980980|455949036|FG000|Overall Study|Withdrawal by Hospital|0|||
126726765|NCT00980980|455949037|FG001|Overall Study|Withdrawal by Hospital|1|||
126726766|NCT00980980|455949038|FG002|Overall Study|Withdrawal by Hospital|0|||
126726767|NCT00121992|455949040|FG000|Overall Study|Treatment not received|2|||
126726768|NCT00121992|455949041|FG001|Overall Study|Treatment not received|11|||
126726769|NCT01449682|455949042|FG000|Overall Study|Death|0|||
126726770|NCT01449682|455949043|FG001|Overall Study|Death|1|||
126726771|NCT01449682|455949042|FG000|Overall Study|Adverse Event|1|||
126726772|NCT01449682|455949043|FG001|Overall Study|Adverse Event|0|||
126726773|NCT00414960|455949044|FG000|Overall Study|Adverse Event|4|||
126726774|NCT00414960|455949045|FG001|Overall Study|Adverse Event|0|||
126726775|NCT00414960|455949044|FG000|Overall Study|Withdrawal by Subject|3|||
126726776|NCT00414960|455949045|FG001|Overall Study|Withdrawal by Subject|0|||
126726777|NCT00414960|455949044|FG000|Overall Study|Physician Decision|0|||
126726778|NCT00414960|455949045|FG001|Overall Study|Physician Decision|1|||
126726779|NCT04863014|455949046|FG000|Overall Study|Lost to Follow-up|3|||
126726780|NCT04863014|455949047|FG001|Overall Study|Lost to Follow-up|2|||
126726781|NCT04863014|455949046|FG000|Overall Study|Subject Decision|0|||
126726782|NCT04863014|455949047|FG001|Overall Study|Subject Decision|4|||
126726783|NCT04633473|455949051|FG000|Overall Study|Withdrawal by Subject|6|||
126726784|NCT00264849|455949053|FG000|Overall Study|Adverse Event|7|||
126726785|NCT00264849|455949054|FG001|Overall Study|Adverse Event|2|||
126726786|NCT00264849|455949053|FG000|Overall Study|Withdrawal by Subject|7|||
126726787|NCT00264849|455949054|FG001|Overall Study|Withdrawal by Subject|11|||
126726788|NCT00264849|455949053|FG000|Overall Study|Protocol Violation|5|||
126726789|NCT00264849|455949054|FG001|Overall Study|Protocol Violation|3|||
126726790|NCT00264849|455949053|FG000|Overall Study|Lack of Efficacy|1|||
126726791|NCT00264849|455949054|FG001|Overall Study|Lack of Efficacy|6|||
126726792|NCT00264849|455949053|FG000|Overall Study|Lost to Follow-up|0|||
126726793|NCT00264849|455949054|FG001|Overall Study|Lost to Follow-up|2|||
126502623|NCT02256891|455141642|FG000|Overall Study|Physician Decision|7|||
126502624|NCT02256891|455141643|FG001|Overall Study|Physician Decision|3|||
126502625|NCT02256891|455141642|FG000|Overall Study|Screen Fail|5|||
126502626|NCT02256891|455141643|FG001|Overall Study|Screen Fail|4|||
126502627|NCT02256891|455141642|FG000|Overall Study|Equipment Malfunction|0|||
126726794|NCT00264849|455949053|FG000|Overall Study|Death|0|||
126562090|NCT05550337|455352069|FG000|Overall Study|Protocol Violation|1|||
126562091|NCT05550337|455352070|FG001|Overall Study|Protocol Violation|3|||
126562092|NCT05550337|455352071|FG002|Overall Study|Protocol Violation|4|||
126562093|NCT05550337|455352069|FG000|Overall Study|Physician Decision|2|||
126562094|NCT05550337|455352070|FG001|Overall Study|Physician Decision|1|||
126562095|NCT05550337|455352071|FG002|Overall Study|Physician Decision|1|||
126562096|NCT05550337|455352069|FG000|Overall Study|Lost to Follow-up|16|||
126562097|NCT05550337|455352070|FG001|Overall Study|Lost to Follow-up|11|||
126562098|NCT05550337|455352071|FG002|Overall Study|Lost to Follow-up|11|||
126562099|NCT03115346|455352072|FG000|Overall Study|Did not have AAA surgery|28|||
126562100|NCT03115346|455352073|FG001|Overall Study|Did not have AAA surgery|15|||
126562101|NCT03115346|455352072|FG000|Overall Study|Death|3|||
126562102|NCT03115346|455352073|FG001|Overall Study|Death|1|||
126562103|NCT03115346|455352072|FG000|Overall Study|Withdrawal by Subject|0|||
126562104|NCT03115346|455352073|FG001|Overall Study|Withdrawal by Subject|3|||
126562105|NCT03115346|455352072|FG000|Overall Study|Lost to Follow-up|0|||
126562106|NCT03115346|455352073|FG001|Overall Study|Lost to Follow-up|3|||
126562107|NCT01737268|455352074|FG000|Overall Study|Adverse Event|6|||
126562108|NCT01737268|455352074|FG000|Overall Study|Worsening of Target Disease|2|||
126562109|NCT01737268|455352074|FG000|Overall Study|In consideration of the patient's safety|1|||
126562110|NCT01458275|455352078|FG000|Overall Study|Adverse Event|3|||
126562111|NCT01458275|455352079|FG001|Overall Study|Adverse Event|4|||
126562112|NCT01458275|455352080|FG002|Overall Study|Adverse Event|1|||
126562113|NCT01458275|455352078|FG000|Overall Study|Lost to Follow-up|3|||
126562114|NCT01458275|455352079|FG001|Overall Study|Lost to Follow-up|2|||
126562115|NCT01458275|455352080|FG002|Overall Study|Lost to Follow-up|5|||
126562116|NCT01458275|455352078|FG000|Overall Study|Protocol Violation|5|||
126562117|NCT01458275|455352079|FG001|Overall Study|Protocol Violation|5|||
126562118|NCT01458275|455352080|FG002|Overall Study|Protocol Violation|2|||
126562119|NCT01458275|455352078|FG000|Overall Study|Withdrawal by Subject|3|||
126562120|NCT01458275|455352079|FG001|Overall Study|Withdrawal by Subject|2|||
126562121|NCT01458275|455352080|FG002|Overall Study|Withdrawal by Subject|1|||
126562122|NCT03697460|455352081|FG000|Overall Study|Withdrawal by Subject|3|||
126562123|NCT03499600|455352088|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
126562124|NCT03499600|455352089|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
126562125|NCT00445692|455352090|FG000|Overall Study|Adverse Event|11|||
126562126|NCT00445692|455352090|FG000|Overall Study|Lack of Efficacy|5|||
126562127|NCT01137292|455352091|FG000|Overall Study|Death|30|||
126562128|NCT01137292|455352091|FG000|Overall Study|Adverse Event|3|||
126562129|NCT01137292|455352091|FG000|Overall Study|Lack of Efficacy|13|||
126562130|NCT01137292|455352091|FG000|Overall Study|Lost to Follow-up|1|||
126562131|NCT01137292|455352091|FG000|Overall Study|Other|7|||
126562132|NCT03425539|455352092|FG000|Overall Study|Randomized but not treated|0|||
126562133|NCT03425539|455352093|FG001|Overall Study|Randomized but not treated|1|||
126562134|NCT03425539|455352092|FG000|Overall Study|Adverse Event|2|||
126562135|NCT03425539|455352093|FG001|Overall Study|Adverse Event|2|||
126562136|NCT03425539|455352092|FG000|Overall Study|Withdrawal by Subject|3|||
126562137|NCT03425539|455352093|FG001|Overall Study|Withdrawal by Subject|0|||
126562138|NCT03425539|455352092|FG000|Overall Study|Lost to Follow-up|0|||
126562139|NCT03425539|455352093|FG001|Overall Study|Lost to Follow-up|1|||
126562140|NCT02014558|455352094|FG000|Overall Study|Never Received Study Drug|0|||
126562141|NCT02014558|455352095|FG001|Overall Study|Never Received Study Drug|0|||
126562142|NCT02014558|455352096|FG002|Overall Study|Never Received Study Drug|0|||
126562143|NCT02014558|455352097|FG003|Overall Study|Never Received Study Drug|0|||
126562144|NCT02014558|455352098|FG004|Overall Study|Never Received Study Drug|1|||
126562145|NCT02014558|455352099|FG005|Overall Study|Never Received Study Drug|0|||
126562146|NCT02014558|455352100|FG006|Overall Study|Never Received Study Drug|1|||
126562147|NCT02014558|455352101|FG007|Overall Study|Never Received Study Drug|0|||
126562148|NCT02014558|455352102|FG008|Overall Study|Never Received Study Drug|2|||
126562149|NCT02014558|455352103|FG009|Overall Study|Never Received Study Drug|0|||
126562150|NCT02014558|455352104|FG010|Overall Study|Never Received Study Drug|2|||
126562151|NCT02014558|455352105|FG011|Overall Study|Never Received Study Drug|2|||
126562152|NCT02014558|455352106|FG012|Overall Study|Never Received Study Drug|0|||
126562153|NCT02014558|455352094|FG000|Overall Study|Adverse Event|0|||
126562154|NCT02014558|455352095|FG001|Overall Study|Adverse Event|0|||
126562155|NCT02014558|455352096|FG002|Overall Study|Adverse Event|0|||
126562156|NCT02014558|455352097|FG003|Overall Study|Adverse Event|0|||
126562157|NCT02014558|455352098|FG004|Overall Study|Adverse Event|1|||
126562158|NCT02014558|455352099|FG005|Overall Study|Adverse Event|0|||
126562159|NCT02014558|455352100|FG006|Overall Study|Adverse Event|0|||
126562160|NCT02014558|455352101|FG007|Overall Study|Adverse Event|0|||
126562161|NCT02014558|455352102|FG008|Overall Study|Adverse Event|2|||
126562162|NCT02014558|455352103|FG009|Overall Study|Adverse Event|2|||
126562163|NCT02014558|455352104|FG010|Overall Study|Adverse Event|5|||
126562164|NCT02014558|455352105|FG011|Overall Study|Adverse Event|21|||
126562165|NCT02014558|455352106|FG012|Overall Study|Adverse Event|3|||
126562166|NCT02014558|455352094|FG000|Overall Study|Death|1|||
126562167|NCT02014558|455352095|FG001|Overall Study|Death|0|||
126502628|NCT02256891|455141643|FG001|Overall Study|Equipment Malfunction|1|||
126502629|NCT01344447|455141644|FG000|Overall Study|Adverse Event|1|||
126502630|NCT01344447|455141644|FG000|Overall Study|Protocol Violation|1|||
126726795|NCT00264849|455949054|FG001|Overall Study|Death|1|||
126726796|NCT00264849|455949053|FG000|Overall Study|Administrative Problems|2|||
126726797|NCT00264849|455949054|FG001|Overall Study|Administrative Problems|0|||
126502631|NCT01344447|455141644|FG000|Overall Study|Withdrawal by Subject|1|||
126502632|NCT01344447|455141644|FG000|Overall Study|The contrast was not seen|1|||
126502633|NCT01344447|455141644|FG000|Overall Study|Physician Decision|1|||
126502634|NCT01344447|455141644|FG000|Overall Study|MRA unsuccessful|1|||
126502635|NCT01344447|455141644|FG000|Overall Study|Bolus tracking failed|1|||
126502636|NCT01344447|455141644|FG000|Overall Study|Error of power injector|1|||
126502637|NCT01293240|455141645|FG000|Overall Study|Noncompliance|2|||
126502638|NCT03261947|455141652|FG000|Overall Study|Death|10|||
126502639|NCT03261947|455141653|FG001|Overall Study|Death|13|||
126502640|NCT03261947|455141654|FG002|Overall Study|Death|17|||
126726798|NCT01982773|455949057|FG000|Overall Study|Withdrawal by Subject|1|||
126726799|NCT01982773|455949058|FG001|Overall Study|Withdrawal by Subject|3|||
126726800|NCT01982773|455949057|FG000|Overall Study|Lost to Follow-up|7|||
126726801|NCT01982773|455949058|FG001|Overall Study|Lost to Follow-up|1|||
126726802|NCT01029886|455949061|FG000|Overall Study|Adverse Event|12|||
126726803|NCT01029886|455949062|FG001|Overall Study|Adverse Event|25|||
126726804|NCT01029886|455949061|FG000|Overall Study|Lost to Follow-up|1|||
126726805|NCT01029886|455949062|FG001|Overall Study|Lost to Follow-up|0|||
126726806|NCT01029886|455949061|FG000|Overall Study|Physician Decision|2|||
126726807|NCT01029886|455949062|FG001|Overall Study|Physician Decision|6|||
126726808|NCT01029886|455949061|FG000|Overall Study|Protocol Violation|17|||
126726809|NCT01029886|455949062|FG001|Overall Study|Protocol Violation|5|||
126726810|NCT01029886|455949061|FG000|Overall Study|Withdrawal by Subject|8|||
126726811|NCT01029886|455949062|FG001|Overall Study|Withdrawal by Subject|18|||
126726812|NCT01029886|455949061|FG000|Overall Study|Entry Criteria Not Met|13|||
126726813|NCT01029886|455949062|FG001|Overall Study|Entry Criteria Not Met|5|||
126726814|NCT01029886|455949061|FG000|Overall Study|Sponsor Decision|1|||
126726815|NCT01029886|455949062|FG001|Overall Study|Sponsor Decision|0|||
126726816|NCT01029886|455949061|FG000|Overall Study|Loss Glucose Control|7|||
126726817|NCT01029886|455949062|FG001|Overall Study|Loss Glucose Control|1|||
126726818|NCT01553916|455949063|FG000|Overall Study|Withdrawal by Subject|2|||
126726819|NCT01553916|455949063|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
126726820|NCT03294681|455949064|FG000|Overall Study|Withdrawal by Subject|1|||
126726821|NCT03089216|455949067|FG000|Overall Study|Adverse Event|0|||
126726822|NCT03089216|455949068|FG001|Overall Study|Adverse Event|0|||
126726823|NCT03089216|455949069|FG002|Overall Study|Adverse Event|0|||
126726824|NCT03089216|455949070|FG003|Overall Study|Adverse Event|1|||
126726825|NCT00417976|455949073|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
126726826|NCT00417976|455949073|FG000|Overall Study|Treatment -related toxicity|2|||
126726827|NCT04348591|455949074|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
126726828|NCT04348591|455949075|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
126726829|NCT04348591|455949074|FG000|Imaging Session (120 Min)|Physician Decision|0|||
126726830|NCT04348591|455949075|FG001|Imaging Session (120 Min)|Physician Decision|1|||
126726831|NCT04348591|455949074|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
126726832|NCT04348591|455949075|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
126726833|NCT01778127|455949078|FG000|Overall Study|Lost to Follow-up|5|||
126726834|NCT01778127|455949079|FG001|Overall Study|Lost to Follow-up|1|||
126726835|NCT01778127|455949080|FG002|Overall Study|Lost to Follow-up|2|||
126726836|NCT01778127|455949078|FG000|Overall Study|Withdrawal by Subject|3|||
126726837|NCT01778127|455949079|FG001|Overall Study|Withdrawal by Subject|1|||
126726838|NCT01778127|455949080|FG002|Overall Study|Withdrawal by Subject|4|||
126726839|NCT02104804|455949081|FG000|Overall Study|Did not take study medication|0|||
126726840|NCT02104804|455949082|FG001|Overall Study|Did not take study medication|1|||
126726841|NCT02104804|455949081|FG000|Overall Study|Study specific discontinuation criteria|6|||
126726842|NCT02104804|455949082|FG001|Overall Study|Study specific discontinuation criteria|1|||
126726843|NCT02104804|455949081|FG000|Overall Study|Other listed|2|||
126726844|NCT02104804|455949082|FG001|Overall Study|Other listed|1|||
126726845|NCT02104804|455949081|FG000|Overall Study|Protocol Violation|0|||
126502641|NCT03261947|455141655|FG003|Overall Study|Death|12|||
126502642|NCT03261947|455141656|FG004|Overall Study|Death|8|||
126502643|NCT03261947|455141652|FG000|Overall Study|Lost to Follow-up|0|||
126502644|NCT03261947|455141653|FG001|Overall Study|Lost to Follow-up|0|||
126726846|NCT02104804|455949082|FG001|Overall Study|Protocol Violation|1|||
126726847|NCT02104804|455949081|FG000|Overall Study|Adverse Event|4|||
126726848|NCT02104804|455949082|FG001|Overall Study|Adverse Event|3|||
126726849|NCT02104804|455949081|FG000|Overall Study|Withdrawal by Subject|4|||
126726850|NCT02104804|455949082|FG001|Overall Study|Withdrawal by Subject|12|||
126726851|NCT01348425|455949083|FG000|Overall Study|Imaging was not taken.|1|||
126726852|NCT01348425|455949084|FG001|Overall Study|Imaging was not taken.|1|||
126726853|NCT03722784|455949087|FG000|Overall Study|Withdrawal by Subject|1|||
126726854|NCT03722784|455949088|FG001|Overall Study|Withdrawal by Subject|0|||
126776060|NCT00449930|456135826|FG001|Overall Study|Lost to Follow-up|14|||
126502645|NCT03261947|455141654|FG002|Overall Study|Lost to Follow-up|2|||
126502646|NCT03261947|455141655|FG003|Overall Study|Lost to Follow-up|1|||
126502647|NCT03261947|455141656|FG004|Overall Study|Lost to Follow-up|0|||
126502648|NCT03261947|455141652|FG000|Overall Study|Withdrawal by Subject|0|||
126502649|NCT03261947|455141653|FG001|Overall Study|Withdrawal by Subject|0|||
126502650|NCT03261947|455141654|FG002|Overall Study|Withdrawal by Subject|3|||
126502651|NCT03261947|455141655|FG003|Overall Study|Withdrawal by Subject|0|||
126502652|NCT03261947|455141656|FG004|Overall Study|Withdrawal by Subject|1|||
126502653|NCT03261947|455141652|FG000|Overall Study|Site Terminated by Sponsor|0|||
126502654|NCT03261947|455141653|FG001|Overall Study|Site Terminated by Sponsor|0|||
126502655|NCT03261947|455141654|FG002|Overall Study|Site Terminated by Sponsor|4|||
126502656|NCT03261947|455141655|FG003|Overall Study|Site Terminated by Sponsor|7|||
126502657|NCT03261947|455141656|FG004|Overall Study|Site Terminated by Sponsor|5|||
126502658|NCT03261947|455141652|FG000|Overall Study|Reason not Specified|2|||
126502659|NCT03261947|455141653|FG001|Overall Study|Reason not Specified|0|||
126502660|NCT03261947|455141654|FG002|Overall Study|Reason not Specified|4|||
126502661|NCT03261947|455141655|FG003|Overall Study|Reason not Specified|1|||
126502662|NCT03261947|455141656|FG004|Overall Study|Reason not Specified|3|||
126502663|NCT03969992|455141657|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
126502664|NCT03969992|455141658|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
126502665|NCT03969992|455141659|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
126502666|NCT03969992|455141657|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
126502667|NCT03969992|455141658|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
126502668|NCT03969992|455141659|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
126502669|NCT03969992|455141657|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
126502670|NCT03969992|455141658|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
126502671|NCT03969992|455141659|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
126502672|NCT03969992|455141657|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
126502673|NCT03969992|455141658|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
126502674|NCT03969992|455141659|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
126502675|NCT03969992|455141657|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
126502676|NCT03969992|455141658|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
126502677|NCT03969992|455141659|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
126502678|NCT02063737|455141664|FG000|Overall Study|Lost to Follow-up|11|||
126502679|NCT02063737|455141665|FG001|Overall Study|Lost to Follow-up|4|||
126502680|NCT02689258|455141668|FG000|Overall Study|Subject Non-Compliance|0|||
126502681|NCT02689258|455141669|FG001|Overall Study|Subject Non-Compliance|1|||
126502682|NCT02689258|455141670|FG002|Overall Study|Subject Non-Compliance|0|||
126502683|NCT02689258|455141671|FG003|Overall Study|Subject Non-Compliance|0|||
126502684|NCT02689258|455141672|FG004|Overall Study|Subject Non-Compliance|0|||
126502685|NCT02689258|455141673|FG005|Overall Study|Subject Non-Compliance|0|||
126502686|NCT02689258|455141674|FG006|Overall Study|Subject Non-Compliance|0|||
126502687|NCT02689258|455141675|FG007|Overall Study|Subject Non-Compliance|0|||
126502688|NCT02689258|455141676|FG008|Overall Study|Subject Non-Compliance|0|||
126502689|NCT02689258|455141677|FG009|Overall Study|Subject Non-Compliance|0|||
126502690|NCT02689258|455141678|FG010|Overall Study|Subject Non-Compliance|0|||
126502691|NCT02689258|455141679|FG011|Overall Study|Subject Non-Compliance|0|||
126502692|NCT02689258|455141668|FG000|Overall Study|Subject Refusal to Continue|0|||
126502693|NCT02689258|455141669|FG001|Overall Study|Subject Refusal to Continue|1|||
126502694|NCT02689258|455141670|FG002|Overall Study|Subject Refusal to Continue|0|||
126502695|NCT02689258|455141671|FG003|Overall Study|Subject Refusal to Continue|0|||
126502696|NCT02689258|455141672|FG004|Overall Study|Subject Refusal to Continue|0|||
126502697|NCT02689258|455141673|FG005|Overall Study|Subject Refusal to Continue|0|||
126502698|NCT02689258|455141674|FG006|Overall Study|Subject Refusal to Continue|0|||
126502699|NCT02689258|455141675|FG007|Overall Study|Subject Refusal to Continue|0|||
126502700|NCT02689258|455141676|FG008|Overall Study|Subject Refusal to Continue|1|||
126502701|NCT02689258|455141677|FG009|Overall Study|Subject Refusal to Continue|0|||
126502702|NCT02689258|455141678|FG010|Overall Study|Subject Refusal to Continue|0|||
126502703|NCT02689258|455141679|FG011|Overall Study|Subject Refusal to Continue|1|||
126502704|NCT02689258|455141668|FG000|Overall Study|Other|0|||
126502705|NCT02689258|455141669|FG001|Overall Study|Other|2|||
126502706|NCT02689258|455141670|FG002|Overall Study|Other|0|||
126502707|NCT02689258|455141671|FG003|Overall Study|Other|0|||
126502708|NCT02689258|455141672|FG004|Overall Study|Other|1|||
126502709|NCT02689258|455141673|FG005|Overall Study|Other|0|||
126502710|NCT02689258|455141674|FG006|Overall Study|Other|0|||
126502711|NCT02689258|455141675|FG007|Overall Study|Other|0|||
126502712|NCT02689258|455141676|FG008|Overall Study|Other|1|||
126502713|NCT02689258|455141677|FG009|Overall Study|Other|0|||
126502714|NCT02689258|455141678|FG010|Overall Study|Other|0|||
126502715|NCT02689258|455141679|FG011|Overall Study|Other|0|||
126502716|NCT03373383|455141680|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
126502717|NCT03373383|455141681|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
126502718|NCT03373383|455141682|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
126562168|NCT02014558|455352096|FG002|Overall Study|Death|0|||
126562169|NCT02014558|455352097|FG003|Overall Study|Death|0|||
126562170|NCT02014558|455352098|FG004|Overall Study|Death|0|||
126562171|NCT02014558|455352099|FG005|Overall Study|Death|0|||
126562172|NCT02014558|455352100|FG006|Overall Study|Death|1|||
126562173|NCT02014558|455352101|FG007|Overall Study|Death|1|||
126562174|NCT02014558|455352102|FG008|Overall Study|Death|2|||
126562175|NCT02014558|455352103|FG009|Overall Study|Death|5|||
126562176|NCT02014558|455352104|FG010|Overall Study|Death|5|||
126562177|NCT02014558|455352105|FG011|Overall Study|Death|19|||
126562178|NCT02014558|455352106|FG012|Overall Study|Death|2|||
126562179|NCT02014558|455352094|FG000|Overall Study|Lack of Efficacy|1|||
126562180|NCT02014558|455352095|FG001|Overall Study|Lack of Efficacy|2|||
126562181|NCT02014558|455352096|FG002|Overall Study|Lack of Efficacy|1|||
126562182|NCT02014558|455352097|FG003|Overall Study|Lack of Efficacy|1|||
126562183|NCT02014558|455352098|FG004|Overall Study|Lack of Efficacy|0|||
126562184|NCT02014558|455352099|FG005|Overall Study|Lack of Efficacy|0|||
126562185|NCT02014558|455352100|FG006|Overall Study|Lack of Efficacy|1|||
126562186|NCT02014558|455352101|FG007|Overall Study|Lack of Efficacy|3|||
126562187|NCT02014558|455352102|FG008|Overall Study|Lack of Efficacy|3|||
126562188|NCT02014558|455352103|FG009|Overall Study|Lack of Efficacy|3|||
126562189|NCT02014558|455352104|FG010|Overall Study|Lack of Efficacy|16|||
126562190|NCT02014558|455352105|FG011|Overall Study|Lack of Efficacy|8|||
126562191|NCT02014558|455352106|FG012|Overall Study|Lack of Efficacy|5|||
126562192|NCT02014558|455352094|FG000|Overall Study|Lost to Follow-up|0|||
126562193|NCT02014558|455352095|FG001|Overall Study|Lost to Follow-up|0|||
126562194|NCT02014558|455352096|FG002|Overall Study|Lost to Follow-up|0|||
126562195|NCT02014558|455352097|FG003|Overall Study|Lost to Follow-up|0|||
126562196|NCT02014558|455352098|FG004|Overall Study|Lost to Follow-up|0|||
126562197|NCT02014558|455352099|FG005|Overall Study|Lost to Follow-up|0|||
126562198|NCT02014558|455352100|FG006|Overall Study|Lost to Follow-up|0|||
126562199|NCT02014558|455352101|FG007|Overall Study|Lost to Follow-up|0|||
126562200|NCT02014558|455352102|FG008|Overall Study|Lost to Follow-up|0|||
126562201|NCT02014558|455352103|FG009|Overall Study|Lost to Follow-up|0|||
126562202|NCT02014558|455352104|FG010|Overall Study|Lost to Follow-up|1|||
126562203|NCT02014558|455352105|FG011|Overall Study|Lost to Follow-up|0|||
126562204|NCT02014558|455352106|FG012|Overall Study|Lost to Follow-up|0|||
126562205|NCT02014558|455352094|FG000|Overall Study|Progressive Disease|1|||
126562206|NCT02014558|455352095|FG001|Overall Study|Progressive Disease|0|||
126562207|NCT02014558|455352096|FG002|Overall Study|Progressive Disease|1|||
126562208|NCT02014558|455352097|FG003|Overall Study|Progressive Disease|1|||
126562209|NCT02014558|455352098|FG004|Overall Study|Progressive Disease|1|||
126562210|NCT02014558|455352099|FG005|Overall Study|Progressive Disease|2|||
126562211|NCT02014558|455352100|FG006|Overall Study|Progressive Disease|1|||
126562212|NCT02014558|455352101|FG007|Overall Study|Progressive Disease|6|||
126562213|NCT02014558|455352102|FG008|Overall Study|Progressive Disease|5|||
126562214|NCT02014558|455352103|FG009|Overall Study|Progressive Disease|6|||
126562215|NCT02014558|455352104|FG010|Overall Study|Progressive Disease|22|||
126562216|NCT02014558|455352105|FG011|Overall Study|Progressive Disease|31|||
126562217|NCT02014558|455352106|FG012|Overall Study|Progressive Disease|6|||
126562218|NCT02014558|455352094|FG000|Overall Study|Withdrawal by Subject|0|||
126562219|NCT02014558|455352095|FG001|Overall Study|Withdrawal by Subject|0|||
126726855|NCT03722784|455949087|FG000|Overall Study|Physician Decision|1|||
126726856|NCT03722784|455949088|FG001|Overall Study|Physician Decision|1|||
126726857|NCT03722784|455949087|FG000|Overall Study|Protocol Violation|0|||
126726858|NCT03722784|455949088|FG001|Overall Study|Protocol Violation|1|||
126726859|NCT01968954|455949092|FG000|Overall Study|Adverse Event|6|||
126726860|NCT01968954|455949093|FG001|Overall Study|Adverse Event|3|||
126726861|NCT01968954|455949092|FG000|Overall Study|Death|1|||
126502719|NCT03373383|455141683|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
126502720|NCT03373383|455141684|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
126502721|NCT03373383|455141680|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
126502722|NCT03373383|455141681|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
126502723|NCT03373383|455141682|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
126502724|NCT03373383|455141683|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
126502725|NCT03373383|455141684|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
126502726|NCT03373383|455141680|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
126502727|NCT03373383|455141681|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
126502728|NCT03373383|455141682|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
126502729|NCT03373383|455141683|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
126502730|NCT03373383|455141684|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
126562220|NCT02014558|455352096|FG002|Overall Study|Withdrawal by Subject|0|||
126562221|NCT02014558|455352097|FG003|Overall Study|Withdrawal by Subject|0|||
126562222|NCT02014558|455352098|FG004|Overall Study|Withdrawal by Subject|1|||
126562223|NCT02014558|455352099|FG005|Overall Study|Withdrawal by Subject|0|||
126726862|NCT01968954|455949093|FG001|Overall Study|Death|2|||
126726863|NCT01968954|455949092|FG000|Overall Study|Lost to Follow-up|6|||
126562224|NCT02014558|455352100|FG006|Overall Study|Withdrawal by Subject|0|||
126562225|NCT02014558|455352101|FG007|Overall Study|Withdrawal by Subject|0|||
126562226|NCT02014558|455352102|FG008|Overall Study|Withdrawal by Subject|0|||
126502731|NCT03373383|455141680|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
126502732|NCT03373383|455141681|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
126502733|NCT03373383|455141682|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
126502734|NCT03373383|455141683|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
126502735|NCT03373383|455141684|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
126502736|NCT03373383|455141680|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
126502737|NCT03373383|455141681|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
126502738|NCT03373383|455141682|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
126502739|NCT03373383|455141683|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
126502740|NCT03373383|455141684|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
126502741|NCT03373383|455141680|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
126502742|NCT03373383|455141681|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
126502743|NCT03373383|455141682|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
126502744|NCT03373383|455141683|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
126502745|NCT03373383|455141684|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
126502746|NCT03373383|455141680|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
126502747|NCT03373383|455141681|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
126502748|NCT03373383|455141682|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
126502749|NCT03373383|455141683|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
126502750|NCT03373383|455141684|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
126502751|NCT03373383|455141680|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
126502752|NCT03373383|455141681|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
126502753|NCT03373383|455141682|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
126502754|NCT03373383|455141683|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
126502755|NCT03373383|455141684|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
126502756|NCT03373383|455141680|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
126502757|NCT03373383|455141681|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
126502758|NCT03373383|455141682|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
126502759|NCT03373383|455141683|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
126502760|NCT03373383|455141684|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
126502761|NCT04753164|455141688|FG000|Overall Study|Adverse Event|0|||
126502762|NCT04753164|455141689|FG001|Overall Study|Adverse Event|2|||
126502763|NCT04753164|455141688|FG000|Overall Study|Withdrawal by Subject|9|||
126502764|NCT04753164|455141689|FG001|Overall Study|Withdrawal by Subject|7|||
126502765|NCT04753164|455141688|FG000|Overall Study|Lost to Follow-up|6|||
126502766|NCT04753164|455141689|FG001|Overall Study|Lost to Follow-up|6|||
126502767|NCT04753164|455141688|FG000|Overall Study|Other|12|||
126502768|NCT04753164|455141689|FG001|Overall Study|Other|5|||
126502769|NCT00694369|455141690|FG000|Overall Study|Adverse Event|0|||
126502770|NCT00694369|455141691|FG001|Overall Study|Adverse Event|1|||
126502771|NCT00694369|455141692|FG002|Overall Study|Adverse Event|0|||
126502772|NCT00694369|455141693|FG003|Overall Study|Adverse Event|1|||
126502773|NCT00694369|455141694|FG004|Overall Study|Adverse Event|3|||
126502774|NCT00694369|455141690|FG000|Overall Study|Lost to Follow-up|0|||
126502775|NCT00694369|455141691|FG001|Overall Study|Lost to Follow-up|0|||
126502776|NCT00694369|455141692|FG002|Overall Study|Lost to Follow-up|1|||
126502777|NCT00694369|455141693|FG003|Overall Study|Lost to Follow-up|1|||
126502778|NCT00694369|455141694|FG004|Overall Study|Lost to Follow-up|0|||
126502779|NCT00694369|455141690|FG000|Overall Study|Physician Decision|0|||
126502780|NCT00694369|455141691|FG001|Overall Study|Physician Decision|0|||
126502781|NCT00694369|455141692|FG002|Overall Study|Physician Decision|0|||
126502782|NCT00694369|455141693|FG003|Overall Study|Physician Decision|0|||
126502783|NCT00694369|455141694|FG004|Overall Study|Physician Decision|1|||
126502784|NCT00694369|455141690|FG000|Overall Study|Protocol Violation|0|||
126502785|NCT00694369|455141691|FG001|Overall Study|Protocol Violation|1|||
126502786|NCT00694369|455141692|FG002|Overall Study|Protocol Violation|0|||
126502787|NCT00694369|455141693|FG003|Overall Study|Protocol Violation|0|||
126502788|NCT00694369|455141694|FG004|Overall Study|Protocol Violation|0|||
126502789|NCT00694369|455141690|FG000|Overall Study|Withdrawal by Subject|1|||
126502790|NCT00694369|455141691|FG001|Overall Study|Withdrawal by Subject|1|||
126502791|NCT00694369|455141692|FG002|Overall Study|Withdrawal by Subject|1|||
126502792|NCT00694369|455141693|FG003|Overall Study|Withdrawal by Subject|1|||
126502793|NCT00694369|455141694|FG004|Overall Study|Withdrawal by Subject|2|||
126502794|NCT00907374|455141699|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
126502795|NCT00907374|455141700|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
126502796|NCT02871739|455141703|FG000|Overall Study|Lost to Follow-up|3|||
126502797|NCT02871739|455141704|FG001|Overall Study|Lost to Follow-up|2|||
126502798|NCT02871739|455141705|FG002|Overall Study|Lost to Follow-up|0|||
126502799|NCT02871739|455141706|FG003|Overall Study|Lost to Follow-up|2|||
126502800|NCT00439556|455141707|FG000|Overall Study|Patient was taken off study for non-comp|0|||
126502801|NCT00439556|455141708|FG001|Overall Study|Patient was taken off study for non-comp|1|||
126502802|NCT00439556|455141709|FG002|Overall Study|Patient was taken off study for non-comp|0|||
126502803|NCT03818516|455141710|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
126776061|NCT00449930|456135825|FG000|Overall Study|Physician Decision|1|||
126776062|NCT00449930|456135826|FG001|Overall Study|Physician Decision|2|||
126776063|NCT00449930|456135825|FG000|Overall Study|Protocol Violation|14|||
126776064|NCT00449930|456135826|FG001|Overall Study|Protocol Violation|15|||
126776065|NCT00449930|456135825|FG000|Overall Study|Withdrawal by Subject|16|||
126776066|NCT00449930|456135826|FG001|Overall Study|Withdrawal by Subject|23|||
126562227|NCT02014558|455352103|FG009|Overall Study|Withdrawal by Subject|2|||
126562228|NCT02014558|455352104|FG010|Overall Study|Withdrawal by Subject|6|||
126562229|NCT02014558|455352105|FG011|Overall Study|Withdrawal by Subject|10|||
126562230|NCT02014558|455352106|FG012|Overall Study|Withdrawal by Subject|0|||
126562231|NCT02014558|455352094|FG000|Overall Study|Miscellaneous|2|||
126562232|NCT02014558|455352095|FG001|Overall Study|Miscellaneous|1|||
126562233|NCT02014558|455352096|FG002|Overall Study|Miscellaneous|1|||
126562234|NCT02014558|455352097|FG003|Overall Study|Miscellaneous|1|||
126562235|NCT02014558|455352098|FG004|Overall Study|Miscellaneous|0|||
126562236|NCT02014558|455352099|FG005|Overall Study|Miscellaneous|1|||
126562237|NCT02014558|455352100|FG006|Overall Study|Miscellaneous|0|||
126562238|NCT02014558|455352101|FG007|Overall Study|Miscellaneous|1|||
126562239|NCT02014558|455352102|FG008|Overall Study|Miscellaneous|1|||
126562240|NCT02014558|455352103|FG009|Overall Study|Miscellaneous|3|||
126562241|NCT02014558|455352104|FG010|Overall Study|Miscellaneous|12|||
126562242|NCT02014558|455352105|FG011|Overall Study|Miscellaneous|11|||
126562243|NCT02014558|455352106|FG012|Overall Study|Miscellaneous|1|||
126562244|NCT04580407|455352107|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
126562245|NCT05567159|455352112|FG000|Overall Study|Adverse Event|4|||
126562246|NCT05567159|455352112|FG000|Overall Study|Physician Decision|3|||
126562247|NCT05567159|455352112|FG000|Overall Study|Protocol deviation|1|||
126562248|NCT01244984|455353694|FG000|Overall Study|Adverse Event|2|||
126562249|NCT01244984|455353695|FG001|Overall Study|Adverse Event|11|||
126562250|NCT01244984|455353696|FG002|Overall Study|Adverse Event|2|||
126562251|NCT01244984|455353694|FG000|Overall Study|Protocol Violation|1|||
126562252|NCT01244984|455353695|FG001|Overall Study|Protocol Violation|0|||
126562253|NCT01244984|455353696|FG002|Overall Study|Protocol Violation|0|||
126562254|NCT01244984|455353694|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
126562255|NCT01244984|455353695|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
126562256|NCT01244984|455353696|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
126562257|NCT01244984|455353694|FG000|Overall Study|Withdrawal by Subject|1|||
126562258|NCT01244984|455353695|FG001|Overall Study|Withdrawal by Subject|2|||
126562259|NCT01244984|455353696|FG002|Overall Study|Withdrawal by Subject|2|||
126562260|NCT03006341|455353700|FG000|Overall Study|Not linked in the EMR|25069|||
126562261|NCT03006341|455353701|FG001|Overall Study|Not linked in the EMR|67505|||
126562262|NCT03006341|455353702|FG002|Overall Study|Not linked in the EMR|30993|||
126562263|NCT03006341|455353703|FG003|Overall Study|Not linked in the EMR|10685|||
126562264|NCT02950545|455353706|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
126562265|NCT02950545|455353707|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
126562266|NCT02950545|455353708|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
126562267|NCT02950545|455353709|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
126562268|NCT02950545|455353710|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
126562269|NCT02950545|455353711|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
126562270|NCT02950545|455353706|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
126562271|NCT02950545|455353707|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
126562272|NCT02950545|455353708|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
126562273|NCT02950545|455353709|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
126562274|NCT02950545|455353710|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
126562275|NCT02950545|455353711|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
126562276|NCT02950545|455353706|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
126562277|NCT02950545|455353707|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
126562278|NCT02950545|455353708|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
126562279|NCT02950545|455353709|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
126562280|NCT02950545|455353710|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
126776067|NCT00449930|456135825|FG000|Overall Study|Glycemic discontinuation criteria|1|||
126776068|NCT00449930|456135826|FG001|Overall Study|Glycemic discontinuation criteria|1|||
126776069|NCT03712228|456135827|FG000|Treatment Period 1|Lack of Efficacy|0|||
126562281|NCT02950545|455353711|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
126562282|NCT02950545|455353706|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
126562283|NCT02950545|455353707|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
126562284|NCT02950545|455353708|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
126562285|NCT02950545|455353709|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
126562286|NCT02950545|455353710|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
126562287|NCT02950545|455353711|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
126562288|NCT02950545|455353706|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
126562289|NCT02950545|455353707|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
126562290|NCT02950545|455353708|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
126562291|NCT02950545|455353709|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
126502804|NCT04372602|455141713|FG000|Overall Study|Withdrawal by Subject|1|||
126502805|NCT04372602|455141714|FG001|Overall Study|Withdrawal by Subject|1|||
126502806|NCT04372602|455141713|FG000|Overall Study|Adverse Event|0|||
126502807|NCT04372602|455141714|FG001|Overall Study|Adverse Event|1|||
126502808|NCT04372602|455141713|FG000|Overall Study|Transitioned to comfort care|0|||
126502809|NCT04372602|455141714|FG001|Overall Study|Transitioned to comfort care|1|||
126502810|NCT02907359|455141715|FG000|Overall Study|Death|234|||
126502811|NCT02907359|455141716|FG001|Overall Study|Death|117|||
126502812|NCT02907359|455141715|FG000|Overall Study|Withdrawal by Subject|6|||
126502813|NCT02907359|455141716|FG001|Overall Study|Withdrawal by Subject|11|||
126502814|NCT02907359|455141715|FG000|Overall Study|Lost to Follow-up|1|||
126502815|NCT02907359|455141716|FG001|Overall Study|Lost to Follow-up|0|||
126502816|NCT01405963|455141717|FG000|Overall Study|Moved Away|2|||
126502817|NCT01405963|455141718|FG001|Overall Study|Moved Away|0|||
126502818|NCT01405963|455141717|FG000|Overall Study|Adverse Event|0|||
126502819|NCT01405963|455141718|FG001|Overall Study|Adverse Event|1|||
126502820|NCT01405963|455141717|FG000|Overall Study|Lost to Follow-up|0|||
126502821|NCT01405963|455141718|FG001|Overall Study|Lost to Follow-up|1|||
126502822|NCT04371380|455141729|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
126502823|NCT04371380|455141730|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
126502824|NCT04371380|455141731|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
126502825|NCT00680901|455141740|FG000|Overall Study|Ongoing: On Study Treatment|1|||
126502826|NCT00680901|455141741|FG001|Overall Study|Ongoing: On Study Treatment|0|||
126502827|NCT00680901|455141740|FG000|Overall Study|Ongoing: In Follow Up|1|||
126502828|NCT00680901|455141741|FG001|Overall Study|Ongoing: In Follow Up|0|||
126502829|NCT00680901|455141740|FG000|Overall Study|Adverse Event|1|||
126502830|NCT00680901|455141741|FG001|Overall Study|Adverse Event|1|||
126502831|NCT00680901|455141740|FG000|Overall Study|Lost to Follow-up|3|||
126502832|NCT00680901|455141741|FG001|Overall Study|Lost to Follow-up|5|||
126726864|NCT01968954|455949093|FG001|Overall Study|Lost to Follow-up|4|||
126726865|NCT01968954|455949092|FG000|Overall Study|Withdrawal by Subject|20|||
126726866|NCT01968954|455949093|FG001|Overall Study|Withdrawal by Subject|23|||
126726867|NCT01968954|455949092|FG000|Overall Study|Other|7|||
126726868|NCT01968954|455949093|FG001|Overall Study|Other|8|||
126726869|NCT01968954|455949092|FG000|Overall Study|Protocol Violation|0|||
126726870|NCT01968954|455949093|FG001|Overall Study|Protocol Violation|1|||
126726871|NCT01968954|455949092|FG000|Overall Study|Did not met inclusion criteria|0|||
126726872|NCT01968954|455949093|FG001|Overall Study|Did not met inclusion criteria|2|||
126726873|NCT00751114|455949095|FG000|Overall Study|Adverse Event|2|||
126726874|NCT00751114|455949096|FG001|Overall Study|Adverse Event|4|||
126726875|NCT00751114|455949095|FG000|Overall Study|Protocol Violation|8|||
126726876|NCT00751114|455949096|FG001|Overall Study|Protocol Violation|9|||
126726877|NCT00751114|455949095|FG000|Overall Study|Withdrawal by Subject|9|||
126726878|NCT00751114|455949096|FG001|Overall Study|Withdrawal by Subject|4|||
126726879|NCT00751114|455949095|FG000|Overall Study|Lost to Follow-up|4|||
126726880|NCT00751114|455949096|FG001|Overall Study|Lost to Follow-up|7|||
126726881|NCT00751114|455949095|FG000|Overall Study|Lack of Efficacy|0|||
126726882|NCT00751114|455949096|FG001|Overall Study|Lack of Efficacy|7|||
126726883|NCT00751114|455949095|FG000|Overall Study|Not Treated|13|||
126726884|NCT00751114|455949096|FG001|Overall Study|Not Treated|1|||
126726885|NCT00751114|455949095|FG000|Overall Study|Out of country for 2 months|1|||
126726886|NCT00751114|455949096|FG001|Overall Study|Out of country for 2 months|0|||
126726887|NCT00751114|455949095|FG000|Overall Study|Move to another city|1|||
126726888|NCT00751114|455949096|FG001|Overall Study|Move to another city|0|||
126726889|NCT05319080|455949097|FG000|Overall Study|Withdrawal by Subject|2|||
126726890|NCT05319080|455949097|FG000|Overall Study|Physician Decision|4|||
126726891|NCT02648724|455949100|FG000|Overall Study|Withdrawal by Subject|0|||
126726892|NCT02648724|455949101|FG001|Overall Study|Withdrawal by Subject|1|||
126726893|NCT02648724|455949102|FG002|Overall Study|Withdrawal by Subject|1|||
126726894|NCT02648724|455949103|FG003|Overall Study|Withdrawal by Subject|0|||
126726895|NCT02648724|455949104|FG004|Overall Study|Withdrawal by Subject|1|||
126726896|NCT02648724|455949105|FG005|Overall Study|Withdrawal by Subject|0|||
126726897|NCT02648724|455949106|FG006|Overall Study|Withdrawal by Subject|0|||
126726898|NCT02648724|455949100|FG000|Overall Study|Progressive disease|2|||
126726899|NCT02648724|455949101|FG001|Overall Study|Progressive disease|2|||
126726900|NCT02648724|455949102|FG002|Overall Study|Progressive disease|2|||
126726901|NCT02648724|455949103|FG003|Overall Study|Progressive disease|3|||
126726902|NCT02648724|455949104|FG004|Overall Study|Progressive disease|22|||
126726903|NCT02648724|455949105|FG005|Overall Study|Progressive disease|7|||
126726904|NCT02648724|455949106|FG006|Overall Study|Progressive disease|8|||
126726905|NCT02648724|455949100|FG000|Overall Study|Other reason (unknown)|1|||
126726906|NCT02648724|455949101|FG001|Overall Study|Other reason (unknown)|0|||
126726907|NCT02648724|455949102|FG002|Overall Study|Other reason (unknown)|0|||
126726908|NCT02648724|455949103|FG003|Overall Study|Other reason (unknown)|0|||
126726909|NCT02648724|455949104|FG004|Overall Study|Other reason (unknown)|0|||
126726910|NCT02648724|455949105|FG005|Overall Study|Other reason (unknown)|0|||
126562292|NCT02950545|455353710|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
126562293|NCT02950545|455353711|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
126562294|NCT03101592|455353712|FG000|Overall Study|participant files could not be located|111|||
126562295|NCT03101592|455353713|FG001|Overall Study|participant files could not be located|170|||
126562296|NCT03101592|455353714|FG002|Overall Study|participant files could not be located|118|||
126562297|NCT01770860|455353715|FG000|Overall Study|Withdrawal by Subject|4|||
126562298|NCT01770860|455353715|FG000|Overall Study|Lost to Follow-up|1|||
126562299|NCT01770860|455353715|FG000|Overall Study|Administrative decision made by the PI|1|||
126562300|NCT03398356|455353718|FG000|Before Treatment|Lost to Follow-up|1|||
126562301|NCT03398356|455353719|FG001|Before Treatment|Lost to Follow-up|2|||
126562302|NCT03398356|455353720|FG002|Before Treatment|Lost to Follow-up|0|||
126562303|NCT03398356|455353718|FG000|Before Treatment|drug intolerance|2|||
126562304|NCT03398356|455353719|FG001|Before Treatment|drug intolerance|1|||
126562305|NCT03398356|455353720|FG002|Before Treatment|drug intolerance|0|||
126562306|NCT03398356|455353718|FG000|Before Treatment|Withdrawal by Subject|0|||
126562307|NCT03398356|455353719|FG001|Before Treatment|Withdrawal by Subject|5|||
126562308|NCT03398356|455353720|FG002|Before Treatment|Withdrawal by Subject|0|||
126562309|NCT03398356|455353718|FG000|Before Treatment|Physician Decision|0|||
126562310|NCT03398356|455353719|FG001|Before Treatment|Physician Decision|0|||
126562311|NCT03398356|455353720|FG002|Before Treatment|Physician Decision|11|||
126562312|NCT03398356|455353718|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
126726911|NCT02648724|455949106|FG006|Overall Study|Other reason (unknown)|0|||
126726912|NCT02648724|455949100|FG000|Overall Study|Protocol Violation|0|||
126726913|NCT02648724|455949101|FG001|Overall Study|Protocol Violation|0|||
126726914|NCT02648724|455949102|FG002|Overall Study|Protocol Violation|0|||
126726915|NCT02648724|455949103|FG003|Overall Study|Protocol Violation|0|||
126726916|NCT02648724|455949104|FG004|Overall Study|Protocol Violation|1|||
126726917|NCT02648724|455949105|FG005|Overall Study|Protocol Violation|0|||
126726918|NCT02648724|455949106|FG006|Overall Study|Protocol Violation|0|||
126726919|NCT02648724|455949100|FG000|Overall Study|Death|0|||
126726920|NCT02648724|455949101|FG001|Overall Study|Death|0|||
126726921|NCT02648724|455949102|FG002|Overall Study|Death|0|||
126726922|NCT02648724|455949103|FG003|Overall Study|Death|0|||
126726923|NCT02648724|455949104|FG004|Overall Study|Death|0|||
126726924|NCT02648724|455949105|FG005|Overall Study|Death|0|||
126726925|NCT02648724|455949106|FG006|Overall Study|Death|3|||
126726926|NCT02648724|455949100|FG000|Overall Study|Physician Decision|0|||
126726927|NCT02648724|455949101|FG001|Overall Study|Physician Decision|0|||
126726928|NCT02648724|455949102|FG002|Overall Study|Physician Decision|0|||
126726929|NCT02648724|455949103|FG003|Overall Study|Physician Decision|0|||
126726930|NCT02648724|455949104|FG004|Overall Study|Physician Decision|1|||
126726931|NCT02648724|455949105|FG005|Overall Study|Physician Decision|0|||
126726932|NCT02648724|455949106|FG006|Overall Study|Physician Decision|1|||
126726933|NCT02648724|455949100|FG000|Overall Study|Transferred to named patient program|0|||
126726934|NCT02648724|455949101|FG001|Overall Study|Transferred to named patient program|0|||
126726935|NCT02648724|455949102|FG002|Overall Study|Transferred to named patient program|0|||
126726936|NCT02648724|455949103|FG003|Overall Study|Transferred to named patient program|0|||
126726937|NCT02648724|455949104|FG004|Overall Study|Transferred to named patient program|0|||
126726938|NCT02648724|455949105|FG005|Overall Study|Transferred to named patient program|1|||
126726939|NCT02648724|455949106|FG006|Overall Study|Transferred to named patient program|0|||
126726940|NCT03076190|455949107|FG000|Overall Study|Lost to Follow-up|9|||
126726941|NCT03076190|455949108|FG001|Overall Study|Lost to Follow-up|34|||
126726942|NCT03076190|455949107|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
126726943|NCT03076190|455949108|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
126726944|NCT00434122|455949109|FG000|Overall Study|Non-compliance with protocol|0|||
126726945|NCT00434122|455949110|FG001|Overall Study|Non-compliance with protocol|1|||
126726946|NCT00434122|455949109|FG000|Overall Study|loss of subject contact|1|||
126726947|NCT00434122|455949110|FG001|Overall Study|loss of subject contact|1|||
126726948|NCT00434122|455949109|FG000|Overall Study|Personal reasons|1|||
126726949|NCT00434122|455949110|FG001|Overall Study|Personal reasons|1|||
126726950|NCT00434122|455949109|FG000|Overall Study|Large follicle size|2|||
126726951|NCT00434122|455949110|FG001|Overall Study|Large follicle size|2|||
126726952|NCT00434122|455949109|FG000|Overall Study|Low follicular response.|1|||
126726953|NCT00434122|455949110|FG001|Overall Study|Low follicular response.|2|||
126726954|NCT00434122|455949109|FG000|Overall Study|Travelling of subject.|1|||
126726955|NCT00434122|455949110|FG001|Overall Study|Travelling of subject.|0|||
126726956|NCT04191577|455949111|FG000|Overall Study|Withdrawal by Subject|2|||
126726957|NCT04191577|455949112|FG001|Overall Study|Withdrawal by Subject|2|||
126726958|NCT04191577|455949113|FG002|Overall Study|Withdrawal by Subject|1|||
126726959|NCT04191577|455949111|FG000|Overall Study|Physician Decision|1|||
126726960|NCT04191577|455949112|FG001|Overall Study|Physician Decision|1|||
126726961|NCT04191577|455949113|FG002|Overall Study|Physician Decision|0|||
126726962|NCT04191577|455949111|FG000|Overall Study|Adverse Event|0|||
126726963|NCT04191577|455949112|FG001|Overall Study|Adverse Event|0|||
126726964|NCT04191577|455949113|FG002|Overall Study|Adverse Event|1|||
126726965|NCT04191577|455949111|FG000|Overall Study|Death|0|||
126776070|NCT03712228|456135828|FG001|Treatment Period 1|Lack of Efficacy|0|||
126776071|NCT03712228|456135829|FG002|Treatment Period 1|Lack of Efficacy|0|||
126776072|NCT03712228|456135830|FG003|Treatment Period 1|Lack of Efficacy|0|||
126776073|NCT03712228|456135831|FG004|Treatment Period 1|Lack of Efficacy|0|||
126776074|NCT03712228|456135832|FG005|Treatment Period 1|Lack of Efficacy|1|||
126776075|NCT03712228|456135827|FG000|Treatment Period 2|Pregnancy|0|||
126776076|NCT03712228|456135828|FG001|Treatment Period 2|Pregnancy|0|||
126776077|NCT03712228|456135829|FG002|Treatment Period 2|Pregnancy|0|||
126776078|NCT03712228|456135830|FG003|Treatment Period 2|Pregnancy|1|||
126776079|NCT03712228|456135831|FG004|Treatment Period 2|Pregnancy|0|||
126776080|NCT03712228|456135832|FG005|Treatment Period 2|Pregnancy|0|||
126776081|NCT03712228|456135827|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126776082|NCT03712228|456135828|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126776083|NCT03712228|456135829|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126776084|NCT03712228|456135830|FG003|Treatment Period 2|Withdrawal by Subject|1|||
126776085|NCT03712228|456135831|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126776086|NCT03712228|456135832|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126776087|NCT01964105|456135833|FG000|Overall Study|Lost to Follow-up|2|||
126776088|NCT01964105|456135834|FG001|Overall Study|Lost to Follow-up|13|||
126776089|NCT01964105|456135835|FG002|Overall Study|Lost to Follow-up|0|||
126776090|NCT02295280|456135836|FG000|Overall Study|Adverse Event|0|||
126776091|NCT02295280|456135837|FG001|Overall Study|Adverse Event|1|||
126776092|NCT00558519|456135838|FG000|Overall Study|Ph+|20|||
126776093|NCT00558519|456135838|FG000|Overall Study|Ineligible|1|||
126776094|NCT00558519|456135838|FG000|Overall Study|Insufficient data|1|||
126776095|NCT00558519|456135838|FG000|Overall Study|Never received treatment|1|||
126776096|NCT03001011|456135839|FG000|Overall Study|Adverse Event|9|||
126776097|NCT03001011|456135840|FG001|Overall Study|Adverse Event|3|||
126776098|NCT03001011|456135839|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
126776099|NCT03001011|456135840|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
126776100|NCT03001011|456135839|FG000|Overall Study|Other than specified above|3|||
126776101|NCT03001011|456135840|FG001|Overall Study|Other than specified above|8|||
126776102|NCT02875067|456135841|FG000|Overall Study|Withdrawal by Subject|1|||
126776103|NCT02875067|456135841|FG000|Overall Study|Withdrawal by Termination of Study|5|||
126776104|NCT00065065|456135842|FG000|Overall Study|Adverse Event|3|||
126776105|NCT00065065|456135843|FG001|Overall Study|Adverse Event|2|||
126776106|NCT00065065|456135842|FG000|Overall Study|Withdrawal by Subject|1|||
126776107|NCT00065065|456135843|FG001|Overall Study|Withdrawal by Subject|5|||
126776108|NCT00065065|456135842|FG000|Overall Study|Lack of Efficacy|4|||
126502833|NCT00680901|455141740|FG000|Overall Study|Subject decided to withdraw from the study|4|||
126502834|NCT00680901|455141741|FG001|Overall Study|Subject decided to withdraw from the study|15|||
126502835|NCT00680901|455141740|FG000|Overall Study|Sponsor decision|1|||
126502836|NCT00680901|455141741|FG001|Overall Study|Sponsor decision|0|||
126502837|NCT00680901|455141740|FG000|Overall Study|Physician Decision|0|||
126502838|NCT00680901|455141741|FG001|Overall Study|Physician Decision|2|||
126502839|NCT00680901|455141740|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
126502840|NCT00680901|455141741|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
126502841|NCT00680901|455141740|FG000|Overall Study|Other protocol defined stopping criteria|17|||
126502842|NCT00680901|455141741|FG001|Overall Study|Other protocol defined stopping criteria|17|||
126502843|NCT04544293|455141742|FG000|Double-blind|Adverse Event|2|||
126502844|NCT04544293|455141743|FG001|Double-blind|Adverse Event|1|||
126502845|NCT04544293|455141742|FG000|Double-blind|Pregnancy|0|||
126502846|NCT04544293|455141743|FG001|Double-blind|Pregnancy|1|||
126502847|NCT04544293|455141742|FG000|Double-blind|Lost to Follow-up|0|||
126502848|NCT04544293|455141743|FG001|Double-blind|Lost to Follow-up|1|||
126562313|NCT03398356|455353719|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
126562314|NCT03398356|455353720|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
126562315|NCT01648283|455353723|FG000|Overall Study|Withdrawal by Subject|14|||
126562316|NCT00601640|455353729|FG000|Overall Study|Withdrawal by Subject|3|||
126562317|NCT00601640|455353730|FG001|Overall Study|Withdrawal by Subject|0|||
126502849|NCT04544293|455141742|FG000|Open-Label Extension|Study ongoing|79|||
126502850|NCT04544293|455141743|FG001|Open-Label Extension|Study ongoing|81|||
126562318|NCT00601640|455353731|FG002|Overall Study|Withdrawal by Subject|7|||
126562319|NCT00601640|455353729|FG000|Overall Study|Death|1|||
126776109|NCT00065065|456135843|FG001|Overall Study|Lack of Efficacy|11|||
126776110|NCT00065065|456135842|FG000|Overall Study|Other|2|||
126776111|NCT00065065|456135843|FG001|Overall Study|Other|2|||
126776112|NCT01050673|456135847|FG000|Overall Study|Physician Decision|4|||
126776113|NCT01050673|456135848|FG001|Overall Study|Physician Decision|5|||
126776114|NCT05288673|456135849|FG000|Overall Study|Consent withdrawn by subject|0|||
126776115|NCT05288673|456135850|FG001|Overall Study|Consent withdrawn by subject|0|||
126502851|NCT01951157|455141744|FG000|Overall Study|Progressive Disease|12|||
126776116|NCT05288673|456135851|FG002|Overall Study|Consent withdrawn by subject|1|||
126776117|NCT03056352|456135852|FG000|Overall Study|Lost to Follow-up|1|||
126776118|NCT00124449|456135857|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
126776119|NCT00124449|456135858|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
126502852|NCT01951157|455141745|FG001|Overall Study|Progressive Disease|13|||
126502853|NCT01951157|455141746|FG002|Overall Study|Progressive Disease|10|||
126502854|NCT01951157|455141744|FG000|Overall Study|Treatment-unrelated AE|1|||
126502855|NCT01951157|455141745|FG001|Overall Study|Treatment-unrelated AE|0|||
126502856|NCT01951157|455141746|FG002|Overall Study|Treatment-unrelated AE|3|||
126776120|NCT00124449|456135857|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
126776121|NCT00124449|456135858|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
126776122|NCT00124449|456135857|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
126776123|NCT00124449|456135858|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
126776124|NCT00124449|456135857|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
126776125|NCT00124449|456135858|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
126562320|NCT00601640|455353730|FG001|Overall Study|Death|0|||
126562321|NCT00601640|455353731|FG002|Overall Study|Death|0|||
126562322|NCT00601640|455353729|FG000|Overall Study|Adverse Event|0|||
126562323|NCT00601640|455353730|FG001|Overall Study|Adverse Event|4|||
126562324|NCT00601640|455353731|FG002|Overall Study|Adverse Event|2|||
126562325|NCT00601640|455353729|FG000|Overall Study|intercurrent illness|1|||
126562326|NCT00601640|455353730|FG001|Overall Study|intercurrent illness|0|||
126562327|NCT00601640|455353731|FG002|Overall Study|intercurrent illness|0|||
126562328|NCT00601640|455353729|FG000|Overall Study|change in eligibility status|0|||
126562329|NCT00601640|455353730|FG001|Overall Study|change in eligibility status|1|||
126562330|NCT00601640|455353731|FG002|Overall Study|change in eligibility status|1|||
126562331|NCT00530777|455353732|FG000|Overall Study|Lost to Follow-up|0|||
126562332|NCT00530777|455353733|FG001|Overall Study|Lost to Follow-up|1|||
126562333|NCT00530777|455353732|FG000|Overall Study|Death|1|||
126562334|NCT00530777|455353733|FG001|Overall Study|Death|2|||
126562335|NCT00530777|455353732|FG000|Overall Study|Physician Decision|1|||
126562336|NCT00530777|455353733|FG001|Overall Study|Physician Decision|0|||
126562337|NCT00530777|455353732|FG000|Overall Study|Withdrawal by Subject|0|||
126562338|NCT00530777|455353733|FG001|Overall Study|Withdrawal by Subject|1|||
126562339|NCT00530777|455353732|FG000|Overall Study|Unable to adhere to visit schedule|5|||
126562340|NCT00530777|455353733|FG001|Overall Study|Unable to adhere to visit schedule|1|||
126562341|NCT03382821|455353738|FG000|Overall Study|Did not receive allocated intervention.|0|||
126562342|NCT03382821|455353739|FG001|Overall Study|Did not receive allocated intervention.|3|||
126562343|NCT00282438|455353740|FG000|Overall Study|Lack of Efficacy|1|||
126562344|NCT00282438|455353741|FG001|Overall Study|Lack of Efficacy|0|||
126562345|NCT00282438|455353740|FG000|Overall Study|Death|0|||
126562346|NCT00282438|455353741|FG001|Overall Study|Death|1|||
126562347|NCT01674569|455353742|FG000|Overall Study|Adverse Event|0|||
126562348|NCT01674569|455353743|FG001|Overall Study|Adverse Event|2|||
126562349|NCT01674569|455353744|FG002|Overall Study|Adverse Event|0|||
126562350|NCT01674569|455353745|FG003|Overall Study|Adverse Event|1|||
126562351|NCT01674569|455353746|FG004|Overall Study|Adverse Event|2|||
126562352|NCT01674569|455353747|FG005|Overall Study|Adverse Event|2|||
126562353|NCT01674569|455353742|FG000|Overall Study|Protocol Violation|0|||
126562354|NCT01674569|455353743|FG001|Overall Study|Protocol Violation|1|||
126562355|NCT01674569|455353744|FG002|Overall Study|Protocol Violation|1|||
126562356|NCT01674569|455353745|FG003|Overall Study|Protocol Violation|0|||
126562357|NCT01674569|455353746|FG004|Overall Study|Protocol Violation|0|||
126562358|NCT01674569|455353747|FG005|Overall Study|Protocol Violation|0|||
126562359|NCT01674569|455353742|FG000|Overall Study|Withdrawal by Subject|0|||
126562360|NCT01674569|455353743|FG001|Overall Study|Withdrawal by Subject|0|||
126562361|NCT01674569|455353744|FG002|Overall Study|Withdrawal by Subject|1|||
126562362|NCT01674569|455353745|FG003|Overall Study|Withdrawal by Subject|0|||
126562363|NCT01674569|455353746|FG004|Overall Study|Withdrawal by Subject|0|||
126562364|NCT01674569|455353747|FG005|Overall Study|Withdrawal by Subject|0|||
126562365|NCT02095158|455353759|FG000|Overall Study|Adverse Event|14|||
126562366|NCT02095158|455353759|FG000|Overall Study|Lack of Efficacy|3|||
126562367|NCT02095158|455353759|FG000|Overall Study|Pregnancy|1|||
126562368|NCT02095158|455353759|FG000|Overall Study|Lost to Follow-up|20|||
126562369|NCT02095158|455353759|FG000|Overall Study|Personal Reasons|35|||
126776126|NCT00124449|456135857|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
126502857|NCT01951157|455141744|FG000|Overall Study|Study Termination|0|||
126502858|NCT01951157|455141745|FG001|Overall Study|Study Termination|0|||
126562370|NCT02095158|455353759|FG000|Overall Study|Protocol Violation|1|||
126562371|NCT02095158|455353759|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126562372|NCT01008748|455353760|FG000|Overall Study|Lost to Follow-up|80|||
126562373|NCT01008748|455353760|FG000|Overall Study|Other|1|||
126562374|NCT02775435|455353761|FG000|Overall Study|Adverse Event|32|||
126562375|NCT02775435|455353762|FG001|Overall Study|Adverse Event|27|||
126776127|NCT00124449|456135858|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
126776128|NCT00124449|456135857|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
126502859|NCT01951157|455141746|FG002|Overall Study|Study Termination|1|||
126562376|NCT02775435|455353761|FG000|Overall Study|Lost to Follow-up|2|||
126562377|NCT02775435|455353762|FG001|Overall Study|Lost to Follow-up|2|||
126562378|NCT02775435|455353761|FG000|Overall Study|Sponsor decision|44|||
126562379|NCT02775435|455353762|FG001|Overall Study|Sponsor decision|19|||
126502860|NCT01951157|455141744|FG000|Overall Study|Physician Decision|5|||
126502861|NCT01951157|455141745|FG001|Overall Study|Physician Decision|3|||
126502862|NCT01951157|455141746|FG002|Overall Study|Physician Decision|2|||
126502863|NCT01951157|455141744|FG000|Overall Study|Non-treatmentrelated death|2|||
126502864|NCT01951157|455141745|FG001|Overall Study|Non-treatmentrelated death|2|||
126502865|NCT01951157|455141746|FG002|Overall Study|Non-treatmentrelated death|2|||
126502866|NCT01951157|455141744|FG000|Overall Study|No treated|0|||
126502867|NCT01951157|455141745|FG001|Overall Study|No treated|1|||
126502868|NCT01951157|455141746|FG002|Overall Study|No treated|0|||
126502869|NCT01951157|455141744|FG000|Overall Study|Treatment-related AE|2|||
126502870|NCT01951157|455141745|FG001|Overall Study|Treatment-related AE|0|||
126502871|NCT01951157|455141746|FG002|Overall Study|Treatment-related AE|4|||
126502872|NCT01951157|455141744|FG000|Overall Study|Consent withdrawn by subject|0|||
126502873|NCT01951157|455141745|FG001|Overall Study|Consent withdrawn by subject|1|||
126502874|NCT01951157|455141746|FG002|Overall Study|Consent withdrawn by subject|3|||
126502875|NCT01951157|455141744|FG000|Overall Study|Treatment-related death|0|||
126502876|NCT01951157|455141745|FG001|Overall Study|Treatment-related death|2|||
126502877|NCT01951157|455141746|FG002|Overall Study|Treatment-related death|0|||
126502878|NCT04809220|455141747|FG000|Overall Study|Adverse Event|4|||
126502879|NCT04809220|455141748|FG001|Overall Study|Adverse Event|0|||
126502880|NCT04809220|455141747|FG000|Overall Study|Death|1|||
126502881|NCT04809220|455141748|FG001|Overall Study|Death|0|||
126502882|NCT04809220|455141747|FG000|Overall Study|Lost to Follow-up|3|||
126502883|NCT04809220|455141748|FG001|Overall Study|Lost to Follow-up|0|||
126502884|NCT04809220|455141747|FG000|Overall Study|Physician Decision|0|||
126502885|NCT04809220|455141748|FG001|Overall Study|Physician Decision|1|||
126502886|NCT04809220|455141747|FG000|Overall Study|Withdrawal by Subject|9|||
126502887|NCT04809220|455141748|FG001|Overall Study|Withdrawal by Subject|5|||
126502888|NCT04809220|455141747|FG000|Overall Study|Due to long-term overseas business trips|1|||
126502889|NCT04809220|455141748|FG001|Overall Study|Due to long-term overseas business trips|0|||
126502890|NCT01062555|455141754|FG000|Phase 1|Death|10|||
126502891|NCT01062555|455141755|FG001|Phase 1|Death|17|||
126502892|NCT01062555|455141756|FG002|Phase 1|Death|0|||
126502893|NCT01062555|455141757|FG003|Phase 1|Death|0|||
126502894|NCT01062555|455141754|FG000|Phase 1|Graft Failure|12|||
126502895|NCT01062555|455141755|FG001|Phase 1|Graft Failure|8|||
126502896|NCT01062555|455141756|FG002|Phase 1|Graft Failure|0|||
126502897|NCT01062555|455141757|FG003|Phase 1|Graft Failure|0|||
126502898|NCT01062555|455141754|FG000|Phase 1|Withdrawal by Subject|1|||
126502899|NCT01062555|455141755|FG001|Phase 1|Withdrawal by Subject|1|||
126502900|NCT01062555|455141756|FG002|Phase 1|Withdrawal by Subject|0|||
126502901|NCT01062555|455141757|FG003|Phase 1|Withdrawal by Subject|0|||
126502902|NCT01062555|455141754|FG000|Phase 2|Death|0|||
126502903|NCT01062555|455141755|FG001|Phase 2|Death|0|||
126502904|NCT01062555|455141756|FG002|Phase 2|Death|8|||
126502905|NCT01062555|455141757|FG003|Phase 2|Death|3|||
126502906|NCT01062555|455141754|FG000|Phase 2|Graft failure|0|||
126502907|NCT01062555|455141755|FG001|Phase 2|Graft failure|0|||
126502908|NCT01062555|455141756|FG002|Phase 2|Graft failure|7|||
126502909|NCT01062555|455141757|FG003|Phase 2|Graft failure|4|||
126502910|NCT01062555|455141754|FG000|Phase 2|Withdrawal by Subject|0|||
126502911|NCT01062555|455141755|FG001|Phase 2|Withdrawal by Subject|0|||
126502912|NCT01062555|455141756|FG002|Phase 2|Withdrawal by Subject|0|||
126502913|NCT01062555|455141757|FG003|Phase 2|Withdrawal by Subject|7|||
126502914|NCT01062555|455141754|FG000|Phase 2|Protocol Violation|0|||
126502915|NCT01062555|455141755|FG001|Phase 2|Protocol Violation|0|||
126502916|NCT01062555|455141756|FG002|Phase 2|Protocol Violation|0|||
126502917|NCT01062555|455141757|FG003|Phase 2|Protocol Violation|3|||
126502918|NCT01062555|455141754|FG000|Phase 2|Physician Decision|0|||
126502919|NCT01062555|455141755|FG001|Phase 2|Physician Decision|0|||
126502920|NCT01062555|455141756|FG002|Phase 2|Physician Decision|0|||
126502921|NCT01062555|455141757|FG003|Phase 2|Physician Decision|17|||
126502922|NCT00329407|455141760|FG000|Overall Study|Withdrawal by Subject|1|||
126502923|NCT00978068|455141761|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
126502924|NCT00978068|455141762|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
126502925|NCT00978068|455141761|FG000|Overall Study|Death|1|||
126502926|NCT00978068|455141762|FG001|Overall Study|Death|2|||
126502927|NCT00978068|455141761|FG000|Overall Study|Lost to Follow-up|1|||
126502928|NCT00978068|455141762|FG001|Overall Study|Lost to Follow-up|2|||
126502929|NCT00978068|455141761|FG000|Overall Study|Physician Decision|0|||
126502930|NCT00978068|455141762|FG001|Overall Study|Physician Decision|1|||
126502931|NCT00978068|455141761|FG000|Overall Study|Unable to Comply with Study|0|||
126502932|NCT00978068|455141762|FG001|Overall Study|Unable to Comply with Study|2|||
126502933|NCT04964128|455141763|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
126502934|NCT04964128|455141763|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
126502935|NCT01471379|455141764|FG000|Overall Study|Adverse Event|1|||
126502936|NCT01471379|455141765|FG001|Overall Study|Adverse Event|0|||
126502937|NCT01471379|455141766|FG002|Overall Study|Adverse Event|0|||
126502938|NCT01471379|455141764|FG000|Overall Study|Study terminated|0|||
126502939|NCT01471379|455141765|FG001|Overall Study|Study terminated|1|||
126502940|NCT01471379|455141766|FG002|Overall Study|Study terminated|0|||
126502941|NCT02120794|455141767|FG000|Overall Study|Withdrawal by Subject|43|||
126502942|NCT02120794|455141767|FG000|Overall Study|Adverse Event|10|||
126502943|NCT02120794|455141767|FG000|Overall Study|Physician Decision|4|||
126502944|NCT02120794|455141767|FG000|Overall Study|Due to insurance coverage|1|||
126502945|NCT01324349|455141794|FG000|Overall Study|Death|1|||
126502946|NCT01324349|455141795|FG001|Overall Study|Death|1|||
126502947|NCT01324349|455141794|FG000|Overall Study|Withdrawal by Subject|0|||
126502948|NCT01324349|455141795|FG001|Overall Study|Withdrawal by Subject|1|||
126502949|NCT01712256|455141796|FG000|Overall Study|Lost to Follow-up|1|||
126502950|NCT00748215|455141801|FG000|Overall Study|Withdrawal by Subject|7|||
126502951|NCT00748215|455141802|FG001|Overall Study|Withdrawal by Subject|7|||
126502952|NCT00748215|455141801|FG000|Overall Study|Treatment change|2|||
126562380|NCT02775435|455353761|FG000|Overall Study|Withdrawal by Subject|4|||
126562381|NCT02775435|455353762|FG001|Overall Study|Withdrawal by Subject|9|||
126562382|NCT02775435|455353761|FG000|Overall Study|Death|196|||
126562383|NCT02775435|455353762|FG001|Overall Study|Death|224|||
126562384|NCT03537651|455353773|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
126562385|NCT03537651|455353773|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
126562386|NCT03537651|455353773|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
126562387|NCT03537651|455353773|FG000|Part A (Up to 96 Weeks)|Other|1|||
126562388|NCT03537651|455353773|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
126562389|NCT03537651|455353773|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
126562390|NCT03537651|455353773|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
126562391|NCT03537651|455353773|FG000|Part B (Up to 192 Weeks)|Other|1|||
126562392|NCT02403323|455353774|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
126562393|NCT02403323|455353775|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
126562394|NCT02403323|455353776|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
126562395|NCT02403323|455353774|FG000|Part 1: Open Label Extension Period|Death|3|||
126562396|NCT02403323|455353775|FG001|Part 1: Open Label Extension Period|Death|0|||
126562397|NCT02403323|455353776|FG002|Part 1: Open Label Extension Period|Death|0|||
126562398|NCT02403323|455353774|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
126562399|NCT02403323|455353775|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
126562400|NCT02403323|455353776|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
126562401|NCT02403323|455353774|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
126562402|NCT02403323|455353775|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
126562403|NCT02403323|455353776|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
126562404|NCT02403323|455353774|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
126562405|NCT02403323|455353775|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
126562406|NCT02403323|455353776|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
126562407|NCT02403323|455353774|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
126562408|NCT02403323|455353775|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
126562409|NCT02403323|455353776|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
126562410|NCT02403323|455353774|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
126562411|NCT02403323|455353775|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
126562412|NCT02403323|455353776|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
126562413|NCT02403323|455353774|FG000|Part 1: Open Label Extension Period|Other|1|||
126562414|NCT02403323|455353775|FG001|Part 1: Open Label Extension Period|Other|0|||
126562415|NCT02403323|455353776|FG002|Part 1: Open Label Extension Period|Other|0|||
126562416|NCT02403323|455353774|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
126562417|NCT02403323|455353775|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
126562418|NCT02403323|455353776|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
126562419|NCT02403323|455353774|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
126562420|NCT02403323|455353775|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
126562421|NCT02403323|455353776|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
126562422|NCT02403323|455353774|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
126562423|NCT02403323|455353775|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
126562424|NCT02403323|455353776|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
126562425|NCT02403323|455353774|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
126562426|NCT02403323|455353775|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
126562427|NCT02403323|455353776|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
126562428|NCT02403323|455353774|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
126562429|NCT02403323|455353775|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
126562430|NCT02403323|455353776|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
126562431|NCT02403323|455353774|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
126562432|NCT02403323|455353775|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
126562433|NCT02403323|455353776|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
126562434|NCT02403323|455353774|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
126562435|NCT02403323|455353775|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
126502953|NCT00748215|455141802|FG001|Overall Study|Treatment change|1|||
126502954|NCT00748215|455141801|FG000|Overall Study|Change in patient condition|0|||
126562436|NCT02403323|455353776|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
126562437|NCT02403323|455353774|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
126562438|NCT02403323|455353775|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
126562439|NCT02403323|455353776|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
126562440|NCT02403323|455353774|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
126562441|NCT02403323|455353775|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
126562442|NCT02403323|455353776|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
126562443|NCT02403323|455353774|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
126562444|NCT02403323|455353775|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
126562445|NCT02403323|455353776|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
126562446|NCT03885596|455353777|FG000|Overall Study|Withdrawal by Subject|2|||
126562447|NCT03885596|455353778|FG001|Overall Study|Withdrawal by Subject|1|||
126562448|NCT03885596|455353779|FG002|Overall Study|Withdrawal by Subject|0|||
126562449|NCT03885596|455353780|FG003|Overall Study|Withdrawal by Subject|0|||
126562450|NCT03852433|455353781|FG000|Overall Study|Withdrawal of consent|5|||
126562451|NCT03852433|455353782|FG001|Overall Study|Withdrawal of consent|8|||
126562452|NCT03852433|455353783|FG002|Overall Study|Withdrawal of consent|1|||
126562453|NCT03852433|455353784|FG003|Overall Study|Withdrawal of consent|1|||
126562454|NCT03852433|455353781|FG000|Overall Study|Adverse Event|1|||
126562455|NCT03852433|455353782|FG001|Overall Study|Adverse Event|1|||
126562456|NCT03852433|455353783|FG002|Overall Study|Adverse Event|1|||
126562457|NCT03852433|455353784|FG003|Overall Study|Adverse Event|1|||
126562458|NCT03852433|455353781|FG000|Overall Study|Lost to Follow-up|0|||
126562459|NCT03852433|455353782|FG001|Overall Study|Lost to Follow-up|1|||
126562460|NCT03852433|455353783|FG002|Overall Study|Lost to Follow-up|0|||
126562461|NCT03852433|455353784|FG003|Overall Study|Lost to Follow-up|1|||
126562462|NCT03852433|455353781|FG000|Overall Study|Pregnancy|0|||
126562463|NCT03852433|455353782|FG001|Overall Study|Pregnancy|1|||
126562464|NCT03852433|455353783|FG002|Overall Study|Pregnancy|1|||
126562465|NCT03852433|455353784|FG003|Overall Study|Pregnancy|0|||
126562466|NCT03852433|455353781|FG000|Overall Study|Protocol Violation|0|||
126562467|NCT03852433|455353782|FG001|Overall Study|Protocol Violation|0|||
126562468|NCT03852433|455353783|FG002|Overall Study|Protocol Violation|1|||
126562469|NCT03852433|455353784|FG003|Overall Study|Protocol Violation|1|||
126562470|NCT03852433|455353781|FG000|Overall Study|Death|0|||
126562471|NCT03852433|455353782|FG001|Overall Study|Death|0|||
126562472|NCT03852433|455353783|FG002|Overall Study|Death|1|||
126562473|NCT03852433|455353784|FG003|Overall Study|Death|0|||
126562474|NCT03852433|455353781|FG000|Overall Study|Lack of Efficacy|0|||
126562475|NCT03852433|455353782|FG001|Overall Study|Lack of Efficacy|1|||
126562476|NCT03852433|455353783|FG002|Overall Study|Lack of Efficacy|0|||
126562477|NCT03852433|455353784|FG003|Overall Study|Lack of Efficacy|0|||
126562478|NCT03852433|455353781|FG000|Overall Study|Non-compliance with study drug|0|||
126562479|NCT03852433|455353782|FG001|Overall Study|Non-compliance with study drug|0|||
126562480|NCT03852433|455353783|FG002|Overall Study|Non-compliance with study drug|0|||
126562481|NCT03852433|455353784|FG003|Overall Study|Non-compliance with study drug|1|||
126562482|NCT03852433|455353781|FG000|Overall Study|Physician Decision|1|||
126562483|NCT03852433|455353782|FG001|Overall Study|Physician Decision|0|||
126562484|NCT03852433|455353783|FG002|Overall Study|Physician Decision|0|||
126562485|NCT03852433|455353784|FG003|Overall Study|Physician Decision|0|||
126562486|NCT03852433|455353781|FG000|Overall Study|Randomized but never treated|1|||
126562487|NCT03852433|455353782|FG001|Overall Study|Randomized but never treated|0|||
126562488|NCT03852433|455353783|FG002|Overall Study|Randomized but never treated|0|||
126562489|NCT03852433|455353784|FG003|Overall Study|Randomized but never treated|0|||
126562490|NCT01076335|455353785|FG000|Overall Study|Withdrawal by Subject|3|||
126562491|NCT01076335|455353785|FG000|Overall Study|Withdrawal without treatment|1|||
126562492|NCT00654238|455353788|FG000|Overall Study|Screen Failures|4|||
126562493|NCT02138916|455353794|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
126562494|NCT02138916|455353795|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
126562495|NCT02138916|455353796|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
126562496|NCT02138916|455353794|FG000|Overall Study|Death|14|||
126562497|NCT02138916|455353795|FG001|Overall Study|Death|11|||
126562498|NCT02138916|455353796|FG002|Overall Study|Death|12|||
126562499|NCT02138916|455353794|FG000|Overall Study|Withdrawal by Subject|27|||
126562500|NCT02138916|455353795|FG001|Overall Study|Withdrawal by Subject|31|||
126562501|NCT02138916|455353796|FG002|Overall Study|Withdrawal by Subject|32|||
126562502|NCT02138916|455353794|FG000|Overall Study|Study specific withdrawal criteria|0|||
126562503|NCT02138916|455353795|FG001|Overall Study|Study specific withdrawal criteria|0|||
126726966|NCT04191577|455949112|FG001|Overall Study|Death|0|||
126726967|NCT04191577|455949113|FG002|Overall Study|Death|1|||
126726968|NCT01185249|455949114|FG000|Overall Study|Patients discharged or change in status|42|||
126726969|NCT00406783|455949117|FG000|Overall Study|Adverse Event|4|||
126726970|NCT00406783|455949118|FG001|Overall Study|Adverse Event|4|||
126726971|NCT00406783|455949117|FG000|Overall Study|Treatment Failure|2|||
126726972|NCT00406783|455949118|FG001|Overall Study|Treatment Failure|3|||
126726973|NCT00406783|455949117|FG000|Overall Study|Lost to Follow-up|3|||
126502955|NCT00748215|455141802|FG001|Overall Study|Change in patient condition|3|||
126502956|NCT00748215|455141801|FG000|Overall Study|Non-compliant|0|||
126502957|NCT00748215|455141802|FG001|Overall Study|Non-compliant|2|||
126502958|NCT00748215|455141801|FG000|Overall Study|Adverse Event|0|||
126502959|NCT00748215|455141802|FG001|Overall Study|Adverse Event|5|||
126502960|NCT02013167|455141803|FG000|Overall Study|Withdrawal by Subject|15|||
126502961|NCT02013167|455141804|FG001|Overall Study|Withdrawal by Subject|14|||
126502962|NCT02013167|455141803|FG000|Overall Study|Sponsor Decision|1|||
126502963|NCT02013167|455141804|FG001|Overall Study|Sponsor Decision|3|||
126502964|NCT02013167|455141803|FG000|Overall Study|Lost to Follow-up|0|||
126502965|NCT02013167|455141804|FG001|Overall Study|Lost to Follow-up|1|||
126502966|NCT02013167|455141803|FG000|Overall Study|Death|85|||
126502967|NCT02013167|455141804|FG001|Overall Study|Death|160|||
126502968|NCT00026793|455141808|FG000|Overall Study|Death on study due to underlying disease|4|||
126502969|NCT00026793|455141808|FG000|Overall Study|Physician Decision|2|||
126502970|NCT00026793|455141808|FG000|Overall Study|Off study|2|||
126502971|NCT04151290|455141809|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
126502972|NCT00969553|455141810|FG000|Overall Study|Progressive disease (PD)|2|||
126502973|NCT00969553|455141811|FG001|Overall Study|Progressive disease (PD)|2|||
126502974|NCT00969553|455141812|FG002|Overall Study|Progressive disease (PD)|6|||
126502975|NCT00969553|455141813|FG003|Overall Study|Progressive disease (PD)|9|||
126502976|NCT00969553|455141814|FG004|Overall Study|Progressive disease (PD)|2|||
126502977|NCT00969553|455141815|FG005|Overall Study|Progressive disease (PD)|4|||
126502978|NCT00969553|455141816|FG006|Overall Study|Progressive disease (PD)|2|||
126502979|NCT00969553|455141817|FG007|Overall Study|Progressive disease (PD)|12|||
126502980|NCT00969553|455141818|FG008|Overall Study|Progressive disease (PD)|3|||
126502981|NCT00969553|455141810|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
126502982|NCT00969553|455141811|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
126502983|NCT00969553|455141812|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
126502984|NCT00969553|455141813|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
126502985|NCT00969553|455141814|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
126502986|NCT00969553|455141815|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
126502987|NCT00969553|455141816|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
126502988|NCT00969553|455141817|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
126502989|NCT00969553|455141818|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
126502990|NCT00969553|455141810|FG000|Overall Study|Other Adverse Event|0|||
126502991|NCT00969553|455141811|FG001|Overall Study|Other Adverse Event|0|||
126502992|NCT00969553|455141812|FG002|Overall Study|Other Adverse Event|0|||
126502993|NCT00969553|455141813|FG003|Overall Study|Other Adverse Event|1|||
126502994|NCT00969553|455141814|FG004|Overall Study|Other Adverse Event|0|||
126502995|NCT00969553|455141815|FG005|Overall Study|Other Adverse Event|0|||
126502996|NCT00969553|455141816|FG006|Overall Study|Other Adverse Event|1|||
126502997|NCT00969553|455141817|FG007|Overall Study|Other Adverse Event|0|||
126502998|NCT00969553|455141818|FG008|Overall Study|Other Adverse Event|0|||
126502999|NCT00969553|455141810|FG000|Overall Study|Refused cont. medication|1|||
126503000|NCT00969553|455141811|FG001|Overall Study|Refused cont. medication|1|||
126503001|NCT00969553|455141812|FG002|Overall Study|Refused cont. medication|0|||
126503002|NCT00969553|455141813|FG003|Overall Study|Refused cont. medication|2|||
126503003|NCT00969553|455141814|FG004|Overall Study|Refused cont. medication|0|||
126503004|NCT00969553|455141815|FG005|Overall Study|Refused cont. medication|0|||
126503005|NCT00969553|455141816|FG006|Overall Study|Refused cont. medication|0|||
126503006|NCT00969553|455141817|FG007|Overall Study|Refused cont. medication|1|||
126503007|NCT00969553|455141818|FG008|Overall Study|Refused cont. medication|0|||
126503008|NCT00969553|455141810|FG000|Overall Study|Not specified above|0|||
126503009|NCT00969553|455141811|FG001|Overall Study|Not specified above|0|||
126503010|NCT00969553|455141812|FG002|Overall Study|Not specified above|0|||
126503011|NCT00969553|455141813|FG003|Overall Study|Not specified above|4|||
126503012|NCT00969553|455141814|FG004|Overall Study|Not specified above|0|||
126503013|NCT00969553|455141815|FG005|Overall Study|Not specified above|0|||
126503014|NCT00969553|455141816|FG006|Overall Study|Not specified above|1|||
126503015|NCT00969553|455141817|FG007|Overall Study|Not specified above|1|||
126503016|NCT00969553|455141818|FG008|Overall Study|Not specified above|0|||
126503017|NCT03711162|455143495|FG000|Overall Study|Adverse Event|5|||
126503018|NCT03711162|455143496|FG001|Overall Study|Adverse Event|2|||
126503019|NCT03711162|455143497|FG002|Overall Study|Adverse Event|4|||
126503020|NCT03711162|455143495|FG000|Overall Study|Death|11|||
126503021|NCT03711162|455143496|FG001|Overall Study|Death|7|||
126503022|NCT03711162|455143497|FG002|Overall Study|Death|8|||
126503023|NCT03711162|455143495|FG000|Overall Study|Lost to Follow-up|1|||
126503024|NCT03711162|455143496|FG001|Overall Study|Lost to Follow-up|0|||
126503025|NCT03711162|455143497|FG002|Overall Study|Lost to Follow-up|1|||
126726974|NCT00406783|455949118|FG001|Overall Study|Lost to Follow-up|0|||
126726975|NCT00406783|455949117|FG000|Overall Study|Withdrawal by Subject|1|||
126503026|NCT03711162|455143495|FG000|Overall Study|Study Terminated by Sponsor|139|||
126503027|NCT03711162|455143496|FG001|Overall Study|Study Terminated by Sponsor|152|||
126503028|NCT03711162|455143497|FG002|Overall Study|Study Terminated by Sponsor|146|||
126503029|NCT03711162|455143495|FG000|Overall Study|Withdrawal by Subject|17|||
126562504|NCT02138916|455353796|FG002|Overall Study|Study specific withdrawal criteria|1|||
126562505|NCT02138916|455353794|FG000|Overall Study|incorrect enrolment|1|||
126562506|NCT02138916|455353795|FG001|Overall Study|incorrect enrolment|1|||
126562507|NCT02138916|455353796|FG002|Overall Study|incorrect enrolment|0|||
126562508|NCT02138916|455353794|FG000|Overall Study|Severe non-compliance|1|||
126562509|NCT02138916|455353795|FG001|Overall Study|Severe non-compliance|2|||
126562510|NCT02138916|455353796|FG002|Overall Study|Severe non-compliance|1|||
126562511|NCT02138916|455353794|FG000|Overall Study|Lost to Follow-up|4|||
126562512|NCT02138916|455353795|FG001|Overall Study|Lost to Follow-up|2|||
126562513|NCT02138916|455353796|FG002|Overall Study|Lost to Follow-up|3|||
126562514|NCT02138916|455353794|FG000|Overall Study|Adverse Event|4|||
126562515|NCT02138916|455353795|FG001|Overall Study|Adverse Event|4|||
126562516|NCT02138916|455353796|FG002|Overall Study|Adverse Event|3|||
126562517|NCT01348087|455353797|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
126562518|NCT01348087|455353797|FG000|Overall Study|Administrative problems|79|||
126562519|NCT01348087|455353797|FG000|Overall Study|protocol deviation|1|||
126562520|NCT01348087|455353797|FG000|Overall Study|Lost to Follow-up|1|||
126562521|NCT01348087|455353797|FG000|Overall Study|Subject withdrew consent|7|||
126562522|NCT01348087|455353797|FG000|Overall Study|Adverse Event|25|||
126562523|NCT03781804|455353801|FG000|Overall Study|Adverse Event|2|||
126562524|NCT03781804|455353802|FG001|Overall Study|Adverse Event|2|||
126562525|NCT03781804|455353803|FG002|Overall Study|Adverse Event|3|||
126562526|NCT03781804|455353801|FG000|Overall Study|Lost to Follow-up|1|||
126562527|NCT03781804|455353802|FG001|Overall Study|Lost to Follow-up|1|||
126562528|NCT03781804|455353803|FG002|Overall Study|Lost to Follow-up|2|||
126562529|NCT03781804|455353801|FG000|Overall Study|Lack of Efficacy|4|||
126562530|NCT03781804|455353802|FG001|Overall Study|Lack of Efficacy|2|||
126562531|NCT03781804|455353803|FG002|Overall Study|Lack of Efficacy|9|||
126562532|NCT03781804|455353801|FG000|Overall Study|Protocol Violation|0|||
126562533|NCT03781804|455353802|FG001|Overall Study|Protocol Violation|0|||
126562534|NCT03781804|455353803|FG002|Overall Study|Protocol Violation|1|||
126562535|NCT03781804|455353801|FG000|Overall Study|Withdrawal by Subject|0|||
126562536|NCT03781804|455353802|FG001|Overall Study|Withdrawal by Subject|1|||
126562537|NCT03781804|455353803|FG002|Overall Study|Withdrawal by Subject|1|||
126562538|NCT03781804|455353801|FG000|Overall Study|Reason not provided|2|||
126562539|NCT03781804|455353802|FG001|Overall Study|Reason not provided|2|||
126562540|NCT03781804|455353803|FG002|Overall Study|Reason not provided|0|||
126562541|NCT04678830|455353804|FG000|Overall Study|Lack of Efficacy|2|||
126562542|NCT04678830|455353805|FG001|Overall Study|Lack of Efficacy|0|||
126562543|NCT04678830|455353804|FG000|Overall Study|Withdrawal by Subject|0|||
126562544|NCT04678830|455353805|FG001|Overall Study|Withdrawal by Subject|1|||
126562545|NCT01190176|455353807|FG000|Overall Study|Withdrawal by Subject|1|||
126562546|NCT01190176|455353807|FG000|Overall Study|Lost to Follow-up|1|||
126503030|NCT03711162|455143496|FG001|Overall Study|Withdrawal by Subject|10|||
126503031|NCT03711162|455143497|FG002|Overall Study|Withdrawal by Subject|10|||
126503032|NCT03711162|455143495|FG000|Overall Study|Miscellaneous|1|||
126503033|NCT03711162|455143496|FG001|Overall Study|Miscellaneous|2|||
126503034|NCT03711162|455143497|FG002|Overall Study|Miscellaneous|2|||
126503035|NCT03711162|455143495|FG000|Overall Study|Not Treated|1|||
126503036|NCT03711162|455143496|FG001|Overall Study|Not Treated|0|||
126503037|NCT03711162|455143497|FG002|Overall Study|Not Treated|1|||
126503038|NCT03711162|455143495|FG000|Overall Study|Physician Decision|0|||
126503039|NCT03711162|455143496|FG001|Overall Study|Physician Decision|2|||
126503040|NCT03711162|455143497|FG002|Overall Study|Physician Decision|0|||
126503041|NCT03711162|455143495|FG000|Overall Study|Lack of Efficacy|0|||
126503042|NCT03711162|455143496|FG001|Overall Study|Lack of Efficacy|0|||
126503043|NCT03711162|455143497|FG002|Overall Study|Lack of Efficacy|2|||
126503044|NCT03711162|455143495|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
126503045|NCT03711162|455143496|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
126503046|NCT03711162|455143497|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
126503047|NCT03034954|455143498|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
126503048|NCT03034954|455143499|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
126503049|NCT00394212|455143502|FG000|Overall Study|Lost to Follow-up|3|||
126503050|NCT00394212|455143503|FG001|Overall Study|Lost to Follow-up|0|||
126503051|NCT00394212|455143502|FG000|Overall Study|Withdrawal by Subject|4|||
126503052|NCT00394212|455143503|FG001|Overall Study|Withdrawal by Subject|1|||
126503053|NCT00588445|455143504|FG000|Overall Study|Protocol Violation|1|||
126503054|NCT00588445|455143504|FG000|Overall Study|Withdrawal by Subject|3|||
126503055|NCT00588445|455143504|FG000|Overall Study|Disease Progression|1|||
126503056|NCT00588445|455143504|FG000|Overall Study|Not Treated|10|||
126503057|NCT03240133|455143505|FG000|Overall Study|Withdrawal by Subject|0|||
126503058|NCT03240133|455143506|FG001|Overall Study|Withdrawal by Subject|1|||
126503059|NCT03240133|455143507|FG002|Overall Study|Withdrawal by Subject|0|||
126562547|NCT01836458|455353808|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
126562548|NCT01836458|455353809|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126562549|NCT01836458|455353810|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
126562550|NCT01836458|455353811|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
126562551|NCT02189863|455353812|FG000|First 2 Weeks|Motion Sickness|4|||
126503060|NCT03240133|455143505|FG000|Overall Study|Adverse Event|1|||
126503061|NCT03240133|455143506|FG001|Overall Study|Adverse Event|1|||
126503062|NCT03240133|455143507|FG002|Overall Study|Adverse Event|0|||
126503063|NCT03240133|455143505|FG000|Overall Study|Rash|1|||
126503064|NCT03240133|455143506|FG001|Overall Study|Rash|0|||
126503065|NCT03240133|455143507|FG002|Overall Study|Rash|0|||
126503066|NCT03240133|455143505|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
126503067|NCT03240133|455143506|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
126503068|NCT03240133|455143507|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
126503069|NCT03240133|455143505|FG000|Overall Study|Intercurrent illness.|0|||
126503070|NCT03240133|455143506|FG001|Overall Study|Intercurrent illness.|1|||
126503071|NCT03240133|455143507|FG002|Overall Study|Intercurrent illness.|0|||
126503072|NCT03240133|455143505|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
126503073|NCT03240133|455143506|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
126503074|NCT03240133|455143507|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
126503075|NCT01176292|455143508|FG000|Overall Study|Lost to Follow-up|2|||
126503076|NCT01176292|455143509|FG001|Overall Study|Lost to Follow-up|4|||
126562552|NCT02189863|455353813|FG001|First 2 Weeks|Motion Sickness|2|||
126562553|NCT02926937|455353814|FG000|Overall Study|Adverse Event|0|||
126562554|NCT02926937|455353815|FG001|Overall Study|Adverse Event|1|||
126562555|NCT02926937|455353816|FG002|Overall Study|Adverse Event|1|||
126562556|NCT02926937|455353814|FG000|Overall Study|Poor Compliance to Protocol|1|||
126562557|NCT02926937|455353815|FG001|Overall Study|Poor Compliance to Protocol|0|||
126503077|NCT01176292|455143508|FG000|Overall Study|Adverse Event|1|||
126503078|NCT01176292|455143509|FG001|Overall Study|Adverse Event|1|||
126503079|NCT01176292|455143508|FG000|Overall Study|Physician Decision|0|||
126503080|NCT01176292|455143509|FG001|Overall Study|Physician Decision|2|||
126503081|NCT01176292|455143508|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
126503082|NCT01176292|455143509|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
126503083|NCT00997503|455143510|FG000|Overall Study|Death|53|||
126503084|NCT00997503|455143510|FG000|Overall Study|Withdrawal by Subject|76|||
126503085|NCT00997503|455143510|FG000|Overall Study|Lost to Follow-up|33|||
126503086|NCT00997503|455143510|FG000|Overall Study|Adverse Event|3|||
126503087|NCT00997503|455143510|FG000|Overall Study|Physician Decision|10|||
126503088|NCT00997503|455143510|FG000|Overall Study|Missed 12-month follow-up|85|||
126503089|NCT00997503|455143510|FG000|Overall Study|Other reason|13|||
126726976|NCT00406783|455949118|FG001|Overall Study|Withdrawal by Subject|4|||
126726977|NCT00406783|455949117|FG000|Overall Study|Protocol Violation|4|||
126726978|NCT00406783|455949118|FG001|Overall Study|Protocol Violation|4|||
126726979|NCT00012012|455949119|FG000|Overall Study|Protocol Violation|1|||
126726980|NCT00012012|455949120|FG001|Overall Study|Protocol Violation|1|||
126726981|NCT00012012|455949119|FG000|Overall Study|Withdrawal by Subject|0|||
126726982|NCT00012012|455949120|FG001|Overall Study|Withdrawal by Subject|2|||
126726983|NCT01391819|455949121|FG000|Overall Study|Withdrawal by Subject|56|||
126726984|NCT01391819|455949121|FG000|Overall Study|Migrated/moved from study area|82|||
126726985|NCT01391819|455949121|FG000|Overall Study|Lost to Follow-up|252|||
126726986|NCT01391819|455949121|FG000|Overall Study|Death|3|||
126726987|NCT01391819|455949121|FG000|Overall Study|Other|9|||
126726988|NCT01208038|455949124|FG000|Overall Study|Withdrawal by Subject|1|||
126726989|NCT04752189|455949128|FG000|Overall Study|Withdrawal by Subject|0|||
126726990|NCT04752189|455949129|FG001|Overall Study|Withdrawal by Subject|150|||
126726991|NCT04752189|455949128|FG000|Overall Study|Lost to Follow-up|261|||
126726992|NCT04752189|455949129|FG001|Overall Study|Lost to Follow-up|126|||
126726993|NCT03422133|455949130|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
126726994|NCT03422133|455949131|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
126726995|NCT02198651|455951014|FG000|Lead-in Period|Withdrew consent|13|||
126726996|NCT02198651|455951015|FG001|Lead-in Period|Withdrew consent|0|||
126726997|NCT02198651|455951016|FG002|Lead-in Period|Withdrew consent|0|||
126726998|NCT02198651|455951017|FG003|Lead-in Period|Withdrew consent|0|||
126503090|NCT00116831|455143511|FG000|Overall Study|Adverse Event|14|||
126503091|NCT00116831|455143512|FG001|Overall Study|Adverse Event|16|||
126503092|NCT00116831|455143511|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
126503093|NCT00116831|455143512|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
126726999|NCT02198651|455951018|FG004|Lead-in Period|Withdrew consent|0|||
126503094|NCT00116831|455143511|FG000|Overall Study|Lost to Follow-up|8|||
126503095|NCT00116831|455143512|FG001|Overall Study|Lost to Follow-up|6|||
126503096|NCT00116831|455143511|FG000|Overall Study|Protocol Violation|3|||
126727000|NCT02198651|455951014|FG000|Lead-in Period|Adverse Event|2|||
126727001|NCT02198651|455951015|FG001|Lead-in Period|Adverse Event|0|||
126727002|NCT02198651|455951016|FG002|Lead-in Period|Adverse Event|0|||
126727003|NCT02198651|455951017|FG003|Lead-in Period|Adverse Event|0|||
126727004|NCT02198651|455951018|FG004|Lead-in Period|Adverse Event|0|||
126727005|NCT02198651|455951014|FG000|Lead-in Period|Other, not specified|22|||
126727006|NCT02198651|455951015|FG001|Lead-in Period|Other, not specified|0|||
126727007|NCT02198651|455951016|FG002|Lead-in Period|Other, not specified|0|||
126503097|NCT00116831|455143512|FG001|Overall Study|Protocol Violation|6|||
126503098|NCT00116831|455143511|FG000|Overall Study|Hypoglycaemic events|1|||
126503099|NCT00116831|455143512|FG001|Overall Study|Hypoglycaemic events|0|||
126503100|NCT00116831|455143511|FG000|Overall Study|Low haemoglobin on screening|1|||
126503101|NCT00116831|455143512|FG001|Overall Study|Low haemoglobin on screening|0|||
126503102|NCT00116831|455143511|FG000|Overall Study|Withdrawn investigational product|1|||
126503103|NCT00116831|455143512|FG001|Overall Study|Withdrawn investigational product|0|||
126503104|NCT00116831|455143511|FG000|Overall Study|Withdrawal by Subject|32|||
126503105|NCT00116831|455143512|FG001|Overall Study|Withdrawal by Subject|32|||
126503106|NCT00116831|455143511|FG000|Overall Study|Insufficient therapeutic effect|0|||
126503107|NCT00116831|455143512|FG001|Overall Study|Insufficient therapeutic effect|1|||
126503108|NCT00116831|455143511|FG000|Overall Study|Missing data for participant|1|||
126503109|NCT00116831|455143512|FG001|Overall Study|Missing data for participant|0|||
126503110|NCT00380393|455143513|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
126503111|NCT00380393|455143514|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
126503112|NCT00380393|455143513|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
126503113|NCT00380393|455143514|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
126503114|NCT00380393|455143513|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
126503115|NCT00380393|455143514|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
126503116|NCT00380393|455143513|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
126503117|NCT00380393|455143514|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
126503118|NCT00380393|455143513|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
126503119|NCT00380393|455143514|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
126503120|NCT00380393|455143513|FG000|Month 14|Withdrawal by Subject|9|||
126503121|NCT00380393|455143514|FG001|Month 14|Withdrawal by Subject|7|||
126503122|NCT00380393|455143513|FG000|Month 14|Death|1|||
126503123|NCT00380393|455143514|FG001|Month 14|Death|0|||
126503124|NCT00380393|455143513|FG000|Month 14|Lost to Follow-up|0|||
126503125|NCT00380393|455143514|FG001|Month 14|Lost to Follow-up|1|||
126503126|NCT00380393|455143513|FG000|Month 14|Migrated/moved from study area|39|||
126503127|NCT00380393|455143514|FG001|Month 14|Migrated/moved from study area|42|||
126503128|NCT00380393|455143513|FG000|Month 14|Protocol Violation|2|||
126503129|NCT00380393|455143514|FG001|Month 14|Protocol Violation|0|||
126503130|NCT00380393|455143513|FG000|Month 14|Others|6|||
126503131|NCT00380393|455143514|FG001|Month 14|Others|6|||
126503132|NCT00110812|455143515|FG000|Main Study|Death|0|||
126503133|NCT00110812|455143516|FG001|Main Study|Death|0|||
126503134|NCT00110812|455143517|FG002|Main Study|Death|2|||
126503135|NCT00110812|455143515|FG000|Main Study|Withdrawal by Subject|0|||
126503136|NCT00110812|455143516|FG001|Main Study|Withdrawal by Subject|0|||
126503137|NCT00110812|455143517|FG002|Main Study|Withdrawal by Subject|1|||
126503138|NCT00110812|455143515|FG000|Main Study|Lost to Follow-up|8|||
126503139|NCT00110812|455143516|FG001|Main Study|Lost to Follow-up|11|||
126503140|NCT00110812|455143517|FG002|Main Study|Lost to Follow-up|10|||
126503141|NCT00110812|455143515|FG000|Extended Follow-up|Death|1|||
126503142|NCT00110812|455143516|FG001|Extended Follow-up|Death|0|||
126503143|NCT00110812|455143517|FG002|Extended Follow-up|Death|3|||
126503144|NCT00110812|455143515|FG000|Extended Follow-up|Withdrawal by Subject|0|||
126503145|NCT00110812|455143516|FG001|Extended Follow-up|Withdrawal by Subject|1|||
126503146|NCT00110812|455143517|FG002|Extended Follow-up|Withdrawal by Subject|0|||
126503147|NCT00110812|455143515|FG000|Extended Follow-up|Lost to Follow-up|1|||
126503148|NCT00110812|455143516|FG001|Extended Follow-up|Lost to Follow-up|3|||
126503149|NCT00110812|455143517|FG002|Extended Follow-up|Lost to Follow-up|1|||
126503150|NCT01933048|455143518|FG000|Overall Study|Lost to Follow-up|15|||
126503151|NCT01933048|455143519|FG001|Overall Study|Lost to Follow-up|18|||
126503152|NCT01933048|455143518|FG000|Overall Study|personal reasons|1|||
126503153|NCT01933048|455143519|FG001|Overall Study|personal reasons|1|||
126503154|NCT01933048|455143518|FG000|Overall Study|Protocol Violation|7|||
126503155|NCT01933048|455143519|FG001|Overall Study|Protocol Violation|8|||
126503156|NCT01933048|455143518|FG000|Overall Study|Physician Decision|1|||
126503157|NCT01933048|455143519|FG001|Overall Study|Physician Decision|0|||
126503158|NCT01933048|455143518|FG000|Overall Study|unknown reasons|1|||
126503159|NCT01933048|455143519|FG001|Overall Study|unknown reasons|1|||
126503160|NCT02780804|455143522|FG000|Overall Study|Death|1|||
126503161|NCT02780804|455143523|FG001|Overall Study|Death|0|||
126503162|NCT02780804|455143524|FG002|Overall Study|Death|0|||
126503163|NCT02780804|455143522|FG000|Overall Study|Lack of Efficacy|5|||
126503164|NCT02780804|455143523|FG001|Overall Study|Lack of Efficacy|8|||
126503165|NCT02780804|455143524|FG002|Overall Study|Lack of Efficacy|4|||
126503166|NCT02780804|455143522|FG000|Overall Study|Physician Decision|0|||
126503167|NCT02780804|455143523|FG001|Overall Study|Physician Decision|0|||
126503168|NCT02780804|455143524|FG002|Overall Study|Physician Decision|2|||
126503169|NCT02780804|455143522|FG000|Overall Study|Withdrawal by Subject|0|||
126503170|NCT02780804|455143523|FG001|Overall Study|Withdrawal by Subject|1|||
126503171|NCT02780804|455143524|FG002|Overall Study|Withdrawal by Subject|0|||
126503172|NCT01859507|455143525|FG000|Overall Study|left the country|4|||
126503173|NCT01921829|455143526|FG000|Overall Study|Withdrawal by Subject|0|||
126503174|NCT01921829|455143527|FG001|Overall Study|Withdrawal by Subject|1|||
126776129|NCT00124449|456135858|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
126776130|NCT00124449|456135857|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
126776131|NCT00124449|456135858|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
126776132|NCT00124449|456135857|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
126776133|NCT00124449|456135858|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
126776134|NCT00124449|456135857|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
126776135|NCT00124449|456135858|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
126776136|NCT00124449|456135857|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
126776137|NCT00124449|456135858|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
126776138|NCT00124449|456135857|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
126776139|NCT00124449|456135858|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
126776140|NCT00124449|456135857|FG000|18-Month Untreated Observation Period|Relocated|1|||
126776141|NCT00124449|456135858|FG001|18-Month Untreated Observation Period|Relocated|0|||
126776142|NCT01254045|456135859|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
126776143|NCT01254045|456135860|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
126776144|NCT01254045|456135861|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
126776145|NCT01254045|456135862|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
126776146|NCT01254045|456135863|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
126776147|NCT01254045|456135864|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
126776148|NCT02971605|456135865|FG000|Overall Study|Withdrawal by Subject|1|||
126776149|NCT00597207|456135866|FG000|Overall Study|Lost to Follow-up|5|||
126776150|NCT00597207|456135867|FG001|Overall Study|Lost to Follow-up|7|||
126776151|NCT00520351|456135868|FG000|First Intervention|Withdrawal by Subject|1|||
126776152|NCT00520351|456135869|FG001|First Intervention|Withdrawal by Subject|1|||
126776153|NCT02278952|456135870|FG000|Overall Study|Insufficient Sample|6|||
126776154|NCT00869089|456135876|FG000|Overall Study|Lost to Follow-up|1|||
126776155|NCT00869089|456135876|FG000|Overall Study|Withdrawal by Subject|1|||
126776156|NCT00869089|456135876|FG000|Overall Study|Screen Fail|1|||
126776157|NCT01010230|456135882|FG000|Overall Study|Withdrawal by Subject|6|||
126776158|NCT01010230|456135883|FG001|Overall Study|Withdrawal by Subject|5|||
126776159|NCT01010230|456135882|FG000|Overall Study|Lost to Follow-up|4|||
126776160|NCT01010230|456135883|FG001|Overall Study|Lost to Follow-up|2|||
126776161|NCT00530439|456135884|FG000|Overall Study|GDM|9|||
126776162|NCT00530439|456135885|FG001|Overall Study|GDM|3|||
126776163|NCT00530439|456135884|FG000|Overall Study|Withdraw|18|||
126776164|NCT00530439|456135885|FG001|Overall Study|Withdraw|14|||
126776165|NCT00530439|456135884|FG000|Overall Study|Missed abortion|1|||
126776166|NCT00530439|456135885|FG001|Overall Study|Missed abortion|4|||
126776167|NCT00530439|456135884|FG000|Overall Study|Misclassification|2|||
126776168|NCT00530439|456135885|FG001|Overall Study|Misclassification|0|||
126776169|NCT00530439|456135884|FG000|Overall Study|Twin pregnancy|0|||
126776170|NCT00530439|456135885|FG001|Overall Study|Twin pregnancy|2|||
126776171|NCT00530439|456135884|FG000|Overall Study|Severe malformation/abortion|0|||
126776172|NCT00530439|456135885|FG001|Overall Study|Severe malformation/abortion|3|||
126776173|NCT01963676|456137316|FG000|Overall Study|Withdrawal by Subject|1|||
126776174|NCT01963676|456137317|FG001|Overall Study|Withdrawal by Subject|0|||
126776175|NCT01246973|456137318|FG000|Overall Study|Other|38|||
126776176|NCT01246973|456137319|FG001|Overall Study|Other|25|||
126776177|NCT01246973|456137318|FG000|Overall Study|Adverse Event|16|||
126776178|NCT01246973|456137319|FG001|Overall Study|Adverse Event|9|||
126776179|NCT01246973|456137318|FG000|Overall Study|Withdrawal by Subject|7|||
126776180|NCT01246973|456137319|FG001|Overall Study|Withdrawal by Subject|13|||
126562558|NCT02926937|455353816|FG002|Overall Study|Poor Compliance to Protocol|0|||
126562559|NCT02926937|455353814|FG000|Overall Study|Lost to Follow-up|4|||
126562560|NCT02926937|455353815|FG001|Overall Study|Lost to Follow-up|5|||
126562561|NCT02926937|455353816|FG002|Overall Study|Lost to Follow-up|0|||
126562562|NCT02926937|455353814|FG000|Overall Study|At the Participant's own Request|11|||
126562563|NCT02926937|455353815|FG001|Overall Study|At the Participant's own Request|5|||
126562564|NCT02926937|455353816|FG002|Overall Study|At the Participant's own Request|8|||
126562565|NCT02926937|455353814|FG000|Overall Study|Reason not Specified|3|||
126562566|NCT02926937|455353815|FG001|Overall Study|Reason not Specified|4|||
126562567|NCT02926937|455353816|FG002|Overall Study|Reason not Specified|2|||
126562568|NCT01555762|455353821|FG000|Overall Study|No information on Bevacizumab intake|11|||
126776181|NCT00766506|456137320|FG000|Overall Study|Use rescue medication after 3 hours|3|||
126776182|NCT00766506|456137321|FG001|Overall Study|Use rescue medication after 3 hours|0|||
126776183|NCT00766506|456137320|FG000|Overall Study|Other|2|||
126776184|NCT00766506|456137321|FG001|Overall Study|Other|2|||
126776185|NCT02496221|456137322|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
126776186|NCT02496221|456137323|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
126776187|NCT02496221|456137322|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
126776188|NCT02496221|456137323|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
126776189|NCT02496221|456137322|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
126776190|NCT02496221|456137323|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
126776191|NCT03262233|456137324|FG000|Overall Study|Withdrawal by Subject|12|||
126776192|NCT03262233|456137325|FG001|Overall Study|Withdrawal by Subject|8|||
126776193|NCT03262233|456137326|FG002|Overall Study|Withdrawal by Subject|21|||
126776194|NCT03262233|456137327|FG003|Overall Study|Withdrawal by Subject|13|||
126776195|NCT03262233|456137324|FG000|Overall Study|Declined due to shock|1|||
126776196|NCT03262233|456137325|FG001|Overall Study|Declined due to shock|2|||
126776197|NCT03262233|456137326|FG002|Overall Study|Declined due to shock|2|||
126776198|NCT03262233|456137327|FG003|Overall Study|Declined due to shock|3|||
126776199|NCT03262233|456137324|FG000|Overall Study|Protocol Violation|5|||
126776200|NCT03262233|456137325|FG001|Overall Study|Protocol Violation|10|||
126776201|NCT03262233|456137326|FG002|Overall Study|Protocol Violation|2|||
126776202|NCT03262233|456137327|FG003|Overall Study|Protocol Violation|13|||
126776203|NCT03262233|456137324|FG000|Overall Study|data collection artifact|0|||
126776204|NCT03262233|456137325|FG001|Overall Study|data collection artifact|1|||
126776205|NCT03262233|456137326|FG002|Overall Study|data collection artifact|0|||
126776206|NCT03262233|456137327|FG003|Overall Study|data collection artifact|0|||
126776207|NCT01120600|456137330|FG000|Overall Study|Adverse Event|7|||
126776208|NCT01120600|456137331|FG001|Overall Study|Adverse Event|7|||
126776209|NCT01120600|456137330|FG000|Overall Study|Excessive Bone Loss|0|||
126776210|NCT01120600|456137331|FG001|Overall Study|Excessive Bone Loss|4|||
126776211|NCT01120600|456137330|FG000|Overall Study|Lost to Follow-up|1|||
126776212|NCT01120600|456137331|FG001|Overall Study|Lost to Follow-up|3|||
126776213|NCT01120600|456137330|FG000|Overall Study|Physician Decision|1|||
126776214|NCT01120600|456137331|FG001|Overall Study|Physician Decision|3|||
126776215|NCT01120600|456137330|FG000|Overall Study|Protocol Violation|0|||
126776216|NCT01120600|456137331|FG001|Overall Study|Protocol Violation|4|||
126776217|NCT01120600|456137330|FG000|Overall Study|Withdrawal by Subject|10|||
126776218|NCT01120600|456137331|FG001|Overall Study|Withdrawal by Subject|11|||
126776219|NCT01165242|456137332|FG000|Overall Study|Unreachable Subjects|1|||
126776220|NCT01165242|456137333|FG001|Overall Study|Unreachable Subjects|0|||
126776221|NCT01165242|456137334|FG002|Overall Study|Unreachable Subjects|0|||
126776222|NCT01165242|456137332|FG000|Overall Study|Incarcerated Subjects|0|||
126776223|NCT01165242|456137333|FG001|Overall Study|Incarcerated Subjects|1|||
126776224|NCT01165242|456137334|FG002|Overall Study|Incarcerated Subjects|0|||
126776225|NCT01165242|456137332|FG000|Overall Study|Visit 2 Declined by Subject|0|||
126776226|NCT01165242|456137333|FG001|Overall Study|Visit 2 Declined by Subject|0|||
126776227|NCT01165242|456137334|FG002|Overall Study|Visit 2 Declined by Subject|1|||
126776228|NCT01165242|456137332|FG000|Overall Study|Withdrawal by Subject|0|||
126776229|NCT01165242|456137333|FG001|Overall Study|Withdrawal by Subject|2|||
126776230|NCT01165242|456137334|FG002|Overall Study|Withdrawal by Subject|2|||
126776231|NCT01165242|456137332|FG000|Overall Study|Extended Holiday|0|||
126776232|NCT01165242|456137333|FG001|Overall Study|Extended Holiday|0|||
126776233|NCT01165242|456137334|FG002|Overall Study|Extended Holiday|1|||
126776234|NCT01165242|456137332|FG000|Overall Study|Lost to Follow-up|9|||
126776235|NCT01165242|456137333|FG001|Overall Study|Lost to Follow-up|7|||
126776236|NCT01165242|456137334|FG002|Overall Study|Lost to Follow-up|10|||
126776237|NCT03770000|456137335|FG000|Overall Study|Premature discontinuation due to PD|0|||
126776238|NCT03770000|456137336|FG001|Overall Study|Premature discontinuation due to PD|0|||
126776239|NCT03770000|456137337|FG002|Overall Study|Premature discontinuation due to PD|1|||
126776240|NCT03770000|456137338|FG003|Overall Study|Premature discontinuation due to PD|3|||
126562569|NCT01555762|455353821|FG000|Overall Study|Missing start date of infusion|8|||
126562570|NCT01555762|455353821|FG000|Overall Study|75 years old or more ticked No|1|||
126562571|NCT01555762|455353821|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
126562572|NCT01555762|455353821|FG000|Overall Study|Death linked to progression of disease|165|||
126562573|NCT01555762|455353821|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
126562574|NCT01555762|455353821|FG000|Overall Study|Investigator's decision|10|||
126562575|NCT01555762|455353821|FG000|Overall Study|Participant not wishing to continue|5|||
126562576|NCT01555762|455353821|FG000|Overall Study|Missing data|1|||
126562577|NCT01555762|455353821|FG000|Overall Study|Death linked to an adverse event|14|||
126562578|NCT02040844|455353826|FG000|Overall Study|Adverse Event|0|||
126562579|NCT02040844|455353827|FG001|Overall Study|Adverse Event|0|||
126562580|NCT02040844|455353828|FG002|Overall Study|Adverse Event|1|||
126562581|NCT02040844|455353826|FG000|Overall Study|Withdrawal by Subject|16|||
126562582|NCT02040844|455353827|FG001|Overall Study|Withdrawal by Subject|22|||
126776241|NCT03770000|456137339|FG004|Overall Study|Premature discontinuation due to PD|2|||
126776242|NCT03877237|456137340|FG000|Overall Study|Adverse Event|1|||
126776243|NCT03877237|456137341|FG001|Overall Study|Adverse Event|2|||
126776244|NCT03877237|456137340|FG000|Overall Study|Death|3|||
126776245|NCT03877237|456137341|FG001|Overall Study|Death|2|||
126562583|NCT02040844|455353828|FG002|Overall Study|Withdrawal by Subject|25|||
126562584|NCT02040844|455353826|FG000|Overall Study|Lost to Follow-up|12|||
126776246|NCT03877237|456137340|FG000|Overall Study|Physician Decision|1|||
126776247|NCT03877237|456137341|FG001|Overall Study|Physician Decision|0|||
126776248|NCT03877237|456137340|FG000|Overall Study|Withdrawal by Subject|0|||
126776249|NCT03877237|456137341|FG001|Overall Study|Withdrawal by Subject|2|||
126776250|NCT00566098|456137344|FG000|Collection of MILs|Withdrawal by Subject|1|||
126776251|NCT00566098|456137344|FG000|Collection of MILs|Relapsed|1|||
126776252|NCT00566098|456137344|FG000|Generation of MILs Product|Relapsed|1|||
126776253|NCT00566098|456137344|FG000|Administration of ASCT+MILs|Death|10|||
126776254|NCT00566098|456137344|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
126776255|NCT01690520|456137347|FG000|Overall Study|Death|25|||
126776256|NCT01690520|456137348|FG001|Overall Study|Death|21|||
126776257|NCT01690520|456137347|FG000|Overall Study|Lost to Follow-up|2|||
126776258|NCT01690520|456137348|FG001|Overall Study|Lost to Follow-up|3|||
126776259|NCT01690520|456137347|FG000|Overall Study|Withdrawal by Subject|2|||
126776260|NCT01690520|456137348|FG001|Overall Study|Withdrawal by Subject|0|||
126776261|NCT01690520|456137347|FG000|Overall Study|Relapse|0|||
126776262|NCT01690520|456137348|FG001|Overall Study|Relapse|1|||
126776263|NCT01690520|456137347|FG000|Overall Study|Other|0|||
126776264|NCT01690520|456137348|FG001|Overall Study|Other|1|||
126776265|NCT01690520|456137347|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
126776266|NCT01690520|456137348|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
126776267|NCT02236754|456137349|FG000|Overall Study|Withdrawal by Subject|1|||
126776268|NCT02236754|456137350|FG001|Overall Study|Withdrawal by Subject|0|||
126776269|NCT04006847|456137351|FG000|Overall Study|Product issue|1|||
126776270|NCT00382291|456137352|FG000|Overall Study|Adverse Event|1|||
126776271|NCT00382291|456137353|FG001|Overall Study|Adverse Event|2|||
126776272|NCT00382291|456137354|FG002|Overall Study|Adverse Event|2|||
126776273|NCT00382291|456137352|FG000|Overall Study|Protocol Violation|1|||
126776274|NCT00382291|456137353|FG001|Overall Study|Protocol Violation|0|||
126776275|NCT00382291|456137354|FG002|Overall Study|Protocol Violation|0|||
126776276|NCT00382291|456137352|FG000|Overall Study|Temporary study suspension|2|||
126776277|NCT00382291|456137353|FG001|Overall Study|Temporary study suspension|2|||
126776278|NCT00382291|456137354|FG002|Overall Study|Temporary study suspension|5|||
126776279|NCT00382291|456137352|FG000|Overall Study|Withdrawal by Subject|0|||
126776280|NCT00382291|456137353|FG001|Overall Study|Withdrawal by Subject|2|||
126776281|NCT00382291|456137354|FG002|Overall Study|Withdrawal by Subject|0|||
126776282|NCT00382291|456137352|FG000|Overall Study|Physician Decision|0|||
126776283|NCT00382291|456137353|FG001|Overall Study|Physician Decision|1|||
126776284|NCT00382291|456137354|FG002|Overall Study|Physician Decision|0|||
126776285|NCT00382291|456137352|FG000|Overall Study|Lack of Efficacy|0|||
126776286|NCT00382291|456137353|FG001|Overall Study|Lack of Efficacy|0|||
126776287|NCT00382291|456137354|FG002|Overall Study|Lack of Efficacy|1|||
126776288|NCT01375010|456137355|FG000|Overall Study|Lost to Follow-up|8|||
126776289|NCT01375010|456137356|FG001|Overall Study|Lost to Follow-up|2|||
126776290|NCT01375010|456137355|FG000|Overall Study|Withdrawal by Subject|4|||
126776291|NCT01375010|456137356|FG001|Overall Study|Withdrawal by Subject|2|||
126776292|NCT02614703|456137357|FG000|Overall Study|Withdrawal by Subject|7|||
126776293|NCT02614703|456137358|FG001|Overall Study|Withdrawal by Subject|1|||
126776294|NCT02402933|456137359|FG000|Overall Study|Withdrawal by Subject|4|||
126776295|NCT02402933|456137359|FG000|Overall Study|Discontinued; Site Termination|10|||
126776296|NCT01681771|456137364|FG000|Overall Study|Lost to Follow-up|4|||
126776297|NCT01681771|456137365|FG001|Overall Study|Lost to Follow-up|2|||
126503175|NCT04476030|455143528|FG000|Overall Study|Withdrawal by Subject|20|||
126503176|NCT04476030|455143529|FG001|Overall Study|Withdrawal by Subject|16|||
126503177|NCT04476030|455143528|FG000|Overall Study|Adverse Event|10|||
126503178|NCT04476030|455143529|FG001|Overall Study|Adverse Event|11|||
126503179|NCT04476030|455143528|FG000|Overall Study|Lost to Follow-up|7|||
126503180|NCT04476030|455143529|FG001|Overall Study|Lost to Follow-up|4|||
126503181|NCT04476030|455143528|FG000|Overall Study|Physician Decision|1|||
126503182|NCT04476030|455143529|FG001|Overall Study|Physician Decision|1|||
126503183|NCT04476030|455143528|FG000|Overall Study|Protocol Deviation|2|||
126503184|NCT04476030|455143529|FG001|Overall Study|Protocol Deviation|0|||
126503185|NCT04476030|455143528|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
126503186|NCT04476030|455143529|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
126503187|NCT04476030|455143528|FG000|Overall Study|Randomized but not Dosed|2|||
126503188|NCT04476030|455143529|FG001|Overall Study|Randomized but not Dosed|8|||
126503189|NCT02404311|455143530|FG000|Part A: Month 0-18|Death|2|||
126503190|NCT02404311|455143531|FG001|Part A: Month 0-18|Death|0|||
126503191|NCT02404311|455143532|FG002|Part A: Month 0-18|Death|0|||
126503192|NCT02404311|455143533|FG003|Part A: Month 0-18|Death|0|||
126503193|NCT02404311|455143534|FG004|Part A: Month 0-18|Death|0|||
126503194|NCT02404311|455143530|FG000|Part A: Month 0-18|Physician Decision|1|||
126503195|NCT02404311|455143531|FG001|Part A: Month 0-18|Physician Decision|0|||
126503196|NCT02404311|455143532|FG002|Part A: Month 0-18|Physician Decision|0|||
126503197|NCT02404311|455143533|FG003|Part A: Month 0-18|Physician Decision|0|||
126503198|NCT02404311|455143534|FG004|Part A: Month 0-18|Physician Decision|0|||
126503199|NCT02404311|455143530|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
126503200|NCT02404311|455143531|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
126776298|NCT02919475|456137373|FG000|Overall Study|Adverse Event|3|||
126776299|NCT02919475|456137374|FG001|Overall Study|Adverse Event|3|||
126776300|NCT02919475|456137375|FG002|Overall Study|Adverse Event|3|||
126776301|NCT02919475|456137376|FG003|Overall Study|Adverse Event|9|||
126776302|NCT02919475|456137377|FG004|Overall Study|Adverse Event|2|||
126776303|NCT02919475|456137373|FG000|Overall Study|Death|0|||
126776304|NCT02919475|456137374|FG001|Overall Study|Death|1|||
126776305|NCT02919475|456137375|FG002|Overall Study|Death|0|||
126503201|NCT02404311|455143532|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
126503202|NCT02404311|455143533|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
126503203|NCT02404311|455143534|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
126503204|NCT02404311|455143530|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
126503205|NCT02404311|455143531|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
126503206|NCT02404311|455143532|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
126503207|NCT02404311|455143533|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
126503208|NCT02404311|455143534|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
126503209|NCT02404311|455143530|FG000|Part A: Month 0-18|HIV Infection|6|||
126503210|NCT02404311|455143531|FG001|Part A: Month 0-18|HIV Infection|2|||
126503211|NCT02404311|455143532|FG002|Part A: Month 0-18|HIV Infection|0|||
126503212|NCT02404311|455143533|FG003|Part A: Month 0-18|HIV Infection|0|||
126503213|NCT02404311|455143534|FG004|Part A: Month 0-18|HIV Infection|0|||
126503214|NCT02404311|455143530|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
126503215|NCT02404311|455143531|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
126503216|NCT02404311|455143532|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
126503217|NCT02404311|455143533|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
126503218|NCT02404311|455143534|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
126503219|NCT00218296|455143535|FG000|Overall Study|Lost to Follow-up|9|||
126503220|NCT00218296|455143536|FG001|Overall Study|Lost to Follow-up|7|||
126503221|NCT00218296|455143535|FG000|Overall Study|Withdrawal by Subject|36|||
126503222|NCT00218296|455143536|FG001|Overall Study|Withdrawal by Subject|47|||
126503223|NCT00218296|455143535|FG000|Overall Study|Randomized but did not enter treatment|66|||
126503224|NCT00218296|455143536|FG001|Overall Study|Randomized but did not enter treatment|67|||
126503225|NCT02547129|455143541|FG000|Overall Study|Difficulty with ongoing infection|1|||
126503226|NCT02547129|455143542|FG001|Overall Study|Difficulty with ongoing infection|0|||
126503227|NCT00228917|455143543|FG000|Overall Study|Migrated/moved from study area|0|||
126503228|NCT00228917|455143544|FG001|Overall Study|Migrated/moved from study area|0|||
126503229|NCT00228917|455143545|FG002|Overall Study|Migrated/moved from study area|0|||
126503230|NCT00228917|455143546|FG003|Overall Study|Migrated/moved from study area|0|||
126503231|NCT00228917|455143547|FG004|Overall Study|Migrated/moved from study area|0|||
126503232|NCT00228917|455143548|FG005|Overall Study|Migrated/moved from study area|2|||
126503233|NCT00228917|455143549|FG006|Overall Study|Migrated/moved from study area|0|||
126503234|NCT00228917|455143550|FG007|Overall Study|Migrated/moved from study area|0|||
126503235|NCT00409617|455143551|FG000|Overall Study|Adverse Event|57|||
126503236|NCT00409617|455143551|FG000|Overall Study|Lack of Efficacy|54|||
126727008|NCT02198651|455951017|FG003|Lead-in Period|Other, not specified|0|||
126503237|NCT00409617|455143551|FG000|Overall Study|Lost to Follow-up|2|||
126503238|NCT00409617|455143551|FG000|Overall Study|Protocol Violation|24|||
126503239|NCT00409617|455143551|FG000|Overall Study|Withdrawal by Subject|8|||
126503240|NCT00409617|455143551|FG000|Overall Study|Administrative reasons|1|||
126503241|NCT00409617|455143551|FG000|Overall Study|Not described|14|||
126503242|NCT02159521|455143552|FG000|Overall Study|Enrolled but not treated|3|||
126503243|NCT02159521|455143552|FG000|Overall Study|Withdrawal by Subject|7|||
126503244|NCT02159521|455143552|FG000|Overall Study|Lost to Follow-up|6|||
126503245|NCT02159521|455143552|FG000|Overall Study|Death|1|||
126503246|NCT02159521|455143552|FG000|Overall Study|Other than specified|1|||
126503247|NCT00594464|455143557|FG000|Overall Study|Withdrawal by Subject|1|||
126503248|NCT00594464|455143557|FG000|Overall Study|Delay in operation|2|||
126503249|NCT00775437|455143561|FG000|Overall Study|Loss of efficacy|2|||
126727009|NCT02198651|455951018|FG004|Lead-in Period|Other, not specified|0|||
126727010|NCT02198651|455951014|FG000|Double-blind Period|Withdrew consent|0|||
126727011|NCT02198651|455951015|FG001|Double-blind Period|Withdrew consent|4|||
126727012|NCT02198651|455951016|FG002|Double-blind Period|Withdrew consent|0|||
126727013|NCT02198651|455951017|FG003|Double-blind Period|Withdrew consent|0|||
126727014|NCT02198651|455951018|FG004|Double-blind Period|Withdrew consent|0|||
126727015|NCT02198651|455951014|FG000|Double-blind Period|Adverse Event|0|||
126727016|NCT02198651|455951015|FG001|Double-blind Period|Adverse Event|1|||
126727017|NCT02198651|455951016|FG002|Double-blind Period|Adverse Event|0|||
126727018|NCT02198651|455951017|FG003|Double-blind Period|Adverse Event|0|||
126727019|NCT02198651|455951018|FG004|Double-blind Period|Adverse Event|0|||
126727020|NCT02198651|455951014|FG000|Double-blind Period|Other, not specified|0|||
126727021|NCT02198651|455951015|FG001|Double-blind Period|Other, not specified|4|||
126727022|NCT02198651|455951016|FG002|Double-blind Period|Other, not specified|1|||
126727023|NCT02198651|455951017|FG003|Double-blind Period|Other, not specified|0|||
126727024|NCT02198651|455951018|FG004|Double-blind Period|Other, not specified|0|||
126727025|NCT02198651|455951014|FG000|Open-label Rescue Period|Withdrew consent|0|||
126503250|NCT00775437|455143561|FG000|Overall Study|Withdrawal by Subject|3|||
126503251|NCT00775437|455143561|FG000|Overall Study|Lost to Follow-up|1|||
126503252|NCT01183975|455143562|FG000|Overall Study|Lost to Follow-up|73|||
126503253|NCT03131440|455143564|FG000|Overall Study|Withdrawal by Subject|1|||
126727026|NCT02198651|455951015|FG001|Open-label Rescue Period|Withdrew consent|0|||
126727027|NCT02198651|455951016|FG002|Open-label Rescue Period|Withdrew consent|0|||
126727028|NCT02198651|455951017|FG003|Open-label Rescue Period|Withdrew consent|2|||
126503254|NCT03131440|455143565|FG001|Overall Study|Withdrawal by Subject|3|||
126727029|NCT02198651|455951018|FG004|Open-label Rescue Period|Withdrew consent|0|||
126503255|NCT03131440|455143566|FG002|Overall Study|Withdrawal by Subject|0|||
126503256|NCT03131440|455143567|FG003|Overall Study|Withdrawal by Subject|0|||
126503257|NCT03131440|455143568|FG004|Overall Study|Withdrawal by Subject|1|||
126503258|NCT03131440|455143569|FG005|Overall Study|Withdrawal by Subject|0|||
126503259|NCT03131440|455143570|FG006|Overall Study|Withdrawal by Subject|0|||
126503260|NCT03131440|455143571|FG007|Overall Study|Withdrawal by Subject|1|||
126503261|NCT03131440|455143572|FG008|Overall Study|Withdrawal by Subject|1|||
126503262|NCT03131440|455143573|FG009|Overall Study|Withdrawal by Subject|1|||
126503263|NCT03131440|455143574|FG010|Overall Study|Withdrawal by Subject|0|||
126503264|NCT03131440|455143575|FG011|Overall Study|Withdrawal by Subject|1|||
126503265|NCT03131440|455143576|FG012|Overall Study|Withdrawal by Subject|1|||
126503266|NCT03131440|455143577|FG013|Overall Study|Withdrawal by Subject|0|||
126503267|NCT03131440|455143578|FG014|Overall Study|Withdrawal by Subject|1|||
126503268|NCT03131440|455143579|FG015|Overall Study|Withdrawal by Subject|0|||
126503269|NCT03131440|455143580|FG016|Overall Study|Withdrawal by Subject|0|||
126503270|NCT03131440|455143581|FG017|Overall Study|Withdrawal by Subject|0|||
126503271|NCT03131440|455143582|FG018|Overall Study|Withdrawal by Subject|1|||
126503272|NCT03131440|455143583|FG019|Overall Study|Withdrawal by Subject|0|||
126503273|NCT03131440|455143584|FG020|Overall Study|Withdrawal by Subject|1|||
126503274|NCT03131440|455143585|FG021|Overall Study|Withdrawal by Subject|1|||
126503275|NCT03131440|455143586|FG022|Overall Study|Withdrawal by Subject|1|||
126503276|NCT03131440|455143587|FG023|Overall Study|Withdrawal by Subject|0|||
126503277|NCT03131440|455143588|FG024|Overall Study|Withdrawal by Subject|0|||
126503278|NCT03131440|455143589|FG025|Overall Study|Withdrawal by Subject|0|||
126503279|NCT03131440|455143590|FG026|Overall Study|Withdrawal by Subject|0|||
126503280|NCT03131440|455143591|FG027|Overall Study|Withdrawal by Subject|0|||
126503281|NCT03131440|455143592|FG028|Overall Study|Withdrawal by Subject|0|||
126503282|NCT03131440|455143593|FG029|Overall Study|Withdrawal by Subject|0|||
126503283|NCT03131440|455143594|FG030|Overall Study|Withdrawal by Subject|1|||
126503284|NCT03131440|455143595|FG031|Overall Study|Withdrawal by Subject|0|||
126503285|NCT03131440|455143564|FG000|Overall Study|Lost to Follow-up|0|||
126503286|NCT03131440|455143565|FG001|Overall Study|Lost to Follow-up|0|||
126503287|NCT03131440|455143566|FG002|Overall Study|Lost to Follow-up|0|||
126503288|NCT03131440|455143567|FG003|Overall Study|Lost to Follow-up|0|||
126503289|NCT03131440|455143568|FG004|Overall Study|Lost to Follow-up|0|||
126503290|NCT03131440|455143569|FG005|Overall Study|Lost to Follow-up|1|||
126503291|NCT03131440|455143570|FG006|Overall Study|Lost to Follow-up|0|||
126503292|NCT03131440|455143571|FG007|Overall Study|Lost to Follow-up|0|||
126503293|NCT03131440|455143572|FG008|Overall Study|Lost to Follow-up|0|||
126503294|NCT03131440|455143573|FG009|Overall Study|Lost to Follow-up|0|||
126503295|NCT03131440|455143574|FG010|Overall Study|Lost to Follow-up|0|||
126503296|NCT03131440|455143575|FG011|Overall Study|Lost to Follow-up|0|||
126503297|NCT03131440|455143576|FG012|Overall Study|Lost to Follow-up|0|||
126503298|NCT03131440|455143577|FG013|Overall Study|Lost to Follow-up|0|||
126503299|NCT03131440|455143578|FG014|Overall Study|Lost to Follow-up|0|||
126503300|NCT03131440|455143579|FG015|Overall Study|Lost to Follow-up|0|||
126503301|NCT03131440|455143580|FG016|Overall Study|Lost to Follow-up|0|||
126503302|NCT03131440|455143581|FG017|Overall Study|Lost to Follow-up|0|||
126503303|NCT03131440|455143582|FG018|Overall Study|Lost to Follow-up|0|||
126503304|NCT03131440|455143583|FG019|Overall Study|Lost to Follow-up|2|||
126503305|NCT03131440|455143584|FG020|Overall Study|Lost to Follow-up|1|||
126503306|NCT03131440|455143585|FG021|Overall Study|Lost to Follow-up|0|||
126503307|NCT03131440|455143586|FG022|Overall Study|Lost to Follow-up|1|||
126503308|NCT03131440|455143587|FG023|Overall Study|Lost to Follow-up|0|||
126503309|NCT03131440|455143588|FG024|Overall Study|Lost to Follow-up|1|||
126503310|NCT03131440|455143589|FG025|Overall Study|Lost to Follow-up|0|||
126503311|NCT03131440|455143590|FG026|Overall Study|Lost to Follow-up|0|||
126503312|NCT03131440|455143591|FG027|Overall Study|Lost to Follow-up|2|||
126503313|NCT03131440|455143592|FG028|Overall Study|Lost to Follow-up|0|||
126503314|NCT03131440|455143593|FG029|Overall Study|Lost to Follow-up|2|||
126503315|NCT03131440|455143594|FG030|Overall Study|Lost to Follow-up|0|||
126503316|NCT03131440|455143595|FG031|Overall Study|Lost to Follow-up|0|||
126503317|NCT03131440|455143564|FG000|Overall Study|Death|0|||
126503318|NCT03131440|455143565|FG001|Overall Study|Death|0|||
126503319|NCT03131440|455143566|FG002|Overall Study|Death|0|||
126503320|NCT03131440|455143567|FG003|Overall Study|Death|0|||
126503321|NCT03131440|455143568|FG004|Overall Study|Death|0|||
126503322|NCT03131440|455143569|FG005|Overall Study|Death|0|||
126503323|NCT03131440|455143570|FG006|Overall Study|Death|0|||
126503324|NCT03131440|455143571|FG007|Overall Study|Death|0|||
126503325|NCT03131440|455143572|FG008|Overall Study|Death|0|||
126503326|NCT03131440|455143573|FG009|Overall Study|Death|0|||
126503327|NCT03131440|455143574|FG010|Overall Study|Death|0|||
126503328|NCT03131440|455143575|FG011|Overall Study|Death|0|||
126503329|NCT03131440|455143576|FG012|Overall Study|Death|0|||
126503330|NCT03131440|455143577|FG013|Overall Study|Death|0|||
126503331|NCT03131440|455143578|FG014|Overall Study|Death|0|||
126503332|NCT03131440|455143579|FG015|Overall Study|Death|0|||
126503333|NCT03131440|455143580|FG016|Overall Study|Death|0|||
126503334|NCT03131440|455143581|FG017|Overall Study|Death|0|||
126503335|NCT03131440|455143582|FG018|Overall Study|Death|0|||
126503336|NCT03131440|455143583|FG019|Overall Study|Death|0|||
126503337|NCT03131440|455143584|FG020|Overall Study|Death|0|||
126503338|NCT03131440|455143585|FG021|Overall Study|Death|0|||
126503339|NCT03131440|455143586|FG022|Overall Study|Death|0|||
126503340|NCT03131440|455143587|FG023|Overall Study|Death|0|||
126503341|NCT03131440|455143588|FG024|Overall Study|Death|0|||
126503342|NCT03131440|455143589|FG025|Overall Study|Death|1|||
126503343|NCT03131440|455143590|FG026|Overall Study|Death|0|||
126503344|NCT03131440|455143591|FG027|Overall Study|Death|0|||
126503345|NCT03131440|455143592|FG028|Overall Study|Death|0|||
126503346|NCT03131440|455143593|FG029|Overall Study|Death|0|||
126503347|NCT03131440|455143594|FG030|Overall Study|Death|0|||
126503348|NCT03131440|455143595|FG031|Overall Study|Death|0|||
126503349|NCT00746941|455143598|FG000|Overall Study|Death|2|||
126503350|NCT00746941|455143599|FG001|Overall Study|Death|0|||
126503351|NCT00746941|455143600|FG002|Overall Study|Death|0|||
126503352|NCT00746941|455143601|FG003|Overall Study|Death|6|||
126503353|NCT00746941|455143598|FG000|Overall Study|Physician Decision|0|||
126503354|NCT00746941|455143599|FG001|Overall Study|Physician Decision|0|||
126503355|NCT00746941|455143600|FG002|Overall Study|Physician Decision|2|||
126503356|NCT00746941|455143601|FG003|Overall Study|Physician Decision|0|||
126503357|NCT00746941|455143598|FG000|Overall Study|Withdrawal by Subject|3|||
126503358|NCT00746941|455143599|FG001|Overall Study|Withdrawal by Subject|0|||
126503359|NCT00746941|455143600|FG002|Overall Study|Withdrawal by Subject|0|||
126503360|NCT00746941|455143601|FG003|Overall Study|Withdrawal by Subject|2|||
126503361|NCT00746941|455143598|FG000|Overall Study|Other, reason not provided|2|||
126503362|NCT00746941|455143599|FG001|Overall Study|Other, reason not provided|4|||
126503363|NCT00746941|455143600|FG002|Overall Study|Other, reason not provided|0|||
126503364|NCT00746941|455143601|FG003|Overall Study|Other, reason not provided|4|||
126776306|NCT02919475|456137376|FG003|Overall Study|Death|0|||
126503365|NCT00746941|455143598|FG000|Overall Study|Adverse Event|0|||
126503366|NCT00746941|455143599|FG001|Overall Study|Adverse Event|0|||
126503367|NCT00746941|455143600|FG002|Overall Study|Adverse Event|0|||
126503368|NCT00746941|455143601|FG003|Overall Study|Adverse Event|1|||
126503369|NCT03316885|455143602|FG000|Overall Study|Adverse Event|1|||
126503370|NCT03316885|455143602|FG000|Overall Study|Death|10|||
126503371|NCT03316885|455143602|FG000|Overall Study|Lost to Follow-up|4|||
126503372|NCT03316885|455143602|FG000|Overall Study|Withdrawal by Subject|9|||
126503373|NCT03316885|455143602|FG000|Overall Study|COVID related|8|||
126503374|NCT03216850|455143608|FG000|Overall Study|Pre-analytical error|6|||
126503375|NCT00405548|455143609|FG000|Overall Study|Cognitive Memory problems on study day|1|||
126503376|NCT00405548|455143610|FG001|Overall Study|Cognitive Memory problems on study day|0|||
126503377|NCT00405548|455143609|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
126503378|NCT00405548|455143610|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
126503379|NCT00405548|455143609|FG000|Overall Study|Unable to self-administer shots|1|||
126503380|NCT00405548|455143610|FG001|Overall Study|Unable to self-administer shots|0|||
126503381|NCT00405548|455143609|FG000|Overall Study|Venous access failed during study day|1|||
126503382|NCT00405548|455143610|FG001|Overall Study|Venous access failed during study day|0|||
126503383|NCT00405548|455143609|FG000|Overall Study|Withdrawal by Subject|1|||
126503384|NCT00405548|455143610|FG001|Overall Study|Withdrawal by Subject|0|||
126503385|NCT00923559|455143611|FG000|Overall Study|Lost to Follow-up|2|||
126503386|NCT00923559|455143612|FG001|Overall Study|Lost to Follow-up|3|||
126503387|NCT01148511|455143616|FG000|Exposed to Study Drug|Protocol Violation|2|||
126503388|NCT01148511|455143617|FG001|Exposed to Study Drug|Protocol Violation|0|||
126503389|NCT01148511|455143618|FG002|Exposed to Study Drug|Protocol Violation|0|||
126503390|NCT01148511|455143616|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
126503391|NCT01148511|455143617|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
126503392|NCT01148511|455143618|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
126503393|NCT01148511|455143616|FG000|Randomized|Adverse Event|0|||
126503394|NCT01148511|455143617|FG001|Randomized|Adverse Event|1|||
126503395|NCT01148511|455143618|FG002|Randomized|Adverse Event|0|||
126503396|NCT01148511|455143616|FG000|Randomized|Protocol Violation|0|||
126503397|NCT01148511|455143617|FG001|Randomized|Protocol Violation|2|||
126503398|NCT01148511|455143618|FG002|Randomized|Protocol Violation|1|||
126503399|NCT01148511|455143616|FG000|Randomized|Lost to Follow-up|0|||
126503400|NCT01148511|455143617|FG001|Randomized|Lost to Follow-up|1|||
126503401|NCT01148511|455143618|FG002|Randomized|Lost to Follow-up|1|||
126503402|NCT01148511|455143616|FG000|Randomized|Consent withdrawal|0|||
126503403|NCT01148511|455143617|FG001|Randomized|Consent withdrawal|5|||
126562585|NCT02040844|455353827|FG001|Overall Study|Lost to Follow-up|9|||
126776307|NCT02919475|456137377|FG004|Overall Study|Death|0|||
126503404|NCT01148511|455143618|FG002|Randomized|Consent withdrawal|3|||
126503405|NCT01148511|455143616|FG000|Randomized|Other|0|||
126503406|NCT01148511|455143617|FG001|Randomized|Other|1|||
126503407|NCT01148511|455143618|FG002|Randomized|Other|1|||
126503408|NCT04258605|455143621|FG000|Overall Study|Death|1|||
126503409|NCT04258605|455143622|FG001|Overall Study|Death|0|||
126503410|NCT04258605|455143621|FG000|Overall Study|Early study termination|21|||
126503411|NCT04258605|455143622|FG001|Overall Study|Early study termination|2|||
126562586|NCT02040844|455353828|FG002|Overall Study|Lost to Follow-up|13|||
126562587|NCT02040844|455353826|FG000|Overall Study|Missing|13|||
126562588|NCT02040844|455353827|FG001|Overall Study|Missing|3|||
126562589|NCT02040844|455353828|FG002|Overall Study|Missing|2|||
126562590|NCT02040844|455353826|FG000|Overall Study|Non-specified|8|||
126562591|NCT02040844|455353827|FG001|Overall Study|Non-specified|2|||
126562592|NCT02040844|455353828|FG002|Overall Study|Non-specified|5|||
126562593|NCT02040844|455353826|FG000|Overall Study|Concomitant medication|1|||
126562594|NCT02040844|455353827|FG001|Overall Study|Concomitant medication|3|||
126562595|NCT02040844|455353828|FG002|Overall Study|Concomitant medication|1|||
126562596|NCT01560949|455353831|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
126562597|NCT01560949|455353831|FG000|Surgery Phase|Physician Decision|3|||
126562598|NCT02068885|455353836|FG000|Overall Study|Withdrew|3|||
126562599|NCT02068885|455353837|FG001|Overall Study|Withdrew|5|||
126562600|NCT02068885|455353838|FG002|Overall Study|Withdrew|8|||
126562601|NCT00681811|455353839|FG000|Overall Study|Adverse Event|1|||
126562602|NCT00681811|455353840|FG001|Overall Study|Adverse Event|1|||
126562603|NCT00681811|455353839|FG000|Overall Study|Withdrawal by Subject|2|||
126562604|NCT00681811|455353840|FG001|Overall Study|Withdrawal by Subject|2|||
126562605|NCT00681811|455353839|FG000|Overall Study|Non-compliance|0|||
126562606|NCT00681811|455353840|FG001|Overall Study|Non-compliance|1|||
126562607|NCT01562743|455353846|FG000|Overall Study|Adverse Event|29|||
126562608|NCT01562743|455353846|FG000|Overall Study|Lack of Efficacy|3|||
126562609|NCT01562743|455353846|FG000|Overall Study|Withdrawal by Subject|13|||
126562610|NCT01562743|455353846|FG000|Overall Study|Protocol Violation|1|||
126562611|NCT01562743|455353846|FG000|Overall Study|Discontinuation criteria|2|||
126562612|NCT01562743|455353846|FG000|Overall Study|Lost to Follow-up|2|||
126562613|NCT01562743|455353846|FG000|Overall Study|Physician Decision|2|||
126562614|NCT03015740|455353847|FG000|Overall Study|Adverse Event|1|||
126562615|NCT03015740|455353848|FG001|Overall Study|Adverse Event|0|||
126562616|NCT03015740|455353849|FG002|Overall Study|Adverse Event|0|||
126562617|NCT03015740|455353847|FG000|Overall Study|Death|3|||
126562618|NCT03015740|455353848|FG001|Overall Study|Death|5|||
126562619|NCT03015740|455353849|FG002|Overall Study|Death|0|||
126562620|NCT03015740|455353847|FG000|Overall Study|Withdrawal by Subject|2|||
126562621|NCT03015740|455353848|FG001|Overall Study|Withdrawal by Subject|0|||
126562622|NCT03015740|455353849|FG002|Overall Study|Withdrawal by Subject|0|||
126562623|NCT02449044|455353850|FG000|Overall Study|Lost to Follow-up|2|||
126562624|NCT02449044|455353850|FG000|Overall Study|Withdrawal by Subject|13|||
126562625|NCT02449044|455353850|FG000|Overall Study|Adverse Event|30|||
126562626|NCT02449044|455353850|FG000|Overall Study|Met Withdrawal Criteria|7|||
126562627|NCT02449044|455353850|FG000|Overall Study|Physician Decision|9|||
126562628|NCT02449044|455353850|FG000|Overall Study|Sponsor Discontinued Trial|3|||
126640403|NCT03926195|455642771|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
126640404|NCT03926195|455642772|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
126640405|NCT03926195|455642771|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
126640406|NCT03926195|455642772|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
126640407|NCT03926195|455642771|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
126640408|NCT03926195|455642772|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
126640409|NCT03926195|455642771|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
126640410|NCT03926195|455642772|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
126640411|NCT03926195|455642771|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
126640412|NCT03926195|455642772|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
126640413|NCT03926195|455642771|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
126640414|NCT03926195|455642772|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
126640415|NCT01736540|455642773|FG000|Overall Study|Did not complete scan within 45 days|2|||
126640416|NCT01736540|455642773|FG000|Overall Study|Death|1|||
126640417|NCT01736540|455642773|FG000|Overall Study|Abnormal test procedure|1|||
126640418|NCT01736540|455642773|FG000|Overall Study|Withdrawal by Subject|5|||
126640419|NCT01736540|455642773|FG000|Overall Study|Protocol Violation|1|||
126640420|NCT01736540|455642773|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
126640421|NCT01736540|455642773|FG000|Overall Study|No show for MRI appointment|1|||
126640422|NCT01736540|455642773|FG000|Overall Study|Unable to make MRI appointment|3|||
126640423|NCT00479882|455642774|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
126640424|NCT00479882|455642775|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
126640425|NCT00479882|455642776|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
126640426|NCT00479882|455642777|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
126640427|NCT00479882|455642774|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
126640428|NCT00479882|455642775|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
126640429|NCT00479882|455642776|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
126640430|NCT00479882|455642777|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
126640431|NCT00479882|455642774|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
126640432|NCT00479882|455642775|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
126640433|NCT00479882|455642776|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
126776308|NCT02919475|456137373|FG000|Overall Study|Lost to Follow-up|0|||
126503412|NCT02818777|455143627|FG000|Overall Study|Adverse Event|3|||
126503413|NCT00856908|455143632|FG000|Overall Study|Lost to Follow-up|1|||
126503414|NCT00856908|455143633|FG001|Overall Study|Lost to Follow-up|0|||
126503415|NCT00962104|455143635|FG000|Overall Study|Adverse Event|10|||
126503416|NCT00962104|455143636|FG001|Overall Study|Adverse Event|3|||
126503417|NCT00962104|455143635|FG000|Overall Study|Entry Criteria Not Met|1|||
126503418|NCT00962104|455143636|FG001|Overall Study|Entry Criteria Not Met|2|||
126503419|NCT00962104|455143635|FG000|Overall Study|Lack of Efficacy|0|||
126503420|NCT00962104|455143636|FG001|Overall Study|Lack of Efficacy|1|||
126503421|NCT00962104|455143635|FG000|Overall Study|Lost to Follow-up|10|||
126503422|NCT00962104|455143636|FG001|Overall Study|Lost to Follow-up|4|||
126503423|NCT00962104|455143635|FG000|Overall Study|Physician Decision|1|||
126503424|NCT00962104|455143636|FG001|Overall Study|Physician Decision|0|||
126503425|NCT00962104|455143635|FG000|Overall Study|Protocol Violation|6|||
126776309|NCT02919475|456137374|FG001|Overall Study|Lost to Follow-up|0|||
126776310|NCT02919475|456137375|FG002|Overall Study|Lost to Follow-up|0|||
126776311|NCT02919475|456137376|FG003|Overall Study|Lost to Follow-up|1|||
126776312|NCT02919475|456137377|FG004|Overall Study|Lost to Follow-up|0|||
126776313|NCT02919475|456137373|FG000|Overall Study|Withdrawal by Subject|2|||
126776314|NCT02919475|456137374|FG001|Overall Study|Withdrawal by Subject|3|||
126776315|NCT02919475|456137375|FG002|Overall Study|Withdrawal by Subject|1|||
126776316|NCT02919475|456137376|FG003|Overall Study|Withdrawal by Subject|2|||
126776317|NCT02919475|456137377|FG004|Overall Study|Withdrawal by Subject|2|||
126776318|NCT02919475|456137373|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
126776319|NCT02919475|456137374|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
126776320|NCT02919475|456137375|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
126776321|NCT02919475|456137376|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
126776322|NCT02919475|456137377|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126776323|NCT00775983|456137381|FG000|Overall Study|Protocol Violation|1|||
126776324|NCT00775983|456137382|FG001|Overall Study|Protocol Violation|2|||
126776325|NCT02762565|456137383|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
126776326|NCT00623623|456137384|FG000|Overall Study|Previous enrolment into this study|1|||
126776327|NCT00623623|456137385|FG001|Overall Study|Previous enrolment into this study|1|||
126503426|NCT00962104|455143636|FG001|Overall Study|Protocol Violation|8|||
126503427|NCT00962104|455143635|FG000|Overall Study|Sponsor Decision|0|||
126503428|NCT00962104|455143636|FG001|Overall Study|Sponsor Decision|1|||
126503429|NCT00962104|455143635|FG000|Overall Study|Withdrawal by Subject|10|||
126503430|NCT00962104|455143636|FG001|Overall Study|Withdrawal by Subject|6|||
126503431|NCT00962104|455143635|FG000|Overall Study|Other|2|||
126503432|NCT00962104|455143636|FG001|Overall Study|Other|0|||
126503433|NCT01113879|455143639|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
126503434|NCT01113879|455143640|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
126503435|NCT03913091|455143641|FG000|Overall Study|Lost to Follow-up|18|||
126503436|NCT03913091|455143642|FG001|Overall Study|Lost to Follow-up|11|||
126503437|NCT03913091|455143641|FG000|Overall Study|Required additional meds/surgery|1|||
126503438|NCT03913091|455143642|FG001|Overall Study|Required additional meds/surgery|2|||
126503439|NCT03913091|455143641|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
126503440|NCT03913091|455143642|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
126503441|NCT02196324|455143643|FG000|Overall Study|Withdrawal by Subject|8|||
126503442|NCT02196324|455143644|FG001|Overall Study|Withdrawal by Subject|4|||
126503443|NCT02196324|455143643|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
126503444|NCT02196324|455143644|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
126503445|NCT02196324|455143643|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
126503446|NCT02196324|455143644|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
126503447|NCT02196324|455143643|FG000|Overall Study|Other|1|||
126503448|NCT02196324|455143644|FG001|Overall Study|Other|0|||
126503449|NCT00692770|455143645|FG000|Overall Study|Protocol Violation|2|||
126503450|NCT00692770|455143646|FG001|Overall Study|Protocol Violation|7|||
126503451|NCT00692770|455143645|FG000|Overall Study|Withdrawal by Subject|97|||
126503452|NCT00692770|455143646|FG001|Overall Study|Withdrawal by Subject|36|||
126503453|NCT00692770|455143645|FG000|Overall Study|Adverse Event|136|||
126503454|NCT00692770|455143646|FG001|Overall Study|Adverse Event|41|||
126503455|NCT00692770|455143645|FG000|Overall Study|Death|10|||
126503456|NCT00692770|455143646|FG001|Overall Study|Death|5|||
126503457|NCT00692770|455143645|FG000|Overall Study|Lost to Follow-up|7|||
126503458|NCT00692770|455143646|FG001|Overall Study|Lost to Follow-up|3|||
126503459|NCT00692770|455143645|FG000|Overall Study|Non-compliant with study medication|11|||
126562629|NCT02624778|455355796|FG000|Overall Study|Lost to Follow-up|0|||
126776328|NCT02499354|456137386|FG000|Overall Study|Withdrawal by Subject|1|||
126776329|NCT02499354|456137387|FG001|Overall Study|Withdrawal by Subject|0|||
126776330|NCT00447603|456137389|FG000|Screening|Withdrawal by Subject|1|||
126503460|NCT00692770|455143646|FG001|Overall Study|Non-compliant with study medication|5|||
126503461|NCT00692770|455143645|FG000|Overall Study|Progression by clinical judgment|2|||
126503462|NCT00692770|455143646|FG001|Overall Study|Progression by clinical judgment|3|||
126503463|NCT00692770|455143645|FG000|Overall Study|Physician decision not protocol driven|10|||
126503464|NCT00692770|455143646|FG001|Overall Study|Physician decision not protocol driven|14|||
126503465|NCT00692770|455143645|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
126503466|NCT00692770|455143646|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
126503467|NCT00692770|455143645|FG000|Overall Study|Protocol driven decision point|3|||
126503468|NCT00692770|455143646|FG001|Overall Study|Protocol driven decision point|7|||
126503469|NCT00692770|455143645|FG000|Overall Study|Completed all planned assessments|79|||
126503470|NCT00692770|455143646|FG001|Overall Study|Completed all planned assessments|101|||
126503471|NCT00692770|455143645|FG000|Overall Study|Radiological and clinical progression|8|||
126503472|NCT00692770|455143646|FG001|Overall Study|Radiological and clinical progression|8|||
126503473|NCT00692770|455143645|FG000|Overall Study|Clinical endpoint reached|16|||
126727030|NCT02198651|455951014|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
126727031|NCT02198651|455951015|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
126727032|NCT02198651|455951016|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
126727033|NCT02198651|455951017|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
126503474|NCT00692770|455143646|FG001|Overall Study|Clinical endpoint reached|43|||
126503475|NCT00692770|455143645|FG000|Overall Study|Study terminated by sponsor|2|||
126503476|NCT00692770|455143646|FG001|Overall Study|Study terminated by sponsor|2|||
126503477|NCT00692770|455143645|FG000|Overall Study|Randomized but not treated|3|||
126503478|NCT00692770|455143646|FG001|Overall Study|Randomized but not treated|4|||
126503479|NCT04248816|455143647|FG000|Overall Study|Ineligible post-randomization|7|||
126503480|NCT04248816|455143648|FG001|Overall Study|Ineligible post-randomization|21|||
126503481|NCT04248816|455143649|FG002|Overall Study|Ineligible post-randomization|25|||
126503482|NCT04327986|455143650|FG000|Overall Study|Physician Decision|2|||
126503483|NCT04327986|455143651|FG001|Overall Study|Physician Decision|0|||
126503484|NCT04327986|455143652|FG002|Overall Study|Physician Decision|0|||
126503485|NCT04327986|455143650|FG000|Overall Study|Death|1|||
126503486|NCT04327986|455143651|FG001|Overall Study|Death|0|||
126503487|NCT04327986|455143652|FG002|Overall Study|Death|0|||
126503488|NCT01077804|455143653|FG000|Overall Study|Unreachable|102|||
126503489|NCT01077804|455143653|FG000|Overall Study|Refused to continue|79|||
126503490|NCT01077804|455143653|FG000|Overall Study|Other|18|||
126503491|NCT02620046|455143654|FG000|Overall Study|Adverse Event|22|||
126503492|NCT02620046|455143655|FG001|Overall Study|Adverse Event|42|||
126503493|NCT02620046|455143654|FG000|Overall Study|Lost to Follow-up|4|||
126503494|NCT02620046|455143655|FG001|Overall Study|Lost to Follow-up|10|||
126503495|NCT02620046|455143654|FG000|Overall Study|Withdrawal by Subject|36|||
126503496|NCT02620046|455143655|FG001|Overall Study|Withdrawal by Subject|66|||
126503497|NCT02620046|455143654|FG000|Overall Study|Site Termination|3|||
126503498|NCT02620046|455143655|FG001|Overall Study|Site Termination|3|||
126503499|NCT02620046|455143654|FG000|Overall Study|Pregnancy|3|||
126503500|NCT02620046|455143655|FG001|Overall Study|Pregnancy|7|||
126503501|NCT02620046|455143654|FG000|Overall Study|Lack of Efficacy|81|||
126503502|NCT02620046|455143655|FG001|Overall Study|Lack of Efficacy|146|||
126503503|NCT02620046|455143654|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
126503504|NCT02620046|455143655|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
126503505|NCT02620046|455143654|FG000|Overall Study|Reason Not Specified|13|||
126503506|NCT02620046|455143655|FG001|Overall Study|Reason Not Specified|21|||
126503507|NCT02620046|455143654|FG000|Overall Study|Significant Protocol Deviation|0|||
126503508|NCT02620046|455143655|FG001|Overall Study|Significant Protocol Deviation|1|||
126503509|NCT01714310|455145089|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
126503510|NCT01714310|455145090|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
126503511|NCT01714310|455145091|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
126503512|NCT01714310|455145089|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
126503513|NCT01714310|455145090|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
126503514|NCT01714310|455145091|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
126503515|NCT01714310|455145089|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
126503516|NCT01714310|455145090|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
126503517|NCT01714310|455145091|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
126503518|NCT01714310|455145089|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
126503519|NCT01714310|455145090|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
126503520|NCT01714310|455145091|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
126503521|NCT00654381|455145096|FG000|1st Stage|Adverse Event|3|||
126503522|NCT00654381|455145097|FG001|1st Stage|Adverse Event|3|||
126503523|NCT00654381|455145098|FG002|1st Stage|Adverse Event|3|||
126503524|NCT00654381|455145099|FG003|1st Stage|Adverse Event|3|||
126562630|NCT02624778|455355797|FG001|Overall Study|Lost to Follow-up|0|||
126562631|NCT02624778|455355798|FG002|Overall Study|Lost to Follow-up|1|||
126503525|NCT00654381|455145100|FG004|1st Stage|Adverse Event|2|||
126503526|NCT00654381|455145101|FG005|1st Stage|Adverse Event|1|||
126503527|NCT00654381|455145096|FG000|1st Stage|Withdrawal by Subject|0|||
126503528|NCT00654381|455145097|FG001|1st Stage|Withdrawal by Subject|0|||
126503529|NCT00654381|455145098|FG002|1st Stage|Withdrawal by Subject|0|||
126503530|NCT00654381|455145099|FG003|1st Stage|Withdrawal by Subject|1|||
126503531|NCT00654381|455145100|FG004|1st Stage|Withdrawal by Subject|0|||
126503532|NCT00654381|455145101|FG005|1st Stage|Withdrawal by Subject|1|||
126776331|NCT00447603|456137390|FG001|Screening|Withdrawal by Subject|0|||
126776332|NCT00447603|456137391|FG002|Screening|Withdrawal by Subject|0|||
126776333|NCT00447603|456137389|FG000|Screening|Protocol Violation|1|||
126776334|NCT00447603|456137390|FG001|Screening|Protocol Violation|0|||
126776335|NCT00447603|456137391|FG002|Screening|Protocol Violation|0|||
126776336|NCT00447603|456137389|FG000|Screening|Screen Failure|4|||
126776337|NCT00447603|456137390|FG001|Screening|Screen Failure|0|||
126776338|NCT00447603|456137391|FG002|Screening|Screen Failure|0|||
126776339|NCT00447603|456137389|FG000|Screening|Study Terminated by Sponsor|15|||
126776340|NCT00447603|456137390|FG001|Screening|Study Terminated by Sponsor|0|||
126776341|NCT00447603|456137391|FG002|Screening|Study Terminated by Sponsor|0|||
126776342|NCT00447603|456137389|FG000|Filter Period|Adverse Event|0|||
126776343|NCT00447603|456137390|FG001|Filter Period|Adverse Event|0|||
126776344|NCT00447603|456137391|FG002|Filter Period|Adverse Event|1|||
126776345|NCT00447603|456137389|FG000|Filter Period|Screen Failure|0|||
126776346|NCT00447603|456137390|FG001|Filter Period|Screen Failure|3|||
126776347|NCT00447603|456137391|FG002|Filter Period|Screen Failure|4|||
126776348|NCT00447603|456137389|FG000|Filter Period|Study terminated by Sponsor|0|||
126776349|NCT00447603|456137390|FG001|Filter Period|Study terminated by Sponsor|1|||
126776350|NCT00447603|456137391|FG002|Filter Period|Study terminated by Sponsor|10|||
126776351|NCT01427920|456137394|FG000|Overall Study|Adverse Event|1|||
126776352|NCT01427920|456137395|FG001|Overall Study|Adverse Event|2|||
126776353|NCT01427920|456137394|FG000|Overall Study|Lack of Efficacy|1|||
126776354|NCT01427920|456137395|FG001|Overall Study|Lack of Efficacy|0|||
126776355|NCT01427920|456137394|FG000|Overall Study|Protocol Violation|1|||
126776356|NCT01427920|456137395|FG001|Overall Study|Protocol Violation|3|||
126776357|NCT01427920|456137394|FG000|Overall Study|Withdrawal Criteria|4|||
126776358|NCT01427920|456137395|FG001|Overall Study|Withdrawal Criteria|4|||
126776359|NCT01427920|456137394|FG000|Overall Study|Unclassified|2|||
126776360|NCT01427920|456137395|FG001|Overall Study|Unclassified|8|||
126776361|NCT02732561|456137397|FG000|Overall Study|Lost to Follow-up|1|||
126776362|NCT02732561|456137398|FG001|Overall Study|Lost to Follow-up|1|||
126776363|NCT02732561|456137397|FG000|Overall Study|Withdrawal by Subject|1|||
126776364|NCT02732561|456137398|FG001|Overall Study|Withdrawal by Subject|0|||
126776365|NCT02410837|456137405|FG000|Overall Study|Death|387|||
126776366|NCT02410837|456137405|FG000|Overall Study|Lost to Follow-up|50|||
126776367|NCT02410837|456137405|FG000|Overall Study|Withdrawal by Subject|44|||
126776368|NCT02410837|456137405|FG000|Overall Study|Physician Decision|6|||
126776369|NCT02410837|456137405|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
126776370|NCT00837577|456137406|FG000|Double-blind Period|Clinical Adverse Event|1|||
126776371|NCT00837577|456137407|FG001|Double-blind Period|Clinical Adverse Event|0|||
126776372|NCT00837577|456137406|FG000|Double-blind Period|Withdrawal by Subject|1|||
126776373|NCT00837577|456137407|FG001|Double-blind Period|Withdrawal by Subject|0|||
126776374|NCT00837577|456137406|FG000|Open-label Period|Clinical Adverse Event|2|||
126776375|NCT00837577|456137407|FG001|Open-label Period|Clinical Adverse Event|2|||
126776376|NCT00837577|456137406|FG000|Open-label Period|Laboratory Adverse Event|0|||
126776377|NCT00837577|456137407|FG001|Open-label Period|Laboratory Adverse Event|1|||
126776378|NCT00837577|456137406|FG000|Open-label Period|Lack of Efficacy|4|||
126776379|NCT00837577|456137407|FG001|Open-label Period|Lack of Efficacy|3|||
126776380|NCT00837577|456137406|FG000|Open-label Period|Withdrawal by Subject|1|||
126776381|NCT00837577|456137407|FG001|Open-label Period|Withdrawal by Subject|2|||
126776382|NCT00837577|456137406|FG000|Open-label Period|Other Reason|1|||
126776383|NCT00837577|456137407|FG001|Open-label Period|Other Reason|1|||
126776384|NCT00272961|456137412|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
126776385|NCT00272961|456137413|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
126776386|NCT00272961|456137414|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
126776387|NCT00272961|456137415|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
126776388|NCT00272961|456137416|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
126776389|NCT00272961|456137412|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
126776390|NCT00272961|456137413|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
126776391|NCT00272961|456137414|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
126776392|NCT00272961|456137415|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
126776393|NCT00272961|456137416|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
126776394|NCT00272961|456137412|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
126776395|NCT00272961|456137413|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
126776396|NCT00272961|456137414|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
126503533|NCT00654381|455145096|FG000|1st Stage|Investigator's decision|0|||
126503534|NCT00654381|455145097|FG001|1st Stage|Investigator's decision|0|||
126503535|NCT00654381|455145098|FG002|1st Stage|Investigator's decision|0|||
126503536|NCT00654381|455145099|FG003|1st Stage|Investigator's decision|1|||
126503537|NCT00654381|455145100|FG004|1st Stage|Investigator's decision|0|||
126776397|NCT00272961|456137415|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
126776398|NCT00272961|456137416|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
126503538|NCT00654381|455145101|FG005|1st Stage|Investigator's decision|0|||
126503539|NCT00654381|455145096|FG000|2nd Stage|Adverse Event|2|||
126503540|NCT00654381|455145097|FG001|2nd Stage|Adverse Event|0|||
126503541|NCT00654381|455145098|FG002|2nd Stage|Adverse Event|2|||
126503542|NCT00654381|455145099|FG003|2nd Stage|Adverse Event|3|||
126503543|NCT00654381|455145100|FG004|2nd Stage|Adverse Event|7|||
126503544|NCT00654381|455145101|FG005|2nd Stage|Adverse Event|2|||
126503545|NCT00654381|455145096|FG000|2nd Stage|Withdrawal by Subject|0|||
126503546|NCT00654381|455145097|FG001|2nd Stage|Withdrawal by Subject|0|||
126503547|NCT00654381|455145098|FG002|2nd Stage|Withdrawal by Subject|0|||
126503548|NCT00654381|455145099|FG003|2nd Stage|Withdrawal by Subject|0|||
126503549|NCT00654381|455145100|FG004|2nd Stage|Withdrawal by Subject|1|||
126503550|NCT00654381|455145101|FG005|2nd Stage|Withdrawal by Subject|1|||
126503551|NCT00654381|455145096|FG000|2nd Stage|Investigator's decision|0|||
126503552|NCT00654381|455145097|FG001|2nd Stage|Investigator's decision|0|||
126503553|NCT00654381|455145098|FG002|2nd Stage|Investigator's decision|1|||
126503554|NCT00654381|455145099|FG003|2nd Stage|Investigator's decision|1|||
126503555|NCT00654381|455145100|FG004|2nd Stage|Investigator's decision|0|||
126503556|NCT00654381|455145101|FG005|2nd Stage|Investigator's decision|0|||
126503557|NCT00654381|455145096|FG000|Extension Stage|Adverse Event|1|||
126503558|NCT00654381|455145097|FG001|Extension Stage|Adverse Event|2|||
126503559|NCT00654381|455145098|FG002|Extension Stage|Adverse Event|9|||
126503560|NCT00654381|455145099|FG003|Extension Stage|Adverse Event|7|||
126503561|NCT00654381|455145100|FG004|Extension Stage|Adverse Event|1|||
126503562|NCT00654381|455145101|FG005|Extension Stage|Adverse Event|1|||
126503563|NCT00654381|455145096|FG000|Extension Stage|Protocol Violation|0|||
126503564|NCT00654381|455145097|FG001|Extension Stage|Protocol Violation|0|||
126503565|NCT00654381|455145098|FG002|Extension Stage|Protocol Violation|0|||
126503566|NCT00654381|455145099|FG003|Extension Stage|Protocol Violation|1|||
126503567|NCT00654381|455145100|FG004|Extension Stage|Protocol Violation|0|||
126503568|NCT00654381|455145101|FG005|Extension Stage|Protocol Violation|0|||
126503569|NCT00654381|455145096|FG000|Extension Stage|Lack of Efficacy|0|||
126503570|NCT00654381|455145097|FG001|Extension Stage|Lack of Efficacy|0|||
126503571|NCT00654381|455145098|FG002|Extension Stage|Lack of Efficacy|1|||
126503572|NCT00654381|455145099|FG003|Extension Stage|Lack of Efficacy|0|||
126503573|NCT00654381|455145100|FG004|Extension Stage|Lack of Efficacy|0|||
126503574|NCT00654381|455145101|FG005|Extension Stage|Lack of Efficacy|0|||
126503575|NCT00654381|455145096|FG000|Extension Stage|Withdrawal by Subject|0|||
126503576|NCT00654381|455145097|FG001|Extension Stage|Withdrawal by Subject|0|||
126503577|NCT00654381|455145098|FG002|Extension Stage|Withdrawal by Subject|1|||
126503578|NCT00654381|455145099|FG003|Extension Stage|Withdrawal by Subject|1|||
126503579|NCT00654381|455145100|FG004|Extension Stage|Withdrawal by Subject|1|||
126503580|NCT00654381|455145101|FG005|Extension Stage|Withdrawal by Subject|1|||
126503581|NCT00654381|455145096|FG000|Extension Stage|Closure of the trial site|0|||
126503582|NCT00654381|455145097|FG001|Extension Stage|Closure of the trial site|0|||
126503583|NCT00654381|455145098|FG002|Extension Stage|Closure of the trial site|0|||
126503584|NCT00654381|455145099|FG003|Extension Stage|Closure of the trial site|0|||
126503585|NCT00654381|455145100|FG004|Extension Stage|Closure of the trial site|1|||
126503586|NCT00654381|455145101|FG005|Extension Stage|Closure of the trial site|1|||
126503587|NCT04164901|455145106|FG000|Overall Study|Withdrawal by Subject|4|||
126503588|NCT04164901|455145107|FG001|Overall Study|Withdrawal by Subject|4|||
126503589|NCT00097721|455145113|FG000|Overall Study|Adverse Event|8|||
126503590|NCT00097721|455145114|FG001|Overall Study|Adverse Event|1|||
126503591|NCT00097721|455145113|FG000|Overall Study|Withdrawal by Subject|6|||
126503592|NCT00097721|455145114|FG001|Overall Study|Withdrawal by Subject|1|||
126503593|NCT00097721|455145113|FG000|Overall Study|Progressive Disease|55|||
126503594|NCT00097721|455145114|FG001|Overall Study|Progressive Disease|27|||
126503595|NCT00097721|455145113|FG000|Overall Study|Physician Decision|1|||
126503596|NCT00097721|455145114|FG001|Overall Study|Physician Decision|3|||
126503597|NCT00097721|455145113|FG000|Overall Study|Reason not given|1|||
126503598|NCT00097721|455145114|FG001|Overall Study|Reason not given|1|||
126503599|NCT01752855|455145118|FG000|Overall Study|Adverse Event|1|||
126503600|NCT01752855|455145119|FG001|Overall Study|Adverse Event|0|||
126503601|NCT01752855|455145118|FG000|Overall Study|Withdrew Consent|0|||
126503602|NCT01752855|455145119|FG001|Overall Study|Withdrew Consent|2|||
126503603|NCT01752855|455145118|FG000|Overall Study|Lack of Efficacy|0|||
126503604|NCT01752855|455145119|FG001|Overall Study|Lack of Efficacy|2|||
126503605|NCT01364428|455145136|FG000|Overall Study|Adverse Event|1|||
126503606|NCT01364428|455145137|FG001|Overall Study|Adverse Event|2|||
126503607|NCT01364428|455145136|FG000|Overall Study|Protocol Violation|2|||
126503608|NCT01364428|455145137|FG001|Overall Study|Protocol Violation|0|||
126503609|NCT01364428|455145136|FG000|Overall Study|Withdrawal Criteria|14|||
126503610|NCT01364428|455145137|FG001|Overall Study|Withdrawal Criteria|10|||
126503611|NCT01364428|455145136|FG000|Overall Study|Other|3|||
126503612|NCT01364428|455145137|FG001|Overall Study|Other|3|||
126503613|NCT00743652|455145138|FG000|Overall Study|Parent/Legal Guardian Request|3|||
126503614|NCT00743652|455145139|FG001|Overall Study|Parent/Legal Guardian Request|2|||
126503615|NCT00743652|455145140|FG002|Overall Study|Parent/Legal Guardian Request|2|||
126503616|NCT00743652|455145141|FG003|Overall Study|Parent/Legal Guardian Request|2|||
126503617|NCT00743652|455145142|FG004|Overall Study|Parent/Legal Guardian Request|0|||
126503618|NCT00743652|455145138|FG000|Overall Study|Adverse Event|3|||
126503619|NCT00743652|455145139|FG001|Overall Study|Adverse Event|0|||
126503620|NCT00743652|455145140|FG002|Overall Study|Adverse Event|0|||
126503621|NCT00743652|455145141|FG003|Overall Study|Adverse Event|0|||
126503622|NCT00743652|455145142|FG004|Overall Study|Adverse Event|0|||
126503623|NCT00743652|455145138|FG000|Overall Study|Death|2|||
126503624|NCT00743652|455145139|FG001|Overall Study|Death|0|||
126503625|NCT00743652|455145140|FG002|Overall Study|Death|0|||
126503626|NCT00743652|455145141|FG003|Overall Study|Death|0|||
126503627|NCT00743652|455145142|FG004|Overall Study|Death|0|||
126503628|NCT00743652|455145138|FG000|Overall Study|Investigator Request|0|||
126503629|NCT00743652|455145139|FG001|Overall Study|Investigator Request|0|||
126503630|NCT00743652|455145140|FG002|Overall Study|Investigator Request|0|||
126503631|NCT00743652|455145141|FG003|Overall Study|Investigator Request|2|||
126503632|NCT00743652|455145142|FG004|Overall Study|Investigator Request|0|||
126503633|NCT00743652|455145138|FG000|Overall Study|Other|1|||
126503634|NCT00743652|455145139|FG001|Overall Study|Other|1|||
126503635|NCT00743652|455145140|FG002|Overall Study|Other|0|||
126503636|NCT00743652|455145141|FG003|Overall Study|Other|0|||
126503637|NCT00743652|455145142|FG004|Overall Study|Other|0|||
126503638|NCT00743652|455145138|FG000|Overall Study|Lost to Follow-up|1|||
126503639|NCT00743652|455145139|FG001|Overall Study|Lost to Follow-up|0|||
126503640|NCT00743652|455145140|FG002|Overall Study|Lost to Follow-up|0|||
126503641|NCT00743652|455145141|FG003|Overall Study|Lost to Follow-up|0|||
126503642|NCT00743652|455145142|FG004|Overall Study|Lost to Follow-up|0|||
126503643|NCT03925324|455145143|FG000|Overall Study|Death|1|||
126503644|NCT03925324|455145144|FG001|Overall Study|Death|1|||
126503645|NCT06049043|455145146|FG000|Overall Study|Lost to Follow-up|11|||
126503646|NCT06049043|455145147|FG001|Overall Study|Lost to Follow-up|9|||
126503647|NCT02739269|455145151|FG000|Overall Study|Protocol Violation|5|||
126503648|NCT02739269|455145152|FG001|Overall Study|Protocol Violation|0|||
126503649|NCT02739269|455145151|FG000|Overall Study|Cycle cancellation|2|||
126503650|NCT02739269|455145152|FG001|Overall Study|Cycle cancellation|2|||
126503651|NCT02739269|455145151|FG000|Overall Study|Withdrawal by Subject|0|||
126503652|NCT02739269|455145152|FG001|Overall Study|Withdrawal by Subject|2|||
126503653|NCT03190889|455145153|FG000|Overall Study|Lost to Follow-up|7|||
126503654|NCT03190889|455145154|FG001|Overall Study|Lost to Follow-up|7|||
126503655|NCT03190889|455145155|FG002|Overall Study|Lost to Follow-up|3|||
126503656|NCT03190889|455145153|FG000|Overall Study|Withdrawal by Subject|1|||
126503657|NCT03190889|455145154|FG001|Overall Study|Withdrawal by Subject|1|||
126503658|NCT03190889|455145155|FG002|Overall Study|Withdrawal by Subject|2|||
126503659|NCT03190889|455145153|FG000|Overall Study|Did not complete protocol|4|||
126503660|NCT03190889|455145154|FG001|Overall Study|Did not complete protocol|9|||
126503661|NCT03190889|455145155|FG002|Overall Study|Did not complete protocol|0|||
126503662|NCT03190889|455145153|FG000|Overall Study|COVID-19|1|||
126503663|NCT03190889|455145154|FG001|Overall Study|COVID-19|0|||
126503664|NCT03190889|455145155|FG002|Overall Study|COVID-19|2|||
126503665|NCT03554291|455145156|FG000|Overall Study|Death|2|||
126503666|NCT03554291|455145157|FG001|Overall Study|Death|1|||
126503667|NCT03554291|455145156|FG000|Overall Study|Lost to Follow-up|1|||
126503668|NCT03554291|455145157|FG001|Overall Study|Lost to Follow-up|0|||
126503669|NCT03554291|455145156|FG000|Overall Study|Withdrawal by Subject|1|||
126503670|NCT03554291|455145157|FG001|Overall Study|Withdrawal by Subject|0|||
126503671|NCT03554291|455145156|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
126503672|NCT03554291|455145157|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
126503673|NCT02741700|455145158|FG000|Overall Study|Lost to Follow-up|17|||
126503674|NCT02741700|455145159|FG001|Overall Study|Lost to Follow-up|8|||
126503675|NCT02741700|455145158|FG000|Overall Study|Withdrawal by Subject|2|||
126503676|NCT02741700|455145159|FG001|Overall Study|Withdrawal by Subject|5|||
126503677|NCT02741700|455145158|FG000|Overall Study|Physician Decision|3|||
126503678|NCT02741700|455145159|FG001|Overall Study|Physician Decision|0|||
126503679|NCT02741700|455145158|FG000|Overall Study|Moved out of State|0|||
126503680|NCT02741700|455145159|FG001|Overall Study|Moved out of State|1|||
126503681|NCT02741700|455145158|FG000|Overall Study|Death|4|||
126503682|NCT02741700|455145159|FG001|Overall Study|Death|5|||
126503683|NCT00811577|455145160|FG000|Overall Study|Lost to Follow-up|7|||
126503684|NCT00811577|455145161|FG001|Overall Study|Lost to Follow-up|1|||
126503685|NCT00811577|455145160|FG000|Overall Study|Withdrawal by Subject|3|||
126503686|NCT00811577|455145161|FG001|Overall Study|Withdrawal by Subject|0|||
126503687|NCT02641379|455145164|FG000|Overall Study|Exclusion criterion during screening|1|||
126503688|NCT02641379|455145165|FG001|Overall Study|Exclusion criterion during screening|0|||
126503689|NCT02641379|455145166|FG002|Overall Study|Exclusion criterion during screening|0|||
126503690|NCT02641379|455145167|FG003|Overall Study|Exclusion criterion during screening|1|||
126503691|NCT02641379|455145168|FG004|Overall Study|Exclusion criterion during screening|2|||
126503692|NCT02641379|455145169|FG005|Overall Study|Exclusion criterion during screening|0|||
126503693|NCT02641379|455145170|FG006|Overall Study|Exclusion criterion during screening|0|||
126503694|NCT02641379|455145171|FG007|Overall Study|Exclusion criterion during screening|0|||
126503695|NCT02641379|455145172|FG008|Overall Study|Exclusion criterion during screening|0|||
126503696|NCT02641379|455145173|FG009|Overall Study|Exclusion criterion during screening|0|||
126503697|NCT02641379|455145174|FG010|Overall Study|Exclusion criterion during screening|0|||
126562632|NCT02624778|455355799|FG003|Overall Study|Lost to Follow-up|0|||
126562633|NCT02624778|455355800|FG004|Overall Study|Lost to Follow-up|0|||
126562634|NCT02624778|455355801|FG005|Overall Study|Lost to Follow-up|0|||
126562635|NCT02624778|455355802|FG006|Overall Study|Lost to Follow-up|0|||
126562636|NCT02624778|455355803|FG007|Overall Study|Lost to Follow-up|0|||
126562637|NCT02624778|455355804|FG008|Overall Study|Lost to Follow-up|0|||
126562638|NCT02624778|455355796|FG000|Overall Study|Withdrawal by Subject|0|||
126562639|NCT02624778|455355797|FG001|Overall Study|Withdrawal by Subject|1|||
126562640|NCT02624778|455355798|FG002|Overall Study|Withdrawal by Subject|0|||
126562641|NCT02624778|455355799|FG003|Overall Study|Withdrawal by Subject|0|||
126562642|NCT02624778|455355800|FG004|Overall Study|Withdrawal by Subject|0|||
126562643|NCT02624778|455355801|FG005|Overall Study|Withdrawal by Subject|1|||
126562644|NCT02624778|455355802|FG006|Overall Study|Withdrawal by Subject|1|||
126562645|NCT02624778|455355803|FG007|Overall Study|Withdrawal by Subject|1|||
126562646|NCT02624778|455355804|FG008|Overall Study|Withdrawal by Subject|1|||
126562647|NCT02624778|455355796|FG000|Overall Study|Adverse Event|0|||
126562648|NCT02624778|455355797|FG001|Overall Study|Adverse Event|0|||
126503698|NCT02641379|455145164|FG000|Overall Study|Withdrawal of informed consent|0|||
126503699|NCT02641379|455145165|FG001|Overall Study|Withdrawal of informed consent|1|||
126503700|NCT02641379|455145166|FG002|Overall Study|Withdrawal of informed consent|0|||
126503701|NCT02641379|455145167|FG003|Overall Study|Withdrawal of informed consent|0|||
126503702|NCT02641379|455145168|FG004|Overall Study|Withdrawal of informed consent|0|||
126503703|NCT02641379|455145169|FG005|Overall Study|Withdrawal of informed consent|0|||
126503704|NCT02641379|455145170|FG006|Overall Study|Withdrawal of informed consent|0|||
126503705|NCT02641379|455145171|FG007|Overall Study|Withdrawal of informed consent|1|||
126503706|NCT02641379|455145172|FG008|Overall Study|Withdrawal of informed consent|0|||
126503707|NCT02641379|455145173|FG009|Overall Study|Withdrawal of informed consent|0|||
126503708|NCT02641379|455145174|FG010|Overall Study|Withdrawal of informed consent|0|||
126503709|NCT02641379|455145164|FG000|Overall Study|Adverse Event|7|||
126503710|NCT02641379|455145165|FG001|Overall Study|Adverse Event|8|||
126503711|NCT02641379|455145166|FG002|Overall Study|Adverse Event|2|||
126503712|NCT02641379|455145167|FG003|Overall Study|Adverse Event|2|||
126503713|NCT02641379|455145168|FG004|Overall Study|Adverse Event|5|||
126503714|NCT02641379|455145169|FG005|Overall Study|Adverse Event|1|||
126503715|NCT02641379|455145170|FG006|Overall Study|Adverse Event|5|||
126503716|NCT02641379|455145171|FG007|Overall Study|Adverse Event|0|||
126503717|NCT02641379|455145172|FG008|Overall Study|Adverse Event|1|||
126503718|NCT02641379|455145173|FG009|Overall Study|Adverse Event|1|||
126503719|NCT02641379|455145174|FG010|Overall Study|Adverse Event|5|||
126503720|NCT02641379|455145164|FG000|Overall Study|Lack of Efficacy|0|||
126503721|NCT02641379|455145165|FG001|Overall Study|Lack of Efficacy|0|||
126503722|NCT02641379|455145166|FG002|Overall Study|Lack of Efficacy|2|||
126503723|NCT02641379|455145167|FG003|Overall Study|Lack of Efficacy|0|||
126503724|NCT02641379|455145168|FG004|Overall Study|Lack of Efficacy|0|||
126503725|NCT02641379|455145169|FG005|Overall Study|Lack of Efficacy|2|||
126503726|NCT02641379|455145170|FG006|Overall Study|Lack of Efficacy|0|||
126503727|NCT02641379|455145171|FG007|Overall Study|Lack of Efficacy|5|||
126503728|NCT02641379|455145172|FG008|Overall Study|Lack of Efficacy|0|||
126503729|NCT02641379|455145173|FG009|Overall Study|Lack of Efficacy|0|||
126503730|NCT02641379|455145174|FG010|Overall Study|Lack of Efficacy|0|||
126503731|NCT02641379|455145164|FG000|Overall Study|Participant unable to attend study visit|4|||
126503732|NCT02641379|455145165|FG001|Overall Study|Participant unable to attend study visit|10|||
126503733|NCT02641379|455145166|FG002|Overall Study|Participant unable to attend study visit|1|||
126503734|NCT02641379|455145167|FG003|Overall Study|Participant unable to attend study visit|2|||
126503735|NCT02641379|455145168|FG004|Overall Study|Participant unable to attend study visit|5|||
126503736|NCT02641379|455145169|FG005|Overall Study|Participant unable to attend study visit|1|||
126503737|NCT02641379|455145170|FG006|Overall Study|Participant unable to attend study visit|1|||
126503738|NCT02641379|455145171|FG007|Overall Study|Participant unable to attend study visit|1|||
126503739|NCT02641379|455145172|FG008|Overall Study|Participant unable to attend study visit|0|||
126503740|NCT02641379|455145173|FG009|Overall Study|Participant unable to attend study visit|2|||
126503741|NCT02641379|455145174|FG010|Overall Study|Participant unable to attend study visit|0|||
126503742|NCT02641379|455145164|FG000|Overall Study|Participant's compliance|0|||
126503743|NCT02641379|455145165|FG001|Overall Study|Participant's compliance|1|||
126503744|NCT02641379|455145166|FG002|Overall Study|Participant's compliance|0|||
126503745|NCT02641379|455145167|FG003|Overall Study|Participant's compliance|1|||
126503746|NCT02641379|455145168|FG004|Overall Study|Participant's compliance|0|||
126503747|NCT02641379|455145169|FG005|Overall Study|Participant's compliance|2|||
126562649|NCT02624778|455355798|FG002|Overall Study|Adverse Event|0|||
126562650|NCT02624778|455355799|FG003|Overall Study|Adverse Event|0|||
126562651|NCT02624778|455355800|FG004|Overall Study|Adverse Event|0|||
126562652|NCT02624778|455355801|FG005|Overall Study|Adverse Event|0|||
126562653|NCT02624778|455355802|FG006|Overall Study|Adverse Event|0|||
126503748|NCT02641379|455145170|FG006|Overall Study|Participant's compliance|0|||
126503749|NCT02641379|455145171|FG007|Overall Study|Participant's compliance|0|||
126562654|NCT02624778|455355803|FG007|Overall Study|Adverse Event|0|||
126503750|NCT02641379|455145172|FG008|Overall Study|Participant's compliance|1|||
126503751|NCT02641379|455145173|FG009|Overall Study|Participant's compliance|1|||
126503752|NCT02641379|455145174|FG010|Overall Study|Participant's compliance|1|||
126503753|NCT02641379|455145164|FG000|Overall Study|Participant cannot be reached|4|||
126503754|NCT02641379|455145165|FG001|Overall Study|Participant cannot be reached|4|||
126503755|NCT02641379|455145166|FG002|Overall Study|Participant cannot be reached|0|||
126503756|NCT02641379|455145167|FG003|Overall Study|Participant cannot be reached|8|||
126503757|NCT02641379|455145168|FG004|Overall Study|Participant cannot be reached|2|||
126503758|NCT02641379|455145169|FG005|Overall Study|Participant cannot be reached|1|||
126503759|NCT02641379|455145170|FG006|Overall Study|Participant cannot be reached|0|||
126503760|NCT02641379|455145171|FG007|Overall Study|Participant cannot be reached|1|||
126503761|NCT02641379|455145172|FG008|Overall Study|Participant cannot be reached|0|||
126503762|NCT02641379|455145173|FG009|Overall Study|Participant cannot be reached|2|||
126503763|NCT02641379|455145174|FG010|Overall Study|Participant cannot be reached|1|||
126503764|NCT02641379|455145164|FG000|Overall Study|PCR positive at Week 24|15|||
126503765|NCT02641379|455145165|FG001|Overall Study|PCR positive at Week 24|21|||
126503766|NCT02641379|455145166|FG002|Overall Study|PCR positive at Week 24|62|||
126503767|NCT02641379|455145167|FG003|Overall Study|PCR positive at Week 24|0|||
126503768|NCT02641379|455145168|FG004|Overall Study|PCR positive at Week 24|0|||
126503769|NCT02641379|455145169|FG005|Overall Study|PCR positive at Week 24|6|||
126503770|NCT02641379|455145170|FG006|Overall Study|PCR positive at Week 24|3|||
126503771|NCT02641379|455145171|FG007|Overall Study|PCR positive at Week 24|8|||
126503772|NCT02641379|455145172|FG008|Overall Study|PCR positive at Week 24|0|||
126503773|NCT02641379|455145173|FG009|Overall Study|PCR positive at Week 24|1|||
126503774|NCT02641379|455145174|FG010|Overall Study|PCR positive at Week 24|0|||
126503775|NCT02641379|455145164|FG000|Overall Study|PCR positive at follow up 2|1|||
126503776|NCT02641379|455145165|FG001|Overall Study|PCR positive at follow up 2|0|||
126503777|NCT02641379|455145166|FG002|Overall Study|PCR positive at follow up 2|0|||
126503778|NCT02641379|455145167|FG003|Overall Study|PCR positive at follow up 2|0|||
126503779|NCT02641379|455145168|FG004|Overall Study|PCR positive at follow up 2|0|||
126503780|NCT02641379|455145169|FG005|Overall Study|PCR positive at follow up 2|0|||
126503781|NCT02641379|455145170|FG006|Overall Study|PCR positive at follow up 2|0|||
126503782|NCT02641379|455145171|FG007|Overall Study|PCR positive at follow up 2|0|||
126503783|NCT02641379|455145172|FG008|Overall Study|PCR positive at follow up 2|0|||
126503784|NCT02641379|455145173|FG009|Overall Study|PCR positive at follow up 2|0|||
126503785|NCT02641379|455145174|FG010|Overall Study|PCR positive at follow up 2|0|||
126503786|NCT02641379|455145164|FG000|Overall Study|Participant showed relapse|1|||
126503787|NCT02641379|455145165|FG001|Overall Study|Participant showed relapse|0|||
126503788|NCT02641379|455145166|FG002|Overall Study|Participant showed relapse|0|||
126503789|NCT02641379|455145167|FG003|Overall Study|Participant showed relapse|0|||
126503790|NCT02641379|455145168|FG004|Overall Study|Participant showed relapse|0|||
126503791|NCT02641379|455145169|FG005|Overall Study|Participant showed relapse|0|||
126503792|NCT02641379|455145170|FG006|Overall Study|Participant showed relapse|1|||
126503793|NCT02641379|455145171|FG007|Overall Study|Participant showed relapse|0|||
126503794|NCT02641379|455145172|FG008|Overall Study|Participant showed relapse|0|||
126503795|NCT02641379|455145173|FG009|Overall Study|Participant showed relapse|0|||
126503796|NCT02641379|455145174|FG010|Overall Study|Participant showed relapse|0|||
126503797|NCT02641379|455145164|FG000|Overall Study|Participant stopped study/treatment|1|||
126503798|NCT02641379|455145165|FG001|Overall Study|Participant stopped study/treatment|3|||
126503799|NCT02641379|455145166|FG002|Overall Study|Participant stopped study/treatment|1|||
126503800|NCT02641379|455145167|FG003|Overall Study|Participant stopped study/treatment|0|||
126503801|NCT02641379|455145168|FG004|Overall Study|Participant stopped study/treatment|0|||
126503802|NCT02641379|455145169|FG005|Overall Study|Participant stopped study/treatment|1|||
126503803|NCT02641379|455145170|FG006|Overall Study|Participant stopped study/treatment|2|||
126503804|NCT02641379|455145171|FG007|Overall Study|Participant stopped study/treatment|0|||
126503805|NCT02641379|455145172|FG008|Overall Study|Participant stopped study/treatment|1|||
126503806|NCT02641379|455145173|FG009|Overall Study|Participant stopped study/treatment|0|||
126503807|NCT02641379|455145174|FG010|Overall Study|Participant stopped study/treatment|0|||
126503808|NCT02641379|455145164|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
126503809|NCT02641379|455145165|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
126503810|NCT02641379|455145166|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
126503811|NCT02641379|455145167|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
126503812|NCT02641379|455145168|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
126503813|NCT02641379|455145169|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
126503814|NCT02641379|455145170|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
126503815|NCT02641379|455145171|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
126503816|NCT02641379|455145172|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
126503817|NCT02641379|455145173|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
126503818|NCT02641379|455145174|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
126503819|NCT02641379|455145164|FG000|Overall Study|Financial problems|0|||
126503820|NCT02641379|455145165|FG001|Overall Study|Financial problems|1|||
126503821|NCT02641379|455145166|FG002|Overall Study|Financial problems|0|||
126776399|NCT00272961|456137412|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
126727034|NCT02198651|455951018|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
126727035|NCT04124692|455951020|FG000|Overall Study|Medical reason|0|||
126727036|NCT04124692|455951021|FG001|Overall Study|Medical reason|1|||
126727037|NCT04124692|455951020|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
126727038|NCT04124692|455951021|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
126727039|NCT04124692|455951020|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
126727040|NCT04124692|455951021|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
126727041|NCT04124692|455951020|FG000|Overall Study|Lost to Follow-up|2|||
126727042|NCT04124692|455951021|FG001|Overall Study|Lost to Follow-up|4|||
126727043|NCT04124692|455951020|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
126727044|NCT04124692|455951021|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
126727045|NCT02370498|455951022|FG000|Overall Study|Adverse Event|10|||
126727046|NCT02370498|455951023|FG001|Overall Study|Adverse Event|8|||
126727047|NCT02370498|455951022|FG000|Overall Study|Death|263|||
126727048|NCT02370498|455951023|FG001|Overall Study|Death|265|||
126727049|NCT02370498|455951022|FG000|Overall Study|Protocol Violation|1|||
126727050|NCT02370498|455951023|FG001|Overall Study|Protocol Violation|2|||
126727051|NCT02370498|455951022|FG000|Overall Study|Withdrawal by Subject|7|||
126727052|NCT02370498|455951023|FG001|Overall Study|Withdrawal by Subject|12|||
126727053|NCT02370498|455951022|FG000|Overall Study|Sponsor's decision|15|||
126727054|NCT02370498|455951023|FG001|Overall Study|Sponsor's decision|9|||
126727055|NCT01453998|455951034|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
126727056|NCT01453998|455951035|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
126727057|NCT01453998|455951036|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
126727058|NCT03943953|455951037|FG000|Trial of ITG 1|Lost to Follow-up|19|||
126727059|NCT03943953|455951038|FG001|Trial of ITG 1|Lost to Follow-up|1|||
126727060|NCT03943953|455951037|FG000|Trial of ITG 2|Lost to Follow-up|8|||
126727061|NCT03943953|455951038|FG001|Trial of ITG 2|Lost to Follow-up|0|||
126727062|NCT03943953|455951037|FG000|Trial of ITG 3|Lost to Follow-up|2|||
126727063|NCT03943953|455951038|FG001|Trial of ITG 3|Lost to Follow-up|0|||
126727064|NCT03943953|455951037|FG000|Trial of ITG 4|Lost to Follow-up|2|||
126727065|NCT03943953|455951038|FG001|Trial of ITG 4|Lost to Follow-up|0|||
126727066|NCT01199055|455951039|FG000|Overall Study|Death|0|||
126727067|NCT01199055|455951040|FG001|Overall Study|Death|1|||
126727068|NCT01199055|455951041|FG002|Overall Study|Death|0|||
126727069|NCT01199055|455951039|FG000|Overall Study|Physician Decision|0|||
126727070|NCT01199055|455951040|FG001|Overall Study|Physician Decision|1|||
126727071|NCT01199055|455951041|FG002|Overall Study|Physician Decision|1|||
126727072|NCT01199055|455951039|FG000|Overall Study|Progressive disease|2|||
126727073|NCT01199055|455951040|FG001|Overall Study|Progressive disease|1|||
126727074|NCT01199055|455951041|FG002|Overall Study|Progressive disease|2|||
126727075|NCT01199055|455951039|FG000|Overall Study|Withdrawal by Subject|0|||
126727076|NCT01199055|455951040|FG001|Overall Study|Withdrawal by Subject|0|||
126727077|NCT01199055|455951041|FG002|Overall Study|Withdrawal by Subject|1|||
126727078|NCT01486784|455951042|FG000|Overall Study|Withdrawal by Subject|0|||
126727079|NCT01486784|455951043|FG001|Overall Study|Withdrawal by Subject|0|||
126727080|NCT01486784|455951044|FG002|Overall Study|Withdrawal by Subject|1|||
126727081|NCT01486784|455951045|FG003|Overall Study|Withdrawal by Subject|0|||
126727082|NCT01486784|455951046|FG004|Overall Study|Withdrawal by Subject|1|||
126727083|NCT01486784|455951047|FG005|Overall Study|Withdrawal by Subject|2|||
126727084|NCT01486784|455951042|FG000|Overall Study|Subject did not meet entry criteria|0|||
126727085|NCT01486784|455951043|FG001|Overall Study|Subject did not meet entry criteria|0|||
126727086|NCT01486784|455951044|FG002|Overall Study|Subject did not meet entry criteria|0|||
126727087|NCT01486784|455951045|FG003|Overall Study|Subject did not meet entry criteria|0|||
126727088|NCT01486784|455951046|FG004|Overall Study|Subject did not meet entry criteria|1|||
126727089|NCT01486784|455951047|FG005|Overall Study|Subject did not meet entry criteria|0|||
126727090|NCT01486784|455951042|FG000|Overall Study|Death|0|||
126727091|NCT01486784|455951043|FG001|Overall Study|Death|0|||
126727092|NCT01486784|455951044|FG002|Overall Study|Death|0|||
126727093|NCT01486784|455951045|FG003|Overall Study|Death|0|||
126727094|NCT01486784|455951046|FG004|Overall Study|Death|0|||
126727095|NCT01486784|455951047|FG005|Overall Study|Death|1|||
126727096|NCT00488592|455951048|FG000|Overall Study|Withdrawal by Subject|1|||
126727097|NCT00488592|455951048|FG000|Overall Study|Disease progression|1|||
126727098|NCT00488592|455951048|FG000|Overall Study|Enrolled but not treated|1|||
126727099|NCT03670641|455951053|FG000|Overall Study|Lost to Follow-up|3|||
126727100|NCT01096849|455951054|FG000|Overall Study|Consent Withdrawn|1|||
126727101|NCT01096849|455951055|FG001|Overall Study|Consent Withdrawn|4|||
126727102|NCT01096849|455951056|FG002|Overall Study|Consent Withdrawn|2|||
126727103|NCT01096849|455951054|FG000|Overall Study|Lack of Efficacy|0|||
126727104|NCT01096849|455951055|FG001|Overall Study|Lack of Efficacy|2|||
126727105|NCT01096849|455951056|FG002|Overall Study|Lack of Efficacy|0|||
126727106|NCT01096849|455951054|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
126727107|NCT01096849|455951055|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
126776400|NCT00272961|456137413|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
126776401|NCT00272961|456137414|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
126776402|NCT00272961|456137415|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
126776403|NCT00272961|456137416|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
126776404|NCT00272961|456137412|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
126776405|NCT00272961|456137413|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
126776406|NCT00272961|456137414|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
126776407|NCT00272961|456137415|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
126776408|NCT00272961|456137416|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
126776409|NCT00272961|456137412|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
126776410|NCT00272961|456137413|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
126776411|NCT00272961|456137414|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
126776412|NCT00272961|456137415|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
126776413|NCT00272961|456137416|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
126562655|NCT02624778|455355804|FG008|Overall Study|Adverse Event|2|||
126562656|NCT02624778|455355796|FG000|Overall Study|Death|0|||
126562657|NCT02624778|455355797|FG001|Overall Study|Death|0|||
126562658|NCT02624778|455355798|FG002|Overall Study|Death|0|||
126562659|NCT02624778|455355799|FG003|Overall Study|Death|0|||
126562660|NCT02624778|455355800|FG004|Overall Study|Death|0|||
126562661|NCT02624778|455355801|FG005|Overall Study|Death|0|||
126562662|NCT02624778|455355802|FG006|Overall Study|Death|1|||
126562663|NCT02624778|455355803|FG007|Overall Study|Death|0|||
126562664|NCT02624778|455355804|FG008|Overall Study|Death|0|||
126562665|NCT02624778|455355796|FG000|Overall Study|Physician Decision|0|||
126562666|NCT02624778|455355797|FG001|Overall Study|Physician Decision|0|||
126562667|NCT02624778|455355798|FG002|Overall Study|Physician Decision|0|||
126562668|NCT02624778|455355799|FG003|Overall Study|Physician Decision|0|||
126562669|NCT02624778|455355800|FG004|Overall Study|Physician Decision|0|||
126562670|NCT02624778|455355801|FG005|Overall Study|Physician Decision|0|||
126562671|NCT02624778|455355802|FG006|Overall Study|Physician Decision|0|||
126562672|NCT02624778|455355803|FG007|Overall Study|Physician Decision|3|||
126562673|NCT02624778|455355804|FG008|Overall Study|Physician Decision|3|||
126562674|NCT01537133|455355812|FG000|Overall Study|Withdrawal by Subject|2|||
126562675|NCT01537133|455355813|FG001|Overall Study|Withdrawal by Subject|0|||
126562676|NCT01537133|455355814|FG002|Overall Study|Withdrawal by Subject|0|||
126562677|NCT01537133|455355815|FG003|Overall Study|Withdrawal by Subject|0|||
126562678|NCT01537133|455355812|FG000|Overall Study|Lost to Follow-up|1|||
126562679|NCT01537133|455355813|FG001|Overall Study|Lost to Follow-up|0|||
126562680|NCT01537133|455355814|FG002|Overall Study|Lost to Follow-up|0|||
126562681|NCT01537133|455355815|FG003|Overall Study|Lost to Follow-up|0|||
126562682|NCT00587288|455355816|FG000|Overall Study|Adverse Event|0|||
126562683|NCT00587288|455355817|FG001|Overall Study|Adverse Event|1|||
126562684|NCT00587288|455355816|FG000|Overall Study|Lack of Efficacy|2|||
126503822|NCT02641379|455145167|FG003|Overall Study|Financial problems|0|||
126503823|NCT02641379|455145168|FG004|Overall Study|Financial problems|0|||
126503824|NCT02641379|455145169|FG005|Overall Study|Financial problems|0|||
126503825|NCT02641379|455145170|FG006|Overall Study|Financial problems|0|||
126503826|NCT02641379|455145171|FG007|Overall Study|Financial problems|0|||
126503827|NCT02641379|455145172|FG008|Overall Study|Financial problems|0|||
126503828|NCT02641379|455145173|FG009|Overall Study|Financial problems|0|||
126503829|NCT02641379|455145174|FG010|Overall Study|Financial problems|0|||
126503830|NCT02641379|455145164|FG000|Overall Study|PCR positive at Week 68|0|||
126503831|NCT02641379|455145165|FG001|Overall Study|PCR positive at Week 68|1|||
126503832|NCT02641379|455145166|FG002|Overall Study|PCR positive at Week 68|0|||
126503833|NCT02641379|455145167|FG003|Overall Study|PCR positive at Week 68|0|||
126503834|NCT02641379|455145168|FG004|Overall Study|PCR positive at Week 68|0|||
126503835|NCT02641379|455145169|FG005|Overall Study|PCR positive at Week 68|0|||
126503836|NCT02641379|455145170|FG006|Overall Study|PCR positive at Week 68|0|||
126503837|NCT02641379|455145171|FG007|Overall Study|PCR positive at Week 68|0|||
126503838|NCT02641379|455145172|FG008|Overall Study|PCR positive at Week 68|0|||
126562685|NCT00587288|455355817|FG001|Overall Study|Lack of Efficacy|8|||
126562686|NCT00587288|455355816|FG000|Overall Study|Protocol Violation|1|||
126776414|NCT00272961|456137412|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
126503839|NCT02641379|455145173|FG009|Overall Study|PCR positive at Week 68|0|||
126503840|NCT02641379|455145174|FG010|Overall Study|PCR positive at Week 68|0|||
126503841|NCT02641379|455145164|FG000|Overall Study|PCR positive at Week 48|0|||
126562687|NCT00587288|455355817|FG001|Overall Study|Protocol Violation|0|||
126562688|NCT00531479|455355818|FG000|Overall Study|Death|68|||
126562689|NCT00531479|455355819|FG001|Overall Study|Death|71|||
126562690|NCT00531479|455355818|FG000|Overall Study|Lost to Follow-up|0|||
126562691|NCT00531479|455355819|FG001|Overall Study|Lost to Follow-up|2|||
126503842|NCT02641379|455145165|FG001|Overall Study|PCR positive at Week 48|1|||
126562692|NCT00531479|455355818|FG000|Overall Study|Other|0|||
126562693|NCT00531479|455355819|FG001|Overall Study|Other|1|||
126562694|NCT00531479|455355818|FG000|Overall Study|Withdrawal by Subject|6|||
126562695|NCT00531479|455355819|FG001|Overall Study|Withdrawal by Subject|6|||
126562696|NCT00531479|455355818|FG000|Overall Study|Did not receive treatment|2|||
126562697|NCT00531479|455355819|FG001|Overall Study|Did not receive treatment|3|||
126562698|NCT00926393|455355820|FG000|Overall Study|Withdrawal by Subject|1|||
126562699|NCT00926393|455355821|FG001|Overall Study|Withdrawal by Subject|2|||
126562700|NCT00926393|455355820|FG000|Overall Study|Adverse Event|1|||
126562701|NCT00926393|455355821|FG001|Overall Study|Adverse Event|1|||
126562702|NCT01168401|455355828|FG000|Overall Study|Lost to Follow-up|1|||
126562703|NCT01168401|455355829|FG001|Overall Study|Lost to Follow-up|1|||
126562704|NCT01168401|455355830|FG002|Overall Study|Lost to Follow-up|2|||
126562705|NCT01168401|455355831|FG003|Overall Study|Lost to Follow-up|1|||
126562706|NCT01168401|455355832|FG004|Overall Study|Lost to Follow-up|0|||
126562707|NCT01168401|455355833|FG005|Overall Study|Lost to Follow-up|0|||
126562708|NCT01168401|455355834|FG006|Overall Study|Lost to Follow-up|0|||
126562709|NCT01168401|455355835|FG007|Overall Study|Lost to Follow-up|0|||
126562710|NCT01168401|455355836|FG008|Overall Study|Lost to Follow-up|0|||
126562711|NCT01168401|455355837|FG009|Overall Study|Lost to Follow-up|0|||
126562712|NCT01168401|455355838|FG010|Overall Study|Lost to Follow-up|0|||
126562713|NCT01168401|455355828|FG000|Overall Study|Withdrawal by Subject|0|||
126562714|NCT01168401|455355829|FG001|Overall Study|Withdrawal by Subject|0|||
126562715|NCT01168401|455355830|FG002|Overall Study|Withdrawal by Subject|0|||
126562716|NCT01168401|455355831|FG003|Overall Study|Withdrawal by Subject|1|||
126562717|NCT01168401|455355832|FG004|Overall Study|Withdrawal by Subject|0|||
126562718|NCT01168401|455355833|FG005|Overall Study|Withdrawal by Subject|0|||
126562719|NCT01168401|455355834|FG006|Overall Study|Withdrawal by Subject|0|||
126562720|NCT01168401|455355835|FG007|Overall Study|Withdrawal by Subject|0|||
126562721|NCT01168401|455355836|FG008|Overall Study|Withdrawal by Subject|0|||
126562722|NCT01168401|455355837|FG009|Overall Study|Withdrawal by Subject|0|||
126562723|NCT01168401|455355838|FG010|Overall Study|Withdrawal by Subject|0|||
126562724|NCT00672256|455355840|FG000|Overall Study|PI dropped, bad data|44|||
126562725|NCT02072226|455355847|FG000|Overall Study|Lost to Follow-up|11|||
126562726|NCT02072226|455355848|FG001|Overall Study|Lost to Follow-up|7|||
126562727|NCT02072226|455355847|FG000|Overall Study|Patient Non-compliance|2|||
126562728|NCT02072226|455355848|FG001|Overall Study|Patient Non-compliance|3|||
126562729|NCT02072226|455355847|FG000|Overall Study|Death|1|||
126562730|NCT02072226|455355848|FG001|Overall Study|Death|0|||
126562731|NCT02072226|455355847|FG000|Overall Study|Patient Withdrawal of Consent|1|||
126562732|NCT02072226|455355848|FG001|Overall Study|Patient Withdrawal of Consent|0|||
126562733|NCT01124162|455355853|FG000|First Intervention|Adverse Event|2|||
126562734|NCT01124162|455355854|FG001|First Intervention|Adverse Event|0|||
126562735|NCT01124162|455355853|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
126562736|NCT01124162|455355854|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
126562737|NCT02680756|455355855|FG000|Overall Study|Adverse Event|10|||
126562738|NCT02680756|455355856|FG001|Overall Study|Adverse Event|2|||
126562739|NCT02680756|455355855|FG000|Overall Study|Lost to Follow-up|7|||
126562740|NCT02680756|455355856|FG001|Overall Study|Lost to Follow-up|6|||
126562741|NCT02680756|455355855|FG000|Overall Study|Withdrawal by Subject|5|||
126562742|NCT02680756|455355856|FG001|Overall Study|Withdrawal by Subject|5|||
126562743|NCT02680756|455355855|FG000|Overall Study|Physician Decision|4|||
126562744|NCT02680756|455355856|FG001|Overall Study|Physician Decision|1|||
126562745|NCT02680756|455355855|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
126562746|NCT02680756|455355856|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
126562747|NCT02680756|455355855|FG000|Overall Study|Blood transfusion for any reason|0|||
126562748|NCT02680756|455355856|FG001|Overall Study|Blood transfusion for any reason|1|||
126562749|NCT02680756|455355855|FG000|Overall Study|Death|1|||
126562750|NCT02680756|455355856|FG001|Overall Study|Death|0|||
126562751|NCT02680756|455355855|FG000|Overall Study|Protocol Violation|1|||
126562752|NCT02680756|455355856|FG001|Overall Study|Protocol Violation|0|||
126562753|NCT02680756|455355855|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
126562754|NCT02680756|455355856|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
126562755|NCT02680756|455355855|FG000|Overall Study|None of above or not recorded|3|||
126562756|NCT02680756|455355856|FG001|Overall Study|None of above or not recorded|2|||
126562757|NCT01516892|455355859|FG000|Overall Study|Adverse Event|25|||
126562758|NCT01516892|455355859|FG000|Overall Study|Lack of Efficacy|35|||
126562759|NCT01516892|455355859|FG000|Overall Study|Pregnancy|5|||
126562760|NCT01516892|455355859|FG000|Overall Study|Lost to Follow-up|82|||
126562761|NCT01516892|455355859|FG000|Overall Study|Subject Withdrew Consent|92|||
126562762|NCT01516892|455355859|FG000|Overall Study|Protocol Violation|60|||
126562763|NCT01516892|455355859|FG000|Overall Study|Other Miscellaneous Reasons|43|||
126562764|NCT01516892|455355859|FG000|Overall Study|Missing|1|||
126562765|NCT00938340|455355860|FG000|Overall Study|Withdrawal by Subject|3|||
126562766|NCT00938340|455355860|FG000|Overall Study|Protocol Violation|1|||
126562767|NCT00938340|455355860|FG000|Overall Study|Adverse Event|1|||
126562768|NCT04353037|455355861|FG000|Overall Study|Lost to Follow-up|0|||
126562769|NCT04353037|455355862|FG001|Overall Study|Lost to Follow-up|1|||
126562770|NCT04353037|455355863|FG002|Overall Study|Lost to Follow-up|2|||
126562771|NCT04353037|455355864|FG003|Overall Study|Lost to Follow-up|3|||
126562772|NCT04353037|455355861|FG000|Overall Study|Withdrawal by Subject|0|||
126562773|NCT04353037|455355862|FG001|Overall Study|Withdrawal by Subject|2|||
126776415|NCT00272961|456137413|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
126776416|NCT00272961|456137414|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
126776417|NCT00272961|456137415|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
126776418|NCT00272961|456137416|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
126776419|NCT00272961|456137412|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
126776420|NCT00272961|456137413|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
126776421|NCT00272961|456137414|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
126776422|NCT00272961|456137415|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
126776423|NCT00272961|456137416|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
126776424|NCT02065791|456137417|FG000|Overall Study|Closed Site|1|||
126776425|NCT02065791|456137418|FG001|Overall Study|Closed Site|1|||
126776426|NCT02065791|456137417|FG000|Overall Study|Withdrawal by Subject|11|||
126776427|NCT02065791|456137418|FG001|Overall Study|Withdrawal by Subject|5|||
126776428|NCT02065791|456137417|FG000|Overall Study|Lost to Follow-up|13|||
126776429|NCT02065791|456137418|FG001|Overall Study|Lost to Follow-up|9|||
126776430|NCT01238211|456137419|FG000|Overall Study|Continues active treatment|31|||
126776431|NCT01238211|456137419|FG000|Overall Study|Adverse Event|7|||
126776432|NCT01238211|456137419|FG000|Overall Study|Death|4|||
126776433|NCT01238211|456137419|FG000|Overall Study|Relapse/Progression|2|||
126776434|NCT01238211|456137419|FG000|Overall Study|Withdrawal by Subject|7|||
126776435|NCT01238211|456137419|FG000|Overall Study|Non-protocol treatment|4|||
126776436|NCT01238211|456137419|FG000|Overall Study|Investigator/Patient Decision|3|||
126776437|NCT04428502|456137420|FG000|Overall Study|Did not meet entrance criteria|14|||
126776438|NCT03550794|456137426|FG000|Overall Study|No longer met inclusion criteria|1|||
126776439|NCT03550794|456137427|FG001|Overall Study|No longer met inclusion criteria|2|||
126776440|NCT03550794|456137426|FG000|Overall Study|Goals of care changed|1|||
126776441|NCT03550794|456137427|FG001|Overall Study|Goals of care changed|0|||
126776442|NCT03550794|456137426|FG000|Overall Study|Withdrawal by Subject|2|||
126776443|NCT03550794|456137427|FG001|Overall Study|Withdrawal by Subject|0|||
126776444|NCT03550794|456137426|FG000|Overall Study|Death|0|||
126776445|NCT03550794|456137427|FG001|Overall Study|Death|1|||
126776446|NCT01864525|456137428|FG000|Overall Study|Adverse Event|1|||
126776447|NCT01864525|456137429|FG001|Overall Study|Adverse Event|0|||
126776448|NCT00575328|456137432|FG000|Overall Study|Adverse Event|1|||
126776449|NCT00575328|456137433|FG001|Overall Study|Adverse Event|1|||
126776450|NCT00575328|456137432|FG000|Overall Study|Lost to Follow-up|2|||
126776451|NCT00575328|456137433|FG001|Overall Study|Lost to Follow-up|1|||
126776452|NCT01298596|456137445|FG000|Overall Study|Withdrawal by Subject|1|||
126776453|NCT01298596|456137446|FG001|Overall Study|Withdrawal by Subject|1|||
126776454|NCT01298596|456137445|FG000|Overall Study|Death|5|||
126776455|NCT01298596|456137446|FG001|Overall Study|Death|3|||
126776456|NCT01298596|456137445|FG000|Overall Study|Lost to Follow-up|6|||
126776457|NCT01298596|456137446|FG001|Overall Study|Lost to Follow-up|14|||
126776458|NCT01298596|456137445|FG000|Overall Study|Referred for further management|16|||
126776459|NCT01298596|456137446|FG001|Overall Study|Referred for further management|15|||
126776460|NCT04128696|456137449|FG000|Overall Study|Lost to Follow-up|3|||
126776461|NCT04128696|456137450|FG001|Overall Study|Lost to Follow-up|7|||
126776462|NCT04128696|456137449|FG000|Overall Study|Withdrawal by Subject|12|||
126562774|NCT04353037|455355863|FG002|Overall Study|Withdrawal by Subject|3|||
126562775|NCT04353037|455355864|FG003|Overall Study|Withdrawal by Subject|5|||
126562776|NCT04353037|455355861|FG000|Overall Study|Adverse Event|0|||
126562777|NCT04353037|455355862|FG001|Overall Study|Adverse Event|0|||
126562778|NCT04353037|455355863|FG002|Overall Study|Adverse Event|2|||
126562779|NCT04353037|455355864|FG003|Overall Study|Adverse Event|0|||
126562780|NCT04353037|455355861|FG000|Overall Study|Exposure Change|0|||
126562781|NCT04353037|455355862|FG001|Overall Study|Exposure Change|0|||
126562782|NCT04353037|455355863|FG002|Overall Study|Exposure Change|0|||
126776463|NCT04128696|456137450|FG001|Overall Study|Withdrawal by Subject|11|||
126776464|NCT04128696|456137449|FG000|Overall Study|Study Closed/Terminated|26|||
126776465|NCT04128696|456137450|FG001|Overall Study|Study Closed/Terminated|38|||
126776466|NCT04128696|456137449|FG000|Overall Study|Physician Decision|2|||
126776467|NCT04128696|456137450|FG001|Overall Study|Physician Decision|3|||
126776468|NCT00585039|456137451|FG000|Overall Study|medication spilled|2|||
126776469|NCT00585039|456137452|FG001|Overall Study|medication spilled|0|||
126776470|NCT01585831|456137459|FG000|Overall Study|Physician Decision|0|||
126562783|NCT04353037|455355864|FG003|Overall Study|Exposure Change|2|||
126776471|NCT01585831|456137460|FG001|Overall Study|Physician Decision|1|||
126776472|NCT01585831|456137459|FG000|Overall Study|Withdrawal by Subject|2|||
126776473|NCT01585831|456137460|FG001|Overall Study|Withdrawal by Subject|1|||
126562784|NCT03635112|455355865|FG000|Overall Study|Adverse Event|5|||
126562785|NCT03635112|455355866|FG001|Overall Study|Adverse Event|9|||
126562786|NCT03635112|455355867|FG002|Overall Study|Adverse Event|14|||
126776474|NCT02046369|456137461|FG000|Overall Study|Adverse Event|3|||
126776475|NCT02046369|456137462|FG001|Overall Study|Adverse Event|3|||
126776476|NCT02046369|456137461|FG000|Overall Study|Lack of Efficacy|3|||
126776477|NCT02046369|456137462|FG001|Overall Study|Lack of Efficacy|3|||
126776478|NCT02046369|456137461|FG000|Overall Study|Lost to Follow-up|3|||
126503843|NCT02641379|455145166|FG002|Overall Study|PCR positive at Week 48|0|||
126503844|NCT02641379|455145167|FG003|Overall Study|PCR positive at Week 48|0|||
126503845|NCT02641379|455145168|FG004|Overall Study|PCR positive at Week 48|0|||
126503846|NCT02641379|455145169|FG005|Overall Study|PCR positive at Week 48|0|||
126503847|NCT02641379|455145170|FG006|Overall Study|PCR positive at Week 48|0|||
126503848|NCT02641379|455145171|FG007|Overall Study|PCR positive at Week 48|0|||
126503849|NCT02641379|455145172|FG008|Overall Study|PCR positive at Week 48|0|||
126503850|NCT02641379|455145173|FG009|Overall Study|PCR positive at Week 48|0|||
126503851|NCT02641379|455145174|FG010|Overall Study|PCR positive at Week 48|0|||
126503852|NCT02641379|455145164|FG000|Overall Study|PCR not performed at Week 12|0|||
126503853|NCT02641379|455145165|FG001|Overall Study|PCR not performed at Week 12|0|||
126503854|NCT02641379|455145166|FG002|Overall Study|PCR not performed at Week 12|1|||
126503855|NCT02641379|455145167|FG003|Overall Study|PCR not performed at Week 12|0|||
126503856|NCT02641379|455145168|FG004|Overall Study|PCR not performed at Week 12|0|||
126503857|NCT02641379|455145169|FG005|Overall Study|PCR not performed at Week 12|0|||
126503858|NCT02641379|455145170|FG006|Overall Study|PCR not performed at Week 12|0|||
126503859|NCT02641379|455145171|FG007|Overall Study|PCR not performed at Week 12|0|||
126503860|NCT02641379|455145172|FG008|Overall Study|PCR not performed at Week 12|0|||
126503861|NCT02641379|455145173|FG009|Overall Study|PCR not performed at Week 12|0|||
126503862|NCT02641379|455145174|FG010|Overall Study|PCR not performed at Week 12|0|||
126503863|NCT02641379|455145164|FG000|Overall Study|No PCR at baseline|0|||
126503864|NCT02641379|455145165|FG001|Overall Study|No PCR at baseline|0|||
126503865|NCT02641379|455145166|FG002|Overall Study|No PCR at baseline|1|||
126503866|NCT02641379|455145167|FG003|Overall Study|No PCR at baseline|0|||
126503867|NCT02641379|455145168|FG004|Overall Study|No PCR at baseline|0|||
126503868|NCT02641379|455145169|FG005|Overall Study|No PCR at baseline|0|||
126503869|NCT02641379|455145170|FG006|Overall Study|No PCR at baseline|0|||
126503870|NCT02641379|455145171|FG007|Overall Study|No PCR at baseline|0|||
126503871|NCT02641379|455145172|FG008|Overall Study|No PCR at baseline|0|||
126503872|NCT02641379|455145173|FG009|Overall Study|No PCR at baseline|0|||
126503873|NCT02641379|455145174|FG010|Overall Study|No PCR at baseline|0|||
126503874|NCT02641379|455145164|FG000|Overall Study|PCR positive at Week 28|0|||
126503875|NCT02641379|455145165|FG001|Overall Study|PCR positive at Week 28|0|||
126503876|NCT02641379|455145166|FG002|Overall Study|PCR positive at Week 28|1|||
126503877|NCT02641379|455145167|FG003|Overall Study|PCR positive at Week 28|0|||
126503878|NCT02641379|455145168|FG004|Overall Study|PCR positive at Week 28|0|||
126503879|NCT02641379|455145169|FG005|Overall Study|PCR positive at Week 28|0|||
126503880|NCT02641379|455145170|FG006|Overall Study|PCR positive at Week 28|0|||
126503881|NCT02641379|455145171|FG007|Overall Study|PCR positive at Week 28|0|||
126503882|NCT02641379|455145172|FG008|Overall Study|PCR positive at Week 28|0|||
126503883|NCT02641379|455145173|FG009|Overall Study|PCR positive at Week 28|0|||
126503884|NCT02641379|455145174|FG010|Overall Study|PCR positive at Week 28|0|||
126503885|NCT02641379|455145164|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
126503886|NCT02641379|455145165|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
126503887|NCT02641379|455145166|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
126503888|NCT02641379|455145167|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
126503889|NCT02641379|455145168|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
126503890|NCT02641379|455145169|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
126503891|NCT02641379|455145170|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
126503892|NCT02641379|455145171|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
126503893|NCT02641379|455145172|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
126503894|NCT02641379|455145173|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
126503895|NCT02641379|455145174|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
126503896|NCT02641379|455145164|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
126503897|NCT02641379|455145165|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
126503898|NCT02641379|455145166|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
126503899|NCT02641379|455145167|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
126503900|NCT02641379|455145168|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
126503901|NCT02641379|455145169|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
126503902|NCT02641379|455145170|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
126503903|NCT02641379|455145171|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
126503904|NCT02641379|455145172|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
126503905|NCT02641379|455145173|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
126503906|NCT02641379|455145174|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
126503907|NCT02641379|455145164|FG000|Overall Study|Baseline viral load unavailable|0|||
126503908|NCT02641379|455145165|FG001|Overall Study|Baseline viral load unavailable|0|||
126503909|NCT02641379|455145166|FG002|Overall Study|Baseline viral load unavailable|0|||
126503910|NCT02641379|455145167|FG003|Overall Study|Baseline viral load unavailable|1|||
126503911|NCT02641379|455145168|FG004|Overall Study|Baseline viral load unavailable|0|||
126503912|NCT02641379|455145169|FG005|Overall Study|Baseline viral load unavailable|0|||
126503913|NCT02641379|455145170|FG006|Overall Study|Baseline viral load unavailable|0|||
126503914|NCT02641379|455145171|FG007|Overall Study|Baseline viral load unavailable|0|||
126503915|NCT02641379|455145172|FG008|Overall Study|Baseline viral load unavailable|0|||
126503916|NCT02641379|455145173|FG009|Overall Study|Baseline viral load unavailable|0|||
126503917|NCT02641379|455145174|FG010|Overall Study|Baseline viral load unavailable|0|||
126503918|NCT02641379|455145164|FG000|Overall Study|Blood could not be drawn|0|||
126503919|NCT02641379|455145165|FG001|Overall Study|Blood could not be drawn|0|||
126503920|NCT02641379|455145166|FG002|Overall Study|Blood could not be drawn|0|||
126503921|NCT02641379|455145167|FG003|Overall Study|Blood could not be drawn|0|||
126503922|NCT02641379|455145168|FG004|Overall Study|Blood could not be drawn|1|||
126503923|NCT02641379|455145169|FG005|Overall Study|Blood could not be drawn|0|||
126503924|NCT02641379|455145170|FG006|Overall Study|Blood could not be drawn|0|||
126503925|NCT02641379|455145171|FG007|Overall Study|Blood could not be drawn|0|||
126503926|NCT02641379|455145172|FG008|Overall Study|Blood could not be drawn|0|||
126503927|NCT02641379|455145173|FG009|Overall Study|Blood could not be drawn|0|||
126503928|NCT02641379|455145174|FG010|Overall Study|Blood could not be drawn|0|||
126503929|NCT02641379|455145164|FG000|Overall Study|Protocol Violation|0|||
126503930|NCT02641379|455145165|FG001|Overall Study|Protocol Violation|0|||
126503931|NCT02641379|455145166|FG002|Overall Study|Protocol Violation|0|||
126503932|NCT02641379|455145167|FG003|Overall Study|Protocol Violation|0|||
126503933|NCT02641379|455145168|FG004|Overall Study|Protocol Violation|2|||
126503934|NCT02641379|455145169|FG005|Overall Study|Protocol Violation|0|||
126503935|NCT02641379|455145170|FG006|Overall Study|Protocol Violation|0|||
126503936|NCT02641379|455145171|FG007|Overall Study|Protocol Violation|0|||
126503937|NCT02641379|455145172|FG008|Overall Study|Protocol Violation|1|||
126503938|NCT02641379|455145173|FG009|Overall Study|Protocol Violation|0|||
126503939|NCT02641379|455145174|FG010|Overall Study|Protocol Violation|0|||
126503940|NCT02641379|455145164|FG000|Overall Study|Participation in sili rescue study|0|||
126503941|NCT02641379|455145165|FG001|Overall Study|Participation in sili rescue study|0|||
126503942|NCT02641379|455145166|FG002|Overall Study|Participation in sili rescue study|0|||
126503943|NCT02641379|455145167|FG003|Overall Study|Participation in sili rescue study|0|||
126503944|NCT02641379|455145168|FG004|Overall Study|Participation in sili rescue study|0|||
126503945|NCT02641379|455145169|FG005|Overall Study|Participation in sili rescue study|1|||
126503946|NCT02641379|455145170|FG006|Overall Study|Participation in sili rescue study|0|||
126503947|NCT02641379|455145171|FG007|Overall Study|Participation in sili rescue study|0|||
126503948|NCT02641379|455145172|FG008|Overall Study|Participation in sili rescue study|0|||
126503949|NCT02641379|455145173|FG009|Overall Study|Participation in sili rescue study|0|||
126503950|NCT02641379|455145174|FG010|Overall Study|Participation in sili rescue study|0|||
126503951|NCT02641379|455145164|FG000|Overall Study|Lost to Follow-up|0|||
126503952|NCT02641379|455145165|FG001|Overall Study|Lost to Follow-up|0|||
126503953|NCT02641379|455145166|FG002|Overall Study|Lost to Follow-up|0|||
126503954|NCT02641379|455145167|FG003|Overall Study|Lost to Follow-up|0|||
126503955|NCT02641379|455145168|FG004|Overall Study|Lost to Follow-up|0|||
126503956|NCT02641379|455145169|FG005|Overall Study|Lost to Follow-up|0|||
126503957|NCT02641379|455145170|FG006|Overall Study|Lost to Follow-up|0|||
126503958|NCT02641379|455145171|FG007|Overall Study|Lost to Follow-up|0|||
126503959|NCT02641379|455145172|FG008|Overall Study|Lost to Follow-up|1|||
126503960|NCT02641379|455145173|FG009|Overall Study|Lost to Follow-up|0|||
126503961|NCT02641379|455145174|FG010|Overall Study|Lost to Follow-up|0|||
126503962|NCT02641379|455145164|FG000|Overall Study|Source data not found|0|||
126503963|NCT02641379|455145165|FG001|Overall Study|Source data not found|0|||
126503964|NCT02641379|455145166|FG002|Overall Study|Source data not found|0|||
126503965|NCT02641379|455145167|FG003|Overall Study|Source data not found|0|||
126503966|NCT02641379|455145168|FG004|Overall Study|Source data not found|0|||
126503967|NCT02641379|455145169|FG005|Overall Study|Source data not found|1|||
126503968|NCT02641379|455145170|FG006|Overall Study|Source data not found|0|||
126503969|NCT02641379|455145171|FG007|Overall Study|Source data not found|0|||
126503970|NCT02641379|455145172|FG008|Overall Study|Source data not found|0|||
126503971|NCT02641379|455145173|FG009|Overall Study|Source data not found|0|||
126727108|NCT01096849|455951056|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
126727109|NCT01096849|455951054|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
126727110|NCT01096849|455951055|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
126727111|NCT01096849|455951056|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
126503972|NCT02641379|455145174|FG010|Overall Study|Source data not found|0|||
126503973|NCT02641379|455145164|FG000|Overall Study|Participant showed weight reduction|0|||
126503974|NCT02641379|455145165|FG001|Overall Study|Participant showed weight reduction|0|||
126503975|NCT02641379|455145166|FG002|Overall Study|Participant showed weight reduction|0|||
126503976|NCT02641379|455145167|FG003|Overall Study|Participant showed weight reduction|0|||
126503977|NCT02641379|455145168|FG004|Overall Study|Participant showed weight reduction|0|||
126503978|NCT02641379|455145169|FG005|Overall Study|Participant showed weight reduction|0|||
126503979|NCT02641379|455145170|FG006|Overall Study|Participant showed weight reduction|0|||
126503980|NCT02641379|455145171|FG007|Overall Study|Participant showed weight reduction|1|||
126503981|NCT02641379|455145172|FG008|Overall Study|Participant showed weight reduction|0|||
126503982|NCT02641379|455145173|FG009|Overall Study|Participant showed weight reduction|0|||
126503983|NCT02641379|455145174|FG010|Overall Study|Participant showed weight reduction|0|||
126503984|NCT02641379|455145164|FG000|Overall Study|Non-response Week 12|0|||
126503985|NCT02641379|455145165|FG001|Overall Study|Non-response Week 12|0|||
126776479|NCT02046369|456137462|FG001|Overall Study|Lost to Follow-up|3|||
126562787|NCT03635112|455355865|FG000|Overall Study|Lost to Follow-up|1|||
126562788|NCT03635112|455355866|FG001|Overall Study|Lost to Follow-up|0|||
126562789|NCT03635112|455355867|FG002|Overall Study|Lost to Follow-up|1|||
126562790|NCT03635112|455355865|FG000|Overall Study|Physician Decision|5|||
126562791|NCT03635112|455355866|FG001|Overall Study|Physician Decision|7|||
126562792|NCT03635112|455355867|FG002|Overall Study|Physician Decision|5|||
126562793|NCT03635112|455355865|FG000|Overall Study|Protocol Violation|0|||
126562794|NCT03635112|455355866|FG001|Overall Study|Protocol Violation|0|||
126562795|NCT03635112|455355867|FG002|Overall Study|Protocol Violation|1|||
126562796|NCT03635112|455355865|FG000|Overall Study|Study Terminated by Sponsor|11|||
126562797|NCT03635112|455355866|FG001|Overall Study|Study Terminated by Sponsor|17|||
126562798|NCT03635112|455355867|FG002|Overall Study|Study Terminated by Sponsor|21|||
126562799|NCT03635112|455355865|FG000|Overall Study|Withdrawal by Subject|4|||
126562800|NCT03635112|455355866|FG001|Overall Study|Withdrawal by Subject|9|||
126562801|NCT03635112|455355867|FG002|Overall Study|Withdrawal by Subject|7|||
126562802|NCT03635112|455355865|FG000|Overall Study|Miscellaneous|0|||
126562803|NCT03635112|455355866|FG001|Overall Study|Miscellaneous|0|||
126562804|NCT03635112|455355867|FG002|Overall Study|Miscellaneous|1|||
126562805|NCT01941316|455355868|FG000|Overall Study|Adverse Event|0|||
126562806|NCT01941316|455355869|FG001|Overall Study|Adverse Event|1|||
126562807|NCT01941316|455355870|FG002|Overall Study|Adverse Event|0|||
126562808|NCT01941316|455355871|FG003|Overall Study|Adverse Event|7|||
126562809|NCT01941316|455355868|FG000|Overall Study|Progressive Disease|3|||
126562810|NCT01941316|455355869|FG001|Overall Study|Progressive Disease|6|||
126562811|NCT01941316|455355870|FG002|Overall Study|Progressive Disease|2|||
126562812|NCT01941316|455355871|FG003|Overall Study|Progressive Disease|29|||
126562813|NCT01941316|455355868|FG000|Overall Study|Withdrawal by Subject|0|||
126562814|NCT01941316|455355869|FG001|Overall Study|Withdrawal by Subject|2|||
126562815|NCT01941316|455355870|FG002|Overall Study|Withdrawal by Subject|1|||
126562816|NCT01941316|455355871|FG003|Overall Study|Withdrawal by Subject|8|||
126562817|NCT01941316|455355868|FG000|Overall Study|Death|0|||
126562818|NCT01941316|455355869|FG001|Overall Study|Death|0|||
126562819|NCT01941316|455355870|FG002|Overall Study|Death|0|||
126562820|NCT01941316|455355871|FG003|Overall Study|Death|3|||
126562821|NCT01941316|455355868|FG000|Overall Study|Physician Decision|0|||
126562822|NCT01941316|455355869|FG001|Overall Study|Physician Decision|0|||
126562823|NCT01941316|455355870|FG002|Overall Study|Physician Decision|0|||
126562824|NCT01941316|455355871|FG003|Overall Study|Physician Decision|3|||
126562825|NCT01941316|455355868|FG000|Overall Study|Protocol Violation|0|||
126562826|NCT01941316|455355869|FG001|Overall Study|Protocol Violation|0|||
126562827|NCT01941316|455355870|FG002|Overall Study|Protocol Violation|0|||
126562828|NCT01941316|455355871|FG003|Overall Study|Protocol Violation|3|||
126562829|NCT01941316|455355868|FG000|Overall Study|Intercurrent illness|0|||
126562830|NCT01941316|455355869|FG001|Overall Study|Intercurrent illness|0|||
126562831|NCT01941316|455355870|FG002|Overall Study|Intercurrent illness|0|||
126562832|NCT01941316|455355871|FG003|Overall Study|Intercurrent illness|1|||
126562833|NCT01941316|455355868|FG000|Overall Study|Other, not specified|0|||
126562834|NCT01941316|455355869|FG001|Overall Study|Other, not specified|0|||
126562835|NCT01941316|455355870|FG002|Overall Study|Other, not specified|0|||
126562836|NCT01941316|455355871|FG003|Overall Study|Other, not specified|1|||
126562837|NCT00117988|455355878|FG000|Overall Study|Death|3|||
126562838|NCT00117988|455355878|FG000|Overall Study|Adverse Event|1|||
126503986|NCT02641379|455145166|FG002|Overall Study|Non-response Week 12|0|||
126503987|NCT02641379|455145167|FG003|Overall Study|Non-response Week 12|0|||
126503988|NCT02641379|455145168|FG004|Overall Study|Non-response Week 12|0|||
126503989|NCT02641379|455145169|FG005|Overall Study|Non-response Week 12|0|||
126503990|NCT02641379|455145170|FG006|Overall Study|Non-response Week 12|0|||
126503991|NCT02641379|455145171|FG007|Overall Study|Non-response Week 12|1|||
126503992|NCT02641379|455145172|FG008|Overall Study|Non-response Week 12|0|||
126503993|NCT02641379|455145173|FG009|Overall Study|Non-response Week 12|0|||
126503994|NCT02641379|455145174|FG010|Overall Study|Non-response Week 12|0|||
126503995|NCT02641379|455145164|FG000|Overall Study|No 2 Log drop at Week 12|0|||
126503996|NCT02641379|455145165|FG001|Overall Study|No 2 Log drop at Week 12|0|||
126562839|NCT05196737|455355879|FG000|Non-intervention Week|Lost to Follow-up|2|||
126562840|NCT05196737|455355879|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
126562841|NCT05096884|455355880|FG000|Overall Study|Excluded based on negative tilt table test|4|||
126562842|NCT01096056|455355881|FG000|Overall Study|Lost to Follow-up|0|||
126562843|NCT01096056|455355882|FG001|Overall Study|Lost to Follow-up|1|||
126562844|NCT03568162|455355884|FG000|Overall Study|Adverse Event|0|||
126562845|NCT03568162|455355885|FG001|Overall Study|Adverse Event|1|||
126562846|NCT03568162|455355886|FG002|Overall Study|Adverse Event|2|||
126503997|NCT02641379|455145166|FG002|Overall Study|No 2 Log drop at Week 12|0|||
126503998|NCT02641379|455145167|FG003|Overall Study|No 2 Log drop at Week 12|0|||
126562847|NCT03568162|455355887|FG003|Overall Study|Adverse Event|0|||
126562848|NCT03568162|455355888|FG004|Overall Study|Adverse Event|0|||
126562849|NCT03568162|455355889|FG005|Overall Study|Adverse Event|1|||
126562850|NCT03568162|455355884|FG000|Overall Study|Death|0|||
126562851|NCT03568162|455355885|FG001|Overall Study|Death|0|||
126562852|NCT03568162|455355886|FG002|Overall Study|Death|0|||
126776480|NCT02046369|456137461|FG000|Overall Study|Protocol Violation|1|||
126776481|NCT02046369|456137462|FG001|Overall Study|Protocol Violation|2|||
126776482|NCT02046369|456137461|FG000|Overall Study|Withdrawal by Subject|3|||
126776483|NCT02046369|456137462|FG001|Overall Study|Withdrawal by Subject|6|||
126776484|NCT02046369|456137461|FG000|Overall Study|never received study drug|0|||
126776485|NCT02046369|456137462|FG001|Overall Study|never received study drug|1|||
126776486|NCT02046369|456137461|FG000|Overall Study|non compliance|1|||
126776487|NCT02046369|456137462|FG001|Overall Study|non compliance|0|||
126503999|NCT02641379|455145168|FG004|Overall Study|No 2 Log drop at Week 12|0|||
126562853|NCT03568162|455355887|FG003|Overall Study|Death|0|||
126562854|NCT03568162|455355888|FG004|Overall Study|Death|1|||
126562855|NCT03568162|455355889|FG005|Overall Study|Death|0|||
126562856|NCT03568162|455355884|FG000|Overall Study|Lost to Follow-up|3|||
126562857|NCT03568162|455355885|FG001|Overall Study|Lost to Follow-up|2|||
126562858|NCT03568162|455355886|FG002|Overall Study|Lost to Follow-up|4|||
126562859|NCT03568162|455355887|FG003|Overall Study|Lost to Follow-up|2|||
126562860|NCT03568162|455355888|FG004|Overall Study|Lost to Follow-up|3|||
126562861|NCT03568162|455355889|FG005|Overall Study|Lost to Follow-up|2|||
126562862|NCT03568162|455355884|FG000|Overall Study|Physician Decision|0|||
126562863|NCT03568162|455355885|FG001|Overall Study|Physician Decision|1|||
126562864|NCT03568162|455355886|FG002|Overall Study|Physician Decision|1|||
126562865|NCT03568162|455355887|FG003|Overall Study|Physician Decision|0|||
126562866|NCT03568162|455355888|FG004|Overall Study|Physician Decision|1|||
126562867|NCT03568162|455355889|FG005|Overall Study|Physician Decision|0|||
126562868|NCT03568162|455355884|FG000|Overall Study|Pregnancy|0|||
126562869|NCT03568162|455355885|FG001|Overall Study|Pregnancy|0|||
126562870|NCT03568162|455355886|FG002|Overall Study|Pregnancy|0|||
126562871|NCT03568162|455355887|FG003|Overall Study|Pregnancy|1|||
126562872|NCT03568162|455355888|FG004|Overall Study|Pregnancy|0|||
126562873|NCT03568162|455355889|FG005|Overall Study|Pregnancy|0|||
126562874|NCT03568162|455355884|FG000|Overall Study|Protocol Violation|1|||
126562875|NCT03568162|455355885|FG001|Overall Study|Protocol Violation|0|||
126562876|NCT03568162|455355886|FG002|Overall Study|Protocol Violation|1|||
126562877|NCT03568162|455355887|FG003|Overall Study|Protocol Violation|1|||
126562878|NCT03568162|455355888|FG004|Overall Study|Protocol Violation|1|||
126562879|NCT03568162|455355889|FG005|Overall Study|Protocol Violation|1|||
126776488|NCT03120520|456137463|FG000|Overall Study|Lost to Follow-up|1|||
126776489|NCT03120520|456137464|FG001|Overall Study|Lost to Follow-up|1|||
126504000|NCT02641379|455145169|FG005|Overall Study|No 2 Log drop at Week 12|0|||
126504001|NCT02641379|455145170|FG006|Overall Study|No 2 Log drop at Week 12|0|||
126504002|NCT02641379|455145171|FG007|Overall Study|No 2 Log drop at Week 12|0|||
126504003|NCT02641379|455145172|FG008|Overall Study|No 2 Log drop at Week 12|0|||
126504004|NCT02641379|455145173|FG009|Overall Study|No 2 Log drop at Week 12|0|||
126504005|NCT02641379|455145174|FG010|Overall Study|No 2 Log drop at Week 12|1|||
126504006|NCT02641379|455145164|FG000|Overall Study|Negative PCR result|0|||
126504007|NCT02641379|455145165|FG001|Overall Study|Negative PCR result|0|||
126504008|NCT02641379|455145166|FG002|Overall Study|Negative PCR result|0|||
126504009|NCT02641379|455145167|FG003|Overall Study|Negative PCR result|0|||
126504010|NCT02641379|455145168|FG004|Overall Study|Negative PCR result|0|||
126504011|NCT02641379|455145169|FG005|Overall Study|Negative PCR result|0|||
126504012|NCT02641379|455145170|FG006|Overall Study|Negative PCR result|0|||
126504013|NCT02641379|455145171|FG007|Overall Study|Negative PCR result|0|||
126504014|NCT02641379|455145172|FG008|Overall Study|Negative PCR result|0|||
126504015|NCT02641379|455145173|FG009|Overall Study|Negative PCR result|1|||
126504016|NCT02641379|455145174|FG010|Overall Study|Negative PCR result|0|||
126504017|NCT02641379|455145164|FG000|Overall Study|Participant's PCR high|0|||
126504018|NCT02641379|455145165|FG001|Overall Study|Participant's PCR high|0|||
126504019|NCT02641379|455145166|FG002|Overall Study|Participant's PCR high|0|||
126504020|NCT02641379|455145167|FG003|Overall Study|Participant's PCR high|0|||
126504021|NCT02641379|455145168|FG004|Overall Study|Participant's PCR high|0|||
126504022|NCT02641379|455145169|FG005|Overall Study|Participant's PCR high|0|||
126504023|NCT02641379|455145170|FG006|Overall Study|Participant's PCR high|0|||
126504024|NCT02641379|455145171|FG007|Overall Study|Participant's PCR high|1|||
126504025|NCT02641379|455145172|FG008|Overall Study|Participant's PCR high|0|||
126504026|NCT02641379|455145173|FG009|Overall Study|Participant's PCR high|0|||
126504027|NCT02641379|455145174|FG010|Overall Study|Participant's PCR high|0|||
126562880|NCT03568162|455355884|FG000|Overall Study|Withdrawal by Subject|15|||
126562881|NCT03568162|455355885|FG001|Overall Study|Withdrawal by Subject|15|||
126562882|NCT03568162|455355886|FG002|Overall Study|Withdrawal by Subject|26|||
126562883|NCT03568162|455355887|FG003|Overall Study|Withdrawal by Subject|22|||
126562884|NCT03568162|455355888|FG004|Overall Study|Withdrawal by Subject|6|||
126562885|NCT03568162|455355889|FG005|Overall Study|Withdrawal by Subject|9|||
126776490|NCT03120520|456137465|FG002|Overall Study|Lost to Follow-up|1|||
126776491|NCT03120520|456137466|FG003|Overall Study|Lost to Follow-up|1|||
126562886|NCT03568162|455355884|FG000|Overall Study|Others|3|||
126562887|NCT03568162|455355885|FG001|Overall Study|Others|4|||
126562888|NCT03568162|455355886|FG002|Overall Study|Others|1|||
126562889|NCT03568162|455355887|FG003|Overall Study|Others|4|||
126562890|NCT03568162|455355888|FG004|Overall Study|Others|2|||
126562891|NCT03568162|455355889|FG005|Overall Study|Others|1|||
126776492|NCT03120520|456137463|FG000|Overall Study|Withdrawal by Subject|3|||
126776493|NCT03120520|456137464|FG001|Overall Study|Withdrawal by Subject|2|||
126776494|NCT03120520|456137465|FG002|Overall Study|Withdrawal by Subject|3|||
126776495|NCT03120520|456137466|FG003|Overall Study|Withdrawal by Subject|2|||
126776496|NCT03120520|456137463|FG000|Overall Study|Other|0|||
126776497|NCT03120520|456137464|FG001|Overall Study|Other|1|||
126776498|NCT03120520|456137465|FG002|Overall Study|Other|0|||
126776499|NCT03120520|456137466|FG003|Overall Study|Other|0|||
126776500|NCT02133352|456137470|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
126776501|NCT00579254|456137471|FG000|Overall Study|Lost to Follow-up|39|||
126776502|NCT00579254|456137471|FG000|Overall Study|Discontinued when study terminated|73|||
126776503|NCT02557672|456137472|FG000|Overall Study|Withdrawal by Subject|4|||
126776504|NCT02557672|456137473|FG001|Overall Study|Withdrawal by Subject|2|||
126776505|NCT03705169|456137474|FG000|Overall Study|Lost to Follow-up|0|||
126776506|NCT03705169|456137475|FG001|Overall Study|Lost to Follow-up|0|||
126776507|NCT03705169|456137476|FG002|Overall Study|Lost to Follow-up|0|||
126776508|NCT03705169|456137477|FG003|Overall Study|Lost to Follow-up|2|||
126776509|NCT03705169|456137478|FG004|Overall Study|Lost to Follow-up|0|||
126776510|NCT03705169|456137479|FG005|Overall Study|Lost to Follow-up|2|||
126776511|NCT03705169|456137480|FG006|Overall Study|Lost to Follow-up|1|||
126776512|NCT03705169|456137481|FG007|Overall Study|Lost to Follow-up|0|||
126776513|NCT03705169|456137482|FG008|Overall Study|Lost to Follow-up|0|||
126776514|NCT03705169|456137483|FG009|Overall Study|Lost to Follow-up|1|||
126776515|NCT03705169|456137474|FG000|Overall Study|Adverse Event|0|||
126776516|NCT03705169|456137475|FG001|Overall Study|Adverse Event|0|||
126776517|NCT03705169|456137476|FG002|Overall Study|Adverse Event|0|||
126776518|NCT03705169|456137477|FG003|Overall Study|Adverse Event|1|||
126776519|NCT03705169|456137478|FG004|Overall Study|Adverse Event|0|||
126776520|NCT03705169|456137479|FG005|Overall Study|Adverse Event|0|||
126776521|NCT03705169|456137480|FG006|Overall Study|Adverse Event|0|||
126776522|NCT03705169|456137481|FG007|Overall Study|Adverse Event|0|||
126776523|NCT03705169|456137482|FG008|Overall Study|Adverse Event|0|||
126776524|NCT03705169|456137483|FG009|Overall Study|Adverse Event|0|||
126776525|NCT03705169|456137474|FG000|Overall Study|Site Closure|0|||
126776526|NCT03705169|456137475|FG001|Overall Study|Site Closure|0|||
126776527|NCT03705169|456137476|FG002|Overall Study|Site Closure|0|||
126776528|NCT03705169|456137477|FG003|Overall Study|Site Closure|1|||
126776529|NCT03705169|456137478|FG004|Overall Study|Site Closure|0|||
126776530|NCT03705169|456137479|FG005|Overall Study|Site Closure|0|||
126776531|NCT03705169|456137480|FG006|Overall Study|Site Closure|0|||
126776532|NCT03705169|456137481|FG007|Overall Study|Site Closure|0|||
126776533|NCT03705169|456137482|FG008|Overall Study|Site Closure|0|||
126776534|NCT03705169|456137483|FG009|Overall Study|Site Closure|0|||
126504028|NCT02641379|455145164|FG000|Overall Study|Participant treated after Week 24|0|||
126504029|NCT02641379|455145165|FG001|Overall Study|Participant treated after Week 24|0|||
126504030|NCT02641379|455145166|FG002|Overall Study|Participant treated after Week 24|0|||
126504031|NCT02641379|455145167|FG003|Overall Study|Participant treated after Week 24|0|||
126504032|NCT02641379|455145168|FG004|Overall Study|Participant treated after Week 24|0|||
126504033|NCT02641379|455145169|FG005|Overall Study|Participant treated after Week 24|0|||
126504034|NCT02641379|455145170|FG006|Overall Study|Participant treated after Week 24|0|||
126504035|NCT02641379|455145171|FG007|Overall Study|Participant treated after Week 24|0|||
126504036|NCT02641379|455145172|FG008|Overall Study|Participant treated after Week 24|1|||
126504037|NCT02641379|455145173|FG009|Overall Study|Participant treated after Week 24|0|||
126504038|NCT02641379|455145174|FG010|Overall Study|Participant treated after Week 24|0|||
126504039|NCT02641379|455145164|FG000|Overall Study|Missing PCR result at Week 8|0|||
126504040|NCT02641379|455145165|FG001|Overall Study|Missing PCR result at Week 8|0|||
126504041|NCT02641379|455145166|FG002|Overall Study|Missing PCR result at Week 8|0|||
126504042|NCT02641379|455145167|FG003|Overall Study|Missing PCR result at Week 8|0|||
126504043|NCT02641379|455145168|FG004|Overall Study|Missing PCR result at Week 8|0|||
126504044|NCT02641379|455145169|FG005|Overall Study|Missing PCR result at Week 8|0|||
126504045|NCT02641379|455145170|FG006|Overall Study|Missing PCR result at Week 8|0|||
126504046|NCT02641379|455145171|FG007|Overall Study|Missing PCR result at Week 8|0|||
126504047|NCT02641379|455145172|FG008|Overall Study|Missing PCR result at Week 8|0|||
126504048|NCT02641379|455145173|FG009|Overall Study|Missing PCR result at Week 8|1|||
126504049|NCT02641379|455145174|FG010|Overall Study|Missing PCR result at Week 8|0|||
126504050|NCT02641379|455145164|FG000|Overall Study|PCR positive|0|||
126504051|NCT02641379|455145165|FG001|Overall Study|PCR positive|0|||
126504052|NCT02641379|455145166|FG002|Overall Study|PCR positive|0|||
126504053|NCT02641379|455145167|FG003|Overall Study|PCR positive|0|||
126504054|NCT02641379|455145168|FG004|Overall Study|PCR positive|0|||
126504055|NCT02641379|455145169|FG005|Overall Study|PCR positive|0|||
126776535|NCT03705169|456137474|FG000|Overall Study|Did not receive study treatment|0|||
126776536|NCT03705169|456137475|FG001|Overall Study|Did not receive study treatment|0|||
126776537|NCT03705169|456137476|FG002|Overall Study|Did not receive study treatment|0|||
126776538|NCT03705169|456137477|FG003|Overall Study|Did not receive study treatment|1|||
126504056|NCT02641379|455145170|FG006|Overall Study|PCR positive|1|||
126504057|NCT02641379|455145171|FG007|Overall Study|PCR positive|0|||
126504058|NCT02641379|455145172|FG008|Overall Study|PCR positive|0|||
126504059|NCT02641379|455145173|FG009|Overall Study|PCR positive|0|||
126504060|NCT02641379|455145174|FG010|Overall Study|PCR positive|0|||
126504061|NCT01165138|455145175|FG000|Overall Study|Adverse Event|0|||
126504062|NCT01165138|455145176|FG001|Overall Study|Adverse Event|1|||
126504063|NCT01165138|455145177|FG002|Overall Study|Adverse Event|0|||
126504064|NCT01165138|455145178|FG003|Overall Study|Adverse Event|2|||
126504065|NCT01165138|455145175|FG000|Overall Study|Lack of Efficacy|0|||
126562892|NCT03717194|455355890|FG000|Overall Study|Withdrawal by Subject|2|||
126562893|NCT03717194|455355891|FG001|Overall Study|Withdrawal by Subject|4|||
126562894|NCT03717194|455355890|FG000|Overall Study|Adverse Event|1|||
126562895|NCT03717194|455355891|FG001|Overall Study|Adverse Event|1|||
126562896|NCT00337818|455355892|FG000|Overall Study|Lost to Follow-up|289|||
126562897|NCT00337818|455355893|FG001|Overall Study|Lost to Follow-up|91|||
126562898|NCT00337818|455355894|FG002|Overall Study|Lost to Follow-up|107|||
126562899|NCT03563053|455355897|FG000|Overall Study|Withdrawal by Subject|17|||
126562900|NCT03563053|455355897|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
126562901|NCT03563053|455355897|FG000|Overall Study|Adverse Event|3|||
126562902|NCT03563053|455355897|FG000|Overall Study|Physician Decision|1|||
126562903|NCT03563053|455355897|FG000|Overall Study|study terminated by sponsor|71|||
126562904|NCT02081391|455355898|FG000|12-hour Treatment|Withdrawal by Subject|3|||
126562905|NCT02081391|455355899|FG001|12-hour Treatment|Withdrawal by Subject|2|||
126562906|NCT02081391|455355900|FG002|12-hour Treatment|Withdrawal by Subject|0|||
126562907|NCT02081391|455355901|FG003|12-hour Treatment|Withdrawal by Subject|0|||
126562908|NCT02081391|455355898|FG000|12-hour Treatment|Physician Decision|4|||
126562909|NCT02081391|455355899|FG001|12-hour Treatment|Physician Decision|1|||
126562910|NCT02081391|455355900|FG002|12-hour Treatment|Physician Decision|0|||
126562911|NCT02081391|455355901|FG003|12-hour Treatment|Physician Decision|0|||
126562912|NCT02081391|455355898|FG000|12-hour Treatment|Lack of Efficacy|3|||
126562913|NCT02081391|455355899|FG001|12-hour Treatment|Lack of Efficacy|0|||
126504066|NCT01165138|455145176|FG001|Overall Study|Lack of Efficacy|32|||
126504067|NCT01165138|455145177|FG002|Overall Study|Lack of Efficacy|6|||
126504068|NCT01165138|455145178|FG003|Overall Study|Lack of Efficacy|7|||
126504069|NCT01165138|455145175|FG000|Overall Study|Protocol Violation|0|||
126504070|NCT01165138|455145176|FG001|Overall Study|Protocol Violation|7|||
126504071|NCT01165138|455145177|FG002|Overall Study|Protocol Violation|0|||
126504072|NCT01165138|455145178|FG003|Overall Study|Protocol Violation|2|||
126504073|NCT01165138|455145175|FG000|Overall Study|Lost to Follow-up|0|||
126504074|NCT01165138|455145176|FG001|Overall Study|Lost to Follow-up|0|||
126504075|NCT01165138|455145177|FG002|Overall Study|Lost to Follow-up|1|||
126504076|NCT01165138|455145178|FG003|Overall Study|Lost to Follow-up|2|||
126504077|NCT01165138|455145175|FG000|Overall Study|Physician Decision|0|||
126504078|NCT01165138|455145176|FG001|Overall Study|Physician Decision|6|||
126504079|NCT01165138|455145177|FG002|Overall Study|Physician Decision|7|||
126504080|NCT01165138|455145178|FG003|Overall Study|Physician Decision|6|||
126504081|NCT01165138|455145175|FG000|Overall Study|Withdrawal by Subject|0|||
126504082|NCT01165138|455145176|FG001|Overall Study|Withdrawal by Subject|6|||
126504083|NCT01165138|455145177|FG002|Overall Study|Withdrawal by Subject|6|||
126504084|NCT01165138|455145178|FG003|Overall Study|Withdrawal by Subject|3|||
126504085|NCT04982250|455145179|FG000|Overall Study|Lost to Follow-up|0|||
126504086|NCT04982250|455145180|FG001|Overall Study|Lost to Follow-up|26|||
126504087|NCT04982250|455145181|FG002|Overall Study|Lost to Follow-up|0|||
126504088|NCT04982250|455145182|FG003|Overall Study|Lost to Follow-up|0|||
126504089|NCT04982250|455145183|FG004|Overall Study|Lost to Follow-up|72|||
126562914|NCT02081391|455355900|FG002|12-hour Treatment|Lack of Efficacy|0|||
126504090|NCT04982250|455145184|FG005|Overall Study|Lost to Follow-up|69|||
126504091|NCT04982250|455145179|FG000|Overall Study|Not Eligible to Enroll|0|||
126504092|NCT04982250|455145180|FG001|Overall Study|Not Eligible to Enroll|0|||
126504093|NCT04982250|455145181|FG002|Overall Study|Not Eligible to Enroll|0|||
126504094|NCT04982250|455145182|FG003|Overall Study|Not Eligible to Enroll|0|||
126504095|NCT04982250|455145183|FG004|Overall Study|Not Eligible to Enroll|10|||
126504096|NCT04982250|455145184|FG005|Overall Study|Not Eligible to Enroll|7|||
126504097|NCT01644175|455145185|FG000|Overall Study|Randomized But Not Treated|0|||
126504098|NCT01644175|455145186|FG001|Overall Study|Randomized But Not Treated|2|||
126504099|NCT01644175|455145185|FG000|Overall Study|Adverse Event|8|||
126504100|NCT01644175|455145186|FG001|Overall Study|Adverse Event|13|||
126562915|NCT02081391|455355901|FG003|12-hour Treatment|Lack of Efficacy|0|||
126504101|NCT01644175|455145185|FG000|Overall Study|Death|1|||
126504102|NCT01644175|455145186|FG001|Overall Study|Death|2|||
126562916|NCT02081391|455355898|FG000|12-hour Treatment|Adverse Event|4|||
126562917|NCT02081391|455355899|FG001|12-hour Treatment|Adverse Event|2|||
126562918|NCT02081391|455355900|FG002|12-hour Treatment|Adverse Event|0|||
126562919|NCT02081391|455355901|FG003|12-hour Treatment|Adverse Event|0|||
126504103|NCT01644175|455145185|FG000|Overall Study|Poor compliance to protocol|9|||
126504104|NCT01644175|455145186|FG001|Overall Study|Poor compliance to protocol|10|||
126504105|NCT01644175|455145185|FG000|Overall Study|Physician Decision|1|||
126504106|NCT01644175|455145186|FG001|Overall Study|Physician Decision|2|||
126504107|NCT01644175|455145185|FG000|Overall Study|Participant Moved|1|||
126504108|NCT01644175|455145186|FG001|Overall Study|Participant Moved|2|||
126504109|NCT01644175|455145185|FG000|Overall Study|Consent withdrawn by participant|3|||
126562920|NCT02081391|455355898|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
126562921|NCT02081391|455355899|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
126562922|NCT02081391|455355900|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
126504110|NCT01644175|455145186|FG001|Overall Study|Consent withdrawn by participant|4|||
126504111|NCT01644175|455145185|FG000|Overall Study|Related to Autoinjector Administration|2|||
126504112|NCT01644175|455145186|FG001|Overall Study|Related to Autoinjector Administration|1|||
126504113|NCT01644175|455145185|FG000|Overall Study|Last visit outside protocol visit window|4|||
126504114|NCT01644175|455145186|FG001|Overall Study|Last visit outside protocol visit window|11|||
126562923|NCT02081391|455355901|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
126562924|NCT02081391|455355898|FG000|12-hour Treatment|Further reasons|2|||
126562925|NCT02081391|455355899|FG001|12-hour Treatment|Further reasons|1|||
126562926|NCT02081391|455355900|FG002|12-hour Treatment|Further reasons|0|||
126504115|NCT01644175|455145185|FG000|Overall Study|Selection criteria finally not met|0|||
126504116|NCT01644175|455145186|FG001|Overall Study|Selection criteria finally not met|1|||
126504117|NCT01644175|455145185|FG000|Overall Study|Site closure|2|||
126504118|NCT01644175|455145186|FG001|Overall Study|Site closure|2|||
126504119|NCT01644175|455145185|FG000|Overall Study|Lost to Follow-up|1|||
126504120|NCT01644175|455145186|FG001|Overall Study|Lost to Follow-up|0|||
126504121|NCT01644175|455145185|FG000|Overall Study|Other than specified above|0|||
126562927|NCT02081391|455355901|FG003|12-hour Treatment|Further reasons|0|||
126562928|NCT02081391|455355898|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
126562929|NCT02081391|455355899|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
126562930|NCT02081391|455355900|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
126562931|NCT02081391|455355901|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
126562932|NCT02081391|455355898|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
126562933|NCT02081391|455355899|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
126562934|NCT02081391|455355900|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
126562935|NCT02081391|455355901|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
126562936|NCT02081391|455355898|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
126562937|NCT02081391|455355899|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
126562938|NCT02081391|455355900|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
126562939|NCT02081391|455355901|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
126562940|NCT02081391|455355898|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
126562941|NCT02081391|455355899|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
126562942|NCT02081391|455355900|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
126562943|NCT02081391|455355901|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
126562944|NCT02081391|455355898|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
126727112|NCT01096849|455951054|FG000|Overall Study|Administrative Reasons|0|||
126727113|NCT01096849|455951055|FG001|Overall Study|Administrative Reasons|1|||
126727114|NCT01096849|455951056|FG002|Overall Study|Administrative Reasons|2|||
126727115|NCT01096849|455951054|FG000|Overall Study|Lost to Follow-up|1|||
126727116|NCT01096849|455951055|FG001|Overall Study|Lost to Follow-up|3|||
126727117|NCT01096849|455951056|FG002|Overall Study|Lost to Follow-up|1|||
126727118|NCT00118482|455951058|FG000|Overall Study|Lost to Follow-up|7|||
126727119|NCT00118482|455951059|FG001|Overall Study|Lost to Follow-up|7|||
126727120|NCT00118482|455951058|FG000|Overall Study|Withdrawal by Subject|23|||
126504122|NCT01644175|455145186|FG001|Overall Study|Other than specified above|3|||
126504123|NCT01418937|455145192|FG000|Overall Study|Lost to Follow-up|5|||
126504124|NCT01418937|455145192|FG000|Overall Study|Protocol Violation|1|||
126504125|NCT01418937|455145192|FG000|Overall Study|Pregnancy|1|||
126504126|NCT01418937|455145192|FG000|Overall Study|Withdrawal by Subject|1|||
126504127|NCT00842348|455145193|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
126504128|NCT00842348|455145194|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
126504129|NCT00842348|455145193|FG000|Study 729|Disease progression/death|19|||
126504130|NCT00842348|455145194|FG001|Study 729|Disease progression/death|30|||
126504131|NCT00842348|455145193|FG000|Study 729|Adverse Event|1|||
126504132|NCT00842348|455145194|FG001|Study 729|Adverse Event|1|||
126562945|NCT02081391|455355899|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
126727121|NCT00118482|455951059|FG001|Overall Study|Withdrawal by Subject|22|||
126727122|NCT00242580|455951060|FG000|Overall Study|Adverse Event|3|||
126504133|NCT00842348|455145193|FG000|Study 729|Protocol Violation|1|||
126562946|NCT02081391|455355900|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
126562947|NCT02081391|455355901|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
126562948|NCT02081391|455355898|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
126562949|NCT02081391|455355899|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
126727123|NCT00242580|455951061|FG001|Overall Study|Adverse Event|0|||
126727124|NCT00242580|455951062|FG002|Overall Study|Adverse Event|2|||
126727125|NCT00242580|455951060|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126504134|NCT00842348|455145194|FG001|Study 729|Protocol Violation|1|||
126504135|NCT00842348|455145193|FG000|Study 729|Withdrawal by Subject|2|||
126504136|NCT00842348|455145194|FG001|Study 729|Withdrawal by Subject|4|||
126504137|NCT00842348|455145193|FG000|Study 729|Due to Sponsor stopping the study|1|||
126504138|NCT00842348|455145194|FG001|Study 729|Due to Sponsor stopping the study|1|||
126504139|NCT00842348|455145193|FG000|Study 729|Due to non-availability of IP|0|||
126504140|NCT00842348|455145194|FG001|Study 729|Due to non-availability of IP|1|||
126504141|NCT00842348|455145193|FG000|Study 729|Sponsor's decision|1|||
126504142|NCT00842348|455145194|FG001|Study 729|Sponsor's decision|0|||
126504143|NCT00842348|455145193|FG000|Study 729|Surgical resection|1|||
126504144|NCT00842348|455145194|FG001|Study 729|Surgical resection|0|||
126504145|NCT03274986|455145195|FG000|Overall Study|Withdrawal by Subject|0|||
126504146|NCT03274986|455145196|FG001|Overall Study|Withdrawal by Subject|1|||
126504147|NCT03274986|455145195|FG000|Overall Study|Lost to Follow-up|0|||
126504148|NCT03274986|455145196|FG001|Overall Study|Lost to Follow-up|1|||
126504149|NCT01524627|455145202|FG000|Overall Study|Physician Decision|0|||
126504150|NCT01524627|455145203|FG001|Overall Study|Physician Decision|1|||
126504151|NCT01524627|455145202|FG000|Overall Study|Lost to Follow-up|1|||
126504152|NCT01524627|455145203|FG001|Overall Study|Lost to Follow-up|1|||
126504153|NCT03323658|455145204|FG000|Overall Study|Adverse Event|0|||
126504154|NCT03323658|455145205|FG001|Overall Study|Adverse Event|1|||
126504155|NCT03323658|455145206|FG002|Overall Study|Adverse Event|0|||
126504156|NCT00615056|455145207|FG000|Overall Study|Death|31|||
126504157|NCT00615056|455145208|FG001|Overall Study|Death|31|||
126504158|NCT00615056|455145209|FG002|Overall Study|Death|21|||
126504159|NCT00615056|455145210|FG003|Overall Study|Death|23|||
126504160|NCT00615056|455145207|FG000|Overall Study|Lost to Follow-up|1|||
126504161|NCT00615056|455145208|FG001|Overall Study|Lost to Follow-up|2|||
126504162|NCT00615056|455145209|FG002|Overall Study|Lost to Follow-up|4|||
126504163|NCT00615056|455145210|FG003|Overall Study|Lost to Follow-up|5|||
126504164|NCT00615056|455145207|FG000|Overall Study|Other|13|||
126504165|NCT00615056|455145208|FG001|Overall Study|Other|15|||
126504166|NCT00615056|455145209|FG002|Overall Study|Other|10|||
126504167|NCT00615056|455145210|FG003|Overall Study|Other|7|||
126504168|NCT00615056|455145207|FG000|Overall Study|Objective progression or relapse|0|||
126504169|NCT00615056|455145208|FG001|Overall Study|Objective progression or relapse|2|||
126504170|NCT00615056|455145209|FG002|Overall Study|Objective progression or relapse|0|||
126504171|NCT00615056|455145210|FG003|Overall Study|Objective progression or relapse|0|||
126504172|NCT00615056|455145207|FG000|Overall Study|Withdrawal by Subject|0|||
126504173|NCT00615056|455145208|FG001|Overall Study|Withdrawal by Subject|1|||
126504174|NCT00615056|455145209|FG002|Overall Study|Withdrawal by Subject|1|||
126504175|NCT00615056|455145210|FG003|Overall Study|Withdrawal by Subject|0|||
126504176|NCT00615056|455145207|FG000|Overall Study|Discontinued by Sponsor|1|||
126504177|NCT00615056|455145208|FG001|Overall Study|Discontinued by Sponsor|0|||
126504178|NCT00615056|455145209|FG002|Overall Study|Discontinued by Sponsor|0|||
126504179|NCT00615056|455145210|FG003|Overall Study|Discontinued by Sponsor|0|||
126504180|NCT00615056|455145207|FG000|Overall Study|Randomized but not treated|3|||
126504181|NCT00615056|455145208|FG001|Overall Study|Randomized but not treated|0|||
126504182|NCT00615056|455145209|FG002|Overall Study|Randomized but not treated|0|||
126504183|NCT00615056|455145210|FG003|Overall Study|Randomized but not treated|0|||
126504184|NCT02276612|455145211|FG000|Overall Study|Death|1|||
126504185|NCT02276612|455145212|FG001|Overall Study|Death|0|||
126504186|NCT02276612|455145211|FG000|Overall Study|Pregnancy|1|||
126504187|NCT02276612|455145212|FG001|Overall Study|Pregnancy|0|||
126504188|NCT02276612|455145211|FG000|Overall Study|Withdrew Consent|1|||
126504189|NCT02276612|455145212|FG001|Overall Study|Withdrew Consent|0|||
126504190|NCT02276612|455145211|FG000|Overall Study|Lost to Follow-up|1|||
126504191|NCT02276612|455145212|FG001|Overall Study|Lost to Follow-up|0|||
126504192|NCT00262067|455145213|FG000|Overall Study|Death|190|||
126504193|NCT00262067|455145214|FG001|Overall Study|Death|89|||
126504194|NCT00262067|455145215|FG002|Overall Study|Death|186|||
126504195|NCT00262067|455145216|FG003|Overall Study|Death|99|||
126504196|NCT00262067|455145213|FG000|Overall Study|Lost to Follow-up|5|||
126504197|NCT00262067|455145214|FG001|Overall Study|Lost to Follow-up|4|||
126504198|NCT00262067|455145215|FG002|Overall Study|Lost to Follow-up|7|||
126504199|NCT00262067|455145216|FG003|Overall Study|Lost to Follow-up|5|||
126504200|NCT00262067|455145213|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
126504201|NCT00262067|455145214|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
126504202|NCT00262067|455145215|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
126504203|NCT00262067|455145216|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
126504204|NCT00262067|455145213|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
126504205|NCT00262067|455145214|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
126504206|NCT00262067|455145215|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
126504207|NCT00262067|455145216|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
126504208|NCT00655564|455145217|FG000|Overall Study|Adverse Event|1|||
126504209|NCT00655564|455145217|FG000|Overall Study|Lost to Follow-up|1|||
126504210|NCT00655564|455145217|FG000|Overall Study|Desired Alternate Therapy|1|||
126504211|NCT03962543|455145218|FG000|Treatment Phase|Death|0|||
126504212|NCT03962543|455145219|FG001|Treatment Phase|Death|1|||
126504213|NCT03962543|455145218|FG000|Treatment Phase|Withdrawal by Subject|3|||
126504214|NCT03962543|455145219|FG001|Treatment Phase|Withdrawal by Subject|0|||
126504215|NCT03962543|455145218|FG000|Treatment Phase|Adverse Event|3|||
126504216|NCT03962543|455145219|FG001|Treatment Phase|Adverse Event|12|||
126504217|NCT03962543|455145218|FG000|Treatment Phase|Lost to Follow-up|1|||
126504218|NCT03962543|455145219|FG001|Treatment Phase|Lost to Follow-up|2|||
126504219|NCT03962543|455145218|FG000|Treatment Phase|Radiographic PD|9|||
126504220|NCT03962543|455145219|FG001|Treatment Phase|Radiographic PD|3|||
126504221|NCT03962543|455145218|FG000|Treatment Phase|Participant Decision|3|||
126504222|NCT03962543|455145219|FG001|Treatment Phase|Participant Decision|8|||
126504223|NCT03962543|455145218|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
126504224|NCT03962543|455145219|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
126504225|NCT03962543|455145218|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
126504226|NCT03962543|455145219|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
126504227|NCT03962543|455145218|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
126504228|NCT03962543|455145219|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
126504229|NCT03962543|455145218|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
126504230|NCT03962543|455145219|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
126504231|NCT03962543|455145218|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
126504232|NCT03962543|455145219|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
126504233|NCT03962543|455145218|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
126504234|NCT03962543|455145219|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
126504235|NCT03962543|455145218|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
126504236|NCT03962543|455145219|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
126504237|NCT03962543|455145218|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
126504238|NCT03962543|455145219|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
126504239|NCT03962543|455145218|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
126504240|NCT03962543|455145219|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
126504241|NCT03962543|455145218|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
126504242|NCT03962543|455145219|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
126504243|NCT00560950|455145220|FG000|Overall Study|Lost to Follow-up|1|||
126504244|NCT00560950|455145221|FG001|Overall Study|Lost to Follow-up|0|||
126504245|NCT03264404|455147074|FG000|Overall Study|Death|2|||
126504246|NCT03264404|455147074|FG000|Overall Study|Physician Decision|1|||
126504247|NCT03264404|455147074|FG000|Overall Study|Disease Progression|28|||
126504248|NCT03264404|455147074|FG000|Overall Study|Adverse Event|1|||
126504249|NCT03264404|455147074|FG000|Overall Study|Off study prior to treatment|2|||
126504250|NCT02181556|455147075|FG000|Overall Study|Withdrawal by Subject|1|||
126504251|NCT01940120|455147076|FG000|Overall Study|Death|40|||
126504252|NCT01940120|455147076|FG000|Overall Study|Withdrawal by Subject|8|||
126504253|NCT00427635|455147077|FG000|Treatment Phase|Withdrawal by Subject|1|||
126504254|NCT00427635|455147078|FG001|Treatment Phase|Withdrawal by Subject|0|||
126504255|NCT00427635|455147077|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
126504256|NCT00427635|455147078|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
126504257|NCT03277846|455147079|FG000|Overall Study|Inpatient stay too brief|12|||
126504258|NCT03277846|455147080|FG001|Overall Study|Inpatient stay too brief|11|||
126504259|NCT01572038|455147082|FG000|Overall Study|Death|648|||
126504260|NCT01572038|455147082|FG000|Overall Study|Withdrawal by Subject|204|||
126504261|NCT01572038|455147082|FG000|Overall Study|Lost to Follow-up|81|||
126504262|NCT01572038|455147082|FG000|Overall Study|Physician Decision|20|||
126504263|NCT01572038|455147082|FG000|Overall Study|Patient Decision|14|||
126504264|NCT01572038|455147082|FG000|Overall Study|Progressive Disease|8|||
126504265|NCT01572038|455147082|FG000|Overall Study|Site Closed Before Completing Form|6|||
126504266|NCT01572038|455147082|FG000|Overall Study|Enrolled into Another Trial|3|||
126504267|NCT01572038|455147082|FG000|Overall Study|Participated in Another Trial|3|||
126504268|NCT01572038|455147082|FG000|Overall Study|Termination by Sponsor|2|||
126504269|NCT01572038|455147082|FG000|Overall Study|Patient Deterioration|1|||
126504270|NCT01572038|455147082|FG000|Overall Study|Sponsor Decision|1|||
126504271|NCT01888497|455147083|FG000|Washout Period 1|Withdrawal by Subject|0|||
126504272|NCT01888497|455147084|FG001|Washout Period 1|Withdrawal by Subject|0|||
126504273|NCT01888497|455147085|FG002|Washout Period 1|Withdrawal by Subject|1|||
126504274|NCT01888497|455147086|FG003|Washout Period 1|Withdrawal by Subject|1|||
126504275|NCT01888497|455147083|FG000|Washout Period 2|Adverse Event|0|||
126504276|NCT01888497|455147084|FG001|Washout Period 2|Adverse Event|0|||
126504277|NCT01888497|455147085|FG002|Washout Period 2|Adverse Event|0|||
126504278|NCT01888497|455147086|FG003|Washout Period 2|Adverse Event|1|||
126504279|NCT01888497|455147083|FG000|Washout Period 2|Withdrawal by Subject|0|||
126504280|NCT01888497|455147084|FG001|Washout Period 2|Withdrawal by Subject|0|||
126504281|NCT01888497|455147085|FG002|Washout Period 2|Withdrawal by Subject|0|||
126504282|NCT01888497|455147086|FG003|Washout Period 2|Withdrawal by Subject|1|||
126504283|NCT04152447|455147087|FG000|Overall Study|Lost to Follow-up|1|||
126504284|NCT04152447|455147088|FG001|Overall Study|Lost to Follow-up|0|||
126504285|NCT04152447|455147087|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
126504286|NCT04152447|455147088|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
126504287|NCT04152447|455147087|FG000|Overall Study|Withdrawal by Subject|0|||
126504288|NCT04152447|455147088|FG001|Overall Study|Withdrawal by Subject|1|||
126504289|NCT04152447|455147087|FG000|Overall Study|Found ineligible after enrolling|1|||
126504290|NCT04152447|455147088|FG001|Overall Study|Found ineligible after enrolling|1|||
126504291|NCT04152447|455147087|FG000|Overall Study|Did not receive VR headset in time.|0|||
126504292|NCT04152447|455147088|FG001|Overall Study|Did not receive VR headset in time.|2|||
126504293|NCT04013191|455147089|FG000|Overall Study|Adverse Event|1|||
126504294|NCT04013191|455147090|FG001|Overall Study|Adverse Event|0|||
126504295|NCT01275066|455147103|FG000|Overall Study|Withdrawal by Subject|0|||
126504296|NCT01275066|455147104|FG001|Overall Study|Withdrawal by Subject|0|||
126504297|NCT01275066|455147105|FG002|Overall Study|Withdrawal by Subject|1|||
126504298|NCT01275066|455147103|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
126504299|NCT01275066|455147104|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
126504300|NCT01275066|455147105|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
126504301|NCT04200248|455147113|FG000|Overall Study|Personal reasons|0|||
126504302|NCT04200248|455147114|FG001|Overall Study|Personal reasons|0|||
126504303|NCT04200248|455147115|FG002|Overall Study|Personal reasons|1|||
126504304|NCT04200248|455147113|FG000|Overall Study|Discontinued prior to treatment|3|||
126504305|NCT04200248|455147114|FG001|Overall Study|Discontinued prior to treatment|3|||
126504306|NCT04200248|455147115|FG002|Overall Study|Discontinued prior to treatment|2|||
126504307|NCT00934544|455147119|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
126504308|NCT00934544|455147120|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
126504309|NCT00934544|455147121|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
126504310|NCT00934544|455147119|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
126504311|NCT00934544|455147120|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
126504312|NCT00934544|455147121|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
126504313|NCT00934544|455147119|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
126504314|NCT00934544|455147120|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
126504315|NCT00934544|455147121|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
126504316|NCT00934544|455147119|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
126504317|NCT00934544|455147120|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
126504318|NCT00934544|455147121|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
126504319|NCT00934544|455147119|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
126504320|NCT00934544|455147120|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
126504321|NCT00934544|455147121|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
126504322|NCT00934544|455147119|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
126504323|NCT00934544|455147120|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
126504324|NCT00934544|455147121|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
126504325|NCT00934544|455147119|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
126504326|NCT00934544|455147120|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
126504327|NCT00934544|455147121|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
126504328|NCT00934544|455147119|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
126504329|NCT00934544|455147120|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
126504330|NCT00934544|455147121|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
126504331|NCT00934544|455147119|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
126504332|NCT00934544|455147120|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
126504333|NCT00934544|455147121|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
126504334|NCT00934544|455147119|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
126504335|NCT00934544|455147120|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
126504336|NCT00934544|455147121|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
126504337|NCT00934544|455147119|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
126504338|NCT00934544|455147120|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
126504339|NCT00934544|455147121|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
126504340|NCT00934544|455147119|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
126504341|NCT00934544|455147120|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
126504342|NCT00934544|455147121|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
126504343|NCT00934544|455147119|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
126504344|NCT00934544|455147120|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
126504345|NCT00934544|455147121|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
126504346|NCT00934544|455147119|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
126504347|NCT00934544|455147120|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
126504348|NCT00934544|455147121|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
126504349|NCT00934544|455147119|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
126504350|NCT00934544|455147120|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
126776539|NCT03705169|456137478|FG004|Overall Study|Did not receive study treatment|0|||
126504351|NCT00934544|455147121|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
126504352|NCT00934544|455147119|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
126504353|NCT00934544|455147120|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
126504354|NCT00934544|455147121|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
126504355|NCT01218516|455147122|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
126504356|NCT01218516|455147123|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
126504357|NCT01218516|455147124|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
126504358|NCT01218516|455147125|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
126504359|NCT01218516|455147122|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
126504360|NCT01218516|455147123|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
126504361|NCT01218516|455147124|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
126504362|NCT01218516|455147125|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
126504363|NCT01218516|455147122|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
126504364|NCT01218516|455147123|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
126504365|NCT01218516|455147124|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
126504366|NCT01218516|455147125|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
126504367|NCT01218516|455147122|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
126504368|NCT01218516|455147123|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
126504369|NCT01218516|455147124|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
126504370|NCT01218516|455147125|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
126504371|NCT01218516|455147122|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
126504372|NCT01218516|455147123|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
126504373|NCT01218516|455147124|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
126504374|NCT01218516|455147125|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
126504375|NCT01218516|455147122|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
126504376|NCT01218516|455147123|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
126504377|NCT01218516|455147124|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
126504378|NCT01218516|455147125|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
126504379|NCT01218516|455147122|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
126504380|NCT01218516|455147123|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
126504381|NCT01218516|455147124|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
126504382|NCT01218516|455147125|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
126504383|NCT01218516|455147122|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
126504384|NCT01218516|455147123|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
126504385|NCT01218516|455147124|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
126504386|NCT01218516|455147125|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
126504387|NCT01218516|455147122|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
126504388|NCT01218516|455147123|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
126504389|NCT01218516|455147124|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
126504390|NCT01218516|455147125|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
126504391|NCT01218516|455147122|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
126776540|NCT03705169|456137479|FG005|Overall Study|Did not receive study treatment|0|||
126504392|NCT01218516|455147123|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
126504393|NCT01218516|455147124|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
126504394|NCT01218516|455147125|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
126504395|NCT01218516|455147122|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
126504396|NCT01218516|455147123|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
126504397|NCT01218516|455147124|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
126504398|NCT01218516|455147125|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
126504399|NCT01218516|455147122|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
126504400|NCT01218516|455147123|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
126504401|NCT01218516|455147124|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
126504402|NCT01218516|455147125|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
126504403|NCT04033003|455147127|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
126504404|NCT04033003|455147128|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
126504405|NCT04033003|455147127|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
126504406|NCT04033003|455147128|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
126504407|NCT04033003|455147127|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
126504408|NCT04033003|455147128|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
126504409|NCT04033003|455147127|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
126776541|NCT03705169|456137480|FG006|Overall Study|Did not receive study treatment|0|||
126776542|NCT03705169|456137481|FG007|Overall Study|Did not receive study treatment|0|||
126776543|NCT03705169|456137482|FG008|Overall Study|Did not receive study treatment|0|||
126776544|NCT03705169|456137483|FG009|Overall Study|Did not receive study treatment|0|||
126776545|NCT03705169|456137474|FG000|Overall Study|Concerns about study visit compliance|0|||
126776546|NCT03705169|456137475|FG001|Overall Study|Concerns about study visit compliance|0|||
126776547|NCT03705169|456137476|FG002|Overall Study|Concerns about study visit compliance|0|||
126776548|NCT03705169|456137477|FG003|Overall Study|Concerns about study visit compliance|1|||
126562950|NCT02081391|455355900|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
126562951|NCT02081391|455355901|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
126562952|NCT03369951|455355903|FG000|Overall Study|Withdrawal by Subject|3|||
126562953|NCT03369951|455355903|FG000|Overall Study|Death|1|||
126562954|NCT03369951|455355903|FG000|Overall Study|Lost to Follow-up|1|||
126776549|NCT03705169|456137478|FG004|Overall Study|Concerns about study visit compliance|0|||
126776550|NCT03705169|456137479|FG005|Overall Study|Concerns about study visit compliance|0|||
126776551|NCT03705169|456137480|FG006|Overall Study|Concerns about study visit compliance|0|||
126776552|NCT03705169|456137481|FG007|Overall Study|Concerns about study visit compliance|0|||
126776553|NCT03705169|456137482|FG008|Overall Study|Concerns about study visit compliance|0|||
126776554|NCT03705169|456137483|FG009|Overall Study|Concerns about study visit compliance|0|||
126776555|NCT00420290|456137484|FG000|Overall Study|Adverse Event|3|||
126776556|NCT00420290|456137485|FG001|Overall Study|Adverse Event|1|||
126776557|NCT00420290|456137484|FG000|Overall Study|Withdrawal by Subject|0|||
126776558|NCT00420290|456137485|FG001|Overall Study|Withdrawal by Subject|2|||
126776559|NCT00420290|456137484|FG000|Overall Study|did not meet inclusion/exclusion|1|||
126776560|NCT00420290|456137485|FG001|Overall Study|did not meet inclusion/exclusion|1|||
126776561|NCT02092961|456139009|FG000|Overall Study|Not reported|1|||
126776562|NCT02092961|456139010|FG001|Overall Study|Not reported|0|||
126776563|NCT02092961|456139011|FG002|Overall Study|Not reported|1|||
126776564|NCT02092961|456139009|FG000|Overall Study|Study stopped|13|||
126776565|NCT02092961|456139010|FG001|Overall Study|Study stopped|9|||
126776566|NCT02092961|456139011|FG002|Overall Study|Study stopped|12|||
126776567|NCT02092961|456139009|FG000|Overall Study|Lack of therapeutic response|2|||
126776568|NCT02092961|456139010|FG001|Overall Study|Lack of therapeutic response|1|||
126776569|NCT02092961|456139011|FG002|Overall Study|Lack of therapeutic response|3|||
126776570|NCT02092961|456139009|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
126776571|NCT02092961|456139010|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
126776572|NCT02092961|456139011|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
126776573|NCT02092961|456139009|FG000|Overall Study|Adverse Event|2|||
126776574|NCT02092961|456139010|FG001|Overall Study|Adverse Event|4|||
126776575|NCT02092961|456139011|FG002|Overall Study|Adverse Event|0|||
126776576|NCT01792284|456139012|FG000|Lead-in Period|Adverse Event|15|||
126776577|NCT01792284|456139013|FG001|Lead-in Period|Adverse Event|0|||
126776578|NCT01792284|456139014|FG002|Lead-in Period|Adverse Event|0|||
126776579|NCT01792284|456139012|FG000|Lead-in Period|Lost to Follow-up|2|||
126776580|NCT01792284|456139013|FG001|Lead-in Period|Lost to Follow-up|0|||
126776581|NCT01792284|456139014|FG002|Lead-in Period|Lost to Follow-up|0|||
126776582|NCT01792284|456139012|FG000|Lead-in Period|Protocol Violation|1|||
126776583|NCT01792284|456139013|FG001|Lead-in Period|Protocol Violation|0|||
126776584|NCT01792284|456139014|FG002|Lead-in Period|Protocol Violation|0|||
126776585|NCT01792284|456139012|FG000|Lead-in Period|Withdrawal by Subject|10|||
126776586|NCT01792284|456139013|FG001|Lead-in Period|Withdrawal by Subject|0|||
126776587|NCT01792284|456139014|FG002|Lead-in Period|Withdrawal by Subject|0|||
126776588|NCT01792284|456139012|FG000|Lead-in Period|Physician Decision|1|||
126776589|NCT01792284|456139013|FG001|Lead-in Period|Physician Decision|0|||
126776590|NCT01792284|456139014|FG002|Lead-in Period|Physician Decision|0|||
126776591|NCT01792284|456139012|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
126562955|NCT03369951|455355903|FG000|Overall Study|Protocol Violation|1|||
126562956|NCT03677375|455355904|FG000|Overall Study|Incomplete procedure|8|||
126562957|NCT03677375|455355904|FG000|Overall Study|Adverse Event|3|||
126562958|NCT03677375|455355904|FG000|Overall Study|Physician Decision|1|||
126562959|NCT00561574|455355907|FG000|Overall Study|Adverse Event|21|||
126776592|NCT01792284|456139013|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
126776593|NCT01792284|456139014|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
126776594|NCT01792284|456139012|FG000|Randomization Period 1|Withdrawal by Subject|0|||
126776595|NCT01792284|456139013|FG001|Randomization Period 1|Withdrawal by Subject|1|||
126776596|NCT01792284|456139014|FG002|Randomization Period 1|Withdrawal by Subject|1|||
126776597|NCT01792284|456139012|FG000|Randomization Period 1|Physician Decision|0|||
126776598|NCT01792284|456139013|FG001|Randomization Period 1|Physician Decision|1|||
126776599|NCT01792284|456139014|FG002|Randomization Period 1|Physician Decision|1|||
126776600|NCT01792284|456139012|FG000|Randomization Period 1|Adverse Event|0|||
126776601|NCT01792284|456139013|FG001|Randomization Period 1|Adverse Event|0|||
126776602|NCT01792284|456139014|FG002|Randomization Period 1|Adverse Event|2|||
126562960|NCT00561574|455355908|FG001|Overall Study|Adverse Event|24|||
126562961|NCT00561574|455355907|FG000|Overall Study|Lack of Efficacy|11|||
126562962|NCT00561574|455355908|FG001|Overall Study|Lack of Efficacy|21|||
126504410|NCT04033003|455147128|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
126504411|NCT04033003|455147127|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
126504412|NCT04033003|455147128|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
126504413|NCT04033003|455147127|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
126504414|NCT04033003|455147128|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
126504415|NCT04033003|455147127|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
126504416|NCT04033003|455147128|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
126504417|NCT04033003|455147127|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
126504418|NCT04033003|455147128|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
126504419|NCT04033003|455147127|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
126504420|NCT04033003|455147128|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
126504421|NCT04033003|455147127|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
126504422|NCT04033003|455147128|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
126504423|NCT04033003|455147127|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
126504424|NCT04033003|455147128|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
126504425|NCT04033003|455147127|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
126504426|NCT04033003|455147128|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
126504427|NCT04033003|455147127|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
126504428|NCT04033003|455147128|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
126504429|NCT00706966|455147129|FG000|Overall Study|Adverse Event|1|||
126504430|NCT02046148|455147140|FG000|Overall Study|Lost to Follow-up|1|||
126504431|NCT02046148|455147141|FG001|Overall Study|Lost to Follow-up|1|||
126504432|NCT02046148|455147140|FG000|Overall Study|Withdrawal by Subject|0|||
126504433|NCT02046148|455147141|FG001|Overall Study|Withdrawal by Subject|2|||
126504434|NCT00314574|455147142|FG000|Overall Study|Death|3|||
126504435|NCT00314574|455147143|FG001|Overall Study|Death|0|||
126504436|NCT00314574|455147142|FG000|Overall Study|Adverse Event|11|||
126504437|NCT00314574|455147143|FG001|Overall Study|Adverse Event|16|||
126504438|NCT00314574|455147142|FG000|Overall Study|Lost to Follow-up|19|||
126504439|NCT00314574|455147143|FG001|Overall Study|Lost to Follow-up|25|||
126504440|NCT00314574|455147142|FG000|Overall Study|Withdrawal by Subject|33|||
126504441|NCT00314574|455147143|FG001|Overall Study|Withdrawal by Subject|22|||
126504442|NCT00314574|455147142|FG000|Overall Study|Physician Decision|22|||
126504443|NCT00314574|455147143|FG001|Overall Study|Physician Decision|15|||
126504444|NCT00314574|455147142|FG000|Overall Study|Pregnancy|6|||
126504445|NCT00314574|455147143|FG001|Overall Study|Pregnancy|4|||
126504446|NCT00314574|455147142|FG000|Overall Study|Data unknown at database lock|0|||
126504447|NCT00314574|455147143|FG001|Overall Study|Data unknown at database lock|1|||
126504448|NCT00449956|455147144|FG000|Overall Study|Adverse Event|7|||
126504449|NCT00449956|455147145|FG001|Overall Study|Adverse Event|1|||
126504450|NCT00449956|455147146|FG002|Overall Study|Adverse Event|6|||
126504451|NCT00449956|455147144|FG000|Overall Study|Lack of Efficacy|0|||
126504452|NCT00449956|455147145|FG001|Overall Study|Lack of Efficacy|0|||
126504453|NCT00449956|455147146|FG002|Overall Study|Lack of Efficacy|1|||
126504454|NCT00449956|455147144|FG000|Overall Study|Protocol Violation|1|||
126504455|NCT00449956|455147145|FG001|Overall Study|Protocol Violation|1|||
126504456|NCT00449956|455147146|FG002|Overall Study|Protocol Violation|1|||
126504457|NCT00449956|455147144|FG000|Overall Study|Withdrawal by Subject|0|||
126504458|NCT00449956|455147145|FG001|Overall Study|Withdrawal by Subject|1|||
126504459|NCT00449956|455147146|FG002|Overall Study|Withdrawal by Subject|0|||
126504460|NCT00449956|455147144|FG000|Overall Study|Physician Decision|2|||
126504461|NCT00449956|455147145|FG001|Overall Study|Physician Decision|1|||
126504462|NCT00449956|455147146|FG002|Overall Study|Physician Decision|1|||
126504463|NCT00235872|455147147|FG000|Overall Study|Adverse Event|34|||
126504464|NCT00235872|455147147|FG000|Overall Study|Death|1|||
126504465|NCT00235872|455147147|FG000|Overall Study|Lost to Follow-up|1|||
126504466|NCT00235872|455147147|FG000|Overall Study|Withdrawal by Subject|50|||
126504467|NCT00235872|455147147|FG000|Overall Study|Administrative reason|61|||
126504468|NCT01446965|455147148|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
126504469|NCT01446965|455147149|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
126504470|NCT01446965|455147148|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
126504471|NCT01446965|455147149|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
126504472|NCT02852265|455147150|FG000|3-month Follow-up|Lost to Follow-up|1|||
126504473|NCT02852265|455147151|FG001|3-month Follow-up|Lost to Follow-up|1|||
126504474|NCT01828034|455147154|FG000|Overall Study|Withdrawal by Subject|0|||
126504475|NCT01828034|455147155|FG001|Overall Study|Withdrawal by Subject|0|||
126504476|NCT01828034|455147156|FG002|Overall Study|Withdrawal by Subject|0|||
126504477|NCT01828034|455147157|FG003|Overall Study|Withdrawal by Subject|1|||
126504478|NCT01232296|455147158|FG000|Overall Study|Adverse Event|24|||
126504479|NCT01232296|455147159|FG001|Overall Study|Adverse Event|12|||
126504480|NCT01232296|455147158|FG000|Overall Study|Physician Decision|1|||
126504481|NCT01232296|455147159|FG001|Overall Study|Physician Decision|1|||
126504482|NCT01232296|455147158|FG000|Overall Study|Progressive disease|43|||
126504483|NCT01232296|455147159|FG001|Overall Study|Progressive disease|61|||
126504484|NCT01232296|455147158|FG000|Overall Study|Study terminated by sponsor|0|||
126562963|NCT00561574|455355907|FG000|Overall Study|Withdrawal by Subject|4|||
126562964|NCT00561574|455355908|FG001|Overall Study|Withdrawal by Subject|4|||
126562965|NCT00561574|455355907|FG000|Overall Study|Reason Unrelated to Trial|6|||
126562966|NCT00561574|455355908|FG001|Overall Study|Reason Unrelated to Trial|2|||
126562967|NCT00561574|455355907|FG000|Overall Study|Lost to Follow-up|1|||
126562968|NCT00561574|455355908|FG001|Overall Study|Lost to Follow-up|0|||
126562969|NCT00561574|455355907|FG000|Overall Study|Other|5|||
126562970|NCT00561574|455355908|FG001|Overall Study|Other|7|||
126562971|NCT03971357|455355909|FG000|Overall Study|Lack of Efficacy|0|||
126562972|NCT03971357|455355910|FG001|Overall Study|Lack of Efficacy|1|||
126562973|NCT00630864|455355917|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
126562974|NCT00630864|455355917|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
126562975|NCT00124982|455355918|FG000|Short-term Period|Death|1|||
126562976|NCT00124982|455355919|FG001|Short-term Period|Death|1|||
126562977|NCT00124982|455355920|FG002|Short-term Period|Death|0|||
126562978|NCT00124982|455355918|FG000|Short-term Period|Adverse Event|17|||
126562979|NCT00124982|455355919|FG001|Short-term Period|Adverse Event|22|||
126562980|NCT00124982|455355920|FG002|Short-term Period|Adverse Event|0|||
126562981|NCT00124982|455355918|FG000|Short-term Period|Lack of Efficacy|32|||
126562982|NCT00124982|455355919|FG001|Short-term Period|Lack of Efficacy|73|||
126562983|NCT00124982|455355920|FG002|Short-term Period|Lack of Efficacy|0|||
126562984|NCT00124982|455355918|FG000|Short-term Period|Lost to Follow-up|8|||
126562985|NCT00124982|455355919|FG001|Short-term Period|Lost to Follow-up|5|||
126562986|NCT00124982|455355920|FG002|Short-term Period|Lost to Follow-up|0|||
126562987|NCT00124982|455355918|FG000|Short-term Period|Withdrawal of Consent|7|||
126562988|NCT00124982|455355919|FG001|Short-term Period|Withdrawal of Consent|9|||
126562989|NCT00124982|455355920|FG002|Short-term Period|Withdrawal of Consent|0|||
126562990|NCT00124982|455355918|FG000|Short-term Period|Poor/Non-compliance|3|||
126562991|NCT00124982|455355919|FG001|Short-term Period|Poor/Non-compliance|1|||
126562992|NCT00124982|455355920|FG002|Short-term Period|Poor/Non-compliance|0|||
126562993|NCT00124982|455355918|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
126562994|NCT00124982|455355919|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
126562995|NCT00124982|455355920|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
126562996|NCT00124982|455355918|FG000|Short-term Period|Participant Decision|1|||
126562997|NCT00124982|455355919|FG001|Short-term Period|Participant Decision|0|||
126562998|NCT00124982|455355920|FG002|Short-term Period|Participant Decision|0|||
126562999|NCT00124982|455355918|FG000|Short-term Period|Participant Chose Own Doctor|0|||
126563000|NCT00124982|455355919|FG001|Short-term Period|Participant Chose Own Doctor|1|||
126563001|NCT00124982|455355920|FG002|Short-term Period|Participant Chose Own Doctor|0|||
126563002|NCT00124982|455355918|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
126563003|NCT00124982|455355919|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
126563004|NCT00124982|455355920|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
126563005|NCT00124982|455355918|FG000|Short-term Period|Participant Had Lymphopenia|1|||
126563006|NCT00124982|455355919|FG001|Short-term Period|Participant Had Lymphopenia|0|||
126563007|NCT00124982|455355920|FG002|Short-term Period|Participant Had Lymphopenia|0|||
126563008|NCT00124982|455355918|FG000|Long-term Period|Death|0|||
126563009|NCT00124982|455355919|FG001|Long-term Period|Death|0|||
126563010|NCT00124982|455355920|FG002|Long-term Period|Death|1|||
126563011|NCT00124982|455355918|FG000|Long-term Period|Adverse Event|0|||
126563012|NCT00124982|455355919|FG001|Long-term Period|Adverse Event|0|||
126563013|NCT00124982|455355920|FG002|Long-term Period|Adverse Event|17|||
126563014|NCT00124982|455355918|FG000|Long-term Period|Lack of Efficacy|0|||
126563015|NCT00124982|455355919|FG001|Long-term Period|Lack of Efficacy|0|||
126563016|NCT00124982|455355920|FG002|Long-term Period|Lack of Efficacy|46|||
126563017|NCT00124982|455355918|FG000|Long-term Period|Lost to Follow-up|0|||
126563018|NCT00124982|455355919|FG001|Long-term Period|Lost to Follow-up|0|||
126563019|NCT00124982|455355920|FG002|Long-term Period|Lost to Follow-up|4|||
126563020|NCT00124982|455355918|FG000|Long-term Period|Withdrawal by Subject|0|||
126563021|NCT00124982|455355919|FG001|Long-term Period|Withdrawal by Subject|0|||
126563022|NCT00124982|455355920|FG002|Long-term Period|Withdrawal by Subject|16|||
126563023|NCT00124982|455355918|FG000|Long-term Period|Pregnancy|0|||
126776603|NCT01792284|456139012|FG000|Randomization Period 1|Lost to Follow-up|0|||
126776604|NCT01792284|456139013|FG001|Randomization Period 1|Lost to Follow-up|0|||
126776605|NCT01792284|456139014|FG002|Randomization Period 1|Lost to Follow-up|1|||
126776606|NCT01792284|456139012|FG000|Randomization Period 2|Protocol Violation|0|||
126776607|NCT01792284|456139013|FG001|Randomization Period 2|Protocol Violation|1|||
126776608|NCT01792284|456139014|FG002|Randomization Period 2|Protocol Violation|0|||
126776609|NCT01792284|456139012|FG000|Randomization Period 2|Withdrawal by Subject|0|||
126563024|NCT00124982|455355919|FG001|Long-term Period|Pregnancy|0|||
126563025|NCT00124982|455355920|FG002|Long-term Period|Pregnancy|1|||
126563026|NCT00124982|455355918|FG000|Long-term Period|Poor/Non-compliance|0|||
126563027|NCT00124982|455355919|FG001|Long-term Period|Poor/Non-compliance|0|||
126563028|NCT00124982|455355920|FG002|Long-term Period|Poor/Non-compliance|2|||
126563029|NCT00124982|455355918|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
126563030|NCT00124982|455355919|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
126563031|NCT00124982|455355920|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
126563032|NCT00124982|455355918|FG000|Long-term Period|Neurologist Recommendation|0|||
126563033|NCT00124982|455355919|FG001|Long-term Period|Neurologist Recommendation|0|||
126563034|NCT00124982|455355920|FG002|Long-term Period|Neurologist Recommendation|1|||
126563035|NCT00430677|455355921|FG000|Short-term Period|Death|1|||
126563036|NCT00430677|455355922|FG001|Short-term Period|Death|1|||
126563037|NCT00430677|455355923|FG002|Short-term Period|Death|5|||
126563038|NCT00430677|455355921|FG000|Short-term Period|Adverse Event|15|||
126563039|NCT00430677|455355922|FG001|Short-term Period|Adverse Event|13|||
126563040|NCT00430677|455355923|FG002|Short-term Period|Adverse Event|9|||
126563041|NCT00430677|455355921|FG000|Short-term Period|Lack of Efficacy|5|||
126563042|NCT00430677|455355922|FG001|Short-term Period|Lack of Efficacy|6|||
126563043|NCT00430677|455355923|FG002|Short-term Period|Lack of Efficacy|4|||
126563044|NCT00430677|455355921|FG000|Short-term Period|Withdrawal by Subject|1|||
126563045|NCT00430677|455355922|FG001|Short-term Period|Withdrawal by Subject|1|||
126563046|NCT00430677|455355923|FG002|Short-term Period|Withdrawal by Subject|2|||
126563047|NCT00430677|455355921|FG000|Short-term Period|Participant no longer met study criteria|1|||
126563048|NCT00430677|455355922|FG001|Short-term Period|Participant no longer met study criteria|1|||
126563049|NCT00430677|455355923|FG002|Short-term Period|Participant no longer met study criteria|2|||
126563050|NCT00430677|455355921|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
126563051|NCT00430677|455355922|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
126563052|NCT00430677|455355923|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
126563053|NCT00430677|455355921|FG000|Short-term Period|Pregnancy|0|||
126563054|NCT00430677|455355922|FG001|Short-term Period|Pregnancy|2|||
126563055|NCT00430677|455355923|FG002|Short-term Period|Pregnancy|0|||
126563056|NCT00430677|455355921|FG000|Long-term Extension Period|Death|1|||
126563057|NCT00430677|455355922|FG001|Long-term Extension Period|Death|0|||
126563058|NCT00430677|455355923|FG002|Long-term Extension Period|Death|0|||
126563059|NCT00430677|455355921|FG000|Long-term Extension Period|Adverse Event|3|||
126563060|NCT00430677|455355922|FG001|Long-term Extension Period|Adverse Event|2|||
126563061|NCT00430677|455355923|FG002|Long-term Extension Period|Adverse Event|5|||
126563062|NCT00430677|455355921|FG000|Long-term Extension Period|Lack of Efficacy|5|||
126563063|NCT00430677|455355922|FG001|Long-term Extension Period|Lack of Efficacy|3|||
126563064|NCT00430677|455355923|FG002|Long-term Extension Period|Lack of Efficacy|8|||
126563065|NCT00430677|455355921|FG000|Long-term Extension Period|Lost to Follow-up|1|||
126563066|NCT00430677|455355922|FG001|Long-term Extension Period|Lost to Follow-up|1|||
126563067|NCT00430677|455355923|FG002|Long-term Extension Period|Lost to Follow-up|1|||
126563068|NCT00430677|455355921|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
126563069|NCT00430677|455355922|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
126563070|NCT00430677|455355923|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
126563071|NCT00430677|455355921|FG000|Long-term Extension Period|Pregnancy|1|||
126563072|NCT00430677|455355922|FG001|Long-term Extension Period|Pregnancy|1|||
126563073|NCT00430677|455355923|FG002|Long-term Extension Period|Pregnancy|0|||
126563074|NCT00430677|455355921|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
126563075|NCT00430677|455355922|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
126563076|NCT00430677|455355923|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
126563077|NCT00430677|455355921|FG000|Long-term Extension Period|Other|2|||
126563078|NCT00430677|455355922|FG001|Long-term Extension Period|Other|1|||
126563079|NCT00430677|455355923|FG002|Long-term Extension Period|Other|1|||
126563080|NCT00430677|455355921|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
126563081|NCT00430677|455355922|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
126563082|NCT00430677|455355923|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
126563083|NCT01333514|455355924|FG000|Overall Study|Withdrawal by Subject|1|||
126563084|NCT01333514|455355925|FG001|Overall Study|Withdrawal by Subject|0|||
126563085|NCT00836810|455355926|FG000|Overall Study|New diagnosis|1|||
126563086|NCT00836810|455355927|FG001|Overall Study|New diagnosis|0|||
126563087|NCT00389519|455355930|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
126563088|NCT00389519|455355931|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
126563089|NCT00389519|455355932|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
126563090|NCT00389519|455355933|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
126563091|NCT00389519|455355930|FG000|Placebo Run-In|Withdrawal by Subject|19|||
126563092|NCT00389519|455355931|FG001|Placebo Run-In|Withdrawal by Subject|0|||
126563093|NCT00389519|455355932|FG002|Placebo Run-In|Withdrawal by Subject|0|||
126563094|NCT00389519|455355933|FG003|Placebo Run-In|Withdrawal by Subject|0|||
126563095|NCT00389519|455355930|FG000|Placebo Run-In|Reason not specified|40|||
126563096|NCT00389519|455355931|FG001|Placebo Run-In|Reason not specified|0|||
126563097|NCT00389519|455355932|FG002|Placebo Run-In|Reason not specified|0|||
126563098|NCT00389519|455355933|FG003|Placebo Run-In|Reason not specified|0|||
126563099|NCT00389519|455355930|FG000|Randomized|Did not receive study drug|2|||
126563100|NCT00389519|455355931|FG001|Randomized|Did not receive study drug|0|||
126563101|NCT00389519|455355932|FG002|Randomized|Did not receive study drug|0|||
126563102|NCT00389519|455355933|FG003|Randomized|Did not receive study drug|0|||
126563103|NCT00389519|455355930|FG000|Treated|Adverse Event|1|||
126563104|NCT00389519|455355931|FG001|Treated|Adverse Event|0|||
126563105|NCT00389519|455355932|FG002|Treated|Adverse Event|0|||
126504485|NCT01232296|455147159|FG001|Overall Study|Study terminated by sponsor|1|||
126504486|NCT01232296|455147158|FG000|Overall Study|Technical problems|3|||
126504487|NCT01232296|455147159|FG001|Overall Study|Technical problems|0|||
126504488|NCT01232296|455147158|FG000|Overall Study|Subject/guardian decision|10|||
126504489|NCT01232296|455147159|FG001|Overall Study|Subject/guardian decision|2|||
126504490|NCT01232296|455147158|FG000|Overall Study|Death|1|||
126504491|NCT01232296|455147159|FG001|Overall Study|Death|6|||
126504492|NCT02871375|455147160|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
126504493|NCT02871375|455147161|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
126504494|NCT01988571|455147162|FG000|Overall Study|Death|3|||
126504495|NCT01988571|455147163|FG001|Overall Study|Death|1|||
126504496|NCT01988571|455147162|FG000|Overall Study|Physician Decision|2|||
126504497|NCT01988571|455147163|FG001|Overall Study|Physician Decision|1|||
126504498|NCT01988571|455147162|FG000|Overall Study|Lost to Follow-up|3|||
126504499|NCT01988571|455147163|FG001|Overall Study|Lost to Follow-up|0|||
126504500|NCT01988571|455147162|FG000|Overall Study|Withdrawal by Subject|31|||
126504501|NCT01988571|455147163|FG001|Overall Study|Withdrawal by Subject|33|||
126504502|NCT00004412|455147164|FG000|Randomized Period|Moved to Crossover Period|3|||
126504503|NCT00004412|455147165|FG001|Randomized Period|Moved to Crossover Period|0|||
126504504|NCT00004412|455147166|FG002|Randomized Period|Moved to Crossover Period|0|||
126504505|NCT03144180|455147168|FG000|Overall Study|STAT Delivery|1|||
126504506|NCT03144180|455147169|FG001|Overall Study|STAT Delivery|1|||
126504507|NCT03144180|455147168|FG000|Overall Study|Provider forgot to fill out forms|1|||
126504508|NCT03144180|455147169|FG001|Overall Study|Provider forgot to fill out forms|3|||
126504509|NCT03144180|455147168|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
126504510|NCT03144180|455147169|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
126504511|NCT03144180|455147168|FG000|Overall Study|Scrub tech removed tube cap|0|||
126504512|NCT03144180|455147169|FG001|Overall Study|Scrub tech removed tube cap|1|||
126504513|NCT02346136|455147172|FG000|Overall Study|Withdrawal by Subject|7|||
126504514|NCT02346136|455147173|FG001|Overall Study|Withdrawal by Subject|5|||
126504515|NCT02346136|455147172|FG000|Overall Study|Death|1|||
126504516|NCT02346136|455147173|FG001|Overall Study|Death|0|||
126504517|NCT02346136|455147172|FG000|Overall Study|Study termination|14|||
126504518|NCT02346136|455147173|FG001|Overall Study|Study termination|18|||
126504519|NCT02308735|455147176|FG000|Overall Study|Physician Decision|2|||
126504520|NCT02308735|455147177|FG001|Overall Study|Physician Decision|0|||
126504521|NCT02308735|455147178|FG002|Overall Study|Physician Decision|0|||
126504522|NCT02308735|455147179|FG003|Overall Study|Physician Decision|2|||
126504523|NCT00453999|455147180|FG000|Overall Study|Adverse Event|1|||
126504524|NCT00453999|455147181|FG001|Overall Study|Adverse Event|2|||
126504525|NCT00453999|455147182|FG002|Overall Study|Adverse Event|1|||
126504526|NCT00453999|455147180|FG000|Overall Study|Lost to Follow-up|0|||
126504527|NCT00453999|455147181|FG001|Overall Study|Lost to Follow-up|1|||
126504528|NCT00453999|455147182|FG002|Overall Study|Lost to Follow-up|1|||
126504529|NCT00453999|455147180|FG000|Overall Study|Withdrawal by Subject|2|||
126504530|NCT00453999|455147181|FG001|Overall Study|Withdrawal by Subject|1|||
126504531|NCT00453999|455147182|FG002|Overall Study|Withdrawal by Subject|1|||
126504532|NCT00453999|455147180|FG000|Overall Study|Subject Request|2|||
126504533|NCT00453999|455147181|FG001|Overall Study|Subject Request|1|||
126504534|NCT00453999|455147182|FG002|Overall Study|Subject Request|0|||
126504535|NCT00606892|455147185|FG000|First Intervention|Protocol Violation|1|||
126504536|NCT00606892|455147186|FG001|First Intervention|Protocol Violation|4|||
126504537|NCT00794196|455147196|FG000|Overall Study|Lost to Follow-up|5|||
126504538|NCT00794196|455147197|FG001|Overall Study|Lost to Follow-up|23|||
126504539|NCT02129803|455147198|FG000|Overall Study|Protocol Violation|4|||
126504540|NCT02129803|455147199|FG001|Overall Study|Protocol Violation|0|||
126504541|NCT02129803|455147198|FG000|Overall Study|Physician Decision|0|||
126504542|NCT02129803|455147199|FG001|Overall Study|Physician Decision|1|||
126504543|NCT02129803|455147198|FG000|Overall Study|Difficulty sleeping|1|||
126504544|NCT02129803|455147199|FG001|Overall Study|Difficulty sleeping|0|||
126504545|NCT02129803|455147198|FG000|Overall Study|Morning headache|0|||
126504546|NCT02129803|455147199|FG001|Overall Study|Morning headache|1|||
126504547|NCT02129803|455147198|FG000|Overall Study|Withdrawal by Subject|1|||
126504548|NCT02129803|455147199|FG001|Overall Study|Withdrawal by Subject|1|||
126504549|NCT00149747|455147200|FG000|Overall Study|Death|1|||
126504550|NCT00149747|455147201|FG001|Overall Study|Death|0|||
126504551|NCT00149747|455147200|FG000|Overall Study|Withdrawal by Subject|3|||
126504552|NCT00149747|455147201|FG001|Overall Study|Withdrawal by Subject|3|||
126504553|NCT01354496|455147202|FG000|Period 1|Adverse Event|0|||
126563106|NCT00389519|455355933|FG003|Treated|Adverse Event|2|||
126504554|NCT01354496|455147203|FG001|Period 1|Adverse Event|0|||
126504555|NCT01354496|455147204|FG002|Period 1|Adverse Event|1|||
126504556|NCT01354496|455147205|FG003|Period 1|Adverse Event|0|||
126504557|NCT01354496|455147206|FG004|Period 1|Adverse Event|0|||
126504558|NCT01354496|455147207|FG005|Period 1|Adverse Event|0|||
126504559|NCT01354496|455147202|FG000|Period 1|Physician Decision|0|||
126504560|NCT01354496|455147203|FG001|Period 1|Physician Decision|0|||
126504561|NCT01354496|455147204|FG002|Period 1|Physician Decision|1|||
126504562|NCT01354496|455147205|FG003|Period 1|Physician Decision|0|||
126563107|NCT00389519|455355930|FG000|Treated|Reason not specified|1|||
126563108|NCT00389519|455355931|FG001|Treated|Reason not specified|1|||
126563109|NCT00389519|455355932|FG002|Treated|Reason not specified|0|||
126563110|NCT00389519|455355933|FG003|Treated|Reason not specified|2|||
126563111|NCT00946192|455355934|FG000|Overall Study|Lost to Follow-up|6|||
126563112|NCT00946192|455355935|FG001|Overall Study|Lost to Follow-up|11|||
126563113|NCT00946192|455355936|FG002|Overall Study|Lost to Follow-up|9|||
126563114|NCT00946192|455355934|FG000|Overall Study|Withdrawal by Subject|10|||
126563115|NCT00946192|455355935|FG001|Overall Study|Withdrawal by Subject|7|||
126563116|NCT00946192|455355936|FG002|Overall Study|Withdrawal by Subject|3|||
126563117|NCT00946192|455355934|FG000|Overall Study|Did not start medication|2|||
126563118|NCT00946192|455355935|FG001|Overall Study|Did not start medication|0|||
126563119|NCT00946192|455355936|FG002|Overall Study|Did not start medication|0|||
126563120|NCT01080131|455355937|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
126563121|NCT01080131|455355938|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
126563122|NCT01080131|455355937|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
126563123|NCT01080131|455355938|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
126563124|NCT01080131|455355937|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
126563125|NCT01080131|455355938|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
126563126|NCT01080131|455355937|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
126563127|NCT01080131|455355938|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
126563128|NCT01080131|455355937|FG000|Core Study (0- 12 Weeks)|Death|1|||
126563129|NCT01080131|455355938|FG001|Core Study (0- 12 Weeks)|Death|0|||
126563130|NCT01080131|455355937|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
126563131|NCT01080131|455355938|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
126563132|NCT01080131|455355937|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
126563133|NCT01080131|455355938|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
126563134|NCT01080131|455355937|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
126563135|NCT01080131|455355938|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
126563136|NCT01080131|455355937|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
126563137|NCT01080131|455355938|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
126563138|NCT01080131|455355937|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
126563139|NCT01080131|455355938|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
126563140|NCT01080131|455355937|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
126563141|NCT01080131|455355938|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
126563142|NCT01080131|455355937|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
126563143|NCT01080131|455355938|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
126563144|NCT01080131|455355937|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
126563145|NCT01080131|455355938|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
126563146|NCT04155424|455355939|FG000|Overall Study|Other than specified|3|||
126563147|NCT04155424|455355939|FG000|Overall Study|Withdrawal by Subject|1|||
126563148|NCT04155424|455355939|FG000|Overall Study|Adverse Event|1|||
126563149|NCT04159506|455355940|FG000|Overall Study|Lost to Follow-up|2|||
126563150|NCT04159506|455355941|FG001|Overall Study|Lost to Follow-up|5|||
126563151|NCT00409708|455357362|FG000|Treatment|Abnormal test procedure result(s)|1|||
126563152|NCT00409708|455357363|FG001|Treatment|Abnormal test procedure result(s)|0|||
126563153|NCT00409708|455357362|FG000|Treatment|Lack of Efficacy|0|||
126563154|NCT00409708|455357363|FG001|Treatment|Lack of Efficacy|1|||
126563155|NCT00409708|455357362|FG000|Treatment|Protocol Violation|6|||
126563156|NCT00409708|455357363|FG001|Treatment|Protocol Violation|2|||
126563157|NCT00409708|455357362|FG000|Treatment|Withdrawal by Subject|3|||
126563158|NCT00409708|455357363|FG001|Treatment|Withdrawal by Subject|8|||
126563159|NCT00409708|455357362|FG000|Treatment|Lost to Follow-up|0|||
126563160|NCT00409708|455357363|FG001|Treatment|Lost to Follow-up|6|||
126563161|NCT00409708|455357362|FG000|Treatment|Administrative problems|5|||
126563162|NCT00409708|455357363|FG001|Treatment|Administrative problems|0|||
126563163|NCT00409708|455357362|FG000|Washout|Lack of Efficacy|9|||
126563164|NCT00409708|455357363|FG001|Washout|Lack of Efficacy|1|||
126504563|NCT01354496|455147206|FG004|Period 1|Physician Decision|0|||
126504564|NCT01354496|455147207|FG005|Period 1|Physician Decision|0|||
126504565|NCT01354496|455147202|FG000|Period 2|Adverse Event|0|||
126504566|NCT01354496|455147203|FG001|Period 2|Adverse Event|0|||
126504567|NCT01354496|455147204|FG002|Period 2|Adverse Event|0|||
126504568|NCT01354496|455147205|FG003|Period 2|Adverse Event|1|||
126504569|NCT01354496|455147206|FG004|Period 2|Adverse Event|0|||
126504570|NCT01354496|455147207|FG005|Period 2|Adverse Event|0|||
126563165|NCT00409708|455357362|FG000|Washout|Protocol Violation|0|||
126563166|NCT00409708|455357363|FG001|Washout|Protocol Violation|1|||
126563167|NCT00409708|455357362|FG000|Washout|Withdrawal by Subject|11|||
126563168|NCT00409708|455357363|FG001|Washout|Withdrawal by Subject|5|||
126504571|NCT01354496|455147202|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
126504572|NCT01354496|455147203|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
126504573|NCT01354496|455147204|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
126563169|NCT00409708|455357362|FG000|Washout|Lost to Follow-up|1|||
126563170|NCT00409708|455357363|FG001|Washout|Lost to Follow-up|3|||
126727126|NCT00242580|455951061|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
126504574|NCT01354496|455147205|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
126504575|NCT01354496|455147206|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
126504576|NCT01354496|455147207|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
126504577|NCT01228747|455147208|FG000|Overall Study|Adverse Event|8|||
126504578|NCT01228747|455147209|FG001|Overall Study|Adverse Event|4|||
126504579|NCT01228747|455147208|FG000|Overall Study|Lack of Efficacy|40|||
126504580|NCT01228747|455147209|FG001|Overall Study|Lack of Efficacy|27|||
126504581|NCT01228747|455147208|FG000|Overall Study|Protocol Violation|6|||
126504582|NCT01228747|455147209|FG001|Overall Study|Protocol Violation|5|||
126504583|NCT01228747|455147208|FG000|Overall Study|Lost to Follow-up|4|||
126504584|NCT01228747|455147209|FG001|Overall Study|Lost to Follow-up|3|||
126504585|NCT01228747|455147208|FG000|Overall Study|Withdrawal by Subject|5|||
126504586|NCT01228747|455147209|FG001|Overall Study|Withdrawal by Subject|1|||
126504587|NCT01228747|455147208|FG000|Overall Study|Other Reason|2|||
126504588|NCT01228747|455147209|FG001|Overall Study|Other Reason|5|||
126504589|NCT02036502|455147210|FG000|Part 1:Dose Determination/Escalation|Death|3|||
126504590|NCT02036502|455147211|FG001|Part 1:Dose Determination/Escalation|Death|2|||
126504591|NCT02036502|455147212|FG002|Part 1:Dose Determination/Escalation|Death|0|||
126504592|NCT02036502|455147213|FG003|Part 1:Dose Determination/Escalation|Death|0|||
126504593|NCT02036502|455147214|FG004|Part 1:Dose Determination/Escalation|Death|0|||
126504594|NCT02036502|455147215|FG005|Part 1:Dose Determination/Escalation|Death|0|||
126504595|NCT02036502|455147216|FG006|Part 1:Dose Determination/Escalation|Death|0|||
126504596|NCT02036502|455147217|FG007|Part 1:Dose Determination/Escalation|Death|0|||
126504597|NCT02036502|455147210|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
126504598|NCT02036502|455147211|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
126504599|NCT02036502|455147212|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
126504600|NCT02036502|455147213|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
126504601|NCT02036502|455147214|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
126504602|NCT02036502|455147215|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
126504603|NCT02036502|455147216|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
126504604|NCT02036502|455147217|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
126504605|NCT02036502|455147210|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
126504606|NCT02036502|455147211|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
126504607|NCT02036502|455147212|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
126504608|NCT02036502|455147213|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
126504609|NCT02036502|455147214|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
126504610|NCT02036502|455147215|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
126504611|NCT02036502|455147216|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
126504612|NCT02036502|455147217|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
126504613|NCT02036502|455147210|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
126504614|NCT02036502|455147211|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
126504615|NCT02036502|455147212|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
126504616|NCT02036502|455147213|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
126504617|NCT02036502|455147214|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
126504618|NCT02036502|455147215|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
126504619|NCT02036502|455147216|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
126504620|NCT02036502|455147217|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
126504621|NCT02036502|455147210|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
126504622|NCT02036502|455147211|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
126504623|NCT02036502|455147212|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
126504624|NCT02036502|455147213|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
126504625|NCT02036502|455147214|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
126504626|NCT02036502|455147215|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
126504627|NCT02036502|455147216|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
126504628|NCT02036502|455147217|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
126504629|NCT02036502|455147210|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
126504630|NCT02036502|455147211|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
126504631|NCT02036502|455147212|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
126504632|NCT02036502|455147213|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
126504633|NCT02036502|455147214|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
126504634|NCT02036502|455147215|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
126504635|NCT02036502|455147216|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
126504636|NCT02036502|455147217|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
126504637|NCT02036502|455147210|FG000|Part 2:Dose Confirmation|Death|0|||
126504638|NCT02036502|455147211|FG001|Part 2:Dose Confirmation|Death|0|||
126504639|NCT02036502|455147212|FG002|Part 2:Dose Confirmation|Death|1|||
126504640|NCT02036502|455147213|FG003|Part 2:Dose Confirmation|Death|0|||
126504641|NCT02036502|455147214|FG004|Part 2:Dose Confirmation|Death|0|||
126504642|NCT02036502|455147215|FG005|Part 2:Dose Confirmation|Death|0|||
126776610|NCT01792284|456139013|FG001|Randomization Period 2|Withdrawal by Subject|2|||
126776611|NCT01792284|456139014|FG002|Randomization Period 2|Withdrawal by Subject|0|||
126776612|NCT01847313|456139015|FG000|Overall Study|Death|0|||
126776613|NCT01847313|456139016|FG001|Overall Study|Death|1|||
126776614|NCT01847313|456139015|FG000|Overall Study|Withdrawal by Subject|0|||
126776615|NCT01847313|456139016|FG001|Overall Study|Withdrawal by Subject|1|||
126776616|NCT02962882|456139018|FG000|Overall Study|Adverse Event|2|||
126776617|NCT02962882|456139018|FG000|Overall Study|Withdrawal by Subject|2|||
126776618|NCT02962882|456139018|FG000|Overall Study|Transfer from ICU|32|||
126776619|NCT01312779|456139019|FG000|Overall Study|Withdrawal by Subject|2|||
126776620|NCT01312779|456139019|FG000|Overall Study|Death|3|||
126776621|NCT01312779|456139019|FG000|Overall Study|Not Implanted with Device|27|||
126776622|NCT01663714|456139022|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
126776623|NCT01663714|456139022|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
126776624|NCT01663714|456139022|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
126776625|NCT01663714|456139022|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
126776626|NCT01663714|456139022|FG000|Long-Term Follow-Up|Death|4|||
126776627|NCT01663714|456139022|FG000|Long-Term Follow-Up|Non-compliance|1|||
126776628|NCT00597584|456139023|FG000|Overall Study|Adverse Event|4|||
126776629|NCT00597584|456139024|FG001|Overall Study|Adverse Event|2|||
126776630|NCT00597584|456139023|FG000|Overall Study|Death|53|||
126776631|NCT00597584|456139024|FG001|Overall Study|Death|30|||
126776632|NCT00597584|456139023|FG000|Overall Study|Lack of Efficacy|1|||
126776633|NCT00597584|456139024|FG001|Overall Study|Lack of Efficacy|0|||
126776634|NCT00597584|456139023|FG000|Overall Study|Lost to Follow-up|2|||
126776635|NCT00597584|456139024|FG001|Overall Study|Lost to Follow-up|4|||
126776636|NCT00597584|456139023|FG000|Overall Study|Physician Decision|3|||
126776637|NCT00597584|456139024|FG001|Overall Study|Physician Decision|0|||
126776638|NCT00597584|456139023|FG000|Overall Study|Pregnancy|2|||
126776639|NCT00597584|456139024|FG001|Overall Study|Pregnancy|0|||
126776640|NCT00597584|456139023|FG000|Overall Study|Withdrawal by Subject|44|||
126776641|NCT00597584|456139024|FG001|Overall Study|Withdrawal by Subject|12|||
126776642|NCT00597584|456139023|FG000|Overall Study|Discontinued Dialysis|0|||
126776643|NCT00597584|456139024|FG001|Overall Study|Discontinued Dialysis|1|||
126776644|NCT00597584|456139023|FG000|Overall Study|Lost ability to consent|1|||
126776645|NCT00597584|456139024|FG001|Overall Study|Lost ability to consent|1|||
126776646|NCT00597584|456139023|FG000|Overall Study|Never dosed|1|||
126776647|NCT00597584|456139024|FG001|Overall Study|Never dosed|0|||
126776648|NCT00597584|456139023|FG000|Overall Study|Relocation|8|||
126776649|NCT00597584|456139024|FG001|Overall Study|Relocation|6|||
126776650|NCT00597584|456139023|FG000|Overall Study|Renal transplant|9|||
126776651|NCT00597584|456139024|FG001|Overall Study|Renal transplant|7|||
126776652|NCT00660790|456139025|FG000|Baseline to 3 Months|Death|1|||
126776653|NCT00660790|456139025|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
126776654|NCT00660790|456139025|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
126776655|NCT02791659|456139026|FG000|Overall Study|Protocol Violation|0|||
126776656|NCT02791659|456139027|FG001|Overall Study|Protocol Violation|1|||
126776657|NCT03840811|456139028|FG000|Overall Study|Lost to Follow-up|0|||
126776658|NCT03840811|456139029|FG001|Overall Study|Lost to Follow-up|0|||
126776659|NCT03840811|456139030|FG002|Overall Study|Lost to Follow-up|1|||
126776660|NCT01904383|456139031|FG000|Overall Study|CRF not collected|117|||
126776661|NCT01904383|456139031|FG000|Overall Study|Reason not listed|147|||
126776662|NCT01904383|456139031|FG000|Overall Study|Lost to Follow-up|674|||
126776663|NCT01904383|456139031|FG000|Overall Study|Lack of Efficacy|370|||
126776664|NCT01904383|456139031|FG000|Overall Study|Improvement|141|||
126776665|NCT01904383|456139031|FG000|Overall Study|Adverse Event|271|||
126776666|NCT01904383|456139031|FG000|Overall Study|No patient visit after entry|54|||
126776667|NCT01625845|456139032|FG000|Overall Study|Adverse Event|1|||
126776668|NCT01625845|456139033|FG001|Overall Study|Adverse Event|2|||
126776669|NCT01625845|456139032|FG000|Overall Study|Lost to Follow-up|2|||
126776670|NCT01625845|456139033|FG001|Overall Study|Lost to Follow-up|1|||
126776671|NCT01625845|456139032|FG000|Overall Study|Withdrawal by Subject|2|||
126776672|NCT01625845|456139033|FG001|Overall Study|Withdrawal by Subject|0|||
126776673|NCT02853929|456139034|FG000|Overall Study|Lost to Follow-up|3|||
126776674|NCT02853929|456139035|FG001|Overall Study|Lost to Follow-up|0|||
126776675|NCT02853929|456139034|FG000|Overall Study|Withdrawal by Subject|1|||
126776676|NCT02853929|456139035|FG001|Overall Study|Withdrawal by Subject|0|||
126776677|NCT02853929|456139034|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
126504643|NCT02036502|455147216|FG006|Part 2:Dose Confirmation|Death|0|||
126776678|NCT02853929|456139035|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
126776679|NCT01294592|456139036|FG000|Overall Study|Adverse Event|28|||
126776680|NCT01294592|456139037|FG001|Overall Study|Adverse Event|13|||
126776681|NCT01294592|456139036|FG000|Overall Study|Lack of Efficacy|7|||
126776682|NCT01294592|456139037|FG001|Overall Study|Lack of Efficacy|5|||
126776683|NCT01294592|456139036|FG000|Overall Study|Protocol Violation|1|||
126776684|NCT01294592|456139037|FG001|Overall Study|Protocol Violation|7|||
126776685|NCT01294592|456139036|FG000|Overall Study|Lost to Follow-up|7|||
126776686|NCT01294592|456139037|FG001|Overall Study|Lost to Follow-up|9|||
126776687|NCT01294592|456139036|FG000|Overall Study|Physician Decision|6|||
126563171|NCT02501629|455357367|FG000|Overall Study|Death|0|||
126776688|NCT01294592|456139037|FG001|Overall Study|Physician Decision|11|||
126776689|NCT01294592|456139036|FG000|Overall Study|Withdrawal by Subject|28|||
126776690|NCT01294592|456139037|FG001|Overall Study|Withdrawal by Subject|28|||
126776691|NCT03549130|456139038|FG000|Overall Study|Adverse Event|0|||
126776692|NCT03549130|456139039|FG001|Overall Study|Adverse Event|1|||
126776693|NCT03549130|456139038|FG000|Overall Study|Lost to Follow-up|0|||
126776694|NCT03549130|456139039|FG001|Overall Study|Lost to Follow-up|1|||
126776695|NCT01078623|456139040|FG000|Treatment Period 1|Adverse Event|1|||
126776696|NCT01078623|456139041|FG001|Treatment Period 1|Adverse Event|1|||
126776697|NCT01078623|456139042|FG002|Treatment Period 1|Adverse Event|1|||
126776698|NCT01078623|456139043|FG003|Treatment Period 1|Adverse Event|0|||
126776699|NCT01078623|456139044|FG004|Treatment Period 1|Adverse Event|0|||
126776700|NCT01078623|456139045|FG005|Treatment Period 1|Adverse Event|0|||
126776701|NCT01078623|456139046|FG006|Treatment Period 1|Adverse Event|1|||
126776702|NCT01078623|456139047|FG007|Treatment Period 1|Adverse Event|0|||
126776703|NCT01078623|456139048|FG008|Treatment Period 1|Adverse Event|1|||
126776704|NCT01078623|456139049|FG009|Treatment Period 1|Adverse Event|1|||
126776705|NCT01078623|456139050|FG010|Treatment Period 1|Adverse Event|0|||
126776706|NCT01078623|456139051|FG011|Treatment Period 1|Adverse Event|0|||
126776707|NCT01078623|456139052|FG012|Treatment Period 1|Adverse Event|0|||
126776708|NCT01078623|456139053|FG013|Treatment Period 1|Adverse Event|0|||
126776709|NCT01078623|456139054|FG014|Treatment Period 1|Adverse Event|0|||
126776710|NCT01078623|456139055|FG015|Treatment Period 1|Adverse Event|0|||
126776711|NCT01078623|456139056|FG016|Treatment Period 1|Adverse Event|0|||
126776712|NCT01078623|456139057|FG017|Treatment Period 1|Adverse Event|0|||
126776713|NCT01078623|456139058|FG018|Treatment Period 1|Adverse Event|0|||
126776714|NCT01078623|456139059|FG019|Treatment Period 1|Adverse Event|0|||
126776715|NCT01078623|456139040|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126776716|NCT01078623|456139041|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126776717|NCT01078623|456139042|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126504644|NCT02036502|455147217|FG007|Part 2:Dose Confirmation|Death|0|||
126504645|NCT02036502|455147210|FG000|Part 2:Dose Confirmation|Not treated|0|||
126504646|NCT02036502|455147211|FG001|Part 2:Dose Confirmation|Not treated|0|||
126504647|NCT02036502|455147212|FG002|Part 2:Dose Confirmation|Not treated|0|||
126504648|NCT02036502|455147213|FG003|Part 2:Dose Confirmation|Not treated|1|||
126504649|NCT02036502|455147214|FG004|Part 2:Dose Confirmation|Not treated|0|||
126504650|NCT02036502|455147215|FG005|Part 2:Dose Confirmation|Not treated|0|||
126504651|NCT02036502|455147216|FG006|Part 2:Dose Confirmation|Not treated|0|||
126504652|NCT02036502|455147217|FG007|Part 2:Dose Confirmation|Not treated|0|||
126504653|NCT02036502|455147210|FG000|Part 3:Dose Expansion|Adverse Event|0|||
126504654|NCT02036502|455147211|FG001|Part 3:Dose Expansion|Adverse Event|0|||
126504655|NCT02036502|455147212|FG002|Part 3:Dose Expansion|Adverse Event|0|||
126504656|NCT02036502|455147213|FG003|Part 3:Dose Expansion|Adverse Event|0|||
126504657|NCT02036502|455147214|FG004|Part 3:Dose Expansion|Adverse Event|0|||
126504658|NCT02036502|455147215|FG005|Part 3:Dose Expansion|Adverse Event|4|||
126504659|NCT02036502|455147216|FG006|Part 3:Dose Expansion|Adverse Event|0|||
126504660|NCT02036502|455147217|FG007|Part 3:Dose Expansion|Adverse Event|2|||
126504661|NCT02036502|455147210|FG000|Part 3:Dose Expansion|Death|0|||
126504662|NCT02036502|455147211|FG001|Part 3:Dose Expansion|Death|0|||
126504663|NCT02036502|455147212|FG002|Part 3:Dose Expansion|Death|0|||
126504664|NCT02036502|455147213|FG003|Part 3:Dose Expansion|Death|0|||
126504665|NCT02036502|455147214|FG004|Part 3:Dose Expansion|Death|0|||
126504666|NCT02036502|455147215|FG005|Part 3:Dose Expansion|Death|24|||
126504667|NCT02036502|455147216|FG006|Part 3:Dose Expansion|Death|0|||
126504668|NCT02036502|455147217|FG007|Part 3:Dose Expansion|Death|3|||
126504669|NCT02036502|455147210|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
126504670|NCT02036502|455147211|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
126504671|NCT02036502|455147212|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
126504672|NCT02036502|455147213|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
126504673|NCT02036502|455147214|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
126563172|NCT02501629|455357368|FG001|Overall Study|Death|1|||
126563173|NCT02501629|455357367|FG000|Overall Study|Withdrawn from study by sponsor|1|||
126776718|NCT01078623|456139043|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126776719|NCT01078623|456139044|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126776720|NCT01078623|456139045|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126776721|NCT01078623|456139046|FG006|Treatment Period 1|Withdrawal by Subject|0|||
126504674|NCT02036502|455147215|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
126504675|NCT02036502|455147216|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
126504676|NCT02036502|455147217|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
126504677|NCT02036502|455147210|FG000|Part 3:Dose Expansion|Physician Decision|0|||
126504678|NCT02036502|455147211|FG001|Part 3:Dose Expansion|Physician Decision|0|||
126504679|NCT02036502|455147212|FG002|Part 3:Dose Expansion|Physician Decision|0|||
126776722|NCT01078623|456139047|FG007|Treatment Period 1|Withdrawal by Subject|1|||
126776723|NCT01078623|456139048|FG008|Treatment Period 1|Withdrawal by Subject|0|||
126776724|NCT01078623|456139049|FG009|Treatment Period 1|Withdrawal by Subject|0|||
126776725|NCT01078623|456139050|FG010|Treatment Period 1|Withdrawal by Subject|1|||
126776726|NCT01078623|456139051|FG011|Treatment Period 1|Withdrawal by Subject|0|||
126504680|NCT02036502|455147213|FG003|Part 3:Dose Expansion|Physician Decision|0|||
126504681|NCT02036502|455147214|FG004|Part 3:Dose Expansion|Physician Decision|0|||
126504682|NCT02036502|455147215|FG005|Part 3:Dose Expansion|Physician Decision|1|||
126504683|NCT02036502|455147216|FG006|Part 3:Dose Expansion|Physician Decision|0|||
126504684|NCT02036502|455147217|FG007|Part 3:Dose Expansion|Physician Decision|0|||
126504685|NCT02036502|455147210|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
126504686|NCT02036502|455147211|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
126504687|NCT02036502|455147212|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
126504688|NCT02036502|455147213|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
126504689|NCT02036502|455147214|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
126504690|NCT02036502|455147215|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
126504691|NCT02036502|455147216|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
126504692|NCT02036502|455147217|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
126504693|NCT02036502|455147210|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
126504694|NCT02036502|455147211|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
126504695|NCT02036502|455147212|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
126504696|NCT02036502|455147213|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
126504697|NCT02036502|455147214|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
126504698|NCT02036502|455147215|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
126504699|NCT02036502|455147216|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
126504700|NCT02036502|455147217|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
126504701|NCT02036502|455147210|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
126504702|NCT02036502|455147211|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
126504703|NCT02036502|455147212|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
126504704|NCT02036502|455147213|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
126504705|NCT02036502|455147214|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
126504706|NCT02036502|455147215|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
126504707|NCT02036502|455147216|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
126504708|NCT02036502|455147217|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
126504709|NCT02036502|455147210|FG000|Part 3:Dose Expansion|Not Treated|0|||
126504710|NCT02036502|455147211|FG001|Part 3:Dose Expansion|Not Treated|0|||
126504711|NCT02036502|455147212|FG002|Part 3:Dose Expansion|Not Treated|0|||
126504712|NCT02036502|455147213|FG003|Part 3:Dose Expansion|Not Treated|0|||
126504713|NCT02036502|455147214|FG004|Part 3:Dose Expansion|Not Treated|0|||
126504714|NCT02036502|455147215|FG005|Part 3:Dose Expansion|Not Treated|2|||
126504715|NCT02036502|455147216|FG006|Part 3:Dose Expansion|Not Treated|0|||
126504716|NCT02036502|455147217|FG007|Part 3:Dose Expansion|Not Treated|0|||
126504717|NCT00500292|455147221|FG000|Overall Study|Adverse Event|3|||
126504718|NCT00500292|455147222|FG001|Overall Study|Adverse Event|6|||
126504719|NCT00500292|455147223|FG002|Overall Study|Adverse Event|4|||
126504720|NCT00500292|455147221|FG000|Overall Study|Condition under investigation worsened|21|||
126504721|NCT00500292|455147222|FG001|Overall Study|Condition under investigation worsened|23|||
126504722|NCT00500292|455147223|FG002|Overall Study|Condition under investigation worsened|19|||
126504723|NCT00500292|455147221|FG000|Overall Study|Withdrawal by Subject|0|||
126504724|NCT00500292|455147222|FG001|Overall Study|Withdrawal by Subject|1|||
126504725|NCT00500292|455147223|FG002|Overall Study|Withdrawal by Subject|0|||
126504726|NCT00500292|455147221|FG000|Overall Study|Other|1|||
126504727|NCT00500292|455147222|FG001|Overall Study|Other|1|||
126504728|NCT00500292|455147223|FG002|Overall Study|Other|4|||
126504729|NCT01068509|455147224|FG000|Overall Study|Death|0|||
126504730|NCT01068509|455147225|FG001|Overall Study|Death|0|||
126504731|NCT01068509|455147226|FG002|Overall Study|Death|1|||
126504732|NCT01068509|455147224|FG000|Overall Study|Disease Progression|5|||
126504733|NCT01068509|455147225|FG001|Overall Study|Disease Progression|20|||
126727127|NCT00242580|455951062|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
126727128|NCT00242580|455951060|FG000|Overall Study|Protocol Violation|0|||
126727129|NCT00242580|455951061|FG001|Overall Study|Protocol Violation|0|||
126727130|NCT00242580|455951062|FG002|Overall Study|Protocol Violation|1|||
126727131|NCT00242580|455951060|FG000|Overall Study|Subject withdrew consent|2|||
126727132|NCT00242580|455951061|FG001|Overall Study|Subject withdrew consent|2|||
126727133|NCT00242580|455951062|FG002|Overall Study|Subject withdrew consent|5|||
126727134|NCT00242580|455951060|FG000|Overall Study|Lost to Follow-up|0|||
126727135|NCT00242580|455951061|FG001|Overall Study|Lost to Follow-up|3|||
126727136|NCT00242580|455951062|FG002|Overall Study|Lost to Follow-up|0|||
126727137|NCT00242580|455951060|FG000|Overall Study|Death|1|||
126727138|NCT00242580|455951061|FG001|Overall Study|Death|2|||
126727139|NCT00242580|455951062|FG002|Overall Study|Death|1|||
126727140|NCT01232894|455951063|FG000|Overall Study|Lost to Follow-up|0|||
126727141|NCT01232894|455951064|FG001|Overall Study|Lost to Follow-up|1|||
126727142|NCT01232894|455951063|FG000|Overall Study|Death|1|||
126504734|NCT01068509|455147226|FG002|Overall Study|Disease Progression|18|||
126727143|NCT01232894|455951064|FG001|Overall Study|Death|0|||
126504735|NCT01068509|455147224|FG000|Overall Study|Lost to Follow-up|1|||
126727144|NCT01232894|455951063|FG000|Overall Study|Protocol Violation|1|||
126727145|NCT01232894|455951064|FG001|Overall Study|Protocol Violation|1|||
126727146|NCT01232894|455951063|FG000|Overall Study|Withdrawal by Subject|8|||
126727147|NCT01232894|455951064|FG001|Overall Study|Withdrawal by Subject|5|||
126563174|NCT02501629|455357368|FG001|Overall Study|Withdrawn from study by sponsor|0|||
126563175|NCT02501629|455357367|FG000|Overall Study|Early termination by sponsor|1|||
126563176|NCT02501629|455357368|FG001|Overall Study|Early termination by sponsor|0|||
126563177|NCT02501629|455357367|FG000|Overall Study|Withdrawal by Subject|3|||
126563178|NCT02501629|455357368|FG001|Overall Study|Withdrawal by Subject|5|||
126504736|NCT01068509|455147225|FG001|Overall Study|Lost to Follow-up|0|||
126563179|NCT02501629|455357367|FG000|Overall Study|Subject did not return to site|0|||
126504737|NCT01068509|455147226|FG002|Overall Study|Lost to Follow-up|0|||
126504738|NCT01068509|455147224|FG000|Overall Study|Withdrew Consent|0|||
126504739|NCT01068509|455147225|FG001|Overall Study|Withdrew Consent|1|||
126504740|NCT01068509|455147226|FG002|Overall Study|Withdrew Consent|2|||
126504741|NCT01068509|455147224|FG000|Overall Study|Reason Not Specified|0|||
126504742|NCT01068509|455147225|FG001|Overall Study|Reason Not Specified|1|||
126504743|NCT01068509|455147226|FG002|Overall Study|Reason Not Specified|0|||
126504744|NCT02442778|455147227|FG000|Overall Study|Adverse Event|2|||
126504745|NCT02442778|455147228|FG001|Overall Study|Adverse Event|6|||
126504746|NCT02442778|455147229|FG002|Overall Study|Adverse Event|6|||
126504747|NCT02442778|455147227|FG000|Overall Study|Death|0|||
126504748|NCT02442778|455147228|FG001|Overall Study|Death|2|||
126504749|NCT02442778|455147229|FG002|Overall Study|Death|0|||
126504750|NCT02442778|455147227|FG000|Overall Study|Lack of Efficacy|1|||
126504751|NCT02442778|455147228|FG001|Overall Study|Lack of Efficacy|0|||
126504752|NCT02442778|455147229|FG002|Overall Study|Lack of Efficacy|0|||
126504753|NCT02442778|455147227|FG000|Overall Study|Lost to Follow-up|1|||
126504754|NCT02442778|455147228|FG001|Overall Study|Lost to Follow-up|1|||
126504755|NCT02442778|455147229|FG002|Overall Study|Lost to Follow-up|1|||
126504756|NCT02442778|455147227|FG000|Overall Study|Non-compliance with study drug|2|||
126504757|NCT02442778|455147228|FG001|Overall Study|Non-compliance with study drug|0|||
126504758|NCT02442778|455147229|FG002|Overall Study|Non-compliance with study drug|1|||
126504759|NCT02442778|455147227|FG000|Overall Study|Physician Decision|1|||
126504760|NCT02442778|455147228|FG001|Overall Study|Physician Decision|1|||
126504761|NCT02442778|455147229|FG002|Overall Study|Physician Decision|1|||
126504762|NCT02442778|455147227|FG000|Overall Study|Protocol Deviation|3|||
126504763|NCT02442778|455147228|FG001|Overall Study|Protocol Deviation|0|||
126504764|NCT02442778|455147229|FG002|Overall Study|Protocol Deviation|1|||
126504765|NCT02442778|455147227|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
126504766|NCT02442778|455147228|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
126504767|NCT02442778|455147229|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
126504768|NCT02442778|455147227|FG000|Overall Study|Withdrawal by Subject|4|||
126504769|NCT02442778|455147228|FG001|Overall Study|Withdrawal by Subject|4|||
126504770|NCT02442778|455147229|FG002|Overall Study|Withdrawal by Subject|3|||
126504771|NCT02442778|455147227|FG000|Overall Study|Reason not specified|1|||
126504772|NCT02442778|455147228|FG001|Overall Study|Reason not specified|4|||
126504773|NCT02442778|455147229|FG002|Overall Study|Reason not specified|0|||
126504774|NCT00603746|455147230|FG000|Overall Study|Adverse Event|2|||
126504775|NCT00603746|455147231|FG001|Overall Study|Adverse Event|3|||
126504776|NCT00603746|455147232|FG002|Overall Study|Adverse Event|0|||
126504777|NCT00603746|455147233|FG003|Overall Study|Adverse Event|1|||
126504778|NCT00603746|455147234|FG004|Overall Study|Adverse Event|0|||
126504779|NCT00603746|455147235|FG005|Overall Study|Adverse Event|4|||
126504780|NCT00603746|455147230|FG000|Overall Study|Lack of Efficacy|34|||
126504781|NCT00603746|455147231|FG001|Overall Study|Lack of Efficacy|11|||
126504782|NCT00603746|455147232|FG002|Overall Study|Lack of Efficacy|6|||
126504783|NCT00603746|455147233|FG003|Overall Study|Lack of Efficacy|11|||
126504784|NCT00603746|455147234|FG004|Overall Study|Lack of Efficacy|12|||
126504785|NCT00603746|455147235|FG005|Overall Study|Lack of Efficacy|8|||
126504786|NCT00603746|455147230|FG000|Overall Study|Protocol Violation|0|||
126504787|NCT00603746|455147231|FG001|Overall Study|Protocol Violation|3|||
126504788|NCT00603746|455147232|FG002|Overall Study|Protocol Violation|1|||
126504789|NCT00603746|455147233|FG003|Overall Study|Protocol Violation|0|||
126504790|NCT00603746|455147234|FG004|Overall Study|Protocol Violation|1|||
126504791|NCT00603746|455147235|FG005|Overall Study|Protocol Violation|0|||
126504792|NCT00603746|455147230|FG000|Overall Study|Lost to Follow-up|0|||
126504793|NCT00603746|455147231|FG001|Overall Study|Lost to Follow-up|1|||
126563180|NCT02501629|455357368|FG001|Overall Study|Subject did not return to site|1|||
126504794|NCT00603746|455147232|FG002|Overall Study|Lost to Follow-up|1|||
126504795|NCT00603746|455147233|FG003|Overall Study|Lost to Follow-up|0|||
126504796|NCT00603746|455147234|FG004|Overall Study|Lost to Follow-up|0|||
126504797|NCT00603746|455147235|FG005|Overall Study|Lost to Follow-up|0|||
126504798|NCT00603746|455147230|FG000|Overall Study|Physician Decision|1|||
126504799|NCT00603746|455147231|FG001|Overall Study|Physician Decision|0|||
126504800|NCT00603746|455147232|FG002|Overall Study|Physician Decision|0|||
126504801|NCT00603746|455147233|FG003|Overall Study|Physician Decision|0|||
126504802|NCT00603746|455147234|FG004|Overall Study|Physician Decision|1|||
126504803|NCT00603746|455147235|FG005|Overall Study|Physician Decision|0|||
126504804|NCT00603746|455147230|FG000|Overall Study|Withdrawal by Subject|1|||
126504805|NCT00603746|455147231|FG001|Overall Study|Withdrawal by Subject|0|||
126504806|NCT00603746|455147232|FG002|Overall Study|Withdrawal by Subject|0|||
126776727|NCT01078623|456139052|FG012|Treatment Period 1|Withdrawal by Subject|0|||
126776728|NCT01078623|456139053|FG013|Treatment Period 1|Withdrawal by Subject|0|||
126776729|NCT01078623|456139054|FG014|Treatment Period 1|Withdrawal by Subject|0|||
126776730|NCT01078623|456139055|FG015|Treatment Period 1|Withdrawal by Subject|0|||
126776731|NCT01078623|456139056|FG016|Treatment Period 1|Withdrawal by Subject|0|||
126776732|NCT01078623|456139057|FG017|Treatment Period 1|Withdrawal by Subject|0|||
126776733|NCT01078623|456139058|FG018|Treatment Period 1|Withdrawal by Subject|0|||
126776734|NCT01078623|456139059|FG019|Treatment Period 1|Withdrawal by Subject|0|||
126776735|NCT01078623|456139040|FG000|Treatment Period 1|Protocol Violation|0|||
126776736|NCT01078623|456139041|FG001|Treatment Period 1|Protocol Violation|0|||
126776737|NCT01078623|456139042|FG002|Treatment Period 1|Protocol Violation|0|||
126776738|NCT01078623|456139043|FG003|Treatment Period 1|Protocol Violation|0|||
126776739|NCT01078623|456139044|FG004|Treatment Period 1|Protocol Violation|0|||
126776740|NCT01078623|456139045|FG005|Treatment Period 1|Protocol Violation|1|||
126776741|NCT01078623|456139046|FG006|Treatment Period 1|Protocol Violation|0|||
126776742|NCT01078623|456139047|FG007|Treatment Period 1|Protocol Violation|0|||
126776743|NCT01078623|456139048|FG008|Treatment Period 1|Protocol Violation|0|||
126776744|NCT01078623|456139049|FG009|Treatment Period 1|Protocol Violation|0|||
126776745|NCT01078623|456139050|FG010|Treatment Period 1|Protocol Violation|0|||
126776746|NCT01078623|456139051|FG011|Treatment Period 1|Protocol Violation|0|||
126776747|NCT01078623|456139052|FG012|Treatment Period 1|Protocol Violation|0|||
126776748|NCT01078623|456139053|FG013|Treatment Period 1|Protocol Violation|0|||
126776749|NCT01078623|456139054|FG014|Treatment Period 1|Protocol Violation|0|||
126776750|NCT01078623|456139055|FG015|Treatment Period 1|Protocol Violation|0|||
126776751|NCT01078623|456139056|FG016|Treatment Period 1|Protocol Violation|0|||
126776752|NCT01078623|456139057|FG017|Treatment Period 1|Protocol Violation|0|||
126776753|NCT01078623|456139058|FG018|Treatment Period 1|Protocol Violation|0|||
126776754|NCT01078623|456139059|FG019|Treatment Period 1|Protocol Violation|0|||
126776755|NCT01078623|456139040|FG000|Treatment Period 2|Adverse Event|0|||
126776756|NCT01078623|456139041|FG001|Treatment Period 2|Adverse Event|0|||
126776757|NCT01078623|456139042|FG002|Treatment Period 2|Adverse Event|0|||
126776758|NCT01078623|456139043|FG003|Treatment Period 2|Adverse Event|0|||
126776759|NCT01078623|456139044|FG004|Treatment Period 2|Adverse Event|0|||
126563181|NCT00868231|455357371|FG000|Treatment Period 1|Adverse Event|0|||
126776760|NCT01078623|456139045|FG005|Treatment Period 2|Adverse Event|0|||
126776761|NCT01078623|456139046|FG006|Treatment Period 2|Adverse Event|1|||
126776762|NCT01078623|456139047|FG007|Treatment Period 2|Adverse Event|0|||
126504807|NCT00603746|455147233|FG003|Overall Study|Withdrawal by Subject|1|||
126504808|NCT00603746|455147234|FG004|Overall Study|Withdrawal by Subject|3|||
126504809|NCT00603746|455147235|FG005|Overall Study|Withdrawal by Subject|1|||
126504810|NCT04536727|455147241|FG000|Overall Study|Lost to Follow-up|1|||
126504811|NCT04536727|455147242|FG001|Overall Study|Lost to Follow-up|1|||
126504812|NCT04536727|455147241|FG000|Overall Study|Death|0|||
126504813|NCT04536727|455147242|FG001|Overall Study|Death|1|||
126504814|NCT02849548|455147243|FG000|Overall Study|Lost to Follow-up|1|||
126504815|NCT02849548|455147244|FG001|Overall Study|Lost to Follow-up|2|||
126504816|NCT02849548|455147243|FG000|Overall Study|Protocol Violation|1|||
126504817|NCT02849548|455147244|FG001|Overall Study|Protocol Violation|0|||
126504818|NCT02357147|455147246|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
126504819|NCT02357147|455147247|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
126504820|NCT02357147|455147246|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
126504821|NCT02357147|455147247|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
126504822|NCT02357147|455147246|FG000|Combination Treatment Phase|Investigator Discretion|1|||
126504823|NCT02357147|455147247|FG001|Combination Treatment Phase|Investigator Discretion|1|||
126504824|NCT02357147|455147246|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
126504825|NCT02357147|455147247|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
126504826|NCT02357147|455147246|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
126504827|NCT02357147|455147247|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
126504828|NCT02357147|455147246|FG000|Combination Treatment Phase|Adverse Event|12|||
126504829|NCT02357147|455147247|FG001|Combination Treatment Phase|Adverse Event|4|||
126504830|NCT02357147|455147246|FG000|Combination Treatment Phase|Death|1|||
126504831|NCT02357147|455147247|FG001|Combination Treatment Phase|Death|1|||
126504832|NCT02357147|455147246|FG000|Combination Treatment Phase|Sponsor Decision|0|||
126504833|NCT02357147|455147247|FG001|Combination Treatment Phase|Sponsor Decision|12|||
126504834|NCT02357147|455147246|FG000|Combination Treatment Phase|Other|1|||
126504835|NCT02357147|455147247|FG001|Combination Treatment Phase|Other|0|||
126776763|NCT01078623|456139048|FG008|Treatment Period 2|Adverse Event|0|||
126504836|NCT02357147|455147246|FG000|Combination Treatment Phase|Not treated|0|||
126504837|NCT02357147|455147247|FG001|Combination Treatment Phase|Not treated|2|||
126776764|NCT01078623|456139049|FG009|Treatment Period 2|Adverse Event|0|||
126776765|NCT01078623|456139050|FG010|Treatment Period 2|Adverse Event|0|||
126776766|NCT01078623|456139051|FG011|Treatment Period 2|Adverse Event|0|||
126776767|NCT01078623|456139052|FG012|Treatment Period 2|Adverse Event|0|||
126776768|NCT01078623|456139053|FG013|Treatment Period 2|Adverse Event|0|||
126504838|NCT02357147|455147246|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
126563182|NCT00868231|455357372|FG001|Treatment Period 1|Adverse Event|0|||
126563183|NCT00868231|455357373|FG002|Treatment Period 1|Adverse Event|0|||
126563184|NCT00868231|455357374|FG003|Treatment Period 1|Adverse Event|0|||
126563185|NCT00868231|455357375|FG004|Treatment Period 1|Adverse Event|1|||
126563186|NCT00868231|455357376|FG005|Treatment Period 1|Adverse Event|0|||
126563187|NCT00868231|455357371|FG000|Treatment Period 2|Adverse Event|1|||
126563188|NCT00868231|455357372|FG001|Treatment Period 2|Adverse Event|0|||
126563189|NCT00868231|455357373|FG002|Treatment Period 2|Adverse Event|0|||
126563190|NCT00868231|455357374|FG003|Treatment Period 2|Adverse Event|0|||
126563191|NCT00868231|455357375|FG004|Treatment Period 2|Adverse Event|0|||
126563192|NCT00868231|455357376|FG005|Treatment Period 2|Adverse Event|0|||
126563193|NCT00868231|455357371|FG000|Treatment Period 3|Adverse Event|0|||
126563194|NCT00868231|455357372|FG001|Treatment Period 3|Adverse Event|0|||
126563195|NCT00868231|455357373|FG002|Treatment Period 3|Adverse Event|1|||
126563196|NCT00868231|455357374|FG003|Treatment Period 3|Adverse Event|0|||
126563197|NCT00868231|455357375|FG004|Treatment Period 3|Adverse Event|0|||
126563198|NCT00868231|455357376|FG005|Treatment Period 3|Adverse Event|0|||
126563199|NCT00530335|455357379|FG000|Overall Study|Adverse Event|3|||
126563200|NCT00530335|455357379|FG000|Overall Study|Protocol Violation|1|||
126563201|NCT00530335|455357379|FG000|Overall Study|Withdrawal by Subject|1|||
126563202|NCT00530335|455357379|FG000|Overall Study|Physician Decision|1|||
126563203|NCT02321540|455357380|FG000|Overall Study|Death|0|||
126563204|NCT02321540|455357381|FG001|Overall Study|Death|1|||
126563205|NCT02321540|455357380|FG000|Overall Study|Progression|3|||
126563206|NCT02321540|455357381|FG001|Overall Study|Progression|9|||
126563207|NCT04577183|455357382|FG000|Overall Study|Death|1|||
126563208|NCT04577183|455357382|FG000|Overall Study|Withdrawal by Subject|3|||
126563209|NCT04577183|455357382|FG000|Overall Study|Early termination|2|||
126563210|NCT01268891|455357385|FG000|Overall Study|Adverse Event|3|||
126563211|NCT01268891|455357386|FG001|Overall Study|Adverse Event|7|||
126563212|NCT01268891|455357385|FG000|Overall Study|Lack of Efficacy|1|||
126563213|NCT01268891|455357386|FG001|Overall Study|Lack of Efficacy|0|||
126563214|NCT01268891|455357385|FG000|Overall Study|Withdrawal of Consent|3|||
126563215|NCT01268891|455357386|FG001|Overall Study|Withdrawal of Consent|1|||
126563216|NCT01268891|455357385|FG000|Overall Study|Administrative or other reason(s)|1|||
126563217|NCT01268891|455357386|FG001|Overall Study|Administrative or other reason(s)|0|||
126563218|NCT01720043|455357388|FG000|Overall Study|Withdrawal by Subject|1|||
126563219|NCT01688973|455357389|FG000|Overall Study|Ineligible|2|||
126563220|NCT01688973|455357390|FG001|Overall Study|Ineligible|3|||
126563221|NCT02534896|455357395|FG000|Overall Study|Adverse Event|2|||
126563222|NCT02534896|455357396|FG001|Overall Study|Adverse Event|1|||
126563223|NCT02534896|455357397|FG002|Overall Study|Adverse Event|1|||
126563224|NCT02534896|455357395|FG000|Overall Study|Insufficient therapeutic response|2|||
126563225|NCT02534896|455357396|FG001|Overall Study|Insufficient therapeutic response|0|||
126563226|NCT02534896|455357397|FG002|Overall Study|Insufficient therapeutic response|0|||
126563227|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
126563228|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
126563229|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
126563230|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
126563231|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Adverse Event|198|||
126563232|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Adverse Event|0|||
126563233|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Adverse Event|0|||
126563234|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Adverse Event|0|||
126563235|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Death|62|||
126563236|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Death|0|||
126563237|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Death|0|||
126563238|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Death|0|||
126563239|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
126563240|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
126563241|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
126563242|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
126563243|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Complicating disease|13|||
126563244|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Complicating disease|0|||
126563245|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Complicating disease|0|||
126563246|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Complicating disease|0|||
126563247|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
126563248|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
126563249|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
126563250|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
126563251|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
126563252|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
126563253|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
126563254|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
126563255|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Non-compliance|4|||
126563256|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Non-compliance|0|||
126563257|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Non-compliance|0|||
126776769|NCT01078623|456139054|FG014|Treatment Period 2|Adverse Event|0|||
126776770|NCT01078623|456139055|FG015|Treatment Period 2|Adverse Event|0|||
126776771|NCT01078623|456139056|FG016|Treatment Period 2|Adverse Event|0|||
126776772|NCT01078623|456139057|FG017|Treatment Period 2|Adverse Event|0|||
126776773|NCT01078623|456139058|FG018|Treatment Period 2|Adverse Event|1|||
126776774|NCT01078623|456139059|FG019|Treatment Period 2|Adverse Event|0|||
126776775|NCT01078623|456139040|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126776776|NCT01078623|456139041|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126776777|NCT01078623|456139042|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126776778|NCT01078623|456139043|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126776779|NCT01078623|456139044|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126563258|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Non-compliance|0|||
126563259|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Pain|4|||
126563260|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Pain|0|||
126563261|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Pain|0|||
126563262|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Pain|0|||
126563263|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
126563264|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
126563265|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
126563266|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
126563267|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Hospice care|1|||
126563268|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Hospice care|0|||
126563269|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Hospice care|0|||
126563270|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Hospice care|0|||
126563271|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Physician Decision|1|||
126563272|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Physician Decision|0|||
126563273|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Physician Decision|0|||
126563274|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Physician Decision|0|||
126563275|NCT01107626|455357398|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
126563276|NCT01107626|455357399|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
126563277|NCT01107626|455357400|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
126563278|NCT01107626|455357401|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
126563279|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
126563280|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
126563281|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
126563282|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
126563283|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
126563284|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
126776780|NCT01078623|456139045|FG005|Treatment Period 2|Withdrawal by Subject|1|||
126776781|NCT01078623|456139046|FG006|Treatment Period 2|Withdrawal by Subject|0|||
126776782|NCT01078623|456139047|FG007|Treatment Period 2|Withdrawal by Subject|0|||
126504839|NCT02357147|455147247|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
126504840|NCT02357147|455147246|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
126504841|NCT02357147|455147247|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
126504842|NCT02357147|455147246|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
126504843|NCT02357147|455147247|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
126504844|NCT02357147|455147246|FG000|Maintenance Treatment Phase|Adverse Event|0|||
126504845|NCT02357147|455147247|FG001|Maintenance Treatment Phase|Adverse Event|3|||
126504846|NCT02357147|455147246|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
126504847|NCT02357147|455147247|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
126504848|NCT02357147|455147246|FG000|Maintenance Treatment Phase|Not Treated|1|||
126504849|NCT02357147|455147247|FG001|Maintenance Treatment Phase|Not Treated|0|||
126504850|NCT00256698|455147248|FG000|Overall Study|Withdrawal by Subject|7|||
126504851|NCT00256698|455147249|FG001|Overall Study|Withdrawal by Subject|7|||
126504852|NCT00256698|455147248|FG000|Overall Study|Adverse Event|13|||
126504853|NCT00256698|455147249|FG001|Overall Study|Adverse Event|6|||
126504854|NCT00256698|455147248|FG000|Overall Study|Protocol Violation|6|||
126504855|NCT00256698|455147249|FG001|Overall Study|Protocol Violation|5|||
126504856|NCT00256698|455147248|FG000|Overall Study|Lost to Follow-up|1|||
126504857|NCT00256698|455147249|FG001|Overall Study|Lost to Follow-up|3|||
126504858|NCT00256698|455147248|FG000|Overall Study|disease progression|97|||
126504859|NCT00256698|455147249|FG001|Overall Study|disease progression|105|||
126504860|NCT00256698|455147248|FG000|Overall Study|still ongoing at data cut-off|41|||
126504861|NCT00256698|455147249|FG001|Overall Study|still ongoing at data cut-off|46|||
126504862|NCT00256698|455147248|FG000|Overall Study|withdrawn due to osteoporosis|1|||
126563285|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
126563286|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
126563287|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Death|0|||
126563288|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Death|8|||
126776783|NCT01078623|456139048|FG008|Treatment Period 2|Withdrawal by Subject|0|||
126776784|NCT01078623|456139049|FG009|Treatment Period 2|Withdrawal by Subject|0|||
126504863|NCT00256698|455147249|FG001|Overall Study|withdrawn due to osteoporosis|0|||
126776785|NCT01078623|456139050|FG010|Treatment Period 2|Withdrawal by Subject|0|||
126504864|NCT00256698|455147248|FG000|Overall Study|Prematurely Discontinued|1|||
126504865|NCT00256698|455147249|FG001|Overall Study|Prematurely Discontinued|0|||
126504866|NCT02917031|455147251|FG000|Overall Study|Reason not specified|7|||
126504867|NCT02917031|455147252|FG001|Overall Study|Reason not specified|5|||
126504868|NCT02917031|455147253|FG002|Overall Study|Reason not specified|6|||
126504869|NCT02917031|455147251|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
126504870|NCT02917031|455147252|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
126504871|NCT02917031|455147253|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
126504872|NCT02917031|455147251|FG000|Overall Study|Withdrawal by Subject|3|||
126504873|NCT02917031|455147252|FG001|Overall Study|Withdrawal by Subject|3|||
126504874|NCT02917031|455147253|FG002|Overall Study|Withdrawal by Subject|0|||
126504875|NCT02917031|455147251|FG000|Overall Study|Physician Decision|1|||
126504876|NCT02917031|455147252|FG001|Overall Study|Physician Decision|0|||
126504877|NCT02917031|455147253|FG002|Overall Study|Physician Decision|0|||
126504878|NCT02917031|455147251|FG000|Overall Study|Adverse Event|4|||
126504879|NCT02917031|455147252|FG001|Overall Study|Adverse Event|1|||
126504880|NCT02917031|455147253|FG002|Overall Study|Adverse Event|5|||
126504881|NCT02917031|455147251|FG000|Overall Study|Death|2|||
126504882|NCT02917031|455147252|FG001|Overall Study|Death|3|||
126504883|NCT02917031|455147253|FG002|Overall Study|Death|4|||
126504884|NCT03036566|455149012|FG000|Overall Study|Lost to Follow-up|3|||
126504885|NCT01914666|455149016|FG000|Treatment Period|Lack of Efficacy|0|||
126504886|NCT01914666|455149017|FG001|Treatment Period|Lack of Efficacy|0|||
126504887|NCT01914666|455149018|FG002|Treatment Period|Lack of Efficacy|2|||
126504888|NCT01914666|455149016|FG000|Treatment Period|Adverse Event|10|||
126504889|NCT01914666|455149017|FG001|Treatment Period|Adverse Event|4|||
126504890|NCT01914666|455149018|FG002|Treatment Period|Adverse Event|2|||
126504891|NCT01914666|455149016|FG000|Treatment Period|Withdrawal by Subject|3|||
126504892|NCT01914666|455149017|FG001|Treatment Period|Withdrawal by Subject|2|||
126504893|NCT01914666|455149018|FG002|Treatment Period|Withdrawal by Subject|2|||
126504894|NCT01914666|455149016|FG000|Treatment Period|Physician Decision|0|||
126504895|NCT01914666|455149017|FG001|Treatment Period|Physician Decision|0|||
126504896|NCT01914666|455149018|FG002|Treatment Period|Physician Decision|2|||
126504897|NCT03252522|455149019|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
126504898|NCT03252522|455149020|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
126504899|NCT03252522|455149021|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
126504900|NCT03252522|455149019|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
126504901|NCT03252522|455149020|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
126504902|NCT03252522|455149021|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
126504903|NCT03252522|455149019|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
126504904|NCT03252522|455149020|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
126504905|NCT03252522|455149021|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
126504906|NCT03252522|455149019|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
126504907|NCT03252522|455149020|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
126504908|NCT03252522|455149021|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
126504909|NCT03252522|455149019|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
126504910|NCT03252522|455149020|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
126563289|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Death|2|||
126504911|NCT03252522|455149021|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
126504912|NCT03252522|455149019|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
126504913|NCT03252522|455149020|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
126504914|NCT03252522|455149021|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
126504915|NCT03252522|455149019|FG000|Phase 2: Open Label|Adverse Event|0|||
126504916|NCT03252522|455149020|FG001|Phase 2: Open Label|Adverse Event|0|||
126504917|NCT03252522|455149021|FG002|Phase 2: Open Label|Adverse Event|2|||
126504918|NCT03252522|455149019|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
126504919|NCT03252522|455149020|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
126504920|NCT03252522|455149021|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
126504921|NCT00913744|455149023|FG000|Overall Study|Adverse Event|2|||
126504922|NCT00913744|455149024|FG001|Overall Study|Adverse Event|0|||
126504923|NCT00913744|455149023|FG000|Overall Study|Withdrawal by Subject|2|||
126504924|NCT00913744|455149024|FG001|Overall Study|Withdrawal by Subject|1|||
126504925|NCT00913744|455149023|FG000|Overall Study|Death|1|||
126504926|NCT00913744|455149024|FG001|Overall Study|Death|0|||
126504927|NCT00805935|455149025|FG000|Overall Study|Stimulation Failure|1|||
126504928|NCT00805935|455149026|FG001|Overall Study|Stimulation Failure|5|||
126504929|NCT00805935|455149027|FG002|Overall Study|Stimulation Failure|2|||
126504930|NCT00805935|455149028|FG003|Overall Study|Stimulation Failure|2|||
126504931|NCT00805935|455149025|FG000|Overall Study|Cycle cancelled|0|||
126504932|NCT00805935|455149026|FG001|Overall Study|Cycle cancelled|0|||
126504933|NCT00805935|455149027|FG002|Overall Study|Cycle cancelled|2|||
126504934|NCT00805935|455149028|FG003|Overall Study|Cycle cancelled|0|||
126504935|NCT00805935|455149025|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
126504936|NCT00805935|455149026|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
126504937|NCT00805935|455149027|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
126504938|NCT00805935|455149028|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
126504939|NCT00805935|455149025|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
126504940|NCT00805935|455149026|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
126504941|NCT00805935|455149027|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
126504942|NCT00805935|455149028|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
126504943|NCT00805935|455149025|FG000|Overall Study|Lost to Follow-up|1|||
126504944|NCT00805935|455149026|FG001|Overall Study|Lost to Follow-up|0|||
126504945|NCT00805935|455149027|FG002|Overall Study|Lost to Follow-up|0|||
126504946|NCT00805935|455149028|FG003|Overall Study|Lost to Follow-up|0|||
126504947|NCT00805935|455149025|FG000|Overall Study|No positive serum pregnancy|8|||
126504948|NCT00805935|455149026|FG001|Overall Study|No positive serum pregnancy|7|||
126504949|NCT00805935|455149027|FG002|Overall Study|No positive serum pregnancy|6|||
126504950|NCT00805935|455149028|FG003|Overall Study|No positive serum pregnancy|5|||
126504951|NCT00805935|455149025|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
126504952|NCT00805935|455149026|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
126504953|NCT00805935|455149027|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
126504954|NCT00805935|455149028|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
126504955|NCT00805935|455149025|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
126504956|NCT00805935|455149026|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
126504957|NCT00805935|455149027|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
126504958|NCT00805935|455149028|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
126504959|NCT00805935|455149025|FG000|Overall Study|Biochemical pregnancy|0|||
126504960|NCT00805935|455149026|FG001|Overall Study|Biochemical pregnancy|1|||
126504961|NCT00805935|455149027|FG002|Overall Study|Biochemical pregnancy|0|||
126504962|NCT00805935|455149028|FG003|Overall Study|Biochemical pregnancy|0|||
126504963|NCT00805935|455149025|FG000|Overall Study|Chemical pregnancy|0|||
126504964|NCT00805935|455149026|FG001|Overall Study|Chemical pregnancy|5|||
126504965|NCT00805935|455149027|FG002|Overall Study|Chemical pregnancy|3|||
126504966|NCT00805935|455149028|FG003|Overall Study|Chemical pregnancy|2|||
126504967|NCT00805935|455149025|FG000|Overall Study|Ectopic pregnancy|0|||
126504968|NCT00805935|455149026|FG001|Overall Study|Ectopic pregnancy|0|||
126504969|NCT00805935|455149027|FG002|Overall Study|Ectopic pregnancy|1|||
126504970|NCT00805935|455149028|FG003|Overall Study|Ectopic pregnancy|0|||
126504971|NCT00805935|455149025|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
126504972|NCT00805935|455149026|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
126504973|NCT00805935|455149027|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
126504974|NCT00805935|455149028|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
126504975|NCT02945410|455149029|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
126504976|NCT02945410|455149030|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
126504977|NCT02945410|455149031|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
126504978|NCT02945410|455149032|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
126504979|NCT02945410|455149033|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
126504980|NCT02945410|455149034|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
126504981|NCT02945410|455149029|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
126504982|NCT02945410|455149030|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
126504983|NCT02945410|455149031|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
126504984|NCT02945410|455149032|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
126504985|NCT02945410|455149033|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
126504986|NCT02945410|455149034|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
126504987|NCT02945410|455149029|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
126504988|NCT02945410|455149030|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
126504989|NCT02945410|455149031|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
126504990|NCT02945410|455149032|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
126504991|NCT02945410|455149033|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
126504992|NCT02945410|455149034|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
126504993|NCT01344369|455149035|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
126504994|NCT01344369|455149036|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
126504995|NCT01344369|455149035|FG000|Washout of 28 Days|Physician Decision|0|||
126504996|NCT01344369|455149036|FG001|Washout of 28 Days|Physician Decision|1|||
126504997|NCT01344369|455149035|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
126504998|NCT01344369|455149036|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
126504999|NCT03848845|455149037|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
126505000|NCT03848845|455149038|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
126505001|NCT03848845|455149039|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
126505002|NCT03848845|455149040|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
126505003|NCT03848845|455149037|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
126505004|NCT03848845|455149038|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
126505005|NCT03848845|455149039|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
126505006|NCT03848845|455149040|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
126505007|NCT03848845|455149037|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
126505008|NCT03848845|455149038|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
126505009|NCT03848845|455149039|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
126776786|NCT01078623|456139051|FG011|Treatment Period 2|Withdrawal by Subject|0|||
126776787|NCT01078623|456139052|FG012|Treatment Period 2|Withdrawal by Subject|0|||
126776788|NCT01078623|456139053|FG013|Treatment Period 2|Withdrawal by Subject|0|||
126776789|NCT01078623|456139054|FG014|Treatment Period 2|Withdrawal by Subject|0|||
126776790|NCT01078623|456139055|FG015|Treatment Period 2|Withdrawal by Subject|0|||
126776791|NCT01078623|456139056|FG016|Treatment Period 2|Withdrawal by Subject|0|||
126776792|NCT01078623|456139057|FG017|Treatment Period 2|Withdrawal by Subject|0|||
126776793|NCT01078623|456139058|FG018|Treatment Period 2|Withdrawal by Subject|0|||
126776794|NCT01078623|456139059|FG019|Treatment Period 2|Withdrawal by Subject|0|||
126776795|NCT01078623|456139040|FG000|Treatment Period 3|Adverse Event|0|||
126776796|NCT01078623|456139041|FG001|Treatment Period 3|Adverse Event|0|||
126776797|NCT01078623|456139042|FG002|Treatment Period 3|Adverse Event|0|||
126776798|NCT01078623|456139043|FG003|Treatment Period 3|Adverse Event|0|||
126776799|NCT01078623|456139044|FG004|Treatment Period 3|Adverse Event|1|||
126776800|NCT01078623|456139045|FG005|Treatment Period 3|Adverse Event|0|||
126776801|NCT01078623|456139046|FG006|Treatment Period 3|Adverse Event|0|||
126776802|NCT01078623|456139047|FG007|Treatment Period 3|Adverse Event|0|||
126776803|NCT01078623|456139048|FG008|Treatment Period 3|Adverse Event|0|||
126776804|NCT01078623|456139049|FG009|Treatment Period 3|Adverse Event|0|||
126776805|NCT01078623|456139050|FG010|Treatment Period 3|Adverse Event|0|||
126776806|NCT01078623|456139051|FG011|Treatment Period 3|Adverse Event|0|||
126776807|NCT01078623|456139052|FG012|Treatment Period 3|Adverse Event|0|||
126776808|NCT01078623|456139053|FG013|Treatment Period 3|Adverse Event|1|||
126776809|NCT01078623|456139054|FG014|Treatment Period 3|Adverse Event|0|||
126776810|NCT01078623|456139055|FG015|Treatment Period 3|Adverse Event|0|||
126776811|NCT01078623|456139056|FG016|Treatment Period 3|Adverse Event|0|||
126776812|NCT01078623|456139057|FG017|Treatment Period 3|Adverse Event|0|||
126776813|NCT01078623|456139058|FG018|Treatment Period 3|Adverse Event|0|||
126776814|NCT01078623|456139059|FG019|Treatment Period 3|Adverse Event|0|||
126776815|NCT01078623|456139040|FG000|Treatment Period 4|Adverse Event|0|||
126776816|NCT01078623|456139041|FG001|Treatment Period 4|Adverse Event|0|||
126776817|NCT01078623|456139042|FG002|Treatment Period 4|Adverse Event|1|||
126776818|NCT01078623|456139043|FG003|Treatment Period 4|Adverse Event|0|||
126776819|NCT01078623|456139044|FG004|Treatment Period 4|Adverse Event|0|||
126776820|NCT01078623|456139045|FG005|Treatment Period 4|Adverse Event|0|||
126776821|NCT01078623|456139046|FG006|Treatment Period 4|Adverse Event|0|||
126776822|NCT01078623|456139047|FG007|Treatment Period 4|Adverse Event|0|||
126776823|NCT01078623|456139048|FG008|Treatment Period 4|Adverse Event|0|||
126776824|NCT01078623|456139049|FG009|Treatment Period 4|Adverse Event|0|||
126776825|NCT01078623|456139050|FG010|Treatment Period 4|Adverse Event|0|||
126776826|NCT01078623|456139051|FG011|Treatment Period 4|Adverse Event|0|||
126776827|NCT01078623|456139052|FG012|Treatment Period 4|Adverse Event|0|||
126776828|NCT01078623|456139053|FG013|Treatment Period 4|Adverse Event|0|||
126505010|NCT03848845|455149040|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
126505011|NCT03848845|455149037|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
126505012|NCT03848845|455149038|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
126505013|NCT03848845|455149039|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
126505014|NCT03848845|455149040|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
126505015|NCT01454726|455149041|FG000|Overall Study|Withdrawal by Subject|0|||
126505016|NCT01454726|455149042|FG001|Overall Study|Withdrawal by Subject|1|||
126505017|NCT00302003|455149045|FG000|Overall Study|Lack of Efficacy|62|||
126505018|NCT00302003|455149045|FG000|Overall Study|Lost to Follow-up|1|||
126505019|NCT00302003|455149045|FG000|Overall Study|Physician Decision|2|||
126505020|NCT00302003|455149045|FG000|Overall Study|Withdrawal by Subject|5|||
126563290|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Death|13|||
126563291|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
126776829|NCT01078623|456139054|FG014|Treatment Period 4|Adverse Event|0|||
126776830|NCT01078623|456139055|FG015|Treatment Period 4|Adverse Event|0|||
126776831|NCT01078623|456139056|FG016|Treatment Period 4|Adverse Event|0|||
126563292|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
126563293|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
126563294|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
126776832|NCT01078623|456139057|FG017|Treatment Period 4|Adverse Event|0|||
126776833|NCT01078623|456139058|FG018|Treatment Period 4|Adverse Event|0|||
126776834|NCT01078623|456139059|FG019|Treatment Period 4|Adverse Event|0|||
126776835|NCT01078623|456139040|FG000|Treatment Period 4|Withdrawal by Subject|0|||
126776836|NCT01078623|456139041|FG001|Treatment Period 4|Withdrawal by Subject|0|||
126776837|NCT01078623|456139042|FG002|Treatment Period 4|Withdrawal by Subject|0|||
126505021|NCT00302003|455149045|FG000|Overall Study|Ineligible|9|||
126505022|NCT00302003|455149045|FG000|Overall Study|Protocol Violation|1|||
126505023|NCT02042924|455149046|FG000|Overall Study|Early Death|1|||
126776838|NCT01078623|456139043|FG003|Treatment Period 4|Withdrawal by Subject|0|||
126776839|NCT01078623|456139044|FG004|Treatment Period 4|Withdrawal by Subject|0|||
126776840|NCT01078623|456139045|FG005|Treatment Period 4|Withdrawal by Subject|0|||
126776841|NCT01078623|456139046|FG006|Treatment Period 4|Withdrawal by Subject|0|||
126776842|NCT01078623|456139047|FG007|Treatment Period 4|Withdrawal by Subject|0|||
126776843|NCT01078623|456139048|FG008|Treatment Period 4|Withdrawal by Subject|0|||
126776844|NCT01078623|456139049|FG009|Treatment Period 4|Withdrawal by Subject|0|||
126505024|NCT00283439|455149047|FG000|Overall Study|Adverse Event|0|||
126505025|NCT00283439|455149048|FG001|Overall Study|Adverse Event|0|||
126505026|NCT00283439|455149049|FG002|Overall Study|Adverse Event|0|||
126505027|NCT00283439|455149050|FG003|Overall Study|Adverse Event|1|||
126505028|NCT00283439|455149047|FG000|Overall Study|Death|0|||
126505029|NCT00283439|455149048|FG001|Overall Study|Death|0|||
126505030|NCT00283439|455149049|FG002|Overall Study|Death|1|||
126505031|NCT00283439|455149050|FG003|Overall Study|Death|0|||
126505032|NCT00283439|455149047|FG000|Overall Study|Disease progression|0|||
126505033|NCT00283439|455149048|FG001|Overall Study|Disease progression|1|||
126505034|NCT00283439|455149049|FG002|Overall Study|Disease progression|0|||
126505035|NCT00283439|455149050|FG003|Overall Study|Disease progression|0|||
126505036|NCT00283439|455149047|FG000|Overall Study|Requirement for alternative therapy|1|||
126505037|NCT00283439|455149048|FG001|Overall Study|Requirement for alternative therapy|2|||
126505038|NCT00283439|455149049|FG002|Overall Study|Requirement for alternative therapy|5|||
126505039|NCT00283439|455149050|FG003|Overall Study|Requirement for alternative therapy|2|||
126505040|NCT00283439|455149047|FG000|Overall Study|Stem cell transplant|6|||
126505041|NCT00283439|455149048|FG001|Overall Study|Stem cell transplant|6|||
126505042|NCT00283439|455149049|FG002|Overall Study|Stem cell transplant|4|||
126505043|NCT00283439|455149050|FG003|Overall Study|Stem cell transplant|3|||
126505044|NCT00283439|455149047|FG000|Overall Study|Treatment discontinued|0|||
126505045|NCT00283439|455149048|FG001|Overall Study|Treatment discontinued|2|||
126505046|NCT00283439|455149049|FG002|Overall Study|Treatment discontinued|1|||
126505047|NCT00283439|455149050|FG003|Overall Study|Treatment discontinued|3|||
126505048|NCT00283439|455149047|FG000|Overall Study|Other|1|||
126505049|NCT00283439|455149048|FG001|Overall Study|Other|0|||
126505050|NCT00283439|455149049|FG002|Overall Study|Other|0|||
126505051|NCT00283439|455149050|FG003|Overall Study|Other|0|||
126505052|NCT01466270|455149051|FG000|Overall Study|Withdrawal by Subject|4|||
126505053|NCT01466270|455149052|FG001|Overall Study|Withdrawal by Subject|1|||
126505054|NCT01466270|455149051|FG000|Overall Study|Physician Decision|1|||
126505055|NCT01466270|455149052|FG001|Overall Study|Physician Decision|0|||
126505056|NCT01466270|455149051|FG000|Overall Study|Lost to Follow-up|1|||
126505057|NCT01466270|455149052|FG001|Overall Study|Lost to Follow-up|3|||
126505058|NCT01466270|455149051|FG000|Overall Study|Progression|1|||
126505059|NCT01466270|455149052|FG001|Overall Study|Progression|0|||
126505060|NCT01466270|455149051|FG000|Overall Study|Toxicity|4|||
126505061|NCT01466270|455149052|FG001|Overall Study|Toxicity|1|||
126505062|NCT01466270|455149051|FG000|Overall Study|Multiple|1|||
126505063|NCT01466270|455149052|FG001|Overall Study|Multiple|1|||
126505064|NCT00430092|455149059|FG000|Overall Study|Adverse Event|0|||
126505065|NCT00430092|455149060|FG001|Overall Study|Adverse Event|0|||
126505066|NCT00430092|455149061|FG002|Overall Study|Adverse Event|1|||
126505067|NCT00430092|455149059|FG000|Overall Study|Lack of Efficacy|5|||
126505068|NCT00430092|455149060|FG001|Overall Study|Lack of Efficacy|2|||
126505069|NCT00430092|455149061|FG002|Overall Study|Lack of Efficacy|54|||
126505070|NCT00430092|455149059|FG000|Overall Study|Lost to Follow-up|1|||
126505071|NCT00430092|455149060|FG001|Overall Study|Lost to Follow-up|0|||
126505072|NCT00430092|455149061|FG002|Overall Study|Lost to Follow-up|0|||
126505073|NCT00430092|455149059|FG000|Overall Study|Protocol Violation|0|||
126505074|NCT00430092|455149060|FG001|Overall Study|Protocol Violation|1|||
126505075|NCT00430092|455149061|FG002|Overall Study|Protocol Violation|1|||
126505076|NCT00430092|455149059|FG000|Overall Study|Withdrawal by Subject|0|||
126505077|NCT00430092|455149060|FG001|Overall Study|Withdrawal by Subject|1|||
126505078|NCT00430092|455149061|FG002|Overall Study|Withdrawal by Subject|1|||
126505079|NCT04171414|455149065|FG000|Overall Study|Death|1|||
126505080|NCT04171414|455149065|FG000|Overall Study|Withdrawal by Subject|1|||
126505081|NCT02884089|455149072|FG000|Period 1|Dosing error|2|||
126505082|NCT02884089|455149073|FG001|Period 1|Dosing error|2|||
126727148|NCT01232894|455951063|FG000|Overall Study|Physician Decision|2|||
126727149|NCT01232894|455951064|FG001|Overall Study|Physician Decision|1|||
126727150|NCT03970395|455951065|FG000|Overall Study|Withdrawal by Subject|3|||
126727151|NCT03970395|455951066|FG001|Overall Study|Withdrawal by Subject|4|||
126505083|NCT02884089|455149074|FG002|Period 1|Dosing error|0|||
126505084|NCT02884089|455149075|FG003|Period 1|Dosing error|0|||
126505085|NCT02884089|455149072|FG000|Washout Period 1|Lost to Follow-up|0|||
126505086|NCT02884089|455149073|FG001|Washout Period 1|Lost to Follow-up|1|||
126505087|NCT02884089|455149074|FG002|Washout Period 1|Lost to Follow-up|0|||
126505088|NCT02884089|455149075|FG003|Washout Period 1|Lost to Follow-up|1|||
126505089|NCT02884089|455149072|FG000|Washout Period 1|Withdrawal by Subject|0|||
126505090|NCT02884089|455149073|FG001|Washout Period 1|Withdrawal by Subject|1|||
126505091|NCT02884089|455149074|FG002|Washout Period 1|Withdrawal by Subject|0|||
126505092|NCT02884089|455149075|FG003|Washout Period 1|Withdrawal by Subject|0|||
126505093|NCT02884089|455149072|FG000|Period 2|Adverse Event|1|||
126505094|NCT02884089|455149073|FG001|Period 2|Adverse Event|0|||
126505095|NCT02884089|455149074|FG002|Period 2|Adverse Event|0|||
126505096|NCT02884089|455149075|FG003|Period 2|Adverse Event|0|||
126505097|NCT02884089|455149072|FG000|Period 3|Withdrawal by Subject|0|||
126727152|NCT03970395|455951065|FG000|Overall Study|Lost to Follow-up|4|||
126727153|NCT03970395|455951066|FG001|Overall Study|Lost to Follow-up|8|||
126776845|NCT01078623|456139050|FG010|Treatment Period 4|Withdrawal by Subject|0|||
126776846|NCT01078623|456139051|FG011|Treatment Period 4|Withdrawal by Subject|0|||
126776847|NCT01078623|456139052|FG012|Treatment Period 4|Withdrawal by Subject|0|||
126776848|NCT01078623|456139053|FG013|Treatment Period 4|Withdrawal by Subject|0|||
126776849|NCT01078623|456139054|FG014|Treatment Period 4|Withdrawal by Subject|0|||
126776850|NCT01078623|456139055|FG015|Treatment Period 4|Withdrawal by Subject|1|||
126776851|NCT01078623|456139056|FG016|Treatment Period 4|Withdrawal by Subject|0|||
126776852|NCT01078623|456139057|FG017|Treatment Period 4|Withdrawal by Subject|0|||
126776853|NCT01078623|456139058|FG018|Treatment Period 4|Withdrawal by Subject|0|||
126776854|NCT01078623|456139059|FG019|Treatment Period 4|Withdrawal by Subject|0|||
126776855|NCT00463866|456139060|FG000|Overall Study|Adverse Event|70|||
126776856|NCT00463866|456139061|FG001|Overall Study|Adverse Event|93|||
126776857|NCT00463866|456139060|FG000|Overall Study|Withdrawal by Subject|81|||
126776858|NCT00463866|456139061|FG001|Overall Study|Withdrawal by Subject|79|||
126776859|NCT00463866|456139060|FG000|Overall Study|Lost to Follow-up|46|||
126776860|NCT00463866|456139061|FG001|Overall Study|Lost to Follow-up|55|||
126776861|NCT00463866|456139060|FG000|Overall Study|Incorrect Enrolment|64|||
126776862|NCT00463866|456139061|FG001|Overall Study|Incorrect Enrolment|66|||
126776863|NCT00463866|456139060|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
126776864|NCT00463866|456139061|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
126776865|NCT00463866|456139060|FG000|Overall Study|Safety Reason|1|||
126776866|NCT00463866|456139061|FG001|Overall Study|Safety Reason|3|||
126776867|NCT00463866|456139060|FG000|Overall Study|Mis-Randomization of subject|0|||
126776868|NCT00463866|456139061|FG001|Overall Study|Mis-Randomization of subject|1|||
126776869|NCT00463866|456139060|FG000|Overall Study|Other|22|||
126776870|NCT00463866|456139061|FG001|Overall Study|Other|22|||
126776871|NCT02265952|456139063|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
126776872|NCT02265952|456139064|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
126776873|NCT02265952|456139063|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
126776874|NCT02265952|456139064|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
126776875|NCT01042977|456139065|FG000|Overall Study|Adverse Event|4|||
126776876|NCT01042977|456139066|FG001|Overall Study|Adverse Event|12|||
126776877|NCT01042977|456139065|FG000|Overall Study|Death|2|||
126776878|NCT01042977|456139066|FG001|Overall Study|Death|1|||
126776879|NCT01042977|456139065|FG000|Overall Study|Withdrawal by Subject|8|||
126776880|NCT01042977|456139066|FG001|Overall Study|Withdrawal by Subject|16|||
126776881|NCT01042977|456139065|FG000|Overall Study|Lost to Follow-up|0|||
126776882|NCT01042977|456139066|FG001|Overall Study|Lost to Follow-up|2|||
126776883|NCT01042977|456139065|FG000|Overall Study|Poor/non-compliance|3|||
126776884|NCT01042977|456139066|FG001|Overall Study|Poor/non-compliance|4|||
126776885|NCT01042977|456139065|FG000|Overall Study|Subject no longer meets study criteria|15|||
126776886|NCT01042977|456139066|FG001|Overall Study|Subject no longer meets study criteria|13|||
126776887|NCT01042977|456139065|FG000|Overall Study|Incorrect enrollment|6|||
126776888|NCT01042977|456139066|FG001|Overall Study|Incorrect enrollment|4|||
126776889|NCT01042977|456139065|FG000|Overall Study|Safety|0|||
126776890|NCT01042977|456139066|FG001|Overall Study|Safety|2|||
126776891|NCT01042977|456139065|FG000|Overall Study|Administrative reason by sponsor|0|||
126776892|NCT01042977|456139066|FG001|Overall Study|Administrative reason by sponsor|1|||
126776893|NCT01042977|456139065|FG000|Overall Study|Various|3|||
126776894|NCT01042977|456139066|FG001|Overall Study|Various|0|||
126776895|NCT04356573|456139069|FG000|Overall Study|Didn't Qualify|1|||
126776896|NCT04356573|456139070|FG001|Overall Study|Didn't Qualify|0|||
126776897|NCT02424565|456139071|FG000|Period 1 (D0)|Protocol Violation|0|||
126776898|NCT02424565|456139072|FG001|Period 1 (D0)|Protocol Violation|1|||
126776899|NCT03568500|456139073|FG000|Overall Study|Lost to Follow-up|1|||
126776900|NCT03568500|456139074|FG001|Overall Study|Lost to Follow-up|1|||
126776901|NCT03568500|456139075|FG002|Overall Study|Lost to Follow-up|2|||
126505098|NCT02884089|455149073|FG001|Period 3|Withdrawal by Subject|0|||
126505099|NCT02884089|455149074|FG002|Period 3|Withdrawal by Subject|1|||
126505100|NCT02884089|455149075|FG003|Period 3|Withdrawal by Subject|0|||
126505101|NCT02884089|455149072|FG000|Washout Period 3|Withdrawal by Subject|0|||
126505102|NCT02884089|455149073|FG001|Washout Period 3|Withdrawal by Subject|0|||
126505103|NCT02884089|455149074|FG002|Washout Period 3|Withdrawal by Subject|1|||
126505104|NCT02884089|455149075|FG003|Washout Period 3|Withdrawal by Subject|0|||
126505105|NCT02884089|455149072|FG000|Washout Period 3|Lost to Follow-up|0|||
126505106|NCT02884089|455149073|FG001|Washout Period 3|Lost to Follow-up|0|||
126776902|NCT03568500|456139073|FG000|Overall Study|Adverse Event|1|||
126776903|NCT03568500|456139074|FG001|Overall Study|Adverse Event|1|||
126776904|NCT03568500|456139075|FG002|Overall Study|Adverse Event|2|||
126776905|NCT03568500|456139073|FG000|Overall Study|Physician Decision|1|||
126776906|NCT03568500|456139074|FG001|Overall Study|Physician Decision|0|||
126776907|NCT03568500|456139075|FG002|Overall Study|Physician Decision|0|||
126505107|NCT02884089|455149074|FG002|Washout Period 3|Lost to Follow-up|0|||
126505108|NCT02884089|455149075|FG003|Washout Period 3|Lost to Follow-up|1|||
126505109|NCT02884089|455149072|FG000|Period 4|Withdrawal by Subject|0|||
126776908|NCT03568500|456139073|FG000|Overall Study|Withdrawal by Subject|4|||
126776909|NCT03568500|456139074|FG001|Overall Study|Withdrawal by Subject|2|||
126563295|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
126563296|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
126505110|NCT02884089|455149073|FG001|Period 4|Withdrawal by Subject|1|||
126505111|NCT02884089|455149074|FG002|Period 4|Withdrawal by Subject|0|||
126505112|NCT02884089|455149075|FG003|Period 4|Withdrawal by Subject|0|||
126505113|NCT02884089|455149072|FG000|Period 4|Lost to Follow-up|1|||
126505114|NCT02884089|455149073|FG001|Period 4|Lost to Follow-up|0|||
126505115|NCT02884089|455149074|FG002|Period 4|Lost to Follow-up|0|||
126505116|NCT02884089|455149075|FG003|Period 4|Lost to Follow-up|0|||
126505117|NCT02884089|455149072|FG000|Follow-up Visit|Withdrawal by Subject|1|||
126505118|NCT02884089|455149073|FG001|Follow-up Visit|Withdrawal by Subject|0|||
126505119|NCT02884089|455149074|FG002|Follow-up Visit|Withdrawal by Subject|0|||
126505120|NCT02884089|455149075|FG003|Follow-up Visit|Withdrawal by Subject|1|||
126505121|NCT01631474|455149076|FG000|Overall Study|Lost to Follow-up|8|||
126505122|NCT01631474|455149077|FG001|Overall Study|Lost to Follow-up|5|||
126505123|NCT01631474|455149078|FG002|Overall Study|Lost to Follow-up|7|||
126505124|NCT01631474|455149079|FG003|Overall Study|Lost to Follow-up|5|||
126505125|NCT01631474|455149080|FG004|Overall Study|Lost to Follow-up|5|||
126505126|NCT01631474|455149076|FG000|Overall Study|Withdrawal by Subject|4|||
126505127|NCT01631474|455149077|FG001|Overall Study|Withdrawal by Subject|4|||
126505128|NCT01631474|455149078|FG002|Overall Study|Withdrawal by Subject|2|||
126505129|NCT01631474|455149079|FG003|Overall Study|Withdrawal by Subject|6|||
126505130|NCT01631474|455149080|FG004|Overall Study|Withdrawal by Subject|5|||
126505131|NCT01631474|455149076|FG000|Overall Study|Lack of Efficacy|2|||
126505132|NCT01631474|455149077|FG001|Overall Study|Lack of Efficacy|2|||
126505133|NCT01631474|455149078|FG002|Overall Study|Lack of Efficacy|0|||
126505134|NCT01631474|455149079|FG003|Overall Study|Lack of Efficacy|0|||
126505135|NCT01631474|455149080|FG004|Overall Study|Lack of Efficacy|2|||
126505136|NCT01631474|455149076|FG000|Overall Study|Noncompliance with Study Drug|0|||
126505137|NCT01631474|455149077|FG001|Overall Study|Noncompliance with Study Drug|0|||
126505138|NCT01631474|455149078|FG002|Overall Study|Noncompliance with Study Drug|0|||
126505139|NCT01631474|455149079|FG003|Overall Study|Noncompliance with Study Drug|0|||
126505140|NCT01631474|455149080|FG004|Overall Study|Noncompliance with Study Drug|1|||
126505141|NCT01631474|455149076|FG000|Overall Study|Adverse Event|0|||
126505142|NCT01631474|455149077|FG001|Overall Study|Adverse Event|1|||
126505143|NCT01631474|455149078|FG002|Overall Study|Adverse Event|0|||
126505144|NCT01631474|455149079|FG003|Overall Study|Adverse Event|0|||
126505145|NCT01631474|455149080|FG004|Overall Study|Adverse Event|0|||
126505146|NCT02624284|455149081|FG000|Overall Study|Withdrawal by Subject|3|||
126505147|NCT02624284|455149082|FG001|Overall Study|Withdrawal by Subject|6|||
126505148|NCT02624284|455149083|FG002|Overall Study|Withdrawal by Subject|3|||
126505149|NCT02624284|455149081|FG000|Overall Study|Protocol Violation|9|||
126505150|NCT02624284|455149082|FG001|Overall Study|Protocol Violation|10|||
126505151|NCT02624284|455149083|FG002|Overall Study|Protocol Violation|7|||
126505152|NCT02624284|455149081|FG000|Overall Study|Revealed exclusionary condition|2|||
126505153|NCT02624284|455149082|FG001|Overall Study|Revealed exclusionary condition|2|||
126505154|NCT02624284|455149083|FG002|Overall Study|Revealed exclusionary condition|0|||
126505155|NCT02624284|455149081|FG000|Overall Study|Adverse Event|0|||
126505156|NCT02624284|455149082|FG001|Overall Study|Adverse Event|0|||
126505157|NCT02624284|455149083|FG002|Overall Study|Adverse Event|1|||
126505158|NCT02487394|455149084|FG000|Phase 1|Withdrawal by Subject|0|||
126505159|NCT02487394|455149085|FG001|Phase 1|Withdrawal by Subject|1|||
126505160|NCT01641367|455149089|FG000|Cohorts|Death|18|||
126505161|NCT01641367|455149090|FG001|Cohorts|Death|1|||
126505162|NCT01641367|455149091|FG002|Cohorts|Death|2|||
126505163|NCT01641367|455149092|FG003|Cohorts|Death|0|||
126505164|NCT01641367|455149093|FG004|Cohorts|Death|1|||
126505165|NCT01641367|455149094|FG005|Cohorts|Death|1|||
126505166|NCT01641367|455149095|FG006|Cohorts|Death|0|||
126563297|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
126563298|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
126505167|NCT01641367|455149096|FG007|Cohorts|Death|0|||
126505168|NCT01641367|455149089|FG000|Cohorts|Lost to Follow-up|16|||
126505169|NCT01641367|455149090|FG001|Cohorts|Lost to Follow-up|0|||
126505170|NCT01641367|455149091|FG002|Cohorts|Lost to Follow-up|2|||
126505171|NCT01641367|455149092|FG003|Cohorts|Lost to Follow-up|0|||
126505172|NCT01641367|455149093|FG004|Cohorts|Lost to Follow-up|2|||
126505173|NCT01641367|455149094|FG005|Cohorts|Lost to Follow-up|0|||
126505174|NCT01641367|455149095|FG006|Cohorts|Lost to Follow-up|0|||
126505175|NCT01641367|455149096|FG007|Cohorts|Lost to Follow-up|0|||
126505176|NCT01641367|455149089|FG000|Randomized Adherence Intervention|Death|0|||
126505177|NCT01641367|455149090|FG001|Randomized Adherence Intervention|Death|0|||
126505178|NCT01641367|455149091|FG002|Randomized Adherence Intervention|Death|0|||
126505179|NCT01641367|455149092|FG003|Randomized Adherence Intervention|Death|0|||
126505180|NCT01641367|455149093|FG004|Randomized Adherence Intervention|Death|0|||
126505181|NCT01641367|455149094|FG005|Randomized Adherence Intervention|Death|0|||
126505182|NCT01641367|455149095|FG006|Randomized Adherence Intervention|Death|11|||
126505183|NCT01641367|455149096|FG007|Randomized Adherence Intervention|Death|12|||
126505184|NCT01641367|455149089|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
126776910|NCT03568500|456139075|FG002|Overall Study|Withdrawal by Subject|0|||
126776911|NCT03568500|456139073|FG000|Overall Study|Technical Problems|2|||
126776912|NCT03568500|456139074|FG001|Overall Study|Technical Problems|1|||
126776913|NCT03568500|456139075|FG002|Overall Study|Technical Problems|0|||
126776914|NCT03568500|456139073|FG000|Overall Study|Participant Noncompliance|1|||
126776915|NCT03568500|456139074|FG001|Overall Study|Participant Noncompliance|1|||
126505185|NCT01641367|455149090|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
126505186|NCT01641367|455149091|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
126505187|NCT01641367|455149092|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
126505188|NCT01641367|455149093|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
126505189|NCT01641367|455149094|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
126505190|NCT01641367|455149095|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
126505191|NCT01641367|455149096|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
126505192|NCT01604343|455149104|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
126505193|NCT01604343|455149105|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
126505194|NCT01604343|455149106|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
126505195|NCT01604343|455149107|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
126505196|NCT01604343|455149108|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
126505197|NCT01604343|455149104|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
126505198|NCT01604343|455149105|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
126505199|NCT01604343|455149106|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
126505200|NCT01604343|455149107|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
126505201|NCT01604343|455149108|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
126505202|NCT01604343|455149104|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
126505203|NCT01604343|455149105|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
126505204|NCT01604343|455149106|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
126505205|NCT01604343|455149107|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
126505206|NCT01604343|455149108|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
126505207|NCT01604343|455149104|FG000|Prior to W52 Administration(Through W52)|Death|5|||
126505208|NCT01604343|455149105|FG001|Prior to W52 Administration(Through W52)|Death|0|||
126505209|NCT01604343|455149106|FG002|Prior to W52 Administration(Through W52)|Death|2|||
126505210|NCT01604343|455149107|FG003|Prior to W52 Administration(Through W52)|Death|0|||
126505211|NCT01604343|455149108|FG004|Prior to W52 Administration(Through W52)|Death|4|||
126505212|NCT01604343|455149104|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
126505213|NCT01604343|455149105|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
126505214|NCT01604343|455149106|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
126505215|NCT01604343|455149107|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
126505216|NCT01604343|455149108|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
126505217|NCT01604343|455149104|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
126505218|NCT01604343|455149105|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
126505219|NCT01604343|455149106|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
126505220|NCT01604343|455149107|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
126505221|NCT01604343|455149108|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
126505222|NCT01604343|455149104|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
126505223|NCT01604343|455149105|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
126505224|NCT01604343|455149106|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
126505225|NCT01604343|455149107|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
126505226|NCT01604343|455149108|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
126505227|NCT01604343|455149104|FG000|Prior to W52 Administration(Through W52)|Other|15|||
126505228|NCT01604343|455149105|FG001|Prior to W52 Administration(Through W52)|Other|0|||
126505229|NCT01604343|455149106|FG002|Prior to W52 Administration(Through W52)|Other|10|||
126505230|NCT01604343|455149107|FG003|Prior to W52 Administration(Through W52)|Other|0|||
126505231|NCT01604343|455149108|FG004|Prior to W52 Administration(Through W52)|Other|6|||
126505232|NCT01604343|455149104|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
126505233|NCT01604343|455149105|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
126505234|NCT01604343|455149106|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
126505235|NCT01604343|455149107|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
126505236|NCT01604343|455149108|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
126505237|NCT01604343|455149104|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
126505238|NCT01604343|455149105|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
126505239|NCT01604343|455149106|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
126505240|NCT01604343|455149107|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
126563299|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
126776916|NCT03568500|456139075|FG002|Overall Study|Participant Noncompliance|0|||
126776917|NCT03650400|456139076|FG000|Overall Study|Study terminated by sponsor|0|||
126505241|NCT01604343|455149108|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
126505242|NCT01604343|455149104|FG000|Week 52 to Week 104|Adverse Event|0|||
126505243|NCT01604343|455149105|FG001|Week 52 to Week 104|Adverse Event|12|||
126505244|NCT01604343|455149106|FG002|Week 52 to Week 104|Adverse Event|26|||
126505245|NCT01604343|455149107|FG003|Week 52 to Week 104|Adverse Event|21|||
126505246|NCT01604343|455149108|FG004|Week 52 to Week 104|Adverse Event|27|||
126505247|NCT01604343|455149104|FG000|Week 52 to Week 104|Death|0|||
126505248|NCT01604343|455149105|FG001|Week 52 to Week 104|Death|4|||
126505249|NCT01604343|455149106|FG002|Week 52 to Week 104|Death|2|||
126505250|NCT01604343|455149107|FG003|Week 52 to Week 104|Death|5|||
126505251|NCT01604343|455149108|FG004|Week 52 to Week 104|Death|0|||
126505252|NCT01604343|455149104|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
126505253|NCT01604343|455149105|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
126505254|NCT01604343|455149106|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
126505255|NCT01604343|455149107|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
126505256|NCT01604343|455149108|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
126505257|NCT01604343|455149104|FG000|Week 52 to Week 104|Physician Decision|0|||
126505258|NCT01604343|455149105|FG001|Week 52 to Week 104|Physician Decision|1|||
126505259|NCT01604343|455149106|FG002|Week 52 to Week 104|Physician Decision|0|||
126505260|NCT01604343|455149107|FG003|Week 52 to Week 104|Physician Decision|0|||
126505261|NCT01604343|455149108|FG004|Week 52 to Week 104|Physician Decision|2|||
126505262|NCT01604343|455149104|FG000|Week 52 to Week 104|Pregnancy|0|||
126505263|NCT01604343|455149105|FG001|Week 52 to Week 104|Pregnancy|0|||
126505264|NCT01604343|455149106|FG002|Week 52 to Week 104|Pregnancy|1|||
126505265|NCT01604343|455149107|FG003|Week 52 to Week 104|Pregnancy|2|||
126505266|NCT01604343|455149108|FG004|Week 52 to Week 104|Pregnancy|1|||
126505267|NCT01604343|455149104|FG000|Week 52 to Week 104|Other|0|||
126505268|NCT01604343|455149105|FG001|Week 52 to Week 104|Other|11|||
126505269|NCT01604343|455149106|FG002|Week 52 to Week 104|Other|11|||
126505270|NCT01604343|455149107|FG003|Week 52 to Week 104|Other|6|||
126505271|NCT01604343|455149108|FG004|Week 52 to Week 104|Other|3|||
126505272|NCT01604343|455149104|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
126505273|NCT01604343|455149105|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
126505274|NCT01604343|455149106|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
126505275|NCT01604343|455149107|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
126505276|NCT01604343|455149108|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
126505277|NCT01604343|455149104|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
126505278|NCT01604343|455149105|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
126505279|NCT01604343|455149106|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
126505280|NCT01604343|455149107|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
126505281|NCT01604343|455149108|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
126505282|NCT01604343|455149104|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
126505283|NCT01604343|455149105|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
126505284|NCT01604343|455149106|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
126505285|NCT01604343|455149107|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
126505286|NCT01604343|455149108|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
126505287|NCT00850200|455149112|FG000|Overall Study|Physician Decision|2|||
126505288|NCT00850200|455149112|FG000|Overall Study|Did not recieve treatment|2|||
126505289|NCT00850200|455149112|FG000|Overall Study|Withdrawal by Subject|1|||
126505290|NCT02711800|455149113|FG000|Overall Study|Lost to Follow-up|1|||
126505291|NCT02711800|455149113|FG000|Overall Study|Withdrawal by Subject|1|||
126505292|NCT05040152|455149116|FG000|Overall Study|Withdrawal by Subject|5|||
126505293|NCT05040152|455149117|FG001|Overall Study|Withdrawal by Subject|0|||
126505294|NCT05040152|455149116|FG000|Overall Study|Lost to Follow-up|0|||
126505295|NCT05040152|455149117|FG001|Overall Study|Lost to Follow-up|2|||
126505296|NCT00423891|455149128|FG000|Enrolled|Withdrawal by Subject|0|||
126505297|NCT00423891|455149129|FG001|Enrolled|Withdrawal by Subject|0|||
126505298|NCT00423891|455149130|FG002|Enrolled|Withdrawal by Subject|1|||
126505299|NCT00423891|455149128|FG000|Enrolled|Lost to Follow-up|0|||
126505300|NCT00423891|455149129|FG001|Enrolled|Lost to Follow-up|0|||
126505301|NCT00423891|455149130|FG002|Enrolled|Lost to Follow-up|1|||
126505302|NCT00423891|455149128|FG000|Enrolled|No longer met criteria|11|||
126505303|NCT00423891|455149129|FG001|Enrolled|No longer met criteria|2|||
126505304|NCT00423891|455149130|FG002|Enrolled|No longer met criteria|1|||
126563300|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
126505305|NCT00423891|455149128|FG000|Treatment|Withdrawal by Subject|1|||
126505306|NCT00423891|455149129|FG001|Treatment|Withdrawal by Subject|0|||
126505307|NCT00423891|455149130|FG002|Treatment|Withdrawal by Subject|0|||
126505308|NCT00423891|455149128|FG000|Treatment|Lost to Follow-up|1|||
126505309|NCT00423891|455149129|FG001|Treatment|Lost to Follow-up|0|||
126505310|NCT00423891|455149130|FG002|Treatment|Lost to Follow-up|0|||
126505311|NCT00423891|455149128|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
126505312|NCT00423891|455149129|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
126505313|NCT00423891|455149130|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
126505314|NCT00423891|455149128|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
126505315|NCT00423891|455149129|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
126505316|NCT00423891|455149130|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
126505317|NCT00414661|455149131|FG000|Overall Study|Death|2|||
126505318|NCT00414661|455149132|FG001|Overall Study|Death|5|||
126563301|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
126563302|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
126563303|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
126563304|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
126563305|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
126563306|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
126563307|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
126563308|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
126563309|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
126563310|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
126563311|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
126563312|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
126563313|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
126563314|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
126563315|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
126505319|NCT00414661|455149133|FG002|Overall Study|Death|0|||
126505320|NCT00414661|455149134|FG003|Overall Study|Death|0|||
126505321|NCT00414661|455149131|FG000|Overall Study|Lost to Follow-up|1|||
126505322|NCT00414661|455149132|FG001|Overall Study|Lost to Follow-up|4|||
126505323|NCT00414661|455149133|FG002|Overall Study|Lost to Follow-up|0|||
126505324|NCT00414661|455149134|FG003|Overall Study|Lost to Follow-up|1|||
126505325|NCT00414661|455149131|FG000|Overall Study|Withdrawal by Subject|5|||
126505326|NCT00414661|455149132|FG001|Overall Study|Withdrawal by Subject|2|||
126505327|NCT00414661|455149133|FG002|Overall Study|Withdrawal by Subject|2|||
126505328|NCT00414661|455149134|FG003|Overall Study|Withdrawal by Subject|2|||
126505329|NCT00414661|455149131|FG000|Overall Study|Other|6|||
126505330|NCT00414661|455149132|FG001|Overall Study|Other|3|||
126505331|NCT00414661|455149133|FG002|Overall Study|Other|0|||
126505332|NCT00414661|455149134|FG003|Overall Study|Other|0|||
126505333|NCT00696137|455149146|FG000|Overall Study|Withdrawal by Subject|2|||
126505334|NCT03742141|455149157|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
126505335|NCT00850395|455149158|FG000|Overall Study|Death|1|||
126505336|NCT00850395|455149158|FG000|Overall Study|Adverse Event|1|||
126505337|NCT00850395|455149158|FG000|Overall Study|Insufficient clinical response|3|||
126505338|NCT00850395|455149158|FG000|Overall Study|Other|5|||
126505339|NCT02376166|455149159|FG000|Overall Study|Adverse Event|1|||
126505340|NCT02376166|455149159|FG000|Overall Study|Discontinued metformin early|2|||
126505341|NCT04180020|455149160|FG000|Overall Study|missed visit|18|||
126505342|NCT04180020|455149161|FG001|Overall Study|missed visit|16|||
126505343|NCT04180020|455149160|FG000|Overall Study|Death|2|||
126505344|NCT04180020|455149161|FG001|Overall Study|Death|3|||
126505345|NCT04180020|455149160|FG000|Overall Study|Withdrawal by Subject|1|||
126505346|NCT04180020|455149161|FG001|Overall Study|Withdrawal by Subject|5|||
126505347|NCT04180020|455149160|FG000|Overall Study|incarcerated|1|||
126505348|NCT04180020|455149161|FG001|Overall Study|incarcerated|1|||
126505349|NCT04180020|455149160|FG000|Overall Study|Physician Decision|0|||
126505350|NCT04180020|455149161|FG001|Overall Study|Physician Decision|2|||
126505351|NCT00717769|455149163|FG000|Overall Study|Adverse Event|9|||
126505352|NCT00717769|455149164|FG001|Overall Study|Adverse Event|6|||
126505353|NCT00717769|455149165|FG002|Overall Study|Adverse Event|1|||
126505354|NCT00717769|455149163|FG000|Overall Study|Lack of compliance|0|||
126505355|NCT00717769|455149164|FG001|Overall Study|Lack of compliance|2|||
126505356|NCT00717769|455149165|FG002|Overall Study|Lack of compliance|0|||
126505357|NCT00717769|455149163|FG000|Overall Study|Lost to Follow-up|3|||
126505358|NCT00717769|455149164|FG001|Overall Study|Lost to Follow-up|4|||
126505359|NCT00717769|455149165|FG002|Overall Study|Lost to Follow-up|0|||
126505360|NCT00717769|455149163|FG000|Overall Study|Lack of Efficacy|1|||
126505361|NCT00717769|455149164|FG001|Overall Study|Lack of Efficacy|2|||
126505362|NCT00717769|455149165|FG002|Overall Study|Lack of Efficacy|0|||
126505363|NCT00717769|455149163|FG000|Overall Study|Protocol Violation|0|||
126505364|NCT00717769|455149164|FG001|Overall Study|Protocol Violation|2|||
126505365|NCT00717769|455149165|FG002|Overall Study|Protocol Violation|0|||
126505366|NCT00717769|455149163|FG000|Overall Study|Sponsor decision|1|||
126505367|NCT00717769|455149164|FG001|Overall Study|Sponsor decision|0|||
126505368|NCT00717769|455149165|FG002|Overall Study|Sponsor decision|10|||
126505369|NCT00717769|455149163|FG000|Overall Study|Withdrew consent|2|||
126505370|NCT00717769|455149164|FG001|Overall Study|Withdrew consent|2|||
126505371|NCT00717769|455149165|FG002|Overall Study|Withdrew consent|0|||
126505372|NCT03350503|455149169|FG000|Overall Study|Adverse Event|5|||
126505373|NCT03350503|455149169|FG000|Overall Study|Withdrawal by Subject|5|||
126505374|NCT03350503|455149169|FG000|Overall Study|Continuation impossible due to move|4|||
126505375|NCT03350503|455149169|FG000|Overall Study|Physician Decision|3|||
126505376|NCT01399593|455149175|FG000|Overall Study|Physician Decision|1|||
126505377|NCT01399593|455149176|FG001|Overall Study|Physician Decision|0|||
126505378|NCT01399593|455149175|FG000|Overall Study|Adverse Event|1|||
126505379|NCT01399593|455149176|FG001|Overall Study|Adverse Event|0|||
126563316|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
126563317|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
126563318|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
126563319|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
126505380|NCT01399593|455149175|FG000|Overall Study|Death|1|||
126505381|NCT01399593|455149176|FG001|Overall Study|Death|1|||
126505382|NCT01399593|455149175|FG000|Overall Study|Transplantectomy|0|||
126505383|NCT01399593|455149176|FG001|Overall Study|Transplantectomy|1|||
126563320|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
126563321|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
126563322|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
126563323|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
126563324|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
126563325|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
126563326|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
126563327|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
126563328|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
126563329|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
126563330|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
126563331|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Pain|0|||
126563332|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Pain|0|||
126563333|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Pain|0|||
126563334|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Pain|1|||
126563335|NCT01107626|455357398|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
126563336|NCT01107626|455357399|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
126563337|NCT01107626|455357400|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
126563338|NCT01107626|455357401|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
126563339|NCT04381494|455357402|FG000|Overall Study|Early termination of trial|19|||
126563340|NCT04381494|455357402|FG000|Overall Study|Investigator's discretion|1|||
126563341|NCT04381494|455357402|FG000|Overall Study|Withdrawal by Subject|9|||
126563342|NCT04381494|455357402|FG000|Overall Study|NSCLC disease progression|4|||
126563343|NCT04381494|455357402|FG000|Overall Study|Device-Related Adverse Event|2|||
126563344|NCT04310579|455357403|FG000|Overall Study|Adverse Event|0|||
126563345|NCT04310579|455357404|FG001|Overall Study|Adverse Event|0|||
126563346|NCT04310579|455357405|FG002|Overall Study|Adverse Event|0|||
126563347|NCT04310579|455357406|FG003|Overall Study|Adverse Event|0|||
126563348|NCT04310579|455357407|FG004|Overall Study|Adverse Event|0|||
126563349|NCT04310579|455357408|FG005|Overall Study|Adverse Event|0|||
126563350|NCT04310579|455357409|FG006|Overall Study|Adverse Event|2|||
126563351|NCT04310579|455357410|FG007|Overall Study|Adverse Event|0|||
126505384|NCT00403273|455150964|FG000|Overall Study|Lost to Follow-up|3|||
126505385|NCT00403273|455150965|FG001|Overall Study|Lost to Follow-up|2|||
126505386|NCT00403273|455150964|FG000|Overall Study|Physician Decision|0|||
126505387|NCT00403273|455150965|FG001|Overall Study|Physician Decision|1|||
126505388|NCT00403273|455150964|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
126505389|NCT00403273|455150965|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
126505390|NCT01852292|455150974|FG000|Overall Study|Untreated - did not receive study drug|3|||
126505391|NCT01852292|455150975|FG001|Overall Study|Untreated - did not receive study drug|1|||
126505392|NCT01852292|455150974|FG000|Overall Study|Death|9|||
126505393|NCT01852292|455150975|FG001|Overall Study|Death|8|||
126505394|NCT01852292|455150974|FG000|Overall Study|Patient/guardian decision|8|||
126505395|NCT01852292|455150975|FG001|Overall Study|Patient/guardian decision|4|||
126505396|NCT01852292|455150974|FG000|Overall Study|Adverse Event|8|||
126505397|NCT01852292|455150975|FG001|Overall Study|Adverse Event|11|||
126505398|NCT01852292|455150974|FG000|Overall Study|Physician Decision|6|||
126505399|NCT01852292|455150975|FG001|Overall Study|Physician Decision|2|||
126563352|NCT04310579|455357411|FG008|Overall Study|Adverse Event|1|||
126563353|NCT04310579|455357412|FG009|Overall Study|Adverse Event|1|||
126563354|NCT04310579|455357413|FG010|Overall Study|Adverse Event|0|||
126563355|NCT04310579|455357403|FG000|Overall Study|Withdrawal by Subject|0|||
126563356|NCT04310579|455357404|FG001|Overall Study|Withdrawal by Subject|0|||
126563357|NCT04310579|455357405|FG002|Overall Study|Withdrawal by Subject|0|||
126563358|NCT04310579|455357406|FG003|Overall Study|Withdrawal by Subject|0|||
126563359|NCT04310579|455357407|FG004|Overall Study|Withdrawal by Subject|0|||
126563360|NCT04310579|455357408|FG005|Overall Study|Withdrawal by Subject|1|||
126563361|NCT04310579|455357409|FG006|Overall Study|Withdrawal by Subject|0|||
126563362|NCT04310579|455357410|FG007|Overall Study|Withdrawal by Subject|0|||
126505400|NCT01852292|455150974|FG000|Overall Study|Protocol Violation|2|||
126505401|NCT01852292|455150975|FG001|Overall Study|Protocol Violation|0|||
126505402|NCT01852292|455150974|FG000|Overall Study|Non-compliance with study treatment|1|||
126505403|NCT01852292|455150975|FG001|Overall Study|Non-compliance with study treatment|0|||
126505404|NCT01852292|455150974|FG000|Overall Study|Study terminated by Sponsor|0|||
126563363|NCT04310579|455357411|FG008|Overall Study|Withdrawal by Subject|0|||
126563364|NCT04310579|455357412|FG009|Overall Study|Withdrawal by Subject|0|||
126563365|NCT04310579|455357413|FG010|Overall Study|Withdrawal by Subject|0|||
126563366|NCT04310579|455357403|FG000|Overall Study|Positive COVID-19 test|0|||
126563367|NCT04310579|455357404|FG001|Overall Study|Positive COVID-19 test|0|||
126563368|NCT04310579|455357405|FG002|Overall Study|Positive COVID-19 test|0|||
126563369|NCT04310579|455357406|FG003|Overall Study|Positive COVID-19 test|0|||
126563370|NCT04310579|455357407|FG004|Overall Study|Positive COVID-19 test|0|||
126563371|NCT04310579|455357408|FG005|Overall Study|Positive COVID-19 test|0|||
126563372|NCT04310579|455357409|FG006|Overall Study|Positive COVID-19 test|0|||
126563373|NCT04310579|455357410|FG007|Overall Study|Positive COVID-19 test|0|||
126563374|NCT04310579|455357411|FG008|Overall Study|Positive COVID-19 test|0|||
126563375|NCT04310579|455357412|FG009|Overall Study|Positive COVID-19 test|0|||
126563376|NCT04310579|455357413|FG010|Overall Study|Positive COVID-19 test|1|||
126563377|NCT03710564|455357414|FG000|Overall Study|Study Terminated by Sponsor|104|||
126563378|NCT03710564|455357415|FG001|Overall Study|Study Terminated by Sponsor|55|||
126563379|NCT03710564|455357414|FG000|Overall Study|Withdrawal by Subject|57|||
126563380|NCT03710564|455357415|FG001|Overall Study|Withdrawal by Subject|25|||
126505405|NCT01852292|455150975|FG001|Overall Study|Study terminated by Sponsor|1|||
126505406|NCT01852292|455150974|FG000|Overall Study|Progressive disease|42|||
126505407|NCT01852292|455150975|FG001|Overall Study|Progressive disease|52|||
126505408|NCT02586012|455150976|FG000|Overall Study|Withdrawal by Subject|1|||
126505409|NCT02586012|455150977|FG001|Overall Study|Withdrawal by Subject|1|||
126505410|NCT02586012|455150978|FG002|Overall Study|Withdrawal by Subject|0|||
126505411|NCT02586012|455150979|FG003|Overall Study|Withdrawal by Subject|1|||
126505412|NCT02586012|455150980|FG004|Overall Study|Withdrawal by Subject|0|||
126505413|NCT02586012|455150981|FG005|Overall Study|Withdrawal by Subject|2|||
126505414|NCT02586012|455150976|FG000|Overall Study|Protocol Violation|0|||
126505415|NCT02586012|455150977|FG001|Overall Study|Protocol Violation|0|||
126505416|NCT02586012|455150978|FG002|Overall Study|Protocol Violation|0|||
126505417|NCT02586012|455150979|FG003|Overall Study|Protocol Violation|0|||
126505418|NCT02586012|455150980|FG004|Overall Study|Protocol Violation|0|||
126505419|NCT02586012|455150981|FG005|Overall Study|Protocol Violation|1|||
126505420|NCT02586012|455150976|FG000|Overall Study|study terminated|0|||
126505421|NCT02586012|455150977|FG001|Overall Study|study terminated|2|||
126505422|NCT02586012|455150978|FG002|Overall Study|study terminated|1|||
126505423|NCT02586012|455150979|FG003|Overall Study|study terminated|1|||
126505424|NCT02586012|455150980|FG004|Overall Study|study terminated|1|||
126505425|NCT02586012|455150981|FG005|Overall Study|study terminated|0|||
126505426|NCT02388737|455150983|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
126505427|NCT02388737|455150984|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
126505428|NCT02388737|455150985|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
126505429|NCT02388737|455150983|FG000|Overall Study|Major Protocol Deviation|18|||
126505430|NCT02388737|455150984|FG001|Overall Study|Major Protocol Deviation|25|||
126505431|NCT02388737|455150985|FG002|Overall Study|Major Protocol Deviation|22|||
126505432|NCT02388737|455150983|FG000|Overall Study|Lost to Follow-up|5|||
126505433|NCT02388737|455150984|FG001|Overall Study|Lost to Follow-up|1|||
126505434|NCT02388737|455150985|FG002|Overall Study|Lost to Follow-up|4|||
126505435|NCT02388737|455150983|FG000|Overall Study|Voluntary Withdrawal|10|||
126505436|NCT02388737|455150984|FG001|Overall Study|Voluntary Withdrawal|18|||
126505437|NCT02388737|455150985|FG002|Overall Study|Voluntary Withdrawal|17|||
126505438|NCT02388737|455150983|FG000|Overall Study|Lack of Efficacy|3|||
126505439|NCT02388737|455150984|FG001|Overall Study|Lack of Efficacy|0|||
126505440|NCT02388737|455150985|FG002|Overall Study|Lack of Efficacy|3|||
126505441|NCT02388737|455150983|FG000|Overall Study|Reason Not Specified|5|||
126505442|NCT02388737|455150984|FG001|Overall Study|Reason Not Specified|5|||
126505443|NCT02388737|455150985|FG002|Overall Study|Reason Not Specified|4|||
126505444|NCT03299842|455150986|FG000|Overall Study|Caregiver withdrew consent|2|||
126505445|NCT03299842|455150986|FG000|Overall Study|Child would not keep the watch on|3|||
126505446|NCT01816139|455150989|FG000|Overall Study|Adverse Event|6|||
126505447|NCT01816139|455150990|FG001|Overall Study|Adverse Event|8|||
126505448|NCT01816139|455150989|FG000|Overall Study|Lack of Efficacy|1|||
126505449|NCT01816139|455150990|FG001|Overall Study|Lack of Efficacy|2|||
126505450|NCT01816139|455150989|FG000|Overall Study|Lost to Follow-up|5|||
126505451|NCT01816139|455150990|FG001|Overall Study|Lost to Follow-up|3|||
126505452|NCT01816139|455150989|FG000|Overall Study|Withdrew Consent|6|||
126563381|NCT03710564|455357414|FG000|Overall Study|Death|10|||
126505453|NCT01816139|455150990|FG001|Overall Study|Withdrew Consent|4|||
126505454|NCT01816139|455150989|FG000|Overall Study|Protocol Violation|6|||
126505455|NCT01816139|455150990|FG001|Overall Study|Protocol Violation|3|||
126505456|NCT01816139|455150989|FG000|Overall Study|Reason not Specified|4|||
126505457|NCT01816139|455150990|FG001|Overall Study|Reason not Specified|2|||
126505458|NCT03240575|455150991|FG000|Overall Study|Adverse Event|0|||
126505459|NCT03240575|455150992|FG001|Overall Study|Adverse Event|2|||
126505460|NCT03240575|455150993|FG002|Overall Study|Adverse Event|0|||
126505461|NCT03240575|455150994|FG003|Overall Study|Adverse Event|1|||
126563382|NCT03710564|455357415|FG001|Overall Study|Death|4|||
126563383|NCT03710564|455357414|FG000|Overall Study|Lost to Follow-up|5|||
126563384|NCT03710564|455357415|FG001|Overall Study|Lost to Follow-up|4|||
126505462|NCT03240575|455150991|FG000|Overall Study|Withdrawal by Subject|2|||
126505463|NCT03240575|455150992|FG001|Overall Study|Withdrawal by Subject|11|||
126505464|NCT03240575|455150993|FG002|Overall Study|Withdrawal by Subject|0|||
126505465|NCT03240575|455150994|FG003|Overall Study|Withdrawal by Subject|1|||
126505466|NCT03240575|455150991|FG000|Overall Study|Other|0|||
126505467|NCT03240575|455150992|FG001|Overall Study|Other|1|||
126505468|NCT03240575|455150993|FG002|Overall Study|Other|0|||
126505469|NCT03240575|455150994|FG003|Overall Study|Other|0|||
126505470|NCT02223767|455151002|FG000|Overall Study|Withdrawal by Subject|4|||
126505471|NCT02223767|455151003|FG001|Overall Study|Withdrawal by Subject|4|||
126505472|NCT02342704|455151004|FG000|Overall Study|Physician Decision|0|||
126505473|NCT02342704|455151005|FG001|Overall Study|Physician Decision|3|||
126505474|NCT02342704|455151004|FG000|Overall Study|Sponsor Termination|49|||
126505475|NCT02342704|455151005|FG001|Overall Study|Sponsor Termination|43|||
126505476|NCT02342704|455151004|FG000|Overall Study|Other|0|||
126505477|NCT02342704|455151005|FG001|Overall Study|Other|1|||
126505478|NCT02342704|455151004|FG000|Overall Study|Withdrawal by Subject|1|||
126505479|NCT02342704|455151005|FG001|Overall Study|Withdrawal by Subject|0|||
126505480|NCT02342704|455151004|FG000|Overall Study|Lost to Follow-up|2|||
126505481|NCT02342704|455151005|FG001|Overall Study|Lost to Follow-up|1|||
126505482|NCT02342704|455151004|FG000|Overall Study|Adverse Event|1|||
126505483|NCT02342704|455151005|FG001|Overall Study|Adverse Event|3|||
126505484|NCT02347527|455151006|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
126505485|NCT02347527|455151007|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
126505486|NCT02347527|455151008|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
126505487|NCT02347527|455151009|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
126505488|NCT02347527|455151006|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
126505489|NCT02347527|455151007|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
126505490|NCT02347527|455151008|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
126505491|NCT02347527|455151009|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
126505492|NCT02347527|455151006|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
126505493|NCT02347527|455151007|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
126505494|NCT02347527|455151008|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
126505495|NCT02347527|455151009|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
126505496|NCT02347527|455151006|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
126505497|NCT02347527|455151007|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
126505498|NCT02347527|455151008|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
126505499|NCT02347527|455151009|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
126505500|NCT02347527|455151006|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
126505501|NCT02347527|455151007|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
126505502|NCT02347527|455151008|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
126505503|NCT02347527|455151009|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
126505504|NCT01632891|455151011|FG000|Overall Study|Lost to Follow-up|0|||
126505505|NCT01632891|455151012|FG001|Overall Study|Lost to Follow-up|1|||
126505506|NCT01632891|455151011|FG000|Overall Study|Withdrawal by Subject|1|||
126505507|NCT01632891|455151012|FG001|Overall Study|Withdrawal by Subject|0|||
126505508|NCT02919670|455151013|FG000|Overall Study|Only 17 participants met compliance|43|||
126505509|NCT02919670|455151014|FG001|Overall Study|Only 17 participants met compliance|39|||
126505510|NCT04206293|455151015|FG000|Overall Study|Consent withdrawal|1|||
126505511|NCT01454934|455151018|FG000|Overall Study|Clinical progression|28|||
126505512|NCT01454934|455151019|FG001|Overall Study|Clinical progression|25|||
126505513|NCT01454934|455151018|FG000|Overall Study|Other|6|||
126505514|NCT01454934|455151019|FG001|Overall Study|Other|17|||
126505515|NCT01454934|455151018|FG000|Overall Study|Adverse Event|28|||
126505516|NCT01454934|455151019|FG001|Overall Study|Adverse Event|24|||
126505517|NCT01454934|455151018|FG000|Overall Study|Withdrawn consent|2|||
126505518|NCT01454934|455151019|FG001|Overall Study|Withdrawn consent|5|||
126505519|NCT01454934|455151018|FG000|Overall Study|Withdrawal by Subject|11|||
126505520|NCT01454934|455151019|FG001|Overall Study|Withdrawal by Subject|15|||
126505521|NCT01454934|455151018|FG000|Overall Study|Disease progression|194|||
126505522|NCT01454934|455151019|FG001|Overall Study|Disease progression|181|||
126505523|NCT01454934|455151018|FG000|Overall Study|Lost to Follow-up|0|||
126505524|NCT01454934|455151019|FG001|Overall Study|Lost to Follow-up|1|||
126505525|NCT01454934|455151018|FG000|Overall Study|Not treated|1|||
126505526|NCT01454934|455151019|FG001|Overall Study|Not treated|2|||
126505527|NCT02118428|455151020|FG000|Overall Study|Physician Decision|0|||
126505528|NCT02118428|455151021|FG001|Overall Study|Physician Decision|1|||
126505529|NCT02118428|455151022|FG002|Overall Study|Physician Decision|0|||
126505530|NCT02118428|455151020|FG000|Overall Study|Withdrawal by Subject|2|||
126505531|NCT02118428|455151021|FG001|Overall Study|Withdrawal by Subject|2|||
126505532|NCT02118428|455151022|FG002|Overall Study|Withdrawal by Subject|0|||
126505533|NCT02118428|455151020|FG000|Overall Study|Death|7|||
126505534|NCT02118428|455151021|FG001|Overall Study|Death|5|||
126505535|NCT02118428|455151022|FG002|Overall Study|Death|0|||
126505536|NCT02118428|455151020|FG000|Overall Study|Lost to Follow-up|3|||
126505537|NCT02118428|455151021|FG001|Overall Study|Lost to Follow-up|1|||
126505538|NCT02118428|455151022|FG002|Overall Study|Lost to Follow-up|0|||
126505539|NCT02118428|455151020|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
126505540|NCT02118428|455151021|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
126505541|NCT02118428|455151022|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
126505542|NCT00782210|455151030|FG000|Overall Study|Adverse Event|21|||
126505543|NCT00782210|455151031|FG001|Overall Study|Adverse Event|17|||
126505544|NCT00782210|455151032|FG002|Overall Study|Adverse Event|16|||
126505545|NCT00782210|455151030|FG000|Overall Study|Lost to Follow-up|2|||
126505546|NCT00782210|455151031|FG001|Overall Study|Lost to Follow-up|1|||
126505547|NCT00782210|455151032|FG002|Overall Study|Lost to Follow-up|2|||
126505548|NCT00782210|455151030|FG000|Overall Study|Withdrawal by Subject|11|||
126505549|NCT00782210|455151031|FG001|Overall Study|Withdrawal by Subject|8|||
126505550|NCT00782210|455151032|FG002|Overall Study|Withdrawal by Subject|11|||
126505551|NCT00782210|455151030|FG000|Overall Study|Non compliance with protocol|0|||
126505552|NCT00782210|455151031|FG001|Overall Study|Non compliance with protocol|3|||
126505553|NCT00782210|455151032|FG002|Overall Study|Non compliance with protocol|2|||
126505554|NCT00782210|455151030|FG000|Overall Study|Lack of Efficacy|13|||
126505555|NCT00782210|455151031|FG001|Overall Study|Lack of Efficacy|4|||
126505556|NCT00782210|455151032|FG002|Overall Study|Lack of Efficacy|1|||
126505557|NCT00782210|455151030|FG000|Overall Study|Other reason not described above|3|||
126505558|NCT00782210|455151031|FG001|Overall Study|Other reason not described above|2|||
126505559|NCT00782210|455151032|FG002|Overall Study|Other reason not described above|3|||
126505560|NCT03100825|455151035|FG000|Overall Study|Participant/Guardian Decision|7|||
126505561|NCT03100825|455151035|FG000|Overall Study|Physician Decision|1|||
126505562|NCT00826267|455151036|FG000|Overall Study|Other Adverse Event|1|||
126505563|NCT00826267|455151037|FG001|Overall Study|Other Adverse Event|0|||
126505564|NCT00826267|455151038|FG002|Overall Study|Other Adverse Event|0|||
126505565|NCT02586493|455151047|FG000|Overall Study|Adverse Event|4|||
126505566|NCT02586493|455151047|FG000|Overall Study|Protocol Violation|6|||
126505567|NCT02586493|455151047|FG000|Overall Study|Lost to Follow-up|1|||
126505568|NCT02586493|455151047|FG000|Overall Study|Withdrawal by Subject|1|||
126505569|NCT01675882|455151058|FG000|Overall Study|Adverse Event|0|||
126505570|NCT01675882|455151059|FG001|Overall Study|Adverse Event|2|||
126505571|NCT01675882|455151060|FG002|Overall Study|Adverse Event|1|||
126505572|NCT01675882|455151061|FG003|Overall Study|Adverse Event|0|||
126505573|NCT01675882|455151058|FG000|Overall Study|Participant unwilling to continue|2|||
126505574|NCT01675882|455151059|FG001|Overall Study|Participant unwilling to continue|4|||
126505575|NCT01675882|455151060|FG002|Overall Study|Participant unwilling to continue|2|||
126505576|NCT01675882|455151061|FG003|Overall Study|Participant unwilling to continue|1|||
126505577|NCT01675882|455151058|FG000|Overall Study|Lost to Follow-up|0|||
126505578|NCT01675882|455151059|FG001|Overall Study|Lost to Follow-up|1|||
126505579|NCT01675882|455151060|FG002|Overall Study|Lost to Follow-up|0|||
126505580|NCT01675882|455151061|FG003|Overall Study|Lost to Follow-up|0|||
126505581|NCT01675882|455151058|FG000|Overall Study|Non-compliance|0|||
126505582|NCT01675882|455151059|FG001|Overall Study|Non-compliance|0|||
126505583|NCT01675882|455151060|FG002|Overall Study|Non-compliance|0|||
126505584|NCT01675882|455151061|FG003|Overall Study|Non-compliance|1|||
126505585|NCT00735371|455151062|FG000|Overall Study|Adverse Event|3|||
126505586|NCT00735371|455151063|FG001|Overall Study|Adverse Event|3|||
126505587|NCT00735371|455151064|FG002|Overall Study|Adverse Event|4|||
126505588|NCT00735371|455151065|FG003|Overall Study|Adverse Event|1|||
126505589|NCT00735371|455151062|FG000|Overall Study|Protocol Violation|2|||
126505590|NCT00735371|455151063|FG001|Overall Study|Protocol Violation|2|||
126505591|NCT00735371|455151064|FG002|Overall Study|Protocol Violation|0|||
126505592|NCT00735371|455151065|FG003|Overall Study|Protocol Violation|3|||
126505593|NCT00735371|455151062|FG000|Overall Study|Withdrawal by Subject|0|||
126505594|NCT00735371|455151063|FG001|Overall Study|Withdrawal by Subject|2|||
126505595|NCT00735371|455151064|FG002|Overall Study|Withdrawal by Subject|2|||
126505596|NCT00735371|455151065|FG003|Overall Study|Withdrawal by Subject|0|||
126505597|NCT00735371|455151062|FG000|Overall Study|Lost to Follow-up|1|||
126505598|NCT00735371|455151063|FG001|Overall Study|Lost to Follow-up|1|||
126505599|NCT00735371|455151064|FG002|Overall Study|Lost to Follow-up|3|||
126505600|NCT00735371|455151065|FG003|Overall Study|Lost to Follow-up|1|||
126505601|NCT00735371|455151062|FG000|Overall Study|Lack of Efficacy|4|||
126505602|NCT00735371|455151063|FG001|Overall Study|Lack of Efficacy|2|||
126505603|NCT00735371|455151064|FG002|Overall Study|Lack of Efficacy|0|||
126505604|NCT00735371|455151065|FG003|Overall Study|Lack of Efficacy|4|||
126505605|NCT00735371|455151062|FG000|Overall Study|Sponsor Decision|3|||
126505606|NCT00735371|455151063|FG001|Overall Study|Sponsor Decision|1|||
126505607|NCT00735371|455151064|FG002|Overall Study|Sponsor Decision|0|||
126505608|NCT00735371|455151065|FG003|Overall Study|Sponsor Decision|1|||
126505609|NCT00735371|455151062|FG000|Overall Study|Protocol Violation|0|||
126505610|NCT00735371|455151063|FG001|Overall Study|Protocol Violation|1|||
126505611|NCT00735371|455151064|FG002|Overall Study|Protocol Violation|2|||
126505612|NCT00735371|455151065|FG003|Overall Study|Protocol Violation|0|||
126505613|NCT00735371|455151062|FG000|Overall Study|Prior Vyvanse Exposure|1|||
126505614|NCT00735371|455151063|FG001|Overall Study|Prior Vyvanse Exposure|1|||
126505615|NCT00735371|455151064|FG002|Overall Study|Prior Vyvanse Exposure|0|||
126505616|NCT00735371|455151065|FG003|Overall Study|Prior Vyvanse Exposure|0|||
126505617|NCT00735371|455151062|FG000|Overall Study|Exclusion criteria|1|||
126505618|NCT00735371|455151063|FG001|Overall Study|Exclusion criteria|0|||
126505619|NCT00735371|455151064|FG002|Overall Study|Exclusion criteria|0|||
126505620|NCT00735371|455151065|FG003|Overall Study|Exclusion criteria|0|||
126505621|NCT00994448|455151066|FG000|Overall Study|Adverse Event|1|||
126505622|NCT00994448|455151067|FG001|Overall Study|Adverse Event|0|||
126505623|NCT00994448|455151066|FG000|Overall Study|Lost to Follow-up|5|||
126505624|NCT00994448|455151067|FG001|Overall Study|Lost to Follow-up|1|||
126505625|NCT00994448|455151066|FG000|Overall Study|Withdrawal by Subject|1|||
126505626|NCT00994448|455151067|FG001|Overall Study|Withdrawal by Subject|1|||
126505627|NCT00994448|455151066|FG000|Overall Study|Physician Decision|1|||
126505628|NCT00994448|455151067|FG001|Overall Study|Physician Decision|0|||
126505629|NCT00436748|455151070|FG000|Overall Study|Ineligibility Determined|1|||
126505630|NCT00436748|455151071|FG001|Overall Study|Ineligibility Determined|1|||
126505631|NCT00436748|455151070|FG000|Overall Study|Adverse Event|0|||
126505632|NCT00436748|455151071|FG001|Overall Study|Adverse Event|2|||
126505633|NCT00436748|455151070|FG000|Overall Study|Consent Withdrawn|1|||
126505634|NCT00436748|455151071|FG001|Overall Study|Consent Withdrawn|4|||
126505635|NCT00436748|455151070|FG000|Overall Study|Administrative Decision|1|||
126505636|NCT00436748|455151071|FG001|Overall Study|Administrative Decision|0|||
126505637|NCT00436748|455151070|FG000|Overall Study|Lost to Follow-up|0|||
126505638|NCT00436748|455151071|FG001|Overall Study|Lost to Follow-up|1|||
126505639|NCT00436748|455151070|FG000|Overall Study|Protocol-specified Criteria|5|||
126505640|NCT00436748|455151071|FG001|Overall Study|Protocol-specified Criteria|4|||
126505641|NCT00436748|455151070|FG000|Overall Study|Other|3|||
126505642|NCT00436748|455151071|FG001|Overall Study|Other|0|||
126505643|NCT01610791|455151072|FG000|Overall Study|Lost to Follow-up|7|||
126505644|NCT01610791|455151072|FG000|Overall Study|Adverse Event|6|||
126505645|NCT01610791|455151072|FG000|Overall Study|Physician Decision|1|||
126505646|NCT01610791|455151072|FG000|Overall Study|Adverse event and Investigator decision|1|||
126505647|NCT01610791|455151072|FG000|Overall Study|Death|1|||
126505648|NCT01610791|455151072|FG000|Overall Study|Not determined|5|||
126505649|NCT02086110|455151077|FG000|Overall Study|Withdrawal by Subject|1|||
126505650|NCT02086110|455151078|FG001|Overall Study|Withdrawal by Subject|1|||
126505651|NCT01869192|455151079|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
126505652|NCT01869192|455151080|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
126505653|NCT01869192|455151079|FG000|Postoperative Chemotherapy|Physician Decision|0|||
126505654|NCT01869192|455151080|FG001|Postoperative Chemotherapy|Physician Decision|2|||
126505655|NCT02126969|455151081|FG000|Overall Study|Withdrawal by Subject|1|||
126505656|NCT02126969|455151082|FG001|Overall Study|Withdrawal by Subject|2|||
126505657|NCT00357370|455151083|FG000|Cohort 2|Lack of Efficacy|0|||
126505658|NCT00357370|455151084|FG001|Cohort 2|Lack of Efficacy|2|||
126505659|NCT00357370|455151085|FG002|Cohort 2|Lack of Efficacy|1|||
126505660|NCT00357370|455151083|FG000|Cohort 2|Adverse Event|1|||
126505661|NCT00357370|455151084|FG001|Cohort 2|Adverse Event|1|||
126505662|NCT00357370|455151085|FG002|Cohort 2|Adverse Event|1|||
126505663|NCT00357370|455151083|FG000|Cohort 2|Lost to Follow-up|0|||
126505664|NCT00357370|455151084|FG001|Cohort 2|Lost to Follow-up|1|||
126505665|NCT00357370|455151085|FG002|Cohort 2|Lost to Follow-up|0|||
126505666|NCT00357370|455151083|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
126505667|NCT00357370|455151084|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
126505668|NCT00357370|455151085|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
126505669|NCT00357370|455151083|FG000|Cohort 2|Withdrawal by Subject|0|||
126505670|NCT00357370|455151084|FG001|Cohort 2|Withdrawal by Subject|2|||
126505671|NCT00357370|455151085|FG002|Cohort 2|Withdrawal by Subject|0|||
126505672|NCT00937547|455151086|FG000|Overall Study|misdiagnosis|1|||
126505673|NCT00937547|455151087|FG001|Overall Study|misdiagnosis|6|||
126505674|NCT00937547|455151088|FG002|Overall Study|misdiagnosis|7|||
126505675|NCT00404352|455151089|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
126505676|NCT00404352|455151090|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
126505677|NCT00404352|455151091|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
126505678|NCT00404352|455151092|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
126505679|NCT00404352|455151093|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
126505680|NCT00404352|455151094|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
126505681|NCT00404352|455151095|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
126505682|NCT00404352|455151096|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
126505683|NCT00404352|455151097|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
126505684|NCT00404352|455151089|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
126505685|NCT00404352|455151090|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
126505686|NCT00404352|455151091|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
126505687|NCT00404352|455151092|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
126505688|NCT00404352|455151093|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
126505689|NCT00404352|455151094|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
126505690|NCT00404352|455151095|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
126505691|NCT00404352|455151096|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
126505692|NCT00404352|455151097|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
126505693|NCT00404352|455151089|FG000|Double Blind (up to 24 Month)|Death|0|||
126505694|NCT00404352|455151090|FG001|Double Blind (up to 24 Month)|Death|0|||
126505695|NCT00404352|455151091|FG002|Double Blind (up to 24 Month)|Death|1|||
126505696|NCT00404352|455151092|FG003|Double Blind (up to 24 Month)|Death|0|||
126505697|NCT00404352|455151093|FG004|Double Blind (up to 24 Month)|Death|0|||
126505698|NCT00404352|455151094|FG005|Double Blind (up to 24 Month)|Death|0|||
126505699|NCT00404352|455151095|FG006|Double Blind (up to 24 Month)|Death|0|||
126505700|NCT00404352|455151096|FG007|Double Blind (up to 24 Month)|Death|0|||
126505701|NCT00404352|455151097|FG008|Double Blind (up to 24 Month)|Death|0|||
126505702|NCT00404352|455151089|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
126505703|NCT00404352|455151090|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
126505704|NCT00404352|455151091|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
126505705|NCT00404352|455151092|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
126505706|NCT00404352|455151093|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
126505707|NCT00404352|455151094|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
126505708|NCT00404352|455151095|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
126505709|NCT00404352|455151096|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
126505710|NCT00404352|455151097|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
126505711|NCT00404352|455151089|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
126505712|NCT00404352|455151090|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
126505713|NCT00404352|455151091|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
126505714|NCT00404352|455151092|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
126505715|NCT00404352|455151093|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
126505716|NCT00404352|455151094|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
126505717|NCT00404352|455151095|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
126505718|NCT00404352|455151096|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
126505719|NCT00404352|455151097|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
126505720|NCT00404352|455151089|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
126505721|NCT00404352|455151090|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
126505722|NCT00404352|455151091|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
126505723|NCT00404352|455151092|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
126505724|NCT00404352|455151093|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
126505725|NCT00404352|455151094|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
126505726|NCT00404352|455151095|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
126505727|NCT00404352|455151096|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
126505728|NCT00404352|455151097|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
126505729|NCT00404352|455151089|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
126505730|NCT00404352|455151090|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
126505731|NCT00404352|455151091|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
126505732|NCT00404352|455151092|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
126505733|NCT00404352|455151093|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
126505734|NCT00404352|455151094|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
126505735|NCT00404352|455151095|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
126505736|NCT00404352|455151096|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
126505737|NCT00404352|455151097|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
126505738|NCT00404352|455151089|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
126505739|NCT00404352|455151090|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
126505740|NCT00404352|455151091|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
126505741|NCT00404352|455151092|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
126505742|NCT00404352|455151093|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
126505743|NCT00404352|455151094|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
126505744|NCT00404352|455151095|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
126505745|NCT00404352|455151096|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
126505746|NCT00404352|455151097|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
126505747|NCT00404352|455151089|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
126505748|NCT00404352|455151090|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
126505749|NCT00404352|455151091|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
126505750|NCT00404352|455151092|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
126505751|NCT00404352|455151093|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
126505752|NCT00404352|455151094|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
126505753|NCT00404352|455151095|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
126505754|NCT00404352|455151096|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
126505755|NCT00404352|455151097|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
126505756|NCT00404352|455151089|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
126505757|NCT00404352|455151090|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
126505758|NCT00404352|455151091|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
126505759|NCT00404352|455151092|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
126505760|NCT00404352|455151093|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
126505761|NCT00404352|455151094|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
126505762|NCT00404352|455151095|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
126505763|NCT00404352|455151096|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
126505764|NCT00404352|455151097|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
126505765|NCT00404352|455151089|FG000|Double Blind (up to 24 Month)|Other|0|||
126505766|NCT00404352|455151090|FG001|Double Blind (up to 24 Month)|Other|1|||
126505767|NCT00404352|455151091|FG002|Double Blind (up to 24 Month)|Other|0|||
126505768|NCT00404352|455151092|FG003|Double Blind (up to 24 Month)|Other|0|||
126505769|NCT00404352|455151093|FG004|Double Blind (up to 24 Month)|Other|0|||
126505770|NCT00404352|455151094|FG005|Double Blind (up to 24 Month)|Other|0|||
126505771|NCT00404352|455151095|FG006|Double Blind (up to 24 Month)|Other|0|||
126505772|NCT00404352|455151096|FG007|Double Blind (up to 24 Month)|Other|0|||
126505773|NCT00404352|455151097|FG008|Double Blind (up to 24 Month)|Other|0|||
126505774|NCT00404352|455151089|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
126505775|NCT00404352|455151090|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
126505776|NCT00404352|455151091|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
126505777|NCT00404352|455151092|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
126505778|NCT00404352|455151093|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
126505779|NCT00404352|455151094|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
126505780|NCT00404352|455151095|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
126505781|NCT00404352|455151096|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
126505782|NCT00404352|455151097|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
126505783|NCT00404352|455151089|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
126505784|NCT00404352|455151090|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
126505785|NCT00404352|455151091|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
126505786|NCT00404352|455151092|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
126505787|NCT00404352|455151093|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
126505788|NCT00404352|455151094|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
126505789|NCT00404352|455151095|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
126505790|NCT00404352|455151096|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
126505791|NCT00404352|455151097|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
126505792|NCT00404352|455151089|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
126505793|NCT00404352|455151090|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
126505794|NCT00404352|455151091|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
126505795|NCT00404352|455151092|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
126505796|NCT00404352|455151093|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
126505797|NCT00404352|455151094|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
126505798|NCT00404352|455151095|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
126505799|NCT00404352|455151096|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
126505800|NCT00404352|455151097|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
126505801|NCT00404352|455151089|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
126505802|NCT00404352|455151090|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
126505803|NCT00404352|455151091|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
126505804|NCT00404352|455151092|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
126505805|NCT00404352|455151093|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
126505806|NCT00404352|455151094|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
126505807|NCT00404352|455151095|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
126505808|NCT00404352|455151096|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
126505809|NCT00404352|455151097|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
126505810|NCT00404352|455151089|FG000|Open Label (up to 24 Month)|Disease progression|0|||
126505811|NCT00404352|455151090|FG001|Open Label (up to 24 Month)|Disease progression|0|||
126505812|NCT00404352|455151091|FG002|Open Label (up to 24 Month)|Disease progression|0|||
126505813|NCT00404352|455151092|FG003|Open Label (up to 24 Month)|Disease progression|1|||
126505814|NCT00404352|455151093|FG004|Open Label (up to 24 Month)|Disease progression|0|||
126505815|NCT00404352|455151094|FG005|Open Label (up to 24 Month)|Disease progression|0|||
126505816|NCT00404352|455151095|FG006|Open Label (up to 24 Month)|Disease progression|0|||
126505817|NCT00404352|455151096|FG007|Open Label (up to 24 Month)|Disease progression|0|||
126505818|NCT00404352|455151097|FG008|Open Label (up to 24 Month)|Disease progression|0|||
126505819|NCT00404352|455151089|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
126505820|NCT00404352|455151090|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
126505821|NCT00404352|455151091|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
126505822|NCT00404352|455151092|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
126505823|NCT00404352|455151093|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
126505824|NCT00404352|455151094|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
126505825|NCT00404352|455151095|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
126505826|NCT00404352|455151096|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
126505827|NCT00404352|455151097|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
126563385|NCT03710564|455357414|FG000|Overall Study|Protocol Violation|3|||
126563386|NCT03710564|455357415|FG001|Overall Study|Protocol Violation|2|||
126563387|NCT03710564|455357414|FG000|Overall Study|Adverse Event|3|||
126505828|NCT00404352|455151089|FG000|Open Label Extension (up to 36 Months)|Other|0|||
126505829|NCT00404352|455151090|FG001|Open Label Extension (up to 36 Months)|Other|0|||
126505830|NCT00404352|455151091|FG002|Open Label Extension (up to 36 Months)|Other|0|||
126505831|NCT00404352|455151092|FG003|Open Label Extension (up to 36 Months)|Other|0|||
126505832|NCT00404352|455151093|FG004|Open Label Extension (up to 36 Months)|Other|0|||
126505833|NCT00404352|455151094|FG005|Open Label Extension (up to 36 Months)|Other|0|||
126505834|NCT00404352|455151095|FG006|Open Label Extension (up to 36 Months)|Other|0|||
126505835|NCT00404352|455151096|FG007|Open Label Extension (up to 36 Months)|Other|0|||
126505836|NCT00404352|455151097|FG008|Open Label Extension (up to 36 Months)|Other|2|||
126505837|NCT04370691|455151098|FG000|Overall Study|Pending visit|48|||
126505838|NCT04370691|455151098|FG000|Overall Study|Have Not Reached Lower Window|15|||
126505839|NCT04370691|455151098|FG000|Overall Study|Termination|14|||
126505840|NCT04370691|455151098|FG000|Overall Study|Missed or Overdue|10|||
126505841|NCT04960228|455151105|FG000|Overall Study|Withdrawal by Subject|216|||
126505842|NCT04960228|455151106|FG001|Overall Study|Withdrawal by Subject|35|||
126505843|NCT04960228|455151105|FG000|Overall Study|Failed attention check|69|||
126505844|NCT04960228|455151106|FG001|Overall Study|Failed attention check|148|||
126505845|NCT04960228|455151105|FG000|Overall Study|Flagged for response quality by Dynata|3|||
126505846|NCT04960228|455151106|FG001|Overall Study|Flagged for response quality by Dynata|3|||
126505847|NCT03837899|455151108|FG000|Overall Study|Death|6|||
126505848|NCT03837899|455151109|FG001|Overall Study|Death|8|||
126505849|NCT03837899|455151110|FG002|Overall Study|Death|3|||
126505850|NCT03837899|455151111|FG003|Overall Study|Death|7|||
126505851|NCT03837899|455151112|FG004|Overall Study|Death|8|||
126505852|NCT03837899|455151113|FG005|Overall Study|Death|7|||
126505853|NCT03837899|455151108|FG000|Overall Study|Moved to post-trial access program|0|||
126505854|NCT03837899|455151109|FG001|Overall Study|Moved to post-trial access program|1|||
126505855|NCT03837899|455151110|FG002|Overall Study|Moved to post-trial access program|0|||
126505856|NCT03837899|455151111|FG003|Overall Study|Moved to post-trial access program|0|||
126505857|NCT03837899|455151112|FG004|Overall Study|Moved to post-trial access program|0|||
126505858|NCT03837899|455151113|FG005|Overall Study|Moved to post-trial access program|0|||
126505859|NCT03837899|455151108|FG000|Overall Study|Other|0|||
126505860|NCT03837899|455151109|FG001|Overall Study|Other|0|||
126505861|NCT03837899|455151110|FG002|Overall Study|Other|0|||
126505862|NCT03837899|455151111|FG003|Overall Study|Other|0|||
126505863|NCT03837899|455151112|FG004|Overall Study|Other|0|||
126505864|NCT03837899|455151113|FG005|Overall Study|Other|2|||
126505865|NCT03837899|455151108|FG000|Overall Study|Lost to Follow-up|0|||
126505866|NCT03837899|455151109|FG001|Overall Study|Lost to Follow-up|1|||
126505867|NCT03837899|455151110|FG002|Overall Study|Lost to Follow-up|0|||
126505868|NCT03837899|455151111|FG003|Overall Study|Lost to Follow-up|0|||
126505869|NCT03837899|455151112|FG004|Overall Study|Lost to Follow-up|0|||
126505870|NCT03837899|455151113|FG005|Overall Study|Lost to Follow-up|0|||
126505871|NCT03837899|455151108|FG000|Overall Study|Withdrawal by Subject|0|||
126505872|NCT03837899|455151109|FG001|Overall Study|Withdrawal by Subject|0|||
126505873|NCT03837899|455151110|FG002|Overall Study|Withdrawal by Subject|0|||
126563388|NCT03710564|455357415|FG001|Overall Study|Adverse Event|0|||
126563389|NCT03710564|455357414|FG000|Overall Study|Physician Decision|2|||
126563390|NCT03710564|455357415|FG001|Overall Study|Physician Decision|3|||
126563391|NCT02993471|455357416|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
126563392|NCT02993471|455357416|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
126563393|NCT04582877|455357419|FG000|Overall Study|Did not use device measurement|5|||
126563394|NCT04582877|455357419|FG000|Overall Study|No fractional flow reserve test results|2|||
126505874|NCT03837899|455151111|FG003|Overall Study|Withdrawal by Subject|1|||
126505875|NCT03837899|455151112|FG004|Overall Study|Withdrawal by Subject|0|||
126505876|NCT03837899|455151113|FG005|Overall Study|Withdrawal by Subject|0|||
126505877|NCT03837899|455151108|FG000|Overall Study|Study specific discontinuation criteria|0|||
126505878|NCT03837899|455151109|FG001|Overall Study|Study specific discontinuation criteria|1|||
126505879|NCT03837899|455151110|FG002|Overall Study|Study specific discontinuation criteria|0|||
126505880|NCT03837899|455151111|FG003|Overall Study|Study specific discontinuation criteria|0|||
126505881|NCT03837899|455151112|FG004|Overall Study|Study specific discontinuation criteria|3|||
126505882|NCT03837899|455151113|FG005|Overall Study|Study specific discontinuation criteria|1|||
126505883|NCT01116232|455151117|FG000|Overall Study|Progressive diease|4|||
126505884|NCT02357940|455151118|FG000|Overall Study|Adverse Event|0|||
126505885|NCT02357940|455151119|FG001|Overall Study|Adverse Event|1|||
126505886|NCT02357940|455151118|FG000|Overall Study|Investigator's judgement|0|||
126505887|NCT02357940|455151119|FG001|Overall Study|Investigator's judgement|1|||
126505888|NCT02275481|455151120|FG000|Overall Study|Death|2|||
126505889|NCT02275481|455151121|FG001|Overall Study|Death|1|||
126505890|NCT02275481|455151120|FG000|Overall Study|Lost to Follow-up|2|||
126505891|NCT02275481|455151121|FG001|Overall Study|Lost to Follow-up|0|||
126505892|NCT02275481|455151120|FG000|Overall Study|Withdrawal by Subject|3|||
126505893|NCT02275481|455151121|FG001|Overall Study|Withdrawal by Subject|0|||
126505894|NCT02275481|455151120|FG000|Overall Study|all other reasons combined|2|||
126563395|NCT04582877|455357419|FG000|Overall Study|Protocol Violation|1|||
126563396|NCT00003656|455357420|FG000|Overall Study|Adverse Event|0|||
126563397|NCT00003656|455357421|FG001|Overall Study|Adverse Event|1|||
126563398|NCT03055767|455357422|FG000|Open-Label Period|Lost to Follow-up|0|||
126563399|NCT03055767|455357423|FG001|Open-Label Period|Lost to Follow-up|0|||
126563400|NCT03055767|455357424|FG002|Open-Label Period|Lost to Follow-up|2|||
126563401|NCT03055767|455357425|FG003|Open-Label Period|Lost to Follow-up|0|||
126563402|NCT03055767|455357422|FG000|Open-Label Period|Withdrawal by Subject|0|||
126563403|NCT03055767|455357423|FG001|Open-Label Period|Withdrawal by Subject|0|||
126563404|NCT03055767|455357424|FG002|Open-Label Period|Withdrawal by Subject|0|||
126563405|NCT03055767|455357425|FG003|Open-Label Period|Withdrawal by Subject|1|||
126563406|NCT02759731|455357426|FG000|Overall Study|Did not complete treatment.|8|||
126563407|NCT00763282|455357427|FG000|Overall Study|Withdrawal by Subject|6|||
126563408|NCT00763282|455357428|FG001|Overall Study|Withdrawal by Subject|5|||
126563409|NCT00763282|455357427|FG000|Overall Study|Death|4|||
126563410|NCT00763282|455357428|FG001|Overall Study|Death|3|||
126563411|NCT00763282|455357427|FG000|Overall Study|Lost to Follow-up|22|||
126563412|NCT00763282|455357428|FG001|Overall Study|Lost to Follow-up|26|||
126563413|NCT00335556|455357431|FG000|Overall Study|Death|0|||
126563414|NCT00335556|455357432|FG001|Overall Study|Death|5|||
126563415|NCT00335556|455357433|FG002|Overall Study|Death|0|||
126563416|NCT00335556|455357434|FG003|Overall Study|Death|0|||
126563417|NCT00335556|455357435|FG004|Overall Study|Death|1|||
126563418|NCT00335556|455357436|FG005|Overall Study|Death|0|||
126563419|NCT00335556|455357431|FG000|Overall Study|Lack of Efficacy|0|||
126563420|NCT00335556|455357432|FG001|Overall Study|Lack of Efficacy|19|||
126563421|NCT00335556|455357433|FG002|Overall Study|Lack of Efficacy|3|||
126563422|NCT00335556|455357434|FG003|Overall Study|Lack of Efficacy|3|||
126563423|NCT00335556|455357435|FG004|Overall Study|Lack of Efficacy|0|||
126563424|NCT00335556|455357436|FG005|Overall Study|Lack of Efficacy|1|||
126563425|NCT00335556|455357431|FG000|Overall Study|Physician Decision|0|||
126563426|NCT00335556|455357432|FG001|Overall Study|Physician Decision|6|||
126563427|NCT00335556|455357433|FG002|Overall Study|Physician Decision|2|||
126563428|NCT00335556|455357434|FG003|Overall Study|Physician Decision|1|||
126563429|NCT00335556|455357435|FG004|Overall Study|Physician Decision|0|||
126563430|NCT00335556|455357436|FG005|Overall Study|Physician Decision|0|||
126563431|NCT00335556|455357431|FG000|Overall Study|Ineligible|2|||
126563432|NCT00335556|455357432|FG001|Overall Study|Ineligible|0|||
126563433|NCT00335556|455357433|FG002|Overall Study|Ineligible|0|||
126776918|NCT03650400|456139077|FG001|Overall Study|Study terminated by sponsor|5|||
126776919|NCT04132232|456139089|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
126776920|NCT04132232|456139090|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
126505895|NCT02275481|455151121|FG001|Overall Study|all other reasons combined|1|||
126505896|NCT02275481|455151120|FG000|Overall Study|Physician Decision|0|||
126505897|NCT02275481|455151121|FG001|Overall Study|Physician Decision|1|||
126505898|NCT00344773|455151126|FG000|Overall Study|Adverse Event|2|||
126505899|NCT00344773|455151126|FG000|Overall Study|Objective Disease Progression|16|||
126505900|NCT00344773|455151126|FG000|Overall Study|Withdrawal by Subject|1|||
126505901|NCT00344773|455151126|FG000|Overall Study|Not Eligible for the study|2|||
126505902|NCT00714259|455151128|FG000|Overall Study|Death|2|||
126505903|NCT02141074|455151129|FG000|Pre-prophylaxis|Adverse Event|3|||
126505904|NCT02141074|455151130|FG001|Pre-prophylaxis|Adverse Event|0|||
126505905|NCT02141074|455151129|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
126505906|NCT02141074|455151130|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
126505907|NCT02141074|455151129|FG000|Prophylaxis|Adverse Event|0|||
126505908|NCT02141074|455151130|FG001|Prophylaxis|Adverse Event|4|||
126505909|NCT02141074|455151129|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
126505910|NCT02141074|455151130|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
126505911|NCT02141074|455151129|FG000|Prophylaxis|Withdrawal by Subject|0|||
126505912|NCT02141074|455151130|FG001|Prophylaxis|Withdrawal by Subject|1|||
126505913|NCT05627518|455151131|FG000|Treatment Period 1|Adverse Event|0|||
126505914|NCT05627518|455151132|FG001|Treatment Period 1|Adverse Event|0|||
126505915|NCT05627518|455151133|FG002|Treatment Period 1|Adverse Event|1|||
126505916|NCT05627518|455151134|FG003|Treatment Period 1|Adverse Event|0|||
126505917|NCT05627518|455151135|FG004|Treatment Period 1|Adverse Event|0|||
126505918|NCT05627518|455151136|FG005|Treatment Period 1|Adverse Event|0|||
126505919|NCT05627518|455151137|FG006|Treatment Period 1|Adverse Event|0|||
126505920|NCT05627518|455151138|FG007|Treatment Period 1|Adverse Event|1|||
126505921|NCT05627518|455151131|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126505922|NCT05627518|455151132|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126563434|NCT00335556|455357434|FG003|Overall Study|Ineligible|0|||
126563435|NCT00335556|455357435|FG004|Overall Study|Ineligible|0|||
126563436|NCT00335556|455357436|FG005|Overall Study|Ineligible|0|||
126563437|NCT00335556|455357431|FG000|Overall Study|Refusal of further protocol therapy|0|||
126563438|NCT00335556|455357432|FG001|Overall Study|Refusal of further protocol therapy|4|||
126563439|NCT00335556|455357433|FG002|Overall Study|Refusal of further protocol therapy|0|||
126563440|NCT00335556|455357434|FG003|Overall Study|Refusal of further protocol therapy|1|||
126563441|NCT00335556|455357435|FG004|Overall Study|Refusal of further protocol therapy|0|||
126563442|NCT00335556|455357436|FG005|Overall Study|Refusal of further protocol therapy|0|||
126505923|NCT05627518|455151133|FG002|Treatment Period 1|Withdrawal by Subject|1|||
126505924|NCT05627518|455151134|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126505925|NCT05627518|455151135|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126505926|NCT05627518|455151136|FG005|Treatment Period 1|Withdrawal by Subject|1|||
126505927|NCT05627518|455151137|FG006|Treatment Period 1|Withdrawal by Subject|0|||
126505928|NCT05627518|455151138|FG007|Treatment Period 1|Withdrawal by Subject|0|||
126505929|NCT05627518|455151131|FG000|Treatment Period 1|Protocol Violation|0|||
126505930|NCT05627518|455151132|FG001|Treatment Period 1|Protocol Violation|0|||
126505931|NCT05627518|455151133|FG002|Treatment Period 1|Protocol Violation|0|||
126505932|NCT05627518|455151134|FG003|Treatment Period 1|Protocol Violation|0|||
126505933|NCT05627518|455151135|FG004|Treatment Period 1|Protocol Violation|0|||
126505934|NCT05627518|455151136|FG005|Treatment Period 1|Protocol Violation|0|||
126505935|NCT05627518|455151137|FG006|Treatment Period 1|Protocol Violation|6|||
126505936|NCT05627518|455151138|FG007|Treatment Period 1|Protocol Violation|6|||
126505937|NCT05627518|455151131|FG000|Treatment Period 2|Adverse Event|1|||
126505938|NCT05627518|455151132|FG001|Treatment Period 2|Adverse Event|0|||
126505939|NCT05627518|455151133|FG002|Treatment Period 2|Adverse Event|0|||
126505940|NCT05627518|455151134|FG003|Treatment Period 2|Adverse Event|0|||
126505941|NCT05627518|455151135|FG004|Treatment Period 2|Adverse Event|0|||
126505942|NCT05627518|455151136|FG005|Treatment Period 2|Adverse Event|0|||
126505943|NCT05627518|455151137|FG006|Treatment Period 2|Adverse Event|0|||
126505944|NCT05627518|455151138|FG007|Treatment Period 2|Adverse Event|0|||
126505945|NCT05627518|455151131|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126505946|NCT05627518|455151132|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126505947|NCT05627518|455151133|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126505948|NCT05627518|455151134|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126505949|NCT05627518|455151135|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126505950|NCT05627518|455151136|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126505951|NCT05627518|455151137|FG006|Treatment Period 2|Withdrawal by Subject|0|||
126505952|NCT05627518|455151138|FG007|Treatment Period 2|Withdrawal by Subject|0|||
126505953|NCT06023394|455151140|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
126505954|NCT06023394|455151141|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
126505955|NCT06023394|455151140|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
126505956|NCT06023394|455151141|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
126505957|NCT06023394|455151140|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
126505958|NCT06023394|455151141|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
126505959|NCT06023394|455151140|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
126505960|NCT06023394|455151141|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
126505961|NCT02283788|455151143|FG000|Overall Study|Adverse Event|1|||
126505962|NCT02283788|455151144|FG001|Overall Study|Adverse Event|3|||
126505963|NCT02283788|455151145|FG002|Overall Study|Adverse Event|5|||
126505964|NCT02283788|455151146|FG003|Overall Study|Adverse Event|1|||
126505965|NCT02283788|455151143|FG000|Overall Study|Withdrawal by Subject|0|||
126505966|NCT02283788|455151144|FG001|Overall Study|Withdrawal by Subject|1|||
126505967|NCT02283788|455151145|FG002|Overall Study|Withdrawal by Subject|0|||
126505968|NCT02283788|455151146|FG003|Overall Study|Withdrawal by Subject|1|||
126505969|NCT01336738|455152893|FG000|Overall Study|Adverse Event|0|||
126505970|NCT01336738|455152894|FG001|Overall Study|Adverse Event|3|||
126505971|NCT01336738|455152895|FG002|Overall Study|Adverse Event|2|||
126505972|NCT01336738|455152896|FG003|Overall Study|Adverse Event|1|||
126505973|NCT01336738|455152897|FG004|Overall Study|Adverse Event|3|||
126505974|NCT01336738|455152893|FG000|Overall Study|Lost to Follow-up|2|||
126505975|NCT01336738|455152894|FG001|Overall Study|Lost to Follow-up|1|||
126505976|NCT01336738|455152895|FG002|Overall Study|Lost to Follow-up|2|||
126505977|NCT01336738|455152896|FG003|Overall Study|Lost to Follow-up|2|||
126505978|NCT01336738|455152897|FG004|Overall Study|Lost to Follow-up|2|||
126505979|NCT01336738|455152893|FG000|Overall Study|Did not meet entrance criteria|0|||
126505980|NCT01336738|455152894|FG001|Overall Study|Did not meet entrance criteria|1|||
126505981|NCT01336738|455152895|FG002|Overall Study|Did not meet entrance criteria|0|||
126505982|NCT01336738|455152896|FG003|Overall Study|Did not meet entrance criteria|0|||
126505983|NCT01336738|455152897|FG004|Overall Study|Did not meet entrance criteria|0|||
126505984|NCT01336738|455152893|FG000|Overall Study|Protocol Violation|0|||
126505985|NCT01336738|455152894|FG001|Overall Study|Protocol Violation|1|||
126505986|NCT01336738|455152895|FG002|Overall Study|Protocol Violation|0|||
126505987|NCT01336738|455152896|FG003|Overall Study|Protocol Violation|0|||
126505988|NCT01336738|455152897|FG004|Overall Study|Protocol Violation|0|||
126505989|NCT01336738|455152893|FG000|Overall Study|Withdrawal by Subject|2|||
126505990|NCT01336738|455152894|FG001|Overall Study|Withdrawal by Subject|0|||
126505991|NCT01336738|455152895|FG002|Overall Study|Withdrawal by Subject|2|||
126505992|NCT01336738|455152896|FG003|Overall Study|Withdrawal by Subject|1|||
126505993|NCT01336738|455152897|FG004|Overall Study|Withdrawal by Subject|1|||
126505994|NCT01336738|455152893|FG000|Overall Study|Other|3|||
126505995|NCT01336738|455152894|FG001|Overall Study|Other|3|||
126505996|NCT01336738|455152895|FG002|Overall Study|Other|2|||
126505997|NCT01336738|455152896|FG003|Overall Study|Other|3|||
126505998|NCT01336738|455152897|FG004|Overall Study|Other|4|||
126563443|NCT02974010|455357439|FG000|Overall Study|Lost to Follow-up|3|||
126563444|NCT02974010|455357440|FG001|Overall Study|Lost to Follow-up|1|||
126563445|NCT02974010|455357441|FG002|Overall Study|Lost to Follow-up|0|||
126563446|NCT02974010|455357442|FG003|Overall Study|Lost to Follow-up|0|||
126563447|NCT02974010|455357439|FG000|Overall Study|Withdrawal by Subject|2|||
126563448|NCT02974010|455357440|FG001|Overall Study|Withdrawal by Subject|1|||
126563449|NCT02974010|455357441|FG002|Overall Study|Withdrawal by Subject|0|||
126563450|NCT02974010|455357442|FG003|Overall Study|Withdrawal by Subject|0|||
126563451|NCT02974010|455357439|FG000|Overall Study|Adverse Event|0|||
126563452|NCT02974010|455357440|FG001|Overall Study|Adverse Event|1|||
126563453|NCT02974010|455357441|FG002|Overall Study|Adverse Event|0|||
126563454|NCT02974010|455357442|FG003|Overall Study|Adverse Event|0|||
126563455|NCT02974010|455357439|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
126563456|NCT02974010|455357440|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
126563457|NCT02974010|455357441|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
126563458|NCT02974010|455357442|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
126563459|NCT02974010|455357439|FG000|Overall Study|Lack of Efficacy|0|||
126563460|NCT02974010|455357440|FG001|Overall Study|Lack of Efficacy|0|||
126563461|NCT02974010|455357441|FG002|Overall Study|Lack of Efficacy|1|||
126563462|NCT02974010|455357442|FG003|Overall Study|Lack of Efficacy|0|||
126563463|NCT04555044|455357454|FG000|Overall Study|Adverse Event|0|||
126563464|NCT04555044|455357455|FG001|Overall Study|Adverse Event|1|||
126563465|NCT01670019|455357458|FG000|Overall Study|Adverse Event|3|||
126563466|NCT01670019|455357459|FG001|Overall Study|Adverse Event|0|||
126563467|NCT01670019|455357458|FG000|Overall Study|Withdrawal by Subject|6|||
126563468|NCT01670019|455357459|FG001|Overall Study|Withdrawal by Subject|0|||
126563469|NCT03601507|455357460|FG000|Overall Study|Adverse Event|1|||
126563470|NCT02107014|455357463|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
126563471|NCT00586339|455357465|FG000|Overall Study|Withdrawal by Subject|1|||
126563472|NCT00586339|455357466|FG001|Overall Study|Withdrawal by Subject|3|||
126563473|NCT00586339|455357467|FG002|Overall Study|Withdrawal by Subject|1|||
126563474|NCT00586339|455357465|FG000|Overall Study|Migrated/moved from study area|3|||
126563475|NCT00586339|455357466|FG001|Overall Study|Migrated/moved from study area|2|||
126563476|NCT00586339|455357467|FG002|Overall Study|Migrated/moved from study area|4|||
126563477|NCT00586339|455357465|FG000|Overall Study|Lost to Follow-up|3|||
126563478|NCT00586339|455357466|FG001|Overall Study|Lost to Follow-up|2|||
126563479|NCT00586339|455357467|FG002|Overall Study|Lost to Follow-up|1|||
126563480|NCT01835899|455357469|FG000|Overall Study|Adverse Event|0|||
126563481|NCT01835899|455357470|FG001|Overall Study|Adverse Event|0|||
126563482|NCT01835899|455357471|FG002|Overall Study|Adverse Event|1|||
126563483|NCT01835899|455357469|FG000|Overall Study|Other than stated above|0|||
126563484|NCT01835899|455357470|FG001|Overall Study|Other than stated above|1|||
126563485|NCT01835899|455357471|FG002|Overall Study|Other than stated above|0|||
126563486|NCT03168438|455357473|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
126563487|NCT03168438|455357474|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
126563488|NCT05015478|455357477|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
126563489|NCT05015478|455357478|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
126563490|NCT05015478|455357479|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
126563491|NCT05015478|455357480|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
126563492|NCT01649427|455357485|FG000|Overall Study|Adverse Event|1|||
126563493|NCT01649427|455357486|FG001|Overall Study|Adverse Event|1|||
126563494|NCT01649427|455357485|FG000|Overall Study|Withdrawal by Subject|8|||
126563495|NCT01649427|455357486|FG001|Overall Study|Withdrawal by Subject|7|||
126563496|NCT01649427|455357485|FG000|Overall Study|Lost to Follow-up|0|||
126563497|NCT01649427|455357486|FG001|Overall Study|Lost to Follow-up|1|||
126563498|NCT01649427|455357485|FG000|Overall Study|Graft loss|0|||
126563499|NCT01649427|455357486|FG001|Overall Study|Graft loss|1|||
126563500|NCT01649427|455357485|FG000|Overall Study|Surgical problems during nephrectomy|2|||
126563501|NCT01649427|455357486|FG001|Overall Study|Surgical problems during nephrectomy|2|||
126563502|NCT04927975|455357487|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
126563503|NCT04927975|455357488|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
126563504|NCT04927975|455357489|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
126563505|NCT04927975|455357490|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
126563506|NCT04927975|455357491|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
126563507|NCT04927975|455357492|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
126563508|NCT04927975|455357487|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
126563509|NCT04927975|455357488|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
126563510|NCT04927975|455357489|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
126563511|NCT04927975|455357490|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
126563512|NCT04927975|455357491|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
126563513|NCT04927975|455357492|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
126563514|NCT04927975|455357487|FG000|Period 1 (Baseline-Week 24)|Death|0|||
126563515|NCT04927975|455357488|FG001|Period 1 (Baseline-Week 24)|Death|0|||
126563516|NCT04927975|455357489|FG002|Period 1 (Baseline-Week 24)|Death|0|||
126505999|NCT02970968|455152899|FG000|Overall Study|Withdrawal by Subject|3|||
126506000|NCT02970968|455152900|FG001|Overall Study|Withdrawal by Subject|3|||
126506001|NCT02970968|455152899|FG000|Overall Study|Adverse Event|1|||
126506002|NCT02970968|455152900|FG001|Overall Study|Adverse Event|2|||
126506003|NCT02970968|455152899|FG000|Overall Study|Lost to Follow-up|1|||
126506004|NCT02970968|455152900|FG001|Overall Study|Lost to Follow-up|1|||
126506005|NCT02970968|455152899|FG000|Overall Study|Non-Compliance|0|||
126506006|NCT02970968|455152900|FG001|Overall Study|Non-Compliance|1|||
126506007|NCT03003520|455152901|FG000|Overall Study|Adverse Event|9|||
126506008|NCT03003520|455152902|FG001|Overall Study|Adverse Event|0|||
126506009|NCT03003520|455152901|FG000|Overall Study|Death|1|||
126506010|NCT03003520|455152902|FG001|Overall Study|Death|0|||
126506011|NCT03003520|455152901|FG000|Overall Study|Other reasons|4|||
126506012|NCT03003520|455152902|FG001|Overall Study|Other reasons|0|||
126506013|NCT03003520|455152901|FG000|Overall Study|Withdrawal by Subject|6|||
126506014|NCT03003520|455152902|FG001|Overall Study|Withdrawal by Subject|0|||
126506015|NCT03003520|455152901|FG000|Overall Study|Progressive disease|9|||
126506016|NCT03003520|455152902|FG001|Overall Study|Progressive disease|1|||
126563517|NCT04927975|455357490|FG003|Period 1 (Baseline-Week 24)|Death|0|||
126563518|NCT04927975|455357491|FG004|Period 1 (Baseline-Week 24)|Death|0|||
126563519|NCT04927975|455357492|FG005|Period 1 (Baseline-Week 24)|Death|1|||
126563520|NCT04927975|455357487|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
126563521|NCT04927975|455357488|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
126563522|NCT04927975|455357489|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
126563523|NCT04927975|455357490|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
126563524|NCT04927975|455357491|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
126563525|NCT04927975|455357492|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
126563526|NCT04927975|455357487|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
126563527|NCT04927975|455357488|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
126563528|NCT04927975|455357489|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
126563529|NCT04927975|455357490|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
126563530|NCT04927975|455357491|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
126563531|NCT04927975|455357492|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
126563532|NCT01559090|455357493|FG000|Stage I|Withdrawal by Subject|2|||
126563533|NCT01559090|455357494|FG001|Stage I|Withdrawal by Subject|2|||
126563534|NCT01559090|455357495|FG002|Stage I|Withdrawal by Subject|3|||
126563535|NCT01559090|455357493|FG000|Stage II|Withdrawal by Subject|1|||
126563536|NCT01559090|455357494|FG001|Stage II|Withdrawal by Subject|0|||
126563537|NCT01559090|455357495|FG002|Stage II|Withdrawal by Subject|0|||
126563538|NCT03722446|455357496|FG000|Overall Study|Protocol Violation|15|||
126563539|NCT03722446|455357497|FG001|Overall Study|Protocol Violation|2|||
126563540|NCT03102242|455357500|FG000|Overall Study|Adverse Event|2|||
126563541|NCT02908464|455357501|FG000|Overall Study|Withdrawal by Subject|2|||
126563542|NCT02908464|455357502|FG001|Overall Study|Withdrawal by Subject|1|||
126563543|NCT02908464|455357501|FG000|Overall Study|Found ineligible after randomization|0|||
126563544|NCT02908464|455357502|FG001|Overall Study|Found ineligible after randomization|2|||
126563545|NCT01311713|455357505|FG000|Overall Study|Death|0|||
126563546|NCT01311713|455357506|FG001|Overall Study|Death|0|||
126563547|NCT01311713|455357507|FG002|Overall Study|Death|1|||
126563548|NCT01311713|455357508|FG003|Overall Study|Death|1|||
126563549|NCT01311713|455357509|FG004|Overall Study|Death|0|||
126563550|NCT01311713|455357510|FG005|Overall Study|Death|1|||
126563551|NCT01311713|455357511|FG006|Overall Study|Death|0|||
126563552|NCT01311713|455357505|FG000|Overall Study|Adverse Event|0|||
126563553|NCT01311713|455357506|FG001|Overall Study|Adverse Event|1|||
126563554|NCT01311713|455357507|FG002|Overall Study|Adverse Event|0|||
126563555|NCT01311713|455357508|FG003|Overall Study|Adverse Event|2|||
126563556|NCT01311713|455357509|FG004|Overall Study|Adverse Event|0|||
126563557|NCT01311713|455357510|FG005|Overall Study|Adverse Event|0|||
126563558|NCT01311713|455357511|FG006|Overall Study|Adverse Event|2|||
126563559|NCT01311713|455357505|FG000|Overall Study|Withdrawal by Subject|0|||
126563560|NCT01311713|455357506|FG001|Overall Study|Withdrawal by Subject|1|||
126506017|NCT01332149|455152903|FG000|Overall Study|Adverse Event|11|||
126563561|NCT01311713|455357507|FG002|Overall Study|Withdrawal by Subject|1|||
126563562|NCT01311713|455357508|FG003|Overall Study|Withdrawal by Subject|0|||
126563563|NCT01311713|455357509|FG004|Overall Study|Withdrawal by Subject|0|||
126563564|NCT01311713|455357510|FG005|Overall Study|Withdrawal by Subject|1|||
126563565|NCT01311713|455357511|FG006|Overall Study|Withdrawal by Subject|2|||
126563566|NCT01311713|455357505|FG000|Overall Study|Disease progression|3|||
126563567|NCT01311713|455357506|FG001|Overall Study|Disease progression|4|||
126506018|NCT01332149|455152904|FG001|Overall Study|Adverse Event|9|||
126506019|NCT01332149|455152903|FG000|Overall Study|Other unspecified|5|||
126506020|NCT01332149|455152904|FG001|Overall Study|Other unspecified|7|||
126506021|NCT01332149|455152903|FG000|Overall Study|Protocol Violation|1|||
126563568|NCT01311713|455357507|FG002|Overall Study|Disease progression|3|||
126563569|NCT01311713|455357508|FG003|Overall Study|Disease progression|2|||
126563570|NCT01311713|455357509|FG004|Overall Study|Disease progression|4|||
126563571|NCT01311713|455357510|FG005|Overall Study|Disease progression|4|||
126563572|NCT01311713|455357511|FG006|Overall Study|Disease progression|5|||
126563573|NCT01311713|455357505|FG000|Overall Study|Lost to Follow-up|0|||
126506022|NCT01332149|455152904|FG001|Overall Study|Protocol Violation|3|||
126506023|NCT01332149|455152903|FG000|Overall Study|Withdrawal by Subject|4|||
126506024|NCT01332149|455152904|FG001|Overall Study|Withdrawal by Subject|5|||
126506025|NCT01332149|455152903|FG000|Overall Study|Lost to Follow-up|1|||
126506026|NCT01332149|455152904|FG001|Overall Study|Lost to Follow-up|1|||
126506027|NCT01332149|455152903|FG000|Overall Study|Insufficient clinical response|4|||
126506028|NCT01332149|455152904|FG001|Overall Study|Insufficient clinical response|7|||
126506029|NCT01332149|455152903|FG000|Overall Study|Did not meet entrance criteria|3|||
126506030|NCT01332149|455152904|FG001|Overall Study|Did not meet entrance criteria|4|||
126506031|NCT01332149|455152903|FG000|Overall Study|Randomized but not treated|1|||
126506032|NCT01332149|455152904|FG001|Overall Study|Randomized but not treated|2|||
126506033|NCT02565381|455152905|FG000|Overall Study|Lost to Follow-up|1|||
126506034|NCT02565381|455152906|FG001|Overall Study|Lost to Follow-up|0|||
126506035|NCT02565381|455152907|FG002|Overall Study|Lost to Follow-up|1|||
126506036|NCT04615949|455152908|FG000|Overall Study|Withdrawal by Subject|2|||
126506037|NCT04615949|455152909|FG001|Overall Study|Withdrawal by Subject|4|||
126506038|NCT04615949|455152908|FG000|Overall Study|Lost to Follow-up|2|||
126506039|NCT04615949|455152909|FG001|Overall Study|Lost to Follow-up|2|||
126506040|NCT04615949|455152908|FG000|Overall Study|Death|0|||
126506041|NCT04615949|455152909|FG001|Overall Study|Death|2|||
126506042|NCT02554656|455152910|FG000|Overall Study|Protocol Violation|3|||
126506043|NCT00749463|455152915|FG000|Overall Study|Adverse Event|0|||
126506044|NCT00749463|455152916|FG001|Overall Study|Adverse Event|4|||
126506045|NCT00749463|455152917|FG002|Overall Study|Adverse Event|1|||
126506046|NCT00749463|455152915|FG000|Overall Study|Withdrawal by Subject|1|||
126506047|NCT00749463|455152916|FG001|Overall Study|Withdrawal by Subject|0|||
126506048|NCT00749463|455152917|FG002|Overall Study|Withdrawal by Subject|0|||
126506049|NCT03643562|455152924|FG000|Overall Study|Adverse Event|1|||
126506050|NCT03643562|455152925|FG001|Overall Study|Adverse Event|0|||
126506051|NCT03643562|455152924|FG000|Overall Study|Lack of Efficacy|0|||
126506052|NCT03643562|455152925|FG001|Overall Study|Lack of Efficacy|1|||
126506053|NCT03643562|455152924|FG000|Overall Study|Physician Decision|0|||
126506054|NCT03643562|455152925|FG001|Overall Study|Physician Decision|1|||
126506055|NCT03643562|455152924|FG000|Overall Study|Study Terminated by Sponsor|2|||
126506056|NCT03643562|455152925|FG001|Overall Study|Study Terminated by Sponsor|10|||
126506057|NCT03643562|455152924|FG000|Overall Study|Withdrawal by Subject|2|||
126506058|NCT03643562|455152925|FG001|Overall Study|Withdrawal by Subject|2|||
126506059|NCT03643562|455152924|FG000|Overall Study|Other than specified|3|||
126506060|NCT03643562|455152925|FG001|Overall Study|Other than specified|2|||
126506061|NCT01982253|455152926|FG000|Overall Study|Withdrawal by Subject|1|||
126506062|NCT01982253|455152927|FG001|Overall Study|Withdrawal by Subject|0|||
126506063|NCT01982253|455152928|FG002|Overall Study|Withdrawal by Subject|0|||
126506064|NCT01982253|455152926|FG000|Overall Study|Study terminated by sponsor|1|||
126506065|NCT01982253|455152927|FG001|Overall Study|Study terminated by sponsor|4|||
126506066|NCT01982253|455152928|FG002|Overall Study|Study terminated by sponsor|4|||
126506067|NCT01886833|455152930|FG000|Overall Study|IgA not available from both periods|204|||
126506068|NCT00048542|455152934|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
126506069|NCT00048542|455152935|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
126506070|NCT00048542|455152936|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
126506071|NCT00048542|455152937|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
126506072|NCT00048542|455152938|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
126506073|NCT00048542|455152939|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
126506074|NCT00048542|455152940|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
126506075|NCT00048542|455152941|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
126506076|NCT00048542|455152934|FG000|Double-Blind Phase|Protocol Violation|0|||
126506077|NCT00048542|455152935|FG001|Double-Blind Phase|Protocol Violation|0|||
126506078|NCT00048542|455152936|FG002|Double-Blind Phase|Protocol Violation|1|||
126506079|NCT00048542|455152937|FG003|Double-Blind Phase|Protocol Violation|0|||
126506080|NCT00048542|455152938|FG004|Double-Blind Phase|Protocol Violation|0|||
126506081|NCT00048542|455152939|FG005|Double-Blind Phase|Protocol Violation|0|||
126506082|NCT00048542|455152940|FG006|Double-Blind Phase|Protocol Violation|0|||
126563574|NCT01311713|455357506|FG001|Overall Study|Lost to Follow-up|0|||
126563575|NCT01311713|455357507|FG002|Overall Study|Lost to Follow-up|1|||
126563576|NCT01311713|455357508|FG003|Overall Study|Lost to Follow-up|0|||
126563577|NCT01311713|455357509|FG004|Overall Study|Lost to Follow-up|0|||
126506083|NCT00048542|455152941|FG007|Double-Blind Phase|Protocol Violation|0|||
126506084|NCT00048542|455152934|FG000|Double-Blind Phase|Sponsor request or decision|2|||
126506085|NCT00048542|455152935|FG001|Double-Blind Phase|Sponsor request or decision|0|||
126506086|NCT00048542|455152936|FG002|Double-Blind Phase|Sponsor request or decision|0|||
126506087|NCT00048542|455152937|FG003|Double-Blind Phase|Sponsor request or decision|0|||
126506088|NCT00048542|455152938|FG004|Double-Blind Phase|Sponsor request or decision|0|||
126506089|NCT00048542|455152939|FG005|Double-Blind Phase|Sponsor request or decision|0|||
126506090|NCT00048542|455152940|FG006|Double-Blind Phase|Sponsor request or decision|0|||
126506091|NCT00048542|455152941|FG007|Double-Blind Phase|Sponsor request or decision|0|||
126563578|NCT01311713|455357510|FG005|Overall Study|Lost to Follow-up|0|||
126506092|NCT00048542|455152934|FG000|Double-Blind Phase|Randomized in error|1|||
126506093|NCT00048542|455152935|FG001|Double-Blind Phase|Randomized in error|0|||
126506094|NCT00048542|455152936|FG002|Double-Blind Phase|Randomized in error|0|||
126506095|NCT00048542|455152937|FG003|Double-Blind Phase|Randomized in error|0|||
126506096|NCT00048542|455152938|FG004|Double-Blind Phase|Randomized in error|0|||
126506097|NCT00048542|455152939|FG005|Double-Blind Phase|Randomized in error|0|||
126506098|NCT00048542|455152940|FG006|Double-Blind Phase|Randomized in error|0|||
126506099|NCT00048542|455152941|FG007|Double-Blind Phase|Randomized in error|0|||
126506100|NCT00048542|455152934|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
126506101|NCT00048542|455152935|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
126506102|NCT00048542|455152936|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
126506103|NCT00048542|455152937|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
126506104|NCT00048542|455152938|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
126506105|NCT00048542|455152939|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
126506106|NCT00048542|455152940|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
126506107|NCT00048542|455152941|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
126506108|NCT00048542|455152934|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
126506109|NCT00048542|455152935|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
126506110|NCT00048542|455152936|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
126506111|NCT00048542|455152937|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
126506112|NCT00048542|455152938|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
126506113|NCT00048542|455152939|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
126506114|NCT00048542|455152940|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
126506115|NCT00048542|455152941|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
126506116|NCT00048542|455152934|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
126506117|NCT00048542|455152935|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
126506118|NCT00048542|455152936|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
126506119|NCT00048542|455152937|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
126506120|NCT00048542|455152938|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
126506121|NCT00048542|455152939|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
126506122|NCT00048542|455152940|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
126506123|NCT00048542|455152941|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
126506124|NCT00048542|455152934|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
126506125|NCT00048542|455152935|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
126506126|NCT00048542|455152936|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
126506127|NCT00048542|455152937|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
126506128|NCT00048542|455152938|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
126506129|NCT00048542|455152939|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
126506130|NCT00048542|455152940|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
126506131|NCT00048542|455152941|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
126506132|NCT00048542|455152934|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
126506133|NCT00048542|455152935|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
126506134|NCT00048542|455152936|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
126506135|NCT00048542|455152937|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
126506136|NCT00048542|455152938|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
126506137|NCT00048542|455152939|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
126506138|NCT00048542|455152940|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
126506139|NCT00048542|455152941|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
126506140|NCT00048542|455152934|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
126506141|NCT00048542|455152935|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
126506142|NCT00048542|455152936|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
126506143|NCT00048542|455152937|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
126506144|NCT00048542|455152938|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
126506145|NCT00048542|455152939|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
126506146|NCT00048542|455152940|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
126506147|NCT00048542|455152941|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
126506148|NCT00048542|455152934|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
126506149|NCT00048542|455152935|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
126506150|NCT00048542|455152936|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
126506151|NCT00048542|455152937|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
126506152|NCT00048542|455152938|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
126506153|NCT00048542|455152939|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
126506154|NCT00048542|455152940|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
126506155|NCT00048542|455152941|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
126506156|NCT00048542|455152934|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
126506157|NCT00048542|455152935|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
126506158|NCT00048542|455152936|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
126563579|NCT01311713|455357511|FG006|Overall Study|Lost to Follow-up|0|||
126563580|NCT01311713|455357505|FG000|Overall Study|Stopped taking study medication|0|||
126563581|NCT01311713|455357506|FG001|Overall Study|Stopped taking study medication|0|||
126563582|NCT01311713|455357507|FG002|Overall Study|Stopped taking study medication|0|||
126563583|NCT01311713|455357508|FG003|Overall Study|Stopped taking study medication|1|||
126563584|NCT01311713|455357509|FG004|Overall Study|Stopped taking study medication|1|||
126563585|NCT01311713|455357510|FG005|Overall Study|Stopped taking study medication|0|||
126563586|NCT01311713|455357511|FG006|Overall Study|Stopped taking study medication|0|||
126563587|NCT01311713|455357505|FG000|Overall Study|Enrolled but not treated|0|||
126563588|NCT01311713|455357506|FG001|Overall Study|Enrolled but not treated|0|||
126563589|NCT01311713|455357507|FG002|Overall Study|Enrolled but not treated|1|||
126563590|NCT01311713|455357508|FG003|Overall Study|Enrolled but not treated|0|||
126563591|NCT01311713|455357509|FG004|Overall Study|Enrolled but not treated|0|||
126563592|NCT01311713|455357510|FG005|Overall Study|Enrolled but not treated|0|||
126563593|NCT01311713|455357511|FG006|Overall Study|Enrolled but not treated|0|||
126563594|NCT01311713|455357505|FG000|Overall Study|Other than specified|0|||
126563595|NCT01311713|455357506|FG001|Overall Study|Other than specified|1|||
126563596|NCT01311713|455357507|FG002|Overall Study|Other than specified|2|||
126563597|NCT01311713|455357508|FG003|Overall Study|Other than specified|0|||
126563598|NCT01311713|455357509|FG004|Overall Study|Other than specified|0|||
126563599|NCT01311713|455357510|FG005|Overall Study|Other than specified|0|||
126563600|NCT01311713|455357511|FG006|Overall Study|Other than specified|0|||
126563601|NCT00797862|455359933|FG000|Overall Study|Adverse Event|86|||
126563602|NCT00797862|455359934|FG001|Overall Study|Adverse Event|44|||
126563603|NCT00797862|455359935|FG002|Overall Study|Adverse Event|58|||
126563604|NCT00797862|455359933|FG000|Overall Study|Abnormal Test Procedure Result|0|||
126563605|NCT00797862|455359934|FG001|Overall Study|Abnormal Test Procedure Result|1|||
126563606|NCT00797862|455359935|FG002|Overall Study|Abnormal Test Procedure Result|1|||
126563607|NCT00797862|455359933|FG000|Overall Study|Lack of Efficacy|1|||
126563608|NCT00797862|455359934|FG001|Overall Study|Lack of Efficacy|7|||
126563609|NCT00797862|455359935|FG002|Overall Study|Lack of Efficacy|6|||
126563610|NCT00797862|455359933|FG000|Overall Study|No longer required study medication|1|||
126563611|NCT00797862|455359934|FG001|Overall Study|No longer required study medication|0|||
126563612|NCT00797862|455359935|FG002|Overall Study|No longer required study medication|0|||
126563613|NCT00797862|455359933|FG000|Overall Study|Withdrawal by Subject|14|||
126563614|NCT00797862|455359934|FG001|Overall Study|Withdrawal by Subject|7|||
126563615|NCT00797862|455359935|FG002|Overall Study|Withdrawal by Subject|7|||
126563616|NCT00797862|455359933|FG000|Overall Study|Lost to Follow-up|11|||
126563617|NCT00797862|455359934|FG001|Overall Study|Lost to Follow-up|0|||
126563618|NCT00797862|455359935|FG002|Overall Study|Lost to Follow-up|5|||
126563619|NCT00797862|455359933|FG000|Overall Study|Administrative Problem|4|||
126563620|NCT00797862|455359934|FG001|Overall Study|Administrative Problem|0|||
126563621|NCT00797862|455359935|FG002|Overall Study|Administrative Problem|0|||
126563622|NCT00797862|455359933|FG000|Overall Study|Protocol Violation|4|||
126563623|NCT00797862|455359934|FG001|Overall Study|Protocol Violation|6|||
126563624|NCT00797862|455359935|FG002|Overall Study|Protocol Violation|8|||
126563625|NCT00797862|455359933|FG000|Overall Study|Mis-randomized|3|||
126563626|NCT00797862|455359934|FG001|Overall Study|Mis-randomized|3|||
126563627|NCT00797862|455359935|FG002|Overall Study|Mis-randomized|1|||
126563628|NCT01474538|455359946|FG000|Treatment Period 1|Death|1|||
126563629|NCT01474538|455359947|FG001|Treatment Period 1|Death|0|||
126563630|NCT01474538|455359946|FG000|Treatment Period 1|Physician Decision|1|||
126563631|NCT01474538|455359947|FG001|Treatment Period 1|Physician Decision|0|||
126563632|NCT01474538|455359946|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126563633|NCT01474538|455359947|FG001|Treatment Period 1|Withdrawal by Subject|3|||
126563634|NCT01474538|455359946|FG000|Treatment Period 1|Protocol Violation|0|||
126563635|NCT01474538|455359947|FG001|Treatment Period 1|Protocol Violation|1|||
126563636|NCT01474538|455359946|FG000|Treatment Period 2|Death|1|||
126563637|NCT01474538|455359947|FG001|Treatment Period 2|Death|0|||
126563638|NCT01474538|455359946|FG000|Treatment Period 2|Adverse Event|1|||
126563639|NCT01474538|455359947|FG001|Treatment Period 2|Adverse Event|1|||
126563640|NCT01474538|455359946|FG000|Treatment Period 2|Withdrawal by Subject|2|||
126563641|NCT01474538|455359947|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126563642|NCT01474538|455359946|FG000|Treatment Period 2|Sponsor decision|1|||
126563643|NCT01474538|455359947|FG001|Treatment Period 2|Sponsor decision|0|||
126563644|NCT01474538|455359946|FG000|Treatment Period 2|Physician Decision|0|||
126563645|NCT01474538|455359947|FG001|Treatment Period 2|Physician Decision|1|||
126563646|NCT01474538|455359946|FG000|Treatment Period 2|Protocol Violation|1|||
126563647|NCT01474538|455359947|FG001|Treatment Period 2|Protocol Violation|0|||
126563648|NCT01456780|455359948|FG000|Overall Study|Lost to Follow-up|3|||
126563649|NCT01456780|455359949|FG001|Overall Study|Lost to Follow-up|3|||
126563650|NCT01456780|455359950|FG002|Overall Study|Lost to Follow-up|0|||
126563651|NCT00349908|455359953|FG000|Overall Study|Withdrawal by Subject|0|||
126563652|NCT00349908|455359954|FG001|Overall Study|Withdrawal by Subject|4|||
126563653|NCT04565249|455359955|FG000|Overall Study|Death|0|||
126563654|NCT04565249|455359956|FG001|Overall Study|Death|0|||
126563655|NCT04565249|455359957|FG002|Overall Study|Death|0|||
126506159|NCT00048542|455152937|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
126506160|NCT00048542|455152938|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
126506161|NCT00048542|455152939|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
126506162|NCT00048542|455152940|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
126506163|NCT00048542|455152941|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
126506164|NCT00048542|455152934|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
126506165|NCT00048542|455152935|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
126506166|NCT00048542|455152936|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
126506167|NCT00048542|455152937|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
126506168|NCT00048542|455152938|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
126506169|NCT00048542|455152939|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
126506170|NCT00048542|455152940|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
126506171|NCT00048542|455152941|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
126506172|NCT00048542|455152934|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
126506173|NCT00048542|455152935|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
126506174|NCT00048542|455152936|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
126506175|NCT00048542|455152937|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
126506176|NCT00048542|455152938|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
126506177|NCT00048542|455152939|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
126563656|NCT04565249|455359958|FG003|Overall Study|Death|1|||
126506178|NCT00048542|455152940|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
126506179|NCT00048542|455152941|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
126506180|NCT00048542|455152934|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
126506181|NCT00048542|455152935|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
126506182|NCT00048542|455152936|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
126506183|NCT00048542|455152937|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
126506184|NCT00048542|455152938|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
126506185|NCT00048542|455152939|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
126506186|NCT00048542|455152940|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
126506187|NCT00048542|455152941|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
126506188|NCT00578175|455152942|FG000|Overall Study|Adverse Event|0|||
126506189|NCT00578175|455152943|FG001|Overall Study|Adverse Event|1|||
126506190|NCT00578175|455152944|FG002|Overall Study|Adverse Event|1|||
126506191|NCT00578175|455152942|FG000|Overall Study|Other reasons|70|||
126506192|NCT00578175|455152943|FG001|Overall Study|Other reasons|42|||
126563657|NCT03120676|455359959|FG000|Overall Study|Not treated|1|||
126563658|NCT02333630|455359960|FG000|Overall Study|Lost to Follow-up|5|||
126563659|NCT02333630|455359961|FG001|Overall Study|Lost to Follow-up|2|||
126563660|NCT05349864|455359962|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
126563661|NCT05349864|455359963|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
126563662|NCT00984282|455359964|FG000|Double Blind Treatment|Adverse Event|40|||
126563663|NCT00984282|455359965|FG001|Double Blind Treatment|Adverse Event|6|||
126563664|NCT00984282|455359964|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
126563665|NCT00984282|455359965|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
126506193|NCT00578175|455152944|FG002|Overall Study|Other reasons|23|||
126506194|NCT02272413|455152946|FG000|Randomized Through Treatment Start|Not treated|3|||
126506195|NCT02272413|455152947|FG001|Randomized Through Treatment Start|Not treated|5|||
126506196|NCT02272413|455152946|FG000|Pre-switch Period|Adverse Event|38|||
126506197|NCT02272413|455152947|FG001|Pre-switch Period|Adverse Event|37|||
126506198|NCT02272413|455152946|FG000|Pre-switch Period|Death|26|||
126506199|NCT02272413|455152947|FG001|Pre-switch Period|Death|26|||
126506200|NCT02272413|455152946|FG000|Pre-switch Period|Withdrawal by Subject|27|||
126506201|NCT02272413|455152947|FG001|Pre-switch Period|Withdrawal by Subject|15|||
126506202|NCT02272413|455152946|FG000|Pre-switch Period|Physician Decision|6|||
126506203|NCT02272413|455152947|FG001|Pre-switch Period|Physician Decision|18|||
126506204|NCT02272413|455152946|FG000|Pre-switch Period|Progressive disease|185|||
126506205|NCT02272413|455152947|FG001|Pre-switch Period|Progressive disease|173|||
126506206|NCT02272413|455152946|FG000|Pre-switch Period|Lost to Follow-up|0|||
126506207|NCT02272413|455152947|FG001|Pre-switch Period|Lost to Follow-up|2|||
126506208|NCT02272413|455152946|FG000|Pre-switch Period|Protocol Violation|1|||
126506209|NCT02272413|455152947|FG001|Pre-switch Period|Protocol Violation|0|||
126506210|NCT02272413|455152946|FG000|Pre-switch Period|Other than listed|10|||
126506211|NCT02272413|455152947|FG001|Pre-switch Period|Other than listed|11|||
126506212|NCT02272413|455152946|FG000|Post-switch Period|Adverse Event|4|||
126506213|NCT02272413|455152947|FG001|Post-switch Period|Adverse Event|4|||
126563666|NCT00984282|455359964|FG000|Double Blind Treatment|Physician Decision|1|||
126563667|NCT00984282|455359965|FG001|Double Blind Treatment|Physician Decision|2|||
126563668|NCT00984282|455359964|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
126727154|NCT00125190|455951068|FG000|Overall Study|Subject/Parent Decision|7|||
126506214|NCT02272413|455152946|FG000|Post-switch Period|Death|3|||
126727155|NCT00125190|455951068|FG000|Overall Study|Non-compliance|2|||
126506215|NCT02272413|455152947|FG001|Post-switch Period|Death|2|||
126506216|NCT02272413|455152946|FG000|Post-switch Period|Withdrawal by Subject|1|||
126506217|NCT02272413|455152947|FG001|Post-switch Period|Withdrawal by Subject|2|||
126506218|NCT02272413|455152946|FG000|Post-switch Period|Physician Decision|1|||
126506219|NCT02272413|455152947|FG001|Post-switch Period|Physician Decision|1|||
126506220|NCT02272413|455152946|FG000|Post-switch Period|Progressive disease|21|||
126506221|NCT02272413|455152947|FG001|Post-switch Period|Progressive disease|21|||
126506222|NCT02272413|455152946|FG000|Post-switch Period|Study terminated by sponsor|8|||
126506223|NCT02272413|455152947|FG001|Post-switch Period|Study terminated by sponsor|11|||
126506224|NCT02272413|455152946|FG000|Post-switch Period|Other than listed|4|||
126506225|NCT02272413|455152947|FG001|Post-switch Period|Other than listed|5|||
126506226|NCT01533246|455152948|FG000|Overall Study|Adverse Event|1|||
126506227|NCT01533246|455152948|FG000|Overall Study|Withdrawal by Subject|1|||
126506228|NCT01143090|455152949|FG000|Overall Study|Lack of Efficacy|2|||
126506229|NCT01143090|455152949|FG000|Overall Study|Adverse Event|17|||
126506230|NCT01143090|455152949|FG000|Overall Study|Lost to Follow-up|9|||
126506231|NCT01143090|455152949|FG000|Overall Study|Protocol Violation|2|||
126506232|NCT01143090|455152949|FG000|Overall Study|Withdrawal by Subject|18|||
126506233|NCT01143090|455152949|FG000|Overall Study|Non-compliance with study drug|1|||
126506234|NCT01143090|455152949|FG000|Overall Study|Failure to meet eligibility criteria|1|||
126506235|NCT01143090|455152949|FG000|Overall Study|Administrative|1|||
126506236|NCT01461096|455152952|FG000|Overall Study|Death|3|||
126506237|NCT01461096|455152953|FG001|Overall Study|Death|6|||
126506238|NCT01461096|455152952|FG000|Overall Study|Severe debilitation, unable to continue|1|||
126506239|NCT01461096|455152953|FG001|Overall Study|Severe debilitation, unable to continue|1|||
126506240|NCT01461096|455152952|FG000|Overall Study|Subj not able to get to clinic|15|||
126506241|NCT01461096|455152953|FG001|Overall Study|Subj not able to get to clinic|13|||
126506242|NCT01461096|455152952|FG000|Overall Study|Site is closing|27|||
126506243|NCT01461096|455152953|FG001|Overall Study|Site is closing|30|||
126506244|NCT01461096|455152952|FG000|Overall Study|Withdrawal by Subject|5|||
126506245|NCT01461096|455152953|FG001|Overall Study|Withdrawal by Subject|3|||
126506246|NCT01461096|455152952|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
126506247|NCT01461096|455152953|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
126506248|NCT01461096|455152952|FG000|Overall Study|Lost to Follow-up|8|||
126506249|NCT01461096|455152953|FG001|Overall Study|Lost to Follow-up|4|||
126506250|NCT00855309|455152959|FG000|Overall Study|patient never recieved drug|1|||
126506251|NCT00855309|455152960|FG001|Overall Study|patient never recieved drug|0|||
126506252|NCT00829296|455152961|FG000|Overall Study|Adverse Event|5|||
126506253|NCT00829296|455152962|FG001|Overall Study|Adverse Event|4|||
126506254|NCT00582933|455152965|FG000|Overall Study|Physician Decision|3|||
126506255|NCT01077960|455152966|FG000|Overall Study|Adverse Event|6|||
126506256|NCT01077960|455152966|FG000|Overall Study|Protocol Violation|3|||
126506257|NCT01077960|455152966|FG000|Overall Study|Lost to Follow-up|5|||
126506258|NCT01077960|455152966|FG000|Overall Study|Subject decision|1|||
126506259|NCT01077960|455152966|FG000|Overall Study|Reason unspecified|1|||
126506260|NCT01371656|455152967|FG000|Overall Study|Death|7|||
126506261|NCT01371656|455152968|FG001|Overall Study|Death|4|||
126506262|NCT01371656|455152967|FG000|Overall Study|Physician Decision|46|||
126506263|NCT01371656|455152968|FG001|Overall Study|Physician Decision|7|||
126506264|NCT01371656|455152967|FG000|Overall Study|Withdrawal by Subject|7|||
126506265|NCT01371656|455152968|FG001|Overall Study|Withdrawal by Subject|0|||
126506266|NCT01371656|455152967|FG000|Overall Study|Ineligible|4|||
126506267|NCT01371656|455152968|FG001|Overall Study|Ineligible|3|||
126506268|NCT01465464|455152969|FG000|Overall Study|Adverse Event|96|||
126506269|NCT01465464|455152970|FG001|Overall Study|Adverse Event|49|||
126506270|NCT01465464|455152969|FG000|Overall Study|Lack of Efficacy|139|||
126506271|NCT01465464|455152970|FG001|Overall Study|Lack of Efficacy|190|||
126506272|NCT01465464|455152969|FG000|Overall Study|Physician Decision|13|||
126506273|NCT01465464|455152970|FG001|Overall Study|Physician Decision|5|||
126506274|NCT01465464|455152969|FG000|Overall Study|Protocol Violation|1|||
126506275|NCT01465464|455152970|FG001|Overall Study|Protocol Violation|1|||
126506276|NCT01465464|455152969|FG000|Overall Study|Withdrawal by Subject|46|||
126506277|NCT01465464|455152970|FG001|Overall Study|Withdrawal by Subject|30|||
126506278|NCT01465464|455152969|FG000|Overall Study|Other|9|||
126506279|NCT01465464|455152970|FG001|Overall Study|Other|3|||
126506280|NCT01465464|455152969|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
126506281|NCT01465464|455152970|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
126506282|NCT00785486|455152971|FG000|Midazolam Alone|Withdrawal by Subject|1|||
126506283|NCT01554618|455152972|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
126506284|NCT01554618|455152973|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
126506285|NCT01554618|455152972|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
126506286|NCT01554618|455152973|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
126506287|NCT01554618|455152972|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
126506288|NCT01554618|455152973|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
126506289|NCT01554618|455152972|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
126506290|NCT01554618|455152973|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
126506291|NCT01554618|455152972|FG000|Open-Label Extension Period|Physician Decision|0|||
126506292|NCT01554618|455152973|FG001|Open-Label Extension Period|Physician Decision|1|||
126506293|NCT01554618|455152972|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
126506294|NCT01554618|455152973|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
126506295|NCT01640366|455152975|FG000|Overall Study|Withdrawal by Subject|1|||
126506296|NCT01640366|455152975|FG000|Overall Study|Protocol Violation|16|||
126506297|NCT01640366|455152975|FG000|Overall Study|Lost to Follow-up|5|||
126506298|NCT00291668|455152982|FG000|Overall Study|Lack of Efficacy|1|||
126506299|NCT00291668|455152983|FG001|Overall Study|Lack of Efficacy|0|||
126506300|NCT00291668|455152984|FG002|Overall Study|Lack of Efficacy|0|||
126506301|NCT00291668|455152982|FG000|Overall Study|SAE, non-fatal|1|||
126506302|NCT00291668|455152983|FG001|Overall Study|SAE, non-fatal|1|||
126506303|NCT00291668|455152984|FG002|Overall Study|SAE, non-fatal|1|||
126506304|NCT00291668|455152982|FG000|Overall Study|AE, non-serious non-fatal|1|||
126506305|NCT00291668|455152983|FG001|Overall Study|AE, non-serious non-fatal|0|||
126506306|NCT00291668|455152984|FG002|Overall Study|AE, non-serious non-fatal|0|||
126506307|NCT00291668|455152982|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126506308|NCT00291668|455152983|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
126506309|NCT00291668|455152984|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
126506310|NCT00313612|455152987|FG000|Overall Study|Patient never received treatment|0|||
126506311|NCT00313612|455152988|FG001|Overall Study|Patient never received treatment|1|||
126506312|NCT00451035|455152989|FG000|Overall Study|Disease progression|11|||
126506313|NCT00451035|455152989|FG000|Overall Study|Death|3|||
126506314|NCT00451035|455152989|FG000|Overall Study|New anti-neoplastic therapy|3|||
126506315|NCT01393405|455152992|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
126506316|NCT01393405|455152993|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
126506317|NCT01393405|455152994|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
126506318|NCT01393405|455152992|FG000|Induction Period (week1-16)|Adverse Event|16|||
126506319|NCT01393405|455152993|FG001|Induction Period (week1-16)|Adverse Event|0|||
126506320|NCT01393405|455152994|FG002|Induction Period (week1-16)|Adverse Event|0|||
126506321|NCT01393405|455152992|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
126506322|NCT01393405|455152993|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
126506323|NCT01393405|455152994|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
126506324|NCT01393405|455152992|FG000|Maintenance Period Week|Lack of Efficacy|0|||
126506325|NCT01393405|455152993|FG001|Maintenance Period Week|Lack of Efficacy|22|||
126506326|NCT01393405|455152994|FG002|Maintenance Period Week|Lack of Efficacy|22|||
126506327|NCT01393405|455152992|FG000|Maintenance Period Week|Adverse Event|0|||
126506328|NCT01393405|455152993|FG001|Maintenance Period Week|Adverse Event|5|||
126506329|NCT01393405|455152994|FG002|Maintenance Period Week|Adverse Event|2|||
126506330|NCT01393405|455152992|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
126506331|NCT01393405|455152993|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
126506332|NCT01393405|455152994|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
126506333|NCT01393405|455152992|FG000|Maintenance Period Week|Lost to Follow-up|0|||
126506334|NCT01393405|455152993|FG001|Maintenance Period Week|Lost to Follow-up|1|||
126506335|NCT01393405|455152994|FG002|Maintenance Period Week|Lost to Follow-up|0|||
126506336|NCT04656132|455152999|FG000|Overall Study|Lost to Follow-up|4|||
126506337|NCT04656132|455152999|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
126506338|NCT00677807|455153000|FG000|Overall Study|Adverse Event|4|||
126506339|NCT00677807|455153001|FG001|Overall Study|Adverse Event|1|||
126506340|NCT00677807|455153002|FG002|Overall Study|Adverse Event|6|||
126506341|NCT00677807|455153000|FG000|Overall Study|Lack of Efficacy|0|||
126506342|NCT00677807|455153001|FG001|Overall Study|Lack of Efficacy|0|||
126506343|NCT00677807|455153002|FG002|Overall Study|Lack of Efficacy|2|||
126506344|NCT00677807|455153000|FG000|Overall Study|Participant no longer needs study drug|0|||
126506345|NCT00677807|455153001|FG001|Overall Study|Participant no longer needs study drug|0|||
126506346|NCT00677807|455153002|FG002|Overall Study|Participant no longer needs study drug|1|||
126506347|NCT00677807|455153000|FG000|Overall Study|Withdrawal by Subject|10|||
126506348|NCT00677807|455153001|FG001|Overall Study|Withdrawal by Subject|3|||
126506349|NCT00677807|455153002|FG002|Overall Study|Withdrawal by Subject|6|||
126506350|NCT00677807|455153000|FG000|Overall Study|Lost to Follow-up|2|||
126506351|NCT00677807|455153001|FG001|Overall Study|Lost to Follow-up|2|||
126506352|NCT00677807|455153002|FG002|Overall Study|Lost to Follow-up|2|||
126506353|NCT00677807|455153000|FG000|Overall Study|Administrative problems|1|||
126506354|NCT00677807|455153001|FG001|Overall Study|Administrative problems|1|||
126506355|NCT00677807|455153002|FG002|Overall Study|Administrative problems|2|||
126506356|NCT00677807|455153000|FG000|Overall Study|Death|0|||
126506357|NCT00677807|455153001|FG001|Overall Study|Death|1|||
126506358|NCT00677807|455153002|FG002|Overall Study|Death|1|||
126506359|NCT00677807|455153000|FG000|Overall Study|Protocol Deviation|1|||
126506360|NCT00677807|455153001|FG001|Overall Study|Protocol Deviation|3|||
126506361|NCT00677807|455153002|FG002|Overall Study|Protocol Deviation|0|||
126506362|NCT04365699|455153003|FG000|Overall Study|Death|2|||
126506363|NCT04365699|455153004|FG001|Overall Study|Death|5|||
126506364|NCT04365699|455153005|FG002|Overall Study|Death|15|||
126506365|NCT04019041|455153006|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
126506366|NCT04019041|455153007|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
126506367|NCT04019041|455153008|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
126506368|NCT04019041|455153009|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
126506369|NCT04019041|455153010|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
126506370|NCT04019041|455153011|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
126506371|NCT04019041|455153006|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
126506372|NCT04019041|455153007|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
126506373|NCT04019041|455153008|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
126563669|NCT00984282|455359965|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
126563670|NCT00984282|455359964|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
126563671|NCT00984282|455359965|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
126563672|NCT00984282|455359964|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
126506374|NCT04019041|455153009|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
126506375|NCT04019041|455153010|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
126506376|NCT04019041|455153011|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
126506377|NCT04019041|455153006|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
126506378|NCT04019041|455153007|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
126506379|NCT04019041|455153008|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
126506380|NCT04019041|455153009|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
126506381|NCT04019041|455153010|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
126506382|NCT04019041|455153011|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
126506383|NCT04019041|455153006|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
126506384|NCT04019041|455153007|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
126506385|NCT04019041|455153008|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
126506386|NCT04019041|455153009|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
126506387|NCT04019041|455153010|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
126506388|NCT04019041|455153011|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
126506389|NCT04019041|455153006|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
126506390|NCT04019041|455153007|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
126506391|NCT04019041|455153008|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
126506392|NCT04019041|455153009|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
126506393|NCT04019041|455153010|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
126506394|NCT04019041|455153011|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
126506395|NCT04019041|455153006|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
126506396|NCT04019041|455153007|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
126506397|NCT04019041|455153008|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
126506398|NCT04019041|455153009|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
126506399|NCT04019041|455153010|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
126506400|NCT04019041|455153011|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
126506401|NCT04019041|455153006|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
126506402|NCT04019041|455153007|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
126506403|NCT04019041|455153008|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
126506404|NCT04019041|455153009|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
126506405|NCT04019041|455153010|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
126506406|NCT04019041|455153011|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
126506407|NCT04019041|455153006|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
126506408|NCT04019041|455153007|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
126506409|NCT04019041|455153008|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
126506410|NCT04019041|455153009|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
126506411|NCT04019041|455153010|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
126563673|NCT00984282|455359965|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
126563674|NCT00984282|455359964|FG000|Double Blind Treatment|Lost to Follow-up|3|||
126563675|NCT00984282|455359965|FG001|Double Blind Treatment|Lost to Follow-up|0|||
126563676|NCT00984282|455359964|FG000|Double Blind Treatment|Death|8|||
126563677|NCT00984282|455359965|FG001|Double Blind Treatment|Death|4|||
126563678|NCT00984282|455359964|FG000|Double Blind Treatment|Not treated|0|||
126563679|NCT00984282|455359965|FG001|Double Blind Treatment|Not treated|1|||
126563680|NCT00984282|455359964|FG000|Double Blind Treatment|Switched to commercial drug|6|||
126563681|NCT00984282|455359965|FG001|Double Blind Treatment|Switched to commercial drug|1|||
126563682|NCT00984282|455359964|FG000|Double Blind Treatment|protocol driven decision point|1|||
126506412|NCT04019041|455153011|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
126506413|NCT04019041|455153006|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
126506414|NCT04019041|455153007|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
126506415|NCT04019041|455153008|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
126563683|NCT00984282|455359965|FG001|Double Blind Treatment|protocol driven decision point|1|||
126563684|NCT00984282|455359964|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
126727156|NCT00125190|455951068|FG000|Overall Study|Adverse Event|1|||
126506416|NCT04019041|455153009|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
126506417|NCT04019041|455153010|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
126506418|NCT04019041|455153011|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
126506419|NCT02540954|455153012|FG000|Overall Study|Physician Decision|3|||
126506420|NCT02540954|455153013|FG001|Overall Study|Physician Decision|1|||
126506421|NCT02540954|455153012|FG000|Overall Study|Withdrawal by Subject|6|||
126506422|NCT02540954|455153013|FG001|Overall Study|Withdrawal by Subject|5|||
126506423|NCT02540954|455153012|FG000|Overall Study|Lost to Follow-up|1|||
126506424|NCT02540954|455153013|FG001|Overall Study|Lost to Follow-up|1|||
126506425|NCT02540954|455153012|FG000|Overall Study|Adverse Event|4|||
126506426|NCT02540954|455153013|FG001|Overall Study|Adverse Event|2|||
126506427|NCT02540954|455153012|FG000|Overall Study|Death|0|||
126506428|NCT02540954|455153013|FG001|Overall Study|Death|3|||
126506429|NCT02540954|455153012|FG000|Overall Study|Treatment failure|1|||
126506430|NCT02540954|455153013|FG001|Overall Study|Treatment failure|0|||
126506431|NCT02540954|455153012|FG000|Overall Study|Other reason|4|||
126506432|NCT02540954|455153013|FG001|Overall Study|Other reason|2|||
126506433|NCT00314366|455153014|FG000|Overall Study|not treated due to patient medical condi|1|||
126506434|NCT00314366|455153015|FG001|Overall Study|not treated due to patient medical condi|0|||
126506435|NCT01393743|455153016|FG000|Core Study|Adverse Event|5|||
126506436|NCT01393743|455153017|FG001|Core Study|Adverse Event|9|||
126506437|NCT01393743|455153018|FG002|Core Study|Adverse Event|0|||
126506438|NCT01393743|455153016|FG000|Core Study|Lost to Follow-up|1|||
126506439|NCT01393743|455153017|FG001|Core Study|Lost to Follow-up|1|||
126506440|NCT01393743|455153018|FG002|Core Study|Lost to Follow-up|0|||
126506441|NCT01393743|455153016|FG000|Core Study|Participant's Choice|2|||
126506442|NCT01393743|455153017|FG001|Core Study|Participant's Choice|3|||
126506443|NCT01393743|455153018|FG002|Core Study|Participant's Choice|0|||
126506444|NCT01393743|455153016|FG000|Core Study|Inadequate therapeutic effect|2|||
126506445|NCT01393743|455153017|FG001|Core Study|Inadequate therapeutic effect|0|||
126506446|NCT01393743|455153018|FG002|Core Study|Inadequate therapeutic effect|0|||
126506447|NCT01393743|455153016|FG000|Extension Phase|Adverse Event|0|||
126506448|NCT01393743|455153017|FG001|Extension Phase|Adverse Event|0|||
126506449|NCT01393743|455153018|FG002|Extension Phase|Adverse Event|12|||
126506450|NCT01393743|455153016|FG000|Extension Phase|Lost to Follow-up|0|||
126506451|NCT01393743|455153017|FG001|Extension Phase|Lost to Follow-up|0|||
126506452|NCT01393743|455153018|FG002|Extension Phase|Lost to Follow-up|2|||
126506453|NCT01393743|455153016|FG000|Extension Phase|Participant choice|0|||
126506454|NCT01393743|455153017|FG001|Extension Phase|Participant choice|0|||
126506455|NCT01393743|455153018|FG002|Extension Phase|Participant choice|16|||
126506456|NCT01393743|455153016|FG000|Extension Phase|Inadequate therapeutic effect|0|||
126506457|NCT01393743|455153017|FG001|Extension Phase|Inadequate therapeutic effect|0|||
126506458|NCT01393743|455153018|FG002|Extension Phase|Inadequate therapeutic effect|7|||
126506459|NCT01393743|455153016|FG000|Extension Phase|Withdrawal by Subject|0|||
126506460|NCT01393743|455153017|FG001|Extension Phase|Withdrawal by Subject|0|||
126506461|NCT01393743|455153018|FG002|Extension Phase|Withdrawal by Subject|8|||
126506462|NCT01393743|455153016|FG000|Extension Phase|Pregnancy|0|||
126506463|NCT01393743|455153017|FG001|Extension Phase|Pregnancy|0|||
126506464|NCT01393743|455153018|FG002|Extension Phase|Pregnancy|1|||
126506465|NCT01393743|455153016|FG000|Extension Phase|Other|0|||
126506466|NCT01393743|455153017|FG001|Extension Phase|Other|0|||
126506467|NCT01393743|455153018|FG002|Extension Phase|Other|14|||
126506468|NCT02321462|455153022|FG000|Overall Study|Withdrawal by Subject|5|||
126506469|NCT02321462|455153023|FG001|Overall Study|Withdrawal by Subject|2|||
126506470|NCT02321462|455153022|FG000|Overall Study|Subject withdrawn before any treatment|1|||
126506471|NCT02321462|455153023|FG001|Overall Study|Subject withdrawn before any treatment|1|||
126506472|NCT00834912|455153033|FG000|Treatment Period 1|Adverse Event|0|||
126506473|NCT00834912|455153034|FG001|Treatment Period 1|Adverse Event|1|||
126506474|NCT00834912|455153035|FG002|Treatment Period 1|Adverse Event|0|||
126506475|NCT00834912|455153036|FG003|Treatment Period 1|Adverse Event|1|||
126506476|NCT00834912|455153037|FG004|Treatment Period 1|Adverse Event|0|||
126506477|NCT00834912|455153038|FG005|Treatment Period 1|Adverse Event|0|||
126506478|NCT00834912|455153033|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126506479|NCT00834912|455153034|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126506480|NCT00834912|455153035|FG002|Treatment Period 2|Withdrawal by Subject|1|||
126506481|NCT00834912|455153036|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126506482|NCT00834912|455153037|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126506483|NCT00834912|455153038|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126506484|NCT03829046|455153043|FG000|Overall Study|Withdrawal by Subject|1|||
126506485|NCT03829046|455153044|FG001|Overall Study|Withdrawal by Subject|0|||
126776921|NCT04132232|456139089|FG000|Overall Study|Lost to Follow-up|6|||
126506486|NCT00989833|455153049|FG000|Overall Study|Lost to Follow-up|0|||
126506487|NCT00989833|455153050|FG001|Overall Study|Lost to Follow-up|1|||
126506488|NCT00989833|455153051|FG002|Overall Study|Lost to Follow-up|0|||
126506489|NCT00989833|455153049|FG000|Overall Study|Protocol Violation|1|||
126506490|NCT00989833|455153050|FG001|Overall Study|Protocol Violation|2|||
126506491|NCT00989833|455153051|FG002|Overall Study|Protocol Violation|1|||
126506492|NCT00989833|455153049|FG000|Overall Study|Withdrawal by Subject|0|||
126563685|NCT00984282|455359965|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
126563686|NCT00984282|455359964|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
126563687|NCT00984282|455359965|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
126563688|NCT00984282|455359964|FG000|Open-label Treatment|Adverse Event|20|||
126563689|NCT00984282|455359965|FG001|Open-label Treatment|Adverse Event|30|||
126563690|NCT00984282|455359964|FG000|Open-label Treatment|Withdrawal by Subject|6|||
126563691|NCT00984282|455359965|FG001|Open-label Treatment|Withdrawal by Subject|21|||
126563692|NCT00984282|455359964|FG000|Open-label Treatment|Death|7|||
126563693|NCT00984282|455359965|FG001|Open-label Treatment|Death|15|||
126563694|NCT00984282|455359964|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
126563695|NCT00984282|455359965|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
126563696|NCT00984282|455359964|FG000|Open-label Treatment|Lost to Follow-up|1|||
126563697|NCT00984282|455359965|FG001|Open-label Treatment|Lost to Follow-up|1|||
126563698|NCT00984282|455359964|FG000|Open-label Treatment|Patient convenience|1|||
126563699|NCT00984282|455359965|FG001|Open-label Treatment|Patient convenience|0|||
126563700|NCT00984282|455359964|FG000|Open-label Treatment|Non-compliant with study medication|1|||
126563701|NCT00984282|455359965|FG001|Open-label Treatment|Non-compliant with study medication|0|||
126563702|NCT00984282|455359964|FG000|Open-label Treatment|Target lesion removed|0|||
126563703|NCT00984282|455359965|FG001|Open-label Treatment|Target lesion removed|1|||
126563704|NCT00984282|455359964|FG000|Open-label Treatment|Protocol driven decision point|1|||
126563705|NCT00984282|455359965|FG001|Open-label Treatment|Protocol driven decision point|1|||
126563706|NCT00984282|455359964|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
126563707|NCT00984282|455359965|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
126563708|NCT00984282|455359964|FG000|Open-label Treatment|Switched to commercial drug|6|||
126563709|NCT00984282|455359965|FG001|Open-label Treatment|Switched to commercial drug|7|||
126563710|NCT00984282|455359964|FG000|Open-label Treatment|Physician Decision|1|||
126563711|NCT00984282|455359965|FG001|Open-label Treatment|Physician Decision|0|||
126563712|NCT00984282|455359964|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
126563713|NCT00984282|455359965|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
126563714|NCT00984282|455359964|FG000|Long Term Follow-up|Death|27|||
126563715|NCT00984282|455359965|FG001|Long Term Follow-up|Death|68|||
126563716|NCT00984282|455359964|FG000|Long Term Follow-up|Lost to Follow-up|3|||
126563717|NCT00984282|455359965|FG001|Long Term Follow-up|Lost to Follow-up|6|||
126563718|NCT00984282|455359964|FG000|Long Term Follow-up|Protocol driven decision point|25|||
126563719|NCT00984282|455359965|FG001|Long Term Follow-up|Protocol driven decision point|26|||
126563720|NCT00984282|455359964|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
126563721|NCT00984282|455359965|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
126563722|NCT00984282|455359964|FG000|Long Term Follow-up|Switched to commercial drug|4|||
126563723|NCT00984282|455359965|FG001|Long Term Follow-up|Switched to commercial drug|2|||
126563724|NCT00984282|455359964|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
126563725|NCT00984282|455359965|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
126563726|NCT02223793|455359966|FG000|Overall Study|Lost to Follow-up|10|||
126563727|NCT02223793|455359967|FG001|Overall Study|Lost to Follow-up|1|||
126563728|NCT02223793|455359968|FG002|Overall Study|Lost to Follow-up|2|||
126563729|NCT02223793|455359966|FG000|Overall Study|Withdrawal by Subject|3|||
126563730|NCT02223793|455359967|FG001|Overall Study|Withdrawal by Subject|2|||
126563731|NCT02223793|455359968|FG002|Overall Study|Withdrawal by Subject|3|||
126563732|NCT02223793|455359966|FG000|Overall Study|Moved/studycenter unable to participate|4|||
126563733|NCT02223793|455359967|FG001|Overall Study|Moved/studycenter unable to participate|6|||
126563734|NCT02223793|455359968|FG002|Overall Study|Moved/studycenter unable to participate|8|||
126563735|NCT02359435|455359969|FG000|Overall Study|Lost to Follow-up|4|||
126563736|NCT02359435|455359970|FG001|Overall Study|Lost to Follow-up|4|||
126563737|NCT00315055|455359971|FG000|Overall Study|Protocol Violation|2|||
126563738|NCT00315055|455359972|FG001|Overall Study|Protocol Violation|4|||
126563739|NCT00315055|455359971|FG000|Overall Study|Lost to Follow-up|1|||
126563740|NCT00315055|455359972|FG001|Overall Study|Lost to Follow-up|1|||
126563741|NCT01289119|455359977|FG000|Overall Study|Adverse Event|2|||
126563742|NCT01289119|455359978|FG001|Overall Study|Adverse Event|1|||
126563743|NCT01289119|455359979|FG002|Overall Study|Adverse Event|0|||
126563744|NCT01289119|455359980|FG003|Overall Study|Adverse Event|2|||
126563745|NCT01289119|455359981|FG004|Overall Study|Adverse Event|1|||
126563746|NCT01289119|455359982|FG005|Overall Study|Adverse Event|0|||
126563747|NCT01289119|455359977|FG000|Overall Study|Major Protocol Deviation|2|||
126563748|NCT01289119|455359978|FG001|Overall Study|Major Protocol Deviation|1|||
126563749|NCT01289119|455359979|FG002|Overall Study|Major Protocol Deviation|3|||
126563750|NCT01289119|455359980|FG003|Overall Study|Major Protocol Deviation|0|||
126563751|NCT01289119|455359981|FG004|Overall Study|Major Protocol Deviation|2|||
126563752|NCT01289119|455359982|FG005|Overall Study|Major Protocol Deviation|1|||
126563753|NCT01289119|455359977|FG000|Overall Study|Lost to Follow-up|0|||
126563754|NCT01289119|455359978|FG001|Overall Study|Lost to Follow-up|3|||
126563755|NCT01289119|455359979|FG002|Overall Study|Lost to Follow-up|0|||
126563756|NCT01289119|455359980|FG003|Overall Study|Lost to Follow-up|0|||
126563757|NCT01289119|455359981|FG004|Overall Study|Lost to Follow-up|0|||
126563758|NCT01289119|455359982|FG005|Overall Study|Lost to Follow-up|1|||
126563759|NCT01289119|455359977|FG000|Overall Study|Withdrawal by Subject|4|||
126563760|NCT01289119|455359978|FG001|Overall Study|Withdrawal by Subject|2|||
126563761|NCT01289119|455359979|FG002|Overall Study|Withdrawal by Subject|4|||
126563762|NCT01289119|455359980|FG003|Overall Study|Withdrawal by Subject|3|||
126563763|NCT01289119|455359981|FG004|Overall Study|Withdrawal by Subject|1|||
126563764|NCT01289119|455359982|FG005|Overall Study|Withdrawal by Subject|1|||
126563765|NCT01289119|455359977|FG000|Overall Study|Pregnancy|0|||
126563766|NCT01289119|455359978|FG001|Overall Study|Pregnancy|1|||
126563767|NCT01289119|455359979|FG002|Overall Study|Pregnancy|0|||
126563768|NCT01289119|455359980|FG003|Overall Study|Pregnancy|0|||
126563769|NCT01289119|455359981|FG004|Overall Study|Pregnancy|0|||
126563770|NCT01289119|455359982|FG005|Overall Study|Pregnancy|0|||
126563771|NCT01289119|455359977|FG000|Overall Study|Lack of Efficacy|0|||
126563772|NCT01289119|455359978|FG001|Overall Study|Lack of Efficacy|1|||
126563773|NCT01289119|455359979|FG002|Overall Study|Lack of Efficacy|1|||
126563774|NCT01289119|455359980|FG003|Overall Study|Lack of Efficacy|1|||
126563775|NCT01289119|455359981|FG004|Overall Study|Lack of Efficacy|1|||
126563776|NCT01289119|455359982|FG005|Overall Study|Lack of Efficacy|1|||
126563777|NCT01289119|455359977|FG000|Overall Study|Other|1|||
126563778|NCT01289119|455359978|FG001|Overall Study|Other|0|||
126563779|NCT01289119|455359979|FG002|Overall Study|Other|1|||
126563780|NCT01289119|455359980|FG003|Overall Study|Other|0|||
126563781|NCT01289119|455359981|FG004|Overall Study|Other|0|||
126563782|NCT01289119|455359982|FG005|Overall Study|Other|0|||
126563783|NCT01704846|455359983|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126563784|NCT01704846|455359984|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126563785|NCT01649791|455359987|FG000|Overall Study|Disease Progression|2|||
126563786|NCT01649791|455359987|FG000|Overall Study|Adverse Event|1|||
126563787|NCT00991276|455359991|FG000|First Intervention Period|Adverse Event|0|||
126563788|NCT00991276|455359992|FG001|First Intervention Period|Adverse Event|1|||
126563789|NCT00991276|455359993|FG002|First Intervention Period|Adverse Event|0|||
126563790|NCT00991276|455359994|FG003|First Intervention Period|Adverse Event|1|||
126563791|NCT00991276|455359995|FG004|First Intervention Period|Adverse Event|0|||
126563792|NCT00991276|455359996|FG005|First Intervention Period|Adverse Event|0|||
126563793|NCT00991276|455359991|FG000|First Intervention Period|Protocol Violation|0|||
126563794|NCT00991276|455359992|FG001|First Intervention Period|Protocol Violation|0|||
126563795|NCT00991276|455359993|FG002|First Intervention Period|Protocol Violation|0|||
126563796|NCT00991276|455359994|FG003|First Intervention Period|Protocol Violation|0|||
126563797|NCT00991276|455359995|FG004|First Intervention Period|Protocol Violation|2|||
126563798|NCT00991276|455359996|FG005|First Intervention Period|Protocol Violation|0|||
126563799|NCT00991276|455359991|FG000|First Intervention Period|Insufficient clinical response|0|||
126563800|NCT00991276|455359992|FG001|First Intervention Period|Insufficient clinical response|0|||
126563801|NCT00991276|455359993|FG002|First Intervention Period|Insufficient clinical response|0|||
126563802|NCT00991276|455359994|FG003|First Intervention Period|Insufficient clinical response|0|||
126563803|NCT00991276|455359995|FG004|First Intervention Period|Insufficient clinical response|1|||
126563804|NCT00991276|455359996|FG005|First Intervention Period|Insufficient clinical response|0|||
126563805|NCT00991276|455359991|FG000|First Intervention Period|Other|0|||
126563806|NCT00991276|455359992|FG001|First Intervention Period|Other|0|||
126563807|NCT00991276|455359993|FG002|First Intervention Period|Other|0|||
126563808|NCT00991276|455359994|FG003|First Intervention Period|Other|1|||
126563809|NCT00991276|455359995|FG004|First Intervention Period|Other|1|||
126563810|NCT00991276|455359996|FG005|First Intervention Period|Other|0|||
126563811|NCT00991276|455359991|FG000|First Intervention Period|Withdrawal by Subject|0|||
126563812|NCT00991276|455359992|FG001|First Intervention Period|Withdrawal by Subject|1|||
126563813|NCT00991276|455359993|FG002|First Intervention Period|Withdrawal by Subject|0|||
126563814|NCT00991276|455359994|FG003|First Intervention Period|Withdrawal by Subject|1|||
126563815|NCT00991276|455359995|FG004|First Intervention Period|Withdrawal by Subject|0|||
126563816|NCT00991276|455359996|FG005|First Intervention Period|Withdrawal by Subject|1|||
126563817|NCT00991276|455359991|FG000|First Intervention Period|Lost to Follow-up|0|||
126563818|NCT00991276|455359992|FG001|First Intervention Period|Lost to Follow-up|1|||
126563819|NCT00991276|455359993|FG002|First Intervention Period|Lost to Follow-up|0|||
126563820|NCT00991276|455359994|FG003|First Intervention Period|Lost to Follow-up|1|||
126563821|NCT00991276|455359995|FG004|First Intervention Period|Lost to Follow-up|0|||
126563822|NCT00991276|455359996|FG005|First Intervention Period|Lost to Follow-up|0|||
126563823|NCT00991276|455359991|FG000|Second Intervention Period|Adverse Event|0|||
126563824|NCT00991276|455359992|FG001|Second Intervention Period|Adverse Event|2|||
126563825|NCT00991276|455359993|FG002|Second Intervention Period|Adverse Event|0|||
126563826|NCT00991276|455359994|FG003|Second Intervention Period|Adverse Event|1|||
126563827|NCT00991276|455359995|FG004|Second Intervention Period|Adverse Event|1|||
126563828|NCT00991276|455359996|FG005|Second Intervention Period|Adverse Event|0|||
126563829|NCT00991276|455359991|FG000|Second Intervention Period|Protocol Violation|1|||
126563830|NCT00991276|455359992|FG001|Second Intervention Period|Protocol Violation|0|||
126563831|NCT00991276|455359993|FG002|Second Intervention Period|Protocol Violation|0|||
126563832|NCT00991276|455359994|FG003|Second Intervention Period|Protocol Violation|0|||
126727157|NCT00125190|455951068|FG000|Overall Study|Other|1|||
126563833|NCT00991276|455359995|FG004|Second Intervention Period|Protocol Violation|0|||
126563834|NCT00991276|455359996|FG005|Second Intervention Period|Protocol Violation|0|||
126563835|NCT00991276|455359991|FG000|Second Intervention Period|Other|0|||
126563836|NCT00991276|455359992|FG001|Second Intervention Period|Other|0|||
126563837|NCT00991276|455359993|FG002|Second Intervention Period|Other|0|||
126563838|NCT00991276|455359994|FG003|Second Intervention Period|Other|1|||
126563839|NCT00991276|455359995|FG004|Second Intervention Period|Other|0|||
126563840|NCT00991276|455359996|FG005|Second Intervention Period|Other|1|||
126563841|NCT00991276|455359991|FG000|Third Intervention Period|Protocol Violation|1|||
126563842|NCT00991276|455359992|FG001|Third Intervention Period|Protocol Violation|0|||
126563843|NCT00991276|455359993|FG002|Third Intervention Period|Protocol Violation|0|||
126563844|NCT00991276|455359994|FG003|Third Intervention Period|Protocol Violation|0|||
126563845|NCT00991276|455359995|FG004|Third Intervention Period|Protocol Violation|0|||
126563846|NCT00991276|455359996|FG005|Third Intervention Period|Protocol Violation|0|||
126563847|NCT00991276|455359991|FG000|Third Intervention Period|Other|0|||
126563848|NCT00991276|455359992|FG001|Third Intervention Period|Other|0|||
126563849|NCT00991276|455359993|FG002|Third Intervention Period|Other|0|||
126563850|NCT00991276|455359994|FG003|Third Intervention Period|Other|0|||
126563851|NCT00991276|455359995|FG004|Third Intervention Period|Other|0|||
126563852|NCT00991276|455359996|FG005|Third Intervention Period|Other|1|||
126563853|NCT00991276|455359991|FG000|Third Intervention Period|Adverse Event|0|||
126563854|NCT00991276|455359992|FG001|Third Intervention Period|Adverse Event|0|||
126563855|NCT00991276|455359993|FG002|Third Intervention Period|Adverse Event|1|||
126563856|NCT00991276|455359994|FG003|Third Intervention Period|Adverse Event|0|||
126563857|NCT00991276|455359995|FG004|Third Intervention Period|Adverse Event|0|||
126563858|NCT00991276|455359996|FG005|Third Intervention Period|Adverse Event|0|||
126563859|NCT00991276|455359991|FG000|Third Intervention Period|Withdrawal by Subject|0|||
126563860|NCT00991276|455359992|FG001|Third Intervention Period|Withdrawal by Subject|0|||
126563861|NCT00991276|455359993|FG002|Third Intervention Period|Withdrawal by Subject|0|||
126563862|NCT00991276|455359994|FG003|Third Intervention Period|Withdrawal by Subject|1|||
126563863|NCT00991276|455359995|FG004|Third Intervention Period|Withdrawal by Subject|0|||
126563864|NCT00991276|455359996|FG005|Third Intervention Period|Withdrawal by Subject|0|||
126563865|NCT00711646|455359999|FG000|Overall Study|Adverse Event|6|||
126563866|NCT00711646|455360000|FG001|Overall Study|Adverse Event|1|||
126563867|NCT00711646|455359999|FG000|Overall Study|Withdrawal by Subject|4|||
126563868|NCT00711646|455360000|FG001|Overall Study|Withdrawal by Subject|0|||
126563869|NCT00711646|455359999|FG000|Overall Study|Protocol Violation|0|||
126563870|NCT00711646|455360000|FG001|Overall Study|Protocol Violation|1|||
126563871|NCT00711646|455359999|FG000|Overall Study|Lost to Follow-up|1|||
126563872|NCT00711646|455360000|FG001|Overall Study|Lost to Follow-up|0|||
126563873|NCT00711646|455359999|FG000|Overall Study|administrative decision|0|||
126563874|NCT00711646|455360000|FG001|Overall Study|administrative decision|1|||
126563875|NCT00711646|455359999|FG000|Overall Study|patient non-compliance|1|||
126563876|NCT00711646|455360000|FG001|Overall Study|patient non-compliance|0|||
126563877|NCT03467724|455360001|FG000|Overall Study|Lost to Follow-up|5|||
126563878|NCT03467724|455360001|FG000|Overall Study|Withdrawal by Subject|1|||
126563879|NCT03467724|455360001|FG000|Overall Study|Protocol Violation|1|||
126563880|NCT03467724|455360001|FG000|Overall Study|Adverse Event|1|||
126563881|NCT01149681|455360002|FG000|Overall Study|Withdrawal by Subject|7|||
126563882|NCT01149681|455360002|FG000|Overall Study|Progressive disease|1|||
126563883|NCT01149681|455360002|FG000|Overall Study|Physician Decision|2|||
126563884|NCT01149681|455360002|FG000|Overall Study|adverse events nonrelated study drug|2|||
126563885|NCT01908634|455360004|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
126563886|NCT01908634|455360004|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
126563887|NCT04176458|455360005|FG000|Overall Study|Covid 19|4|||
126563888|NCT01570751|455360006|FG000|Period A (16 Weeks)|Protocol Violation|1|||
126563889|NCT01570751|455360007|FG001|Period A (16 Weeks)|Protocol Violation|1|||
126563890|NCT01570751|455360006|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
126563891|NCT01570751|455360007|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
126563892|NCT01570751|455360006|FG000|Period A (16 Weeks)|Unclassified|2|||
126563893|NCT01570751|455360007|FG001|Period A (16 Weeks)|Unclassified|3|||
126563894|NCT01570751|455360006|FG000|Period B (16 Weeks)|Adverse Event|1|||
126563895|NCT01570751|455360007|FG001|Period B (16 Weeks)|Adverse Event|0|||
126563896|NCT01570751|455360006|FG000|Period B (16 Weeks)|Protocol Violation|0|||
126563897|NCT01570751|455360007|FG001|Period B (16 Weeks)|Protocol Violation|1|||
126563898|NCT00930813|455360008|FG000|Overall Study|Death|4|||
126563899|NCT00930813|455360009|FG001|Overall Study|Death|5|||
126563900|NCT00930813|455360008|FG000|Overall Study|Withdrawal by Subject|2|||
126563901|NCT00930813|455360009|FG001|Overall Study|Withdrawal by Subject|5|||
126563902|NCT00930813|455360008|FG000|Overall Study|Lost to Follow-up|2|||
126563903|NCT00930813|455360009|FG001|Overall Study|Lost to Follow-up|4|||
126563904|NCT05790408|455360014|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
126563905|NCT02145182|455360016|FG000|Overall Study|Adverse Event|4|||
126563906|NCT02145182|455360017|FG001|Overall Study|Adverse Event|1|||
126563907|NCT02145182|455360016|FG000|Overall Study|Death|7|||
126563908|NCT02145182|455360017|FG001|Overall Study|Death|7|||
126506493|NCT00989833|455153050|FG001|Overall Study|Withdrawal by Subject|0|||
126506494|NCT00989833|455153051|FG002|Overall Study|Withdrawal by Subject|1|||
126506495|NCT00989833|455153049|FG000|Overall Study|Incorrectly randomized|1|||
126506496|NCT00989833|455153050|FG001|Overall Study|Incorrectly randomized|0|||
126506497|NCT00989833|455153051|FG002|Overall Study|Incorrectly randomized|0|||
126506498|NCT00244712|455153054|FG000|Overall Study|Adverse Event|20|||
126506499|NCT00244712|455153055|FG001|Overall Study|Adverse Event|21|||
126506500|NCT00244712|455153054|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
126506501|NCT00244712|455153055|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
126506502|NCT00244712|455153054|FG000|Overall Study|Lack of Compliance|10|||
126506503|NCT00244712|455153055|FG001|Overall Study|Lack of Compliance|11|||
126506504|NCT00244712|455153054|FG000|Overall Study|Lost to Follow-up|45|||
126506505|NCT00244712|455153055|FG001|Overall Study|Lost to Follow-up|52|||
126506506|NCT00244712|455153054|FG000|Overall Study|Withdrawal by Subject|13|||
126506507|NCT00244712|455153055|FG001|Overall Study|Withdrawal by Subject|23|||
126506508|NCT00244712|455153054|FG000|Overall Study|Protocol Violation, disease progression|13|||
126506509|NCT00244712|455153055|FG001|Overall Study|Protocol Violation, disease progression|11|||
126506510|NCT00500370|455153056|FG000|Overall Study|Adverse Event|9|||
126506511|NCT00500370|455153057|FG001|Overall Study|Adverse Event|3|||
126506512|NCT00500370|455153056|FG000|Overall Study|Lost to Follow-up|10|||
126506513|NCT00500370|455153057|FG001|Overall Study|Lost to Follow-up|10|||
126506514|NCT00500370|455153056|FG000|Overall Study|Protocol Violation|2|||
126506515|NCT00500370|455153057|FG001|Overall Study|Protocol Violation|4|||
126506516|NCT00500370|455153056|FG000|Overall Study|Sponsor Decision|2|||
126506517|NCT00500370|455153057|FG001|Overall Study|Sponsor Decision|0|||
126506518|NCT00500370|455153056|FG000|Overall Study|Subject Decision|10|||
126506519|NCT00500370|455153057|FG001|Overall Study|Subject Decision|17|||
126563909|NCT02145182|455360016|FG000|Overall Study|Lost to Follow-up|2|||
126563910|NCT02145182|455360017|FG001|Overall Study|Lost to Follow-up|2|||
126563911|NCT02145182|455360016|FG000|Overall Study|Pre-transplant Withdrawal|0|||
126563912|NCT02145182|455360017|FG001|Overall Study|Pre-transplant Withdrawal|2|||
126563913|NCT02145182|455360016|FG000|Overall Study|Withdrawal by Subject|5|||
126563914|NCT02145182|455360017|FG001|Overall Study|Withdrawal by Subject|4|||
126563915|NCT00588666|455360019|FG000|Overall Study|Adverse Event|4|||
126563916|NCT03999554|455360020|FG000|Overall Study|Lost to Follow-up|4|||
126563917|NCT03999554|455360021|FG001|Overall Study|Lost to Follow-up|5|||
126563918|NCT03999554|455360022|FG002|Overall Study|Lost to Follow-up|4|||
126563919|NCT03999554|455360023|FG003|Overall Study|Lost to Follow-up|5|||
126563920|NCT03999554|455360024|FG004|Overall Study|Lost to Follow-up|8|||
126563921|NCT03999554|455360020|FG000|Overall Study|Protocol Violation|0|||
126563922|NCT03999554|455360021|FG001|Overall Study|Protocol Violation|0|||
126563923|NCT03999554|455360022|FG002|Overall Study|Protocol Violation|5|||
126563924|NCT03999554|455360023|FG003|Overall Study|Protocol Violation|0|||
126563925|NCT03999554|455360024|FG004|Overall Study|Protocol Violation|0|||
126563926|NCT03999554|455360020|FG000|Overall Study|Pregnancy|0|||
126563927|NCT03999554|455360021|FG001|Overall Study|Pregnancy|0|||
126563928|NCT03999554|455360022|FG002|Overall Study|Pregnancy|1|||
126563929|NCT03999554|455360023|FG003|Overall Study|Pregnancy|0|||
126563930|NCT03999554|455360024|FG004|Overall Study|Pregnancy|0|||
126563931|NCT03999554|455360020|FG000|Overall Study|Withdrawal by Subject|2|||
126563932|NCT03999554|455360021|FG001|Overall Study|Withdrawal by Subject|2|||
126563933|NCT03999554|455360022|FG002|Overall Study|Withdrawal by Subject|2|||
126563934|NCT03999554|455360023|FG003|Overall Study|Withdrawal by Subject|1|||
126563935|NCT03999554|455360024|FG004|Overall Study|Withdrawal by Subject|1|||
126563936|NCT03999554|455360020|FG000|Overall Study|failure to comply with protocol requirements|0|||
126563937|NCT03999554|455360021|FG001|Overall Study|failure to comply with protocol requirements|0|||
126563938|NCT03999554|455360022|FG002|Overall Study|failure to comply with protocol requirements|0|||
126563939|NCT03999554|455360023|FG003|Overall Study|failure to comply with protocol requirements|1|||
126563940|NCT03999554|455360024|FG004|Overall Study|failure to comply with protocol requirements|0|||
126563941|NCT00742274|455360027|FG000|Overall Study|Death|1|||
126563942|NCT00742274|455360028|FG001|Overall Study|Death|0|||
126563943|NCT00742274|455360027|FG000|Overall Study|Withdrawal by Subject|1|||
126563944|NCT00742274|455360028|FG001|Overall Study|Withdrawal by Subject|2|||
126563945|NCT00742274|455360027|FG000|Overall Study|Removed for medical reasons|1|||
126563946|NCT00742274|455360028|FG001|Overall Study|Removed for medical reasons|1|||
126563947|NCT02365298|455360029|FG000|Period 2|incorrect Rx dispensed|1|||
126563948|NCT02365298|455360030|FG001|Period 2|incorrect Rx dispensed|0|||
126563949|NCT02365298|455360029|FG000|Period 2|Discontinued at request of Sponsor|1|||
126563950|NCT02365298|455360030|FG001|Period 2|Discontinued at request of Sponsor|0|||
126563951|NCT02365298|455360029|FG000|Period 2|Test Article longer available|0|||
126563952|NCT02365298|455360030|FG001|Period 2|Test Article longer available|1|||
126563953|NCT02365298|455360029|FG000|Period 2|Protocol Violation|0|||
126563954|NCT02365298|455360030|FG001|Period 2|Protocol Violation|1|||
126563955|NCT01878890|455360031|FG000|Overall Study|Protocol Violation|0|||
126563956|NCT01878890|455360032|FG001|Overall Study|Protocol Violation|1|||
126563957|NCT01878890|455360033|FG002|Overall Study|Protocol Violation|0|||
126563958|NCT01878890|455360034|FG003|Overall Study|Protocol Violation|0|||
126563959|NCT03404843|455360035|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
126563960|NCT03404843|455360036|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
126563961|NCT00320489|455360037|FG000|Overall Study|Adverse Event|26|||
126563962|NCT00320489|455360038|FG001|Overall Study|Adverse Event|25|||
126563963|NCT00320489|455360037|FG000|Overall Study|Clinical Relapse|26|||
126563964|NCT00320489|455360038|FG001|Overall Study|Clinical Relapse|20|||
126563965|NCT00320489|455360037|FG000|Overall Study|Death|0|||
126563966|NCT00320489|455360038|FG001|Overall Study|Death|2|||
126563967|NCT00320489|455360037|FG000|Overall Study|Entry Criteria Exclusion|2|||
126563968|NCT00320489|455360038|FG001|Overall Study|Entry Criteria Exclusion|4|||
126563969|NCT00320489|455360037|FG000|Overall Study|Lack of Efficacy|16|||
126563970|NCT00320489|455360038|FG001|Overall Study|Lack of Efficacy|7|||
126563971|NCT00320489|455360037|FG000|Overall Study|Lost to Follow-up|21|||
126563972|NCT00320489|455360038|FG001|Overall Study|Lost to Follow-up|22|||
126563973|NCT00320489|455360037|FG000|Overall Study|Physician Decision|8|||
126563974|NCT00320489|455360038|FG001|Overall Study|Physician Decision|8|||
126563975|NCT00320489|455360037|FG000|Overall Study|Protocol Violation|4|||
126563976|NCT00320489|455360038|FG001|Overall Study|Protocol Violation|4|||
126563977|NCT00320489|455360037|FG000|Overall Study|Sponsor Decision|3|||
126563978|NCT00320489|455360038|FG001|Overall Study|Sponsor Decision|3|||
126563979|NCT00320489|455360037|FG000|Overall Study|Withdrawal by Subject|39|||
126563980|NCT00320489|455360038|FG001|Overall Study|Withdrawal by Subject|41|||
126563981|NCT03441984|455360039|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126563982|NCT03441984|455360040|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126563983|NCT03441984|455360041|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
126563984|NCT03441984|455360042|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126563985|NCT03441984|455360043|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126563986|NCT03441984|455360044|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126563987|NCT03441984|455360045|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126563988|NCT03441984|455360046|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126563989|NCT03441984|455360047|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126563990|NCT03441984|455360048|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126563991|NCT03441984|455360049|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126563992|NCT03441984|455360050|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
126563993|NCT04088188|455360053|FG000|Overall Study|Withdrawal by Subject|2|||
126563994|NCT04088188|455360054|FG001|Overall Study|Withdrawal by Subject|0|||
126563995|NCT04088188|455360053|FG000|Overall Study|Adverse Event|2|||
126563996|NCT04088188|455360054|FG001|Overall Study|Adverse Event|0|||
126563997|NCT00580801|455360057|FG000|Overall Study|Physician Decision|1|||
126563998|NCT00580801|455360058|FG001|Overall Study|Physician Decision|0|||
126563999|NCT00580801|455360059|FG002|Overall Study|Physician Decision|0|||
126564000|NCT00580801|455360057|FG000|Overall Study|Adverse Event|2|||
126564001|NCT00580801|455360058|FG001|Overall Study|Adverse Event|0|||
126564002|NCT00580801|455360059|FG002|Overall Study|Adverse Event|0|||
126564003|NCT00580801|455360057|FG000|Overall Study|Lost to Follow-up|2|||
126564004|NCT00580801|455360058|FG001|Overall Study|Lost to Follow-up|0|||
126564005|NCT00580801|455360059|FG002|Overall Study|Lost to Follow-up|0|||
126564006|NCT00580801|455360057|FG000|Overall Study|Reached a virologic endpoint|0|||
126564007|NCT00580801|455360058|FG001|Overall Study|Reached a virologic endpoint|1|||
126564008|NCT00580801|455360059|FG002|Overall Study|Reached a virologic endpoint|2|||
126564009|NCT00580801|455360057|FG000|Overall Study|Participant non-compliant|0|||
126564010|NCT00580801|455360058|FG001|Overall Study|Participant non-compliant|0|||
126564011|NCT00580801|455360059|FG002|Overall Study|Participant non-compliant|1|||
126564012|NCT00580801|455360057|FG000|Overall Study|Travel|1|||
126564013|NCT00580801|455360058|FG001|Overall Study|Travel|0|||
126564014|NCT00580801|455360059|FG002|Overall Study|Travel|0|||
126564015|NCT00502593|455360060|FG000|Overall Study|Withdrawn unspecified reason|1|||
126564016|NCT00502593|455360061|FG001|Overall Study|Withdrawn unspecified reason|1|||
126564017|NCT00502593|455360062|FG002|Overall Study|Withdrawn unspecified reason|3|||
126564018|NCT00502593|455360063|FG003|Overall Study|Withdrawn unspecified reason|1|||
126564019|NCT00502593|455360064|FG004|Overall Study|Withdrawn unspecified reason|2|||
126564020|NCT00502593|455360065|FG005|Overall Study|Withdrawn unspecified reason|0|||
126564021|NCT00502593|455360066|FG006|Overall Study|Withdrawn unspecified reason|2|||
126564022|NCT00502593|455360067|FG007|Overall Study|Withdrawn unspecified reason|0|||
126564023|NCT00502593|455360068|FG008|Overall Study|Withdrawn unspecified reason|0|||
126564024|NCT00502593|455360069|FG009|Overall Study|Withdrawn unspecified reason|0|||
126564025|NCT00502593|455360070|FG010|Overall Study|Withdrawn unspecified reason|0|||
126564026|NCT00502593|455360071|FG011|Overall Study|Withdrawn unspecified reason|0|||
126564027|NCT00502593|455360060|FG000|Overall Study|Withdrawal by Subject|0|||
126564028|NCT00502593|455360061|FG001|Overall Study|Withdrawal by Subject|0|||
126564029|NCT00502593|455360062|FG002|Overall Study|Withdrawal by Subject|6|||
126564030|NCT00502593|455360063|FG003|Overall Study|Withdrawal by Subject|2|||
126564031|NCT00502593|455360064|FG004|Overall Study|Withdrawal by Subject|2|||
126564032|NCT00502593|455360065|FG005|Overall Study|Withdrawal by Subject|0|||
126564033|NCT00502593|455360066|FG006|Overall Study|Withdrawal by Subject|3|||
126564034|NCT00502593|455360067|FG007|Overall Study|Withdrawal by Subject|0|||
126564035|NCT00502593|455360068|FG008|Overall Study|Withdrawal by Subject|3|||
126564036|NCT00502593|455360069|FG009|Overall Study|Withdrawal by Subject|0|||
126564037|NCT00502593|455360070|FG010|Overall Study|Withdrawal by Subject|1|||
126564038|NCT00502593|455360071|FG011|Overall Study|Withdrawal by Subject|0|||
126564039|NCT00502593|455360060|FG000|Overall Study|Lost to Follow-up|2|||
126564040|NCT00502593|455360061|FG001|Overall Study|Lost to Follow-up|1|||
126564041|NCT00502593|455360062|FG002|Overall Study|Lost to Follow-up|1|||
126564042|NCT00502593|455360063|FG003|Overall Study|Lost to Follow-up|1|||
126564043|NCT00502593|455360064|FG004|Overall Study|Lost to Follow-up|0|||
126564044|NCT00502593|455360065|FG005|Overall Study|Lost to Follow-up|0|||
126564045|NCT00502593|455360066|FG006|Overall Study|Lost to Follow-up|0|||
126564046|NCT00502593|455360067|FG007|Overall Study|Lost to Follow-up|0|||
126564047|NCT00502593|455360068|FG008|Overall Study|Lost to Follow-up|3|||
126564048|NCT00502593|455360069|FG009|Overall Study|Lost to Follow-up|0|||
126564049|NCT00502593|455360070|FG010|Overall Study|Lost to Follow-up|1|||
126564050|NCT00502593|455360071|FG011|Overall Study|Lost to Follow-up|0|||
126564051|NCT01664104|455360072|FG000|Overall Study|Adverse Event|6|||
126564052|NCT01664104|455360072|FG000|Overall Study|Lack of Efficacy|2|||
126564053|NCT01664104|455360072|FG000|Overall Study|Withdrawal by Subject|1|||
126564054|NCT01664104|455360072|FG000|Overall Study|Lost to Follow-up|4|||
126564055|NCT01664104|455360072|FG000|Overall Study|Other|1|||
126564056|NCT01664104|455360072|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
126564057|NCT03761784|455360073|FG000|Overall Study|Adverse Event|4|||
126506520|NCT00574405|455154509|FG000|Overall Study|Withdrawal by Subject|3|||
126506521|NCT00574405|455154510|FG001|Overall Study|Withdrawal by Subject|2|||
126506522|NCT05084053|455154513|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
126506523|NCT05084053|455154514|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
126506524|NCT05084053|455154515|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
126506525|NCT05084053|455154516|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
126506526|NCT05084053|455154513|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
126506527|NCT05084053|455154514|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
126506528|NCT05084053|455154515|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
126506529|NCT05084053|455154516|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
126506530|NCT05084053|455154513|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
126506531|NCT05084053|455154514|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
126506532|NCT05084053|455154515|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
126506533|NCT05084053|455154516|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
126506534|NCT01920932|455154517|FG000|Overall Study|Death|1|||
126506535|NCT01920932|455154517|FG000|Overall Study|Withdrawal of consent|1|||
126506536|NCT00071812|455154518|FG000|24-Week Double-Blind Period|Adverse Event|2|||
126506537|NCT00071812|455154519|FG001|24-Week Double-Blind Period|Adverse Event|3|||
126506538|NCT00071812|455154520|FG002|24-Week Double-Blind Period|Adverse Event|4|||
126506539|NCT00071812|455154521|FG003|24-Week Double-Blind Period|Adverse Event|4|||
126506540|NCT00071812|455154518|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
126506541|NCT00071812|455154519|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
126506542|NCT00071812|455154520|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
126506543|NCT00071812|455154521|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
126506544|NCT00071812|455154518|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
126506545|NCT00071812|455154519|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
126506546|NCT00071812|455154520|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
126506547|NCT00071812|455154521|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
126506548|NCT00071812|455154518|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
126506549|NCT00071812|455154519|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
126506550|NCT00071812|455154520|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
126506551|NCT00071812|455154521|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
126506552|NCT00071812|455154518|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
126506553|NCT00071812|455154519|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
126506554|NCT00071812|455154520|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
126506555|NCT00071812|455154521|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
126506556|NCT00071812|455154518|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
126564058|NCT03761784|455360074|FG001|Overall Study|Adverse Event|0|||
126564059|NCT03761784|455360073|FG000|Overall Study|Lost to Follow-up|10|||
126564060|NCT03761784|455360074|FG001|Overall Study|Lost to Follow-up|7|||
126564061|NCT03761784|455360073|FG000|Overall Study|Pregnancy|1|||
126564062|NCT03761784|455360074|FG001|Overall Study|Pregnancy|0|||
126506557|NCT00071812|455154519|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
126506558|NCT00071812|455154520|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
126506559|NCT00071812|455154521|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
126506560|NCT00071812|455154518|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
126506561|NCT00071812|455154519|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
126506562|NCT00071812|455154520|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
126564063|NCT03761784|455360073|FG000|Overall Study|Protocol Violation|2|||
126564064|NCT03761784|455360074|FG001|Overall Study|Protocol Violation|0|||
126564065|NCT03761784|455360073|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
126564066|NCT03761784|455360074|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
126564067|NCT03761784|455360073|FG000|Overall Study|Withdrawal by Subject|9|||
126564068|NCT03761784|455360074|FG001|Overall Study|Withdrawal by Subject|4|||
126564069|NCT03761784|455360073|FG000|Overall Study|Physician Decision|1|||
126564070|NCT03761784|455360074|FG001|Overall Study|Physician Decision|0|||
126564071|NCT03761784|455360073|FG000|Overall Study|Other Than Specified|1|||
126564072|NCT03761784|455360074|FG001|Overall Study|Other Than Specified|0|||
126564073|NCT00197236|455360079|FG000|Overall Study|Adverse Event|1|||
126564074|NCT00197236|455360080|FG001|Overall Study|Adverse Event|0|||
126564075|NCT00197236|455360081|FG002|Overall Study|Adverse Event|1|||
126506563|NCT00071812|455154521|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
126506564|NCT00071812|455154518|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
126506565|NCT00071812|455154519|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
126506566|NCT00071812|455154520|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
126506567|NCT00071812|455154521|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
126506568|NCT00071812|455154518|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
126506569|NCT00071812|455154519|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
126506570|NCT00071812|455154520|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
126506571|NCT00071812|455154521|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
126506572|NCT00071812|455154518|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
126506573|NCT00071812|455154519|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
126506574|NCT00071812|455154520|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
126506575|NCT00071812|455154521|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
126506576|NCT00697346|455154522|FG000|Overall Study|Adverse Event|4|||
126506577|NCT00697346|455154523|FG001|Overall Study|Adverse Event|5|||
126506578|NCT00697346|455154524|FG002|Overall Study|Adverse Event|0|||
126506579|NCT00697346|455154522|FG000|Overall Study|Progressive Disease|19|||
126506580|NCT00697346|455154523|FG001|Overall Study|Progressive Disease|18|||
126506581|NCT00697346|455154524|FG002|Overall Study|Progressive Disease|0|||
126506582|NCT00697346|455154522|FG000|Overall Study|Symptomatic Deterioration|0|||
126506583|NCT00697346|455154523|FG001|Overall Study|Symptomatic Deterioration|1|||
126506584|NCT00697346|455154524|FG002|Overall Study|Symptomatic Deterioration|0|||
126506585|NCT00697346|455154522|FG000|Overall Study|Withdrawal by Subject|2|||
126506586|NCT00697346|455154523|FG001|Overall Study|Withdrawal by Subject|2|||
126506587|NCT00697346|455154524|FG002|Overall Study|Withdrawal by Subject|0|||
126506588|NCT00697346|455154522|FG000|Overall Study|Reason not Specified|3|||
126506589|NCT00697346|455154523|FG001|Overall Study|Reason not Specified|0|||
126506590|NCT00697346|455154524|FG002|Overall Study|Reason not Specified|1|||
126506591|NCT00348556|455154529|FG000|Overall Study|Adverse Event|1|||
126506592|NCT00333229|455154532|FG000|Overall Study|Lack of Efficacy|0|||
126506593|NCT00333229|455154533|FG001|Overall Study|Lack of Efficacy|1|||
126506594|NCT00240071|455154534|FG000|Overall Study|Withdrawal by Subject|3|||
126506595|NCT01944059|455154535|FG000|Overall Study|Lost to Follow-up|1|||
126506596|NCT01944059|455154535|FG000|Overall Study|Physician Decision|3|||
126506597|NCT01944059|455154535|FG000|Overall Study|Withdrawal by Subject|1|||
126506598|NCT01944059|455154535|FG000|Overall Study|Adverse Event|2|||
126506599|NCT00463060|455154546|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
126506600|NCT00463060|455154546|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
126506601|NCT01802775|455154549|FG000|Overall Study|Death|0|||
126506602|NCT01802775|455154550|FG001|Overall Study|Death|3|||
126506603|NCT01802775|455154549|FG000|Overall Study|Reason not provided|0|||
126506604|NCT01802775|455154550|FG001|Overall Study|Reason not provided|1|||
126506605|NCT01802775|455154549|FG000|Overall Study|Physician Decision|1|||
126506606|NCT01802775|455154550|FG001|Overall Study|Physician Decision|0|||
126506607|NCT01802775|455154549|FG000|Overall Study|Adverse Event|1|||
126506608|NCT01802775|455154550|FG001|Overall Study|Adverse Event|1|||
126506609|NCT01802775|455154549|FG000|Overall Study|Withdrawal by Subject|3|||
126506610|NCT01802775|455154550|FG001|Overall Study|Withdrawal by Subject|5|||
126506611|NCT01802775|455154549|FG000|Overall Study|Lost to Follow-up|1|||
126506612|NCT01802775|455154550|FG001|Overall Study|Lost to Follow-up|2|||
126506613|NCT05923229|455154555|FG000|Overall Study|Withdrawal by Subject|3|||
126506614|NCT05923229|455154556|FG001|Overall Study|Withdrawal by Subject|0|||
126564076|NCT00197236|455360079|FG000|Overall Study|Lost to Follow-up|5|||
126506615|NCT05923229|455154555|FG000|Overall Study|Health related|2|||
126506616|NCT05923229|455154556|FG001|Overall Study|Health related|1|||
126506617|NCT03064126|455154557|FG000|Overall Study|Death|40|||
126506618|NCT03064126|455154558|FG001|Overall Study|Death|16|||
126506619|NCT03064126|455154559|FG002|Overall Study|Death|4|||
126506620|NCT03064126|455154560|FG003|Overall Study|Death|2|||
126506621|NCT03064126|455154557|FG000|Overall Study|Withdrawal by Subject|17|||
126506622|NCT03064126|455154558|FG001|Overall Study|Withdrawal by Subject|9|||
126506623|NCT03064126|455154559|FG002|Overall Study|Withdrawal by Subject|0|||
126506624|NCT03064126|455154560|FG003|Overall Study|Withdrawal by Subject|2|||
126564077|NCT00197236|455360080|FG001|Overall Study|Lost to Follow-up|14|||
126564078|NCT00197236|455360081|FG002|Overall Study|Lost to Follow-up|6|||
126564079|NCT00197236|455360079|FG000|Overall Study|Protocol Violation|0|||
126564080|NCT00197236|455360080|FG001|Overall Study|Protocol Violation|0|||
126564081|NCT00197236|455360081|FG002|Overall Study|Protocol Violation|1|||
126564082|NCT00197236|455360079|FG000|Overall Study|Withdrawal by Subject|7|||
126564083|NCT00197236|455360080|FG001|Overall Study|Withdrawal by Subject|3|||
126564084|NCT00197236|455360081|FG002|Overall Study|Withdrawal by Subject|11|||
126564085|NCT00197236|455360079|FG000|Overall Study|Study drug/medication expiration|1|||
126564086|NCT00197236|455360080|FG001|Overall Study|Study drug/medication expiration|0|||
126564087|NCT00197236|455360081|FG002|Overall Study|Study drug/medication expiration|3|||
126564088|NCT00197236|455360079|FG000|Overall Study|Returned out of specified time window|0|||
126564089|NCT00197236|455360080|FG001|Overall Study|Returned out of specified time window|0|||
126564090|NCT00197236|455360081|FG002|Overall Study|Returned out of specified time window|1|||
126564091|NCT00746330|455360082|FG000|Period 1|Abnormal test procedure result|0|||
126564092|NCT00746330|455360083|FG001|Period 1|Abnormal test procedure result|0|||
126564093|NCT00746330|455360084|FG002|Period 1|Abnormal test procedure result|1|||
126564094|NCT00746330|455360085|FG003|Period 1|Abnormal test procedure result|0|||
126564095|NCT01981850|455360086|FG000|Main Phase Stage 1|Death|2|||
126564096|NCT01981850|455360087|FG001|Main Phase Stage 1|Death|0|||
126564097|NCT01981850|455360088|FG002|Main Phase Stage 1|Death|0|||
126564098|NCT01981850|455360089|FG003|Main Phase Stage 1|Death|0|||
126564099|NCT01981850|455360090|FG004|Main Phase Stage 1|Death|0|||
126564100|NCT01981850|455360091|FG005|Main Phase Stage 1|Death|0|||
126564101|NCT01981850|455360092|FG006|Main Phase Stage 1|Death|0|||
126564102|NCT01981850|455360093|FG007|Main Phase Stage 1|Death|0|||
126564103|NCT01981850|455360094|FG008|Main Phase Stage 1|Death|0|||
126564104|NCT01981850|455360095|FG009|Main Phase Stage 1|Death|0|||
126564105|NCT01981850|455360086|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
126564106|NCT01981850|455360087|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126564107|NCT01981850|455360088|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126564108|NCT01981850|455360089|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126564109|NCT01981850|455360090|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126564110|NCT01981850|455360091|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126564111|NCT01981850|455360092|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126564112|NCT01981850|455360093|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126564113|NCT01981850|455360094|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126564114|NCT01981850|455360095|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
126564115|NCT01981850|455360086|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
126564116|NCT01981850|455360087|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
126564117|NCT01981850|455360088|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
126564118|NCT01981850|455360089|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
126564119|NCT01981850|455360090|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
126564120|NCT01981850|455360091|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
126564121|NCT01981850|455360092|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
126564122|NCT01981850|455360093|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
126564123|NCT01981850|455360094|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
126564124|NCT01981850|455360095|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
126564125|NCT01981850|455360086|FG000|Main Phase Stage 1|Various reasons|0|||
126564126|NCT01981850|455360087|FG001|Main Phase Stage 1|Various reasons|0|||
126564127|NCT01981850|455360088|FG002|Main Phase Stage 1|Various reasons|2|||
126564128|NCT01981850|455360089|FG003|Main Phase Stage 1|Various reasons|0|||
126564129|NCT01981850|455360090|FG004|Main Phase Stage 1|Various reasons|0|||
126564130|NCT01981850|455360091|FG005|Main Phase Stage 1|Various reasons|0|||
126564131|NCT01981850|455360092|FG006|Main Phase Stage 1|Various reasons|0|||
126564132|NCT01981850|455360093|FG007|Main Phase Stage 1|Various reasons|0|||
126564133|NCT01981850|455360094|FG008|Main Phase Stage 1|Various reasons|0|||
126564134|NCT01981850|455360095|FG009|Main Phase Stage 1|Various reasons|0|||
126564135|NCT01981850|455360086|FG000|Main Phase Stage 2|Adverse Event|0|||
126564136|NCT01981850|455360087|FG001|Main Phase Stage 2|Adverse Event|0|||
126564137|NCT01981850|455360088|FG002|Main Phase Stage 2|Adverse Event|0|||
126564138|NCT01981850|455360089|FG003|Main Phase Stage 2|Adverse Event|0|||
126564139|NCT01981850|455360090|FG004|Main Phase Stage 2|Adverse Event|6|||
126564140|NCT01981850|455360091|FG005|Main Phase Stage 2|Adverse Event|5|||
126564141|NCT01981850|455360092|FG006|Main Phase Stage 2|Adverse Event|7|||
126564142|NCT01981850|455360093|FG007|Main Phase Stage 2|Adverse Event|0|||
126564143|NCT01981850|455360094|FG008|Main Phase Stage 2|Adverse Event|0|||
126564144|NCT01981850|455360095|FG009|Main Phase Stage 2|Adverse Event|0|||
126564145|NCT01981850|455360086|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126564146|NCT01981850|455360087|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126564147|NCT01981850|455360088|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126564148|NCT01981850|455360089|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126564149|NCT01981850|455360090|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
126564150|NCT01981850|455360091|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
126564151|NCT01981850|455360092|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
126564152|NCT01981850|455360093|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126564153|NCT01981850|455360094|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126564154|NCT01981850|455360095|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
126564155|NCT01981850|455360086|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
126564156|NCT01981850|455360087|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
126564157|NCT01981850|455360088|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
126506625|NCT03064126|455154557|FG000|Overall Study|Lost to Follow-up|7|||
126506626|NCT03064126|455154558|FG001|Overall Study|Lost to Follow-up|3|||
126506627|NCT03064126|455154559|FG002|Overall Study|Lost to Follow-up|0|||
126506628|NCT03064126|455154560|FG003|Overall Study|Lost to Follow-up|0|||
126506629|NCT03064126|455154557|FG000|Overall Study|Adverse Event|2|||
126506630|NCT03064126|455154558|FG001|Overall Study|Adverse Event|0|||
126506631|NCT03064126|455154559|FG002|Overall Study|Adverse Event|0|||
126506632|NCT03064126|455154560|FG003|Overall Study|Adverse Event|0|||
126506633|NCT03064126|455154557|FG000|Overall Study|Physician Decision|3|||
126506634|NCT03064126|455154558|FG001|Overall Study|Physician Decision|0|||
126506635|NCT03064126|455154559|FG002|Overall Study|Physician Decision|0|||
126506636|NCT03064126|455154560|FG003|Overall Study|Physician Decision|0|||
126506637|NCT03064126|455154557|FG000|Overall Study|Other reason for early termination|3|||
126506638|NCT03064126|455154558|FG001|Overall Study|Other reason for early termination|2|||
126506639|NCT03064126|455154559|FG002|Overall Study|Other reason for early termination|0|||
126506640|NCT03064126|455154560|FG003|Overall Study|Other reason for early termination|0|||
126506641|NCT03064126|455154557|FG000|Overall Study|Missed Visit|3|||
126506642|NCT03064126|455154558|FG001|Overall Study|Missed Visit|1|||
126506643|NCT03064126|455154559|FG002|Overall Study|Missed Visit|0|||
126506644|NCT03064126|455154560|FG003|Overall Study|Missed Visit|0|||
126506645|NCT05288556|455154564|FG000|Overall Study|Protocol Violation|1|||
126506646|NCT05288556|455154564|FG000|Overall Study|Withdrawal by Subject|1|||
126506647|NCT02775344|455154566|FG000|Overall Study|No ovarian cyst identified|3|||
126506648|NCT02775344|455154567|FG001|Overall Study|No ovarian cyst identified|2|||
126506649|NCT04627064|455154579|FG000|Overall Study|Progressive disease|8|||
126506650|NCT04627064|455154580|FG001|Overall Study|Progressive disease|0|||
126506651|NCT04627064|455154579|FG000|Overall Study|Withdrawal by Subject|2|||
126506652|NCT04627064|455154580|FG001|Overall Study|Withdrawal by Subject|0|||
126506653|NCT04627064|455154579|FG000|Overall Study|Physician Decision|1|||
126506654|NCT04627064|455154580|FG001|Overall Study|Physician Decision|0|||
126506655|NCT02018458|455154581|FG000|Overall Study|Death|4|||
126506656|NCT03491150|455154584|FG000|Overall Study|Adverse Event|1|||
126506657|NCT03491150|455154585|FG001|Overall Study|Adverse Event|0|||
126506658|NCT03491150|455154584|FG000|Overall Study|Study Terminated by Sponsor|74|||
126506659|NCT03491150|455154585|FG001|Overall Study|Study Terminated by Sponsor|70|||
126506660|NCT03491150|455154584|FG000|Overall Study|Other|0|||
126506661|NCT03491150|455154585|FG001|Overall Study|Other|1|||
126506662|NCT03491150|455154584|FG000|Overall Study|Withdrawal by Subject|1|||
126506663|NCT03491150|455154585|FG001|Overall Study|Withdrawal by Subject|2|||
126506664|NCT01800916|455154586|FG000|Test Period 1 (1 Week)|Convex product user|0|||
126506665|NCT01800916|455154587|FG001|Test Period 1 (1 Week)|Convex product user|0|||
126506666|NCT01800916|455154588|FG002|Test Period 1 (1 Week)|Convex product user|0|||
126506667|NCT01800916|455154589|FG003|Test Period 1 (1 Week)|Convex product user|1|||
126506668|NCT01800916|455154590|FG004|Test Period 1 (1 Week)|Convex product user|0|||
126506669|NCT01800916|455154591|FG005|Test Period 1 (1 Week)|Convex product user|0|||
126506670|NCT01800916|455154592|FG006|Test Period 1 (1 Week)|Convex product user|0|||
126506671|NCT01800916|455154593|FG007|Test Period 1 (1 Week)|Convex product user|0|||
126506672|NCT01800916|455154594|FG008|Test Period 1 (1 Week)|Convex product user|0|||
126506673|NCT01800916|455154586|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
126506674|NCT01800916|455154587|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
126506675|NCT01800916|455154588|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
126506676|NCT01800916|455154589|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
126506677|NCT01800916|455154590|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
126506678|NCT01800916|455154591|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
126506679|NCT01800916|455154592|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
126506680|NCT01800916|455154593|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
126506681|NCT01800916|455154594|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
126506682|NCT00727714|455154595|FG000|Overall Study|Lost to Follow-up|2|||
126564158|NCT01981850|455360089|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
126564159|NCT01981850|455360090|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
126564160|NCT01981850|455360091|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
126564161|NCT01981850|455360092|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
126564162|NCT01981850|455360093|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
126506683|NCT00325234|455154596|FG000|Overall Study|Adverse Event|10|||
126506684|NCT00325234|455154597|FG001|Overall Study|Adverse Event|7|||
126506685|NCT00325234|455154596|FG000|Overall Study|Death due to Study Disease|1|||
126506686|NCT00325234|455154597|FG001|Overall Study|Death due to Study Disease|0|||
126506687|NCT00325234|455154596|FG000|Overall Study|Entry Criteria Not Met|1|||
126564163|NCT01981850|455360094|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
126564164|NCT01981850|455360095|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
126564165|NCT01981850|455360086|FG000|Main Phase Stage 2|Various reasons|0|||
126506688|NCT00325234|455154597|FG001|Overall Study|Entry Criteria Not Met|2|||
126506689|NCT00325234|455154596|FG000|Overall Study|Subject Decision|6|||
126506690|NCT00325234|455154597|FG001|Overall Study|Subject Decision|8|||
126506691|NCT00325234|455154596|FG000|Overall Study|Physician Decision|17|||
126506692|NCT00325234|455154597|FG001|Overall Study|Physician Decision|12|||
126506693|NCT00325234|455154596|FG000|Overall Study|Progressive Disease|34|||
126506694|NCT00325234|455154597|FG001|Overall Study|Progressive Disease|37|||
126506695|NCT01234467|455154598|FG000|Overall Study|Adverse Event|3|||
126506696|NCT01234467|455154598|FG000|Overall Study|Death|2|||
126506697|NCT01234467|455154598|FG000|Overall Study|Withdrawal by Subject|2|||
126506698|NCT01234467|455154598|FG000|Overall Study|Disease Progression|2|||
126506699|NCT01234467|455154598|FG000|Overall Study|Clinical deterioration|1|||
126506700|NCT01234467|455154598|FG000|Overall Study|Physician Decision|1|||
126506701|NCT01234467|455154598|FG000|Overall Study|Other complicating disease (stroke)|1|||
126506702|NCT01479621|455154599|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
126506703|NCT01479621|455154600|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
126506704|NCT01479621|455154601|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
126506705|NCT01479621|455154602|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
126506706|NCT01479621|455154603|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
126506707|NCT01479621|455154604|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
126506708|NCT01479621|455154605|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
126506709|NCT01479621|455154599|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
126506710|NCT01479621|455154600|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
126506711|NCT01479621|455154601|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
126506712|NCT01479621|455154602|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
126506713|NCT01479621|455154603|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
126506714|NCT01479621|455154604|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
126506715|NCT01479621|455154605|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
126506716|NCT01479621|455154599|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
126506717|NCT01479621|455154600|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126506718|NCT01479621|455154601|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126506719|NCT01479621|455154602|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126506720|NCT01479621|455154603|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126506721|NCT01479621|455154604|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126506722|NCT01479621|455154605|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
126506723|NCT01479621|455154599|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
126506724|NCT01479621|455154600|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
126506725|NCT01479621|455154601|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
126506726|NCT01479621|455154602|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
126506727|NCT01479621|455154603|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
126506728|NCT01479621|455154604|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
126506729|NCT01479621|455154605|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
126506730|NCT01479621|455154599|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
126506731|NCT01479621|455154600|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
126506732|NCT01479621|455154601|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
126506733|NCT01479621|455154602|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
126506734|NCT01479621|455154603|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
126506735|NCT01479621|455154604|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
126506736|NCT01479621|455154605|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
126506737|NCT01479621|455154599|FG000|Treatment Period|Adverse Event|0|||
126506738|NCT01479621|455154600|FG001|Treatment Period|Adverse Event|0|||
126506739|NCT01479621|455154601|FG002|Treatment Period|Adverse Event|0|||
126506740|NCT01479621|455154602|FG003|Treatment Period|Adverse Event|0|||
126506741|NCT01479621|455154603|FG004|Treatment Period|Adverse Event|1|||
126506742|NCT01479621|455154604|FG005|Treatment Period|Adverse Event|2|||
126506743|NCT01479621|455154605|FG006|Treatment Period|Adverse Event|2|||
126506744|NCT01479621|455154599|FG000|Treatment Period|Withdrawal by Subject|0|||
126506745|NCT01479621|455154600|FG001|Treatment Period|Withdrawal by Subject|4|||
126506746|NCT01479621|455154601|FG002|Treatment Period|Withdrawal by Subject|2|||
126506747|NCT01479621|455154602|FG003|Treatment Period|Withdrawal by Subject|2|||
126506748|NCT01479621|455154603|FG004|Treatment Period|Withdrawal by Subject|5|||
126564166|NCT01981850|455360087|FG001|Main Phase Stage 2|Various reasons|0|||
126564167|NCT01981850|455360088|FG002|Main Phase Stage 2|Various reasons|0|||
126506749|NCT01479621|455154604|FG005|Treatment Period|Withdrawal by Subject|5|||
126506750|NCT01479621|455154605|FG006|Treatment Period|Withdrawal by Subject|1|||
126506751|NCT01479621|455154599|FG000|Treatment Period|Physician Decision|0|||
126506752|NCT01479621|455154600|FG001|Treatment Period|Physician Decision|0|||
126506753|NCT01479621|455154601|FG002|Treatment Period|Physician Decision|0|||
126506754|NCT01479621|455154602|FG003|Treatment Period|Physician Decision|0|||
126506755|NCT01479621|455154603|FG004|Treatment Period|Physician Decision|1|||
126506756|NCT01479621|455154604|FG005|Treatment Period|Physician Decision|1|||
126506757|NCT01479621|455154605|FG006|Treatment Period|Physician Decision|0|||
126506758|NCT01479621|455154599|FG000|Treatment Period|Non-compliance to study drug|0|||
126506759|NCT01479621|455154600|FG001|Treatment Period|Non-compliance to study drug|1|||
126506760|NCT01479621|455154601|FG002|Treatment Period|Non-compliance to study drug|0|||
126506761|NCT01479621|455154602|FG003|Treatment Period|Non-compliance to study drug|0|||
126506762|NCT01479621|455154603|FG004|Treatment Period|Non-compliance to study drug|0|||
126506763|NCT01479621|455154604|FG005|Treatment Period|Non-compliance to study drug|0|||
126506764|NCT01479621|455154605|FG006|Treatment Period|Non-compliance to study drug|1|||
126506765|NCT01479621|455154599|FG000|Treatment Period|Protocol Violation|0|||
126506766|NCT01479621|455154600|FG001|Treatment Period|Protocol Violation|9|||
126506767|NCT01479621|455154601|FG002|Treatment Period|Protocol Violation|6|||
126506768|NCT01479621|455154602|FG003|Treatment Period|Protocol Violation|5|||
126506769|NCT01479621|455154603|FG004|Treatment Period|Protocol Violation|2|||
126506770|NCT01479621|455154604|FG005|Treatment Period|Protocol Violation|10|||
126506771|NCT01479621|455154605|FG006|Treatment Period|Protocol Violation|6|||
126506772|NCT01479621|455154599|FG000|Treatment Period|Pregnancy|0|||
126506773|NCT01479621|455154600|FG001|Treatment Period|Pregnancy|0|||
126506774|NCT01479621|455154601|FG002|Treatment Period|Pregnancy|2|||
126506775|NCT01479621|455154602|FG003|Treatment Period|Pregnancy|0|||
126506776|NCT01479621|455154603|FG004|Treatment Period|Pregnancy|0|||
126506777|NCT01479621|455154604|FG005|Treatment Period|Pregnancy|0|||
126506778|NCT01479621|455154605|FG006|Treatment Period|Pregnancy|0|||
126506779|NCT01479621|455154599|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
126506780|NCT01479621|455154600|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
126506781|NCT01479621|455154601|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
126506782|NCT01479621|455154602|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
126506783|NCT01479621|455154603|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
126506784|NCT01479621|455154604|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
126506785|NCT01479621|455154605|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
126506786|NCT01479621|455154599|FG000|Treatment Period|Lost to Follow-up|0|||
126506787|NCT01479621|455154600|FG001|Treatment Period|Lost to Follow-up|0|||
126506788|NCT01479621|455154601|FG002|Treatment Period|Lost to Follow-up|1|||
126506789|NCT01479621|455154602|FG003|Treatment Period|Lost to Follow-up|0|||
126506790|NCT01479621|455154603|FG004|Treatment Period|Lost to Follow-up|2|||
126506791|NCT01479621|455154604|FG005|Treatment Period|Lost to Follow-up|2|||
126506792|NCT01479621|455154605|FG006|Treatment Period|Lost to Follow-up|1|||
126506793|NCT01479621|455154599|FG000|Treatment Period|Met stopping criteria|0|||
126506794|NCT01479621|455154600|FG001|Treatment Period|Met stopping criteria|8|||
126506795|NCT01479621|455154601|FG002|Treatment Period|Met stopping criteria|7|||
126506796|NCT01479621|455154602|FG003|Treatment Period|Met stopping criteria|4|||
126506797|NCT01479621|455154603|FG004|Treatment Period|Met stopping criteria|9|||
126506798|NCT01479621|455154604|FG005|Treatment Period|Met stopping criteria|20|||
126506799|NCT01479621|455154605|FG006|Treatment Period|Met stopping criteria|6|||
126506800|NCT00486265|455154606|FG000|Overall Study|Adverse Event|1|||
126506801|NCT00486265|455154606|FG000|Overall Study|Lack of Efficacy|8|||
126506802|NCT01452412|455154607|FG000|Overall Study|Withdrawal by Subject|15|||
126506803|NCT01452412|455154608|FG001|Overall Study|Withdrawal by Subject|11|||
126506804|NCT01452412|455154607|FG000|Overall Study|Adverse Event|4|||
126506805|NCT01452412|455154608|FG001|Overall Study|Adverse Event|3|||
126506806|NCT01452412|455154607|FG000|Overall Study|Lost to Follow-up|5|||
126506807|NCT01452412|455154608|FG001|Overall Study|Lost to Follow-up|3|||
126506808|NCT01452412|455154607|FG000|Overall Study|Death|1|||
126506809|NCT01452412|455154608|FG001|Overall Study|Death|0|||
126506810|NCT01452412|455154607|FG000|Overall Study|Initiated dialysis|1|||
126506811|NCT01452412|455154608|FG001|Overall Study|Initiated dialysis|0|||
126506812|NCT01452412|455154607|FG000|Overall Study|Other|2|||
126506813|NCT01452412|455154608|FG001|Overall Study|Other|0|||
126506814|NCT03013543|455154611|FG000|Overall Study|Withdrawal by Subject|0|||
126506815|NCT03013543|455154612|FG001|Overall Study|Withdrawal by Subject|2|||
126506816|NCT03013543|455154613|FG002|Overall Study|Withdrawal by Subject|0|||
126506817|NCT03013543|455154614|FG003|Overall Study|Withdrawal by Subject|5|||
126506818|NCT03013543|455154615|FG004|Overall Study|Withdrawal by Subject|6|||
126506819|NCT03013543|455154616|FG005|Overall Study|Withdrawal by Subject|2|||
126506820|NCT03013543|455154617|FG006|Overall Study|Withdrawal by Subject|3|||
126506821|NCT03013543|455154618|FG007|Overall Study|Withdrawal by Subject|1|||
126506822|NCT03013543|455154619|FG008|Overall Study|Withdrawal by Subject|0|||
126506823|NCT03013543|455154620|FG009|Overall Study|Withdrawal by Subject|4|||
126506824|NCT03013543|455154611|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
126506825|NCT03013543|455154612|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
126506826|NCT03013543|455154613|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
126506827|NCT03013543|455154614|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
126506828|NCT03013543|455154615|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
126506829|NCT03013543|455154616|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
126564168|NCT01981850|455360089|FG003|Main Phase Stage 2|Various reasons|0|||
126564169|NCT01981850|455360090|FG004|Main Phase Stage 2|Various reasons|2|||
126564170|NCT01981850|455360091|FG005|Main Phase Stage 2|Various reasons|0|||
126564171|NCT01981850|455360092|FG006|Main Phase Stage 2|Various reasons|1|||
126564172|NCT01981850|455360093|FG007|Main Phase Stage 2|Various reasons|0|||
126564173|NCT01981850|455360094|FG008|Main Phase Stage 2|Various reasons|0|||
126564174|NCT01981850|455360095|FG009|Main Phase Stage 2|Various reasons|0|||
126564175|NCT01981850|455360086|FG000|Main Phase Stage 2|Progressive Disease|0|||
126564176|NCT01981850|455360087|FG001|Main Phase Stage 2|Progressive Disease|0|||
126564177|NCT01981850|455360088|FG002|Main Phase Stage 2|Progressive Disease|0|||
126564178|NCT01981850|455360089|FG003|Main Phase Stage 2|Progressive Disease|0|||
126564179|NCT01981850|455360090|FG004|Main Phase Stage 2|Progressive Disease|0|||
126564180|NCT01981850|455360091|FG005|Main Phase Stage 2|Progressive Disease|6|||
126564181|NCT01981850|455360092|FG006|Main Phase Stage 2|Progressive Disease|6|||
126564182|NCT01981850|455360093|FG007|Main Phase Stage 2|Progressive Disease|0|||
126564183|NCT01981850|455360094|FG008|Main Phase Stage 2|Progressive Disease|0|||
126564184|NCT01981850|455360095|FG009|Main Phase Stage 2|Progressive Disease|0|||
126564185|NCT01981850|455360086|FG000|Open Label Extension (OLE)|Adverse Event|0|||
126564186|NCT01981850|455360087|FG001|Open Label Extension (OLE)|Adverse Event|0|||
126564187|NCT01981850|455360088|FG002|Open Label Extension (OLE)|Adverse Event|0|||
126564188|NCT01981850|455360089|FG003|Open Label Extension (OLE)|Adverse Event|0|||
126564189|NCT01981850|455360090|FG004|Open Label Extension (OLE)|Adverse Event|0|||
126564190|NCT01981850|455360091|FG005|Open Label Extension (OLE)|Adverse Event|0|||
126564191|NCT01981850|455360092|FG006|Open Label Extension (OLE)|Adverse Event|0|||
126564192|NCT01981850|455360093|FG007|Open Label Extension (OLE)|Adverse Event|2|||
126564193|NCT01981850|455360094|FG008|Open Label Extension (OLE)|Adverse Event|1|||
126564194|NCT01981850|455360095|FG009|Open Label Extension (OLE)|Adverse Event|8|||
126564195|NCT01981850|455360086|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
126506830|NCT03013543|455154617|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
126506831|NCT03013543|455154618|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
126506832|NCT03013543|455154619|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
126506833|NCT03013543|455154620|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
126506834|NCT03013543|455154611|FG000|Overall Study|Other|0|||
126506835|NCT03013543|455154612|FG001|Overall Study|Other|0|||
126506836|NCT03013543|455154613|FG002|Overall Study|Other|2|||
126506837|NCT03013543|455154614|FG003|Overall Study|Other|0|||
126506838|NCT03013543|455154615|FG004|Overall Study|Other|2|||
126506839|NCT03013543|455154616|FG005|Overall Study|Other|0|||
126506840|NCT03013543|455154617|FG006|Overall Study|Other|0|||
126506841|NCT03013543|455154618|FG007|Overall Study|Other|0|||
126506842|NCT03013543|455154619|FG008|Overall Study|Other|1|||
126506843|NCT03013543|455154620|FG009|Overall Study|Other|0|||
126506844|NCT03013543|455154611|FG000|Overall Study|Adverse Event|0|||
126506845|NCT03013543|455154612|FG001|Overall Study|Adverse Event|0|||
126506846|NCT03013543|455154613|FG002|Overall Study|Adverse Event|0|||
126506847|NCT03013543|455154614|FG003|Overall Study|Adverse Event|3|||
126506848|NCT03013543|455154615|FG004|Overall Study|Adverse Event|2|||
126506849|NCT03013543|455154616|FG005|Overall Study|Adverse Event|1|||
126506850|NCT03013543|455154617|FG006|Overall Study|Adverse Event|3|||
126506851|NCT03013543|455154618|FG007|Overall Study|Adverse Event|8|||
126506852|NCT03013543|455154619|FG008|Overall Study|Adverse Event|0|||
126506853|NCT03013543|455154620|FG009|Overall Study|Adverse Event|2|||
126506854|NCT03013543|455154611|FG000|Overall Study|Death|0|||
126506855|NCT03013543|455154612|FG001|Overall Study|Death|0|||
126506856|NCT03013543|455154613|FG002|Overall Study|Death|0|||
126506857|NCT03013543|455154614|FG003|Overall Study|Death|1|||
126506858|NCT03013543|455154615|FG004|Overall Study|Death|0|||
126506859|NCT03013543|455154616|FG005|Overall Study|Death|0|||
126506860|NCT03013543|455154617|FG006|Overall Study|Death|0|||
126506861|NCT03013543|455154618|FG007|Overall Study|Death|0|||
126506862|NCT03013543|455154619|FG008|Overall Study|Death|0|||
126506863|NCT03013543|455154620|FG009|Overall Study|Death|0|||
126506864|NCT03013543|455154611|FG000|Overall Study|Lack of Efficacy|0|||
126506865|NCT03013543|455154612|FG001|Overall Study|Lack of Efficacy|0|||
126506866|NCT03013543|455154613|FG002|Overall Study|Lack of Efficacy|0|||
126564196|NCT01981850|455360087|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
126564197|NCT01981850|455360088|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
126564198|NCT01981850|455360089|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
126564199|NCT01981850|455360090|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
126506867|NCT03013543|455154614|FG003|Overall Study|Lack of Efficacy|1|||
126506868|NCT03013543|455154615|FG004|Overall Study|Lack of Efficacy|0|||
126506869|NCT03013543|455154616|FG005|Overall Study|Lack of Efficacy|0|||
126506870|NCT03013543|455154617|FG006|Overall Study|Lack of Efficacy|0|||
126506871|NCT03013543|455154618|FG007|Overall Study|Lack of Efficacy|0|||
126506872|NCT03013543|455154619|FG008|Overall Study|Lack of Efficacy|0|||
126506873|NCT03013543|455154620|FG009|Overall Study|Lack of Efficacy|0|||
126506874|NCT03013543|455154611|FG000|Overall Study|Lost to Follow-up|0|||
126506875|NCT03013543|455154612|FG001|Overall Study|Lost to Follow-up|0|||
126506876|NCT03013543|455154613|FG002|Overall Study|Lost to Follow-up|0|||
126506877|NCT03013543|455154614|FG003|Overall Study|Lost to Follow-up|1|||
126506878|NCT03013543|455154615|FG004|Overall Study|Lost to Follow-up|0|||
126506879|NCT03013543|455154616|FG005|Overall Study|Lost to Follow-up|0|||
126506880|NCT03013543|455154617|FG006|Overall Study|Lost to Follow-up|1|||
126506881|NCT03013543|455154618|FG007|Overall Study|Lost to Follow-up|0|||
126506882|NCT03013543|455154619|FG008|Overall Study|Lost to Follow-up|0|||
126506883|NCT03013543|455154620|FG009|Overall Study|Lost to Follow-up|2|||
126506884|NCT03013543|455154611|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126506885|NCT03013543|455154612|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126506886|NCT03013543|455154613|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126506887|NCT03013543|455154614|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126506888|NCT03013543|455154615|FG004|Overall Study|Non-Compliance With Study Drug|0|||
126506889|NCT03013543|455154616|FG005|Overall Study|Non-Compliance With Study Drug|0|||
126506890|NCT03013543|455154617|FG006|Overall Study|Non-Compliance With Study Drug|0|||
126506891|NCT03013543|455154618|FG007|Overall Study|Non-Compliance With Study Drug|0|||
126506892|NCT03013543|455154619|FG008|Overall Study|Non-Compliance With Study Drug|1|||
126506893|NCT03013543|455154620|FG009|Overall Study|Non-Compliance With Study Drug|0|||
126506894|NCT03013543|455154611|FG000|Overall Study|Physician Decision|0|||
126506895|NCT03013543|455154612|FG001|Overall Study|Physician Decision|0|||
126506896|NCT03013543|455154613|FG002|Overall Study|Physician Decision|0|||
126506897|NCT03013543|455154614|FG003|Overall Study|Physician Decision|0|||
126506898|NCT03013543|455154615|FG004|Overall Study|Physician Decision|1|||
126506899|NCT03013543|455154616|FG005|Overall Study|Physician Decision|0|||
126506900|NCT03013543|455154617|FG006|Overall Study|Physician Decision|0|||
126506901|NCT03013543|455154618|FG007|Overall Study|Physician Decision|0|||
126506902|NCT03013543|455154619|FG008|Overall Study|Physician Decision|0|||
126506903|NCT03013543|455154620|FG009|Overall Study|Physician Decision|0|||
126506904|NCT03013543|455154611|FG000|Overall Study|Protocol Violation|0|||
126506905|NCT03013543|455154612|FG001|Overall Study|Protocol Violation|0|||
126506906|NCT03013543|455154613|FG002|Overall Study|Protocol Violation|0|||
126506907|NCT03013543|455154614|FG003|Overall Study|Protocol Violation|0|||
126506908|NCT03013543|455154615|FG004|Overall Study|Protocol Violation|0|||
126506909|NCT03013543|455154616|FG005|Overall Study|Protocol Violation|0|||
126506910|NCT03013543|455154617|FG006|Overall Study|Protocol Violation|0|||
126506911|NCT03013543|455154618|FG007|Overall Study|Protocol Violation|0|||
126506912|NCT03013543|455154619|FG008|Overall Study|Protocol Violation|0|||
126506913|NCT03013543|455154620|FG009|Overall Study|Protocol Violation|1|||
126506914|NCT04225923|455154621|FG000|Overall Study|Protocol Violation|1|||
126506915|NCT04225923|455154622|FG001|Overall Study|Protocol Violation|0|||
126506916|NCT04225923|455154623|FG002|Overall Study|Protocol Violation|1|||
126506917|NCT04225923|455154621|FG000|Overall Study|Withdrawal by Subject|4|||
126506918|NCT04225923|455154622|FG001|Overall Study|Withdrawal by Subject|1|||
126506919|NCT04225923|455154623|FG002|Overall Study|Withdrawal by Subject|3|||
126506920|NCT04225923|455154621|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
126506921|NCT04225923|455154622|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
126506922|NCT04225923|455154623|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
126506923|NCT01417481|455154624|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
126506924|NCT01417481|455154625|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
126506925|NCT03029624|455154626|FG000|Overall Study|Adverse Event|1|||
126506926|NCT03029624|455154626|FG000|Overall Study|Withdrawal by Subject|1|||
126506927|NCT03029624|455154626|FG000|Overall Study|Lack of Efficacy|1|||
126506928|NCT03029624|455154626|FG000|Overall Study|MRI need|2|||
126506929|NCT04116710|455154627|FG000|Overall Study|Death|4|||
126506930|NCT04116710|455154628|FG001|Overall Study|Death|6|||
126506931|NCT04116710|455154629|FG002|Overall Study|Death|3|||
126506932|NCT04116710|455154630|FG003|Overall Study|Death|1|||
126506933|NCT04116710|455154627|FG000|Overall Study|Withdrawal by Subject|0|||
126506934|NCT04116710|455154628|FG001|Overall Study|Withdrawal by Subject|0|||
126506935|NCT04116710|455154629|FG002|Overall Study|Withdrawal by Subject|0|||
126506936|NCT04116710|455154630|FG003|Overall Study|Withdrawal by Subject|1|||
126506937|NCT01537783|455154635|FG000|Overall Study|Lost to Follow-up|11|||
126506938|NCT01537783|455154636|FG001|Overall Study|Lost to Follow-up|2|||
126506939|NCT02281552|455154639|FG000|Overall Study|Medication error|1|||
126506940|NCT02281552|455154640|FG001|Overall Study|Medication error|0|||
126506941|NCT02281552|455154639|FG000|Overall Study|Insufficient clinical response|0|||
126506942|NCT02281552|455154640|FG001|Overall Study|Insufficient clinical response|1|||
126506943|NCT02281552|455154639|FG000|Overall Study|Adverse Event|3|||
126506944|NCT02281552|455154640|FG001|Overall Study|Adverse Event|9|||
126506945|NCT01224639|455154641|FG000|Overall Study|Withdrawal by Subject|0|||
126506946|NCT01224639|455154642|FG001|Overall Study|Withdrawal by Subject|0|||
126506947|NCT01224639|455154643|FG002|Overall Study|Withdrawal by Subject|0|||
126506948|NCT01224639|455154644|FG003|Overall Study|Withdrawal by Subject|0|||
126506949|NCT01224639|455154645|FG004|Overall Study|Withdrawal by Subject|2|||
126506950|NCT01224639|455154646|FG005|Overall Study|Withdrawal by Subject|0|||
126506951|NCT01224639|455154647|FG006|Overall Study|Withdrawal by Subject|1|||
126506952|NCT01224639|455154648|FG007|Overall Study|Withdrawal by Subject|1|||
126506953|NCT01224639|455154641|FG000|Overall Study|Adverse Event|0|||
126506954|NCT01224639|455154642|FG001|Overall Study|Adverse Event|0|||
126506955|NCT01224639|455154643|FG002|Overall Study|Adverse Event|0|||
126506956|NCT01224639|455154644|FG003|Overall Study|Adverse Event|0|||
126506957|NCT01224639|455154645|FG004|Overall Study|Adverse Event|0|||
126506958|NCT01224639|455154646|FG005|Overall Study|Adverse Event|0|||
126506959|NCT01224639|455154647|FG006|Overall Study|Adverse Event|0|||
126506960|NCT01224639|455154648|FG007|Overall Study|Adverse Event|1|||
126506961|NCT03044197|455154649|FG000|Overall Study|Withdrawal by Subject|3|||
126506962|NCT03044197|455154650|FG001|Overall Study|Withdrawal by Subject|1|||
126506963|NCT01282424|455154661|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
126506964|NCT01282424|455154661|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
126506965|NCT01282424|455154661|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
126506966|NCT01282424|455154661|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
126506967|NCT01282424|455154661|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
126506968|NCT01282424|455154661|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
126506969|NCT01282424|455154661|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
126506970|NCT01282424|455154661|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
126506971|NCT04804813|455154662|FG000|Overall Study|Protocol Violation|2|||
126506972|NCT04804813|455154663|FG001|Overall Study|Protocol Violation|0|||
126506973|NCT04804813|455154662|FG000|Overall Study|Withdrawal by Subject|1|||
126506974|NCT04804813|455154663|FG001|Overall Study|Withdrawal by Subject|0|||
126506975|NCT02777125|455154670|FG000|Overall Study|Consent form violation|14|||
126506976|NCT02777125|455154671|FG001|Overall Study|Consent form violation|12|||
126506977|NCT02777125|455154670|FG000|Overall Study|Assent form violation|21|||
126506978|NCT02777125|455154671|FG001|Overall Study|Assent form violation|23|||
126506979|NCT02777125|455154670|FG000|Overall Study|Protocol Violation|8|||
126506980|NCT02777125|455154671|FG001|Overall Study|Protocol Violation|12|||
126506981|NCT05458856|455155975|FG000|Overall Study|Withdrawal by Subject|5|||
126506982|NCT05458856|455155975|FG000|Overall Study|Death|4|||
126506983|NCT05458856|455155975|FG000|Overall Study|Protocol Deviation|3|||
126506984|NCT05458856|455155975|FG000|Overall Study|Physician Decision|1|||
126506985|NCT01589822|455155976|FG000|Overall Study|Withdrawal by Subject|1|||
126506986|NCT01589822|455155977|FG001|Overall Study|Withdrawal by Subject|2|||
126506987|NCT01589822|455155978|FG002|Overall Study|Withdrawal by Subject|0|||
126506988|NCT01589822|455155976|FG000|Overall Study|Death|1|||
126506989|NCT01589822|455155977|FG001|Overall Study|Death|0|||
126506990|NCT01589822|455155978|FG002|Overall Study|Death|0|||
126506991|NCT01589822|455155976|FG000|Overall Study|Missed 90 day visit|2|||
126506992|NCT01589822|455155977|FG001|Overall Study|Missed 90 day visit|1|||
126506993|NCT01589822|455155978|FG002|Overall Study|Missed 90 day visit|1|||
126506994|NCT05168475|455155979|FG000|Period 1|Protocol Violation|1|||
126506995|NCT05168475|455155979|FG000|Period 1|IMP shortage|2|||
126506996|NCT05168475|455155979|FG000|Period 1|Not randomised|2|||
126506997|NCT05168475|455155979|FG000|Period 2|IMP shortage|1|||
126506998|NCT01140477|455155980|FG000|Overall Study|Lost to Follow-up|4|||
126506999|NCT01140477|455155981|FG001|Overall Study|Lost to Follow-up|0|||
126507000|NCT01140477|455155980|FG000|Overall Study|Withdrawal by Subject|1|||
126507001|NCT01140477|455155981|FG001|Overall Study|Withdrawal by Subject|4|||
126507002|NCT01140477|455155980|FG000|Overall Study|Surgical complication preventing implant|2|||
126507003|NCT01140477|455155981|FG001|Overall Study|Surgical complication preventing implant|0|||
126507004|NCT01140477|455155980|FG000|Overall Study|Death|1|||
126507005|NCT01140477|455155981|FG001|Overall Study|Death|1|||
126507006|NCT01140477|455155980|FG000|Overall Study|Subject explanted|0|||
126507007|NCT01140477|455155981|FG001|Overall Study|Subject explanted|1|||
126507008|NCT01945489|455155988|FG000|Cycle 1|Adverse Event|2|||
126507009|NCT01945489|455155989|FG001|Cycle 1|Adverse Event|0|||
126564200|NCT01981850|455360091|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
126564201|NCT01981850|455360092|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
126564202|NCT01981850|455360093|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
126564203|NCT01981850|455360094|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
126507010|NCT01945489|455155988|FG000|Cycle 1|Lost to Follow-up|4|||
126507011|NCT01945489|455155989|FG001|Cycle 1|Lost to Follow-up|0|||
126507012|NCT01945489|455155988|FG000|Cycle 1|Personal Reasons|4|||
126507013|NCT01945489|455155989|FG001|Cycle 1|Personal Reasons|2|||
126507014|NCT01945489|455155988|FG000|Cycle 1|Protocol Violation|0|||
126507015|NCT01945489|455155989|FG001|Cycle 1|Protocol Violation|1|||
126507016|NCT01945489|455155988|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
126507017|NCT01945489|455155989|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
126507018|NCT01945489|455155988|FG000|Cycle 2|Adverse Event|1|||
126507019|NCT01945489|455155989|FG001|Cycle 2|Adverse Event|0|||
126507020|NCT01945489|455155988|FG000|Cycle 2|Lost to Follow-up|0|||
126507021|NCT01945489|455155989|FG001|Cycle 2|Lost to Follow-up|1|||
126507022|NCT03569371|455155990|FG000|Overall Study|Lack of Efficacy|1|||
126507023|NCT03569371|455155990|FG000|Overall Study|Lost to Follow-up|1|||
126507024|NCT03569371|455155990|FG000|Overall Study|Adverse Event|1|||
126507025|NCT01236755|455155991|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
126507026|NCT01236755|455155991|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
126507027|NCT01236755|455155991|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
126507028|NCT01236755|455155991|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
126507029|NCT04904185|455155992|FG000|Overall Study|Expansion failure|1|||
126507030|NCT04904185|455155993|FG001|Overall Study|Expansion failure|0|||
126507031|NCT04904185|455155992|FG000|Overall Study|Late response on prior treatment|1|||
126507032|NCT04904185|455155993|FG001|Overall Study|Late response on prior treatment|0|||
126507033|NCT02433834|455155997|FG000|Overall Study|Protocol-specified criteria|7|||
126507034|NCT02433834|455155997|FG000|Overall Study|Protocol Violation|3|||
126507035|NCT02433834|455155997|FG000|Overall Study|Lost to Follow-up|6|||
126507036|NCT02433834|455155997|FG000|Overall Study|Withdrawal by Subject|14|||
126507037|NCT02433834|455155997|FG000|Overall Study|Adverse Event|6|||
126507038|NCT02433834|455155997|FG000|Overall Study|Physician Decision|1|||
126507039|NCT01539226|455155998|FG000|Overall Study|Withdrawal by Subject|24|||
126507040|NCT01539226|455155999|FG001|Overall Study|Withdrawal by Subject|54|||
126507041|NCT01539226|455155998|FG000|Overall Study|Lost to Follow-up|20|||
126507042|NCT01539226|455155999|FG001|Overall Study|Lost to Follow-up|54|||
126507043|NCT01539226|455155998|FG000|Overall Study|Death|1|||
126507044|NCT01539226|455155999|FG001|Overall Study|Death|2|||
126507045|NCT01539226|455155998|FG000|Overall Study|Adverse Event|2|||
126507046|NCT01539226|455155999|FG001|Overall Study|Adverse Event|0|||
126507047|NCT01539226|455155998|FG000|Overall Study|Pregnancy|13|||
126507048|NCT01539226|455155999|FG001|Overall Study|Pregnancy|29|||
126507049|NCT01539226|455155998|FG000|Overall Study|inappropriate enrollment|0|||
126507050|NCT01539226|455155999|FG001|Overall Study|inappropriate enrollment|1|||
126507051|NCT01539226|455155998|FG000|Overall Study|Multiple Reasons|3|||
126507052|NCT01539226|455155999|FG001|Overall Study|Multiple Reasons|1|||
126507053|NCT01539226|455155998|FG000|Overall Study|not HIV seroconversion-related|93|||
126507054|NCT01539226|455155999|FG001|Overall Study|not HIV seroconversion-related|176|||
126507055|NCT01539226|455155998|FG000|Overall Study|HIV seroconversion-related|55|||
126507056|NCT01539226|455155999|FG001|Overall Study|HIV seroconversion-related|80|||
126507057|NCT01539226|455155998|FG000|Overall Study|Non-compliance|6|||
126507058|NCT01539226|455155999|FG001|Overall Study|Non-compliance|8|||
126507059|NCT02643251|455156000|FG000|Overall Study|Adverse Event|3|||
126507060|NCT02643251|455156001|FG001|Overall Study|Adverse Event|1|||
126507061|NCT02643251|455156000|FG000|Overall Study|Withdrawal by Subject|2|||
126507062|NCT02643251|455156001|FG001|Overall Study|Withdrawal by Subject|0|||
126564204|NCT01981850|455360095|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
126564205|NCT01981850|455360086|FG000|Open Label Extension (OLE)|Various reasons|0|||
126507063|NCT02643251|455156000|FG000|Overall Study|Lost to Follow-up|4|||
126507064|NCT02643251|455156001|FG001|Overall Study|Lost to Follow-up|1|||
126507065|NCT02643251|455156000|FG000|Overall Study|Protocol Violation|1|||
126564206|NCT01981850|455360087|FG001|Open Label Extension (OLE)|Various reasons|0|||
126564207|NCT01981850|455360088|FG002|Open Label Extension (OLE)|Various reasons|0|||
126564208|NCT01981850|455360089|FG003|Open Label Extension (OLE)|Various reasons|0|||
126564209|NCT01981850|455360090|FG004|Open Label Extension (OLE)|Various reasons|0|||
126564210|NCT01981850|455360091|FG005|Open Label Extension (OLE)|Various reasons|0|||
126564211|NCT01981850|455360092|FG006|Open Label Extension (OLE)|Various reasons|0|||
126564212|NCT01981850|455360093|FG007|Open Label Extension (OLE)|Various reasons|3|||
126564213|NCT01981850|455360094|FG008|Open Label Extension (OLE)|Various reasons|1|||
126564214|NCT01981850|455360095|FG009|Open Label Extension (OLE)|Various reasons|3|||
126564215|NCT01981850|455360086|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
126507066|NCT02643251|455156001|FG001|Overall Study|Protocol Violation|0|||
126507067|NCT02643251|455156000|FG000|Overall Study|PI Decision to terminate patient|1|||
126507068|NCT02643251|455156001|FG001|Overall Study|PI Decision to terminate patient|0|||
126507069|NCT02365636|455156002|FG000|Overall Study|Adverse Event|3|||
126507070|NCT02365636|455156003|FG001|Overall Study|Adverse Event|3|||
126507071|NCT02365636|455156004|FG002|Overall Study|Adverse Event|2|||
126507072|NCT02365636|455156002|FG000|Overall Study|Protocol Violation|1|||
126507073|NCT02365636|455156003|FG001|Overall Study|Protocol Violation|4|||
126507074|NCT02365636|455156004|FG002|Overall Study|Protocol Violation|0|||
126507075|NCT02365636|455156002|FG000|Overall Study|Lost to Follow-up|0|||
126507076|NCT02365636|455156003|FG001|Overall Study|Lost to Follow-up|0|||
126507077|NCT02365636|455156004|FG002|Overall Study|Lost to Follow-up|1|||
126507078|NCT02365636|455156002|FG000|Overall Study|Other|2|||
126564216|NCT01981850|455360087|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
126507079|NCT02365636|455156003|FG001|Overall Study|Other|0|||
126507080|NCT02365636|455156004|FG002|Overall Study|Other|0|||
126507081|NCT01956110|455156012|FG000|Overall Study|Protocol Violation|25|||
126507082|NCT01956110|455156013|FG001|Overall Study|Protocol Violation|11|||
126507083|NCT01956110|455156012|FG000|Overall Study|Adverse Event|9|||
126507084|NCT01956110|455156013|FG001|Overall Study|Adverse Event|10|||
126564217|NCT01981850|455360088|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
126507085|NCT01956110|455156012|FG000|Overall Study|Personal reasons|1|||
126507086|NCT01956110|455156013|FG001|Overall Study|Personal reasons|1|||
126507087|NCT01782313|455156018|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
126507088|NCT01782313|455156018|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
126564218|NCT01981850|455360089|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
126564219|NCT01981850|455360090|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
126564220|NCT01981850|455360091|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
126564221|NCT01981850|455360092|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
126564222|NCT01981850|455360093|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
126564223|NCT01981850|455360094|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
126564224|NCT01981850|455360095|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
126564225|NCT01981850|455360086|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126564226|NCT01981850|455360087|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126564227|NCT01981850|455360088|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126564228|NCT01981850|455360089|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126564229|NCT01981850|455360090|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126564230|NCT01981850|455360091|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126564231|NCT01981850|455360092|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126564232|NCT01981850|455360093|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126564233|NCT01981850|455360094|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
126564234|NCT01981850|455360095|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
126564235|NCT01981850|455360086|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
126564236|NCT01981850|455360087|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
126564237|NCT01981850|455360088|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
126564238|NCT01981850|455360089|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
126564239|NCT01981850|455360090|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
126564240|NCT01981850|455360091|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
126564241|NCT01981850|455360092|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
126564242|NCT01981850|455360093|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
126564243|NCT01981850|455360094|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
126564244|NCT01981850|455360095|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
126564245|NCT02524288|455360096|FG000|Overall Study|Adverse Event|115|||
126564246|NCT02524288|455360096|FG000|Overall Study|Lost to Follow-up|216|||
126564247|NCT02524288|455360096|FG000|Overall Study|Non-Compliance With Protocol|32|||
126564248|NCT02524288|455360096|FG000|Overall Study|Non-Compliance With Study Drug|14|||
126564249|NCT02524288|455360096|FG000|Overall Study|Pregnancy Wish|6|||
126564250|NCT02524288|455360096|FG000|Overall Study|Protocol Violation|6|||
126564251|NCT02524288|455360096|FG000|Overall Study|Screen Failure|2|||
126564252|NCT02524288|455360096|FG000|Overall Study|Site Discontinued Study Participation|1|||
126564253|NCT02524288|455360096|FG000|Overall Study|Study Terminated By Sponsor|1417|||
126564254|NCT02524288|455360096|FG000|Overall Study|Subject Moved|32|||
126564255|NCT02524288|455360096|FG000|Overall Study|Withdrawal by Subject|76|||
126564256|NCT02524288|455360096|FG000|Overall Study|Pregnancy|22|||
126564257|NCT02524288|455360096|FG000|Overall Study|Physician Decision|2|||
126564258|NCT00517933|455360097|FG000|Period 1|Death|2|||
126564259|NCT00517933|455360098|FG001|Period 1|Death|1|||
126564260|NCT00517933|455360097|FG000|Period 1|Adverse Event|4|||
126564261|NCT00517933|455360098|FG001|Period 1|Adverse Event|4|||
126564262|NCT00517933|455360097|FG000|Period 1|Lost to Follow-up|2|||
126564263|NCT00517933|455360098|FG001|Period 1|Lost to Follow-up|0|||
126564264|NCT00517933|455360097|FG000|Period 1|Underwent lung transplant|0|||
126564265|NCT00517933|455360098|FG001|Period 1|Underwent lung transplant|1|||
126564266|NCT00517933|455360097|FG000|Period 2|Death|2|||
126564267|NCT00517933|455360098|FG001|Period 2|Death|4|||
126564268|NCT00517933|455360097|FG000|Period 2|Adverse Event|2|||
126507089|NCT01782313|455156018|FG000|Treated Cycle 3|Progressive Disease|21|||
126507090|NCT01782313|455156018|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
126507091|NCT01782313|455156018|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
126507092|NCT01782313|455156018|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
126507093|NCT01782313|455156018|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
126507094|NCT01782313|455156018|FG000|Survival Follow up|Lost to Follow-up|1|||
126507095|NCT02506816|455156019|FG000|Overall Study|Adverse Event|3|||
126507096|NCT01067352|455156024|FG000|Overall Study|Withdrawal by Subject|1|||
126507097|NCT01067352|455156025|FG001|Overall Study|Withdrawal by Subject|2|||
126507098|NCT01067352|455156026|FG002|Overall Study|Withdrawal by Subject|1|||
126507099|NCT01067352|455156024|FG000|Overall Study|Physician Decision|0|||
126507100|NCT01067352|455156025|FG001|Overall Study|Physician Decision|1|||
126507101|NCT01067352|455156026|FG002|Overall Study|Physician Decision|0|||
126507102|NCT01096784|455156027|FG000|Overall Study|Withdrawal by Subject|2|||
126564269|NCT00517933|455360098|FG001|Period 2|Adverse Event|4|||
126507103|NCT01096784|455156028|FG001|Overall Study|Withdrawal by Subject|1|||
126507104|NCT01096784|455156027|FG000|Overall Study|Adverse Event|11|||
126564270|NCT00517933|455360097|FG000|Period 2|Physician Decision|1|||
126564271|NCT00517933|455360098|FG001|Period 2|Physician Decision|0|||
126564272|NCT00517933|455360097|FG000|Period 2|Withdrawal by Subject|1|||
126564273|NCT00517933|455360098|FG001|Period 2|Withdrawal by Subject|3|||
126564274|NCT00517933|455360097|FG000|Period 2|Underwent lung transplant|0|||
126564275|NCT00517933|455360098|FG001|Period 2|Underwent lung transplant|2|||
126507105|NCT01096784|455156028|FG001|Overall Study|Adverse Event|9|||
126564276|NCT04305912|455360099|FG000|First Intervention|COVID-19 Suspension|2|||
126564277|NCT04305912|455360100|FG001|First Intervention|COVID-19 Suspension|0|||
126564278|NCT04305912|455360099|FG000|First Intervention|Withdrawal by Subject|0|||
126564279|NCT04305912|455360100|FG001|First Intervention|Withdrawal by Subject|1|||
126564280|NCT04305912|455360099|FG000|Second Intervention|Adverse Event|0|||
126564281|NCT04305912|455360100|FG001|Second Intervention|Adverse Event|1|||
126564282|NCT04888585|455360101|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
126564283|NCT04888585|455360102|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
126564284|NCT04888585|455360103|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
126564285|NCT04888585|455360104|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
126564286|NCT04888585|455360105|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
126564287|NCT04888585|455360106|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
126564288|NCT04888585|455360107|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
126564289|NCT04888585|455360108|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
126564290|NCT04888585|455360109|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
126564291|NCT04888585|455360110|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
126564292|NCT04888585|455360111|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
126564293|NCT04888585|455360101|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126564294|NCT04888585|455360102|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
126564295|NCT04888585|455360103|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
126776922|NCT04132232|456139090|FG001|Overall Study|Lost to Follow-up|7|||
126776923|NCT00368537|456139091|FG000|Randomization|No study drug dosed|13|||
126776924|NCT00368537|456139092|FG001|Randomization|No study drug dosed|6|||
126776925|NCT00368537|456139091|FG000|Baseline Participants|Lost to Follow-up|16|||
126776926|NCT00368537|456139092|FG001|Baseline Participants|Lost to Follow-up|17|||
126776927|NCT00368537|456139091|FG000|Baseline Participants|Withdrawal by Subject|6|||
126507106|NCT01096784|455156027|FG000|Overall Study|Protocol Deviation|2|||
126507107|NCT01096784|455156028|FG001|Overall Study|Protocol Deviation|2|||
126564296|NCT04888585|455360104|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
126564297|NCT04888585|455360105|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
126564298|NCT04888585|455360106|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126564299|NCT04888585|455360107|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126564300|NCT04888585|455360108|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126564301|NCT04888585|455360109|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126564302|NCT04888585|455360110|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126564303|NCT04888585|455360111|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
126564304|NCT04888585|455360101|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126564305|NCT04888585|455360102|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126507108|NCT01096784|455156027|FG000|Overall Study|Administrative Decision|0|||
126507109|NCT01096784|455156028|FG001|Overall Study|Administrative Decision|1|||
126507110|NCT01096784|455156027|FG000|Overall Study|Other Unspecified|0|||
126507111|NCT01096784|455156028|FG001|Overall Study|Other Unspecified|1|||
126507112|NCT03761628|455156029|FG000|Overall Study|Withdrawal by Subject|3|||
126507113|NCT03761628|455156029|FG000|Overall Study|Physician Decision|1|||
126507114|NCT03761628|455156029|FG000|Overall Study|Pregnancy|1|||
126507115|NCT03761628|455156029|FG000|Overall Study|Lost to Follow-up|1|||
126507116|NCT00354172|455156032|FG000|Overall Study|Did not receive transplant|1|||
126507117|NCT02287896|455156048|FG000|Second Injection Visit|Withdrawal by Subject|0|||
126507118|NCT02287896|455156049|FG001|Second Injection Visit|Withdrawal by Subject|1|||
126507119|NCT00559962|455156050|FG000|Overall Study|Adverse Event|1|||
126507120|NCT00559962|455156051|FG001|Overall Study|Adverse Event|7|||
126507121|NCT00559962|455156052|FG002|Overall Study|Adverse Event|8|||
126507122|NCT00559962|455156053|FG003|Overall Study|Adverse Event|5|||
126507123|NCT00559962|455156054|FG004|Overall Study|Adverse Event|11|||
126507124|NCT00559962|455156055|FG005|Overall Study|Adverse Event|4|||
126507125|NCT00559962|455156056|FG006|Overall Study|Adverse Event|4|||
126507126|NCT00559962|455156057|FG007|Overall Study|Adverse Event|2|||
126507127|NCT00559962|455156050|FG000|Overall Study|Lost to Follow-up|0|||
126507128|NCT00559962|455156051|FG001|Overall Study|Lost to Follow-up|1|||
126507129|NCT00559962|455156052|FG002|Overall Study|Lost to Follow-up|0|||
126507130|NCT00559962|455156053|FG003|Overall Study|Lost to Follow-up|0|||
126507131|NCT00559962|455156054|FG004|Overall Study|Lost to Follow-up|0|||
126564306|NCT04888585|455360103|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
126564307|NCT04888585|455360104|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126564308|NCT04888585|455360105|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
126564309|NCT04888585|455360106|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126564310|NCT04888585|455360107|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126564311|NCT04888585|455360108|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126507132|NCT00559962|455156055|FG005|Overall Study|Lost to Follow-up|0|||
126507133|NCT00559962|455156056|FG006|Overall Study|Lost to Follow-up|0|||
126507134|NCT00559962|455156057|FG007|Overall Study|Lost to Follow-up|0|||
126507135|NCT00559962|455156050|FG000|Overall Study|Withdrawal by Subject|1|||
126507136|NCT00559962|455156051|FG001|Overall Study|Withdrawal by Subject|1|||
126507137|NCT00559962|455156052|FG002|Overall Study|Withdrawal by Subject|2|||
126507138|NCT00559962|455156053|FG003|Overall Study|Withdrawal by Subject|0|||
126507139|NCT00559962|455156054|FG004|Overall Study|Withdrawal by Subject|3|||
126507140|NCT00559962|455156055|FG005|Overall Study|Withdrawal by Subject|1|||
126507141|NCT00559962|455156056|FG006|Overall Study|Withdrawal by Subject|0|||
126507142|NCT00559962|455156057|FG007|Overall Study|Withdrawal by Subject|2|||
126507143|NCT00559962|455156050|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
126507144|NCT00559962|455156051|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
126507145|NCT00559962|455156052|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
126507146|NCT00559962|455156053|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
126507147|NCT00559962|455156054|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
126507148|NCT00559962|455156055|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
126507149|NCT00559962|455156056|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
126507150|NCT00559962|455156057|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
126507151|NCT01639040|455156058|FG000|Overall Study|Adverse Event|1|||
126507152|NCT01639040|455156059|FG001|Overall Study|Adverse Event|0|||
126507153|NCT03047135|455156063|FG000|Overall Study|Still being treated|3|||
126507154|NCT01585766|455156064|FG000|Overall Study|Withdrawal by Subject|0|||
126507155|NCT01585766|455156065|FG001|Overall Study|Withdrawal by Subject|1|||
126507156|NCT01585766|455156066|FG002|Overall Study|Withdrawal by Subject|1|||
126507157|NCT01585766|455156067|FG003|Overall Study|Withdrawal by Subject|0|||
126507158|NCT01585766|455156068|FG004|Overall Study|Withdrawal by Subject|0|||
126507159|NCT01585766|455156069|FG005|Overall Study|Withdrawal by Subject|0|||
126507160|NCT01585766|455156064|FG000|Overall Study|Death|0|||
126507161|NCT01585766|455156065|FG001|Overall Study|Death|1|||
126507162|NCT01585766|455156066|FG002|Overall Study|Death|0|||
126507163|NCT01585766|455156067|FG003|Overall Study|Death|0|||
126507164|NCT01585766|455156068|FG004|Overall Study|Death|0|||
126507165|NCT01585766|455156069|FG005|Overall Study|Death|0|||
126507166|NCT01585766|455156064|FG000|Overall Study|Physician Decision|0|||
126507167|NCT01585766|455156065|FG001|Overall Study|Physician Decision|0|||
126507168|NCT01585766|455156066|FG002|Overall Study|Physician Decision|1|||
126507169|NCT01585766|455156067|FG003|Overall Study|Physician Decision|0|||
126507170|NCT01585766|455156068|FG004|Overall Study|Physician Decision|0|||
126507171|NCT01585766|455156069|FG005|Overall Study|Physician Decision|0|||
126507172|NCT02385799|455156070|FG000|Overall Study|Lost to Follow-up|1|||
126507173|NCT02385799|455156071|FG001|Overall Study|Lost to Follow-up|2|||
126507174|NCT02385799|455156070|FG000|Overall Study|Adverse Event|4|||
126507175|NCT02385799|455156071|FG001|Overall Study|Adverse Event|2|||
126507176|NCT02385799|455156070|FG000|Overall Study|Withdrawal by Subject|0|||
126507177|NCT02385799|455156071|FG001|Overall Study|Withdrawal by Subject|4|||
126507178|NCT02130765|455156072|FG000|Overall Study|Did not receive treatment|4|||
126507179|NCT02130765|455156073|FG001|Overall Study|Did not receive treatment|0|||
126507180|NCT02130765|455156074|FG002|Overall Study|Did not receive treatment|0|||
126507181|NCT02130765|455156075|FG003|Overall Study|Did not receive treatment|0|||
126507182|NCT00058825|455156083|FG000|Overall Study|Relapse|9|||
126507183|NCT00058825|455156083|FG000|Overall Study|Progressive Disease|5|||
126507184|NCT00058825|455156083|FG000|Overall Study|Graft Failure|5|||
126507185|NCT00058825|455156083|FG000|Overall Study|Death|3|||
126507186|NCT02244580|455156086|FG000|Overall Study|No cancer tissues available|241|||
126507187|NCT02722928|455156087|FG000|Overall Study|Standard CT was not as required per prot|5|||
126507188|NCT02722928|455156088|FG001|Overall Study|Standard CT was not as required per prot|13|||
126507189|NCT02722928|455156087|FG000|Overall Study|Required Intraoperative MRI|5|||
126507190|NCT02722928|455156088|FG001|Overall Study|Required Intraoperative MRI|7|||
126507191|NCT03571516|455156089|FG000|Overall Study|Severe diarrhea|1|||
126507192|NCT03571516|455156090|FG001|Overall Study|Severe diarrhea|0|||
126507193|NCT03571516|455156089|FG000|Overall Study|Withdrawal by Subject|0|||
126507194|NCT03571516|455156090|FG001|Overall Study|Withdrawal by Subject|1|||
126507195|NCT04011410|455156091|FG000|Overall Study|Withdrawal by Subject|1|||
126507196|NCT01838642|455156093|FG000|Overall Study|Died on study|1|||
126507197|NCT01398956|455156095|FG000|Overall Study|Withdrawal by Subject|4|||
126507198|NCT01398956|455156095|FG000|Overall Study|AE, non-serious non-fatal|4|||
126507199|NCT01398956|455156095|FG000|Overall Study|Withdrawal Criteria No.3|1|||
126507200|NCT01398956|455156095|FG000|Overall Study|Subject moved a long distance|1|||
126507201|NCT01557400|455156096|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
126507202|NCT01557400|455156096|FG000|Overall Study|Adverse Event|3|||
126507203|NCT01557400|455156096|FG000|Overall Study|Lost to Follow-up|5|||
126507204|NCT01557400|455156096|FG000|Overall Study|Withdrawal by Subject|9|||
126507205|NCT03465878|455156097|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
126507206|NCT03465878|455156098|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
126507207|NCT03465878|455156099|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
126507208|NCT03465878|455156100|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
126507209|NCT03465878|455156097|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
126507210|NCT03465878|455156098|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
126507211|NCT03465878|455156099|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
126507212|NCT03465878|455156100|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
126507213|NCT03465878|455156097|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
126507214|NCT03465878|455156098|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
126507215|NCT03465878|455156099|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
126507216|NCT03465878|455156100|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
126507217|NCT03925727|455156101|FG000|Overall Study|Adverse Event|4|||
126507218|NCT03925727|455156102|FG001|Overall Study|Adverse Event|0|||
126507219|NCT03925727|455156103|FG002|Overall Study|Adverse Event|3|||
126507220|NCT03925727|455156101|FG000|Overall Study|Protocol Violation|1|||
126507221|NCT03925727|455156102|FG001|Overall Study|Protocol Violation|2|||
126507222|NCT03925727|455156103|FG002|Overall Study|Protocol Violation|2|||
126507223|NCT03925727|455156101|FG000|Overall Study|Withdrawal by Subject|3|||
126507224|NCT03925727|455156102|FG001|Overall Study|Withdrawal by Subject|2|||
126507225|NCT03925727|455156103|FG002|Overall Study|Withdrawal by Subject|4|||
126507226|NCT03925727|455156101|FG000|Overall Study|Administrative Reasons|3|||
126507227|NCT03925727|455156102|FG001|Overall Study|Administrative Reasons|1|||
126507228|NCT03925727|455156103|FG002|Overall Study|Administrative Reasons|2|||
126507229|NCT03925727|455156101|FG000|Overall Study|Randomized in error or Disqualified|8|||
126507230|NCT03925727|455156102|FG001|Overall Study|Randomized in error or Disqualified|1|||
126507231|NCT03925727|455156103|FG002|Overall Study|Randomized in error or Disqualified|7|||
126564312|NCT04888585|455360109|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126507232|NCT01083433|455158180|FG000|Overall Study|Lost to Follow-up|2|||
126507233|NCT01083433|455158181|FG001|Overall Study|Lost to Follow-up|1|||
126507234|NCT01083433|455158182|FG002|Overall Study|Lost to Follow-up|1|||
126507235|NCT01083433|455158180|FG000|Overall Study|Withdrawal by Subject|0|||
126507236|NCT01083433|455158181|FG001|Overall Study|Withdrawal by Subject|5|||
126507237|NCT01083433|455158182|FG002|Overall Study|Withdrawal by Subject|3|||
126507238|NCT01083433|455158180|FG000|Overall Study|Pregnancy|0|||
126507239|NCT01083433|455158181|FG001|Overall Study|Pregnancy|0|||
126507240|NCT01083433|455158182|FG002|Overall Study|Pregnancy|1|||
126507241|NCT01581593|455158183|FG000|Overall Study|Withdrawal by Subject|1|||
126507242|NCT04982029|455158184|FG000|Overall Study|Lost to Follow-up|2|||
126507243|NCT04982029|455158185|FG001|Overall Study|Lost to Follow-up|3|||
126507244|NCT00773175|455158188|FG000|Overall Study|Adverse Event|2|||
126507245|NCT00773175|455158189|FG001|Overall Study|Adverse Event|0|||
126507246|NCT00773175|455158188|FG000|Overall Study|Consent Withdrawn|0|||
126507247|NCT00773175|455158189|FG001|Overall Study|Consent Withdrawn|2|||
126507248|NCT04127786|455158192|FG000|Primary Series|Adverse Event|1|||
126507249|NCT04127786|455158193|FG001|Primary Series|Adverse Event|0|||
126507250|NCT04127786|455158194|FG002|Primary Series|Adverse Event|0|||
126507251|NCT04127786|455158195|FG003|Primary Series|Adverse Event|1|||
126507252|NCT04127786|455158196|FG004|Primary Series|Adverse Event|0|||
126564313|NCT04888585|455360110|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126564314|NCT04888585|455360111|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
126564315|NCT04888585|455360101|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
126564316|NCT04888585|455360102|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
126564317|NCT04888585|455360103|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
126564318|NCT04888585|455360104|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
126564319|NCT04888585|455360105|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
126564320|NCT04888585|455360106|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
126564321|NCT04888585|455360107|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
126564322|NCT04888585|455360108|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
126564323|NCT04888585|455360109|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
126564324|NCT04888585|455360110|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
126507253|NCT04127786|455158197|FG005|Primary Series|Adverse Event|1|||
126507254|NCT04127786|455158192|FG000|Primary Series|Protocol Violation|5|||
126507255|NCT04127786|455158193|FG001|Primary Series|Protocol Violation|3|||
126507256|NCT04127786|455158194|FG002|Primary Series|Protocol Violation|4|||
126507257|NCT04127786|455158195|FG003|Primary Series|Protocol Violation|3|||
126507258|NCT04127786|455158196|FG004|Primary Series|Protocol Violation|2|||
126507259|NCT04127786|455158197|FG005|Primary Series|Protocol Violation|0|||
126564325|NCT04888585|455360111|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
126564326|NCT04888585|455360101|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
126564327|NCT04888585|455360102|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
126564328|NCT04888585|455360103|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
126564329|NCT04888585|455360104|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
126564330|NCT04888585|455360105|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
126507260|NCT04127786|455158192|FG000|Primary Series|Withdrawal by Subject|0|||
126507261|NCT04127786|455158193|FG001|Primary Series|Withdrawal by Subject|0|||
126507262|NCT04127786|455158194|FG002|Primary Series|Withdrawal by Subject|0|||
126507263|NCT04127786|455158195|FG003|Primary Series|Withdrawal by Subject|1|||
126564331|NCT04888585|455360106|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
126564332|NCT04888585|455360107|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
126564333|NCT04888585|455360108|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
126564334|NCT04888585|455360109|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
126564335|NCT04888585|455360110|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
126564336|NCT04888585|455360111|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
126507264|NCT04127786|455158196|FG004|Primary Series|Withdrawal by Subject|0|||
126507265|NCT04127786|455158197|FG005|Primary Series|Withdrawal by Subject|0|||
126507266|NCT04127786|455158192|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
126507267|NCT04127786|455158193|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
126507268|NCT04127786|455158194|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
126507269|NCT04127786|455158195|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
126507270|NCT04127786|455158196|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
126507271|NCT04127786|455158197|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
126507272|NCT04127786|455158192|FG000|Booster Phase|Withdrawal by Subject|2|||
126507273|NCT04127786|455158193|FG001|Booster Phase|Withdrawal by Subject|0|||
126507274|NCT04127786|455158194|FG002|Booster Phase|Withdrawal by Subject|0|||
126507275|NCT04127786|455158195|FG003|Booster Phase|Withdrawal by Subject|0|||
126507276|NCT04127786|455158196|FG004|Booster Phase|Withdrawal by Subject|0|||
126507277|NCT04127786|455158197|FG005|Booster Phase|Withdrawal by Subject|0|||
126507278|NCT01904604|455158198|FG000|Overall Study|Withdrew before receiving dosing|0|||
126507279|NCT01904604|455158199|FG001|Overall Study|Withdrew before receiving dosing|1|||
126507280|NCT01904604|455158200|FG002|Overall Study|Withdrew before receiving dosing|0|||
126507281|NCT01904604|455158198|FG000|Overall Study|Non-compliance|1|||
126507282|NCT01904604|455158199|FG001|Overall Study|Non-compliance|0|||
126507283|NCT01904604|455158200|FG002|Overall Study|Non-compliance|0|||
126507284|NCT01904604|455158198|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
126507285|NCT01904604|455158199|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
126507286|NCT01904604|455158200|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
126507287|NCT01904604|455158198|FG000|Overall Study|Patch site reactions|1|||
126507288|NCT01904604|455158199|FG001|Overall Study|Patch site reactions|1|||
126507289|NCT01904604|455158200|FG002|Overall Study|Patch site reactions|0|||
126507290|NCT01904604|455158198|FG000|Overall Study|Increased syncope|0|||
126507291|NCT01904604|455158199|FG001|Overall Study|Increased syncope|1|||
126507292|NCT01904604|455158200|FG002|Overall Study|Increased syncope|0|||
126564337|NCT04888585|455360101|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
126564338|NCT04888585|455360102|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
126564339|NCT04888585|455360103|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
126564340|NCT04888585|455360104|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
126564341|NCT04888585|455360105|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
126564342|NCT04888585|455360106|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
126564343|NCT04888585|455360107|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
126564344|NCT04888585|455360108|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
126564345|NCT04888585|455360109|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
126564346|NCT04888585|455360110|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
126564347|NCT04888585|455360111|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
126564348|NCT04888585|455360101|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
126564349|NCT04888585|455360102|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
126564350|NCT04888585|455360103|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
126564351|NCT04888585|455360104|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
126564352|NCT04888585|455360105|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
126564353|NCT04888585|455360106|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
126564354|NCT04888585|455360107|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
126564355|NCT04888585|455360108|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
126564356|NCT04888585|455360109|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
126564357|NCT04888585|455360110|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
126564358|NCT04888585|455360111|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
126564359|NCT04888585|455360101|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126564360|NCT04888585|455360102|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126564361|NCT04888585|455360103|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126564362|NCT04888585|455360104|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126727158|NCT00125190|455951068|FG000|Overall Study|Lost to Follow-up|4|||
126507293|NCT01904604|455158198|FG000|Overall Study|Unrelated illness|0|||
126507294|NCT01904604|455158199|FG001|Overall Study|Unrelated illness|1|||
126507295|NCT01904604|455158200|FG002|Overall Study|Unrelated illness|0|||
126507296|NCT01904604|455158198|FG000|Overall Study|Passed Week 52 OFC|1|||
126507297|NCT01904604|455158199|FG001|Overall Study|Passed Week 52 OFC|0|||
126507298|NCT01904604|455158200|FG002|Overall Study|Passed Week 52 OFC|0|||
126507299|NCT01904604|455158198|FG000|Overall Study|Withdrawal by Subject|1|||
126564363|NCT04888585|455360105|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126564364|NCT04888585|455360106|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126564365|NCT04888585|455360107|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
126564366|NCT04888585|455360108|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
126564367|NCT04888585|455360109|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
126507300|NCT01904604|455158199|FG001|Overall Study|Withdrawal by Subject|2|||
126507301|NCT01904604|455158200|FG002|Overall Study|Withdrawal by Subject|0|||
126507302|NCT01904604|455158198|FG000|Overall Study|Participant Relocated|1|||
126507303|NCT01904604|455158199|FG001|Overall Study|Participant Relocated|1|||
126507304|NCT01904604|455158200|FG002|Overall Study|Participant Relocated|1|||
126507305|NCT01904604|455158198|FG000|Overall Study|Lost to Follow-up|0|||
126507306|NCT01904604|455158199|FG001|Overall Study|Lost to Follow-up|0|||
126507307|NCT01904604|455158200|FG002|Overall Study|Lost to Follow-up|1|||
126507308|NCT03568942|455158203|FG000|Overall Study|Family emergency|1|||
126507309|NCT03568942|455158203|FG000|Overall Study|Lost to Follow-up|1|||
126507310|NCT00358527|455158205|FG000|Overall Study|Adverse Event|4|||
126507311|NCT00358527|455158206|FG001|Overall Study|Adverse Event|0|||
126507312|NCT00358527|455158205|FG000|Overall Study|Withdrawal by Subject|1|||
126507313|NCT00358527|455158206|FG001|Overall Study|Withdrawal by Subject|1|||
126507314|NCT00358527|455158205|FG000|Overall Study|Non-compliance with protocol|6|||
126507315|NCT00358527|455158206|FG001|Overall Study|Non-compliance with protocol|1|||
126507316|NCT00358527|455158205|FG000|Overall Study|Administrative|2|||
126507317|NCT00358527|455158206|FG001|Overall Study|Administrative|1|||
126507318|NCT04144166|455158207|FG000|Overall Study|Discharged before study start|1|||
126507319|NCT04144166|455158207|FG000|Overall Study|Pregnancy|1|||
126507320|NCT04144166|455158207|FG000|Overall Study|Nail polish could not be removed from finger|1|||
126507321|NCT04145895|455158209|FG000|Overall Study|Physician Decision|2|||
126507322|NCT04145895|455158210|FG001|Overall Study|Physician Decision|0|||
126507323|NCT04145895|455158209|FG000|Overall Study|Withdrawal by Subject|0|||
126507324|NCT04145895|455158210|FG001|Overall Study|Withdrawal by Subject|2|||
126507325|NCT01481116|455158211|FG000|Overall Study|Adverse Event|26|||
126507326|NCT01481116|455158212|FG001|Overall Study|Adverse Event|26|||
126507327|NCT01481116|455158213|FG002|Overall Study|Adverse Event|42|||
126564368|NCT04888585|455360110|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
126564369|NCT04888585|455360111|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
126564370|NCT00819910|455360112|FG000|Overall Study|Adverse Event|0|||
126564371|NCT00819910|455360113|FG001|Overall Study|Adverse Event|0|||
126564372|NCT00819910|455360114|FG002|Overall Study|Adverse Event|2|||
126564373|NCT00819910|455360115|FG003|Overall Study|Adverse Event|1|||
126564374|NCT00819910|455360112|FG000|Overall Study|Withdrawal by Subject|1|||
126564375|NCT00819910|455360113|FG001|Overall Study|Withdrawal by Subject|1|||
126564376|NCT00819910|455360114|FG002|Overall Study|Withdrawal by Subject|1|||
126564377|NCT00819910|455360115|FG003|Overall Study|Withdrawal by Subject|0|||
126564378|NCT00819910|455360112|FG000|Overall Study|Lost to Follow-up|1|||
126564379|NCT00819910|455360113|FG001|Overall Study|Lost to Follow-up|0|||
126564380|NCT00819910|455360114|FG002|Overall Study|Lost to Follow-up|0|||
126564381|NCT00819910|455360115|FG003|Overall Study|Lost to Follow-up|0|||
126564382|NCT05273801|455360116|FG000|Overall Study|Physician Decision|1|||
126564383|NCT02049866|455361621|FG000|Overall Study|Withdrawal by Subject|1|||
126564384|NCT03721016|455361623|FG000|Overall Study|Adverse Event|0|||
126564385|NCT03721016|455361624|FG001|Overall Study|Adverse Event|1|||
126564386|NCT03721016|455361625|FG002|Overall Study|Adverse Event|1|||
126564387|NCT03721016|455361623|FG000|Overall Study|Withdrawal by Subject|8|||
126564388|NCT03721016|455361624|FG001|Overall Study|Withdrawal by Subject|16|||
126564389|NCT03721016|455361625|FG002|Overall Study|Withdrawal by Subject|13|||
126564390|NCT03721016|455361623|FG000|Overall Study|Lost to Follow-up|4|||
126564391|NCT03721016|455361624|FG001|Overall Study|Lost to Follow-up|6|||
126564392|NCT03721016|455361625|FG002|Overall Study|Lost to Follow-up|5|||
126564393|NCT03721016|455361623|FG000|Overall Study|Physician Decision|0|||
126564394|NCT03721016|455361624|FG001|Overall Study|Physician Decision|1|||
126564395|NCT03721016|455361625|FG002|Overall Study|Physician Decision|2|||
126564396|NCT03721016|455361623|FG000|Overall Study|Protocol Violation|0|||
126564397|NCT03721016|455361624|FG001|Overall Study|Protocol Violation|1|||
126564398|NCT03721016|455361625|FG002|Overall Study|Protocol Violation|0|||
126564399|NCT03721016|455361623|FG000|Overall Study|Site terminated by sponsor|3|||
126564400|NCT03721016|455361624|FG001|Overall Study|Site terminated by sponsor|7|||
126564401|NCT03721016|455361625|FG002|Overall Study|Site terminated by sponsor|6|||
126564402|NCT03721016|455361623|FG000|Overall Study|Subject exited early due to COVID-19|1|||
126564403|NCT03721016|455361624|FG001|Overall Study|Subject exited early due to COVID-19|0|||
126564404|NCT03721016|455361625|FG002|Overall Study|Subject exited early due to COVID-19|0|||
126507328|NCT01481116|455158211|FG000|Overall Study|Major Protocol Deviation|3|||
126564405|NCT02232178|455361628|FG000|Overall Study|Lost to Follow-up|0|||
126507329|NCT01481116|455158212|FG001|Overall Study|Major Protocol Deviation|7|||
126507330|NCT01481116|455158213|FG002|Overall Study|Major Protocol Deviation|1|||
126507331|NCT01481116|455158211|FG000|Overall Study|Lost to Follow-up|8|||
126507332|NCT01481116|455158212|FG001|Overall Study|Lost to Follow-up|12|||
126564406|NCT02232178|455361629|FG001|Overall Study|Lost to Follow-up|1|||
126564407|NCT02232178|455361630|FG002|Overall Study|Lost to Follow-up|0|||
126564408|NCT02232178|455361628|FG000|Overall Study|ineligibility|0|||
126564409|NCT02232178|455361629|FG001|Overall Study|ineligibility|0|||
126564410|NCT02232178|455361630|FG002|Overall Study|ineligibility|1|||
126564411|NCT02232178|455361628|FG000|Overall Study|surgical complication|1|||
126564412|NCT02232178|455361629|FG001|Overall Study|surgical complication|0|||
126564413|NCT02232178|455361630|FG002|Overall Study|surgical complication|0|||
126564414|NCT00817635|455361632|FG000|Overall Study|Adverse Event|1|||
126564415|NCT00817635|455361633|FG001|Overall Study|Adverse Event|0|||
126564416|NCT00817635|455361634|FG002|Overall Study|Adverse Event|0|||
126564417|NCT00817635|455361635|FG003|Overall Study|Adverse Event|1|||
126564418|NCT00817635|455361636|FG004|Overall Study|Adverse Event|1|||
126564419|NCT00817635|455361632|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
126564420|NCT00817635|455361633|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
126564421|NCT00817635|455361634|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
126564422|NCT00817635|455361635|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
126564423|NCT00817635|455361636|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
126564424|NCT00817635|455361632|FG000|Overall Study|Withdrawal by Subject|2|||
126564425|NCT00817635|455361633|FG001|Overall Study|Withdrawal by Subject|1|||
126564426|NCT00817635|455361634|FG002|Overall Study|Withdrawal by Subject|0|||
126564427|NCT00817635|455361635|FG003|Overall Study|Withdrawal by Subject|1|||
126564428|NCT00817635|455361636|FG004|Overall Study|Withdrawal by Subject|2|||
126564429|NCT00817635|455361632|FG000|Overall Study|Lost to Follow-up|0|||
126564430|NCT00817635|455361633|FG001|Overall Study|Lost to Follow-up|1|||
126564431|NCT00817635|455361634|FG002|Overall Study|Lost to Follow-up|0|||
126564432|NCT00817635|455361635|FG003|Overall Study|Lost to Follow-up|1|||
126564433|NCT00817635|455361636|FG004|Overall Study|Lost to Follow-up|0|||
126564434|NCT00817635|455361632|FG000|Overall Study|Administrative Problems|0|||
126564435|NCT00817635|455361633|FG001|Overall Study|Administrative Problems|0|||
126564436|NCT00817635|455361634|FG002|Overall Study|Administrative Problems|0|||
126564437|NCT00817635|455361635|FG003|Overall Study|Administrative Problems|0|||
126564438|NCT00817635|455361636|FG004|Overall Study|Administrative Problems|1|||
126564439|NCT00817635|455361632|FG000|Overall Study|Protocol Violation|5|||
126564440|NCT00817635|455361633|FG001|Overall Study|Protocol Violation|1|||
126564441|NCT00817635|455361634|FG002|Overall Study|Protocol Violation|3|||
126564442|NCT00817635|455361635|FG003|Overall Study|Protocol Violation|2|||
126564443|NCT00817635|455361636|FG004|Overall Study|Protocol Violation|3|||
126564444|NCT03107611|455361638|FG000|Overall Study|Adverse Event|1|||
126564445|NCT03107611|455361639|FG001|Overall Study|Adverse Event|0|||
126564446|NCT03107611|455361640|FG002|Overall Study|Adverse Event|2|||
126564447|NCT03107611|455361638|FG000|Overall Study|Lost to Follow-up|3|||
126564448|NCT03107611|455361639|FG001|Overall Study|Lost to Follow-up|3|||
126564449|NCT03107611|455361640|FG002|Overall Study|Lost to Follow-up|3|||
126564450|NCT03107611|455361638|FG000|Overall Study|Protocol Violation|0|||
126564451|NCT03107611|455361639|FG001|Overall Study|Protocol Violation|0|||
126564452|NCT03107611|455361640|FG002|Overall Study|Protocol Violation|1|||
126564453|NCT03107611|455361638|FG000|Overall Study|Withdrawal by Subject|1|||
126564454|NCT03107611|455361639|FG001|Overall Study|Withdrawal by Subject|0|||
126564455|NCT03107611|455361640|FG002|Overall Study|Withdrawal by Subject|1|||
126564456|NCT03107611|455361638|FG000|Overall Study|Worsening signs/symptoms|2|||
126564457|NCT03107611|455361639|FG001|Overall Study|Worsening signs/symptoms|1|||
126564458|NCT03107611|455361640|FG002|Overall Study|Worsening signs/symptoms|2|||
126564459|NCT01720446|455361643|FG000|Overall Study|Lost to Follow-up|12|||
126564460|NCT01720446|455361644|FG001|Overall Study|Lost to Follow-up|6|||
126564461|NCT01720446|455361645|FG002|Overall Study|Lost to Follow-up|16|||
126564462|NCT01720446|455361646|FG003|Overall Study|Lost to Follow-up|16|||
126564463|NCT01720446|455361643|FG000|Overall Study|Withdrawal by Subject|2|||
126564464|NCT01720446|455361644|FG001|Overall Study|Withdrawal by Subject|5|||
126564465|NCT01720446|455361645|FG002|Overall Study|Withdrawal by Subject|4|||
126564466|NCT01720446|455361646|FG003|Overall Study|Withdrawal by Subject|4|||
126564467|NCT04464421|455361647|FG000|Overall Study|Lost to Follow-up|2|||
126564468|NCT04464421|455361648|FG001|Overall Study|Lost to Follow-up|2|||
126564469|NCT01020838|455361649|FG000|Overall Study|Death|90|||
126564470|NCT01020838|455361649|FG000|Overall Study|Adverse Event|1|||
126564471|NCT01020838|455361649|FG000|Overall Study|Withdrawal by Subject|9|||
126564472|NCT01020838|455361649|FG000|Overall Study|Lost to Follow-up|6|||
126564473|NCT01020838|455361649|FG000|Overall Study|Most common: Study ended by sponsor|77|||
126564474|NCT01167426|455361651|FG000|Overall Study|Lost to Follow-up|6|||
126564475|NCT01167426|455361651|FG000|Overall Study|Protocol Violation|1|||
126564476|NCT01167426|455361651|FG000|Overall Study|Withdrawal by Subject|2|||
126564477|NCT01167426|455361651|FG000|Overall Study|Sponsor Decision|1|||
126564478|NCT02274493|455361654|FG000|Overall Study|Withdrawal by Subject|1|||
126564479|NCT00558363|455361655|FG000|Overall Study|Physician Decision|18|||
126564480|NCT00558363|455361656|FG001|Overall Study|Physician Decision|4|||
126564481|NCT00558363|455361655|FG000|Overall Study|Withdrawal by Subject|11|||
126564482|NCT00558363|455361656|FG001|Overall Study|Withdrawal by Subject|4|||
126564483|NCT00558363|455361655|FG000|Overall Study|Adverse Event|5|||
126507333|NCT01481116|455158213|FG002|Overall Study|Lost to Follow-up|11|||
126507334|NCT01481116|455158211|FG000|Overall Study|Withdrawal by Subject|37|||
126507335|NCT01481116|455158212|FG001|Overall Study|Withdrawal by Subject|33|||
126507336|NCT01481116|455158213|FG002|Overall Study|Withdrawal by Subject|37|||
126507337|NCT01481116|455158211|FG000|Overall Study|Study Termination|730|||
126507338|NCT01481116|455158212|FG001|Overall Study|Study Termination|729|||
126507339|NCT01481116|455158213|FG002|Overall Study|Study Termination|713|||
126507340|NCT01481116|455158211|FG000|Overall Study|Pregnancy|0|||
126507341|NCT01481116|455158212|FG001|Overall Study|Pregnancy|0|||
126507342|NCT01481116|455158213|FG002|Overall Study|Pregnancy|1|||
126507343|NCT01481116|455158211|FG000|Overall Study|Lack of Efficacy|3|||
126507344|NCT01481116|455158212|FG001|Overall Study|Lack of Efficacy|3|||
126507345|NCT01481116|455158213|FG002|Overall Study|Lack of Efficacy|1|||
126507346|NCT01481116|455158211|FG000|Overall Study|Contraindications|1|||
126507347|NCT01481116|455158212|FG001|Overall Study|Contraindications|1|||
126507348|NCT01481116|455158213|FG002|Overall Study|Contraindications|0|||
126507349|NCT01481116|455158211|FG000|Overall Study|Other|1|||
126507350|NCT01481116|455158212|FG001|Overall Study|Other|1|||
126507351|NCT01481116|455158213|FG002|Overall Study|Other|0|||
126507352|NCT01481116|455158211|FG000|Overall Study|Participant Started Taking Glipizide|1|||
126507353|NCT01481116|455158212|FG001|Overall Study|Participant Started Taking Glipizide|0|||
126507354|NCT01481116|455158213|FG002|Overall Study|Participant Started Taking Glipizide|0|||
126507355|NCT01481116|455158211|FG000|Overall Study|Participant Moved Out of Area|2|||
126507356|NCT01481116|455158212|FG001|Overall Study|Participant Moved Out of Area|0|||
126507357|NCT01481116|455158213|FG002|Overall Study|Participant Moved Out of Area|1|||
126507358|NCT01481116|455158211|FG000|Overall Study|Participant Moved Out of Country|1|||
126507359|NCT01481116|455158212|FG001|Overall Study|Participant Moved Out of Country|0|||
126507360|NCT01481116|455158213|FG002|Overall Study|Participant Moved Out of Country|1|||
126507361|NCT01481116|455158211|FG000|Overall Study|Investigator Decision|3|||
126507362|NCT01481116|455158212|FG001|Overall Study|Investigator Decision|2|||
126507363|NCT01481116|455158213|FG002|Overall Study|Investigator Decision|1|||
126507364|NCT01481116|455158211|FG000|Overall Study|Sponsor Decision|0|||
126507365|NCT01481116|455158212|FG001|Overall Study|Sponsor Decision|1|||
126507366|NCT01481116|455158213|FG002|Overall Study|Sponsor Decision|3|||
126507367|NCT01481116|455158211|FG000|Overall Study|Non-Compliant With Study Drug|0|||
126507368|NCT01481116|455158212|FG001|Overall Study|Non-Compliant With Study Drug|1|||
126507369|NCT01481116|455158213|FG002|Overall Study|Non-Compliant With Study Drug|1|||
126507370|NCT01481116|455158211|FG000|Overall Study|Investigator's Discretion|2|||
126507371|NCT01481116|455158212|FG001|Overall Study|Investigator's Discretion|0|||
126507372|NCT01481116|455158213|FG002|Overall Study|Investigator's Discretion|0|||
126564484|NCT00558363|455361656|FG001|Overall Study|Adverse Event|5|||
126564485|NCT00558363|455361655|FG000|Overall Study|Lack of Efficacy|2|||
126564486|NCT00558363|455361656|FG001|Overall Study|Lack of Efficacy|2|||
126564487|NCT00558363|455361655|FG000|Overall Study|Protocol Violation|2|||
126564488|NCT00558363|455361656|FG001|Overall Study|Protocol Violation|1|||
126564489|NCT00558363|455361655|FG000|Overall Study|Lost to Follow-up|0|||
126564490|NCT00558363|455361656|FG001|Overall Study|Lost to Follow-up|1|||
126564491|NCT00558363|455361655|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
126564492|NCT00558363|455361656|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
126564493|NCT00558363|455361655|FG000|Overall Study|Randomized in Error|1|||
126564494|NCT00558363|455361656|FG001|Overall Study|Randomized in Error|2|||
126564495|NCT00558363|455361655|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
126564496|NCT00558363|455361656|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
126564497|NCT03102710|455361657|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
126564498|NCT03102710|455361658|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
126564499|NCT03102710|455361659|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
126564500|NCT03102710|455361657|FG000|Overall Study|Technical issues during final MRI scan|0|||
126564501|NCT03102710|455361658|FG001|Overall Study|Technical issues during final MRI scan|1|||
126564502|NCT03102710|455361659|FG002|Overall Study|Technical issues during final MRI scan|0|||
126564503|NCT03102710|455361657|FG000|Overall Study|Nausea during MRI scan|0|||
126564504|NCT03102710|455361658|FG001|Overall Study|Nausea during MRI scan|1|||
126564505|NCT03102710|455361659|FG002|Overall Study|Nausea during MRI scan|0|||
126564506|NCT03102710|455361657|FG000|Overall Study|Subject unable to attend final session|0|||
126564507|NCT03102710|455361658|FG001|Overall Study|Subject unable to attend final session|1|||
126564508|NCT03102710|455361659|FG002|Overall Study|Subject unable to attend final session|0|||
126564509|NCT04012853|455361660|FG000|Overall Study|Withdrawal by Subject|1|||
126564510|NCT04012853|455361661|FG001|Overall Study|Withdrawal by Subject|1|||
126507373|NCT01481116|455158211|FG000|Overall Study|Death|2|||
126507374|NCT01481116|455158212|FG001|Overall Study|Death|1|||
126507375|NCT01481116|455158213|FG002|Overall Study|Death|0|||
126507376|NCT01481116|455158211|FG000|Overall Study|Hypoglycemic Event|4|||
126507377|NCT01481116|455158212|FG001|Overall Study|Hypoglycemic Event|0|||
126507378|NCT01481116|455158213|FG002|Overall Study|Hypoglycemic Event|0|||
126507379|NCT00640510|455158214|FG000|Overall Study|Lack of Efficacy|0|||
126507380|NCT00640510|455158215|FG001|Overall Study|Lack of Efficacy|1|||
126564511|NCT04012853|455361660|FG000|Overall Study|Protocol Violation|1|||
126564512|NCT04012853|455361661|FG001|Overall Study|Protocol Violation|0|||
126564513|NCT04012853|455361660|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
126564514|NCT04012853|455361661|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
126564515|NCT01101165|455361664|FG000|Period 1|Adverse Event|1|||
126564516|NCT01101165|455361665|FG001|Period 1|Adverse Event|2|||
126564517|NCT01101165|455361664|FG000|Period 1|Withdrawal by Subject|0|||
126564518|NCT01101165|455361665|FG001|Period 1|Withdrawal by Subject|2|||
126564519|NCT01101165|455361664|FG000|Period 1|Positive Drug Screen|0|||
126564520|NCT01101165|455361665|FG001|Period 1|Positive Drug Screen|1|||
126564521|NCT01101165|455361664|FG000|Period 1|Lost to Follow-up|1|||
126564522|NCT01101165|455361665|FG001|Period 1|Lost to Follow-up|0|||
126564523|NCT01101165|455361664|FG000|Period 2|Withdrawal by Subject|3|||
126564524|NCT01101165|455361665|FG001|Period 2|Withdrawal by Subject|1|||
126564525|NCT01101165|455361664|FG000|Period 2|Adverse Event|1|||
126564526|NCT01101165|455361665|FG001|Period 2|Adverse Event|0|||
126564527|NCT00015457|455361666|FG000|First Intervention|Adverse Event|0|||
126564528|NCT00015457|455361667|FG001|First Intervention|Adverse Event|2|||
126564529|NCT00015457|455361666|FG000|First Intervention|Lack of Efficacy|0|||
126564530|NCT00015457|455361667|FG001|First Intervention|Lack of Efficacy|1|||
126564531|NCT00015457|455361666|FG000|Second Intervention|Withdrawal by Subject|1|||
126564532|NCT00015457|455361667|FG001|Second Intervention|Withdrawal by Subject|0|||
126564533|NCT02317705|455361668|FG000|Overall Study|Withdrawal by Subject|3|||
126564534|NCT02317705|455361668|FG000|Overall Study|Physician Decision|1|||
126564535|NCT02317705|455361668|FG000|Overall Study|Drug not usable|1|||
126564536|NCT02219490|455361669|FG000|Overall Study|Adverse Event|24|||
126564537|NCT02219490|455361669|FG000|Overall Study|Withdrew consent|96|||
126564538|NCT02219490|455361669|FG000|Overall Study|Lost to Follow-up|126|||
126564539|NCT02219490|455361669|FG000|Overall Study|COVID-19 infection|2|||
126564540|NCT02219490|455361669|FG000|Overall Study|COVID-19 logistical restrictions|33|||
126564541|NCT02219490|455361669|FG000|Overall Study|Other, not specified|57|||
126564542|NCT01599325|455361670|FG000|Primary Parent Phase|Adverse Event|5|||
126564543|NCT01599325|455361670|FG000|Primary Parent Phase|Disease Progression|7|||
126564544|NCT01599325|455361670|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
126564545|NCT01599325|455361670|FG000|Primary Parent Phase|Death|13|||
126564546|NCT01599325|455361670|FG000|Primary Parent Phase|Protocol Violation|1|||
126564547|NCT01599325|455361670|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
126564548|NCT01599325|455361670|FG000|Primary Parent Phase|Other|2|||
126564549|NCT01599325|455361670|FG000|Extension Phase|Study Closure|1|||
126564550|NCT01599325|455361670|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
126564551|NCT01599325|455361670|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
126564552|NCT01599325|455361670|FG000|Extension Phase|Disease Progression|1|||
126564553|NCT01599325|455361670|FG000|Extension Phase|Withdrawal by Subject|8|||
126564554|NCT00567164|455361674|FG000|Overall Study|Withdrawal by Subject|171|||
126564555|NCT00567164|455361675|FG001|Overall Study|Withdrawal by Subject|21|||
126564556|NCT00567164|455361676|FG002|Overall Study|Withdrawal by Subject|17|||
126564557|NCT00567164|455361674|FG000|Overall Study|Protocol Violation|23|||
126564558|NCT00567164|455361675|FG001|Overall Study|Protocol Violation|4|||
126564559|NCT00567164|455361676|FG002|Overall Study|Protocol Violation|2|||
126564560|NCT00567164|455361674|FG000|Overall Study|Adverse Event|92|||
126564561|NCT00567164|455361675|FG001|Overall Study|Adverse Event|13|||
126564562|NCT00567164|455361676|FG002|Overall Study|Adverse Event|9|||
126564563|NCT00567164|455361674|FG000|Overall Study|Death|0|||
126564564|NCT00567164|455361675|FG001|Overall Study|Death|0|||
126564565|NCT00567164|455361676|FG002|Overall Study|Death|1|||
126564566|NCT00567164|455361674|FG000|Overall Study|Lost to Follow-up|202|||
126564567|NCT00567164|455361675|FG001|Overall Study|Lost to Follow-up|23|||
126564568|NCT00567164|455361676|FG002|Overall Study|Lost to Follow-up|21|||
126564569|NCT00567164|455361674|FG000|Overall Study|Pregnancy|20|||
126564570|NCT00567164|455361675|FG001|Overall Study|Pregnancy|4|||
126564571|NCT00567164|455361676|FG002|Overall Study|Pregnancy|6|||
126564572|NCT00567164|455361674|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
126564573|NCT00567164|455361675|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
126564574|NCT00567164|455361676|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
126564575|NCT00567164|455361674|FG000|Overall Study|Missing|1|||
126564576|NCT00567164|455361675|FG001|Overall Study|Missing|0|||
126564577|NCT00567164|455361676|FG002|Overall Study|Missing|0|||
126564578|NCT02430532|455361677|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
126564579|NCT02430532|455361678|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
126564580|NCT02430532|455361677|FG000|Overall Study|Consent Withdrawn|0|||
126564581|NCT02430532|455361678|FG001|Overall Study|Consent Withdrawn|2|||
126564582|NCT02430532|455361677|FG000|Overall Study|Adverse Event|0|||
126564583|NCT02430532|455361678|FG001|Overall Study|Adverse Event|1|||
126564584|NCT03256344|455361679|FG000|Overall Study|Death|6|||
126564585|NCT03256344|455361680|FG001|Overall Study|Death|22|||
126564586|NCT03256344|455361679|FG000|Overall Study|Withdrawal by Subject|3|||
126564587|NCT03256344|455361680|FG001|Overall Study|Withdrawal by Subject|3|||
126564588|NCT03256344|455361679|FG000|Overall Study|Sponsor Decision|1|||
126564589|NCT03256344|455361680|FG001|Overall Study|Sponsor Decision|0|||
126564590|NCT03586167|455361692|FG000|Overall Study|Other|1|||
126507381|NCT00640510|455158214|FG000|Overall Study|Protocol Violation|1|||
126507382|NCT00640510|455158215|FG001|Overall Study|Protocol Violation|0|||
126507383|NCT00640510|455158214|FG000|Overall Study|Physician Decision|0|||
126507384|NCT00640510|455158215|FG001|Overall Study|Physician Decision|1|||
126507385|NCT00355238|455158221|FG000|Overall Study|Adverse event unrelated to study drug|2|||
126507386|NCT00355238|455158222|FG001|Overall Study|Adverse event unrelated to study drug|2|||
126507387|NCT00355238|455158223|FG002|Overall Study|Adverse event unrelated to study drug|0|||
126507388|NCT00355238|455158224|FG003|Overall Study|Adverse event unrelated to study drug|1|||
126507389|NCT00355238|455158221|FG000|Overall Study|Death|1|||
126507390|NCT00355238|455158222|FG001|Overall Study|Death|0|||
126507391|NCT00355238|455158223|FG002|Overall Study|Death|0|||
126507392|NCT00355238|455158224|FG003|Overall Study|Death|0|||
126507393|NCT00355238|455158221|FG000|Overall Study|Disease progression|37|||
126507394|NCT00355238|455158222|FG001|Overall Study|Disease progression|36|||
126507395|NCT00355238|455158223|FG002|Overall Study|Disease progression|16|||
126507396|NCT00355238|455158224|FG003|Overall Study|Disease progression|11|||
126507397|NCT00355238|455158221|FG000|Overall Study|Study drug toxicity|11|||
126507398|NCT00355238|455158222|FG001|Overall Study|Study drug toxicity|7|||
126507399|NCT00355238|455158223|FG002|Overall Study|Study drug toxicity|5|||
126507400|NCT00355238|455158224|FG003|Overall Study|Study drug toxicity|2|||
126507401|NCT00355238|455158221|FG000|Overall Study|Participant withdrew consent|3|||
126507402|NCT00355238|455158222|FG001|Overall Study|Participant withdrew consent|1|||
126507403|NCT00355238|455158223|FG002|Overall Study|Participant withdrew consent|0|||
126507404|NCT00355238|455158224|FG003|Overall Study|Participant withdrew consent|0|||
126507405|NCT00355238|455158221|FG000|Overall Study|Participant request to discontinue study treatment|1|||
126507406|NCT00355238|455158222|FG001|Overall Study|Participant request to discontinue study treatment|0|||
126507407|NCT00355238|455158223|FG002|Overall Study|Participant request to discontinue study treatment|1|||
126507408|NCT00355238|455158224|FG003|Overall Study|Participant request to discontinue study treatment|0|||
126507409|NCT00910715|455158231|FG000|Overall Study|Lost to Follow-up|22|||
126507410|NCT00910715|455158232|FG001|Overall Study|Lost to Follow-up|26|||
126507411|NCT00910715|455158233|FG002|Overall Study|Lost to Follow-up|0|||
126507412|NCT01467076|455158234|FG000|Overall Study|Lost to Follow-up|1|||
126507413|NCT01467076|455158235|FG001|Overall Study|Lost to Follow-up|0|||
126507414|NCT01467076|455158236|FG002|Overall Study|Lost to Follow-up|0|||
126507415|NCT00418691|455158238|FG000|Overall Study|Lost to Follow-up|1|||
126507416|NCT00418691|455158239|FG001|Overall Study|Lost to Follow-up|2|||
126507417|NCT00418691|455158240|FG002|Overall Study|Lost to Follow-up|3|||
126507418|NCT00418691|455158238|FG000|Overall Study|Started new medication voiding entry|0|||
126507419|NCT00418691|455158239|FG001|Overall Study|Started new medication voiding entry|0|||
126507420|NCT00418691|455158240|FG002|Overall Study|Started new medication voiding entry|1|||
126507421|NCT00418691|455158238|FG000|Overall Study|Progressive Disease|1|||
126507422|NCT00418691|455158239|FG001|Overall Study|Progressive Disease|0|||
126507423|NCT00418691|455158240|FG002|Overall Study|Progressive Disease|1|||
126507424|NCT02465528|455158243|FG000|Overall Study|Progressive disease|0|||
126507425|NCT02465528|455158244|FG001|Overall Study|Progressive disease|2|||
126507426|NCT02465528|455158245|FG002|Overall Study|Progressive disease|9|||
126507427|NCT02465528|455158246|FG003|Overall Study|Progressive disease|4|||
126507428|NCT02465528|455158243|FG000|Overall Study|Study terminated by sponsor|1|||
126507429|NCT02465528|455158244|FG001|Overall Study|Study terminated by sponsor|2|||
126507430|NCT02465528|455158245|FG002|Overall Study|Study terminated by sponsor|0|||
126507431|NCT02465528|455158246|FG003|Overall Study|Study terminated by sponsor|0|||
126507432|NCT02465528|455158243|FG000|Overall Study|Withdrawal by Subject|0|||
126507433|NCT02465528|455158244|FG001|Overall Study|Withdrawal by Subject|0|||
126507434|NCT02465528|455158245|FG002|Overall Study|Withdrawal by Subject|2|||
126507435|NCT02465528|455158246|FG003|Overall Study|Withdrawal by Subject|0|||
126507436|NCT02465528|455158243|FG000|Overall Study|Adverse Event|0|||
126507437|NCT02465528|455158244|FG001|Overall Study|Adverse Event|0|||
126507438|NCT02465528|455158245|FG002|Overall Study|Adverse Event|0|||
126507439|NCT02465528|455158246|FG003|Overall Study|Adverse Event|1|||
126507440|NCT02465528|455158243|FG000|Overall Study|Physician Decision|0|||
126507441|NCT02465528|455158244|FG001|Overall Study|Physician Decision|0|||
126507442|NCT02465528|455158245|FG002|Overall Study|Physician Decision|1|||
126507443|NCT02465528|455158246|FG003|Overall Study|Physician Decision|0|||
126507444|NCT04649151|455158249|FG000|Overall Study|Pregnancy|0|||
126507445|NCT04649151|455158250|FG001|Overall Study|Pregnancy|0|||
126507446|NCT04649151|455158251|FG002|Overall Study|Pregnancy|0|||
126507447|NCT04649151|455158252|FG003|Overall Study|Pregnancy|0|||
126507448|NCT04649151|455158253|FG004|Overall Study|Pregnancy|3|||
126507449|NCT04649151|455158249|FG000|Overall Study|Physician Decision|10|||
126507450|NCT04649151|455158250|FG001|Overall Study|Physician Decision|0|||
126507451|NCT04649151|455158251|FG002|Overall Study|Physician Decision|0|||
126507452|NCT04649151|455158252|FG003|Overall Study|Physician Decision|1|||
126507453|NCT04649151|455158253|FG004|Overall Study|Physician Decision|1|||
126507454|NCT04649151|455158249|FG000|Overall Study|Protocol Deviation|25|||
126507455|NCT04649151|455158250|FG001|Overall Study|Protocol Deviation|3|||
126507456|NCT04649151|455158251|FG002|Overall Study|Protocol Deviation|0|||
126507457|NCT04649151|455158252|FG003|Overall Study|Protocol Deviation|0|||
126507458|NCT04649151|455158253|FG004|Overall Study|Protocol Deviation|0|||
126507459|NCT04649151|455158249|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
126507460|NCT04649151|455158250|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
126507461|NCT04649151|455158251|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
126507462|NCT04649151|455158252|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
126507463|NCT04649151|455158253|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
126507464|NCT04649151|455158249|FG000|Overall Study|Withdrawal by Subject|370|||
126507465|NCT04649151|455158250|FG001|Overall Study|Withdrawal by Subject|113|||
126507466|NCT04649151|455158251|FG002|Overall Study|Withdrawal by Subject|2|||
126507467|NCT04649151|455158252|FG003|Overall Study|Withdrawal by Subject|7|||
126507468|NCT04649151|455158253|FG004|Overall Study|Withdrawal by Subject|15|||
126507469|NCT04649151|455158249|FG000|Overall Study|Adverse Event|1|||
126507470|NCT04649151|455158250|FG001|Overall Study|Adverse Event|0|||
126507471|NCT04649151|455158251|FG002|Overall Study|Adverse Event|0|||
126507472|NCT04649151|455158252|FG003|Overall Study|Adverse Event|0|||
126507473|NCT04649151|455158253|FG004|Overall Study|Adverse Event|0|||
126507474|NCT04649151|455158249|FG000|Overall Study|Lost to Follow-up|256|||
126507475|NCT04649151|455158250|FG001|Overall Study|Lost to Follow-up|29|||
126507476|NCT04649151|455158251|FG002|Overall Study|Lost to Follow-up|10|||
126507477|NCT04649151|455158252|FG003|Overall Study|Lost to Follow-up|3|||
126507478|NCT04649151|455158253|FG004|Overall Study|Lost to Follow-up|6|||
126507479|NCT04649151|455158249|FG000|Overall Study|Other than specified|59|||
126507480|NCT04649151|455158250|FG001|Overall Study|Other than specified|294|||
126507481|NCT04649151|455158251|FG002|Overall Study|Other than specified|0|||
126507482|NCT04649151|455158252|FG003|Overall Study|Other than specified|0|||
126507483|NCT04649151|455158253|FG004|Overall Study|Other than specified|4|||
126507484|NCT04649151|455158249|FG000|Overall Study|Death|0|||
126507485|NCT04649151|455158250|FG001|Overall Study|Death|0|||
126507486|NCT04649151|455158251|FG002|Overall Study|Death|0|||
126507487|NCT04649151|455158252|FG003|Overall Study|Death|0|||
126507488|NCT04649151|455158253|FG004|Overall Study|Death|1|||
126507489|NCT03752619|455158254|FG000|Overall Study|Lost to Follow-up|2|||
126507490|NCT03752619|455158255|FG001|Overall Study|Lost to Follow-up|1|||
126507491|NCT03752619|455158254|FG000|Overall Study|Withdrawal by Subject|1|||
126507492|NCT03752619|455158255|FG001|Overall Study|Withdrawal by Subject|1|||
126507493|NCT03752619|455158254|FG000|Overall Study|Adverse Event|0|||
126507494|NCT03752619|455158255|FG001|Overall Study|Adverse Event|1|||
126507495|NCT03907683|455158257|FG000|Overall Study|Pregnancy|1|||
126507496|NCT03907683|455158257|FG000|Overall Study|Withdrawal by Subject|1|||
126507497|NCT03400332|455158258|FG000|Pre-Treatment|Other reasons|0|||
126507498|NCT03400332|455158259|FG001|Pre-Treatment|Other reasons|0|||
126507499|NCT03400332|455158260|FG002|Pre-Treatment|Other reasons|0|||
126507500|NCT03400332|455158261|FG003|Pre-Treatment|Other reasons|0|||
126507501|NCT03400332|455158262|FG004|Pre-Treatment|Other reasons|0|||
126507502|NCT03400332|455158263|FG005|Pre-Treatment|Other reasons|0|||
126507503|NCT03400332|455158264|FG006|Pre-Treatment|Other reasons|0|||
126507504|NCT03400332|455158265|FG007|Pre-Treatment|Other reasons|0|||
126507505|NCT03400332|455158266|FG008|Pre-Treatment|Other reasons|1|||
126507506|NCT03400332|455158258|FG000|Pre-Treatment|No longer met study criteria|0|||
126507507|NCT03400332|455158259|FG001|Pre-Treatment|No longer met study criteria|0|||
126507508|NCT03400332|455158260|FG002|Pre-Treatment|No longer met study criteria|0|||
126507509|NCT03400332|455158261|FG003|Pre-Treatment|No longer met study criteria|0|||
126507510|NCT03400332|455158262|FG004|Pre-Treatment|No longer met study criteria|0|||
126507511|NCT03400332|455158263|FG005|Pre-Treatment|No longer met study criteria|0|||
126507512|NCT03400332|455158264|FG006|Pre-Treatment|No longer met study criteria|0|||
126507513|NCT03400332|455158265|FG007|Pre-Treatment|No longer met study criteria|0|||
126507514|NCT03400332|455158266|FG008|Pre-Treatment|No longer met study criteria|1|||
126507515|NCT03400332|455158258|FG000|Pre-Treatment|Withdrawal by Subject|0|||
126507516|NCT03400332|455158259|FG001|Pre-Treatment|Withdrawal by Subject|0|||
126507517|NCT03400332|455158260|FG002|Pre-Treatment|Withdrawal by Subject|0|||
126507518|NCT03400332|455158261|FG003|Pre-Treatment|Withdrawal by Subject|0|||
126507519|NCT03400332|455158262|FG004|Pre-Treatment|Withdrawal by Subject|0|||
126507520|NCT03400332|455158263|FG005|Pre-Treatment|Withdrawal by Subject|0|||
126507521|NCT03400332|455158264|FG006|Pre-Treatment|Withdrawal by Subject|0|||
126507522|NCT03400332|455158265|FG007|Pre-Treatment|Withdrawal by Subject|0|||
126507523|NCT03400332|455158266|FG008|Pre-Treatment|Withdrawal by Subject|1|||
126507524|NCT03400332|455158258|FG000|Treatment|Participant withdrew consent|2|||
126507525|NCT03400332|455158259|FG001|Treatment|Participant withdrew consent|2|||
126507526|NCT03400332|455158260|FG002|Treatment|Participant withdrew consent|0|||
126507527|NCT03400332|455158261|FG003|Treatment|Participant withdrew consent|0|||
126507528|NCT03400332|455158262|FG004|Treatment|Participant withdrew consent|3|||
126507529|NCT03400332|455158263|FG005|Treatment|Participant withdrew consent|3|||
126507530|NCT03400332|455158264|FG006|Treatment|Participant withdrew consent|1|||
126507531|NCT03400332|455158265|FG007|Treatment|Participant withdrew consent|1|||
126507532|NCT03400332|455158266|FG008|Treatment|Participant withdrew consent|1|||
126507533|NCT03400332|455158258|FG000|Treatment|Other reasons|0|||
126507534|NCT03400332|455158259|FG001|Treatment|Other reasons|1|||
126507535|NCT03400332|455158260|FG002|Treatment|Other reasons|1|||
126564591|NCT03586167|455361693|FG001|Overall Study|Other|0|||
126564592|NCT00591838|455361694|FG000|Overall Study|Withdrawal by Subject|0|||
126564593|NCT00591838|455361695|FG001|Overall Study|Withdrawal by Subject|0|||
126564594|NCT00591838|455361696|FG002|Overall Study|Withdrawal by Subject|0|||
126564595|NCT00591838|455361697|FG003|Overall Study|Withdrawal by Subject|1|||
126564596|NCT00591838|455361698|FG004|Overall Study|Withdrawal by Subject|0|||
126564597|NCT04163458|455361701|FG000|Overall Study|Protocol Deviation|7|||
126564598|NCT04163458|455361702|FG001|Overall Study|Protocol Deviation|13|||
126564599|NCT04163458|455361701|FG000|Overall Study|Adverse Event|5|||
126564600|NCT04163458|455361702|FG001|Overall Study|Adverse Event|8|||
126564601|NCT04163458|455361701|FG000|Overall Study|Due to COVID-19 pandemic|4|||
126564602|NCT04163458|455361702|FG001|Overall Study|Due to COVID-19 pandemic|2|||
126564603|NCT04163458|455361701|FG000|Overall Study|Participant withdrew consent|2|||
126564604|NCT04163458|455361702|FG001|Overall Study|Participant withdrew consent|3|||
126564605|NCT04163458|455361701|FG000|Overall Study|Randomization failure|2|||
126564606|NCT04163458|455361702|FG001|Overall Study|Randomization failure|2|||
126564607|NCT04163458|455361701|FG000|Overall Study|Other|4|||
126564608|NCT04163458|455361702|FG001|Overall Study|Other|2|||
126564609|NCT01467700|455361703|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
126564610|NCT01467700|455361704|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
126564611|NCT01467700|455361705|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
126564612|NCT01467700|455361706|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
126564613|NCT01467700|455361703|FG000|Overall Study|Major Protocol Deviation|3|||
126564614|NCT01467700|455361704|FG001|Overall Study|Major Protocol Deviation|3|||
126564615|NCT01467700|455361705|FG002|Overall Study|Major Protocol Deviation|2|||
126564616|NCT01467700|455361706|FG003|Overall Study|Major Protocol Deviation|3|||
126564617|NCT01467700|455361703|FG000|Overall Study|Lost to Follow-up|6|||
126564618|NCT01467700|455361704|FG001|Overall Study|Lost to Follow-up|5|||
126564619|NCT01467700|455361705|FG002|Overall Study|Lost to Follow-up|2|||
126564620|NCT01467700|455361706|FG003|Overall Study|Lost to Follow-up|3|||
126564621|NCT01467700|455361703|FG000|Overall Study|Voluntary Withdrawal|5|||
126564622|NCT01467700|455361704|FG001|Overall Study|Voluntary Withdrawal|7|||
126564623|NCT01467700|455361705|FG002|Overall Study|Voluntary Withdrawal|6|||
126564624|NCT01467700|455361706|FG003|Overall Study|Voluntary Withdrawal|2|||
126564625|NCT01467700|455361703|FG000|Overall Study|Study Termination|6|||
126564626|NCT01467700|455361704|FG001|Overall Study|Study Termination|5|||
126564627|NCT01467700|455361705|FG002|Overall Study|Study Termination|10|||
126564628|NCT01467700|455361706|FG003|Overall Study|Study Termination|7|||
126564629|NCT01467700|455361703|FG000|Overall Study|Pregnancy|0|||
126564630|NCT01467700|455361704|FG001|Overall Study|Pregnancy|1|||
126564631|NCT01467700|455361705|FG002|Overall Study|Pregnancy|1|||
126564632|NCT01467700|455361706|FG003|Overall Study|Pregnancy|0|||
126564633|NCT01467700|455361703|FG000|Overall Study|Lack of Efficacy|2|||
126564634|NCT01467700|455361704|FG001|Overall Study|Lack of Efficacy|0|||
126564635|NCT01467700|455361705|FG002|Overall Study|Lack of Efficacy|2|||
126564636|NCT01467700|455361706|FG003|Overall Study|Lack of Efficacy|1|||
126564637|NCT01467700|455361703|FG000|Overall Study|Reason not Specified|1|||
126564638|NCT01467700|455361704|FG001|Overall Study|Reason not Specified|3|||
126564639|NCT01467700|455361705|FG002|Overall Study|Reason not Specified|2|||
126564640|NCT01467700|455361706|FG003|Overall Study|Reason not Specified|8|||
126564641|NCT00121199|455361708|FG000|Overall Study|Adverse Event|11|||
126564642|NCT00121199|455361708|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
126564643|NCT00121199|455361708|FG000|Overall Study|Progression/Relapse|1|||
126564644|NCT00121199|455361708|FG000|Overall Study|Death|3|||
126564645|NCT00121199|455361708|FG000|Overall Study|Other - Not Protocol Specified|3|||
126564646|NCT00121199|455361708|FG000|Overall Study|Ineligible|9|||
126564647|NCT04109118|455361711|FG000|Overall Study|Lost to Follow-up|3|||
126564648|NCT03235349|455361714|FG000|Overall Study|Adverse Event|1|||
126564649|NCT03235349|455361714|FG000|Overall Study|Other|1|||
126564650|NCT01018511|455361717|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
126564651|NCT01018511|455361718|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
126564652|NCT01018511|455361719|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
126564653|NCT01018511|455361720|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
126564654|NCT01018511|455361717|FG000|Overall Study|Adverse Event|5|||
126564655|NCT01018511|455361718|FG001|Overall Study|Adverse Event|9|||
126564656|NCT01018511|455361719|FG002|Overall Study|Adverse Event|13|||
126564657|NCT01018511|455361720|FG003|Overall Study|Adverse Event|10|||
126564658|NCT01018511|455361717|FG000|Overall Study|Lack of Efficacy|4|||
126564659|NCT01018511|455361718|FG001|Overall Study|Lack of Efficacy|1|||
126564660|NCT01018511|455361719|FG002|Overall Study|Lack of Efficacy|1|||
126564661|NCT01018511|455361720|FG003|Overall Study|Lack of Efficacy|2|||
126564662|NCT01018511|455361717|FG000|Overall Study|Withdrawal by Subject|6|||
126564663|NCT01018511|455361718|FG001|Overall Study|Withdrawal by Subject|5|||
126564664|NCT01018511|455361719|FG002|Overall Study|Withdrawal by Subject|11|||
126564665|NCT01018511|455361720|FG003|Overall Study|Withdrawal by Subject|9|||
126564666|NCT01018511|455361717|FG000|Overall Study|Lost to Follow-up|0|||
126564667|NCT01018511|455361718|FG001|Overall Study|Lost to Follow-up|0|||
126564668|NCT01018511|455361719|FG002|Overall Study|Lost to Follow-up|1|||
126564669|NCT01018511|455361720|FG003|Overall Study|Lost to Follow-up|0|||
126564670|NCT01018511|455361717|FG000|Overall Study|Protocol Violation|5|||
126564671|NCT01018511|455361718|FG001|Overall Study|Protocol Violation|8|||
126564672|NCT01018511|455361719|FG002|Overall Study|Protocol Violation|7|||
126564673|NCT01018511|455361720|FG003|Overall Study|Protocol Violation|9|||
126564674|NCT01018511|455361717|FG000|Overall Study|Miscellaneous|0|||
126564675|NCT01018511|455361718|FG001|Overall Study|Miscellaneous|2|||
126564676|NCT01018511|455361719|FG002|Overall Study|Miscellaneous|0|||
126564677|NCT01018511|455361720|FG003|Overall Study|Miscellaneous|0|||
126564678|NCT04550039|455361721|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
126564679|NCT04550039|455361722|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
126564680|NCT04550039|455361721|FG000|Overall Study|patient self-withdrew from study|0|||
126564681|NCT04550039|455361722|FG001|Overall Study|patient self-withdrew from study|1|||
126564682|NCT03396913|455361724|FG000|Overall Study|Lost to Follow-up|0|||
126564683|NCT03396913|455361725|FG001|Overall Study|Lost to Follow-up|6|||
126564684|NCT00828945|455361728|FG000|Overall Study|Death|4|||
126564685|NCT00828945|455361728|FG000|Overall Study|Participant was missing|1|||
126564686|NCT00828945|455361728|FG000|Overall Study|Other|36|||
126564687|NCT02482233|455361729|FG000|Overall Study|Lost to Follow-up|1|||
126564688|NCT02482233|455361730|FG001|Overall Study|Lost to Follow-up|1|||
126564689|NCT00871429|455361732|FG000|Overall Study|Lost to Follow-up|6|||
126564690|NCT00871429|455361732|FG000|Overall Study|Withdrawal by Subject|17|||
126564691|NCT00871429|455361732|FG000|Overall Study|Questionnaire not completed|1|||
126564692|NCT01772719|455361735|FG000|Overall Study|Withdrawal by Subject|3|||
126564693|NCT01772719|455361735|FG000|Overall Study|Adverse Event|2|||
126564694|NCT01772719|455361735|FG000|Overall Study|Protocol Violation|1|||
126564695|NCT01772719|455361735|FG000|Overall Study|Lost to Follow-up|1|||
126564696|NCT00299702|455361737|FG000|Overall Study|Death|1|||
126564697|NCT00299702|455361738|FG001|Overall Study|Death|0|||
126564698|NCT00299702|455361737|FG000|Overall Study|Adverse Event|0|||
126564699|NCT00299702|455361738|FG001|Overall Study|Adverse Event|4|||
126507536|NCT03400332|455158261|FG003|Treatment|Other reasons|0|||
126507537|NCT03400332|455158262|FG004|Treatment|Other reasons|3|||
126507538|NCT03400332|455158263|FG005|Treatment|Other reasons|1|||
126507539|NCT03400332|455158264|FG006|Treatment|Other reasons|2|||
126507540|NCT03400332|455158265|FG007|Treatment|Other reasons|0|||
126507541|NCT03400332|455158266|FG008|Treatment|Other reasons|1|||
126507542|NCT03400332|455158258|FG000|Treatment|Lost to Follow-up|0|||
126507543|NCT03400332|455158259|FG001|Treatment|Lost to Follow-up|1|||
126507544|NCT03400332|455158260|FG002|Treatment|Lost to Follow-up|0|||
126507545|NCT03400332|455158261|FG003|Treatment|Lost to Follow-up|0|||
126507546|NCT03400332|455158262|FG004|Treatment|Lost to Follow-up|0|||
126507547|NCT03400332|455158263|FG005|Treatment|Lost to Follow-up|0|||
126564700|NCT00299702|455361737|FG000|Overall Study|Lost to Follow-up|18|||
126564701|NCT00299702|455361738|FG001|Overall Study|Lost to Follow-up|10|||
126564702|NCT00299702|455361737|FG000|Overall Study|Withdrawal by Subject|25|||
126564703|NCT00299702|455361738|FG001|Overall Study|Withdrawal by Subject|23|||
126564704|NCT00299702|455361737|FG000|Overall Study|Pregnancy|0|||
126564705|NCT00299702|455361738|FG001|Overall Study|Pregnancy|1|||
126564706|NCT00299702|455361737|FG000|Overall Study|Insufficient Response|4|||
126564707|NCT00299702|455361738|FG001|Overall Study|Insufficient Response|3|||
126564708|NCT00299702|455361737|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
126564709|NCT00299702|455361738|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
126564710|NCT00751036|455361739|FG000|Overall Study|Disease Progression|28|||
126564711|NCT00751036|455361740|FG001|Overall Study|Disease Progression|29|||
126564712|NCT00751036|455361739|FG000|Overall Study|Adverse Event|6|||
126564713|NCT00751036|455361740|FG001|Overall Study|Adverse Event|4|||
126564714|NCT00751036|455361739|FG000|Overall Study|Administrative Problems|3|||
126564715|NCT00751036|455361740|FG001|Overall Study|Administrative Problems|4|||
126564716|NCT00751036|455361739|FG000|Overall Study|Withdrawal by Subject|5|||
126507548|NCT03400332|455158264|FG006|Treatment|Lost to Follow-up|0|||
126564717|NCT00751036|455361740|FG001|Overall Study|Withdrawal by Subject|2|||
126564718|NCT00751036|455361739|FG000|Overall Study|Death|3|||
126564719|NCT00751036|455361740|FG001|Overall Study|Death|3|||
126507549|NCT03400332|455158265|FG007|Treatment|Lost to Follow-up|0|||
126564720|NCT00751036|455361739|FG000|Overall Study|Lost to Follow-up|0|||
126564721|NCT00751036|455361740|FG001|Overall Study|Lost to Follow-up|1|||
126564722|NCT00751036|455361739|FG000|Overall Study|Protocol Violation|1|||
126564723|NCT00751036|455361740|FG001|Overall Study|Protocol Violation|0|||
126564724|NCT00751036|455361739|FG000|Overall Study|Missing end of Treatment Page|2|||
126564725|NCT00751036|455361740|FG001|Overall Study|Missing end of Treatment Page|3|||
126564726|NCT05460663|455361741|FG000|Overall Study|Withdrawal by Subject|2|||
126507550|NCT03400332|455158266|FG008|Treatment|Lost to Follow-up|0|||
126507551|NCT03400332|455158258|FG000|Treatment|Death|3|||
126507552|NCT03400332|455158259|FG001|Treatment|Death|1|||
126564727|NCT05460663|455361742|FG001|Overall Study|Withdrawal by Subject|5|||
126507553|NCT03400332|455158260|FG002|Treatment|Death|2|||
126507554|NCT03400332|455158261|FG003|Treatment|Death|3|||
126507555|NCT03400332|455158262|FG004|Treatment|Death|6|||
126507556|NCT03400332|455158263|FG005|Treatment|Death|2|||
126564728|NCT03820986|455361743|FG000|Overall Study|Death|177|||
126564729|NCT03820986|455361744|FG001|Overall Study|Death|156|||
126564730|NCT03820986|455361743|FG000|Overall Study|Lost to Follow-up|0|||
126564731|NCT03820986|455361744|FG001|Overall Study|Lost to Follow-up|1|||
126564732|NCT03820986|455361743|FG000|Overall Study|Withdrawal by Subject|8|||
126564733|NCT03820986|455361744|FG001|Overall Study|Withdrawal by Subject|3|||
126564734|NCT03820986|455361743|FG000|Overall Study|Ongoing|149|||
126564735|NCT03820986|455361744|FG001|Overall Study|Ongoing|180|||
126564736|NCT05526911|455363272|FG000|Overall Study|Adverse Event|2|||
126564737|NCT05025449|455363273|FG000|Overall Study|Withdrawal by Subject|1|||
126564738|NCT05025449|455363273|FG000|Overall Study|Patient emergently taken to operating room|1|||
126564739|NCT00613301|455363274|FG000|Overall Study|Adverse Event|49|||
126564740|NCT00613301|455363274|FG000|Overall Study|Lost to Follow-up|88|||
126564741|NCT00613301|455363274|FG000|Overall Study|Withdrawal by Subject|5|||
126564742|NCT00613301|455363274|FG000|Overall Study|Death|6|||
126564743|NCT00613301|455363274|FG000|Overall Study|Lack of Efficacy|13|||
126564744|NCT00613301|455363274|FG000|Overall Study|Physician Decision|2|||
126564745|NCT00613301|455363274|FG000|Overall Study|No data was collected|53|||
126564746|NCT00613301|455363274|FG000|Overall Study|Irregularly enrolled patients|12|||
126564747|NCT00569946|455363275|FG000|Overall Study|Adverse Event|16|||
126564748|NCT00569946|455363275|FG000|Overall Study|Objective Progression or Relapse|42|||
126564749|NCT00569946|455363275|FG000|Overall Study|Global Deterioration of Health Status|1|||
126564750|NCT00762463|455363277|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
126564751|NCT00762463|455363278|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
126564752|NCT00762463|455363279|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
126564753|NCT00762463|455363280|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
126564754|NCT00762463|455363277|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
126564755|NCT00762463|455363278|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
126564756|NCT00762463|455363279|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
126564757|NCT00762463|455363280|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
126564758|NCT00762463|455363277|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
126564759|NCT00762463|455363278|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
126564760|NCT00762463|455363279|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
126564761|NCT00762463|455363280|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
126564762|NCT00762463|455363277|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
126564763|NCT00762463|455363278|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
126564764|NCT00762463|455363279|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
126564765|NCT00762463|455363280|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
126564766|NCT00762463|455363277|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
126564767|NCT00762463|455363278|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
126564768|NCT00762463|455363279|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
126564769|NCT00762463|455363280|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
126564770|NCT00762463|455363277|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
126507557|NCT03400332|455158264|FG006|Treatment|Death|1|||
126507558|NCT03400332|455158265|FG007|Treatment|Death|3|||
126507559|NCT03400332|455158266|FG008|Treatment|Death|6|||
126507560|NCT04476017|455158271|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
126507561|NCT04476017|455158272|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
126507562|NCT02704364|455158273|FG000|Overall Study|Adverse Event|1|||
126507563|NCT02704364|455158274|FG001|Overall Study|Adverse Event|1|||
126507564|NCT02704364|455158275|FG002|Overall Study|Adverse Event|0|||
126507565|NCT02704364|455158273|FG000|Overall Study|Noncompliance with study drug|1|||
126507566|NCT02704364|455158274|FG001|Overall Study|Noncompliance with study drug|1|||
126507567|NCT02704364|455158275|FG002|Overall Study|Noncompliance with study drug|0|||
126507568|NCT02704364|455158273|FG000|Overall Study|Other|0|||
126507569|NCT02704364|455158274|FG001|Overall Study|Other|1|||
126507570|NCT02704364|455158275|FG002|Overall Study|Other|1|||
126507571|NCT02975934|455158276|FG000|Treatment Phase|Never initiated study drug|0|||
126507572|NCT02975934|455158277|FG001|Treatment Phase|Never initiated study drug|5|||
126507573|NCT02975934|455158278|FG002|Treatment Phase|Never initiated study drug|0|||
126507574|NCT03362502|455158279|FG000|Overall Study|Death|0|||
126507575|NCT03362502|455158280|FG001|Overall Study|Death|0|||
126507576|NCT03362502|455158281|FG002|Overall Study|Death|1|||
126507577|NCT02075840|455158282|FG000|Overall Study|Withdrawal by Subject|13|||
126507578|NCT02075840|455158283|FG001|Overall Study|Withdrawal by Subject|22|||
126507579|NCT02075840|455158282|FG000|Overall Study|Reason not specified|1|||
126507580|NCT02075840|455158283|FG001|Overall Study|Reason not specified|0|||
126507581|NCT02075840|455158282|FG000|Overall Study|Adverse Event|0|||
126507582|NCT02075840|455158283|FG001|Overall Study|Adverse Event|2|||
126507583|NCT02075840|455158282|FG000|Overall Study|Death|35|||
126507584|NCT02075840|455158283|FG001|Overall Study|Death|40|||
126507585|NCT02075840|455158282|FG000|Overall Study|Lost to Follow-up|3|||
126507586|NCT02075840|455158283|FG001|Overall Study|Lost to Follow-up|2|||
126564771|NCT00762463|455363278|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
126564772|NCT00762463|455363279|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
126564773|NCT00762463|455363280|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
126564774|NCT00762463|455363277|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
126564775|NCT00762463|455363278|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
126564776|NCT00762463|455363279|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
126564777|NCT00762463|455363280|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
126776928|NCT00368537|456139092|FG001|Baseline Participants|Withdrawal by Subject|4|||
126776929|NCT00368537|456139091|FG000|Baseline Participants|Death|1|||
126776930|NCT00368537|456139092|FG001|Baseline Participants|Death|2|||
126776931|NCT00368537|456139091|FG000|Baseline Participants|No susceptibility|1|||
126507587|NCT02075840|455158282|FG000|Overall Study|Physician Decision|1|||
126507588|NCT02075840|455158283|FG001|Overall Study|Physician Decision|3|||
126564778|NCT00762463|455363277|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
126564779|NCT00762463|455363278|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
126564780|NCT00762463|455363279|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
126564781|NCT00762463|455363280|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
126564782|NCT01306331|455363281|FG000|Overall Study|Adverse Event|28|||
126564783|NCT01306331|455363282|FG001|Overall Study|Adverse Event|25|||
126564784|NCT01306331|455363281|FG000|Overall Study|Lost to Follow-up|321|||
126564785|NCT01306331|455363282|FG001|Overall Study|Lost to Follow-up|323|||
126564786|NCT01306331|455363281|FG000|Overall Study|Physician Decision|26|||
126564787|NCT01306331|455363282|FG001|Overall Study|Physician Decision|22|||
126564788|NCT01306331|455363281|FG000|Overall Study|Pregnancy|136|||
126564789|NCT01306331|455363282|FG001|Overall Study|Pregnancy|151|||
126564790|NCT01306331|455363281|FG000|Overall Study|Protocol Violation|154|||
126564791|NCT01306331|455363282|FG001|Overall Study|Protocol Violation|124|||
126564792|NCT01306331|455363281|FG000|Overall Study|Withdrawal by Subject|163|||
126564793|NCT01306331|455363282|FG001|Overall Study|Withdrawal by Subject|152|||
126564794|NCT01306331|455363281|FG000|Overall Study|Not sexually active|29|||
126564795|NCT01306331|455363282|FG001|Overall Study|Not sexually active|28|||
126564796|NCT01306331|455363281|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
126564797|NCT01306331|455363282|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
126564798|NCT01306331|455363281|FG000|Overall Study|Other|34|||
126564799|NCT01306331|455363282|FG001|Overall Study|Other|32|||
126564800|NCT04048135|455363285|FG000|Overall Study|Withdrawal by Subject|1|||
126564801|NCT04048135|455363286|FG001|Overall Study|Withdrawal by Subject|1|||
126564802|NCT04048135|455363287|FG002|Overall Study|Withdrawal by Subject|1|||
126564803|NCT04048135|455363288|FG003|Overall Study|Withdrawal by Subject|2|||
126564804|NCT04048135|455363289|FG004|Overall Study|Withdrawal by Subject|0|||
126564805|NCT04048135|455363290|FG005|Overall Study|Withdrawal by Subject|0|||
126564806|NCT04048135|455363291|FG006|Overall Study|Withdrawal by Subject|1|||
126564807|NCT04048135|455363292|FG007|Overall Study|Withdrawal by Subject|1|||
126564808|NCT04048135|455363285|FG000|Overall Study|Adverse Event|0|||
126564809|NCT04048135|455363286|FG001|Overall Study|Adverse Event|0|||
126564810|NCT04048135|455363287|FG002|Overall Study|Adverse Event|0|||
126564811|NCT04048135|455363288|FG003|Overall Study|Adverse Event|1|||
126564812|NCT04048135|455363289|FG004|Overall Study|Adverse Event|1|||
126564813|NCT04048135|455363290|FG005|Overall Study|Adverse Event|0|||
126564814|NCT04048135|455363291|FG006|Overall Study|Adverse Event|0|||
126564815|NCT04048135|455363292|FG007|Overall Study|Adverse Event|0|||
126564816|NCT04048135|455363285|FG000|Overall Study|Protocol Violation|0|||
126564817|NCT04048135|455363286|FG001|Overall Study|Protocol Violation|0|||
126564818|NCT04048135|455363287|FG002|Overall Study|Protocol Violation|0|||
126564819|NCT04048135|455363288|FG003|Overall Study|Protocol Violation|0|||
126507589|NCT02075840|455158282|FG000|Overall Study|Ongoing at CCOD|99|||
126507590|NCT02075840|455158283|FG001|Overall Study|Ongoing at CCOD|82|||
126507591|NCT00846742|455158284|FG000|Overall Study|Withdrawal by Subject|1|||
126507592|NCT03795610|455158285|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
126507593|NCT03795610|455158285|FG000|Overall Study|Withdrawal by Subject|1|||
126507594|NCT03795610|455158285|FG000|Overall Study|Screen Failure (Unknown)|1|||
126564820|NCT04048135|455363289|FG004|Overall Study|Protocol Violation|0|||
126564821|NCT04048135|455363290|FG005|Overall Study|Protocol Violation|1|||
126564822|NCT04048135|455363291|FG006|Overall Study|Protocol Violation|0|||
126564823|NCT04048135|455363292|FG007|Overall Study|Protocol Violation|0|||
126564824|NCT00172185|455363293|FG000|Overall Study|Adverse Event|0|||
126564825|NCT00172185|455363294|FG001|Overall Study|Adverse Event|1|||
126564826|NCT00172185|455363295|FG002|Overall Study|Adverse Event|3|||
126507595|NCT03909165|455158286|FG000|Overall Study|Physician Decision|0|||
126507596|NCT03909165|455158287|FG001|Overall Study|Physician Decision|1|||
126564827|NCT00172185|455363296|FG003|Overall Study|Adverse Event|4|||
126564828|NCT00172185|455363293|FG000|Overall Study|Physician Decision|0|||
126564829|NCT00172185|455363294|FG001|Overall Study|Physician Decision|0|||
126564830|NCT00172185|455363295|FG002|Overall Study|Physician Decision|1|||
126564831|NCT00172185|455363296|FG003|Overall Study|Physician Decision|0|||
126564832|NCT00172185|455363293|FG000|Overall Study|SPONSOR Decision|0|||
126507597|NCT03909165|455158288|FG002|Overall Study|Physician Decision|0|||
126507598|NCT03909165|455158289|FG003|Overall Study|Physician Decision|0|||
126507599|NCT03909165|455158290|FG004|Overall Study|Physician Decision|0|||
126507600|NCT03909165|455158286|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126507601|NCT03909165|455158287|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126507602|NCT03909165|455158288|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126507603|NCT03909165|455158289|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126507604|NCT03909165|455158290|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126507605|NCT03909165|455158286|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
126507606|NCT03909165|455158287|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
126507607|NCT03909165|455158288|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
126507608|NCT03909165|455158289|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
126564833|NCT00172185|455363294|FG001|Overall Study|SPONSOR Decision|1|||
126564834|NCT00172185|455363295|FG002|Overall Study|SPONSOR Decision|0|||
126564835|NCT00172185|455363296|FG003|Overall Study|SPONSOR Decision|0|||
126564836|NCT00172185|455363293|FG000|Overall Study|Withdrawal by Subject|0|||
126564837|NCT00172185|455363294|FG001|Overall Study|Withdrawal by Subject|0|||
126564838|NCT00172185|455363295|FG002|Overall Study|Withdrawal by Subject|1|||
126564839|NCT00172185|455363296|FG003|Overall Study|Withdrawal by Subject|0|||
126564840|NCT04358549|455363299|FG000|Overall Study|Adverse Event|0|||
126564841|NCT04358549|455363300|FG001|Overall Study|Adverse Event|1|||
126564842|NCT04358549|455363299|FG000|Overall Study|Death|1|||
126564843|NCT04358549|455363300|FG001|Overall Study|Death|0|||
126564844|NCT04358549|455363299|FG000|Overall Study|Lost to Follow-up|2|||
126564845|NCT04358549|455363300|FG001|Overall Study|Lost to Follow-up|1|||
126564846|NCT04358549|455363299|FG000|Overall Study|Withdrawal by Subject|6|||
126564847|NCT04358549|455363300|FG001|Overall Study|Withdrawal by Subject|6|||
126564848|NCT04358549|455363299|FG000|Overall Study|Start remdesivir|1|||
126564849|NCT04358549|455363300|FG001|Overall Study|Start remdesivir|0|||
126564850|NCT04867902|455363301|FG000|Overall Study|Lost to Follow-up|1|||
126564851|NCT04867902|455363301|FG000|Overall Study|Withdrawal by Subject|2|||
126564852|NCT04867902|455363301|FG000|Overall Study|Protocol Violation|1|||
126564853|NCT05355116|455363302|FG000|Overall Study|Withdrawal by Subject|2|||
126564854|NCT00470626|455363305|FG000|Overall Study|Lost to Follow-up|10|||
126564855|NCT00470626|455363305|FG000|Overall Study|Withdrawal by Subject|7|||
126564856|NCT02380742|455363308|FG000|Overall Study|Withdrawal by Subject|1|||
126564857|NCT02380742|455363309|FG001|Overall Study|Withdrawal by Subject|0|||
126564858|NCT00151996|455363310|FG000|Overall Study|Adverse Event|3|||
126564859|NCT00151996|455363311|FG001|Overall Study|Adverse Event|2|||
126564860|NCT00151996|455363310|FG000|Overall Study|Withdrawal by Subject|1|||
126564861|NCT00151996|455363311|FG001|Overall Study|Withdrawal by Subject|1|||
126564862|NCT00151996|455363310|FG000|Overall Study|Protocol Violation|1|||
126564863|NCT00151996|455363311|FG001|Overall Study|Protocol Violation|2|||
126564864|NCT00151996|455363310|FG000|Overall Study|Sponsor's decision|0|||
126564865|NCT00151996|455363311|FG001|Overall Study|Sponsor's decision|2|||
126564866|NCT01729819|455363312|FG000|Overall Study|Adverse Event|2|||
126564867|NCT01729819|455363313|FG001|Overall Study|Adverse Event|4|||
126564868|NCT01729819|455363312|FG000|Overall Study|Lack of Efficacy|1|||
126564869|NCT01729819|455363313|FG001|Overall Study|Lack of Efficacy|0|||
126564870|NCT01729819|455363312|FG000|Overall Study|Lost to Follow-up|2|||
126564871|NCT01729819|455363313|FG001|Overall Study|Lost to Follow-up|0|||
126564872|NCT01729819|455363312|FG000|Overall Study|Other reason|1|||
126564873|NCT01729819|455363313|FG001|Overall Study|Other reason|0|||
126564874|NCT01729819|455363312|FG000|Overall Study|Protocol Violation|0|||
126564875|NCT01729819|455363313|FG001|Overall Study|Protocol Violation|1|||
126564876|NCT01729819|455363312|FG000|Overall Study|Withdrawal by Subject|0|||
126564877|NCT01729819|455363313|FG001|Overall Study|Withdrawal by Subject|2|||
126564878|NCT03646669|455363314|FG000|Overall Study|Withdrawal by Subject|5|||
126564879|NCT03646669|455363315|FG001|Overall Study|Withdrawal by Subject|0|||
126564880|NCT01801930|455363318|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
126564881|NCT01801930|455363319|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
126564882|NCT01801930|455363320|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
126564883|NCT01801930|455363321|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
126564884|NCT01801930|455363318|FG000|Overall Study|DLT occurs|0|||
126564885|NCT01801930|455363319|FG001|Overall Study|DLT occurs|1|||
126564886|NCT01801930|455363320|FG002|Overall Study|DLT occurs|0|||
126564887|NCT01801930|455363321|FG003|Overall Study|DLT occurs|0|||
126564888|NCT03441360|455363329|FG000|Overall Study|Radiological disease progression|5|||
126564889|NCT03441360|455363330|FG001|Overall Study|Radiological disease progression|6|||
126564890|NCT03441360|455363331|FG002|Overall Study|Radiological disease progression|4|||
126564891|NCT03441360|455363329|FG000|Overall Study|Clinical disease progression|2|||
126564892|NCT03441360|455363330|FG001|Overall Study|Clinical disease progression|2|||
126564893|NCT03441360|455363331|FG002|Overall Study|Clinical disease progression|0|||
126564894|NCT03441360|455363329|FG000|Overall Study|Adverse Event|1|||
126564895|NCT03441360|455363330|FG001|Overall Study|Adverse Event|0|||
126564896|NCT03441360|455363331|FG002|Overall Study|Adverse Event|1|||
126507609|NCT03909165|455158290|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
126507610|NCT03909165|455158286|FG000|Overall Study|Previous Drug Exposure|0|||
126507611|NCT03909165|455158287|FG001|Overall Study|Previous Drug Exposure|0|||
126507612|NCT03909165|455158288|FG002|Overall Study|Previous Drug Exposure|1|||
126507613|NCT03909165|455158289|FG003|Overall Study|Previous Drug Exposure|0|||
126507614|NCT03909165|455158290|FG004|Overall Study|Previous Drug Exposure|0|||
126507615|NCT03909165|455158286|FG000|Overall Study|Early Discharge|1|||
126507616|NCT03909165|455158287|FG001|Overall Study|Early Discharge|0|||
126507617|NCT03909165|455158288|FG002|Overall Study|Early Discharge|0|||
126507618|NCT03909165|455158289|FG003|Overall Study|Early Discharge|0|||
126507619|NCT03909165|455158290|FG004|Overall Study|Early Discharge|0|||
126507620|NCT04098458|455158314|FG000|Overall Study|Death|1|||
126507621|NCT04098458|455158314|FG000|Overall Study|did not meet study inclusion criteria|3|||
126507622|NCT04033159|455158315|FG000|Washout Period|Physician Decision|0|||
126507623|NCT04033159|455158316|FG001|Washout Period|Physician Decision|1|||
126507624|NCT04033159|455158317|FG002|Washout Period|Physician Decision|0|||
126507625|NCT04033159|455158315|FG000|Washout Period|Study terminated by Sponsor|0|||
126507626|NCT04033159|455158316|FG001|Washout Period|Study terminated by Sponsor|7|||
126507627|NCT04033159|455158317|FG002|Washout Period|Study terminated by Sponsor|0|||
126507628|NCT04033159|455158315|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
126507629|NCT04033159|455158316|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
126507630|NCT04033159|455158317|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
126507631|NCT00006489|455158320|FG000|Overall Study|Adverse Event|3|||
126507632|NCT00006489|455158321|FG001|Overall Study|Adverse Event|2|||
126507633|NCT00006489|455158322|FG002|Overall Study|Adverse Event|4|||
126507634|NCT00006489|455158323|FG003|Overall Study|Adverse Event|3|||
126507635|NCT00006489|455158320|FG000|Overall Study|Withdrawal by Subject|10|||
126507636|NCT00006489|455158321|FG001|Overall Study|Withdrawal by Subject|9|||
126507637|NCT00006489|455158322|FG002|Overall Study|Withdrawal by Subject|9|||
126507638|NCT00006489|455158323|FG003|Overall Study|Withdrawal by Subject|6|||
126507639|NCT00006489|455158320|FG000|Overall Study|Scheduling Conflict|0|||
126507640|NCT00006489|455158321|FG001|Overall Study|Scheduling Conflict|3|||
126507641|NCT00006489|455158322|FG002|Overall Study|Scheduling Conflict|2|||
126507642|NCT00006489|455158323|FG003|Overall Study|Scheduling Conflict|1|||
126507643|NCT00006489|455158320|FG000|Overall Study|Death|0|||
126507644|NCT00006489|455158321|FG001|Overall Study|Death|0|||
126507645|NCT00006489|455158322|FG002|Overall Study|Death|0|||
126507646|NCT00006489|455158323|FG003|Overall Study|Death|1|||
126507647|NCT03762083|455158324|FG000|Overall Study|Withdrawal by Subject|2|||
126507648|NCT03762083|455158324|FG000|Overall Study|Physician Decision|1|||
126507649|NCT00116558|455158325|FG000|Overall Study|Death|11|||
126507650|NCT00116558|455158326|FG001|Overall Study|Death|5|||
126507651|NCT00116558|455158327|FG002|Overall Study|Death|3|||
126507652|NCT00116558|455158325|FG000|Overall Study|Withdrawal by Subject|17|||
126507653|NCT00116558|455158326|FG001|Overall Study|Withdrawal by Subject|3|||
126507654|NCT00116558|455158327|FG002|Overall Study|Withdrawal by Subject|12|||
126507655|NCT00116558|455158325|FG000|Overall Study|disease progression|3|||
126507656|NCT00116558|455158326|FG001|Overall Study|disease progression|7|||
126507657|NCT00116558|455158327|FG002|Overall Study|disease progression|18|||
126507658|NCT04399161|455158328|FG000|Overall Study|Withdrawal by Subject|1|||
126507659|NCT04399161|455158329|FG001|Overall Study|Withdrawal by Subject|0|||
126507660|NCT04399161|455158330|FG002|Overall Study|Withdrawal by Subject|2|||
126507661|NCT04399161|455158328|FG000|Overall Study|Protocol Violation|1|||
126507662|NCT04399161|455158329|FG001|Overall Study|Protocol Violation|2|||
126507663|NCT04399161|455158330|FG002|Overall Study|Protocol Violation|0|||
126507664|NCT00477672|455158331|FG000|Overall Study|Adverse Event|3|||
126507665|NCT00477672|455158332|FG001|Overall Study|Adverse Event|5|||
126507666|NCT00477672|455158333|FG002|Overall Study|Adverse Event|6|||
126507667|NCT00477672|455158331|FG000|Overall Study|Death|0|||
126507668|NCT00477672|455158332|FG001|Overall Study|Death|1|||
126507669|NCT00477672|455158333|FG002|Overall Study|Death|0|||
126507670|NCT00477672|455158331|FG000|Overall Study|Disease progression|0|||
126507671|NCT00477672|455158332|FG001|Overall Study|Disease progression|1|||
126776932|NCT00368537|456139092|FG001|Baseline Participants|No susceptibility|0|||
126507672|NCT00477672|455158333|FG002|Overall Study|Disease progression|0|||
126507673|NCT00477672|455158331|FG000|Overall Study|Physician Decision|1|||
126507674|NCT00477672|455158332|FG001|Overall Study|Physician Decision|0|||
126507675|NCT00477672|455158333|FG002|Overall Study|Physician Decision|0|||
126507676|NCT00477672|455158331|FG000|Overall Study|Protocol noncompliance|0|||
126507677|NCT00477672|455158332|FG001|Overall Study|Protocol noncompliance|2|||
126507678|NCT00477672|455158333|FG002|Overall Study|Protocol noncompliance|0|||
126507679|NCT00477672|455158331|FG000|Overall Study|Consent withdrawn|2|||
126507680|NCT00477672|455158332|FG001|Overall Study|Consent withdrawn|5|||
126507681|NCT00477672|455158333|FG002|Overall Study|Consent withdrawn|10|||
126507682|NCT00477672|455158331|FG000|Overall Study|Discretion of Sponsor|1|||
126507683|NCT00477672|455158332|FG001|Overall Study|Discretion of Sponsor|2|||
126507684|NCT00477672|455158333|FG002|Overall Study|Discretion of Sponsor|0|||
126507685|NCT00838565|455158334|FG000|Overall Study|Withdrawal by Subject|0|||
126507686|NCT00838565|455158335|FG001|Overall Study|Withdrawal by Subject|0|||
126507687|NCT00838565|455158336|FG002|Overall Study|Withdrawal by Subject|1|||
126507688|NCT00838565|455158337|FG003|Overall Study|Withdrawal by Subject|0|||
126507689|NCT00838565|455158338|FG004|Overall Study|Withdrawal by Subject|0|||
126507690|NCT00838565|455158339|FG005|Overall Study|Withdrawal by Subject|2|||
126507691|NCT00838565|455158334|FG000|Overall Study|Other|0|||
126507692|NCT00838565|455158335|FG001|Overall Study|Other|2|||
126507693|NCT00838565|455158336|FG002|Overall Study|Other|0|||
126507694|NCT00838565|455158337|FG003|Overall Study|Other|0|||
126507695|NCT00838565|455158338|FG004|Overall Study|Other|0|||
126507696|NCT00838565|455158339|FG005|Overall Study|Other|0|||
126507697|NCT00838565|455158334|FG000|Overall Study|Randomized but not Treated|0|||
126507698|NCT00838565|455158335|FG001|Overall Study|Randomized but not Treated|1|||
126507699|NCT00838565|455158336|FG002|Overall Study|Randomized but not Treated|0|||
126507700|NCT00838565|455158337|FG003|Overall Study|Randomized but not Treated|0|||
126507701|NCT00838565|455158338|FG004|Overall Study|Randomized but not Treated|0|||
126507702|NCT00838565|455158339|FG005|Overall Study|Randomized but not Treated|0|||
126507703|NCT01455012|455158344|FG000|Overall Study|Adverse Event|0|||
126507704|NCT01455012|455158345|FG001|Overall Study|Adverse Event|2|||
126507705|NCT01455012|455158344|FG000|Overall Study|Lack of Efficacy|6|||
126507706|NCT01455012|455158345|FG001|Overall Study|Lack of Efficacy|1|||
126507707|NCT01455012|455158344|FG000|Overall Study|Withdrawal by Subject|3|||
126507708|NCT01455012|455158345|FG001|Overall Study|Withdrawal by Subject|1|||
126507709|NCT01455012|455158344|FG000|Overall Study|Unknown reason|2|||
126507710|NCT01455012|455158345|FG001|Overall Study|Unknown reason|0|||
126507711|NCT01215227|455158346|FG000|Overall Study|Adverse Event|11|||
126507712|NCT01215227|455158347|FG001|Overall Study|Adverse Event|11|||
126507713|NCT01215227|455158348|FG002|Overall Study|Adverse Event|4|||
126507714|NCT01215227|455158349|FG003|Overall Study|Adverse Event|8|||
126507715|NCT01215227|455158350|FG004|Overall Study|Adverse Event|7|||
126507716|NCT01215227|455158351|FG005|Overall Study|Adverse Event|6|||
126507717|NCT01215227|455158346|FG000|Overall Study|Treatment Failure|8|||
126507718|NCT01215227|455158347|FG001|Overall Study|Treatment Failure|4|||
126507719|NCT01215227|455158348|FG002|Overall Study|Treatment Failure|1|||
126507720|NCT01215227|455158349|FG003|Overall Study|Treatment Failure|5|||
126507721|NCT01215227|455158350|FG004|Overall Study|Treatment Failure|1|||
126507722|NCT01215227|455158351|FG005|Overall Study|Treatment Failure|1|||
126507723|NCT01215227|455158346|FG000|Overall Study|Lost to Follow-up|1|||
126507724|NCT01215227|455158347|FG001|Overall Study|Lost to Follow-up|4|||
126507725|NCT01215227|455158348|FG002|Overall Study|Lost to Follow-up|1|||
126507726|NCT01215227|455158349|FG003|Overall Study|Lost to Follow-up|1|||
126507727|NCT01215227|455158350|FG004|Overall Study|Lost to Follow-up|1|||
126507728|NCT01215227|455158351|FG005|Overall Study|Lost to Follow-up|2|||
126507729|NCT01215227|455158346|FG000|Overall Study|Subject Withdrew Consent|16|||
126507730|NCT01215227|455158347|FG001|Overall Study|Subject Withdrew Consent|20|||
126507731|NCT01215227|455158348|FG002|Overall Study|Subject Withdrew Consent|7|||
126507732|NCT01215227|455158349|FG003|Overall Study|Subject Withdrew Consent|10|||
126507733|NCT01215227|455158350|FG004|Overall Study|Subject Withdrew Consent|11|||
126507734|NCT01215227|455158351|FG005|Overall Study|Subject Withdrew Consent|8|||
126507735|NCT01215227|455158346|FG000|Overall Study|Non-Compliance With Protocol|2|||
126507736|NCT01215227|455158347|FG001|Overall Study|Non-Compliance With Protocol|6|||
126507737|NCT01215227|455158348|FG002|Overall Study|Non-Compliance With Protocol|1|||
126507738|NCT01215227|455158349|FG003|Overall Study|Non-Compliance With Protocol|0|||
126507739|NCT01215227|455158350|FG004|Overall Study|Non-Compliance With Protocol|0|||
126507740|NCT01215227|455158351|FG005|Overall Study|Non-Compliance With Protocol|0|||
126507741|NCT01215227|455158346|FG000|Overall Study|Administrative|83|||
126507742|NCT01215227|455158347|FG001|Overall Study|Administrative|73|||
126507743|NCT01215227|455158348|FG002|Overall Study|Administrative|42|||
126507744|NCT01215227|455158349|FG003|Overall Study|Administrative|24|||
126507745|NCT01215227|455158350|FG004|Overall Study|Administrative|28|||
126507746|NCT01215227|455158351|FG005|Overall Study|Administrative|40|||
126507747|NCT01215227|455158346|FG000|Overall Study|Missing Status|0|||
126507748|NCT01215227|455158347|FG001|Overall Study|Missing Status|1|||
126507749|NCT01215227|455158348|FG002|Overall Study|Missing Status|0|||
126507750|NCT01215227|455158349|FG003|Overall Study|Missing Status|0|||
126507751|NCT01215227|455158350|FG004|Overall Study|Missing Status|0|||
126507752|NCT01215227|455158351|FG005|Overall Study|Missing Status|0|||
126507753|NCT01215227|455158346|FG000|Overall Study|Randomized but not treated|0|||
126507754|NCT01215227|455158347|FG001|Overall Study|Randomized but not treated|0|||
126507755|NCT01215227|455158348|FG002|Overall Study|Randomized but not treated|1|||
126507756|NCT01215227|455158349|FG003|Overall Study|Randomized but not treated|1|||
126507757|NCT01215227|455158350|FG004|Overall Study|Randomized but not treated|0|||
126507758|NCT01215227|455158351|FG005|Overall Study|Randomized but not treated|1|||
126507759|NCT02253810|455158352|FG000|Overall Study|Withdrawal by Subject|2|||
126507760|NCT02253810|455158353|FG001|Overall Study|Withdrawal by Subject|1|||
126507761|NCT02253810|455158352|FG000|Overall Study|Unknown concomitant procedure|3|||
126507762|NCT02253810|455158353|FG001|Overall Study|Unknown concomitant procedure|2|||
126507763|NCT01434290|455158360|FG000|Overall Study|Protocol Violation|6|||
126564897|NCT00269399|455363332|FG000|Overall Study|Lack of Efficacy|27|||
126564898|NCT00269399|455363333|FG001|Overall Study|Lack of Efficacy|10|||
126564899|NCT00269399|455363332|FG000|Overall Study|Adverse Event|10|||
126564900|NCT00269399|455363333|FG001|Overall Study|Adverse Event|4|||
126564901|NCT00269399|455363332|FG000|Overall Study|Withdrawal by Subject|2|||
126507764|NCT01434290|455158361|FG001|Overall Study|Protocol Violation|3|||
126507765|NCT01434290|455158360|FG000|Overall Study|No protocol treatment|2|||
126507766|NCT01434290|455158361|FG001|Overall Study|No protocol treatment|4|||
126507767|NCT00213148|455158363|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
126507768|NCT00213148|455158364|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
126507769|NCT00213148|455158365|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
126507770|NCT00213148|455158366|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
126507771|NCT00213148|455158367|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
126507772|NCT00213148|455158363|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
126507773|NCT00213148|455158364|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
126507774|NCT00213148|455158365|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
126507775|NCT00213148|455158366|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
126507776|NCT00213148|455158367|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
126507777|NCT00213148|455158363|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
126507778|NCT00213148|455158364|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
126507779|NCT00213148|455158365|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
126507780|NCT00213148|455158366|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
126507781|NCT00213148|455158367|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
126507782|NCT00213148|455158363|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
126507783|NCT00213148|455158364|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
126507784|NCT00213148|455158365|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
126507785|NCT00213148|455158366|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
126507786|NCT00213148|455158367|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
126507787|NCT00213148|455158363|FG000|Cycle 1 (1 Month)|Other|3|||
126507788|NCT00213148|455158364|FG001|Cycle 1 (1 Month)|Other|0|||
126507789|NCT00213148|455158365|FG002|Cycle 1 (1 Month)|Other|2|||
126507790|NCT00213148|455158366|FG003|Cycle 1 (1 Month)|Other|2|||
126507791|NCT00213148|455158367|FG004|Cycle 1 (1 Month)|Other|7|||
126507792|NCT00213148|455158363|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
126507793|NCT00213148|455158364|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
126507794|NCT00213148|455158365|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
126507795|NCT00213148|455158366|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
126507796|NCT00213148|455158367|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
126507797|NCT00213148|455158363|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
126507798|NCT00213148|455158364|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
126507799|NCT00213148|455158365|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
126507800|NCT00213148|455158366|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
126507801|NCT00213148|455158367|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
126507802|NCT00213148|455158363|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
126507803|NCT00213148|455158364|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
126507804|NCT00213148|455158365|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
126507805|NCT00213148|455158366|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
126507806|NCT00213148|455158367|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
126507807|NCT00213148|455158363|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
126507808|NCT00213148|455158364|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
126564902|NCT00269399|455363333|FG001|Overall Study|Withdrawal by Subject|5|||
126564903|NCT00269399|455363332|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
126564904|NCT00269399|455363333|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
126564905|NCT00269399|455363332|FG000|Overall Study|Other|0|||
126564906|NCT00269399|455363333|FG001|Overall Study|Other|4|||
126564907|NCT00269399|455363332|FG000|Overall Study|Development of exclusion criteria|0|||
126564908|NCT00269399|455363333|FG001|Overall Study|Development of exclusion criteria|1|||
126564909|NCT03396835|455363334|FG000|Overall Study|Withdrawn prior to completion|1|||
126564910|NCT03396835|455363334|FG000|Overall Study|Did not meet criteria for data analysis|1|||
126564911|NCT03439124|455363345|FG000|Overall Study|Adverse Event|2|||
126564912|NCT03439124|455363346|FG001|Overall Study|Adverse Event|0|||
126564913|NCT03439124|455363345|FG000|Overall Study|Lost to Follow-up|1|||
126564914|NCT03439124|455363346|FG001|Overall Study|Lost to Follow-up|0|||
126564915|NCT03439124|455363345|FG000|Overall Study|Other reasons|1|||
126564916|NCT03439124|455363346|FG001|Overall Study|Other reasons|0|||
126507809|NCT00213148|455158365|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
126507810|NCT00213148|455158366|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
126507811|NCT00213148|455158367|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
126507812|NCT00213148|455158363|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
126507813|NCT00213148|455158364|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
126507814|NCT00213148|455158365|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
126564917|NCT02236559|455363347|FG000|Overall Study|Met Exclusion|3|||
126564918|NCT02236559|455363348|FG001|Overall Study|Met Exclusion|6|||
126564919|NCT02236559|455363347|FG000|Overall Study|Did not Meet Inclusion|3|||
126507815|NCT00213148|455158366|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
126564920|NCT02236559|455363348|FG001|Overall Study|Did not Meet Inclusion|3|||
126564921|NCT02236559|455363347|FG000|Overall Study|Subject Did Not Consent|4|||
126564922|NCT02236559|455363348|FG001|Overall Study|Subject Did Not Consent|2|||
126564923|NCT02236559|455363347|FG000|Overall Study|Physician Decision|1|||
126564924|NCT02236559|455363348|FG001|Overall Study|Physician Decision|1|||
126564925|NCT02236559|455363347|FG000|Overall Study|Withdrawal by Subject|1|||
126564926|NCT02236559|455363348|FG001|Overall Study|Withdrawal by Subject|0|||
126564927|NCT01117480|455363349|FG000|Overall Study|Protocol Violation|8|||
126564928|NCT01117480|455363349|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
126564929|NCT02955069|455363350|FG000|Overall Study|Adverse Event|7|||
126564930|NCT02955069|455363351|FG001|Overall Study|Adverse Event|2|||
126564931|NCT02955069|455363350|FG000|Overall Study|Death|7|||
126564932|NCT02955069|455363351|FG001|Overall Study|Death|3|||
126564933|NCT02955069|455363350|FG000|Overall Study|Physician Decision|10|||
126564934|NCT02955069|455363351|FG001|Overall Study|Physician Decision|2|||
126564935|NCT02955069|455363350|FG000|Overall Study|Progressive disease|64|||
126564936|NCT02955069|455363351|FG001|Overall Study|Progressive disease|13|||
126564937|NCT02955069|455363350|FG000|Overall Study|Study terminated by sponsor|4|||
126564938|NCT02955069|455363351|FG001|Overall Study|Study terminated by sponsor|0|||
126564939|NCT02955069|455363350|FG000|Overall Study|Subject/Guardian decision|3|||
126564940|NCT02955069|455363351|FG001|Overall Study|Subject/Guardian decision|1|||
126564941|NCT04148937|455363353|FG000|Overall Study|Withdrawal by Subject|0|||
126564942|NCT04148937|455363354|FG001|Overall Study|Withdrawal by Subject|0|||
126564943|NCT04148937|455363355|FG002|Overall Study|Withdrawal by Subject|0|||
126564944|NCT04148937|455363356|FG003|Overall Study|Withdrawal by Subject|1|||
126564945|NCT04148937|455363357|FG004|Overall Study|Withdrawal by Subject|0|||
126564946|NCT04148937|455363358|FG005|Overall Study|Withdrawal by Subject|1|||
126564947|NCT04148937|455363359|FG006|Overall Study|Withdrawal by Subject|1|||
126564948|NCT04148937|455363360|FG007|Overall Study|Withdrawal by Subject|0|||
126564949|NCT04148937|455363353|FG000|Overall Study|Lost to Follow-up|0|||
126564950|NCT04148937|455363354|FG001|Overall Study|Lost to Follow-up|0|||
126564951|NCT04148937|455363355|FG002|Overall Study|Lost to Follow-up|1|||
126564952|NCT04148937|455363356|FG003|Overall Study|Lost to Follow-up|0|||
126564953|NCT04148937|455363357|FG004|Overall Study|Lost to Follow-up|0|||
126564954|NCT04148937|455363358|FG005|Overall Study|Lost to Follow-up|2|||
126564955|NCT04148937|455363359|FG006|Overall Study|Lost to Follow-up|0|||
126564956|NCT04148937|455363360|FG007|Overall Study|Lost to Follow-up|0|||
126507816|NCT00213148|455158367|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
126507817|NCT00213148|455158363|FG000|Cycle 2 (1 Month)|Other|2|||
126507818|NCT00213148|455158364|FG001|Cycle 2 (1 Month)|Other|1|||
126507819|NCT00213148|455158365|FG002|Cycle 2 (1 Month)|Other|2|||
126507820|NCT00213148|455158366|FG003|Cycle 2 (1 Month)|Other|8|||
126507821|NCT00213148|455158367|FG004|Cycle 2 (1 Month)|Other|7|||
126507822|NCT00213148|455158363|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
126507823|NCT00213148|455158364|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
126507824|NCT00213148|455158365|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
126507825|NCT00213148|455158366|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
126564957|NCT00544440|455363361|FG000|Overall Study|Other|1|||
126564958|NCT00544440|455363361|FG000|Overall Study|Adverse Event|1|||
126564959|NCT00544440|455363361|FG000|Overall Study|Withdrawal by Subject|2|||
126564960|NCT00544440|455363361|FG000|Overall Study|Subject Non-compliance|1|||
126564961|NCT00544440|455363361|FG000|Overall Study|Progressive Disease|47|||
126564962|NCT00544440|455363361|FG000|Overall Study|Other|5|||
126564963|NCT02512042|455363362|FG000|Overall Study|Adverse Event|0|||
126564964|NCT02512042|455363363|FG001|Overall Study|Adverse Event|4|||
126564965|NCT02512042|455363362|FG000|Overall Study|Withdrawal by Subject|6|||
126564966|NCT02512042|455363363|FG001|Overall Study|Withdrawal by Subject|6|||
126564967|NCT02512042|455363362|FG000|Overall Study|Non-compliance with study drug|1|||
126564968|NCT02512042|455363363|FG001|Overall Study|Non-compliance with study drug|2|||
126564969|NCT02512042|455363362|FG000|Overall Study|Lost to Follow-up|5|||
126564970|NCT02512042|455363363|FG001|Overall Study|Lost to Follow-up|2|||
126564971|NCT02512042|455363362|FG000|Overall Study|Other|11|||
126564972|NCT02512042|455363363|FG001|Overall Study|Other|11|||
126564973|NCT00881335|455363371|FG000|Overall Study|Lost to Follow-up|3|||
126564974|NCT00881335|455363372|FG001|Overall Study|Lost to Follow-up|2|||
126564975|NCT05824351|455363373|FG000|Overall Study|Adverse Event|6|||
126564976|NCT03822351|455363378|FG000|Overall Study|Death|27|||
126564977|NCT03822351|455363379|FG001|Overall Study|Death|23|||
126564978|NCT03822351|455363380|FG002|Overall Study|Death|24|||
126564979|NCT03822351|455363378|FG000|Overall Study|Lost to Follow-up|6|||
126564980|NCT03822351|455363379|FG001|Overall Study|Lost to Follow-up|2|||
126564981|NCT03822351|455363380|FG002|Overall Study|Lost to Follow-up|1|||
126564982|NCT03822351|455363378|FG000|Overall Study|Withdrawal by Subject|10|||
126564983|NCT03822351|455363379|FG001|Overall Study|Withdrawal by Subject|4|||
126564984|NCT03822351|455363380|FG002|Overall Study|Withdrawal by Subject|6|||
126564985|NCT03822351|455363378|FG000|Overall Study|Progressive Disease|2|||
126564986|NCT03822351|455363379|FG001|Overall Study|Progressive Disease|1|||
126564987|NCT03822351|455363380|FG002|Overall Study|Progressive Disease|0|||
126564988|NCT03822351|455363378|FG000|Overall Study|Not Treated|1|||
126507826|NCT00213148|455158367|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
126507827|NCT00213148|455158363|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
126507828|NCT00213148|455158364|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
126507829|NCT00213148|455158365|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
126507830|NCT00213148|455158366|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
126507831|NCT00213148|455158367|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
126507832|NCT00213148|455158363|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
126507833|NCT00213148|455158364|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
126507834|NCT00213148|455158365|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
126507835|NCT00213148|455158366|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
126507836|NCT00213148|455158367|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
126507837|NCT00213148|455158363|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
126507838|NCT00213148|455158364|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
126564989|NCT03822351|455363379|FG001|Overall Study|Not Treated|1|||
126564990|NCT03822351|455363380|FG002|Overall Study|Not Treated|1|||
126564991|NCT00462943|455363381|FG000|Overall Study|Failure to achieve a response|5|||
126564992|NCT00462943|455363382|FG001|Overall Study|Failure to achieve a response|5|||
126564993|NCT00462943|455363383|FG002|Overall Study|Failure to achieve a response|1|||
126564994|NCT00462943|455363381|FG000|Overall Study|Adverse Event|6|||
126564995|NCT00462943|455363382|FG001|Overall Study|Adverse Event|4|||
126564996|NCT00462943|455363383|FG002|Overall Study|Adverse Event|1|||
126564997|NCT00462943|455363381|FG000|Overall Study|Protocol Violation|1|||
126564998|NCT00462943|455363382|FG001|Overall Study|Protocol Violation|0|||
126564999|NCT00462943|455363383|FG002|Overall Study|Protocol Violation|0|||
126565000|NCT00462943|455363381|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
126565001|NCT00462943|455363382|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
126565002|NCT00462943|455363383|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
126565003|NCT00462943|455363381|FG000|Overall Study|Disease Progression|15|||
126565004|NCT00462943|455363382|FG001|Overall Study|Disease Progression|15|||
126565005|NCT00462943|455363383|FG002|Overall Study|Disease Progression|9|||
126565006|NCT00462943|455363381|FG000|Overall Study|Death|5|||
126565007|NCT00462943|455363382|FG001|Overall Study|Death|2|||
126565008|NCT00462943|455363383|FG002|Overall Study|Death|7|||
126565009|NCT00462943|455363381|FG000|Overall Study|Stem Cell Transplant|1|||
126565010|NCT00462943|455363382|FG001|Overall Study|Stem Cell Transplant|1|||
126565011|NCT00462943|455363383|FG002|Overall Study|Stem Cell Transplant|0|||
126565012|NCT00462943|455363381|FG000|Overall Study|Bone Marrow Transplant|1|||
126565013|NCT00462943|455363382|FG001|Overall Study|Bone Marrow Transplant|0|||
126565014|NCT00462943|455363383|FG002|Overall Study|Bone Marrow Transplant|0|||
126565015|NCT00462943|455363381|FG000|Overall Study|Required Lymphocyte Infusion|1|||
126565016|NCT00462943|455363382|FG001|Overall Study|Required Lymphocyte Infusion|0|||
126565017|NCT00462943|455363383|FG002|Overall Study|Required Lymphocyte Infusion|0|||
126565018|NCT00462943|455363381|FG000|Overall Study|Transplant - not specified|1|||
126565019|NCT00462943|455363382|FG001|Overall Study|Transplant - not specified|0|||
126565020|NCT00462943|455363383|FG002|Overall Study|Transplant - not specified|1|||
126565021|NCT00462943|455363381|FG000|Overall Study|Physician Decision|1|||
126565022|NCT00462943|455363382|FG001|Overall Study|Physician Decision|0|||
126565023|NCT00462943|455363383|FG002|Overall Study|Physician Decision|0|||
126565024|NCT00462943|455363381|FG000|Overall Study|Withdrawal by Subject|0|||
126565025|NCT00462943|455363382|FG001|Overall Study|Withdrawal by Subject|1|||
126565026|NCT00462943|455363383|FG002|Overall Study|Withdrawal by Subject|0|||
126565027|NCT00813488|455363389|FG000|Titration Period 1|Adverse Event|6|||
126565028|NCT00813488|455363390|FG001|Titration Period 1|Adverse Event|1|||
126565029|NCT00813488|455363389|FG000|Titration Period 1|Lack of Efficacy|9|||
126565030|NCT00813488|455363390|FG001|Titration Period 1|Lack of Efficacy|7|||
126565031|NCT00813488|455363389|FG000|Titration Period 1|Withdrawal by Subject|2|||
126565032|NCT00813488|455363390|FG001|Titration Period 1|Withdrawal by Subject|2|||
126565033|NCT00813488|455363389|FG000|Titration Period 1|Protocol Violation|4|||
126565034|NCT00813488|455363390|FG001|Titration Period 1|Protocol Violation|3|||
126565035|NCT00813488|455363389|FG000|Titration Period 1|Non-compliance to study medication|4|||
126565036|NCT00813488|455363390|FG001|Titration Period 1|Non-compliance to study medication|1|||
126565037|NCT00813488|455363389|FG000|Titration Period 1|Non-compliance to study procedures|2|||
126565038|NCT00813488|455363390|FG001|Titration Period 1|Non-compliance to study procedures|2|||
126565039|NCT00813488|455363389|FG000|Titration Period 1|Technical Difficulties|0|||
126565040|NCT00813488|455363390|FG001|Titration Period 1|Technical Difficulties|1|||
126565041|NCT00813488|455363389|FG000|Titration Period 2|Adverse Event|2|||
126565042|NCT00813488|455363390|FG001|Titration Period 2|Adverse Event|3|||
126565043|NCT00813488|455363389|FG000|Titration Period 2|Lack of Efficacy|8|||
126565044|NCT00813488|455363390|FG001|Titration Period 2|Lack of Efficacy|4|||
126565045|NCT00813488|455363389|FG000|Titration Period 2|Protocol Violation|3|||
126565046|NCT00813488|455363390|FG001|Titration Period 2|Protocol Violation|2|||
126565047|NCT00813488|455363389|FG000|Titration Period 2|Lost to Follow-up|1|||
126565048|NCT00813488|455363390|FG001|Titration Period 2|Lost to Follow-up|0|||
126565049|NCT00813488|455363389|FG000|Titration Period 2|Non-compliance with study procedures|2|||
126565050|NCT00813488|455363390|FG001|Titration Period 2|Non-compliance with study procedures|1|||
126565051|NCT00813488|455363389|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
126565052|NCT00813488|455363390|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
126565053|NCT00813488|455363389|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
126565054|NCT00813488|455363390|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
126565055|NCT00813488|455363389|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
126565056|NCT00813488|455363390|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
126565057|NCT00813488|455363389|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
126565058|NCT00813488|455363390|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
126565059|NCT00813488|455363389|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
126507839|NCT00213148|455158365|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
126507840|NCT00213148|455158366|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
126507841|NCT00213148|455158367|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
126507842|NCT00213148|455158363|FG000|Cycle 3 (1 Month)|Other|0|||
126507843|NCT00213148|455158364|FG001|Cycle 3 (1 Month)|Other|0|||
126507844|NCT00213148|455158365|FG002|Cycle 3 (1 Month)|Other|1|||
126507845|NCT00213148|455158366|FG003|Cycle 3 (1 Month)|Other|1|||
126507846|NCT00213148|455158367|FG004|Cycle 3 (1 Month)|Other|0|||
126507847|NCT02469610|455158368|FG000|Overall Study|Death|1|||
126507848|NCT02469610|455158369|FG001|Overall Study|Death|0|||
126507849|NCT02469610|455158368|FG000|Overall Study|Lost to Follow-up|1|||
126507850|NCT02469610|455158369|FG001|Overall Study|Lost to Follow-up|0|||
126507851|NCT02469610|455158368|FG000|Overall Study|exclusion criteria|2|||
126507852|NCT02469610|455158369|FG001|Overall Study|exclusion criteria|1|||
126507853|NCT01806896|455158370|FG000|Overall Study|Adverse Event|2|||
126507854|NCT01806896|455158371|FG001|Overall Study|Adverse Event|0|||
126507855|NCT01806896|455158370|FG000|Overall Study|Other|1|||
126507856|NCT01806896|455158371|FG001|Overall Study|Other|0|||
126507857|NCT02434770|455158372|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
126507858|NCT02434770|455158373|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
126507859|NCT02434770|455158374|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
126507860|NCT02434770|455158372|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
126507861|NCT02434770|455158373|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
126507862|NCT02434770|455158374|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
126507863|NCT02434770|455158372|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
126507864|NCT02434770|455158373|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
126507865|NCT02434770|455158374|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
126507866|NCT02434770|455158372|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
126507867|NCT02434770|455158373|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
126507868|NCT02434770|455158374|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
126507869|NCT02434770|455158372|FG000|Week 1 to Week 18|Death|1|||
126507870|NCT02434770|455158373|FG001|Week 1 to Week 18|Death|0|||
126507871|NCT02434770|455158374|FG002|Week 1 to Week 18|Death|0|||
126507872|NCT02434770|455158372|FG000|Week 18 to Week|Lost to Follow-up|2|||
126507873|NCT02434770|455158373|FG001|Week 18 to Week|Lost to Follow-up|2|||
126507874|NCT02434770|455158374|FG002|Week 18 to Week|Lost to Follow-up|1|||
126507875|NCT02434770|455158372|FG000|Week 18 to Week|Withdrawal by Subject|0|||
126507876|NCT02434770|455158373|FG001|Week 18 to Week|Withdrawal by Subject|0|||
126507877|NCT02434770|455158374|FG002|Week 18 to Week|Withdrawal by Subject|2|||
126507878|NCT02434770|455158372|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
126507879|NCT02434770|455158373|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
126507880|NCT02434770|455158374|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
126507881|NCT00245765|455158375|FG000|Overall Study|Adverse Event|1|||
126507882|NCT00245765|455158376|FG001|Overall Study|Adverse Event|1|||
126507883|NCT00245765|455158377|FG002|Overall Study|Adverse Event|0|||
126507884|NCT00245765|455158375|FG000|Overall Study|Lack of Efficacy|14|||
126507885|NCT00245765|455158376|FG001|Overall Study|Lack of Efficacy|7|||
126507886|NCT00245765|455158377|FG002|Overall Study|Lack of Efficacy|0|||
126507887|NCT00245765|455158375|FG000|Overall Study|Lost to Follow-up|1|||
126507888|NCT00245765|455158376|FG001|Overall Study|Lost to Follow-up|2|||
126507889|NCT00245765|455158377|FG002|Overall Study|Lost to Follow-up|0|||
126507890|NCT00245765|455158375|FG000|Overall Study|Withdrawal by Subject|1|||
126507891|NCT00245765|455158376|FG001|Overall Study|Withdrawal by Subject|0|||
126507892|NCT00245765|455158377|FG002|Overall Study|Withdrawal by Subject|3|||
126507893|NCT00245765|455158375|FG000|Overall Study|Other reason|2|||
126507894|NCT00245765|455158376|FG001|Overall Study|Other reason|0|||
126507895|NCT00245765|455158377|FG002|Overall Study|Other reason|1|||
126565060|NCT00813488|455363390|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
126507896|NCT00245765|455158375|FG000|Overall Study|Other|13|||
126507897|NCT00245765|455158376|FG001|Overall Study|Other|4|||
126507898|NCT00245765|455158377|FG002|Overall Study|Other|4|||
126507899|NCT01574352|455158378|FG000|Overall Study|Withdrawal by Subject|6|||
126507900|NCT01574352|455158379|FG001|Overall Study|Withdrawal by Subject|13|||
126507901|NCT01574352|455158378|FG000|Overall Study|Injury in non-camp related sport|1|||
126507902|NCT01574352|455158379|FG001|Overall Study|Injury in non-camp related sport|0|||
126507903|NCT03316872|455158383|FG000|Overall Study|Death|1|||
126507904|NCT04074317|455158386|FG000|Third Period|Withdrawal by Subject|0|||
126565061|NCT00813488|455363389|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
126565062|NCT00813488|455363390|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
126565063|NCT00813488|455363389|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
126565064|NCT00813488|455363390|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
126565065|NCT00813488|455363389|FG000|Double-blind Treatment Period 2|Other|1|||
126565066|NCT00813488|455363390|FG001|Double-blind Treatment Period 2|Other|0|||
126565067|NCT00813488|455363389|FG000|Open-label Extension|Adverse Event|1|||
126565068|NCT00813488|455363390|FG001|Open-label Extension|Adverse Event|2|||
126565069|NCT00813488|455363389|FG000|Open-label Extension|Lack of Efficacy|3|||
126565070|NCT00813488|455363390|FG001|Open-label Extension|Lack of Efficacy|0|||
126565071|NCT00813488|455363389|FG000|Open-label Extension|Withdrawal by Subject|0|||
126565072|NCT00813488|455363390|FG001|Open-label Extension|Withdrawal by Subject|2|||
126565073|NCT00813488|455363389|FG000|Open-label Extension|Protocol Violation|1|||
126565074|NCT00813488|455363390|FG001|Open-label Extension|Protocol Violation|2|||
126565075|NCT00813488|455363389|FG000|Open-label Extension|Non-compliance study medication|4|||
126565076|NCT00813488|455363390|FG001|Open-label Extension|Non-compliance study medication|0|||
126565077|NCT00813488|455363389|FG000|Open-label Extension|Non-compliance study procedures|2|||
126565078|NCT00813488|455363390|FG001|Open-label Extension|Non-compliance study procedures|1|||
126565079|NCT00813488|455363389|FG000|Open-label Extension|Other|1|||
126565080|NCT00813488|455363390|FG001|Open-label Extension|Other|0|||
126565081|NCT01729871|455363392|FG000|Overall Study|Adverse Event|7|||
126565082|NCT01729871|455363393|FG001|Overall Study|Adverse Event|7|||
126565083|NCT01729871|455363392|FG000|Overall Study|Death|0|||
126565084|NCT01729871|455363393|FG001|Overall Study|Death|1|||
126565085|NCT01729871|455363392|FG000|Overall Study|Lack of Efficacy|0|||
126565086|NCT01729871|455363393|FG001|Overall Study|Lack of Efficacy|1|||
126565087|NCT01729871|455363392|FG000|Overall Study|Physician Decision|0|||
126565088|NCT01729871|455363393|FG001|Overall Study|Physician Decision|2|||
126565089|NCT01729871|455363392|FG000|Overall Study|Protocol Violation|1|||
126565090|NCT01729871|455363393|FG001|Overall Study|Protocol Violation|0|||
126565091|NCT01729871|455363392|FG000|Overall Study|Withdrawal by Subject|0|||
126565092|NCT01729871|455363393|FG001|Overall Study|Withdrawal by Subject|3|||
126565093|NCT01729871|455363392|FG000|Overall Study|Other|4|||
126565094|NCT01729871|455363393|FG001|Overall Study|Other|9|||
126565095|NCT01143077|455363394|FG000|Overall Study|Lack of Efficacy|0|||
126565096|NCT01143077|455363395|FG001|Overall Study|Lack of Efficacy|2|||
126565097|NCT01143077|455363396|FG002|Overall Study|Lack of Efficacy|1|||
126565098|NCT01143077|455363394|FG000|Overall Study|Adverse Event|5|||
126565099|NCT01143077|455363395|FG001|Overall Study|Adverse Event|6|||
126565100|NCT01143077|455363396|FG002|Overall Study|Adverse Event|5|||
126565101|NCT01143077|455363394|FG000|Overall Study|Lost to Follow-up|2|||
126565102|NCT01143077|455363395|FG001|Overall Study|Lost to Follow-up|3|||
126565103|NCT01143077|455363396|FG002|Overall Study|Lost to Follow-up|4|||
126565104|NCT01143077|455363394|FG000|Overall Study|Protocol Violation|2|||
126565105|NCT01143077|455363395|FG001|Overall Study|Protocol Violation|0|||
126565106|NCT01143077|455363396|FG002|Overall Study|Protocol Violation|0|||
126565107|NCT01143077|455363394|FG000|Overall Study|Withdrawal by Subject|4|||
126565108|NCT01143077|455363395|FG001|Overall Study|Withdrawal by Subject|3|||
126565109|NCT01143077|455363396|FG002|Overall Study|Withdrawal by Subject|3|||
126565110|NCT01143077|455363394|FG000|Overall Study|Non-compliance with study drug|0|||
126565111|NCT01143077|455363395|FG001|Overall Study|Non-compliance with study drug|1|||
126565112|NCT01143077|455363396|FG002|Overall Study|Non-compliance with study drug|1|||
126565113|NCT01143077|455363394|FG000|Overall Study|Administrative|1|||
126565114|NCT01143077|455363395|FG001|Overall Study|Administrative|0|||
126507905|NCT04074317|455158387|FG001|Third Period|Withdrawal by Subject|0|||
126507906|NCT04074317|455158388|FG002|Third Period|Withdrawal by Subject|0|||
126507907|NCT04074317|455158389|FG003|Third Period|Withdrawal by Subject|1|||
126507908|NCT04074317|455158390|FG004|Third Period|Withdrawal by Subject|0|||
126507909|NCT04074317|455158391|FG005|Third Period|Withdrawal by Subject|0|||
126507910|NCT03548584|455160827|FG000|Overall Study|Lost to Follow-up|0|||
126507911|NCT03548584|455160828|FG001|Overall Study|Lost to Follow-up|0|||
126507912|NCT03548584|455160829|FG002|Overall Study|Lost to Follow-up|1|||
126507913|NCT03548584|455160827|FG000|Overall Study|Adverse Event|1|||
126507914|NCT03548584|455160828|FG001|Overall Study|Adverse Event|11|||
126507915|NCT03548584|455160829|FG002|Overall Study|Adverse Event|5|||
126507916|NCT03548584|455160827|FG000|Overall Study|Site Terminated by Sponsor|1|||
126507917|NCT03548584|455160828|FG001|Overall Study|Site Terminated by Sponsor|3|||
126565115|NCT01143077|455363396|FG002|Overall Study|Administrative|0|||
126507918|NCT03548584|455160829|FG002|Overall Study|Site Terminated by Sponsor|2|||
126507919|NCT03548584|455160827|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
126507920|NCT03548584|455160828|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
126507921|NCT03548584|455160829|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
126565116|NCT01143077|455363394|FG000|Overall Study|Principal Investigator Decision|2|||
126565117|NCT01143077|455363395|FG001|Overall Study|Principal Investigator Decision|0|||
126565118|NCT01143077|455363396|FG002|Overall Study|Principal Investigator Decision|1|||
126565119|NCT00477412|455363401|FG000|Overall Study|Death|0|||
126507922|NCT03548584|455160827|FG000|Overall Study|Lack of Efficacy|0|||
126507923|NCT03548584|455160828|FG001|Overall Study|Lack of Efficacy|1|||
126507924|NCT03548584|455160829|FG002|Overall Study|Lack of Efficacy|0|||
126507925|NCT03548584|455160827|FG000|Overall Study|Non-compliance with Study Drug|0|||
126507926|NCT03548584|455160828|FG001|Overall Study|Non-compliance with Study Drug|1|||
126507927|NCT03548584|455160829|FG002|Overall Study|Non-compliance with Study Drug|0|||
126507928|NCT03548584|455160827|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
126507929|NCT03548584|455160828|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
126507930|NCT03548584|455160829|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
126507931|NCT00653224|455160836|FG000|Overall Study|Adverse Event|2|||
126507932|NCT00653224|455160837|FG001|Overall Study|Adverse Event|1|||
126507933|NCT00653224|455160836|FG000|Overall Study|Lack of Efficacy|1|||
126507934|NCT00653224|455160837|FG001|Overall Study|Lack of Efficacy|2|||
126507935|NCT00653224|455160836|FG000|Overall Study|Loss of efficacy|1|||
126507936|NCT00653224|455160837|FG001|Overall Study|Loss of efficacy|0|||
126507937|NCT00653224|455160836|FG000|Overall Study|Lost to Follow-up|1|||
126507938|NCT00653224|455160837|FG001|Overall Study|Lost to Follow-up|0|||
126507939|NCT00653224|455160836|FG000|Overall Study|Other|2|||
126507940|NCT00653224|455160837|FG001|Overall Study|Other|4|||
126507941|NCT05308901|455160838|FG000|Overall Study|Death|6|||
126507942|NCT00978731|455160839|FG000|Overall Study|Death|4|||
126507943|NCT00978731|455160840|FG001|Overall Study|Death|1|||
126507944|NCT00978731|455160841|FG002|Overall Study|Death|1|||
126507945|NCT00978731|455160842|FG003|Overall Study|Death|0|||
126507946|NCT00978731|455160839|FG000|Overall Study|Lost to Follow-up|0|||
126507947|NCT00978731|455160840|FG001|Overall Study|Lost to Follow-up|0|||
126507948|NCT00978731|455160841|FG002|Overall Study|Lost to Follow-up|0|||
126507949|NCT00978731|455160842|FG003|Overall Study|Lost to Follow-up|1|||
126507950|NCT00978731|455160839|FG000|Overall Study|Adverse Event|5|||
126507951|NCT00978731|455160840|FG001|Overall Study|Adverse Event|2|||
126507952|NCT00978731|455160841|FG002|Overall Study|Adverse Event|0|||
126507953|NCT00978731|455160842|FG003|Overall Study|Adverse Event|0|||
126507954|NCT00978731|455160839|FG000|Overall Study|Participant's request|1|||
126507955|NCT00978731|455160840|FG001|Overall Study|Participant's request|0|||
126507956|NCT00978731|455160841|FG002|Overall Study|Participant's request|0|||
126507957|NCT00978731|455160842|FG003|Overall Study|Participant's request|0|||
126507958|NCT00978731|455160839|FG000|Overall Study|Administrative reason|3|||
126507959|NCT00978731|455160840|FG001|Overall Study|Administrative reason|3|||
126507960|NCT00978731|455160841|FG002|Overall Study|Administrative reason|1|||
126507961|NCT00978731|455160842|FG003|Overall Study|Administrative reason|0|||
126507962|NCT00978731|455160839|FG000|Overall Study|Deterioration without progression|0|||
126507963|NCT00978731|455160840|FG001|Overall Study|Deterioration without progression|1|||
126507964|NCT00978731|455160841|FG002|Overall Study|Deterioration without progression|0|||
126507965|NCT00978731|455160842|FG003|Overall Study|Deterioration without progression|0|||
126507966|NCT00978731|455160839|FG000|Overall Study|Disease progression/relapse|5|||
126507967|NCT00978731|455160840|FG001|Overall Study|Disease progression/relapse|4|||
126507968|NCT00978731|455160841|FG002|Overall Study|Disease progression/relapse|2|||
126507969|NCT00978731|455160842|FG003|Overall Study|Disease progression/relapse|2|||
126507970|NCT00978731|455160839|FG000|Overall Study|Study closure|3|||
126507971|NCT00978731|455160840|FG001|Overall Study|Study closure|4|||
126507972|NCT00978731|455160841|FG002|Overall Study|Study closure|1|||
126507973|NCT00978731|455160842|FG003|Overall Study|Study closure|1|||
126507974|NCT00978731|455160839|FG000|Overall Study|No response|1|||
126507975|NCT00978731|455160840|FG001|Overall Study|No response|0|||
126507976|NCT00978731|455160841|FG002|Overall Study|No response|0|||
126507977|NCT00978731|455160842|FG003|Overall Study|No response|0|||
126507978|NCT01896895|455160843|FG000|Double-blind MP|Physician Decision|0|||
126507979|NCT01896895|455160844|FG001|Double-blind MP|Physician Decision|0|||
126507980|NCT01896895|455160845|FG002|Double-blind MP|Physician Decision|1|||
126507981|NCT01896895|455160846|FG003|Double-blind MP|Physician Decision|0|||
126507982|NCT01896895|455160843|FG000|Double-blind MP|Withdrawal by Subject|0|||
126507983|NCT01896895|455160844|FG001|Double-blind MP|Withdrawal by Subject|2|||
126507984|NCT01896895|455160845|FG002|Double-blind MP|Withdrawal by Subject|1|||
126507985|NCT01896895|455160846|FG003|Double-blind MP|Withdrawal by Subject|0|||
126507986|NCT01896895|455160843|FG000|Double-blind MP|Lost to Follow-up|1|||
126507987|NCT01896895|455160844|FG001|Double-blind MP|Lost to Follow-up|0|||
126507988|NCT01896895|455160845|FG002|Double-blind MP|Lost to Follow-up|1|||
126507989|NCT01896895|455160846|FG003|Double-blind MP|Lost to Follow-up|0|||
126507990|NCT00293384|455160847|FG000|Overall Study|Non-compliance|2|||
126507991|NCT00293384|455160847|FG000|Overall Study|Missed dosage/study drug|1|||
126507992|NCT00293384|455160847|FG000|Overall Study|Ineligible|2|||
126507993|NCT04482179|455160848|FG000|Overall Study|Death|1|||
126507994|NCT04482179|455160849|FG001|Overall Study|Death|0|||
126507995|NCT04482179|455160848|FG000|Overall Study|Withdrawal by Subject|1|||
126507996|NCT04482179|455160849|FG001|Overall Study|Withdrawal by Subject|0|||
126507997|NCT04709237|455160850|FG000|Overall Study|Lost to Follow-up|1|||
126565120|NCT00477412|455363402|FG001|Overall Study|Death|0|||
126565121|NCT00477412|455363403|FG002|Overall Study|Death|0|||
126507998|NCT04709237|455160851|FG001|Overall Study|Lost to Follow-up|0|||
126507999|NCT04709237|455160852|FG002|Overall Study|Lost to Follow-up|0|||
126508000|NCT01302964|455160854|FG000|Overall Study|Adverse Event|1|||
126508001|NCT01302964|455160855|FG001|Overall Study|Adverse Event|0|||
126508002|NCT00145509|455160859|FG000|Overall Study|Adverse Event|10|||
126508003|NCT00145509|455160860|FG001|Overall Study|Adverse Event|3|||
126508004|NCT00145509|455160859|FG000|Overall Study|Lack of Efficacy|3|||
126508005|NCT00145509|455160860|FG001|Overall Study|Lack of Efficacy|1|||
126508006|NCT00145509|455160859|FG000|Overall Study|Lost to Follow-up|5|||
126508007|NCT00145509|455160860|FG001|Overall Study|Lost to Follow-up|9|||
126508008|NCT00145509|455160859|FG000|Overall Study|Withdrew Consent|2|||
126508009|NCT00145509|455160860|FG001|Overall Study|Withdrew Consent|7|||
126508010|NCT00145509|455160859|FG000|Overall Study|Reason not provided|2|||
126508011|NCT00145509|455160860|FG001|Overall Study|Reason not provided|1|||
126508012|NCT02789176|455160863|FG000|Overall Study|Death|0|||
126508013|NCT02789176|455160864|FG001|Overall Study|Death|0|||
126508014|NCT02789176|455160865|FG002|Overall Study|Death|3|||
126508015|NCT02789176|455160866|FG003|Overall Study|Death|0|||
126508016|NCT02789176|455160863|FG000|Overall Study|Withdrawal by Subject|0|||
126508017|NCT02789176|455160864|FG001|Overall Study|Withdrawal by Subject|0|||
126508018|NCT02789176|455160865|FG002|Overall Study|Withdrawal by Subject|1|||
126508019|NCT02789176|455160866|FG003|Overall Study|Withdrawal by Subject|0|||
126508020|NCT02789176|455160863|FG000|Overall Study|Lost to Follow-up|8|||
126508021|NCT02789176|455160864|FG001|Overall Study|Lost to Follow-up|2|||
126508022|NCT02789176|455160865|FG002|Overall Study|Lost to Follow-up|6|||
126508023|NCT02789176|455160866|FG003|Overall Study|Lost to Follow-up|1|||
126508024|NCT00596011|455160867|FG000|Overall Study|Withdrawal by Subject|2|||
126508025|NCT00596011|455160868|FG001|Overall Study|Withdrawal by Subject|3|||
126508026|NCT00596011|455160867|FG000|Overall Study|Adverse Event|11|||
126508027|NCT00596011|455160868|FG001|Overall Study|Adverse Event|7|||
126508028|NCT00192075|455160869|FG000|Overall Study|Disease Progression|23|||
126508029|NCT00192075|455160870|FG001|Overall Study|Disease Progression|6|||
126508030|NCT00192075|455160869|FG000|Overall Study|Adverse Event|1|||
126508031|NCT00192075|455160870|FG001|Overall Study|Adverse Event|3|||
126508032|NCT00192075|455160869|FG000|Overall Study|Death|0|||
126508033|NCT00192075|455160870|FG001|Overall Study|Death|1|||
126508034|NCT00192075|455160869|FG000|Overall Study|Lack of Efficacy|0|||
126508035|NCT00192075|455160870|FG001|Overall Study|Lack of Efficacy|0|||
126508036|NCT00192075|455160869|FG000|Overall Study|Physician Decision|3|||
126508037|NCT00192075|455160870|FG001|Overall Study|Physician Decision|0|||
126508038|NCT00192075|455160869|FG000|Overall Study|Withdrawal by Subject|5|||
126508039|NCT00192075|455160870|FG001|Overall Study|Withdrawal by Subject|5|||
126508040|NCT00192075|455160869|FG000|Overall Study|Patient Non-Compliance|0|||
126508041|NCT00192075|455160870|FG001|Overall Study|Patient Non-Compliance|1|||
126508042|NCT00192075|455160869|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
126508043|NCT00192075|455160870|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
126508044|NCT00192075|455160869|FG000|Overall Study|Other|5|||
126508045|NCT00192075|455160870|FG001|Overall Study|Other|2|||
126508046|NCT00779675|455160871|FG000|Treatment Period|Adverse Event|87|||
126508047|NCT00779675|455160871|FG000|Treatment Period|Treatment Failure|80|||
126508048|NCT00779675|455160871|FG000|Treatment Period|Transferred to Another Study|38|||
126508049|NCT00779675|455160871|FG000|Treatment Period|Lost to Follow-up|23|||
126508050|NCT00779675|455160871|FG000|Treatment Period|Withdrawal by Subject|46|||
126508051|NCT00779675|455160871|FG000|Treatment Period|Protocol Violation|54|||
126508052|NCT00779675|455160871|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
126508053|NCT00779675|455160871|FG000|Treatment Period|Administrative|3|||
126508054|NCT00779675|455160871|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
126508055|NCT00779675|455160871|FG000|Extended Treatment Period|Protocol Violation|13|||
126508056|NCT00779675|455160871|FG000|Extended Treatment Period|Adverse Event|6|||
126508057|NCT00779675|455160871|FG000|Extended Treatment Period|Treatment Failure|11|||
126508058|NCT00779675|455160871|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
126508059|NCT00779675|455160871|FG000|Extended Treatment Period|Lost to Follow-up|6|||
126508060|NCT02821962|455160874|FG000|Overall Study|Lost to Follow-up|2|||
126508061|NCT02821962|455160875|FG001|Overall Study|Lost to Follow-up|0|||
126508062|NCT04300296|455160878|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
126508063|NCT04300296|455160879|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
126508064|NCT04300296|455160880|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
126508065|NCT04300296|455160881|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
126508066|NCT04300296|455160882|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
126565122|NCT00477412|455363404|FG003|Overall Study|Death|4|||
126508067|NCT04300296|455160883|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
126508068|NCT04300296|455160878|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
126508069|NCT04300296|455160879|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
126508070|NCT04300296|455160880|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
126508071|NCT04300296|455160881|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
126565123|NCT00477412|455363401|FG000|Overall Study|Lost to Follow-up|0|||
126508072|NCT04300296|455160882|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
126508073|NCT04300296|455160883|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
126508074|NCT04300296|455160878|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
126508075|NCT04300296|455160879|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
126508076|NCT04300296|455160880|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
126508077|NCT04300296|455160881|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
126508078|NCT04300296|455160882|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
126508079|NCT04300296|455160883|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
126508080|NCT04300296|455160878|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
126508081|NCT04300296|455160879|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
126508082|NCT04300296|455160880|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
126508083|NCT04300296|455160881|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
126508084|NCT04300296|455160882|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
126508085|NCT04300296|455160883|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
126565124|NCT00477412|455363402|FG001|Overall Study|Lost to Follow-up|0|||
126565125|NCT00477412|455363403|FG002|Overall Study|Lost to Follow-up|0|||
126565126|NCT00477412|455363404|FG003|Overall Study|Lost to Follow-up|1|||
126565127|NCT00477412|455363401|FG000|Overall Study|Withdrawal by Subject|0|||
126565128|NCT00477412|455363402|FG001|Overall Study|Withdrawal by Subject|0|||
126565129|NCT00477412|455363403|FG002|Overall Study|Withdrawal by Subject|0|||
126565130|NCT00477412|455363404|FG003|Overall Study|Withdrawal by Subject|2|||
126565131|NCT00477412|455363401|FG000|Overall Study|Second Malignancy|0|||
126565132|NCT00477412|455363402|FG001|Overall Study|Second Malignancy|0|||
126565133|NCT00477412|455363403|FG002|Overall Study|Second Malignancy|0|||
126565134|NCT00477412|455363404|FG003|Overall Study|Second Malignancy|1|||
126565135|NCT00477412|455363401|FG000|Overall Study|Adverse Event|1|||
126565136|NCT00477412|455363402|FG001|Overall Study|Adverse Event|0|||
126565137|NCT00477412|455363403|FG002|Overall Study|Adverse Event|1|||
126565138|NCT00477412|455363404|FG003|Overall Study|Adverse Event|0|||
126565139|NCT00708097|455363405|FG000|Period 1|Protocol Violation|0|||
126565140|NCT00708097|455363406|FG001|Period 1|Protocol Violation|1|||
126565141|NCT00708097|455363407|FG002|Period 1|Protocol Violation|0|||
126565142|NCT00708097|455363408|FG003|Period 1|Protocol Violation|2|||
126565143|NCT00708097|455363409|FG004|Period 1|Protocol Violation|0|||
126565144|NCT00708097|455363405|FG000|Period 1|Other Reason|0|||
126565145|NCT00708097|455363406|FG001|Period 1|Other Reason|0|||
126565146|NCT00708097|455363407|FG002|Period 1|Other Reason|0|||
126565147|NCT00708097|455363408|FG003|Period 1|Other Reason|0|||
126565148|NCT00708097|455363409|FG004|Period 1|Other Reason|1|||
126565149|NCT00708097|455363405|FG000|Period 2|Protocol Violation|0|||
126565150|NCT00708097|455363406|FG001|Period 2|Protocol Violation|1|||
126565151|NCT00708097|455363407|FG002|Period 2|Protocol Violation|1|||
126565152|NCT00708097|455363408|FG003|Period 2|Protocol Violation|1|||
126565153|NCT00708097|455363409|FG004|Period 2|Protocol Violation|0|||
126565154|NCT01677936|455364831|FG000|Overall Study|Lost to Follow-up|4|||
126565155|NCT01677936|455364832|FG001|Overall Study|Lost to Follow-up|1|||
126565156|NCT01677936|455364831|FG000|Overall Study|Protocol Violation|3|||
126565157|NCT01677936|455364832|FG001|Overall Study|Protocol Violation|0|||
126565158|NCT01677936|455364831|FG000|Overall Study|Adverse Event|1|||
126565159|NCT01677936|455364832|FG001|Overall Study|Adverse Event|0|||
126565160|NCT01677936|455364831|FG000|Overall Study|Lost to Follow-up|1|||
126565161|NCT01677936|455364832|FG001|Overall Study|Lost to Follow-up|0|||
126565162|NCT01677936|455364831|FG000|Overall Study|Protocol Violation|0|||
126565163|NCT01677936|455364832|FG001|Overall Study|Protocol Violation|4|||
126565164|NCT01118377|455364833|FG000|Overall Study|Did Not Receive Study Medication|1|||
126565165|NCT01118377|455364833|FG000|Overall Study|Death|38|||
126565166|NCT01118377|455364833|FG000|Overall Study|Failure to Return|3|||
126565167|NCT00157014|455364834|FG000|Overall Study|Death|4|||
126565168|NCT00157014|455364835|FG001|Overall Study|Death|2|||
126565169|NCT00157014|455364836|FG002|Overall Study|Death|1|||
126565170|NCT00157014|455364837|FG003|Overall Study|Death|1|||
126565171|NCT00157014|455364834|FG000|Overall Study|Physician Decision|0|||
126565172|NCT00157014|455364835|FG001|Overall Study|Physician Decision|1|||
126565173|NCT00157014|455364836|FG002|Overall Study|Physician Decision|0|||
126565174|NCT00157014|455364837|FG003|Overall Study|Physician Decision|0|||
126565175|NCT00157014|455364834|FG000|Overall Study|Medications withdrawn on family request|0|||
126565176|NCT00157014|455364835|FG001|Overall Study|Medications withdrawn on family request|1|||
126565177|NCT00157014|455364836|FG002|Overall Study|Medications withdrawn on family request|0|||
126565178|NCT00157014|455364837|FG003|Overall Study|Medications withdrawn on family request|0|||
126565179|NCT00157014|455364834|FG000|Overall Study|Patient withdrawn by investigator|1|||
126565180|NCT00157014|455364835|FG001|Overall Study|Patient withdrawn by investigator|0|||
126565181|NCT00157014|455364836|FG002|Overall Study|Patient withdrawn by investigator|0|||
126565182|NCT00157014|455364837|FG003|Overall Study|Patient withdrawn by investigator|0|||
126565183|NCT00157014|455364834|FG000|Overall Study|Patient unable to return in nursing home|1|||
126565184|NCT00157014|455364835|FG001|Overall Study|Patient unable to return in nursing home|0|||
126727159|NCT02921919|455951069|FG000|Overall Study|Other|5|||
126508086|NCT04300296|455160878|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
126508087|NCT04300296|455160879|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
126508088|NCT04300296|455160880|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
126508089|NCT04300296|455160881|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
126508090|NCT04300296|455160882|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
126508091|NCT04300296|455160883|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
126508092|NCT04300296|455160878|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
126508093|NCT04300296|455160879|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
126508094|NCT04300296|455160880|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
126508095|NCT04300296|455160881|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
126508096|NCT04300296|455160882|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
126508097|NCT04300296|455160883|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
126508098|NCT04300296|455160878|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
126508099|NCT04300296|455160879|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
126508100|NCT04300296|455160880|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
126508101|NCT04300296|455160881|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
126508102|NCT04300296|455160882|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
126508103|NCT04300296|455160883|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
126508104|NCT03325166|455160884|FG000|Overall Study|Adverse Event|1|||
126508105|NCT01633944|455160885|FG000|Open-label Titration Phase|Adverse Event|109|||
126508106|NCT01633944|455160886|FG001|Open-label Titration Phase|Adverse Event|0|||
126508107|NCT01633944|455160887|FG002|Open-label Titration Phase|Adverse Event|0|||
126508108|NCT01633944|455160885|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
126508109|NCT01633944|455160886|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
126508110|NCT01633944|455160887|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
126508111|NCT01633944|455160885|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
126508112|NCT01633944|455160886|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
126508113|NCT01633944|455160887|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
126508114|NCT01633944|455160885|FG000|Open-label Titration Phase|Protocol Violation|24|||
126508115|NCT01633944|455160886|FG001|Open-label Titration Phase|Protocol Violation|0|||
126508116|NCT01633944|455160887|FG002|Open-label Titration Phase|Protocol Violation|0|||
126508117|NCT01633944|455160885|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
126508118|NCT01633944|455160886|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
126508119|NCT01633944|455160887|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
126508120|NCT01633944|455160885|FG000|Open-label Titration Phase|Other|68|||
126508121|NCT01633944|455160886|FG001|Open-label Titration Phase|Other|0|||
126508122|NCT01633944|455160887|FG002|Open-label Titration Phase|Other|0|||
126508123|NCT01633944|455160885|FG000|Double-blind Treatment Phase|Adverse Event|0|||
126508124|NCT01633944|455160886|FG001|Double-blind Treatment Phase|Adverse Event|13|||
126508125|NCT01633944|455160887|FG002|Double-blind Treatment Phase|Adverse Event|7|||
126508126|NCT01633944|455160885|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
126508127|NCT01633944|455160886|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
126508128|NCT01633944|455160887|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
126508129|NCT01633944|455160885|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126508130|NCT01633944|455160886|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
126508131|NCT01633944|455160887|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
126565185|NCT00157014|455364836|FG002|Overall Study|Patient unable to return in nursing home|0|||
126565186|NCT00157014|455364837|FG003|Overall Study|Patient unable to return in nursing home|0|||
126565187|NCT00157014|455364834|FG000|Overall Study|Patient would not receive transplant|0|||
126565188|NCT00157014|455364835|FG001|Overall Study|Patient would not receive transplant|1|||
126565189|NCT00157014|455364836|FG002|Overall Study|Patient would not receive transplant|0|||
126565190|NCT00157014|455364837|FG003|Overall Study|Patient would not receive transplant|0|||
126565191|NCT00157014|455364834|FG000|Overall Study|Withdrawal by Subject|1|||
126565192|NCT00157014|455364835|FG001|Overall Study|Withdrawal by Subject|0|||
126565193|NCT00157014|455364836|FG002|Overall Study|Withdrawal by Subject|0|||
126565194|NCT00157014|455364837|FG003|Overall Study|Withdrawal by Subject|0|||
126565195|NCT03181958|455364838|FG000|Overall Study|Lost to Follow-up|17|||
126565196|NCT03181958|455364839|FG001|Overall Study|Lost to Follow-up|21|||
126565197|NCT03181958|455364840|FG002|Overall Study|Lost to Follow-up|15|||
126565198|NCT00943605|455364841|FG000|Overall Study|Study termination|30|||
126565199|NCT00943605|455364842|FG001|Overall Study|Study termination|30|||
126565200|NCT01072357|455364847|FG000|Overall Study|Lost to Follow-up|0|||
126565201|NCT01072357|455364848|FG001|Overall Study|Lost to Follow-up|1|||
126565202|NCT01876511|455364849|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
126565203|NCT01876511|455364850|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
126565204|NCT01876511|455364851|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
126565205|NCT01876511|455364849|FG000|Overall Study|Death (unrelated)|3|||
126565206|NCT01876511|455364850|FG001|Overall Study|Death (unrelated)|0|||
126565207|NCT01876511|455364851|FG002|Overall Study|Death (unrelated)|2|||
126565208|NCT01876511|455364849|FG000|Overall Study|Drug-related Toxicity|5|||
126508132|NCT01633944|455160885|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
126508133|NCT01633944|455160886|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
126508134|NCT01633944|455160887|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
126508135|NCT01633944|455160885|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
126508136|NCT01633944|455160886|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
126508137|NCT01633944|455160887|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
126508138|NCT01633944|455160885|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
126508139|NCT01633944|455160886|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
126508140|NCT01633944|455160887|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
126508141|NCT01633944|455160885|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
126508142|NCT01633944|455160886|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
126508143|NCT01633944|455160887|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
126508144|NCT01633944|455160885|FG000|Double-blind Treatment Phase|Other|0|||
126508145|NCT01633944|455160886|FG001|Double-blind Treatment Phase|Other|7|||
126508146|NCT01633944|455160887|FG002|Double-blind Treatment Phase|Other|0|||
126508147|NCT00701129|455160889|FG000|Overall Study|Death|2|||
126508148|NCT02027844|455160892|FG000|Overall Study|Withdrawal by Subject|3|||
126508149|NCT02027844|455160893|FG001|Overall Study|Withdrawal by Subject|2|||
126508150|NCT02027844|455160894|FG002|Overall Study|Withdrawal by Subject|1|||
126508151|NCT02027844|455160892|FG000|Overall Study|Lost to Follow-up|0|||
126508152|NCT02027844|455160893|FG001|Overall Study|Lost to Follow-up|2|||
126508153|NCT02027844|455160894|FG002|Overall Study|Lost to Follow-up|1|||
126508154|NCT02027844|455160892|FG000|Overall Study|Protocol Violation|0|||
126508155|NCT02027844|455160893|FG001|Overall Study|Protocol Violation|2|||
126508156|NCT02027844|455160894|FG002|Overall Study|Protocol Violation|0|||
126508157|NCT02027844|455160892|FG000|Overall Study|Incomlete data|2|||
126508158|NCT02027844|455160893|FG001|Overall Study|Incomlete data|0|||
126508159|NCT02027844|455160894|FG002|Overall Study|Incomlete data|0|||
126508160|NCT00378014|455160895|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
126508161|NCT00378014|455160896|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
126508162|NCT00378014|455160895|FG000|Core (Randomization to Month 11)|Graft loss|1|||
126508163|NCT00378014|455160896|FG001|Core (Randomization to Month 11)|Graft loss|2|||
126508164|NCT00378014|455160895|FG000|Core (Randomization to Month 11)|Death|5|||
126508165|NCT00378014|455160896|FG001|Core (Randomization to Month 11)|Death|3|||
126508166|NCT00378014|455160895|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
126508167|NCT00378014|455160896|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
126508168|NCT00378014|455160895|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
126508169|NCT00378014|455160896|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
126508170|NCT00378014|455160895|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
126508171|NCT00378014|455160896|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
126508172|NCT00378014|455160895|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
126508173|NCT00378014|455160896|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
126508174|NCT00378014|455160895|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
126508175|NCT00378014|455160896|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
126508176|NCT00378014|455160895|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
126508177|NCT00378014|455160896|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
126508178|NCT00378014|455160895|FG000|Extension (Month 12 to Month 59)|Death|1|||
126508179|NCT00378014|455160896|FG001|Extension (Month 12 to Month 59)|Death|2|||
126508180|NCT00378014|455160895|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
126508181|NCT00378014|455160896|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
126508182|NCT00378014|455160895|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
126508183|NCT00378014|455160896|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
126508184|NCT00378014|455160895|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
126508185|NCT00378014|455160896|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
126508186|NCT00378014|455160895|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
126508187|NCT00378014|455160896|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
126508188|NCT04889625|455160899|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
126508189|NCT04889625|455160900|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
126508190|NCT04889625|455160899|FG000|Period 1|Subject out of window|0|||
126508191|NCT04889625|455160900|FG001|Period 1|Subject out of window|1|||
126508192|NCT04889625|455160899|FG000|Period 1|Wrong add power dispensed|0|||
126508193|NCT04889625|455160900|FG001|Period 1|Wrong add power dispensed|1|||
126508194|NCT04889625|455160899|FG000|Period 1|Discontinued due to fitting guide error|1|||
126508195|NCT04889625|455160900|FG001|Period 1|Discontinued due to fitting guide error|1|||
126508196|NCT04889625|455160899|FG000|Period 2|Test article no longer available|1|||
126508197|NCT04889625|455160900|FG001|Period 2|Test article no longer available|0|||
126508198|NCT04889625|455160899|FG000|Period 2|Incorrect lens dispensed|1|||
126508199|NCT04889625|455160900|FG001|Period 2|Incorrect lens dispensed|0|||
126508200|NCT04889625|455160899|FG000|Period 2|Wrong add power dispensed|0|||
126508201|NCT04889625|455160900|FG001|Period 2|Wrong add power dispensed|1|||
126508202|NCT03746522|455160910|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
126508203|NCT03746522|455160911|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
126508204|NCT03746522|455160912|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
126508205|NCT03746522|455160910|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
126508206|NCT03746522|455160911|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
126508207|NCT03746522|455160912|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
126508208|NCT03746522|455160910|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
126508209|NCT03746522|455160911|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
126508210|NCT03746522|455160912|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
126508211|NCT03746522|455160910|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
126508212|NCT03746522|455160911|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
126508213|NCT03746522|455160912|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
126508214|NCT03746522|455160910|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
126508215|NCT03746522|455160911|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
126508216|NCT03746522|455160912|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
126508217|NCT00323414|455160915|FG000|Overall Study|Withdrawal by Subject|0|||
126508218|NCT00323414|455160916|FG001|Overall Study|Withdrawal by Subject|1|||
126508219|NCT02552316|455160918|FG000|Overall Study|Withdrawal by Subject|1|||
126508220|NCT02552316|455160918|FG000|Overall Study|Withdrawal due to non-compliance|1|||
126508221|NCT02659020|455160919|FG000|Overall Study|Adverse Event|0|||
126565209|NCT01876511|455364850|FG001|Overall Study|Drug-related Toxicity|1|||
126508222|NCT02659020|455160920|FG001|Overall Study|Adverse Event|0|||
126508223|NCT02659020|455160921|FG002|Overall Study|Adverse Event|0|||
126508224|NCT02659020|455160922|FG003|Overall Study|Adverse Event|2|||
126508225|NCT02659020|455160923|FG004|Overall Study|Adverse Event|0|||
126508226|NCT02659020|455160924|FG005|Overall Study|Adverse Event|0|||
126565210|NCT01876511|455364851|FG002|Overall Study|Drug-related Toxicity|6|||
126565211|NCT01876511|455364849|FG000|Overall Study|Patient Decision|3|||
126565212|NCT01876511|455364850|FG001|Overall Study|Patient Decision|0|||
126565213|NCT01876511|455364851|FG002|Overall Study|Patient Decision|6|||
126565214|NCT01876511|455364849|FG000|Overall Study|Physician Decision|1|||
126565215|NCT01876511|455364850|FG001|Overall Study|Physician Decision|0|||
126565216|NCT01876511|455364851|FG002|Overall Study|Physician Decision|1|||
126508227|NCT02659020|455160925|FG006|Overall Study|Adverse Event|2|||
126508228|NCT02659020|455160919|FG000|Overall Study|Lost to Follow-up|1|||
126508229|NCT02659020|455160920|FG001|Overall Study|Lost to Follow-up|2|||
126508230|NCT02659020|455160921|FG002|Overall Study|Lost to Follow-up|1|||
126508231|NCT02659020|455160922|FG003|Overall Study|Lost to Follow-up|6|||
126508232|NCT02659020|455160923|FG004|Overall Study|Lost to Follow-up|1|||
126508233|NCT02659020|455160924|FG005|Overall Study|Lost to Follow-up|5|||
126508234|NCT02659020|455160925|FG006|Overall Study|Lost to Follow-up|0|||
126508235|NCT02659020|455160919|FG000|Overall Study|Physician Decision|0|||
126508236|NCT02659020|455160920|FG001|Overall Study|Physician Decision|0|||
126508237|NCT02659020|455160921|FG002|Overall Study|Physician Decision|0|||
126508238|NCT02659020|455160922|FG003|Overall Study|Physician Decision|1|||
126508239|NCT02659020|455160923|FG004|Overall Study|Physician Decision|1|||
126508240|NCT02659020|455160924|FG005|Overall Study|Physician Decision|0|||
126508241|NCT02659020|455160925|FG006|Overall Study|Physician Decision|1|||
126508242|NCT02659020|455160919|FG000|Overall Study|Withdrawal by Subject|2|||
126508243|NCT02659020|455160920|FG001|Overall Study|Withdrawal by Subject|1|||
126508244|NCT02659020|455160921|FG002|Overall Study|Withdrawal by Subject|0|||
126508245|NCT02659020|455160922|FG003|Overall Study|Withdrawal by Subject|3|||
126508246|NCT02659020|455160923|FG004|Overall Study|Withdrawal by Subject|3|||
126508247|NCT02659020|455160924|FG005|Overall Study|Withdrawal by Subject|6|||
126508248|NCT02659020|455160925|FG006|Overall Study|Withdrawal by Subject|3|||
126508249|NCT02659020|455160919|FG000|Overall Study|Progressive Disease|0|||
126508250|NCT02659020|455160920|FG001|Overall Study|Progressive Disease|0|||
126508251|NCT02659020|455160921|FG002|Overall Study|Progressive Disease|0|||
126508252|NCT02659020|455160922|FG003|Overall Study|Progressive Disease|4|||
126565217|NCT00891618|455364852|FG000|Overall Study|Withdrawal by Subject|1|||
126508253|NCT02659020|455160923|FG004|Overall Study|Progressive Disease|1|||
126508254|NCT02659020|455160924|FG005|Overall Study|Progressive Disease|0|||
126508255|NCT02659020|455160925|FG006|Overall Study|Progressive Disease|2|||
126565218|NCT01048788|455364853|FG000|Overall Study|Adverse Event|5|||
126565219|NCT01048788|455364854|FG001|Overall Study|Adverse Event|1|||
126508256|NCT04382911|455160926|FG000|Overall Study|unable to be imaged prior to surgery|2|||
126508257|NCT01120210|455160927|FG000|MAIN INFUSION|Adverse Event|1|||
126508258|NCT01120210|455160928|FG001|MAIN INFUSION|Adverse Event|0|||
126508259|NCT01120210|455160927|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
126508260|NCT01120210|455160928|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
126508261|NCT02043015|455160939|FG000|Overall Study|Lost to Follow-up|4|||
126508262|NCT02043015|455160939|FG000|Overall Study|Withdrawal by Subject|4|||
126508263|NCT02043015|455160939|FG000|Overall Study|Removed once target enrollment reached|15|||
126565220|NCT01048788|455364855|FG002|Overall Study|Adverse Event|1|||
126565221|NCT01048788|455364853|FG000|Overall Study|Lack of Efficacy|0|||
126565222|NCT01048788|455364854|FG001|Overall Study|Lack of Efficacy|0|||
126565223|NCT01048788|455364855|FG002|Overall Study|Lack of Efficacy|1|||
126508264|NCT02043015|455160939|FG000|Overall Study|Participant moved away from study city|4|||
126508265|NCT02043015|455160939|FG000|Overall Study|Incarceration|1|||
126508266|NCT02457598|455160941|FG000|Overall Study|Progressive Disease|2|||
126508267|NCT02457598|455160942|FG001|Overall Study|Progressive Disease|2|||
126508268|NCT02457598|455160943|FG002|Overall Study|Progressive Disease|1|||
126508269|NCT02457598|455160944|FG003|Overall Study|Progressive Disease|11|||
126508270|NCT02457598|455160945|FG004|Overall Study|Progressive Disease|7|||
126508271|NCT02457598|455160946|FG005|Overall Study|Progressive Disease|3|||
126565224|NCT01048788|455364853|FG000|Overall Study|Withdrawal by Subject|0|||
126565225|NCT01048788|455364854|FG001|Overall Study|Withdrawal by Subject|1|||
126565226|NCT01048788|455364855|FG002|Overall Study|Withdrawal by Subject|0|||
126565227|NCT01313182|455364858|FG000|Overall Study|Protocol Violation|66|||
126565228|NCT01313182|455364859|FG001|Overall Study|Protocol Violation|92|||
126565229|NCT01695317|455364860|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
126565230|NCT01695317|455364861|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
126565231|NCT01695317|455364860|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
126565232|NCT01695317|455364861|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
126565233|NCT00464672|455364862|FG000|Overall Study|withdrawal of consent|0|||
126565234|NCT00464672|455364863|FG001|Overall Study|withdrawal of consent|0|||
126565235|NCT00464672|455364864|FG002|Overall Study|withdrawal of consent|0|||
126565236|NCT00464672|455364865|FG003|Overall Study|withdrawal of consent|1|||
126565237|NCT00464672|455364866|FG004|Overall Study|withdrawal of consent|9|||
126565238|NCT00464672|455364867|FG005|Overall Study|withdrawal of consent|4|||
126565239|NCT00464672|455364862|FG000|Overall Study|Lost to Follow-up|25|||
126565240|NCT00464672|455364863|FG001|Overall Study|Lost to Follow-up|10|||
126565241|NCT00464672|455364864|FG002|Overall Study|Lost to Follow-up|0|||
126565242|NCT00464672|455364865|FG003|Overall Study|Lost to Follow-up|0|||
126565243|NCT00464672|455364866|FG004|Overall Study|Lost to Follow-up|1|||
126565244|NCT00464672|455364867|FG005|Overall Study|Lost to Follow-up|0|||
126565245|NCT00957229|455364869|FG000|Study Start|Adverse Event|0|||
126565246|NCT00957229|455364870|FG001|Study Start|Adverse Event|3|||
126565247|NCT00957229|455364869|FG000|Study Start|Disease Progression|1|||
126565248|NCT00957229|455364870|FG001|Study Start|Disease Progression|0|||
126565249|NCT00957229|455364869|FG000|Reallocated to or Continued Vismodegib|Death|1|||
126565250|NCT00957229|455364870|FG001|Reallocated to or Continued Vismodegib|Death|1|||
126565251|NCT00957229|455364869|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
126565252|NCT00957229|455364870|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
126565253|NCT00606580|455364871|FG000|Overall Study|Lost to Follow-up|1|||
126565254|NCT00606580|455364872|FG001|Overall Study|Lost to Follow-up|1|||
126565255|NCT00606580|455364873|FG002|Overall Study|Lost to Follow-up|4|||
126565256|NCT00606580|455364871|FG000|Overall Study|Clinical failures|1|||
126565257|NCT00606580|455364872|FG001|Overall Study|Clinical failures|0|||
126565258|NCT00606580|455364873|FG002|Overall Study|Clinical failures|12|||
126565259|NCT00606580|455364871|FG000|Overall Study|Withdrawal by investigator|0|||
126565260|NCT00606580|455364872|FG001|Overall Study|Withdrawal by investigator|1|||
126565261|NCT00606580|455364873|FG002|Overall Study|Withdrawal by investigator|6|||
126565262|NCT00606580|455364871|FG000|Overall Study|Withdrawal by Subject|0|||
126565263|NCT00606580|455364872|FG001|Overall Study|Withdrawal by Subject|1|||
126565264|NCT00606580|455364873|FG002|Overall Study|Withdrawal by Subject|0|||
126565265|NCT01250002|455364878|FG000|Overall Study|Change to open surgical procedure|4|||
126565266|NCT01250002|455364879|FG001|Overall Study|Change to open surgical procedure|3|||
126565267|NCT04044664|455364894|FG000|Stage 1|Adverse Event|3|||
126565268|NCT04044664|455364895|FG001|Stage 1|Adverse Event|3|||
126565269|NCT04044664|455364896|FG002|Stage 1|Adverse Event|1|||
126565270|NCT04044664|455364894|FG000|Stage 1|Lost to Follow-up|3|||
126565271|NCT04044664|455364895|FG001|Stage 1|Lost to Follow-up|2|||
126565272|NCT04044664|455364896|FG002|Stage 1|Lost to Follow-up|2|||
126565273|NCT04044664|455364894|FG000|Stage 1|Withdrawal by Subject|9|||
126565274|NCT04044664|455364895|FG001|Stage 1|Withdrawal by Subject|1|||
126565275|NCT04044664|455364896|FG002|Stage 1|Withdrawal by Subject|0|||
126565276|NCT04044664|455364894|FG000|Stage 1|noncompliance, personal reason|2|||
126565277|NCT04044664|455364895|FG001|Stage 1|noncompliance, personal reason|0|||
126565278|NCT04044664|455364896|FG002|Stage 1|noncompliance, personal reason|0|||
126565279|NCT04044664|455364894|FG000|Stage 1|randomization error|0|||
126565280|NCT04044664|455364895|FG001|Stage 1|randomization error|1|||
126565281|NCT04044664|455364896|FG002|Stage 1|randomization error|0|||
126565282|NCT04044664|455364894|FG000|Stage 2|Adverse Event|2|||
126565283|NCT04044664|455364895|FG001|Stage 2|Adverse Event|0|||
126565284|NCT04044664|455364896|FG002|Stage 2|Adverse Event|0|||
126565285|NCT04044664|455364894|FG000|Stage 2|Lost to Follow-up|3|||
126565286|NCT04044664|455364895|FG001|Stage 2|Lost to Follow-up|2|||
126565287|NCT04044664|455364896|FG002|Stage 2|Lost to Follow-up|1|||
126565288|NCT04044664|455364894|FG000|Stage 2|Withdrawal by Subject|3|||
126565289|NCT04044664|455364895|FG001|Stage 2|Withdrawal by Subject|0|||
126565290|NCT04044664|455364896|FG002|Stage 2|Withdrawal by Subject|0|||
126508272|NCT02457598|455160947|FG006|Overall Study|Progressive Disease|2|||
126565291|NCT04044664|455364894|FG000|Stage 2|protocol deviation|1|||
126565292|NCT04044664|455364895|FG001|Stage 2|protocol deviation|0|||
126565293|NCT04044664|455364896|FG002|Stage 2|protocol deviation|0|||
126508273|NCT02457598|455160948|FG007|Overall Study|Progressive Disease|1|||
126508274|NCT02457598|455160949|FG008|Overall Study|Progressive Disease|1|||
126508275|NCT02457598|455160950|FG009|Overall Study|Progressive Disease|2|||
126508276|NCT02457598|455160951|FG010|Overall Study|Progressive Disease|45|||
126508277|NCT02457598|455160952|FG011|Overall Study|Progressive Disease|6|||
126508278|NCT02457598|455160953|FG012|Overall Study|Progressive Disease|2|||
126508279|NCT02457598|455160954|FG013|Overall Study|Progressive Disease|2|||
126508280|NCT02457598|455160955|FG014|Overall Study|Progressive Disease|10|||
126508281|NCT02457598|455160956|FG015|Overall Study|Progressive Disease|1|||
126508282|NCT02457598|455160957|FG016|Overall Study|Progressive Disease|1|||
126508283|NCT02457598|455160941|FG000|Overall Study|Investigator's Discretion|0|||
126508284|NCT02457598|455160942|FG001|Overall Study|Investigator's Discretion|2|||
126508285|NCT02457598|455160943|FG002|Overall Study|Investigator's Discretion|2|||
126508286|NCT02457598|455160944|FG003|Overall Study|Investigator's Discretion|2|||
126508287|NCT02457598|455160945|FG004|Overall Study|Investigator's Discretion|0|||
126508288|NCT02457598|455160946|FG005|Overall Study|Investigator's Discretion|0|||
126508289|NCT02457598|455160947|FG006|Overall Study|Investigator's Discretion|0|||
126508290|NCT02457598|455160948|FG007|Overall Study|Investigator's Discretion|1|||
126508291|NCT02457598|455160949|FG008|Overall Study|Investigator's Discretion|2|||
126508292|NCT02457598|455160950|FG009|Overall Study|Investigator's Discretion|0|||
126508293|NCT02457598|455160951|FG010|Overall Study|Investigator's Discretion|10|||
126508294|NCT02457598|455160952|FG011|Overall Study|Investigator's Discretion|2|||
126508295|NCT02457598|455160953|FG012|Overall Study|Investigator's Discretion|2|||
126508296|NCT02457598|455160954|FG013|Overall Study|Investigator's Discretion|1|||
126508297|NCT02457598|455160955|FG014|Overall Study|Investigator's Discretion|5|||
126508298|NCT02457598|455160956|FG015|Overall Study|Investigator's Discretion|0|||
126508299|NCT02457598|455160957|FG016|Overall Study|Investigator's Discretion|0|||
126508300|NCT02457598|455160941|FG000|Overall Study|Study Terminated by Sponsor|0|||
126508301|NCT02457598|455160942|FG001|Overall Study|Study Terminated by Sponsor|1|||
126508302|NCT02457598|455160943|FG002|Overall Study|Study Terminated by Sponsor|0|||
126508303|NCT02457598|455160944|FG003|Overall Study|Study Terminated by Sponsor|4|||
126508304|NCT02457598|455160945|FG004|Overall Study|Study Terminated by Sponsor|1|||
126508305|NCT02457598|455160946|FG005|Overall Study|Study Terminated by Sponsor|0|||
126508306|NCT02457598|455160947|FG006|Overall Study|Study Terminated by Sponsor|1|||
126508307|NCT02457598|455160948|FG007|Overall Study|Study Terminated by Sponsor|0|||
126508308|NCT02457598|455160949|FG008|Overall Study|Study Terminated by Sponsor|0|||
126508309|NCT02457598|455160950|FG009|Overall Study|Study Terminated by Sponsor|0|||
126508310|NCT02457598|455160951|FG010|Overall Study|Study Terminated by Sponsor|4|||
126508311|NCT02457598|455160952|FG011|Overall Study|Study Terminated by Sponsor|0|||
126508312|NCT02457598|455160953|FG012|Overall Study|Study Terminated by Sponsor|1|||
126508313|NCT02457598|455160954|FG013|Overall Study|Study Terminated by Sponsor|0|||
126508314|NCT02457598|455160955|FG014|Overall Study|Study Terminated by Sponsor|8|||
126508315|NCT02457598|455160956|FG015|Overall Study|Study Terminated by Sponsor|1|||
126508316|NCT02457598|455160957|FG016|Overall Study|Study Terminated by Sponsor|0|||
126508317|NCT02457598|455160941|FG000|Overall Study|Adverse Event|0|||
126508318|NCT02457598|455160942|FG001|Overall Study|Adverse Event|1|||
126508319|NCT02457598|455160943|FG002|Overall Study|Adverse Event|1|||
126508320|NCT02457598|455160944|FG003|Overall Study|Adverse Event|4|||
126508321|NCT02457598|455160945|FG004|Overall Study|Adverse Event|1|||
126508322|NCT02457598|455160946|FG005|Overall Study|Adverse Event|0|||
126508323|NCT02457598|455160947|FG006|Overall Study|Adverse Event|0|||
126508324|NCT02457598|455160948|FG007|Overall Study|Adverse Event|1|||
126508325|NCT02457598|455160949|FG008|Overall Study|Adverse Event|0|||
126508326|NCT02457598|455160950|FG009|Overall Study|Adverse Event|1|||
126508327|NCT02457598|455160951|FG010|Overall Study|Adverse Event|6|||
126508328|NCT02457598|455160952|FG011|Overall Study|Adverse Event|0|||
126508329|NCT02457598|455160953|FG012|Overall Study|Adverse Event|0|||
126508330|NCT02457598|455160954|FG013|Overall Study|Adverse Event|1|||
126508331|NCT02457598|455160955|FG014|Overall Study|Adverse Event|2|||
126508332|NCT02457598|455160956|FG015|Overall Study|Adverse Event|0|||
126508333|NCT02457598|455160957|FG016|Overall Study|Adverse Event|0|||
126508334|NCT02457598|455160941|FG000|Overall Study|Death|0|||
126508335|NCT02457598|455160942|FG001|Overall Study|Death|0|||
126508336|NCT02457598|455160943|FG002|Overall Study|Death|0|||
126508337|NCT02457598|455160944|FG003|Overall Study|Death|3|||
126776933|NCT00368537|456139091|FG000|Baseline Participants|Patient uncompliant|0|||
126776934|NCT00368537|456139092|FG001|Baseline Participants|Patient uncompliant|1|||
126776935|NCT01368276|456139104|FG000|Overall Study|Death|1|||
126776936|NCT01368276|456139105|FG001|Overall Study|Death|10|||
126508338|NCT02457598|455160945|FG004|Overall Study|Death|0|||
126508339|NCT02457598|455160946|FG005|Overall Study|Death|1|||
126508340|NCT02457598|455160947|FG006|Overall Study|Death|0|||
126508341|NCT02457598|455160948|FG007|Overall Study|Death|0|||
126565294|NCT03736785|455364898|FG000|Overall Study|Adverse Event|1|||
126508342|NCT02457598|455160949|FG008|Overall Study|Death|0|||
126508343|NCT02457598|455160950|FG009|Overall Study|Death|0|||
126508344|NCT02457598|455160951|FG010|Overall Study|Death|3|||
126508345|NCT02457598|455160952|FG011|Overall Study|Death|0|||
126565295|NCT03736785|455364899|FG001|Overall Study|Adverse Event|1|||
126565296|NCT03736785|455364900|FG002|Overall Study|Adverse Event|1|||
126565297|NCT03736785|455364898|FG000|Overall Study|Death|1|||
126565298|NCT03736785|455364899|FG001|Overall Study|Death|0|||
126565299|NCT03736785|455364900|FG002|Overall Study|Death|1|||
126565300|NCT03736785|455364898|FG000|Overall Study|Lost to Follow-up|0|||
126565301|NCT03736785|455364899|FG001|Overall Study|Lost to Follow-up|2|||
126565302|NCT03736785|455364900|FG002|Overall Study|Lost to Follow-up|3|||
126565303|NCT03736785|455364898|FG000|Overall Study|Non compliance with study drug|1|||
126565304|NCT03736785|455364899|FG001|Overall Study|Non compliance with study drug|1|||
126565305|NCT03736785|455364900|FG002|Overall Study|Non compliance with study drug|0|||
126565306|NCT03736785|455364898|FG000|Overall Study|Physician Decision|0|||
126565307|NCT03736785|455364899|FG001|Overall Study|Physician Decision|1|||
126565308|NCT03736785|455364900|FG002|Overall Study|Physician Decision|1|||
126565309|NCT03736785|455364898|FG000|Overall Study|Protocol Violation|1|||
126565310|NCT03736785|455364899|FG001|Overall Study|Protocol Violation|4|||
126776937|NCT04228302|456139107|FG000|Overall Study|Adverse Event|0|||
126565311|NCT03736785|455364900|FG002|Overall Study|Protocol Violation|3|||
126565312|NCT03736785|455364898|FG000|Overall Study|Sponsor Decision|1|||
126565313|NCT03736785|455364899|FG001|Overall Study|Sponsor Decision|0|||
126565314|NCT03736785|455364900|FG002|Overall Study|Sponsor Decision|0|||
126565315|NCT03736785|455364898|FG000|Overall Study|Unknown/Missing data|3|||
126565316|NCT03736785|455364899|FG001|Overall Study|Unknown/Missing data|2|||
126565317|NCT03736785|455364900|FG002|Overall Study|Unknown/Missing data|1|||
126565318|NCT03736785|455364898|FG000|Overall Study|Withdrawal by Subject|9|||
126776938|NCT04228302|456139108|FG001|Overall Study|Adverse Event|0|||
126508346|NCT02457598|455160953|FG012|Overall Study|Death|0|||
126508347|NCT02457598|455160954|FG013|Overall Study|Death|1|||
126565319|NCT03736785|455364899|FG001|Overall Study|Withdrawal by Subject|6|||
126565320|NCT03736785|455364900|FG002|Overall Study|Withdrawal by Subject|4|||
126565321|NCT01744691|455364901|FG000|Overall Study|Progressive Disease|18|||
126565322|NCT01744691|455364901|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
126565323|NCT01744691|455364901|FG000|Overall Study|Withdrawal of consent for treatment|3|||
126565324|NCT01744691|455364901|FG000|Overall Study|Physician Decision|4|||
126565325|NCT04588480|455364902|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
126565326|NCT04588480|455364903|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
126565327|NCT04588480|455364904|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
126565328|NCT04588480|455364902|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
126565329|NCT04588480|455364903|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
126565330|NCT04588480|455364904|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
126565331|NCT04511650|455364906|FG000|Overall Study|Lost to Follow-up|1|||
126565332|NCT04511650|455364907|FG001|Overall Study|Lost to Follow-up|0|||
126565333|NCT04511650|455364908|FG002|Overall Study|Lost to Follow-up|0|||
126565334|NCT04511650|455364906|FG000|Overall Study|Withdrawal by Subject|1|||
126565335|NCT04511650|455364907|FG001|Overall Study|Withdrawal by Subject|0|||
126565336|NCT04511650|455364908|FG002|Overall Study|Withdrawal by Subject|0|||
126565337|NCT04511650|455364906|FG000|Overall Study|reason not provided|0|||
126508348|NCT02457598|455160955|FG014|Overall Study|Death|2|||
126508349|NCT02457598|455160956|FG015|Overall Study|Death|0|||
126508350|NCT02457598|455160957|FG016|Overall Study|Death|1|||
126508351|NCT02457598|455160941|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
126508352|NCT02457598|455160942|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
126508353|NCT02457598|455160943|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
126508354|NCT02457598|455160944|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
126508355|NCT02457598|455160945|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
126508356|NCT02457598|455160946|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
126508357|NCT02457598|455160947|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
126508358|NCT02457598|455160948|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
126565338|NCT04511650|455364907|FG001|Overall Study|reason not provided|0|||
126565339|NCT04511650|455364908|FG002|Overall Study|reason not provided|1|||
126565340|NCT04511650|455364906|FG000|Overall Study|Death|1|||
126565341|NCT04511650|455364907|FG001|Overall Study|Death|1|||
126565342|NCT04511650|455364908|FG002|Overall Study|Death|1|||
126565343|NCT01549652|455364909|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
126565344|NCT01549652|455364910|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
126565345|NCT01549652|455364911|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
126565346|NCT01549652|455364912|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
126565347|NCT01549652|455364909|FG000|Overall Study|Study Drug Titration Failure|5|||
126565348|NCT01549652|455364910|FG001|Overall Study|Study Drug Titration Failure|6|||
126776939|NCT04228302|456139109|FG002|Overall Study|Adverse Event|0|||
126776940|NCT04228302|456139110|FG003|Overall Study|Adverse Event|0|||
126508359|NCT02457598|455160949|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
126565349|NCT01549652|455364911|FG002|Overall Study|Study Drug Titration Failure|0|||
126565350|NCT01549652|455364912|FG003|Overall Study|Study Drug Titration Failure|0|||
126565351|NCT01549652|455364909|FG000|Overall Study|Withdrawal Effect|0|||
126565352|NCT01549652|455364910|FG001|Overall Study|Withdrawal Effect|2|||
126776941|NCT04228302|456139111|FG004|Overall Study|Adverse Event|1|||
126508360|NCT02457598|455160950|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
126508361|NCT02457598|455160951|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
126508362|NCT02457598|455160952|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
126508363|NCT02457598|455160953|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
126508364|NCT02457598|455160954|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
126508365|NCT02457598|455160955|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
126508366|NCT02457598|455160956|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
126508367|NCT02457598|455160957|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
126508368|NCT02457598|455160941|FG000|Overall Study|Withdrew Consent|0|||
126508369|NCT02457598|455160942|FG001|Overall Study|Withdrew Consent|0|||
126508370|NCT02457598|455160943|FG002|Overall Study|Withdrew Consent|0|||
126508371|NCT02457598|455160944|FG003|Overall Study|Withdrew Consent|0|||
126508372|NCT02457598|455160945|FG004|Overall Study|Withdrew Consent|0|||
126508373|NCT02457598|455160946|FG005|Overall Study|Withdrew Consent|0|||
126508374|NCT02457598|455160947|FG006|Overall Study|Withdrew Consent|0|||
126508375|NCT02457598|455160948|FG007|Overall Study|Withdrew Consent|2|||
126508376|NCT02457598|455160949|FG008|Overall Study|Withdrew Consent|0|||
126508377|NCT02457598|455160950|FG009|Overall Study|Withdrew Consent|0|||
126508378|NCT02457598|455160951|FG010|Overall Study|Withdrew Consent|3|||
126508379|NCT02457598|455160952|FG011|Overall Study|Withdrew Consent|0|||
126508380|NCT02457598|455160953|FG012|Overall Study|Withdrew Consent|0|||
126508381|NCT02457598|455160954|FG013|Overall Study|Withdrew Consent|1|||
126508382|NCT02457598|455160955|FG014|Overall Study|Withdrew Consent|0|||
126508383|NCT02457598|455160956|FG015|Overall Study|Withdrew Consent|0|||
126508384|NCT02457598|455160957|FG016|Overall Study|Withdrew Consent|0|||
126508385|NCT02457598|455160941|FG000|Overall Study|Unacceptable Toxicity|0|||
126508386|NCT02457598|455160942|FG001|Overall Study|Unacceptable Toxicity|0|||
126508387|NCT02457598|455160943|FG002|Overall Study|Unacceptable Toxicity|0|||
126508388|NCT02457598|455160944|FG003|Overall Study|Unacceptable Toxicity|0|||
126508389|NCT02457598|455160945|FG004|Overall Study|Unacceptable Toxicity|0|||
126508390|NCT02457598|455160946|FG005|Overall Study|Unacceptable Toxicity|0|||
126508391|NCT02457598|455160947|FG006|Overall Study|Unacceptable Toxicity|0|||
126508392|NCT02457598|455160948|FG007|Overall Study|Unacceptable Toxicity|0|||
126508393|NCT02457598|455160949|FG008|Overall Study|Unacceptable Toxicity|0|||
126508394|NCT02457598|455160950|FG009|Overall Study|Unacceptable Toxicity|0|||
126508395|NCT02457598|455160951|FG010|Overall Study|Unacceptable Toxicity|1|||
126508396|NCT02457598|455160952|FG011|Overall Study|Unacceptable Toxicity|0|||
126508397|NCT02457598|455160953|FG012|Overall Study|Unacceptable Toxicity|1|||
126508398|NCT02457598|455160954|FG013|Overall Study|Unacceptable Toxicity|1|||
126508399|NCT02457598|455160955|FG014|Overall Study|Unacceptable Toxicity|1|||
126508400|NCT02457598|455160956|FG015|Overall Study|Unacceptable Toxicity|0|||
126508401|NCT02457598|455160957|FG016|Overall Study|Unacceptable Toxicity|0|||
126508402|NCT02457598|455160941|FG000|Overall Study|Intercurrent Illness|0|||
126508403|NCT02457598|455160942|FG001|Overall Study|Intercurrent Illness|0|||
126508404|NCT02457598|455160943|FG002|Overall Study|Intercurrent Illness|0|||
126508405|NCT02457598|455160944|FG003|Overall Study|Intercurrent Illness|0|||
126508406|NCT02457598|455160945|FG004|Overall Study|Intercurrent Illness|0|||
126508407|NCT02457598|455160946|FG005|Overall Study|Intercurrent Illness|0|||
126508408|NCT02457598|455160947|FG006|Overall Study|Intercurrent Illness|0|||
126508409|NCT02457598|455160948|FG007|Overall Study|Intercurrent Illness|0|||
126508410|NCT02457598|455160949|FG008|Overall Study|Intercurrent Illness|0|||
126508411|NCT02457598|455160950|FG009|Overall Study|Intercurrent Illness|0|||
126565353|NCT01549652|455364911|FG002|Overall Study|Withdrawal Effect|0|||
126565354|NCT01549652|455364912|FG003|Overall Study|Withdrawal Effect|0|||
126565355|NCT01549652|455364909|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
126565356|NCT01549652|455364910|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
126565357|NCT01549652|455364911|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
126565358|NCT01549652|455364912|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
126565359|NCT01549652|455364909|FG000|Overall Study|Problem with Infusion|1|||
126565360|NCT01549652|455364910|FG001|Overall Study|Problem with Infusion|0|||
126565361|NCT01549652|455364911|FG002|Overall Study|Problem with Infusion|0|||
126565362|NCT01549652|455364912|FG003|Overall Study|Problem with Infusion|0|||
126565363|NCT01549652|455364909|FG000|Overall Study|Titration Non-Compliance|1|||
126565364|NCT01549652|455364910|FG001|Overall Study|Titration Non-Compliance|3|||
126565365|NCT01549652|455364911|FG002|Overall Study|Titration Non-Compliance|4|||
126565366|NCT01549652|455364912|FG003|Overall Study|Titration Non-Compliance|5|||
126565367|NCT01549652|455364909|FG000|Overall Study|Titration Side Effects|0|||
126565368|NCT01549652|455364910|FG001|Overall Study|Titration Side Effects|0|||
126565369|NCT01549652|455364911|FG002|Overall Study|Titration Side Effects|6|||
126565370|NCT01549652|455364912|FG003|Overall Study|Titration Side Effects|3|||
126508412|NCT02457598|455160951|FG010|Overall Study|Intercurrent Illness|1|||
126508413|NCT02457598|455160952|FG011|Overall Study|Intercurrent Illness|0|||
126508414|NCT02457598|455160953|FG012|Overall Study|Intercurrent Illness|0|||
126508415|NCT02457598|455160954|FG013|Overall Study|Intercurrent Illness|0|||
126565371|NCT01549652|455364909|FG000|Overall Study|Withdrawal by Subject|0|||
126508416|NCT02457598|455160955|FG014|Overall Study|Intercurrent Illness|0|||
126508417|NCT02457598|455160956|FG015|Overall Study|Intercurrent Illness|0|||
126508418|NCT02457598|455160957|FG016|Overall Study|Intercurrent Illness|0|||
126508419|NCT02457598|455160941|FG000|Overall Study|Protocol Violation|0|||
126508420|NCT02457598|455160942|FG001|Overall Study|Protocol Violation|0|||
126508421|NCT02457598|455160943|FG002|Overall Study|Protocol Violation|0|||
126508422|NCT02457598|455160944|FG003|Overall Study|Protocol Violation|0|||
126508423|NCT02457598|455160945|FG004|Overall Study|Protocol Violation|0|||
126508424|NCT02457598|455160946|FG005|Overall Study|Protocol Violation|0|||
126565372|NCT01549652|455364910|FG001|Overall Study|Withdrawal by Subject|0|||
126565373|NCT01549652|455364911|FG002|Overall Study|Withdrawal by Subject|5|||
126565374|NCT01549652|455364912|FG003|Overall Study|Withdrawal by Subject|3|||
126565375|NCT01972152|455364913|FG000|First Treatment Visit|Lost to Follow-up|0|||
126565376|NCT01972152|455364914|FG001|First Treatment Visit|Lost to Follow-up|1|||
126565377|NCT01972152|455364915|FG002|First Treatment Visit|Lost to Follow-up|0|||
126565378|NCT01972152|455364916|FG003|First Treatment Visit|Lost to Follow-up|0|||
126565379|NCT01972152|455364917|FG004|First Treatment Visit|Lost to Follow-up|0|||
126565380|NCT01972152|455364918|FG005|First Treatment Visit|Lost to Follow-up|0|||
126565381|NCT01972152|455364913|FG000|Second Treatment Visit|Protocol Violation|0|||
126565382|NCT01972152|455364914|FG001|Second Treatment Visit|Protocol Violation|1|||
126565383|NCT01972152|455364915|FG002|Second Treatment Visit|Protocol Violation|0|||
126565384|NCT01972152|455364916|FG003|Second Treatment Visit|Protocol Violation|0|||
126565385|NCT01972152|455364917|FG004|Second Treatment Visit|Protocol Violation|0|||
126565386|NCT01972152|455364918|FG005|Second Treatment Visit|Protocol Violation|0|||
126565387|NCT01194258|455364921|FG000|Titration Period|Withdrawal by Subject|6|||
126565388|NCT01194258|455364922|FG001|Titration Period|Withdrawal by Subject|0|||
126565389|NCT01194258|455364923|FG002|Titration Period|Withdrawal by Subject|0|||
126565390|NCT01194258|455364924|FG003|Titration Period|Withdrawal by Subject|0|||
126565391|NCT01194258|455364925|FG004|Titration Period|Withdrawal by Subject|0|||
126565392|NCT01194258|455364921|FG000|Titration Period|Lost to Follow-up|2|||
126565393|NCT01194258|455364922|FG001|Titration Period|Lost to Follow-up|0|||
126565394|NCT01194258|455364923|FG002|Titration Period|Lost to Follow-up|0|||
126565395|NCT01194258|455364924|FG003|Titration Period|Lost to Follow-up|0|||
126565396|NCT01194258|455364925|FG004|Titration Period|Lost to Follow-up|0|||
126565397|NCT01194258|455364921|FG000|Titration Period|Titration failure|3|||
126565398|NCT01194258|455364922|FG001|Titration Period|Titration failure|0|||
126565399|NCT01194258|455364923|FG002|Titration Period|Titration failure|0|||
126565400|NCT01194258|455364924|FG003|Titration Period|Titration failure|0|||
126565401|NCT01194258|455364925|FG004|Titration Period|Titration failure|0|||
126565402|NCT01194258|455364921|FG000|Period 1 (12 Weeks)|Death|0|||
126565403|NCT01194258|455364922|FG001|Period 1 (12 Weeks)|Death|0|||
126565404|NCT01194258|455364923|FG002|Period 1 (12 Weeks)|Death|0|||
126565405|NCT01194258|455364924|FG003|Period 1 (12 Weeks)|Death|0|||
126565406|NCT01194258|455364925|FG004|Period 1 (12 Weeks)|Death|1|||
126565407|NCT01194258|455364921|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126508425|NCT02457598|455160947|FG006|Overall Study|Protocol Violation|0|||
126508426|NCT02457598|455160948|FG007|Overall Study|Protocol Violation|0|||
126508427|NCT02457598|455160949|FG008|Overall Study|Protocol Violation|0|||
126508428|NCT02457598|455160950|FG009|Overall Study|Protocol Violation|0|||
126508429|NCT02457598|455160951|FG010|Overall Study|Protocol Violation|1|||
126508430|NCT02457598|455160952|FG011|Overall Study|Protocol Violation|0|||
126508431|NCT02457598|455160953|FG012|Overall Study|Protocol Violation|0|||
126508432|NCT02457598|455160954|FG013|Overall Study|Protocol Violation|0|||
126508433|NCT02457598|455160955|FG014|Overall Study|Protocol Violation|0|||
126508434|NCT02457598|455160956|FG015|Overall Study|Protocol Violation|0|||
126508435|NCT02457598|455160957|FG016|Overall Study|Protocol Violation|0|||
126508436|NCT01403974|455160958|FG000|Overall Study|Progressive disease according to RECIST|3|||
126508437|NCT01403974|455160959|FG001|Overall Study|Progressive disease according to RECIST|3|||
126508438|NCT01403974|455160960|FG002|Overall Study|Progressive disease according to RECIST|2|||
126508439|NCT01403974|455160961|FG003|Overall Study|Progressive disease according to RECIST|3|||
126508440|NCT01403974|455160962|FG004|Overall Study|Progressive disease according to RECIST|3|||
126508441|NCT01403974|455160963|FG005|Overall Study|Progressive disease according to RECIST|2|||
126508442|NCT01403974|455160964|FG006|Overall Study|Progressive disease according to RECIST|3|||
126508443|NCT01403974|455160965|FG007|Overall Study|Progressive disease according to RECIST|2|||
126508444|NCT01403974|455160966|FG008|Overall Study|Progressive disease according to RECIST|6|||
126508445|NCT01403974|455160967|FG009|Overall Study|Progressive disease according to RECIST|2|||
126508446|NCT01403974|455160968|FG010|Overall Study|Progressive disease according to RECIST|3|||
126508447|NCT01403974|455160969|FG011|Overall Study|Progressive disease according to RECIST|2|||
126508448|NCT01403974|455160970|FG012|Overall Study|Progressive disease according to RECIST|2|||
126508449|NCT01403974|455160971|FG013|Overall Study|Progressive disease according to RECIST|3|||
126508450|NCT01403974|455160972|FG014|Overall Study|Progressive disease according to RECIST|1|||
126565408|NCT01194258|455364922|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126565409|NCT01194258|455364923|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126565410|NCT01194258|455364924|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
126565411|NCT01194258|455364925|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
126508451|NCT01403974|455160973|FG015|Overall Study|Progressive disease according to RECIST|8|||
126508452|NCT01403974|455160958|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
126508453|NCT01403974|455160959|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
126508454|NCT01403974|455160960|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
126508455|NCT01403974|455160961|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
126508456|NCT01403974|455160962|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
126508457|NCT01403974|455160963|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
126508458|NCT01403974|455160964|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
126508459|NCT01403974|455160965|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
126508460|NCT01403974|455160966|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
126508461|NCT01403974|455160967|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
126508462|NCT01403974|455160968|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
126508463|NCT01403974|455160969|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
126508464|NCT01403974|455160970|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
126508465|NCT01403974|455160971|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
126508466|NCT01403974|455160972|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
126508467|NCT01403974|455160973|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
126508468|NCT01403974|455160958|FG000|Overall Study|Refused to continue study medication|0|||
126508469|NCT01403974|455160959|FG001|Overall Study|Refused to continue study medication|0|||
126508470|NCT01403974|455160960|FG002|Overall Study|Refused to continue study medication|0|||
126508471|NCT01403974|455160961|FG003|Overall Study|Refused to continue study medication|0|||
126508472|NCT01403974|455160962|FG004|Overall Study|Refused to continue study medication|0|||
126508473|NCT01403974|455160963|FG005|Overall Study|Refused to continue study medication|1|||
126508474|NCT01403974|455160964|FG006|Overall Study|Refused to continue study medication|0|||
126508475|NCT01403974|455160965|FG007|Overall Study|Refused to continue study medication|0|||
126508476|NCT01403974|455160966|FG008|Overall Study|Refused to continue study medication|1|||
126508477|NCT01403974|455160967|FG009|Overall Study|Refused to continue study medication|0|||
126508478|NCT01403974|455160968|FG010|Overall Study|Refused to continue study medication|1|||
126508479|NCT01403974|455160969|FG011|Overall Study|Refused to continue study medication|0|||
126508480|NCT01403974|455160970|FG012|Overall Study|Refused to continue study medication|0|||
126508481|NCT01403974|455160971|FG013|Overall Study|Refused to continue study medication|0|||
126508482|NCT01403974|455160972|FG014|Overall Study|Refused to continue study medication|0|||
126508483|NCT01403974|455160973|FG015|Overall Study|Refused to continue study medication|4|||
126508484|NCT01403974|455160958|FG000|Overall Study|Adverse Event|0|||
126508485|NCT01403974|455160959|FG001|Overall Study|Adverse Event|0|||
126508486|NCT01403974|455160960|FG002|Overall Study|Adverse Event|1|||
126508487|NCT01403974|455160961|FG003|Overall Study|Adverse Event|0|||
126508488|NCT01403974|455160962|FG004|Overall Study|Adverse Event|0|||
126508489|NCT01403974|455160963|FG005|Overall Study|Adverse Event|0|||
126508490|NCT01403974|455160964|FG006|Overall Study|Adverse Event|0|||
126508491|NCT01403974|455160965|FG007|Overall Study|Adverse Event|1|||
126508492|NCT01403974|455160966|FG008|Overall Study|Adverse Event|0|||
126508493|NCT01403974|455160967|FG009|Overall Study|Adverse Event|0|||
126508494|NCT01403974|455160968|FG010|Overall Study|Adverse Event|0|||
126508495|NCT01403974|455160969|FG011|Overall Study|Adverse Event|0|||
126508496|NCT01403974|455160970|FG012|Overall Study|Adverse Event|1|||
126508497|NCT01403974|455160971|FG013|Overall Study|Adverse Event|0|||
126508498|NCT01403974|455160972|FG014|Overall Study|Adverse Event|0|||
126508499|NCT01403974|455160973|FG015|Overall Study|Adverse Event|0|||
126508500|NCT01403974|455160958|FG000|Overall Study|Other than specified|0|||
126508501|NCT01403974|455160959|FG001|Overall Study|Other than specified|0|||
126508502|NCT01403974|455160960|FG002|Overall Study|Other than specified|0|||
126508503|NCT01403974|455160961|FG003|Overall Study|Other than specified|0|||
126508504|NCT01403974|455160962|FG004|Overall Study|Other than specified|0|||
126508505|NCT01403974|455160963|FG005|Overall Study|Other than specified|0|||
126508506|NCT01403974|455160964|FG006|Overall Study|Other than specified|0|||
126508507|NCT01403974|455160965|FG007|Overall Study|Other than specified|0|||
126508508|NCT01403974|455160966|FG008|Overall Study|Other than specified|0|||
126508509|NCT01403974|455160967|FG009|Overall Study|Other than specified|1|||
126508510|NCT01403974|455160968|FG010|Overall Study|Other than specified|0|||
126508511|NCT01403974|455160969|FG011|Overall Study|Other than specified|1|||
126508512|NCT01403974|455160970|FG012|Overall Study|Other than specified|0|||
126508513|NCT01403974|455160971|FG013|Overall Study|Other than specified|0|||
126508514|NCT01403974|455160972|FG014|Overall Study|Other than specified|0|||
126508515|NCT01403974|455160973|FG015|Overall Study|Other than specified|0|||
126508516|NCT01526889|455160974|FG000|Treatment Period|Adverse Event|2|||
126508517|NCT01526889|455160975|FG001|Treatment Period|Adverse Event|0|||
126508518|NCT01526889|455160974|FG000|Treatment Extension Period|Administrative problems|1|||
126508519|NCT01526889|455160975|FG001|Treatment Extension Period|Administrative problems|0|||
126508520|NCT00974571|455160976|FG000|Overall Study|Adverse Event|31|||
126508521|NCT00974571|455160977|FG001|Overall Study|Adverse Event|4|||
126508522|NCT00974571|455160978|FG002|Overall Study|Adverse Event|27|||
126508523|NCT00974571|455160976|FG000|Overall Study|Lack of Efficacy|3|||
126508524|NCT00974571|455160977|FG001|Overall Study|Lack of Efficacy|2|||
126508525|NCT00974571|455160978|FG002|Overall Study|Lack of Efficacy|9|||
126508526|NCT00974571|455160976|FG000|Overall Study|Lost to Follow-up|2|||
126508527|NCT00974571|455160977|FG001|Overall Study|Lost to Follow-up|1|||
126508528|NCT00974571|455160978|FG002|Overall Study|Lost to Follow-up|2|||
126508529|NCT00974571|455160976|FG000|Overall Study|Protocol Violation|13|||
126508530|NCT00974571|455160977|FG001|Overall Study|Protocol Violation|4|||
126508531|NCT00974571|455160978|FG002|Overall Study|Protocol Violation|18|||
126508532|NCT00974571|455160976|FG000|Overall Study|Withdrawal by Subject|14|||
126508533|NCT00974571|455160977|FG001|Overall Study|Withdrawal by Subject|5|||
126508534|NCT00974571|455160978|FG002|Overall Study|Withdrawal by Subject|16|||
126508535|NCT00974571|455160976|FG000|Overall Study|Patient Moved|1|||
126508536|NCT00974571|455160977|FG001|Overall Study|Patient Moved|0|||
126508537|NCT00974571|455160978|FG002|Overall Study|Patient Moved|1|||
126508538|NCT00974571|455160976|FG000|Overall Study|Other|4|||
126508539|NCT00974571|455160977|FG001|Overall Study|Other|0|||
126508540|NCT00974571|455160978|FG002|Overall Study|Other|10|||
126508541|NCT01494610|455160998|FG000|Period 1|Withdrawal by Subject|1|||
126508542|NCT01494610|455160999|FG001|Period 1|Withdrawal by Subject|1|||
126508543|NCT01494610|455160998|FG000|Period 3|Adverse Event|1|||
126508544|NCT01494610|455160999|FG001|Period 3|Adverse Event|0|||
126508545|NCT01494610|455160998|FG000|Period 3|Withdrawal by Subject|1|||
126508546|NCT01494610|455160999|FG001|Period 3|Withdrawal by Subject|0|||
126508547|NCT01494610|455160998|FG000|Period 4|Protocol Violation|1|||
126508548|NCT01494610|455160999|FG001|Period 4|Protocol Violation|0|||
126508549|NCT04334460|455161000|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
126508550|NCT04334460|455161001|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
126508551|NCT04334460|455161000|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
126508552|NCT04334460|455161001|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
126508553|NCT00547703|455161004|FG000|Overall Study|Lost to Follow-up|1|||
126508554|NCT00547703|455161005|FG001|Overall Study|Lost to Follow-up|0|||
126508555|NCT03995953|455161008|FG000|Overall Study|Death|3|||
126508556|NCT03995953|455161009|FG001|Overall Study|Death|0|||
126508557|NCT03995953|455161010|FG002|Overall Study|Death|3|||
126508558|NCT03995953|455161011|FG003|Overall Study|Death|0|||
126508559|NCT03995953|455161012|FG004|Overall Study|Death|3|||
126508560|NCT03995953|455161013|FG005|Overall Study|Death|0|||
126508561|NCT03995953|455161014|FG006|Overall Study|Death|0|||
126508562|NCT03995953|455161015|FG007|Overall Study|Death|0|||
126508563|NCT03995953|455161016|FG008|Overall Study|Death|1|||
126508564|NCT03995953|455161017|FG009|Overall Study|Death|0|||
126508565|NCT03995953|455161018|FG010|Overall Study|Death|0|||
126508566|NCT03995953|455161019|FG011|Overall Study|Death|0|||
126508567|NCT03995953|455161008|FG000|Overall Study|Lost to Follow-up|6|||
126508568|NCT03995953|455161009|FG001|Overall Study|Lost to Follow-up|54|||
126508569|NCT03995953|455161010|FG002|Overall Study|Lost to Follow-up|3|||
126508570|NCT03995953|455161011|FG003|Overall Study|Lost to Follow-up|32|||
126508571|NCT03995953|455161012|FG004|Overall Study|Lost to Follow-up|5|||
126508572|NCT03995953|455161013|FG005|Overall Study|Lost to Follow-up|44|||
126508573|NCT03995953|455161014|FG006|Overall Study|Lost to Follow-up|0|||
126508574|NCT03995953|455161015|FG007|Overall Study|Lost to Follow-up|31|||
126508575|NCT03995953|455161016|FG008|Overall Study|Lost to Follow-up|8|||
126508576|NCT03995953|455161017|FG009|Overall Study|Lost to Follow-up|36|||
126508577|NCT03995953|455161018|FG010|Overall Study|Lost to Follow-up|5|||
126508578|NCT03995953|455161019|FG011|Overall Study|Lost to Follow-up|41|||
126508579|NCT03995953|455161008|FG000|Overall Study|Withdrawal by Subject|4|||
126508580|NCT03995953|455161009|FG001|Overall Study|Withdrawal by Subject|0|||
126508581|NCT03995953|455161010|FG002|Overall Study|Withdrawal by Subject|1|||
126508582|NCT03995953|455161011|FG003|Overall Study|Withdrawal by Subject|0|||
126508583|NCT03995953|455161012|FG004|Overall Study|Withdrawal by Subject|1|||
126508584|NCT03995953|455161013|FG005|Overall Study|Withdrawal by Subject|0|||
126508585|NCT03995953|455161014|FG006|Overall Study|Withdrawal by Subject|1|||
126508586|NCT03995953|455161015|FG007|Overall Study|Withdrawal by Subject|0|||
126508587|NCT03995953|455161016|FG008|Overall Study|Withdrawal by Subject|3|||
126508588|NCT03995953|455161017|FG009|Overall Study|Withdrawal by Subject|0|||
126508589|NCT03995953|455161018|FG010|Overall Study|Withdrawal by Subject|3|||
126508590|NCT03995953|455161019|FG011|Overall Study|Withdrawal by Subject|0|||
126508591|NCT03995953|455161008|FG000|Overall Study|Health Issues|0|||
126508592|NCT03995953|455161009|FG001|Overall Study|Health Issues|0|||
126508593|NCT03995953|455161010|FG002|Overall Study|Health Issues|0|||
126508594|NCT03995953|455161011|FG003|Overall Study|Health Issues|0|||
126508595|NCT03995953|455161012|FG004|Overall Study|Health Issues|1|||
126508596|NCT03995953|455161013|FG005|Overall Study|Health Issues|0|||
126508597|NCT03995953|455161014|FG006|Overall Study|Health Issues|0|||
126508598|NCT03995953|455161015|FG007|Overall Study|Health Issues|0|||
126508599|NCT03995953|455161016|FG008|Overall Study|Health Issues|4|||
126508600|NCT03995953|455161017|FG009|Overall Study|Health Issues|0|||
126508601|NCT03995953|455161018|FG010|Overall Study|Health Issues|0|||
126508602|NCT03995953|455161019|FG011|Overall Study|Health Issues|0|||
126508603|NCT03995953|455161008|FG000|Overall Study|Relocated|11|||
126508604|NCT03995953|455161009|FG001|Overall Study|Relocated|0|||
126508605|NCT03995953|455161010|FG002|Overall Study|Relocated|16|||
126508606|NCT03995953|455161011|FG003|Overall Study|Relocated|0|||
126508607|NCT03995953|455161012|FG004|Overall Study|Relocated|14|||
126508608|NCT03995953|455161013|FG005|Overall Study|Relocated|0|||
126508609|NCT03995953|455161014|FG006|Overall Study|Relocated|16|||
126508610|NCT03995953|455161015|FG007|Overall Study|Relocated|0|||
126508611|NCT03995953|455161016|FG008|Overall Study|Relocated|14|||
126508612|NCT03995953|455161017|FG009|Overall Study|Relocated|0|||
126508613|NCT03995953|455161018|FG010|Overall Study|Relocated|15|||
126508614|NCT03995953|455161019|FG011|Overall Study|Relocated|0|||
126508615|NCT04951622|455161029|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
126508616|NCT04951622|455161030|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
126508617|NCT04951622|455161031|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
126508618|NCT04951622|455161032|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
126508619|NCT04951622|455161033|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
126508620|NCT04951622|455161029|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
126508621|NCT04951622|455161030|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
126565412|NCT01194258|455364921|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
126565413|NCT01194258|455364922|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
126565414|NCT01194258|455364923|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
126565415|NCT01194258|455364924|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
126565416|NCT01194258|455364925|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
126565417|NCT01194258|455364921|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126565418|NCT01194258|455364922|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126565419|NCT01194258|455364923|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126565420|NCT01194258|455364924|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126565421|NCT01194258|455364925|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126565422|NCT03523962|455364927|FG000|Closed Fractures|Death|86|||
126565423|NCT03523962|455364928|FG001|Closed Fractures|Death|71|||
126565424|NCT03523962|455364929|FG002|Closed Fractures|Death|0|||
126565425|NCT03523962|455364930|FG003|Closed Fractures|Death|0|||
126565426|NCT03523962|455364927|FG000|Closed Fractures|Lost to Follow-up|62|||
126565427|NCT03523962|455364928|FG001|Closed Fractures|Lost to Follow-up|36|||
126565428|NCT03523962|455364929|FG002|Closed Fractures|Lost to Follow-up|0|||
126565429|NCT03523962|455364930|FG003|Closed Fractures|Lost to Follow-up|0|||
126565430|NCT03523962|455364927|FG000|Closed Fractures|Withdrawal by Subject|19|||
126565431|NCT03523962|455364928|FG001|Closed Fractures|Withdrawal by Subject|29|||
126565432|NCT03523962|455364929|FG002|Closed Fractures|Withdrawal by Subject|0|||
126565433|NCT03523962|455364930|FG003|Closed Fractures|Withdrawal by Subject|0|||
126565434|NCT03523962|455364927|FG000|Closed Fractures|Incarceration|1|||
126565435|NCT03523962|455364928|FG001|Closed Fractures|Incarceration|4|||
126565436|NCT03523962|455364929|FG002|Closed Fractures|Incarceration|0|||
126565437|NCT03523962|455364930|FG003|Closed Fractures|Incarceration|0|||
126565438|NCT03523962|455364927|FG000|Open Fractures|Death|0|||
126565439|NCT03523962|455364928|FG001|Open Fractures|Death|0|||
126565440|NCT03523962|455364929|FG002|Open Fractures|Death|11|||
126565441|NCT03523962|455364930|FG003|Open Fractures|Death|6|||
126565442|NCT03523962|455364927|FG000|Open Fractures|Lost to Follow-up|0|||
126565443|NCT03523962|455364928|FG001|Open Fractures|Lost to Follow-up|0|||
126565444|NCT03523962|455364929|FG002|Open Fractures|Lost to Follow-up|15|||
126565445|NCT03523962|455364930|FG003|Open Fractures|Lost to Follow-up|8|||
126565446|NCT03523962|455364927|FG000|Open Fractures|Withdrawal by Subject|0|||
126565447|NCT03523962|455364928|FG001|Open Fractures|Withdrawal by Subject|0|||
126565448|NCT03523962|455364929|FG002|Open Fractures|Withdrawal by Subject|6|||
126508622|NCT04951622|455161031|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
126565449|NCT03523962|455364930|FG003|Open Fractures|Withdrawal by Subject|2|||
126565450|NCT03523962|455364927|FG000|Open Fractures|Incarceration|0|||
126565451|NCT03523962|455364928|FG001|Open Fractures|Incarceration|0|||
126565452|NCT03523962|455364929|FG002|Open Fractures|Incarceration|1|||
126565453|NCT03523962|455364930|FG003|Open Fractures|Incarceration|0|||
126565454|NCT01081145|455364941|FG000|Open-Label Phase|Lack of Efficacy|56|||
126508623|NCT04951622|455161032|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
126508624|NCT04951622|455161033|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
126508625|NCT04951622|455161029|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
126508626|NCT04951622|455161030|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
126508627|NCT04951622|455161031|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
126508628|NCT04951622|455161032|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
126508629|NCT04951622|455161033|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
126565455|NCT01081145|455364942|FG001|Open-Label Phase|Lack of Efficacy|0|||
126565456|NCT01081145|455364941|FG000|Open-Label Phase|Response criteria not met|46|||
126565457|NCT01081145|455364942|FG001|Open-Label Phase|Response criteria not met|0|||
126565458|NCT01081145|455364941|FG000|Open-Label Phase|Adverse Event|42|||
126565459|NCT01081145|455364942|FG001|Open-Label Phase|Adverse Event|0|||
126565460|NCT01081145|455364941|FG000|Open-Label Phase|Withdrawal by Subject|41|||
126565461|NCT01081145|455364942|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126565462|NCT01081145|455364941|FG000|Open-Label Phase|Other|12|||
126565463|NCT01081145|455364942|FG001|Open-Label Phase|Other|0|||
126565464|NCT01081145|455364941|FG000|Open-Label Phase|Lost to Follow-up|11|||
126565465|NCT01081145|455364942|FG001|Open-Label Phase|Lost to Follow-up|0|||
126565466|NCT01081145|455364941|FG000|Open-Label Phase|Protocol Violation|4|||
126565467|NCT01081145|455364942|FG001|Open-Label Phase|Protocol Violation|0|||
126508630|NCT04951622|455161029|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
126508631|NCT04951622|455161030|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
126508632|NCT04951622|455161031|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
126508633|NCT04951622|455161032|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
126508634|NCT04951622|455161033|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
126508635|NCT04951622|455161029|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
126508636|NCT04951622|455161030|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
126508637|NCT04951622|455161031|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
126508638|NCT04951622|455161032|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
126508639|NCT04951622|455161033|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
126508640|NCT04951622|455161029|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
126508641|NCT04951622|455161030|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
126508642|NCT04951622|455161031|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
126508643|NCT04951622|455161032|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
126508644|NCT04951622|455161033|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
126508645|NCT04951622|455161029|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
126508646|NCT04951622|455161030|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
126508647|NCT04951622|455161031|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
126508648|NCT04951622|455161032|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
126508649|NCT04951622|455161033|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
126508650|NCT04951622|455161029|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
126508651|NCT04951622|455161030|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
126508652|NCT04951622|455161031|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
126508653|NCT04951622|455161032|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
126508654|NCT04951622|455161033|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
126508655|NCT04951622|455161029|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
126508656|NCT04951622|455161030|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
126508657|NCT04951622|455161031|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
126508658|NCT04951622|455161032|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
126508659|NCT04951622|455161033|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
126508660|NCT04951622|455161029|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
126508661|NCT04951622|455161030|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
126508662|NCT04951622|455161031|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
126508663|NCT04951622|455161032|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
126508664|NCT04951622|455161033|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
126508665|NCT04951622|455161029|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
126508666|NCT04951622|455161030|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
126508667|NCT04951622|455161031|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
126508668|NCT04951622|455161032|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
126508669|NCT04951622|455161033|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
126508670|NCT04951622|455161029|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
126508671|NCT04951622|455161030|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
126508672|NCT04951622|455161031|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
126508673|NCT04951622|455161032|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
126508674|NCT04951622|455161033|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
126508675|NCT04951622|455161029|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
126508676|NCT04951622|455161030|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
126508677|NCT04951622|455161031|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
126565468|NCT01081145|455364941|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
126565469|NCT01081145|455364942|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
126565470|NCT01081145|455364941|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
126565471|NCT01081145|455364942|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
126565472|NCT01081145|455364941|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
126565473|NCT01081145|455364942|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
126565474|NCT01081145|455364941|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
126565475|NCT01081145|455364942|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
126565476|NCT01081145|455364941|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
126565477|NCT01081145|455364942|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
126727160|NCT02921919|455951070|FG001|Overall Study|Other|6|||
126727161|NCT02921919|455951069|FG000|Overall Study|Lost to Follow-up|0|||
126508678|NCT04951622|455161032|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
126508679|NCT04951622|455161033|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
126508680|NCT04951622|455161029|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
126508681|NCT04951622|455161030|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
126508682|NCT04951622|455161031|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
126508683|NCT04951622|455161032|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
126508684|NCT04951622|455161033|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
126508685|NCT04951622|455161029|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
126508686|NCT04951622|455161030|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
126508687|NCT04951622|455161031|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
126508688|NCT04951622|455161032|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
126508689|NCT04951622|455161033|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
126508690|NCT04951622|455161029|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
126508691|NCT04951622|455161030|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
126508692|NCT04951622|455161031|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
126508693|NCT04951622|455161032|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
126508694|NCT04951622|455161033|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
126508695|NCT04951622|455161029|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
126508696|NCT04951622|455161030|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
126508697|NCT04951622|455161031|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
126508698|NCT04951622|455161032|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
126508699|NCT04951622|455161033|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
126508700|NCT04951622|455161029|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
126508701|NCT04951622|455161030|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
126508702|NCT04951622|455161031|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
126508703|NCT04951622|455161032|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
126508704|NCT04951622|455161033|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
126508705|NCT04951622|455161029|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
126508706|NCT04951622|455161030|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
126508707|NCT04951622|455161031|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
126508708|NCT04951622|455161032|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
126508709|NCT04951622|455161033|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
126508710|NCT04951622|455161029|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
126508711|NCT04951622|455161030|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
126508712|NCT04951622|455161031|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
126508713|NCT04951622|455161032|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
126508714|NCT04951622|455161033|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
126508715|NCT04108208|455161034|FG000|Overall Study|Withdrawal by Subject|2|||
126508716|NCT04108208|455161035|FG001|Overall Study|Withdrawal by Subject|6|||
126508717|NCT04108208|455161034|FG000|Overall Study|other-ongoing|20|||
126508718|NCT04108208|455161035|FG001|Overall Study|other-ongoing|40|||
126508719|NCT04108208|455161034|FG000|Overall Study|Death|1|||
126508720|NCT04108208|455161035|FG001|Overall Study|Death|4|||
126508721|NCT04108208|455161034|FG000|Overall Study|Lost to Follow-up|2|||
126508722|NCT04108208|455161035|FG001|Overall Study|Lost to Follow-up|0|||
126508723|NCT02948842|455161038|FG000|Overall Study|Withdrawal by Subject|4|||
126508724|NCT00376168|455161042|FG000|Overall Study|Adverse Event|1|||
126508725|NCT00376168|455161043|FG001|Overall Study|Adverse Event|1|||
126508726|NCT00376168|455161042|FG000|Overall Study|Pregnancy|1|||
126508727|NCT00376168|455161043|FG001|Overall Study|Pregnancy|0|||
126508728|NCT02350309|455161044|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
126508729|NCT02350309|455161045|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
126508730|NCT02350309|455161046|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
126508731|NCT02350309|455161047|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
126508732|NCT02350309|455161048|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
126508733|NCT02350309|455161049|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
126508734|NCT02350309|455161044|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
126508735|NCT02350309|455161045|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
126508736|NCT02350309|455161046|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
126508737|NCT02350309|455161047|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
126508738|NCT02350309|455161048|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
126508739|NCT02350309|455161049|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
126508740|NCT01736696|455161050|FG000|Overall Study|Withdrawal by Subject|0|||
126508741|NCT01736696|455161051|FG001|Overall Study|Withdrawal by Subject|0|||
126508742|NCT01736696|455161052|FG002|Overall Study|Withdrawal by Subject|1|||
126508743|NCT01736696|455161053|FG003|Overall Study|Withdrawal by Subject|0|||
126508744|NCT01736696|455161054|FG004|Overall Study|Withdrawal by Subject|0|||
126508745|NCT01736696|455161055|FG005|Overall Study|Withdrawal by Subject|0|||
126508746|NCT01736696|455161056|FG006|Overall Study|Withdrawal by Subject|0|||
126508747|NCT02114879|455161057|FG000|Overall Study|Withdrawal by Subject|9|||
126508748|NCT02114879|455161058|FG001|Overall Study|Withdrawal by Subject|5|||
126508749|NCT02114879|455161057|FG000|Overall Study|Death|6|||
126508750|NCT02114879|455161058|FG001|Overall Study|Death|11|||
126508751|NCT02114879|455161057|FG000|Overall Study|Lost to Follow-up|4|||
126508752|NCT02114879|455161058|FG001|Overall Study|Lost to Follow-up|6|||
126508753|NCT02114879|455161057|FG000|Overall Study|Physician Decision|0|||
126508754|NCT02114879|455161058|FG001|Overall Study|Physician Decision|2|||
126508755|NCT00558103|455161059|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
126508756|NCT00558103|455161060|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
126508757|NCT00558103|455161061|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
126508758|NCT00558103|455161062|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
126508759|NCT00558103|455161063|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
126508760|NCT00558103|455161064|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
126508761|NCT00558103|455161059|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
126508762|NCT00558103|455161060|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
126508763|NCT00558103|455161061|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
126508764|NCT00558103|455161062|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
126508765|NCT00558103|455161063|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
126508766|NCT00558103|455161064|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
126508767|NCT00558103|455161059|FG000|Randomized Treatment Phase|Disease Progression|1|||
126508768|NCT00558103|455161060|FG001|Randomized Treatment Phase|Disease Progression|0|||
126508769|NCT00558103|455161061|FG002|Randomized Treatment Phase|Disease Progression|1|||
126508770|NCT00558103|455161062|FG003|Randomized Treatment Phase|Disease Progression|0|||
126508771|NCT00558103|455161063|FG004|Randomized Treatment Phase|Disease Progression|0|||
126508772|NCT00558103|455161064|FG005|Randomized Treatment Phase|Disease Progression|0|||
126508773|NCT00558103|455161059|FG000|Randomized Treatment Phase|Adverse Event|0|||
126508774|NCT00558103|455161060|FG001|Randomized Treatment Phase|Adverse Event|0|||
126508775|NCT00558103|455161061|FG002|Randomized Treatment Phase|Adverse Event|0|||
126508776|NCT00558103|455161062|FG003|Randomized Treatment Phase|Adverse Event|1|||
126508777|NCT00558103|455161063|FG004|Randomized Treatment Phase|Adverse Event|1|||
126508778|NCT00558103|455161064|FG005|Randomized Treatment Phase|Adverse Event|0|||
126508779|NCT00558103|455161059|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
126508780|NCT00558103|455161060|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
126508781|NCT00558103|455161061|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
126508782|NCT00558103|455161062|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
126508783|NCT00558103|455161063|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
126508784|NCT00558103|455161064|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
126508785|NCT00558103|455161059|FG000|Monotherapy Extension Phase|Disease Progression|0|||
126508786|NCT00558103|455161060|FG001|Monotherapy Extension Phase|Disease Progression|0|||
126508787|NCT00558103|455161061|FG002|Monotherapy Extension Phase|Disease Progression|0|||
126508788|NCT00558103|455161062|FG003|Monotherapy Extension Phase|Disease Progression|0|||
126508789|NCT00558103|455161063|FG004|Monotherapy Extension Phase|Disease Progression|0|||
126508790|NCT00558103|455161064|FG005|Monotherapy Extension Phase|Disease Progression|8|||
126508791|NCT00660348|455161067|FG000|Overall Study|Withdrawal by Subject|1|||
126508792|NCT00660348|455161068|FG001|Overall Study|Withdrawal by Subject|0|||
126508793|NCT05723770|455162789|FG000|Overall Study|Lost to Follow-up|4|||
126508794|NCT05723770|455162789|FG000|Overall Study|Withdrawal by Subject|2|||
126508795|NCT01359592|455162790|FG000|Initial Registration|Adverse Event|1|||
126508796|NCT01359592|455162791|FG001|Initial Registration|Adverse Event|0|||
126508797|NCT01359592|455162792|FG002|Initial Registration|Adverse Event|0|||
126508798|NCT01359592|455162793|FG003|Initial Registration|Adverse Event|0|||
126508799|NCT01359592|455162790|FG000|Initial Registration|Death|1|||
126508800|NCT01359592|455162791|FG001|Initial Registration|Death|0|||
126508801|NCT01359592|455162792|FG002|Initial Registration|Death|0|||
126508802|NCT01359592|455162793|FG003|Initial Registration|Death|0|||
126508803|NCT01359592|455162790|FG000|Initial Registration|Other reason not protocol specified|1|||
126508804|NCT01359592|455162791|FG001|Initial Registration|Other reason not protocol specified|0|||
126508805|NCT01359592|455162792|FG002|Initial Registration|Other reason not protocol specified|0|||
126508806|NCT01359592|455162793|FG003|Initial Registration|Other reason not protocol specified|0|||
126508807|NCT01359592|455162790|FG000|Initial Registration|Ineligible|26|||
126508808|NCT01359592|455162791|FG001|Initial Registration|Ineligible|0|||
126508809|NCT01359592|455162792|FG002|Initial Registration|Ineligible|0|||
126508810|NCT01359592|455162793|FG003|Initial Registration|Ineligible|0|||
126508811|NCT01359592|455162790|FG000|PET-Directed Therapy|Adverse Event|0|||
126508812|NCT01359592|455162791|FG001|PET-Directed Therapy|Adverse Event|0|||
126565478|NCT01081145|455364941|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
126565479|NCT01081145|455364942|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
126776942|NCT04228302|456139112|FG005|Overall Study|Adverse Event|0|||
126508813|NCT01359592|455162792|FG002|PET-Directed Therapy|Adverse Event|1|||
126508814|NCT01359592|455162793|FG003|PET-Directed Therapy|Adverse Event|0|||
126508815|NCT01359592|455162790|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
126508816|NCT01359592|455162791|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
126508817|NCT01359592|455162792|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
126508818|NCT01359592|455162793|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
126508819|NCT01359592|455162790|FG000|PET-Directed Therapy|Ineligible|0|||
126508820|NCT01359592|455162791|FG001|PET-Directed Therapy|Ineligible|0|||
126508821|NCT01359592|455162792|FG002|PET-Directed Therapy|Ineligible|24|||
126508822|NCT01359592|455162793|FG003|PET-Directed Therapy|Ineligible|0|||
126508823|NCT00419562|455162794|FG000|Overall Study|Lost to Follow-up|12|||
126508824|NCT00419562|455162795|FG001|Overall Study|Lost to Follow-up|13|||
126508825|NCT00419562|455162794|FG000|Overall Study|Withdrawal by Subject|20|||
126508826|NCT00419562|455162795|FG001|Overall Study|Withdrawal by Subject|18|||
126508827|NCT00419562|455162794|FG000|Overall Study|Participant Institutionalized|1|||
126508828|NCT00419562|455162795|FG001|Overall Study|Participant Institutionalized|0|||
126508829|NCT01400841|455162803|FG000|Initial Study Phase (6 Months)|Death|1|||
126508830|NCT01400841|455162803|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
126508831|NCT02412631|455162804|FG000|Overall Study|Adverse Event|1|||
126565480|NCT01081145|455364941|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
126565481|NCT01081145|455364942|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
126565482|NCT01253226|455364943|FG000|Overall Study|Adverse Event|0|||
126565483|NCT01253226|455364944|FG001|Overall Study|Adverse Event|0|||
126565484|NCT01253226|455364945|FG002|Overall Study|Adverse Event|1|||
126565485|NCT01253226|455364946|FG003|Overall Study|Adverse Event|0|||
126565486|NCT01253226|455364947|FG004|Overall Study|Adverse Event|0|||
126565487|NCT01253226|455364943|FG000|Overall Study|Death|0|||
126565488|NCT01253226|455364944|FG001|Overall Study|Death|1|||
126565489|NCT01253226|455364945|FG002|Overall Study|Death|0|||
126565490|NCT01253226|455364946|FG003|Overall Study|Death|0|||
126565491|NCT01253226|455364947|FG004|Overall Study|Death|0|||
126565492|NCT01253226|455364943|FG000|Overall Study|Physician Decision|0|||
126565493|NCT01253226|455364944|FG001|Overall Study|Physician Decision|0|||
126565494|NCT01253226|455364945|FG002|Overall Study|Physician Decision|0|||
126565495|NCT01253226|455364946|FG003|Overall Study|Physician Decision|0|||
126565496|NCT01253226|455364947|FG004|Overall Study|Physician Decision|2|||
126565497|NCT01253226|455364943|FG000|Overall Study|Withdrawal by Subject|0|||
126565498|NCT01253226|455364944|FG001|Overall Study|Withdrawal by Subject|0|||
126565499|NCT01253226|455364945|FG002|Overall Study|Withdrawal by Subject|0|||
126565500|NCT01253226|455364946|FG003|Overall Study|Withdrawal by Subject|1|||
126565501|NCT01253226|455364947|FG004|Overall Study|Withdrawal by Subject|0|||
126565502|NCT00988637|455364948|FG000|Overall Study|Lost to Follow-up|2|||
126565503|NCT00988637|455364949|FG001|Overall Study|Lost to Follow-up|1|||
126565504|NCT00988637|455364948|FG000|Overall Study|Withdrawal by Subject|1|||
126565505|NCT00988637|455364949|FG001|Overall Study|Withdrawal by Subject|1|||
126565506|NCT00988637|455364948|FG000|Overall Study|non-compliance with study drug|0|||
126565507|NCT00988637|455364949|FG001|Overall Study|non-compliance with study drug|1|||
126565508|NCT03593070|455364950|FG000|Overall Study|administrative withdrawal|1|||
126565509|NCT03593070|455364951|FG001|Overall Study|administrative withdrawal|1|||
126565510|NCT01582945|455364952|FG000|Overall Study|Intolerable side-effects|1|||
126565511|NCT01582945|455364952|FG000|Overall Study|Scheduling conflicts|1|||
126565512|NCT03394027|455364955|FG000|Overall Study|Ineligible|3|||
126565513|NCT03394027|455364956|FG001|Overall Study|Ineligible|1|||
126565514|NCT03394027|455364957|FG002|Overall Study|Ineligible|3|||
126565515|NCT03394027|455364955|FG000|Overall Study|Participant declined to participate before treatment started|0|||
126565516|NCT03394027|455364956|FG001|Overall Study|Participant declined to participate before treatment started|0|||
126565517|NCT03394027|455364957|FG002|Overall Study|Participant declined to participate before treatment started|1|||
126565518|NCT03310983|455364958|FG000|Overall Study|Lost to Follow-up|15|||
126565519|NCT03310983|455364959|FG001|Overall Study|Lost to Follow-up|17|||
126565520|NCT02197234|455364960|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
126565521|NCT02197234|455364960|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
126565522|NCT02197234|455364960|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
126565523|NCT02197234|455364960|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
126565524|NCT02197234|455364960|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
126565525|NCT02197234|455364960|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
126565526|NCT04523181|455364963|FG000|Overall Study|Withdrawal by Subject|4|||
126508832|NCT02412631|455162805|FG001|Overall Study|Adverse Event|2|||
126508833|NCT02412631|455162804|FG000|Overall Study|Lost to Follow-up|5|||
126508834|NCT02412631|455162805|FG001|Overall Study|Lost to Follow-up|9|||
126508835|NCT02412631|455162804|FG000|Overall Study|Withdrawal by Subject|9|||
126508836|NCT02412631|455162805|FG001|Overall Study|Withdrawal by Subject|3|||
126508837|NCT02412631|455162804|FG000|Overall Study|Early stop by FDA|5|||
126565527|NCT04523181|455364964|FG001|Overall Study|Withdrawal by Subject|5|||
126565528|NCT04523181|455364963|FG000|Overall Study|Lost to Follow-up|2|||
126565529|NCT04523181|455364964|FG001|Overall Study|Lost to Follow-up|3|||
126565530|NCT04523181|455364963|FG000|Overall Study|Physician Decision|1|||
126565531|NCT04523181|455364964|FG001|Overall Study|Physician Decision|0|||
126508838|NCT02412631|455162805|FG001|Overall Study|Early stop by FDA|2|||
126508839|NCT02412631|455162804|FG000|Overall Study|Unspecified reason|6|||
126508840|NCT02412631|455162805|FG001|Overall Study|Unspecified reason|8|||
126508841|NCT00770120|455162806|FG000|Overall Study|Progression|31|||
126508842|NCT00770120|455162806|FG000|Overall Study|Adverse Event|11|||
126508843|NCT00770120|455162806|FG000|Overall Study|Not Protocol Specified|11|||
126508844|NCT00770120|455162806|FG000|Overall Study|Death|3|||
126508845|NCT00770120|455162806|FG000|Overall Study|Withdrawal by Subject|2|||
126508846|NCT00770120|455162806|FG000|Overall Study|Ineligible|1|||
126508847|NCT00770120|455162806|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
126508848|NCT00770120|455162806|FG000|Overall Study|Reason under Review|1|||
126508849|NCT00958776|455162807|FG000|Overall Study|Adverse Event|0|||
126508850|NCT00958776|455162808|FG001|Overall Study|Adverse Event|1|||
126508851|NCT00958776|455162807|FG000|Overall Study|Physician Decision|1|||
126508852|NCT00958776|455162808|FG001|Overall Study|Physician Decision|0|||
126508853|NCT00958776|455162807|FG000|Overall Study|Lost to Follow-up|2|||
126508854|NCT00958776|455162808|FG001|Overall Study|Lost to Follow-up|6|||
126508855|NCT00958776|455162807|FG000|Overall Study|Withdrawal by Subject|7|||
126508856|NCT00958776|455162808|FG001|Overall Study|Withdrawal by Subject|16|||
126508857|NCT00958776|455162807|FG000|Overall Study|Protocol Violation|1|||
126508858|NCT00958776|455162808|FG001|Overall Study|Protocol Violation|1|||
126508859|NCT00958776|455162807|FG000|Overall Study|Death|2|||
126508860|NCT00958776|455162808|FG001|Overall Study|Death|1|||
126508861|NCT00958776|455162807|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
126508862|NCT00958776|455162808|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
126508863|NCT00958776|455162807|FG000|Overall Study|Missing|1|||
126508864|NCT00958776|455162808|FG001|Overall Study|Missing|1|||
126508865|NCT00480636|455162809|FG000|Overall Study|Death|12|||
126508866|NCT00480636|455162809|FG000|Overall Study|Lost to Follow-up|4|||
126508867|NCT00480636|455162809|FG000|Overall Study|Other|2|||
126508868|NCT00480636|455162809|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
126508869|NCT02583256|455162810|FG000|Overall Study|Withdrawal by Subject|0|||
126508870|NCT02583256|455162811|FG001|Overall Study|Withdrawal by Subject|1|||
126508871|NCT02583256|455162812|FG002|Overall Study|Withdrawal by Subject|1|||
126508872|NCT02583256|455162813|FG003|Overall Study|Withdrawal by Subject|0|||
126508873|NCT02583256|455162810|FG000|Overall Study|Lost to Follow-up|1|||
126508874|NCT02583256|455162811|FG001|Overall Study|Lost to Follow-up|1|||
126508875|NCT02583256|455162812|FG002|Overall Study|Lost to Follow-up|0|||
126508876|NCT02583256|455162813|FG003|Overall Study|Lost to Follow-up|1|||
126508877|NCT02583256|455162810|FG000|Overall Study|Administrative/Other|2|||
126508878|NCT02583256|455162811|FG001|Overall Study|Administrative/Other|0|||
126508879|NCT02583256|455162812|FG002|Overall Study|Administrative/Other|1|||
126508880|NCT02583256|455162813|FG003|Overall Study|Administrative/Other|2|||
126508881|NCT00326911|455162814|FG000|Overall Study|Hospitalization prior to treatment|0|||
126508882|NCT00326911|455162815|FG001|Overall Study|Hospitalization prior to treatment|1|||
126508883|NCT00326911|455162814|FG000|Overall Study|Physician decision prior to treatment|1|||
126508884|NCT00326911|455162815|FG001|Overall Study|Physician decision prior to treatment|0|||
126565532|NCT04523181|455364963|FG000|Overall Study|Transferred to external facility.|1|||
126565533|NCT04523181|455364964|FG001|Overall Study|Transferred to external facility.|1|||
126565534|NCT01656304|455364966|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
126565535|NCT04391309|455364967|FG000|Overall Study|Death|1|||
126565536|NCT04391309|455364968|FG001|Overall Study|Death|1|||
126565537|NCT04391309|455364967|FG000|Overall Study|Lost to Follow-up|3|||
126565538|NCT04391309|455364968|FG001|Overall Study|Lost to Follow-up|2|||
126565539|NCT04391309|455364967|FG000|Overall Study|Withdrawal by Subject|2|||
126565540|NCT04391309|455364968|FG001|Overall Study|Withdrawal by Subject|2|||
126565541|NCT01155869|455364970|FG000|Overall Study|Lost to Follow-up|3|||
126565542|NCT01155869|455364971|FG001|Overall Study|Lost to Follow-up|1|||
126565543|NCT05826431|455364973|FG000|Overall Study|Withdrawal by Subject|1|||
126565544|NCT04771273|455364974|FG000|Dose Escalation Period|Not treated with trial medication|0|||
126565545|NCT04771273|455364975|FG001|Dose Escalation Period|Not treated with trial medication|1|||
126565546|NCT04771273|455364976|FG002|Dose Escalation Period|Not treated with trial medication|1|||
126565547|NCT04771273|455364977|FG003|Dose Escalation Period|Not treated with trial medication|0|||
126508885|NCT00326911|455162814|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
126508886|NCT00326911|455162815|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
126565548|NCT04771273|455364974|FG000|Dose Escalation Period|Other reasons than listed|2|||
126565549|NCT04771273|455364975|FG001|Dose Escalation Period|Other reasons than listed|0|||
126565550|NCT04771273|455364976|FG002|Dose Escalation Period|Other reasons than listed|2|||
126508887|NCT03019627|455162827|FG000|Overall Study|Adverse Event|8|||
126508888|NCT03019627|455162828|FG001|Overall Study|Adverse Event|0|||
126508889|NCT03019627|455162827|FG000|Overall Study|Unrelated to adverse event|1|||
126508890|NCT03019627|455162828|FG001|Overall Study|Unrelated to adverse event|3|||
126508891|NCT03019627|455162827|FG000|Overall Study|Lost to Follow-up|2|||
126508892|NCT03019627|455162828|FG001|Overall Study|Lost to Follow-up|1|||
126565551|NCT04771273|455364977|FG003|Dose Escalation Period|Other reasons than listed|1|||
126508893|NCT03019627|455162827|FG000|Overall Study|not compliance|2|||
126508894|NCT03019627|455162828|FG001|Overall Study|not compliance|2|||
126508895|NCT03019627|455162827|FG000|Overall Study|Other|2|||
126508896|NCT03019627|455162828|FG001|Overall Study|Other|2|||
126508897|NCT03364049|455162829|FG000|Overall Study|Death|6|||
126508898|NCT03364049|455162830|FG001|Overall Study|Death|4|||
126508899|NCT03364049|455162831|FG002|Overall Study|Death|5|||
126508900|NCT03364049|455162832|FG003|Overall Study|Death|14|||
126508901|NCT03364049|455162829|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
126508902|NCT03364049|455162830|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
126508903|NCT03364049|455162831|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
126508904|NCT03364049|455162832|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
126508905|NCT03364049|455162829|FG000|Overall Study|Withdrawal by Subject|0|||
126508906|NCT03364049|455162830|FG001|Overall Study|Withdrawal by Subject|1|||
126508907|NCT03364049|455162831|FG002|Overall Study|Withdrawal by Subject|1|||
126508908|NCT03364049|455162832|FG003|Overall Study|Withdrawal by Subject|1|||
126508909|NCT02953821|455162833|FG000|Overall Study|Adverse Event|0|||
126508910|NCT02953821|455162834|FG001|Overall Study|Adverse Event|4|||
126508911|NCT02953821|455162833|FG000|Overall Study|Death|1|||
126508912|NCT02953821|455162834|FG001|Overall Study|Death|0|||
126508913|NCT02953821|455162833|FG000|Overall Study|Progressive Disease|5|||
126508914|NCT02953821|455162834|FG001|Overall Study|Progressive Disease|1|||
126508915|NCT02953821|455162833|FG000|Overall Study|Lost to Follow-up|2|||
126508916|NCT02953821|455162834|FG001|Overall Study|Lost to Follow-up|0|||
126508917|NCT02953821|455162833|FG000|Overall Study|Physician Decision|1|||
126508918|NCT02953821|455162834|FG001|Overall Study|Physician Decision|1|||
126508919|NCT02953821|455162833|FG000|Overall Study|Withdrawal by Subject|3|||
126508920|NCT02953821|455162834|FG001|Overall Study|Withdrawal by Subject|3|||
126508921|NCT02953821|455162833|FG000|Overall Study|Change of address|0|||
126508922|NCT02953821|455162834|FG001|Overall Study|Change of address|1|||
126508923|NCT02953821|455162833|FG000|Overall Study|Lack of Efficacy|1|||
126508924|NCT02953821|455162834|FG001|Overall Study|Lack of Efficacy|0|||
126508925|NCT02953821|455162833|FG000|Overall Study|Out of state for indeterminate time|0|||
126508926|NCT02953821|455162834|FG001|Overall Study|Out of state for indeterminate time|1|||
126508927|NCT02953821|455162833|FG000|Overall Study|No improvement|0|||
126508928|NCT02953821|455162834|FG001|Overall Study|No improvement|1|||
126508929|NCT02953821|455162833|FG000|Overall Study|Refused follow-up visit|2|||
126508930|NCT02953821|455162834|FG001|Overall Study|Refused follow-up visit|1|||
126508931|NCT02103478|455162835|FG000|Overall Study|Adverse Event|0|||
126508932|NCT02103478|455162836|FG001|Overall Study|Adverse Event|0|||
126508933|NCT02103478|455162837|FG002|Overall Study|Adverse Event|1|||
126508934|NCT02103478|455162838|FG003|Overall Study|Adverse Event|1|||
126508935|NCT02103478|455162839|FG004|Overall Study|Adverse Event|2|||
126508936|NCT02103478|455162840|FG005|Overall Study|Adverse Event|1|||
126508937|NCT02103478|455162841|FG006|Overall Study|Adverse Event|0|||
126508938|NCT02103478|455162842|FG007|Overall Study|Adverse Event|0|||
126508939|NCT02103478|455162843|FG008|Overall Study|Adverse Event|0|||
126508940|NCT02103478|455162835|FG000|Overall Study|Death|2|||
126508941|NCT02103478|455162836|FG001|Overall Study|Death|2|||
126508942|NCT02103478|455162837|FG002|Overall Study|Death|1|||
126508943|NCT02103478|455162838|FG003|Overall Study|Death|1|||
126508944|NCT02103478|455162839|FG004|Overall Study|Death|5|||
126508945|NCT02103478|455162840|FG005|Overall Study|Death|15|||
126508946|NCT02103478|455162841|FG006|Overall Study|Death|14|||
126508947|NCT02103478|455162842|FG007|Overall Study|Death|10|||
126508948|NCT02103478|455162843|FG008|Overall Study|Death|11|||
126508949|NCT02103478|455162835|FG000|Overall Study|Progressive Disease|2|||
126508950|NCT02103478|455162836|FG001|Overall Study|Progressive Disease|1|||
126508951|NCT02103478|455162837|FG002|Overall Study|Progressive Disease|2|||
126508952|NCT02103478|455162838|FG003|Overall Study|Progressive Disease|0|||
126508953|NCT02103478|455162839|FG004|Overall Study|Progressive Disease|9|||
126508954|NCT02103478|455162840|FG005|Overall Study|Progressive Disease|1|||
126508955|NCT02103478|455162841|FG006|Overall Study|Progressive Disease|2|||
126508956|NCT02103478|455162842|FG007|Overall Study|Progressive Disease|0|||
126508957|NCT02103478|455162843|FG008|Overall Study|Progressive Disease|1|||
126727162|NCT02921919|455951070|FG001|Overall Study|Lost to Follow-up|1|||
126508958|NCT02103478|455162835|FG000|Overall Study|Withdrawal by Subject|2|||
126508959|NCT02103478|455162836|FG001|Overall Study|Withdrawal by Subject|0|||
126508960|NCT02103478|455162837|FG002|Overall Study|Withdrawal by Subject|0|||
126508961|NCT02103478|455162838|FG003|Overall Study|Withdrawal by Subject|4|||
126508962|NCT02103478|455162839|FG004|Overall Study|Withdrawal by Subject|0|||
126508963|NCT02103478|455162840|FG005|Overall Study|Withdrawal by Subject|0|||
126508964|NCT02103478|455162841|FG006|Overall Study|Withdrawal by Subject|1|||
126508965|NCT02103478|455162842|FG007|Overall Study|Withdrawal by Subject|1|||
126508966|NCT02103478|455162843|FG008|Overall Study|Withdrawal by Subject|0|||
126508967|NCT02103478|455162835|FG000|Overall Study|Lost to Follow-up|0|||
126508968|NCT02103478|455162836|FG001|Overall Study|Lost to Follow-up|0|||
126508969|NCT02103478|455162837|FG002|Overall Study|Lost to Follow-up|0|||
126508970|NCT02103478|455162838|FG003|Overall Study|Lost to Follow-up|0|||
126508971|NCT02103478|455162839|FG004|Overall Study|Lost to Follow-up|0|||
126508972|NCT02103478|455162840|FG005|Overall Study|Lost to Follow-up|0|||
126508973|NCT02103478|455162841|FG006|Overall Study|Lost to Follow-up|0|||
126508974|NCT02103478|455162842|FG007|Overall Study|Lost to Follow-up|1|||
126508975|NCT02103478|455162843|FG008|Overall Study|Lost to Follow-up|0|||
126508976|NCT02103478|455162835|FG000|Overall Study|Other|1|||
126508977|NCT02103478|455162836|FG001|Overall Study|Other|3|||
126508978|NCT02103478|455162837|FG002|Overall Study|Other|2|||
126508979|NCT02103478|455162838|FG003|Overall Study|Other|0|||
126508980|NCT02103478|455162839|FG004|Overall Study|Other|3|||
126508981|NCT02103478|455162840|FG005|Overall Study|Other|8|||
126508982|NCT02103478|455162841|FG006|Overall Study|Other|8|||
126508983|NCT02103478|455162842|FG007|Overall Study|Other|4|||
126508984|NCT02103478|455162843|FG008|Overall Study|Other|2|||
126508985|NCT03219333|455162844|FG000|Overall Study|Withdrawal by Subject|9|||
126508986|NCT03219333|455162845|FG001|Overall Study|Withdrawal by Subject|4|||
126508987|NCT03219333|455162844|FG000|Overall Study|Lost to Follow-up|1|||
126508988|NCT03219333|455162845|FG001|Overall Study|Lost to Follow-up|1|||
126776943|NCT01886300|456139119|FG000|Overall Study|Trial terminated by sponsor|16|||
126776944|NCT02008721|456139120|FG000|Overall Study|Withdrawal by Subject|5|||
126776945|NCT02008721|456139121|FG001|Overall Study|Withdrawal by Subject|1|||
126776946|NCT02008721|456139120|FG000|Overall Study|Death|4|||
126776947|NCT02008721|456139121|FG001|Overall Study|Death|2|||
126776948|NCT02008721|456139120|FG000|Overall Study|Adverse Event|3|||
126776949|NCT02008721|456139121|FG001|Overall Study|Adverse Event|5|||
126776950|NCT02008721|456139120|FG000|Overall Study|Protocol Violation|3|||
126508989|NCT03219333|455162844|FG000|Overall Study|Death|104|||
126508990|NCT03219333|455162845|FG001|Overall Study|Death|72|||
126508991|NCT03219333|455162844|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
126508992|NCT03219333|455162845|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
126508993|NCT03219333|455162844|FG000|Overall Study|Other|2|||
126508994|NCT03219333|455162845|FG001|Overall Study|Other|2|||
126508995|NCT00976898|455162846|FG000|Overall Study|Protocol Violation|1|||
126508996|NCT00976898|455162846|FG000|Overall Study|Adverse Event|1|||
126508997|NCT00976898|455162846|FG000|Overall Study|Physician Decision|1|||
126508998|NCT00976898|455162846|FG000|Overall Study|Liver Transplant|1|||
126508999|NCT00976898|455162846|FG000|Overall Study|Progressive Disease|1|||
126509000|NCT05107128|455162847|FG000|Overall Study|Adverse Event|2|||
126509001|NCT05107128|455162848|FG001|Overall Study|Adverse Event|0|||
126509002|NCT05107128|455162847|FG000|Overall Study|Withdrawal by Subject|3|||
126509003|NCT05107128|455162848|FG001|Overall Study|Withdrawal by Subject|3|||
126509004|NCT05107128|455162847|FG000|Overall Study|Withdrawal of Consent|0|||
126509005|NCT05107128|455162848|FG001|Overall Study|Withdrawal of Consent|1|||
126509006|NCT05107128|455162847|FG000|Overall Study|Reason Not Specified|2|||
126509007|NCT05107128|455162848|FG001|Overall Study|Reason Not Specified|0|||
126509008|NCT01470469|455162849|FG000|Overall Study|Withdrawal by Subject|4|||
126509009|NCT01470469|455162850|FG001|Overall Study|Withdrawal by Subject|6|||
126509010|NCT01470469|455162849|FG000|Overall Study|Lack of Efficacy|1|||
126509011|NCT01470469|455162850|FG001|Overall Study|Lack of Efficacy|7|||
126509012|NCT01470469|455162849|FG000|Overall Study|Adverse Event|0|||
126509013|NCT01470469|455162850|FG001|Overall Study|Adverse Event|7|||
126509014|NCT01470469|455162849|FG000|Overall Study|Lost to Follow-up|2|||
126509015|NCT01470469|455162850|FG001|Overall Study|Lost to Follow-up|2|||
126509016|NCT01470469|455162849|FG000|Overall Study|Protocol Violation|1|||
126509017|NCT01470469|455162850|FG001|Overall Study|Protocol Violation|1|||
126509018|NCT01470469|455162849|FG000|Overall Study|Other|2|||
126509019|NCT01470469|455162850|FG001|Overall Study|Other|1|||
126509020|NCT04182100|455162851|FG000|Overall Study|Adverse Event|1|||
126509021|NCT04182100|455162851|FG000|Overall Study|Withdrawal by Subject|1|||
126565552|NCT04771273|455364974|FG000|Dose Escalation Period|Protocol Violation|0|||
126565553|NCT04771273|455364975|FG001|Dose Escalation Period|Protocol Violation|0|||
126565554|NCT04771273|455364976|FG002|Dose Escalation Period|Protocol Violation|3|||
126509022|NCT04988295|455162853|FG000|Overall Study|Withdrawal by Subject|9|||
126509023|NCT04988295|455162854|FG001|Overall Study|Withdrawal by Subject|29|||
126509024|NCT04988295|455162855|FG002|Overall Study|Withdrawal by Subject|6|||
126565555|NCT04771273|455364977|FG003|Dose Escalation Period|Protocol Violation|1|||
126565556|NCT04771273|455364974|FG000|Dose Escalation Period|Burden of study procedures|1|||
126509025|NCT04988295|455162856|FG003|Overall Study|Withdrawal by Subject|0|||
126565557|NCT04771273|455364975|FG001|Dose Escalation Period|Burden of study procedures|0|||
126565558|NCT04771273|455364976|FG002|Dose Escalation Period|Burden of study procedures|0|||
126565559|NCT04771273|455364977|FG003|Dose Escalation Period|Burden of study procedures|0|||
126776951|NCT02008721|456139121|FG001|Overall Study|Protocol Violation|2|||
126509026|NCT04988295|455162853|FG000|Overall Study|Lost to Follow-up|1|||
126509027|NCT04988295|455162854|FG001|Overall Study|Lost to Follow-up|0|||
126509028|NCT04988295|455162855|FG002|Overall Study|Lost to Follow-up|0|||
126509029|NCT04988295|455162856|FG003|Overall Study|Lost to Follow-up|0|||
126776952|NCT00267007|456139124|FG000|Overall Study|Withdrawal by Subject|6|||
126776953|NCT00267007|456139125|FG001|Overall Study|Withdrawal by Subject|0|||
126509030|NCT04988295|455162853|FG000|Overall Study|Study participation ongoing|186|||
126509031|NCT04988295|455162854|FG001|Overall Study|Study participation ongoing|169|||
126509032|NCT04988295|455162855|FG002|Overall Study|Study participation ongoing|99|||
126509033|NCT04988295|455162856|FG003|Overall Study|Study participation ongoing|119|||
126509034|NCT04083976|455162857|FG000|Overall Study|Lost to Follow-up|3|||
126509035|NCT04083976|455162858|FG001|Overall Study|Lost to Follow-up|0|||
126509036|NCT04083976|455162859|FG002|Overall Study|Lost to Follow-up|0|||
126509037|NCT04083976|455162860|FG003|Overall Study|Lost to Follow-up|1|||
126509038|NCT04083976|455162857|FG000|Overall Study|Withdrawal by Subject|16|||
126509039|NCT04083976|455162858|FG001|Overall Study|Withdrawal by Subject|1|||
126509040|NCT04083976|455162859|FG002|Overall Study|Withdrawal by Subject|9|||
126509041|NCT04083976|455162860|FG003|Overall Study|Withdrawal by Subject|0|||
126509042|NCT04083976|455162857|FG000|Overall Study|Sponsor Decision|14|||
126509043|NCT04083976|455162858|FG001|Overall Study|Sponsor Decision|0|||
126509044|NCT04083976|455162859|FG002|Overall Study|Sponsor Decision|0|||
126509045|NCT04083976|455162860|FG003|Overall Study|Sponsor Decision|7|||
126509046|NCT04083976|455162857|FG000|Overall Study|Other|1|||
126509047|NCT04083976|455162858|FG001|Overall Study|Other|0|||
126509048|NCT04083976|455162859|FG002|Overall Study|Other|1|||
126509049|NCT04083976|455162860|FG003|Overall Study|Other|0|||
126509050|NCT05358821|455162861|FG000|Overall Study|Withdrawal by Subject|0|||
126509051|NCT05358821|455162862|FG001|Overall Study|Withdrawal by Subject|1|||
126509052|NCT05358821|455162863|FG002|Overall Study|Withdrawal by Subject|0|||
126509053|NCT05358821|455162861|FG000|Overall Study|Withdrawal of Consent|0|||
126509054|NCT05358821|455162862|FG001|Overall Study|Withdrawal of Consent|0|||
126509055|NCT05358821|455162863|FG002|Overall Study|Withdrawal of Consent|1|||
126509056|NCT02504372|455162864|FG000|Overall Study|Death|136|||
126509057|NCT02504372|455162865|FG001|Overall Study|Death|154|||
126509058|NCT02504372|455162864|FG000|Overall Study|Lost to Follow-up|0|||
126509059|NCT02504372|455162865|FG001|Overall Study|Lost to Follow-up|2|||
126509060|NCT02504372|455162864|FG000|Overall Study|Withdrawal of consent|25|||
126509061|NCT02504372|455162865|FG001|Overall Study|Withdrawal of consent|16|||
126509062|NCT02504372|455162864|FG000|Overall Study|Participants ongoing|429|||
126509063|NCT02504372|455162865|FG001|Overall Study|Participants ongoing|415|||
126509064|NCT03901963|455162866|FG000|Overall Study|Lost to Follow-up|1|||
126509065|NCT03901963|455162867|FG001|Overall Study|Lost to Follow-up|1|||
126509066|NCT03901963|455162866|FG000|Overall Study|Physician Decision|1|||
126509067|NCT03901963|455162867|FG001|Overall Study|Physician Decision|2|||
126509068|NCT03901963|455162866|FG000|Overall Study|Protocol Violation|1|||
126509069|NCT03901963|455162867|FG001|Overall Study|Protocol Violation|1|||
126509070|NCT03901963|455162866|FG000|Overall Study|Withdrawal by Subject|4|||
126509071|NCT03901963|455162867|FG001|Overall Study|Withdrawal by Subject|11|||
126509072|NCT03901963|455162866|FG000|Overall Study|Ongoing|84|||
126509073|NCT03901963|455162867|FG001|Overall Study|Ongoing|73|||
126509074|NCT03901963|455162866|FG000|Overall Study|Randomized but not treated|3|||
126509075|NCT03901963|455162867|FG001|Overall Study|Randomized but not treated|3|||
126509076|NCT00433654|455162874|FG000|Overall Study|Death|4|||
126509077|NCT00433654|455162875|FG001|Overall Study|Death|0|||
126509078|NCT00433654|455162874|FG000|Overall Study|Missed visit|6|||
126509079|NCT00433654|455162875|FG001|Overall Study|Missed visit|3|||
126509080|NCT00433654|455162874|FG000|Overall Study|Subject not yet due for visit|4|||
126509081|NCT00433654|455162875|FG001|Overall Study|Subject not yet due for visit|0|||
126509082|NCT00433654|455162874|FG000|Overall Study|Withdrawal by Subject|1|||
126509083|NCT00433654|455162875|FG001|Overall Study|Withdrawal by Subject|2|||
126509084|NCT03748641|455162876|FG000|Overall Study|Ongoing|155|||
126509085|NCT03748641|455162877|FG001|Overall Study|Ongoing|148|||
126509086|NCT03748641|455162878|FG002|Overall Study|Ongoing|66|||
126509087|NCT03748641|455162879|FG003|Overall Study|Ongoing|79|||
126509088|NCT03748641|455162880|FG004|Overall Study|Ongoing|84|||
126509089|NCT03748641|455162876|FG000|Overall Study|Death|54|||
126509090|NCT03748641|455162877|FG001|Overall Study|Death|59|||
126509091|NCT03748641|455162878|FG002|Overall Study|Death|51|||
126509092|NCT03748641|455162879|FG003|Overall Study|Death|42|||
126509093|NCT03748641|455162880|FG004|Overall Study|Death|9|||
126509094|NCT03748641|455162876|FG000|Overall Study|Lost to Follow-up|0|||
126509095|NCT03748641|455162877|FG001|Overall Study|Lost to Follow-up|2|||
126509096|NCT03748641|455162878|FG002|Overall Study|Lost to Follow-up|1|||
126509097|NCT03748641|455162879|FG003|Overall Study|Lost to Follow-up|0|||
126509098|NCT03748641|455162880|FG004|Overall Study|Lost to Follow-up|0|||
126509099|NCT03748641|455162876|FG000|Overall Study|Withdrawal by Subject|3|||
126509100|NCT03748641|455162877|FG001|Overall Study|Withdrawal by Subject|2|||
126509101|NCT03748641|455162878|FG002|Overall Study|Withdrawal by Subject|5|||
126509102|NCT03748641|455162879|FG003|Overall Study|Withdrawal by Subject|3|||
126509103|NCT03748641|455162880|FG004|Overall Study|Withdrawal by Subject|2|||
126509104|NCT01428193|455162881|FG000|Overall Study|Physician Decision|1|||
126509105|NCT01428193|455162881|FG000|Overall Study|Elevated screening liver enzymes|1|||
126509106|NCT05179421|455162882|FG000|First Infusion Day|Adverse Event|1|||
126509107|NCT05179421|455162883|FG001|First Infusion Day|Adverse Event|0|||
126509108|NCT03473743|455162885|FG000|Overall Study|Withdrawal by Subject|0|||
126509109|NCT03473743|455162886|FG001|Overall Study|Withdrawal by Subject|0|||
126509110|NCT03473743|455162887|FG002|Overall Study|Withdrawal by Subject|0|||
126509111|NCT03473743|455162888|FG003|Overall Study|Withdrawal by Subject|0|||
126509112|NCT03473743|455162889|FG004|Overall Study|Withdrawal by Subject|0|||
126509113|NCT03473743|455162890|FG005|Overall Study|Withdrawal by Subject|0|||
126509114|NCT03473743|455162891|FG006|Overall Study|Withdrawal by Subject|0|||
126509115|NCT03473743|455162892|FG007|Overall Study|Withdrawal by Subject|3|||
126509116|NCT03473743|455162885|FG000|Overall Study|Other|0|||
126509117|NCT03473743|455162886|FG001|Overall Study|Other|0|||
126509118|NCT03473743|455162887|FG002|Overall Study|Other|0|||
126509119|NCT03473743|455162888|FG003|Overall Study|Other|1|||
126509120|NCT03473743|455162889|FG004|Overall Study|Other|0|||
126565560|NCT04771273|455364974|FG000|Dose Escalation Period|Change of residence|0|||
126565561|NCT04771273|455364975|FG001|Dose Escalation Period|Change of residence|0|||
126565562|NCT04771273|455364976|FG002|Dose Escalation Period|Change of residence|0|||
126565563|NCT04771273|455364977|FG003|Dose Escalation Period|Change of residence|1|||
126565564|NCT04771273|455364974|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
126509121|NCT03473743|455162890|FG005|Overall Study|Other|0|||
126509122|NCT03473743|455162891|FG006|Overall Study|Other|0|||
126509123|NCT03473743|455162892|FG007|Overall Study|Other|0|||
126509124|NCT03473743|455162885|FG000|Overall Study|Ongoing|0|||
126509125|NCT03473743|455162886|FG001|Overall Study|Ongoing|0|||
126509126|NCT03473743|455162887|FG002|Overall Study|Ongoing|6|||
126509127|NCT03473743|455162888|FG003|Overall Study|Ongoing|8|||
126509128|NCT03473743|455162889|FG004|Overall Study|Ongoing|1|||
126509129|NCT03473743|455162890|FG005|Overall Study|Ongoing|1|||
126509130|NCT03473743|455162891|FG006|Overall Study|Ongoing|22|||
126509131|NCT03473743|455162892|FG007|Overall Study|Ongoing|24|||
126509132|NCT03473743|455162885|FG000|Overall Study|Randomized but not treated|0|||
126509133|NCT03473743|455162886|FG001|Overall Study|Randomized but not treated|0|||
126509134|NCT03473743|455162887|FG002|Overall Study|Randomized but not treated|0|||
126509135|NCT03473743|455162888|FG003|Overall Study|Randomized but not treated|0|||
126509136|NCT03473743|455162889|FG004|Overall Study|Randomized but not treated|0|||
126509137|NCT03473743|455162890|FG005|Overall Study|Randomized but not treated|0|||
126509138|NCT03473743|455162891|FG006|Overall Study|Randomized but not treated|1|||
126509139|NCT03473743|455162892|FG007|Overall Study|Randomized but not treated|1|||
126509140|NCT02052739|455162898|FG000|Overall Study|Withdrew due to Adverse Event|3|||
126509141|NCT02052739|455162899|FG001|Overall Study|Withdrew due to Adverse Event|0|||
126509142|NCT02052739|455162898|FG000|Overall Study|Participant Died|2|||
126509143|NCT02052739|455162899|FG001|Overall Study|Participant Died|1|||
126509144|NCT05619692|455162900|FG000|Overall Study|Adverse Event|2|||
126509145|NCT05619692|455162901|FG001|Overall Study|Adverse Event|2|||
126509146|NCT05619692|455162900|FG000|Overall Study|Withdrawal by Participant|3|||
126509147|NCT05619692|455162901|FG001|Overall Study|Withdrawal by Participant|4|||
126509148|NCT05619692|455162900|FG000|Overall Study|Lost to Follow-up|2|||
126509149|NCT05619692|455162901|FG001|Overall Study|Lost to Follow-up|1|||
126509150|NCT05619692|455162900|FG000|Overall Study|Randomized but not treated|1|||
126509151|NCT05619692|455162901|FG001|Overall Study|Randomized but not treated|3|||
126509152|NCT05267054|455162902|FG000|Overall Study|Death|13|||
126509153|NCT05267054|455162903|FG001|Overall Study|Death|14|||
126509154|NCT05267054|455162902|FG000|Overall Study|Study Ended by Sponsor|9|||
126509155|NCT05267054|455162903|FG001|Overall Study|Study Ended by Sponsor|13|||
126509156|NCT05267054|455162902|FG000|Overall Study|Lost to Follow-up|1|||
126509157|NCT05267054|455162903|FG001|Overall Study|Lost to Follow-up|1|||
126509158|NCT05267054|455162902|FG000|Overall Study|Withdrawal by Subject|1|||
126509159|NCT05267054|455162903|FG001|Overall Study|Withdrawal by Subject|1|||
126509160|NCT04049760|455162904|FG000|Overall Study|Withdrawal by Subject|1|||
126509161|NCT03604692|455162905|FG000|Overall Study|Investigator's Decision|0|||
126509162|NCT03604692|455162906|FG001|Overall Study|Investigator's Decision|0|||
126509163|NCT03604692|455162907|FG002|Overall Study|Investigator's Decision|0|||
126509164|NCT03604692|455162908|FG003|Overall Study|Investigator's Decision|1|||
126565565|NCT04771273|455364975|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
126565566|NCT04771273|455364976|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
126565567|NCT04771273|455364977|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
126565568|NCT04771273|455364974|FG000|Dose Escalation Period|Adverse Event|8|||
126565569|NCT04771273|455364975|FG001|Dose Escalation Period|Adverse Event|9|||
126565570|NCT04771273|455364976|FG002|Dose Escalation Period|Adverse Event|12|||
126565571|NCT04771273|455364977|FG003|Dose Escalation Period|Adverse Event|2|||
126565572|NCT04771273|455364974|FG000|Maintenance Period|Other than listed|4|||
126509165|NCT03604692|455162909|FG004|Overall Study|Investigator's Decision|0|||
126565573|NCT04771273|455364975|FG001|Maintenance Period|Other than listed|2|||
126509166|NCT03604692|455162910|FG005|Overall Study|Investigator's Decision|7|||
126509167|NCT03604692|455162905|FG000|Overall Study|Withdrawal by Subject|0|||
126509168|NCT03604692|455162906|FG001|Overall Study|Withdrawal by Subject|0|||
126509169|NCT03604692|455162907|FG002|Overall Study|Withdrawal by Subject|0|||
126509170|NCT03604692|455162908|FG003|Overall Study|Withdrawal by Subject|0|||
126509171|NCT03604692|455162909|FG004|Overall Study|Withdrawal by Subject|0|||
126565574|NCT04771273|455364976|FG002|Maintenance Period|Other than listed|0|||
126565575|NCT04771273|455364977|FG003|Maintenance Period|Other than listed|3|||
126509172|NCT03604692|455162910|FG005|Overall Study|Withdrawal by Subject|2|||
126509173|NCT03604692|455162905|FG000|Overall Study|Progressive Disease|1|||
126509174|NCT03604692|455162906|FG001|Overall Study|Progressive Disease|0|||
126509175|NCT03604692|455162907|FG002|Overall Study|Progressive Disease|1|||
126509176|NCT03604692|455162908|FG003|Overall Study|Progressive Disease|0|||
126509177|NCT03604692|455162909|FG004|Overall Study|Progressive Disease|3|||
126509178|NCT03604692|455162910|FG005|Overall Study|Progressive Disease|4|||
126509179|NCT03604692|455162905|FG000|Overall Study|Difficulty Coming into Site|0|||
126509180|NCT03604692|455162906|FG001|Overall Study|Difficulty Coming into Site|0|||
126509181|NCT03604692|455162907|FG002|Overall Study|Difficulty Coming into Site|0|||
126509182|NCT03604692|455162908|FG003|Overall Study|Difficulty Coming into Site|0|||
126509183|NCT03604692|455162909|FG004|Overall Study|Difficulty Coming into Site|0|||
126509184|NCT03604692|455162910|FG005|Overall Study|Difficulty Coming into Site|1|||
126509185|NCT03604692|455162905|FG000|Overall Study|Death|0|||
126509186|NCT03604692|455162906|FG001|Overall Study|Death|0|||
126509187|NCT03604692|455162907|FG002|Overall Study|Death|1|||
126509188|NCT03604692|455162908|FG003|Overall Study|Death|0|||
126509189|NCT03604692|455162909|FG004|Overall Study|Death|0|||
126509190|NCT03604692|455162910|FG005|Overall Study|Death|0|||
126509191|NCT03604692|455162905|FG000|Overall Study|Drug Intolerance|0|||
126509192|NCT03604692|455162906|FG001|Overall Study|Drug Intolerance|0|||
126509193|NCT03604692|455162907|FG002|Overall Study|Drug Intolerance|0|||
126509194|NCT03604692|455162908|FG003|Overall Study|Drug Intolerance|1|||
126509195|NCT03604692|455162909|FG004|Overall Study|Drug Intolerance|0|||
126509196|NCT03604692|455162910|FG005|Overall Study|Drug Intolerance|0|||
126509197|NCT03604692|455162905|FG000|Overall Study|Noncompliance with follow-up visit|0|||
126509198|NCT03604692|455162906|FG001|Overall Study|Noncompliance with follow-up visit|0|||
126509199|NCT03604692|455162907|FG002|Overall Study|Noncompliance with follow-up visit|0|||
126509200|NCT03604692|455162908|FG003|Overall Study|Noncompliance with follow-up visit|1|||
126509201|NCT03604692|455162909|FG004|Overall Study|Noncompliance with follow-up visit|0|||
126509202|NCT03604692|455162910|FG005|Overall Study|Noncompliance with follow-up visit|0|||
126509203|NCT03604692|455162905|FG000|Overall Study|Not Treated|0|||
126509204|NCT03604692|455162906|FG001|Overall Study|Not Treated|0|||
126509205|NCT03604692|455162907|FG002|Overall Study|Not Treated|0|||
126509206|NCT03604692|455162908|FG003|Overall Study|Not Treated|0|||
126509207|NCT03604692|455162909|FG004|Overall Study|Not Treated|1|||
126509208|NCT03604692|455162910|FG005|Overall Study|Not Treated|0|||
126509209|NCT02681302|455162911|FG000|Overall Study|Withdrawal by Subject|1|||
126509210|NCT02681302|455162912|FG001|Overall Study|Withdrawal by Subject|1|||
126509211|NCT02681302|455162913|FG002|Overall Study|Withdrawal by Subject|0|||
126509212|NCT02681302|455162914|FG003|Overall Study|Withdrawal by Subject|0|||
126509213|NCT02681302|455162915|FG004|Overall Study|Withdrawal by Subject|1|||
126509214|NCT02681302|455162916|FG005|Overall Study|Withdrawal by Subject|0|||
126509215|NCT02681302|455162911|FG000|Overall Study|Screen Failure|2|||
126509216|NCT02681302|455162912|FG001|Overall Study|Screen Failure|4|||
126509217|NCT02681302|455162913|FG002|Overall Study|Screen Failure|2|||
126509218|NCT02681302|455162914|FG003|Overall Study|Screen Failure|0|||
126509219|NCT02681302|455162915|FG004|Overall Study|Screen Failure|1|||
126509220|NCT02681302|455162916|FG005|Overall Study|Screen Failure|1|||
126509221|NCT02681302|455162911|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
126509222|NCT02681302|455162912|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
126509223|NCT02681302|455162913|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
126509224|NCT02681302|455162914|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
126509225|NCT02681302|455162915|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
126509226|NCT02681302|455162916|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
126509227|NCT05059600|455162917|FG000|Overall Study|Enrolled but not Treated|10|||
126509228|NCT02152995|455162918|FG000|Overall Study|Withdrawal by Subject|1|||
126509229|NCT02152995|455162919|FG001|Overall Study|Withdrawal by Subject|0|||
126509230|NCT04552587|455162921|FG000|Overall Study|Lost to Follow-up|4|||
126509231|NCT00613509|455162923|FG000|Cycle 1|Adverse Event|2|||
126509232|NCT00613509|455162924|FG001|Cycle 1|Adverse Event|1|||
126509233|NCT00613509|455162923|FG000|Cycle 1|Disease Progression|2|||
126509234|NCT00613509|455162924|FG001|Cycle 1|Disease Progression|6|||
126509235|NCT00613509|455162923|FG000|Cycle 1|Unacceptable Toxicity|1|||
126509236|NCT00613509|455162924|FG001|Cycle 1|Unacceptable Toxicity|0|||
126509237|NCT00613509|455162923|FG000|Cycle 1|Other administrative reason|0|||
126509238|NCT00613509|455162924|FG001|Cycle 1|Other administrative reason|1|||
126509239|NCT03400033|455162934|FG000|Overall Study|Withdrawal by Subject|1|||
126509240|NCT03400033|455162935|FG001|Overall Study|Withdrawal by Subject|2|||
126509241|NCT02741115|455162941|FG000|Overall Study|Adverse Event|1|||
126509242|NCT02741115|455162942|FG001|Overall Study|Adverse Event|0|||
126509243|NCT02741115|455162941|FG000|Overall Study|Lost to Follow-up|7|||
126509244|NCT02741115|455162942|FG001|Overall Study|Lost to Follow-up|4|||
126509245|NCT02741115|455162941|FG000|Overall Study|Withdrawal by Subject|4|||
126509246|NCT02741115|455162942|FG001|Overall Study|Withdrawal by Subject|2|||
126509247|NCT01101841|455164444|FG000|Overall Study|Adverse Event|15|||
126509248|NCT01101841|455164445|FG001|Overall Study|Adverse Event|15|||
126509249|NCT01101841|455164444|FG000|Overall Study|Lost to Follow-up|9|||
126509250|NCT01101841|455164445|FG001|Overall Study|Lost to Follow-up|3|||
126509251|NCT01101841|455164444|FG000|Overall Study|Withdrawal by Subject|21|||
126509252|NCT01101841|455164445|FG001|Overall Study|Withdrawal by Subject|40|||
126509253|NCT01101841|455164444|FG000|Overall Study|Protocol Violation|1|||
126509254|NCT01101841|455164445|FG001|Overall Study|Protocol Violation|1|||
126509255|NCT01101841|455164444|FG000|Overall Study|Physician Decision|0|||
126509256|NCT01101841|455164445|FG001|Overall Study|Physician Decision|2|||
126509257|NCT01101841|455164444|FG000|Overall Study|Lack of Efficacy|0|||
126509258|NCT01101841|455164445|FG001|Overall Study|Lack of Efficacy|2|||
126509259|NCT01101841|455164444|FG000|Overall Study|Other|0|||
126509260|NCT01101841|455164445|FG001|Overall Study|Other|1|||
126509261|NCT01101841|455164444|FG000|Overall Study|Suicidality Tracking Scale|3|||
126509262|NCT01101841|455164445|FG001|Overall Study|Suicidality Tracking Scale|1|||
126509263|NCT01101841|455164444|FG000|Overall Study|Eligibility Criteria|1|||
126509264|NCT01101841|455164445|FG001|Overall Study|Eligibility Criteria|2|||
126509265|NCT03633396|455164450|FG000|Overall Study|Withdrawal by Subject|4|||
126509266|NCT03633396|455164451|FG001|Overall Study|Withdrawal by Subject|4|||
126509267|NCT03633396|455164450|FG000|Overall Study|Adverse Event|1|||
126509268|NCT03633396|455164451|FG001|Overall Study|Adverse Event|1|||
126509269|NCT03633396|455164450|FG000|Overall Study|Lack of Efficacy|1|||
126509270|NCT03633396|455164451|FG001|Overall Study|Lack of Efficacy|0|||
126509271|NCT03633396|455164450|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
126509272|NCT03633396|455164451|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
126509273|NCT01012817|455164452|FG000|Overall Study|Withdrawal by Subject|0|||
126509274|NCT01012817|455164453|FG001|Overall Study|Withdrawal by Subject|0|||
126509275|NCT01012817|455164454|FG002|Overall Study|Withdrawal by Subject|0|||
126509276|NCT01012817|455164455|FG003|Overall Study|Withdrawal by Subject|1|||
126509277|NCT01012817|455164456|FG004|Overall Study|Withdrawal by Subject|0|||
126509278|NCT01012817|455164457|FG005|Overall Study|Withdrawal by Subject|0|||
126509279|NCT01012817|455164458|FG006|Overall Study|Withdrawal by Subject|0|||
126509280|NCT01012817|455164459|FG007|Overall Study|Withdrawal by Subject|1|||
126509281|NCT01012817|455164460|FG008|Overall Study|Withdrawal by Subject|0|||
126509282|NCT01012817|455164461|FG009|Overall Study|Withdrawal by Subject|0|||
126509283|NCT01012817|455164462|FG010|Overall Study|Withdrawal by Subject|1|||
126509284|NCT01012817|455164463|FG011|Overall Study|Withdrawal by Subject|1|||
126509285|NCT01012817|455164464|FG012|Overall Study|Withdrawal by Subject|0|||
126509286|NCT01012817|455164465|FG013|Overall Study|Withdrawal by Subject|1|||
126509287|NCT01012817|455164452|FG000|Overall Study|Adverse Event|0|||
126509288|NCT01012817|455164453|FG001|Overall Study|Adverse Event|0|||
126509289|NCT01012817|455164454|FG002|Overall Study|Adverse Event|0|||
126509290|NCT01012817|455164455|FG003|Overall Study|Adverse Event|0|||
126509291|NCT01012817|455164456|FG004|Overall Study|Adverse Event|0|||
126509292|NCT01012817|455164457|FG005|Overall Study|Adverse Event|1|||
126509293|NCT01012817|455164458|FG006|Overall Study|Adverse Event|0|||
126509294|NCT01012817|455164459|FG007|Overall Study|Adverse Event|0|||
126509295|NCT01012817|455164460|FG008|Overall Study|Adverse Event|0|||
126509296|NCT01012817|455164461|FG009|Overall Study|Adverse Event|0|||
126509297|NCT01012817|455164462|FG010|Overall Study|Adverse Event|1|||
126509298|NCT01012817|455164463|FG011|Overall Study|Adverse Event|0|||
126509299|NCT01012817|455164464|FG012|Overall Study|Adverse Event|0|||
126509300|NCT01012817|455164465|FG013|Overall Study|Adverse Event|1|||
126509301|NCT03756558|455164466|FG000|Overall Study|Death|1|||
126509302|NCT03756558|455164466|FG000|Overall Study|Lost to Follow-up|2|||
126509303|NCT03756558|455164466|FG000|Overall Study|Withdrawal by Subject|2|||
126509304|NCT01433263|455164473|FG000|Overall Study|Adverse Event|3|||
126509305|NCT01433263|455164474|FG001|Overall Study|Adverse Event|1|||
126509306|NCT01433263|455164473|FG000|Overall Study|Death|5|||
126509307|NCT01433263|455164474|FG001|Overall Study|Death|3|||
126509308|NCT01433263|455164473|FG000|Overall Study|Lost to Follow-up|0|||
126509309|NCT01433263|455164474|FG001|Overall Study|Lost to Follow-up|1|||
126509310|NCT01433263|455164473|FG000|Overall Study|Protocol Deviation|1|||
126509311|NCT01433263|455164474|FG001|Overall Study|Protocol Deviation|0|||
126509312|NCT01433263|455164473|FG000|Overall Study|Withdrawal by Subject|10|||
126509313|NCT01433263|455164474|FG001|Overall Study|Withdrawal by Subject|7|||
126509314|NCT03107988|455164475|FG000|Overall Study|Adverse Event|0|||
126509315|NCT03107988|455164476|FG001|Overall Study|Adverse Event|0|||
126509316|NCT03107988|455164477|FG002|Overall Study|Adverse Event|0|||
126509317|NCT03107988|455164478|FG003|Overall Study|Adverse Event|1|||
126509318|NCT03107988|455164479|FG004|Overall Study|Adverse Event|0|||
126509319|NCT03107988|455164480|FG005|Overall Study|Adverse Event|1|||
126509320|NCT03107988|455164481|FG006|Overall Study|Adverse Event|0|||
126509321|NCT03107988|455164482|FG007|Overall Study|Adverse Event|1|||
126509322|NCT03107988|455164483|FG008|Overall Study|Adverse Event|0|||
126509323|NCT03107988|455164484|FG009|Overall Study|Adverse Event|0|||
126509324|NCT03107988|455164485|FG010|Overall Study|Adverse Event|0|||
126509325|NCT03107988|455164486|FG011|Overall Study|Adverse Event|0|||
126509326|NCT03107988|455164487|FG012|Overall Study|Adverse Event|0|||
126509327|NCT03107988|455164475|FG000|Overall Study|Disease Progression or Relapse|1|||
126509328|NCT03107988|455164476|FG001|Overall Study|Disease Progression or Relapse|2|||
126509329|NCT03107988|455164477|FG002|Overall Study|Disease Progression or Relapse|2|||
126509330|NCT03107988|455164478|FG003|Overall Study|Disease Progression or Relapse|5|||
126509331|NCT03107988|455164479|FG004|Overall Study|Disease Progression or Relapse|1|||
126509332|NCT03107988|455164480|FG005|Overall Study|Disease Progression or Relapse|1|||
126509333|NCT03107988|455164481|FG006|Overall Study|Disease Progression or Relapse|0|||
126509334|NCT03107988|455164482|FG007|Overall Study|Disease Progression or Relapse|0|||
126509335|NCT03107988|455164483|FG008|Overall Study|Disease Progression or Relapse|0|||
126509336|NCT03107988|455164484|FG009|Overall Study|Disease Progression or Relapse|1|||
126509337|NCT03107988|455164485|FG010|Overall Study|Disease Progression or Relapse|4|||
126509338|NCT03107988|455164486|FG011|Overall Study|Disease Progression or Relapse|0|||
126509339|NCT03107988|455164487|FG012|Overall Study|Disease Progression or Relapse|0|||
126509340|NCT03107988|455164475|FG000|Overall Study|Ineligible|0|||
126509341|NCT03107988|455164476|FG001|Overall Study|Ineligible|0|||
126509342|NCT03107988|455164477|FG002|Overall Study|Ineligible|0|||
126509343|NCT03107988|455164478|FG003|Overall Study|Ineligible|0|||
126509344|NCT03107988|455164479|FG004|Overall Study|Ineligible|0|||
126509345|NCT03107988|455164480|FG005|Overall Study|Ineligible|0|||
126509346|NCT03107988|455164481|FG006|Overall Study|Ineligible|0|||
126509347|NCT03107988|455164482|FG007|Overall Study|Ineligible|0|||
126509348|NCT03107988|455164483|FG008|Overall Study|Ineligible|1|||
126509349|NCT03107988|455164484|FG009|Overall Study|Ineligible|0|||
126509350|NCT03107988|455164485|FG010|Overall Study|Ineligible|0|||
126509351|NCT03107988|455164486|FG011|Overall Study|Ineligible|0|||
126509352|NCT03107988|455164487|FG012|Overall Study|Ineligible|0|||
126509353|NCT02489318|455164488|FG000|Randomized|Withdrawal by Subject|0|||
126509354|NCT02489318|455164489|FG001|Randomized|Withdrawal by Subject|1|||
126509355|NCT02489318|455164488|FG000|Treated|Adverse Event|19|||
126509356|NCT02489318|455164489|FG001|Treated|Adverse Event|62|||
126509357|NCT02489318|455164488|FG000|Treated|Death|13|||
126509358|NCT02489318|455164489|FG001|Treated|Death|11|||
126509359|NCT02489318|455164488|FG000|Treated|Physician Decision|4|||
126509360|NCT02489318|455164489|FG001|Treated|Physician Decision|6|||
126509361|NCT02489318|455164488|FG000|Treated|Protocol Violation|1|||
126509362|NCT02489318|455164489|FG001|Treated|Protocol Violation|2|||
126509363|NCT02489318|455164488|FG000|Treated|Withdrawal by Subject|37|||
126509364|NCT02489318|455164489|FG001|Treated|Withdrawal by Subject|36|||
126509365|NCT02489318|455164488|FG000|Treated|Other: Progressive Disease|245|||
126509366|NCT02489318|455164489|FG001|Treated|Other: Progressive Disease|138|||
126509367|NCT02489318|455164488|FG000|Treated|Other|0|||
126509368|NCT02489318|455164489|FG001|Treated|Other|2|||
126509369|NCT02489318|455164488|FG000|Treated|Ongoing|0|||
126509370|NCT02489318|455164489|FG001|Treated|Ongoing|267|||
126509371|NCT01171898|455164490|FG000|Overall Study|Death|0|||
126509372|NCT01171898|455164491|FG001|Overall Study|Death|0|||
126509373|NCT01171898|455164492|FG002|Overall Study|Death|2|||
126509374|NCT01171898|455164493|FG003|Overall Study|Death|0|||
126509375|NCT01171898|455164490|FG000|Overall Study|Lost to Follow-up|0|||
126509376|NCT01171898|455164491|FG001|Overall Study|Lost to Follow-up|1|||
126565576|NCT04771273|455364974|FG000|Maintenance Period|Burden of study procedures|1|||
126565577|NCT04771273|455364975|FG001|Maintenance Period|Burden of study procedures|0|||
126565578|NCT04771273|455364976|FG002|Maintenance Period|Burden of study procedures|0|||
126565579|NCT04771273|455364977|FG003|Maintenance Period|Burden of study procedures|0|||
126565580|NCT04771273|455364974|FG000|Maintenance Period|Change of residence|0|||
126565581|NCT04771273|455364975|FG001|Maintenance Period|Change of residence|1|||
126565582|NCT04771273|455364976|FG002|Maintenance Period|Change of residence|3|||
126509377|NCT01171898|455164492|FG002|Overall Study|Lost to Follow-up|1|||
126509378|NCT01171898|455164493|FG003|Overall Study|Lost to Follow-up|1|||
126509379|NCT01171898|455164490|FG000|Overall Study|Withdrawal by Subject|1|||
126509380|NCT01171898|455164491|FG001|Overall Study|Withdrawal by Subject|4|||
126509381|NCT01171898|455164492|FG002|Overall Study|Withdrawal by Subject|6|||
126565583|NCT04771273|455364977|FG003|Maintenance Period|Change of residence|0|||
126565584|NCT04771273|455364974|FG000|Maintenance Period|Perceived lack of efficacy|0|||
126509382|NCT01171898|455164493|FG003|Overall Study|Withdrawal by Subject|3|||
126509383|NCT01171898|455164490|FG000|Overall Study|Terminated by Sponsor|1|||
126509384|NCT01171898|455164491|FG001|Overall Study|Terminated by Sponsor|0|||
126509385|NCT01171898|455164492|FG002|Overall Study|Terminated by Sponsor|0|||
126509386|NCT01171898|455164493|FG003|Overall Study|Terminated by Sponsor|0|||
126509387|NCT01171898|455164490|FG000|Overall Study|Ongoing|1|||
126509388|NCT01171898|455164491|FG001|Overall Study|Ongoing|9|||
126509389|NCT01171898|455164492|FG002|Overall Study|Ongoing|3|||
126509390|NCT01171898|455164493|FG003|Overall Study|Ongoing|0|||
126509391|NCT01171898|455164490|FG000|Overall Study|Other|1|||
126509392|NCT01171898|455164491|FG001|Overall Study|Other|5|||
126509393|NCT01171898|455164492|FG002|Overall Study|Other|0|||
126509394|NCT01171898|455164493|FG003|Overall Study|Other|2|||
126509395|NCT00326612|455164494|FG000|Overall Study|They did not have a seizure requiring tx|129|||
126509396|NCT00326612|455164495|FG001|Overall Study|They did not have a seizure requiring tx|137|||
126509397|NCT00548808|455164497|FG000|Overall Study|Lost to Follow-up|9|||
126509398|NCT00548808|455164498|FG001|Overall Study|Lost to Follow-up|3|||
126509399|NCT00548808|455164497|FG000|Overall Study|Protocol Violation|8|||
126509400|NCT00548808|455164498|FG001|Overall Study|Protocol Violation|8|||
126509401|NCT00548808|455164497|FG000|Overall Study|Withdrawal by Subject|8|||
126509402|NCT00548808|455164498|FG001|Overall Study|Withdrawal by Subject|4|||
126509403|NCT00548808|455164497|FG000|Overall Study|Physician Decision|6|||
126509404|NCT00548808|455164498|FG001|Overall Study|Physician Decision|3|||
126509405|NCT00548808|455164497|FG000|Overall Study|Adverse Event|4|||
126509406|NCT00548808|455164498|FG001|Overall Study|Adverse Event|5|||
126509407|NCT00548808|455164497|FG000|Overall Study|Death|2|||
126509408|NCT00548808|455164498|FG001|Overall Study|Death|0|||
126509409|NCT00548808|455164497|FG000|Overall Study|Entry Criteria Not Met|2|||
126509410|NCT00548808|455164498|FG001|Overall Study|Entry Criteria Not Met|2|||
126509411|NCT00548808|455164497|FG000|Overall Study|Lack of Efficacy|2|||
126509412|NCT00548808|455164498|FG001|Overall Study|Lack of Efficacy|0|||
126509413|NCT00548808|455164497|FG000|Overall Study|Sponsor Decision|1|||
126509414|NCT00548808|455164498|FG001|Overall Study|Sponsor Decision|1|||
126509415|NCT00749775|455164499|FG000|Overall Study|Protocol Violation|24|||
126509416|NCT00749775|455164499|FG000|Overall Study|Lost to Follow-up|36|||
126509417|NCT00749775|455164499|FG000|Overall Study|No visit after first day of treatment|44|||
126509418|NCT00749775|455164499|FG000|Overall Study|No drug administration|3|||
126509419|NCT04537806|455164502|FG000|Overall Study|Randomized but not treated|1|||
126509420|NCT04537806|455164503|FG001|Overall Study|Randomized but not treated|0|||
126509421|NCT04537806|455164502|FG000|Overall Study|Adverse Event|1|||
126509422|NCT04537806|455164503|FG001|Overall Study|Adverse Event|1|||
126509423|NCT05459129|455164504|FG000|Overall Study|Death|1|||
126509424|NCT05459129|455164505|FG001|Overall Study|Death|0|||
126509425|NCT05459129|455164504|FG000|Overall Study|Study Terminated By Sponsor|5|||
126509426|NCT05459129|455164505|FG001|Overall Study|Study Terminated By Sponsor|6|||
126509427|NCT04530552|455164508|FG000|Overall Study|Physician Decision|0|||
126509428|NCT04530552|455164509|FG001|Overall Study|Physician Decision|1|||
126509429|NCT04530552|455164508|FG000|Overall Study|Withdrawal by Subject|0|||
126509430|NCT04530552|455164509|FG001|Overall Study|Withdrawal by Subject|1|||
126509431|NCT04530552|455164508|FG000|Overall Study|Adverse Event|0|||
126509432|NCT04530552|455164509|FG001|Overall Study|Adverse Event|1|||
126509433|NCT04530552|455164508|FG000|Overall Study|No surgery|0|||
126509434|NCT04530552|455164509|FG001|Overall Study|No surgery|1|||
126509435|NCT06034496|455164510|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
126509436|NCT06034496|455164511|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
126509437|NCT06034496|455164510|FG000|Overall Study|Withdrawal by Subject|5|||
126509438|NCT06034496|455164511|FG001|Overall Study|Withdrawal by Subject|4|||
126509439|NCT04397263|455164512|FG000|Overall Study|Withdrawal by Subject|2|||
126509440|NCT03277261|455164515|FG000|Overall Study|Adverse Event|17|||
126509441|NCT03277261|455164516|FG001|Overall Study|Adverse Event|1|||
126509442|NCT03277261|455164515|FG000|Overall Study|Participant Withdrawal of Consent|6|||
126509443|NCT03277261|455164516|FG001|Overall Study|Participant Withdrawal of Consent|15|||
126509444|NCT03277261|455164515|FG000|Overall Study|Investigator / Sponsor Decision|4|||
126509445|NCT03277261|455164516|FG001|Overall Study|Investigator / Sponsor Decision|2|||
126509446|NCT03277261|455164515|FG000|Overall Study|Pregnancy|2|||
126509447|NCT03277261|455164516|FG001|Overall Study|Pregnancy|0|||
126509448|NCT03277261|455164515|FG000|Overall Study|Lost to Follow-up|2|||
126509449|NCT03277261|455164516|FG001|Overall Study|Lost to Follow-up|2|||
126509450|NCT03277261|455164515|FG000|Overall Study|Lack of Efficacy|2|||
126509451|NCT03277261|455164516|FG001|Overall Study|Lack of Efficacy|2|||
126509452|NCT03277261|455164515|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
126509453|NCT03277261|455164516|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
126509454|NCT00499603|455164520|FG000|Overall Study|Adverse Event|0|||
126509455|NCT00499603|455164521|FG001|Overall Study|Adverse Event|1|||
126509456|NCT05132127|455164522|FG000|Overall Study|Adverse Event|1|||
126509457|NCT02703636|455164523|FG000|Overall Study|Adverse Event|14|||
126509458|NCT02703636|455164523|FG000|Overall Study|Study stopped by sponsor|1|||
126509459|NCT02703636|455164523|FG000|Overall Study|Withdrawal by Subject|1|||
126509460|NCT00393939|455164524|FG000|Overall Study|Protocol Violation|1|||
126509461|NCT00393939|455164525|FG001|Overall Study|Protocol Violation|1|||
126509462|NCT00393939|455164524|FG000|Overall Study|Lost to Follow-up|2|||
126509463|NCT00393939|455164525|FG001|Overall Study|Lost to Follow-up|4|||
126509464|NCT00393939|455164524|FG000|Overall Study|Death|10|||
126509465|NCT00393939|455164525|FG001|Overall Study|Death|4|||
126509466|NCT00393939|455164524|FG000|Overall Study|Sponsor|5|||
126509467|NCT00393939|455164525|FG001|Overall Study|Sponsor|13|||
126509468|NCT00393939|455164524|FG000|Overall Study|Objective progression or relapse|239|||
126509469|NCT00393939|455164525|FG001|Overall Study|Objective progression or relapse|223|||
126509470|NCT00393939|455164524|FG000|Overall Study|Withdrawal by Subject|2|||
126509471|NCT00393939|455164525|FG001|Overall Study|Withdrawal by Subject|7|||
126509472|NCT00393939|455164524|FG000|Overall Study|Other|37|||
126509473|NCT00393939|455164525|FG001|Overall Study|Other|45|||
126509474|NCT00006184|455164526|FG000|Overall Study|Death|1|||
126509475|NCT00006184|455164527|FG001|Overall Study|Death|0|||
126509476|NCT02161718|455164528|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
126509477|NCT02161718|455164529|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
126509478|NCT02161718|455164530|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
126509479|NCT02161718|455164528|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
126509480|NCT02161718|455164529|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
126509481|NCT02161718|455164530|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
126509482|NCT02161718|455164528|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
126509483|NCT02161718|455164529|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
126509484|NCT02161718|455164530|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
126509485|NCT02161718|455164528|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
126509486|NCT02161718|455164529|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
126509487|NCT02161718|455164530|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
126509488|NCT02161718|455164528|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
126509489|NCT02161718|455164529|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
126509490|NCT02161718|455164530|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
126509491|NCT02161718|455164528|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
126509492|NCT02161718|455164529|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
126509493|NCT02161718|455164530|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
126509494|NCT02161718|455164528|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
126509495|NCT02161718|455164529|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
126509496|NCT02161718|455164530|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
126509497|NCT02161718|455164528|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
126509498|NCT02161718|455164529|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
126509499|NCT02161718|455164530|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
126509500|NCT02161718|455164528|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
126509501|NCT02161718|455164529|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
126509502|NCT02161718|455164530|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
126509503|NCT02161718|455164528|FG000|Post- Randomization Period|Lost to Follow-up|0|||
126509504|NCT02161718|455164529|FG001|Post- Randomization Period|Lost to Follow-up|9|||
126509505|NCT02161718|455164530|FG002|Post- Randomization Period|Lost to Follow-up|15|||
126509506|NCT02161718|455164528|FG000|Post- Randomization Period|Adverse Event|0|||
126509507|NCT02161718|455164529|FG001|Post- Randomization Period|Adverse Event|9|||
126509508|NCT02161718|455164530|FG002|Post- Randomization Period|Adverse Event|10|||
126509509|NCT02161718|455164528|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
126509510|NCT02161718|455164529|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
126509511|NCT02161718|455164530|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
126509512|NCT02161718|455164528|FG000|Post- Randomization Period|Physician Decision|0|||
126509513|NCT02161718|455164529|FG001|Post- Randomization Period|Physician Decision|2|||
126509514|NCT02161718|455164530|FG002|Post- Randomization Period|Physician Decision|4|||
126509515|NCT02161718|455164528|FG000|Post- Randomization Period|Protocol Violation|0|||
126509516|NCT02161718|455164529|FG001|Post- Randomization Period|Protocol Violation|2|||
126509517|NCT02161718|455164530|FG002|Post- Randomization Period|Protocol Violation|3|||
126509518|NCT02161718|455164528|FG000|Post- Randomization Period|Lack of Efficacy|0|||
126509519|NCT02161718|455164529|FG001|Post- Randomization Period|Lack of Efficacy|0|||
126509520|NCT02161718|455164530|FG002|Post- Randomization Period|Lack of Efficacy|1|||
126509521|NCT02161718|455164528|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
126509522|NCT02161718|455164529|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
126509523|NCT02161718|455164530|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
126509524|NCT02161718|455164528|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
126509525|NCT02161718|455164529|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
126509526|NCT02161718|455164530|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
126509527|NCT02161718|455164528|FG000|Post- Randomization Period|Relocation|0|||
126509528|NCT02161718|455164529|FG001|Post- Randomization Period|Relocation|3|||
126509529|NCT02161718|455164530|FG002|Post- Randomization Period|Relocation|0|||
126509530|NCT04181827|455164533|FG000|Overall Study|Ongoing|124|||
126509531|NCT04181827|455164534|FG001|Overall Study|Ongoing|157|||
126509532|NCT04181827|455164533|FG000|Overall Study|Death|82|||
126509533|NCT04181827|455164534|FG001|Overall Study|Death|50|||
126509534|NCT04181827|455164533|FG000|Overall Study|Lost to Follow-up|0|||
126509535|NCT04181827|455164534|FG001|Overall Study|Lost to Follow-up|1|||
126509536|NCT04181827|455164533|FG000|Overall Study|Withdrawal by Subject|5|||
126509537|NCT04181827|455164534|FG001|Overall Study|Withdrawal by Subject|0|||
126509538|NCT01857063|455164535|FG000|Period 1 (7 Days)|Adverse Event|0|||
126509539|NCT01857063|455164536|FG001|Period 1 (7 Days)|Adverse Event|1|||
126509540|NCT01857063|455164535|FG000|Period 1 (7 Days)|Physician Decision|1|||
126509541|NCT01857063|455164536|FG001|Period 1 (7 Days)|Physician Decision|0|||
126509542|NCT01857063|455164535|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
126509543|NCT01857063|455164536|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
126509544|NCT01857063|455164535|FG000|Period 2 (7 Days)|Adverse Event|2|||
126509545|NCT01857063|455164536|FG001|Period 2 (7 Days)|Adverse Event|1|||
126509546|NCT01857063|455164535|FG000|Period 2 (7 Days)|Physician Decision|1|||
126509547|NCT01857063|455164536|FG001|Period 2 (7 Days)|Physician Decision|1|||
126509548|NCT01857063|455164535|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
126509549|NCT01857063|455164536|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
126509550|NCT01256710|455164539|FG000|Overall Study|Death|449|||
126509551|NCT01256710|455164539|FG000|Overall Study|System Explant|67|||
126509552|NCT01256710|455164539|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
126509553|NCT01256710|455164539|FG000|Overall Study|Lost to Follow-up|67|||
126509554|NCT01256710|455164539|FG000|Overall Study|Withdrawal by Subject|29|||
126509555|NCT01256710|455164539|FG000|Overall Study|Physician Decision|9|||
126509556|NCT01256710|455164539|FG000|Overall Study|Subject Noncompliance|2|||
126509557|NCT01256710|455164539|FG000|Overall Study|Study Terminated by Sponsor|273|||
126509558|NCT04115358|455164540|FG000|Overall Study|exfoliation|0|||
126509559|NCT04115358|455164541|FG001|Overall Study|exfoliation|0|||
126509560|NCT04115358|455164542|FG002|Overall Study|exfoliation|1|||
126509561|NCT01205165|455164543|FG000|Overall Study|Lost to Follow-up|2|||
126509562|NCT02942017|455164546|FG000|Overall Study|Adverse Event|0|||
126509563|NCT02942017|455164547|FG001|Overall Study|Adverse Event|1|||
126509564|NCT02942017|455164546|FG000|Overall Study|Withdrawal by Subject|0|||
126509565|NCT02942017|455164547|FG001|Overall Study|Withdrawal by Subject|1|||
126509566|NCT02942017|455164546|FG000|Overall Study|Lost to Follow-up|1|||
126509567|NCT02942017|455164547|FG001|Overall Study|Lost to Follow-up|1|||
126509568|NCT02942017|455164546|FG000|Overall Study|Randomized but not dosed|1|||
126509569|NCT02942017|455164547|FG001|Overall Study|Randomized but not dosed|3|||
126509570|NCT02115282|455164548|FG000|Overall Study|Disease progression during treatment|216|||
126509571|NCT02115282|455164549|FG001|Overall Study|Disease progression during treatment|229|||
126509572|NCT02115282|455164548|FG000|Overall Study|Adverse Event|49|||
126509573|NCT02115282|455164549|FG001|Overall Study|Adverse Event|23|||
126509574|NCT02115282|455164548|FG000|Overall Study|Death|1|||
126509575|NCT02115282|455164549|FG001|Overall Study|Death|3|||
126509576|NCT02115282|455164548|FG000|Overall Study|Alternative therapy|1|||
126509577|NCT02115282|455164549|FG001|Overall Study|Alternative therapy|1|||
126509578|NCT02115282|455164548|FG000|Overall Study|Complicating disease|0|||
126509579|NCT02115282|455164549|FG001|Overall Study|Complicating disease|3|||
126509580|NCT02115282|455164548|FG000|Overall Study|Withdrawal by Subject|12|||
126509581|NCT02115282|455164549|FG001|Overall Study|Withdrawal by Subject|10|||
126509582|NCT02115282|455164548|FG000|Overall Study|Symptomatic progression/deterioration|7|||
126509583|NCT02115282|455164549|FG001|Overall Study|Symptomatic progression/deterioration|18|||
126509584|NCT02115282|455164548|FG000|Overall Study|Non-compliance|5|||
126509585|NCT02115282|455164549|FG001|Overall Study|Non-compliance|1|||
126509586|NCT02115282|455164548|FG000|Overall Study|Protocol Violation|2|||
126509587|NCT02115282|455164549|FG001|Overall Study|Protocol Violation|2|||
126509588|NCT02115282|455164548|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
126509589|NCT02115282|455164549|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
126509590|NCT02115282|455164548|FG000|Overall Study|Not start protocol therapy|9|||
126509591|NCT02115282|455164549|FG001|Overall Study|Not start protocol therapy|10|||
126509592|NCT00458484|455164552|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
126509593|NCT00458484|455164553|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
126509594|NCT00458484|455164554|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
126509595|NCT00458484|455164555|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
126509596|NCT00458484|455164556|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
126509597|NCT00458484|455164557|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
126509598|NCT00458484|455164558|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
126509599|NCT04538664|455164559|FG000|Overall Study|Withdrawal by Subject|5|||
126509600|NCT04538664|455164560|FG001|Overall Study|Withdrawal by Subject|9|||
126509601|NCT04538664|455164559|FG000|Overall Study|Lost to Follow-up|2|||
126509602|NCT04538664|455164560|FG001|Overall Study|Lost to Follow-up|1|||
126509603|NCT04538664|455164559|FG000|Overall Study|Ongoing|106|||
126509604|NCT04538664|455164560|FG001|Overall Study|Ongoing|115|||
126509605|NCT00480779|455164561|FG000|Overall Study|Other|2|||
126509606|NCT00480779|455164562|FG001|Overall Study|Other|0|||
126509607|NCT00480779|455164561|FG000|Overall Study|Job and Health-related|0|||
126509608|NCT00480779|455164562|FG001|Overall Study|Job and Health-related|3|||
126509609|NCT04907032|455164563|FG000|Overall Study|Withdrawal by Subject|7|||
126509610|NCT04907032|455164564|FG001|Overall Study|Withdrawal by Subject|1|||
126509611|NCT02167256|455164565|FG000|Overall Study|Adverse Event|13|||
126509612|NCT02167256|455164566|FG001|Overall Study|Adverse Event|6|||
126509613|NCT02167256|455164565|FG000|Overall Study|Withdrawal by Subject|4|||
126509614|NCT02167256|455164566|FG001|Overall Study|Withdrawal by Subject|4|||
126509615|NCT02167256|455164565|FG000|Overall Study|non-compliance|3|||
126509616|NCT02167256|455164566|FG001|Overall Study|non-compliance|0|||
126509617|NCT02167256|455164565|FG000|Overall Study|Study partner unable to participate|1|||
126509618|NCT02167256|455164566|FG001|Overall Study|Study partner unable to participate|0|||
126509619|NCT03431350|455164567|FG000|Overall Study|ONGOING|0|||
126509620|NCT03431350|455164568|FG001|Overall Study|ONGOING|0|||
126509621|NCT03431350|455164569|FG002|Overall Study|ONGOING|2|||
126509622|NCT03431350|455164570|FG003|Overall Study|ONGOING|0|||
126509623|NCT03431350|455164571|FG004|Overall Study|ONGOING|1|||
126509624|NCT03431350|455164572|FG005|Overall Study|ONGOING|3|||
126509625|NCT03431350|455164573|FG006|Overall Study|ONGOING|0|||
126509626|NCT03431350|455164574|FG007|Overall Study|ONGOING|1|||
126509627|NCT03431350|455164575|FG008|Overall Study|ONGOING|3|||
126509628|NCT03431350|455164576|FG009|Overall Study|ONGOING|4|||
126509629|NCT03431350|455164577|FG010|Overall Study|ONGOING|2|||
126509630|NCT03431350|455164578|FG011|Overall Study|ONGOING|1|||
126509631|NCT03431350|455164567|FG000|Overall Study|Death|6|||
126509632|NCT03431350|455164568|FG001|Overall Study|Death|5|||
126509633|NCT03431350|455164569|FG002|Overall Study|Death|18|||
126509634|NCT03431350|455164570|FG003|Overall Study|Death|7|||
126509635|NCT03431350|455164571|FG004|Overall Study|Death|4|||
126509636|NCT03431350|455164572|FG005|Overall Study|Death|3|||
126509637|NCT03431350|455164573|FG006|Overall Study|Death|2|||
126509638|NCT03431350|455164574|FG007|Overall Study|Death|0|||
126509639|NCT03431350|455164575|FG008|Overall Study|Death|0|||
126509640|NCT03431350|455164576|FG009|Overall Study|Death|0|||
126509641|NCT03431350|455164577|FG010|Overall Study|Death|4|||
126509642|NCT03431350|455164578|FG011|Overall Study|Death|0|||
126509643|NCT03431350|455164567|FG000|Overall Study|Lost to Follow-up|0|||
126509644|NCT03431350|455164568|FG001|Overall Study|Lost to Follow-up|1|||
126509645|NCT03431350|455164569|FG002|Overall Study|Lost to Follow-up|0|||
126509646|NCT03431350|455164570|FG003|Overall Study|Lost to Follow-up|0|||
126509647|NCT03431350|455164571|FG004|Overall Study|Lost to Follow-up|0|||
126509648|NCT03431350|455164572|FG005|Overall Study|Lost to Follow-up|0|||
126509649|NCT03431350|455164573|FG006|Overall Study|Lost to Follow-up|0|||
126509650|NCT03431350|455164574|FG007|Overall Study|Lost to Follow-up|0|||
126509651|NCT03431350|455164575|FG008|Overall Study|Lost to Follow-up|0|||
126509652|NCT03431350|455164576|FG009|Overall Study|Lost to Follow-up|0|||
126509653|NCT03431350|455164577|FG010|Overall Study|Lost to Follow-up|0|||
126509654|NCT03431350|455164578|FG011|Overall Study|Lost to Follow-up|0|||
126509655|NCT03431350|455164567|FG000|Overall Study|Withdrawal by Subject|0|||
126509656|NCT03431350|455164568|FG001|Overall Study|Withdrawal by Subject|0|||
126509657|NCT03431350|455164569|FG002|Overall Study|Withdrawal by Subject|0|||
126509658|NCT03431350|455164570|FG003|Overall Study|Withdrawal by Subject|1|||
126509659|NCT03431350|455164571|FG004|Overall Study|Withdrawal by Subject|1|||
126509660|NCT03431350|455164572|FG005|Overall Study|Withdrawal by Subject|1|||
126509661|NCT03431350|455164573|FG006|Overall Study|Withdrawal by Subject|0|||
126509662|NCT03431350|455164574|FG007|Overall Study|Withdrawal by Subject|0|||
126509663|NCT03431350|455164575|FG008|Overall Study|Withdrawal by Subject|0|||
126509664|NCT03431350|455164576|FG009|Overall Study|Withdrawal by Subject|2|||
126509665|NCT03431350|455164577|FG010|Overall Study|Withdrawal by Subject|0|||
126509666|NCT03431350|455164578|FG011|Overall Study|Withdrawal by Subject|1|||
126509667|NCT03431350|455164567|FG000|Overall Study|Other|0|||
126509668|NCT03431350|455164568|FG001|Overall Study|Other|0|||
126509669|NCT03431350|455164569|FG002|Overall Study|Other|1|||
126509670|NCT03431350|455164570|FG003|Overall Study|Other|3|||
126509671|NCT03431350|455164571|FG004|Overall Study|Other|2|||
126509672|NCT03431350|455164572|FG005|Overall Study|Other|2|||
126509673|NCT03431350|455164573|FG006|Overall Study|Other|4|||
126509674|NCT03431350|455164574|FG007|Overall Study|Other|0|||
126509675|NCT03431350|455164575|FG008|Overall Study|Other|14|||
126509676|NCT03431350|455164576|FG009|Overall Study|Other|11|||
126509677|NCT03431350|455164577|FG010|Overall Study|Other|11|||
126509678|NCT03431350|455164578|FG011|Overall Study|Other|15|||
126509679|NCT01723228|455164579|FG000|Overall Study|Adverse Event|2|||
126509680|NCT01723228|455164580|FG001|Overall Study|Adverse Event|6|||
126509681|NCT01723228|455164579|FG000|Overall Study|Withdrawal by Subject|2|||
126509682|NCT01723228|455164580|FG001|Overall Study|Withdrawal by Subject|1|||
126509683|NCT01723228|455164579|FG000|Overall Study|Protocol Violation|0|||
126509684|NCT01723228|455164580|FG001|Overall Study|Protocol Violation|2|||
126509685|NCT01723228|455164579|FG000|Overall Study|Lost to Follow-up|2|||
126509686|NCT01723228|455164580|FG001|Overall Study|Lost to Follow-up|1|||
126509687|NCT01723228|455164579|FG000|Overall Study|Other|2|||
126509688|NCT01723228|455164580|FG001|Overall Study|Other|1|||
126509689|NCT00218543|455164581|FG000|Overall Study|Lost to Follow-up|8|||
126509690|NCT00218543|455164581|FG000|Overall Study|relocated|1|||
126509691|NCT00218543|455164581|FG000|Overall Study|Withdrawal by Subject|1|||
126509692|NCT00218543|455164581|FG000|Overall Study|Physician Decision|3|||
126509693|NCT00218543|455164581|FG000|Overall Study|Adverse Event|2|||
126509694|NCT02448875|455164582|FG000|Overall Study|Adverse Event|2|||
126509695|NCT02448875|455164583|FG001|Overall Study|Adverse Event|1|||
126509696|NCT02448875|455164584|FG002|Overall Study|Adverse Event|0|||
126509697|NCT02448875|455164582|FG000|Overall Study|Lost to Follow-up|1|||
126509698|NCT02448875|455164583|FG001|Overall Study|Lost to Follow-up|0|||
126565585|NCT04771273|455364975|FG001|Maintenance Period|Perceived lack of efficacy|0|||
126565586|NCT04771273|455364976|FG002|Maintenance Period|Perceived lack of efficacy|0|||
126509699|NCT02448875|455164584|FG002|Overall Study|Lost to Follow-up|0|||
126509700|NCT02448875|455164582|FG000|Overall Study|Investigator Decision|3|||
126509701|NCT02448875|455164583|FG001|Overall Study|Investigator Decision|0|||
126509702|NCT02448875|455164584|FG002|Overall Study|Investigator Decision|1|||
126509703|NCT02448875|455164582|FG000|Overall Study|Withdrawal by Subject|1|||
126509704|NCT02448875|455164583|FG001|Overall Study|Withdrawal by Subject|0|||
126509705|NCT02448875|455164584|FG002|Overall Study|Withdrawal by Subject|0|||
126509706|NCT01864291|455164585|FG000|Overall Study|need for revision surgery|2|||
126509707|NCT01451424|455164587|FG000|Overall Study|Withdrawal by Subject|1|||
126509708|NCT01451424|455164588|FG001|Overall Study|Withdrawal by Subject|1|||
126509709|NCT01451424|455164589|FG002|Overall Study|Withdrawal by Subject|0|||
126509710|NCT01451424|455164590|FG003|Overall Study|Withdrawal by Subject|2|||
126509711|NCT01451424|455164587|FG000|Overall Study|Lost to Follow-up|0|||
126509712|NCT01451424|455164588|FG001|Overall Study|Lost to Follow-up|1|||
126509713|NCT01451424|455164589|FG002|Overall Study|Lost to Follow-up|0|||
126509714|NCT01451424|455164590|FG003|Overall Study|Lost to Follow-up|1|||
126509715|NCT01451424|455164587|FG000|Overall Study|Physician Decision|0|||
126509716|NCT01451424|455164588|FG001|Overall Study|Physician Decision|0|||
126509717|NCT01451424|455164589|FG002|Overall Study|Physician Decision|1|||
126509718|NCT01451424|455164590|FG003|Overall Study|Physician Decision|1|||
126509719|NCT01451424|455164587|FG000|Overall Study|Adverse Event|0|||
126509720|NCT01451424|455164588|FG001|Overall Study|Adverse Event|0|||
126509721|NCT01451424|455164589|FG002|Overall Study|Adverse Event|0|||
126509722|NCT01451424|455164590|FG003|Overall Study|Adverse Event|1|||
126509723|NCT00689481|455164592|FG000|Overall Study|Adverse Event|7|||
126509724|NCT00689481|455164593|FG001|Overall Study|Adverse Event|1|||
126509725|NCT00689481|455164592|FG000|Overall Study|Lost to Follow-up|4|||
126509726|NCT00689481|455164593|FG001|Overall Study|Lost to Follow-up|3|||
126509727|NCT00689481|455164592|FG000|Overall Study|Lack of Efficacy|4|||
126509728|NCT00689481|455164593|FG001|Overall Study|Lack of Efficacy|3|||
126509729|NCT00689481|455164592|FG000|Overall Study|Non-compliance with study treatment|1|||
126509730|NCT00689481|455164593|FG001|Overall Study|Non-compliance with study treatment|1|||
126509731|NCT00689481|455164592|FG000|Overall Study|Withdrawal by Subject|8|||
126509732|NCT00689481|455164593|FG001|Overall Study|Withdrawal by Subject|4|||
126509733|NCT00689481|455164592|FG000|Overall Study|Excluded medication started during study|0|||
126509734|NCT00689481|455164593|FG001|Overall Study|Excluded medication started during study|1|||
126509735|NCT00689481|455164592|FG000|Overall Study|Subject early term, left on vacation|0|||
126509736|NCT00689481|455164593|FG001|Overall Study|Subject early term, left on vacation|1|||
126509737|NCT06425458|455164594|FG000|Overall Study|Removed by study team|2|||
126509738|NCT06425458|455164594|FG000|Overall Study|Lost to Follow-up|5|||
126509739|NCT04466891|455164595|FG000|Overall Study|Death|60|||
126509740|NCT04466891|455164596|FG001|Overall Study|Death|6|||
126509741|NCT04466891|455164595|FG000|Overall Study|Withdrawal by Subject|8|||
126509742|NCT04466891|455164596|FG001|Overall Study|Withdrawal by Subject|1|||
126509743|NCT04466891|455164595|FG000|Overall Study|Study terminated by sponsor|5|||
126509744|NCT04466891|455164596|FG001|Overall Study|Study terminated by sponsor|0|||
126509745|NCT04466891|455164595|FG000|Overall Study|Lost to Follow-up|2|||
126509746|NCT04466891|455164596|FG001|Overall Study|Lost to Follow-up|0|||
126509747|NCT04466891|455164595|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
126509748|NCT04466891|455164596|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
126509749|NCT00445328|455164597|FG000|Overall Study|Death|0|||
126509750|NCT00445328|455164598|FG001|Overall Study|Death|1|||
126509751|NCT00445328|455164597|FG000|Overall Study|Adverse Event|0|||
126509752|NCT00445328|455164598|FG001|Overall Study|Adverse Event|3|||
126509753|NCT00445328|455164597|FG000|Overall Study|Other|0|||
126509754|NCT00445328|455164598|FG001|Overall Study|Other|2|||
126509755|NCT00445328|455164597|FG000|Overall Study|Withdrawal by Subject|2|||
126509756|NCT00445328|455164598|FG001|Overall Study|Withdrawal by Subject|0|||
126509757|NCT00445328|455164597|FG000|Overall Study|Protocol Violation|1|||
126509758|NCT00445328|455164598|FG001|Overall Study|Protocol Violation|0|||
126509759|NCT02254278|455164599|FG000|Overall Study|Protocol Violation|1|||
126509760|NCT02254278|455164600|FG001|Overall Study|Protocol Violation|1|||
126509761|NCT00316199|455164603|FG000|Overall Study|Adverse Event|2|||
126509762|NCT00316199|455164603|FG000|Overall Study|Death|8|||
126509763|NCT00316199|455164603|FG000|Overall Study|Lost to Follow-up|2|||
126509764|NCT00590954|455164604|FG000|Overall Study|Inevaluable|2|||
126509765|NCT02782949|455164606|FG000|Overall Study|Protocol Violation|1|||
126509766|NCT02782949|455164607|FG001|Overall Study|Protocol Violation|0|||
126509767|NCT02782949|455164606|FG000|Overall Study|Withdrawal by Subject|0|||
126509768|NCT02782949|455164607|FG001|Overall Study|Withdrawal by Subject|1|||
126509769|NCT03890367|455164608|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126509770|NCT03890367|455164609|FG001|Overall Study|Withdrawal by parent/guardian|3|||
126509771|NCT03890367|455164610|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126509772|NCT03890367|455164608|FG000|Overall Study|Protocol deviation|2|||
126509773|NCT03890367|455164609|FG001|Overall Study|Protocol deviation|2|||
126509774|NCT03890367|455164610|FG002|Overall Study|Protocol deviation|1|||
126509775|NCT03890367|455164608|FG000|Overall Study|Lost to Follow-up|1|||
126509776|NCT03890367|455164609|FG001|Overall Study|Lost to Follow-up|1|||
126509777|NCT03890367|455164610|FG002|Overall Study|Lost to Follow-up|0|||
126509778|NCT03370341|455165863|FG000|Overall Study|Lost to Follow-up|0|||
126509779|NCT03370341|455165864|FG001|Overall Study|Lost to Follow-up|1|||
126509780|NCT01707004|455165865|FG000|Overall Study|Physician Decision|3|||
126509781|NCT04368429|455165866|FG000|Overall Study|Adverse Event|1|||
126509782|NCT04368429|455165867|FG001|Overall Study|Adverse Event|0|||
126509783|NCT02143414|455165868|FG000|Induction|Adverse Event|1|||
126509784|NCT02143414|455165869|FG001|Induction|Adverse Event|2|||
126509785|NCT02143414|455165868|FG000|Induction|Death|1|||
126509786|NCT02143414|455165869|FG001|Induction|Death|2|||
126509787|NCT02143414|455165868|FG000|Induction|Patient refusal|1|||
126509788|NCT02143414|455165869|FG001|Induction|Patient refusal|1|||
126509789|NCT02143414|455165868|FG000|Induction|Refractory|1|||
126509790|NCT02143414|455165869|FG001|Induction|Refractory|0|||
126509791|NCT02143414|455165868|FG000|Induction|Began alternative treatment|1|||
126509792|NCT02143414|455165869|FG001|Induction|Began alternative treatment|0|||
126509793|NCT02143414|455165868|FG000|Induction|Ineligible for postremission|5|||
126509794|NCT02143414|455165869|FG001|Induction|Ineligible for postremission|1|||
126509795|NCT02143414|455165868|FG000|Post-remission|Adverse Event|0|||
126509796|NCT02143414|455165869|FG001|Post-remission|Adverse Event|2|||
126509797|NCT02143414|455165868|FG000|Post-remission|Disease progression/relapse|5|||
126509798|NCT02143414|455165869|FG001|Post-remission|Disease progression/relapse|0|||
126509799|NCT02143414|455165868|FG000|Maintenance|Adverse Event|4|||
126509800|NCT02143414|455165869|FG001|Maintenance|Adverse Event|6|||
126509801|NCT02143414|455165868|FG000|Maintenance|Disease progression/relapse|3|||
126509802|NCT02143414|455165869|FG001|Maintenance|Disease progression/relapse|2|||
126509803|NCT02143414|455165868|FG000|Maintenance|Patient refusal|2|||
126509804|NCT02143414|455165869|FG001|Maintenance|Patient refusal|1|||
126509805|NCT02143414|455165868|FG000|Maintenance|Physician Decision|1|||
126509806|NCT02143414|455165869|FG001|Maintenance|Physician Decision|0|||
126509807|NCT02143414|455165868|FG000|Maintenance|Death|0|||
126509808|NCT02143414|455165869|FG001|Maintenance|Death|1|||
126509809|NCT02143414|455165868|FG000|Maintenance|On protocol treatment|0|||
126509810|NCT02143414|455165869|FG001|Maintenance|On protocol treatment|6|||
126509811|NCT00679341|455165871|FG000|Overall Study|Disease progression|42|||
126509812|NCT00679341|455165872|FG001|Overall Study|Disease progression|36|||
126509813|NCT00679341|455165871|FG000|Overall Study|Adverse Event|5|||
126509814|NCT00679341|455165872|FG001|Overall Study|Adverse Event|6|||
126509815|NCT00679341|455165871|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
126509816|NCT00679341|455165872|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
126509817|NCT00679341|455165871|FG000|Overall Study|Death|1|||
126509818|NCT00679341|455165872|FG001|Overall Study|Death|1|||
126509819|NCT00679341|455165871|FG000|Overall Study|Other|1|||
126509820|NCT00679341|455165872|FG001|Overall Study|Other|0|||
126509821|NCT00679341|455165871|FG000|Overall Study|Physician Decision|1|||
126509822|NCT00679341|455165872|FG001|Overall Study|Physician Decision|0|||
126509823|NCT00679341|455165871|FG000|Overall Study|Not treated|0|||
126509824|NCT00679341|455165872|FG001|Overall Study|Not treated|2|||
126509825|NCT00679341|455165871|FG000|Overall Study|Physician/patient decision to withdraw|0|||
126509826|NCT00679341|455165872|FG001|Overall Study|Physician/patient decision to withdraw|6|||
126509827|NCT01700179|455165873|FG000|Overall Study|Physician Decision|2|||
126509828|NCT02365597|455165876|FG000|Overall Study|Lost to Follow-up|0|||
126509829|NCT02365597|455165877|FG001|Overall Study|Lost to Follow-up|1|||
126509830|NCT02365597|455165878|FG002|Overall Study|Lost to Follow-up|0|||
126509831|NCT02365597|455165879|FG003|Overall Study|Lost to Follow-up|1|||
126509832|NCT02365597|455165876|FG000|Overall Study|Withdrawal by Subject|1|||
126509833|NCT02365597|455165877|FG001|Overall Study|Withdrawal by Subject|8|||
126509834|NCT02365597|455165878|FG002|Overall Study|Withdrawal by Subject|5|||
126509835|NCT02365597|455165879|FG003|Overall Study|Withdrawal by Subject|1|||
126509836|NCT02365597|455165876|FG000|Overall Study|Sponsor's decision|1|||
126509837|NCT02365597|455165877|FG001|Overall Study|Sponsor's decision|3|||
126509838|NCT02365597|455165878|FG002|Overall Study|Sponsor's decision|13|||
126509839|NCT02365597|455165879|FG003|Overall Study|Sponsor's decision|0|||
126509840|NCT02365597|455165876|FG000|Overall Study|Other|0|||
126509841|NCT02365597|455165877|FG001|Overall Study|Other|4|||
126509842|NCT02365597|455165878|FG002|Overall Study|Other|0|||
126509843|NCT02365597|455165879|FG003|Overall Study|Other|0|||
126509844|NCT02365597|455165876|FG000|Overall Study|Enrolled but not treated|0|||
126509845|NCT02365597|455165877|FG001|Overall Study|Enrolled but not treated|1|||
126509846|NCT02365597|455165878|FG002|Overall Study|Enrolled but not treated|1|||
126509847|NCT02365597|455165879|FG003|Overall Study|Enrolled but not treated|0|||
126509848|NCT02365597|455165876|FG000|Overall Study|Ongoing|0|||
126509849|NCT02365597|455165877|FG001|Overall Study|Ongoing|0|||
126509850|NCT02365597|455165878|FG002|Overall Study|Ongoing|0|||
126509851|NCT02365597|455165879|FG003|Overall Study|Ongoing|17|||
126509852|NCT01552226|455165880|FG000|Overall Study|Withdrawal by Subject|4|||
126509853|NCT01552226|455165881|FG001|Overall Study|Withdrawal by Subject|4|||
126509854|NCT04697628|455165882|FG000|Overall Study|Withdrawal by Subject|17|||
126509855|NCT04697628|455165883|FG001|Overall Study|Withdrawal by Subject|23|||
126509856|NCT04697628|455165882|FG000|Overall Study|Lost to Follow-up|0|||
126509857|NCT04697628|455165883|FG001|Overall Study|Lost to Follow-up|4|||
126509858|NCT04697628|455165882|FG000|Overall Study|On-going in study|122|||
126509859|NCT04697628|455165883|FG001|Overall Study|On-going in study|91|||
126509860|NCT01946204|455165884|FG000|Overall Study|Death|38|||
126509861|NCT01946204|455165885|FG001|Overall Study|Death|59|||
126509862|NCT01946204|455165884|FG000|Overall Study|Withdrawal by Subject|37|||
126509863|NCT01946204|455165885|FG001|Overall Study|Withdrawal by Subject|50|||
126509864|NCT01946204|455165884|FG000|Overall Study|Lost to Follow-up|3|||
126509865|NCT01946204|455165885|FG001|Overall Study|Lost to Follow-up|7|||
126509866|NCT01946204|455165884|FG000|Overall Study|Ongoing|316|||
126509867|NCT01946204|455165885|FG001|Overall Study|Ongoing|687|||
126509868|NCT01946204|455165884|FG000|Overall Study|Other|7|||
126509869|NCT01946204|455165885|FG001|Overall Study|Other|3|||
126509870|NCT03466411|455165886|FG000|Overall Study|Lost to Follow-up|0|||
126509871|NCT03466411|455165887|FG001|Overall Study|Lost to Follow-up|1|||
126509872|NCT03466411|455165888|FG002|Overall Study|Lost to Follow-up|1|||
126509873|NCT03466411|455165889|FG003|Overall Study|Lost to Follow-up|0|||
126509874|NCT03466411|455165890|FG004|Overall Study|Lost to Follow-up|0|||
126509875|NCT03466411|455165891|FG005|Overall Study|Lost to Follow-up|0|||
126509876|NCT03466411|455165892|FG006|Overall Study|Lost to Follow-up|1|||
126509877|NCT03466411|455165893|FG007|Overall Study|Lost to Follow-up|1|||
126509878|NCT03466411|455165894|FG008|Overall Study|Lost to Follow-up|0|||
126509879|NCT03466411|455165895|FG009|Overall Study|Lost to Follow-up|1|||
126509880|NCT03466411|455165896|FG010|Overall Study|Lost to Follow-up|1|||
126509881|NCT03466411|455165897|FG011|Overall Study|Lost to Follow-up|1|||
126509882|NCT03466411|455165898|FG012|Overall Study|Lost to Follow-up|0|||
126509883|NCT03466411|455165886|FG000|Overall Study|Withdrawal by Subject|14|||
126509884|NCT03466411|455165887|FG001|Overall Study|Withdrawal by Subject|7|||
126509885|NCT03466411|455165888|FG002|Overall Study|Withdrawal by Subject|8|||
126509886|NCT03466411|455165889|FG003|Overall Study|Withdrawal by Subject|4|||
126509887|NCT03466411|455165890|FG004|Overall Study|Withdrawal by Subject|6|||
126509888|NCT03466411|455165891|FG005|Overall Study|Withdrawal by Subject|3|||
126509889|NCT03466411|455165892|FG006|Overall Study|Withdrawal by Subject|6|||
126509890|NCT03466411|455165893|FG007|Overall Study|Withdrawal by Subject|9|||
126509891|NCT03466411|455165894|FG008|Overall Study|Withdrawal by Subject|6|||
126509892|NCT03466411|455165895|FG009|Overall Study|Withdrawal by Subject|11|||
126509893|NCT03466411|455165896|FG010|Overall Study|Withdrawal by Subject|14|||
126509894|NCT03466411|455165897|FG011|Overall Study|Withdrawal by Subject|12|||
126509895|NCT03466411|455165898|FG012|Overall Study|Withdrawal by Subject|7|||
126509896|NCT03466411|455165886|FG000|Overall Study|Other|1|||
126509897|NCT03466411|455165887|FG001|Overall Study|Other|1|||
126509898|NCT03466411|455165888|FG002|Overall Study|Other|0|||
126509899|NCT03466411|455165889|FG003|Overall Study|Other|1|||
126509900|NCT03466411|455165890|FG004|Overall Study|Other|2|||
126509901|NCT03466411|455165891|FG005|Overall Study|Other|0|||
126565587|NCT04771273|455364977|FG003|Maintenance Period|Perceived lack of efficacy|1|||
126565588|NCT04771273|455364974|FG000|Maintenance Period|Adverse Event|4|||
126565589|NCT04771273|455364975|FG001|Maintenance Period|Adverse Event|5|||
126565590|NCT04771273|455364976|FG002|Maintenance Period|Adverse Event|5|||
126565591|NCT04771273|455364977|FG003|Maintenance Period|Adverse Event|0|||
126565592|NCT04776213|455364978|FG000|Overall Study|Other|1|||
126565593|NCT04776213|455364978|FG000|Overall Study|Withdrawal by Subject|7|||
126565594|NCT04776213|455364978|FG000|Overall Study|Protocol Violation|1|||
126565595|NCT04776213|455364978|FG000|Overall Study|Lost to Follow-up|2|||
126565596|NCT02163915|455364979|FG000|Overall Study|Withdrawal by Subject|2|||
126565597|NCT02163915|455364980|FG001|Overall Study|Withdrawal by Subject|0|||
126565598|NCT02163915|455364981|FG002|Overall Study|Withdrawal by Subject|2|||
126509902|NCT03466411|455165892|FG006|Overall Study|Other|0|||
126509903|NCT03466411|455165893|FG007|Overall Study|Other|0|||
126509904|NCT03466411|455165894|FG008|Overall Study|Other|0|||
126509905|NCT03466411|455165895|FG009|Overall Study|Other|1|||
126509906|NCT03466411|455165896|FG010|Overall Study|Other|2|||
126509907|NCT03466411|455165897|FG011|Overall Study|Other|0|||
126509908|NCT03466411|455165898|FG012|Overall Study|Other|0|||
126509909|NCT03466411|455165886|FG000|Overall Study|Randomized but not Treated|0|||
126509910|NCT03466411|455165887|FG001|Overall Study|Randomized but not Treated|0|||
126509911|NCT03466411|455165888|FG002|Overall Study|Randomized but not Treated|0|||
126509912|NCT03466411|455165889|FG003|Overall Study|Randomized but not Treated|0|||
126509913|NCT03466411|455165890|FG004|Overall Study|Randomized but not Treated|0|||
126509914|NCT03466411|455165891|FG005|Overall Study|Randomized but not Treated|0|||
126509915|NCT03466411|455165892|FG006|Overall Study|Randomized but not Treated|1|||
126509916|NCT03466411|455165893|FG007|Overall Study|Randomized but not Treated|0|||
126509917|NCT03466411|455165894|FG008|Overall Study|Randomized but not Treated|0|||
126509918|NCT03466411|455165895|FG009|Overall Study|Randomized but not Treated|0|||
126509919|NCT03466411|455165896|FG010|Overall Study|Randomized but not Treated|0|||
126509920|NCT03466411|455165897|FG011|Overall Study|Randomized but not Treated|0|||
126509921|NCT03466411|455165898|FG012|Overall Study|Randomized but not Treated|0|||
126509922|NCT03778931|455165899|FG000|Overall Study|Withdrawal by Subject|12|||
126509923|NCT03778931|455165900|FG001|Overall Study|Withdrawal by Subject|25|||
126509924|NCT03778931|455165899|FG000|Overall Study|Physician Decision|1|||
126509925|NCT03778931|455165900|FG001|Overall Study|Physician Decision|3|||
126509926|NCT03778931|455165899|FG000|Overall Study|Participant Noncompliance|1|||
126509927|NCT03778931|455165900|FG001|Overall Study|Participant Noncompliance|1|||
126509928|NCT03778931|455165899|FG000|Overall Study|Lost to Follow-up|4|||
126565599|NCT02163915|455364982|FG003|Overall Study|Withdrawal by Subject|2|||
126565600|NCT02163915|455364983|FG004|Overall Study|Withdrawal by Subject|2|||
126565601|NCT02163915|455364979|FG000|Overall Study|Study termination|1|||
126509929|NCT03778931|455165900|FG001|Overall Study|Lost to Follow-up|1|||
126509930|NCT03778931|455165899|FG000|Overall Study|Death|69|||
126509931|NCT03778931|455165900|FG001|Overall Study|Death|79|||
126509932|NCT03306264|455165905|FG000|Overall Study|Death|33|||
126509933|NCT03306264|455165906|FG001|Overall Study|Death|25|||
126509934|NCT03306264|455165907|FG002|Overall Study|Death|34|||
126509935|NCT03306264|455165908|FG003|Overall Study|Death|34|||
126509936|NCT03306264|455165905|FG000|Overall Study|Complete Consent Withdrawal|4|||
126509937|NCT03306264|455165906|FG001|Overall Study|Complete Consent Withdrawal|4|||
126509938|NCT03306264|455165907|FG002|Overall Study|Complete Consent Withdrawal|1|||
126509939|NCT03306264|455165908|FG003|Overall Study|Complete Consent Withdrawal|8|||
126509940|NCT03306264|455165905|FG000|Overall Study|Lost to Follow-up|1|||
126509941|NCT03306264|455165906|FG001|Overall Study|Lost to Follow-up|0|||
126509942|NCT03306264|455165907|FG002|Overall Study|Lost to Follow-up|1|||
126509943|NCT03306264|455165908|FG003|Overall Study|Lost to Follow-up|0|||
126509944|NCT03306264|455165905|FG000|Overall Study|Rollover to ASTX727-06|10|||
126509945|NCT03306264|455165906|FG001|Overall Study|Rollover to ASTX727-06|18|||
126509946|NCT03306264|455165907|FG002|Overall Study|Rollover to ASTX727-06|4|||
126509947|NCT03306264|455165908|FG003|Overall Study|Rollover to ASTX727-06|2|||
126509948|NCT03306264|455165905|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
126509949|NCT03306264|455165906|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
126509950|NCT03306264|455165907|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
126509951|NCT03306264|455165908|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
126509952|NCT02257736|455165919|FG000|Overall Study|Progressive disease|365|||
126509953|NCT02257736|455165920|FG001|Overall Study|Progressive disease|327|||
126509954|NCT02257736|455165919|FG000|Overall Study|Adverse Event|45|||
126509955|NCT02257736|455165920|FG001|Overall Study|Adverse Event|56|||
126509956|NCT02257736|455165919|FG000|Overall Study|Withdrawal by Subject|21|||
126509957|NCT02257736|455165920|FG001|Overall Study|Withdrawal by Subject|38|||
126509958|NCT02257736|455165919|FG000|Overall Study|Death|11|||
126509959|NCT02257736|455165920|FG001|Overall Study|Death|6|||
126509960|NCT02257736|455165919|FG000|Overall Study|Physician Decision|5|||
126509961|NCT02257736|455165920|FG001|Overall Study|Physician Decision|9|||
126509962|NCT02257736|455165919|FG000|Overall Study|Non-Compliance with study drug|1|||
126509963|NCT02257736|455165920|FG001|Overall Study|Non-Compliance with study drug|2|||
126509964|NCT02257736|455165919|FG000|Overall Study|Protocol Violation|1|||
126509965|NCT02257736|455165920|FG001|Overall Study|Protocol Violation|0|||
126509966|NCT02257736|455165919|FG000|Overall Study|Other|1|||
126509967|NCT02257736|455165920|FG001|Overall Study|Other|7|||
126509968|NCT02257736|455165919|FG000|Overall Study|Randomized, not treated|1|||
126509969|NCT02257736|455165920|FG001|Overall Study|Randomized, not treated|2|||
126509970|NCT04136912|455165921|FG000|Overall Study|Operational reasons|0|||
126509971|NCT04136912|455165922|FG001|Overall Study|Operational reasons|0|||
126509972|NCT04136912|455165923|FG002|Overall Study|Operational reasons|2|||
126509973|NCT00308711|455165924|FG000|Overall Study|Withdrawal by Subject|1|||
126509974|NCT00308711|455165925|FG001|Overall Study|Withdrawal by Subject|0|||
126509975|NCT00308711|455165926|FG002|Overall Study|Withdrawal by Subject|1|||
126509976|NCT00308711|455165924|FG000|Overall Study|Protocol Violation|0|||
126509977|NCT00308711|455165925|FG001|Overall Study|Protocol Violation|1|||
126509978|NCT00308711|455165926|FG002|Overall Study|Protocol Violation|1|||
126509979|NCT00308711|455165924|FG000|Overall Study|Lost to Follow-up|0|||
126509980|NCT00308711|455165925|FG001|Overall Study|Lost to Follow-up|1|||
126509981|NCT00308711|455165926|FG002|Overall Study|Lost to Follow-up|0|||
126509982|NCT00308711|455165924|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
126509983|NCT00308711|455165925|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
126509984|NCT00308711|455165926|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
126509985|NCT00308711|455165924|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
126509986|NCT00308711|455165925|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
126509987|NCT00308711|455165926|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
126509988|NCT01420081|455165927|FG000|Overall Study|Death|1|||
126509989|NCT01420081|455165928|FG001|Overall Study|Death|0|||
126509990|NCT01420081|455165929|FG002|Overall Study|Death|8|||
126509991|NCT01420081|455165930|FG003|Overall Study|Death|0|||
126565602|NCT02163915|455364980|FG001|Overall Study|Study termination|0|||
126565603|NCT02163915|455364981|FG002|Overall Study|Study termination|0|||
126509992|NCT01420081|455165931|FG004|Overall Study|Death|7|||
126509993|NCT01420081|455165932|FG005|Overall Study|Death|12|||
126509994|NCT01420081|455165933|FG006|Overall Study|Death|0|||
126509995|NCT01420081|455165934|FG007|Overall Study|Death|1|||
126509996|NCT01420081|455165935|FG008|Overall Study|Death|1|||
126509997|NCT01420081|455165927|FG000|Overall Study|Lost to Follow-up|0|||
126509998|NCT01420081|455165928|FG001|Overall Study|Lost to Follow-up|0|||
126509999|NCT01420081|455165929|FG002|Overall Study|Lost to Follow-up|0|||
126510000|NCT01420081|455165930|FG003|Overall Study|Lost to Follow-up|0|||
126510001|NCT01420081|455165931|FG004|Overall Study|Lost to Follow-up|1|||
126510002|NCT01420081|455165932|FG005|Overall Study|Lost to Follow-up|1|||
126510003|NCT01420081|455165933|FG006|Overall Study|Lost to Follow-up|0|||
126510004|NCT01420081|455165934|FG007|Overall Study|Lost to Follow-up|0|||
126565604|NCT02163915|455364982|FG003|Overall Study|Study termination|0|||
126565605|NCT02163915|455364983|FG004|Overall Study|Study termination|2|||
126565606|NCT02163915|455364979|FG000|Overall Study|Physician Decision|0|||
126565607|NCT02163915|455364980|FG001|Overall Study|Physician Decision|0|||
126565608|NCT02163915|455364981|FG002|Overall Study|Physician Decision|0|||
126565609|NCT02163915|455364982|FG003|Overall Study|Physician Decision|1|||
126565610|NCT02163915|455364983|FG004|Overall Study|Physician Decision|0|||
126565611|NCT02013037|455364985|FG000|Overall Study|Death|6|||
126565612|NCT02013037|455364985|FG000|Overall Study|Withdrawal by Subject|1|||
126565613|NCT02013037|455364985|FG000|Overall Study|Awaiting Transplantation|7|||
126565614|NCT02013037|455364985|FG000|Overall Study|Transplanted without DSA|2|||
126565615|NCT02465359|455364986|FG000|Overall Study|Lack of Efficacy|1|||
126565616|NCT02465359|455364986|FG000|Overall Study|Withdrawal by Subject|1|||
126565617|NCT02465359|455364986|FG000|Overall Study|Adverse Event|1|||
126565618|NCT01244828|455364987|FG000|Overall Study|Adverse Event|37|||
126565619|NCT01244828|455364987|FG000|Overall Study|Withdrawal by Subject|31|||
126565620|NCT01244828|455364987|FG000|Overall Study|Lack of Efficacy|7|||
126565621|NCT01244828|455364987|FG000|Overall Study|Lost to Follow-up|2|||
126565622|NCT01244828|455364987|FG000|Overall Study|Other reason (not specified)|1|||
126565623|NCT01838200|455364988|FG000|Overall Study|Adverse Event|0|||
126565624|NCT01838200|455364989|FG001|Overall Study|Adverse Event|2|||
126565625|NCT01838200|455364988|FG000|Overall Study|Progressive disease|3|||
126565626|NCT01838200|455364989|FG001|Overall Study|Progressive disease|0|||
126565627|NCT03895034|455366543|FG000|Overall Study|Lost to Follow-up|2|||
126565628|NCT00739102|455366548|FG000|Overall Study|Death|5|||
126565629|NCT00739102|455366548|FG000|Overall Study|Withdrawal by Subject|10|||
126565630|NCT01091454|455366549|FG000|Overall Study|Ineligible|1|||
126565631|NCT03837028|455366552|FG000|Overall Study|Lost to Follow-up|4|||
126565632|NCT03837028|455366553|FG001|Overall Study|Lost to Follow-up|0|||
126565633|NCT03837028|455366554|FG002|Overall Study|Lost to Follow-up|2|||
126565634|NCT03837028|455366555|FG003|Overall Study|Lost to Follow-up|0|||
126565635|NCT03837028|455366552|FG000|Overall Study|Withdrawal by Subject|12|||
126565636|NCT03837028|455366553|FG001|Overall Study|Withdrawal by Subject|11|||
126565637|NCT03837028|455366554|FG002|Overall Study|Withdrawal by Subject|11|||
126565638|NCT03837028|455366555|FG003|Overall Study|Withdrawal by Subject|7|||
126565639|NCT00646451|455366556|FG000|Overall Study|Adverse Event|3|||
126565640|NCT00646451|455366557|FG001|Overall Study|Adverse Event|0|||
126565641|NCT00646451|455366556|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
126565642|NCT00646451|455366557|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
126565643|NCT03784963|455366558|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
126565644|NCT03784963|455366559|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
126565645|NCT03784963|455366560|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
126565646|NCT03784963|455366561|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
126565647|NCT03179787|455366562|FG000|Overall Study|Lost to Follow-up|15|||
126565648|NCT03179787|455366562|FG000|Overall Study|Case report failures|2|||
126565649|NCT03179787|455366562|FG000|Overall Study|Treatment not administered|1|||
126565650|NCT01510912|455366563|FG000|Overall Study|Adverse Event|99|||
126565651|NCT01510912|455366563|FG000|Overall Study|Lack of Efficacy|12|||
126565652|NCT01510912|455366563|FG000|Overall Study|Non-compliance with trial drug|23|||
126565653|NCT01510912|455366563|FG000|Overall Study|Withdrawal by Subject|49|||
126565654|NCT01510912|455366563|FG000|Overall Study|Physician Decision|1|||
126565655|NCT01510912|455366563|FG000|Overall Study|Protocol Violation|27|||
126565656|NCT01510912|455366563|FG000|Overall Study|Lost to Follow-up|26|||
126565657|NCT01510912|455366563|FG000|Overall Study|Other, including joint replacement|5|||
126565658|NCT01362491|455366564|FG000|Overall Study|Ineligible|1|||
126565659|NCT01362491|455366565|FG001|Overall Study|Ineligible|0|||
126565660|NCT01362491|455366566|FG002|Overall Study|Ineligible|0|||
126565661|NCT01257503|455366567|FG000|Overall Study|Lost to Follow-up|7|||
126565662|NCT01257503|455366568|FG001|Overall Study|Lost to Follow-up|10|||
126565663|NCT01257503|455366567|FG000|Overall Study|Over 5 years old at enrollment|0|||
126565664|NCT01257503|455366568|FG001|Overall Study|Over 5 years old at enrollment|1|||
126565665|NCT01257503|455366567|FG000|Overall Study|strep culture positive at enrollment|1|||
126565666|NCT01257503|455366568|FG001|Overall Study|strep culture positive at enrollment|0|||
126565667|NCT01090024|455366569|FG000|Period 1|Met exclusion criteria|0|||
126565668|NCT01090024|455366570|FG001|Period 1|Met exclusion criteria|0|||
126565669|NCT01090024|455366571|FG002|Period 1|Met exclusion criteria|0|||
126565670|NCT01090024|455366572|FG003|Period 1|Met exclusion criteria|0|||
126565671|NCT01090024|455366573|FG004|Period 1|Met exclusion criteria|0|||
126565672|NCT01090024|455366574|FG005|Period 1|Met exclusion criteria|0|||
126565673|NCT01090024|455366575|FG006|Period 1|Met exclusion criteria|0|||
126565674|NCT01090024|455366576|FG007|Period 1|Met exclusion criteria|0|||
126565675|NCT01090024|455366577|FG008|Period 1|Met exclusion criteria|0|||
126565676|NCT01090024|455366578|FG009|Period 1|Met exclusion criteria|0|||
126565677|NCT01090024|455366579|FG010|Period 1|Met exclusion criteria|0|||
126565678|NCT01090024|455366580|FG011|Period 1|Met exclusion criteria|0|||
126565679|NCT01090024|455366581|FG012|Period 1|Met exclusion criteria|0|||
126565680|NCT01090024|455366582|FG013|Period 1|Met exclusion criteria|0|||
126565681|NCT01090024|455366583|FG014|Period 1|Met exclusion criteria|1|||
126565682|NCT01090024|455366584|FG015|Period 1|Met exclusion criteria|0|||
126565683|NCT01090024|455366585|FG016|Period 1|Met exclusion criteria|0|||
126565684|NCT01090024|455366586|FG017|Period 1|Met exclusion criteria|0|||
126565685|NCT01090024|455366569|FG000|Period 1|Adverse Event|0|||
126565686|NCT01090024|455366570|FG001|Period 1|Adverse Event|0|||
126565687|NCT01090024|455366571|FG002|Period 1|Adverse Event|0|||
126565688|NCT01090024|455366572|FG003|Period 1|Adverse Event|0|||
126565689|NCT01090024|455366573|FG004|Period 1|Adverse Event|0|||
126565690|NCT01090024|455366574|FG005|Period 1|Adverse Event|0|||
126565691|NCT01090024|455366575|FG006|Period 1|Adverse Event|0|||
126565692|NCT01090024|455366576|FG007|Period 1|Adverse Event|0|||
126565693|NCT01090024|455366577|FG008|Period 1|Adverse Event|0|||
126565694|NCT01090024|455366578|FG009|Period 1|Adverse Event|1|||
126565695|NCT01090024|455366579|FG010|Period 1|Adverse Event|0|||
126565696|NCT01090024|455366580|FG011|Period 1|Adverse Event|1|||
126565697|NCT01090024|455366581|FG012|Period 1|Adverse Event|0|||
126565698|NCT01090024|455366582|FG013|Period 1|Adverse Event|0|||
126565699|NCT01090024|455366583|FG014|Period 1|Adverse Event|0|||
126565700|NCT01090024|455366584|FG015|Period 1|Adverse Event|0|||
126565701|NCT01090024|455366585|FG016|Period 1|Adverse Event|0|||
126565702|NCT01090024|455366586|FG017|Period 1|Adverse Event|1|||
126565703|NCT01090024|455366569|FG000|Period 1|Withdrawal by Subject|0|||
126565704|NCT01090024|455366570|FG001|Period 1|Withdrawal by Subject|0|||
126565705|NCT01090024|455366571|FG002|Period 1|Withdrawal by Subject|0|||
126565706|NCT01090024|455366572|FG003|Period 1|Withdrawal by Subject|1|||
126565707|NCT01090024|455366573|FG004|Period 1|Withdrawal by Subject|0|||
126565708|NCT01090024|455366574|FG005|Period 1|Withdrawal by Subject|0|||
126565709|NCT01090024|455366575|FG006|Period 1|Withdrawal by Subject|0|||
126565710|NCT01090024|455366576|FG007|Period 1|Withdrawal by Subject|0|||
126565711|NCT01090024|455366577|FG008|Period 1|Withdrawal by Subject|0|||
126565712|NCT01090024|455366578|FG009|Period 1|Withdrawal by Subject|0|||
126565713|NCT01090024|455366579|FG010|Period 1|Withdrawal by Subject|0|||
126565714|NCT01090024|455366580|FG011|Period 1|Withdrawal by Subject|0|||
126565715|NCT01090024|455366581|FG012|Period 1|Withdrawal by Subject|0|||
126510005|NCT01420081|455165935|FG008|Overall Study|Lost to Follow-up|0|||
126510006|NCT01420081|455165927|FG000|Overall Study|Study Terminated by Sponsor|2|||
126510007|NCT01420081|455165928|FG001|Overall Study|Study Terminated by Sponsor|1|||
126510008|NCT01420081|455165929|FG002|Overall Study|Study Terminated by Sponsor|1|||
126510009|NCT01420081|455165930|FG003|Overall Study|Study Terminated by Sponsor|3|||
126510010|NCT01420081|455165931|FG004|Overall Study|Study Terminated by Sponsor|11|||
126510011|NCT01420081|455165932|FG005|Overall Study|Study Terminated by Sponsor|7|||
126510012|NCT01420081|455165933|FG006|Overall Study|Study Terminated by Sponsor|3|||
126510013|NCT01420081|455165934|FG007|Overall Study|Study Terminated by Sponsor|2|||
126510014|NCT01420081|455165935|FG008|Overall Study|Study Terminated by Sponsor|2|||
126510015|NCT01420081|455165927|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
126510016|NCT01420081|455165928|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
126510017|NCT01420081|455165929|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
126510018|NCT01420081|455165930|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
126510019|NCT01420081|455165931|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
126510020|NCT01420081|455165932|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
126510021|NCT01420081|455165933|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
126510022|NCT01420081|455165934|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
126510023|NCT01420081|455165935|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
126510024|NCT01420081|455165927|FG000|Overall Study|Other Reasons|0|||
126510025|NCT01420081|455165928|FG001|Overall Study|Other Reasons|0|||
126510026|NCT01420081|455165929|FG002|Overall Study|Other Reasons|1|||
126510027|NCT01420081|455165930|FG003|Overall Study|Other Reasons|0|||
126510028|NCT01420081|455165931|FG004|Overall Study|Other Reasons|0|||
126510029|NCT01420081|455165932|FG005|Overall Study|Other Reasons|0|||
126565716|NCT01090024|455366582|FG013|Period 1|Withdrawal by Subject|0|||
126565717|NCT01090024|455366583|FG014|Period 1|Withdrawal by Subject|0|||
126565718|NCT01090024|455366584|FG015|Period 1|Withdrawal by Subject|0|||
126565719|NCT01090024|455366585|FG016|Period 1|Withdrawal by Subject|0|||
126565720|NCT01090024|455366586|FG017|Period 1|Withdrawal by Subject|0|||
126565721|NCT01090024|455366569|FG000|Period 1|Lost to Follow-up|0|||
126565722|NCT01090024|455366570|FG001|Period 1|Lost to Follow-up|1|||
126510030|NCT01420081|455165933|FG006|Overall Study|Other Reasons|0|||
126510031|NCT01420081|455165934|FG007|Overall Study|Other Reasons|0|||
126510032|NCT01420081|455165935|FG008|Overall Study|Other Reasons|0|||
126510033|NCT00414388|455165938|FG000|Overall Study|Adverse Event|1|||
126510034|NCT03591575|455165940|FG000|Overall Study|Adverse Event|2|||
126510035|NCT03591575|455165941|FG001|Overall Study|Adverse Event|0|||
126510036|NCT03591575|455165940|FG000|Overall Study|Withdrawal by Subject|4|||
126510037|NCT03591575|455165941|FG001|Overall Study|Withdrawal by Subject|1|||
126510038|NCT00528528|455165943|FG000|Overall Study|Lost to Follow-up|0|||
126510039|NCT00528528|455165944|FG001|Overall Study|Lost to Follow-up|0|||
126510040|NCT00528528|455165945|FG002|Overall Study|Lost to Follow-up|1|||
126510041|NCT00528528|455165946|FG003|Overall Study|Lost to Follow-up|1|||
126510042|NCT00528528|455165943|FG000|Overall Study|Ineligible to continue the trial|0|||
126510043|NCT00528528|455165944|FG001|Overall Study|Ineligible to continue the trial|0|||
126510044|NCT00528528|455165945|FG002|Overall Study|Ineligible to continue the trial|0|||
126510045|NCT00528528|455165946|FG003|Overall Study|Ineligible to continue the trial|1|||
126510046|NCT00528528|455165943|FG000|Overall Study|Other|0|||
126510047|NCT00528528|455165944|FG001|Overall Study|Other|1|||
126510048|NCT00528528|455165945|FG002|Overall Study|Other|0|||
126510049|NCT00528528|455165946|FG003|Overall Study|Other|0|||
126510050|NCT00528528|455165943|FG000|Overall Study|Withdrawal by Subject|3|||
126510051|NCT00528528|455165944|FG001|Overall Study|Withdrawal by Subject|2|||
126510052|NCT00528528|455165945|FG002|Overall Study|Withdrawal by Subject|1|||
126510053|NCT00528528|455165946|FG003|Overall Study|Withdrawal by Subject|1|||
126510054|NCT00528528|455165943|FG000|Overall Study|Ongoing participant|0|||
126510055|NCT00528528|455165944|FG001|Overall Study|Ongoing participant|0|||
126510056|NCT00528528|455165945|FG002|Overall Study|Ongoing participant|1|||
126510057|NCT00528528|455165946|FG003|Overall Study|Ongoing participant|0|||
126510058|NCT04325828|455165947|FG000|Overall Study|Ongoing|26|||
126510059|NCT04602624|455165952|FG000|Overall Study|Protocol Deviation|1|||
126510060|NCT04602624|455165952|FG000|Overall Study|Withdrawal by Participant|1|||
126510061|NCT04084769|455165953|FG000|Overall Study|Protocol Violation|1|||
126510062|NCT04084769|455165954|FG001|Overall Study|Protocol Violation|3|||
126510063|NCT04084769|455165955|FG002|Overall Study|Protocol Violation|0|||
126510064|NCT04084769|455165956|FG003|Overall Study|Protocol Violation|1|||
126510065|NCT04084769|455165953|FG000|Overall Study|Withdrawal by Subject|0|||
126510066|NCT04084769|455165954|FG001|Overall Study|Withdrawal by Subject|1|||
126510067|NCT04084769|455165955|FG002|Overall Study|Withdrawal by Subject|0|||
126510068|NCT04084769|455165956|FG003|Overall Study|Withdrawal by Subject|0|||
126510069|NCT04084769|455165953|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126510070|NCT04084769|455165954|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126510071|NCT04084769|455165955|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126510072|NCT04084769|455165956|FG003|Overall Study|Withdrawal by parent/guardian|1|||
126510073|NCT04084769|455165953|FG000|Overall Study|Lost to Follow-up|2|||
126510074|NCT04084769|455165954|FG001|Overall Study|Lost to Follow-up|0|||
126510075|NCT04084769|455165955|FG002|Overall Study|Lost to Follow-up|0|||
126510076|NCT04084769|455165956|FG003|Overall Study|Lost to Follow-up|0|||
126510077|NCT03390504|455165957|FG000|Overall Study|Lost to Follow-up|2|||
126510078|NCT03390504|455165958|FG001|Overall Study|Lost to Follow-up|4|||
126510079|NCT03390504|455165959|FG002|Overall Study|Lost to Follow-up|0|||
126510080|NCT03390504|455165960|FG003|Overall Study|Lost to Follow-up|1|||
126510081|NCT03390504|455165957|FG000|Overall Study|Withdrawal by Subject|3|||
126510082|NCT03390504|455165958|FG001|Overall Study|Withdrawal by Subject|15|||
126510083|NCT03390504|455165959|FG002|Overall Study|Withdrawal by Subject|5|||
126510084|NCT03390504|455165960|FG003|Overall Study|Withdrawal by Subject|2|||
126510085|NCT03390504|455165957|FG000|Overall Study|Other|1|||
126510086|NCT03390504|455165958|FG001|Overall Study|Other|2|||
126510087|NCT03390504|455165959|FG002|Overall Study|Other|2|||
126510088|NCT03390504|455165960|FG003|Overall Study|Other|6|||
126510089|NCT03492177|455165961|FG000|Overall Study|Adverse Event|1|||
126510090|NCT03492177|455165962|FG001|Overall Study|Adverse Event|0|||
126510091|NCT03492177|455165963|FG002|Overall Study|Adverse Event|0|||
126510092|NCT03492177|455165961|FG000|Overall Study|Death|3|||
126510093|NCT03492177|455165962|FG001|Overall Study|Death|0|||
126510094|NCT03492177|455165963|FG002|Overall Study|Death|3|||
126510095|NCT03492177|455165961|FG000|Overall Study|Lack of Efficacy|1|||
126510096|NCT03492177|455165962|FG001|Overall Study|Lack of Efficacy|2|||
126510097|NCT03492177|455165963|FG002|Overall Study|Lack of Efficacy|0|||
126510098|NCT03492177|455165961|FG000|Overall Study|Other|1|||
126510099|NCT03492177|455165962|FG001|Overall Study|Other|0|||
126510100|NCT03492177|455165963|FG002|Overall Study|Other|0|||
126510101|NCT03492177|455165961|FG000|Overall Study|Ongoing|16|||
126510102|NCT03492177|455165962|FG001|Overall Study|Ongoing|19|||
126510103|NCT03492177|455165963|FG002|Overall Study|Ongoing|17|||
126510104|NCT03508219|455165964|FG000|Overall Study|Death|2|||
126510105|NCT03508219|455165964|FG000|Overall Study|Withdrawal by Subject|1|||
126510106|NCT03508219|455165964|FG000|Overall Study|Lost to Follow-up|4|||
126510107|NCT03508219|455165964|FG000|Overall Study|Missed visit|2|||
126510108|NCT03945981|455165967|FG000|Overall Study|Lost to Follow-up|12|||
126510109|NCT03945981|455165967|FG000|Overall Study|Physician Decision|4|||
126510110|NCT03945981|455165967|FG000|Overall Study|Withdrawal by Subject|6|||
126510111|NCT03945981|455165967|FG000|Overall Study|Protocol Violation|1|||
126510112|NCT03665038|455165968|FG000|Overall Study|Lost to Follow-up|0|||
126565723|NCT01090024|455366571|FG002|Period 1|Lost to Follow-up|0|||
126510113|NCT03665038|455165969|FG001|Overall Study|Lost to Follow-up|0|||
126510114|NCT03665038|455165970|FG002|Overall Study|Lost to Follow-up|1|||
126510115|NCT04579679|455165971|FG000|Overall Study|New Antitumor Therapy|6|||
126510116|NCT04579679|455165972|FG001|Overall Study|New Antitumor Therapy|4|||
126510117|NCT04579679|455165973|FG002|Overall Study|New Antitumor Therapy|7|||
126510118|NCT04579679|455165974|FG003|Overall Study|New Antitumor Therapy|0|||
126510119|NCT04579679|455165971|FG000|Overall Study|Withdrawal of Consent|1|||
126510120|NCT04579679|455165972|FG001|Overall Study|Withdrawal of Consent|1|||
126510121|NCT04579679|455165973|FG002|Overall Study|Withdrawal of Consent|2|||
126510122|NCT04579679|455165974|FG003|Overall Study|Withdrawal of Consent|4|||
126510123|NCT04579679|455165971|FG000|Overall Study|Death|2|||
126510124|NCT04579679|455165972|FG001|Overall Study|Death|2|||
126510125|NCT04579679|455165973|FG002|Overall Study|Death|2|||
126510126|NCT04579679|455165974|FG003|Overall Study|Death|0|||
126510127|NCT04579679|455165971|FG000|Overall Study|Adverse Event|0|||
126510128|NCT04579679|455165972|FG001|Overall Study|Adverse Event|4|||
126510129|NCT04579679|455165973|FG002|Overall Study|Adverse Event|0|||
126510130|NCT04579679|455165974|FG003|Overall Study|Adverse Event|0|||
126510131|NCT04579679|455165971|FG000|Overall Study|Disease Progression|9|||
126510132|NCT04579679|455165972|FG001|Overall Study|Disease Progression|13|||
126510133|NCT04579679|455165973|FG002|Overall Study|Disease Progression|7|||
126510134|NCT04579679|455165974|FG003|Overall Study|Disease Progression|0|||
126510135|NCT04579679|455165971|FG000|Overall Study|Physician Decision|0|||
126510136|NCT04579679|455165972|FG001|Overall Study|Physician Decision|0|||
126510137|NCT04579679|455165973|FG002|Overall Study|Physician Decision|1|||
126510138|NCT04579679|455165974|FG003|Overall Study|Physician Decision|0|||
126510139|NCT04579679|455165971|FG000|Overall Study|Study Terminated by Sponsor|2|||
126510140|NCT04579679|455165972|FG001|Overall Study|Study Terminated by Sponsor|7|||
126510141|NCT04579679|455165973|FG002|Overall Study|Study Terminated by Sponsor|1|||
126510142|NCT04579679|455165974|FG003|Overall Study|Study Terminated by Sponsor|0|||
126510143|NCT04745689|455165975|FG000|Overall Study|Death|9|||
126510144|NCT04745689|455165976|FG001|Overall Study|Death|6|||
126510145|NCT04745689|455165975|FG000|Overall Study|Lost to Follow-up|1|||
126510146|NCT04745689|455165976|FG001|Overall Study|Lost to Follow-up|0|||
126510147|NCT04745689|455165975|FG000|Overall Study|Withdrawal by Subject|2|||
126510148|NCT04745689|455165976|FG001|Overall Study|Withdrawal by Subject|0|||
126510149|NCT04745689|455165975|FG000|Overall Study|Study terminated by sponsor|10|||
126510150|NCT04745689|455165976|FG001|Overall Study|Study terminated by sponsor|3|||
126510151|NCT03091192|455165977|FG000|Overall Study|Study terminated by sponsor|21|||
126510152|NCT03091192|455165978|FG001|Overall Study|Study terminated by sponsor|14|||
126510153|NCT03091192|455165977|FG000|Overall Study|Death|9|||
126510154|NCT03091192|455165978|FG001|Overall Study|Death|13|||
126510155|NCT03091192|455165977|FG000|Overall Study|Withdrawal by Subject|2|||
126510156|NCT03091192|455165978|FG001|Overall Study|Withdrawal by Subject|0|||
126510157|NCT03091192|455165977|FG000|Overall Study|Lost to Follow-up|1|||
126510158|NCT03091192|455165978|FG001|Overall Study|Lost to Follow-up|0|||
126510159|NCT01677195|455166872|FG000|Overall Study|Lost to Follow-up|14|||
126510160|NCT01677195|455166873|FG001|Overall Study|Lost to Follow-up|22|||
126510161|NCT01677195|455166874|FG002|Overall Study|Lost to Follow-up|22|||
126510162|NCT01677195|455166872|FG000|Overall Study|Withdrawal by Subject|1|||
126510163|NCT01677195|455166873|FG001|Overall Study|Withdrawal by Subject|0|||
126510164|NCT01677195|455166874|FG002|Overall Study|Withdrawal by Subject|1|||
126510165|NCT01677195|455166872|FG000|Overall Study|Adverse Event|6|||
126510166|NCT01677195|455166873|FG001|Overall Study|Adverse Event|4|||
126510167|NCT01677195|455166874|FG002|Overall Study|Adverse Event|1|||
126510168|NCT01677195|455166872|FG000|Overall Study|Physician Decision|1|||
126510169|NCT01677195|455166873|FG001|Overall Study|Physician Decision|2|||
126510170|NCT01677195|455166874|FG002|Overall Study|Physician Decision|2|||
126510171|NCT01677195|455166872|FG000|Overall Study|Pregnancy|0|||
126510172|NCT01677195|455166873|FG001|Overall Study|Pregnancy|1|||
126510173|NCT01677195|455166874|FG002|Overall Study|Pregnancy|0|||
126510174|NCT01677195|455166872|FG000|Overall Study|Protocol Violation|7|||
126510175|NCT01677195|455166873|FG001|Overall Study|Protocol Violation|3|||
126510176|NCT01677195|455166874|FG002|Overall Study|Protocol Violation|4|||
126510177|NCT02472756|455166876|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
126510178|NCT02472756|455166876|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
126510179|NCT02472756|455166876|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
126510180|NCT02472756|455166876|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
126510181|NCT02472756|455166876|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
126510182|NCT00110266|455166881|FG000|Overall Study|Adverse Event|27|||
126510183|NCT00110266|455166881|FG000|Overall Study|Abnormal laboratory value|15|||
126510184|NCT00110266|455166881|FG000|Overall Study|Withdrawal by Subject|16|||
126510185|NCT00110266|455166881|FG000|Overall Study|Death|17|||
126510186|NCT00110266|455166881|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126510187|NCT00110266|455166881|FG000|Overall Study|Participant condition no longer requires study drug|1|||
126510188|NCT02896400|455166882|FG000|1 Month Follow-up|Lost to Follow-up|7|||
126510189|NCT02896400|455166883|FG001|1 Month Follow-up|Lost to Follow-up|7|||
126510190|NCT02896400|455166884|FG002|1 Month Follow-up|Lost to Follow-up|5|||
126510191|NCT02896400|455166885|FG003|1 Month Follow-up|Lost to Follow-up|8|||
126510192|NCT02896400|455166886|FG004|1 Month Follow-up|Lost to Follow-up|9|||
126510193|NCT02896400|455166887|FG005|1 Month Follow-up|Lost to Follow-up|6|||
126510194|NCT02896400|455166888|FG006|1 Month Follow-up|Lost to Follow-up|5|||
126510195|NCT02896400|455166889|FG007|1 Month Follow-up|Lost to Follow-up|6|||
126510196|NCT02896400|455166890|FG008|1 Month Follow-up|Lost to Follow-up|4|||
126510197|NCT02896400|455166891|FG009|1 Month Follow-up|Lost to Follow-up|7|||
126510198|NCT02896400|455166892|FG010|1 Month Follow-up|Lost to Follow-up|5|||
126510199|NCT02896400|455166893|FG011|1 Month Follow-up|Lost to Follow-up|5|||
126565724|NCT01090024|455366572|FG003|Period 1|Lost to Follow-up|0|||
126510200|NCT02896400|455166894|FG012|1 Month Follow-up|Lost to Follow-up|3|||
126510201|NCT02896400|455166895|FG013|1 Month Follow-up|Lost to Follow-up|4|||
126510202|NCT02896400|455166896|FG014|1 Month Follow-up|Lost to Follow-up|1|||
126510203|NCT02896400|455166897|FG015|1 Month Follow-up|Lost to Follow-up|2|||
126510204|NCT02896400|455166882|FG000|1 Month Follow-up|Death|0|||
126510205|NCT02896400|455166883|FG001|1 Month Follow-up|Death|0|||
126510206|NCT02896400|455166884|FG002|1 Month Follow-up|Death|0|||
126510207|NCT02896400|455166885|FG003|1 Month Follow-up|Death|0|||
126510208|NCT02896400|455166886|FG004|1 Month Follow-up|Death|0|||
126510209|NCT02896400|455166887|FG005|1 Month Follow-up|Death|0|||
126510210|NCT02896400|455166888|FG006|1 Month Follow-up|Death|0|||
126510211|NCT02896400|455166889|FG007|1 Month Follow-up|Death|0|||
126510212|NCT02896400|455166890|FG008|1 Month Follow-up|Death|0|||
126510213|NCT02896400|455166891|FG009|1 Month Follow-up|Death|0|||
126510214|NCT02896400|455166892|FG010|1 Month Follow-up|Death|0|||
126510215|NCT02896400|455166893|FG011|1 Month Follow-up|Death|0|||
126510216|NCT02896400|455166894|FG012|1 Month Follow-up|Death|0|||
126510217|NCT02896400|455166895|FG013|1 Month Follow-up|Death|0|||
126510218|NCT02896400|455166896|FG014|1 Month Follow-up|Death|0|||
126510219|NCT02896400|455166897|FG015|1 Month Follow-up|Death|1|||
126510220|NCT02896400|455166882|FG000|3 Month Follow-up|Lost to Follow-up|6|||
126510221|NCT02896400|455166883|FG001|3 Month Follow-up|Lost to Follow-up|3|||
126510222|NCT02896400|455166884|FG002|3 Month Follow-up|Lost to Follow-up|6|||
126510223|NCT02896400|455166885|FG003|3 Month Follow-up|Lost to Follow-up|11|||
126510224|NCT02896400|455166886|FG004|3 Month Follow-up|Lost to Follow-up|12|||
126510225|NCT02896400|455166887|FG005|3 Month Follow-up|Lost to Follow-up|6|||
126510226|NCT02896400|455166888|FG006|3 Month Follow-up|Lost to Follow-up|4|||
126510227|NCT02896400|455166889|FG007|3 Month Follow-up|Lost to Follow-up|3|||
126510228|NCT02896400|455166890|FG008|3 Month Follow-up|Lost to Follow-up|6|||
126510229|NCT02896400|455166891|FG009|3 Month Follow-up|Lost to Follow-up|5|||
126510230|NCT02896400|455166892|FG010|3 Month Follow-up|Lost to Follow-up|6|||
126510231|NCT02896400|455166893|FG011|3 Month Follow-up|Lost to Follow-up|6|||
126510232|NCT02896400|455166894|FG012|3 Month Follow-up|Lost to Follow-up|3|||
126510233|NCT02896400|455166895|FG013|3 Month Follow-up|Lost to Follow-up|5|||
126510234|NCT02896400|455166896|FG014|3 Month Follow-up|Lost to Follow-up|3|||
126510235|NCT02896400|455166897|FG015|3 Month Follow-up|Lost to Follow-up|2|||
126510236|NCT02896400|455166882|FG000|3 Month Follow-up|Death|0|||
126510237|NCT02896400|455166883|FG001|3 Month Follow-up|Death|0|||
126510238|NCT02896400|455166884|FG002|3 Month Follow-up|Death|0|||
126510239|NCT02896400|455166885|FG003|3 Month Follow-up|Death|0|||
126510240|NCT02896400|455166886|FG004|3 Month Follow-up|Death|0|||
126510241|NCT02896400|455166887|FG005|3 Month Follow-up|Death|0|||
126510242|NCT02896400|455166888|FG006|3 Month Follow-up|Death|0|||
126510243|NCT02896400|455166889|FG007|3 Month Follow-up|Death|0|||
126510244|NCT02896400|455166890|FG008|3 Month Follow-up|Death|0|||
126510245|NCT02896400|455166891|FG009|3 Month Follow-up|Death|0|||
126510246|NCT02896400|455166892|FG010|3 Month Follow-up|Death|0|||
126510247|NCT02896400|455166893|FG011|3 Month Follow-up|Death|0|||
126510248|NCT02896400|455166894|FG012|3 Month Follow-up|Death|0|||
126510249|NCT02896400|455166895|FG013|3 Month Follow-up|Death|1|||
126510250|NCT02896400|455166896|FG014|3 Month Follow-up|Death|1|||
126510251|NCT02896400|455166897|FG015|3 Month Follow-up|Death|0|||
126510252|NCT02896400|455166882|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
126510253|NCT02896400|455166883|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
126510254|NCT02896400|455166884|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
126510255|NCT02896400|455166885|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
126510256|NCT02896400|455166886|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
126510257|NCT02896400|455166887|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
126510258|NCT02896400|455166888|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
126510259|NCT02896400|455166889|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
126565725|NCT01090024|455366573|FG004|Period 1|Lost to Follow-up|0|||
126510260|NCT02896400|455166890|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
126510261|NCT02896400|455166891|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
126510262|NCT02896400|455166892|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
126565726|NCT01090024|455366574|FG005|Period 1|Lost to Follow-up|0|||
126565727|NCT01090024|455366575|FG006|Period 1|Lost to Follow-up|0|||
126565728|NCT01090024|455366576|FG007|Period 1|Lost to Follow-up|0|||
126565729|NCT01090024|455366577|FG008|Period 1|Lost to Follow-up|0|||
126510263|NCT02896400|455166893|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
126510264|NCT02896400|455166894|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
126510265|NCT02896400|455166895|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
126510266|NCT02896400|455166896|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
126510267|NCT02896400|455166897|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
126510268|NCT02896400|455166882|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
126565730|NCT01090024|455366578|FG009|Period 1|Lost to Follow-up|0|||
126510269|NCT02896400|455166883|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
126510270|NCT02896400|455166884|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
126565731|NCT01090024|455366579|FG010|Period 1|Lost to Follow-up|0|||
126565732|NCT01090024|455366580|FG011|Period 1|Lost to Follow-up|0|||
126565733|NCT01090024|455366581|FG012|Period 1|Lost to Follow-up|0|||
126565734|NCT01090024|455366582|FG013|Period 1|Lost to Follow-up|0|||
126565735|NCT01090024|455366583|FG014|Period 1|Lost to Follow-up|0|||
126565736|NCT01090024|455366584|FG015|Period 1|Lost to Follow-up|0|||
126565737|NCT01090024|455366585|FG016|Period 1|Lost to Follow-up|0|||
126565738|NCT01090024|455366586|FG017|Period 1|Lost to Follow-up|0|||
126565739|NCT01090024|455366569|FG000|Period 2|Lost to Follow-up|0|||
126565740|NCT01090024|455366570|FG001|Period 2|Lost to Follow-up|0|||
126565741|NCT01090024|455366571|FG002|Period 2|Lost to Follow-up|0|||
126565742|NCT01090024|455366572|FG003|Period 2|Lost to Follow-up|1|||
126565743|NCT01090024|455366573|FG004|Period 2|Lost to Follow-up|0|||
126565744|NCT01090024|455366574|FG005|Period 2|Lost to Follow-up|0|||
126565745|NCT01090024|455366575|FG006|Period 2|Lost to Follow-up|0|||
126565746|NCT01090024|455366576|FG007|Period 2|Lost to Follow-up|0|||
126565747|NCT01090024|455366577|FG008|Period 2|Lost to Follow-up|0|||
126565748|NCT01090024|455366578|FG009|Period 2|Lost to Follow-up|0|||
126565749|NCT01090024|455366579|FG010|Period 2|Lost to Follow-up|0|||
126565750|NCT01090024|455366580|FG011|Period 2|Lost to Follow-up|0|||
126565751|NCT01090024|455366581|FG012|Period 2|Lost to Follow-up|0|||
126565752|NCT01090024|455366582|FG013|Period 2|Lost to Follow-up|0|||
126565753|NCT01090024|455366583|FG014|Period 2|Lost to Follow-up|0|||
126565754|NCT01090024|455366584|FG015|Period 2|Lost to Follow-up|0|||
126565755|NCT01090024|455366585|FG016|Period 2|Lost to Follow-up|0|||
126565756|NCT01090024|455366586|FG017|Period 2|Lost to Follow-up|0|||
126565757|NCT01090024|455366569|FG000|Period 2|Adverse Event|1|||
126565758|NCT01090024|455366570|FG001|Period 2|Adverse Event|0|||
126565759|NCT01090024|455366571|FG002|Period 2|Adverse Event|0|||
126565760|NCT01090024|455366572|FG003|Period 2|Adverse Event|0|||
126565761|NCT01090024|455366573|FG004|Period 2|Adverse Event|0|||
126565762|NCT01090024|455366574|FG005|Period 2|Adverse Event|0|||
126565763|NCT01090024|455366575|FG006|Period 2|Adverse Event|0|||
126565764|NCT01090024|455366576|FG007|Period 2|Adverse Event|0|||
126510271|NCT02896400|455166885|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
126510272|NCT02896400|455166886|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
126510273|NCT02896400|455166887|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
126510274|NCT02896400|455166888|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
126510275|NCT02896400|455166889|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
126510276|NCT02896400|455166890|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
126510277|NCT02896400|455166891|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
126510278|NCT02896400|455166892|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
126510279|NCT02896400|455166893|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
126510280|NCT02896400|455166894|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
126510281|NCT02896400|455166895|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
126510282|NCT02896400|455166896|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
126510283|NCT02896400|455166897|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
126510284|NCT00634647|455166898|FG000|Overall Study|death on study|3|||
126510285|NCT00634647|455166898|FG000|Overall Study|refused further treatment|3|||
126510286|NCT00634647|455166898|FG000|Overall Study|declined to participate before treatment|1|||
126510287|NCT02984020|455166899|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
126510288|NCT02984020|455166899|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
126510289|NCT02984020|455166899|FG000|Overall Study|Other significant protocol violation|2|||
126510290|NCT00667342|455166900|FG000|Overall Study|Protocol Violation|1|||
126510291|NCT00667342|455166901|FG001|Overall Study|Protocol Violation|0|||
126510292|NCT00667342|455166902|FG002|Overall Study|Protocol Violation|0|||
126510293|NCT00667342|455166900|FG000|Overall Study|Withdrawal by Subject|1|||
126510294|NCT00667342|455166901|FG001|Overall Study|Withdrawal by Subject|0|||
126510295|NCT00667342|455166902|FG002|Overall Study|Withdrawal by Subject|0|||
126510296|NCT00667342|455166900|FG000|Overall Study|Physician Decision|3|||
126510297|NCT00667342|455166901|FG001|Overall Study|Physician Decision|0|||
126565765|NCT01090024|455366577|FG008|Period 2|Adverse Event|0|||
126565766|NCT01090024|455366578|FG009|Period 2|Adverse Event|0|||
126565767|NCT01090024|455366579|FG010|Period 2|Adverse Event|0|||
126565768|NCT01090024|455366580|FG011|Period 2|Adverse Event|0|||
126565769|NCT01090024|455366581|FG012|Period 2|Adverse Event|0|||
126565770|NCT01090024|455366582|FG013|Period 2|Adverse Event|0|||
126565771|NCT01090024|455366583|FG014|Period 2|Adverse Event|0|||
126565772|NCT01090024|455366584|FG015|Period 2|Adverse Event|0|||
126565773|NCT01090024|455366585|FG016|Period 2|Adverse Event|0|||
126565774|NCT01090024|455366586|FG017|Period 2|Adverse Event|0|||
126565775|NCT01090024|455366569|FG000|Period 3|Withdrawal by Subject|0|||
126565776|NCT01090024|455366570|FG001|Period 3|Withdrawal by Subject|0|||
126565777|NCT01090024|455366571|FG002|Period 3|Withdrawal by Subject|0|||
126565778|NCT01090024|455366572|FG003|Period 3|Withdrawal by Subject|0|||
126565779|NCT01090024|455366573|FG004|Period 3|Withdrawal by Subject|0|||
126565780|NCT01090024|455366574|FG005|Period 3|Withdrawal by Subject|0|||
126565781|NCT01090024|455366575|FG006|Period 3|Withdrawal by Subject|0|||
126565782|NCT01090024|455366576|FG007|Period 3|Withdrawal by Subject|0|||
126565783|NCT01090024|455366577|FG008|Period 3|Withdrawal by Subject|0|||
126565784|NCT01090024|455366578|FG009|Period 3|Withdrawal by Subject|0|||
126565785|NCT01090024|455366579|FG010|Period 3|Withdrawal by Subject|0|||
126565786|NCT01090024|455366580|FG011|Period 3|Withdrawal by Subject|0|||
126565787|NCT01090024|455366581|FG012|Period 3|Withdrawal by Subject|0|||
126565788|NCT01090024|455366582|FG013|Period 3|Withdrawal by Subject|0|||
126565789|NCT01090024|455366583|FG014|Period 3|Withdrawal by Subject|0|||
126565790|NCT01090024|455366584|FG015|Period 3|Withdrawal by Subject|1|||
126565791|NCT01090024|455366585|FG016|Period 3|Withdrawal by Subject|0|||
126565792|NCT01090024|455366586|FG017|Period 3|Withdrawal by Subject|0|||
126565793|NCT01090024|455366569|FG000|Period 3|Protocol Violation|0|||
126565794|NCT01090024|455366570|FG001|Period 3|Protocol Violation|0|||
126565795|NCT01090024|455366571|FG002|Period 3|Protocol Violation|0|||
126565796|NCT01090024|455366572|FG003|Period 3|Protocol Violation|0|||
126565797|NCT01090024|455366573|FG004|Period 3|Protocol Violation|0|||
126565798|NCT01090024|455366574|FG005|Period 3|Protocol Violation|0|||
126565799|NCT01090024|455366575|FG006|Period 3|Protocol Violation|0|||
126565800|NCT01090024|455366576|FG007|Period 3|Protocol Violation|0|||
126565801|NCT01090024|455366577|FG008|Period 3|Protocol Violation|1|||
126565802|NCT01090024|455366578|FG009|Period 3|Protocol Violation|0|||
126565803|NCT01090024|455366579|FG010|Period 3|Protocol Violation|0|||
126565804|NCT01090024|455366580|FG011|Period 3|Protocol Violation|0|||
126565805|NCT01090024|455366581|FG012|Period 3|Protocol Violation|0|||
126565806|NCT01090024|455366582|FG013|Period 3|Protocol Violation|0|||
126565807|NCT01090024|455366583|FG014|Period 3|Protocol Violation|0|||
126565808|NCT01090024|455366584|FG015|Period 3|Protocol Violation|0|||
126565809|NCT01090024|455366585|FG016|Period 3|Protocol Violation|0|||
126565810|NCT01090024|455366586|FG017|Period 3|Protocol Violation|0|||
126565811|NCT01090024|455366569|FG000|Period 3|Adverse Event|0|||
126565812|NCT01090024|455366570|FG001|Period 3|Adverse Event|0|||
126565813|NCT01090024|455366571|FG002|Period 3|Adverse Event|0|||
126565814|NCT01090024|455366572|FG003|Period 3|Adverse Event|0|||
126565815|NCT01090024|455366573|FG004|Period 3|Adverse Event|0|||
126565816|NCT01090024|455366574|FG005|Period 3|Adverse Event|1|||
126565817|NCT01090024|455366575|FG006|Period 3|Adverse Event|0|||
126565818|NCT01090024|455366576|FG007|Period 3|Adverse Event|0|||
126565819|NCT01090024|455366577|FG008|Period 3|Adverse Event|0|||
126565820|NCT01090024|455366578|FG009|Period 3|Adverse Event|0|||
126565821|NCT01090024|455366579|FG010|Period 3|Adverse Event|0|||
126565822|NCT01090024|455366580|FG011|Period 3|Adverse Event|0|||
126565823|NCT01090024|455366581|FG012|Period 3|Adverse Event|0|||
126565824|NCT01090024|455366582|FG013|Period 3|Adverse Event|0|||
126565825|NCT01090024|455366583|FG014|Period 3|Adverse Event|0|||
126565826|NCT01090024|455366584|FG015|Period 3|Adverse Event|0|||
126565827|NCT01090024|455366585|FG016|Period 3|Adverse Event|0|||
126565828|NCT01090024|455366586|FG017|Period 3|Adverse Event|0|||
126565829|NCT00567879|455366589|FG000|Overall Study|Adverse Event|2|||
126565830|NCT00567879|455366590|FG001|Overall Study|Adverse Event|0|||
126565831|NCT00567879|455366591|FG002|Overall Study|Adverse Event|1|||
126565832|NCT00567879|455366592|FG003|Overall Study|Adverse Event|0|||
126565833|NCT00567879|455366593|FG004|Overall Study|Adverse Event|1|||
126565834|NCT00567879|455366594|FG005|Overall Study|Adverse Event|0|||
126565835|NCT00567879|455366589|FG000|Overall Study|Abnormal test procedure(s)|0|||
126565836|NCT00567879|455366590|FG001|Overall Study|Abnormal test procedure(s)|0|||
126565837|NCT00567879|455366591|FG002|Overall Study|Abnormal test procedure(s)|1|||
126565838|NCT00567879|455366592|FG003|Overall Study|Abnormal test procedure(s)|0|||
126565839|NCT00567879|455366593|FG004|Overall Study|Abnormal test procedure(s)|0|||
126565840|NCT00567879|455366594|FG005|Overall Study|Abnormal test procedure(s)|0|||
126565841|NCT00567879|455366589|FG000|Overall Study|Withdrawal by Subject|0|||
126565842|NCT00567879|455366590|FG001|Overall Study|Withdrawal by Subject|0|||
126565843|NCT00567879|455366591|FG002|Overall Study|Withdrawal by Subject|3|||
126565844|NCT00567879|455366592|FG003|Overall Study|Withdrawal by Subject|1|||
126565845|NCT00567879|455366593|FG004|Overall Study|Withdrawal by Subject|0|||
126565846|NCT00567879|455366594|FG005|Overall Study|Withdrawal by Subject|0|||
126565847|NCT00567879|455366589|FG000|Overall Study|New cancer therapy|0|||
126565848|NCT00567879|455366590|FG001|Overall Study|New cancer therapy|0|||
126565849|NCT00567879|455366591|FG002|Overall Study|New cancer therapy|1|||
126565850|NCT00567879|455366592|FG003|Overall Study|New cancer therapy|0|||
126565851|NCT00567879|455366593|FG004|Overall Study|New cancer therapy|0|||
126565852|NCT00567879|455366594|FG005|Overall Study|New cancer therapy|0|||
126565853|NCT00567879|455366589|FG000|Overall Study|Disease progression|5|||
126565854|NCT00567879|455366590|FG001|Overall Study|Disease progression|7|||
126565855|NCT00567879|455366591|FG002|Overall Study|Disease progression|15|||
126565856|NCT00567879|455366592|FG003|Overall Study|Disease progression|5|||
126565857|NCT00567879|455366593|FG004|Overall Study|Disease progression|11|||
126565858|NCT00567879|455366594|FG005|Overall Study|Disease progression|3|||
126510298|NCT00667342|455166902|FG002|Overall Study|Physician Decision|0|||
126510299|NCT00667342|455166900|FG000|Overall Study|Relapse or tumor progression|9|||
126510300|NCT00667342|455166901|FG001|Overall Study|Relapse or tumor progression|0|||
126510301|NCT00667342|455166902|FG002|Overall Study|Relapse or tumor progression|7|||
126510302|NCT00667342|455166900|FG000|Overall Study|Adverse Event|0|||
126510303|NCT00667342|455166901|FG001|Overall Study|Adverse Event|0|||
126510304|NCT00667342|455166902|FG002|Overall Study|Adverse Event|1|||
126510305|NCT00667342|455166900|FG000|Overall Study|Ineligible|0|||
126510306|NCT00667342|455166901|FG001|Overall Study|Ineligible|0|||
126510307|NCT00667342|455166902|FG002|Overall Study|Ineligible|1|||
126510308|NCT03912233|455166903|FG000|Overall Study|Adverse Event|1|||
126510309|NCT03912233|455166904|FG001|Overall Study|Adverse Event|0|||
126510310|NCT03912233|455166905|FG002|Overall Study|Adverse Event|0|||
126510311|NCT03912233|455166906|FG003|Overall Study|Adverse Event|0|||
126510312|NCT03912233|455166907|FG004|Overall Study|Adverse Event|0|||
126510313|NCT03912233|455166908|FG005|Overall Study|Adverse Event|0|||
126510314|NCT03912233|455166903|FG000|Overall Study|Physician Decision|1|||
126510315|NCT03912233|455166904|FG001|Overall Study|Physician Decision|0|||
126510316|NCT03912233|455166905|FG002|Overall Study|Physician Decision|0|||
126510317|NCT03912233|455166906|FG003|Overall Study|Physician Decision|0|||
126510318|NCT03912233|455166907|FG004|Overall Study|Physician Decision|0|||
126510319|NCT03912233|455166908|FG005|Overall Study|Physician Decision|0|||
126510320|NCT03912233|455166903|FG000|Overall Study|Other|0|||
126510321|NCT03912233|455166904|FG001|Overall Study|Other|0|||
126510322|NCT03912233|455166905|FG002|Overall Study|Other|0|||
126510323|NCT03912233|455166906|FG003|Overall Study|Other|0|||
126510324|NCT03912233|455166907|FG004|Overall Study|Other|7|||
126510325|NCT03912233|455166908|FG005|Overall Study|Other|12|||
126510326|NCT02177266|455166909|FG000|Overall Study|Adverse Event|0|||
126510327|NCT02177266|455166910|FG001|Overall Study|Adverse Event|1|||
126510328|NCT02177266|455166909|FG000|Overall Study|Withdrawal by Subject|1|||
126510329|NCT02177266|455166910|FG001|Overall Study|Withdrawal by Subject|0|||
126510330|NCT00546715|455166912|FG000|Overall Study|Withdrawal by Subject|0|||
126510331|NCT00546715|455166913|FG001|Overall Study|Withdrawal by Subject|1|||
126510332|NCT00546715|455166914|FG002|Overall Study|Withdrawal by Subject|0|||
126510333|NCT00546715|455166915|FG003|Overall Study|Withdrawal by Subject|0|||
126510334|NCT00723606|455166916|FG000|Overall Study|Adverse Event|2|||
126510335|NCT00723606|455166917|FG001|Overall Study|Adverse Event|5|||
126510336|NCT00723606|455166916|FG000|Overall Study|Other|2|||
126510337|NCT00723606|455166917|FG001|Overall Study|Other|0|||
126510338|NCT00723606|455166916|FG000|Overall Study|Withdrawal by Subject|0|||
126510339|NCT00723606|455166917|FG001|Overall Study|Withdrawal by Subject|2|||
126510340|NCT05220397|455166920|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
126510341|NCT05220397|455166921|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
126510342|NCT05220397|455166922|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
126510343|NCT05220397|455166923|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
126510344|NCT05220397|455166924|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
126510345|NCT00637195|455166925|FG000|Overall Study|Lost to Follow-up|1|||
126510346|NCT00637195|455166926|FG001|Overall Study|Lost to Follow-up|0|||
126510347|NCT00637195|455166925|FG000|Overall Study|Other|2|||
126510348|NCT00637195|455166926|FG001|Overall Study|Other|0|||
126510349|NCT00637195|455166925|FG000|Overall Study|Withdrawal by Subject|0|||
126510350|NCT00637195|455166926|FG001|Overall Study|Withdrawal by Subject|1|||
126510351|NCT01110915|455166927|FG000|Overall Study|Death|2|||
126510352|NCT01110915|455166928|FG001|Overall Study|Death|1|||
126510353|NCT01110915|455166927|FG000|Overall Study|Lost to Follow-up|1|||
126510354|NCT01110915|455166928|FG001|Overall Study|Lost to Follow-up|0|||
126510355|NCT01110915|455166927|FG000|Overall Study|Withdrawal by Subject|7|||
126510356|NCT01110915|455166928|FG001|Overall Study|Withdrawal by Subject|1|||
126510357|NCT00207142|455166929|FG000|Induction Phase|Adverse Event|9|||
126510358|NCT00207142|455166930|FG001|Induction Phase|Adverse Event|0|||
126510359|NCT00207142|455166931|FG002|Induction Phase|Adverse Event|0|||
126510360|NCT00207142|455166932|FG003|Induction Phase|Adverse Event|0|||
126510361|NCT00207142|455166929|FG000|Induction Phase|Death|1|||
126510362|NCT00207142|455166930|FG001|Induction Phase|Death|0|||
126510363|NCT00207142|455166931|FG002|Induction Phase|Death|0|||
126510364|NCT00207142|455166932|FG003|Induction Phase|Death|0|||
126510365|NCT00207142|455166929|FG000|Induction Phase|Lack of Efficacy|1|||
126510366|NCT00207142|455166930|FG001|Induction Phase|Lack of Efficacy|0|||
126510367|NCT00207142|455166931|FG002|Induction Phase|Lack of Efficacy|0|||
126510368|NCT00207142|455166932|FG003|Induction Phase|Lack of Efficacy|0|||
126510369|NCT00207142|455166929|FG000|Induction Phase|Lost to Follow-up|5|||
126510370|NCT00207142|455166930|FG001|Induction Phase|Lost to Follow-up|0|||
126510371|NCT00207142|455166931|FG002|Induction Phase|Lost to Follow-up|0|||
126510372|NCT00207142|455166932|FG003|Induction Phase|Lost to Follow-up|0|||
126510373|NCT00207142|455166929|FG000|Induction Phase|Physician Decision|2|||
126510374|NCT00207142|455166930|FG001|Induction Phase|Physician Decision|0|||
126510375|NCT00207142|455166931|FG002|Induction Phase|Physician Decision|0|||
126510376|NCT00207142|455166932|FG003|Induction Phase|Physician Decision|0|||
126510377|NCT00207142|455166929|FG000|Induction Phase|Poor/noncompliance|2|||
126510378|NCT00207142|455166930|FG001|Induction Phase|Poor/noncompliance|0|||
126510379|NCT00207142|455166931|FG002|Induction Phase|Poor/noncompliance|0|||
126510380|NCT00207142|455166932|FG003|Induction Phase|Poor/noncompliance|0|||
126510381|NCT00207142|455166929|FG000|Induction Phase|Pregnancy|1|||
126510382|NCT00207142|455166930|FG001|Induction Phase|Pregnancy|0|||
126510383|NCT00207142|455166931|FG002|Induction Phase|Pregnancy|0|||
126510384|NCT00207142|455166932|FG003|Induction Phase|Pregnancy|0|||
126510385|NCT00207142|455166929|FG000|Induction Phase|Subject no longer meets study criteria|3|||
126510386|NCT00207142|455166930|FG001|Induction Phase|Subject no longer meets study criteria|0|||
126510387|NCT00207142|455166931|FG002|Induction Phase|Subject no longer meets study criteria|0|||
126510388|NCT00207142|455166932|FG003|Induction Phase|Subject no longer meets study criteria|0|||
126510389|NCT00207142|455166929|FG000|Induction Phase|Withdrawal by Subject|4|||
126510390|NCT00207142|455166930|FG001|Induction Phase|Withdrawal by Subject|0|||
126510391|NCT00207142|455166931|FG002|Induction Phase|Withdrawal by Subject|0|||
126510392|NCT00207142|455166932|FG003|Induction Phase|Withdrawal by Subject|0|||
126510393|NCT00207142|455166929|FG000|Induction Phase|Incarceration|1|||
126510394|NCT00207142|455166930|FG001|Induction Phase|Incarceration|0|||
126510395|NCT00207142|455166931|FG002|Induction Phase|Incarceration|0|||
126510396|NCT00207142|455166932|FG003|Induction Phase|Incarceration|0|||
126510397|NCT00207142|455166929|FG000|Induction Phase|Missing lab data|1|||
126510398|NCT00207142|455166930|FG001|Induction Phase|Missing lab data|0|||
126510399|NCT00207142|455166931|FG002|Induction Phase|Missing lab data|0|||
126510400|NCT00207142|455166932|FG003|Induction Phase|Missing lab data|0|||
126510401|NCT00207142|455166929|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
126510402|NCT00207142|455166930|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
126510403|NCT00207142|455166931|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
126510404|NCT00207142|455166932|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
126510405|NCT00207142|455166929|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
126510406|NCT00207142|455166930|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
126510407|NCT00207142|455166931|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
126510408|NCT00207142|455166932|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
126510409|NCT00207142|455166929|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
126510410|NCT00207142|455166930|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
126510411|NCT00207142|455166931|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
126510412|NCT00207142|455166932|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
126510413|NCT00207142|455166929|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
126510414|NCT00207142|455166930|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
126510415|NCT00207142|455166931|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
126510416|NCT00207142|455166932|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
126510417|NCT00207142|455166929|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
126510418|NCT00207142|455166930|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
126510419|NCT00207142|455166931|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
126510420|NCT00207142|455166932|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
126510421|NCT00207142|455166929|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
126510422|NCT00207142|455166930|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
126510423|NCT00207142|455166931|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
126510424|NCT00207142|455166932|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
126510425|NCT00207142|455166929|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
126510426|NCT00207142|455166930|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
126510427|NCT00207142|455166931|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
126510428|NCT00207142|455166932|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
126510429|NCT00207142|455166929|FG000|Maintenance Phase/Rescue Phase|Death|0|||
126510430|NCT00207142|455166930|FG001|Maintenance Phase/Rescue Phase|Death|0|||
126510431|NCT00207142|455166931|FG002|Maintenance Phase/Rescue Phase|Death|0|||
126510432|NCT00207142|455166932|FG003|Maintenance Phase/Rescue Phase|Death|1|||
126510433|NCT00207142|455166929|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
126510434|NCT00207142|455166930|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
126510435|NCT00207142|455166931|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
126510436|NCT00207142|455166932|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
126510437|NCT01020019|455166933|FG000|Overall Study|Lost to Follow-up|21|||
126510438|NCT01020019|455166934|FG001|Overall Study|Lost to Follow-up|18|||
126510439|NCT01020019|455166933|FG000|Overall Study|Adverse Event|1|||
126510440|NCT01020019|455166934|FG001|Overall Study|Adverse Event|5|||
126510441|NCT01020019|455166933|FG000|Overall Study|not interested in treatment|4|||
126510442|NCT01020019|455166934|FG001|Overall Study|not interested in treatment|4|||
126510443|NCT01020019|455166933|FG000|Overall Study|moving|0|||
126510444|NCT01020019|455166934|FG001|Overall Study|moving|2|||
126510445|NCT05091528|455166935|FG000|Overall Study|Study Termination by Sponsor|0|||
126510446|NCT05091528|455166936|FG001|Overall Study|Study Termination by Sponsor|1|||
126510447|NCT05091528|455166937|FG002|Overall Study|Study Termination by Sponsor|0|||
126510448|NCT05091528|455166938|FG003|Overall Study|Study Termination by Sponsor|1|||
126776954|NCT00267007|456139124|FG000|Overall Study|Lost to Follow-up|1|||
126565859|NCT00777556|455366595|FG000|Overall Study|Inappropriate self-selection|34|||
126565860|NCT00777556|455366595|FG000|Overall Study|Dispensed but did not use product|12|||
126565861|NCT00777556|455366595|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
126565862|NCT02987543|455366601|FG000|Overall Study|Ongoing study at data cut off|49|||
126565863|NCT02987543|455366602|FG001|Overall Study|Ongoing study at data cut off|21|||
126565864|NCT02987543|455366603|FG002|Overall Study|Ongoing study at data cut off|19|||
126565865|NCT02987543|455366604|FG003|Overall Study|Ongoing study at data cut off|12|||
126565866|NCT02987543|455366601|FG000|Overall Study|Death|88|||
126565867|NCT02987543|455366602|FG001|Overall Study|Death|54|||
126565868|NCT02987543|455366603|FG002|Overall Study|Death|67|||
126565869|NCT02987543|455366604|FG003|Overall Study|Death|28|||
126565870|NCT02987543|455366601|FG000|Overall Study|Lost to Follow-up|3|||
126565871|NCT02987543|455366602|FG001|Overall Study|Lost to Follow-up|0|||
126565872|NCT02987543|455366603|FG002|Overall Study|Lost to Follow-up|1|||
126565873|NCT02987543|455366604|FG003|Overall Study|Lost to Follow-up|0|||
126565874|NCT02987543|455366601|FG000|Overall Study|Screen failure|0|||
126565875|NCT02987543|455366602|FG001|Overall Study|Screen failure|0|||
126565876|NCT02987543|455366603|FG002|Overall Study|Screen failure|0|||
126565877|NCT02987543|455366604|FG003|Overall Study|Screen failure|1|||
126565878|NCT02987543|455366601|FG000|Overall Study|Withdrawal by Subject|21|||
126565879|NCT02987543|455366602|FG001|Overall Study|Withdrawal by Subject|7|||
126565880|NCT02987543|455366603|FG002|Overall Study|Withdrawal by Subject|7|||
126565881|NCT02987543|455366604|FG003|Overall Study|Withdrawal by Subject|6|||
126565882|NCT02987543|455366601|FG000|Overall Study|Study terminated by sponsor|1|||
126565883|NCT02987543|455366602|FG001|Overall Study|Study terminated by sponsor|0|||
126565884|NCT02987543|455366603|FG002|Overall Study|Study terminated by sponsor|0|||
126565885|NCT02987543|455366604|FG003|Overall Study|Study terminated by sponsor|0|||
126565886|NCT02987543|455366601|FG000|Overall Study|Investigator decision|0|||
126565887|NCT02987543|455366602|FG001|Overall Study|Investigator decision|1|||
126565888|NCT02987543|455366603|FG002|Overall Study|Investigator decision|0|||
126565889|NCT02987543|455366604|FG003|Overall Study|Investigator decision|0|||
126565890|NCT02987543|455366601|FG000|Overall Study|Disease progression|0|||
126565891|NCT02987543|455366602|FG001|Overall Study|Disease progression|0|||
126565892|NCT02987543|455366603|FG002|Overall Study|Disease progression|0|||
126565893|NCT02987543|455366604|FG003|Overall Study|Disease progression|1|||
126565894|NCT01977612|455366605|FG000|Overall Study|Lost to Follow-up|1|||
126565895|NCT01977612|455366606|FG001|Overall Study|Lost to Follow-up|1|||
126565896|NCT01451814|455366607|FG000|Overall Study|Withdrawal by Subject|1|||
126565897|NCT01451814|455366608|FG001|Overall Study|Withdrawal by Subject|1|||
126565898|NCT01451814|455366607|FG000|Overall Study|Lost to Follow-up|5|||
126565899|NCT01451814|455366608|FG001|Overall Study|Lost to Follow-up|4|||
126565900|NCT01280591|455366610|FG000|Overall Study|Withdrawal by Subject|0|||
126565901|NCT01280591|455366611|FG001|Overall Study|Withdrawal by Subject|0|||
126565902|NCT01280591|455366612|FG002|Overall Study|Withdrawal by Subject|0|||
126565903|NCT01280591|455366613|FG003|Overall Study|Withdrawal by Subject|2|||
126565904|NCT01280591|455366610|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
126565905|NCT01280591|455366611|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
126565906|NCT01280591|455366612|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
126565907|NCT01280591|455366613|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
126565908|NCT01883492|455366615|FG000|Overall Study|Lost to Follow-up|3|||
126565909|NCT01883492|455366616|FG001|Overall Study|Lost to Follow-up|4|||
126565910|NCT01883492|455366615|FG000|Overall Study|Surgery on contra-lateral hip|0|||
126565911|NCT01883492|455366616|FG001|Overall Study|Surgery on contra-lateral hip|1|||
126565912|NCT01883492|455366615|FG000|Overall Study|Poor X-ray quality|7|||
126565913|NCT01883492|455366616|FG001|Overall Study|Poor X-ray quality|4|||
126565914|NCT01883492|455366615|FG000|Overall Study|Withdrawal by Subject|1|||
126565915|NCT01883492|455366616|FG001|Overall Study|Withdrawal by Subject|0|||
126565916|NCT01883492|455366615|FG000|Overall Study|inappropriate implant used|1|||
126565917|NCT01883492|455366616|FG001|Overall Study|inappropriate implant used|1|||
126565918|NCT01883492|455366615|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
126565919|NCT01883492|455366616|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
126565920|NCT01259102|455366619|FG000|Overall Study|Adverse Event|1|||
126565921|NCT01259102|455366620|FG001|Overall Study|Adverse Event|0|||
126565922|NCT01259102|455366621|FG002|Overall Study|Adverse Event|1|||
126565923|NCT01259102|455366622|FG003|Overall Study|Adverse Event|1|||
126565924|NCT01259102|455366623|FG004|Overall Study|Adverse Event|0|||
126565925|NCT01259102|455366619|FG000|Overall Study|Other|0|||
126565926|NCT01259102|455366620|FG001|Overall Study|Other|0|||
126565927|NCT01259102|455366621|FG002|Overall Study|Other|1|||
126565928|NCT01259102|455366622|FG003|Overall Study|Other|1|||
126565929|NCT01259102|455366623|FG004|Overall Study|Other|1|||
126565930|NCT01956669|455366625|FG000|Overall Study|Disease Progression|12|||
126565931|NCT01956669|455366626|FG001|Overall Study|Disease Progression|7|||
126565932|NCT01956669|455366627|FG002|Overall Study|Disease Progression|7|||
126565933|NCT01956669|455366628|FG003|Overall Study|Disease Progression|8|||
126565934|NCT01956669|455366629|FG004|Overall Study|Disease Progression|4|||
126565935|NCT01956669|455366630|FG005|Overall Study|Disease Progression|3|||
126565936|NCT01956669|455366631|FG006|Overall Study|Disease Progression|5|||
126565937|NCT01956669|455366625|FG000|Overall Study|Adverse Event|0|||
126565938|NCT01956669|455366626|FG001|Overall Study|Adverse Event|2|||
126565939|NCT01956669|455366627|FG002|Overall Study|Adverse Event|2|||
126565940|NCT01956669|455366628|FG003|Overall Study|Adverse Event|1|||
126565941|NCT01956669|455366629|FG004|Overall Study|Adverse Event|0|||
126565942|NCT01956669|455366630|FG005|Overall Study|Adverse Event|0|||
126565943|NCT01956669|455366631|FG006|Overall Study|Adverse Event|0|||
126565944|NCT01956669|455366625|FG000|Overall Study|Physician Decision|0|||
126565945|NCT01956669|455366626|FG001|Overall Study|Physician Decision|2|||
126565946|NCT01956669|455366627|FG002|Overall Study|Physician Decision|0|||
126565947|NCT01956669|455366628|FG003|Overall Study|Physician Decision|0|||
126565948|NCT01956669|455366629|FG004|Overall Study|Physician Decision|0|||
126565949|NCT01956669|455366630|FG005|Overall Study|Physician Decision|1|||
126565950|NCT01956669|455366631|FG006|Overall Study|Physician Decision|0|||
126565951|NCT01956669|455366625|FG000|Overall Study|Withdrawal by Subject|0|||
126565952|NCT01956669|455366626|FG001|Overall Study|Withdrawal by Subject|0|||
126565953|NCT01956669|455366627|FG002|Overall Study|Withdrawal by Subject|1|||
126565954|NCT01956669|455366628|FG003|Overall Study|Withdrawal by Subject|1|||
126565955|NCT01956669|455366629|FG004|Overall Study|Withdrawal by Subject|0|||
126565956|NCT01956669|455366630|FG005|Overall Study|Withdrawal by Subject|0|||
126565957|NCT01956669|455366631|FG006|Overall Study|Withdrawal by Subject|1|||
126565958|NCT02131324|455366632|FG000|Overall Study|Withdrawal by Subject|1|||
126565959|NCT02131324|455366633|FG001|Overall Study|Withdrawal by Subject|2|||
126565960|NCT02131324|455366632|FG000|Overall Study|Lost to Follow-up|1|||
126565961|NCT02131324|455366633|FG001|Overall Study|Lost to Follow-up|1|||
126565962|NCT01693614|455366634|FG000|Overall Study|Adverse Event|7|||
126565963|NCT01693614|455366635|FG001|Overall Study|Adverse Event|11|||
126565964|NCT01693614|455366636|FG002|Overall Study|Adverse Event|5|||
126565965|NCT01693614|455366634|FG000|Overall Study|Disease progression|11|||
126565966|NCT01693614|455366635|FG001|Overall Study|Disease progression|8|||
126565967|NCT01693614|455366636|FG002|Overall Study|Disease progression|7|||
126565968|NCT01693614|455366634|FG000|Overall Study|Protocol Violation|5|||
126565969|NCT01693614|455366635|FG001|Overall Study|Protocol Violation|2|||
126565970|NCT01693614|455366636|FG002|Overall Study|Protocol Violation|1|||
126565971|NCT01693614|455366634|FG000|Overall Study|Death|1|||
126565972|NCT01693614|455366635|FG001|Overall Study|Death|0|||
126565973|NCT01693614|455366636|FG002|Overall Study|Death|0|||
126565974|NCT01693614|455366634|FG000|Overall Study|Physician Decision|1|||
126565975|NCT01693614|455366635|FG001|Overall Study|Physician Decision|1|||
126565976|NCT01693614|455366636|FG002|Overall Study|Physician Decision|4|||
126565977|NCT01693614|455366634|FG000|Overall Study|Withdrawal by subject/guardian|0|||
126565978|NCT01693614|455366635|FG001|Overall Study|Withdrawal by subject/guardian|0|||
126565979|NCT01693614|455366636|FG002|Overall Study|Withdrawal by subject/guardian|2|||
126565980|NCT01693614|455366634|FG000|Overall Study|Withdrawal by Subject|1|||
126565981|NCT01693614|455366635|FG001|Overall Study|Withdrawal by Subject|0|||
126565982|NCT01693614|455366636|FG002|Overall Study|Withdrawal by Subject|5|||
126565983|NCT00420316|455366637|FG000|Overall Study|Withdrawal by Subject|0|||
126565984|NCT00420316|455366638|FG001|Overall Study|Withdrawal by Subject|1|||
126565985|NCT00420316|455366637|FG000|Overall Study|Lost to Follow-up|12|||
126565986|NCT00420316|455366638|FG001|Overall Study|Lost to Follow-up|8|||
126565987|NCT01196988|455366639|FG000|Overall Study|Adverse Event|1|||
126565988|NCT01196988|455366640|FG001|Overall Study|Adverse Event|2|||
126565989|NCT01196988|455366641|FG002|Overall Study|Adverse Event|0|||
126565990|NCT01196988|455366642|FG003|Overall Study|Adverse Event|0|||
126565991|NCT01196988|455366639|FG000|Overall Study|Withdrawal by Subject|5|||
126565992|NCT01196988|455366640|FG001|Overall Study|Withdrawal by Subject|1|||
126565993|NCT01196988|455366641|FG002|Overall Study|Withdrawal by Subject|4|||
126510449|NCT04958109|455166939|FG000|Overall Study|Withdrawal by Subject|0|||
126510450|NCT04958109|455166940|FG001|Overall Study|Withdrawal by Subject|1|||
126510451|NCT04958109|455166939|FG000|Overall Study|Lost to Follow-up|0|||
126510452|NCT04958109|455166940|FG001|Overall Study|Lost to Follow-up|1|||
126510453|NCT01573624|455166944|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
126510454|NCT01573624|455166945|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
126510455|NCT01573624|455166946|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
126510456|NCT01573624|455166947|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
126510457|NCT01573624|455166948|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
126510458|NCT01573624|455166949|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
126510459|NCT01573624|455166950|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
126510460|NCT01573624|455166944|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
126565994|NCT01196988|455366642|FG003|Overall Study|Withdrawal by Subject|0|||
126565995|NCT01196988|455366639|FG000|Overall Study|Lost to Follow-up|16|||
126565996|NCT01196988|455366640|FG001|Overall Study|Lost to Follow-up|29|||
126565997|NCT01196988|455366641|FG002|Overall Study|Lost to Follow-up|21|||
126565998|NCT01196988|455366642|FG003|Overall Study|Lost to Follow-up|1|||
126565999|NCT01196988|455366639|FG000|Overall Study|Other|2|||
126566000|NCT01196988|455366640|FG001|Overall Study|Other|0|||
126566001|NCT01196988|455366641|FG002|Overall Study|Other|0|||
126510461|NCT01573624|455166945|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
126510462|NCT01573624|455166946|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
126510463|NCT01573624|455166947|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
126510464|NCT01573624|455166948|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
126510465|NCT01573624|455166949|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
126510466|NCT01573624|455166950|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
126510467|NCT01573624|455166944|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
126510468|NCT01573624|455166945|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
126510469|NCT01573624|455166946|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
126510470|NCT01573624|455166947|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
126510471|NCT01573624|455166948|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
126510472|NCT01573624|455166949|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
126510473|NCT01573624|455166950|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
126510474|NCT01573624|455166944|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126510475|NCT01573624|455166945|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126510476|NCT01573624|455166946|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126510477|NCT01573624|455166947|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126510478|NCT01573624|455166948|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126510479|NCT01573624|455166949|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
126510480|NCT01573624|455166950|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126510481|NCT01573624|455166944|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
126510482|NCT01573624|455166945|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
126510483|NCT01573624|455166946|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
126510484|NCT01573624|455166947|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
126566002|NCT01196988|455366642|FG003|Overall Study|Other|0|||
126566003|NCT05419557|455366643|FG000|Overall Study|Lost to Follow-up|11|||
126566004|NCT05419557|455366644|FG001|Overall Study|Lost to Follow-up|4|||
126566005|NCT00920686|455366646|FG000|Overall Study|Lost to Follow-up|2|||
126566006|NCT00920686|455366647|FG001|Overall Study|Lost to Follow-up|3|||
126566007|NCT00920686|455366648|FG002|Overall Study|Lost to Follow-up|1|||
126566008|NCT00920686|455366646|FG000|Overall Study|Study drug dosing criteria not met|17|||
126566009|NCT00920686|455366647|FG001|Overall Study|Study drug dosing criteria not met|19|||
126566010|NCT00920686|455366648|FG002|Overall Study|Study drug dosing criteria not met|12|||
126566011|NCT00868192|455366649|FG000|Overall Study|Ineligible|4|||
126566012|NCT04304534|455366650|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
126566013|NCT04304534|455366651|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
126566014|NCT04304534|455366652|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
126566015|NCT04304534|455366653|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
126510485|NCT01573624|455166948|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
126510486|NCT01573624|455166949|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
126510487|NCT01573624|455166950|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
126510488|NCT01573624|455166944|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
126510489|NCT01573624|455166945|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
126510490|NCT01573624|455166946|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
126510491|NCT01573624|455166947|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
126510492|NCT01573624|455166948|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
126566016|NCT04304534|455366650|FG000|Overall Study|Non-Compliance with study drug|0|||
126566017|NCT04304534|455366651|FG001|Overall Study|Non-Compliance with study drug|1|||
126510493|NCT01573624|455166949|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
126510494|NCT01573624|455166950|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
126510495|NCT01573624|455166944|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
126510496|NCT01573624|455166945|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
126510497|NCT01573624|455166946|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
126510498|NCT01573624|455166947|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
126510499|NCT01573624|455166948|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
126510500|NCT01573624|455166949|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
126510501|NCT01573624|455166950|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
126510502|NCT01573624|455166944|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
126510503|NCT01573624|455166945|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
126510504|NCT01573624|455166946|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
126510505|NCT01573624|455166947|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
126510506|NCT01573624|455166948|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
126566018|NCT04304534|455366652|FG002|Overall Study|Non-Compliance with study drug|1|||
126566019|NCT04304534|455366653|FG003|Overall Study|Non-Compliance with study drug|1|||
126566020|NCT04304534|455366650|FG000|Overall Study|Lost to Follow-up|0|||
126510507|NCT01573624|455166949|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
126510508|NCT01573624|455166950|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
126510509|NCT01573624|455166944|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
126510510|NCT01573624|455166945|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
126510511|NCT01573624|455166946|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
126510512|NCT01573624|455166947|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
126566021|NCT04304534|455366651|FG001|Overall Study|Lost to Follow-up|1|||
126566022|NCT04304534|455366652|FG002|Overall Study|Lost to Follow-up|2|||
126566023|NCT04304534|455366653|FG003|Overall Study|Lost to Follow-up|3|||
126566024|NCT04304534|455366650|FG000|Overall Study|Unspecific|4|||
126566025|NCT04304534|455366651|FG001|Overall Study|Unspecific|2|||
126566026|NCT04304534|455366652|FG002|Overall Study|Unspecific|2|||
126566027|NCT04304534|455366653|FG003|Overall Study|Unspecific|2|||
126566028|NCT04304534|455366650|FG000|Overall Study|Technical Problems|2|||
126566029|NCT04304534|455366651|FG001|Overall Study|Technical Problems|2|||
126566030|NCT04304534|455366652|FG002|Overall Study|Technical Problems|3|||
126566031|NCT04304534|455366653|FG003|Overall Study|Technical Problems|4|||
126566032|NCT04304534|455366650|FG000|Overall Study|Death|7|||
126566033|NCT04304534|455366651|FG001|Overall Study|Death|2|||
126566034|NCT04304534|455366652|FG002|Overall Study|Death|4|||
126566035|NCT04304534|455366653|FG003|Overall Study|Death|3|||
126566036|NCT04304534|455366650|FG000|Overall Study|Withdrawal by Subject|7|||
126566037|NCT04304534|455366651|FG001|Overall Study|Withdrawal by Subject|2|||
126566038|NCT04304534|455366652|FG002|Overall Study|Withdrawal by Subject|7|||
126566039|NCT04304534|455366653|FG003|Overall Study|Withdrawal by Subject|4|||
126566040|NCT04304534|455366650|FG000|Overall Study|Physician Decision|4|||
126566041|NCT04304534|455366651|FG001|Overall Study|Physician Decision|9|||
126566042|NCT04304534|455366652|FG002|Overall Study|Physician Decision|9|||
126566043|NCT04304534|455366653|FG003|Overall Study|Physician Decision|5|||
126566044|NCT04304534|455366650|FG000|Overall Study|Subject Decision|34|||
126566045|NCT04304534|455366651|FG001|Overall Study|Subject Decision|25|||
126566046|NCT04304534|455366652|FG002|Overall Study|Subject Decision|25|||
126566047|NCT04304534|455366653|FG003|Overall Study|Subject Decision|26|||
126566048|NCT04304534|455366650|FG000|Overall Study|Adverse Event|35|||
126566049|NCT04304534|455366651|FG001|Overall Study|Adverse Event|40|||
126566050|NCT04304534|455366652|FG002|Overall Study|Adverse Event|39|||
126566051|NCT04304534|455366653|FG003|Overall Study|Adverse Event|44|||
126566052|NCT00001575|455366654|FG000|Overall Study|Screening failures-Ph I portion|22|||
126566053|NCT00001575|455366654|FG000|Overall Study|Withdrawn/deaths|23|||
126566054|NCT02701361|455366664|FG000|Overall Study|Lost to Follow-up|5|||
126566055|NCT02701361|455366665|FG001|Overall Study|Lost to Follow-up|2|||
126566056|NCT02701361|455366666|FG002|Overall Study|Lost to Follow-up|1|||
126566057|NCT02701361|455366664|FG000|Overall Study|Withdrawal by Subject|4|||
126566058|NCT02701361|455366665|FG001|Overall Study|Withdrawal by Subject|0|||
126510513|NCT01573624|455166948|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
126510514|NCT01573624|455166949|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
126510515|NCT01573624|455166950|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
126510516|NCT01573624|455166944|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
126510517|NCT01573624|455166945|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
126510518|NCT01573624|455166946|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
126510519|NCT01573624|455166947|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
126510520|NCT01573624|455166948|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
126510521|NCT01573624|455166949|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
126510522|NCT01573624|455166950|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
126510523|NCT01573624|455166944|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
126510524|NCT01573624|455166945|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
126510525|NCT01573624|455166946|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
126510526|NCT01573624|455166947|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
126510527|NCT01573624|455166948|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
126510528|NCT01573624|455166949|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
126510529|NCT01573624|455166950|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
126510530|NCT01573624|455166944|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
126566059|NCT02701361|455366666|FG002|Overall Study|Withdrawal by Subject|0|||
126566060|NCT02701361|455366664|FG000|Overall Study|timed out in rehab center|0|||
126566061|NCT02701361|455366665|FG001|Overall Study|timed out in rehab center|1|||
126566062|NCT02701361|455366666|FG002|Overall Study|timed out in rehab center|0|||
126566063|NCT02701361|455366664|FG000|Overall Study|incarceration|0|||
126566064|NCT02701361|455366665|FG001|Overall Study|incarceration|0|||
126566065|NCT02701361|455366666|FG002|Overall Study|incarceration|1|||
126566066|NCT01190150|455366671|FG000|First Treatment|Withdrawal by Subject|1|||
126566067|NCT01190150|455366672|FG001|First Treatment|Withdrawal by Subject|0|||
126566068|NCT01190150|455366671|FG000|Washout|Withdrawal by Subject|0|||
126566069|NCT01190150|455366672|FG001|Washout|Withdrawal by Subject|1|||
126566070|NCT01190150|455366671|FG000|Washout|Difficulty in adherence|0|||
126566071|NCT01190150|455366672|FG001|Washout|Difficulty in adherence|1|||
126566072|NCT00843193|455366675|FG000|Overall Study|Adverse Event|2|||
126566073|NCT00843193|455366676|FG001|Overall Study|Adverse Event|4|||
126566074|NCT00843193|455366675|FG000|Overall Study|Lack of Efficacy|1|||
126566075|NCT00843193|455366676|FG001|Overall Study|Lack of Efficacy|1|||
126566076|NCT00843193|455366675|FG000|Overall Study|Protocol Violation|1|||
126566077|NCT00843193|455366676|FG001|Overall Study|Protocol Violation|2|||
126566078|NCT00843193|455366675|FG000|Overall Study|Lost to Follow-up|1|||
126566079|NCT00843193|455366676|FG001|Overall Study|Lost to Follow-up|0|||
126566080|NCT00843193|455366675|FG000|Overall Study|Physician Decision|0|||
126566081|NCT00843193|455366676|FG001|Overall Study|Physician Decision|1|||
126566082|NCT00843193|455366675|FG000|Overall Study|Withdrawal by Subject|3|||
126566083|NCT00843193|455366676|FG001|Overall Study|Withdrawal by Subject|3|||
126566084|NCT02982213|455366677|FG000|Overall Study|Did not complete follow up questionnaire|5|||
126566085|NCT02982213|455366678|FG001|Overall Study|Did not complete follow up questionnaire|1|||
126566086|NCT01543685|455366681|FG000|Overall Study|Lack of Efficacy|1|||
126566087|NCT01543685|455366682|FG001|Overall Study|Lack of Efficacy|2|||
126566088|NCT01543685|455366683|FG002|Overall Study|Lack of Efficacy|2|||
126566089|NCT01543685|455366684|FG003|Overall Study|Lack of Efficacy|0|||
126566090|NCT01543685|455366685|FG004|Overall Study|Lack of Efficacy|2|||
126566091|NCT01543685|455366681|FG000|Overall Study|Adverse Event|2|||
126566092|NCT01543685|455366682|FG001|Overall Study|Adverse Event|1|||
126566093|NCT01543685|455366683|FG002|Overall Study|Adverse Event|0|||
126566094|NCT01543685|455366684|FG003|Overall Study|Adverse Event|0|||
126566095|NCT01543685|455366685|FG004|Overall Study|Adverse Event|2|||
126566096|NCT02931396|455366686|FG000|Overall Study|Lost to Follow-up|3|||
126566097|NCT02931396|455366687|FG001|Overall Study|Lost to Follow-up|0|||
126566098|NCT02931396|455366686|FG000|Overall Study|Withdrawal by Subject|2|||
126566099|NCT02931396|455366687|FG001|Overall Study|Withdrawal by Subject|0|||
126566100|NCT01304147|455366690|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
126566101|NCT01304147|455366691|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
126566102|NCT01278862|455366692|FG000|Overall Study|Lost to Follow-up|1|||
126566103|NCT01278862|455366693|FG001|Overall Study|Lost to Follow-up|1|||
126566104|NCT00603447|455366695|FG000|Overall Study|Adverse Event|0|||
126566105|NCT00603447|455366696|FG001|Overall Study|Adverse Event|1|||
126566106|NCT00603447|455366697|FG002|Overall Study|Adverse Event|1|||
126566107|NCT00603447|455366698|FG003|Overall Study|Adverse Event|2|||
126566108|NCT00603447|455366699|FG004|Overall Study|Adverse Event|1|||
126566109|NCT00603447|455366700|FG005|Overall Study|Adverse Event|2|||
126566110|NCT00603447|455366701|FG006|Overall Study|Adverse Event|10|||
126566111|NCT00603447|455366695|FG000|Overall Study|Other|0|||
126566112|NCT00603447|455366696|FG001|Overall Study|Other|0|||
126566113|NCT00603447|455366697|FG002|Overall Study|Other|1|||
126566114|NCT00603447|455366698|FG003|Overall Study|Other|0|||
126566115|NCT00603447|455366699|FG004|Overall Study|Other|3|||
126566116|NCT00603447|455366700|FG005|Overall Study|Other|0|||
126566117|NCT00603447|455366701|FG006|Overall Study|Other|13|||
126566118|NCT00603447|455366695|FG000|Overall Study|Withdrew Consent|0|||
126566119|NCT00603447|455366696|FG001|Overall Study|Withdrew Consent|2|||
126566120|NCT00603447|455366697|FG002|Overall Study|Withdrew Consent|0|||
126566121|NCT00603447|455366698|FG003|Overall Study|Withdrew Consent|0|||
126566122|NCT00603447|455366699|FG004|Overall Study|Withdrew Consent|1|||
126566123|NCT00603447|455366700|FG005|Overall Study|Withdrew Consent|0|||
126566124|NCT00603447|455366701|FG006|Overall Study|Withdrew Consent|1|||
126566125|NCT02952261|455366702|FG000|Overall Study|Withdrawal by Subject|4|||
126566126|NCT02952261|455366703|FG001|Overall Study|Withdrawal by Subject|5|||
126566127|NCT02952261|455366702|FG000|Overall Study|Protocol Violation|1|||
126566128|NCT02952261|455366703|FG001|Overall Study|Protocol Violation|0|||
126566129|NCT05233085|455366704|FG000|Overall Study|Adverse Event|1|||
126566130|NCT05233085|455366705|FG001|Overall Study|Adverse Event|0|||
126566131|NCT05233085|455366706|FG002|Overall Study|Adverse Event|0|||
126566132|NCT05233085|455366707|FG003|Overall Study|Adverse Event|0|||
126566133|NCT00798265|455366708|FG000|Overall Study|Lost to Follow-up|1|||
126566134|NCT00798265|455366709|FG001|Overall Study|Lost to Follow-up|10|||
126566135|NCT00798265|455366708|FG000|Overall Study|Study closing|7|||
126566136|NCT00798265|455366709|FG001|Overall Study|Study closing|6|||
126566137|NCT00798265|455366708|FG000|Overall Study|Withdrawal by Subject|0|||
126566138|NCT00798265|455366709|FG001|Overall Study|Withdrawal by Subject|1|||
126566139|NCT00798265|455366708|FG000|Overall Study|Screen failure|0|||
126566140|NCT00798265|455366709|FG001|Overall Study|Screen failure|1|||
126566141|NCT01311648|455367996|FG000|Main Study|Protocol Violation|0|||
126566142|NCT01311648|455367997|FG001|Main Study|Protocol Violation|1|||
126566143|NCT01311648|455367996|FG000|Main Study|Adverse Event|0|||
126566144|NCT01311648|455367997|FG001|Main Study|Adverse Event|1|||
126566145|NCT01311648|455367996|FG000|Main Study|Inhibitor management|0|||
126566146|NCT01311648|455367997|FG001|Main Study|Inhibitor management|17|||
126566147|NCT01311648|455367996|FG000|Main Study|Withdrawal by Subject|0|||
126566148|NCT01311648|455367997|FG001|Main Study|Withdrawal by Subject|2|||
126510531|NCT01573624|455166945|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
126510532|NCT01573624|455166946|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
126510533|NCT01573624|455166947|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
126510534|NCT01573624|455166948|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
126566149|NCT01311648|455367996|FG000|Extension Study|Physician Decision|0|||
126566150|NCT01311648|455367997|FG001|Extension Study|Physician Decision|1|||
126566151|NCT01311648|455367996|FG000|Extension Study|ITI therapy with marketed product|0|||
126566152|NCT01311648|455367997|FG001|Extension Study|ITI therapy with marketed product|1|||
126566153|NCT01311648|455367996|FG000|Extension Study|Incorrect visit planning|0|||
126566154|NCT01311648|455367997|FG001|Extension Study|Incorrect visit planning|1|||
126566155|NCT01311648|455367996|FG000|Extension Study|Family's decision|0|||
126566156|NCT01311648|455367997|FG001|Extension Study|Family's decision|1|||
126566157|NCT01311648|455367996|FG000|Extension Study|Failure of ITI therapy|0|||
126566158|NCT01311648|455367997|FG001|Extension Study|Failure of ITI therapy|3|||
126566159|NCT01311648|455367996|FG000|Extension Study|Long travel|0|||
126566160|NCT01311648|455367997|FG001|Extension Study|Long travel|1|||
126566161|NCT01311648|455367996|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
126566162|NCT01311648|455367997|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
126566163|NCT01311648|455367996|FG000|Extension Study|Withdrawal by Subject|0|||
126566164|NCT01311648|455367997|FG001|Extension Study|Withdrawal by Subject|1|||
126566165|NCT01311648|455367996|FG000|Extension Study|Inhibitor management|0|||
126566166|NCT01311648|455367997|FG001|Extension Study|Inhibitor management|2|||
126566167|NCT03712930|455367998|FG000|Overall Study|Death|7|||
126566168|NCT03712930|455367998|FG000|Overall Study|Physician Decision|1|||
126566169|NCT03712930|455367998|FG000|Overall Study|Study Terminated by Sponsor|3|||
126566170|NCT03712930|455367998|FG000|Overall Study|Progressive Disease|2|||
126566171|NCT02030028|455367999|FG000|Overall Study|Withdrawal by Subject|4|||
126566172|NCT02030028|455367999|FG000|Overall Study|lack of transportation|1|||
126566173|NCT01249092|455368000|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
126566174|NCT01249092|455368000|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
126566175|NCT02930343|455368001|FG000|Overall Study|Lost to Follow-up|9|||
126566176|NCT02930343|455368002|FG001|Overall Study|Lost to Follow-up|7|||
126566177|NCT03357341|455368005|FG000|Overall Study|Withdrawal by Subject|3|||
126510535|NCT01573624|455166949|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
126510536|NCT01573624|455166950|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
126510537|NCT01573624|455166944|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
126510538|NCT01573624|455166945|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
126510539|NCT01573624|455166946|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
126510540|NCT01573624|455166947|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
126510541|NCT01573624|455166948|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
126510542|NCT01573624|455166949|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
126510543|NCT01573624|455166950|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
126510544|NCT01573624|455166944|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
126510545|NCT01573624|455166945|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
126510546|NCT01573624|455166946|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
126510547|NCT01573624|455166947|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
126510548|NCT01573624|455166948|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
126510549|NCT01573624|455166949|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
126510550|NCT01573624|455166950|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
126510551|NCT01573624|455166944|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
126510552|NCT01573624|455166945|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
126510553|NCT01573624|455166946|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
126510554|NCT01573624|455166947|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
126510555|NCT01573624|455166948|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
126510556|NCT01573624|455166949|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
126510557|NCT01573624|455166950|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
126510558|NCT01573624|455166944|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
126510559|NCT01573624|455166945|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
126510560|NCT01573624|455166946|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
126510561|NCT01573624|455166947|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
126566178|NCT03357341|455368006|FG001|Overall Study|Withdrawal by Subject|6|||
126566179|NCT03357341|455368005|FG000|Overall Study|Lost to Follow-up|4|||
126566180|NCT03357341|455368006|FG001|Overall Study|Lost to Follow-up|5|||
126566181|NCT03357341|455368005|FG000|Overall Study|Death|0|||
126566182|NCT03357341|455368006|FG001|Overall Study|Death|1|||
126566183|NCT01233050|455368007|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
126566184|NCT01233050|455368008|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
126566185|NCT01064817|455368009|FG000|Study Completion|Physician Decision|1|||
126510562|NCT01573624|455166948|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
126510563|NCT01573624|455166949|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
126510564|NCT01573624|455166950|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
126510565|NCT01573624|455166944|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
126510566|NCT01573624|455166945|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
126510567|NCT01573624|455166946|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
126510568|NCT01573624|455166947|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
126510569|NCT01573624|455166948|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
126510570|NCT01573624|455166949|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
126510571|NCT01573624|455166950|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
126510572|NCT01573624|455166944|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
126510573|NCT01573624|455166945|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
126510574|NCT01573624|455166946|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
126510575|NCT01573624|455166947|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
126510576|NCT01573624|455166948|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
126510577|NCT01573624|455166949|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
126510578|NCT01573624|455166950|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
126510579|NCT01573624|455166944|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
126510580|NCT01573624|455166945|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
126510581|NCT01573624|455166946|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
126510582|NCT01573624|455166947|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
126510583|NCT01573624|455166948|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
126510584|NCT01573624|455166949|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
126510585|NCT01573624|455166950|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
126510586|NCT01573624|455166944|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
126510587|NCT01573624|455166945|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
126510588|NCT01573624|455166946|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
126510589|NCT01573624|455166947|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
126510590|NCT01573624|455166948|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
126510591|NCT01573624|455166949|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
126510592|NCT01573624|455166950|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
126510593|NCT01573624|455166944|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
126510594|NCT01573624|455166945|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
126510595|NCT01573624|455166946|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
126510596|NCT01573624|455166947|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
126510597|NCT01573624|455166948|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
126510598|NCT01573624|455166949|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
126510599|NCT01573624|455166950|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
126510600|NCT01573624|455166944|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
126510601|NCT01573624|455166945|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
126566186|NCT01064817|455368010|FG001|Study Completion|Physician Decision|0|||
126566187|NCT01064817|455368009|FG000|Study Completion|Withdrawal by Subject|1|||
126566188|NCT01064817|455368010|FG001|Study Completion|Withdrawal by Subject|0|||
126566189|NCT01466881|455368012|FG000|Overall Study|Ineligible|5|||
126566190|NCT01466881|455368012|FG000|Overall Study|Adverse Event|6|||
126566191|NCT01466881|455368012|FG000|Overall Study|Progression/relapse|20|||
126566192|NCT01466881|455368012|FG000|Overall Study|Death|4|||
126566193|NCT01466881|455368012|FG000|Overall Study|Other reason not protocol specified|5|||
126566194|NCT04580303|455368015|FG000|Overall Study|Adverse Event|0|||
126566195|NCT04580303|455368016|FG001|Overall Study|Adverse Event|1|||
126566196|NCT04580303|455368017|FG002|Overall Study|Adverse Event|0|||
126566197|NCT04580303|455368018|FG003|Overall Study|Adverse Event|0|||
126566198|NCT04580303|455368015|FG000|Overall Study|Withdrawal by Subject|0|||
126566199|NCT04580303|455368016|FG001|Overall Study|Withdrawal by Subject|0|||
126566200|NCT04580303|455368017|FG002|Overall Study|Withdrawal by Subject|1|||
126566201|NCT04580303|455368018|FG003|Overall Study|Withdrawal by Subject|0|||
126566202|NCT00927823|455368022|FG000|Continuous Dosing Period|Death|0|||
126510602|NCT01573624|455166946|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
126510603|NCT01573624|455166947|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
126510604|NCT01573624|455166948|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
126566203|NCT00927823|455368023|FG001|Continuous Dosing Period|Death|0|||
126566204|NCT00927823|455368024|FG002|Continuous Dosing Period|Death|6|||
126566205|NCT00927823|455368025|FG003|Continuous Dosing Period|Death|0|||
126566206|NCT00927823|455368022|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
126566207|NCT00927823|455368023|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
126566208|NCT00927823|455368024|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
126510605|NCT01573624|455166949|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
126510606|NCT01573624|455166950|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
126510607|NCT01573624|455166944|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
126510608|NCT01573624|455166945|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126510609|NCT01573624|455166946|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126510610|NCT01573624|455166947|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
126510611|NCT01573624|455166948|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
126510612|NCT01573624|455166949|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
126510613|NCT01573624|455166950|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
126510614|NCT01573624|455166944|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
126510615|NCT01573624|455166945|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
126510616|NCT01573624|455166946|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
126510617|NCT01573624|455166947|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
126510618|NCT01573624|455166948|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
126510619|NCT01573624|455166949|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
126510620|NCT01573624|455166950|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
126510621|NCT01573624|455166944|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
126510622|NCT01573624|455166945|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
126510623|NCT01573624|455166946|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
126510624|NCT01573624|455166947|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
126510625|NCT01573624|455166948|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
126510626|NCT01573624|455166949|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
126510627|NCT01573624|455166950|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
126510628|NCT01573624|455166944|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
126510629|NCT01573624|455166945|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
126510630|NCT01573624|455166946|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
126510631|NCT01573624|455166947|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
126510632|NCT01573624|455166948|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
126510633|NCT01573624|455166949|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
126510634|NCT01573624|455166950|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
126510635|NCT01573624|455166944|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
126510636|NCT01573624|455166945|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
126510637|NCT01573624|455166946|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
126510638|NCT01573624|455166947|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
126510639|NCT01573624|455166948|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
126510640|NCT01573624|455166949|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
126510641|NCT01573624|455166950|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
126510642|NCT03417141|455166954|FG000|Overall Study|Withdrawal by Subject|1|||
126510643|NCT03417141|455166954|FG000|Overall Study|Protocol Violation|3|||
126510644|NCT03706690|455166955|FG000|Overall Study|Withdrawal by Subject|8|||
126510645|NCT03706690|455166956|FG001|Overall Study|Withdrawal by Subject|8|||
126510646|NCT03706690|455166955|FG000|Overall Study|Death|143|||
126510647|NCT03706690|455166956|FG001|Overall Study|Death|75|||
126510648|NCT03706690|455166955|FG000|Overall Study|Ongoing at DCO|121|||
126510649|NCT03706690|455166956|FG001|Overall Study|Ongoing at DCO|52|||
126510650|NCT02098109|455166957|FG000|Overall Study|Protocol Violation|3|||
126510651|NCT02098109|455166958|FG001|Overall Study|Protocol Violation|0|||
126510652|NCT02143843|455166959|FG000|Overall Study|Adverse Event|8|||
126510653|NCT02143843|455166959|FG000|Overall Study|Lack of Efficacy|2|||
126510654|NCT02143843|455166959|FG000|Overall Study|Withdrawal by Subject|2|||
126510655|NCT03467425|455166964|FG000|Overall Study|Adverse Event|9|||
126510656|NCT03467425|455166965|FG001|Overall Study|Adverse Event|9|||
126510657|NCT03467425|455166964|FG000|Overall Study|Lack of Efficacy|3|||
126510658|NCT03467425|455166965|FG001|Overall Study|Lack of Efficacy|1|||
126510659|NCT03467425|455166964|FG000|Overall Study|Protocol Violation|0|||
126510660|NCT03467425|455166965|FG001|Overall Study|Protocol Violation|1|||
126510661|NCT03467425|455166964|FG000|Overall Study|Lost to Follow-up|18|||
126510662|NCT03467425|455166965|FG001|Overall Study|Lost to Follow-up|25|||
126510663|NCT03467425|455166964|FG000|Overall Study|Physician Decision|2|||
126510664|NCT03467425|455166965|FG001|Overall Study|Physician Decision|1|||
126510665|NCT03467425|455166964|FG000|Overall Study|Withdrawal by Subject|15|||
126510666|NCT03467425|455166965|FG001|Overall Study|Withdrawal by Subject|17|||
126510667|NCT02318693|455166966|FG000|Overall Study|Protocol Violation|0|||
126510668|NCT02318693|455166967|FG001|Overall Study|Protocol Violation|1|||
126510669|NCT00025883|455166968|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
126510670|NCT00025883|455166968|FG000|Overall Study|no baseline data|1|||
126510671|NCT00025883|455166968|FG000|Overall Study|Death|1|||
126510672|NCT00025883|455166968|FG000|Overall Study|Adverse Event|1|||
126510673|NCT00025883|455166968|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
126510674|NCT03080961|455166969|FG000|Overall Study|Withdrawal by Subject|3|||
126510675|NCT04197713|455166974|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
126510676|NCT04197713|455166975|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
126510677|NCT04487080|455166978|FG000|Overall Study|Withdrawal by Subject|19|||
126510678|NCT04487080|455166979|FG001|Overall Study|Withdrawal by Subject|18|||
126510679|NCT04487080|455166980|FG002|Overall Study|Withdrawal by Subject|13|||
126510680|NCT04487080|455166978|FG000|Overall Study|Lost to Follow-up|3|||
126510681|NCT04487080|455166979|FG001|Overall Study|Lost to Follow-up|1|||
126510682|NCT04487080|455166980|FG002|Overall Study|Lost to Follow-up|0|||
126510683|NCT04487080|455166978|FG000|Overall Study|Ongoing|313|||
126510684|NCT04487080|455166979|FG001|Overall Study|Ongoing|297|||
126510685|NCT04487080|455166980|FG002|Overall Study|Ongoing|149|||
126510686|NCT05645432|455166981|FG000|Overall Study|Withdrawal by Subject|1|||
126510687|NCT03195478|455166982|FG000|Overall Study|Disease Progression|5|||
126510688|NCT03195478|455166983|FG001|Overall Study|Disease Progression|4|||
126510689|NCT03195478|455166984|FG002|Overall Study|Disease Progression|6|||
126510690|NCT03195478|455166985|FG003|Overall Study|Disease Progression|1|||
126510691|NCT03195478|455166982|FG000|Overall Study|Study Drug Toxicity|2|||
126510692|NCT03195478|455166983|FG001|Overall Study|Study Drug Toxicity|0|||
126510693|NCT03195478|455166984|FG002|Overall Study|Study Drug Toxicity|0|||
126510694|NCT03195478|455166985|FG003|Overall Study|Study Drug Toxicity|1|||
126510695|NCT03195478|455166982|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
126510696|NCT03195478|455166983|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
126510697|NCT03195478|455166984|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
126510698|NCT03195478|455166985|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
126510699|NCT03195478|455166982|FG000|Overall Study|Participant Withdrew Consent|1|||
126510700|NCT03195478|455166983|FG001|Overall Study|Participant Withdrew Consent|0|||
126510701|NCT03195478|455166984|FG002|Overall Study|Participant Withdrew Consent|0|||
126510702|NCT03195478|455166985|FG003|Overall Study|Participant Withdrew Consent|0|||
126510703|NCT03195478|455166982|FG000|Overall Study|Maximum Clinical benefit|0|||
126510704|NCT03195478|455166983|FG001|Overall Study|Maximum Clinical benefit|0|||
126510705|NCT03195478|455166984|FG002|Overall Study|Maximum Clinical benefit|1|||
126510706|NCT03195478|455166985|FG003|Overall Study|Maximum Clinical benefit|0|||
126510707|NCT03195478|455166982|FG000|Overall Study|Other Reasons|0|||
126510708|NCT03195478|455166983|FG001|Overall Study|Other Reasons|0|||
126510709|NCT03195478|455166984|FG002|Overall Study|Other Reasons|1|||
126510710|NCT03195478|455166985|FG003|Overall Study|Other Reasons|0|||
126510711|NCT00533949|455168633|FG000|Overall Study|Protocol Violation|12|||
126510712|NCT00533949|455168634|FG001|Overall Study|Protocol Violation|12|||
126510713|NCT00533949|455168635|FG002|Overall Study|Protocol Violation|9|||
126510714|NCT00533949|455168636|FG003|Overall Study|Protocol Violation|9|||
126510715|NCT00533949|455168633|FG000|Overall Study|Withdrawal by Subject|3|||
126510716|NCT00533949|455168634|FG001|Overall Study|Withdrawal by Subject|2|||
126510717|NCT00533949|455168635|FG002|Overall Study|Withdrawal by Subject|1|||
126510718|NCT00533949|455168636|FG003|Overall Study|Withdrawal by Subject|1|||
126510719|NCT00727194|455168637|FG000|Screening Period|Low QMG scores|0|||
126510720|NCT00727194|455168638|FG001|Screening Period|Low QMG scores|0|||
126510721|NCT00727194|455168639|FG002|Screening Period|Low QMG scores|6|||
126510722|NCT00727194|455168637|FG000|Screening Period|Lacked AChR antibodies|0|||
126510723|NCT00727194|455168638|FG001|Screening Period|Lacked AChR antibodies|0|||
126510724|NCT00727194|455168639|FG002|Screening Period|Lacked AChR antibodies|5|||
126510725|NCT00727194|455168637|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
126510726|NCT00727194|455168638|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
126510727|NCT00727194|455168639|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
126510728|NCT00727194|455168637|FG000|Screening Period|Severe infections|0|||
126510729|NCT00727194|455168638|FG001|Screening Period|Severe infections|0|||
126510730|NCT00727194|455168639|FG002|Screening Period|Severe infections|2|||
126510731|NCT00727194|455168637|FG000|Screening Period|History of thymoma|0|||
126510732|NCT00727194|455168638|FG001|Screening Period|History of thymoma|0|||
126510733|NCT00727194|455168639|FG002|Screening Period|History of thymoma|1|||
126510734|NCT00727194|455168637|FG000|Treatment Period 2|Lack of Efficacy|0|||
126510735|NCT00727194|455168638|FG001|Treatment Period 2|Lack of Efficacy|1|||
126510736|NCT00727194|455168639|FG002|Treatment Period 2|Lack of Efficacy|0|||
126510737|NCT04269161|455168645|FG000|Overall Study|Change of modality and no longer eligible|3|||
126510738|NCT04269161|455168646|FG001|Overall Study|Change of modality and no longer eligible|3|||
126510739|NCT04269161|455168645|FG000|Overall Study|Required procedure outside of NICU|1|||
126510740|NCT04269161|455168646|FG001|Overall Study|Required procedure outside of NICU|0|||
126510741|NCT04269161|455168645|FG000|Overall Study|Equipment issue|1|||
126510742|NCT04269161|455168646|FG001|Overall Study|Equipment issue|1|||
126510743|NCT04108130|455168647|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
126510744|NCT04108130|455168648|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
126510745|NCT04108130|455168647|FG000|Overall Study|Consent Withdrawn|9|||
126510746|NCT04108130|455168648|FG001|Overall Study|Consent Withdrawn|6|||
126510747|NCT04108130|455168647|FG000|Overall Study|Surgery Cancelled|4|||
126510748|NCT04108130|455168648|FG001|Overall Study|Surgery Cancelled|4|||
126510749|NCT04108130|455168647|FG000|Overall Study|Found Ineligible for Study|4|||
126510750|NCT04108130|455168648|FG001|Overall Study|Found Ineligible for Study|3|||
126510751|NCT04108130|455168647|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
126510752|NCT04108130|455168648|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
126510753|NCT04108130|455168647|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
126510754|NCT04108130|455168648|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
126510755|NCT01207778|455168649|FG000|Overall Study|Lost to Follow-up|0|||
126510756|NCT01207778|455168650|FG001|Overall Study|Lost to Follow-up|3|||
126510757|NCT01207778|455168651|FG002|Overall Study|Lost to Follow-up|3|||
126510758|NCT00646204|455168652|FG000|Overall Study|Adverse Event|3|||
126510759|NCT00646204|455168653|FG001|Overall Study|Adverse Event|0|||
126510760|NCT00646204|455168652|FG000|Overall Study|Withdrawal by Subject|1|||
126510761|NCT00646204|455168653|FG001|Overall Study|Withdrawal by Subject|0|||
126510762|NCT02488629|455168659|FG000|Overall Study|Lack of Efficacy|3|||
126510763|NCT02488629|455168660|FG001|Overall Study|Lack of Efficacy|1|||
126510764|NCT02488629|455168661|FG002|Overall Study|Lack of Efficacy|0|||
126510765|NCT02488629|455168662|FG003|Overall Study|Lack of Efficacy|0|||
126510766|NCT02488629|455168659|FG000|Overall Study|Withdrawal by Subject|0|||
126510767|NCT02488629|455168660|FG001|Overall Study|Withdrawal by Subject|1|||
126510768|NCT02488629|455168661|FG002|Overall Study|Withdrawal by Subject|0|||
126510769|NCT02488629|455168662|FG003|Overall Study|Withdrawal by Subject|0|||
126510770|NCT02940691|455168663|FG000|Overall Study|Lost to Follow-up|5|||
126510771|NCT02940691|455168663|FG000|Overall Study|Incarceration|1|||
126510772|NCT00953329|455168666|FG000|Overall Study|Lack of Efficacy|1|||
126510773|NCT02477020|455168670|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
126510774|NCT02477020|455168671|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
126510775|NCT02477020|455168670|FG000|Overall Study|Voluntary Withdrawal|7|||
126510776|NCT02477020|455168671|FG001|Overall Study|Voluntary Withdrawal|16|||
126510777|NCT02477020|455168670|FG000|Overall Study|Reason not Specified|3|||
126510778|NCT02477020|455168671|FG001|Overall Study|Reason not Specified|1|||
126510779|NCT02477020|455168670|FG000|Overall Study|Lack of Efficacy|14|||
126510780|NCT02477020|455168671|FG001|Overall Study|Lack of Efficacy|5|||
126510781|NCT01340976|455168672|FG000|Overall Study|Physician Decision|2|||
126510782|NCT01340976|455168673|FG001|Overall Study|Physician Decision|0|||
126510783|NCT01340976|455168674|FG002|Overall Study|Physician Decision|1|||
126510784|NCT01340976|455168675|FG003|Overall Study|Physician Decision|1|||
126510785|NCT01340976|455168676|FG004|Overall Study|Physician Decision|1|||
126510786|NCT01340976|455168677|FG005|Overall Study|Physician Decision|0|||
126510787|NCT01340976|455168672|FG000|Overall Study|Death|0|||
126510788|NCT01340976|455168673|FG001|Overall Study|Death|1|||
126510789|NCT01340976|455168674|FG002|Overall Study|Death|0|||
126510790|NCT01340976|455168675|FG003|Overall Study|Death|0|||
126510791|NCT01340976|455168676|FG004|Overall Study|Death|0|||
126510792|NCT01340976|455168677|FG005|Overall Study|Death|0|||
126510793|NCT01340976|455168672|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
126510794|NCT01340976|455168673|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
126510795|NCT01340976|455168674|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
126510796|NCT01340976|455168675|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
126510797|NCT01340976|455168676|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
126510798|NCT01340976|455168677|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
126510799|NCT01340976|455168672|FG000|Overall Study|Withdrawal by Subject|0|||
126510800|NCT01340976|455168673|FG001|Overall Study|Withdrawal by Subject|0|||
126510801|NCT01340976|455168674|FG002|Overall Study|Withdrawal by Subject|0|||
126566209|NCT00927823|455368025|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
126566210|NCT00927823|455368022|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
126566211|NCT00927823|455368023|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
126566212|NCT00927823|455368024|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
126510802|NCT01340976|455168675|FG003|Overall Study|Withdrawal by Subject|1|||
126510803|NCT01340976|455168676|FG004|Overall Study|Withdrawal by Subject|1|||
126510804|NCT01340976|455168677|FG005|Overall Study|Withdrawal by Subject|0|||
126510805|NCT01340976|455168672|FG000|Overall Study|Other anemia treatment|1|||
126510806|NCT01340976|455168673|FG001|Overall Study|Other anemia treatment|0|||
126510807|NCT01340976|455168674|FG002|Overall Study|Other anemia treatment|2|||
126510808|NCT01340976|455168675|FG003|Overall Study|Other anemia treatment|1|||
126510809|NCT01340976|455168676|FG004|Overall Study|Other anemia treatment|0|||
126510810|NCT01340976|455168677|FG005|Overall Study|Other anemia treatment|1|||
126510811|NCT01340976|455168672|FG000|Overall Study|Adverse Event|0|||
126510812|NCT01340976|455168673|FG001|Overall Study|Adverse Event|1|||
126510813|NCT01340976|455168674|FG002|Overall Study|Adverse Event|0|||
126510814|NCT01340976|455168675|FG003|Overall Study|Adverse Event|0|||
126510815|NCT01340976|455168676|FG004|Overall Study|Adverse Event|0|||
126510816|NCT01340976|455168677|FG005|Overall Study|Adverse Event|0|||
126510817|NCT02331446|455168678|FG000|Overall Study|Lost to Follow-up|2|||
126510818|NCT02331446|455168679|FG001|Overall Study|Lost to Follow-up|1|||
126510819|NCT02331446|455168680|FG002|Overall Study|Lost to Follow-up|0|||
126510820|NCT02331446|455168681|FG003|Overall Study|Lost to Follow-up|1|||
126510821|NCT02331446|455168678|FG000|Overall Study|Personal Problem|2|||
126510822|NCT02331446|455168679|FG001|Overall Study|Personal Problem|0|||
126510823|NCT02331446|455168680|FG002|Overall Study|Personal Problem|0|||
126510824|NCT02331446|455168681|FG003|Overall Study|Personal Problem|0|||
126510825|NCT02331446|455168678|FG000|Overall Study|Disease|0|||
126510826|NCT02331446|455168679|FG001|Overall Study|Disease|2|||
126510827|NCT02331446|455168680|FG002|Overall Study|Disease|2|||
126510828|NCT02331446|455168681|FG003|Overall Study|Disease|1|||
126510829|NCT02331446|455168678|FG000|Overall Study|Physician Decision|0|||
126510830|NCT02331446|455168679|FG001|Overall Study|Physician Decision|1|||
126510831|NCT02331446|455168680|FG002|Overall Study|Physician Decision|0|||
126510832|NCT02331446|455168681|FG003|Overall Study|Physician Decision|1|||
126510833|NCT02331446|455168678|FG000|Overall Study|Lost before baseline analysis|0|||
126510834|NCT02331446|455168679|FG001|Overall Study|Lost before baseline analysis|1|||
126510835|NCT02331446|455168680|FG002|Overall Study|Lost before baseline analysis|1|||
126510836|NCT02331446|455168681|FG003|Overall Study|Lost before baseline analysis|0|||
126510837|NCT02566759|455168688|FG000|All Parts|Withdrawal by Subject|0|||
126510838|NCT02566759|455168689|FG001|All Parts|Withdrawal by Subject|1|||
126510839|NCT02566759|455168690|FG002|All Parts|Withdrawal by Subject|0|||
126510840|NCT02566759|455168691|FG003|All Parts|Withdrawal by Subject|0|||
126510841|NCT02566759|455168692|FG004|All Parts|Withdrawal by Subject|0|||
126510842|NCT02566759|455168693|FG005|All Parts|Withdrawal by Subject|0|||
126510843|NCT02566759|455168694|FG006|All Parts|Withdrawal by Subject|0|||
126510844|NCT02566759|455168695|FG007|All Parts|Withdrawal by Subject|0|||
126510845|NCT02566759|455168696|FG008|All Parts|Withdrawal by Subject|0|||
126510846|NCT02566759|455168697|FG009|All Parts|Withdrawal by Subject|0|||
126510847|NCT02566759|455168698|FG010|All Parts|Withdrawal by Subject|0|||
126510848|NCT02566759|455168699|FG011|All Parts|Withdrawal by Subject|0|||
126510849|NCT02566759|455168700|FG012|All Parts|Withdrawal by Subject|0|||
126510850|NCT02566759|455168701|FG013|All Parts|Withdrawal by Subject|0|||
126510851|NCT02566759|455168702|FG014|All Parts|Withdrawal by Subject|0|||
126510852|NCT02566759|455168703|FG015|All Parts|Withdrawal by Subject|0|||
126510853|NCT02566759|455168704|FG016|All Parts|Withdrawal by Subject|0|||
126510854|NCT02566759|455168688|FG000|All Parts|Adverse Event|0|||
126510855|NCT02566759|455168689|FG001|All Parts|Adverse Event|0|||
126510856|NCT02566759|455168690|FG002|All Parts|Adverse Event|0|||
126510857|NCT02566759|455168691|FG003|All Parts|Adverse Event|0|||
126510858|NCT02566759|455168692|FG004|All Parts|Adverse Event|0|||
126510859|NCT02566759|455168693|FG005|All Parts|Adverse Event|0|||
126510860|NCT02566759|455168694|FG006|All Parts|Adverse Event|0|||
126510861|NCT02566759|455168695|FG007|All Parts|Adverse Event|0|||
126510862|NCT02566759|455168696|FG008|All Parts|Adverse Event|0|||
126510863|NCT02566759|455168697|FG009|All Parts|Adverse Event|0|||
126510864|NCT02566759|455168698|FG010|All Parts|Adverse Event|0|||
126510865|NCT02566759|455168699|FG011|All Parts|Adverse Event|0|||
126510866|NCT02566759|455168700|FG012|All Parts|Adverse Event|1|||
126510867|NCT02566759|455168701|FG013|All Parts|Adverse Event|3|||
126510868|NCT02566759|455168702|FG014|All Parts|Adverse Event|0|||
126510869|NCT02566759|455168703|FG015|All Parts|Adverse Event|0|||
126510870|NCT02566759|455168704|FG016|All Parts|Adverse Event|0|||
126510871|NCT02566759|455168688|FG000|All Parts|Other|0|||
126510872|NCT02566759|455168689|FG001|All Parts|Other|0|||
126510873|NCT02566759|455168690|FG002|All Parts|Other|0|||
126510874|NCT02566759|455168691|FG003|All Parts|Other|0|||
126510875|NCT02566759|455168692|FG004|All Parts|Other|0|||
126510876|NCT02566759|455168693|FG005|All Parts|Other|0|||
126510877|NCT02566759|455168694|FG006|All Parts|Other|0|||
126510878|NCT02566759|455168695|FG007|All Parts|Other|0|||
126510879|NCT02566759|455168696|FG008|All Parts|Other|0|||
126510880|NCT02566759|455168697|FG009|All Parts|Other|0|||
126510881|NCT02566759|455168698|FG010|All Parts|Other|0|||
126510882|NCT02566759|455168699|FG011|All Parts|Other|0|||
126510883|NCT02566759|455168700|FG012|All Parts|Other|0|||
126510884|NCT02566759|455168701|FG013|All Parts|Other|2|||
126510885|NCT02566759|455168702|FG014|All Parts|Other|0|||
126510886|NCT02566759|455168703|FG015|All Parts|Other|0|||
126510887|NCT02566759|455168704|FG016|All Parts|Other|0|||
126510888|NCT02566759|455168688|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510889|NCT02566759|455168689|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510890|NCT02566759|455168690|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510891|NCT02566759|455168691|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510892|NCT02566759|455168692|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510893|NCT02566759|455168693|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510894|NCT02566759|455168694|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510895|NCT02566759|455168695|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510896|NCT02566759|455168696|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510897|NCT02566759|455168697|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510898|NCT02566759|455168698|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510899|NCT02566759|455168699|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510900|NCT02566759|455168700|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510901|NCT02566759|455168701|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126776955|NCT00267007|456139125|FG001|Overall Study|Lost to Follow-up|0|||
126510902|NCT02566759|455168702|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510903|NCT02566759|455168703|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
126510904|NCT02566759|455168704|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
126510905|NCT01126541|455168705|FG000|Overall Study|Adverse Event|0|||
126510906|NCT01126541|455168706|FG001|Overall Study|Adverse Event|2|||
126510907|NCT01126541|455168707|FG002|Overall Study|Adverse Event|4|||
126510908|NCT01126541|455168705|FG000|Overall Study|Death|0|||
126510909|NCT01126541|455168706|FG001|Overall Study|Death|1|||
126510910|NCT01126541|455168707|FG002|Overall Study|Death|0|||
126510911|NCT01126541|455168705|FG000|Overall Study|Lack of Efficacy|6|||
126510912|NCT01126541|455168706|FG001|Overall Study|Lack of Efficacy|1|||
126510913|NCT01126541|455168707|FG002|Overall Study|Lack of Efficacy|11|||
126510914|NCT01126541|455168705|FG000|Overall Study|Lost to Follow-up|1|||
126510915|NCT01126541|455168706|FG001|Overall Study|Lost to Follow-up|2|||
126510916|NCT01126541|455168707|FG002|Overall Study|Lost to Follow-up|2|||
126510917|NCT01126541|455168705|FG000|Overall Study|Withdrawal by Subject|2|||
126510918|NCT01126541|455168706|FG001|Overall Study|Withdrawal by Subject|5|||
126510919|NCT01126541|455168707|FG002|Overall Study|Withdrawal by Subject|6|||
126510920|NCT01126541|455168705|FG000|Overall Study|Protocol Violation|0|||
126510921|NCT01126541|455168706|FG001|Overall Study|Protocol Violation|0|||
126510922|NCT01126541|455168707|FG002|Overall Study|Protocol Violation|1|||
126510923|NCT01126541|455168705|FG000|Overall Study|Administrative reason or other|1|||
126510924|NCT01126541|455168706|FG001|Overall Study|Administrative reason or other|1|||
126510925|NCT01126541|455168707|FG002|Overall Study|Administrative reason or other|2|||
126510926|NCT03670810|455168712|FG000|Main Study|Adverse Event|37|||
126510927|NCT03670810|455168713|FG001|Main Study|Adverse Event|38|||
126510928|NCT03670810|455168714|FG002|Main Study|Adverse Event|3|||
126510929|NCT03670810|455168715|FG003|Main Study|Adverse Event|4|||
126510930|NCT03670810|455168716|FG004|Main Study|Adverse Event|4|||
126510931|NCT03670810|455168717|FG005|Main Study|Adverse Event|5|||
126510932|NCT03670810|455168718|FG006|Main Study|Adverse Event|0|||
126510933|NCT03670810|455168719|FG007|Main Study|Adverse Event|0|||
126510934|NCT03670810|455168720|FG008|Main Study|Adverse Event|0|||
126510935|NCT03670810|455168712|FG000|Main Study|Lack of Efficacy|8|||
126510936|NCT03670810|455168713|FG001|Main Study|Lack of Efficacy|9|||
126510937|NCT03670810|455168714|FG002|Main Study|Lack of Efficacy|3|||
126510938|NCT03670810|455168715|FG003|Main Study|Lack of Efficacy|4|||
126510939|NCT03670810|455168716|FG004|Main Study|Lack of Efficacy|0|||
126510940|NCT03670810|455168717|FG005|Main Study|Lack of Efficacy|0|||
126510941|NCT03670810|455168718|FG006|Main Study|Lack of Efficacy|0|||
126510942|NCT03670810|455168719|FG007|Main Study|Lack of Efficacy|0|||
126510943|NCT03670810|455168720|FG008|Main Study|Lack of Efficacy|0|||
126510944|NCT03670810|455168712|FG000|Main Study|Lost to Follow-up|9|||
126510945|NCT03670810|455168713|FG001|Main Study|Lost to Follow-up|7|||
126510946|NCT03670810|455168714|FG002|Main Study|Lost to Follow-up|4|||
126510947|NCT03670810|455168715|FG003|Main Study|Lost to Follow-up|6|||
126510948|NCT03670810|455168716|FG004|Main Study|Lost to Follow-up|1|||
126510949|NCT03670810|455168717|FG005|Main Study|Lost to Follow-up|0|||
126510950|NCT03670810|455168718|FG006|Main Study|Lost to Follow-up|0|||
126510951|NCT03670810|455168719|FG007|Main Study|Lost to Follow-up|0|||
126510952|NCT03670810|455168720|FG008|Main Study|Lost to Follow-up|0|||
126510953|NCT03670810|455168712|FG000|Main Study|Non-compliance with Study Drug|0|||
126510954|NCT03670810|455168713|FG001|Main Study|Non-compliance with Study Drug|2|||
126510955|NCT03670810|455168714|FG002|Main Study|Non-compliance with Study Drug|3|||
126510956|NCT03670810|455168715|FG003|Main Study|Non-compliance with Study Drug|0|||
126510957|NCT03670810|455168716|FG004|Main Study|Non-compliance with Study Drug|0|||
126510958|NCT03670810|455168717|FG005|Main Study|Non-compliance with Study Drug|0|||
126510959|NCT03670810|455168718|FG006|Main Study|Non-compliance with Study Drug|0|||
126510960|NCT03670810|455168719|FG007|Main Study|Non-compliance with Study Drug|1|||
126510961|NCT03670810|455168720|FG008|Main Study|Non-compliance with Study Drug|0|||
126510962|NCT03670810|455168712|FG000|Main Study|Physician Decision|3|||
126510963|NCT03670810|455168713|FG001|Main Study|Physician Decision|0|||
126510964|NCT03670810|455168714|FG002|Main Study|Physician Decision|1|||
126510965|NCT03670810|455168715|FG003|Main Study|Physician Decision|0|||
126510966|NCT03670810|455168716|FG004|Main Study|Physician Decision|0|||
126510967|NCT03670810|455168717|FG005|Main Study|Physician Decision|0|||
126510968|NCT03670810|455168718|FG006|Main Study|Physician Decision|1|||
126510969|NCT03670810|455168719|FG007|Main Study|Physician Decision|1|||
126510970|NCT03670810|455168720|FG008|Main Study|Physician Decision|0|||
126510971|NCT03670810|455168712|FG000|Main Study|Pregnancy|1|||
126510972|NCT03670810|455168713|FG001|Main Study|Pregnancy|2|||
126510973|NCT03670810|455168714|FG002|Main Study|Pregnancy|0|||
126510974|NCT03670810|455168715|FG003|Main Study|Pregnancy|0|||
126510975|NCT03670810|455168716|FG004|Main Study|Pregnancy|0|||
126510976|NCT03670810|455168717|FG005|Main Study|Pregnancy|0|||
126510977|NCT03670810|455168718|FG006|Main Study|Pregnancy|0|||
126510978|NCT03670810|455168719|FG007|Main Study|Pregnancy|0|||
126510979|NCT03670810|455168720|FG008|Main Study|Pregnancy|0|||
126510980|NCT03670810|455168712|FG000|Main Study|Protocol Deviation|2|||
126510981|NCT03670810|455168713|FG001|Main Study|Protocol Deviation|12|||
126510982|NCT03670810|455168714|FG002|Main Study|Protocol Deviation|8|||
126510983|NCT03670810|455168715|FG003|Main Study|Protocol Deviation|4|||
126510984|NCT03670810|455168716|FG004|Main Study|Protocol Deviation|0|||
126510985|NCT03670810|455168717|FG005|Main Study|Protocol Deviation|0|||
126510986|NCT03670810|455168718|FG006|Main Study|Protocol Deviation|0|||
126510987|NCT03670810|455168719|FG007|Main Study|Protocol Deviation|0|||
126510988|NCT03670810|455168720|FG008|Main Study|Protocol Deviation|0|||
126510989|NCT03670810|455168712|FG000|Main Study|Withdrawal by Subject|21|||
126510990|NCT03670810|455168713|FG001|Main Study|Withdrawal by Subject|21|||
126510991|NCT03670810|455168714|FG002|Main Study|Withdrawal by Subject|8|||
126510992|NCT03670810|455168715|FG003|Main Study|Withdrawal by Subject|9|||
126510993|NCT03670810|455168716|FG004|Main Study|Withdrawal by Subject|5|||
126510994|NCT03670810|455168717|FG005|Main Study|Withdrawal by Subject|2|||
126510995|NCT03670810|455168718|FG006|Main Study|Withdrawal by Subject|1|||
126510996|NCT03670810|455168719|FG007|Main Study|Withdrawal by Subject|1|||
126510997|NCT03670810|455168720|FG008|Main Study|Withdrawal by Subject|0|||
126510998|NCT03670810|455168712|FG000|Main Study|Participant did not want to take the three other treatments|1|||
126510999|NCT03670810|455168713|FG001|Main Study|Participant did not want to take the three other treatments|0|||
126511000|NCT03670810|455168714|FG002|Main Study|Participant did not want to take the three other treatments|0|||
126511001|NCT03670810|455168715|FG003|Main Study|Participant did not want to take the three other treatments|0|||
126511002|NCT03670810|455168716|FG004|Main Study|Participant did not want to take the three other treatments|0|||
126511003|NCT03670810|455168717|FG005|Main Study|Participant did not want to take the three other treatments|0|||
126511004|NCT03670810|455168718|FG006|Main Study|Participant did not want to take the three other treatments|0|||
126511005|NCT03670810|455168719|FG007|Main Study|Participant did not want to take the three other treatments|0|||
126511006|NCT03670810|455168720|FG008|Main Study|Participant did not want to take the three other treatments|0|||
126511007|NCT03670810|455168712|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
126511008|NCT03670810|455168713|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
126511009|NCT03670810|455168714|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
126511010|NCT03670810|455168715|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
126511011|NCT03670810|455168716|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
126511012|NCT03670810|455168717|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
126511013|NCT03670810|455168718|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
126511014|NCT03670810|455168719|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
126511015|NCT03670810|455168720|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
126511016|NCT03670810|455168712|FG000|Main Study|Travel and Coronavirus issues|0|||
126511017|NCT03670810|455168713|FG001|Main Study|Travel and Coronavirus issues|0|||
126511018|NCT03670810|455168714|FG002|Main Study|Travel and Coronavirus issues|0|||
126511019|NCT03670810|455168715|FG003|Main Study|Travel and Coronavirus issues|1|||
126511020|NCT03670810|455168716|FG004|Main Study|Travel and Coronavirus issues|0|||
126511021|NCT03670810|455168717|FG005|Main Study|Travel and Coronavirus issues|0|||
126511022|NCT03670810|455168718|FG006|Main Study|Travel and Coronavirus issues|0|||
126511023|NCT03670810|455168719|FG007|Main Study|Travel and Coronavirus issues|0|||
126511024|NCT03670810|455168720|FG008|Main Study|Travel and Coronavirus issues|0|||
126511025|NCT03670810|455168712|FG000|Open Label Extension|Protocol Deviation|0|||
126511026|NCT03670810|455168713|FG001|Open Label Extension|Protocol Deviation|0|||
126511027|NCT03670810|455168714|FG002|Open Label Extension|Protocol Deviation|0|||
126511028|NCT03670810|455168715|FG003|Open Label Extension|Protocol Deviation|0|||
126511029|NCT03670810|455168716|FG004|Open Label Extension|Protocol Deviation|0|||
126511030|NCT03670810|455168717|FG005|Open Label Extension|Protocol Deviation|0|||
126511031|NCT03670810|455168718|FG006|Open Label Extension|Protocol Deviation|0|||
126511032|NCT03670810|455168719|FG007|Open Label Extension|Protocol Deviation|0|||
126511033|NCT03670810|455168720|FG008|Open Label Extension|Protocol Deviation|5|||
126511034|NCT03670810|455168712|FG000|Open Label Extension|Death|0|||
126511035|NCT03670810|455168713|FG001|Open Label Extension|Death|0|||
126511036|NCT03670810|455168714|FG002|Open Label Extension|Death|0|||
126511037|NCT03670810|455168715|FG003|Open Label Extension|Death|0|||
126511038|NCT03670810|455168716|FG004|Open Label Extension|Death|0|||
126511039|NCT03670810|455168717|FG005|Open Label Extension|Death|0|||
126511040|NCT03670810|455168718|FG006|Open Label Extension|Death|0|||
126511041|NCT03670810|455168719|FG007|Open Label Extension|Death|0|||
126511042|NCT03670810|455168720|FG008|Open Label Extension|Death|1|||
126511043|NCT03670810|455168712|FG000|Open Label Extension|COVID-19|0|||
126511044|NCT03670810|455168713|FG001|Open Label Extension|COVID-19|0|||
126511045|NCT03670810|455168714|FG002|Open Label Extension|COVID-19|0|||
126511046|NCT03670810|455168715|FG003|Open Label Extension|COVID-19|0|||
126511047|NCT03670810|455168716|FG004|Open Label Extension|COVID-19|0|||
126511048|NCT03670810|455168717|FG005|Open Label Extension|COVID-19|0|||
126511049|NCT03670810|455168718|FG006|Open Label Extension|COVID-19|0|||
126511050|NCT03670810|455168719|FG007|Open Label Extension|COVID-19|0|||
126511051|NCT03670810|455168720|FG008|Open Label Extension|COVID-19|1|||
126511052|NCT03670810|455168712|FG000|Open Label Extension|Lack of Efficacy|0|||
126511053|NCT03670810|455168713|FG001|Open Label Extension|Lack of Efficacy|0|||
126511054|NCT03670810|455168714|FG002|Open Label Extension|Lack of Efficacy|0|||
126566213|NCT00927823|455368025|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
126566214|NCT00927823|455368022|FG000|Continuous Dosing Period|Other|1|||
126566215|NCT00927823|455368023|FG001|Continuous Dosing Period|Other|2|||
126566216|NCT00927823|455368024|FG002|Continuous Dosing Period|Other|9|||
126511055|NCT03670810|455168715|FG003|Open Label Extension|Lack of Efficacy|0|||
126511056|NCT03670810|455168716|FG004|Open Label Extension|Lack of Efficacy|0|||
126511057|NCT03670810|455168717|FG005|Open Label Extension|Lack of Efficacy|0|||
126511058|NCT03670810|455168718|FG006|Open Label Extension|Lack of Efficacy|0|||
126511059|NCT03670810|455168719|FG007|Open Label Extension|Lack of Efficacy|0|||
126511060|NCT03670810|455168720|FG008|Open Label Extension|Lack of Efficacy|39|||
126511061|NCT03670810|455168712|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
126511062|NCT03670810|455168713|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
126511063|NCT03670810|455168714|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
126511064|NCT03670810|455168715|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
126511065|NCT03670810|455168716|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
126511066|NCT03670810|455168717|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
126511067|NCT03670810|455168718|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
126511068|NCT03670810|455168719|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
126511069|NCT03670810|455168720|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
126511070|NCT03670810|455168712|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
126511071|NCT03670810|455168713|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
126511072|NCT03670810|455168714|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
126511073|NCT03670810|455168715|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
126511074|NCT03670810|455168716|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
126511075|NCT03670810|455168717|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
126511076|NCT03670810|455168718|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
126511077|NCT03670810|455168719|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
126511078|NCT03670810|455168720|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
126511079|NCT03670810|455168712|FG000|Open Label Extension|Withdrawal by Subject|0|||
126511080|NCT03670810|455168713|FG001|Open Label Extension|Withdrawal by Subject|0|||
126511081|NCT03670810|455168714|FG002|Open Label Extension|Withdrawal by Subject|0|||
126511082|NCT03670810|455168715|FG003|Open Label Extension|Withdrawal by Subject|0|||
126511083|NCT03670810|455168716|FG004|Open Label Extension|Withdrawal by Subject|0|||
126511084|NCT03670810|455168717|FG005|Open Label Extension|Withdrawal by Subject|0|||
126511085|NCT03670810|455168718|FG006|Open Label Extension|Withdrawal by Subject|0|||
126511086|NCT03670810|455168719|FG007|Open Label Extension|Withdrawal by Subject|0|||
126511087|NCT03670810|455168720|FG008|Open Label Extension|Withdrawal by Subject|46|||
126511088|NCT03670810|455168712|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
126511089|NCT03670810|455168713|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
126511090|NCT03670810|455168714|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
126511091|NCT03670810|455168715|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
126511092|NCT03670810|455168716|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
126511093|NCT03670810|455168717|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
126511094|NCT03670810|455168718|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
126511095|NCT03670810|455168719|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
126511096|NCT03670810|455168720|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
126511097|NCT03670810|455168712|FG000|Open Label Extension|Physician Decision|0|||
126511098|NCT03670810|455168713|FG001|Open Label Extension|Physician Decision|0|||
126511099|NCT03670810|455168714|FG002|Open Label Extension|Physician Decision|0|||
126511100|NCT03670810|455168715|FG003|Open Label Extension|Physician Decision|0|||
126511101|NCT03670810|455168716|FG004|Open Label Extension|Physician Decision|0|||
126511102|NCT03670810|455168717|FG005|Open Label Extension|Physician Decision|0|||
126511103|NCT03670810|455168718|FG006|Open Label Extension|Physician Decision|0|||
126566217|NCT00927823|455368025|FG003|Continuous Dosing Period|Other|3|||
126566218|NCT02299635|455368026|FG000|Overall Study|Adverse Event|2|||
126511104|NCT03670810|455168719|FG007|Open Label Extension|Physician Decision|0|||
126511105|NCT03670810|455168720|FG008|Open Label Extension|Physician Decision|2|||
126511106|NCT03670810|455168712|FG000|Open Label Extension|Non-compliance with study drug|0|||
126511107|NCT03670810|455168713|FG001|Open Label Extension|Non-compliance with study drug|0|||
126511108|NCT03670810|455168714|FG002|Open Label Extension|Non-compliance with study drug|0|||
126511109|NCT03670810|455168715|FG003|Open Label Extension|Non-compliance with study drug|0|||
126511110|NCT03670810|455168716|FG004|Open Label Extension|Non-compliance with study drug|0|||
126511111|NCT03670810|455168717|FG005|Open Label Extension|Non-compliance with study drug|0|||
126566219|NCT02299635|455368026|FG000|Overall Study|Death|1|||
126566220|NCT02299635|455368026|FG000|Overall Study|Global deterioration of health status|1|||
126566221|NCT02299635|455368026|FG000|Overall Study|Objective progression or relapse|10|||
126566222|NCT02299635|455368026|FG000|Overall Study|Withdrawal by Subject|2|||
126566223|NCT02299635|455368026|FG000|Overall Study|Other|3|||
126566224|NCT00828672|455368027|FG000|Study Treatment|Lost to Follow-up|1|||
126566225|NCT00828672|455368028|FG001|Study Treatment|Lost to Follow-up|0|||
126566226|NCT00828672|455368027|FG000|Study Treatment|Adverse Event|0|||
126566227|NCT00828672|455368028|FG001|Study Treatment|Adverse Event|1|||
126566228|NCT00828672|455368027|FG000|Study Treatment|Complete response, no surgery|1|||
126566229|NCT00828672|455368028|FG001|Study Treatment|Complete response, no surgery|1|||
126566230|NCT00828672|455368027|FG000|Post-surgery (<30 Days)|No central review materials|0|||
126566231|NCT00828672|455368028|FG001|Post-surgery (<30 Days)|No central review materials|1|||
126566232|NCT00831792|455368037|FG000|Overall Study|Not Eligible|3|||
126566233|NCT00831792|455368037|FG000|Overall Study|Adverse Event|1|||
126566234|NCT00831792|455368037|FG000|Overall Study|Death|1|||
126566235|NCT00831792|455368037|FG000|Overall Study|Lack of Efficacy|1|||
126566236|NCT02469064|455368045|FG000|Overall Study|Request not to receive intervention.|1|||
126566237|NCT02469064|455368046|FG001|Overall Study|Request not to receive intervention.|3|||
126566238|NCT02155829|455368047|FG000|Overall Study|Adverse Event|1|||
126566239|NCT02155829|455368048|FG001|Overall Study|Adverse Event|0|||
126566240|NCT02155829|455368047|FG000|Overall Study|Withdrawal by Subject|3|||
126566241|NCT02155829|455368048|FG001|Overall Study|Withdrawal by Subject|3|||
126566242|NCT02155829|455368047|FG000|Overall Study|Protocol Violation|2|||
126566243|NCT02155829|455368048|FG001|Overall Study|Protocol Violation|0|||
126566244|NCT00678795|455368049|FG000|Overall Study|Adverse Event|7|||
126566245|NCT00678795|455368050|FG001|Overall Study|Adverse Event|3|||
126566246|NCT00678795|455368049|FG000|Overall Study|Withdrawal by Subject|3|||
126566247|NCT00678795|455368050|FG001|Overall Study|Withdrawal by Subject|0|||
126566248|NCT00678795|455368049|FG000|Overall Study|Protocol Violation|0|||
126566249|NCT00678795|455368050|FG001|Overall Study|Protocol Violation|1|||
126566250|NCT00678795|455368049|FG000|Overall Study|Lost to Follow-up|0|||
126566251|NCT00678795|455368050|FG001|Overall Study|Lost to Follow-up|1|||
126566252|NCT00678795|455368049|FG000|Overall Study|Lack of Efficacy|1|||
126566253|NCT00678795|455368050|FG001|Overall Study|Lack of Efficacy|1|||
126566254|NCT02750709|455368051|FG000|Treatment Period 1|Adverse Event|0|||
126566255|NCT02750709|455368052|FG001|Treatment Period 1|Adverse Event|0|||
126566256|NCT02750709|455368053|FG002|Treatment Period 1|Adverse Event|0|||
126566257|NCT02750709|455368054|FG003|Treatment Period 1|Adverse Event|0|||
126566258|NCT02750709|455368055|FG004|Treatment Period 1|Adverse Event|0|||
126566259|NCT02750709|455368056|FG005|Treatment Period 1|Adverse Event|1|||
126566260|NCT00404079|455368057|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
126566261|NCT00404079|455368058|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
126566262|NCT01120275|455368059|FG000|Overall Study|Adverse Event|3|||
126566263|NCT01120275|455368059|FG000|Overall Study|Progression|27|||
126566264|NCT01120275|455368059|FG000|Overall Study|Ineligible|3|||
126566265|NCT01120275|455368059|FG000|Overall Study|Withdrawal by Subject|1|||
126566266|NCT01120275|455368059|FG000|Overall Study|Refusal|1|||
126566267|NCT01120275|455368059|FG000|Overall Study|Not specific|1|||
126566268|NCT00290732|455368060|FG000|Overall Study|Inability to instill drug intraductally.|0|||
126566269|NCT00290732|455368061|FG001|Overall Study|Inability to instill drug intraductally.|1|||
126566270|NCT00290732|455368062|FG002|Overall Study|Inability to instill drug intraductally.|1|||
126566271|NCT00290732|455368063|FG003|Overall Study|Inability to instill drug intraductally.|0|||
126566272|NCT00290732|455368064|FG004|Overall Study|Inability to instill drug intraductally.|0|||
126566273|NCT02595398|455368065|FG000|Overall Study|Non-compliance|1|||
126566274|NCT02595398|455368066|FG001|Overall Study|Non-compliance|0|||
126566275|NCT02595398|455368065|FG000|Overall Study|Withdrawal by Subject|2|||
126566276|NCT02595398|455368066|FG001|Overall Study|Withdrawal by Subject|1|||
126566277|NCT02595398|455368065|FG000|Overall Study|Lost to Follow-up|1|||
126566278|NCT02595398|455368066|FG001|Overall Study|Lost to Follow-up|0|||
126566279|NCT00542386|455368067|FG000|Overall Study|Adverse Event|1|||
126566280|NCT00542386|455368068|FG001|Overall Study|Adverse Event|7|||
126566281|NCT00542386|455368069|FG002|Overall Study|Adverse Event|7|||
126566282|NCT00542386|455368070|FG003|Overall Study|Adverse Event|8|||
126566283|NCT00542386|455368071|FG004|Overall Study|Adverse Event|13|||
126566284|NCT00542386|455368072|FG005|Overall Study|Adverse Event|4|||
126566285|NCT00542386|455368067|FG000|Overall Study|Death|0|||
126566286|NCT00542386|455368068|FG001|Overall Study|Death|0|||
126566287|NCT00542386|455368069|FG002|Overall Study|Death|1|||
126566288|NCT00542386|455368070|FG003|Overall Study|Death|2|||
126566289|NCT00542386|455368071|FG004|Overall Study|Death|1|||
126566290|NCT00542386|455368072|FG005|Overall Study|Death|2|||
126566291|NCT00542386|455368067|FG000|Overall Study|Lack of Efficacy|32|||
126566292|NCT00542386|455368068|FG001|Overall Study|Lack of Efficacy|12|||
126566293|NCT00542386|455368069|FG002|Overall Study|Lack of Efficacy|10|||
126566294|NCT00542386|455368070|FG003|Overall Study|Lack of Efficacy|13|||
126566295|NCT00542386|455368071|FG004|Overall Study|Lack of Efficacy|7|||
126566296|NCT00542386|455368072|FG005|Overall Study|Lack of Efficacy|31|||
126566297|NCT00542386|455368067|FG000|Overall Study|Physician Decision|1|||
126566298|NCT00542386|455368068|FG001|Overall Study|Physician Decision|0|||
126566299|NCT00542386|455368069|FG002|Overall Study|Physician Decision|0|||
126511112|NCT03670810|455168718|FG006|Open Label Extension|Non-compliance with study drug|0|||
126511113|NCT03670810|455168719|FG007|Open Label Extension|Non-compliance with study drug|0|||
126511114|NCT03670810|455168720|FG008|Open Label Extension|Non-compliance with study drug|5|||
126511115|NCT03670810|455168712|FG000|Open Label Extension|Pregnancy|0|||
126511116|NCT03670810|455168713|FG001|Open Label Extension|Pregnancy|0|||
126511117|NCT03670810|455168714|FG002|Open Label Extension|Pregnancy|0|||
126511118|NCT03670810|455168715|FG003|Open Label Extension|Pregnancy|0|||
126511119|NCT03670810|455168716|FG004|Open Label Extension|Pregnancy|0|||
126511120|NCT03670810|455168717|FG005|Open Label Extension|Pregnancy|0|||
126511121|NCT03670810|455168718|FG006|Open Label Extension|Pregnancy|0|||
126511122|NCT03670810|455168719|FG007|Open Label Extension|Pregnancy|0|||
126511123|NCT03670810|455168720|FG008|Open Label Extension|Pregnancy|3|||
126511124|NCT03670810|455168712|FG000|Open Label Extension|Adverse Event|0|||
126511125|NCT03670810|455168713|FG001|Open Label Extension|Adverse Event|0|||
126511126|NCT03670810|455168714|FG002|Open Label Extension|Adverse Event|0|||
126511127|NCT03670810|455168715|FG003|Open Label Extension|Adverse Event|0|||
126511128|NCT03670810|455168716|FG004|Open Label Extension|Adverse Event|0|||
126511129|NCT03670810|455168717|FG005|Open Label Extension|Adverse Event|0|||
126511130|NCT03670810|455168718|FG006|Open Label Extension|Adverse Event|0|||
126511131|NCT03670810|455168719|FG007|Open Label Extension|Adverse Event|0|||
126511132|NCT03670810|455168720|FG008|Open Label Extension|Adverse Event|24|||
126511133|NCT03670810|455168712|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
126511134|NCT03670810|455168713|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
126511135|NCT03670810|455168714|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
126511136|NCT03670810|455168715|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
126511137|NCT03670810|455168716|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
126511138|NCT03670810|455168717|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
126511139|NCT03670810|455168718|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
126511140|NCT03670810|455168719|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
126511141|NCT03670810|455168720|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
126511142|NCT03670810|455168712|FG000|Open Label Extension|Lost to Follow-up|0|||
126511143|NCT03670810|455168713|FG001|Open Label Extension|Lost to Follow-up|0|||
126511144|NCT03670810|455168714|FG002|Open Label Extension|Lost to Follow-up|0|||
126511145|NCT03670810|455168715|FG003|Open Label Extension|Lost to Follow-up|0|||
126511146|NCT03670810|455168716|FG004|Open Label Extension|Lost to Follow-up|0|||
126511147|NCT03670810|455168717|FG005|Open Label Extension|Lost to Follow-up|0|||
126511148|NCT03670810|455168718|FG006|Open Label Extension|Lost to Follow-up|0|||
126511149|NCT03670810|455168719|FG007|Open Label Extension|Lost to Follow-up|0|||
126511150|NCT03670810|455168720|FG008|Open Label Extension|Lost to Follow-up|23|||
126511151|NCT00482391|455168721|FG000|Overall Study|Withdrawal by Subject|1|||
126511152|NCT00482391|455168721|FG000|Overall Study|Adverse Event|1|||
126511153|NCT00482391|455168721|FG000|Overall Study|Death|1|||
126511154|NCT01350128|455168738|FG000|Overall Study|Withdrawal by Subject|3|||
126511155|NCT01350128|455168738|FG000|Overall Study|Protocol discontinuation criteria|8|||
126511156|NCT01350128|455168738|FG000|Overall Study|Physician Decision|1|||
126511157|NCT01350128|455168738|FG000|Overall Study|Lost to Follow-up|2|||
126511158|NCT02644967|455168742|FG000|Overall Study|Death|26|||
126511159|NCT02644967|455168742|FG000|Overall Study|Physician Decision|1|||
126511160|NCT02644967|455168742|FG000|Overall Study|Withdrawal by Subject|2|||
126511161|NCT02644967|455168742|FG000|Overall Study|Protocol Violation|1|||
126511162|NCT02644967|455168742|FG000|Overall Study|Progressive Disease|1|||
126511163|NCT02644967|455168742|FG000|Overall Study|Study Terminated by Sponsor|4|||
126511164|NCT03323099|455168744|FG000|Overall Study|Withdrawal by Subject|6|||
126511165|NCT03323099|455168745|FG001|Overall Study|Withdrawal by Subject|12|||
126511166|NCT03323099|455168744|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
126511167|NCT03323099|455168745|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
126511168|NCT01502644|455168750|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
126511169|NCT01502644|455168751|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
126511170|NCT01502644|455168752|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
126511171|NCT01502644|455168753|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
126511172|NCT01502644|455168750|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
126511173|NCT01502644|455168751|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
126511174|NCT01502644|455168752|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
126511175|NCT01502644|455168753|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
126511176|NCT01502644|455168750|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
126511177|NCT01502644|455168751|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
126511178|NCT01502644|455168752|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
126511179|NCT01502644|455168753|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
126511180|NCT01502644|455168750|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
126566300|NCT00542386|455368070|FG003|Overall Study|Physician Decision|1|||
126566301|NCT00542386|455368071|FG004|Overall Study|Physician Decision|0|||
126566302|NCT00542386|455368072|FG005|Overall Study|Physician Decision|0|||
126566303|NCT00542386|455368067|FG000|Overall Study|Protocol Violation|0|||
126566304|NCT00542386|455368068|FG001|Overall Study|Protocol Violation|0|||
126566305|NCT00542386|455368069|FG002|Overall Study|Protocol Violation|1|||
126566306|NCT00542386|455368070|FG003|Overall Study|Protocol Violation|0|||
126566307|NCT00542386|455368071|FG004|Overall Study|Protocol Violation|0|||
126566308|NCT00542386|455368072|FG005|Overall Study|Protocol Violation|4|||
126566309|NCT00542386|455368067|FG000|Overall Study|Withdrawal by Subject|5|||
126566310|NCT00542386|455368068|FG001|Overall Study|Withdrawal by Subject|8|||
126566311|NCT00542386|455368069|FG002|Overall Study|Withdrawal by Subject|10|||
126566312|NCT00542386|455368070|FG003|Overall Study|Withdrawal by Subject|11|||
126566313|NCT00542386|455368071|FG004|Overall Study|Withdrawal by Subject|15|||
126566314|NCT00542386|455368072|FG005|Overall Study|Withdrawal by Subject|7|||
126566315|NCT00542386|455368067|FG000|Overall Study|Other Reasons|4|||
126566316|NCT00542386|455368068|FG001|Overall Study|Other Reasons|1|||
126566317|NCT00542386|455368069|FG002|Overall Study|Other Reasons|4|||
126566318|NCT00542386|455368070|FG003|Overall Study|Other Reasons|3|||
126566319|NCT00542386|455368071|FG004|Overall Study|Other Reasons|4|||
126566320|NCT00542386|455368072|FG005|Overall Study|Other Reasons|2|||
126566321|NCT00197015|455368073|FG000|Overall Study|Adverse Event|3|||
126566322|NCT00197015|455368074|FG001|Overall Study|Adverse Event|0|||
126566323|NCT00197015|455368075|FG002|Overall Study|Adverse Event|1|||
126566324|NCT00197015|455368073|FG000|Overall Study|Protocol Violation|0|||
126566325|NCT00197015|455368074|FG001|Overall Study|Protocol Violation|3|||
126566326|NCT00197015|455368075|FG002|Overall Study|Protocol Violation|3|||
126566327|NCT00197015|455368073|FG000|Overall Study|Withdrawal by Subject|17|||
126566328|NCT00197015|455368074|FG001|Overall Study|Withdrawal by Subject|37|||
126566329|NCT00197015|455368075|FG002|Overall Study|Withdrawal by Subject|34|||
126566330|NCT00197015|455368073|FG000|Overall Study|Lost to Follow-up|28|||
126566331|NCT00197015|455368074|FG001|Overall Study|Lost to Follow-up|46|||
126566332|NCT00197015|455368075|FG002|Overall Study|Lost to Follow-up|37|||
126566333|NCT00197015|455368073|FG000|Overall Study|Other|2|||
126566334|NCT00197015|455368074|FG001|Overall Study|Other|3|||
126566335|NCT00197015|455368075|FG002|Overall Study|Other|2|||
126566336|NCT00880906|455368078|FG000|Overall Study|Lost to Follow-up|0|||
126566337|NCT00880906|455368079|FG001|Overall Study|Lost to Follow-up|1|||
126566338|NCT00880906|455368078|FG000|Overall Study|Did not meet criteria following patholog|12|||
126566339|NCT00880906|455368079|FG001|Overall Study|Did not meet criteria following patholog|6|||
126566340|NCT00559949|455368088|FG000|Overall Study|Progressive Disease during cycle 1|1|||
126566341|NCT00559949|455368088|FG000|Overall Study|Adverse Event|1|||
126566342|NCT00559949|455368088|FG000|Overall Study|Withdrawal by Subject|4|||
126566343|NCT00559949|455368088|FG000|Overall Study|No disease evaluation per protocol|1|||
126566344|NCT00414648|455368089|FG000|Overall Study|Adverse Event|5|||
126566345|NCT00414648|455368090|FG001|Overall Study|Adverse Event|5|||
126566346|NCT00414648|455368089|FG000|Overall Study|Death|0|||
126566347|NCT00414648|455368090|FG001|Overall Study|Death|1|||
126566348|NCT00414648|455368089|FG000|Overall Study|Lack of Efficacy|0|||
126566349|NCT00414648|455368090|FG001|Overall Study|Lack of Efficacy|2|||
126566350|NCT00414648|455368089|FG000|Overall Study|Withdrawal by Subject|0|||
126566351|NCT00414648|455368090|FG001|Overall Study|Withdrawal by Subject|1|||
126566352|NCT04173572|455368091|FG000|Overall Study|Withdrawal by Subject|1|||
126566353|NCT04173572|455368092|FG001|Overall Study|Withdrawal by Subject|5|||
126566354|NCT04173572|455368091|FG000|Overall Study|Lost to Follow-up|3|||
126566355|NCT04173572|455368092|FG001|Overall Study|Lost to Follow-up|1|||
126566356|NCT03098030|455368093|FG000|Overall Study|Death|10|||
126566357|NCT03098030|455368094|FG001|Overall Study|Death|156|||
126566358|NCT03098030|455368095|FG002|Overall Study|Death|156|||
126566359|NCT03098030|455368096|FG003|Overall Study|Death|82|||
126566360|NCT03098030|455368093|FG000|Overall Study|Withdrawal by Subject|0|||
126566361|NCT03098030|455368094|FG001|Overall Study|Withdrawal by Subject|7|||
126566362|NCT03098030|455368095|FG002|Overall Study|Withdrawal by Subject|8|||
126566363|NCT03098030|455368096|FG003|Overall Study|Withdrawal by Subject|2|||
126566364|NCT03098030|455368093|FG000|Overall Study|Lost to Follow-up|0|||
126566365|NCT03098030|455368094|FG001|Overall Study|Lost to Follow-up|0|||
126566366|NCT03098030|455368095|FG002|Overall Study|Lost to Follow-up|2|||
126566367|NCT03098030|455368096|FG003|Overall Study|Lost to Follow-up|1|||
126566368|NCT03643211|455368097|FG000|Overall Study|Contract violation/deficiency|12|||
126566369|NCT03643211|455368097|FG000|Overall Study|Invalid registration|3|||
126566370|NCT03643211|455368097|FG000|Overall Study|No treatment information|2|||
126776956|NCT00267007|456139124|FG000|Overall Study|Non-compliance|0|||
126566371|NCT03643211|455368097|FG000|Overall Study|No adverse event information - No revisit|4|||
126566372|NCT04858425|455368098|FG000|Overall Study|Adverse Event|2|||
126566373|NCT04858425|455368099|FG001|Overall Study|Adverse Event|2|||
126566374|NCT04858425|455368098|FG000|Overall Study|Withdrawal by Subject|3|||
126566375|NCT04858425|455368099|FG001|Overall Study|Withdrawal by Subject|1|||
126566376|NCT04858425|455368098|FG000|Overall Study|Lost to Follow-up|4|||
126566377|NCT04858425|455368099|FG001|Overall Study|Lost to Follow-up|2|||
126566378|NCT04858425|455368098|FG000|Overall Study|Lost to Follow-up|1|||
126566379|NCT04858425|455368099|FG001|Overall Study|Lost to Follow-up|0|||
126566380|NCT03368001|455368101|FG000|Allocation|Lost to Pretest|16|||
126566381|NCT03368001|455368102|FG001|Allocation|Lost to Pretest|25|||
126566382|NCT03368001|455368101|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
126566383|NCT03368001|455368102|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
126566384|NCT03368001|455368101|FG000|Posttest|Lost to Posttest|7|||
126566385|NCT03368001|455368102|FG001|Posttest|Lost to Posttest|11|||
126566386|NCT03368001|455368101|FG000|Posttest|Discontinued Intervention|6|||
126566387|NCT03368001|455368102|FG001|Posttest|Discontinued Intervention|19|||
126566388|NCT03368001|455368101|FG000|Follow-up|Lost to Follow-up|6|||
126566389|NCT03368001|455368102|FG001|Follow-up|Lost to Follow-up|3|||
126566390|NCT02824432|455368103|FG000|Overall Study|Major Protocol Deviation|1|||
126511181|NCT01502644|455168751|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
126511182|NCT01502644|455168752|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
126511183|NCT01502644|455168753|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
126511184|NCT01502644|455168750|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
126511185|NCT01502644|455168751|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
126511186|NCT01502644|455168752|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
126566391|NCT02824432|455368104|FG001|Overall Study|Major Protocol Deviation|0|||
126566392|NCT04436120|455368110|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
126566393|NCT04436120|455368111|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
126566394|NCT04436120|455368112|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
126566395|NCT04436120|455368113|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
126566396|NCT04436120|455368114|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
126566397|NCT04436120|455368115|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
126566398|NCT04436120|455368116|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
126566399|NCT02357784|455368117|FG000|Overall Study|Withdrawal by Subject|1|||
126566400|NCT02698241|455368119|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
126566401|NCT02698241|455368119|FG000|Overall Study|Screening not met|7|||
126566402|NCT02698241|455368119|FG000|Overall Study|Withdrawal by Subject|7|||
126566403|NCT02698241|455368119|FG000|Overall Study|Physician Decision|2|||
126566404|NCT02698241|455368119|FG000|Overall Study|Subject underwent system modification|2|||
126566405|NCT02698241|455368119|FG000|Overall Study|Lost to Follow-up|3|||
126566406|NCT02698241|455368119|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
126566407|NCT02698241|455368119|FG000|Overall Study|geographic and licensing issue|1|||
126566408|NCT02698241|455368119|FG000|Overall Study|Death|2|||
126566409|NCT00604721|455368120|FG000|Overall Study|Physician Decision|1|||
126566410|NCT00604721|455368120|FG000|Overall Study|Withdrawal by Subject|1|||
126511187|NCT01502644|455168753|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
126511188|NCT02388997|455168756|FG000|Overall Study|Adverse Event|1|||
126511189|NCT02388997|455168757|FG001|Overall Study|Adverse Event|2|||
126511190|NCT02388997|455168756|FG000|Overall Study|Withdrawal by Subject|2|||
126511191|NCT02388997|455168757|FG001|Overall Study|Withdrawal by Subject|1|||
126511192|NCT02388997|455168756|FG000|Overall Study|Lung function exclusion criteria|0|||
126511193|NCT02388997|455168757|FG001|Overall Study|Lung function exclusion criteria|2|||
126511194|NCT02388997|455168756|FG000|Overall Study|Tested positive for virus during run-in|0|||
126511195|NCT02388997|455168757|FG001|Overall Study|Tested positive for virus during run-in|1|||
126511196|NCT03025828|455168758|FG000|Overall Study|Lost to Follow-up|1|||
126511197|NCT02375672|455168759|FG000|Overall Study|remain on follow up|20|||
126511198|NCT01559311|455168760|FG000|Overall Study|Protocol Violation|0|||
126511199|NCT01559311|455168761|FG001|Overall Study|Protocol Violation|0|||
126511200|NCT01559311|455168762|FG002|Overall Study|Protocol Violation|2|||
126511201|NCT01559311|455168760|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
126511202|NCT01559311|455168761|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
126511203|NCT01559311|455168762|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
126511204|NCT01559311|455168760|FG000|Overall Study|Withdrawal by Subject|2|||
126511205|NCT01559311|455168761|FG001|Overall Study|Withdrawal by Subject|1|||
126511206|NCT01559311|455168762|FG002|Overall Study|Withdrawal by Subject|0|||
126511207|NCT01559311|455168760|FG000|Overall Study|Death|0|||
126511208|NCT01559311|455168761|FG001|Overall Study|Death|2|||
126566411|NCT01838551|455368124|FG000|Overall Study|Adverse Event|16|||
126566412|NCT01838551|455368124|FG000|Overall Study|Death|1|||
126566413|NCT01838551|455368124|FG000|Overall Study|Lack of Efficacy|10|||
126511209|NCT01559311|455168762|FG002|Overall Study|Death|3|||
126566414|NCT01838551|455368124|FG000|Overall Study|Physician Decision|4|||
126566415|NCT01838551|455368124|FG000|Overall Study|Withdrawal by Subject|10|||
126566416|NCT01838551|455368124|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
126511210|NCT01559311|455168760|FG000|Overall Study|Lost to Follow-up|0|||
126566417|NCT00906282|455368125|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
126511211|NCT01559311|455168761|FG001|Overall Study|Lost to Follow-up|3|||
126511212|NCT01559311|455168762|FG002|Overall Study|Lost to Follow-up|2|||
126511213|NCT01559311|455168760|FG000|Overall Study|Adverse Event|0|||
126511214|NCT01559311|455168761|FG001|Overall Study|Adverse Event|0|||
126511215|NCT01559311|455168762|FG002|Overall Study|Adverse Event|1|||
126511216|NCT02346240|455168763|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511217|NCT02346240|455168764|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
126511218|NCT02346240|455168765|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
126511219|NCT02346240|455168766|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
126511220|NCT02346240|455168767|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511221|NCT02346240|455168768|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511222|NCT02346240|455168769|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511223|NCT02346240|455168770|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511224|NCT02346240|455168771|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511225|NCT02346240|455168772|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511226|NCT02346240|455168773|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511227|NCT02346240|455168774|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511228|NCT02346240|455168775|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511229|NCT02346240|455168776|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511230|NCT02346240|455168777|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511231|NCT02346240|455168778|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511232|NCT02346240|455168779|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511233|NCT02346240|455168780|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511234|NCT02346240|455168781|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511235|NCT02346240|455168782|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511236|NCT02346240|455168783|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511237|NCT02346240|455168784|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511238|NCT02346240|455168785|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511239|NCT02346240|455168786|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
126511240|NCT02346240|455168763|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511241|NCT02346240|455168764|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
126511242|NCT02346240|455168765|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511243|NCT02346240|455168766|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511244|NCT02346240|455168767|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511245|NCT02346240|455168768|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511246|NCT02346240|455168769|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511247|NCT02346240|455168770|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511248|NCT02346240|455168771|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511249|NCT02346240|455168772|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511250|NCT02346240|455168773|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511251|NCT02346240|455168774|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511252|NCT02346240|455168775|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511253|NCT02346240|455168776|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511254|NCT02346240|455168777|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511255|NCT02346240|455168778|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511256|NCT02346240|455168779|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511257|NCT02346240|455168780|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511258|NCT02346240|455168781|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511259|NCT02346240|455168782|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511260|NCT02346240|455168783|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511261|NCT02346240|455168784|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511262|NCT02346240|455168785|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511263|NCT02346240|455168786|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
126511264|NCT02346240|455168763|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511265|NCT02346240|455168764|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
126511266|NCT02346240|455168765|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511267|NCT02346240|455168766|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511268|NCT02346240|455168767|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511269|NCT02346240|455168768|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511270|NCT02346240|455168769|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511271|NCT02346240|455168770|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511272|NCT02346240|455168771|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511273|NCT02346240|455168772|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511274|NCT02346240|455168773|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511275|NCT02346240|455168774|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511276|NCT02346240|455168775|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511277|NCT02346240|455168776|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511278|NCT02346240|455168777|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511279|NCT02346240|455168778|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511280|NCT02346240|455168779|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126566418|NCT00906282|455368125|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
126566419|NCT00906282|455368125|FG000|Preoperative Chemotherapy|Progressive disease|6|||
126566420|NCT00906282|455368125|FG000|Preoperative Chemotherapy|Toxicity|1|||
126566421|NCT02289560|455368126|FG000|Overall Study|Lost to Follow-up|6|||
126566422|NCT02289560|455368126|FG000|Overall Study|Alternative Treatment|4|||
126566423|NCT02289560|455368126|FG000|Overall Study|Inadequate Treatment|2|||
126566424|NCT02289560|455368126|FG000|Overall Study|Withdrawal by Subject|23|||
126566425|NCT02540213|455368127|FG000|Overall Study|Death/adverse event|18|||
126566426|NCT02540213|455368127|FG000|Overall Study|Administrative reasons|3|||
126566427|NCT02540213|455368127|FG000|Overall Study|Kidney transplant|3|||
126566428|NCT02540213|455368127|FG000|Overall Study|Lack of Efficacy|6|||
126566429|NCT02540213|455368127|FG000|Overall Study|Consent withdrawn|7|||
126566430|NCT02540213|455368127|FG000|Overall Study|Enrolled but not treated|2|||
126566431|NCT01981356|455368130|FG000|Overall Study|Lost to Follow-up|4|||
126566432|NCT01981356|455368131|FG001|Overall Study|Lost to Follow-up|1|||
126566433|NCT01981356|455368130|FG000|Overall Study|Withdrawal by Subject|1|||
126566434|NCT01981356|455368131|FG001|Overall Study|Withdrawal by Subject|1|||
126566435|NCT01981356|455368130|FG000|Overall Study|Protocol Violation|2|||
126566436|NCT01981356|455368131|FG001|Overall Study|Protocol Violation|0|||
126566437|NCT02317016|455368132|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
126566438|NCT02317016|455368132|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
126566439|NCT02317016|455368132|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
126566440|NCT02317016|455368132|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
126566441|NCT02317016|455368132|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
126566442|NCT02317016|455368132|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
126566443|NCT02317016|455368132|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
126566444|NCT00536380|455368133|FG000|Overall Study|Adverse Event|0|||
126566445|NCT00536380|455368134|FG001|Overall Study|Adverse Event|2|||
126566446|NCT00536380|455368135|FG002|Overall Study|Adverse Event|2|||
126566447|NCT00536380|455368133|FG000|Overall Study|Lost to Follow-up|0|||
126566448|NCT00536380|455368134|FG001|Overall Study|Lost to Follow-up|0|||
126566449|NCT00536380|455368135|FG002|Overall Study|Lost to Follow-up|1|||
126566450|NCT00536380|455368133|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
126566451|NCT00536380|455368134|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
126566452|NCT00536380|455368135|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
126566453|NCT00536380|455368133|FG000|Overall Study|Withdrawal related to study drug|7|||
126566454|NCT00536380|455368134|FG001|Overall Study|Withdrawal related to study drug|5|||
126566455|NCT00536380|455368135|FG002|Overall Study|Withdrawal related to study drug|2|||
126566456|NCT00536380|455368133|FG000|Overall Study|Noncompliance with protocol|3|||
126566457|NCT00536380|455368134|FG001|Overall Study|Noncompliance with protocol|2|||
126566458|NCT00536380|455368135|FG002|Overall Study|Noncompliance with protocol|2|||
126566459|NCT00536380|455368133|FG000|Overall Study|Did not meet protocol eligibility|0|||
126566460|NCT00536380|455368134|FG001|Overall Study|Did not meet protocol eligibility|0|||
126566461|NCT00536380|455368135|FG002|Overall Study|Did not meet protocol eligibility|1|||
126566462|NCT00536380|455368133|FG000|Overall Study|Administrative|0|||
126566463|NCT00536380|455368134|FG001|Overall Study|Administrative|0|||
126566464|NCT00536380|455368135|FG002|Overall Study|Administrative|1|||
126566465|NCT00290706|455368136|FG000|Overall Study|Withdrawal by Subject|2|||
126566466|NCT00290706|455368137|FG001|Overall Study|Withdrawal by Subject|0|||
126566467|NCT00290706|455368138|FG002|Overall Study|Withdrawal by Subject|0|||
126566468|NCT00290706|455368139|FG003|Overall Study|Withdrawal by Subject|0|||
126566469|NCT00290706|455368136|FG000|Overall Study|Progressive Disease|3|||
126566470|NCT00290706|455368137|FG001|Overall Study|Progressive Disease|5|||
126566471|NCT00290706|455368138|FG002|Overall Study|Progressive Disease|4|||
126566472|NCT00290706|455368139|FG003|Overall Study|Progressive Disease|10|||
126566473|NCT00290706|455368136|FG000|Overall Study|Adverse Event|0|||
126566474|NCT00290706|455368137|FG001|Overall Study|Adverse Event|1|||
126566475|NCT00290706|455368138|FG002|Overall Study|Adverse Event|2|||
126566476|NCT00290706|455368139|FG003|Overall Study|Adverse Event|0|||
126566477|NCT00290706|455368136|FG000|Overall Study|Receive auto transplant or radiation|0|||
126566478|NCT00290706|455368137|FG001|Overall Study|Receive auto transplant or radiation|0|||
126566479|NCT00290706|455368138|FG002|Overall Study|Receive auto transplant or radiation|0|||
126566480|NCT00290706|455368139|FG003|Overall Study|Receive auto transplant or radiation|1|||
126566481|NCT00290706|455368136|FG000|Overall Study|Physician Decision|0|||
126566482|NCT00290706|455368137|FG001|Overall Study|Physician Decision|0|||
126566483|NCT00290706|455368138|FG002|Overall Study|Physician Decision|0|||
126566484|NCT00290706|455368139|FG003|Overall Study|Physician Decision|1|||
126566485|NCT00605033|455368143|FG000|Overall Study|Adverse Event|2|||
126566486|NCT00605033|455368144|FG001|Overall Study|Adverse Event|2|||
126566487|NCT00605033|455368143|FG000|Overall Study|Lost to Follow-up|1|||
126566488|NCT00605033|455368144|FG001|Overall Study|Lost to Follow-up|1|||
126566489|NCT00605033|455368143|FG000|Overall Study|Withdrawal by Subject|3|||
126566490|NCT00605033|455368144|FG001|Overall Study|Withdrawal by Subject|4|||
126566491|NCT00605033|455368143|FG000|Overall Study|Protocol Violation|1|||
126566492|NCT00605033|455368144|FG001|Overall Study|Protocol Violation|1|||
126511281|NCT02346240|455168780|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511282|NCT02346240|455168781|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511283|NCT02346240|455168782|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511284|NCT02346240|455168783|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511285|NCT02346240|455168784|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511286|NCT02346240|455168785|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511287|NCT02346240|455168786|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
126511288|NCT02346240|455168763|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
126511289|NCT02346240|455168764|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
126511290|NCT02346240|455168765|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
126511291|NCT02346240|455168766|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
126511292|NCT02346240|455168767|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511293|NCT02346240|455168768|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511294|NCT02346240|455168769|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511295|NCT02346240|455168770|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511296|NCT02346240|455168771|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511297|NCT02346240|455168772|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511298|NCT02346240|455168773|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511299|NCT02346240|455168774|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511300|NCT02346240|455168775|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511301|NCT02346240|455168776|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511302|NCT02346240|455168777|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511303|NCT02346240|455168778|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511304|NCT02346240|455168779|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511305|NCT02346240|455168780|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511306|NCT02346240|455168781|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511307|NCT02346240|455168782|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511308|NCT02346240|455168783|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511309|NCT02346240|455168784|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511310|NCT02346240|455168785|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511311|NCT02346240|455168786|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
126511312|NCT02346240|455168763|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
126511313|NCT02346240|455168764|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
126511314|NCT02346240|455168765|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
126511315|NCT02346240|455168766|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
126511316|NCT02346240|455168767|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511317|NCT02346240|455168768|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511318|NCT02346240|455168769|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511319|NCT02346240|455168770|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511320|NCT02346240|455168771|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511321|NCT02346240|455168772|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511322|NCT02346240|455168773|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511323|NCT02346240|455168774|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511324|NCT02346240|455168775|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511325|NCT02346240|455168776|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511326|NCT02346240|455168777|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511327|NCT02346240|455168778|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511328|NCT02346240|455168779|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511329|NCT02346240|455168780|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511330|NCT02346240|455168781|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511331|NCT02346240|455168782|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511332|NCT02346240|455168783|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511333|NCT02346240|455168784|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511334|NCT02346240|455168785|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511335|NCT02346240|455168786|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
126511336|NCT02346240|455168763|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511337|NCT02346240|455168764|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
126511338|NCT02346240|455168765|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511339|NCT02346240|455168766|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
126511340|NCT02346240|455168767|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511341|NCT02346240|455168768|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511342|NCT02346240|455168769|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511343|NCT02346240|455168770|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511344|NCT02346240|455168771|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126566493|NCT03395353|455368145|FG000|Overall Study|Adverse Event|20|||
126566494|NCT03395353|455368145|FG000|Overall Study|Protocol Violation|1|||
126566495|NCT03395353|455368145|FG000|Overall Study|Lack of Efficacy|3|||
126566496|NCT03395353|455368145|FG000|Overall Study|Withdrawal by Subject|24|||
126566497|NCT03395353|455368145|FG000|Overall Study|Discontinued visit|1|||
126566498|NCT03395353|455368145|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
126566499|NCT03395353|455368145|FG000|Overall Study|Physician Decision|4|||
126566500|NCT03395353|455368145|FG000|Overall Study|Early termination of overall study|33|||
126566501|NCT02486588|455368146|FG000|Overall Study|Randomized in error- ineligible|738|||
126566502|NCT02486588|455368147|FG001|Overall Study|Randomized in error- ineligible|750|||
126566503|NCT02486588|455368148|FG002|Overall Study|Randomized in error- ineligible|755|||
126566504|NCT02486588|455368149|FG003|Overall Study|Randomized in error- ineligible|738|||
126566505|NCT02486588|455368150|FG004|Overall Study|Randomized in error- ineligible|746|||
126566506|NCT02486588|455368151|FG005|Overall Study|Randomized in error- ineligible|746|||
126566507|NCT02132702|455368154|FG000|Overall Study|Protocol Violation|2|||
126566508|NCT02132702|455368154|FG000|Overall Study|Adverse Event|3|||
126566509|NCT02132702|455368154|FG000|Overall Study|Withdrawal by Subject|3|||
126566510|NCT03354390|455368155|FG000|Level 1|Death|2|||
126566511|NCT03354390|455368156|FG001|Level 1|Death|0|||
126566512|NCT03354390|455368157|FG002|Level 1|Death|0|||
126566513|NCT03354390|455368158|FG003|Level 1|Death|0|||
126566514|NCT03354390|455368155|FG000|Level 1|Physician Decision|1|||
126566515|NCT03354390|455368156|FG001|Level 1|Physician Decision|0|||
126566516|NCT03354390|455368157|FG002|Level 1|Physician Decision|0|||
126566517|NCT03354390|455368158|FG003|Level 1|Physician Decision|0|||
126566518|NCT03354390|455368155|FG000|Level 2|Physician Decision|0|||
126566519|NCT03354390|455368156|FG001|Level 2|Physician Decision|2|||
126566520|NCT03354390|455368157|FG002|Level 2|Physician Decision|0|||
126566521|NCT03354390|455368158|FG003|Level 2|Physician Decision|0|||
126566522|NCT03354390|455368155|FG000|Level 2|Lack of Efficacy|0|||
126566523|NCT03354390|455368156|FG001|Level 2|Lack of Efficacy|1|||
126566524|NCT03354390|455368157|FG002|Level 2|Lack of Efficacy|0|||
126566525|NCT03354390|455368158|FG003|Level 2|Lack of Efficacy|0|||
126566526|NCT03354390|455368155|FG000|Level 2|Lost to Follow-up|0|||
126566527|NCT03354390|455368156|FG001|Level 2|Lost to Follow-up|1|||
126566528|NCT03354390|455368157|FG002|Level 2|Lost to Follow-up|0|||
126566529|NCT03354390|455368158|FG003|Level 2|Lost to Follow-up|0|||
126566530|NCT03354390|455368155|FG000|Level 3|Death|0|||
126566531|NCT03354390|455368156|FG001|Level 3|Death|0|||
126566532|NCT03354390|455368157|FG002|Level 3|Death|1|||
126566533|NCT03354390|455368158|FG003|Level 3|Death|0|||
126566534|NCT03354390|455368155|FG000|Level 3|Physician Decision|0|||
126566535|NCT03354390|455368156|FG001|Level 3|Physician Decision|0|||
126566536|NCT03354390|455368157|FG002|Level 3|Physician Decision|2|||
126566537|NCT03354390|455368158|FG003|Level 3|Physician Decision|0|||
126566538|NCT03354390|455368155|FG000|Level 4|Death|0|||
126566539|NCT03354390|455368156|FG001|Level 4|Death|0|||
126566540|NCT03354390|455368157|FG002|Level 4|Death|0|||
126566541|NCT03354390|455368158|FG003|Level 4|Death|3|||
126566542|NCT02738840|455370206|FG000|Overall Study|MRI Scan not Performed|5|||
126566543|NCT02738840|455370206|FG000|Overall Study|Lost to Follow-up|1|||
126566544|NCT02738840|455370206|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
126566545|NCT02738840|455370206|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
126566546|NCT01645111|455370208|FG000|Overall Study|Did not require Clevidipine|15|||
126566547|NCT04057196|455370212|FG000|Overall Study|Withdrawal by Subject|3|||
126566548|NCT04057196|455370212|FG000|Overall Study|Death|3|||
126566549|NCT02466516|455370214|FG000|Overall Study|Adverse Event|1|||
126566550|NCT02466516|455370215|FG001|Overall Study|Adverse Event|1|||
126566551|NCT02466516|455370216|FG002|Overall Study|Adverse Event|0|||
126566552|NCT02466516|455370217|FG003|Overall Study|Adverse Event|0|||
126566553|NCT02466516|455370218|FG004|Overall Study|Adverse Event|0|||
126566554|NCT02466516|455370214|FG000|Overall Study|Withdrew Consent|1|||
126566555|NCT02466516|455370215|FG001|Overall Study|Withdrew Consent|0|||
126566556|NCT02466516|455370216|FG002|Overall Study|Withdrew Consent|0|||
126566557|NCT02466516|455370217|FG003|Overall Study|Withdrew Consent|0|||
126566558|NCT02466516|455370218|FG004|Overall Study|Withdrew Consent|0|||
126566559|NCT02466516|455370214|FG000|Overall Study|Lost to Follow-up|2|||
126566560|NCT02466516|455370215|FG001|Overall Study|Lost to Follow-up|0|||
126566561|NCT02466516|455370216|FG002|Overall Study|Lost to Follow-up|1|||
126566562|NCT02466516|455370217|FG003|Overall Study|Lost to Follow-up|0|||
126566563|NCT02466516|455370218|FG004|Overall Study|Lost to Follow-up|0|||
126566564|NCT01062126|455370219|FG000|Overall Study|Death|209|||
126566565|NCT01062126|455370219|FG000|Overall Study|All Withdrawals|324|||
126566566|NCT01331824|455370220|FG000|Overall Study|Adverse Event|2|||
126566567|NCT01331824|455370220|FG000|Overall Study|Death|1|||
126566568|NCT01331824|455370220|FG000|Overall Study|Disease Progression|9|||
126566569|NCT01331824|455370220|FG000|Overall Study|Withdrawal by Subject|1|||
126566570|NCT00486759|455370223|FG000|Treatment|Adverse event/intercurrent illness|86|||
126566571|NCT00486759|455370224|FG001|Treatment|Adverse event/intercurrent illness|39|||
126566572|NCT00486759|455370223|FG000|Treatment|Insufficient therapeutic response|37|||
126566573|NCT00486759|455370224|FG001|Treatment|Insufficient therapeutic response|39|||
126566574|NCT00486759|455370223|FG000|Treatment|Death|17|||
126566575|NCT00486759|455370224|FG001|Treatment|Death|10|||
126566576|NCT00486759|455370223|FG000|Treatment|Withdrew consent|15|||
126566577|NCT00486759|455370224|FG001|Treatment|Withdrew consent|12|||
126566578|NCT00486759|455370223|FG000|Treatment|Administrative/reason not specified|17|||
126566579|NCT00486759|455370224|FG001|Treatment|Administrative/reason not specified|21|||
126566580|NCT00486759|455370223|FG000|Treatment|Refused treatment|10|||
126566581|NCT00486759|455370224|FG001|Treatment|Refused treatment|7|||
126566582|NCT00486759|455370223|FG000|Treatment|Violation of selection criteria at entry|3|||
126566583|NCT00486759|455370224|FG001|Treatment|Violation of selection criteria at entry|3|||
126566584|NCT00486759|455370223|FG000|Treatment|Other protocol violation|1|||
126566585|NCT00486759|455370224|FG001|Treatment|Other protocol violation|5|||
126566586|NCT00486759|455370223|FG000|Treatment|Failure to return|1|||
126566587|NCT00486759|455370224|FG001|Treatment|Failure to return|1|||
126566588|NCT00486759|455370223|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
126566589|NCT00486759|455370224|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
126566590|NCT00486759|455370223|FG000|Safety Follow-up|Death|40|||
126566591|NCT00486759|455370224|FG001|Safety Follow-up|Death|29|||
126566592|NCT00486759|455370223|FG000|Safety Follow-up|Withdrew consent|32|||
126566593|NCT00486759|455370224|FG001|Safety Follow-up|Withdrew consent|23|||
126566594|NCT00486759|455370223|FG000|Safety Follow-up|Failure to return|9|||
126566595|NCT00486759|455370224|FG001|Safety Follow-up|Failure to return|6|||
126566596|NCT00486759|455370223|FG000|Safety Follow-up|Administrative/not specified|8|||
126566597|NCT00486759|455370224|FG001|Safety Follow-up|Administrative/not specified|6|||
126566598|NCT00486759|455370223|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
126566599|NCT00486759|455370224|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
126566600|NCT00486759|455370223|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
126566601|NCT00486759|455370224|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
126566602|NCT00954707|455370225|FG000|Overall Study|Death|34|||
126566603|NCT00954707|455370225|FG000|Overall Study|Withdrawal by Subject|100|||
126566604|NCT00954707|455370225|FG000|Overall Study|Lost to Follow-up|33|||
126566605|NCT01710514|455370231|FG000|Overall Study|Adverse Event|6|||
126566606|NCT01710514|455370232|FG001|Overall Study|Adverse Event|7|||
126566607|NCT01710514|455370231|FG000|Overall Study|Withdrawal by Subject|1|||
126566608|NCT01710514|455370232|FG001|Overall Study|Withdrawal by Subject|0|||
126566609|NCT02846415|455370234|FG000|Overall Study|Lost to Follow-up|2|||
126566610|NCT02846415|455370235|FG001|Overall Study|Lost to Follow-up|0|||
126566611|NCT02846415|455370234|FG000|Overall Study|Withdrawal by Subject|1|||
126566612|NCT02846415|455370235|FG001|Overall Study|Withdrawal by Subject|1|||
126566613|NCT03383887|455370236|FG000|Overall Study|Lost to Follow-up|0|||
126566614|NCT03383887|455370237|FG001|Overall Study|Lost to Follow-up|1|||
126566615|NCT00246012|455370240|FG000|Overall Study|Adverse Event|0|||
126566616|NCT00246012|455370241|FG001|Overall Study|Adverse Event|0|||
126566617|NCT00246012|455370242|FG002|Overall Study|Adverse Event|0|||
126566618|NCT00246012|455370243|FG003|Overall Study|Adverse Event|0|||
126566619|NCT00246012|455370244|FG004|Overall Study|Adverse Event|0|||
126566620|NCT00246012|455370245|FG005|Overall Study|Adverse Event|1|||
126566621|NCT00246012|455370246|FG006|Overall Study|Adverse Event|0|||
126566622|NCT00246012|455370247|FG007|Overall Study|Adverse Event|0|||
126566623|NCT00246012|455370248|FG008|Overall Study|Adverse Event|2|||
126566624|NCT00246012|455370240|FG000|Overall Study|Withdrawal by Subject|0|||
126566625|NCT00246012|455370241|FG001|Overall Study|Withdrawal by Subject|0|||
126566626|NCT00246012|455370242|FG002|Overall Study|Withdrawal by Subject|0|||
126566627|NCT00246012|455370243|FG003|Overall Study|Withdrawal by Subject|0|||
126566628|NCT00246012|455370244|FG004|Overall Study|Withdrawal by Subject|0|||
126566629|NCT00246012|455370245|FG005|Overall Study|Withdrawal by Subject|1|||
126566630|NCT00246012|455370246|FG006|Overall Study|Withdrawal by Subject|0|||
126566631|NCT00246012|455370247|FG007|Overall Study|Withdrawal by Subject|0|||
126566632|NCT00246012|455370248|FG008|Overall Study|Withdrawal by Subject|0|||
126566633|NCT00246012|455370240|FG000|Overall Study|Disease progression|3|||
126566634|NCT00246012|455370241|FG001|Overall Study|Disease progression|1|||
126566635|NCT00246012|455370242|FG002|Overall Study|Disease progression|2|||
126566636|NCT00246012|455370243|FG003|Overall Study|Disease progression|3|||
126566637|NCT00246012|455370244|FG004|Overall Study|Disease progression|3|||
126566638|NCT00246012|455370245|FG005|Overall Study|Disease progression|25|||
126566639|NCT00246012|455370246|FG006|Overall Study|Disease progression|30|||
126566640|NCT00246012|455370247|FG007|Overall Study|Disease progression|27|||
126566641|NCT00246012|455370248|FG008|Overall Study|Disease progression|26|||
126566642|NCT00246012|455370240|FG000|Overall Study|Other|0|||
126566643|NCT00246012|455370241|FG001|Overall Study|Other|0|||
126566644|NCT00246012|455370242|FG002|Overall Study|Other|0|||
126566645|NCT00246012|455370243|FG003|Overall Study|Other|0|||
126566646|NCT00246012|455370244|FG004|Overall Study|Other|0|||
126566647|NCT00246012|455370245|FG005|Overall Study|Other|0|||
126566648|NCT00246012|455370246|FG006|Overall Study|Other|0|||
126566649|NCT00246012|455370247|FG007|Overall Study|Other|1|||
126566650|NCT00246012|455370248|FG008|Overall Study|Other|0|||
126566651|NCT00246012|455370240|FG000|Overall Study|Randomly assigned but not treated|0|||
126566652|NCT00246012|455370241|FG001|Overall Study|Randomly assigned but not treated|0|||
126566653|NCT00246012|455370242|FG002|Overall Study|Randomly assigned but not treated|0|||
126566654|NCT00246012|455370243|FG003|Overall Study|Randomly assigned but not treated|0|||
126566655|NCT00246012|455370244|FG004|Overall Study|Randomly assigned but not treated|0|||
126566656|NCT00246012|455370245|FG005|Overall Study|Randomly assigned but not treated|1|||
126566657|NCT00246012|455370246|FG006|Overall Study|Randomly assigned but not treated|1|||
126566658|NCT00246012|455370247|FG007|Overall Study|Randomly assigned but not treated|0|||
126566659|NCT00246012|455370248|FG008|Overall Study|Randomly assigned but not treated|0|||
126566660|NCT01242085|455370249|FG000|Overall Study|Withdrawal by Subject|4|||
126566661|NCT01242085|455370250|FG001|Overall Study|Withdrawal by Subject|2|||
126566662|NCT01242085|455370251|FG002|Overall Study|Withdrawal by Subject|0|||
126566663|NCT01242085|455370249|FG000|Overall Study|medically unable to have surgery|4|||
126566664|NCT01242085|455370250|FG001|Overall Study|medically unable to have surgery|5|||
126566665|NCT01242085|455370251|FG002|Overall Study|medically unable to have surgery|0|||
126566666|NCT01178762|455370252|FG000|Overall Study|Lost to Follow-up|15|||
126566667|NCT02322216|455370253|FG000|Overall Study|Adverse Event|1|||
126566668|NCT02322216|455370254|FG001|Overall Study|Adverse Event|0|||
126566669|NCT02322216|455370253|FG000|Overall Study|Withdrawal by Subject|1|||
126566670|NCT02322216|455370254|FG001|Overall Study|Withdrawal by Subject|4|||
126566671|NCT01651949|455370255|FG000|Overall Study|Unknown status|4|||
126566672|NCT01651949|455370256|FG001|Overall Study|Unknown status|4|||
126566673|NCT01651949|455370257|FG002|Overall Study|Unknown status|0|||
126566674|NCT01651949|455370255|FG000|Overall Study|Lost to Follow-up|30|||
126566675|NCT01651949|455370256|FG001|Overall Study|Lost to Follow-up|56|||
126566676|NCT01651949|455370257|FG002|Overall Study|Lost to Follow-up|20|||
126566677|NCT01651949|455370255|FG000|Overall Study|Protocol Violation|0|||
126566678|NCT01651949|455370256|FG001|Overall Study|Protocol Violation|2|||
126566679|NCT01651949|455370257|FG002|Overall Study|Protocol Violation|1|||
126566680|NCT01651949|455370255|FG000|Overall Study|Physician Decision|0|||
126566681|NCT01651949|455370256|FG001|Overall Study|Physician Decision|2|||
126566682|NCT01651949|455370257|FG002|Overall Study|Physician Decision|0|||
126566683|NCT01651949|455370255|FG000|Overall Study|Adverse Event|0|||
126566684|NCT01651949|455370256|FG001|Overall Study|Adverse Event|2|||
126566685|NCT01651949|455370257|FG002|Overall Study|Adverse Event|1|||
126566686|NCT01651949|455370255|FG000|Overall Study|Screen failure|2|||
126566687|NCT01651949|455370256|FG001|Overall Study|Screen failure|2|||
126566688|NCT01651949|455370257|FG002|Overall Study|Screen failure|0|||
126566689|NCT01651949|455370255|FG000|Overall Study|Withdrawal by Subject|17|||
126566690|NCT01651949|455370256|FG001|Overall Study|Withdrawal by Subject|18|||
126566691|NCT01651949|455370257|FG002|Overall Study|Withdrawal by Subject|9|||
126566692|NCT01806714|455370258|FG000|Overall Study|No functioning phone number|200|||
126566693|NCT01806714|455370259|FG001|Overall Study|No functioning phone number|170|||
126566694|NCT02596035|455370269|FG000|Overall Study|Disease Progression|64|||
126566695|NCT02596035|455370270|FG001|Overall Study|Disease Progression|32|||
126566696|NCT02596035|455370271|FG002|Overall Study|Disease Progression|1|||
126566697|NCT02596035|455370269|FG000|Overall Study|study drug toxicity|12|||
126566698|NCT02596035|455370270|FG001|Overall Study|study drug toxicity|3|||
126566699|NCT02596035|455370271|FG002|Overall Study|study drug toxicity|0|||
126566700|NCT02596035|455370269|FG000|Overall Study|AE unrelated to study drug|5|||
126566701|NCT02596035|455370270|FG001|Overall Study|AE unrelated to study drug|2|||
126566702|NCT02596035|455370271|FG002|Overall Study|AE unrelated to study drug|0|||
126566703|NCT02596035|455370269|FG000|Overall Study|participant request to discontinue study treatment|2|||
126511345|NCT02346240|455168772|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511346|NCT02346240|455168773|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511347|NCT02346240|455168774|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511348|NCT02346240|455168775|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511349|NCT02346240|455168776|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511350|NCT02346240|455168777|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511351|NCT02346240|455168778|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511352|NCT02346240|455168779|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511353|NCT02346240|455168780|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511354|NCT02346240|455168781|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511355|NCT02346240|455168782|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511356|NCT02346240|455168783|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511357|NCT02346240|455168784|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511358|NCT02346240|455168785|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126511359|NCT02346240|455168786|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
126566704|NCT02596035|455370270|FG001|Overall Study|participant request to discontinue study treatment|0|||
126566705|NCT02596035|455370271|FG002|Overall Study|participant request to discontinue study treatment|0|||
126566706|NCT02596035|455370269|FG000|Overall Study|participant withdrew consent|2|||
126566707|NCT02596035|455370270|FG001|Overall Study|participant withdrew consent|2|||
126566708|NCT02596035|455370271|FG002|Overall Study|participant withdrew consent|0|||
126566709|NCT02596035|455370269|FG000|Overall Study|Poor/Non Comlpiance|0|||
126566710|NCT02596035|455370270|FG001|Overall Study|Poor/Non Comlpiance|1|||
126566711|NCT02596035|455370271|FG002|Overall Study|Poor/Non Comlpiance|0|||
126566712|NCT02596035|455370269|FG000|Overall Study|participant no longer meets study criteria|1|||
126566713|NCT02596035|455370270|FG001|Overall Study|participant no longer meets study criteria|0|||
126566714|NCT02596035|455370271|FG002|Overall Study|participant no longer meets study criteria|0|||
126511360|NCT02346240|455168763|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511361|NCT02346240|455168764|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511362|NCT02346240|455168765|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
126511363|NCT02346240|455168766|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511364|NCT02346240|455168767|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511365|NCT02346240|455168768|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511366|NCT02346240|455168769|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511367|NCT02346240|455168770|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511368|NCT02346240|455168771|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511369|NCT02346240|455168772|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511370|NCT02346240|455168773|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511371|NCT02346240|455168774|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511372|NCT02346240|455168775|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511373|NCT02346240|455168776|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511374|NCT02346240|455168777|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511375|NCT02346240|455168778|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511376|NCT02346240|455168779|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511377|NCT02346240|455168780|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511378|NCT02346240|455168781|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511379|NCT02346240|455168782|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511380|NCT02346240|455168783|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511381|NCT02346240|455168784|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511382|NCT02346240|455168785|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511383|NCT02346240|455168786|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
126511384|NCT02346240|455168763|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511385|NCT02346240|455168764|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511386|NCT02346240|455168765|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511387|NCT02346240|455168766|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511388|NCT02346240|455168767|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511389|NCT02346240|455168768|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511390|NCT02346240|455168769|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511391|NCT02346240|455168770|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
126511392|NCT02346240|455168771|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
126511393|NCT02346240|455168772|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511394|NCT02346240|455168773|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511395|NCT02346240|455168774|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511396|NCT02346240|455168775|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511397|NCT02346240|455168776|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
126511398|NCT02346240|455168777|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
126511399|NCT02346240|455168778|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
126511400|NCT02346240|455168779|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
126511401|NCT02346240|455168780|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511402|NCT02346240|455168781|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511403|NCT02346240|455168782|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511404|NCT02346240|455168783|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511405|NCT02346240|455168784|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511406|NCT02346240|455168785|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511407|NCT02346240|455168786|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
126511408|NCT02346240|455168763|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511409|NCT02346240|455168764|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511410|NCT02346240|455168765|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511411|NCT02346240|455168766|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511412|NCT02346240|455168767|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511413|NCT02346240|455168768|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511414|NCT02346240|455168769|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126566715|NCT02596035|455370269|FG000|Overall Study|other reasons|11|||
126566716|NCT02596035|455370270|FG001|Overall Study|other reasons|4|||
126566717|NCT02596035|455370271|FG002|Overall Study|other reasons|0|||
126511415|NCT02346240|455168770|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126566718|NCT01235949|455370276|FG000|Primary Phase|Migrated/moved from study area|1|||
126566719|NCT01235949|455370277|FG001|Primary Phase|Migrated/moved from study area|1|||
126566720|NCT01235949|455370278|FG002|Primary Phase|Migrated/moved from study area|0|||
126566721|NCT01235949|455370279|FG003|Primary Phase|Migrated/moved from study area|0|||
126566722|NCT01235949|455370280|FG004|Primary Phase|Migrated/moved from study area|1|||
126566723|NCT01235949|455370281|FG005|Primary Phase|Migrated/moved from study area|2|||
126566724|NCT01235949|455370282|FG006|Primary Phase|Migrated/moved from study area|0|||
126511416|NCT02346240|455168771|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511417|NCT02346240|455168772|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511418|NCT02346240|455168773|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511419|NCT02346240|455168774|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511420|NCT02346240|455168775|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511421|NCT02346240|455168776|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
126511422|NCT02346240|455168777|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511423|NCT02346240|455168778|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
126511424|NCT02346240|455168779|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511425|NCT02346240|455168780|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511426|NCT02346240|455168781|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511427|NCT02346240|455168782|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511428|NCT02346240|455168783|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511429|NCT02346240|455168784|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511430|NCT02346240|455168785|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511431|NCT02346240|455168786|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
126511432|NCT02346240|455168763|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511433|NCT02346240|455168764|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511434|NCT02346240|455168765|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511435|NCT02346240|455168766|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511436|NCT02346240|455168767|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511437|NCT02346240|455168768|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511438|NCT02346240|455168769|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511439|NCT02346240|455168770|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511440|NCT02346240|455168771|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511441|NCT02346240|455168772|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511442|NCT02346240|455168773|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511443|NCT02346240|455168774|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511444|NCT02346240|455168775|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511445|NCT02346240|455168776|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511446|NCT02346240|455168777|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
126511447|NCT02346240|455168778|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511448|NCT02346240|455168779|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511449|NCT02346240|455168780|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511450|NCT02346240|455168781|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511451|NCT02346240|455168782|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511452|NCT02346240|455168783|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511453|NCT02346240|455168784|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511454|NCT02346240|455168785|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511455|NCT02346240|455168786|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
126511456|NCT02346240|455168763|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511457|NCT02346240|455168764|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511458|NCT02346240|455168765|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511459|NCT02346240|455168766|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511460|NCT02346240|455168767|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511461|NCT02346240|455168768|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126511462|NCT02346240|455168769|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126511463|NCT02346240|455168770|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126511464|NCT02346240|455168771|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126511465|NCT02346240|455168772|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511466|NCT02346240|455168773|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126511467|NCT02346240|455168774|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
126511468|NCT02346240|455168775|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511469|NCT02346240|455168776|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
126511470|NCT02346240|455168777|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
126566725|NCT01235949|455370283|FG007|Primary Phase|Migrated/moved from study area|0|||
126566726|NCT01235949|455370284|FG008|Primary Phase|Migrated/moved from study area|0|||
126566727|NCT01235949|455370285|FG009|Primary Phase|Migrated/moved from study area|0|||
126511471|NCT02346240|455168778|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
126566728|NCT01235949|455370286|FG010|Primary Phase|Migrated/moved from study area|0|||
126566729|NCT01235949|455370287|FG011|Primary Phase|Migrated/moved from study area|0|||
126566730|NCT01235949|455370288|FG012|Primary Phase|Migrated/moved from study area|0|||
126566731|NCT01235949|455370289|FG013|Primary Phase|Migrated/moved from study area|0|||
126566732|NCT01235949|455370290|FG014|Primary Phase|Migrated/moved from study area|0|||
126566733|NCT01235949|455370291|FG015|Primary Phase|Migrated/moved from study area|0|||
126566734|NCT01235949|455370292|FG016|Primary Phase|Migrated/moved from study area|0|||
126566735|NCT01235949|455370293|FG017|Primary Phase|Migrated/moved from study area|0|||
126566736|NCT01235949|455370276|FG000|Primary Phase|Adverse Event|0|||
126566737|NCT01235949|455370277|FG001|Primary Phase|Adverse Event|0|||
126566738|NCT01235949|455370278|FG002|Primary Phase|Adverse Event|0|||
126566739|NCT01235949|455370279|FG003|Primary Phase|Adverse Event|1|||
126566740|NCT01235949|455370280|FG004|Primary Phase|Adverse Event|0|||
126566741|NCT01235949|455370281|FG005|Primary Phase|Adverse Event|0|||
126566742|NCT01235949|455370282|FG006|Primary Phase|Adverse Event|0|||
126566743|NCT01235949|455370283|FG007|Primary Phase|Adverse Event|0|||
126566744|NCT01235949|455370284|FG008|Primary Phase|Adverse Event|0|||
126566745|NCT01235949|455370285|FG009|Primary Phase|Adverse Event|0|||
126566746|NCT01235949|455370286|FG010|Primary Phase|Adverse Event|0|||
126566747|NCT01235949|455370287|FG011|Primary Phase|Adverse Event|0|||
126566748|NCT01235949|455370288|FG012|Primary Phase|Adverse Event|0|||
126566749|NCT01235949|455370289|FG013|Primary Phase|Adverse Event|0|||
126566750|NCT01235949|455370290|FG014|Primary Phase|Adverse Event|0|||
126566751|NCT01235949|455370291|FG015|Primary Phase|Adverse Event|0|||
126566752|NCT01235949|455370292|FG016|Primary Phase|Adverse Event|0|||
126566753|NCT01235949|455370293|FG017|Primary Phase|Adverse Event|0|||
126566754|NCT01235949|455370276|FG000|Primary Phase|Withdrawal by Subject|3|||
126566755|NCT01235949|455370277|FG001|Primary Phase|Withdrawal by Subject|2|||
126566756|NCT01235949|455370278|FG002|Primary Phase|Withdrawal by Subject|2|||
126566757|NCT01235949|455370279|FG003|Primary Phase|Withdrawal by Subject|0|||
126566758|NCT01235949|455370280|FG004|Primary Phase|Withdrawal by Subject|0|||
126566759|NCT01235949|455370281|FG005|Primary Phase|Withdrawal by Subject|3|||
126566760|NCT01235949|455370282|FG006|Primary Phase|Withdrawal by Subject|0|||
126566761|NCT01235949|455370283|FG007|Primary Phase|Withdrawal by Subject|0|||
126566762|NCT01235949|455370284|FG008|Primary Phase|Withdrawal by Subject|0|||
126566763|NCT01235949|455370285|FG009|Primary Phase|Withdrawal by Subject|0|||
126566764|NCT01235949|455370286|FG010|Primary Phase|Withdrawal by Subject|0|||
126566765|NCT01235949|455370287|FG011|Primary Phase|Withdrawal by Subject|0|||
126566766|NCT01235949|455370288|FG012|Primary Phase|Withdrawal by Subject|0|||
126566767|NCT01235949|455370289|FG013|Primary Phase|Withdrawal by Subject|0|||
126566768|NCT01235949|455370290|FG014|Primary Phase|Withdrawal by Subject|0|||
126566769|NCT01235949|455370291|FG015|Primary Phase|Withdrawal by Subject|0|||
126566770|NCT01235949|455370292|FG016|Primary Phase|Withdrawal by Subject|0|||
126566771|NCT01235949|455370293|FG017|Primary Phase|Withdrawal by Subject|0|||
126566772|NCT01235949|455370276|FG000|Primary Phase|Lost to Follow-up|0|||
126566773|NCT01235949|455370277|FG001|Primary Phase|Lost to Follow-up|0|||
126511472|NCT02346240|455168779|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
126511473|NCT02346240|455168780|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511474|NCT02346240|455168781|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511475|NCT02346240|455168782|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511476|NCT02346240|455168783|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511477|NCT02346240|455168784|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511478|NCT02346240|455168785|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511479|NCT02346240|455168786|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
126511480|NCT02346240|455168763|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511481|NCT02346240|455168764|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511482|NCT02346240|455168765|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511483|NCT02346240|455168766|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511484|NCT02346240|455168767|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511485|NCT02346240|455168768|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511486|NCT02346240|455168769|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511487|NCT02346240|455168770|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511488|NCT02346240|455168771|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511489|NCT02346240|455168772|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126566774|NCT01235949|455370278|FG002|Primary Phase|Lost to Follow-up|1|||
126566775|NCT01235949|455370279|FG003|Primary Phase|Lost to Follow-up|1|||
126566776|NCT01235949|455370280|FG004|Primary Phase|Lost to Follow-up|0|||
126566777|NCT01235949|455370281|FG005|Primary Phase|Lost to Follow-up|2|||
126566778|NCT01235949|455370282|FG006|Primary Phase|Lost to Follow-up|0|||
126566779|NCT01235949|455370283|FG007|Primary Phase|Lost to Follow-up|0|||
126566780|NCT01235949|455370284|FG008|Primary Phase|Lost to Follow-up|0|||
126566781|NCT01235949|455370285|FG009|Primary Phase|Lost to Follow-up|0|||
126566782|NCT01235949|455370286|FG010|Primary Phase|Lost to Follow-up|0|||
126727163|NCT02921919|455951069|FG000|Overall Study|Withdrawal by Subject|5|||
126511490|NCT02346240|455168773|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511491|NCT02346240|455168774|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511492|NCT02346240|455168775|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511493|NCT02346240|455168776|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
126511494|NCT02346240|455168777|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
126511495|NCT02346240|455168778|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
126511496|NCT02346240|455168779|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
126511497|NCT02346240|455168780|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511498|NCT02346240|455168781|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511499|NCT02346240|455168782|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511500|NCT02346240|455168783|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511501|NCT02346240|455168784|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511502|NCT02346240|455168785|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511503|NCT02346240|455168786|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
126511504|NCT02346240|455168763|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511505|NCT02346240|455168764|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511506|NCT02346240|455168765|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511507|NCT02346240|455168766|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511508|NCT02346240|455168767|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511509|NCT02346240|455168768|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511510|NCT02346240|455168769|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
126511511|NCT02346240|455168770|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511512|NCT02346240|455168771|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511513|NCT02346240|455168772|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511514|NCT02346240|455168773|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511515|NCT02346240|455168774|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511516|NCT02346240|455168775|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511517|NCT02346240|455168776|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511518|NCT02346240|455168777|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511519|NCT02346240|455168778|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511520|NCT02346240|455168779|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511521|NCT02346240|455168780|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511522|NCT02346240|455168781|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511523|NCT02346240|455168782|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511524|NCT02346240|455168783|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511525|NCT02346240|455168784|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511526|NCT02346240|455168785|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511527|NCT02346240|455168786|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
126511528|NCT02346240|455168763|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511529|NCT02346240|455168764|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511530|NCT02346240|455168765|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511531|NCT02346240|455168766|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511532|NCT02346240|455168767|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511533|NCT02346240|455168768|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511534|NCT02346240|455168769|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511535|NCT02346240|455168770|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511536|NCT02346240|455168771|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
126511537|NCT02346240|455168772|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511538|NCT02346240|455168773|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511539|NCT02346240|455168774|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
126511540|NCT02346240|455168775|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511541|NCT02346240|455168776|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
126511542|NCT02346240|455168777|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
126511543|NCT02346240|455168778|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511544|NCT02346240|455168779|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511545|NCT02346240|455168780|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511546|NCT02346240|455168781|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511547|NCT02346240|455168782|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511548|NCT02346240|455168783|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511549|NCT02346240|455168784|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511550|NCT02346240|455168785|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511551|NCT02346240|455168786|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
126511552|NCT02346240|455168763|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511553|NCT02346240|455168764|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511554|NCT02346240|455168765|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511555|NCT02346240|455168766|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511556|NCT02346240|455168767|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511557|NCT02346240|455168768|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511558|NCT02346240|455168769|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511559|NCT02346240|455168770|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511560|NCT02346240|455168771|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511561|NCT02346240|455168772|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
126511562|NCT02346240|455168773|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511563|NCT02346240|455168774|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511564|NCT02346240|455168775|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511565|NCT02346240|455168776|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511566|NCT02346240|455168777|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511567|NCT02346240|455168778|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511568|NCT02346240|455168779|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511569|NCT02346240|455168780|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511570|NCT02346240|455168781|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511571|NCT02346240|455168782|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511572|NCT02346240|455168783|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511573|NCT02346240|455168784|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511574|NCT02346240|455168785|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511575|NCT02346240|455168786|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
126511576|NCT02346240|455168763|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511577|NCT02346240|455168764|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511578|NCT02346240|455168765|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511579|NCT02346240|455168766|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511580|NCT02346240|455168767|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511581|NCT02346240|455168768|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511582|NCT02346240|455168769|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511583|NCT02346240|455168770|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511584|NCT02346240|455168771|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511585|NCT02346240|455168772|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511586|NCT02346240|455168773|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
126511587|NCT02346240|455168774|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511588|NCT02346240|455168775|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511589|NCT02346240|455168776|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511590|NCT02346240|455168777|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511591|NCT02346240|455168778|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511592|NCT02346240|455168779|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511593|NCT02346240|455168780|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511594|NCT02346240|455168781|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511595|NCT02346240|455168782|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511596|NCT02346240|455168783|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511597|NCT02346240|455168784|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511598|NCT02346240|455168785|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511599|NCT02346240|455168786|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
126511600|NCT02346240|455168763|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511601|NCT02346240|455168764|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511602|NCT02346240|455168765|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511603|NCT02346240|455168766|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511604|NCT02346240|455168767|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126566783|NCT01235949|455370287|FG011|Primary Phase|Lost to Follow-up|0|||
126511605|NCT02346240|455168768|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511606|NCT02346240|455168769|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511607|NCT02346240|455168770|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511608|NCT02346240|455168771|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511609|NCT02346240|455168772|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511610|NCT02346240|455168773|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511611|NCT02346240|455168774|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511612|NCT02346240|455168775|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511613|NCT02346240|455168776|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511614|NCT02346240|455168777|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
126511615|NCT02346240|455168778|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511616|NCT02346240|455168779|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511617|NCT02346240|455168780|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511618|NCT02346240|455168781|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511619|NCT02346240|455168782|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511620|NCT02346240|455168783|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511621|NCT02346240|455168784|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511622|NCT02346240|455168785|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511623|NCT02346240|455168786|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
126511624|NCT02346240|455168763|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511625|NCT02346240|455168764|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511626|NCT02346240|455168765|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511627|NCT02346240|455168766|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511628|NCT02346240|455168767|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511629|NCT02346240|455168768|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511630|NCT02346240|455168769|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511631|NCT02346240|455168770|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511632|NCT02346240|455168771|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511633|NCT02346240|455168772|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511634|NCT02346240|455168773|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511635|NCT02346240|455168774|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511636|NCT02346240|455168775|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511637|NCT02346240|455168776|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511638|NCT02346240|455168777|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
126511639|NCT02346240|455168778|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511640|NCT02346240|455168779|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511641|NCT02346240|455168780|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511642|NCT02346240|455168781|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511643|NCT02346240|455168782|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511644|NCT02346240|455168783|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511645|NCT02346240|455168784|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511646|NCT02346240|455168785|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511647|NCT02346240|455168786|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
126511648|NCT02346240|455168763|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511649|NCT02346240|455168764|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511650|NCT02346240|455168765|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511651|NCT02346240|455168766|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511652|NCT02346240|455168767|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511653|NCT02346240|455168768|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511654|NCT02346240|455168769|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511655|NCT02346240|455168770|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511656|NCT02346240|455168771|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511657|NCT02346240|455168772|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511658|NCT02346240|455168773|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511659|NCT02346240|455168774|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511660|NCT02346240|455168775|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511661|NCT02346240|455168776|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126566784|NCT01235949|455370288|FG012|Primary Phase|Lost to Follow-up|0|||
126511662|NCT02346240|455168777|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
126511663|NCT02346240|455168778|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511664|NCT02346240|455168779|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511665|NCT02346240|455168780|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511666|NCT02346240|455168781|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511667|NCT02346240|455168782|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511668|NCT02346240|455168783|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511669|NCT02346240|455168784|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511670|NCT02346240|455168785|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511671|NCT02346240|455168786|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
126511672|NCT02346240|455168763|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511673|NCT02346240|455168764|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511674|NCT02346240|455168765|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511675|NCT02346240|455168766|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511676|NCT02346240|455168767|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511677|NCT02346240|455168768|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511678|NCT02346240|455168769|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511679|NCT02346240|455168770|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511680|NCT02346240|455168771|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511681|NCT02346240|455168772|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511682|NCT02346240|455168773|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511683|NCT02346240|455168774|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511684|NCT02346240|455168775|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511685|NCT02346240|455168776|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511686|NCT02346240|455168777|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511687|NCT02346240|455168778|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511688|NCT02346240|455168779|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
126511689|NCT02346240|455168780|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
126511690|NCT02346240|455168781|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
126511691|NCT02346240|455168782|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
126511692|NCT02346240|455168783|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
126511693|NCT02346240|455168784|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
126511694|NCT02346240|455168785|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
126511695|NCT02346240|455168786|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
126511696|NCT02346240|455168763|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511697|NCT02346240|455168764|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511698|NCT02346240|455168765|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511699|NCT02346240|455168766|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511700|NCT02346240|455168767|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511701|NCT02346240|455168768|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511702|NCT02346240|455168769|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511703|NCT02346240|455168770|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511704|NCT02346240|455168771|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511705|NCT02346240|455168772|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511706|NCT02346240|455168773|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511707|NCT02346240|455168774|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511708|NCT02346240|455168775|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511709|NCT02346240|455168776|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511710|NCT02346240|455168777|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511711|NCT02346240|455168778|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511712|NCT02346240|455168779|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511713|NCT02346240|455168780|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511714|NCT02346240|455168781|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
126511715|NCT02346240|455168782|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
126511716|NCT02346240|455168783|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511717|NCT02346240|455168784|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
126511718|NCT02346240|455168785|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511719|NCT02346240|455168786|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
126511720|NCT02346240|455168763|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511721|NCT02346240|455168764|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511722|NCT02346240|455168765|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511723|NCT02346240|455168766|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511724|NCT02346240|455168767|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511725|NCT02346240|455168768|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511726|NCT02346240|455168769|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511727|NCT02346240|455168770|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511728|NCT02346240|455168771|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511729|NCT02346240|455168772|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511730|NCT02346240|455168773|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511731|NCT02346240|455168774|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511732|NCT02346240|455168775|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511733|NCT02346240|455168776|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511734|NCT02346240|455168777|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511735|NCT02346240|455168778|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511736|NCT02346240|455168779|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511737|NCT02346240|455168780|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511738|NCT02346240|455168781|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
126511739|NCT02346240|455168782|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511740|NCT02346240|455168783|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511741|NCT02346240|455168784|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
126511742|NCT02346240|455168785|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511743|NCT02346240|455168786|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
126511744|NCT02346240|455168763|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511745|NCT02346240|455168764|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511746|NCT02346240|455168765|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511747|NCT02346240|455168766|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511748|NCT02346240|455168767|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511749|NCT02346240|455168768|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511750|NCT02346240|455168769|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511751|NCT02346240|455168770|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511752|NCT02346240|455168771|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511753|NCT02346240|455168772|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511754|NCT02346240|455168773|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511755|NCT02346240|455168774|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511756|NCT02346240|455168775|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511757|NCT02346240|455168776|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511758|NCT02346240|455168777|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511759|NCT02346240|455168778|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511760|NCT02346240|455168779|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511761|NCT02346240|455168780|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511762|NCT02346240|455168781|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511763|NCT02346240|455168782|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511764|NCT02346240|455168783|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511765|NCT02346240|455168784|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
126511766|NCT02346240|455168785|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511767|NCT02346240|455168786|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
126511768|NCT02346240|455168763|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511769|NCT02346240|455168764|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511770|NCT02346240|455168765|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511771|NCT02346240|455168766|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511772|NCT02346240|455168767|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511773|NCT02346240|455168768|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511774|NCT02346240|455168769|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511775|NCT02346240|455168770|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511776|NCT02346240|455168771|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511777|NCT02346240|455168772|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511778|NCT02346240|455168773|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511779|NCT02346240|455168774|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511780|NCT02346240|455168775|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511781|NCT02346240|455168776|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511782|NCT02346240|455168777|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511783|NCT02346240|455168778|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511784|NCT02346240|455168779|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511785|NCT02346240|455168780|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
126511786|NCT02346240|455168781|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
126511787|NCT02346240|455168782|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
126511788|NCT02346240|455168783|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
126511789|NCT02346240|455168784|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
126511790|NCT02346240|455168785|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
126511791|NCT02346240|455168786|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
126511792|NCT02346240|455168763|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511793|NCT02346240|455168764|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511794|NCT02346240|455168765|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511795|NCT02346240|455168766|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511796|NCT02346240|455168767|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511797|NCT02346240|455168768|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511798|NCT02346240|455168769|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511799|NCT02346240|455168770|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511800|NCT02346240|455168771|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511801|NCT02346240|455168772|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511802|NCT02346240|455168773|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511803|NCT02346240|455168774|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511804|NCT02346240|455168775|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511805|NCT02346240|455168776|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511806|NCT02346240|455168777|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511807|NCT02346240|455168778|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511808|NCT02346240|455168779|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511809|NCT02346240|455168780|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511810|NCT02346240|455168781|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
126511811|NCT02346240|455168782|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
126511812|NCT02346240|455168783|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
126511813|NCT02346240|455168784|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
126511814|NCT02346240|455168785|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
126511815|NCT02346240|455168786|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
126511816|NCT02346240|455168763|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511817|NCT02346240|455168764|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511818|NCT02346240|455168765|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511819|NCT02346240|455168766|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511820|NCT02346240|455168767|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511821|NCT02346240|455168768|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511822|NCT02346240|455168769|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511823|NCT02346240|455168770|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511824|NCT02346240|455168771|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511825|NCT02346240|455168772|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511826|NCT02346240|455168773|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511827|NCT02346240|455168774|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511828|NCT02346240|455168775|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511829|NCT02346240|455168776|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511830|NCT02346240|455168777|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511831|NCT02346240|455168778|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511832|NCT02346240|455168779|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511833|NCT02346240|455168780|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511834|NCT02346240|455168781|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
126511835|NCT02346240|455168782|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511836|NCT02346240|455168783|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
126511837|NCT02346240|455168784|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
126511838|NCT02346240|455168785|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
126511839|NCT02346240|455168786|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
126511840|NCT02346240|455168763|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511841|NCT02346240|455168764|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511842|NCT02346240|455168765|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511843|NCT02346240|455168766|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511844|NCT02346240|455168767|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511845|NCT02346240|455168768|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511846|NCT02346240|455168769|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511847|NCT02346240|455168770|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511848|NCT02346240|455168771|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511849|NCT02346240|455168772|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511850|NCT02346240|455168773|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126566785|NCT01235949|455370289|FG013|Primary Phase|Lost to Follow-up|0|||
126511851|NCT02346240|455168774|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511852|NCT02346240|455168775|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511853|NCT02346240|455168776|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511854|NCT02346240|455168777|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511855|NCT02346240|455168778|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511856|NCT02346240|455168779|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511857|NCT02346240|455168780|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511858|NCT02346240|455168781|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
126511859|NCT02346240|455168782|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511860|NCT02346240|455168783|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511861|NCT02346240|455168784|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511862|NCT02346240|455168785|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511863|NCT02346240|455168786|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
126511864|NCT01822132|455168789|FG000|Overall Study|Lost to Follow-up|4|||
126511865|NCT01822132|455168790|FG001|Overall Study|Lost to Follow-up|2|||
126511866|NCT01247090|455168795|FG000|Overall Study|Physician Decision|1|||
126511867|NCT01247090|455168796|FG001|Overall Study|Physician Decision|0|||
126511868|NCT01247090|455168797|FG002|Overall Study|Physician Decision|0|||
126511869|NCT01247090|455168795|FG000|Overall Study|Withdrawal by Subject|0|||
126511870|NCT01247090|455168796|FG001|Overall Study|Withdrawal by Subject|1|||
126511871|NCT01247090|455168797|FG002|Overall Study|Withdrawal by Subject|0|||
126511872|NCT00006916|455168799|FG000|Overall Study|Device not inserted|4|||
126511873|NCT00006916|455168799|FG000|Overall Study|Complication of device insertion|1|||
126511874|NCT03385239|455168804|FG000|Overall Study|Voluntary Withdrawal|2|||
126511875|NCT03385239|455168805|FG001|Overall Study|Voluntary Withdrawal|3|||
126511876|NCT03385239|455168806|FG002|Overall Study|Voluntary Withdrawal|2|||
126511877|NCT03385239|455168807|FG003|Overall Study|Voluntary Withdrawal|3|||
126511878|NCT03385239|455168808|FG004|Overall Study|Voluntary Withdrawal|0|||
126511879|NCT03385239|455168804|FG000|Overall Study|Adverse Event|0|||
126511880|NCT03385239|455168805|FG001|Overall Study|Adverse Event|0|||
126511881|NCT03385239|455168806|FG002|Overall Study|Adverse Event|1|||
126511882|NCT03385239|455168807|FG003|Overall Study|Adverse Event|0|||
126511883|NCT03385239|455168808|FG004|Overall Study|Adverse Event|0|||
126511884|NCT03385239|455168804|FG000|Overall Study|Other|0|||
126511885|NCT03385239|455168805|FG001|Overall Study|Other|0|||
126511886|NCT03385239|455168806|FG002|Overall Study|Other|0|||
126511887|NCT03385239|455168807|FG003|Overall Study|Other|1|||
126511888|NCT03385239|455168808|FG004|Overall Study|Other|0|||
126511889|NCT01574703|455168809|FG000|Overall Study|Adverse Event|0|||
126511890|NCT01574703|455168810|FG001|Overall Study|Adverse Event|2|||
126511891|NCT01574703|455168811|FG002|Overall Study|Adverse Event|1|||
126511892|NCT01574703|455168812|FG003|Overall Study|Adverse Event|1|||
126511893|NCT01574703|455168809|FG000|Overall Study|Protocol Violation|0|||
126511894|NCT01574703|455168810|FG001|Overall Study|Protocol Violation|0|||
126511895|NCT01574703|455168811|FG002|Overall Study|Protocol Violation|0|||
126511896|NCT01574703|455168812|FG003|Overall Study|Protocol Violation|1|||
126511897|NCT01574703|455168809|FG000|Overall Study|Unspecified Reason|27|||
126511898|NCT01574703|455168810|FG001|Overall Study|Unspecified Reason|15|||
126511899|NCT01574703|455168811|FG002|Overall Study|Unspecified Reason|20|||
126511900|NCT01574703|455168812|FG003|Overall Study|Unspecified Reason|16|||
126511901|NCT01574703|455168809|FG000|Overall Study|Withdrawal by Subject|53|||
126511902|NCT01574703|455168810|FG001|Overall Study|Withdrawal by Subject|52|||
126511903|NCT01574703|455168811|FG002|Overall Study|Withdrawal by Subject|36|||
126511904|NCT01574703|455168812|FG003|Overall Study|Withdrawal by Subject|61|||
126511905|NCT01574703|455168809|FG000|Overall Study|Met Withdrawal Criteria|0|||
126511906|NCT01574703|455168810|FG001|Overall Study|Met Withdrawal Criteria|1|||
126511907|NCT01574703|455168811|FG002|Overall Study|Met Withdrawal Criteria|1|||
126511908|NCT01574703|455168812|FG003|Overall Study|Met Withdrawal Criteria|0|||
126511909|NCT01574703|455168809|FG000|Overall Study|Lost to Follow-up|43|||
126511910|NCT01574703|455168810|FG001|Overall Study|Lost to Follow-up|41|||
126511911|NCT01574703|455168811|FG002|Overall Study|Lost to Follow-up|46|||
126511912|NCT01574703|455168812|FG003|Overall Study|Lost to Follow-up|35|||
126511913|NCT01574703|455168809|FG000|Overall Study|Death|2|||
126566786|NCT01235949|455370290|FG014|Primary Phase|Lost to Follow-up|0|||
126511914|NCT01574703|455168810|FG001|Overall Study|Death|1|||
126511915|NCT01574703|455168811|FG002|Overall Study|Death|1|||
126511916|NCT01574703|455168812|FG003|Overall Study|Death|0|||
126511917|NCT01524770|455168813|FG000|First Intervention|Withdrawal by Subject|1|||
126511918|NCT01524770|455168814|FG001|First Intervention|Withdrawal by Subject|0|||
126511919|NCT01524770|455168813|FG000|First Intervention|Adverse Event|1|||
126511920|NCT01524770|455168814|FG001|First Intervention|Adverse Event|1|||
126511921|NCT01524770|455168813|FG000|First Intervention|Protocol Violation|1|||
126511922|NCT01524770|455168814|FG001|First Intervention|Protocol Violation|0|||
126511923|NCT01282216|455168815|FG000|Overall Study|Graft failure|0|||
126511924|NCT01282216|455168816|FG001|Overall Study|Graft failure|0|||
126566787|NCT01235949|455370291|FG015|Primary Phase|Lost to Follow-up|0|||
126566788|NCT01235949|455370292|FG016|Primary Phase|Lost to Follow-up|0|||
126566789|NCT01235949|455370293|FG017|Primary Phase|Lost to Follow-up|0|||
126566790|NCT01235949|455370276|FG000|Booster Phase|Migrated/moved from study area|0|||
126566791|NCT01235949|455370277|FG001|Booster Phase|Migrated/moved from study area|0|||
126566792|NCT01235949|455370278|FG002|Booster Phase|Migrated/moved from study area|0|||
126566793|NCT01235949|455370279|FG003|Booster Phase|Migrated/moved from study area|0|||
126566794|NCT01235949|455370280|FG004|Booster Phase|Migrated/moved from study area|0|||
126566795|NCT01235949|455370281|FG005|Booster Phase|Migrated/moved from study area|0|||
126566796|NCT01235949|455370282|FG006|Booster Phase|Migrated/moved from study area|0|||
126566797|NCT01235949|455370283|FG007|Booster Phase|Migrated/moved from study area|0|||
126566798|NCT01235949|455370284|FG008|Booster Phase|Migrated/moved from study area|0|||
126566799|NCT01235949|455370285|FG009|Booster Phase|Migrated/moved from study area|0|||
126566800|NCT01235949|455370286|FG010|Booster Phase|Migrated/moved from study area|0|||
126566801|NCT01235949|455370287|FG011|Booster Phase|Migrated/moved from study area|1|||
126566802|NCT01235949|455370288|FG012|Booster Phase|Migrated/moved from study area|1|||
126566803|NCT01235949|455370289|FG013|Booster Phase|Migrated/moved from study area|0|||
126566804|NCT01235949|455370290|FG014|Booster Phase|Migrated/moved from study area|0|||
126566805|NCT01235949|455370291|FG015|Booster Phase|Migrated/moved from study area|0|||
126566806|NCT01235949|455370292|FG016|Booster Phase|Migrated/moved from study area|0|||
126566807|NCT01235949|455370293|FG017|Booster Phase|Migrated/moved from study area|1|||
126566808|NCT01235949|455370276|FG000|Booster Phase|Adverse Event|0|||
126566809|NCT01235949|455370277|FG001|Booster Phase|Adverse Event|0|||
126566810|NCT01235949|455370278|FG002|Booster Phase|Adverse Event|0|||
126566811|NCT01235949|455370279|FG003|Booster Phase|Adverse Event|0|||
126566812|NCT01235949|455370280|FG004|Booster Phase|Adverse Event|0|||
126566813|NCT01235949|455370281|FG005|Booster Phase|Adverse Event|0|||
126566814|NCT01235949|455370282|FG006|Booster Phase|Adverse Event|0|||
126566815|NCT01235949|455370283|FG007|Booster Phase|Adverse Event|0|||
126566816|NCT01235949|455370284|FG008|Booster Phase|Adverse Event|0|||
126566817|NCT01235949|455370285|FG009|Booster Phase|Adverse Event|0|||
126566818|NCT01235949|455370286|FG010|Booster Phase|Adverse Event|0|||
126566819|NCT01235949|455370287|FG011|Booster Phase|Adverse Event|0|||
126566820|NCT01235949|455370288|FG012|Booster Phase|Adverse Event|0|||
126566821|NCT01235949|455370289|FG013|Booster Phase|Adverse Event|0|||
126566822|NCT01235949|455370290|FG014|Booster Phase|Adverse Event|0|||
126566823|NCT01235949|455370291|FG015|Booster Phase|Adverse Event|1|||
126566824|NCT01235949|455370292|FG016|Booster Phase|Adverse Event|0|||
126566825|NCT01235949|455370293|FG017|Booster Phase|Adverse Event|0|||
126566826|NCT01235949|455370276|FG000|Booster Phase|Withdrawal by Subject|0|||
126566827|NCT01235949|455370277|FG001|Booster Phase|Withdrawal by Subject|0|||
126566828|NCT01235949|455370278|FG002|Booster Phase|Withdrawal by Subject|0|||
126566829|NCT01235949|455370279|FG003|Booster Phase|Withdrawal by Subject|0|||
126566830|NCT01235949|455370280|FG004|Booster Phase|Withdrawal by Subject|0|||
126566831|NCT01235949|455370281|FG005|Booster Phase|Withdrawal by Subject|0|||
126566832|NCT01235949|455370282|FG006|Booster Phase|Withdrawal by Subject|0|||
126566833|NCT01235949|455370283|FG007|Booster Phase|Withdrawal by Subject|1|||
126566834|NCT01235949|455370284|FG008|Booster Phase|Withdrawal by Subject|1|||
126566835|NCT01235949|455370285|FG009|Booster Phase|Withdrawal by Subject|0|||
126566836|NCT01235949|455370286|FG010|Booster Phase|Withdrawal by Subject|1|||
126566837|NCT01235949|455370287|FG011|Booster Phase|Withdrawal by Subject|1|||
126566838|NCT01235949|455370288|FG012|Booster Phase|Withdrawal by Subject|2|||
126566839|NCT01235949|455370289|FG013|Booster Phase|Withdrawal by Subject|0|||
126566840|NCT01235949|455370290|FG014|Booster Phase|Withdrawal by Subject|2|||
126566841|NCT01235949|455370291|FG015|Booster Phase|Withdrawal by Subject|0|||
126566842|NCT01235949|455370292|FG016|Booster Phase|Withdrawal by Subject|0|||
126566843|NCT01235949|455370293|FG017|Booster Phase|Withdrawal by Subject|0|||
126566844|NCT01235949|455370276|FG000|Booster Phase|Lost to Follow-up|0|||
126566845|NCT01235949|455370277|FG001|Booster Phase|Lost to Follow-up|0|||
126566846|NCT01235949|455370278|FG002|Booster Phase|Lost to Follow-up|0|||
126566847|NCT01235949|455370279|FG003|Booster Phase|Lost to Follow-up|0|||
126566848|NCT01235949|455370280|FG004|Booster Phase|Lost to Follow-up|0|||
126566849|NCT01235949|455370281|FG005|Booster Phase|Lost to Follow-up|0|||
126566850|NCT01235949|455370282|FG006|Booster Phase|Lost to Follow-up|0|||
126566851|NCT01235949|455370283|FG007|Booster Phase|Lost to Follow-up|0|||
126566852|NCT01235949|455370284|FG008|Booster Phase|Lost to Follow-up|1|||
126566853|NCT01235949|455370285|FG009|Booster Phase|Lost to Follow-up|1|||
126566854|NCT01235949|455370286|FG010|Booster Phase|Lost to Follow-up|1|||
126566855|NCT01235949|455370287|FG011|Booster Phase|Lost to Follow-up|1|||
126566856|NCT01235949|455370288|FG012|Booster Phase|Lost to Follow-up|0|||
126566857|NCT01235949|455370289|FG013|Booster Phase|Lost to Follow-up|0|||
126566858|NCT01235949|455370290|FG014|Booster Phase|Lost to Follow-up|0|||
126566859|NCT01235949|455370291|FG015|Booster Phase|Lost to Follow-up|0|||
126566860|NCT01235949|455370292|FG016|Booster Phase|Lost to Follow-up|0|||
126566861|NCT01235949|455370293|FG017|Booster Phase|Lost to Follow-up|1|||
126566862|NCT00754936|455370294|FG000|Overall Study|Lost to Follow-up|3|||
126566863|NCT00754936|455370294|FG000|Overall Study|Physician Decision|1|||
126511925|NCT01282216|455168817|FG002|Overall Study|Graft failure|3|||
126511926|NCT01282216|455168818|FG003|Overall Study|Graft failure|2|||
126511927|NCT01282216|455168815|FG000|Overall Study|Physician Decision|0|||
126511928|NCT01282216|455168816|FG001|Overall Study|Physician Decision|0|||
126511929|NCT01282216|455168817|FG002|Overall Study|Physician Decision|11|||
126511930|NCT01282216|455168818|FG003|Overall Study|Physician Decision|0|||
126511931|NCT01282216|455168815|FG000|Overall Study|Relapse|0|||
126511932|NCT01282216|455168816|FG001|Overall Study|Relapse|0|||
126511933|NCT01282216|455168817|FG002|Overall Study|Relapse|17|||
126511934|NCT01282216|455168818|FG003|Overall Study|Relapse|6|||
126511935|NCT01282216|455168815|FG000|Overall Study|Death|0|||
126511936|NCT01282216|455168816|FG001|Overall Study|Death|0|||
126511937|NCT01282216|455168817|FG002|Overall Study|Death|2|||
126511938|NCT01282216|455168818|FG003|Overall Study|Death|0|||
126511939|NCT01387607|455168819|FG000|Overall Study|Adverse Event|23|||
126511940|NCT01387607|455168820|FG001|Overall Study|Adverse Event|11|||
126511941|NCT01387607|455168819|FG000|Overall Study|Lack of Efficacy|8|||
126511942|NCT01387607|455168820|FG001|Overall Study|Lack of Efficacy|6|||
126511943|NCT01387607|455168819|FG000|Overall Study|Lost to Follow-up|2|||
126511944|NCT01387607|455168820|FG001|Overall Study|Lost to Follow-up|1|||
126511945|NCT01387607|455168819|FG000|Overall Study|No longer meets eligibility criteria|0|||
126511946|NCT01387607|455168820|FG001|Overall Study|No longer meets eligibility criteria|1|||
126511947|NCT01387607|455168819|FG000|Overall Study|Protocol Violation|1|||
126511948|NCT01387607|455168820|FG001|Overall Study|Protocol Violation|5|||
126511949|NCT01387607|455168819|FG000|Overall Study|Withdrawal by Subject|13|||
126511950|NCT01387607|455168820|FG001|Overall Study|Withdrawal by Subject|14|||
126511951|NCT01387607|455168819|FG000|Overall Study|Other|1|||
126511952|NCT01387607|455168820|FG001|Overall Study|Other|1|||
126511953|NCT01387607|455168819|FG000|Overall Study|Randomized, not treated|3|||
126511954|NCT01387607|455168820|FG001|Overall Study|Randomized, not treated|6|||
126511955|NCT02908529|455168821|FG000|Overall Study|Lost to Follow-up|0|||
126511956|NCT02908529|455168822|FG001|Overall Study|Lost to Follow-up|2|||
126511957|NCT05569954|455168823|FG000|Overall Study|Lost to Follow-up|3|||
126511958|NCT05569954|455168824|FG001|Overall Study|Lost to Follow-up|4|||
126511959|NCT05569954|455168823|FG000|Overall Study|Protocol Violation|1|||
126511960|NCT05569954|455168824|FG001|Overall Study|Protocol Violation|2|||
126511961|NCT05569954|455168823|FG000|Overall Study|Withdrawal by Subject|4|||
126511962|NCT05569954|455168824|FG001|Overall Study|Withdrawal by Subject|2|||
126511963|NCT02239536|455168825|FG000|Overall Study|Non-neoplastic polyp|23|||
126511964|NCT02239536|455168826|FG001|Overall Study|Non-neoplastic polyp|17|||
126511965|NCT01038778|455168827|FG000|Overall Study|Withdrawal by Subject|0|||
126511966|NCT01038778|455168828|FG001|Overall Study|Withdrawal by Subject|2|||
126511967|NCT01038778|455168829|FG002|Overall Study|Withdrawal by Subject|3|||
126511968|NCT04740034|455168830|FG000|Overall Study|Death|0|||
126511969|NCT04740034|455168831|FG001|Overall Study|Death|1|||
126511970|NCT04740034|455168832|FG002|Overall Study|Death|2|||
126511971|NCT04740034|455168833|FG003|Overall Study|Death|3|||
126511972|NCT04740034|455168834|FG004|Overall Study|Death|4|||
126511973|NCT04740034|455168835|FG005|Overall Study|Death|4|||
126511974|NCT04740034|455168836|FG006|Overall Study|Death|2|||
126511975|NCT04740034|455168837|FG007|Overall Study|Death|2|||
126511976|NCT04740034|455168838|FG008|Overall Study|Death|2|||
126511977|NCT04740034|455168839|FG009|Overall Study|Death|4|||
126511978|NCT04740034|455168840|FG010|Overall Study|Death|0|||
126511979|NCT04740034|455168830|FG000|Overall Study|Lost to Follow-up|0|||
126511980|NCT04740034|455168831|FG001|Overall Study|Lost to Follow-up|0|||
126511981|NCT04740034|455168832|FG002|Overall Study|Lost to Follow-up|0|||
126511982|NCT04740034|455168833|FG003|Overall Study|Lost to Follow-up|1|||
126511983|NCT04740034|455168834|FG004|Overall Study|Lost to Follow-up|2|||
126511984|NCT04740034|455168835|FG005|Overall Study|Lost to Follow-up|2|||
126511985|NCT04740034|455168836|FG006|Overall Study|Lost to Follow-up|0|||
126511986|NCT04740034|455168837|FG007|Overall Study|Lost to Follow-up|0|||
126511987|NCT04740034|455168838|FG008|Overall Study|Lost to Follow-up|0|||
126511988|NCT04740034|455168839|FG009|Overall Study|Lost to Follow-up|1|||
126511989|NCT04740034|455168840|FG010|Overall Study|Lost to Follow-up|0|||
126511990|NCT04740034|455168830|FG000|Overall Study|Withdrawal by Subject|1|||
126511991|NCT04740034|455168831|FG001|Overall Study|Withdrawal by Subject|0|||
126511992|NCT04740034|455168832|FG002|Overall Study|Withdrawal by Subject|0|||
126511993|NCT04740034|455168833|FG003|Overall Study|Withdrawal by Subject|0|||
126511994|NCT04740034|455168834|FG004|Overall Study|Withdrawal by Subject|0|||
126511995|NCT04740034|455168835|FG005|Overall Study|Withdrawal by Subject|0|||
126511996|NCT04740034|455168836|FG006|Overall Study|Withdrawal by Subject|0|||
126511997|NCT04740034|455168837|FG007|Overall Study|Withdrawal by Subject|1|||
126776957|NCT00267007|456139125|FG001|Overall Study|Non-compliance|1|||
126511998|NCT04740034|455168838|FG008|Overall Study|Withdrawal by Subject|0|||
126511999|NCT04740034|455168839|FG009|Overall Study|Withdrawal by Subject|1|||
126512000|NCT04740034|455168840|FG010|Overall Study|Withdrawal by Subject|0|||
126512001|NCT04740034|455168830|FG000|Overall Study|Decision by sponsor|0|||
126512002|NCT04740034|455168831|FG001|Overall Study|Decision by sponsor|0|||
126512003|NCT04740034|455168832|FG002|Overall Study|Decision by sponsor|1|||
126512004|NCT04740034|455168833|FG003|Overall Study|Decision by sponsor|0|||
126512005|NCT04740034|455168834|FG004|Overall Study|Decision by sponsor|0|||
126512006|NCT04740034|455168835|FG005|Overall Study|Decision by sponsor|0|||
126512007|NCT04740034|455168836|FG006|Overall Study|Decision by sponsor|1|||
126512008|NCT04740034|455168837|FG007|Overall Study|Decision by sponsor|2|||
126512009|NCT04740034|455168838|FG008|Overall Study|Decision by sponsor|1|||
126512010|NCT04740034|455168839|FG009|Overall Study|Decision by sponsor|1|||
126512011|NCT04740034|455168840|FG010|Overall Study|Decision by sponsor|2|||
126512012|NCT04346615|455170664|FG000|Overall Study|Lost to Follow-up|0|||
126512013|NCT04346615|455170665|FG001|Overall Study|Lost to Follow-up|2|||
126512014|NCT04346615|455170664|FG000|Overall Study|Withdrawal by Subject|1|||
126512015|NCT04346615|455170665|FG001|Overall Study|Withdrawal by Subject|0|||
126512016|NCT04346615|455170664|FG000|Overall Study|Death|5|||
126512017|NCT04346615|455170665|FG001|Overall Study|Death|1|||
126512018|NCT04346615|455170664|FG000|Overall Study|Other|0|||
126512019|NCT04346615|455170665|FG001|Overall Study|Other|2|||
126512020|NCT04346615|455170664|FG000|Overall Study|Randomized not treated|1|||
126512021|NCT04346615|455170665|FG001|Overall Study|Randomized not treated|0|||
126512022|NCT04524403|455170668|FG000|Overall Study|Withdrawal by Subject|10|||
126512023|NCT04524403|455170669|FG001|Overall Study|Withdrawal by Subject|3|||
126512024|NCT04524403|455170670|FG002|Overall Study|Withdrawal by Subject|8|||
126512025|NCT04524403|455170668|FG000|Overall Study|Lost to Follow-up|3|||
126512026|NCT04524403|455170669|FG001|Overall Study|Lost to Follow-up|4|||
126512027|NCT04524403|455170670|FG002|Overall Study|Lost to Follow-up|3|||
126512028|NCT04524403|455170668|FG000|Overall Study|Adverse Event|3|||
126512029|NCT04524403|455170669|FG001|Overall Study|Adverse Event|1|||
126512030|NCT04524403|455170670|FG002|Overall Study|Adverse Event|4|||
126512031|NCT04524403|455170668|FG000|Overall Study|Non-compliant with study drug|1|||
126512032|NCT04524403|455170669|FG001|Overall Study|Non-compliant with study drug|2|||
126512033|NCT04524403|455170670|FG002|Overall Study|Non-compliant with study drug|3|||
126512034|NCT04524403|455170668|FG000|Overall Study|Moved|0|||
126512035|NCT04524403|455170669|FG001|Overall Study|Moved|1|||
126512036|NCT04524403|455170670|FG002|Overall Study|Moved|0|||
126512037|NCT01513317|455170671|FG000|Overall Study|Withdrawal by Subject|15|||
126512038|NCT01513317|455170672|FG001|Overall Study|Withdrawal by Subject|4|||
126512039|NCT01513317|455170671|FG000|Overall Study|Death|1|||
126512040|NCT01513317|455170672|FG001|Overall Study|Death|1|||
126512041|NCT01513317|455170671|FG000|Overall Study|Study terminated by sponsor|18|||
126512042|NCT01513317|455170672|FG001|Overall Study|Study terminated by sponsor|18|||
126512043|NCT01513317|455170671|FG000|Overall Study|Other|0|||
126512044|NCT01513317|455170672|FG001|Overall Study|Other|1|||
126512045|NCT00298896|455170676|FG000|Overall Study|Death|3|||
126512046|NCT00298896|455170676|FG000|Overall Study|Physician Decision|2|||
126512047|NCT00298896|455170676|FG000|Overall Study|Intercurrent Illness|1|||
126512048|NCT00298896|455170676|FG000|Overall Study|Disease Progression|41|||
126512049|NCT00298896|455170676|FG000|Overall Study|Withdrawal by Subject|2|||
126512050|NCT00298896|455170676|FG000|Overall Study|Assigned to treatment in error|1|||
126512051|NCT02649972|455170679|FG000|Overall Study|Not treated|1|||
126512052|NCT03285646|455170689|FG000|Overall Study|Adverse Event|1|||
126512053|NCT03285646|455170690|FG001|Overall Study|Adverse Event|0|||
126512054|NCT03285646|455170689|FG000|Overall Study|Withdrawal by Subject|10|||
126512055|NCT03285646|455170690|FG001|Overall Study|Withdrawal by Subject|2|||
126512056|NCT03285646|455170689|FG000|Overall Study|Lost to Follow-up|2|||
126512057|NCT03285646|455170690|FG001|Overall Study|Lost to Follow-up|1|||
126512058|NCT03285646|455170689|FG000|Overall Study|Investigator/Sponsor Decision|0|||
126512059|NCT03285646|455170690|FG001|Overall Study|Investigator/Sponsor Decision|1|||
126512060|NCT02610192|455170692|FG000|Overall Study|Received other treatment|8|||
126512061|NCT02610192|455170692|FG000|Overall Study|Physician Decision|1|||
126512062|NCT00503841|455170693|FG000|Overall Study|All screen failures|44|||
126512063|NCT01344057|455170694|FG000|Overall Study|Premature Withdrawal|1|||
126512064|NCT00306592|455170695|FG000|Overall Study|Adverse Event|8|||
126512065|NCT00306592|455170696|FG001|Overall Study|Adverse Event|15|||
126512066|NCT00306592|455170695|FG000|Overall Study|Lost to Follow-up|1|||
126512067|NCT00306592|455170696|FG001|Overall Study|Lost to Follow-up|0|||
126512068|NCT00306592|455170695|FG000|Overall Study|Noncompliance|0|||
126512069|NCT00306592|455170696|FG001|Overall Study|Noncompliance|2|||
126512070|NCT00306592|455170695|FG000|Overall Study|Persistent Antibodies|6|||
126512071|NCT00306592|455170696|FG001|Overall Study|Persistent Antibodies|3|||
126512072|NCT00306592|455170695|FG000|Overall Study|Voluntary|10|||
126512073|NCT00306592|455170696|FG001|Overall Study|Voluntary|6|||
126512074|NCT00306592|455170695|FG000|Overall Study|Other|5|||
126512075|NCT00306592|455170696|FG001|Overall Study|Other|10|||
126512076|NCT00306592|455170695|FG000|Overall Study|Other|1|||
126512077|NCT00306592|455170696|FG001|Overall Study|Other|2|||
126512078|NCT00306592|455170695|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
126512079|NCT00306592|455170696|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
126512080|NCT01440322|455170697|FG000|Overall Study|Discomfort|2|||
126512081|NCT01440322|455170698|FG001|Overall Study|Discomfort|0|||
126512082|NCT01440322|455170697|FG000|Overall Study|Biomicroscopy|1|||
126512083|NCT01440322|455170698|FG001|Overall Study|Biomicroscopy|0|||
126512084|NCT01440322|455170697|FG000|Overall Study|Symptoms and Problems|1|||
126512085|NCT01440322|455170698|FG001|Overall Study|Symptoms and Problems|0|||
126512086|NCT01440322|455170697|FG000|Overall Study|Unacceptable Subjective Vision|1|||
126512087|NCT01440322|455170698|FG001|Overall Study|Unacceptable Subjective Vision|0|||
126512088|NCT01440322|455170697|FG000|Overall Study|Other Product Related|1|||
126512089|NCT01440322|455170698|FG001|Overall Study|Other Product Related|0|||
126512090|NCT01440322|455170697|FG000|Overall Study|Unrelated Medical Problem|0|||
126512091|NCT01440322|455170698|FG001|Overall Study|Unrelated Medical Problem|1|||
126512092|NCT01440322|455170697|FG000|Overall Study|Other Non-Product Related|1|||
126512093|NCT01440322|455170698|FG001|Overall Study|Other Non-Product Related|0|||
126512094|NCT05044234|455170700|FG000|Overall Study|Lost to Follow-up|2|||
126512095|NCT05044234|455170701|FG001|Overall Study|Lost to Follow-up|1|||
126512096|NCT05044234|455170702|FG002|Overall Study|Lost to Follow-up|1|||
126512097|NCT05044234|455170703|FG003|Overall Study|Lost to Follow-up|2|||
126512098|NCT05044234|455170700|FG000|Overall Study|Withdrawal by Subject|6|||
126512099|NCT05044234|455170701|FG001|Overall Study|Withdrawal by Subject|4|||
126512100|NCT05044234|455170702|FG002|Overall Study|Withdrawal by Subject|5|||
126512101|NCT05044234|455170703|FG003|Overall Study|Withdrawal by Subject|8|||
126512102|NCT05044234|455170700|FG000|Overall Study|Study terminated by Sponsor|21|||
126512103|NCT05044234|455170701|FG001|Overall Study|Study terminated by Sponsor|21|||
126512104|NCT05044234|455170702|FG002|Overall Study|Study terminated by Sponsor|20|||
126512105|NCT05044234|455170703|FG003|Overall Study|Study terminated by Sponsor|14|||
126512106|NCT05044234|455170700|FG000|Overall Study|Other, not specified|0|||
126512107|NCT05044234|455170701|FG001|Overall Study|Other, not specified|0|||
126512108|NCT05044234|455170702|FG002|Overall Study|Other, not specified|1|||
126512109|NCT05044234|455170703|FG003|Overall Study|Other, not specified|2|||
126512110|NCT05044234|455170700|FG000|Overall Study|Delayed data entry|0|||
126512111|NCT05044234|455170701|FG001|Overall Study|Delayed data entry|0|||
126512112|NCT05044234|455170702|FG002|Overall Study|Delayed data entry|0|||
126512113|NCT05044234|455170703|FG003|Overall Study|Delayed data entry|1|||
126512114|NCT00279708|455170704|FG000|Overall Study|Withdrawal by Subject|2|||
126512115|NCT00279708|455170705|FG001|Overall Study|Withdrawal by Subject|3|||
126512116|NCT00279708|455170704|FG000|Overall Study|Adverse Event|1|||
126512117|NCT00279708|455170705|FG001|Overall Study|Adverse Event|1|||
126512118|NCT02896127|455170706|FG000|COMPLETED WEEK 52|Adverse Event|9|||
126512119|NCT02896127|455170707|FG001|COMPLETED WEEK 52|Adverse Event|2|||
126512120|NCT02896127|455170706|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
126512121|NCT02896127|455170707|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
126512122|NCT02896127|455170706|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
126512123|NCT02896127|455170707|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
126512124|NCT02896127|455170706|FG000|COMPLETED WEEK 52|Physician Decision|1|||
126512125|NCT02896127|455170707|FG001|COMPLETED WEEK 52|Physician Decision|1|||
126512126|NCT02896127|455170706|FG000|COMPLETED WEEK 52|Pregnancy|2|||
126512127|NCT02896127|455170707|FG001|COMPLETED WEEK 52|Pregnancy|0|||
126512128|NCT02896127|455170706|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
126512129|NCT02896127|455170707|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
126512130|NCT02896127|455170706|FG000|COMPLETED WEEK 52|Technical problems|1|||
126512131|NCT02896127|455170707|FG001|COMPLETED WEEK 52|Technical problems|0|||
126512132|NCT02896127|455170706|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
126512133|NCT02896127|455170707|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
126512134|NCT02896127|455170706|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
126512135|NCT02896127|455170707|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
126512136|NCT02896127|455170706|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
126512137|NCT02896127|455170707|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
126512138|NCT02896127|455170706|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
126512139|NCT02896127|455170707|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
126512140|NCT02896127|455170706|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
126512141|NCT02896127|455170707|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
126512142|NCT03354429|455170708|FG000|Overall Study|Withdrawal by Subject|8|||
126512143|NCT03354429|455170709|FG001|Overall Study|Withdrawal by Subject|7|||
126512144|NCT03354429|455170708|FG000|Overall Study|Lost to Follow-up|1|||
126512145|NCT03354429|455170709|FG001|Overall Study|Lost to Follow-up|0|||
126512146|NCT00654628|455170710|FG000|6-week Active Treatment Period|Adverse Event|9|||
126512147|NCT00654628|455170710|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
126512148|NCT00654628|455170710|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
126566864|NCT00754936|455370294|FG000|Overall Study|Withdrawal by Subject|2|||
126566865|NCT00754936|455370294|FG000|Overall Study|Side Effects|3|||
126512149|NCT00654628|455170710|FG000|6-week Active Treatment Period|Out of window period|1|||
126512150|NCT00654628|455170710|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
126512151|NCT00654628|455170710|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
126512152|NCT01465802|455170713|FG000|Overall Study|Study terminated by sponsor|1|||
126512153|NCT01465802|455170714|FG001|Overall Study|Study terminated by sponsor|0|||
126512154|NCT01465802|455170715|FG002|Overall Study|Study terminated by sponsor|0|||
126512155|NCT01465802|455170716|FG003|Overall Study|Study terminated by sponsor|1|||
126512156|NCT01465802|455170717|FG004|Overall Study|Study terminated by sponsor|7|||
126512157|NCT01465802|455170713|FG000|Overall Study|Withdrawal by Subject|7|||
126512158|NCT01465802|455170714|FG001|Overall Study|Withdrawal by Subject|7|||
126512159|NCT01465802|455170715|FG002|Overall Study|Withdrawal by Subject|0|||
126512160|NCT01465802|455170716|FG003|Overall Study|Withdrawal by Subject|8|||
126512161|NCT01465802|455170717|FG004|Overall Study|Withdrawal by Subject|1|||
126512162|NCT01465802|455170713|FG000|Overall Study|Lost to Follow-up|1|||
126512163|NCT01465802|455170714|FG001|Overall Study|Lost to Follow-up|1|||
126512164|NCT01465802|455170715|FG002|Overall Study|Lost to Follow-up|0|||
126512165|NCT01465802|455170716|FG003|Overall Study|Lost to Follow-up|0|||
126512166|NCT01465802|455170717|FG004|Overall Study|Lost to Follow-up|0|||
126512167|NCT01465802|455170713|FG000|Overall Study|Reason not specified|9|||
126512168|NCT01465802|455170714|FG001|Overall Study|Reason not specified|4|||
126512169|NCT01465802|455170715|FG002|Overall Study|Reason not specified|0|||
126512170|NCT01465802|455170716|FG003|Overall Study|Reason not specified|10|||
126512171|NCT01465802|455170717|FG004|Overall Study|Reason not specified|2|||
126512172|NCT01465802|455170713|FG000|Overall Study|Death|15|||
126512173|NCT01465802|455170714|FG001|Overall Study|Death|12|||
126512174|NCT01465802|455170715|FG002|Overall Study|Death|0|||
126512175|NCT01465802|455170716|FG003|Overall Study|Death|10|||
126512176|NCT01465802|455170717|FG004|Overall Study|Death|2|||
126512177|NCT00226941|455170718|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
126512178|NCT00226941|455170719|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
126512179|NCT00226941|455170720|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
126512180|NCT00226941|455170721|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
126512181|NCT00226941|455170718|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
126512182|NCT00226941|455170719|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
126512183|NCT00226941|455170720|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
126512184|NCT00226941|455170721|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
126512185|NCT01513291|455170722|FG000|Treatment Period|Adverse Event|8|||
126512186|NCT01513291|455170723|FG001|Treatment Period|Adverse Event|4|||
126512187|NCT01513291|455170724|FG002|Treatment Period|Adverse Event|0|||
126512188|NCT01513291|455170725|FG003|Treatment Period|Adverse Event|0|||
126512189|NCT01513291|455170726|FG004|Treatment Period|Adverse Event|0|||
126512190|NCT01513291|455170722|FG000|Treatment Period|Lack of Efficacy|3|||
126512191|NCT01513291|455170723|FG001|Treatment Period|Lack of Efficacy|0|||
126512192|NCT01513291|455170724|FG002|Treatment Period|Lack of Efficacy|0|||
126512193|NCT01513291|455170725|FG003|Treatment Period|Lack of Efficacy|0|||
126512194|NCT01513291|455170726|FG004|Treatment Period|Lack of Efficacy|0|||
126512195|NCT01513291|455170722|FG000|Treatment Period|Lost to Follow-up|2|||
126512196|NCT01513291|455170723|FG001|Treatment Period|Lost to Follow-up|3|||
126512197|NCT01513291|455170724|FG002|Treatment Period|Lost to Follow-up|0|||
126512198|NCT01513291|455170725|FG003|Treatment Period|Lost to Follow-up|0|||
126512199|NCT01513291|455170726|FG004|Treatment Period|Lost to Follow-up|0|||
126512200|NCT01513291|455170722|FG000|Treatment Period|Physician Decision|1|||
126512201|NCT01513291|455170723|FG001|Treatment Period|Physician Decision|0|||
126512202|NCT01513291|455170724|FG002|Treatment Period|Physician Decision|0|||
126512203|NCT01513291|455170725|FG003|Treatment Period|Physician Decision|0|||
126512204|NCT01513291|455170726|FG004|Treatment Period|Physician Decision|0|||
126512205|NCT01513291|455170722|FG000|Treatment Period|Protocol Violation|1|||
126512206|NCT01513291|455170723|FG001|Treatment Period|Protocol Violation|2|||
126512207|NCT01513291|455170724|FG002|Treatment Period|Protocol Violation|0|||
126512208|NCT01513291|455170725|FG003|Treatment Period|Protocol Violation|0|||
126512209|NCT01513291|455170726|FG004|Treatment Period|Protocol Violation|0|||
126512210|NCT01513291|455170722|FG000|Treatment Period|Withdrawal by Subject|8|||
126512211|NCT01513291|455170723|FG001|Treatment Period|Withdrawal by Subject|5|||
126512212|NCT01513291|455170724|FG002|Treatment Period|Withdrawal by Subject|0|||
126512213|NCT01513291|455170725|FG003|Treatment Period|Withdrawal by Subject|0|||
126512214|NCT01513291|455170726|FG004|Treatment Period|Withdrawal by Subject|0|||
126512215|NCT01513291|455170722|FG000|Treatment Period|Randomized not treated|0|||
126512216|NCT01513291|455170723|FG001|Treatment Period|Randomized not treated|2|||
126512217|NCT01513291|455170724|FG002|Treatment Period|Randomized not treated|0|||
126512218|NCT01513291|455170725|FG003|Treatment Period|Randomized not treated|0|||
126512219|NCT01513291|455170726|FG004|Treatment Period|Randomized not treated|0|||
126512220|NCT01513291|455170722|FG000|Run-out Period|Lost to Follow-up|0|||
126512221|NCT01513291|455170723|FG001|Run-out Period|Lost to Follow-up|0|||
126512222|NCT01513291|455170724|FG002|Run-out Period|Lost to Follow-up|0|||
126512223|NCT01513291|455170725|FG003|Run-out Period|Lost to Follow-up|1|||
126512224|NCT01513291|455170726|FG004|Run-out Period|Lost to Follow-up|0|||
126512225|NCT01513291|455170722|FG000|Run-out Period|Withdrawal by Subject|0|||
126512226|NCT01513291|455170723|FG001|Run-out Period|Withdrawal by Subject|0|||
126512227|NCT01513291|455170724|FG002|Run-out Period|Withdrawal by Subject|0|||
126512228|NCT01513291|455170725|FG003|Run-out Period|Withdrawal by Subject|1|||
126512229|NCT01513291|455170726|FG004|Run-out Period|Withdrawal by Subject|0|||
126512230|NCT03732638|455170727|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
126512231|NCT03732638|455170728|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
126512232|NCT03732638|455170727|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
126566866|NCT00754936|455370294|FG000|Overall Study|Inter-current medical events|3|||
126566867|NCT04364269|455370296|FG000|Overall Study|Adverse Event|1|||
126566868|NCT04364269|455370297|FG001|Overall Study|Adverse Event|0|||
126566869|NCT04364269|455370298|FG002|Overall Study|Adverse Event|0|||
126566870|NCT04364269|455370296|FG000|Overall Study|Withdrawal by Subject|0|||
126566871|NCT04364269|455370297|FG001|Overall Study|Withdrawal by Subject|1|||
126566872|NCT04364269|455370298|FG002|Overall Study|Withdrawal by Subject|0|||
126566873|NCT00383188|455370299|FG000|Overall Study|Adverse Event|4|||
126566874|NCT00383188|455370300|FG001|Overall Study|Adverse Event|7|||
126566875|NCT00383188|455370301|FG002|Overall Study|Adverse Event|9|||
126566876|NCT00383188|455370302|FG003|Overall Study|Adverse Event|8|||
126566877|NCT00383188|455370303|FG004|Overall Study|Adverse Event|8|||
126566878|NCT00383188|455370299|FG000|Overall Study|Lack of Efficacy|9|||
126566879|NCT00383188|455370300|FG001|Overall Study|Lack of Efficacy|3|||
126566880|NCT00383188|455370301|FG002|Overall Study|Lack of Efficacy|3|||
126566881|NCT00383188|455370302|FG003|Overall Study|Lack of Efficacy|2|||
126566882|NCT00383188|455370303|FG004|Overall Study|Lack of Efficacy|6|||
126566883|NCT00383188|455370299|FG000|Overall Study|Other|3|||
126566884|NCT00383188|455370300|FG001|Overall Study|Other|1|||
126566885|NCT00383188|455370301|FG002|Overall Study|Other|0|||
126566886|NCT00383188|455370302|FG003|Overall Study|Other|2|||
126566887|NCT00383188|455370303|FG004|Overall Study|Other|6|||
126566888|NCT00383188|455370299|FG000|Overall Study|No longer willing to participate|1|||
126566889|NCT00383188|455370300|FG001|Overall Study|No longer willing to participate|0|||
126566890|NCT00383188|455370301|FG002|Overall Study|No longer willing to participate|1|||
126566891|NCT00383188|455370302|FG003|Overall Study|No longer willing to participate|0|||
126566892|NCT00383188|455370303|FG004|Overall Study|No longer willing to participate|2|||
126566893|NCT00383188|455370299|FG000|Overall Study|Lost to Follow-up|0|||
126566894|NCT00383188|455370300|FG001|Overall Study|Lost to Follow-up|0|||
126566895|NCT00383188|455370301|FG002|Overall Study|Lost to Follow-up|0|||
126566896|NCT00383188|455370302|FG003|Overall Study|Lost to Follow-up|0|||
126566897|NCT00383188|455370303|FG004|Overall Study|Lost to Follow-up|1|||
126566898|NCT00835380|455370308|FG000|Overall Study|Withdrawal by Subject|2|||
126566899|NCT03247543|455370309|FG000|Overall Study|Adverse Event|3|||
126566900|NCT03247543|455370310|FG001|Overall Study|Adverse Event|6|||
126566901|NCT03247543|455370311|FG002|Overall Study|Adverse Event|4|||
126566902|NCT03247543|455370309|FG000|Overall Study|Lost to Follow-up|10|||
126566903|NCT03247543|455370310|FG001|Overall Study|Lost to Follow-up|7|||
126566904|NCT03247543|455370311|FG002|Overall Study|Lost to Follow-up|8|||
126566905|NCT03247543|455370309|FG000|Overall Study|Consent withdrawn by caregiver|2|||
126566906|NCT03247543|455370310|FG001|Overall Study|Consent withdrawn by caregiver|2|||
126566907|NCT03247543|455370311|FG002|Overall Study|Consent withdrawn by caregiver|9|||
126566908|NCT03247543|455370309|FG000|Overall Study|Withdrawal by Subject|0|||
126566909|NCT03247543|455370310|FG001|Overall Study|Withdrawal by Subject|0|||
126566910|NCT03247543|455370311|FG002|Overall Study|Withdrawal by Subject|1|||
126727164|NCT02921919|455951070|FG001|Overall Study|Withdrawal by Subject|1|||
126727165|NCT02921919|455951069|FG000|Overall Study|Disease Progression|47|||
126727166|NCT02921919|455951070|FG001|Overall Study|Disease Progression|38|||
126512233|NCT03732638|455170728|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
126512234|NCT03732638|455170727|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
126512235|NCT03732638|455170728|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
126512236|NCT03732638|455170727|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
126512237|NCT03732638|455170728|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
126512238|NCT03732638|455170727|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
126512239|NCT03732638|455170728|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
126727167|NCT02921919|455951069|FG000|Overall Study|Physician Decision|3|||
126727168|NCT02921919|455951070|FG001|Overall Study|Physician Decision|2|||
126727169|NCT02921919|455951069|FG000|Overall Study|Adverse Event|6|||
126727170|NCT02921919|455951070|FG001|Overall Study|Adverse Event|4|||
126512240|NCT03732638|455170727|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
126512241|NCT03732638|455170728|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
126512242|NCT03732638|455170727|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
126512243|NCT03732638|455170728|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
126566911|NCT03247543|455370309|FG000|Overall Study|Failure to Follow study procedures|1|||
126566912|NCT03247543|455370310|FG001|Overall Study|Failure to Follow study procedures|3|||
126566913|NCT03247543|455370311|FG002|Overall Study|Failure to Follow study procedures|1|||
126566914|NCT03247543|455370309|FG000|Overall Study|Lack of Efficacy|1|||
126566915|NCT03247543|455370310|FG001|Overall Study|Lack of Efficacy|0|||
126566916|NCT03247543|455370311|FG002|Overall Study|Lack of Efficacy|0|||
126566917|NCT03247543|455370309|FG000|Overall Study|Non-compliance with study visits|0|||
126566918|NCT03247543|455370310|FG001|Overall Study|Non-compliance with study visits|1|||
126566919|NCT03247543|455370311|FG002|Overall Study|Non-compliance with study visits|0|||
126566920|NCT02059980|455370314|FG000|Overall Study|Lost to Follow-up|2|||
126566921|NCT02059980|455370315|FG001|Overall Study|Lost to Follow-up|1|||
126566922|NCT01104415|455370316|FG000|Core Phase|Consent withdrawn by subjects|1|||
126512244|NCT03732638|455170727|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
126566923|NCT01104415|455370317|FG001|Core Phase|Consent withdrawn by subjects|0|||
126566924|NCT01104415|455370316|FG000|Extension Period|Progressive disease|0|||
126566925|NCT01104415|455370317|FG001|Extension Period|Progressive disease|4|||
126566926|NCT01104415|455370316|FG000|Extension Period|Death|0|||
126566927|NCT01104415|455370317|FG001|Extension Period|Death|1|||
126566928|NCT01104415|455370316|FG000|Extension Period|Physician Decision|0|||
126566929|NCT01104415|455370317|FG001|Extension Period|Physician Decision|1|||
126566930|NCT01104415|455370316|FG000|Extension Period|Transition to Study LX1606.302|0|||
126566931|NCT01104415|455370317|FG001|Extension Period|Transition to Study LX1606.302|4|||
126566932|NCT01104415|455370316|FG000|Extension Period|Heart surgery/feeling miserable|0|||
126566933|NCT01104415|455370317|FG001|Extension Period|Heart surgery/feeling miserable|1|||
126566934|NCT02341625|455370322|FG000|Overall Study|Disease Progression|2|||
126566935|NCT02341625|455370323|FG001|Overall Study|Disease Progression|2|||
126566936|NCT02341625|455370324|FG002|Overall Study|Disease Progression|3|||
126566937|NCT02341625|455370325|FG003|Overall Study|Disease Progression|6|||
126566938|NCT02341625|455370326|FG004|Overall Study|Disease Progression|7|||
126566939|NCT02341625|455370327|FG005|Overall Study|Disease Progression|7|||
126566940|NCT02341625|455370328|FG006|Overall Study|Disease Progression|28|||
126566941|NCT02341625|455370329|FG007|Overall Study|Disease Progression|5|||
126566942|NCT02341625|455370330|FG008|Overall Study|Disease Progression|4|||
126566943|NCT02341625|455370331|FG009|Overall Study|Disease Progression|19|||
126566944|NCT02341625|455370322|FG000|Overall Study|Study Drug Toxicity|0|||
126566945|NCT02341625|455370323|FG001|Overall Study|Study Drug Toxicity|0|||
126566946|NCT02341625|455370324|FG002|Overall Study|Study Drug Toxicity|0|||
126566947|NCT02341625|455370325|FG003|Overall Study|Study Drug Toxicity|1|||
126566948|NCT02341625|455370326|FG004|Overall Study|Study Drug Toxicity|0|||
126566949|NCT02341625|455370327|FG005|Overall Study|Study Drug Toxicity|3|||
126566950|NCT02341625|455370328|FG006|Overall Study|Study Drug Toxicity|10|||
126566951|NCT02341625|455370329|FG007|Overall Study|Study Drug Toxicity|0|||
126566952|NCT02341625|455370330|FG008|Overall Study|Study Drug Toxicity|0|||
126566953|NCT02341625|455370331|FG009|Overall Study|Study Drug Toxicity|3|||
126566954|NCT02341625|455370322|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126566955|NCT02341625|455370323|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126566956|NCT02341625|455370324|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126566957|NCT02341625|455370325|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126566958|NCT02341625|455370326|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126566959|NCT02341625|455370327|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126566960|NCT02341625|455370328|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
126566961|NCT02341625|455370329|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
126566962|NCT02341625|455370330|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
126566963|NCT02341625|455370331|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
126566964|NCT02341625|455370322|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126566965|NCT02341625|455370323|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126566966|NCT02341625|455370324|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126566967|NCT02341625|455370325|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126566968|NCT02341625|455370326|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126566969|NCT02341625|455370327|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126566970|NCT02341625|455370328|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
126566971|NCT02341625|455370329|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
126566972|NCT02341625|455370330|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126566973|NCT02341625|455370331|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
126566974|NCT02341625|455370322|FG000|Overall Study|Participant Withdrew Consent|0|||
126566975|NCT02341625|455370323|FG001|Overall Study|Participant Withdrew Consent|0|||
126566976|NCT02341625|455370324|FG002|Overall Study|Participant Withdrew Consent|0|||
126566977|NCT02341625|455370325|FG003|Overall Study|Participant Withdrew Consent|1|||
126566978|NCT02341625|455370326|FG004|Overall Study|Participant Withdrew Consent|0|||
126566979|NCT02341625|455370327|FG005|Overall Study|Participant Withdrew Consent|0|||
126566980|NCT02341625|455370328|FG006|Overall Study|Participant Withdrew Consent|0|||
126566981|NCT02341625|455370329|FG007|Overall Study|Participant Withdrew Consent|0|||
126566982|NCT02341625|455370330|FG008|Overall Study|Participant Withdrew Consent|0|||
126727171|NCT03666858|455951071|FG000|Cohort 1|Adverse Event|1|||
126727172|NCT03666858|455951072|FG001|Cohort 1|Adverse Event|0|||
126566983|NCT02341625|455370331|FG009|Overall Study|Participant Withdrew Consent|0|||
126566984|NCT02341625|455370322|FG000|Overall Study|Completed Treatment as per Protocol|0|||
126566985|NCT02341625|455370323|FG001|Overall Study|Completed Treatment as per Protocol|0|||
126566986|NCT02341625|455370324|FG002|Overall Study|Completed Treatment as per Protocol|0|||
126566987|NCT02341625|455370325|FG003|Overall Study|Completed Treatment as per Protocol|0|||
126566988|NCT02341625|455370326|FG004|Overall Study|Completed Treatment as per Protocol|0|||
126566989|NCT02341625|455370327|FG005|Overall Study|Completed Treatment as per Protocol|0|||
126566990|NCT02341625|455370328|FG006|Overall Study|Completed Treatment as per Protocol|0|||
126566991|NCT02341625|455370329|FG007|Overall Study|Completed Treatment as per Protocol|0|||
126566992|NCT02341625|455370330|FG008|Overall Study|Completed Treatment as per Protocol|0|||
126566993|NCT02341625|455370331|FG009|Overall Study|Completed Treatment as per Protocol|1|||
126566994|NCT02341625|455370322|FG000|Overall Study|Other Reasons|0|||
126566995|NCT02341625|455370323|FG001|Overall Study|Other Reasons|0|||
126566996|NCT02341625|455370324|FG002|Overall Study|Other Reasons|0|||
126566997|NCT02341625|455370325|FG003|Overall Study|Other Reasons|0|||
126566998|NCT02341625|455370326|FG004|Overall Study|Other Reasons|1|||
126566999|NCT02341625|455370327|FG005|Overall Study|Other Reasons|0|||
126567000|NCT02341625|455370328|FG006|Overall Study|Other Reasons|5|||
126567001|NCT02341625|455370329|FG007|Overall Study|Other Reasons|0|||
126567002|NCT02341625|455370330|FG008|Overall Study|Other Reasons|0|||
126567003|NCT02341625|455370331|FG009|Overall Study|Other Reasons|2|||
126567004|NCT02341625|455370322|FG000|Overall Study|Not Reported|0|||
126567005|NCT02341625|455370323|FG001|Overall Study|Not Reported|0|||
126567006|NCT02341625|455370324|FG002|Overall Study|Not Reported|0|||
126567007|NCT02341625|455370325|FG003|Overall Study|Not Reported|0|||
126567008|NCT02341625|455370326|FG004|Overall Study|Not Reported|0|||
126567009|NCT02341625|455370327|FG005|Overall Study|Not Reported|0|||
126567010|NCT02341625|455370328|FG006|Overall Study|Not Reported|0|||
126567011|NCT02341625|455370329|FG007|Overall Study|Not Reported|0|||
126567012|NCT02341625|455370330|FG008|Overall Study|Not Reported|0|||
126567013|NCT02341625|455370331|FG009|Overall Study|Not Reported|3|||
126567014|NCT01839877|455370335|FG000|Overall Study|Protocol Violation|1|||
126567015|NCT01227707|455370338|FG000|Overall Study|Adverse Event|10|||
126567016|NCT01227707|455370338|FG000|Overall Study|Progression of disease|3|||
126567017|NCT01227707|455370338|FG000|Overall Study|Withdrawal by Subject|1|||
126567018|NCT01227707|455370338|FG000|Overall Study|Patient non-compliance|3|||
126567019|NCT01227707|455370338|FG000|Overall Study|Medical decision|6|||
126567020|NCT01227707|455370338|FG000|Overall Study|Death|1|||
126567021|NCT01726023|455370342|FG000|Overall Study|Death|1|||
126567022|NCT01726023|455370343|FG001|Overall Study|Death|1|||
126567023|NCT01726023|455370342|FG000|Overall Study|Lost to Follow-up|5|||
126567024|NCT01726023|455370343|FG001|Overall Study|Lost to Follow-up|10|||
126567025|NCT01726023|455370342|FG000|Overall Study|Other Eligibility criteria|7|||
126567026|NCT01726023|455370343|FG001|Overall Study|Other Eligibility criteria|7|||
126567027|NCT01726023|455370342|FG000|Overall Study|Withdrawal by Subject|16|||
126567028|NCT01726023|455370343|FG001|Overall Study|Withdrawal by Subject|8|||
126567029|NCT04536077|455370346|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
126567030|NCT04536077|455370347|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
126567031|NCT04536077|455370346|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
126567032|NCT04536077|455370347|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
126567033|NCT05484726|455370348|FG000|Overall Study|Protocol Violation|3|||
126567034|NCT05484726|455370349|FG001|Overall Study|Protocol Violation|3|||
126567035|NCT05484726|455370348|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
126567036|NCT05484726|455370349|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
126567037|NCT05484726|455370348|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
126567038|NCT05484726|455370349|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
126567039|NCT05484726|455370348|FG000|Overall Study|continued need of mechanical ventilation|2|||
126567040|NCT05484726|455370349|FG001|Overall Study|continued need of mechanical ventilation|3|||
126567041|NCT05484726|455370348|FG000|Overall Study|Withdrawal by Subject|2|||
126567042|NCT05484726|455370349|FG001|Overall Study|Withdrawal by Subject|3|||
126567043|NCT05484726|455370348|FG000|Overall Study|IVH (G III & IV)|2|||
126567044|NCT05484726|455370349|FG001|Overall Study|IVH (G III & IV)|1|||
126567045|NCT05484726|455370348|FG000|Overall Study|NEC (stage II & III)|2|||
126567046|NCT05484726|455370349|FG001|Overall Study|NEC (stage II & III)|3|||
126567047|NCT00554801|455370352|FG000|Overall Study|left area before completion|5|||
126567048|NCT00554801|455370353|FG001|Overall Study|left area before completion|0|||
126567049|NCT00554801|455370352|FG000|Overall Study|Withdrawal by Subject|14|||
126567050|NCT00554801|455370353|FG001|Overall Study|Withdrawal by Subject|0|||
126567051|NCT01093534|455370354|FG000|Overall Study|Adverse Event|2|||
126567052|NCT01093534|455370355|FG001|Overall Study|Adverse Event|5|||
126567053|NCT01093534|455370356|FG002|Overall Study|Adverse Event|2|||
126567054|NCT01093534|455370354|FG000|Overall Study|Lack of Efficacy|2|||
126567055|NCT01093534|455370355|FG001|Overall Study|Lack of Efficacy|1|||
126567056|NCT01093534|455370356|FG002|Overall Study|Lack of Efficacy|1|||
126567057|NCT01093534|455370354|FG000|Overall Study|Withdrawal by Subject|5|||
126567058|NCT01093534|455370355|FG001|Overall Study|Withdrawal by Subject|7|||
126567059|NCT01093534|455370356|FG002|Overall Study|Withdrawal by Subject|2|||
126567060|NCT01093534|455370354|FG000|Overall Study|Other|1|||
126567061|NCT01093534|455370355|FG001|Overall Study|Other|3|||
126567062|NCT01093534|455370356|FG002|Overall Study|Other|4|||
126567063|NCT01837641|455370365|FG000|Overall Study|Sponsor decision|1|||
126567064|NCT01837641|455370366|FG001|Overall Study|Sponsor decision|0|||
126567065|NCT01837641|455370367|FG002|Overall Study|Sponsor decision|0|||
126567066|NCT01837641|455370368|FG003|Overall Study|Sponsor decision|0|||
126567067|NCT01837641|455370369|FG004|Overall Study|Sponsor decision|0|||
126567068|NCT01837641|455370370|FG005|Overall Study|Sponsor decision|1|||
126567069|NCT01837641|455370371|FG006|Overall Study|Sponsor decision|0|||
126567070|NCT01837641|455370372|FG007|Overall Study|Sponsor decision|0|||
126567071|NCT01837641|455370365|FG000|Overall Study|Adverse Event|0|||
126567072|NCT01837641|455370366|FG001|Overall Study|Adverse Event|0|||
126567073|NCT01837641|455370367|FG002|Overall Study|Adverse Event|0|||
126567074|NCT01837641|455370368|FG003|Overall Study|Adverse Event|0|||
126567075|NCT01837641|455370369|FG004|Overall Study|Adverse Event|0|||
126567076|NCT01837641|455370370|FG005|Overall Study|Adverse Event|1|||
126567077|NCT01837641|455370371|FG006|Overall Study|Adverse Event|0|||
126567078|NCT01837641|455370372|FG007|Overall Study|Adverse Event|0|||
126567079|NCT01837641|455370365|FG000|Overall Study|Withdrawal by Subject|0|||
126567080|NCT01837641|455370366|FG001|Overall Study|Withdrawal by Subject|0|||
126567081|NCT01837641|455370367|FG002|Overall Study|Withdrawal by Subject|0|||
126567082|NCT01837641|455370368|FG003|Overall Study|Withdrawal by Subject|0|||
126567083|NCT01837641|455370369|FG004|Overall Study|Withdrawal by Subject|1|||
126567084|NCT01837641|455370370|FG005|Overall Study|Withdrawal by Subject|0|||
126567085|NCT01837641|455370371|FG006|Overall Study|Withdrawal by Subject|1|||
126567086|NCT01837641|455370372|FG007|Overall Study|Withdrawal by Subject|0|||
126567087|NCT01768676|455370387|FG000|Overall Study|Adverse Event|3|||
126567088|NCT01768676|455370388|FG001|Overall Study|Adverse Event|3|||
126567089|NCT01768676|455370387|FG000|Overall Study|Lost to Follow-up|13|||
126567090|NCT01768676|455370388|FG001|Overall Study|Lost to Follow-up|16|||
126567091|NCT01768676|455370387|FG000|Overall Study|Protocol Violation|1|||
126567092|NCT01768676|455370388|FG001|Overall Study|Protocol Violation|1|||
126567093|NCT01768676|455370387|FG000|Overall Study|Physician Decision|4|||
126567094|NCT01768676|455370388|FG001|Overall Study|Physician Decision|1|||
126567095|NCT01768676|455370387|FG000|Overall Study|Withdrawal by Subject|3|||
126567096|NCT01768676|455370388|FG001|Overall Study|Withdrawal by Subject|10|||
126567097|NCT01196429|455370389|FG000|Overall Study|Ineligible - inadequate pathology|1|||
126567098|NCT01196429|455370390|FG001|Overall Study|Ineligible - inadequate pathology|0|||
126567099|NCT01196429|455370389|FG000|Overall Study|Ineligible - wrong cell type|1|||
126567100|NCT01196429|455370390|FG001|Overall Study|Ineligible - wrong cell type|0|||
126567101|NCT01196429|455370389|FG000|Overall Study|Refused - Never Treated|1|||
126512245|NCT03732638|455170728|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
126512246|NCT03732638|455170727|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
126512247|NCT03732638|455170728|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
126512248|NCT03732638|455170727|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
126512249|NCT03732638|455170728|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
126512250|NCT03732638|455170727|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
126512251|NCT03732638|455170728|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
126512252|NCT03732638|455170727|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
126512253|NCT03732638|455170728|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
126512254|NCT03732638|455170727|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
126512255|NCT03732638|455170728|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
126512256|NCT03732638|455170727|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
126512257|NCT03732638|455170728|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
126512258|NCT03732638|455170727|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
126512259|NCT03732638|455170728|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
126512260|NCT03732638|455170727|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
126512261|NCT03732638|455170728|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
126512262|NCT03732638|455170727|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
126512263|NCT03732638|455170728|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
126512264|NCT03732638|455170727|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
126512265|NCT03732638|455170728|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
126512266|NCT03732638|455170727|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
126512267|NCT03732638|455170728|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
126512268|NCT03732638|455170727|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
126512269|NCT03732638|455170728|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
126512270|NCT03732638|455170727|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
126512271|NCT03732638|455170728|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
126512272|NCT03732638|455170727|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
126512273|NCT03732638|455170728|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
126512274|NCT03732638|455170727|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
126512275|NCT03732638|455170728|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
126512276|NCT03732638|455170727|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
126512277|NCT03732638|455170728|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
126512278|NCT01358981|455170729|FG000|Period 1|Withdrawal by Subject|0|||
126512279|NCT01358981|455170730|FG001|Period 1|Withdrawal by Subject|0|||
126512280|NCT01358981|455170731|FG002|Period 1|Withdrawal by Subject|0|||
126512281|NCT01358981|455170732|FG003|Period 1|Withdrawal by Subject|1|||
126512282|NCT01358981|455170733|FG004|Period 1|Withdrawal by Subject|0|||
126512283|NCT01358981|455170734|FG005|Period 1|Withdrawal by Subject|0|||
126512284|NCT01358981|455170735|FG006|Period 1|Withdrawal by Subject|0|||
126512285|NCT03728582|455170736|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
126512286|NCT03728582|455170737|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
126512287|NCT03728582|455170736|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
126567102|NCT01196429|455370390|FG001|Overall Study|Refused - Never Treated|0|||
126567103|NCT04248829|455370391|FG000|Overall Study|Disease progression|44|||
126567104|NCT04248829|455370392|FG001|Overall Study|Disease progression|109|||
126512288|NCT03728582|455170737|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
126512289|NCT01034397|455170738|FG000|Overall Study|Lack of compliance|0|||
126512290|NCT01034397|455170739|FG001|Overall Study|Lack of compliance|1|||
126512291|NCT01034397|455170738|FG000|Overall Study|Lack of Efficacy|3|||
126512292|NCT01034397|455170739|FG001|Overall Study|Lack of Efficacy|0|||
126512293|NCT01034397|455170738|FG000|Overall Study|Adverse Event|4|||
126512294|NCT01034397|455170739|FG001|Overall Study|Adverse Event|0|||
126512295|NCT01034397|455170738|FG000|Overall Study|Other|0|||
126512296|NCT01034397|455170739|FG001|Overall Study|Other|1|||
126512297|NCT01018264|455170740|FG000|Overall Study|Withdrawal by Subject|1|||
126512298|NCT01018264|455170741|FG001|Overall Study|Withdrawal by Subject|0|||
126512299|NCT01018264|455170740|FG000|Overall Study|Lost to Follow-up|0|||
126512300|NCT01018264|455170741|FG001|Overall Study|Lost to Follow-up|1|||
126512301|NCT01785524|455170742|FG000|Overall Study|Withdrawal by Subject|2|||
126512302|NCT01785524|455170743|FG001|Overall Study|Withdrawal by Subject|2|||
126512303|NCT03217136|455170746|FG000|Overall Study|Lost to Follow-up|2|||
126512304|NCT03217136|455170747|FG001|Overall Study|Lost to Follow-up|1|||
126512305|NCT03217136|455170746|FG000|Overall Study|Site Randomized Participant in Error|0|||
126512306|NCT03217136|455170747|FG001|Overall Study|Site Randomized Participant in Error|1|||
126512307|NCT03217136|455170746|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
126512308|NCT03217136|455170747|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
126512309|NCT03217136|455170746|FG000|Overall Study|Dispensing Error|1|||
126512310|NCT03217136|455170747|FG001|Overall Study|Dispensing Error|0|||
126512311|NCT03217136|455170746|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126512312|NCT03217136|455170747|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126512313|NCT03192150|455170748|FG000|Overall Study|Adverse Event|14|||
126512314|NCT03192150|455170749|FG001|Overall Study|Adverse Event|12|||
126512315|NCT03192150|455170748|FG000|Overall Study|Lack of Efficacy|23|||
126512316|NCT03192150|455170749|FG001|Overall Study|Lack of Efficacy|30|||
126512317|NCT03192150|455170748|FG000|Overall Study|Lost to Follow-up|1|||
126512318|NCT03192150|455170749|FG001|Overall Study|Lost to Follow-up|1|||
126512319|NCT03192150|455170748|FG000|Overall Study|Withdrawal by Subject|4|||
126512320|NCT03192150|455170749|FG001|Overall Study|Withdrawal by Subject|2|||
126512321|NCT03192150|455170748|FG000|Overall Study|Protocol Violation|5|||
126512322|NCT03192150|455170749|FG001|Overall Study|Protocol Violation|2|||
126512323|NCT03192150|455170748|FG000|Overall Study|Surgery Canceled|6|||
126512324|NCT03192150|455170749|FG001|Overall Study|Surgery Canceled|2|||
126512325|NCT03192150|455170748|FG000|Overall Study|Other-Various Administrative Reasons|2|||
126512326|NCT03192150|455170749|FG001|Overall Study|Other-Various Administrative Reasons|5|||
126512327|NCT02579616|455170750|FG000|Overall Study|Participants did not receive treatment|3|||
126512328|NCT06640829|455170756|FG000|Overall Study|Withdrawal by Subject|1|||
126512329|NCT06640829|455170756|FG000|Overall Study|Lost to Follow-up|1|||
126567105|NCT04248829|455370391|FG000|Overall Study|Adverse Event|19|||
126567106|NCT04248829|455370392|FG001|Overall Study|Adverse Event|18|||
126567107|NCT04248829|455370391|FG000|Overall Study|Withdrawal by Subject|11|||
126567108|NCT04248829|455370392|FG001|Overall Study|Withdrawal by Subject|2|||
126512330|NCT00261716|455170757|FG000|Overall Study|Withdrawal by Subject|6|||
126512331|NCT00261716|455170758|FG001|Overall Study|Withdrawal by Subject|8|||
126512332|NCT00261716|455170757|FG000|Overall Study|Lost to Follow-up|0|||
126512333|NCT00261716|455170758|FG001|Overall Study|Lost to Follow-up|2|||
126512334|NCT02075437|455170759|FG000|Overall Study|Withdrawal by Subject|5|||
126512335|NCT02075437|455170759|FG000|Overall Study|Lost to Follow-up|1|||
126512336|NCT04439240|455170760|FG000|Overall Study|Ineligible|2|||
126512337|NCT04439240|455170760|FG000|Overall Study|Never started treatment|2|||
126512338|NCT04439240|455170760|FG000|Overall Study|Adverse Event|12|||
126512339|NCT04439240|455170760|FG000|Overall Study|Death|2|||
126512340|NCT04439240|455170760|FG000|Overall Study|Disease progression|25|||
126512341|NCT04439240|455170760|FG000|Overall Study|Other diseases|2|||
126512342|NCT04439240|455170760|FG000|Overall Study|Withdrawal by Subject|3|||
126512343|NCT04439240|455170760|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
126512344|NCT04439240|455170760|FG000|Overall Study|Symptomatic decline|1|||
126512345|NCT04439240|455170760|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
126512346|NCT04439240|455170760|FG000|Overall Study|Clinical progression|1|||
126512347|NCT02214121|455170766|FG000|Part A|Patient decision|2|||
126512348|NCT02214121|455170767|FG001|Part A|Patient decision|0|||
126512349|NCT02214121|455170768|FG002|Part A|Patient decision|0|||
126512350|NCT02214121|455170766|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
126512351|NCT02214121|455170767|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
126512352|NCT02214121|455170768|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
126512353|NCT02214121|455170766|FG000|Part A|Other|1|||
126567109|NCT04248829|455370391|FG000|Overall Study|Lost to Follow-up|0|||
126512354|NCT02214121|455170767|FG001|Part A|Other|0|||
126512355|NCT02214121|455170768|FG002|Part A|Other|0|||
126512356|NCT02214121|455170766|FG000|Part B|Patient decision|0|||
126512357|NCT02214121|455170767|FG001|Part B|Patient decision|1|||
126512358|NCT02214121|455170768|FG002|Part B|Patient decision|0|||
126512359|NCT02214121|455170766|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
126512360|NCT02214121|455170767|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
126512361|NCT02214121|455170768|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
126512362|NCT02214121|455170766|FG000|Part B|Lost to Follow-up|0|||
126512363|NCT02214121|455170767|FG001|Part B|Lost to Follow-up|0|||
126512364|NCT02214121|455170768|FG002|Part B|Lost to Follow-up|1|||
126512365|NCT00715793|455170769|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
126512366|NCT00715793|455170770|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
126512367|NCT00715793|455170769|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
126512368|NCT00715793|455170770|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
126512369|NCT01849588|455170771|FG000|Overall Study|Lack of Efficacy|3|||
126512370|NCT00094653|455170772|FG000|Overall Study|Death|306|||
126512371|NCT00094653|455170773|FG001|Overall Study|Death|100|||
126512372|NCT00094653|455170774|FG002|Overall Study|Death|119|||
126512373|NCT00094653|455170772|FG000|Overall Study|Subject Withdrew Consent|10|||
126512374|NCT00094653|455170773|FG001|Overall Study|Subject Withdrew Consent|2|||
126512375|NCT00094653|455170774|FG002|Overall Study|Subject Withdrew Consent|3|||
126512376|NCT00094653|455170772|FG000|Overall Study|Other|2|||
126512377|NCT00094653|455170773|FG001|Overall Study|Other|2|||
126512378|NCT00094653|455170774|FG002|Overall Study|Other|2|||
126512379|NCT00094653|455170772|FG000|Overall Study|Lost to Follow-up|3|||
126512380|NCT00094653|455170773|FG001|Overall Study|Lost to Follow-up|2|||
126512381|NCT00094653|455170774|FG002|Overall Study|Lost to Follow-up|1|||
126512382|NCT00094653|455170772|FG000|Overall Study|Protocol Violation|0|||
126512383|NCT00094653|455170773|FG001|Overall Study|Protocol Violation|0|||
126512384|NCT00094653|455170774|FG002|Overall Study|Protocol Violation|1|||
126512385|NCT03921411|455170775|FG000|Overall Study|Withdrawal by Subject|1|||
126512386|NCT03921411|455170775|FG000|Overall Study|Protocol Deviation|2|||
126512387|NCT03921411|455170775|FG000|Overall Study|Enrolled, but never treated|2|||
126512388|NCT03120013|455170778|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126512389|NCT03120013|455170779|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126512390|NCT01541826|455170781|FG000|Overall Study|Lost to Follow-up|2|||
126512391|NCT01541826|455170782|FG001|Overall Study|Lost to Follow-up|3|||
126512392|NCT01541826|455170783|FG002|Overall Study|Lost to Follow-up|0|||
126512393|NCT01541826|455170781|FG000|Overall Study|Withdrawal by Subject|2|||
126512394|NCT01541826|455170782|FG001|Overall Study|Withdrawal by Subject|0|||
126512395|NCT01541826|455170783|FG002|Overall Study|Withdrawal by Subject|0|||
126512396|NCT01365273|455170786|FG000|Overall Study|Lost to Follow-up|1|||
126512397|NCT01365273|455170787|FG001|Overall Study|Lost to Follow-up|0|||
126512398|NCT01365273|455170786|FG000|Overall Study|Protocol Violation|0|||
126512399|NCT01365273|455170787|FG001|Overall Study|Protocol Violation|1|||
126512400|NCT01365273|455170786|FG000|Overall Study|Physician Decision|1|||
126512401|NCT01365273|455170787|FG001|Overall Study|Physician Decision|0|||
126567110|NCT04248829|455370392|FG001|Overall Study|Lost to Follow-up|1|||
126567111|NCT04248829|455370391|FG000|Overall Study|Death|12|||
126567112|NCT04248829|455370392|FG001|Overall Study|Death|14|||
126567113|NCT04248829|455370391|FG000|Overall Study|Physician Decision|2|||
126567114|NCT04248829|455370392|FG001|Overall Study|Physician Decision|4|||
126567115|NCT04248829|455370391|FG000|Overall Study|Any reason not specifically recorded|0|||
126567116|NCT04248829|455370392|FG001|Overall Study|Any reason not specifically recorded|2|||
126567117|NCT02685033|455370393|FG000|Overall Study|Withdrawal of Consent|0|||
126512402|NCT02519712|455170788|FG000|Overall Study|Disease Relapse|1|||
126512403|NCT02519712|455170788|FG000|Overall Study|Disease Progression|1|||
126512404|NCT02519712|455170788|FG000|Overall Study|Accruals are donors|2|||
126512405|NCT03254134|455170789|FG000|Overall Study|Not eligible patients|599|||
126512406|NCT03254134|455170790|FG001|Overall Study|Not eligible patients|3630|||
126512407|NCT02702401|455170791|FG000|Overall Study|Death|242|||
126512408|NCT02702401|455170792|FG001|Overall Study|Death|125|||
126512409|NCT02702401|455170791|FG000|Overall Study|Withdrawal by Subject|15|||
126512410|NCT02702401|455170792|FG001|Overall Study|Withdrawal by Subject|5|||
126512411|NCT02702401|455170791|FG000|Overall Study|Sponsor Decision|19|||
126512412|NCT02702401|455170792|FG001|Overall Study|Sponsor Decision|3|||
126512413|NCT02702401|455170791|FG000|Overall Study|Physician Decision|1|||
126512414|NCT02702401|455170792|FG001|Overall Study|Physician Decision|2|||
126512415|NCT02702401|455170791|FG000|Overall Study|Lost to Follow-up|1|||
126512416|NCT02702401|455170792|FG001|Overall Study|Lost to Follow-up|0|||
126512417|NCT01462357|455170793|FG000|Overall Study|Death|0|||
126512418|NCT01462357|455170794|FG001|Overall Study|Death|0|||
126512419|NCT01462357|455170795|FG002|Overall Study|Death|1|||
126512420|NCT01462357|455170793|FG000|Overall Study|Withdrawal by Subject|3|||
126512421|NCT01462357|455170794|FG001|Overall Study|Withdrawal by Subject|11|||
126512422|NCT01462357|455170795|FG002|Overall Study|Withdrawal by Subject|3|||
126512423|NCT01462357|455170793|FG000|Overall Study|Migrated/moved from study area|2|||
126567118|NCT02685033|455370394|FG001|Overall Study|Withdrawal of Consent|1|||
126567119|NCT02685033|455370393|FG000|Overall Study|Lost to Follow-up|2|||
126567120|NCT02685033|455370394|FG001|Overall Study|Lost to Follow-up|1|||
126567121|NCT02685033|455370393|FG000|Overall Study|Adverse Event|1|||
126567122|NCT02685033|455370394|FG001|Overall Study|Adverse Event|0|||
126567123|NCT01066923|455370395|FG000|Overall Study|Withdrawal by Subject|3|||
126567124|NCT01066923|455370396|FG001|Overall Study|Withdrawal by Subject|3|||
126512424|NCT01462357|455170794|FG001|Overall Study|Migrated/moved from study area|3|||
126512425|NCT01462357|455170795|FG002|Overall Study|Migrated/moved from study area|1|||
126512426|NCT01462357|455170793|FG000|Overall Study|Lost to Follow-up|3|||
126512427|NCT01462357|455170794|FG001|Overall Study|Lost to Follow-up|5|||
126512428|NCT01462357|455170795|FG002|Overall Study|Lost to Follow-up|7|||
126512429|NCT01482767|455170799|FG000|Overall Study|Death|1|||
126512430|NCT01482767|455170800|FG001|Overall Study|Death|1|||
126512431|NCT01482767|455170799|FG000|Overall Study|Withdrawal by Subject|7|||
126512432|NCT01482767|455170800|FG001|Overall Study|Withdrawal by Subject|5|||
126512433|NCT01482767|455170799|FG000|Overall Study|Lost to Follow-up|12|||
126512434|NCT01482767|455170800|FG001|Overall Study|Lost to Follow-up|6|||
126512435|NCT01482767|455170799|FG000|Overall Study|Adverse Event|0|||
126512436|NCT01482767|455170800|FG001|Overall Study|Adverse Event|3|||
126512437|NCT01482767|455170799|FG000|Overall Study|Site closure|22|||
126512438|NCT01482767|455170800|FG001|Overall Study|Site closure|14|||
126512439|NCT01482767|455170799|FG000|Overall Study|Non-adherence to study requirements|4|||
126512440|NCT01482767|455170800|FG001|Overall Study|Non-adherence to study requirements|7|||
126512441|NCT01482767|455170799|FG000|Overall Study|Alternate HCV treatment|7|||
126512442|NCT01482767|455170800|FG001|Overall Study|Alternate HCV treatment|8|||
126512443|NCT01482767|455170799|FG000|Overall Study|Ineligible|0|||
126512444|NCT01482767|455170800|FG001|Overall Study|Ineligible|5|||
126512445|NCT01482767|455170799|FG000|Overall Study|Nurse error|1|||
126512446|NCT01482767|455170800|FG001|Overall Study|Nurse error|0|||
126512447|NCT01856543|455170801|FG000|Overall Study|Treatment discontinued|6|||
126512448|NCT01856543|455170802|FG001|Overall Study|Treatment discontinued|3|||
126512449|NCT01856543|455170801|FG000|Overall Study|Withdrawn before start|7|||
126512450|NCT01856543|455170802|FG001|Overall Study|Withdrawn before start|3|||
126512451|NCT00806546|455170803|FG000|Overall Study|Enrolled, not treated|35|||
126512452|NCT00806546|455170803|FG000|Overall Study|Lost to Follow-up|32|||
126512453|NCT00806546|455170803|FG000|Overall Study|Adverse Event|74|||
126512454|NCT00806546|455170803|FG000|Overall Study|Withdrawal by Subject|75|||
126512455|NCT00806546|455170803|FG000|Overall Study|Protocol Violation|49|||
126512456|NCT00806546|455170803|FG000|Overall Study|Various|42|||
126512457|NCT02751983|455170806|FG000|Treatment|Stopped ACT, but Remained in study|2|||
126512458|NCT02751983|455170807|FG001|Treatment|Stopped ACT, but Remained in study|0|||
126512459|NCT02751983|455170806|FG000|Treatment|Discharged prior to beginning ACT|2|||
126512460|NCT02751983|455170807|FG001|Treatment|Discharged prior to beginning ACT|0|||
126512461|NCT02751983|455170806|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
126512462|NCT02751983|455170807|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
126512463|NCT02751983|455170806|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
126512464|NCT02751983|455170807|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
126512465|NCT02751983|455170806|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
126512466|NCT02751983|455170807|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
126512467|NCT00096044|455170808|FG000|Overall Study|Withdrawal by Subject|9|||
126512468|NCT00096044|455170808|FG000|Overall Study|Adverse Event|21|||
126512469|NCT00096044|455170808|FG000|Overall Study|Disease Progression|4|||
126512470|NCT00813358|455170811|FG000|Overall Study|Death|32|||
126512471|NCT00813358|455170811|FG000|Overall Study|Lost to Follow-up|12|||
126512472|NCT00813358|455170811|FG000|Overall Study|other endpoints|5|||
126512473|NCT00813358|455170811|FG000|Overall Study|Withdrawal by Subject|20|||
126512474|NCT00004031|455170812|FG000|Overall Study|Adverse Event|5|||
126512475|NCT00004031|455170813|FG001|Overall Study|Adverse Event|0|||
126512476|NCT00004031|455170812|FG000|Overall Study|Refusal unrelated to adverse events|2|||
126512477|NCT00004031|455170813|FG001|Overall Study|Refusal unrelated to adverse events|11|||
126512478|NCT00004031|455170812|FG000|Overall Study|Progression/relapse|9|||
126512479|NCT00004031|455170813|FG001|Overall Study|Progression/relapse|4|||
126567125|NCT01066923|455370397|FG002|Overall Study|Withdrawal by Subject|8|||
126727173|NCT03666858|455951071|FG000|Cohort 2|Adverse Event|0|||
126512480|NCT00004031|455170812|FG000|Overall Study|Death|3|||
126512481|NCT00004031|455170813|FG001|Overall Study|Death|1|||
126512482|NCT00004031|455170812|FG000|Overall Study|Other- not protocol specified|3|||
126512483|NCT00004031|455170813|FG001|Overall Study|Other- not protocol specified|3|||
126512484|NCT00004031|455170812|FG000|Overall Study|Reason under review|3|||
126512485|NCT00004031|455170813|FG001|Overall Study|Reason under review|2|||
126512486|NCT02920983|455170814|FG000|Dispense 1|Unacceptable Lens Fit|0|||
126512487|NCT02920983|455170815|FG001|Dispense 1|Unacceptable Lens Fit|0|||
126512488|NCT02920983|455170816|FG002|Dispense 1|Unacceptable Lens Fit|0|||
126512489|NCT02920983|455170817|FG003|Dispense 1|Unacceptable Lens Fit|0|||
126512490|NCT02920983|455170818|FG004|Dispense 1|Unacceptable Lens Fit|1|||
126512491|NCT02920983|455170819|FG005|Dispense 1|Unacceptable Lens Fit|0|||
126512492|NCT02920983|455170814|FG000|Dispense 2|Unscceptable lens fit|1|||
126567126|NCT01066923|455370398|FG003|Overall Study|Withdrawal by Subject|8|||
126567127|NCT02960659|455372080|FG000|Overall Study|Withdrawal by Subject|1|||
126567128|NCT02960659|455372081|FG001|Overall Study|Withdrawal by Subject|0|||
126567129|NCT02960659|455372080|FG000|Overall Study|Poor compliance|0|||
126567130|NCT02960659|455372081|FG001|Overall Study|Poor compliance|1|||
126567131|NCT01875250|455372082|FG000|Overall Study|Adverse Event|2|||
126567132|NCT01875250|455372083|FG001|Overall Study|Adverse Event|0|||
126567133|NCT03068468|455372084|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
126567134|NCT03068468|455372085|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
126567135|NCT03068468|455372086|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
126567136|NCT03068468|455372087|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
126567137|NCT03068468|455372084|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
126567138|NCT03068468|455372085|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
126567139|NCT03068468|455372086|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
126567140|NCT03068468|455372087|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
126567141|NCT03068468|455372084|FG000|Placebo-Controlled Period|Adverse Event|16|||
126567142|NCT03068468|455372085|FG001|Placebo-Controlled Period|Adverse Event|21|||
126567143|NCT03068468|455372086|FG002|Placebo-Controlled Period|Adverse Event|0|||
126567144|NCT03068468|455372087|FG003|Placebo-Controlled Period|Adverse Event|0|||
126567145|NCT03068468|455372084|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
126567146|NCT03068468|455372085|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
126567147|NCT03068468|455372086|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
126567148|NCT03068468|455372087|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
126567149|NCT03068468|455372084|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
126567150|NCT03068468|455372085|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
126567151|NCT03068468|455372086|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126567152|NCT03068468|455372087|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126567153|NCT03068468|455372084|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
126567154|NCT03068468|455372085|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
126567155|NCT03068468|455372086|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
126567156|NCT03068468|455372087|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
126567157|NCT03068468|455372084|FG000|Placebo-Controlled Period|Death|0|||
126567158|NCT03068468|455372085|FG001|Placebo-Controlled Period|Death|1|||
126567159|NCT03068468|455372086|FG002|Placebo-Controlled Period|Death|0|||
126567160|NCT03068468|455372087|FG003|Placebo-Controlled Period|Death|0|||
126567161|NCT03068468|455372084|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
126567162|NCT03068468|455372085|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
126567163|NCT03068468|455372086|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
126567164|NCT03068468|455372087|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
126567165|NCT03068468|455372084|FG000|Open-Label Extension Period|Adverse Event|0|||
126567166|NCT03068468|455372085|FG001|Open-Label Extension Period|Adverse Event|0|||
126567167|NCT03068468|455372086|FG002|Open-Label Extension Period|Adverse Event|13|||
126567168|NCT03068468|455372087|FG003|Open-Label Extension Period|Adverse Event|17|||
126567169|NCT03068468|455372084|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
126567170|NCT03068468|455372085|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
126567171|NCT03068468|455372086|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
126567172|NCT03068468|455372087|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
126567173|NCT03068468|455372084|FG000|Open-Label Extension Period|Death|0|||
126567174|NCT03068468|455372085|FG001|Open-Label Extension Period|Death|0|||
126567175|NCT03068468|455372086|FG002|Open-Label Extension Period|Death|0|||
126567176|NCT03068468|455372087|FG003|Open-Label Extension Period|Death|1|||
126567177|NCT03068468|455372084|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
126567178|NCT03068468|455372085|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
126567179|NCT03068468|455372086|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
126567180|NCT03068468|455372087|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
126567181|NCT03068468|455372084|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
126567182|NCT03068468|455372085|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
126567183|NCT03068468|455372086|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
126567184|NCT03068468|455372087|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
126567185|NCT03068468|455372084|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
126567186|NCT03068468|455372085|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
126567187|NCT03068468|455372086|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
126567188|NCT03068468|455372087|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
126567189|NCT03068468|455372084|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
126567190|NCT03068468|455372085|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
126567191|NCT03068468|455372086|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
126567192|NCT03068468|455372087|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
126567193|NCT03068468|455372084|FG000|Open-Label Extension Period|Reason not Specified|0|||
126567194|NCT03068468|455372085|FG001|Open-Label Extension Period|Reason not Specified|0|||
126567195|NCT03068468|455372086|FG002|Open-Label Extension Period|Reason not Specified|1|||
126567196|NCT03068468|455372087|FG003|Open-Label Extension Period|Reason not Specified|4|||
126567197|NCT01185522|455372089|FG000|Overall Study|Lack of Efficacy|28|||
126567198|NCT01185522|455372089|FG000|Overall Study|Lost to Follow-up|19|||
126567199|NCT01185522|455372089|FG000|Overall Study|Withdrawal by Subject|10|||
126567200|NCT01185522|455372089|FG000|Overall Study|Poor tolerance|39|||
126567201|NCT01185522|455372089|FG000|Overall Study|Other reasons|12|||
126567202|NCT02001623|455372090|FG000|Overall Study|Disease Progression|2|||
126567203|NCT02001623|455372091|FG001|Overall Study|Disease Progression|2|||
126567204|NCT02001623|455372092|FG002|Overall Study|Disease Progression|3|||
126567205|NCT02001623|455372093|FG003|Overall Study|Disease Progression|2|||
126567206|NCT02001623|455372094|FG004|Overall Study|Disease Progression|3|||
126567207|NCT02001623|455372095|FG005|Overall Study|Disease Progression|2|||
126567208|NCT02001623|455372096|FG006|Overall Study|Disease Progression|3|||
126567209|NCT02001623|455372097|FG007|Overall Study|Disease Progression|3|||
126567210|NCT02001623|455372098|FG008|Overall Study|Disease Progression|7|||
126567211|NCT02001623|455372099|FG009|Overall Study|Disease Progression|40|||
126567212|NCT02001623|455372100|FG010|Overall Study|Disease Progression|5|||
126567213|NCT02001623|455372101|FG011|Overall Study|Disease Progression|9|||
126567214|NCT02001623|455372102|FG012|Overall Study|Disease Progression|9|||
126567215|NCT02001623|455372103|FG013|Overall Study|Disease Progression|20|||
126567216|NCT02001623|455372104|FG014|Overall Study|Disease Progression|9|||
126567217|NCT02001623|455372090|FG000|Overall Study|Physician Decision|0|||
126567218|NCT02001623|455372091|FG001|Overall Study|Physician Decision|0|||
126567219|NCT02001623|455372092|FG002|Overall Study|Physician Decision|0|||
126567220|NCT02001623|455372093|FG003|Overall Study|Physician Decision|0|||
126567221|NCT02001623|455372094|FG004|Overall Study|Physician Decision|0|||
126567222|NCT02001623|455372095|FG005|Overall Study|Physician Decision|0|||
126567223|NCT02001623|455372096|FG006|Overall Study|Physician Decision|0|||
126567224|NCT02001623|455372097|FG007|Overall Study|Physician Decision|0|||
126567225|NCT02001623|455372098|FG008|Overall Study|Physician Decision|3|||
126567226|NCT02001623|455372099|FG009|Overall Study|Physician Decision|2|||
126567227|NCT02001623|455372100|FG010|Overall Study|Physician Decision|3|||
126567228|NCT02001623|455372101|FG011|Overall Study|Physician Decision|3|||
126567229|NCT02001623|455372102|FG012|Overall Study|Physician Decision|1|||
126567230|NCT02001623|455372103|FG013|Overall Study|Physician Decision|2|||
126567231|NCT02001623|455372104|FG014|Overall Study|Physician Decision|1|||
126567232|NCT02001623|455372090|FG000|Overall Study|Death|0|||
126567233|NCT02001623|455372091|FG001|Overall Study|Death|1|||
126567234|NCT02001623|455372092|FG002|Overall Study|Death|0|||
126567235|NCT02001623|455372093|FG003|Overall Study|Death|0|||
126567236|NCT02001623|455372094|FG004|Overall Study|Death|0|||
126567237|NCT02001623|455372095|FG005|Overall Study|Death|0|||
126567238|NCT02001623|455372096|FG006|Overall Study|Death|0|||
126567239|NCT02001623|455372097|FG007|Overall Study|Death|0|||
126567240|NCT02001623|455372098|FG008|Overall Study|Death|0|||
126567241|NCT02001623|455372099|FG009|Overall Study|Death|0|||
126567242|NCT02001623|455372100|FG010|Overall Study|Death|0|||
126567243|NCT02001623|455372101|FG011|Overall Study|Death|0|||
126567244|NCT02001623|455372102|FG012|Overall Study|Death|0|||
126567245|NCT02001623|455372103|FG013|Overall Study|Death|0|||
126567246|NCT02001623|455372104|FG014|Overall Study|Death|0|||
126567247|NCT02001623|455372090|FG000|Overall Study|Adverse Event|0|||
126567248|NCT02001623|455372091|FG001|Overall Study|Adverse Event|0|||
126567249|NCT02001623|455372092|FG002|Overall Study|Adverse Event|0|||
126567250|NCT02001623|455372093|FG003|Overall Study|Adverse Event|0|||
126567251|NCT02001623|455372094|FG004|Overall Study|Adverse Event|0|||
126567252|NCT02001623|455372095|FG005|Overall Study|Adverse Event|1|||
126567253|NCT02001623|455372096|FG006|Overall Study|Adverse Event|0|||
126567254|NCT02001623|455372097|FG007|Overall Study|Adverse Event|3|||
126567255|NCT02001623|455372098|FG008|Overall Study|Adverse Event|4|||
126567256|NCT02001623|455372099|FG009|Overall Study|Adverse Event|6|||
126567257|NCT02001623|455372100|FG010|Overall Study|Adverse Event|4|||
126567258|NCT02001623|455372101|FG011|Overall Study|Adverse Event|0|||
126567259|NCT02001623|455372102|FG012|Overall Study|Adverse Event|3|||
126567260|NCT02001623|455372103|FG013|Overall Study|Adverse Event|5|||
126567261|NCT02001623|455372104|FG014|Overall Study|Adverse Event|6|||
126567262|NCT02001623|455372090|FG000|Overall Study|Other - Miscellaneous|0|||
126567263|NCT02001623|455372091|FG001|Overall Study|Other - Miscellaneous|0|||
126567264|NCT02001623|455372092|FG002|Overall Study|Other - Miscellaneous|0|||
126567265|NCT02001623|455372093|FG003|Overall Study|Other - Miscellaneous|0|||
126567266|NCT02001623|455372094|FG004|Overall Study|Other - Miscellaneous|0|||
126567267|NCT02001623|455372095|FG005|Overall Study|Other - Miscellaneous|0|||
126567268|NCT02001623|455372096|FG006|Overall Study|Other - Miscellaneous|0|||
126567269|NCT02001623|455372097|FG007|Overall Study|Other - Miscellaneous|0|||
126567270|NCT02001623|455372098|FG008|Overall Study|Other - Miscellaneous|0|||
126567271|NCT02001623|455372099|FG009|Overall Study|Other - Miscellaneous|1|||
126567272|NCT02001623|455372100|FG010|Overall Study|Other - Miscellaneous|0|||
126567273|NCT02001623|455372101|FG011|Overall Study|Other - Miscellaneous|0|||
126567274|NCT02001623|455372102|FG012|Overall Study|Other - Miscellaneous|0|||
126567275|NCT02001623|455372103|FG013|Overall Study|Other - Miscellaneous|1|||
126567276|NCT02001623|455372104|FG014|Overall Study|Other - Miscellaneous|0|||
126567277|NCT02001623|455372090|FG000|Overall Study|Withdrawal by Subject|1|||
126512493|NCT02920983|455170815|FG001|Dispense 2|Unscceptable lens fit|0|||
126512494|NCT02920983|455170816|FG002|Dispense 2|Unscceptable lens fit|0|||
126512495|NCT02920983|455170817|FG003|Dispense 2|Unscceptable lens fit|0|||
126512496|NCT02920983|455170818|FG004|Dispense 2|Unscceptable lens fit|1|||
126512497|NCT02920983|455170819|FG005|Dispense 2|Unscceptable lens fit|0|||
126512498|NCT02920983|455170814|FG000|Dispense 3|Unacceptable Lens Fit|1|||
126512499|NCT02920983|455170815|FG001|Dispense 3|Unacceptable Lens Fit|1|||
126512500|NCT02920983|455170816|FG002|Dispense 3|Unacceptable Lens Fit|0|||
126512501|NCT02920983|455170817|FG003|Dispense 3|Unacceptable Lens Fit|0|||
126512502|NCT02920983|455170818|FG004|Dispense 3|Unacceptable Lens Fit|1|||
126512503|NCT02920983|455170819|FG005|Dispense 3|Unacceptable Lens Fit|0|||
126512504|NCT03878134|455170823|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
126512505|NCT03851016|455170824|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126512506|NCT03851016|455170825|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
126512507|NCT00586469|455170827|FG000|Overall Study|Adverse Event|0|||
126512508|NCT00586469|455170828|FG001|Overall Study|Adverse Event|1|||
126512509|NCT03337724|455170831|FG000|Overall Study|Reason not Specified|12|||
126512510|NCT03337724|455170832|FG001|Overall Study|Reason not Specified|21|||
126512511|NCT03337724|455170833|FG002|Overall Study|Reason not Specified|9|||
126512512|NCT03337724|455170834|FG003|Overall Study|Reason not Specified|9|||
126512513|NCT03337724|455170835|FG004|Overall Study|Reason not Specified|29|||
126512514|NCT03337724|455170831|FG000|Overall Study|Withdrawal by Subject|13|||
126512515|NCT03337724|455170832|FG001|Overall Study|Withdrawal by Subject|15|||
126512516|NCT03337724|455170833|FG002|Overall Study|Withdrawal by Subject|4|||
126512517|NCT03337724|455170834|FG003|Overall Study|Withdrawal by Subject|15|||
126512518|NCT03337724|455170835|FG004|Overall Study|Withdrawal by Subject|6|||
126512519|NCT03337724|455170831|FG000|Overall Study|Protocol Deviation|0|||
126512520|NCT03337724|455170832|FG001|Overall Study|Protocol Deviation|1|||
126512521|NCT03337724|455170833|FG002|Overall Study|Protocol Deviation|1|||
126512522|NCT03337724|455170834|FG003|Overall Study|Protocol Deviation|1|||
126512523|NCT03337724|455170835|FG004|Overall Study|Protocol Deviation|0|||
126512524|NCT03337724|455170831|FG000|Overall Study|Adverse Event|1|||
126512525|NCT03337724|455170832|FG001|Overall Study|Adverse Event|1|||
126512526|NCT03337724|455170833|FG002|Overall Study|Adverse Event|0|||
126512527|NCT03337724|455170834|FG003|Overall Study|Adverse Event|1|||
126512528|NCT03337724|455170835|FG004|Overall Study|Adverse Event|0|||
126512529|NCT03337724|455170831|FG000|Overall Study|Death|40|||
126512530|NCT03337724|455170832|FG001|Overall Study|Death|89|||
126512531|NCT03337724|455170833|FG002|Overall Study|Death|43|||
126512532|NCT03337724|455170834|FG003|Overall Study|Death|76|||
126512533|NCT03337724|455170835|FG004|Overall Study|Death|50|||
126512534|NCT03337724|455170831|FG000|Overall Study|Lost to Follow-up|5|||
126512535|NCT03337724|455170832|FG001|Overall Study|Lost to Follow-up|5|||
126512536|NCT03337724|455170833|FG002|Overall Study|Lost to Follow-up|4|||
126512537|NCT03337724|455170834|FG003|Overall Study|Lost to Follow-up|7|||
126512538|NCT03337724|455170835|FG004|Overall Study|Lost to Follow-up|4|||
126512539|NCT03337724|455170831|FG000|Overall Study|Physician Decision|16|||
126512540|NCT03337724|455170832|FG001|Overall Study|Physician Decision|34|||
126512541|NCT03337724|455170833|FG002|Overall Study|Physician Decision|14|||
126512542|NCT03337724|455170834|FG003|Overall Study|Physician Decision|34|||
126512543|NCT03337724|455170835|FG004|Overall Study|Physician Decision|13|||
126512544|NCT03337724|455170831|FG000|Overall Study|Progressive Disease|0|||
126512545|NCT03337724|455170832|FG001|Overall Study|Progressive Disease|2|||
126512546|NCT03337724|455170833|FG002|Overall Study|Progressive Disease|1|||
126567278|NCT02001623|455372091|FG001|Overall Study|Withdrawal by Subject|0|||
126567279|NCT02001623|455372092|FG002|Overall Study|Withdrawal by Subject|0|||
126512547|NCT03337724|455170834|FG003|Overall Study|Progressive Disease|2|||
126512548|NCT03337724|455170835|FG004|Overall Study|Progressive Disease|0|||
126512549|NCT03337724|455170831|FG000|Overall Study|Symptomatic Deterioration|0|||
126512550|NCT03337724|455170832|FG001|Overall Study|Symptomatic Deterioration|0|||
126512551|NCT03337724|455170833|FG002|Overall Study|Symptomatic Deterioration|0|||
126512552|NCT03337724|455170834|FG003|Overall Study|Symptomatic Deterioration|1|||
126512553|NCT03337724|455170835|FG004|Overall Study|Symptomatic Deterioration|0|||
126512554|NCT01660412|455170838|FG000|Overall Study|Protocol Violation|0|||
126512555|NCT01660412|455170839|FG001|Overall Study|Protocol Violation|3|||
126512556|NCT03085927|455172223|FG000|Overall Study|Withdrawal by Subject|1|||
126512557|NCT03085927|455172224|FG001|Overall Study|Withdrawal by Subject|4|||
126512558|NCT03085927|455172223|FG000|Overall Study|Lost to Follow-up|3|||
126512559|NCT03085927|455172224|FG001|Overall Study|Lost to Follow-up|1|||
126512560|NCT03085927|455172223|FG000|Overall Study|Death|1|||
126512561|NCT03085927|455172224|FG001|Overall Study|Death|0|||
126512562|NCT03085927|455172223|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
126512563|NCT03085927|455172224|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
126512564|NCT03085927|455172223|FG000|Overall Study|Dyad Became Ineligible|0|||
126512565|NCT03085927|455172224|FG001|Overall Study|Dyad Became Ineligible|1|||
126512566|NCT02349711|455172226|FG000|Overall Study|Withdrawal by Subject|2|||
126512567|NCT02349711|455172227|FG001|Overall Study|Withdrawal by Subject|1|||
126512568|NCT02349711|455172226|FG000|Overall Study|Lost to Follow-up|1|||
126567280|NCT02001623|455372093|FG003|Overall Study|Withdrawal by Subject|0|||
126567281|NCT02001623|455372094|FG004|Overall Study|Withdrawal by Subject|0|||
126567282|NCT02001623|455372095|FG005|Overall Study|Withdrawal by Subject|0|||
126567283|NCT02001623|455372096|FG006|Overall Study|Withdrawal by Subject|0|||
126567284|NCT02001623|455372097|FG007|Overall Study|Withdrawal by Subject|0|||
126567285|NCT02001623|455372098|FG008|Overall Study|Withdrawal by Subject|1|||
126567286|NCT02001623|455372099|FG009|Overall Study|Withdrawal by Subject|3|||
126567287|NCT02001623|455372100|FG010|Overall Study|Withdrawal by Subject|2|||
126567288|NCT02001623|455372101|FG011|Overall Study|Withdrawal by Subject|2|||
126567289|NCT02001623|455372102|FG012|Overall Study|Withdrawal by Subject|1|||
126567290|NCT02001623|455372103|FG013|Overall Study|Withdrawal by Subject|5|||
126567291|NCT02001623|455372104|FG014|Overall Study|Withdrawal by Subject|2|||
126567292|NCT02001623|455372090|FG000|Overall Study|Lost to Follow-up|0|||
126567293|NCT02001623|455372091|FG001|Overall Study|Lost to Follow-up|0|||
126567294|NCT02001623|455372092|FG002|Overall Study|Lost to Follow-up|0|||
126567295|NCT02001623|455372093|FG003|Overall Study|Lost to Follow-up|0|||
126567296|NCT02001623|455372094|FG004|Overall Study|Lost to Follow-up|0|||
126567297|NCT02001623|455372095|FG005|Overall Study|Lost to Follow-up|0|||
126567298|NCT02001623|455372096|FG006|Overall Study|Lost to Follow-up|0|||
126567299|NCT02001623|455372097|FG007|Overall Study|Lost to Follow-up|0|||
126567300|NCT02001623|455372098|FG008|Overall Study|Lost to Follow-up|0|||
126567301|NCT02001623|455372099|FG009|Overall Study|Lost to Follow-up|1|||
126567302|NCT02001623|455372100|FG010|Overall Study|Lost to Follow-up|0|||
126567303|NCT02001623|455372101|FG011|Overall Study|Lost to Follow-up|0|||
126567304|NCT02001623|455372102|FG012|Overall Study|Lost to Follow-up|0|||
126567305|NCT02001623|455372103|FG013|Overall Study|Lost to Follow-up|0|||
126567306|NCT02001623|455372104|FG014|Overall Study|Lost to Follow-up|0|||
126567307|NCT02001623|455372090|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
126567308|NCT02001623|455372091|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
126567309|NCT02001623|455372092|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
126567310|NCT02001623|455372093|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
126567311|NCT02001623|455372094|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
126567312|NCT02001623|455372095|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
126567313|NCT02001623|455372096|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
126567314|NCT02001623|455372097|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
126567315|NCT02001623|455372098|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
126567316|NCT02001623|455372099|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
126567317|NCT02001623|455372100|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
126567318|NCT02001623|455372101|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
126567319|NCT02001623|455372102|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
126567320|NCT02001623|455372103|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
126567321|NCT02001623|455372104|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
126567322|NCT02001623|455372090|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
126567323|NCT02001623|455372091|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
126567324|NCT02001623|455372092|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
126567325|NCT02001623|455372093|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
126567326|NCT02001623|455372094|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
126567327|NCT02001623|455372095|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
126567328|NCT02001623|455372096|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
126567329|NCT02001623|455372097|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
126567330|NCT02001623|455372098|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
126567331|NCT02001623|455372099|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
126567332|NCT02001623|455372100|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
126567333|NCT02001623|455372101|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
126567334|NCT02001623|455372102|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
126567335|NCT02001623|455372103|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
126567336|NCT02001623|455372104|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
126567337|NCT00309452|455372105|FG000|Overall Study|Withdrawal by Subject|3|||
126567338|NCT00309452|455372106|FG001|Overall Study|Withdrawal by Subject|0|||
126567339|NCT00771667|455372107|FG000|Induction Phase|Adverse Event|5|||
126567340|NCT00771667|455372108|FG001|Induction Phase|Adverse Event|2|||
126567341|NCT00771667|455372109|FG002|Induction Phase|Adverse Event|4|||
126567342|NCT00771667|455372110|FG003|Induction Phase|Adverse Event|1|||
126567343|NCT00771667|455372111|FG004|Induction Phase|Adverse Event|0|||
126567344|NCT00771667|455372112|FG005|Induction Phase|Adverse Event|0|||
126567345|NCT00771667|455372113|FG006|Induction Phase|Adverse Event|0|||
126567346|NCT00771667|455372114|FG007|Induction Phase|Adverse Event|0|||
126567347|NCT00771667|455372115|FG008|Induction Phase|Adverse Event|0|||
126567348|NCT00771667|455372116|FG009|Induction Phase|Adverse Event|0|||
126567349|NCT00771667|455372107|FG000|Induction Phase|Lack of Efficacy|9|||
126567350|NCT00771667|455372108|FG001|Induction Phase|Lack of Efficacy|2|||
126567351|NCT00771667|455372109|FG002|Induction Phase|Lack of Efficacy|4|||
126567352|NCT00771667|455372110|FG003|Induction Phase|Lack of Efficacy|3|||
126567353|NCT00771667|455372111|FG004|Induction Phase|Lack of Efficacy|0|||
126567354|NCT00771667|455372112|FG005|Induction Phase|Lack of Efficacy|0|||
126567355|NCT00771667|455372113|FG006|Induction Phase|Lack of Efficacy|0|||
126567356|NCT00771667|455372114|FG007|Induction Phase|Lack of Efficacy|0|||
126567357|NCT00771667|455372115|FG008|Induction Phase|Lack of Efficacy|0|||
126567358|NCT00771667|455372116|FG009|Induction Phase|Lack of Efficacy|0|||
126567359|NCT00771667|455372107|FG000|Induction Phase|Lost to Follow-up|1|||
126567360|NCT00771667|455372108|FG001|Induction Phase|Lost to Follow-up|0|||
126567361|NCT00771667|455372109|FG002|Induction Phase|Lost to Follow-up|1|||
126567362|NCT00771667|455372110|FG003|Induction Phase|Lost to Follow-up|0|||
126567363|NCT00771667|455372111|FG004|Induction Phase|Lost to Follow-up|0|||
126567364|NCT00771667|455372112|FG005|Induction Phase|Lost to Follow-up|0|||
126567365|NCT00771667|455372113|FG006|Induction Phase|Lost to Follow-up|0|||
126567366|NCT00771667|455372114|FG007|Induction Phase|Lost to Follow-up|0|||
126567367|NCT00771667|455372115|FG008|Induction Phase|Lost to Follow-up|0|||
126567368|NCT00771667|455372116|FG009|Induction Phase|Lost to Follow-up|0|||
126567369|NCT00771667|455372107|FG000|Induction Phase|Other|4|||
126567370|NCT00771667|455372108|FG001|Induction Phase|Other|6|||
126567371|NCT00771667|455372109|FG002|Induction Phase|Other|3|||
126567372|NCT00771667|455372110|FG003|Induction Phase|Other|4|||
126567373|NCT00771667|455372111|FG004|Induction Phase|Other|0|||
126567374|NCT00771667|455372112|FG005|Induction Phase|Other|0|||
126567375|NCT00771667|455372113|FG006|Induction Phase|Other|0|||
126567376|NCT00771667|455372114|FG007|Induction Phase|Other|0|||
126567377|NCT00771667|455372115|FG008|Induction Phase|Other|0|||
126567378|NCT00771667|455372116|FG009|Induction Phase|Other|0|||
126567379|NCT00771667|455372107|FG000|Maintenance Phase|Adverse Event|0|||
126567380|NCT00771667|455372108|FG001|Maintenance Phase|Adverse Event|0|||
126567381|NCT00771667|455372109|FG002|Maintenance Phase|Adverse Event|0|||
126567382|NCT00771667|455372110|FG003|Maintenance Phase|Adverse Event|0|||
126567383|NCT00771667|455372111|FG004|Maintenance Phase|Adverse Event|1|||
126567384|NCT00771667|455372112|FG005|Maintenance Phase|Adverse Event|3|||
126567385|NCT00771667|455372113|FG006|Maintenance Phase|Adverse Event|5|||
126567386|NCT00771667|455372114|FG007|Maintenance Phase|Adverse Event|1|||
126567387|NCT00771667|455372115|FG008|Maintenance Phase|Adverse Event|8|||
126567388|NCT00771667|455372116|FG009|Maintenance Phase|Adverse Event|7|||
126567389|NCT00771667|455372107|FG000|Maintenance Phase|Lack of Efficacy|0|||
126567390|NCT00771667|455372108|FG001|Maintenance Phase|Lack of Efficacy|0|||
126567391|NCT00771667|455372109|FG002|Maintenance Phase|Lack of Efficacy|0|||
126567392|NCT00771667|455372110|FG003|Maintenance Phase|Lack of Efficacy|0|||
126567393|NCT00771667|455372111|FG004|Maintenance Phase|Lack of Efficacy|1|||
126567394|NCT00771667|455372112|FG005|Maintenance Phase|Lack of Efficacy|3|||
126567395|NCT00771667|455372113|FG006|Maintenance Phase|Lack of Efficacy|3|||
126567396|NCT00771667|455372114|FG007|Maintenance Phase|Lack of Efficacy|2|||
126567397|NCT00771667|455372115|FG008|Maintenance Phase|Lack of Efficacy|11|||
126567398|NCT00771667|455372116|FG009|Maintenance Phase|Lack of Efficacy|7|||
126567399|NCT00771667|455372107|FG000|Maintenance Phase|Other|0|||
126567400|NCT00771667|455372108|FG001|Maintenance Phase|Other|0|||
126567401|NCT00771667|455372109|FG002|Maintenance Phase|Other|0|||
126567402|NCT00771667|455372110|FG003|Maintenance Phase|Other|0|||
126567403|NCT00771667|455372111|FG004|Maintenance Phase|Other|0|||
126567404|NCT00771667|455372112|FG005|Maintenance Phase|Other|1|||
126567405|NCT00771667|455372113|FG006|Maintenance Phase|Other|2|||
126567406|NCT00771667|455372114|FG007|Maintenance Phase|Other|2|||
126567407|NCT00771667|455372115|FG008|Maintenance Phase|Other|3|||
126567408|NCT00771667|455372116|FG009|Maintenance Phase|Other|3|||
126567409|NCT00109967|455372117|FG000|Overall Study|Cancel Prior to Treatment|2|||
126567410|NCT00109967|455372118|FG001|Overall Study|Cancel Prior to Treatment|0|||
126567411|NCT00109967|455372117|FG000|Overall Study|Adverse Event|12|||
126567412|NCT00109967|455372118|FG001|Overall Study|Adverse Event|1|||
126567413|NCT00109967|455372117|FG000|Overall Study|Withdrawal by Subject|5|||
126567414|NCT00109967|455372118|FG001|Overall Study|Withdrawal by Subject|0|||
126567415|NCT00109967|455372117|FG000|Overall Study|Physician Decision|1|||
126567416|NCT00109967|455372118|FG001|Overall Study|Physician Decision|3|||
126567417|NCT00109967|455372117|FG000|Overall Study|Death|0|||
126567418|NCT00109967|455372118|FG001|Overall Study|Death|2|||
126567419|NCT00628862|455372125|FG000|Overall Study|Adverse Event|6|||
126567420|NCT00628862|455372126|FG001|Overall Study|Adverse Event|8|||
126567421|NCT00628862|455372127|FG002|Overall Study|Adverse Event|10|||
126567422|NCT00628862|455372125|FG000|Overall Study|Withdrawal by Subject|4|||
126567423|NCT00628862|455372126|FG001|Overall Study|Withdrawal by Subject|6|||
126567424|NCT00628862|455372127|FG002|Overall Study|Withdrawal by Subject|11|||
126567425|NCT00628862|455372125|FG000|Overall Study|Lost to Follow-up|0|||
126567426|NCT00628862|455372126|FG001|Overall Study|Lost to Follow-up|2|||
126567427|NCT00628862|455372127|FG002|Overall Study|Lost to Follow-up|1|||
126567428|NCT00628862|455372125|FG000|Overall Study|Protocol Violation|1|||
126567429|NCT00628862|455372126|FG001|Overall Study|Protocol Violation|0|||
126567430|NCT00628862|455372127|FG002|Overall Study|Protocol Violation|0|||
126567431|NCT00628862|455372125|FG000|Overall Study|COPD Exacerbation|0|||
126567432|NCT00628862|455372126|FG001|Overall Study|COPD Exacerbation|1|||
126567433|NCT00628862|455372127|FG002|Overall Study|COPD Exacerbation|0|||
126567434|NCT01063036|455372128|FG000|Participants Treated With Study Drug|Adverse Event|1|||
126567435|NCT01063036|455372128|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
126567436|NCT01063036|455372128|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
126567437|NCT01063036|455372128|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
126727174|NCT03666858|455951072|FG001|Cohort 2|Adverse Event|1|||
126567438|NCT01063036|455372128|FG000|Participants Treated With Study Drug|Pregnancy|1|||
126567439|NCT01063036|455372128|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
126567440|NCT01063036|455372128|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
126567441|NCT01063036|455372128|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
126567442|NCT00918957|455372129|FG000|Overall Study|Adverse Event|2|||
126567443|NCT00918957|455372130|FG001|Overall Study|Adverse Event|0|||
126567444|NCT00918957|455372129|FG000|Overall Study|Withdrawal by Subject|1|||
126567445|NCT00918957|455372130|FG001|Overall Study|Withdrawal by Subject|0|||
126567446|NCT00686517|455372131|FG000|Treatment|Serious Adverse Event|1|||
126567447|NCT00686517|455372132|FG001|Treatment|Serious Adverse Event|2|||
126567448|NCT00686517|455372133|FG002|Treatment|Serious Adverse Event|1|||
126567449|NCT00686517|455372131|FG000|Treatment|Adverse Event|2|||
126567450|NCT00686517|455372132|FG001|Treatment|Adverse Event|0|||
126567451|NCT00686517|455372133|FG002|Treatment|Adverse Event|0|||
126567452|NCT00686517|455372131|FG000|Treatment|Poor Protocol Compliance|1|||
126567453|NCT00686517|455372132|FG001|Treatment|Poor Protocol Compliance|0|||
126567454|NCT00686517|455372133|FG002|Treatment|Poor Protocol Compliance|0|||
126567455|NCT00686517|455372131|FG000|Treatment|Protocol Violation|2|||
126567456|NCT00686517|455372132|FG001|Treatment|Protocol Violation|1|||
126567457|NCT00686517|455372133|FG002|Treatment|Protocol Violation|0|||
126567458|NCT01803646|455372134|FG000|Overall Study|Protocol Violation|1|||
126567459|NCT01803646|455372135|FG001|Overall Study|Protocol Violation|0|||
126567460|NCT01803646|455372134|FG000|Overall Study|Adverse Event|1|||
126567461|NCT01803646|455372135|FG001|Overall Study|Adverse Event|1|||
126567462|NCT01803646|455372134|FG000|Overall Study|Withdrawal by Subject|9|||
126567463|NCT01803646|455372135|FG001|Overall Study|Withdrawal by Subject|6|||
126567464|NCT01803646|455372134|FG000|Overall Study|Randomization error|1|||
126567465|NCT01803646|455372135|FG001|Overall Study|Randomization error|2|||
126567466|NCT01803646|455372134|FG000|Overall Study|Lost to Follow-up|5|||
126567467|NCT01803646|455372135|FG001|Overall Study|Lost to Follow-up|1|||
126567468|NCT01131494|455372136|FG000|Overall Study|Withdrawal by Subject|2|||
126567469|NCT02281318|455372137|FG000|Overall Study|Adverse Event|2|||
126567470|NCT02281318|455372138|FG001|Overall Study|Adverse Event|2|||
126567471|NCT02281318|455372137|FG000|Overall Study|Lack of Efficacy|2|||
126567472|NCT02281318|455372138|FG001|Overall Study|Lack of Efficacy|0|||
126567473|NCT02281318|455372137|FG000|Overall Study|Lost to Follow-up|2|||
126567474|NCT02281318|455372138|FG001|Overall Study|Lost to Follow-up|1|||
126567475|NCT02281318|455372137|FG000|Overall Study|Physician Decision|2|||
126567476|NCT02281318|455372138|FG001|Overall Study|Physician Decision|0|||
126567477|NCT02281318|455372137|FG000|Overall Study|Withdrawal by Subject|6|||
126567478|NCT02281318|455372138|FG001|Overall Study|Withdrawal by Subject|2|||
126567479|NCT02614560|455372143|FG000|Overall Study|Death|6|||
126567480|NCT02614560|455372144|FG001|Overall Study|Death|2|||
126567481|NCT00703911|455372145|FG000|Overall Study|Death|1|||
126567482|NCT00703911|455372145|FG000|Overall Study|Physician Decision|6|||
126567483|NCT00703911|455372145|FG000|Overall Study|Lost to Follow-up|1|||
126567484|NCT00703911|455372145|FG000|Overall Study|Withdrawal by Subject|2|||
126567485|NCT01368406|455372148|FG000|Overall Study|Lost to Follow-up|8|||
126567486|NCT01368406|455372149|FG001|Overall Study|Lost to Follow-up|4|||
126567487|NCT01368406|455372148|FG000|Overall Study|Withdrawal by Subject|8|||
126567488|NCT01368406|455372149|FG001|Overall Study|Withdrawal by Subject|4|||
126567489|NCT01368406|455372148|FG000|Overall Study|relapse of the disease|3|||
126567490|NCT01368406|455372149|FG001|Overall Study|relapse of the disease|2|||
126567491|NCT01368406|455372148|FG000|Overall Study|started working|2|||
126567492|NCT01368406|455372149|FG001|Overall Study|started working|3|||
126567493|NCT03670602|455372156|FG000|Overall Study|Lost to Follow-up|1|||
126567494|NCT03670602|455372157|FG001|Overall Study|Lost to Follow-up|0|||
126567495|NCT03670602|455372156|FG000|Overall Study|Withdrawal by Subject|0|||
126567496|NCT03670602|455372157|FG001|Overall Study|Withdrawal by Subject|3|||
126567497|NCT01456936|455372158|FG000|Overall Study|Other reason|41|||
126567498|NCT01456936|455372159|FG001|Overall Study|Other reason|30|||
126567499|NCT01456936|455372160|FG002|Overall Study|Other reason|36|||
126567500|NCT01456936|455372161|FG003|Overall Study|Other reason|33|||
126567501|NCT01456936|455372158|FG000|Overall Study|No longer meets eligibility criteria|4|||
126567502|NCT01456936|455372159|FG001|Overall Study|No longer meets eligibility criteria|8|||
126567503|NCT01456936|455372160|FG002|Overall Study|No longer meets eligibility criteria|6|||
126567504|NCT01456936|455372161|FG003|Overall Study|No longer meets eligibility criteria|5|||
126567505|NCT01456936|455372158|FG000|Overall Study|Protocol Violation|4|||
126567506|NCT01456936|455372159|FG001|Overall Study|Protocol Violation|2|||
126567507|NCT01456936|455372160|FG002|Overall Study|Protocol Violation|5|||
126567508|NCT01456936|455372161|FG003|Overall Study|Protocol Violation|5|||
126567509|NCT01456936|455372158|FG000|Overall Study|Pregnancy|1|||
126567510|NCT01456936|455372159|FG001|Overall Study|Pregnancy|0|||
126567511|NCT01456936|455372160|FG002|Overall Study|Pregnancy|0|||
126567512|NCT01456936|455372161|FG003|Overall Study|Pregnancy|1|||
126567513|NCT01456936|455372158|FG000|Overall Study|Insufficient clinical response|4|||
126567514|NCT01456936|455372159|FG001|Overall Study|Insufficient clinical response|4|||
126567515|NCT01456936|455372160|FG002|Overall Study|Insufficient clinical response|14|||
126567516|NCT01456936|455372161|FG003|Overall Study|Insufficient clinical response|13|||
126567517|NCT01456936|455372158|FG000|Overall Study|No longer willing to participate|195|||
126567518|NCT01456936|455372159|FG001|Overall Study|No longer willing to participate|218|||
126567519|NCT01456936|455372160|FG002|Overall Study|No longer willing to participate|224|||
126567520|NCT01456936|455372161|FG003|Overall Study|No longer willing to participate|248|||
126567521|NCT01456936|455372158|FG000|Overall Study|Lost to Follow-up|135|||
126567522|NCT01456936|455372159|FG001|Overall Study|Lost to Follow-up|126|||
126567523|NCT01456936|455372160|FG002|Overall Study|Lost to Follow-up|144|||
126567524|NCT01456936|455372161|FG003|Overall Study|Lost to Follow-up|127|||
126567525|NCT01456936|455372158|FG000|Overall Study|Medication error|0|||
126567526|NCT01456936|455372159|FG001|Overall Study|Medication error|1|||
126567527|NCT01456936|455372160|FG002|Overall Study|Medication error|0|||
126567528|NCT01456936|455372161|FG003|Overall Study|Medication error|1|||
126567529|NCT01456936|455372158|FG000|Overall Study|Adverse event (study drug)|25|||
126567530|NCT01456936|455372159|FG001|Overall Study|Adverse event (study drug)|21|||
126567531|NCT01456936|455372160|FG002|Overall Study|Adverse event (study drug)|26|||
126567532|NCT01456936|455372161|FG003|Overall Study|Adverse event (study drug)|17|||
126567533|NCT01456936|455372158|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
126567534|NCT01456936|455372159|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
126567535|NCT01456936|455372160|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
126567536|NCT01456936|455372161|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
126567537|NCT01456936|455372158|FG000|Overall Study|Death|0|||
126567538|NCT01456936|455372159|FG001|Overall Study|Death|3|||
126567539|NCT01456936|455372160|FG002|Overall Study|Death|1|||
126567540|NCT01456936|455372161|FG003|Overall Study|Death|3|||
126567541|NCT01456936|455372158|FG000|Overall Study|Randomized but not treated|21|||
126567542|NCT01456936|455372159|FG001|Overall Study|Randomized but not treated|28|||
126567543|NCT01456936|455372160|FG002|Overall Study|Randomized but not treated|16|||
126567544|NCT01456936|455372161|FG003|Overall Study|Randomized but not treated|21|||
126567545|NCT00543725|455372162|FG000|Overall Study|Adverse Event|18|||
126567546|NCT00543725|455372163|FG001|Overall Study|Adverse Event|27|||
126567547|NCT00543725|455372162|FG000|Overall Study|Sponsor's Decision|0|||
126567548|NCT00543725|455372163|FG001|Overall Study|Sponsor's Decision|1|||
126567549|NCT00543725|455372162|FG000|Overall Study|Subject Non-Compliant|4|||
126567550|NCT00543725|455372163|FG001|Overall Study|Subject Non-Compliant|4|||
126567551|NCT00543725|455372162|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
126567552|NCT00543725|455372163|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
126567553|NCT00543725|455372162|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
126567554|NCT00543725|455372163|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
126567555|NCT00543725|455372162|FG000|Overall Study|Protocol Violation|0|||
126567556|NCT00543725|455372163|FG001|Overall Study|Protocol Violation|1|||
126567557|NCT00543725|455372162|FG000|Overall Study|Withdrawal by Subject|4|||
126567558|NCT00543725|455372163|FG001|Overall Study|Withdrawal by Subject|13|||
126567559|NCT00543725|455372162|FG000|Overall Study|Lost to Follow-up|15|||
126567560|NCT00543725|455372163|FG001|Overall Study|Lost to Follow-up|11|||
126567561|NCT00543725|455372162|FG000|Overall Study|Other|3|||
126567562|NCT00543725|455372163|FG001|Overall Study|Other|3|||
126567563|NCT00906698|455372164|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
126567564|NCT00906698|455372165|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
126567565|NCT00906698|455372166|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
126567566|NCT00906698|455372167|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
126567567|NCT00906698|455372168|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
126567568|NCT00906698|455372169|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
126567569|NCT00906698|455372164|FG000|Overall Study|Adverse Event|0|||
126567570|NCT00906698|455372165|FG001|Overall Study|Adverse Event|0|||
126567571|NCT00906698|455372166|FG002|Overall Study|Adverse Event|2|||
126567572|NCT00906698|455372167|FG003|Overall Study|Adverse Event|0|||
126567573|NCT00906698|455372168|FG004|Overall Study|Adverse Event|4|||
126567574|NCT00906698|455372169|FG005|Overall Study|Adverse Event|1|||
126567575|NCT00906698|455372164|FG000|Overall Study|Disease progression|3|||
126567576|NCT00906698|455372165|FG001|Overall Study|Disease progression|12|||
126567577|NCT00906698|455372166|FG002|Overall Study|Disease progression|4|||
126567578|NCT00906698|455372167|FG003|Overall Study|Disease progression|4|||
126567579|NCT00906698|455372168|FG004|Overall Study|Disease progression|12|||
126567580|NCT00906698|455372169|FG005|Overall Study|Disease progression|4|||
126567581|NCT00906698|455372164|FG000|Overall Study|Withdrawal by Subject|0|||
126567582|NCT00906698|455372165|FG001|Overall Study|Withdrawal by Subject|0|||
126567583|NCT00906698|455372166|FG002|Overall Study|Withdrawal by Subject|0|||
126567584|NCT00906698|455372167|FG003|Overall Study|Withdrawal by Subject|0|||
126567585|NCT00906698|455372168|FG004|Overall Study|Withdrawal by Subject|1|||
126567586|NCT00906698|455372169|FG005|Overall Study|Withdrawal by Subject|0|||
126567587|NCT00906698|455372164|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
126567588|NCT00906698|455372165|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
126567589|NCT00906698|455372166|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
126567590|NCT00906698|455372167|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
126776958|NCT00267007|456139124|FG000|Overall Study|Adverse Event|1|||
126512569|NCT02349711|455172227|FG001|Overall Study|Lost to Follow-up|1|||
126512570|NCT00194012|455172228|FG000|Randomized Phase|Lack of Efficacy|8|||
126512571|NCT00194012|455172229|FG001|Randomized Phase|Lack of Efficacy|18|||
126512572|NCT00194012|455172228|FG000|Randomized Phase|Study nonadherence|2|||
126512573|NCT00194012|455172229|FG001|Randomized Phase|Study nonadherence|1|||
126512574|NCT00194012|455172228|FG000|Randomized Phase|Withdrawal by Subject|3|||
126512575|NCT00194012|455172229|FG001|Randomized Phase|Withdrawal by Subject|3|||
126512576|NCT00194012|455172228|FG000|Randomized Phase|Adverse Event|2|||
126512577|NCT00194012|455172229|FG001|Randomized Phase|Adverse Event|1|||
126512578|NCT00194012|455172228|FG000|Randomized Phase|Participant reported having a rash|1|||
126512579|NCT00194012|455172229|FG001|Randomized Phase|Participant reported having a rash|0|||
126512580|NCT00194012|455172228|FG000|Randomized Phase|Emesis and enuresis|0|||
126512581|NCT00194012|455172229|FG001|Randomized Phase|Emesis and enuresis|1|||
126512582|NCT00194012|455172228|FG000|Randomized Phase|Oral/nasal twitching|0|||
126512583|NCT00194012|455172229|FG001|Randomized Phase|Oral/nasal twitching|1|||
126512584|NCT00194012|455172228|FG000|Open Label Extension (OLE)|Weight Gain|1|||
126512585|NCT00194012|455172229|FG001|Open Label Extension (OLE)|Weight Gain|0|||
126512586|NCT00194012|455172228|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
126512587|NCT00194012|455172229|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
126512588|NCT00194012|455172228|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
126512589|NCT00194012|455172229|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
126512590|NCT00194012|455172228|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
126512591|NCT00194012|455172229|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
126512592|NCT02564198|455172235|FG000|Overall Study|Withdrawal by Subject|2|||
126512593|NCT02564198|455172236|FG001|Overall Study|Withdrawal by Subject|4|||
126512594|NCT02564198|455172237|FG002|Overall Study|Withdrawal by Subject|0|||
126512595|NCT02564198|455172235|FG000|Overall Study|Adverse Event|0|||
126512596|NCT02564198|455172236|FG001|Overall Study|Adverse Event|1|||
126512597|NCT02564198|455172237|FG002|Overall Study|Adverse Event|0|||
126512598|NCT02200042|455172238|FG000|Overall Study|Withdrawal by Subject|0|||
126512599|NCT02200042|455172239|FG001|Overall Study|Withdrawal by Subject|1|||
126512600|NCT02097134|455172240|FG000|Overall Study|Physician Decision|4|||
126512601|NCT02097134|455172240|FG000|Overall Study|Non-Protocol Therapy|1|||
126512602|NCT02097134|455172240|FG000|Overall Study|Progressive Disease|3|||
126512603|NCT02097134|455172240|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
126512604|NCT03394391|455172245|FG000|Overall Study|Lost to Follow-up|1|||
126512605|NCT03394391|455172246|FG001|Overall Study|Lost to Follow-up|2|||
126512606|NCT01434823|455172249|FG000|Overall Study|Incomplete data in medical record|4|||
126512607|NCT01434823|455172250|FG001|Overall Study|Incomplete data in medical record|7|||
126512608|NCT00519649|455172251|FG000|Overall Study|Withdrawal by Subject|1|||
126512609|NCT04879745|455172252|FG000|Overall Study|Lost to Follow-up|4|||
126512610|NCT04879745|455172253|FG001|Overall Study|Lost to Follow-up|1|||
126512611|NCT00120042|455172254|FG000|Overall Study|all completed protocl|0|||
126512612|NCT00120042|455172255|FG001|Overall Study|all completed protocl|0|||
126512613|NCT00120042|455172256|FG002|Overall Study|all completed protocl|0|||
126512614|NCT03592641|455172259|FG000|Overall Study|Withdrawal by Subject|1|||
126512615|NCT00436280|455172260|FG000|Period 1: Induction|Adverse Event|8|||
126512616|NCT00436280|455172260|FG000|Period 1: Induction|Progressive Disease|12|||
126512617|NCT00436280|455172260|FG000|Period 1: Induction|Stable Disease|6|||
126512618|NCT00436280|455172260|FG000|Period 1: Induction|Withdrawal by Subject|1|||
126512619|NCT00436280|455172260|FG000|Period 1: Induction|Death|1|||
126512620|NCT00436280|455172260|FG000|Period 2: Consolidation|Adverse Event|1|||
126512621|NCT00436280|455172260|FG000|Period 2: Consolidation|Progressive Disease|10|||
126512622|NCT00436280|455172260|FG000|Period 2: Consolidation|Stable Disease|1|||
126567591|NCT00906698|455372168|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
126567592|NCT00906698|455372169|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
126512623|NCT00436280|455172260|FG000|Period 2: Consolidation|Physician Decision|2|||
126512624|NCT00436280|455172260|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
126512625|NCT00436280|455172260|FG000|Period 2: Consolidation|Death|1|||
126512626|NCT00436280|455172260|FG000|Period 3: Maintenance|Adverse Event|6|||
126512627|NCT00436280|455172260|FG000|Period 3: Maintenance|Progressive Disease|12|||
126512628|NCT01049919|455172264|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
126512629|NCT01049919|455172265|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
126512630|NCT01049919|455172264|FG000|Overall Study|Withdrawal by Subject|5|||
126512631|NCT01049919|455172265|FG001|Overall Study|Withdrawal by Subject|0|||
126512632|NCT01049919|455172264|FG000|Overall Study|Lost to Follow-up|6|||
126512633|NCT01049919|455172265|FG001|Overall Study|Lost to Follow-up|1|||
126512634|NCT01049919|455172264|FG000|Overall Study|Physician Decision|2|||
126512635|NCT01049919|455172265|FG001|Overall Study|Physician Decision|0|||
126512636|NCT01049919|455172264|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
126512637|NCT01049919|455172265|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
126512638|NCT01049919|455172264|FG000|Overall Study|Early study termination by sponsor.|2|||
126512639|NCT01049919|455172265|FG001|Overall Study|Early study termination by sponsor.|0|||
126512640|NCT00673452|455172269|FG000|Acute Double-Blind Phase|Adverse Event|41|||
126567593|NCT03095508|455372170|FG000|Overall Study|Adverse Event|0|||
126567594|NCT03095508|455372171|FG001|Overall Study|Adverse Event|1|||
126512641|NCT00673452|455172270|FG001|Acute Double-Blind Phase|Adverse Event|24|||
126512642|NCT00673452|455172269|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
126512643|NCT00673452|455172270|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
126512644|NCT00673452|455172269|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
126512645|NCT00673452|455172270|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
126512646|NCT00673452|455172269|FG000|Acute Double-Blind Phase|Physician Decision|0|||
126512647|NCT00673452|455172270|FG001|Acute Double-Blind Phase|Physician Decision|6|||
126512648|NCT00673452|455172269|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
126512649|NCT00673452|455172270|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
126512650|NCT00673452|455172269|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
126512651|NCT00673452|455172270|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
126512652|NCT00673452|455172269|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
126512653|NCT00673452|455172270|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
126512654|NCT00673452|455172269|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
126512655|NCT00673452|455172270|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
126512656|NCT00673452|455172269|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
126512657|NCT00673452|455172270|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
126512658|NCT00673452|455172269|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
126512659|NCT00673452|455172270|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
126512660|NCT00673452|455172269|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
126512661|NCT00673452|455172270|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
126512662|NCT00673452|455172269|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
126512663|NCT00673452|455172270|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
126512664|NCT00673452|455172269|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
126512665|NCT00673452|455172270|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
126512666|NCT00673452|455172269|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
126512667|NCT00673452|455172270|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
126512668|NCT00673452|455172269|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
126512669|NCT00673452|455172270|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
126512670|NCT00813124|455172271|FG000|Overall Study|Death|2|||
126512671|NCT00813124|455172271|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
126512672|NCT00813124|455172271|FG000|Overall Study|Withdrawal by Subject|1|||
126512673|NCT00767676|455172272|FG000|Overall Study|Investigator error|54|||
126512674|NCT00617240|455172273|FG000|Overall Study|Lack of Efficacy|1|||
126512675|NCT00617240|455172274|FG001|Overall Study|Lack of Efficacy|0|||
126512676|NCT01611259|455172275|FG000|Overall Study|Physician Decision|1|||
126512677|NCT01611259|455172275|FG000|Overall Study|Lack of Efficacy|2|||
126512678|NCT01611259|455172275|FG000|Overall Study|Adverse Event|4|||
126512679|NCT01611259|455172275|FG000|Overall Study|Withdrawal by Subject|7|||
126512680|NCT04936685|455172276|FG000|Overall Study|Protocol Violation|1|||
126512681|NCT04936685|455172277|FG001|Overall Study|Protocol Violation|0|||
126512682|NCT03969212|455172280|FG000|Overall Study|Adverse Event|1|||
126512683|NCT03969212|455172281|FG001|Overall Study|Adverse Event|0|||
126512684|NCT03969212|455172282|FG002|Overall Study|Adverse Event|0|||
126512685|NCT03969212|455172283|FG003|Overall Study|Adverse Event|0|||
126512686|NCT03969212|455172280|FG000|Overall Study|Lost to Follow-up|2|||
126512687|NCT03969212|455172281|FG001|Overall Study|Lost to Follow-up|2|||
126512688|NCT03969212|455172282|FG002|Overall Study|Lost to Follow-up|2|||
126567595|NCT03201809|455372172|FG000|Overall Study|Lost to Follow-up|2|||
126567596|NCT03201809|455372173|FG001|Overall Study|Lost to Follow-up|0|||
126567597|NCT04889664|455372175|FG000|Screen|Lost to Follow-up|1|||
126567598|NCT04889664|455372175|FG000|Screen|Failed to meet screening criteria|1|||
126567599|NCT04889664|455372175|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
126567600|NCT01585038|455372180|FG000|Overall Study|Adverse Event|2|||
126567601|NCT01585038|455372181|FG001|Overall Study|Adverse Event|2|||
126567602|NCT04107805|455372182|FG000|Overall Study|Adverse Event|0|||
126567603|NCT04107805|455372183|FG001|Overall Study|Adverse Event|0|||
126512689|NCT03969212|455172283|FG003|Overall Study|Lost to Follow-up|2|||
126567604|NCT04107805|455372184|FG002|Overall Study|Adverse Event|0|||
126567605|NCT04107805|455372185|FG003|Overall Study|Adverse Event|1|||
126567606|NCT04107805|455372186|FG004|Overall Study|Adverse Event|0|||
126567607|NCT04107805|455372187|FG005|Overall Study|Adverse Event|1|||
126512690|NCT03969212|455172280|FG000|Overall Study|Protocol Violation|0|||
126512691|NCT03969212|455172281|FG001|Overall Study|Protocol Violation|0|||
126512692|NCT03969212|455172282|FG002|Overall Study|Protocol Violation|0|||
126512693|NCT03969212|455172283|FG003|Overall Study|Protocol Violation|1|||
126512694|NCT03969212|455172280|FG000|Overall Study|Withdrawal by Subject|7|||
126567608|NCT04107805|455372188|FG006|Overall Study|Adverse Event|0|||
126727175|NCT00547378|455951073|FG000|Randomized Cohort|Withdrawal by Subject|7|||
126727176|NCT00547378|455951074|FG001|Randomized Cohort|Withdrawal by Subject|5|||
126512695|NCT03969212|455172281|FG001|Overall Study|Withdrawal by Subject|13|||
126512696|NCT03969212|455172282|FG002|Overall Study|Withdrawal by Subject|5|||
126567609|NCT04107805|455372189|FG007|Overall Study|Adverse Event|0|||
126512697|NCT03969212|455172283|FG003|Overall Study|Withdrawal by Subject|11|||
126512698|NCT03969212|455172280|FG000|Overall Study|Physician Decision|0|||
126512699|NCT03969212|455172281|FG001|Overall Study|Physician Decision|0|||
126512700|NCT03969212|455172282|FG002|Overall Study|Physician Decision|1|||
126512701|NCT03969212|455172283|FG003|Overall Study|Physician Decision|0|||
126512702|NCT03969212|455172280|FG000|Overall Study|Reason not Specified|22|||
126512703|NCT03969212|455172281|FG001|Overall Study|Reason not Specified|23|||
126512704|NCT03969212|455172282|FG002|Overall Study|Reason not Specified|28|||
126512705|NCT03969212|455172283|FG003|Overall Study|Reason not Specified|26|||
126512706|NCT02075320|455172284|FG000|Overall Study|Withdrawal by Subject|2|||
126512707|NCT03773757|455172288|FG000|Overall Study|Withdrawal by Subject|2|||
126512708|NCT03773757|455172289|FG001|Overall Study|Withdrawal by Subject|4|||
126512709|NCT01147653|455172290|FG000|Year 2|Withdrawal by Subject|2|||
126512710|NCT01147653|455172291|FG001|Year 2|Withdrawal by Subject|3|||
126512711|NCT00280566|455172292|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
126512712|NCT00280566|455172293|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
126512713|NCT00280566|455172294|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
126512714|NCT00280566|455172292|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
126512715|NCT00280566|455172293|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
126512716|NCT00280566|455172294|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
126512717|NCT00280566|455172292|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
126512718|NCT00280566|455172293|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
126512719|NCT00280566|455172294|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
126512720|NCT00280566|455172292|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
126512721|NCT00280566|455172293|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
126512722|NCT00280566|455172294|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
126512723|NCT00280566|455172292|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
126512724|NCT00280566|455172293|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
126512725|NCT00280566|455172294|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
126512726|NCT00280566|455172292|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
126512727|NCT00280566|455172293|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
126567610|NCT04107805|455372190|FG008|Overall Study|Adverse Event|1|||
126567611|NCT01191086|455372202|FG000|Overall Study|Adverse Event|20|||
126567612|NCT01191086|455372202|FG000|Overall Study|Lack of Efficacy|10|||
126567613|NCT01191086|455372202|FG000|Overall Study|Lost to Follow-up|4|||
126567614|NCT01191086|455372202|FG000|Overall Study|Physician Decision|2|||
126567615|NCT01191086|455372202|FG000|Overall Study|Withdrawal by Subject|24|||
126567616|NCT01191086|455372202|FG000|Overall Study|Discontinuation criterion met|1|||
126567617|NCT01191086|455372202|FG000|Overall Study|Other|1|||
126567618|NCT00853827|455372203|FG000|Single Blind Period (1 Week)|Other|4|||
126567619|NCT00853827|455372204|FG001|Single Blind Period (1 Week)|Other|0|||
126567620|NCT00853827|455372203|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
126567621|NCT00853827|455372204|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
126567622|NCT00853827|455372203|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
126567623|NCT00853827|455372204|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
126567624|NCT00853827|455372203|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
126567625|NCT00853827|455372204|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
126567626|NCT00853827|455372203|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
126567627|NCT00853827|455372204|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
126567628|NCT00853827|455372203|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
126567629|NCT00853827|455372204|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
126567630|NCT00853827|455372203|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
126567631|NCT00853827|455372204|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
126567632|NCT00853827|455372203|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
126567633|NCT00853827|455372204|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
126567634|NCT00853827|455372203|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
126512728|NCT00280566|455172294|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
126512729|NCT00280566|455172292|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
126512730|NCT00280566|455172293|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
126512731|NCT00280566|455172294|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
126567635|NCT00853827|455372204|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
126567636|NCT00853827|455372203|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
126567637|NCT00853827|455372204|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
126512732|NCT00280566|455172292|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
126567638|NCT00853827|455372203|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
126640434|NCT00479882|455642777|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
126640435|NCT00479882|455642774|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
126640436|NCT00479882|455642775|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
126640437|NCT00479882|455642776|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
126640438|NCT00479882|455642777|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
126640439|NCT00479882|455642774|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
126567639|NCT00853827|455372204|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
126567640|NCT00853827|455372203|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
126567641|NCT00853827|455372204|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
126567642|NCT00853827|455372203|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
126567643|NCT00853827|455372204|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
126567644|NCT00853827|455372203|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
126567645|NCT00853827|455372204|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
126567646|NCT00853827|455372203|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
126567647|NCT00853827|455372204|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
126567648|NCT00853827|455372203|FG000|Double Blind Period (103 Weeks)|Death|1|||
126567649|NCT00853827|455372204|FG001|Double Blind Period (103 Weeks)|Death|6|||
126567650|NCT00771849|455372205|FG000|Overall Study|Lost to Follow-up|1|||
126567651|NCT00771849|455372206|FG001|Overall Study|Lost to Follow-up|2|||
126567652|NCT00771849|455372205|FG000|Overall Study|Withdrawal by Subject|1|||
126567653|NCT00771849|455372206|FG001|Overall Study|Withdrawal by Subject|1|||
126567654|NCT00771849|455372205|FG000|Overall Study|Not vaccinated|0|||
126567655|NCT00771849|455372206|FG001|Overall Study|Not vaccinated|1|||
126567656|NCT02046616|455372211|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
126567657|NCT02046616|455372211|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
126567658|NCT02046616|455372211|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
126567659|NCT02046616|455372211|FG000|24-Week Treatment Period|Physician Decision|3|||
126567660|NCT02046616|455372211|FG000|24-Week Treatment Period|Other|1|||
126567661|NCT02046616|455372211|FG000|8-Week FU Period|Lost to Follow-up|1|||
126567662|NCT02736799|455372212|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
126567663|NCT02736799|455372213|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
126567664|NCT02736799|455372214|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
126567665|NCT02736799|455372215|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
126567666|NCT01156116|455372218|FG000|Overall Study|Withdrawal by Subject|3|||
126567667|NCT01156116|455372219|FG001|Overall Study|Withdrawal by Subject|1|||
126567668|NCT01156116|455372218|FG000|Overall Study|CPAP intolerance|2|||
126567669|NCT01156116|455372219|FG001|Overall Study|CPAP intolerance|0|||
126567670|NCT00344019|455372220|FG000|Overall Study|did not meet final inclusion criteria|0|||
126567671|NCT00344019|455372221|FG001|Overall Study|did not meet final inclusion criteria|0|||
126567672|NCT00344019|455372222|FG002|Overall Study|did not meet final inclusion criteria|74|||
126567673|NCT02057718|455372223|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
126567674|NCT02057718|455372224|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
126567675|NCT02057718|455372223|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
126567676|NCT02057718|455372224|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
126567677|NCT02057718|455372223|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
126567678|NCT02057718|455372224|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
126567679|NCT02057718|455372223|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
126567680|NCT02057718|455372224|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
126567681|NCT02057718|455372223|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
126567682|NCT02057718|455372224|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
126567683|NCT02057718|455372223|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
126567684|NCT02057718|455372224|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
126567685|NCT02057718|455372223|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
126567686|NCT02057718|455372224|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
126567687|NCT02057718|455372223|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
126567688|NCT02057718|455372224|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
126567689|NCT02057718|455372223|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
126567690|NCT02057718|455372224|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
126567691|NCT02057718|455372223|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
126567692|NCT02057718|455372224|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
126567693|NCT02057718|455372223|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
126567694|NCT02057718|455372224|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
126567695|NCT01191788|455372225|FG000|Overall Study|Lost to Follow-up|21|||
126567696|NCT01191788|455372226|FG001|Overall Study|Lost to Follow-up|22|||
126567697|NCT01959412|455372228|FG000|Overall Study|Protocol deviation|1|||
126567698|NCT01959412|455372229|FG001|Overall Study|Protocol deviation|1|||
126567699|NCT01959412|455372230|FG002|Overall Study|Protocol deviation|0|||
126567700|NCT01959412|455372231|FG003|Overall Study|Protocol deviation|1|||
126567701|NCT01959412|455372232|FG004|Overall Study|Protocol deviation|3|||
126567702|NCT01959412|455372233|FG005|Overall Study|Protocol deviation|0|||
126567703|NCT01959412|455372228|FG000|Overall Study|Adverse Event|0|||
126567704|NCT01959412|455372229|FG001|Overall Study|Adverse Event|0|||
126567705|NCT01959412|455372230|FG002|Overall Study|Adverse Event|0|||
126567706|NCT01959412|455372231|FG003|Overall Study|Adverse Event|1|||
126567707|NCT01959412|455372232|FG004|Overall Study|Adverse Event|0|||
126567708|NCT01959412|455372233|FG005|Overall Study|Adverse Event|0|||
126567709|NCT00509769|455372234|FG000|Overall Study|Progressive disease|77|||
126567710|NCT00509769|455372234|FG000|Overall Study|Adverse Event|4|||
126567711|NCT00509769|455372234|FG000|Overall Study|Patient's decision|1|||
126567712|NCT00509769|455372234|FG000|Overall Study|Physician Decision|8|||
126567713|NCT00509769|455372234|FG000|Overall Study|Use of prohibited therapies during study|1|||
126567714|NCT00741988|455372236|FG000|Overall Study|Adverse Event|2|||
126567715|NCT00741988|455372237|FG001|Overall Study|Adverse Event|4|||
126567716|NCT00741988|455372236|FG000|Overall Study|Lack of Efficacy|2|||
126567717|NCT00741988|455372237|FG001|Overall Study|Lack of Efficacy|0|||
126567718|NCT03227757|455373760|FG000|Overall Study|Death|25|||
126567719|NCT03227757|455373760|FG000|Overall Study|Withdrawal|10|||
126567720|NCT03227757|455373760|FG000|Overall Study|Missed visits|1|||
126567721|NCT03227757|455373760|FG000|Overall Study|Lost to Follow-up|2|||
126567722|NCT01144468|455373761|FG000|Overall Study|Lost to Follow-up|4|||
126567723|NCT01144468|455373762|FG001|Overall Study|Lost to Follow-up|7|||
126567724|NCT01144468|455373761|FG000|Overall Study|Adverse Event|3|||
126567725|NCT01144468|455373762|FG001|Overall Study|Adverse Event|2|||
126567726|NCT01144468|455373761|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
126567727|NCT01144468|455373762|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
126567728|NCT03140176|455373768|FG000|Overall Study|Reason missing|23|||
126567729|NCT03140176|455373768|FG000|Overall Study|Death|33|||
126567730|NCT03140176|455373768|FG000|Overall Study|Disease progression|1|||
126567731|NCT03140176|455373768|FG000|Overall Study|Physician Decision|1|||
126567732|NCT03140176|455373768|FG000|Overall Study|Withdrawal by Subject|1|||
126567733|NCT03140176|455373768|FG000|Overall Study|Lost to Follow-up|15|||
126567734|NCT00149630|455373772|FG000|Overall Study|Incarceration|2|||
126567735|NCT00149630|455373773|FG001|Overall Study|Incarceration|0|||
126567736|NCT00149630|455373772|FG000|Overall Study|Treatment Programs|4|||
126567737|NCT00149630|455373773|FG001|Overall Study|Treatment Programs|5|||
126567738|NCT00149630|455373772|FG000|Overall Study|Adverse Event|2|||
126567739|NCT00149630|455373773|FG001|Overall Study|Adverse Event|0|||
126567740|NCT05298111|455373778|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
126567741|NCT05298111|455373779|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
126567742|NCT02689349|455373780|FG000|Overall Study|Not implanted|4|||
126567743|NCT02689349|455373781|FG001|Overall Study|Not implanted|0|||
126567744|NCT02689349|455373780|FG000|Overall Study|Withdrawal by Subject|9|||
126567745|NCT02689349|455373781|FG001|Overall Study|Withdrawal by Subject|0|||
126567746|NCT03518112|455373782|FG000|Overall Study|Withdrawal by Subject|1|||
126567747|NCT01546155|455373783|FG000|Overall Study|could not tolerate long scan duration|3|||
126567748|NCT02715258|455373785|FG000|Overall Study|Withdrawal by Subject|6|||
126567749|NCT02715258|455373786|FG001|Overall Study|Withdrawal by Subject|1|||
126567750|NCT02715258|455373785|FG000|Overall Study|Lost to Follow-up|7|||
126567751|NCT02715258|455373786|FG001|Overall Study|Lost to Follow-up|1|||
126567752|NCT02715258|455373785|FG000|Overall Study|Terminated by Sponsor|0|||
126567753|NCT02715258|455373786|FG001|Overall Study|Terminated by Sponsor|1|||
126567754|NCT02715258|455373785|FG000|Overall Study|Death|0|||
126567755|NCT02715258|455373786|FG001|Overall Study|Death|1|||
126567756|NCT02715258|455373785|FG000|Overall Study|Subject non-compliant|1|||
126567757|NCT02715258|455373786|FG001|Overall Study|Subject non-compliant|1|||
126567758|NCT02715258|455373785|FG000|Overall Study|GCP violation|2|||
126567759|NCT02715258|455373786|FG001|Overall Study|GCP violation|1|||
126567760|NCT02814643|455373787|FG000|Overall Study|Lost to Follow-up|0|||
126567761|NCT02814643|455373788|FG001|Overall Study|Lost to Follow-up|1|||
126567762|NCT02814643|455373787|FG000|Overall Study|Withdrawal by Subject|1|||
126567763|NCT02814643|455373788|FG001|Overall Study|Withdrawal by Subject|2|||
126567764|NCT02263508|455373789|FG000|Overall Study|Withdrawal by Subject|1|||
126567765|NCT02263508|455373790|FG001|Overall Study|Withdrawal by Subject|23|||
126567766|NCT02263508|455373791|FG002|Overall Study|Withdrawal by Subject|17|||
126567767|NCT02263508|455373789|FG000|Overall Study|Sponsor Decision|12|||
126567768|NCT02263508|455373790|FG001|Overall Study|Sponsor Decision|165|||
126567769|NCT02263508|455373791|FG002|Overall Study|Sponsor Decision|182|||
126567770|NCT02263508|455373789|FG000|Overall Study|Lost to Follow-up|2|||
126567771|NCT02263508|455373790|FG001|Overall Study|Lost to Follow-up|7|||
126567772|NCT02263508|455373791|FG002|Overall Study|Lost to Follow-up|7|||
126567773|NCT02263508|455373789|FG000|Overall Study|Death|6|||
126567774|NCT02263508|455373790|FG001|Overall Study|Death|151|||
126567775|NCT02263508|455373791|FG002|Overall Study|Death|140|||
126567776|NCT03265210|455373794|FG000|Overall Study|Withdrawal by Subject|7|||
126567777|NCT03265210|455373795|FG001|Overall Study|Withdrawal by Subject|9|||
126567778|NCT03265210|455373794|FG000|Overall Study|Lost to Follow-up|2|||
126567779|NCT03265210|455373795|FG001|Overall Study|Lost to Follow-up|0|||
126567780|NCT03265210|455373794|FG000|Overall Study|Physician Decision|2|||
126567781|NCT03265210|455373795|FG001|Overall Study|Physician Decision|0|||
126567782|NCT03265210|455373794|FG000|Overall Study|Adverse Event|1|||
126567783|NCT03265210|455373795|FG001|Overall Study|Adverse Event|0|||
126567784|NCT03923491|455373796|FG000|Overall Study|Lost to Follow-up|5|||
126567785|NCT03923491|455373797|FG001|Overall Study|Lost to Follow-up|8|||
126567786|NCT03923491|455373796|FG000|Overall Study|Withdrawal by Subject|4|||
126567787|NCT03923491|455373797|FG001|Overall Study|Withdrawal by Subject|6|||
126567788|NCT02174562|455373798|FG000|Overall Study|Withdrawal by Subject|7|||
126567789|NCT02174562|455373799|FG001|Overall Study|Withdrawal by Subject|2|||
126567790|NCT02174562|455373798|FG000|Overall Study|Death|2|||
126567791|NCT02174562|455373799|FG001|Overall Study|Death|0|||
126567792|NCT02174562|455373798|FG000|Overall Study|Lost to Follow-up|0|||
126567793|NCT02174562|455373799|FG001|Overall Study|Lost to Follow-up|3|||
126567794|NCT05193318|455373800|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
126567795|NCT05193318|455373800|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
126567796|NCT00798096|455373801|FG000|Overall Study|Ongoing|2|||
126567797|NCT01833065|455373802|FG000|Overall Study|Adverse Event|6|||
126567798|NCT01833065|455373803|FG001|Overall Study|Adverse Event|1|||
126567799|NCT01833065|455373804|FG002|Overall Study|Adverse Event|0|||
126567800|NCT01833065|455373805|FG003|Overall Study|Adverse Event|2|||
126567801|NCT01833065|455373806|FG004|Overall Study|Adverse Event|3|||
126567802|NCT01833065|455373802|FG000|Overall Study|Protocol Violation|1|||
126567803|NCT01833065|455373803|FG001|Overall Study|Protocol Violation|0|||
126567804|NCT01833065|455373804|FG002|Overall Study|Protocol Violation|0|||
126567805|NCT01833065|455373805|FG003|Overall Study|Protocol Violation|0|||
126567806|NCT01833065|455373806|FG004|Overall Study|Protocol Violation|2|||
126567807|NCT01833065|455373802|FG000|Overall Study|Lost to Follow-up|1|||
126567808|NCT01833065|455373803|FG001|Overall Study|Lost to Follow-up|0|||
126567809|NCT01833065|455373804|FG002|Overall Study|Lost to Follow-up|0|||
126567810|NCT01833065|455373805|FG003|Overall Study|Lost to Follow-up|0|||
126567811|NCT01833065|455373806|FG004|Overall Study|Lost to Follow-up|3|||
126567812|NCT01833065|455373802|FG000|Overall Study|Withdrawal by Subject|6|||
126567813|NCT01833065|455373803|FG001|Overall Study|Withdrawal by Subject|2|||
126567814|NCT01833065|455373804|FG002|Overall Study|Withdrawal by Subject|4|||
126567815|NCT01833065|455373805|FG003|Overall Study|Withdrawal by Subject|3|||
126567816|NCT01833065|455373806|FG004|Overall Study|Withdrawal by Subject|11|||
126567817|NCT01833065|455373802|FG000|Overall Study|Subject's substantial non-compliance|0|||
126567818|NCT01833065|455373803|FG001|Overall Study|Subject's substantial non-compliance|1|||
126567819|NCT01833065|455373804|FG002|Overall Study|Subject's substantial non-compliance|0|||
126567820|NCT01833065|455373805|FG003|Overall Study|Subject's substantial non-compliance|0|||
126567821|NCT01833065|455373806|FG004|Overall Study|Subject's substantial non-compliance|0|||
126567822|NCT01833065|455373802|FG000|Overall Study|Trial terminated by sponsor|8|||
126567823|NCT01833065|455373803|FG001|Overall Study|Trial terminated by sponsor|8|||
126567824|NCT01833065|455373804|FG002|Overall Study|Trial terminated by sponsor|7|||
126567825|NCT01833065|455373805|FG003|Overall Study|Trial terminated by sponsor|3|||
126567826|NCT01833065|455373806|FG004|Overall Study|Trial terminated by sponsor|13|||
126567827|NCT01833065|455373802|FG000|Overall Study|Others|2|||
126567828|NCT01833065|455373803|FG001|Overall Study|Others|1|||
126567829|NCT01833065|455373804|FG002|Overall Study|Others|1|||
126567830|NCT01833065|455373805|FG003|Overall Study|Others|1|||
126567831|NCT01833065|455373806|FG004|Overall Study|Others|4|||
126567832|NCT00241644|455373810|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
126567833|NCT00241644|455373811|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
126567834|NCT00241644|455373812|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
126567835|NCT00241644|455373813|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
126567836|NCT00241644|455373810|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
126567837|NCT00241644|455373811|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
126567838|NCT00241644|455373812|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
126567839|NCT00241644|455373813|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
126567840|NCT00241644|455373810|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
126567841|NCT00241644|455373811|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
126567842|NCT00241644|455373812|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
126567843|NCT00241644|455373813|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
126567844|NCT00241644|455373810|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
126567845|NCT00241644|455373811|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
126567846|NCT00241644|455373812|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
126567847|NCT00241644|455373813|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
126567848|NCT00241644|455373810|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
126567849|NCT00241644|455373811|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
126567850|NCT00241644|455373812|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
126567851|NCT00241644|455373813|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
126567852|NCT00241644|455373810|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
126567853|NCT00241644|455373811|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
126567854|NCT00241644|455373812|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
126567855|NCT00241644|455373813|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
126567856|NCT00241644|455373810|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
126567857|NCT00241644|455373811|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
126567858|NCT00241644|455373812|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
126776959|NCT00267007|456139125|FG001|Overall Study|Adverse Event|0|||
126727177|NCT00547378|455951075|FG002|Randomized Cohort|Withdrawal by Subject|0|||
126727178|NCT00547378|455951073|FG000|Randomized Cohort|Death|0|||
126512733|NCT00280566|455172293|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
126512734|NCT00280566|455172294|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
126512735|NCT00280566|455172292|FG000|Period 2 Double Blind|Adverse Event|0|||
126512736|NCT00280566|455172293|FG001|Period 2 Double Blind|Adverse Event|11|||
126512737|NCT00280566|455172294|FG002|Period 2 Double Blind|Adverse Event|15|||
126512738|NCT00280566|455172292|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
126512739|NCT00280566|455172293|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
126512740|NCT00280566|455172294|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
126512741|NCT00280566|455172292|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
126512742|NCT00280566|455172293|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
126512743|NCT00280566|455172294|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
126512744|NCT00280566|455172292|FG000|Period 2 Double Blind|miscellaneous|0|||
126512745|NCT00280566|455172293|FG001|Period 2 Double Blind|miscellaneous|10|||
126512746|NCT00280566|455172294|FG002|Period 2 Double Blind|miscellaneous|5|||
126512747|NCT00353366|455172295|FG000|Overall Study|Adverse Event|8|||
126512748|NCT00353366|455172295|FG000|Overall Study|Protocol Violation|12|||
126512749|NCT00353366|455172295|FG000|Overall Study|Withdrawal by Subject|12|||
126512750|NCT00353366|455172295|FG000|Overall Study|Lost to Follow-up|92|||
126512751|NCT00353366|455172295|FG000|Overall Study|Other|19|||
126512752|NCT01109316|455172296|FG000|Study Period 1|Adverse Event|0|||
126512753|NCT01109316|455172297|FG001|Study Period 1|Adverse Event|0|||
126512754|NCT01109316|455172298|FG002|Study Period 1|Adverse Event|1|||
126512755|NCT01109316|455172299|FG003|Study Period 1|Adverse Event|0|||
126512756|NCT01109316|455172300|FG004|Study Period 1|Adverse Event|0|||
126512757|NCT01109316|455172301|FG005|Study Period 1|Adverse Event|0|||
126512758|NCT01109316|455172296|FG000|Study Period 1|Lost to Follow-up|0|||
126512759|NCT01109316|455172297|FG001|Study Period 1|Lost to Follow-up|0|||
126512760|NCT01109316|455172298|FG002|Study Period 1|Lost to Follow-up|1|||
126512761|NCT01109316|455172299|FG003|Study Period 1|Lost to Follow-up|1|||
126512762|NCT01109316|455172300|FG004|Study Period 1|Lost to Follow-up|0|||
126512763|NCT01109316|455172301|FG005|Study Period 1|Lost to Follow-up|0|||
126512764|NCT01109316|455172296|FG000|Study Period 1|Withdrawal by Subject|0|||
126512765|NCT01109316|455172297|FG001|Study Period 1|Withdrawal by Subject|0|||
126512766|NCT01109316|455172298|FG002|Study Period 1|Withdrawal by Subject|1|||
126512767|NCT01109316|455172299|FG003|Study Period 1|Withdrawal by Subject|0|||
126512768|NCT01109316|455172300|FG004|Study Period 1|Withdrawal by Subject|2|||
126512769|NCT01109316|455172301|FG005|Study Period 1|Withdrawal by Subject|0|||
126512770|NCT01109316|455172296|FG000|Study Period 1|Sponsor Decision|0|||
126512771|NCT01109316|455172297|FG001|Study Period 1|Sponsor Decision|0|||
126512772|NCT01109316|455172298|FG002|Study Period 1|Sponsor Decision|0|||
126512773|NCT01109316|455172299|FG003|Study Period 1|Sponsor Decision|0|||
126512774|NCT01109316|455172300|FG004|Study Period 1|Sponsor Decision|0|||
126512775|NCT01109316|455172301|FG005|Study Period 1|Sponsor Decision|2|||
126512776|NCT01109316|455172296|FG000|Study Period 2|Entry Criteria Not Met|0|||
126512777|NCT01109316|455172297|FG001|Study Period 2|Entry Criteria Not Met|1|||
126512778|NCT01109316|455172298|FG002|Study Period 2|Entry Criteria Not Met|0|||
126512779|NCT01109316|455172299|FG003|Study Period 2|Entry Criteria Not Met|0|||
126512780|NCT01109316|455172300|FG004|Study Period 2|Entry Criteria Not Met|0|||
126512781|NCT01109316|455172301|FG005|Study Period 2|Entry Criteria Not Met|0|||
126512782|NCT01109316|455172296|FG000|Study Period 2|Physician Decision|0|||
126512783|NCT01109316|455172297|FG001|Study Period 2|Physician Decision|0|||
126512784|NCT01109316|455172298|FG002|Study Period 2|Physician Decision|0|||
126512785|NCT01109316|455172299|FG003|Study Period 2|Physician Decision|1|||
126512786|NCT01109316|455172300|FG004|Study Period 2|Physician Decision|0|||
126512787|NCT01109316|455172301|FG005|Study Period 2|Physician Decision|0|||
126512788|NCT01109316|455172296|FG000|Study Period 2|Protocol Violation|1|||
126512789|NCT01109316|455172297|FG001|Study Period 2|Protocol Violation|0|||
126512790|NCT01109316|455172298|FG002|Study Period 2|Protocol Violation|0|||
126512791|NCT01109316|455172299|FG003|Study Period 2|Protocol Violation|0|||
126512792|NCT01109316|455172300|FG004|Study Period 2|Protocol Violation|0|||
126512793|NCT01109316|455172301|FG005|Study Period 2|Protocol Violation|0|||
126512794|NCT01109316|455172296|FG000|Study Period 2|Withdrawal by Subject|0|||
126512795|NCT01109316|455172297|FG001|Study Period 2|Withdrawal by Subject|0|||
126512796|NCT01109316|455172298|FG002|Study Period 2|Withdrawal by Subject|1|||
126512797|NCT01109316|455172299|FG003|Study Period 2|Withdrawal by Subject|0|||
126512798|NCT01109316|455172300|FG004|Study Period 2|Withdrawal by Subject|0|||
126512799|NCT01109316|455172301|FG005|Study Period 2|Withdrawal by Subject|1|||
126512800|NCT01109316|455172296|FG000|Study Period 3|Lost to Follow-up|0|||
126512801|NCT01109316|455172297|FG001|Study Period 3|Lost to Follow-up|0|||
126512802|NCT01109316|455172298|FG002|Study Period 3|Lost to Follow-up|0|||
126567859|NCT00241644|455373813|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
126512803|NCT01109316|455172299|FG003|Study Period 3|Lost to Follow-up|0|||
126512804|NCT01109316|455172300|FG004|Study Period 3|Lost to Follow-up|1|||
126512805|NCT01109316|455172301|FG005|Study Period 3|Lost to Follow-up|0|||
126512806|NCT01109316|455172296|FG000|Study Period 3|Withdrawal by Subject|1|||
126512807|NCT01109316|455172297|FG001|Study Period 3|Withdrawal by Subject|0|||
126727179|NCT00547378|455951074|FG001|Randomized Cohort|Death|1|||
126512808|NCT01109316|455172298|FG002|Study Period 3|Withdrawal by Subject|0|||
126512809|NCT01109316|455172299|FG003|Study Period 3|Withdrawal by Subject|0|||
126512810|NCT01109316|455172300|FG004|Study Period 3|Withdrawal by Subject|1|||
126512811|NCT01109316|455172301|FG005|Study Period 3|Withdrawal by Subject|0|||
126512812|NCT01302392|455172304|FG000|Overall Study|Lost to Follow-up|1|||
126512813|NCT01302392|455172305|FG001|Overall Study|Lost to Follow-up|0|||
126512814|NCT01302392|455172304|FG000|Overall Study|Withdrawal by Subject|6|||
126512815|NCT01302392|455172305|FG001|Overall Study|Withdrawal by Subject|1|||
126512816|NCT00259857|455172306|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
126512817|NCT00259857|455172307|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
126512818|NCT00259857|455172306|FG000|24 Months Treatment|Lost to Follow-up|0|||
126512819|NCT00259857|455172307|FG001|24 Months Treatment|Lost to Follow-up|3|||
126512820|NCT00670228|455172308|FG000|Overall Study|Adverse Event|1|||
126512821|NCT00670228|455172309|FG001|Overall Study|Adverse Event|0|||
126512822|NCT00670228|455172308|FG000|Overall Study|Death or MACE|0|||
126512823|NCT00670228|455172309|FG001|Overall Study|Death or MACE|1|||
126512824|NCT00670228|455172308|FG000|Overall Study|Not treated|2|||
126512825|NCT00670228|455172309|FG001|Overall Study|Not treated|2|||
126512826|NCT00670228|455172308|FG000|Overall Study|Not meeting the selection criteria|2|||
126512827|NCT00670228|455172309|FG001|Overall Study|Not meeting the selection criteria|0|||
126512828|NCT03049813|455172320|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
126512829|NCT03049813|455172321|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
126512830|NCT03049813|455172322|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
126512831|NCT03049813|455172323|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
126512832|NCT03049813|455172320|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
126512833|NCT03049813|455172321|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
126512834|NCT03049813|455172322|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
126512835|NCT03049813|455172323|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
126512836|NCT03049813|455172320|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
126512837|NCT03049813|455172321|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
126512838|NCT03049813|455172322|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
126512839|NCT03049813|455172323|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
126512840|NCT03049813|455172320|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
126512841|NCT03049813|455172321|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
126512842|NCT03049813|455172322|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
126512843|NCT03049813|455172323|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
126512844|NCT01813019|455172324|FG000|Overall Study|Adverse Event|0|||
126512845|NCT01813019|455172325|FG001|Overall Study|Adverse Event|3|||
126512846|NCT01813019|455172324|FG000|Overall Study|Withdrawal by Subject|3|||
126512847|NCT01813019|455172325|FG001|Overall Study|Withdrawal by Subject|2|||
126512848|NCT01813019|455172324|FG000|Overall Study|administrative problems|2|||
126512849|NCT01813019|455172325|FG001|Overall Study|administrative problems|0|||
126512850|NCT01813019|455172324|FG000|Overall Study|Protocol Deviation|2|||
126512851|NCT01813019|455172325|FG001|Overall Study|Protocol Deviation|1|||
126512852|NCT01339390|455172334|FG000|Overall Study|Death|32|||
126512853|NCT01339390|455172335|FG001|Overall Study|Death|29|||
126512854|NCT01339390|455172334|FG000|Overall Study|Lost to Follow-up|125|||
126512855|NCT01339390|455172335|FG001|Overall Study|Lost to Follow-up|127|||
126512856|NCT04847674|455172336|FG000|Overall Study|Withdrawal by Subject|0|||
126512857|NCT04847674|455172337|FG001|Overall Study|Withdrawal by Subject|1|||
126512858|NCT04847674|455172338|FG002|Overall Study|Withdrawal by Subject|0|||
126512859|NCT04847674|455172336|FG000|Overall Study|Lost to Follow-up|0|||
126512860|NCT04847674|455172337|FG001|Overall Study|Lost to Follow-up|0|||
126512861|NCT04847674|455172338|FG002|Overall Study|Lost to Follow-up|2|||
126512862|NCT04847674|455172336|FG000|Overall Study|Other than specified|21|||
126512863|NCT04847674|455172337|FG001|Overall Study|Other than specified|20|||
126512864|NCT04847674|455172338|FG002|Overall Study|Other than specified|20|||
126512865|NCT02563028|455172340|FG000|Overall Study|Lack of equipment|1|||
126512866|NCT02563028|455172340|FG000|Overall Study|Unable to elicit VEP post induction|1|||
126512867|NCT04292730|455172348|FG000|Overall Study|Lost to Follow-up|8|||
126512868|NCT04292730|455172349|FG001|Overall Study|Lost to Follow-up|12|||
126512869|NCT04292730|455172350|FG002|Overall Study|Lost to Follow-up|12|||
126512870|NCT04292730|455172351|FG003|Overall Study|Lost to Follow-up|48|||
126727180|NCT00547378|455951075|FG002|Randomized Cohort|Death|0|||
126727181|NCT00547378|455951073|FG000|Randomized Cohort|Lost to Follow-up|1|||
126512871|NCT04292730|455172348|FG000|Overall Study|Death|2|||
126512872|NCT04292730|455172349|FG001|Overall Study|Death|2|||
126512873|NCT04292730|455172350|FG002|Overall Study|Death|4|||
126512874|NCT04292730|455172351|FG003|Overall Study|Death|12|||
126512875|NCT04292730|455172348|FG000|Overall Study|Withdrew Consent|2|||
126512876|NCT04292730|455172349|FG001|Overall Study|Withdrew Consent|2|||
126512877|NCT04292730|455172350|FG002|Overall Study|Withdrew Consent|5|||
126512878|NCT04292730|455172351|FG003|Overall Study|Withdrew Consent|6|||
126727182|NCT00547378|455951074|FG001|Randomized Cohort|Lost to Follow-up|0|||
126567860|NCT00241644|455373810|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
126567861|NCT00241644|455373811|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
126567862|NCT00241644|455373812|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
126567863|NCT00241644|455373813|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
126567864|NCT00241644|455373810|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
126567865|NCT00241644|455373811|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
126567866|NCT00241644|455373812|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
126567867|NCT00241644|455373813|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
126567868|NCT00241644|455373810|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
126567869|NCT00241644|455373811|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
126567870|NCT00241644|455373812|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
126567871|NCT00241644|455373813|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
126567872|NCT00241644|455373810|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
126567873|NCT00241644|455373811|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
126567874|NCT00241644|455373812|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
126567875|NCT00241644|455373813|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
126567876|NCT00241644|455373810|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
126567877|NCT00241644|455373811|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
126567878|NCT00241644|455373812|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
126567879|NCT00241644|455373813|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
126567880|NCT00241644|455373810|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
126567881|NCT00241644|455373811|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
126567882|NCT00241644|455373812|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
126567883|NCT00241644|455373813|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
126567884|NCT01027286|455373814|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
126567885|NCT01027286|455373815|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
126567886|NCT01027286|455373814|FG000|Overall Study|Lost to Follow-up|0|||
126567887|NCT01027286|455373815|FG001|Overall Study|Lost to Follow-up|1|||
126567888|NCT00545844|455373816|FG000|Overall Study|Lost to Follow-up|9|||
126567889|NCT00545844|455373816|FG000|Overall Study|Protocol Violation|1|||
126567890|NCT00545844|455373816|FG000|Overall Study|Withdrawal by Subject|2|||
126567891|NCT00975806|455373817|FG000|Overall Study|Adverse Event|2|||
126567892|NCT00975806|455373818|FG001|Overall Study|Adverse Event|1|||
126567893|NCT00975806|455373819|FG002|Overall Study|Adverse Event|2|||
126567894|NCT00975806|455373817|FG000|Overall Study|Disease Progression|1|||
126567895|NCT00975806|455373818|FG001|Overall Study|Disease Progression|5|||
126567896|NCT00975806|455373819|FG002|Overall Study|Disease Progression|1|||
126567897|NCT00975806|455373817|FG000|Overall Study|Withdrawal by Subject|1|||
126567898|NCT00975806|455373818|FG001|Overall Study|Withdrawal by Subject|0|||
126567899|NCT00975806|455373819|FG002|Overall Study|Withdrawal by Subject|0|||
126567900|NCT00975806|455373817|FG000|Overall Study|Death|0|||
126567901|NCT00975806|455373818|FG001|Overall Study|Death|1|||
126567902|NCT00975806|455373819|FG002|Overall Study|Death|0|||
126567903|NCT00975806|455373817|FG000|Overall Study|Physician decision and disease related|1|||
126567904|NCT00975806|455373818|FG001|Overall Study|Physician decision and disease related|0|||
126567905|NCT00975806|455373819|FG002|Overall Study|Physician decision and disease related|1|||
126776960|NCT01825876|456139127|FG000|Period 2|Withdrawal by Subject|0|||
126776961|NCT01825876|456139128|FG001|Period 2|Withdrawal by Subject|1|||
126567906|NCT00094809|455373820|FG000|Overall Study|Protocol deviation|2|||
126567907|NCT00094809|455373821|FG001|Overall Study|Protocol deviation|2|||
126567908|NCT00094809|455373820|FG000|Overall Study|Noncompliance|1|||
126567909|NCT00094809|455373821|FG001|Overall Study|Noncompliance|0|||
126567910|NCT00094809|455373820|FG000|Overall Study|Adverse Event|3|||
126567911|NCT00094809|455373821|FG001|Overall Study|Adverse Event|1|||
126567912|NCT00094809|455373820|FG000|Overall Study|Withdrawal by Subject|8|||
126567913|NCT00094809|455373821|FG001|Overall Study|Withdrawal by Subject|9|||
126567914|NCT00094809|455373820|FG000|Overall Study|Disease progression|3|||
126567915|NCT00094809|455373821|FG001|Overall Study|Disease progression|3|||
126567916|NCT00094809|455373820|FG000|Overall Study|Physician Decision|3|||
126567917|NCT00094809|455373821|FG001|Overall Study|Physician Decision|5|||
126567918|NCT00094809|455373820|FG000|Overall Study|Lost to Follow-up|6|||
126567919|NCT00094809|455373821|FG001|Overall Study|Lost to Follow-up|6|||
126567920|NCT00094809|455373820|FG000|Overall Study|Death|19|||
126567921|NCT00094809|455373821|FG001|Overall Study|Death|25|||
126567922|NCT00094809|455373820|FG000|Overall Study|Protocol-specified criteria|1|||
126567923|NCT00094809|455373821|FG001|Overall Study|Protocol-specified criteria|1|||
126567924|NCT00094809|455373820|FG000|Overall Study|Other|2|||
126567925|NCT00094809|455373821|FG001|Overall Study|Other|4|||
126567926|NCT00094809|455373820|FG000|Overall Study|Informed consent signed after treatment|1|||
126567927|NCT00094809|455373821|FG001|Overall Study|Informed consent signed after treatment|0|||
126567928|NCT00094809|455373820|FG000|Overall Study|Study drug not received|2|||
126567929|NCT00094809|455373821|FG001|Overall Study|Study drug not received|8|||
126567930|NCT00094809|455373820|FG000|Overall Study|Other|1|||
126776962|NCT04133519|456139133|FG000|Overall Study|Withdrawal by Subject|5|||
126567931|NCT00094809|455373821|FG001|Overall Study|Other|1|||
126567932|NCT02377362|455373822|FG000|Part A Second Treatment|Protocol Violation|0|||
126567933|NCT02377362|455373823|FG001|Part A Second Treatment|Protocol Violation|0|||
126567934|NCT02377362|455373824|FG002|Part A Second Treatment|Protocol Violation|0|||
126567935|NCT02377362|455373825|FG003|Part A Second Treatment|Protocol Violation|0|||
126567936|NCT02377362|455373826|FG004|Part A Second Treatment|Protocol Violation|1|||
126567937|NCT02377362|455373827|FG005|Part A Second Treatment|Protocol Violation|0|||
126567938|NCT02377362|455373828|FG006|Part A Second Treatment|Protocol Violation|0|||
126567939|NCT02377362|455373829|FG007|Part A Second Treatment|Protocol Violation|0|||
126567940|NCT02377362|455373830|FG008|Part A Second Treatment|Protocol Violation|0|||
126567941|NCT02377362|455373831|FG009|Part A Second Treatment|Protocol Violation|0|||
126567942|NCT02377362|455373832|FG010|Part A Second Treatment|Protocol Violation|0|||
126567943|NCT02377362|455373833|FG011|Part A Second Treatment|Protocol Violation|0|||
126567944|NCT02377362|455373834|FG012|Part A Second Treatment|Protocol Violation|0|||
126567945|NCT02377362|455373822|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
126567946|NCT02377362|455373823|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
126567947|NCT02377362|455373824|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
126567948|NCT02377362|455373825|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
126567949|NCT02377362|455373826|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
126567950|NCT02377362|455373827|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
126567951|NCT02377362|455373828|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
126567952|NCT02377362|455373829|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
126567953|NCT02377362|455373830|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
126567954|NCT02377362|455373831|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
126567955|NCT02377362|455373832|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
126567956|NCT02377362|455373833|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
126567957|NCT02377362|455373834|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
126567958|NCT02377362|455373822|FG000|Part B Overall|Protocol Violation|0|||
126567959|NCT02377362|455373823|FG001|Part B Overall|Protocol Violation|0|||
126567960|NCT02377362|455373824|FG002|Part B Overall|Protocol Violation|0|||
126567961|NCT02377362|455373825|FG003|Part B Overall|Protocol Violation|0|||
126567962|NCT02377362|455373826|FG004|Part B Overall|Protocol Violation|0|||
126567963|NCT02377362|455373827|FG005|Part B Overall|Protocol Violation|0|||
126567964|NCT02377362|455373828|FG006|Part B Overall|Protocol Violation|0|||
126567965|NCT02377362|455373829|FG007|Part B Overall|Protocol Violation|0|||
126567966|NCT02377362|455373830|FG008|Part B Overall|Protocol Violation|0|||
126512879|NCT04292730|455172348|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126512880|NCT04292730|455172349|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126512881|NCT04292730|455172350|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126512882|NCT04292730|455172351|FG003|Overall Study|Non-Compliance with Study Drug|0|||
126512883|NCT04292730|455172348|FG000|Overall Study|Protocol Violation|0|||
126512884|NCT04292730|455172349|FG001|Overall Study|Protocol Violation|0|||
126512885|NCT04292730|455172350|FG002|Overall Study|Protocol Violation|1|||
126512886|NCT04292730|455172351|FG003|Overall Study|Protocol Violation|0|||
126512887|NCT04292730|455172348|FG000|Overall Study|Randomized but not Treated|8|||
126512888|NCT04292730|455172349|FG001|Overall Study|Randomized but not Treated|4|||
126512889|NCT04292730|455172350|FG002|Overall Study|Randomized but not Treated|0|||
126512890|NCT04292730|455172351|FG003|Overall Study|Randomized but not Treated|14|||
126512891|NCT01527292|455172353|FG000|Overall Study|Physician Decision|0|||
126512892|NCT01527292|455172354|FG001|Overall Study|Physician Decision|3|||
126512893|NCT02553421|455172356|FG000|Overall Study|Lost to Follow-up|21|||
126512894|NCT02553421|455172357|FG001|Overall Study|Lost to Follow-up|1|||
126512895|NCT02553421|455172356|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
126512896|NCT02553421|455172357|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
126512897|NCT02553421|455172356|FG000|Overall Study|Improper Device Placement|3|||
126512898|NCT02553421|455172357|FG001|Overall Study|Improper Device Placement|0|||
126512899|NCT03551210|455172359|FG000|Overall Study|Adverse Event|5|||
126512900|NCT03551210|455172360|FG001|Overall Study|Adverse Event|6|||
126512901|NCT03551210|455172359|FG000|Overall Study|Withdrawal by Subject|1|||
126512902|NCT03551210|455172360|FG001|Overall Study|Withdrawal by Subject|7|||
126512903|NCT03551210|455172359|FG000|Overall Study|Needed in other antibiotic treatment|2|||
126512904|NCT03551210|455172360|FG001|Overall Study|Needed in other antibiotic treatment|5|||
126512905|NCT03551210|455172359|FG000|Overall Study|Lost to Follow-up|1|||
126512906|NCT03551210|455172360|FG001|Overall Study|Lost to Follow-up|1|||
126512907|NCT03551210|455172359|FG000|Overall Study|Absence of visit 4 and 5|1|||
126512908|NCT03551210|455172360|FG001|Overall Study|Absence of visit 4 and 5|0|||
126512909|NCT03551210|455172359|FG000|Overall Study|No drug for dispensing|0|||
126512910|NCT03551210|455172360|FG001|Overall Study|No drug for dispensing|1|||
126512911|NCT03013491|455172361|FG000|Main Study|Death|2|||
126512912|NCT03013491|455172362|FG001|Main Study|Death|2|||
126512913|NCT03013491|455172363|FG002|Main Study|Death|5|||
126512914|NCT03013491|455172364|FG003|Main Study|Death|3|||
126512915|NCT03013491|455172365|FG004|Main Study|Death|9|||
126512916|NCT03013491|455172366|FG005|Main Study|Death|12|||
126512917|NCT03013491|455172367|FG006|Main Study|Death|3|||
126567967|NCT02377362|455373831|FG009|Part B Overall|Protocol Violation|1|||
126567968|NCT02377362|455373832|FG010|Part B Overall|Protocol Violation|0|||
126567969|NCT02377362|455373833|FG011|Part B Overall|Protocol Violation|0|||
126567970|NCT02377362|455373834|FG012|Part B Overall|Protocol Violation|0|||
126567971|NCT02377362|455373822|FG000|Part B Overall|Adverse Event|0|||
126567972|NCT02377362|455373823|FG001|Part B Overall|Adverse Event|0|||
126567973|NCT02377362|455373824|FG002|Part B Overall|Adverse Event|0|||
126567974|NCT02377362|455373825|FG003|Part B Overall|Adverse Event|0|||
126567975|NCT02377362|455373826|FG004|Part B Overall|Adverse Event|0|||
126567976|NCT02377362|455373827|FG005|Part B Overall|Adverse Event|0|||
126567977|NCT02377362|455373828|FG006|Part B Overall|Adverse Event|1|||
126567978|NCT02377362|455373829|FG007|Part B Overall|Adverse Event|1|||
126567979|NCT02377362|455373830|FG008|Part B Overall|Adverse Event|0|||
126567980|NCT02377362|455373831|FG009|Part B Overall|Adverse Event|0|||
126567981|NCT02377362|455373832|FG010|Part B Overall|Adverse Event|0|||
126567982|NCT02377362|455373833|FG011|Part B Overall|Adverse Event|0|||
126567983|NCT02377362|455373834|FG012|Part B Overall|Adverse Event|0|||
126567984|NCT02377362|455373822|FG000|Part B Overall|Withdrawal by Subject|0|||
126567985|NCT02377362|455373823|FG001|Part B Overall|Withdrawal by Subject|0|||
126567986|NCT02377362|455373824|FG002|Part B Overall|Withdrawal by Subject|0|||
126567987|NCT02377362|455373825|FG003|Part B Overall|Withdrawal by Subject|0|||
126567988|NCT02377362|455373826|FG004|Part B Overall|Withdrawal by Subject|0|||
126567989|NCT02377362|455373827|FG005|Part B Overall|Withdrawal by Subject|0|||
126567990|NCT02377362|455373828|FG006|Part B Overall|Withdrawal by Subject|1|||
126567991|NCT02377362|455373829|FG007|Part B Overall|Withdrawal by Subject|0|||
126567992|NCT02377362|455373830|FG008|Part B Overall|Withdrawal by Subject|0|||
126567993|NCT02377362|455373831|FG009|Part B Overall|Withdrawal by Subject|0|||
126567994|NCT02377362|455373832|FG010|Part B Overall|Withdrawal by Subject|0|||
126567995|NCT02377362|455373833|FG011|Part B Overall|Withdrawal by Subject|1|||
126567996|NCT02377362|455373834|FG012|Part B Overall|Withdrawal by Subject|0|||
126567997|NCT02503202|455373835|FG000|Base Study: Up to Month 6|Death|1|||
126567998|NCT02503202|455373836|FG001|Base Study: Up to Month 6|Death|1|||
126567999|NCT02503202|455373837|FG002|Base Study: Up to Month 6|Death|0|||
126568000|NCT02503202|455373838|FG003|Base Study: Up to Month 6|Death|0|||
126568001|NCT02503202|455373839|FG004|Base Study: Up to Month 6|Death|0|||
126568002|NCT02503202|455373835|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
126568003|NCT02503202|455373836|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
126568004|NCT02503202|455373837|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
126568005|NCT02503202|455373838|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
126568006|NCT02503202|455373839|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
126568007|NCT02503202|455373835|FG000|Base Study: Up to Month 6|Physician Decision|0|||
126568008|NCT02503202|455373836|FG001|Base Study: Up to Month 6|Physician Decision|0|||
126568009|NCT02503202|455373837|FG002|Base Study: Up to Month 6|Physician Decision|0|||
126568010|NCT02503202|455373838|FG003|Base Study: Up to Month 6|Physician Decision|0|||
126568011|NCT02503202|455373839|FG004|Base Study: Up to Month 6|Physician Decision|1|||
126568012|NCT02503202|455373835|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
126568013|NCT02503202|455373836|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
126568014|NCT02503202|455373837|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
126568015|NCT02503202|455373838|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
126568016|NCT02503202|455373839|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
126568017|NCT02503202|455373835|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
126568018|NCT02503202|455373836|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
126568019|NCT02503202|455373837|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
126568020|NCT02503202|455373838|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
126512918|NCT03013491|455172368|FG007|Main Study|Death|5|||
126512919|NCT03013491|455172369|FG008|Main Study|Death|1|||
126512920|NCT03013491|455172370|FG009|Main Study|Death|2|||
126512921|NCT03013491|455172371|FG010|Main Study|Death|4|||
126512922|NCT03013491|455172372|FG011|Main Study|Death|1|||
126512923|NCT03013491|455172373|FG012|Main Study|Death|1|||
126512924|NCT03013491|455172374|FG013|Main Study|Death|4|||
126512925|NCT03013491|455172375|FG014|Main Study|Death|0|||
126512926|NCT03013491|455172376|FG015|Main Study|Death|3|||
126512927|NCT03013491|455172377|FG016|Main Study|Death|5|||
126512928|NCT03013491|455172378|FG017|Main Study|Death|1|||
126568021|NCT02503202|455373839|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
126568022|NCT02503202|455373835|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
126568023|NCT02503202|455373836|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
126568024|NCT02503202|455373837|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
126568025|NCT02503202|455373838|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
126512929|NCT03013491|455172379|FG018|Main Study|Death|47|||
126512930|NCT03013491|455172361|FG000|Main Study|Lost to Follow-up|0|||
126512931|NCT03013491|455172362|FG001|Main Study|Lost to Follow-up|0|||
126512932|NCT03013491|455172363|FG002|Main Study|Lost to Follow-up|1|||
126512933|NCT03013491|455172364|FG003|Main Study|Lost to Follow-up|0|||
126568026|NCT02503202|455373839|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
126568027|NCT02503202|455373835|FG000|Extension: Month 6 to 24|Death|1|||
126568028|NCT02503202|455373836|FG001|Extension: Month 6 to 24|Death|0|||
126512934|NCT03013491|455172365|FG004|Main Study|Lost to Follow-up|1|||
126512935|NCT03013491|455172366|FG005|Main Study|Lost to Follow-up|0|||
126512936|NCT03013491|455172367|FG006|Main Study|Lost to Follow-up|0|||
126512937|NCT03013491|455172368|FG007|Main Study|Lost to Follow-up|0|||
126512938|NCT03013491|455172369|FG008|Main Study|Lost to Follow-up|0|||
126512939|NCT03013491|455172370|FG009|Main Study|Lost to Follow-up|0|||
126512940|NCT03013491|455172371|FG010|Main Study|Lost to Follow-up|0|||
126512941|NCT03013491|455172372|FG011|Main Study|Lost to Follow-up|0|||
126512942|NCT03013491|455172373|FG012|Main Study|Lost to Follow-up|0|||
126512943|NCT03013491|455172374|FG013|Main Study|Lost to Follow-up|0|||
126512944|NCT03013491|455172375|FG014|Main Study|Lost to Follow-up|0|||
126512945|NCT03013491|455172376|FG015|Main Study|Lost to Follow-up|0|||
126512946|NCT03013491|455172377|FG016|Main Study|Lost to Follow-up|0|||
126512947|NCT03013491|455172378|FG017|Main Study|Lost to Follow-up|0|||
126512948|NCT03013491|455172379|FG018|Main Study|Lost to Follow-up|3|||
126512949|NCT03013491|455172361|FG000|Main Study|Termination of the study by Sponsor|0|||
126512950|NCT03013491|455172362|FG001|Main Study|Termination of the study by Sponsor|0|||
126512951|NCT03013491|455172363|FG002|Main Study|Termination of the study by Sponsor|2|||
126512952|NCT03013491|455172364|FG003|Main Study|Termination of the study by Sponsor|0|||
126512953|NCT03013491|455172365|FG004|Main Study|Termination of the study by Sponsor|1|||
126512954|NCT03013491|455172366|FG005|Main Study|Termination of the study by Sponsor|2|||
126512955|NCT03013491|455172367|FG006|Main Study|Termination of the study by Sponsor|0|||
126512956|NCT03013491|455172368|FG007|Main Study|Termination of the study by Sponsor|0|||
126512957|NCT03013491|455172369|FG008|Main Study|Termination of the study by Sponsor|1|||
126512958|NCT03013491|455172370|FG009|Main Study|Termination of the study by Sponsor|1|||
126512959|NCT03013491|455172371|FG010|Main Study|Termination of the study by Sponsor|1|||
126512960|NCT03013491|455172372|FG011|Main Study|Termination of the study by Sponsor|2|||
126512961|NCT03013491|455172373|FG012|Main Study|Termination of the study by Sponsor|0|||
126512962|NCT03013491|455172374|FG013|Main Study|Termination of the study by Sponsor|0|||
126512963|NCT03013491|455172375|FG014|Main Study|Termination of the study by Sponsor|0|||
126512964|NCT03013491|455172376|FG015|Main Study|Termination of the study by Sponsor|0|||
126512965|NCT03013491|455172377|FG016|Main Study|Termination of the study by Sponsor|0|||
126512966|NCT03013491|455172378|FG017|Main Study|Termination of the study by Sponsor|1|||
126512967|NCT03013491|455172379|FG018|Main Study|Termination of the study by Sponsor|13|||
126512968|NCT03013491|455172361|FG000|Main Study|Withdrawal by Subject|0|||
126512969|NCT03013491|455172362|FG001|Main Study|Withdrawal by Subject|0|||
126512970|NCT03013491|455172363|FG002|Main Study|Withdrawal by Subject|0|||
126512971|NCT03013491|455172364|FG003|Main Study|Withdrawal by Subject|4|||
126512972|NCT03013491|455172365|FG004|Main Study|Withdrawal by Subject|2|||
126512973|NCT03013491|455172366|FG005|Main Study|Withdrawal by Subject|1|||
126512974|NCT03013491|455172367|FG006|Main Study|Withdrawal by Subject|0|||
126512975|NCT03013491|455172368|FG007|Main Study|Withdrawal by Subject|0|||
126512976|NCT03013491|455172369|FG008|Main Study|Withdrawal by Subject|0|||
126512977|NCT03013491|455172370|FG009|Main Study|Withdrawal by Subject|0|||
126512978|NCT03013491|455172371|FG010|Main Study|Withdrawal by Subject|1|||
126512979|NCT03013491|455172372|FG011|Main Study|Withdrawal by Subject|2|||
126512980|NCT03013491|455172373|FG012|Main Study|Withdrawal by Subject|0|||
126512981|NCT03013491|455172374|FG013|Main Study|Withdrawal by Subject|2|||
126512982|NCT03013491|455172375|FG014|Main Study|Withdrawal by Subject|0|||
126512983|NCT03013491|455172376|FG015|Main Study|Withdrawal by Subject|0|||
126512984|NCT03013491|455172377|FG016|Main Study|Withdrawal by Subject|0|||
126512985|NCT03013491|455172378|FG017|Main Study|Withdrawal by Subject|0|||
126512986|NCT03013491|455172379|FG018|Main Study|Withdrawal by Subject|18|||
126512987|NCT03013491|455172361|FG000|Main Study|Disease progression|0|||
126512988|NCT03013491|455172362|FG001|Main Study|Disease progression|0|||
126512989|NCT03013491|455172363|FG002|Main Study|Disease progression|0|||
126512990|NCT03013491|455172364|FG003|Main Study|Disease progression|1|||
126512991|NCT03013491|455172365|FG004|Main Study|Disease progression|0|||
126512992|NCT03013491|455172366|FG005|Main Study|Disease progression|0|||
126512993|NCT03013491|455172367|FG006|Main Study|Disease progression|0|||
126512994|NCT03013491|455172368|FG007|Main Study|Disease progression|0|||
126512995|NCT03013491|455172369|FG008|Main Study|Disease progression|1|||
126512996|NCT03013491|455172370|FG009|Main Study|Disease progression|0|||
126512997|NCT03013491|455172371|FG010|Main Study|Disease progression|1|||
126512998|NCT03013491|455172372|FG011|Main Study|Disease progression|0|||
126512999|NCT03013491|455172373|FG012|Main Study|Disease progression|0|||
126513000|NCT03013491|455172374|FG013|Main Study|Disease progression|0|||
126513001|NCT03013491|455172375|FG014|Main Study|Disease progression|0|||
126513002|NCT03013491|455172376|FG015|Main Study|Disease progression|0|||
126513003|NCT03013491|455172377|FG016|Main Study|Disease progression|0|||
126513004|NCT03013491|455172378|FG017|Main Study|Disease progression|0|||
126513005|NCT03013491|455172379|FG018|Main Study|Disease progression|4|||
126513006|NCT03013491|455172361|FG000|Main Study|Symptomatic deterioration|0|||
126513007|NCT03013491|455172362|FG001|Main Study|Symptomatic deterioration|0|||
126513008|NCT03013491|455172363|FG002|Main Study|Symptomatic deterioration|0|||
126513009|NCT03013491|455172364|FG003|Main Study|Symptomatic deterioration|0|||
126513010|NCT03013491|455172365|FG004|Main Study|Symptomatic deterioration|0|||
126513011|NCT03013491|455172366|FG005|Main Study|Symptomatic deterioration|1|||
126513012|NCT03013491|455172367|FG006|Main Study|Symptomatic deterioration|0|||
126513013|NCT03013491|455172368|FG007|Main Study|Symptomatic deterioration|0|||
126513014|NCT03013491|455172369|FG008|Main Study|Symptomatic deterioration|0|||
126513015|NCT03013491|455172370|FG009|Main Study|Symptomatic deterioration|0|||
126513016|NCT03013491|455172371|FG010|Main Study|Symptomatic deterioration|0|||
126513017|NCT03013491|455172372|FG011|Main Study|Symptomatic deterioration|0|||
126513018|NCT03013491|455172373|FG012|Main Study|Symptomatic deterioration|0|||
126513019|NCT03013491|455172374|FG013|Main Study|Symptomatic deterioration|0|||
126513020|NCT03013491|455172375|FG014|Main Study|Symptomatic deterioration|0|||
126513021|NCT03013491|455172376|FG015|Main Study|Symptomatic deterioration|0|||
126513022|NCT03013491|455172377|FG016|Main Study|Symptomatic deterioration|0|||
126513023|NCT03013491|455172378|FG017|Main Study|Symptomatic deterioration|0|||
126513024|NCT03013491|455172379|FG018|Main Study|Symptomatic deterioration|0|||
126513025|NCT03013491|455172361|FG000|Main Study|Protocol version 8.0 approval|0|||
126513026|NCT03013491|455172362|FG001|Main Study|Protocol version 8.0 approval|0|||
126513027|NCT03013491|455172363|FG002|Main Study|Protocol version 8.0 approval|0|||
126513028|NCT03013491|455172364|FG003|Main Study|Protocol version 8.0 approval|0|||
126513029|NCT03013491|455172365|FG004|Main Study|Protocol version 8.0 approval|0|||
126513030|NCT03013491|455172366|FG005|Main Study|Protocol version 8.0 approval|0|||
126513031|NCT03013491|455172367|FG006|Main Study|Protocol version 8.0 approval|0|||
126513032|NCT03013491|455172368|FG007|Main Study|Protocol version 8.0 approval|0|||
126513033|NCT03013491|455172369|FG008|Main Study|Protocol version 8.0 approval|0|||
126513034|NCT03013491|455172370|FG009|Main Study|Protocol version 8.0 approval|0|||
126513035|NCT03013491|455172371|FG010|Main Study|Protocol version 8.0 approval|1|||
126513036|NCT03013491|455172372|FG011|Main Study|Protocol version 8.0 approval|0|||
126513037|NCT03013491|455172373|FG012|Main Study|Protocol version 8.0 approval|0|||
126513038|NCT03013491|455172374|FG013|Main Study|Protocol version 8.0 approval|0|||
126513039|NCT03013491|455172375|FG014|Main Study|Protocol version 8.0 approval|0|||
126513040|NCT03013491|455172376|FG015|Main Study|Protocol version 8.0 approval|0|||
126513041|NCT03013491|455172377|FG016|Main Study|Protocol version 8.0 approval|0|||
126513042|NCT03013491|455172378|FG017|Main Study|Protocol version 8.0 approval|0|||
126513043|NCT03013491|455172379|FG018|Main Study|Protocol version 8.0 approval|0|||
126513044|NCT03013491|455172361|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
126513045|NCT03013491|455172362|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
126513046|NCT03013491|455172363|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
126513047|NCT03013491|455172364|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
126513048|NCT03013491|455172365|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
126513049|NCT03013491|455172366|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
126513050|NCT03013491|455172367|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
126513051|NCT03013491|455172368|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
126513052|NCT03013491|455172369|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
126513053|NCT03013491|455172370|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
126513054|NCT03013491|455172371|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
126513055|NCT03013491|455172372|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
126513056|NCT03013491|455172373|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
126513057|NCT03013491|455172374|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
126513058|NCT03013491|455172375|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
126513059|NCT03013491|455172376|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
126513060|NCT03013491|455172377|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
126513061|NCT03013491|455172378|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
126513062|NCT03013491|455172379|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
126513063|NCT03013491|455172361|FG000|Main Study|Start of new anticancer therapy|0|||
126513064|NCT03013491|455172362|FG001|Main Study|Start of new anticancer therapy|0|||
126513065|NCT03013491|455172363|FG002|Main Study|Start of new anticancer therapy|0|||
126513066|NCT03013491|455172364|FG003|Main Study|Start of new anticancer therapy|0|||
126513067|NCT03013491|455172365|FG004|Main Study|Start of new anticancer therapy|0|||
126513068|NCT03013491|455172366|FG005|Main Study|Start of new anticancer therapy|0|||
126513069|NCT03013491|455172367|FG006|Main Study|Start of new anticancer therapy|0|||
126513070|NCT03013491|455172368|FG007|Main Study|Start of new anticancer therapy|0|||
126513071|NCT03013491|455172369|FG008|Main Study|Start of new anticancer therapy|0|||
126513072|NCT03013491|455172370|FG009|Main Study|Start of new anticancer therapy|0|||
126513073|NCT03013491|455172371|FG010|Main Study|Start of new anticancer therapy|0|||
126513074|NCT03013491|455172372|FG011|Main Study|Start of new anticancer therapy|0|||
126513075|NCT03013491|455172373|FG012|Main Study|Start of new anticancer therapy|0|||
126513076|NCT03013491|455172374|FG013|Main Study|Start of new anticancer therapy|0|||
126513077|NCT03013491|455172375|FG014|Main Study|Start of new anticancer therapy|0|||
126513078|NCT03013491|455172376|FG015|Main Study|Start of new anticancer therapy|0|||
126513079|NCT03013491|455172377|FG016|Main Study|Start of new anticancer therapy|0|||
126513080|NCT03013491|455172378|FG017|Main Study|Start of new anticancer therapy|0|||
126513081|NCT03013491|455172379|FG018|Main Study|Start of new anticancer therapy|2|||
126513082|NCT03013491|455172361|FG000|Long-term Extension|Disease progression|0|||
126513083|NCT03013491|455172362|FG001|Long-term Extension|Disease progression|0|||
126513084|NCT03013491|455172363|FG002|Long-term Extension|Disease progression|0|||
126513085|NCT03013491|455172364|FG003|Long-term Extension|Disease progression|1|||
126513086|NCT03013491|455172365|FG004|Long-term Extension|Disease progression|0|||
126513087|NCT03013491|455172366|FG005|Long-term Extension|Disease progression|0|||
126513088|NCT03013491|455172367|FG006|Long-term Extension|Disease progression|0|||
126513089|NCT03013491|455172368|FG007|Long-term Extension|Disease progression|0|||
126513090|NCT03013491|455172369|FG008|Long-term Extension|Disease progression|0|||
126513091|NCT03013491|455172370|FG009|Long-term Extension|Disease progression|0|||
126513092|NCT03013491|455172371|FG010|Long-term Extension|Disease progression|0|||
126513093|NCT03013491|455172372|FG011|Long-term Extension|Disease progression|0|||
126513094|NCT03013491|455172373|FG012|Long-term Extension|Disease progression|0|||
126513095|NCT03013491|455172374|FG013|Long-term Extension|Disease progression|0|||
126513096|NCT03013491|455172375|FG014|Long-term Extension|Disease progression|0|||
126513097|NCT03013491|455172376|FG015|Long-term Extension|Disease progression|0|||
126513098|NCT03013491|455172377|FG016|Long-term Extension|Disease progression|0|||
126513099|NCT03013491|455172378|FG017|Long-term Extension|Disease progression|0|||
126513100|NCT03013491|455172379|FG018|Long-term Extension|Disease progression|1|||
126513101|NCT03013491|455172361|FG000|Long-term Extension|Withdrawal by Subject|0|||
126513102|NCT03013491|455172362|FG001|Long-term Extension|Withdrawal by Subject|0|||
126513103|NCT03013491|455172363|FG002|Long-term Extension|Withdrawal by Subject|0|||
126513104|NCT03013491|455172364|FG003|Long-term Extension|Withdrawal by Subject|0|||
126513105|NCT03013491|455172365|FG004|Long-term Extension|Withdrawal by Subject|0|||
126513106|NCT03013491|455172366|FG005|Long-term Extension|Withdrawal by Subject|0|||
126513107|NCT03013491|455172367|FG006|Long-term Extension|Withdrawal by Subject|0|||
126513108|NCT03013491|455172368|FG007|Long-term Extension|Withdrawal by Subject|1|||
126513109|NCT03013491|455172369|FG008|Long-term Extension|Withdrawal by Subject|0|||
126513110|NCT03013491|455172370|FG009|Long-term Extension|Withdrawal by Subject|0|||
126513111|NCT03013491|455172371|FG010|Long-term Extension|Withdrawal by Subject|0|||
126513112|NCT03013491|455172372|FG011|Long-term Extension|Withdrawal by Subject|0|||
126513113|NCT03013491|455172373|FG012|Long-term Extension|Withdrawal by Subject|0|||
126513114|NCT03013491|455172374|FG013|Long-term Extension|Withdrawal by Subject|0|||
126513115|NCT03013491|455172375|FG014|Long-term Extension|Withdrawal by Subject|0|||
126513116|NCT03013491|455172376|FG015|Long-term Extension|Withdrawal by Subject|0|||
126513117|NCT03013491|455172377|FG016|Long-term Extension|Withdrawal by Subject|0|||
126513118|NCT03013491|455172378|FG017|Long-term Extension|Withdrawal by Subject|0|||
126513119|NCT03013491|455172379|FG018|Long-term Extension|Withdrawal by Subject|0|||
126513120|NCT03013491|455172361|FG000|Long-term Extension|Adverse Event|0|||
126513121|NCT03013491|455172362|FG001|Long-term Extension|Adverse Event|0|||
126513122|NCT03013491|455172363|FG002|Long-term Extension|Adverse Event|0|||
126513123|NCT03013491|455172364|FG003|Long-term Extension|Adverse Event|0|||
126513124|NCT03013491|455172365|FG004|Long-term Extension|Adverse Event|0|||
126513125|NCT03013491|455172366|FG005|Long-term Extension|Adverse Event|0|||
126513126|NCT03013491|455172367|FG006|Long-term Extension|Adverse Event|0|||
126513127|NCT03013491|455172368|FG007|Long-term Extension|Adverse Event|0|||
126513128|NCT03013491|455172369|FG008|Long-term Extension|Adverse Event|0|||
126513129|NCT03013491|455172370|FG009|Long-term Extension|Adverse Event|0|||
126513130|NCT03013491|455172371|FG010|Long-term Extension|Adverse Event|0|||
126513131|NCT03013491|455172372|FG011|Long-term Extension|Adverse Event|0|||
126513132|NCT03013491|455172373|FG012|Long-term Extension|Adverse Event|0|||
126513133|NCT03013491|455172374|FG013|Long-term Extension|Adverse Event|0|||
126513134|NCT03013491|455172375|FG014|Long-term Extension|Adverse Event|0|||
126513135|NCT03013491|455172376|FG015|Long-term Extension|Adverse Event|0|||
126513136|NCT03013491|455172377|FG016|Long-term Extension|Adverse Event|0|||
126513137|NCT03013491|455172378|FG017|Long-term Extension|Adverse Event|0|||
126513138|NCT03013491|455172379|FG018|Long-term Extension|Adverse Event|1|||
126513139|NCT03013491|455172361|FG000|Long-term Extension|Death|0|||
126513140|NCT03013491|455172362|FG001|Long-term Extension|Death|0|||
126513141|NCT03013491|455172363|FG002|Long-term Extension|Death|0|||
126513142|NCT03013491|455172364|FG003|Long-term Extension|Death|0|||
126513143|NCT03013491|455172365|FG004|Long-term Extension|Death|0|||
126513144|NCT03013491|455172366|FG005|Long-term Extension|Death|0|||
126513145|NCT03013491|455172367|FG006|Long-term Extension|Death|0|||
126513146|NCT03013491|455172368|FG007|Long-term Extension|Death|0|||
126513147|NCT03013491|455172369|FG008|Long-term Extension|Death|0|||
126513148|NCT03013491|455172370|FG009|Long-term Extension|Death|0|||
126513149|NCT03013491|455172371|FG010|Long-term Extension|Death|0|||
126513150|NCT03013491|455172372|FG011|Long-term Extension|Death|0|||
126513151|NCT03013491|455172373|FG012|Long-term Extension|Death|0|||
126513152|NCT03013491|455172374|FG013|Long-term Extension|Death|0|||
126513153|NCT03013491|455172375|FG014|Long-term Extension|Death|0|||
126513154|NCT03013491|455172376|FG015|Long-term Extension|Death|0|||
126513155|NCT03013491|455172377|FG016|Long-term Extension|Death|0|||
126513156|NCT03013491|455172378|FG017|Long-term Extension|Death|0|||
126513157|NCT03013491|455172379|FG018|Long-term Extension|Death|1|||
126513158|NCT03265119|455172380|FG000|Overall Study|Adverse Event|2|||
126513159|NCT03265119|455172381|FG001|Overall Study|Adverse Event|1|||
126513160|NCT03265119|455172380|FG000|Overall Study|Lack of Efficacy|3|||
126568029|NCT02503202|455373837|FG002|Extension: Month 6 to 24|Death|0|||
126568030|NCT02503202|455373838|FG003|Extension: Month 6 to 24|Death|0|||
126568031|NCT02503202|455373839|FG004|Extension: Month 6 to 24|Death|0|||
126568032|NCT02503202|455373835|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
126568033|NCT02503202|455373836|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
126568034|NCT02503202|455373837|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
126568035|NCT02503202|455373838|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
126568036|NCT02503202|455373839|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
126568037|NCT02503202|455373835|FG000|Extension: Month 6 to 24|Physician Decision|1|||
126568038|NCT02503202|455373836|FG001|Extension: Month 6 to 24|Physician Decision|0|||
126568039|NCT02503202|455373837|FG002|Extension: Month 6 to 24|Physician Decision|1|||
126568040|NCT02503202|455373838|FG003|Extension: Month 6 to 24|Physician Decision|3|||
126568041|NCT02503202|455373839|FG004|Extension: Month 6 to 24|Physician Decision|0|||
126568042|NCT02503202|455373835|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
126568043|NCT02503202|455373836|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
126568044|NCT02503202|455373837|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
126568045|NCT02503202|455373838|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
126568046|NCT02503202|455373839|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
126568047|NCT00906035|455373841|FG000|Overall Study|Withdrawal by Subject|2|||
126513161|NCT03265119|455172381|FG001|Overall Study|Lack of Efficacy|0|||
126513162|NCT03265119|455172380|FG000|Overall Study|Protocol Violation|1|||
126513163|NCT03265119|455172381|FG001|Overall Study|Protocol Violation|2|||
126513164|NCT03265119|455172380|FG000|Overall Study|Withdrawal by Subject|2|||
126513165|NCT03265119|455172381|FG001|Overall Study|Withdrawal by Subject|4|||
126513166|NCT03265119|455172380|FG000|Overall Study|Lost to Follow-up|1|||
126513167|NCT03265119|455172381|FG001|Overall Study|Lost to Follow-up|0|||
126513168|NCT03265119|455172380|FG000|Overall Study|Lack of Compliance|1|||
126513169|NCT03265119|455172381|FG001|Overall Study|Lack of Compliance|0|||
126513170|NCT03238911|455172384|FG000|Overall Study|Withdrawal by Subject|1|||
126513171|NCT03238911|455172385|FG001|Overall Study|Withdrawal by Subject|2|||
126513172|NCT03238911|455172384|FG000|Overall Study|Lost to Follow-up|2|||
126513173|NCT03238911|455172385|FG001|Overall Study|Lost to Follow-up|1|||
126513174|NCT03655236|455172386|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
126513175|NCT03655236|455172387|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
126513176|NCT03655236|455172388|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
126513177|NCT03655236|455172386|FG000|Subject Disposition in Part 1 Period|Death|1|||
126513178|NCT03655236|455172387|FG001|Subject Disposition in Part 1 Period|Death|0|||
126513179|NCT03655236|455172388|FG002|Subject Disposition in Part 1 Period|Death|0|||
126513180|NCT03655236|455172386|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
126513181|NCT03655236|455172387|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
126513182|NCT03655236|455172388|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
126513183|NCT03655236|455172386|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
126513184|NCT03655236|455172387|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
126513185|NCT03655236|455172388|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
126513186|NCT03655236|455172386|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
126513187|NCT03655236|455172387|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
126513188|NCT03655236|455172388|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
126513189|NCT03655236|455172386|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
126513190|NCT03655236|455172387|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
126513191|NCT03655236|455172388|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
126513192|NCT03655236|455172386|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
126513193|NCT03655236|455172387|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
126513194|NCT03655236|455172388|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
126513195|NCT03655236|455172386|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
126513196|NCT03655236|455172387|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
126568048|NCT00906035|455373842|FG001|Overall Study|Withdrawal by Subject|3|||
126568049|NCT00906035|455373843|FG002|Overall Study|Withdrawal by Subject|0|||
126568050|NCT03058991|455373846|FG000|Overall Study|Lost to Follow-up|17|||
126568051|NCT03058991|455373847|FG001|Overall Study|Lost to Follow-up|12|||
126568052|NCT03058991|455373848|FG002|Overall Study|Lost to Follow-up|12|||
126568053|NCT03058991|455373846|FG000|Overall Study|Withdrawal by Subject|1|||
126568054|NCT03058991|455373847|FG001|Overall Study|Withdrawal by Subject|0|||
126568055|NCT03058991|455373848|FG002|Overall Study|Withdrawal by Subject|0|||
126513197|NCT03655236|455172388|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
126568056|NCT00130637|455373849|FG000|Overall Study|Adverse Event|2|||
126568057|NCT00130637|455373849|FG000|Overall Study|Withdrawal by Subject|1|||
126568058|NCT01460342|455373851|FG000|Overall Study|Adverse Event|5|||
126568059|NCT01460342|455373852|FG001|Overall Study|Adverse Event|4|||
126568060|NCT01460342|455373851|FG000|Overall Study|Lost to Follow-up|1|||
126568061|NCT01460342|455373852|FG001|Overall Study|Lost to Follow-up|2|||
126568062|NCT01460342|455373851|FG000|Overall Study|Protocol Violation|0|||
126513198|NCT03655236|455172386|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
126513199|NCT03655236|455172387|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
126513200|NCT03655236|455172388|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
126513201|NCT03655236|455172386|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
126513202|NCT03655236|455172387|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
126513203|NCT03655236|455172388|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
126513204|NCT03655236|455172386|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
126513205|NCT03655236|455172387|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
126513206|NCT03655236|455172388|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
126513207|NCT03655236|455172386|FG000|Subject Disposition in Part 1 Period|Other|0|||
126513208|NCT03655236|455172387|FG001|Subject Disposition in Part 1 Period|Other|2|||
126513209|NCT03655236|455172388|FG002|Subject Disposition in Part 1 Period|Other|2|||
126513210|NCT03655236|455172386|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
126513211|NCT03655236|455172387|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
126513212|NCT03655236|455172388|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
126513213|NCT03655236|455172386|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
126513214|NCT03655236|455172387|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
126513215|NCT03655236|455172388|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
126513216|NCT03655236|455172386|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
126513217|NCT03655236|455172387|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
126513218|NCT03655236|455172388|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
126513219|NCT03655236|455172386|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
126513220|NCT03655236|455172387|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
126513221|NCT03655236|455172388|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
126513222|NCT03655236|455172386|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
126513223|NCT03655236|455172387|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
126513224|NCT03655236|455172388|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
126513225|NCT03655236|455172386|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
126513226|NCT03655236|455172387|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
126513227|NCT03655236|455172388|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
126513228|NCT03655236|455172386|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
126513229|NCT03655236|455172387|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
126513230|NCT03655236|455172388|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
126513231|NCT03655236|455172386|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
126513232|NCT03655236|455172387|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
126513233|NCT03655236|455172388|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
126513234|NCT03655236|455172386|FG000|Subject Disposition in Part 2 Period|Other|1|||
126513235|NCT03655236|455172387|FG001|Subject Disposition in Part 2 Period|Other|0|||
126513236|NCT03655236|455172388|FG002|Subject Disposition in Part 2 Period|Other|0|||
126513237|NCT01532687|455174099|FG000|Overall Study|Death|2|||
126513238|NCT01532687|455174100|FG001|Overall Study|Death|0|||
126513239|NCT01532687|455174099|FG000|Overall Study|Adverse Event|6|||
126513240|NCT01532687|455174100|FG001|Overall Study|Adverse Event|1|||
126513241|NCT01532687|455174099|FG000|Overall Study|Withdrawal by Subject|1|||
126513242|NCT01532687|455174100|FG001|Overall Study|Withdrawal by Subject|0|||
126513243|NCT01532687|455174099|FG000|Overall Study|Physician Decision|2|||
126513244|NCT01532687|455174100|FG001|Overall Study|Physician Decision|1|||
126513245|NCT01532687|455174099|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
126513246|NCT01532687|455174100|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
126513247|NCT03160703|455174101|FG000|Overall Study|Withdrawal by Subject|0|||
126513248|NCT03160703|455174102|FG001|Overall Study|Withdrawal by Subject|0|||
126513249|NCT03160703|455174103|FG002|Overall Study|Withdrawal by Subject|0|||
126513250|NCT03160703|455174104|FG003|Overall Study|Withdrawal by Subject|1|||
126513251|NCT02984995|455174105|FG000|Overall Study|Required stem cell transplant|13|||
126513252|NCT02984995|455174106|FG001|Overall Study|Required stem cell transplant|2|||
126513253|NCT02984995|455174105|FG000|Overall Study|Progressive disease|11|||
126513254|NCT02984995|455174106|FG001|Overall Study|Progressive disease|1|||
126513255|NCT02984995|455174105|FG000|Overall Study|Adverse Event|1|||
126513256|NCT02984995|455174106|FG001|Overall Study|Adverse Event|0|||
126513257|NCT01263873|455174109|FG000|Overall Study|One provider unable to complete numbers|1|||
126513258|NCT01263873|455174110|FG001|Overall Study|One provider unable to complete numbers|1|||
126513259|NCT00047463|455174111|FG000|Overall Study|Withdrawal by Subject|0|||
126513260|NCT00047463|455174112|FG001|Overall Study|Withdrawal by Subject|3|||
126513261|NCT01401530|455174114|FG000|Overall Study|Disease Progression|1|||
126513262|NCT01401530|455174115|FG001|Overall Study|Disease Progression|2|||
126513263|NCT01401530|455174116|FG002|Overall Study|Disease Progression|1|||
126513264|NCT01401530|455174114|FG000|Overall Study|Adverse Event|1|||
126513265|NCT01401530|455174115|FG001|Overall Study|Adverse Event|1|||
126513266|NCT01401530|455174116|FG002|Overall Study|Adverse Event|1|||
126513267|NCT01401530|455174114|FG000|Overall Study|Participant Choice|1|||
126513268|NCT01401530|455174115|FG001|Overall Study|Participant Choice|2|||
126513269|NCT01401530|455174116|FG002|Overall Study|Participant Choice|1|||
126513270|NCT01401530|455174114|FG000|Overall Study|Physician Decision|0|||
126513271|NCT01401530|455174115|FG001|Overall Study|Physician Decision|1|||
126513272|NCT01401530|455174116|FG002|Overall Study|Physician Decision|0|||
126513273|NCT01448850|455174117|FG000|Overall Study|Death|3|||
126513274|NCT01448850|455174118|FG001|Overall Study|Death|6|||
126513275|NCT01448850|455174117|FG000|Overall Study|Withdrawal by Subject|13|||
126513276|NCT01448850|455174118|FG001|Overall Study|Withdrawal by Subject|21|||
126513277|NCT01448850|455174117|FG000|Overall Study|Lost to Follow-up|3|||
126513278|NCT01448850|455174118|FG001|Overall Study|Lost to Follow-up|1|||
126513279|NCT01448850|455174117|FG000|Overall Study|Other|15|||
126513280|NCT01448850|455174118|FG001|Overall Study|Other|12|||
126513281|NCT02939404|455174119|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
126513282|NCT02939404|455174120|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
126513283|NCT02939404|455174119|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
126513284|NCT02939404|455174120|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
126513285|NCT02664038|455174129|FG000|13 Week|Lost to Follow-up|7|||
126513286|NCT02664038|455174130|FG001|13 Week|Lost to Follow-up|14|||
126513287|NCT02664038|455174129|FG000|13 Week|Withdrawal by Subject|1|||
126513288|NCT02664038|455174130|FG001|13 Week|Withdrawal by Subject|0|||
126513289|NCT02664038|455174129|FG000|26 Week|Lost to Follow-up|5|||
126513290|NCT02664038|455174130|FG001|26 Week|Lost to Follow-up|4|||
126513291|NCT02606136|455174135|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
126513292|NCT02606136|455174135|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
126513293|NCT02606136|455174135|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
126513294|NCT02606136|455174135|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
126513295|NCT04694131|455174139|FG000|Overall Study|Withdrawal by Subject|7|||
126513296|NCT04694131|455174139|FG000|Overall Study|Screen Failure|1|||
126513297|NCT04694131|455174139|FG000|Overall Study|High stimulation threshold|3|||
126513298|NCT04112810|455174140|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
126513299|NCT01859715|455174148|FG000|Overall Study|No 2nd VAS|16|||
126513300|NCT01859715|455174149|FG001|Overall Study|No 2nd VAS|8|||
126513301|NCT01859715|455174150|FG002|Overall Study|No 2nd VAS|23|||
126513302|NCT01252290|455174151|FG000|Overall Study|Withdrawal by Subject|1|||
126513303|NCT00086580|455174152|FG000|Treatment Period|Disease progression|9|||
126513304|NCT00086580|455174153|FG001|Treatment Period|Disease progression|8|||
126513305|NCT00086580|455174152|FG000|Treatment Period|Unable to comply with protocol|3|||
126513306|NCT00086580|455174153|FG001|Treatment Period|Unable to comply with protocol|1|||
126513307|NCT00086580|455174152|FG000|Treatment Period|Withdrawal by Subject|7|||
126513308|NCT00086580|455174153|FG001|Treatment Period|Withdrawal by Subject|8|||
126513309|NCT00086580|455174152|FG000|Treatment Period|Physician Decision|13|||
126513310|NCT00086580|455174153|FG001|Treatment Period|Physician Decision|7|||
126513311|NCT00086580|455174152|FG000|Treatment Period|AE - not treatment related|7|||
126513312|NCT00086580|455174153|FG001|Treatment Period|AE - not treatment related|7|||
126513313|NCT00086580|455174152|FG000|Treatment Period|Toxicity - treatment related|15|||
126513314|NCT00086580|455174153|FG001|Treatment Period|Toxicity - treatment related|15|||
126513315|NCT00086580|455174152|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
126513316|NCT00086580|455174153|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
126513317|NCT00086580|455174152|FG000|Treatment Period|Death|5|||
126513318|NCT00086580|455174153|FG001|Treatment Period|Death|7|||
126513319|NCT00086580|455174152|FG000|Treatment Period|Other|5|||
126513320|NCT00086580|455174153|FG001|Treatment Period|Other|3|||
126513321|NCT00086580|455174152|FG000|Follow-up Period|Disease progression|72|||
126513322|NCT00086580|455174153|FG001|Follow-up Period|Disease progression|99|||
126568063|NCT01460342|455373852|FG001|Overall Study|Protocol Violation|1|||
126568064|NCT01460342|455373851|FG000|Overall Study|Withdrawal by Subject|3|||
126568065|NCT01460342|455373852|FG001|Overall Study|Withdrawal by Subject|4|||
126568066|NCT01460342|455373851|FG000|Overall Study|Physician Decision|1|||
126568067|NCT01460342|455373852|FG001|Overall Study|Physician Decision|3|||
126513323|NCT00086580|455174152|FG000|Follow-up Period|Unable to comply with protocol|5|||
126513324|NCT00086580|455174153|FG001|Follow-up Period|Unable to comply with protocol|0|||
126513325|NCT00086580|455174152|FG000|Follow-up Period|Withdrawal by Subject|6|||
126513326|NCT00086580|455174153|FG001|Follow-up Period|Withdrawal by Subject|6|||
126513327|NCT00086580|455174152|FG000|Follow-up Period|Physician Decision|0|||
126513328|NCT00086580|455174153|FG001|Follow-up Period|Physician Decision|1|||
126513329|NCT00086580|455174152|FG000|Follow-up Period|AE - not related|1|||
126513330|NCT00086580|455174153|FG001|Follow-up Period|AE - not related|0|||
126513331|NCT00086580|455174152|FG000|Follow-up Period|Death|13|||
126513332|NCT00086580|455174153|FG001|Follow-up Period|Death|7|||
126513333|NCT00086580|455174152|FG000|Follow-up Period|Other|7|||
126513334|NCT00086580|455174153|FG001|Follow-up Period|Other|6|||
126513335|NCT00086580|455174152|FG000|Observation Period|Unable to comply with protocol|1|||
126513336|NCT00086580|455174153|FG001|Observation Period|Unable to comply with protocol|1|||
126513337|NCT00086580|455174152|FG000|Observation Period|Withdrawal by Subject|4|||
126568068|NCT01460342|455373851|FG000|Overall Study|Lack of Efficacy|1|||
126776963|NCT04133519|456139134|FG001|Overall Study|Withdrawal by Subject|4|||
126513338|NCT00086580|455174153|FG001|Observation Period|Withdrawal by Subject|2|||
126513339|NCT00086580|455174152|FG000|Observation Period|Death|33|||
126513340|NCT00086580|455174153|FG001|Observation Period|Death|55|||
126513341|NCT00086580|455174152|FG000|Observation Period|Other|8|||
126513342|NCT00086580|455174153|FG001|Observation Period|Other|7|||
126513343|NCT02047110|455174157|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
126513344|NCT02047110|455174158|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
126513345|NCT02047110|455174159|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
126513346|NCT02047110|455174160|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
126513347|NCT02047110|455174157|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
126513348|NCT02047110|455174158|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
126513349|NCT02047110|455174159|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
126513350|NCT02047110|455174160|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
126513351|NCT02047110|455174157|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
126513352|NCT02047110|455174158|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
126513353|NCT02047110|455174159|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
126513354|NCT02047110|455174160|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
126513355|NCT02047110|455174157|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
126513356|NCT02047110|455174158|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
126513357|NCT02047110|455174159|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
126513358|NCT02047110|455174160|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
126513359|NCT02047110|455174157|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
126513360|NCT02047110|455174158|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
126513361|NCT02047110|455174159|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
126513362|NCT02047110|455174160|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
126513363|NCT02047110|455174157|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
126513364|NCT02047110|455174158|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
126513365|NCT02047110|455174159|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
126513366|NCT02047110|455174160|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
126513367|NCT02047110|455174157|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
126513368|NCT02047110|455174158|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
126513369|NCT02047110|455174159|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
126513370|NCT02047110|455174160|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
126513371|NCT02047110|455174157|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
126513372|NCT02047110|455174158|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
126513373|NCT02047110|455174159|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
126513374|NCT02047110|455174160|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
126513375|NCT02047110|455174157|FG000|Escape Treatment Period|Adverse Event|1|||
126513376|NCT02047110|455174158|FG001|Escape Treatment Period|Adverse Event|2|||
126513377|NCT02047110|455174159|FG002|Escape Treatment Period|Adverse Event|2|||
126513378|NCT02047110|455174160|FG003|Escape Treatment Period|Adverse Event|0|||
126513379|NCT02047110|455174157|FG000|Escape Treatment Period|Other than specified|1|||
126513380|NCT02047110|455174158|FG001|Escape Treatment Period|Other than specified|2|||
126513381|NCT02047110|455174159|FG002|Escape Treatment Period|Other than specified|0|||
126513382|NCT02047110|455174160|FG003|Escape Treatment Period|Other than specified|1|||
126513383|NCT02047110|455174157|FG000|OLE Treatment Period|Other than specified|0|||
126513384|NCT02047110|455174158|FG001|OLE Treatment Period|Other than specified|0|||
126513385|NCT02047110|455174159|FG002|OLE Treatment Period|Other than specified|1|||
126513386|NCT02047110|455174160|FG003|OLE Treatment Period|Other than specified|0|||
126513387|NCT02247349|455174161|FG000|Overall Study|Disease Progression|7|||
126513388|NCT02247349|455174162|FG001|Overall Study|Disease Progression|4|||
126513389|NCT02247349|455174163|FG002|Overall Study|Disease Progression|26|||
126513390|NCT02247349|455174164|FG003|Overall Study|Disease Progression|31|||
126513391|NCT02247349|455174165|FG004|Overall Study|Disease Progression|16|||
126513392|NCT02247349|455174166|FG005|Overall Study|Disease Progression|6|||
126513393|NCT02247349|455174161|FG000|Overall Study|Study drug toxicity|0|||
126513394|NCT02247349|455174162|FG001|Overall Study|Study drug toxicity|1|||
126513395|NCT02247349|455174163|FG002|Overall Study|Study drug toxicity|1|||
126513396|NCT02247349|455174164|FG003|Overall Study|Study drug toxicity|1|||
126513397|NCT02247349|455174165|FG004|Overall Study|Study drug toxicity|2|||
126513398|NCT02247349|455174166|FG005|Overall Study|Study drug toxicity|2|||
126513399|NCT02247349|455174161|FG000|Overall Study|Death|0|||
126513400|NCT02247349|455174162|FG001|Overall Study|Death|0|||
126513401|NCT02247349|455174163|FG002|Overall Study|Death|0|||
126513402|NCT02247349|455174164|FG003|Overall Study|Death|1|||
126513403|NCT02247349|455174165|FG004|Overall Study|Death|0|||
126513404|NCT02247349|455174166|FG005|Overall Study|Death|0|||
126513405|NCT02247349|455174161|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
126513406|NCT02247349|455174162|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
126513407|NCT02247349|455174163|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
126513408|NCT02247349|455174164|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
126776964|NCT04133519|456139133|FG000|Overall Study|Protocol Violation|0|||
126776965|NCT04133519|456139134|FG001|Overall Study|Protocol Violation|1|||
126776966|NCT04133519|456139133|FG000|Overall Study|Never started treatment|1|||
126776967|NCT04133519|456139134|FG001|Overall Study|Never started treatment|1|||
126513409|NCT02247349|455174165|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
126513410|NCT02247349|455174166|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
126513411|NCT02247349|455174161|FG000|Overall Study|Participant request to discontinue study treatment|0|||
126513412|NCT02247349|455174162|FG001|Overall Study|Participant request to discontinue study treatment|0|||
126513413|NCT02247349|455174163|FG002|Overall Study|Participant request to discontinue study treatment|1|||
126513414|NCT02247349|455174164|FG003|Overall Study|Participant request to discontinue study treatment|2|||
126513415|NCT02247349|455174165|FG004|Overall Study|Participant request to discontinue study treatment|1|||
126513416|NCT02247349|455174166|FG005|Overall Study|Participant request to discontinue study treatment|0|||
126513417|NCT02247349|455174161|FG000|Overall Study|Withdrawal by Subject|0|||
126513418|NCT02247349|455174162|FG001|Overall Study|Withdrawal by Subject|1|||
126513419|NCT02247349|455174163|FG002|Overall Study|Withdrawal by Subject|0|||
126513420|NCT02247349|455174164|FG003|Overall Study|Withdrawal by Subject|0|||
126513421|NCT02247349|455174165|FG004|Overall Study|Withdrawal by Subject|0|||
126513422|NCT02247349|455174166|FG005|Overall Study|Withdrawal by Subject|0|||
126513423|NCT02247349|455174161|FG000|Overall Study|Administrative reason by sponsor|0|||
126513424|NCT02247349|455174162|FG001|Overall Study|Administrative reason by sponsor|0|||
126513425|NCT02247349|455174163|FG002|Overall Study|Administrative reason by sponsor|0|||
126513426|NCT02247349|455174164|FG003|Overall Study|Administrative reason by sponsor|0|||
126513427|NCT02247349|455174165|FG004|Overall Study|Administrative reason by sponsor|1|||
126513428|NCT02247349|455174166|FG005|Overall Study|Administrative reason by sponsor|0|||
126513429|NCT02247349|455174161|FG000|Overall Study|Other reasons|0|||
126513430|NCT02247349|455174162|FG001|Overall Study|Other reasons|0|||
126513431|NCT02247349|455174163|FG002|Overall Study|Other reasons|1|||
126513432|NCT02247349|455174164|FG003|Overall Study|Other reasons|0|||
126513433|NCT02247349|455174165|FG004|Overall Study|Other reasons|0|||
126513434|NCT02247349|455174166|FG005|Overall Study|Other reasons|0|||
126513435|NCT01959581|455174171|FG000|Overall Study|Lost to Follow-up|5|||
126513436|NCT00079274|455174172|FG000|Overall Study|Withdrawal by Subject|111|||
126513437|NCT00079274|455174173|FG001|Overall Study|Withdrawal by Subject|10|||
126513438|NCT00079274|455174174|FG002|Overall Study|Withdrawal by Subject|12|||
126513439|NCT00079274|455174175|FG003|Overall Study|Withdrawal by Subject|163|||
126513440|NCT00079274|455174176|FG004|Overall Study|Withdrawal by Subject|7|||
126513441|NCT00079274|455174177|FG005|Overall Study|Withdrawal by Subject|8|||
126513442|NCT00079274|455174178|FG006|Overall Study|Withdrawal by Subject|0|||
126513443|NCT00079274|455174172|FG000|Overall Study|Adverse Event|130|||
126513444|NCT00079274|455174173|FG001|Overall Study|Adverse Event|8|||
126513445|NCT00079274|455174174|FG002|Overall Study|Adverse Event|8|||
126513446|NCT00079274|455174175|FG003|Overall Study|Adverse Event|184|||
126513447|NCT00079274|455174176|FG004|Overall Study|Adverse Event|7|||
126513448|NCT00079274|455174177|FG005|Overall Study|Adverse Event|8|||
126513449|NCT00079274|455174178|FG006|Overall Study|Adverse Event|0|||
126513450|NCT00079274|455174172|FG000|Overall Study|Recurrence|21|||
126513451|NCT00079274|455174173|FG001|Overall Study|Recurrence|0|||
126513452|NCT00079274|455174174|FG002|Overall Study|Recurrence|1|||
126513453|NCT00079274|455174175|FG003|Overall Study|Recurrence|15|||
126513454|NCT00079274|455174176|FG004|Overall Study|Recurrence|0|||
126513455|NCT00079274|455174177|FG005|Overall Study|Recurrence|2|||
126513456|NCT00079274|455174178|FG006|Overall Study|Recurrence|0|||
126513457|NCT00079274|455174172|FG000|Overall Study|Alternate Treatment|6|||
126513458|NCT00079274|455174173|FG001|Overall Study|Alternate Treatment|1|||
126513459|NCT00079274|455174174|FG002|Overall Study|Alternate Treatment|0|||
126513460|NCT00079274|455174175|FG003|Overall Study|Alternate Treatment|3|||
126513461|NCT00079274|455174176|FG004|Overall Study|Alternate Treatment|0|||
126513462|NCT00079274|455174177|FG005|Overall Study|Alternate Treatment|0|||
126513463|NCT00079274|455174178|FG006|Overall Study|Alternate Treatment|0|||
126513464|NCT00079274|455174172|FG000|Overall Study|Other Medical Problems|6|||
126513465|NCT00079274|455174173|FG001|Overall Study|Other Medical Problems|1|||
126513466|NCT00079274|455174174|FG002|Overall Study|Other Medical Problems|0|||
126513467|NCT00079274|455174175|FG003|Overall Study|Other Medical Problems|7|||
126513468|NCT00079274|455174176|FG004|Overall Study|Other Medical Problems|0|||
126513469|NCT00079274|455174177|FG005|Overall Study|Other Medical Problems|0|||
126513470|NCT00079274|455174178|FG006|Overall Study|Other Medical Problems|0|||
126513471|NCT00079274|455174172|FG000|Overall Study|Death|4|||
126513472|NCT00079274|455174173|FG001|Overall Study|Death|0|||
126513473|NCT00079274|455174174|FG002|Overall Study|Death|1|||
126513474|NCT00079274|455174175|FG003|Overall Study|Death|15|||
126513475|NCT00079274|455174176|FG004|Overall Study|Death|0|||
126513476|NCT00079274|455174177|FG005|Overall Study|Death|0|||
126513477|NCT00079274|455174178|FG006|Overall Study|Death|0|||
126513478|NCT00079274|455174172|FG000|Overall Study|Cytogenetic resistance|0|||
126513479|NCT00079274|455174173|FG001|Overall Study|Cytogenetic resistance|0|||
126513480|NCT00079274|455174174|FG002|Overall Study|Cytogenetic resistance|0|||
126776968|NCT02436135|456139135|FG000|Overall Study|Progressive Disease|3|||
126568069|NCT01460342|455373852|FG001|Overall Study|Lack of Efficacy|0|||
126568070|NCT01689519|455373853|FG000|Intent to Treat|Death|157|||
126568071|NCT01689519|455373854|FG001|Intent to Treat|Death|167|||
126568072|NCT01689519|455373853|FG000|Intent to Treat|Lost to Follow-up|4|||
126568073|NCT01689519|455373854|FG001|Intent to Treat|Lost to Follow-up|8|||
126568074|NCT01689519|455373853|FG000|Intent to Treat|Other|2|||
126568075|NCT01689519|455373854|FG001|Intent to Treat|Other|4|||
126568076|NCT01689519|455373853|FG000|Intent to Treat|Physician Decision|4|||
126568077|NCT01689519|455373854|FG001|Intent to Treat|Physician Decision|1|||
126568078|NCT01689519|455373853|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
126568079|NCT01689519|455373854|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
126568080|NCT01689519|455373853|FG000|Intent to Treat|Withdrawal by Subject|21|||
126568081|NCT01689519|455373854|FG001|Intent to Treat|Withdrawal by Subject|20|||
126568082|NCT01689519|455373853|FG000|Safety Population|Death|158|||
126568083|NCT01689519|455373854|FG001|Safety Population|Death|165|||
126568084|NCT01689519|455373853|FG000|Safety Population|Lost to Follow-up|4|||
126568085|NCT01689519|455373854|FG001|Safety Population|Lost to Follow-up|8|||
126568086|NCT01689519|455373853|FG000|Safety Population|Other|2|||
126568087|NCT01689519|455373854|FG001|Safety Population|Other|4|||
126568088|NCT01689519|455373853|FG000|Safety Population|Physician Decision|4|||
126568089|NCT01689519|455373854|FG001|Safety Population|Physician Decision|1|||
126568090|NCT01689519|455373853|FG000|Safety Population|Study Terminated By Sponsor|60|||
126568091|NCT01689519|455373854|FG001|Safety Population|Study Terminated By Sponsor|47|||
126568092|NCT01689519|455373853|FG000|Safety Population|Withdrawal by Subject|20|||
126568093|NCT01689519|455373854|FG001|Safety Population|Withdrawal by Subject|20|||
126568094|NCT01050569|455373857|FG000|Overall Study|Lost to Follow-up|20|||
126568095|NCT01050569|455373858|FG001|Overall Study|Lost to Follow-up|14|||
126568096|NCT01050569|455373859|FG002|Overall Study|Lost to Follow-up|16|||
126568097|NCT01050569|455373857|FG000|Overall Study|Withdrawal by Subject|9|||
126568098|NCT01050569|455373858|FG001|Overall Study|Withdrawal by Subject|3|||
126568099|NCT01050569|455373859|FG002|Overall Study|Withdrawal by Subject|11|||
126568100|NCT01050569|455373857|FG000|Overall Study|Lack of Efficacy|5|||
126568101|NCT01050569|455373858|FG001|Overall Study|Lack of Efficacy|4|||
126568102|NCT01050569|455373859|FG002|Overall Study|Lack of Efficacy|3|||
126568103|NCT01050569|455373857|FG000|Overall Study|Adverse Event|1|||
126568104|NCT01050569|455373858|FG001|Overall Study|Adverse Event|0|||
126568105|NCT01050569|455373859|FG002|Overall Study|Adverse Event|0|||
126568106|NCT01050569|455373857|FG000|Overall Study|Physician Decision|3|||
126568107|NCT01050569|455373858|FG001|Overall Study|Physician Decision|3|||
126568108|NCT01050569|455373859|FG002|Overall Study|Physician Decision|3|||
126568109|NCT03525119|455373861|FG000|Overall Study|Adverse Event|0|||
126568110|NCT03525119|455373862|FG001|Overall Study|Adverse Event|1|||
126568111|NCT03525119|455373863|FG002|Overall Study|Adverse Event|0|||
126727183|NCT00547378|455951075|FG002|Randomized Cohort|Lost to Follow-up|0|||
126727184|NCT00547378|455951073|FG000|Randomized Cohort|Adverse Event|1|||
126727185|NCT00547378|455951074|FG001|Randomized Cohort|Adverse Event|0|||
126513481|NCT00079274|455174175|FG003|Overall Study|Cytogenetic resistance|2|||
126513482|NCT00079274|455174176|FG004|Overall Study|Cytogenetic resistance|0|||
126513483|NCT00079274|455174177|FG005|Overall Study|Cytogenetic resistance|0|||
126513484|NCT00079274|455174178|FG006|Overall Study|Cytogenetic resistance|0|||
126513485|NCT00079274|455174172|FG000|Overall Study|Other|43|||
126513486|NCT00079274|455174173|FG001|Overall Study|Other|7|||
126513487|NCT00079274|455174174|FG002|Overall Study|Other|5|||
126513488|NCT00079274|455174175|FG003|Overall Study|Other|55|||
126513489|NCT00079274|455174176|FG004|Overall Study|Other|1|||
126513490|NCT00079274|455174177|FG005|Overall Study|Other|2|||
126513491|NCT00079274|455174178|FG006|Overall Study|Other|0|||
126513492|NCT04542070|455174180|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
126513493|NCT04542070|455174181|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
126513494|NCT04542070|455174182|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
126513495|NCT04542070|455174183|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
126727186|NCT00547378|455951075|FG002|Randomized Cohort|Adverse Event|0|||
126513496|NCT04542070|455174180|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
126513497|NCT04542070|455174181|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
126513498|NCT04542070|455174182|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
126568112|NCT03525119|455373861|FG000|Overall Study|Lost to Follow-up|32|||
126568113|NCT03525119|455373862|FG001|Overall Study|Lost to Follow-up|33|||
126568114|NCT03525119|455373863|FG002|Overall Study|Lost to Follow-up|37|||
126568115|NCT03525119|455373861|FG000|Overall Study|Withdrawal by Subject|5|||
126568116|NCT03525119|455373862|FG001|Overall Study|Withdrawal by Subject|4|||
126568117|NCT03525119|455373863|FG002|Overall Study|Withdrawal by Subject|2|||
126568118|NCT03525119|455373861|FG000|Overall Study|Reason not Specified|2|||
126568119|NCT03525119|455373862|FG001|Overall Study|Reason not Specified|1|||
126568120|NCT03525119|455373863|FG002|Overall Study|Reason not Specified|2|||
126727187|NCT00547378|455951073|FG000|Randomized Cohort|Other reasons|2|||
126727188|NCT00547378|455951074|FG001|Randomized Cohort|Other reasons|0|||
126727189|NCT00547378|455951075|FG002|Randomized Cohort|Other reasons|0|||
126727190|NCT00547378|455951073|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
126513499|NCT04542070|455174183|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
126513500|NCT04542070|455174180|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
126513501|NCT04542070|455174181|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
126513502|NCT04542070|455174182|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
126513503|NCT04542070|455174183|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
126513504|NCT04542070|455174180|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
126513505|NCT04542070|455174181|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
126513506|NCT04542070|455174182|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
126513507|NCT04542070|455174183|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
126513508|NCT04542070|455174180|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
126513509|NCT04542070|455174181|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
126513510|NCT04542070|455174182|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
126513511|NCT04542070|455174183|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
126513512|NCT04542070|455174180|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
126513513|NCT04542070|455174181|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
126513514|NCT04542070|455174182|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
126513515|NCT04542070|455174183|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
126513516|NCT04542070|455174180|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
126513517|NCT04542070|455174181|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
126513518|NCT04542070|455174182|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
126513519|NCT04542070|455174183|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
126513520|NCT04542070|455174180|FG000|Maintenance + Extension Period|Adverse Event|10|||
126513521|NCT04542070|455174181|FG001|Maintenance + Extension Period|Adverse Event|2|||
126513522|NCT04542070|455174182|FG002|Maintenance + Extension Period|Adverse Event|0|||
126513523|NCT04542070|455174183|FG003|Maintenance + Extension Period|Adverse Event|0|||
126513524|NCT04542070|455174180|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
126513525|NCT04542070|455174181|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
126513526|NCT04542070|455174182|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
126513527|NCT04542070|455174183|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
126513528|NCT04542070|455174180|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
126513529|NCT04542070|455174181|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
126513530|NCT04542070|455174182|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
126513531|NCT04542070|455174183|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
126513532|NCT04542070|455174180|FG000|Maintenance + Extension Period|Physician Decision|1|||
126513533|NCT04542070|455174181|FG001|Maintenance + Extension Period|Physician Decision|1|||
126513534|NCT04542070|455174182|FG002|Maintenance + Extension Period|Physician Decision|0|||
126513535|NCT04542070|455174183|FG003|Maintenance + Extension Period|Physician Decision|0|||
126513536|NCT04542070|455174180|FG000|Maintenance + Extension Period|Protocol Violation|2|||
126513537|NCT04542070|455174181|FG001|Maintenance + Extension Period|Protocol Violation|5|||
126513538|NCT04542070|455174182|FG002|Maintenance + Extension Period|Protocol Violation|0|||
126513539|NCT04542070|455174183|FG003|Maintenance + Extension Period|Protocol Violation|0|||
126513540|NCT04542070|455174180|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
126513541|NCT04542070|455174181|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
126513542|NCT04542070|455174182|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
126513543|NCT04542070|455174183|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
126513544|NCT04542070|455174180|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
126513545|NCT04542070|455174181|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
126513546|NCT04542070|455174182|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
126513547|NCT04542070|455174183|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
126513548|NCT04542070|455174180|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
126513549|NCT04542070|455174181|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
126513550|NCT04542070|455174182|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
126513551|NCT04542070|455174183|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
126513552|NCT04542070|455174180|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
126513553|NCT04542070|455174181|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
126513554|NCT04542070|455174182|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
126513555|NCT04542070|455174183|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
126513556|NCT04542070|455174180|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
126513557|NCT04542070|455174181|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
126513558|NCT04542070|455174182|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
126513559|NCT04542070|455174183|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
126513560|NCT04542070|455174180|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
126513561|NCT04542070|455174181|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
126513562|NCT04542070|455174182|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
126568121|NCT03525119|455373861|FG000|Overall Study|Randomized but not Vaccinated|1|||
126513563|NCT04542070|455174183|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
126513564|NCT04542070|455174180|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
126513565|NCT04542070|455174181|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
126513566|NCT04542070|455174182|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
126513567|NCT04542070|455174183|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
126513568|NCT00550836|455174184|FG000|Overall Study|Withdrawal by Subject|3|||
126513569|NCT00550836|455174185|FG001|Overall Study|Withdrawal by Subject|9|||
126513570|NCT00179413|455174186|FG000|Overall Study|Adverse Event|38|||
126513571|NCT00179413|455174187|FG001|Overall Study|Adverse Event|20|||
126513572|NCT00179413|455174186|FG000|Overall Study|Withdrawal by Subject|87|||
126513573|NCT00179413|455174187|FG001|Overall Study|Withdrawal by Subject|95|||
126513574|NCT03075644|455174190|FG000|Overall Study|Withdrawal by Subject|1|||
126513575|NCT03075644|455174191|FG001|Overall Study|Withdrawal by Subject|1|||
126513576|NCT01458171|455174192|FG000|Overall Study|Adverse Event|1|||
126513577|NCT01696032|455174193|FG000|Overall Study|Withdrawal by Subject|0|||
126513578|NCT01696032|455174194|FG001|Overall Study|Withdrawal by Subject|0|||
126513579|NCT01696032|455174195|FG002|Overall Study|Withdrawal by Subject|1|||
126513580|NCT01696032|455174196|FG003|Overall Study|Withdrawal by Subject|2|||
126513581|NCT01696032|455174193|FG000|Overall Study|Death|14|||
126513582|NCT01696032|455174194|FG001|Overall Study|Death|4|||
126513583|NCT01696032|455174195|FG002|Overall Study|Death|43|||
126513584|NCT01696032|455174196|FG003|Overall Study|Death|18|||
126513585|NCT01696032|455174193|FG000|Overall Study|Lost to Follow-up|0|||
126513586|NCT01696032|455174194|FG001|Overall Study|Lost to Follow-up|1|||
126513587|NCT01696032|455174195|FG002|Overall Study|Lost to Follow-up|0|||
126513588|NCT01696032|455174196|FG003|Overall Study|Lost to Follow-up|0|||
126513589|NCT01696032|455174193|FG000|Overall Study|Database lock|0|||
126513590|NCT01696032|455174194|FG001|Overall Study|Database lock|1|||
126513591|NCT01696032|455174195|FG002|Overall Study|Database lock|7|||
126513592|NCT01696032|455174196|FG003|Overall Study|Database lock|2|||
126513593|NCT01192152|455174199|FG000|Period 1|left prematurely (while on treatment B)|0|||
126513594|NCT01192152|455174200|FG001|Period 1|left prematurely (while on treatment B)|1|||
126513595|NCT01192152|455174199|FG000|Period 3|family emergency|1|||
126513596|NCT01192152|455174200|FG001|Period 3|family emergency|0|||
126513597|NCT05013905|455174202|FG000|Overall Study|Adverse Event|1|||
126513598|NCT05013905|455174202|FG000|Overall Study|Lack of Efficacy|1|||
126513599|NCT04666259|455174205|FG000|Treatment Phase|Physician Decision|9|||
126513600|NCT04666259|455174206|FG001|Treatment Phase|Physician Decision|3|||
126513601|NCT04666259|455174207|FG002|Treatment Phase|Physician Decision|3|||
126513602|NCT04666259|455174205|FG000|Treatment Phase|Adverse Event|3|||
126513603|NCT04666259|455174206|FG001|Treatment Phase|Adverse Event|1|||
126513604|NCT04666259|455174207|FG002|Treatment Phase|Adverse Event|0|||
126513605|NCT04666259|455174205|FG000|Treatment Phase|Subject decision|1|||
126513606|NCT04666259|455174206|FG001|Treatment Phase|Subject decision|2|||
126513607|NCT04666259|455174207|FG002|Treatment Phase|Subject decision|0|||
126513608|NCT04666259|455174205|FG000|Treatment Phase|Progressive disease|0|||
126513609|NCT04666259|455174206|FG001|Treatment Phase|Progressive disease|1|||
126513610|NCT04666259|455174207|FG002|Treatment Phase|Progressive disease|0|||
126513611|NCT04666259|455174205|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
126513612|NCT04666259|455174206|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
126513613|NCT04666259|455174207|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
126513614|NCT04666259|455174205|FG000|Safety Follow-up Phase|Physician Decision|2|||
126513615|NCT04666259|455174206|FG001|Safety Follow-up Phase|Physician Decision|0|||
126513616|NCT04666259|455174207|FG002|Safety Follow-up Phase|Physician Decision|0|||
126513617|NCT04666259|455174205|FG000|Safety Follow-up Phase|Subject decision|1|||
126513618|NCT04666259|455174206|FG001|Safety Follow-up Phase|Subject decision|0|||
126513619|NCT04666259|455174207|FG002|Safety Follow-up Phase|Subject decision|0|||
126513620|NCT04666259|455174205|FG000|Safety Follow-up Phase|Death|0|||
126513621|NCT04666259|455174206|FG001|Safety Follow-up Phase|Death|1|||
126513622|NCT04666259|455174207|FG002|Safety Follow-up Phase|Death|0|||
126513623|NCT00854581|455174208|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
126513624|NCT00854581|455174208|FG000|Induction (Up to Day 21)|Death|1|||
126513625|NCT00854581|455174208|FG000|Induction (Up to Day 21)|Physician Decision|1|||
126513626|NCT00854581|455174208|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
126513627|NCT00378703|455174211|FG000|Overall Study|Disease progression|59|||
126513628|NCT00378703|455174212|FG001|Overall Study|Disease progression|43|||
126513629|NCT00378703|455174213|FG002|Overall Study|Disease progression|48|||
126513630|NCT00378703|455174214|FG003|Overall Study|Disease progression|49|||
126513631|NCT00378703|455174211|FG000|Overall Study|Adverse Event|11|||
126513632|NCT00378703|455174212|FG001|Overall Study|Adverse Event|17|||
126513633|NCT00378703|455174213|FG002|Overall Study|Adverse Event|20|||
126513634|NCT00378703|455174214|FG003|Overall Study|Adverse Event|18|||
126513635|NCT00378703|455174211|FG000|Overall Study|Death|2|||
126513636|NCT00378703|455174212|FG001|Overall Study|Death|2|||
126513637|NCT00378703|455174213|FG002|Overall Study|Death|4|||
126513638|NCT00378703|455174214|FG003|Overall Study|Death|3|||
126513639|NCT00378703|455174211|FG000|Overall Study|Withdrawal by Subject|4|||
126568122|NCT03525119|455373862|FG001|Overall Study|Randomized but not Vaccinated|0|||
126568123|NCT03525119|455373863|FG002|Overall Study|Randomized but not Vaccinated|2|||
126568124|NCT01713530|455373864|FG000|Overall Study|Adverse Event|0|||
126568125|NCT01713530|455373865|FG001|Overall Study|Adverse Event|5|||
126568126|NCT01713530|455373864|FG000|Overall Study|Withdrawal criteria|21|||
126568127|NCT01713530|455373865|FG001|Overall Study|Withdrawal criteria|12|||
126568128|NCT01713530|455373864|FG000|Overall Study|Unclassified|4|||
126568129|NCT01713530|455373865|FG001|Overall Study|Unclassified|2|||
126568130|NCT05046132|455373866|FG000|Overall Study|Adverse Event|4|||
126568131|NCT05046132|455373867|FG001|Overall Study|Adverse Event|0|||
126568132|NCT05046132|455373868|FG002|Overall Study|Adverse Event|0|||
126568133|NCT05046132|455373866|FG000|Overall Study|Withdrawal by Subject|3|||
126568134|NCT05046132|455373867|FG001|Overall Study|Withdrawal by Subject|0|||
126568135|NCT05046132|455373868|FG002|Overall Study|Withdrawal by Subject|0|||
126568136|NCT05046132|455373866|FG000|Overall Study|Positive Covid19 Result.|0|||
126568137|NCT05046132|455373867|FG001|Overall Study|Positive Covid19 Result.|1|||
126568138|NCT05046132|455373868|FG002|Overall Study|Positive Covid19 Result.|0|||
126568139|NCT00619645|455373871|FG000|Overall Study|Adverse Event|1|||
126568140|NCT00597519|455373872|FG000|Overall Study|Death|1|||
126568141|NCT04246762|455373873|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
126568142|NCT00410124|455373874|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
126568143|NCT00410124|455373875|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
126568144|NCT00410124|455373874|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
126568145|NCT00410124|455373875|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
126568146|NCT00410124|455373874|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
126568147|NCT00410124|455373875|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
126568148|NCT00410124|455373874|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
126568149|NCT00410124|455373875|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
126568150|NCT00410124|455373874|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
126568151|NCT00410124|455373875|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
126568152|NCT00410124|455373874|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
126568153|NCT00410124|455373875|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
126568154|NCT00410124|455373874|FG000|Core Phase Double Blind (15 Months)|Death|7|||
126568155|NCT00410124|455373875|FG001|Core Phase Double Blind (15 Months)|Death|4|||
126568156|NCT00410124|455373874|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
126513640|NCT00378703|455174212|FG001|Overall Study|Withdrawal by Subject|8|||
126513641|NCT00378703|455174213|FG002|Overall Study|Withdrawal by Subject|5|||
126513642|NCT00378703|455174214|FG003|Overall Study|Withdrawal by Subject|7|||
126513643|NCT00378703|455174211|FG000|Overall Study|Physician Decision|1|||
126513644|NCT00378703|455174212|FG001|Overall Study|Physician Decision|4|||
126513645|NCT00378703|455174213|FG002|Overall Study|Physician Decision|1|||
126513646|NCT00378703|455174214|FG003|Overall Study|Physician Decision|0|||
126513647|NCT00378703|455174211|FG000|Overall Study|Alternative therapy|4|||
126513648|NCT00378703|455174212|FG001|Overall Study|Alternative therapy|2|||
126513649|NCT00378703|455174213|FG002|Overall Study|Alternative therapy|0|||
126513650|NCT00378703|455174214|FG003|Overall Study|Alternative therapy|0|||
126513651|NCT00378703|455174211|FG000|Overall Study|Other complicated disease|0|||
126513652|NCT00378703|455174212|FG001|Overall Study|Other complicated disease|2|||
126513653|NCT00378703|455174213|FG002|Overall Study|Other complicated disease|2|||
126513654|NCT00378703|455174214|FG003|Overall Study|Other complicated disease|0|||
126513655|NCT00378703|455174211|FG000|Overall Study|Symptomatic deterioration|0|||
126513656|NCT00378703|455174212|FG001|Overall Study|Symptomatic deterioration|1|||
126513657|NCT00378703|455174213|FG002|Overall Study|Symptomatic deterioration|0|||
126513658|NCT00378703|455174214|FG003|Overall Study|Symptomatic deterioration|2|||
126513659|NCT00378703|455174211|FG000|Overall Study|Surgery|1|||
126513660|NCT00378703|455174212|FG001|Overall Study|Surgery|0|||
126513661|NCT00378703|455174213|FG002|Overall Study|Surgery|0|||
126513662|NCT00378703|455174214|FG003|Overall Study|Surgery|1|||
126513663|NCT00378703|455174211|FG000|Overall Study|Joint decision of physician and patient|1|||
126513664|NCT00378703|455174212|FG001|Overall Study|Joint decision of physician and patient|0|||
126513665|NCT00378703|455174213|FG002|Overall Study|Joint decision of physician and patient|0|||
126513666|NCT00378703|455174214|FG003|Overall Study|Joint decision of physician and patient|0|||
126513667|NCT00378703|455174211|FG000|Overall Study|Adverse events and progressive disease|0|||
126568157|NCT00410124|455373875|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
126568158|NCT00410124|455373874|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
126513668|NCT00378703|455174212|FG001|Overall Study|Adverse events and progressive disease|0|||
126513669|NCT00378703|455174213|FG002|Overall Study|Adverse events and progressive disease|0|||
126568159|NCT00410124|455373875|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
126568160|NCT00410124|455373874|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
126568161|NCT00410124|455373875|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
126513670|NCT00378703|455174214|FG003|Overall Study|Adverse events and progressive disease|1|||
126513671|NCT00378703|455174211|FG000|Overall Study|Relocation|0|||
126513672|NCT00378703|455174212|FG001|Overall Study|Relocation|0|||
126513673|NCT00378703|455174213|FG002|Overall Study|Relocation|1|||
126513674|NCT00378703|455174214|FG003|Overall Study|Relocation|0|||
126513675|NCT00378703|455174211|FG000|Overall Study|Ineligible|4|||
126513676|NCT00378703|455174212|FG001|Overall Study|Ineligible|7|||
126513677|NCT00378703|455174213|FG002|Overall Study|Ineligible|7|||
126513678|NCT00378703|455174214|FG003|Overall Study|Ineligible|7|||
126513679|NCT00378703|455174211|FG000|Overall Study|Never started treatment|1|||
126513680|NCT00378703|455174212|FG001|Overall Study|Never started treatment|4|||
126513681|NCT00378703|455174213|FG002|Overall Study|Never started treatment|0|||
126513682|NCT00378703|455174214|FG003|Overall Study|Never started treatment|0|||
126513683|NCT00378703|455174211|FG000|Overall Study|Other|1|||
126513684|NCT00378703|455174212|FG001|Overall Study|Other|1|||
126513685|NCT00378703|455174213|FG002|Overall Study|Other|2|||
126513686|NCT00378703|455174214|FG003|Overall Study|Other|3|||
126513687|NCT05402995|455174215|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
126513688|NCT05402995|455174216|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
126513689|NCT05402995|455174217|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
126513690|NCT05402995|455174218|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
126513691|NCT02705820|455174219|FG000|Overall Study|Death|2|||
126513692|NCT02705820|455174219|FG000|Overall Study|Disease Progression|34|||
126513693|NCT02705820|455174219|FG000|Overall Study|Clinical Deterioration|3|||
126513694|NCT01009099|455174220|FG000|Overall Study|Lost to Follow-up|1|||
126513695|NCT01009099|455174221|FG001|Overall Study|Lost to Follow-up|0|||
126513696|NCT01009099|455174220|FG000|Overall Study|Physician Decision|3|||
126513697|NCT01009099|455174221|FG001|Overall Study|Physician Decision|2|||
126513698|NCT01009099|455174220|FG000|Overall Study|Withdrawal by Subject|1|||
126513699|NCT01009099|455174221|FG001|Overall Study|Withdrawal by Subject|1|||
126513700|NCT01009099|455174220|FG000|Overall Study|Death|0|||
126513701|NCT01009099|455174221|FG001|Overall Study|Death|1|||
126513702|NCT02188485|455174222|FG000|Overall Study|Withdrawal by Subject|2|||
126513703|NCT02188485|455174223|FG001|Overall Study|Withdrawal by Subject|1|||
126513704|NCT02188485|455174222|FG000|Overall Study|PI withdrew, lack of capacity|0|||
126513705|NCT02188485|455174223|FG001|Overall Study|PI withdrew, lack of capacity|2|||
126513706|NCT02457325|455174227|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
126513707|NCT02457325|455174228|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
126513708|NCT01541930|455174229|FG000|Overall Study|Withdrawal by Subject|1|||
126513709|NCT02501096|455174230|FG000|Overall Study|Lost to Follow-up|0|||
126513710|NCT02501096|455174231|FG001|Overall Study|Lost to Follow-up|0|||
126513711|NCT02501096|455174232|FG002|Overall Study|Lost to Follow-up|0|||
126513712|NCT02501096|455174233|FG003|Overall Study|Lost to Follow-up|0|||
126513713|NCT02501096|455174234|FG004|Overall Study|Lost to Follow-up|1|||
126513714|NCT02501096|455174235|FG005|Overall Study|Lost to Follow-up|1|||
126513715|NCT02501096|455174236|FG006|Overall Study|Lost to Follow-up|3|||
126513716|NCT02501096|455174237|FG007|Overall Study|Lost to Follow-up|0|||
126513717|NCT02501096|455174238|FG008|Overall Study|Lost to Follow-up|0|||
126513718|NCT02501096|455174230|FG000|Overall Study|Withdrawal by Subject|1|||
126513719|NCT02501096|455174231|FG001|Overall Study|Withdrawal by Subject|0|||
126513720|NCT02501096|455174232|FG002|Overall Study|Withdrawal by Subject|7|||
126513721|NCT02501096|455174233|FG003|Overall Study|Withdrawal by Subject|13|||
126513722|NCT02501096|455174234|FG004|Overall Study|Withdrawal by Subject|2|||
126513723|NCT02501096|455174235|FG005|Overall Study|Withdrawal by Subject|2|||
126513724|NCT02501096|455174236|FG006|Overall Study|Withdrawal by Subject|2|||
126513725|NCT02501096|455174237|FG007|Overall Study|Withdrawal by Subject|3|||
126513726|NCT02501096|455174238|FG008|Overall Study|Withdrawal by Subject|0|||
126513727|NCT02501096|455174230|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
126513728|NCT02501096|455174231|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
126513729|NCT02501096|455174232|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
126513730|NCT02501096|455174233|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
126513731|NCT02501096|455174234|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
126513732|NCT02501096|455174235|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
126513733|NCT02501096|455174236|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
126513734|NCT02501096|455174237|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
126513735|NCT02501096|455174238|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
126513736|NCT02501096|455174230|FG000|Overall Study|Death|1|||
126513737|NCT02501096|455174231|FG001|Overall Study|Death|1|||
126513738|NCT02501096|455174232|FG002|Overall Study|Death|88|||
126513739|NCT02501096|455174233|FG003|Overall Study|Death|74|||
126513740|NCT02501096|455174234|FG004|Overall Study|Death|15|||
126513741|NCT02501096|455174235|FG005|Overall Study|Death|16|||
126513742|NCT02501096|455174236|FG006|Overall Study|Death|15|||
126513743|NCT02501096|455174237|FG007|Overall Study|Death|16|||
126513744|NCT02501096|455174238|FG008|Overall Study|Death|1|||
126513745|NCT04187196|455174239|FG000|Overall Study|Screen Failure|2|||
126513746|NCT04187196|455174240|FG001|Overall Study|Screen Failure|0|||
126513747|NCT03139916|455174243|FG000|Overall Study|Withdrawal by Subject|2|||
126513748|NCT03139916|455174243|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
126776969|NCT02436135|456139136|FG001|Overall Study|Progressive Disease|1|||
126513749|NCT01957475|455174244|FG000|Test Period 1|Withdrawal by Subject|1|||
126513750|NCT01957475|455174245|FG001|Test Period 1|Withdrawal by Subject|0|||
126513751|NCT01957475|455174244|FG000|Test Period 1|Other|1|||
126513752|NCT01957475|455174245|FG001|Test Period 1|Other|0|||
126513753|NCT01957475|455174244|FG000|Test Period 1|Lack of Efficacy|0|||
126513754|NCT01957475|455174245|FG001|Test Period 1|Lack of Efficacy|1|||
126513755|NCT01957475|455174244|FG000|Test Period 2|Adverse Event|1|||
126513756|NCT01957475|455174245|FG001|Test Period 2|Adverse Event|0|||
126513757|NCT04587193|455174246|FG000|Overall Study|Screen failure after consent|3|||
126513758|NCT04587193|455174247|FG001|Overall Study|Screen failure after consent|0|||
126513759|NCT04587193|455174246|FG000|Overall Study|Device broke during study|3|||
126513760|NCT04587193|455174247|FG001|Overall Study|Device broke during study|2|||
126513761|NCT01552772|455174248|FG000|Overall Study|Lost to Follow-up|2|||
126513762|NCT01552772|455174248|FG000|Overall Study|Adverse Event|1|||
126513763|NCT01552772|455174248|FG000|Overall Study|Protocol Deviation|1|||
126513764|NCT02707640|455174252|FG000|Overall Study|Adverse Event|4|||
126513765|NCT02707640|455174253|FG001|Overall Study|Adverse Event|2|||
126513766|NCT02707640|455174252|FG000|Overall Study|Death|1|||
126513767|NCT02707640|455174253|FG001|Overall Study|Death|2|||
126513768|NCT02707640|455174252|FG000|Overall Study|Physician Decision|2|||
126513769|NCT02707640|455174253|FG001|Overall Study|Physician Decision|0|||
126513770|NCT02707640|455174252|FG000|Overall Study|Withdrawal by Subject|0|||
126513771|NCT02707640|455174253|FG001|Overall Study|Withdrawal by Subject|1|||
126513772|NCT02707640|455174252|FG000|Overall Study|Participant's Personal Decision|1|||
126513773|NCT02707640|455174253|FG001|Overall Study|Participant's Personal Decision|2|||
126513774|NCT02707640|455174252|FG000|Overall Study|Sponsor Discretion|1|||
126513775|NCT02707640|455174253|FG001|Overall Study|Sponsor Discretion|0|||
126513776|NCT02517905|455174254|FG000|Overall Study|Lost to Follow-up|4|||
126513777|NCT02517905|455174255|FG001|Overall Study|Lost to Follow-up|0|||
126513778|NCT02517905|455174254|FG000|Overall Study|Withdrawal by Subject|4|||
126513779|NCT02517905|455174255|FG001|Overall Study|Withdrawal by Subject|0|||
126513780|NCT02517905|455174254|FG000|Overall Study|Screen failure|2|||
126513781|NCT02517905|455174255|FG001|Overall Study|Screen failure|2|||
126513782|NCT02742103|455175402|FG000|Overall Study|Protocol Violation|1|||
126513783|NCT02742103|455175403|FG001|Overall Study|Protocol Violation|0|||
126513784|NCT02742103|455175402|FG000|Overall Study|Death|2|||
126513785|NCT02742103|455175403|FG001|Overall Study|Death|2|||
126513786|NCT02742103|455175402|FG000|Overall Study|Adverse Event|1|||
126513787|NCT02742103|455175403|FG001|Overall Study|Adverse Event|0|||
126513788|NCT02742103|455175402|FG000|Overall Study|Moved to another town|0|||
126513789|NCT02742103|455175403|FG001|Overall Study|Moved to another town|1|||
126513790|NCT02742103|455175402|FG000|Overall Study|Withdrawal by Subject|5|||
126513791|NCT02742103|455175403|FG001|Overall Study|Withdrawal by Subject|2|||
126513792|NCT00991302|455175404|FG000|Overall Study|Death|0|||
126513793|NCT00991302|455175405|FG001|Overall Study|Death|1|||
126513794|NCT00991302|455175404|FG000|Overall Study|Lost to Follow-up|14|||
126513795|NCT00991302|455175405|FG001|Overall Study|Lost to Follow-up|12|||
126513796|NCT01709318|455175406|FG000|Overall Study|Adverse Event|3|||
126513797|NCT01709318|455175407|FG001|Overall Study|Adverse Event|4|||
126513798|NCT01709318|455175408|FG002|Overall Study|Adverse Event|2|||
126513799|NCT01709318|455175409|FG003|Overall Study|Adverse Event|2|||
126513800|NCT01709318|455175410|FG004|Overall Study|Adverse Event|0|||
126513801|NCT01709318|455175411|FG005|Overall Study|Adverse Event|1|||
126513802|NCT01709318|455175412|FG006|Overall Study|Adverse Event|2|||
126513803|NCT01709318|455175406|FG000|Overall Study|Lost to Follow-up|2|||
126513804|NCT01709318|455175407|FG001|Overall Study|Lost to Follow-up|0|||
126513805|NCT01709318|455175408|FG002|Overall Study|Lost to Follow-up|0|||
126513806|NCT01709318|455175409|FG003|Overall Study|Lost to Follow-up|0|||
126513807|NCT01709318|455175410|FG004|Overall Study|Lost to Follow-up|1|||
126513808|NCT01709318|455175411|FG005|Overall Study|Lost to Follow-up|1|||
126513809|NCT01709318|455175412|FG006|Overall Study|Lost to Follow-up|1|||
126513810|NCT01709318|455175406|FG000|Overall Study|Non-compliance with Study Drug|0|||
126513811|NCT01709318|455175407|FG001|Overall Study|Non-compliance with Study Drug|2|||
126513812|NCT01709318|455175408|FG002|Overall Study|Non-compliance with Study Drug|1|||
126513813|NCT01709318|455175409|FG003|Overall Study|Non-compliance with Study Drug|1|||
126513814|NCT01709318|455175410|FG004|Overall Study|Non-compliance with Study Drug|0|||
126513815|NCT01709318|455175411|FG005|Overall Study|Non-compliance with Study Drug|0|||
126513816|NCT01709318|455175412|FG006|Overall Study|Non-compliance with Study Drug|2|||
126513817|NCT01709318|455175406|FG000|Overall Study|Physician Decision|0|||
126513818|NCT01709318|455175407|FG001|Overall Study|Physician Decision|0|||
126513819|NCT01709318|455175408|FG002|Overall Study|Physician Decision|0|||
126513820|NCT01709318|455175409|FG003|Overall Study|Physician Decision|0|||
126513821|NCT01709318|455175410|FG004|Overall Study|Physician Decision|0|||
126513822|NCT01709318|455175411|FG005|Overall Study|Physician Decision|0|||
126513823|NCT01709318|455175412|FG006|Overall Study|Physician Decision|1|||
126513824|NCT01709318|455175406|FG000|Overall Study|Pregnancy|0|||
126513825|NCT01709318|455175407|FG001|Overall Study|Pregnancy|0|||
126513826|NCT01709318|455175408|FG002|Overall Study|Pregnancy|0|||
126513827|NCT01709318|455175409|FG003|Overall Study|Pregnancy|0|||
126513828|NCT01709318|455175410|FG004|Overall Study|Pregnancy|1|||
126568162|NCT00410124|455373874|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
126568163|NCT00410124|455373875|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
126568164|NCT00410124|455373874|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
126568165|NCT00410124|455373875|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
126568166|NCT00410124|455373874|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
126568167|NCT00410124|455373875|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
126568168|NCT00410124|455373874|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
126568169|NCT00410124|455373875|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
126568170|NCT00410124|455373874|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
126568171|NCT00410124|455373875|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
126568172|NCT00410124|455373874|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
126568173|NCT00410124|455373875|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
126568174|NCT02104765|455373878|FG000|Overall Study|Lost to Follow-up|0|||
126568175|NCT02104765|455373879|FG001|Overall Study|Lost to Follow-up|0|||
126568176|NCT02104765|455373880|FG002|Overall Study|Lost to Follow-up|1|||
126568177|NCT02104765|455373881|FG003|Overall Study|Lost to Follow-up|0|||
126568178|NCT02104765|455373882|FG004|Overall Study|Lost to Follow-up|0|||
126568179|NCT02104765|455373883|FG005|Overall Study|Lost to Follow-up|0|||
126568180|NCT02104765|455373884|FG006|Overall Study|Lost to Follow-up|0|||
126568181|NCT02104765|455373878|FG000|Overall Study|Withdrawal by Subject|0|||
126568182|NCT02104765|455373879|FG001|Overall Study|Withdrawal by Subject|0|||
126568183|NCT02104765|455373880|FG002|Overall Study|Withdrawal by Subject|0|||
126568184|NCT02104765|455373881|FG003|Overall Study|Withdrawal by Subject|1|||
126568185|NCT02104765|455373882|FG004|Overall Study|Withdrawal by Subject|1|||
126568186|NCT02104765|455373883|FG005|Overall Study|Withdrawal by Subject|0|||
126568187|NCT02104765|455373884|FG006|Overall Study|Withdrawal by Subject|1|||
126568188|NCT00995709|455373889|FG000|Overall Study|Adverse Event|4|||
126568189|NCT00995709|455373890|FG001|Overall Study|Adverse Event|2|||
126568190|NCT00995709|455373891|FG002|Overall Study|Adverse Event|0|||
126568191|NCT00995709|455373889|FG000|Overall Study|Lack of Efficacy|0|||
126568192|NCT00995709|455373890|FG001|Overall Study|Lack of Efficacy|1|||
126568193|NCT00995709|455373891|FG002|Overall Study|Lack of Efficacy|4|||
126568194|NCT00995709|455373889|FG000|Overall Study|Withdrawal by Subject|0|||
126568195|NCT00995709|455373890|FG001|Overall Study|Withdrawal by Subject|4|||
126568196|NCT00995709|455373891|FG002|Overall Study|Withdrawal by Subject|1|||
126568197|NCT00995709|455373889|FG000|Overall Study|Lost to Follow-up|1|||
126568198|NCT00995709|455373890|FG001|Overall Study|Lost to Follow-up|0|||
126568199|NCT00995709|455373891|FG002|Overall Study|Lost to Follow-up|0|||
126568200|NCT00995709|455373889|FG000|Overall Study|Death|0|||
126568201|NCT00995709|455373890|FG001|Overall Study|Death|1|||
126568202|NCT00995709|455373891|FG002|Overall Study|Death|0|||
126568203|NCT00995709|455373889|FG000|Overall Study|Protocol Violation|2|||
126568204|NCT00995709|455373890|FG001|Overall Study|Protocol Violation|1|||
126568205|NCT00995709|455373891|FG002|Overall Study|Protocol Violation|0|||
126568206|NCT01697319|455373892|FG000|Primary Phase|Withdrawal by Subject|1|||
126568207|NCT01697319|455373892|FG000|Extension Phase|Terminated by Sponsor|15|||
126568208|NCT04222959|455373893|FG000|Overall Study|Lost to Follow-up|76|||
126568209|NCT04222959|455373894|FG001|Overall Study|Lost to Follow-up|28|||
126568210|NCT03008915|455373895|FG000|Treatment 1|Withdrawal by Subject|0|||
126568211|NCT03008915|455373896|FG001|Treatment 1|Withdrawal by Subject|1|||
126568212|NCT00712166|455373899|FG000|Overall Study|Noncompliance|0|||
126568213|NCT00712166|455373900|FG001|Overall Study|Noncompliance|1|||
126568214|NCT01773122|455373901|FG000|Overall Study|Due to amended age eligibility criteria|3|||
126568215|NCT01773122|455373902|FG001|Overall Study|Due to amended age eligibility criteria|1|||
126568216|NCT01773122|455373903|FG002|Overall Study|Due to amended age eligibility criteria|0|||
126568217|NCT01773122|455373904|FG003|Overall Study|Due to amended age eligibility criteria|1|||
126568218|NCT01264718|455373905|FG000|Overall Study|Lost to Follow-up|3|||
126568219|NCT01264718|455373906|FG001|Overall Study|Lost to Follow-up|2|||
126568220|NCT01264718|455373905|FG000|Overall Study|Withdrawal by Subject|9|||
126568221|NCT01264718|455373906|FG001|Overall Study|Withdrawal by Subject|15|||
126568222|NCT01264718|455373905|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
126568223|NCT01264718|455373906|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
126568224|NCT01769391|455373907|FG000|Overall Study|Death|10|||
126568225|NCT01769391|455373908|FG001|Overall Study|Death|1|||
126568226|NCT01769391|455373907|FG000|Overall Study|Adverse Event|0|||
126568227|NCT01769391|455373908|FG001|Overall Study|Adverse Event|3|||
126568228|NCT01769391|455373907|FG000|Overall Study|Progressive Disease|1|||
126568229|NCT01769391|455373908|FG001|Overall Study|Progressive Disease|2|||
126568230|NCT01769391|455373907|FG000|Overall Study|Withdrawal by Subject|4|||
126568231|NCT01769391|455373908|FG001|Overall Study|Withdrawal by Subject|3|||
126568232|NCT01769391|455373907|FG000|Overall Study|Investigator Decision|2|||
126568233|NCT01769391|455373908|FG001|Overall Study|Investigator Decision|0|||
126568234|NCT01144182|455373910|FG000|Overall Study|Death|5|||
126568235|NCT01144182|455373911|FG001|Overall Study|Death|6|||
126568236|NCT01144182|455373910|FG000|Overall Study|Withdrawal by Subject|3|||
126568237|NCT01144182|455373911|FG001|Overall Study|Withdrawal by Subject|6|||
126568238|NCT01144182|455373910|FG000|Overall Study|Lost to Follow-up|9|||
126568239|NCT01144182|455373911|FG001|Overall Study|Lost to Follow-up|9|||
126568240|NCT03546907|455375351|FG000|Overall Study|Lack of Efficacy|1|||
126568241|NCT03546907|455375352|FG001|Overall Study|Lack of Efficacy|1|||
126568242|NCT03546907|455375351|FG000|Overall Study|Withdrawal by Subject|8|||
126568243|NCT03546907|455375352|FG001|Overall Study|Withdrawal by Subject|9|||
126568244|NCT03546907|455375351|FG000|Overall Study|Adverse events (AEs)|7|||
126568245|NCT03546907|455375352|FG001|Overall Study|Adverse events (AEs)|10|||
126568246|NCT03546907|455375351|FG000|Overall Study|Other-unspecified|1|||
126568247|NCT03546907|455375352|FG001|Overall Study|Other-unspecified|1|||
126568248|NCT01281813|455375353|FG000|Overall Study|Adverse Event|0|||
126568249|NCT01281813|455375354|FG001|Overall Study|Adverse Event|0|||
126568250|NCT01281813|455375355|FG002|Overall Study|Adverse Event|10|||
126568251|NCT01281813|455375353|FG000|Overall Study|Lost to Follow-up|0|||
126568252|NCT01281813|455375354|FG001|Overall Study|Lost to Follow-up|0|||
126568253|NCT01281813|455375355|FG002|Overall Study|Lost to Follow-up|31|||
126568254|NCT01281813|455375353|FG000|Overall Study|Withdrawal by Subject|0|||
126568255|NCT01281813|455375354|FG001|Overall Study|Withdrawal by Subject|0|||
126568256|NCT01281813|455375355|FG002|Overall Study|Withdrawal by Subject|13|||
126568257|NCT01281813|455375353|FG000|Overall Study|Subject Non-Compliant|0|||
126568258|NCT01281813|455375354|FG001|Overall Study|Subject Non-Compliant|0|||
126568259|NCT01281813|455375355|FG002|Overall Study|Subject Non-Compliant|6|||
126568260|NCT01281813|455375353|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
126568261|NCT01281813|455375354|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
126568262|NCT01281813|455375355|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
126568263|NCT01281813|455375353|FG000|Overall Study|Sponsor's Decision|4|||
126568264|NCT01281813|455375354|FG001|Overall Study|Sponsor's Decision|3|||
126568265|NCT01281813|455375355|FG002|Overall Study|Sponsor's Decision|7|||
126568266|NCT01281813|455375353|FG000|Overall Study|Switched to Commercially Available Medication|0|||
126568267|NCT01281813|455375354|FG001|Overall Study|Switched to Commercially Available Medication|0|||
126568268|NCT01281813|455375355|FG002|Overall Study|Switched to Commercially Available Medication|26|||
126568269|NCT01281813|455375353|FG000|Overall Study|Other|0|||
126568270|NCT01281813|455375354|FG001|Overall Study|Other|1|||
126568271|NCT01281813|455375355|FG002|Overall Study|Other|39|||
126568272|NCT04033432|455375358|FG000|Overall Study|Progressive Disease|8|||
126568273|NCT04033432|455375358|FG000|Overall Study|Adverse Event|4|||
126568274|NCT04033432|455375358|FG000|Overall Study|Death|1|||
126568275|NCT02192606|455375359|FG000|Overall Study|surgery type was changed|1|||
126568276|NCT02192606|455375360|FG001|Overall Study|surgery type was changed|1|||
126568277|NCT02192606|455375359|FG000|Overall Study|Physician Decision|1|||
126568278|NCT02192606|455375360|FG001|Overall Study|Physician Decision|2|||
126568279|NCT02192606|455375359|FG000|Overall Study|3D equipment rep unable to join|0|||
126568280|NCT02192606|455375360|FG001|Overall Study|3D equipment rep unable to join|1|||
126568281|NCT01458210|455375364|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
126568282|NCT01458210|455375364|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
126568283|NCT01458210|455375364|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
126568284|NCT01458210|455375364|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
126568285|NCT02034916|455375365|FG000|Overall Study|Death|39|||
126568286|NCT02034916|455375366|FG001|Overall Study|Death|28|||
126568287|NCT02034916|455375365|FG000|Overall Study|Withdrawal by Subject|2|||
126568288|NCT02034916|455375366|FG001|Overall Study|Withdrawal by Subject|1|||
126568289|NCT02034916|455375365|FG000|Overall Study|Lost to Follow-up|4|||
126568290|NCT02034916|455375366|FG001|Overall Study|Lost to Follow-up|1|||
126568291|NCT02034916|455375365|FG000|Overall Study|Study terminated by sponsor|4|||
126568292|NCT02034916|455375366|FG001|Overall Study|Study terminated by sponsor|5|||
126568293|NCT01616654|455375371|FG000|Overall Study|Lack of Efficacy|1|||
126568294|NCT01616654|455375372|FG001|Overall Study|Lack of Efficacy|0|||
126568295|NCT01616654|455375373|FG002|Overall Study|Lack of Efficacy|0|||
126568296|NCT01616654|455375374|FG003|Overall Study|Lack of Efficacy|0|||
126568297|NCT01616654|455375375|FG004|Overall Study|Lack of Efficacy|1|||
126568298|NCT01616654|455375371|FG000|Overall Study|Adverse Event|0|||
126568299|NCT01616654|455375372|FG001|Overall Study|Adverse Event|1|||
126568300|NCT01616654|455375373|FG002|Overall Study|Adverse Event|2|||
126568301|NCT01616654|455375374|FG003|Overall Study|Adverse Event|1|||
126568302|NCT01616654|455375375|FG004|Overall Study|Adverse Event|0|||
126568303|NCT01616654|455375371|FG000|Overall Study|Withdrawal by Subject|2|||
126568304|NCT01616654|455375372|FG001|Overall Study|Withdrawal by Subject|2|||
126568305|NCT01616654|455375373|FG002|Overall Study|Withdrawal by Subject|3|||
126568306|NCT01616654|455375374|FG003|Overall Study|Withdrawal by Subject|1|||
126568307|NCT01616654|455375375|FG004|Overall Study|Withdrawal by Subject|5|||
126568308|NCT01616654|455375371|FG000|Overall Study|Protocol Violation|0|||
126568309|NCT01616654|455375372|FG001|Overall Study|Protocol Violation|5|||
126568310|NCT01616654|455375373|FG002|Overall Study|Protocol Violation|2|||
126568311|NCT01616654|455375374|FG003|Overall Study|Protocol Violation|4|||
126568312|NCT01616654|455375375|FG004|Overall Study|Protocol Violation|4|||
126568313|NCT01616654|455375371|FG000|Overall Study|Lost to Follow-up|1|||
126568314|NCT01616654|455375372|FG001|Overall Study|Lost to Follow-up|0|||
126568315|NCT01616654|455375373|FG002|Overall Study|Lost to Follow-up|3|||
126568316|NCT01616654|455375374|FG003|Overall Study|Lost to Follow-up|2|||
126568317|NCT01616654|455375375|FG004|Overall Study|Lost to Follow-up|1|||
126568318|NCT01616654|455375371|FG000|Overall Study|Pregnancy|1|||
126568319|NCT01616654|455375372|FG001|Overall Study|Pregnancy|0|||
126568320|NCT01616654|455375373|FG002|Overall Study|Pregnancy|0|||
126568321|NCT01616654|455375374|FG003|Overall Study|Pregnancy|0|||
126568322|NCT01616654|455375375|FG004|Overall Study|Pregnancy|1|||
126568323|NCT02057692|455375379|FG000|Overall Study|Adverse Event|1|||
126568324|NCT02057692|455375380|FG001|Overall Study|Adverse Event|0|||
126568325|NCT02057692|455375381|FG002|Overall Study|Adverse Event|0|||
126568326|NCT02057692|455375382|FG003|Overall Study|Adverse Event|0|||
126568327|NCT02057692|455375379|FG000|Overall Study|Lost to Follow-up|0|||
126568328|NCT02057692|455375380|FG001|Overall Study|Lost to Follow-up|0|||
126568329|NCT02057692|455375381|FG002|Overall Study|Lost to Follow-up|0|||
126568330|NCT02057692|455375382|FG003|Overall Study|Lost to Follow-up|1|||
126568331|NCT00864682|455375385|FG000|Overall Study|Protocol Violation|2|||
126568332|NCT00864682|455375386|FG001|Overall Study|Protocol Violation|1|||
126568333|NCT00864682|455375387|FG002|Overall Study|Protocol Violation|2|||
126568334|NCT00957658|455375388|FG000|Overall Study|Death|1|||
126568335|NCT00957658|455375388|FG000|Overall Study|Lost to Follow-up|4|||
126568336|NCT00957658|455375388|FG000|Overall Study|Withdrawal by Subject|12|||
126568337|NCT00957658|455375388|FG000|Overall Study|Revision|1|||
126568338|NCT00957658|455375388|FG000|Overall Study|Incomplete 2 yr data|28|||
126568339|NCT00957658|455375388|FG000|Overall Study|Site termination|10|||
126568340|NCT00957658|455375388|FG000|Overall Study|unwilling/unable to return|2|||
126568341|NCT00957658|455375388|FG000|Overall Study|surgery cancelled|2|||
126568342|NCT00957658|455375388|FG000|Overall Study|Protocol Violation|5|||
126568343|NCT01833832|455375389|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
126568344|NCT00608907|455375390|FG000|Overall Study|Adverse Event|6|||
126568345|NCT00608907|455375391|FG001|Overall Study|Adverse Event|0|||
126568346|NCT00608907|455375392|FG002|Overall Study|Adverse Event|1|||
126568347|NCT00608907|455375390|FG000|Overall Study|Death|1|||
126568348|NCT00608907|455375391|FG001|Overall Study|Death|0|||
126568349|NCT00608907|455375392|FG002|Overall Study|Death|0|||
126568350|NCT00608907|455375390|FG000|Overall Study|Withdrawal by Subject|4|||
126568351|NCT00608907|455375391|FG001|Overall Study|Withdrawal by Subject|0|||
126568352|NCT00608907|455375392|FG002|Overall Study|Withdrawal by Subject|0|||
126513829|NCT01709318|455175411|FG005|Overall Study|Pregnancy|0|||
126513830|NCT01709318|455175412|FG006|Overall Study|Pregnancy|0|||
126513831|NCT01709318|455175406|FG000|Overall Study|Protocol Violation|0|||
126513832|NCT01709318|455175407|FG001|Overall Study|Protocol Violation|0|||
126513833|NCT01709318|455175408|FG002|Overall Study|Protocol Violation|0|||
126513834|NCT01709318|455175409|FG003|Overall Study|Protocol Violation|0|||
126513835|NCT01709318|455175410|FG004|Overall Study|Protocol Violation|2|||
126513836|NCT01709318|455175411|FG005|Overall Study|Protocol Violation|0|||
126513837|NCT01709318|455175412|FG006|Overall Study|Protocol Violation|1|||
126513838|NCT01709318|455175406|FG000|Overall Study|Technical Problems|1|||
126513839|NCT01709318|455175407|FG001|Overall Study|Technical Problems|0|||
126513840|NCT01709318|455175408|FG002|Overall Study|Technical Problems|0|||
126513841|NCT01709318|455175409|FG003|Overall Study|Technical Problems|0|||
126513842|NCT01709318|455175410|FG004|Overall Study|Technical Problems|0|||
126513843|NCT01709318|455175411|FG005|Overall Study|Technical Problems|0|||
126513844|NCT01709318|455175412|FG006|Overall Study|Technical Problems|0|||
126513845|NCT01709318|455175406|FG000|Overall Study|Withdrawal by Subject|3|||
126513846|NCT01709318|455175407|FG001|Overall Study|Withdrawal by Subject|0|||
126513847|NCT01709318|455175408|FG002|Overall Study|Withdrawal by Subject|3|||
126513848|NCT01709318|455175409|FG003|Overall Study|Withdrawal by Subject|3|||
126513849|NCT01709318|455175410|FG004|Overall Study|Withdrawal by Subject|0|||
126513850|NCT01709318|455175411|FG005|Overall Study|Withdrawal by Subject|2|||
126513851|NCT01709318|455175412|FG006|Overall Study|Withdrawal by Subject|4|||
126513852|NCT01709318|455175406|FG000|Overall Study|Other Protocol Specified Criteria|0|||
126513853|NCT01709318|455175407|FG001|Overall Study|Other Protocol Specified Criteria|1|||
126513854|NCT01709318|455175408|FG002|Overall Study|Other Protocol Specified Criteria|0|||
126513855|NCT01709318|455175409|FG003|Overall Study|Other Protocol Specified Criteria|0|||
126513856|NCT01709318|455175410|FG004|Overall Study|Other Protocol Specified Criteria|0|||
126513857|NCT01709318|455175411|FG005|Overall Study|Other Protocol Specified Criteria|0|||
126513858|NCT01709318|455175412|FG006|Overall Study|Other Protocol Specified Criteria|0|||
126513859|NCT03042312|455175413|FG000|Overall Study|Administrative Reason|1|||
126513860|NCT03042312|455175414|FG001|Overall Study|Administrative Reason|1|||
126513861|NCT03042312|455175413|FG000|Overall Study|Adverse Event|0|||
126513862|NCT03042312|455175414|FG001|Overall Study|Adverse Event|1|||
126568353|NCT00608907|455375390|FG000|Overall Study|Progressive Disease|1|||
126568354|NCT00608907|455375391|FG001|Overall Study|Progressive Disease|0|||
126568355|NCT00608907|455375392|FG002|Overall Study|Progressive Disease|0|||
126568356|NCT01988233|455375393|FG000|Overall Study|Lost to Follow-up|64|||
126568357|NCT01988233|455375394|FG001|Overall Study|Lost to Follow-up|51|||
126568358|NCT03621761|455375395|FG000|Overall Study|Lost to Follow-up|1|||
126568359|NCT03621761|455375396|FG001|Overall Study|Lost to Follow-up|1|||
126568360|NCT03621761|455375397|FG002|Overall Study|Lost to Follow-up|2|||
126568361|NCT03621761|455375395|FG000|Overall Study|Withdrawal by Subject|2|||
126568362|NCT03621761|455375396|FG001|Overall Study|Withdrawal by Subject|1|||
126568363|NCT03621761|455375397|FG002|Overall Study|Withdrawal by Subject|1|||
126568364|NCT03621761|455375395|FG000|Overall Study|Became Ineligible|0|||
126568365|NCT03621761|455375396|FG001|Overall Study|Became Ineligible|2|||
126568366|NCT03621761|455375397|FG002|Overall Study|Became Ineligible|0|||
126568367|NCT03939819|455375398|FG000|Overall Study|Death|2|||
126568368|NCT03939819|455375399|FG001|Overall Study|Death|0|||
126568369|NCT01186848|455375400|FG000|Overall Study|Lost to Follow-up|4|||
126568370|NCT01186848|455375400|FG000|Overall Study|Withdrawal by Subject|2|||
126568371|NCT01186848|455375400|FG000|Overall Study|Adverse Event|2|||
126568372|NCT01183780|455375413|FG000|Overall Study|Withdrawal by Subject|25|||
126568373|NCT01183780|455375414|FG001|Overall Study|Withdrawal by Subject|14|||
126568374|NCT01183780|455375413|FG000|Overall Study|Lost to Follow-up|6|||
126568375|NCT01183780|455375414|FG001|Overall Study|Lost to Follow-up|11|||
126568376|NCT02148133|455375415|FG000|Overall Study|Investigator discretion|1|||
126568377|NCT02148133|455375415|FG000|Overall Study|Lack of Efficacy|1|||
126568378|NCT02148133|455375415|FG000|Overall Study|Protocol deviation|1|||
126568379|NCT02148133|455375415|FG000|Overall Study|Protocol-defined stopping criteria|2|||
126568380|NCT00079183|455375421|FG000|Overall Study|Withdrawal by Subject|4|||
126568381|NCT00079183|455375421|FG000|Overall Study|Study medication non-compliance|2|||
126568382|NCT00079183|455375421|FG000|Overall Study|Specimen collection non-compliance|1|||
126568383|NCT02613364|455375422|FG000|Overall Study|Other|19|||
126568384|NCT02613364|455375423|FG001|Overall Study|Other|29|||
126568385|NCT02613364|455375424|FG002|Overall Study|Other|17|||
126568386|NCT02613364|455375422|FG000|Overall Study|Too time consuming|21|||
126568387|NCT02613364|455375423|FG001|Overall Study|Too time consuming|26|||
126568388|NCT02613364|455375424|FG002|Overall Study|Too time consuming|26|||
126568389|NCT02613364|455375422|FG000|Overall Study|Withdrawal by Subject|13|||
126568390|NCT02613364|455375423|FG001|Overall Study|Withdrawal by Subject|18|||
126568391|NCT02613364|455375424|FG002|Overall Study|Withdrawal by Subject|17|||
126568392|NCT02613364|455375422|FG000|Overall Study|Medical|12|||
126568393|NCT02613364|455375423|FG001|Overall Study|Medical|13|||
126568394|NCT02613364|455375424|FG002|Overall Study|Medical|9|||
126568395|NCT02613364|455375422|FG000|Overall Study|Disliked Study Procedure|1|||
126568396|NCT02613364|455375423|FG001|Overall Study|Disliked Study Procedure|1|||
126568397|NCT02613364|455375424|FG002|Overall Study|Disliked Study Procedure|4|||
126568398|NCT02613364|455375422|FG000|Overall Study|Disliked Intervention|0|||
126568399|NCT02613364|455375423|FG001|Overall Study|Disliked Intervention|3|||
126568400|NCT02613364|455375424|FG002|Overall Study|Disliked Intervention|3|||
126568401|NCT00371566|455375427|FG000|Treatment Phase|Withdrawal by Subject|0|||
126568402|NCT00371566|455375428|FG001|Treatment Phase|Withdrawal by Subject|1|||
126568403|NCT00371566|455375427|FG000|Treatment Phase|Adverse Event|0|||
126568404|NCT00371566|455375428|FG001|Treatment Phase|Adverse Event|1|||
126568405|NCT00371566|455375427|FG000|Treatment Phase|Protocol Violation|0|||
126568406|NCT00371566|455375428|FG001|Treatment Phase|Protocol Violation|1|||
126568407|NCT00371566|455375427|FG000|Chemoradiation Phase|Physician Decision|2|||
126568408|NCT00371566|455375428|FG001|Chemoradiation Phase|Physician Decision|0|||
126568409|NCT00371566|455375427|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
126568410|NCT00371566|455375428|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
126568411|NCT00371566|455375427|FG000|Chemoradiation Phase|Non compliant|0|||
126568412|NCT00371566|455375428|FG001|Chemoradiation Phase|Non compliant|1|||
126568413|NCT00371566|455375427|FG000|Chemoradiation Phase|Progressive Disease|1|||
126568414|NCT00371566|455375428|FG001|Chemoradiation Phase|Progressive Disease|1|||
126568415|NCT00371566|455375427|FG000|Chemoradiation Phase|Death|2|||
126568416|NCT00371566|455375428|FG001|Chemoradiation Phase|Death|0|||
126568417|NCT00371566|455375427|FG000|Follow Up Phase|Death|0|||
126568418|NCT00371566|455375428|FG001|Follow Up Phase|Death|5|||
126568419|NCT00371566|455375427|FG000|Follow Up Phase|Disease progression|1|||
126568420|NCT00371566|455375428|FG001|Follow Up Phase|Disease progression|0|||
126568421|NCT00371566|455375427|FG000|Follow Up Phase|Withdrawal by Subject|0|||
126568422|NCT00371566|455375428|FG001|Follow Up Phase|Withdrawal by Subject|1|||
126568423|NCT00371566|455375427|FG000|Follow Up Phase|Physician Decision|1|||
126568424|NCT00371566|455375428|FG001|Follow Up Phase|Physician Decision|1|||
126568425|NCT00371566|455375427|FG000|Follow Up Phase|Lost to Follow-up|1|||
126568426|NCT00371566|455375428|FG001|Follow Up Phase|Lost to Follow-up|0|||
126568427|NCT02873754|455375429|FG000|Overall Study|Lost to Follow-up|5|||
126568428|NCT02873754|455375429|FG000|Overall Study|Couldn't complete study procedures|1|||
126568429|NCT00972504|455375430|FG000|Overall Study|Adverse Event|2|||
126568430|NCT00972504|455375430|FG000|Overall Study|Investigator discretion|1|||
126568431|NCT01161498|455375431|FG000|Overall Study|Disease Progression|0|||
126568432|NCT01161498|455375432|FG001|Overall Study|Disease Progression|1|||
126568433|NCT02807493|455375435|FG000|Overall Study|Adverse Event|5|||
126568434|NCT02807493|455375436|FG001|Overall Study|Adverse Event|2|||
126568435|NCT02807493|455375435|FG000|Overall Study|Lost to Follow-up|6|||
126568436|NCT02807493|455375436|FG001|Overall Study|Lost to Follow-up|0|||
126568437|NCT02807493|455375435|FG000|Overall Study|Physician Decision|4|||
126568438|NCT02807493|455375436|FG001|Overall Study|Physician Decision|1|||
126568439|NCT02807493|455375435|FG000|Overall Study|Protocol Violation|7|||
126568440|NCT02807493|455375436|FG001|Overall Study|Protocol Violation|0|||
126568441|NCT02807493|455375435|FG000|Overall Study|Withdrawal by Subject|17|||
126568442|NCT02807493|455375436|FG001|Overall Study|Withdrawal by Subject|10|||
126568443|NCT02807493|455375435|FG000|Overall Study|Other withdrawal|17|||
126568444|NCT02807493|455375436|FG001|Overall Study|Other withdrawal|0|||
126568445|NCT02807493|455375435|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
126568446|NCT02807493|455375436|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
126568447|NCT00811057|455375437|FG000|Overall Study|Protocol Violation|5|||
126568448|NCT00811057|455375438|FG001|Overall Study|Protocol Violation|10|||
126568449|NCT00811057|455375439|FG002|Overall Study|Protocol Violation|10|||
126568450|NCT00768651|455375444|FG000|Overall Study|Withdrawal by Subject|1|||
126568451|NCT03264456|455375451|FG000|Overall Study|Withdrawal by Subject|3|||
126568452|NCT03264456|455375451|FG000|Overall Study|Lost to Follow-up|1|||
126568453|NCT03538054|455375452|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
126568454|NCT03538054|455375452|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
126568455|NCT03538054|455375452|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
126568456|NCT03254394|455375453|FG000|Overall Study|Withdrawal by Subject|0|||
126568457|NCT03254394|455375454|FG001|Overall Study|Withdrawal by Subject|2|||
126568458|NCT02351180|455375457|FG000|Overall Study|Withdrawal by Subject|1|||
126568459|NCT02351180|455375458|FG001|Overall Study|Withdrawal by Subject|0|||
126568460|NCT01123083|455375465|FG000|Overall Study|Investigator recommendation|1|||
126568461|NCT01123083|455375466|FG001|Overall Study|Investigator recommendation|1|||
126568462|NCT01123083|455375465|FG000|Overall Study|Administrative reasons|0|||
126568463|NCT01123083|455375466|FG001|Overall Study|Administrative reasons|4|||
126568464|NCT01123083|455375465|FG000|Overall Study|Lost to Follow-up|2|||
126568465|NCT01123083|455375466|FG001|Overall Study|Lost to Follow-up|6|||
126568466|NCT01123083|455375465|FG000|Overall Study|Adverse Event|1|||
126568467|NCT01123083|455375466|FG001|Overall Study|Adverse Event|0|||
126568468|NCT01123083|455375465|FG000|Overall Study|Withdrew for another reason not covered|0|||
126568469|NCT01123083|455375466|FG001|Overall Study|Withdrew for another reason not covered|1|||
126568470|NCT01123083|455375465|FG000|Overall Study|Participant/legal representative request|7|||
126568471|NCT01123083|455375466|FG001|Overall Study|Participant/legal representative request|3|||
126568472|NCT03418324|455375467|FG000|Overall Study|Death|0|||
126568473|NCT03418324|455375468|FG001|Overall Study|Death|1|||
126568474|NCT03418324|455375467|FG000|Overall Study|Physician Decision|1|||
126568475|NCT03418324|455375468|FG001|Overall Study|Physician Decision|1|||
126568476|NCT01751724|455375469|FG000|Overall Study|extubated bef.start assigned treatment|1|||
126568477|NCT01751724|455375470|FG001|Overall Study|extubated bef.start assigned treatment|0|||
126568478|NCT01751724|455375469|FG000|Overall Study|withdrawn by parent|0|||
126568479|NCT01751724|455375470|FG001|Overall Study|withdrawn by parent|2|||
126568480|NCT03121950|455375472|FG000|Overall Study|Withdrawal by Subject|11|||
126568481|NCT03121950|455375473|FG001|Overall Study|Withdrawal by Subject|2|||
126568482|NCT01867580|455375474|FG000|Overall Study|Withdrawal by Subject|2|||
126568483|NCT01867580|455375475|FG001|Overall Study|Withdrawal by Subject|3|||
126568484|NCT01867580|455375474|FG000|Overall Study|Physician Decision|17|||
126568485|NCT01867580|455375475|FG001|Overall Study|Physician Decision|12|||
126568486|NCT01867580|455375474|FG000|Overall Study|Lost to Follow-up|3|||
126513863|NCT03042312|455175413|FG000|Overall Study|Lost to Follow-up|1|||
126513864|NCT03042312|455175414|FG001|Overall Study|Lost to Follow-up|3|||
126513865|NCT03042312|455175413|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
126513866|NCT03042312|455175414|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
126513867|NCT03042312|455175413|FG000|Overall Study|Withdrawal by Subject|4|||
126513868|NCT03042312|455175414|FG001|Overall Study|Withdrawal by Subject|5|||
126513869|NCT02383758|455175415|FG000|Overall Study|Withdrawal by Subject|0|||
126513870|NCT02383758|455175416|FG001|Overall Study|Withdrawal by Subject|2|||
126513871|NCT00646958|455175421|FG000|Overall Study|Lack of Efficacy|1|||
126513872|NCT00646958|455175422|FG001|Overall Study|Lack of Efficacy|0|||
126513873|NCT00646958|455175423|FG002|Overall Study|Lack of Efficacy|0|||
126513874|NCT00646958|455175421|FG000|Overall Study|Adverse Event|4|||
126513875|NCT00646958|455175422|FG001|Overall Study|Adverse Event|0|||
126513876|NCT00646958|455175423|FG002|Overall Study|Adverse Event|0|||
126513877|NCT00646958|455175421|FG000|Overall Study|Lost to Follow-up|1|||
126513878|NCT00646958|455175422|FG001|Overall Study|Lost to Follow-up|5|||
126513879|NCT00646958|455175423|FG002|Overall Study|Lost to Follow-up|7|||
126513880|NCT00646958|455175421|FG000|Overall Study|Protocol Violation|1|||
126513881|NCT00646958|455175422|FG001|Overall Study|Protocol Violation|1|||
126513882|NCT00646958|455175423|FG002|Overall Study|Protocol Violation|0|||
126513883|NCT00646958|455175421|FG000|Overall Study|Abnormal screening lab tests|1|||
126568487|NCT01867580|455375475|FG001|Overall Study|Lost to Follow-up|5|||
126568488|NCT01867580|455375474|FG000|Overall Study|Sponsor terminated study|1|||
126568489|NCT01867580|455375475|FG001|Overall Study|Sponsor terminated study|0|||
126568490|NCT01867580|455375474|FG000|Overall Study|Missed follow-up assessment|2|||
126568491|NCT01867580|455375475|FG001|Overall Study|Missed follow-up assessment|1|||
126513884|NCT00646958|455175422|FG001|Overall Study|Abnormal screening lab tests|1|||
126513885|NCT00646958|455175423|FG002|Overall Study|Abnormal screening lab tests|0|||
126513886|NCT00646958|455175421|FG000|Overall Study|Withdrawal by Subject|1|||
126513887|NCT00646958|455175422|FG001|Overall Study|Withdrawal by Subject|2|||
126513888|NCT00646958|455175423|FG002|Overall Study|Withdrawal by Subject|0|||
126513889|NCT00646958|455175421|FG000|Overall Study|Did not receive study drug|2|||
126513890|NCT00646958|455175422|FG001|Overall Study|Did not receive study drug|0|||
126513891|NCT00646958|455175423|FG002|Overall Study|Did not receive study drug|2|||
126513892|NCT00600821|455175425|FG000|Overall Study|Death|45|||
126513893|NCT00600821|455175426|FG001|Overall Study|Death|46|||
126513894|NCT00600821|455175425|FG000|Overall Study|Lost to Follow-up|2|||
126513895|NCT00600821|455175426|FG001|Overall Study|Lost to Follow-up|2|||
126513896|NCT00600821|455175425|FG000|Overall Study|Withdrawal by Subject|1|||
126513897|NCT00600821|455175426|FG001|Overall Study|Withdrawal by Subject|1|||
126513898|NCT00600821|455175425|FG000|Overall Study|Terminated by sponsor|8|||
126513899|NCT00600821|455175426|FG001|Overall Study|Terminated by sponsor|6|||
126513900|NCT00600821|455175425|FG000|Overall Study|Objective progression or relapse|0|||
126513901|NCT00600821|455175426|FG001|Overall Study|Objective progression or relapse|1|||
126513902|NCT00600821|455175425|FG000|Overall Study|Randomized but not treated|0|||
126513903|NCT00600821|455175426|FG001|Overall Study|Randomized but not treated|1|||
126513904|NCT00600821|455175425|FG000|Overall Study|Other|2|||
126513905|NCT00600821|455175426|FG001|Overall Study|Other|3|||
126513906|NCT00659646|455175432|FG000|Overall Study|Protocol Violation|12|||
126513907|NCT00659646|455175433|FG001|Overall Study|Protocol Violation|8|||
126513908|NCT00659646|455175432|FG000|Overall Study|Adverse Event|1|||
126513909|NCT00659646|455175433|FG001|Overall Study|Adverse Event|0|||
126513910|NCT00659646|455175432|FG000|Overall Study|Lost to Follow-up|1|||
126513911|NCT00659646|455175433|FG001|Overall Study|Lost to Follow-up|0|||
126513912|NCT00659646|455175432|FG000|Overall Study|protocol noncompliance after randomized|1|||
126513913|NCT00659646|455175433|FG001|Overall Study|protocol noncompliance after randomized|0|||
126513914|NCT00023673|455175434|FG000|Overall Study|Ineligible / no protocol treatment|0|||
126513915|NCT00023673|455175435|FG001|Overall Study|Ineligible / no protocol treatment|0|||
126513916|NCT00023673|455175436|FG002|Overall Study|Ineligible / no protocol treatment|0|||
126513917|NCT00023673|455175437|FG003|Overall Study|Ineligible / no protocol treatment|1|||
126513918|NCT00023673|455175434|FG000|Overall Study|Patient withdrew consent|0|||
126513919|NCT00023673|455175435|FG001|Overall Study|Patient withdrew consent|0|||
126513920|NCT00023673|455175436|FG002|Overall Study|Patient withdrew consent|0|||
126513921|NCT00023673|455175437|FG003|Overall Study|Patient withdrew consent|1|||
126513922|NCT02453594|455175441|FG000|Overall Study|Protocol Violation|0|||
126513923|NCT02453594|455175442|FG001|Overall Study|Protocol Violation|0|||
126513924|NCT02453594|455175443|FG002|Overall Study|Protocol Violation|1|||
126513925|NCT02453594|455175441|FG000|Overall Study|Cohort Was Closed|17|||
126513926|NCT02453594|455175442|FG001|Overall Study|Cohort Was Closed|21|||
126513927|NCT02453594|455175443|FG002|Overall Study|Cohort Was Closed|14|||
126513928|NCT02453594|455175441|FG000|Overall Study|Death|20|||
126513929|NCT02453594|455175442|FG001|Overall Study|Death|24|||
126513930|NCT02453594|455175443|FG002|Overall Study|Death|16|||
126513931|NCT02453594|455175441|FG000|Overall Study|Lost to Follow-up|6|||
126513932|NCT02453594|455175442|FG001|Overall Study|Lost to Follow-up|14|||
126513933|NCT02453594|455175443|FG002|Overall Study|Lost to Follow-up|2|||
126513934|NCT02453594|455175441|FG000|Overall Study|Physician Decision|2|||
126513935|NCT02453594|455175442|FG001|Overall Study|Physician Decision|4|||
126513936|NCT02453594|455175443|FG002|Overall Study|Physician Decision|0|||
126513937|NCT02453594|455175441|FG000|Overall Study|Site Terminated by Sponsor|1|||
126513938|NCT02453594|455175442|FG001|Overall Study|Site Terminated by Sponsor|0|||
126513939|NCT02453594|455175443|FG002|Overall Study|Site Terminated by Sponsor|1|||
126513940|NCT02453594|455175441|FG000|Overall Study|Transitioned to Extension Study|16|||
126513941|NCT02453594|455175442|FG001|Overall Study|Transitioned to Extension Study|9|||
126513942|NCT02453594|455175443|FG002|Overall Study|Transitioned to Extension Study|16|||
126513943|NCT02453594|455175441|FG000|Overall Study|Withdrawal by Subject|7|||
126513944|NCT02453594|455175442|FG001|Overall Study|Withdrawal by Subject|9|||
126513945|NCT02453594|455175443|FG002|Overall Study|Withdrawal by Subject|11|||
126513946|NCT04101526|455175453|FG000|Overall Study|Did not complete all sleep diary entries|0|||
126513947|NCT04101526|455175454|FG001|Overall Study|Did not complete all sleep diary entries|1|||
126513948|NCT02652624|455175455|FG000|Randomized Phase|Pregnancy|3|||
126513949|NCT02652624|455175456|FG001|Randomized Phase|Pregnancy|1|||
126513950|NCT02652624|455175455|FG000|Randomized Phase|Investigator's Discretion|0|||
126513951|NCT02652624|455175456|FG001|Randomized Phase|Investigator's Discretion|2|||
126513952|NCT02652624|455175455|FG000|Randomized Phase|Death|0|||
126513953|NCT02652624|455175456|FG001|Randomized Phase|Death|1|||
126513954|NCT02652624|455175455|FG000|Randomized Phase|Lost to Follow-up|0|||
126513955|NCT02652624|455175456|FG001|Randomized Phase|Lost to Follow-up|1|||
126513956|NCT02652624|455175455|FG000|Extension Phase|Lost to Follow-up|3|||
126513957|NCT02652624|455175456|FG001|Extension Phase|Lost to Follow-up|1|||
126513958|NCT02652624|455175455|FG000|Extension Phase|Pregnancy|1|||
126513959|NCT02652624|455175456|FG001|Extension Phase|Pregnancy|1|||
126513960|NCT02652624|455175455|FG000|Extension Phase|Adverse Event|0|||
126513961|NCT02652624|455175456|FG001|Extension Phase|Adverse Event|1|||
126513962|NCT02652624|455175455|FG000|Extension Phase|Withdrew Consent|0|||
126513963|NCT02652624|455175456|FG001|Extension Phase|Withdrew Consent|1|||
126513964|NCT01023659|455175457|FG000|Overall Study|Lost to Follow-up|73|||
126513965|NCT01023659|455175458|FG001|Overall Study|Lost to Follow-up|228|||
126513966|NCT01023659|455175459|FG002|Overall Study|Lost to Follow-up|99|||
126513967|NCT00912405|455175460|FG000|Overall Study|Lost to Follow-up|5|||
126513968|NCT00501540|455175463|FG000|Overall Study|Death|5|||
126513969|NCT01797536|455175464|FG000|Overall Study|Adverse Event|0|||
126513970|NCT01797536|455175465|FG001|Overall Study|Adverse Event|1|||
126513971|NCT01797536|455175466|FG002|Overall Study|Adverse Event|0|||
126513972|NCT01797536|455175467|FG003|Overall Study|Adverse Event|0|||
126513973|NCT00098839|455175468|FG000|Overall Study|Adverse Event|5|||
126513974|NCT00098839|455175469|FG001|Overall Study|Adverse Event|2|||
126513975|NCT00098839|455175468|FG000|Overall Study|Death|1|||
126513976|NCT00098839|455175469|FG001|Overall Study|Death|2|||
126513977|NCT00098839|455175468|FG000|Overall Study|Physician Decision|4|||
126513978|NCT00098839|455175469|FG001|Overall Study|Physician Decision|14|||
126513979|NCT00098839|455175468|FG000|Overall Study|Withdrawal by Subject|1|||
126513980|NCT00098839|455175469|FG001|Overall Study|Withdrawal by Subject|0|||
126513981|NCT00098839|455175468|FG000|Overall Study|Refusal of further protocol therapy|3|||
126513982|NCT00098839|455175469|FG001|Overall Study|Refusal of further protocol therapy|1|||
126513983|NCT00098839|455175468|FG000|Overall Study|Relapse|6|||
126513984|NCT00098839|455175469|FG001|Overall Study|Relapse|3|||
126513985|NCT00098839|455175468|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
126513986|NCT00098839|455175469|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
126513987|NCT00098839|455175468|FG000|Overall Study|Ineligible|2|||
126513988|NCT00098839|455175469|FG001|Overall Study|Ineligible|0|||
126513989|NCT02167035|455175471|FG000|Overall Study|Adverse Event|2|||
126513990|NCT02167035|455175472|FG001|Overall Study|Adverse Event|2|||
126513991|NCT02167035|455175471|FG000|Overall Study|Lost to Follow-up|3|||
126513992|NCT02167035|455175472|FG001|Overall Study|Lost to Follow-up|3|||
126513993|NCT02167035|455175471|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
126513994|NCT02167035|455175472|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
126513995|NCT02148003|455175473|FG000|Overall Study|Failed inclusion criteria|1|||
126513996|NCT02148003|455175474|FG001|Overall Study|Failed inclusion criteria|0|||
126513997|NCT02148003|455175473|FG000|Overall Study|Met exclusion criteria|0|||
126513998|NCT02148003|455175474|FG001|Overall Study|Met exclusion criteria|1|||
126513999|NCT02148003|455175473|FG000|Overall Study|Withdrawal by Subject|0|||
126514000|NCT02148003|455175474|FG001|Overall Study|Withdrawal by Subject|1|||
126514001|NCT02489981|455175475|FG000|Overall Study|Adverse Event|21|||
126514002|NCT02489981|455175475|FG000|Overall Study|Insufficient effectiveness|16|||
126514003|NCT02489981|455175475|FG000|Overall Study|Improved|31|||
126514004|NCT02489981|455175475|FG000|Overall Study|Lost to Follow-up|31|||
126514005|NCT02489981|455175475|FG000|Overall Study|Other than listed|28|||
126514006|NCT03852316|455175478|FG000|Overall Study|Protocol Violation|1|||
126514007|NCT03852316|455175478|FG000|Overall Study|Withdrawal by Subject|2|||
126514008|NCT03852316|455175478|FG000|Overall Study|Enrolled but Device not Utilized|1|||
126514009|NCT02178475|455175479|FG000|Overall Study|Withdrawal by Subject|7|||
126514010|NCT02178475|455175479|FG000|Overall Study|Lost to Follow-up|10|||
126514011|NCT02178475|455175479|FG000|Overall Study|Death|13|||
126514012|NCT02178475|455175479|FG000|Overall Study|Protocol-specified Criteria|99|||
126514013|NCT01412424|455175480|FG000|Core Treatment Period|Treatment Failure|24|||
126514014|NCT01412424|455175480|FG000|Core Treatment Period|Adverse Event|21|||
126514015|NCT01412424|455175480|FG000|Core Treatment Period|Patient Request|5|||
126514016|NCT01412424|455175480|FG000|Core Treatment Period|Lost to Follow-up|2|||
126514017|NCT01412424|455175480|FG000|Core Treatment Period|Sponsor Request|1|||
126514018|NCT01412424|455175480|FG000|Extension Treatment Period|Adverse Event|2|||
126514019|NCT01412424|455175480|FG000|Extension Treatment Period|Treatment Failure|2|||
126514020|NCT01412424|455175480|FG000|Extension Treatment Period|Patient Request|2|||
126514021|NCT04304001|455175483|FG000|Overall Study|Lost to Follow-up|13|||
126514022|NCT04304001|455175484|FG001|Overall Study|Lost to Follow-up|9|||
126514023|NCT03296696|455175487|FG000|Overall Study|Started Other Antitumor Therapy|1|||
126514024|NCT03296696|455175488|FG001|Overall Study|Started Other Antitumor Therapy|2|||
126514025|NCT03296696|455175489|FG002|Overall Study|Started Other Antitumor Therapy|1|||
126514026|NCT03296696|455175490|FG003|Overall Study|Started Other Antitumor Therapy|2|||
126514027|NCT03296696|455175491|FG004|Overall Study|Started Other Antitumor Therapy|1|||
126514028|NCT03296696|455175492|FG005|Overall Study|Started Other Antitumor Therapy|1|||
126514029|NCT03296696|455175493|FG006|Overall Study|Started Other Antitumor Therapy|2|||
126514030|NCT03296696|455175494|FG007|Overall Study|Started Other Antitumor Therapy|3|||
126514031|NCT03296696|455175495|FG008|Overall Study|Started Other Antitumor Therapy|1|||
126514032|NCT03296696|455175496|FG009|Overall Study|Started Other Antitumor Therapy|0|||
126514033|NCT03296696|455175487|FG000|Overall Study|Death|0|||
126514034|NCT03296696|455175488|FG001|Overall Study|Death|1|||
126514035|NCT03296696|455175489|FG002|Overall Study|Death|1|||
126514036|NCT03296696|455175490|FG003|Overall Study|Death|2|||
126514037|NCT03296696|455175491|FG004|Overall Study|Death|2|||
126514038|NCT03296696|455175492|FG005|Overall Study|Death|3|||
126568492|NCT01867580|455375474|FG000|Overall Study|Interruption to therapy|3|||
126568493|NCT01867580|455375475|FG001|Overall Study|Interruption to therapy|0|||
126568494|NCT01867580|455375474|FG000|Overall Study|Osteomyelitis|0|||
126568495|NCT01867580|455375475|FG001|Overall Study|Osteomyelitis|1|||
126568496|NCT01867580|455375474|FG000|Overall Study|Continuation of therapy|0|||
126568497|NCT01867580|455375475|FG001|Overall Study|Continuation of therapy|1|||
126568498|NCT01867580|455375474|FG000|Overall Study|Wound recurrence|0|||
126568499|NCT01867580|455375475|FG001|Overall Study|Wound recurrence|1|||
126568500|NCT03425643|455375478|FG000|Overall Study|Withdrawal by Subject|10|||
126568501|NCT03425643|455375479|FG001|Overall Study|Withdrawal by Subject|12|||
126568502|NCT03425643|455375478|FG000|Overall Study|Lost to Follow-up|2|||
126568503|NCT03425643|455375479|FG001|Overall Study|Lost to Follow-up|0|||
126568504|NCT03425643|455375478|FG000|Overall Study|Death|109|||
126568505|NCT03425643|455375479|FG001|Overall Study|Death|141|||
126568506|NCT03425643|455375478|FG000|Overall Study|Ongoing in study|276|||
126568507|NCT03425643|455375479|FG001|Overall Study|Ongoing in study|247|||
126568508|NCT03141788|455375480|FG000|Overall Study|Lost to Follow-up|1|||
126568509|NCT03141788|455375480|FG000|Overall Study|Protocol Violation|3|||
126568510|NCT03141788|455375480|FG000|Overall Study|Withdrawal by Subject|4|||
126568511|NCT01025843|455377312|FG000|Washout 4|Withdrawal by Subject|0|||
126568512|NCT01025843|455377313|FG001|Washout 4|Withdrawal by Subject|0|||
126568513|NCT01025843|455377314|FG002|Washout 4|Withdrawal by Subject|1|||
126568514|NCT01025843|455377315|FG003|Washout 4|Withdrawal by Subject|1|||
126568515|NCT01025843|455377316|FG004|Washout 4|Withdrawal by Subject|0|||
126568516|NCT01025843|455377317|FG005|Washout 4|Withdrawal by Subject|0|||
126568517|NCT01025843|455377318|FG006|Washout 4|Withdrawal by Subject|0|||
126568518|NCT01025843|455377319|FG007|Washout 4|Withdrawal by Subject|0|||
126568519|NCT01025843|455377320|FG008|Washout 4|Withdrawal by Subject|0|||
126568520|NCT01025843|455377321|FG009|Washout 4|Withdrawal by Subject|0|||
126568521|NCT00377455|455377324|FG000|Overall Study|Withdrawal by Subject|1|||
126568522|NCT01070888|455377325|FG000|First Intervention (14 Days)|Adverse Event|0|||
126568523|NCT01070888|455377326|FG001|First Intervention (14 Days)|Adverse Event|1|||
126568524|NCT01070888|455377325|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
126568525|NCT01070888|455377326|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
126568526|NCT01070888|455377325|FG000|Washout (14 Days)|Physician Decision|1|||
126568527|NCT01070888|455377326|FG001|Washout (14 Days)|Physician Decision|0|||
126568528|NCT01897233|455377331|FG000|Part B (24 Weeks)|Adverse Event|1|||
126568529|NCT01897233|455377331|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
126568530|NCT01897233|455377331|FG000|Part B (24 Weeks)|Physician Decision|1|||
126568531|NCT02525796|455377336|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
126568532|NCT02525796|455377337|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
126568533|NCT02525796|455377338|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
126568534|NCT02525796|455377336|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
126568535|NCT02525796|455377337|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
126568536|NCT02525796|455377338|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
126568537|NCT02525796|455377336|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
126568538|NCT02525796|455377337|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
126568539|NCT02525796|455377338|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
126568540|NCT02525796|455377336|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
126568541|NCT02525796|455377337|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
126568542|NCT02525796|455377338|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
126568543|NCT02525796|455377336|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
126568544|NCT02525796|455377337|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
126568545|NCT02525796|455377338|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
126568546|NCT02488980|455377339|FG000|Overall Study|Protocol Violation|2|||
126568547|NCT02488980|455377340|FG001|Overall Study|Protocol Violation|2|||
126568548|NCT02488980|455377341|FG002|Overall Study|Protocol Violation|2|||
126568549|NCT02385669|455377345|FG000|Overall Study|Adverse Event|2|||
126568550|NCT00970307|455377346|FG000|Overall Study|Serious Adverse Event|1|||
126568551|NCT00970307|455377347|FG001|Overall Study|Serious Adverse Event|0|||
126568552|NCT00970307|455377348|FG002|Overall Study|Serious Adverse Event|0|||
126568553|NCT00970307|455377346|FG000|Overall Study|Withdrawal by Subject|2|||
126568554|NCT00970307|455377347|FG001|Overall Study|Withdrawal by Subject|3|||
126568555|NCT00970307|455377348|FG002|Overall Study|Withdrawal by Subject|2|||
126568556|NCT02810080|455377355|FG000|Overall Study|Adverse Event|3|||
126568557|NCT02810080|455377356|FG001|Overall Study|Adverse Event|0|||
126568558|NCT02810080|455377355|FG000|Overall Study|Death|0|||
126568559|NCT02810080|455377356|FG001|Overall Study|Death|2|||
126568560|NCT02810080|455377355|FG000|Overall Study|Physician Decision|4|||
126568561|NCT02810080|455377356|FG001|Overall Study|Physician Decision|0|||
126568562|NCT02810080|455377355|FG000|Overall Study|Withdrawal by Subject|0|||
126568563|NCT02810080|455377356|FG001|Overall Study|Withdrawal by Subject|2|||
126568564|NCT00393848|455377360|FG000|Overall Study|Surgical schedule|0|||
126568565|NCT00393848|455377361|FG001|Overall Study|Surgical schedule|0|||
126568566|NCT00393848|455377362|FG002|Overall Study|Surgical schedule|0|||
126776970|NCT02436135|456139135|FG000|Overall Study|Investigator Discretion|1|||
126776971|NCT02436135|456139136|FG001|Overall Study|Investigator Discretion|2|||
126776972|NCT02436135|456139135|FG000|Overall Study|Adverse Event|1|||
126776973|NCT02436135|456139136|FG001|Overall Study|Adverse Event|0|||
126776974|NCT02436135|456139135|FG000|Overall Study|Withdrawal by Participant|1|||
126776975|NCT02436135|456139136|FG001|Overall Study|Withdrawal by Participant|0|||
126776976|NCT02436135|456139135|FG000|Overall Study|Study Terminated By Sponsor|0|||
126776977|NCT02436135|456139136|FG001|Overall Study|Study Terminated By Sponsor|1|||
126776978|NCT00475852|456139139|FG000|Overall Study|Death|444|||
126776979|NCT00475852|456139140|FG001|Overall Study|Death|456|||
126776980|NCT00475852|456139139|FG000|Overall Study|Withdrawal by Subject|19|||
126776981|NCT00475852|456139140|FG001|Overall Study|Withdrawal by Subject|24|||
126514039|NCT03296696|455175493|FG006|Overall Study|Death|1|||
126514040|NCT03296696|455175494|FG007|Overall Study|Death|2|||
126514041|NCT03296696|455175495|FG008|Overall Study|Death|0|||
126514042|NCT03296696|455175496|FG009|Overall Study|Death|0|||
126514043|NCT03296696|455175487|FG000|Overall Study|Withdrawal by Subject|0|||
126514044|NCT03296696|455175488|FG001|Overall Study|Withdrawal by Subject|0|||
126514045|NCT03296696|455175489|FG002|Overall Study|Withdrawal by Subject|1|||
126514046|NCT03296696|455175490|FG003|Overall Study|Withdrawal by Subject|0|||
126514047|NCT03296696|455175491|FG004|Overall Study|Withdrawal by Subject|1|||
126514048|NCT03296696|455175492|FG005|Overall Study|Withdrawal by Subject|0|||
126514049|NCT03296696|455175493|FG006|Overall Study|Withdrawal by Subject|0|||
126514050|NCT03296696|455175494|FG007|Overall Study|Withdrawal by Subject|0|||
126514051|NCT03296696|455175495|FG008|Overall Study|Withdrawal by Subject|0|||
126514052|NCT03296696|455175496|FG009|Overall Study|Withdrawal by Subject|1|||
126514053|NCT04456699|455175497|FG000|Overall Study|Death|48|||
126514054|NCT04456699|455175498|FG001|Overall Study|Death|50|||
126514055|NCT04456699|455175499|FG002|Overall Study|Death|52|||
126514056|NCT04456699|455175497|FG000|Overall Study|Physician Decision|0|||
126514057|NCT04456699|455175498|FG001|Overall Study|Physician Decision|0|||
126514058|NCT04456699|455175499|FG002|Overall Study|Physician Decision|2|||
126514059|NCT04456699|455175497|FG000|Overall Study|Sponsor Decision|55|||
126514060|NCT04456699|455175498|FG001|Overall Study|Sponsor Decision|61|||
126514061|NCT04456699|455175499|FG002|Overall Study|Sponsor Decision|50|||
126514062|NCT04456699|455175497|FG000|Overall Study|Withdrawal by Subject|8|||
126514063|NCT04456699|455175498|FG001|Overall Study|Withdrawal by Subject|4|||
126514064|NCT04456699|455175499|FG002|Overall Study|Withdrawal by Subject|5|||
126514065|NCT00578565|455175500|FG000|Overall Study|Adverse Event|3|||
126514066|NCT02203591|455175501|FG000|Overall Study|Did not meet treatment day baseline|147|||
126514067|NCT02203591|455175502|FG001|Overall Study|Did not meet treatment day baseline|141|||
126514068|NCT02203591|455175503|FG002|Overall Study|Did not meet treatment day baseline|150|||
126514069|NCT02203591|455175504|FG003|Overall Study|Did not meet treatment day baseline|45|||
126514070|NCT02203591|455175505|FG004|Overall Study|Did not meet treatment day baseline|33|||
126514071|NCT02203591|455175506|FG005|Overall Study|Did not meet treatment day baseline|35|||
126514072|NCT02203591|455175507|FG006|Overall Study|Did not meet treatment day baseline|29|||
126514073|NCT02203591|455175508|FG007|Overall Study|Did not meet treatment day baseline|12|||
126514074|NCT02203591|455175501|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
126514075|NCT02203591|455175502|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
126514076|NCT02203591|455175503|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
126514077|NCT02203591|455175504|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
126514078|NCT02203591|455175505|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
126514079|NCT02203591|455175506|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
126514080|NCT02203591|455175507|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
126514081|NCT02203591|455175508|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
126514082|NCT00298038|455175511|FG000|Overall Study|Lost to Follow-up|0|||
126514083|NCT00298038|455175512|FG001|Overall Study|Lost to Follow-up|1|||
126514084|NCT00298038|455175511|FG000|Overall Study|Liver Transplant|0|||
126514085|NCT00298038|455175512|FG001|Overall Study|Liver Transplant|1|||
126514086|NCT00298038|455175511|FG000|Overall Study|Protocol Violation|1|||
126514087|NCT00298038|455175512|FG001|Overall Study|Protocol Violation|3|||
126514088|NCT00298038|455175511|FG000|Overall Study|Death|6|||
126514089|NCT00298038|455175512|FG001|Overall Study|Death|3|||
126514090|NCT00298038|455175511|FG000|Overall Study|Withdrawal by Subject|6|||
126514091|NCT00298038|455175512|FG001|Overall Study|Withdrawal by Subject|9|||
126514092|NCT00298038|455175511|FG000|Overall Study|Adverse Event|8|||
126514093|NCT00298038|455175512|FG001|Overall Study|Adverse Event|7|||
126514094|NCT00298038|455175511|FG000|Overall Study|Breakthrough overt HE episode|28|||
126514095|NCT00298038|455175512|FG001|Overall Study|Breakthrough overt HE episode|69|||
126514096|NCT00298038|455175511|FG000|Overall Study|Noncompliance|1|||
126514097|NCT00298038|455175512|FG001|Overall Study|Noncompliance|0|||
126514098|NCT00298038|455175511|FG000|Overall Study|Cocaine Abuse|1|||
126514099|NCT00298038|455175512|FG001|Overall Study|Cocaine Abuse|0|||
126776982|NCT00475852|456139139|FG000|Overall Study|Lost to Follow-up|54|||
126514100|NCT00298038|455175511|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
126776983|NCT00475852|456139140|FG001|Overall Study|Lost to Follow-up|68|||
126568567|NCT00393848|455377363|FG003|Overall Study|Surgical schedule|1|||
126568568|NCT00393848|455377360|FG000|Overall Study|Personal reasons|0|||
126568569|NCT00393848|455377361|FG001|Overall Study|Personal reasons|0|||
126568570|NCT00393848|455377362|FG002|Overall Study|Personal reasons|2|||
126568571|NCT00393848|455377363|FG003|Overall Study|Personal reasons|0|||
126568572|NCT04842604|455377367|FG000|Overall Study|Death|1|||
126568573|NCT04842604|455377368|FG001|Overall Study|Death|0|||
126568574|NCT04842604|455377367|FG000|Overall Study|Other|4|||
126568575|NCT04842604|455377368|FG001|Overall Study|Other|4|||
126568576|NCT04842604|455377367|FG000|Overall Study|Randomized but not treated|1|||
126568577|NCT04842604|455377368|FG001|Overall Study|Randomized but not treated|0|||
126568578|NCT01193153|455377369|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
126568579|NCT01193153|455377370|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
126568580|NCT01193153|455377369|FG000|Open-label Lead in Period|Pregnancy|1|||
126568581|NCT01193153|455377370|FG001|Open-label Lead in Period|Pregnancy|0|||
126568582|NCT01193153|455377369|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
126568583|NCT01193153|455377370|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
126568584|NCT01193153|455377369|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
126568585|NCT01193153|455377370|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
126568586|NCT01193153|455377369|FG000|Open-label Lead in Period|Other|14|||
126568587|NCT01193153|455377370|FG001|Open-label Lead in Period|Other|0|||
126568588|NCT01193153|455377369|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
126568589|NCT01193153|455377370|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
126568590|NCT01193153|455377369|FG000|Open-label Lead in Period|Adverse Event|41|||
126568591|NCT01193153|455377370|FG001|Open-label Lead in Period|Adverse Event|0|||
126568592|NCT01193153|455377369|FG000|Open-label Lead in Period|Death|1|||
126568593|NCT01193153|455377370|FG001|Open-label Lead in Period|Death|0|||
126568594|NCT01193153|455377369|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
126568595|NCT01193153|455377370|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
126568596|NCT01193153|455377369|FG000|Open-label Stabilization Period|Adverse Event|9|||
126568597|NCT01193153|455377370|FG001|Open-label Stabilization Period|Adverse Event|0|||
126568598|NCT01193153|455377369|FG000|Open-label Stabilization Period|Death|2|||
126568599|NCT01193153|455377370|FG001|Open-label Stabilization Period|Death|0|||
126568600|NCT01193153|455377369|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
126568601|NCT01193153|455377370|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
126568602|NCT01193153|455377369|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
126568603|NCT01193153|455377370|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
126568604|NCT01193153|455377369|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
126568605|NCT01193153|455377370|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
126568606|NCT01193153|455377369|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
126568607|NCT01193153|455377370|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
126568608|NCT01193153|455377369|FG000|Open-label Stabilization Period|Other|8|||
126568609|NCT01193153|455377370|FG001|Open-label Stabilization Period|Other|0|||
126568610|NCT01193153|455377369|FG000|Double Blind Relapse Prevention Period|Other|2|||
126568611|NCT01193153|455377370|FG001|Double Blind Relapse Prevention Period|Other|3|||
126568612|NCT01193153|455377369|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
126514101|NCT00298038|455175512|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
126514102|NCT02696096|455175513|FG000|Overall Study|ruled out at screening|1|||
126514103|NCT02696096|455175513|FG000|Overall Study|did not attend second fMRI|1|||
126514104|NCT00773097|455175516|FG000|Overall Study|Withdrawal by Subject|1|||
126514105|NCT00773097|455175516|FG000|Overall Study|Physician Decision|6|||
126514106|NCT01755416|455175522|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
126514107|NCT01755416|455175523|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
126514108|NCT02573324|455177585|FG000|Overall Study|Withdrawal by Subject|26|||
126514109|NCT02573324|455177586|FG001|Overall Study|Withdrawal by Subject|23|||
126514110|NCT02573324|455177587|FG002|Overall Study|Withdrawal by Subject|3|||
126514111|NCT02573324|455177585|FG000|Overall Study|Lost to Follow-up|4|||
126514112|NCT02573324|455177586|FG001|Overall Study|Lost to Follow-up|5|||
126514113|NCT02573324|455177587|FG002|Overall Study|Lost to Follow-up|0|||
126514114|NCT02573324|455177585|FG000|Overall Study|Study Terminated by Sponsor|107|||
126514115|NCT02573324|455177586|FG001|Overall Study|Study Terminated by Sponsor|89|||
126514116|NCT02573324|455177587|FG002|Overall Study|Study Terminated by Sponsor|2|||
126514117|NCT02573324|455177585|FG000|Overall Study|Death|182|||
126514118|NCT02573324|455177586|FG001|Overall Study|Death|200|||
126514119|NCT02573324|455177587|FG002|Overall Study|Death|1|||
126514120|NCT02573324|455177585|FG000|Overall Study|Other, Not Specified|20|||
126514121|NCT02573324|455177586|FG001|Overall Study|Other, Not Specified|27|||
126514122|NCT02573324|455177587|FG002|Overall Study|Other, Not Specified|0|||
126514123|NCT02573324|455177585|FG000|Overall Study|Unknown Reason|2|||
126514124|NCT02573324|455177586|FG001|Overall Study|Unknown Reason|0|||
126514125|NCT02573324|455177587|FG002|Overall Study|Unknown Reason|0|||
126514126|NCT01607905|455177588|FG000|Overall Study|Withdrawal by participant|7|||
126568613|NCT01193153|455377370|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
126514127|NCT01607905|455177589|FG001|Overall Study|Withdrawal by participant|2|||
126568614|NCT01193153|455377369|FG000|Double Blind Relapse Prevention Period|Death|2|||
126568615|NCT01193153|455377370|FG001|Double Blind Relapse Prevention Period|Death|0|||
126568616|NCT01193153|455377369|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
126568617|NCT01193153|455377370|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
126568618|NCT01193153|455377369|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
126568619|NCT01193153|455377370|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
126568620|NCT01193153|455377369|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
126568621|NCT01193153|455377370|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
126568622|NCT01193153|455377369|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
126568623|NCT01193153|455377370|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
126568624|NCT01193153|455377369|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
126568625|NCT01193153|455377370|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
126568626|NCT01648140|455377371|FG000|Overall Study|Physician Decision|1|||
126568627|NCT01648140|455377372|FG001|Overall Study|Physician Decision|0|||
126568628|NCT01648140|455377373|FG002|Overall Study|Physician Decision|0|||
126568629|NCT01648140|455377374|FG003|Overall Study|Physician Decision|0|||
126568630|NCT01648140|455377371|FG000|Overall Study|Lack of Efficacy|4|||
126568631|NCT01648140|455377372|FG001|Overall Study|Lack of Efficacy|7|||
126568632|NCT01648140|455377373|FG002|Overall Study|Lack of Efficacy|1|||
126568633|NCT01648140|455377374|FG003|Overall Study|Lack of Efficacy|0|||
126568634|NCT01648140|455377371|FG000|Overall Study|Adverse Event|3|||
126568635|NCT01648140|455377372|FG001|Overall Study|Adverse Event|1|||
126568636|NCT01648140|455377373|FG002|Overall Study|Adverse Event|2|||
126568637|NCT01648140|455377374|FG003|Overall Study|Adverse Event|0|||
126568638|NCT01648140|455377371|FG000|Overall Study|Withdrawal by Subject|2|||
126568639|NCT01648140|455377372|FG001|Overall Study|Withdrawal by Subject|3|||
126568640|NCT01648140|455377373|FG002|Overall Study|Withdrawal by Subject|3|||
126568641|NCT01648140|455377374|FG003|Overall Study|Withdrawal by Subject|2|||
126568642|NCT01648140|455377371|FG000|Overall Study|Lost to Follow-up|2|||
126568643|NCT01648140|455377372|FG001|Overall Study|Lost to Follow-up|1|||
126568644|NCT01648140|455377373|FG002|Overall Study|Lost to Follow-up|2|||
126568645|NCT01648140|455377374|FG003|Overall Study|Lost to Follow-up|0|||
126568646|NCT01563354|455377375|FG000|Core Phase|Adverse Event|5|||
126568647|NCT01563354|455377376|FG001|Core Phase|Adverse Event|15|||
126568648|NCT01563354|455377377|FG002|Core Phase|Adverse Event|13|||
126568649|NCT01563354|455377375|FG000|Core Phase|Withdrawal by Subject|1|||
126568650|NCT01563354|455377376|FG001|Core Phase|Withdrawal by Subject|0|||
126568651|NCT01563354|455377377|FG002|Core Phase|Withdrawal by Subject|3|||
126568652|NCT01563354|455377375|FG000|Core Phase|Lost to Follow-up|1|||
126568653|NCT01563354|455377376|FG001|Core Phase|Lost to Follow-up|0|||
126568654|NCT01563354|455377377|FG002|Core Phase|Lost to Follow-up|0|||
126568655|NCT01563354|455377375|FG000|Core Phase|Death|1|||
126568656|NCT01563354|455377376|FG001|Core Phase|Death|5|||
126568657|NCT01563354|455377377|FG002|Core Phase|Death|2|||
126568658|NCT01563354|455377375|FG000|Core Phase|Diseasse progression|18|||
126568659|NCT01563354|455377376|FG001|Core Phase|Diseasse progression|7|||
126568660|NCT01563354|455377377|FG002|Core Phase|Diseasse progression|8|||
126568661|NCT01563354|455377375|FG000|Core Phase|Protocol deviation|2|||
126568662|NCT01563354|455377376|FG001|Core Phase|Protocol deviation|0|||
126568663|NCT01563354|455377377|FG002|Core Phase|Protocol deviation|0|||
126568664|NCT01563354|455377375|FG000|Core Phase|PI decision - did not enter extension|0|||
126568665|NCT01563354|455377376|FG001|Core Phase|PI decision - did not enter extension|1|||
126568666|NCT01563354|455377377|FG002|Core Phase|PI decision - did not enter extension|0|||
126568667|NCT01563354|455377375|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
126568668|NCT01563354|455377376|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
126568669|NCT01563354|455377377|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
126568670|NCT01563354|455377375|FG000|Extension Phase|Adverse Event|0|||
126568671|NCT01563354|455377376|FG001|Extension Phase|Adverse Event|3|||
126568672|NCT01563354|455377377|FG002|Extension Phase|Adverse Event|2|||
126568673|NCT01563354|455377375|FG000|Extension Phase|Withdrawal by Subject|0|||
126568674|NCT01563354|455377376|FG001|Extension Phase|Withdrawal by Subject|1|||
126568675|NCT01563354|455377377|FG002|Extension Phase|Withdrawal by Subject|0|||
126568676|NCT01563354|455377375|FG000|Extension Phase|Administration problems|3|||
126568677|NCT01563354|455377376|FG001|Extension Phase|Administration problems|2|||
126568678|NCT01563354|455377377|FG002|Extension Phase|Administration problems|3|||
126568679|NCT01563354|455377375|FG000|Extension Phase|Disease progression|9|||
126568680|NCT01563354|455377376|FG001|Extension Phase|Disease progression|8|||
126568681|NCT01563354|455377377|FG002|Extension Phase|Disease progression|10|||
126568682|NCT01565928|455377378|FG000|Overall Study|Adverse Event|3|||
126568683|NCT01565928|455377378|FG000|Overall Study|Other|3|||
126568684|NCT01565928|455377378|FG000|Overall Study|Progressive Disease|13|||
126568685|NCT01565928|455377378|FG000|Overall Study|Withdrawal by Subject|1|||
126568686|NCT01565928|455377378|FG000|Overall Study|Death|2|||
126568687|NCT01591616|455377388|FG000|Overall Study|Withdrawal by Subject|1|||
126568688|NCT00758602|455377389|FG000|Overall Study|Adverse Event|11|||
126568689|NCT00758602|455377390|FG001|Overall Study|Adverse Event|10|||
126514128|NCT01607905|455177590|FG002|Overall Study|Withdrawal by participant|4|||
126514129|NCT01607905|455177591|FG003|Overall Study|Withdrawal by participant|6|||
126514130|NCT01607905|455177592|FG004|Overall Study|Withdrawal by participant|0|||
126514131|NCT01607905|455177593|FG005|Overall Study|Withdrawal by participant|4|||
126514132|NCT01607905|455177594|FG006|Overall Study|Withdrawal by participant|12|||
126514133|NCT01607905|455177588|FG000|Overall Study|Incidence or severity of AEs|5|||
126514134|NCT01607905|455177589|FG001|Overall Study|Incidence or severity of AEs|1|||
126514135|NCT01607905|455177590|FG002|Overall Study|Incidence or severity of AEs|1|||
126514136|NCT01607905|455177591|FG003|Overall Study|Incidence or severity of AEs|3|||
126514137|NCT01607905|455177592|FG004|Overall Study|Incidence or severity of AEs|0|||
126514138|NCT01607905|455177593|FG005|Overall Study|Incidence or severity of AEs|2|||
126514139|NCT01607905|455177594|FG006|Overall Study|Incidence or severity of AEs|8|||
126514140|NCT01607905|455177588|FG000|Overall Study|Disease progression|44|||
126514141|NCT01607905|455177589|FG001|Overall Study|Disease progression|16|||
126514142|NCT01607905|455177590|FG002|Overall Study|Disease progression|15|||
126514143|NCT01607905|455177591|FG003|Overall Study|Disease progression|11|||
126514144|NCT01607905|455177592|FG004|Overall Study|Disease progression|6|||
126514145|NCT01607905|455177593|FG005|Overall Study|Disease progression|7|||
126514146|NCT01607905|455177594|FG006|Overall Study|Disease progression|21|||
126514147|NCT01607905|455177588|FG000|Overall Study|Non-compliance with study procedures|0|||
126514148|NCT01607905|455177589|FG001|Overall Study|Non-compliance with study procedures|0|||
126514149|NCT01607905|455177590|FG002|Overall Study|Non-compliance with study procedures|0|||
126514150|NCT01607905|455177591|FG003|Overall Study|Non-compliance with study procedures|0|||
126514151|NCT01607905|455177592|FG004|Overall Study|Non-compliance with study procedures|0|||
126514152|NCT01607905|455177593|FG005|Overall Study|Non-compliance with study procedures|0|||
126514153|NCT01607905|455177594|FG006|Overall Study|Non-compliance with study procedures|1|||
126514154|NCT01607905|455177588|FG000|Overall Study|Death|1|||
126514155|NCT01607905|455177589|FG001|Overall Study|Death|1|||
126514156|NCT01607905|455177590|FG002|Overall Study|Death|1|||
126514157|NCT01607905|455177591|FG003|Overall Study|Death|1|||
126514158|NCT01607905|455177592|FG004|Overall Study|Death|0|||
126514159|NCT01607905|455177593|FG005|Overall Study|Death|0|||
126514160|NCT01607905|455177594|FG006|Overall Study|Death|3|||
126514161|NCT01607905|455177588|FG000|Overall Study|Other treatments become available|1|||
126514162|NCT01607905|455177589|FG001|Overall Study|Other treatments become available|0|||
126514163|NCT01607905|455177590|FG002|Overall Study|Other treatments become available|0|||
126514164|NCT01607905|455177591|FG003|Overall Study|Other treatments become available|0|||
126514165|NCT01607905|455177592|FG004|Overall Study|Other treatments become available|0|||
126514166|NCT01607905|455177593|FG005|Overall Study|Other treatments become available|0|||
126514167|NCT01607905|455177594|FG006|Overall Study|Other treatments become available|1|||
126514168|NCT01607905|455177588|FG000|Overall Study|Investigator discretion|0|||
126514169|NCT01607905|455177589|FG001|Overall Study|Investigator discretion|0|||
126514170|NCT01607905|455177590|FG002|Overall Study|Investigator discretion|0|||
126514171|NCT01607905|455177591|FG003|Overall Study|Investigator discretion|0|||
126514172|NCT01607905|455177592|FG004|Overall Study|Investigator discretion|0|||
126514173|NCT01607905|455177593|FG005|Overall Study|Investigator discretion|1|||
126514174|NCT01607905|455177594|FG006|Overall Study|Investigator discretion|0|||
126514175|NCT01607905|455177588|FG000|Overall Study|Other|1|||
126514176|NCT01607905|455177589|FG001|Overall Study|Other|0|||
126514177|NCT01607905|455177590|FG002|Overall Study|Other|0|||
126514178|NCT01607905|455177591|FG003|Overall Study|Other|0|||
126514179|NCT01607905|455177592|FG004|Overall Study|Other|0|||
126514180|NCT01607905|455177593|FG005|Overall Study|Other|0|||
126514181|NCT01607905|455177594|FG006|Overall Study|Other|1|||
126514182|NCT01607905|455177588|FG000|Overall Study|Randomized but not treated|1|||
126514183|NCT01607905|455177589|FG001|Overall Study|Randomized but not treated|0|||
126514184|NCT01607905|455177590|FG002|Overall Study|Randomized but not treated|0|||
126514185|NCT01607905|455177591|FG003|Overall Study|Randomized but not treated|0|||
126514186|NCT01607905|455177592|FG004|Overall Study|Randomized but not treated|1|||
126514187|NCT01607905|455177593|FG005|Overall Study|Randomized but not treated|1|||
126514188|NCT01607905|455177594|FG006|Overall Study|Randomized but not treated|0|||
126514189|NCT01105533|455177595|FG000|Overall Study|Death|0|||
126514190|NCT01105533|455177596|FG001|Overall Study|Death|0|||
126514191|NCT01105533|455177597|FG002|Overall Study|Death|0|||
126514192|NCT01105533|455177598|FG003|Overall Study|Death|0|||
126514193|NCT01105533|455177599|FG004|Overall Study|Death|1|||
126514194|NCT01105533|455177600|FG005|Overall Study|Death|0|||
126514195|NCT01105533|455177601|FG006|Overall Study|Death|0|||
126514196|NCT01105533|455177602|FG007|Overall Study|Death|0|||
126514197|NCT01105533|455177603|FG008|Overall Study|Death|0|||
126514198|NCT01105533|455177595|FG000|Overall Study|Lack of Efficacy|1|||
126514199|NCT01105533|455177596|FG001|Overall Study|Lack of Efficacy|1|||
126514200|NCT01105533|455177597|FG002|Overall Study|Lack of Efficacy|3|||
126514201|NCT01105533|455177598|FG003|Overall Study|Lack of Efficacy|3|||
126514202|NCT01105533|455177599|FG004|Overall Study|Lack of Efficacy|4|||
126514203|NCT01105533|455177600|FG005|Overall Study|Lack of Efficacy|5|||
126514204|NCT01105533|455177601|FG006|Overall Study|Lack of Efficacy|3|||
126514205|NCT01105533|455177602|FG007|Overall Study|Lack of Efficacy|2|||
126568690|NCT00758602|455377389|FG000|Overall Study|Lost to Follow-up|4|||
126568691|NCT00758602|455377390|FG001|Overall Study|Lost to Follow-up|3|||
126568692|NCT00758602|455377389|FG000|Overall Study|Withdrawal by Subject|1|||
126568693|NCT00758602|455377390|FG001|Overall Study|Withdrawal by Subject|3|||
126568694|NCT00758602|455377389|FG000|Overall Study|Protocol Violation|0|||
126568695|NCT00758602|455377390|FG001|Overall Study|Protocol Violation|2|||
126568696|NCT00758602|455377389|FG000|Overall Study|Death|0|||
126568697|NCT00758602|455377390|FG001|Overall Study|Death|1|||
126568698|NCT00758602|455377389|FG000|Overall Study|Reason not specified|3|||
126568699|NCT00758602|455377390|FG001|Overall Study|Reason not specified|3|||
126568700|NCT04379713|455377391|FG000|Overall Study|Adverse Event|2|||
126568701|NCT04379713|455377392|FG001|Overall Study|Adverse Event|0|||
126568702|NCT04379713|455377391|FG000|Overall Study|Physician Decision|2|||
126568703|NCT04379713|455377392|FG001|Overall Study|Physician Decision|1|||
126568704|NCT04379713|455377391|FG000|Overall Study|Protocol Violation|11|||
126568705|NCT04379713|455377392|FG001|Overall Study|Protocol Violation|6|||
126568706|NCT04379713|455377391|FG000|Overall Study|No longer met eligibility criteria|14|||
126568707|NCT04379713|455377392|FG001|Overall Study|No longer met eligibility criteria|11|||
126568708|NCT04379713|455377391|FG000|Overall Study|Withdrawal by parent/guardian|36|||
126568709|NCT04379713|455377392|FG001|Overall Study|Withdrawal by parent/guardian|15|||
126568710|NCT04379713|455377391|FG000|Overall Study|Lost to Follow-up|31|||
126568711|NCT04379713|455377392|FG001|Overall Study|Lost to Follow-up|21|||
126568712|NCT03808883|455377396|FG000|Overall Study|Withdrawal by Subject|2|||
126568713|NCT03808883|455377397|FG001|Overall Study|Withdrawal by Subject|0|||
126568714|NCT03808883|455377396|FG000|Overall Study|Did not complete pre test or post test survey|4|||
126568715|NCT03808883|455377397|FG001|Overall Study|Did not complete pre test or post test survey|3|||
126568716|NCT00158054|455377399|FG000|Overall Study|Refused to continue|3|||
126568717|NCT00158054|455377400|FG001|Overall Study|Refused to continue|0|||
126568718|NCT00158054|455377399|FG000|Overall Study|Unavailable for follow up|7|||
126568719|NCT00158054|455377400|FG001|Overall Study|Unavailable for follow up|3|||
126568720|NCT00855465|455377401|FG000|Treatment Period|Adverse Event|4|||
126568721|NCT00855465|455377402|FG001|Treatment Period|Adverse Event|2|||
126568722|NCT00855465|455377401|FG000|Treatment Period|Death|2|||
126568723|NCT00855465|455377402|FG001|Treatment Period|Death|2|||
126568724|NCT00855465|455377401|FG000|Treatment Period|Lack of Efficacy|2|||
126568725|NCT00855465|455377402|FG001|Treatment Period|Lack of Efficacy|1|||
126568726|NCT00855465|455377401|FG000|Treatment Period|Non-compliance|1|||
126568727|NCT00855465|455377402|FG001|Treatment Period|Non-compliance|0|||
126568728|NCT00855465|455377401|FG000|Treatment Period|Protocol Violation|2|||
126568729|NCT00855465|455377402|FG001|Treatment Period|Protocol Violation|0|||
126568730|NCT00855465|455377401|FG000|Treatment Period|Withdrawal by Subject|2|||
126568731|NCT00855465|455377402|FG001|Treatment Period|Withdrawal by Subject|0|||
126568732|NCT00855465|455377401|FG000|Treatment Period|Not treated|1|||
126568733|NCT00855465|455377402|FG001|Treatment Period|Not treated|0|||
126568734|NCT00855465|455377401|FG000|Follow-up Period (FUP)|Adverse Event|0|||
126568735|NCT00855465|455377402|FG001|Follow-up Period (FUP)|Adverse Event|1|||
126568736|NCT00855465|455377401|FG000|Follow-up Period (FUP)|Death|0|||
126568737|NCT00855465|455377402|FG001|Follow-up Period (FUP)|Death|1|||
126568738|NCT00855465|455377401|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
126568739|NCT00855465|455377402|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
126568740|NCT00855465|455377401|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
126568741|NCT00855465|455377402|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
126568742|NCT00855465|455377401|FG000|Follow-up Period (FUP)|Missing|1|||
126568743|NCT00855465|455377402|FG001|Follow-up Period (FUP)|Missing|0|||
126568744|NCT04567888|455377413|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
126568745|NCT04567888|455377414|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
126568746|NCT04567888|455377413|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
126568747|NCT04567888|455377414|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
126568748|NCT04567888|455377413|FG000|Overall Study|Reported Unusual Birth Year|2|||
126568749|NCT04567888|455377414|FG001|Overall Study|Reported Unusual Birth Year|3|||
126568750|NCT04567888|455377413|FG000|Overall Study|Duplicate Responses|0|||
126568751|NCT04567888|455377414|FG001|Overall Study|Duplicate Responses|1|||
126568752|NCT00436644|455377416|FG000|Overall Study|Adverse Event|2|||
126568753|NCT00436644|455377416|FG000|Overall Study|Death|1|||
126568754|NCT01490580|455377421|FG000|Overall Study|Parents withdrew consent|0|||
126568755|NCT01490580|455377422|FG001|Overall Study|Parents withdrew consent|2|||
126568756|NCT00878722|455377424|FG000|Overall Study|Progressive disease|3|||
126568757|NCT00878722|455377425|FG001|Overall Study|Progressive disease|3|||
126568758|NCT00878722|455377426|FG002|Overall Study|Progressive disease|3|||
126568759|NCT00878722|455377427|FG003|Overall Study|Progressive disease|7|||
126568760|NCT00878722|455377428|FG004|Overall Study|Progressive disease|7|||
126568761|NCT00878722|455377429|FG005|Overall Study|Progressive disease|1|||
126568762|NCT00878722|455377430|FG006|Overall Study|Progressive disease|4|||
126568763|NCT00878722|455377431|FG007|Overall Study|Progressive disease|3|||
126568764|NCT00878722|455377424|FG000|Overall Study|Death|0|||
126568765|NCT00878722|455377425|FG001|Overall Study|Death|0|||
126568766|NCT00878722|455377426|FG002|Overall Study|Death|0|||
126568767|NCT00878722|455377427|FG003|Overall Study|Death|1|||
126568768|NCT00878722|455377428|FG004|Overall Study|Death|0|||
126568769|NCT00878722|455377429|FG005|Overall Study|Death|1|||
126568770|NCT00878722|455377430|FG006|Overall Study|Death|0|||
126568771|NCT00878722|455377431|FG007|Overall Study|Death|2|||
126568772|NCT00878722|455377424|FG000|Overall Study|Adverse Event|0|||
126568773|NCT00878722|455377425|FG001|Overall Study|Adverse Event|0|||
126568774|NCT00878722|455377426|FG002|Overall Study|Adverse Event|0|||
126568775|NCT00878722|455377427|FG003|Overall Study|Adverse Event|0|||
126568776|NCT00878722|455377428|FG004|Overall Study|Adverse Event|0|||
126568777|NCT00878722|455377429|FG005|Overall Study|Adverse Event|0|||
126568778|NCT00878722|455377430|FG006|Overall Study|Adverse Event|2|||
126568779|NCT00878722|455377431|FG007|Overall Study|Adverse Event|0|||
126568780|NCT00878722|455377424|FG000|Overall Study|Withdrawal by Subject|0|||
126568781|NCT00878722|455377425|FG001|Overall Study|Withdrawal by Subject|0|||
126568782|NCT00878722|455377426|FG002|Overall Study|Withdrawal by Subject|0|||
126568783|NCT00878722|455377427|FG003|Overall Study|Withdrawal by Subject|0|||
126568784|NCT00878722|455377428|FG004|Overall Study|Withdrawal by Subject|0|||
126568785|NCT00878722|455377429|FG005|Overall Study|Withdrawal by Subject|0|||
126568786|NCT00878722|455377430|FG006|Overall Study|Withdrawal by Subject|0|||
126568787|NCT00878722|455377431|FG007|Overall Study|Withdrawal by Subject|2|||
126514206|NCT01105533|455177603|FG008|Overall Study|Lack of Efficacy|9|||
126514207|NCT01105533|455177595|FG000|Overall Study|Adverse Event|0|||
126514208|NCT01105533|455177596|FG001|Overall Study|Adverse Event|0|||
126514209|NCT01105533|455177597|FG002|Overall Study|Adverse Event|0|||
126514210|NCT01105533|455177598|FG003|Overall Study|Adverse Event|0|||
126514211|NCT01105533|455177599|FG004|Overall Study|Adverse Event|1|||
126514212|NCT01105533|455177600|FG005|Overall Study|Adverse Event|2|||
126514213|NCT01105533|455177601|FG006|Overall Study|Adverse Event|2|||
126514214|NCT01105533|455177602|FG007|Overall Study|Adverse Event|0|||
126514215|NCT01105533|455177603|FG008|Overall Study|Adverse Event|1|||
126514216|NCT01105533|455177595|FG000|Overall Study|Other|0|||
126514217|NCT01105533|455177596|FG001|Overall Study|Other|0|||
126514218|NCT01105533|455177597|FG002|Overall Study|Other|0|||
126514219|NCT01105533|455177598|FG003|Overall Study|Other|0|||
126514220|NCT01105533|455177599|FG004|Overall Study|Other|1|||
126514221|NCT01105533|455177600|FG005|Overall Study|Other|0|||
126514222|NCT01105533|455177601|FG006|Overall Study|Other|3|||
126514223|NCT01105533|455177602|FG007|Overall Study|Other|1|||
126514224|NCT01105533|455177603|FG008|Overall Study|Other|2|||
126514225|NCT01105533|455177595|FG000|Overall Study|Physician Decision|0|||
126514226|NCT01105533|455177596|FG001|Overall Study|Physician Decision|0|||
126514227|NCT01105533|455177597|FG002|Overall Study|Physician Decision|0|||
126514228|NCT01105533|455177598|FG003|Overall Study|Physician Decision|0|||
126514229|NCT01105533|455177599|FG004|Overall Study|Physician Decision|0|||
126514230|NCT01105533|455177600|FG005|Overall Study|Physician Decision|0|||
126514231|NCT01105533|455177601|FG006|Overall Study|Physician Decision|0|||
126514232|NCT01105533|455177602|FG007|Overall Study|Physician Decision|1|||
126514233|NCT01105533|455177603|FG008|Overall Study|Physician Decision|0|||
126514234|NCT02096835|455177604|FG000|Overall Study|Withdrawal by Subject|1|||
126514235|NCT02096835|455177605|FG001|Overall Study|Withdrawal by Subject|0|||
126514236|NCT02096835|455177606|FG002|Overall Study|Withdrawal by Subject|0|||
126514237|NCT02096835|455177604|FG000|Overall Study|converted to open procedures|1|||
126514238|NCT02096835|455177605|FG001|Overall Study|converted to open procedures|0|||
126514239|NCT02096835|455177606|FG002|Overall Study|converted to open procedures|0|||
126514240|NCT02096835|455177604|FG000|Overall Study|Lost to Follow-up|1|||
126514241|NCT02096835|455177605|FG001|Overall Study|Lost to Follow-up|0|||
126514242|NCT02096835|455177606|FG002|Overall Study|Lost to Follow-up|1|||
126514243|NCT03892889|455177607|FG000|Overall Study|Adverse Event|17|||
126514244|NCT03892889|455177607|FG000|Overall Study|Lack of Efficacy|1|||
126514245|NCT03892889|455177607|FG000|Overall Study|Lost to Follow-up|46|||
126514246|NCT03892889|455177607|FG000|Overall Study|Non-compliance with study drug|22|||
126514247|NCT03892889|455177607|FG000|Overall Study|Pregnancy|1|||
126514248|NCT03892889|455177607|FG000|Overall Study|Protocol Deviation|3|||
126568788|NCT00878722|455377424|FG000|Overall Study|Relapse|0|||
126568789|NCT00878722|455377425|FG001|Overall Study|Relapse|0|||
126514249|NCT03892889|455177607|FG000|Overall Study|Withdrawal by Subject|50|||
126514250|NCT03892889|455177607|FG000|Overall Study|Withdrawal by Caregiver|1|||
126514251|NCT03892889|455177607|FG000|Overall Study|Study Terminated by Sponsor|50|||
126514252|NCT03892889|455177607|FG000|Overall Study|Physician Decision|8|||
126514253|NCT03892889|455177607|FG000|Overall Study|Reason not Specified|5|||
126514254|NCT04260191|455177608|FG000|Overall Study|Decision by Sponsor|0|||
126514255|NCT04260191|455177609|FG001|Overall Study|Decision by Sponsor|1|||
126514256|NCT04260191|455177610|FG002|Overall Study|Decision by Sponsor|0|||
126514257|NCT04260191|455177608|FG000|Overall Study|Withdrawal by Subject|1|||
126514258|NCT04260191|455177609|FG001|Overall Study|Withdrawal by Subject|0|||
126568790|NCT00878722|455377426|FG002|Overall Study|Relapse|0|||
126568791|NCT00878722|455377427|FG003|Overall Study|Relapse|1|||
126568792|NCT00878722|455377428|FG004|Overall Study|Relapse|0|||
126568793|NCT00878722|455377429|FG005|Overall Study|Relapse|0|||
126568794|NCT00878722|455377430|FG006|Overall Study|Relapse|0|||
126568795|NCT00878722|455377431|FG007|Overall Study|Relapse|0|||
126568796|NCT00949975|455377432|FG000|Overall Study|Voluntary discontinuation|6|||
126514259|NCT04260191|455177610|FG002|Overall Study|Withdrawal by Subject|3|||
126514260|NCT04260191|455177608|FG000|Overall Study|Death|4|||
126514261|NCT04260191|455177609|FG001|Overall Study|Death|3|||
126514262|NCT04260191|455177610|FG002|Overall Study|Death|2|||
126514263|NCT02086591|455177611|FG000|Overall Study|Adverse Event|1|||
126514264|NCT02086591|455177611|FG000|Overall Study|Withdrawal by Subject|1|||
126514265|NCT02086591|455177611|FG000|Overall Study|protocol terminated|3|||
126514266|NCT02880371|455177612|FG000|Phase 1b|Lost to Follow-up|1|||
126514267|NCT02880371|455177613|FG001|Phase 1b|Lost to Follow-up|0|||
126568797|NCT00949975|455377433|FG001|Overall Study|Voluntary discontinuation|5|||
126568798|NCT00949975|455377434|FG002|Overall Study|Voluntary discontinuation|3|||
126568799|NCT00949975|455377435|FG003|Overall Study|Voluntary discontinuation|6|||
126568800|NCT00949975|455377432|FG000|Overall Study|Adverse Event|11|||
126568801|NCT00949975|455377433|FG001|Overall Study|Adverse Event|11|||
126568802|NCT00949975|455377434|FG002|Overall Study|Adverse Event|10|||
126568803|NCT00949975|455377435|FG003|Overall Study|Adverse Event|10|||
126568804|NCT00949975|455377432|FG000|Overall Study|Safety reason|0|||
126568805|NCT00949975|455377433|FG001|Overall Study|Safety reason|1|||
126568806|NCT00949975|455377434|FG002|Overall Study|Safety reason|0|||
126568807|NCT00949975|455377435|FG003|Overall Study|Safety reason|0|||
126568808|NCT00949975|455377432|FG000|Overall Study|Study-specific criteria|0|||
126568809|NCT00949975|455377433|FG001|Overall Study|Study-specific criteria|1|||
126568810|NCT00949975|455377434|FG002|Overall Study|Study-specific criteria|1|||
126568811|NCT00949975|455377435|FG003|Overall Study|Study-specific criteria|0|||
126568812|NCT00949975|455377432|FG000|Overall Study|Incorrect enrolment|5|||
126568813|NCT00949975|455377433|FG001|Overall Study|Incorrect enrolment|10|||
126568814|NCT00949975|455377434|FG002|Overall Study|Incorrect enrolment|4|||
126568815|NCT00949975|455377435|FG003|Overall Study|Incorrect enrolment|7|||
126568816|NCT00949975|455377432|FG000|Overall Study|Severe non-compliance|3|||
126568817|NCT00949975|455377433|FG001|Overall Study|Severe non-compliance|1|||
126568818|NCT00949975|455377434|FG002|Overall Study|Severe non-compliance|0|||
126568819|NCT00949975|455377435|FG003|Overall Study|Severe non-compliance|2|||
126568820|NCT00949975|455377432|FG000|Overall Study|Lost to Follow-up|1|||
126568821|NCT00949975|455377433|FG001|Overall Study|Lost to Follow-up|0|||
126568822|NCT00949975|455377434|FG002|Overall Study|Lost to Follow-up|1|||
126568823|NCT00949975|455377435|FG003|Overall Study|Lost to Follow-up|3|||
126568824|NCT00949975|455377432|FG000|Overall Study|Other|1|||
126568825|NCT00949975|455377433|FG001|Overall Study|Other|0|||
126568826|NCT00949975|455377434|FG002|Overall Study|Other|0|||
126568827|NCT00949975|455377435|FG003|Overall Study|Other|0|||
126568828|NCT00716144|455377436|FG000|Overall Study|Withdrawal by Subject|4|||
126568829|NCT00716144|455377437|FG001|Overall Study|Withdrawal by Subject|2|||
126568830|NCT00716144|455377438|FG002|Overall Study|Withdrawal by Subject|6|||
126568831|NCT00716144|455377439|FG003|Overall Study|Withdrawal by Subject|6|||
126568832|NCT00716144|455377436|FG000|Overall Study|Lost to Follow-up|2|||
126568833|NCT00716144|455377437|FG001|Overall Study|Lost to Follow-up|2|||
126568834|NCT00716144|455377438|FG002|Overall Study|Lost to Follow-up|1|||
126568835|NCT00716144|455377439|FG003|Overall Study|Lost to Follow-up|2|||
126568836|NCT00716144|455377436|FG000|Overall Study|Adverse Event|0|||
126568837|NCT00716144|455377437|FG001|Overall Study|Adverse Event|0|||
126568838|NCT00716144|455377438|FG002|Overall Study|Adverse Event|0|||
126568839|NCT00716144|455377439|FG003|Overall Study|Adverse Event|2|||
126568840|NCT00716144|455377436|FG000|Overall Study|Non-compliance|1|||
126568841|NCT00716144|455377437|FG001|Overall Study|Non-compliance|0|||
126568842|NCT00716144|455377438|FG002|Overall Study|Non-compliance|0|||
126568843|NCT00716144|455377439|FG003|Overall Study|Non-compliance|0|||
126568844|NCT00716144|455377436|FG000|Overall Study|Protocol Violation|2|||
126568845|NCT00716144|455377437|FG001|Overall Study|Protocol Violation|0|||
126514268|NCT02880371|455177614|FG002|Phase 1b|Lost to Follow-up|0|||
126514269|NCT02880371|455177615|FG003|Phase 1b|Lost to Follow-up|0|||
126514270|NCT02880371|455177616|FG004|Phase 1b|Lost to Follow-up|0|||
126568846|NCT00716144|455377438|FG002|Overall Study|Protocol Violation|1|||
126514271|NCT02880371|455177617|FG005|Phase 1b|Lost to Follow-up|0|||
126514272|NCT02880371|455177618|FG006|Phase 1b|Lost to Follow-up|0|||
126514273|NCT02880371|455177619|FG007|Phase 1b|Lost to Follow-up|0|||
126514274|NCT02880371|455177612|FG000|Phase 1b|Participants terminated by Sponsor|1|||
126568847|NCT00716144|455377439|FG003|Overall Study|Protocol Violation|0|||
126568848|NCT00716144|455377436|FG000|Overall Study|Physician Decision|0|||
126568849|NCT00716144|455377437|FG001|Overall Study|Physician Decision|1|||
126568850|NCT00716144|455377438|FG002|Overall Study|Physician Decision|2|||
126568851|NCT00716144|455377439|FG003|Overall Study|Physician Decision|2|||
126568852|NCT00716144|455377436|FG000|Overall Study|Intercurrent illness|0|||
126514275|NCT02880371|455177613|FG001|Phase 1b|Participants terminated by Sponsor|0|||
126568853|NCT00716144|455377437|FG001|Overall Study|Intercurrent illness|0|||
126568854|NCT00716144|455377438|FG002|Overall Study|Intercurrent illness|1|||
126568855|NCT00716144|455377439|FG003|Overall Study|Intercurrent illness|0|||
126568856|NCT00716144|455377436|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
126568857|NCT00716144|455377437|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
126514276|NCT02880371|455177614|FG002|Phase 1b|Participants terminated by Sponsor|0|||
126514277|NCT02880371|455177615|FG003|Phase 1b|Participants terminated by Sponsor|0|||
126514278|NCT02880371|455177616|FG004|Phase 1b|Participants terminated by Sponsor|0|||
126514279|NCT02880371|455177617|FG005|Phase 1b|Participants terminated by Sponsor|0|||
126514280|NCT02880371|455177618|FG006|Phase 1b|Participants terminated by Sponsor|0|||
126514281|NCT02880371|455177619|FG007|Phase 1b|Participants terminated by Sponsor|0|||
126514282|NCT02880371|455177612|FG000|Phase 1b|Withdrawal by Subject|0|||
126514283|NCT02880371|455177613|FG001|Phase 1b|Withdrawal by Subject|0|||
126514284|NCT02880371|455177614|FG002|Phase 1b|Withdrawal by Subject|1|||
126514285|NCT02880371|455177615|FG003|Phase 1b|Withdrawal by Subject|0|||
126514286|NCT02880371|455177616|FG004|Phase 1b|Withdrawal by Subject|0|||
126514287|NCT02880371|455177617|FG005|Phase 1b|Withdrawal by Subject|0|||
126514288|NCT02880371|455177618|FG006|Phase 1b|Withdrawal by Subject|0|||
126514289|NCT02880371|455177619|FG007|Phase 1b|Withdrawal by Subject|0|||
126514290|NCT02880371|455177612|FG000|Phase 1b|Death|4|||
126514291|NCT02880371|455177613|FG001|Phase 1b|Death|6|||
126514292|NCT02880371|455177614|FG002|Phase 1b|Death|5|||
126514293|NCT02880371|455177615|FG003|Phase 1b|Death|1|||
126514294|NCT02880371|455177616|FG004|Phase 1b|Death|0|||
126514295|NCT02880371|455177617|FG005|Phase 1b|Death|0|||
126514296|NCT02880371|455177618|FG006|Phase 1b|Death|0|||
126514297|NCT02880371|455177619|FG007|Phase 1b|Death|0|||
126514298|NCT02880371|455177612|FG000|Phase 1b|Enrolled but not Treated|0|||
126514299|NCT02880371|455177613|FG001|Phase 1b|Enrolled but not Treated|1|||
126514300|NCT02880371|455177614|FG002|Phase 1b|Enrolled but not Treated|0|||
126514301|NCT02880371|455177615|FG003|Phase 1b|Enrolled but not Treated|0|||
126514302|NCT02880371|455177616|FG004|Phase 1b|Enrolled but not Treated|0|||
126514303|NCT02880371|455177617|FG005|Phase 1b|Enrolled but not Treated|0|||
126514304|NCT02880371|455177618|FG006|Phase 1b|Enrolled but not Treated|0|||
126514305|NCT02880371|455177619|FG007|Phase 1b|Enrolled but not Treated|0|||
126514306|NCT02880371|455177612|FG000|Phase 2|Enrolled but not Treated|0|||
126514307|NCT02880371|455177613|FG001|Phase 2|Enrolled but not Treated|0|||
126514308|NCT02880371|455177614|FG002|Phase 2|Enrolled but not Treated|0|||
126514309|NCT02880371|455177615|FG003|Phase 2|Enrolled but not Treated|0|||
126514310|NCT02880371|455177616|FG004|Phase 2|Enrolled but not Treated|0|||
126514311|NCT02880371|455177617|FG005|Phase 2|Enrolled but not Treated|1|||
126514312|NCT02880371|455177618|FG006|Phase 2|Enrolled but not Treated|1|||
126514313|NCT02880371|455177619|FG007|Phase 2|Enrolled but not Treated|0|||
126514314|NCT02880371|455177612|FG000|Phase 2|Other|0|||
126514315|NCT02880371|455177613|FG001|Phase 2|Other|0|||
126514316|NCT02880371|455177614|FG002|Phase 2|Other|0|||
126514317|NCT02880371|455177615|FG003|Phase 2|Other|0|||
126514318|NCT02880371|455177616|FG004|Phase 2|Other|0|||
126514319|NCT02880371|455177617|FG005|Phase 2|Other|1|||
126514320|NCT02880371|455177618|FG006|Phase 2|Other|2|||
126514321|NCT02880371|455177619|FG007|Phase 2|Other|1|||
126514322|NCT02880371|455177612|FG000|Phase 2|Participants terminated by Sponsor|0|||
126514323|NCT02880371|455177613|FG001|Phase 2|Participants terminated by Sponsor|0|||
126514324|NCT02880371|455177614|FG002|Phase 2|Participants terminated by Sponsor|0|||
126514325|NCT02880371|455177615|FG003|Phase 2|Participants terminated by Sponsor|0|||
126514326|NCT02880371|455177616|FG004|Phase 2|Participants terminated by Sponsor|1|||
126514327|NCT02880371|455177617|FG005|Phase 2|Participants terminated by Sponsor|6|||
126514328|NCT02880371|455177618|FG006|Phase 2|Participants terminated by Sponsor|1|||
126514329|NCT02880371|455177619|FG007|Phase 2|Participants terminated by Sponsor|5|||
126514330|NCT02880371|455177612|FG000|Phase 2|Death|0|||
126514331|NCT02880371|455177613|FG001|Phase 2|Death|0|||
126568858|NCT00716144|455377438|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
126568859|NCT00716144|455377439|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
126568860|NCT00716144|455377436|FG000|Overall Study|Adverse event: left foot pain|0|||
126568861|NCT00716144|455377437|FG001|Overall Study|Adverse event: left foot pain|1|||
126568862|NCT00716144|455377438|FG002|Overall Study|Adverse event: left foot pain|0|||
126514332|NCT02880371|455177614|FG002|Phase 2|Death|0|||
126568863|NCT00716144|455377439|FG003|Overall Study|Adverse event: left foot pain|0|||
126568864|NCT00716144|455377436|FG000|Overall Study|Clinical Depression|0|||
126568865|NCT00716144|455377437|FG001|Overall Study|Clinical Depression|1|||
126514333|NCT02880371|455177615|FG003|Phase 2|Death|0|||
126514334|NCT02880371|455177616|FG004|Phase 2|Death|1|||
126514335|NCT02880371|455177617|FG005|Phase 2|Death|10|||
126514336|NCT02880371|455177618|FG006|Phase 2|Death|20|||
126514337|NCT02880371|455177619|FG007|Phase 2|Death|5|||
126514338|NCT02880371|455177612|FG000|Phase 2|Lost to Follow-up|0|||
126514339|NCT02880371|455177613|FG001|Phase 2|Lost to Follow-up|0|||
126514340|NCT02880371|455177614|FG002|Phase 2|Lost to Follow-up|0|||
126514341|NCT02880371|455177615|FG003|Phase 2|Lost to Follow-up|0|||
126514342|NCT02880371|455177616|FG004|Phase 2|Lost to Follow-up|0|||
126514343|NCT02880371|455177617|FG005|Phase 2|Lost to Follow-up|0|||
126514344|NCT02880371|455177618|FG006|Phase 2|Lost to Follow-up|3|||
126568866|NCT00716144|455377438|FG002|Overall Study|Clinical Depression|0|||
126514345|NCT02880371|455177619|FG007|Phase 2|Lost to Follow-up|0|||
126514346|NCT02880371|455177612|FG000|Phase 2|Withdrawal by Subject|0|||
126514347|NCT02880371|455177613|FG001|Phase 2|Withdrawal by Subject|0|||
126514348|NCT02880371|455177614|FG002|Phase 2|Withdrawal by Subject|0|||
126568867|NCT00716144|455377439|FG003|Overall Study|Clinical Depression|0|||
126568868|NCT05641311|455377440|FG000|Dosing Period 1|Adverse Event|1|||
126568869|NCT05641311|455377441|FG001|Dosing Period 1|Adverse Event|0|||
126568870|NCT00909363|455377442|FG000|Overall Study|Withdrawal by Subject|1|||
126568871|NCT00909363|455377443|FG001|Overall Study|Withdrawal by Subject|0|||
126568872|NCT00909363|455377444|FG002|Overall Study|Withdrawal by Subject|0|||
126568873|NCT00909363|455377442|FG000|Overall Study|Lack of Efficacy|1|||
126568874|NCT00909363|455377443|FG001|Overall Study|Lack of Efficacy|0|||
126568875|NCT00909363|455377444|FG002|Overall Study|Lack of Efficacy|0|||
126568876|NCT00082810|455377445|FG000|Overall Study|Adverse Event|3|||
126568877|NCT00082810|455377445|FG000|Overall Study|Progressive disease|24|||
126568878|NCT00082810|455377445|FG000|Overall Study|Withdrawal by Subject|4|||
126568879|NCT02950558|455377446|FG000|Overall Study|Lost to Follow-up|2|||
126568880|NCT02950558|455377447|FG001|Overall Study|Lost to Follow-up|0|||
126568881|NCT00319436|455377448|FG000|Overall Study|Withdrawal by Subject|6|||
126568882|NCT00319436|455377449|FG001|Overall Study|Withdrawal by Subject|7|||
126568883|NCT01321606|455377452|FG000|Overall Study|Lost to Follow-up|0|||
126568884|NCT01321606|455377453|FG001|Overall Study|Lost to Follow-up|0|||
126568885|NCT01321606|455377454|FG002|Overall Study|Lost to Follow-up|0|||
126568886|NCT01321606|455377455|FG003|Overall Study|Lost to Follow-up|1|||
126568887|NCT02914522|455377456|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
126568888|NCT02914522|455377457|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
126568889|NCT02914522|455377458|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
126568890|NCT02914522|455377459|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
126568891|NCT02914522|455377460|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
126568892|NCT02914522|455377461|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
126568893|NCT02914522|455377462|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
126568894|NCT02914522|455377463|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
126568895|NCT02914522|455377464|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
126568896|NCT02914522|455377465|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
126568897|NCT02914522|455377466|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
126568898|NCT02914522|455377456|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
126568899|NCT02914522|455377457|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
126568900|NCT02914522|455377458|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
126568901|NCT02914522|455377459|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
126568902|NCT02914522|455377460|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
126568903|NCT02914522|455377461|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
126568904|NCT02914522|455377462|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
126568905|NCT02914522|455377463|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
126568906|NCT02914522|455377464|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
126568907|NCT02914522|455377465|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
126568908|NCT02914522|455377466|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
126568909|NCT02914522|455377456|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
126568910|NCT02914522|455377457|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
126568911|NCT02914522|455377458|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
126568912|NCT02914522|455377459|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
126568913|NCT02914522|455377460|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
126568914|NCT02914522|455377461|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
126568915|NCT02914522|455377462|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
126568916|NCT02914522|455377463|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
126568917|NCT02914522|455377464|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
126568918|NCT02914522|455377465|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
126568919|NCT02914522|455377466|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
126568920|NCT02914522|455377456|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126568921|NCT02914522|455377457|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
126568922|NCT02914522|455377458|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
126568923|NCT02914522|455377459|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
126568924|NCT02914522|455377460|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126568925|NCT02914522|455377461|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126568926|NCT02914522|455377462|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126568927|NCT02914522|455377463|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126568928|NCT02914522|455377464|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126568929|NCT02914522|455377465|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126568930|NCT02914522|455377466|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
126568931|NCT02914522|455377456|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126568932|NCT02914522|455377457|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126568933|NCT02914522|455377458|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126568934|NCT02914522|455377459|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126568935|NCT02914522|455377460|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
126568936|NCT02914522|455377461|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126568937|NCT02914522|455377462|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126568938|NCT02914522|455377463|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126568939|NCT02914522|455377464|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126568940|NCT02914522|455377465|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126568941|NCT02914522|455377466|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
126568942|NCT02914522|455377456|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
126568943|NCT02914522|455377457|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126568944|NCT02914522|455377458|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126568945|NCT02914522|455377459|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126568946|NCT02914522|455377460|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126568947|NCT02914522|455377461|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126568948|NCT02914522|455377462|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126568949|NCT02914522|455377463|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126568950|NCT02914522|455377464|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126568951|NCT02914522|455377465|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126568952|NCT02914522|455377466|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
126568953|NCT02914522|455377456|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
126568954|NCT02914522|455377457|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
126568955|NCT02914522|455377458|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
126568956|NCT02914522|455377459|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
126568957|NCT02914522|455377460|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
126568958|NCT02914522|455377461|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
126568959|NCT02914522|455377462|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
126514349|NCT02880371|455177615|FG003|Phase 2|Withdrawal by Subject|0|||
126514350|NCT02880371|455177616|FG004|Phase 2|Withdrawal by Subject|0|||
126514351|NCT02880371|455177617|FG005|Phase 2|Withdrawal by Subject|1|||
126514352|NCT02880371|455177618|FG006|Phase 2|Withdrawal by Subject|1|||
126514353|NCT02880371|455177619|FG007|Phase 2|Withdrawal by Subject|0|||
126514354|NCT02880371|455177612|FG000|Phase 2|End of Study page not completed by error|0|||
126514355|NCT02880371|455177613|FG001|Phase 2|End of Study page not completed by error|0|||
126514356|NCT02880371|455177614|FG002|Phase 2|End of Study page not completed by error|0|||
126514357|NCT02880371|455177615|FG003|Phase 2|End of Study page not completed by error|0|||
126514358|NCT02880371|455177616|FG004|Phase 2|End of Study page not completed by error|0|||
126514359|NCT02880371|455177617|FG005|Phase 2|End of Study page not completed by error|1|||
126514360|NCT02880371|455177618|FG006|Phase 2|End of Study page not completed by error|0|||
126514361|NCT02880371|455177619|FG007|Phase 2|End of Study page not completed by error|0|||
126514362|NCT01777997|455177622|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
126514363|NCT01777997|455177622|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
126514364|NCT01777997|455177622|FG000|Weeks 48 to 72/96 on ART|Death|1|||
126514365|NCT01777997|455177622|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
126514366|NCT02660359|455177623|FG000|Overall Study|Protocol Deviation|0|||
126514367|NCT02660359|455177624|FG001|Overall Study|Protocol Deviation|0|||
126514368|NCT02660359|455177625|FG002|Overall Study|Protocol Deviation|1|||
126514369|NCT02660359|455177623|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
126514370|NCT02660359|455177624|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
126514371|NCT02660359|455177625|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
126514372|NCT02660359|455177623|FG000|Overall Study|Lack of Efficacy|1|||
126514373|NCT02660359|455177624|FG001|Overall Study|Lack of Efficacy|1|||
126514374|NCT02660359|455177625|FG002|Overall Study|Lack of Efficacy|1|||
126514375|NCT02660359|455177623|FG000|Overall Study|Adverse Event|0|||
126514376|NCT02660359|455177624|FG001|Overall Study|Adverse Event|1|||
126514377|NCT02660359|455177625|FG002|Overall Study|Adverse Event|0|||
126514378|NCT02660359|455177623|FG000|Overall Study|Other|2|||
126514379|NCT02660359|455177624|FG001|Overall Study|Other|1|||
126514380|NCT02660359|455177625|FG002|Overall Study|Other|3|||
126514381|NCT02660359|455177623|FG000|Overall Study|Withdrawal by Subject|7|||
126514382|NCT02660359|455177624|FG001|Overall Study|Withdrawal by Subject|5|||
126514383|NCT02660359|455177625|FG002|Overall Study|Withdrawal by Subject|8|||
126514384|NCT02660359|455177623|FG000|Overall Study|Lost to Follow-up|3|||
126514385|NCT02660359|455177624|FG001|Overall Study|Lost to Follow-up|3|||
126514386|NCT02660359|455177625|FG002|Overall Study|Lost to Follow-up|0|||
126514387|NCT00424372|455177626|FG000|Overall Study|Death|1|||
126514388|NCT00424372|455177626|FG000|Overall Study|Adverse Event|18|||
126514389|NCT00424372|455177626|FG000|Overall Study|Lack of Efficacy|6|||
126514390|NCT00424372|455177626|FG000|Overall Study|Withdrawal by Subject|4|||
126514391|NCT00424372|455177626|FG000|Overall Study|Protocol Violation|1|||
126514392|NCT00424372|455177626|FG000|Overall Study|Health deterioration|1|||
126514393|NCT02932891|455177627|FG000|Overall Study|Lost to Follow-up|2|||
126514394|NCT02932891|455177627|FG000|Overall Study|HPA Suppress|2|||
126514395|NCT04622254|455177628|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
126514396|NCT04622254|455177629|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
126514397|NCT04622254|455177630|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
126514398|NCT04622254|455177631|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
126514399|NCT04622254|455177632|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
126514400|NCT04622254|455177633|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
126514401|NCT04622254|455177628|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
126514402|NCT04622254|455177629|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
126514403|NCT04622254|455177630|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
126514404|NCT04622254|455177631|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
126514405|NCT04622254|455177632|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
126514406|NCT04622254|455177633|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
126514407|NCT04622254|455177628|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
126514408|NCT04622254|455177629|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
126514409|NCT04622254|455177630|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
126514410|NCT04622254|455177631|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
126514411|NCT04622254|455177632|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
126514412|NCT04622254|455177633|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
126514413|NCT04622254|455177628|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
126514414|NCT04622254|455177629|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
126514415|NCT04622254|455177630|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
126514416|NCT04622254|455177631|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
126514417|NCT04622254|455177632|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
126514418|NCT04622254|455177633|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
126514419|NCT04622254|455177628|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126514420|NCT04622254|455177629|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126514421|NCT04622254|455177630|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126514422|NCT04622254|455177631|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
126514423|NCT04622254|455177632|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126514424|NCT04622254|455177633|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
126514425|NCT04622254|455177628|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
126514426|NCT04622254|455177629|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
126514427|NCT04622254|455177630|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
126514428|NCT04622254|455177631|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
126514429|NCT04622254|455177632|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
126514430|NCT04622254|455177633|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
126514431|NCT04622254|455177628|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126514432|NCT04622254|455177629|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126514433|NCT04622254|455177630|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126514434|NCT04622254|455177631|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
126514435|NCT04622254|455177632|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126514436|NCT04622254|455177633|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
126514437|NCT04622254|455177628|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126514438|NCT04622254|455177629|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126514439|NCT04622254|455177630|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126514440|NCT04622254|455177631|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
126514441|NCT04622254|455177632|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126514442|NCT04622254|455177633|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
126514443|NCT04622254|455177628|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
126514444|NCT04622254|455177629|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
126514445|NCT04622254|455177630|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
126514446|NCT04622254|455177631|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
126514447|NCT04622254|455177632|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
126514448|NCT04622254|455177633|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
126514449|NCT04622254|455177628|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
126514450|NCT04622254|455177629|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
126514451|NCT04622254|455177630|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
126514452|NCT04622254|455177631|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
126514453|NCT04622254|455177632|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
126514454|NCT04622254|455177633|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
126514455|NCT04622254|455177628|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
126514456|NCT04622254|455177629|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
126514457|NCT04622254|455177630|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
126514458|NCT04622254|455177631|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
126514459|NCT04622254|455177632|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
126514460|NCT04622254|455177633|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
126514461|NCT03228680|455177635|FG000|Overall Study|Adverse Event|13|||
126514462|NCT03228680|455177636|FG001|Overall Study|Adverse Event|18|||
126514463|NCT03228680|455177635|FG000|Overall Study|Randomization failure|0|||
126514464|NCT03228680|455177636|FG001|Overall Study|Randomization failure|1|||
126514465|NCT03228680|455177635|FG000|Overall Study|Withdrawal by Subject|1|||
126514466|NCT03228680|455177636|FG001|Overall Study|Withdrawal by Subject|0|||
126514467|NCT03228680|455177635|FG000|Overall Study|Other|9|||
126514468|NCT03228680|455177636|FG001|Overall Study|Other|16|||
126514469|NCT00796861|455177644|FG000|Overall Study|Withdrawal by Subject|2|||
126568960|NCT02914522|455377463|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
126568961|NCT02914522|455377464|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
126568962|NCT02914522|455377465|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
126568963|NCT02914522|455377466|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
126568964|NCT02914522|455377456|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126568965|NCT02914522|455377457|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
126568966|NCT02914522|455377458|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126568967|NCT02914522|455377459|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126568968|NCT02914522|455377460|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
126568969|NCT02914522|455377461|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
126568970|NCT02914522|455377462|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126568971|NCT02914522|455377463|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126568972|NCT02914522|455377464|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126568973|NCT02914522|455377465|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126568974|NCT02914522|455377466|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
126568975|NCT02914522|455377456|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
126568976|NCT02914522|455377457|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
126568977|NCT02914522|455377458|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
126568978|NCT02914522|455377459|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
126568979|NCT02914522|455377460|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
126568980|NCT02914522|455377461|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
126568981|NCT02914522|455377462|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
126568982|NCT02914522|455377463|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
126568983|NCT02914522|455377464|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
126568984|NCT02914522|455377465|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
126568985|NCT02914522|455377466|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
126568986|NCT02914522|455377456|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
126568987|NCT02914522|455377457|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
126568988|NCT02914522|455377458|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
126568989|NCT02914522|455377459|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
126568990|NCT02914522|455377460|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
126568991|NCT02914522|455377461|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
126568992|NCT02914522|455377462|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
126568993|NCT02914522|455377463|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
126568994|NCT02914522|455377464|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
126568995|NCT02914522|455377465|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
126568996|NCT02914522|455377466|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
126568997|NCT02914522|455377456|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126568998|NCT02914522|455377457|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126568999|NCT02914522|455377458|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126569000|NCT02914522|455377459|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126569001|NCT02914522|455377460|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126569002|NCT02914522|455377461|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126569003|NCT02914522|455377462|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
126569004|NCT02914522|455377463|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
126569005|NCT02914522|455377464|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
126569006|NCT02914522|455377465|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
126569007|NCT02914522|455377466|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
126569008|NCT02914522|455377456|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
126569009|NCT02914522|455377457|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
126569010|NCT02914522|455377458|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
126569011|NCT02914522|455377459|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
126569012|NCT02914522|455377460|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
126569013|NCT02914522|455377461|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
126569014|NCT02914522|455377462|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
126569015|NCT02914522|455377463|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
126569016|NCT02914522|455377464|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
126569017|NCT02914522|455377465|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
126569018|NCT02914522|455377466|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
126569019|NCT02914522|455377456|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
126569020|NCT02914522|455377457|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
126569021|NCT02914522|455377458|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
126569022|NCT02914522|455377459|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
126569023|NCT02914522|455377460|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
126514470|NCT00796861|455177644|FG000|Overall Study|Death|2|||
126514471|NCT04354831|455177645|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
126514472|NCT04354831|455177646|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
126514473|NCT02370888|455177647|FG000|Overall Study|disease progression|2|||
126514474|NCT02370888|455177647|FG000|Overall Study|did not meet chimerism criteria|6|||
126514475|NCT02104557|455177648|FG000|Overall Study|Adverse Event|24|||
126514476|NCT02104557|455177648|FG000|Overall Study|Lost to Follow-up|34|||
126514477|NCT02104557|455177648|FG000|Overall Study|Violated the usage and dosage|14|||
126514478|NCT02104557|455177648|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
126514479|NCT02104557|455177648|FG000|Overall Study|Administered Sayana prior to the contract|1|||
126514480|NCT02104557|455177648|FG000|Overall Study|Other|17|||
126514481|NCT02104557|455177648|FG000|Overall Study|Change to other contraception methods|5|||
126514482|NCT02104557|455177648|FG000|Overall Study|Discontinuation due to no pain|1|||
126514483|NCT02104557|455177648|FG000|Overall Study|Withdrawal consent|2|||
126514484|NCT02104557|455177648|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
126514485|NCT02104557|455177648|FG000|Overall Study|Discontinuation of contraception|9|||
126514486|NCT01430585|455177650|FG000|Overall Study|Death|1|||
126514487|NCT01430585|455177650|FG000|Overall Study|Objective Progression or Relapse|3|||
126514488|NCT01430585|455177650|FG000|Overall Study|Study Terminated by Sponsor|3|||
126514489|NCT01430585|455177650|FG000|Overall Study|Other|7|||
126514490|NCT00779766|455177651|FG000|Month 24|Serious Adverse Event|2|||
126514491|NCT00779766|455177652|FG001|Month 24|Serious Adverse Event|3|||
126514492|NCT00779766|455177651|FG000|Month 24|Adverse Event|3|||
126514493|NCT00779766|455177652|FG001|Month 24|Adverse Event|3|||
126514494|NCT00779766|455177651|FG000|Month 24|Protocol Violation|3|||
126514495|NCT00779766|455177652|FG001|Month 24|Protocol Violation|1|||
126514496|NCT00779766|455177651|FG000|Month 24|Withdrawal by Subject|159|||
126514497|NCT00779766|455177652|FG001|Month 24|Withdrawal by Subject|127|||
126514498|NCT00779766|455177651|FG000|Month 24|Migrated/moved from study area|138|||
126514499|NCT00779766|455177652|FG001|Month 24|Migrated/moved from study area|162|||
126514500|NCT00779766|455177651|FG000|Month 24|Lost to Follow-up|9|||
126514501|NCT00779766|455177652|FG001|Month 24|Lost to Follow-up|9|||
126514502|NCT00779766|455177651|FG000|Month 24|Other|18|||
126514503|NCT00779766|455177652|FG001|Month 24|Other|27|||
126514504|NCT00779766|455177651|FG000|Month 48|Withdrawal by Subject|68|||
126514505|NCT00779766|455177652|FG001|Month 48|Withdrawal by Subject|63|||
126514506|NCT00779766|455177651|FG000|Month 48|Migrated/moved from study area|76|||
126514507|NCT00779766|455177652|FG001|Month 48|Migrated/moved from study area|75|||
126514508|NCT00779766|455177651|FG000|Month 48|Lost to Follow-up|29|||
126514509|NCT00779766|455177652|FG001|Month 48|Lost to Follow-up|30|||
126514510|NCT00779766|455177651|FG000|Month 48|Other|1|||
126514511|NCT00779766|455177652|FG001|Month 48|Other|0|||
126514512|NCT00779766|455177651|FG000|Month 72|Withdrawal by Subject|55|||
126514513|NCT00779766|455177652|FG001|Month 72|Withdrawal by Subject|71|||
126514514|NCT00779766|455177651|FG000|Month 72|Migrated/moved from study area|124|||
126514515|NCT00779766|455177652|FG001|Month 72|Migrated/moved from study area|109|||
126514516|NCT00779766|455177651|FG000|Month 72|Lost to Follow-up|6|||
126514517|NCT00779766|455177652|FG001|Month 72|Lost to Follow-up|8|||
126514518|NCT00779766|455177651|FG000|Month 72|Other|0|||
126514519|NCT00779766|455177652|FG001|Month 72|Other|1|||
126514520|NCT01274637|455177655|FG000|Overall Study|Withdrawal by Subject|0|||
126514521|NCT01274637|455177656|FG001|Overall Study|Withdrawal by Subject|1|||
126514522|NCT01274637|455177655|FG000|Overall Study|Lost to Follow-up|0|||
126514523|NCT01274637|455177656|FG001|Overall Study|Lost to Follow-up|1|||
126514524|NCT02357576|455177660|FG000|Treatment Period|Withdrawal by Subject|0|||
126514525|NCT02357576|455177661|FG001|Treatment Period|Withdrawal by Subject|1|||
126514526|NCT02357576|455177660|FG000|Treatment Period|Physician Decision|0|||
126514527|NCT02357576|455177661|FG001|Treatment Period|Physician Decision|1|||
126514528|NCT02357576|455177660|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
126514529|NCT02357576|455177661|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
126514530|NCT02357576|455177660|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
126514531|NCT02357576|455177661|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
126514532|NCT02357576|455177660|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
126514533|NCT02357576|455177661|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
126514534|NCT02357576|455177660|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
126514535|NCT02357576|455177661|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
126514536|NCT00699699|455177662|FG000|Overall Study|Adverse Event|36|||
126514537|NCT00699699|455177662|FG000|Overall Study|Individual different reasons|21|||
126514538|NCT01000051|455177663|FG000|Overall Study|Withdrawal by Subject|1|||
126514539|NCT01000051|455177664|FG001|Overall Study|Withdrawal by Subject|1|||
126514540|NCT01000051|455177663|FG000|Overall Study|Disease Progression|1|||
126514541|NCT01000051|455177664|FG001|Overall Study|Disease Progression|0|||
126514542|NCT01000051|455177663|FG000|Overall Study|Serious noncompliance|1|||
126514543|NCT01000051|455177664|FG001|Overall Study|Serious noncompliance|0|||
126514544|NCT00414050|455177665|FG000|Overall Study|Adverse Event|1|||
126514545|NCT00414050|455177666|FG001|Overall Study|Adverse Event|1|||
126514546|NCT00414050|455177667|FG002|Overall Study|Adverse Event|1|||
126514547|NCT00414050|455177668|FG003|Overall Study|Adverse Event|1|||
126514548|NCT00414050|455177665|FG000|Overall Study|Lost to Follow-up|2|||
126514549|NCT00414050|455177666|FG001|Overall Study|Lost to Follow-up|2|||
126514550|NCT00414050|455177667|FG002|Overall Study|Lost to Follow-up|1|||
126514551|NCT00414050|455177668|FG003|Overall Study|Lost to Follow-up|1|||
126514552|NCT00414050|455177665|FG000|Overall Study|Withdrawal by Subject|5|||
126514553|NCT00414050|455177666|FG001|Overall Study|Withdrawal by Subject|3|||
126514554|NCT00414050|455177667|FG002|Overall Study|Withdrawal by Subject|2|||
126514555|NCT00414050|455177668|FG003|Overall Study|Withdrawal by Subject|4|||
126514556|NCT00414050|455177665|FG000|Overall Study|Subject discontinued for other reason|1|||
126514557|NCT00414050|455177666|FG001|Overall Study|Subject discontinued for other reason|2|||
126514558|NCT00414050|455177667|FG002|Overall Study|Subject discontinued for other reason|2|||
126514559|NCT00414050|455177668|FG003|Overall Study|Subject discontinued for other reason|1|||
126514560|NCT00414050|455177665|FG000|Overall Study|Subject Moved|0|||
126514561|NCT00414050|455177666|FG001|Overall Study|Subject Moved|0|||
126514562|NCT00414050|455177667|FG002|Overall Study|Subject Moved|0|||
126514563|NCT00414050|455177668|FG003|Overall Study|Subject Moved|1|||
126514564|NCT03495908|455177674|FG000|Overall Study|Withdrawal by Subject|3|||
126514565|NCT03495908|455177675|FG001|Overall Study|Withdrawal by Subject|1|||
126514566|NCT03495908|455177674|FG000|Overall Study|Lost to Follow-up|1|||
126514567|NCT03495908|455177675|FG001|Overall Study|Lost to Follow-up|4|||
126514568|NCT03495908|455177674|FG000|Overall Study|Adverse Event|0|||
126514569|NCT03495908|455177675|FG001|Overall Study|Adverse Event|2|||
126514570|NCT03495908|455177674|FG000|Overall Study|Death|1|||
126514571|NCT03495908|455177675|FG001|Overall Study|Death|0|||
126514572|NCT03495908|455177674|FG000|Overall Study|Physician Decision|5|||
126514573|NCT03495908|455177675|FG001|Overall Study|Physician Decision|4|||
126514574|NCT03495908|455177674|FG000|Overall Study|No documented reason|0|||
126514575|NCT03495908|455177675|FG001|Overall Study|No documented reason|2|||
126514576|NCT03304379|455177676|FG000|Overall Study|Protocol Violation|8|||
126514577|NCT03304379|455177677|FG001|Overall Study|Protocol Violation|10|||
126514578|NCT03304379|455177678|FG002|Overall Study|Protocol Violation|5|||
126514579|NCT03304379|455177679|FG003|Overall Study|Protocol Violation|0|||
126514580|NCT03304379|455177680|FG004|Overall Study|Protocol Violation|2|||
126514581|NCT03304379|455177676|FG000|Overall Study|Adverse Event|4|||
126514582|NCT03304379|455177677|FG001|Overall Study|Adverse Event|20|||
126514583|NCT03304379|455177678|FG002|Overall Study|Adverse Event|17|||
126514584|NCT03304379|455177679|FG003|Overall Study|Adverse Event|1|||
126514585|NCT03304379|455177680|FG004|Overall Study|Adverse Event|0|||
126514586|NCT03304379|455177676|FG000|Overall Study|Lack of Efficacy|17|||
126514587|NCT03304379|455177677|FG001|Overall Study|Lack of Efficacy|16|||
126514588|NCT03304379|455177678|FG002|Overall Study|Lack of Efficacy|20|||
126514589|NCT03304379|455177679|FG003|Overall Study|Lack of Efficacy|0|||
126514590|NCT03304379|455177680|FG004|Overall Study|Lack of Efficacy|0|||
126514591|NCT03304379|455177676|FG000|Overall Study|Physician Decision|6|||
126514592|NCT03304379|455177677|FG001|Overall Study|Physician Decision|10|||
126514593|NCT03304379|455177678|FG002|Overall Study|Physician Decision|6|||
126514594|NCT03304379|455177679|FG003|Overall Study|Physician Decision|9|||
126514595|NCT03304379|455177680|FG004|Overall Study|Physician Decision|10|||
126514596|NCT03304379|455177676|FG000|Overall Study|Withdrawal by Subject|26|||
126514597|NCT03304379|455177677|FG001|Overall Study|Withdrawal by Subject|58|||
126514598|NCT03304379|455177678|FG002|Overall Study|Withdrawal by Subject|66|||
126514599|NCT03304379|455177679|FG003|Overall Study|Withdrawal by Subject|3|||
126514600|NCT03304379|455177680|FG004|Overall Study|Withdrawal by Subject|5|||
126514601|NCT03304379|455177676|FG000|Overall Study|Lost to Follow-up|8|||
126514602|NCT03304379|455177677|FG001|Overall Study|Lost to Follow-up|24|||
126514603|NCT03304379|455177678|FG002|Overall Study|Lost to Follow-up|35|||
126514604|NCT03304379|455177679|FG003|Overall Study|Lost to Follow-up|4|||
126514605|NCT03304379|455177680|FG004|Overall Study|Lost to Follow-up|0|||
126514606|NCT03304379|455177676|FG000|Overall Study|Death|1|||
126514607|NCT03304379|455177677|FG001|Overall Study|Death|2|||
126514608|NCT03304379|455177678|FG002|Overall Study|Death|0|||
126514609|NCT03304379|455177679|FG003|Overall Study|Death|0|||
126514610|NCT03304379|455177680|FG004|Overall Study|Death|0|||
126514611|NCT03304379|455177676|FG000|Overall Study|Other|0|||
126514612|NCT03304379|455177677|FG001|Overall Study|Other|1|||
126514613|NCT03304379|455177678|FG002|Overall Study|Other|0|||
126514614|NCT03304379|455177679|FG003|Overall Study|Other|0|||
126514615|NCT03304379|455177680|FG004|Overall Study|Other|0|||
126514616|NCT01469065|455177694|FG000|Overall Study|Lack of Efficacy|0|||
126514617|NCT01469065|455177695|FG001|Overall Study|Lack of Efficacy|0|||
126514618|NCT01469065|455177696|FG002|Overall Study|Lack of Efficacy|0|||
126514619|NCT01469065|455177697|FG003|Overall Study|Lack of Efficacy|0|||
126514620|NCT01469065|455177698|FG004|Overall Study|Lack of Efficacy|1|||
126514621|NCT01469065|455177694|FG000|Overall Study|Other|0|||
126514622|NCT01469065|455177695|FG001|Overall Study|Other|1|||
126514623|NCT01469065|455177696|FG002|Overall Study|Other|0|||
126776984|NCT00297479|456139142|FG000|Overall Study|Lost to Follow-up|37|||
126514624|NCT01469065|455177697|FG003|Overall Study|Other|0|||
126514625|NCT01469065|455177698|FG004|Overall Study|Other|0|||
126569024|NCT02914522|455377461|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
126569025|NCT02914522|455377462|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
126569026|NCT02914522|455377463|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
126569027|NCT02914522|455377464|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
126569028|NCT02914522|455377465|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
126569029|NCT02914522|455377466|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
126569030|NCT02914522|455377456|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126569031|NCT02914522|455377457|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126569032|NCT02914522|455377458|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126569033|NCT02914522|455377459|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126569034|NCT02914522|455377460|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126569035|NCT02914522|455377461|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126569036|NCT02914522|455377462|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126569037|NCT02914522|455377463|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
126569038|NCT02914522|455377464|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
126569039|NCT02914522|455377465|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126569040|NCT02914522|455377466|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
126569041|NCT02914522|455377456|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126569042|NCT02914522|455377457|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126569043|NCT02914522|455377458|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126569044|NCT02914522|455377459|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126569045|NCT02914522|455377460|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126569046|NCT02914522|455377461|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126569047|NCT02914522|455377462|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126569048|NCT02914522|455377463|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126569049|NCT02914522|455377464|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
126569050|NCT02914522|455377465|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
126569051|NCT02914522|455377466|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
126569052|NCT02914522|455377456|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126569053|NCT02914522|455377457|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126569054|NCT02914522|455377458|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126569055|NCT02914522|455377459|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126569056|NCT02914522|455377460|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126569057|NCT02914522|455377461|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126569058|NCT02914522|455377462|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126569059|NCT02914522|455377463|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126569060|NCT02914522|455377464|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126569061|NCT02914522|455377465|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
126569062|NCT02914522|455377466|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
126569063|NCT00756730|455377467|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
126569064|NCT00756730|455377468|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
126569065|NCT00756730|455377467|FG000|Overall Study|persistent low-level viremmia|0|||
126569066|NCT00756730|455377468|FG001|Overall Study|persistent low-level viremmia|1|||
126569067|NCT03386929|455377473|FG000|Overall Study|Death|0|||
126569068|NCT03386929|455377474|FG001|Overall Study|Death|0|||
126569069|NCT03386929|455377475|FG002|Overall Study|Death|1|||
126569070|NCT03386929|455377473|FG000|Overall Study|Withdrawal by Subject|0|||
126569071|NCT03386929|455377474|FG001|Overall Study|Withdrawal by Subject|1|||
126569072|NCT03386929|455377475|FG002|Overall Study|Withdrawal by Subject|0|||
126569073|NCT03386929|455377473|FG000|Overall Study|Physician Decision|0|||
126569074|NCT03386929|455377474|FG001|Overall Study|Physician Decision|0|||
126569075|NCT03386929|455377475|FG002|Overall Study|Physician Decision|1|||
126569076|NCT03386929|455377473|FG000|Overall Study|Progression|4|||
126569077|NCT03386929|455377474|FG001|Overall Study|Progression|4|||
126569078|NCT03386929|455377475|FG002|Overall Study|Progression|0|||
126569079|NCT03386929|455377473|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
126569080|NCT03386929|455377474|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
126569081|NCT03386929|455377475|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
126569082|NCT03386929|455377473|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
126569083|NCT03386929|455377474|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
126569084|NCT03386929|455377475|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
126569085|NCT00387465|455377478|FG000|Overall Study|Withdrawal by Subject|0|||
126569086|NCT00387465|455377479|FG001|Overall Study|Withdrawal by Subject|1|||
126569087|NCT00387465|455377480|FG002|Overall Study|Withdrawal by Subject|0|||
126569088|NCT05052983|455377485|FG000|Overall Study|Lack of Efficacy|3|||
126569089|NCT05052983|455377486|FG001|Overall Study|Lack of Efficacy|12|||
126569090|NCT05052983|455377485|FG000|Overall Study|Adverse Event|1|||
126569091|NCT05052983|455377486|FG001|Overall Study|Adverse Event|0|||
126569092|NCT04133363|455377487|FG000|Overall Study|Lost to Follow-up|2|||
126569093|NCT04133363|455377488|FG001|Overall Study|Lost to Follow-up|1|||
126569094|NCT04133363|455377489|FG002|Overall Study|Lost to Follow-up|4|||
126569095|NCT00849147|455377493|FG000|Overall Study|Withdrawal by Subject|1|||
126569096|NCT00849147|455377493|FG000|Overall Study|Protocol Violation|2|||
126569097|NCT00849147|455377493|FG000|Overall Study|Disease Relapse/Progression|2|||
126569098|NCT00482729|455379374|FG000|Overall Study|Adverse Event|29|||
126569099|NCT00482729|455379375|FG001|Overall Study|Adverse Event|33|||
126569100|NCT00482729|455379374|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
126569101|NCT00482729|455379375|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
126569102|NCT00482729|455379374|FG000|Overall Study|Hyperglycemia Criteria|7|||
126569103|NCT00482729|455379375|FG001|Overall Study|Hyperglycemia Criteria|5|||
126569104|NCT00482729|455379374|FG000|Overall Study|Lack of Efficacy|4|||
126569105|NCT00482729|455379375|FG001|Overall Study|Lack of Efficacy|16|||
126569106|NCT00482729|455379374|FG000|Overall Study|Lost to Follow-up|86|||
126569107|NCT00482729|455379375|FG001|Overall Study|Lost to Follow-up|66|||
126569108|NCT00482729|455379374|FG000|Overall Study|Physician Decision|10|||
126569109|NCT00482729|455379375|FG001|Overall Study|Physician Decision|7|||
126569110|NCT00482729|455379374|FG000|Overall Study|Pregnancy|4|||
126569111|NCT00482729|455379375|FG001|Overall Study|Pregnancy|2|||
126569112|NCT00482729|455379374|FG000|Overall Study|Protocol Violation|10|||
126569113|NCT00482729|455379375|FG001|Overall Study|Protocol Violation|18|||
126569114|NCT00482729|455379374|FG000|Overall Study|Withdrawal by Subject|67|||
126569115|NCT00482729|455379375|FG001|Overall Study|Withdrawal by Subject|69|||
126569116|NCT02631148|455379379|FG000|Overall Study|8 were ineligible|8|||
126569117|NCT02631148|455379380|FG001|Overall Study|8 were ineligible|0|||
126569118|NCT02631148|455379379|FG000|Overall Study|Withdrawal by Subject|1|||
126569119|NCT02631148|455379380|FG001|Overall Study|Withdrawal by Subject|0|||
126569120|NCT02631148|455379379|FG000|Overall Study|PAH not available to study participant|1|||
126569121|NCT02631148|455379380|FG001|Overall Study|PAH not available to study participant|0|||
126569122|NCT04860258|455379381|FG000|Overall Study|Withdrawal by Subject|0|||
126514626|NCT00439140|455177699|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
126514627|NCT00439140|455177700|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
126514628|NCT00439140|455177701|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
126514629|NCT00439140|455177699|FG000|Treatment Cycle 1|Personal reasons|0|||
126514630|NCT00439140|455177700|FG001|Treatment Cycle 1|Personal reasons|2|||
126514631|NCT00439140|455177701|FG002|Treatment Cycle 1|Personal reasons|0|||
126514632|NCT00439140|455177699|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
126514633|NCT00439140|455177700|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
126514634|NCT00439140|455177701|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
126514635|NCT00439140|455177699|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
126514636|NCT00439140|455177700|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
126514637|NCT00439140|455177701|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
126514638|NCT00439140|455177699|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
126514639|NCT00439140|455177700|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
126514640|NCT00439140|455177701|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
126514641|NCT03286140|455177703|FG000|Overall Study|Withdrawal by Subject|10|||
126514642|NCT03286140|455177704|FG001|Overall Study|Withdrawal by Subject|5|||
126514643|NCT03286140|455177703|FG000|Overall Study|Lost to Follow-up|5|||
126514644|NCT03286140|455177704|FG001|Overall Study|Lost to Follow-up|10|||
126514645|NCT03286140|455177703|FG000|Overall Study|Failure to comply|0|||
126514646|NCT03286140|455177704|FG001|Overall Study|Failure to comply|1|||
126514647|NCT01565291|455177705|FG000|Overall Study|Withdrawal by Subject|1|||
126514648|NCT01565291|455177706|FG001|Overall Study|Withdrawal by Subject|0|||
126514649|NCT00515827|455177707|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
126514650|NCT00515827|455177708|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
126514651|NCT00515827|455177707|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
126514652|NCT00515827|455177708|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
126569123|NCT04860258|455379382|FG001|Overall Study|Withdrawal by Subject|0|||
126569124|NCT04860258|455379383|FG002|Overall Study|Withdrawal by Subject|4|||
126569125|NCT04860258|455379384|FG003|Overall Study|Withdrawal by Subject|1|||
126569126|NCT04860258|455379385|FG004|Overall Study|Withdrawal by Subject|4|||
126569127|NCT04860258|455379386|FG005|Overall Study|Withdrawal by Subject|1|||
126569128|NCT04860258|455379387|FG006|Overall Study|Withdrawal by Subject|0|||
126569129|NCT01134562|455379389|FG000|Overall Study|Adverse Event|0|||
126569130|NCT01134562|455379390|FG001|Overall Study|Adverse Event|1|||
126569131|NCT01134562|455379391|FG002|Overall Study|Adverse Event|0|||
126569132|NCT01134562|455379392|FG003|Overall Study|Adverse Event|0|||
126569133|NCT01134562|455379393|FG004|Overall Study|Adverse Event|0|||
126514653|NCT03149237|455177723|FG000|Overall Study|Withdrawal by Subject|4|||
126514654|NCT03149237|455177724|FG001|Overall Study|Withdrawal by Subject|5|||
126569134|NCT02496702|455379395|FG000|Overall Study|Lost to Follow-up|8|||
126569135|NCT02496702|455379396|FG001|Overall Study|Lost to Follow-up|6|||
126569136|NCT02496702|455379395|FG000|Overall Study|Only partially tested|0|||
126569137|NCT02496702|455379396|FG001|Overall Study|Only partially tested|2|||
126569138|NCT00753012|455379402|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
126569139|NCT00753012|455379403|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
126569140|NCT00753012|455379402|FG000|Overall Study|Adverse Event|2|||
126569141|NCT00753012|455379403|FG001|Overall Study|Adverse Event|0|||
126569142|NCT00753012|455379402|FG000|Overall Study|Withdrawal by Subject|0|||
126569143|NCT00753012|455379403|FG001|Overall Study|Withdrawal by Subject|1|||
126569144|NCT00753012|455379402|FG000|Overall Study|Lost to Follow-up|4|||
126569145|NCT00753012|455379403|FG001|Overall Study|Lost to Follow-up|0|||
126569146|NCT00753012|455379402|FG000|Overall Study|Confounded endpoint data|1|||
126569147|NCT00753012|455379403|FG001|Overall Study|Confounded endpoint data|0|||
126569148|NCT00943735|455379406|FG000|Overall Study|Adverse Event|12|||
126569149|NCT00943735|455379406|FG000|Overall Study|Withdrawal by Subject|8|||
126569150|NCT00943735|455379406|FG000|Overall Study|Death|1|||
126569151|NCT00943735|455379406|FG000|Overall Study|Other|8|||
126569152|NCT00943735|455379406|FG000|Overall Study|Other|3|||
126569153|NCT03804918|455379407|FG000|Overall Study|Participant did not use the app|1|||
126569154|NCT01329328|455379408|FG000|Overall Study|Withdrawal by Subject|2|||
126569155|NCT01329328|455379409|FG001|Overall Study|Withdrawal by Subject|4|||
126569156|NCT01329328|455379410|FG002|Overall Study|Withdrawal by Subject|3|||
126569157|NCT00964366|455379412|FG000|Overall Study|Did not qualify at Day 1|1|||
126569158|NCT00964366|455379413|FG001|Overall Study|Did not qualify at Day 1|0|||
126569159|NCT00964366|455379412|FG000|Overall Study|Withdrawal by Subject|0|||
126569160|NCT00964366|455379413|FG001|Overall Study|Withdrawal by Subject|1|||
126569161|NCT01370694|455379414|FG000|Overall Study|Switched to rituximab|4|||
126569162|NCT01370694|455379414|FG000|Overall Study|Progressive disease|2|||
126569163|NCT02393716|455379415|FG000|Overall Study|Death|29|||
126569164|NCT02393716|455379415|FG000|Overall Study|Withdrawal by Subject|8|||
126569165|NCT02393716|455379415|FG000|Overall Study|Device Explanted|8|||
126569166|NCT02393716|455379415|FG000|Overall Study|Missed visit|16|||
126569167|NCT02957539|455379416|FG000|Baseline to Week 16|Lost to Follow-up|8|||
126569168|NCT02957539|455379417|FG001|Baseline to Week 16|Lost to Follow-up|10|||
126569169|NCT02957539|455379418|FG002|Baseline to Week 16|Lost to Follow-up|16|||
126569170|NCT02957539|455379416|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
126569171|NCT02957539|455379417|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
126569172|NCT02957539|455379418|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
126569173|NCT02957539|455379416|FG000|Week 16 to 32|Withdrawal by Subject|3|||
126569174|NCT02957539|455379417|FG001|Week 16 to 32|Withdrawal by Subject|3|||
126569175|NCT02957539|455379418|FG002|Week 16 to 32|Withdrawal by Subject|1|||
126569176|NCT02957539|455379416|FG000|Week 16 to 32|Lost to Follow-up|8|||
126569177|NCT02957539|455379417|FG001|Week 16 to 32|Lost to Follow-up|7|||
126569178|NCT02957539|455379418|FG002|Week 16 to 32|Lost to Follow-up|5|||
126569179|NCT02957539|455379416|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
126569180|NCT02957539|455379417|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
126569181|NCT02957539|455379418|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
126569182|NCT02957539|455379416|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
126569183|NCT02957539|455379417|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
126569184|NCT02957539|455379418|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
126569185|NCT01119950|455379423|FG000|Overall Study|Adverse Event|25|||
126569186|NCT01119950|455379423|FG000|Overall Study|Withdrawal by Subject|9|||
126569187|NCT01119950|455379423|FG000|Overall Study|Protocol Violation|5|||
126569188|NCT01119950|455379423|FG000|Overall Study|Lost to Follow-up|4|||
126569189|NCT01119950|455379423|FG000|Overall Study|Administrative|2|||
126569190|NCT01119950|455379423|FG000|Overall Study|Abnormal lab value|1|||
126569191|NCT01119950|455379423|FG000|Overall Study|Death|1|||
126569192|NCT00217672|455379427|FG000|Allocation|Ineligible|2|||
126569193|NCT00217672|455379428|FG001|Allocation|Ineligible|0|||
126569194|NCT00217672|455379427|FG000|Treatment|disease progression|33|||
126569195|NCT00217672|455379428|FG001|Treatment|disease progression|4|||
126569196|NCT00217672|455379427|FG000|Treatment|Adverse Event|18|||
126569197|NCT00217672|455379428|FG001|Treatment|Adverse Event|2|||
126569198|NCT00217672|455379427|FG000|Treatment|reqd treatment not permitted by protocol|6|||
126569199|NCT00217672|455379428|FG001|Treatment|reqd treatment not permitted by protocol|0|||
126569200|NCT00217672|455379427|FG000|Treatment|Physician Decision|6|||
126569201|NCT00217672|455379428|FG001|Treatment|Physician Decision|0|||
126569202|NCT00217672|455379427|FG000|Treatment|insurance issues|1|||
126569203|NCT00217672|455379428|FG001|Treatment|insurance issues|1|||
126569204|NCT00217672|455379427|FG000|Treatment|Death|2|||
126569205|NCT00217672|455379428|FG001|Treatment|Death|0|||
126569206|NCT00217672|455379427|FG000|Treatment|secondary malignancy|1|||
126569207|NCT00217672|455379428|FG001|Treatment|secondary malignancy|0|||
126569208|NCT00217672|455379427|FG000|Follow-up|Withdrawal by Subject|4|||
126569209|NCT00217672|455379428|FG001|Follow-up|Withdrawal by Subject|0|||
126569210|NCT00217672|455379427|FG000|Follow-up|Lost to Follow-up|1|||
126569211|NCT00217672|455379428|FG001|Follow-up|Lost to Follow-up|0|||
126569212|NCT02371746|455379435|FG000|Overall Study|Consent withdrawn|0|||
126569213|NCT02371746|455379436|FG001|Overall Study|Consent withdrawn|0|||
126569214|NCT02371746|455379437|FG002|Overall Study|Consent withdrawn|0|||
126569215|NCT02371746|455379438|FG003|Overall Study|Consent withdrawn|0|||
126569216|NCT02371746|455379439|FG004|Overall Study|Consent withdrawn|0|||
126569217|NCT02371746|455379440|FG005|Overall Study|Consent withdrawn|0|||
126569218|NCT02371746|455379441|FG006|Overall Study|Consent withdrawn|1|||
126569219|NCT01157182|455379442|FG000|Washout of 28 Days|Adverse Event|2|||
126569220|NCT01157182|455379443|FG001|Washout of 28 Days|Adverse Event|0|||
126569221|NCT03743246|455379444|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
126569222|NCT03743246|455379445|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
126569223|NCT03743246|455379446|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
126569224|NCT03743246|455379447|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
126569225|NCT03743246|455379444|FG000|Pre-Treatment Period|Death|0|||
126569226|NCT03743246|455379445|FG001|Pre-Treatment Period|Death|1|||
126569227|NCT03743246|455379446|FG002|Pre-Treatment Period|Death|0|||
126569228|NCT03743246|455379447|FG003|Pre-Treatment Period|Death|1|||
126569229|NCT03743246|455379444|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
126569230|NCT03743246|455379445|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
126569231|NCT03743246|455379446|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
126569232|NCT03743246|455379447|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
126569233|NCT03743246|455379444|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
126569234|NCT03743246|455379445|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
126569235|NCT03743246|455379446|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
126569236|NCT03743246|455379447|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
126569237|NCT03743246|455379444|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
126569238|NCT03743246|455379445|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
126569239|NCT03743246|455379446|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
126569240|NCT03743246|455379447|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
126569241|NCT03743246|455379444|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
126569242|NCT03743246|455379445|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
126569243|NCT03743246|455379446|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
126569244|NCT03743246|455379447|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
126569245|NCT03743246|455379444|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
126569246|NCT03743246|455379445|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
126569247|NCT03743246|455379446|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
126569248|NCT03743246|455379447|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
126569249|NCT03743246|455379444|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
126569250|NCT03743246|455379445|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
126569251|NCT03743246|455379446|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
126569252|NCT03743246|455379447|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
126569253|NCT03743246|455379444|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
126569254|NCT03743246|455379445|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
126569255|NCT03743246|455379446|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
126569256|NCT03743246|455379447|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
126569257|NCT05382104|455379461|FG000|Period 2 (2 Days)|Adverse Event|0|||
126569258|NCT05382104|455379462|FG001|Period 2 (2 Days)|Adverse Event|1|||
126569259|NCT05382104|455379463|FG002|Period 2 (2 Days)|Adverse Event|0|||
126569260|NCT05382104|455379464|FG003|Period 2 (2 Days)|Adverse Event|0|||
126569261|NCT05382104|455379465|FG004|Period 2 (2 Days)|Adverse Event|0|||
126569262|NCT05382104|455379466|FG005|Period 2 (2 Days)|Adverse Event|0|||
126569263|NCT00639002|455379467|FG000|Overall Study|Death|1|||
126569264|NCT00639002|455379467|FG000|Overall Study|Adverse Event|1|||
126569265|NCT00639002|455379467|FG000|Overall Study|Protocol Violation|1|||
126569266|NCT00639002|455379467|FG000|Overall Study|Disease progression|3|||
126569267|NCT00639002|455379467|FG000|Overall Study|Physician Decision|6|||
126569268|NCT00639002|455379467|FG000|Overall Study|Lack of Efficacy|1|||
126569269|NCT05686421|455379475|FG000|Overall Study|Screen failure|22|||
126569270|NCT05686421|455379476|FG001|Overall Study|Screen failure|0|||
126569271|NCT05686421|455379477|FG002|Overall Study|Screen failure|0|||
126569272|NCT05686421|455379478|FG003|Overall Study|Screen failure|0|||
126569273|NCT00367055|455379480|FG000|Overall Study|Adverse Event|6|||
126569274|NCT00367055|455379481|FG001|Overall Study|Adverse Event|3|||
126569275|NCT00367055|455379480|FG000|Overall Study|Patient's Willing|3|||
126569276|NCT00367055|455379481|FG001|Overall Study|Patient's Willing|2|||
126569277|NCT00367055|455379480|FG000|Overall Study|Lack of Efficacy|1|||
126569278|NCT00367055|455379481|FG001|Overall Study|Lack of Efficacy|2|||
126569279|NCT00367055|455379480|FG000|Overall Study|Lost to Follow-up|1|||
126569280|NCT00367055|455379481|FG001|Overall Study|Lost to Follow-up|1|||
126569281|NCT00367055|455379480|FG000|Overall Study|Protocol Violation|0|||
126569282|NCT00367055|455379481|FG001|Overall Study|Protocol Violation|1|||
126569283|NCT00367055|455379480|FG000|Overall Study|Stopping Criterion Met|0|||
126569284|NCT00367055|455379481|FG001|Overall Study|Stopping Criterion Met|1|||
126569285|NCT00367055|455379480|FG000|Overall Study|Participant Living too Far from Hospital|0|||
126569286|NCT00367055|455379481|FG001|Overall Study|Participant Living too Far from Hospital|1|||
126569287|NCT02459899|455379482|FG000|Overall Study|Adverse Event|1|||
126569288|NCT02459899|455379483|FG001|Overall Study|Adverse Event|1|||
126569289|NCT02459899|455379484|FG002|Overall Study|Adverse Event|0|||
126569290|NCT02459899|455379485|FG003|Overall Study|Adverse Event|0|||
126569291|NCT02459899|455379482|FG000|Overall Study|Lost to Follow-up|1|||
126569292|NCT02459899|455379483|FG001|Overall Study|Lost to Follow-up|2|||
126569293|NCT02459899|455379484|FG002|Overall Study|Lost to Follow-up|0|||
126569294|NCT02459899|455379485|FG003|Overall Study|Lost to Follow-up|1|||
126569295|NCT02459899|455379482|FG000|Overall Study|Non-compliance with the treatment|0|||
126569296|NCT02459899|455379483|FG001|Overall Study|Non-compliance with the treatment|0|||
126569297|NCT02459899|455379484|FG002|Overall Study|Non-compliance with the treatment|0|||
126569298|NCT02459899|455379485|FG003|Overall Study|Non-compliance with the treatment|1|||
126569299|NCT02459899|455379482|FG000|Overall Study|Withdrawal by Subject|1|||
126569300|NCT02459899|455379483|FG001|Overall Study|Withdrawal by Subject|3|||
126569301|NCT02459899|455379484|FG002|Overall Study|Withdrawal by Subject|0|||
126569302|NCT02459899|455379485|FG003|Overall Study|Withdrawal by Subject|0|||
126569303|NCT00940992|455379488|FG000|Overall Study|Adverse Event|2|||
126569304|NCT00940992|455379489|FG001|Overall Study|Adverse Event|0|||
126514655|NCT01466192|455177725|FG000|Overall Study|Physician Decision|1|||
126514656|NCT01466192|455177725|FG000|Overall Study|Withdrawal by Subject|3|||
126514657|NCT01227512|455177728|FG000|Overall Study|Physician Decision|6|||
126514658|NCT01227512|455177729|FG001|Overall Study|Physician Decision|6|||
126514659|NCT01227512|455177728|FG000|Overall Study|Adverse Event|4|||
126514660|NCT01227512|455177729|FG001|Overall Study|Adverse Event|3|||
126514661|NCT01227512|455177728|FG000|Overall Study|Withdrawal by Subject|3|||
126514662|NCT01227512|455177729|FG001|Overall Study|Withdrawal by Subject|0|||
126514663|NCT01227512|455177728|FG000|Overall Study|Participant met withdrawal criteria|0|||
126514664|NCT01227512|455177729|FG001|Overall Study|Participant met withdrawal criteria|1|||
126514665|NCT04055116|455177730|FG000|First Intervention|Physician Decision|2|||
126514666|NCT04055116|455177731|FG001|First Intervention|Physician Decision|7|||
126514667|NCT02774681|455177738|FG000|Treatment on Study|Progressive Disease|7|||
126514668|NCT02774681|455177738|FG000|Follow-Up for 3 Years|Death|11|||
126514669|NCT02774681|455177738|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
126514670|NCT04497987|455177739|FG000|Overall Study|Adverse Event|1|||
126514671|NCT04497987|455177740|FG001|Overall Study|Adverse Event|0|||
126514672|NCT04497987|455177739|FG000|Overall Study|Death|21|||
126514673|NCT04497987|455177740|FG001|Overall Study|Death|13|||
126514674|NCT04497987|455177739|FG000|Overall Study|Lost to Follow-up|19|||
126514675|NCT04497987|455177740|FG001|Overall Study|Lost to Follow-up|17|||
126514676|NCT04497987|455177739|FG000|Overall Study|Other - as reported by the investigator|22|||
126514677|NCT04497987|455177740|FG001|Overall Study|Other - as reported by the investigator|16|||
126514678|NCT04497987|455177739|FG000|Overall Study|Physician Decision|1|||
126514679|NCT04497987|455177740|FG001|Overall Study|Physician Decision|0|||
126514680|NCT04497987|455177739|FG000|Overall Study|Withdrawal by Subject|35|||
126514681|NCT04497987|455177740|FG001|Overall Study|Withdrawal by Subject|21|||
126514682|NCT00512096|455177741|FG000|Overall Study|Adverse Event|2|||
126514683|NCT00512096|455177741|FG000|Overall Study|Withdrawal by Subject|2|||
126514684|NCT00512096|455177741|FG000|Overall Study|Lack of Efficacy|3|||
126514685|NCT01069289|455177742|FG000|Overall Study|Withdrawal by Subject|15|||
126514686|NCT01069289|455177743|FG001|Overall Study|Withdrawal by Subject|26|||
126514687|NCT01069289|455177742|FG000|Overall Study|Adverse Event|21|||
126514688|NCT01069289|455177743|FG001|Overall Study|Adverse Event|28|||
126514689|NCT01069289|455177742|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
126514690|NCT01069289|455177743|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126514691|NCT01069289|455177742|FG000|Overall Study|Severe non-compliance to protocol|3|||
126514692|NCT01069289|455177743|FG001|Overall Study|Severe non-compliance to protocol|2|||
126514693|NCT01069289|455177742|FG000|Overall Study|Due to deteriorating health condition|1|||
126514694|NCT01069289|455177743|FG001|Overall Study|Due to deteriorating health condition|0|||
126514695|NCT02047604|455177744|FG000|Overall Study|Withdrawal by Subject|0|||
126514696|NCT02047604|455177745|FG001|Overall Study|Withdrawal by Subject|0|||
126514697|NCT02047604|455177746|FG002|Overall Study|Withdrawal by Subject|0|||
126514698|NCT02047604|455177747|FG003|Overall Study|Withdrawal by Subject|0|||
126514699|NCT02047604|455177748|FG004|Overall Study|Withdrawal by Subject|1|||
126514700|NCT02047604|455177749|FG005|Overall Study|Withdrawal by Subject|1|||
126514701|NCT04035486|455177750|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
126514702|NCT04035486|455177751|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
126514703|NCT04035486|455177752|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
126514704|NCT04035486|455177753|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
126514705|NCT04035486|455177750|FG000|Overall Study|Death|6|||
126514706|NCT04035486|455177751|FG001|Overall Study|Death|3|||
126514707|NCT04035486|455177752|FG002|Overall Study|Death|70|||
126514708|NCT04035486|455177753|FG003|Overall Study|Death|77|||
126514709|NCT04035486|455177750|FG000|Overall Study|Screen Failure|0|||
126514710|NCT04035486|455177751|FG001|Overall Study|Screen Failure|0|||
126514711|NCT04035486|455177752|FG002|Overall Study|Screen Failure|1|||
126514712|NCT04035486|455177753|FG003|Overall Study|Screen Failure|1|||
126514713|NCT04035486|455177750|FG000|Overall Study|Withdrawal by Subject|1|||
126569305|NCT00940992|455379490|FG002|Overall Study|Adverse Event|1|||
126569306|NCT00940992|455379488|FG000|Overall Study|subject request|2|||
126569307|NCT00940992|455379489|FG001|Overall Study|subject request|1|||
126514714|NCT04035486|455177751|FG001|Overall Study|Withdrawal by Subject|1|||
126514715|NCT04035486|455177752|FG002|Overall Study|Withdrawal by Subject|11|||
126514716|NCT04035486|455177753|FG003|Overall Study|Withdrawal by Subject|9|||
126514717|NCT01643473|455179854|FG000|Overall Study|Lost to Follow-up|1|||
126514718|NCT01643473|455179855|FG001|Overall Study|Lost to Follow-up|0|||
126514719|NCT01519518|455179856|FG000|Overall Study|Consent not available|7|||
126514720|NCT01519518|455179857|FG001|Overall Study|Consent not available|10|||
126514721|NCT01312909|455179859|FG000|Overall Study|Randomized but not treated|1|||
126514722|NCT01312909|455179860|FG001|Overall Study|Randomized but not treated|3|||
126514723|NCT01312909|455179861|FG002|Overall Study|Randomized but not treated|1|||
126514724|NCT01312909|455179859|FG000|Overall Study|Adverse Event|1|||
126514725|NCT01312909|455179860|FG001|Overall Study|Adverse Event|0|||
126514726|NCT01312909|455179861|FG002|Overall Study|Adverse Event|3|||
126514727|NCT01312909|455179859|FG000|Overall Study|Protocol Violation|2|||
126514728|NCT01312909|455179860|FG001|Overall Study|Protocol Violation|0|||
126514729|NCT01312909|455179861|FG002|Overall Study|Protocol Violation|2|||
126514730|NCT01312909|455179859|FG000|Overall Study|Other|9|||
126514731|NCT01312909|455179860|FG001|Overall Study|Other|6|||
126514732|NCT01312909|455179861|FG002|Overall Study|Other|11|||
126514733|NCT01312909|455179859|FG000|Overall Study|Withdrawal by Subject|8|||
126514734|NCT01312909|455179860|FG001|Overall Study|Withdrawal by Subject|10|||
126514735|NCT01312909|455179861|FG002|Overall Study|Withdrawal by Subject|7|||
126514736|NCT01312909|455179859|FG000|Overall Study|Lost to Follow-up|21|||
126514737|NCT01312909|455179860|FG001|Overall Study|Lost to Follow-up|17|||
126514738|NCT01312909|455179861|FG002|Overall Study|Lost to Follow-up|20|||
126514739|NCT01312909|455179859|FG000|Overall Study|Insufficient clinical response|0|||
126514740|NCT01312909|455179860|FG001|Overall Study|Insufficient clinical response|0|||
126514741|NCT01312909|455179861|FG002|Overall Study|Insufficient clinical response|1|||
126514742|NCT01312909|455179859|FG000|Overall Study|Entrance criteria not met|0|||
126514743|NCT01312909|455179860|FG001|Overall Study|Entrance criteria not met|0|||
126514744|NCT01312909|455179861|FG002|Overall Study|Entrance criteria not met|2|||
126514745|NCT00938431|455179866|FG000|Overall Study|Adverse Event|5|||
126514746|NCT00938431|455179867|FG001|Overall Study|Adverse Event|8|||
126514747|NCT00938431|455179868|FG002|Overall Study|Adverse Event|6|||
126514748|NCT00938431|455179866|FG000|Overall Study|Lack of Efficacy|0|||
126514749|NCT00938431|455179867|FG001|Overall Study|Lack of Efficacy|1|||
126514750|NCT00938431|455179868|FG002|Overall Study|Lack of Efficacy|0|||
126514751|NCT00938431|455179866|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
126514752|NCT00938431|455179867|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
126514753|NCT00938431|455179868|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
126514754|NCT00938431|455179866|FG000|Overall Study|Dosing compliance issue|0|||
126514755|NCT00938431|455179867|FG001|Overall Study|Dosing compliance issue|0|||
126514756|NCT00938431|455179868|FG002|Overall Study|Dosing compliance issue|1|||
126514757|NCT00938431|455179866|FG000|Overall Study|Reached maximum dose early|0|||
126514758|NCT00938431|455179867|FG001|Overall Study|Reached maximum dose early|0|||
126514759|NCT00938431|455179868|FG002|Overall Study|Reached maximum dose early|1|||
126514760|NCT01774903|455179869|FG000|Overall Study|Adverse Event|7|||
126514761|NCT01774903|455179869|FG000|Overall Study|Withdrawal by Subject|2|||
126514762|NCT01774903|455179869|FG000|Overall Study|Lack of Efficacy|1|||
126514763|NCT01774903|455179869|FG000|Overall Study|Ineligible to continue the trial|1|||
126514764|NCT02212730|455179872|FG000|Overall Study|Tumor not of the required cell histology|1|||
126514765|NCT02212730|455179873|FG001|Overall Study|Tumor not of the required cell histology|0|||
126514766|NCT02212730|455179872|FG000|Overall Study|Withdrawal by Subject|1|||
126514767|NCT02212730|455179873|FG001|Overall Study|Withdrawal by Subject|0|||
126514768|NCT02212730|455179872|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
126514769|NCT02212730|455179873|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
126514770|NCT00451282|455179879|FG000|Overall Study|Lost to Follow-up|6|||
126514771|NCT00451282|455179880|FG001|Overall Study|Lost to Follow-up|5|||
126514772|NCT00577122|455179881|FG000|Overall Study|Adverse Event|0|||
126514773|NCT00577122|455179882|FG001|Overall Study|Adverse Event|2|||
126514774|NCT00577122|455179881|FG000|Overall Study|Progression, relapse during active trt|6|||
126514775|NCT00577122|455179882|FG001|Overall Study|Progression, relapse during active trt|8|||
126514776|NCT00577122|455179881|FG000|Overall Study|Prog, refract disease during active trt|8|||
126514777|NCT00577122|455179882|FG001|Overall Study|Prog, refract disease during active trt|5|||
126514778|NCT00577122|455179881|FG000|Overall Study|Alternative Therapy|0|||
126514779|NCT00577122|455179882|FG001|Overall Study|Alternative Therapy|1|||
126514780|NCT04532112|455179883|FG000|Overall Study|Adverse Event|3|||
126514781|NCT04532112|455179884|FG001|Overall Study|Adverse Event|0|||
126514782|NCT00529386|455179885|FG000|Overall Study|Lost to Follow-up|1|||
126569308|NCT00940992|455379490|FG002|Overall Study|subject request|0|||
126514783|NCT03348904|455179886|FG000|Overall Study|Administrative reason by the sponsor|0|||
126514784|NCT03348904|455179887|FG001|Overall Study|Administrative reason by the sponsor|1|||
126514785|NCT03348904|455179888|FG002|Overall Study|Administrative reason by the sponsor|0|||
126514786|NCT02039427|455179894|FG000|Overall Study|Duration of surgery > 3h|1|||
126514787|NCT02039427|455179895|FG001|Overall Study|Duration of surgery > 3h|1|||
126569309|NCT00940992|455379488|FG000|Overall Study|Lost to Follow-up|0|||
126569310|NCT00940992|455379489|FG001|Overall Study|Lost to Follow-up|1|||
126569311|NCT00940992|455379490|FG002|Overall Study|Lost to Follow-up|1|||
126569312|NCT03612804|455379505|FG000|Overall Study|Death|0|||
126569313|NCT03612804|455379506|FG001|Overall Study|Death|7|||
126569314|NCT03612804|455379507|FG002|Overall Study|Death|0|||
126569315|NCT03612804|455379508|FG003|Overall Study|Death|8|||
126569316|NCT03612804|455379505|FG000|Overall Study|Medication copay coverage issues|0|||
126569317|NCT03612804|455379506|FG001|Overall Study|Medication copay coverage issues|0|||
126569318|NCT03612804|455379507|FG002|Overall Study|Medication copay coverage issues|0|||
126569319|NCT03612804|455379508|FG003|Overall Study|Medication copay coverage issues|17|||
126569320|NCT03612804|455379505|FG000|Overall Study|Not current smoker at time of screening|0|||
126569321|NCT03612804|455379506|FG001|Overall Study|Not current smoker at time of screening|1|||
126569322|NCT03612804|455379507|FG002|Overall Study|Not current smoker at time of screening|0|||
126569323|NCT03612804|455379508|FG003|Overall Study|Not current smoker at time of screening|3|||
126569324|NCT03612804|455379505|FG000|Overall Study|Non-veteran status|0|||
126569325|NCT03612804|455379506|FG001|Overall Study|Non-veteran status|1|||
126569326|NCT03612804|455379507|FG002|Overall Study|Non-veteran status|0|||
126569327|NCT03612804|455379508|FG003|Overall Study|Non-veteran status|0|||
126569328|NCT03612804|455379505|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
126569329|NCT03612804|455379506|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
126569330|NCT03612804|455379507|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
126569331|NCT03612804|455379508|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
126569332|NCT03612804|455379505|FG000|Overall Study|Provider retired from VA|0|||
126569333|NCT03612804|455379506|FG001|Overall Study|Provider retired from VA|0|||
126569334|NCT03612804|455379507|FG002|Overall Study|Provider retired from VA|2|||
126569335|NCT03612804|455379508|FG003|Overall Study|Provider retired from VA|0|||
126569336|NCT03612804|455379505|FG000|Overall Study|Withdrawal by Subject|0|||
126569337|NCT03612804|455379506|FG001|Overall Study|Withdrawal by Subject|0|||
126569338|NCT03612804|455379507|FG002|Overall Study|Withdrawal by Subject|7|||
126569339|NCT03612804|455379508|FG003|Overall Study|Withdrawal by Subject|0|||
126569340|NCT03612804|455379505|FG000|Overall Study|Provider involved with study activities|1|||
126569341|NCT03612804|455379506|FG001|Overall Study|Provider involved with study activities|0|||
126569342|NCT03612804|455379507|FG002|Overall Study|Provider involved with study activities|0|||
126569343|NCT03612804|455379508|FG003|Overall Study|Provider involved with study activities|0|||
126569344|NCT02781584|455379516|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
126569345|NCT02781584|455379517|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
126569346|NCT02781584|455379518|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
126569347|NCT02781584|455379519|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
126569348|NCT02781584|455379520|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
126569349|NCT02781584|455379521|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
126569350|NCT02781584|455379522|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
126569351|NCT02781584|455379523|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
126569352|NCT02781584|455379524|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
126569353|NCT02781584|455379525|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
126569354|NCT02781584|455379526|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
126569355|NCT02781584|455379527|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
126569356|NCT02781584|455379528|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
126569357|NCT02781584|455379516|FG000|Pre-treatment Phase|Adverse Event|0|||
126569358|NCT02781584|455379517|FG001|Pre-treatment Phase|Adverse Event|0|||
126569359|NCT02781584|455379518|FG002|Pre-treatment Phase|Adverse Event|0|||
126569360|NCT02781584|455379519|FG003|Pre-treatment Phase|Adverse Event|0|||
126569361|NCT02781584|455379520|FG004|Pre-treatment Phase|Adverse Event|0|||
126569362|NCT02781584|455379521|FG005|Pre-treatment Phase|Adverse Event|0|||
126569363|NCT02781584|455379522|FG006|Pre-treatment Phase|Adverse Event|0|||
126569364|NCT02781584|455379523|FG007|Pre-treatment Phase|Adverse Event|0|||
126569365|NCT02781584|455379524|FG008|Pre-treatment Phase|Adverse Event|0|||
126569366|NCT02781584|455379525|FG009|Pre-treatment Phase|Adverse Event|0|||
126569367|NCT02781584|455379526|FG010|Pre-treatment Phase|Adverse Event|0|||
126569368|NCT02781584|455379527|FG011|Pre-treatment Phase|Adverse Event|1|||
126569369|NCT02781584|455379528|FG012|Pre-treatment Phase|Adverse Event|0|||
126569370|NCT02781584|455379516|FG000|Treatment Phase|Withdrew Consent|0|||
126569371|NCT02781584|455379517|FG001|Treatment Phase|Withdrew Consent|0|||
126569372|NCT02781584|455379518|FG002|Treatment Phase|Withdrew Consent|0|||
126569373|NCT02781584|455379519|FG003|Treatment Phase|Withdrew Consent|0|||
126569374|NCT02781584|455379520|FG004|Treatment Phase|Withdrew Consent|0|||
126569375|NCT02781584|455379521|FG005|Treatment Phase|Withdrew Consent|1|||
126569376|NCT02781584|455379522|FG006|Treatment Phase|Withdrew Consent|0|||
126569377|NCT02781584|455379523|FG007|Treatment Phase|Withdrew Consent|0|||
126569378|NCT02781584|455379524|FG008|Treatment Phase|Withdrew Consent|0|||
126569379|NCT02781584|455379525|FG009|Treatment Phase|Withdrew Consent|0|||
126569380|NCT02781584|455379526|FG010|Treatment Phase|Withdrew Consent|1|||
126569381|NCT02781584|455379527|FG011|Treatment Phase|Withdrew Consent|2|||
126569382|NCT02781584|455379528|FG012|Treatment Phase|Withdrew Consent|0|||
126569383|NCT02781584|455379516|FG000|Treatment Phase|Adverse Event|0|||
126569384|NCT02781584|455379517|FG001|Treatment Phase|Adverse Event|0|||
126514788|NCT02039427|455179896|FG002|Overall Study|Duration of surgery > 3h|0|||
126514789|NCT02039427|455179897|FG003|Overall Study|Duration of surgery > 3h|0|||
126514790|NCT02039427|455179894|FG000|Overall Study|Withdrawal on concent|0|||
126514791|NCT02039427|455179895|FG001|Overall Study|Withdrawal on concent|0|||
126514792|NCT02039427|455179896|FG002|Overall Study|Withdrawal on concent|0|||
126514793|NCT02039427|455179897|FG003|Overall Study|Withdrawal on concent|1|||
126514794|NCT02039427|455179894|FG000|Overall Study|Cancellation of surgery|0|||
126514795|NCT02039427|455179895|FG001|Overall Study|Cancellation of surgery|0|||
126514796|NCT02039427|455179896|FG002|Overall Study|Cancellation of surgery|1|||
126514797|NCT02039427|455179897|FG003|Overall Study|Cancellation of surgery|0|||
126514798|NCT02039427|455179894|FG000|Overall Study|Loss of follow - up|1|||
126514799|NCT02039427|455179895|FG001|Overall Study|Loss of follow - up|0|||
126514800|NCT02039427|455179896|FG002|Overall Study|Loss of follow - up|2|||
126514801|NCT02039427|455179897|FG003|Overall Study|Loss of follow - up|4|||
126514802|NCT02039427|455179894|FG000|Overall Study|Steroid Use|1|||
126514803|NCT02039427|455179895|FG001|Overall Study|Steroid Use|0|||
126514804|NCT02039427|455179896|FG002|Overall Study|Steroid Use|0|||
126514805|NCT02039427|455179897|FG003|Overall Study|Steroid Use|0|||
126514806|NCT02732847|455179898|FG000|Overall Study|some filled early|42|||
126514807|NCT02732847|455179899|FG001|Overall Study|some filled early|42|||
126514808|NCT04574362|455179900|FG000|Overall Study|Other|0|||
126514809|NCT04574362|455179901|FG001|Overall Study|Other|5|||
126514810|NCT04574362|455179900|FG000|Overall Study|COVID-19|0|||
126514811|NCT04574362|455179901|FG001|Overall Study|COVID-19|1|||
126514812|NCT04574362|455179900|FG000|Overall Study|Adverse Event|1|||
126514813|NCT04574362|455179901|FG001|Overall Study|Adverse Event|1|||
126514814|NCT04574362|455179900|FG000|Overall Study|Withdrawal by Subject|2|||
126514815|NCT04574362|455179901|FG001|Overall Study|Withdrawal by Subject|4|||
126514816|NCT04574362|455179900|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
126514817|NCT04574362|455179901|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
126514818|NCT04574362|455179900|FG000|Overall Study|Participant refused to come to the hospital|1|||
126514819|NCT04574362|455179901|FG001|Overall Study|Participant refused to come to the hospital|0|||
126514820|NCT04574362|455179900|FG000|Overall Study|Participant refused the visit|1|||
126514821|NCT04574362|455179901|FG001|Overall Study|Participant refused the visit|0|||
126514822|NCT04574362|455179900|FG000|Overall Study|Participant quit early because of business trip|1|||
126514823|NCT04574362|455179901|FG001|Overall Study|Participant quit early because of business trip|0|||
126514824|NCT01060384|455179902|FG000|Overall Study|Withdrawal by Subject|0|||
126514825|NCT01060384|455179903|FG001|Overall Study|Withdrawal by Subject|1|||
126514826|NCT01060384|455179904|FG002|Overall Study|Withdrawal by Subject|0|||
126514827|NCT01060384|455179905|FG003|Overall Study|Withdrawal by Subject|0|||
126514828|NCT01060384|455179906|FG004|Overall Study|Withdrawal by Subject|0|||
126514829|NCT01060384|455179902|FG000|Overall Study|Death|0|||
126514830|NCT01060384|455179903|FG001|Overall Study|Death|0|||
126514831|NCT01060384|455179904|FG002|Overall Study|Death|0|||
126514832|NCT01060384|455179905|FG003|Overall Study|Death|0|||
126514833|NCT01060384|455179906|FG004|Overall Study|Death|1|||
126514834|NCT01060384|455179902|FG000|Overall Study|Intercurrent illness|0|||
126514835|NCT01060384|455179903|FG001|Overall Study|Intercurrent illness|0|||
126514836|NCT01060384|455179904|FG002|Overall Study|Intercurrent illness|0|||
126514837|NCT01060384|455179905|FG003|Overall Study|Intercurrent illness|0|||
126514838|NCT01060384|455179906|FG004|Overall Study|Intercurrent illness|1|||
126514839|NCT00812929|455179910|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
126514840|NCT00812929|455179911|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
126514841|NCT00812929|455179912|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
126514842|NCT00812929|455179913|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
126514843|NCT00812929|455179914|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
126514844|NCT00812929|455179915|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
126514845|NCT00812929|455179916|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
126514846|NCT00812929|455179917|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
126514847|NCT00812929|455179918|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
126514848|NCT00812929|455179919|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
126514849|NCT00812929|455179910|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
126514850|NCT00812929|455179911|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
126514851|NCT00812929|455179912|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
126514852|NCT00812929|455179913|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
126514853|NCT00812929|455179914|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
126514854|NCT00812929|455179915|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
126514855|NCT00812929|455179916|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
126514856|NCT00812929|455179917|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
126514857|NCT00812929|455179918|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
126514858|NCT00812929|455179919|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
126514859|NCT00812929|455179910|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
126514860|NCT00812929|455179911|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
126514861|NCT00812929|455179912|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
126514862|NCT00812929|455179913|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
126569385|NCT02781584|455379518|FG002|Treatment Phase|Adverse Event|0|||
126569386|NCT02781584|455379519|FG003|Treatment Phase|Adverse Event|0|||
126569387|NCT02781584|455379520|FG004|Treatment Phase|Adverse Event|0|||
126569388|NCT02781584|455379521|FG005|Treatment Phase|Adverse Event|0|||
126569389|NCT02781584|455379522|FG006|Treatment Phase|Adverse Event|0|||
126569390|NCT02781584|455379523|FG007|Treatment Phase|Adverse Event|1|||
126569391|NCT02781584|455379524|FG008|Treatment Phase|Adverse Event|0|||
126569392|NCT02781584|455379525|FG009|Treatment Phase|Adverse Event|0|||
126569393|NCT02781584|455379526|FG010|Treatment Phase|Adverse Event|0|||
126569394|NCT02781584|455379527|FG011|Treatment Phase|Adverse Event|0|||
126569395|NCT02781584|455379528|FG012|Treatment Phase|Adverse Event|0|||
126569396|NCT05019729|455379529|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
126569397|NCT05019729|455379530|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
126569398|NCT05019729|455379531|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
126569399|NCT05019729|455379532|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
126569400|NCT05019729|455379533|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
126569401|NCT05019729|455379534|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
126569402|NCT00361283|455379543|FG000|Overall Study|Lost to Follow-up|27|||
126569403|NCT00038103|455379544|FG000|Overall Study|Adverse Event|5|||
126569404|NCT00038103|455379545|FG001|Overall Study|Adverse Event|6|||
126569405|NCT00038103|455379544|FG000|Overall Study|Lack of Efficacy|48|||
126569406|NCT00038103|455379545|FG001|Overall Study|Lack of Efficacy|41|||
126569407|NCT00038103|455379544|FG000|Overall Study|Withdrawal by Subject|0|||
126569408|NCT00038103|455379545|FG001|Overall Study|Withdrawal by Subject|3|||
126569409|NCT00038103|455379544|FG000|Overall Study|Lost to Follow-up|0|||
126569410|NCT00038103|455379545|FG001|Overall Study|Lost to Follow-up|3|||
126569411|NCT00038103|455379544|FG000|Overall Study|Protocol Violation|0|||
126569412|NCT00038103|455379545|FG001|Overall Study|Protocol Violation|2|||
126569413|NCT00038103|455379544|FG000|Overall Study|Sponsor Decision|0|||
126569414|NCT00038103|455379545|FG001|Overall Study|Sponsor Decision|1|||
126569415|NCT00038103|455379544|FG000|Overall Study|Randomized/never treated|2|||
126569416|NCT00038103|455379545|FG001|Overall Study|Randomized/never treated|0|||
126569417|NCT00208767|455379548|FG000|Overall Study|Adverse Event|9|||
126569418|NCT00208767|455379549|FG001|Overall Study|Adverse Event|1|||
126569419|NCT00208767|455379548|FG000|Overall Study|Withdrawal by Subject|14|||
126569420|NCT00208767|455379549|FG001|Overall Study|Withdrawal by Subject|3|||
126569421|NCT00208767|455379548|FG000|Overall Study|Death|1|||
126569422|NCT00208767|455379549|FG001|Overall Study|Death|0|||
126569423|NCT00208767|455379548|FG000|Overall Study|Lost to Follow-up|3|||
126569424|NCT00208767|455379549|FG001|Overall Study|Lost to Follow-up|3|||
126569425|NCT03545984|455379550|FG000|Overall Study|CSF cases not present during rotation|11|||
126569426|NCT03545984|455379551|FG001|Overall Study|CSF cases not present during rotation|9|||
126569427|NCT04257058|455381306|FG000|Overall Study|Lost to Follow-up|31|||
126569428|NCT05147233|455381313|FG000|Overall Study|Adverse Event|0|||
126569429|NCT05147233|455381314|FG001|Overall Study|Adverse Event|1|||
126569430|NCT05147233|455381313|FG000|Overall Study|Lost to Follow-up|1|||
126569431|NCT05147233|455381314|FG001|Overall Study|Lost to Follow-up|1|||
126569432|NCT05147233|455381313|FG000|Overall Study|Protocol Violation|0|||
126569433|NCT05147233|455381314|FG001|Overall Study|Protocol Violation|1|||
126569434|NCT05147233|455381313|FG000|Overall Study|Withdrawal by Subject|2|||
126569435|NCT05147233|455381314|FG001|Overall Study|Withdrawal by Subject|1|||
126569436|NCT04199728|455381321|FG000|Overall Study|Adverse Event|1|||
126569437|NCT04199728|455381322|FG001|Overall Study|Adverse Event|0|||
126569438|NCT04199728|455381321|FG000|Overall Study|Withdrawal by Subject|8|||
126569439|NCT04199728|455381322|FG001|Overall Study|Withdrawal by Subject|3|||
126569440|NCT04199728|455381321|FG000|Overall Study|Screen fail after consent|0|||
126569441|NCT04199728|455381322|FG001|Overall Study|Screen fail after consent|1|||
126569442|NCT04199728|455381321|FG000|Overall Study|Early withdraw criteria met|0|||
126569443|NCT04199728|455381322|FG001|Overall Study|Early withdraw criteria met|1|||
126569444|NCT04199728|455381321|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
126569445|NCT04199728|455381322|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
126569446|NCT00726596|455381323|FG000|Overall Study|Adverse Event|2|||
126569447|NCT00726596|455381324|FG001|Overall Study|Adverse Event|1|||
126569448|NCT00726596|455381323|FG000|Overall Study|Withdrawal by Subject|3|||
126569449|NCT00726596|455381324|FG001|Overall Study|Withdrawal by Subject|3|||
126569450|NCT00661778|455381328|FG000|Overall Study|Disease Progression|23|||
126569451|NCT00661778|455381328|FG000|Overall Study|Adverse Event|18|||
126569452|NCT00661778|455381328|FG000|Overall Study|Reason not Specified|6|||
126569453|NCT00661778|455381328|FG000|Overall Study|Protocol Violation|2|||
126776985|NCT00297479|456139143|FG001|Overall Study|Lost to Follow-up|54|||
126776986|NCT00297479|456139144|FG002|Overall Study|Lost to Follow-up|51|||
126569454|NCT00661778|455381328|FG000|Overall Study|Withdrawal of Consent|1|||
126776987|NCT01664494|456139145|FG000|Overall Study|Withdrawal by Subject|27|||
126776988|NCT01664494|456139145|FG000|Overall Study|Death|18|||
126776989|NCT01664494|456139145|FG000|Overall Study|Other|49|||
126514863|NCT00812929|455179914|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
126514864|NCT00812929|455179915|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
126514865|NCT00812929|455179916|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
126514866|NCT00812929|455179917|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
126514867|NCT00812929|455179918|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
126514868|NCT00812929|455179919|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
126514869|NCT00211081|455179920|FG000|Overall Study|Withdrawal by Subject|2|||
126514870|NCT01332305|455179921|FG000|Overall Study|Adverse Event|1|||
126514871|NCT01332305|455179922|FG001|Overall Study|Adverse Event|4|||
126514872|NCT01332305|455179923|FG002|Overall Study|Adverse Event|6|||
126514873|NCT01332305|455179924|FG003|Overall Study|Adverse Event|3|||
126514874|NCT01332305|455179925|FG004|Overall Study|Adverse Event|5|||
126514875|NCT01332305|455179921|FG000|Overall Study|Withdrawal by Subject|6|||
126514876|NCT01332305|455179922|FG001|Overall Study|Withdrawal by Subject|5|||
126514877|NCT01332305|455179923|FG002|Overall Study|Withdrawal by Subject|4|||
126514878|NCT01332305|455179924|FG003|Overall Study|Withdrawal by Subject|1|||
126514879|NCT01332305|455179925|FG004|Overall Study|Withdrawal by Subject|0|||
126514880|NCT01332305|455179921|FG000|Overall Study|Lost to Follow-up|0|||
126514881|NCT01332305|455179922|FG001|Overall Study|Lost to Follow-up|2|||
126514882|NCT01332305|455179923|FG002|Overall Study|Lost to Follow-up|3|||
126514883|NCT01332305|455179924|FG003|Overall Study|Lost to Follow-up|2|||
126514884|NCT01332305|455179925|FG004|Overall Study|Lost to Follow-up|3|||
126514885|NCT01332305|455179921|FG000|Overall Study|Protocol Violation|1|||
126514886|NCT01332305|455179922|FG001|Overall Study|Protocol Violation|2|||
126514887|NCT01332305|455179923|FG002|Overall Study|Protocol Violation|1|||
126514888|NCT01332305|455179924|FG003|Overall Study|Protocol Violation|0|||
126514889|NCT01332305|455179925|FG004|Overall Study|Protocol Violation|3|||
126514890|NCT01332305|455179921|FG000|Overall Study|Withdrawal by Sponsor|1|||
126514891|NCT01332305|455179922|FG001|Overall Study|Withdrawal by Sponsor|0|||
126514892|NCT01332305|455179923|FG002|Overall Study|Withdrawal by Sponsor|0|||
126514893|NCT01332305|455179924|FG003|Overall Study|Withdrawal by Sponsor|1|||
126514894|NCT01332305|455179925|FG004|Overall Study|Withdrawal by Sponsor|1|||
126514895|NCT01332305|455179921|FG000|Overall Study|Treatment Failure|1|||
126514896|NCT01332305|455179922|FG001|Overall Study|Treatment Failure|1|||
126514897|NCT01332305|455179923|FG002|Overall Study|Treatment Failure|0|||
126514898|NCT01332305|455179924|FG003|Overall Study|Treatment Failure|0|||
126514899|NCT01332305|455179925|FG004|Overall Study|Treatment Failure|0|||
126514900|NCT01332305|455179921|FG000|Overall Study|Physician Decision|0|||
126514901|NCT01332305|455179922|FG001|Overall Study|Physician Decision|0|||
126514902|NCT01332305|455179923|FG002|Overall Study|Physician Decision|0|||
126514903|NCT01332305|455179924|FG003|Overall Study|Physician Decision|1|||
126514904|NCT01332305|455179925|FG004|Overall Study|Physician Decision|0|||
126514905|NCT04027686|455179926|FG000|Overall Study|Lost to Follow-up|2|||
126514906|NCT04027686|455179927|FG001|Overall Study|Lost to Follow-up|0|||
126514907|NCT04027686|455179926|FG000|Overall Study|Withdrawal by Subject|0|||
126514908|NCT04027686|455179927|FG001|Overall Study|Withdrawal by Subject|1|||
126514909|NCT03755765|455179934|FG000|Overall Study|Withdrawal by Subject|2|||
126514910|NCT03755765|455179935|FG001|Overall Study|Withdrawal by Subject|4|||
126514911|NCT03755765|455179936|FG002|Overall Study|Withdrawal by Subject|4|||
126514912|NCT00111228|455179939|FG000|Overall Study|Withdrawal by Subject|5|||
126514913|NCT00111228|455179940|FG001|Overall Study|Withdrawal by Subject|1|||
126514914|NCT00111228|455179941|FG002|Overall Study|Withdrawal by Subject|0|||
126514915|NCT00678691|455179942|FG000|Overall Study|Adverse Event|6|||
126514916|NCT00678691|455179943|FG001|Overall Study|Adverse Event|4|||
126514917|NCT01632800|455179954|FG000|Overall Study|Subject did not fit in apparatus|1|||
126514918|NCT00057746|455179956|FG000|Overall Study|Withdrawal by Subject|0|||
126514919|NCT00057746|455179957|FG001|Overall Study|Withdrawal by Subject|0|||
126514920|NCT00057746|455179958|FG002|Overall Study|Withdrawal by Subject|1|||
126514921|NCT01752933|455179963|FG000|Treatment|Disease Progression|3|||
126514922|NCT01752933|455179964|FG001|Treatment|Disease Progression|29|||
126514923|NCT01752933|455179963|FG000|Treatment|Withdrawal by Subject|0|||
126514924|NCT01752933|455179964|FG001|Treatment|Withdrawal by Subject|5|||
126514925|NCT01752933|455179963|FG000|Treatment|Adverse Event|1|||
126514926|NCT01752933|455179964|FG001|Treatment|Adverse Event|4|||
126514927|NCT01752933|455179963|FG000|Treatment|Physician Decision|0|||
126514928|NCT01752933|455179964|FG001|Treatment|Physician Decision|3|||
126514929|NCT01752933|455179963|FG000|Treatment|Death|0|||
126640440|NCT00479882|455642775|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
126514930|NCT01752933|455179964|FG001|Treatment|Death|2|||
126514931|NCT01752933|455179963|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
126514932|NCT01752933|455179964|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
126514933|NCT01752933|455179963|FG000|Treatment|Patient noncompliant|0|||
126514934|NCT01752933|455179964|FG001|Treatment|Patient noncompliant|1|||
126514935|NCT01752933|455179963|FG000|Treatment|Patient unable to travel to appointments|0|||
126514936|NCT01752933|455179964|FG001|Treatment|Patient unable to travel to appointments|1|||
126514937|NCT01752933|455179963|FG000|Overall Study and Follow-up|Death|4|||
126514938|NCT01752933|455179964|FG001|Overall Study and Follow-up|Death|34|||
126514939|NCT01752933|455179963|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
126569455|NCT02962674|455381334|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
126569456|NCT00364286|455381335|FG000|Overall Study|Withdrawal by Subject|1|||
126569457|NCT00364286|455381335|FG000|Overall Study|Adverse Event|2|||
126569458|NCT02577523|455381338|FG000|Overall Study|Adverse Event|1|||
126569459|NCT02577523|455381339|FG001|Overall Study|Adverse Event|1|||
126569460|NCT02577523|455381338|FG000|Overall Study|Lack of Efficacy|1|||
126569461|NCT02577523|455381339|FG001|Overall Study|Lack of Efficacy|1|||
126569462|NCT02577523|455381338|FG000|Overall Study|Withdrawal by Subject|1|||
126569463|NCT02577523|455381339|FG001|Overall Study|Withdrawal by Subject|0|||
126569464|NCT00028769|455381342|FG000|Overall Study|Adverse Event|2|||
126569465|NCT00028769|455381342|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
126569466|NCT00028769|455381342|FG000|Overall Study|Progression or Death|31|||
126569467|NCT00028769|455381342|FG000|Overall Study|Other - Not Protocol Specified|1|||
126569468|NCT00028769|455381342|FG000|Overall Study|Ineligible|5|||
126569469|NCT00028769|455381342|FG000|Overall Study|Not Analyzable|1|||
126569470|NCT00357396|455381343|FG000|Overall Study|Adverse Event|1|||
126569471|NCT00357396|455381344|FG001|Overall Study|Adverse Event|0|||
126569472|NCT00487578|455381345|FG000|Overall Study|Adverse Event|1|||
126569473|NCT00487578|455381346|FG001|Overall Study|Adverse Event|2|||
126569474|NCT00487578|455381345|FG000|Overall Study|Lack of Efficacy|0|||
126569475|NCT00487578|455381346|FG001|Overall Study|Lack of Efficacy|1|||
126569476|NCT00487578|455381345|FG000|Overall Study|Lost to Follow-up|0|||
126569477|NCT00487578|455381346|FG001|Overall Study|Lost to Follow-up|1|||
126569478|NCT00726999|455381349|FG000|Overall Study|Physician Decision|0|||
126569479|NCT00726999|455381350|FG001|Overall Study|Physician Decision|1|||
126569480|NCT00726999|455381349|FG000|Overall Study|Withdrawal by Subject|2|||
126569481|NCT00726999|455381350|FG001|Overall Study|Withdrawal by Subject|0|||
126569482|NCT00726999|455381349|FG000|Overall Study|Protocol Violation|1|||
126569483|NCT00726999|455381350|FG001|Overall Study|Protocol Violation|0|||
126569484|NCT01499134|455381351|FG000|Overall Study|Withdrawal by Subject|0|||
126569485|NCT01499134|455381352|FG001|Overall Study|Withdrawal by Subject|1|||
126569486|NCT00955825|455381353|FG000|Overall Study|Adverse Event|15|||
126569487|NCT00955825|455381354|FG001|Overall Study|Adverse Event|2|||
126569488|NCT00955825|455381353|FG000|Overall Study|Withdrawal by Subject|4|||
126514940|NCT01752933|455179964|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
126514941|NCT01752933|455179963|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
126514942|NCT01752933|455179964|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
126514943|NCT01752933|455179963|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
126514944|NCT01752933|455179964|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
126514945|NCT04154631|455179967|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
126514946|NCT04154631|455179968|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
126514947|NCT02185768|455179969|FG000|Overall Study|Patients were not treated|2|||
126514948|NCT02550652|455179971|FG000|Overall Study|Death|1|||
126514949|NCT02550652|455179972|FG001|Overall Study|Death|4|||
126514950|NCT02550652|455179971|FG000|Overall Study|Lack of Efficacy|1|||
126514951|NCT02550652|455179972|FG001|Overall Study|Lack of Efficacy|0|||
126514952|NCT02550652|455179971|FG000|Overall Study|Withdrawal by Subject|4|||
126514953|NCT02550652|455179972|FG001|Overall Study|Withdrawal by Subject|7|||
126514954|NCT02550652|455179971|FG000|Overall Study|Post Trial Access|1|||
126514955|NCT02550652|455179972|FG001|Overall Study|Post Trial Access|0|||
126514956|NCT02550652|455179971|FG000|Overall Study|Lost to Follow-up|1|||
126514957|NCT02550652|455179972|FG001|Overall Study|Lost to Follow-up|3|||
126514958|NCT02550652|455179971|FG000|Overall Study|Physician Decision|0|||
126514959|NCT02550652|455179972|FG001|Overall Study|Physician Decision|2|||
126514960|NCT02550652|455179971|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
126514961|NCT02550652|455179972|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
126514962|NCT01706250|455179973|FG000|Overall Study|Lost to Follow-up|2|||
126514963|NCT03181542|455179977|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
126514964|NCT03181542|455179978|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
126514965|NCT00799617|455179981|FG000|Main Testosterone Trial|Randomized in error|1|||
126514966|NCT00799617|455179982|FG001|Main Testosterone Trial|Randomized in error|1|||
126514967|NCT00799617|455179981|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
126514968|NCT00799617|455179982|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
126514969|NCT00799617|455179981|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
126514970|NCT00799617|455179982|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
126514971|NCT00799617|455179981|FG000|Sexual Funtion Trial|No Baseline Data|4|||
126514972|NCT00799617|455179982|FG001|Sexual Funtion Trial|No Baseline Data|7|||
126514973|NCT00799617|455179981|FG000|Physical Function Trial|Lost to Follow-up|6|||
126514974|NCT00799617|455179982|FG001|Physical Function Trial|Lost to Follow-up|11|||
126569489|NCT00955825|455381354|FG001|Overall Study|Withdrawal by Subject|6|||
126514975|NCT00799617|455179981|FG000|Vitality Trial|Lost to Follow-up|7|||
126514976|NCT00799617|455179982|FG001|Vitality Trial|Lost to Follow-up|22|||
126514977|NCT00799617|455179981|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
126514978|NCT00799617|455179982|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
126514979|NCT00799617|455179981|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
126514980|NCT00799617|455179982|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
126514981|NCT00799617|455179981|FG000|Bone Trial|Month 12 scan not available|6|||
126514982|NCT00799617|455179982|FG001|Bone Trial|Month 12 scan not available|16|||
126514983|NCT00799617|455179981|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
126514984|NCT00799617|455179982|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
126514985|NCT00799617|455179981|FG000|Anemia Trial|Withdrawal by Subject|3|||
126514986|NCT00799617|455179982|FG001|Anemia Trial|Withdrawal by Subject|3|||
126514987|NCT04545515|455179983|FG000|Overall Study|Adverse Event|1|||
126514988|NCT04545515|455179983|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
126514989|NCT04545515|455179983|FG000|Overall Study|Commercial drug is available for participant|7|||
126514990|NCT01848990|455179984|FG000|Overall Study|Adverse Event|6|||
126514991|NCT01848990|455179985|FG001|Overall Study|Adverse Event|2|||
126514992|NCT01848990|455179986|FG002|Overall Study|Adverse Event|0|||
126514993|NCT01848990|455179984|FG000|Overall Study|Lost to Follow-up|6|||
126514994|NCT01848990|455179985|FG001|Overall Study|Lost to Follow-up|2|||
126514995|NCT01848990|455179986|FG002|Overall Study|Lost to Follow-up|2|||
126514996|NCT01848990|455179984|FG000|Overall Study|Protocol Violation|1|||
126514997|NCT01848990|455179985|FG001|Overall Study|Protocol Violation|1|||
126514998|NCT01848990|455179986|FG002|Overall Study|Protocol Violation|0|||
126514999|NCT01848990|455179984|FG000|Overall Study|Withdrawal by Subject|29|||
126515000|NCT01848990|455179985|FG001|Overall Study|Withdrawal by Subject|10|||
126515001|NCT01848990|455179986|FG002|Overall Study|Withdrawal by Subject|11|||
126515002|NCT01848990|455179984|FG000|Overall Study|Physician Decision|1|||
126515003|NCT01848990|455179985|FG001|Overall Study|Physician Decision|1|||
126515004|NCT01848990|455179986|FG002|Overall Study|Physician Decision|0|||
126515005|NCT01848990|455179984|FG000|Overall Study|Non Compliance|1|||
126515006|NCT01848990|455179985|FG001|Overall Study|Non Compliance|0|||
126515007|NCT01848990|455179986|FG002|Overall Study|Non Compliance|0|||
126515008|NCT01848990|455179984|FG000|Overall Study|Death|1|||
126515009|NCT01848990|455179985|FG001|Overall Study|Death|0|||
126515010|NCT01848990|455179986|FG002|Overall Study|Death|1|||
126515011|NCT01848990|455179984|FG000|Overall Study|Other|1|||
126515012|NCT01848990|455179985|FG001|Overall Study|Other|4|||
126515013|NCT01848990|455179986|FG002|Overall Study|Other|2|||
126515014|NCT00958880|455179987|FG000|Overall Study|Lost to Follow-up|2|||
126515015|NCT00958880|455179988|FG001|Overall Study|Lost to Follow-up|2|||
126515016|NCT01712984|455179989|FG000|Overall Study|Adverse Event|0|||
126515017|NCT01712984|455179990|FG001|Overall Study|Adverse Event|0|||
126515018|NCT01712984|455179991|FG002|Overall Study|Adverse Event|1|||
126515019|NCT01712984|455179989|FG000|Overall Study|Protocol Violation|2|||
126515020|NCT01712984|455179990|FG001|Overall Study|Protocol Violation|0|||
126515021|NCT01712984|455179991|FG002|Overall Study|Protocol Violation|1|||
126515022|NCT01712984|455179989|FG000|Overall Study|Lost to Follow-up|8|||
126515023|NCT01712984|455179990|FG001|Overall Study|Lost to Follow-up|10|||
126515024|NCT01712984|455179991|FG002|Overall Study|Lost to Follow-up|1|||
126515025|NCT01712984|455179989|FG000|Overall Study|Withdrawal by Subject|6|||
126515026|NCT01712984|455179990|FG001|Overall Study|Withdrawal by Subject|6|||
126515027|NCT01712984|455179991|FG002|Overall Study|Withdrawal by Subject|7|||
126515028|NCT02755831|455179992|FG000|Overall Study|Lost to Follow-up|3|||
126515029|NCT02755831|455179993|FG001|Overall Study|Lost to Follow-up|3|||
126515030|NCT01720069|455179994|FG000|Overall Study|Could not use e-diary correctly|0|||
126515031|NCT01720069|455179995|FG001|Overall Study|Could not use e-diary correctly|1|||
126515032|NCT01720069|455179996|FG002|Overall Study|Could not use e-diary correctly|1|||
126515033|NCT01720069|455179994|FG000|Overall Study|Randomised without baseline values|0|||
126515034|NCT01720069|455179995|FG001|Overall Study|Randomised without baseline values|0|||
126515035|NCT01720069|455179996|FG002|Overall Study|Randomised without baseline values|1|||
126515036|NCT01720069|455179994|FG000|Overall Study|Adverse Event|0|||
126515037|NCT01720069|455179995|FG001|Overall Study|Adverse Event|0|||
126515038|NCT01720069|455179996|FG002|Overall Study|Adverse Event|1|||
126515039|NCT01720069|455179994|FG000|Overall Study|Lack of Efficacy|0|||
126515040|NCT01720069|455179995|FG001|Overall Study|Lack of Efficacy|4|||
126515041|NCT01720069|455179996|FG002|Overall Study|Lack of Efficacy|0|||
126515042|NCT01720069|455179994|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
126515043|NCT01720069|455179995|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
126515044|NCT01720069|455179996|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
126515045|NCT01720069|455179994|FG000|Overall Study|Withdrawal by Subject|0|||
126515046|NCT01720069|455179995|FG001|Overall Study|Withdrawal by Subject|2|||
126515047|NCT01720069|455179996|FG002|Overall Study|Withdrawal by Subject|1|||
126515048|NCT01720069|455179994|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
126515049|NCT01720069|455179995|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
126515050|NCT01720069|455179996|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
126515051|NCT01720069|455179994|FG000|Overall Study|Non-compliance on using e-diary|0|||
126515052|NCT01720069|455179995|FG001|Overall Study|Non-compliance on using e-diary|0|||
126515053|NCT01720069|455179996|FG002|Overall Study|Non-compliance on using e-diary|1|||
126515054|NCT01720069|455179994|FG000|Overall Study|Lost to Follow-up|0|||
126515055|NCT01720069|455179995|FG001|Overall Study|Lost to Follow-up|0|||
126515056|NCT01720069|455179996|FG002|Overall Study|Lost to Follow-up|1|||
126515057|NCT00508742|455179997|FG000|Period 1: Infant Series|Adverse Event|5|||
126515058|NCT00508742|455179998|FG001|Period 1: Infant Series|Adverse Event|4|||
126515059|NCT00508742|455179997|FG000|Period 1: Infant Series|Protocol Violation|1|||
126515060|NCT00508742|455179998|FG001|Period 1: Infant Series|Protocol Violation|0|||
126515061|NCT00508742|455179997|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
126515062|NCT00508742|455179998|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
126515063|NCT00508742|455179997|FG000|Period 1: Infant Series|Physician Decision|1|||
126515064|NCT00508742|455179998|FG001|Period 1: Infant Series|Physician Decision|0|||
126515065|NCT00508742|455179997|FG000|Period 1: Infant Series|Other|4|||
126515066|NCT00508742|455179998|FG001|Period 1: Infant Series|Other|1|||
126515067|NCT00508742|455179997|FG000|Period 2: After Infant Series|Adverse Event|2|||
126515068|NCT00508742|455179998|FG001|Period 2: After Infant Series|Adverse Event|6|||
126515069|NCT00508742|455179997|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
126515070|NCT00508742|455179998|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
126515071|NCT00508742|455179997|FG000|Period 2: After Infant Series|Protocol Violation|1|||
126515072|NCT00508742|455179998|FG001|Period 2: After Infant Series|Protocol Violation|0|||
126515073|NCT00508742|455179997|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
126515074|NCT00508742|455179998|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
126515075|NCT00508742|455179997|FG000|Period 2: After Infant Series|Failed to Return|1|||
126515076|NCT00508742|455179998|FG001|Period 2: After Infant Series|Failed to Return|0|||
126515077|NCT00508742|455179997|FG000|Period 2: After Infant Series|Other|2|||
126515078|NCT00508742|455179998|FG001|Period 2: After Infant Series|Other|1|||
126515079|NCT00508742|455179997|FG000|Period 3: Toddler Dose|Adverse Event|1|||
126515080|NCT00508742|455179998|FG001|Period 3: Toddler Dose|Adverse Event|0|||
126515081|NCT00508742|455179997|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
126515082|NCT00508742|455179998|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
126515083|NCT00508742|455179997|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
126515084|NCT00508742|455179998|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
126515085|NCT00508742|455179997|FG000|Period 3: Toddler Dose|Other|5|||
126515086|NCT00508742|455179998|FG001|Period 3: Toddler Dose|Other|4|||
126515087|NCT04568122|455179999|FG000|Overall Study|Lost to Follow-up|48|||
126515088|NCT04568122|455180000|FG001|Overall Study|Lost to Follow-up|44|||
126515089|NCT04568122|455180001|FG002|Overall Study|Lost to Follow-up|4|||
126515090|NCT04568122|455180002|FG003|Overall Study|Lost to Follow-up|0|||
126515091|NCT04568122|455180003|FG004|Overall Study|Lost to Follow-up|0|||
126515092|NCT00678561|455180009|FG000|Overall Study|Adverse Event|0|||
126515093|NCT00678561|455180010|FG001|Overall Study|Adverse Event|1|||
126515094|NCT00678561|455180011|FG002|Overall Study|Adverse Event|1|||
126515095|NCT00678561|455180012|FG003|Overall Study|Adverse Event|0|||
126515096|NCT00678561|455180013|FG004|Overall Study|Adverse Event|1|||
126515097|NCT00678561|455180014|FG005|Overall Study|Adverse Event|0|||
126515098|NCT00678561|455180015|FG006|Overall Study|Adverse Event|0|||
126515099|NCT00678561|455180016|FG007|Overall Study|Adverse Event|0|||
126515100|NCT00678561|455180009|FG000|Overall Study|Protocol Violation|0|||
126515101|NCT00678561|455180010|FG001|Overall Study|Protocol Violation|0|||
126515102|NCT00678561|455180011|FG002|Overall Study|Protocol Violation|0|||
126515103|NCT00678561|455180012|FG003|Overall Study|Protocol Violation|0|||
126515104|NCT00678561|455180013|FG004|Overall Study|Protocol Violation|1|||
126515105|NCT00678561|455180014|FG005|Overall Study|Protocol Violation|1|||
126515106|NCT00678561|455180015|FG006|Overall Study|Protocol Violation|0|||
126515107|NCT00678561|455180016|FG007|Overall Study|Protocol Violation|0|||
126515108|NCT00678561|455180009|FG000|Overall Study|Withdrawal by Subject|0|||
126515109|NCT00678561|455180010|FG001|Overall Study|Withdrawal by Subject|0|||
126515110|NCT00678561|455180011|FG002|Overall Study|Withdrawal by Subject|0|||
126515111|NCT00678561|455180012|FG003|Overall Study|Withdrawal by Subject|0|||
126515112|NCT00678561|455180013|FG004|Overall Study|Withdrawal by Subject|0|||
126515113|NCT00678561|455180014|FG005|Overall Study|Withdrawal by Subject|0|||
126515114|NCT00678561|455180015|FG006|Overall Study|Withdrawal by Subject|0|||
126515115|NCT00678561|455180016|FG007|Overall Study|Withdrawal by Subject|1|||
126569490|NCT00955825|455381353|FG000|Overall Study|Any other reason not above-mentioned|7|||
126569491|NCT00955825|455381354|FG001|Overall Study|Any other reason not above-mentioned|9|||
126515116|NCT00700011|455180017|FG000|Overall Study|Death|0|||
126569492|NCT01198275|455381355|FG000|Overall Study|Adverse Event|2|||
126569493|NCT01198275|455381356|FG001|Overall Study|Adverse Event|3|||
126569494|NCT01198275|455381355|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
126515117|NCT00700011|455180018|FG001|Overall Study|Death|1|||
126515118|NCT00437034|455180019|FG000|Overall Study|Adverse Event|1|||
126515119|NCT00437034|455180019|FG000|Overall Study|Disease progression during treatment|5|||
126515120|NCT02460224|455180022|FG000|Overall Study|Adverse Event|0|||
126515121|NCT02460224|455180023|FG001|Overall Study|Adverse Event|0|||
126515122|NCT02460224|455180024|FG002|Overall Study|Adverse Event|0|||
126515123|NCT02460224|455180025|FG003|Overall Study|Adverse Event|0|||
126515124|NCT02460224|455180026|FG004|Overall Study|Adverse Event|0|||
126515125|NCT02460224|455180027|FG005|Overall Study|Adverse Event|0|||
126515126|NCT02460224|455180028|FG006|Overall Study|Adverse Event|1|||
126569495|NCT01198275|455381356|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
126569496|NCT00391846|455381357|FG000|Overall Study|Adverse Event|4|||
126569497|NCT00391846|455381358|FG001|Overall Study|Adverse Event|1|||
126569498|NCT00391846|455381357|FG000|Overall Study|Did not meet the required elig. crit|2|||
126569499|NCT00391846|455381358|FG001|Overall Study|Did not meet the required elig. crit|2|||
126569500|NCT00391846|455381357|FG000|Overall Study|Withdrawal by Subject|2|||
126569501|NCT00391846|455381358|FG001|Overall Study|Withdrawal by Subject|3|||
126569502|NCT00391846|455381357|FG000|Overall Study|Developed study specific DC criteria|0|||
126569503|NCT00391846|455381358|FG001|Overall Study|Developed study specific DC criteria|1|||
126569504|NCT00150176|455381359|FG000|Overall Study|Adverse Event|16|||
126569505|NCT00150176|455381360|FG001|Overall Study|Adverse Event|53|||
126569506|NCT00150176|455381359|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
126569507|NCT00150176|455381360|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
126569508|NCT00150176|455381359|FG000|Overall Study|Withdrawal by Subject|19|||
126569509|NCT00150176|455381360|FG001|Overall Study|Withdrawal by Subject|12|||
126569510|NCT00150176|455381359|FG000|Overall Study|Lost to Follow-up|3|||
126569511|NCT00150176|455381360|FG001|Overall Study|Lost to Follow-up|3|||
126569512|NCT00150176|455381359|FG000|Overall Study|OTHER|11|||
126569513|NCT00150176|455381360|FG001|Overall Study|OTHER|13|||
126569514|NCT01227278|455381361|FG000|Overall Study|Withdrawal by Subject|4|||
126569515|NCT01227278|455381362|FG001|Overall Study|Withdrawal by Subject|4|||
126569516|NCT01227278|455381361|FG000|Overall Study|Death|0|||
126569517|NCT01227278|455381362|FG001|Overall Study|Death|2|||
126569518|NCT01227278|455381361|FG000|Overall Study|Other|1|||
126569519|NCT01227278|455381362|FG001|Overall Study|Other|2|||
126569520|NCT04035668|455381363|FG000|Overall Study|Adverse Event|3|||
126569521|NCT04035668|455381364|FG001|Overall Study|Adverse Event|4|||
126569522|NCT04035668|455381365|FG002|Overall Study|Adverse Event|2|||
126569523|NCT04035668|455381363|FG000|Overall Study|Lost to Follow-up|0|||
126569524|NCT04035668|455381364|FG001|Overall Study|Lost to Follow-up|1|||
126569525|NCT04035668|455381365|FG002|Overall Study|Lost to Follow-up|0|||
126569526|NCT04035668|455381363|FG000|Overall Study|Physician Decision|2|||
126569527|NCT04035668|455381364|FG001|Overall Study|Physician Decision|1|||
126569528|NCT04035668|455381365|FG002|Overall Study|Physician Decision|1|||
126569529|NCT04035668|455381363|FG000|Overall Study|Subject Decision|2|||
126569530|NCT04035668|455381364|FG001|Overall Study|Subject Decision|2|||
126569531|NCT04035668|455381365|FG002|Overall Study|Subject Decision|0|||
126569532|NCT05257798|455381366|FG000|Follow-up Phase|Lost to Follow-up|1|||
126569533|NCT05257798|455381367|FG001|Follow-up Phase|Lost to Follow-up|0|||
126569534|NCT02082158|455381370|FG000|Overall Study|Withdrawal by Subject|0|||
126569535|NCT02082158|455381371|FG001|Overall Study|Withdrawal by Subject|0|||
126569536|NCT02082158|455381372|FG002|Overall Study|Withdrawal by Subject|0|||
126569537|NCT02082158|455381373|FG003|Overall Study|Withdrawal by Subject|0|||
126569538|NCT02082158|455381374|FG004|Overall Study|Withdrawal by Subject|1|||
126569539|NCT02082158|455381375|FG005|Overall Study|Withdrawal by Subject|0|||
126569540|NCT02082158|455381370|FG000|Overall Study|Failed Fit-testing|8|||
126569541|NCT02082158|455381371|FG001|Overall Study|Failed Fit-testing|8|||
126569542|NCT02082158|455381372|FG002|Overall Study|Failed Fit-testing|14|||
126569543|NCT02082158|455381373|FG003|Overall Study|Failed Fit-testing|4|||
126569544|NCT02082158|455381374|FG004|Overall Study|Failed Fit-testing|3|||
126569545|NCT02082158|455381375|FG005|Overall Study|Failed Fit-testing|7|||
126569546|NCT00738699|455381376|FG000|Overall Study|Withdrawal by Subject|5|||
126569547|NCT00738699|455381377|FG001|Overall Study|Withdrawal by Subject|0|||
126569548|NCT00738699|455381376|FG000|Overall Study|Lost to Follow-up|1|||
126569549|NCT00738699|455381377|FG001|Overall Study|Lost to Follow-up|0|||
126569550|NCT00738699|455381376|FG000|Overall Study|Death|144|||
126569551|NCT00738699|455381377|FG001|Overall Study|Death|68|||
126569552|NCT00738699|455381376|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
126569553|NCT00738699|455381377|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
126569554|NCT00738699|455381376|FG000|Overall Study|Other|2|||
126569555|NCT00738699|455381377|FG001|Overall Study|Other|0|||
126569556|NCT01376089|455381380|FG000|Overall Study|Patient received no contrast media|3|||
126569557|NCT01376089|455381381|FG001|Overall Study|Patient received no contrast media|4|||
126569558|NCT00549848|455381382|FG000|Overall Study|Death|1|||
126569559|NCT00549848|455381383|FG001|Overall Study|Death|4|||
126569560|NCT00549848|455381384|FG002|Overall Study|Death|13|||
126569561|NCT00549848|455381382|FG000|Overall Study|Physician Decision|0|||
126569562|NCT00549848|455381383|FG001|Overall Study|Physician Decision|0|||
126569563|NCT00549848|455381384|FG002|Overall Study|Physician Decision|4|||
126569564|NCT00549848|455381382|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
126569565|NCT00549848|455381383|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
126569566|NCT00549848|455381384|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
126569567|NCT00549848|455381382|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
126569568|NCT00549848|455381383|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
126569569|NCT00549848|455381384|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
126569570|NCT00549848|455381382|FG000|Overall Study|Participant/Family Withdraw|2|||
126569571|NCT00549848|455381383|FG001|Overall Study|Participant/Family Withdraw|3|||
126515127|NCT02460224|455180029|FG007|Overall Study|Adverse Event|0|||
126515128|NCT02460224|455180030|FG008|Overall Study|Adverse Event|0|||
126515129|NCT02460224|455180031|FG009|Overall Study|Adverse Event|0|||
126515130|NCT02460224|455180032|FG010|Overall Study|Adverse Event|0|||
126515131|NCT02460224|455180033|FG011|Overall Study|Adverse Event|0|||
126515132|NCT02460224|455180034|FG012|Overall Study|Adverse Event|1|||
126515133|NCT02460224|455180035|FG013|Overall Study|Adverse Event|0|||
126515134|NCT02460224|455180036|FG014|Overall Study|Adverse Event|0|||
126515135|NCT02460224|455180037|FG015|Overall Study|Adverse Event|0|||
126515136|NCT02460224|455180038|FG016|Overall Study|Adverse Event|1|||
126515137|NCT02460224|455180039|FG017|Overall Study|Adverse Event|0|||
126515138|NCT02460224|455180040|FG018|Overall Study|Adverse Event|1|||
126515139|NCT02460224|455180041|FG019|Overall Study|Adverse Event|0|||
126515140|NCT02460224|455180042|FG020|Overall Study|Adverse Event|1|||
126515141|NCT02460224|455180043|FG021|Overall Study|Adverse Event|1|||
126515142|NCT02460224|455180044|FG022|Overall Study|Adverse Event|1|||
126515143|NCT02460224|455180045|FG023|Overall Study|Adverse Event|0|||
126515144|NCT02460224|455180046|FG024|Overall Study|Adverse Event|0|||
126515145|NCT02460224|455180047|FG025|Overall Study|Adverse Event|0|||
126515146|NCT02460224|455180048|FG026|Overall Study|Adverse Event|11|||
126515147|NCT02460224|455180049|FG027|Overall Study|Adverse Event|1|||
126515148|NCT02460224|455180050|FG028|Overall Study|Adverse Event|6|||
126515149|NCT02460224|455180022|FG000|Overall Study|Death|0|||
126515150|NCT02460224|455180023|FG001|Overall Study|Death|0|||
126515151|NCT02460224|455180024|FG002|Overall Study|Death|0|||
126515152|NCT02460224|455180025|FG003|Overall Study|Death|0|||
126515153|NCT02460224|455180026|FG004|Overall Study|Death|0|||
126515154|NCT02460224|455180027|FG005|Overall Study|Death|2|||
126515155|NCT02460224|455180028|FG006|Overall Study|Death|1|||
126515156|NCT02460224|455180029|FG007|Overall Study|Death|0|||
126515157|NCT02460224|455180030|FG008|Overall Study|Death|0|||
126515158|NCT02460224|455180031|FG009|Overall Study|Death|1|||
126515159|NCT02460224|455180032|FG010|Overall Study|Death|0|||
126515160|NCT02460224|455180033|FG011|Overall Study|Death|0|||
126515161|NCT02460224|455180034|FG012|Overall Study|Death|0|||
126515162|NCT02460224|455180035|FG013|Overall Study|Death|1|||
126515163|NCT02460224|455180036|FG014|Overall Study|Death|0|||
126515164|NCT02460224|455180037|FG015|Overall Study|Death|0|||
126515165|NCT02460224|455180038|FG016|Overall Study|Death|2|||
126515166|NCT02460224|455180039|FG017|Overall Study|Death|1|||
126515167|NCT02460224|455180040|FG018|Overall Study|Death|0|||
126515168|NCT02460224|455180041|FG019|Overall Study|Death|2|||
126515169|NCT02460224|455180042|FG020|Overall Study|Death|0|||
126515170|NCT02460224|455180043|FG021|Overall Study|Death|0|||
126515171|NCT02460224|455180044|FG022|Overall Study|Death|0|||
126515172|NCT02460224|455180045|FG023|Overall Study|Death|0|||
126515173|NCT02460224|455180046|FG024|Overall Study|Death|1|||
126515174|NCT02460224|455180047|FG025|Overall Study|Death|1|||
126515175|NCT02460224|455180048|FG026|Overall Study|Death|5|||
126515176|NCT02460224|455180049|FG027|Overall Study|Death|0|||
126515177|NCT02460224|455180050|FG028|Overall Study|Death|1|||
126515178|NCT02460224|455180022|FG000|Overall Study|Lost to Follow-up|0|||
126515179|NCT02460224|455180023|FG001|Overall Study|Lost to Follow-up|0|||
126515180|NCT02460224|455180024|FG002|Overall Study|Lost to Follow-up|0|||
126515181|NCT02460224|455180025|FG003|Overall Study|Lost to Follow-up|0|||
126515182|NCT02460224|455180026|FG004|Overall Study|Lost to Follow-up|0|||
126515183|NCT02460224|455180027|FG005|Overall Study|Lost to Follow-up|0|||
126515184|NCT02460224|455180028|FG006|Overall Study|Lost to Follow-up|0|||
126515185|NCT02460224|455180029|FG007|Overall Study|Lost to Follow-up|0|||
126515186|NCT02460224|455180030|FG008|Overall Study|Lost to Follow-up|0|||
126515187|NCT02460224|455180031|FG009|Overall Study|Lost to Follow-up|0|||
126515188|NCT02460224|455180032|FG010|Overall Study|Lost to Follow-up|0|||
126515189|NCT02460224|455180033|FG011|Overall Study|Lost to Follow-up|0|||
126515190|NCT02460224|455180034|FG012|Overall Study|Lost to Follow-up|0|||
126515191|NCT02460224|455180035|FG013|Overall Study|Lost to Follow-up|0|||
126515192|NCT02460224|455180036|FG014|Overall Study|Lost to Follow-up|0|||
126515193|NCT02460224|455180037|FG015|Overall Study|Lost to Follow-up|0|||
126515194|NCT02460224|455180038|FG016|Overall Study|Lost to Follow-up|0|||
126515195|NCT02460224|455180039|FG017|Overall Study|Lost to Follow-up|0|||
126515196|NCT02460224|455180040|FG018|Overall Study|Lost to Follow-up|0|||
126515197|NCT02460224|455180041|FG019|Overall Study|Lost to Follow-up|0|||
126515198|NCT02460224|455180042|FG020|Overall Study|Lost to Follow-up|0|||
126515199|NCT02460224|455180043|FG021|Overall Study|Lost to Follow-up|0|||
126515200|NCT02460224|455180044|FG022|Overall Study|Lost to Follow-up|1|||
126515201|NCT02460224|455180045|FG023|Overall Study|Lost to Follow-up|0|||
126515202|NCT02460224|455180046|FG024|Overall Study|Lost to Follow-up|0|||
126515203|NCT02460224|455180047|FG025|Overall Study|Lost to Follow-up|0|||
126515204|NCT02460224|455180048|FG026|Overall Study|Lost to Follow-up|0|||
126515205|NCT02460224|455180049|FG027|Overall Study|Lost to Follow-up|0|||
126515206|NCT02460224|455180050|FG028|Overall Study|Lost to Follow-up|0|||
126515207|NCT02460224|455180022|FG000|Overall Study|Physician Decision|0|||
126515208|NCT02460224|455180023|FG001|Overall Study|Physician Decision|1|||
126515209|NCT02460224|455180024|FG002|Overall Study|Physician Decision|0|||
126515210|NCT02460224|455180025|FG003|Overall Study|Physician Decision|0|||
126515211|NCT02460224|455180026|FG004|Overall Study|Physician Decision|1|||
126515212|NCT02460224|455180027|FG005|Overall Study|Physician Decision|0|||
126515213|NCT02460224|455180028|FG006|Overall Study|Physician Decision|0|||
126515214|NCT02460224|455180029|FG007|Overall Study|Physician Decision|1|||
126515215|NCT02460224|455180030|FG008|Overall Study|Physician Decision|0|||
126515216|NCT02460224|455180031|FG009|Overall Study|Physician Decision|0|||
126515217|NCT02460224|455180032|FG010|Overall Study|Physician Decision|0|||
126515218|NCT02460224|455180033|FG011|Overall Study|Physician Decision|1|||
126515219|NCT02460224|455180034|FG012|Overall Study|Physician Decision|0|||
126515220|NCT02460224|455180035|FG013|Overall Study|Physician Decision|1|||
126515221|NCT02460224|455180036|FG014|Overall Study|Physician Decision|0|||
126515222|NCT02460224|455180037|FG015|Overall Study|Physician Decision|0|||
126515223|NCT02460224|455180038|FG016|Overall Study|Physician Decision|2|||
126515224|NCT02460224|455180039|FG017|Overall Study|Physician Decision|1|||
126515225|NCT02460224|455180040|FG018|Overall Study|Physician Decision|1|||
126515226|NCT02460224|455180041|FG019|Overall Study|Physician Decision|2|||
126515227|NCT02460224|455180042|FG020|Overall Study|Physician Decision|1|||
126515228|NCT02460224|455180043|FG021|Overall Study|Physician Decision|1|||
126515229|NCT02460224|455180044|FG022|Overall Study|Physician Decision|0|||
126515230|NCT02460224|455180045|FG023|Overall Study|Physician Decision|0|||
126515231|NCT02460224|455180046|FG024|Overall Study|Physician Decision|1|||
126515232|NCT02460224|455180047|FG025|Overall Study|Physician Decision|0|||
126515233|NCT02460224|455180048|FG026|Overall Study|Physician Decision|14|||
126515234|NCT02460224|455180049|FG027|Overall Study|Physician Decision|1|||
126515235|NCT02460224|455180050|FG028|Overall Study|Physician Decision|6|||
126515236|NCT02460224|455180022|FG000|Overall Study|Progressive disease|15|||
126515237|NCT02460224|455180023|FG001|Overall Study|Progressive disease|11|||
126515238|NCT02460224|455180024|FG002|Overall Study|Progressive disease|5|||
126515239|NCT02460224|455180025|FG003|Overall Study|Progressive disease|6|||
126515240|NCT02460224|455180026|FG004|Overall Study|Progressive disease|3|||
126515241|NCT02460224|455180027|FG005|Overall Study|Progressive disease|26|||
126515242|NCT02460224|455180028|FG006|Overall Study|Progressive disease|28|||
126515243|NCT02460224|455180029|FG007|Overall Study|Progressive disease|4|||
126515244|NCT02460224|455180030|FG008|Overall Study|Progressive disease|5|||
126515245|NCT02460224|455180031|FG009|Overall Study|Progressive disease|9|||
126515246|NCT02460224|455180032|FG010|Overall Study|Progressive disease|5|||
126515247|NCT02460224|455180033|FG011|Overall Study|Progressive disease|4|||
126515248|NCT02460224|455180034|FG012|Overall Study|Progressive disease|5|||
126515249|NCT02460224|455180035|FG013|Overall Study|Progressive disease|4|||
126515250|NCT02460224|455180036|FG014|Overall Study|Progressive disease|5|||
126515251|NCT02460224|455180037|FG015|Overall Study|Progressive disease|5|||
126515252|NCT02460224|455180038|FG016|Overall Study|Progressive disease|15|||
126515253|NCT02460224|455180039|FG017|Overall Study|Progressive disease|3|||
126515254|NCT02460224|455180040|FG018|Overall Study|Progressive disease|8|||
126515255|NCT02460224|455180041|FG019|Overall Study|Progressive disease|3|||
126515256|NCT02460224|455180042|FG020|Overall Study|Progressive disease|4|||
126515257|NCT02460224|455180043|FG021|Overall Study|Progressive disease|9|||
126515258|NCT02460224|455180044|FG022|Overall Study|Progressive disease|4|||
126515259|NCT02460224|455180045|FG023|Overall Study|Progressive disease|11|||
126515260|NCT02460224|455180046|FG024|Overall Study|Progressive disease|4|||
126515261|NCT02460224|455180047|FG025|Overall Study|Progressive disease|5|||
126515262|NCT02460224|455180048|FG026|Overall Study|Progressive disease|85|||
126515263|NCT02460224|455180049|FG027|Overall Study|Progressive disease|17|||
126515264|NCT02460224|455180050|FG028|Overall Study|Progressive disease|77|||
126515265|NCT02460224|455180022|FG000|Overall Study|Subject/guardian decision|2|||
126515266|NCT02460224|455180023|FG001|Overall Study|Subject/guardian decision|0|||
126515267|NCT02460224|455180024|FG002|Overall Study|Subject/guardian decision|1|||
126515268|NCT02460224|455180025|FG003|Overall Study|Subject/guardian decision|0|||
126515269|NCT02460224|455180026|FG004|Overall Study|Subject/guardian decision|2|||
126515270|NCT02460224|455180027|FG005|Overall Study|Subject/guardian decision|2|||
126515271|NCT02460224|455180028|FG006|Overall Study|Subject/guardian decision|0|||
126515272|NCT02460224|455180029|FG007|Overall Study|Subject/guardian decision|0|||
126515273|NCT02460224|455180030|FG008|Overall Study|Subject/guardian decision|1|||
126515274|NCT02460224|455180031|FG009|Overall Study|Subject/guardian decision|1|||
126515275|NCT02460224|455180032|FG010|Overall Study|Subject/guardian decision|0|||
126515276|NCT02460224|455180033|FG011|Overall Study|Subject/guardian decision|1|||
126515277|NCT02460224|455180034|FG012|Overall Study|Subject/guardian decision|0|||
126515278|NCT02460224|455180035|FG013|Overall Study|Subject/guardian decision|0|||
126515279|NCT02460224|455180036|FG014|Overall Study|Subject/guardian decision|0|||
126515280|NCT02460224|455180037|FG015|Overall Study|Subject/guardian decision|1|||
126515281|NCT02460224|455180038|FG016|Overall Study|Subject/guardian decision|0|||
126515282|NCT02460224|455180039|FG017|Overall Study|Subject/guardian decision|1|||
126515283|NCT02460224|455180040|FG018|Overall Study|Subject/guardian decision|2|||
126515284|NCT02460224|455180041|FG019|Overall Study|Subject/guardian decision|0|||
126515285|NCT02460224|455180042|FG020|Overall Study|Subject/guardian decision|0|||
126515286|NCT02460224|455180043|FG021|Overall Study|Subject/guardian decision|1|||
126515287|NCT02460224|455180044|FG022|Overall Study|Subject/guardian decision|0|||
126515288|NCT02460224|455180045|FG023|Overall Study|Subject/guardian decision|0|||
126569572|NCT00549848|455381384|FG002|Overall Study|Participant/Family Withdraw|5|||
126569573|NCT00549848|455381382|FG000|Overall Study|Second Malignancy|1|||
126569574|NCT00549848|455381383|FG001|Overall Study|Second Malignancy|0|||
126569575|NCT00549848|455381384|FG002|Overall Study|Second Malignancy|0|||
126569576|NCT00549848|455381382|FG000|Overall Study|Transplant|3|||
126569577|NCT00549848|455381383|FG001|Overall Study|Transplant|3|||
126569578|NCT00549848|455381384|FG002|Overall Study|Transplant|18|||
126569579|NCT00549848|455381382|FG000|Overall Study|Unacceptable Toxicity|1|||
126569580|NCT00549848|455381383|FG001|Overall Study|Unacceptable Toxicity|6|||
126569581|NCT00549848|455381384|FG002|Overall Study|Unacceptable Toxicity|6|||
126569582|NCT00419094|455381387|FG000|Overall Study|Adverse Event|3|||
126569583|NCT00419094|455381388|FG001|Overall Study|Adverse Event|7|||
126569584|NCT00419094|455381387|FG000|Overall Study|Lack of Efficacy|1|||
126569585|NCT00419094|455381388|FG001|Overall Study|Lack of Efficacy|0|||
126569586|NCT00419094|455381387|FG000|Overall Study|Lost to Follow-up|0|||
126569587|NCT00419094|455381388|FG001|Overall Study|Lost to Follow-up|2|||
126569588|NCT00419094|455381387|FG000|Overall Study|Protocol Violation|1|||
126569589|NCT00419094|455381388|FG001|Overall Study|Protocol Violation|14|||
126569590|NCT00419094|455381387|FG000|Overall Study|Withdrawal of consent|1|||
126569591|NCT00419094|455381388|FG001|Overall Study|Withdrawal of consent|5|||
126569592|NCT00419094|455381387|FG000|Overall Study|Other: Error determining exit criteria|1|||
126569593|NCT00419094|455381388|FG001|Overall Study|Other: Error determining exit criteria|0|||
126569594|NCT00419094|455381387|FG000|Overall Study|Other: Patient non-compliant|0|||
126569595|NCT00419094|455381388|FG001|Overall Study|Other: Patient non-compliant|1|||
126569596|NCT00419094|455381387|FG000|Overall Study|Other: No contact for extended period|0|||
126569597|NCT00419094|455381388|FG001|Overall Study|Other: No contact for extended period|1|||
126569598|NCT03262935|455381389|FG000|Overall Study|Withdrawal by Subject|6|||
126569599|NCT03262935|455381390|FG001|Overall Study|Withdrawal by Subject|7|||
126569600|NCT03262935|455381389|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
126569601|NCT03262935|455381390|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
126569602|NCT03262935|455381389|FG000|Overall Study|Death|181|||
126569603|NCT03262935|455381390|FG001|Overall Study|Death|94|||
126569604|NCT03262935|455381389|FG000|Overall Study|Lost to Follow-up|9|||
126569605|NCT03262935|455381390|FG001|Overall Study|Lost to Follow-up|4|||
126569606|NCT03262935|455381389|FG000|Overall Study|Other reason|5|||
126569607|NCT03262935|455381390|FG001|Overall Study|Other reason|0|||
126569608|NCT01811706|455381391|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
126569609|NCT01811706|455381392|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
126569610|NCT02224924|455381393|FG000|Overall Study|Withdrawal by Subject|7|||
126569611|NCT02224924|455381394|FG001|Overall Study|Withdrawal by Subject|6|||
126569612|NCT02224924|455381393|FG000|Overall Study|Biopsy cancelled|20|||
126569613|NCT02224924|455381394|FG001|Overall Study|Biopsy cancelled|14|||
126569614|NCT02224924|455381393|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
126569615|NCT02224924|455381394|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
126569616|NCT02224924|455381393|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
126569617|NCT02224924|455381394|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
126569618|NCT03020745|455381395|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
126569619|NCT03020745|455381396|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
126569620|NCT03020745|455381397|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
126569621|NCT03020745|455381398|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
126569622|NCT03020745|455381399|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
126569623|NCT03020745|455381400|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
126569624|NCT03020745|455381401|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
126569625|NCT03020745|455381402|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
126569626|NCT03020745|455381403|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
126569627|NCT03020745|455381404|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
126569628|NCT03020745|455381395|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126569629|NCT03020745|455381396|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126569630|NCT03020745|455381397|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126569631|NCT03020745|455381398|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126569632|NCT03020745|455381399|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126569633|NCT03020745|455381400|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126569634|NCT03020745|455381401|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126569635|NCT03020745|455381402|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
126569636|NCT03020745|455381403|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126569637|NCT03020745|455381404|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
126569638|NCT03020745|455381395|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126569639|NCT03020745|455381396|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126569640|NCT03020745|455381397|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126569641|NCT03020745|455381398|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126569642|NCT03020745|455381399|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126569643|NCT03020745|455381400|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
126569644|NCT03020745|455381401|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126776990|NCT01664494|456139145|FG000|Overall Study|Lost to Follow-up|99|||
126569645|NCT03020745|455381402|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126569646|NCT03020745|455381403|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
126569647|NCT03020745|455381404|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
126569648|NCT03020745|455381395|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126569649|NCT03020745|455381396|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126569650|NCT03020745|455381397|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126569651|NCT03020745|455381398|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126569652|NCT03020745|455381399|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126569653|NCT03020745|455381400|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126569654|NCT03020745|455381401|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126569655|NCT03020745|455381402|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126569656|NCT03020745|455381403|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
126569657|NCT03020745|455381404|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
126569658|NCT03781336|455381410|FG000|Overall Study|Withdrawal by Subject|2|||
126569659|NCT03781336|455381411|FG001|Overall Study|Withdrawal by Subject|2|||
126569660|NCT01596504|455381412|FG000|Overall Study|Participant's Private Reason|0|||
126569661|NCT01596504|455381413|FG001|Overall Study|Participant's Private Reason|1|||
126569662|NCT01596504|455381414|FG002|Overall Study|Participant's Private Reason|0|||
126569663|NCT01596504|455381412|FG000|Overall Study|Adverse Event|1|||
126569664|NCT01596504|455381413|FG001|Overall Study|Adverse Event|2|||
126569665|NCT01596504|455381414|FG002|Overall Study|Adverse Event|1|||
126569666|NCT01596504|455381412|FG000|Overall Study|Withdrawal by Subject|1|||
126569667|NCT01596504|455381413|FG001|Overall Study|Withdrawal by Subject|0|||
126569668|NCT01596504|455381414|FG002|Overall Study|Withdrawal by Subject|0|||
126569669|NCT01901276|455381415|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
126569670|NCT01901276|455381416|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
126569671|NCT04347954|455381417|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
126569672|NCT04347954|455381418|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
126569673|NCT04347954|455381419|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
126569674|NCT04347954|455381417|FG000|Overall Study|Lost to Follow-up|0|||
126569675|NCT04347954|455381418|FG001|Overall Study|Lost to Follow-up|1|||
126569676|NCT04347954|455381419|FG002|Overall Study|Lost to Follow-up|0|||
126569677|NCT03257813|455381423|FG000|Overall Study|Protocol Violation|6|||
126569678|NCT03257813|455381424|FG001|Overall Study|Protocol Violation|3|||
126569679|NCT02878330|455381425|FG000|Overall Study|Death|3|||
126569680|NCT02878330|455381426|FG001|Overall Study|Death|2|||
126569681|NCT02878330|455381425|FG000|Overall Study|Lost to Follow-up|11|||
126569682|NCT02878330|455381426|FG001|Overall Study|Lost to Follow-up|26|||
126569683|NCT02878330|455381425|FG000|Overall Study|Withdrawal by Subject|11|||
126569684|NCT02878330|455381426|FG001|Overall Study|Withdrawal by Subject|21|||
126569685|NCT02878330|455381425|FG000|Overall Study|Other|4|||
126569686|NCT02878330|455381426|FG001|Overall Study|Other|7|||
126569687|NCT02194933|455381429|FG000|Overall Study|Lost to Follow-up|1|||
126569688|NCT02194933|455381430|FG001|Overall Study|Lost to Follow-up|2|||
126569689|NCT02194933|455381429|FG000|Overall Study|Participant met withdrawal criteria|1|||
126569690|NCT02194933|455381430|FG001|Overall Study|Participant met withdrawal criteria|3|||
126569691|NCT02194933|455381429|FG000|Overall Study|Withdrawal by Subject|0|||
126569692|NCT02194933|455381430|FG001|Overall Study|Withdrawal by Subject|2|||
126569693|NCT02194933|455381429|FG000|Overall Study|Lack of Efficacy|1|||
126569694|NCT02194933|455381430|FG001|Overall Study|Lack of Efficacy|2|||
126569695|NCT02045836|455381434|FG000|Overall Study|Adverse Event|4|||
126569696|NCT02045836|455381435|FG001|Overall Study|Adverse Event|4|||
126569697|NCT02045836|455381434|FG000|Overall Study|Withdrawal by Subject|1|||
126569698|NCT02045836|455381435|FG001|Overall Study|Withdrawal by Subject|1|||
126569699|NCT02045836|455381434|FG000|Overall Study|Lost to Follow-up|4|||
126569700|NCT02045836|455381435|FG001|Overall Study|Lost to Follow-up|7|||
126569701|NCT02045836|455381434|FG000|Overall Study|Migrated from study area|0|||
126569702|NCT02045836|455381435|FG001|Overall Study|Migrated from study area|2|||
126569703|NCT00177216|455381440|FG000|Overall Study|Withdrawal by Subject|6|||
126569704|NCT00177216|455381441|FG001|Overall Study|Withdrawal by Subject|3|||
126569705|NCT00177216|455381442|FG002|Overall Study|Withdrawal by Subject|1|||
126569706|NCT03383146|455381447|FG000|Overall Study|Screen Failure|1|||
126569707|NCT03383146|455381448|FG001|Overall Study|Screen Failure|0|||
126569708|NCT03383146|455381447|FG000|Overall Study|Adverse Event|6|||
126569709|NCT03383146|455381448|FG001|Overall Study|Adverse Event|18|||
126569710|NCT03383146|455381447|FG000|Overall Study|Lack of Efficacy|0|||
126569711|NCT03383146|455381448|FG001|Overall Study|Lack of Efficacy|3|||
126569712|NCT03383146|455381447|FG000|Overall Study|Withdrawal by Subject|20|||
126569713|NCT03383146|455381448|FG001|Overall Study|Withdrawal by Subject|36|||
126569714|NCT03383146|455381447|FG000|Overall Study|Lost to Follow-up|5|||
126569715|NCT03383146|455381448|FG001|Overall Study|Lost to Follow-up|15|||
126569716|NCT03383146|455381447|FG000|Overall Study|Death|0|||
126569717|NCT03383146|455381448|FG001|Overall Study|Death|2|||
126569718|NCT03383146|455381447|FG000|Overall Study|Physician Decision|0|||
126569719|NCT03383146|455381448|FG001|Overall Study|Physician Decision|1|||
126569720|NCT03383146|455381447|FG000|Overall Study|Protocol Deviation|1|||
126569721|NCT03383146|455381448|FG001|Overall Study|Protocol Deviation|8|||
126569722|NCT03383146|455381447|FG000|Overall Study|Study Terminated by the Sponsor|48|||
126569723|NCT03383146|455381448|FG001|Overall Study|Study Terminated by the Sponsor|95|||
126569724|NCT03383146|455381447|FG000|Overall Study|Reason not Specified|4|||
126569725|NCT03383146|455381448|FG001|Overall Study|Reason not Specified|6|||
126569726|NCT02739035|455381451|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
126569727|NCT02739035|455381452|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
126569728|NCT02739035|455381451|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
126569729|NCT02739035|455381452|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
126569730|NCT02739035|455381451|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
126569731|NCT02739035|455381452|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
126569732|NCT02739035|455381451|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
126569733|NCT02739035|455381452|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
126569734|NCT03210402|455381453|FG000|Overall Study|Withdrawal by Subject|0|||
126569735|NCT03210402|455381454|FG001|Overall Study|Withdrawal by Subject|1|||
126569736|NCT02517307|455381457|FG000|Overall Study|Withdrawal by Subject|1|||
126569737|NCT02517307|455381458|FG001|Overall Study|Withdrawal by Subject|0|||
126569738|NCT02517307|455381459|FG002|Overall Study|Withdrawal by Subject|1|||
126569739|NCT02517307|455381460|FG003|Overall Study|Withdrawal by Subject|0|||
126569740|NCT02517307|455381457|FG000|Overall Study|Protocol Violation|0|||
126569741|NCT02517307|455381458|FG001|Overall Study|Protocol Violation|0|||
126569742|NCT02517307|455381459|FG002|Overall Study|Protocol Violation|1|||
126569743|NCT02517307|455381460|FG003|Overall Study|Protocol Violation|1|||
126569744|NCT01212757|455381463|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
126569745|NCT01212757|455381464|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
126569746|NCT01212757|455381465|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
126569747|NCT01212757|455381466|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126569748|NCT01212757|455381467|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126569749|NCT01212757|455381468|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126569750|NCT01212757|455381469|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126569751|NCT01212757|455381470|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126569752|NCT01212757|455381471|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
126569753|NCT01212757|455381463|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
126569754|NCT01212757|455381464|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
126569755|NCT01212757|455381465|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
126569756|NCT01212757|455381466|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126569757|NCT01212757|455381467|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126569758|NCT01212757|455381468|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126569759|NCT01212757|455381469|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126569760|NCT01212757|455381470|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126569761|NCT01212757|455381471|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
126569762|NCT01212757|455381463|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
126569763|NCT01212757|455381464|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
126569764|NCT01212757|455381465|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
126569765|NCT01212757|455381466|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126569766|NCT01212757|455381467|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126569767|NCT01212757|455381468|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126515289|NCT02460224|455180046|FG024|Overall Study|Subject/guardian decision|0|||
126515290|NCT02460224|455180047|FG025|Overall Study|Subject/guardian decision|0|||
126515291|NCT02460224|455180048|FG026|Overall Study|Subject/guardian decision|6|||
126515292|NCT02460224|455180049|FG027|Overall Study|Subject/guardian decision|2|||
126515293|NCT02460224|455180050|FG028|Overall Study|Subject/guardian decision|3|||
126515294|NCT00853658|455180051|FG000|Overall Study|Death|713|||
126515295|NCT00853658|455180052|FG001|Overall Study|Death|768|||
126515296|NCT00853658|455180053|FG002|Overall Study|Death|753|||
126515297|NCT00853658|455180051|FG000|Overall Study|Lost to Follow-up|11|||
126515298|NCT00853658|455180052|FG001|Overall Study|Lost to Follow-up|6|||
126515299|NCT00853658|455180053|FG002|Overall Study|Lost to Follow-up|11|||
126515300|NCT00853658|455180051|FG000|Overall Study|H.A. Request|26|||
126515301|NCT00853658|455180052|FG001|Overall Study|H.A. Request|23|||
126515302|NCT00853658|455180053|FG002|Overall Study|H.A. Request|19|||
126569768|NCT01212757|455381469|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126569769|NCT01212757|455381470|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126569770|NCT01212757|455381471|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
126727191|NCT00547378|455951074|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
126727192|NCT00547378|455951075|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
126727193|NCT00547378|455951073|FG000|All Implanted Cohort|Adverse Event|4|||
126515303|NCT00853658|455180051|FG000|Overall Study|IRB request|0|||
126515304|NCT00853658|455180052|FG001|Overall Study|IRB request|0|||
126515305|NCT00853658|455180053|FG002|Overall Study|IRB request|2|||
126515306|NCT00853658|455180051|FG000|Overall Study|Vital Status known (alive) at study end|2|||
126515307|NCT00853658|455180052|FG001|Overall Study|Vital Status known (alive) at study end|3|||
126515308|NCT00853658|455180053|FG002|Overall Study|Vital Status known (alive) at study end|3|||
126515309|NCT00853658|455180051|FG000|Overall Study|Vital Status unknown at study end|1|||
126515310|NCT00853658|455180052|FG001|Overall Study|Vital Status unknown at study end|1|||
126515311|NCT00853658|455180053|FG002|Overall Study|Vital Status unknown at study end|0|||
126515312|NCT00853658|455180051|FG000|Overall Study|Vital Status at study end N/A|8|||
126515313|NCT00853658|455180052|FG001|Overall Study|Vital Status at study end N/A|10|||
126515314|NCT00853658|455180053|FG002|Overall Study|Vital Status at study end N/A|10|||
126515315|NCT00853658|455180051|FG000|Overall Study|Patient's request|21|||
126515316|NCT00853658|455180052|FG001|Overall Study|Patient's request|17|||
126515317|NCT00853658|455180053|FG002|Overall Study|Patient's request|11|||
126515318|NCT00853658|455180051|FG000|Overall Study|Missing study completion information|5|||
126569771|NCT01212757|455381463|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
126569772|NCT01212757|455381464|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126569773|NCT01212757|455381465|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
126569774|NCT01212757|455381466|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126569775|NCT01212757|455381467|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126569776|NCT01212757|455381468|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126569777|NCT01212757|455381469|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126569778|NCT01212757|455381470|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126569779|NCT01212757|455381471|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
126569780|NCT01212757|455381463|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
126569781|NCT01212757|455381464|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
126569782|NCT01212757|455381465|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
126569783|NCT01212757|455381466|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126569784|NCT01212757|455381467|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126569785|NCT01212757|455381468|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126569786|NCT01212757|455381469|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126569787|NCT01212757|455381470|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126569788|NCT01212757|455381471|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
126569789|NCT01212757|455381463|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126569790|NCT01212757|455381464|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
126569791|NCT01212757|455381465|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
126569792|NCT01212757|455381466|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126569793|NCT01212757|455381467|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126569794|NCT01212757|455381468|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126569795|NCT01212757|455381469|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126569796|NCT01212757|455381470|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126569797|NCT01212757|455381471|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
126569798|NCT01212757|455381463|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
126569799|NCT01212757|455381464|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
126569800|NCT01212757|455381465|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126569801|NCT01212757|455381466|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126569802|NCT01212757|455381467|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126569803|NCT01212757|455381468|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126569804|NCT01212757|455381469|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126569805|NCT01212757|455381470|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126569806|NCT01212757|455381471|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
126569807|NCT01212757|455381463|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
126569808|NCT01212757|455381464|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
126569809|NCT01212757|455381465|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
126569810|NCT01212757|455381466|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
126569811|NCT01212757|455381467|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
126569812|NCT01212757|455381468|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
126569813|NCT01212757|455381469|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
126569814|NCT01212757|455381470|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
126569815|NCT01212757|455381471|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
126569816|NCT01212757|455381463|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
126569817|NCT01212757|455381464|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
126569818|NCT01212757|455381465|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
126776991|NCT03196791|456139146|FG000|Overall Study|Protocol Violation|7|||
126515319|NCT00853658|455180052|FG001|Overall Study|Missing study completion information|4|||
126515320|NCT00853658|455180053|FG002|Overall Study|Missing study completion information|6|||
126515321|NCT01976845|455180056|FG000|Overall Study|Physician Decision|8|||
126515322|NCT01976845|455180057|FG001|Overall Study|Physician Decision|8|||
126515323|NCT01976845|455180058|FG002|Overall Study|Physician Decision|3|||
126515324|NCT06748040|455180059|FG000|Overall Study|Death|3|||
126569819|NCT01212757|455381466|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
126569820|NCT01212757|455381467|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
126569821|NCT01212757|455381468|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
126569822|NCT01212757|455381469|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
126569823|NCT01212757|455381470|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
126569824|NCT01212757|455381471|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
126569825|NCT01212757|455381463|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126569826|NCT01212757|455381464|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126569827|NCT01212757|455381465|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
126569828|NCT01212757|455381466|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126569829|NCT01212757|455381467|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126569830|NCT01212757|455381468|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126569831|NCT01212757|455381469|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126569832|NCT01212757|455381470|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126569833|NCT01212757|455381471|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
126569834|NCT01212757|455381463|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126569835|NCT01212757|455381464|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
126569836|NCT01212757|455381465|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
126569837|NCT01212757|455381466|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
126569838|NCT01212757|455381467|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
126569839|NCT01212757|455381468|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
126569840|NCT01212757|455381469|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126569841|NCT01212757|455381470|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126569842|NCT01212757|455381471|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
126569843|NCT01212757|455381463|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126569844|NCT01212757|455381464|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
126569845|NCT01212757|455381465|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126569846|NCT01212757|455381466|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126569847|NCT01212757|455381467|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
126569848|NCT01212757|455381468|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126569849|NCT01212757|455381469|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126569850|NCT01212757|455381470|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126569851|NCT01212757|455381471|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
126569852|NCT01212757|455381463|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126569853|NCT01212757|455381464|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
126569854|NCT01212757|455381465|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
126569855|NCT01212757|455381466|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126569856|NCT01212757|455381467|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126569857|NCT01212757|455381468|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126569858|NCT01212757|455381469|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126569859|NCT01212757|455381470|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126569860|NCT01212757|455381471|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
126569861|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126569862|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126569863|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126569864|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126569865|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126569866|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126569867|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126569868|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
126569869|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
126569870|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
126569871|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
126569872|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
126569873|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
126569874|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
126569875|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
126569876|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
126569877|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
126569878|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
126569879|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
126569880|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
126569881|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
126569882|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
126569883|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
126569884|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
126569885|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
126569886|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
126569887|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
126569888|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126569889|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
126569890|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
126569891|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126569892|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126569893|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126569894|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
126569895|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
126515325|NCT06748040|455180060|FG001|Overall Study|Death|4|||
126515326|NCT06748040|455180059|FG000|Overall Study|Lost to Follow-up|134|||
126515327|NCT06748040|455180060|FG001|Overall Study|Lost to Follow-up|132|||
126515328|NCT06748040|455180059|FG000|Overall Study|Withdrawal by Subject|3|||
126515329|NCT06748040|455180060|FG001|Overall Study|Withdrawal by Subject|5|||
126515330|NCT02556710|455182233|FG000|Overall Study|Surgical treatment|3|||
126515331|NCT02556710|455182234|FG001|Overall Study|Surgical treatment|0|||
126515332|NCT02556710|455182233|FG000|Overall Study|Required proscribed pain medication|2|||
126515333|NCT02556710|455182234|FG001|Overall Study|Required proscribed pain medication|1|||
126515334|NCT02556710|455182233|FG000|Overall Study|Lack of Efficacy|1|||
126515335|NCT02556710|455182234|FG001|Overall Study|Lack of Efficacy|0|||
126515336|NCT02556710|455182233|FG000|Overall Study|Worsening osteoarthritis|1|||
126515337|NCT02556710|455182234|FG001|Overall Study|Worsening osteoarthritis|0|||
126515338|NCT02556710|455182233|FG000|Overall Study|Moved out of state|1|||
126515339|NCT02556710|455182234|FG001|Overall Study|Moved out of state|0|||
126515340|NCT02556710|455182233|FG000|Overall Study|Missing reason|3|||
126515341|NCT02556710|455182234|FG001|Overall Study|Missing reason|1|||
126515342|NCT02556710|455182233|FG000|Overall Study|Pain as lack of efficacy|0|||
126515343|NCT02556710|455182234|FG001|Overall Study|Pain as lack of efficacy|4|||
126515344|NCT04258839|455182235|FG000|Overall Study|Adverse Event|2|||
126515345|NCT04258839|455182236|FG001|Overall Study|Adverse Event|4|||
126515346|NCT04258839|455182235|FG000|Overall Study|Lack of Efficacy|0|||
126515347|NCT04258839|455182236|FG001|Overall Study|Lack of Efficacy|2|||
126515348|NCT04258839|455182235|FG000|Overall Study|Lost to Follow-up|2|||
126515349|NCT04258839|455182236|FG001|Overall Study|Lost to Follow-up|0|||
126515350|NCT04258839|455182235|FG000|Overall Study|Withdrawal by Subject|1|||
126515351|NCT04258839|455182236|FG001|Overall Study|Withdrawal by Subject|2|||
126515352|NCT04258839|455182235|FG000|Overall Study|Withdrawal by Caregiver|5|||
126515353|NCT04258839|455182236|FG001|Overall Study|Withdrawal by Caregiver|6|||
126515354|NCT04258839|455182235|FG000|Overall Study|Reason not Specified|0|||
126515355|NCT04258839|455182236|FG001|Overall Study|Reason not Specified|1|||
126515356|NCT01529645|455182237|FG000|Overall Study|Lost to Follow-up|0|||
126515357|NCT01529645|455182238|FG001|Overall Study|Lost to Follow-up|1|||
126515358|NCT01529645|455182239|FG002|Overall Study|Lost to Follow-up|1|||
126515359|NCT01529645|455182240|FG003|Overall Study|Lost to Follow-up|1|||
126515360|NCT01529645|455182241|FG004|Overall Study|Lost to Follow-up|1|||
126515361|NCT01529645|455182242|FG005|Overall Study|Lost to Follow-up|0|||
126515362|NCT01529645|455182243|FG006|Overall Study|Lost to Follow-up|2|||
126515363|NCT01529645|455182244|FG007|Overall Study|Lost to Follow-up|0|||
126515364|NCT01529645|455182245|FG008|Overall Study|Lost to Follow-up|1|||
126515365|NCT01529645|455182246|FG009|Overall Study|Lost to Follow-up|0|||
126515366|NCT01529645|455182237|FG000|Overall Study|SAE - Premature contractions|0|||
126515367|NCT01529645|455182238|FG001|Overall Study|SAE - Premature contractions|0|||
126515368|NCT01529645|455182239|FG002|Overall Study|SAE - Premature contractions|1|||
126515369|NCT01529645|455182240|FG003|Overall Study|SAE - Premature contractions|0|||
126515370|NCT01529645|455182241|FG004|Overall Study|SAE - Premature contractions|0|||
126515371|NCT01529645|455182242|FG005|Overall Study|SAE - Premature contractions|0|||
126515372|NCT01529645|455182243|FG006|Overall Study|SAE - Premature contractions|0|||
126515373|NCT01529645|455182244|FG007|Overall Study|SAE - Premature contractions|0|||
126515374|NCT01529645|455182245|FG008|Overall Study|SAE - Premature contractions|0|||
126515375|NCT01529645|455182246|FG009|Overall Study|SAE - Premature contractions|0|||
126569896|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
126515376|NCT01529645|455182237|FG000|Overall Study|Withdrawal by Subject|2|||
126515377|NCT01529645|455182238|FG001|Overall Study|Withdrawal by Subject|0|||
126515378|NCT01529645|455182239|FG002|Overall Study|Withdrawal by Subject|0|||
126515379|NCT01529645|455182240|FG003|Overall Study|Withdrawal by Subject|1|||
126569897|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126776992|NCT03196791|456139147|FG001|Overall Study|Protocol Violation|3|||
126515380|NCT01529645|455182241|FG004|Overall Study|Withdrawal by Subject|1|||
126515381|NCT01529645|455182242|FG005|Overall Study|Withdrawal by Subject|1|||
126515382|NCT01529645|455182243|FG006|Overall Study|Withdrawal by Subject|0|||
126515383|NCT01529645|455182244|FG007|Overall Study|Withdrawal by Subject|0|||
126515384|NCT01529645|455182245|FG008|Overall Study|Withdrawal by Subject|0|||
126515385|NCT01529645|455182246|FG009|Overall Study|Withdrawal by Subject|0|||
126569898|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126569899|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
126569900|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126569901|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126569902|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126569903|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126569904|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126569905|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
126569906|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
126569907|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
126569908|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
126569909|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
126569910|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
126569911|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
126569912|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
126569913|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
126569914|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
126569915|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
126569916|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
126569917|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
126569918|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
126569919|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
126569920|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
126569921|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
126569922|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
126569923|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
126569924|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126569925|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126569926|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
126569927|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126569928|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126569929|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126569930|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126569931|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126569932|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
126569933|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126569934|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
126569935|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
126569936|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126569937|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126569938|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126569939|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
126569940|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
126569941|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
126569942|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126569943|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126569944|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126569945|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126569946|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126569947|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126569948|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126569949|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
126569950|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
126569951|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126569952|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
126569953|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126569954|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126569955|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126569956|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126569957|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126569958|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126569959|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
126569960|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126569961|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126569962|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
126569963|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126569964|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126569965|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126569966|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126569967|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
126569968|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
126569969|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126569970|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
126569971|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126569972|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126569973|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126569974|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126569975|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126569976|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
126569977|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
126569978|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
126569979|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
126569980|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
126569981|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
126569982|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
126569983|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
126569984|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
126569985|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
126569986|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
126569987|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
126569988|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
126569989|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
126569990|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
126569991|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
126569992|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
126569993|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
126569994|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
126569995|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
126569996|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126569997|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
126569998|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
126569999|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126570000|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126570001|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126570002|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
126570003|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
126570004|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
126570005|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
126570006|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
126570007|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
126570008|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
126570009|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
126570010|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
126570011|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
126570012|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
126570013|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
126570014|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126570015|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126570016|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126570017|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126570018|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126570019|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126570020|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126570021|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
126570022|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
126570023|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126570024|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
126570025|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
126570026|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126570027|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126570028|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126570029|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
126570030|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
126570031|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
126570032|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
126570033|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
126570034|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
126570035|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
126570036|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
126570037|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
126570038|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
126570039|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
126570040|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
126570041|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
126570042|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
126570043|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
126570044|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
126570045|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
126570046|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
126570047|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
126570048|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
126570049|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
126570050|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126570051|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
126570052|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126570053|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126570054|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126570055|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126570056|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126570057|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126570058|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
126570059|NCT01212757|455381463|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126570060|NCT01212757|455381464|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
126570061|NCT01212757|455381465|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
126570062|NCT01212757|455381466|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126570063|NCT01212757|455381467|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126570064|NCT01212757|455381468|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126570065|NCT01212757|455381469|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126570066|NCT01212757|455381470|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126570067|NCT01212757|455381471|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
126570068|NCT04517864|455383056|FG000|Placebo-Controlled Phase|Adverse Event|1|||
126570069|NCT04517864|455383057|FG001|Placebo-Controlled Phase|Adverse Event|0|||
126570070|NCT04517864|455383058|FG002|Placebo-Controlled Phase|Adverse Event|0|||
126570071|NCT04517864|455383056|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
126570072|NCT04517864|455383057|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
126570073|NCT04517864|455383058|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
126570074|NCT04517864|455383056|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
126570075|NCT04517864|455383057|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
126570076|NCT04517864|455383058|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
126570077|NCT04517864|455383056|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
126570078|NCT04517864|455383057|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
126570079|NCT04517864|455383058|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
126570080|NCT04517864|455383056|FG000|Active Therapy Extension Phase|Adverse Event|1|||
126570081|NCT04517864|455383057|FG001|Active Therapy Extension Phase|Adverse Event|0|||
126570082|NCT04517864|455383058|FG002|Active Therapy Extension Phase|Adverse Event|0|||
126570083|NCT04517864|455383056|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
126570084|NCT04517864|455383057|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
126570085|NCT04517864|455383058|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
126570086|NCT04517864|455383056|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
126570087|NCT04517864|455383057|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
126570088|NCT04517864|455383058|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
126570089|NCT04517864|455383056|FG000|Active Therapy Extension Phase|Physician Decision|1|||
126570090|NCT04517864|455383057|FG001|Active Therapy Extension Phase|Physician Decision|0|||
126570091|NCT04517864|455383058|FG002|Active Therapy Extension Phase|Physician Decision|0|||
126570092|NCT04517864|455383056|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
126570093|NCT04517864|455383057|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
126570094|NCT04517864|455383058|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
126570095|NCT04517864|455383056|FG000|Extension Phase|Adverse Event|0|||
126570096|NCT04517864|455383057|FG001|Extension Phase|Adverse Event|0|||
126570097|NCT04517864|455383058|FG002|Extension Phase|Adverse Event|1|||
126570098|NCT04517864|455383056|FG000|Extension Phase|Lack of Efficacy|0|||
126570099|NCT04517864|455383057|FG001|Extension Phase|Lack of Efficacy|0|||
126570100|NCT04517864|455383058|FG002|Extension Phase|Lack of Efficacy|2|||
126570101|NCT04517864|455383056|FG000|Extension Phase|Study Terminated By Sponsor|0|||
126570102|NCT04517864|455383057|FG001|Extension Phase|Study Terminated By Sponsor|0|||
126570103|NCT04517864|455383058|FG002|Extension Phase|Study Terminated By Sponsor|32|||
126515386|NCT01602315|455182247|FG000|Overall Study|Protocol Violation|0|||
126515387|NCT01602315|455182248|FG001|Overall Study|Protocol Violation|0|||
126515388|NCT01602315|455182249|FG002|Overall Study|Protocol Violation|0|||
126515389|NCT01602315|455182250|FG003|Overall Study|Protocol Violation|0|||
126515390|NCT01602315|455182251|FG004|Overall Study|Protocol Violation|0|||
126515391|NCT01602315|455182252|FG005|Overall Study|Protocol Violation|1|||
126515392|NCT01602315|455182253|FG006|Overall Study|Protocol Violation|0|||
126515393|NCT01602315|455182247|FG000|Overall Study|Physician Decision|2|||
126515394|NCT01602315|455182248|FG001|Overall Study|Physician Decision|0|||
126515395|NCT01602315|455182249|FG002|Overall Study|Physician Decision|0|||
126515396|NCT01602315|455182250|FG003|Overall Study|Physician Decision|0|||
126515397|NCT01602315|455182251|FG004|Overall Study|Physician Decision|2|||
126515398|NCT01602315|455182252|FG005|Overall Study|Physician Decision|1|||
126515399|NCT01602315|455182253|FG006|Overall Study|Physician Decision|1|||
126515400|NCT01602315|455182247|FG000|Overall Study|Disease progression|6|||
126515401|NCT01602315|455182248|FG001|Overall Study|Disease progression|3|||
126515402|NCT01602315|455182249|FG002|Overall Study|Disease progression|10|||
126515403|NCT01602315|455182250|FG003|Overall Study|Disease progression|1|||
126515404|NCT01602315|455182251|FG004|Overall Study|Disease progression|41|||
126515405|NCT01602315|455182252|FG005|Overall Study|Disease progression|12|||
126515406|NCT01602315|455182253|FG006|Overall Study|Disease progression|15|||
126515407|NCT01602315|455182247|FG000|Overall Study|Death|1|||
126515408|NCT01602315|455182248|FG001|Overall Study|Death|1|||
126515409|NCT01602315|455182249|FG002|Overall Study|Death|1|||
126515410|NCT01602315|455182250|FG003|Overall Study|Death|1|||
126515411|NCT01602315|455182251|FG004|Overall Study|Death|7|||
126515412|NCT01602315|455182252|FG005|Overall Study|Death|2|||
126515413|NCT01602315|455182253|FG006|Overall Study|Death|2|||
126515414|NCT01602315|455182247|FG000|Overall Study|Withdrawal by Subject|2|||
126515415|NCT01602315|455182248|FG001|Overall Study|Withdrawal by Subject|0|||
126515416|NCT01602315|455182249|FG002|Overall Study|Withdrawal by Subject|2|||
126515417|NCT01602315|455182250|FG003|Overall Study|Withdrawal by Subject|0|||
126515418|NCT01602315|455182251|FG004|Overall Study|Withdrawal by Subject|6|||
126515419|NCT01602315|455182252|FG005|Overall Study|Withdrawal by Subject|0|||
126515420|NCT01602315|455182253|FG006|Overall Study|Withdrawal by Subject|1|||
126515421|NCT01602315|455182247|FG000|Overall Study|Adverse Event|5|||
126515422|NCT01602315|455182248|FG001|Overall Study|Adverse Event|1|||
126515423|NCT01602315|455182249|FG002|Overall Study|Adverse Event|5|||
126515424|NCT01602315|455182250|FG003|Overall Study|Adverse Event|4|||
126515425|NCT01602315|455182251|FG004|Overall Study|Adverse Event|15|||
126515426|NCT01602315|455182252|FG005|Overall Study|Adverse Event|3|||
126515427|NCT01602315|455182253|FG006|Overall Study|Adverse Event|9|||
126515428|NCT01602315|455182247|FG000|Overall Study|Subject/guardian decision|0|||
126515429|NCT01602315|455182248|FG001|Overall Study|Subject/guardian decision|0|||
126515430|NCT01602315|455182249|FG002|Overall Study|Subject/guardian decision|0|||
126515431|NCT01602315|455182250|FG003|Overall Study|Subject/guardian decision|0|||
126515432|NCT01602315|455182251|FG004|Overall Study|Subject/guardian decision|0|||
126515433|NCT01602315|455182252|FG005|Overall Study|Subject/guardian decision|0|||
126515434|NCT01602315|455182253|FG006|Overall Study|Subject/guardian decision|1|||
126515435|NCT01602315|455182247|FG000|Overall Study|Cross-over patients to combo treatment|0|||
126515436|NCT01602315|455182248|FG001|Overall Study|Cross-over patients to combo treatment|0|||
126515437|NCT01602315|455182249|FG002|Overall Study|Cross-over patients to combo treatment|0|||
126515438|NCT01602315|455182250|FG003|Overall Study|Cross-over patients to combo treatment|0|||
126515439|NCT01602315|455182251|FG004|Overall Study|Cross-over patients to combo treatment|0|||
126515440|NCT01602315|455182252|FG005|Overall Study|Cross-over patients to combo treatment|16|||
126515441|NCT01602315|455182253|FG006|Overall Study|Cross-over patients to combo treatment|0|||
126515442|NCT02944578|455182254|FG000|Overall Study|Physician Decision|1|||
126515443|NCT02944578|455182255|FG001|Overall Study|Physician Decision|0|||
126515444|NCT02691455|455182256|FG000|Overall Study|Withdrawal by Subject|1|||
126515445|NCT02691455|455182257|FG001|Overall Study|Withdrawal by Subject|2|||
126515446|NCT02691455|455182256|FG000|Overall Study|Lost to Follow-up|15|||
126515447|NCT02691455|455182257|FG001|Overall Study|Lost to Follow-up|15|||
126515448|NCT01257204|455182258|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126515449|NCT01257204|455182259|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
126515450|NCT01257204|455182260|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
126515451|NCT01257204|455182258|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
126515452|NCT01257204|455182259|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
126515453|NCT01257204|455182260|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
126515454|NCT01257204|455182258|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
126515455|NCT01257204|455182259|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
126515456|NCT01257204|455182260|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
126515457|NCT01257204|455182258|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
126515458|NCT01257204|455182259|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
126515459|NCT01257204|455182260|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
126515460|NCT01257204|455182258|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
126515461|NCT01257204|455182259|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
126570104|NCT04517864|455383056|FG000|Extension Phase|Withdrawal by Subject|0|||
126570105|NCT04517864|455383057|FG001|Extension Phase|Withdrawal by Subject|0|||
126570106|NCT04517864|455383058|FG002|Extension Phase|Withdrawal by Subject|3|||
126570107|NCT04517864|455383056|FG000|Extension Phase|Approved Drug Available for Indication|0|||
126570108|NCT04517864|455383057|FG001|Extension Phase|Approved Drug Available for Indication|0|||
126570109|NCT04517864|455383058|FG002|Extension Phase|Approved Drug Available for Indication|7|||
126570110|NCT04722003|455383059|FG000|Overall Study|Lost to Follow-up|2|||
126570111|NCT04722003|455383060|FG001|Overall Study|Lost to Follow-up|0|||
126570112|NCT04722003|455383059|FG000|Overall Study|Physician Decision|1|||
126570113|NCT04722003|455383060|FG001|Overall Study|Physician Decision|0|||
126570114|NCT01049503|455383061|FG000|Overall Study|Lost to Follow-up|11|||
126570115|NCT01049503|455383062|FG001|Overall Study|Lost to Follow-up|12|||
126570116|NCT01049503|455383063|FG002|Overall Study|Lost to Follow-up|24|||
126570117|NCT01049503|455383064|FG003|Overall Study|Lost to Follow-up|26|||
126570118|NCT01049503|455383065|FG004|Overall Study|Lost to Follow-up|27|||
126570119|NCT01049503|455383066|FG005|Overall Study|Lost to Follow-up|8|||
126570120|NCT02974634|455383067|FG000|Overall Study|Advanced disease|12|||
126570121|NCT02974634|455383068|FG001|Overall Study|Advanced disease|3|||
126570122|NCT02974634|455383067|FG000|Overall Study|Noncompliance|3|||
126570123|NCT02974634|455383068|FG001|Overall Study|Noncompliance|7|||
126570124|NCT02974634|455383067|FG000|Overall Study|intervention technology related issues|5|||
126570125|NCT02974634|455383068|FG001|Overall Study|intervention technology related issues|0|||
126570126|NCT02974634|455383067|FG000|Overall Study|Death|8|||
126570127|NCT02974634|455383068|FG001|Overall Study|Death|11|||
126570128|NCT01266265|455383070|FG000|Overall Study|Death|95|||
126570129|NCT01266265|455383071|FG001|Overall Study|Death|73|||
126570130|NCT01266265|455383070|FG000|Overall Study|Lost to Follow-up|23|||
126570131|NCT01266265|455383071|FG001|Overall Study|Lost to Follow-up|28|||
126570132|NCT01266265|455383070|FG000|Overall Study|Withdrawal by Subject|13|||
126570133|NCT01266265|455383071|FG001|Overall Study|Withdrawal by Subject|11|||
126570134|NCT01266265|455383070|FG000|Overall Study|Respiratory-related adverse event|2|||
126570135|NCT01266265|455383071|FG001|Overall Study|Respiratory-related adverse event|1|||
126570136|NCT01266265|455383070|FG000|Overall Study|Transferred care to another provider|22|||
126570137|NCT01266265|455383071|FG001|Overall Study|Transferred care to another provider|28|||
126570138|NCT01266265|455383070|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
126570139|NCT01266265|455383071|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
126570140|NCT01266265|455383070|FG000|Overall Study|Enrolled in another clinical study|15|||
126570141|NCT01266265|455383071|FG001|Overall Study|Enrolled in another clinical study|26|||
126570142|NCT01266265|455383070|FG000|Overall Study|Non-compliance|8|||
126570143|NCT01266265|455383071|FG001|Overall Study|Non-compliance|5|||
126570144|NCT01266265|455383070|FG000|Overall Study|Lung transplant|6|||
126570145|NCT01266265|455383071|FG001|Overall Study|Lung transplant|5|||
126570146|NCT01266265|455383070|FG000|Overall Study|Site closed early|4|||
126570147|NCT01266265|455383071|FG001|Overall Study|Site closed early|3|||
126570148|NCT01266265|455383070|FG000|Overall Study|Clinical worsening|1|||
126570149|NCT01266265|455383071|FG001|Overall Study|Clinical worsening|1|||
126570150|NCT01580293|455383072|FG000|Part A_Main Trial|Adverse Event|0|||
126570151|NCT01580293|455383073|FG001|Part A_Main Trial|Adverse Event|2|||
126570152|NCT01580293|455383074|FG002|Part A_Main Trial|Adverse Event|0|||
126570153|NCT01580293|455383072|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
126570154|NCT01580293|455383073|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
126570155|NCT01580293|455383074|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
126570156|NCT01580293|455383072|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
126570157|NCT01580293|455383073|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
126570158|NCT01580293|455383074|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
126570159|NCT01580293|455383072|FG000|Part A_Extension|Adverse Event|0|||
126570160|NCT01580293|455383073|FG001|Part A_Extension|Adverse Event|2|||
126570161|NCT01580293|455383074|FG002|Part A_Extension|Adverse Event|0|||
126570162|NCT01580293|455383072|FG000|Part A_Extension|Withdrawal by Subject|0|||
126570163|NCT01580293|455383073|FG001|Part A_Extension|Withdrawal by Subject|3|||
126570164|NCT01580293|455383074|FG002|Part A_Extension|Withdrawal by Subject|0|||
126570165|NCT01580293|455383072|FG000|Part A_Extension|Lost to Follow-up|0|||
126570166|NCT01580293|455383073|FG001|Part A_Extension|Lost to Follow-up|1|||
126570167|NCT01580293|455383074|FG002|Part A_Extension|Lost to Follow-up|0|||
126570168|NCT01580293|455383072|FG000|Part A_Extension|Other Reason|0|||
126570169|NCT01580293|455383073|FG001|Part A_Extension|Other Reason|1|||
126570170|NCT01580293|455383074|FG002|Part A_Extension|Other Reason|0|||
126570171|NCT01580293|455383072|FG000|Part A_Extension|Completed Japan only|0|||
126570172|NCT01580293|455383073|FG001|Part A_Extension|Completed Japan only|5|||
126570173|NCT01580293|455383074|FG002|Part A_Extension|Completed Japan only|0|||
126570174|NCT01580293|455383072|FG000|Part B|Withdrawal by Subject|0|||
126570175|NCT01580293|455383073|FG001|Part B|Withdrawal by Subject|0|||
126570176|NCT01580293|455383074|FG002|Part B|Withdrawal by Subject|1|||
126570177|NCT01580293|455383072|FG000|Part B|Other reason|0|||
126570178|NCT01580293|455383073|FG001|Part B|Other reason|0|||
126570179|NCT01580293|455383074|FG002|Part B|Other reason|1|||
126570180|NCT00004124|455383075|FG000|Overall Study|Received no protocol therapy|12|||
126515462|NCT01257204|455182260|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
126727194|NCT00547378|455951074|FG001|All Implanted Cohort|Adverse Event|10|||
126727195|NCT00547378|455951075|FG002|All Implanted Cohort|Adverse Event|17|||
126727196|NCT00547378|455951073|FG000|All Implanted Cohort|Lost to Follow-up|0|||
126515463|NCT01257204|455182258|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
126515464|NCT01257204|455182259|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
126515465|NCT01257204|455182260|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
126515466|NCT01257204|455182258|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
126515467|NCT01257204|455182259|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
126515468|NCT01257204|455182260|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
126515469|NCT01257204|455182258|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
126515470|NCT01257204|455182259|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
126515471|NCT01257204|455182260|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
126515472|NCT01257204|455182258|FG000|Follow-up Period (up to Week 48)|Other|0|||
126515473|NCT01257204|455182259|FG001|Follow-up Period (up to Week 48)|Other|0|||
126515474|NCT01257204|455182260|FG002|Follow-up Period (up to Week 48)|Other|5|||
126515475|NCT00440271|455182265|FG000|Overall Study|Protocol Violation|1|||
126515476|NCT00440271|455182266|FG001|Overall Study|Protocol Violation|1|||
126515477|NCT00440271|455182265|FG000|Overall Study|Adverse Event|0|||
126515478|NCT00440271|455182266|FG001|Overall Study|Adverse Event|1|||
126515479|NCT00440271|455182265|FG000|Overall Study|Lost to Follow-up|1|||
126515480|NCT00440271|455182266|FG001|Overall Study|Lost to Follow-up|0|||
126515481|NCT00440271|455182265|FG000|Overall Study|Withdrawal by Subject|0|||
126515482|NCT00440271|455182266|FG001|Overall Study|Withdrawal by Subject|2|||
126515483|NCT00440271|455182265|FG000|Overall Study|Lack of Efficacy|0|||
126515484|NCT00440271|455182266|FG001|Overall Study|Lack of Efficacy|1|||
126515485|NCT00440271|455182265|FG000|Overall Study|Due to closure of trial|8|||
126515486|NCT00440271|455182266|FG001|Overall Study|Due to closure of trial|10|||
126515487|NCT00440271|455182265|FG000|Overall Study|Other|2|||
126515488|NCT00440271|455182266|FG001|Overall Study|Other|0|||
126515489|NCT00723801|455182267|FG000|Overall Study|Lost to Follow-up|1|||
126515490|NCT00723801|455182268|FG001|Overall Study|Lost to Follow-up|2|||
126515491|NCT00723801|455182267|FG000|Overall Study|Protocol Violation|2|||
126515492|NCT00723801|455182268|FG001|Overall Study|Protocol Violation|1|||
126515493|NCT01565993|455182276|FG000|Overall Study|Physician Decision|0|||
126515494|NCT01565993|455182277|FG001|Overall Study|Physician Decision|3|||
126515495|NCT01824303|455182278|FG000|Randomized Study|Withdrawal by Subject|1|||
126515496|NCT01824303|455182279|FG001|Randomized Study|Withdrawal by Subject|1|||
126515497|NCT01824303|455182278|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
126515498|NCT01824303|455182279|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
126515499|NCT04086472|455182280|FG000|Overall Study|Lost to Follow-up|1|||
126515500|NCT04086472|455182281|FG001|Overall Study|Lost to Follow-up|0|||
126515501|NCT04086472|455182282|FG002|Overall Study|Lost to Follow-up|0|||
126515502|NCT04086472|455182283|FG003|Overall Study|Lost to Follow-up|0|||
126515503|NCT04086472|455182284|FG004|Overall Study|Lost to Follow-up|1|||
126515504|NCT04086472|455182280|FG000|Overall Study|Physician Decision|0|||
126515505|NCT04086472|455182281|FG001|Overall Study|Physician Decision|1|||
126515506|NCT04086472|455182282|FG002|Overall Study|Physician Decision|1|||
126515507|NCT04086472|455182283|FG003|Overall Study|Physician Decision|0|||
126515508|NCT04086472|455182284|FG004|Overall Study|Physician Decision|0|||
126515509|NCT04086472|455182280|FG000|Overall Study|Withdrawal by Subject|1|||
126515510|NCT04086472|455182281|FG001|Overall Study|Withdrawal by Subject|1|||
126515511|NCT04086472|455182282|FG002|Overall Study|Withdrawal by Subject|1|||
126515512|NCT04086472|455182283|FG003|Overall Study|Withdrawal by Subject|0|||
126515513|NCT04086472|455182284|FG004|Overall Study|Withdrawal by Subject|0|||
126515514|NCT04086472|455182280|FG000|Overall Study|Various reasons|2|||
126515515|NCT04086472|455182281|FG001|Overall Study|Various reasons|0|||
126515516|NCT04086472|455182282|FG002|Overall Study|Various reasons|0|||
126515517|NCT04086472|455182283|FG003|Overall Study|Various reasons|3|||
126515518|NCT04086472|455182284|FG004|Overall Study|Various reasons|1|||
126515519|NCT00048724|455182285|FG000|Overall Study|Adverse Event|53|||
126515520|NCT00048724|455182286|FG001|Overall Study|Adverse Event|12|||
126515521|NCT00048724|455182285|FG000|Overall Study|Withdrawal by Subject|34|||
126515522|NCT00048724|455182286|FG001|Overall Study|Withdrawal by Subject|54|||
126515523|NCT00048724|455182285|FG000|Overall Study|Lost to Follow-up|5|||
126515524|NCT00048724|455182286|FG001|Overall Study|Lost to Follow-up|5|||
126515525|NCT00048724|455182285|FG000|Overall Study|Protocol-defined Clinical Event|17|||
126515526|NCT00048724|455182286|FG001|Overall Study|Protocol-defined Clinical Event|32|||
126727197|NCT00547378|455951074|FG001|All Implanted Cohort|Lost to Follow-up|1|||
126727198|NCT00547378|455951075|FG002|All Implanted Cohort|Lost to Follow-up|14|||
126515527|NCT00048724|455182285|FG000|Overall Study|Noncompliance With Protocol|4|||
126515528|NCT00048724|455182286|FG001|Overall Study|Noncompliance With Protocol|12|||
126515529|NCT00048724|455182285|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
126515530|NCT00048724|455182286|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
126515531|NCT00048724|455182285|FG000|Overall Study|Administrative|1|||
126515532|NCT00048724|455182286|FG001|Overall Study|Administrative|1|||
126570181|NCT00004124|455383076|FG001|Overall Study|Received no protocol therapy|20|||
126570182|NCT00446550|455383078|FG000|Overall Study|Adverse Event|1|||
126570183|NCT00446550|455383079|FG001|Overall Study|Adverse Event|0|||
126570184|NCT02937831|455383080|FG000|Overall Study|Protocol Violation|4|||
126570185|NCT02983617|455383083|FG000|Overall Study|Adverse Event|0|||
126570186|NCT02983617|455383084|FG001|Overall Study|Adverse Event|7|||
126570187|NCT02983617|455383083|FG000|Overall Study|Death|0|||
126570188|NCT02983617|455383084|FG001|Overall Study|Death|1|||
126570189|NCT02983617|455383083|FG000|Overall Study|Investigator's Discretion|0|||
126570190|NCT02983617|455383084|FG001|Overall Study|Investigator's Discretion|1|||
126570191|NCT03720210|455383087|FG000|Overall Study|Lost to Follow-up|1|||
126570192|NCT00516386|455383092|FG000|Overall Study|not interested in the study|4|||
126570193|NCT00516386|455383092|FG000|Overall Study|Lost to Follow-up|2|||
126570194|NCT02698891|455383093|FG000|Overall Study|Withdrawal by Subject|2|||
126570195|NCT02698891|455383093|FG000|Overall Study|deemed ineligible|1|||
126570196|NCT02698891|455383093|FG000|Overall Study|Adverse Event|9|||
126570197|NCT00114244|455383094|FG000|Overall Study|Adverse Event|2|||
126570198|NCT00114244|455383095|FG001|Overall Study|Adverse Event|5|||
126570199|NCT00114244|455383094|FG000|Overall Study|Withdrawal by Subject|0|||
126570200|NCT00114244|455383095|FG001|Overall Study|Withdrawal by Subject|2|||
126570201|NCT00711958|455383096|FG000|Overall Study|Withdrawal by Subject|6|||
126570202|NCT00711958|455383097|FG001|Overall Study|Withdrawal by Subject|8|||
126570203|NCT00711958|455383096|FG000|Overall Study|Lack of Efficacy|3|||
126570204|NCT00711958|455383097|FG001|Overall Study|Lack of Efficacy|1|||
126570205|NCT00711958|455383096|FG000|Overall Study|Clinical deterioration|1|||
126570206|NCT00711958|455383097|FG001|Overall Study|Clinical deterioration|0|||
126570207|NCT00711958|455383096|FG000|Overall Study|Adverse Event|9|||
126570208|NCT00711958|455383097|FG001|Overall Study|Adverse Event|7|||
126570209|NCT00711958|455383096|FG000|Overall Study|Protocol Violation|1|||
126570210|NCT00711958|455383097|FG001|Overall Study|Protocol Violation|0|||
126570211|NCT00711958|455383096|FG000|Overall Study|Lost to Follow-up|2|||
126570212|NCT00711958|455383097|FG001|Overall Study|Lost to Follow-up|2|||
126570213|NCT00711958|455383096|FG000|Overall Study|Death|10|||
126570214|NCT00711958|455383097|FG001|Overall Study|Death|5|||
126570215|NCT00711958|455383096|FG000|Overall Study|Progression of disease|1|||
126570216|NCT00711958|455383097|FG001|Overall Study|Progression of disease|0|||
126570217|NCT02694978|455383100|FG000|Overall Study|Adverse Event|10|||
126570218|NCT02694978|455383101|FG001|Overall Study|Adverse Event|9|||
126570219|NCT02694978|455383100|FG000|Overall Study|Withdrawal by Subject|22|||
126570220|NCT02694978|455383101|FG001|Overall Study|Withdrawal by Subject|19|||
126570221|NCT02694978|455383100|FG000|Overall Study|Lost to Follow-up|14|||
126570222|NCT02694978|455383101|FG001|Overall Study|Lost to Follow-up|17|||
126570223|NCT02694978|455383100|FG000|Overall Study|Death|4|||
126570224|NCT02694978|455383101|FG001|Overall Study|Death|1|||
126570225|NCT02694978|455383100|FG000|Overall Study|Other-Decision of Participant|6|||
126570226|NCT02694978|455383101|FG001|Overall Study|Other-Decision of Participant|1|||
126570227|NCT02694978|455383100|FG000|Overall Study|Other-Investigator's decision|1|||
126570228|NCT02694978|455383101|FG001|Overall Study|Other-Investigator's decision|0|||
126570229|NCT02694978|455383100|FG000|Overall Study|Other-Unable to be reached|0|||
126570230|NCT02694978|455383101|FG001|Overall Study|Other-Unable to be reached|1|||
126570231|NCT02694978|455383100|FG000|Overall Study|Other-Protocol noncompliant|2|||
126570232|NCT02694978|455383101|FG001|Overall Study|Other-Protocol noncompliant|1|||
126570233|NCT02694978|455383100|FG000|Overall Study|Other-Personal reasons|3|||
126570234|NCT02694978|455383101|FG001|Overall Study|Other-Personal reasons|3|||
126570235|NCT02694978|455383100|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
126570236|NCT02694978|455383101|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
126570237|NCT00818454|455383102|FG000|Treatment Period 1|Adverse Event|0|||
126570238|NCT00818454|455383103|FG001|Treatment Period 1|Adverse Event|1|||
126570239|NCT00818454|455383104|FG002|Treatment Period 1|Adverse Event|0|||
126570240|NCT00818454|455383105|FG003|Treatment Period 1|Adverse Event|0|||
126570241|NCT00818454|455383102|FG000|Treatment Period 1|Other|3|||
126570242|NCT00818454|455383103|FG001|Treatment Period 1|Other|0|||
126570243|NCT00818454|455383104|FG002|Treatment Period 1|Other|0|||
126570244|NCT00818454|455383105|FG003|Treatment Period 1|Other|0|||
126570245|NCT00818454|455383102|FG000|Washout Period of 1 Week|Adverse Event|1|||
126570246|NCT00818454|455383103|FG001|Washout Period of 1 Week|Adverse Event|1|||
126570247|NCT00818454|455383104|FG002|Washout Period of 1 Week|Adverse Event|0|||
126570248|NCT00818454|455383105|FG003|Washout Period of 1 Week|Adverse Event|0|||
126570249|NCT00818454|455383102|FG000|Washout Period of 1 Week|Protocol Violation|2|||
126570250|NCT00818454|455383103|FG001|Washout Period of 1 Week|Protocol Violation|0|||
126570251|NCT00818454|455383104|FG002|Washout Period of 1 Week|Protocol Violation|0|||
126570252|NCT00818454|455383105|FG003|Washout Period of 1 Week|Protocol Violation|0|||
126570253|NCT00818454|455383102|FG000|Washout Period of 1 Week|Other|1|||
126570254|NCT00818454|455383103|FG001|Washout Period of 1 Week|Other|2|||
126570255|NCT00818454|455383104|FG002|Washout Period of 1 Week|Other|0|||
126570256|NCT00818454|455383105|FG003|Washout Period of 1 Week|Other|0|||
126570257|NCT00818454|455383102|FG000|Treatment Period 2|Other|2|||
126570258|NCT00818454|455383103|FG001|Treatment Period 2|Other|1|||
126570259|NCT00818454|455383104|FG002|Treatment Period 2|Other|0|||
126570260|NCT00818454|455383105|FG003|Treatment Period 2|Other|0|||
126570261|NCT00818454|455383102|FG000|Treatment Period 3|Adverse Event|0|||
126570262|NCT00818454|455383103|FG001|Treatment Period 3|Adverse Event|0|||
126570263|NCT00818454|455383104|FG002|Treatment Period 3|Adverse Event|0|||
126570264|NCT00818454|455383105|FG003|Treatment Period 3|Adverse Event|1|||
126570265|NCT01613716|455383106|FG000|Overall Study|screen failures|3|||
126570266|NCT01613716|455383106|FG000|Overall Study|Lost to Follow-up|4|||
126570267|NCT01171625|455383108|FG000|Overall Study|On-Protocol|67|||
126570268|NCT01171625|455383108|FG000|Overall Study|Death|38|||
126570269|NCT01171625|455383108|FG000|Overall Study|Withdrawal by Subject|31|||
126570270|NCT01171625|455383108|FG000|Overall Study|Explanted|10|||
126570271|NCT01171625|455383108|FG000|Overall Study|Lost to Follow-up|5|||
126570272|NCT01171625|455383108|FG000|Overall Study|Patient received valve-in-valve|3|||
126570273|NCT01171625|455383108|FG000|Overall Study|Other|1|||
126570274|NCT01171625|455383108|FG000|Overall Study|Consented but did not receive device|25|||
126570275|NCT03287622|455383115|FG000|Overall Study|Withdrawal by Subject|1|||
126570276|NCT03287622|455383116|FG001|Overall Study|Withdrawal by Subject|0|||
126570277|NCT03287622|455383115|FG000|Overall Study|Lost to Follow-up|27|||
126570278|NCT03287622|455383116|FG001|Overall Study|Lost to Follow-up|15|||
126570279|NCT03287622|455383115|FG000|Overall Study|No prescripion after surgery|28|||
126570280|NCT03287622|455383116|FG001|Overall Study|No prescripion after surgery|31|||
126570281|NCT03287622|455383115|FG000|Overall Study|prolonged Length of stay|2|||
126570282|NCT03287622|455383116|FG001|Overall Study|prolonged Length of stay|0|||
126570283|NCT03287622|455383115|FG000|Overall Study|surgery related|0|||
126570284|NCT03287622|455383116|FG001|Overall Study|surgery related|2|||
126570285|NCT03823300|455383117|FG000|Overall Study|Withdrawal by Subject|16|||
126570286|NCT03823300|455383118|FG001|Overall Study|Withdrawal by Subject|22|||
126570287|NCT03823300|455383117|FG000|Overall Study|Death|10|||
126570288|NCT03823300|455383118|FG001|Overall Study|Death|14|||
126570289|NCT03823300|455383117|FG000|Overall Study|Adverse Event|3|||
126570290|NCT03823300|455383118|FG001|Overall Study|Adverse Event|5|||
126570291|NCT03823300|455383117|FG000|Overall Study|Physician Decision|1|||
126570292|NCT03823300|455383118|FG001|Overall Study|Physician Decision|7|||
126570293|NCT03823300|455383117|FG000|Overall Study|Lost to Follow-up|1|||
126570294|NCT03823300|455383118|FG001|Overall Study|Lost to Follow-up|3|||
126570295|NCT03823300|455383117|FG000|Overall Study|Protocol Violation|1|||
126570296|NCT03823300|455383118|FG001|Overall Study|Protocol Violation|1|||
126570297|NCT03823300|455383117|FG000|Overall Study|Lack of Efficacy|1|||
126570298|NCT03823300|455383118|FG001|Overall Study|Lack of Efficacy|1|||
126570299|NCT03823300|455383117|FG000|Overall Study|Not Eligible|0|||
126570300|NCT03823300|455383118|FG001|Overall Study|Not Eligible|1|||
126570301|NCT03823300|455383117|FG000|Overall Study|Other|1|||
126570302|NCT03823300|455383118|FG001|Overall Study|Other|0|||
126570303|NCT00139737|455383126|FG000|Overall Study|Withdrawal by Subject|190|||
126570304|NCT00139737|455383126|FG000|Overall Study|Adverse Event|58|||
126570305|NCT00139737|455383126|FG000|Overall Study|Lack of Efficacy|40|||
126570306|NCT00139737|455383126|FG000|Overall Study|Lost to Follow-up|8|||
126570307|NCT00139737|455383126|FG000|Overall Study|Death|3|||
126570308|NCT00139737|455383126|FG000|Overall Study|Laboratory Abnormality|2|||
126570309|NCT00139737|455383126|FG000|Overall Study|Protocol Violation|18|||
126570310|NCT00139737|455383126|FG000|Overall Study|Withdrew During Screening Phase|8|||
126570311|NCT00139737|455383126|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
126570312|NCT00139737|455383126|FG000|Overall Study|Screened, Not Treated|13|||
126570313|NCT03460756|455383127|FG000|Overall Study|Adverse Event|0|||
126570314|NCT03460756|455383128|FG001|Overall Study|Adverse Event|0|||
126570315|NCT03460756|455383129|FG002|Overall Study|Adverse Event|0|||
126570316|NCT03460756|455383130|FG003|Overall Study|Adverse Event|1|||
126570317|NCT03460756|455383127|FG000|Overall Study|Lack of Efficacy|0|||
126570318|NCT03460756|455383128|FG001|Overall Study|Lack of Efficacy|0|||
126570319|NCT03460756|455383129|FG002|Overall Study|Lack of Efficacy|0|||
126570320|NCT03460756|455383130|FG003|Overall Study|Lack of Efficacy|2|||
126570321|NCT03460756|455383127|FG000|Overall Study|Lost to Follow-up|0|||
126570322|NCT03460756|455383128|FG001|Overall Study|Lost to Follow-up|1|||
126570323|NCT03460756|455383129|FG002|Overall Study|Lost to Follow-up|2|||
126570324|NCT03460756|455383130|FG003|Overall Study|Lost to Follow-up|1|||
126570325|NCT03460756|455383127|FG000|Overall Study|Pregnancy|0|||
126570326|NCT03460756|455383128|FG001|Overall Study|Pregnancy|0|||
126570327|NCT03460756|455383129|FG002|Overall Study|Pregnancy|0|||
126570328|NCT03460756|455383130|FG003|Overall Study|Pregnancy|1|||
126570329|NCT03460756|455383127|FG000|Overall Study|Protocol Violation|0|||
126570330|NCT03460756|455383128|FG001|Overall Study|Protocol Violation|0|||
126570331|NCT03460756|455383129|FG002|Overall Study|Protocol Violation|0|||
126570332|NCT03460756|455383130|FG003|Overall Study|Protocol Violation|1|||
126570333|NCT03460756|455383127|FG000|Overall Study|Withdrawal by Subject|0|||
126570334|NCT03460756|455383128|FG001|Overall Study|Withdrawal by Subject|4|||
126570335|NCT03460756|455383129|FG002|Overall Study|Withdrawal by Subject|7|||
126570336|NCT03460756|455383130|FG003|Overall Study|Withdrawal by Subject|3|||
126570337|NCT03987451|455383131|FG000|Overall Study|Lost to Follow-up|1|||
126570338|NCT03987451|455383132|FG001|Overall Study|Lost to Follow-up|0|||
126570339|NCT03987451|455383131|FG000|Overall Study|Withdrawal by Subject|1|||
126570340|NCT03987451|455383132|FG001|Overall Study|Withdrawal by Subject|1|||
126570341|NCT02441036|455383135|FG000|Overall Study|No tissue resected|0|||
126570342|NCT02441036|455383136|FG001|Overall Study|No tissue resected|1|||
126515533|NCT00844545|455182287|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
126515534|NCT00844545|455182287|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
126570343|NCT02441036|455383137|FG002|Overall Study|No tissue resected|0|||
126570344|NCT02441036|455383138|FG003|Overall Study|No tissue resected|1|||
126570345|NCT02441036|455383139|FG004|Overall Study|No tissue resected|0|||
126570346|NCT01194154|455383141|FG000|Overall Study|Adverse Event|12|||
126570347|NCT01194154|455383142|FG001|Overall Study|Adverse Event|7|||
126570348|NCT01194154|455383141|FG000|Overall Study|Lost to Follow-up|2|||
126570349|NCT01194154|455383142|FG001|Overall Study|Lost to Follow-up|3|||
126570350|NCT01194154|455383141|FG000|Overall Study|Protocol Violation|0|||
126570351|NCT01194154|455383142|FG001|Overall Study|Protocol Violation|1|||
126570352|NCT01194154|455383141|FG000|Overall Study|Withdrawal by Subject|5|||
126570353|NCT01194154|455383142|FG001|Overall Study|Withdrawal by Subject|6|||
126570354|NCT01194154|455383141|FG000|Overall Study|Blood pressure increase|5|||
126570355|NCT01194154|455383142|FG001|Overall Study|Blood pressure increase|3|||
126570356|NCT01194154|455383141|FG000|Overall Study|Hemoglobin decrease|0|||
126570357|NCT01194154|455383142|FG001|Overall Study|Hemoglobin decrease|1|||
126570358|NCT01194154|455383141|FG000|Overall Study|Hemoglobin increase|12|||
126570359|NCT01194154|455383142|FG001|Overall Study|Hemoglobin increase|3|||
126570360|NCT01194154|455383141|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
126570361|NCT01194154|455383142|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
126570362|NCT01194154|455383141|FG000|Overall Study|Treatment with prohibited medication|4|||
126570363|NCT01194154|455383142|FG001|Overall Study|Treatment with prohibited medication|5|||
126570364|NCT01194154|455383141|FG000|Overall Study|Other|4|||
126570365|NCT01194154|455383142|FG001|Overall Study|Other|0|||
126570366|NCT01194154|455383141|FG000|Overall Study|Did not receive study medication|2|||
126570367|NCT01194154|455383142|FG001|Overall Study|Did not receive study medication|4|||
126570368|NCT02314117|455383143|FG000|Overall Study|Lost to Follow-up|9|||
126570369|NCT02314117|455383144|FG001|Overall Study|Lost to Follow-up|14|||
126570370|NCT02314117|455383143|FG000|Overall Study|Withdrawal by Subject|3|||
126570371|NCT02314117|455383144|FG001|Overall Study|Withdrawal by Subject|2|||
126570372|NCT02026258|455383145|FG000|Randomized|Did not start treatment|2|||
126570373|NCT02026258|455383146|FG001|Randomized|Did not start treatment|1|||
126570374|NCT02026258|455383145|FG000|Randomized|Change in treatment plan|1|||
126570375|NCT02026258|455383146|FG001|Randomized|Change in treatment plan|0|||
126570376|NCT02026258|455383145|FG000|Randomized|Presence of periodontal disease|1|||
126570377|NCT02026258|455383146|FG001|Randomized|Presence of periodontal disease|1|||
126570378|NCT02026258|455383145|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
126570379|NCT02026258|455383146|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
126570380|NCT02026258|455383145|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
126570381|NCT02026258|455383146|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
126570382|NCT02534350|455383147|FG000|Overall Study|Randomized But Not Treated|1|||
126570383|NCT02534350|455383148|FG001|Overall Study|Randomized But Not Treated|0|||
126515535|NCT00844545|455182287|FG000|Extension Treatment Period|Adverse Event|2|||
126515536|NCT00844545|455182287|FG000|Post Treatment Period|Withdrawal by Subject|1|||
126515537|NCT01743092|455182288|FG000|Overall Study|Lost to Follow-up|14|||
126515538|NCT01743092|455182289|FG001|Overall Study|Lost to Follow-up|15|||
126515539|NCT03586869|455182295|FG000|Overall Study|Progressive Disease|3|||
126515540|NCT00403455|455182296|FG000|Overall Study|Withdrawal by Subject|1|||
126515541|NCT02809976|455182305|FG000|Overall Study|Lost to Follow-up|1|||
126515542|NCT02809976|455182305|FG000|Overall Study|Withdrawal by Subject|1|||
126515543|NCT00087568|455182306|FG000|Overall Study|Adverse Event|4|||
126515544|NCT00087568|455182307|FG001|Overall Study|Adverse Event|0|||
126515545|NCT00087568|455182306|FG000|Overall Study|Withdrawal by Subject|1|||
126515546|NCT00087568|455182307|FG001|Overall Study|Withdrawal by Subject|1|||
126515547|NCT00087568|455182306|FG000|Overall Study|Lost to Follow-up|1|||
126515548|NCT00087568|455182307|FG001|Overall Study|Lost to Follow-up|0|||
126515549|NCT00087568|455182306|FG000|Overall Study|Lack of Efficacy|24|||
126570384|NCT02534350|455383147|FG000|Overall Study|Protocol Violation|1|||
126570385|NCT02534350|455383148|FG001|Overall Study|Protocol Violation|0|||
126570386|NCT02534350|455383147|FG000|Overall Study|Withdrew Consent|2|||
126515550|NCT00087568|455182307|FG001|Overall Study|Lack of Efficacy|1|||
126515551|NCT04394351|455182308|FG000|Part A (16 Weeks)|Adverse Event|1|||
126515552|NCT04394351|455182309|FG001|Part A (16 Weeks)|Adverse Event|0|||
126515553|NCT04394351|455182310|FG002|Part A (16 Weeks)|Adverse Event|0|||
126515554|NCT04394351|455182311|FG003|Part A (16 Weeks)|Adverse Event|0|||
126570387|NCT02534350|455383148|FG001|Overall Study|Withdrew Consent|0|||
126515555|NCT04394351|455182312|FG004|Part A (16 Weeks)|Adverse Event|0|||
126570388|NCT02954848|455383153|FG000|Overall Study|Randomized but Not Treated|0|||
126570389|NCT02954848|455383154|FG001|Overall Study|Randomized but Not Treated|1|||
126570390|NCT02954848|455383153|FG000|Overall Study|Adverse Event|2|||
126570391|NCT02954848|455383154|FG001|Overall Study|Adverse Event|3|||
126570392|NCT02954848|455383153|FG000|Overall Study|Withdrawal by Participant|0|||
126515556|NCT04394351|455182313|FG005|Part A (16 Weeks)|Adverse Event|0|||
126570393|NCT02954848|455383154|FG001|Overall Study|Withdrawal by Participant|1|||
126570394|NCT01069341|455383155|FG000|Overall Study|Lost to Follow-up|1|||
126570395|NCT00922207|455383156|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
126570396|NCT00922207|455383157|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
126570397|NCT00922207|455383158|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
126570398|NCT00922207|455383156|FG000|Overall Study|Insufficient Therapeutic Response|0|||
126570399|NCT00922207|455383157|FG001|Overall Study|Insufficient Therapeutic Response|0|||
126570400|NCT00922207|455383158|FG002|Overall Study|Insufficient Therapeutic Response|1|||
126570401|NCT00922207|455383156|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
126570402|NCT00922207|455383157|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
126570403|NCT00922207|455383158|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
126570404|NCT00922207|455383156|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
126570405|NCT00922207|455383157|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
126570406|NCT00922207|455383158|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
126570407|NCT00922207|455383156|FG000|Overall Study|Withdrew Consent|2|||
126570408|NCT00922207|455383157|FG001|Overall Study|Withdrew Consent|5|||
126570409|NCT00922207|455383158|FG002|Overall Study|Withdrew Consent|2|||
126570410|NCT00922207|455383156|FG000|Overall Study|Abnormality of Laboratory Test|0|||
126570411|NCT00922207|455383157|FG001|Overall Study|Abnormality of Laboratory Test|1|||
126570412|NCT00922207|455383158|FG002|Overall Study|Abnormality of Laboratory Test|1|||
126570413|NCT01802632|455383159|FG000|Overall Study|Death|28|||
126570414|NCT01802632|455383160|FG001|Overall Study|Death|1|||
126570415|NCT01802632|455383161|FG002|Overall Study|Death|38|||
126570416|NCT01802632|455383162|FG003|Overall Study|Death|0|||
126570417|NCT01802632|455383163|FG004|Overall Study|Death|2|||
126570418|NCT01802632|455383164|FG005|Overall Study|Death|0|||
126570419|NCT01802632|455383159|FG000|Overall Study|Withdrawal by Subject|4|||
126570420|NCT01802632|455383160|FG001|Overall Study|Withdrawal by Subject|2|||
126570421|NCT01802632|455383161|FG002|Overall Study|Withdrawal by Subject|7|||
126570422|NCT01802632|455383162|FG003|Overall Study|Withdrawal by Subject|3|||
126570423|NCT01802632|455383163|FG004|Overall Study|Withdrawal by Subject|0|||
126570424|NCT01802632|455383164|FG005|Overall Study|Withdrawal by Subject|1|||
126570425|NCT01802632|455383159|FG000|Overall Study|Objective Disease Progression|1|||
126570426|NCT01802632|455383160|FG001|Overall Study|Objective Disease Progression|12|||
126570427|NCT01802632|455383161|FG002|Overall Study|Objective Disease Progression|104|||
126570428|NCT01802632|455383162|FG003|Overall Study|Objective Disease Progression|6|||
126570429|NCT01802632|455383163|FG004|Overall Study|Objective Disease Progression|4|||
126570430|NCT01802632|455383164|FG005|Overall Study|Objective Disease Progression|4|||
126570431|NCT01802632|455383159|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
126570432|NCT01802632|455383160|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
126570433|NCT01802632|455383161|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
126570434|NCT01802632|455383162|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
126570435|NCT01802632|455383163|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
126570436|NCT01802632|455383164|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
126570437|NCT01802632|455383159|FG000|Overall Study|Other (not specified)|0|||
126570438|NCT01802632|455383160|FG001|Overall Study|Other (not specified)|0|||
126570439|NCT01802632|455383161|FG002|Overall Study|Other (not specified)|7|||
126570440|NCT01802632|455383162|FG003|Overall Study|Other (not specified)|1|||
126570441|NCT01802632|455383163|FG004|Overall Study|Other (not specified)|0|||
126570442|NCT01802632|455383164|FG005|Overall Study|Other (not specified)|1|||
126570443|NCT02880241|455383177|FG000|Overall Study|Lack of Efficacy|1|||
126570444|NCT02880241|455383178|FG001|Overall Study|Lack of Efficacy|0|||
126570445|NCT02880241|455383179|FG002|Overall Study|Lack of Efficacy|0|||
126570446|NCT02880241|455383180|FG003|Overall Study|Lack of Efficacy|0|||
126570447|NCT02880241|455383181|FG004|Overall Study|Lack of Efficacy|0|||
126570448|NCT02880241|455383182|FG005|Overall Study|Lack of Efficacy|0|||
126570449|NCT02705586|455383184|FG000|Overall Study|Health Issues|2|||
126727199|NCT00547378|455951073|FG000|All Implanted Cohort|Death|3|||
126727200|NCT00547378|455951074|FG001|All Implanted Cohort|Death|1|||
126727201|NCT00547378|455951075|FG002|All Implanted Cohort|Death|4|||
126727202|NCT00547378|455951073|FG000|All Implanted Cohort|Physician Decision|0|||
126727203|NCT00547378|455951074|FG001|All Implanted Cohort|Physician Decision|2|||
126570450|NCT02705586|455383184|FG000|Overall Study|Transportation Difficulties|5|||
126570451|NCT02705586|455383184|FG000|Overall Study|Vacation/Planned Absence|1|||
126570452|NCT03920215|455383189|FG000|Overall Study|Lost to Follow-up|1|||
126570453|NCT03920215|455383190|FG001|Overall Study|Lost to Follow-up|2|||
126570454|NCT03920215|455383191|FG002|Overall Study|Lost to Follow-up|0|||
126570455|NCT03920215|455383192|FG003|Overall Study|Lost to Follow-up|0|||
126570456|NCT03920215|455383189|FG000|Overall Study|Death|0|||
126570457|NCT03920215|455383190|FG001|Overall Study|Death|0|||
126570458|NCT03920215|455383191|FG002|Overall Study|Death|0|||
126727204|NCT00547378|455951075|FG002|All Implanted Cohort|Physician Decision|6|||
126570459|NCT03920215|455383192|FG003|Overall Study|Death|1|||
126570460|NCT02000817|455383193|FG000|Overall Study|Withdrawal by Subject|2|||
126570461|NCT02000817|455383194|FG001|Overall Study|Withdrawal by Subject|0|||
126570462|NCT02000817|455383195|FG002|Overall Study|Withdrawal by Subject|0|||
126570463|NCT02000817|455383196|FG003|Overall Study|Withdrawal by Subject|0|||
126570464|NCT02000817|455383193|FG000|Overall Study|Adverse Event|0|||
126570465|NCT02000817|455383194|FG001|Overall Study|Adverse Event|1|||
126570466|NCT02000817|455383195|FG002|Overall Study|Adverse Event|0|||
126570467|NCT02000817|455383196|FG003|Overall Study|Adverse Event|0|||
126570468|NCT02000817|455383193|FG000|Overall Study|Lost to Follow-up|0|||
126570469|NCT02000817|455383194|FG001|Overall Study|Lost to Follow-up|0|||
126570470|NCT02000817|455383195|FG002|Overall Study|Lost to Follow-up|1|||
126570471|NCT02000817|455383196|FG003|Overall Study|Lost to Follow-up|0|||
126570472|NCT00823979|455383199|FG000|Overall Study|Lack of Efficacy|13|||
126570473|NCT00823979|455383200|FG001|Overall Study|Lack of Efficacy|16|||
126570474|NCT00823979|455383201|FG002|Overall Study|Lack of Efficacy|9|||
126570475|NCT00823979|455383199|FG000|Overall Study|Lost to Follow-up|2|||
126570476|NCT00823979|455383200|FG001|Overall Study|Lost to Follow-up|1|||
126570477|NCT00823979|455383201|FG002|Overall Study|Lost to Follow-up|0|||
126570478|NCT00823979|455383199|FG000|Overall Study|Withdrawal by Subject|2|||
126570479|NCT00823979|455383200|FG001|Overall Study|Withdrawal by Subject|3|||
126570480|NCT00823979|455383201|FG002|Overall Study|Withdrawal by Subject|2|||
126570481|NCT00823979|455383199|FG000|Overall Study|Protocol Violation|1|||
126570482|NCT00823979|455383200|FG001|Overall Study|Protocol Violation|1|||
126570483|NCT00823979|455383201|FG002|Overall Study|Protocol Violation|0|||
126570484|NCT00823979|455383199|FG000|Overall Study|Pregnancy|0|||
126570485|NCT00823979|455383200|FG001|Overall Study|Pregnancy|1|||
126570486|NCT00823979|455383201|FG002|Overall Study|Pregnancy|0|||
126570487|NCT00823979|455383199|FG000|Overall Study|Adverse Event|0|||
126570488|NCT00823979|455383200|FG001|Overall Study|Adverse Event|2|||
126570489|NCT00823979|455383201|FG002|Overall Study|Adverse Event|4|||
126570490|NCT00823979|455383199|FG000|Overall Study|Other|2|||
126570491|NCT00823979|455383200|FG001|Overall Study|Other|0|||
126570492|NCT00823979|455383201|FG002|Overall Study|Other|1|||
126570493|NCT00823979|455383199|FG000|Overall Study|Randomized but not Treated|4|||
126570494|NCT00823979|455383200|FG001|Overall Study|Randomized but not Treated|3|||
126570495|NCT00823979|455383201|FG002|Overall Study|Randomized but not Treated|1|||
126570496|NCT00823979|455383199|FG000|Overall Study|Study Terminated by Sponsor|5|||
126570497|NCT00823979|455383200|FG001|Overall Study|Study Terminated by Sponsor|5|||
126570498|NCT00823979|455383201|FG002|Overall Study|Study Terminated by Sponsor|7|||
126570499|NCT03586544|455383202|FG000|First Intervention|Adverse Event|0|||
126570500|NCT03586544|455383203|FG001|First Intervention|Adverse Event|1|||
126570501|NCT03586544|455383202|FG000|Second Intervention|Withdrawal by Subject|0|||
126570502|NCT03586544|455383203|FG001|Second Intervention|Withdrawal by Subject|1|||
126570503|NCT03523091|455383204|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
126570504|NCT03523091|455383205|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
126570505|NCT03523091|455383204|FG000|Overall Study|Withdrawal by Subject|0|||
126570506|NCT03523091|455383205|FG001|Overall Study|Withdrawal by Subject|3|||
126570507|NCT03523091|455383204|FG000|Overall Study|Increase Botox dose|0|||
126570508|NCT03523091|455383205|FG001|Overall Study|Increase Botox dose|1|||
126570509|NCT03863834|455383211|FG000|Overall Study|Lost to Follow-up|3|||
126570510|NCT02685488|455383212|FG000|Overall Study|Withdrawal by Subject|0|||
126570511|NCT02685488|455383213|FG001|Overall Study|Withdrawal by Subject|1|||
126570512|NCT00324038|455383214|FG000|Overall Study|Adverse Event|38|||
126570513|NCT00324038|455383215|FG001|Overall Study|Adverse Event|23|||
126570514|NCT00324038|455383214|FG000|Overall Study|Lack of Efficacy|5|||
126570515|NCT00324038|455383215|FG001|Overall Study|Lack of Efficacy|13|||
126570516|NCT00324038|455383214|FG000|Overall Study|Lost to Follow-up|0|||
126570517|NCT00324038|455383215|FG001|Overall Study|Lost to Follow-up|2|||
126570518|NCT00324038|455383214|FG000|Overall Study|Other|6|||
126570519|NCT00324038|455383215|FG001|Overall Study|Other|13|||
126570520|NCT02770248|455383216|FG000|Overall Study|Adverse Event|0|||
126570521|NCT02770248|455383217|FG001|Overall Study|Adverse Event|1|||
126570522|NCT02770248|455383216|FG000|Overall Study|Randomized in error, prior to treatment|0|||
126570523|NCT02770248|455383217|FG001|Overall Study|Randomized in error, prior to treatment|1|||
126570524|NCT03768206|455383220|FG000|Overall Study|Lost to Follow-up|2|||
126570525|NCT03768206|455383221|FG001|Overall Study|Lost to Follow-up|1|||
126570526|NCT03768206|455383220|FG000|Overall Study|Withdrawal by Subject|0|||
126570527|NCT03768206|455383221|FG001|Overall Study|Withdrawal by Subject|1|||
126570528|NCT04493242|455383222|FG000|Overall Study|Death|10|||
126570529|NCT04493242|455383223|FG001|Overall Study|Death|14|||
126570530|NCT04493242|455383224|FG002|Overall Study|Death|16|||
126570531|NCT04493242|455383222|FG000|Overall Study|Lost to Follow-up|1|||
126570532|NCT04493242|455383223|FG001|Overall Study|Lost to Follow-up|1|||
126570533|NCT04493242|455383224|FG002|Overall Study|Lost to Follow-up|0|||
126570534|NCT04493242|455383222|FG000|Overall Study|Withdrawal by Subject|1|||
126570535|NCT04493242|455383223|FG001|Overall Study|Withdrawal by Subject|0|||
126570536|NCT04493242|455383224|FG002|Overall Study|Withdrawal by Subject|0|||
126570537|NCT04493242|455383222|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
126570538|NCT04493242|455383223|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
126570539|NCT04493242|455383224|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
126570540|NCT04493242|455383222|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
126570541|NCT04493242|455383223|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
126570542|NCT04493242|455383224|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
126570543|NCT02812966|455383227|FG000|Overall Study|Death|1|||
126570544|NCT02812966|455383228|FG001|Overall Study|Death|0|||
126570545|NCT04513522|455385652|FG000|Overall Study|Other reasons|1|||
126570546|NCT04513522|455385652|FG000|Overall Study|Adverse event unrelated to study drug|9|||
126570547|NCT04513522|455385652|FG000|Overall Study|Study drug toxicity|14|||
126570548|NCT04513522|455385652|FG000|Overall Study|Disease progression|39|||
126570549|NCT04513522|455385652|FG000|Overall Study|Participants withdrew consent|2|||
126570550|NCT00589667|455385653|FG000|Overall Study|Adverse Event|2|||
126570551|NCT00589667|455385653|FG000|Overall Study|Withdrawal by Subject|1|||
126570552|NCT03538041|455385656|FG000|12-Week Treatment Period|Adverse Event|1|||
126570553|NCT03538041|455385657|FG001|12-Week Treatment Period|Adverse Event|1|||
126570554|NCT03538041|455385656|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
126570555|NCT03538041|455385657|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
126570556|NCT03538041|455385656|FG000|Treatment Extension Period|Adverse Event|4|||
126570557|NCT03538041|455385657|FG001|Treatment Extension Period|Adverse Event|1|||
126570558|NCT03538041|455385656|FG000|Treatment Extension Period|Physician Decision|1|||
126570559|NCT03538041|455385657|FG001|Treatment Extension Period|Physician Decision|1|||
126570560|NCT03538041|455385656|FG000|Treatment Extension Period|Lack of Efficacy|1|||
126570561|NCT03538041|455385657|FG001|Treatment Extension Period|Lack of Efficacy|4|||
126570562|NCT03538041|455385656|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
126570563|NCT03538041|455385657|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
126570564|NCT03538041|455385656|FG000|Treatment Extension Period|Death|0|||
126570565|NCT03538041|455385657|FG001|Treatment Extension Period|Death|1|||
126570566|NCT00768664|455385662|FG000|Overall Study|Death|57|||
126570567|NCT00768664|455385662|FG000|Overall Study|Lost to Follow-up|2|||
126570568|NCT00768664|455385662|FG000|Overall Study|Other|9|||
126570569|NCT00768664|455385662|FG000|Overall Study|Participant refused|1|||
126570570|NCT00708032|455385665|FG000|Overall Study|Adverse Event|0|||
126570571|NCT00708032|455385666|FG001|Overall Study|Adverse Event|2|||
126570572|NCT00708032|455385665|FG000|Overall Study|Lost to Follow-up|1|||
126570573|NCT00708032|455385666|FG001|Overall Study|Lost to Follow-up|2|||
126570574|NCT00708032|455385665|FG000|Overall Study|Pregnancy|0|||
126570575|NCT00708032|455385666|FG001|Overall Study|Pregnancy|1|||
126570576|NCT00708032|455385665|FG000|Overall Study|Poor vision|0|||
126570577|NCT00708032|455385666|FG001|Overall Study|Poor vision|6|||
126570578|NCT00708032|455385665|FG000|Overall Study|Visit out of range at month 12|4|||
126570579|NCT00708032|455385666|FG001|Overall Study|Visit out of range at month 12|1|||
126570580|NCT00708032|455385665|FG000|Overall Study|Did not meet protocol criteria|1|||
126570581|NCT00708032|455385666|FG001|Overall Study|Did not meet protocol criteria|2|||
126570582|NCT00708032|455385665|FG000|Overall Study|Protocol Violation|4|||
126570583|NCT00708032|455385666|FG001|Overall Study|Protocol Violation|1|||
126570584|NCT00708032|455385665|FG000|Overall Study|Withdrawal by Subject|0|||
126570585|NCT00708032|455385666|FG001|Overall Study|Withdrawal by Subject|1|||
126570586|NCT01400776|455385667|FG000|Overall Study|Adverse Event|7|||
126570587|NCT01400776|455385668|FG001|Overall Study|Adverse Event|2|||
126570588|NCT01400776|455385669|FG002|Overall Study|Adverse Event|9|||
126570589|NCT01400776|455385670|FG003|Overall Study|Adverse Event|2|||
126570590|NCT01400776|455385667|FG000|Overall Study|Lost to Follow-up|1|||
126570591|NCT01400776|455385668|FG001|Overall Study|Lost to Follow-up|0|||
126570592|NCT01400776|455385669|FG002|Overall Study|Lost to Follow-up|4|||
126570593|NCT01400776|455385670|FG003|Overall Study|Lost to Follow-up|1|||
126570594|NCT01400776|455385667|FG000|Overall Study|Withdrew Consent|4|||
126570595|NCT01400776|455385668|FG001|Overall Study|Withdrew Consent|2|||
126570596|NCT01400776|455385669|FG002|Overall Study|Withdrew Consent|6|||
126570597|NCT01400776|455385670|FG003|Overall Study|Withdrew Consent|1|||
126570598|NCT01400776|455385667|FG000|Overall Study|Protocol Deviation|6|||
126570599|NCT01400776|455385668|FG001|Overall Study|Protocol Deviation|1|||
126570600|NCT01400776|455385669|FG002|Overall Study|Protocol Deviation|5|||
126570601|NCT01400776|455385670|FG003|Overall Study|Protocol Deviation|2|||
126570602|NCT01400776|455385667|FG000|Overall Study|Reason not Specified|3|||
126570603|NCT01400776|455385668|FG001|Overall Study|Reason not Specified|0|||
126570604|NCT01400776|455385669|FG002|Overall Study|Reason not Specified|4|||
126570605|NCT01400776|455385670|FG003|Overall Study|Reason not Specified|3|||
126570606|NCT00423098|455385671|FG000|Overall Study|Adverse Event|1|||
126570607|NCT00423098|455385672|FG001|Overall Study|Adverse Event|2|||
126570608|NCT00423098|455385671|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126570609|NCT00423098|455385672|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126570610|NCT00423098|455385671|FG000|Overall Study|Administrative problems|0|||
126570611|NCT00423098|455385672|FG001|Overall Study|Administrative problems|1|||
126570612|NCT00423098|455385671|FG000|Overall Study|Death|2|||
126570613|NCT00423098|455385672|FG001|Overall Study|Death|0|||
126570614|NCT02320123|455385675|FG000|Overall Study|Lost to Follow-up|4|||
126570615|NCT02320123|455385676|FG001|Overall Study|Lost to Follow-up|6|||
126570616|NCT02320123|455385675|FG000|Overall Study|Death|6|||
126570617|NCT02320123|455385676|FG001|Overall Study|Death|5|||
126570618|NCT04480827|455385677|FG000|Overall Study|Adverse Event|0|||
126570619|NCT04480827|455385678|FG001|Overall Study|Adverse Event|0|||
126570620|NCT04480827|455385679|FG002|Overall Study|Adverse Event|0|||
126570621|NCT04480827|455385680|FG003|Overall Study|Adverse Event|0|||
126570622|NCT04480827|455385681|FG004|Overall Study|Adverse Event|0|||
126570623|NCT04480827|455385682|FG005|Overall Study|Adverse Event|1|||
126570624|NCT04480827|455385683|FG006|Overall Study|Adverse Event|0|||
126570625|NCT00465816|455385684|FG000|Overall Study|Lost to Follow-up|0|||
126570626|NCT00465816|455385685|FG001|Overall Study|Lost to Follow-up|0|||
126570627|NCT00465816|455385686|FG002|Overall Study|Lost to Follow-up|2|||
126570628|NCT00941655|455385693|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
126570629|NCT00941655|455385694|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
126570630|NCT00941655|455385693|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
126570631|NCT00941655|455385694|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
126570632|NCT00941655|455385693|FG000|Overall Study|progressed while on chemo|0|||
126570633|NCT00941655|455385694|FG001|Overall Study|progressed while on chemo|2|||
126570634|NCT00941655|455385693|FG000|Overall Study|refused further treatment|0|||
126570635|NCT00941655|455385694|FG001|Overall Study|refused further treatment|1|||
126570636|NCT00941655|455385693|FG000|Overall Study|withdrew consent|0|||
126570637|NCT00941655|455385694|FG001|Overall Study|withdrew consent|1|||
126570638|NCT00941655|455385693|FG000|Overall Study|non-compliant|0|||
126570639|NCT00941655|455385694|FG001|Overall Study|non-compliant|1|||
126570640|NCT02477670|455385698|FG000|Stage 1|Adverse Event|2|||
126570641|NCT02477670|455385699|FG001|Stage 1|Adverse Event|7|||
126570642|NCT02477670|455385700|FG002|Stage 1|Adverse Event|0|||
126570643|NCT02477670|455385701|FG003|Stage 1|Adverse Event|0|||
126570644|NCT02477670|455385702|FG004|Stage 1|Adverse Event|0|||
126570645|NCT02477670|455385703|FG005|Stage 1|Adverse Event|0|||
126570646|NCT02477670|455385704|FG006|Stage 1|Adverse Event|0|||
126570647|NCT02477670|455385698|FG000|Stage 1|Lost to Follow-up|0|||
126570648|NCT02477670|455385699|FG001|Stage 1|Lost to Follow-up|2|||
126570649|NCT02477670|455385700|FG002|Stage 1|Lost to Follow-up|0|||
126570650|NCT02477670|455385701|FG003|Stage 1|Lost to Follow-up|0|||
126570651|NCT02477670|455385702|FG004|Stage 1|Lost to Follow-up|0|||
126570652|NCT02477670|455385703|FG005|Stage 1|Lost to Follow-up|0|||
126570653|NCT02477670|455385704|FG006|Stage 1|Lost to Follow-up|0|||
126570654|NCT02477670|455385698|FG000|Stage 1|Withdrawal by Subject|1|||
126570655|NCT02477670|455385699|FG001|Stage 1|Withdrawal by Subject|2|||
126570656|NCT02477670|455385700|FG002|Stage 1|Withdrawal by Subject|0|||
126570657|NCT02477670|455385701|FG003|Stage 1|Withdrawal by Subject|0|||
126727205|NCT00547378|455951073|FG000|All Implanted Cohort|Site closure|2|||
126727206|NCT00547378|455951074|FG001|All Implanted Cohort|Site closure|0|||
126727207|NCT00547378|455951075|FG002|All Implanted Cohort|Site closure|1|||
126515557|NCT04394351|455182314|FG006|Part A (16 Weeks)|Adverse Event|0|||
126515558|NCT04394351|455182315|FG007|Part A (16 Weeks)|Adverse Event|0|||
126515559|NCT04394351|455182308|FG000|Part A (16 Weeks)|Physician Decision|0|||
126515560|NCT04394351|455182309|FG001|Part A (16 Weeks)|Physician Decision|1|||
126515561|NCT04394351|455182310|FG002|Part A (16 Weeks)|Physician Decision|0|||
126515562|NCT04394351|455182311|FG003|Part A (16 Weeks)|Physician Decision|0|||
126515563|NCT04394351|455182312|FG004|Part A (16 Weeks)|Physician Decision|0|||
126515564|NCT04394351|455182313|FG005|Part A (16 Weeks)|Physician Decision|0|||
126515565|NCT04394351|455182314|FG006|Part A (16 Weeks)|Physician Decision|0|||
126515566|NCT04394351|455182315|FG007|Part A (16 Weeks)|Physician Decision|0|||
126515567|NCT04394351|455182308|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
126515568|NCT04394351|455182309|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
126515569|NCT04394351|455182310|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
126515570|NCT04394351|455182311|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
126515571|NCT04394351|455182312|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
126515572|NCT04394351|455182313|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
126515573|NCT04394351|455182314|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
126515574|NCT04394351|455182315|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
126515575|NCT04394351|455182308|FG000|Part B (36 Weeks)|Adverse Event|0|||
126515576|NCT04394351|455182309|FG001|Part B (36 Weeks)|Adverse Event|0|||
126515577|NCT04394351|455182310|FG002|Part B (36 Weeks)|Adverse Event|0|||
126515578|NCT04394351|455182311|FG003|Part B (36 Weeks)|Adverse Event|0|||
126515579|NCT04394351|455182312|FG004|Part B (36 Weeks)|Adverse Event|0|||
126515580|NCT04394351|455182313|FG005|Part B (36 Weeks)|Adverse Event|0|||
126515581|NCT04394351|455182314|FG006|Part B (36 Weeks)|Adverse Event|1|||
126515582|NCT04394351|455182315|FG007|Part B (36 Weeks)|Adverse Event|0|||
126515583|NCT02992899|455182320|FG000|Overall Study|Withdrawal by Subject|1|||
126515584|NCT02992899|455182321|FG001|Overall Study|Withdrawal by Subject|0|||
126570658|NCT02477670|455385702|FG004|Stage 1|Withdrawal by Subject|0|||
126570659|NCT02477670|455385703|FG005|Stage 1|Withdrawal by Subject|0|||
126570660|NCT02477670|455385704|FG006|Stage 1|Withdrawal by Subject|0|||
126570661|NCT02477670|455385698|FG000|Stage 1|Non-compliance with Study Drug|1|||
126570662|NCT02477670|455385699|FG001|Stage 1|Non-compliance with Study Drug|2|||
126570663|NCT02477670|455385700|FG002|Stage 1|Non-compliance with Study Drug|0|||
126570664|NCT02477670|455385701|FG003|Stage 1|Non-compliance with Study Drug|0|||
126570665|NCT02477670|455385702|FG004|Stage 1|Non-compliance with Study Drug|0|||
126515585|NCT02992899|455182320|FG000|Overall Study|Lost to Follow-up|1|||
126515586|NCT02992899|455182321|FG001|Overall Study|Lost to Follow-up|3|||
126515587|NCT02738775|455182322|FG000|Overall Study|Withdrawal by Subject|0|||
126515588|NCT02738775|455182323|FG001|Overall Study|Withdrawal by Subject|1|||
126515589|NCT02738775|455182324|FG002|Overall Study|Withdrawal by Subject|0|||
126515590|NCT02738775|455182325|FG003|Overall Study|Withdrawal by Subject|0|||
126515591|NCT02738775|455182326|FG004|Overall Study|Withdrawal by Subject|0|||
126515592|NCT02738775|455182327|FG005|Overall Study|Withdrawal by Subject|0|||
126515593|NCT02738775|455182322|FG000|Overall Study|Adverse Event|0|||
126515594|NCT02738775|455182323|FG001|Overall Study|Adverse Event|0|||
126515595|NCT02738775|455182324|FG002|Overall Study|Adverse Event|0|||
126515596|NCT02738775|455182325|FG003|Overall Study|Adverse Event|1|||
126515597|NCT02738775|455182326|FG004|Overall Study|Adverse Event|0|||
126515598|NCT02738775|455182327|FG005|Overall Study|Adverse Event|0|||
126515599|NCT02738775|455182322|FG000|Overall Study|Pregnancy|0|||
126515600|NCT02738775|455182323|FG001|Overall Study|Pregnancy|1|||
126515601|NCT02738775|455182324|FG002|Overall Study|Pregnancy|0|||
126515602|NCT02738775|455182325|FG003|Overall Study|Pregnancy|0|||
126515603|NCT02738775|455182326|FG004|Overall Study|Pregnancy|0|||
126515604|NCT02738775|455182327|FG005|Overall Study|Pregnancy|0|||
126515605|NCT02738775|455182322|FG000|Overall Study|Missing|0|||
126515606|NCT02738775|455182323|FG001|Overall Study|Missing|0|||
126515607|NCT02738775|455182324|FG002|Overall Study|Missing|0|||
126515608|NCT02738775|455182325|FG003|Overall Study|Missing|0|||
126515609|NCT02738775|455182326|FG004|Overall Study|Missing|0|||
126515610|NCT02738775|455182327|FG005|Overall Study|Missing|1|||
126515611|NCT01600040|455182328|FG000|Overall Study|Withdrawal by Subject|1|||
126515612|NCT00812812|455182332|FG000|Overall Study|Adverse Event|2|||
126515613|NCT00812812|455182333|FG001|Overall Study|Adverse Event|1|||
126515614|NCT00812812|455182332|FG000|Overall Study|Lack of Efficacy|1|||
126515615|NCT00812812|455182333|FG001|Overall Study|Lack of Efficacy|0|||
126515616|NCT00812812|455182332|FG000|Overall Study|Lost to Follow-up|0|||
126515617|NCT00812812|455182333|FG001|Overall Study|Lost to Follow-up|1|||
126515618|NCT00812812|455182332|FG000|Overall Study|Withdrawal by Subject|0|||
126515619|NCT00812812|455182333|FG001|Overall Study|Withdrawal by Subject|2|||
126515620|NCT02170727|455182337|FG000|Overall Study|Lost to Follow-up|1|||
126515621|NCT02170727|455182338|FG001|Overall Study|Lost to Follow-up|0|||
126515622|NCT02170727|455182337|FG000|Overall Study|Withdrawal by Subject|2|||
126515623|NCT02170727|455182338|FG001|Overall Study|Withdrawal by Subject|0|||
126515624|NCT00720876|455182339|FG000|Overall Study|found to be ineligible after starting tx|2|||
126515625|NCT00684424|455182345|FG000|Overall Study|Adverse Event|1|||
126515626|NCT00684424|455182345|FG000|Overall Study|Lost to Follow-up|2|||
126515627|NCT00684424|455182345|FG000|Overall Study|Other|2|||
126515628|NCT02410811|455182346|FG000|Overall Study|Withdrawal by Subject|0|||
126515629|NCT02410811|455182347|FG001|Overall Study|Withdrawal by Subject|0|||
126515630|NCT02410811|455182348|FG002|Overall Study|Withdrawal by Subject|1|||
126515631|NCT02410811|455182349|FG003|Overall Study|Withdrawal by Subject|0|||
126515632|NCT03511560|455182355|FG000|Overall Study|Death|0|||
126515633|NCT03511560|455182356|FG001|Overall Study|Death|1|||
126515634|NCT03511560|455182355|FG000|Overall Study|Adverse Event|0|||
126515635|NCT03511560|455182356|FG001|Overall Study|Adverse Event|2|||
126515636|NCT03511560|455182355|FG000|Overall Study|Transplant cancelled|0|||
126515637|NCT03511560|455182356|FG001|Overall Study|Transplant cancelled|1|||
126515638|NCT03511560|455182355|FG000|Overall Study|Patient switched to another drug|1|||
126515639|NCT03511560|455182356|FG001|Overall Study|Patient switched to another drug|0|||
126515640|NCT02985736|455182361|FG000|Overall Study|Lost to Follow-up|3|||
126515641|NCT00382733|455182362|FG000|Overall Study|Withdrawal by Subject|0|||
126515642|NCT00382733|455182363|FG001|Overall Study|Withdrawal by Subject|1|||
126515643|NCT00382733|455182364|FG002|Overall Study|Withdrawal by Subject|0|||
126515644|NCT00382733|455182365|FG003|Overall Study|Withdrawal by Subject|0|||
126515645|NCT00382733|455182366|FG004|Overall Study|Withdrawal by Subject|0|||
126515646|NCT01858194|455182369|FG000|Overall Study|Total Artificial Heart Implant|0|||
126515647|NCT01858194|455182370|FG001|Overall Study|Total Artificial Heart Implant|1|||
126515648|NCT01858194|455182369|FG000|Overall Study|Lost to Follow-up|0|||
126515649|NCT01858194|455182370|FG001|Overall Study|Lost to Follow-up|1|||
126515650|NCT03062891|455182377|FG000|Overall Study|Withdrawal by Subject|2|||
126515651|NCT03062891|455182378|FG001|Overall Study|Withdrawal by Subject|0|||
126515652|NCT03062891|455182377|FG000|Overall Study|Lost to Follow-up|50|||
126515653|NCT03062891|455182378|FG001|Overall Study|Lost to Follow-up|38|||
126515654|NCT02127307|455182379|FG000|Overall Study|Protocol Violation|36|||
126515655|NCT02127307|455182379|FG000|Overall Study|Lost to Follow-up|2|||
126515656|NCT02127307|455182379|FG000|Overall Study|Death|101|||
126515657|NCT02127307|455182379|FG000|Overall Study|Other than specified above|169|||
126515658|NCT03509948|455182380|FG000|Overall Study|Protocol Violation|0|||
126515659|NCT03509948|455182381|FG001|Overall Study|Protocol Violation|1|||
126515660|NCT01071512|455182384|FG000|Overall Study|Adverse Event|1|||
126515661|NCT01071512|455182384|FG000|Overall Study|Development of antibodies to drug|2|||
126515662|NCT01071512|455182384|FG000|Overall Study|positive anti-JC virus antibody test|2|||
126515663|NCT03146650|455182400|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
126570666|NCT02477670|455385703|FG005|Stage 1|Non-compliance with Study Drug|0|||
126570667|NCT02477670|455385704|FG006|Stage 1|Non-compliance with Study Drug|0|||
126570668|NCT02477670|455385698|FG000|Stage 2|Adverse Event|0|||
126570669|NCT02477670|455385699|FG001|Stage 2|Adverse Event|0|||
126570670|NCT02477670|455385700|FG002|Stage 2|Adverse Event|1|||
126570671|NCT02477670|455385701|FG003|Stage 2|Adverse Event|0|||
126570672|NCT02477670|455385702|FG004|Stage 2|Adverse Event|0|||
126570673|NCT02477670|455385703|FG005|Stage 2|Adverse Event|0|||
126570674|NCT02477670|455385704|FG006|Stage 2|Adverse Event|0|||
126570675|NCT02477670|455385698|FG000|Stage 2|Antipsychotic Medication Changed|0|||
126570676|NCT02477670|455385699|FG001|Stage 2|Antipsychotic Medication Changed|0|||
126570677|NCT02477670|455385700|FG002|Stage 2|Antipsychotic Medication Changed|1|||
126570678|NCT02477670|455385701|FG003|Stage 2|Antipsychotic Medication Changed|0|||
126570679|NCT02477670|455385702|FG004|Stage 2|Antipsychotic Medication Changed|0|||
126570680|NCT02477670|455385703|FG005|Stage 2|Antipsychotic Medication Changed|0|||
126570681|NCT02477670|455385704|FG006|Stage 2|Antipsychotic Medication Changed|0|||
126570682|NCT02477670|455385698|FG000|Stage 2|Withdrawal by Subject|0|||
126570683|NCT02477670|455385699|FG001|Stage 2|Withdrawal by Subject|0|||
126570684|NCT02477670|455385700|FG002|Stage 2|Withdrawal by Subject|0|||
126570685|NCT02477670|455385701|FG003|Stage 2|Withdrawal by Subject|1|||
126570686|NCT02477670|455385702|FG004|Stage 2|Withdrawal by Subject|0|||
126570687|NCT02477670|455385703|FG005|Stage 2|Withdrawal by Subject|0|||
126570688|NCT02477670|455385704|FG006|Stage 2|Withdrawal by Subject|0|||
126570689|NCT05174013|455385705|FG000|Overall Study|Lost to Follow-up|0|||
126570690|NCT05174013|455385706|FG001|Overall Study|Lost to Follow-up|0|||
126570691|NCT05174013|455385707|FG002|Overall Study|Lost to Follow-up|0|||
126570692|NCT05174013|455385708|FG003|Overall Study|Lost to Follow-up|1|||
126570693|NCT05174013|455385709|FG004|Overall Study|Lost to Follow-up|0|||
126570694|NCT05174013|455385710|FG005|Overall Study|Lost to Follow-up|0|||
126570695|NCT05174013|455385705|FG000|Overall Study|Withdrawal by Subject|0|||
126570696|NCT05174013|455385706|FG001|Overall Study|Withdrawal by Subject|0|||
126570697|NCT05174013|455385707|FG002|Overall Study|Withdrawal by Subject|1|||
126570698|NCT05174013|455385708|FG003|Overall Study|Withdrawal by Subject|0|||
126570699|NCT05174013|455385709|FG004|Overall Study|Withdrawal by Subject|0|||
126570700|NCT05174013|455385710|FG005|Overall Study|Withdrawal by Subject|0|||
126570701|NCT00854906|455385711|FG000|Overall Study|One person had no ocular history|1|||
126570702|NCT00507689|455385714|FG000|Pre-Randomization Period|Adverse Event|1|||
126570703|NCT00507689|455385715|FG001|Pre-Randomization Period|Adverse Event|0|||
126570704|NCT00507689|455385714|FG000|Pre-Randomization Period|Physician Decision|1|||
126570705|NCT00507689|455385715|FG001|Pre-Randomization Period|Physician Decision|0|||
126570706|NCT00507689|455385714|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
126570707|NCT00507689|455385715|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
126570708|NCT00507689|455385714|FG000|Randomized Period|Adverse Event|1|||
126727208|NCT00547378|455951073|FG000|All Implanted Cohort|Other reasons|1|||
126727209|NCT00547378|455951074|FG001|All Implanted Cohort|Other reasons|0|||
126727210|NCT00547378|455951075|FG002|All Implanted Cohort|Other reasons|1|||
126515664|NCT03146650|455182400|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
126515665|NCT03146650|455182400|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
126515666|NCT03146650|455182400|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
126515667|NCT03146650|455182400|FG000|2 Year Follow-up|Death|11|||
126515668|NCT03146650|455182400|FG000|2 Year Follow-up|Still in follow-up|7|||
126515669|NCT03146650|455182400|FG000|2 Year Follow-up|Lost to Follow-up|1|||
126515670|NCT03333486|455182403|FG000|Overall Study|Withdrawal by Subject|1|||
126515671|NCT03333486|455182403|FG000|Overall Study|Lost to Follow-up|1|||
126515672|NCT03246529|455182405|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
126515673|NCT03246529|455182406|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
126515674|NCT03246529|455182407|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
126515675|NCT03246529|455182405|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
126515676|NCT03246529|455182406|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
126515677|NCT03246529|455182407|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
126515678|NCT03246529|455182405|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
126515679|NCT03246529|455182406|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
126515680|NCT03246529|455182407|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
126515681|NCT03246529|455182405|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
126515682|NCT03246529|455182406|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
126515683|NCT03246529|455182407|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
126515684|NCT03246529|455182405|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
126515685|NCT03246529|455182406|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
126570709|NCT00507689|455385715|FG001|Randomized Period|Adverse Event|1|||
126570710|NCT00507689|455385714|FG000|Randomized Period|Withdrawal by Subject|0|||
126570711|NCT00507689|455385715|FG001|Randomized Period|Withdrawal by Subject|1|||
126570712|NCT01786564|455385716|FG000|Overall Study|Lost to Follow-up|47|||
126570713|NCT01786564|455385716|FG000|Overall Study|Ineligible|17|||
126570714|NCT00486330|455385717|FG000|Overall Study|Adverse Event|2|||
126570715|NCT03184558|455385718|FG000|Overall Study|Withdrawal by Subject|2|||
126515686|NCT03246529|455182407|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
126515687|NCT03246529|455182405|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
126515688|NCT03246529|455182406|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
126515689|NCT03246529|455182407|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
126515690|NCT03246529|455182405|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
126515691|NCT03246529|455182406|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
126515692|NCT03246529|455182407|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
126515693|NCT03246529|455182405|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
126515694|NCT03246529|455182406|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
126515695|NCT03246529|455182407|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
126515696|NCT03246529|455182405|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
126515697|NCT03246529|455182406|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
126515698|NCT03246529|455182407|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
126515699|NCT01209624|455182408|FG000|Overall Study|Death|2|||
126515700|NCT01209624|455182408|FG000|Overall Study|Adverse Event|13|||
126515701|NCT01209624|455182408|FG000|Overall Study|Lack of Efficacy|17|||
126515702|NCT01209624|455182408|FG000|Overall Study|Lost to Follow-up|290|||
126515703|NCT01209624|455182408|FG000|Overall Study|Other|4|||
126515704|NCT00441337|455182413|FG000|Overall Study|Disease Progression|6|||
126515705|NCT00441337|455182414|FG001|Overall Study|Disease Progression|6|||
126515706|NCT00441337|455182415|FG002|Overall Study|Disease Progression|4|||
126515707|NCT00441337|455182416|FG003|Overall Study|Disease Progression|18|||
126515708|NCT00441337|455182413|FG000|Overall Study|Lost to Follow-up|0|||
126515709|NCT00441337|455182414|FG001|Overall Study|Lost to Follow-up|0|||
126515710|NCT00441337|455182415|FG002|Overall Study|Lost to Follow-up|0|||
126515711|NCT00441337|455182416|FG003|Overall Study|Lost to Follow-up|1|||
126515712|NCT00441337|455182413|FG000|Overall Study|Sponsor Decision|0|||
126515713|NCT00441337|455182414|FG001|Overall Study|Sponsor Decision|0|||
126515714|NCT00441337|455182415|FG002|Overall Study|Sponsor Decision|1|||
126515715|NCT00441337|455182416|FG003|Overall Study|Sponsor Decision|2|||
126515716|NCT00441337|455182413|FG000|Overall Study|Did not meet inclusion criteria|0|||
126515717|NCT00441337|455182414|FG001|Overall Study|Did not meet inclusion criteria|0|||
126515718|NCT00441337|455182415|FG002|Overall Study|Did not meet inclusion criteria|1|||
126515719|NCT00441337|455182416|FG003|Overall Study|Did not meet inclusion criteria|0|||
126515720|NCT01818336|455183995|FG000|Overall Study|Declined retest visit|0|||
126515721|NCT01818336|455183996|FG001|Overall Study|Declined retest visit|11|||
126515722|NCT01818336|455183995|FG000|Overall Study|Lost to Follow-up|0|||
126515723|NCT01818336|455183996|FG001|Overall Study|Lost to Follow-up|1|||
126515724|NCT00827372|455184001|FG000|Overall Study|Adverse Event|5|||
126515725|NCT00827372|455184001|FG000|Overall Study|Lack of Efficacy|3|||
126515726|NCT02602288|455184009|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
126515727|NCT02602288|455184010|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
126515728|NCT02602288|455184009|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
126515729|NCT02602288|455184010|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
126515730|NCT02602288|455184009|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
126515731|NCT02602288|455184010|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
126515732|NCT02602288|455184009|FG000|12 Month Follow-up|Lost to Follow-up|0|||
126515733|NCT02602288|455184010|FG001|12 Month Follow-up|Lost to Follow-up|4|||
126515734|NCT02602288|455184009|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
126515735|NCT02602288|455184010|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
126515736|NCT01310413|455184011|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
126515737|NCT01310413|455184012|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
126515738|NCT01310413|455184013|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
126515739|NCT01310413|455184014|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
126515740|NCT01310413|455184015|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
126515741|NCT01310413|455184016|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
126515742|NCT01310413|455184017|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
126515743|NCT01310413|455184011|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
126515744|NCT01310413|455184012|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
126515745|NCT01310413|455184013|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
126515746|NCT01310413|455184014|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
126515747|NCT01310413|455184015|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
126515748|NCT01310413|455184016|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
126515749|NCT01310413|455184017|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
126515750|NCT01310413|455184011|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
126515751|NCT01310413|455184012|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
126570716|NCT03184558|455385718|FG000|Overall Study|Death|16|||
126515752|NCT01310413|455184013|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
126515753|NCT01310413|455184014|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
126515754|NCT01310413|455184015|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
126570717|NCT03184558|455385718|FG000|Overall Study|Lost to Follow-up|2|||
126570718|NCT03184558|455385718|FG000|Overall Study|Other|9|||
126570719|NCT02506257|455385719|FG000|Overall Study|Adverse Event|0|||
126570720|NCT02506257|455385720|FG001|Overall Study|Adverse Event|2|||
126570721|NCT02506257|455385721|FG002|Overall Study|Adverse Event|3|||
126570722|NCT02506257|455385722|FG003|Overall Study|Adverse Event|0|||
126570723|NCT02506257|455385719|FG000|Overall Study|Protocol Violation|0|||
126570724|NCT02506257|455385720|FG001|Overall Study|Protocol Violation|0|||
126570725|NCT02506257|455385721|FG002|Overall Study|Protocol Violation|1|||
126570726|NCT02506257|455385722|FG003|Overall Study|Protocol Violation|0|||
126570727|NCT01924767|455385725|FG000|Overall Study|Adverse Event|1|||
126570728|NCT01924767|455385726|FG001|Overall Study|Adverse Event|0|||
126570729|NCT01924767|455385727|FG002|Overall Study|Adverse Event|1|||
126570730|NCT01924767|455385728|FG003|Overall Study|Adverse Event|0|||
126570731|NCT01924767|455385729|FG004|Overall Study|Adverse Event|0|||
126570732|NCT00723450|455385730|FG000|Open-Label Phase|Adverse Event|26|||
126570733|NCT00723450|455385731|FG001|Open-Label Phase|Adverse Event|0|||
126570734|NCT00723450|455385732|FG002|Open-Label Phase|Adverse Event|0|||
126570735|NCT00723450|455385730|FG000|Open-Label Phase|Lack of Efficacy|18|||
126570736|NCT00723450|455385731|FG001|Open-Label Phase|Lack of Efficacy|0|||
126570737|NCT00723450|455385732|FG002|Open-Label Phase|Lack of Efficacy|0|||
126570738|NCT00723450|455385730|FG000|Open-Label Phase|Protocol Violation|35|||
126570739|NCT00723450|455385731|FG001|Open-Label Phase|Protocol Violation|0|||
126570740|NCT00723450|455385732|FG002|Open-Label Phase|Protocol Violation|0|||
126570741|NCT00723450|455385730|FG000|Open-Label Phase|Lost to Follow-up|7|||
126570742|NCT00723450|455385731|FG001|Open-Label Phase|Lost to Follow-up|0|||
126570743|NCT00723450|455385732|FG002|Open-Label Phase|Lost to Follow-up|0|||
126570744|NCT00723450|455385730|FG000|Open-Label Phase|Physician Decision|2|||
126570745|NCT00723450|455385731|FG001|Open-Label Phase|Physician Decision|0|||
126570746|NCT00723450|455385732|FG002|Open-Label Phase|Physician Decision|0|||
126570747|NCT00723450|455385730|FG000|Open-Label Phase|Withdrawal by Subject|37|||
126570748|NCT00723450|455385731|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126570749|NCT00723450|455385732|FG002|Open-Label Phase|Withdrawal by Subject|0|||
126570750|NCT00723450|455385730|FG000|Randomized Phase|Adverse Event|0|||
126570751|NCT00723450|455385731|FG001|Randomized Phase|Adverse Event|26|||
126570752|NCT00723450|455385732|FG002|Randomized Phase|Adverse Event|17|||
126570753|NCT00723450|455385730|FG000|Randomized Phase|Lack of Efficacy|0|||
126570754|NCT00723450|455385731|FG001|Randomized Phase|Lack of Efficacy|11|||
126570755|NCT00723450|455385732|FG002|Randomized Phase|Lack of Efficacy|11|||
126570756|NCT00723450|455385730|FG000|Randomized Phase|Protocol Violation|0|||
126570757|NCT00723450|455385731|FG001|Randomized Phase|Protocol Violation|9|||
126570758|NCT00723450|455385732|FG002|Randomized Phase|Protocol Violation|13|||
126570759|NCT00723450|455385730|FG000|Randomized Phase|Lost to Follow-up|0|||
126570760|NCT00723450|455385731|FG001|Randomized Phase|Lost to Follow-up|2|||
126570761|NCT00723450|455385732|FG002|Randomized Phase|Lost to Follow-up|3|||
126570762|NCT00723450|455385730|FG000|Randomized Phase|Physician Decision|0|||
126570763|NCT00723450|455385731|FG001|Randomized Phase|Physician Decision|3|||
126570764|NCT00723450|455385732|FG002|Randomized Phase|Physician Decision|1|||
126570765|NCT00723450|455385730|FG000|Randomized Phase|Withdrawal by Subject|0|||
126570766|NCT00723450|455385731|FG001|Randomized Phase|Withdrawal by Subject|14|||
126570767|NCT00723450|455385732|FG002|Randomized Phase|Withdrawal by Subject|22|||
126570768|NCT00612586|455385733|FG000|Overall Study|Adverse Event|6|||
126570769|NCT00612586|455385734|FG001|Overall Study|Adverse Event|2|||
126570770|NCT00612586|455385733|FG000|Overall Study|Death|1|||
126570771|NCT00612586|455385734|FG001|Overall Study|Death|0|||
126570772|NCT00612586|455385733|FG000|Overall Study|Entry Criteria Not Met|0|||
126570773|NCT00612586|455385734|FG001|Overall Study|Entry Criteria Not Met|2|||
126570774|NCT00612586|455385733|FG000|Overall Study|Withdrawal by Subject|7|||
126570775|NCT00612586|455385734|FG001|Overall Study|Withdrawal by Subject|9|||
126570776|NCT00612586|455385733|FG000|Overall Study|Physician Decision|1|||
126570777|NCT00612586|455385734|FG001|Overall Study|Physician Decision|2|||
126570778|NCT00612586|455385733|FG000|Overall Study|Sponsor Decision|1|||
126570779|NCT00612586|455385734|FG001|Overall Study|Sponsor Decision|1|||
126570780|NCT00612586|455385733|FG000|Overall Study|Progressive Disease|26|||
126570781|NCT00612586|455385734|FG001|Overall Study|Progressive Disease|24|||
126570782|NCT00612586|455385733|FG000|Overall Study|Randomized and Not Treated|1|||
126570783|NCT00612586|455385734|FG001|Overall Study|Randomized and Not Treated|1|||
126570784|NCT03192046|455385735|FG000|Overall Study|Withdrawal by Subject|1|||
126570785|NCT03192046|455385736|FG001|Overall Study|Withdrawal by Subject|1|||
126570786|NCT00762606|455385737|FG000|Overall Study|Lost to Follow-up|18|||
126570787|NCT00762606|455385738|FG001|Overall Study|Lost to Follow-up|13|||
126570788|NCT01505881|455385739|FG000|Overall Study|Adverse Event|0|||
126570789|NCT01505881|455385740|FG001|Overall Study|Adverse Event|1|||
126570790|NCT01505881|455385739|FG000|Overall Study|Lost to Follow-up|2|||
126570791|NCT01505881|455385740|FG001|Overall Study|Lost to Follow-up|0|||
126570792|NCT01505881|455385739|FG000|Overall Study|Withdrawal by Subject|2|||
126570793|NCT01505881|455385740|FG001|Overall Study|Withdrawal by Subject|0|||
126570794|NCT01909336|455385741|FG000|Overall Study|Lost to Follow-up|4|||
126570795|NCT01909336|455385742|FG001|Overall Study|Lost to Follow-up|2|||
126570796|NCT01909336|455385743|FG002|Overall Study|Lost to Follow-up|2|||
126570797|NCT01909336|455385741|FG000|Overall Study|Physician Decision|0|||
126515755|NCT01310413|455184016|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
126515756|NCT01310413|455184017|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
126515757|NCT01310413|455184011|FG000|Day 0 to Day 385|Other|1|||
126515758|NCT01310413|455184012|FG001|Day 0 to Day 385|Other|0|||
126515759|NCT01310413|455184013|FG002|Day 0 to Day 385|Other|3|||
126515760|NCT01310413|455184014|FG003|Day 0 to Day 385|Other|0|||
126515761|NCT01310413|455184015|FG004|Day 0 to Day 385|Other|0|||
126515762|NCT01310413|455184016|FG005|Day 0 to Day 385|Other|0|||
126515763|NCT01310413|455184017|FG006|Day 0 to Day 385|Other|0|||
126515764|NCT01310413|455184011|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
126515765|NCT01310413|455184012|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
126515766|NCT01310413|455184013|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
126515767|NCT01310413|455184014|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
126515768|NCT01310413|455184015|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
126515769|NCT01310413|455184016|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
126515770|NCT01310413|455184017|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
126515771|NCT01310413|455184011|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
126515772|NCT01310413|455184012|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
126515773|NCT01310413|455184013|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
126515774|NCT01310413|455184014|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
126515775|NCT01310413|455184015|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
126515776|NCT01310413|455184016|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
126515777|NCT01310413|455184017|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
126515778|NCT00941733|455184018|FG000|Overall Study|Death|24|||
126515779|NCT00941733|455184019|FG001|Overall Study|Death|10|||
126515780|NCT00941733|455184018|FG000|Overall Study|Withdrawal by Subject|14|||
126515781|NCT00941733|455184019|FG001|Overall Study|Withdrawal by Subject|6|||
126515782|NCT00941733|455184018|FG000|Overall Study|Adverse Event|20|||
126515783|NCT00941733|455184019|FG001|Overall Study|Adverse Event|4|||
126515784|NCT00941733|455184018|FG000|Overall Study|Lost to Follow-up|1|||
126515785|NCT00941733|455184019|FG001|Overall Study|Lost to Follow-up|2|||
126515786|NCT00941733|455184018|FG000|Overall Study|Protocol Violation|15|||
126515787|NCT00941733|455184019|FG001|Overall Study|Protocol Violation|6|||
126515788|NCT00612066|455184022|FG000|Overall Study|Adverse Event|1|||
126515789|NCT00630877|455184023|FG000|Overall Study|Adverse Event|11|||
126515790|NCT00630877|455184024|FG001|Overall Study|Adverse Event|8|||
126515791|NCT00630877|455184025|FG002|Overall Study|Adverse Event|7|||
126515792|NCT00630877|455184023|FG000|Overall Study|Withdrawal by Subject|3|||
126515793|NCT00630877|455184024|FG001|Overall Study|Withdrawal by Subject|4|||
126515794|NCT00630877|455184025|FG002|Overall Study|Withdrawal by Subject|0|||
126515795|NCT00630877|455184023|FG000|Overall Study|Lost to Follow-up|2|||
126515796|NCT00630877|455184024|FG001|Overall Study|Lost to Follow-up|0|||
126515797|NCT00630877|455184025|FG002|Overall Study|Lost to Follow-up|0|||
126515798|NCT00630877|455184023|FG000|Overall Study|Noncompliance|2|||
126515799|NCT00630877|455184024|FG001|Overall Study|Noncompliance|3|||
126515800|NCT00630877|455184025|FG002|Overall Study|Noncompliance|1|||
126515801|NCT00630877|455184023|FG000|Overall Study|Protocol violation|1|||
126515802|NCT00630877|455184024|FG001|Overall Study|Protocol violation|0|||
126515803|NCT00630877|455184025|FG002|Overall Study|Protocol violation|1|||
126515804|NCT00630877|455184023|FG000|Overall Study|Personal reasons|0|||
126515805|NCT00630877|455184024|FG001|Overall Study|Personal reasons|0|||
126515806|NCT00630877|455184025|FG002|Overall Study|Personal reasons|1|||
126515807|NCT01913041|455184026|FG000|Overall Study|Protocol Violation|35|||
126515808|NCT01913041|455184026|FG000|Overall Study|Withdrawal by Subject|3|||
126515809|NCT01913041|455184026|FG000|Overall Study|Physician Decision|1|||
126515810|NCT01265953|455184028|FG000|Overall Study|Non compliance|5|||
126515811|NCT01265953|455184029|FG001|Overall Study|Non compliance|3|||
126515812|NCT01610700|455184030|FG000|Overall Study|Adverse Event|3|||
126515813|NCT01610700|455184031|FG001|Overall Study|Adverse Event|1|||
126515814|NCT01610700|455184030|FG000|Overall Study|Withdrawal by Subject|0|||
126515815|NCT01610700|455184031|FG001|Overall Study|Withdrawal by Subject|1|||
126515816|NCT01610700|455184030|FG000|Overall Study|subject took one dose of street cannabis|0|||
126515817|NCT01610700|455184031|FG001|Overall Study|subject took one dose of street cannabis|1|||
126515818|NCT02648698|455184032|FG000|Overall Study|Protocol Violation|1|||
126515819|NCT02648698|455184033|FG001|Overall Study|Protocol Violation|5|||
126515820|NCT01640301|455184034|FG000|Overall Study|Death|0|||
126515821|NCT01640301|455184035|FG001|Overall Study|Death|8|||
126515822|NCT03143829|455184036|FG000|Overall Study|Withdrawal by Subject|2|||
126515823|NCT03143829|455184037|FG001|Overall Study|Withdrawal by Subject|5|||
126515824|NCT03143829|455184036|FG000|Overall Study|Lost to Follow-up|0|||
126515825|NCT03143829|455184037|FG001|Overall Study|Lost to Follow-up|2|||
126515826|NCT03143829|455184036|FG000|Overall Study|Death|1|||
126515827|NCT03143829|455184037|FG001|Overall Study|Death|1|||
126515828|NCT03143829|455184036|FG000|Overall Study|changed treatment, no longer eligible|2|||
126515829|NCT03143829|455184037|FG001|Overall Study|changed treatment, no longer eligible|2|||
126515830|NCT02391948|455184042|FG000|6-month Assessment|Death|0|||
126515831|NCT02391948|455184043|FG001|6-month Assessment|Death|0|||
126515832|NCT02391948|455184044|FG002|6-month Assessment|Death|0|||
126515833|NCT02391948|455184045|FG003|6-month Assessment|Death|0|||
126515834|NCT02391948|455184046|FG004|6-month Assessment|Death|1|||
126515835|NCT02391948|455184042|FG000|6-month Assessment|Withdrawal by Subject|0|||
126515836|NCT02391948|455184043|FG001|6-month Assessment|Withdrawal by Subject|0|||
126515837|NCT02391948|455184044|FG002|6-month Assessment|Withdrawal by Subject|1|||
126515838|NCT02391948|455184045|FG003|6-month Assessment|Withdrawal by Subject|2|||
126515839|NCT02391948|455184046|FG004|6-month Assessment|Withdrawal by Subject|0|||
126515840|NCT02391948|455184042|FG000|6-month Assessment|Lost to Follow-up|4|||
126515841|NCT02391948|455184043|FG001|6-month Assessment|Lost to Follow-up|5|||
126515842|NCT02391948|455184044|FG002|6-month Assessment|Lost to Follow-up|2|||
126515843|NCT02391948|455184045|FG003|6-month Assessment|Lost to Follow-up|3|||
126515844|NCT02391948|455184046|FG004|6-month Assessment|Lost to Follow-up|1|||
126515845|NCT02391948|455184042|FG000|6-month Assessment|Medical issue/illness|1|||
126515846|NCT02391948|455184043|FG001|6-month Assessment|Medical issue/illness|1|||
126515847|NCT02391948|455184044|FG002|6-month Assessment|Medical issue/illness|0|||
126515848|NCT02391948|455184045|FG003|6-month Assessment|Medical issue/illness|0|||
126515849|NCT02391948|455184046|FG004|6-month Assessment|Medical issue/illness|0|||
126515850|NCT02391948|455184042|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
126515851|NCT02391948|455184043|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
126515852|NCT02391948|455184044|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
126515853|NCT02391948|455184045|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
126515854|NCT02391948|455184046|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
126515855|NCT02391948|455184042|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
126515856|NCT02391948|455184043|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
126515857|NCT02391948|455184044|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
126515858|NCT02391948|455184045|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
126515859|NCT02391948|455184046|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
126515860|NCT02391948|455184042|FG000|12-month Assessment|Death|0|||
126515861|NCT02391948|455184043|FG001|12-month Assessment|Death|0|||
126515862|NCT02391948|455184044|FG002|12-month Assessment|Death|0|||
126515863|NCT02391948|455184045|FG003|12-month Assessment|Death|1|||
126515864|NCT02391948|455184046|FG004|12-month Assessment|Death|0|||
126515865|NCT02391948|455184042|FG000|12-month Assessment|Withdrawal by Subject|1|||
126515866|NCT02391948|455184043|FG001|12-month Assessment|Withdrawal by Subject|0|||
126515867|NCT02391948|455184044|FG002|12-month Assessment|Withdrawal by Subject|0|||
126515868|NCT02391948|455184045|FG003|12-month Assessment|Withdrawal by Subject|1|||
126515869|NCT02391948|455184046|FG004|12-month Assessment|Withdrawal by Subject|0|||
126515870|NCT02391948|455184042|FG000|12-month Assessment|Lost to Follow-up|5|||
126515871|NCT02391948|455184043|FG001|12-month Assessment|Lost to Follow-up|4|||
126515872|NCT02391948|455184044|FG002|12-month Assessment|Lost to Follow-up|4|||
126515873|NCT02391948|455184045|FG003|12-month Assessment|Lost to Follow-up|4|||
126515874|NCT02391948|455184046|FG004|12-month Assessment|Lost to Follow-up|5|||
126515875|NCT02391948|455184042|FG000|12-month Assessment|Medical issue/illness|0|||
126515876|NCT02391948|455184043|FG001|12-month Assessment|Medical issue/illness|1|||
126515877|NCT02391948|455184044|FG002|12-month Assessment|Medical issue/illness|0|||
126515878|NCT02391948|455184045|FG003|12-month Assessment|Medical issue/illness|1|||
126515879|NCT02391948|455184046|FG004|12-month Assessment|Medical issue/illness|0|||
126515880|NCT02391948|455184042|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
126515881|NCT02391948|455184043|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
126515882|NCT02391948|455184044|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
126515883|NCT02391948|455184045|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
126515884|NCT02391948|455184046|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
126515885|NCT02391948|455184042|FG000|18-month Assessment|Death|0|||
126515886|NCT02391948|455184043|FG001|18-month Assessment|Death|0|||
126515887|NCT02391948|455184044|FG002|18-month Assessment|Death|0|||
126515888|NCT02391948|455184045|FG003|18-month Assessment|Death|1|||
126515889|NCT02391948|455184046|FG004|18-month Assessment|Death|1|||
126515890|NCT02391948|455184042|FG000|18-month Assessment|Withdrawal by Subject|1|||
126515891|NCT02391948|455184043|FG001|18-month Assessment|Withdrawal by Subject|0|||
126515892|NCT02391948|455184044|FG002|18-month Assessment|Withdrawal by Subject|0|||
126515893|NCT02391948|455184045|FG003|18-month Assessment|Withdrawal by Subject|1|||
126515894|NCT02391948|455184046|FG004|18-month Assessment|Withdrawal by Subject|0|||
126515895|NCT02391948|455184042|FG000|18-month Assessment|Lost to Follow-up|2|||
126515896|NCT02391948|455184043|FG001|18-month Assessment|Lost to Follow-up|6|||
126515897|NCT02391948|455184044|FG002|18-month Assessment|Lost to Follow-up|2|||
126515898|NCT02391948|455184045|FG003|18-month Assessment|Lost to Follow-up|2|||
126515899|NCT02391948|455184046|FG004|18-month Assessment|Lost to Follow-up|3|||
126515900|NCT02391948|455184042|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
126515901|NCT02391948|455184043|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
126515902|NCT02391948|455184044|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
126515903|NCT02391948|455184045|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
126515904|NCT02391948|455184046|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
126515905|NCT02391948|455184042|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
126515906|NCT02391948|455184043|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
126570798|NCT01909336|455385742|FG001|Overall Study|Physician Decision|1|||
126570799|NCT01909336|455385743|FG002|Overall Study|Physician Decision|1|||
126570800|NCT00842257|455385744|FG000|Overall Study|Adverse Event|1|||
126570801|NCT00395018|455385745|FG000|On-Treatment|Death|4|||
126570802|NCT00395018|455385745|FG000|On-Treatment|Other Reason|2|||
126570803|NCT00395018|455385745|FG000|On-Treatment|Poor/non-compliance|2|||
126570804|NCT00395018|455385745|FG000|On-Treatment|Subject no longer meets study criteria|2|||
126570805|NCT00395018|455385745|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
126570806|NCT00395018|455385745|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
126570807|NCT00395018|455385745|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
126570808|NCT04439799|455385746|FG000|Overall Study|Lost to Follow-up|6|||
126570809|NCT04439799|455385747|FG001|Overall Study|Lost to Follow-up|6|||
126570810|NCT04439799|455385746|FG000|Overall Study|Withdrawal by Subject|2|||
126570811|NCT04439799|455385747|FG001|Overall Study|Withdrawal by Subject|6|||
126570812|NCT04439799|455385746|FG000|Overall Study|Adverse Event|2|||
126570813|NCT04439799|455385747|FG001|Overall Study|Adverse Event|5|||
126570814|NCT00530842|455385753|FG000|Overall Study|Adverse Event|10|||
126570815|NCT00530842|455385754|FG001|Overall Study|Adverse Event|6|||
126570816|NCT00530842|455385753|FG000|Overall Study|Lack of Efficacy|2|||
126570817|NCT00530842|455385754|FG001|Overall Study|Lack of Efficacy|1|||
126570818|NCT00530842|455385753|FG000|Overall Study|Lost to Follow-up|0|||
126570819|NCT00530842|455385754|FG001|Overall Study|Lost to Follow-up|4|||
126570820|NCT00530842|455385753|FG000|Overall Study|Protocol Violation|3|||
126570821|NCT00530842|455385754|FG001|Overall Study|Protocol Violation|2|||
126570822|NCT00530842|455385753|FG000|Overall Study|Withdrawal by Subject|4|||
126570823|NCT00530842|455385754|FG001|Overall Study|Withdrawal by Subject|5|||
126570824|NCT00530842|455385753|FG000|Overall Study|Individual different reasons|4|||
126570825|NCT00530842|455385754|FG001|Overall Study|Individual different reasons|3|||
126570826|NCT00530842|455385753|FG000|Period 1|Adverse Event|7|||
126570827|NCT00530842|455385754|FG001|Period 1|Adverse Event|3|||
126570828|NCT00530842|455385753|FG000|Period 1|Lack of Efficacy|1|||
126570829|NCT00530842|455385754|FG001|Period 1|Lack of Efficacy|1|||
126570830|NCT00530842|455385753|FG000|Period 1|Protocol Violation|2|||
126570831|NCT00530842|455385754|FG001|Period 1|Protocol Violation|1|||
126570832|NCT00530842|455385753|FG000|Period 1|Withdrawal by Subject|2|||
126570833|NCT00530842|455385754|FG001|Period 1|Withdrawal by Subject|3|||
126570834|NCT00530842|455385753|FG000|Period 1|Individual different reasons|2|||
126570835|NCT00530842|455385754|FG001|Period 1|Individual different reasons|3|||
126570836|NCT00530842|455385753|FG000|Period 2|Adverse Event|3|||
126570837|NCT00530842|455385754|FG001|Period 2|Adverse Event|3|||
126570838|NCT00530842|455385753|FG000|Period 2|Lack of Efficacy|1|||
126570839|NCT00530842|455385754|FG001|Period 2|Lack of Efficacy|0|||
126570840|NCT00530842|455385753|FG000|Period 2|Lost to Follow-up|0|||
126570841|NCT00530842|455385754|FG001|Period 2|Lost to Follow-up|4|||
126570842|NCT00530842|455385753|FG000|Period 2|Protocol Violation|1|||
126570843|NCT00530842|455385754|FG001|Period 2|Protocol Violation|0|||
126570844|NCT00530842|455385753|FG000|Period 2|Withdrawal by Subject|1|||
126570845|NCT00530842|455385754|FG001|Period 2|Withdrawal by Subject|2|||
126570846|NCT00530842|455385753|FG000|Period 2|Individual different reasons|2|||
126570847|NCT00530842|455385754|FG001|Period 2|Individual different reasons|0|||
126570848|NCT01184508|455385755|FG000|Overall Study|Adverse Event|4|||
126570849|NCT01184508|455385756|FG001|Overall Study|Adverse Event|6|||
126570850|NCT01184508|455385755|FG000|Overall Study|Lack of Efficacy|1|||
126570851|NCT01184508|455385756|FG001|Overall Study|Lack of Efficacy|1|||
126570852|NCT01184508|455385755|FG000|Overall Study|Lost to Follow-up|1|||
126570853|NCT01184508|455385756|FG001|Overall Study|Lost to Follow-up|1|||
126570854|NCT01184508|455385755|FG000|Overall Study|Physician Decision|1|||
126570855|NCT01184508|455385756|FG001|Overall Study|Physician Decision|0|||
126570856|NCT01184508|455385755|FG000|Overall Study|Protocol Violation|3|||
126570857|NCT01184508|455385756|FG001|Overall Study|Protocol Violation|1|||
126570858|NCT01184508|455385755|FG000|Overall Study|Sponsor Decision|5|||
126570859|NCT01184508|455385756|FG001|Overall Study|Sponsor Decision|2|||
126570860|NCT01184508|455385755|FG000|Overall Study|Withdrawal by Subject|1|||
126570861|NCT01184508|455385756|FG001|Overall Study|Withdrawal by Subject|3|||
126570862|NCT01184508|455385755|FG000|Overall Study|Randomized, Not Treated|0|||
126570863|NCT01184508|455385756|FG001|Overall Study|Randomized, Not Treated|1|||
126570864|NCT00790790|455385764|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
126570865|NCT00790790|455385765|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
126570866|NCT00790790|455385766|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
126570867|NCT00790790|455385764|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
126570868|NCT00790790|455385765|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
126570869|NCT00790790|455385766|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
126570870|NCT00790790|455385764|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
126570871|NCT00790790|455385765|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
126570872|NCT00790790|455385766|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
126570873|NCT00790790|455385764|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
126570874|NCT00790790|455385765|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
126570875|NCT00790790|455385766|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
126515907|NCT02391948|455184044|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
126515908|NCT02391948|455184045|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
126515909|NCT02391948|455184046|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
126515910|NCT02391948|455184042|FG000|24-month Assessment|Death|0|||
126515911|NCT02391948|455184043|FG001|24-month Assessment|Death|0|||
126515912|NCT02391948|455184044|FG002|24-month Assessment|Death|0|||
126515913|NCT02391948|455184045|FG003|24-month Assessment|Death|0|||
126515914|NCT02391948|455184046|FG004|24-month Assessment|Death|1|||
126515915|NCT02391948|455184042|FG000|24-month Assessment|Withdrawal by Subject|1|||
126515916|NCT02391948|455184043|FG001|24-month Assessment|Withdrawal by Subject|1|||
126515917|NCT02391948|455184044|FG002|24-month Assessment|Withdrawal by Subject|0|||
126515918|NCT02391948|455184045|FG003|24-month Assessment|Withdrawal by Subject|0|||
126515919|NCT02391948|455184046|FG004|24-month Assessment|Withdrawal by Subject|1|||
126515920|NCT02391948|455184042|FG000|24-month Assessment|Lost to Follow-up|5|||
126515921|NCT02391948|455184043|FG001|24-month Assessment|Lost to Follow-up|4|||
126515922|NCT02391948|455184044|FG002|24-month Assessment|Lost to Follow-up|0|||
126515923|NCT02391948|455184045|FG003|24-month Assessment|Lost to Follow-up|0|||
126515924|NCT02391948|455184046|FG004|24-month Assessment|Lost to Follow-up|0|||
126515925|NCT02391948|455184042|FG000|24-month Assessment|Medical issue/illness|0|||
126515926|NCT02391948|455184043|FG001|24-month Assessment|Medical issue/illness|0|||
126515927|NCT02391948|455184044|FG002|24-month Assessment|Medical issue/illness|1|||
126515928|NCT02391948|455184045|FG003|24-month Assessment|Medical issue/illness|0|||
126515929|NCT02391948|455184046|FG004|24-month Assessment|Medical issue/illness|0|||
126515930|NCT02391948|455184042|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
126515931|NCT02391948|455184043|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
126515932|NCT02391948|455184044|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
126515933|NCT02391948|455184045|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
126515934|NCT02391948|455184046|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
126515935|NCT04713748|455184047|FG000|Overall Study|Not enough kits allocated|35|||
126515936|NCT00113516|455184048|FG000|Part 1|Adverse Event|6|||
126515937|NCT00113516|455184049|FG001|Part 1|Adverse Event|0|||
126515938|NCT00113516|455184048|FG000|Part 1|Death|3|||
126515939|NCT00113516|455184049|FG001|Part 1|Death|0|||
126515940|NCT00113516|455184048|FG000|Part 1|Other|3|||
126515941|NCT00113516|455184049|FG001|Part 1|Other|0|||
126515942|NCT00113516|455184048|FG000|Part 1|Withdrawal by Subject|2|||
126515943|NCT00113516|455184049|FG001|Part 1|Withdrawal by Subject|0|||
126515944|NCT00113516|455184048|FG000|Part 1|Lack of Efficacy|2|||
126515945|NCT00113516|455184049|FG001|Part 1|Lack of Efficacy|0|||
126515946|NCT00113516|455184048|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
126515947|NCT00113516|455184049|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
126515948|NCT00113516|455184048|FG000|Part 1|Laboratory Abnormality|1|||
126515949|NCT00113516|455184049|FG001|Part 1|Laboratory Abnormality|0|||
126515950|NCT00113516|455184048|FG000|Part 1|Ongoing|1|||
126515951|NCT00113516|455184049|FG001|Part 1|Ongoing|0|||
126515952|NCT00113516|455184048|FG000|Part 1|Missing|65|||
126515953|NCT00113516|455184049|FG001|Part 1|Missing|0|||
126515954|NCT00113516|455184048|FG000|Part 2|Adverse Event|0|||
126515955|NCT00113516|455184049|FG001|Part 2|Adverse Event|16|||
126515956|NCT00113516|455184048|FG000|Part 2|Death|0|||
126515957|NCT00113516|455184049|FG001|Part 2|Death|5|||
126515958|NCT00113516|455184048|FG000|Part 2|Lack of Efficacy|0|||
126515959|NCT00113516|455184049|FG001|Part 2|Lack of Efficacy|37|||
126515960|NCT00113516|455184048|FG000|Part 2|Withdrawal by Subject|0|||
126515961|NCT00113516|455184049|FG001|Part 2|Withdrawal by Subject|3|||
126515962|NCT00113516|455184048|FG000|Part 2|Other|0|||
126515963|NCT00113516|455184049|FG001|Part 2|Other|3|||
126515964|NCT00113516|455184048|FG000|Part 2|Laboratory Abnormality|0|||
126515965|NCT00113516|455184049|FG001|Part 2|Laboratory Abnormality|1|||
126570876|NCT00790790|455385764|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
126570877|NCT00790790|455385765|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
126515966|NCT00113516|455184048|FG000|Part 2|Ongoing|0|||
126570878|NCT00790790|455385766|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
126515967|NCT00113516|455184049|FG001|Part 2|Ongoing|1|||
126515968|NCT00642304|455184050|FG000|Overall Study|Adverse Event|1|||
126515969|NCT00642304|455184050|FG000|Overall Study|Death|1|||
126515970|NCT00642304|455184050|FG000|Overall Study|Blood transfusion|2|||
126515971|NCT00642304|455184050|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
126515972|NCT00642304|455184050|FG000|Overall Study|Transplantation|1|||
126515973|NCT02863354|455184051|FG000|Year 1|Lost to Follow-up|1|||
126515974|NCT02863354|455184052|FG001|Year 1|Lost to Follow-up|1|||
126515975|NCT02863354|455184051|FG000|Year 1|Withdrawal by Subject|3|||
126570879|NCT02570711|455385767|FG000|Overall Study|Death|1|||
126515976|NCT02863354|455184052|FG001|Year 1|Withdrawal by Subject|0|||
126515977|NCT02863354|455184051|FG000|Year 1|Death|0|||
126515978|NCT02863354|455184052|FG001|Year 1|Death|1|||
126515979|NCT02863354|455184051|FG000|Year 2|Lost to Follow-up|2|||
126515980|NCT02863354|455184052|FG001|Year 2|Lost to Follow-up|2|||
126515981|NCT03235024|455184056|FG000|Overall Study|Adverse Event|2|||
126515982|NCT03235024|455184057|FG001|Overall Study|Adverse Event|2|||
126515983|NCT03235024|455184056|FG000|Overall Study|Death|1|||
126515984|NCT03235024|455184057|FG001|Overall Study|Death|0|||
126515985|NCT03235024|455184056|FG000|Overall Study|Lost to Follow-up|2|||
126515986|NCT03235024|455184057|FG001|Overall Study|Lost to Follow-up|5|||
126515987|NCT03235024|455184056|FG000|Overall Study|Protocol Violation|1|||
126515988|NCT03235024|455184057|FG001|Overall Study|Protocol Violation|0|||
126515989|NCT03235024|455184056|FG000|Overall Study|Withdrawal by Subject|0|||
126515990|NCT03235024|455184057|FG001|Overall Study|Withdrawal by Subject|3|||
126515991|NCT00705575|455184058|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126515992|NCT00705575|455184059|FG001|Overall Study|Abnormal laboratory value(s)|3|||
126515993|NCT00705575|455184058|FG000|Overall Study|Abnormal test procedure result(s)|2|||
126515994|NCT00705575|455184059|FG001|Overall Study|Abnormal test procedure result(s)|12|||
126515995|NCT00705575|455184058|FG000|Overall Study|Adverse Event|11|||
126515996|NCT00705575|455184059|FG001|Overall Study|Adverse Event|15|||
126515997|NCT00705575|455184058|FG000|Overall Study|Lost to Follow-up|3|||
126515998|NCT00705575|455184059|FG001|Overall Study|Lost to Follow-up|4|||
126515999|NCT00705575|455184058|FG000|Overall Study|Protocol Violation|2|||
126516000|NCT00705575|455184059|FG001|Overall Study|Protocol Violation|2|||
126516001|NCT00705575|455184058|FG000|Overall Study|Withdrawal by Subject|5|||
126516002|NCT00705575|455184059|FG001|Overall Study|Withdrawal by Subject|10|||
126516003|NCT01599650|455184060|FG000|Overall Study|Administrative issue|1|||
126516004|NCT01599650|455184061|FG001|Overall Study|Administrative issue|0|||
126516005|NCT01599650|455184062|FG002|Overall Study|Administrative issue|1|||
126516006|NCT01599650|455184060|FG000|Overall Study|Physician Decision|2|||
126516007|NCT01599650|455184061|FG001|Overall Study|Physician Decision|0|||
126516008|NCT01599650|455184062|FG002|Overall Study|Physician Decision|7|||
126516009|NCT01599650|455184060|FG000|Overall Study|Protocol Violation|0|||
126516010|NCT01599650|455184061|FG001|Overall Study|Protocol Violation|3|||
126727211|NCT02112994|455951076|FG000|Overall Study|Progressive Disease|0|||
126727212|NCT02112994|455951077|FG001|Overall Study|Progressive Disease|0|||
126727213|NCT02112994|455951078|FG002|Overall Study|Progressive Disease|1|||
126727214|NCT02112994|455951076|FG000|Overall Study|Pregnancy|0|||
126727215|NCT02112994|455951077|FG001|Overall Study|Pregnancy|1|||
126516011|NCT01599650|455184062|FG002|Overall Study|Protocol Violation|0|||
126516012|NCT01599650|455184060|FG000|Overall Study|Death|2|||
126516013|NCT01599650|455184061|FG001|Overall Study|Death|1|||
126516014|NCT01599650|455184062|FG002|Overall Study|Death|2|||
126516015|NCT01599650|455184060|FG000|Overall Study|Lost to Follow-up|3|||
126516016|NCT01599650|455184061|FG001|Overall Study|Lost to Follow-up|3|||
126516017|NCT01599650|455184062|FG002|Overall Study|Lost to Follow-up|3|||
126516018|NCT01599650|455184060|FG000|Overall Study|Withdrawal by Subject|11|||
126516019|NCT01599650|455184061|FG001|Overall Study|Withdrawal by Subject|11|||
126516020|NCT01599650|455184062|FG002|Overall Study|Withdrawal by Subject|10|||
126516021|NCT01599650|455184060|FG000|Overall Study|Adverse Event|3|||
126516022|NCT01599650|455184061|FG001|Overall Study|Adverse Event|8|||
126516023|NCT01599650|455184062|FG002|Overall Study|Adverse Event|4|||
126516024|NCT02802345|455184063|FG000|Overall Study|Not Treated|0|||
126516025|NCT02802345|455184064|FG001|Overall Study|Not Treated|1|||
126516026|NCT02802345|455184063|FG000|Overall Study|Adverse Event|28|||
126727216|NCT02112994|455951078|FG002|Overall Study|Pregnancy|1|||
126727217|NCT02112994|455951076|FG000|Overall Study|Liver Transplant|0|||
126727218|NCT02112994|455951077|FG001|Overall Study|Liver Transplant|1|||
126727219|NCT02112994|455951078|FG002|Overall Study|Liver Transplant|0|||
126727220|NCT02112994|455951076|FG000|Overall Study|Withdrawal by Subject|0|||
126727221|NCT02112994|455951077|FG001|Overall Study|Withdrawal by Subject|0|||
126727222|NCT02112994|455951078|FG002|Overall Study|Withdrawal by Subject|1|||
126776993|NCT03196791|456139146|FG000|Overall Study|Withdrawal by Subject|3|||
126516027|NCT02802345|455184064|FG001|Overall Study|Adverse Event|20|||
126516028|NCT02802345|455184063|FG000|Overall Study|Withdrawal by Subject|3|||
126516029|NCT02802345|455184064|FG001|Overall Study|Withdrawal by Subject|3|||
126727223|NCT04105244|455951080|FG000|Overall Study|Withdrawal by Subject|10|||
126727224|NCT04105244|455951081|FG001|Overall Study|Withdrawal by Subject|12|||
126727225|NCT04105244|455951080|FG000|Overall Study|Lost to Follow-up|20|||
126727226|NCT04105244|455951081|FG001|Overall Study|Lost to Follow-up|15|||
126570880|NCT02570711|455385768|FG001|Overall Study|Death|0|||
126570881|NCT02570711|455385767|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
126570882|NCT02570711|455385768|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
126727227|NCT04105244|455951080|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
126727228|NCT04105244|455951081|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
126776994|NCT03196791|456139147|FG001|Overall Study|Withdrawal by Subject|2|||
126516030|NCT02802345|455184063|FG000|Overall Study|Protocol Violation|0|||
126516031|NCT02802345|455184064|FG001|Overall Study|Protocol Violation|1|||
126516032|NCT02802345|455184063|FG000|Overall Study|Other than listed|1|||
126516033|NCT02802345|455184064|FG001|Overall Study|Other than listed|5|||
126516034|NCT05857527|455184067|FG000|Overall Study|Withdrawal by Subject|0|||
126516035|NCT05857527|455184068|FG001|Overall Study|Withdrawal by Subject|1|||
126516036|NCT01748994|455184073|FG000|Overall Study|Lost to Follow-up|8|||
126570883|NCT02798835|455385769|FG000|Overall Study|Protocol Violation|0|||
126727229|NCT04105244|455951080|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
126570884|NCT02798835|455385770|FG001|Overall Study|Protocol Violation|0|||
126570885|NCT02798835|455385771|FG002|Overall Study|Protocol Violation|3|||
126570886|NCT04707313|455385778|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
126570887|NCT04707313|455385779|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
126570888|NCT04707313|455385780|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
126570889|NCT04707313|455385781|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
126570890|NCT04707313|455385782|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
126570891|NCT04707313|455385783|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
126570892|NCT04707313|455385784|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
126570893|NCT04707313|455385785|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
126570894|NCT04707313|455385786|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
126570895|NCT04707313|455385787|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
126570896|NCT04707313|455385788|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
126570897|NCT04707313|455385789|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
126570898|NCT04707313|455385790|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
126570899|NCT04707313|455385778|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
126570900|NCT04707313|455385779|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
126570901|NCT04707313|455385780|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126570902|NCT04707313|455385781|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126570903|NCT04707313|455385782|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
126570904|NCT04707313|455385783|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126570905|NCT04707313|455385784|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126570906|NCT04707313|455385785|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126570907|NCT04707313|455385786|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126570908|NCT04707313|455385787|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126570909|NCT04707313|455385788|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126570910|NCT04707313|455385789|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126570911|NCT04707313|455385790|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
126570912|NCT04707313|455385778|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
126570913|NCT04707313|455385779|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
126570914|NCT04707313|455385780|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
126570915|NCT04707313|455385781|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
126570916|NCT04707313|455385782|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
126570917|NCT04707313|455385783|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
126570918|NCT04707313|455385784|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
126570919|NCT04707313|455385785|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
126570920|NCT04707313|455385786|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
126570921|NCT04707313|455385787|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
126570922|NCT04707313|455385788|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
126570923|NCT04707313|455385789|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
126570924|NCT04707313|455385790|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
126570925|NCT04707313|455385778|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126570926|NCT04707313|455385779|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
126570927|NCT04707313|455385780|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
126570928|NCT04707313|455385781|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126570929|NCT04707313|455385782|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
126570930|NCT04707313|455385783|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126570931|NCT04707313|455385784|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126570932|NCT04707313|455385785|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126570933|NCT04707313|455385786|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126570934|NCT04707313|455385787|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126570935|NCT04707313|455385788|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126570936|NCT04707313|455385789|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126570937|NCT04707313|455385790|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
126570938|NCT04707313|455385778|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
126570939|NCT04707313|455385779|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
126570940|NCT04707313|455385780|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
126570941|NCT04707313|455385781|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
126570942|NCT04707313|455385782|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
126570943|NCT04707313|455385783|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126570944|NCT04707313|455385784|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126570945|NCT04707313|455385785|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126570946|NCT04707313|455385786|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
126570947|NCT04707313|455385787|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126727230|NCT04105244|455951081|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
126727231|NCT02768194|455951082|FG000|Period 1|Adverse Event|0|||
126727232|NCT02768194|455951083|FG001|Period 1|Adverse Event|0|||
126776995|NCT00373685|456139152|FG000|Overall Study|Death|2|||
126570948|NCT04707313|455385788|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126776996|NCT00373685|456139153|FG001|Overall Study|Death|1|||
126516037|NCT01748994|455184074|FG001|Overall Study|Lost to Follow-up|6|||
126516038|NCT02520531|455184077|FG000|Overall Study|Revision of study device components|2|||
126516039|NCT02520531|455184078|FG001|Overall Study|Revision of study device components|2|||
126516040|NCT02520531|455184077|FG000|Overall Study|Death|1|||
126516041|NCT02520531|455184078|FG001|Overall Study|Death|2|||
126516042|NCT02520531|455184077|FG000|Overall Study|Lost to Follow-up|1|||
126516043|NCT02520531|455184078|FG001|Overall Study|Lost to Follow-up|1|||
126516044|NCT02520531|455184077|FG000|Overall Study|Meet exclusion criterion|0|||
126516045|NCT02520531|455184078|FG001|Overall Study|Meet exclusion criterion|1|||
126516046|NCT02520531|455184077|FG000|Overall Study|Withdrawal by Subject|1|||
126516047|NCT02520531|455184078|FG001|Overall Study|Withdrawal by Subject|0|||
126516048|NCT02520531|455184077|FG000|Overall Study|Not study device|1|||
126516049|NCT02520531|455184078|FG001|Overall Study|Not study device|0|||
126516050|NCT01723904|455184081|FG000|Overall Study|Noncompliant|3|||
126516051|NCT01723904|455184081|FG000|Overall Study|Adverse Event|5|||
126516052|NCT01723904|455184081|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
126516053|NCT01193556|455184090|FG000|Overall Study|Study termination|26|||
126516054|NCT01193556|455184091|FG001|Overall Study|Study termination|25|||
126516055|NCT00179647|455184096|FG000|Overall Study|Adverse Event|294|||
126516056|NCT00179647|455184096|FG000|Overall Study|Lack of Efficacy|478|||
126516057|NCT00179647|455184096|FG000|Overall Study|Withdrawal by Subject|83|||
126516058|NCT00179647|455184096|FG000|Overall Study|Lost to Follow-up|4|||
126516059|NCT00179647|455184096|FG000|Overall Study|Death|94|||
126516060|NCT00179647|455184096|FG000|Overall Study|Other|960|||
126516061|NCT00835406|455184097|FG000|Period: First Intervention|Adverse Event|0|||
126516062|NCT00835406|455184098|FG001|Period: First Intervention|Adverse Event|1|||
126516063|NCT00835406|455184097|FG000|Period: First Intervention|Withdrawal by Subject|2|||
126516064|NCT00835406|455184098|FG001|Period: First Intervention|Withdrawal by Subject|0|||
126516065|NCT00835406|455184097|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
126516066|NCT00835406|455184098|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
126516067|NCT02138214|455184101|FG000|Overall Study|Withdrawal by Subject|0|||
126516068|NCT02138214|455184102|FG001|Overall Study|Withdrawal by Subject|1|||
126516069|NCT02138214|455184103|FG002|Overall Study|Withdrawal by Subject|0|||
126516070|NCT02138214|455184101|FG000|Overall Study|Lost to Follow-up|0|||
126516071|NCT02138214|455184102|FG001|Overall Study|Lost to Follow-up|2|||
126516072|NCT02138214|455184103|FG002|Overall Study|Lost to Follow-up|4|||
126516073|NCT02138214|455184101|FG000|Overall Study|Screen Failure|0|||
126516074|NCT02138214|455184102|FG001|Overall Study|Screen Failure|1|||
126516075|NCT02138214|455184103|FG002|Overall Study|Screen Failure|0|||
126516076|NCT03027466|455184106|FG000|Overall Study|Opting out of the app|1869|||
126516077|NCT03027466|455184107|FG001|Overall Study|Opting out of the app|1819|||
126516078|NCT03027466|455184108|FG002|Overall Study|Opting out of the app|1743|||
126516079|NCT03027466|455184109|FG003|Overall Study|Opting out of the app|1821|||
126516080|NCT02486406|455184110|FG000|Overall Study|Withdrew consent|1|||
126516081|NCT02486406|455184111|FG001|Overall Study|Withdrew consent|0|||
126516082|NCT02486406|455184112|FG002|Overall Study|Withdrew consent|0|||
126516083|NCT02486406|455184113|FG003|Overall Study|Withdrew consent|1|||
126516084|NCT02486406|455184110|FG000|Overall Study|Lost to Follow-up|1|||
126516085|NCT02486406|455184111|FG001|Overall Study|Lost to Follow-up|3|||
126516086|NCT02486406|455184112|FG002|Overall Study|Lost to Follow-up|1|||
126516087|NCT02486406|455184113|FG003|Overall Study|Lost to Follow-up|3|||
126516088|NCT02486406|455184110|FG000|Overall Study|Other, not specified|0|||
126516089|NCT02486406|455184111|FG001|Overall Study|Other, not specified|0|||
126516090|NCT02486406|455184112|FG002|Overall Study|Other, not specified|1|||
126516091|NCT02486406|455184113|FG003|Overall Study|Other, not specified|0|||
126516092|NCT01826825|455184118|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
126516093|NCT01826825|455184119|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
126516094|NCT02158039|455184120|FG000|Overall Study|Withdrawal by Subject|1|||
126516095|NCT02158039|455184120|FG000|Overall Study|Screen Failure|9|||
126516096|NCT03221257|455184126|FG000|Overall Study|Lost to Follow-up|0|||
126776997|NCT00373685|456139152|FG000|Overall Study|Adverse Event|278|||
126776998|NCT00373685|456139153|FG001|Overall Study|Adverse Event|253|||
126776999|NCT00373685|456139152|FG000|Overall Study|Insufficient clinical response|169|||
126516097|NCT03221257|455184127|FG001|Overall Study|Lost to Follow-up|1|||
126516098|NCT03221257|455184126|FG000|Overall Study|Withdrawal by Subject|1|||
126516099|NCT03221257|455184127|FG001|Overall Study|Withdrawal by Subject|1|||
126516100|NCT01334866|455184129|FG000|Overall Study|Withdrawal by Subject|10|||
126516101|NCT01334866|455184129|FG000|Overall Study|Lost to Follow-up|3|||
126516102|NCT01334866|455184129|FG000|Overall Study|Physician Decision|3|||
126516103|NCT01334866|455184129|FG000|Overall Study|medically necessary prior to procedure|2|||
126516104|NCT01334866|455184129|FG000|Overall Study|medically necessary post-procedure|1|||
126516105|NCT01687166|455184138|FG000|Overall Study|Attempt subject|2|||
126516106|NCT01687166|455184139|FG001|Overall Study|Attempt subject|3|||
126516107|NCT01687166|455184140|FG002|Overall Study|Attempt subject|2|||
126570949|NCT04707313|455385789|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126570950|NCT04707313|455385790|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
126570951|NCT04707313|455385778|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
126570952|NCT04707313|455385779|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126570953|NCT04707313|455385780|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126570954|NCT04707313|455385781|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126570955|NCT04707313|455385782|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126570956|NCT04707313|455385783|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
126570957|NCT04707313|455385784|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
126570958|NCT04707313|455385785|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
126570959|NCT04707313|455385786|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126570960|NCT04707313|455385787|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126570961|NCT04707313|455385788|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126570962|NCT04707313|455385789|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126570963|NCT04707313|455385790|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
126570964|NCT04707313|455385778|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
126570965|NCT04707313|455385779|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
126570966|NCT04707313|455385780|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
126570967|NCT04707313|455385781|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
126570968|NCT04707313|455385782|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
126570969|NCT04707313|455385783|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
126570970|NCT04707313|455385784|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
126570971|NCT04707313|455385785|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
126570972|NCT04707313|455385786|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
126570973|NCT04707313|455385787|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
126570974|NCT04707313|455385788|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
126570975|NCT04707313|455385789|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
126570976|NCT04707313|455385790|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
126570977|NCT04707313|455385778|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126570978|NCT04707313|455385779|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126570979|NCT04707313|455385780|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
126570980|NCT04707313|455385781|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126570981|NCT04707313|455385782|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126570982|NCT04707313|455385783|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126570983|NCT04707313|455385784|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126570984|NCT04707313|455385785|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
126570985|NCT04707313|455385786|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126570986|NCT04707313|455385787|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126570987|NCT04707313|455385788|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126570988|NCT04707313|455385789|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126570989|NCT04707313|455385790|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
126570990|NCT04707313|455385778|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126570991|NCT04707313|455385779|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126570992|NCT04707313|455385780|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126570993|NCT04707313|455385781|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126570994|NCT04707313|455385782|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126570995|NCT04707313|455385783|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126570996|NCT04707313|455385784|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126570997|NCT04707313|455385785|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126570998|NCT04707313|455385786|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126570999|NCT04707313|455385787|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
126571000|NCT04707313|455385788|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
126571001|NCT04707313|455385789|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
126571002|NCT04707313|455385790|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
126571003|NCT04707313|455385778|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126571004|NCT04707313|455385779|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126571005|NCT04707313|455385780|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126571006|NCT04707313|455385781|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126571007|NCT04707313|455385782|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126571008|NCT04707313|455385783|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126571009|NCT04707313|455385784|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126571010|NCT04707313|455385785|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126571011|NCT04707313|455385786|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126571012|NCT04707313|455385787|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
126571013|NCT04707313|455385788|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
126571014|NCT04707313|455385789|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
126571015|NCT04707313|455385790|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
126727233|NCT02768194|455951084|FG002|Period 1|Adverse Event|0|||
126516108|NCT01687166|455184141|FG003|Overall Study|Attempt subject|0|||
126516109|NCT01687166|455184138|FG000|Overall Study|Did not meet eligibility criteria|4|||
126516110|NCT01687166|455184139|FG001|Overall Study|Did not meet eligibility criteria|6|||
126516111|NCT01687166|455184140|FG002|Overall Study|Did not meet eligibility criteria|1|||
126516112|NCT01687166|455184141|FG003|Overall Study|Did not meet eligibility criteria|1|||
126516113|NCT01687166|455184138|FG000|Overall Study|Adverse Event|2|||
126516114|NCT01687166|455184139|FG001|Overall Study|Adverse Event|1|||
126516115|NCT01687166|455184140|FG002|Overall Study|Adverse Event|0|||
126516116|NCT01687166|455184141|FG003|Overall Study|Adverse Event|0|||
126516117|NCT01687166|455184138|FG000|Overall Study|Physician Decision|3|||
126516118|NCT01687166|455184139|FG001|Overall Study|Physician Decision|2|||
126516119|NCT01687166|455184140|FG002|Overall Study|Physician Decision|1|||
126516120|NCT01687166|455184141|FG003|Overall Study|Physician Decision|0|||
126516121|NCT01687166|455184138|FG000|Overall Study|Withdrawal by Subject|11|||
126516122|NCT01687166|455184139|FG001|Overall Study|Withdrawal by Subject|4|||
126516123|NCT01687166|455184140|FG002|Overall Study|Withdrawal by Subject|3|||
126516124|NCT01687166|455184141|FG003|Overall Study|Withdrawal by Subject|0|||
126516125|NCT01687166|455184138|FG000|Overall Study|Lost to Follow-up|2|||
126516126|NCT01687166|455184139|FG001|Overall Study|Lost to Follow-up|5|||
126516127|NCT01687166|455184140|FG002|Overall Study|Lost to Follow-up|1|||
126516128|NCT01687166|455184141|FG003|Overall Study|Lost to Follow-up|0|||
126516129|NCT01687166|455184138|FG000|Overall Study|Equipment/Device Availability|0|||
126516130|NCT01687166|455184139|FG001|Overall Study|Equipment/Device Availability|1|||
126516131|NCT01687166|455184140|FG002|Overall Study|Equipment/Device Availability|0|||
126516132|NCT01687166|455184141|FG003|Overall Study|Equipment/Device Availability|0|||
126516133|NCT01687166|455184138|FG000|Overall Study|Death|1|||
126516134|NCT01687166|455184139|FG001|Overall Study|Death|1|||
126516135|NCT01687166|455184140|FG002|Overall Study|Death|0|||
126516136|NCT01687166|455184141|FG003|Overall Study|Death|0|||
126516137|NCT01687166|455184138|FG000|Overall Study|Protocol Violation|1|||
126516138|NCT01687166|455184139|FG001|Overall Study|Protocol Violation|1|||
126516139|NCT01687166|455184140|FG002|Overall Study|Protocol Violation|1|||
126516140|NCT01687166|455184141|FG003|Overall Study|Protocol Violation|0|||
126516141|NCT01687166|455184138|FG000|Overall Study|Subject moved out of state|0|||
126516142|NCT01687166|455184139|FG001|Overall Study|Subject moved out of state|1|||
126516143|NCT01687166|455184140|FG002|Overall Study|Subject moved out of state|0|||
126516144|NCT01687166|455184141|FG003|Overall Study|Subject moved out of state|0|||
126516145|NCT01687166|455184138|FG000|Overall Study|Patient unable to be compliant|1|||
126516146|NCT01687166|455184139|FG001|Overall Study|Patient unable to be compliant|0|||
126516147|NCT01687166|455184140|FG002|Overall Study|Patient unable to be compliant|0|||
126516148|NCT01687166|455184141|FG003|Overall Study|Patient unable to be compliant|0|||
126516149|NCT01687166|455184138|FG000|Overall Study|Physician choice to use different device|1|||
126516150|NCT01687166|455184139|FG001|Overall Study|Physician choice to use different device|2|||
126516151|NCT01687166|455184140|FG002|Overall Study|Physician choice to use different device|4|||
126516152|NCT01687166|455184141|FG003|Overall Study|Physician choice to use different device|0|||
126516153|NCT01687166|455184138|FG000|Overall Study|Insurance|0|||
126516154|NCT01687166|455184139|FG001|Overall Study|Insurance|0|||
126516155|NCT01687166|455184140|FG002|Overall Study|Insurance|1|||
126516156|NCT01687166|455184141|FG003|Overall Study|Insurance|1|||
126516157|NCT02296112|455184142|FG000|Overall Study|Disease progression|7|||
126516158|NCT02296112|455184142|FG000|Overall Study|Toxicity|1|||
126516159|NCT02296112|455184142|FG000|Overall Study|Began an alternate therapy|1|||
126516160|NCT02442830|455184143|FG000|Overall Study|Technical Failure|0|||
126516161|NCT02442830|455184144|FG001|Overall Study|Technical Failure|1|||
126516162|NCT00183872|455184145|FG000|Overall Study|Death|3|||
126516163|NCT00183872|455184145|FG000|Overall Study|Adverse Event|9|||
126516164|NCT00183872|455184145|FG000|Overall Study|Withdrawal by Subject|2|||
126516165|NCT00183872|455184145|FG000|Overall Study|Drug delayed more than 28 days|2|||
126516166|NCT01516879|455184146|FG000|Overall Study|Withdrawal by Subject|9|||
126516167|NCT01516879|455184147|FG001|Overall Study|Withdrawal by Subject|11|||
126516168|NCT01516879|455184146|FG000|Overall Study|Death|0|||
126516169|NCT01516879|455184147|FG001|Overall Study|Death|2|||
126516170|NCT01516879|455184146|FG000|Overall Study|Lost to Follow-up|2|||
126516171|NCT01516879|455184147|FG001|Overall Study|Lost to Follow-up|11|||
126516172|NCT01516879|455184146|FG000|Overall Study|Other|5|||
126516173|NCT01516879|455184147|FG001|Overall Study|Other|10|||
126516174|NCT02797262|455184148|FG000|Overall Study|Withdrawal by Subject|5|||
126516175|NCT02797262|455184149|FG001|Overall Study|Withdrawal by Subject|1|||
126516176|NCT02797262|455184148|FG000|Overall Study|Lost to Follow-up|10|||
126516177|NCT02797262|455184149|FG001|Overall Study|Lost to Follow-up|7|||
126516178|NCT02797262|455184148|FG000|Overall Study|Death|1|||
126516179|NCT02797262|455184149|FG001|Overall Study|Death|2|||
126516180|NCT02797262|455184148|FG000|Overall Study|Adverse Event|1|||
126516181|NCT02797262|455184149|FG001|Overall Study|Adverse Event|0|||
126516182|NCT02797262|455184148|FG000|Overall Study|COVID-19|2|||
126516183|NCT02797262|455184149|FG001|Overall Study|COVID-19|1|||
126516184|NCT02797262|455184148|FG000|Overall Study|Out-of-country|1|||
126516185|NCT02797262|455184149|FG001|Overall Study|Out-of-country|0|||
126516186|NCT01600586|455184150|FG000|Overall Study|Physician Decision|3|||
126516187|NCT01600586|455184151|FG001|Overall Study|Physician Decision|3|||
126516188|NCT01898793|455184152|FG000|Overall Study|Death|2|||
126516189|NCT01898793|455184153|FG001|Overall Study|Death|1|||
126516190|NCT01898793|455184154|FG002|Overall Study|Death|4|||
126516191|NCT01898793|455184155|FG003|Overall Study|Death|0|||
126516192|NCT01898793|455184156|FG004|Overall Study|Death|0|||
126516193|NCT01898793|455184157|FG005|Overall Study|Death|0|||
126516194|NCT01898793|455184158|FG006|Overall Study|Death|0|||
126516195|NCT00983814|455184159|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
126516196|NCT00983814|455184160|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
126516197|NCT00983814|455184161|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
126516198|NCT00983814|455184159|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
126516199|NCT00983814|455184160|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
126516200|NCT00983814|455184161|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
126516201|NCT00983814|455184159|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
126516202|NCT00983814|455184160|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
126516203|NCT00983814|455184161|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
126516204|NCT00983814|455184159|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
126516205|NCT00983814|455184160|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
126516206|NCT00983814|455184161|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
126516207|NCT00983814|455184159|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
126516208|NCT00983814|455184160|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
126516209|NCT00983814|455184161|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
126516210|NCT00829621|455184162|FG000|Overall Study|Death|1|||
126516211|NCT00829621|455184163|FG001|Overall Study|Death|0|||
126516212|NCT00829621|455184162|FG000|Overall Study|Lost to Follow-up|3|||
126516213|NCT00829621|455184163|FG001|Overall Study|Lost to Follow-up|4|||
126516214|NCT02293005|455185971|FG000|Overall Study|Adverse Event|2|||
126516215|NCT02293005|455185971|FG000|Overall Study|Death|4|||
126516216|NCT02293005|455185971|FG000|Overall Study|Lost to Follow-up|1|||
126516217|NCT02293005|455185971|FG000|Overall Study|Withdrawal by Subject|2|||
126516218|NCT02293005|455185971|FG000|Overall Study|Progression|17|||
126516219|NCT02139644|455185972|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
126516220|NCT02139644|455185973|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126516221|NCT02139644|455185974|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126516222|NCT02139644|455185975|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126516223|NCT02139644|455185976|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126516224|NCT02139644|455185977|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126516225|NCT02139644|455185972|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
126516226|NCT02139644|455185973|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126516227|NCT02139644|455185974|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126516228|NCT02139644|455185975|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126516229|NCT02139644|455185976|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126516230|NCT02139644|455185977|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126516231|NCT02139644|455185972|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
126516232|NCT02139644|455185973|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126516233|NCT02139644|455185974|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126516234|NCT02139644|455185975|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126516235|NCT02139644|455185976|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126516236|NCT02139644|455185977|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126516237|NCT02139644|455185972|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
126516238|NCT02139644|455185973|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126516239|NCT02139644|455185974|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126516240|NCT02139644|455185975|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126516241|NCT02139644|455185976|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126516242|NCT02139644|455185977|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126516243|NCT02139644|455185972|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
126516244|NCT02139644|455185973|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126516245|NCT02139644|455185974|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126516246|NCT02139644|455185975|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126516247|NCT02139644|455185976|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126516248|NCT02139644|455185977|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126516249|NCT02139644|455185972|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
126516250|NCT02139644|455185973|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
126516251|NCT02139644|455185974|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
126516252|NCT02139644|455185975|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
126516253|NCT02139644|455185976|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
126516254|NCT02139644|455185977|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
126516255|NCT02139644|455185972|FG000|Run-In Period (Pre-assignment)|Other|6|||
126516256|NCT02139644|455185973|FG001|Run-In Period (Pre-assignment)|Other|0|||
126516257|NCT02139644|455185974|FG002|Run-In Period (Pre-assignment)|Other|0|||
126727234|NCT02768194|455951085|FG003|Period 1|Adverse Event|1|||
126727235|NCT02768194|455951086|FG004|Period 1|Adverse Event|0|||
126727236|NCT02768194|455951087|FG005|Period 1|Adverse Event|0|||
126727237|NCT02768194|455951082|FG000|Period 2|Other (Reason not specified)|1|||
126727238|NCT02768194|455951083|FG001|Period 2|Other (Reason not specified)|0|||
126727239|NCT02768194|455951084|FG002|Period 2|Other (Reason not specified)|0|||
126727240|NCT02768194|455951085|FG003|Period 2|Other (Reason not specified)|0|||
126516258|NCT02139644|455185975|FG003|Run-In Period (Pre-assignment)|Other|0|||
126516259|NCT02139644|455185976|FG004|Run-In Period (Pre-assignment)|Other|0|||
126516260|NCT02139644|455185977|FG005|Run-In Period (Pre-assignment)|Other|0|||
126516261|NCT02139644|455185972|FG000|Treatment Period|Adverse Event|0|||
126516262|NCT02139644|455185973|FG001|Treatment Period|Adverse Event|0|||
126516263|NCT02139644|455185974|FG002|Treatment Period|Adverse Event|3|||
126516264|NCT02139644|455185975|FG003|Treatment Period|Adverse Event|2|||
126516265|NCT02139644|455185976|FG004|Treatment Period|Adverse Event|1|||
126516266|NCT02139644|455185977|FG005|Treatment Period|Adverse Event|6|||
126516267|NCT02139644|455185972|FG000|Treatment Period|Withdrawal by Subject|0|||
126516268|NCT02139644|455185973|FG001|Treatment Period|Withdrawal by Subject|0|||
126516269|NCT02139644|455185974|FG002|Treatment Period|Withdrawal by Subject|2|||
126516270|NCT02139644|455185975|FG003|Treatment Period|Withdrawal by Subject|2|||
126516271|NCT02139644|455185976|FG004|Treatment Period|Withdrawal by Subject|3|||
126516272|NCT02139644|455185977|FG005|Treatment Period|Withdrawal by Subject|2|||
126516273|NCT02139644|455185972|FG000|Treatment Period|Non-compliance|0|||
126516274|NCT02139644|455185973|FG001|Treatment Period|Non-compliance|0|||
126516275|NCT02139644|455185974|FG002|Treatment Period|Non-compliance|0|||
126516276|NCT02139644|455185975|FG003|Treatment Period|Non-compliance|1|||
126516277|NCT02139644|455185976|FG004|Treatment Period|Non-compliance|0|||
126516278|NCT02139644|455185977|FG005|Treatment Period|Non-compliance|0|||
126516279|NCT02139644|455185972|FG000|Treatment Period|Protocol Violation|0|||
126516280|NCT02139644|455185973|FG001|Treatment Period|Protocol Violation|0|||
126516281|NCT02139644|455185974|FG002|Treatment Period|Protocol Violation|0|||
126516282|NCT02139644|455185975|FG003|Treatment Period|Protocol Violation|1|||
126516283|NCT02139644|455185976|FG004|Treatment Period|Protocol Violation|1|||
126516284|NCT02139644|455185977|FG005|Treatment Period|Protocol Violation|1|||
126516285|NCT02139644|455185972|FG000|Treatment Period|Disease progression|0|||
126516286|NCT02139644|455185973|FG001|Treatment Period|Disease progression|0|||
126516287|NCT02139644|455185974|FG002|Treatment Period|Disease progression|0|||
126516288|NCT02139644|455185975|FG003|Treatment Period|Disease progression|1|||
126516289|NCT02139644|455185976|FG004|Treatment Period|Disease progression|1|||
126516290|NCT02139644|455185977|FG005|Treatment Period|Disease progression|2|||
126516291|NCT02139644|455185972|FG000|Treatment Period|Lost to Follow-up|0|||
126516292|NCT02139644|455185973|FG001|Treatment Period|Lost to Follow-up|0|||
126516293|NCT02139644|455185974|FG002|Treatment Period|Lost to Follow-up|1|||
126516294|NCT02139644|455185975|FG003|Treatment Period|Lost to Follow-up|1|||
126516295|NCT02139644|455185976|FG004|Treatment Period|Lost to Follow-up|1|||
126516296|NCT02139644|455185977|FG005|Treatment Period|Lost to Follow-up|1|||
126516297|NCT02139644|455185972|FG000|Treatment Period|Lack of Efficacy|0|||
126516298|NCT02139644|455185973|FG001|Treatment Period|Lack of Efficacy|0|||
126516299|NCT02139644|455185974|FG002|Treatment Period|Lack of Efficacy|1|||
126516300|NCT02139644|455185975|FG003|Treatment Period|Lack of Efficacy|0|||
126516301|NCT02139644|455185976|FG004|Treatment Period|Lack of Efficacy|1|||
126516302|NCT02139644|455185977|FG005|Treatment Period|Lack of Efficacy|4|||
126516303|NCT02139644|455185972|FG000|Treatment Period|Other|0|||
126516304|NCT02139644|455185973|FG001|Treatment Period|Other|3|||
126516305|NCT02139644|455185974|FG002|Treatment Period|Other|1|||
126516306|NCT02139644|455185975|FG003|Treatment Period|Other|1|||
126516307|NCT02139644|455185976|FG004|Treatment Period|Other|0|||
126516308|NCT02139644|455185977|FG005|Treatment Period|Other|1|||
126516309|NCT03328897|455185978|FG000|Randomized-treatment Epoch|Adverse Event|4|||
126516310|NCT03328897|455185979|FG001|Randomized-treatment Epoch|Adverse Event|1|||
126516311|NCT03328897|455185980|FG002|Randomized-treatment Epoch|Adverse Event|1|||
126516312|NCT03328897|455185978|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
126516313|NCT03328897|455185979|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
126516314|NCT03328897|455185980|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
126516315|NCT03328897|455185978|FG000|Randomized-treatment Epoch|Pregnancy|3|||
126516316|NCT03328897|455185979|FG001|Randomized-treatment Epoch|Pregnancy|0|||
126516317|NCT03328897|455185980|FG002|Randomized-treatment Epoch|Pregnancy|0|||
126516318|NCT03328897|455185978|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
126516319|NCT03328897|455185979|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
126516320|NCT03328897|455185980|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
126516321|NCT03328897|455185978|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
126516322|NCT03328897|455185979|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
126516323|NCT03328897|455185980|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
126516324|NCT03328897|455185978|FG000|Follow-up Epoch|Adverse Event|4|||
126516325|NCT03328897|455185979|FG001|Follow-up Epoch|Adverse Event|0|||
126516326|NCT03328897|455185980|FG002|Follow-up Epoch|Adverse Event|1|||
126727241|NCT02768194|455951086|FG004|Period 2|Other (Reason not specified)|0|||
126571016|NCT04707313|455385778|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126571017|NCT04707313|455385779|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126571018|NCT04707313|455385780|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126571019|NCT04707313|455385781|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126571020|NCT04707313|455385782|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126571021|NCT04707313|455385783|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126571022|NCT04707313|455385784|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126571023|NCT04707313|455385785|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126571024|NCT04707313|455385786|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
126571025|NCT04707313|455385787|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
126571026|NCT04707313|455385788|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
126571027|NCT04707313|455385789|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
126571028|NCT04707313|455385790|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
126571029|NCT04707313|455385778|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
126571030|NCT04707313|455385779|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
126571031|NCT04707313|455385780|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
126571032|NCT04707313|455385781|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
126571033|NCT04707313|455385782|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
126571034|NCT04707313|455385783|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
126571035|NCT04707313|455385784|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
126571036|NCT04707313|455385785|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
126571037|NCT04707313|455385786|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
126571038|NCT04707313|455385787|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
126571039|NCT04707313|455385788|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
126571040|NCT04707313|455385789|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
126571041|NCT04707313|455385790|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
126571042|NCT04707313|455385778|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126571043|NCT04707313|455385779|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126571044|NCT04707313|455385780|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126571045|NCT04707313|455385781|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126571046|NCT04707313|455385782|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126571047|NCT04707313|455385783|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126571048|NCT04707313|455385784|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126571049|NCT04707313|455385785|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126571050|NCT04707313|455385786|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126571051|NCT04707313|455385787|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
126571052|NCT04707313|455385788|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
126571053|NCT04707313|455385789|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126571054|NCT04707313|455385790|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
126571055|NCT04707313|455385778|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126571056|NCT04707313|455385779|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126571057|NCT04707313|455385780|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126571058|NCT04707313|455385781|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126571059|NCT04707313|455385782|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126571060|NCT04707313|455385783|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126571061|NCT04707313|455385784|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126571062|NCT04707313|455385785|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126571063|NCT04707313|455385786|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
126571064|NCT04707313|455385787|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
126571065|NCT04707313|455385788|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
126571066|NCT04707313|455385789|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
126571067|NCT04707313|455385790|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
126571068|NCT03070483|455385794|FG000|Overall Study|Lost to Follow-up|2|||
126727242|NCT02768194|455951087|FG005|Period 2|Other (Reason not specified)|0|||
126727243|NCT02768194|455951082|FG000|Period 3|Other (Reason not specified)|0|||
126727244|NCT02768194|455951083|FG001|Period 3|Other (Reason not specified)|1|||
126727245|NCT02768194|455951084|FG002|Period 3|Other (Reason not specified)|0|||
126727246|NCT02768194|455951085|FG003|Period 3|Other (Reason not specified)|0|||
126727247|NCT02768194|455951086|FG004|Period 3|Other (Reason not specified)|0|||
126727248|NCT02768194|455951087|FG005|Period 3|Other (Reason not specified)|0|||
126727249|NCT00363246|455951088|FG000|Overall Study|Death|40|||
126727250|NCT00363246|455951088|FG000|Overall Study|Withdrawal by Subject|19|||
126571069|NCT01585558|455385798|FG000|Overall Study|Withdrawal by Subject|4|||
126571070|NCT01585558|455385799|FG001|Overall Study|Withdrawal by Subject|5|||
126571071|NCT01585558|455385800|FG002|Overall Study|Withdrawal by Subject|8|||
126571072|NCT01585558|455385798|FG000|Overall Study|Lost to Follow-up|2|||
126571073|NCT01585558|455385799|FG001|Overall Study|Lost to Follow-up|0|||
126571074|NCT01585558|455385800|FG002|Overall Study|Lost to Follow-up|3|||
126571075|NCT01585558|455385798|FG000|Overall Study|Adverse Event|3|||
126571076|NCT01585558|455385799|FG001|Overall Study|Adverse Event|4|||
126727251|NCT00363246|455951088|FG000|Overall Study|Lost to Follow-up|14|||
126727252|NCT00363246|455951088|FG000|Overall Study|Bad health|6|||
126516327|NCT03328897|455185978|FG000|Follow-up Epoch|Lack of Efficacy|1|||
126516328|NCT03328897|455185979|FG001|Follow-up Epoch|Lack of Efficacy|1|||
126516329|NCT03328897|455185980|FG002|Follow-up Epoch|Lack of Efficacy|1|||
126516330|NCT03328897|455185978|FG000|Follow-up Epoch|Lost to Follow-up|0|||
126516331|NCT03328897|455185979|FG001|Follow-up Epoch|Lost to Follow-up|1|||
126516332|NCT03328897|455185980|FG002|Follow-up Epoch|Lost to Follow-up|0|||
126516333|NCT03328897|455185978|FG000|Follow-up Epoch|Pregnancy|1|||
126516334|NCT03328897|455185979|FG001|Follow-up Epoch|Pregnancy|0|||
126516335|NCT03328897|455185980|FG002|Follow-up Epoch|Pregnancy|0|||
126516336|NCT03328897|455185978|FG000|Follow-up Epoch|Patient/guardian decision|2|||
126516337|NCT03328897|455185979|FG001|Follow-up Epoch|Patient/guardian decision|1|||
126516338|NCT03328897|455185980|FG002|Follow-up Epoch|Patient/guardian decision|0|||
126516339|NCT00608829|455185981|FG000|Overall Study|Death|6|||
126516340|NCT00608829|455185981|FG000|Overall Study|Withdrawal by Subject|4|||
126516341|NCT00608829|455185981|FG000|Overall Study|Subject refuses to follow up or return.|5|||
126516342|NCT02564471|455185982|FG000|Overall Study|Adverse Event|1|||
126516343|NCT02564471|455185983|FG001|Overall Study|Adverse Event|0|||
126516344|NCT02564471|455185984|FG002|Overall Study|Adverse Event|0|||
126516345|NCT02564471|455185985|FG003|Overall Study|Adverse Event|0|||
126516346|NCT02564471|455185982|FG000|Overall Study|Withdrawal by Subject|2|||
126516347|NCT02564471|455185983|FG001|Overall Study|Withdrawal by Subject|1|||
126516348|NCT02564471|455185984|FG002|Overall Study|Withdrawal by Subject|3|||
126516349|NCT02564471|455185985|FG003|Overall Study|Withdrawal by Subject|0|||
126516350|NCT02564471|455185982|FG000|Overall Study|Lost to Follow-up|0|||
126516351|NCT02564471|455185983|FG001|Overall Study|Lost to Follow-up|2|||
126516352|NCT02564471|455185984|FG002|Overall Study|Lost to Follow-up|0|||
126516353|NCT02564471|455185985|FG003|Overall Study|Lost to Follow-up|0|||
126516354|NCT02805257|455185986|FG000|Overall Study|Lost to Follow-up|7|||
126516355|NCT02805257|455185987|FG001|Overall Study|Lost to Follow-up|6|||
126516356|NCT02805257|455185986|FG000|Overall Study|Death|0|||
126516357|NCT02805257|455185987|FG001|Overall Study|Death|1|||
126516358|NCT02766608|455185993|FG000|Overall Study|Adverse Event|27|||
126516359|NCT02766608|455185994|FG001|Overall Study|Adverse Event|22|||
126516360|NCT02766608|455185995|FG002|Overall Study|Adverse Event|17|||
126516361|NCT02766608|455185996|FG003|Overall Study|Adverse Event|13|||
126516362|NCT02766608|455185997|FG004|Overall Study|Adverse Event|12|||
126516363|NCT02766608|455185993|FG000|Overall Study|Withdrawal by Subject|21|||
126516364|NCT02766608|455185994|FG001|Overall Study|Withdrawal by Subject|20|||
126516365|NCT02766608|455185995|FG002|Overall Study|Withdrawal by Subject|24|||
126516366|NCT02766608|455185996|FG003|Overall Study|Withdrawal by Subject|13|||
126516367|NCT02766608|455185997|FG004|Overall Study|Withdrawal by Subject|10|||
126516368|NCT02766608|455185993|FG000|Overall Study|Lack of Efficacy|16|||
126516369|NCT02766608|455185994|FG001|Overall Study|Lack of Efficacy|15|||
126516370|NCT02766608|455185995|FG002|Overall Study|Lack of Efficacy|32|||
126516371|NCT02766608|455185996|FG003|Overall Study|Lack of Efficacy|8|||
126516372|NCT02766608|455185997|FG004|Overall Study|Lack of Efficacy|2|||
126516373|NCT02766608|455185993|FG000|Overall Study|Lost to Follow-up|6|||
126516374|NCT02766608|455185994|FG001|Overall Study|Lost to Follow-up|3|||
126516375|NCT02766608|455185995|FG002|Overall Study|Lost to Follow-up|5|||
126516376|NCT02766608|455185996|FG003|Overall Study|Lost to Follow-up|2|||
126516377|NCT02766608|455185997|FG004|Overall Study|Lost to Follow-up|2|||
126516378|NCT02766608|455185993|FG000|Overall Study|Physician Decision|3|||
126516379|NCT02766608|455185994|FG001|Overall Study|Physician Decision|2|||
126516380|NCT02766608|455185995|FG002|Overall Study|Physician Decision|3|||
126516381|NCT02766608|455185996|FG003|Overall Study|Physician Decision|1|||
126516382|NCT02766608|455185997|FG004|Overall Study|Physician Decision|2|||
126516383|NCT02766608|455185993|FG000|Overall Study|Protocol disc criteria|3|||
126516384|NCT02766608|455185994|FG001|Overall Study|Protocol disc criteria|3|||
126516385|NCT02766608|455185995|FG002|Overall Study|Protocol disc criteria|4|||
126516386|NCT02766608|455185996|FG003|Overall Study|Protocol disc criteria|0|||
126516387|NCT02766608|455185997|FG004|Overall Study|Protocol disc criteria|0|||
126516388|NCT02766608|455185993|FG000|Overall Study|Protocol Violation|0|||
126516389|NCT02766608|455185994|FG001|Overall Study|Protocol Violation|4|||
126516390|NCT02766608|455185995|FG002|Overall Study|Protocol Violation|4|||
126516391|NCT02766608|455185996|FG003|Overall Study|Protocol Violation|0|||
126516392|NCT02766608|455185997|FG004|Overall Study|Protocol Violation|1|||
126516393|NCT02766608|455185993|FG000|Overall Study|Administrative Reasons|3|||
126516394|NCT02766608|455185994|FG001|Overall Study|Administrative Reasons|1|||
126516395|NCT02766608|455185995|FG002|Overall Study|Administrative Reasons|1|||
126516396|NCT02766608|455185996|FG003|Overall Study|Administrative Reasons|0|||
126516397|NCT02766608|455185997|FG004|Overall Study|Administrative Reasons|0|||
126516398|NCT02066298|455185998|FG000|Overall Study|Lost to Follow-up|3|||
126516399|NCT02066298|455185999|FG001|Overall Study|Lost to Follow-up|2|||
126516400|NCT02066298|455186000|FG002|Overall Study|Lost to Follow-up|3|||
126516401|NCT02066298|455186001|FG003|Overall Study|Lost to Follow-up|2|||
126516402|NCT02066298|455186002|FG004|Overall Study|Lost to Follow-up|3|||
126516403|NCT02066298|455186003|FG005|Overall Study|Lost to Follow-up|4|||
126516404|NCT02066298|455185998|FG000|Overall Study|Withdrawal by Subject|6|||
126516405|NCT02066298|455185999|FG001|Overall Study|Withdrawal by Subject|6|||
126571077|NCT01585558|455385800|FG002|Overall Study|Adverse Event|1|||
126571078|NCT01585558|455385798|FG000|Overall Study|Protocol Violation|4|||
126571079|NCT01585558|455385799|FG001|Overall Study|Protocol Violation|3|||
126571080|NCT01585558|455385800|FG002|Overall Study|Protocol Violation|2|||
126571081|NCT01585558|455385798|FG000|Overall Study|Lack of Efficacy|0|||
126571082|NCT01585558|455385799|FG001|Overall Study|Lack of Efficacy|0|||
126571083|NCT01585558|455385800|FG002|Overall Study|Lack of Efficacy|1|||
126571084|NCT01713946|455385805|FG000|Overall Study|Death|0|||
126571085|NCT01713946|455385806|FG001|Overall Study|Death|2|||
126571086|NCT01713946|455385807|FG002|Overall Study|Death|2|||
126571087|NCT01713946|455385805|FG000|Overall Study|Adverse Event|19|||
126571088|NCT01713946|455385806|FG001|Overall Study|Adverse Event|14|||
126571089|NCT01713946|455385807|FG002|Overall Study|Adverse Event|13|||
126571090|NCT01713946|455385805|FG000|Overall Study|Withdrawal by Subject|12|||
126571091|NCT01713946|455385806|FG001|Overall Study|Withdrawal by Subject|12|||
126571092|NCT01713946|455385807|FG002|Overall Study|Withdrawal by Subject|8|||
126571093|NCT01713946|455385805|FG000|Overall Study|Lack of Efficacy|8|||
126571094|NCT01713946|455385806|FG001|Overall Study|Lack of Efficacy|8|||
126571095|NCT01713946|455385807|FG002|Overall Study|Lack of Efficacy|14|||
126571096|NCT01713946|455385805|FG000|Overall Study|Protocol Violation|2|||
126571097|NCT01713946|455385806|FG001|Overall Study|Protocol Violation|4|||
126571098|NCT01713946|455385807|FG002|Overall Study|Protocol Violation|1|||
126571099|NCT01713946|455385805|FG000|Overall Study|Lost to Follow-up|0|||
126571100|NCT01713946|455385806|FG001|Overall Study|Lost to Follow-up|0|||
126571101|NCT01713946|455385807|FG002|Overall Study|Lost to Follow-up|1|||
126571102|NCT01713946|455385805|FG000|Overall Study|Administrative problems|1|||
126571103|NCT01713946|455385806|FG001|Overall Study|Administrative problems|0|||
126571104|NCT01713946|455385807|FG002|Overall Study|Administrative problems|0|||
126571105|NCT01713946|455385805|FG000|Overall Study|Did not continue in Ext|0|||
126571106|NCT01713946|455385806|FG001|Overall Study|Did not continue in Ext|3|||
126571107|NCT01713946|455385807|FG002|Overall Study|Did not continue in Ext|0|||
126727253|NCT00363246|455951088|FG000|Overall Study|Stopped using wheelchair|11|||
126727254|NCT00363246|455951088|FG000|Overall Study|Subject expressed security concerns|2|||
126727255|NCT00363246|455951088|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
126727256|NCT01608724|455951089|FG000|Overall Study|Withdrawal by Subject|131|||
126727257|NCT01608724|455951089|FG000|Overall Study|Lost to Follow-up|41|||
126727258|NCT01608724|455951089|FG000|Overall Study|Study-specific discontinuation criteria|32|||
126727259|NCT01608724|455951089|FG000|Overall Study|Adverse Event|29|||
126727260|NCT01608724|455951089|FG000|Overall Study|Protocol Violation|6|||
126516406|NCT02066298|455186000|FG002|Overall Study|Withdrawal by Subject|6|||
126516407|NCT02066298|455186001|FG003|Overall Study|Withdrawal by Subject|4|||
126516408|NCT02066298|455186002|FG004|Overall Study|Withdrawal by Subject|5|||
126516409|NCT02066298|455186003|FG005|Overall Study|Withdrawal by Subject|8|||
126516410|NCT02066298|455185998|FG000|Overall Study|Physician Decision|0|||
126516411|NCT02066298|455185999|FG001|Overall Study|Physician Decision|0|||
126516412|NCT02066298|455186000|FG002|Overall Study|Physician Decision|1|||
126516413|NCT02066298|455186001|FG003|Overall Study|Physician Decision|0|||
126516414|NCT02066298|455186002|FG004|Overall Study|Physician Decision|1|||
126516415|NCT02066298|455186003|FG005|Overall Study|Physician Decision|0|||
126516416|NCT02033889|455186006|FG000|Overall Study|Adverse Event|3|||
126516417|NCT02033889|455186007|FG001|Overall Study|Adverse Event|1|||
126516418|NCT02033889|455186008|FG002|Overall Study|Adverse Event|3|||
126516419|NCT02033889|455186006|FG000|Overall Study|Death|3|||
126516420|NCT02033889|455186007|FG001|Overall Study|Death|1|||
126516421|NCT02033889|455186008|FG002|Overall Study|Death|2|||
126516422|NCT02033889|455186006|FG000|Overall Study|Excluded Medication|1|||
126516423|NCT02033889|455186007|FG001|Overall Study|Excluded Medication|1|||
126516424|NCT02033889|455186008|FG002|Overall Study|Excluded Medication|0|||
126516425|NCT02033889|455186006|FG000|Overall Study|Lost to Follow-up|8|||
126571108|NCT01713946|455385805|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
126571109|NCT01713946|455385806|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
126571110|NCT01713946|455385807|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
126516426|NCT02033889|455186007|FG001|Overall Study|Lost to Follow-up|5|||
126516427|NCT02033889|455186008|FG002|Overall Study|Lost to Follow-up|6|||
126571111|NCT01713946|455385805|FG000|Overall Study|Patients never switched to everolimus|0|||
126571112|NCT01713946|455385806|FG001|Overall Study|Patients never switched to everolimus|0|||
126571113|NCT01713946|455385807|FG002|Overall Study|Patients never switched to everolimus|5|||
126571114|NCT03183518|455385808|FG000|Overall Study|Other (Not specified)|2|||
126571115|NCT03183518|455385808|FG000|Overall Study|Other (Withdrawal of consent)|1|||
126571116|NCT02296424|455387873|FG000|Part 1|New therapy for study indication|0|||
126571117|NCT02296424|455387874|FG001|Part 1|New therapy for study indication|1|||
126727261|NCT01608724|455951089|FG000|Overall Study|bood sugar too high, etc.|3|||
126727262|NCT01608724|455951089|FG000|Overall Study|Safety reasons|1|||
126516428|NCT02033889|455186006|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126516429|NCT02033889|455186007|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126516430|NCT02033889|455186008|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126516431|NCT02033889|455186006|FG000|Overall Study|Physician Decision|0|||
126571118|NCT02296424|455387875|FG002|Part 1|New therapy for study indication|0|||
126571119|NCT02296424|455387876|FG003|Part 1|New therapy for study indication|0|||
126571120|NCT02296424|455387873|FG000|Part 1|Protocol Violation|0|||
126571121|NCT02296424|455387874|FG001|Part 1|Protocol Violation|1|||
126571122|NCT02296424|455387875|FG002|Part 1|Protocol Violation|0|||
126571123|NCT02296424|455387876|FG003|Part 1|Protocol Violation|0|||
126571124|NCT02296424|455387873|FG000|Part 1|Withdrawal by Subject|0|||
126571125|NCT02296424|455387874|FG001|Part 1|Withdrawal by Subject|2|||
126571126|NCT02296424|455387875|FG002|Part 1|Withdrawal by Subject|0|||
126571127|NCT02296424|455387876|FG003|Part 1|Withdrawal by Subject|0|||
126571128|NCT02296424|455387873|FG000|Part 1|Study terminated by sponsor|0|||
126571129|NCT02296424|455387874|FG001|Part 1|Study terminated by sponsor|1|||
126571130|NCT02296424|455387875|FG002|Part 1|Study terminated by sponsor|0|||
126571131|NCT02296424|455387876|FG003|Part 1|Study terminated by sponsor|0|||
126571132|NCT02296424|455387873|FG000|Part 1|Adverse Event|2|||
126571133|NCT02296424|455387874|FG001|Part 1|Adverse Event|11|||
126571134|NCT02296424|455387875|FG002|Part 1|Adverse Event|0|||
126516432|NCT02033889|455186007|FG001|Overall Study|Physician Decision|1|||
126516433|NCT02033889|455186008|FG002|Overall Study|Physician Decision|1|||
126516434|NCT02033889|455186006|FG000|Overall Study|Participant moved|0|||
126516435|NCT02033889|455186007|FG001|Overall Study|Participant moved|1|||
126516436|NCT02033889|455186008|FG002|Overall Study|Participant moved|0|||
126516437|NCT02033889|455186006|FG000|Overall Study|Withdrawal by Subject|18|||
126516438|NCT02033889|455186007|FG001|Overall Study|Withdrawal by Subject|10|||
126516439|NCT02033889|455186008|FG002|Overall Study|Withdrawal by Subject|13|||
126516440|NCT02343458|455186011|FG000|Overall Study|Adverse Event|15|||
126516441|NCT02343458|455186012|FG001|Overall Study|Adverse Event|14|||
126516442|NCT02343458|455186013|FG002|Overall Study|Adverse Event|15|||
126516443|NCT02343458|455186014|FG003|Overall Study|Adverse Event|3|||
126516444|NCT02343458|455186011|FG000|Overall Study|Lack of Efficacy|3|||
126516445|NCT02343458|455186012|FG001|Overall Study|Lack of Efficacy|8|||
126516446|NCT02343458|455186013|FG002|Overall Study|Lack of Efficacy|4|||
126516447|NCT02343458|455186014|FG003|Overall Study|Lack of Efficacy|8|||
126516448|NCT02343458|455186011|FG000|Overall Study|Withdrawal by Subject|18|||
126516449|NCT02343458|455186012|FG001|Overall Study|Withdrawal by Subject|17|||
126516450|NCT02343458|455186013|FG002|Overall Study|Withdrawal by Subject|23|||
126516451|NCT02343458|455186014|FG003|Overall Study|Withdrawal by Subject|14|||
126516452|NCT02343458|455186011|FG000|Overall Study|Physician Decision|1|||
126516453|NCT02343458|455186012|FG001|Overall Study|Physician Decision|4|||
126516454|NCT02343458|455186013|FG002|Overall Study|Physician Decision|2|||
126516455|NCT02343458|455186014|FG003|Overall Study|Physician Decision|2|||
126516456|NCT02343458|455186011|FG000|Overall Study|Lost to Follow-up|5|||
126516457|NCT02343458|455186012|FG001|Overall Study|Lost to Follow-up|5|||
126516458|NCT02343458|455186013|FG002|Overall Study|Lost to Follow-up|3|||
126516459|NCT02343458|455186014|FG003|Overall Study|Lost to Follow-up|1|||
126516460|NCT02343458|455186011|FG000|Overall Study|Protocol Violation|2|||
126516461|NCT02343458|455186012|FG001|Overall Study|Protocol Violation|5|||
126516462|NCT02343458|455186013|FG002|Overall Study|Protocol Violation|2|||
126516463|NCT02343458|455186014|FG003|Overall Study|Protocol Violation|2|||
126516464|NCT02343458|455186011|FG000|Overall Study|Protocol Specified Criteria|17|||
126516465|NCT02343458|455186012|FG001|Overall Study|Protocol Specified Criteria|13|||
126516466|NCT02343458|455186013|FG002|Overall Study|Protocol Specified Criteria|14|||
126516467|NCT02343458|455186014|FG003|Overall Study|Protocol Specified Criteria|8|||
126516468|NCT02080091|455186015|FG000|Overall Study|Study Terminated|22|||
126516469|NCT02080091|455186015|FG000|Overall Study|Death|1|||
126516470|NCT02080091|455186015|FG000|Overall Study|Withdrawal by Subject|1|||
126516471|NCT02080091|455186015|FG000|Overall Study|Other|1|||
126516472|NCT00672477|455186017|FG000|Overall Study|Adverse Event|10|||
126516473|NCT00672477|455186018|FG001|Overall Study|Adverse Event|7|||
126516474|NCT00672477|455186017|FG000|Overall Study|Death|7|||
126516475|NCT00672477|455186018|FG001|Overall Study|Death|11|||
126516476|NCT00672477|455186017|FG000|Overall Study|Physician Decision|2|||
126516477|NCT00672477|455186018|FG001|Overall Study|Physician Decision|0|||
126516478|NCT00672477|455186017|FG000|Overall Study|Protocol Violation|1|||
126516479|NCT00672477|455186018|FG001|Overall Study|Protocol Violation|1|||
126516480|NCT00672477|455186017|FG000|Overall Study|Withdrawal by Subject|5|||
126516481|NCT00672477|455186018|FG001|Overall Study|Withdrawal by Subject|3|||
126516482|NCT00672477|455186017|FG000|Overall Study|Lack of Efficacy|1|||
126516483|NCT00672477|455186018|FG001|Overall Study|Lack of Efficacy|1|||
126516484|NCT00672477|455186017|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
126516485|NCT00672477|455186018|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
126516486|NCT02866682|455186021|FG000|Overall Study|Death|0|||
126516487|NCT02866682|455186022|FG001|Overall Study|Death|1|||
126516488|NCT02866682|455186021|FG000|Overall Study|Lost to Follow-up|0|||
126516489|NCT02866682|455186022|FG001|Overall Study|Lost to Follow-up|4|||
126516490|NCT02866682|455186021|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
126516491|NCT02866682|455186022|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
126571135|NCT02296424|455387876|FG003|Part 1|Adverse Event|0|||
126516492|NCT02866682|455186021|FG000|Overall Study|Other|0|||
126571136|NCT02296424|455387873|FG000|Part 1|Lack of Efficacy|5|||
126516493|NCT02866682|455186022|FG001|Overall Study|Other|1|||
126516494|NCT02886572|455186024|FG000|Overall Study|Death|8|||
126516495|NCT00274716|455186029|FG000|Phase A|Other non-reported reason|4|||
126516496|NCT00274716|455186030|FG001|Phase A|Other non-reported reason|2|||
126516497|NCT00274716|455186031|FG002|Phase A|Other non-reported reason|1|||
126516498|NCT00274716|455186032|FG003|Phase A|Other non-reported reason|2|||
126516499|NCT00274716|455186033|FG004|Phase A|Other non-reported reason|0|||
126516500|NCT00274716|455186034|FG005|Phase A|Other non-reported reason|1|||
126516501|NCT00274716|455186029|FG000|Phase A|Participant moved|0|||
126516502|NCT00274716|455186030|FG001|Phase A|Participant moved|0|||
126516503|NCT00274716|455186031|FG002|Phase A|Participant moved|1|||
126516504|NCT00274716|455186032|FG003|Phase A|Participant moved|0|||
126516505|NCT00274716|455186033|FG004|Phase A|Participant moved|0|||
126516506|NCT00274716|455186034|FG005|Phase A|Participant moved|1|||
126516507|NCT00274716|455186029|FG000|Phase A|Site Terminated|0|||
126516508|NCT00274716|455186030|FG001|Phase A|Site Terminated|0|||
126516509|NCT00274716|455186031|FG002|Phase A|Site Terminated|0|||
126516510|NCT00274716|455186032|FG003|Phase A|Site Terminated|1|||
126516511|NCT00274716|455186033|FG004|Phase A|Site Terminated|0|||
126516512|NCT00274716|455186034|FG005|Phase A|Site Terminated|0|||
126516513|NCT00274716|455186029|FG000|Phase A|Protocol Violation|1|||
126516514|NCT00274716|455186030|FG001|Phase A|Protocol Violation|0|||
126516515|NCT00274716|455186031|FG002|Phase A|Protocol Violation|0|||
126516516|NCT00274716|455186032|FG003|Phase A|Protocol Violation|1|||
126516517|NCT00274716|455186033|FG004|Phase A|Protocol Violation|0|||
126516518|NCT00274716|455186034|FG005|Phase A|Protocol Violation|0|||
126516519|NCT00274716|455186029|FG000|Phase A|Met criteria for discontinuation|1|||
126516520|NCT00274716|455186030|FG001|Phase A|Met criteria for discontinuation|1|||
126516521|NCT00274716|455186031|FG002|Phase A|Met criteria for discontinuation|0|||
126516522|NCT00274716|455186032|FG003|Phase A|Met criteria for discontinuation|0|||
126516523|NCT00274716|455186033|FG004|Phase A|Met criteria for discontinuation|0|||
126516524|NCT00274716|455186034|FG005|Phase A|Met criteria for discontinuation|0|||
126516525|NCT00274716|455186029|FG000|Phase A|Withdrawal by Subject|2|||
126516526|NCT00274716|455186030|FG001|Phase A|Withdrawal by Subject|2|||
126516527|NCT00274716|455186031|FG002|Phase A|Withdrawal by Subject|1|||
126516528|NCT00274716|455186032|FG003|Phase A|Withdrawal by Subject|3|||
126516529|NCT00274716|455186033|FG004|Phase A|Withdrawal by Subject|0|||
126516530|NCT00274716|455186034|FG005|Phase A|Withdrawal by Subject|1|||
126516531|NCT00274716|455186029|FG000|Phase A|Adverse Event|2|||
126516532|NCT00274716|455186030|FG001|Phase A|Adverse Event|3|||
126516533|NCT00274716|455186031|FG002|Phase A|Adverse Event|3|||
126516534|NCT00274716|455186032|FG003|Phase A|Adverse Event|0|||
126516535|NCT00274716|455186033|FG004|Phase A|Adverse Event|2|||
126516536|NCT00274716|455186034|FG005|Phase A|Adverse Event|0|||
126516537|NCT00274716|455186029|FG000|Phase A|Completed but did not enter Phase B|1|||
126516538|NCT00274716|455186030|FG001|Phase A|Completed but did not enter Phase B|2|||
126516539|NCT00274716|455186031|FG002|Phase A|Completed but did not enter Phase B|2|||
126516540|NCT00274716|455186032|FG003|Phase A|Completed but did not enter Phase B|2|||
126516541|NCT00274716|455186033|FG004|Phase A|Completed but did not enter Phase B|1|||
126516542|NCT00274716|455186034|FG005|Phase A|Completed but did not enter Phase B|1|||
126516543|NCT00274716|455186029|FG000|Phase B|Adverse Event|0|||
126516544|NCT00274716|455186030|FG001|Phase B|Adverse Event|0|||
126516545|NCT00274716|455186031|FG002|Phase B|Adverse Event|2|||
126516546|NCT00274716|455186032|FG003|Phase B|Adverse Event|0|||
126516547|NCT00274716|455186033|FG004|Phase B|Adverse Event|0|||
126516548|NCT00274716|455186034|FG005|Phase B|Adverse Event|1|||
126516549|NCT00274716|455186029|FG000|Phase B|Protocol Violation|0|||
126516550|NCT00274716|455186030|FG001|Phase B|Protocol Violation|2|||
126516551|NCT00274716|455186031|FG002|Phase B|Protocol Violation|0|||
126516552|NCT00274716|455186032|FG003|Phase B|Protocol Violation|0|||
126516553|NCT00274716|455186033|FG004|Phase B|Protocol Violation|0|||
126516554|NCT00274716|455186034|FG005|Phase B|Protocol Violation|0|||
126516555|NCT00274716|455186029|FG000|Phase B|Withdrawal by Subject|0|||
126516556|NCT00274716|455186030|FG001|Phase B|Withdrawal by Subject|1|||
126516557|NCT00274716|455186031|FG002|Phase B|Withdrawal by Subject|0|||
126516558|NCT00274716|455186032|FG003|Phase B|Withdrawal by Subject|0|||
126516559|NCT00274716|455186033|FG004|Phase B|Withdrawal by Subject|0|||
126516560|NCT00274716|455186034|FG005|Phase B|Withdrawal by Subject|0|||
126516561|NCT00274716|455186029|FG000|Phase B|Participant moved|1|||
126516562|NCT00274716|455186030|FG001|Phase B|Participant moved|0|||
126516563|NCT00274716|455186031|FG002|Phase B|Participant moved|0|||
126516564|NCT00274716|455186032|FG003|Phase B|Participant moved|0|||
126516565|NCT00274716|455186033|FG004|Phase B|Participant moved|0|||
126516566|NCT00274716|455186034|FG005|Phase B|Participant moved|0|||
126516567|NCT00274716|455186029|FG000|Phase B|Other non-reported reason|0|||
126516568|NCT00274716|455186030|FG001|Phase B|Other non-reported reason|0|||
126516569|NCT00274716|455186031|FG002|Phase B|Other non-reported reason|1|||
126516570|NCT00274716|455186032|FG003|Phase B|Other non-reported reason|1|||
126516571|NCT00274716|455186033|FG004|Phase B|Other non-reported reason|0|||
126516572|NCT00274716|455186034|FG005|Phase B|Other non-reported reason|0|||
126516573|NCT00274716|455186029|FG000|Phase B|Lost to Follow-up|0|||
126516574|NCT00274716|455186030|FG001|Phase B|Lost to Follow-up|1|||
126516575|NCT00274716|455186031|FG002|Phase B|Lost to Follow-up|0|||
126516576|NCT00274716|455186032|FG003|Phase B|Lost to Follow-up|0|||
126516577|NCT00274716|455186033|FG004|Phase B|Lost to Follow-up|0|||
126516578|NCT00274716|455186034|FG005|Phase B|Lost to Follow-up|0|||
126516579|NCT00982319|455186037|FG000|Overall Study|Surgery date change|1|||
126516580|NCT00982319|455186038|FG001|Overall Study|Surgery date change|0|||
126516581|NCT00982319|455186037|FG000|Overall Study|Preop values out of acceptable range|1|||
126516582|NCT00982319|455186038|FG001|Overall Study|Preop values out of acceptable range|1|||
126516583|NCT00982319|455186037|FG000|Overall Study|Pregnancy|0|||
126516584|NCT00982319|455186038|FG001|Overall Study|Pregnancy|1|||
126516585|NCT00975975|455186039|FG000|Overall Study|Death|6|||
126516586|NCT00961259|455186040|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
126516587|NCT00961259|455186041|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
126516588|NCT00961259|455186042|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
126516589|NCT01252251|455186045|FG000|Overall Study|Withdrawal by Subject|1|||
126516590|NCT01324024|455186046|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
126516591|NCT01324024|455186047|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126516592|NCT01923181|455186048|FG000|Overall Study|Protocol Violation|2|||
126516593|NCT01923181|455186049|FG001|Overall Study|Protocol Violation|2|||
126516594|NCT01923181|455186050|FG002|Overall Study|Protocol Violation|0|||
126516595|NCT01923181|455186051|FG003|Overall Study|Protocol Violation|2|||
126516596|NCT01923181|455186052|FG004|Overall Study|Protocol Violation|2|||
126516597|NCT01923181|455186053|FG005|Overall Study|Protocol Violation|1|||
126516598|NCT01923181|455186054|FG006|Overall Study|Protocol Violation|1|||
126516599|NCT01923181|455186055|FG007|Overall Study|Protocol Violation|2|||
126516600|NCT01923181|455186056|FG008|Overall Study|Protocol Violation|1|||
126516601|NCT01923181|455186048|FG000|Overall Study|Withdrawal by Subject|0|||
126516602|NCT01923181|455186049|FG001|Overall Study|Withdrawal by Subject|1|||
126516603|NCT01923181|455186050|FG002|Overall Study|Withdrawal by Subject|0|||
126516604|NCT01923181|455186051|FG003|Overall Study|Withdrawal by Subject|1|||
126516605|NCT01923181|455186052|FG004|Overall Study|Withdrawal by Subject|4|||
126516606|NCT01923181|455186053|FG005|Overall Study|Withdrawal by Subject|2|||
126516607|NCT01923181|455186054|FG006|Overall Study|Withdrawal by Subject|4|||
126516608|NCT01923181|455186055|FG007|Overall Study|Withdrawal by Subject|3|||
126516609|NCT01923181|455186056|FG008|Overall Study|Withdrawal by Subject|1|||
126516610|NCT01923181|455186048|FG000|Overall Study|Other|1|||
126516611|NCT01923181|455186049|FG001|Overall Study|Other|0|||
126516612|NCT01923181|455186050|FG002|Overall Study|Other|0|||
126516613|NCT01923181|455186051|FG003|Overall Study|Other|1|||
126516614|NCT01923181|455186052|FG004|Overall Study|Other|0|||
126516615|NCT01923181|455186053|FG005|Overall Study|Other|0|||
126516616|NCT01923181|455186054|FG006|Overall Study|Other|0|||
126516617|NCT01923181|455186055|FG007|Overall Study|Other|0|||
126516618|NCT01923181|455186056|FG008|Overall Study|Other|0|||
126516619|NCT01923181|455186048|FG000|Overall Study|Lost to Follow-up|0|||
126516620|NCT01923181|455186049|FG001|Overall Study|Lost to Follow-up|3|||
126516621|NCT01923181|455186050|FG002|Overall Study|Lost to Follow-up|2|||
126516622|NCT01923181|455186051|FG003|Overall Study|Lost to Follow-up|1|||
126516623|NCT01923181|455186052|FG004|Overall Study|Lost to Follow-up|2|||
126516624|NCT01923181|455186053|FG005|Overall Study|Lost to Follow-up|1|||
126516625|NCT01923181|455186054|FG006|Overall Study|Lost to Follow-up|3|||
126516626|NCT01923181|455186055|FG007|Overall Study|Lost to Follow-up|3|||
126516627|NCT01923181|455186056|FG008|Overall Study|Lost to Follow-up|1|||
126516628|NCT01863446|455186062|FG000|Overall Study|Withdrawal by Subject|1|||
126516629|NCT01863446|455186063|FG001|Overall Study|Withdrawal by Subject|0|||
126516630|NCT01863446|455186064|FG002|Overall Study|Withdrawal by Subject|1|||
126516631|NCT01863446|455186065|FG003|Overall Study|Withdrawal by Subject|2|||
126516632|NCT01863446|455186062|FG000|Overall Study|Physician Decision|0|||
126516633|NCT01863446|455186063|FG001|Overall Study|Physician Decision|0|||
126516634|NCT01863446|455186064|FG002|Overall Study|Physician Decision|1|||
126516635|NCT01863446|455186065|FG003|Overall Study|Physician Decision|0|||
126516636|NCT02840877|455186066|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
126516637|NCT02840877|455186066|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
126516638|NCT02840877|455186066|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
126516639|NCT02840877|455186066|FG000|Baseline to 12 Weeks|Death|1|||
126516640|NCT02840877|455186066|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
126516641|NCT02840877|455186066|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
126516642|NCT02840877|455186066|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
126516643|NCT02840877|455186066|FG000|12 Weeks to 6 Months|Treatment failure|1|||
126516644|NCT02840877|455186066|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
126516645|NCT02840877|455186066|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
126516646|NCT02840877|455186066|FG000|12 Weeks to 6 Months|Death|1|||
126516647|NCT02840877|455186066|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
126516648|NCT02840877|455186066|FG000|6 Months to 18 Months|Treatment failure|7|||
126516649|NCT02840877|455186066|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
126516650|NCT02840877|455186066|FG000|6 Months to 18 Months|Moved/transferred out|6|||
126516651|NCT02840877|455186066|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
126516652|NCT02840877|455186066|FG000|6 Months to 18 Months|Death|4|||
126571137|NCT02296424|455387874|FG001|Part 1|Lack of Efficacy|17|||
126571138|NCT02296424|455387875|FG002|Part 1|Lack of Efficacy|0|||
126571139|NCT02296424|455387876|FG003|Part 1|Lack of Efficacy|0|||
126571140|NCT02296424|455387873|FG000|Part 1|16 directly started part II|16|||
126571141|NCT02296424|455387874|FG001|Part 1|16 directly started part II|0|||
126516653|NCT02840877|455186066|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
126516654|NCT02840877|455186066|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
126516655|NCT02840877|455186066|FG000|6 Months to 18 Months|Still in study.|14|||
126571142|NCT02296424|455387875|FG002|Part 1|16 directly started part II|0|||
126571143|NCT02296424|455387876|FG003|Part 1|16 directly started part II|0|||
126571144|NCT02296424|455387873|FG000|Part 2|Lack of Efficacy|0|||
126571145|NCT02296424|455387874|FG001|Part 2|Lack of Efficacy|0|||
126571146|NCT02296424|455387875|FG002|Part 2|Lack of Efficacy|1|||
126571147|NCT02296424|455387876|FG003|Part 2|Lack of Efficacy|0|||
126571148|NCT02296424|455387873|FG000|Part 2|Adverse Event|0|||
126571149|NCT02296424|455387874|FG001|Part 2|Adverse Event|0|||
126571150|NCT02296424|455387875|FG002|Part 2|Adverse Event|1|||
126571151|NCT02296424|455387876|FG003|Part 2|Adverse Event|0|||
126571152|NCT02296424|455387873|FG000|Part 2|Lost to Follow-up|0|||
126571153|NCT02296424|455387874|FG001|Part 2|Lost to Follow-up|0|||
126571154|NCT02296424|455387875|FG002|Part 2|Lost to Follow-up|1|||
126571155|NCT02296424|455387876|FG003|Part 2|Lost to Follow-up|0|||
126571156|NCT00807144|455387879|FG000|Overall Study|Lost to Follow-up|0|||
126571157|NCT00807144|455387880|FG001|Overall Study|Lost to Follow-up|1|||
126571158|NCT01307267|455387881|FG000|Overall Study|Death|4|||
126571159|NCT01307267|455387882|FG001|Overall Study|Death|3|||
126571160|NCT01307267|455387883|FG002|Overall Study|Death|5|||
126571161|NCT01307267|455387884|FG003|Overall Study|Death|3|||
126571162|NCT01307267|455387885|FG004|Overall Study|Death|1|||
126571163|NCT01307267|455387886|FG005|Overall Study|Death|26|||
126571164|NCT01307267|455387887|FG006|Overall Study|Death|2|||
126571165|NCT01307267|455387888|FG007|Overall Study|Death|2|||
126571166|NCT01307267|455387889|FG008|Overall Study|Death|21|||
126571167|NCT01307267|455387890|FG009|Overall Study|Death|2|||
126571168|NCT01307267|455387891|FG010|Overall Study|Death|3|||
126571169|NCT01307267|455387892|FG011|Overall Study|Death|9|||
126571170|NCT01307267|455387893|FG012|Overall Study|Death|0|||
126571171|NCT01307267|455387894|FG013|Overall Study|Death|0|||
126571172|NCT01307267|455387895|FG014|Overall Study|Death|0|||
126571173|NCT01307267|455387896|FG015|Overall Study|Death|0|||
126571174|NCT01307267|455387897|FG016|Overall Study|Death|1|||
126571175|NCT01307267|455387898|FG017|Overall Study|Death|1|||
126571176|NCT01307267|455387899|FG018|Overall Study|Death|2|||
126571177|NCT01307267|455387900|FG019|Overall Study|Death|8|||
126571178|NCT01307267|455387901|FG020|Overall Study|Death|1|||
126571179|NCT01307267|455387902|FG021|Overall Study|Death|2|||
126571180|NCT01307267|455387903|FG022|Overall Study|Death|2|||
126571181|NCT01307267|455387881|FG000|Overall Study|Lost to Follow-up|0|||
126571182|NCT01307267|455387882|FG001|Overall Study|Lost to Follow-up|0|||
126571183|NCT01307267|455387883|FG002|Overall Study|Lost to Follow-up|0|||
126571184|NCT01307267|455387884|FG003|Overall Study|Lost to Follow-up|0|||
126571185|NCT01307267|455387885|FG004|Overall Study|Lost to Follow-up|0|||
126571186|NCT01307267|455387886|FG005|Overall Study|Lost to Follow-up|7|||
126571187|NCT01307267|455387887|FG006|Overall Study|Lost to Follow-up|0|||
126516656|NCT02252081|455186069|FG000|Overall Study|Withdrawal by Subject|2|||
126516657|NCT02252081|455186070|FG001|Overall Study|Withdrawal by Subject|1|||
126516658|NCT02252081|455186069|FG000|Overall Study|Adverse Event|4|||
126516659|NCT02252081|455186070|FG001|Overall Study|Adverse Event|1|||
126516660|NCT02252081|455186069|FG000|Overall Study|non compliance & others|0|||
126516661|NCT02252081|455186070|FG001|Overall Study|non compliance & others|2|||
126516662|NCT01168999|455186075|FG000|Overall Study|Lost to Follow-up|2|||
126516663|NCT01168999|455186076|FG001|Overall Study|Lost to Follow-up|1|||
126516664|NCT01168999|455186077|FG002|Overall Study|Lost to Follow-up|0|||
126516665|NCT01168999|455186078|FG003|Overall Study|Lost to Follow-up|0|||
126516666|NCT03603964|455186079|FG000|Overall Study|Death|9|||
126571188|NCT01307267|455387888|FG007|Overall Study|Lost to Follow-up|0|||
126571189|NCT01307267|455387889|FG008|Overall Study|Lost to Follow-up|1|||
126571190|NCT01307267|455387890|FG009|Overall Study|Lost to Follow-up|2|||
126571191|NCT01307267|455387891|FG010|Overall Study|Lost to Follow-up|1|||
126571192|NCT01307267|455387892|FG011|Overall Study|Lost to Follow-up|0|||
126571193|NCT01307267|455387893|FG012|Overall Study|Lost to Follow-up|0|||
126571194|NCT01307267|455387894|FG013|Overall Study|Lost to Follow-up|0|||
126571195|NCT01307267|455387895|FG014|Overall Study|Lost to Follow-up|0|||
126516667|NCT03603964|455186079|FG000|Overall Study|Withdrawal by participant|7|||
126516668|NCT03603964|455186079|FG000|Overall Study|Study terminated by Sponsor|19|||
126571196|NCT01307267|455387896|FG015|Overall Study|Lost to Follow-up|0|||
126571197|NCT01307267|455387897|FG016|Overall Study|Lost to Follow-up|0|||
126571198|NCT01307267|455387898|FG017|Overall Study|Lost to Follow-up|0|||
126571199|NCT01307267|455387899|FG018|Overall Study|Lost to Follow-up|0|||
126571200|NCT01307267|455387900|FG019|Overall Study|Lost to Follow-up|2|||
126571201|NCT01307267|455387901|FG020|Overall Study|Lost to Follow-up|0|||
126571202|NCT01307267|455387902|FG021|Overall Study|Lost to Follow-up|0|||
126571203|NCT01307267|455387903|FG022|Overall Study|Lost to Follow-up|0|||
126516669|NCT04317586|455186080|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
126516670|NCT04317586|455186080|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
126516671|NCT01276327|455186083|FG000|Overall Study|Adverse Event|1|||
126516672|NCT01276327|455186084|FG001|Overall Study|Adverse Event|3|||
126516673|NCT01276327|455186083|FG000|Overall Study|Withdrawal by Subject|1|||
126516674|NCT01276327|455186084|FG001|Overall Study|Withdrawal by Subject|0|||
126516675|NCT00807092|455186085|FG000|Overall Study|Adverse Event|0|||
126516676|NCT00807092|455186086|FG001|Overall Study|Adverse Event|1|||
126516677|NCT00807092|455186085|FG000|Overall Study|Protocol Violation|0|||
126516678|NCT00807092|455186086|FG001|Overall Study|Protocol Violation|2|||
126516679|NCT00807092|455186085|FG000|Overall Study|Withdrawal by Subject|1|||
126516680|NCT00807092|455186086|FG001|Overall Study|Withdrawal by Subject|0|||
126516681|NCT00807092|455186085|FG000|Overall Study|CGMS data collection failed|0|||
126516682|NCT00807092|455186086|FG001|Overall Study|CGMS data collection failed|1|||
126516683|NCT04116229|455186087|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
126516684|NCT04116229|455186088|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
126516685|NCT04116229|455186087|FG000|Overall Study|Scheduling not possible.|0|||
126516686|NCT04116229|455186088|FG001|Overall Study|Scheduling not possible.|1|||
126516687|NCT01794949|455186089|FG000|Overall Study|Lost to Follow-up|1|||
126516688|NCT01794949|455186090|FG001|Overall Study|Lost to Follow-up|0|||
126516689|NCT03003676|455186091|FG000|Overall Study|Lack of Efficacy|5|||
126516690|NCT03003676|455186092|FG001|Overall Study|Lack of Efficacy|7|||
126516691|NCT03003676|455186091|FG000|Overall Study|Withdrawal by Subject|0|||
126516692|NCT03003676|455186092|FG001|Overall Study|Withdrawal by Subject|1|||
126516693|NCT03003676|455186091|FG000|Overall Study|Hepatitis B infection|1|||
126516694|NCT03003676|455186092|FG001|Overall Study|Hepatitis B infection|0|||
126516695|NCT03766646|455186099|FG000|Overall Study|Withdrawal by Subject|1|||
126516696|NCT03766646|455186100|FG001|Overall Study|Withdrawal by Subject|0|||
126516697|NCT03766646|455186099|FG000|Overall Study|Protocol Violation|0|||
126516698|NCT03766646|455186100|FG001|Overall Study|Protocol Violation|3|||
126516699|NCT03698773|455186120|FG000|Overall Study|Lost to Follow-up|2|||
126516700|NCT03698773|455186121|FG001|Overall Study|Lost to Follow-up|1|||
126516701|NCT02822794|455186122|FG000|Overall Study|Withdrew Consent|1|||
126516702|NCT02822794|455186123|FG001|Overall Study|Withdrew Consent|0|||
126516703|NCT01243944|455186129|FG000|Overall Study|Adverse Event|15|||
126516704|NCT01243944|455186130|FG001|Overall Study|Adverse Event|13|||
126516705|NCT01243944|455186129|FG000|Overall Study|Lost to Follow-up|2|||
126516706|NCT01243944|455186130|FG001|Overall Study|Lost to Follow-up|1|||
126516707|NCT01243944|455186129|FG000|Overall Study|Physician Decision|2|||
126516708|NCT01243944|455186130|FG001|Overall Study|Physician Decision|7|||
126516709|NCT01243944|455186129|FG000|Overall Study|Disease progression|12|||
126516710|NCT01243944|455186130|FG001|Overall Study|Disease progression|11|||
126516711|NCT01243944|455186129|FG000|Overall Study|Protocol deviation|1|||
126516712|NCT01243944|455186130|FG001|Overall Study|Protocol deviation|1|||
126516713|NCT01243944|455186129|FG000|Overall Study|Participant decision|10|||
126516714|NCT01243944|455186130|FG001|Overall Study|Participant decision|15|||
126516715|NCT01243944|455186129|FG000|Overall Study|Death|2|||
126516716|NCT01243944|455186130|FG001|Overall Study|Death|3|||
126516717|NCT01243944|455186129|FG000|Overall Study|Non-compliance with study treatment|1|||
126516718|NCT01243944|455186130|FG001|Overall Study|Non-compliance with study treatment|0|||
126516719|NCT01416805|455186131|FG000|Overall Study|Lost to Follow-up|4|||
126516720|NCT01416805|455186132|FG001|Overall Study|Lost to Follow-up|4|||
126516721|NCT04632940|455186133|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
126516722|NCT04632940|455186134|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
126516723|NCT04632940|455186133|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
126516724|NCT04632940|455186134|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
126516725|NCT04632940|455186133|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
126516726|NCT04632940|455186134|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
126516727|NCT04632940|455186133|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
126516728|NCT04632940|455186134|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
126516729|NCT04632940|455186133|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
126516730|NCT04632940|455186134|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
126516731|NCT04632940|455186133|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
126516732|NCT04632940|455186134|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
126516733|NCT04632940|455186133|FG000|OLE Period (52 Weeks)|Other than specified|0|||
126516734|NCT04632940|455186134|FG001|OLE Period (52 Weeks)|Other than specified|1|||
126516735|NCT04632940|455186133|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
126516736|NCT04632940|455186134|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
126516737|NCT02799082|455186135|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
126516738|NCT02799082|455186136|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
126516739|NCT02799082|455186135|FG000|Overall Study|Protocol Violation|0|||
126516740|NCT02799082|455186136|FG001|Overall Study|Protocol Violation|1|||
126516741|NCT03251924|455186139|FG000|Overall Study|Disease Progression|6|||
126571204|NCT01307267|455387881|FG000|Overall Study|Withdrawal by Subject|0|||
126571205|NCT01307267|455387882|FG001|Overall Study|Withdrawal by Subject|0|||
126516742|NCT03251924|455186140|FG001|Overall Study|Disease Progression|6|||
126516743|NCT03251924|455186141|FG002|Overall Study|Disease Progression|7|||
126516744|NCT03251924|455186142|FG003|Overall Study|Disease Progression|8|||
126516745|NCT03251924|455186143|FG004|Overall Study|Disease Progression|8|||
126516746|NCT03251924|455186144|FG005|Overall Study|Disease Progression|7|||
126516747|NCT03251924|455186145|FG006|Overall Study|Disease Progression|6|||
126516748|NCT03251924|455186146|FG007|Overall Study|Disease Progression|10|||
126516749|NCT03251924|455186147|FG008|Overall Study|Disease Progression|6|||
126516750|NCT03251924|455186139|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
126516751|NCT03251924|455186140|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
126516752|NCT03251924|455186141|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
126516753|NCT03251924|455186142|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
126516754|NCT03251924|455186143|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
126516755|NCT03251924|455186144|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
126516756|NCT03251924|455186145|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
126516757|NCT03251924|455186146|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
126516758|NCT03251924|455186147|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
126516759|NCT03251924|455186139|FG000|Overall Study|Death|0|||
126516760|NCT03251924|455186140|FG001|Overall Study|Death|1|||
126516761|NCT03251924|455186141|FG002|Overall Study|Death|0|||
126516762|NCT03251924|455186142|FG003|Overall Study|Death|1|||
126516763|NCT03251924|455186143|FG004|Overall Study|Death|1|||
126516764|NCT03251924|455186144|FG005|Overall Study|Death|1|||
126516765|NCT03251924|455186145|FG006|Overall Study|Death|0|||
126516766|NCT03251924|455186146|FG007|Overall Study|Death|0|||
126516767|NCT03251924|455186147|FG008|Overall Study|Death|0|||
126516768|NCT03251924|455186139|FG000|Overall Study|Study Drug Toxicity|0|||
126516769|NCT03251924|455186140|FG001|Overall Study|Study Drug Toxicity|0|||
126516770|NCT03251924|455186141|FG002|Overall Study|Study Drug Toxicity|0|||
126516771|NCT03251924|455186142|FG003|Overall Study|Study Drug Toxicity|1|||
126516772|NCT03251924|455186143|FG004|Overall Study|Study Drug Toxicity|0|||
126516773|NCT03251924|455186144|FG005|Overall Study|Study Drug Toxicity|0|||
126516774|NCT03251924|455186145|FG006|Overall Study|Study Drug Toxicity|0|||
126516775|NCT03251924|455186146|FG007|Overall Study|Study Drug Toxicity|0|||
126516776|NCT03251924|455186147|FG008|Overall Study|Study Drug Toxicity|1|||
126516777|NCT03251924|455186139|FG000|Overall Study|Other Reasons|0|||
126516778|NCT03251924|455186140|FG001|Overall Study|Other Reasons|0|||
126516779|NCT03251924|455186141|FG002|Overall Study|Other Reasons|0|||
126516780|NCT03251924|455186142|FG003|Overall Study|Other Reasons|0|||
126516781|NCT03251924|455186143|FG004|Overall Study|Other Reasons|0|||
126516782|NCT03251924|455186144|FG005|Overall Study|Other Reasons|0|||
126516783|NCT03251924|455186145|FG006|Overall Study|Other Reasons|0|||
126516784|NCT03251924|455186146|FG007|Overall Study|Other Reasons|0|||
126516785|NCT03251924|455186147|FG008|Overall Study|Other Reasons|1|||
126516786|NCT03251924|455186139|FG000|Overall Study|Participant request to discontinue study treatment|0|||
126516787|NCT03251924|455186140|FG001|Overall Study|Participant request to discontinue study treatment|0|||
126516788|NCT03251924|455186141|FG002|Overall Study|Participant request to discontinue study treatment|0|||
126516789|NCT03251924|455186142|FG003|Overall Study|Participant request to discontinue study treatment|0|||
126516790|NCT03251924|455186143|FG004|Overall Study|Participant request to discontinue study treatment|0|||
126516791|NCT03251924|455186144|FG005|Overall Study|Participant request to discontinue study treatment|0|||
126516792|NCT03251924|455186145|FG006|Overall Study|Participant request to discontinue study treatment|0|||
126516793|NCT03251924|455186146|FG007|Overall Study|Participant request to discontinue study treatment|1|||
126516794|NCT03251924|455186147|FG008|Overall Study|Participant request to discontinue study treatment|0|||
126516795|NCT02617589|455186148|FG000|Randomization|Request to Discontinue Study Treatment|1|||
126516796|NCT02617589|455186149|FG001|Randomization|Request to Discontinue Study Treatment|3|||
126516797|NCT02617589|455186148|FG000|Randomization|Participant Withdrew Consent|1|||
126516798|NCT02617589|455186149|FG001|Randomization|Participant Withdrew Consent|2|||
126516799|NCT02617589|455186148|FG000|Treatment|Other Reasons|3|||
126516800|NCT02617589|455186149|FG001|Treatment|Other Reasons|3|||
126516801|NCT02617589|455186148|FG000|Treatment|Poor/Non Compliance|1|||
126516802|NCT02617589|455186149|FG001|Treatment|Poor/Non Compliance|1|||
126516803|NCT02617589|455186148|FG000|Treatment|Maximum Clinical Benefit|0|||
126516804|NCT02617589|455186149|FG001|Treatment|Maximum Clinical Benefit|2|||
126516805|NCT02617589|455186148|FG000|Treatment|Participant Withdrew Consent|2|||
126516806|NCT02617589|455186149|FG001|Treatment|Participant Withdrew Consent|6|||
126516807|NCT02617589|455186148|FG000|Treatment|Participant Request to Discontinue|12|||
126516808|NCT02617589|455186149|FG001|Treatment|Participant Request to Discontinue|21|||
126516809|NCT02617589|455186148|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
126516810|NCT02617589|455186149|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
126516811|NCT02617589|455186148|FG000|Treatment|Death|1|||
126516812|NCT02617589|455186149|FG001|Treatment|Death|1|||
126516813|NCT02617589|455186148|FG000|Treatment|Study Drug Toxicity|27|||
126516814|NCT02617589|455186149|FG001|Treatment|Study Drug Toxicity|20|||
126516815|NCT02617589|455186148|FG000|Treatment|Disease Progression|216|||
126516816|NCT02617589|455186149|FG001|Treatment|Disease Progression|136|||
126571206|NCT01307267|455387883|FG002|Overall Study|Withdrawal by Subject|0|||
126571207|NCT01307267|455387884|FG003|Overall Study|Withdrawal by Subject|0|||
126571208|NCT01307267|455387885|FG004|Overall Study|Withdrawal by Subject|0|||
126571209|NCT01307267|455387886|FG005|Overall Study|Withdrawal by Subject|1|||
126571210|NCT01307267|455387887|FG006|Overall Study|Withdrawal by Subject|0|||
126571211|NCT01307267|455387888|FG007|Overall Study|Withdrawal by Subject|1|||
126516817|NCT01591681|455186150|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
126516818|NCT01591681|455186150|FG000|Overall Study|Failed to use system during run-in|1|||
126516819|NCT00931307|455186151|FG000|Overall Study|Lack of Efficacy|12|||
126516820|NCT00931307|455186151|FG000|Overall Study|Biomicroscopy|1|||
126516821|NCT00774995|455186152|FG000|Overall Study|Protocol Violation|0|||
126516822|NCT00774995|455186153|FG001|Overall Study|Protocol Violation|0|||
126516823|NCT00774995|455186154|FG002|Overall Study|Protocol Violation|1|||
126516824|NCT00774995|455186155|FG003|Overall Study|Protocol Violation|0|||
126516825|NCT02348489|455187837|FG000|Overall Study|Death|336|||
126516826|NCT02348489|455187838|FG001|Overall Study|Death|335|||
126516827|NCT02348489|455187837|FG000|Overall Study|Withdrawal by Subject|14|||
126516828|NCT02348489|455187838|FG001|Overall Study|Withdrawal by Subject|27|||
126516829|NCT02348489|455187837|FG000|Overall Study|Lost to Follow-up|3|||
126516830|NCT02348489|455187838|FG001|Overall Study|Lost to Follow-up|5|||
126516831|NCT01639001|455187839|FG000|Overall Study|Refused further follow-up|9|||
126516832|NCT01639001|455187840|FG001|Overall Study|Refused further follow-up|12|||
126516833|NCT01639001|455187839|FG000|Overall Study|Lost to Follow-up|3|||
126516834|NCT01639001|455187840|FG001|Overall Study|Lost to Follow-up|0|||
126516835|NCT01639001|455187839|FG000|Overall Study|Death|62|||
126516836|NCT01639001|455187840|FG001|Overall Study|Death|61|||
126516837|NCT01639001|455187839|FG000|Overall Study|Randomized but not treated|0|||
126516838|NCT01639001|455187840|FG001|Overall Study|Randomized but not treated|2|||
126516839|NCT01639001|455187839|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
126516840|NCT01639001|455187840|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
126516841|NCT00201006|455187841|FG000|Overall Study|Withdrawal by Subject|7|||
126516842|NCT00201006|455187842|FG001|Overall Study|Withdrawal by Subject|2|||
126516843|NCT00201006|455187843|FG002|Overall Study|Withdrawal by Subject|3|||
126516844|NCT00201006|455187841|FG000|Overall Study|Adverse Event|1|||
126516845|NCT00201006|455187842|FG001|Overall Study|Adverse Event|0|||
126516846|NCT00201006|455187843|FG002|Overall Study|Adverse Event|1|||
126516847|NCT01750268|455187844|FG000|Overall Study|Lost to Follow-up|0|||
126516848|NCT01750268|455187845|FG001|Overall Study|Lost to Follow-up|2|||
126516849|NCT01750268|455187844|FG000|Overall Study|Physician Decision|0|||
126516850|NCT01750268|455187845|FG001|Overall Study|Physician Decision|3|||
126516851|NCT01750268|455187844|FG000|Overall Study|Withdrawal by Subject|2|||
126516852|NCT01750268|455187845|FG001|Overall Study|Withdrawal by Subject|0|||
126516853|NCT01969838|455187848|FG000|Double-blind Phase|Adverse Event|10|||
126516854|NCT01969838|455187849|FG001|Double-blind Phase|Adverse Event|4|||
126516855|NCT01969838|455187850|FG002|Double-blind Phase|Adverse Event|0|||
126516856|NCT01969838|455187851|FG003|Double-blind Phase|Adverse Event|0|||
126516857|NCT01969838|455187848|FG000|Double-blind Phase|Death|5|||
126516858|NCT01969838|455187849|FG001|Double-blind Phase|Death|2|||
126516859|NCT01969838|455187850|FG002|Double-blind Phase|Death|0|||
126516860|NCT01969838|455187851|FG003|Double-blind Phase|Death|0|||
126516861|NCT01969838|455187848|FG000|Double-blind Phase|Physician Decision|5|||
126516862|NCT01969838|455187849|FG001|Double-blind Phase|Physician Decision|1|||
126516863|NCT01969838|455187850|FG002|Double-blind Phase|Physician Decision|0|||
126516864|NCT01969838|455187851|FG003|Double-blind Phase|Physician Decision|0|||
126516865|NCT01969838|455187848|FG000|Double-blind Phase|Subject Decision|4|||
126516866|NCT01969838|455187849|FG001|Double-blind Phase|Subject Decision|2|||
126516867|NCT01969838|455187850|FG002|Double-blind Phase|Subject Decision|0|||
126516868|NCT01969838|455187851|FG003|Double-blind Phase|Subject Decision|0|||
126516869|NCT01969838|455187848|FG000|Double-blind Phase|Disease Progression|2|||
126516870|NCT01969838|455187849|FG001|Double-blind Phase|Disease Progression|0|||
126516871|NCT01969838|455187850|FG002|Double-blind Phase|Disease Progression|0|||
126516872|NCT01969838|455187851|FG003|Double-blind Phase|Disease Progression|0|||
126516873|NCT01969838|455187848|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
126516874|NCT01969838|455187849|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
126516875|NCT01969838|455187850|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
126516876|NCT01969838|455187851|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
126516877|NCT01969838|455187848|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
126516878|NCT01969838|455187849|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
126516879|NCT01969838|455187850|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
126516880|NCT01969838|455187851|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
126516881|NCT01969838|455187848|FG000|Open-label Phase|Adverse Event|0|||
126516882|NCT01969838|455187849|FG001|Open-label Phase|Adverse Event|0|||
126516883|NCT01969838|455187850|FG002|Open-label Phase|Adverse Event|37|||
126516884|NCT01969838|455187851|FG003|Open-label Phase|Adverse Event|49|||
126516885|NCT01969838|455187848|FG000|Open-label Phase|Disease Progression|0|||
126571212|NCT01307267|455387889|FG008|Overall Study|Withdrawal by Subject|5|||
126516886|NCT01969838|455187849|FG001|Open-label Phase|Disease Progression|0|||
126516887|NCT01969838|455187850|FG002|Open-label Phase|Disease Progression|26|||
126516888|NCT01969838|455187851|FG003|Open-label Phase|Disease Progression|27|||
126516889|NCT01969838|455187848|FG000|Open-label Phase|Lack of Efficacy|0|||
126516890|NCT01969838|455187849|FG001|Open-label Phase|Lack of Efficacy|0|||
126516891|NCT01969838|455187850|FG002|Open-label Phase|Lack of Efficacy|17|||
126516892|NCT01969838|455187851|FG003|Open-label Phase|Lack of Efficacy|19|||
126516893|NCT01969838|455187848|FG000|Open-label Phase|Subject Decision|0|||
126516894|NCT01969838|455187849|FG001|Open-label Phase|Subject Decision|0|||
126516895|NCT01969838|455187850|FG002|Open-label Phase|Subject Decision|14|||
126516896|NCT01969838|455187851|FG003|Open-label Phase|Subject Decision|15|||
126516897|NCT01969838|455187848|FG000|Open-label Phase|Death|0|||
126516898|NCT01969838|455187849|FG001|Open-label Phase|Death|0|||
126516899|NCT01969838|455187850|FG002|Open-label Phase|Death|13|||
126516900|NCT01969838|455187851|FG003|Open-label Phase|Death|11|||
126516901|NCT01969838|455187848|FG000|Open-label Phase|Physician Decision|0|||
126516902|NCT01969838|455187849|FG001|Open-label Phase|Physician Decision|0|||
126516903|NCT01969838|455187850|FG002|Open-label Phase|Physician Decision|9|||
126516904|NCT01969838|455187851|FG003|Open-label Phase|Physician Decision|14|||
126516905|NCT01969838|455187848|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
126777000|NCT00373685|456139153|FG001|Overall Study|Insufficient clinical response|119|||
126777001|NCT00373685|456139152|FG000|Overall Study|Did not meet entrance criteria|167|||
126777002|NCT00373685|456139153|FG001|Overall Study|Did not meet entrance criteria|184|||
126777003|NCT00373685|456139152|FG000|Overall Study|Lost to follow up|83|||
126777004|NCT00373685|456139153|FG001|Overall Study|Lost to follow up|103|||
126777005|NCT00373685|456139152|FG000|Overall Study|No longer willing to participate|337|||
126777006|NCT00373685|456139153|FG001|Overall Study|No longer willing to participate|352|||
126777007|NCT00373685|456139152|FG000|Overall Study|Other|149|||
126777008|NCT00373685|456139153|FG001|Overall Study|Other|146|||
126777009|NCT00373685|456139152|FG000|Overall Study|Protocol Violation|191|||
126777010|NCT00373685|456139153|FG001|Overall Study|Protocol Violation|182|||
126777011|NCT00373685|456139152|FG000|Overall Study|Final Status Unknown|12|||
126777012|NCT00373685|456139153|FG001|Overall Study|Final Status Unknown|4|||
126516906|NCT01969838|455187849|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
126516907|NCT01969838|455187850|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
126516908|NCT01969838|455187851|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
126516909|NCT03087591|455187853|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
126516910|NCT03087591|455187853|FG000|Overall Study|Withdrawal by Subject|1|||
126516911|NCT00408993|455187854|FG000|Overall Study|Adverse Event|15|||
126516912|NCT00408993|455187855|FG001|Overall Study|Adverse Event|4|||
126516913|NCT00408993|455187854|FG000|Overall Study|Protocol Violation|1|||
126516914|NCT00408993|455187855|FG001|Overall Study|Protocol Violation|6|||
126516915|NCT00408993|455187854|FG000|Overall Study|Lack of Efficacy|1|||
126516916|NCT00408993|455187855|FG001|Overall Study|Lack of Efficacy|4|||
126516917|NCT00408993|455187854|FG000|Overall Study|Withdrawal by Subject|2|||
126516918|NCT00408993|455187855|FG001|Overall Study|Withdrawal by Subject|3|||
126516919|NCT03738865|455187856|FG000|Overall Study|Withdrawal by Subject|3|||
126516920|NCT03738865|455187857|FG001|Overall Study|Withdrawal by Subject|3|||
126516921|NCT03738865|455187856|FG000|Overall Study|Adverse Event|2|||
126516922|NCT03738865|455187857|FG001|Overall Study|Adverse Event|0|||
126516923|NCT03738865|455187856|FG000|Overall Study|Physician Decision|0|||
126516924|NCT03738865|455187857|FG001|Overall Study|Physician Decision|1|||
126516925|NCT02621606|455187858|FG000|Overall Study|Withdrawal by Subject|0|||
126516926|NCT02621606|455187859|FG001|Overall Study|Withdrawal by Subject|1|||
126516927|NCT02621606|455187860|FG002|Overall Study|Withdrawal by Subject|0|||
126516928|NCT01694706|455187861|FG000|Overall Study|Adverse Event|0|||
126516929|NCT01694706|455187862|FG001|Overall Study|Adverse Event|1|||
126516930|NCT01694706|455187863|FG002|Overall Study|Adverse Event|0|||
126516931|NCT01694706|455187861|FG000|Overall Study|other reason not defined above|1|||
126516932|NCT01694706|455187862|FG001|Overall Study|other reason not defined above|0|||
126516933|NCT01694706|455187863|FG002|Overall Study|other reason not defined above|0|||
126516934|NCT02057757|455187864|FG000|Overall Study|Withdrawal by Subject|3|||
126516935|NCT02057757|455187865|FG001|Overall Study|Withdrawal by Subject|5|||
126516936|NCT02057757|455187864|FG000|Overall Study|Death|2|||
126516937|NCT02057757|455187865|FG001|Overall Study|Death|0|||
126516938|NCT02057757|455187864|FG000|Overall Study|Lost to Follow-up|8|||
126516939|NCT02057757|455187865|FG001|Overall Study|Lost to Follow-up|3|||
126516940|NCT02057757|455187864|FG000|Overall Study|Non-compliance|1|||
126516941|NCT02057757|455187865|FG001|Overall Study|Non-compliance|0|||
126516942|NCT03614793|455187866|FG000|Overall Study|Lost to Follow-up|1|||
126516943|NCT03614793|455187867|FG001|Overall Study|Lost to Follow-up|2|||
126516944|NCT03614793|455187866|FG000|Overall Study|Lack of Efficacy|0|||
126516945|NCT03614793|455187867|FG001|Overall Study|Lack of Efficacy|5|||
126516946|NCT03614793|455187866|FG000|Overall Study|Withdrawal by Subject|0|||
126516947|NCT03614793|455187867|FG001|Overall Study|Withdrawal by Subject|1|||
126777013|NCT00373685|456139152|FG000|Overall Study|Randomized, not treated|51|||
126777014|NCT00373685|456139153|FG001|Overall Study|Randomized, not treated|77|||
126777015|NCT01789281|456139154|FG000|Overall Study|Disease progression|15|||
126516948|NCT03614793|455187866|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
126516949|NCT03614793|455187867|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
126516950|NCT02082522|455187868|FG000|Overall Study|Sponsor termination|5|||
126516951|NCT02082522|455187869|FG001|Overall Study|Sponsor termination|3|||
126516952|NCT02082522|455187868|FG000|Overall Study|Withdrawal by Subject|2|||
126516953|NCT02082522|455187869|FG001|Overall Study|Withdrawal by Subject|4|||
126516954|NCT02082522|455187868|FG000|Overall Study|Death|1|||
126516955|NCT02082522|455187869|FG001|Overall Study|Death|0|||
126516956|NCT02082522|455187868|FG000|Overall Study|Lost to Follow-up|1|||
126516957|NCT02082522|455187869|FG001|Overall Study|Lost to Follow-up|0|||
126516958|NCT02082522|455187868|FG000|Overall Study|Physician Decision|3|||
126516959|NCT02082522|455187869|FG001|Overall Study|Physician Decision|1|||
126516960|NCT02082522|455187868|FG000|Overall Study|Disease progression|2|||
126516961|NCT02082522|455187869|FG001|Overall Study|Disease progression|2|||
126516962|NCT02082522|455187868|FG000|Overall Study|Chemotherapy change|1|||
126516963|NCT02082522|455187869|FG001|Overall Study|Chemotherapy change|3|||
126516964|NCT00456092|455187870|FG000|Extension Phase|Grade 2 or Greater AE|2|||
126516965|NCT00456092|455187871|FG001|Extension Phase|Grade 2 or Greater AE|2|||
126516966|NCT00456092|455187872|FG002|Extension Phase|Grade 2 or Greater AE|0|||
126516967|NCT00456092|455187873|FG003|Extension Phase|Grade 2 or Greater AE|0|||
126516968|NCT00456092|455187874|FG004|Extension Phase|Grade 2 or Greater AE|2|||
126516969|NCT00456092|455187870|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
126516970|NCT00456092|455187871|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
126516971|NCT00456092|455187872|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
126516972|NCT00456092|455187873|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
126516973|NCT00456092|455187874|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
126516974|NCT00456092|455187870|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
126516975|NCT00456092|455187871|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
126516976|NCT00456092|455187872|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
126516977|NCT00456092|455187873|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
126516978|NCT00456092|455187874|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
126516979|NCT00456092|455187870|FG000|Extension Phase|Withdrew Consent|2|||
126516980|NCT00456092|455187871|FG001|Extension Phase|Withdrew Consent|0|||
126516981|NCT00456092|455187872|FG002|Extension Phase|Withdrew Consent|0|||
126516982|NCT00456092|455187873|FG003|Extension Phase|Withdrew Consent|0|||
126516983|NCT00456092|455187874|FG004|Extension Phase|Withdrew Consent|0|||
126516984|NCT00456092|455187870|FG000|Extension Phase|Lost to Follow-up|1|||
126516985|NCT00456092|455187871|FG001|Extension Phase|Lost to Follow-up|1|||
126516986|NCT00456092|455187872|FG002|Extension Phase|Lost to Follow-up|0|||
126516987|NCT00456092|455187873|FG003|Extension Phase|Lost to Follow-up|0|||
126516988|NCT00456092|455187874|FG004|Extension Phase|Lost to Follow-up|1|||
126516989|NCT00456092|455187870|FG000|Extension Phase|Other|2|||
126516990|NCT00456092|455187871|FG001|Extension Phase|Other|0|||
126516991|NCT00456092|455187872|FG002|Extension Phase|Other|0|||
126516992|NCT00456092|455187873|FG003|Extension Phase|Other|1|||
126516993|NCT00456092|455187874|FG004|Extension Phase|Other|1|||
126516994|NCT00456092|455187870|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
126516995|NCT00456092|455187871|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
126516996|NCT00456092|455187872|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
126516997|NCT00456092|455187873|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
126516998|NCT00456092|455187874|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
126516999|NCT00456092|455187870|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
126517000|NCT00456092|455187871|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
126517001|NCT00456092|455187872|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
126517002|NCT00456092|455187873|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
126517003|NCT00456092|455187874|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
126517004|NCT00456092|455187870|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
126517005|NCT00456092|455187871|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
126517006|NCT00456092|455187872|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
126517007|NCT00456092|455187873|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
126517008|NCT00456092|455187874|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
126517009|NCT00456092|455187870|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
126517010|NCT00456092|455187871|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
126517011|NCT00456092|455187872|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
126517012|NCT00456092|455187873|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
126517013|NCT00456092|455187874|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
126517014|NCT00456092|455187870|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
126517015|NCT00456092|455187871|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
126517016|NCT00456092|455187872|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
126517017|NCT00456092|455187873|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
126517018|NCT00456092|455187874|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
126571213|NCT01307267|455387890|FG009|Overall Study|Withdrawal by Subject|1|||
126517019|NCT00456092|455187870|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
126571214|NCT01307267|455387891|FG010|Overall Study|Withdrawal by Subject|1|||
126571215|NCT01307267|455387892|FG011|Overall Study|Withdrawal by Subject|1|||
126571216|NCT01307267|455387893|FG012|Overall Study|Withdrawal by Subject|0|||
126571217|NCT01307267|455387894|FG013|Overall Study|Withdrawal by Subject|0|||
126571218|NCT01307267|455387895|FG014|Overall Study|Withdrawal by Subject|0|||
126571219|NCT01307267|455387896|FG015|Overall Study|Withdrawal by Subject|0|||
126571220|NCT01307267|455387897|FG016|Overall Study|Withdrawal by Subject|0|||
126571221|NCT01307267|455387898|FG017|Overall Study|Withdrawal by Subject|0|||
126517020|NCT00456092|455187871|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
126517021|NCT00456092|455187872|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
126517022|NCT00456092|455187873|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
126517023|NCT00456092|455187874|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
126517024|NCT00456092|455187870|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
126517025|NCT00456092|455187871|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
126517026|NCT00456092|455187872|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
126517027|NCT00456092|455187873|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
126517028|NCT00456092|455187874|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
126517029|NCT00456092|455187870|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
126517030|NCT00456092|455187871|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
126517031|NCT00456092|455187872|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
126517032|NCT00456092|455187873|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
126517033|NCT00456092|455187874|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
126517034|NCT00456092|455187870|FG000|Treatment Phase (12 Weeks)|Other|1|||
126517035|NCT00456092|455187871|FG001|Treatment Phase (12 Weeks)|Other|0|||
126517036|NCT00456092|455187872|FG002|Treatment Phase (12 Weeks)|Other|1|||
126517037|NCT00456092|455187873|FG003|Treatment Phase (12 Weeks)|Other|0|||
126517038|NCT00456092|455187874|FG004|Treatment Phase (12 Weeks)|Other|0|||
126517039|NCT00563797|455187875|FG000|Overall Study|Lost to Follow-up|7|||
126517040|NCT00563797|455187876|FG001|Overall Study|Lost to Follow-up|2|||
126517041|NCT00659269|455187877|FG000|Overall Study|Physician Decision|1|||
126517042|NCT00659269|455187878|FG001|Overall Study|Physician Decision|1|||
126517043|NCT01158222|455187879|FG000|Overall Study|Not eligible for intermediate phase|17|||
126517044|NCT02443298|455187880|FG000|Overall Study|Adverse Event|3|||
126517045|NCT02443298|455187881|FG001|Overall Study|Adverse Event|3|||
126517046|NCT02443298|455187880|FG000|Overall Study|Withdrawal by Subject|1|||
126517047|NCT02443298|455187881|FG001|Overall Study|Withdrawal by Subject|2|||
126517048|NCT01490060|455187886|FG000|Cycle 1|Change of Treatment|0|||
126517049|NCT01490060|455187887|FG001|Cycle 1|Change of Treatment|1|||
126517050|NCT01490060|455187888|FG002|Cycle 1|Change of Treatment|1|||
126517051|NCT01490060|455187889|FG003|Cycle 1|Change of Treatment|1|||
126517052|NCT01490060|455187886|FG000|Cycle 1|Insurance Denied|0|||
126517053|NCT01490060|455187887|FG001|Cycle 1|Insurance Denied|0|||
126517054|NCT01490060|455187888|FG002|Cycle 1|Insurance Denied|2|||
126517055|NCT01490060|455187889|FG003|Cycle 1|Insurance Denied|0|||
126517056|NCT01490060|455187886|FG000|Cycle 1|Withdrawal by Subject|0|||
126517057|NCT01490060|455187887|FG001|Cycle 1|Withdrawal by Subject|0|||
126517058|NCT01490060|455187888|FG002|Cycle 1|Withdrawal by Subject|0|||
126517059|NCT01490060|455187889|FG003|Cycle 1|Withdrawal by Subject|1|||
126517060|NCT01490060|455187886|FG000|Cycle 1|Treatment at Another Facility|0|||
126517061|NCT01490060|455187887|FG001|Cycle 1|Treatment at Another Facility|0|||
126517062|NCT01490060|455187888|FG002|Cycle 1|Treatment at Another Facility|0|||
126517063|NCT01490060|455187889|FG003|Cycle 1|Treatment at Another Facility|1|||
126517064|NCT01490060|455187886|FG000|Cycle 2|Change of Treatment|1|||
126517065|NCT01490060|455187887|FG001|Cycle 2|Change of Treatment|1|||
126517066|NCT01490060|455187888|FG002|Cycle 2|Change of Treatment|0|||
126517067|NCT01490060|455187889|FG003|Cycle 2|Change of Treatment|0|||
126517068|NCT01490060|455187886|FG000|Cycle 2|Non-Compliance|0|||
126517069|NCT01490060|455187887|FG001|Cycle 2|Non-Compliance|0|||
126517070|NCT01490060|455187888|FG002|Cycle 2|Non-Compliance|1|||
126517071|NCT01490060|455187889|FG003|Cycle 2|Non-Compliance|0|||
126517072|NCT01490060|455187886|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
126517073|NCT01490060|455187887|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
126517074|NCT01490060|455187888|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
126517075|NCT01490060|455187889|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
126517076|NCT01877421|455187890|FG000|Phase 2|Lost to Follow-up|0|||
126517077|NCT01877421|455187891|FG001|Phase 2|Lost to Follow-up|0|||
126517078|NCT01877421|455187892|FG002|Phase 2|Lost to Follow-up|0|||
126517079|NCT01877421|455187893|FG003|Phase 2|Lost to Follow-up|0|||
126517080|NCT01877421|455187894|FG004|Phase 2|Lost to Follow-up|0|||
126571222|NCT01307267|455387899|FG018|Overall Study|Withdrawal by Subject|0|||
126727263|NCT04387136|455951094|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
126517081|NCT01877421|455187895|FG005|Phase 2|Lost to Follow-up|0|||
126517082|NCT01877421|455187896|FG006|Phase 2|Lost to Follow-up|1|||
126517083|NCT01877421|455187897|FG007|Phase 2|Lost to Follow-up|0|||
126517084|NCT01877421|455187898|FG008|Phase 2|Lost to Follow-up|0|||
126517085|NCT01877421|455187899|FG009|Phase 2|Lost to Follow-up|0|||
126517086|NCT01877421|455187900|FG010|Phase 2|Lost to Follow-up|0|||
126517087|NCT01877421|455187901|FG011|Phase 2|Lost to Follow-up|0|||
126517088|NCT01877421|455187902|FG012|Phase 2|Lost to Follow-up|0|||
126517089|NCT01877421|455187903|FG013|Phase 2|Lost to Follow-up|0|||
126517090|NCT01877421|455187904|FG014|Phase 2|Lost to Follow-up|0|||
126517091|NCT01877421|455187905|FG015|Phase 2|Lost to Follow-up|0|||
126517092|NCT01877421|455187906|FG016|Phase 2|Lost to Follow-up|0|||
126517093|NCT01877421|455187907|FG017|Phase 2|Lost to Follow-up|0|||
126517094|NCT01877421|455187890|FG000|Phase 2|Withdrawal by Subject|0|||
126517095|NCT01877421|455187891|FG001|Phase 2|Withdrawal by Subject|0|||
126517096|NCT01877421|455187892|FG002|Phase 2|Withdrawal by Subject|0|||
126517097|NCT01877421|455187893|FG003|Phase 2|Withdrawal by Subject|0|||
126517098|NCT01877421|455187894|FG004|Phase 2|Withdrawal by Subject|0|||
126517099|NCT01877421|455187895|FG005|Phase 2|Withdrawal by Subject|0|||
126517100|NCT01877421|455187896|FG006|Phase 2|Withdrawal by Subject|0|||
126517101|NCT01877421|455187897|FG007|Phase 2|Withdrawal by Subject|0|||
126517102|NCT01877421|455187898|FG008|Phase 2|Withdrawal by Subject|1|||
126517103|NCT01877421|455187899|FG009|Phase 2|Withdrawal by Subject|0|||
126517104|NCT01877421|455187900|FG010|Phase 2|Withdrawal by Subject|1|||
126517105|NCT01877421|455187901|FG011|Phase 2|Withdrawal by Subject|0|||
126517106|NCT01877421|455187902|FG012|Phase 2|Withdrawal by Subject|1|||
126517107|NCT01877421|455187903|FG013|Phase 2|Withdrawal by Subject|0|||
126517108|NCT01877421|455187904|FG014|Phase 2|Withdrawal by Subject|0|||
126517109|NCT01877421|455187905|FG015|Phase 2|Withdrawal by Subject|1|||
126517110|NCT01877421|455187906|FG016|Phase 2|Withdrawal by Subject|0|||
126517111|NCT01877421|455187907|FG017|Phase 2|Withdrawal by Subject|0|||
126517112|NCT01877421|455187890|FG000|Phase 2|Protocol Violation|0|||
126517113|NCT01877421|455187891|FG001|Phase 2|Protocol Violation|0|||
126517114|NCT01877421|455187892|FG002|Phase 2|Protocol Violation|0|||
126517115|NCT01877421|455187893|FG003|Phase 2|Protocol Violation|0|||
126517116|NCT01877421|455187894|FG004|Phase 2|Protocol Violation|0|||
126517117|NCT01877421|455187895|FG005|Phase 2|Protocol Violation|0|||
126517118|NCT01877421|455187896|FG006|Phase 2|Protocol Violation|0|||
126517119|NCT01877421|455187897|FG007|Phase 2|Protocol Violation|0|||
126517120|NCT01877421|455187898|FG008|Phase 2|Protocol Violation|0|||
126517121|NCT01877421|455187899|FG009|Phase 2|Protocol Violation|0|||
126517122|NCT01877421|455187900|FG010|Phase 2|Protocol Violation|1|||
126517123|NCT01877421|455187901|FG011|Phase 2|Protocol Violation|0|||
126517124|NCT01877421|455187902|FG012|Phase 2|Protocol Violation|0|||
126517125|NCT01877421|455187903|FG013|Phase 2|Protocol Violation|0|||
126517126|NCT01877421|455187904|FG014|Phase 2|Protocol Violation|0|||
126517127|NCT01877421|455187905|FG015|Phase 2|Protocol Violation|0|||
126517128|NCT01877421|455187906|FG016|Phase 2|Protocol Violation|0|||
126517129|NCT01877421|455187907|FG017|Phase 2|Protocol Violation|0|||
126517130|NCT01047683|455187908|FG000|Overall Study|Adverse Event|3|||
126517131|NCT01047683|455187909|FG001|Overall Study|Adverse Event|1|||
126517132|NCT01047683|455187910|FG002|Overall Study|Adverse Event|0|||
126517133|NCT01047683|455187908|FG000|Overall Study|Withdrew Consent|1|||
126517134|NCT01047683|455187909|FG001|Overall Study|Withdrew Consent|4|||
126517135|NCT01047683|455187910|FG002|Overall Study|Withdrew Consent|2|||
126517136|NCT01047683|455187908|FG000|Overall Study|Lost to Follow-up|0|||
126517137|NCT01047683|455187909|FG001|Overall Study|Lost to Follow-up|1|||
126517138|NCT01047683|455187910|FG002|Overall Study|Lost to Follow-up|0|||
126517139|NCT01047683|455187908|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
126517140|NCT01047683|455187909|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
126517141|NCT01047683|455187910|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
126517142|NCT00908960|455187912|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
126517143|NCT00908960|455187913|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
126517144|NCT00908960|455187914|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
126517145|NCT05074433|455187915|FG000|Overall Study|Adverse Event|0|||
126517146|NCT05074433|455187916|FG001|Overall Study|Adverse Event|2|||
126517147|NCT05074433|455187917|FG002|Overall Study|Adverse Event|0|||
126517148|NCT05074433|455187918|FG003|Overall Study|Adverse Event|1|||
126517149|NCT05074433|455187915|FG000|Overall Study|Sponsor Request|0|||
126517150|NCT05074433|455187916|FG001|Overall Study|Sponsor Request|1|||
126517151|NCT05074433|455187917|FG002|Overall Study|Sponsor Request|1|||
126517152|NCT05074433|455187918|FG003|Overall Study|Sponsor Request|0|||
126517153|NCT05074433|455187915|FG000|Overall Study|Death|1|||
126517154|NCT05074433|455187916|FG001|Overall Study|Death|0|||
126517155|NCT05074433|455187917|FG002|Overall Study|Death|0|||
126517156|NCT05074433|455187918|FG003|Overall Study|Death|0|||
126517157|NCT05074433|455187915|FG000|Overall Study|Lost to Follow-up|0|||
126517158|NCT05074433|455187916|FG001|Overall Study|Lost to Follow-up|0|||
126517159|NCT05074433|455187917|FG002|Overall Study|Lost to Follow-up|2|||
126517160|NCT05074433|455187918|FG003|Overall Study|Lost to Follow-up|0|||
126517161|NCT05074433|455187915|FG000|Overall Study|Subject Decision|8|||
126517162|NCT05074433|455187916|FG001|Overall Study|Subject Decision|6|||
126517163|NCT05074433|455187917|FG002|Overall Study|Subject Decision|4|||
126517164|NCT05074433|455187918|FG003|Overall Study|Subject Decision|5|||
126517165|NCT01158924|455187920|FG000|Overall Study|Withdrawal by Subject|1|||
126517166|NCT01158924|455187921|FG001|Overall Study|Withdrawal by Subject|2|||
126517167|NCT01158924|455187920|FG000|Overall Study|Lost to Follow-up|0|||
126517168|NCT01158924|455187921|FG001|Overall Study|Lost to Follow-up|1|||
126517169|NCT03795922|455187922|FG000|Overall Study|Adverse Event|2|||
126517170|NCT03795922|455187923|FG001|Overall Study|Adverse Event|1|||
126517171|NCT03795922|455187922|FG000|Overall Study|Withdrawal by Subject|5|||
126517172|NCT03795922|455187923|FG001|Overall Study|Withdrawal by Subject|13|||
126517173|NCT03795922|455187922|FG000|Overall Study|Lost to Follow-up|2|||
126517174|NCT03795922|455187923|FG001|Overall Study|Lost to Follow-up|3|||
126517175|NCT03795922|455187922|FG000|Overall Study|Pregnancy|0|||
126727264|NCT04387136|455951095|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
126727265|NCT00099359|455951096|FG000|Overall Study|Death|11|||
126517176|NCT03795922|455187923|FG001|Overall Study|Pregnancy|1|||
126517177|NCT03795922|455187922|FG000|Overall Study|Physician Decision|1|||
126517178|NCT03795922|455187923|FG001|Overall Study|Physician Decision|2|||
126517179|NCT03795922|455187922|FG000|Overall Study|Protocol Violation|0|||
126517180|NCT03795922|455187923|FG001|Overall Study|Protocol Violation|1|||
126517181|NCT03795922|455187922|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
126517182|NCT03795922|455187923|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
126517183|NCT00733824|455187926|FG000|Phase I|Withdrawal by Subject|1|||
126517184|NCT00733824|455187927|FG001|Phase I|Withdrawal by Subject|0|||
126517185|NCT00733824|455187928|FG002|Phase I|Withdrawal by Subject|0|||
126517186|NCT00733824|455187929|FG003|Phase I|Withdrawal by Subject|0|||
126517187|NCT00733824|455187930|FG004|Phase I|Withdrawal by Subject|0|||
126517188|NCT02480621|455187931|FG000|Randomization|Withdrawal by Subject|1|||
126517189|NCT02480621|455187932|FG001|Randomization|Withdrawal by Subject|0|||
126517190|NCT02480621|455187931|FG000|Randomization|Surgeon did not give intervention|0|||
126517191|NCT02480621|455187932|FG001|Randomization|Surgeon did not give intervention|1|||
126517192|NCT02480621|455187931|FG000|Follow Up|Lost to Follow-up|4|||
126517193|NCT02480621|455187932|FG001|Follow Up|Lost to Follow-up|2|||
126517194|NCT03056690|455187933|FG000|Overall Study|Adverse Event|3|||
126517195|NCT03056690|455187934|FG001|Overall Study|Adverse Event|2|||
126517196|NCT03056690|455187933|FG000|Overall Study|Lack of Efficacy|1|||
126517197|NCT03056690|455187934|FG001|Overall Study|Lack of Efficacy|2|||
126517198|NCT03056690|455187933|FG000|Overall Study|Lost to Follow-up|3|||
126517199|NCT03056690|455187934|FG001|Overall Study|Lost to Follow-up|2|||
126517200|NCT03056690|455187933|FG000|Overall Study|Protocol Violation|2|||
126517201|NCT03056690|455187934|FG001|Overall Study|Protocol Violation|2|||
126517202|NCT03056690|455187933|FG000|Overall Study|Withdrawal by Subject|3|||
126517203|NCT03056690|455187934|FG001|Overall Study|Withdrawal by Subject|6|||
126517204|NCT03056690|455187933|FG000|Overall Study|Non-compliance with Study Drug|1|||
126517205|NCT03056690|455187934|FG001|Overall Study|Non-compliance with Study Drug|0|||
126517206|NCT03056690|455187933|FG000|Overall Study|Miscellaneous|1|||
126517207|NCT03056690|455187934|FG001|Overall Study|Miscellaneous|2|||
126517208|NCT02141516|455187935|FG000|Overall Study|Adverse Event|0|||
126517209|NCT02141516|455187936|FG001|Overall Study|Adverse Event|1|||
126517210|NCT02141516|455187937|FG002|Overall Study|Adverse Event|0|||
126517211|NCT02141516|455187935|FG000|Overall Study|Lost to Follow-up|0|||
126517212|NCT02141516|455187936|FG001|Overall Study|Lost to Follow-up|1|||
126517213|NCT02141516|455187937|FG002|Overall Study|Lost to Follow-up|0|||
126517214|NCT02141516|455187935|FG000|Overall Study|Other|0|||
126517215|NCT02141516|455187936|FG001|Overall Study|Other|3|||
126517216|NCT02141516|455187937|FG002|Overall Study|Other|0|||
126517217|NCT00153101|455187942|FG000|Overall Study|Lost to Follow-up|14|||
126517218|NCT00153101|455187943|FG001|Overall Study|Lost to Follow-up|14|||
126517219|NCT00153101|455187944|FG002|Overall Study|Lost to Follow-up|12|||
126517220|NCT00153101|455187945|FG003|Overall Study|Lost to Follow-up|5|||
126517221|NCT00153101|455187946|FG004|Overall Study|Lost to Follow-up|5|||
126517222|NCT00153101|455187942|FG000|Overall Study|Withdrawal by Subject|3|||
126517223|NCT00153101|455187943|FG001|Overall Study|Withdrawal by Subject|4|||
126517224|NCT00153101|455187944|FG002|Overall Study|Withdrawal by Subject|3|||
126517225|NCT00153101|455187945|FG003|Overall Study|Withdrawal by Subject|3|||
126517226|NCT00153101|455187946|FG004|Overall Study|Withdrawal by Subject|5|||
126517227|NCT02610140|455187947|FG000|Randomization and Treatment Period|Radiological progression|23|||
126517228|NCT02610140|455187948|FG001|Randomization and Treatment Period|Radiological progression|15|||
126517229|NCT02610140|455187947|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
126517230|NCT02610140|455187948|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
126517231|NCT02610140|455187947|FG000|Randomization and Treatment Period|Protocol Violation|1|||
126517232|NCT02610140|455187948|FG001|Randomization and Treatment Period|Protocol Violation|0|||
126517233|NCT02610140|455187947|FG000|Randomization and Treatment Period|Physician Decision|0|||
126517234|NCT02610140|455187948|FG001|Randomization and Treatment Period|Physician Decision|1|||
126517235|NCT02610140|455187947|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
126517236|NCT02610140|455187948|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
126517237|NCT02610140|455187947|FG000|Randomization and Treatment Period|Death|7|||
126517238|NCT02610140|455187948|FG001|Randomization and Treatment Period|Death|1|||
126517239|NCT02610140|455187947|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
126517240|NCT02610140|455187948|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
126571223|NCT01307267|455387900|FG019|Overall Study|Withdrawal by Subject|3|||
126571224|NCT01307267|455387901|FG020|Overall Study|Withdrawal by Subject|0|||
126571225|NCT01307267|455387902|FG021|Overall Study|Withdrawal by Subject|0|||
126571226|NCT01307267|455387903|FG022|Overall Study|Withdrawal by Subject|0|||
126571227|NCT01307267|455387881|FG000|Overall Study|Other|0|||
126571228|NCT01307267|455387882|FG001|Overall Study|Other|0|||
126571229|NCT01307267|455387883|FG002|Overall Study|Other|0|||
126571230|NCT01307267|455387884|FG003|Overall Study|Other|0|||
126571231|NCT01307267|455387885|FG004|Overall Study|Other|0|||
126517241|NCT02610140|455187947|FG000|Randomization and Treatment Period|Adverse Event|44|||
126727266|NCT00099359|455951097|FG001|Overall Study|Death|15|||
126517242|NCT02610140|455187948|FG001|Randomization and Treatment Period|Adverse Event|13|||
126517243|NCT02610140|455187947|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
126517244|NCT02610140|455187948|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
126517245|NCT02610140|455187947|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
126517246|NCT02610140|455187948|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
126517247|NCT02610140|455187947|FG000|Randomization and Treatment Period|Not treated|3|||
126517248|NCT02610140|455187948|FG001|Randomization and Treatment Period|Not treated|10|||
126517249|NCT02610140|455187947|FG000|Safety Follow-up|Other|0|||
126517250|NCT02610140|455187948|FG001|Safety Follow-up|Other|2|||
126517251|NCT02610140|455187947|FG000|Safety Follow-up|Lost to Follow-up|1|||
126517252|NCT02610140|455187948|FG001|Safety Follow-up|Lost to Follow-up|0|||
126517253|NCT02610140|455187947|FG000|Safety Follow-up|No follow-up|5|||
126517254|NCT02610140|455187948|FG001|Safety Follow-up|No follow-up|3|||
126517255|NCT02610140|455187947|FG000|Safety Follow-up|Death|12|||
126517256|NCT02610140|455187948|FG001|Safety Follow-up|Death|2|||
126517257|NCT02610140|455187947|FG000|Safety Follow-up|Deterioration of general conditions|15|||
126517258|NCT02610140|455187948|FG001|Safety Follow-up|Deterioration of general conditions|5|||
126517259|NCT02610140|455187947|FG000|Safety Follow-up|Withdrawal by Subject|12|||
126517260|NCT02610140|455187948|FG001|Safety Follow-up|Withdrawal by Subject|12|||
126517261|NCT02610140|455187947|FG000|Active Follow-up|Progressive disease - radiological|30|||
126517262|NCT02610140|455187948|FG001|Active Follow-up|Progressive disease - radiological|22|||
126517263|NCT02610140|455187947|FG000|Active Follow-up|Death|8|||
126517264|NCT02610140|455187948|FG001|Active Follow-up|Death|1|||
126517265|NCT02610140|455187947|FG000|Active Follow-up|Withdrawal by Subject|4|||
126517266|NCT02610140|455187948|FG001|Active Follow-up|Withdrawal by Subject|0|||
126517267|NCT02610140|455187947|FG000|Active Follow-up|Progressive disease - clinical|1|||
126517268|NCT02610140|455187948|FG001|Active Follow-up|Progressive disease - clinical|2|||
126517269|NCT02610140|455187947|FG000|Active Follow-up|Deterioration of general conditions|1|||
126517270|NCT02610140|455187948|FG001|Active Follow-up|Deterioration of general conditions|0|||
126517271|NCT02610140|455187947|FG000|Active Follow-up|Ongoing but not completed|4|||
126517272|NCT02610140|455187948|FG001|Active Follow-up|Ongoing but not completed|1|||
126517273|NCT02610140|455187947|FG000|Long-term Follow-up|Death|86|||
126517274|NCT02610140|455187948|FG001|Long-term Follow-up|Death|44|||
126517275|NCT02610140|455187947|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
126517276|NCT02610140|455187948|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
126517277|NCT02610140|455187947|FG000|Long-term Follow-up|Lost to Follow-up|1|||
126517278|NCT02610140|455187948|FG001|Long-term Follow-up|Lost to Follow-up|2|||
126517279|NCT02610140|455187947|FG000|Long-term Follow-up|Ongoing but not completed|30|||
126517280|NCT02610140|455187948|FG001|Long-term Follow-up|Ongoing but not completed|17|||
126517281|NCT03169153|455187949|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
126517282|NCT03169153|455187950|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
126517283|NCT03169153|455187949|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
126517284|NCT03169153|455187950|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
126517285|NCT03169153|455187949|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
126517286|NCT03169153|455187950|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
126517287|NCT03169153|455187949|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
126517288|NCT03169153|455187950|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
126517289|NCT00887341|455187951|FG000|Overall Study|Refused treatment|1|||
126517290|NCT00887341|455187952|FG001|Overall Study|Refused treatment|0|||
126517291|NCT00887341|455187951|FG000|Overall Study|Withdrawal by Subject|1|||
126517292|NCT00887341|455187952|FG001|Overall Study|Withdrawal by Subject|1|||
126517293|NCT00887341|455187951|FG000|Overall Study|Adverse Event|0|||
126571232|NCT01307267|455387886|FG005|Overall Study|Other|7|||
126727267|NCT00099359|455951098|FG002|Overall Study|Death|17|||
126517294|NCT00887341|455187952|FG001|Overall Study|Adverse Event|1|||
126517295|NCT00887341|455187951|FG000|Overall Study|Lost to Follow-up|0|||
126517296|NCT00887341|455187952|FG001|Overall Study|Lost to Follow-up|1|||
126517297|NCT01649856|455187955|FG000|Overall Study|Withdrawal by Subject|14|||
126517298|NCT01649856|455187956|FG001|Overall Study|Withdrawal by Subject|14|||
126517299|NCT01649856|455187955|FG000|Overall Study|Protocol Violation|4|||
126517300|NCT01649856|455187956|FG001|Overall Study|Protocol Violation|4|||
126517301|NCT01649856|455187955|FG000|Overall Study|Treatment Failure|1|||
126517302|NCT01649856|455187956|FG001|Overall Study|Treatment Failure|1|||
126517303|NCT01649856|455187955|FG000|Overall Study|Death|69|||
126571233|NCT01307267|455387887|FG006|Overall Study|Other|0|||
126571234|NCT01307267|455387888|FG007|Overall Study|Other|1|||
126571235|NCT01307267|455387889|FG008|Overall Study|Other|3|||
126571236|NCT01307267|455387890|FG009|Overall Study|Other|0|||
126571237|NCT01307267|455387891|FG010|Overall Study|Other|1|||
126571238|NCT01307267|455387892|FG011|Overall Study|Other|1|||
126571239|NCT01307267|455387893|FG012|Overall Study|Other|1|||
126571240|NCT01307267|455387894|FG013|Overall Study|Other|0|||
126571241|NCT01307267|455387895|FG014|Overall Study|Other|2|||
126571242|NCT01307267|455387896|FG015|Overall Study|Other|1|||
126571243|NCT01307267|455387897|FG016|Overall Study|Other|0|||
126571244|NCT01307267|455387898|FG017|Overall Study|Other|0|||
126571245|NCT01307267|455387899|FG018|Overall Study|Other|0|||
126571246|NCT01307267|455387900|FG019|Overall Study|Other|19|||
126571247|NCT01307267|455387901|FG020|Overall Study|Other|2|||
126571248|NCT01307267|455387902|FG021|Overall Study|Other|3|||
126571249|NCT01307267|455387903|FG022|Overall Study|Other|2|||
126571250|NCT04956575|455387906|FG000|Overall Study|Death|1|||
126571251|NCT04956575|455387907|FG001|Overall Study|Death|0|||
126571252|NCT04956575|455387908|FG002|Overall Study|Death|0|||
126571253|NCT04956575|455387909|FG003|Overall Study|Death|0|||
126571254|NCT04956575|455387910|FG004|Overall Study|Death|0|||
126571255|NCT04956575|455387911|FG005|Overall Study|Death|0|||
126571256|NCT04956575|455387912|FG006|Overall Study|Death|0|||
126571257|NCT04956575|455387913|FG007|Overall Study|Death|1|||
126571258|NCT04956575|455387914|FG008|Overall Study|Death|0|||
126571259|NCT04956575|455387915|FG009|Overall Study|Death|1|||
126571260|NCT04956575|455387916|FG010|Overall Study|Death|0|||
126571261|NCT04956575|455387917|FG011|Overall Study|Death|0|||
126571262|NCT04956575|455387906|FG000|Overall Study|Lost to Follow-up|3|||
126571263|NCT04956575|455387907|FG001|Overall Study|Lost to Follow-up|4|||
126571264|NCT04956575|455387908|FG002|Overall Study|Lost to Follow-up|2|||
126571265|NCT04956575|455387909|FG003|Overall Study|Lost to Follow-up|3|||
126571266|NCT04956575|455387910|FG004|Overall Study|Lost to Follow-up|1|||
126571267|NCT04956575|455387911|FG005|Overall Study|Lost to Follow-up|10|||
126571268|NCT04956575|455387912|FG006|Overall Study|Lost to Follow-up|11|||
126571269|NCT04956575|455387913|FG007|Overall Study|Lost to Follow-up|7|||
126571270|NCT04956575|455387914|FG008|Overall Study|Lost to Follow-up|4|||
126571271|NCT04956575|455387915|FG009|Overall Study|Lost to Follow-up|2|||
126571272|NCT04956575|455387916|FG010|Overall Study|Lost to Follow-up|3|||
126571273|NCT04956575|455387917|FG011|Overall Study|Lost to Follow-up|8|||
126571274|NCT04956575|455387906|FG000|Overall Study|Withdrawal by Subject|1|||
126571275|NCT04956575|455387907|FG001|Overall Study|Withdrawal by Subject|2|||
126571276|NCT04956575|455387908|FG002|Overall Study|Withdrawal by Subject|1|||
126571277|NCT04956575|455387909|FG003|Overall Study|Withdrawal by Subject|4|||
126571278|NCT04956575|455387910|FG004|Overall Study|Withdrawal by Subject|2|||
126571279|NCT04956575|455387911|FG005|Overall Study|Withdrawal by Subject|8|||
126571280|NCT04956575|455387912|FG006|Overall Study|Withdrawal by Subject|5|||
126571281|NCT04956575|455387913|FG007|Overall Study|Withdrawal by Subject|1|||
126571282|NCT04956575|455387914|FG008|Overall Study|Withdrawal by Subject|1|||
126571283|NCT04956575|455387915|FG009|Overall Study|Withdrawal by Subject|0|||
126571284|NCT04956575|455387916|FG010|Overall Study|Withdrawal by Subject|3|||
126571285|NCT04956575|455387917|FG011|Overall Study|Withdrawal by Subject|1|||
126571286|NCT03593876|455387918|FG000|Overall Study|Withdrawal by Subject|1|||
126571287|NCT03593876|455387918|FG000|Overall Study|Discharged home before intervention completion|2|||
126571288|NCT01290224|455387926|FG000|Overall Study|Adverse Event|1|||
126571289|NCT01290224|455387926|FG000|Overall Study|Refused Further Treatment|4|||
126571290|NCT01241292|455387927|FG000|Overall Study|Administrative Reason by Sponsor|1|||
126571291|NCT01241292|455387928|FG001|Overall Study|Administrative Reason by Sponsor|0|||
126571292|NCT01241292|455387927|FG000|Overall Study|Disease Progression|2|||
126571293|NCT01241292|455387928|FG001|Overall Study|Disease Progression|0|||
126571294|NCT01241292|455387927|FG000|Overall Study|Study Drug Toxicity|0|||
126571295|NCT01241292|455387928|FG001|Overall Study|Study Drug Toxicity|1|||
126571296|NCT01241292|455387927|FG000|Overall Study|Participant Discontinued Treatment|0|||
126571297|NCT01241292|455387928|FG001|Overall Study|Participant Discontinued Treatment|2|||
126571298|NCT00346333|455387931|FG000|Overall Study|Death|1|||
126571299|NCT00346333|455387932|FG001|Overall Study|Death|0|||
126571300|NCT00346333|455387931|FG000|Overall Study|unwilling or unable to continue|4|||
126571301|NCT00346333|455387932|FG001|Overall Study|unwilling or unable to continue|8|||
126571302|NCT01405924|455387933|FG000|Overall Study|Protocol Violation|8|||
126571303|NCT01405924|455387933|FG000|Overall Study|Missing/Incomplete Data|2|||
126571304|NCT00770965|455387937|FG000|Safety Set|Withdrawal by Subject|0|||
126571305|NCT00770965|455387938|FG001|Safety Set|Withdrawal by Subject|0|||
126571306|NCT00770965|455387939|FG002|Safety Set|Withdrawal by Subject|0|||
126571307|NCT00770965|455387940|FG003|Safety Set|Withdrawal by Subject|1|||
126571308|NCT00770965|455387937|FG000|Safety Set|Protocol deviation|0|||
126571309|NCT00770965|455387938|FG001|Safety Set|Protocol deviation|0|||
126571310|NCT00770965|455387939|FG002|Safety Set|Protocol deviation|1|||
126571311|NCT00770965|455387940|FG003|Safety Set|Protocol deviation|0|||
126571312|NCT00770965|455387937|FG000|Excluded Set|Administrative problems|14|||
126571313|NCT00770965|455387938|FG001|Excluded Set|Administrative problems|12|||
126571314|NCT00770965|455387939|FG002|Excluded Set|Administrative problems|12|||
126571315|NCT00770965|455387940|FG003|Excluded Set|Administrative problems|10|||
126571316|NCT00770965|455387937|FG000|Excluded Set|Withdrawal by Subject|1|||
126571317|NCT00770965|455387938|FG001|Excluded Set|Withdrawal by Subject|1|||
126571318|NCT00770965|455387939|FG002|Excluded Set|Withdrawal by Subject|2|||
126571319|NCT00770965|455387940|FG003|Excluded Set|Withdrawal by Subject|3|||
126571320|NCT01391130|455387944|FG000|Overall Study|Withdrawal by Subject|3|||
126571321|NCT01391130|455387945|FG001|Overall Study|Withdrawal by Subject|2|||
126571322|NCT01391130|455387944|FG000|Overall Study|Physician Decision|2|||
126571323|NCT01391130|455387945|FG001|Overall Study|Physician Decision|3|||
126571324|NCT01391130|455387944|FG000|Overall Study|Did not Receive Drug|1|||
126571325|NCT01391130|455387945|FG001|Overall Study|Did not Receive Drug|1|||
126571326|NCT03478696|455387946|FG000|Overall Study|Adverse Event|1|||
126571327|NCT03478696|455387947|FG001|Overall Study|Adverse Event|5|||
126571328|NCT03478696|455387946|FG000|Overall Study|Lost to Follow-up|1|||
126571329|NCT03478696|455387947|FG001|Overall Study|Lost to Follow-up|0|||
126571330|NCT03478696|455387946|FG000|Overall Study|Physician Decision|6|||
126571331|NCT03478696|455387947|FG001|Overall Study|Physician Decision|3|||
126571332|NCT03478696|455387946|FG000|Overall Study|Withdrawal by Subject|9|||
126571333|NCT03478696|455387947|FG001|Overall Study|Withdrawal by Subject|4|||
126571334|NCT03615924|455387948|FG000|Overall Study|Withdrawal by Subject|2|||
126571335|NCT03615924|455387949|FG001|Overall Study|Withdrawal by Subject|5|||
126571336|NCT03615924|455387948|FG000|Overall Study|Death|3|||
126571337|NCT03615924|455387949|FG001|Overall Study|Death|1|||
126571338|NCT03615924|455387948|FG000|Overall Study|Lost to Follow-up|1|||
126571339|NCT03615924|455387949|FG001|Overall Study|Lost to Follow-up|0|||
126571340|NCT03615924|455387948|FG000|Overall Study|Randomized in error|1|||
126571341|NCT03615924|455387949|FG001|Overall Study|Randomized in error|0|||
126571342|NCT03615924|455387948|FG000|Overall Study|Study termination by Sponsor|94|||
126571343|NCT03615924|455387949|FG001|Overall Study|Study termination by Sponsor|86|||
126571344|NCT00880048|455387957|FG000|Overall Study|Adverse Event|2|||
126571345|NCT00880048|455387958|FG001|Overall Study|Adverse Event|3|||
126571346|NCT00880048|455387959|FG002|Overall Study|Adverse Event|5|||
126571347|NCT00880048|455387957|FG000|Overall Study|Lack of Efficacy|1|||
126571348|NCT00880048|455387958|FG001|Overall Study|Lack of Efficacy|2|||
126571349|NCT00880048|455387959|FG002|Overall Study|Lack of Efficacy|2|||
126571350|NCT00880048|455387957|FG000|Overall Study|Protocol Violation|4|||
126571351|NCT00880048|455387958|FG001|Overall Study|Protocol Violation|6|||
126571352|NCT00880048|455387959|FG002|Overall Study|Protocol Violation|5|||
126571353|NCT00880048|455387957|FG000|Overall Study|Lost to Follow-up|6|||
126571354|NCT00880048|455387958|FG001|Overall Study|Lost to Follow-up|6|||
126571355|NCT00880048|455387959|FG002|Overall Study|Lost to Follow-up|5|||
126571356|NCT00880048|455387957|FG000|Overall Study|Physician Decision|1|||
126571357|NCT00880048|455387958|FG001|Overall Study|Physician Decision|1|||
126571358|NCT00880048|455387959|FG002|Overall Study|Physician Decision|7|||
126571359|NCT00880048|455387957|FG000|Overall Study|Withdrawal by Subject|5|||
126571360|NCT00880048|455387958|FG001|Overall Study|Withdrawal by Subject|8|||
126571361|NCT00880048|455387959|FG002|Overall Study|Withdrawal by Subject|5|||
126571362|NCT00880048|455387957|FG000|Overall Study|Study closed/terminated|9|||
126571363|NCT00880048|455387958|FG001|Overall Study|Study closed/terminated|7|||
126571364|NCT00880048|455387959|FG002|Overall Study|Study closed/terminated|6|||
126571365|NCT00367991|455387964|FG000|Overall Study|Withdrawal by Subject|1|||
126571366|NCT00367991|455387965|FG001|Overall Study|Withdrawal by Subject|1|||
126571367|NCT00367991|455387964|FG000|Overall Study|Adverse Event|1|||
126571368|NCT00367991|455387965|FG001|Overall Study|Adverse Event|1|||
126571369|NCT00346151|455387967|FG000|Overall Study|Withdrawal by Subject|3|||
126571370|NCT00841035|455387970|FG000|Phase 1 Overall Study|Physician Decision|13|||
126571371|NCT00094575|455387971|FG000|Overall Study|Death|146|||
126571372|NCT00094575|455387972|FG001|Overall Study|Death|146|||
126571373|NCT00961636|455387982|FG000|Overall Study|Adverse Event|35|||
126571374|NCT00961636|455387983|FG001|Overall Study|Adverse Event|54|||
126571375|NCT00961636|455387984|FG002|Overall Study|Adverse Event|13|||
126571376|NCT00961636|455387982|FG000|Overall Study|Flushing Symptoms|29|||
126571377|NCT00961636|455387983|FG001|Overall Study|Flushing Symptoms|46|||
126571378|NCT00961636|455387984|FG002|Overall Study|Flushing Symptoms|3|||
126571379|NCT00961636|455387982|FG000|Overall Study|Lost to Follow-up|2|||
126571380|NCT00961636|455387983|FG001|Overall Study|Lost to Follow-up|3|||
126571381|NCT00961636|455387984|FG002|Overall Study|Lost to Follow-up|1|||
126571382|NCT00961636|455387982|FG000|Overall Study|Physician Decision|3|||
126571383|NCT00961636|455387983|FG001|Overall Study|Physician Decision|1|||
126571384|NCT00961636|455387984|FG002|Overall Study|Physician Decision|1|||
126571385|NCT00961636|455387982|FG000|Overall Study|Protocol Violation|9|||
126571386|NCT00961636|455387983|FG001|Overall Study|Protocol Violation|5|||
126571387|NCT00961636|455387984|FG002|Overall Study|Protocol Violation|1|||
126571388|NCT00961636|455387982|FG000|Overall Study|Withdrawal by Subject|29|||
126571389|NCT00961636|455387983|FG001|Overall Study|Withdrawal by Subject|22|||
126571390|NCT00961636|455387984|FG002|Overall Study|Withdrawal by Subject|13|||
126571391|NCT01390402|455387985|FG000|Overall Study|Death|1|||
126571392|NCT01390402|455387985|FG000|Overall Study|Disease Progression|4|||
126571393|NCT02551055|455387988|FG000|Overall Study|Death|2|||
126571394|NCT02551055|455387989|FG001|Overall Study|Death|4|||
126571395|NCT02551055|455387990|FG002|Overall Study|Death|2|||
126571396|NCT02551055|455387991|FG003|Overall Study|Death|2|||
126571397|NCT02551055|455387992|FG004|Overall Study|Death|2|||
126571398|NCT02551055|455387993|FG005|Overall Study|Death|1|||
126571399|NCT02551055|455387994|FG006|Overall Study|Death|2|||
126571400|NCT02551055|455387995|FG007|Overall Study|Death|0|||
126571401|NCT02551055|455387988|FG000|Overall Study|Study Terminated by Sponsor|1|||
126571402|NCT02551055|455387989|FG001|Overall Study|Study Terminated by Sponsor|1|||
126571403|NCT02551055|455387990|FG002|Overall Study|Study Terminated by Sponsor|0|||
126571404|NCT02551055|455387991|FG003|Overall Study|Study Terminated by Sponsor|2|||
126571405|NCT02551055|455387992|FG004|Overall Study|Study Terminated by Sponsor|2|||
126571406|NCT02551055|455387993|FG005|Overall Study|Study Terminated by Sponsor|0|||
126571407|NCT02551055|455387994|FG006|Overall Study|Study Terminated by Sponsor|0|||
126571408|NCT02551055|455387995|FG007|Overall Study|Study Terminated by Sponsor|0|||
126571409|NCT02551055|455387988|FG000|Overall Study|Withdrawal by Subject|1|||
126571410|NCT02551055|455387989|FG001|Overall Study|Withdrawal by Subject|1|||
126571411|NCT02551055|455387990|FG002|Overall Study|Withdrawal by Subject|0|||
126571412|NCT02551055|455387991|FG003|Overall Study|Withdrawal by Subject|1|||
126571413|NCT02551055|455387992|FG004|Overall Study|Withdrawal by Subject|2|||
126571414|NCT02551055|455387993|FG005|Overall Study|Withdrawal by Subject|0|||
126571415|NCT02551055|455387994|FG006|Overall Study|Withdrawal by Subject|0|||
126571416|NCT02551055|455387995|FG007|Overall Study|Withdrawal by Subject|0|||
126571417|NCT02551055|455387988|FG000|Overall Study|Reason not specified|0|||
126571418|NCT02551055|455387989|FG001|Overall Study|Reason not specified|0|||
126571419|NCT02551055|455387990|FG002|Overall Study|Reason not specified|0|||
126571420|NCT02551055|455387991|FG003|Overall Study|Reason not specified|0|||
126571421|NCT02551055|455387992|FG004|Overall Study|Reason not specified|1|||
126571422|NCT02551055|455387993|FG005|Overall Study|Reason not specified|0|||
126571423|NCT02551055|455387994|FG006|Overall Study|Reason not specified|1|||
126571424|NCT02551055|455387995|FG007|Overall Study|Reason not specified|0|||
126571425|NCT00430300|455387999|FG000|Overall Study|Adverse Event|0|||
126571426|NCT00430300|455388000|FG001|Overall Study|Adverse Event|2|||
126571427|NCT00430300|455388001|FG002|Overall Study|Adverse Event|1|||
126571428|NCT00430300|455388002|FG003|Overall Study|Adverse Event|1|||
126571429|NCT00430300|455387999|FG000|Overall Study|Withdrawal by Subject|1|||
126571430|NCT00430300|455388000|FG001|Overall Study|Withdrawal by Subject|0|||
126571431|NCT00430300|455388001|FG002|Overall Study|Withdrawal by Subject|5|||
126571432|NCT00430300|455388002|FG003|Overall Study|Withdrawal by Subject|0|||
126571433|NCT00430300|455387999|FG000|Overall Study|Laboratory abnormality|1|||
126571434|NCT00430300|455388000|FG001|Overall Study|Laboratory abnormality|0|||
126571435|NCT00430300|455388001|FG002|Overall Study|Laboratory abnormality|0|||
126571436|NCT00430300|455388002|FG003|Overall Study|Laboratory abnormality|0|||
126571437|NCT00430300|455387999|FG000|Overall Study|Other|0|||
126571438|NCT00430300|455388000|FG001|Overall Study|Other|0|||
126571439|NCT00430300|455388001|FG002|Overall Study|Other|0|||
126571440|NCT00430300|455388002|FG003|Overall Study|Other|1|||
126571441|NCT02754479|455388003|FG000|Overall Study|Lost to Follow-up|1|||
126571442|NCT01063517|455388008|FG000|Overall Study|Consent withdrawal|1|||
126571443|NCT01063517|455388009|FG001|Overall Study|Consent withdrawal|0|||
126571444|NCT01063517|455388008|FG000|Overall Study|Study reached data cut-off|19|||
126571445|NCT01063517|455388009|FG001|Overall Study|Study reached data cut-off|7|||
126571446|NCT01063517|455388008|FG000|Overall Study|Lost to Follow-up|4|||
126571447|NCT01063517|455388009|FG001|Overall Study|Lost to Follow-up|3|||
126571448|NCT01063517|455388008|FG000|Overall Study|Withdrawal by Subject|1|||
126571449|NCT01063517|455388009|FG001|Overall Study|Withdrawal by Subject|2|||
126571450|NCT01063517|455388008|FG000|Overall Study|Death|33|||
126571451|NCT01063517|455388009|FG001|Overall Study|Death|48|||
126571452|NCT02041104|455388010|FG000|Overall Study|Lost to Follow-up|1|||
126571453|NCT02041104|455388011|FG001|Overall Study|Lost to Follow-up|4|||
126571454|NCT02041104|455388010|FG000|Overall Study|discomfort during OGTT|0|||
126571455|NCT02041104|455388011|FG001|Overall Study|discomfort during OGTT|3|||
126571456|NCT00617201|455388014|FG000|Overall Study|Lost to Follow-up|9|||
126571457|NCT00617201|455388015|FG001|Overall Study|Lost to Follow-up|13|||
126571458|NCT00546871|455388016|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
126571459|NCT00546871|455388017|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
126571460|NCT00546871|455388016|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
126571461|NCT00546871|455388017|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
126571462|NCT00546871|455388016|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
126571463|NCT00546871|455388017|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
126571464|NCT00546871|455388016|FG000|Study Extension Period|Protocol Violation|1|||
126571465|NCT00546871|455388017|FG001|Study Extension Period|Protocol Violation|0|||
126571466|NCT00546871|455388016|FG000|Study Extension Period|Withdrawal by Subject|0|||
126571467|NCT00546871|455388017|FG001|Study Extension Period|Withdrawal by Subject|1|||
126571468|NCT01350804|455388018|FG000|Core Study|Withdrawal by Subject|11|||
126571469|NCT01350804|455388019|FG001|Core Study|Withdrawal by Subject|17|||
126517304|NCT01649856|455187956|FG001|Overall Study|Death|34|||
126517305|NCT01649856|455187955|FG000|Overall Study|Stable or Progressed Disease|5|||
126517306|NCT01649856|455187956|FG001|Overall Study|Stable or Progressed Disease|3|||
126517307|NCT01649856|455187955|FG000|Overall Study|Lost to Follow-up|20|||
126517308|NCT01649856|455187956|FG001|Overall Study|Lost to Follow-up|16|||
126517309|NCT01649856|455187955|FG000|Overall Study|Lack of Compliance|6|||
126517310|NCT01649856|455187956|FG001|Overall Study|Lack of Compliance|1|||
126517311|NCT01649856|455187955|FG000|Overall Study|Other|20|||
126517312|NCT01649856|455187956|FG001|Overall Study|Other|5|||
126517313|NCT00622635|455187957|FG000|Treatment Period 1|Adverse Event|0|||
126517314|NCT00622635|455187958|FG001|Treatment Period 1|Adverse Event|0|||
126517315|NCT00622635|455187959|FG002|Treatment Period 1|Adverse Event|1|||
126517316|NCT00622635|455187960|FG003|Treatment Period 1|Adverse Event|0|||
126517317|NCT00622635|455187961|FG004|Treatment Period 1|Adverse Event|0|||
126517318|NCT00622635|455187962|FG005|Treatment Period 1|Adverse Event|0|||
126517319|NCT00622635|455187957|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126517320|NCT00622635|455187958|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126517321|NCT00622635|455187959|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126517322|NCT00622635|455187960|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126517323|NCT00622635|455187961|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126517324|NCT00622635|455187962|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126517325|NCT00622635|455187957|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
126517326|NCT00622635|455187958|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
126517327|NCT00622635|455187959|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
126517328|NCT00622635|455187960|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
126517329|NCT00622635|455187961|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
126517330|NCT00622635|455187962|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
126517331|NCT00622635|455187957|FG000|Treatment Period 2|Adverse Event|1|||
126517332|NCT00622635|455187958|FG001|Treatment Period 2|Adverse Event|0|||
126517333|NCT00622635|455187959|FG002|Treatment Period 2|Adverse Event|0|||
126517334|NCT00622635|455187960|FG003|Treatment Period 2|Adverse Event|0|||
126517335|NCT00622635|455187961|FG004|Treatment Period 2|Adverse Event|0|||
126517336|NCT00622635|455187962|FG005|Treatment Period 2|Adverse Event|0|||
126517337|NCT00622635|455187957|FG000|Treatment Period 3|Adverse Event|0|||
126517338|NCT00622635|455187958|FG001|Treatment Period 3|Adverse Event|0|||
126517339|NCT00622635|455187959|FG002|Treatment Period 3|Adverse Event|0|||
126517340|NCT00622635|455187960|FG003|Treatment Period 3|Adverse Event|2|||
126517341|NCT00622635|455187961|FG004|Treatment Period 3|Adverse Event|0|||
126517342|NCT00622635|455187962|FG005|Treatment Period 3|Adverse Event|0|||
126517343|NCT00622635|455187957|FG000|Treatment Period 3|Withdrawal by Subject|0|||
126517344|NCT00622635|455187958|FG001|Treatment Period 3|Withdrawal by Subject|0|||
126517345|NCT00622635|455187959|FG002|Treatment Period 3|Withdrawal by Subject|0|||
126517346|NCT00622635|455187960|FG003|Treatment Period 3|Withdrawal by Subject|1|||
126517347|NCT00622635|455187961|FG004|Treatment Period 3|Withdrawal by Subject|0|||
126517348|NCT00622635|455187962|FG005|Treatment Period 3|Withdrawal by Subject|0|||
126517349|NCT00281840|455187963|FG000|Overall Study|Adverse Event|12|||
126517350|NCT00281840|455187963|FG000|Overall Study|Physician Decision|6|||
126517351|NCT00281840|455187963|FG000|Overall Study|Withdrawal by Subject|3|||
126517352|NCT00281840|455187963|FG000|Overall Study|Disease Progression|2|||
126517353|NCT00281840|455187963|FG000|Overall Study|exceed maximum delay in treatment|1|||
126517354|NCT00281840|455187963|FG000|Overall Study|Complicating Disease|1|||
126517355|NCT01440946|455187973|FG000|Overall Study|Lost to Follow-up|1|||
126517356|NCT01440946|455187974|FG001|Overall Study|Lost to Follow-up|1|||
126517357|NCT01440946|455187973|FG000|Overall Study|Physician Decision|1|||
126517358|NCT01440946|455187974|FG001|Overall Study|Physician Decision|0|||
126517359|NCT00235989|455187975|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
126517360|NCT00235989|455187976|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
126517361|NCT00235989|455187977|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
126517362|NCT00235989|455187978|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
126517363|NCT00235989|455187979|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
126517364|NCT00235989|455187980|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
126517365|NCT00235989|455187975|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
126517366|NCT00235989|455187976|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
126517367|NCT00235989|455187977|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
126517368|NCT00235989|455187978|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
126517369|NCT00235989|455187979|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
126517370|NCT00235989|455187980|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
126517371|NCT00235989|455187975|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
126517372|NCT00235989|455187976|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
126517373|NCT00235989|455187977|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
126517374|NCT00235989|455187978|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
126517375|NCT00235989|455187979|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
126517376|NCT00235989|455187980|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
126517377|NCT00235989|455187975|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
126517378|NCT00235989|455187976|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
126571470|NCT01350804|455388020|FG002|Core Study|Withdrawal by Subject|16|||
126571471|NCT01350804|455388021|FG003|Core Study|Withdrawal by Subject|7|||
126571472|NCT01350804|455388018|FG000|Core Study|Study terminated by Sponsor|0|||
126571473|NCT01350804|455388019|FG001|Core Study|Study terminated by Sponsor|0|||
126571474|NCT01350804|455388020|FG002|Core Study|Study terminated by Sponsor|0|||
126571475|NCT01350804|455388021|FG003|Core Study|Study terminated by Sponsor|2|||
126571476|NCT01350804|455388018|FG000|Core Study|Protocol deviation|1|||
126571477|NCT01350804|455388019|FG001|Core Study|Protocol deviation|0|||
126571478|NCT01350804|455388020|FG002|Core Study|Protocol deviation|1|||
126571479|NCT01350804|455388021|FG003|Core Study|Protocol deviation|0|||
126571480|NCT01350804|455388018|FG000|Core Study|Physician Decision|1|||
126571481|NCT01350804|455388019|FG001|Core Study|Physician Decision|0|||
126571482|NCT01350804|455388020|FG002|Core Study|Physician Decision|1|||
126571483|NCT01350804|455388021|FG003|Core Study|Physician Decision|3|||
126571484|NCT01350804|455388018|FG000|Core Study|Lost to Follow-up|3|||
126571485|NCT01350804|455388019|FG001|Core Study|Lost to Follow-up|0|||
126571486|NCT01350804|455388020|FG002|Core Study|Lost to Follow-up|2|||
126571487|NCT01350804|455388021|FG003|Core Study|Lost to Follow-up|1|||
126571488|NCT01350804|455388018|FG000|Core Study|Lack of Efficacy|16|||
126571489|NCT01350804|455388019|FG001|Core Study|Lack of Efficacy|19|||
126571490|NCT01350804|455388020|FG002|Core Study|Lack of Efficacy|18|||
126571491|NCT01350804|455388021|FG003|Core Study|Lack of Efficacy|5|||
126571492|NCT01350804|455388018|FG000|Core Study|Death|1|||
126571493|NCT01350804|455388019|FG001|Core Study|Death|1|||
126571494|NCT01350804|455388020|FG002|Core Study|Death|1|||
126571495|NCT01350804|455388021|FG003|Core Study|Death|0|||
126571496|NCT01350804|455388018|FG000|Core Study|Adverse Event|8|||
126571497|NCT01350804|455388019|FG001|Core Study|Adverse Event|10|||
126571498|NCT01350804|455388020|FG002|Core Study|Adverse Event|8|||
126571499|NCT01350804|455388021|FG003|Core Study|Adverse Event|8|||
126571500|NCT01350804|455388018|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
126571501|NCT01350804|455388019|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
126571502|NCT01350804|455388020|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
126571503|NCT01350804|455388021|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
126571504|NCT01350804|455388018|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
126571505|NCT01350804|455388019|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
126571506|NCT01350804|455388020|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
126571507|NCT01350804|455388021|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
126571508|NCT01350804|455388018|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
126571509|NCT01350804|455388019|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
126571510|NCT01350804|455388020|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
126571511|NCT01350804|455388021|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
126571512|NCT01350804|455388018|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
126571513|NCT01350804|455388019|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
126571514|NCT01350804|455388020|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
126571515|NCT01350804|455388021|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
126571516|NCT01350804|455388018|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
126571517|NCT01350804|455388019|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
126571518|NCT01350804|455388020|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
126571519|NCT01350804|455388021|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
126571520|NCT01350804|455388018|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
126571521|NCT01350804|455388019|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
126571522|NCT01350804|455388020|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
126571523|NCT01350804|455388021|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
126571524|NCT02299336|455388022|FG000|Overall Study|Withdrawal by Subject|11|||
126571525|NCT02299336|455388022|FG000|Overall Study|Adverse Event|1|||
126571526|NCT02299336|455388022|FG000|Overall Study|Death|1|||
126571527|NCT02299336|455388022|FG000|Overall Study|Lost to Follow-up|1|||
126571528|NCT02106442|455388024|FG000|Overall Study|Case Report Forms Uncollected|7|||
126571529|NCT02106442|455388024|FG000|Overall Study|Protocol Deviation|30|||
126571530|NCT03762668|455389460|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
126571531|NCT03762668|455389461|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
126571532|NCT02027558|455389462|FG000|Overall Study|Death|0|||
126571533|NCT02027558|455389463|FG001|Overall Study|Death|1|||
126571534|NCT02027558|455389462|FG000|Overall Study|Withdrawal by Subject|2|||
126571535|NCT02027558|455389463|FG001|Overall Study|Withdrawal by Subject|0|||
126571536|NCT02027558|455389462|FG000|Overall Study|Lost to Follow-up|4|||
126571537|NCT02027558|455389463|FG001|Overall Study|Lost to Follow-up|1|||
126571538|NCT02027558|455389462|FG000|Overall Study|Refused assessment|3|||
126571539|NCT02027558|455389463|FG001|Overall Study|Refused assessment|0|||
126571540|NCT02383472|455389464|FG000|Overall Study|Withdrawal by Subject|1|||
126571541|NCT02383472|455389465|FG001|Overall Study|Withdrawal by Subject|1|||
126571542|NCT02013830|455389466|FG000|Overall Study|Adverse Event|3|||
126571543|NCT02013830|455389466|FG000|Overall Study|Death|1|||
126571544|NCT02013830|455389466|FG000|Overall Study|Insufficient therapeutic response|25|||
126571545|NCT02013830|455389466|FG000|Overall Study|Refused treatment|1|||
126727268|NCT00099359|455951096|FG000|Overall Study|Withdrawal by Subject|19|||
126727269|NCT00099359|455951097|FG001|Overall Study|Withdrawal by Subject|19|||
126517379|NCT00235989|455187977|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
126517380|NCT00235989|455187978|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
126517381|NCT00235989|455187979|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
126517382|NCT00235989|455187980|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
126517383|NCT00235989|455187975|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
126517384|NCT00235989|455187976|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
126517385|NCT00235989|455187977|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
126517386|NCT00235989|455187978|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
126517387|NCT00235989|455187979|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
126517388|NCT00235989|455187980|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
126517389|NCT00983580|455187990|FG000|Overall Study|Cancel Prior to treatment|1|||
126517390|NCT00983580|455187991|FG001|Overall Study|Cancel Prior to treatment|3|||
126517391|NCT00983580|455187990|FG000|Overall Study|Protocol Violation|1|||
126517392|NCT00983580|455187991|FG001|Overall Study|Protocol Violation|1|||
126517393|NCT00983580|455187990|FG000|Overall Study|Ineligible|3|||
126517394|NCT00983580|455187991|FG001|Overall Study|Ineligible|0|||
126517395|NCT01652716|455187992|FG000|Overall Study|Loss of glucose control|1|||
126517396|NCT01652716|455187993|FG001|Overall Study|Loss of glucose control|0|||
126517397|NCT01652716|455187992|FG000|Overall Study|Administrative|0|||
126517398|NCT01652716|455187993|FG001|Overall Study|Administrative|2|||
126517399|NCT01652716|455187992|FG000|Overall Study|Investigator decision|1|||
126517400|NCT01652716|455187993|FG001|Overall Study|Investigator decision|4|||
126517401|NCT01652716|455187992|FG000|Overall Study|Lost to Follow-up|12|||
126517402|NCT01652716|455187993|FG001|Overall Study|Lost to Follow-up|11|||
126517403|NCT01652716|455187992|FG000|Overall Study|Protocol Violation|2|||
126517404|NCT01652716|455187993|FG001|Overall Study|Protocol Violation|1|||
126517405|NCT01652716|455187992|FG000|Overall Study|Adverse Event|7|||
126517406|NCT01652716|455187993|FG001|Overall Study|Adverse Event|10|||
126517407|NCT01652716|455187992|FG000|Overall Study|Withdrawal by Subject|33|||
126517408|NCT01652716|455187993|FG001|Overall Study|Withdrawal by Subject|18|||
126517409|NCT02447991|455188003|FG000|Overall Study|Withdrawn by subject - no data|0|||
126517410|NCT02447991|455188004|FG001|Overall Study|Withdrawn by subject - no data|2|||
126517411|NCT02447991|455188003|FG000|Overall Study|Withdrawn by Subject - with data|4|||
126517412|NCT02447991|455188004|FG001|Overall Study|Withdrawn by Subject - with data|4|||
126517413|NCT02447991|455188003|FG000|Overall Study|Lost to Follow-up - no data|3|||
126517414|NCT02447991|455188004|FG001|Overall Study|Lost to Follow-up - no data|6|||
126517415|NCT02447991|455188003|FG000|Overall Study|Lost to follow-up - with data|0|||
126517416|NCT02447991|455188004|FG001|Overall Study|Lost to follow-up - with data|3|||
126517417|NCT02447991|455188003|FG000|Overall Study|End of study - no treatment results|3|||
126517418|NCT02447991|455188004|FG001|Overall Study|End of study - no treatment results|6|||
126517419|NCT02447991|455188003|FG000|Overall Study|End of study - partial treatment results|0|||
126517420|NCT02447991|455188004|FG001|Overall Study|End of study - partial treatment results|9|||
126517421|NCT00459134|455188005|FG000|Overall Study|Physician Decision|1|||
126517422|NCT00459134|455188006|FG001|Overall Study|Physician Decision|1|||
126517423|NCT00459134|455188005|FG000|Overall Study|Withdrawal by Subject|8|||
126517424|NCT00459134|455188006|FG001|Overall Study|Withdrawal by Subject|7|||
126517425|NCT00459134|455188005|FG000|Overall Study|Lost to Follow-up|6|||
126517426|NCT00459134|455188006|FG001|Overall Study|Lost to Follow-up|7|||
126517427|NCT00459134|455188005|FG000|Overall Study|Surgery|1|||
126517428|NCT00459134|455188006|FG001|Overall Study|Surgery|2|||
126517429|NCT00459134|455188005|FG000|Overall Study|Toxicity|4|||
126517430|NCT00459134|455188006|FG001|Overall Study|Toxicity|5|||
126517431|NCT00459134|455188005|FG000|Overall Study|Progression|1|||
126517432|NCT00459134|455188006|FG001|Overall Study|Progression|0|||
126517433|NCT00459134|455188005|FG000|Overall Study|Multiple Reasons|2|||
126517434|NCT00459134|455188006|FG001|Overall Study|Multiple Reasons|3|||
126517435|NCT03568461|455188013|FG000|Overall Study|Death|7|||
126517436|NCT03568461|455188013|FG000|Overall Study|Physician Decision|5|||
126517437|NCT03568461|455188013|FG000|Overall Study|Subject decision|5|||
126517438|NCT03568461|455188013|FG000|Overall Study|Lost to Follow-up|1|||
126517439|NCT03964454|455188014|FG000|Overall Study|Lost to Follow-up|13|||
126517440|NCT03964454|455188015|FG001|Overall Study|Lost to Follow-up|7|||
126517441|NCT03964454|455188014|FG000|Overall Study|Withdrawal by Subject|4|||
126517442|NCT03964454|455188015|FG001|Overall Study|Withdrawal by Subject|11|||
126517443|NCT01993719|455189812|FG000|First Drug Administration|Not treated|1|||
126517444|NCT01993719|455189813|FG001|First Drug Administration|Not treated|0|||
126517445|NCT01993719|455189814|FG002|First Drug Administration|Not treated|0|||
126517446|NCT01993719|455189815|FG003|First Drug Administration|Not treated|0|||
126517447|NCT01993719|455189816|FG004|First Drug Administration|Not treated|0|||
126517448|NCT03224468|455189829|FG000|Overall Study|Did not obtain MM card|53|||
126517449|NCT03224468|455189830|FG001|Overall Study|Did not obtain MM card|0|||
126517450|NCT03224468|455189829|FG000|Overall Study|Lost to Follow-up|4|||
126517451|NCT03224468|455189830|FG001|Overall Study|Lost to Follow-up|11|||
126571546|NCT01111526|455389467|FG000|Overall Study|GVHD Disease Progression|0|||
126571547|NCT01111526|455389468|FG001|Overall Study|GVHD Disease Progression|1|||
126571548|NCT01111526|455389469|FG002|Overall Study|GVHD Disease Progression|2|||
126571549|NCT04424641|455389470|FG000|Overall Study|Death|1|||
126571550|NCT04424641|455389471|FG001|Overall Study|Death|2|||
126571551|NCT04424641|455389472|FG002|Overall Study|Death|3|||
126571552|NCT04424641|455389473|FG003|Overall Study|Death|0|||
126571553|NCT04424641|455389474|FG004|Overall Study|Death|3|||
126571554|NCT04424641|455389475|FG005|Overall Study|Death|0|||
126571555|NCT04424641|455389476|FG006|Overall Study|Death|1|||
126571556|NCT04424641|455389477|FG007|Overall Study|Death|2|||
126571557|NCT04424641|455389470|FG000|Overall Study|Sponsor decision|0|||
126571558|NCT04424641|455389471|FG001|Overall Study|Sponsor decision|2|||
126571559|NCT04424641|455389472|FG002|Overall Study|Sponsor decision|3|||
126571560|NCT04424641|455389473|FG003|Overall Study|Sponsor decision|7|||
126571561|NCT04424641|455389474|FG004|Overall Study|Sponsor decision|2|||
126571562|NCT04424641|455389475|FG005|Overall Study|Sponsor decision|2|||
126571563|NCT04424641|455389476|FG006|Overall Study|Sponsor decision|3|||
126571564|NCT04424641|455389477|FG007|Overall Study|Sponsor decision|4|||
126571565|NCT04424641|455389470|FG000|Overall Study|Withdrawal by Subject|0|||
126571566|NCT04424641|455389471|FG001|Overall Study|Withdrawal by Subject|0|||
126571567|NCT04424641|455389472|FG002|Overall Study|Withdrawal by Subject|0|||
126571568|NCT04424641|455389473|FG003|Overall Study|Withdrawal by Subject|0|||
126571569|NCT04424641|455389474|FG004|Overall Study|Withdrawal by Subject|1|||
126571570|NCT04424641|455389475|FG005|Overall Study|Withdrawal by Subject|0|||
126571571|NCT04424641|455389476|FG006|Overall Study|Withdrawal by Subject|0|||
126571572|NCT04424641|455389477|FG007|Overall Study|Withdrawal by Subject|0|||
126571573|NCT04424641|455389470|FG000|Overall Study|Other|0|||
126571574|NCT04424641|455389471|FG001|Overall Study|Other|0|||
126571575|NCT04424641|455389472|FG002|Overall Study|Other|1|||
126571576|NCT04424641|455389473|FG003|Overall Study|Other|0|||
126571577|NCT04424641|455389474|FG004|Overall Study|Other|0|||
126571578|NCT04424641|455389475|FG005|Overall Study|Other|0|||
126571579|NCT04424641|455389476|FG006|Overall Study|Other|0|||
126571580|NCT04424641|455389477|FG007|Overall Study|Other|0|||
126571581|NCT00743444|455389484|FG000|First Intervention|Catheter placement problems|0|||
126571582|NCT00743444|455389485|FG001|First Intervention|Catheter placement problems|1|||
126571583|NCT00743444|455389484|FG000|Washout Period|Adverse Event|0|||
126571584|NCT00743444|455389485|FG001|Washout Period|Adverse Event|1|||
126571585|NCT01337635|455389486|FG000|Overall Study|Lost to Follow-up|0|||
126571586|NCT01337635|455389487|FG001|Overall Study|Lost to Follow-up|1|||
126571587|NCT00814346|455389488|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
126571588|NCT00814346|455389489|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
126571589|NCT00814346|455389488|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
126571590|NCT00814346|455389489|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
126571591|NCT00814346|455389488|FG000|Open Phase (17 Months)|Adverse Event|5|||
126517452|NCT03224468|455189829|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
126517453|NCT03224468|455189830|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
126517454|NCT02461589|455189831|FG000|Overall Study|Withdrawal by Subject|5|||
126517455|NCT02461589|455189832|FG001|Overall Study|Withdrawal by Subject|1|||
126517456|NCT02461589|455189833|FG002|Overall Study|Withdrawal by Subject|3|||
126517457|NCT02461589|455189834|FG003|Overall Study|Withdrawal by Subject|2|||
126517458|NCT02461589|455189835|FG004|Overall Study|Withdrawal by Subject|1|||
126517459|NCT02461589|455189836|FG005|Overall Study|Withdrawal by Subject|2|||
126517460|NCT02461589|455189837|FG006|Overall Study|Withdrawal by Subject|1|||
126517461|NCT02461589|455189838|FG007|Overall Study|Withdrawal by Subject|3|||
126517462|NCT02461589|455189839|FG008|Overall Study|Withdrawal by Subject|3|||
126517463|NCT02461589|455189840|FG009|Overall Study|Withdrawal by Subject|1|||
126517464|NCT02461589|455189831|FG000|Overall Study|Lost to Follow-up|0|||
126517465|NCT02461589|455189832|FG001|Overall Study|Lost to Follow-up|0|||
126517466|NCT02461589|455189833|FG002|Overall Study|Lost to Follow-up|2|||
126517467|NCT02461589|455189834|FG003|Overall Study|Lost to Follow-up|3|||
126517468|NCT02461589|455189835|FG004|Overall Study|Lost to Follow-up|1|||
126517469|NCT02461589|455189836|FG005|Overall Study|Lost to Follow-up|1|||
126517470|NCT02461589|455189837|FG006|Overall Study|Lost to Follow-up|3|||
126517471|NCT02461589|455189838|FG007|Overall Study|Lost to Follow-up|1|||
126517472|NCT02461589|455189839|FG008|Overall Study|Lost to Follow-up|3|||
126517473|NCT02461589|455189840|FG009|Overall Study|Lost to Follow-up|1|||
126517474|NCT02461589|455189831|FG000|Overall Study|Death|0|||
126517475|NCT02461589|455189832|FG001|Overall Study|Death|0|||
126517476|NCT02461589|455189833|FG002|Overall Study|Death|0|||
126517477|NCT02461589|455189834|FG003|Overall Study|Death|0|||
126517478|NCT02461589|455189835|FG004|Overall Study|Death|0|||
126517479|NCT02461589|455189836|FG005|Overall Study|Death|0|||
126517480|NCT02461589|455189837|FG006|Overall Study|Death|0|||
126517481|NCT02461589|455189838|FG007|Overall Study|Death|1|||
126571592|NCT00814346|455389489|FG001|Open Phase (17 Months)|Adverse Event|0|||
126571593|NCT00814346|455389488|FG000|Open Phase (17 Months)|Consent|2|||
126571594|NCT00814346|455389489|FG001|Open Phase (17 Months)|Consent|0|||
126571595|NCT00814346|455389488|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
126517482|NCT02461589|455189839|FG008|Overall Study|Death|0|||
126517483|NCT02461589|455189840|FG009|Overall Study|Death|0|||
126517484|NCT02461589|455189831|FG000|Overall Study|Unclassified|0|||
126517485|NCT02461589|455189832|FG001|Overall Study|Unclassified|0|||
126517486|NCT02461589|455189833|FG002|Overall Study|Unclassified|0|||
126517487|NCT02461589|455189834|FG003|Overall Study|Unclassified|0|||
126517488|NCT02461589|455189835|FG004|Overall Study|Unclassified|0|||
126517489|NCT02461589|455189836|FG005|Overall Study|Unclassified|0|||
126517490|NCT02461589|455189837|FG006|Overall Study|Unclassified|1|||
126517491|NCT02461589|455189838|FG007|Overall Study|Unclassified|0|||
126517492|NCT02461589|455189839|FG008|Overall Study|Unclassified|0|||
126517493|NCT02461589|455189840|FG009|Overall Study|Unclassified|2|||
126517494|NCT02461589|455189831|FG000|Overall Study|Missing follow-up information|1|||
126517495|NCT02461589|455189832|FG001|Overall Study|Missing follow-up information|1|||
126517496|NCT02461589|455189833|FG002|Overall Study|Missing follow-up information|0|||
126517497|NCT02461589|455189834|FG003|Overall Study|Missing follow-up information|0|||
126517498|NCT02461589|455189835|FG004|Overall Study|Missing follow-up information|0|||
126517499|NCT02461589|455189836|FG005|Overall Study|Missing follow-up information|0|||
126517500|NCT02461589|455189837|FG006|Overall Study|Missing follow-up information|1|||
126517501|NCT02461589|455189838|FG007|Overall Study|Missing follow-up information|0|||
126517502|NCT02461589|455189839|FG008|Overall Study|Missing follow-up information|0|||
126517503|NCT02461589|455189840|FG009|Overall Study|Missing follow-up information|0|||
126517504|NCT02461589|455189831|FG000|Overall Study|Withdrawal from trial before exposure|0|||
126517505|NCT02461589|455189832|FG001|Overall Study|Withdrawal from trial before exposure|0|||
126517506|NCT02461589|455189833|FG002|Overall Study|Withdrawal from trial before exposure|0|||
126517507|NCT02461589|455189834|FG003|Overall Study|Withdrawal from trial before exposure|0|||
126517508|NCT02461589|455189835|FG004|Overall Study|Withdrawal from trial before exposure|0|||
126517509|NCT02461589|455189836|FG005|Overall Study|Withdrawal from trial before exposure|0|||
126517510|NCT02461589|455189837|FG006|Overall Study|Withdrawal from trial before exposure|0|||
126517511|NCT02461589|455189838|FG007|Overall Study|Withdrawal from trial before exposure|0|||
126517512|NCT02461589|455189839|FG008|Overall Study|Withdrawal from trial before exposure|0|||
126517513|NCT02461589|455189840|FG009|Overall Study|Withdrawal from trial before exposure|1|||
126517514|NCT04067141|455189841|FG000|First Intervention|Withdrawal by Subject|0|||
126517515|NCT04067141|455189842|FG001|First Intervention|Withdrawal by Subject|1|||
126517516|NCT04067141|455189841|FG000|Second Intervention|Adverse Event|0|||
126517517|NCT04067141|455189842|FG001|Second Intervention|Adverse Event|2|||
126517518|NCT01038921|455189843|FG000|Overall Study|Withdrawal by Subject|1|||
126517519|NCT01038921|455189844|FG001|Overall Study|Withdrawal by Subject|0|||
126517520|NCT01038921|455189843|FG000|Overall Study|Physician Decision|1|||
126517521|NCT01038921|455189844|FG001|Overall Study|Physician Decision|0|||
126517522|NCT01978119|455189845|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
126517523|NCT01978119|455189846|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
126517524|NCT01978119|455189845|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
126517525|NCT01978119|455189846|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126517526|NCT01978119|455189845|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126517527|NCT01978119|455189846|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
126517528|NCT03295201|455189847|FG000|Overall Study|Lost to Follow-up|1|||
126517529|NCT03295201|455189848|FG001|Overall Study|Lost to Follow-up|1|||
126517530|NCT03295201|455189847|FG000|Overall Study|Hospital admission|0|||
126517531|NCT03295201|455189848|FG001|Overall Study|Hospital admission|1|||
126517532|NCT00572572|455189849|FG000|Overall Study|Withdrawal by Subject|3|||
126517533|NCT00572572|455189850|FG001|Overall Study|Withdrawal by Subject|6|||
126517534|NCT01831089|455189851|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
126517535|NCT01831089|455189852|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
126517536|NCT01831089|455189853|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
126517537|NCT01831089|455189854|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
126517538|NCT01831089|455189855|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
126517539|NCT01831089|455189856|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
126517540|NCT01831089|455189851|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
126517541|NCT01831089|455189852|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
126517542|NCT01831089|455189853|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
126517543|NCT01831089|455189854|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
126517544|NCT01831089|455189855|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
126517545|NCT01831089|455189856|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
126517546|NCT01831089|455189851|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
126517547|NCT01831089|455189852|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
126517548|NCT01831089|455189853|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
126517549|NCT01831089|455189854|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
126517550|NCT01831089|455189855|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
126517551|NCT01831089|455189856|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
126517552|NCT01831089|455189851|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
126777016|NCT01789281|456139155|FG001|Overall Study|Disease progression|4|||
126571596|NCT00814346|455389489|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
126571597|NCT00814346|455389488|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
126517553|NCT01831089|455189852|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
126517554|NCT01831089|455189853|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
126517555|NCT01831089|455189854|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
126517556|NCT01831089|455189855|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
126517557|NCT01831089|455189856|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
126517558|NCT01831089|455189851|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
126517559|NCT01831089|455189852|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
126517560|NCT01831089|455189853|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
126517561|NCT01831089|455189854|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
126517562|NCT01831089|455189855|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
126517563|NCT01831089|455189856|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
126517564|NCT01831089|455189851|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
126517565|NCT01831089|455189852|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
126517566|NCT01831089|455189853|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
126517567|NCT01831089|455189854|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
126517568|NCT01831089|455189855|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
126517569|NCT01831089|455189856|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
126517570|NCT01831089|455189851|FG000|Cohort III: Dose Level 3|Global end of study|0|||
126517571|NCT01831089|455189852|FG001|Cohort III: Dose Level 3|Global end of study|0|||
126517572|NCT01831089|455189853|FG002|Cohort III: Dose Level 3|Global end of study|1|||
126517573|NCT01831089|455189854|FG003|Cohort III: Dose Level 3|Global end of study|0|||
126517574|NCT01831089|455189855|FG004|Cohort III: Dose Level 3|Global end of study|0|||
126517575|NCT01831089|455189856|FG005|Cohort III: Dose Level 3|Global end of study|0|||
126517576|NCT01831089|455189851|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
126517577|NCT01831089|455189852|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
126517578|NCT01831089|455189853|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
126517579|NCT01831089|455189854|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
126517580|NCT01831089|455189855|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
126517581|NCT01831089|455189856|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
126517582|NCT01831089|455189851|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
126517583|NCT01831089|455189852|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
126517584|NCT01831089|455189853|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
126517585|NCT01831089|455189854|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
126517586|NCT01831089|455189855|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
126517587|NCT01831089|455189856|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
126517588|NCT01831089|455189851|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
126517589|NCT01831089|455189852|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
126517590|NCT01831089|455189853|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
126517591|NCT01831089|455189854|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
126517592|NCT01831089|455189855|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
126517593|NCT01831089|455189856|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
126517594|NCT01831089|455189851|FG000|Cohort V: Dose Level 5|Death|0|||
126517595|NCT01831089|455189852|FG001|Cohort V: Dose Level 5|Death|0|||
126517596|NCT01831089|455189853|FG002|Cohort V: Dose Level 5|Death|0|||
126517597|NCT01831089|455189854|FG003|Cohort V: Dose Level 5|Death|0|||
126517598|NCT01831089|455189855|FG004|Cohort V: Dose Level 5|Death|1|||
126517599|NCT01831089|455189856|FG005|Cohort V: Dose Level 5|Death|0|||
126517600|NCT01831089|455189851|FG000|Cohort V: Dose Level 5|Global end of study|0|||
126517601|NCT01831089|455189852|FG001|Cohort V: Dose Level 5|Global end of study|0|||
126517602|NCT01831089|455189853|FG002|Cohort V: Dose Level 5|Global end of study|0|||
126517603|NCT01831089|455189854|FG003|Cohort V: Dose Level 5|Global end of study|0|||
126517604|NCT01831089|455189855|FG004|Cohort V: Dose Level 5|Global end of study|2|||
126517605|NCT01831089|455189856|FG005|Cohort V: Dose Level 5|Global end of study|0|||
126517606|NCT01831089|455189851|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
126517607|NCT01831089|455189852|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
126517608|NCT01831089|455189853|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
126517609|NCT01831089|455189854|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
126517610|NCT01831089|455189855|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
126517611|NCT01831089|455189856|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
126517612|NCT01831089|455189851|FG000|Cohort B: Arm B|Progressive disease|0|||
126517613|NCT01831089|455189852|FG001|Cohort B: Arm B|Progressive disease|0|||
126517614|NCT01831089|455189853|FG002|Cohort B: Arm B|Progressive disease|0|||
126517615|NCT01831089|455189854|FG003|Cohort B: Arm B|Progressive disease|0|||
126571598|NCT00814346|455389489|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
126517616|NCT01831089|455189855|FG004|Cohort B: Arm B|Progressive disease|0|||
126517617|NCT01831089|455189856|FG005|Cohort B: Arm B|Progressive disease|8|||
126517618|NCT01831089|455189851|FG000|Cohort B: Arm B|Physician Decision|0|||
126517619|NCT01831089|455189852|FG001|Cohort B: Arm B|Physician Decision|0|||
126517620|NCT01831089|455189853|FG002|Cohort B: Arm B|Physician Decision|0|||
126517621|NCT01831089|455189854|FG003|Cohort B: Arm B|Physician Decision|0|||
126571599|NCT03622580|455389495|FG000|Overall Study|Death|16|||
126777017|NCT01789281|456139154|FG000|Overall Study|Adverse Event|5|||
126517622|NCT01831089|455189855|FG004|Cohort B: Arm B|Physician Decision|0|||
126517623|NCT01831089|455189856|FG005|Cohort B: Arm B|Physician Decision|2|||
126517624|NCT01831089|455189851|FG000|Cohort B: Arm B|Never treated|0|||
126517625|NCT01831089|455189852|FG001|Cohort B: Arm B|Never treated|0|||
126517626|NCT01831089|455189853|FG002|Cohort B: Arm B|Never treated|0|||
126517627|NCT01831089|455189854|FG003|Cohort B: Arm B|Never treated|0|||
126517628|NCT01831089|455189855|FG004|Cohort B: Arm B|Never treated|0|||
126517629|NCT01831089|455189856|FG005|Cohort B: Arm B|Never treated|2|||
126517630|NCT01831089|455189851|FG000|Cohort B: Arm B|Adverse Event|0|||
126517631|NCT01831089|455189852|FG001|Cohort B: Arm B|Adverse Event|0|||
126517632|NCT01831089|455189853|FG002|Cohort B: Arm B|Adverse Event|0|||
126517633|NCT01831089|455189854|FG003|Cohort B: Arm B|Adverse Event|0|||
126517634|NCT01831089|455189855|FG004|Cohort B: Arm B|Adverse Event|0|||
126517635|NCT01831089|455189856|FG005|Cohort B: Arm B|Adverse Event|1|||
126517636|NCT01831089|455189851|FG000|Cohort B: Arm B|Global end of study|0|||
126517637|NCT01831089|455189852|FG001|Cohort B: Arm B|Global end of study|0|||
126517638|NCT01831089|455189853|FG002|Cohort B: Arm B|Global end of study|0|||
126517639|NCT01831089|455189854|FG003|Cohort B: Arm B|Global end of study|0|||
126517640|NCT01831089|455189855|FG004|Cohort B: Arm B|Global end of study|0|||
126517641|NCT01831089|455189856|FG005|Cohort B: Arm B|Global end of study|1|||
126517642|NCT00889421|455189857|FG000|Overall Study|Lack of Efficacy|3|||
126517643|NCT01958918|455189858|FG000|Overall Study|Death|1|||
126517644|NCT01958918|455189859|FG001|Overall Study|Death|3|||
126517645|NCT01958918|455189858|FG000|Overall Study|Lost to Follow-up|4|||
126517646|NCT01958918|455189859|FG001|Overall Study|Lost to Follow-up|7|||
126517647|NCT01958918|455189858|FG000|Overall Study|Withdrawal by Subject|13|||
126517648|NCT01958918|455189859|FG001|Overall Study|Withdrawal by Subject|8|||
126517649|NCT01958918|455189858|FG000|Overall Study|Lack of Efficacy|13|||
126517650|NCT01958918|455189859|FG001|Overall Study|Lack of Efficacy|10|||
126517651|NCT01958918|455189858|FG000|Overall Study|Adverse Event|12|||
126517652|NCT01958918|455189859|FG001|Overall Study|Adverse Event|12|||
126517653|NCT01958918|455189858|FG000|Overall Study|administrative problems|0|||
126517654|NCT01958918|455189859|FG001|Overall Study|administrative problems|2|||
126517655|NCT04327934|455189860|FG000|Overall Study|Did not qualify|7|||
126517656|NCT04327934|455189861|FG001|Overall Study|Did not qualify|4|||
126517657|NCT04327934|455189860|FG000|Overall Study|Physician Decision|0|||
126517658|NCT04327934|455189861|FG001|Overall Study|Physician Decision|1|||
126517659|NCT03525834|455189862|FG000|Overall Study|Progressive disease|1|||
126517660|NCT03095417|455189863|FG000|Overall Study|missed|1|||
126517661|NCT03095417|455189864|FG001|Overall Study|missed|2|||
126517662|NCT03095417|455189865|FG002|Overall Study|missed|0|||
126517663|NCT03095417|455189866|FG003|Overall Study|missed|1|||
126517664|NCT03095417|455189863|FG000|Overall Study|Lost to Follow-up|2|||
126517665|NCT03095417|455189864|FG001|Overall Study|Lost to Follow-up|2|||
126517666|NCT03095417|455189865|FG002|Overall Study|Lost to Follow-up|1|||
126517667|NCT03095417|455189866|FG003|Overall Study|Lost to Follow-up|0|||
126517668|NCT03095417|455189863|FG000|Overall Study|refusal|0|||
126517669|NCT03095417|455189864|FG001|Overall Study|refusal|1|||
126517670|NCT03095417|455189865|FG002|Overall Study|refusal|0|||
126517671|NCT03095417|455189866|FG003|Overall Study|refusal|1|||
126517672|NCT03095417|455189863|FG000|Overall Study|Withdrawal by Subject|8|||
126517673|NCT03095417|455189864|FG001|Overall Study|Withdrawal by Subject|2|||
126517674|NCT03095417|455189865|FG002|Overall Study|Withdrawal by Subject|5|||
126517675|NCT03095417|455189866|FG003|Overall Study|Withdrawal by Subject|4|||
126517676|NCT03095417|455189863|FG000|Overall Study|Physician Decision|1|||
126517677|NCT03095417|455189864|FG001|Overall Study|Physician Decision|2|||
126517678|NCT03095417|455189865|FG002|Overall Study|Physician Decision|2|||
126517679|NCT03095417|455189866|FG003|Overall Study|Physician Decision|2|||
126517680|NCT03095417|455189863|FG000|Overall Study|Death|1|||
126517681|NCT03095417|455189864|FG001|Overall Study|Death|2|||
126517682|NCT03095417|455189865|FG002|Overall Study|Death|1|||
126517683|NCT03095417|455189866|FG003|Overall Study|Death|3|||
126517684|NCT00724451|455189870|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
126517685|NCT00724451|455189870|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
126517686|NCT00724451|455189870|FG000|Overall Study|Not Eligible for Treatment|431|||
126517687|NCT00724451|455189870|FG000|Overall Study|Participant Refused Treatment|89|||
126517688|NCT00724451|455189870|FG000|Overall Study|Never Started Treatment|89|||
126517689|NCT00724451|455189870|FG000|Overall Study|Unknown; No Data Sources Available|9|||
126517690|NCT00724451|455189870|FG000|Overall Study|Physician Decision|116|||
126517691|NCT00724451|455189870|FG000|Overall Study|Withdrawal by Subject|45|||
126517692|NCT00724451|455189870|FG000|Overall Study|Investigator + Participant Decision|13|||
126517693|NCT01260922|455189872|FG000|First Intervention|Withdrawal by Subject|0|||
126517694|NCT01260922|455189873|FG001|First Intervention|Withdrawal by Subject|1|||
126517695|NCT01260922|455189872|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
126517696|NCT01260922|455189873|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
126777018|NCT01789281|456139155|FG001|Overall Study|Adverse Event|5|||
126517697|NCT01260922|455189872|FG000|Second Intervention|Emesis|0|||
126517698|NCT01260922|455189873|FG001|Second Intervention|Emesis|2|||
126571600|NCT03622580|455389496|FG001|Overall Study|Death|21|||
126571601|NCT03622580|455389497|FG002|Overall Study|Death|13|||
126571602|NCT03622580|455389495|FG000|Overall Study|Adverse Event|6|||
126571603|NCT03622580|455389496|FG001|Overall Study|Adverse Event|6|||
126571604|NCT03622580|455389497|FG002|Overall Study|Adverse Event|5|||
126571605|NCT03622580|455389495|FG000|Overall Study|Withdrawal by Subject|12|||
126571606|NCT03622580|455389496|FG001|Overall Study|Withdrawal by Subject|7|||
126571607|NCT03622580|455389497|FG002|Overall Study|Withdrawal by Subject|19|||
126571608|NCT03622580|455389495|FG000|Overall Study|Lost to Follow-up|12|||
126571609|NCT03622580|455389496|FG001|Overall Study|Lost to Follow-up|9|||
126571610|NCT03622580|455389497|FG002|Overall Study|Lost to Follow-up|9|||
126571611|NCT03622580|455389495|FG000|Overall Study|Protocol Violation|1|||
126571612|NCT03622580|455389496|FG001|Overall Study|Protocol Violation|0|||
126571613|NCT03622580|455389497|FG002|Overall Study|Protocol Violation|1|||
126571614|NCT03622580|455389495|FG000|Overall Study|Physician Decision|3|||
126571615|NCT03622580|455389496|FG001|Overall Study|Physician Decision|0|||
126571616|NCT03622580|455389497|FG002|Overall Study|Physician Decision|1|||
126571617|NCT03622580|455389495|FG000|Overall Study|Pregnancy|0|||
126571618|NCT03622580|455389496|FG001|Overall Study|Pregnancy|1|||
126571619|NCT03622580|455389497|FG002|Overall Study|Pregnancy|0|||
126571620|NCT03622580|455389495|FG000|Overall Study|Lack of Efficacy|0|||
126571621|NCT03622580|455389496|FG001|Overall Study|Lack of Efficacy|0|||
126571622|NCT03622580|455389497|FG002|Overall Study|Lack of Efficacy|1|||
126571623|NCT03622580|455389495|FG000|Overall Study|Other|2|||
126571624|NCT03622580|455389496|FG001|Overall Study|Other|0|||
126571625|NCT03622580|455389497|FG002|Overall Study|Other|3|||
126571626|NCT05136443|455389498|FG000|Overall Study|Lost to Follow-up|2|||
126571627|NCT05136443|455389498|FG000|Overall Study|Adverse Event|2|||
126571628|NCT02613871|455389503|FG000|Overall Study|Death|2|||
126571629|NCT02613871|455389503|FG000|Overall Study|Withdrew Consent|1|||
126571630|NCT01930045|455389504|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
126571631|NCT01930045|455389505|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
126571632|NCT01930045|455389506|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
126571633|NCT01930045|455389507|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
126571634|NCT01930045|455389508|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
126571635|NCT01930045|455389509|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
126571636|NCT01930045|455389504|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
126571637|NCT01930045|455389505|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
126571638|NCT01930045|455389506|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
126571639|NCT01930045|455389507|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
126571640|NCT01930045|455389508|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
126571641|NCT01930045|455389509|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
126571642|NCT00494442|455389510|FG000|Overall Study|Death|1|||
126571643|NCT00494442|455389511|FG001|Overall Study|Death|1|||
126571644|NCT00494442|455389510|FG000|Overall Study|Lack of Efficacy|16|||
126571645|NCT00494442|455389511|FG001|Overall Study|Lack of Efficacy|10|||
126571646|NCT00494442|455389510|FG000|Overall Study|Adverse Event|0|||
126571647|NCT00494442|455389511|FG001|Overall Study|Adverse Event|2|||
126517699|NCT03732248|455189876|FG000|Overall Study|Withdrawal by Subject|1|||
126517700|NCT03732248|455189877|FG001|Overall Study|Withdrawal by Subject|0|||
126517701|NCT01410110|455189879|FG000|Overall Study|Withdrawal by Subject|4|||
126517702|NCT01410110|455189880|FG001|Overall Study|Withdrawal by Subject|2|||
126517703|NCT03653429|455189885|FG000|Overall Study|Physician Decision|4|||
126517704|NCT03653429|455189886|FG001|Overall Study|Physician Decision|10|||
126517705|NCT01525082|455189887|FG000|Overall Study|Death|1|||
126517706|NCT02543346|455189890|FG000|Second Priming Visit|Withdrawal by Subject|0|||
126571648|NCT00494442|455389510|FG000|Overall Study|Physician Decision|0|||
126571649|NCT00494442|455389511|FG001|Overall Study|Physician Decision|1|||
126571650|NCT00494442|455389510|FG000|Overall Study|Non-compliance|0|||
126571651|NCT00494442|455389511|FG001|Overall Study|Non-compliance|1|||
126571652|NCT00494442|455389510|FG000|Overall Study|Intercurrent illness|0|||
126571653|NCT00494442|455389511|FG001|Overall Study|Intercurrent illness|1|||
126571654|NCT00831415|455389512|FG000|Overall Study|Adverse Event|14|||
126571655|NCT00831415|455389512|FG000|Overall Study|Failed to return|3|||
126571656|NCT00831415|455389512|FG000|Overall Study|Physician Decision|6|||
126571657|NCT00831415|455389512|FG000|Overall Study|Lost to Follow-up|9|||
126571658|NCT00831415|455389512|FG000|Overall Study|Protocol Violation|3|||
126571659|NCT00831415|455389512|FG000|Overall Study|Withdrawal by Subject|35|||
126571660|NCT00831415|455389512|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
126571661|NCT00831415|455389512|FG000|Overall Study|Death|1|||
126517707|NCT02543346|455189891|FG001|Second Priming Visit|Withdrawal by Subject|2|||
126517708|NCT02543346|455189892|FG002|Second Priming Visit|Withdrawal by Subject|2|||
126517709|NCT02543346|455189893|FG003|Second Priming Visit|Withdrawal by Subject|2|||
126517710|NCT02543346|455189890|FG000|Second Priming Visit|Adverse Event|1|||
126571662|NCT03034915|455389513|FG000|Overall Study|Adverse Event|29|||
126517711|NCT02543346|455189891|FG001|Second Priming Visit|Adverse Event|0|||
126571663|NCT03034915|455389514|FG001|Overall Study|Adverse Event|32|||
126571664|NCT03034915|455389515|FG002|Overall Study|Adverse Event|22|||
126727270|NCT00099359|455951098|FG002|Overall Study|Withdrawal by Subject|23|||
126571665|NCT03034915|455389513|FG000|Overall Study|Lost to Follow-up|5|||
126571666|NCT03034915|455389514|FG001|Overall Study|Lost to Follow-up|13|||
126571667|NCT03034915|455389515|FG002|Overall Study|Lost to Follow-up|3|||
126571668|NCT03034915|455389513|FG000|Overall Study|Withdrawal by Subject|29|||
126571669|NCT03034915|455389514|FG001|Overall Study|Withdrawal by Subject|46|||
126571670|NCT03034915|455389515|FG002|Overall Study|Withdrawal by Subject|41|||
126571671|NCT03034915|455389513|FG000|Overall Study|Protocol Deviation|2|||
126571672|NCT03034915|455389514|FG001|Overall Study|Protocol Deviation|14|||
126571673|NCT03034915|455389515|FG002|Overall Study|Protocol Deviation|7|||
126571674|NCT03034915|455389513|FG000|Overall Study|Lack of Efficacy|8|||
126571675|NCT03034915|455389514|FG001|Overall Study|Lack of Efficacy|16|||
126571676|NCT03034915|455389515|FG002|Overall Study|Lack of Efficacy|18|||
126571677|NCT03034915|455389513|FG000|Overall Study|Site closed|2|||
126571678|NCT03034915|455389514|FG001|Overall Study|Site closed|2|||
126571679|NCT03034915|455389515|FG002|Overall Study|Site closed|4|||
126571680|NCT03034915|455389513|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
126571681|NCT03034915|455389514|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
126571682|NCT03034915|455389515|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
126571683|NCT03034915|455389513|FG000|Overall Study|Physician Decision|1|||
126571684|NCT03034915|455389514|FG001|Overall Study|Physician Decision|5|||
126571685|NCT03034915|455389515|FG002|Overall Study|Physician Decision|2|||
126571686|NCT03861767|455389518|FG000|Overall Study|Withdrawal by Subject|2|||
126571687|NCT03861767|455389519|FG001|Overall Study|Withdrawal by Subject|1|||
126571688|NCT03861767|455389520|FG002|Overall Study|Withdrawal by Subject|0|||
126571689|NCT03861767|455389521|FG003|Overall Study|Withdrawal by Subject|5|||
126571690|NCT03861767|455389522|FG004|Overall Study|Withdrawal by Subject|2|||
126571691|NCT03861767|455389523|FG005|Overall Study|Withdrawal by Subject|1|||
126571692|NCT03861767|455389524|FG006|Overall Study|Withdrawal by Subject|3|||
126571693|NCT03861767|455389525|FG007|Overall Study|Withdrawal by Subject|1|||
126571694|NCT03861767|455389526|FG008|Overall Study|Withdrawal by Subject|0|||
126571695|NCT03861767|455389527|FG009|Overall Study|Withdrawal by Subject|5|||
126571696|NCT01087762|455389528|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
126571697|NCT01087762|455389529|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
126571698|NCT01087762|455389530|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
126571699|NCT01087762|455389531|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
126571700|NCT01087762|455389532|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
126571701|NCT01087762|455389528|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
126571702|NCT01087762|455389529|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
126571703|NCT01087762|455389530|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
126571704|NCT01087762|455389531|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
126571705|NCT01087762|455389532|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
126571706|NCT01087762|455389528|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
126571707|NCT01087762|455389529|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
126571708|NCT01087762|455389530|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
126571709|NCT01087762|455389531|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
126571710|NCT01087762|455389532|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
126571711|NCT01087762|455389528|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
126571712|NCT01087762|455389529|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
126571713|NCT01087762|455389530|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
126571714|NCT01087762|455389531|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
126571715|NCT01087762|455389532|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
126571716|NCT01087762|455389528|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
126571717|NCT01087762|455389529|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
126571718|NCT01087762|455389530|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
126571719|NCT01087762|455389531|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
126571720|NCT01087762|455389532|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
126571721|NCT01087762|455389528|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
126571722|NCT01087762|455389529|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
126571723|NCT01087762|455389530|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
126571724|NCT01087762|455389531|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
126571725|NCT01087762|455389532|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
126571726|NCT01087762|455389528|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
126571727|NCT01087762|455389529|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
126571728|NCT01087762|455389530|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
126571729|NCT01087762|455389531|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
126571730|NCT01087762|455389532|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
126571731|NCT01087762|455389528|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
126571732|NCT01087762|455389529|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
126727271|NCT00099359|455951096|FG000|Overall Study|Lost to Follow-up|15|||
126571733|NCT01087762|455389530|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
126727272|NCT00099359|455951097|FG001|Overall Study|Lost to Follow-up|24|||
126727273|NCT00099359|455951098|FG002|Overall Study|Lost to Follow-up|24|||
126517712|NCT02543346|455189892|FG002|Second Priming Visit|Adverse Event|0|||
126517713|NCT02543346|455189893|FG003|Second Priming Visit|Adverse Event|0|||
126517714|NCT01767116|455189894|FG000|Overall Study|Lost to Follow-up|2|||
126517715|NCT01767116|455189895|FG001|Overall Study|Lost to Follow-up|2|||
126517716|NCT01975389|455189900|FG000|Overall Study|Adverse Event|10|||
126517717|NCT01975389|455189901|FG001|Overall Study|Adverse Event|6|||
126517718|NCT01975389|455189900|FG000|Overall Study|Death|61|||
126517719|NCT01975389|455189901|FG001|Overall Study|Death|54|||
126517720|NCT01975389|455189900|FG000|Overall Study|Lost to Follow-up|81|||
126517721|NCT01975389|455189901|FG001|Overall Study|Lost to Follow-up|86|||
126517722|NCT01975389|455189900|FG000|Overall Study|Withdrawal by Subject|90|||
126517723|NCT01975389|455189901|FG001|Overall Study|Withdrawal by Subject|76|||
126517724|NCT01975389|455189900|FG000|Overall Study|Other|6|||
126517725|NCT01975389|455189901|FG001|Overall Study|Other|9|||
126517726|NCT01975389|455189900|FG000|Overall Study|Randomized, not treated|4|||
126517727|NCT01975389|455189901|FG001|Overall Study|Randomized, not treated|5|||
126517728|NCT01079234|455189909|FG000|Main: Week 0 to 26|Adverse Event|5|||
126517729|NCT01079234|455189910|FG001|Main: Week 0 to 26|Adverse Event|4|||
126517730|NCT01079234|455189911|FG002|Main: Week 0 to 26|Adverse Event|1|||
126517731|NCT01079234|455189912|FG003|Main: Week 0 to 26|Adverse Event|0|||
126517732|NCT01079234|455189909|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
126517733|NCT01079234|455189910|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
126517734|NCT01079234|455189911|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
126517735|NCT01079234|455189912|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
126517736|NCT01079234|455189909|FG000|Main: Week 0 to 26|Protocol Violation|6|||
126517737|NCT01079234|455189910|FG001|Main: Week 0 to 26|Protocol Violation|2|||
126517738|NCT01079234|455189911|FG002|Main: Week 0 to 26|Protocol Violation|4|||
126517739|NCT01079234|455189912|FG003|Main: Week 0 to 26|Protocol Violation|0|||
126517740|NCT01079234|455189909|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
126517741|NCT01079234|455189910|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
126517742|NCT01079234|455189911|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
126517743|NCT01079234|455189912|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
126517744|NCT01079234|455189909|FG000|Main: Week 0 to 26|Unclassified|7|||
126517745|NCT01079234|455189910|FG001|Main: Week 0 to 26|Unclassified|13|||
126517746|NCT01079234|455189911|FG002|Main: Week 0 to 26|Unclassified|4|||
126517747|NCT01079234|455189912|FG003|Main: Week 0 to 26|Unclassified|0|||
126517748|NCT01079234|455189909|FG000|Extension: Week 27 to 52|Adverse Event|0|||
126517749|NCT01079234|455189910|FG001|Extension: Week 27 to 52|Adverse Event|0|||
126517750|NCT01079234|455189911|FG002|Extension: Week 27 to 52|Adverse Event|1|||
126517751|NCT01079234|455189912|FG003|Extension: Week 27 to 52|Adverse Event|0|||
126517752|NCT01079234|455189909|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
126517753|NCT01079234|455189910|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
126517754|NCT01079234|455189911|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
126517755|NCT01079234|455189912|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
126517756|NCT01079234|455189909|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
126517757|NCT01079234|455189910|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
126517758|NCT01079234|455189911|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
126517759|NCT01079234|455189912|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
126517760|NCT01079234|455189909|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
126517761|NCT01079234|455189910|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
126517762|NCT01079234|455189911|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
126517763|NCT01079234|455189912|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
126517764|NCT01079234|455189909|FG000|Extension: Week 27 to 52|Unclassified|0|||
126517765|NCT01079234|455189910|FG001|Extension: Week 27 to 52|Unclassified|0|||
126517766|NCT01079234|455189911|FG002|Extension: Week 27 to 52|Unclassified|4|||
126517767|NCT01079234|455189912|FG003|Extension: Week 27 to 52|Unclassified|7|||
126517768|NCT01312961|455189913|FG000|Overall Study|Adverse Event|3|||
126517769|NCT01312961|455189914|FG001|Overall Study|Adverse Event|3|||
126517770|NCT01312961|455189913|FG000|Overall Study|Lack of Efficacy|11|||
126517771|NCT01312961|455189914|FG001|Overall Study|Lack of Efficacy|1|||
126517772|NCT01312961|455189913|FG000|Overall Study|Poor compliance to protocol|1|||
126517773|NCT01312961|455189914|FG001|Overall Study|Poor compliance to protocol|0|||
126517774|NCT01312961|455189913|FG000|Overall Study|Other than specified above|2|||
126517775|NCT01312961|455189914|FG001|Overall Study|Other than specified above|3|||
126517776|NCT04278417|455189920|FG000|Overall Study|Withdrawal by Subject|20|||
126517777|NCT04278417|455189921|FG001|Overall Study|Withdrawal by Subject|20|||
126517778|NCT04278417|455189920|FG000|Overall Study|Progressive disease|0|||
126517779|NCT04278417|455189921|FG001|Overall Study|Progressive disease|2|||
126517780|NCT04278417|455189920|FG000|Overall Study|Physician Decision|4|||
126517781|NCT04278417|455189921|FG001|Overall Study|Physician Decision|6|||
126517782|NCT04278417|455189920|FG000|Overall Study|Lost to Follow-up|11|||
126517783|NCT04278417|455189921|FG001|Overall Study|Lost to Follow-up|13|||
126517784|NCT04278417|455189920|FG000|Overall Study|Death|8|||
126517785|NCT04278417|455189921|FG001|Overall Study|Death|9|||
126517786|NCT04278417|455189920|FG000|Overall Study|Adverse Event|3|||
126517787|NCT04278417|455189921|FG001|Overall Study|Adverse Event|5|||
126517788|NCT00205712|455189923|FG000|Overall Study|Lost to Follow-up|0|||
126517789|NCT00205712|455189924|FG001|Overall Study|Lost to Follow-up|1|||
126571734|NCT01087762|455389531|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
126571735|NCT01087762|455389532|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
126571736|NCT01087762|455389528|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
126571737|NCT01087762|455389529|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
126571738|NCT01087762|455389530|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
126571739|NCT01087762|455389531|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
126571740|NCT01087762|455389532|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
126571741|NCT01087762|455389528|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
126571742|NCT01087762|455389529|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
126571743|NCT01087762|455389530|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
126571744|NCT01087762|455389531|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
126571745|NCT01087762|455389532|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
126571746|NCT01087762|455389528|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
126571747|NCT01087762|455389529|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
126571748|NCT01087762|455389530|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
126571749|NCT01087762|455389531|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
126571750|NCT01087762|455389532|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
126571751|NCT01087762|455389528|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
126571752|NCT01087762|455389529|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
126571753|NCT01087762|455389530|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
126571754|NCT01087762|455389531|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
126571755|NCT01087762|455389532|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
126571756|NCT01087762|455389528|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
126571757|NCT01087762|455389529|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
126571758|NCT01087762|455389530|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
126571759|NCT01087762|455389531|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
126571760|NCT01087762|455389532|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
126571761|NCT00813904|455389533|FG000|Overall Study|Death|1|||
126571762|NCT00424762|455389539|FG000|Overall Study|Withdrawal by Subject|18|||
126571763|NCT00424762|455389540|FG001|Overall Study|Withdrawal by Subject|19|||
126571764|NCT00424762|455389539|FG000|Overall Study|Lost to Follow-up|2|||
126571765|NCT00424762|455389540|FG001|Overall Study|Lost to Follow-up|3|||
126571766|NCT01147341|455389547|FG000|Double Blind Period|Lack of Efficacy|1|||
126571767|NCT01147341|455389548|FG001|Double Blind Period|Lack of Efficacy|1|||
126571768|NCT01147341|455389547|FG000|Double Blind Period|Withdrawal by Subject|0|||
126571769|NCT01147341|455389548|FG001|Double Blind Period|Withdrawal by Subject|1|||
126571770|NCT01147341|455389547|FG000|Open Label Period|Lack of Efficacy|3|||
126571771|NCT01147341|455389548|FG001|Open Label Period|Lack of Efficacy|0|||
126571772|NCT01147341|455389547|FG000|Open Label Period|Subject moved|1|||
126571773|NCT01147341|455389548|FG001|Open Label Period|Subject moved|0|||
126571774|NCT02808338|455389551|FG000|Screening|Screen Failure|10|||
126571775|NCT02808338|455389551|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
126571776|NCT02808338|455389551|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
126571777|NCT00057837|455389552|FG000|Overall Study|Progression/relapse|12|||
126571778|NCT00057837|455389553|FG001|Overall Study|Progression/relapse|14|||
126571779|NCT00057837|455389552|FG000|Overall Study|Adverse Event|2|||
126571780|NCT00057837|455389553|FG001|Overall Study|Adverse Event|12|||
126571781|NCT00057837|455389552|FG000|Overall Study|Death|5|||
126571782|NCT00057837|455389553|FG001|Overall Study|Death|4|||
126571783|NCT00057837|455389552|FG000|Overall Study|Withdrawal by Subject|5|||
126571784|NCT00057837|455389553|FG001|Overall Study|Withdrawal by Subject|3|||
126727274|NCT00099359|455951096|FG000|Overall Study|moved out of area|9|||
126727275|NCT00099359|455951097|FG001|Overall Study|moved out of area|7|||
126727276|NCT00099359|455951098|FG002|Overall Study|moved out of area|4|||
126727277|NCT02756650|455951099|FG000|Overall Study|Physician Decision|1|||
126727278|NCT02756650|455951099|FG000|Overall Study|Adverse Event|1|||
126727279|NCT01822691|455951100|FG000|Overall Study|Withdrawal by Subject|2|||
126727280|NCT02720016|455951104|FG000|Overall Study|Separation of couple|6|||
126727281|NCT02720016|455951105|FG001|Overall Study|Separation of couple|8|||
126517790|NCT01603875|455189932|FG000|Overall Study|Preexisting rabies antibody|3|||
126517791|NCT01603875|455189933|FG001|Overall Study|Preexisting rabies antibody|4|||
126517792|NCT01603875|455189934|FG002|Overall Study|Preexisting rabies antibody|3|||
126517793|NCT01603875|455189932|FG000|Overall Study|Lost to Follow-up|4|||
126517794|NCT01603875|455189933|FG001|Overall Study|Lost to Follow-up|3|||
126517795|NCT01603875|455189934|FG002|Overall Study|Lost to Follow-up|6|||
126517796|NCT01603875|455189932|FG000|Overall Study|Protocol Violation|0|||
126517797|NCT01603875|455189933|FG001|Overall Study|Protocol Violation|1|||
126571785|NCT00057837|455389552|FG000|Overall Study|Alternative therapy|0|||
126571786|NCT00057837|455389553|FG001|Overall Study|Alternative therapy|1|||
126571787|NCT00057837|455389552|FG000|Overall Study|Other complicating disease|2|||
126727282|NCT02720016|455951106|FG002|Overall Study|Separation of couple|2|||
126727283|NCT02720016|455951104|FG000|Overall Study|Withdrawal by Subject|6|||
126517798|NCT01603875|455189934|FG002|Overall Study|Protocol Violation|0|||
126571788|NCT00057837|455389553|FG001|Overall Study|Other complicating disease|1|||
126571789|NCT00057837|455389552|FG000|Overall Study|Physician Decision|1|||
126571790|NCT00057837|455389553|FG001|Overall Study|Physician Decision|0|||
126571791|NCT00057837|455389552|FG000|Overall Study|Ineligible|3|||
126571792|NCT00057837|455389553|FG001|Overall Study|Ineligible|3|||
126571793|NCT00057837|455389552|FG000|Overall Study|Never started treatment|1|||
126571794|NCT00057837|455389553|FG001|Overall Study|Never started treatment|1|||
126571795|NCT02537522|455389554|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
126571796|NCT02537522|455389555|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
126571797|NCT02537522|455389556|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
126571798|NCT02537522|455389557|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
126571799|NCT02537522|455389554|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
126571800|NCT02537522|455389555|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
126571801|NCT02537522|455389556|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
126571802|NCT02537522|455389557|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
126571803|NCT02537522|455389554|FG000|Phase I - Contralateral|incorrect randomization|0|||
126571804|NCT02537522|455389555|FG001|Phase I - Contralateral|incorrect randomization|1|||
126571805|NCT02537522|455389556|FG002|Phase I - Contralateral|incorrect randomization|0|||
126571806|NCT02537522|455389557|FG003|Phase I - Contralateral|incorrect randomization|0|||
126571807|NCT02537522|455389554|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
126571808|NCT02537522|455389555|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
126571809|NCT02537522|455389556|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
126571810|NCT02537522|455389557|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
126571811|NCT02537522|455389554|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
126571812|NCT02537522|455389555|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
126571813|NCT02537522|455389556|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
126571814|NCT02537522|455389557|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
126571815|NCT03024606|455389561|FG000|Overall Study|Withdrawal by Subject|9|||
126571816|NCT03024606|455389562|FG001|Overall Study|Withdrawal by Subject|10|||
126571817|NCT01692938|455389564|FG000|Overall Study|Protocol Deviation|1|||
126571818|NCT01692938|455389565|FG001|Overall Study|Protocol Deviation|1|||
126571819|NCT01692938|455389564|FG000|Overall Study|Study completed prior to site completion|3|||
126571820|NCT01692938|455389565|FG001|Overall Study|Study completed prior to site completion|3|||
126571821|NCT00256243|455389571|FG000|Overall Study|Lost to Follow-up|2|||
126571822|NCT00256243|455389571|FG000|Overall Study|Death|7|||
126571823|NCT00256243|455389571|FG000|Overall Study|Not treated|1|||
126571824|NCT00547118|455389574|FG000|Overall Study|Did not qualify prior to starting drug|1|||
126571825|NCT00547118|455389575|FG001|Overall Study|Did not qualify prior to starting drug|1|||
126571826|NCT00547118|455389574|FG000|Overall Study|Study suspended|7|||
126571827|NCT00547118|455389575|FG001|Overall Study|Study suspended|8|||
126571828|NCT00834834|455389576|FG000|Overall Study|Withdrawal by Subject|4|||
126571829|NCT00834834|455389577|FG001|Overall Study|Withdrawal by Subject|3|||
126571830|NCT00539292|455389578|FG000|Overall Study|Physician Decision|1|||
126571831|NCT00539292|455389579|FG001|Overall Study|Physician Decision|0|||
126571832|NCT02020616|455389580|FG000|Overall Study|Adverse Event|0|||
126571833|NCT02020616|455389581|FG001|Overall Study|Adverse Event|0|||
126571834|NCT02020616|455389582|FG002|Overall Study|Adverse Event|0|||
126571835|NCT02020616|455389583|FG003|Overall Study|Adverse Event|0|||
126571836|NCT02020616|455389584|FG004|Overall Study|Adverse Event|0|||
126571837|NCT02020616|455389585|FG005|Overall Study|Adverse Event|1|||
126571838|NCT02020616|455389586|FG006|Overall Study|Adverse Event|1|||
126571839|NCT02020616|455389580|FG000|Overall Study|Physician Decision|0|||
126571840|NCT02020616|455389581|FG001|Overall Study|Physician Decision|0|||
126571841|NCT02020616|455389582|FG002|Overall Study|Physician Decision|0|||
126571842|NCT02020616|455389583|FG003|Overall Study|Physician Decision|0|||
126571843|NCT02020616|455389584|FG004|Overall Study|Physician Decision|0|||
126571844|NCT02020616|455389585|FG005|Overall Study|Physician Decision|1|||
126571845|NCT02020616|455389586|FG006|Overall Study|Physician Decision|2|||
126571846|NCT02020616|455389580|FG000|Overall Study|Withdrawal by Subject|0|||
126571847|NCT02020616|455389581|FG001|Overall Study|Withdrawal by Subject|0|||
126571848|NCT02020616|455389582|FG002|Overall Study|Withdrawal by Subject|1|||
126571849|NCT02020616|455389583|FG003|Overall Study|Withdrawal by Subject|0|||
126571850|NCT02020616|455389584|FG004|Overall Study|Withdrawal by Subject|0|||
126571851|NCT02020616|455389585|FG005|Overall Study|Withdrawal by Subject|1|||
126571852|NCT02020616|455389586|FG006|Overall Study|Withdrawal by Subject|1|||
126571853|NCT02020616|455389580|FG000|Overall Study|Lost to Follow-up|0|||
126571854|NCT02020616|455389581|FG001|Overall Study|Lost to Follow-up|1|||
126571855|NCT02020616|455389582|FG002|Overall Study|Lost to Follow-up|0|||
126571856|NCT02020616|455389583|FG003|Overall Study|Lost to Follow-up|1|||
126571857|NCT02020616|455389584|FG004|Overall Study|Lost to Follow-up|1|||
126571858|NCT02020616|455389585|FG005|Overall Study|Lost to Follow-up|1|||
126571859|NCT02020616|455389586|FG006|Overall Study|Lost to Follow-up|0|||
126571860|NCT02020616|455389580|FG000|Overall Study|Early Termination Criteria Met|0|||
126571861|NCT02020616|455389581|FG001|Overall Study|Early Termination Criteria Met|0|||
126571862|NCT02020616|455389582|FG002|Overall Study|Early Termination Criteria Met|1|||
126571863|NCT02020616|455389583|FG003|Overall Study|Early Termination Criteria Met|0|||
126571864|NCT02020616|455389584|FG004|Overall Study|Early Termination Criteria Met|0|||
126571865|NCT02020616|455389585|FG005|Overall Study|Early Termination Criteria Met|1|||
126571866|NCT02020616|455389586|FG006|Overall Study|Early Termination Criteria Met|0|||
126571867|NCT02020616|455389580|FG000|Overall Study|Randomized in Error|0|||
126571868|NCT02020616|455389581|FG001|Overall Study|Randomized in Error|0|||
126571869|NCT02020616|455389582|FG002|Overall Study|Randomized in Error|0|||
126571870|NCT02020616|455389583|FG003|Overall Study|Randomized in Error|1|||
126571871|NCT02020616|455389584|FG004|Overall Study|Randomized in Error|0|||
126571872|NCT02020616|455389585|FG005|Overall Study|Randomized in Error|0|||
126571873|NCT02020616|455389586|FG006|Overall Study|Randomized in Error|0|||
126571874|NCT02020616|455389580|FG000|Overall Study|Lack of Efficacy|0|||
126571875|NCT02020616|455389581|FG001|Overall Study|Lack of Efficacy|0|||
126571876|NCT02020616|455389582|FG002|Overall Study|Lack of Efficacy|0|||
126571877|NCT02020616|455389583|FG003|Overall Study|Lack of Efficacy|0|||
126571878|NCT02020616|455389584|FG004|Overall Study|Lack of Efficacy|1|||
126571879|NCT02020616|455389585|FG005|Overall Study|Lack of Efficacy|0|||
126571880|NCT02020616|455389586|FG006|Overall Study|Lack of Efficacy|0|||
126571881|NCT00305695|455389591|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
126571882|NCT00305695|455389592|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
126517799|NCT01971346|455189935|FG000|Overall Study|Protocol Violation|3|||
126571883|NCT00305695|455389591|FG000|Overall Study|Did not have baseline scan|1|||
126571884|NCT00305695|455389592|FG001|Overall Study|Did not have baseline scan|1|||
126571885|NCT02031471|455389595|FG000|24 Week Treatment Period|Adverse Event|6|||
126571886|NCT02031471|455389595|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
126571887|NCT02031471|455389595|FG000|24 Week Treatment Period|Protocol Violation|1|||
126571888|NCT02031471|455389595|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
126571889|NCT02031471|455389595|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
126571890|NCT02031471|455389595|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
126571891|NCT02031471|455389595|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
126571892|NCT00997386|455389596|FG000|Overall Study|Death|7|||
126571893|NCT02994654|455389598|FG000|Overall Study|Lost to Follow-up|1|||
126517800|NCT01971346|455189935|FG000|Overall Study|Lost to Follow-up|2|||
126517801|NCT01971346|455189935|FG000|Overall Study|Withdrawal by Subject|2|||
126517802|NCT01971346|455189935|FG000|Overall Study|Physician Decision|1|||
126517803|NCT01337297|455189938|FG000|Overall Study|They entered to single anodal tDCS|4|||
126517804|NCT01337297|455189939|FG001|Overall Study|They entered to single anodal tDCS|3|||
126517805|NCT01337297|455189938|FG000|Overall Study|Lost to Follow-up|1|||
126517806|NCT01337297|455189939|FG001|Overall Study|Lost to Follow-up|3|||
126517807|NCT02316717|455189940|FG000|Overall Study|Adverse Event|2|||
126517808|NCT02316717|455189941|FG001|Overall Study|Adverse Event|2|||
126517809|NCT02316717|455189942|FG002|Overall Study|Adverse Event|0|||
126517810|NCT02316717|455189940|FG000|Overall Study|Lost to Follow-up|1|||
126517811|NCT02316717|455189941|FG001|Overall Study|Lost to Follow-up|2|||
126517812|NCT02316717|455189942|FG002|Overall Study|Lost to Follow-up|1|||
126517813|NCT02316717|455189940|FG000|Overall Study|Non compliance|3|||
126517814|NCT02316717|455189941|FG001|Overall Study|Non compliance|1|||
126517815|NCT02316717|455189942|FG002|Overall Study|Non compliance|0|||
126517816|NCT02316717|455189940|FG000|Overall Study|Protocol Violation|2|||
126517817|NCT02316717|455189941|FG001|Overall Study|Protocol Violation|0|||
126517818|NCT02316717|455189942|FG002|Overall Study|Protocol Violation|0|||
126517819|NCT02316717|455189940|FG000|Overall Study|Withdrawal by Subject|2|||
126517820|NCT02316717|455189941|FG001|Overall Study|Withdrawal by Subject|1|||
126517821|NCT02316717|455189942|FG002|Overall Study|Withdrawal by Subject|1|||
126517822|NCT02316717|455189940|FG000|Overall Study|Death|0|||
126517823|NCT02316717|455189941|FG001|Overall Study|Death|0|||
126517824|NCT02316717|455189942|FG002|Overall Study|Death|1|||
126517825|NCT02316717|455189940|FG000|Overall Study|Physician Decision|0|||
126517826|NCT02316717|455189941|FG001|Overall Study|Physician Decision|1|||
126517827|NCT02316717|455189942|FG002|Overall Study|Physician Decision|0|||
126517828|NCT02316717|455189940|FG000|Overall Study|TBC|1|||
126571894|NCT03603717|455389603|FG000|Overall Study|Lost to Follow-up|20|||
126571895|NCT03603717|455389604|FG001|Overall Study|Lost to Follow-up|20|||
126571896|NCT03603717|455389603|FG000|Overall Study|Withdrawal by Subject|16|||
126571897|NCT03603717|455389604|FG001|Overall Study|Withdrawal by Subject|10|||
126571898|NCT05328297|455391334|FG000|Overall Study|Adverse Event|5|||
126571899|NCT05328297|455391335|FG001|Overall Study|Adverse Event|7|||
126517829|NCT02316717|455189941|FG001|Overall Study|TBC|0|||
126517830|NCT02316717|455189942|FG002|Overall Study|TBC|0|||
126517831|NCT02778204|455189943|FG000|Overall Study|Adverse Event|1|||
126517832|NCT02778204|455189944|FG001|Overall Study|Adverse Event|0|||
126517833|NCT02778204|455189945|FG002|Overall Study|Adverse Event|0|||
126571900|NCT05328297|455391334|FG000|Overall Study|Withdrawal by Subject|4|||
126571901|NCT05328297|455391335|FG001|Overall Study|Withdrawal by Subject|3|||
126571902|NCT05328297|455391334|FG000|Overall Study|Lack of Efficacy|1|||
126517834|NCT02778204|455189946|FG003|Overall Study|Adverse Event|0|||
126517835|NCT02778204|455189943|FG000|Overall Study|Withdrawal by Subject|0|||
126517836|NCT02778204|455189944|FG001|Overall Study|Withdrawal by Subject|0|||
126517837|NCT02778204|455189945|FG002|Overall Study|Withdrawal by Subject|1|||
126517838|NCT02778204|455189946|FG003|Overall Study|Withdrawal by Subject|2|||
126517839|NCT02778204|455189943|FG000|Overall Study|Lost to Follow-up|1|||
126517840|NCT02778204|455189944|FG001|Overall Study|Lost to Follow-up|0|||
126517841|NCT02778204|455189945|FG002|Overall Study|Lost to Follow-up|2|||
126517842|NCT02778204|455189946|FG003|Overall Study|Lost to Follow-up|1|||
126517843|NCT02778204|455189943|FG000|Overall Study|Protocol Violation|0|||
126517844|NCT02778204|455189944|FG001|Overall Study|Protocol Violation|0|||
126517845|NCT02778204|455189945|FG002|Overall Study|Protocol Violation|1|||
126517846|NCT02778204|455189946|FG003|Overall Study|Protocol Violation|0|||
126517847|NCT02778204|455189943|FG000|Overall Study|Eligibility Violation|0|||
126517848|NCT02778204|455189944|FG001|Overall Study|Eligibility Violation|0|||
126517849|NCT02778204|455189945|FG002|Overall Study|Eligibility Violation|0|||
126517850|NCT02778204|455189946|FG003|Overall Study|Eligibility Violation|1|||
126517851|NCT00360334|455189947|FG000|Overall Study|Adverse Event|7|||
126517852|NCT00360334|455189948|FG001|Overall Study|Adverse Event|4|||
126517853|NCT00360334|455189947|FG000|Overall Study|Protocol Violation|1|||
126517854|NCT00360334|455189948|FG001|Overall Study|Protocol Violation|1|||
126517855|NCT00360334|455189947|FG000|Overall Study|Physician Decision|2|||
126517856|NCT00360334|455189948|FG001|Overall Study|Physician Decision|3|||
126517857|NCT00360334|455189947|FG000|Overall Study|Lack of Efficacy|0|||
126517858|NCT00360334|455189948|FG001|Overall Study|Lack of Efficacy|1|||
126517859|NCT00360334|455189947|FG000|Overall Study|Entry criterion not met|1|||
126517860|NCT00360334|455189948|FG001|Overall Study|Entry criterion not met|2|||
126517861|NCT00360334|455189947|FG000|Overall Study|Subject decision|8|||
126517862|NCT00360334|455189948|FG001|Overall Study|Subject decision|2|||
126517863|NCT01978184|455189951|FG000|Overall Study|Progressive disease|5|||
126517864|NCT01978184|455189952|FG001|Overall Study|Progressive disease|5|||
126517865|NCT01978184|455189951|FG000|Overall Study|Other than PDA|2|||
126517866|NCT01978184|455189952|FG001|Overall Study|Other than PDA|2|||
126517867|NCT01978184|455189951|FG000|Overall Study|Physician Decision|0|||
126517868|NCT01978184|455189952|FG001|Overall Study|Physician Decision|3|||
126517869|NCT01978184|455189951|FG000|Overall Study|Noncompliance|1|||
126517870|NCT01978184|455189952|FG001|Overall Study|Noncompliance|2|||
126517871|NCT01978184|455189951|FG000|Overall Study|Death|1|||
126517872|NCT01978184|455189952|FG001|Overall Study|Death|0|||
126517873|NCT01978184|455189951|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
126517874|NCT01978184|455189952|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
126517875|NCT03779841|455189961|FG000|Randomized Population|Did Not Receive Treatment|3|||
126517876|NCT03779841|455189962|FG001|Randomized Population|Did Not Receive Treatment|1|||
126517877|NCT03779841|455189963|FG002|Randomized Population|Did Not Receive Treatment|0|||
126517878|NCT03779841|455189961|FG000|Treated (Safety) Population|Adverse Event|1|||
126517879|NCT03779841|455189962|FG001|Treated (Safety) Population|Adverse Event|1|||
126517880|NCT03779841|455189963|FG002|Treated (Safety) Population|Adverse Event|0|||
126517881|NCT03779841|455189961|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
126517882|NCT03779841|455189962|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
126517883|NCT03779841|455189963|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
126517884|NCT03779841|455189961|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
126517885|NCT03779841|455189962|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
126517886|NCT03779841|455189963|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
126517887|NCT03779841|455189961|FG000|Treated (Safety) Population|Death|1|||
126517888|NCT03779841|455189962|FG001|Treated (Safety) Population|Death|0|||
126517889|NCT03779841|455189963|FG002|Treated (Safety) Population|Death|2|||
126517890|NCT00162136|455189964|FG000|Overall Study|Adverse Event|1|||
126517891|NCT00162136|455189964|FG000|Overall Study|Death|1|||
126517892|NCT00162136|455189964|FG000|Overall Study|Disease Progression/Relapse|23|||
126517893|NCT00162136|455189964|FG000|Overall Study|Investigator Request|5|||
126517894|NCT00162136|455189964|FG000|Overall Study|Study Drug Toxicity|4|||
126517895|NCT00162136|455189964|FG000|Overall Study|Withdrawal by Subject|1|||
126517896|NCT02788175|455189965|FG000|Overall Study|Protocol Violation|3|||
126517897|NCT02788175|455189965|FG000|Overall Study|Withdrawal by Subject|4|||
126517898|NCT02788175|455189965|FG000|Overall Study|Ineligible prior to study agent|6|||
126517899|NCT03930745|455189966|FG000|Overall Study|Lost to Follow-up|10|||
126517900|NCT03930745|455189967|FG001|Overall Study|Lost to Follow-up|5|||
126517901|NCT03930745|455189966|FG000|Overall Study|Withdrawal by Subject|1|||
126517902|NCT03930745|455189967|FG001|Overall Study|Withdrawal by Subject|2|||
126517903|NCT03930745|455189966|FG000|Overall Study|Protocol Violation|2|||
126517904|NCT03930745|455189967|FG001|Overall Study|Protocol Violation|2|||
126517905|NCT03930745|455189966|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
126517906|NCT03930745|455189967|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
126517907|NCT03930745|455189966|FG000|Overall Study|Adverse Event|0|||
126517908|NCT03930745|455189967|FG001|Overall Study|Adverse Event|1|||
126517909|NCT03930745|455189966|FG000|Overall Study|Pregnancy|0|||
126517910|NCT03930745|455189967|FG001|Overall Study|Pregnancy|1|||
126517911|NCT03483623|455189973|FG000|Overall Study|43 complete sets achieved|1|||
126517912|NCT02770391|455189974|FG000|Overall Study|Lost to Follow-up|2|||
126517913|NCT02770391|455189974|FG000|Overall Study|Withdrawal by Subject|1|||
126517914|NCT02770391|455189974|FG000|Overall Study|Surgery delayed unevaluable|2|||
126517915|NCT02770391|455189974|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
126517916|NCT00612313|455189979|FG000|Overall Study|Withdrawal by Subject|6|||
126517917|NCT00612313|455189980|FG001|Overall Study|Withdrawal by Subject|9|||
126517918|NCT00612313|455189979|FG000|Overall Study|Lost to Follow-up|11|||
126517919|NCT00612313|455189980|FG001|Overall Study|Lost to Follow-up|4|||
126517920|NCT01175824|455192445|FG000|Overall Study|Adverse Event|2|||
126517921|NCT01175824|455192446|FG001|Overall Study|Adverse Event|1|||
126517922|NCT01175824|455192445|FG000|Overall Study|Lack of Efficacy|2|||
126517923|NCT01175824|455192446|FG001|Overall Study|Lack of Efficacy|0|||
126517924|NCT01175824|455192445|FG000|Overall Study|Lost to Follow-up|0|||
126517925|NCT01175824|455192446|FG001|Overall Study|Lost to Follow-up|1|||
126517926|NCT01175824|455192445|FG000|Overall Study|Physician Decision|0|||
126517927|NCT01175824|455192446|FG001|Overall Study|Physician Decision|4|||
126517928|NCT01175824|455192445|FG000|Overall Study|Protocol Violation|2|||
126517929|NCT01175824|455192446|FG001|Overall Study|Protocol Violation|5|||
126517930|NCT01175824|455192445|FG000|Overall Study|Withdrawal by Subject|3|||
126517931|NCT01175824|455192446|FG001|Overall Study|Withdrawal by Subject|7|||
126517932|NCT01175824|455192445|FG000|Overall Study|Sponsor Decision|1|||
126517933|NCT01175824|455192446|FG001|Overall Study|Sponsor Decision|0|||
126517934|NCT01175824|455192445|FG000|Overall Study|Entry Criteria Not Met|6|||
126517935|NCT01175824|455192446|FG001|Overall Study|Entry Criteria Not Met|4|||
126517936|NCT00009737|455192450|FG000|Overall Study|Adverse Event|112|||
126517937|NCT00009737|455192451|FG001|Overall Study|Adverse Event|75|||
126517938|NCT00009737|455192450|FG000|Overall Study|Death|4|||
126517939|NCT00009737|455192451|FG001|Overall Study|Death|6|||
126517940|NCT00009737|455192450|FG000|Overall Study|Lack of Efficacy|17|||
126517941|NCT00009737|455192451|FG001|Overall Study|Lack of Efficacy|15|||
126517942|NCT00009737|455192450|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
126517943|NCT00009737|455192451|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
126517944|NCT00009737|455192450|FG000|Overall Study|Other Protocol Violation|1|||
126517945|NCT00009737|455192451|FG001|Overall Study|Other Protocol Violation|0|||
126517946|NCT00009737|455192450|FG000|Overall Study|Refused Treatment|15|||
126517947|NCT00009737|455192451|FG001|Overall Study|Refused Treatment|16|||
126517948|NCT00009737|455192450|FG000|Overall Study|Lost to Follow-up|1|||
126517949|NCT00009737|455192451|FG001|Overall Study|Lost to Follow-up|1|||
126517950|NCT00009737|455192450|FG000|Overall Study|Administrative/Other Reasons|7|||
126517951|NCT00009737|455192451|FG001|Overall Study|Administrative/Other Reasons|1|||
126517952|NCT01163682|455192455|FG000|Overall Study|Lost to Follow-up|6|||
126517953|NCT01163682|455192456|FG001|Overall Study|Lost to Follow-up|9|||
126517954|NCT00359762|455192460|FG000|Period II|Adverse Event|17|||
126517955|NCT00359762|455192461|FG001|Period II|Adverse Event|0|||
126517956|NCT00359762|455192462|FG002|Period II|Adverse Event|0|||
126517957|NCT00359762|455192463|FG003|Period II|Adverse Event|0|||
126517958|NCT00359762|455192464|FG004|Period II|Adverse Event|49|||
126517959|NCT00359762|455192460|FG000|Period II|Protocol Violation|18|||
126517960|NCT00359762|455192461|FG001|Period II|Protocol Violation|0|||
126517961|NCT00359762|455192462|FG002|Period II|Protocol Violation|0|||
126517962|NCT00359762|455192463|FG003|Period II|Protocol Violation|0|||
126517963|NCT00359762|455192464|FG004|Period II|Protocol Violation|11|||
126517964|NCT00359762|455192460|FG000|Period II|Physician Decision|17|||
126517965|NCT00359762|455192461|FG001|Period II|Physician Decision|0|||
126517966|NCT00359762|455192462|FG002|Period II|Physician Decision|0|||
126517967|NCT00359762|455192463|FG003|Period II|Physician Decision|0|||
126517968|NCT00359762|455192464|FG004|Period II|Physician Decision|23|||
126517969|NCT00359762|455192460|FG000|Period II|Death|2|||
126517970|NCT00359762|455192461|FG001|Period II|Death|0|||
126517971|NCT00359762|455192462|FG002|Period II|Death|0|||
126517972|NCT00359762|455192463|FG003|Period II|Death|0|||
126517973|NCT00359762|455192464|FG004|Period II|Death|4|||
126517974|NCT00359762|455192460|FG000|Period II|Lack of Efficacy|11|||
126517975|NCT00359762|455192461|FG001|Period II|Lack of Efficacy|0|||
126517976|NCT00359762|455192462|FG002|Period II|Lack of Efficacy|0|||
126517977|NCT00359762|455192463|FG003|Period II|Lack of Efficacy|0|||
126517978|NCT00359762|455192464|FG004|Period II|Lack of Efficacy|8|||
126517979|NCT00359762|455192460|FG000|Period II|Lost to follow up|5|||
126517980|NCT00359762|455192461|FG001|Period II|Lost to follow up|0|||
126517981|NCT00359762|455192462|FG002|Period II|Lost to follow up|0|||
126517982|NCT00359762|455192463|FG003|Period II|Lost to follow up|0|||
126517983|NCT00359762|455192464|FG004|Period II|Lost to follow up|5|||
126517984|NCT00359762|455192460|FG000|Period II|Entry Criteria Not Met|8|||
126517985|NCT00359762|455192461|FG001|Period II|Entry Criteria Not Met|0|||
126517986|NCT00359762|455192462|FG002|Period II|Entry Criteria Not Met|0|||
126517987|NCT00359762|455192463|FG003|Period II|Entry Criteria Not Met|0|||
126517988|NCT00359762|455192464|FG004|Period II|Entry Criteria Not Met|4|||
126517989|NCT00359762|455192460|FG000|Period II|Subject Decision|50|||
126517990|NCT00359762|455192461|FG001|Period II|Subject Decision|0|||
126517991|NCT00359762|455192462|FG002|Period II|Subject Decision|0|||
126517992|NCT00359762|455192463|FG003|Period II|Subject Decision|0|||
126517993|NCT00359762|455192464|FG004|Period II|Subject Decision|70|||
126517994|NCT00359762|455192460|FG000|Period III|Protocol Violation|0|||
126517995|NCT00359762|455192461|FG001|Period III|Protocol Violation|5|||
126571903|NCT05328297|455391335|FG001|Overall Study|Lack of Efficacy|0|||
126571904|NCT05328297|455391334|FG000|Overall Study|Lost to Follow-up|1|||
126571905|NCT05328297|455391335|FG001|Overall Study|Lost to Follow-up|0|||
126571906|NCT05328297|455391334|FG000|Overall Study|Protocol Violation|1|||
126571907|NCT05328297|455391335|FG001|Overall Study|Protocol Violation|0|||
126571908|NCT05328297|455391334|FG000|Overall Study|Randomized but not treated|1|||
126571909|NCT05328297|455391335|FG001|Overall Study|Randomized but not treated|1|||
126571910|NCT03544515|455391336|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
126571911|NCT03544515|455391337|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
126571912|NCT03544515|455391336|FG000|Overall Study|Lost to Follow-up|2|||
126571913|NCT03544515|455391337|FG001|Overall Study|Lost to Follow-up|0|||
126571914|NCT03175172|455391338|FG000|Overall Study|Death|3|||
126571915|NCT03175172|455391338|FG000|Overall Study|Withdrawal by Subject|3|||
126571916|NCT03175172|455391338|FG000|Overall Study|Lost to Follow-up|1|||
126571917|NCT03175172|455391338|FG000|Overall Study|Study Terminated by Sponsor|3|||
126571918|NCT03169244|455391339|FG000|Overall Study|Lost to Follow-up|1|||
126571919|NCT03169244|455391340|FG001|Overall Study|Lost to Follow-up|2|||
126571920|NCT03169244|455391339|FG000|Overall Study|Adverse Event|1|||
126571921|NCT03169244|455391340|FG001|Overall Study|Adverse Event|0|||
126571922|NCT03169244|455391339|FG000|Overall Study|Withdrawal by Subject|2|||
126571923|NCT03169244|455391340|FG001|Overall Study|Withdrawal by Subject|2|||
126571924|NCT03169244|455391339|FG000|Overall Study|Physician Decision|1|||
126571925|NCT03169244|455391340|FG001|Overall Study|Physician Decision|0|||
126571926|NCT01662336|455391341|FG000|Overall Study|Adverse Event|1|||
126571927|NCT01662336|455391341|FG000|Overall Study|No longer on LPV/r|30|||
126571928|NCT01662336|455391341|FG000|Overall Study|Other|29|||
126517996|NCT00359762|455192462|FG002|Period III|Protocol Violation|3|||
126517997|NCT00359762|455192463|FG003|Period III|Protocol Violation|8|||
126517998|NCT00359762|455192464|FG004|Period III|Protocol Violation|0|||
126517999|NCT00359762|455192460|FG000|Period III|Adverse Event|0|||
126518000|NCT00359762|455192461|FG001|Period III|Adverse Event|3|||
126518001|NCT00359762|455192462|FG002|Period III|Adverse Event|4|||
126518002|NCT00359762|455192463|FG003|Period III|Adverse Event|10|||
126518003|NCT00359762|455192464|FG004|Period III|Adverse Event|0|||
126518004|NCT00359762|455192460|FG000|Period III|Physician Decision|0|||
126518005|NCT00359762|455192461|FG001|Period III|Physician Decision|5|||
126518006|NCT00359762|455192462|FG002|Period III|Physician Decision|9|||
126518007|NCT00359762|455192463|FG003|Period III|Physician Decision|15|||
126518008|NCT00359762|455192464|FG004|Period III|Physician Decision|0|||
126518009|NCT00359762|455192460|FG000|Period III|Lack of Efficacy|0|||
126518010|NCT00359762|455192461|FG001|Period III|Lack of Efficacy|7|||
126518011|NCT00359762|455192462|FG002|Period III|Lack of Efficacy|5|||
126518012|NCT00359762|455192463|FG003|Period III|Lack of Efficacy|9|||
126518013|NCT00359762|455192464|FG004|Period III|Lack of Efficacy|0|||
126518014|NCT00359762|455192460|FG000|Period III|Lost to follow up|0|||
126518015|NCT00359762|455192461|FG001|Period III|Lost to follow up|1|||
126518016|NCT00359762|455192462|FG002|Period III|Lost to follow up|1|||
126518017|NCT00359762|455192463|FG003|Period III|Lost to follow up|2|||
126518018|NCT00359762|455192464|FG004|Period III|Lost to follow up|0|||
126518019|NCT00359762|455192460|FG000|Period III|Entry Criteria Not Met|0|||
126518020|NCT00359762|455192461|FG001|Period III|Entry Criteria Not Met|1|||
126518021|NCT00359762|455192462|FG002|Period III|Entry Criteria Not Met|0|||
126518022|NCT00359762|455192463|FG003|Period III|Entry Criteria Not Met|1|||
126518023|NCT00359762|455192464|FG004|Period III|Entry Criteria Not Met|0|||
126518024|NCT00359762|455192460|FG000|Period III|Subject Decision|0|||
126518025|NCT00359762|455192461|FG001|Period III|Subject Decision|7|||
126571929|NCT01662336|455391341|FG000|Overall Study|Withdrawal by Subject|6|||
126571930|NCT03622593|455391345|FG000|Overall Study|Withdrawal by Subject|11|||
126571931|NCT03622593|455391346|FG001|Overall Study|Withdrawal by Subject|9|||
126571932|NCT03622593|455391347|FG002|Overall Study|Withdrawal by Subject|13|||
126571933|NCT03622593|455391345|FG000|Overall Study|Death|12|||
126571934|NCT03622593|455391346|FG001|Overall Study|Death|9|||
126571935|NCT03622593|455391347|FG002|Overall Study|Death|10|||
126571936|NCT03622593|455391345|FG000|Overall Study|Lost to Follow-up|11|||
126571937|NCT03622593|455391346|FG001|Overall Study|Lost to Follow-up|5|||
126571938|NCT03622593|455391347|FG002|Overall Study|Lost to Follow-up|8|||
126571939|NCT03622593|455391345|FG000|Overall Study|Adverse Event|4|||
126571940|NCT03622593|455391346|FG001|Overall Study|Adverse Event|5|||
126777019|NCT01789281|456139154|FG000|Overall Study|Withdrawal by Subject|1|||
126518026|NCT00359762|455192462|FG002|Period III|Subject Decision|8|||
126518027|NCT00359762|455192463|FG003|Period III|Subject Decision|20|||
126518028|NCT00359762|455192464|FG004|Period III|Subject Decision|0|||
126518029|NCT00530023|455192465|FG000|Overall Study|Withdrawal by Subject|0|||
126518030|NCT00530023|455192466|FG001|Overall Study|Withdrawal by Subject|1|||
126518031|NCT01172938|455192470|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
126518032|NCT01172938|455192471|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
126518033|NCT01172938|455192472|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
126518034|NCT01172938|455192473|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126571941|NCT03622593|455391347|FG002|Overall Study|Adverse Event|6|||
126518035|NCT01172938|455192474|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126518036|NCT01172938|455192475|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126518037|NCT01172938|455192476|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126518038|NCT01172938|455192477|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126518039|NCT01172938|455192478|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
126518040|NCT01172938|455192470|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
126518041|NCT01172938|455192471|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
126518042|NCT01172938|455192472|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
126518043|NCT01172938|455192473|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126518044|NCT01172938|455192474|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126518045|NCT01172938|455192475|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126518046|NCT01172938|455192476|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126518047|NCT01172938|455192477|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126518048|NCT01172938|455192478|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
126518049|NCT01172938|455192470|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126518050|NCT01172938|455192471|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
126518051|NCT01172938|455192472|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
126518052|NCT01172938|455192473|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126518053|NCT01172938|455192474|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126518054|NCT01172938|455192475|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126518055|NCT01172938|455192476|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126518056|NCT01172938|455192477|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126518057|NCT01172938|455192478|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
126518058|NCT01172938|455192470|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
126518059|NCT01172938|455192471|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
126518060|NCT01172938|455192472|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
126518061|NCT01172938|455192473|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126518062|NCT01172938|455192474|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126518063|NCT01172938|455192475|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126518064|NCT01172938|455192476|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126518065|NCT01172938|455192477|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126518066|NCT01172938|455192478|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
126518067|NCT01172938|455192470|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
126518068|NCT01172938|455192471|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
126518069|NCT01172938|455192472|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
126518070|NCT01172938|455192473|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
126518071|NCT01172938|455192474|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
126518072|NCT01172938|455192475|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
126518073|NCT01172938|455192476|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
126518074|NCT01172938|455192477|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
126518075|NCT01172938|455192478|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
126518076|NCT01172938|455192470|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
126518077|NCT01172938|455192471|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126518078|NCT01172938|455192472|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126518079|NCT01172938|455192473|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126518080|NCT01172938|455192474|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126518081|NCT01172938|455192475|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126518082|NCT01172938|455192476|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126518083|NCT01172938|455192477|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126518084|NCT01172938|455192478|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
126518085|NCT01172938|455192470|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
126518086|NCT01172938|455192471|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
126518087|NCT01172938|455192472|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
126518088|NCT01172938|455192473|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
126518089|NCT01172938|455192474|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
126518090|NCT01172938|455192475|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
126518091|NCT01172938|455192476|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
126518092|NCT01172938|455192477|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
126518093|NCT01172938|455192478|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
126518094|NCT01172938|455192470|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
126518095|NCT01172938|455192471|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
126518096|NCT01172938|455192472|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
126518097|NCT01172938|455192473|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
126518098|NCT01172938|455192474|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
126518099|NCT01172938|455192475|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
126518100|NCT01172938|455192476|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
126518101|NCT01172938|455192477|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
126518102|NCT01172938|455192478|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
126518103|NCT01172938|455192470|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
126518104|NCT01172938|455192471|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
126518105|NCT01172938|455192472|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
126518106|NCT01172938|455192473|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
126518107|NCT01172938|455192474|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
126518108|NCT01172938|455192475|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
126518109|NCT01172938|455192476|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
126518110|NCT01172938|455192477|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
126518111|NCT01172938|455192478|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
126518112|NCT01172938|455192470|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
126518113|NCT01172938|455192471|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
126518114|NCT01172938|455192472|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
126518115|NCT01172938|455192473|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
126518116|NCT01172938|455192474|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
126518117|NCT01172938|455192475|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
126518118|NCT01172938|455192476|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
126518119|NCT01172938|455192477|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
126518120|NCT01172938|455192478|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
126518121|NCT01172938|455192470|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
126518122|NCT01172938|455192471|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
126518123|NCT01172938|455192472|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
126518124|NCT01172938|455192473|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
126518125|NCT01172938|455192474|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
126518126|NCT01172938|455192475|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
126518127|NCT01172938|455192476|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
126518128|NCT01172938|455192477|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
126518129|NCT01172938|455192478|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
126518130|NCT01172938|455192470|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
126518131|NCT01172938|455192471|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
126518132|NCT01172938|455192472|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
126518133|NCT01172938|455192473|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
126518134|NCT01172938|455192474|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
126518135|NCT01172938|455192475|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
126518136|NCT01172938|455192476|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
126518137|NCT01172938|455192477|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
126518138|NCT01172938|455192478|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
126518139|NCT01172938|455192470|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
126518140|NCT01172938|455192471|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
126518141|NCT01172938|455192472|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
126518142|NCT01172938|455192473|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
126518143|NCT01172938|455192474|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
126518144|NCT01172938|455192475|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
126518145|NCT01172938|455192476|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
126518146|NCT01172938|455192477|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
126518147|NCT01172938|455192478|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
126518148|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
126518149|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
126518150|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
126518151|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
126518152|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
126518153|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
126518154|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
126518155|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
126518156|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
126518157|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
126518158|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
126518159|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
126518160|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
126518161|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
126518162|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
126518163|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
126571942|NCT03622593|455391345|FG000|Overall Study|Physician Decision|2|||
126571943|NCT03622593|455391346|FG001|Overall Study|Physician Decision|1|||
126571944|NCT03622593|455391347|FG002|Overall Study|Physician Decision|6|||
126571945|NCT03622593|455391345|FG000|Overall Study|Other|2|||
126571946|NCT03622593|455391346|FG001|Overall Study|Other|2|||
126571947|NCT03622593|455391347|FG002|Overall Study|Other|3|||
126571948|NCT03622593|455391345|FG000|Overall Study|Protocol Violation|0|||
126571949|NCT03622593|455391346|FG001|Overall Study|Protocol Violation|0|||
126518164|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
126518165|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
126518166|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
126518167|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
126518168|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
126518169|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
126518170|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
126518171|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
126518172|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
126518173|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
126518174|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
126518175|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
126518176|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
126518177|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
126518178|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
126518179|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
126518180|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
126518181|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
126518182|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
126518183|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
126518184|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
126518185|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
126518186|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
126518187|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
126518188|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
126518189|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
126518190|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
126518191|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
126518192|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
126518193|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
126518194|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
126518195|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
126518196|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
126518197|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
126518198|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
126518199|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
126518200|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
126518201|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
126518202|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
126518203|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
126518204|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
126518205|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
126518206|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
126518207|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
126518208|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
126518209|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
126518210|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
126518211|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
126518212|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
126518213|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
126571950|NCT03622593|455391347|FG002|Overall Study|Protocol Violation|1|||
126518214|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
126518215|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
126518216|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
126518217|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
126571951|NCT03622593|455391345|FG000|Overall Study|Pregnancy|0|||
126571952|NCT03622593|455391346|FG001|Overall Study|Pregnancy|0|||
126571953|NCT03622593|455391347|FG002|Overall Study|Pregnancy|1|||
126571954|NCT00178399|455391348|FG000|Overall Study|Physician Decision|4|||
126571955|NCT00178399|455391348|FG000|Overall Study|Withdrawal by Subject|8|||
126518218|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
126518219|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
126518220|NCT01172938|455192470|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
126518221|NCT01172938|455192471|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
126518222|NCT01172938|455192472|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
126518223|NCT01172938|455192473|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
126518224|NCT01172938|455192474|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
126518225|NCT01172938|455192475|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
126518226|NCT01172938|455192476|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
126518227|NCT01172938|455192477|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
126518228|NCT01172938|455192478|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
126518229|NCT01172938|455192470|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
126518230|NCT01172938|455192471|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
126518231|NCT01172938|455192472|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
126518232|NCT01172938|455192473|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
126518233|NCT01172938|455192474|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
126518234|NCT01172938|455192475|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
126518235|NCT01172938|455192476|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
126518236|NCT01172938|455192477|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
126518237|NCT01172938|455192478|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
126518238|NCT01172938|455192470|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
126518239|NCT01172938|455192471|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
126518240|NCT01172938|455192472|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
126518241|NCT01172938|455192473|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
126518242|NCT01172938|455192474|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
126518243|NCT01172938|455192475|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
126518244|NCT01172938|455192476|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
126518245|NCT01172938|455192477|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
126518246|NCT01172938|455192478|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
126518247|NCT01172938|455192470|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
126518248|NCT01172938|455192471|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
126518249|NCT01172938|455192472|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
126518250|NCT01172938|455192473|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
126518251|NCT01172938|455192474|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
126518252|NCT01172938|455192475|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
126518253|NCT01172938|455192476|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
126518254|NCT01172938|455192477|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
126518255|NCT01172938|455192478|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
126518256|NCT01172938|455192470|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
126518257|NCT01172938|455192471|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
126518258|NCT01172938|455192472|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
126518259|NCT01172938|455192473|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
126518260|NCT01172938|455192474|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
126518261|NCT01172938|455192475|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
126518262|NCT01172938|455192476|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
126518263|NCT01172938|455192477|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
126518264|NCT01172938|455192478|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
126518265|NCT01172938|455192470|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
126518266|NCT01172938|455192471|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
126518267|NCT01172938|455192472|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
126518268|NCT01172938|455192473|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
126518269|NCT01172938|455192474|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
126518270|NCT01172938|455192475|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
126518271|NCT01172938|455192476|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
126518272|NCT01172938|455192477|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
126518273|NCT01172938|455192478|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
126518274|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
126518275|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
126518276|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
126518277|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
126518278|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
126518279|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
126518280|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
126518281|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
126518282|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
126571956|NCT00178399|455391348|FG000|Overall Study|Lost to Follow-up|1|||
126571957|NCT01393119|455391349|FG000|Overall Study|Adverse Event|1|||
126571958|NCT01393119|455391350|FG001|Overall Study|Adverse Event|1|||
126571959|NCT01393119|455391351|FG002|Overall Study|Adverse Event|0|||
126571960|NCT01393119|455391352|FG003|Overall Study|Adverse Event|1|||
126571961|NCT01393119|455391349|FG000|Overall Study|Withdrawal by Subject|0|||
126571962|NCT01393119|455391350|FG001|Overall Study|Withdrawal by Subject|1|||
126571963|NCT01393119|455391351|FG002|Overall Study|Withdrawal by Subject|1|||
126571964|NCT01393119|455391352|FG003|Overall Study|Withdrawal by Subject|0|||
126571965|NCT01393119|455391349|FG000|Overall Study|Lack of Efficacy|1|||
126571966|NCT01393119|455391350|FG001|Overall Study|Lack of Efficacy|0|||
126571967|NCT01393119|455391351|FG002|Overall Study|Lack of Efficacy|2|||
126571968|NCT01393119|455391352|FG003|Overall Study|Lack of Efficacy|1|||
126571969|NCT01393119|455391349|FG000|Overall Study|Protocol Violation|0|||
126571970|NCT01393119|455391350|FG001|Overall Study|Protocol Violation|0|||
126571971|NCT01393119|455391351|FG002|Overall Study|Protocol Violation|1|||
126571972|NCT01393119|455391352|FG003|Overall Study|Protocol Violation|0|||
126571973|NCT01393119|455391349|FG000|Overall Study|Death|0|||
126571974|NCT01393119|455391350|FG001|Overall Study|Death|0|||
126571975|NCT01393119|455391351|FG002|Overall Study|Death|0|||
126571976|NCT01393119|455391352|FG003|Overall Study|Death|1|||
126571977|NCT01393119|455391349|FG000|Overall Study|Randomized but Not treated|1|||
126571978|NCT01393119|455391350|FG001|Overall Study|Randomized but Not treated|0|||
126571979|NCT01393119|455391351|FG002|Overall Study|Randomized but Not treated|1|||
126571980|NCT01393119|455391352|FG003|Overall Study|Randomized but Not treated|1|||
126571981|NCT01393119|455391349|FG000|Overall Study|Sponsor Termination of Study|11|||
126571982|NCT01393119|455391350|FG001|Overall Study|Sponsor Termination of Study|12|||
126571983|NCT01393119|455391351|FG002|Overall Study|Sponsor Termination of Study|9|||
126571984|NCT01393119|455391352|FG003|Overall Study|Sponsor Termination of Study|12|||
126571985|NCT02544152|455391353|FG000|Overall Study|Adverse Event|0|||
126571986|NCT02544152|455391354|FG001|Overall Study|Adverse Event|4|||
126571987|NCT02544152|455391353|FG000|Overall Study|Withdrawal by Subject|0|||
126571988|NCT02544152|455391354|FG001|Overall Study|Withdrawal by Subject|3|||
126571989|NCT02544152|455391353|FG000|Overall Study|Other|1|||
126571990|NCT02544152|455391354|FG001|Overall Study|Other|0|||
126571991|NCT01759264|455391357|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
126571992|NCT01759264|455391357|FG000|Overall Study|Adverse Event|1|||
126571993|NCT01759264|455391357|FG000|Overall Study|Other|2|||
126571994|NCT01759264|455391357|FG000|Overall Study|Lost to Follow-up|2|||
126571995|NCT01759264|455391357|FG000|Overall Study|Withdrawal by Subject|3|||
126571996|NCT01759264|455391357|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
126571997|NCT00516321|455391358|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
126571998|NCT00516321|455391359|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
126571999|NCT00516321|455391360|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
126572000|NCT00516321|455391358|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
126572001|NCT00516321|455391359|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
126572002|NCT00516321|455391360|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
126572003|NCT00516321|455391358|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
126572004|NCT00516321|455391359|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
126572005|NCT00516321|455391360|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
126572006|NCT00516321|455391358|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
126572007|NCT00516321|455391359|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
126572008|NCT00516321|455391360|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
126572009|NCT00516321|455391358|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
126572010|NCT00516321|455391359|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
126572011|NCT00516321|455391360|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
126572012|NCT00516321|455391358|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
126572013|NCT00516321|455391359|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
126572014|NCT00516321|455391360|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
126572015|NCT00516321|455391358|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
126572016|NCT00516321|455391359|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
126572017|NCT00516321|455391360|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
126572018|NCT00516321|455391358|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
126572019|NCT00516321|455391359|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
126572020|NCT00516321|455391360|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
126572021|NCT00516321|455391358|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
126572022|NCT00516321|455391359|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
126572023|NCT00516321|455391360|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
126572024|NCT00516321|455391358|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
126572025|NCT00516321|455391359|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
126572026|NCT00516321|455391360|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
126572027|NCT00516321|455391358|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
126572028|NCT00516321|455391359|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
126518283|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
126518284|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
126572029|NCT00516321|455391360|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
126572030|NCT02139046|455391362|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
126572031|NCT02139046|455391363|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
126572032|NCT02139046|455391364|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
126572033|NCT02139046|455391365|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
126572034|NCT02139046|455391366|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
126572035|NCT02139046|455391362|FG000|Overall Study|Major Protocol Deviation|9|||
126572036|NCT02139046|455391363|FG001|Overall Study|Major Protocol Deviation|10|||
126572037|NCT02139046|455391364|FG002|Overall Study|Major Protocol Deviation|16|||
126572038|NCT02139046|455391365|FG003|Overall Study|Major Protocol Deviation|12|||
126572039|NCT02139046|455391366|FG004|Overall Study|Major Protocol Deviation|6|||
126572040|NCT02139046|455391362|FG000|Overall Study|Lost to Follow-up|13|||
126572041|NCT02139046|455391363|FG001|Overall Study|Lost to Follow-up|16|||
126572042|NCT02139046|455391364|FG002|Overall Study|Lost to Follow-up|16|||
126572043|NCT02139046|455391365|FG003|Overall Study|Lost to Follow-up|18|||
126572044|NCT02139046|455391366|FG004|Overall Study|Lost to Follow-up|13|||
126572045|NCT02139046|455391362|FG000|Overall Study|Voluntary Withdrawal|20|||
126572046|NCT02139046|455391363|FG001|Overall Study|Voluntary Withdrawal|8|||
126572047|NCT02139046|455391364|FG002|Overall Study|Voluntary Withdrawal|10|||
126572048|NCT02139046|455391365|FG003|Overall Study|Voluntary Withdrawal|15|||
126572049|NCT02139046|455391366|FG004|Overall Study|Voluntary Withdrawal|16|||
126518285|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
126518286|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
126518287|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
126518288|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
126518289|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
126518290|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
126518291|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
126518292|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
126518293|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
126518294|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
126518295|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
126518296|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
126518297|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
126518298|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
126518299|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
126518300|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
126518301|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
126518302|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
126518303|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
126518304|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
126518305|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
126518306|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
126518307|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
126518308|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
126518309|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
126518310|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
126518311|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
126518312|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
126572050|NCT02139046|455391362|FG000|Overall Study|Lack of Efficacy|0|||
126572051|NCT02139046|455391363|FG001|Overall Study|Lack of Efficacy|1|||
126572052|NCT02139046|455391364|FG002|Overall Study|Lack of Efficacy|2|||
126572053|NCT02139046|455391365|FG003|Overall Study|Lack of Efficacy|1|||
126572054|NCT02139046|455391366|FG004|Overall Study|Lack of Efficacy|2|||
126572055|NCT02139046|455391362|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
126727284|NCT02720016|455951105|FG001|Overall Study|Withdrawal by Subject|6|||
126518313|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
126518314|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
126518315|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
126518316|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
126518317|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
126518318|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
126518319|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
126572056|NCT02139046|455391363|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
126727285|NCT02720016|455951106|FG002|Overall Study|Withdrawal by Subject|4|||
126572057|NCT02139046|455391364|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
126572058|NCT02139046|455391365|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
126572059|NCT02139046|455391366|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
126572060|NCT02139046|455391362|FG000|Overall Study|Other Miscellaneous Reasons|10|||
126572061|NCT02139046|455391363|FG001|Overall Study|Other Miscellaneous Reasons|9|||
126572062|NCT02139046|455391364|FG002|Overall Study|Other Miscellaneous Reasons|4|||
126572063|NCT02139046|455391365|FG003|Overall Study|Other Miscellaneous Reasons|9|||
126572064|NCT02139046|455391366|FG004|Overall Study|Other Miscellaneous Reasons|12|||
126572065|NCT02015546|455391367|FG000|Overall Study|Withdrawal by Subject|1|||
126572066|NCT02015546|455391368|FG001|Overall Study|Withdrawal by Subject|1|||
126572067|NCT02015546|455391369|FG002|Overall Study|Withdrawal by Subject|1|||
126572068|NCT02015546|455391367|FG000|Overall Study|Screem Failure|2|||
126572069|NCT02015546|455391368|FG001|Overall Study|Screem Failure|1|||
126518320|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
126518321|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
126518322|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
126518323|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
126518324|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
126518325|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
126518326|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
126518327|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
126518328|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
126518329|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
126518330|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
126518331|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
126518332|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
126518333|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
126518334|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
126518335|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
126518336|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
126518337|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
126518338|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
126518339|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
126518340|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
126518341|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
126518342|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
126518343|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
126518344|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
126518345|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
126518346|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
126518347|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
126518348|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
126518349|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
126518350|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
126518351|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
126518352|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
126518353|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
126518354|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
126518355|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
126518356|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
126518357|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
126518358|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
126518359|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
126518360|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
126518361|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
126572070|NCT02015546|455391369|FG002|Overall Study|Screem Failure|3|||
126572071|NCT01426269|455391370|FG000|Period 1: 12 Weeks|Adverse Event|5|||
126572072|NCT01426269|455391371|FG001|Period 1: 12 Weeks|Adverse Event|0|||
126572073|NCT01426269|455391372|FG002|Period 1: 12 Weeks|Adverse Event|0|||
126518362|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
126518363|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
126518364|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
126518365|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
126518366|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
126518367|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
126518368|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
126572074|NCT01426269|455391370|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
126572075|NCT01426269|455391371|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
126572076|NCT01426269|455391372|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
126572077|NCT01426269|455391370|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
126572078|NCT01426269|455391371|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
126572079|NCT01426269|455391372|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
126572080|NCT01426269|455391370|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
126572081|NCT01426269|455391371|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
126572082|NCT01426269|455391372|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
126572083|NCT01426269|455391370|FG000|Period 1: 12 Weeks|Pregnancy|1|||
126572084|NCT01426269|455391371|FG001|Period 1: 12 Weeks|Pregnancy|0|||
126572085|NCT01426269|455391372|FG002|Period 1: 12 Weeks|Pregnancy|0|||
126572086|NCT01426269|455391370|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
126572087|NCT01426269|455391371|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
126572088|NCT01426269|455391372|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
126572089|NCT01426269|455391370|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
126572090|NCT01426269|455391371|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
126572091|NCT01426269|455391372|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
126572092|NCT01426269|455391370|FG000|Period 2: 40 Weeks|Adverse Event|0|||
126572093|NCT01426269|455391371|FG001|Period 2: 40 Weeks|Adverse Event|1|||
126572094|NCT01426269|455391372|FG002|Period 2: 40 Weeks|Adverse Event|2|||
126572095|NCT01426269|455391370|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
126572096|NCT01426269|455391371|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
126572097|NCT01426269|455391372|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
126572098|NCT01426269|455391370|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
126572099|NCT01426269|455391371|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
126572100|NCT01426269|455391372|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
126572101|NCT01426269|455391370|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
126572102|NCT01426269|455391371|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
126572103|NCT01426269|455391372|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
126572104|NCT01426269|455391370|FG000|Period 2: 40 Weeks|Site closed|0|||
126572105|NCT01426269|455391371|FG001|Period 2: 40 Weeks|Site closed|6|||
126572106|NCT01426269|455391372|FG002|Period 2: 40 Weeks|Site closed|5|||
126572107|NCT01426269|455391370|FG000|Period 2: 40 Weeks|Relapsed|0|||
126572108|NCT01426269|455391371|FG001|Period 2: 40 Weeks|Relapsed|9|||
126572109|NCT01426269|455391372|FG002|Period 2: 40 Weeks|Relapsed|18|||
126572110|NCT00186186|455391376|FG000|Overall Study|Lack of Efficacy|3|||
126572111|NCT00186186|455391376|FG000|Overall Study|Withdrawal by Subject|3|||
126572112|NCT00186186|455391376|FG000|Overall Study|Not reported as to reason|2|||
126572113|NCT01113931|455391377|FG000|Overall Study|Adverse Event|2|||
126572114|NCT01113931|455391378|FG001|Overall Study|Adverse Event|2|||
126572115|NCT01113931|455391377|FG000|Overall Study|Physician Decision|0|||
126572116|NCT01113931|455391378|FG001|Overall Study|Physician Decision|2|||
126572117|NCT01113931|455391377|FG000|Overall Study|Lost to Follow-up|12|||
126572118|NCT01113931|455391378|FG001|Overall Study|Lost to Follow-up|9|||
126572119|NCT01113931|455391377|FG000|Overall Study|Various|2|||
126572120|NCT01113931|455391378|FG001|Overall Study|Various|4|||
126572121|NCT01113931|455391377|FG000|Overall Study|Withdrawal by Subject|3|||
126572122|NCT01113931|455391378|FG001|Overall Study|Withdrawal by Subject|0|||
126572123|NCT02567656|455391381|FG000|Overall Study|Premature discontinuation due to PD|1|||
126572124|NCT02567656|455391382|FG001|Overall Study|Premature discontinuation due to PD|1|||
126572125|NCT02567656|455391383|FG002|Overall Study|Premature discontinuation due to PD|2|||
126572126|NCT02567656|455391384|FG003|Overall Study|Premature discontinuation due to PD|0|||
126572127|NCT02567656|455391385|FG004|Overall Study|Premature discontinuation due to PD|0|||
126572128|NCT02567656|455391386|FG005|Overall Study|Premature discontinuation due to PD|0|||
126572129|NCT03959241|455391392|FG000|Overall Study|Withdrawal by Subject|7|||
126572130|NCT03959241|455391393|FG001|Overall Study|Withdrawal by Subject|8|||
126572131|NCT03959241|455391392|FG000|Overall Study|Lost to Follow-up|1|||
126572132|NCT03959241|455391393|FG001|Overall Study|Lost to Follow-up|0|||
126572133|NCT03959241|455391392|FG000|Overall Study|Move to Hospice Care|1|||
126572134|NCT03959241|455391393|FG001|Overall Study|Move to Hospice Care|0|||
126572135|NCT03959241|455391392|FG000|Overall Study|Screen Failure|1|||
126572136|NCT03959241|455391393|FG001|Overall Study|Screen Failure|0|||
126572137|NCT03959241|455391392|FG000|Overall Study|Disease Relapse|0|||
126572138|NCT03959241|455391393|FG001|Overall Study|Disease Relapse|1|||
126572139|NCT03959241|455391392|FG000|Overall Study|Off Study|1|||
126572140|NCT03959241|455391393|FG001|Overall Study|Off Study|0|||
126572141|NCT00463788|455391394|FG000|Overall Study|Progressive Disease|86|||
126572142|NCT00463788|455391395|FG001|Overall Study|Progressive Disease|42|||
126572143|NCT00463788|455391394|FG000|Overall Study|Adverse Event|6|||
126572144|NCT00463788|455391395|FG001|Overall Study|Adverse Event|2|||
126572145|NCT00463788|455391394|FG000|Overall Study|Withdrawal by Subject|6|||
126572146|NCT00463788|455391395|FG001|Overall Study|Withdrawal by Subject|2|||
126572147|NCT00463788|455391394|FG000|Overall Study|Death|4|||
126572148|NCT00463788|455391395|FG001|Overall Study|Death|3|||
126572149|NCT00463788|455391394|FG000|Overall Study|Symptomatic Deterioration|2|||
126572150|NCT00463788|455391395|FG001|Overall Study|Symptomatic Deterioration|3|||
126572151|NCT00463788|455391394|FG000|Overall Study|Lost to Follow-up|1|||
126572152|NCT00463788|455391395|FG001|Overall Study|Lost to Follow-up|0|||
126572153|NCT00463788|455391394|FG000|Overall Study|Protocol Violation|0|||
126572154|NCT00463788|455391395|FG001|Overall Study|Protocol Violation|1|||
126572155|NCT00463788|455391394|FG000|Overall Study|Other|3|||
126572156|NCT00463788|455391395|FG001|Overall Study|Other|0|||
126572157|NCT00463788|455391394|FG000|Overall Study|Randomized but not treated|1|||
126572158|NCT00463788|455391395|FG001|Overall Study|Randomized but not treated|1|||
126572159|NCT00360698|455391396|FG000|Run-In|Physician Decision|0|||
126572160|NCT00360698|455391397|FG001|Run-In|Physician Decision|1|||
126572161|NCT00360698|455391396|FG000|Run-In|Withdrawal by Subject|0|||
126572162|NCT00360698|455391397|FG001|Run-In|Withdrawal by Subject|2|||
126572163|NCT00360698|455391396|FG000|Run-In|Non compliance with treatment procedure|0|||
126572164|NCT00360698|455391397|FG001|Run-In|Non compliance with treatment procedure|1|||
126572165|NCT00360698|455391396|FG000|Run-In|Sponsor request|0|||
126572166|NCT00360698|455391397|FG001|Run-In|Sponsor request|2|||
126572167|NCT00360698|455391396|FG000|Run-In|Patient did not meet inclusion criteria|0|||
126572168|NCT00360698|455391397|FG001|Run-In|Patient did not meet inclusion criteria|1|||
126572169|NCT00360698|455391396|FG000|Run-In|Patient personal reasons|0|||
126572170|NCT00360698|455391397|FG001|Run-In|Patient personal reasons|2|||
126572171|NCT00360698|455391396|FG000|Run-In|Need of insulin with meals|0|||
126572172|NCT00360698|455391397|FG001|Run-In|Need of insulin with meals|1|||
126572173|NCT00360698|455391396|FG000|Treatment Period|Non compliance with treatment procedure|1|||
126572174|NCT00360698|455391397|FG001|Treatment Period|Non compliance with treatment procedure|0|||
126572175|NCT00360698|455391396|FG000|Treatment Period|Early termination by error|0|||
126572176|NCT00360698|455391397|FG001|Treatment Period|Early termination by error|1|||
126572177|NCT02547922|455391400|FG000|Overall Study|Withdrawal by Subject|9|||
126572178|NCT02547922|455391401|FG001|Overall Study|Withdrawal by Subject|6|||
126572179|NCT02547922|455391402|FG002|Overall Study|Withdrawal by Subject|10|||
126572180|NCT02547922|455391400|FG000|Overall Study|Adverse Event|3|||
126572181|NCT02547922|455391401|FG001|Overall Study|Adverse Event|1|||
126572182|NCT02547922|455391402|FG002|Overall Study|Adverse Event|2|||
126518369|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
126518370|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
126518371|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
126518372|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
126518373|NCT01172938|455192470|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
126518374|NCT01172938|455192471|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
126518375|NCT01172938|455192472|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
126518376|NCT01172938|455192473|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
126518377|NCT01172938|455192474|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
126518378|NCT01172938|455192475|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
126518379|NCT01172938|455192476|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
126518380|NCT01172938|455192477|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
126518381|NCT01172938|455192478|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
126518382|NCT00003498|455192479|FG000|Overall Study|Not evaluable.|4|||
126518383|NCT05282004|455192483|FG000|Overall Study|Adverse Event|2|||
126518384|NCT04808609|455192484|FG000|Overall Study|Lost to Follow-up|0|||
126518385|NCT04808609|455192485|FG001|Overall Study|Lost to Follow-up|2|||
126518386|NCT04808609|455192484|FG000|Overall Study|Administrative Withdrawal|0|||
126518387|NCT04808609|455192485|FG001|Overall Study|Administrative Withdrawal|1|||
126518388|NCT04382326|455192487|FG000|Overall Study|Adverse Event, not serious|1|||
126518389|NCT04382326|455192488|FG001|Overall Study|Adverse Event, not serious|2|||
126518390|NCT04382326|455192487|FG000|Overall Study|Other|1|||
126518391|NCT04382326|455192488|FG001|Overall Study|Other|0|||
126518392|NCT04382326|455192487|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
126518393|NCT04382326|455192488|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
126518394|NCT04382326|455192487|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
126518395|NCT04382326|455192488|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
126518396|NCT04382326|455192487|FG000|Overall Study|Protocol Violation|29|||
126518397|NCT04382326|455192488|FG001|Overall Study|Protocol Violation|23|||
126518398|NCT04382326|455192487|FG000|Overall Study|Physician Decision|0|||
126518399|NCT04382326|455192488|FG001|Overall Study|Physician Decision|1|||
126518400|NCT04382326|455192487|FG000|Overall Study|Lost to Follow-up|48|||
126572183|NCT02547922|455391400|FG000|Overall Study|Lost to Follow-up|1|||
126572184|NCT02547922|455391401|FG001|Overall Study|Lost to Follow-up|0|||
126572185|NCT02547922|455391402|FG002|Overall Study|Lost to Follow-up|0|||
126518401|NCT04382326|455192488|FG001|Overall Study|Lost to Follow-up|63|||
126518402|NCT04382326|455192487|FG000|Overall Study|Adverse Event, non-fatal|1|||
126518403|NCT04382326|455192488|FG001|Overall Study|Adverse Event, non-fatal|1|||
126518404|NCT01557946|455192491|FG000|Overall Study|Adverse Event|3|||
126518405|NCT01557946|455192492|FG001|Overall Study|Adverse Event|0|||
126518406|NCT02352493|455192494|FG000|Overall Study|Pregnancy|0|||
126518407|NCT02352493|455192495|FG001|Overall Study|Pregnancy|0|||
126518408|NCT02352493|455192496|FG002|Overall Study|Pregnancy|0|||
126518409|NCT02352493|455192497|FG003|Overall Study|Pregnancy|0|||
126572186|NCT02547922|455391400|FG000|Overall Study|Lack of Efficacy|5|||
126572187|NCT02547922|455391401|FG001|Overall Study|Lack of Efficacy|7|||
126518410|NCT02352493|455192498|FG004|Overall Study|Pregnancy|0|||
126518411|NCT02352493|455192499|FG005|Overall Study|Pregnancy|0|||
126518412|NCT02352493|455192500|FG006|Overall Study|Pregnancy|1|||
126518413|NCT02352493|455192501|FG007|Overall Study|Pregnancy|0|||
126518414|NCT02352493|455192502|FG008|Overall Study|Pregnancy|1|||
126518415|NCT02352493|455192503|FG009|Overall Study|Pregnancy|0|||
126518416|NCT02352493|455192504|FG010|Overall Study|Pregnancy|0|||
126518417|NCT02352493|455192505|FG011|Overall Study|Pregnancy|0|||
126518418|NCT02352493|455192506|FG012|Overall Study|Pregnancy|0|||
126518419|NCT02352493|455192507|FG013|Overall Study|Pregnancy|0|||
126518420|NCT02352493|455192508|FG014|Overall Study|Pregnancy|0|||
126518421|NCT02352493|455192509|FG015|Overall Study|Pregnancy|0|||
126518422|NCT02352493|455192510|FG016|Overall Study|Pregnancy|0|||
126518423|NCT02352493|455192511|FG017|Overall Study|Pregnancy|0|||
126518424|NCT02352493|455192494|FG000|Overall Study|Withdrawal by Subject|0|||
126518425|NCT02352493|455192495|FG001|Overall Study|Withdrawal by Subject|0|||
126518426|NCT02352493|455192496|FG002|Overall Study|Withdrawal by Subject|0|||
126518427|NCT02352493|455192497|FG003|Overall Study|Withdrawal by Subject|0|||
126518428|NCT02352493|455192498|FG004|Overall Study|Withdrawal by Subject|0|||
126518429|NCT02352493|455192499|FG005|Overall Study|Withdrawal by Subject|0|||
126518430|NCT02352493|455192500|FG006|Overall Study|Withdrawal by Subject|0|||
126518431|NCT02352493|455192501|FG007|Overall Study|Withdrawal by Subject|0|||
126518432|NCT02352493|455192502|FG008|Overall Study|Withdrawal by Subject|1|||
126518433|NCT02352493|455192503|FG009|Overall Study|Withdrawal by Subject|0|||
126518434|NCT02352493|455192504|FG010|Overall Study|Withdrawal by Subject|0|||
126518435|NCT02352493|455192505|FG011|Overall Study|Withdrawal by Subject|0|||
126518436|NCT02352493|455192506|FG012|Overall Study|Withdrawal by Subject|0|||
126518437|NCT02352493|455192507|FG013|Overall Study|Withdrawal by Subject|0|||
126518438|NCT02352493|455192508|FG014|Overall Study|Withdrawal by Subject|1|||
126518439|NCT02352493|455192509|FG015|Overall Study|Withdrawal by Subject|0|||
126518440|NCT02352493|455192510|FG016|Overall Study|Withdrawal by Subject|0|||
126518441|NCT02352493|455192511|FG017|Overall Study|Withdrawal by Subject|0|||
126518442|NCT02352493|455192494|FG000|Overall Study|Lost to Follow-up|0|||
126518443|NCT02352493|455192495|FG001|Overall Study|Lost to Follow-up|0|||
126518444|NCT02352493|455192496|FG002|Overall Study|Lost to Follow-up|0|||
126518445|NCT02352493|455192497|FG003|Overall Study|Lost to Follow-up|0|||
126518446|NCT02352493|455192498|FG004|Overall Study|Lost to Follow-up|0|||
126518447|NCT02352493|455192499|FG005|Overall Study|Lost to Follow-up|0|||
126518448|NCT02352493|455192500|FG006|Overall Study|Lost to Follow-up|0|||
126518449|NCT02352493|455192501|FG007|Overall Study|Lost to Follow-up|0|||
126518450|NCT02352493|455192502|FG008|Overall Study|Lost to Follow-up|0|||
126518451|NCT02352493|455192503|FG009|Overall Study|Lost to Follow-up|1|||
126518452|NCT02352493|455192504|FG010|Overall Study|Lost to Follow-up|0|||
126518453|NCT02352493|455192505|FG011|Overall Study|Lost to Follow-up|0|||
126518454|NCT02352493|455192506|FG012|Overall Study|Lost to Follow-up|1|||
126518455|NCT02352493|455192507|FG013|Overall Study|Lost to Follow-up|2|||
126518456|NCT02352493|455192508|FG014|Overall Study|Lost to Follow-up|0|||
126518457|NCT02352493|455192509|FG015|Overall Study|Lost to Follow-up|0|||
126518458|NCT02352493|455192510|FG016|Overall Study|Lost to Follow-up|0|||
126518459|NCT02352493|455192511|FG017|Overall Study|Lost to Follow-up|0|||
126518460|NCT01465334|455192512|FG000|Overall Study|Disease Progression|1|||
126518461|NCT01465334|455192513|FG001|Overall Study|Disease Progression|0|||
126518462|NCT01465334|455192512|FG000|Overall Study|Adverse Event|1|||
126518463|NCT01465334|455192513|FG001|Overall Study|Adverse Event|0|||
126518464|NCT01465334|455192512|FG000|Overall Study|Richter's transformation|0|||
126518465|NCT01465334|455192513|FG001|Overall Study|Richter's transformation|3|||
126518466|NCT01465334|455192512|FG000|Overall Study|Refractory Disease|0|||
126518467|NCT01465334|455192513|FG001|Overall Study|Refractory Disease|3|||
126518468|NCT01925183|455192517|FG000|Overall Study|Adverse Event|1|||
126518469|NCT01925183|455192518|FG001|Overall Study|Adverse Event|0|||
126518470|NCT02114892|455192519|FG000|Overall Study|Lost to Follow-up|1|||
126518471|NCT02114892|455192520|FG001|Overall Study|Lost to Follow-up|2|||
126518472|NCT03586999|455192523|FG000|Overall Study|Lack of Efficacy|2|||
126518473|NCT04096560|455192524|FG000|Overall Study|Reason not Specified|1|||
126518474|NCT04096560|455192525|FG001|Overall Study|Reason not Specified|0|||
126518475|NCT04096560|455192526|FG002|Overall Study|Reason not Specified|0|||
126518476|NCT04096560|455192527|FG003|Overall Study|Reason not Specified|0|||
126518477|NCT04096560|455192528|FG004|Overall Study|Reason not Specified|1|||
126518478|NCT04096560|455192529|FG005|Overall Study|Reason not Specified|1|||
126518479|NCT04096560|455192530|FG006|Overall Study|Reason not Specified|1|||
126518480|NCT04096560|455192531|FG007|Overall Study|Reason not Specified|0|||
126518481|NCT04096560|455192524|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
126518482|NCT04096560|455192525|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
126572188|NCT02547922|455391402|FG002|Overall Study|Lack of Efficacy|4|||
126518483|NCT04096560|455192526|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
126518484|NCT04096560|455192527|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
126518485|NCT04096560|455192528|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
126572189|NCT02547922|455391400|FG000|Overall Study|Death|1|||
126572190|NCT02547922|455391401|FG001|Overall Study|Death|0|||
126572191|NCT02547922|455391402|FG002|Overall Study|Death|0|||
126572192|NCT02547922|455391400|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
126572193|NCT02547922|455391401|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
126572194|NCT02547922|455391402|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
126572195|NCT02547922|455391400|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
126572196|NCT02547922|455391401|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
126572197|NCT02547922|455391402|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
126572198|NCT02547922|455391400|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
126572199|NCT02547922|455391401|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
126572200|NCT02547922|455391402|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
126572201|NCT02547922|455391400|FG000|Overall Study|Physician Decision|2|||
126572202|NCT02547922|455391401|FG001|Overall Study|Physician Decision|1|||
126572203|NCT02547922|455391402|FG002|Overall Study|Physician Decision|2|||
126572204|NCT02547922|455391400|FG000|Overall Study|Patients did not receive IP|1|||
126572205|NCT02547922|455391401|FG001|Overall Study|Patients did not receive IP|1|||
126572206|NCT02547922|455391402|FG002|Overall Study|Patients did not receive IP|0|||
126572207|NCT01317420|455391407|FG000|Overall Study|Progressive disease according to RECIST|2|||
126572208|NCT01317420|455391408|FG001|Overall Study|Progressive disease according to RECIST|3|||
126572209|NCT01317420|455391409|FG002|Overall Study|Progressive disease according to RECIST|3|||
126572210|NCT01317420|455391410|FG003|Overall Study|Progressive disease according to RECIST|3|||
126572211|NCT01317420|455391411|FG004|Overall Study|Progressive disease according to RECIST|3|||
126572212|NCT01317420|455391412|FG005|Overall Study|Progressive disease according to RECIST|3|||
126572213|NCT01317420|455391413|FG006|Overall Study|Progressive disease according to RECIST|3|||
126572214|NCT01317420|455391414|FG007|Overall Study|Progressive disease according to RECIST|3|||
126572215|NCT01317420|455391415|FG008|Overall Study|Progressive disease according to RECIST|3|||
126572216|NCT01317420|455391416|FG009|Overall Study|Progressive disease according to RECIST|2|||
126572217|NCT01317420|455391417|FG010|Overall Study|Progressive disease according to RECIST|3|||
126572218|NCT01317420|455391418|FG011|Overall Study|Progressive disease according to RECIST|11|||
126572219|NCT01317420|455391419|FG012|Overall Study|Progressive disease according to RECIST|16|||
126572220|NCT01317420|455391407|FG000|Overall Study|Other adverse event|1|||
126572221|NCT01317420|455391408|FG001|Overall Study|Other adverse event|0|||
126572222|NCT01317420|455391409|FG002|Overall Study|Other adverse event|0|||
126572223|NCT01317420|455391410|FG003|Overall Study|Other adverse event|0|||
126572224|NCT01317420|455391411|FG004|Overall Study|Other adverse event|0|||
126572225|NCT01317420|455391412|FG005|Overall Study|Other adverse event|0|||
126572226|NCT01317420|455391413|FG006|Overall Study|Other adverse event|0|||
126572227|NCT01317420|455391414|FG007|Overall Study|Other adverse event|0|||
126572228|NCT01317420|455391415|FG008|Overall Study|Other adverse event|0|||
126572229|NCT01317420|455391416|FG009|Overall Study|Other adverse event|0|||
126572230|NCT01317420|455391417|FG010|Overall Study|Other adverse event|0|||
126572231|NCT01317420|455391418|FG011|Overall Study|Other adverse event|0|||
126572232|NCT01317420|455391419|FG012|Overall Study|Other adverse event|2|||
126572233|NCT01317420|455391407|FG000|Overall Study|Non-compliant with protocol|0|||
126572234|NCT01317420|455391408|FG001|Overall Study|Non-compliant with protocol|0|||
126572235|NCT01317420|455391409|FG002|Overall Study|Non-compliant with protocol|0|||
126572236|NCT01317420|455391410|FG003|Overall Study|Non-compliant with protocol|0|||
126572237|NCT01317420|455391411|FG004|Overall Study|Non-compliant with protocol|0|||
126572238|NCT01317420|455391412|FG005|Overall Study|Non-compliant with protocol|0|||
126572239|NCT01317420|455391413|FG006|Overall Study|Non-compliant with protocol|0|||
126572240|NCT01317420|455391414|FG007|Overall Study|Non-compliant with protocol|0|||
126572241|NCT01317420|455391415|FG008|Overall Study|Non-compliant with protocol|0|||
126572242|NCT01317420|455391416|FG009|Overall Study|Non-compliant with protocol|0|||
126572243|NCT01317420|455391417|FG010|Overall Study|Non-compliant with protocol|0|||
126572244|NCT01317420|455391418|FG011|Overall Study|Non-compliant with protocol|0|||
126572245|NCT01317420|455391419|FG012|Overall Study|Non-compliant with protocol|1|||
126572246|NCT01317420|455391407|FG000|Overall Study|Refused to cont. taking trial medication|0|||
126572247|NCT01317420|455391408|FG001|Overall Study|Refused to cont. taking trial medication|0|||
126572248|NCT01317420|455391409|FG002|Overall Study|Refused to cont. taking trial medication|0|||
126572249|NCT01317420|455391410|FG003|Overall Study|Refused to cont. taking trial medication|0|||
126572250|NCT01317420|455391411|FG004|Overall Study|Refused to cont. taking trial medication|0|||
126572251|NCT01317420|455391412|FG005|Overall Study|Refused to cont. taking trial medication|0|||
126572252|NCT01317420|455391413|FG006|Overall Study|Refused to cont. taking trial medication|0|||
126572253|NCT01317420|455391414|FG007|Overall Study|Refused to cont. taking trial medication|0|||
126572254|NCT01317420|455391415|FG008|Overall Study|Refused to cont. taking trial medication|0|||
126727286|NCT02720016|455951104|FG000|Overall Study|Scheduling issues|2|||
126572255|NCT01317420|455391416|FG009|Overall Study|Refused to cont. taking trial medication|0|||
126572256|NCT01317420|455391417|FG010|Overall Study|Refused to cont. taking trial medication|0|||
126572257|NCT01317420|455391418|FG011|Overall Study|Refused to cont. taking trial medication|0|||
126572258|NCT01317420|455391419|FG012|Overall Study|Refused to cont. taking trial medication|1|||
126727287|NCT02720016|455951105|FG001|Overall Study|Scheduling issues|4|||
126518486|NCT04096560|455192529|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
126518487|NCT04096560|455192530|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
126518488|NCT04096560|455192531|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
126518489|NCT04096560|455192524|FG000|Overall Study|Study Terminated by Sponsor|0|||
126518490|NCT04096560|455192525|FG001|Overall Study|Study Terminated by Sponsor|0|||
126518491|NCT04096560|455192526|FG002|Overall Study|Study Terminated by Sponsor|0|||
126518492|NCT04096560|455192527|FG003|Overall Study|Study Terminated by Sponsor|5|||
126518493|NCT04096560|455192528|FG004|Overall Study|Study Terminated by Sponsor|6|||
126518494|NCT04096560|455192529|FG005|Overall Study|Study Terminated by Sponsor|4|||
126518495|NCT04096560|455192530|FG006|Overall Study|Study Terminated by Sponsor|6|||
126518496|NCT04096560|455192531|FG007|Overall Study|Study Terminated by Sponsor|1|||
126518497|NCT04096560|455192524|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
126518498|NCT04096560|455192525|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
126518499|NCT04096560|455192526|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
126518500|NCT04096560|455192527|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
126518501|NCT04096560|455192528|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
126518502|NCT04096560|455192529|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
126518503|NCT04096560|455192530|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
126518504|NCT04096560|455192531|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
126518505|NCT02464969|455192532|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
126518506|NCT02464969|455192533|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
126518507|NCT02464969|455192532|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
126518508|NCT02464969|455192533|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
126518509|NCT02464969|455192532|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
126518510|NCT02464969|455192533|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
126518511|NCT02464969|455192532|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
126518512|NCT02464969|455192533|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
126518513|NCT02464969|455192532|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
126518514|NCT02464969|455192533|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
126518515|NCT02464969|455192532|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
126518516|NCT02464969|455192533|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
126518517|NCT02464969|455192532|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
126518518|NCT02464969|455192533|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
126518519|NCT02464969|455192532|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
126518520|NCT02464969|455192533|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
126518521|NCT02464969|455192532|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
126518522|NCT02464969|455192533|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
126518523|NCT02464969|455192532|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
126518524|NCT02464969|455192533|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
126518525|NCT02464969|455192532|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
126518526|NCT02464969|455192533|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
126518527|NCT00534352|455192534|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
126518528|NCT00534352|455192534|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
126518529|NCT00534352|455192534|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
126518530|NCT00534352|455192534|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
126518531|NCT00534352|455192534|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
126518532|NCT00534352|455192534|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
126518533|NCT02399085|455192539|FG000|Overall Study|Adverse Event|16|||
126518534|NCT02399085|455192539|FG000|Overall Study|Death|2|||
126518535|NCT02399085|455192539|FG000|Overall Study|Withdrawal by Subject|8|||
126518536|NCT02399085|455192539|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
126518537|NCT02399085|455192539|FG000|Overall Study|Physician Decision|5|||
126518538|NCT00833924|455192540|FG000|Overall Study|Death|21|||
126518539|NCT00833924|455192540|FG000|Overall Study|Conversion|2|||
126518540|NCT00833924|455192540|FG000|Overall Study|Lost to Follow-up|2|||
126518541|NCT00833924|455192540|FG000|Overall Study|Withdrawal by Subject|13|||
126518542|NCT00833924|455192540|FG000|Overall Study|In study follow-up|71|||
126518543|NCT01485861|455192541|FG000|Phase Ib|Death|1|||
126518544|NCT01485861|455192542|FG001|Phase Ib|Death|0|||
126518545|NCT01485861|455192543|FG002|Phase Ib|Death|0|||
126518546|NCT01485861|455192544|FG003|Phase Ib|Death|0|||
126518547|NCT01485861|455192545|FG004|Phase Ib|Death|0|||
126518548|NCT01485861|455192546|FG005|Phase Ib|Death|0|||
126518549|NCT01485861|455192541|FG000|Phase Ib|Physician Decision|1|||
126518550|NCT01485861|455192542|FG001|Phase Ib|Physician Decision|1|||
126518551|NCT01485861|455192543|FG002|Phase Ib|Physician Decision|0|||
126518552|NCT01485861|455192544|FG003|Phase Ib|Physician Decision|0|||
126518553|NCT01485861|455192545|FG004|Phase Ib|Physician Decision|0|||
126518554|NCT01485861|455192546|FG005|Phase Ib|Physician Decision|0|||
126518555|NCT01485861|455192541|FG000|Phase Ib|Adverse Event|0|||
126518556|NCT01485861|455192542|FG001|Phase Ib|Adverse Event|4|||
126518557|NCT01485861|455192543|FG002|Phase Ib|Adverse Event|0|||
126518558|NCT01485861|455192544|FG003|Phase Ib|Adverse Event|0|||
126518559|NCT01485861|455192545|FG004|Phase Ib|Adverse Event|0|||
126518560|NCT01485861|455192546|FG005|Phase Ib|Adverse Event|0|||
126518561|NCT01485861|455192541|FG000|Phase Ib|Progression of disease|5|||
126518562|NCT01485861|455192542|FG001|Phase Ib|Progression of disease|0|||
126518563|NCT01485861|455192543|FG002|Phase Ib|Progression of disease|0|||
126518564|NCT01485861|455192544|FG003|Phase Ib|Progression of disease|0|||
126518565|NCT01485861|455192545|FG004|Phase Ib|Progression of disease|0|||
126518566|NCT01485861|455192546|FG005|Phase Ib|Progression of disease|0|||
126518567|NCT01485861|455192541|FG000|Phase Ib|Other|3|||
126518568|NCT01485861|455192542|FG001|Phase Ib|Other|0|||
126518569|NCT01485861|455192543|FG002|Phase Ib|Other|0|||
126518570|NCT01485861|455192544|FG003|Phase Ib|Other|0|||
126518571|NCT01485861|455192545|FG004|Phase Ib|Other|0|||
126518572|NCT01485861|455192546|FG005|Phase Ib|Other|0|||
126518573|NCT01485861|455192541|FG000|Phase Ib|Withdrawal by Subject|4|||
126518574|NCT01485861|455192542|FG001|Phase Ib|Withdrawal by Subject|1|||
126518575|NCT01485861|455192543|FG002|Phase Ib|Withdrawal by Subject|0|||
126518576|NCT01485861|455192544|FG003|Phase Ib|Withdrawal by Subject|0|||
126518577|NCT01485861|455192545|FG004|Phase Ib|Withdrawal by Subject|0|||
126518578|NCT01485861|455192546|FG005|Phase Ib|Withdrawal by Subject|0|||
126518579|NCT01485861|455192541|FG000|Phase II|Death|0|||
126518580|NCT01485861|455192542|FG001|Phase II|Death|0|||
126518581|NCT01485861|455192543|FG002|Phase II|Death|67|||
126518582|NCT01485861|455192544|FG003|Phase II|Death|71|||
126518583|NCT01485861|455192545|FG004|Phase II|Death|68|||
126518584|NCT01485861|455192546|FG005|Phase II|Death|0|||
126518585|NCT01485861|455192541|FG000|Phase II|Progression of Disease|0|||
126518586|NCT01485861|455192542|FG001|Phase II|Progression of Disease|0|||
126518587|NCT01485861|455192543|FG002|Phase II|Progression of Disease|1|||
126518588|NCT01485861|455192544|FG003|Phase II|Progression of Disease|0|||
126518589|NCT01485861|455192545|FG004|Phase II|Progression of Disease|0|||
126518590|NCT01485861|455192546|FG005|Phase II|Progression of Disease|0|||
126518591|NCT01485861|455192541|FG000|Phase II|Other|0|||
126518592|NCT01485861|455192542|FG001|Phase II|Other|0|||
126518593|NCT01485861|455192543|FG002|Phase II|Other|0|||
126518594|NCT01485861|455192544|FG003|Phase II|Other|1|||
126518595|NCT01485861|455192545|FG004|Phase II|Other|0|||
126518596|NCT01485861|455192546|FG005|Phase II|Other|0|||
126518597|NCT01485861|455192541|FG000|Phase II|Withdrawal by Subject|0|||
126518598|NCT01485861|455192542|FG001|Phase II|Withdrawal by Subject|0|||
126518599|NCT01485861|455192543|FG002|Phase II|Withdrawal by Subject|6|||
126518600|NCT01485861|455192544|FG003|Phase II|Withdrawal by Subject|3|||
126518601|NCT01485861|455192545|FG004|Phase II|Withdrawal by Subject|4|||
126518602|NCT01485861|455192546|FG005|Phase II|Withdrawal by Subject|0|||
126518603|NCT01485861|455192541|FG000|Phase II|Lost to Follow-up|0|||
126518604|NCT01485861|455192542|FG001|Phase II|Lost to Follow-up|0|||
126518605|NCT01485861|455192543|FG002|Phase II|Lost to Follow-up|2|||
126518606|NCT01485861|455192544|FG003|Phase II|Lost to Follow-up|3|||
126518607|NCT01485861|455192545|FG004|Phase II|Lost to Follow-up|5|||
126518608|NCT01485861|455192546|FG005|Phase II|Lost to Follow-up|0|||
126518609|NCT01485861|455192541|FG000|Phase II|Study Ended|0|||
126518610|NCT01485861|455192542|FG001|Phase II|Study Ended|0|||
126518611|NCT01485861|455192543|FG002|Phase II|Study Ended|7|||
126518612|NCT01485861|455192544|FG003|Phase II|Study Ended|8|||
126518613|NCT01485861|455192545|FG004|Phase II|Study Ended|6|||
126518614|NCT01485861|455192546|FG005|Phase II|Study Ended|0|||
126518615|NCT01485861|455192541|FG000|Safety Phase|Death|0|||
126518616|NCT01485861|455192542|FG001|Safety Phase|Death|0|||
126518617|NCT01485861|455192543|FG002|Safety Phase|Death|0|||
126518618|NCT01485861|455192544|FG003|Safety Phase|Death|0|||
126518619|NCT01485861|455192545|FG004|Safety Phase|Death|0|||
126518620|NCT01485861|455192546|FG005|Safety Phase|Death|2|||
126518621|NCT01485861|455192541|FG000|Safety Phase|Adverse Event|0|||
126518622|NCT01485861|455192542|FG001|Safety Phase|Adverse Event|0|||
126518623|NCT01485861|455192543|FG002|Safety Phase|Adverse Event|0|||
126518624|NCT01485861|455192544|FG003|Safety Phase|Adverse Event|0|||
126518625|NCT01485861|455192545|FG004|Safety Phase|Adverse Event|0|||
126518626|NCT01485861|455192546|FG005|Safety Phase|Adverse Event|1|||
126518627|NCT01485861|455192541|FG000|Safety Phase|Other|0|||
126518628|NCT01485861|455192542|FG001|Safety Phase|Other|0|||
126518629|NCT01485861|455192543|FG002|Safety Phase|Other|0|||
126518630|NCT01485861|455192544|FG003|Safety Phase|Other|0|||
126518631|NCT01485861|455192545|FG004|Safety Phase|Other|0|||
126518632|NCT01485861|455192546|FG005|Safety Phase|Other|5|||
126518633|NCT01485861|455192541|FG000|Safety Phase|Progression of Disease|0|||
126518634|NCT01485861|455192542|FG001|Safety Phase|Progression of Disease|0|||
126518635|NCT01485861|455192543|FG002|Safety Phase|Progression of Disease|0|||
126518636|NCT01485861|455192544|FG003|Safety Phase|Progression of Disease|0|||
126518637|NCT01485861|455192545|FG004|Safety Phase|Progression of Disease|0|||
126518638|NCT01485861|455192546|FG005|Safety Phase|Progression of Disease|9|||
126518639|NCT01485861|455192541|FG000|Safety Phase|Withdrawal by Subject|0|||
126518640|NCT01485861|455192542|FG001|Safety Phase|Withdrawal by Subject|0|||
126518641|NCT01485861|455192543|FG002|Safety Phase|Withdrawal by Subject|0|||
126518642|NCT01485861|455192544|FG003|Safety Phase|Withdrawal by Subject|0|||
126727288|NCT02720016|455951106|FG002|Overall Study|Scheduling issues|7|||
126727289|NCT02720016|455951104|FG000|Overall Study|Childcare|2|||
126727290|NCT02720016|455951105|FG001|Overall Study|Childcare|0|||
126727291|NCT02720016|455951106|FG002|Overall Study|Childcare|2|||
126727292|NCT02720016|455951104|FG000|Overall Study|Withdrawal by PI|2|||
126518643|NCT01485861|455192545|FG004|Safety Phase|Withdrawal by Subject|0|||
126518644|NCT01485861|455192546|FG005|Safety Phase|Withdrawal by Subject|6|||
126518645|NCT01485861|455192541|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
126518646|NCT01485861|455192542|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
126518647|NCT01485861|455192543|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
126518648|NCT01485861|455192544|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
126518649|NCT01485861|455192545|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
126518650|NCT01485861|455192546|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
126518651|NCT03783923|455192557|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
126518652|NCT03783923|455192558|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
126518653|NCT03783923|455192557|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
126518654|NCT03783923|455192558|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
126518655|NCT03783923|455192557|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
126518656|NCT03783923|455192558|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
126518657|NCT03783923|455192557|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
126518658|NCT03783923|455192558|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
126518659|NCT03783923|455192557|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
126518660|NCT03783923|455192558|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
126518661|NCT00298831|455192560|FG000|Overall Study|Adverse Event|1|||
126518662|NCT00298831|455192560|FG000|Overall Study|Lost to Follow-up|3|||
126518663|NCT00298831|455192560|FG000|Overall Study|Withdrawal by Subject|1|||
126518664|NCT00298831|455192560|FG000|Overall Study|Participants did not receive treatment|27|||
126518665|NCT04122443|455192561|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
126518666|NCT04122443|455192562|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
126518667|NCT04122443|455192563|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
126518668|NCT04122443|455192561|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
126518669|NCT04122443|455192562|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
126518670|NCT04122443|455192563|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
126518671|NCT01072201|455192564|FG000|Overall Study|Lost to Follow-up|0|||
126518672|NCT01072201|455192565|FG001|Overall Study|Lost to Follow-up|1|||
126518673|NCT02052466|455192566|FG000|Overall Study|Withdrawal by Subject|1|||
126518674|NCT02052466|455192566|FG000|Overall Study|Acromial fracture|1|||
126518675|NCT00595582|455192567|FG000|Overall Study|Pilot study that PI terminated|2|||
126518676|NCT00595582|455192567|FG000|Overall Study|Lost to Follow-up|1|||
126518677|NCT00595582|455192567|FG000|Overall Study|Adverse Event|2|||
126518678|NCT00595582|455192567|FG000|Overall Study|Physician Decision|5|||
126518679|NCT00965848|455192569|FG000|Overall Study|Protocol Violation|3|||
126518680|NCT00965848|455192570|FG001|Overall Study|Protocol Violation|0|||
126518681|NCT00965848|455192571|FG002|Overall Study|Protocol Violation|1|||
126518682|NCT00965848|455192569|FG000|Overall Study|Death|11|||
126518683|NCT00965848|455192570|FG001|Overall Study|Death|1|||
126518684|NCT00965848|455192571|FG002|Overall Study|Death|5|||
126518685|NCT00965848|455192569|FG000|Overall Study|Lost to Follow-up|0|||
126518686|NCT00965848|455192570|FG001|Overall Study|Lost to Follow-up|0|||
126518687|NCT00965848|455192571|FG002|Overall Study|Lost to Follow-up|1|||
126518688|NCT00965848|455192569|FG000|Overall Study|Withdrawal by Subject|1|||
126518689|NCT00965848|455192570|FG001|Overall Study|Withdrawal by Subject|0|||
126518690|NCT00965848|455192571|FG002|Overall Study|Withdrawal by Subject|0|||
126518691|NCT00965848|455192569|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
126518692|NCT00965848|455192570|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
126518693|NCT00965848|455192571|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
126518694|NCT00965848|455192569|FG000|Overall Study|Not Clinically Evaluable|7|||
126518695|NCT00965848|455192570|FG001|Overall Study|Not Clinically Evaluable|1|||
126518696|NCT00965848|455192571|FG002|Overall Study|Not Clinically Evaluable|1|||
126518697|NCT00965848|455192569|FG000|Overall Study|Other|5|||
126518698|NCT00965848|455192570|FG001|Overall Study|Other|0|||
126518699|NCT00965848|455192571|FG002|Overall Study|Other|1|||
126518700|NCT01328002|455192572|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
126518701|NCT01328002|455192573|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
126518702|NCT01328002|455192572|FG000|Open-Label Period|Adverse Event|8|||
126518703|NCT01328002|455192573|FG001|Open-Label Period|Adverse Event|0|||
126518704|NCT01328002|455192572|FG000|Open-Label Period|Lack of Efficacy|3|||
126518705|NCT01328002|455192573|FG001|Open-Label Period|Lack of Efficacy|0|||
126518706|NCT01328002|455192572|FG000|Open-Label Period|Protocol Violation|2|||
126518707|NCT01328002|455192573|FG001|Open-Label Period|Protocol Violation|0|||
126518708|NCT01328002|455192572|FG000|Open-Label Period|Withdrawal by Subject|9|||
126518709|NCT01328002|455192573|FG001|Open-Label Period|Withdrawal by Subject|0|||
126518710|NCT01328002|455192572|FG000|Open-Label Period|Lost to Follow-up|6|||
126518711|NCT01328002|455192573|FG001|Open-Label Period|Lost to Follow-up|0|||
126518712|NCT01328002|455192572|FG000|Open-Label Period|Other Reason|2|||
126518713|NCT01328002|455192573|FG001|Open-Label Period|Other Reason|0|||
126518714|NCT01328002|455192572|FG000|Double-Blind Period|Adverse Event|1|||
126518715|NCT01328002|455192573|FG001|Double-Blind Period|Adverse Event|0|||
126518716|NCT01328002|455192572|FG000|Double-Blind Period|Lack of Efficacy|1|||
126518717|NCT01328002|455192573|FG001|Double-Blind Period|Lack of Efficacy|0|||
126518718|NCT03149328|455192574|FG000|Overall Study|Withdrawal by Subject|30|||
126518719|NCT03149328|455192575|FG001|Overall Study|Withdrawal by Subject|26|||
126518720|NCT03149328|455192574|FG000|Overall Study|Changed Dialysis Modality|18|||
126518721|NCT03149328|455192575|FG001|Overall Study|Changed Dialysis Modality|1|||
126518722|NCT03149328|455192574|FG000|Overall Study|Transplant|9|||
126518723|NCT03149328|455192575|FG001|Overall Study|Transplant|1|||
126518724|NCT03149328|455192574|FG000|Overall Study|Lost to Follow-up|25|||
126518725|NCT03149328|455192575|FG001|Overall Study|Lost to Follow-up|16|||
126518726|NCT03149328|455192574|FG000|Overall Study|Left Study Site|1|||
126518727|NCT03149328|455192575|FG001|Overall Study|Left Study Site|2|||
126518728|NCT03149328|455192574|FG000|Overall Study|Language Barrier|1|||
126518729|NCT03149328|455192575|FG001|Overall Study|Language Barrier|0|||
126518730|NCT00813761|455192576|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
126518731|NCT00813761|455192577|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
126518732|NCT00813761|455192578|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
126518733|NCT00813761|455192579|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
126518734|NCT00813761|455192576|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
126518735|NCT00813761|455192577|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
126518736|NCT00813761|455192578|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
126518737|NCT00813761|455192579|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
126518738|NCT00813761|455192576|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
126518739|NCT00813761|455192577|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
126518740|NCT00813761|455192578|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
126518741|NCT00813761|455192579|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
126518742|NCT00813761|455192576|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
126518743|NCT00813761|455192577|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
126518744|NCT00813761|455192578|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
126518745|NCT00813761|455192579|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
126518746|NCT00813761|455192576|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
126518747|NCT00813761|455192577|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
126518748|NCT00813761|455192578|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
126518749|NCT00813761|455192579|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
126518750|NCT00813761|455192576|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
126518751|NCT00813761|455192577|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
126518752|NCT00813761|455192578|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
126518753|NCT00813761|455192579|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
126518754|NCT00813761|455192576|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
126518755|NCT00813761|455192577|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
126518756|NCT00813761|455192578|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
126518757|NCT00813761|455192579|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
126518758|NCT00813761|455192576|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
126518759|NCT00813761|455192577|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
126518760|NCT00813761|455192578|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
126518761|NCT00813761|455192579|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
126518762|NCT00813761|455192576|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
126518763|NCT00813761|455192577|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
126518764|NCT00813761|455192578|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
126518765|NCT00813761|455192579|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
126572259|NCT01317420|455391407|FG000|Overall Study|Reason other than those specified|0|||
126572260|NCT01317420|455391408|FG001|Overall Study|Reason other than those specified|0|||
126572261|NCT01317420|455391409|FG002|Overall Study|Reason other than those specified|0|||
126572262|NCT01317420|455391410|FG003|Overall Study|Reason other than those specified|0|||
126572263|NCT01317420|455391411|FG004|Overall Study|Reason other than those specified|0|||
126518766|NCT00813761|455192576|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
126518767|NCT00813761|455192577|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
126572264|NCT01317420|455391412|FG005|Overall Study|Reason other than those specified|0|||
126518768|NCT00813761|455192578|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
126518769|NCT00813761|455192579|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
126518770|NCT00813761|455192576|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
126518771|NCT00813761|455192577|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
126518772|NCT00813761|455192578|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
126518773|NCT00813761|455192579|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
126518774|NCT00813761|455192576|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
126518775|NCT00813761|455192577|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
126518776|NCT00813761|455192578|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
126572265|NCT01317420|455391413|FG006|Overall Study|Reason other than those specified|0|||
126572266|NCT01317420|455391414|FG007|Overall Study|Reason other than those specified|0|||
126572267|NCT01317420|455391415|FG008|Overall Study|Reason other than those specified|0|||
126572268|NCT01317420|455391416|FG009|Overall Study|Reason other than those specified|1|||
126572269|NCT01317420|455391417|FG010|Overall Study|Reason other than those specified|0|||
126572270|NCT01317420|455391418|FG011|Overall Study|Reason other than those specified|0|||
126572271|NCT01317420|455391419|FG012|Overall Study|Reason other than those specified|0|||
126572272|NCT03194958|455391420|FG000|Overall Study|Death|0|||
126572273|NCT03194958|455391421|FG001|Overall Study|Death|1|||
126572274|NCT03194958|455391422|FG002|Overall Study|Death|1|||
126572275|NCT03194958|455391423|FG003|Overall Study|Death|1|||
126572276|NCT03194958|455391420|FG000|Overall Study|Withdrawal by Subject|24|||
126572277|NCT03194958|455391421|FG001|Overall Study|Withdrawal by Subject|27|||
126572278|NCT03194958|455391422|FG002|Overall Study|Withdrawal by Subject|7|||
126572279|NCT03194958|455391423|FG003|Overall Study|Withdrawal by Subject|22|||
126572280|NCT03194958|455391420|FG000|Overall Study|Lost to Follow-up|168|||
126572281|NCT03194958|455391421|FG001|Overall Study|Lost to Follow-up|196|||
126572282|NCT03194958|455391422|FG002|Overall Study|Lost to Follow-up|174|||
126572283|NCT03194958|455391423|FG003|Overall Study|Lost to Follow-up|186|||
126572284|NCT01968226|455391425|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
126572285|NCT04975308|455391433|FG000|Overall Study|Withdrawal by Subject|6|||
126572286|NCT04975308|455391434|FG001|Overall Study|Withdrawal by Subject|16|||
126572287|NCT04975308|455391435|FG002|Overall Study|Withdrawal by Subject|6|||
126572288|NCT04975308|455391433|FG000|Overall Study|Physician Decision|0|||
126572289|NCT04975308|455391434|FG001|Overall Study|Physician Decision|3|||
126572290|NCT04975308|455391435|FG002|Overall Study|Physician Decision|1|||
126572291|NCT04975308|455391433|FG000|Overall Study|Adverse Event|10|||
126572292|NCT04975308|455391434|FG001|Overall Study|Adverse Event|1|||
126572293|NCT04975308|455391435|FG002|Overall Study|Adverse Event|12|||
126572294|NCT04975308|455391433|FG000|Overall Study|On study treatment (Ongoing)|65|||
126572295|NCT04975308|455391434|FG001|Overall Study|On study treatment (Ongoing)|43|||
126572296|NCT04975308|455391435|FG002|Overall Study|On study treatment (Ongoing)|75|||
126572297|NCT04975308|455391433|FG000|Overall Study|Protocol Deviation|4|||
126572298|NCT04975308|455391434|FG001|Overall Study|Protocol Deviation|3|||
126572299|NCT04975308|455391435|FG002|Overall Study|Protocol Deviation|2|||
126572300|NCT02709655|455391436|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
126572301|NCT02709655|455391437|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
126572302|NCT02709655|455391438|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
126572303|NCT02709655|455391439|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
126572304|NCT02709655|455391440|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
126572305|NCT02709655|455391436|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
126572306|NCT02709655|455391437|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
126572307|NCT02709655|455391438|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
126572308|NCT02709655|455391439|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
126572309|NCT02709655|455391440|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
126572310|NCT02709655|455391436|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
126572311|NCT02709655|455391437|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
126572312|NCT02709655|455391438|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
126572313|NCT02709655|455391439|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
126572314|NCT02709655|455391440|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
126572315|NCT02709655|455391436|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
126572316|NCT02709655|455391437|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
126572317|NCT02709655|455391438|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
126572318|NCT02709655|455391439|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
126572319|NCT02709655|455391440|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
126572320|NCT02709655|455391436|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
126572321|NCT02709655|455391437|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
126572322|NCT02709655|455391438|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
126572323|NCT02709655|455391439|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
126572324|NCT02709655|455391440|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
126572325|NCT02709655|455391436|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
126572326|NCT02709655|455391437|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
126572327|NCT02709655|455391438|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
126572328|NCT02709655|455391439|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
126572329|NCT02709655|455391440|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
126572330|NCT02709655|455391436|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
126572331|NCT02709655|455391437|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
126572332|NCT02709655|455391438|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
126572333|NCT02709655|455391439|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
126572334|NCT02709655|455391440|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
126572335|NCT02709655|455391436|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
126572336|NCT02709655|455391437|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
126572337|NCT02709655|455391438|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
126572338|NCT02709655|455391439|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
126572339|NCT02709655|455391440|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
126572340|NCT02709655|455391436|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
126572341|NCT02709655|455391437|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
126572342|NCT02709655|455391438|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
126572343|NCT02709655|455391439|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
126572344|NCT02709655|455391440|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
126572345|NCT02709655|455391436|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
126572346|NCT02709655|455391437|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
126572347|NCT02709655|455391438|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
126572348|NCT02709655|455391439|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
126572349|NCT02709655|455391440|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
126572350|NCT02709655|455391436|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
126572351|NCT02709655|455391437|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
126572352|NCT02709655|455391438|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
126572353|NCT02709655|455391439|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
126572354|NCT02709655|455391440|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
126572355|NCT02709655|455391436|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
126572356|NCT02709655|455391437|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
126572357|NCT02709655|455391438|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
126572358|NCT02709655|455391439|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
126572359|NCT02709655|455391440|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
126572360|NCT02709655|455391436|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
126572361|NCT02709655|455391437|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
126572362|NCT02709655|455391438|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
126572363|NCT02709655|455391439|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
126572364|NCT02709655|455391440|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
126572365|NCT02709655|455391436|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
126572366|NCT02709655|455391437|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
126572367|NCT02709655|455391438|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
126572368|NCT02709655|455391439|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
126572369|NCT02709655|455391440|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
126572370|NCT02709655|455391436|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
126572371|NCT02709655|455391437|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
126572372|NCT02709655|455391438|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
126572373|NCT02709655|455391439|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
126572374|NCT02709655|455391440|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
126572375|NCT02709655|455391436|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
126572376|NCT02709655|455391437|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
126572377|NCT02709655|455391438|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
126572378|NCT02709655|455391439|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
126572379|NCT02709655|455391440|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
126572380|NCT00102063|455391441|FG000|Overall Study|Lack of Efficacy|5|||
126572381|NCT00102063|455391442|FG001|Overall Study|Lack of Efficacy|1|||
126572382|NCT00102063|455391443|FG002|Overall Study|Lack of Efficacy|1|||
126572383|NCT00102063|455391441|FG000|Overall Study|Adverse Event|7|||
126572384|NCT00102063|455391442|FG001|Overall Study|Adverse Event|4|||
126572385|NCT00102063|455391443|FG002|Overall Study|Adverse Event|2|||
126572386|NCT00102063|455391441|FG000|Overall Study|Withdrawal by Subject|4|||
126572387|NCT00102063|455391442|FG001|Overall Study|Withdrawal by Subject|12|||
126572388|NCT00102063|455391443|FG002|Overall Study|Withdrawal by Subject|5|||
126572389|NCT00102063|455391441|FG000|Overall Study|Lost to Follow-up|0|||
126777020|NCT01789281|456139155|FG001|Overall Study|Withdrawal by Subject|0|||
126777021|NCT01789281|456139154|FG000|Overall Study|Lost to Follow-up|1|||
126572390|NCT00102063|455391442|FG001|Overall Study|Lost to Follow-up|0|||
126572391|NCT00102063|455391443|FG002|Overall Study|Lost to Follow-up|1|||
126572392|NCT00102063|455391441|FG000|Overall Study|Protocol Violation|0|||
126572393|NCT00102063|455391442|FG001|Overall Study|Protocol Violation|1|||
126572394|NCT00102063|455391443|FG002|Overall Study|Protocol Violation|1|||
126572395|NCT01493778|455391444|FG000|Overall Study|Withdrawal by Subject|8|||
126572396|NCT05082025|455391445|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
126572397|NCT04210180|455391446|FG000|Overall Study|Withdrawal by Subject|2|||
126572398|NCT01179334|455391447|FG000|Treatment Period|Adverse Event|1|||
126572399|NCT01179334|455391448|FG001|Treatment Period|Adverse Event|0|||
126572400|NCT01179334|455391447|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
126572401|NCT01179334|455391448|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
126572402|NCT01179334|455391447|FG000|Long-term Extension (LTE) Period|Death|3|||
126572403|NCT01179334|455391448|FG001|Long-term Extension (LTE) Period|Death|0|||
126572404|NCT01179334|455391447|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
126777022|NCT01789281|456139155|FG001|Overall Study|Lost to Follow-up|0|||
126518777|NCT00813761|455192579|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
126518778|NCT00691210|455192580|FG000|Overall Study|Progression of Disease|0|||
126518779|NCT00691210|455192581|FG001|Overall Study|Progression of Disease|0|||
126518780|NCT00691210|455192582|FG002|Overall Study|Progression of Disease|0|||
126518781|NCT00691210|455192583|FG003|Overall Study|Progression of Disease|2|||
126518782|NCT00691210|455192584|FG004|Overall Study|Progression of Disease|0|||
126518783|NCT00691210|455192585|FG005|Overall Study|Progression of Disease|0|||
126518784|NCT00691210|455192586|FG006|Overall Study|Progression of Disease|0|||
126518785|NCT00691210|455192587|FG007|Overall Study|Progression of Disease|0|||
126518786|NCT00691210|455192580|FG000|Overall Study|Lack of Efficacy|0|||
126518787|NCT00691210|455192581|FG001|Overall Study|Lack of Efficacy|0|||
126518788|NCT00691210|455192582|FG002|Overall Study|Lack of Efficacy|0|||
126518789|NCT00691210|455192583|FG003|Overall Study|Lack of Efficacy|1|||
126518790|NCT00691210|455192584|FG004|Overall Study|Lack of Efficacy|0|||
126518791|NCT00691210|455192585|FG005|Overall Study|Lack of Efficacy|1|||
126518792|NCT00691210|455192586|FG006|Overall Study|Lack of Efficacy|0|||
126518793|NCT00691210|455192587|FG007|Overall Study|Lack of Efficacy|0|||
126518794|NCT01306617|455192588|FG000|Overall Study|Adverse Event|1|||
126518795|NCT01306617|455192589|FG001|Overall Study|Adverse Event|0|||
126518796|NCT01306617|455192590|FG002|Overall Study|Adverse Event|0|||
126518797|NCT01306617|455192588|FG000|Overall Study|Virologic Failure|0|||
126518798|NCT01306617|455192589|FG001|Overall Study|Virologic Failure|0|||
126518799|NCT01306617|455192590|FG002|Overall Study|Virologic Failure|5|||
126518800|NCT01306617|455192588|FG000|Overall Study|Non-compliance|0|||
126518801|NCT01306617|455192589|FG001|Overall Study|Non-compliance|1|||
126518802|NCT01306617|455192590|FG002|Overall Study|Non-compliance|0|||
126518803|NCT01208233|455192593|FG000|Overall Study|Adverse Event|0|||
126518804|NCT01208233|455192594|FG001|Overall Study|Adverse Event|1|||
126518805|NCT01208233|455192595|FG002|Overall Study|Adverse Event|2|||
126518806|NCT01208233|455192596|FG003|Overall Study|Adverse Event|0|||
126518807|NCT01208233|455192597|FG004|Overall Study|Adverse Event|3|||
126518808|NCT01208233|455192598|FG005|Overall Study|Adverse Event|5|||
126518809|NCT01208233|455192593|FG000|Overall Study|Death|0|||
126518810|NCT01208233|455192594|FG001|Overall Study|Death|0|||
126518811|NCT01208233|455192595|FG002|Overall Study|Death|0|||
126518812|NCT01208233|455192596|FG003|Overall Study|Death|0|||
126518813|NCT01208233|455192597|FG004|Overall Study|Death|3|||
126518814|NCT01208233|455192598|FG005|Overall Study|Death|5|||
126518815|NCT01208233|455192593|FG000|Overall Study|Did not meet entrance criteria|2|||
126518816|NCT01208233|455192594|FG001|Overall Study|Did not meet entrance criteria|1|||
126518817|NCT01208233|455192595|FG002|Overall Study|Did not meet entrance criteria|1|||
126518818|NCT01208233|455192596|FG003|Overall Study|Did not meet entrance criteria|0|||
126518819|NCT01208233|455192597|FG004|Overall Study|Did not meet entrance criteria|1|||
126518820|NCT01208233|455192598|FG005|Overall Study|Did not meet entrance criteria|0|||
126518821|NCT01208233|455192593|FG000|Overall Study|Medication error without adverse event|0|||
126518822|NCT01208233|455192594|FG001|Overall Study|Medication error without adverse event|0|||
126518823|NCT01208233|455192595|FG002|Overall Study|Medication error without adverse event|0|||
126518824|NCT01208233|455192596|FG003|Overall Study|Medication error without adverse event|0|||
126518825|NCT01208233|455192597|FG004|Overall Study|Medication error without adverse event|0|||
126518826|NCT01208233|455192598|FG005|Overall Study|Medication error without adverse event|1|||
126518827|NCT01208233|455192593|FG000|Overall Study|Study terminated by sponsor|0|||
126518828|NCT01208233|455192594|FG001|Overall Study|Study terminated by sponsor|0|||
126518829|NCT01208233|455192595|FG002|Overall Study|Study terminated by sponsor|0|||
126518830|NCT01208233|455192596|FG003|Overall Study|Study terminated by sponsor|0|||
126518831|NCT01208233|455192597|FG004|Overall Study|Study terminated by sponsor|10|||
126518832|NCT01208233|455192598|FG005|Overall Study|Study terminated by sponsor|7|||
126518833|NCT01208233|455192593|FG000|Overall Study|Protocol Violation|0|||
126518834|NCT01208233|455192594|FG001|Overall Study|Protocol Violation|0|||
126518835|NCT01208233|455192595|FG002|Overall Study|Protocol Violation|0|||
126518836|NCT01208233|455192596|FG003|Overall Study|Protocol Violation|0|||
126518837|NCT01208233|455192597|FG004|Overall Study|Protocol Violation|3|||
126518838|NCT01208233|455192598|FG005|Overall Study|Protocol Violation|0|||
126518839|NCT01208233|455192593|FG000|Overall Study|Other|2|||
126518840|NCT01208233|455192594|FG001|Overall Study|Other|1|||
126518841|NCT01208233|455192595|FG002|Overall Study|Other|0|||
126518842|NCT01208233|455192596|FG003|Overall Study|Other|0|||
126518843|NCT01208233|455192597|FG004|Overall Study|Other|0|||
126518844|NCT01208233|455192598|FG005|Overall Study|Other|1|||
126518845|NCT01208233|455192593|FG000|Overall Study|Withdrawal by Subject|1|||
126518846|NCT01208233|455192594|FG001|Overall Study|Withdrawal by Subject|0|||
126518847|NCT01208233|455192595|FG002|Overall Study|Withdrawal by Subject|1|||
126518848|NCT01208233|455192596|FG003|Overall Study|Withdrawal by Subject|1|||
126518849|NCT01208233|455192597|FG004|Overall Study|Withdrawal by Subject|4|||
126518850|NCT01208233|455192598|FG005|Overall Study|Withdrawal by Subject|2|||
126518851|NCT01181895|455192602|FG000|Overall Study|Adverse Event|3|||
126518852|NCT01181895|455192603|FG001|Overall Study|Adverse Event|1|||
126518853|NCT01181895|455192604|FG002|Overall Study|Adverse Event|1|||
126518854|NCT01181895|455192602|FG000|Overall Study|Lack of Efficacy|8|||
126572405|NCT01179334|455391448|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
126572406|NCT00857649|455391449|FG000|Overall Study|Adverse Event|15|||
126572407|NCT00857649|455391450|FG001|Overall Study|Adverse Event|10|||
126572408|NCT00857649|455391449|FG000|Overall Study|Non-compliance|1|||
126572409|NCT00857649|455391450|FG001|Overall Study|Non-compliance|1|||
126572410|NCT00857649|455391449|FG000|Overall Study|Protocol Violation|2|||
126572411|NCT00857649|455391450|FG001|Overall Study|Protocol Violation|2|||
126572412|NCT00857649|455391449|FG000|Overall Study|Withdrawal of Consent|10|||
126572413|NCT00857649|455391450|FG001|Overall Study|Withdrawal of Consent|7|||
126572414|NCT00857649|455391449|FG000|Overall Study|Nursing Home Placement|2|||
126572415|NCT00857649|455391450|FG001|Overall Study|Nursing Home Placement|9|||
126572416|NCT00857649|455391449|FG000|Overall Study|Other Reasons|1|||
126572417|NCT00857649|455391450|FG001|Overall Study|Other Reasons|3|||
126572418|NCT05190419|455391451|FG000|Overall Study|Lack of Efficacy|8|||
126572419|NCT05190419|455391452|FG001|Overall Study|Lack of Efficacy|0|||
126572420|NCT05190419|455391453|FG002|Overall Study|Lack of Efficacy|1|||
126572421|NCT05190419|455391454|FG003|Overall Study|Lack of Efficacy|0|||
126572422|NCT05190419|455391451|FG000|Overall Study|Withdrawal by Subject|7|||
126572423|NCT05190419|455391452|FG001|Overall Study|Withdrawal by Subject|1|||
126572424|NCT05190419|455391453|FG002|Overall Study|Withdrawal by Subject|2|||
126572425|NCT05190419|455391454|FG003|Overall Study|Withdrawal by Subject|2|||
126572426|NCT05190419|455391451|FG000|Overall Study|Adverse Event|2|||
126572427|NCT05190419|455391452|FG001|Overall Study|Adverse Event|10|||
126572428|NCT05190419|455391453|FG002|Overall Study|Adverse Event|11|||
126572429|NCT05190419|455391454|FG003|Overall Study|Adverse Event|21|||
126572430|NCT05190419|455391451|FG000|Overall Study|Lost to Follow-up|1|||
126572431|NCT05190419|455391452|FG001|Overall Study|Lost to Follow-up|2|||
126572432|NCT05190419|455391453|FG002|Overall Study|Lost to Follow-up|3|||
126572433|NCT05190419|455391454|FG003|Overall Study|Lost to Follow-up|1|||
126572434|NCT05190419|455391451|FG000|Overall Study|Other|1|||
126572435|NCT05190419|455391452|FG001|Overall Study|Other|1|||
126572436|NCT05190419|455391453|FG002|Overall Study|Other|0|||
126572437|NCT05190419|455391454|FG003|Overall Study|Other|3|||
126572438|NCT00919763|455391455|FG000|Overall Study|Adverse Event|7|||
126572439|NCT00919763|455391456|FG001|Overall Study|Adverse Event|1|||
126572440|NCT00919763|455391455|FG000|Overall Study|Lost to Follow-up|1|||
126572441|NCT00919763|455391456|FG001|Overall Study|Lost to Follow-up|0|||
126572442|NCT00919763|455391455|FG000|Overall Study|Protocol Violation|1|||
126572443|NCT00919763|455391456|FG001|Overall Study|Protocol Violation|1|||
126572444|NCT00919763|455391455|FG000|Overall Study|Withdrawal by Subject|3|||
126572445|NCT00919763|455391456|FG001|Overall Study|Withdrawal by Subject|1|||
126572446|NCT00919763|455391455|FG000|Overall Study|Non-compliance|0|||
126572447|NCT00919763|455391456|FG001|Overall Study|Non-compliance|1|||
126572448|NCT05323734|455391462|FG000|Overall Study|Adverse Event|5|||
126572449|NCT05323734|455391463|FG001|Overall Study|Adverse Event|2|||
126572450|NCT05323734|455391462|FG000|Overall Study|Physician Decision|1|||
126572451|NCT05323734|455391463|FG001|Overall Study|Physician Decision|0|||
126572452|NCT05323734|455391462|FG000|Overall Study|Lack of Efficacy|1|||
126572453|NCT05323734|455391463|FG001|Overall Study|Lack of Efficacy|2|||
126572454|NCT05323734|455391462|FG000|Overall Study|Withdrawal by Subject|2|||
126572455|NCT05323734|455391463|FG001|Overall Study|Withdrawal by Subject|0|||
126572456|NCT05323734|455391462|FG000|Overall Study|Participant Withdrawn Due|0|||
126572457|NCT05323734|455391463|FG001|Overall Study|Participant Withdrawn Due|1|||
126572458|NCT02486718|455391464|FG000|Enrollment Phase|Death|19|||
126572459|NCT02486718|455391465|FG001|Enrollment Phase|Death|0|||
126572460|NCT02486718|455391466|FG002|Enrollment Phase|Death|0|||
126572461|NCT02486718|455391464|FG000|Enrollment Phase|Symptomatic deterioration|1|||
126572462|NCT02486718|455391465|FG001|Enrollment Phase|Symptomatic deterioration|0|||
126572463|NCT02486718|455391466|FG002|Enrollment Phase|Symptomatic deterioration|0|||
126572464|NCT02486718|455391464|FG000|Enrollment Phase|Withdrawal by Subject|86|||
126572465|NCT02486718|455391465|FG001|Enrollment Phase|Withdrawal by Subject|0|||
126572466|NCT02486718|455391466|FG002|Enrollment Phase|Withdrawal by Subject|0|||
126572467|NCT02486718|455391464|FG000|Enrollment Phase|Protocol Violation|18|||
126572468|NCT02486718|455391465|FG001|Enrollment Phase|Protocol Violation|0|||
126572469|NCT02486718|455391466|FG002|Enrollment Phase|Protocol Violation|0|||
126572470|NCT02486718|455391464|FG000|Enrollment Phase|Physician Decision|18|||
126518855|NCT01181895|455192603|FG001|Overall Study|Lack of Efficacy|9|||
126518856|NCT01181895|455192604|FG002|Overall Study|Lack of Efficacy|9|||
126518857|NCT01181895|455192602|FG000|Overall Study|Protocol Violation|2|||
126518858|NCT01181895|455192603|FG001|Overall Study|Protocol Violation|1|||
126518859|NCT01181895|455192604|FG002|Overall Study|Protocol Violation|0|||
126518860|NCT01181895|455192602|FG000|Overall Study|Lost to Follow-up|0|||
126518861|NCT01181895|455192603|FG001|Overall Study|Lost to Follow-up|1|||
126518862|NCT01181895|455192604|FG002|Overall Study|Lost to Follow-up|2|||
126518863|NCT01181895|455192602|FG000|Overall Study|Investigator Discretion|1|||
126518864|NCT01181895|455192603|FG001|Overall Study|Investigator Discretion|2|||
126518865|NCT01181895|455192604|FG002|Overall Study|Investigator Discretion|1|||
126518866|NCT01181895|455192602|FG000|Overall Study|Withdrawal by Subject|3|||
126518867|NCT01181895|455192603|FG001|Overall Study|Withdrawal by Subject|0|||
126518868|NCT01181895|455192604|FG002|Overall Study|Withdrawal by Subject|5|||
126518869|NCT04028388|455192613|FG000|Overall Study|Evaluations missing|3|||
126518870|NCT04028388|455192614|FG001|Overall Study|Evaluations missing|6|||
126518871|NCT04028388|455192613|FG000|Overall Study|Not started|2|||
126518872|NCT04028388|455192614|FG001|Overall Study|Not started|0|||
126518873|NCT00555438|455192615|FG000|10 Days Post-operative|Death|4|||
126518874|NCT00555438|455192615|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
126518875|NCT00766415|455192616|FG000|Overall Study|Withdrawal by Subject|0|||
126518876|NCT00766415|455192617|FG001|Overall Study|Withdrawal by Subject|1|||
126518877|NCT00061048|455192618|FG000|Overall Study|Adverse Event|2|||
126518878|NCT00061048|455192618|FG000|Overall Study|disease progression|20|||
126518879|NCT01114516|455192619|FG000|Overall Study|Lost to Follow-up|2|||
126518880|NCT01114516|455192620|FG001|Overall Study|Lost to Follow-up|1|||
126518881|NCT01431508|455192621|FG000|Overall Study|Lack of Efficacy|1|||
126518882|NCT01431508|455192621|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
126518883|NCT00129259|455192622|FG000|Overall Study|Lost to Follow-up|1|||
126518884|NCT00129259|455192623|FG001|Overall Study|Lost to Follow-up|1|||
126518885|NCT00129259|455192622|FG000|Overall Study|Withdrawal by Subject|2|||
126518886|NCT00129259|455192623|FG001|Overall Study|Withdrawal by Subject|1|||
126518887|NCT00129259|455192622|FG000|Overall Study|Only available minimal phone assessments|0|||
126518888|NCT00129259|455192623|FG001|Overall Study|Only available minimal phone assessments|1|||
126518889|NCT01609556|455192628|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
126518890|NCT01609556|455192629|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
126518891|NCT01609556|455192630|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
126518892|NCT01609556|455192631|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
126518893|NCT01609556|455192632|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
126518894|NCT01609556|455192633|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
126518895|NCT01609556|455192634|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
126518896|NCT01609556|455192635|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
126518897|NCT01609556|455192636|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
126518898|NCT01609556|455192637|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
126518899|NCT01609556|455192638|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
126518900|NCT01609556|455192639|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
126518901|NCT01609556|455192640|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
126518902|NCT01609556|455192641|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
126518903|NCT01609556|455192642|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
126518904|NCT01609556|455192643|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
126518905|NCT01609556|455192628|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
126518906|NCT01609556|455192629|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
126518907|NCT01609556|455192630|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
126518908|NCT01609556|455192631|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
126518909|NCT01609556|455192632|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
126518910|NCT01609556|455192633|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
126518911|NCT01609556|455192634|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
126518912|NCT01609556|455192635|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
126518913|NCT01609556|455192636|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
126518914|NCT01609556|455192637|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
126518915|NCT01609556|455192638|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
126518916|NCT01609556|455192639|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
126518917|NCT01609556|455192640|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
126518918|NCT01609556|455192641|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
126518919|NCT01609556|455192642|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
126518920|NCT01609556|455192643|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
126518921|NCT01609556|455192628|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
126518922|NCT01609556|455192629|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
126518923|NCT01609556|455192630|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
126518924|NCT01609556|455192631|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
126518925|NCT01609556|455192632|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
126518926|NCT01609556|455192633|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
126518927|NCT01609556|455192634|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
126518928|NCT01609556|455192635|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
126518929|NCT01609556|455192636|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
126518930|NCT01609556|455192637|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
126518931|NCT01609556|455192638|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
126518932|NCT01609556|455192639|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
126518933|NCT01609556|455192640|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
126727293|NCT02720016|455951105|FG001|Overall Study|Withdrawal by PI|2|||
126727294|NCT02720016|455951106|FG002|Overall Study|Withdrawal by PI|0|||
126727295|NCT02720016|455951104|FG000|Overall Study|Moved away|2|||
126572471|NCT02486718|455391465|FG001|Enrollment Phase|Physician Decision|0|||
126572472|NCT02486718|455391466|FG002|Enrollment Phase|Physician Decision|0|||
126572473|NCT02486718|455391464|FG000|Enrollment Phase|Reason not provided|41|||
126572474|NCT02486718|455391465|FG001|Enrollment Phase|Reason not provided|0|||
126572475|NCT02486718|455391466|FG002|Enrollment Phase|Reason not provided|0|||
126572476|NCT02486718|455391464|FG000|Enrollment Phase|Disease relapse|54|||
126572477|NCT02486718|455391465|FG001|Enrollment Phase|Disease relapse|0|||
126572478|NCT02486718|455391466|FG002|Enrollment Phase|Disease relapse|0|||
126572479|NCT02486718|455391464|FG000|Enrollment Phase|Lost to Follow-up|4|||
126572480|NCT02486718|455391465|FG001|Enrollment Phase|Lost to Follow-up|0|||
126572481|NCT02486718|455391466|FG002|Enrollment Phase|Lost to Follow-up|0|||
126572482|NCT02486718|455391464|FG000|Enrollment Phase|Adverse Event|34|||
126572483|NCT02486718|455391465|FG001|Enrollment Phase|Adverse Event|0|||
126572484|NCT02486718|455391466|FG002|Enrollment Phase|Adverse Event|0|||
126572485|NCT02486718|455391464|FG000|Randomized Phase|Withdrawal by Subject|0|||
126572486|NCT02486718|455391465|FG001|Randomized Phase|Withdrawal by Subject|44|||
126572487|NCT02486718|455391466|FG002|Randomized Phase|Withdrawal by Subject|47|||
126572488|NCT02486718|455391464|FG000|Randomized Phase|Protocol Violation|0|||
126572489|NCT02486718|455391465|FG001|Randomized Phase|Protocol Violation|2|||
126572490|NCT02486718|455391466|FG002|Randomized Phase|Protocol Violation|0|||
126572491|NCT02486718|455391464|FG000|Randomized Phase|Physician Decision|0|||
126572492|NCT02486718|455391465|FG001|Randomized Phase|Physician Decision|0|||
126572493|NCT02486718|455391466|FG002|Randomized Phase|Physician Decision|3|||
126518934|NCT01609556|455192641|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
126518935|NCT01609556|455192642|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
126518936|NCT01609556|455192643|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
126518937|NCT01609556|455192628|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518938|NCT01609556|455192629|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518939|NCT01609556|455192630|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518940|NCT01609556|455192631|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518941|NCT01609556|455192632|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518942|NCT01609556|455192633|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
126518943|NCT01609556|455192634|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518944|NCT01609556|455192635|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518945|NCT01609556|455192636|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518946|NCT01609556|455192637|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518947|NCT01609556|455192638|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518948|NCT01609556|455192639|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
126518949|NCT01609556|455192640|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518950|NCT01609556|455192641|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518951|NCT01609556|455192642|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518952|NCT01609556|455192643|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
126518953|NCT01609556|455192628|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518954|NCT01609556|455192629|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518955|NCT01609556|455192630|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518956|NCT01609556|455192631|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518957|NCT01609556|455192632|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518958|NCT01609556|455192633|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
126518959|NCT01609556|455192634|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518960|NCT01609556|455192635|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518961|NCT01609556|455192636|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518962|NCT01609556|455192637|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518963|NCT01609556|455192638|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518964|NCT01609556|455192639|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518965|NCT01609556|455192640|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518966|NCT01609556|455192641|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518967|NCT01609556|455192642|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518968|NCT01609556|455192643|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
126518969|NCT01609556|455192628|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518970|NCT01609556|455192629|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518971|NCT01609556|455192630|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126572494|NCT02486718|455391464|FG000|Randomized Phase|Lost to Follow-up|0|||
126572495|NCT02486718|455391465|FG001|Randomized Phase|Lost to Follow-up|5|||
126572496|NCT02486718|455391466|FG002|Randomized Phase|Lost to Follow-up|11|||
126572497|NCT02486718|455391464|FG000|Randomized Phase|Disease Relapse|0|||
126572498|NCT02486718|455391465|FG001|Randomized Phase|Disease Relapse|1|||
126572499|NCT02486718|455391466|FG002|Randomized Phase|Disease Relapse|0|||
126572500|NCT02486718|455391464|FG000|Randomized Phase|Death|0|||
126572501|NCT02486718|455391465|FG001|Randomized Phase|Death|154|||
126572502|NCT02486718|455391466|FG002|Randomized Phase|Death|155|||
126572503|NCT02486718|455391464|FG000|Randomized Phase|Ongoing|0|||
126572504|NCT02486718|455391465|FG001|Randomized Phase|Ongoing|301|||
126572505|NCT02486718|455391466|FG002|Randomized Phase|Ongoing|282|||
126572506|NCT05061693|455391467|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
126572507|NCT05061693|455391468|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
126572508|NCT05061693|455391469|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
126572509|NCT05061693|455391470|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126572510|NCT05061693|455391471|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126572511|NCT05061693|455391472|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126572512|NCT05061693|455391473|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126572513|NCT05061693|455391474|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126572514|NCT05061693|455391475|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126572515|NCT05061693|455391476|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126572516|NCT05061693|455391477|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126572517|NCT05061693|455391478|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
126572518|NCT05061693|455391467|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
126572519|NCT05061693|455391468|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
126572520|NCT05061693|455391469|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
126572521|NCT05061693|455391470|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
126572522|NCT05061693|455391471|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
126572523|NCT05061693|455391472|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
126572524|NCT05061693|455391473|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
126572525|NCT05061693|455391474|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
126572526|NCT05061693|455391475|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
126572527|NCT05061693|455391476|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
126572528|NCT05061693|455391477|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
126572529|NCT05061693|455391478|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
126572530|NCT05061693|455391467|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
126572531|NCT05061693|455391468|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126572532|NCT05061693|455391469|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126572533|NCT05061693|455391470|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126572534|NCT05061693|455391471|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126572535|NCT05061693|455391472|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126572536|NCT05061693|455391473|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126572537|NCT05061693|455391474|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126572538|NCT05061693|455391475|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126572539|NCT05061693|455391476|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126572540|NCT05061693|455391477|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126572541|NCT05061693|455391478|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
126572542|NCT05061693|455391467|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126572543|NCT05061693|455391468|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126572544|NCT05061693|455391469|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
126572545|NCT05061693|455391470|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126572546|NCT05061693|455391471|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126572547|NCT05061693|455391472|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126572548|NCT05061693|455391473|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126572549|NCT05061693|455391474|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126572550|NCT05061693|455391475|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126572551|NCT05061693|455391476|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126572552|NCT05061693|455391477|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126572553|NCT05061693|455391478|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
126572554|NCT05061693|455391467|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
126572555|NCT05061693|455391468|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
126572556|NCT05061693|455391469|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
126572557|NCT05061693|455391470|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
126572558|NCT05061693|455391471|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126572559|NCT05061693|455391472|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126572560|NCT05061693|455391473|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126572561|NCT05061693|455391474|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126572562|NCT05061693|455391475|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126572563|NCT05061693|455391476|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126572564|NCT05061693|455391477|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126572565|NCT05061693|455391478|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
126572566|NCT05061693|455391467|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
126572567|NCT05061693|455391468|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
126727296|NCT02720016|455951105|FG001|Overall Study|Moved away|0|||
126518972|NCT01609556|455192631|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518973|NCT01609556|455192632|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518974|NCT01609556|455192633|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518975|NCT01609556|455192634|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518976|NCT01609556|455192635|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518977|NCT01609556|455192636|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
126518978|NCT01609556|455192637|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518979|NCT01609556|455192638|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518980|NCT01609556|455192639|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518981|NCT01609556|455192640|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518982|NCT01609556|455192641|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518983|NCT01609556|455192642|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518984|NCT01609556|455192643|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
126518985|NCT01609556|455192628|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
126518986|NCT01609556|455192629|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126518987|NCT01609556|455192630|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126518988|NCT01609556|455192631|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126518989|NCT01609556|455192632|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126518990|NCT01609556|455192633|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
126518991|NCT01609556|455192634|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126518992|NCT01609556|455192635|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126518993|NCT01609556|455192636|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126518994|NCT01609556|455192637|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126518995|NCT01609556|455192638|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
126518996|NCT01609556|455192639|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126518997|NCT01609556|455192640|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126518998|NCT01609556|455192641|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126518999|NCT01609556|455192642|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126519000|NCT01609556|455192643|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
126519001|NCT01609556|455192628|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126519002|NCT01609556|455192629|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126519003|NCT01609556|455192630|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126519004|NCT01609556|455192631|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126519005|NCT01609556|455192632|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126519006|NCT01609556|455192633|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126519007|NCT01609556|455192634|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126519008|NCT01609556|455192635|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126519009|NCT01609556|455192636|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126519010|NCT01609556|455192637|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126519011|NCT01609556|455192638|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126519012|NCT01609556|455192639|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
126519013|NCT01609556|455192640|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
126519014|NCT01609556|455192641|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
126519015|NCT01609556|455192642|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
126519016|NCT01609556|455192643|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
126519017|NCT01609556|455192628|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
126519018|NCT01609556|455192629|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
126519019|NCT01609556|455192630|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
126519020|NCT01609556|455192631|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
126519021|NCT01609556|455192632|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
126519022|NCT01609556|455192633|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
126519023|NCT01609556|455192634|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
126519024|NCT01609556|455192635|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
126519025|NCT01609556|455192636|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
126519026|NCT01609556|455192637|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
126519027|NCT01609556|455192638|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
126519028|NCT01609556|455192639|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
126519029|NCT01609556|455192640|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
126519030|NCT01609556|455192641|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
126572568|NCT05061693|455391469|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
126519031|NCT01609556|455192642|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
126519032|NCT01609556|455192643|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
126519033|NCT01609556|455192628|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
126519034|NCT01609556|455192629|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
126519035|NCT01609556|455192630|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
126519036|NCT01609556|455192631|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
126727297|NCT02720016|455951106|FG002|Overall Study|Moved away|0|||
126572569|NCT05061693|455391470|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
126572570|NCT05061693|455391471|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126572571|NCT05061693|455391472|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126572572|NCT05061693|455391473|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126572573|NCT05061693|455391474|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126572574|NCT05061693|455391475|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126572575|NCT05061693|455391476|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126572576|NCT05061693|455391477|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126572577|NCT05061693|455391478|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
126572578|NCT05061693|455391467|FG000|24-week Extension Period|Adverse Event|0|||
126572579|NCT05061693|455391468|FG001|24-week Extension Period|Adverse Event|0|||
126572580|NCT05061693|455391469|FG002|24-week Extension Period|Adverse Event|0|||
126572581|NCT05061693|455391470|FG003|24-week Extension Period|Adverse Event|0|||
126572582|NCT05061693|455391471|FG004|24-week Extension Period|Adverse Event|0|||
126572583|NCT05061693|455391472|FG005|24-week Extension Period|Adverse Event|0|||
126572584|NCT05061693|455391473|FG006|24-week Extension Period|Adverse Event|0|||
126572585|NCT05061693|455391474|FG007|24-week Extension Period|Adverse Event|2|||
126572586|NCT05061693|455391475|FG008|24-week Extension Period|Adverse Event|2|||
126572587|NCT05061693|455391476|FG009|24-week Extension Period|Adverse Event|0|||
126572588|NCT05061693|455391477|FG010|24-week Extension Period|Adverse Event|1|||
126572589|NCT05061693|455391478|FG011|24-week Extension Period|Adverse Event|3|||
126572590|NCT05061693|455391467|FG000|24-week Extension Period|Lack of Efficacy|0|||
126572591|NCT05061693|455391468|FG001|24-week Extension Period|Lack of Efficacy|0|||
126572592|NCT05061693|455391469|FG002|24-week Extension Period|Lack of Efficacy|0|||
126572593|NCT05061693|455391470|FG003|24-week Extension Period|Lack of Efficacy|0|||
126572594|NCT05061693|455391471|FG004|24-week Extension Period|Lack of Efficacy|0|||
126572595|NCT05061693|455391472|FG005|24-week Extension Period|Lack of Efficacy|0|||
126572596|NCT05061693|455391473|FG006|24-week Extension Period|Lack of Efficacy|0|||
126572597|NCT05061693|455391474|FG007|24-week Extension Period|Lack of Efficacy|0|||
126572598|NCT05061693|455391475|FG008|24-week Extension Period|Lack of Efficacy|0|||
126572599|NCT05061693|455391476|FG009|24-week Extension Period|Lack of Efficacy|0|||
126572600|NCT05061693|455391477|FG010|24-week Extension Period|Lack of Efficacy|2|||
126572601|NCT05061693|455391478|FG011|24-week Extension Period|Lack of Efficacy|0|||
126572602|NCT05061693|455391467|FG000|24-week Extension Period|Lost to Follow-up|0|||
126572603|NCT05061693|455391468|FG001|24-week Extension Period|Lost to Follow-up|0|||
126572604|NCT05061693|455391469|FG002|24-week Extension Period|Lost to Follow-up|0|||
126572605|NCT05061693|455391470|FG003|24-week Extension Period|Lost to Follow-up|0|||
126572606|NCT05061693|455391471|FG004|24-week Extension Period|Lost to Follow-up|0|||
126572607|NCT05061693|455391472|FG005|24-week Extension Period|Lost to Follow-up|0|||
126572608|NCT05061693|455391473|FG006|24-week Extension Period|Lost to Follow-up|1|||
126572609|NCT05061693|455391474|FG007|24-week Extension Period|Lost to Follow-up|0|||
126572610|NCT05061693|455391475|FG008|24-week Extension Period|Lost to Follow-up|1|||
126572611|NCT05061693|455391476|FG009|24-week Extension Period|Lost to Follow-up|1|||
126572612|NCT05061693|455391477|FG010|24-week Extension Period|Lost to Follow-up|0|||
126572613|NCT05061693|455391478|FG011|24-week Extension Period|Lost to Follow-up|0|||
126572614|NCT05061693|455391467|FG000|24-week Extension Period|Withdrawal by Subject|0|||
126572615|NCT05061693|455391468|FG001|24-week Extension Period|Withdrawal by Subject|0|||
126572616|NCT05061693|455391469|FG002|24-week Extension Period|Withdrawal by Subject|0|||
126572617|NCT05061693|455391470|FG003|24-week Extension Period|Withdrawal by Subject|0|||
126572618|NCT05061693|455391471|FG004|24-week Extension Period|Withdrawal by Subject|0|||
126572619|NCT05061693|455391472|FG005|24-week Extension Period|Withdrawal by Subject|0|||
126572620|NCT05061693|455391473|FG006|24-week Extension Period|Withdrawal by Subject|0|||
126572621|NCT05061693|455391474|FG007|24-week Extension Period|Withdrawal by Subject|0|||
126572622|NCT05061693|455391475|FG008|24-week Extension Period|Withdrawal by Subject|1|||
126572623|NCT05061693|455391476|FG009|24-week Extension Period|Withdrawal by Subject|2|||
126572624|NCT05061693|455391477|FG010|24-week Extension Period|Withdrawal by Subject|2|||
126572625|NCT05061693|455391478|FG011|24-week Extension Period|Withdrawal by Subject|1|||
126572626|NCT05061693|455391467|FG000|24-week Extension Period|Sponsor Decision|0|||
126572627|NCT05061693|455391468|FG001|24-week Extension Period|Sponsor Decision|0|||
126572628|NCT05061693|455391469|FG002|24-week Extension Period|Sponsor Decision|0|||
126572629|NCT05061693|455391470|FG003|24-week Extension Period|Sponsor Decision|0|||
126572630|NCT05061693|455391471|FG004|24-week Extension Period|Sponsor Decision|0|||
126572631|NCT05061693|455391472|FG005|24-week Extension Period|Sponsor Decision|0|||
126572632|NCT05061693|455391473|FG006|24-week Extension Period|Sponsor Decision|0|||
126572633|NCT05061693|455391474|FG007|24-week Extension Period|Sponsor Decision|1|||
126572634|NCT05061693|455391475|FG008|24-week Extension Period|Sponsor Decision|0|||
126572635|NCT05061693|455391476|FG009|24-week Extension Period|Sponsor Decision|0|||
126572636|NCT05061693|455391477|FG010|24-week Extension Period|Sponsor Decision|0|||
126572637|NCT05061693|455391478|FG011|24-week Extension Period|Sponsor Decision|0|||
126572638|NCT05061693|455391467|FG000|24-week Extension Period|Site Closure|0|||
126572639|NCT05061693|455391468|FG001|24-week Extension Period|Site Closure|0|||
126572640|NCT05061693|455391469|FG002|24-week Extension Period|Site Closure|0|||
126572641|NCT05061693|455391470|FG003|24-week Extension Period|Site Closure|0|||
126572642|NCT05061693|455391471|FG004|24-week Extension Period|Site Closure|0|||
126572643|NCT05061693|455391472|FG005|24-week Extension Period|Site Closure|0|||
126572644|NCT05061693|455391473|FG006|24-week Extension Period|Site Closure|0|||
126572645|NCT05061693|455391474|FG007|24-week Extension Period|Site Closure|0|||
126572646|NCT05061693|455391475|FG008|24-week Extension Period|Site Closure|1|||
126572647|NCT05061693|455391476|FG009|24-week Extension Period|Site Closure|0|||
126572648|NCT05061693|455391477|FG010|24-week Extension Period|Site Closure|0|||
126572649|NCT05061693|455391478|FG011|24-week Extension Period|Site Closure|1|||
126572650|NCT03823911|455391479|FG000|Overall Study|Lost to Follow-up|1|||
126572651|NCT03823911|455391480|FG001|Overall Study|Lost to Follow-up|5|||
126572652|NCT03823911|455391481|FG002|Overall Study|Lost to Follow-up|2|||
126572653|NCT03823911|455391479|FG000|Overall Study|Did not meet eligibility criteria|13|||
126572654|NCT03823911|455391480|FG001|Overall Study|Did not meet eligibility criteria|7|||
126572655|NCT03823911|455391481|FG002|Overall Study|Did not meet eligibility criteria|4|||
126572656|NCT03823911|455391479|FG000|Overall Study|Death|0|||
126572657|NCT03823911|455391480|FG001|Overall Study|Death|1|||
126572658|NCT03823911|455391481|FG002|Overall Study|Death|0|||
126572659|NCT01152190|455391482|FG000|Overall Study|Adverse Event|2|||
126572660|NCT01152190|455391483|FG001|Overall Study|Adverse Event|4|||
126572661|NCT01152190|455391482|FG000|Overall Study|Death|1|||
126572662|NCT01152190|455391483|FG001|Overall Study|Death|0|||
126572663|NCT01152190|455391482|FG000|Overall Study|Protocol Violation|1|||
126572664|NCT01152190|455391483|FG001|Overall Study|Protocol Violation|1|||
126572665|NCT01152190|455391482|FG000|Overall Study|Withdrawal by Subject|1|||
126572666|NCT01152190|455391483|FG001|Overall Study|Withdrawal by Subject|3|||
126572667|NCT00258895|455391484|FG000|Overall Study|Lost to Follow-up|3|||
126572668|NCT00258895|455391485|FG001|Overall Study|Lost to Follow-up|1|||
126572669|NCT00258895|455391484|FG000|Overall Study|Protocol Violation|6|||
126572670|NCT00258895|455391485|FG001|Overall Study|Protocol Violation|2|||
126572671|NCT00258895|455391484|FG000|Overall Study|Withdrawal by Subject|1|||
126572672|NCT00258895|455391485|FG001|Overall Study|Withdrawal by Subject|0|||
126572673|NCT04504916|455391487|FG000|Overall Study|Study terminated|7|||
126572674|NCT04504916|455391488|FG001|Overall Study|Study terminated|8|||
126572675|NCT04504916|455391487|FG000|Overall Study|Death|54|||
126572676|NCT04504916|455391488|FG001|Overall Study|Death|18|||
126572677|NCT04504916|455391487|FG000|Overall Study|Lost to Follow-up|1|||
126572678|NCT04504916|455391488|FG001|Overall Study|Lost to Follow-up|1|||
126572679|NCT04504916|455391487|FG000|Overall Study|Withdrawal by Subject|8|||
126572680|NCT04504916|455391488|FG001|Overall Study|Withdrawal by Subject|4|||
126572681|NCT04504916|455391487|FG000|Overall Study|Did not agree to follow-up|0|||
126572682|NCT04504916|455391488|FG001|Overall Study|Did not agree to follow-up|1|||
126572683|NCT00442117|455391489|FG000|Overall Study|Adverse Event|3|||
126572684|NCT00442117|455391490|FG001|Overall Study|Adverse Event|2|||
126572685|NCT00442117|455391489|FG000|Overall Study|Lack of Efficacy|2|||
126572686|NCT00442117|455391490|FG001|Overall Study|Lack of Efficacy|6|||
126572687|NCT00442117|455391489|FG000|Overall Study|Lost to Follow-up|1|||
126572688|NCT00442117|455391490|FG001|Overall Study|Lost to Follow-up|2|||
126572689|NCT00442117|455391489|FG000|Overall Study|Withdrawal by Subject|2|||
126572690|NCT00442117|455391490|FG001|Overall Study|Withdrawal by Subject|2|||
126572691|NCT00442117|455391489|FG000|Overall Study|Major Deviation|25|||
126572692|NCT00442117|455391490|FG001|Overall Study|Major Deviation|20|||
126572693|NCT00442117|455391489|FG000|Overall Study|Non compliance with protocol|3|||
126572694|NCT00442117|455391490|FG001|Overall Study|Non compliance with protocol|5|||
126572695|NCT00442117|455391489|FG000|Overall Study|Met Withdrawal Criteria|2|||
126572696|NCT00442117|455391490|FG001|Overall Study|Met Withdrawal Criteria|1|||
126572697|NCT01579916|455391503|FG000|Overall Study|Lost to Follow-up|6|||
126572698|NCT01579916|455391504|FG001|Overall Study|Lost to Follow-up|1|||
126572699|NCT01579916|455391503|FG000|Overall Study|Withdrawal by Subject|1|||
126572700|NCT01579916|455391504|FG001|Overall Study|Withdrawal by Subject|1|||
126572701|NCT01579916|455391503|FG000|Overall Study|Death|1|||
126572702|NCT01579916|455391504|FG001|Overall Study|Death|0|||
126572703|NCT01765543|455392526|FG000|Overall Study|Death|1|||
126572704|NCT01765543|455392526|FG000|Overall Study|Withdrawal by Subject|2|||
126572705|NCT01145885|455392527|FG000|Overall Study|Progressive Disease|7|||
126572706|NCT03691428|455392528|FG000|Overall Study|Withdrawal by Subject|6|||
126572707|NCT03691428|455392529|FG001|Overall Study|Withdrawal by Subject|8|||
126572708|NCT02527148|455392530|FG000|Overall Study|Did not receive study intervention|1|||
126572709|NCT02527148|455392531|FG001|Overall Study|Did not receive study intervention|0|||
126572710|NCT00666276|455392532|FG000|Overall Study|Protocol Violation|34|||
126572711|NCT04054635|455392540|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
126572712|NCT04054635|455392541|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
126572713|NCT04054635|455392542|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
126572714|NCT04054635|455392540|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
126572715|NCT04054635|455392541|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
126572716|NCT04054635|455392542|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
126572717|NCT00891930|455392543|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
126519037|NCT01609556|455192632|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
126519038|NCT01609556|455192633|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
126519039|NCT01609556|455192634|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
126519040|NCT01609556|455192635|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
126519041|NCT01609556|455192636|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
126519042|NCT01609556|455192637|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
126519043|NCT01609556|455192638|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
126519044|NCT01609556|455192639|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
126519045|NCT01609556|455192640|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
126519046|NCT01609556|455192641|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
126519047|NCT01609556|455192642|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
126519048|NCT01609556|455192643|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
126519049|NCT01609556|455192628|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519050|NCT01609556|455192629|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519051|NCT01609556|455192630|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519052|NCT01609556|455192631|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519053|NCT01609556|455192632|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519054|NCT01609556|455192633|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519055|NCT01609556|455192634|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519056|NCT01609556|455192635|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519057|NCT01609556|455192636|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519058|NCT01609556|455192637|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519059|NCT01609556|455192638|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519060|NCT01609556|455192639|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519061|NCT01609556|455192640|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
126519062|NCT01609556|455192641|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519063|NCT01609556|455192642|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519064|NCT01609556|455192643|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
126519065|NCT01609556|455192628|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126519066|NCT01609556|455192629|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126519067|NCT01609556|455192630|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126519068|NCT01609556|455192631|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126519069|NCT01609556|455192632|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126519070|NCT01609556|455192633|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126519071|NCT01609556|455192634|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126519072|NCT01609556|455192635|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126519073|NCT01609556|455192636|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126519074|NCT01609556|455192637|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126519075|NCT01609556|455192638|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126519076|NCT01609556|455192639|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
126519077|NCT01609556|455192640|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
126519078|NCT01609556|455192641|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
126519079|NCT01609556|455192642|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
126519080|NCT01609556|455192643|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
126519081|NCT01609556|455192628|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519082|NCT01609556|455192629|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519083|NCT01609556|455192630|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519084|NCT01609556|455192631|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519085|NCT01609556|455192632|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519086|NCT01609556|455192633|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519087|NCT01609556|455192634|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519088|NCT01609556|455192635|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519089|NCT01609556|455192636|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519090|NCT01609556|455192637|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519091|NCT01609556|455192638|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519092|NCT01609556|455192639|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519093|NCT01609556|455192640|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519094|NCT01609556|455192641|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519095|NCT01609556|455192642|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
126519096|NCT01609556|455192643|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
126519097|NCT01609556|455192628|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
126519098|NCT01609556|455192629|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
126519099|NCT01609556|455192630|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
126519100|NCT01609556|455192631|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
126572718|NCT00891930|455392543|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
126572719|NCT00891930|455392543|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
126572720|NCT00891930|455392543|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
126572721|NCT00891930|455392543|FG000|Part 2 Panitumumab + AMG479|Death|30|||
126572722|NCT00638963|455392544|FG000|Overall Study|Withdrawal by Subject|1|||
126572723|NCT00638963|455392545|FG001|Overall Study|Withdrawal by Subject|0|||
126572724|NCT05001945|455392554|FG000|Overall Study|Adverse Event|0|||
126572725|NCT05001945|455392555|FG001|Overall Study|Adverse Event|0|||
126572726|NCT05001945|455392556|FG002|Overall Study|Adverse Event|0|||
126572727|NCT05001945|455392557|FG003|Overall Study|Adverse Event|1|||
126572728|NCT05001945|455392558|FG004|Overall Study|Adverse Event|0|||
126572729|NCT05001945|455392559|FG005|Overall Study|Adverse Event|0|||
126572730|NCT05001945|455392560|FG006|Overall Study|Adverse Event|0|||
126572731|NCT05001945|455392561|FG007|Overall Study|Adverse Event|0|||
126572732|NCT05001945|455392554|FG000|Overall Study|Lost to Follow-up|0|||
126572733|NCT05001945|455392555|FG001|Overall Study|Lost to Follow-up|1|||
126572734|NCT05001945|455392556|FG002|Overall Study|Lost to Follow-up|1|||
126572735|NCT05001945|455392557|FG003|Overall Study|Lost to Follow-up|2|||
126572736|NCT05001945|455392558|FG004|Overall Study|Lost to Follow-up|0|||
126572737|NCT05001945|455392559|FG005|Overall Study|Lost to Follow-up|1|||
126572738|NCT05001945|455392560|FG006|Overall Study|Lost to Follow-up|0|||
126572739|NCT05001945|455392561|FG007|Overall Study|Lost to Follow-up|0|||
126572740|NCT05001945|455392554|FG000|Overall Study|Protocol Violation|1|||
126572741|NCT05001945|455392555|FG001|Overall Study|Protocol Violation|0|||
126572742|NCT05001945|455392556|FG002|Overall Study|Protocol Violation|1|||
126572743|NCT05001945|455392557|FG003|Overall Study|Protocol Violation|1|||
126572744|NCT05001945|455392558|FG004|Overall Study|Protocol Violation|0|||
126572745|NCT05001945|455392559|FG005|Overall Study|Protocol Violation|1|||
126572746|NCT05001945|455392560|FG006|Overall Study|Protocol Violation|0|||
126572747|NCT05001945|455392561|FG007|Overall Study|Protocol Violation|0|||
126572748|NCT05001945|455392554|FG000|Overall Study|Withdrawal by Subject|0|||
126572749|NCT05001945|455392555|FG001|Overall Study|Withdrawal by Subject|0|||
126572750|NCT05001945|455392556|FG002|Overall Study|Withdrawal by Subject|0|||
126572751|NCT05001945|455392557|FG003|Overall Study|Withdrawal by Subject|1|||
126572752|NCT05001945|455392558|FG004|Overall Study|Withdrawal by Subject|1|||
126572753|NCT05001945|455392559|FG005|Overall Study|Withdrawal by Subject|1|||
126572754|NCT05001945|455392560|FG006|Overall Study|Withdrawal by Subject|0|||
126572755|NCT05001945|455392561|FG007|Overall Study|Withdrawal by Subject|1|||
126572756|NCT05001945|455392554|FG000|Overall Study|Not specified by Investigator|0|||
126572757|NCT05001945|455392555|FG001|Overall Study|Not specified by Investigator|3|||
126572758|NCT05001945|455392556|FG002|Overall Study|Not specified by Investigator|0|||
126572759|NCT05001945|455392557|FG003|Overall Study|Not specified by Investigator|0|||
126572760|NCT05001945|455392558|FG004|Overall Study|Not specified by Investigator|1|||
126572761|NCT05001945|455392559|FG005|Overall Study|Not specified by Investigator|0|||
126572762|NCT05001945|455392560|FG006|Overall Study|Not specified by Investigator|0|||
126572763|NCT05001945|455392561|FG007|Overall Study|Not specified by Investigator|0|||
126572764|NCT02448446|455392562|FG000|Overall Study|Withdrawal by Subject|1|||
126572765|NCT02448446|455392563|FG001|Overall Study|Withdrawal by Subject|0|||
126572766|NCT02425111|455392564|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
126572767|NCT02425111|455392564|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
126572768|NCT02425111|455392564|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
126777023|NCT01789281|456139154|FG000|Overall Study|Administrative problems|0|||
126519101|NCT01609556|455192632|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
126519102|NCT01609556|455192633|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
126519103|NCT01609556|455192634|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
126519104|NCT01609556|455192635|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
126519105|NCT01609556|455192636|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
126519106|NCT01609556|455192637|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
126519107|NCT01609556|455192638|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
126519108|NCT01609556|455192639|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
126519109|NCT01609556|455192640|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
126572769|NCT02425111|455392564|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
126572770|NCT02425111|455392564|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
126572771|NCT02425111|455392564|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
126572772|NCT00545077|455392566|FG000|Overall Study|Treatment not received|5|||
126572773|NCT00545077|455392567|FG001|Overall Study|Treatment not received|1|||
126572774|NCT00545077|455392566|FG000|Overall Study|Disease Progression|131|||
126572775|NCT00545077|455392567|FG001|Overall Study|Disease Progression|98|||
126519110|NCT01609556|455192641|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
126519111|NCT01609556|455192642|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
126519112|NCT01609556|455192643|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
126519113|NCT01609556|455192628|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126572776|NCT00545077|455392566|FG000|Overall Study|Withdrawal by Subject|3|||
126572777|NCT00545077|455392567|FG001|Overall Study|Withdrawal by Subject|14|||
126572778|NCT00545077|455392566|FG000|Overall Study|Physician Decision|6|||
126572779|NCT00545077|455392567|FG001|Overall Study|Physician Decision|3|||
126777024|NCT01789281|456139155|FG001|Overall Study|Administrative problems|1|||
126572780|NCT00545077|455392566|FG000|Overall Study|Lost to Follow-up|2|||
126572781|NCT00545077|455392567|FG001|Overall Study|Lost to Follow-up|0|||
126572782|NCT00545077|455392566|FG000|Overall Study|Protocol Violation|1|||
126572783|NCT00545077|455392567|FG001|Overall Study|Protocol Violation|0|||
126572784|NCT00545077|455392566|FG000|Overall Study|Adverse Event|0|||
126572785|NCT00545077|455392567|FG001|Overall Study|Adverse Event|31|||
126572786|NCT00545077|455392566|FG000|Overall Study|Death|0|||
126572787|NCT00545077|455392567|FG001|Overall Study|Death|8|||
126572788|NCT02202499|455392568|FG000|Overall Study|Cancer diagnosis|0|||
126572789|NCT02202499|455392569|FG001|Overall Study|Cancer diagnosis|0|||
126572790|NCT02202499|455392570|FG002|Overall Study|Cancer diagnosis|1|||
126572791|NCT02202499|455392568|FG000|Overall Study|Moved from area|0|||
126572792|NCT02202499|455392569|FG001|Overall Study|Moved from area|0|||
126572793|NCT02202499|455392570|FG002|Overall Study|Moved from area|1|||
126572794|NCT02202499|455392568|FG000|Overall Study|Declined before randomization|1|||
126572795|NCT02202499|455392569|FG001|Overall Study|Declined before randomization|0|||
126572796|NCT02202499|455392570|FG002|Overall Study|Declined before randomization|0|||
126572797|NCT02202499|455392568|FG000|Overall Study|Auto accident|1|||
126572798|NCT02202499|455392569|FG001|Overall Study|Auto accident|0|||
126572799|NCT02202499|455392570|FG002|Overall Study|Auto accident|0|||
126572800|NCT00535145|455392571|FG000|Phase I|Adverse Event|3|||
126572801|NCT00535145|455392571|FG000|Phase I|Lost to Follow-up|7|||
126572802|NCT00535145|455392571|FG000|Phase I|Withdrawal by Subject|6|||
126572803|NCT00535145|455392571|FG000|Phase I|(eligibility)|8|||
126572804|NCT00535145|455392571|FG000|Phase I|(protocol violation)|1|||
126572805|NCT00535145|455392571|FG000|Phase I|(PI decision)|1|||
126572806|NCT00535145|455392571|FG000|Phase I|(diagnosis)|3|||
126572807|NCT00535145|455392571|FG000|Phase II|Adverse Event|2|||
126519114|NCT01609556|455192629|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519115|NCT01609556|455192630|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519116|NCT01609556|455192631|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519117|NCT01609556|455192632|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519118|NCT01609556|455192633|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519119|NCT01609556|455192634|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519120|NCT01609556|455192635|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519121|NCT01609556|455192636|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519122|NCT01609556|455192637|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519123|NCT01609556|455192638|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519124|NCT01609556|455192639|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519125|NCT01609556|455192640|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
126519126|NCT01609556|455192641|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519127|NCT01609556|455192642|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519128|NCT01609556|455192643|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
126519129|NCT02758236|455192644|FG000|Overall Study|Investigator discretion|43|||
126519130|NCT04452344|455192645|FG000|Overall Study|Withdrawal by Subject|3|||
126519131|NCT04452344|455192646|FG001|Overall Study|Withdrawal by Subject|6|||
126519132|NCT04452344|455192645|FG000|Overall Study|Adverse Event|1|||
126519133|NCT04452344|455192646|FG001|Overall Study|Adverse Event|2|||
126519134|NCT04452344|455192645|FG000|Overall Study|Lost to Follow-up|2|||
126519135|NCT04452344|455192646|FG001|Overall Study|Lost to Follow-up|2|||
126519136|NCT04452344|455192645|FG000|Overall Study|No Post-Op Visit|6|||
126519137|NCT04452344|455192646|FG001|Overall Study|No Post-Op Visit|7|||
126519138|NCT00023452|455192647|FG000|Overall Study|Ineligible for Study|163|||
126519139|NCT00023452|455192648|FG001|Overall Study|Ineligible for Study|159|||
126519140|NCT00023452|455192647|FG000|Overall Study|Out of Window|129|||
126519141|NCT00023452|455192648|FG001|Overall Study|Out of Window|69|||
126519142|NCT00023452|455192647|FG000|Overall Study|Death|2|||
126519143|NCT00023452|455192648|FG001|Overall Study|Death|0|||
126519144|NCT00023452|455192647|FG000|Overall Study|Withdrawal by Subject|66|||
126572808|NCT00535145|455392571|FG000|Phase II|Lack of Efficacy|1|||
126572809|NCT00535145|455392571|FG000|Phase II|Lost to Follow-up|5|||
126519145|NCT00023452|455192648|FG001|Overall Study|Withdrawal by Subject|54|||
126519146|NCT00023452|455192647|FG000|Overall Study|Adverse Event|139|||
126572810|NCT00535145|455392571|FG000|Phase II|Withdrawal by Subject|5|||
126572811|NCT00535145|455392571|FG000|Phase II|Subject non-compliance|2|||
126572812|NCT03260140|455392572|FG000|Overall Study|Death|4|||
126572813|NCT03260140|455392573|FG001|Overall Study|Death|1|||
126572814|NCT03260140|455392572|FG000|Overall Study|Withdrawal by Subject|1|||
126572815|NCT03260140|455392573|FG001|Overall Study|Withdrawal by Subject|4|||
126572816|NCT02423291|455392574|FG000|Overall Study|Lack of Efficacy|14|||
126519147|NCT00023452|455192648|FG001|Overall Study|Adverse Event|196|||
126519148|NCT00023452|455192647|FG000|Overall Study|Lost to Follow-up|293|||
126519149|NCT00023452|455192648|FG001|Overall Study|Lost to Follow-up|60|||
126519150|NCT00023452|455192647|FG000|Overall Study|Physician Decision|49|||
126572817|NCT02423291|455392574|FG000|Overall Study|Adverse Event|1|||
126572818|NCT05283395|455392576|FG000|Overall Study|Adverse Event|4|||
126572819|NCT05283395|455392577|FG001|Overall Study|Adverse Event|4|||
126572820|NCT05283395|455392578|FG002|Overall Study|Adverse Event|0|||
126572821|NCT05283395|455392576|FG000|Overall Study|Patient Lost to Follow-Up|0|||
126572822|NCT05283395|455392577|FG001|Overall Study|Patient Lost to Follow-Up|0|||
126572823|NCT05283395|455392578|FG002|Overall Study|Patient Lost to Follow-Up|1|||
126572824|NCT05283395|455392576|FG000|Overall Study|Patient Withdrawal|2|||
126572825|NCT05283395|455392577|FG001|Overall Study|Patient Withdrawal|4|||
126572826|NCT05283395|455392578|FG002|Overall Study|Patient Withdrawal|2|||
126572827|NCT05283395|455392576|FG000|Overall Study|Investigator Decision|1|||
126572828|NCT05283395|455392577|FG001|Overall Study|Investigator Decision|0|||
126572829|NCT05283395|455392578|FG002|Overall Study|Investigator Decision|1|||
126572830|NCT05283395|455392576|FG000|Overall Study|Enrolled in error|0|||
126572831|NCT05283395|455392577|FG001|Overall Study|Enrolled in error|0|||
126572832|NCT05283395|455392578|FG002|Overall Study|Enrolled in error|1|||
126519151|NCT00023452|455192648|FG001|Overall Study|Physician Decision|21|||
126519152|NCT00023452|455192647|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
126519153|NCT00023452|455192648|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
126519154|NCT00023452|455192647|FG000|Overall Study|Pregnant|53|||
126519155|NCT00023452|455192648|FG001|Overall Study|Pregnant|20|||
126519156|NCT00023452|455192647|FG000|Overall Study|Other|204|||
126519157|NCT00023452|455192648|FG001|Overall Study|Other|69|||
126519158|NCT05789875|455192649|FG000|Overall Study|Lost to Follow-up|6|||
126519159|NCT01994395|455192650|FG000|Overall Study|Withdrawal by Subject|1|||
126519160|NCT01994395|455192651|FG001|Overall Study|Withdrawal by Subject|2|||
126519161|NCT01940705|455192653|FG000|Overall Study|Lost to Follow-up|1|||
126519162|NCT01940705|455192654|FG001|Overall Study|Lost to Follow-up|3|||
126519163|NCT01940705|455192655|FG002|Overall Study|Lost to Follow-up|2|||
126519164|NCT01940705|455192656|FG003|Overall Study|Lost to Follow-up|2|||
126519165|NCT01940705|455192653|FG000|Overall Study|Withdrawal by Subject|2|||
126519166|NCT01940705|455192654|FG001|Overall Study|Withdrawal by Subject|2|||
126519167|NCT01940705|455192655|FG002|Overall Study|Withdrawal by Subject|3|||
126519168|NCT01940705|455192656|FG003|Overall Study|Withdrawal by Subject|2|||
126519169|NCT01940705|455192653|FG000|Overall Study|Intervention not given|0|||
126519170|NCT01940705|455192654|FG001|Overall Study|Intervention not given|3|||
126519171|NCT01940705|455192655|FG002|Overall Study|Intervention not given|3|||
126519172|NCT01940705|455192656|FG003|Overall Study|Intervention not given|0|||
126519173|NCT01940705|455192653|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
126519174|NCT01940705|455192654|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
126519175|NCT01940705|455192655|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
126519176|NCT01940705|455192656|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
126519177|NCT01632579|455192659|FG000|Washout Period|Adverse Event|1|||
126519178|NCT01632579|455192660|FG001|Washout Period|Adverse Event|0|||
126519179|NCT01632579|455192661|FG002|Washout Period|Adverse Event|0|||
126519180|NCT01632579|455192662|FG003|Washout Period|Adverse Event|0|||
126519181|NCT01632579|455192663|FG004|Washout Period|Adverse Event|0|||
126519182|NCT01632579|455192664|FG005|Washout Period|Adverse Event|0|||
126519183|NCT01632579|455192665|FG006|Washout Period|Adverse Event|0|||
126519184|NCT01632579|455192666|FG007|Washout Period|Adverse Event|0|||
126519185|NCT01632579|455192667|FG008|Washout Period|Adverse Event|0|||
126519186|NCT01632579|455192659|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
126519187|NCT01632579|455192660|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
126519188|NCT01632579|455192661|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
126519189|NCT01632579|455192662|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
126519190|NCT01632579|455192663|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
126519191|NCT01632579|455192664|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
126519192|NCT01632579|455192665|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
126572833|NCT00712335|455392582|FG000|Overall Study|Withdrawal by Subject|0|||
126572834|NCT00712335|455392583|FG001|Overall Study|Withdrawal by Subject|7|||
126519193|NCT01632579|455192666|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
126519194|NCT01632579|455192667|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
126519195|NCT00818441|455192668|FG000|Overall Study|Death|69|||
126519196|NCT00818441|455192669|FG001|Overall Study|Death|26|||
126519197|NCT00818441|455192668|FG000|Overall Study|Other|5|||
126572835|NCT00712335|455392584|FG002|Overall Study|Withdrawal by Subject|2|||
126572836|NCT00712335|455392585|FG003|Overall Study|Withdrawal by Subject|3|||
126519198|NCT00818441|455192669|FG001|Overall Study|Other|0|||
126519199|NCT00818441|455192668|FG000|Overall Study|Lost to Follow-up|2|||
126519200|NCT00818441|455192669|FG001|Overall Study|Lost to Follow-up|1|||
126519201|NCT00818441|455192668|FG000|Overall Study|Withdrawal by Subject|2|||
126519202|NCT00818441|455192669|FG001|Overall Study|Withdrawal by Subject|0|||
126519203|NCT00818441|455192668|FG000|Overall Study|Adverse Event|0|||
126519204|NCT00818441|455192669|FG001|Overall Study|Adverse Event|1|||
126519205|NCT00818441|455192668|FG000|Overall Study|Study terminated by sponsor|11|||
126572837|NCT00712335|455392586|FG004|Overall Study|Withdrawal by Subject|0|||
126519206|NCT00818441|455192669|FG001|Overall Study|Study terminated by sponsor|2|||
126519207|NCT04095858|455192670|FG000|Overall Study|Death|1|||
126519208|NCT04095858|455192671|FG001|Overall Study|Death|0|||
126519209|NCT04095858|455192670|FG000|Overall Study|Study terminated by Sponsor|2|||
126572838|NCT00712335|455392582|FG000|Overall Study|Lost to Follow-up|2|||
126572839|NCT00712335|455392583|FG001|Overall Study|Lost to Follow-up|5|||
126572840|NCT00712335|455392584|FG002|Overall Study|Lost to Follow-up|0|||
126572841|NCT00712335|455392585|FG003|Overall Study|Lost to Follow-up|1|||
126572842|NCT00712335|455392586|FG004|Overall Study|Lost to Follow-up|0|||
126572843|NCT00712335|455392582|FG000|Overall Study|Protocol Violation|1|||
126572844|NCT00712335|455392583|FG001|Overall Study|Protocol Violation|2|||
126572845|NCT00712335|455392584|FG002|Overall Study|Protocol Violation|1|||
126572846|NCT00712335|455392585|FG003|Overall Study|Protocol Violation|0|||
126572847|NCT00712335|455392586|FG004|Overall Study|Protocol Violation|0|||
126572848|NCT00712335|455392582|FG000|Overall Study|Lack of Efficacy|0|||
126572849|NCT00712335|455392583|FG001|Overall Study|Lack of Efficacy|0|||
126572850|NCT00712335|455392584|FG002|Overall Study|Lack of Efficacy|1|||
126572851|NCT00712335|455392585|FG003|Overall Study|Lack of Efficacy|1|||
126572852|NCT00712335|455392586|FG004|Overall Study|Lack of Efficacy|0|||
126572853|NCT00712335|455392582|FG000|Overall Study|Other Reason|0|||
126572854|NCT00712335|455392583|FG001|Overall Study|Other Reason|3|||
126572855|NCT00712335|455392584|FG002|Overall Study|Other Reason|1|||
126572856|NCT00712335|455392585|FG003|Overall Study|Other Reason|0|||
126572857|NCT00712335|455392586|FG004|Overall Study|Other Reason|0|||
126572858|NCT03401112|455392588|FG000|Overall Study|Adverse Event|1|||
126572859|NCT03401112|455392589|FG001|Overall Study|Adverse Event|2|||
126572860|NCT03401112|455392590|FG002|Overall Study|Adverse Event|3|||
126572861|NCT03401112|455392591|FG003|Overall Study|Adverse Event|2|||
126572862|NCT03401112|455392592|FG004|Overall Study|Adverse Event|0|||
126572863|NCT03401112|455392588|FG000|Overall Study|Lost to Follow-up|1|||
126572864|NCT03401112|455392589|FG001|Overall Study|Lost to Follow-up|0|||
126572865|NCT03401112|455392590|FG002|Overall Study|Lost to Follow-up|0|||
126572866|NCT03401112|455392591|FG003|Overall Study|Lost to Follow-up|0|||
126572867|NCT03401112|455392592|FG004|Overall Study|Lost to Follow-up|0|||
126572868|NCT03401112|455392588|FG000|Overall Study|Noncompliance|1|||
126572869|NCT03401112|455392589|FG001|Overall Study|Noncompliance|2|||
126572870|NCT03401112|455392590|FG002|Overall Study|Noncompliance|3|||
126572871|NCT03401112|455392591|FG003|Overall Study|Noncompliance|0|||
126572872|NCT03401112|455392592|FG004|Overall Study|Noncompliance|0|||
126572873|NCT03401112|455392588|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
126572874|NCT03401112|455392589|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
126572875|NCT03401112|455392590|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
126572876|NCT03401112|455392591|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
126572877|NCT03401112|455392592|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
126572878|NCT03401112|455392588|FG000|Overall Study|Withdrawal by Subject|0|||
126572879|NCT03401112|455392589|FG001|Overall Study|Withdrawal by Subject|3|||
126572880|NCT03401112|455392590|FG002|Overall Study|Withdrawal by Subject|2|||
126519210|NCT04095858|455192671|FG001|Overall Study|Study terminated by Sponsor|4|||
126519211|NCT01043874|455193923|FG000|Overall Study|Adverse Event|3|||
126519212|NCT01043874|455193923|FG000|Overall Study|Withdrawal by Subject|1|||
126519213|NCT01043874|455193923|FG000|Overall Study|Lack of Efficacy|1|||
126519214|NCT01043874|455193923|FG000|Overall Study|Administrative Problems|1|||
126519215|NCT00182689|455193929|FG000|Overall Study|Adverse Event|8|||
126519216|NCT00182689|455193930|FG001|Overall Study|Adverse Event|11|||
126519217|NCT00182689|455193929|FG000|Overall Study|Withdrawal by Subject|2|||
126519218|NCT00182689|455193930|FG001|Overall Study|Withdrawal by Subject|2|||
126519219|NCT00182689|455193929|FG000|Overall Study|Progression|27|||
126519220|NCT00182689|455193930|FG001|Overall Study|Progression|29|||
126519221|NCT00182689|455193929|FG000|Overall Study|Death|1|||
126519222|NCT00182689|455193930|FG001|Overall Study|Death|0|||
126572881|NCT03401112|455392591|FG003|Overall Study|Withdrawal by Subject|1|||
126572882|NCT03401112|455392592|FG004|Overall Study|Withdrawal by Subject|0|||
126572883|NCT03401112|455392588|FG000|Overall Study|Physician Decision|0|||
126572884|NCT03401112|455392589|FG001|Overall Study|Physician Decision|0|||
126572885|NCT03401112|455392590|FG002|Overall Study|Physician Decision|0|||
126572886|NCT03401112|455392591|FG003|Overall Study|Physician Decision|2|||
126572887|NCT03401112|455392592|FG004|Overall Study|Physician Decision|0|||
126572888|NCT03401112|455392588|FG000|Overall Study|Study was Terminated by Sponsor|0|||
126572889|NCT03401112|455392589|FG001|Overall Study|Study was Terminated by Sponsor|0|||
126572890|NCT03401112|455392590|FG002|Overall Study|Study was Terminated by Sponsor|0|||
126572891|NCT03401112|455392591|FG003|Overall Study|Study was Terminated by Sponsor|1|||
126572892|NCT03401112|455392592|FG004|Overall Study|Study was Terminated by Sponsor|0|||
126572893|NCT03401112|455392588|FG000|Overall Study|Day 1 Assessment not Done|1|||
126572894|NCT03401112|455392589|FG001|Overall Study|Day 1 Assessment not Done|0|||
126572895|NCT03401112|455392590|FG002|Overall Study|Day 1 Assessment not Done|0|||
126519223|NCT00182689|455193929|FG000|Overall Study|not protocol specified|0|||
126572896|NCT03401112|455392591|FG003|Overall Study|Day 1 Assessment not Done|0|||
126572897|NCT03401112|455392592|FG004|Overall Study|Day 1 Assessment not Done|0|||
126519224|NCT00182689|455193930|FG001|Overall Study|not protocol specified|3|||
126519225|NCT00182689|455193929|FG000|Overall Study|Ineligible|1|||
126519226|NCT00182689|455193930|FG001|Overall Study|Ineligible|4|||
126572898|NCT03401112|455392588|FG000|Overall Study|Not Dosed|0|||
126519227|NCT00182689|455193929|FG000|Overall Study|Never received treatment|1|||
126519228|NCT00182689|455193930|FG001|Overall Study|Never received treatment|0|||
126519229|NCT03422003|455193931|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
126519230|NCT03422003|455193932|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
126519231|NCT03422003|455193931|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
126519232|NCT03422003|455193932|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
126519233|NCT01337089|455193933|FG000|Overall Study|Adverse Event|237|||
126519234|NCT01337089|455193933|FG000|Overall Study|Withdrawal by Subject|129|||
126519235|NCT01337089|455193933|FG000|Overall Study|Withdrawal by Investigator|33|||
126519236|NCT01337089|455193933|FG000|Overall Study|Met Withdrawal Criteria|3|||
126519237|NCT01337089|455193933|FG000|Overall Study|Lost to Follow-up|2|||
126519238|NCT01040871|455193938|FG000|Overall Study|Adverse Event|6|||
126519239|NCT01040871|455193939|FG001|Overall Study|Adverse Event|2|||
126519240|NCT01040871|455193938|FG000|Overall Study|Withdrawal by Subject|2|||
126519241|NCT01040871|455193939|FG001|Overall Study|Withdrawal by Subject|0|||
126519242|NCT01040871|455193938|FG000|Overall Study|Death|1|||
126519243|NCT01040871|455193939|FG001|Overall Study|Death|3|||
126519244|NCT01040871|455193938|FG000|Overall Study|Lack of Efficacy|1|||
126519245|NCT01040871|455193939|FG001|Overall Study|Lack of Efficacy|1|||
126519246|NCT01040871|455193938|FG000|Overall Study|drug supply issue|1|||
126519247|NCT01040871|455193939|FG001|Overall Study|drug supply issue|0|||
126519248|NCT01040871|455193938|FG000|Overall Study|Randomized and Not Treated|2|||
126519249|NCT01040871|455193939|FG001|Overall Study|Randomized and Not Treated|1|||
126519250|NCT02696850|455193944|FG000|Overall Study|Withdrawal by Subject|3|||
126519251|NCT02696850|455193945|FG001|Overall Study|Withdrawal by Subject|3|||
126519252|NCT02696850|455193944|FG000|Overall Study|Lost to Follow-up|8|||
126519253|NCT02696850|455193945|FG001|Overall Study|Lost to Follow-up|5|||
126519254|NCT00673049|455193946|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
126519255|NCT00673049|455193947|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
126519256|NCT00673049|455193948|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
126519257|NCT00673049|455193949|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
126519258|NCT00673049|455193946|FG000|Before Progression on Erlotinib|Death|235|||
126519259|NCT00673049|455193947|FG001|Before Progression on Erlotinib|Death|167|||
126519260|NCT00673049|455193948|FG002|Before Progression on Erlotinib|Death|1|||
126519261|NCT00673049|455193949|FG003|Before Progression on Erlotinib|Death|0|||
126519262|NCT00673049|455193946|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
126519263|NCT00673049|455193947|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
126519264|NCT00673049|455193948|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
126519265|NCT00673049|455193949|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
126519266|NCT00673049|455193946|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
126519267|NCT00673049|455193947|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
126519268|NCT00673049|455193948|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
126519269|NCT00673049|455193949|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
126519270|NCT00673049|455193946|FG000|Before Progression on Erlotinib|Other|1|||
126519271|NCT00673049|455193947|FG001|Before Progression on Erlotinib|Other|2|||
126519272|NCT00673049|455193948|FG002|Before Progression on Erlotinib|Other|0|||
126519273|NCT00673049|455193949|FG003|Before Progression on Erlotinib|Other|0|||
126519274|NCT00673049|455193946|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
126519275|NCT00673049|455193947|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
126519276|NCT00673049|455193948|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
126519277|NCT00673049|455193949|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
126519278|NCT00673049|455193946|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
126519279|NCT00673049|455193947|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
126519280|NCT00673049|455193948|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
126519281|NCT00673049|455193949|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
126519282|NCT00673049|455193946|FG000|After Progression on Erlotinib|Death|0|||
126519283|NCT00673049|455193947|FG001|After Progression on Erlotinib|Death|0|||
126519284|NCT00673049|455193948|FG002|After Progression on Erlotinib|Death|0|||
126519285|NCT00673049|455193949|FG003|After Progression on Erlotinib|Death|71|||
126519286|NCT00673049|455193946|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
126519287|NCT00673049|455193947|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
126519288|NCT00673049|455193948|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
126519289|NCT00673049|455193949|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
126519290|NCT00673049|455193946|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
126519291|NCT00673049|455193947|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
126519292|NCT00673049|455193948|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
126519293|NCT00673049|455193949|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
126572899|NCT03401112|455392589|FG001|Overall Study|Not Dosed|0|||
126519294|NCT00673049|455193946|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
126572900|NCT03401112|455392590|FG002|Overall Study|Not Dosed|1|||
126572901|NCT03401112|455392591|FG003|Overall Study|Not Dosed|0|||
126519295|NCT00673049|455193947|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
126519296|NCT00673049|455193948|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
126519297|NCT00673049|455193949|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
126519298|NCT00924950|455193950|FG000|Overall Study|Lost to Follow-up|2|||
126519299|NCT04193202|455193951|FG000|Overall Study|Adverse Event|2|||
126519300|NCT04193202|455193952|FG001|Overall Study|Adverse Event|1|||
126519301|NCT04193202|455193951|FG000|Overall Study|Death|0|||
126519302|NCT04193202|455193952|FG001|Overall Study|Death|1|||
126519303|NCT04193202|455193951|FG000|Overall Study|Physician Decision|1|||
126519304|NCT04193202|455193952|FG001|Overall Study|Physician Decision|1|||
126519305|NCT04193202|455193951|FG000|Overall Study|Protocol Violation|2|||
126519306|NCT04193202|455193952|FG001|Overall Study|Protocol Violation|2|||
126519307|NCT04193202|455193951|FG000|Overall Study|Withdrawal by Subject|11|||
126519308|NCT04193202|455193952|FG001|Overall Study|Withdrawal by Subject|5|||
126519309|NCT02979535|455193953|FG000|Overall Study|Non compliance with the protocol|78|||
126519310|NCT02979535|455193954|FG001|Overall Study|Non compliance with the protocol|82|||
126519311|NCT02979535|455193953|FG000|Overall Study|Consent withdrawn by participant|11|||
126519312|NCT02979535|455193954|FG001|Overall Study|Consent withdrawn by participant|18|||
126519313|NCT02979535|455193953|FG000|Overall Study|Lost to Follow-up|6|||
126519314|NCT02979535|455193954|FG001|Overall Study|Lost to Follow-up|1|||
126519315|NCT04820673|455193955|FG000|Overall Study|Adverse Event|6|||
126519316|NCT04820673|455193955|FG000|Overall Study|Due to Lack of Effectiveness|1|||
126519317|NCT04820673|455193955|FG000|Overall Study|Pregnancy|1|||
126519318|NCT04820673|455193955|FG000|Overall Study|Voluntary Withdrawal|20|||
126519319|NCT04820673|455193955|FG000|Overall Study|Lost to Follow-up|10|||
126519320|NCT00587587|455193958|FG000|Overall Study|Lost to Follow-up|6|||
126519321|NCT00587587|455193959|FG001|Overall Study|Lost to Follow-up|1|||
126519322|NCT00767000|455193963|FG000|54-week Study|Adverse Event|4|||
126519323|NCT00767000|455193964|FG001|54-week Study|Adverse Event|6|||
126519324|NCT00767000|455193965|FG002|54-week Study|Adverse Event|6|||
126519325|NCT00767000|455193966|FG003|54-week Study|Adverse Event|8|||
126519326|NCT00767000|455193967|FG004|54-week Study|Adverse Event|4|||
126519327|NCT00767000|455193963|FG000|54-week Study|Creaninine/creatinine clearance|2|||
126519328|NCT00767000|455193964|FG001|54-week Study|Creaninine/creatinine clearance|1|||
126519329|NCT00767000|455193965|FG002|54-week Study|Creaninine/creatinine clearance|2|||
126519330|NCT00767000|455193966|FG003|54-week Study|Creaninine/creatinine clearance|2|||
126519331|NCT00767000|455193967|FG004|54-week Study|Creaninine/creatinine clearance|4|||
126519332|NCT00767000|455193963|FG000|54-week Study|Hyperglycemia|0|||
126572902|NCT03401112|455392592|FG004|Overall Study|Not Dosed|0|||
126572903|NCT03401112|455392588|FG000|Overall Study|Missed Clinical Visit|0|||
126572904|NCT03401112|455392589|FG001|Overall Study|Missed Clinical Visit|0|||
126572905|NCT03401112|455392590|FG002|Overall Study|Missed Clinical Visit|1|||
126572906|NCT03401112|455392591|FG003|Overall Study|Missed Clinical Visit|0|||
126572907|NCT03401112|455392592|FG004|Overall Study|Missed Clinical Visit|0|||
126572908|NCT03401112|455392588|FG000|Overall Study|Missed Doses|0|||
126572909|NCT03401112|455392589|FG001|Overall Study|Missed Doses|0|||
126572910|NCT03401112|455392590|FG002|Overall Study|Missed Doses|1|||
126572911|NCT03401112|455392591|FG003|Overall Study|Missed Doses|0|||
126572912|NCT03401112|455392592|FG004|Overall Study|Missed Doses|0|||
126572913|NCT01202955|455392593|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
126572914|NCT01202955|455392594|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
126572915|NCT02115139|455392595|FG000|Overall Study|Protocol Violation|1|||
126572916|NCT02115139|455392595|FG000|Overall Study|treatment discontinuation|6|||
126572917|NCT01909778|455392596|FG000|Overall Study|failed screening|1|||
126572918|NCT02471755|455392598|FG000|Overall Study|Withdrawal by Subject|1|||
126572919|NCT02471755|455392599|FG001|Overall Study|Withdrawal by Subject|0|||
126572920|NCT02471755|455392598|FG000|Overall Study|Lost to Follow-up|0|||
126572921|NCT02471755|455392599|FG001|Overall Study|Lost to Follow-up|1|||
126572922|NCT04740164|455392600|FG000|Overall Study|Lack of Efficacy|4|||
126572923|NCT04740164|455392601|FG001|Overall Study|Lack of Efficacy|0|||
126572924|NCT04740164|455392600|FG000|Overall Study|Physician Decision|3|||
126572925|NCT04740164|455392601|FG001|Overall Study|Physician Decision|3|||
126519333|NCT00767000|455193964|FG001|54-week Study|Hyperglycemia|0|||
126519334|NCT00767000|455193965|FG002|54-week Study|Hyperglycemia|1|||
126519335|NCT00767000|455193966|FG003|54-week Study|Hyperglycemia|0|||
126519336|NCT00767000|455193967|FG004|54-week Study|Hyperglycemia|1|||
126519337|NCT00767000|455193963|FG000|54-week Study|Hypoglycemia|0|||
126572926|NCT04177394|455392602|FG000|Overall Study|Death|16|||
126572927|NCT04177394|455392602|FG000|Overall Study|Withdrawal by Subject|19|||
126572928|NCT04177394|455392602|FG000|Overall Study|Missed visits|61|||
126519338|NCT00767000|455193964|FG001|54-week Study|Hypoglycemia|1|||
126519339|NCT00767000|455193965|FG002|54-week Study|Hypoglycemia|0|||
126519340|NCT00767000|455193966|FG003|54-week Study|Hypoglycemia|0|||
126519341|NCT00767000|455193967|FG004|54-week Study|Hypoglycemia|0|||
126519342|NCT00767000|455193963|FG000|54-week Study|Interruption of study medication|0|||
126519343|NCT00767000|455193964|FG001|54-week Study|Interruption of study medication|0|||
126519344|NCT00767000|455193965|FG002|54-week Study|Interruption of study medication|1|||
126572929|NCT04177394|455392602|FG000|Overall Study|Expected Visits|15|||
126572930|NCT02248480|455392603|FG000|Overall Study|Lack of Efficacy|4|||
126572931|NCT02248480|455392604|FG001|Overall Study|Lack of Efficacy|6|||
126572932|NCT02248480|455392603|FG000|Overall Study|Adverse Event|11|||
126572933|NCT02248480|455392604|FG001|Overall Study|Adverse Event|2|||
126572934|NCT02248480|455392603|FG000|Overall Study|Withdrawal by Subject|2|||
126572935|NCT02248480|455392604|FG001|Overall Study|Withdrawal by Subject|4|||
126572936|NCT02248480|455392603|FG000|Overall Study|Entry Criteria Not Met|0|||
126572937|NCT02248480|455392604|FG001|Overall Study|Entry Criteria Not Met|1|||
126572938|NCT02248480|455392603|FG000|Overall Study|Other:Physician Decision|0|||
126572939|NCT02248480|455392604|FG001|Overall Study|Other:Physician Decision|1|||
126572940|NCT01595321|455392605|FG000|Overall Study|Adverse Event|1|||
126572941|NCT01595321|455392606|FG001|Overall Study|Adverse Event|1|||
126572942|NCT01595321|455392607|FG002|Overall Study|Adverse Event|1|||
126572943|NCT01595321|455392605|FG000|Overall Study|Lack of Efficacy|0|||
126572944|NCT01595321|455392606|FG001|Overall Study|Lack of Efficacy|0|||
126572945|NCT01595321|455392607|FG002|Overall Study|Lack of Efficacy|4|||
126572946|NCT00373529|455392608|FG000|Overall Study|Physician Decision|19|||
126572947|NCT00373529|455392608|FG000|Overall Study|Withdrawal by Subject|7|||
126572948|NCT00373529|455392608|FG000|Overall Study|Adverse Event|7|||
126572949|NCT00373529|455392608|FG000|Overall Study|Treatment failure|36|||
126572950|NCT00373529|455392608|FG000|Overall Study|Disease recurrence|10|||
126572951|NCT00373529|455392608|FG000|Overall Study|Death|16|||
126572952|NCT00373529|455392608|FG000|Overall Study|Need for treatment prohibited by study|1|||
126572953|NCT00373529|455392608|FG000|Overall Study|Other|8|||
126572954|NCT00373529|455392608|FG000|Overall Study|Failed independent confirmation of AML|3|||
126572955|NCT00373529|455392608|FG000|Overall Study|Consent violation|1|||
126572956|NCT00630786|455392609|FG000|Overall Study|Physician Decision|0|||
126572957|NCT00630786|455392610|FG001|Overall Study|Physician Decision|0|||
126572958|NCT00630786|455392611|FG002|Overall Study|Physician Decision|1|||
126572959|NCT00630786|455392609|FG000|Overall Study|Withdrawal by Subject|0|||
126572960|NCT00630786|455392610|FG001|Overall Study|Withdrawal by Subject|1|||
126572961|NCT00630786|455392611|FG002|Overall Study|Withdrawal by Subject|1|||
126572962|NCT00630786|455392609|FG000|Overall Study|Lost to Follow-up|0|||
126572963|NCT00630786|455392610|FG001|Overall Study|Lost to Follow-up|1|||
126572964|NCT00630786|455392611|FG002|Overall Study|Lost to Follow-up|0|||
126572965|NCT00630786|455392609|FG000|Overall Study|Other|1|||
126572966|NCT00630786|455392610|FG001|Overall Study|Other|0|||
126572967|NCT00630786|455392611|FG002|Overall Study|Other|0|||
126572968|NCT04009577|455392612|FG000|Core Study|Adverse Event|1|||
126572969|NCT04009577|455392613|FG001|Core Study|Adverse Event|0|||
126572970|NCT04009577|455392614|FG002|Core Study|Adverse Event|2|||
126572971|NCT04009577|455392615|FG003|Core Study|Adverse Event|4|||
126572972|NCT04009577|455392612|FG000|Core Study|Withdrawal by Subject|0|||
126572973|NCT04009577|455392613|FG001|Core Study|Withdrawal by Subject|0|||
126572974|NCT04009577|455392614|FG002|Core Study|Withdrawal by Subject|2|||
126572975|NCT04009577|455392615|FG003|Core Study|Withdrawal by Subject|0|||
126572976|NCT04009577|455392612|FG000|Core Study|Other|0|||
126572977|NCT04009577|455392613|FG001|Core Study|Other|0|||
126572978|NCT04009577|455392614|FG002|Core Study|Other|0|||
126572979|NCT04009577|455392615|FG003|Core Study|Other|1|||
126572980|NCT04009577|455392612|FG000|Extension Phase|Adverse Event|0|||
126572981|NCT04009577|455392613|FG001|Extension Phase|Adverse Event|0|||
126572982|NCT04009577|455392614|FG002|Extension Phase|Adverse Event|0|||
126572983|NCT04009577|455392615|FG003|Extension Phase|Adverse Event|1|||
126572984|NCT04009577|455392612|FG000|Extension Phase|Inadequate therapeutic effect|0|||
126572985|NCT04009577|455392613|FG001|Extension Phase|Inadequate therapeutic effect|0|||
126572986|NCT04009577|455392614|FG002|Extension Phase|Inadequate therapeutic effect|1|||
126572987|NCT04009577|455392615|FG003|Extension Phase|Inadequate therapeutic effect|0|||
126572988|NCT04009577|455392612|FG000|Extension Phase|Withdrawal by Subject|0|||
126572989|NCT04009577|455392613|FG001|Extension Phase|Withdrawal by Subject|0|||
126572990|NCT04009577|455392614|FG002|Extension Phase|Withdrawal by Subject|1|||
126572991|NCT04009577|455392615|FG003|Extension Phase|Withdrawal by Subject|0|||
126572992|NCT04009577|455392612|FG000|Extension Phase|Not Treated|0|||
126572993|NCT04009577|455392613|FG001|Extension Phase|Not Treated|0|||
126572994|NCT04009577|455392614|FG002|Extension Phase|Not Treated|2|||
126572995|NCT04009577|455392615|FG003|Extension Phase|Not Treated|0|||
126572996|NCT00732381|455392618|FG000|Overall Study|Adverse Event|1|||
126572997|NCT00732381|455392619|FG001|Overall Study|Adverse Event|0|||
126572998|NCT00732381|455392618|FG000|Overall Study|Treatment Failure|1|||
126572999|NCT00732381|455392619|FG001|Overall Study|Treatment Failure|1|||
126573000|NCT02999477|455392622|FG000|Overall Study|found ineligible after first dose|0|||
126573001|NCT02999477|455392623|FG001|Overall Study|found ineligible after first dose|1|||
126573002|NCT02999477|455392622|FG000|Overall Study|Withdrawal by Subject|1|||
126573003|NCT02999477|455392623|FG001|Overall Study|Withdrawal by Subject|1|||
126573004|NCT00573833|455392624|FG000|Overall Study|Not Treated|2|||
126573005|NCT04668339|455394304|FG000|Overall Study|Physician Decision|1|||
126573006|NCT04668339|455394305|FG001|Overall Study|Physician Decision|0|||
126573007|NCT04668339|455394306|FG002|Overall Study|Physician Decision|1|||
126573008|NCT04668339|455394307|FG003|Overall Study|Physician Decision|1|||
126573009|NCT04668339|455394304|FG000|Overall Study|Lost to Follow-up|14|||
126573010|NCT04668339|455394305|FG001|Overall Study|Lost to Follow-up|12|||
126573011|NCT04668339|455394306|FG002|Overall Study|Lost to Follow-up|8|||
126573012|NCT04668339|455394307|FG003|Overall Study|Lost to Follow-up|5|||
126573013|NCT04668339|455394304|FG000|Overall Study|Adverse Event|0|||
126573014|NCT04668339|455394305|FG001|Overall Study|Adverse Event|0|||
126573015|NCT04668339|455394306|FG002|Overall Study|Adverse Event|1|||
126573016|NCT04668339|455394307|FG003|Overall Study|Adverse Event|0|||
126573017|NCT04668339|455394304|FG000|Overall Study|Other than specified|3|||
126573018|NCT04668339|455394305|FG001|Overall Study|Other than specified|0|||
126573019|NCT04668339|455394306|FG002|Overall Study|Other than specified|1|||
126573020|NCT04668339|455394307|FG003|Overall Study|Other than specified|0|||
126573021|NCT04668339|455394304|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
126573022|NCT04668339|455394305|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
126573023|NCT04668339|455394306|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
126573024|NCT04668339|455394307|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
126573025|NCT04668339|455394304|FG000|Overall Study|Vaccine not Administered|0|||
126573026|NCT04668339|455394305|FG001|Overall Study|Vaccine not Administered|0|||
126573027|NCT04668339|455394306|FG002|Overall Study|Vaccine not Administered|1|||
126573028|NCT04668339|455394307|FG003|Overall Study|Vaccine not Administered|0|||
126573029|NCT04668339|455394304|FG000|Overall Study|Protocol Violation|18|||
126573030|NCT04668339|455394305|FG001|Overall Study|Protocol Violation|23|||
126573031|NCT04668339|455394306|FG002|Overall Study|Protocol Violation|12|||
126573032|NCT04668339|455394307|FG003|Overall Study|Protocol Violation|20|||
126573033|NCT04668339|455394304|FG000|Overall Study|Withdrawal by Subject|45|||
126573034|NCT04668339|455394305|FG001|Overall Study|Withdrawal by Subject|46|||
126573035|NCT04668339|455394306|FG002|Overall Study|Withdrawal by Subject|46|||
126573036|NCT04668339|455394307|FG003|Overall Study|Withdrawal by Subject|27|||
126573037|NCT04668339|455394304|FG000|Overall Study|Study Terminated by Sponsor|59|||
126519345|NCT00767000|455193966|FG003|54-week Study|Interruption of study medication|0|||
126519346|NCT00767000|455193967|FG004|54-week Study|Interruption of study medication|0|||
126519347|NCT00767000|455193963|FG000|54-week Study|Lack of Efficacy|2|||
126519348|NCT00767000|455193964|FG001|54-week Study|Lack of Efficacy|0|||
126519349|NCT00767000|455193965|FG002|54-week Study|Lack of Efficacy|1|||
126519350|NCT00767000|455193966|FG003|54-week Study|Lack of Efficacy|0|||
126519351|NCT00767000|455193967|FG004|54-week Study|Lack of Efficacy|5|||
126519352|NCT00767000|455193963|FG000|54-week Study|Lost to Follow-up|4|||
126519353|NCT00767000|455193964|FG001|54-week Study|Lost to Follow-up|0|||
126519354|NCT00767000|455193965|FG002|54-week Study|Lost to Follow-up|1|||
126519355|NCT00767000|455193966|FG003|54-week Study|Lost to Follow-up|4|||
126573038|NCT04668339|455394305|FG001|Overall Study|Study Terminated by Sponsor|59|||
126573039|NCT04668339|455394306|FG002|Overall Study|Study Terminated by Sponsor|71|||
126573040|NCT04668339|455394307|FG003|Overall Study|Study Terminated by Sponsor|1|||
126573041|NCT00002842|455394312|FG000|Overall Study|ineligible for surgical resection|27|||
126573042|NCT03557008|455394313|FG000|Overall Study|Withdrawal by Subject|2|||
126573043|NCT03557008|455394314|FG001|Overall Study|Withdrawal by Subject|2|||
126573044|NCT03557008|455394313|FG000|Overall Study|Early termination from study|3|||
126573045|NCT03557008|455394314|FG001|Overall Study|Early termination from study|1|||
126573046|NCT01424397|455394316|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
126573047|NCT01424397|455394317|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
126573048|NCT01424397|455394318|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
126573049|NCT01424397|455394319|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
126573050|NCT01424397|455394320|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
126573051|NCT01424397|455394321|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
126573052|NCT01424397|455394322|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
126573053|NCT01424397|455394323|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
126573054|NCT01424397|455394324|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
126573055|NCT01424397|455394325|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
126573056|NCT01424397|455394326|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
126519356|NCT00767000|455193967|FG004|54-week Study|Lost to Follow-up|2|||
126519357|NCT00767000|455193963|FG000|54-week Study|Physician Decision|4|||
126519358|NCT00767000|455193964|FG001|54-week Study|Physician Decision|0|||
126519359|NCT00767000|455193965|FG002|54-week Study|Physician Decision|1|||
126573057|NCT01424397|455394327|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
126573058|NCT05876949|455394328|FG000|Overall Study|Withdrawal by Subject|1|||
126573059|NCT05876949|455394329|FG001|Overall Study|Withdrawal by Subject|3|||
126573060|NCT05876949|455394328|FG000|Overall Study|Physician Decision|0|||
126573061|NCT05876949|455394329|FG001|Overall Study|Physician Decision|2|||
126573062|NCT05876949|455394328|FG000|Overall Study|Death|0|||
126573063|NCT05876949|455394329|FG001|Overall Study|Death|1|||
126519360|NCT00767000|455193966|FG003|54-week Study|Physician Decision|1|||
126519361|NCT00767000|455193967|FG004|54-week Study|Physician Decision|1|||
126519362|NCT00767000|455193963|FG000|54-week Study|Progressive disease|0|||
126573064|NCT03644849|455394330|FG000|Overall Study|Lost to Follow-up|1|||
126573065|NCT03644849|455394331|FG001|Overall Study|Lost to Follow-up|3|||
126519363|NCT00767000|455193964|FG001|54-week Study|Progressive disease|0|||
126519364|NCT00767000|455193965|FG002|54-week Study|Progressive disease|1|||
126573066|NCT01177670|455394332|FG000|Overall Study|Study Terminated|115|||
126573067|NCT01177670|455394332|FG000|Overall Study|Physician Decision|50|||
126573068|NCT01177670|455394332|FG000|Overall Study|Withdrawal by Subject|4|||
126573069|NCT01140048|455394335|FG000|Overall Study|Physician Decision|1|||
126573070|NCT01140048|455394335|FG000|Overall Study|Withdrawal by Subject|13|||
126573071|NCT01140048|455394335|FG000|Overall Study|Lost to Follow-up|31|||
126573072|NCT01831791|455394336|FG000|Overall Study|Withdrawal by Subject|10|||
126573073|NCT00494780|455394337|FG000|Overall Study|Adverse Event|1|||
126573074|NCT00494780|455394338|FG001|Overall Study|Adverse Event|0|||
126573075|NCT00494780|455394337|FG000|Overall Study|Withdrew before Dosed|0|||
126573076|NCT00494780|455394338|FG001|Overall Study|Withdrew before Dosed|1|||
126573077|NCT00494780|455394337|FG000|Overall Study|Progression of Study Disease|7|||
126573078|NCT00494780|455394338|FG001|Overall Study|Progression of Study Disease|8|||
126573079|NCT00494780|455394337|FG000|Overall Study|New Treatment|2|||
126573080|NCT00494780|455394338|FG001|Overall Study|New Treatment|2|||
126519365|NCT00767000|455193966|FG003|54-week Study|Progressive disease|0|||
126519366|NCT00767000|455193967|FG004|54-week Study|Progressive disease|0|||
126519367|NCT00767000|455193963|FG000|54-week Study|Protocol Violation|0|||
126519368|NCT00767000|455193964|FG001|54-week Study|Protocol Violation|0|||
126519369|NCT00767000|455193965|FG002|54-week Study|Protocol Violation|1|||
126519370|NCT00767000|455193966|FG003|54-week Study|Protocol Violation|2|||
126519371|NCT00767000|455193967|FG004|54-week Study|Protocol Violation|0|||
126519372|NCT00767000|455193963|FG000|54-week Study|Withdrawal by Subject|2|||
126519373|NCT00767000|455193964|FG001|54-week Study|Withdrawal by Subject|3|||
126519374|NCT00767000|455193965|FG002|54-week Study|Withdrawal by Subject|5|||
126519375|NCT00767000|455193966|FG003|54-week Study|Withdrawal by Subject|11|||
126519376|NCT00767000|455193967|FG004|54-week Study|Withdrawal by Subject|13|||
126519377|NCT00767000|455193963|FG000|54-week Study|Study terminated by sponsor|90|||
126519378|NCT00767000|455193964|FG001|54-week Study|Study terminated by sponsor|102|||
126519379|NCT00767000|455193965|FG002|54-week Study|Study terminated by sponsor|89|||
126519380|NCT00767000|455193966|FG003|54-week Study|Study terminated by sponsor|196|||
126519381|NCT00767000|455193967|FG004|54-week Study|Study terminated by sponsor|194|||
126519382|NCT00767000|455193963|FG000|54-week Study|Reason not reported|0|||
126519383|NCT00767000|455193964|FG001|54-week Study|Reason not reported|0|||
126519384|NCT00767000|455193965|FG002|54-week Study|Reason not reported|0|||
126519385|NCT00767000|455193966|FG003|54-week Study|Reason not reported|1|||
126519386|NCT00767000|455193967|FG004|54-week Study|Reason not reported|0|||
126519387|NCT00767000|455193963|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
126519388|NCT00767000|455193964|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
126519389|NCT00767000|455193965|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
126519390|NCT00767000|455193966|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
126519391|NCT00767000|455193967|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
126519392|NCT02039505|455193969|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
126519393|NCT02039505|455193970|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
126519394|NCT02039505|455193971|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
126519395|NCT02039505|455193972|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
126519396|NCT02039505|455193973|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
126519397|NCT02039505|455193974|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
126519398|NCT02039505|455193975|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
126519399|NCT02039505|455193969|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
126519400|NCT02039505|455193970|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
126519401|NCT02039505|455193971|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
126519402|NCT02039505|455193972|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
126519403|NCT02039505|455193973|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
126519404|NCT02039505|455193974|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
126519405|NCT02039505|455193975|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
126519406|NCT02039505|455193969|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
126519407|NCT02039505|455193970|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
126519408|NCT02039505|455193971|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
126519409|NCT02039505|455193972|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
126519410|NCT02039505|455193973|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
126519411|NCT02039505|455193974|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
126519412|NCT02039505|455193975|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
126519413|NCT02039505|455193969|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
126519414|NCT02039505|455193970|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
126519415|NCT02039505|455193971|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
126519416|NCT02039505|455193972|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
126519417|NCT02039505|455193973|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
126519418|NCT02039505|455193974|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
126573081|NCT00494780|455394337|FG000|Overall Study|Non-compliance|1|||
126573082|NCT00494780|455394338|FG001|Overall Study|Non-compliance|0|||
126573083|NCT00494780|455394337|FG000|Overall Study|Residual Tumour Mass|0|||
126573084|NCT00494780|455394338|FG001|Overall Study|Residual Tumour Mass|1|||
126573085|NCT00494780|455394337|FG000|Overall Study|Insurance Issues|0|||
126573086|NCT00494780|455394338|FG001|Overall Study|Insurance Issues|1|||
126573087|NCT01254019|455394339|FG000|Overall Study|Adverse Event|0|||
126573088|NCT01254019|455394340|FG001|Overall Study|Adverse Event|2|||
126573089|NCT01254019|455394339|FG000|Overall Study|Protocol Violation|1|||
126573090|NCT01254019|455394340|FG001|Overall Study|Protocol Violation|0|||
126573091|NCT01254019|455394339|FG000|Overall Study|Withdrawal by Subject|0|||
126573092|NCT01254019|455394340|FG001|Overall Study|Withdrawal by Subject|2|||
126573093|NCT03061474|455394341|FG000|Overall Study|Adverse Event|2|||
126573094|NCT03061474|455394342|FG001|Overall Study|Adverse Event|0|||
126573095|NCT03061474|455394341|FG000|Overall Study|Safety Risk|0|||
126573096|NCT03061474|455394342|FG001|Overall Study|Safety Risk|1|||
126573097|NCT03061474|455394341|FG000|Overall Study|Participant unwilling or unable to participate|0|||
126573098|NCT03061474|455394342|FG001|Overall Study|Participant unwilling or unable to participate|2|||
126573099|NCT03061474|455394341|FG000|Overall Study|Lost to Follow-up|0|||
126573100|NCT03061474|455394342|FG001|Overall Study|Lost to Follow-up|1|||
126573101|NCT00980330|455394343|FG000|Overall Study|Adverse Event|0|||
126573102|NCT00980330|455394344|FG001|Overall Study|Adverse Event|0|||
126573103|NCT00980330|455394345|FG002|Overall Study|Adverse Event|0|||
126573104|NCT00980330|455394346|FG003|Overall Study|Adverse Event|1|||
126573105|NCT00980330|455394347|FG004|Overall Study|Adverse Event|0|||
126573106|NCT00980330|455394348|FG005|Overall Study|Adverse Event|0|||
126573107|NCT00980330|455394349|FG006|Overall Study|Adverse Event|0|||
126573108|NCT00980330|455394343|FG000|Overall Study|Lost to Follow-up|1|||
126573109|NCT00980330|455394344|FG001|Overall Study|Lost to Follow-up|1|||
126573110|NCT00980330|455394345|FG002|Overall Study|Lost to Follow-up|4|||
126573111|NCT00980330|455394346|FG003|Overall Study|Lost to Follow-up|2|||
126573112|NCT00980330|455394347|FG004|Overall Study|Lost to Follow-up|1|||
126573113|NCT00980330|455394348|FG005|Overall Study|Lost to Follow-up|1|||
126573114|NCT00980330|455394349|FG006|Overall Study|Lost to Follow-up|2|||
126573115|NCT00980330|455394343|FG000|Overall Study|Withdrawal by Subject|2|||
126573116|NCT00980330|455394344|FG001|Overall Study|Withdrawal by Subject|4|||
126573117|NCT00980330|455394345|FG002|Overall Study|Withdrawal by Subject|4|||
126573118|NCT00980330|455394346|FG003|Overall Study|Withdrawal by Subject|1|||
126573119|NCT00980330|455394347|FG004|Overall Study|Withdrawal by Subject|3|||
126573120|NCT00980330|455394348|FG005|Overall Study|Withdrawal by Subject|2|||
126573121|NCT00980330|455394349|FG006|Overall Study|Withdrawal by Subject|5|||
126573122|NCT00980330|455394343|FG000|Overall Study|(not specified)|2|||
126573123|NCT00980330|455394344|FG001|Overall Study|(not specified)|0|||
126573124|NCT00980330|455394345|FG002|Overall Study|(not specified)|0|||
126573125|NCT00980330|455394346|FG003|Overall Study|(not specified)|1|||
126573126|NCT00980330|455394347|FG004|Overall Study|(not specified)|1|||
126573127|NCT00980330|455394348|FG005|Overall Study|(not specified)|1|||
126573128|NCT00980330|455394349|FG006|Overall Study|(not specified)|0|||
126573129|NCT00665444|455394352|FG000|Overall Study|Physician Decision|1|||
126573130|NCT00665444|455394352|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
126573131|NCT03299816|455394353|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
126573132|NCT03299816|455394354|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
126573133|NCT03299816|455394353|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
126573134|NCT03299816|455394354|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
126573135|NCT03299816|455394353|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
126573136|NCT03299816|455394354|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
126573137|NCT03520413|455394357|FG000|Overall Study|Lost to Follow-up|1|||
126573138|NCT03520413|455394358|FG001|Overall Study|Lost to Follow-up|1|||
126573139|NCT03520413|455394357|FG000|Overall Study|Withdrawal by Subject|1|||
126573140|NCT03520413|455394358|FG001|Overall Study|Withdrawal by Subject|2|||
126573141|NCT03520413|455394357|FG000|Overall Study|Death|0|||
126573142|NCT03520413|455394358|FG001|Overall Study|Death|1|||
126573143|NCT03520413|455394357|FG000|Overall Study|Physician Decision|3|||
126573144|NCT03520413|455394358|FG001|Overall Study|Physician Decision|3|||
126573145|NCT03520413|455394357|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
126573146|NCT03520413|455394358|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
126573147|NCT00869323|455394361|FG000|Maintenance Therapy|concurrent illness|1|||
126573148|NCT01135511|455394363|FG000|Overall Study|Adverse Event|0|||
126573149|NCT01135511|455394364|FG001|Overall Study|Adverse Event|1|||
126573150|NCT01135511|455394365|FG002|Overall Study|Adverse Event|2|||
126573151|NCT01135511|455394366|FG003|Overall Study|Adverse Event|0|||
126573152|NCT01135511|455394367|FG004|Overall Study|Adverse Event|0|||
126573153|NCT01135511|455394368|FG005|Overall Study|Adverse Event|1|||
126573154|NCT01135511|455394369|FG006|Overall Study|Adverse Event|0|||
126573155|NCT01135511|455394370|FG007|Overall Study|Adverse Event|1|||
126573156|NCT01135511|455394371|FG008|Overall Study|Adverse Event|0|||
126573157|NCT01135511|455394363|FG000|Overall Study|Lack of Efficacy|0|||
126573158|NCT01135511|455394364|FG001|Overall Study|Lack of Efficacy|1|||
126573159|NCT01135511|455394365|FG002|Overall Study|Lack of Efficacy|1|||
126519419|NCT02039505|455193975|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
126519420|NCT02039505|455193969|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
126519421|NCT02039505|455193970|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
126519422|NCT02039505|455193971|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
126519423|NCT02039505|455193972|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
126519424|NCT02039505|455193973|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
126519425|NCT02039505|455193974|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
126519426|NCT02039505|455193975|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
126519427|NCT02039505|455193969|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
126519428|NCT02039505|455193970|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
126519429|NCT02039505|455193971|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
126519430|NCT02039505|455193972|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
126519431|NCT02039505|455193973|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
126519432|NCT02039505|455193974|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
126519433|NCT02039505|455193975|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
126519434|NCT02039505|455193969|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
126519435|NCT02039505|455193970|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
126519436|NCT02039505|455193971|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
126519437|NCT02039505|455193972|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
126519438|NCT02039505|455193973|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
126519439|NCT02039505|455193974|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
126519440|NCT02039505|455193975|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
126519441|NCT02039505|455193969|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
126519442|NCT02039505|455193970|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
126519443|NCT02039505|455193971|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
126519444|NCT02039505|455193972|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
126519445|NCT02039505|455193973|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
126519446|NCT02039505|455193974|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
126519447|NCT02039505|455193975|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
126519448|NCT02039505|455193969|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
126519449|NCT02039505|455193970|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
126519450|NCT02039505|455193971|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
126519451|NCT02039505|455193972|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
126519452|NCT02039505|455193973|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
126519453|NCT02039505|455193974|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
126519454|NCT02039505|455193975|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
126519455|NCT02039505|455193969|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
126519456|NCT02039505|455193970|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
126519457|NCT02039505|455193971|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
126519458|NCT02039505|455193972|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
126519459|NCT02039505|455193973|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
126519460|NCT02039505|455193974|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
126519461|NCT02039505|455193975|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
126519462|NCT02039505|455193969|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
126519463|NCT02039505|455193970|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
126519464|NCT02039505|455193971|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
126519465|NCT02039505|455193972|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
126519466|NCT02039505|455193973|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
126519467|NCT02039505|455193974|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
126519468|NCT02039505|455193975|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
126519469|NCT04265755|455193981|FG000|Overall Study|Withdrawal by Subject|39|||
126519470|NCT04265755|455193981|FG000|Overall Study|Decision by sponsor|2|||
126519471|NCT04265755|455193981|FG000|Overall Study|Lost to Follow-up|11|||
126519472|NCT04265755|455193981|FG000|Overall Study|Death|1|||
126519473|NCT00633984|455193982|FG000|Overall Study|Lost to Follow-up|0|||
126519474|NCT00633984|455193983|FG001|Overall Study|Lost to Follow-up|6|||
126519475|NCT00633984|455193982|FG000|Overall Study|Withdrawal by Subject|8|||
126519476|NCT00633984|455193983|FG001|Overall Study|Withdrawal by Subject|7|||
126519477|NCT00633984|455193982|FG000|Overall Study|Hospitalized|1|||
126519478|NCT00633984|455193983|FG001|Overall Study|Hospitalized|0|||
126519479|NCT00097591|455193984|FG000|Overall Study|Withdrawal of consent|342|||
126519480|NCT00097591|455193985|FG001|Overall Study|Withdrawal of consent|323|||
126519481|NCT00097591|455193984|FG000|Overall Study|Less than 6 months on study drug|9|||
126519482|NCT00097591|455193985|FG001|Overall Study|Less than 6 months on study drug|7|||
126519483|NCT00097591|455193984|FG000|Overall Study|Unable to attend termination visit|53|||
126519484|NCT00097591|455193985|FG001|Overall Study|Unable to attend termination visit|51|||
126519485|NCT00097591|455193984|FG000|Overall Study|Lost to follow up|6|||
126519486|NCT00097591|455193985|FG001|Overall Study|Lost to follow up|10|||
126519487|NCT00097591|455193984|FG000|Overall Study|Other|0|||
126519488|NCT00097591|455193985|FG001|Overall Study|Other|3|||
126519489|NCT02530619|455193986|FG000|Registered for Study|Withdrawal by Subject|2|||
126519490|NCT02530619|455193986|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
126519491|NCT02530619|455193986|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
126519492|NCT02530619|455193986|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
126519493|NCT02530619|455193986|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
126519494|NCT02530619|455193986|FG000|Follow-up Period (6 Months)|Death|4|||
126519495|NCT02530619|455193986|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
126519496|NCT02530619|455193986|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
126519497|NCT01046110|455193992|FG000|Overall Study|Adverse Event|9|||
126519498|NCT01046110|455193993|FG001|Overall Study|Adverse Event|2|||
126519499|NCT01046110|455193992|FG000|Overall Study|Lack of Efficacy|0|||
126519500|NCT01046110|455193993|FG001|Overall Study|Lack of Efficacy|1|||
126519501|NCT01046110|455193992|FG000|Overall Study|Protocol Violation|7|||
126519502|NCT01046110|455193993|FG001|Overall Study|Protocol Violation|12|||
126519503|NCT01046110|455193992|FG000|Overall Study|Withdrawal Criteria|3|||
126519504|NCT01046110|455193993|FG001|Overall Study|Withdrawal Criteria|5|||
126519505|NCT01046110|455193992|FG000|Overall Study|Unclassified|36|||
126519506|NCT01046110|455193993|FG001|Overall Study|Unclassified|35|||
126519507|NCT00718042|455193996|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
126519508|NCT00718042|455193997|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
126519509|NCT00718042|455193998|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
126519510|NCT00718042|455193999|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
126519511|NCT00718042|455194000|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
126519512|NCT00718042|455194001|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
126519513|NCT00718042|455193996|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
126519514|NCT00718042|455193997|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
126519515|NCT00718042|455193998|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
126519516|NCT00718042|455193999|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
126519517|NCT00718042|455194000|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
126519518|NCT00718042|455194001|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
126519519|NCT00718042|455193996|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
126519520|NCT00718042|455193997|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
126519521|NCT00718042|455193998|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
126519522|NCT00718042|455193999|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
126519523|NCT00718042|455194000|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
126519524|NCT00718042|455194001|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
126519525|NCT00718042|455193996|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
126519526|NCT00718042|455193997|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
126519527|NCT00718042|455193998|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
126519528|NCT00718042|455193999|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
126519529|NCT00718042|455194000|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
126519530|NCT00718042|455194001|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
126519531|NCT00718042|455193996|FG000|Donor Follow-up|Lost to Follow-up|13|||
126519532|NCT00718042|455193997|FG001|Donor Follow-up|Lost to Follow-up|0|||
126519533|NCT00718042|455193998|FG002|Donor Follow-up|Lost to Follow-up|0|||
126519534|NCT00718042|455193999|FG003|Donor Follow-up|Lost to Follow-up|0|||
126519535|NCT00718042|455194000|FG004|Donor Follow-up|Lost to Follow-up|19|||
126519536|NCT00718042|455194001|FG005|Donor Follow-up|Lost to Follow-up|0|||
126519537|NCT00614939|455194002|FG000|Overall Study|Withdrawal by Subject|10|||
126519538|NCT00614939|455194003|FG001|Overall Study|Withdrawal by Subject|17|||
126519539|NCT00614939|455194002|FG000|Overall Study|Study specific discontinuation criteris|13|||
126519540|NCT00614939|455194003|FG001|Overall Study|Study specific discontinuation criteris|16|||
126519541|NCT00614939|455194002|FG000|Overall Study|Adverse Event|2|||
126519542|NCT00614939|455194003|FG001|Overall Study|Adverse Event|5|||
126519543|NCT00614939|455194002|FG000|Overall Study|Incorrect enrollment|1|||
126519544|NCT00614939|455194003|FG001|Overall Study|Incorrect enrollment|2|||
126519545|NCT00614939|455194002|FG000|Overall Study|Death|4|||
126519546|NCT00614939|455194003|FG001|Overall Study|Death|3|||
126519547|NCT00614939|455194002|FG000|Overall Study|Poor/non-compliance|4|||
126519548|NCT00614939|455194003|FG001|Overall Study|Poor/non-compliance|0|||
126519549|NCT00614939|455194002|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
126519550|NCT00614939|455194003|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
126519551|NCT00840970|455194004|FG000|Overall Study|Adverse Event|0|||
126519552|NCT00840970|455194005|FG001|Overall Study|Adverse Event|0|||
126519553|NCT00840970|455194006|FG002|Overall Study|Adverse Event|1|||
126519554|NCT05061446|455194012|FG000|Overall Study|Adverse Event|2|||
126519555|NCT05061446|455194013|FG001|Overall Study|Adverse Event|0|||
126519556|NCT05061446|455194014|FG002|Overall Study|Adverse Event|0|||
126519557|NCT05061446|455194012|FG000|Overall Study|Participant no longer available due to personal reason|0|||
126519558|NCT05061446|455194013|FG001|Overall Study|Participant no longer available due to personal reason|1|||
126519559|NCT05061446|455194014|FG002|Overall Study|Participant no longer available due to personal reason|0|||
126519560|NCT03880578|455194015|FG000|Overall Study|Withdrawal by Subject|0|||
126519561|NCT03880578|455194016|FG001|Overall Study|Withdrawal by Subject|3|||
126519562|NCT03880578|455194017|FG002|Overall Study|Withdrawal by Subject|1|||
126519563|NCT03880578|455194015|FG000|Overall Study|Death|0|||
126519564|NCT03880578|455194016|FG001|Overall Study|Death|1|||
126519565|NCT03880578|455194017|FG002|Overall Study|Death|0|||
126519566|NCT02041429|455194022|FG000|Overall Study|Progressive Disease|2|||
126519567|NCT02041429|455194023|FG001|Overall Study|Progressive Disease|2|||
126519568|NCT02041429|455194024|FG002|Overall Study|Progressive Disease|3|||
126519569|NCT02041429|455194025|FG003|Overall Study|Progressive Disease|2|||
126519570|NCT02041429|455194022|FG000|Overall Study|Toxicity|0|||
126519571|NCT02041429|455194023|FG001|Overall Study|Toxicity|1|||
126519572|NCT02041429|455194024|FG002|Overall Study|Toxicity|4|||
126519573|NCT02041429|455194025|FG003|Overall Study|Toxicity|2|||
126519574|NCT02041429|455194022|FG000|Overall Study|Withdrawal by Subject|0|||
126519575|NCT02041429|455194023|FG001|Overall Study|Withdrawal by Subject|1|||
126519576|NCT02041429|455194024|FG002|Overall Study|Withdrawal by Subject|0|||
126519577|NCT02041429|455194025|FG003|Overall Study|Withdrawal by Subject|0|||
126519578|NCT02041429|455194022|FG000|Overall Study|On Maintenance Therapy|1|||
126519579|NCT02041429|455194023|FG001|Overall Study|On Maintenance Therapy|0|||
126519580|NCT02041429|455194024|FG002|Overall Study|On Maintenance Therapy|0|||
126519581|NCT02041429|455194025|FG003|Overall Study|On Maintenance Therapy|2|||
126519582|NCT00861341|455194026|FG000|Overall Study|Withdrawal by Subject|2|||
126519583|NCT03299192|455194027|FG000|Overall Study|Fell before classes started|1|||
126519584|NCT03299192|455194028|FG001|Overall Study|Fell before classes started|0|||
126519585|NCT03299192|455194029|FG002|Overall Study|Fell before classes started|0|||
126519586|NCT03299192|455194027|FG000|Overall Study|Other|0|||
126519587|NCT03299192|455194028|FG001|Overall Study|Other|2|||
126519588|NCT03299192|455194029|FG002|Overall Study|Other|1|||
126519589|NCT01418209|455194030|FG000|Overall Study|Withdrawal by Subject|1|||
126519590|NCT01418209|455194031|FG001|Overall Study|Withdrawal by Subject|0|||
126519591|NCT01418209|455194032|FG002|Overall Study|Withdrawal by Subject|1|||
126519592|NCT01418209|455194030|FG000|Overall Study|Did not provide hot flash diary data|1|||
126519593|NCT01418209|455194031|FG001|Overall Study|Did not provide hot flash diary data|3|||
126519594|NCT01418209|455194032|FG002|Overall Study|Did not provide hot flash diary data|3|||
126519595|NCT00560833|455194037|FG000|Overall Study|Adverse Event|16|||
126519596|NCT00560833|455194038|FG001|Overall Study|Adverse Event|10|||
126519597|NCT00560833|455194039|FG002|Overall Study|Adverse Event|25|||
126519598|NCT00560833|455194040|FG003|Overall Study|Adverse Event|23|||
126519599|NCT00560833|455194041|FG004|Overall Study|Adverse Event|35|||
126519600|NCT00560833|455194037|FG000|Overall Study|Lost to Follow-up|0|||
126519601|NCT00560833|455194038|FG001|Overall Study|Lost to Follow-up|0|||
126519602|NCT00560833|455194039|FG002|Overall Study|Lost to Follow-up|1|||
126519603|NCT00560833|455194040|FG003|Overall Study|Lost to Follow-up|0|||
126519604|NCT00560833|455194041|FG004|Overall Study|Lost to Follow-up|0|||
126519605|NCT00560833|455194037|FG000|Overall Study|Lack of Efficacy|22|||
126519606|NCT00560833|455194038|FG001|Overall Study|Lack of Efficacy|9|||
126519607|NCT00560833|455194039|FG002|Overall Study|Lack of Efficacy|6|||
126519608|NCT00560833|455194040|FG003|Overall Study|Lack of Efficacy|4|||
126519609|NCT00560833|455194041|FG004|Overall Study|Lack of Efficacy|4|||
126519610|NCT00560833|455194037|FG000|Overall Study|Participant uncooperative|5|||
126519611|NCT00560833|455194038|FG001|Overall Study|Participant uncooperative|5|||
126519612|NCT00560833|455194039|FG002|Overall Study|Participant uncooperative|4|||
126519613|NCT00560833|455194040|FG003|Overall Study|Participant uncooperative|4|||
126519614|NCT00560833|455194041|FG004|Overall Study|Participant uncooperative|2|||
126519615|NCT00560833|455194037|FG000|Overall Study|Other|1|||
126519616|NCT00560833|455194038|FG001|Overall Study|Other|1|||
126519617|NCT00560833|455194039|FG002|Overall Study|Other|3|||
126519618|NCT00560833|455194040|FG003|Overall Study|Other|0|||
126519619|NCT00560833|455194041|FG004|Overall Study|Other|0|||
126519620|NCT00560833|455194037|FG000|Overall Study|Never received drug|0|||
126519621|NCT00560833|455194038|FG001|Overall Study|Never received drug|1|||
126519622|NCT00560833|455194039|FG002|Overall Study|Never received drug|0|||
126519623|NCT00560833|455194040|FG003|Overall Study|Never received drug|0|||
126519624|NCT00560833|455194041|FG004|Overall Study|Never received drug|1|||
126519625|NCT00898677|455194044|FG000|Overall Study|Adverse Event|0|||
126519626|NCT00898677|455194045|FG001|Overall Study|Adverse Event|0|||
126519627|NCT00898677|455194046|FG002|Overall Study|Adverse Event|1|||
126519628|NCT00898677|455194047|FG003|Overall Study|Adverse Event|0|||
126519629|NCT00898677|455194044|FG000|Overall Study|Lost to Follow-up|0|||
126519630|NCT00898677|455194045|FG001|Overall Study|Lost to Follow-up|0|||
126519631|NCT00898677|455194046|FG002|Overall Study|Lost to Follow-up|2|||
126519632|NCT00898677|455194047|FG003|Overall Study|Lost to Follow-up|0|||
126519633|NCT00898677|455194044|FG000|Overall Study|Protocol Violation|1|||
126519634|NCT00898677|455194045|FG001|Overall Study|Protocol Violation|1|||
126519635|NCT00898677|455194046|FG002|Overall Study|Protocol Violation|2|||
126519636|NCT00898677|455194047|FG003|Overall Study|Protocol Violation|0|||
126727298|NCT02720016|455951104|FG000|Overall Study|Not Primary Health Concern|0|||
126727299|NCT02720016|455951105|FG001|Overall Study|Not Primary Health Concern|0|||
126727300|NCT02720016|455951106|FG002|Overall Study|Not Primary Health Concern|2|||
126519637|NCT00898677|455194044|FG000|Overall Study|Withdrawal by Subject|0|||
126519638|NCT00898677|455194045|FG001|Overall Study|Withdrawal by Subject|0|||
126519639|NCT00898677|455194046|FG002|Overall Study|Withdrawal by Subject|0|||
126519640|NCT00898677|455194047|FG003|Overall Study|Withdrawal by Subject|1|||
126519641|NCT00898677|455194044|FG000|Overall Study|Not Treated: Adverse Event|0|||
126519642|NCT00898677|455194045|FG001|Overall Study|Not Treated: Adverse Event|2|||
126519643|NCT00898677|455194046|FG002|Overall Study|Not Treated: Adverse Event|1|||
126519644|NCT00898677|455194047|FG003|Overall Study|Not Treated: Adverse Event|0|||
126519645|NCT00898677|455194044|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
126519646|NCT00898677|455194045|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
126519647|NCT00898677|455194046|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
126519648|NCT00898677|455194047|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
126519649|NCT00898677|455194044|FG000|Overall Study|Not Treated: Pregnancy|0|||
126519650|NCT00898677|455194045|FG001|Overall Study|Not Treated: Pregnancy|0|||
126519651|NCT00898677|455194046|FG002|Overall Study|Not Treated: Pregnancy|1|||
126519652|NCT00898677|455194047|FG003|Overall Study|Not Treated: Pregnancy|0|||
126519653|NCT00898677|455194044|FG000|Overall Study|Not Treated: Protocol Violation|2|||
126519654|NCT00898677|455194045|FG001|Overall Study|Not Treated: Protocol Violation|0|||
126519655|NCT00898677|455194046|FG002|Overall Study|Not Treated: Protocol Violation|2|||
126519656|NCT00898677|455194047|FG003|Overall Study|Not Treated: Protocol Violation|0|||
126519657|NCT00898677|455194044|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
126519658|NCT00898677|455194045|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
126519659|NCT00898677|455194046|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
126519660|NCT00898677|455194047|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
126519661|NCT00898677|455194044|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
126519662|NCT00898677|455194045|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
126519663|NCT00898677|455194046|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
126519664|NCT00898677|455194047|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
126519665|NCT00898677|455194044|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
126519666|NCT00898677|455194045|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
126519667|NCT00898677|455194046|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
126519668|NCT00898677|455194047|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
126519669|NCT00898677|455194044|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
126519670|NCT00898677|455194045|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
126519671|NCT00898677|455194046|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
126519672|NCT00898677|455194047|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
126519673|NCT00898677|455194044|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
126519674|NCT00898677|455194045|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
126519675|NCT00898677|455194046|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
126519676|NCT00898677|455194047|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
126519677|NCT00898677|455194044|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
126519678|NCT00898677|455194045|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
126519679|NCT00898677|455194046|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
126519680|NCT00898677|455194047|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
126519681|NCT00898677|455194044|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
126519682|NCT00898677|455194045|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
126519683|NCT00898677|455194046|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
126519684|NCT00898677|455194047|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
126519685|NCT02199691|455194050|FG000|Overall Study|Protocol Violation|3|||
126519686|NCT02199691|455194051|FG001|Overall Study|Protocol Violation|3|||
126519687|NCT02199691|455194052|FG002|Overall Study|Protocol Violation|6|||
126519688|NCT02199691|455194053|FG003|Overall Study|Protocol Violation|7|||
126519689|NCT02199691|455194050|FG000|Overall Study|Withdrawal by Subject|5|||
126519690|NCT02199691|455194051|FG001|Overall Study|Withdrawal by Subject|3|||
126519691|NCT02199691|455194052|FG002|Overall Study|Withdrawal by Subject|12|||
126519692|NCT02199691|455194053|FG003|Overall Study|Withdrawal by Subject|13|||
126519693|NCT02199691|455194050|FG000|Overall Study|Lost to Follow-up|2|||
126519694|NCT02199691|455194051|FG001|Overall Study|Lost to Follow-up|1|||
126519695|NCT02199691|455194052|FG002|Overall Study|Lost to Follow-up|9|||
126519696|NCT02199691|455194053|FG003|Overall Study|Lost to Follow-up|10|||
126519697|NCT00836875|455194056|FG000|Overall Study|Death|3|||
126519698|NCT00836875|455194057|FG001|Overall Study|Death|2|||
126519699|NCT00836875|455194056|FG000|Overall Study|Withdrawal by Subject|0|||
126519700|NCT00836875|455194057|FG001|Overall Study|Withdrawal by Subject|1|||
126519701|NCT03403634|455194058|FG000|Overall Study|Disease progression|3|||
126519702|NCT03403634|455194058|FG000|Overall Study|Did not meet eligibility criteria|4|||
126727301|NCT02720016|455951104|FG000|Overall Study|Transportation issues|0|||
126727302|NCT02720016|455951105|FG001|Overall Study|Transportation issues|0|||
126519703|NCT00428610|455194059|FG000|Overall Study|Death Due to Adverse Event|3|||
126519704|NCT00428610|455194060|FG001|Overall Study|Death Due to Adverse Event|0|||
126519705|NCT00428610|455194061|FG002|Overall Study|Death Due to Adverse Event|5|||
126519706|NCT00428610|455194059|FG000|Overall Study|Death Due to Progressive Disease|0|||
126519707|NCT00428610|455194060|FG001|Overall Study|Death Due to Progressive Disease|0|||
126519708|NCT00428610|455194061|FG002|Overall Study|Death Due to Progressive Disease|2|||
126519709|NCT00428610|455194059|FG000|Overall Study|Adverse Event|2|||
126519710|NCT00428610|455194060|FG001|Overall Study|Adverse Event|3|||
126519711|NCT00428610|455194061|FG002|Overall Study|Adverse Event|2|||
126519712|NCT00428610|455194059|FG000|Overall Study|Investigator Decision|2|||
126519713|NCT00428610|455194060|FG001|Overall Study|Investigator Decision|1|||
126519714|NCT00428610|455194061|FG002|Overall Study|Investigator Decision|1|||
126519715|NCT00428610|455194059|FG000|Overall Study|Progressive Disease|42|||
126519716|NCT00428610|455194060|FG001|Overall Study|Progressive Disease|14|||
126519717|NCT00428610|455194061|FG002|Overall Study|Progressive Disease|22|||
126519718|NCT00428610|455194059|FG000|Overall Study|Withdrawal by Subject|4|||
126519719|NCT00428610|455194060|FG001|Overall Study|Withdrawal by Subject|0|||
126519720|NCT00428610|455194061|FG002|Overall Study|Withdrawal by Subject|0|||
126519721|NCT05350449|455194062|FG000|Overall Study|Withdrawal by Subject|4|||
126519722|NCT05350449|455194063|FG001|Overall Study|Withdrawal by Subject|8|||
126519723|NCT01076400|455196014|FG000|Overall Study|Adverse Event|2|||
126519724|NCT01076400|455196015|FG001|Overall Study|Adverse Event|0|||
126519725|NCT01076400|455196016|FG002|Overall Study|Adverse Event|0|||
126519726|NCT01076400|455196014|FG000|Overall Study|Progressive Disease|5|||
126519727|NCT01076400|455196015|FG001|Overall Study|Progressive Disease|0|||
126519728|NCT01076400|455196016|FG002|Overall Study|Progressive Disease|0|||
126519729|NCT03019536|455196018|FG000|Overall Study|Withdrawal by Subject|1|||
126519730|NCT03019536|455196019|FG001|Overall Study|Withdrawal by Subject|1|||
126519731|NCT03019536|455196020|FG002|Overall Study|Withdrawal by Subject|0|||
126519732|NCT03019536|455196018|FG000|Overall Study|Adverse Event|0|||
126519733|NCT03019536|455196019|FG001|Overall Study|Adverse Event|0|||
126519734|NCT03019536|455196020|FG002|Overall Study|Adverse Event|2|||
126519735|NCT01782131|455196025|FG000|Overall Study|Death|93|||
126519736|NCT01782131|455196026|FG001|Overall Study|Death|96|||
126519737|NCT01782131|455196025|FG000|Overall Study|Lost to Follow-up|1|||
126519738|NCT01782131|455196026|FG001|Overall Study|Lost to Follow-up|3|||
126519739|NCT01782131|455196025|FG000|Overall Study|Withdrawal by Subject|10|||
126519740|NCT01782131|455196026|FG001|Overall Study|Withdrawal by Subject|10|||
126519741|NCT01782131|455196025|FG000|Overall Study|Randomized but not treated|5|||
126519742|NCT01782131|455196026|FG001|Overall Study|Randomized but not treated|5|||
126519743|NCT01782131|455196025|FG000|Overall Study|Reason not provided|0|||
126519744|NCT01782131|455196026|FG001|Overall Study|Reason not provided|1|||
126519745|NCT01627249|455196027|FG000|Overall Study|Death|3|||
126519746|NCT01627249|455196028|FG001|Overall Study|Death|5|||
126519747|NCT01627249|455196029|FG002|Overall Study|Death|3|||
126519748|NCT01627249|455196027|FG000|Overall Study|Withdrawal by Subject|12|||
126519749|NCT01627249|455196028|FG001|Overall Study|Withdrawal by Subject|6|||
126519750|NCT01627249|455196029|FG002|Overall Study|Withdrawal by Subject|9|||
126519751|NCT01627249|455196027|FG000|Overall Study|Missed Visit|1|||
126519752|NCT01627249|455196028|FG001|Overall Study|Missed Visit|1|||
126519753|NCT01627249|455196029|FG002|Overall Study|Missed Visit|0|||
126519754|NCT00796718|455196030|FG000|Overall Study|Adverse Event|2|||
126519755|NCT00796718|455196030|FG000|Overall Study|Exclusion Criteria|1|||
126519756|NCT00796718|455196030|FG000|Overall Study|Lost to Follow-up|5|||
126519757|NCT00796718|455196030|FG000|Overall Study|Withdrawal by Informed Consent|1|||
126519758|NCT03266588|455196031|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
126519759|NCT03266588|455196032|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
126519760|NCT03266588|455196033|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
126519761|NCT03266588|455196031|FG000|Observational Period|Withdrawal by Subject|44|||
126519762|NCT03266588|455196032|FG001|Observational Period|Withdrawal by Subject|22|||
126519763|NCT03266588|455196033|FG002|Observational Period|Withdrawal by Subject|13|||
126519764|NCT03266588|455196031|FG000|Observational Period|Non-compliance|18|||
126519765|NCT03266588|455196032|FG001|Observational Period|Non-compliance|12|||
126519766|NCT03266588|455196033|FG002|Observational Period|Non-compliance|10|||
126519767|NCT03266588|455196031|FG000|Observational Period|Lost to Follow-up|8|||
126519768|NCT03266588|455196032|FG001|Observational Period|Lost to Follow-up|12|||
126519769|NCT03266588|455196033|FG002|Observational Period|Lost to Follow-up|4|||
126519770|NCT03266588|455196031|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
126519771|NCT03266588|455196032|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
126519772|NCT03266588|455196033|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
126519773|NCT03266588|455196031|FG000|Observational Period|Protocol Deviation|1|||
126519774|NCT03266588|455196032|FG001|Observational Period|Protocol Deviation|0|||
126519775|NCT03266588|455196033|FG002|Observational Period|Protocol Deviation|0|||
126519776|NCT03266588|455196031|FG000|Observational Period|Other Reasons|3|||
126519777|NCT03266588|455196032|FG001|Observational Period|Other Reasons|0|||
126519778|NCT03266588|455196033|FG002|Observational Period|Other Reasons|1|||
126519779|NCT03266588|455196031|FG000|Long-term Treatment Period|Adverse Event|33|||
126519780|NCT03266588|455196032|FG001|Long-term Treatment Period|Adverse Event|17|||
126519781|NCT03266588|455196033|FG002|Long-term Treatment Period|Adverse Event|8|||
126519782|NCT03266588|455196031|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
126727303|NCT02720016|455951106|FG002|Overall Study|Transportation issues|1|||
126727304|NCT02720016|455951104|FG000|Overall Study|Other|0|||
126727305|NCT02720016|455951105|FG001|Overall Study|Other|0|||
126727306|NCT02720016|455951106|FG002|Overall Study|Other|2|||
126519783|NCT03266588|455196032|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
126519784|NCT03266588|455196033|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
126519785|NCT03266588|455196031|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
126519786|NCT03266588|455196032|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
126519787|NCT03266588|455196033|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
126519788|NCT03266588|455196031|FG000|Long-term Treatment Period|Non-Compliance|126|||
126519789|NCT03266588|455196032|FG001|Long-term Treatment Period|Non-Compliance|57|||
126519790|NCT03266588|455196033|FG002|Long-term Treatment Period|Non-Compliance|7|||
126519791|NCT03266588|455196031|FG000|Long-term Treatment Period|Pregnancy|11|||
126519792|NCT03266588|455196032|FG001|Long-term Treatment Period|Pregnancy|5|||
126519793|NCT03266588|455196033|FG002|Long-term Treatment Period|Pregnancy|0|||
126519794|NCT03266588|455196031|FG000|Long-term Treatment Period|Protocol Deviation|17|||
126519795|NCT03266588|455196032|FG001|Long-term Treatment Period|Protocol Deviation|10|||
126519796|NCT03266588|455196033|FG002|Long-term Treatment Period|Protocol Deviation|4|||
126519797|NCT03266588|455196031|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
126519798|NCT03266588|455196032|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
126519799|NCT03266588|455196033|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
126519800|NCT03266588|455196031|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
126519801|NCT03266588|455196032|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
126519802|NCT03266588|455196033|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
126519803|NCT03266588|455196031|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
126519804|NCT03266588|455196032|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
126519805|NCT03266588|455196033|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
126519806|NCT03266588|455196031|FG000|Long-term Treatment Period|Other Reasons|5|||
126519807|NCT03266588|455196032|FG001|Long-term Treatment Period|Other Reasons|0|||
126519808|NCT03266588|455196033|FG002|Long-term Treatment Period|Other Reasons|0|||
126519809|NCT03266588|455196031|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
126519810|NCT03266588|455196032|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
126519811|NCT03266588|455196033|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
126519812|NCT02627677|455196035|FG000|Overall Study|Adverse event (not progressive disease)|1|||
126519813|NCT02627677|455196036|FG001|Overall Study|Adverse event (not progressive disease)|4|||
126519814|NCT02627677|455196037|FG002|Overall Study|Adverse event (not progressive disease)|1|||
126519815|NCT02627677|455196035|FG000|Overall Study|Progressive disease|1|||
126519816|NCT02627677|455196036|FG001|Overall Study|Progressive disease|3|||
126519817|NCT02627677|455196037|FG002|Overall Study|Progressive disease|0|||
126519818|NCT02627677|455196035|FG000|Overall Study|Lack of Efficacy|1|||
126519819|NCT02627677|455196036|FG001|Overall Study|Lack of Efficacy|2|||
126519820|NCT02627677|455196037|FG002|Overall Study|Lack of Efficacy|0|||
126519821|NCT02627677|455196035|FG000|Overall Study|Lost to Follow-up|0|||
126519822|NCT02627677|455196036|FG001|Overall Study|Lost to Follow-up|0|||
126519823|NCT02627677|455196037|FG002|Overall Study|Lost to Follow-up|1|||
126519824|NCT02627677|455196035|FG000|Overall Study|Pregnancy|0|||
126519825|NCT02627677|455196036|FG001|Overall Study|Pregnancy|1|||
126519826|NCT02627677|455196037|FG002|Overall Study|Pregnancy|0|||
126519827|NCT02627677|455196035|FG000|Overall Study|Study Terminated by Sponsor|5|||
126519828|NCT02627677|455196036|FG001|Overall Study|Study Terminated by Sponsor|10|||
126519829|NCT02627677|455196037|FG002|Overall Study|Study Terminated by Sponsor|6|||
126519830|NCT02627677|455196035|FG000|Overall Study|Physician Decision|0|||
126519831|NCT02627677|455196036|FG001|Overall Study|Physician Decision|0|||
126519832|NCT02627677|455196037|FG002|Overall Study|Physician Decision|2|||
126519833|NCT02627677|455196035|FG000|Overall Study|Withdrawal by Subject|2|||
126519834|NCT02627677|455196036|FG001|Overall Study|Withdrawal by Subject|1|||
126519835|NCT02627677|455196037|FG002|Overall Study|Withdrawal by Subject|1|||
126519836|NCT02627677|455196035|FG000|Overall Study|Reason not Specified|0|||
126519837|NCT02627677|455196036|FG001|Overall Study|Reason not Specified|0|||
126519838|NCT02627677|455196037|FG002|Overall Study|Reason not Specified|1|||
126519839|NCT02627677|455196035|FG000|Overall Study|Randomized but not Treated|1|||
126519840|NCT02627677|455196036|FG001|Overall Study|Randomized but not Treated|0|||
126519841|NCT02627677|455196037|FG002|Overall Study|Randomized but not Treated|0|||
126519842|NCT00966940|455196038|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
126519843|NCT00966940|455196039|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
126519844|NCT00966940|455196038|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
126519845|NCT00966940|455196039|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
126519846|NCT02044510|455196040|FG000|Overall Study|Adverse Event|1|||
126727307|NCT02358369|455951111|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
126727308|NCT02358369|455951112|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
126519847|NCT02044510|455196041|FG001|Overall Study|Adverse Event|2|||
126519848|NCT03455855|455196042|FG000|Overall Study|Lost to Follow-up|4|||
126519849|NCT03455855|455196043|FG001|Overall Study|Lost to Follow-up|2|||
126519850|NCT00581945|455196046|FG000|Overall Study|Adverse Event|4|||
126519851|NCT00581945|455196047|FG001|Overall Study|Adverse Event|4|||
126519852|NCT00581945|455196046|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126519853|NCT00581945|455196047|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126519854|NCT00581945|455196046|FG000|Overall Study|Withdrawal by Subject|2|||
126519855|NCT00581945|455196047|FG001|Overall Study|Withdrawal by Subject|6|||
126519856|NCT00581945|455196046|FG000|Overall Study|Death|1|||
126519857|NCT00581945|455196047|FG001|Overall Study|Death|0|||
126519858|NCT01075321|455196052|FG000|Overall Study|Withdrawal by Subject|0|||
126519859|NCT01075321|455196053|FG001|Overall Study|Withdrawal by Subject|0|||
126519860|NCT01075321|455196054|FG002|Overall Study|Withdrawal by Subject|1|||
126519861|NCT01075321|455196055|FG003|Overall Study|Withdrawal by Subject|1|||
126519862|NCT01075321|455196052|FG000|Overall Study|Protocol Violation|0|||
126519863|NCT01075321|455196053|FG001|Overall Study|Protocol Violation|0|||
126519864|NCT01075321|455196054|FG002|Overall Study|Protocol Violation|1|||
126519865|NCT01075321|455196055|FG003|Overall Study|Protocol Violation|0|||
126519866|NCT01075321|455196052|FG000|Overall Study|Treatment Incomplete due to progression|1|||
126519867|NCT01075321|455196053|FG001|Overall Study|Treatment Incomplete due to progression|0|||
126519868|NCT01075321|455196054|FG002|Overall Study|Treatment Incomplete due to progression|0|||
126519869|NCT01075321|455196055|FG003|Overall Study|Treatment Incomplete due to progression|0|||
126519870|NCT01075321|455196052|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
126519871|NCT01075321|455196053|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
126519872|NCT01075321|455196054|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
126519873|NCT01075321|455196055|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
126519874|NCT01933334|455196059|FG000|Overall Study|Adverse Event|5|||
126519875|NCT01933334|455196060|FG001|Overall Study|Adverse Event|1|||
126519876|NCT01933334|455196059|FG000|Overall Study|Withdrawal by Subject|0|||
126519877|NCT01933334|455196060|FG001|Overall Study|Withdrawal by Subject|1|||
126519878|NCT01722331|455196061|FG000|Part 1|Adverse Event|5|||
126519879|NCT01722331|455196062|FG001|Part 1|Adverse Event|0|||
126519880|NCT01722331|455196063|FG002|Part 1|Adverse Event|0|||
126519881|NCT01722331|455196064|FG003|Part 1|Adverse Event|0|||
126519882|NCT01722331|455196065|FG004|Part 1|Adverse Event|0|||
126519883|NCT01722331|455196066|FG005|Part 1|Adverse Event|0|||
126519884|NCT01722331|455196067|FG006|Part 1|Adverse Event|0|||
126519885|NCT01722331|455196061|FG000|Part 1|Lack of Efficacy|0|||
126519886|NCT01722331|455196062|FG001|Part 1|Lack of Efficacy|0|||
126519887|NCT01722331|455196063|FG002|Part 1|Lack of Efficacy|1|||
126519888|NCT01722331|455196064|FG003|Part 1|Lack of Efficacy|0|||
126519889|NCT01722331|455196065|FG004|Part 1|Lack of Efficacy|2|||
126519890|NCT01722331|455196066|FG005|Part 1|Lack of Efficacy|0|||
126519891|NCT01722331|455196067|FG006|Part 1|Lack of Efficacy|0|||
126519892|NCT01722331|455196061|FG000|Part 1|Lost to Follow-up|1|||
126519893|NCT01722331|455196062|FG001|Part 1|Lost to Follow-up|0|||
126519894|NCT01722331|455196063|FG002|Part 1|Lost to Follow-up|2|||
126519895|NCT01722331|455196064|FG003|Part 1|Lost to Follow-up|0|||
126519896|NCT01722331|455196065|FG004|Part 1|Lost to Follow-up|1|||
126519897|NCT01722331|455196066|FG005|Part 1|Lost to Follow-up|0|||
126519898|NCT01722331|455196067|FG006|Part 1|Lost to Follow-up|0|||
126519899|NCT01722331|455196061|FG000|Part 1|Physician Decision|0|||
126519900|NCT01722331|455196062|FG001|Part 1|Physician Decision|0|||
126519901|NCT01722331|455196063|FG002|Part 1|Physician Decision|3|||
126519902|NCT01722331|455196064|FG003|Part 1|Physician Decision|0|||
126519903|NCT01722331|455196065|FG004|Part 1|Physician Decision|1|||
126519904|NCT01722331|455196066|FG005|Part 1|Physician Decision|0|||
126519905|NCT01722331|455196067|FG006|Part 1|Physician Decision|0|||
126519906|NCT01722331|455196061|FG000|Part 1|Pregnancy|1|||
126519907|NCT01722331|455196062|FG001|Part 1|Pregnancy|0|||
126519908|NCT01722331|455196063|FG002|Part 1|Pregnancy|0|||
126519909|NCT01722331|455196064|FG003|Part 1|Pregnancy|0|||
126519910|NCT01722331|455196065|FG004|Part 1|Pregnancy|0|||
126519911|NCT01722331|455196066|FG005|Part 1|Pregnancy|0|||
126519912|NCT01722331|455196067|FG006|Part 1|Pregnancy|0|||
126519913|NCT01722331|455196061|FG000|Part 1|Progressive Disease|0|||
126519914|NCT01722331|455196062|FG001|Part 1|Progressive Disease|0|||
126519915|NCT01722331|455196063|FG002|Part 1|Progressive Disease|0|||
126519916|NCT01722331|455196064|FG003|Part 1|Progressive Disease|0|||
126519917|NCT01722331|455196065|FG004|Part 1|Progressive Disease|1|||
126519918|NCT01722331|455196066|FG005|Part 1|Progressive Disease|0|||
126519919|NCT01722331|455196067|FG006|Part 1|Progressive Disease|0|||
126519920|NCT01722331|455196061|FG000|Part 1|Protocol Violation|1|||
126519921|NCT01722331|455196062|FG001|Part 1|Protocol Violation|0|||
126519922|NCT01722331|455196063|FG002|Part 1|Protocol Violation|0|||
126519923|NCT01722331|455196064|FG003|Part 1|Protocol Violation|0|||
126519924|NCT01722331|455196065|FG004|Part 1|Protocol Violation|1|||
126519925|NCT01722331|455196066|FG005|Part 1|Protocol Violation|0|||
126519926|NCT01722331|455196067|FG006|Part 1|Protocol Violation|0|||
126519927|NCT01722331|455196061|FG000|Part 1|Withdrawal by Subject|2|||
126519928|NCT01722331|455196062|FG001|Part 1|Withdrawal by Subject|0|||
126519929|NCT01722331|455196063|FG002|Part 1|Withdrawal by Subject|3|||
126519930|NCT01722331|455196064|FG003|Part 1|Withdrawal by Subject|0|||
126519931|NCT01722331|455196065|FG004|Part 1|Withdrawal by Subject|3|||
126519932|NCT01722331|455196066|FG005|Part 1|Withdrawal by Subject|0|||
126519933|NCT01722331|455196067|FG006|Part 1|Withdrawal by Subject|0|||
126519934|NCT01722331|455196061|FG000|Part 2|Adverse Event|3|||
126519935|NCT01722331|455196062|FG001|Part 2|Adverse Event|0|||
126519936|NCT01722331|455196063|FG002|Part 2|Adverse Event|0|||
126519937|NCT01722331|455196064|FG003|Part 2|Adverse Event|0|||
126519938|NCT01722331|455196065|FG004|Part 2|Adverse Event|0|||
126519939|NCT01722331|455196066|FG005|Part 2|Adverse Event|1|||
126519940|NCT01722331|455196067|FG006|Part 2|Adverse Event|0|||
126519941|NCT01722331|455196061|FG000|Part 2|Lack of Efficacy|3|||
126519942|NCT01722331|455196062|FG001|Part 2|Lack of Efficacy|0|||
126519943|NCT01722331|455196063|FG002|Part 2|Lack of Efficacy|11|||
126519944|NCT01722331|455196064|FG003|Part 2|Lack of Efficacy|0|||
126519945|NCT01722331|455196065|FG004|Part 2|Lack of Efficacy|0|||
126519946|NCT01722331|455196066|FG005|Part 2|Lack of Efficacy|3|||
126519947|NCT01722331|455196067|FG006|Part 2|Lack of Efficacy|3|||
126519948|NCT01722331|455196061|FG000|Part 2|Lost to Follow-up|0|||
126519949|NCT01722331|455196062|FG001|Part 2|Lost to Follow-up|0|||
126519950|NCT01722331|455196063|FG002|Part 2|Lost to Follow-up|3|||
126519951|NCT01722331|455196064|FG003|Part 2|Lost to Follow-up|0|||
126519952|NCT01722331|455196065|FG004|Part 2|Lost to Follow-up|0|||
126519953|NCT01722331|455196066|FG005|Part 2|Lost to Follow-up|1|||
126519954|NCT01722331|455196067|FG006|Part 2|Lost to Follow-up|1|||
126519955|NCT01722331|455196061|FG000|Part 2|Non-Compliance with Study Drug|1|||
126519956|NCT01722331|455196062|FG001|Part 2|Non-Compliance with Study Drug|0|||
126519957|NCT01722331|455196063|FG002|Part 2|Non-Compliance with Study Drug|1|||
126519958|NCT01722331|455196064|FG003|Part 2|Non-Compliance with Study Drug|0|||
126519959|NCT01722331|455196065|FG004|Part 2|Non-Compliance with Study Drug|0|||
126519960|NCT01722331|455196066|FG005|Part 2|Non-Compliance with Study Drug|0|||
126519961|NCT01722331|455196067|FG006|Part 2|Non-Compliance with Study Drug|0|||
126519962|NCT01722331|455196061|FG000|Part 2|Physician Decision|0|||
126519963|NCT01722331|455196062|FG001|Part 2|Physician Decision|0|||
126519964|NCT01722331|455196063|FG002|Part 2|Physician Decision|2|||
126519965|NCT01722331|455196064|FG003|Part 2|Physician Decision|0|||
126519966|NCT01722331|455196065|FG004|Part 2|Physician Decision|0|||
126519967|NCT01722331|455196066|FG005|Part 2|Physician Decision|0|||
126519968|NCT01722331|455196067|FG006|Part 2|Physician Decision|0|||
126519969|NCT01722331|455196061|FG000|Part 2|Pregnancy|0|||
126519970|NCT01722331|455196062|FG001|Part 2|Pregnancy|0|||
126519971|NCT01722331|455196063|FG002|Part 2|Pregnancy|0|||
126519972|NCT01722331|455196064|FG003|Part 2|Pregnancy|0|||
126519973|NCT01722331|455196065|FG004|Part 2|Pregnancy|0|||
126519974|NCT01722331|455196066|FG005|Part 2|Pregnancy|1|||
126519975|NCT01722331|455196067|FG006|Part 2|Pregnancy|0|||
126519976|NCT01722331|455196061|FG000|Part 2|Progressive Disease|0|||
126519977|NCT01722331|455196062|FG001|Part 2|Progressive Disease|0|||
126519978|NCT01722331|455196063|FG002|Part 2|Progressive Disease|1|||
126519979|NCT01722331|455196064|FG003|Part 2|Progressive Disease|0|||
126519980|NCT01722331|455196065|FG004|Part 2|Progressive Disease|0|||
126519981|NCT01722331|455196066|FG005|Part 2|Progressive Disease|0|||
126519982|NCT01722331|455196067|FG006|Part 2|Progressive Disease|0|||
126519983|NCT01722331|455196061|FG000|Part 2|Protocol Violation|1|||
126519984|NCT01722331|455196062|FG001|Part 2|Protocol Violation|0|||
126519985|NCT01722331|455196063|FG002|Part 2|Protocol Violation|0|||
126519986|NCT01722331|455196064|FG003|Part 2|Protocol Violation|0|||
126519987|NCT01722331|455196065|FG004|Part 2|Protocol Violation|0|||
126519988|NCT01722331|455196066|FG005|Part 2|Protocol Violation|0|||
126519989|NCT01722331|455196067|FG006|Part 2|Protocol Violation|0|||
126519990|NCT01722331|455196061|FG000|Part 2|Withdrawal by Subject|5|||
126519991|NCT01722331|455196062|FG001|Part 2|Withdrawal by Subject|0|||
126519992|NCT01722331|455196063|FG002|Part 2|Withdrawal by Subject|3|||
126519993|NCT01722331|455196064|FG003|Part 2|Withdrawal by Subject|0|||
126519994|NCT01722331|455196065|FG004|Part 2|Withdrawal by Subject|0|||
126519995|NCT01722331|455196066|FG005|Part 2|Withdrawal by Subject|2|||
126519996|NCT01722331|455196067|FG006|Part 2|Withdrawal by Subject|2|||
126519997|NCT01722331|455196061|FG000|Part 2|Other Protocol Specified Criteria|6|||
126519998|NCT01722331|455196062|FG001|Part 2|Other Protocol Specified Criteria|0|||
126519999|NCT01722331|455196063|FG002|Part 2|Other Protocol Specified Criteria|10|||
126520000|NCT01722331|455196064|FG003|Part 2|Other Protocol Specified Criteria|0|||
126520001|NCT01722331|455196065|FG004|Part 2|Other Protocol Specified Criteria|0|||
126520002|NCT01722331|455196066|FG005|Part 2|Other Protocol Specified Criteria|2|||
126520003|NCT01722331|455196067|FG006|Part 2|Other Protocol Specified Criteria|1|||
126520004|NCT01722331|455196061|FG000|Part 3|Adverse Event|2|||
126520005|NCT01722331|455196062|FG001|Part 3|Adverse Event|2|||
126520006|NCT01722331|455196063|FG002|Part 3|Adverse Event|0|||
126520007|NCT01722331|455196064|FG003|Part 3|Adverse Event|1|||
126520008|NCT01722331|455196065|FG004|Part 3|Adverse Event|0|||
126520009|NCT01722331|455196066|FG005|Part 3|Adverse Event|0|||
126520010|NCT01722331|455196067|FG006|Part 3|Adverse Event|0|||
126520011|NCT01722331|455196061|FG000|Part 3|Death|1|||
126520012|NCT01722331|455196062|FG001|Part 3|Death|0|||
126520013|NCT01722331|455196063|FG002|Part 3|Death|0|||
126520014|NCT01722331|455196064|FG003|Part 3|Death|0|||
126520015|NCT01722331|455196065|FG004|Part 3|Death|0|||
126520016|NCT01722331|455196066|FG005|Part 3|Death|0|||
126520017|NCT01722331|455196067|FG006|Part 3|Death|0|||
126520018|NCT01722331|455196061|FG000|Part 3|Lack of Efficacy|1|||
126520019|NCT01722331|455196062|FG001|Part 3|Lack of Efficacy|0|||
126520020|NCT01722331|455196063|FG002|Part 3|Lack of Efficacy|0|||
126520021|NCT01722331|455196064|FG003|Part 3|Lack of Efficacy|0|||
126520022|NCT01722331|455196065|FG004|Part 3|Lack of Efficacy|0|||
126520023|NCT01722331|455196066|FG005|Part 3|Lack of Efficacy|0|||
126520024|NCT01722331|455196067|FG006|Part 3|Lack of Efficacy|0|||
126520025|NCT01722331|455196061|FG000|Part 3|Lost to Follow-up|3|||
126520026|NCT01722331|455196062|FG001|Part 3|Lost to Follow-up|4|||
126520027|NCT01722331|455196063|FG002|Part 3|Lost to Follow-up|0|||
126520028|NCT01722331|455196064|FG003|Part 3|Lost to Follow-up|0|||
126520029|NCT01722331|455196065|FG004|Part 3|Lost to Follow-up|0|||
126520030|NCT01722331|455196066|FG005|Part 3|Lost to Follow-up|1|||
126520031|NCT01722331|455196067|FG006|Part 3|Lost to Follow-up|0|||
126520032|NCT01722331|455196061|FG000|Part 3|Non-Compliance with Study Drug|0|||
126520033|NCT01722331|455196062|FG001|Part 3|Non-Compliance with Study Drug|1|||
126520034|NCT01722331|455196063|FG002|Part 3|Non-Compliance with Study Drug|0|||
126520035|NCT01722331|455196064|FG003|Part 3|Non-Compliance with Study Drug|0|||
126520036|NCT01722331|455196065|FG004|Part 3|Non-Compliance with Study Drug|0|||
126520037|NCT01722331|455196066|FG005|Part 3|Non-Compliance with Study Drug|0|||
126520038|NCT01722331|455196067|FG006|Part 3|Non-Compliance with Study Drug|0|||
126520039|NCT01722331|455196061|FG000|Part 3|Physician Decision|1|||
126520040|NCT01722331|455196062|FG001|Part 3|Physician Decision|1|||
126520041|NCT01722331|455196063|FG002|Part 3|Physician Decision|0|||
126520042|NCT01722331|455196064|FG003|Part 3|Physician Decision|0|||
126520043|NCT01722331|455196065|FG004|Part 3|Physician Decision|0|||
126520044|NCT01722331|455196066|FG005|Part 3|Physician Decision|0|||
126520045|NCT01722331|455196067|FG006|Part 3|Physician Decision|1|||
126520046|NCT01722331|455196061|FG000|Part 3|Protocol Violation|2|||
126520047|NCT01722331|455196062|FG001|Part 3|Protocol Violation|1|||
126520048|NCT01722331|455196063|FG002|Part 3|Protocol Violation|0|||
126520049|NCT01722331|455196064|FG003|Part 3|Protocol Violation|0|||
126520050|NCT01722331|455196065|FG004|Part 3|Protocol Violation|0|||
126520051|NCT01722331|455196066|FG005|Part 3|Protocol Violation|0|||
126520052|NCT01722331|455196067|FG006|Part 3|Protocol Violation|0|||
126520053|NCT01722331|455196061|FG000|Part 3|Withdrawal by Subject|4|||
126520054|NCT01722331|455196062|FG001|Part 3|Withdrawal by Subject|7|||
126520055|NCT01722331|455196063|FG002|Part 3|Withdrawal by Subject|0|||
126520056|NCT01722331|455196064|FG003|Part 3|Withdrawal by Subject|0|||
126520057|NCT01722331|455196065|FG004|Part 3|Withdrawal by Subject|0|||
126520058|NCT01722331|455196066|FG005|Part 3|Withdrawal by Subject|2|||
126520059|NCT01722331|455196067|FG006|Part 3|Withdrawal by Subject|1|||
126520060|NCT01722331|455196061|FG000|Part 3|Other Protocol Specified Criteria|1|||
126520061|NCT01722331|455196062|FG001|Part 3|Other Protocol Specified Criteria|1|||
126520062|NCT01722331|455196063|FG002|Part 3|Other Protocol Specified Criteria|0|||
126520063|NCT01722331|455196064|FG003|Part 3|Other Protocol Specified Criteria|0|||
126520064|NCT01722331|455196065|FG004|Part 3|Other Protocol Specified Criteria|0|||
126520065|NCT01722331|455196066|FG005|Part 3|Other Protocol Specified Criteria|0|||
126520066|NCT01722331|455196067|FG006|Part 3|Other Protocol Specified Criteria|0|||
126520067|NCT00262834|455196068|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
126520068|NCT00262834|455196069|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
126520069|NCT00003457|455196070|FG000|Overall Study|Not evaluable|9|||
126520070|NCT00466193|455196071|FG000|Overall Study|Adverse Event|0|||
126520071|NCT00466193|455196072|FG001|Overall Study|Adverse Event|1|||
126520072|NCT00466193|455196071|FG000|Overall Study|Lost to Follow-up|2|||
126520073|NCT00466193|455196072|FG001|Overall Study|Lost to Follow-up|4|||
126520074|NCT00466193|455196071|FG000|Overall Study|Physician Decision|1|||
126520075|NCT00466193|455196072|FG001|Overall Study|Physician Decision|0|||
126520076|NCT00466193|455196071|FG000|Overall Study|Protocol Violation|1|||
126520077|NCT00466193|455196072|FG001|Overall Study|Protocol Violation|1|||
126520078|NCT00466193|455196071|FG000|Overall Study|Withdrawal by Subject|7|||
126520079|NCT00466193|455196072|FG001|Overall Study|Withdrawal by Subject|2|||
126520080|NCT00466193|455196071|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
126520081|NCT00466193|455196072|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
126520082|NCT02246998|455196073|FG000|Overall Study|Adverse Event|0|||
126520083|NCT02246998|455196074|FG001|Overall Study|Adverse Event|1|||
126520084|NCT02246998|455196075|FG002|Overall Study|Adverse Event|1|||
126520085|NCT02246998|455196076|FG003|Overall Study|Adverse Event|0|||
126520086|NCT02246998|455196073|FG000|Overall Study|Lost to Follow-up|1|||
126520087|NCT02246998|455196074|FG001|Overall Study|Lost to Follow-up|0|||
126520088|NCT02246998|455196075|FG002|Overall Study|Lost to Follow-up|0|||
126520089|NCT02246998|455196076|FG003|Overall Study|Lost to Follow-up|1|||
126520090|NCT02246998|455196073|FG000|Overall Study|Randomized but Never Dosed|1|||
126520091|NCT02246998|455196074|FG001|Overall Study|Randomized but Never Dosed|2|||
126520092|NCT02246998|455196075|FG002|Overall Study|Randomized but Never Dosed|2|||
126520093|NCT02246998|455196076|FG003|Overall Study|Randomized but Never Dosed|1|||
126520094|NCT02525133|455196079|FG000|Overall Study|Adverse Event|0|||
126520095|NCT02525133|455196080|FG001|Overall Study|Adverse Event|1|||
126520096|NCT02525133|455196079|FG000|Overall Study|Death|0|||
126520097|NCT02525133|455196080|FG001|Overall Study|Death|1|||
126520098|NCT02525133|455196079|FG000|Overall Study|did not meet randomization criteria|1|||
126520099|NCT02525133|455196080|FG001|Overall Study|did not meet randomization criteria|0|||
126520100|NCT02525133|455196079|FG000|Overall Study|Lost to Follow-up|5|||
126520101|NCT02525133|455196080|FG001|Overall Study|Lost to Follow-up|1|||
126520102|NCT02525133|455196079|FG000|Overall Study|randomized not enrolled|3|||
126520103|NCT02525133|455196080|FG001|Overall Study|randomized not enrolled|0|||
126520104|NCT02525133|455196079|FG000|Overall Study|Withdrawal by Subject|1|||
126520105|NCT02525133|455196080|FG001|Overall Study|Withdrawal by Subject|0|||
126520106|NCT01343082|455196081|FG000|The run-in Period|Not meeting criteria|3|||
126520107|NCT01343082|455196082|FG001|The run-in Period|Not meeting criteria|4|||
126520108|NCT01343082|455196083|FG002|The run-in Period|Not meeting criteria|5|||
126520109|NCT01343082|455196081|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
126520110|NCT01343082|455196082|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
126520111|NCT01343082|455196083|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
126520112|NCT01343082|455196081|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
126520113|NCT01343082|455196082|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
126520114|NCT01343082|455196083|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
126520115|NCT01343082|455196081|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
126520116|NCT01343082|455196082|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
126520117|NCT01343082|455196083|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
126520118|NCT01343082|455196081|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
126520119|NCT01343082|455196082|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
126520120|NCT01343082|455196083|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
126520121|NCT01075074|455196084|FG000|Overall Study|Surgeon changed to open incisional case|1|||
126520122|NCT01075074|455196085|FG001|Overall Study|Surgeon changed to open incisional case|2|||
126520123|NCT01075074|455196086|FG002|Overall Study|Surgeon changed to open incisional case|2|||
126520124|NCT01054729|455196087|FG000|Overall Study|Randomized but Not Treated|0|||
126520125|NCT01054729|455196088|FG001|Overall Study|Randomized but Not Treated|1|||
126520126|NCT01054729|455196089|FG002|Overall Study|Randomized but Not Treated|0|||
126520127|NCT01054729|455196090|FG003|Overall Study|Randomized but Not Treated|0|||
126520128|NCT01054729|455196087|FG000|Overall Study|Adverse Event|1|||
126520129|NCT01054729|455196088|FG001|Overall Study|Adverse Event|1|||
126520130|NCT01054729|455196089|FG002|Overall Study|Adverse Event|2|||
126520131|NCT01054729|455196090|FG003|Overall Study|Adverse Event|1|||
126520132|NCT01054729|455196087|FG000|Overall Study|Withdrawal by Subject|1|||
126520133|NCT01054729|455196088|FG001|Overall Study|Withdrawal by Subject|0|||
126520134|NCT01054729|455196089|FG002|Overall Study|Withdrawal by Subject|1|||
126520135|NCT01054729|455196090|FG003|Overall Study|Withdrawal by Subject|0|||
126520136|NCT01054729|455196087|FG000|Overall Study|Lost to Follow-up|0|||
126520137|NCT01054729|455196088|FG001|Overall Study|Lost to Follow-up|1|||
126520138|NCT01054729|455196089|FG002|Overall Study|Lost to Follow-up|0|||
126520139|NCT01054729|455196090|FG003|Overall Study|Lost to Follow-up|0|||
126520140|NCT01054729|455196087|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
126520141|NCT01054729|455196088|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
126520142|NCT01054729|455196089|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
126520143|NCT01054729|455196090|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
126520144|NCT01054729|455196087|FG000|Overall Study|Non-responder|1|||
126520145|NCT01054729|455196088|FG001|Overall Study|Non-responder|0|||
126520146|NCT01054729|455196089|FG002|Overall Study|Non-responder|1|||
126520147|NCT01054729|455196090|FG003|Overall Study|Non-responder|1|||
126520148|NCT01054729|455196087|FG000|Overall Study|PEG/RBV Non-responder|1|||
126520149|NCT01054729|455196088|FG001|Overall Study|PEG/RBV Non-responder|0|||
126520150|NCT01054729|455196089|FG002|Overall Study|PEG/RBV Non-responder|1|||
126520151|NCT01054729|455196090|FG003|Overall Study|PEG/RBV Non-responder|0|||
126520152|NCT01054729|455196087|FG000|Overall Study|Personal/Obligations|0|||
126520153|NCT01054729|455196088|FG001|Overall Study|Personal/Obligations|1|||
126520154|NCT01054729|455196089|FG002|Overall Study|Personal/Obligations|0|||
126520155|NCT01054729|455196090|FG003|Overall Study|Personal/Obligations|0|||
126520156|NCT01054729|455196087|FG000|Overall Study|Subject moved|0|||
126520157|NCT01054729|455196088|FG001|Overall Study|Subject moved|0|||
126520158|NCT01054729|455196089|FG002|Overall Study|Subject moved|1|||
126520159|NCT01054729|455196090|FG003|Overall Study|Subject moved|0|||
126520160|NCT01054729|455196087|FG000|Overall Study|Lack of Efficacy|0|||
126727309|NCT02358369|455951113|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
126520161|NCT01054729|455196088|FG001|Overall Study|Lack of Efficacy|0|||
126520162|NCT01054729|455196089|FG002|Overall Study|Lack of Efficacy|0|||
126520163|NCT01054729|455196090|FG003|Overall Study|Lack of Efficacy|1|||
126520164|NCT01575561|455196091|FG000|Overall Study|Adverse Event|9|||
126520165|NCT01575561|455196091|FG000|Overall Study|Lack of Efficacy|8|||
126520166|NCT01575561|455196091|FG000|Overall Study|Lost to Follow-up|6|||
126520167|NCT01575561|455196091|FG000|Overall Study|Protocol Violation|4|||
126520168|NCT01575561|455196091|FG000|Overall Study|Withdrawal by Subject|11|||
126520169|NCT01575561|455196091|FG000|Overall Study|administration|1|||
126520170|NCT02496884|455196092|FG000|Overall Study|Counted twice as enrolled|2|||
126520171|NCT02496884|455196093|FG001|Overall Study|Counted twice as enrolled|0|||
126520172|NCT02496884|455196094|FG002|Overall Study|Counted twice as enrolled|0|||
126520173|NCT02496884|455196095|FG003|Overall Study|Counted twice as enrolled|0|||
126520174|NCT02496884|455196092|FG000|Overall Study|Withdrawal by Subject|0|||
126520175|NCT02496884|455196093|FG001|Overall Study|Withdrawal by Subject|3|||
126520176|NCT02496884|455196094|FG002|Overall Study|Withdrawal by Subject|0|||
126520177|NCT02496884|455196095|FG003|Overall Study|Withdrawal by Subject|0|||
126520178|NCT01033747|455196096|FG000|Overall Study|Adverse Event|9|||
126520179|NCT01033747|455196097|FG001|Overall Study|Adverse Event|4|||
126520180|NCT01033747|455196096|FG000|Overall Study|Abnormal Laboratory Value|1|||
126520181|NCT01033747|455196097|FG001|Overall Study|Abnormal Laboratory Value|0|||
126520182|NCT01033747|455196096|FG000|Overall Study|Abnormal test procedure|0|||
126520183|NCT01033747|455196097|FG001|Overall Study|Abnormal test procedure|1|||
126520184|NCT01033747|455196096|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
126520185|NCT01033747|455196097|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
126520186|NCT01033747|455196096|FG000|Overall Study|Protocol Violation|1|||
126520187|NCT01033747|455196097|FG001|Overall Study|Protocol Violation|0|||
126520188|NCT01033747|455196096|FG000|Overall Study|Withdrawal by Subject|9|||
126520189|NCT01033747|455196097|FG001|Overall Study|Withdrawal by Subject|6|||
126520190|NCT01033747|455196096|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
126520191|NCT01033747|455196097|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
126520192|NCT01033747|455196096|FG000|Overall Study|Stopped at end of Extension 1|2|||
126520193|NCT01033747|455196097|FG001|Overall Study|Stopped at end of Extension 1|0|||
126520194|NCT02956629|455196098|FG000|Overall Study|Adverse Event|0|||
126520195|NCT02956629|455196099|FG001|Overall Study|Adverse Event|0|||
126520196|NCT02956629|455196100|FG002|Overall Study|Adverse Event|1|||
126520197|NCT02956629|455196101|FG003|Overall Study|Adverse Event|0|||
126520198|NCT02956629|455196102|FG004|Overall Study|Adverse Event|0|||
126520199|NCT02956629|455196103|FG005|Overall Study|Adverse Event|0|||
126520200|NCT02956629|455196098|FG000|Overall Study|Lost to Follow-up|2|||
126520201|NCT02956629|455196099|FG001|Overall Study|Lost to Follow-up|5|||
126520202|NCT02956629|455196100|FG002|Overall Study|Lost to Follow-up|3|||
126520203|NCT02956629|455196101|FG003|Overall Study|Lost to Follow-up|1|||
126520204|NCT02956629|455196102|FG004|Overall Study|Lost to Follow-up|0|||
126520205|NCT02956629|455196103|FG005|Overall Study|Lost to Follow-up|1|||
126520206|NCT02956629|455196098|FG000|Overall Study|Withdrawal by Subject|3|||
126520207|NCT02956629|455196099|FG001|Overall Study|Withdrawal by Subject|1|||
126520208|NCT02956629|455196100|FG002|Overall Study|Withdrawal by Subject|0|||
126520209|NCT02956629|455196101|FG003|Overall Study|Withdrawal by Subject|0|||
126520210|NCT02956629|455196102|FG004|Overall Study|Withdrawal by Subject|0|||
126520211|NCT02956629|455196103|FG005|Overall Study|Withdrawal by Subject|0|||
126520212|NCT00844194|455196104|FG000|Overall Study|Adverse Event|17|||
126520213|NCT00844194|455196105|FG001|Overall Study|Adverse Event|5|||
126520214|NCT00844194|455196104|FG000|Overall Study|Protocol Violation|1|||
126520215|NCT00844194|455196105|FG001|Overall Study|Protocol Violation|1|||
126520216|NCT00844194|455196104|FG000|Overall Study|Lost to Follow-up|1|||
126520217|NCT00844194|455196105|FG001|Overall Study|Lost to Follow-up|1|||
126520218|NCT00844194|455196104|FG000|Overall Study|Withdrawal by Subject|2|||
126520219|NCT00844194|455196105|FG001|Overall Study|Withdrawal by Subject|1|||
126520220|NCT00844194|455196104|FG000|Overall Study|Lack of Efficacy|3|||
126520221|NCT00844194|455196105|FG001|Overall Study|Lack of Efficacy|0|||
126520222|NCT00844194|455196104|FG000|Overall Study|Other reason (not specified)|1|||
126520223|NCT00844194|455196105|FG001|Overall Study|Other reason (not specified)|0|||
126520224|NCT00803023|455196110|FG000|Overall Study|Adverse Event|5|||
126520225|NCT00803023|455196111|FG001|Overall Study|Adverse Event|4|||
126520226|NCT00803023|455196112|FG002|Overall Study|Adverse Event|8|||
126520227|NCT00803023|455196113|FG003|Overall Study|Adverse Event|6|||
126520228|NCT00803023|455196110|FG000|Overall Study|Withdrawal by Subject|0|||
126520229|NCT00803023|455196111|FG001|Overall Study|Withdrawal by Subject|2|||
126520230|NCT00803023|455196112|FG002|Overall Study|Withdrawal by Subject|0|||
126520231|NCT00803023|455196113|FG003|Overall Study|Withdrawal by Subject|0|||
126520232|NCT00803023|455196110|FG000|Overall Study|Lost to Follow-up|0|||
126520233|NCT00803023|455196111|FG001|Overall Study|Lost to Follow-up|1|||
126520234|NCT00803023|455196112|FG002|Overall Study|Lost to Follow-up|2|||
126520235|NCT00803023|455196113|FG003|Overall Study|Lost to Follow-up|1|||
126520236|NCT00803023|455196110|FG000|Overall Study|Lack of Efficacy|0|||
126520237|NCT00803023|455196111|FG001|Overall Study|Lack of Efficacy|1|||
126520238|NCT00803023|455196112|FG002|Overall Study|Lack of Efficacy|1|||
126520239|NCT00803023|455196113|FG003|Overall Study|Lack of Efficacy|1|||
126520240|NCT02647658|455196114|FG000|Overall Study|Consent refusal|15|||
126573160|NCT01135511|455394366|FG003|Overall Study|Lack of Efficacy|2|||
126520241|NCT02647658|455196115|FG001|Overall Study|Consent refusal|24|||
126573161|NCT01135511|455394367|FG004|Overall Study|Lack of Efficacy|0|||
126520242|NCT01542528|455196116|FG000|Overall Study|Lost to Follow-up|2|||
126520243|NCT01542528|455196117|FG001|Overall Study|Lost to Follow-up|1|||
126520244|NCT01542528|455196116|FG000|Overall Study|Physician Decision|1|||
126520245|NCT01542528|455196117|FG001|Overall Study|Physician Decision|0|||
126520246|NCT01542528|455196116|FG000|Overall Study|Withdrawal by Subject|9|||
126520247|NCT01542528|455196117|FG001|Overall Study|Withdrawal by Subject|6|||
126520248|NCT01931839|455196120|FG000|Overall Study|Death|0|||
126520249|NCT01931839|455196121|FG001|Overall Study|Death|1|||
126520250|NCT01931839|455196122|FG002|Overall Study|Death|2|||
126520251|NCT01931839|455196123|FG003|Overall Study|Death|0|||
126520252|NCT01931839|455196124|FG004|Overall Study|Death|0|||
126520253|NCT01931839|455196125|FG005|Overall Study|Death|0|||
126520254|NCT01931839|455196126|FG006|Overall Study|Death|0|||
126520255|NCT01931839|455196120|FG000|Overall Study|Physician Decision|1|||
126520256|NCT01931839|455196121|FG001|Overall Study|Physician Decision|0|||
126520257|NCT01931839|455196122|FG002|Overall Study|Physician Decision|1|||
126520258|NCT01931839|455196123|FG003|Overall Study|Physician Decision|0|||
126520259|NCT01931839|455196124|FG004|Overall Study|Physician Decision|0|||
126520260|NCT01931839|455196125|FG005|Overall Study|Physician Decision|0|||
126520261|NCT01931839|455196126|FG006|Overall Study|Physician Decision|1|||
126520262|NCT01931839|455196120|FG000|Overall Study|Withdrawal of consent|0|||
126520263|NCT01931839|455196121|FG001|Overall Study|Withdrawal of consent|0|||
126520264|NCT01931839|455196122|FG002|Overall Study|Withdrawal of consent|0|||
126520265|NCT01931839|455196123|FG003|Overall Study|Withdrawal of consent|0|||
126520266|NCT01931839|455196124|FG004|Overall Study|Withdrawal of consent|1|||
126520267|NCT01931839|455196125|FG005|Overall Study|Withdrawal of consent|0|||
126520268|NCT01931839|455196126|FG006|Overall Study|Withdrawal of consent|0|||
126520269|NCT01931839|455196120|FG000|Overall Study|Adverse Event|9|||
126520270|NCT01931839|455196121|FG001|Overall Study|Adverse Event|4|||
126520271|NCT01931839|455196122|FG002|Overall Study|Adverse Event|1|||
126520272|NCT01931839|455196123|FG003|Overall Study|Adverse Event|3|||
126520273|NCT01931839|455196124|FG004|Overall Study|Adverse Event|0|||
126520274|NCT01931839|455196125|FG005|Overall Study|Adverse Event|0|||
126520275|NCT01931839|455196126|FG006|Overall Study|Adverse Event|1|||
126520276|NCT01931839|455196120|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
126520277|NCT01931839|455196121|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
126520278|NCT01931839|455196122|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
126520279|NCT01931839|455196123|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
126520280|NCT01931839|455196124|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
126520281|NCT01931839|455196125|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
126520282|NCT01931839|455196126|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
126520283|NCT01931839|455196120|FG000|Overall Study|Other non-compliance|15|||
126520284|NCT01931839|455196121|FG001|Overall Study|Other non-compliance|9|||
126520285|NCT01931839|455196122|FG002|Overall Study|Other non-compliance|12|||
126520286|NCT01931839|455196123|FG003|Overall Study|Other non-compliance|3|||
126520287|NCT01931839|455196124|FG004|Overall Study|Other non-compliance|0|||
126520288|NCT01931839|455196125|FG005|Overall Study|Other non-compliance|3|||
126520289|NCT01931839|455196126|FG006|Overall Study|Other non-compliance|0|||
126520290|NCT01931839|455196120|FG000|Overall Study|Lost to Follow-up|1|||
126520291|NCT01931839|455196121|FG001|Overall Study|Lost to Follow-up|2|||
126520292|NCT01931839|455196122|FG002|Overall Study|Lost to Follow-up|4|||
126520293|NCT01931839|455196123|FG003|Overall Study|Lost to Follow-up|5|||
126520294|NCT01931839|455196124|FG004|Overall Study|Lost to Follow-up|0|||
126520295|NCT01931839|455196125|FG005|Overall Study|Lost to Follow-up|0|||
126520296|NCT01931839|455196126|FG006|Overall Study|Lost to Follow-up|0|||
126520297|NCT01931839|455196120|FG000|Overall Study|Other|4|||
126520298|NCT01931839|455196121|FG001|Overall Study|Other|2|||
126520299|NCT01931839|455196122|FG002|Overall Study|Other|6|||
126520300|NCT01931839|455196123|FG003|Overall Study|Other|0|||
126520301|NCT01931839|455196124|FG004|Overall Study|Other|0|||
126520302|NCT01931839|455196125|FG005|Overall Study|Other|0|||
126520303|NCT01931839|455196126|FG006|Overall Study|Other|0|||
126520304|NCT01762761|455196129|FG000|Overall Study|Adverse Event|15|||
126520305|NCT01762761|455196130|FG001|Overall Study|Adverse Event|17|||
126520306|NCT01762761|455196129|FG000|Overall Study|Lack of Efficacy|9|||
126520307|NCT01762761|455196130|FG001|Overall Study|Lack of Efficacy|25|||
126520308|NCT01762761|455196129|FG000|Overall Study|Protocol Violation|1|||
126520309|NCT01762761|455196130|FG001|Overall Study|Protocol Violation|1|||
126520310|NCT01762761|455196129|FG000|Overall Study|Study closed/terminated|0|||
126520311|NCT01762761|455196130|FG001|Overall Study|Study closed/terminated|2|||
126520312|NCT01762761|455196129|FG000|Overall Study|Lost to Follow-up|3|||
126520313|NCT01762761|455196130|FG001|Overall Study|Lost to Follow-up|6|||
126520314|NCT01762761|455196129|FG000|Overall Study|Physician Decision|4|||
126520315|NCT01762761|455196130|FG001|Overall Study|Physician Decision|6|||
126520316|NCT01762761|455196129|FG000|Overall Study|Withdrawal by Subject|7|||
126520317|NCT01762761|455196130|FG001|Overall Study|Withdrawal by Subject|8|||
126520318|NCT01114646|455196136|FG000|Overall Study|Withdrawal by Subject|3|||
126520319|NCT01114646|455196137|FG001|Overall Study|Withdrawal by Subject|2|||
126520320|NCT02013765|455196145|FG000|Overall Study|Trial was terminated by sponsor|1|||
126520321|NCT00575588|455196150|FG000|Overall Study|Adverse Event|11|||
126520322|NCT00575588|455196151|FG001|Overall Study|Adverse Event|13|||
126520323|NCT00575588|455196150|FG000|Overall Study|Withdrawal by Subject|27|||
126520324|NCT00575588|455196151|FG001|Overall Study|Withdrawal by Subject|31|||
126520325|NCT00575588|455196150|FG000|Overall Study|Lost to Follow-up|1|||
126520326|NCT00575588|455196151|FG001|Overall Study|Lost to Follow-up|3|||
126520327|NCT00575588|455196150|FG000|Overall Study|Death|4|||
126520328|NCT00575588|455196151|FG001|Overall Study|Death|2|||
126520329|NCT00575588|455196150|FG000|Overall Study|Incorrect enrollment|8|||
126520330|NCT00575588|455196151|FG001|Overall Study|Incorrect enrollment|4|||
126520331|NCT00575588|455196150|FG000|Overall Study|Study specific discontinuation criteria|203|||
126520332|NCT00575588|455196151|FG001|Overall Study|Study specific discontinuation criteria|218|||
126520333|NCT00575588|455196150|FG000|Overall Study|Severe non-compliance to protocol|5|||
126520334|NCT00575588|455196151|FG001|Overall Study|Severe non-compliance to protocol|7|||
126520335|NCT00575588|455196150|FG000|Overall Study|Safety reasons|2|||
126520336|NCT00575588|455196151|FG001|Overall Study|Safety reasons|1|||
126520337|NCT00575588|455196150|FG000|Overall Study|Elevated triglyceride|1|||
126520338|NCT00575588|455196151|FG001|Overall Study|Elevated triglyceride|0|||
126520339|NCT00575588|455196150|FG000|Overall Study|Patient moved|1|||
126520340|NCT00575588|455196151|FG001|Overall Study|Patient moved|3|||
126520341|NCT00575588|455196150|FG000|Overall Study|Impossible to determine HbA1c|0|||
126520342|NCT00575588|455196151|FG001|Overall Study|Impossible to determine HbA1c|1|||
126520343|NCT00504829|455196152|FG000|Overall Study|Protocol Violation|6|||
126520344|NCT00504829|455196153|FG001|Overall Study|Protocol Violation|4|||
126520345|NCT00504829|455196154|FG002|Overall Study|Protocol Violation|10|||
126520346|NCT01854827|455196155|FG000|Overall Study|Death|1|||
126520347|NCT02571452|455196156|FG000|Overall Study Treatment|Protocol Violation|0|||
126520348|NCT02571452|455196157|FG001|Overall Study Treatment|Protocol Violation|1|||
126520349|NCT02571452|455196156|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
126520350|NCT02571452|455196157|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
126520351|NCT02571452|455196156|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
126520352|NCT02571452|455196157|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
126520353|NCT01751568|455196162|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
126520354|NCT01751568|455196163|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
126520355|NCT01751568|455196164|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
126520356|NCT02660944|455196173|FG000|Overall Study|Adverse Event|3|||
126520357|NCT02660944|455196174|FG001|Overall Study|Adverse Event|4|||
126520358|NCT02660944|455196173|FG000|Overall Study|Physician Decision|3|||
126520359|NCT02660944|455196174|FG001|Overall Study|Physician Decision|1|||
126520360|NCT02660944|455196173|FG000|Overall Study|Withdrawal by Subject|5|||
126520361|NCT02660944|455196174|FG001|Overall Study|Withdrawal by Subject|3|||
126520362|NCT02660944|455196173|FG000|Overall Study|Lost to Follow-up|4|||
126520363|NCT02660944|455196174|FG001|Overall Study|Lost to Follow-up|1|||
126520364|NCT02660944|455196173|FG000|Overall Study|Subject schedule|0|||
126520365|NCT02660944|455196174|FG001|Overall Study|Subject schedule|1|||
126520366|NCT02660944|455196173|FG000|Overall Study|Exclusion criteria met|2|||
126520367|NCT02660944|455196174|FG001|Overall Study|Exclusion criteria met|0|||
126520368|NCT04796610|455196175|FG000|Overall Study|Withdrawal by Subject|1|||
126520369|NCT04796610|455196176|FG001|Overall Study|Withdrawal by Subject|0|||
126520370|NCT04796610|455196177|FG002|Overall Study|Withdrawal by Subject|0|||
126520371|NCT04796610|455196178|FG003|Overall Study|Withdrawal by Subject|0|||
126520372|NCT04796610|455196175|FG000|Overall Study|Lost to Follow-up|2|||
126520373|NCT04796610|455196176|FG001|Overall Study|Lost to Follow-up|0|||
126520374|NCT04796610|455196177|FG002|Overall Study|Lost to Follow-up|1|||
126520375|NCT04796610|455196178|FG003|Overall Study|Lost to Follow-up|1|||
126520376|NCT02059148|455196179|FG000|Treatment 1|Protocol Violation|0|||
126520377|NCT02059148|455196180|FG001|Treatment 1|Protocol Violation|0|||
126520378|NCT02059148|455196181|FG002|Treatment 1|Protocol Violation|0|||
126520379|NCT02059148|455196182|FG003|Treatment 1|Protocol Violation|0|||
126520380|NCT02059148|455196183|FG004|Treatment 1|Protocol Violation|0|||
126520381|NCT02059148|455196184|FG005|Treatment 1|Protocol Violation|1|||
126520382|NCT00403546|455196190|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
126520383|NCT00403546|455196191|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
126520384|NCT00403546|455196192|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
126520385|NCT00403546|455196190|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
126520386|NCT00403546|455196191|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
126520387|NCT00403546|455196192|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
126520388|NCT00403546|455196190|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
126520389|NCT00403546|455196191|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
126520390|NCT00403546|455196192|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
126520391|NCT00403546|455196190|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
126520392|NCT00403546|455196191|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
126520393|NCT00403546|455196192|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
126520394|NCT00403546|455196190|FG000|Screening Phase|Screening Failure|22|||
126520395|NCT00403546|455196191|FG001|Screening Phase|Screening Failure|0|||
126520396|NCT00403546|455196192|FG002|Screening Phase|Screening Failure|0|||
126520397|NCT00403546|455196190|FG000|Screening Phase|Adverse Event|1|||
126520398|NCT00403546|455196191|FG001|Screening Phase|Adverse Event|0|||
126520399|NCT00403546|455196192|FG002|Screening Phase|Adverse Event|0|||
126520400|NCT00403546|455196190|FG000|Screening Phase|Terminated Prior to Randomization|5|||
126520401|NCT00403546|455196191|FG001|Screening Phase|Terminated Prior to Randomization|0|||
126520402|NCT00403546|455196192|FG002|Screening Phase|Terminated Prior to Randomization|0|||
126520403|NCT00403546|455196190|FG000|Randomized Trial|Early Terminations|0|||
126520404|NCT00403546|455196191|FG001|Randomized Trial|Early Terminations|17|||
126520405|NCT00403546|455196192|FG002|Randomized Trial|Early Terminations|16|||
126520406|NCT02673697|455196193|FG000|Overall Study|Adverse Event|2|||
126520407|NCT02673697|455196194|FG001|Overall Study|Adverse Event|0|||
126520408|NCT02673697|455196193|FG000|Overall Study|Death|32|||
126520409|NCT02673697|455196194|FG001|Overall Study|Death|24|||
126520410|NCT02673697|455196193|FG000|Overall Study|Lost to Follow-up|5|||
126520411|NCT02673697|455196194|FG001|Overall Study|Lost to Follow-up|2|||
126520412|NCT02673697|455196193|FG000|Overall Study|Physician Decision|2|||
126520413|NCT02673697|455196194|FG001|Overall Study|Physician Decision|1|||
126520414|NCT02673697|455196193|FG000|Overall Study|Withdrawal by Subject|10|||
126520415|NCT02673697|455196194|FG001|Overall Study|Withdrawal by Subject|7|||
126520416|NCT02673697|455196193|FG000|Overall Study|Change subj medical status|1|||
126520417|NCT02673697|455196194|FG001|Overall Study|Change subj medical status|2|||
126520418|NCT02673697|455196193|FG000|Overall Study|Explant|10|||
126520419|NCT02673697|455196194|FG001|Overall Study|Explant|5|||
126520420|NCT02673697|455196193|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
126520421|NCT02673697|455196194|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
126520422|NCT00437489|455196195|FG000|Overall Study|Study terminated by sponsor|23|||
126520423|NCT00437489|455196196|FG001|Overall Study|Study terminated by sponsor|21|||
126520424|NCT00437489|455196195|FG000|Overall Study|Lost to Follow-up|0|||
126520425|NCT00437489|455196196|FG001|Overall Study|Lost to Follow-up|1|||
126520426|NCT03893448|455196202|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
126520427|NCT03893448|455196203|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
126520428|NCT03893448|455196202|FG000|Overall Study|Physician Decision|8|||
126520429|NCT03893448|455196203|FG001|Overall Study|Physician Decision|14|||
126520430|NCT03893448|455196202|FG000|Overall Study|Lost to Follow-up|34|||
126520431|NCT03893448|455196203|FG001|Overall Study|Lost to Follow-up|27|||
126520432|NCT03893448|455196202|FG000|Overall Study|Death|1|||
126520433|NCT03893448|455196203|FG001|Overall Study|Death|0|||
126520434|NCT04934670|455196206|FG000|Overall Study|Death|4|||
126520435|NCT04934670|455196207|FG001|Overall Study|Death|0|||
126520436|NCT04934670|455196206|FG000|Overall Study|Lost to Follow-up|1|||
126520437|NCT04934670|455196207|FG001|Overall Study|Lost to Follow-up|4|||
126520438|NCT01916304|455196208|FG000|Overall Study|Screening failure|17|||
126520439|NCT02460198|455196210|FG000|Overall Study|Adverse Event|1|||
126520440|NCT02460198|455196211|FG001|Overall Study|Adverse Event|3|||
126520441|NCT02460198|455196210|FG000|Overall Study|Death|36|||
126520442|NCT02460198|455196211|FG001|Overall Study|Death|28|||
126520443|NCT02460198|455196210|FG000|Overall Study|Lost to Follow-up|1|||
126520444|NCT02460198|455196211|FG001|Overall Study|Lost to Follow-up|1|||
126520445|NCT02460198|455196210|FG000|Overall Study|Transferred to Extension Study|15|||
126520446|NCT02460198|455196211|FG001|Overall Study|Transferred to Extension Study|15|||
126520447|NCT02460198|455196210|FG000|Overall Study|Withdrawal by Subject|2|||
126520448|NCT02460198|455196211|FG001|Overall Study|Withdrawal by Subject|4|||
126520449|NCT02460198|455196210|FG000|Overall Study|Site Terminated By Sponsor|0|||
126520450|NCT02460198|455196211|FG001|Overall Study|Site Terminated By Sponsor|1|||
126520451|NCT02460198|455196210|FG000|Overall Study|Did Not Continue on Extension Study|6|||
126520452|NCT02460198|455196211|FG001|Overall Study|Did Not Continue on Extension Study|11|||
126520453|NCT04382612|455196212|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
126520454|NCT04666441|455196213|FG000|Overall Study|Lost to Follow-up|1|||
126520455|NCT04666441|455196214|FG001|Overall Study|Lost to Follow-up|4|||
126520456|NCT04666441|455196215|FG002|Overall Study|Lost to Follow-up|1|||
126520457|NCT04666441|455196216|FG003|Overall Study|Lost to Follow-up|3|||
126520458|NCT04666441|455196217|FG004|Overall Study|Lost to Follow-up|0|||
126520459|NCT04666441|455196218|FG005|Overall Study|Lost to Follow-up|2|||
126520460|NCT04666441|455196219|FG006|Overall Study|Lost to Follow-up|2|||
126520461|NCT04666441|455196220|FG007|Overall Study|Lost to Follow-up|2|||
126520462|NCT04666441|455196213|FG000|Overall Study|Subject Decision|1|||
126520463|NCT04666441|455196214|FG001|Overall Study|Subject Decision|1|||
126520464|NCT04666441|455196215|FG002|Overall Study|Subject Decision|3|||
126520465|NCT04666441|455196216|FG003|Overall Study|Subject Decision|1|||
126520466|NCT04666441|455196217|FG004|Overall Study|Subject Decision|0|||
126520467|NCT04666441|455196218|FG005|Overall Study|Subject Decision|1|||
126520468|NCT04666441|455196219|FG006|Overall Study|Subject Decision|3|||
126520469|NCT04666441|455196220|FG007|Overall Study|Subject Decision|2|||
126520470|NCT02752048|455196221|FG000|Overall Study|Withdrawal by Subject|0|||
126520471|NCT02752048|455196222|FG001|Overall Study|Withdrawal by Subject|0|||
126520472|NCT02752048|455196223|FG002|Overall Study|Withdrawal by Subject|3|||
126520473|NCT01312467|455196226|FG000|Overall Study|Adverse Event|4|||
126520474|NCT01312467|455196226|FG000|Overall Study|Lost to Follow-up|1|||
126520475|NCT01312467|455196226|FG000|Overall Study|Withdrawal by Subject|2|||
126520476|NCT01312467|455196226|FG000|Overall Study|Deported to country of origin|1|||
126520477|NCT01312467|455196226|FG000|Overall Study|Another medical condition|1|||
126520478|NCT01312467|455196226|FG000|Overall Study|Ineligible|4|||
126520479|NCT00132769|455196227|FG000|Overall Study|Withdrawal by Subject|1|||
126520480|NCT00132769|455196228|FG001|Overall Study|Withdrawal by Subject|3|||
126520481|NCT00132769|455196227|FG000|Overall Study|Lack of Efficacy|7|||
126520482|NCT00132769|455196228|FG001|Overall Study|Lack of Efficacy|6|||
126520483|NCT00132769|455196227|FG000|Overall Study|Adverse Event|2|||
126520484|NCT00132769|455196228|FG001|Overall Study|Adverse Event|1|||
126520485|NCT00132769|455196227|FG000|Overall Study|Protocol Violation|1|||
126520486|NCT00132769|455196228|FG001|Overall Study|Protocol Violation|1|||
126520487|NCT03136068|455198100|FG000|Overall Study|Lost to Follow-up|1|||
126520488|NCT03136068|455198101|FG001|Overall Study|Lost to Follow-up|1|||
126520489|NCT03136068|455198100|FG000|Overall Study|Protocol Violation|1|||
126520490|NCT03136068|455198101|FG001|Overall Study|Protocol Violation|0|||
126520491|NCT00432380|455198107|FG000|Overall Study|Migrated/moved from study area|3|||
126520492|NCT00432380|455198108|FG001|Overall Study|Migrated/moved from study area|4|||
126520493|NCT00432380|455198109|FG002|Overall Study|Migrated/moved from study area|1|||
126520494|NCT00432380|455198107|FG000|Overall Study|Adverse Event|1|||
126520495|NCT00432380|455198108|FG001|Overall Study|Adverse Event|0|||
126520496|NCT00432380|455198109|FG002|Overall Study|Adverse Event|0|||
126520497|NCT01071395|455198117|FG000|Overall Study|Withdrawal by Subject|2|||
126520498|NCT01071395|455198118|FG001|Overall Study|Withdrawal by Subject|1|||
126520499|NCT01071395|455198117|FG000|Overall Study|Adverse Event|3|||
126520500|NCT01071395|455198118|FG001|Overall Study|Adverse Event|1|||
126520501|NCT01539291|455198119|FG000|Study GS-US-312-0116|Adverse Event|9|||
126520502|NCT01539291|455198120|FG001|Study GS-US-312-0116|Adverse Event|0|||
126520503|NCT01539291|455198121|FG002|Study GS-US-312-0116|Adverse Event|0|||
126520504|NCT01539291|455198122|FG003|Study GS-US-312-0116|Adverse Event|0|||
126520505|NCT01539291|455198119|FG000|Study GS-US-312-0116|Physician Decision|1|||
126520506|NCT01539291|455198120|FG001|Study GS-US-312-0116|Physician Decision|0|||
126520507|NCT01539291|455198121|FG002|Study GS-US-312-0116|Physician Decision|0|||
126520508|NCT01539291|455198122|FG003|Study GS-US-312-0116|Physician Decision|0|||
126520509|NCT01539291|455198119|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
126520510|NCT01539291|455198120|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
126520511|NCT01539291|455198121|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
126520512|NCT01539291|455198122|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
126520513|NCT01539291|455198119|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
126520514|NCT01539291|455198120|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
126520515|NCT01539291|455198121|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
126520516|NCT01539291|455198122|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
126520517|NCT01539291|455198119|FG000|Study GS-US-312-0116|Other|1|||
126520518|NCT01539291|455198120|FG001|Study GS-US-312-0116|Other|0|||
126520519|NCT01539291|455198121|FG002|Study GS-US-312-0116|Other|0|||
126520520|NCT01539291|455198122|FG003|Study GS-US-312-0116|Other|0|||
126520521|NCT01539291|455198119|FG000|Study GS-US-312-0117|Adverse Event|22|||
126520522|NCT01539291|455198120|FG001|Study GS-US-312-0117|Adverse Event|1|||
126520523|NCT01539291|455198121|FG002|Study GS-US-312-0117|Adverse Event|9|||
126520524|NCT01539291|455198122|FG003|Study GS-US-312-0117|Adverse Event|12|||
126520525|NCT01539291|455198119|FG000|Study GS-US-312-0117|Physician Decision|9|||
126520526|NCT01539291|455198120|FG001|Study GS-US-312-0117|Physician Decision|0|||
126520527|NCT01539291|455198121|FG002|Study GS-US-312-0117|Physician Decision|6|||
126520528|NCT01539291|455198122|FG003|Study GS-US-312-0117|Physician Decision|4|||
126520529|NCT01539291|455198119|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
126520530|NCT01539291|455198120|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
126520531|NCT01539291|455198121|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
126520532|NCT01539291|455198122|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
126520533|NCT01539291|455198119|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
126520534|NCT01539291|455198120|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
126520535|NCT01539291|455198121|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
126520536|NCT01539291|455198122|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
126520537|NCT01539291|455198119|FG000|Study GS-US-312-0117|Other|2|||
126520538|NCT01539291|455198120|FG001|Study GS-US-312-0117|Other|1|||
126520539|NCT01539291|455198121|FG002|Study GS-US-312-0117|Other|1|||
126573162|NCT01135511|455394368|FG005|Overall Study|Lack of Efficacy|0|||
126520540|NCT01539291|455198122|FG003|Study GS-US-312-0117|Other|1|||
126520541|NCT02239510|455198125|FG000|Overall Study|Lost to Follow-up|2|||
126520542|NCT02239510|455198126|FG001|Overall Study|Lost to Follow-up|1|||
126520543|NCT01073618|455198129|FG000|Overall Study|Death|208|||
126520544|NCT01073618|455198129|FG000|Overall Study|Adverse Event|19|||
126520545|NCT01073618|455198129|FG000|Overall Study|Other|80|||
126520546|NCT02032901|455198132|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
126520547|NCT02032901|455198133|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
126520548|NCT02032901|455198132|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
126520549|NCT02032901|455198133|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
126520550|NCT00982020|455198134|FG000|Overall Study|Adverse Event|19|||
126520551|NCT00982020|455198135|FG001|Overall Study|Adverse Event|15|||
126520552|NCT00982020|455198134|FG000|Overall Study|Withdrawal by Subject|11|||
126727310|NCT02358369|455951114|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
126727311|NCT02358369|455951115|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
126727312|NCT02358369|455951111|FG000|Treatment Period A/B|Adverse Event|0|||
126727313|NCT02358369|455951112|FG001|Treatment Period A/B|Adverse Event|0|||
126727314|NCT02358369|455951113|FG002|Treatment Period A/B|Adverse Event|1|||
126727315|NCT02358369|455951114|FG003|Treatment Period A/B|Adverse Event|2|||
126520553|NCT00982020|455198135|FG001|Overall Study|Withdrawal by Subject|14|||
126520554|NCT00982020|455198134|FG000|Overall Study|Lost to Follow-up|5|||
126520555|NCT00982020|455198135|FG001|Overall Study|Lost to Follow-up|11|||
126520556|NCT00982020|455198134|FG000|Overall Study|Lack of Efficacy|10|||
126520557|NCT00982020|455198135|FG001|Overall Study|Lack of Efficacy|4|||
126520558|NCT00982020|455198134|FG000|Overall Study|Parent/Caregiver Decision|5|||
126520559|NCT00982020|455198135|FG001|Overall Study|Parent/Caregiver Decision|5|||
126520560|NCT00982020|455198134|FG000|Overall Study|Treatment Non-compliance|3|||
126520561|NCT00982020|455198135|FG001|Overall Study|Treatment Non-compliance|6|||
126520562|NCT00982020|455198134|FG000|Overall Study|Physician Decision|2|||
126520563|NCT00982020|455198135|FG001|Overall Study|Physician Decision|5|||
126520564|NCT00982020|455198134|FG000|Overall Study|Entry Criteria Not Met|2|||
126520565|NCT00982020|455198135|FG001|Overall Study|Entry Criteria Not Met|1|||
126520566|NCT00982020|455198134|FG000|Overall Study|Protocol Violation|0|||
126520567|NCT00982020|455198135|FG001|Overall Study|Protocol Violation|2|||
126520568|NCT00982020|455198134|FG000|Overall Study|Clinical Relapse|0|||
126520569|NCT00982020|455198135|FG001|Overall Study|Clinical Relapse|1|||
126520570|NCT01992536|455198137|FG000|Overall Study|Administrative Reason|0|||
126520571|NCT01992536|455198138|FG001|Overall Study|Administrative Reason|0|||
126520572|NCT01992536|455198139|FG002|Overall Study|Administrative Reason|0|||
126520573|NCT01992536|455198140|FG003|Overall Study|Administrative Reason|0|||
126520574|NCT01992536|455198141|FG004|Overall Study|Administrative Reason|0|||
126520575|NCT01992536|455198142|FG005|Overall Study|Administrative Reason|0|||
126520576|NCT01992536|455198143|FG006|Overall Study|Administrative Reason|7|||
126520577|NCT01992536|455198144|FG007|Overall Study|Administrative Reason|0|||
126520578|NCT01992536|455198145|FG008|Overall Study|Administrative Reason|0|||
126520579|NCT01992536|455198146|FG009|Overall Study|Administrative Reason|0|||
126520580|NCT01992536|455198137|FG000|Overall Study|Lost to Follow-up|4|||
126520581|NCT01992536|455198138|FG001|Overall Study|Lost to Follow-up|2|||
126520582|NCT01992536|455198139|FG002|Overall Study|Lost to Follow-up|1|||
126520583|NCT01992536|455198140|FG003|Overall Study|Lost to Follow-up|0|||
126520584|NCT01992536|455198141|FG004|Overall Study|Lost to Follow-up|0|||
126520585|NCT01992536|455198142|FG005|Overall Study|Lost to Follow-up|1|||
126520586|NCT01992536|455198143|FG006|Overall Study|Lost to Follow-up|0|||
126520587|NCT01992536|455198144|FG007|Overall Study|Lost to Follow-up|0|||
126520588|NCT01992536|455198145|FG008|Overall Study|Lost to Follow-up|1|||
126520589|NCT01992536|455198146|FG009|Overall Study|Lost to Follow-up|1|||
126520590|NCT01992536|455198137|FG000|Overall Study|Withdrawal by Subject|0|||
126520591|NCT01992536|455198138|FG001|Overall Study|Withdrawal by Subject|1|||
126520592|NCT01992536|455198139|FG002|Overall Study|Withdrawal by Subject|0|||
126520593|NCT01992536|455198140|FG003|Overall Study|Withdrawal by Subject|2|||
126520594|NCT01992536|455198141|FG004|Overall Study|Withdrawal by Subject|0|||
126520595|NCT01992536|455198142|FG005|Overall Study|Withdrawal by Subject|0|||
126520596|NCT01992536|455198143|FG006|Overall Study|Withdrawal by Subject|0|||
126520597|NCT01992536|455198144|FG007|Overall Study|Withdrawal by Subject|0|||
126520598|NCT01992536|455198145|FG008|Overall Study|Withdrawal by Subject|0|||
126520599|NCT01992536|455198146|FG009|Overall Study|Withdrawal by Subject|0|||
126727316|NCT02358369|455951115|FG004|Treatment Period A/B|Adverse Event|0|||
126520600|NCT00406029|455198150|FG000|Overall Study|Adverse Event|12|||
126520601|NCT00406029|455198151|FG001|Overall Study|Adverse Event|2|||
126520602|NCT00406029|455198152|FG002|Overall Study|Adverse Event|5|||
126727317|NCT02358369|455951111|FG000|Treatment Period A/B|Death|0|||
126520603|NCT00406029|455198153|FG003|Overall Study|Adverse Event|10|||
126727318|NCT02358369|455951112|FG001|Treatment Period A/B|Death|0|||
126520604|NCT00406029|455198154|FG004|Overall Study|Adverse Event|7|||
126727319|NCT02358369|455951113|FG002|Treatment Period A/B|Death|1|||
126727320|NCT02358369|455951114|FG003|Treatment Period A/B|Death|0|||
126520605|NCT00406029|455198150|FG000|Overall Study|Withdrawal by Subject|3|||
126520606|NCT00406029|455198151|FG001|Overall Study|Withdrawal by Subject|4|||
126520607|NCT00406029|455198152|FG002|Overall Study|Withdrawal by Subject|2|||
126520608|NCT00406029|455198153|FG003|Overall Study|Withdrawal by Subject|2|||
126520609|NCT00406029|455198154|FG004|Overall Study|Withdrawal by Subject|0|||
126520610|NCT00406029|455198150|FG000|Overall Study|Protocol Violation|1|||
126520611|NCT00406029|455198151|FG001|Overall Study|Protocol Violation|2|||
126520612|NCT00406029|455198152|FG002|Overall Study|Protocol Violation|0|||
126520613|NCT00406029|455198153|FG003|Overall Study|Protocol Violation|2|||
126520614|NCT00406029|455198154|FG004|Overall Study|Protocol Violation|0|||
126520615|NCT00406029|455198150|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
126520616|NCT00406029|455198151|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
126520617|NCT00406029|455198152|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
126520618|NCT00406029|455198153|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
126520619|NCT00406029|455198154|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
126520620|NCT00406029|455198150|FG000|Overall Study|Randomized in Error|0|||
126520621|NCT00406029|455198151|FG001|Overall Study|Randomized in Error|0|||
126520622|NCT00406029|455198152|FG002|Overall Study|Randomized in Error|2|||
126520623|NCT00406029|455198153|FG003|Overall Study|Randomized in Error|3|||
126520624|NCT00406029|455198154|FG004|Overall Study|Randomized in Error|1|||
126520625|NCT01709227|455198155|FG000|Overall Study|Physician Decision|1|||
126520626|NCT01709227|455198156|FG001|Overall Study|Physician Decision|0|||
126520627|NCT01709227|455198155|FG000|Overall Study|Pleural Peritoneal communication|0|||
126520628|NCT01709227|455198156|FG001|Overall Study|Pleural Peritoneal communication|9|||
126520629|NCT03669081|455198159|FG000|Overall Study|Data could not be validated|1|||
126520630|NCT03669081|455198160|FG001|Overall Study|Data could not be validated|1|||
126520631|NCT00389324|455198161|FG000|Run-In Phase|Adverse Event|1|||
126520632|NCT00389324|455198161|FG000|Run-In Phase|Lost to Follow-up|1|||
126520633|NCT00389324|455198161|FG000|Run-In Phase|Withdrawal by Subject|1|||
126520634|NCT00389324|455198161|FG000|Subcutaneous Phase|Adverse Event|2|||
126520635|NCT00389324|455198161|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
126520636|NCT00389324|455198161|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
126520637|NCT00389324|455198161|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
126520638|NCT02317575|455198162|FG000|Period 1|Difficulty with venous cannulation|0|||
126520639|NCT02317575|455198163|FG001|Period 1|Difficulty with venous cannulation|1|||
126520640|NCT02317575|455198164|FG002|Period 1|Difficulty with venous cannulation|0|||
126520641|NCT02317575|455198165|FG003|Period 1|Difficulty with venous cannulation|0|||
126520642|NCT02317575|455198166|FG004|Period 1|Difficulty with venous cannulation|0|||
126520643|NCT02317575|455198162|FG000|Period 1|Withdrawal by Subject|1|||
126520644|NCT02317575|455198163|FG001|Period 1|Withdrawal by Subject|0|||
126520645|NCT02317575|455198164|FG002|Period 1|Withdrawal by Subject|0|||
126520646|NCT02317575|455198165|FG003|Period 1|Withdrawal by Subject|0|||
126520647|NCT02317575|455198166|FG004|Period 1|Withdrawal by Subject|0|||
126520648|NCT04079933|455198170|FG000|Overall Study|Withdrawal by Subject|3|||
126520649|NCT04079933|455198171|FG001|Overall Study|Withdrawal by Subject|4|||
126520650|NCT04079933|455198170|FG000|Overall Study|Lost to Follow-up|0|||
126520651|NCT04079933|455198171|FG001|Overall Study|Lost to Follow-up|1|||
126520652|NCT01229436|455198172|FG000|Overall Study|Withdrawal by Subject|2|||
126520653|NCT01229436|455198172|FG000|Overall Study|Lost to Follow-up|3|||
126520654|NCT00345579|455198186|FG000|Overall Study|Adverse Event|9|||
126520655|NCT00345579|455198187|FG001|Overall Study|Adverse Event|6|||
126520656|NCT00345579|455198186|FG000|Overall Study|Protocol Violation|14|||
126520657|NCT00345579|455198187|FG001|Overall Study|Protocol Violation|5|||
126520658|NCT00345579|455198186|FG000|Overall Study|Withdrawal by Subject|50|||
126520659|NCT00345579|455198187|FG001|Overall Study|Withdrawal by Subject|17|||
126520660|NCT00345579|455198186|FG000|Overall Study|Lost to Follow-up|82|||
126520661|NCT00345579|455198187|FG001|Overall Study|Lost to Follow-up|36|||
126520662|NCT00345579|455198186|FG000|Overall Study|Other|9|||
126520663|NCT00345579|455198187|FG001|Overall Study|Other|1|||
126520664|NCT01731171|455198188|FG000|Overall Study|Withdrawal by Subject|4|||
126520665|NCT01731171|455198189|FG001|Overall Study|Withdrawal by Subject|1|||
126520666|NCT01731171|455198188|FG000|Overall Study|Lost to Follow-up|3|||
126520667|NCT01731171|455198189|FG001|Overall Study|Lost to Follow-up|2|||
126520668|NCT01731171|455198188|FG000|Overall Study|Moved out of Area|0|||
126520669|NCT01731171|455198189|FG001|Overall Study|Moved out of Area|2|||
126520670|NCT01731171|455198188|FG000|Overall Study|Terminated for Lack of Adherence|0|||
126520671|NCT01731171|455198189|FG001|Overall Study|Terminated for Lack of Adherence|1|||
126520672|NCT01731171|455198188|FG000|Overall Study|Terminated for Safety Reasons|0|||
126520673|NCT01731171|455198189|FG001|Overall Study|Terminated for Safety Reasons|1|||
126520674|NCT00413413|455198190|FG000|Single-Blind|Adverse Event|0|||
126520675|NCT00413413|455198191|FG001|Single-Blind|Adverse Event|9|||
126520676|NCT00413413|455198192|FG002|Single-Blind|Adverse Event|0|||
126520677|NCT00413413|455198190|FG000|Single-Blind|Lack of Efficacy|0|||
126520678|NCT00413413|455198191|FG001|Single-Blind|Lack of Efficacy|5|||
126520679|NCT00413413|455198192|FG002|Single-Blind|Lack of Efficacy|0|||
126520680|NCT00413413|455198190|FG000|Single-Blind|Subject no longer requires study drug|0|||
126520681|NCT00413413|455198191|FG001|Single-Blind|Subject no longer requires study drug|151|||
126520682|NCT00413413|455198192|FG002|Single-Blind|Subject no longer requires study drug|0|||
126520683|NCT00413413|455198190|FG000|Single-Blind|Protocol Violation|0|||
126520684|NCT00413413|455198191|FG001|Single-Blind|Protocol Violation|16|||
126520685|NCT00413413|455198192|FG002|Single-Blind|Protocol Violation|0|||
126520686|NCT00413413|455198190|FG000|Single-Blind|Withdrawal by Subject|0|||
126520687|NCT00413413|455198191|FG001|Single-Blind|Withdrawal by Subject|27|||
126520688|NCT00413413|455198192|FG002|Single-Blind|Withdrawal by Subject|0|||
126520689|NCT00413413|455198190|FG000|Single-Blind|Lost to Follow-up|0|||
126520690|NCT00413413|455198191|FG001|Single-Blind|Lost to Follow-up|8|||
126520691|NCT00413413|455198192|FG002|Single-Blind|Lost to Follow-up|0|||
126520692|NCT00413413|455198190|FG000|Double-Blind|Adverse Event|6|||
126520693|NCT00413413|455198191|FG001|Double-Blind|Adverse Event|0|||
126573163|NCT01135511|455394369|FG006|Overall Study|Lack of Efficacy|0|||
126727321|NCT02358369|455951115|FG004|Treatment Period A/B|Death|0|||
126727322|NCT02358369|455951111|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
126727323|NCT02358369|455951112|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
126520694|NCT00413413|455198192|FG002|Double-Blind|Adverse Event|5|||
126520695|NCT00413413|455198190|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
126520696|NCT00413413|455198191|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
126520697|NCT00413413|455198192|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
126520698|NCT00413413|455198190|FG000|Double-Blind|Protocol deviation|1|||
126520699|NCT00413413|455198191|FG001|Double-Blind|Protocol deviation|2|||
126520700|NCT00413413|455198192|FG002|Double-Blind|Protocol deviation|1|||
126520701|NCT00413413|455198190|FG000|Double-Blind|Subject withdrew consent|4|||
126520702|NCT00413413|455198191|FG001|Double-Blind|Subject withdrew consent|6|||
126520703|NCT00413413|455198192|FG002|Double-Blind|Subject withdrew consent|9|||
126520704|NCT00413413|455198190|FG000|Double-Blind|Lost to Follow-up|3|||
126520705|NCT00413413|455198191|FG001|Double-Blind|Lost to Follow-up|4|||
126520706|NCT00413413|455198192|FG002|Double-Blind|Lost to Follow-up|2|||
126520707|NCT03207750|455198197|FG000|Overall Study|Adverse Event|3|||
126520708|NCT03207750|455198198|FG001|Overall Study|Adverse Event|2|||
126520709|NCT03207750|455198197|FG000|Overall Study|Lost to Follow-up|21|||
126520710|NCT03207750|455198198|FG001|Overall Study|Lost to Follow-up|29|||
126520711|NCT03207750|455198197|FG000|Overall Study|Protocol Violation|0|||
126520712|NCT03207750|455198198|FG001|Overall Study|Protocol Violation|1|||
126520713|NCT03207750|455198197|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
126520714|NCT03207750|455198198|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
126520715|NCT03207750|455198197|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
126520716|NCT03207750|455198198|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
126520717|NCT03207750|455198197|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
126520718|NCT03207750|455198198|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
126520719|NCT03207750|455198197|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
126520720|NCT03207750|455198198|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
126520721|NCT03207750|455198197|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
126520722|NCT03207750|455198198|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
126520723|NCT02604589|455198201|FG000|Overall Study|catheter dislodgement|0|||
126520724|NCT02604589|455198202|FG001|Overall Study|catheter dislodgement|0|||
126520725|NCT02604589|455198203|FG002|Overall Study|catheter dislodgement|1|||
126520726|NCT00793910|455198204|FG000|Overall Study|discarded study pills|0|||
126520727|NCT00793910|455198205|FG001|Overall Study|discarded study pills|1|||
126520728|NCT00793910|455198204|FG000|Overall Study|did not pick up medications|1|||
126520729|NCT00793910|455198205|FG001|Overall Study|did not pick up medications|1|||
126520730|NCT00793910|455198204|FG000|Overall Study|ineligible based on entry criteria|2|||
126520731|NCT00793910|455198205|FG001|Overall Study|ineligible based on entry criteria|3|||
126520732|NCT00793910|455198204|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
126520733|NCT00793910|455198205|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
126520734|NCT00793910|455198204|FG000|Overall Study|Withdrawal by Subject|0|||
126520735|NCT00793910|455198205|FG001|Overall Study|Withdrawal by Subject|1|||
126520736|NCT01700946|455198206|FG000|Overall Study|Lost to Follow-up|1|||
126520737|NCT01700946|455198207|FG001|Overall Study|Lost to Follow-up|0|||
126520738|NCT01700946|455198206|FG000|Overall Study|Physician Decision|7|||
126520739|NCT01700946|455198207|FG001|Overall Study|Physician Decision|12|||
126520740|NCT01700946|455198206|FG000|Overall Study|Withdrawal by Subject|0|||
126520741|NCT01700946|455198207|FG001|Overall Study|Withdrawal by Subject|2|||
126520742|NCT01700946|455198206|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
126520743|NCT01700946|455198207|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
126520744|NCT01700946|455198206|FG000|Overall Study|Relapse|2|||
126520745|NCT01700946|455198207|FG001|Overall Study|Relapse|1|||
126520746|NCT01700946|455198206|FG000|Overall Study|Unacceptable toxicity|1|||
126520747|NCT01700946|455198207|FG001|Overall Study|Unacceptable toxicity|0|||
126520748|NCT03634579|455198215|FG000|Overall Study|study termination|9|||
126520749|NCT03321981|455198216|FG000|Overall Study|Progressive Disease (PD)|15|||
126520750|NCT03321981|455198217|FG001|Overall Study|Progressive Disease (PD)|30|||
126520751|NCT03321981|455198218|FG002|Overall Study|Progressive Disease (PD)|47|||
126520752|NCT03321981|455198216|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
126520753|NCT03321981|455198217|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
126520754|NCT03321981|455198218|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
126520755|NCT03321981|455198216|FG000|Overall Study|Adverse Event|0|||
126520756|NCT03321981|455198217|FG001|Overall Study|Adverse Event|0|||
126520757|NCT03321981|455198218|FG002|Overall Study|Adverse Event|2|||
126520758|NCT03321981|455198216|FG000|Overall Study|symptomatic deterioration|0|||
126520759|NCT03321981|455198217|FG001|Overall Study|symptomatic deterioration|1|||
126520760|NCT03321981|455198218|FG002|Overall Study|symptomatic deterioration|1|||
126520761|NCT03321981|455198216|FG000|Overall Study|Lack of compliance|0|||
126520762|NCT03321981|455198217|FG001|Overall Study|Lack of compliance|1|||
126520763|NCT03321981|455198218|FG002|Overall Study|Lack of compliance|0|||
126520764|NCT03321981|455198216|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
126520765|NCT03321981|455198217|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
126520766|NCT03321981|455198218|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
126520767|NCT03321981|455198216|FG000|Overall Study|Death|0|||
126520768|NCT03321981|455198217|FG001|Overall Study|Death|1|||
126520769|NCT03321981|455198218|FG002|Overall Study|Death|0|||
126520770|NCT03321981|455198216|FG000|Overall Study|Subject withdrawal of investigational product|0|||
126520771|NCT03321981|455198217|FG001|Overall Study|Subject withdrawal of investigational product|1|||
126520772|NCT03321981|455198218|FG002|Overall Study|Subject withdrawal of investigational product|0|||
126520773|NCT03321981|455198216|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
126520774|NCT03321981|455198217|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
126520775|NCT03321981|455198218|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
126520776|NCT03321981|455198216|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
126520777|NCT03321981|455198217|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
126520778|NCT03321981|455198218|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
126520779|NCT03067441|455198227|FG000|Overall Study|Withdrawal by Subject|16|||
126520780|NCT03067441|455198228|FG001|Overall Study|Withdrawal by Subject|34|||
126520781|NCT03067441|455198227|FG000|Overall Study|Lost to Follow-up|7|||
126520782|NCT03067441|455198228|FG001|Overall Study|Lost to Follow-up|5|||
126520783|NCT03067441|455198227|FG000|Overall Study|Adverse Event|7|||
126520784|NCT03067441|455198228|FG001|Overall Study|Adverse Event|14|||
126520785|NCT03067441|455198227|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
126520786|NCT03067441|455198228|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
126520787|NCT03067441|455198227|FG000|Overall Study|Physician Decision|1|||
126520788|NCT03067441|455198228|FG001|Overall Study|Physician Decision|3|||
126520789|NCT03067441|455198227|FG000|Overall Study|Other|1|||
126520790|NCT03067441|455198228|FG001|Overall Study|Other|1|||
126520791|NCT00817089|455198229|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
126520792|NCT00817089|455198230|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
126520793|NCT00817089|455198231|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
126520794|NCT00817089|455198232|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
126520795|NCT00817089|455198229|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
126520796|NCT00817089|455198230|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
126520797|NCT00817089|455198231|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
126520798|NCT00817089|455198232|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
126520799|NCT01592708|455198236|FG000|Overall Study|Protocol Violation|3|||
126520800|NCT01592708|455198237|FG001|Overall Study|Protocol Violation|0|||
126520801|NCT01785602|455198238|FG000|Overall Study|Withdrawal by Subject|2|||
126520802|NCT01785602|455198239|FG001|Overall Study|Withdrawal by Subject|0|||
126520803|NCT01785602|455198238|FG000|Overall Study|Lost to Follow-up|1|||
126520804|NCT01785602|455198239|FG001|Overall Study|Lost to Follow-up|1|||
126520805|NCT01785602|455198238|FG000|Overall Study|Adverse Event|3|||
126520806|NCT01785602|455198239|FG001|Overall Study|Adverse Event|5|||
126520807|NCT01785602|455198238|FG000|Overall Study|Administrative problems|7|||
126520808|NCT01785602|455198239|FG001|Overall Study|Administrative problems|3|||
126520809|NCT04177108|455198240|FG000|Overall Study|Withdrawal by Subject|4|||
126520810|NCT04177108|455198241|FG001|Overall Study|Withdrawal by Subject|8|||
126520811|NCT04177108|455198242|FG002|Overall Study|Withdrawal by Subject|9|||
126520812|NCT04177108|455198243|FG003|Overall Study|Withdrawal by Subject|11|||
126520813|NCT04177108|455198244|FG004|Overall Study|Withdrawal by Subject|13|||
126520814|NCT04177108|455198240|FG000|Overall Study|Physician Decision|23|||
126520815|NCT04177108|455198241|FG001|Overall Study|Physician Decision|15|||
126520816|NCT04177108|455198242|FG002|Overall Study|Physician Decision|18|||
126520817|NCT04177108|455198243|FG003|Overall Study|Physician Decision|29|||
126520818|NCT04177108|455198244|FG004|Overall Study|Physician Decision|23|||
126520819|NCT04177108|455198240|FG000|Overall Study|Reason Not Specified|0|||
126520820|NCT04177108|455198241|FG001|Overall Study|Reason Not Specified|1|||
126520821|NCT04177108|455198242|FG002|Overall Study|Reason Not Specified|0|||
126520822|NCT04177108|455198243|FG003|Overall Study|Reason Not Specified|0|||
126520823|NCT04177108|455198244|FG004|Overall Study|Reason Not Specified|2|||
126520824|NCT04177108|455198240|FG000|Overall Study|Lost to Follow-up|0|||
126520825|NCT04177108|455198241|FG001|Overall Study|Lost to Follow-up|0|||
126520826|NCT04177108|455198242|FG002|Overall Study|Lost to Follow-up|1|||
126520827|NCT04177108|455198243|FG003|Overall Study|Lost to Follow-up|1|||
126520828|NCT04177108|455198244|FG004|Overall Study|Lost to Follow-up|1|||
126520829|NCT04177108|455198240|FG000|Overall Study|Death|16|||
126520830|NCT04177108|455198241|FG001|Overall Study|Death|19|||
126520831|NCT04177108|455198242|FG002|Overall Study|Death|13|||
126520832|NCT04177108|455198243|FG003|Overall Study|Death|17|||
126520833|NCT04177108|455198244|FG004|Overall Study|Death|18|||
126520834|NCT01827904|455198248|FG000|Main Study|Withdrawal by Subject|1|||
126520835|NCT01827904|455198249|FG001|Main Study|Withdrawal by Subject|0|||
126520836|NCT01827904|455198250|FG002|Main Study|Withdrawal by Subject|0|||
126520837|NCT01827904|455198248|FG000|Main Study|Adverse Event|1|||
126520838|NCT01827904|455198249|FG001|Main Study|Adverse Event|0|||
126520839|NCT01827904|455198250|FG002|Main Study|Adverse Event|0|||
126520840|NCT01827904|455198248|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
126520841|NCT01827904|455198249|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
126520842|NCT01827904|455198250|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
126520843|NCT01827904|455198248|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
126520844|NCT01827904|455198249|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
126520845|NCT01827904|455198250|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
126520846|NCT01827904|455198248|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
126520847|NCT01827904|455198249|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
126520848|NCT01827904|455198250|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
126520849|NCT01827904|455198248|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
126520850|NCT01827904|455198249|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
126520851|NCT01827904|455198250|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
126520852|NCT01827904|455198248|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
126520853|NCT01827904|455198249|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
126520854|NCT01827904|455198250|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
126520855|NCT01827904|455198248|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
126520856|NCT01827904|455198249|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
126520857|NCT01827904|455198250|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
126520858|NCT01827904|455198248|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
126520859|NCT01827904|455198249|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
126520860|NCT01827904|455198250|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
126520861|NCT01827904|455198248|FG000|Long-term Annual Follow-up|Physician Decision|1|||
126520862|NCT01827904|455198249|FG001|Long-term Annual Follow-up|Physician Decision|0|||
126520863|NCT01827904|455198250|FG002|Long-term Annual Follow-up|Physician Decision|0|||
126520864|NCT01827904|455198248|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
126520865|NCT01827904|455198249|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
126520866|NCT01827904|455198250|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
126520867|NCT01827904|455198248|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
126520868|NCT01827904|455198249|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
126520869|NCT01827904|455198250|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
126520870|NCT00101101|455198251|FG000|Overall Study|never received vaccine|20|||
126520871|NCT01800903|455198252|FG000|Second Test Period|unable to catheterise|1|||
126520872|NCT01800903|455198253|FG001|Second Test Period|unable to catheterise|0|||
126520873|NCT01800903|455198254|FG002|Second Test Period|unable to catheterise|0|||
126520874|NCT01800903|455198255|FG003|Second Test Period|unable to catheterise|0|||
126520875|NCT01800903|455198256|FG004|Second Test Period|unable to catheterise|0|||
126520876|NCT01800903|455198257|FG005|Second Test Period|unable to catheterise|0|||
126520877|NCT01344460|455198260|FG000|Overall Study|Withdrawal by Subject|1|||
126520878|NCT01344460|455198260|FG000|Overall Study|Lost to Follow-up|2|||
126520879|NCT03285477|455198261|FG000|Treatment and Response Assessment Period|Death|1|||
126520880|NCT03285477|455198262|FG001|Treatment and Response Assessment Period|Death|0|||
126520881|NCT03285477|455198261|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
126520882|NCT03285477|455198262|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
126520883|NCT03285477|455198261|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
126520884|NCT03285477|455198262|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
126520885|NCT03285477|455198261|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
126520886|NCT03285477|455198262|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
126520887|NCT03285477|455198261|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
126520888|NCT03285477|455198262|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
126520889|NCT03283670|455198263|FG000|Placebo Gas|Withdrawal by Subject|2|||
126520890|NCT03283670|455198263|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
126520891|NCT03283670|455198263|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
126520892|NCT00852397|455198267|FG000|Overall Study|Adverse Event|4|||
126520893|NCT00852397|455198268|FG001|Overall Study|Adverse Event|6|||
126520894|NCT00852397|455198269|FG002|Overall Study|Adverse Event|4|||
126520895|NCT00852397|455198267|FG000|Overall Study|Death|0|||
126520896|NCT00852397|455198268|FG001|Overall Study|Death|0|||
126520897|NCT00852397|455198269|FG002|Overall Study|Death|1|||
126520898|NCT00852397|455198267|FG000|Overall Study|Withdrawal by Subject|4|||
126520899|NCT00852397|455198268|FG001|Overall Study|Withdrawal by Subject|1|||
126520900|NCT00852397|455198269|FG002|Overall Study|Withdrawal by Subject|2|||
126520901|NCT00852397|455198267|FG000|Overall Study|Study terminated by sponsor|2|||
126727324|NCT02358369|455951113|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
126520902|NCT00852397|455198268|FG001|Overall Study|Study terminated by sponsor|1|||
126520903|NCT00852397|455198269|FG002|Overall Study|Study terminated by sponsor|6|||
126520904|NCT00852397|455198267|FG000|Overall Study|Difficulty in study site visit|1|||
126520905|NCT00852397|455198268|FG001|Overall Study|Difficulty in study site visit|0|||
126520906|NCT00852397|455198269|FG002|Overall Study|Difficulty in study site visit|0|||
126520907|NCT00852397|455198267|FG000|Overall Study|Protocol Violation|0|||
126520908|NCT00852397|455198268|FG001|Overall Study|Protocol Violation|0|||
126520909|NCT00852397|455198269|FG002|Overall Study|Protocol Violation|1|||
126520910|NCT03823651|455198274|FG000|Overall Study|Death|5|||
126520911|NCT03823651|455198275|FG001|Overall Study|Death|0|||
126520912|NCT03823651|455198274|FG000|Overall Study|Physician Decision|1|||
126520913|NCT03823651|455198275|FG001|Overall Study|Physician Decision|0|||
126520914|NCT03823651|455198274|FG000|Overall Study|Caregiver to patient who died|0|||
126520915|NCT03823651|455198275|FG001|Overall Study|Caregiver to patient who died|5|||
126520916|NCT03823651|455198274|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
126520917|NCT03823651|455198275|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
126520918|NCT01850004|455198279|FG000|Overall Study|Poor/Non-compliance|1|||
126520919|NCT01850004|455198279|FG000|Overall Study|Participant Withdrew Consent|9|||
126520920|NCT01850004|455198279|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
126520921|NCT01850004|455198279|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
126520922|NCT01850004|455198279|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
126520923|NCT01850004|455198279|FG000|Overall Study|Other Reasons|2|||
126520924|NCT01850004|455198279|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
126520925|NCT01850004|455198279|FG000|Overall Study|Maximum Clinical Benefit|4|||
126520926|NCT02031276|455200105|FG000|Period 1 Double-blind IV|Adverse Event|6|||
126520927|NCT02031276|455200106|FG001|Period 1 Double-blind IV|Adverse Event|5|||
126520928|NCT02031276|455200107|FG002|Period 1 Double-blind IV|Adverse Event|1|||
126520929|NCT02031276|455200105|FG000|Period 1 Double-blind IV|Other|0|||
126520930|NCT02031276|455200106|FG001|Period 1 Double-blind IV|Other|1|||
126520931|NCT02031276|455200107|FG002|Period 1 Double-blind IV|Other|0|||
126520932|NCT02031276|455200105|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
126520933|NCT02031276|455200106|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
126520934|NCT02031276|455200107|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
126520935|NCT02031276|455200105|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
126520936|NCT02031276|455200106|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
126520937|NCT02031276|455200107|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
126520938|NCT02031276|455200105|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
126520939|NCT02031276|455200106|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
126520940|NCT02031276|455200107|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
126520941|NCT02031276|455200105|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
126520942|NCT02031276|455200106|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
126520943|NCT02031276|455200107|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
126520944|NCT02031276|455200105|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
126520945|NCT02031276|455200106|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
126520946|NCT02031276|455200107|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
126520947|NCT02031276|455200105|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
126520948|NCT02031276|455200106|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
126520949|NCT02031276|455200107|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
126520950|NCT02031276|455200105|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
126520951|NCT02031276|455200106|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
126520952|NCT02031276|455200107|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
126520953|NCT01854554|455200108|FG000|Overall Study|Denial of Insurance Coverage|12|||
126520954|NCT01854554|455200109|FG001|Overall Study|Denial of Insurance Coverage|0|||
126520955|NCT01854554|455200108|FG000|Overall Study|Decided to get treatment locally|1|||
126520956|NCT01854554|455200109|FG001|Overall Study|Decided to get treatment locally|5|||
126520957|NCT01854554|455200108|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
126520958|NCT01854554|455200109|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
126520959|NCT01854554|455200108|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
126520960|NCT01854554|455200109|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
126520961|NCT01854554|455200108|FG000|Overall Study|Progression|0|||
126520962|NCT01854554|455200109|FG001|Overall Study|Progression|1|||
126520963|NCT01854554|455200108|FG000|Overall Study|Lost to Follow-up|0|||
126520964|NCT01854554|455200109|FG001|Overall Study|Lost to Follow-up|1|||
126520965|NCT02819726|455200114|FG000|Part A (All Participants)|Lost to Follow-up|0|||
126520966|NCT02819726|455200115|FG001|Part A (All Participants)|Lost to Follow-up|1|||
126520967|NCT02819726|455200116|FG002|Part A (All Participants)|Lost to Follow-up|0|||
126520968|NCT02819726|455200117|FG003|Part A (All Participants)|Lost to Follow-up|0|||
126520969|NCT02819726|455200114|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
126520970|NCT02819726|455200115|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
126520971|NCT02819726|455200116|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
126520972|NCT02819726|455200117|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
126520973|NCT02819726|455200114|FG000|Part A (All Participants)|Protocol non-compliance|3|||
126520974|NCT02819726|455200115|FG001|Part A (All Participants)|Protocol non-compliance|4|||
126520975|NCT02819726|455200116|FG002|Part A (All Participants)|Protocol non-compliance|5|||
126520976|NCT02819726|455200117|FG003|Part A (All Participants)|Protocol non-compliance|0|||
126520977|NCT02819726|455200114|FG000|Part B (All Participants)|Lost to Follow-up|1|||
126520978|NCT02819726|455200115|FG001|Part B (All Participants)|Lost to Follow-up|1|||
126520979|NCT02819726|455200116|FG002|Part B (All Participants)|Lost to Follow-up|2|||
126520980|NCT02819726|455200117|FG003|Part B (All Participants)|Lost to Follow-up|2|||
126520981|NCT02819726|455200114|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
126520982|NCT02819726|455200115|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
126520983|NCT02819726|455200116|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
126520984|NCT02819726|455200117|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
126520985|NCT02819726|455200114|FG000|Part B (All Participants)|Protocol non-compliance|0|||
126520986|NCT02819726|455200115|FG001|Part B (All Participants)|Protocol non-compliance|0|||
126520987|NCT02819726|455200116|FG002|Part B (All Participants)|Protocol non-compliance|1|||
126520988|NCT02819726|455200117|FG003|Part B (All Participants)|Protocol non-compliance|0|||
126520989|NCT02613481|455200118|FG000|Overall Study|Lost to Follow-up|7|||
126520990|NCT02613481|455200118|FG000|Overall Study|Withdrawal by Subject|2|||
126520991|NCT01921348|455200119|FG000|Overall Study|Withdrawal by Subject|1|||
126520992|NCT01921348|455200120|FG001|Overall Study|Withdrawal by Subject|0|||
126520993|NCT01921348|455200119|FG000|Overall Study|Lost to Follow-up|0|||
126520994|NCT01921348|455200120|FG001|Overall Study|Lost to Follow-up|2|||
126520995|NCT00795600|455200126|FG000|Overall Study|Adverse Event|1|||
126520996|NCT00795600|455200127|FG001|Overall Study|Adverse Event|1|||
126520997|NCT00795600|455200126|FG000|Overall Study|Protocol Violation|1|||
126520998|NCT00795600|455200127|FG001|Overall Study|Protocol Violation|2|||
126520999|NCT00795600|455200126|FG000|Overall Study|Withdrawal by Subject|1|||
126521000|NCT00795600|455200127|FG001|Overall Study|Withdrawal by Subject|0|||
126521001|NCT00795600|455200126|FG000|Overall Study|Unclassified|1|||
126521002|NCT00795600|455200127|FG001|Overall Study|Unclassified|1|||
126521003|NCT03936244|455200128|FG000|Overall Study|Lost to Follow-up|5|||
126521004|NCT03936244|455200129|FG001|Overall Study|Lost to Follow-up|1|||
126521005|NCT03936244|455200128|FG000|Overall Study|Physician Decision|7|||
126521006|NCT03936244|455200129|FG001|Overall Study|Physician Decision|3|||
126521007|NCT01430130|455200136|FG000|Overall Study|Lost to Follow-up|1|||
126521008|NCT01430130|455200136|FG000|Overall Study|Infection on Control Side of Incision|1|||
126521009|NCT02843568|455200138|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
126521010|NCT02843568|455200139|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
126521011|NCT02843568|455200138|FG000|Overall Study|Death|3|||
126521012|NCT02843568|455200139|FG001|Overall Study|Death|3|||
126521013|NCT02843568|455200138|FG000|Overall Study|Withdrawal by Subject|1|||
126521014|NCT02843568|455200139|FG001|Overall Study|Withdrawal by Subject|1|||
126521015|NCT02843568|455200138|FG000|Overall Study|Lost to Follow-up|2|||
126521016|NCT02843568|455200139|FG001|Overall Study|Lost to Follow-up|0|||
126521017|NCT01255358|455200140|FG000|Overall Study|Adverse Event|2|||
126521018|NCT01255358|455200140|FG000|Overall Study|Protocol Violation|2|||
126521019|NCT04788147|455200156|FG000|Overall Study|Screen Failure|3|||
126521020|NCT04788147|455200157|FG001|Overall Study|Screen Failure|10|||
126521021|NCT04788147|455200156|FG000|Overall Study|Incomplete RMRS image session|2|||
126521022|NCT04788147|455200157|FG001|Overall Study|Incomplete RMRS image session|0|||
126521023|NCT00781326|455200158|FG000|Phase I|Adverse Event|1|||
126521024|NCT00781326|455200158|FG000|Phase I|Withdrawal by Subject|1|||
126521025|NCT00781326|455200158|FG000|Phase I|Physician Decision|2|||
126521026|NCT02266381|455200159|FG000|Overall Study|Physician Decision|3|||
126521027|NCT02266381|455200160|FG001|Overall Study|Physician Decision|5|||
126521028|NCT02266381|455200161|FG002|Overall Study|Physician Decision|4|||
126521029|NCT05101252|455200162|FG000|Overall Study|Unsatisfactory Test Article|1|||
126521030|NCT05101252|455200163|FG001|Overall Study|Unsatisfactory Test Article|0|||
126521031|NCT05101252|455200162|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
126521032|NCT05101252|455200163|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
126521033|NCT05101252|455200162|FG000|Overall Study|Withdrew Consent during study|0|||
126521034|NCT05101252|455200163|FG001|Overall Study|Withdrew Consent during study|1|||
126521035|NCT05101252|455200162|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
126521036|NCT05101252|455200163|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
126521037|NCT02401672|455200164|FG000|Overall Study|Withdrawal by Subject|1|||
126521038|NCT02401672|455200165|FG001|Overall Study|Withdrawal by Subject|3|||
126521039|NCT01459796|455200166|FG000|Overall Study|Non compliance with protocol|2|||
126521040|NCT01459796|455200167|FG001|Overall Study|Non compliance with protocol|4|||
126521041|NCT01459796|455200166|FG000|Overall Study|Adverse Event|5|||
126521042|NCT01459796|455200167|FG001|Overall Study|Adverse Event|5|||
126521043|NCT01459796|455200166|FG000|Overall Study|Withdrawal by Subject|6|||
126521044|NCT01459796|455200167|FG001|Overall Study|Withdrawal by Subject|3|||
126521045|NCT01459796|455200166|FG000|Overall Study|Lost to Follow-up|5|||
126521046|NCT01459796|455200167|FG001|Overall Study|Lost to Follow-up|4|||
126521047|NCT01459796|455200166|FG000|Overall Study|Reason unspecified|1|||
126521048|NCT01459796|455200167|FG001|Overall Study|Reason unspecified|2|||
126521049|NCT01459796|455200166|FG000|Overall Study|Decision by the sponsor|75|||
126521050|NCT01459796|455200167|FG001|Overall Study|Decision by the sponsor|108|||
126521051|NCT00701051|455200168|FG000|Screening|Failed Screening|40|||
126521052|NCT00701051|455200169|FG001|Screening|Failed Screening|0|||
126521053|NCT00701051|455200170|FG002|Screening|Failed Screening|0|||
126521054|NCT00701051|455200168|FG000|Screening|Time conflicts|19|||
126521055|NCT00701051|455200169|FG001|Screening|Time conflicts|0|||
126521056|NCT00701051|455200170|FG002|Screening|Time conflicts|0|||
126521057|NCT00701051|455200168|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
126521058|NCT00701051|455200169|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
126521059|NCT00701051|455200170|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
126521060|NCT04111497|455200171|FG000|Overall Study|relapse of primary disease|1|||
126521061|NCT04111497|455200171|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
126521062|NCT03321019|455200172|FG000|Overall Study|Withdrawal by Subject|0|||
126521063|NCT03321019|455200173|FG001|Overall Study|Withdrawal by Subject|6|||
126521064|NCT03321019|455200172|FG000|Overall Study|Lost to Follow-up|0|||
126521065|NCT03321019|455200173|FG001|Overall Study|Lost to Follow-up|22|||
126521066|NCT02056301|455200178|FG000|Overall Study|Protocol Violation|1|||
126521067|NCT02056301|455200179|FG001|Overall Study|Protocol Violation|2|||
126521068|NCT02056301|455200178|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
126521069|NCT02056301|455200179|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
126521070|NCT02056301|455200178|FG000|Overall Study|Withdrawal by Subject|0|||
126521071|NCT02056301|455200179|FG001|Overall Study|Withdrawal by Subject|1|||
126521072|NCT02056301|455200178|FG000|Overall Study|Issues with epidural|0|||
126521073|NCT02056301|455200179|FG001|Overall Study|Issues with epidural|3|||
126521074|NCT02209324|455200182|FG000|Overall Study|Adverse Event|2|||
126521075|NCT02209324|455200182|FG000|Overall Study|Lack of Efficacy|1|||
126521076|NCT02209324|455200182|FG000|Overall Study|Lost to Follow-up|1|||
126521077|NCT02209324|455200182|FG000|Overall Study|Physician Decision|3|||
126521078|NCT02209324|455200182|FG000|Overall Study|Protocol Violation|14|||
126521079|NCT02209324|455200182|FG000|Overall Study|Withdrawal by Subject|8|||
126521080|NCT02209324|455200182|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
126521081|NCT02209324|455200182|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
126521082|NCT02209324|455200182|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
126521083|NCT03433456|455200183|FG000|Overall Study|Death|1|||
126521084|NCT03433456|455200184|FG001|Overall Study|Death|1|||
126521085|NCT03433456|455200183|FG000|Overall Study|Lost to Follow-up|14|||
126521086|NCT03433456|455200184|FG001|Overall Study|Lost to Follow-up|11|||
126521087|NCT03433456|455200183|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
126521088|NCT03433456|455200184|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
126521089|NCT05799495|455200185|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
126521090|NCT05799495|455200186|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
126521091|NCT05799495|455200187|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
126521092|NCT05799495|455200188|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
126521093|NCT05799495|455200185|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
126521094|NCT05799495|455200186|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
126521095|NCT05799495|455200187|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
126521096|NCT05799495|455200188|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
126521097|NCT05799495|455200185|FG000|Treatment (Up to 5 Days)|Other|0|||
126521098|NCT05799495|455200186|FG001|Treatment (Up to 5 Days)|Other|1|||
126521099|NCT05799495|455200187|FG002|Treatment (Up to 5 Days)|Other|0|||
126521100|NCT05799495|455200188|FG003|Treatment (Up to 5 Days)|Other|0|||
126521101|NCT05799495|455200185|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
126521102|NCT05799495|455200186|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
126521103|NCT05799495|455200187|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
126521104|NCT05799495|455200188|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
126521105|NCT05799495|455200185|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
126521106|NCT05799495|455200186|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
126521107|NCT05799495|455200187|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
126521108|NCT05799495|455200188|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
126521109|NCT05799495|455200185|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126521110|NCT05799495|455200186|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126521111|NCT05799495|455200187|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
126521112|NCT05799495|455200188|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
126521113|NCT03105362|455200189|FG000|Overall Study|Withdrawal by Subject|1|||
126521114|NCT03105362|455200189|FG000|Overall Study|Lost to Follow-up|1|||
126521115|NCT01198600|455200190|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
126521116|NCT01198600|455200191|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
126521117|NCT01198600|455200192|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
126521118|NCT01198600|455200193|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
126521119|NCT01198600|455200190|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
126521120|NCT01198600|455200191|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
126521121|NCT01198600|455200192|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
126521122|NCT01198600|455200193|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
126521123|NCT01198600|455200190|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
126521124|NCT01198600|455200191|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
126521125|NCT01198600|455200192|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
126521126|NCT01198600|455200193|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
126521127|NCT01198600|455200190|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
126521128|NCT01198600|455200191|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
126521129|NCT01198600|455200192|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
126521130|NCT01198600|455200193|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
126521131|NCT01198600|455200190|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
126521132|NCT01198600|455200191|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
126521133|NCT01198600|455200192|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
126521134|NCT01198600|455200193|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
126521135|NCT01198600|455200190|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
126521136|NCT01198600|455200191|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
126521137|NCT01198600|455200192|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
126521138|NCT01198600|455200193|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
126521139|NCT01198600|455200190|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
126521140|NCT01198600|455200191|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
126521141|NCT01198600|455200192|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
126521142|NCT01198600|455200193|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
126521143|NCT03694548|455200194|FG000|Part A Survey|Protocol Violation|3|||
126521144|NCT03694548|455200195|FG001|Part A Survey|Protocol Violation|3|||
126521145|NCT03694548|455200196|FG002|Part A Survey|Protocol Violation|0|||
126521146|NCT03694548|455200194|FG000|Part B Yoga Program|Protocol Violation|0|||
126521147|NCT03694548|455200195|FG001|Part B Yoga Program|Protocol Violation|0|||
126521148|NCT03694548|455200196|FG002|Part B Yoga Program|Protocol Violation|3|||
126521149|NCT03694548|455200194|FG000|Part B Yoga Program|Did not attend intervention|0|||
126521150|NCT03694548|455200195|FG001|Part B Yoga Program|Did not attend intervention|0|||
126521151|NCT03694548|455200196|FG002|Part B Yoga Program|Did not attend intervention|8|||
126521152|NCT04496258|455200197|FG000|Overall Study|Withdrawal by Subject|2|||
126521153|NCT04496258|455200198|FG001|Overall Study|Withdrawal by Subject|1|||
126521154|NCT04102501|455200199|FG000|Overall Study|Withdrawal by Subject|7|||
126521155|NCT04102501|455200200|FG001|Overall Study|Withdrawal by Subject|9|||
126521156|NCT04102501|455200199|FG000|Overall Study|Adverse Event|1|||
126521157|NCT04102501|455200200|FG001|Overall Study|Adverse Event|3|||
126521158|NCT01427712|455200201|FG000|Overall Study|Transfer to a different hospital|2|||
126521159|NCT01427712|455200201|FG000|Overall Study|Lost to Follow-up|1|||
126521160|NCT01427712|455200201|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
126521161|NCT01427712|455200201|FG000|Overall Study|Failure to visit|1|||
126521162|NCT00968617|455200203|FG000|Overall Study|Study terminated by sponsor|6|||
126521163|NCT00439777|455200207|FG000|Treatment Period|Death|29|||
126521164|NCT00439777|455200208|FG001|Treatment Period|Death|21|||
126521165|NCT00439777|455200207|FG000|Treatment Period|Study terminated by sponsor|125|||
126521166|NCT00439777|455200208|FG001|Treatment Period|Study terminated by sponsor|132|||
126521167|NCT00439777|455200207|FG000|Treatment Period|Site closed by investigator|0|||
126521168|NCT00439777|455200208|FG001|Treatment Period|Site closed by investigator|1|||
126521169|NCT00439777|455200207|FG000|Treatment Period|Did not take study treatment|7|||
126521170|NCT00439777|455200208|FG001|Treatment Period|Did not take study treatment|8|||
126521171|NCT00439777|455200207|FG000|Treatment Period|Adverse Event|111|||
126521172|NCT00439777|455200208|FG001|Treatment Period|Adverse Event|92|||
126521173|NCT00439777|455200207|FG000|Treatment Period|Protocol Violation|23|||
126521174|NCT00439777|455200208|FG001|Treatment Period|Protocol Violation|30|||
126521175|NCT00439777|455200207|FG000|Treatment Period|Withdrawal by Subject|66|||
126521176|NCT00439777|455200208|FG001|Treatment Period|Withdrawal by Subject|118|||
126521177|NCT00439777|455200207|FG000|Treatment Period|Lack of Efficacy|1|||
126521178|NCT00439777|455200208|FG001|Treatment Period|Lack of Efficacy|4|||
126521179|NCT00439777|455200207|FG000|Treatment Period|Lost to Follow-up|8|||
126521180|NCT00439777|455200208|FG001|Treatment Period|Lost to Follow-up|10|||
126521181|NCT00439777|455200207|FG000|Treatment Period|Protocol driven decision point|1|||
126521182|NCT00439777|455200208|FG001|Treatment Period|Protocol driven decision point|3|||
126521183|NCT00439777|455200207|FG000|Treatment Period|Physician Decision|7|||
126521184|NCT00439777|455200208|FG001|Treatment Period|Physician Decision|18|||
126521185|NCT00439777|455200207|FG000|Treatment Period|Clinical endpoint reached|26|||
126521186|NCT00439777|455200208|FG001|Treatment Period|Clinical endpoint reached|13|||
126521187|NCT00439777|455200207|FG000|Treatment Period|Technical problems|3|||
126521188|NCT00439777|455200208|FG001|Treatment Period|Technical problems|1|||
126521189|NCT00439777|455200207|FG000|Treatment Period|Participant convenience|12|||
126521190|NCT00439777|455200208|FG001|Treatment Period|Participant convenience|8|||
126521191|NCT00439777|455200207|FG000|Observational Period|Protocol Violation|0|||
126521192|NCT00439777|455200208|FG001|Observational Period|Protocol Violation|2|||
126521193|NCT00439777|455200207|FG000|Observational Period|Withdrawal by Subject|9|||
126521194|NCT00439777|455200208|FG001|Observational Period|Withdrawal by Subject|5|||
126521195|NCT00439777|455200207|FG000|Observational Period|Lost to Follow-up|1|||
126521196|NCT00439777|455200208|FG001|Observational Period|Lost to Follow-up|11|||
126521197|NCT00439777|455200207|FG000|Observational Period|Death|27|||
126521198|NCT00439777|455200208|FG001|Observational Period|Death|20|||
126521199|NCT00439777|455200207|FG000|Observational Period|Study terminated by sponsor|3|||
126521200|NCT00439777|455200208|FG001|Observational Period|Study terminated by sponsor|1|||
126521201|NCT00439777|455200207|FG000|Observational Period|Protocol driven decision point|0|||
126521202|NCT00439777|455200208|FG001|Observational Period|Protocol driven decision point|1|||
126521203|NCT00439777|455200207|FG000|Observational Period|Lack of Efficacy|1|||
126521204|NCT00439777|455200208|FG001|Observational Period|Lack of Efficacy|0|||
126521205|NCT00439777|455200207|FG000|Observational Period|Technical problems|0|||
126521206|NCT00439777|455200208|FG001|Observational Period|Technical problems|1|||
126521207|NCT00661492|455200211|FG000|Overall Study|Adverse Event|16|||
126521208|NCT00661492|455200212|FG001|Overall Study|Adverse Event|13|||
126521209|NCT00661492|455200211|FG000|Overall Study|Disease Progression|44|||
126521210|NCT00661492|455200212|FG001|Overall Study|Disease Progression|14|||
126521211|NCT00661492|455200211|FG000|Overall Study|Patient Request|6|||
126521212|NCT00661492|455200212|FG001|Overall Study|Patient Request|1|||
126521213|NCT00661492|455200211|FG000|Overall Study|Investigator Request|1|||
126521214|NCT00661492|455200212|FG001|Overall Study|Investigator Request|0|||
126521215|NCT00661492|455200211|FG000|Overall Study|Lost to Follow-up|0|||
126521216|NCT00661492|455200212|FG001|Overall Study|Lost to Follow-up|1|||
126521217|NCT00661492|455200211|FG000|Overall Study|Other|1|||
126521218|NCT00661492|455200212|FG001|Overall Study|Other|0|||
126521219|NCT01024387|455200213|FG000|Overall Study|Radiographic Progression|29|||
126521220|NCT01024387|455200213|FG000|Overall Study|Symptomatic Progression|10|||
126521221|NCT01024387|455200213|FG000|Overall Study|Physician Decision|5|||
126521222|NCT01024387|455200213|FG000|Overall Study|Withdrawal by Subject|5|||
126521223|NCT01024387|455200213|FG000|Overall Study|Death|2|||
126521224|NCT01024387|455200213|FG000|Overall Study|Prolonged Treatment Delay|1|||
126521225|NCT01024387|455200213|FG000|Overall Study|Adverse Event|3|||
126521226|NCT01024387|455200213|FG000|Overall Study|Other|5|||
126521227|NCT03855189|455200214|FG000|Overall Study|Adverse Event|5|||
126521228|NCT03855189|455200215|FG001|Overall Study|Adverse Event|2|||
126521229|NCT03855189|455200216|FG002|Overall Study|Adverse Event|4|||
126521230|NCT03855189|455200214|FG000|Overall Study|Treatment Failure|1|||
126521231|NCT03855189|455200215|FG001|Overall Study|Treatment Failure|1|||
126521232|NCT03855189|455200216|FG002|Overall Study|Treatment Failure|2|||
126521233|NCT03855189|455200214|FG000|Overall Study|Noncompliance with Protocol|0|||
126521234|NCT03855189|455200215|FG001|Overall Study|Noncompliance with Protocol|1|||
126521235|NCT03855189|455200216|FG002|Overall Study|Noncompliance with Protocol|0|||
126521236|NCT03855189|455200214|FG000|Overall Study|Did Not Return|4|||
126521237|NCT03855189|455200215|FG001|Overall Study|Did Not Return|3|||
126521238|NCT03855189|455200216|FG002|Overall Study|Did Not Return|0|||
126521239|NCT01143259|455200217|FG000|Overall Study|Withdrawal by Subject|3|||
126521240|NCT01143259|455200218|FG001|Overall Study|Withdrawal by Subject|2|||
126521241|NCT01143259|455200217|FG000|Overall Study|Protocol Violation|13|||
126521242|NCT01143259|455200218|FG001|Overall Study|Protocol Violation|9|||
126521243|NCT01143259|455200217|FG000|Overall Study|Screen Failure|7|||
126521244|NCT01143259|455200218|FG001|Overall Study|Screen Failure|9|||
126521245|NCT00099983|455200219|FG000|Overall Study|Lost to Follow-up|2|||
126521246|NCT00099983|455200220|FG001|Overall Study|Lost to Follow-up|3|||
126521247|NCT00099983|455200219|FG000|Overall Study|Missing Source Documents|14|||
126521248|NCT00099983|455200220|FG001|Overall Study|Missing Source Documents|15|||
126521249|NCT00099983|455200219|FG000|Overall Study|Withdrawal by Subject|3|||
126521250|NCT00099983|455200220|FG001|Overall Study|Withdrawal by Subject|2|||
126521251|NCT00099983|455200219|FG000|Overall Study|Adverse Event|1|||
126521252|NCT00099983|455200220|FG001|Overall Study|Adverse Event|1|||
126521253|NCT00099983|455200219|FG000|Overall Study|Lack of Efficacy|0|||
126521254|NCT00099983|455200220|FG001|Overall Study|Lack of Efficacy|1|||
126521255|NCT00099983|455200219|FG000|Overall Study|Unable to return for appointments|1|||
126521256|NCT00099983|455200220|FG001|Overall Study|Unable to return for appointments|1|||
126521257|NCT00099983|455200219|FG000|Overall Study|Moved|1|||
126521258|NCT00099983|455200220|FG001|Overall Study|Moved|0|||
126521259|NCT00099983|455200219|FG000|Overall Study|Other psychiatric problem|1|||
126521260|NCT00099983|455200220|FG001|Overall Study|Other psychiatric problem|0|||
126521261|NCT00099983|455200219|FG000|Overall Study|Incarcerated|0|||
126521262|NCT00099983|455200220|FG001|Overall Study|Incarcerated|1|||
126573164|NCT01135511|455394370|FG007|Overall Study|Lack of Efficacy|0|||
126573165|NCT01135511|455394371|FG008|Overall Study|Lack of Efficacy|0|||
126573166|NCT01135511|455394363|FG000|Overall Study|Protocol Violation|0|||
126573167|NCT01135511|455394364|FG001|Overall Study|Protocol Violation|0|||
126521263|NCT00099983|455200219|FG000|Overall Study|Intolerant of burden of visits|0|||
126521264|NCT00099983|455200220|FG001|Overall Study|Intolerant of burden of visits|1|||
126521265|NCT00099983|455200219|FG000|Overall Study|Other issue|1|||
126521266|NCT00099983|455200220|FG001|Overall Study|Other issue|0|||
126521267|NCT03864900|455200221|FG000|Overall Study|Withdrawal by Subject|1|||
126521268|NCT03864900|455200222|FG001|Overall Study|Withdrawal by Subject|1|||
126521269|NCT03864900|455200221|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
126521270|NCT03864900|455200222|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
126521271|NCT00759109|455200224|FG000|Overall Study|Adverse Event|17|||
126521272|NCT00759109|455200225|FG001|Overall Study|Adverse Event|12|||
126521273|NCT00759109|455200224|FG000|Overall Study|Inability to comply|1|||
126521274|NCT00759109|455200225|FG001|Overall Study|Inability to comply|1|||
126521275|NCT00759109|455200224|FG000|Overall Study|Withdrawal by Subject|9|||
126521276|NCT00759109|455200225|FG001|Overall Study|Withdrawal by Subject|5|||
126521277|NCT00759109|455200224|FG000|Overall Study|Death|4|||
126521278|NCT00759109|455200225|FG001|Overall Study|Death|3|||
126521279|NCT00759109|455200224|FG000|Overall Study|Lost to Follow-up|4|||
126521280|NCT00759109|455200225|FG001|Overall Study|Lost to Follow-up|6|||
126521281|NCT00759109|455200224|FG000|Overall Study|Started new therapy|2|||
126521282|NCT00759109|455200225|FG001|Overall Study|Started new therapy|6|||
126521283|NCT00759109|455200224|FG000|Overall Study|HCV RNA negative|1|||
126521284|NCT00759109|455200225|FG001|Overall Study|HCV RNA negative|0|||
126521285|NCT00759109|455200224|FG000|Overall Study|Participant moved to a different city|0|||
126521286|NCT00759109|455200225|FG001|Overall Study|Participant moved to a different city|1|||
126521287|NCT00759109|455200224|FG000|Overall Study|Participant had a liver transplant|0|||
126521288|NCT00759109|455200225|FG001|Overall Study|Participant had a liver transplant|1|||
126521289|NCT00759109|455200224|FG000|Overall Study|Lost during study|1|||
126521290|NCT00759109|455200225|FG001|Overall Study|Lost during study|0|||
126521291|NCT03238001|455200226|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
126521292|NCT03238001|455200226|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
126521293|NCT03238001|455200226|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
126521294|NCT03238001|455200226|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
126521295|NCT03238001|455200226|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
126521296|NCT03238001|455200226|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
126521297|NCT03238001|455200226|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
126521298|NCT03238001|455200226|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
126521299|NCT03165045|455200227|FG000|Visit 1|No registration after visit 1|9|||
126521300|NCT03165045|455200227|FG000|Visit 1|No treatment documented|10|||
126521301|NCT03165045|455200227|FG000|Visit 1|No visit 1|10|||
126521302|NCT03165045|455200227|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
126521303|NCT03165045|455200227|FG000|Visit 2|No available total CCQ score at all|29|||
126521304|NCT03165045|455200227|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
126521305|NCT01866709|455200231|FG000|Overall Study|Adverse Event|1|||
126521306|NCT01866709|455200232|FG001|Overall Study|Adverse Event|0|||
126521307|NCT03791398|455200233|FG000|Overall Study|Progression of Disease Under Study|2|||
126521308|NCT03791398|455200234|FG001|Overall Study|Progression of Disease Under Study|0|||
126521309|NCT03791398|455200235|FG002|Overall Study|Progression of Disease Under Study|0|||
126521310|NCT02207829|455200236|FG000|Overall Study|Adverse Event|10|||
126521311|NCT02207829|455200237|FG001|Overall Study|Adverse Event|9|||
126521312|NCT02207829|455200236|FG000|Overall Study|Lack of Efficacy|7|||
126521313|NCT02207829|455200237|FG001|Overall Study|Lack of Efficacy|5|||
126521314|NCT02207829|455200236|FG000|Overall Study|Lost to Follow-up|2|||
126521315|NCT02207829|455200237|FG001|Overall Study|Lost to Follow-up|2|||
126521316|NCT02207829|455200236|FG000|Overall Study|Protocol deviation|5|||
126521317|NCT02207829|455200237|FG001|Overall Study|Protocol deviation|4|||
126521318|NCT02207829|455200236|FG000|Overall Study|Withdrew consent|18|||
126521319|NCT02207829|455200237|FG001|Overall Study|Withdrew consent|14|||
126521320|NCT00766376|455200238|FG000|Overall Study|Withdrawal by Subject|27|||
126521321|NCT03191903|455200239|FG000|Overall Study|Withdrawal by Subject|6|||
126521322|NCT03191903|455200240|FG001|Overall Study|Withdrawal by Subject|5|||
126521323|NCT03191903|455200241|FG002|Overall Study|Withdrawal by Subject|4|||
126521324|NCT03191903|455200239|FG000|Overall Study|Adverse Event|1|||
126521325|NCT03191903|455200240|FG001|Overall Study|Adverse Event|0|||
126521326|NCT03191903|455200241|FG002|Overall Study|Adverse Event|0|||
126521327|NCT01578551|455200244|FG000|Overall Study|Adverse Event|1|||
126521328|NCT01578551|455200245|FG001|Overall Study|Adverse Event|0|||
126521329|NCT04369469|455200252|FG000|Overall Study|Lost to Follow-up|2|||
126521330|NCT04369469|455200253|FG001|Overall Study|Lost to Follow-up|4|||
126521331|NCT04369469|455200252|FG000|Overall Study|Physician Decision|2|||
126521332|NCT04369469|455200253|FG001|Overall Study|Physician Decision|1|||
126521333|NCT04369469|455200252|FG000|Overall Study|Withdrawal by Subject|2|||
126521334|NCT04369469|455200253|FG001|Overall Study|Withdrawal by Subject|3|||
126521335|NCT04369469|455200252|FG000|Overall Study|Adverse Event|1|||
126521336|NCT04369469|455200253|FG001|Overall Study|Adverse Event|0|||
126521337|NCT04369469|455200252|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
126521338|NCT04369469|455200253|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
126521339|NCT04369469|455200252|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
126521340|NCT04369469|455200253|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
126521341|NCT04369469|455200252|FG000|Overall Study|Unable to Provide Consent|0|||
126521342|NCT04369469|455200253|FG001|Overall Study|Unable to Provide Consent|1|||
126521343|NCT03099382|455200256|FG000|Overall Study|Protocol Violation|2|||
126521344|NCT03099382|455200257|FG001|Overall Study|Protocol Violation|3|||
126521345|NCT00499369|455200258|FG000|Overall Study|Adverse Event|2|||
126521346|NCT00499369|455200259|FG001|Overall Study|Adverse Event|2|||
126521347|NCT00499369|455200260|FG002|Overall Study|Adverse Event|3|||
126521348|NCT00499369|455200261|FG003|Overall Study|Adverse Event|1|||
126521349|NCT00499369|455200262|FG004|Overall Study|Adverse Event|2|||
126521350|NCT00499369|455200258|FG000|Overall Study|Withdrawal by Subject|0|||
126521351|NCT00499369|455200259|FG001|Overall Study|Withdrawal by Subject|1|||
126521352|NCT00499369|455200260|FG002|Overall Study|Withdrawal by Subject|1|||
126521353|NCT00499369|455200261|FG003|Overall Study|Withdrawal by Subject|0|||
126521354|NCT00499369|455200262|FG004|Overall Study|Withdrawal by Subject|0|||
126521355|NCT00499369|455200258|FG000|Overall Study|Progression|10|||
126521356|NCT00499369|455200259|FG001|Overall Study|Progression|12|||
126521357|NCT00499369|455200260|FG002|Overall Study|Progression|9|||
126521358|NCT00499369|455200261|FG003|Overall Study|Progression|6|||
126521359|NCT00499369|455200262|FG004|Overall Study|Progression|10|||
126521360|NCT00499369|455200258|FG000|Overall Study|Death|0|||
126521361|NCT00499369|455200259|FG001|Overall Study|Death|1|||
126521362|NCT00499369|455200260|FG002|Overall Study|Death|0|||
126521363|NCT00499369|455200261|FG003|Overall Study|Death|0|||
126521364|NCT00499369|455200262|FG004|Overall Study|Death|0|||
126521365|NCT00499369|455200258|FG000|Overall Study|Not protocol specified|2|||
126521366|NCT00499369|455200259|FG001|Overall Study|Not protocol specified|0|||
126521367|NCT00499369|455200260|FG002|Overall Study|Not protocol specified|3|||
126521368|NCT00499369|455200261|FG003|Overall Study|Not protocol specified|1|||
126521369|NCT00499369|455200262|FG004|Overall Study|Not protocol specified|0|||
126521370|NCT00499369|455200258|FG000|Overall Study|Ineligible|2|||
126521371|NCT00499369|455200259|FG001|Overall Study|Ineligible|2|||
126521372|NCT00499369|455200260|FG002|Overall Study|Ineligible|1|||
126521373|NCT00499369|455200261|FG003|Overall Study|Ineligible|1|||
126521374|NCT00499369|455200262|FG004|Overall Study|Ineligible|0|||
126521375|NCT01802411|455200263|FG000|Overall Study|Death|2|||
126521376|NCT01802411|455200264|FG001|Overall Study|Death|1|||
126521377|NCT01802411|455200263|FG000|Overall Study|Adverse Event|2|||
126521378|NCT01802411|455200264|FG001|Overall Study|Adverse Event|7|||
126521379|NCT01802411|455200263|FG000|Overall Study|Lack of Efficacy|8|||
126521380|NCT01802411|455200264|FG001|Overall Study|Lack of Efficacy|10|||
126521381|NCT01802411|455200263|FG000|Overall Study|Withdrawal by Subject|0|||
126521382|NCT01802411|455200264|FG001|Overall Study|Withdrawal by Subject|2|||
126521383|NCT01802411|455200263|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
126521384|NCT01802411|455200264|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
126521385|NCT01802411|455200263|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
126521386|NCT01802411|455200264|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
126521387|NCT01802411|455200263|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
126521388|NCT01802411|455200264|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
126521389|NCT03864614|455200267|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
126521390|NCT03864614|455200268|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
126521391|NCT03864614|455200269|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
126521392|NCT03864614|455200270|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
126521393|NCT03864614|455200267|FG000|Overall Study|Withdrawal by Subject|72|||
126521394|NCT03864614|455200268|FG001|Overall Study|Withdrawal by Subject|100|||
126521395|NCT03864614|455200269|FG002|Overall Study|Withdrawal by Subject|1|||
126521396|NCT03864614|455200270|FG003|Overall Study|Withdrawal by Subject|21|||
126521397|NCT03864614|455200267|FG000|Overall Study|Lost to Follow-up|45|||
126521398|NCT03864614|455200268|FG001|Overall Study|Lost to Follow-up|54|||
126521399|NCT03864614|455200269|FG002|Overall Study|Lost to Follow-up|0|||
126727325|NCT02358369|455951114|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
126727326|NCT02358369|455951115|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
126727327|NCT02358369|455951111|FG000|Treatment Period C|Adverse Event|0|||
126727328|NCT02358369|455951112|FG001|Treatment Period C|Adverse Event|0|||
126521400|NCT03864614|455200270|FG003|Overall Study|Lost to Follow-up|9|||
126521401|NCT03864614|455200267|FG000|Overall Study|Adverse Event|42|||
126727329|NCT02358369|455951113|FG002|Treatment Period C|Adverse Event|0|||
126727330|NCT02358369|455951114|FG003|Treatment Period C|Adverse Event|0|||
126521402|NCT03864614|455200268|FG001|Overall Study|Adverse Event|30|||
126521403|NCT03864614|455200269|FG002|Overall Study|Adverse Event|1|||
126521404|NCT03864614|455200270|FG003|Overall Study|Adverse Event|9|||
126521405|NCT03864614|455200267|FG000|Overall Study|Protocol Deviation|6|||
126521406|NCT03864614|455200268|FG001|Overall Study|Protocol Deviation|26|||
126521407|NCT03864614|455200269|FG002|Overall Study|Protocol Deviation|0|||
126521408|NCT03864614|455200270|FG003|Overall Study|Protocol Deviation|1|||
126521409|NCT03864614|455200267|FG000|Overall Study|Physician Decision|7|||
126521410|NCT03864614|455200268|FG001|Overall Study|Physician Decision|10|||
126727331|NCT02358369|455951115|FG004|Treatment Period C|Adverse Event|7|||
126521411|NCT03864614|455200269|FG002|Overall Study|Physician Decision|1|||
126521412|NCT03864614|455200270|FG003|Overall Study|Physician Decision|5|||
126521413|NCT03864614|455200267|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
126521414|NCT03864614|455200268|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
126521415|NCT03864614|455200269|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
126521416|NCT03864614|455200270|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
126727332|NCT04465396|455951116|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
126521417|NCT03864614|455200267|FG000|Overall Study|Sponsor Decision|1|||
126521418|NCT03864614|455200268|FG001|Overall Study|Sponsor Decision|2|||
126521419|NCT03864614|455200269|FG002|Overall Study|Sponsor Decision|0|||
126521420|NCT03864614|455200270|FG003|Overall Study|Sponsor Decision|0|||
126521421|NCT03864614|455200267|FG000|Overall Study|Pregnancy|0|||
126521422|NCT03864614|455200268|FG001|Overall Study|Pregnancy|1|||
126521423|NCT03864614|455200269|FG002|Overall Study|Pregnancy|0|||
126521424|NCT03864614|455200270|FG003|Overall Study|Pregnancy|0|||
126521425|NCT03864614|455200267|FG000|Overall Study|Other|7|||
126521426|NCT03864614|455200268|FG001|Overall Study|Other|9|||
126521427|NCT03864614|455200269|FG002|Overall Study|Other|1|||
126521428|NCT03864614|455200270|FG003|Overall Study|Other|4|||
126521429|NCT03864614|455200267|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
126521430|NCT03864614|455200268|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
126521431|NCT03864614|455200269|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
126521432|NCT03864614|455200270|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
126521433|NCT03859323|455202165|FG000|Overall Study|Lost to Follow-up|0|||
126521434|NCT03859323|455202166|FG001|Overall Study|Lost to Follow-up|0|||
126521435|NCT03859323|455202167|FG002|Overall Study|Lost to Follow-up|0|||
126521436|NCT03859323|455202168|FG003|Overall Study|Lost to Follow-up|0|||
126521437|NCT03859323|455202169|FG004|Overall Study|Lost to Follow-up|0|||
126521438|NCT03859323|455202170|FG005|Overall Study|Lost to Follow-up|0|||
126521439|NCT03859323|455202171|FG006|Overall Study|Lost to Follow-up|1|||
126521440|NCT03859323|455202172|FG007|Overall Study|Lost to Follow-up|0|||
126521441|NCT03859323|455202173|FG008|Overall Study|Lost to Follow-up|0|||
126521442|NCT03859323|455202174|FG009|Overall Study|Lost to Follow-up|0|||
126521443|NCT03859323|455202175|FG010|Overall Study|Lost to Follow-up|0|||
126521444|NCT03859323|455202176|FG011|Overall Study|Lost to Follow-up|0|||
126521445|NCT03859323|455202177|FG012|Overall Study|Lost to Follow-up|0|||
126521446|NCT03859323|455202165|FG000|Overall Study|Withdrawal by Subject|0|||
126521447|NCT03859323|455202166|FG001|Overall Study|Withdrawal by Subject|0|||
126521448|NCT03859323|455202167|FG002|Overall Study|Withdrawal by Subject|1|||
126521449|NCT03859323|455202168|FG003|Overall Study|Withdrawal by Subject|0|||
126521450|NCT03859323|455202169|FG004|Overall Study|Withdrawal by Subject|0|||
126521451|NCT03859323|455202170|FG005|Overall Study|Withdrawal by Subject|1|||
126521452|NCT03859323|455202171|FG006|Overall Study|Withdrawal by Subject|0|||
126521453|NCT03859323|455202172|FG007|Overall Study|Withdrawal by Subject|0|||
126521454|NCT03859323|455202173|FG008|Overall Study|Withdrawal by Subject|0|||
126521455|NCT03859323|455202174|FG009|Overall Study|Withdrawal by Subject|1|||
126521456|NCT03859323|455202175|FG010|Overall Study|Withdrawal by Subject|1|||
126521457|NCT03859323|455202176|FG011|Overall Study|Withdrawal by Subject|2|||
126521458|NCT03859323|455202177|FG012|Overall Study|Withdrawal by Subject|1|||
126521459|NCT03859323|455202165|FG000|Overall Study|Pregnancy|0|||
126521460|NCT03859323|455202166|FG001|Overall Study|Pregnancy|0|||
126521461|NCT03859323|455202167|FG002|Overall Study|Pregnancy|0|||
126521462|NCT03859323|455202168|FG003|Overall Study|Pregnancy|0|||
126521463|NCT03859323|455202169|FG004|Overall Study|Pregnancy|0|||
126521464|NCT03859323|455202170|FG005|Overall Study|Pregnancy|0|||
126521465|NCT03859323|455202171|FG006|Overall Study|Pregnancy|0|||
126521466|NCT03859323|455202172|FG007|Overall Study|Pregnancy|0|||
126521467|NCT03859323|455202173|FG008|Overall Study|Pregnancy|0|||
126521468|NCT03859323|455202174|FG009|Overall Study|Pregnancy|1|||
126521469|NCT03859323|455202175|FG010|Overall Study|Pregnancy|0|||
126521470|NCT03859323|455202176|FG011|Overall Study|Pregnancy|0|||
126521471|NCT03859323|455202177|FG012|Overall Study|Pregnancy|0|||
126521472|NCT01404312|455202180|FG000|Overall Study|Death|21|||
126521473|NCT01404312|455202181|FG001|Overall Study|Death|27|||
126521474|NCT01404312|455202180|FG000|Overall Study|Withdrawal by Subject|15|||
126521475|NCT01404312|455202181|FG001|Overall Study|Withdrawal by Subject|18|||
126521476|NCT01404312|455202180|FG000|Overall Study|Participant Unable to get to clinic|93|||
126521477|NCT01404312|455202181|FG001|Overall Study|Participant Unable to get to clinic|103|||
126521478|NCT01404312|455202180|FG000|Overall Study|Lost to Follow-up|115|||
126521479|NCT01404312|455202181|FG001|Overall Study|Lost to Follow-up|111|||
126521480|NCT01404312|455202180|FG000|Overall Study|Site closed|22|||
126521481|NCT01404312|455202181|FG001|Overall Study|Site closed|21|||
126521482|NCT01404312|455202180|FG000|Overall Study|Participant not willing to adhere to req|31|||
126521483|NCT01404312|455202181|FG001|Overall Study|Participant not willing to adhere to req|29|||
126521484|NCT01404312|455202180|FG000|Overall Study|Severe debilitation, unable to continue|1|||
126521485|NCT01404312|455202181|FG001|Overall Study|Severe debilitation, unable to continue|2|||
126521486|NCT04419493|455202182|FG000|Wash-out After Period 1|Adverse Event|1|||
126521487|NCT04419493|455202183|FG001|Wash-out After Period 1|Adverse Event|2|||
126521488|NCT04419493|455202184|FG002|Wash-out After Period 1|Adverse Event|1|||
126521489|NCT04419493|455202185|FG003|Wash-out After Period 1|Adverse Event|0|||
126521490|NCT00524134|455202186|FG000|Overall Study|Withdrawal by Subject|1|||
126521491|NCT00524134|455202186|FG000|Overall Study|Physician Decision|1|||
126521492|NCT03794089|455202187|FG000|Overall Study|Lost to Follow-up|4|||
126521493|NCT03794089|455202188|FG001|Overall Study|Lost to Follow-up|1|||
126521494|NCT03794089|455202187|FG000|Overall Study|Withdrawal by Subject|2|||
126521495|NCT03794089|455202188|FG001|Overall Study|Withdrawal by Subject|0|||
126521496|NCT03985423|455202189|FG000|Overall Study|Adverse Event|1|||
126521497|NCT03985423|455202189|FG000|Overall Study|Death|2|||
126521498|NCT03985423|455202189|FG000|Overall Study|Physician Decision|1|||
126521499|NCT03985423|455202189|FG000|Overall Study|Withdrawal by Subject|2|||
126521500|NCT03985423|455202189|FG000|Overall Study|Lack of insurance and citizenship|1|||
126521501|NCT00129987|455202190|FG000|1st Educational Session|Withdrawal by Subject|141|||
126521502|NCT00129987|455202191|FG001|1st Educational Session|Withdrawal by Subject|109|||
126521503|NCT00129987|455202190|FG000|1 Year|Withdrawal by Subject|32|||
126521504|NCT00129987|455202191|FG001|1 Year|Withdrawal by Subject|21|||
126521505|NCT00116805|455202195|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
126521506|NCT00116805|455202196|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
126521507|NCT00116805|455202195|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
126521508|NCT00116805|455202196|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
126521509|NCT00116805|455202195|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
126521510|NCT00116805|455202196|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
126521511|NCT00116805|455202195|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
126521512|NCT00116805|455202196|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
126521513|NCT00116805|455202195|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
126521514|NCT00116805|455202196|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
126521515|NCT00116805|455202195|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
126521516|NCT00116805|455202196|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
126521517|NCT00116805|455202195|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
126521518|NCT00116805|455202196|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
126521519|NCT00116805|455202195|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
126521520|NCT00116805|455202196|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
126521521|NCT00116805|455202195|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
126521522|NCT00116805|455202196|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
126521523|NCT00116805|455202195|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
126521524|NCT00116805|455202196|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
126521525|NCT00116805|455202195|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
126521526|NCT00116805|455202196|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
126521527|NCT00116805|455202195|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
126521528|NCT00116805|455202196|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
126521529|NCT00116805|455202195|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
126521530|NCT00116805|455202196|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
126521531|NCT00116805|455202195|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
126521532|NCT00116805|455202196|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
126521533|NCT00116805|455202195|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
126521534|NCT00116805|455202196|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
126521535|NCT00116805|455202195|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
126521536|NCT00116805|455202196|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
126521537|NCT00116805|455202195|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
126521538|NCT00116805|455202196|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
126521539|NCT00116805|455202195|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
126521540|NCT00116805|455202196|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
126521541|NCT00116805|455202195|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
126521542|NCT00116805|455202196|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
126521543|NCT00116805|455202195|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
126521544|NCT00116805|455202196|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
126521545|NCT00116805|455202195|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
126521546|NCT00116805|455202196|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
126521547|NCT00116805|455202195|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
126521548|NCT00116805|455202196|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
126521549|NCT00116805|455202195|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
126521550|NCT00116805|455202196|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
126521551|NCT00116805|455202195|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
126521552|NCT00116805|455202196|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
126521553|NCT00116805|455202195|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
126521554|NCT00116805|455202196|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
126521555|NCT00116805|455202195|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
126521556|NCT00116805|455202196|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
126521557|NCT00116805|455202195|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
126521558|NCT00116805|455202196|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
126521559|NCT00116805|455202195|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
126573168|NCT01135511|455394365|FG002|Overall Study|Protocol Violation|3|||
126521560|NCT00116805|455202196|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
126521561|NCT00116805|455202195|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
126521562|NCT00116805|455202196|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
126521563|NCT00116805|455202195|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
126521564|NCT00116805|455202196|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
126521565|NCT00116805|455202195|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
126521566|NCT00116805|455202196|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
126521567|NCT00116805|455202195|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
126521568|NCT00116805|455202196|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
126521569|NCT00116805|455202195|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
126521570|NCT00116805|455202196|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
126521571|NCT00116805|455202195|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
126521572|NCT00116805|455202196|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
126521573|NCT00116805|455202195|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
126521574|NCT00116805|455202196|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
126521575|NCT00116805|455202195|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
126521576|NCT00116805|455202196|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
126521577|NCT00116805|455202195|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
126521578|NCT00116805|455202196|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
126521579|NCT00116805|455202195|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
126521580|NCT00116805|455202196|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
126521581|NCT00116805|455202195|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
126521582|NCT00116805|455202196|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
126521583|NCT00116805|455202195|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
126521584|NCT00116805|455202196|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
126521585|NCT00116805|455202195|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
126521586|NCT00116805|455202196|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
126521587|NCT00116805|455202195|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
126521588|NCT00116805|455202196|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
126521589|NCT00116805|455202195|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
126521590|NCT00116805|455202196|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
126521591|NCT00116805|455202195|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
126521592|NCT00116805|455202196|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
126521593|NCT00116805|455202195|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
126521594|NCT00116805|455202196|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
126521595|NCT01760954|455202197|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
126521596|NCT01760954|455202198|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
126521597|NCT01760954|455202199|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
126521598|NCT01760954|455202200|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
126521599|NCT01760954|455202197|FG000|Treatment Period (6 Months)|Adverse Event|5|||
126521600|NCT01760954|455202198|FG001|Treatment Period (6 Months)|Adverse Event|3|||
126521601|NCT01760954|455202199|FG002|Treatment Period (6 Months)|Adverse Event|4|||
126521602|NCT01760954|455202200|FG003|Treatment Period (6 Months)|Adverse Event|10|||
126521603|NCT01760954|455202197|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
126521604|NCT01760954|455202198|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
126521605|NCT01760954|455202199|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
126521606|NCT01760954|455202200|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
126521607|NCT01760954|455202197|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
126521608|NCT01760954|455202198|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
126521609|NCT01760954|455202199|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
126521610|NCT01760954|455202200|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
126521611|NCT01760954|455202197|FG000|Treatment Period (6 Months)|Pregnancy|5|||
126727333|NCT04465396|455951117|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
126727334|NCT04465396|455951118|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
126727335|NCT04465396|455951119|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
126573169|NCT01135511|455394366|FG003|Overall Study|Protocol Violation|0|||
126727336|NCT03655717|455951126|FG000|Overall Study|Withdrawal by Subject|4|||
126727337|NCT03655717|455951127|FG001|Overall Study|Withdrawal by Subject|8|||
126727338|NCT03655717|455951128|FG002|Overall Study|Withdrawal by Subject|1|||
126521612|NCT01760954|455202198|FG001|Treatment Period (6 Months)|Pregnancy|0|||
126521613|NCT01760954|455202199|FG002|Treatment Period (6 Months)|Pregnancy|3|||
126521614|NCT01760954|455202200|FG003|Treatment Period (6 Months)|Pregnancy|2|||
126521615|NCT01760954|455202197|FG000|Treatment Period (6 Months)|Non-compliance|1|||
126521616|NCT01760954|455202198|FG001|Treatment Period (6 Months)|Non-compliance|4|||
126521617|NCT01760954|455202199|FG002|Treatment Period (6 Months)|Non-compliance|0|||
126521618|NCT01760954|455202200|FG003|Treatment Period (6 Months)|Non-compliance|3|||
126521619|NCT01760954|455202197|FG000|Treatment Period (6 Months)|Other|0|||
126521620|NCT01760954|455202198|FG001|Treatment Period (6 Months)|Other|3|||
126521621|NCT01760954|455202199|FG002|Treatment Period (6 Months)|Other|3|||
126521622|NCT01760954|455202200|FG003|Treatment Period (6 Months)|Other|1|||
126521623|NCT01760954|455202197|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
126521624|NCT01760954|455202198|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
126521625|NCT01760954|455202199|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
126521626|NCT01760954|455202200|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
126521627|NCT01760954|455202197|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
126521628|NCT01760954|455202198|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
126521629|NCT01760954|455202199|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
126521630|NCT01760954|455202200|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
126521631|NCT01760954|455202197|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
126521632|NCT01760954|455202198|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
126521633|NCT01760954|455202199|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
126521634|NCT01760954|455202200|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
126521635|NCT01760954|455202197|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
126521636|NCT01760954|455202198|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
126521637|NCT01760954|455202199|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
126521638|NCT01760954|455202200|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
126521639|NCT01760954|455202197|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
126521640|NCT01760954|455202198|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
126521641|NCT01760954|455202199|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
126521642|NCT01760954|455202200|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
126521643|NCT01760954|455202197|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
126521644|NCT01760954|455202198|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
126521645|NCT01760954|455202199|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
126521646|NCT01760954|455202200|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
126521647|NCT01760954|455202197|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
126521648|NCT01760954|455202198|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
126521649|NCT01760954|455202199|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
126521650|NCT01760954|455202200|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
126521651|NCT01760954|455202197|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
126521652|NCT01760954|455202198|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
126521653|NCT01760954|455202199|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
126521654|NCT01760954|455202200|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
126521655|NCT03320070|455202201|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
126521656|NCT03320070|455202202|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
126521657|NCT03320070|455202201|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
126521658|NCT03320070|455202202|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
126521659|NCT03320070|455202201|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
126521660|NCT03320070|455202202|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
126521661|NCT03320070|455202201|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
126521662|NCT03320070|455202202|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
126521663|NCT03320070|455202201|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
126521664|NCT03320070|455202202|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
126521665|NCT03320070|455202201|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
126521666|NCT03320070|455202202|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
126521667|NCT00317772|455202206|FG000|Overall Study|Adverse Event|0|||
126521668|NCT00317772|455202207|FG001|Overall Study|Adverse Event|0|||
126521669|NCT00317772|455202208|FG002|Overall Study|Adverse Event|0|||
126521670|NCT00317772|455202209|FG003|Overall Study|Adverse Event|2|||
126521671|NCT00317772|455202206|FG000|Overall Study|Disease Progression|2|||
126521672|NCT00317772|455202207|FG001|Overall Study|Disease Progression|2|||
126521673|NCT00317772|455202208|FG002|Overall Study|Disease Progression|1|||
126727339|NCT03655717|455951129|FG003|Overall Study|Withdrawal by Subject|0|||
126727340|NCT03655717|455951130|FG004|Overall Study|Withdrawal by Subject|0|||
126727341|NCT03655717|455951131|FG005|Overall Study|Withdrawal by Subject|1|||
126727342|NCT03655717|455951132|FG006|Overall Study|Withdrawal by Subject|3|||
126521674|NCT00317772|455202209|FG003|Overall Study|Disease Progression|7|||
126521675|NCT04495374|455202222|FG000|Overall Study|Protocol Violation|2|||
126521676|NCT04495374|455202223|FG001|Overall Study|Protocol Violation|1|||
126521677|NCT00353704|455202224|FG000|Overall Study|Protocol Violation|3|||
126521678|NCT00353704|455202225|FG001|Overall Study|Protocol Violation|1|||
126521679|NCT02473614|455202226|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
126521680|NCT02473614|455202227|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
126521681|NCT00996996|455202228|FG000|Overall Study|Progressive Disease|10|||
126521682|NCT00996996|455202228|FG000|Overall Study|Non-compliance|8|||
126521683|NCT00996996|455202228|FG000|Overall Study|Lost to Follow-up|9|||
126521684|NCT00996996|455202228|FG000|Overall Study|Death|5|||
126521685|NCT00996996|455202228|FG000|Overall Study|Did Not Receive Study Medications|1|||
126521686|NCT01375049|455202229|FG000|Overall Study|Adverse Event|2|||
126521687|NCT01375049|455202229|FG000|Overall Study|Lost to Follow-up|1|||
126521688|NCT01375049|455202229|FG000|Overall Study|Withdrawal by Subject|2|||
126521689|NCT01375049|455202229|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
126521690|NCT01175382|455202232|FG000|Overall Study|Lost to Follow-up|4|||
126521691|NCT01175382|455202233|FG001|Overall Study|Lost to Follow-up|3|||
126521692|NCT01175382|455202234|FG002|Overall Study|Lost to Follow-up|1|||
126521693|NCT01175382|455202232|FG000|Overall Study|Physician Decision|0|||
126521694|NCT01175382|455202233|FG001|Overall Study|Physician Decision|1|||
126521695|NCT01175382|455202234|FG002|Overall Study|Physician Decision|0|||
126521696|NCT01175382|455202232|FG000|Overall Study|Withdrawal by Subject|0|||
126521697|NCT01175382|455202233|FG001|Overall Study|Withdrawal by Subject|0|||
126521698|NCT01175382|455202234|FG002|Overall Study|Withdrawal by Subject|1|||
126521699|NCT01175382|455202232|FG000|Overall Study|No longer having problem|1|||
126521700|NCT01175382|455202233|FG001|Overall Study|No longer having problem|0|||
126521701|NCT01175382|455202234|FG002|Overall Study|No longer having problem|1|||
126521702|NCT01175382|455202232|FG000|Overall Study|Unable/unwilling to attend visits|3|||
126521703|NCT01175382|455202233|FG001|Overall Study|Unable/unwilling to attend visits|1|||
126521704|NCT01175382|455202234|FG002|Overall Study|Unable/unwilling to attend visits|2|||
126521705|NCT01175382|455202232|FG000|Overall Study|Unwilling to follow protocol|0|||
126521706|NCT01175382|455202233|FG001|Overall Study|Unwilling to follow protocol|1|||
126521707|NCT01175382|455202234|FG002|Overall Study|Unwilling to follow protocol|0|||
126521708|NCT01175382|455202232|FG000|Overall Study|Unable to tolerate study meds|0|||
126521709|NCT01175382|455202233|FG001|Overall Study|Unable to tolerate study meds|1|||
126521710|NCT01175382|455202234|FG002|Overall Study|Unable to tolerate study meds|1|||
126521711|NCT00774787|455202235|FG000|Overall Study|Lost to Follow-up|1|||
126521712|NCT02554773|455202236|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
126521713|NCT02554773|455202237|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
126521714|NCT02554773|455202236|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
126521715|NCT02554773|455202237|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
126521716|NCT02554773|455202236|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
126521717|NCT02554773|455202237|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
126521718|NCT02554773|455202236|FG000|Original Dose Regimen (SAS 1)|Death|1|||
126521719|NCT02554773|455202237|FG001|Original Dose Regimen (SAS 1)|Death|0|||
126521720|NCT02554773|455202236|FG000|Original Dose Regimen (SAS 1)|Other|4|||
126521721|NCT02554773|455202237|FG001|Original Dose Regimen (SAS 1)|Other|0|||
126521722|NCT02554773|455202236|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
126521723|NCT02554773|455202237|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
126521724|NCT02554773|455202236|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
126521725|NCT02554773|455202237|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
126521726|NCT02554773|455202236|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
126521727|NCT02554773|455202237|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
126521728|NCT02554773|455202236|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
126521729|NCT02554773|455202237|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
126521730|NCT01148810|455202238|FG000|Overall Study|Adverse Event|0|||
126521731|NCT01148810|455202239|FG001|Overall Study|Adverse Event|2|||
126521732|NCT01148810|455202238|FG000|Overall Study|Lack of Efficacy|0|||
126521733|NCT01148810|455202239|FG001|Overall Study|Lack of Efficacy|1|||
126521734|NCT01148810|455202238|FG000|Overall Study|Withdrawal by Subject|0|||
126521735|NCT01148810|455202239|FG001|Overall Study|Withdrawal by Subject|2|||
126521736|NCT01148810|455202238|FG000|Overall Study|Protocol Violation|1|||
126521737|NCT01148810|455202239|FG001|Overall Study|Protocol Violation|0|||
126521738|NCT04408469|455202240|FG000|Overall Study|Lost to Follow-up|6|||
126521739|NCT04408469|455202241|FG001|Overall Study|Lost to Follow-up|9|||
126521740|NCT04408469|455202240|FG000|Overall Study|Withdrawal by Subject|6|||
126521741|NCT04408469|455202241|FG001|Overall Study|Withdrawal by Subject|1|||
126727343|NCT03655717|455951133|FG007|Overall Study|Withdrawal by Subject|1|||
126727344|NCT03655717|455951134|FG008|Overall Study|Withdrawal by Subject|2|||
126727345|NCT03655717|455951135|FG009|Overall Study|Withdrawal by Subject|0|||
126727346|NCT03655717|455951136|FG010|Overall Study|Withdrawal by Subject|0|||
126727347|NCT03655717|455951137|FG011|Overall Study|Withdrawal by Subject|1|||
126521742|NCT04408469|455202240|FG000|Overall Study|Dismissal due to ineligibility|0|||
126521743|NCT04408469|455202241|FG001|Overall Study|Dismissal due to ineligibility|1|||
126521744|NCT01248884|455202244|FG000|Overall Study|Withdrawal by Subject|1|||
126521745|NCT01248884|455202245|FG001|Overall Study|Withdrawal by Subject|3|||
126521746|NCT01248884|455202246|FG002|Overall Study|Withdrawal by Subject|1|||
126521747|NCT01248884|455202244|FG000|Overall Study|Adverse Event|1|||
126521748|NCT01248884|455202245|FG001|Overall Study|Adverse Event|0|||
126521749|NCT01248884|455202246|FG002|Overall Study|Adverse Event|0|||
126521750|NCT02511431|455202247|FG000|Treatment|Lost to Follow-up|0|||
126521751|NCT02511431|455202248|FG001|Treatment|Lost to Follow-up|0|||
126521752|NCT02511431|455202249|FG002|Treatment|Lost to Follow-up|1|||
126521753|NCT02511431|455202250|FG003|Treatment|Lost to Follow-up|0|||
126521754|NCT02511431|455202251|FG004|Treatment|Lost to Follow-up|0|||
126521755|NCT02511431|455202252|FG005|Treatment|Lost to Follow-up|1|||
126521756|NCT04479618|455202253|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
126521757|NCT04479618|455202254|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
126521758|NCT04479618|455202255|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
126521759|NCT04479618|455202253|FG000|Overall Study|Lack of Efficacy|1|||
126521760|NCT04479618|455202254|FG001|Overall Study|Lack of Efficacy|0|||
126521761|NCT04479618|455202255|FG002|Overall Study|Lack of Efficacy|0|||
126521762|NCT04479618|455202253|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
126521763|NCT04479618|455202254|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
126521764|NCT04479618|455202255|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
126521765|NCT04479618|455202253|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
126521766|NCT04479618|455202254|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
126521767|NCT04479618|455202255|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
126521768|NCT04479618|455202253|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
126521769|NCT04479618|455202254|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
126521770|NCT04479618|455202255|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
126521771|NCT04479618|455202253|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
126521772|NCT04479618|455202254|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
126521773|NCT04479618|455202255|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
126521774|NCT01202773|455202256|FG000|Overall Study|Adverse Event|4|||
126521775|NCT01202773|455202257|FG001|Overall Study|Adverse Event|5|||
126521776|NCT01202773|455202258|FG002|Overall Study|Adverse Event|5|||
126521777|NCT01202773|455202256|FG000|Overall Study|Lack of Efficacy|5|||
126521778|NCT01202773|455202257|FG001|Overall Study|Lack of Efficacy|4|||
126521779|NCT01202773|455202258|FG002|Overall Study|Lack of Efficacy|9|||
126521780|NCT01202773|455202256|FG000|Overall Study|Entry Criteria Not Met|2|||
126521781|NCT01202773|455202257|FG001|Overall Study|Entry Criteria Not Met|0|||
126521782|NCT01202773|455202258|FG002|Overall Study|Entry Criteria Not Met|1|||
126521783|NCT01202773|455202256|FG000|Overall Study|Lost to Follow-up|1|||
126521784|NCT01202773|455202257|FG001|Overall Study|Lost to Follow-up|2|||
126521785|NCT01202773|455202258|FG002|Overall Study|Lost to Follow-up|2|||
126521786|NCT01202773|455202256|FG000|Overall Study|Withdrawal by Subject|13|||
126521787|NCT01202773|455202257|FG001|Overall Study|Withdrawal by Subject|6|||
126521788|NCT01202773|455202258|FG002|Overall Study|Withdrawal by Subject|5|||
126521789|NCT01202773|455202256|FG000|Overall Study|Physician Decision|2|||
126521790|NCT01202773|455202257|FG001|Overall Study|Physician Decision|0|||
126521791|NCT01202773|455202258|FG002|Overall Study|Physician Decision|0|||
126521792|NCT01202773|455202256|FG000|Overall Study|Protocol Violation|11|||
126521793|NCT01202773|455202257|FG001|Overall Study|Protocol Violation|6|||
126521794|NCT01202773|455202258|FG002|Overall Study|Protocol Violation|10|||
126521795|NCT01202773|455202256|FG000|Overall Study|Sponsor Decision|19|||
126521796|NCT01202773|455202257|FG001|Overall Study|Sponsor Decision|20|||
126521797|NCT01202773|455202258|FG002|Overall Study|Sponsor Decision|23|||
126521798|NCT02828111|455202264|FG000|Overall Study|Withdrawal by Subject|0|||
126521799|NCT02828111|455202265|FG001|Overall Study|Withdrawal by Subject|0|||
126521800|NCT02828111|455202266|FG002|Overall Study|Withdrawal by Subject|2|||
126521801|NCT02828111|455202267|FG003|Overall Study|Withdrawal by Subject|0|||
126521802|NCT02828111|455202268|FG004|Overall Study|Withdrawal by Subject|0|||
126521803|NCT02828111|455202264|FG000|Overall Study|Lost to Follow-up|0|||
126521804|NCT02828111|455202265|FG001|Overall Study|Lost to Follow-up|0|||
126521805|NCT02828111|455202266|FG002|Overall Study|Lost to Follow-up|0|||
126521806|NCT02828111|455202267|FG003|Overall Study|Lost to Follow-up|1|||
126521807|NCT02828111|455202268|FG004|Overall Study|Lost to Follow-up|1|||
126521808|NCT03465540|455202271|FG000|Overall Study|Withdrawal by Subject|0|||
126521809|NCT03465540|455202272|FG001|Overall Study|Withdrawal by Subject|0|||
126521810|NCT03465540|455202273|FG002|Overall Study|Withdrawal by Subject|1|||
126521811|NCT03465540|455202274|FG003|Overall Study|Withdrawal by Subject|1|||
126521812|NCT03465540|455202275|FG004|Overall Study|Withdrawal by Subject|1|||
126521813|NCT03465540|455202276|FG005|Overall Study|Withdrawal by Subject|0|||
126521814|NCT03465540|455202271|FG000|Overall Study|Lost to Follow-up|0|||
126521815|NCT03465540|455202272|FG001|Overall Study|Lost to Follow-up|1|||
126521816|NCT03465540|455202273|FG002|Overall Study|Lost to Follow-up|0|||
126521817|NCT03465540|455202274|FG003|Overall Study|Lost to Follow-up|0|||
126521818|NCT03465540|455202275|FG004|Overall Study|Lost to Follow-up|1|||
126521819|NCT03465540|455202276|FG005|Overall Study|Lost to Follow-up|0|||
126521820|NCT03465540|455202271|FG000|Overall Study|Death|1|||
126521821|NCT03465540|455202272|FG001|Overall Study|Death|1|||
126573170|NCT01135511|455394367|FG004|Overall Study|Protocol Violation|0|||
126573171|NCT01135511|455394368|FG005|Overall Study|Protocol Violation|0|||
126573172|NCT01135511|455394369|FG006|Overall Study|Protocol Violation|0|||
126521822|NCT03465540|455202273|FG002|Overall Study|Death|0|||
126521823|NCT03465540|455202274|FG003|Overall Study|Death|2|||
126521824|NCT03465540|455202275|FG004|Overall Study|Death|0|||
126521825|NCT03465540|455202276|FG005|Overall Study|Death|2|||
126521826|NCT03465540|455202271|FG000|Overall Study|Protocol specified criteria|0|||
126521827|NCT03465540|455202272|FG001|Overall Study|Protocol specified criteria|2|||
126521828|NCT03465540|455202273|FG002|Overall Study|Protocol specified criteria|2|||
126521829|NCT03465540|455202274|FG003|Overall Study|Protocol specified criteria|0|||
126521830|NCT03465540|455202275|FG004|Overall Study|Protocol specified criteria|2|||
126521831|NCT03465540|455202276|FG005|Overall Study|Protocol specified criteria|0|||
126521832|NCT00736996|455202277|FG000|Overall Study|Lost to Follow-up|1|||
126521833|NCT00736996|455202278|FG001|Overall Study|Lost to Follow-up|9|||
126521834|NCT00736996|455202279|FG002|Overall Study|Lost to Follow-up|2|||
126521835|NCT02844946|455202280|FG000|Overall Study|Lost to Follow-up|7|||
126521836|NCT02844946|455202281|FG001|Overall Study|Lost to Follow-up|0|||
126521837|NCT02806986|455202282|FG000|Treatment Stage 1|Adverse Event|1|||
126521838|NCT02806986|455202282|FG000|Treatment Stage 2|Adverse Event|3|||
126521839|NCT02806986|455202282|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
126521840|NCT00462384|455202283|FG000|Overall Study|Adverse Event|2|||
126521841|NCT00462384|455202283|FG000|Overall Study|Death|2|||
126521842|NCT00462384|455202283|FG000|Overall Study|Withdrawal by Subject|1|||
126521843|NCT00462384|455202283|FG000|Overall Study|Other|4|||
126521844|NCT02667912|455202284|FG000|Overall Study|Death|3|||
126521845|NCT02667912|455202285|FG001|Overall Study|Death|1|||
126521846|NCT02667912|455202284|FG000|Overall Study|Withdrawal by Subject|1|||
126521847|NCT02667912|455202285|FG001|Overall Study|Withdrawal by Subject|2|||
126521848|NCT02667912|455202284|FG000|Overall Study|Withdrawal by Subject|1|||
126521849|NCT02667912|455202285|FG001|Overall Study|Withdrawal by Subject|0|||
126521850|NCT04443218|455202286|FG000|Overall Study|Exited study for other reasons|9|||
126521851|NCT04443218|455202286|FG000|Overall Study|Withdrawal by Subject|1|||
126521852|NCT04443218|455202286|FG000|Overall Study|Lost to Follow-up|4|||
126521853|NCT04443218|455202286|FG000|Overall Study|Death|19|||
126521854|NCT00346034|455202287|FG000|Overall Study|Adverse Event|34|||
126521855|NCT00346034|455202287|FG000|Overall Study|Lack of Efficacy|8|||
126521856|NCT00346034|455202287|FG000|Overall Study|Withdrawal by Subject|13|||
126521857|NCT00346034|455202287|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
126521858|NCT00346034|455202287|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
126521859|NCT00096941|455202288|FG000|Overall Study|disease progression|3|||
126521860|NCT00022516|455202289|FG000|Overall Study|Adverse Event|0|||
126521861|NCT00022516|455202290|FG001|Overall Study|Adverse Event|59|||
126521862|NCT00022516|455202289|FG000|Overall Study|Lack of Efficacy|0|||
126521863|NCT00022516|455202290|FG001|Overall Study|Lack of Efficacy|27|||
126521864|NCT00022516|455202289|FG000|Overall Study|Physician Decision|0|||
126521865|NCT00022516|455202290|FG001|Overall Study|Physician Decision|1|||
126521866|NCT00022516|455202289|FG000|Overall Study|Protocol Violation|1|||
126521867|NCT00022516|455202290|FG001|Overall Study|Protocol Violation|3|||
126521868|NCT00022516|455202289|FG000|Overall Study|Withdrawal by Subject|2|||
126521869|NCT00022516|455202290|FG001|Overall Study|Withdrawal by Subject|113|||
126573173|NCT01135511|455394370|FG007|Overall Study|Protocol Violation|0|||
126521870|NCT00022516|455202289|FG000|Overall Study|Incomplete documentation|0|||
126521871|NCT00022516|455202290|FG001|Overall Study|Incomplete documentation|27|||
126521872|NCT01669343|455202291|FG000|Part A: All Patients|Withdrawal by Subject|7|||
126521873|NCT01669343|455202291|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
126521874|NCT01669343|455202291|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
126521875|NCT01669343|455202291|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
126573174|NCT01135511|455394371|FG008|Overall Study|Protocol Violation|0|||
126573175|NCT01135511|455394363|FG000|Overall Study|Pregnancy|0|||
126573176|NCT01135511|455394364|FG001|Overall Study|Pregnancy|0|||
126573177|NCT01135511|455394365|FG002|Overall Study|Pregnancy|0|||
126573178|NCT01135511|455394366|FG003|Overall Study|Pregnancy|1|||
126573179|NCT01135511|455394367|FG004|Overall Study|Pregnancy|0|||
126521876|NCT01669343|455202291|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
126521877|NCT04798586|455202292|FG000|Overall Study|Death|2|||
126521878|NCT04433767|455202294|FG000|Overall Study|Adverse Event|1|||
126521879|NCT02371369|455202299|FG000|Part 1|Physician Decision|0|||
126521880|NCT02371369|455202300|FG001|Part 1|Physician Decision|3|||
126521881|NCT02371369|455202299|FG000|Part 1|Adverse Event|8|||
126521882|NCT02371369|455202300|FG001|Part 1|Adverse Event|0|||
126521883|NCT02371369|455202299|FG000|Part 1|Withdrawal by Subject|1|||
126521884|NCT02371369|455202300|FG001|Part 1|Withdrawal by Subject|6|||
126521885|NCT02371369|455202299|FG000|Part 1|Disease progression|0|||
126521886|NCT02371369|455202300|FG001|Part 1|Disease progression|1|||
126521887|NCT02371369|455202299|FG000|Part 1|Protocol Violation|0|||
126573180|NCT01135511|455394368|FG005|Overall Study|Pregnancy|0|||
126521888|NCT02371369|455202300|FG001|Part 1|Protocol Violation|1|||
126521889|NCT02371369|455202299|FG000|Part 2|Adverse Event|6|||
126521890|NCT02371369|455202300|FG001|Part 2|Adverse Event|5|||
126521891|NCT02371369|455202299|FG000|Part 2|Withdrawal by Subject|16|||
126573181|NCT01135511|455394369|FG006|Overall Study|Pregnancy|0|||
126573182|NCT01135511|455394370|FG007|Overall Study|Pregnancy|0|||
126573183|NCT01135511|455394371|FG008|Overall Study|Pregnancy|0|||
126573184|NCT01135511|455394363|FG000|Overall Study|could not visit the clinic|0|||
126573185|NCT01135511|455394364|FG001|Overall Study|could not visit the clinic|1|||
126573186|NCT01135511|455394365|FG002|Overall Study|could not visit the clinic|2|||
126573187|NCT01135511|455394366|FG003|Overall Study|could not visit the clinic|0|||
126573188|NCT01135511|455394367|FG004|Overall Study|could not visit the clinic|0|||
126573189|NCT01135511|455394368|FG005|Overall Study|could not visit the clinic|0|||
126573190|NCT01135511|455394369|FG006|Overall Study|could not visit the clinic|0|||
126573191|NCT01135511|455394370|FG007|Overall Study|could not visit the clinic|0|||
126573192|NCT01135511|455394371|FG008|Overall Study|could not visit the clinic|0|||
126573193|NCT01135511|455394363|FG000|Overall Study|noncompliance with study drug taken|0|||
126573194|NCT01135511|455394364|FG001|Overall Study|noncompliance with study drug taken|0|||
126573195|NCT01135511|455394365|FG002|Overall Study|noncompliance with study drug taken|0|||
126573196|NCT01135511|455394366|FG003|Overall Study|noncompliance with study drug taken|0|||
126573197|NCT01135511|455394367|FG004|Overall Study|noncompliance with study drug taken|1|||
126573198|NCT01135511|455394368|FG005|Overall Study|noncompliance with study drug taken|0|||
126573199|NCT01135511|455394369|FG006|Overall Study|noncompliance with study drug taken|0|||
126573200|NCT01135511|455394370|FG007|Overall Study|noncompliance with study drug taken|0|||
126573201|NCT01135511|455394371|FG008|Overall Study|noncompliance with study drug taken|0|||
126573202|NCT01135511|455394363|FG000|Overall Study|Withdrawal by Subject|0|||
126573203|NCT01135511|455394364|FG001|Overall Study|Withdrawal by Subject|0|||
126573204|NCT01135511|455394365|FG002|Overall Study|Withdrawal by Subject|0|||
126573205|NCT01135511|455394366|FG003|Overall Study|Withdrawal by Subject|0|||
126573206|NCT01135511|455394367|FG004|Overall Study|Withdrawal by Subject|0|||
126573207|NCT01135511|455394368|FG005|Overall Study|Withdrawal by Subject|0|||
126573208|NCT01135511|455394369|FG006|Overall Study|Withdrawal by Subject|1|||
126573209|NCT01135511|455394370|FG007|Overall Study|Withdrawal by Subject|0|||
126573210|NCT01135511|455394371|FG008|Overall Study|Withdrawal by Subject|1|||
126573211|NCT05082935|455394380|FG000|Overall Study|Lost to Follow-up|549|||
126573212|NCT05082935|455394381|FG001|Overall Study|Lost to Follow-up|631|||
126573213|NCT05082935|455394380|FG000|Overall Study|Withdrawal by Subject|27|||
126573214|NCT05082935|455394381|FG001|Overall Study|Withdrawal by Subject|58|||
126573215|NCT02957136|455394382|FG000|Overall Study|Withdrawal by Subject|2|||
126573216|NCT02957136|455394383|FG001|Overall Study|Withdrawal by Subject|1|||
126573217|NCT02200770|455394384|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
126573218|NCT02200770|455394385|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
126573219|NCT02200770|455394384|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
126573220|NCT02200770|455394385|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
126573221|NCT02200770|455394384|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
126573222|NCT02200770|455394385|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
126573223|NCT02200770|455394384|FG000|Randomized-controlled Period (RCP)|Other|1|||
126573224|NCT02200770|455394385|FG001|Randomized-controlled Period (RCP)|Other|2|||
126573225|NCT02200770|455394384|FG000|Open-label Period (OLP)|Adverse Event|1|||
126573226|NCT02200770|455394385|FG001|Open-label Period (OLP)|Adverse Event|2|||
126573227|NCT02200770|455394384|FG000|Open-label Period (OLP)|Death|1|||
126573228|NCT02200770|455394385|FG001|Open-label Period (OLP)|Death|2|||
126573229|NCT02200770|455394384|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
126573230|NCT02200770|455394385|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
126573231|NCT02200770|455394384|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
126573232|NCT02200770|455394385|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
126573233|NCT02200770|455394384|FG000|Open-label Period (OLP)|Other|6|||
126573234|NCT02200770|455394385|FG001|Open-label Period (OLP)|Other|15|||
126573235|NCT03475316|455394387|FG000|6 Month Intervention|Adverse Event|2|||
126573236|NCT03475316|455394388|FG001|6 Month Intervention|Adverse Event|1|||
126573237|NCT03475316|455394387|FG000|6 Month Intervention|Withdrawal by Subject|2|||
126573238|NCT03475316|455394388|FG001|6 Month Intervention|Withdrawal by Subject|0|||
126573239|NCT03475316|455394387|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
126573240|NCT03475316|455394388|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
126573241|NCT03475316|455394387|FG000|9 Months|Study stopped due to COVID pandemic|3|||
126573242|NCT03475316|455394388|FG001|9 Months|Study stopped due to COVID pandemic|4|||
126573243|NCT00424645|455394389|FG000|Overall Study|Death|1|||
126573244|NCT00424645|455394390|FG001|Overall Study|Death|0|||
126573245|NCT02555215|455394391|FG000|Overall Study|Other|1|||
126573246|NCT02555215|455394391|FG000|Overall Study|Investigator Decision|2|||
126573247|NCT00529789|455394392|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
126573248|NCT00529789|455394392|FG000|Study Period II/III|Adverse Event|3|||
126573249|NCT00529789|455394392|FG000|Study Period II/III|Lack of Efficacy|2|||
126573250|NCT00529789|455394392|FG000|Study Period II/III|Withdrawal by Subject|1|||
126573251|NCT00529789|455394392|FG000|Study Period II/III|Protocol Violation|3|||
126573252|NCT00529789|455394392|FG000|Study Period II/III|Physician Decision|3|||
126573253|NCT00529789|455394392|FG000|Study Period II/III|Lost to Follow-up|3|||
126573254|NCT00529789|455394392|FG000|Study Period IV|Parent/Caregiver Decision|1|||
126573255|NCT00529789|455394392|FG000|Study Period IV|Adverse Event|1|||
126573256|NCT00529789|455394392|FG000|Study Period IV|Lack of Efficacy|1|||
126573257|NCT00529789|455394392|FG000|Study Period IV|Lost to Follow-up|3|||
126573258|NCT01430611|455394393|FG000|Overall Study|Adverse Event|0|||
126573259|NCT01430611|455394394|FG001|Overall Study|Adverse Event|1|||
126573260|NCT01430611|455394393|FG000|Overall Study|Protocol Violation|1|||
126573261|NCT01430611|455394394|FG001|Overall Study|Protocol Violation|0|||
126573262|NCT01430611|455394393|FG000|Overall Study|Lost to Follow-up|1|||
126573263|NCT01430611|455394394|FG001|Overall Study|Lost to Follow-up|0|||
126573264|NCT01430611|455394393|FG000|Overall Study|Withdrawal by Subject|15|||
126573265|NCT01430611|455394394|FG001|Overall Study|Withdrawal by Subject|14|||
126573266|NCT00959946|455394397|FG000|Overall Study|Adverse Event|0|||
126573267|NCT00959946|455394398|FG001|Overall Study|Adverse Event|0|||
126573268|NCT00959946|455394399|FG002|Overall Study|Adverse Event|2|||
126573269|NCT00959946|455394400|FG003|Overall Study|Adverse Event|1|||
126573270|NCT00959946|455394401|FG004|Overall Study|Adverse Event|0|||
126573271|NCT00959946|455394402|FG005|Overall Study|Adverse Event|1|||
126573272|NCT00959946|455394403|FG006|Overall Study|Adverse Event|0|||
126573273|NCT00959946|455394404|FG007|Overall Study|Adverse Event|0|||
126573274|NCT00959946|455394397|FG000|Overall Study|Death|0|||
126573275|NCT00959946|455394398|FG001|Overall Study|Death|0|||
126573276|NCT00959946|455394399|FG002|Overall Study|Death|0|||
126573277|NCT00959946|455394400|FG003|Overall Study|Death|0|||
126573278|NCT00959946|455394401|FG004|Overall Study|Death|0|||
126573279|NCT00959946|455394402|FG005|Overall Study|Death|1|||
126573280|NCT00959946|455394403|FG006|Overall Study|Death|0|||
126573281|NCT00959946|455394404|FG007|Overall Study|Death|0|||
126573282|NCT00959946|455394397|FG000|Overall Study|Disease Progression|2|||
126573283|NCT00959946|455394398|FG001|Overall Study|Disease Progression|4|||
126573284|NCT00959946|455394399|FG002|Overall Study|Disease Progression|2|||
126573285|NCT00959946|455394400|FG003|Overall Study|Disease Progression|4|||
126573286|NCT00959946|455394401|FG004|Overall Study|Disease Progression|4|||
126573287|NCT00959946|455394402|FG005|Overall Study|Disease Progression|6|||
126573288|NCT00959946|455394403|FG006|Overall Study|Disease Progression|2|||
126573289|NCT00959946|455394404|FG007|Overall Study|Disease Progression|2|||
126573290|NCT00959946|455394397|FG000|Overall Study|Withdrawal by Subject|0|||
126573291|NCT00959946|455394398|FG001|Overall Study|Withdrawal by Subject|0|||
126573292|NCT00959946|455394399|FG002|Overall Study|Withdrawal by Subject|0|||
126573293|NCT00959946|455394400|FG003|Overall Study|Withdrawal by Subject|0|||
126573294|NCT00959946|455394401|FG004|Overall Study|Withdrawal by Subject|0|||
126573295|NCT00959946|455394402|FG005|Overall Study|Withdrawal by Subject|1|||
126573296|NCT00959946|455394403|FG006|Overall Study|Withdrawal by Subject|0|||
126573297|NCT00959946|455394404|FG007|Overall Study|Withdrawal by Subject|0|||
126573298|NCT00356265|455394405|FG000|Overall Study|Withdrawal by Subject|0|||
126573299|NCT00356265|455394406|FG001|Overall Study|Withdrawal by Subject|0|||
126573300|NCT00356265|455394407|FG002|Overall Study|Withdrawal by Subject|1|||
126573301|NCT03144674|455394415|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
126573302|NCT03144674|455394416|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
126573303|NCT03144674|455394417|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
126573304|NCT03144674|455394418|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
126573305|NCT03144674|455394415|FG000|Overall Study|Death|3|||
126573306|NCT03144674|455394416|FG001|Overall Study|Death|2|||
126573307|NCT03144674|455394417|FG002|Overall Study|Death|6|||
126573308|NCT03144674|455394418|FG003|Overall Study|Death|24|||
126573309|NCT03144674|455394415|FG000|Overall Study|Lost to Follow-up|0|||
126573310|NCT03144674|455394416|FG001|Overall Study|Lost to Follow-up|1|||
126573311|NCT03144674|455394417|FG002|Overall Study|Lost to Follow-up|0|||
126573312|NCT03144674|455394418|FG003|Overall Study|Lost to Follow-up|4|||
126573313|NCT03144674|455394415|FG000|Overall Study|Withdrawal by Participant|0|||
126573314|NCT03144674|455394416|FG001|Overall Study|Withdrawal by Participant|0|||
126573315|NCT03144674|455394417|FG002|Overall Study|Withdrawal by Participant|2|||
126573316|NCT03144674|455394418|FG003|Overall Study|Withdrawal by Participant|6|||
126573317|NCT03144674|455394415|FG000|Overall Study|Discharged from the Trust|0|||
126573318|NCT03144674|455394416|FG001|Overall Study|Discharged from the Trust|0|||
126573319|NCT03144674|455394417|FG002|Overall Study|Discharged from the Trust|1|||
126573320|NCT03144674|455394418|FG003|Overall Study|Discharged from the Trust|0|||
126573321|NCT03144674|455394415|FG000|Overall Study|Exclusion Criteria Met|0|||
126573322|NCT03144674|455394416|FG001|Overall Study|Exclusion Criteria Met|0|||
126573323|NCT03144674|455394417|FG002|Overall Study|Exclusion Criteria Met|1|||
126573324|NCT03144674|455394418|FG003|Overall Study|Exclusion Criteria Met|0|||
126573325|NCT03144674|455394415|FG000|Overall Study|Changed Physicians|0|||
126573326|NCT03144674|455394416|FG001|Overall Study|Changed Physicians|0|||
126573327|NCT03144674|455394417|FG002|Overall Study|Changed Physicians|0|||
126573328|NCT03144674|455394418|FG003|Overall Study|Changed Physicians|1|||
126573329|NCT03144674|455394415|FG000|Overall Study|Removed for Safety|0|||
126727348|NCT03655717|455951138|FG012|Overall Study|Withdrawal by Subject|0|||
126573330|NCT03144674|455394416|FG001|Overall Study|Removed for Safety|0|||
126573331|NCT03144674|455394417|FG002|Overall Study|Removed for Safety|0|||
126573332|NCT03144674|455394418|FG003|Overall Study|Removed for Safety|1|||
126573333|NCT03144674|455394415|FG000|Overall Study|Site Closed|0|||
126573334|NCT03144674|455394416|FG001|Overall Study|Site Closed|0|||
126573335|NCT03144674|455394417|FG002|Overall Study|Site Closed|0|||
126573336|NCT03144674|455394418|FG003|Overall Study|Site Closed|1|||
126573337|NCT03144674|455394415|FG000|Overall Study|Histological Criteria Not Met|0|||
126573338|NCT03144674|455394416|FG001|Overall Study|Histological Criteria Not Met|0|||
126573339|NCT03144674|455394417|FG002|Overall Study|Histological Criteria Not Met|0|||
126573340|NCT03144674|455394418|FG003|Overall Study|Histological Criteria Not Met|1|||
126573341|NCT03144674|455394415|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
126573342|NCT03144674|455394416|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
126573343|NCT03144674|455394417|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
126573344|NCT03144674|455394418|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
126573345|NCT03144674|455394415|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
126573346|NCT03144674|455394416|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
126573347|NCT03144674|455394417|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
126573348|NCT03144674|455394418|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
126573349|NCT00658996|455394419|FG000|First Intervention|Positive slit lamp finding|1|||
126573350|NCT00658996|455394420|FG001|First Intervention|Positive slit lamp finding|0|||
126573351|NCT00658996|455394419|FG000|First Intervention|Lack of lenses|0|||
126573352|NCT00658996|455394420|FG001|First Intervention|Lack of lenses|1|||
126573353|NCT00658996|455394419|FG000|Crossover Period|Physician Decision|1|||
126573354|NCT00658996|455394420|FG001|Crossover Period|Physician Decision|0|||
126573355|NCT00658996|455394419|FG000|Crossover Period|Ineligible|1|||
126573356|NCT00658996|455394420|FG001|Crossover Period|Ineligible|1|||
126573357|NCT00658996|455394419|FG000|Second Intervention|Developed a stye on upper lid|1|||
126573358|NCT00658996|455394420|FG001|Second Intervention|Developed a stye on upper lid|0|||
126573359|NCT00658996|455394419|FG000|Second Intervention|Positive slit lamp finding|0|||
126573360|NCT00658996|455394420|FG001|Second Intervention|Positive slit lamp finding|1|||
126573361|NCT00206375|455394421|FG000|Overall Study|Lost to Follow-up|1|||
126573362|NCT00206375|455394422|FG001|Overall Study|Lost to Follow-up|0|||
126573363|NCT00206375|455394423|FG002|Overall Study|Lost to Follow-up|0|||
126573364|NCT00206375|455394421|FG000|Overall Study|Withdrawal by Subject|2|||
126573365|NCT00206375|455394422|FG001|Overall Study|Withdrawal by Subject|1|||
126573366|NCT00206375|455394423|FG002|Overall Study|Withdrawal by Subject|3|||
126573367|NCT00206375|455394421|FG000|Overall Study|Study terminated due to lack of funds|0|||
126573368|NCT00206375|455394422|FG001|Overall Study|Study terminated due to lack of funds|1|||
126573369|NCT00206375|455394423|FG002|Overall Study|Study terminated due to lack of funds|1|||
126573370|NCT03368664|455394424|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
126573371|NCT03368664|455394424|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
126573372|NCT03368664|455394424|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
126573373|NCT03368664|455394424|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
126573374|NCT00837616|455394425|FG000|Overall Study|Withdrawal by Subject|0|||
126573375|NCT00837616|455394426|FG001|Overall Study|Withdrawal by Subject|1|||
126573376|NCT01810263|455394433|FG000|Overall Study|Lost to Follow-up|8|||
126573377|NCT01810263|455394434|FG001|Overall Study|Lost to Follow-up|7|||
126573378|NCT00457691|455394436|FG000|Overall Study|Adverse Event|4|||
126573379|NCT00457691|455394437|FG001|Overall Study|Adverse Event|1|||
126573380|NCT00457691|455394436|FG000|Overall Study|Death|163|||
126573381|NCT00457691|455394437|FG001|Overall Study|Death|148|||
126573382|NCT00457691|455394436|FG000|Overall Study|Protocol Violation|1|||
126573383|NCT00457691|455394437|FG001|Overall Study|Protocol Violation|3|||
126573384|NCT00457691|455394436|FG000|Overall Study|Lost to Follow-up|23|||
126573385|NCT00457691|455394437|FG001|Overall Study|Lost to Follow-up|14|||
126573386|NCT00457691|455394436|FG000|Overall Study|Study terminated by Sponsor|1|||
126573387|NCT00457691|455394437|FG001|Overall Study|Study terminated by Sponsor|1|||
126573388|NCT00457691|455394436|FG000|Overall Study|Subject refused (reason other than AE)|14|||
126573389|NCT00457691|455394437|FG001|Overall Study|Subject refused (reason other than AE)|19|||
126573390|NCT00457691|455394436|FG000|Overall Study|Disease progression, study terminated|180|||
126727349|NCT03655717|455951139|FG013|Overall Study|Withdrawal by Subject|3|||
126727350|NCT03655717|455951140|FG014|Overall Study|Withdrawal by Subject|0|||
126727351|NCT03655717|455951141|FG015|Overall Study|Withdrawal by Subject|1|||
126573391|NCT00457691|455394437|FG001|Overall Study|Disease progression, study terminated|196|||
126573392|NCT00688519|455394440|FG000|Overall Study|Adverse Event|2|||
126573393|NCT00688519|455394441|FG001|Overall Study|Adverse Event|3|||
126573394|NCT00688519|455394440|FG000|Overall Study|Lost to Follow-up|3|||
126573395|NCT00688519|455394441|FG001|Overall Study|Lost to Follow-up|3|||
126573396|NCT00688519|455394440|FG000|Overall Study|Lack of Efficacy|3|||
126573397|NCT00688519|455394441|FG001|Overall Study|Lack of Efficacy|1|||
126573398|NCT00688519|455394440|FG000|Overall Study|Withdrawal by Subject|7|||
126573399|NCT00688519|455394441|FG001|Overall Study|Withdrawal by Subject|6|||
126573400|NCT00688519|455394440|FG000|Overall Study|Prohibited medication|1|||
126727352|NCT03655717|455951142|FG016|Overall Study|Withdrawal by Subject|0|||
126727353|NCT03655717|455951143|FG017|Overall Study|Withdrawal by Subject|0|||
126727354|NCT03655717|455951144|FG018|Overall Study|Withdrawal by Subject|1|||
126573401|NCT00688519|455394441|FG001|Overall Study|Prohibited medication|0|||
126573402|NCT00688519|455394440|FG000|Overall Study|Non-compliance|0|||
126573403|NCT00688519|455394441|FG001|Overall Study|Non-compliance|1|||
126573404|NCT00688519|455394440|FG000|Overall Study|Subject moved out of state|1|||
126573405|NCT00688519|455394441|FG001|Overall Study|Subject moved out of state|0|||
126573406|NCT00688519|455394440|FG000|Overall Study|Investigator decision|1|||
126573407|NCT00688519|455394441|FG001|Overall Study|Investigator decision|0|||
126521892|NCT02371369|455202300|FG001|Part 2|Withdrawal by Subject|6|||
126521893|NCT02371369|455202299|FG000|Part 2|Investigator decision|1|||
126521894|NCT02371369|455202300|FG001|Part 2|Investigator decision|2|||
126521895|NCT02371369|455202299|FG000|Part 2|Death|0|||
126521896|NCT02371369|455202300|FG001|Part 2|Death|1|||
126521897|NCT02371369|455202299|FG000|Part 2|Disease progression|1|||
126521898|NCT02371369|455202300|FG001|Part 2|Disease progression|0|||
126521899|NCT02371369|455202299|FG000|Part 2|Subject Noncompliance|1|||
126521900|NCT02371369|455202300|FG001|Part 2|Subject Noncompliance|0|||
126521901|NCT02371369|455202299|FG000|Part 2|Lost to Follow-up|1|||
126521902|NCT02371369|455202300|FG001|Part 2|Lost to Follow-up|1|||
126521903|NCT02371369|455202299|FG000|Part 2|Subject transitioned to commercial supply|6|||
126521904|NCT02371369|455202300|FG001|Part 2|Subject transitioned to commercial supply|4|||
126521905|NCT02371369|455202299|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
126521906|NCT02371369|455202300|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
126521907|NCT02371369|455202299|FG000|Part 2|Surgical resection of tumor|1|||
126521908|NCT02371369|455202300|FG001|Part 2|Surgical resection of tumor|1|||
126521909|NCT02371369|455202299|FG000|Part 2|Other|0|||
126521910|NCT02371369|455202300|FG001|Part 2|Other|1|||
126521911|NCT02641080|455202301|FG000|Overall Study|Physician Decision|2|||
126521912|NCT02641080|455202302|FG001|Overall Study|Physician Decision|0|||
126521913|NCT02641080|455202301|FG000|Overall Study|Withdrawal by Subject|0|||
126521914|NCT02641080|455202302|FG001|Overall Study|Withdrawal by Subject|1|||
126521915|NCT02641080|455202301|FG000|Overall Study|Rehab Center denied use of pumps|0|||
126521916|NCT02641080|455202302|FG001|Overall Study|Rehab Center denied use of pumps|3|||
126521917|NCT02641080|455202301|FG000|Overall Study|Lost to Follow-up|0|||
126521918|NCT02641080|455202302|FG001|Overall Study|Lost to Follow-up|3|||
126521919|NCT00803634|455202303|FG000|Overall Study|Withdrew Consent|1|||
126521920|NCT00803634|455202304|FG001|Overall Study|Withdrew Consent|0|||
126521921|NCT00803634|455202303|FG000|Overall Study|Lost to Follow-up|2|||
126521922|NCT00803634|455202304|FG001|Overall Study|Lost to Follow-up|3|||
126521923|NCT00803634|455202303|FG000|Overall Study|Death|3|||
126521924|NCT00803634|455202304|FG001|Overall Study|Death|2|||
126521925|NCT04307186|455202307|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
126521926|NCT04307186|455202307|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
126521927|NCT04307186|455202307|FG000|Washout 3-14 Days|Progressive disease|1|||
126521928|NCT04307186|455202307|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
126521929|NCT04307186|455202307|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
126521930|NCT00927927|455202314|FG000|Overall Study|Withdrawal by Subject|0|||
126521931|NCT00927927|455202315|FG001|Overall Study|Withdrawal by Subject|0|||
126521932|NCT00927927|455202316|FG002|Overall Study|Withdrawal by Subject|0|||
126521933|NCT00927927|455202317|FG003|Overall Study|Withdrawal by Subject|0|||
126521934|NCT00927927|455202318|FG004|Overall Study|Withdrawal by Subject|0|||
126521935|NCT00927927|455202319|FG005|Overall Study|Withdrawal by Subject|0|||
126521936|NCT00927927|455202320|FG006|Overall Study|Withdrawal by Subject|0|||
126521937|NCT00927927|455202321|FG007|Overall Study|Withdrawal by Subject|2|||
126521938|NCT00927927|455202322|FG008|Overall Study|Withdrawal by Subject|0|||
126521939|NCT00927927|455202323|FG009|Overall Study|Withdrawal by Subject|0|||
126521940|NCT00927927|455202324|FG010|Overall Study|Withdrawal by Subject|0|||
126521941|NCT00927927|455202325|FG011|Overall Study|Withdrawal by Subject|2|||
126521942|NCT00927927|455202326|FG012|Overall Study|Withdrawal by Subject|0|||
126521943|NCT00927927|455202327|FG013|Overall Study|Withdrawal by Subject|0|||
126521944|NCT00927927|455202328|FG014|Overall Study|Withdrawal by Subject|0|||
126521945|NCT01110239|455202335|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
126521946|NCT01110239|455202336|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
126521947|NCT01110239|455202337|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
126521948|NCT01110239|455202338|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
126521949|NCT01110239|455202335|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
126521950|NCT01110239|455202336|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
126521951|NCT01110239|455202337|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
126521952|NCT01110239|455202338|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
126521953|NCT00080223|455202343|FG000|Overall Study|Adverse Event|23|||
126521954|NCT00080223|455202343|FG000|Overall Study|Death|21|||
126521955|NCT00080223|455202343|FG000|Overall Study|Withdrawal by Subject|13|||
126573408|NCT00688519|455394440|FG000|Overall Study|Subject moved out of area|1|||
126521956|NCT00080223|455202343|FG000|Overall Study|Lung Transplantation|9|||
126521957|NCT00080223|455202343|FG000|Overall Study|Non-compliance With Study Treatment|7|||
126521958|NCT00080223|455202343|FG000|Overall Study|Participant unwilling to continue|2|||
126521959|NCT00080223|455202343|FG000|Overall Study|Physician Decision|1|||
126573409|NCT00688519|455394441|FG001|Overall Study|Subject moved out of area|0|||
126521960|NCT05204134|455202344|FG000|Overall Study|Withdrawal by Subject|3|||
126521961|NCT05204134|455202344|FG000|Overall Study|Physician Decision|1|||
126521962|NCT03135522|455202345|FG000|Overall Study|Adverse Event|1|||
126521963|NCT03135522|455202346|FG001|Overall Study|Adverse Event|0|||
126521964|NCT01045447|455204403|FG000|Overall Study|Adverse Event|0|||
126521965|NCT01045447|455204404|FG001|Overall Study|Adverse Event|1|||
126521966|NCT01045447|455204403|FG000|Overall Study|Lack of Efficacy|3|||
126521967|NCT01045447|455204404|FG001|Overall Study|Lack of Efficacy|1|||
126521968|NCT01045447|455204403|FG000|Overall Study|Protocol Violation|6|||
126521969|NCT01045447|455204404|FG001|Overall Study|Protocol Violation|3|||
126521970|NCT01045447|455204403|FG000|Overall Study|Withdrawal Criteria|10|||
126521971|NCT01045447|455204404|FG001|Overall Study|Withdrawal Criteria|10|||
126521972|NCT01045447|455204403|FG000|Overall Study|Unclassified|17|||
126521973|NCT01045447|455204404|FG001|Overall Study|Unclassified|13|||
126521974|NCT00489970|455204406|FG000|Persistence Year 9|Lost to Follow-up|2|||
126521975|NCT00489970|455204407|FG001|Persistence Year 9|Lost to Follow-up|2|||
126521976|NCT00489970|455204408|FG002|Persistence Year 9|Lost to Follow-up|3|||
126521977|NCT00489970|455204406|FG000|Persistence Year 9|Other|1|||
126521978|NCT00489970|455204407|FG001|Persistence Year 9|Other|0|||
126521979|NCT00489970|455204408|FG002|Persistence Year 9|Other|2|||
126521980|NCT02707055|455204415|FG000|Phase 1|Withdrawal by Subject|1|||
126521981|NCT02707055|455204416|FG001|Phase 1|Withdrawal by Subject|2|||
126521982|NCT02707055|455204415|FG000|Phase 1|Physician Decision|0|||
126521983|NCT02707055|455204416|FG001|Phase 1|Physician Decision|1|||
126521984|NCT02707055|455204415|FG000|Phase 2|Adverse Event|1|||
126521985|NCT02707055|455204416|FG001|Phase 2|Adverse Event|2|||
126521986|NCT03564496|455204417|FG000|Overall Study|Withdrawal by Subject|1|||
126521987|NCT03564496|455204418|FG001|Overall Study|Withdrawal by Subject|1|||
126521988|NCT03564496|455204419|FG002|Overall Study|Withdrawal by Subject|0|||
126521989|NCT03564496|455204417|FG000|Overall Study|Screen failure|0|||
126521990|NCT03564496|455204418|FG001|Overall Study|Screen failure|3|||
126521991|NCT03564496|455204419|FG002|Overall Study|Screen failure|0|||
126521992|NCT01159938|455204420|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
126521993|NCT01159938|455204421|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
126521994|NCT01159938|455204422|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
126521995|NCT01159938|455204423|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
126521996|NCT01159938|455204424|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
126521997|NCT02318329|455204428|FG000|Overall Study|Progressive Disease|2|||
126521998|NCT02318329|455204429|FG001|Overall Study|Progressive Disease|3|||
126521999|NCT02318329|455204430|FG002|Overall Study|Progressive Disease|2|||
126522000|NCT02318329|455204431|FG003|Overall Study|Progressive Disease|3|||
126522001|NCT02318329|455204432|FG004|Overall Study|Progressive Disease|3|||
126522002|NCT02318329|455204433|FG005|Overall Study|Progressive Disease|3|||
126522003|NCT02318329|455204434|FG006|Overall Study|Progressive Disease|1|||
126522004|NCT02318329|455204435|FG007|Overall Study|Progressive Disease|1|||
126522005|NCT02318329|455204436|FG008|Overall Study|Progressive Disease|5|||
126522006|NCT02318329|455204437|FG009|Overall Study|Progressive Disease|39|||
126522007|NCT02318329|455204428|FG000|Overall Study|Death|0|||
126522008|NCT02318329|455204429|FG001|Overall Study|Death|0|||
126522009|NCT02318329|455204430|FG002|Overall Study|Death|0|||
126522010|NCT02318329|455204431|FG003|Overall Study|Death|0|||
126522011|NCT02318329|455204432|FG004|Overall Study|Death|0|||
126522012|NCT02318329|455204433|FG005|Overall Study|Death|0|||
126522013|NCT02318329|455204434|FG006|Overall Study|Death|0|||
126522014|NCT02318329|455204435|FG007|Overall Study|Death|0|||
126522015|NCT02318329|455204436|FG008|Overall Study|Death|0|||
126522016|NCT02318329|455204437|FG009|Overall Study|Death|5|||
126522017|NCT02318329|455204428|FG000|Overall Study|Lost to Follow-up|0|||
126522018|NCT02318329|455204429|FG001|Overall Study|Lost to Follow-up|0|||
126522019|NCT02318329|455204430|FG002|Overall Study|Lost to Follow-up|0|||
126522020|NCT02318329|455204431|FG003|Overall Study|Lost to Follow-up|0|||
126522021|NCT02318329|455204432|FG004|Overall Study|Lost to Follow-up|0|||
126522022|NCT02318329|455204433|FG005|Overall Study|Lost to Follow-up|0|||
126522023|NCT02318329|455204434|FG006|Overall Study|Lost to Follow-up|0|||
126522024|NCT02318329|455204435|FG007|Overall Study|Lost to Follow-up|0|||
126522025|NCT02318329|455204436|FG008|Overall Study|Lost to Follow-up|0|||
126522026|NCT02318329|455204437|FG009|Overall Study|Lost to Follow-up|1|||
126522027|NCT02318329|455204428|FG000|Overall Study|Withdrawal by Subject|0|||
126522028|NCT02318329|455204429|FG001|Overall Study|Withdrawal by Subject|0|||
126522029|NCT02318329|455204430|FG002|Overall Study|Withdrawal by Subject|0|||
126522030|NCT02318329|455204431|FG003|Overall Study|Withdrawal by Subject|0|||
126522031|NCT02318329|455204432|FG004|Overall Study|Withdrawal by Subject|0|||
126522032|NCT02318329|455204433|FG005|Overall Study|Withdrawal by Subject|0|||
126522033|NCT02318329|455204434|FG006|Overall Study|Withdrawal by Subject|0|||
126522034|NCT02318329|455204435|FG007|Overall Study|Withdrawal by Subject|0|||
126522035|NCT02318329|455204436|FG008|Overall Study|Withdrawal by Subject|0|||
126522036|NCT02318329|455204437|FG009|Overall Study|Withdrawal by Subject|6|||
126522037|NCT02318329|455204428|FG000|Overall Study|Other|1|||
126522038|NCT02318329|455204429|FG001|Overall Study|Other|1|||
126522039|NCT02318329|455204430|FG002|Overall Study|Other|1|||
126573410|NCT00688519|455394440|FG000|Overall Study|Pregnancy|0|||
126573411|NCT00688519|455394441|FG001|Overall Study|Pregnancy|1|||
126573412|NCT01353963|455394442|FG000|Overall Study|Adverse Event|2|||
126573413|NCT01121549|455394443|FG000|Overall Study|Adverse Event|10|||
126573414|NCT01121549|455394443|FG000|Overall Study|Lack of Efficacy|11|||
126573415|NCT01121549|455394443|FG000|Overall Study|Lost to Follow-up|12|||
126522040|NCT02318329|455204431|FG003|Overall Study|Other|0|||
126522041|NCT02318329|455204432|FG004|Overall Study|Other|0|||
126522042|NCT02318329|455204433|FG005|Overall Study|Other|0|||
126522043|NCT02318329|455204434|FG006|Overall Study|Other|0|||
126522044|NCT02318329|455204435|FG007|Overall Study|Other|0|||
126522045|NCT02318329|455204436|FG008|Overall Study|Other|1|||
126522046|NCT02318329|455204437|FG009|Overall Study|Other|1|||
126522047|NCT00086346|455204438|FG000|Randomization|Did not receive test article|4|||
126522048|NCT00086346|455204439|FG001|Randomization|Did not receive test article|4|||
126522049|NCT00086346|455204438|FG000|Patients Dosed With Test Article|Adverse Event|94|||
126522050|NCT00086346|455204439|FG001|Patients Dosed With Test Article|Adverse Event|11|||
126522051|NCT00086346|455204438|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
126522052|NCT00086346|455204439|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
126522053|NCT00086346|455204438|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
126522054|NCT00086346|455204439|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
126522055|NCT00086346|455204438|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
126522056|NCT00086346|455204439|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
126522057|NCT00086346|455204438|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
126522058|NCT00086346|455204439|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
126522059|NCT00086346|455204438|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
126522060|NCT00086346|455204439|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
126522061|NCT01303627|455204440|FG000|Overall Study|the failure while performing URS|0|||
126522062|NCT01303627|455204441|FG001|Overall Study|the failure while performing URS|1|||
126522063|NCT02416791|455204443|FG000|6 Months|Lost to Follow-up|0|||
126522064|NCT02416791|455204444|FG001|6 Months|Lost to Follow-up|0|||
126522065|NCT02416791|455204445|FG002|6 Months|Lost to Follow-up|1|||
126522066|NCT01054820|455204446|FG000|Overall Study|Withdrawal by Subject|2|||
126522067|NCT01154166|455204448|FG000|Overall Study|Adverse Event|14|||
126522068|NCT01154166|455204449|FG001|Overall Study|Adverse Event|9|||
126522069|NCT01154166|455204448|FG000|Overall Study|Lost to Follow-up|1|||
126522070|NCT01154166|455204449|FG001|Overall Study|Lost to Follow-up|1|||
126522071|NCT01154166|455204448|FG000|Overall Study|Protocol Violation|4|||
126522072|NCT01154166|455204449|FG001|Overall Study|Protocol Violation|1|||
126522073|NCT01154166|455204448|FG000|Overall Study|Withdrawal by Subject|10|||
126522074|NCT01154166|455204449|FG001|Overall Study|Withdrawal by Subject|1|||
126522075|NCT01154166|455204448|FG000|Overall Study|Lack of Efficacy|3|||
126522076|NCT01154166|455204449|FG001|Overall Study|Lack of Efficacy|0|||
126522077|NCT01154166|455204448|FG000|Overall Study|Disease Progression|1|||
126522078|NCT01154166|455204449|FG001|Overall Study|Disease Progression|0|||
126522079|NCT01154166|455204448|FG000|Overall Study|Poor Compliance|1|||
126522080|NCT01154166|455204449|FG001|Overall Study|Poor Compliance|0|||
126522081|NCT04121962|455204452|FG000|Overall Study|Lost to Follow-up|42|||
126522082|NCT04121962|455204453|FG001|Overall Study|Lost to Follow-up|39|||
126522083|NCT02019719|455204454|FG000|Overall Study|Adverse Event|1|||
126522084|NCT02019719|455204455|FG001|Overall Study|Adverse Event|0|||
126522085|NCT02019719|455204456|FG002|Overall Study|Adverse Event|0|||
126522086|NCT02019719|455204457|FG003|Overall Study|Adverse Event|1|||
126522087|NCT02019719|455204458|FG004|Overall Study|Adverse Event|1|||
126522088|NCT02019719|455204454|FG000|Overall Study|Protocol Violation|1|||
126522089|NCT02019719|455204455|FG001|Overall Study|Protocol Violation|1|||
126522090|NCT02019719|455204456|FG002|Overall Study|Protocol Violation|0|||
126522091|NCT02019719|455204457|FG003|Overall Study|Protocol Violation|0|||
126522092|NCT02019719|455204458|FG004|Overall Study|Protocol Violation|0|||
126522093|NCT02019719|455204454|FG000|Overall Study|Protocol defined stopping criteria|2|||
126522094|NCT02019719|455204455|FG001|Overall Study|Protocol defined stopping criteria|0|||
126522095|NCT02019719|455204456|FG002|Overall Study|Protocol defined stopping criteria|0|||
126522096|NCT02019719|455204457|FG003|Overall Study|Protocol defined stopping criteria|1|||
126522097|NCT02019719|455204458|FG004|Overall Study|Protocol defined stopping criteria|1|||
126522098|NCT02019719|455204454|FG000|Overall Study|Physician Decision|2|||
126522099|NCT02019719|455204455|FG001|Overall Study|Physician Decision|0|||
126522100|NCT02019719|455204456|FG002|Overall Study|Physician Decision|0|||
126522101|NCT02019719|455204457|FG003|Overall Study|Physician Decision|0|||
126522102|NCT02019719|455204458|FG004|Overall Study|Physician Decision|0|||
126573416|NCT01121549|455394443|FG000|Overall Study|Did not meet entrance criteria|9|||
126573417|NCT01121549|455394443|FG000|Overall Study|Study terminated by sponsor|197|||
126573418|NCT01121549|455394443|FG000|Overall Study|Pregnancy|1|||
126522103|NCT04535037|455204459|FG000|Overall Study|Protocol Violation|1|||
126522104|NCT04535037|455204460|FG001|Overall Study|Protocol Violation|0|||
126522105|NCT04535037|455204459|FG000|Overall Study|Withdrawal by Subject|8|||
126522106|NCT04535037|455204460|FG001|Overall Study|Withdrawal by Subject|9|||
126573419|NCT01121549|455394443|FG000|Overall Study|Protocol Violation|33|||
126522107|NCT04535037|455204459|FG000|Overall Study|Migrated / moved from the study area|1|||
126522108|NCT04535037|455204460|FG001|Overall Study|Migrated / moved from the study area|4|||
126522109|NCT04535037|455204459|FG000|Overall Study|Other|2|||
126522110|NCT04535037|455204460|FG001|Overall Study|Other|5|||
126727355|NCT03655717|455951145|FG019|Overall Study|Withdrawal by Subject|0|||
126727356|NCT03655717|455951146|FG020|Overall Study|Withdrawal by Subject|0|||
126727357|NCT03655717|455951147|FG021|Overall Study|Withdrawal by Subject|1|||
126727358|NCT03655717|455951148|FG022|Overall Study|Withdrawal by Subject|2|||
126522111|NCT02731131|455204461|FG000|Overall Study|Psychiatric Disorder|0|||
126522112|NCT02731131|455204462|FG001|Overall Study|Psychiatric Disorder|1|||
126522113|NCT02731131|455204461|FG000|Overall Study|Refused Therapy|0|||
126522114|NCT02731131|455204462|FG001|Overall Study|Refused Therapy|1|||
126522115|NCT02348216|455204463|FG000|Overall Study|Death|5|||
126522116|NCT02348216|455204464|FG001|Overall Study|Death|53|||
126522117|NCT02348216|455204465|FG002|Overall Study|Death|11|||
126522118|NCT02348216|455204466|FG003|Overall Study|Death|20|||
126522119|NCT02348216|455204467|FG004|Overall Study|Death|16|||
126522120|NCT02348216|455204468|FG005|Overall Study|Death|32|||
126522121|NCT02348216|455204469|FG006|Overall Study|Death|17|||
126522122|NCT02348216|455204463|FG000|Overall Study|Full consent withdrawal|0|||
126522123|NCT02348216|455204464|FG001|Overall Study|Full consent withdrawal|0|||
126522124|NCT02348216|455204465|FG002|Overall Study|Full consent withdrawal|0|||
126522125|NCT02348216|455204466|FG003|Overall Study|Full consent withdrawal|1|||
126522126|NCT02348216|455204467|FG004|Overall Study|Full consent withdrawal|3|||
126522127|NCT02348216|455204468|FG005|Overall Study|Full consent withdrawal|0|||
126522128|NCT02348216|455204469|FG006|Overall Study|Full consent withdrawal|3|||
126522129|NCT02348216|455204463|FG000|Overall Study|Lost to Follow-up|0|||
126522130|NCT02348216|455204464|FG001|Overall Study|Lost to Follow-up|5|||
126522131|NCT02348216|455204465|FG002|Overall Study|Lost to Follow-up|2|||
126522132|NCT02348216|455204466|FG003|Overall Study|Lost to Follow-up|0|||
126522133|NCT02348216|455204467|FG004|Overall Study|Lost to Follow-up|1|||
126522134|NCT02348216|455204468|FG005|Overall Study|Lost to Follow-up|1|||
126522135|NCT02348216|455204469|FG006|Overall Study|Lost to Follow-up|1|||
126522136|NCT02348216|455204463|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
126522137|NCT02348216|455204464|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
126522138|NCT02348216|455204465|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
126522139|NCT02348216|455204466|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
126522140|NCT02348216|455204467|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
126522141|NCT02348216|455204468|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
126522142|NCT02348216|455204469|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
126522143|NCT02348216|455204463|FG000|Overall Study|Reason not specified|2|||
126573420|NCT01121549|455394443|FG000|Overall Study|Withdrawal by Subject|16|||
126573421|NCT01121549|455394443|FG000|Overall Study|Other|58|||
126573422|NCT02079844|455394444|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
126573423|NCT02079844|455394445|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
126573424|NCT02079844|455394446|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
126573425|NCT02079844|455394444|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
126573426|NCT02079844|455394445|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
126573427|NCT02079844|455394446|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
126573428|NCT01420549|455394447|FG000|Overall Study|Adverse Event|1|||
126573429|NCT01420549|455394448|FG001|Overall Study|Adverse Event|1|||
126573430|NCT01420549|455394447|FG000|Overall Study|Lost to Follow-up|2|||
126573431|NCT01420549|455394448|FG001|Overall Study|Lost to Follow-up|2|||
126573432|NCT01420549|455394447|FG000|Overall Study|Protocol Violation|0|||
126573433|NCT01420549|455394448|FG001|Overall Study|Protocol Violation|1|||
126573434|NCT01420549|455394447|FG000|Overall Study|Non-adherence to medication|4|||
126573435|NCT01420549|455394448|FG001|Overall Study|Non-adherence to medication|1|||
126573436|NCT03351075|455395650|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
126573437|NCT03351075|455395651|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
126573438|NCT03351075|455395650|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
126573439|NCT03351075|455395651|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
126573440|NCT03351075|455395650|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
126727359|NCT03655717|455951149|FG023|Overall Study|Withdrawal by Subject|1|||
126522144|NCT02348216|455204464|FG001|Overall Study|Reason not specified|19|||
126522145|NCT02348216|455204465|FG002|Overall Study|Reason not specified|11|||
126522146|NCT02348216|455204466|FG003|Overall Study|Reason not specified|17|||
126522147|NCT02348216|455204467|FG004|Overall Study|Reason not specified|21|||
126522148|NCT02348216|455204468|FG005|Overall Study|Reason not specified|17|||
126573441|NCT03351075|455395651|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
126573442|NCT03351075|455395650|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
126573443|NCT03351075|455395651|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
126573444|NCT00493649|455395652|FG000|Overall Study|Adverse Event|44|||
126727360|NCT03655717|455951150|FG024|Overall Study|Withdrawal by Subject|1|||
126727361|NCT03655717|455951151|FG025|Overall Study|Withdrawal by Subject|0|||
126727362|NCT03655717|455951126|FG000|Overall Study|Physician Decision|3|||
126573445|NCT00493649|455395652|FG000|Overall Study|Patient Request|21|||
126573446|NCT00493649|455395652|FG000|Overall Study|Investigator Request|2|||
126573447|NCT00493649|455395652|FG000|Overall Study|Disease Progression|1|||
126573448|NCT00493649|455395652|FG000|Overall Study|Lost to Follow-up|1|||
126573449|NCT00493649|455395652|FG000|Overall Study|Other|13|||
126573450|NCT05219253|455395653|FG000|Overall Study|Withdrawal by Subject|1|||
126573451|NCT05219253|455395654|FG001|Overall Study|Withdrawal by Subject|2|||
126573452|NCT03086369|455395655|FG000|Overall Study|Lost to Follow-up|1|||
126573453|NCT03086369|455395656|FG001|Overall Study|Lost to Follow-up|0|||
126573454|NCT03086369|455395657|FG002|Overall Study|Lost to Follow-up|0|||
126573455|NCT03086369|455395658|FG003|Overall Study|Lost to Follow-up|2|||
126573456|NCT03086369|455395659|FG004|Overall Study|Lost to Follow-up|1|||
126573457|NCT03086369|455395655|FG000|Overall Study|Physician Decision|0|||
126573458|NCT03086369|455395656|FG001|Overall Study|Physician Decision|0|||
126573459|NCT03086369|455395657|FG002|Overall Study|Physician Decision|0|||
126573460|NCT03086369|455395658|FG003|Overall Study|Physician Decision|1|||
126573461|NCT03086369|455395659|FG004|Overall Study|Physician Decision|2|||
126573462|NCT03086369|455395655|FG000|Overall Study|Withdrawal by Subject|0|||
126573463|NCT03086369|455395656|FG001|Overall Study|Withdrawal by Subject|0|||
126573464|NCT03086369|455395657|FG002|Overall Study|Withdrawal by Subject|0|||
126573465|NCT03086369|455395658|FG003|Overall Study|Withdrawal by Subject|5|||
126573466|NCT03086369|455395659|FG004|Overall Study|Withdrawal by Subject|3|||
126573467|NCT03086369|455395655|FG000|Overall Study|Progressive Disease|0|||
126573468|NCT03086369|455395656|FG001|Overall Study|Progressive Disease|0|||
126573469|NCT03086369|455395657|FG002|Overall Study|Progressive Disease|0|||
126573470|NCT03086369|455395658|FG003|Overall Study|Progressive Disease|1|||
126573471|NCT03086369|455395659|FG004|Overall Study|Progressive Disease|1|||
126573472|NCT04603924|455395662|FG000|Overall Study|Not Dosed|2|||
126573473|NCT04603924|455395663|FG001|Overall Study|Not Dosed|1|||
126573474|NCT04603924|455395662|FG000|Overall Study|Withdrawal by Subject|6|||
126573475|NCT04603924|455395663|FG001|Overall Study|Withdrawal by Subject|6|||
126573476|NCT04603924|455395662|FG000|Overall Study|Adverse Event|2|||
126573477|NCT04603924|455395663|FG001|Overall Study|Adverse Event|2|||
126573478|NCT00189202|455395669|FG000|Overall Study|Physician Decision|5|||
126573479|NCT01444417|455395670|FG000|Overall Study|Ineligibility Determined|0|||
126573480|NCT01444417|455395671|FG001|Overall Study|Ineligibility Determined|1|||
126573481|NCT01444417|455395670|FG000|Overall Study|Withdrawal by Subject|2|||
126573482|NCT01444417|455395671|FG001|Overall Study|Withdrawal by Subject|0|||
126573483|NCT00468052|455395679|FG000|Overall Study|Protocol Violation|7|||
126573484|NCT00468052|455395680|FG001|Overall Study|Protocol Violation|8|||
126573485|NCT01595061|455395681|FG000|Overall Study|Never Treated|3|||
126573486|NCT01595061|455395681|FG000|Overall Study|Inadequate Pathology|1|||
126573487|NCT00960141|455395684|FG000|Overall Study|Adverse Event|4|||
126573488|NCT00960141|455395685|FG001|Overall Study|Adverse Event|8|||
126573489|NCT00960141|455395686|FG002|Overall Study|Adverse Event|2|||
126573490|NCT00960141|455395684|FG000|Overall Study|Lack of Efficacy|3|||
126573491|NCT00960141|455395685|FG001|Overall Study|Lack of Efficacy|4|||
126573492|NCT00960141|455395686|FG002|Overall Study|Lack of Efficacy|2|||
126573493|NCT00960141|455395684|FG000|Overall Study|Lost to Follow-up|1|||
126573494|NCT00960141|455395685|FG001|Overall Study|Lost to Follow-up|0|||
126573495|NCT00960141|455395686|FG002|Overall Study|Lost to Follow-up|0|||
126573496|NCT00960141|455395684|FG000|Overall Study|Protocol Violation|1|||
126573497|NCT00960141|455395685|FG001|Overall Study|Protocol Violation|3|||
126573498|NCT00960141|455395686|FG002|Overall Study|Protocol Violation|2|||
126573499|NCT00960141|455395684|FG000|Overall Study|Withdrawal by Subject|1|||
126573500|NCT00960141|455395685|FG001|Overall Study|Withdrawal by Subject|2|||
126573501|NCT00960141|455395686|FG002|Overall Study|Withdrawal by Subject|1|||
126573502|NCT00566527|455395687|FG000|Overall Study|Reason not provided|3|||
126573503|NCT00566527|455395688|FG001|Overall Study|Reason not provided|11|||
126727363|NCT03655717|455951127|FG001|Overall Study|Physician Decision|3|||
126727364|NCT03655717|455951128|FG002|Overall Study|Physician Decision|0|||
126727365|NCT03655717|455951129|FG003|Overall Study|Physician Decision|0|||
126573504|NCT00566527|455395689|FG002|Overall Study|Reason not provided|10|||
126573505|NCT00566527|455395687|FG000|Overall Study|Adverse Event|2|||
126573506|NCT00566527|455395688|FG001|Overall Study|Adverse Event|0|||
126573507|NCT00566527|455395689|FG002|Overall Study|Adverse Event|1|||
126573508|NCT00566527|455395687|FG000|Overall Study|Physician Decision|3|||
126573509|NCT00566527|455395688|FG001|Overall Study|Physician Decision|8|||
126573510|NCT00566527|455395689|FG002|Overall Study|Physician Decision|20|||
126573511|NCT00566527|455395687|FG000|Overall Study|Lost to Follow-up|3|||
126727366|NCT03655717|455951130|FG004|Overall Study|Physician Decision|0|||
126573512|NCT00566527|455395688|FG001|Overall Study|Lost to Follow-up|4|||
126573513|NCT00566527|455395689|FG002|Overall Study|Lost to Follow-up|4|||
126573514|NCT00566527|455395687|FG000|Overall Study|Withdrawal by Subject|6|||
126573515|NCT00566527|455395688|FG001|Overall Study|Withdrawal by Subject|43|||
126573516|NCT00566527|455395689|FG002|Overall Study|Withdrawal by Subject|43|||
126573517|NCT00457743|455395690|FG000|Overall Study|Adverse Event|0|||
126727367|NCT03655717|455951131|FG005|Overall Study|Physician Decision|0|||
126573518|NCT00457743|455395691|FG001|Overall Study|Adverse Event|4|||
126727368|NCT03655717|455951132|FG006|Overall Study|Physician Decision|0|||
126573519|NCT00457743|455395692|FG002|Overall Study|Adverse Event|0|||
126573520|NCT00457743|455395690|FG000|Overall Study|Lack of Efficacy|3|||
126573521|NCT00457743|455395691|FG001|Overall Study|Lack of Efficacy|23|||
126777025|NCT01890785|456139156|FG000|Third Intervention|Withdrawal by Subject|0|||
126522149|NCT02348216|455204469|FG006|Overall Study|Reason not specified|19|||
126522150|NCT00562159|455204470|FG000|Overall Study|Adverse Event|11|||
126522151|NCT00562159|455204471|FG001|Overall Study|Adverse Event|8|||
126522152|NCT00562159|455204470|FG000|Overall Study|Lost to Follow-up|5|||
126522153|NCT00562159|455204471|FG001|Overall Study|Lost to Follow-up|4|||
126522154|NCT00562159|455204470|FG000|Overall Study|Withdrawal by Subject|9|||
126522155|NCT00562159|455204471|FG001|Overall Study|Withdrawal by Subject|8|||
126522156|NCT00562159|455204470|FG000|Overall Study|Protocol Violation|12|||
126522157|NCT00562159|455204471|FG001|Overall Study|Protocol Violation|12|||
126522158|NCT00562159|455204470|FG000|Overall Study|Did not meet protocol eligibility|1|||
126522159|NCT00562159|455204471|FG001|Overall Study|Did not meet protocol eligibility|1|||
126522160|NCT02417246|455204472|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
126522161|NCT02417246|455204473|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
126522162|NCT02417246|455204472|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
126522163|NCT02417246|455204473|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
126522164|NCT02417246|455204472|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
126522165|NCT02417246|455204473|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
126522166|NCT02417246|455204472|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
126522167|NCT02417246|455204473|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
126522168|NCT01181921|455204476|FG000|Overall Study|Lost to Follow-up|1|||
126522169|NCT04321460|455204477|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
126522170|NCT04321460|455204478|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
126522171|NCT02162810|455204481|FG000|Overall Study|Protocol Violation|1|||
126522172|NCT02162810|455204482|FG001|Overall Study|Protocol Violation|0|||
126522173|NCT02162810|455204481|FG000|Overall Study|patients did not report compliance|4|||
126522174|NCT02162810|455204482|FG001|Overall Study|patients did not report compliance|1|||
126522175|NCT01308749|455204487|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
126522176|NCT01308749|455204488|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
126522177|NCT01308749|455204487|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
126522178|NCT01308749|455204488|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
126522179|NCT01308749|455204487|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
126522180|NCT01308749|455204488|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
126522181|NCT02519504|455204489|FG000|Overall Study|Protocol Violation|6|||
126522182|NCT02519504|455204490|FG001|Overall Study|Protocol Violation|5|||
126522183|NCT02519504|455204489|FG000|Overall Study|Ineligible for direct testing|12|||
126522184|NCT02519504|455204490|FG001|Overall Study|Ineligible for direct testing|12|||
126522185|NCT02519504|455204489|FG000|Overall Study|Did not participate in direct testing|95|||
126522186|NCT02519504|455204490|FG001|Overall Study|Did not participate in direct testing|86|||
126522187|NCT04726709|455204491|FG000|Overall Study|Withdrawal by Subject|2|||
126522188|NCT04726709|455204492|FG001|Overall Study|Withdrawal by Subject|2|||
126522189|NCT02546544|455204493|FG000|Overall Study|Disease Progression|14|||
126522190|NCT02546544|455204493|FG000|Overall Study|Adverse Event|1|||
126522191|NCT02546544|455204493|FG000|Overall Study|Withdrawal by Subject|1|||
126522192|NCT02223390|455204494|FG000|Overall Study|Lost to Follow-up|9|||
126522193|NCT02223390|455204495|FG001|Overall Study|Lost to Follow-up|4|||
126522194|NCT01666002|455204497|FG000|Overall Study|Lost to Follow-up|5|||
126522195|NCT01666002|455204498|FG001|Overall Study|Lost to Follow-up|0|||
126522196|NCT02159482|455204499|FG000|Overall Study|Withdrawal by Subject|2|||
126522197|NCT02159482|455204499|FG000|Overall Study|Physician Decision|3|||
126522198|NCT01233817|455204500|FG000|Overall Study|Lost to Follow-up|1|||
126522199|NCT01233817|455204500|FG000|Overall Study|Withdrawal by Subject|2|||
126522200|NCT04000165|455204505|FG000|Overall Study|Physician Decision|1|||
126522201|NCT04000165|455204505|FG000|Overall Study|Withdrawal by Subject|1|||
126522202|NCT03447769|455204507|FG000|Overall Study|Progressive disease|138|||
126522203|NCT03447769|455204508|FG001|Overall Study|Progressive disease|148|||
126522204|NCT03447769|455204507|FG000|Overall Study|Study terminated by Sponsor|60|||
126522205|NCT03447769|455204508|FG001|Overall Study|Study terminated by Sponsor|44|||
126522206|NCT03447769|455204507|FG000|Overall Study|Adverse Event|34|||
126522207|NCT03447769|455204508|FG001|Overall Study|Adverse Event|31|||
126522208|NCT03447769|455204507|FG000|Overall Study|Patient decision|27|||
126522209|NCT03447769|455204508|FG001|Overall Study|Patient decision|27|||
126522210|NCT03447769|455204507|FG000|Overall Study|Protocol deviation|4|||
126522211|NCT03447769|455204508|FG001|Overall Study|Protocol deviation|6|||
126522212|NCT03447769|455204507|FG000|Overall Study|Death|2|||
126522213|NCT03447769|455204508|FG001|Overall Study|Death|7|||
126522214|NCT03447769|455204507|FG000|Overall Study|Technical problems|1|||
126522215|NCT03447769|455204508|FG001|Overall Study|Technical problems|0|||
126573522|NCT00457743|455395692|FG002|Overall Study|Lack of Efficacy|3|||
126573523|NCT01837966|455395693|FG000|Overall Study|Withdrawal by Subject|2|||
126522216|NCT03447769|455204507|FG000|Overall Study|Lost to Follow-up|0|||
126522217|NCT03447769|455204508|FG001|Overall Study|Lost to Follow-up|1|||
126573524|NCT01837966|455395694|FG001|Overall Study|Withdrawal by Subject|1|||
126573525|NCT00159783|455395695|FG000|Overall Study|Adverse Event|5|||
126573526|NCT00159783|455395696|FG001|Overall Study|Adverse Event|7|||
126573527|NCT00159783|455395697|FG002|Overall Study|Adverse Event|9|||
126573528|NCT00159783|455395695|FG000|Overall Study|Lack of Efficacy|1|||
126573529|NCT00159783|455395696|FG001|Overall Study|Lack of Efficacy|2|||
126573530|NCT00159783|455395697|FG002|Overall Study|Lack of Efficacy|3|||
126573531|NCT00159783|455395695|FG000|Overall Study|Withdrawal by Subject|7|||
126573532|NCT00159783|455395696|FG001|Overall Study|Withdrawal by Subject|11|||
126573533|NCT00159783|455395697|FG002|Overall Study|Withdrawal by Subject|12|||
126573534|NCT00159783|455395695|FG000|Overall Study|Lost to Follow-up|6|||
126573535|NCT00159783|455395696|FG001|Overall Study|Lost to Follow-up|5|||
126573536|NCT00159783|455395697|FG002|Overall Study|Lost to Follow-up|11|||
126573537|NCT00159783|455395695|FG000|Overall Study|Other|0|||
126573538|NCT00159783|455395696|FG001|Overall Study|Other|2|||
126573539|NCT00159783|455395697|FG002|Overall Study|Other|4|||
126573540|NCT02928224|455395698|FG000|Overall Study|Lost to Follow-up|1|||
126573541|NCT02928224|455395699|FG001|Overall Study|Lost to Follow-up|1|||
126573542|NCT02928224|455395700|FG002|Overall Study|Lost to Follow-up|3|||
126573543|NCT02928224|455395701|FG003|Overall Study|Lost to Follow-up|0|||
126573544|NCT02928224|455395698|FG000|Overall Study|Death|30|||
126573545|NCT02928224|455395699|FG001|Overall Study|Death|209|||
126573546|NCT02928224|455395700|FG002|Overall Study|Death|193|||
126573547|NCT02928224|455395701|FG003|Overall Study|Death|198|||
126573548|NCT02928224|455395698|FG000|Overall Study|Withdrawal by Subject|0|||
126573549|NCT02928224|455395699|FG001|Overall Study|Withdrawal by Subject|3|||
126573550|NCT02928224|455395700|FG002|Overall Study|Withdrawal by Subject|7|||
126573551|NCT02928224|455395701|FG003|Overall Study|Withdrawal by Subject|20|||
126573552|NCT02928224|455395698|FG000|Overall Study|Study participation terminated by sponsor|3|||
126573553|NCT02928224|455395699|FG001|Overall Study|Study participation terminated by sponsor|8|||
126573554|NCT02928224|455395700|FG002|Overall Study|Study participation terminated by sponsor|12|||
126573555|NCT02928224|455395701|FG003|Overall Study|Study participation terminated by sponsor|3|||
126573556|NCT02928224|455395698|FG000|Overall Study|Other|3|||
126573557|NCT02928224|455395699|FG001|Overall Study|Other|3|||
126573558|NCT02928224|455395700|FG002|Overall Study|Other|5|||
126573559|NCT02928224|455395701|FG003|Overall Study|Other|0|||
126573560|NCT01278394|455395702|FG000|Overall Study|Lost to Follow-up|1|||
126573561|NCT01236560|455395705|FG000|Overall Study|Adverse Event|0|||
126573562|NCT01236560|455395706|FG001|Overall Study|Adverse Event|2|||
126573563|NCT01236560|455395707|FG002|Overall Study|Adverse Event|1|||
126573564|NCT01236560|455395708|FG003|Overall Study|Adverse Event|3|||
126573565|NCT01236560|455395709|FG004|Overall Study|Adverse Event|0|||
126573566|NCT01236560|455395710|FG005|Overall Study|Adverse Event|0|||
126573567|NCT01236560|455395705|FG000|Overall Study|Death|0|||
126573568|NCT01236560|455395706|FG001|Overall Study|Death|1|||
126573569|NCT01236560|455395707|FG002|Overall Study|Death|0|||
126573570|NCT01236560|455395708|FG003|Overall Study|Death|1|||
126573571|NCT01236560|455395709|FG004|Overall Study|Death|0|||
126573572|NCT01236560|455395710|FG005|Overall Study|Death|0|||
126573573|NCT01236560|455395705|FG000|Overall Study|Lost to Follow-up|0|||
126573574|NCT01236560|455395706|FG001|Overall Study|Lost to Follow-up|1|||
126573575|NCT01236560|455395707|FG002|Overall Study|Lost to Follow-up|1|||
126573576|NCT01236560|455395708|FG003|Overall Study|Lost to Follow-up|0|||
126573577|NCT01236560|455395709|FG004|Overall Study|Lost to Follow-up|0|||
126573578|NCT01236560|455395710|FG005|Overall Study|Lost to Follow-up|0|||
126573579|NCT01236560|455395705|FG000|Overall Study|Physician Decision|0|||
126573580|NCT01236560|455395706|FG001|Overall Study|Physician Decision|1|||
126573581|NCT01236560|455395707|FG002|Overall Study|Physician Decision|8|||
126573582|NCT01236560|455395708|FG003|Overall Study|Physician Decision|0|||
126573583|NCT01236560|455395709|FG004|Overall Study|Physician Decision|0|||
126573584|NCT01236560|455395710|FG005|Overall Study|Physician Decision|0|||
126573585|NCT01236560|455395705|FG000|Overall Study|Withdrawal by Subject|0|||
126573586|NCT01236560|455395706|FG001|Overall Study|Withdrawal by Subject|0|||
126573587|NCT01236560|455395707|FG002|Overall Study|Withdrawal by Subject|1|||
126573588|NCT01236560|455395708|FG003|Overall Study|Withdrawal by Subject|2|||
126727369|NCT03655717|455951133|FG007|Overall Study|Physician Decision|0|||
126727370|NCT03655717|455951134|FG008|Overall Study|Physician Decision|0|||
126573589|NCT01236560|455395709|FG004|Overall Study|Withdrawal by Subject|0|||
126573590|NCT01236560|455395710|FG005|Overall Study|Withdrawal by Subject|0|||
126573591|NCT01236560|455395705|FG000|Overall Study|Progressive disease|5|||
126573592|NCT01236560|455395706|FG001|Overall Study|Progressive disease|19|||
126573593|NCT01236560|455395707|FG002|Overall Study|Progressive disease|9|||
126573594|NCT01236560|455395708|FG003|Overall Study|Progressive disease|16|||
126573595|NCT01236560|455395709|FG004|Overall Study|Progressive disease|0|||
126573596|NCT01236560|455395710|FG005|Overall Study|Progressive disease|0|||
126573597|NCT00468910|455395711|FG000|Overall Study|Lost to Follow-up|2|||
126573598|NCT00468910|455395712|FG001|Overall Study|Lost to Follow-up|1|||
126573599|NCT00468910|455395711|FG000|Overall Study|Withdrawal by Subject|2|||
126573600|NCT00468910|455395712|FG001|Overall Study|Withdrawal by Subject|1|||
126573601|NCT00468910|455395711|FG000|Overall Study|Medical Contraindication|0|||
126573602|NCT00468910|455395712|FG001|Overall Study|Medical Contraindication|1|||
126573603|NCT01198028|455395733|FG000|Overall Study|Adverse Event|5|||
126573604|NCT01198028|455395733|FG000|Overall Study|Death|3|||
126573605|NCT01198028|455395733|FG000|Overall Study|Physician Decision|2|||
126573606|NCT04789408|455395740|FG000|Overall Study|Death|4|||
126573607|NCT04789408|455395741|FG001|Overall Study|Death|3|||
126573608|NCT04789408|455395742|FG002|Overall Study|Death|6|||
126573609|NCT04789408|455395740|FG000|Overall Study|Did not meet eligibility criteria|1|||
126573610|NCT04789408|455395741|FG001|Overall Study|Did not meet eligibility criteria|0|||
126573611|NCT04789408|455395742|FG002|Overall Study|Did not meet eligibility criteria|0|||
126573612|NCT04789408|455395740|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
126573613|NCT04789408|455395741|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
126573614|NCT04789408|455395742|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
126573615|NCT00925899|455397332|FG000|Part 1|Death|1|||
126573616|NCT00925899|455397333|FG001|Part 1|Death|2|||
126573617|NCT00925899|455397332|FG000|Part 1|Withdrawal by Subject|10|||
126573618|NCT00925899|455397333|FG001|Part 1|Withdrawal by Subject|9|||
126573619|NCT00683696|455397334|FG000|Overall Study|Withdrawn due to study closure|337|||
126573620|NCT00683696|455397335|FG001|Overall Study|Withdrawn due to study closure|338|||
126573621|NCT00683696|455397334|FG000|Overall Study|Withdrawn prior to study closure|13|||
126573622|NCT00683696|455397335|FG001|Overall Study|Withdrawn prior to study closure|28|||
126573623|NCT00683696|455397334|FG000|Overall Study|Lost to Follow-up|5|||
126573624|NCT00683696|455397335|FG001|Overall Study|Lost to Follow-up|6|||
126573625|NCT00683696|455397334|FG000|Overall Study|Vital status follow-up only|3|||
126573626|NCT00683696|455397335|FG001|Overall Study|Vital status follow-up only|3|||
126573627|NCT00683696|455397334|FG000|Overall Study|Death|46|||
126573628|NCT00683696|455397335|FG001|Overall Study|Death|30|||
126573629|NCT02396316|455397336|FG000|Overall Study|Physician Decision|1|||
126573630|NCT02396316|455397337|FG001|Overall Study|Physician Decision|0|||
126573631|NCT02396316|455397336|FG000|Overall Study|Progressive disease|6|||
126573632|NCT02396316|455397337|FG001|Overall Study|Progressive disease|3|||
126573633|NCT02396316|455397336|FG000|Overall Study|Protocol Violation|0|||
126573634|NCT02396316|455397337|FG001|Overall Study|Protocol Violation|1|||
126573635|NCT02396316|455397336|FG000|Overall Study|Treatment unblinded|0|||
126573636|NCT02396316|455397337|FG001|Overall Study|Treatment unblinded|1|||
126573637|NCT00566735|455397341|FG000|Overall Study|Withdrawal by Subject|0|||
126573638|NCT00566735|455397342|FG001|Overall Study|Withdrawal by Subject|1|||
126573639|NCT00566735|455397341|FG000|Overall Study|Refused neuropsychological testing|2|||
126573640|NCT00566735|455397342|FG001|Overall Study|Refused neuropsychological testing|5|||
126573641|NCT00566735|455397341|FG000|Overall Study|Switched into a manic episode|0|||
126573642|NCT00566735|455397342|FG001|Overall Study|Switched into a manic episode|1|||
126573643|NCT00925587|455397344|FG000|Overall Study|Protocol Specified Criteria|6|||
126573644|NCT00925587|455397345|FG001|Overall Study|Protocol Specified Criteria|6|||
126573645|NCT00925587|455397344|FG000|Overall Study|Physician Decision|4|||
126573646|NCT00925587|455397345|FG001|Overall Study|Physician Decision|1|||
126573647|NCT00925587|455397344|FG000|Overall Study|Protocol Violation|6|||
126573648|NCT00925587|455397345|FG001|Overall Study|Protocol Violation|4|||
126573649|NCT00925587|455397344|FG000|Overall Study|Withdrawal by Subject|9|||
126573650|NCT00925587|455397345|FG001|Overall Study|Withdrawal by Subject|6|||
126573651|NCT00925587|455397344|FG000|Overall Study|Death|5|||
126573652|NCT00925587|455397345|FG001|Overall Study|Death|5|||
126573653|NCT00925587|455397344|FG000|Overall Study|Adverse Event|6|||
126573654|NCT00925587|455397345|FG001|Overall Study|Adverse Event|2|||
126573655|NCT00925587|455397344|FG000|Overall Study|Lost to Follow-up|0|||
126573656|NCT00925587|455397345|FG001|Overall Study|Lost to Follow-up|1|||
126573657|NCT00714714|455397352|FG000|Overall Study|Adverse Event|1|||
126573658|NCT02564744|455397364|FG000|Overall Study|Investigator decision|0|||
126573659|NCT02564744|455397365|FG001|Overall Study|Investigator decision|0|||
126573660|NCT02564744|455397366|FG002|Overall Study|Investigator decision|0|||
126573661|NCT02564744|455397367|FG003|Overall Study|Investigator decision|0|||
126573662|NCT02564744|455397368|FG004|Overall Study|Investigator decision|1|||
126573663|NCT02564744|455397364|FG000|Overall Study|Death|10|||
126573664|NCT02564744|455397365|FG001|Overall Study|Death|5|||
126573665|NCT02564744|455397366|FG002|Overall Study|Death|4|||
126573666|NCT02564744|455397367|FG003|Overall Study|Death|16|||
126573667|NCT02564744|455397368|FG004|Overall Study|Death|16|||
126573668|NCT02564744|455397364|FG000|Overall Study|End of study Page Missing|0|||
126573669|NCT02564744|455397365|FG001|Overall Study|End of study Page Missing|0|||
126573670|NCT02564744|455397366|FG002|Overall Study|End of study Page Missing|3|||
126573671|NCT02564744|455397367|FG003|Overall Study|End of study Page Missing|3|||
126573672|NCT02564744|455397368|FG004|Overall Study|End of study Page Missing|0|||
126573673|NCT02564744|455397364|FG000|Overall Study|Subject Withdrew Consent|1|||
126573674|NCT02564744|455397365|FG001|Overall Study|Subject Withdrew Consent|1|||
126573675|NCT02564744|455397366|FG002|Overall Study|Subject Withdrew Consent|1|||
126573676|NCT02564744|455397367|FG003|Overall Study|Subject Withdrew Consent|0|||
126573677|NCT02564744|455397368|FG004|Overall Study|Subject Withdrew Consent|2|||
126573678|NCT02564744|455397364|FG000|Overall Study|Lost to Follow-up|0|||
126573679|NCT02564744|455397365|FG001|Overall Study|Lost to Follow-up|1|||
126522218|NCT03447769|455204507|FG000|Overall Study|Physician Decision|13|||
126522219|NCT03447769|455204508|FG001|Overall Study|Physician Decision|5|||
126522220|NCT01343407|455204510|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
126522221|NCT01343407|455204511|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
126522222|NCT01343407|455204512|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
126522223|NCT01343407|455204513|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
126522224|NCT01343407|455204514|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
126522225|NCT01343407|455204515|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
126522226|NCT01343407|455204510|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
126522227|NCT01343407|455204511|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
126522228|NCT01343407|455204512|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
126522229|NCT01343407|455204513|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
126522230|NCT01343407|455204514|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
126522231|NCT01343407|455204515|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
126522232|NCT03950739|455204516|FG000|Treatment Phase|Adverse Event|2|||
126522233|NCT03950739|455204516|FG000|Optional Extension Phase|Death|1|||
126522234|NCT03950739|455204516|FG000|Optional Extension Phase|Progressive Disease|5|||
126522235|NCT03950739|455204516|FG000|Optional Extension Phase|Adverse Event|7|||
126522236|NCT03950739|455204516|FG000|Optional Extension Phase|Lost to Follow-up|2|||
126522237|NCT03950739|455204516|FG000|Optional Extension Phase|Site Closure|2|||
126522238|NCT03950739|455204516|FG000|Optional Extension Phase|Pregnancy|1|||
126522239|NCT03264989|455204520|FG000|Overall Study|Lost to Follow-up|1|||
126522240|NCT03264989|455204521|FG001|Overall Study|Lost to Follow-up|0|||
126522241|NCT03264989|455204520|FG000|Overall Study|New Therapy for study Indication|1|||
126522242|NCT03264989|455204521|FG001|Overall Study|New Therapy for study Indication|0|||
126522243|NCT03264989|455204520|FG000|Overall Study|Protocol Violation|0|||
126522244|NCT03264989|455204521|FG001|Overall Study|Protocol Violation|1|||
126522245|NCT03264989|455204520|FG000|Overall Study|Patient decision|13|||
126522246|NCT03264989|455204521|FG001|Overall Study|Patient decision|0|||
126522247|NCT03264989|455204520|FG000|Overall Study|Physician Decision|6|||
126522248|NCT03264989|455204521|FG001|Overall Study|Physician Decision|4|||
126522249|NCT03264989|455204520|FG000|Overall Study|Adverse Event|2|||
126522250|NCT03264989|455204521|FG001|Overall Study|Adverse Event|1|||
126522251|NCT03264989|455204520|FG000|Overall Study|Death|1|||
126522252|NCT03264989|455204521|FG001|Overall Study|Death|1|||
126522253|NCT03264989|455204520|FG000|Overall Study|Pregnancy|2|||
126522254|NCT03264989|455204521|FG001|Overall Study|Pregnancy|0|||
126522255|NCT03264989|455204520|FG000|Overall Study|End of Study|19|||
126522256|NCT03264989|455204521|FG001|Overall Study|End of Study|5|||
126522257|NCT00797667|455204522|FG000|Overall Study|Lack of Efficacy|0|||
126522258|NCT00797667|455204523|FG001|Overall Study|Lack of Efficacy|1|||
126522259|NCT00797667|455204524|FG002|Overall Study|Lack of Efficacy|0|||
126522260|NCT00797667|455204522|FG000|Overall Study|Lost to Follow-up|8|||
126522261|NCT00797667|455204523|FG001|Overall Study|Lost to Follow-up|12|||
126522262|NCT00797667|455204524|FG002|Overall Study|Lost to Follow-up|2|||
126522263|NCT00797667|455204522|FG000|Overall Study|Physician Decision|3|||
126522264|NCT00797667|455204523|FG001|Overall Study|Physician Decision|1|||
126522265|NCT00797667|455204524|FG002|Overall Study|Physician Decision|0|||
126522266|NCT00797667|455204522|FG000|Overall Study|Pregnancy|2|||
126522267|NCT00797667|455204523|FG001|Overall Study|Pregnancy|0|||
126522268|NCT00797667|455204524|FG002|Overall Study|Pregnancy|0|||
126522269|NCT00797667|455204522|FG000|Overall Study|Protocol Violation|2|||
126522270|NCT00797667|455204523|FG001|Overall Study|Protocol Violation|7|||
126522271|NCT00797667|455204524|FG002|Overall Study|Protocol Violation|0|||
126522272|NCT00797667|455204522|FG000|Overall Study|Study Terminated by Sponsor|217|||
126522273|NCT00797667|455204523|FG001|Overall Study|Study Terminated by Sponsor|216|||
126522274|NCT00797667|455204524|FG002|Overall Study|Study Terminated by Sponsor|115|||
126522275|NCT00797667|455204522|FG000|Overall Study|Withdrawal by Subject|9|||
126522276|NCT00797667|455204523|FG001|Overall Study|Withdrawal by Subject|14|||
126522277|NCT00797667|455204524|FG002|Overall Study|Withdrawal by Subject|2|||
126522278|NCT00797667|455204522|FG000|Overall Study|Adverse Event|19|||
126522279|NCT00797667|455204523|FG001|Overall Study|Adverse Event|8|||
126522280|NCT00797667|455204524|FG002|Overall Study|Adverse Event|8|||
126522281|NCT01986829|455204525|FG000|Overall Study|Death|1|||
126522282|NCT02504866|455204526|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
126522283|NCT02504866|455204527|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
126522284|NCT02504866|455204528|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
126573680|NCT02564744|455397366|FG002|Overall Study|Lost to Follow-up|0|||
126522285|NCT01343056|455204531|FG000|Overall Study|Lost to Follow-up|7|||
126522286|NCT01343056|455204532|FG001|Overall Study|Lost to Follow-up|5|||
126522287|NCT01343056|455204533|FG002|Overall Study|Lost to Follow-up|3|||
126522288|NCT01343056|455204534|FG003|Overall Study|Lost to Follow-up|9|||
126522289|NCT03231371|455204535|FG000|Overall Study|Withdrawal by Subject|1|||
126522290|NCT03231371|455204535|FG000|Overall Study|chose or were ineligible to have MRI|12|||
126522291|NCT03029208|455204536|FG000|Overall Study|Withdrawal by Subject|2|||
126522292|NCT03029208|455204537|FG001|Overall Study|Withdrawal by Subject|3|||
126522293|NCT03029208|455204536|FG000|Overall Study|Lost to Follow-up|0|||
126573681|NCT02564744|455397367|FG003|Overall Study|Lost to Follow-up|0|||
126573682|NCT02564744|455397368|FG004|Overall Study|Lost to Follow-up|1|||
126573683|NCT02564744|455397364|FG000|Overall Study|Reason not specified|1|||
126573684|NCT02564744|455397365|FG001|Overall Study|Reason not specified|0|||
126573685|NCT02564744|455397366|FG002|Overall Study|Reason not specified|0|||
126573686|NCT02564744|455397367|FG003|Overall Study|Reason not specified|0|||
126573687|NCT02564744|455397368|FG004|Overall Study|Reason not specified|0|||
126573688|NCT00508924|455397372|FG000|Overall Study|Protocol Violation|0|||
126573689|NCT00508924|455397373|FG001|Overall Study|Protocol Violation|0|||
126573690|NCT00508924|455397374|FG002|Overall Study|Protocol Violation|1|||
126573691|NCT00508924|455397375|FG003|Overall Study|Protocol Violation|1|||
126573692|NCT02755805|455397376|FG000|Overall Study|Lost to Follow-up|1|||
126573693|NCT02755805|455397377|FG001|Overall Study|Lost to Follow-up|2|||
126573694|NCT02755805|455397376|FG000|Overall Study|Refused assessments|1|||
126573695|NCT02755805|455397377|FG001|Overall Study|Refused assessments|0|||
126573696|NCT02755805|455397376|FG000|Overall Study|Withdrawal by Subject|0|||
126573697|NCT02755805|455397377|FG001|Overall Study|Withdrawal by Subject|2|||
126573698|NCT02252042|455397382|FG000|Overall Study|Adverse Event|9|||
126573699|NCT02252042|455397383|FG001|Overall Study|Adverse Event|6|||
126573700|NCT02252042|455397382|FG000|Overall Study|Death|209|||
126573701|NCT02252042|455397383|FG001|Overall Study|Death|217|||
126573702|NCT02252042|455397382|FG000|Overall Study|Physician Decision|0|||
126573703|NCT02252042|455397383|FG001|Overall Study|Physician Decision|2|||
126573704|NCT02252042|455397382|FG000|Overall Study|Transferred to Extension Study|7|||
126573705|NCT02252042|455397383|FG001|Overall Study|Transferred to Extension Study|1|||
126573706|NCT02252042|455397382|FG000|Overall Study|Did Not Continue on Extension Study|7|||
126573707|NCT02252042|455397383|FG001|Overall Study|Did Not Continue on Extension Study|2|||
126573708|NCT02252042|455397382|FG000|Overall Study|Withdrawal by Subject|15|||
126573709|NCT02252042|455397383|FG001|Overall Study|Withdrawal by Subject|20|||
126573710|NCT02593149|455397384|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
126573711|NCT02593149|455397385|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
126573712|NCT02593149|455397384|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
126573713|NCT02593149|455397385|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
126573714|NCT00071799|455397386|FG000|Overall Study|Adverse Event|19|||
126573715|NCT00071799|455397387|FG001|Overall Study|Adverse Event|10|||
126573716|NCT00071799|455397386|FG000|Overall Study|Protocol Violation|1|||
126573717|NCT00071799|455397387|FG001|Overall Study|Protocol Violation|7|||
126573718|NCT00071799|455397386|FG000|Overall Study|Lost to Follow-up|1|||
126573719|NCT00071799|455397387|FG001|Overall Study|Lost to Follow-up|1|||
126573720|NCT00071799|455397386|FG000|Overall Study|Withdrawal by Subject|15|||
126573721|NCT00071799|455397387|FG001|Overall Study|Withdrawal by Subject|37|||
126573722|NCT00071799|455397386|FG000|Overall Study|Physician Decision|0|||
126573723|NCT00071799|455397387|FG001|Overall Study|Physician Decision|2|||
126573724|NCT00071799|455397386|FG000|Overall Study|Lack of Efficacy|11|||
126573725|NCT00071799|455397387|FG001|Overall Study|Lack of Efficacy|18|||
126573726|NCT00071799|455397386|FG000|Overall Study|Disease Progression|23|||
126573727|NCT00071799|455397387|FG001|Overall Study|Disease Progression|20|||
126573728|NCT00071799|455397386|FG000|Overall Study|Different Central+Local Pathology Review|0|||
126573729|NCT00071799|455397387|FG001|Overall Study|Different Central+Local Pathology Review|1|||
126573730|NCT00071799|455397386|FG000|Overall Study|Not Documented|0|||
126573731|NCT00071799|455397387|FG001|Overall Study|Not Documented|2|||
126573732|NCT00979992|455397389|FG000|Overall Study|Ineligible - inadequate pathology|1|||
126573733|NCT00979992|455397389|FG000|Overall Study|Ineligible - wrong cell type|2|||
126573734|NCT00979992|455397389|FG000|Overall Study|Refused - Never Treated|2|||
126573735|NCT04532528|455397393|FG000|Overall Study|Adverse Event|12|||
126573736|NCT04532528|455397394|FG001|Overall Study|Adverse Event|17|||
126573737|NCT04532528|455397393|FG000|Overall Study|Withdrawal of consent|16|||
126573738|NCT04532528|455397394|FG001|Overall Study|Withdrawal of consent|17|||
126573739|NCT04532528|455397393|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
126573740|NCT04532528|455397394|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
126573741|NCT04532528|455397393|FG000|Overall Study|Lost to Follow-up|69|||
126573742|NCT04532528|455397394|FG001|Overall Study|Lost to Follow-up|68|||
126573743|NCT04532528|455397393|FG000|Overall Study|Administrative problems|12|||
126727371|NCT03655717|455951135|FG009|Overall Study|Physician Decision|1|||
126727372|NCT03655717|455951136|FG010|Overall Study|Physician Decision|0|||
126573744|NCT04532528|455397394|FG001|Overall Study|Administrative problems|14|||
126573745|NCT04532528|455397393|FG000|Overall Study|Death|3|||
126573746|NCT04532528|455397394|FG001|Overall Study|Death|3|||
126573747|NCT04532528|455397393|FG000|Overall Study|Other|38|||
126573748|NCT04532528|455397394|FG001|Overall Study|Other|46|||
126573749|NCT01636687|455397395|FG000|Induction Period|Withdrawal by Subject|1|||
126573750|NCT01636687|455397396|FG001|Induction Period|Withdrawal by Subject|0|||
126573751|NCT01636687|455397397|FG002|Induction Period|Withdrawal by Subject|0|||
126573752|NCT01636687|455397398|FG003|Induction Period|Withdrawal by Subject|0|||
126573753|NCT01636687|455397399|FG004|Induction Period|Withdrawal by Subject|0|||
126573754|NCT01636687|455397395|FG000|Induction Period|Adverse Event|1|||
126573755|NCT01636687|455397396|FG001|Induction Period|Adverse Event|0|||
126573756|NCT01636687|455397397|FG002|Induction Period|Adverse Event|0|||
126573757|NCT01636687|455397398|FG003|Induction Period|Adverse Event|0|||
126573758|NCT01636687|455397399|FG004|Induction Period|Adverse Event|1|||
126573759|NCT01636687|455397395|FG000|Induction Period|Lack of Efficacy|0|||
126573760|NCT01636687|455397396|FG001|Induction Period|Lack of Efficacy|0|||
126573761|NCT01636687|455397397|FG002|Induction Period|Lack of Efficacy|0|||
126573762|NCT01636687|455397398|FG003|Induction Period|Lack of Efficacy|0|||
126573763|NCT01636687|455397399|FG004|Induction Period|Lack of Efficacy|1|||
126573764|NCT01636687|455397395|FG000|Induction Period|Physician Decision|1|||
126573765|NCT01636687|455397396|FG001|Induction Period|Physician Decision|0|||
126573766|NCT01636687|455397397|FG002|Induction Period|Physician Decision|0|||
126573767|NCT01636687|455397398|FG003|Induction Period|Physician Decision|0|||
126573768|NCT01636687|455397399|FG004|Induction Period|Physician Decision|0|||
126573769|NCT01636687|455397395|FG000|Maintenance Period|Withdrawal by Subject|2|||
126573770|NCT01636687|455397396|FG001|Maintenance Period|Withdrawal by Subject|0|||
126573771|NCT01636687|455397397|FG002|Maintenance Period|Withdrawal by Subject|2|||
126573772|NCT01636687|455397398|FG003|Maintenance Period|Withdrawal by Subject|0|||
126573773|NCT01636687|455397399|FG004|Maintenance Period|Withdrawal by Subject|0|||
126573774|NCT01636687|455397395|FG000|Maintenance Period|Adverse Event|1|||
126573775|NCT01636687|455397396|FG001|Maintenance Period|Adverse Event|0|||
126573776|NCT01636687|455397397|FG002|Maintenance Period|Adverse Event|0|||
126573777|NCT01636687|455397398|FG003|Maintenance Period|Adverse Event|0|||
126573778|NCT01636687|455397399|FG004|Maintenance Period|Adverse Event|0|||
126573779|NCT01636687|455397395|FG000|Maintenance Period|Lack of Efficacy|4|||
126573780|NCT01636687|455397396|FG001|Maintenance Period|Lack of Efficacy|1|||
126573781|NCT01636687|455397397|FG002|Maintenance Period|Lack of Efficacy|0|||
126573782|NCT01636687|455397398|FG003|Maintenance Period|Lack of Efficacy|0|||
126573783|NCT01636687|455397399|FG004|Maintenance Period|Lack of Efficacy|0|||
126573784|NCT01636687|455397395|FG000|Maintenance Period|Lost to Follow-up|1|||
126573785|NCT01636687|455397396|FG001|Maintenance Period|Lost to Follow-up|1|||
126573786|NCT01636687|455397397|FG002|Maintenance Period|Lost to Follow-up|0|||
126573787|NCT01636687|455397398|FG003|Maintenance Period|Lost to Follow-up|0|||
126573788|NCT01636687|455397399|FG004|Maintenance Period|Lost to Follow-up|1|||
126573789|NCT01636687|455397395|FG000|Maintenance Period|Physician Decision|0|||
126573790|NCT01636687|455397396|FG001|Maintenance Period|Physician Decision|0|||
126573791|NCT01636687|455397397|FG002|Maintenance Period|Physician Decision|0|||
126573792|NCT01636687|455397398|FG003|Maintenance Period|Physician Decision|0|||
126573793|NCT01636687|455397399|FG004|Maintenance Period|Physician Decision|1|||
126573794|NCT01636687|455397395|FG000|Extension Period|technical problems|0|||
126573795|NCT01636687|455397396|FG001|Extension Period|technical problems|1|||
126573796|NCT01636687|455397397|FG002|Extension Period|technical problems|2|||
126573797|NCT01636687|455397398|FG003|Extension Period|technical problems|1|||
126573798|NCT01636687|455397399|FG004|Extension Period|technical problems|0|||
126573799|NCT01636687|455397395|FG000|Extension Period|Adverse Event|4|||
126573800|NCT01636687|455397396|FG001|Extension Period|Adverse Event|3|||
126573801|NCT01636687|455397397|FG002|Extension Period|Adverse Event|2|||
126573802|NCT01636687|455397398|FG003|Extension Period|Adverse Event|1|||
126573803|NCT01636687|455397399|FG004|Extension Period|Adverse Event|0|||
126573804|NCT01636687|455397395|FG000|Extension Period|Lack of Efficacy|7|||
126573805|NCT01636687|455397396|FG001|Extension Period|Lack of Efficacy|0|||
126573806|NCT01636687|455397397|FG002|Extension Period|Lack of Efficacy|2|||
126573807|NCT01636687|455397398|FG003|Extension Period|Lack of Efficacy|1|||
126573808|NCT01636687|455397399|FG004|Extension Period|Lack of Efficacy|0|||
126573809|NCT01636687|455397395|FG000|Extension Period|Lost to Follow-up|1|||
126573810|NCT01636687|455397396|FG001|Extension Period|Lost to Follow-up|0|||
126573811|NCT01636687|455397397|FG002|Extension Period|Lost to Follow-up|1|||
126573812|NCT01636687|455397398|FG003|Extension Period|Lost to Follow-up|0|||
126573813|NCT01636687|455397399|FG004|Extension Period|Lost to Follow-up|0|||
126573814|NCT01636687|455397395|FG000|Extension Period|Physician Decision|1|||
126573815|NCT01636687|455397396|FG001|Extension Period|Physician Decision|0|||
126573816|NCT01636687|455397397|FG002|Extension Period|Physician Decision|0|||
126573817|NCT01636687|455397398|FG003|Extension Period|Physician Decision|1|||
126573818|NCT01636687|455397399|FG004|Extension Period|Physician Decision|0|||
126573819|NCT01636687|455397395|FG000|Extension Period|study terminated by sponsor|33|||
126573820|NCT01636687|455397396|FG001|Extension Period|study terminated by sponsor|50|||
126573821|NCT01636687|455397397|FG002|Extension Period|study terminated by sponsor|17|||
126573822|NCT01636687|455397398|FG003|Extension Period|study terminated by sponsor|23|||
126573823|NCT01636687|455397399|FG004|Extension Period|study terminated by sponsor|0|||
126573824|NCT01636687|455397395|FG000|Extension Period|Withdrawal by Subject|1|||
126573825|NCT01636687|455397396|FG001|Extension Period|Withdrawal by Subject|0|||
126573826|NCT01636687|455397397|FG002|Extension Period|Withdrawal by Subject|1|||
126573827|NCT01636687|455397398|FG003|Extension Period|Withdrawal by Subject|1|||
126573828|NCT01636687|455397399|FG004|Extension Period|Withdrawal by Subject|0|||
126573829|NCT01636687|455397395|FG000|Follow-up Period|Withdrawal by Subject|1|||
126573830|NCT01636687|455397396|FG001|Follow-up Period|Withdrawal by Subject|0|||
126573831|NCT01636687|455397397|FG002|Follow-up Period|Withdrawal by Subject|0|||
126573832|NCT01636687|455397398|FG003|Follow-up Period|Withdrawal by Subject|0|||
126573833|NCT01636687|455397399|FG004|Follow-up Period|Withdrawal by Subject|1|||
126573834|NCT03593213|455397405|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
126522294|NCT03029208|455204537|FG001|Overall Study|Lost to Follow-up|1|||
126522295|NCT01732835|455204540|FG000|6-month Primary Endpoint|Did not receive device|19|||
126522296|NCT01732835|455204540|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
126522297|NCT01732835|455204540|FG000|6-month Primary Endpoint|Adverse Event|3|||
126522298|NCT01732835|455204540|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
126573835|NCT03593213|455397406|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
126573836|NCT03593213|455397407|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
126522299|NCT01732835|455204540|FG000|2-year Extended Follow-up|Adverse Event|3|||
126522300|NCT01732835|455204540|FG000|2-year Extended Follow-up|Death|1|||
126522301|NCT02493361|455204541|FG000|Overall Study|Withdrawal by Subject|3|||
126522302|NCT02334748|455204542|FG000|Overall Study|Adverse Event|1|||
126522303|NCT02334748|455204542|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
126522304|NCT02334748|455204542|FG000|Overall Study|Patient no longer required study drug|2|||
126522305|NCT02334748|455204542|FG000|Overall Study|Lack of Efficacy|4|||
126522306|NCT01046643|455204543|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
126522307|NCT01046643|455204544|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
126522308|NCT01046643|455204545|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
126522309|NCT01046643|455204546|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
126522310|NCT00305058|455204553|FG000|Overall Study|Participant too young|1|||
126522311|NCT00305058|455204554|FG001|Overall Study|Participant too young|0|||
126573837|NCT03593213|455397408|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
126573838|NCT03593213|455397405|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
126573839|NCT03593213|455397406|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
126573840|NCT03593213|455397407|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
126573841|NCT03593213|455397408|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
126573842|NCT03593213|455397405|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
126573843|NCT03593213|455397406|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
126573844|NCT03593213|455397407|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
126573845|NCT03593213|455397408|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
126573846|NCT03593213|455397405|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
126573847|NCT03593213|455397406|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
126573848|NCT03593213|455397407|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
126573849|NCT03593213|455397408|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
126573850|NCT03593213|455397405|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
126573851|NCT03593213|455397406|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
126573852|NCT03593213|455397407|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
126573853|NCT03593213|455397408|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
126573854|NCT03593213|455397405|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
126573855|NCT03593213|455397406|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
126573856|NCT03593213|455397407|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
126727373|NCT03655717|455951137|FG011|Overall Study|Physician Decision|0|||
126522312|NCT00305058|455204553|FG000|Overall Study|Missing data collection instrument|3|||
126522313|NCT00305058|455204554|FG001|Overall Study|Missing data collection instrument|2|||
126522314|NCT00305058|455204553|FG000|Overall Study|Missing outcome data|3|||
126522315|NCT00305058|455204554|FG001|Overall Study|Missing outcome data|2|||
126522316|NCT00503685|455204562|FG000|Overall Study|Adverse Event|0|||
126522317|NCT00503685|455204563|FG001|Overall Study|Adverse Event|0|||
126522318|NCT00503685|455204564|FG002|Overall Study|Adverse Event|2|||
126522319|NCT00503685|455204562|FG000|Overall Study|Withdrawal by Subject|0|||
126522320|NCT00503685|455204563|FG001|Overall Study|Withdrawal by Subject|1|||
126522321|NCT00503685|455204564|FG002|Overall Study|Withdrawal by Subject|0|||
126522322|NCT00503685|455204562|FG000|Overall Study|Protocol Violation|0|||
126522323|NCT00503685|455204563|FG001|Overall Study|Protocol Violation|1|||
126522324|NCT00503685|455204564|FG002|Overall Study|Protocol Violation|0|||
126522325|NCT00503685|455204562|FG000|Overall Study|Eligibility Criteria Not Met|0|||
126727374|NCT03655717|455951138|FG012|Overall Study|Physician Decision|0|||
126727375|NCT03655717|455951139|FG013|Overall Study|Physician Decision|0|||
126727376|NCT03655717|455951140|FG014|Overall Study|Physician Decision|0|||
126727377|NCT03655717|455951141|FG015|Overall Study|Physician Decision|0|||
126727378|NCT03655717|455951142|FG016|Overall Study|Physician Decision|0|||
126727379|NCT03655717|455951143|FG017|Overall Study|Physician Decision|0|||
126727380|NCT03655717|455951144|FG018|Overall Study|Physician Decision|0|||
126522326|NCT00503685|455204563|FG001|Overall Study|Eligibility Criteria Not Met|1|||
126727381|NCT03655717|455951145|FG019|Overall Study|Physician Decision|1|||
126522327|NCT00503685|455204564|FG002|Overall Study|Eligibility Criteria Not Met|0|||
126522328|NCT02838017|455204566|FG000|Overall Study|Lost to Follow-up|14|||
126522329|NCT02838017|455204567|FG001|Overall Study|Lost to Follow-up|11|||
126522330|NCT02120924|455204568|FG000|Overall Study|Lack of Efficacy|1|||
126522331|NCT02120924|455204569|FG001|Overall Study|Lack of Efficacy|2|||
126522332|NCT02120924|455204570|FG002|Overall Study|Lack of Efficacy|3|||
126522333|NCT02120924|455204568|FG000|Overall Study|Adverse Event|0|||
126522334|NCT02120924|455204569|FG001|Overall Study|Adverse Event|1|||
126522335|NCT02120924|455204570|FG002|Overall Study|Adverse Event|3|||
126522336|NCT02120924|455204568|FG000|Overall Study|Withdrawal by Subject|16|||
126522337|NCT02120924|455204569|FG001|Overall Study|Withdrawal by Subject|20|||
126522338|NCT02120924|455204570|FG002|Overall Study|Withdrawal by Subject|8|||
126522339|NCT02120924|455204568|FG000|Overall Study|Lost to Follow-up|14|||
126522340|NCT02120924|455204569|FG001|Overall Study|Lost to Follow-up|14|||
126522341|NCT02120924|455204570|FG002|Overall Study|Lost to Follow-up|11|||
126522342|NCT02120924|455204568|FG000|Overall Study|Pregnancy|2|||
126522343|NCT02120924|455204569|FG001|Overall Study|Pregnancy|0|||
126522344|NCT02120924|455204570|FG002|Overall Study|Pregnancy|0|||
126522345|NCT02120924|455204568|FG000|Overall Study|Protocol Violation|3|||
126522346|NCT02120924|455204569|FG001|Overall Study|Protocol Violation|7|||
126522347|NCT02120924|455204570|FG002|Overall Study|Protocol Violation|2|||
126522348|NCT02120924|455204568|FG000|Overall Study|Physician Decision|0|||
126522349|NCT02120924|455204569|FG001|Overall Study|Physician Decision|1|||
126522350|NCT02120924|455204570|FG002|Overall Study|Physician Decision|1|||
126522351|NCT02120924|455204568|FG000|Overall Study|Death|1|||
126522352|NCT02120924|455204569|FG001|Overall Study|Death|0|||
126522353|NCT02120924|455204570|FG002|Overall Study|Death|0|||
126522354|NCT02120924|455204568|FG000|Overall Study|Compliance with IP|5|||
126522355|NCT02120924|455204569|FG001|Overall Study|Compliance with IP|1|||
126522356|NCT02120924|455204570|FG002|Overall Study|Compliance with IP|1|||
126522357|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
126522358|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
126522359|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
126522360|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
126522361|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
126522362|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
126522363|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
126522364|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
126522365|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
126522366|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
126522367|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
126522368|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
126522369|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
126522370|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
126522371|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
126522372|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
126522373|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
126522374|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
126522375|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
126522376|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
126522377|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
126522378|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
126522379|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
126522380|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
126522381|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
126522382|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
126522383|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
126522384|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
126522385|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
126522386|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
126522387|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
126522388|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
126522389|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
126522390|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
126522391|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
126522392|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
126522393|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
126522394|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
126573857|NCT03593213|455397408|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
126573858|NCT03593213|455397405|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
126727382|NCT03655717|455951146|FG020|Overall Study|Physician Decision|0|||
126522395|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
126522396|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
126522397|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
126573859|NCT03593213|455397406|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
126573860|NCT03593213|455397407|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
126573861|NCT03593213|455397408|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
126573862|NCT03593213|455397405|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
126573863|NCT03593213|455397406|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
126573864|NCT03593213|455397407|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
126573865|NCT03593213|455397408|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
126573866|NCT03593213|455397405|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
126573867|NCT03593213|455397406|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
126573868|NCT03593213|455397407|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
126573869|NCT03593213|455397408|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
126573870|NCT03593213|455397405|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
126573871|NCT03593213|455397406|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
126573872|NCT03593213|455397407|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
126573873|NCT03593213|455397408|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
126573874|NCT03593213|455397405|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
126573875|NCT03593213|455397406|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
126573876|NCT03593213|455397407|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
126573877|NCT03593213|455397408|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
126573878|NCT03593213|455397405|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
126573879|NCT03593213|455397406|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
126573880|NCT03593213|455397407|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
126573881|NCT03593213|455397408|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
126573882|NCT03593213|455397405|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
126573883|NCT03593213|455397406|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
126573884|NCT03593213|455397407|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
126573885|NCT03593213|455397408|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
126573886|NCT03593213|455397405|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
126573887|NCT03593213|455397406|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
126573888|NCT03593213|455397407|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
126573889|NCT03593213|455397408|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
126573890|NCT03593213|455397405|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
126573891|NCT03593213|455397406|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
126573892|NCT03593213|455397407|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
126573893|NCT03593213|455397408|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
126573894|NCT03593213|455397405|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
126573895|NCT03593213|455397406|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
126573896|NCT03593213|455397407|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
126573897|NCT03593213|455397408|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
126573898|NCT03593213|455397405|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
126573899|NCT03593213|455397406|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
126573900|NCT03593213|455397407|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
126573901|NCT03593213|455397408|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
126573902|NCT03593213|455397405|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
126573903|NCT03593213|455397406|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
126573904|NCT03593213|455397407|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
126573905|NCT03593213|455397408|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
126573906|NCT03593213|455397405|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
126573907|NCT03593213|455397406|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
126573908|NCT03593213|455397407|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
126573909|NCT03593213|455397408|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
126573910|NCT01460290|455397411|FG000|Overall Study|Adverse Event|3|||
126573911|NCT01460290|455397411|FG000|Overall Study|Elevated liver function|1|||
126573912|NCT02888080|455397420|FG000|Overall Study|Subject / Guardian decision|1|||
126573913|NCT02888080|455397421|FG001|Overall Study|Subject / Guardian decision|3|||
126573914|NCT02888080|455397420|FG000|Overall Study|New Therapy for study indication|1|||
126573915|NCT02888080|455397421|FG001|Overall Study|New Therapy for study indication|0|||
126573916|NCT02888080|455397420|FG000|Overall Study|Lack of Efficacy|0|||
126573917|NCT02888080|455397421|FG001|Overall Study|Lack of Efficacy|1|||
126573918|NCT02888080|455397420|FG000|Overall Study|Adverse Event|0|||
126573919|NCT02888080|455397421|FG001|Overall Study|Adverse Event|1|||
126573920|NCT00845832|455397422|FG000|Treatment Period|Adverse Event|0|||
126522398|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
126522399|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
126522400|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
126522401|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
126522402|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
126522403|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
126522404|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
126522405|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
126522406|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
126522407|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
126522408|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
126522409|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
126522410|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
126522411|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
126522412|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
126522413|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
126522414|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
126522415|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
126522416|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
126522417|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
126522418|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
126522419|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
126522420|NCT01884350|455204571|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
126522421|NCT01884350|455204572|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
126522422|NCT01884350|455204573|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
126522423|NCT01059617|455204574|FG000|Overall Study|Other|7|||
126522424|NCT01059617|455204575|FG001|Overall Study|Other|1|||
126522425|NCT01059617|455204576|FG002|Overall Study|Other|8|||
126522426|NCT01059617|455204577|FG003|Overall Study|Other|6|||
126522427|NCT02345512|455204578|FG000|Overall Study|Adverse Event|1|||
126522428|NCT02345512|455204578|FG000|Overall Study|Withdrawal by Subject|1|||
126522429|NCT02663817|455204579|FG000|Overall Study|Screen failure|2|||
126522430|NCT01438541|455204580|FG000|Overall Study|Physician Decision|1|||
126522431|NCT01438541|455204580|FG000|Overall Study|Withdrawal by Subject|1|||
126522432|NCT01438541|455204580|FG000|Overall Study|discharge from the hospital|5|||
126522433|NCT01968434|455204583|FG000|Overall Study|Lost to Follow-up|3|||
126522434|NCT01968434|455204584|FG001|Overall Study|Lost to Follow-up|6|||
126522435|NCT02091167|455204585|FG000|Overall Study|Lost to Follow-up|0|||
126522436|NCT02091167|455204586|FG001|Overall Study|Lost to Follow-up|2|||
126522437|NCT00074282|455206056|FG000|Step 1|Adverse Event|32|||
126522438|NCT00074282|455206057|FG001|Step 1|Adverse Event|0|||
126522439|NCT00074282|455206058|FG002|Step 1|Adverse Event|0|||
126522440|NCT00074282|455206056|FG000|Step 1|Death|6|||
126522441|NCT00074282|455206057|FG001|Step 1|Death|0|||
126522442|NCT00074282|455206058|FG002|Step 1|Death|0|||
126522443|NCT00074282|455206056|FG000|Step 1|Withdrawal by Subject|7|||
126522444|NCT00074282|455206057|FG001|Step 1|Withdrawal by Subject|0|||
126522445|NCT00074282|455206058|FG002|Step 1|Withdrawal by Subject|0|||
126522446|NCT00074282|455206056|FG000|Step 1|Disease progression|2|||
126522447|NCT00074282|455206057|FG001|Step 1|Disease progression|0|||
126522448|NCT00074282|455206058|FG002|Step 1|Disease progression|0|||
126522449|NCT00074282|455206056|FG000|Step 1|Alternative therapy|2|||
126522450|NCT00074282|455206057|FG001|Step 1|Alternative therapy|0|||
126522451|NCT00074282|455206058|FG002|Step 1|Alternative therapy|0|||
126522452|NCT00074282|455206056|FG000|Step 1|Other complicating disease|2|||
126522453|NCT00074282|455206057|FG001|Step 1|Other complicating disease|0|||
126522454|NCT00074282|455206058|FG002|Step 1|Other complicating disease|0|||
126522455|NCT00074282|455206056|FG000|Step 1|Physician Decision|1|||
126522456|NCT00074282|455206057|FG001|Step 1|Physician Decision|0|||
126522457|NCT00074282|455206058|FG002|Step 1|Physician Decision|0|||
126522458|NCT00074282|455206056|FG000|Step 1|Ineligible|4|||
126522459|NCT00074282|455206057|FG001|Step 1|Ineligible|0|||
126522460|NCT00074282|455206058|FG002|Step 1|Ineligible|0|||
126522461|NCT00074282|455206056|FG000|Step 1|Never started treatment|2|||
126522462|NCT00074282|455206057|FG001|Step 1|Never started treatment|0|||
126522463|NCT00074282|455206058|FG002|Step 1|Never started treatment|0|||
126522464|NCT00074282|455206056|FG000|Step 2|Adverse Event|0|||
126522465|NCT00074282|455206057|FG001|Step 2|Adverse Event|2|||
126522466|NCT00074282|455206058|FG002|Step 2|Adverse Event|12|||
126522467|NCT00074282|455206056|FG000|Step 2|Disease progression|0|||
126522468|NCT00074282|455206057|FG001|Step 2|Disease progression|0|||
126522469|NCT00074282|455206058|FG002|Step 2|Disease progression|5|||
126522470|NCT00074282|455206056|FG000|Step 2|Death|0|||
126522471|NCT00074282|455206057|FG001|Step 2|Death|0|||
126522472|NCT00074282|455206058|FG002|Step 2|Death|3|||
126573921|NCT00845832|455397423|FG001|Treatment Period|Adverse Event|2|||
126573922|NCT00845832|455397424|FG002|Treatment Period|Adverse Event|0|||
126573923|NCT00845832|455397422|FG000|Treatment Period|Protocol Violation|1|||
126522473|NCT00074282|455206056|FG000|Step 2|Withdrawal by Subject|0|||
126522474|NCT00074282|455206057|FG001|Step 2|Withdrawal by Subject|0|||
126522475|NCT00074282|455206058|FG002|Step 2|Withdrawal by Subject|2|||
126522476|NCT00074282|455206056|FG000|Step 2|Physician Decision|0|||
126522477|NCT00074282|455206057|FG001|Step 2|Physician Decision|0|||
126522478|NCT00074282|455206058|FG002|Step 2|Physician Decision|1|||
126522479|NCT00074282|455206056|FG000|Step 2|Ineligible|0|||
126522480|NCT00074282|455206057|FG001|Step 2|Ineligible|0|||
126522481|NCT00074282|455206058|FG002|Step 2|Ineligible|1|||
126522482|NCT00464542|455206059|FG000|Pre-treatment|Withdrawal by Subject|2|||
126522483|NCT01773226|455206061|FG000|Overall Study|Withdrawal by Subject|1|||
126522484|NCT02055352|455206066|FG000|Overall Study|Adverse Event|0|||
126522485|NCT02055352|455206067|FG001|Overall Study|Adverse Event|1|||
126522486|NCT02055352|455206066|FG000|Overall Study|Non-eligible|0|||
126522487|NCT02055352|455206067|FG001|Overall Study|Non-eligible|1|||
126522488|NCT02055352|455206066|FG000|Overall Study|Poor compliance|1|||
126522489|NCT02055352|455206067|FG001|Overall Study|Poor compliance|1|||
126522490|NCT02055352|455206066|FG000|Overall Study|Death|1|||
126522491|NCT02055352|455206067|FG001|Overall Study|Death|2|||
126522492|NCT02055352|455206066|FG000|Overall Study|Patient decision|1|||
126522493|NCT02055352|455206067|FG001|Overall Study|Patient decision|1|||
126522494|NCT02055352|455206066|FG000|Overall Study|Use of prohibited treatment|0|||
126522495|NCT02055352|455206067|FG001|Overall Study|Use of prohibited treatment|3|||
126522496|NCT02055352|455206066|FG000|Overall Study|AE, study drug would be detrimental|1|||
126522497|NCT02055352|455206067|FG001|Overall Study|AE, study drug would be detrimental|3|||
126522498|NCT02055352|455206066|FG000|Overall Study|Withdrawal of informed consent|1|||
126522499|NCT02055352|455206067|FG001|Overall Study|Withdrawal of informed consent|0|||
126522500|NCT02055352|455206066|FG000|Overall Study|Reason unknown|1|||
126522501|NCT02055352|455206067|FG001|Overall Study|Reason unknown|5|||
126522502|NCT03268811|455206074|FG000|Overall Study|Adverse Event|0|||
126522503|NCT03268811|455206075|FG001|Overall Study|Adverse Event|1|||
126522504|NCT01055639|455206083|FG000|Overall Study|Adverse Event|0|||
126522505|NCT01055639|455206084|FG001|Overall Study|Adverse Event|1|||
126522506|NCT01055639|455206083|FG000|Overall Study|Lack of Efficacy|0|||
126522507|NCT01055639|455206084|FG001|Overall Study|Lack of Efficacy|1|||
126522508|NCT01055639|455206083|FG000|Overall Study|Lost to Follow-up|8|||
126522509|NCT01055639|455206084|FG001|Overall Study|Lost to Follow-up|11|||
126522510|NCT01055639|455206083|FG000|Overall Study|Protocol Violation|5|||
126522511|NCT01055639|455206084|FG001|Overall Study|Protocol Violation|5|||
126522512|NCT01055639|455206083|FG000|Overall Study|Withdrawal by Subject|8|||
126522513|NCT01055639|455206084|FG001|Overall Study|Withdrawal by Subject|11|||
126522514|NCT00765245|455206085|FG000|Overall Study|disease progression|3|||
126522515|NCT00765245|455206086|FG001|Overall Study|disease progression|2|||
126522516|NCT00765245|455206085|FG000|Overall Study|Withdrawal by Subject|3|||
126522517|NCT00765245|455206086|FG001|Overall Study|Withdrawal by Subject|0|||
126522518|NCT00765245|455206085|FG000|Overall Study|Adverse Event|5|||
126522519|NCT00765245|455206086|FG001|Overall Study|Adverse Event|0|||
126522520|NCT00765245|455206085|FG000|Overall Study|Physician Decision|1|||
126522521|NCT00765245|455206086|FG001|Overall Study|Physician Decision|0|||
126522522|NCT00765245|455206085|FG000|Overall Study|Death|1|||
126522523|NCT00765245|455206086|FG001|Overall Study|Death|0|||
126522524|NCT02548962|455206088|FG000|Overall Study|Withdrawal by Subject|1|||
126522525|NCT02548962|455206089|FG001|Overall Study|Withdrawal by Subject|0|||
126522526|NCT01197950|455206090|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
126522527|NCT01197950|455206091|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
126522528|NCT01197950|455206092|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
126573924|NCT00845832|455397423|FG001|Treatment Period|Protocol Violation|1|||
126573925|NCT00845832|455397424|FG002|Treatment Period|Protocol Violation|0|||
126573926|NCT00845832|455397422|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
126573927|NCT00845832|455397423|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
126777026|NCT01890785|456139157|FG001|Third Intervention|Withdrawal by Subject|1|||
126777027|NCT01890785|456139158|FG002|Third Intervention|Withdrawal by Subject|0|||
126777028|NCT01890785|456139159|FG003|Third Intervention|Withdrawal by Subject|0|||
126522529|NCT04831736|455206093|FG000|Overall Study|Withdrawal by Subject|0|||
126522530|NCT04831736|455206094|FG001|Overall Study|Withdrawal by Subject|1|||
126522531|NCT02265705|455206100|FG000|Treatment Period Week 0-24|Adverse Event|3|||
126522532|NCT02265705|455206101|FG001|Treatment Period Week 0-24|Adverse Event|2|||
126522533|NCT02265705|455206102|FG002|Treatment Period Week 0-24|Adverse Event|0|||
126522534|NCT02265705|455206103|FG003|Treatment Period Week 0-24|Adverse Event|0|||
126522535|NCT02265705|455206104|FG004|Treatment Period Week 0-24|Adverse Event|0|||
126522536|NCT02265705|455206105|FG005|Treatment Period Week 0-24|Adverse Event|0|||
126522537|NCT02265705|455206106|FG006|Treatment Period Week 0-24|Adverse Event|0|||
126522538|NCT02265705|455206100|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
126522539|NCT02265705|455206101|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
126522540|NCT02265705|455206102|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
126522541|NCT02265705|455206103|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
126522542|NCT02265705|455206104|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
126522543|NCT02265705|455206105|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
126522544|NCT02265705|455206106|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
126522545|NCT02265705|455206100|FG000|Treatment Period Week 0-24|Physician Decision|1|||
126522546|NCT02265705|455206101|FG001|Treatment Period Week 0-24|Physician Decision|0|||
126522547|NCT02265705|455206102|FG002|Treatment Period Week 0-24|Physician Decision|0|||
126522548|NCT02265705|455206103|FG003|Treatment Period Week 0-24|Physician Decision|0|||
126522549|NCT02265705|455206104|FG004|Treatment Period Week 0-24|Physician Decision|0|||
126522550|NCT02265705|455206105|FG005|Treatment Period Week 0-24|Physician Decision|0|||
126522551|NCT02265705|455206106|FG006|Treatment Period Week 0-24|Physician Decision|0|||
126522552|NCT02265705|455206100|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
126522553|NCT02265705|455206101|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
126522554|NCT02265705|455206102|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
126522555|NCT02265705|455206103|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
126522556|NCT02265705|455206104|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
126522557|NCT02265705|455206105|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
126522558|NCT02265705|455206106|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
126522559|NCT02265705|455206100|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
126522560|NCT02265705|455206101|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
126522561|NCT02265705|455206102|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
126522562|NCT02265705|455206103|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
126522563|NCT02265705|455206104|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
126522564|NCT02265705|455206105|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
126522565|NCT02265705|455206106|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
126522566|NCT02265705|455206100|FG000|Rescue Period|Withdrawal by Subject|0|||
126522567|NCT02265705|455206101|FG001|Rescue Period|Withdrawal by Subject|0|||
126522568|NCT02265705|455206102|FG002|Rescue Period|Withdrawal by Subject|1|||
126522569|NCT02265705|455206103|FG003|Rescue Period|Withdrawal by Subject|0|||
126522570|NCT02265705|455206104|FG004|Rescue Period|Withdrawal by Subject|0|||
126522571|NCT02265705|455206105|FG005|Rescue Period|Withdrawal by Subject|0|||
126522572|NCT02265705|455206106|FG006|Rescue Period|Withdrawal by Subject|0|||
126522573|NCT02265705|455206100|FG000|Rescue Period|Death|0|||
126522574|NCT02265705|455206101|FG001|Rescue Period|Death|0|||
126522575|NCT02265705|455206102|FG002|Rescue Period|Death|1|||
126522576|NCT02265705|455206103|FG003|Rescue Period|Death|0|||
126522577|NCT02265705|455206104|FG004|Rescue Period|Death|0|||
126522578|NCT02265705|455206105|FG005|Rescue Period|Death|0|||
126522579|NCT02265705|455206106|FG006|Rescue Period|Death|0|||
126522580|NCT02265705|455206100|FG000|Rescue Period|Lack of Efficacy|0|||
126522581|NCT02265705|455206101|FG001|Rescue Period|Lack of Efficacy|0|||
126522582|NCT02265705|455206102|FG002|Rescue Period|Lack of Efficacy|1|||
126522583|NCT02265705|455206103|FG003|Rescue Period|Lack of Efficacy|0|||
126522584|NCT02265705|455206104|FG004|Rescue Period|Lack of Efficacy|0|||
126522585|NCT02265705|455206105|FG005|Rescue Period|Lack of Efficacy|0|||
126522586|NCT02265705|455206106|FG006|Rescue Period|Lack of Efficacy|0|||
126522587|NCT02265705|455206100|FG000|Open Label Period|Adverse Event|0|||
126522588|NCT02265705|455206101|FG001|Open Label Period|Adverse Event|0|||
126522589|NCT02265705|455206102|FG002|Open Label Period|Adverse Event|0|||
126522590|NCT02265705|455206103|FG003|Open Label Period|Adverse Event|2|||
126522591|NCT02265705|455206104|FG004|Open Label Period|Adverse Event|2|||
126522592|NCT02265705|455206105|FG005|Open Label Period|Adverse Event|0|||
126522593|NCT02265705|455206106|FG006|Open Label Period|Adverse Event|0|||
126522594|NCT02265705|455206100|FG000|Open Label Period|Physician Decision|0|||
126522595|NCT02265705|455206101|FG001|Open Label Period|Physician Decision|0|||
126522596|NCT02265705|455206102|FG002|Open Label Period|Physician Decision|0|||
126522597|NCT02265705|455206103|FG003|Open Label Period|Physician Decision|0|||
126522598|NCT02265705|455206104|FG004|Open Label Period|Physician Decision|1|||
126522599|NCT02265705|455206105|FG005|Open Label Period|Physician Decision|0|||
126522600|NCT02265705|455206106|FG006|Open Label Period|Physician Decision|0|||
126522601|NCT02265705|455206100|FG000|Open Label Period|Withdrawal by Subject|0|||
126522602|NCT02265705|455206101|FG001|Open Label Period|Withdrawal by Subject|0|||
126522603|NCT02265705|455206102|FG002|Open Label Period|Withdrawal by Subject|0|||
126522604|NCT02265705|455206103|FG003|Open Label Period|Withdrawal by Subject|0|||
126522605|NCT02265705|455206104|FG004|Open Label Period|Withdrawal by Subject|2|||
126522606|NCT02265705|455206105|FG005|Open Label Period|Withdrawal by Subject|0|||
126522607|NCT02265705|455206106|FG006|Open Label Period|Withdrawal by Subject|0|||
126522608|NCT02265705|455206100|FG000|Follow-up Period|Sponsor Decision|0|||
126522609|NCT02265705|455206101|FG001|Follow-up Period|Sponsor Decision|0|||
126522610|NCT02265705|455206102|FG002|Follow-up Period|Sponsor Decision|0|||
126522611|NCT02265705|455206103|FG003|Follow-up Period|Sponsor Decision|0|||
126522612|NCT02265705|455206104|FG004|Follow-up Period|Sponsor Decision|0|||
126522613|NCT02265705|455206105|FG005|Follow-up Period|Sponsor Decision|1|||
126522614|NCT02265705|455206106|FG006|Follow-up Period|Sponsor Decision|6|||
126573928|NCT00845832|455397424|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
126573929|NCT00845832|455397422|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
126573930|NCT00845832|455397423|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
126573931|NCT00845832|455397424|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
126573932|NCT01039688|455397431|FG000|Overall Study|Adverse Event|38|||
126573933|NCT01039688|455397432|FG001|Overall Study|Adverse Event|39|||
126573934|NCT01039688|455397433|FG002|Overall Study|Adverse Event|24|||
126573935|NCT01039688|455397431|FG000|Overall Study|Lack of Efficacy|20|||
126573936|NCT01039688|455397432|FG001|Overall Study|Lack of Efficacy|11|||
126573937|NCT01039688|455397433|FG002|Overall Study|Lack of Efficacy|26|||
126573938|NCT01039688|455397431|FG000|Overall Study|Lost to Follow-up|11|||
126573939|NCT01039688|455397432|FG001|Overall Study|Lost to Follow-up|9|||
126573940|NCT01039688|455397433|FG002|Overall Study|Lost to Follow-up|5|||
126573941|NCT01039688|455397431|FG000|Overall Study|Other|13|||
126573942|NCT01039688|455397432|FG001|Overall Study|Other|25|||
126573943|NCT01039688|455397433|FG002|Overall Study|Other|12|||
126573944|NCT01039688|455397431|FG000|Overall Study|Withdrawal by Subject|23|||
126573945|NCT01039688|455397432|FG001|Overall Study|Withdrawal by Subject|27|||
126573946|NCT01039688|455397433|FG002|Overall Study|Withdrawal by Subject|13|||
126573947|NCT01039688|455397431|FG000|Overall Study|Death|2|||
126573948|NCT01039688|455397432|FG001|Overall Study|Death|0|||
126573949|NCT01039688|455397433|FG002|Overall Study|Death|0|||
126573950|NCT00668863|455397434|FG000|Overall Study|Objective Progression or Relapse|42|||
126573951|NCT00668863|455397434|FG000|Overall Study|Adverse Event|13|||
126573952|NCT00668863|455397434|FG000|Overall Study|Study Terminated by Sponsor|8|||
126573953|NCT00668863|455397434|FG000|Overall Study|Global Deterioration of Health Status|4|||
126573954|NCT00668863|455397434|FG000|Overall Study|Withdrawal by Subject|1|||
126573955|NCT00668863|455397434|FG000|Overall Study|Surgery|1|||
126573956|NCT00668863|455397434|FG000|Overall Study|Subject's work scheduling problem|1|||
126573957|NCT00668863|455397434|FG000|Overall Study|Physician Decision|1|||
126573958|NCT03844269|455397439|FG000|Overall Study|Withdrawal pre-intervention|1|||
126573959|NCT03844269|455397439|FG000|Overall Study|Did not complete the intervention|2|||
126573960|NCT00101010|455397440|FG000|Overall Study|Physician Decision|1|||
126573961|NCT00439569|455397451|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
126573962|NCT00439569|455397451|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
126573963|NCT00439569|455397451|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
126573964|NCT02755116|455397452|FG000|Overall Study|surgery converted to open, pt admitted|3|||
126573965|NCT02755116|455397453|FG001|Overall Study|surgery converted to open, pt admitted|1|||
126573966|NCT02214160|455397454|FG000|Overall Study|Withdrawal by Subject|1|||
126573967|NCT02214160|455397455|FG001|Overall Study|Withdrawal by Subject|0|||
126573968|NCT02214160|455397456|FG002|Overall Study|Withdrawal by Subject|6|||
126573969|NCT02214160|455397454|FG000|Overall Study|Death|2|||
126573970|NCT02214160|455397455|FG001|Overall Study|Death|2|||
126573971|NCT02214160|455397456|FG002|Overall Study|Death|1|||
126573972|NCT02214160|455397454|FG000|Overall Study|Subject Non-Compliance|0|||
126573973|NCT02214160|455397455|FG001|Overall Study|Subject Non-Compliance|3|||
126573974|NCT02214160|455397456|FG002|Overall Study|Subject Non-Compliance|1|||
126573975|NCT02214160|455397454|FG000|Overall Study|Adverse Event|0|||
126573976|NCT02214160|455397455|FG001|Overall Study|Adverse Event|1|||
126573977|NCT02214160|455397456|FG002|Overall Study|Adverse Event|1|||
126573978|NCT02214160|455397454|FG000|Overall Study|Sponsor Decision|0|||
126573979|NCT02214160|455397455|FG001|Overall Study|Sponsor Decision|2|||
126573980|NCT02214160|455397456|FG002|Overall Study|Sponsor Decision|0|||
126573981|NCT02214160|455397454|FG000|Overall Study|Protocol Violation|1|||
126573982|NCT02214160|455397455|FG001|Overall Study|Protocol Violation|0|||
126573983|NCT02214160|455397456|FG002|Overall Study|Protocol Violation|0|||
126573984|NCT02214160|455397454|FG000|Overall Study|Physician Decision|0|||
126573985|NCT02214160|455397455|FG001|Overall Study|Physician Decision|0|||
126573986|NCT02214160|455397456|FG002|Overall Study|Physician Decision|1|||
126573987|NCT02423798|455397457|FG000|Overall Study|Withdrawal by Subject|3|||
126573988|NCT01063972|455397458|FG000|Overall Study|Death|12|||
126573989|NCT01063972|455397459|FG001|Overall Study|Death|11|||
126573990|NCT01063972|455397458|FG000|Overall Study|Incarcerated|2|||
126573991|NCT01063972|455397459|FG001|Overall Study|Incarcerated|1|||
126573992|NCT01510717|455397461|FG000|Overall Study|Adverse Event|1|||
126573993|NCT01510717|455397462|FG001|Overall Study|Adverse Event|2|||
126573994|NCT01510717|455397461|FG000|Overall Study|Death|1|||
126573995|NCT01510717|455397462|FG001|Overall Study|Death|0|||
126573996|NCT01510717|455397461|FG000|Overall Study|Lost to Follow-up|0|||
126573997|NCT01510717|455397462|FG001|Overall Study|Lost to Follow-up|1|||
126573998|NCT01510717|455397461|FG000|Overall Study|Withdrawal by Subject|0|||
126573999|NCT01510717|455397462|FG001|Overall Study|Withdrawal by Subject|2|||
126574000|NCT01264679|455397463|FG000|Overall Study|Participation in Another Clinical Trial|1|||
126574001|NCT01264679|455397463|FG000|Overall Study|Physician Decision|1|||
126574002|NCT01264679|455397463|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
126574003|NCT01264679|455397463|FG000|Overall Study|Withdrawal by Subject|1|||
126574004|NCT02204982|455397465|FG000|Overall Study|Patient ineligible-medical monitor|1|||
126574005|NCT02204982|455397466|FG001|Overall Study|Patient ineligible-medical monitor|0|||
126574006|NCT02204982|455397465|FG000|Overall Study|Withdrawal by Subject|1|||
126522615|NCT02265705|455206100|FG000|Follow-up Period|Adverse Event|0|||
126522616|NCT02265705|455206101|FG001|Follow-up Period|Adverse Event|0|||
126522617|NCT02265705|455206102|FG002|Follow-up Period|Adverse Event|0|||
126522618|NCT02265705|455206103|FG003|Follow-up Period|Adverse Event|0|||
126522619|NCT02265705|455206104|FG004|Follow-up Period|Adverse Event|0|||
126522620|NCT02265705|455206105|FG005|Follow-up Period|Adverse Event|0|||
126522621|NCT02265705|455206106|FG006|Follow-up Period|Adverse Event|3|||
126522622|NCT02265705|455206100|FG000|Follow-up Period|Physician Decision|0|||
126522623|NCT02265705|455206101|FG001|Follow-up Period|Physician Decision|0|||
126522624|NCT02265705|455206102|FG002|Follow-up Period|Physician Decision|0|||
126522625|NCT02265705|455206103|FG003|Follow-up Period|Physician Decision|0|||
126522626|NCT02265705|455206104|FG004|Follow-up Period|Physician Decision|0|||
126522627|NCT02265705|455206105|FG005|Follow-up Period|Physician Decision|0|||
126522628|NCT02265705|455206106|FG006|Follow-up Period|Physician Decision|1|||
126522629|NCT02265705|455206100|FG000|Follow-up Period|Withdrawal by Subject|0|||
126522630|NCT02265705|455206101|FG001|Follow-up Period|Withdrawal by Subject|0|||
126522631|NCT02265705|455206102|FG002|Follow-up Period|Withdrawal by Subject|0|||
126522632|NCT02265705|455206103|FG003|Follow-up Period|Withdrawal by Subject|0|||
126522633|NCT02265705|455206104|FG004|Follow-up Period|Withdrawal by Subject|0|||
126522634|NCT02265705|455206105|FG005|Follow-up Period|Withdrawal by Subject|0|||
126522635|NCT02265705|455206106|FG006|Follow-up Period|Withdrawal by Subject|1|||
126522636|NCT00779246|455206107|FG000|Overall Study|Missing sufficient data for analysis|33|||
126522637|NCT00779246|455206108|FG001|Overall Study|Missing sufficient data for analysis|53|||
126522638|NCT00383435|455206111|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
126522639|NCT00383435|455206112|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
126522640|NCT00383435|455206113|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
126522641|NCT00383435|455206114|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
126522642|NCT00383435|455206115|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
126522643|NCT00383435|455206111|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
126522644|NCT00383435|455206112|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
126522645|NCT00383435|455206113|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
126522646|NCT00383435|455206114|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
126522647|NCT00383435|455206115|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
126522648|NCT00383435|455206111|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
126522649|NCT00383435|455206112|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
126522650|NCT00383435|455206113|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
126522651|NCT00383435|455206114|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
126522652|NCT00383435|455206115|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
126522653|NCT00383435|455206111|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
126522654|NCT00383435|455206112|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
126522655|NCT00383435|455206113|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
126522656|NCT00383435|455206114|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
126522657|NCT00383435|455206115|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
126522658|NCT00383435|455206111|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
126522659|NCT00383435|455206112|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
126522660|NCT00383435|455206113|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
126522661|NCT00383435|455206114|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
126522662|NCT00383435|455206115|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
126522663|NCT00383435|455206111|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
126522664|NCT00383435|455206112|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
126522665|NCT00383435|455206113|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
126522666|NCT00383435|455206114|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
126522667|NCT00383435|455206115|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
126522668|NCT00383435|455206111|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
126522669|NCT00383435|455206112|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
126522670|NCT00383435|455206113|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
126522671|NCT00383435|455206114|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
126522672|NCT00383435|455206115|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
126522673|NCT00383435|455206111|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
126522674|NCT00383435|455206112|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
126522675|NCT00383435|455206113|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
126522676|NCT00383435|455206114|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
126522677|NCT00383435|455206115|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
126522678|NCT00383435|455206111|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
126522679|NCT00383435|455206112|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
126522680|NCT00383435|455206113|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
126574007|NCT02204982|455397466|FG001|Overall Study|Withdrawal by Subject|0|||
126574008|NCT02204982|455397465|FG000|Overall Study|Adverse Event|1|||
126574009|NCT02204982|455397466|FG001|Overall Study|Adverse Event|0|||
126574010|NCT02204982|455397465|FG000|Overall Study|Adverse Event and Investigator decision|1|||
126574011|NCT02204982|455397466|FG001|Overall Study|Adverse Event and Investigator decision|0|||
126574012|NCT02204982|455397465|FG000|Overall Study|Physician Decision|0|||
126574013|NCT02204982|455397466|FG001|Overall Study|Physician Decision|2|||
126574014|NCT02204982|455397465|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
126574015|NCT02204982|455397466|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
126574016|NCT02204982|455397465|FG000|Overall Study|Termination of Study bySponsor|0|||
126574017|NCT02204982|455397466|FG001|Overall Study|Termination of Study bySponsor|1|||
126574018|NCT01792830|455397468|FG000|Overall Study|Withdrawal by Subject|22|||
126574019|NCT01792830|455397469|FG001|Overall Study|Withdrawal by Subject|0|||
126574020|NCT01792830|455397470|FG002|Overall Study|Withdrawal by Subject|0|||
126574021|NCT01792830|455397471|FG003|Overall Study|Withdrawal by Subject|2|||
126574022|NCT01792830|455397472|FG004|Overall Study|Withdrawal by Subject|1|||
126574023|NCT01792830|455397473|FG005|Overall Study|Withdrawal by Subject|1|||
126574024|NCT01792830|455397474|FG006|Overall Study|Withdrawal by Subject|1|||
126574025|NCT01792830|455397475|FG007|Overall Study|Withdrawal by Subject|1|||
126574026|NCT01792830|455397476|FG008|Overall Study|Withdrawal by Subject|7|||
126574027|NCT01792830|455397477|FG009|Overall Study|Withdrawal by Subject|0|||
126574028|NCT01792830|455397478|FG010|Overall Study|Withdrawal by Subject|2|||
126574029|NCT01792830|455397468|FG000|Overall Study|Death|3|||
126574030|NCT01792830|455397469|FG001|Overall Study|Death|0|||
126574031|NCT01792830|455397470|FG002|Overall Study|Death|0|||
126574032|NCT01792830|455397471|FG003|Overall Study|Death|1|||
126574033|NCT01792830|455397472|FG004|Overall Study|Death|0|||
126574034|NCT01792830|455397473|FG005|Overall Study|Death|0|||
126574035|NCT01792830|455397474|FG006|Overall Study|Death|1|||
126574036|NCT01792830|455397475|FG007|Overall Study|Death|0|||
126574037|NCT01792830|455397476|FG008|Overall Study|Death|1|||
126574038|NCT01792830|455397477|FG009|Overall Study|Death|0|||
126574039|NCT01792830|455397478|FG010|Overall Study|Death|1|||
126574040|NCT01792830|455397468|FG000|Overall Study|Adverse Event|0|||
126574041|NCT01792830|455397469|FG001|Overall Study|Adverse Event|0|||
126574042|NCT01792830|455397470|FG002|Overall Study|Adverse Event|0|||
126574043|NCT01792830|455397471|FG003|Overall Study|Adverse Event|0|||
126574044|NCT01792830|455397472|FG004|Overall Study|Adverse Event|0|||
126574045|NCT01792830|455397473|FG005|Overall Study|Adverse Event|0|||
126574046|NCT01792830|455397474|FG006|Overall Study|Adverse Event|0|||
126574047|NCT01792830|455397475|FG007|Overall Study|Adverse Event|0|||
126574048|NCT01792830|455397476|FG008|Overall Study|Adverse Event|1|||
126574049|NCT01792830|455397477|FG009|Overall Study|Adverse Event|0|||
126574050|NCT01792830|455397478|FG010|Overall Study|Adverse Event|0|||
126574051|NCT02674750|455397484|FG000|Overall Study|Death|4|||
126574052|NCT02674750|455397485|FG001|Overall Study|Death|5|||
126574053|NCT02674750|455397486|FG002|Overall Study|Death|8|||
126574054|NCT02674750|455397484|FG000|Overall Study|Lost to Follow-up|0|||
126574055|NCT02674750|455397485|FG001|Overall Study|Lost to Follow-up|8|||
126574056|NCT02674750|455397486|FG002|Overall Study|Lost to Follow-up|0|||
126574057|NCT02674750|455397484|FG000|Overall Study|Lack of Efficacy|1|||
126574058|NCT02674750|455397485|FG001|Overall Study|Lack of Efficacy|17|||
126574059|NCT02674750|455397486|FG002|Overall Study|Lack of Efficacy|3|||
126574060|NCT02674750|455397484|FG000|Overall Study|Withdrawal by Subject|0|||
126574061|NCT02674750|455397485|FG001|Overall Study|Withdrawal by Subject|7|||
126574062|NCT02674750|455397486|FG002|Overall Study|Withdrawal by Subject|1|||
126574063|NCT02674750|455397484|FG000|Overall Study|Other|0|||
126574064|NCT02674750|455397485|FG001|Overall Study|Other|8|||
126574065|NCT02674750|455397486|FG002|Overall Study|Other|0|||
126574066|NCT01685606|455397489|FG000|Overall Study|Withdrawal by Subject|1|||
126574067|NCT01597258|455397490|FG000|Overall Study|No Drug Administration|1|||
126574068|NCT01415349|455397491|FG000|Treatment Period 1|Adverse Event|0|||
126574069|NCT01415349|455397492|FG001|Treatment Period 1|Adverse Event|1|||
126574070|NCT01415349|455397491|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126574071|NCT01415349|455397492|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126574072|NCT01616459|455397493|FG000|Overall Study|Adverse Event|1|||
126574073|NCT01616459|455397494|FG001|Overall Study|Adverse Event|1|||
126574074|NCT01616459|455397495|FG002|Overall Study|Adverse Event|2|||
126727383|NCT03655717|455951147|FG021|Overall Study|Physician Decision|0|||
126574075|NCT01616459|455397496|FG003|Overall Study|Adverse Event|0|||
126574076|NCT01616459|455397493|FG000|Overall Study|Lost to Follow-up|1|||
126574077|NCT01616459|455397494|FG001|Overall Study|Lost to Follow-up|11|||
126574078|NCT01616459|455397495|FG002|Overall Study|Lost to Follow-up|3|||
126574079|NCT01616459|455397496|FG003|Overall Study|Lost to Follow-up|2|||
126574080|NCT01616459|455397493|FG000|Overall Study|Protocol Violation|0|||
126574081|NCT01616459|455397494|FG001|Overall Study|Protocol Violation|0|||
126574082|NCT01616459|455397495|FG002|Overall Study|Protocol Violation|0|||
126574083|NCT01616459|455397496|FG003|Overall Study|Protocol Violation|2|||
126574084|NCT01616459|455397493|FG000|Overall Study|Withdrawal by Subject|2|||
126574085|NCT01616459|455397494|FG001|Overall Study|Withdrawal by Subject|4|||
126574086|NCT01616459|455397495|FG002|Overall Study|Withdrawal by Subject|4|||
126574087|NCT01616459|455397496|FG003|Overall Study|Withdrawal by Subject|4|||
126574088|NCT01616459|455397493|FG000|Overall Study|Other reason|0|||
126574089|NCT01616459|455397494|FG001|Overall Study|Other reason|1|||
126574090|NCT01616459|455397495|FG002|Overall Study|Other reason|1|||
126574091|NCT01616459|455397496|FG003|Overall Study|Other reason|0|||
126574092|NCT04980755|455397497|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
126574093|NCT04980755|455397497|FG000|Body Reprogramming Courses|Work commitment|2|||
126574094|NCT04980755|455397497|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
126574095|NCT04980755|455397497|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
126574096|NCT00304031|455399208|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
126574097|NCT00304031|455399209|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
126574098|NCT00304031|455399210|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
126574099|NCT00304031|455399208|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
126574100|NCT00304031|455399209|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
126574101|NCT00304031|455399210|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
126574102|NCT00304031|455399208|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
126574103|NCT00304031|455399209|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
126574104|NCT00304031|455399210|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
126574105|NCT00304031|455399208|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
126574106|NCT00304031|455399209|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
126574107|NCT00304031|455399210|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
126574108|NCT00304031|455399208|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
126574109|NCT00304031|455399209|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
126574110|NCT00304031|455399210|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
126574111|NCT00304031|455399208|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
126574112|NCT00304031|455399209|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
126574113|NCT00304031|455399210|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
126574114|NCT00304031|455399208|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
126574115|NCT00304031|455399209|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
126574116|NCT00304031|455399210|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
126574117|NCT00304031|455399208|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
126574118|NCT00304031|455399209|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
126574119|NCT00304031|455399210|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
126574120|NCT00304031|455399208|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
126574121|NCT00304031|455399209|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
126574122|NCT00304031|455399210|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
126574123|NCT01188655|455399212|FG000|Overall Study|Lack of Efficacy|1|||
126574124|NCT01188655|455399212|FG000|Overall Study|Lost to Follow-up|1|||
126574125|NCT01188655|455399212|FG000|Overall Study|Other|11|||
126574126|NCT03648762|455399216|FG000|Overall Study|Lost to Follow-up|1|||
126574127|NCT03648762|455399217|FG001|Overall Study|Lost to Follow-up|2|||
126574128|NCT03648762|455399218|FG002|Overall Study|Lost to Follow-up|0|||
126574129|NCT03648762|455399216|FG000|Overall Study|Withdrawal by Subject|5|||
126574130|NCT03648762|455399217|FG001|Overall Study|Withdrawal by Subject|2|||
126574131|NCT03648762|455399218|FG002|Overall Study|Withdrawal by Subject|1|||
126574132|NCT01875848|455399228|FG000|Overall Study|Withdrawal by Subject|2|||
126574133|NCT01875848|455399229|FG001|Overall Study|Withdrawal by Subject|0|||
126574134|NCT02189252|455399230|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
126574135|NCT02189252|455399231|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
126574136|NCT02189252|455399232|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
126574137|NCT02189252|455399233|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
126574138|NCT02189252|455399230|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
126574139|NCT02189252|455399231|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
126574140|NCT02189252|455399232|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
126574141|NCT02189252|455399233|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
126574142|NCT00840177|455399234|FG000|Overall Study|Adverse Event|5|||
126574143|NCT00840177|455399235|FG001|Overall Study|Adverse Event|1|||
126574144|NCT00840177|455399236|FG002|Overall Study|Adverse Event|1|||
126574145|NCT00840177|455399234|FG000|Overall Study|Refusal unrelated to adverse events|1|||
126574146|NCT00840177|455399235|FG001|Overall Study|Refusal unrelated to adverse events|0|||
126574147|NCT00840177|455399236|FG002|Overall Study|Refusal unrelated to adverse events|1|||
126574148|NCT00840177|455399234|FG000|Overall Study|Progression/relapse|2|||
126574149|NCT00840177|455399235|FG001|Overall Study|Progression/relapse|0|||
126574150|NCT00840177|455399236|FG002|Overall Study|Progression/relapse|0|||
126574151|NCT00840177|455399234|FG000|Overall Study|Death|4|||
126574152|NCT00840177|455399235|FG001|Overall Study|Death|5|||
126574153|NCT00840177|455399236|FG002|Overall Study|Death|5|||
126574154|NCT00840177|455399234|FG000|Overall Study|not protocol specified|6|||
126574155|NCT00840177|455399235|FG001|Overall Study|not protocol specified|3|||
126522681|NCT00383435|455206114|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
126522682|NCT00383435|455206115|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
126522683|NCT00383435|455206111|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
126522684|NCT00383435|455206112|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
126522685|NCT00383435|455206113|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
126522686|NCT00383435|455206114|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
126522687|NCT00383435|455206115|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
126522688|NCT00383435|455206111|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
126522689|NCT00383435|455206112|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
126522690|NCT00383435|455206113|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
126522691|NCT00383435|455206114|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
126522692|NCT00383435|455206115|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
126522693|NCT00383435|455206111|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
126522694|NCT00383435|455206112|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
126522695|NCT00383435|455206113|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
126522696|NCT00383435|455206114|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
126522697|NCT00383435|455206115|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
126522698|NCT00383435|455206111|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
126522699|NCT00383435|455206112|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
126522700|NCT00383435|455206113|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
126522701|NCT00383435|455206114|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
126522702|NCT00383435|455206115|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
126522703|NCT00383435|455206111|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
126522704|NCT00383435|455206112|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
126522705|NCT00383435|455206113|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
126522706|NCT00383435|455206114|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
126522707|NCT00383435|455206115|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
126522708|NCT00383435|455206111|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
126522709|NCT00383435|455206112|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
126522710|NCT00383435|455206113|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
126522711|NCT00383435|455206114|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
126522712|NCT00383435|455206115|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
126522713|NCT00383435|455206111|FG000|26-Week Treatment Safety Extension|Administrative|1|||
126522714|NCT00383435|455206112|FG001|26-Week Treatment Safety Extension|Administrative|1|||
126522715|NCT00383435|455206113|FG002|26-Week Treatment Safety Extension|Administrative|0|||
126522716|NCT00383435|455206114|FG003|26-Week Treatment Safety Extension|Administrative|1|||
126522717|NCT00383435|455206115|FG004|26-Week Treatment Safety Extension|Administrative|0|||
126522718|NCT01753193|455206116|FG000|Overall Study|Withdrawal by Subject|23|||
126522719|NCT01753193|455206116|FG000|Overall Study|Lost to Follow-up|6|||
126522720|NCT01753193|455206116|FG000|Overall Study|Death|1|||
126522721|NCT01753193|455206116|FG000|Overall Study|Other|16|||
126522722|NCT00583557|455206117|FG000|Overall Study|Withdrawal by Subject|18|||
126522723|NCT00583557|455206117|FG000|Overall Study|Adverse Event|9|||
126522724|NCT00583557|455206117|FG000|Overall Study|Lack of Efficacy|31|||
126522725|NCT00583557|455206117|FG000|Overall Study|Lack of Compliance|5|||
126522726|NCT00583557|455206117|FG000|Overall Study|Other|5|||
126522727|NCT00583557|455206117|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
126522728|NCT02682264|455206118|FG000|Overall Study|Withdrawal by Subject|56|||
126522729|NCT02682264|455206119|FG001|Overall Study|Withdrawal by Subject|45|||
126522730|NCT02682264|455206118|FG000|Overall Study|Lost to Follow-up|49|||
126522731|NCT02682264|455206119|FG001|Overall Study|Lost to Follow-up|41|||
126522732|NCT02682264|455206118|FG000|Overall Study|Lack of Efficacy|14|||
126522733|NCT02682264|455206119|FG001|Overall Study|Lack of Efficacy|16|||
126522734|NCT02682264|455206118|FG000|Overall Study|Withdrawal by Parent|6|||
126522735|NCT02682264|455206119|FG001|Overall Study|Withdrawal by Parent|7|||
126522736|NCT02682264|455206118|FG000|Overall Study|Adverse Event|9|||
126522737|NCT02682264|455206119|FG001|Overall Study|Adverse Event|0|||
126522738|NCT02682264|455206118|FG000|Overall Study|Noncompliance with study drug|1|||
126522739|NCT02682264|455206119|FG001|Overall Study|Noncompliance with study drug|4|||
126522740|NCT02682264|455206118|FG000|Overall Study|Pregnancy|1|||
126522741|NCT02682264|455206119|FG001|Overall Study|Pregnancy|2|||
126522742|NCT02682264|455206118|FG000|Overall Study|Recovery|1|||
126522743|NCT02682264|455206119|FG001|Overall Study|Recovery|2|||
126522744|NCT02682264|455206118|FG000|Overall Study|Progressive Disease|1|||
126522745|NCT02682264|455206119|FG001|Overall Study|Progressive Disease|0|||
126522746|NCT02682264|455206118|FG000|Overall Study|Technical Problems|0|||
126522747|NCT02682264|455206119|FG001|Overall Study|Technical Problems|1|||
126574156|NCT00840177|455399236|FG002|Overall Study|not protocol specified|0|||
126574157|NCT00840177|455399234|FG000|Overall Study|Ineligible|0|||
126574158|NCT00840177|455399235|FG001|Overall Study|Ineligible|0|||
126574159|NCT00840177|455399236|FG002|Overall Study|Ineligible|3|||
126574160|NCT00840177|455399234|FG000|Overall Study|Did not start treatment|0|||
126574161|NCT00840177|455399235|FG001|Overall Study|Did not start treatment|0|||
126574162|NCT00840177|455399236|FG002|Overall Study|Did not start treatment|1|||
126574163|NCT01391832|455399237|FG000|Overall Study|Withdrawal by Subject|21|||
126574164|NCT01391832|455399238|FG001|Overall Study|Withdrawal by Subject|22|||
126574165|NCT01391832|455399237|FG000|Overall Study|Lost to Follow-up|0|||
126574166|NCT01391832|455399238|FG001|Overall Study|Lost to Follow-up|1|||
126574167|NCT00686855|455399242|FG000|Overall Study|Lost to Follow-up|1|||
126574168|NCT00686855|455399243|FG001|Overall Study|Lost to Follow-up|0|||
126574169|NCT00686855|455399242|FG000|Overall Study|Progressive GVHD|0|||
126574170|NCT00686855|455399243|FG001|Overall Study|Progressive GVHD|1|||
126574171|NCT01460446|455399249|FG000|Overall Study|Non-compliance|2|||
126522748|NCT02682264|455206118|FG000|Overall Study|Moved abroad and unable to continue|0|||
126522749|NCT02682264|455206119|FG001|Overall Study|Moved abroad and unable to continue|3|||
126522750|NCT02682264|455206118|FG000|Overall Study|Stopped test article application|0|||
126522751|NCT02682264|455206119|FG001|Overall Study|Stopped test article application|1|||
126522752|NCT01131312|455206120|FG000|Overall Study|Lost to Follow-up|425|||
126522753|NCT01131312|455206121|FG001|Overall Study|Lost to Follow-up|229|||
126522754|NCT01131312|455206122|FG002|Overall Study|Lost to Follow-up|351|||
126522755|NCT01775137|455206123|FG000|Overall Study|Death|1|||
126522756|NCT01775137|455206123|FG000|Overall Study|Protocol deviation|2|||
126522757|NCT01775137|455206123|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126522758|NCT01775137|455206123|FG000|Overall Study|Adverse Event|1|||
126522759|NCT01775137|455206123|FG000|Overall Study|Withdrawal by participants|5|||
126522760|NCT01310036|455206135|FG000|Overall Study|Administrative/other|10|||
126522761|NCT01310036|455206135|FG000|Overall Study|Withdrew Consent|11|||
126522762|NCT01310036|455206135|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
126522763|NCT01310036|455206135|FG000|Overall Study|Progression of Disease|164|||
126522764|NCT01310036|455206135|FG000|Overall Study|Death|1|||
126522765|NCT01310036|455206135|FG000|Overall Study|Adverse event or intercurrent illness|12|||
126522766|NCT00553267|455206136|FG000|Overall Study|Adverse Event|8|||
126522767|NCT00553267|455206137|FG001|Overall Study|Adverse Event|10|||
126522768|NCT00553267|455206138|FG002|Overall Study|Adverse Event|5|||
126522769|NCT00553267|455206136|FG000|Overall Study|Non compliant with protocol|3|||
126522770|NCT00553267|455206137|FG001|Overall Study|Non compliant with protocol|3|||
126522771|NCT00553267|455206138|FG002|Overall Study|Non compliant with protocol|2|||
126522772|NCT00553267|455206136|FG000|Overall Study|Lost to Follow-up|0|||
126522773|NCT00553267|455206137|FG001|Overall Study|Lost to Follow-up|0|||
126522774|NCT00553267|455206138|FG002|Overall Study|Lost to Follow-up|1|||
126522775|NCT00553267|455206136|FG000|Overall Study|Consent withdrawn|2|||
126522776|NCT00553267|455206137|FG001|Overall Study|Consent withdrawn|3|||
126522777|NCT00553267|455206138|FG002|Overall Study|Consent withdrawn|1|||
126522778|NCT00553267|455206136|FG000|Overall Study|Specified category|1|||
126522779|NCT00553267|455206137|FG001|Overall Study|Specified category|2|||
126522780|NCT00553267|455206138|FG002|Overall Study|Specified category|1|||
126522781|NCT01175668|455206139|FG000|Overall Study|Withdrawal by Subject|2|||
126522782|NCT01175668|455206140|FG001|Overall Study|Withdrawal by Subject|0|||
126522783|NCT00856583|455206141|FG000|Overall Study|Lack of Efficacy|389|||
126522784|NCT00856583|455206142|FG001|Overall Study|Lack of Efficacy|377|||
126522785|NCT00856583|455206141|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
126522786|NCT00856583|455206142|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
126522787|NCT00856583|455206141|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
126522788|NCT00856583|455206142|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
126522789|NCT00856583|455206141|FG000|Overall Study|Non-compliance|305|||
126522790|NCT00856583|455206142|FG001|Overall Study|Non-compliance|262|||
126522791|NCT00856583|455206141|FG000|Overall Study|Withdrawal by Subject|1092|||
126522792|NCT00856583|455206142|FG001|Overall Study|Withdrawal by Subject|919|||
126522793|NCT00856583|455206141|FG000|Overall Study|Physician Decision|59|||
126522794|NCT00856583|455206142|FG001|Overall Study|Physician Decision|82|||
126522795|NCT00856583|455206141|FG000|Overall Study|Pregnancy|14|||
126522796|NCT00856583|455206142|FG001|Overall Study|Pregnancy|5|||
126522797|NCT00856583|455206141|FG000|Overall Study|Other|92|||
126522798|NCT00856583|455206142|FG001|Overall Study|Other|104|||
126522799|NCT00856583|455206141|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
126522800|NCT00856583|455206142|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
126522801|NCT01944046|455206145|FG000|Randomized to DB|Adverse Event|5|||
126522802|NCT01944046|455206146|FG001|Randomized to DB|Adverse Event|2|||
126522803|NCT01944046|455206145|FG000|Randomized to DB|Clinical Worsening|3|||
126522804|NCT01944046|455206146|FG001|Randomized to DB|Clinical Worsening|2|||
126522805|NCT01944046|455206145|FG000|Randomized to DB|Lost to Follow-up|3|||
126522806|NCT01944046|455206146|FG001|Randomized to DB|Lost to Follow-up|3|||
126522807|NCT01944046|455206145|FG000|Randomized to DB|Withdrawal by Subject|2|||
126522808|NCT01944046|455206146|FG001|Randomized to DB|Withdrawal by Subject|4|||
126574172|NCT01460446|455399250|FG001|Overall Study|Non-compliance|9|||
126522809|NCT01944046|455206145|FG000|Randomized to DB|Physician Decision|1|||
126522810|NCT01944046|455206146|FG001|Randomized to DB|Physician Decision|2|||
126522811|NCT01944046|455206145|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
126522812|NCT01944046|455206146|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
126522813|NCT01944046|455206145|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
126522814|NCT01944046|455206146|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
126522815|NCT01944046|455206145|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
126522816|NCT01944046|455206146|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
126522817|NCT01944046|455206145|FG000|Open Label Eligible and Consented|Adverse Event|6|||
126522818|NCT01944046|455206146|FG001|Open Label Eligible and Consented|Adverse Event|1|||
126522819|NCT01944046|455206145|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
126522820|NCT01944046|455206146|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
126522821|NCT01944046|455206145|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
126522822|NCT01944046|455206146|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
126522823|NCT02328326|455206149|FG000|Overall Study|Withdrawal by Subject|10|||
126522824|NCT02328326|455206150|FG001|Overall Study|Withdrawal by Subject|3|||
126522825|NCT02328326|455206149|FG000|Overall Study|Death|2|||
126522826|NCT02328326|455206150|FG001|Overall Study|Death|1|||
126522827|NCT02328326|455206149|FG000|Overall Study|Lost to Follow-up|10|||
126522828|NCT02328326|455206150|FG001|Overall Study|Lost to Follow-up|4|||
126522829|NCT01618838|455206162|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
126522830|NCT03965052|455206164|FG000|Overall Study|Protocol Violation|1|||
126522831|NCT03965052|455206165|FG001|Overall Study|Protocol Violation|0|||
126522832|NCT01910519|455206171|FG000|Overall Study|Withdrawal by Subject|2|||
126522833|NCT01910519|455206172|FG001|Overall Study|Withdrawal by Subject|0|||
126522834|NCT01910519|455206171|FG000|Overall Study|Adverse Event|2|||
126522835|NCT01910519|455206172|FG001|Overall Study|Adverse Event|0|||
126522836|NCT04266028|455206173|FG000|Overall Study|Adverse Event|0|||
126522837|NCT04266028|455206174|FG001|Overall Study|Adverse Event|0|||
126522838|NCT04266028|455206175|FG002|Overall Study|Adverse Event|1|||
126522839|NCT04266028|455206176|FG003|Overall Study|Adverse Event|0|||
126522840|NCT04266028|455206177|FG004|Overall Study|Adverse Event|1|||
126522841|NCT04266028|455206178|FG005|Overall Study|Adverse Event|0|||
126522842|NCT04266028|455206179|FG006|Overall Study|Adverse Event|2|||
126522843|NCT04266028|455206180|FG007|Overall Study|Adverse Event|0|||
126522844|NCT04266028|455206173|FG000|Overall Study|temporary halt of the study|0|||
126522845|NCT04266028|455206174|FG001|Overall Study|temporary halt of the study|0|||
126522846|NCT04266028|455206175|FG002|Overall Study|temporary halt of the study|0|||
126522847|NCT04266028|455206176|FG003|Overall Study|temporary halt of the study|0|||
126522848|NCT04266028|455206177|FG004|Overall Study|temporary halt of the study|0|||
126522849|NCT04266028|455206178|FG005|Overall Study|temporary halt of the study|0|||
126522850|NCT04266028|455206179|FG006|Overall Study|temporary halt of the study|2|||
126522851|NCT04266028|455206180|FG007|Overall Study|temporary halt of the study|1|||
126522852|NCT04266028|455206173|FG000|Overall Study|Onset of birch pollen season|0|||
126522853|NCT04266028|455206174|FG001|Overall Study|Onset of birch pollen season|0|||
126522854|NCT04266028|455206175|FG002|Overall Study|Onset of birch pollen season|0|||
126522855|NCT04266028|455206176|FG003|Overall Study|Onset of birch pollen season|0|||
126522856|NCT04266028|455206177|FG004|Overall Study|Onset of birch pollen season|1|||
126522857|NCT04266028|455206178|FG005|Overall Study|Onset of birch pollen season|0|||
126522858|NCT04266028|455206179|FG006|Overall Study|Onset of birch pollen season|0|||
126522859|NCT04266028|455206180|FG007|Overall Study|Onset of birch pollen season|0|||
126522860|NCT02863991|455206181|FG000|Overall Study|Death|0|||
126522861|NCT02863991|455206182|FG001|Overall Study|Death|3|||
126522862|NCT02863991|455206181|FG000|Overall Study|Lack of Efficacy|0|||
126522863|NCT02863991|455206182|FG001|Overall Study|Lack of Efficacy|1|||
126522864|NCT02863991|455206181|FG000|Overall Study|Study Terminated|2|||
126522865|NCT02863991|455206182|FG001|Overall Study|Study Terminated|8|||
126522866|NCT03096782|455206186|FG000|Overall Study|Death|1|||
126522867|NCT03096782|455206186|FG000|Overall Study|Participant Relapsed|1|||
126522868|NCT00993447|455208119|FG000|Overall Study|Withdrawal by Subject|23|||
126522869|NCT00993447|455208120|FG001|Overall Study|Withdrawal by Subject|8|||
126522870|NCT00993447|455208119|FG000|Overall Study|Protocol Violation|12|||
126522871|NCT00993447|455208120|FG001|Overall Study|Protocol Violation|8|||
126522872|NCT00993447|455208119|FG000|Overall Study|Lost to Follow-up|1|||
126522873|NCT00993447|455208120|FG001|Overall Study|Lost to Follow-up|3|||
126522874|NCT00993447|455208119|FG000|Overall Study|Adverse Event|1|||
126522875|NCT00993447|455208120|FG001|Overall Study|Adverse Event|0|||
126574173|NCT01460446|455399249|FG000|Overall Study|Consent Withdrawn|0|||
126522876|NCT00970502|455208123|FG000|Overall Study|Withdrawal by Subject|1|||
126522877|NCT03811912|455208124|FG000|Overall Study|Withdrew Consent|4|||
126522878|NCT03811912|455208125|FG001|Overall Study|Withdrew Consent|2|||
126522879|NCT04401579|455208126|FG000|Overall Study|Death|23|||
126522880|NCT04401579|455208127|FG001|Overall Study|Death|36|||
126522881|NCT04401579|455208126|FG000|Overall Study|Lost to Follow-up|40|||
126522882|NCT04401579|455208127|FG001|Overall Study|Lost to Follow-up|41|||
126522883|NCT04401579|455208126|FG000|Overall Study|Withdrawal by Subject|8|||
126574174|NCT01460446|455399250|FG001|Overall Study|Consent Withdrawn|4|||
126574175|NCT01460446|455399249|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
126574176|NCT01460446|455399250|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
126574177|NCT01460446|455399249|FG000|Overall Study|Surgery/Illness|1|||
126574178|NCT01460446|455399250|FG001|Overall Study|Surgery/Illness|1|||
126574179|NCT01460446|455399249|FG000|Overall Study|Pregnancy|1|||
126574180|NCT01460446|455399250|FG001|Overall Study|Pregnancy|0|||
126574181|NCT01460446|455399249|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
126574182|NCT01460446|455399250|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
126574183|NCT01318382|455399251|FG000|Overall Study|Physician Decision|2|||
126574184|NCT01318382|455399251|FG000|Overall Study|Device Malfunction|10|||
126574185|NCT01318382|455399251|FG000|Overall Study|Protocol Violation|1|||
126574186|NCT01867216|455399254|FG000|Overall Study|Withdrawal by Subject|2|||
126574187|NCT01867216|455399255|FG001|Overall Study|Withdrawal by Subject|0|||
126574188|NCT01867216|455399256|FG002|Overall Study|Withdrawal by Subject|0|||
126574189|NCT01867216|455399257|FG003|Overall Study|Withdrawal by Subject|0|||
126574190|NCT01867216|455399258|FG004|Overall Study|Withdrawal by Subject|1|||
126574191|NCT01867216|455399259|FG005|Overall Study|Withdrawal by Subject|0|||
126574192|NCT01867216|455399260|FG006|Overall Study|Withdrawal by Subject|1|||
126574193|NCT01867216|455399254|FG000|Overall Study|Physician Decision|1|||
126574194|NCT01867216|455399255|FG001|Overall Study|Physician Decision|0|||
126574195|NCT01867216|455399256|FG002|Overall Study|Physician Decision|0|||
126574196|NCT01867216|455399257|FG003|Overall Study|Physician Decision|0|||
126574197|NCT01867216|455399258|FG004|Overall Study|Physician Decision|0|||
126574198|NCT01867216|455399259|FG005|Overall Study|Physician Decision|0|||
126574199|NCT01867216|455399260|FG006|Overall Study|Physician Decision|0|||
126574200|NCT01867216|455399254|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
126574201|NCT01867216|455399255|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
126574202|NCT01867216|455399256|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
126574203|NCT01867216|455399257|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
126574204|NCT01867216|455399258|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
126574205|NCT01867216|455399259|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
126574206|NCT01867216|455399260|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
126574207|NCT01599104|455399261|FG000|Overall Study|Withdrawal by Subject|1|||
126574208|NCT01599104|455399262|FG001|Overall Study|Withdrawal by Subject|1|||
126574209|NCT01599104|455399263|FG002|Overall Study|Withdrawal by Subject|2|||
126574210|NCT01599104|455399261|FG000|Overall Study|Technical Problems|1|||
126574211|NCT01599104|455399262|FG001|Overall Study|Technical Problems|0|||
126574212|NCT01599104|455399263|FG002|Overall Study|Technical Problems|0|||
126574213|NCT01599104|455399261|FG000|Overall Study|Physician Decision|3|||
126574214|NCT01599104|455399262|FG001|Overall Study|Physician Decision|2|||
126574215|NCT01599104|455399263|FG002|Overall Study|Physician Decision|2|||
126574216|NCT01599104|455399261|FG000|Overall Study|Non-compliance with study treatment|0|||
126574217|NCT01599104|455399262|FG001|Overall Study|Non-compliance with study treatment|1|||
126574218|NCT01599104|455399263|FG002|Overall Study|Non-compliance with study treatment|0|||
126574219|NCT01599104|455399261|FG000|Overall Study|Lack of Efficacy|4|||
126574220|NCT01599104|455399262|FG001|Overall Study|Lack of Efficacy|4|||
126574221|NCT01599104|455399263|FG002|Overall Study|Lack of Efficacy|10|||
126574222|NCT01599104|455399261|FG000|Overall Study|Adverse Event|7|||
126574223|NCT01599104|455399262|FG001|Overall Study|Adverse Event|6|||
126574224|NCT01599104|455399263|FG002|Overall Study|Adverse Event|12|||
126574225|NCT01308567|455399264|FG000|Overall Study|Lost to Follow-up|2|||
126574226|NCT01308567|455399265|FG001|Overall Study|Lost to Follow-up|4|||
126574227|NCT01308567|455399266|FG002|Overall Study|Lost to Follow-up|4|||
126574228|NCT00542789|455399267|FG000|Overall Study|Adverse Event|18|||
126574229|NCT00542789|455399268|FG001|Overall Study|Adverse Event|17|||
126574230|NCT00542789|455399267|FG000|Overall Study|Withdrawal by Subject|7|||
126574231|NCT00542789|455399268|FG001|Overall Study|Withdrawal by Subject|3|||
126574232|NCT00542789|455399267|FG000|Overall Study|Protocol Violation|8|||
126574233|NCT00542789|455399268|FG001|Overall Study|Protocol Violation|1|||
126574234|NCT00542789|455399267|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
126574235|NCT00542789|455399268|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
126574236|NCT03454529|455399278|FG000|Overall Study|Did not receive treatment|6|||
126574237|NCT03454529|455399278|FG000|Overall Study|Received < 80% doses|1|||
126574238|NCT01582100|455399282|FG000|Overall Study|Adverse Event|1|||
126777029|NCT01890785|456139160|FG004|Third Intervention|Withdrawal by Subject|0|||
126574239|NCT01582100|455399282|FG000|Overall Study|Withdrawal by Subject|1|||
126574240|NCT01149369|455399283|FG000|Overall Study|Adverse Event|6|||
126574241|NCT01149369|455399284|FG001|Overall Study|Adverse Event|3|||
126574242|NCT01040689|455399291|FG000|Overall Study|Adverse Event|0|||
126574243|NCT01040689|455399292|FG001|Overall Study|Adverse Event|0|||
126574244|NCT01040689|455399293|FG002|Overall Study|Adverse Event|2|||
126574245|NCT01040689|455399294|FG003|Overall Study|Adverse Event|4|||
126574246|NCT01040689|455399291|FG000|Overall Study|Lack of Efficacy|0|||
126574247|NCT01040689|455399292|FG001|Overall Study|Lack of Efficacy|0|||
126574248|NCT01040689|455399293|FG002|Overall Study|Lack of Efficacy|1|||
126574249|NCT01040689|455399294|FG003|Overall Study|Lack of Efficacy|0|||
126574250|NCT01040689|455399291|FG000|Overall Study|Lost to Follow-up|1|||
126574251|NCT01040689|455399292|FG001|Overall Study|Lost to Follow-up|0|||
126574252|NCT01040689|455399293|FG002|Overall Study|Lost to Follow-up|0|||
126574253|NCT01040689|455399294|FG003|Overall Study|Lost to Follow-up|0|||
126574254|NCT01040689|455399291|FG000|Overall Study|Withdrawal by Subject|2|||
126574255|NCT01040689|455399292|FG001|Overall Study|Withdrawal by Subject|1|||
126574256|NCT01040689|455399293|FG002|Overall Study|Withdrawal by Subject|1|||
126574257|NCT01040689|455399294|FG003|Overall Study|Withdrawal by Subject|0|||
126574258|NCT01040689|455399291|FG000|Overall Study|Other reasons not listed above|0|||
126574259|NCT01040689|455399292|FG001|Overall Study|Other reasons not listed above|1|||
126574260|NCT01040689|455399293|FG002|Overall Study|Other reasons not listed above|0|||
126574261|NCT01040689|455399294|FG003|Overall Study|Other reasons not listed above|0|||
126574262|NCT01185561|455399295|FG000|Overall Study|Lost to Follow-up|0|||
126574263|NCT01185561|455399296|FG001|Overall Study|Lost to Follow-up|4|||
126574264|NCT01185561|455399295|FG000|Overall Study|Withdrawal by Subject|2|||
126574265|NCT01185561|455399296|FG001|Overall Study|Withdrawal by Subject|8|||
126574266|NCT01078116|455399297|FG000|Overall Study|Lost to Follow-up|17|||
126574267|NCT01078116|455399297|FG000|Overall Study|Adverse Event|5|||
126574268|NCT01078116|455399297|FG000|Overall Study|Withdrawal by Subject|8|||
126574269|NCT01078116|455399297|FG000|Overall Study|Lack of effectiveness|15|||
126574270|NCT01078116|455399297|FG000|Overall Study|Case report form not completed|3|||
126574271|NCT02616900|455399298|FG000|Overall Study|Lack of Efficacy|7|||
126574272|NCT02616900|455399298|FG000|Overall Study|Lost to Follow-up|2|||
126574273|NCT02616900|455399298|FG000|Overall Study|Protocol Violation|5|||
126574274|NCT02616900|455399298|FG000|Overall Study|Withdrawal by Subject|3|||
126574275|NCT02616900|455399298|FG000|Overall Study|Incomplete data|6|||
126574276|NCT02499159|455399299|FG000|Randomization|Protocol Violation|1|||
126574277|NCT02499159|455399300|FG001|Randomization|Protocol Violation|1|||
126574278|NCT02499159|455399299|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
126574279|NCT02499159|455399300|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
126574280|NCT02499159|455399299|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
126574281|NCT02499159|455399300|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
126574282|NCT02499159|455399299|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
126522884|NCT04401579|455208127|FG001|Overall Study|Withdrawal by Subject|16|||
126522885|NCT04401579|455208126|FG000|Overall Study|Physician Decision|1|||
126522886|NCT04401579|455208127|FG001|Overall Study|Physician Decision|2|||
126522887|NCT04401579|455208126|FG000|Overall Study|Became ineligible after enrollment|1|||
126522888|NCT04401579|455208127|FG001|Overall Study|Became ineligible after enrollment|1|||
126522889|NCT04401579|455208126|FG000|Overall Study|Enrolled but treatment not administered|7|||
126522890|NCT04401579|455208127|FG001|Overall Study|Enrolled but treatment not administered|9|||
126522891|NCT04401579|455208126|FG000|Overall Study|Adverse Event|2|||
126522892|NCT04401579|455208127|FG001|Overall Study|Adverse Event|1|||
126522893|NCT04401579|455208126|FG000|Overall Study|Scheduling error|1|||
126522894|NCT04401579|455208127|FG001|Overall Study|Scheduling error|2|||
126522895|NCT04401579|455208126|FG000|Overall Study|Transferred to another hospital|1|||
126522896|NCT04401579|455208127|FG001|Overall Study|Transferred to another hospital|2|||
126522897|NCT01438411|455208128|FG000|Overall Study|Adverse Event|8|||
126522898|NCT01438411|455208128|FG000|Overall Study|Lost to Follow-up|1|||
126522899|NCT01438411|455208128|FG000|Overall Study|Lack of Efficacy|1|||
126522900|NCT01438411|455208128|FG000|Overall Study|Withdrawal by Subject|3|||
126522901|NCT01863680|455208129|FG000|Overall Study|Adverse Event|17|||
126522902|NCT01863680|455208129|FG000|Overall Study|Risk of OHSS|17|||
126522903|NCT01863680|455208129|FG000|Overall Study|Spontaneous pregnancy|2|||
126522904|NCT01863680|455208129|FG000|Overall Study|Withdrawal by Subject|1|||
126522905|NCT01863680|455208129|FG000|Overall Study|Did not undergo IVF/ET|14|||
126522906|NCT01863680|455208129|FG000|Overall Study|Other|6|||
126522907|NCT00618514|455208130|FG000|Overall Study|Lost to Follow-up|11|||
126522908|NCT00618514|455208131|FG001|Overall Study|Lost to Follow-up|12|||
126522909|NCT00618514|455208132|FG002|Overall Study|Lost to Follow-up|4|||
126522910|NCT00566228|455208133|FG000|Overall Study|Withdrawal by Subject|1|||
126522911|NCT00566228|455208134|FG001|Overall Study|Withdrawal by Subject|0|||
126522912|NCT00566228|455208133|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
126522913|NCT00566228|455208134|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
126522914|NCT00566228|455208133|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
126522915|NCT00566228|455208134|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
126522916|NCT00566228|455208133|FG000|Overall Study|progressed before infusion could occur|0|||
126574283|NCT02499159|455399300|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
126574284|NCT02499159|455399299|FG000|30-Day Follow-Up Phone Call|Other|1|||
126574285|NCT02499159|455399300|FG001|30-Day Follow-Up Phone Call|Other|0|||
126574286|NCT02601820|455399301|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
126574287|NCT02601820|455399301|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
126574288|NCT02601820|455399301|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
126777030|NCT01890785|456139161|FG005|Third Intervention|Withdrawal by Subject|0|||
126574289|NCT02601820|455399301|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
126574290|NCT02242487|455399302|FG000|Overall Study|Adverse Event|13|||
126574291|NCT02242487|455399303|FG001|Overall Study|Adverse Event|15|||
126574292|NCT02242487|455399302|FG000|Overall Study|Lack of Efficacy|4|||
126574293|NCT02242487|455399303|FG001|Overall Study|Lack of Efficacy|6|||
126574294|NCT02242487|455399302|FG000|Overall Study|Protocol Violation|2|||
126574295|NCT02242487|455399303|FG001|Overall Study|Protocol Violation|0|||
126574296|NCT02242487|455399302|FG000|Overall Study|Lost to Follow-up|2|||
126574297|NCT02242487|455399303|FG001|Overall Study|Lost to Follow-up|1|||
126574298|NCT02242487|455399302|FG000|Overall Study|Other - Miscellaneous|4|||
126574299|NCT02242487|455399303|FG001|Overall Study|Other - Miscellaneous|6|||
126574300|NCT02242487|455399302|FG000|Overall Study|Withdrawal by Subject|37|||
126574301|NCT02242487|455399303|FG001|Overall Study|Withdrawal by Subject|19|||
126574302|NCT01599793|455399304|FG000|Overall Study|Adverse Event|2|||
126574303|NCT01190007|455399305|FG000|Overall Study|Withdrawal by Subject|4|||
126574304|NCT01190007|455399305|FG000|Overall Study|Adverse Event|8|||
126574305|NCT01190007|455399305|FG000|Overall Study|Difficulty of visit for complications|1|||
126574306|NCT01190007|455399305|FG000|Overall Study|Participant was arrested|1|||
126574307|NCT00636207|455399306|FG000|Overall Study|Adverse Event|1|||
126574308|NCT00636207|455399307|FG001|Overall Study|Adverse Event|0|||
126574309|NCT00636207|455399308|FG002|Overall Study|Adverse Event|0|||
126574310|NCT00636207|455399309|FG003|Overall Study|Adverse Event|0|||
126574311|NCT00636207|455399310|FG004|Overall Study|Adverse Event|0|||
126574312|NCT00636207|455399311|FG005|Overall Study|Adverse Event|0|||
126574313|NCT00636207|455399312|FG006|Overall Study|Adverse Event|0|||
126574314|NCT00636207|455399306|FG000|Overall Study|Withdrawal by Subject|0|||
126574315|NCT00636207|455399307|FG001|Overall Study|Withdrawal by Subject|1|||
126574316|NCT00636207|455399308|FG002|Overall Study|Withdrawal by Subject|0|||
126574317|NCT00636207|455399309|FG003|Overall Study|Withdrawal by Subject|0|||
126574318|NCT00636207|455399310|FG004|Overall Study|Withdrawal by Subject|1|||
126574319|NCT00636207|455399311|FG005|Overall Study|Withdrawal by Subject|0|||
126574320|NCT00636207|455399312|FG006|Overall Study|Withdrawal by Subject|0|||
126574321|NCT02594735|455399315|FG000|Overall Study|Adverse Event|1|||
126574322|NCT01075217|455399322|FG000|Overall Study|Adverse Event|1|||
126574323|NCT01075217|455399323|FG001|Overall Study|Adverse Event|1|||
126574324|NCT01075217|455399322|FG000|Overall Study|Physician Decision|1|||
126574325|NCT01075217|455399323|FG001|Overall Study|Physician Decision|0|||
126574326|NCT02969863|455399324|FG000|Overall Study|Physician Decision|1|||
126574327|NCT02969863|455399325|FG001|Overall Study|Physician Decision|0|||
126574328|NCT02969863|455399326|FG002|Overall Study|Physician Decision|0|||
126574329|NCT02969863|455399327|FG003|Overall Study|Physician Decision|0|||
126574330|NCT02969863|455399328|FG004|Overall Study|Physician Decision|0|||
126574331|NCT02969863|455399329|FG005|Overall Study|Physician Decision|0|||
126574332|NCT03737240|455399330|FG000|Overall Study|Lost to Follow-up|16|||
126574333|NCT03737240|455399331|FG001|Overall Study|Lost to Follow-up|15|||
126574334|NCT00364013|455399332|FG000|Overall Study|Ineligibility determined|4|||
126574335|NCT00364013|455399333|FG001|Overall Study|Ineligibility determined|2|||
126574336|NCT00364013|455399332|FG000|Overall Study|Adverse Event|4|||
126574337|NCT00364013|455399333|FG001|Overall Study|Adverse Event|3|||
126574338|NCT00364013|455399332|FG000|Overall Study|Withdrawal by Subject|13|||
126574339|NCT00364013|455399333|FG001|Overall Study|Withdrawal by Subject|18|||
126574340|NCT00364013|455399332|FG000|Overall Study|Physician Decision|3|||
126574341|NCT00364013|455399333|FG001|Overall Study|Physician Decision|3|||
126574342|NCT00364013|455399332|FG000|Overall Study|Lost to Follow-up|10|||
126574343|NCT00364013|455399333|FG001|Overall Study|Lost to Follow-up|3|||
126574344|NCT00364013|455399332|FG000|Overall Study|Protocol-specified criteria|6|||
126574345|NCT00364013|455399333|FG001|Overall Study|Protocol-specified criteria|6|||
126574346|NCT00364013|455399332|FG000|Overall Study|Other|41|||
126574347|NCT00364013|455399333|FG001|Overall Study|Other|47|||
126574348|NCT00364013|455399332|FG000|Overall Study|Ongoing|20|||
126574349|NCT00364013|455399333|FG001|Overall Study|Ongoing|13|||
126574350|NCT00585533|455399334|FG000|Overall Study|objective or symptomatic progression|9|||
126777031|NCT02746705|456139162|FG000|Overall Study|Physician Decision|1|||
126574351|NCT01254188|455399335|FG000|Overall Study|Disease Progression|6|||
126574352|NCT01254188|455399335|FG000|Overall Study|Protocol Violation|6|||
126574353|NCT01254188|455399335|FG000|Overall Study|Pregnancy|2|||
126574354|NCT01254188|455399335|FG000|Overall Study|Death|4|||
126574355|NCT01254188|455399335|FG000|Overall Study|Lost to Follow-up|5|||
126574356|NCT01254188|455399335|FG000|Overall Study|Withdrawal by Subject|7|||
126574357|NCT01254188|455399335|FG000|Overall Study|Adverse Event|43|||
126574358|NCT01254188|455399335|FG000|Overall Study|per investigator discretion|20|||
126574359|NCT01369498|455399336|FG000|Overall Study|Lack of Efficacy|9|||
126574360|NCT01369498|455399337|FG001|Overall Study|Lack of Efficacy|9|||
126574361|NCT01369498|455399338|FG002|Overall Study|Lack of Efficacy|1|||
126574362|NCT01369498|455399339|FG003|Overall Study|Lack of Efficacy|3|||
126574363|NCT01369498|455399336|FG000|Overall Study|Adverse Event|1|||
126574364|NCT01369498|455399337|FG001|Overall Study|Adverse Event|2|||
126574365|NCT01369498|455399338|FG002|Overall Study|Adverse Event|0|||
126574366|NCT01369498|455399339|FG003|Overall Study|Adverse Event|1|||
126574367|NCT01369498|455399336|FG000|Overall Study|Withdrawal of Consent|0|||
126574368|NCT01369498|455399337|FG001|Overall Study|Withdrawal of Consent|1|||
126574369|NCT01369498|455399338|FG002|Overall Study|Withdrawal of Consent|1|||
126574370|NCT01369498|455399339|FG003|Overall Study|Withdrawal of Consent|1|||
126574371|NCT01369498|455399336|FG000|Overall Study|Death|0|||
126574372|NCT01369498|455399337|FG001|Overall Study|Death|0|||
126574373|NCT01369498|455399338|FG002|Overall Study|Death|1|||
126574374|NCT01369498|455399339|FG003|Overall Study|Death|0|||
126574375|NCT01369498|455399336|FG000|Overall Study|Investigator's Discretion|1|||
126574376|NCT01369498|455399337|FG001|Overall Study|Investigator's Discretion|0|||
126574377|NCT01369498|455399338|FG002|Overall Study|Investigator's Discretion|1|||
126574378|NCT01369498|455399339|FG003|Overall Study|Investigator's Discretion|3|||
126574379|NCT01369498|455399336|FG000|Overall Study|Unknown Reason|1|||
126574380|NCT01369498|455399337|FG001|Overall Study|Unknown Reason|0|||
126574381|NCT01369498|455399338|FG002|Overall Study|Unknown Reason|11|||
126574382|NCT01369498|455399339|FG003|Overall Study|Unknown Reason|6|||
126574383|NCT01369498|455399336|FG000|Overall Study|Disease Progression|0|||
126574384|NCT01369498|455399337|FG001|Overall Study|Disease Progression|0|||
126574385|NCT01369498|455399338|FG002|Overall Study|Disease Progression|0|||
126574386|NCT01369498|455399339|FG003|Overall Study|Disease Progression|1|||
126574387|NCT01124734|455399343|FG000|Overall Study|Disease progression|13|||
126574388|NCT01124734|455399343|FG000|Overall Study|Adverse Event|1|||
126574389|NCT01124734|455399343|FG000|Overall Study|Withdrawal by Subject|1|||
126574390|NCT01124734|455399343|FG000|Overall Study|Elected for alternative treatment|2|||
126574391|NCT03482011|455399344|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
126574392|NCT03482011|455399345|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
126574393|NCT03482011|455399346|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
126574394|NCT03482011|455399347|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
126574395|NCT03482011|455399348|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
126574396|NCT03482011|455399349|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
126574397|NCT03482011|455399350|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
126574398|NCT03482011|455399351|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
126574399|NCT03482011|455399344|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
126574400|NCT03482011|455399345|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
126574401|NCT03482011|455399346|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126574402|NCT03482011|455399347|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126574403|NCT03482011|455399348|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126574404|NCT03482011|455399349|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126574405|NCT03482011|455399350|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126574406|NCT03482011|455399351|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
126574407|NCT03482011|455399344|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126574408|NCT03482011|455399345|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
126574409|NCT03482011|455399346|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126574410|NCT03482011|455399347|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126574411|NCT03482011|455399348|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126574412|NCT03482011|455399349|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126574413|NCT03482011|455399350|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126574414|NCT03482011|455399351|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
126574415|NCT03482011|455399344|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
126574416|NCT03482011|455399345|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
126574417|NCT03482011|455399346|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
126574418|NCT03482011|455399347|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
126574419|NCT03482011|455399348|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
126574420|NCT03482011|455399349|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
126574421|NCT03482011|455399350|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
126574422|NCT03482011|455399351|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
126574423|NCT03482011|455399344|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
126574424|NCT03482011|455399345|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
126574425|NCT03482011|455399346|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126574426|NCT03482011|455399347|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126574427|NCT03482011|455399348|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126574428|NCT03482011|455399349|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126574429|NCT03482011|455399350|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126574430|NCT03482011|455399351|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126574431|NCT03482011|455399344|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
126574432|NCT03482011|455399345|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
126574433|NCT03482011|455399346|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
126574434|NCT03482011|455399347|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
126574435|NCT03482011|455399348|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
126574436|NCT03482011|455399349|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
126574437|NCT03482011|455399350|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
126574438|NCT03482011|455399351|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
126574439|NCT03482011|455399344|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
126574440|NCT03482011|455399345|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
126574441|NCT03482011|455399346|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
126574442|NCT03482011|455399347|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
126574443|NCT03482011|455399348|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
126574444|NCT03482011|455399349|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
126574445|NCT03482011|455399350|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
126574446|NCT03482011|455399351|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
126574447|NCT03482011|455399344|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126574448|NCT03482011|455399345|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126574449|NCT03482011|455399346|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126574450|NCT03482011|455399347|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126574451|NCT03482011|455399348|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
126574452|NCT03482011|455399349|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126574453|NCT03482011|455399350|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
126574454|NCT03482011|455399351|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
126574455|NCT03482011|455399344|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
126574456|NCT03482011|455399345|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
126574457|NCT03482011|455399346|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
126574458|NCT03482011|455399347|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
126574459|NCT03482011|455399348|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
126574460|NCT03482011|455399349|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
126574461|NCT03482011|455399350|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
126574462|NCT03482011|455399351|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
126574463|NCT03482011|455399344|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126574464|NCT03482011|455399345|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126574465|NCT03482011|455399346|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
126574466|NCT03482011|455399347|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
126574467|NCT03482011|455399348|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
126574468|NCT03482011|455399349|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
126574469|NCT03482011|455399350|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
126574470|NCT03482011|455399351|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
126574471|NCT03482011|455399344|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126574472|NCT03482011|455399345|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126574473|NCT03482011|455399346|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126574474|NCT03482011|455399347|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
126574475|NCT03482011|455399348|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
126574476|NCT03482011|455399349|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
126574477|NCT03482011|455399350|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
126574478|NCT03482011|455399351|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
126574479|NCT03482011|455399344|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
126574480|NCT03482011|455399345|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
126574481|NCT03482011|455399346|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
126574482|NCT03482011|455399347|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
126574483|NCT03482011|455399348|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
126574484|NCT03482011|455399349|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
126574485|NCT03482011|455399350|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
126574486|NCT03482011|455399351|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
126574487|NCT03482011|455399344|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
126574488|NCT03482011|455399345|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
126574489|NCT03482011|455399346|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
126522917|NCT00566228|455208134|FG001|Overall Study|progressed before infusion could occur|1|||
126522918|NCT03521635|455208135|FG000|Overall Study|Adverse Event|1|||
126522919|NCT03521635|455208136|FG001|Overall Study|Adverse Event|1|||
126522920|NCT03521635|455208135|FG000|Overall Study|Refused to complete study visit|1|||
126522921|NCT03521635|455208136|FG001|Overall Study|Refused to complete study visit|0|||
126522922|NCT03521635|455208135|FG000|Overall Study|Refused to continue trial medication|2|||
126522923|NCT03521635|455208136|FG001|Overall Study|Refused to continue trial medication|2|||
126522924|NCT03521635|455208135|FG000|Overall Study|Lost to Follow-up|0|||
126522925|NCT03521635|455208136|FG001|Overall Study|Lost to Follow-up|1|||
126522926|NCT03521635|455208135|FG000|Overall Study|Meet exclusion criteria|0|||
126522927|NCT03521635|455208136|FG001|Overall Study|Meet exclusion criteria|1|||
126522928|NCT03521635|455208135|FG000|Overall Study|Patient not taken study medicine|0|||
126522929|NCT03521635|455208136|FG001|Overall Study|Patient not taken study medicine|1|||
126522930|NCT02244944|455208137|FG000|Overall Study|Withdrawal by Subject|1|||
126522931|NCT02244944|455208137|FG000|Overall Study|Study Terminated|1|||
126522932|NCT02367911|455208142|FG000|Overall Study|Withdrawal by Subject|3|||
126522933|NCT02367911|455208143|FG001|Overall Study|Withdrawal by Subject|2|||
126574490|NCT03482011|455399347|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
126574491|NCT03482011|455399348|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
126574492|NCT03482011|455399349|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
126574493|NCT03482011|455399350|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
126522934|NCT02367911|455208142|FG000|Overall Study|Lost to Follow-up|2|||
126522935|NCT02367911|455208143|FG001|Overall Study|Lost to Follow-up|2|||
126574494|NCT03482011|455399351|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
126574495|NCT03482011|455399344|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
126574496|NCT03482011|455399345|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
126574497|NCT03482011|455399346|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
126574498|NCT03482011|455399347|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
126574499|NCT03482011|455399348|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
126574500|NCT03482011|455399349|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
126574501|NCT03482011|455399350|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
126574502|NCT03482011|455399351|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
126574503|NCT03482011|455399344|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126574504|NCT03482011|455399345|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126574505|NCT03482011|455399346|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126574506|NCT03482011|455399347|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126574507|NCT03482011|455399348|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126574508|NCT03482011|455399349|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126574509|NCT03482011|455399350|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126574510|NCT03482011|455399351|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
126574511|NCT02538107|455399352|FG000|Overall Study|Did not receive any Mircera dose|11|||
126574512|NCT02538107|455399352|FG000|Overall Study|Missing|5|||
126574513|NCT02538107|455399352|FG000|Overall Study|Necessity of dialysis|20|||
126574514|NCT02538107|455399352|FG000|Overall Study|Administration of other ESA|11|||
126574515|NCT02538107|455399352|FG000|Overall Study|No further treatment necessary|18|||
126574516|NCT02538107|455399352|FG000|Overall Study|Withdrawal by Subject|17|||
126574517|NCT02538107|455399352|FG000|Overall Study|Death|4|||
126574518|NCT02538107|455399352|FG000|Overall Study|Administrative reason|5|||
126574519|NCT02538107|455399352|FG000|Overall Study|Adverse Event|4|||
126574520|NCT02538107|455399352|FG000|Overall Study|Surgery|1|||
126574521|NCT02538107|455399352|FG000|Overall Study|Other|7|||
126574522|NCT02538107|455399352|FG000|Overall Study|Not recorded|7|||
126574523|NCT01576484|455399353|FG000|Overall Study|Adverse Event|1|||
126574524|NCT01576484|455399354|FG001|Overall Study|Adverse Event|1|||
126574525|NCT01576484|455399353|FG000|Overall Study|Protocol Violation|0|||
126574526|NCT01576484|455399354|FG001|Overall Study|Protocol Violation|2|||
126574527|NCT01576484|455399353|FG000|Overall Study|Sponsor Decision|2|||
126727384|NCT03655717|455951148|FG022|Overall Study|Physician Decision|0|||
126727385|NCT03655717|455951149|FG023|Overall Study|Physician Decision|1|||
126727386|NCT03655717|455951150|FG024|Overall Study|Physician Decision|0|||
126727387|NCT03655717|455951151|FG025|Overall Study|Physician Decision|0|||
126727388|NCT03655717|455951126|FG000|Overall Study|Lost to Follow-up|3|||
126727389|NCT03655717|455951127|FG001|Overall Study|Lost to Follow-up|1|||
126522936|NCT02807948|455208144|FG000|Overall Study|Physician Decision|1|||
126522937|NCT02807948|455208145|FG001|Overall Study|Physician Decision|0|||
126522938|NCT02624804|455208146|FG000|Overall Study|Screen Failure|5|||
126522939|NCT03073603|455208152|FG000|Overall Study|Noncompliance|3|||
126522940|NCT03073603|455208153|FG001|Overall Study|Noncompliance|1|||
126522941|NCT03073603|455208152|FG000|Overall Study|Adverse Event|5|||
126522942|NCT03073603|455208153|FG001|Overall Study|Adverse Event|3|||
126522943|NCT03073603|455208152|FG000|Overall Study|Physician Decision|1|||
126522944|NCT03073603|455208153|FG001|Overall Study|Physician Decision|2|||
126522945|NCT03073603|455208152|FG000|Overall Study|Required treatment not allowed by protocol|1|||
126522946|NCT03073603|455208153|FG001|Overall Study|Required treatment not allowed by protocol|0|||
126522947|NCT03073603|455208152|FG000|Overall Study|Financial or insurance-related|8|||
126522948|NCT03073603|455208153|FG001|Overall Study|Financial or insurance-related|0|||
126522949|NCT03073603|455208152|FG000|Overall Study|Withdrawal by Subject|0|||
126522950|NCT03073603|455208153|FG001|Overall Study|Withdrawal by Subject|1|||
126522951|NCT03073603|455208152|FG000|Overall Study|Discontinued DMT|4|||
126522952|NCT03073603|455208153|FG001|Overall Study|Discontinued DMT|0|||
126522953|NCT03073603|455208152|FG000|Overall Study|Restarted DMT|0|||
126522954|NCT03073603|455208153|FG001|Overall Study|Restarted DMT|1|||
126522955|NCT02553330|455208156|FG000|Overall Study|Study Terminated by Sponsor|2|||
126522956|NCT02553330|455208157|FG001|Overall Study|Study Terminated by Sponsor|13|||
126522957|NCT02553330|455208158|FG002|Overall Study|Study Terminated by Sponsor|12|||
126522958|NCT02553330|455208156|FG000|Overall Study|Withdrawal by Subject|3|||
126522959|NCT02553330|455208157|FG001|Overall Study|Withdrawal by Subject|19|||
126574528|NCT01576484|455399354|FG001|Overall Study|Sponsor Decision|8|||
126574529|NCT01576484|455399353|FG000|Overall Study|Withdrawal by Subject|0|||
126727390|NCT03655717|455951128|FG002|Overall Study|Lost to Follow-up|0|||
126727391|NCT03655717|455951129|FG003|Overall Study|Lost to Follow-up|1|||
126522960|NCT02553330|455208158|FG002|Overall Study|Withdrawal by Subject|21|||
126522961|NCT02553330|455208156|FG000|Overall Study|Other|0|||
126522962|NCT02553330|455208157|FG001|Overall Study|Other|1|||
126522963|NCT02553330|455208158|FG002|Overall Study|Other|0|||
126522964|NCT02553330|455208156|FG000|Overall Study|Non compliance to study treatment|0|||
126522965|NCT02553330|455208157|FG001|Overall Study|Non compliance to study treatment|1|||
126522966|NCT02553330|455208158|FG002|Overall Study|Non compliance to study treatment|0|||
126574530|NCT01576484|455399354|FG001|Overall Study|Withdrawal by Subject|3|||
126522967|NCT02553330|455208156|FG000|Overall Study|Adverse Event|0|||
126522968|NCT02553330|455208157|FG001|Overall Study|Adverse Event|1|||
126522969|NCT02553330|455208158|FG002|Overall Study|Adverse Event|0|||
126522970|NCT02553330|455208156|FG000|Overall Study|Lost to Follow-up|0|||
126522971|NCT02553330|455208157|FG001|Overall Study|Lost to Follow-up|4|||
126522972|NCT02553330|455208158|FG002|Overall Study|Lost to Follow-up|4|||
126522973|NCT01659021|455208161|FG000|Main Study|Adverse Event|2|||
126522974|NCT01659021|455208162|FG001|Main Study|Adverse Event|3|||
126522975|NCT01659021|455208161|FG000|Main Study|Lost to Follow-up|1|||
126522976|NCT01659021|455208162|FG001|Main Study|Lost to Follow-up|0|||
126522977|NCT01659021|455208161|FG000|Main Study|Unknown Reasons|2|||
126522978|NCT01659021|455208162|FG001|Main Study|Unknown Reasons|1|||
126522979|NCT01659021|455208161|FG000|Main Study|Physician Decision|34|||
126522980|NCT01659021|455208162|FG001|Main Study|Physician Decision|16|||
126522981|NCT01659021|455208161|FG000|Main Study|Withdrawal by Subject|19|||
126522982|NCT01659021|455208162|FG001|Main Study|Withdrawal by Subject|16|||
126522983|NCT01659021|455208161|FG000|Main Study|Study Terminated by Sponsor|16|||
126522984|NCT01659021|455208162|FG001|Main Study|Study Terminated by Sponsor|1|||
126522985|NCT01659021|455208161|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
126522986|NCT01659021|455208162|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
126522987|NCT01659021|455208161|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
126522988|NCT01659021|455208162|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
126522989|NCT03551938|455208163|FG000|3-Month Follow Up|Lost to Follow-up|39|||
126522990|NCT03551938|455208164|FG001|3-Month Follow Up|Lost to Follow-up|38|||
126522991|NCT03551938|455208163|FG000|6-Month Follow Up|Lost to Follow-up|46|||
126522992|NCT03551938|455208164|FG001|6-Month Follow Up|Lost to Follow-up|42|||
126522993|NCT03551938|455208163|FG000|9-Month Follow Up|Lost to Follow-up|44|||
126522994|NCT03551938|455208164|FG001|9-Month Follow Up|Lost to Follow-up|43|||
126522995|NCT01205685|455208165|FG000|Overall Study|Disease Progression|10|||
126522996|NCT01205685|455208165|FG000|Overall Study|Withdrawal by Subject|1|||
126522997|NCT04827212|455208169|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
126522998|NCT04827212|455208170|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
126522999|NCT04827212|455208169|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
126523000|NCT04827212|455208170|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
126523001|NCT03058679|455208171|FG000|Baseline to Week 6|Lost to Follow-up|3|||
126523002|NCT03058679|455208172|FG001|Baseline to Week 6|Lost to Follow-up|2|||
126523003|NCT03058679|455208171|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
126523004|NCT03058679|455208172|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
126523005|NCT03058679|455208171|FG000|Baseline to Week 6|Adverse Event|6|||
126523006|NCT03058679|455208172|FG001|Baseline to Week 6|Adverse Event|6|||
126523007|NCT03058679|455208171|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
126523008|NCT03058679|455208172|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
126523009|NCT03058679|455208171|FG000|Baseline to Week 6|Difficulty following the diet|0|||
126523010|NCT03058679|455208172|FG001|Baseline to Week 6|Difficulty following the diet|2|||
126523011|NCT03058679|455208171|FG000|Baseline to Week 6|Physician Decision|1|||
126523012|NCT03058679|455208172|FG001|Baseline to Week 6|Physician Decision|0|||
126523013|NCT03058679|455208171|FG000|Week 6 to Week 12|Change in medication|5|||
126523014|NCT03058679|455208172|FG001|Week 6 to Week 12|Change in medication|7|||
126523015|NCT03058679|455208171|FG000|Week 6 to Week 12|Adverse Event|4|||
126523016|NCT03058679|455208172|FG001|Week 6 to Week 12|Adverse Event|3|||
126523017|NCT03058679|455208171|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
126523018|NCT03058679|455208172|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
126523019|NCT03058679|455208171|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
126523020|NCT03058679|455208172|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
126523021|NCT00599326|455208181|FG000|Overall Study|Lost to Follow-up|1|||
126523022|NCT00599326|455208181|FG000|Overall Study|Noncompliant|1|||
126523023|NCT00784810|455208184|FG000|Overall Study|Adverse Event|32|||
126523024|NCT00784810|455208185|FG001|Overall Study|Adverse Event|20|||
126523025|NCT00784810|455208184|FG000|Overall Study|Lack of Efficacy|14|||
126523026|NCT00784810|455208185|FG001|Overall Study|Lack of Efficacy|11|||
126523027|NCT00784810|455208184|FG000|Overall Study|Withdrawal by Subject|11|||
126523028|NCT00784810|455208185|FG001|Overall Study|Withdrawal by Subject|9|||
126523029|NCT00784810|455208184|FG000|Overall Study|Administrative|5|||
126523030|NCT00784810|455208185|FG001|Overall Study|Administrative|8|||
126523031|NCT00784810|455208184|FG000|Overall Study|Lost to Follow-up|1|||
126523032|NCT00784810|455208185|FG001|Overall Study|Lost to Follow-up|1|||
126523033|NCT02862106|455208186|FG000|Overall Study|Adverse Event|4|||
126523034|NCT02862106|455208187|FG001|Overall Study|Adverse Event|0|||
126523035|NCT02862106|455208186|FG000|Overall Study|Protocol Violation|16|||
126523036|NCT02862106|455208187|FG001|Overall Study|Protocol Violation|1|||
126523037|NCT02862106|455208186|FG000|Overall Study|Lost to Follow-up|15|||
126523038|NCT02862106|455208187|FG001|Overall Study|Lost to Follow-up|5|||
126523039|NCT02862106|455208186|FG000|Overall Study|Withdrawal by Subject|2|||
126523040|NCT02862106|455208187|FG001|Overall Study|Withdrawal by Subject|0|||
126523041|NCT02862106|455208186|FG000|Overall Study|Subjects moved to other city|1|||
126523042|NCT02862106|455208187|FG001|Overall Study|Subjects moved to other city|0|||
126523043|NCT04137380|455208190|FG000|Overall Study|Physician Decision|0|||
126574531|NCT01576484|455399353|FG000|Overall Study|Other|2|||
126574532|NCT01576484|455399354|FG001|Overall Study|Other|5|||
126574533|NCT01943799|455399355|FG000|Overall Study|Lost to Follow-up|0|||
126574534|NCT01943799|455399356|FG001|Overall Study|Lost to Follow-up|1|||
126574535|NCT01943799|455399357|FG002|Overall Study|Lost to Follow-up|1|||
126574536|NCT01943799|455399358|FG003|Overall Study|Lost to Follow-up|0|||
126574537|NCT01943799|455399355|FG000|Overall Study|Protocol Violation|1|||
126574538|NCT01943799|455399356|FG001|Overall Study|Protocol Violation|0|||
126574539|NCT01943799|455399357|FG002|Overall Study|Protocol Violation|0|||
126574540|NCT01943799|455399358|FG003|Overall Study|Protocol Violation|0|||
126574541|NCT01943799|455399355|FG000|Overall Study|Withdrawal by Subject|4|||
126574542|NCT01943799|455399356|FG001|Overall Study|Withdrawal by Subject|2|||
126574543|NCT01943799|455399357|FG002|Overall Study|Withdrawal by Subject|1|||
126574544|NCT01943799|455399358|FG003|Overall Study|Withdrawal by Subject|0|||
126574545|NCT04594759|455399359|FG000|Overall Study|Lost to Follow-up|3|||
126574546|NCT03811574|455399360|FG000|Overall Study|Withdrawal by Subject|2|||
126574547|NCT03811574|455399361|FG001|Overall Study|Withdrawal by Subject|4|||
126574548|NCT03811574|455399362|FG002|Overall Study|Withdrawal by Subject|0|||
126574549|NCT01832480|455399363|FG000|Overall Study|Lost to Follow-up|33|||
126574550|NCT01832480|455399364|FG001|Overall Study|Lost to Follow-up|30|||
126574551|NCT01832480|455399363|FG000|Overall Study|Withdrawal by Subject|0|||
126574552|NCT01832480|455399364|FG001|Overall Study|Withdrawal by Subject|2|||
126574553|NCT01832480|455399363|FG000|Overall Study|post randomization ineligible|8|||
126574554|NCT01832480|455399364|FG001|Overall Study|post randomization ineligible|10|||
126574555|NCT00958633|455399365|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
126574556|NCT00958633|455399366|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
126574557|NCT00958633|455399367|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
126574558|NCT00958633|455399365|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
126574559|NCT00958633|455399366|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
126574560|NCT00958633|455399367|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
126574561|NCT00958633|455399365|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
126574562|NCT00958633|455399366|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
126574563|NCT00958633|455399367|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
126574564|NCT00958633|455399365|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
126574565|NCT00958633|455399366|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
126574566|NCT00958633|455399367|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
126574567|NCT00958633|455399365|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
126574568|NCT00958633|455399366|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
126574569|NCT00958633|455399367|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
126574570|NCT00958633|455399365|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
126574571|NCT00958633|455399366|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
126574572|NCT00958633|455399367|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
126574573|NCT00958633|455399365|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
126574574|NCT00958633|455399366|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
126574575|NCT00958633|455399367|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
126574576|NCT03215927|455400937|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
126574577|NCT03215927|455400938|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
126574578|NCT03215927|455400937|FG000|Open Label Extension|Adverse Event|1|||
126574579|NCT03215927|455400938|FG001|Open Label Extension|Adverse Event|0|||
126574580|NCT03215927|455400937|FG000|Open Label Extension|Lack of Efficacy|1|||
126574581|NCT03215927|455400938|FG001|Open Label Extension|Lack of Efficacy|0|||
126574582|NCT03215927|455400937|FG000|Open Label Extension|Death|0|||
126574583|NCT03215927|455400938|FG001|Open Label Extension|Death|1|||
126574584|NCT03889925|455400941|FG000|Overall Study|Lost to Follow-up|11|||
126574585|NCT03889925|455400942|FG001|Overall Study|Lost to Follow-up|10|||
126574586|NCT03073941|455400943|FG000|Overall Study|Received non-study device intraoperatively|0|||
126574587|NCT03073941|455400944|FG001|Overall Study|Received non-study device intraoperatively|2|||
126574588|NCT03073941|455400943|FG000|Overall Study|Death|1|||
126574589|NCT03073941|455400944|FG001|Overall Study|Death|0|||
126574590|NCT03073941|455400943|FG000|Overall Study|Withdrawal by Subject|1|||
126574591|NCT03073941|455400944|FG001|Overall Study|Withdrawal by Subject|3|||
126574592|NCT03073941|455400943|FG000|Overall Study|Lost to Follow-up|5|||
126574593|NCT03073941|455400944|FG001|Overall Study|Lost to Follow-up|4|||
126574594|NCT03073941|455400943|FG000|Overall Study|Adverse Event|4|||
126574595|NCT03073941|455400944|FG001|Overall Study|Adverse Event|2|||
126574596|NCT03073941|455400943|FG000|Overall Study|Met an exclusion criterion|0|||
126574597|NCT03073941|455400944|FG001|Overall Study|Met an exclusion criterion|1|||
126574598|NCT04250883|455400945|FG000|Overall Study|Lost to Follow-up|1|||
126574599|NCT04250883|455400946|FG001|Overall Study|Lost to Follow-up|0|||
126574600|NCT01823536|455400947|FG000|Overall Study|Lost to Follow-up|1|||
126574601|NCT01823536|455400948|FG001|Overall Study|Lost to Follow-up|0|||
126574602|NCT01823536|455400949|FG002|Overall Study|Lost to Follow-up|0|||
126574603|NCT01823536|455400950|FG003|Overall Study|Lost to Follow-up|1|||
126574604|NCT01823536|455400951|FG004|Overall Study|Lost to Follow-up|1|||
126574605|NCT01823536|455400952|FG005|Overall Study|Lost to Follow-up|0|||
126574606|NCT01823536|455400947|FG000|Overall Study|Protocol Violation|0|||
126574607|NCT01823536|455400948|FG001|Overall Study|Protocol Violation|1|||
126574608|NCT01823536|455400949|FG002|Overall Study|Protocol Violation|0|||
126574609|NCT01823536|455400950|FG003|Overall Study|Protocol Violation|0|||
126574610|NCT01823536|455400951|FG004|Overall Study|Protocol Violation|0|||
126574611|NCT01823536|455400952|FG005|Overall Study|Protocol Violation|0|||
126574612|NCT01823536|455400947|FG000|Overall Study|Withdrawal by Subject|1|||
126574613|NCT01823536|455400948|FG001|Overall Study|Withdrawal by Subject|1|||
126574614|NCT01823536|455400949|FG002|Overall Study|Withdrawal by Subject|0|||
126574615|NCT01823536|455400950|FG003|Overall Study|Withdrawal by Subject|0|||
126574616|NCT01823536|455400951|FG004|Overall Study|Withdrawal by Subject|0|||
126574617|NCT01823536|455400952|FG005|Overall Study|Withdrawal by Subject|0|||
126574618|NCT01823536|455400947|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
126574619|NCT01823536|455400948|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
126574620|NCT01823536|455400949|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
126574621|NCT01823536|455400950|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
126574622|NCT01823536|455400951|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
126574623|NCT01823536|455400952|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
126574624|NCT01823536|455400947|FG000|Overall Study|Met exclusion criterion No 6|0|||
126574625|NCT01823536|455400948|FG001|Overall Study|Met exclusion criterion No 6|0|||
126574626|NCT01823536|455400949|FG002|Overall Study|Met exclusion criterion No 6|0|||
126574627|NCT01823536|455400950|FG003|Overall Study|Met exclusion criterion No 6|1|||
126574628|NCT01823536|455400951|FG004|Overall Study|Met exclusion criterion No 6|0|||
126574629|NCT01823536|455400952|FG005|Overall Study|Met exclusion criterion No 6|0|||
126574630|NCT01823536|455400947|FG000|Overall Study|Subject moved out of the state|0|||
126574631|NCT01823536|455400948|FG001|Overall Study|Subject moved out of the state|0|||
126574632|NCT01823536|455400949|FG002|Overall Study|Subject moved out of the state|0|||
126574633|NCT01823536|455400950|FG003|Overall Study|Subject moved out of the state|0|||
126574634|NCT01823536|455400951|FG004|Overall Study|Subject moved out of the state|1|||
126574635|NCT01823536|455400952|FG005|Overall Study|Subject moved out of the state|0|||
126574636|NCT02407249|455400953|FG000|Overall Study|Did not complete 12-month follow-up|13|||
126574637|NCT02407249|455400953|FG000|Overall Study|Not treated|13|||
126574638|NCT03345901|455400956|FG000|Overall Study|The study was terminated|18|||
126574639|NCT00722046|455400957|FG000|Overall Study|Adverse Event|0|||
126574640|NCT00722046|455400958|FG001|Overall Study|Adverse Event|1|||
126574641|NCT00722046|455400959|FG002|Overall Study|Adverse Event|2|||
126574642|NCT00722046|455400960|FG003|Overall Study|Adverse Event|1|||
126574643|NCT00722046|455400961|FG004|Overall Study|Adverse Event|2|||
126574644|NCT00722046|455400962|FG005|Overall Study|Adverse Event|1|||
126574645|NCT00722046|455400963|FG006|Overall Study|Adverse Event|0|||
126574646|NCT00722046|455400957|FG000|Overall Study|Death|0|||
126574647|NCT00722046|455400958|FG001|Overall Study|Death|1|||
126574648|NCT00722046|455400959|FG002|Overall Study|Death|0|||
126574649|NCT00722046|455400960|FG003|Overall Study|Death|0|||
126574650|NCT00722046|455400961|FG004|Overall Study|Death|0|||
126574651|NCT00722046|455400962|FG005|Overall Study|Death|0|||
126574652|NCT00722046|455400963|FG006|Overall Study|Death|2|||
126574653|NCT00722046|455400957|FG000|Overall Study|Protocol Violation|1|||
126574654|NCT00722046|455400958|FG001|Overall Study|Protocol Violation|0|||
126574655|NCT00722046|455400959|FG002|Overall Study|Protocol Violation|0|||
126574656|NCT00722046|455400960|FG003|Overall Study|Protocol Violation|0|||
126574657|NCT00722046|455400961|FG004|Overall Study|Protocol Violation|0|||
126574658|NCT00722046|455400962|FG005|Overall Study|Protocol Violation|1|||
126574659|NCT00722046|455400963|FG006|Overall Study|Protocol Violation|0|||
126574660|NCT00722046|455400957|FG000|Overall Study|Withdrawal by Subject|3|||
126574661|NCT00722046|455400958|FG001|Overall Study|Withdrawal by Subject|3|||
126574662|NCT00722046|455400959|FG002|Overall Study|Withdrawal by Subject|4|||
126574663|NCT00722046|455400960|FG003|Overall Study|Withdrawal by Subject|4|||
126574664|NCT00722046|455400961|FG004|Overall Study|Withdrawal by Subject|4|||
126574665|NCT00722046|455400962|FG005|Overall Study|Withdrawal by Subject|7|||
126574666|NCT00722046|455400963|FG006|Overall Study|Withdrawal by Subject|3|||
126574667|NCT00722046|455400957|FG000|Overall Study|Randomized, but not treated|1|||
126574668|NCT00722046|455400958|FG001|Overall Study|Randomized, but not treated|1|||
126574669|NCT00722046|455400959|FG002|Overall Study|Randomized, but not treated|0|||
126574670|NCT00722046|455400960|FG003|Overall Study|Randomized, but not treated|2|||
126574671|NCT00722046|455400961|FG004|Overall Study|Randomized, but not treated|0|||
126574672|NCT00722046|455400962|FG005|Overall Study|Randomized, but not treated|0|||
126574673|NCT00722046|455400963|FG006|Overall Study|Randomized, but not treated|0|||
126574674|NCT00722046|455400957|FG000|Overall Study|Other|0|||
126574675|NCT00722046|455400958|FG001|Overall Study|Other|0|||
126574676|NCT00722046|455400959|FG002|Overall Study|Other|1|||
126574677|NCT00722046|455400960|FG003|Overall Study|Other|1|||
126727392|NCT03655717|455951130|FG004|Overall Study|Lost to Follow-up|0|||
126574678|NCT00722046|455400961|FG004|Overall Study|Other|3|||
126574679|NCT00722046|455400962|FG005|Overall Study|Other|2|||
126574680|NCT00722046|455400963|FG006|Overall Study|Other|1|||
126574681|NCT02731755|455400964|FG000|First Intervention|Withdrawal by Subject|0|||
126523044|NCT04137380|455208191|FG001|Overall Study|Physician Decision|0|||
126523045|NCT04137380|455208192|FG002|Overall Study|Physician Decision|0|||
126523046|NCT04137380|455208193|FG003|Overall Study|Physician Decision|1|||
126523047|NCT04137380|455208194|FG004|Overall Study|Physician Decision|0|||
126523048|NCT04137380|455208195|FG005|Overall Study|Physician Decision|0|||
126523049|NCT04137380|455208196|FG006|Overall Study|Physician Decision|0|||
126523050|NCT00563784|455208199|FG000|Overall Study|Withdrawal by Subject|2|||
126523051|NCT00563784|455208199|FG000|Overall Study|Screen Failures|20|||
126523052|NCT03434119|455208202|FG000|Overall Study|Randomized but not treated|1|||
126523053|NCT03434119|455208203|FG001|Overall Study|Randomized but not treated|0|||
126523054|NCT03434119|455208202|FG000|Overall Study|Adverse Event|1|||
126523055|NCT03434119|455208203|FG001|Overall Study|Adverse Event|0|||
126523056|NCT03434119|455208202|FG000|Overall Study|Poor Compliance to Protocol|0|||
126523057|NCT03434119|455208203|FG001|Overall Study|Poor Compliance to Protocol|1|||
126523058|NCT03434119|455208202|FG000|Overall Study|Study Terminated by Sponsor|91|||
126523059|NCT03434119|455208203|FG001|Overall Study|Study Terminated by Sponsor|102|||
126523060|NCT03434119|455208202|FG000|Overall Study|Withdrawal by Subject|7|||
126523061|NCT03434119|455208203|FG001|Overall Study|Withdrawal by Subject|5|||
126523062|NCT03434119|455208202|FG000|Overall Study|Other than specified|7|||
126523063|NCT03434119|455208203|FG001|Overall Study|Other than specified|5|||
126523064|NCT04360824|455208206|FG000|Overall Study|Withdrawal by Subject|2|||
126523065|NCT04360824|455208207|FG001|Overall Study|Withdrawal by Subject|1|||
126523066|NCT04360824|455208206|FG000|Overall Study|Did not receive assigned treatment|1|||
126523067|NCT04360824|455208207|FG001|Overall Study|Did not receive assigned treatment|3|||
126523068|NCT00304070|455208208|FG000|Overall Study|Death|0|||
126523069|NCT00304070|455208209|FG001|Overall Study|Death|0|||
126523070|NCT00304070|455208210|FG002|Overall Study|Death|3|||
126523071|NCT00304070|455208208|FG000|Overall Study|Lost to Follow-up|0|||
126523072|NCT00304070|455208209|FG001|Overall Study|Lost to Follow-up|0|||
126523073|NCT00304070|455208210|FG002|Overall Study|Lost to Follow-up|1|||
126523074|NCT00304070|455208208|FG000|Overall Study|Physician Decision|0|||
126523075|NCT00304070|455208209|FG001|Overall Study|Physician Decision|0|||
126523076|NCT00304070|455208210|FG002|Overall Study|Physician Decision|3|||
126523077|NCT00304070|455208208|FG000|Overall Study|Withdrawal by Subject|0|||
126523078|NCT00304070|455208209|FG001|Overall Study|Withdrawal by Subject|0|||
126523079|NCT00304070|455208210|FG002|Overall Study|Withdrawal by Subject|1|||
126523080|NCT00304070|455208208|FG000|Overall Study|Progressive Disease|3|||
126523081|NCT00304070|455208209|FG001|Overall Study|Progressive Disease|7|||
126523082|NCT00304070|455208210|FG002|Overall Study|Progressive Disease|4|||
126523083|NCT00320216|455208211|FG000|Overall Study|Adverse Event|0|||
126523084|NCT00320216|455208212|FG001|Overall Study|Adverse Event|6|||
126523085|NCT00320216|455208213|FG002|Overall Study|Adverse Event|0|||
126523086|NCT00320216|455208214|FG003|Overall Study|Adverse Event|2|||
126523087|NCT00320216|455208215|FG004|Overall Study|Adverse Event|2|||
126523088|NCT00320216|455208211|FG000|Overall Study|Lack of Efficacy|6|||
126523089|NCT00320216|455208212|FG001|Overall Study|Lack of Efficacy|2|||
126523090|NCT00320216|455208213|FG002|Overall Study|Lack of Efficacy|1|||
126523091|NCT00320216|455208214|FG003|Overall Study|Lack of Efficacy|0|||
126523092|NCT00320216|455208215|FG004|Overall Study|Lack of Efficacy|1|||
126523093|NCT00320216|455208211|FG000|Overall Study|Lost to Follow-up|3|||
126523094|NCT00320216|455208212|FG001|Overall Study|Lost to Follow-up|0|||
126523095|NCT00320216|455208213|FG002|Overall Study|Lost to Follow-up|0|||
126523096|NCT00320216|455208214|FG003|Overall Study|Lost to Follow-up|0|||
126523097|NCT00320216|455208215|FG004|Overall Study|Lost to Follow-up|0|||
126523098|NCT00320216|455208211|FG000|Overall Study|Other|7|||
126523099|NCT00320216|455208212|FG001|Overall Study|Other|2|||
126523100|NCT00320216|455208213|FG002|Overall Study|Other|5|||
126523101|NCT00320216|455208214|FG003|Overall Study|Other|1|||
126523102|NCT00320216|455208215|FG004|Overall Study|Other|3|||
126523103|NCT00377676|455208217|FG000|Overall Study|Adverse Event|498|||
126523104|NCT00377676|455208218|FG001|Overall Study|Adverse Event|107|||
126523105|NCT00377676|455208217|FG000|Overall Study|Protocol Violation|33|||
126523106|NCT00377676|455208218|FG001|Overall Study|Protocol Violation|27|||
126523107|NCT00377676|455208217|FG000|Overall Study|Death|5|||
126523108|NCT00377676|455208218|FG001|Overall Study|Death|2|||
126523109|NCT00377676|455208217|FG000|Overall Study|Withdrawal by Subject|187|||
126523110|NCT00377676|455208218|FG001|Overall Study|Withdrawal by Subject|72|||
126523111|NCT00377676|455208217|FG000|Overall Study|Lost to Follow-up|120|||
126523112|NCT00377676|455208218|FG001|Overall Study|Lost to Follow-up|56|||
126523113|NCT00377676|455208217|FG000|Overall Study|Other|118|||
126523114|NCT00377676|455208218|FG001|Overall Study|Other|58|||
126523115|NCT00148343|455208223|FG000|Overall Study|Withdrawal by Subject|12|||
126523116|NCT00148343|455208224|FG001|Overall Study|Withdrawal by Subject|7|||
126523117|NCT00148343|455208223|FG000|Overall Study|Physician Decision|3|||
126523118|NCT00148343|455208224|FG001|Overall Study|Physician Decision|4|||
126523119|NCT03579459|455208227|FG000|Overall Study|Adverse Event|7|||
126523120|NCT03579459|455208228|FG001|Overall Study|Adverse Event|6|||
126523121|NCT03579459|455208229|FG002|Overall Study|Adverse Event|2|||
126523122|NCT03579459|455208230|FG003|Overall Study|Adverse Event|6|||
126523123|NCT03579459|455208227|FG000|Overall Study|Death|1|||
126523124|NCT03579459|455208228|FG001|Overall Study|Death|0|||
126523125|NCT03579459|455208229|FG002|Overall Study|Death|1|||
126727393|NCT03655717|455951131|FG005|Overall Study|Lost to Follow-up|1|||
126727394|NCT03655717|455951132|FG006|Overall Study|Lost to Follow-up|0|||
126727395|NCT03655717|455951133|FG007|Overall Study|Lost to Follow-up|0|||
126727396|NCT03655717|455951134|FG008|Overall Study|Lost to Follow-up|0|||
126727397|NCT03655717|455951135|FG009|Overall Study|Lost to Follow-up|0|||
126727398|NCT03655717|455951136|FG010|Overall Study|Lost to Follow-up|0|||
126727399|NCT03655717|455951137|FG011|Overall Study|Lost to Follow-up|1|||
126523126|NCT03579459|455208230|FG003|Overall Study|Death|2|||
126523127|NCT03579459|455208227|FG000|Overall Study|Lost to Follow-up|6|||
126523128|NCT03579459|455208228|FG001|Overall Study|Lost to Follow-up|2|||
126523129|NCT03579459|455208229|FG002|Overall Study|Lost to Follow-up|4|||
126523130|NCT03579459|455208230|FG003|Overall Study|Lost to Follow-up|1|||
126523131|NCT03579459|455208227|FG000|Overall Study|Physician Decision|0|||
126523132|NCT03579459|455208228|FG001|Overall Study|Physician Decision|1|||
126523133|NCT03579459|455208229|FG002|Overall Study|Physician Decision|0|||
126523134|NCT03579459|455208230|FG003|Overall Study|Physician Decision|1|||
126523135|NCT03579459|455208227|FG000|Overall Study|Protocol Violation|1|||
126523136|NCT03579459|455208228|FG001|Overall Study|Protocol Violation|2|||
126523137|NCT03579459|455208229|FG002|Overall Study|Protocol Violation|3|||
126523138|NCT03579459|455208230|FG003|Overall Study|Protocol Violation|5|||
126523139|NCT03579459|455208227|FG000|Overall Study|Withdrawal by Subject|12|||
126523140|NCT03579459|455208228|FG001|Overall Study|Withdrawal by Subject|8|||
126523141|NCT03579459|455208229|FG002|Overall Study|Withdrawal by Subject|11|||
126523142|NCT03579459|455208230|FG003|Overall Study|Withdrawal by Subject|8|||
126523143|NCT03579459|455208227|FG000|Overall Study|Medication error without associated adverse event|2|||
126523144|NCT03579459|455208228|FG001|Overall Study|Medication error without associated adverse event|1|||
126523145|NCT03579459|455208229|FG002|Overall Study|Medication error without associated adverse event|1|||
126523146|NCT03579459|455208230|FG003|Overall Study|Medication error without associated adverse event|0|||
126523147|NCT03579459|455208227|FG000|Overall Study|Other|0|||
126523148|NCT03579459|455208228|FG001|Overall Study|Other|1|||
126523149|NCT03579459|455208229|FG002|Overall Study|Other|1|||
126523150|NCT03579459|455208230|FG003|Overall Study|Other|0|||
126523151|NCT03579459|455208227|FG000|Overall Study|Randomized not vaccinated|0|||
126523152|NCT03579459|455208228|FG001|Overall Study|Randomized not vaccinated|2|||
126523153|NCT03579459|455208229|FG002|Overall Study|Randomized not vaccinated|0|||
126523154|NCT03579459|455208230|FG003|Overall Study|Randomized not vaccinated|1|||
126523155|NCT02528214|455208238|FG000|Overall Study|Protocol Violation|0|||
126523156|NCT02528214|455208239|FG001|Overall Study|Protocol Violation|1|||
126523157|NCT02528214|455208238|FG000|Overall Study|Adverse Event|0|||
126523158|NCT02528214|455208239|FG001|Overall Study|Adverse Event|1|||
126523159|NCT02528214|455208238|FG000|Overall Study|Other than specified above|0|||
126523160|NCT02528214|455208239|FG001|Overall Study|Other than specified above|1|||
126523161|NCT00941603|455208243|FG000|Overall Study|Adverse Event|10|||
126523162|NCT00941603|455208244|FG001|Overall Study|Adverse Event|15|||
126523163|NCT00941603|455208245|FG002|Overall Study|Adverse Event|5|||
126523164|NCT00941603|455208246|FG003|Overall Study|Adverse Event|1|||
126523165|NCT00941603|455208247|FG004|Overall Study|Adverse Event|4|||
126523166|NCT00941603|455208248|FG005|Overall Study|Adverse Event|0|||
126523167|NCT00941603|455208243|FG000|Overall Study|Lost to Follow-up|0|||
126523168|NCT00941603|455208244|FG001|Overall Study|Lost to Follow-up|0|||
126523169|NCT00941603|455208245|FG002|Overall Study|Lost to Follow-up|0|||
126523170|NCT00941603|455208246|FG003|Overall Study|Lost to Follow-up|1|||
126523171|NCT00941603|455208247|FG004|Overall Study|Lost to Follow-up|0|||
126523172|NCT00941603|455208248|FG005|Overall Study|Lost to Follow-up|2|||
126523173|NCT00941603|455208243|FG000|Overall Study|Withdrawal by Subject|0|||
126523174|NCT00941603|455208244|FG001|Overall Study|Withdrawal by Subject|0|||
126523175|NCT00941603|455208245|FG002|Overall Study|Withdrawal by Subject|0|||
126523176|NCT00941603|455208246|FG003|Overall Study|Withdrawal by Subject|2|||
126523177|NCT00941603|455208247|FG004|Overall Study|Withdrawal by Subject|0|||
126523178|NCT00941603|455208248|FG005|Overall Study|Withdrawal by Subject|1|||
126523179|NCT00941603|455208243|FG000|Overall Study|Protocol Violation|0|||
126523180|NCT00941603|455208244|FG001|Overall Study|Protocol Violation|1|||
126523181|NCT00941603|455208245|FG002|Overall Study|Protocol Violation|0|||
126523182|NCT00941603|455208246|FG003|Overall Study|Protocol Violation|0|||
126523183|NCT00941603|455208247|FG004|Overall Study|Protocol Violation|0|||
126523184|NCT00941603|455208248|FG005|Overall Study|Protocol Violation|0|||
126523185|NCT00941603|455208243|FG000|Overall Study|Did not meet protocol eligibility|1|||
126523186|NCT00941603|455208244|FG001|Overall Study|Did not meet protocol eligibility|0|||
126727400|NCT03655717|455951138|FG012|Overall Study|Lost to Follow-up|0|||
126727401|NCT03655717|455951139|FG013|Overall Study|Lost to Follow-up|0|||
126727402|NCT03655717|455951140|FG014|Overall Study|Lost to Follow-up|0|||
126523187|NCT00941603|455208245|FG002|Overall Study|Did not meet protocol eligibility|0|||
126523188|NCT00941603|455208246|FG003|Overall Study|Did not meet protocol eligibility|0|||
126523189|NCT00941603|455208247|FG004|Overall Study|Did not meet protocol eligibility|0|||
126523190|NCT00941603|455208248|FG005|Overall Study|Did not meet protocol eligibility|0|||
126523191|NCT02079805|455208249|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126574682|NCT02731755|455400965|FG001|First Intervention|Withdrawal by Subject|2|||
126574683|NCT04425629|455400966|FG000|Overall Study|Adverse Event|0|||
126574684|NCT04425629|455400967|FG001|Overall Study|Adverse Event|0|||
126574685|NCT04425629|455400968|FG002|Overall Study|Adverse Event|0|||
126574686|NCT04425629|455400969|FG003|Overall Study|Adverse Event|0|||
126574687|NCT04425629|455400970|FG004|Overall Study|Adverse Event|1|||
126574688|NCT04425629|455400971|FG005|Overall Study|Adverse Event|0|||
126574689|NCT04425629|455400972|FG006|Overall Study|Adverse Event|0|||
126574690|NCT04425629|455400973|FG007|Overall Study|Adverse Event|0|||
126574691|NCT04425629|455400974|FG008|Overall Study|Adverse Event|0|||
126574692|NCT04425629|455400975|FG009|Overall Study|Adverse Event|3|||
126574693|NCT04425629|455400976|FG010|Overall Study|Adverse Event|2|||
126574694|NCT04425629|455400977|FG011|Overall Study|Adverse Event|1|||
126574695|NCT04425629|455400978|FG012|Overall Study|Adverse Event|1|||
126574696|NCT04425629|455400979|FG013|Overall Study|Adverse Event|0|||
126574697|NCT04425629|455400980|FG014|Overall Study|Adverse Event|0|||
126574698|NCT04425629|455400981|FG015|Overall Study|Adverse Event|0|||
126574699|NCT04425629|455400982|FG016|Overall Study|Adverse Event|0|||
126574700|NCT04425629|455400983|FG017|Overall Study|Adverse Event|0|||
126574701|NCT04425629|455400984|FG018|Overall Study|Adverse Event|0|||
126574702|NCT04425629|455400966|FG000|Overall Study|Lost to Follow-up|1|||
126574703|NCT04425629|455400967|FG001|Overall Study|Lost to Follow-up|3|||
126574704|NCT04425629|455400968|FG002|Overall Study|Lost to Follow-up|1|||
126574705|NCT04425629|455400969|FG003|Overall Study|Lost to Follow-up|7|||
126574706|NCT04425629|455400970|FG004|Overall Study|Lost to Follow-up|1|||
126574707|NCT04425629|455400971|FG005|Overall Study|Lost to Follow-up|2|||
126574708|NCT04425629|455400972|FG006|Overall Study|Lost to Follow-up|1|||
126574709|NCT04425629|455400973|FG007|Overall Study|Lost to Follow-up|0|||
126574710|NCT04425629|455400974|FG008|Overall Study|Lost to Follow-up|1|||
126574711|NCT04425629|455400975|FG009|Overall Study|Lost to Follow-up|64|||
126574712|NCT04425629|455400976|FG010|Overall Study|Lost to Follow-up|70|||
126574713|NCT04425629|455400977|FG011|Overall Study|Lost to Follow-up|98|||
126574714|NCT04425629|455400978|FG012|Overall Study|Lost to Follow-up|30|||
126574715|NCT04425629|455400979|FG013|Overall Study|Lost to Follow-up|0|||
126574716|NCT04425629|455400980|FG014|Overall Study|Lost to Follow-up|5|||
126574717|NCT04425629|455400981|FG015|Overall Study|Lost to Follow-up|4|||
126574718|NCT04425629|455400982|FG016|Overall Study|Lost to Follow-up|0|||
126574719|NCT04425629|455400983|FG017|Overall Study|Lost to Follow-up|3|||
126574720|NCT04425629|455400984|FG018|Overall Study|Lost to Follow-up|1|||
126574721|NCT04425629|455400966|FG000|Overall Study|Subject Decision|0|||
126574722|NCT04425629|455400967|FG001|Overall Study|Subject Decision|2|||
126574723|NCT04425629|455400968|FG002|Overall Study|Subject Decision|1|||
126574724|NCT04425629|455400969|FG003|Overall Study|Subject Decision|3|||
126574725|NCT04425629|455400970|FG004|Overall Study|Subject Decision|6|||
126574726|NCT04425629|455400971|FG005|Overall Study|Subject Decision|6|||
126574727|NCT04425629|455400972|FG006|Overall Study|Subject Decision|3|||
126574728|NCT04425629|455400973|FG007|Overall Study|Subject Decision|3|||
126574729|NCT04425629|455400974|FG008|Overall Study|Subject Decision|1|||
126574730|NCT04425629|455400975|FG009|Overall Study|Subject Decision|70|||
126574731|NCT04425629|455400976|FG010|Overall Study|Subject Decision|95|||
126574732|NCT04425629|455400977|FG011|Overall Study|Subject Decision|124|||
126574733|NCT04425629|455400978|FG012|Overall Study|Subject Decision|25|||
126574734|NCT04425629|455400979|FG013|Overall Study|Subject Decision|0|||
126574735|NCT04425629|455400980|FG014|Overall Study|Subject Decision|1|||
126574736|NCT04425629|455400981|FG015|Overall Study|Subject Decision|4|||
126574737|NCT04425629|455400982|FG016|Overall Study|Subject Decision|1|||
126574738|NCT04425629|455400983|FG017|Overall Study|Subject Decision|0|||
126574739|NCT04425629|455400984|FG018|Overall Study|Subject Decision|2|||
126574740|NCT04425629|455400966|FG000|Overall Study|Death|0|||
126574741|NCT04425629|455400967|FG001|Overall Study|Death|0|||
126574742|NCT04425629|455400968|FG002|Overall Study|Death|0|||
126574743|NCT04425629|455400969|FG003|Overall Study|Death|0|||
126574744|NCT04425629|455400970|FG004|Overall Study|Death|0|||
126574745|NCT04425629|455400971|FG005|Overall Study|Death|0|||
126574746|NCT04425629|455400972|FG006|Overall Study|Death|0|||
126574747|NCT04425629|455400973|FG007|Overall Study|Death|0|||
126574748|NCT04425629|455400974|FG008|Overall Study|Death|0|||
126574749|NCT04425629|455400975|FG009|Overall Study|Death|11|||
126574750|NCT04425629|455400976|FG010|Overall Study|Death|2|||
126574751|NCT04425629|455400977|FG011|Overall Study|Death|4|||
126574752|NCT04425629|455400978|FG012|Overall Study|Death|0|||
126574753|NCT04425629|455400979|FG013|Overall Study|Death|0|||
126574754|NCT04425629|455400980|FG014|Overall Study|Death|0|||
126574755|NCT04425629|455400981|FG015|Overall Study|Death|0|||
126574756|NCT04425629|455400982|FG016|Overall Study|Death|0|||
126574757|NCT04425629|455400983|FG017|Overall Study|Death|0|||
126574758|NCT04425629|455400984|FG018|Overall Study|Death|0|||
126574759|NCT04425629|455400966|FG000|Overall Study|Sponsor Request|0|||
126574760|NCT04425629|455400967|FG001|Overall Study|Sponsor Request|0|||
126574761|NCT04425629|455400968|FG002|Overall Study|Sponsor Request|0|||
126574762|NCT04425629|455400969|FG003|Overall Study|Sponsor Request|2|||
126574763|NCT04425629|455400970|FG004|Overall Study|Sponsor Request|2|||
126574764|NCT04425629|455400971|FG005|Overall Study|Sponsor Request|2|||
126574765|NCT04425629|455400972|FG006|Overall Study|Sponsor Request|1|||
126574766|NCT04425629|455400973|FG007|Overall Study|Sponsor Request|0|||
126574767|NCT04425629|455400974|FG008|Overall Study|Sponsor Request|0|||
126574768|NCT04425629|455400975|FG009|Overall Study|Sponsor Request|9|||
126574769|NCT04425629|455400976|FG010|Overall Study|Sponsor Request|9|||
126574770|NCT04425629|455400977|FG011|Overall Study|Sponsor Request|10|||
126574771|NCT04425629|455400978|FG012|Overall Study|Sponsor Request|8|||
126574772|NCT04425629|455400979|FG013|Overall Study|Sponsor Request|0|||
126574773|NCT04425629|455400980|FG014|Overall Study|Sponsor Request|0|||
126574774|NCT04425629|455400981|FG015|Overall Study|Sponsor Request|1|||
126574775|NCT04425629|455400982|FG016|Overall Study|Sponsor Request|0|||
126574776|NCT04425629|455400983|FG017|Overall Study|Sponsor Request|0|||
126574777|NCT04425629|455400984|FG018|Overall Study|Sponsor Request|0|||
126574778|NCT04425629|455400966|FG000|Overall Study|Physician Decision|0|||
126574779|NCT04425629|455400967|FG001|Overall Study|Physician Decision|0|||
126574780|NCT04425629|455400968|FG002|Overall Study|Physician Decision|0|||
126574781|NCT04425629|455400969|FG003|Overall Study|Physician Decision|0|||
126574782|NCT04425629|455400970|FG004|Overall Study|Physician Decision|0|||
126574783|NCT04425629|455400971|FG005|Overall Study|Physician Decision|0|||
126574784|NCT04425629|455400972|FG006|Overall Study|Physician Decision|0|||
126574785|NCT04425629|455400973|FG007|Overall Study|Physician Decision|0|||
126574786|NCT04425629|455400974|FG008|Overall Study|Physician Decision|0|||
126523192|NCT02079805|455208250|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
126574787|NCT04425629|455400975|FG009|Overall Study|Physician Decision|4|||
126574788|NCT04425629|455400976|FG010|Overall Study|Physician Decision|3|||
126574789|NCT04425629|455400977|FG011|Overall Study|Physician Decision|5|||
126574790|NCT04425629|455400978|FG012|Overall Study|Physician Decision|1|||
126574791|NCT04425629|455400979|FG013|Overall Study|Physician Decision|0|||
126574792|NCT04425629|455400980|FG014|Overall Study|Physician Decision|0|||
126523193|NCT02079805|455208249|FG000|Overall Study|Voluntary Withdrawal|0|||
126523194|NCT02079805|455208250|FG001|Overall Study|Voluntary Withdrawal|1|||
126523195|NCT02014116|455208251|FG000|Overall Study|Progressive Disease|3|||
126523196|NCT02014116|455208252|FG001|Overall Study|Progressive Disease|4|||
126523197|NCT02014116|455208253|FG002|Overall Study|Progressive Disease|2|||
126523198|NCT02014116|455208254|FG003|Overall Study|Progressive Disease|6|||
126523199|NCT02014116|455208255|FG004|Overall Study|Progressive Disease|1|||
126523200|NCT02014116|455208256|FG005|Overall Study|Progressive Disease|13|||
126523201|NCT02014116|455208257|FG006|Overall Study|Progressive Disease|1|||
126523202|NCT02014116|455208258|FG007|Overall Study|Progressive Disease|3|||
126523203|NCT02014116|455208259|FG008|Overall Study|Progressive Disease|7|||
126523204|NCT02014116|455208251|FG000|Overall Study|Adverse Event|0|||
126523205|NCT02014116|455208252|FG001|Overall Study|Adverse Event|0|||
126523206|NCT02014116|455208253|FG002|Overall Study|Adverse Event|0|||
126523207|NCT02014116|455208254|FG003|Overall Study|Adverse Event|0|||
126523208|NCT02014116|455208255|FG004|Overall Study|Adverse Event|1|||
126523209|NCT02014116|455208256|FG005|Overall Study|Adverse Event|0|||
126523210|NCT02014116|455208257|FG006|Overall Study|Adverse Event|0|||
126523211|NCT02014116|455208258|FG007|Overall Study|Adverse Event|1|||
126523212|NCT02014116|455208259|FG008|Overall Study|Adverse Event|0|||
126523213|NCT02014116|455208251|FG000|Overall Study|Lost to Follow-up|0|||
126523214|NCT02014116|455208252|FG001|Overall Study|Lost to Follow-up|0|||
126523215|NCT02014116|455208253|FG002|Overall Study|Lost to Follow-up|0|||
126523216|NCT02014116|455208254|FG003|Overall Study|Lost to Follow-up|0|||
126523217|NCT02014116|455208255|FG004|Overall Study|Lost to Follow-up|0|||
126523218|NCT02014116|455208256|FG005|Overall Study|Lost to Follow-up|1|||
126523219|NCT02014116|455208257|FG006|Overall Study|Lost to Follow-up|0|||
126523220|NCT02014116|455208258|FG007|Overall Study|Lost to Follow-up|0|||
126523221|NCT02014116|455208259|FG008|Overall Study|Lost to Follow-up|1|||
126523222|NCT02014116|455208251|FG000|Overall Study|Death|0|||
126523223|NCT02014116|455208252|FG001|Overall Study|Death|0|||
126523224|NCT02014116|455208253|FG002|Overall Study|Death|0|||
126523225|NCT02014116|455208254|FG003|Overall Study|Death|0|||
126523226|NCT02014116|455208255|FG004|Overall Study|Death|0|||
126523227|NCT02014116|455208256|FG005|Overall Study|Death|0|||
126523228|NCT02014116|455208257|FG006|Overall Study|Death|0|||
126523229|NCT02014116|455208258|FG007|Overall Study|Death|1|||
126523230|NCT02014116|455208259|FG008|Overall Study|Death|1|||
126523231|NCT02014116|455208251|FG000|Overall Study|Withdrawal by Subject|0|||
126523232|NCT02014116|455208252|FG001|Overall Study|Withdrawal by Subject|0|||
126523233|NCT02014116|455208253|FG002|Overall Study|Withdrawal by Subject|1|||
126523234|NCT02014116|455208254|FG003|Overall Study|Withdrawal by Subject|1|||
126523235|NCT02014116|455208255|FG004|Overall Study|Withdrawal by Subject|0|||
126523236|NCT02014116|455208256|FG005|Overall Study|Withdrawal by Subject|1|||
126523237|NCT02014116|455208257|FG006|Overall Study|Withdrawal by Subject|0|||
126574793|NCT04425629|455400981|FG015|Overall Study|Physician Decision|1|||
126574794|NCT04425629|455400982|FG016|Overall Study|Physician Decision|0|||
126523238|NCT02014116|455208258|FG007|Overall Study|Withdrawal by Subject|0|||
126523239|NCT02014116|455208259|FG008|Overall Study|Withdrawal by Subject|0|||
126523240|NCT02014116|455208251|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
126523241|NCT02014116|455208252|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
126574795|NCT04425629|455400983|FG017|Overall Study|Physician Decision|0|||
126523242|NCT02014116|455208253|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
126523243|NCT02014116|455208254|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
126523244|NCT02014116|455208255|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
126523245|NCT02014116|455208256|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
126523246|NCT02014116|455208257|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
126523247|NCT02014116|455208258|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
126523248|NCT02014116|455208259|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
126523249|NCT02014116|455208251|FG000|Overall Study|Physician Decision|0|||
126523250|NCT02014116|455208252|FG001|Overall Study|Physician Decision|0|||
126523251|NCT02014116|455208253|FG002|Overall Study|Physician Decision|0|||
126523252|NCT02014116|455208254|FG003|Overall Study|Physician Decision|0|||
126523253|NCT02014116|455208255|FG004|Overall Study|Physician Decision|0|||
126523254|NCT02014116|455208256|FG005|Overall Study|Physician Decision|0|||
126523255|NCT02014116|455208257|FG006|Overall Study|Physician Decision|0|||
126523256|NCT02014116|455208258|FG007|Overall Study|Physician Decision|0|||
126523257|NCT02014116|455208259|FG008|Overall Study|Physician Decision|1|||
126523258|NCT02347761|455208260|FG000|All Collected|Death|1|||
126523259|NCT02347761|455208261|FG001|All Collected|Death|0|||
126523260|NCT02347761|455208262|FG002|All Collected|Death|0|||
126523261|NCT02347761|455208260|FG000|All Collected|Lost to Follow-up|3|||
126523262|NCT02347761|455208261|FG001|All Collected|Lost to Follow-up|2|||
126523263|NCT02347761|455208262|FG002|All Collected|Lost to Follow-up|3|||
126523264|NCT02347761|455208260|FG000|All Collected|Withdrawal by Subject|11|||
126523265|NCT02347761|455208261|FG001|All Collected|Withdrawal by Subject|11|||
126523266|NCT02347761|455208262|FG002|All Collected|Withdrawal by Subject|22|||
126523267|NCT02347761|455208260|FG000|All Collected|invetigator disretion|2|||
126523268|NCT02347761|455208261|FG001|All Collected|invetigator disretion|0|||
126523269|NCT02347761|455208262|FG002|All Collected|invetigator disretion|0|||
126523270|NCT02347761|455208260|FG000|All Collected|instillation site pain|0|||
126523271|NCT02347761|455208261|FG001|All Collected|instillation site pain|0|||
126523272|NCT02347761|455208262|FG002|All Collected|instillation site pain|1|||
126523273|NCT02347761|455208260|FG000|All Collected|exacerbation of COPD|0|||
126523274|NCT02347761|455208261|FG001|All Collected|exacerbation of COPD|0|||
126523275|NCT02347761|455208262|FG002|All Collected|exacerbation of COPD|1|||
126523276|NCT02347761|455208260|FG000|All Collected|moved/travel|0|||
126523277|NCT02347761|455208261|FG001|All Collected|moved/travel|1|||
126523278|NCT02347761|455208262|FG002|All Collected|moved/travel|0|||
126523279|NCT02347761|455208260|FG000|On Study Treatment|Lack of Efficacy|2|||
126523280|NCT02347761|455208261|FG001|On Study Treatment|Lack of Efficacy|3|||
126523281|NCT02347761|455208262|FG002|On Study Treatment|Lack of Efficacy|4|||
126523282|NCT02347761|455208260|FG000|On Study Treatment|non-compliance with study medication|0|||
126523283|NCT02347761|455208261|FG001|On Study Treatment|non-compliance with study medication|0|||
126523284|NCT02347761|455208262|FG002|On Study Treatment|non-compliance with study medication|2|||
126523285|NCT02347761|455208260|FG000|On Study Treatment|Withdrawal by Subject|7|||
126523286|NCT02347761|455208261|FG001|On Study Treatment|Withdrawal by Subject|3|||
126523287|NCT02347761|455208262|FG002|On Study Treatment|Withdrawal by Subject|5|||
126523288|NCT02347761|455208260|FG000|On Study Treatment|move/travel|2|||
126523289|NCT02347761|455208261|FG001|On Study Treatment|move/travel|6|||
126523290|NCT02347761|455208262|FG002|On Study Treatment|move/travel|5|||
126523291|NCT02347761|455208260|FG000|On Study Treatment|dissastisfaction with device|2|||
126523292|NCT02347761|455208261|FG001|On Study Treatment|dissastisfaction with device|1|||
126523293|NCT02347761|455208262|FG002|On Study Treatment|dissastisfaction with device|4|||
126523294|NCT02347761|455208260|FG000|On Study Treatment|Lost to Follow-up|2|||
126523295|NCT02347761|455208261|FG001|On Study Treatment|Lost to Follow-up|1|||
126523296|NCT02347761|455208262|FG002|On Study Treatment|Lost to Follow-up|1|||
126523297|NCT02347761|455208260|FG000|On Study Treatment|investigator discretion|2|||
126523298|NCT02347761|455208261|FG001|On Study Treatment|investigator discretion|0|||
126523299|NCT02347761|455208262|FG002|On Study Treatment|investigator discretion|0|||
126523300|NCT02347761|455208260|FG000|On Study Treatment|durg not working|0|||
126523301|NCT02347761|455208261|FG001|On Study Treatment|durg not working|1|||
126523302|NCT02347761|455208262|FG002|On Study Treatment|durg not working|1|||
126523303|NCT02347761|455208260|FG000|On Study Treatment|Adverse Event|10|||
126523304|NCT02347761|455208261|FG001|On Study Treatment|Adverse Event|8|||
126523305|NCT02347761|455208262|FG002|On Study Treatment|Adverse Event|20|||
126574796|NCT04425629|455400984|FG018|Overall Study|Physician Decision|0|||
126574797|NCT04425629|455400966|FG000|Overall Study|Lack of Efficacy|0|||
126523306|NCT03879798|455208263|FG000|Overall Study|Adverse Event|0|||
126523307|NCT03879798|455208264|FG001|Overall Study|Adverse Event|0|||
126523308|NCT03879798|455208265|FG002|Overall Study|Adverse Event|0|||
126523309|NCT03879798|455208266|FG003|Overall Study|Adverse Event|0|||
126523310|NCT03879798|455208267|FG004|Overall Study|Adverse Event|0|||
126523311|NCT03879798|455208268|FG005|Overall Study|Adverse Event|1|||
126523312|NCT03879798|455208263|FG000|Overall Study|Lack of Efficacy|0|||
126523313|NCT03879798|455208264|FG001|Overall Study|Lack of Efficacy|0|||
126523314|NCT03879798|455208265|FG002|Overall Study|Lack of Efficacy|0|||
126523315|NCT03879798|455208266|FG003|Overall Study|Lack of Efficacy|0|||
126523316|NCT03879798|455208267|FG004|Overall Study|Lack of Efficacy|0|||
126523317|NCT03879798|455208268|FG005|Overall Study|Lack of Efficacy|1|||
126523318|NCT03879798|455208263|FG000|Overall Study|Withdrawal by Subject|0|||
126523319|NCT03879798|455208264|FG001|Overall Study|Withdrawal by Subject|0|||
126523320|NCT03879798|455208265|FG002|Overall Study|Withdrawal by Subject|0|||
126523321|NCT03879798|455208266|FG003|Overall Study|Withdrawal by Subject|0|||
126523322|NCT03879798|455208267|FG004|Overall Study|Withdrawal by Subject|0|||
126523323|NCT03879798|455208268|FG005|Overall Study|Withdrawal by Subject|1|||
126523324|NCT03625570|455208269|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
126523325|NCT03625570|455208270|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
126523326|NCT03625570|455208269|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
126523327|NCT03625570|455208270|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
126523328|NCT03625570|455208269|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
126523329|NCT03625570|455208270|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
126523330|NCT01040130|455208278|FG000|Overall Study|Adverse Event|1|||
126523331|NCT01040130|455208279|FG001|Overall Study|Adverse Event|1|||
126523332|NCT01040130|455208280|FG002|Overall Study|Adverse Event|0|||
126523333|NCT01040130|455208281|FG003|Overall Study|Adverse Event|5|||
126523334|NCT01040130|455208282|FG004|Overall Study|Adverse Event|0|||
126523335|NCT01040130|455208283|FG005|Overall Study|Adverse Event|3|||
126523336|NCT01040130|455208278|FG000|Overall Study|Protocol Violation|0|||
126523337|NCT01040130|455208279|FG001|Overall Study|Protocol Violation|0|||
126523338|NCT01040130|455208280|FG002|Overall Study|Protocol Violation|2|||
126523339|NCT01040130|455208281|FG003|Overall Study|Protocol Violation|0|||
126523340|NCT01040130|455208282|FG004|Overall Study|Protocol Violation|0|||
126523341|NCT01040130|455208283|FG005|Overall Study|Protocol Violation|0|||
126523342|NCT01040130|455208278|FG000|Overall Study|Withdrawal by Subject|0|||
126523343|NCT01040130|455208279|FG001|Overall Study|Withdrawal by Subject|2|||
126523344|NCT01040130|455208280|FG002|Overall Study|Withdrawal by Subject|0|||
126523345|NCT01040130|455208281|FG003|Overall Study|Withdrawal by Subject|0|||
126523346|NCT01040130|455208282|FG004|Overall Study|Withdrawal by Subject|0|||
126523347|NCT01040130|455208283|FG005|Overall Study|Withdrawal by Subject|1|||
126523348|NCT01040130|455208278|FG000|Overall Study|Other reasons not listed above|2|||
126523349|NCT01040130|455208279|FG001|Overall Study|Other reasons not listed above|0|||
126523350|NCT01040130|455208280|FG002|Overall Study|Other reasons not listed above|0|||
126523351|NCT01040130|455208281|FG003|Overall Study|Other reasons not listed above|0|||
126523352|NCT01040130|455208282|FG004|Overall Study|Other reasons not listed above|0|||
126523353|NCT01040130|455208283|FG005|Overall Study|Other reasons not listed above|0|||
126523354|NCT00096135|455208289|FG000|Overall Study|Physician Decision|20|||
126523355|NCT00096135|455208290|FG001|Overall Study|Physician Decision|4|||
126523356|NCT00096135|455208289|FG000|Overall Study|Refusal of further protocol therapy|4|||
126523357|NCT00096135|455208290|FG001|Overall Study|Refusal of further protocol therapy|1|||
126523358|NCT00096135|455208289|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
126523359|NCT00096135|455208290|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
126523360|NCT00096135|455208289|FG000|Overall Study|Other, specify|15|||
126523361|NCT00096135|455208290|FG001|Overall Study|Other, specify|3|||
126523362|NCT00096135|455208289|FG000|Overall Study|Ineligible|2|||
126523363|NCT00096135|455208290|FG001|Overall Study|Ineligible|0|||
126523364|NCT01568047|455208292|FG000|Overall Study|Ineligibility|1|||
126523365|NCT01568047|455208293|FG001|Overall Study|Ineligibility|0|||
126523366|NCT01568047|455208294|FG002|Overall Study|Ineligibility|0|||
126523367|NCT01568047|455208295|FG003|Overall Study|Ineligibility|0|||
126523368|NCT01568047|455208292|FG000|Overall Study|Withdrawal by Subject|0|||
126523369|NCT01568047|455208293|FG001|Overall Study|Withdrawal by Subject|1|||
126523370|NCT01568047|455208294|FG002|Overall Study|Withdrawal by Subject|0|||
126523371|NCT01568047|455208295|FG003|Overall Study|Withdrawal by Subject|0|||
126523372|NCT01568047|455208292|FG000|Overall Study|Adverse Event|0|||
126523373|NCT01568047|455208293|FG001|Overall Study|Adverse Event|0|||
126523374|NCT01568047|455208294|FG002|Overall Study|Adverse Event|1|||
126523375|NCT01568047|455208295|FG003|Overall Study|Adverse Event|1|||
126523376|NCT00874029|455208296|FG000|Overall Study|Withdrawal by Subject|10|||
126523377|NCT00874029|455208296|FG000|Overall Study|Pregnancy|4|||
126523378|NCT00874029|455208296|FG000|Overall Study|Physician Decision|1|||
126523379|NCT00874029|455208296|FG000|Overall Study|Adverse Event|1|||
126523380|NCT00874029|455208296|FG000|Overall Study|Lost to Follow-up|5|||
126523381|NCT03359096|455208297|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
126523382|NCT03359096|455208298|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
126523383|NCT03359096|455208297|FG000|First Intervention (4 Weeks)|Death|1|||
126523384|NCT03359096|455208298|FG001|First Intervention (4 Weeks)|Death|0|||
126523385|NCT03359096|455208297|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
126523386|NCT03359096|455208298|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
126523387|NCT00499889|455208309|FG000|Overall Study|Infection prior to treatment|1|||
126523388|NCT00142909|455208313|FG000|Randomization|Various Reasons|7|||
126523389|NCT00142909|455208314|FG001|Randomization|Various Reasons|10|||
126523390|NCT00142909|455208313|FG000|Medications Begin|Protocol Violation|2|||
126523391|NCT00142909|455208314|FG001|Medications Begin|Protocol Violation|0|||
126574798|NCT04425629|455400967|FG001|Overall Study|Lack of Efficacy|0|||
126574799|NCT04425629|455400968|FG002|Overall Study|Lack of Efficacy|0|||
126574800|NCT04425629|455400969|FG003|Overall Study|Lack of Efficacy|0|||
126574801|NCT04425629|455400970|FG004|Overall Study|Lack of Efficacy|0|||
126574802|NCT04425629|455400971|FG005|Overall Study|Lack of Efficacy|0|||
126574803|NCT04425629|455400972|FG006|Overall Study|Lack of Efficacy|0|||
126574804|NCT04425629|455400973|FG007|Overall Study|Lack of Efficacy|0|||
126574805|NCT04425629|455400974|FG008|Overall Study|Lack of Efficacy|0|||
126574806|NCT04425629|455400975|FG009|Overall Study|Lack of Efficacy|0|||
126574807|NCT04425629|455400976|FG010|Overall Study|Lack of Efficacy|1|||
126574808|NCT04425629|455400977|FG011|Overall Study|Lack of Efficacy|0|||
126574809|NCT04425629|455400978|FG012|Overall Study|Lack of Efficacy|0|||
126574810|NCT04425629|455400979|FG013|Overall Study|Lack of Efficacy|0|||
126574811|NCT04425629|455400980|FG014|Overall Study|Lack of Efficacy|0|||
126574812|NCT04425629|455400981|FG015|Overall Study|Lack of Efficacy|0|||
126574813|NCT04425629|455400982|FG016|Overall Study|Lack of Efficacy|0|||
126574814|NCT04425629|455400983|FG017|Overall Study|Lack of Efficacy|0|||
126574815|NCT04425629|455400984|FG018|Overall Study|Lack of Efficacy|0|||
126574816|NCT04218110|455400985|FG000|Overall Study|Withdrawal by Subject|0|||
126574817|NCT04218110|455400986|FG001|Overall Study|Withdrawal by Subject|0|||
126574818|NCT04218110|455400987|FG002|Overall Study|Withdrawal by Subject|0|||
126574819|NCT04218110|455400988|FG003|Overall Study|Withdrawal by Subject|1|||
126574820|NCT00414544|455400991|FG000|Overall Study|Lost to Follow-up|14|||
126574821|NCT00799396|455400993|FG000|Clopidogrel Treatment|Adverse Event|6|||
126574822|NCT00799396|455400993|FG000|Clopidogrel Treatment|Physician Decision|5|||
126574823|NCT00799396|455400993|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
126574824|NCT00799396|455400993|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
126574825|NCT00799396|455400993|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
126574826|NCT02271854|455400994|FG000|Overall Study|Withdrawal by Subject|2|||
126574827|NCT02271854|455400994|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
126574828|NCT02271854|455400994|FG000|Overall Study|Lost to Follow-up|1|||
126574829|NCT01236001|455400997|FG000|Overall Study|Adverse Event|5|||
126574830|NCT01236001|455400998|FG001|Overall Study|Adverse Event|14|||
126574831|NCT01236001|455400997|FG000|Overall Study|Lack of Efficacy|6|||
126574832|NCT01236001|455400998|FG001|Overall Study|Lack of Efficacy|6|||
126574833|NCT01236001|455400997|FG000|Overall Study|Lost to Follow-up|6|||
126574834|NCT01236001|455400998|FG001|Overall Study|Lost to Follow-up|1|||
126574835|NCT01236001|455400997|FG000|Overall Study|Incompliance|1|||
126574836|NCT01236001|455400998|FG001|Overall Study|Incompliance|0|||
126574837|NCT01236001|455400997|FG000|Overall Study|Planned Visit After End of Study|0|||
126574838|NCT01236001|455400998|FG001|Overall Study|Planned Visit After End of Study|1|||
126574839|NCT01943916|455401000|FG000|Overall Study|Technically invalid images|10|||
126574840|NCT01943916|455401000|FG000|Overall Study|Enrollment Failure|23|||
126574841|NCT01943916|455401000|FG000|Overall Study|Pilot Phase exclusion|100|||
126574842|NCT01943916|455401000|FG000|Overall Study|Quality Assurance Reader Fail|130|||
126574843|NCT01943916|455401000|FG000|Overall Study|Technical Failure|39|||
126574844|NCT01943916|455401000|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
126574845|NCT01943916|455401000|FG000|Overall Study|No Truth Panel Review|38|||
126574846|NCT01943916|455401000|FG000|Overall Study|Protocol Deviation|1|||
126574847|NCT05782231|455401001|FG000|Overall Study|Withdrawal by Subject|1|||
126574848|NCT05274217|455401002|FG000|Overall Study|Study terminated.|11|||
126574849|NCT05274217|455401003|FG001|Overall Study|Study terminated.|0|||
126574850|NCT05609032|455401006|FG000|Overall Study|Lost to Follow-up|3|||
126574851|NCT05609032|455401007|FG001|Overall Study|Lost to Follow-up|1|||
126574852|NCT05609032|455401006|FG000|Overall Study|Withdrawal by Subject|1|||
126574853|NCT05609032|455401007|FG001|Overall Study|Withdrawal by Subject|0|||
126574854|NCT01373346|455401011|FG000|Overall Study|Death|1|||
126574855|NCT01395758|455401013|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
126574856|NCT01395758|455401014|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
126574857|NCT01395758|455401015|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
126574858|NCT00433199|455401016|FG000|Double-Blind Period|Adverse Event|0|||
126727403|NCT03655717|455951141|FG015|Overall Study|Lost to Follow-up|0|||
126574859|NCT00433199|455401017|FG001|Double-Blind Period|Adverse Event|25|||
126574860|NCT00433199|455401016|FG000|Double-Blind Period|Lack of Efficacy|0|||
126574861|NCT00433199|455401017|FG001|Double-Blind Period|Lack of Efficacy|2|||
126574862|NCT00433199|455401016|FG000|Double-Blind Period|Lost to Follow-up|2|||
126574863|NCT00433199|455401017|FG001|Double-Blind Period|Lost to Follow-up|5|||
126574864|NCT00433199|455401016|FG000|Double-Blind Period|Withdrawal by Subject|8|||
126574865|NCT00433199|455401017|FG001|Double-Blind Period|Withdrawal by Subject|19|||
126574866|NCT00433199|455401016|FG000|Double-Blind Period|Protocol Violation|1|||
126574867|NCT00433199|455401017|FG001|Double-Blind Period|Protocol Violation|10|||
126574868|NCT00433199|455401016|FG000|Double-Blind Period|Administrative|1|||
126574869|NCT00433199|455401017|FG001|Double-Blind Period|Administrative|5|||
126574870|NCT00433199|455401016|FG000|Open-Label Period|Adverse Event|0|||
126574871|NCT00433199|455401017|FG001|Open-Label Period|Adverse Event|19|||
126574872|NCT00433199|455401016|FG000|Open-Label Period|Lack of Efficacy|0|||
126574873|NCT00433199|455401017|FG001|Open-Label Period|Lack of Efficacy|2|||
126727404|NCT03655717|455951142|FG016|Overall Study|Lost to Follow-up|0|||
126574874|NCT00433199|455401016|FG000|Open-Label Period|Lost to Follow-up|0|||
126574875|NCT00433199|455401017|FG001|Open-Label Period|Lost to Follow-up|3|||
126574876|NCT00433199|455401016|FG000|Open-Label Period|Withdrawal by Subject|0|||
126574877|NCT00433199|455401017|FG001|Open-Label Period|Withdrawal by Subject|7|||
126574878|NCT00433199|455401016|FG000|Open-Label Period|Protocol Violation|0|||
126574879|NCT00433199|455401017|FG001|Open-Label Period|Protocol Violation|2|||
126574880|NCT00433199|455401016|FG000|Open-Label Period|Administrative|0|||
126574881|NCT00433199|455401017|FG001|Open-Label Period|Administrative|1|||
126574882|NCT00357097|455401018|FG000|Overall Study|Did not meet inclusion criteria|5|||
126574883|NCT00357097|455401019|FG001|Overall Study|Did not meet inclusion criteria|3|||
126574884|NCT00357097|455401018|FG000|Overall Study|Adverse Event|34|||
126574885|NCT00357097|455401019|FG001|Overall Study|Adverse Event|6|||
126574886|NCT00357097|455401018|FG000|Overall Study|Withdrawal by Subject|8|||
126574887|NCT00357097|455401019|FG001|Overall Study|Withdrawal by Subject|7|||
126574888|NCT00357097|455401018|FG000|Overall Study|Non-compliance|1|||
126574889|NCT00357097|455401019|FG001|Overall Study|Non-compliance|2|||
126574890|NCT00357097|455401018|FG000|Overall Study|Lack of Efficacy|2|||
126574891|NCT00357097|455401019|FG001|Overall Study|Lack of Efficacy|8|||
126574892|NCT00357097|455401018|FG000|Overall Study|Met Exclusion Criteria|3|||
126574893|NCT00357097|455401019|FG001|Overall Study|Met Exclusion Criteria|1|||
126574894|NCT00357097|455401018|FG000|Overall Study|Other|1|||
126574895|NCT00357097|455401019|FG001|Overall Study|Other|1|||
126574896|NCT00357097|455401018|FG000|Overall Study|Increase of RLS Symptoms|0|||
126574897|NCT00357097|455401019|FG001|Overall Study|Increase of RLS Symptoms|1|||
126574898|NCT00794118|455401020|FG000|Overall Study|Lost to Follow-up|16|||
126574899|NCT00794118|455401020|FG000|Overall Study|Withdrawal by Subject|9|||
126574900|NCT00794118|455401020|FG000|Overall Study|Changed hospital center|2|||
126574901|NCT04305405|455401021|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126574902|NCT04305405|455401022|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126574903|NCT00529659|455401023|FG000|Overall Study|Adverse Event|8|||
126574904|NCT00529659|455401024|FG001|Overall Study|Adverse Event|7|||
126574905|NCT00529659|455401023|FG000|Overall Study|Lost to Follow-up|0|||
126574906|NCT00529659|455401024|FG001|Overall Study|Lost to Follow-up|2|||
126574907|NCT00529659|455401023|FG000|Overall Study|Physician Decision|0|||
126574908|NCT00529659|455401024|FG001|Overall Study|Physician Decision|2|||
126574909|NCT00529659|455401023|FG000|Overall Study|Protocol Violation|2|||
126574910|NCT00529659|455401024|FG001|Overall Study|Protocol Violation|6|||
126574911|NCT00529659|455401023|FG000|Overall Study|Withdrawal by Subject|1|||
126574912|NCT00529659|455401024|FG001|Overall Study|Withdrawal by Subject|6|||
126574913|NCT01170962|455401026|FG000|Treatment Period|Lack of Efficacy|96|||
126574914|NCT01170962|455401027|FG001|Treatment Period|Lack of Efficacy|91|||
126574915|NCT01170962|455401028|FG002|Treatment Period|Lack of Efficacy|7|||
126574916|NCT01170962|455401026|FG000|Treatment Period|Adverse Event|11|||
126574917|NCT01170962|455401027|FG001|Treatment Period|Adverse Event|12|||
126574918|NCT01170962|455401028|FG002|Treatment Period|Adverse Event|3|||
126574919|NCT01170962|455401026|FG000|Treatment Period|Withdrawal by Subject|2|||
126574920|NCT01170962|455401027|FG001|Treatment Period|Withdrawal by Subject|1|||
126574921|NCT01170962|455401028|FG002|Treatment Period|Withdrawal by Subject|0|||
126574922|NCT01170962|455401026|FG000|Treatment Period|Lost to Follow-up|1|||
126574923|NCT01170962|455401027|FG001|Treatment Period|Lost to Follow-up|1|||
126574924|NCT01170962|455401028|FG002|Treatment Period|Lost to Follow-up|1|||
126574925|NCT01170962|455401026|FG000|Treatment Period|Participant no longer meets criteria|0|||
126574926|NCT01170962|455401027|FG001|Treatment Period|Participant no longer meets criteria|1|||
126574927|NCT01170962|455401028|FG002|Treatment Period|Participant no longer meets criteria|0|||
126574928|NCT01170962|455401026|FG000|Treatment Period|Request to discontinue treatment|7|||
126574929|NCT01170962|455401027|FG001|Treatment Period|Request to discontinue treatment|3|||
126574930|NCT01170962|455401028|FG002|Treatment Period|Request to discontinue treatment|1|||
126574931|NCT01170962|455401026|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
126574932|NCT01170962|455401027|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
126574933|NCT01170962|455401028|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
126574934|NCT01170962|455401026|FG000|Follow up Period|Withdrawal by Subject|14|||
126727405|NCT03655717|455951143|FG017|Overall Study|Lost to Follow-up|0|||
126727406|NCT03655717|455951144|FG018|Overall Study|Lost to Follow-up|0|||
126727407|NCT03655717|455951145|FG019|Overall Study|Lost to Follow-up|0|||
126574935|NCT01170962|455401027|FG001|Follow up Period|Withdrawal by Subject|10|||
126574936|NCT01170962|455401028|FG002|Follow up Period|Withdrawal by Subject|2|||
126574937|NCT01170962|455401026|FG000|Follow up Period|Lost to Follow-up|13|||
126574938|NCT01170962|455401027|FG001|Follow up Period|Lost to Follow-up|8|||
126574939|NCT01170962|455401028|FG002|Follow up Period|Lost to Follow-up|1|||
126574940|NCT01170962|455401026|FG000|Follow up Period|Death|2|||
126574941|NCT01170962|455401027|FG001|Follow up Period|Death|2|||
126574942|NCT01170962|455401028|FG002|Follow up Period|Death|0|||
126574943|NCT01170962|455401026|FG000|Follow up Period|Others|10|||
126574944|NCT01170962|455401027|FG001|Follow up Period|Others|7|||
126574945|NCT01170962|455401028|FG002|Follow up Period|Others|3|||
126727408|NCT03655717|455951146|FG020|Overall Study|Lost to Follow-up|0|||
126574946|NCT03887650|455401029|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
126574947|NCT03887650|455401030|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
126574948|NCT03887650|455401029|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
126574949|NCT03887650|455401030|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
126574950|NCT03887650|455401029|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
126574951|NCT03887650|455401030|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
126574952|NCT03512756|455401037|FG000|Part 1|Death|23|||
126574953|NCT03512756|455401038|FG001|Part 1|Death|18|||
126574954|NCT03512756|455401039|FG002|Part 1|Death|0|||
126574955|NCT03512756|455401040|FG003|Part 1|Death|0|||
126574956|NCT03512756|455401037|FG000|Part 1|Lost to Follow-up|0|||
126574957|NCT03512756|455401038|FG001|Part 1|Lost to Follow-up|3|||
126574958|NCT03512756|455401039|FG002|Part 1|Lost to Follow-up|0|||
126574959|NCT03512756|455401040|FG003|Part 1|Lost to Follow-up|0|||
126574960|NCT03512756|455401037|FG000|Part 1|Physician Decision|0|||
126574961|NCT03512756|455401038|FG001|Part 1|Physician Decision|1|||
126574962|NCT03512756|455401039|FG002|Part 1|Physician Decision|0|||
126574963|NCT03512756|455401040|FG003|Part 1|Physician Decision|0|||
126574964|NCT03512756|455401037|FG000|Part 1|Withdrawal by Subject|2|||
126574965|NCT03512756|455401038|FG001|Part 1|Withdrawal by Subject|2|||
126574966|NCT03512756|455401039|FG002|Part 1|Withdrawal by Subject|0|||
126574967|NCT03512756|455401040|FG003|Part 1|Withdrawal by Subject|0|||
126574968|NCT03512756|455401037|FG000|Part 2|Death|0|||
126574969|NCT03512756|455401038|FG001|Part 2|Death|0|||
126574970|NCT03512756|455401039|FG002|Part 2|Death|32|||
126574971|NCT03512756|455401040|FG003|Part 2|Death|21|||
126574972|NCT03512756|455401037|FG000|Part 2|Lost to Follow-up|0|||
126574973|NCT03512756|455401038|FG001|Part 2|Lost to Follow-up|0|||
126574974|NCT03512756|455401039|FG002|Part 2|Lost to Follow-up|1|||
126574975|NCT03512756|455401040|FG003|Part 2|Lost to Follow-up|0|||
126574976|NCT03512756|455401037|FG000|Part 2|Physician Decision|0|||
126574977|NCT03512756|455401038|FG001|Part 2|Physician Decision|0|||
126574978|NCT03512756|455401039|FG002|Part 2|Physician Decision|2|||
126574979|NCT03512756|455401040|FG003|Part 2|Physician Decision|4|||
126574980|NCT03512756|455401037|FG000|Part 2|Study Terminated by Sponsor|0|||
126574981|NCT03512756|455401038|FG001|Part 2|Study Terminated by Sponsor|0|||
126574982|NCT03512756|455401039|FG002|Part 2|Study Terminated by Sponsor|2|||
126574983|NCT03512756|455401040|FG003|Part 2|Study Terminated by Sponsor|6|||
126574984|NCT03512756|455401037|FG000|Part 2|Protocol Violation|0|||
126574985|NCT03512756|455401038|FG001|Part 2|Protocol Violation|0|||
126574986|NCT03512756|455401039|FG002|Part 2|Protocol Violation|1|||
126574987|NCT03512756|455401040|FG003|Part 2|Protocol Violation|0|||
126574988|NCT03512756|455401037|FG000|Part 2|Withdrawal by Subject|0|||
126574989|NCT03512756|455401038|FG001|Part 2|Withdrawal by Subject|0|||
126574990|NCT03512756|455401039|FG002|Part 2|Withdrawal by Subject|3|||
126574991|NCT03512756|455401040|FG003|Part 2|Withdrawal by Subject|9|||
126574992|NCT00736853|455401041|FG000|Open-Label Period|Physician Decision|2|||
126574993|NCT00736853|455401042|FG001|Open-Label Period|Physician Decision|0|||
126574994|NCT00736853|455401043|FG002|Open-Label Period|Physician Decision|0|||
126574995|NCT00736853|455401041|FG000|Open-Label Period|Adverse Event|31|||
126574996|NCT00736853|455401042|FG001|Open-Label Period|Adverse Event|0|||
126574997|NCT00736853|455401043|FG002|Open-Label Period|Adverse Event|0|||
126574998|NCT00736853|455401041|FG000|Open-Label Period|Withdrawal by Subject|16|||
126574999|NCT00736853|455401042|FG001|Open-Label Period|Withdrawal by Subject|0|||
126575000|NCT00736853|455401043|FG002|Open-Label Period|Withdrawal by Subject|0|||
126575001|NCT00736853|455401041|FG000|Open-Label Period|Started but not treated|42|||
126575002|NCT00736853|455401042|FG001|Open-Label Period|Started but not treated|0|||
126575003|NCT00736853|455401043|FG002|Open-Label Period|Started but not treated|0|||
126575004|NCT00736853|455401041|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
126575005|NCT00736853|455401042|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
126727409|NCT03655717|455951147|FG021|Overall Study|Lost to Follow-up|0|||
126727410|NCT03655717|455951148|FG022|Overall Study|Lost to Follow-up|0|||
126727411|NCT03655717|455951149|FG023|Overall Study|Lost to Follow-up|0|||
126727412|NCT03655717|455951150|FG024|Overall Study|Lost to Follow-up|0|||
126727413|NCT03655717|455951151|FG025|Overall Study|Lost to Follow-up|0|||
126727414|NCT03260205|455951154|FG000|Overall Study|Adverse Event|2|||
126727415|NCT03260205|455951155|FG001|Overall Study|Adverse Event|0|||
126575006|NCT00736853|455401043|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
126727416|NCT03260205|455951156|FG002|Overall Study|Adverse Event|2|||
126575007|NCT00736853|455401041|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
126575008|NCT00736853|455401042|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
126575009|NCT00736853|455401043|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
126575010|NCT00736853|455401041|FG000|Double-Blind Period|Lack of Efficacy|0|||
126575011|NCT00736853|455401042|FG001|Double-Blind Period|Lack of Efficacy|19|||
126575012|NCT00736853|455401043|FG002|Double-Blind Period|Lack of Efficacy|42|||
126575013|NCT00736853|455401041|FG000|Double-Blind Period|Adverse Event|0|||
126575014|NCT00736853|455401042|FG001|Double-Blind Period|Adverse Event|3|||
126575015|NCT00736853|455401043|FG002|Double-Blind Period|Adverse Event|2|||
126575016|NCT00736853|455401041|FG000|Double-Blind Period|Withdrawal by Subject|0|||
126575017|NCT00736853|455401042|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126575018|NCT00736853|455401043|FG002|Double-Blind Period|Withdrawal by Subject|4|||
126575019|NCT00736853|455401041|FG000|Double-Blind Period|Ineligible to participate the study|0|||
126575020|NCT00736853|455401042|FG001|Double-Blind Period|Ineligible to participate the study|1|||
126575021|NCT00736853|455401043|FG002|Double-Blind Period|Ineligible to participate the study|0|||
126575022|NCT01199705|455401044|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
126575023|NCT00089544|455402504|FG000|Overall Study|Ineligible|1|||
126575024|NCT00089544|455402505|FG001|Overall Study|Ineligible|0|||
126575025|NCT01622868|455402511|FG000|Overall Study|Protocol Violation|7|||
126575026|NCT01622868|455402512|FG001|Overall Study|Protocol Violation|0|||
126575027|NCT00610649|455402514|FG000|Overall Study|Adverse Event|1|||
126575028|NCT00610649|455402515|FG001|Overall Study|Adverse Event|0|||
126575029|NCT00610649|455402516|FG002|Overall Study|Adverse Event|0|||
126575030|NCT00610649|455402517|FG003|Overall Study|Adverse Event|0|||
126575031|NCT00610649|455402518|FG004|Overall Study|Adverse Event|0|||
126575032|NCT00610649|455402519|FG005|Overall Study|Adverse Event|0|||
126575033|NCT00610649|455402520|FG006|Overall Study|Adverse Event|0|||
126575034|NCT00610649|455402521|FG007|Overall Study|Adverse Event|0|||
126575035|NCT00610649|455402522|FG008|Overall Study|Adverse Event|0|||
126575036|NCT00610649|455402523|FG009|Overall Study|Adverse Event|0|||
126575037|NCT00610649|455402524|FG010|Overall Study|Adverse Event|1|||
126575038|NCT00610649|455402514|FG000|Overall Study|Family Emergency|0|||
126575039|NCT00610649|455402515|FG001|Overall Study|Family Emergency|1|||
126575040|NCT00610649|455402516|FG002|Overall Study|Family Emergency|0|||
126575041|NCT00610649|455402517|FG003|Overall Study|Family Emergency|0|||
126575042|NCT00610649|455402518|FG004|Overall Study|Family Emergency|0|||
126575043|NCT00610649|455402519|FG005|Overall Study|Family Emergency|0|||
126575044|NCT00610649|455402520|FG006|Overall Study|Family Emergency|0|||
126575045|NCT00610649|455402521|FG007|Overall Study|Family Emergency|0|||
126575046|NCT00610649|455402522|FG008|Overall Study|Family Emergency|0|||
126575047|NCT00610649|455402523|FG009|Overall Study|Family Emergency|0|||
126575048|NCT00610649|455402524|FG010|Overall Study|Family Emergency|0|||
126575049|NCT00610649|455402514|FG000|Overall Study|Withdrawal by Subject|0|||
126575050|NCT00610649|455402515|FG001|Overall Study|Withdrawal by Subject|0|||
126575051|NCT00610649|455402516|FG002|Overall Study|Withdrawal by Subject|0|||
126575052|NCT00610649|455402517|FG003|Overall Study|Withdrawal by Subject|0|||
126575053|NCT00610649|455402518|FG004|Overall Study|Withdrawal by Subject|0|||
126575054|NCT00610649|455402519|FG005|Overall Study|Withdrawal by Subject|0|||
126575055|NCT00610649|455402520|FG006|Overall Study|Withdrawal by Subject|0|||
126575056|NCT00610649|455402521|FG007|Overall Study|Withdrawal by Subject|0|||
126575057|NCT00610649|455402522|FG008|Overall Study|Withdrawal by Subject|0|||
126575058|NCT00610649|455402523|FG009|Overall Study|Withdrawal by Subject|1|||
126575059|NCT00610649|455402524|FG010|Overall Study|Withdrawal by Subject|0|||
126575060|NCT00446459|455402525|FG000|8 Months|Protocol Violation|12|||
126575061|NCT00446459|455402525|FG000|12 Months|Protocol Violation|4|||
126575062|NCT00446459|455402525|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
126575063|NCT02918279|455402530|FG000|Overall Study|Lost to Follow-up|3|||
126575064|NCT02918279|455402531|FG001|Overall Study|Lost to Follow-up|6|||
126727417|NCT03260205|455951157|FG003|Overall Study|Adverse Event|2|||
126727418|NCT03260205|455951158|FG004|Overall Study|Adverse Event|4|||
126727419|NCT03260205|455951154|FG000|Overall Study|Lost to Follow-up|2|||
126727420|NCT03260205|455951155|FG001|Overall Study|Lost to Follow-up|2|||
126575065|NCT02918279|455402530|FG000|Overall Study|Withdrawal by Subject|5|||
126575066|NCT02918279|455402531|FG001|Overall Study|Withdrawal by Subject|15|||
126575067|NCT02918279|455402530|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126575068|NCT02918279|455402531|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126575069|NCT02918279|455402530|FG000|Overall Study|Other|3|||
126575070|NCT02918279|455402531|FG001|Overall Study|Other|1|||
126575071|NCT00309907|455402532|FG000|Overall Study|Death|4|||
126575072|NCT00309907|455402532|FG000|Overall Study|Physician Decision|1|||
126575073|NCT00309907|455402532|FG000|Overall Study|Ineligible|11|||
126575074|NCT00309907|455402532|FG000|Overall Study|Major infectious event|4|||
126727421|NCT03260205|455951156|FG002|Overall Study|Lost to Follow-up|1|||
126727422|NCT03260205|455951157|FG003|Overall Study|Lost to Follow-up|1|||
126727423|NCT03260205|455951158|FG004|Overall Study|Lost to Follow-up|5|||
126575075|NCT00244855|455402533|FG000|Overall Study|Withdrawal by Subject|0|||
126575076|NCT00244855|455402534|FG001|Overall Study|Withdrawal by Subject|1|||
126575077|NCT00869258|455402535|FG000|Overall Study|Physician Decision|1|||
126575078|NCT01641198|455402536|FG000|After 12 Months of Function|Lost to Follow-up|3|||
126575079|NCT01641198|455402537|FG001|After 12 Months of Function|Lost to Follow-up|2|||
126727424|NCT03260205|455951154|FG000|Overall Study|Protocol Violation|0|||
126575080|NCT01641198|455402538|FG002|After 12 Months of Function|Lost to Follow-up|2|||
126575081|NCT01641198|455402536|FG000|After 12 Months of Function|Protocol Violation|1|||
126575082|NCT01641198|455402537|FG001|After 12 Months of Function|Protocol Violation|0|||
126727425|NCT03260205|455951155|FG001|Overall Study|Protocol Violation|0|||
126575083|NCT01641198|455402538|FG002|After 12 Months of Function|Protocol Violation|0|||
126575084|NCT01641198|455402536|FG000|After 12 Months of Function|Adverse Event|0|||
126575085|NCT01641198|455402537|FG001|After 12 Months of Function|Adverse Event|1|||
126575086|NCT01641198|455402538|FG002|After 12 Months of Function|Adverse Event|0|||
126727426|NCT03260205|455951156|FG002|Overall Study|Protocol Violation|2|||
126575087|NCT01641198|455402536|FG000|After 24 Months of Function|Lost to Follow-up|4|||
126575088|NCT01641198|455402537|FG001|After 24 Months of Function|Lost to Follow-up|9|||
126575089|NCT01641198|455402538|FG002|After 24 Months of Function|Lost to Follow-up|6|||
126575090|NCT01641198|455402536|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
126575091|NCT01641198|455402537|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
126575092|NCT01641198|455402538|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
126575093|NCT01641198|455402536|FG000|At 15-20 Years of Function|Death|1|||
126575094|NCT01641198|455402537|FG001|At 15-20 Years of Function|Death|0|||
126575095|NCT01641198|455402538|FG002|At 15-20 Years of Function|Death|1|||
126575096|NCT02529995|455402540|FG000|Part A|Ongoing Study at Data Cut-off|14|||
126575097|NCT02529995|455402541|FG001|Part A|Ongoing Study at Data Cut-off|16|||
126575098|NCT02529995|455402540|FG000|Part A|Discontinued Study|1|||
126575099|NCT02529995|455402541|FG001|Part A|Discontinued Study|0|||
126575100|NCT02529995|455402540|FG000|Part B|Ongoing Study at Data Cut-off|0|||
126575101|NCT02529995|455402541|FG001|Part B|Ongoing Study at Data Cut-off|7|||
126575102|NCT02529995|455402540|FG000|Part B|Discontinued Study|6|||
126575103|NCT02529995|455402541|FG001|Part B|Discontinued Study|5|||
126575104|NCT01068743|455402542|FG000|Period 3|Adverse Event|0|||
126575105|NCT01068743|455402543|FG001|Period 3|Adverse Event|1|||
126575106|NCT01068743|455402544|FG002|Period 3|Adverse Event|0|||
126575107|NCT01068743|455402545|FG003|Period 3|Adverse Event|0|||
126575108|NCT02261467|455402559|FG000|Overall Study|Enrolled in Error|1|||
126575109|NCT02261467|455402560|FG001|Overall Study|Enrolled in Error|0|||
126575110|NCT02261467|455402559|FG000|Overall Study|Protocol Violation|0|||
126575111|NCT02261467|455402560|FG001|Overall Study|Protocol Violation|1|||
126575112|NCT02261467|455402559|FG000|Overall Study|Personal Reasons|17|||
126575113|NCT02261467|455402560|FG001|Overall Study|Personal Reasons|22|||
126575114|NCT02261467|455402559|FG000|Overall Study|Lost to Follow-up|2|||
126575115|NCT02261467|455402560|FG001|Overall Study|Lost to Follow-up|13|||
126575116|NCT02261467|455402559|FG000|Overall Study|Adverse Event|1|||
126575117|NCT02261467|455402560|FG001|Overall Study|Adverse Event|1|||
126575118|NCT02528188|455402561|FG000|Overall Study|Adverse Event|23|||
126575119|NCT02528188|455402562|FG001|Overall Study|Adverse Event|22|||
126575120|NCT02528188|455402563|FG002|Overall Study|Adverse Event|8|||
126575121|NCT02528188|455402561|FG000|Overall Study|Protocol Violation|4|||
126575122|NCT02528188|455402562|FG001|Overall Study|Protocol Violation|6|||
126575123|NCT02528188|455402563|FG002|Overall Study|Protocol Violation|4|||
126575124|NCT02528188|455402561|FG000|Overall Study|Lack of Efficacy|19|||
126575125|NCT02528188|455402562|FG001|Overall Study|Lack of Efficacy|21|||
126575126|NCT02528188|455402563|FG002|Overall Study|Lack of Efficacy|22|||
126575127|NCT02528188|455402561|FG000|Overall Study|Withdrawal by Subject|97|||
126575128|NCT02528188|455402562|FG001|Overall Study|Withdrawal by Subject|104|||
126575129|NCT02528188|455402563|FG002|Overall Study|Withdrawal by Subject|100|||
126575130|NCT02528188|455402561|FG000|Overall Study|Lost to Follow-up|25|||
126575131|NCT02528188|455402562|FG001|Overall Study|Lost to Follow-up|21|||
126575132|NCT02528188|455402563|FG002|Overall Study|Lost to Follow-up|31|||
126575133|NCT02528188|455402561|FG000|Overall Study|Death|4|||
126575134|NCT02528188|455402562|FG001|Overall Study|Death|4|||
126575135|NCT02528188|455402563|FG002|Overall Study|Death|0|||
126575136|NCT02528188|455402561|FG000|Overall Study|Other|89|||
126575137|NCT02528188|455402562|FG001|Overall Study|Other|91|||
126575138|NCT02528188|455402563|FG002|Overall Study|Other|74|||
126727427|NCT03260205|455951157|FG003|Overall Study|Protocol Violation|0|||
126575139|NCT02528188|455402561|FG000|Overall Study|Randomized but not treated|6|||
126575140|NCT02528188|455402562|FG001|Overall Study|Randomized but not treated|7|||
126575141|NCT02528188|455402563|FG002|Overall Study|Randomized but not treated|12|||
126575142|NCT01787760|455402564|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
126575143|NCT01787760|455402565|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
126575144|NCT01787760|455402566|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
126575145|NCT01787760|455402564|FG000|Overall Study|Decompensated on left exotropia|0|||
126575146|NCT01787760|455402565|FG001|Overall Study|Decompensated on left exotropia|0|||
126575147|NCT01787760|455402566|FG002|Overall Study|Decompensated on left exotropia|1|||
126575148|NCT01787760|455402564|FG000|Overall Study|Dryness|0|||
126575149|NCT01787760|455402565|FG001|Overall Study|Dryness|1|||
126575150|NCT01787760|455402566|FG002|Overall Study|Dryness|0|||
126575151|NCT01787760|455402564|FG000|Overall Study|Relocation|1|||
126575152|NCT01787760|455402565|FG001|Overall Study|Relocation|1|||
126575153|NCT01787760|455402566|FG002|Overall Study|Relocation|0|||
126575154|NCT01787760|455402564|FG000|Overall Study|Lens discomfort|3|||
126575155|NCT01787760|455402565|FG001|Overall Study|Lens discomfort|0|||
126575156|NCT01787760|455402566|FG002|Overall Study|Lens discomfort|0|||
126575157|NCT01787760|455402564|FG000|Overall Study|Lens handling difficulty|1|||
126575158|NCT01787760|455402565|FG001|Overall Study|Lens handling difficulty|2|||
126575159|NCT01787760|455402566|FG002|Overall Study|Lens handling difficulty|0|||
126575160|NCT01787760|455402564|FG000|Overall Study|Protocol Violation|6|||
126575161|NCT01787760|455402565|FG001|Overall Study|Protocol Violation|0|||
126575162|NCT01787760|455402566|FG002|Overall Study|Protocol Violation|1|||
126727428|NCT03260205|455951158|FG004|Overall Study|Protocol Violation|1|||
126575163|NCT01787760|455402564|FG000|Overall Study|Withdrawal by Subject|5|||
126777032|NCT02746705|456139163|FG001|Overall Study|Physician Decision|1|||
126727429|NCT03260205|455951154|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
126727430|NCT03260205|455951155|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
126727431|NCT03260205|455951156|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
126523392|NCT00142909|455208313|FG000|Medications Begin|Withdrawal by Subject|5|||
126523393|NCT00142909|455208314|FG001|Medications Begin|Withdrawal by Subject|3|||
126523394|NCT00142909|455208313|FG000|Medications Begin|Withdrawal by Subject|2|||
126523395|NCT00142909|455208314|FG001|Medications Begin|Withdrawal by Subject|0|||
126523396|NCT01898195|455208315|FG000|Smoking Abstinence|Did not have good measurements|35|||
126523397|NCT01898195|455208316|FG001|Smoking Abstinence|Did not have good measurements|38|||
126523398|NCT01898195|455208317|FG002|Smoking Abstinence|Did not have good measurements|36|||
126523399|NCT02720484|455208322|FG000|Treatment on Study|Adverse Event|1|||
126523400|NCT02720484|455208322|FG000|Treatment on Study|Withdrawal by Subject|1|||
126523401|NCT02720484|455208322|FG000|Treatment on Study|Progressive Disease|4|||
126523402|NCT02720484|455208322|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
126523403|NCT02720484|455208322|FG000|Follow Up for 2 Years|Death|3|||
126523404|NCT02720484|455208322|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
126523405|NCT05070897|455208325|FG000|Overall Study|Protocol Violation|123|||
126523406|NCT05070897|455208326|FG001|Overall Study|Protocol Violation|68|||
126523407|NCT01617629|455208327|FG000|Overall Study|Death|2|||
126523408|NCT01617629|455208327|FG000|Overall Study|Investigator's Clinical Judgement|1|||
126523409|NCT01617629|455208327|FG000|Overall Study|Reason Not Specified|1|||
126523410|NCT01617629|455208327|FG000|Overall Study|Participant Withdrew Consent|2|||
126523411|NCT01663636|455208328|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
126523412|NCT01663636|455208329|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
126523413|NCT01337245|455208330|FG000|Overall Study|Lost to Follow-up|1|||
126523414|NCT03832946|455208331|FG000|Overall Study|Adverse Event|3|||
126523415|NCT03832946|455208332|FG001|Overall Study|Adverse Event|1|||
126523416|NCT03832946|455208331|FG000|Overall Study|Lost to Follow-up|1|||
126523417|NCT03832946|455208332|FG001|Overall Study|Lost to Follow-up|0|||
126523418|NCT03832946|455208331|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
126523419|NCT03832946|455208332|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
126523420|NCT03832946|455208331|FG000|Overall Study|Lack of Efficacy|1|||
126523421|NCT03832946|455208332|FG001|Overall Study|Lack of Efficacy|0|||
126523422|NCT03832946|455208331|FG000|Overall Study|Withdrawal by Subject|12|||
126523423|NCT03832946|455208332|FG001|Overall Study|Withdrawal by Subject|9|||
126523424|NCT00136955|455210258|FG000|Overall Study|Adverse Event|8|||
126523425|NCT00136955|455210258|FG000|Overall Study|Lost to Follow-up|1|||
126523426|NCT00136955|455210258|FG000|Overall Study|Withdrawal by Subject|2|||
126523427|NCT00136955|455210258|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
126523428|NCT04450264|455210259|FG000|Overall Study|Incomplete survey|13|||
126523429|NCT04450264|455210260|FG001|Overall Study|Incomplete survey|19|||
126523430|NCT05349617|455210261|FG000|Overall Study|Death|1|||
126523431|NCT05349617|455210262|FG001|Overall Study|Death|1|||
126523432|NCT05349617|455210261|FG000|Overall Study|Lost to Follow-up|3|||
126523433|NCT05349617|455210262|FG001|Overall Study|Lost to Follow-up|8|||
126523434|NCT05349617|455210261|FG000|Overall Study|Withdrawal by Subject|2|||
126523435|NCT05349617|455210262|FG001|Overall Study|Withdrawal by Subject|10|||
126523436|NCT02053350|455210266|FG000|Overall Study|Withdrawal by Subject|1|||
126523437|NCT02053350|455210266|FG000|Overall Study|Adverse Event|4|||
126523438|NCT00902304|455210270|FG000|Overall Study|Adverse Event|4|||
126523439|NCT00902304|455210271|FG001|Overall Study|Adverse Event|10|||
126523440|NCT00902304|455210272|FG002|Overall Study|Adverse Event|25|||
126523441|NCT00902304|455210270|FG000|Overall Study|Investigator discretion|3|||
126523442|NCT00902304|455210271|FG001|Overall Study|Investigator discretion|5|||
126523443|NCT00902304|455210272|FG002|Overall Study|Investigator discretion|13|||
126523444|NCT00902304|455210270|FG000|Overall Study|Lost to Follow-up|7|||
126523445|NCT00902304|455210271|FG001|Overall Study|Lost to Follow-up|7|||
126523446|NCT00902304|455210272|FG002|Overall Study|Lost to Follow-up|7|||
126523447|NCT00902304|455210270|FG000|Overall Study|Protocol Violation|9|||
126523448|NCT00902304|455210271|FG001|Overall Study|Protocol Violation|18|||
126523449|NCT00902304|455210272|FG002|Overall Study|Protocol Violation|20|||
126523450|NCT00902304|455210270|FG000|Overall Study|Withdrawal by Subject|32|||
126523451|NCT00902304|455210271|FG001|Overall Study|Withdrawal by Subject|22|||
126523452|NCT00902304|455210272|FG002|Overall Study|Withdrawal by Subject|43|||
126523453|NCT00902304|455210270|FG000|Overall Study|includes pregnancy|3|||
126523454|NCT00902304|455210271|FG001|Overall Study|includes pregnancy|9|||
126523455|NCT00902304|455210272|FG002|Overall Study|includes pregnancy|2|||
126523456|NCT04579757|455210273|FG000|Overall Study|Adverse Event|0|||
126523457|NCT04579757|455210274|FG001|Overall Study|Adverse Event|0|||
126523458|NCT04579757|455210275|FG002|Overall Study|Adverse Event|0|||
126523459|NCT04579757|455210276|FG003|Overall Study|Adverse Event|2|||
126523460|NCT04579757|455210277|FG004|Overall Study|Adverse Event|1|||
126523461|NCT04579757|455210278|FG005|Overall Study|Adverse Event|1|||
126523462|NCT04579757|455210279|FG006|Overall Study|Adverse Event|0|||
126523463|NCT04579757|455210280|FG007|Overall Study|Adverse Event|0|||
126523464|NCT04579757|455210281|FG008|Overall Study|Adverse Event|0|||
126523465|NCT04579757|455210273|FG000|Overall Study|Death|4|||
126575164|NCT01787760|455402565|FG001|Overall Study|Withdrawal by Subject|1|||
126575165|NCT01787760|455402566|FG002|Overall Study|Withdrawal by Subject|2|||
126575166|NCT01787760|455402564|FG000|Overall Study|Lost to Follow-up|1|||
126575167|NCT01787760|455402565|FG001|Overall Study|Lost to Follow-up|0|||
126575168|NCT01787760|455402566|FG002|Overall Study|Lost to Follow-up|1|||
126575169|NCT01787760|455402564|FG000|Overall Study|Stroke|1|||
126575170|NCT01787760|455402565|FG001|Overall Study|Stroke|0|||
126575171|NCT01787760|455402566|FG002|Overall Study|Stroke|0|||
126575172|NCT01787760|455402564|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
126575173|NCT01787760|455402565|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
126575174|NCT01787760|455402566|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
126575175|NCT01787760|455402564|FG000|Overall Study|Unsatisfactory physiological response|2|||
126575176|NCT01787760|455402565|FG001|Overall Study|Unsatisfactory physiological response|4|||
126575177|NCT01787760|455402566|FG002|Overall Study|Unsatisfactory physiological response|0|||
126575178|NCT01787760|455402564|FG000|Overall Study|Unsatisfactory visual response|1|||
126575179|NCT01787760|455402565|FG001|Overall Study|Unsatisfactory visual response|1|||
126575180|NCT01787760|455402566|FG002|Overall Study|Unsatisfactory visual response|0|||
126575181|NCT01787760|455402564|FG000|Overall Study|Near vision blur|1|||
126575182|NCT01787760|455402565|FG001|Overall Study|Near vision blur|0|||
126575183|NCT01787760|455402566|FG002|Overall Study|Near vision blur|0|||
126575184|NCT01692730|455402572|FG000|Overall Study|Lost to Follow-up|225|||
126575185|NCT01692730|455402573|FG001|Overall Study|Lost to Follow-up|227|||
126575186|NCT00933400|455402574|FG000|Overall Study|Withdrawal by Subject|21|||
126575187|NCT00933400|455402575|FG001|Overall Study|Withdrawal by Subject|1|||
126575188|NCT01041417|455402578|FG000|Overall Study|Adverse Event|5|||
126575189|NCT01041417|455402579|FG001|Overall Study|Adverse Event|2|||
126575190|NCT01041417|455402578|FG000|Overall Study|Lost to Follow-up|1|||
126575191|NCT01041417|455402579|FG001|Overall Study|Lost to Follow-up|1|||
126575192|NCT01041417|455402578|FG000|Overall Study|Death|1|||
126575193|NCT01041417|455402579|FG001|Overall Study|Death|0|||
126575194|NCT02299375|455402580|FG000|Overall Study|Adverse Event, serious fatal|1|||
126575195|NCT02299375|455402581|FG001|Overall Study|Adverse Event, serious fatal|3|||
126575196|NCT02299375|455402580|FG000|Overall Study|Adverse Event, non-fatal|8|||
126575197|NCT02299375|455402581|FG001|Overall Study|Adverse Event, non-fatal|9|||
126575198|NCT02299375|455402580|FG000|Overall Study|Lack of Efficacy|1|||
126575199|NCT02299375|455402581|FG001|Overall Study|Lack of Efficacy|3|||
126575200|NCT02299375|455402580|FG000|Overall Study|Protocol Violation|1|||
126575201|NCT02299375|455402581|FG001|Overall Study|Protocol Violation|3|||
126575202|NCT02299375|455402580|FG000|Overall Study|Other: Met stopping criteria|1|||
126727432|NCT03260205|455951157|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
126727433|NCT03260205|455951158|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
126727434|NCT03260205|455951154|FG000|Overall Study|Other: Unspecified|0|||
126727435|NCT03260205|455951155|FG001|Overall Study|Other: Unspecified|0|||
126727436|NCT03260205|455951156|FG002|Overall Study|Other: Unspecified|3|||
126727437|NCT03260205|455951157|FG003|Overall Study|Other: Unspecified|1|||
126523466|NCT04579757|455210274|FG001|Overall Study|Death|1|||
126523467|NCT04579757|455210275|FG002|Overall Study|Death|14|||
126523468|NCT04579757|455210276|FG003|Overall Study|Death|3|||
126523469|NCT04579757|455210277|FG004|Overall Study|Death|2|||
126523470|NCT04579757|455210278|FG005|Overall Study|Death|7|||
126523471|NCT04579757|455210279|FG006|Overall Study|Death|0|||
126523472|NCT04579757|455210280|FG007|Overall Study|Death|1|||
126523473|NCT04579757|455210281|FG008|Overall Study|Death|3|||
126523474|NCT04579757|455210273|FG000|Overall Study|Physician Decision|0|||
126523475|NCT04579757|455210274|FG001|Overall Study|Physician Decision|0|||
126523476|NCT04579757|455210275|FG002|Overall Study|Physician Decision|0|||
126523477|NCT04579757|455210276|FG003|Overall Study|Physician Decision|2|||
126523478|NCT04579757|455210277|FG004|Overall Study|Physician Decision|1|||
126523479|NCT04579757|455210278|FG005|Overall Study|Physician Decision|1|||
126523480|NCT04579757|455210279|FG006|Overall Study|Physician Decision|1|||
126523481|NCT04579757|455210280|FG007|Overall Study|Physician Decision|0|||
126523482|NCT04579757|455210281|FG008|Overall Study|Physician Decision|0|||
126523483|NCT04579757|455210273|FG000|Overall Study|Study Terminated By Sponsor|0|||
126523484|NCT04579757|455210274|FG001|Overall Study|Study Terminated By Sponsor|0|||
126523485|NCT04579757|455210275|FG002|Overall Study|Study Terminated By Sponsor|0|||
126523486|NCT04579757|455210276|FG003|Overall Study|Study Terminated By Sponsor|0|||
126523487|NCT04579757|455210277|FG004|Overall Study|Study Terminated By Sponsor|2|||
126523488|NCT04579757|455210278|FG005|Overall Study|Study Terminated By Sponsor|0|||
126523489|NCT04579757|455210279|FG006|Overall Study|Study Terminated By Sponsor|0|||
126575203|NCT02299375|455402581|FG001|Overall Study|Other: Met stopping criteria|0|||
126575204|NCT02299375|455402580|FG000|Overall Study|Other: Study closed/terminated|66|||
126575205|NCT02299375|455402581|FG001|Overall Study|Other: Study closed/terminated|55|||
126523490|NCT04579757|455210280|FG007|Overall Study|Study Terminated By Sponsor|2|||
126575206|NCT02299375|455402580|FG000|Overall Study|Lost to Follow-up|0|||
126575207|NCT02299375|455402581|FG001|Overall Study|Lost to Follow-up|2|||
126727438|NCT03260205|455951158|FG004|Overall Study|Other: Unspecified|1|||
126777033|NCT02746705|456139162|FG000|Overall Study|Lost to Follow-up|1|||
126523491|NCT04579757|455210281|FG008|Overall Study|Study Terminated By Sponsor|0|||
126523492|NCT04579757|455210273|FG000|Overall Study|Withdrawal by Subject|1|||
126523493|NCT04579757|455210274|FG001|Overall Study|Withdrawal by Subject|1|||
126523494|NCT04579757|455210275|FG002|Overall Study|Withdrawal by Subject|0|||
126523495|NCT04579757|455210276|FG003|Overall Study|Withdrawal by Subject|0|||
126523496|NCT04579757|455210277|FG004|Overall Study|Withdrawal by Subject|2|||
126523497|NCT04579757|455210278|FG005|Overall Study|Withdrawal by Subject|1|||
126523498|NCT04579757|455210279|FG006|Overall Study|Withdrawal by Subject|0|||
126523499|NCT04579757|455210280|FG007|Overall Study|Withdrawal by Subject|3|||
126523500|NCT04579757|455210281|FG008|Overall Study|Withdrawal by Subject|0|||
126523501|NCT04579757|455210273|FG000|Overall Study|Radiological or Clinical PD|1|||
126523502|NCT04579757|455210274|FG001|Overall Study|Radiological or Clinical PD|4|||
126523503|NCT04579757|455210275|FG002|Overall Study|Radiological or Clinical PD|1|||
126523504|NCT04579757|455210276|FG003|Overall Study|Radiological or Clinical PD|3|||
126523505|NCT04579757|455210277|FG004|Overall Study|Radiological or Clinical PD|9|||
126523506|NCT04579757|455210278|FG005|Overall Study|Radiological or Clinical PD|4|||
126523507|NCT04579757|455210279|FG006|Overall Study|Radiological or Clinical PD|2|||
126523508|NCT04579757|455210280|FG007|Overall Study|Radiological or Clinical PD|2|||
126523509|NCT04579757|455210281|FG008|Overall Study|Radiological or Clinical PD|0|||
126523510|NCT04579757|455210273|FG000|Overall Study|Start of New Therapy|0|||
126523511|NCT04579757|455210274|FG001|Overall Study|Start of New Therapy|0|||
126523512|NCT04579757|455210275|FG002|Overall Study|Start of New Therapy|0|||
126523513|NCT04579757|455210276|FG003|Overall Study|Start of New Therapy|0|||
126523514|NCT04579757|455210277|FG004|Overall Study|Start of New Therapy|2|||
126523515|NCT04579757|455210278|FG005|Overall Study|Start of New Therapy|1|||
126523516|NCT04579757|455210279|FG006|Overall Study|Start of New Therapy|0|||
126523517|NCT04579757|455210280|FG007|Overall Study|Start of New Therapy|0|||
126523518|NCT04579757|455210281|FG008|Overall Study|Start of New Therapy|0|||
126523519|NCT01153633|455210282|FG000|Overall Study|Protocol Violation|1|||
126523520|NCT01153633|455210283|FG001|Overall Study|Protocol Violation|1|||
126523521|NCT01153633|455210282|FG000|Overall Study|Therapeutic failure|3|||
126523522|NCT01153633|455210283|FG001|Overall Study|Therapeutic failure|3|||
126523523|NCT00384085|455210284|FG000|Overall Study|Adverse Event|5|||
126523524|NCT00384085|455210285|FG001|Overall Study|Adverse Event|5|||
126523525|NCT00384085|455210286|FG002|Overall Study|Adverse Event|4|||
126523526|NCT00384085|455210284|FG000|Overall Study|Lack of Efficacy|0|||
126523527|NCT00384085|455210285|FG001|Overall Study|Lack of Efficacy|3|||
126523528|NCT00384085|455210286|FG002|Overall Study|Lack of Efficacy|2|||
126523529|NCT00384085|455210284|FG000|Overall Study|No longer Requires Study Treatment|1|||
126523530|NCT00384085|455210285|FG001|Overall Study|No longer Requires Study Treatment|0|||
126523531|NCT00384085|455210286|FG002|Overall Study|No longer Requires Study Treatment|1|||
126523532|NCT00384085|455210284|FG000|Overall Study|Protocol Violation|2|||
126523533|NCT00384085|455210285|FG001|Overall Study|Protocol Violation|2|||
126523534|NCT00384085|455210286|FG002|Overall Study|Protocol Violation|2|||
126523535|NCT00384085|455210284|FG000|Overall Study|Lost to Follow-up|9|||
126523536|NCT00384085|455210285|FG001|Overall Study|Lost to Follow-up|9|||
126523537|NCT00384085|455210286|FG002|Overall Study|Lost to Follow-up|10|||
126523538|NCT00384085|455210284|FG000|Overall Study|Progressive Disease|0|||
126523539|NCT00384085|455210285|FG001|Overall Study|Progressive Disease|1|||
126523540|NCT00384085|455210286|FG002|Overall Study|Progressive Disease|0|||
126523541|NCT00384085|455210284|FG000|Overall Study|Withdrawal by Subject|14|||
126523542|NCT00384085|455210285|FG001|Overall Study|Withdrawal by Subject|19|||
126523543|NCT00384085|455210286|FG002|Overall Study|Withdrawal by Subject|29|||
126523544|NCT00384085|455210284|FG000|Overall Study|Patient non-compliant|4|||
126523545|NCT00384085|455210285|FG001|Overall Study|Patient non-compliant|4|||
126523546|NCT00384085|455210286|FG002|Overall Study|Patient non-compliant|5|||
126523547|NCT00384085|455210284|FG000|Overall Study|Physician Decision|1|||
126523548|NCT00384085|455210285|FG001|Overall Study|Physician Decision|0|||
126523549|NCT00384085|455210286|FG002|Overall Study|Physician Decision|0|||
126523550|NCT00384085|455210284|FG000|Overall Study|Loss of site personnel|1|||
126523551|NCT00384085|455210285|FG001|Overall Study|Loss of site personnel|0|||
126523552|NCT00384085|455210286|FG002|Overall Study|Loss of site personnel|1|||
126523553|NCT00384085|455210284|FG000|Overall Study|Sponsor decision|1|||
126523554|NCT00384085|455210285|FG001|Overall Study|Sponsor decision|2|||
126523555|NCT00384085|455210286|FG002|Overall Study|Sponsor decision|1|||
126523556|NCT00384085|455210284|FG000|Overall Study|Patient moved|1|||
126523557|NCT00384085|455210285|FG001|Overall Study|Patient moved|0|||
126523558|NCT00384085|455210286|FG002|Overall Study|Patient moved|1|||
126523559|NCT00384085|455210284|FG000|Overall Study|Patient required surgery|0|||
126523560|NCT00384085|455210285|FG001|Overall Study|Patient required surgery|1|||
126523561|NCT00384085|455210286|FG002|Overall Study|Patient required surgery|0|||
126523562|NCT00071487|455210287|FG000|52-Week Double-Blind Period|Adverse Event|5|||
126523563|NCT00071487|455210288|FG001|52-Week Double-Blind Period|Adverse Event|8|||
126523564|NCT00071487|455210289|FG002|52-Week Double-Blind Period|Adverse Event|4|||
126523565|NCT00071487|455210290|FG003|52-Week Double-Blind Period|Adverse Event|8|||
126523566|NCT00071487|455210287|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
126523567|NCT00071487|455210288|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
126523568|NCT00071487|455210289|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
126727439|NCT03260205|455951154|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
126727440|NCT03260205|455951155|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
126727441|NCT03260205|455951156|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
126727442|NCT03260205|455951157|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
126727443|NCT03260205|455951158|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
126727444|NCT00808249|455951161|FG000|Overall Study|Adverse Event|4|||
126727445|NCT00808249|455951162|FG001|Overall Study|Adverse Event|7|||
126727446|NCT00808249|455951163|FG002|Overall Study|Adverse Event|10|||
126523569|NCT00071487|455210290|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
126575208|NCT02299375|455402580|FG000|Overall Study|Physician Decision|1|||
126575209|NCT02299375|455402581|FG001|Overall Study|Physician Decision|1|||
126575210|NCT02299375|455402580|FG000|Overall Study|Withdrawal by Subject|1|||
126575211|NCT02299375|455402581|FG001|Overall Study|Withdrawal by Subject|4|||
126575212|NCT00704184|455402582|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
126575213|NCT00704184|455402583|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
126575214|NCT00704184|455402584|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
126575215|NCT00704184|455402585|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
126575216|NCT00704184|455402586|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
126575217|NCT00704184|455402582|FG000|Open-Label Treatment|Adverse Event|0|||
126575218|NCT00704184|455402583|FG001|Open-Label Treatment|Adverse Event|0|||
126575219|NCT00704184|455402584|FG002|Open-Label Treatment|Adverse Event|2|||
126575220|NCT00704184|455402585|FG003|Open-Label Treatment|Adverse Event|0|||
126575221|NCT00704184|455402586|FG004|Open-Label Treatment|Adverse Event|1|||
126575222|NCT00704184|455402582|FG000|Open-Label Treatment|Lack of Efficacy|0|||
126575223|NCT00704184|455402583|FG001|Open-Label Treatment|Lack of Efficacy|2|||
126575224|NCT00704184|455402584|FG002|Open-Label Treatment|Lack of Efficacy|2|||
126575225|NCT00704184|455402585|FG003|Open-Label Treatment|Lack of Efficacy|2|||
126523570|NCT00071487|455210287|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
126523571|NCT00071487|455210288|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
126523572|NCT00071487|455210289|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
126523573|NCT00071487|455210290|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
126523574|NCT00071487|455210287|FG000|52-Week Double-Blind Period|Physician Decision|1|||
126523575|NCT00071487|455210288|FG001|52-Week Double-Blind Period|Physician Decision|0|||
126523576|NCT00071487|455210289|FG002|52-Week Double-Blind Period|Physician Decision|0|||
126523577|NCT00071487|455210290|FG003|52-Week Double-Blind Period|Physician Decision|0|||
126523578|NCT00071487|455210287|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
126523579|NCT00071487|455210288|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
126523580|NCT00071487|455210289|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
126523581|NCT00071487|455210290|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
126523582|NCT00071487|455210287|FG000|52-Week Double-Blind Period|Pregnancy|0|||
126523583|NCT00071487|455210288|FG001|52-Week Double-Blind Period|Pregnancy|1|||
126523584|NCT00071487|455210289|FG002|52-Week Double-Blind Period|Pregnancy|0|||
126523585|NCT00071487|455210290|FG003|52-Week Double-Blind Period|Pregnancy|0|||
126523586|NCT00071487|455210287|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
126523587|NCT00071487|455210288|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
126523588|NCT00071487|455210289|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
126523589|NCT00071487|455210290|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
126523590|NCT00071487|455210287|FG000|52-Week Double-Blind Period|Death|0|||
126523591|NCT00071487|455210288|FG001|52-Week Double-Blind Period|Death|1|||
126523592|NCT00071487|455210289|FG002|52-Week Double-Blind Period|Death|0|||
126523593|NCT00071487|455210290|FG003|52-Week Double-Blind Period|Death|0|||
126523594|NCT00071487|455210287|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
126523595|NCT00071487|455210288|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
126523596|NCT00071487|455210289|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
126523597|NCT00071487|455210290|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
126523598|NCT00071487|455210287|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
126523599|NCT00071487|455210288|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
126523600|NCT00071487|455210289|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
126523601|NCT00071487|455210290|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
126523602|NCT00071487|455210287|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
126575226|NCT00704184|455402586|FG004|Open-Label Treatment|Lack of Efficacy|1|||
126575227|NCT00704184|455402582|FG000|Open-Label Treatment|Physician Decision|0|||
126523603|NCT00071487|455210288|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
126523604|NCT00071487|455210289|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
126523605|NCT00071487|455210290|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
126523606|NCT00071487|455210287|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
126523607|NCT00071487|455210288|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
126523608|NCT00071487|455210289|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
126523609|NCT00071487|455210290|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
126523610|NCT00071487|455210287|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
126523611|NCT00071487|455210288|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
126727447|NCT00808249|455951164|FG003|Overall Study|Adverse Event|6|||
126575228|NCT00704184|455402583|FG001|Open-Label Treatment|Physician Decision|0|||
126575229|NCT00704184|455402584|FG002|Open-Label Treatment|Physician Decision|0|||
126575230|NCT00704184|455402585|FG003|Open-Label Treatment|Physician Decision|0|||
126575231|NCT00704184|455402586|FG004|Open-Label Treatment|Physician Decision|1|||
126575232|NCT00704184|455402582|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
126575233|NCT00704184|455402583|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
126575234|NCT00704184|455402584|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
126575235|NCT00704184|455402585|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
126575236|NCT00704184|455402586|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
126575237|NCT01764464|455402587|FG000|First Intervention|Withdrawal by Subject|1|||
126575238|NCT01764464|455402588|FG001|First Intervention|Withdrawal by Subject|0|||
126575239|NCT01764464|455402587|FG000|First Intervention|Lost to Follow-up|1|||
126575240|NCT01764464|455402588|FG001|First Intervention|Lost to Follow-up|0|||
126575241|NCT01764464|455402587|FG000|First Intervention|Adverse Event|0|||
126575242|NCT01764464|455402588|FG001|First Intervention|Adverse Event|2|||
126575243|NCT01764464|455402587|FG000|First Intervention|did not receive study drug|0|||
126575244|NCT01764464|455402588|FG001|First Intervention|did not receive study drug|1|||
126575245|NCT01764464|455402587|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
126575246|NCT01764464|455402588|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
126575247|NCT03473340|455402598|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
126575248|NCT03473340|455402599|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
126575249|NCT03473340|455402598|FG000|Overall Study|Withdrawal by Subject|1|||
126575250|NCT03473340|455402599|FG001|Overall Study|Withdrawal by Subject|0|||
126575251|NCT03473340|455402598|FG000|Overall Study|Lost to Follow-up|1|||
126575252|NCT03473340|455402599|FG001|Overall Study|Lost to Follow-up|2|||
126575253|NCT03394885|455402601|FG000|Overall Study|Adverse Event|4|||
126575254|NCT03394885|455402601|FG000|Overall Study|Lack of Efficacy|1|||
126575255|NCT03394885|455402601|FG000|Overall Study|Physician Decision|1|||
126575256|NCT03394885|455402601|FG000|Overall Study|Withdrawal by Subject|8|||
126575257|NCT03394885|455402601|FG000|Overall Study|Alternative Therapy|1|||
126575258|NCT01212991|455402609|FG000|Double-blind|Lost to Follow-up|8|||
126575259|NCT01212991|455402610|FG001|Double-blind|Lost to Follow-up|4|||
126575260|NCT01212991|455402611|FG002|Double-blind|Lost to Follow-up|0|||
126575261|NCT01212991|455402609|FG000|Double-blind|Death|699|||
126575262|NCT01212991|455402610|FG001|Double-blind|Death|550|||
126575263|NCT01212991|455402611|FG002|Double-blind|Death|0|||
126575264|NCT01212991|455402609|FG000|Double-blind|Withdrawal by Subject|16|||
126575265|NCT01212991|455402610|FG001|Double-blind|Withdrawal by Subject|19|||
126575266|NCT01212991|455402611|FG002|Double-blind|Withdrawal by Subject|0|||
126575267|NCT01212991|455402609|FG000|Double-blind|Other|7|||
126575268|NCT01212991|455402610|FG001|Double-blind|Other|0|||
126575269|NCT01212991|455402611|FG002|Double-blind|Other|0|||
126575270|NCT01212991|455402609|FG000|Double-blind|Sponsor decision|142|||
126575271|NCT01212991|455402610|FG001|Double-blind|Sponsor decision|38|||
126575272|NCT01212991|455402611|FG002|Double-blind|Sponsor decision|0|||
126575273|NCT01212991|455402609|FG000|Open-label|Death|0|||
126575274|NCT01212991|455402610|FG001|Open-label|Death|0|||
126575275|NCT01212991|455402611|FG002|Open-label|Death|166|||
126523612|NCT00071487|455210289|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
126523613|NCT00071487|455210290|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
126523614|NCT00071487|455210287|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
126523615|NCT00071487|455210288|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
126523616|NCT00071487|455210289|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
126523617|NCT00071487|455210290|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
126523618|NCT00071487|455210287|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
126523619|NCT00071487|455210288|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
126523620|NCT00071487|455210289|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
126523621|NCT00071487|455210290|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
126523622|NCT03725982|455210293|FG000|First Intervention|Withdrawal by Subject|0|||
126575276|NCT01212991|455402609|FG000|Open-label|Lost to Follow-up|0|||
126575277|NCT01212991|455402610|FG001|Open-label|Lost to Follow-up|0|||
126575278|NCT01212991|455402611|FG002|Open-label|Lost to Follow-up|5|||
126575279|NCT01212991|455402609|FG000|Open-label|Withdrawal by Subject|0|||
126575280|NCT01212991|455402610|FG001|Open-label|Withdrawal by Subject|0|||
126523623|NCT03725982|455210294|FG001|First Intervention|Withdrawal by Subject|1|||
126523624|NCT03725982|455210293|FG000|First Intervention|Physician Decision|1|||
126575281|NCT01212991|455402611|FG002|Open-label|Withdrawal by Subject|7|||
126575282|NCT01212991|455402609|FG000|Open-label|Sponsor decision|0|||
126575283|NCT01212991|455402610|FG001|Open-label|Sponsor decision|0|||
126575284|NCT01212991|455402611|FG002|Open-label|Sponsor decision|53|||
126575285|NCT01212991|455402609|FG000|Open-label|Other|0|||
126575286|NCT01212991|455402610|FG001|Open-label|Other|0|||
126575287|NCT01212991|455402611|FG002|Open-label|Other|3|||
126575288|NCT00801983|455402614|FG000|Period 1|Lost to Follow-up|2|||
126575289|NCT00801983|455402615|FG001|Period 1|Lost to Follow-up|0|||
126575290|NCT00801983|455402614|FG000|Period 1|Withdrawal by Subject|2|||
126575291|NCT00801983|455402615|FG001|Period 1|Withdrawal by Subject|8|||
126575292|NCT00801983|455402614|FG000|Period 2|Withdrawal by Subject|2|||
126575293|NCT00801983|455402615|FG001|Period 2|Withdrawal by Subject|1|||
126575294|NCT01251354|455402616|FG000|Overall Study|Adverse Event|1|||
126575295|NCT01251354|455402616|FG000|Overall Study|Investigator's Decision|1|||
126575296|NCT01251354|455402616|FG000|Overall Study|Disease Progression|4|||
126575297|NCT05135000|455402617|FG000|Overall Study|Adverse Event|2|||
126575298|NCT05135000|455402618|FG001|Overall Study|Adverse Event|0|||
126575299|NCT05135000|455402617|FG000|Overall Study|Lost to Follow-up|1|||
126575300|NCT05135000|455402618|FG001|Overall Study|Lost to Follow-up|0|||
126575301|NCT05135000|455402617|FG000|Overall Study|Study Terminated by Sponsor|6|||
126575302|NCT05135000|455402618|FG001|Overall Study|Study Terminated by Sponsor|3|||
126727448|NCT00808249|455951161|FG000|Overall Study|Lost to Follow-up|2|||
126727449|NCT00808249|455951162|FG001|Overall Study|Lost to Follow-up|3|||
126727450|NCT00808249|455951163|FG002|Overall Study|Lost to Follow-up|3|||
126727451|NCT00808249|455951164|FG003|Overall Study|Lost to Follow-up|5|||
126727452|NCT00808249|455951161|FG000|Overall Study|Withdrawal by Subject|4|||
126727453|NCT00808249|455951162|FG001|Overall Study|Withdrawal by Subject|0|||
126727454|NCT00808249|455951163|FG002|Overall Study|Withdrawal by Subject|2|||
126727455|NCT00808249|455951164|FG003|Overall Study|Withdrawal by Subject|4|||
126727456|NCT00808249|455951161|FG000|Overall Study|Protocol Violation|3|||
126727457|NCT00808249|455951162|FG001|Overall Study|Protocol Violation|3|||
126727458|NCT00808249|455951163|FG002|Overall Study|Protocol Violation|3|||
126727459|NCT00808249|455951164|FG003|Overall Study|Protocol Violation|0|||
126727460|NCT00808249|455951161|FG000|Overall Study|Lack of Efficacy|1|||
126575303|NCT01170026|455403877|FG000|Overall Study|Lost to Follow-up|4|||
126575304|NCT01170026|455403878|FG001|Overall Study|Lost to Follow-up|2|||
126575305|NCT03785782|455403879|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
126575306|NCT03785782|455403880|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
126575307|NCT03785782|455403879|FG000|Overall Study|Withdrawal by Subject|1|||
126575308|NCT03785782|455403880|FG001|Overall Study|Withdrawal by Subject|1|||
126575309|NCT03785782|455403879|FG000|Overall Study|insufficient image quality.|3|||
126575310|NCT03785782|455403880|FG001|Overall Study|insufficient image quality.|0|||
126575311|NCT05777785|455403881|FG000|Overall Study|Withdrawal by Subject|5|||
126575312|NCT05777785|455403881|FG000|Overall Study|Lost to Follow-up|1|||
126575313|NCT02763319|455403886|FG000|Overall Study|Adverse Event|12|||
126575314|NCT02763319|455403887|FG001|Overall Study|Adverse Event|3|||
126575315|NCT02763319|455403886|FG000|Overall Study|Death|123|||
126575316|NCT02763319|455403887|FG001|Overall Study|Death|123|||
126575317|NCT02763319|455403886|FG000|Overall Study|Lost to Follow-up|6|||
126575318|NCT02763319|455403887|FG001|Overall Study|Lost to Follow-up|7|||
126575319|NCT02763319|455403886|FG000|Overall Study|Noncompliance with Study Drug|2|||
126575320|NCT02763319|455403887|FG001|Overall Study|Noncompliance with Study Drug|0|||
126575321|NCT02763319|455403886|FG000|Overall Study|"Captured as Other in Database"|29|||
126575322|NCT02763319|455403887|FG001|Overall Study|"Captured as Other in Database"|34|||
126575323|NCT02763319|455403886|FG000|Overall Study|Physician Decision|1|||
126575324|NCT02763319|455403887|FG001|Overall Study|Physician Decision|7|||
126575325|NCT02763319|455403886|FG000|Overall Study|Progressive Disease|24|||
126575326|NCT02763319|455403887|FG001|Overall Study|Progressive Disease|27|||
126575327|NCT02763319|455403886|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
126575328|NCT02763319|455403887|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
126575329|NCT02763319|455403886|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
126575330|NCT02763319|455403887|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
126575331|NCT02763319|455403886|FG000|Overall Study|Withdrawal by Subject|26|||
126575332|NCT02763319|455403887|FG001|Overall Study|Withdrawal by Subject|25|||
126575333|NCT04252586|455403888|FG000|Overall Study|Withdrawal by parent/guardian|3|||
126575334|NCT04252586|455403888|FG000|Overall Study|Adverse Event|1|||
126575335|NCT04252586|455403888|FG000|Overall Study|Death|2|||
126575336|NCT04252586|455403888|FG000|Overall Study|Study terminated by sponsor|4|||
126575337|NCT04252586|455403888|FG000|Overall Study|Sponsor request|10|||
126575338|NCT04252586|455403888|FG000|Overall Study|Did not complete treatment period|1|||
126575339|NCT02767765|455403889|FG000|Overall Study|Adverse Event|4|||
126727461|NCT00808249|455951162|FG001|Overall Study|Lack of Efficacy|1|||
126575340|NCT02767765|455403889|FG000|Overall Study|Death|1|||
126575341|NCT02767765|455403889|FG000|Overall Study|Insufficient response|1|||
126575342|NCT02767765|455403889|FG000|Overall Study|Lost to Follow-up|2|||
126727462|NCT00808249|455951163|FG002|Overall Study|Lack of Efficacy|0|||
126727463|NCT00808249|455951164|FG003|Overall Study|Lack of Efficacy|0|||
126727464|NCT00808249|455951161|FG000|Overall Study|study specific discontinuation criteria|1|||
126575343|NCT02767765|455403889|FG000|Overall Study|Investigator decision|1|||
126575344|NCT02767765|455403889|FG000|Overall Study|Non-Compliance|1|||
126575345|NCT02767765|455403889|FG000|Overall Study|Withdrawal by Subject|1|||
126727465|NCT00808249|455951162|FG001|Overall Study|study specific discontinuation criteria|0|||
126777034|NCT02746705|456139163|FG001|Overall Study|Lost to Follow-up|0|||
126575346|NCT01951170|455403891|FG000|Overall Study|Investigator decision|1|||
126575347|NCT04512482|455403896|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
126575348|NCT04512482|455403897|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
126575349|NCT00391898|455403910|FG000|Overall Study|Adverse Event|3|||
126575350|NCT00391898|455403911|FG001|Overall Study|Adverse Event|0|||
126575351|NCT00391898|455403910|FG000|Overall Study|Other|8|||
126575352|NCT00391898|455403911|FG001|Overall Study|Other|10|||
126575353|NCT02706717|455403914|FG000|Overall Study|Withdrawal by Subject|1|||
126575354|NCT02706717|455403915|FG001|Overall Study|Withdrawal by Subject|8|||
126575355|NCT02706717|455403914|FG000|Overall Study|Lost to Follow-up|0|||
126575356|NCT02706717|455403915|FG001|Overall Study|Lost to Follow-up|1|||
126575357|NCT02706717|455403914|FG000|Overall Study|Physician Decision|0|||
126575358|NCT02706717|455403915|FG001|Overall Study|Physician Decision|1|||
126575359|NCT02706717|455403914|FG000|Overall Study|Death|0|||
126575360|NCT02706717|455403915|FG001|Overall Study|Death|1|||
126575361|NCT02512965|455403919|FG000|Overall Study|Withdrawal by Subject|0|||
126575362|NCT02512965|455403920|FG001|Overall Study|Withdrawal by Subject|4|||
126575363|NCT00835770|455403921|FG000|Overall Study|MS Relapse|17|||
126575364|NCT00835770|455403922|FG001|Overall Study|MS Relapse|23|||
126575365|NCT00835770|455403921|FG000|Overall Study|MS Progression|14|||
126575366|NCT00835770|455403922|FG001|Overall Study|MS Progression|9|||
126575367|NCT00835770|455403921|FG000|Overall Study|Adverse Event|113|||
126575368|NCT00835770|455403922|FG001|Overall Study|Adverse Event|124|||
126575369|NCT00835770|455403921|FG000|Overall Study|Lost to Follow-up|22|||
126575370|NCT00835770|455403922|FG001|Overall Study|Lost to Follow-up|19|||
126575371|NCT00835770|455403921|FG000|Overall Study|Consent Withdrawn|144|||
126575372|NCT00835770|455403922|FG001|Overall Study|Consent Withdrawn|156|||
126575373|NCT00835770|455403921|FG000|Overall Study|Investigator Decision|42|||
126575374|NCT00835770|455403922|FG001|Overall Study|Investigator Decision|42|||
126575375|NCT00835770|455403921|FG000|Overall Study|Participant Non-Compliance|11|||
126575376|NCT00835770|455403922|FG001|Overall Study|Participant Non-Compliance|9|||
126575377|NCT00835770|455403921|FG000|Overall Study|Death|4|||
126575378|NCT00835770|455403922|FG001|Overall Study|Death|6|||
126575379|NCT00835770|455403921|FG000|Overall Study|Other|115|||
126575380|NCT00835770|455403922|FG001|Overall Study|Other|104|||
126575381|NCT00835770|455403921|FG000|Overall Study|Other|2|||
126575382|NCT00835770|455403922|FG001|Overall Study|Other|1|||
126575383|NCT01185782|455403926|FG000|Overall Study|Adverse Event|0|||
126575384|NCT01185782|455403927|FG001|Overall Study|Adverse Event|1|||
126575385|NCT01185782|455403926|FG000|Overall Study|Protocol Violation|1|||
126575386|NCT01185782|455403927|FG001|Overall Study|Protocol Violation|0|||
126575387|NCT01185782|455403926|FG000|Overall Study|Poor Response to Treatment|3|||
126575388|NCT01185782|455403927|FG001|Overall Study|Poor Response to Treatment|1|||
126575389|NCT01185782|455403926|FG000|Overall Study|Other|2|||
126575390|NCT01185782|455403927|FG001|Overall Study|Other|5|||
126575391|NCT01185782|455403926|FG000|Overall Study|Randomized but not treated|0|||
126575392|NCT01185782|455403927|FG001|Overall Study|Randomized but not treated|4|||
126575393|NCT02507752|455403928|FG000|Overall Study|Adverse Event|1|||
126575394|NCT02507752|455403928|FG000|Overall Study|Protocol Violation|6|||
126575395|NCT02507752|455403928|FG000|Overall Study|Lost to Follow-up|7|||
126575396|NCT02507752|455403928|FG000|Overall Study|Infusion reaction at first infusion|1|||
126575397|NCT02507752|455403928|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
126575398|NCT02507752|455403928|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
126575399|NCT01061151|455403933|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
126575400|NCT01061151|455403934|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
126575401|NCT01061151|455403935|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
126575402|NCT01061151|455403936|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
126575403|NCT01061151|455403933|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
126575404|NCT01061151|455403934|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
126575405|NCT01061151|455403935|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
126575406|NCT01061151|455403936|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
126575407|NCT01061151|455403933|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
126575408|NCT01061151|455403934|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
126575409|NCT01061151|455403935|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
126575410|NCT01061151|455403936|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
126575411|NCT01061151|455403933|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
126575412|NCT01061151|455403934|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
126575413|NCT01061151|455403935|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
126575414|NCT01061151|455403936|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
126575415|NCT01061151|455403933|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
126575416|NCT01061151|455403934|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
126575417|NCT01061151|455403935|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
126575418|NCT01061151|455403936|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
126575419|NCT01061151|455403933|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
126575420|NCT01061151|455403934|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
126575421|NCT01061151|455403935|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
126727466|NCT00808249|455951163|FG002|Overall Study|study specific discontinuation criteria|1|||
126575422|NCT01061151|455403936|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
126575423|NCT01061151|455403933|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
126575424|NCT01061151|455403934|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
126575425|NCT01061151|455403935|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
126575426|NCT01061151|455403936|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
126575427|NCT01061151|455403933|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
126575428|NCT01061151|455403934|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
126575429|NCT01061151|455403935|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
126575430|NCT01061151|455403936|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
126575431|NCT01061151|455403933|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
126575432|NCT01061151|455403934|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
126575433|NCT01061151|455403935|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
126575434|NCT01061151|455403936|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
126575435|NCT01061151|455403933|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
126575436|NCT01061151|455403934|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
126575437|NCT01061151|455403935|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
126575438|NCT01061151|455403936|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
126575439|NCT01061151|455403933|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
126575440|NCT01061151|455403934|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
126575441|NCT01061151|455403935|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
126575442|NCT01061151|455403936|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
126575443|NCT01061151|455403933|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
126575444|NCT01061151|455403934|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
126575445|NCT01061151|455403935|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
126575446|NCT01061151|455403936|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
126575447|NCT01061151|455403933|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
126575448|NCT01061151|455403934|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
126575449|NCT01061151|455403935|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
126575450|NCT01061151|455403936|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
126575451|NCT01061151|455403933|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
126575452|NCT01061151|455403934|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
126575453|NCT01061151|455403935|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
126575454|NCT01061151|455403936|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
126575455|NCT01061151|455403933|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
126575456|NCT01061151|455403934|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
126575457|NCT01061151|455403935|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
126575458|NCT01061151|455403936|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
126575459|NCT03740009|455403937|FG000|Overall Study|Physician Decision|9|||
126575460|NCT03740009|455403937|FG000|Overall Study|Lost to Follow-up|1|||
126575461|NCT04530747|455403948|FG000|Overall Study|Withdrawal by Subject|1|||
126575462|NCT04530747|455403949|FG001|Overall Study|Withdrawal by Subject|0|||
126575463|NCT03752151|455403950|FG000|Overall Study|Withdrawal by Subject|1|||
126575464|NCT03752151|455403950|FG000|Overall Study|Protocol Violation|1|||
126727467|NCT00808249|455951164|FG003|Overall Study|study specific discontinuation criteria|0|||
126727468|NCT00808249|455951161|FG000|Overall Study|All other reasons|2|||
126727469|NCT00808249|455951162|FG001|Overall Study|All other reasons|1|||
126727470|NCT00808249|455951163|FG002|Overall Study|All other reasons|3|||
126575465|NCT00529516|455403951|FG000|Overall Study|Adverse Event|2|||
126575466|NCT00529516|455403952|FG001|Overall Study|Adverse Event|1|||
126575467|NCT00529516|455403953|FG002|Overall Study|Adverse Event|0|||
126575468|NCT00529516|455403951|FG000|Overall Study|Withdrawal by Subject|1|||
126575469|NCT00529516|455403952|FG001|Overall Study|Withdrawal by Subject|1|||
126575470|NCT00529516|455403953|FG002|Overall Study|Withdrawal by Subject|0|||
126575471|NCT00529516|455403951|FG000|Overall Study|Lost to Follow-up|0|||
126575472|NCT00529516|455403952|FG001|Overall Study|Lost to Follow-up|0|||
126575473|NCT00529516|455403953|FG002|Overall Study|Lost to Follow-up|1|||
126575474|NCT02092116|455403957|FG000|Overall Study|Withdrawal by Subject|0|||
126575475|NCT02092116|455403958|FG001|Overall Study|Withdrawal by Subject|3|||
126575476|NCT02092116|455403957|FG000|Overall Study|Adverse Event|0|||
126575477|NCT02092116|455403958|FG001|Overall Study|Adverse Event|1|||
126575478|NCT01546753|455403960|FG000|Overall Study|anxiety|1|||
126575479|NCT01546753|455403961|FG001|Overall Study|anxiety|1|||
126575480|NCT01546753|455403960|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
126727471|NCT00808249|455951164|FG003|Overall Study|All other reasons|1|||
126727472|NCT00479557|455951167|FG000|Overall Study|Death|0|||
126575481|NCT01546753|455403961|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
126727473|NCT00479557|455951168|FG001|Overall Study|Death|0|||
126727474|NCT00479557|455951169|FG002|Overall Study|Death|0|||
126575482|NCT00939510|455403962|FG000|Overall Study|Withdrawal by Subject|1|||
126575483|NCT00716859|455403968|FG000|Overall Study|Adverse Event|4|||
126727475|NCT00479557|455951170|FG003|Overall Study|Death|0|||
126575484|NCT00716859|455403969|FG001|Overall Study|Adverse Event|1|||
126575485|NCT00716859|455403968|FG000|Overall Study|Lack of Efficacy|3|||
126575486|NCT00716859|455403969|FG001|Overall Study|Lack of Efficacy|0|||
126575487|NCT00716859|455403968|FG000|Overall Study|Withdrawal by Subject|1|||
126575488|NCT00716859|455403969|FG001|Overall Study|Withdrawal by Subject|3|||
126575489|NCT00716859|455403968|FG000|Overall Study|Not treated|1|||
126575490|NCT00716859|455403969|FG001|Overall Study|Not treated|1|||
126575491|NCT03750968|455403970|FG000|Overall Study|Adverse Event|2|||
126575492|NCT03750968|455403971|FG001|Overall Study|Adverse Event|0|||
126575493|NCT03750968|455403970|FG000|Overall Study|Lost to Follow-up|1|||
126575494|NCT03750968|455403971|FG001|Overall Study|Lost to Follow-up|3|||
126575495|NCT00411216|455403975|FG000|Overall Study|Ten participants were entered into the c|0|||
126575496|NCT00411216|455403976|FG001|Overall Study|Ten participants were entered into the c|2|||
126575497|NCT02918071|455403977|FG000|Overall Study|Withdrawal by Subject|2|||
126575498|NCT02918071|455403977|FG000|Overall Study|Lost to Follow-up|1|||
126575499|NCT00203411|455403980|FG000|Follow-up|Progressive Disease|4|||
126575500|NCT03807778|455403988|FG000|Overall Study|Adverse Event|0|||
126575501|NCT03807778|455403989|FG001|Overall Study|Adverse Event|0|||
126575502|NCT03807778|455403990|FG002|Overall Study|Adverse Event|3|||
126575503|NCT03807778|455403991|FG003|Overall Study|Adverse Event|5|||
126575504|NCT03807778|455403988|FG000|Overall Study|Progressive Disease|4|||
126575505|NCT03807778|455403989|FG001|Overall Study|Progressive Disease|2|||
126575506|NCT03807778|455403990|FG002|Overall Study|Progressive Disease|8|||
126575507|NCT03807778|455403991|FG003|Overall Study|Progressive Disease|15|||
126575508|NCT03807778|455403988|FG000|Overall Study|Symptomatic Deterioration|0|||
126575509|NCT03807778|455403989|FG001|Overall Study|Symptomatic Deterioration|1|||
126575510|NCT03807778|455403990|FG002|Overall Study|Symptomatic Deterioration|0|||
126575511|NCT03807778|455403991|FG003|Overall Study|Symptomatic Deterioration|1|||
126575512|NCT03807778|455403988|FG000|Overall Study|Withdrawal by Subject|0|||
126575513|NCT03807778|455403989|FG001|Overall Study|Withdrawal by Subject|1|||
126575514|NCT03807778|455403990|FG002|Overall Study|Withdrawal by Subject|0|||
126575515|NCT03807778|455403991|FG003|Overall Study|Withdrawal by Subject|1|||
126575516|NCT03807778|455403988|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
126575517|NCT03807778|455403989|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
126575518|NCT03807778|455403990|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
126575519|NCT03807778|455403991|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
126575520|NCT05094141|455403999|FG000|Overall Study|Death|0|||
126575521|NCT05094141|455404000|FG001|Overall Study|Death|0|||
126575522|NCT05094141|455404001|FG002|Overall Study|Death|1|||
126575523|NCT05094141|455403999|FG000|Overall Study|Withdrawal by Subject|0|||
126575524|NCT05094141|455404000|FG001|Overall Study|Withdrawal by Subject|0|||
126575525|NCT05094141|455404001|FG002|Overall Study|Withdrawal by Subject|1|||
126575526|NCT05094141|455403999|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
126575527|NCT05094141|455404000|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
126575528|NCT05094141|455404001|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
126575529|NCT05094141|455403999|FG000|Overall Study|Did not participate in randomization|0|||
126575530|NCT05094141|455404000|FG001|Overall Study|Did not participate in randomization|0|||
126575531|NCT05094141|455404001|FG002|Overall Study|Did not participate in randomization|33|||
126575532|NCT04623008|455405727|FG000|Baseline to T2|Withdrawal by Subject|4|||
126575533|NCT04623008|455405728|FG001|Baseline to T2|Withdrawal by Subject|2|||
126575534|NCT04623008|455405727|FG000|Baseline to T3|Withdrawal by Subject|4|||
126575535|NCT04623008|455405728|FG001|Baseline to T3|Withdrawal by Subject|2|||
126575536|NCT03779048|455405738|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
126575537|NCT03779048|455405739|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
126727476|NCT00479557|455951171|FG004|Overall Study|Death|0|||
126727477|NCT00479557|455951172|FG005|Overall Study|Death|1|||
126727478|NCT00479557|455951173|FG006|Overall Study|Death|0|||
126727479|NCT00479557|455951167|FG000|Overall Study|Lack of Efficacy|1|||
126727480|NCT00479557|455951168|FG001|Overall Study|Lack of Efficacy|0|||
126727481|NCT00479557|455951169|FG002|Overall Study|Lack of Efficacy|0|||
126727482|NCT00479557|455951170|FG003|Overall Study|Lack of Efficacy|0|||
126727483|NCT00479557|455951171|FG004|Overall Study|Lack of Efficacy|0|||
126575538|NCT03779048|455405740|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
126727484|NCT00479557|455951172|FG005|Overall Study|Lack of Efficacy|0|||
126575539|NCT03779048|455405738|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
126575540|NCT03779048|455405739|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
126575541|NCT03779048|455405740|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
126575542|NCT03779048|455405738|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
126575543|NCT03779048|455405739|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
126575544|NCT03779048|455405740|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
126575545|NCT04588259|455405741|FG000|Run-in Period|Run-in failure|0|||
126575546|NCT04588259|455405742|FG001|Run-in Period|Run-in failure|23|||
126575547|NCT04588259|455405741|FG000|Run-in Period|Withdrawn before randomisation|0|||
126575548|NCT04588259|455405742|FG001|Run-in Period|Withdrawn before randomisation|8|||
126575549|NCT04588259|455405741|FG000|Treatment Period|Withdrawal by Subject|6|||
126575550|NCT04588259|455405742|FG001|Treatment Period|Withdrawal by Subject|6|||
126575551|NCT00232180|455405745|FG000|Double-blind (DB) Phase|Death|186|||
126575552|NCT00232180|455405746|FG001|Double-blind (DB) Phase|Death|222|||
126575553|NCT00232180|455405747|FG002|Double-blind (DB) Phase|Death|0|||
126575554|NCT00232180|455405745|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
126575555|NCT00232180|455405746|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
126575556|NCT00232180|455405747|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
126575557|NCT00232180|455405745|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
126575558|NCT00232180|455405746|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
126575559|NCT00232180|455405747|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
126575560|NCT00232180|455405745|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
126575561|NCT00232180|455405746|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
126575562|NCT00232180|455405747|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
126575563|NCT00232180|455405745|FG000|Double-blind (DB) Phase|Adverse Event|83|||
126575564|NCT00232180|455405746|FG001|Double-blind (DB) Phase|Adverse Event|100|||
126575565|NCT00232180|455405747|FG002|Double-blind (DB) Phase|Adverse Event|0|||
126575566|NCT00232180|455405745|FG000|Double-blind (DB) Phase|Other|70|||
126575567|NCT00232180|455405746|FG001|Double-blind (DB) Phase|Other|75|||
126575568|NCT00232180|455405747|FG002|Double-blind (DB) Phase|Other|0|||
126575569|NCT00232180|455405745|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
126575570|NCT00232180|455405746|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
126575571|NCT00232180|455405747|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
126575572|NCT00232180|455405745|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
126575573|NCT00232180|455405746|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
126575574|NCT00232180|455405747|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
126575575|NCT00232180|455405745|FG000|Open Label Phase|Death|0|||
126575576|NCT00232180|455405746|FG001|Open Label Phase|Death|0|||
126575577|NCT00232180|455405747|FG002|Open Label Phase|Death|48|||
126575578|NCT00232180|455405745|FG000|Open Label Phase|Lost to Follow-up|0|||
126575579|NCT00232180|455405746|FG001|Open Label Phase|Lost to Follow-up|0|||
126575580|NCT00232180|455405747|FG002|Open Label Phase|Lost to Follow-up|5|||
126575581|NCT00232180|455405745|FG000|Open Label Phase|Protocol Violation|0|||
126575582|NCT00232180|455405746|FG001|Open Label Phase|Protocol Violation|0|||
126575583|NCT00232180|455405747|FG002|Open Label Phase|Protocol Violation|3|||
126575584|NCT00232180|455405745|FG000|Open Label Phase|Study terminated by sponsor|0|||
126575585|NCT00232180|455405746|FG001|Open Label Phase|Study terminated by sponsor|0|||
126575586|NCT00232180|455405747|FG002|Open Label Phase|Study terminated by sponsor|3|||
126575587|NCT00232180|455405745|FG000|Open Label Phase|Withdrawal by Subject|0|||
126575588|NCT00232180|455405746|FG001|Open Label Phase|Withdrawal by Subject|0|||
126575589|NCT00232180|455405747|FG002|Open Label Phase|Withdrawal by Subject|37|||
126575590|NCT00232180|455405745|FG000|Open Label Phase|Other|0|||
126575591|NCT00232180|455405746|FG001|Open Label Phase|Other|0|||
126575592|NCT00232180|455405747|FG002|Open Label Phase|Other|16|||
126575593|NCT00232180|455405745|FG000|Open Label Phase|Adverse Event|0|||
126575594|NCT00232180|455405746|FG001|Open Label Phase|Adverse Event|0|||
126575595|NCT00232180|455405747|FG002|Open Label Phase|Adverse Event|25|||
126575596|NCT00232180|455405745|FG000|Open Label Phase|Laboratory abnormality|0|||
126575597|NCT00232180|455405746|FG001|Open Label Phase|Laboratory abnormality|0|||
126575598|NCT00232180|455405747|FG002|Open Label Phase|Laboratory abnormality|10|||
126575599|NCT00232180|455405745|FG000|Open Label Phase|Randomized but not treated|0|||
126777035|NCT02746705|456139162|FG000|Overall Study|outlier scores deemed not valid|0|||
126777036|NCT02746705|456139163|FG001|Overall Study|outlier scores deemed not valid|1|||
126575600|NCT00232180|455405746|FG001|Open Label Phase|Randomized but not treated|0|||
126575601|NCT00232180|455405747|FG002|Open Label Phase|Randomized but not treated|1|||
126575602|NCT03452189|455405748|FG000|First Intervention (3 Months)|Adverse Event|1|||
126575603|NCT03452189|455405749|FG001|First Intervention (3 Months)|Adverse Event|0|||
126575604|NCT03452189|455405748|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
126575605|NCT03452189|455405749|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
126575606|NCT01571596|455405756|FG000|Overall Study|Adverse Event|2|||
126575607|NCT01571596|455405757|FG001|Overall Study|Adverse Event|0|||
126575608|NCT01571596|455405758|FG002|Overall Study|Adverse Event|0|||
126575609|NCT01571596|455405756|FG000|Overall Study|Study Terminated by the Sponsor|0|||
126575610|NCT01571596|455405757|FG001|Overall Study|Study Terminated by the Sponsor|1|||
126575611|NCT01571596|455405758|FG002|Overall Study|Study Terminated by the Sponsor|1|||
126575612|NCT04723394|455405766|FG000|Overall Study|Adverse Event|0|||
126575613|NCT04723394|455405767|FG001|Overall Study|Adverse Event|3|||
126575614|NCT04723394|455405766|FG000|Overall Study|Death|8|||
126575615|NCT04723394|455405767|FG001|Overall Study|Death|8|||
126575616|NCT04723394|455405766|FG000|Overall Study|Lost to Follow-up|20|||
126575617|NCT04723394|455405767|FG001|Overall Study|Lost to Follow-up|17|||
126575618|NCT04723394|455405766|FG000|Overall Study|Physician Decision|1|||
126575619|NCT04723394|455405767|FG001|Overall Study|Physician Decision|0|||
126575620|NCT04723394|455405766|FG000|Overall Study|Withdrawal by Subject|20|||
126575621|NCT04723394|455405767|FG001|Overall Study|Withdrawal by Subject|34|||
126575622|NCT04723394|455405766|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
126575623|NCT04723394|455405767|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
126575624|NCT00774397|455405768|FG000|Overall Study|Adverse Event|1|||
126575625|NCT00774397|455405769|FG001|Overall Study|Adverse Event|3|||
126575626|NCT00774397|455405770|FG002|Overall Study|Adverse Event|16|||
126575627|NCT00774397|455405771|FG003|Overall Study|Adverse Event|8|||
126575628|NCT00774397|455405772|FG004|Overall Study|Adverse Event|8|||
126575629|NCT00774397|455405773|FG005|Overall Study|Adverse Event|3|||
126575630|NCT00774397|455405774|FG006|Overall Study|Adverse Event|16|||
126575631|NCT00774397|455405768|FG000|Overall Study|Lack of Efficacy|11|||
126575632|NCT00774397|455405769|FG001|Overall Study|Lack of Efficacy|4|||
126575633|NCT00774397|455405770|FG002|Overall Study|Lack of Efficacy|5|||
126575634|NCT00774397|455405771|FG003|Overall Study|Lack of Efficacy|3|||
126575635|NCT00774397|455405772|FG004|Overall Study|Lack of Efficacy|27|||
126575636|NCT00774397|455405773|FG005|Overall Study|Lack of Efficacy|15|||
126575637|NCT00774397|455405774|FG006|Overall Study|Lack of Efficacy|9|||
126575638|NCT00774397|455405768|FG000|Overall Study|Protocol Violation|0|||
126575639|NCT00774397|455405769|FG001|Overall Study|Protocol Violation|1|||
126575640|NCT00774397|455405770|FG002|Overall Study|Protocol Violation|3|||
126575641|NCT00774397|455405771|FG003|Overall Study|Protocol Violation|1|||
126575642|NCT00774397|455405772|FG004|Overall Study|Protocol Violation|2|||
126575643|NCT00774397|455405773|FG005|Overall Study|Protocol Violation|1|||
126575644|NCT00774397|455405774|FG006|Overall Study|Protocol Violation|0|||
126575645|NCT00774397|455405768|FG000|Overall Study|Lost to Follow-up|0|||
126575646|NCT00774397|455405769|FG001|Overall Study|Lost to Follow-up|1|||
126575647|NCT00774397|455405770|FG002|Overall Study|Lost to Follow-up|1|||
126575648|NCT00774397|455405771|FG003|Overall Study|Lost to Follow-up|1|||
126575649|NCT00774397|455405772|FG004|Overall Study|Lost to Follow-up|0|||
126575650|NCT00774397|455405773|FG005|Overall Study|Lost to Follow-up|1|||
126575651|NCT00774397|455405774|FG006|Overall Study|Lost to Follow-up|0|||
126575652|NCT00774397|455405768|FG000|Overall Study|Refused to continue trial medication|1|||
126575653|NCT00774397|455405769|FG001|Overall Study|Refused to continue trial medication|3|||
126575654|NCT00774397|455405770|FG002|Overall Study|Refused to continue trial medication|2|||
126575655|NCT00774397|455405771|FG003|Overall Study|Refused to continue trial medication|2|||
126575656|NCT00774397|455405772|FG004|Overall Study|Refused to continue trial medication|6|||
126575657|NCT00774397|455405773|FG005|Overall Study|Refused to continue trial medication|2|||
126575658|NCT00774397|455405774|FG006|Overall Study|Refused to continue trial medication|3|||
126575659|NCT00774397|455405768|FG000|Overall Study|Not treated|0|||
126575660|NCT00774397|455405769|FG001|Overall Study|Not treated|0|||
126575661|NCT00774397|455405770|FG002|Overall Study|Not treated|0|||
126575662|NCT00774397|455405771|FG003|Overall Study|Not treated|0|||
126575663|NCT00774397|455405772|FG004|Overall Study|Not treated|1|||
126575664|NCT00774397|455405773|FG005|Overall Study|Not treated|0|||
126575665|NCT00774397|455405774|FG006|Overall Study|Not treated|1|||
126575666|NCT00774397|455405768|FG000|Overall Study|Other than those stated above|1|||
126575667|NCT00774397|455405769|FG001|Overall Study|Other than those stated above|1|||
126575668|NCT00774397|455405770|FG002|Overall Study|Other than those stated above|3|||
126575669|NCT00774397|455405771|FG003|Overall Study|Other than those stated above|2|||
126575670|NCT00774397|455405772|FG004|Overall Study|Other than those stated above|2|||
126575671|NCT00774397|455405773|FG005|Overall Study|Other than those stated above|0|||
126575672|NCT00774397|455405774|FG006|Overall Study|Other than those stated above|1|||
126575673|NCT00077675|455405780|FG000|Overall Study|Adverse Event|1|||
126575674|NCT00077675|455405781|FG001|Overall Study|Adverse Event|2|||
126575675|NCT00077675|455405780|FG000|Overall Study|Lost to Follow-up|6|||
126575676|NCT00077675|455405781|FG001|Overall Study|Lost to Follow-up|3|||
126575677|NCT00077675|455405780|FG000|Overall Study|Withdrawal by Subject|1|||
126575678|NCT00077675|455405781|FG001|Overall Study|Withdrawal by Subject|0|||
126575679|NCT00077675|455405780|FG000|Overall Study|Other|0|||
126575680|NCT00077675|455405781|FG001|Overall Study|Other|1|||
126575681|NCT00077675|455405780|FG000|Overall Study|Never received study treatment|3|||
126575682|NCT00077675|455405781|FG001|Overall Study|Never received study treatment|3|||
126575683|NCT02765100|455405784|FG000|Overall Study|subject found ineligible after baseline|1|||
126575684|NCT02765100|455405785|FG001|Overall Study|subject found ineligible after baseline|1|||
126575685|NCT02765100|455405784|FG000|Overall Study|Lost to Follow-up|0|||
126575686|NCT02765100|455405785|FG001|Overall Study|Lost to Follow-up|1|||
126575687|NCT02675244|455405786|FG000|Overall Study|Death|9|||
126575688|NCT02675244|455405787|FG001|Overall Study|Death|6|||
126575689|NCT02675244|455405786|FG000|Overall Study|Withdrawal by Subject|3|||
126575690|NCT02675244|455405787|FG001|Overall Study|Withdrawal by Subject|6|||
126575691|NCT02675244|455405786|FG000|Overall Study|Lost to Follow-up|1|||
126575692|NCT02675244|455405787|FG001|Overall Study|Lost to Follow-up|1|||
126575693|NCT02675244|455405786|FG000|Overall Study|Ongoing at 2 Years|190|||
126575694|NCT02675244|455405787|FG001|Overall Study|Ongoing at 2 Years|185|||
126575695|NCT02652442|455405788|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
126575696|NCT00293293|455405791|FG000|Overall Study|Withdrawal by Subject|1|||
126575697|NCT00293293|455405792|FG001|Overall Study|Withdrawal by Subject|1|||
126523625|NCT03725982|455210294|FG001|First Intervention|Physician Decision|1|||
126523626|NCT00352365|455210295|FG000|Induction Therapy|Adverse Event|7|||
126523627|NCT00352365|455210295|FG000|Induction Therapy|Progression/Relapse|8|||
126523628|NCT00352365|455210295|FG000|Induction Therapy|Death|7|||
126523629|NCT00352365|455210295|FG000|Induction Therapy|Not protocol specified|1|||
126523630|NCT00352365|455210295|FG000|Induction Therapy|Not eligible|3|||
126523631|NCT00352365|455210295|FG000|Induction Therapy|Death before starting protocol therapy|1|||
126523632|NCT00352365|455210295|FG000|Maintenance Therapy|Progression/Relapse|3|||
126523633|NCT00352365|455210295|FG000|Maintenance Therapy|Death|2|||
126523634|NCT00352365|455210295|FG000|Maintenance Therapy|Not protocol specified|3|||
126523635|NCT00352365|455210295|FG000|Maintenance Therapy|Not eligible|4|||
126523636|NCT00987467|455210301|FG000|Overall Study|Lost to Follow-up|2|||
126523637|NCT00512135|455210302|FG000|Overall Study|Not Treated|5|||
126523638|NCT00512135|455210302|FG000|Overall Study|Lack of Efficacy|2|||
126523639|NCT00512135|455210302|FG000|Overall Study|Adverse Event|6|||
126523640|NCT00512135|455210302|FG000|Overall Study|Withdrawal by Subject|22|||
126523641|NCT00512135|455210302|FG000|Overall Study|Lost to Follow-up|27|||
126523642|NCT00512135|455210302|FG000|Overall Study|Other|22|||
126523643|NCT02646423|455210303|FG000|Overall Study|Adverse Event|5|||
126523644|NCT02646423|455210304|FG001|Overall Study|Adverse Event|7|||
126523645|NCT02646423|455210303|FG000|Overall Study|Ineligible|2|||
126523646|NCT02646423|455210304|FG001|Overall Study|Ineligible|1|||
126523647|NCT01227889|455210305|FG000|Randomized Phase (RP)|Adverse Event|13|||
126523648|NCT01227889|455210306|FG001|Randomized Phase (RP)|Adverse Event|0|||
126523649|NCT01227889|455210305|FG000|Randomized Phase (RP)|Physician Decision|13|||
126523650|NCT01227889|455210306|FG001|Randomized Phase (RP)|Physician Decision|5|||
126523651|NCT01227889|455210305|FG000|Randomized Phase (RP)|Progressive Disease|135|||
126523652|NCT01227889|455210306|FG001|Randomized Phase (RP)|Progressive Disease|52|||
126523653|NCT01227889|455210305|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
126523654|NCT01227889|455210306|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
126523655|NCT01227889|455210305|FG000|Randomized Phase (RP)|Missing|1|||
126523656|NCT01227889|455210306|FG001|Randomized Phase (RP)|Missing|3|||
126523657|NCT01227889|455210305|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
126523658|NCT01227889|455210306|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
126523659|NCT01227889|455210305|FG000|Crossover Phase|Adverse Event|0|||
126523660|NCT01227889|455210306|FG001|Crossover Phase|Adverse Event|1|||
126523661|NCT01227889|455210305|FG000|Crossover Phase|Physician Decision|0|||
126523662|NCT01227889|455210306|FG001|Crossover Phase|Physician Decision|3|||
126523663|NCT01227889|455210305|FG000|Crossover Phase|Progressive Disease|0|||
126523664|NCT01227889|455210306|FG001|Crossover Phase|Progressive Disease|31|||
126523665|NCT01227889|455210305|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
126523666|NCT01227889|455210306|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
126523667|NCT01227889|455210305|FG000|Crossover Phase|Withdrawal by Subject|0|||
126523668|NCT01227889|455210306|FG001|Crossover Phase|Withdrawal by Subject|1|||
126523669|NCT05348681|455210309|FG000|Overall Study|Study terminated by Sponsor|8|||
126523670|NCT05348681|455210310|FG001|Overall Study|Study terminated by Sponsor|3|||
126523671|NCT05348681|455210309|FG000|Overall Study|Withdrawal by Subject|1|||
126523672|NCT05348681|455210310|FG001|Overall Study|Withdrawal by Subject|1|||
126523673|NCT05348681|455210309|FG000|Overall Study|Lost to Follow-up|1|||
126523674|NCT05348681|455210310|FG001|Overall Study|Lost to Follow-up|1|||
126523675|NCT05348681|455210309|FG000|Overall Study|Adverse Event|1|||
126523676|NCT05348681|455210310|FG001|Overall Study|Adverse Event|0|||
126523677|NCT05348681|455210309|FG000|Overall Study|Other|2|||
126523678|NCT05348681|455210310|FG001|Overall Study|Other|1|||
126523679|NCT02937545|455210312|FG000|Overall Study|Withdrawal by Subject|1|||
126523680|NCT02937545|455210313|FG001|Overall Study|Withdrawal by Subject|2|||
126523681|NCT02937545|455210314|FG002|Overall Study|Withdrawal by Subject|6|||
126523682|NCT02937545|455210315|FG003|Overall Study|Withdrawal by Subject|7|||
126523683|NCT02937545|455210312|FG000|Overall Study|Lost to Follow-up|1|||
126523684|NCT02937545|455210313|FG001|Overall Study|Lost to Follow-up|0|||
126523685|NCT02937545|455210314|FG002|Overall Study|Lost to Follow-up|0|||
126523686|NCT02937545|455210315|FG003|Overall Study|Lost to Follow-up|0|||
126523687|NCT02007577|455210316|FG000|Overall Study|Adverse Event|1|||
126523688|NCT02007577|455210317|FG001|Overall Study|Adverse Event|0|||
126523689|NCT02007577|455210316|FG000|Overall Study|Withdrawal by Subject|0|||
126523690|NCT02007577|455210317|FG001|Overall Study|Withdrawal by Subject|1|||
126523691|NCT02504294|455210318|FG000|Overall Study|Adverse Event|15|||
126523692|NCT02504294|455210319|FG001|Overall Study|Adverse Event|12|||
126523693|NCT02504294|455210318|FG000|Overall Study|Withdrawal by Subject|7|||
126523694|NCT02504294|455210319|FG001|Overall Study|Withdrawal by Subject|1|||
126523695|NCT02504294|455210318|FG000|Overall Study|Protocol Violation|27|||
126523696|NCT02504294|455210319|FG001|Overall Study|Protocol Violation|26|||
126523697|NCT02504294|455210318|FG000|Overall Study|Physician Decision|1|||
126523698|NCT02504294|455210319|FG001|Overall Study|Physician Decision|2|||
126523699|NCT02504294|455210318|FG000|Overall Study|Lost to Follow-up|6|||
126523700|NCT02504294|455210319|FG001|Overall Study|Lost to Follow-up|7|||
126523701|NCT01985126|455210320|FG000|Overall Study|Death|15|||
126523702|NCT01985126|455210321|FG001|Overall Study|Death|69|||
126575698|NCT00293293|455405791|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
126575699|NCT00293293|455405792|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
126575700|NCT00293293|455405791|FG000|Overall Study|Patient discontinued chemotherapy|0|||
126575701|NCT00293293|455405792|FG001|Overall Study|Patient discontinued chemotherapy|1|||
126575702|NCT02988817|455405793|FG000|Overall Study|Withdrawal by Subject|1|||
126575703|NCT02988817|455405794|FG001|Overall Study|Withdrawal by Subject|0|||
126575704|NCT02988817|455405795|FG002|Overall Study|Withdrawal by Subject|0|||
126575705|NCT02988817|455405796|FG003|Overall Study|Withdrawal by Subject|1|||
126575706|NCT02988817|455405797|FG004|Overall Study|Withdrawal by Subject|3|||
126727485|NCT00479557|455951173|FG006|Overall Study|Lack of Efficacy|0|||
126727486|NCT00479557|455951167|FG000|Overall Study|Lost to Follow-up|0|||
126727487|NCT00479557|455951168|FG001|Overall Study|Lost to Follow-up|2|||
126727488|NCT00479557|455951169|FG002|Overall Study|Lost to Follow-up|0|||
126727489|NCT00479557|455951170|FG003|Overall Study|Lost to Follow-up|2|||
126727490|NCT00479557|455951171|FG004|Overall Study|Lost to Follow-up|0|||
126727491|NCT00479557|455951172|FG005|Overall Study|Lost to Follow-up|0|||
126727492|NCT00479557|455951173|FG006|Overall Study|Lost to Follow-up|0|||
126575707|NCT02988817|455405798|FG005|Overall Study|Withdrawal by Subject|1|||
126575708|NCT02988817|455405799|FG006|Overall Study|Withdrawal by Subject|2|||
126575709|NCT02988817|455405800|FG007|Overall Study|Withdrawal by Subject|1|||
126575710|NCT02988817|455405801|FG008|Overall Study|Withdrawal by Subject|1|||
126575711|NCT02988817|455405802|FG009|Overall Study|Withdrawal by Subject|1|||
126575712|NCT02988817|455405803|FG010|Overall Study|Withdrawal by Subject|1|||
126575713|NCT02988817|455405804|FG011|Overall Study|Withdrawal by Subject|12|||
126575714|NCT02988817|455405805|FG012|Overall Study|Withdrawal by Subject|6|||
126575715|NCT02988817|455405806|FG013|Overall Study|Withdrawal by Subject|6|||
126575716|NCT02988817|455405807|FG014|Overall Study|Withdrawal by Subject|4|||
126575717|NCT02988817|455405808|FG015|Overall Study|Withdrawal by Subject|5|||
126575718|NCT02988817|455405809|FG016|Overall Study|Withdrawal by Subject|4|||
126575719|NCT02988817|455405810|FG017|Overall Study|Withdrawal by Subject|11|||
126575720|NCT02988817|455405811|FG018|Overall Study|Withdrawal by Subject|4|||
126575721|NCT02988817|455405812|FG019|Overall Study|Withdrawal by Subject|2|||
126575722|NCT02988817|455405793|FG000|Overall Study|Death|0|||
126575723|NCT02988817|455405794|FG001|Overall Study|Death|1|||
126575724|NCT02988817|455405795|FG002|Overall Study|Death|3|||
126575725|NCT02988817|455405796|FG003|Overall Study|Death|1|||
126575726|NCT02988817|455405797|FG004|Overall Study|Death|6|||
126575727|NCT02988817|455405798|FG005|Overall Study|Death|10|||
126575728|NCT02988817|455405799|FG006|Overall Study|Death|1|||
126575729|NCT02988817|455405800|FG007|Overall Study|Death|2|||
126575730|NCT02988817|455405801|FG008|Overall Study|Death|1|||
126575731|NCT02988817|455405802|FG009|Overall Study|Death|5|||
126575732|NCT02988817|455405803|FG010|Overall Study|Death|1|||
126575733|NCT02988817|455405804|FG011|Overall Study|Death|8|||
126575734|NCT02988817|455405805|FG012|Overall Study|Death|9|||
126575735|NCT02988817|455405806|FG013|Overall Study|Death|17|||
126575736|NCT02988817|455405807|FG014|Overall Study|Death|18|||
126575737|NCT02988817|455405808|FG015|Overall Study|Death|30|||
126575738|NCT02988817|455405809|FG016|Overall Study|Death|17|||
126575739|NCT02988817|455405810|FG017|Overall Study|Death|38|||
126575740|NCT02988817|455405811|FG018|Overall Study|Death|14|||
126575741|NCT02988817|455405812|FG019|Overall Study|Death|16|||
126575742|NCT02988817|455405793|FG000|Overall Study|Other|0|||
126575743|NCT02988817|455405794|FG001|Overall Study|Other|0|||
126575744|NCT02988817|455405795|FG002|Overall Study|Other|0|||
126575745|NCT02988817|455405796|FG003|Overall Study|Other|1|||
126575746|NCT02988817|455405797|FG004|Overall Study|Other|1|||
126575747|NCT02988817|455405798|FG005|Overall Study|Other|0|||
126575748|NCT02988817|455405799|FG006|Overall Study|Other|0|||
126575749|NCT02988817|455405800|FG007|Overall Study|Other|0|||
126575750|NCT02988817|455405801|FG008|Overall Study|Other|0|||
126575751|NCT02988817|455405802|FG009|Overall Study|Other|0|||
126575752|NCT02988817|455405803|FG010|Overall Study|Other|0|||
126575753|NCT02988817|455405804|FG011|Overall Study|Other|0|||
126575754|NCT02988817|455405805|FG012|Overall Study|Other|0|||
126575755|NCT02988817|455405806|FG013|Overall Study|Other|0|||
126575756|NCT02988817|455405807|FG014|Overall Study|Other|0|||
126575757|NCT02988817|455405808|FG015|Overall Study|Other|1|||
126575758|NCT02988817|455405809|FG016|Overall Study|Other|0|||
126575759|NCT02988817|455405810|FG017|Overall Study|Other|0|||
126575760|NCT02988817|455405811|FG018|Overall Study|Other|0|||
126727493|NCT00479557|455951167|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
126575761|NCT02988817|455405812|FG019|Overall Study|Other|0|||
126575762|NCT02988817|455405793|FG000|Overall Study|Lost to Follow-up|0|||
126575763|NCT02988817|455405794|FG001|Overall Study|Lost to Follow-up|0|||
126575764|NCT02988817|455405795|FG002|Overall Study|Lost to Follow-up|0|||
126575765|NCT02988817|455405796|FG003|Overall Study|Lost to Follow-up|0|||
126575766|NCT02988817|455405797|FG004|Overall Study|Lost to Follow-up|0|||
126575767|NCT02988817|455405798|FG005|Overall Study|Lost to Follow-up|0|||
126575768|NCT02988817|455405799|FG006|Overall Study|Lost to Follow-up|0|||
126727494|NCT00479557|455951168|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
126777037|NCT02124746|456139164|FG000|Overall Study|Adverse Event|2|||
126575769|NCT02988817|455405800|FG007|Overall Study|Lost to Follow-up|0|||
126575770|NCT02988817|455405801|FG008|Overall Study|Lost to Follow-up|1|||
126575771|NCT02988817|455405802|FG009|Overall Study|Lost to Follow-up|0|||
126575772|NCT02988817|455405803|FG010|Overall Study|Lost to Follow-up|1|||
126575773|NCT02988817|455405804|FG011|Overall Study|Lost to Follow-up|1|||
126727495|NCT00479557|455951169|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
126523703|NCT01985126|455210320|FG000|Overall Study|Lost to Follow-up|0|||
126523704|NCT01985126|455210321|FG001|Overall Study|Lost to Follow-up|8|||
126523705|NCT01985126|455210320|FG000|Overall Study|Study Terminated By Sponsor|1|||
126523706|NCT01985126|455210321|FG001|Overall Study|Study Terminated By Sponsor|22|||
126523707|NCT01985126|455210320|FG000|Overall Study|Withdrawal by Subject|2|||
126523708|NCT01985126|455210321|FG001|Overall Study|Withdrawal by Subject|7|||
126523709|NCT01953926|455210324|FG000|Overall Study|Withdrawal by Subject|23|||
126523710|NCT01953926|455210325|FG001|Overall Study|Withdrawal by Subject|3|||
126523711|NCT01953926|455210326|FG002|Overall Study|Withdrawal by Subject|3|||
126523712|NCT01953926|455210327|FG003|Overall Study|Withdrawal by Subject|5|||
126523713|NCT01953926|455210328|FG004|Overall Study|Withdrawal by Subject|6|||
126523714|NCT01953926|455210329|FG005|Overall Study|Withdrawal by Subject|0|||
126523715|NCT01953926|455210330|FG006|Overall Study|Withdrawal by Subject|1|||
126523716|NCT01953926|455210324|FG000|Overall Study|Physician Decision|1|||
126523717|NCT01953926|455210325|FG001|Overall Study|Physician Decision|0|||
126523718|NCT01953926|455210326|FG002|Overall Study|Physician Decision|0|||
126523719|NCT01953926|455210327|FG003|Overall Study|Physician Decision|0|||
126523720|NCT01953926|455210328|FG004|Overall Study|Physician Decision|2|||
126523721|NCT01953926|455210329|FG005|Overall Study|Physician Decision|0|||
126523722|NCT01953926|455210330|FG006|Overall Study|Physician Decision|0|||
126523723|NCT01953926|455210324|FG000|Overall Study|Lost to Follow-up|18|||
126523724|NCT01953926|455210325|FG001|Overall Study|Lost to Follow-up|3|||
126523725|NCT01953926|455210326|FG002|Overall Study|Lost to Follow-up|0|||
126523726|NCT01953926|455210327|FG003|Overall Study|Lost to Follow-up|5|||
126523727|NCT01953926|455210328|FG004|Overall Study|Lost to Follow-up|3|||
126523728|NCT01953926|455210329|FG005|Overall Study|Lost to Follow-up|0|||
126523729|NCT01953926|455210330|FG006|Overall Study|Lost to Follow-up|0|||
126523730|NCT01953926|455210324|FG000|Overall Study|Protocol Violation|1|||
126523731|NCT01953926|455210325|FG001|Overall Study|Protocol Violation|0|||
126523732|NCT01953926|455210326|FG002|Overall Study|Protocol Violation|0|||
126523733|NCT01953926|455210327|FG003|Overall Study|Protocol Violation|0|||
126523734|NCT01953926|455210328|FG004|Overall Study|Protocol Violation|0|||
126523735|NCT01953926|455210329|FG005|Overall Study|Protocol Violation|0|||
126523736|NCT01953926|455210330|FG006|Overall Study|Protocol Violation|0|||
126523737|NCT01953926|455210324|FG000|Overall Study|Other, Disease progression|2|||
126523738|NCT01953926|455210325|FG001|Overall Study|Other, Disease progression|1|||
126523739|NCT01953926|455210326|FG002|Overall Study|Other, Disease progression|0|||
126523740|NCT01953926|455210327|FG003|Overall Study|Other, Disease progression|0|||
126523741|NCT01953926|455210328|FG004|Overall Study|Other, Disease progression|1|||
126523742|NCT01953926|455210329|FG005|Overall Study|Other, Disease progression|0|||
126523743|NCT01953926|455210330|FG006|Overall Study|Other, Disease progression|0|||
126523744|NCT01953926|455210324|FG000|Overall Study|Discontinuation of study by sponsor|41|||
126523745|NCT01953926|455210325|FG001|Overall Study|Discontinuation of study by sponsor|7|||
126523746|NCT01953926|455210326|FG002|Overall Study|Discontinuation of study by sponsor|5|||
126523747|NCT01953926|455210327|FG003|Overall Study|Discontinuation of study by sponsor|12|||
126523748|NCT01953926|455210328|FG004|Overall Study|Discontinuation of study by sponsor|46|||
126523749|NCT01953926|455210329|FG005|Overall Study|Discontinuation of study by sponsor|5|||
126523750|NCT01953926|455210330|FG006|Overall Study|Discontinuation of study by sponsor|6|||
126523751|NCT01953926|455210324|FG000|Overall Study|Not Treated|1|||
126523752|NCT01953926|455210325|FG001|Overall Study|Not Treated|0|||
126523753|NCT01953926|455210326|FG002|Overall Study|Not Treated|1|||
126523754|NCT01953926|455210327|FG003|Overall Study|Not Treated|0|||
126523755|NCT01953926|455210328|FG004|Overall Study|Not Treated|0|||
126523756|NCT01953926|455210329|FG005|Overall Study|Not Treated|0|||
126523757|NCT01953926|455210330|FG006|Overall Study|Not Treated|0|||
126523758|NCT00784043|455210334|FG000|Overall Study|Withdrawal by Subject|8|||
126523759|NCT00784043|455210335|FG001|Overall Study|Withdrawal by Subject|5|||
126523760|NCT00784043|455210334|FG000|Overall Study|Protocol Terminated|23|||
126523761|NCT00784043|455210335|FG001|Overall Study|Protocol Terminated|1|||
126523762|NCT03585244|455210340|FG000|Overall Study|Withdrawal by Subject|15|||
126523763|NCT06281548|455210342|FG000|Overall Study|Lost to Follow-up|3|||
126523764|NCT00288587|455210343|FG000|Overall Study|Death|4|||
126523765|NCT00288587|455210344|FG001|Overall Study|Death|4|||
126523766|NCT00288587|455210343|FG000|Overall Study|Transplant|0|||
126523767|NCT00288587|455210344|FG001|Overall Study|Transplant|3|||
126523768|NCT00288587|455210343|FG000|Overall Study|Adverse Event|0|||
126523769|NCT00288587|455210344|FG001|Overall Study|Adverse Event|1|||
126523770|NCT00288587|455210343|FG000|Overall Study|Physician Decision|0|||
126523771|NCT00288587|455210344|FG001|Overall Study|Physician Decision|2|||
126523772|NCT00288587|455210343|FG000|Overall Study|Severe Aortic Stenosis|1|||
126523773|NCT00288587|455210344|FG001|Overall Study|Severe Aortic Stenosis|0|||
126523774|NCT03538626|455210345|FG000|Overall Study|Withdrawal by Subject|0|||
126575774|NCT02988817|455405805|FG012|Overall Study|Lost to Follow-up|0|||
126727496|NCT00479557|455951170|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
126727497|NCT00479557|455951171|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
126727498|NCT00479557|455951172|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
126727499|NCT00479557|455951173|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
126727500|NCT00479557|455951167|FG000|Overall Study|AE not related to Study Drug|1|||
126727501|NCT00479557|455951168|FG001|Overall Study|AE not related to Study Drug|3|||
126727502|NCT00479557|455951169|FG002|Overall Study|AE not related to Study Drug|0|||
126727503|NCT00479557|455951170|FG003|Overall Study|AE not related to Study Drug|0|||
126727504|NCT00479557|455951171|FG004|Overall Study|AE not related to Study Drug|2|||
126727505|NCT00479557|455951172|FG005|Overall Study|AE not related to Study Drug|2|||
126727506|NCT00479557|455951173|FG006|Overall Study|AE not related to Study Drug|1|||
126727507|NCT00479557|455951167|FG000|Overall Study|Caregiver Request|2|||
126523775|NCT03538626|455210346|FG001|Overall Study|Withdrawal by Subject|1|||
126523776|NCT03538626|455210347|FG002|Overall Study|Withdrawal by Subject|0|||
126523777|NCT03538626|455210348|FG003|Overall Study|Withdrawal by Subject|0|||
126523778|NCT03538626|455210349|FG004|Overall Study|Withdrawal by Subject|0|||
126523779|NCT03538626|455210350|FG005|Overall Study|Withdrawal by Subject|0|||
126523780|NCT03538626|455210351|FG006|Overall Study|Withdrawal by Subject|0|||
126523781|NCT03538626|455210352|FG007|Overall Study|Withdrawal by Subject|0|||
126523782|NCT03538626|455210345|FG000|Overall Study|Lost to Follow-up|0|||
126523783|NCT03538626|455210346|FG001|Overall Study|Lost to Follow-up|0|||
126523784|NCT03538626|455210347|FG002|Overall Study|Lost to Follow-up|0|||
126523785|NCT03538626|455210348|FG003|Overall Study|Lost to Follow-up|0|||
126523786|NCT03538626|455210349|FG004|Overall Study|Lost to Follow-up|0|||
126523787|NCT03538626|455210350|FG005|Overall Study|Lost to Follow-up|0|||
126523788|NCT03538626|455210351|FG006|Overall Study|Lost to Follow-up|1|||
126523789|NCT03538626|455210352|FG007|Overall Study|Lost to Follow-up|0|||
126523790|NCT01434602|455210357|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
126523791|NCT01434602|455210358|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
126523792|NCT01434602|455210359|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
126523793|NCT01434602|455210360|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
126523794|NCT01434602|455210361|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
126523795|NCT01434602|455210357|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
126523796|NCT01434602|455210358|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
126523797|NCT01434602|455210359|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
126523798|NCT01434602|455210360|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
126523799|NCT01434602|455210361|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
126523800|NCT01434602|455210357|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
126523801|NCT01434602|455210358|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
126523802|NCT01434602|455210359|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
126523803|NCT01434602|455210360|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
126523804|NCT01434602|455210361|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
126523805|NCT01434602|455210357|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
126523806|NCT01434602|455210358|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
126523807|NCT01434602|455210359|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
126523808|NCT01434602|455210360|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
126523809|NCT01434602|455210361|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
126523810|NCT01434602|455210357|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
126523811|NCT01434602|455210358|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
126523812|NCT01434602|455210359|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
126523813|NCT01434602|455210360|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
126523814|NCT01434602|455210361|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
126523815|NCT01434602|455210357|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
126523816|NCT01434602|455210358|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
126523817|NCT01434602|455210359|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
126523818|NCT01434602|455210360|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
126523819|NCT01434602|455210361|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
126523820|NCT01434602|455210357|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
126575775|NCT02988817|455405806|FG013|Overall Study|Lost to Follow-up|0|||
126575776|NCT02988817|455405807|FG014|Overall Study|Lost to Follow-up|1|||
126727508|NCT00479557|455951168|FG001|Overall Study|Caregiver Request|2|||
126727509|NCT00479557|455951169|FG002|Overall Study|Caregiver Request|2|||
126727510|NCT00479557|455951170|FG003|Overall Study|Caregiver Request|0|||
126575777|NCT02988817|455405808|FG015|Overall Study|Lost to Follow-up|1|||
126575778|NCT02988817|455405809|FG016|Overall Study|Lost to Follow-up|2|||
126575779|NCT02988817|455405810|FG017|Overall Study|Lost to Follow-up|3|||
126575780|NCT02988817|455405811|FG018|Overall Study|Lost to Follow-up|0|||
126575781|NCT02988817|455405812|FG019|Overall Study|Lost to Follow-up|0|||
126575782|NCT02988817|455405793|FG000|Overall Study|Sponsor decision|0|||
126575783|NCT02988817|455405794|FG001|Overall Study|Sponsor decision|0|||
126575784|NCT02988817|455405795|FG002|Overall Study|Sponsor decision|0|||
126575785|NCT02988817|455405796|FG003|Overall Study|Sponsor decision|0|||
126575786|NCT02988817|455405797|FG004|Overall Study|Sponsor decision|0|||
126575787|NCT02988817|455405798|FG005|Overall Study|Sponsor decision|0|||
126575788|NCT02988817|455405799|FG006|Overall Study|Sponsor decision|0|||
126575789|NCT02988817|455405800|FG007|Overall Study|Sponsor decision|0|||
126575790|NCT02988817|455405801|FG008|Overall Study|Sponsor decision|0|||
126575791|NCT02988817|455405802|FG009|Overall Study|Sponsor decision|0|||
126575792|NCT02988817|455405803|FG010|Overall Study|Sponsor decision|0|||
126575793|NCT02988817|455405804|FG011|Overall Study|Sponsor decision|1|||
126575794|NCT02988817|455405805|FG012|Overall Study|Sponsor decision|1|||
126575795|NCT02988817|455405806|FG013|Overall Study|Sponsor decision|2|||
126575796|NCT02988817|455405807|FG014|Overall Study|Sponsor decision|2|||
126575797|NCT02988817|455405808|FG015|Overall Study|Sponsor decision|6|||
126575798|NCT02988817|455405809|FG016|Overall Study|Sponsor decision|2|||
126575799|NCT02988817|455405810|FG017|Overall Study|Sponsor decision|3|||
126575800|NCT02988817|455405811|FG018|Overall Study|Sponsor decision|2|||
126575801|NCT02988817|455405812|FG019|Overall Study|Sponsor decision|7|||
126575802|NCT02988817|455405793|FG000|Overall Study|Physician Decision|0|||
126575803|NCT02988817|455405794|FG001|Overall Study|Physician Decision|0|||
126575804|NCT02988817|455405795|FG002|Overall Study|Physician Decision|0|||
126575805|NCT02988817|455405796|FG003|Overall Study|Physician Decision|0|||
126575806|NCT02988817|455405797|FG004|Overall Study|Physician Decision|0|||
126575807|NCT02988817|455405798|FG005|Overall Study|Physician Decision|0|||
126727511|NCT00479557|455951171|FG004|Overall Study|Caregiver Request|1|||
126727512|NCT00479557|455951172|FG005|Overall Study|Caregiver Request|2|||
126575808|NCT02988817|455405799|FG006|Overall Study|Physician Decision|0|||
126575809|NCT02988817|455405800|FG007|Overall Study|Physician Decision|0|||
126575810|NCT02988817|455405801|FG008|Overall Study|Physician Decision|0|||
126575811|NCT02988817|455405802|FG009|Overall Study|Physician Decision|0|||
126575812|NCT02988817|455405803|FG010|Overall Study|Physician Decision|0|||
126575813|NCT02988817|455405804|FG011|Overall Study|Physician Decision|0|||
126575814|NCT02988817|455405805|FG012|Overall Study|Physician Decision|0|||
126575815|NCT02988817|455405806|FG013|Overall Study|Physician Decision|0|||
126575816|NCT02988817|455405807|FG014|Overall Study|Physician Decision|0|||
126575817|NCT02988817|455405808|FG015|Overall Study|Physician Decision|1|||
126575818|NCT02988817|455405809|FG016|Overall Study|Physician Decision|0|||
126575819|NCT02988817|455405810|FG017|Overall Study|Physician Decision|0|||
126575820|NCT02988817|455405811|FG018|Overall Study|Physician Decision|1|||
126575821|NCT02988817|455405812|FG019|Overall Study|Physician Decision|1|||
126575822|NCT03292913|455405813|FG000|Overall Study|Death|9|||
126575823|NCT03292913|455405814|FG001|Overall Study|Death|3|||
126575824|NCT03292913|455405813|FG000|Overall Study|Lost to Follow-up|49|||
126575825|NCT03292913|455405814|FG001|Overall Study|Lost to Follow-up|49|||
126575826|NCT03292913|455405813|FG000|Overall Study|Withdrawal by Subject|2|||
126575827|NCT03292913|455405814|FG001|Overall Study|Withdrawal by Subject|0|||
126575828|NCT03292913|455405813|FG000|Overall Study|Clinic closed due to COVID|22|||
126575829|NCT03292913|455405814|FG001|Overall Study|Clinic closed due to COVID|36|||
126575830|NCT03950622|455405815|FG000|Overall Study|Withdrawal by Subject|1|||
126575831|NCT03950622|455405816|FG001|Overall Study|Withdrawal by Subject|0|||
126575832|NCT03950622|455405815|FG000|Overall Study|Protocol Deviation|0|||
126575833|NCT03950622|455405816|FG001|Overall Study|Protocol Deviation|1|||
126575834|NCT03950622|455405815|FG000|Overall Study|Physician Decision|1|||
126575835|NCT03950622|455405816|FG001|Overall Study|Physician Decision|0|||
126575836|NCT03950622|455405815|FG000|Overall Study|Lost to Follow-up|5|||
126575837|NCT03950622|455405816|FG001|Overall Study|Lost to Follow-up|5|||
126575838|NCT03950622|455405815|FG000|Overall Study|Death|1|||
126575839|NCT03950622|455405816|FG001|Overall Study|Death|1|||
126575840|NCT03051165|455405818|FG000|Overall Study|Withdrawal by Subject|1|||
126575841|NCT03051165|455405818|FG000|Overall Study|Early termination of study|12|||
126575842|NCT03074331|455405820|FG000|Overall Study|Enrolled but Not Treated|1|||
126575843|NCT03074331|455405820|FG000|Overall Study|Lost to Follow-up|5|||
126575844|NCT03074331|455405820|FG000|Overall Study|Withdrew Consent|1|||
126575845|NCT00546754|455405826|FG000|Overall Study|Serious Adverse Event|1|||
126575846|NCT00546754|455405827|FG001|Overall Study|Serious Adverse Event|1|||
126575847|NCT00546754|455405826|FG000|Overall Study|Adverse Event|11|||
126575848|NCT00546754|455405827|FG001|Overall Study|Adverse Event|16|||
126575849|NCT00546754|455405826|FG000|Overall Study|Lack of Efficacy|1|||
126575850|NCT00546754|455405827|FG001|Overall Study|Lack of Efficacy|1|||
126575851|NCT00546754|455405826|FG000|Overall Study|Lost to Follow-up|9|||
126575852|NCT00546754|455405827|FG001|Overall Study|Lost to Follow-up|15|||
126575853|NCT00546754|455405826|FG000|Overall Study|Protocol Violation|3|||
126575854|NCT00546754|455405827|FG001|Overall Study|Protocol Violation|0|||
126727513|NCT00479557|455951173|FG006|Overall Study|Caregiver Request|0|||
126575855|NCT00546754|455405826|FG000|Overall Study|Withdrawal by Subject|6|||
126575856|NCT00546754|455405827|FG001|Overall Study|Withdrawal by Subject|7|||
126575857|NCT00546754|455405826|FG000|Overall Study|Dyspnea|1|||
126575858|NCT00546754|455405827|FG001|Overall Study|Dyspnea|0|||
126575859|NCT00546754|455405826|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
126575860|NCT00546754|455405827|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
126575861|NCT00546754|455405826|FG000|Overall Study|Hip Replacement|1|||
126575862|NCT00546754|455405827|FG001|Overall Study|Hip Replacement|0|||
126575863|NCT00546754|455405826|FG000|Overall Study|Suicide|1|||
126575864|NCT00546754|455405827|FG001|Overall Study|Suicide|0|||
126575865|NCT00546754|455405826|FG000|Overall Study|Missing Cooperation|1|||
126575866|NCT00546754|455405827|FG001|Overall Study|Missing Cooperation|0|||
126575867|NCT00546754|455405826|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
126575868|NCT00546754|455405827|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
126575869|NCT00546754|455405826|FG000|Overall Study|Patient's Decision|0|||
126575870|NCT00546754|455405827|FG001|Overall Study|Patient's Decision|1|||
126575871|NCT00546754|455405826|FG000|Overall Study|Missing|14|||
126575872|NCT00546754|455405827|FG001|Overall Study|Missing|7|||
126575873|NCT03830866|455405830|FG000|Overall Study|Death|90|||
126575874|NCT03830866|455405831|FG001|Overall Study|Death|111|||
126575875|NCT03830866|455405830|FG000|Overall Study|Lost to Follow-up|7|||
126575876|NCT03830866|455405831|FG001|Overall Study|Lost to Follow-up|7|||
126575877|NCT03830866|455405830|FG000|Overall Study|Withdrawal by Subject|19|||
126575878|NCT03830866|455405831|FG001|Overall Study|Withdrawal by Subject|16|||
126575879|NCT03830866|455405830|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
126575880|NCT03830866|455405831|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
126575881|NCT03830866|455405830|FG000|Overall Study|Other|1|||
126575882|NCT03830866|455405831|FG001|Overall Study|Other|1|||
126575883|NCT00311363|455405832|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
126575884|NCT00311363|455405833|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
126575885|NCT00311363|455405834|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
126575886|NCT00311363|455405832|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
126575887|NCT00311363|455405833|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
126575888|NCT00311363|455405834|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
126575889|NCT00311363|455405832|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
126575890|NCT00311363|455405833|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
126575891|NCT00311363|455405834|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
126575892|NCT00311363|455405832|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
126575893|NCT00311363|455405833|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
126575894|NCT00311363|455405834|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
126575895|NCT00311363|455405832|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
126575896|NCT00311363|455405833|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
126575897|NCT00311363|455405834|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
126575898|NCT00311363|455405832|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
126575899|NCT00311363|455405833|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
126575900|NCT00311363|455405834|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
126575901|NCT00311363|455405832|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
126575902|NCT00311363|455405833|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
126575903|NCT00311363|455405834|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
126575904|NCT00311363|455405832|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
126575905|NCT00311363|455405833|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
126575906|NCT00311363|455405834|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
126575907|NCT00311363|455405832|FG000|24-Week Single-Blind Treatment Period|Death|1|||
126575908|NCT00311363|455405833|FG001|24-Week Single-Blind Treatment Period|Death|0|||
126575909|NCT00311363|455405834|FG002|24-Week Single-Blind Treatment Period|Death|0|||
126575910|NCT00311363|455405832|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
126575911|NCT00311363|455405833|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
126575912|NCT00311363|455405834|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
126575913|NCT00311363|455405832|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
126575914|NCT00311363|455405833|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
126575915|NCT00311363|455405834|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
126575916|NCT00311363|455405832|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
126575917|NCT00311363|455405833|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
126575918|NCT00311363|455405834|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
126575919|NCT00311363|455405832|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
126575920|NCT00311363|455405833|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
126575921|NCT00311363|455405834|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
126575922|NCT00311363|455405832|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
126575923|NCT00311363|455405833|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
126777038|NCT02124746|456139165|FG001|Overall Study|Adverse Event|1|||
126575924|NCT00311363|455405834|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
126575925|NCT00311363|455405832|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
126575926|NCT00311363|455405833|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
126575927|NCT00311363|455405834|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
126575928|NCT00988858|455405836|FG000|Overall Study|Adverse Event|7|||
126575929|NCT00988858|455405836|FG000|Overall Study|Death|1|||
126575930|NCT00988858|455405836|FG000|Overall Study|Physician Decision|1|||
126575931|NCT00988858|455405836|FG000|Overall Study|Sponsor Decision|1|||
126575932|NCT03764475|455405837|FG000|Overall Study|Adverse Event|11|||
126575933|NCT03764475|455405838|FG001|Overall Study|Adverse Event|2|||
126575934|NCT03764475|455405837|FG000|Overall Study|Lost to Follow-up|24|||
126575935|NCT03764475|455405838|FG001|Overall Study|Lost to Follow-up|10|||
126575936|NCT03764475|455405837|FG000|Overall Study|Withdrawal by Subject|26|||
126575937|NCT03764475|455405838|FG001|Overall Study|Withdrawal by Subject|10|||
126575938|NCT03764475|455405837|FG000|Overall Study|Lack of Efficacy|3|||
126575939|NCT03764475|455405838|FG001|Overall Study|Lack of Efficacy|0|||
126575940|NCT03764475|455405837|FG000|Overall Study|COVID-19 Disruption|2|||
126575941|NCT03764475|455405838|FG001|Overall Study|COVID-19 Disruption|0|||
126575942|NCT05510245|455405842|FG000|Overall Study|Withdrawal by Subject|1|||
126575943|NCT05510245|455405843|FG001|Overall Study|Withdrawal by Subject|0|||
126575944|NCT05510245|455405844|FG002|Overall Study|Withdrawal by Subject|0|||
126575945|NCT01759771|455405848|FG000|Overall Study|Withdrawal by Subject|1|||
126575946|NCT01759771|455405849|FG001|Overall Study|Withdrawal by Subject|1|||
126575947|NCT03942042|455405850|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
126575948|NCT03942042|455405851|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
126575949|NCT03942042|455405850|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
126575950|NCT03942042|455405851|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
126575951|NCT01849055|455405854|FG000|Overall Study|Withdrawal by Subject|0|||
126575952|NCT01849055|455405855|FG001|Overall Study|Withdrawal by Subject|0|||
126575953|NCT01849055|455405856|FG002|Overall Study|Withdrawal by Subject|1|||
126575954|NCT01849055|455405857|FG003|Overall Study|Withdrawal by Subject|0|||
126575955|NCT01849055|455405858|FG004|Overall Study|Withdrawal by Subject|0|||
126575956|NCT01849055|455405859|FG005|Overall Study|Withdrawal by Subject|0|||
126575957|NCT01239316|455405860|FG000|Overall Study|Progression/Relapse|11|||
126575958|NCT01239316|455405860|FG000|Overall Study|Adverse Event|1|||
126575959|NCT02139943|455405861|FG000|Overall Study|Adverse Event|0|||
126575960|NCT02139943|455405862|FG001|Overall Study|Adverse Event|1|||
126575961|NCT02139943|455405863|FG002|Overall Study|Adverse Event|2|||
126575962|NCT02139943|455405861|FG000|Overall Study|Lost to Follow-up|3|||
126575963|NCT02139943|455405862|FG001|Overall Study|Lost to Follow-up|2|||
126575964|NCT02139943|455405863|FG002|Overall Study|Lost to Follow-up|2|||
126575965|NCT02139943|455405861|FG000|Overall Study|Withdrawal by Subject|4|||
126575966|NCT02139943|455405862|FG001|Overall Study|Withdrawal by Subject|3|||
126575967|NCT02139943|455405863|FG002|Overall Study|Withdrawal by Subject|0|||
126575968|NCT02139943|455405861|FG000|Overall Study|Other|0|||
126575969|NCT02139943|455405862|FG001|Overall Study|Other|0|||
126575970|NCT02139943|455405863|FG002|Overall Study|Other|1|||
126575971|NCT02139943|455405861|FG000|Overall Study|Participant wishes to discontinue|2|||
126575972|NCT02139943|455405862|FG001|Overall Study|Participant wishes to discontinue|0|||
126575973|NCT02139943|455405863|FG002|Overall Study|Participant wishes to discontinue|0|||
126575974|NCT02139943|455405861|FG000|Overall Study|Participant in Poor Compliance|1|||
126575975|NCT02139943|455405862|FG001|Overall Study|Participant in Poor Compliance|0|||
126575976|NCT02139943|455405863|FG002|Overall Study|Participant in Poor Compliance|1|||
126575977|NCT02139943|455405861|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
126575978|NCT02139943|455405862|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
126575979|NCT02139943|455405863|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
126575980|NCT00088413|455405867|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
126575981|NCT00088413|455405868|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
126575982|NCT00088413|455405869|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
126575983|NCT00088413|455405870|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
126575984|NCT00088413|455405867|FG000|Overall Study|Adverse Events/Side Effects|0|||
126575985|NCT00088413|455405868|FG001|Overall Study|Adverse Events/Side Effects|1|||
126575986|NCT00088413|455405869|FG002|Overall Study|Adverse Events/Side Effects|1|||
126575987|NCT00088413|455405870|FG003|Overall Study|Adverse Events/Side Effects|0|||
126575988|NCT00088413|455405867|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
126575989|NCT00088413|455405868|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
126575990|NCT00088413|455405869|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
126575991|NCT00088413|455405870|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
126575992|NCT00088413|455405867|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
126575993|NCT00088413|455405868|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
126575994|NCT00088413|455405869|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
126575995|NCT00088413|455405870|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
126575996|NCT00088413|455405867|FG000|Overall Study|Death|0|||
126575997|NCT00088413|455405868|FG001|Overall Study|Death|1|||
126575998|NCT00088413|455405869|FG002|Overall Study|Death|0|||
126575999|NCT00088413|455405870|FG003|Overall Study|Death|0|||
126576000|NCT00088413|455405867|FG000|Overall Study|Progressive disease|9|||
126576001|NCT00088413|455405868|FG001|Overall Study|Progressive disease|11|||
126576002|NCT00088413|455405869|FG002|Overall Study|Progressive disease|8|||
126576003|NCT00088413|455405870|FG003|Overall Study|Progressive disease|14|||
126576004|NCT00088413|455405867|FG000|Overall Study|Other|0|||
126576005|NCT00088413|455405868|FG001|Overall Study|Other|1|||
126576006|NCT00088413|455405869|FG002|Overall Study|Other|0|||
126576007|NCT00088413|455405870|FG003|Overall Study|Other|0|||
126576008|NCT00088413|455405867|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
126576009|NCT00088413|455405868|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
126576010|NCT00088413|455405869|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
126576011|NCT00088413|455405870|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
126576012|NCT00632424|455405873|FG000|Overall Study|Disease Progression|17|||
126576013|NCT00632424|455405873|FG000|Overall Study|Study Drug Toxicity|1|||
126576014|NCT02531113|455405874|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
126576015|NCT02531113|455405874|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
126576016|NCT02531113|455405874|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
126576017|NCT02531113|455405874|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
126576018|NCT02531113|455405874|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
126576019|NCT02531113|455405874|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
126576020|NCT02531113|455405874|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
126576021|NCT02531113|455405874|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
126576022|NCT04411056|455407171|FG000|Overall Study|surgery cancelled|1|||
126576023|NCT04411056|455407172|FG001|Overall Study|surgery cancelled|0|||
126576024|NCT04411056|455407171|FG000|Overall Study|Equipment problem during intubation|0|||
126576025|NCT04411056|455407172|FG001|Overall Study|Equipment problem during intubation|1|||
126576026|NCT03122886|455407175|FG000|Overall Study|Withdrawal by Subject|1|||
126576027|NCT03122886|455407176|FG001|Overall Study|Withdrawal by Subject|2|||
126576028|NCT03422276|455407177|FG000|Overall Study|Withdrawal by Subject|21|||
126576029|NCT03422276|455407178|FG001|Overall Study|Withdrawal by Subject|25|||
126576030|NCT03422276|455407179|FG002|Overall Study|Withdrawal by Subject|14|||
126576031|NCT03422276|455407180|FG003|Overall Study|Withdrawal by Subject|16|||
126576032|NCT03422276|455407177|FG000|Overall Study|Death|14|||
126576033|NCT03422276|455407178|FG001|Overall Study|Death|21|||
126576034|NCT03422276|455407179|FG002|Overall Study|Death|3|||
126576035|NCT03422276|455407180|FG003|Overall Study|Death|1|||
126576036|NCT03422276|455407177|FG000|Overall Study|Discontinued, ineligible|4|||
126576037|NCT03422276|455407178|FG001|Overall Study|Discontinued, ineligible|3|||
126576038|NCT03422276|455407179|FG002|Overall Study|Discontinued, ineligible|0|||
126576039|NCT03422276|455407180|FG003|Overall Study|Discontinued, ineligible|0|||
126576040|NCT03422276|455407177|FG000|Overall Study|Lost to Follow-up|15|||
126576041|NCT03422276|455407178|FG001|Overall Study|Lost to Follow-up|8|||
126576042|NCT03422276|455407179|FG002|Overall Study|Lost to Follow-up|13|||
126576043|NCT03422276|455407180|FG003|Overall Study|Lost to Follow-up|4|||
126576044|NCT03422276|455407177|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
126576045|NCT03422276|455407178|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
126576046|NCT03422276|455407179|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
126576047|NCT03422276|455407180|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
126576048|NCT03422276|455407177|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
126576049|NCT03422276|455407178|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
126576050|NCT03422276|455407179|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
126576051|NCT03422276|455407180|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
126576052|NCT03422276|455407177|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
126576053|NCT03422276|455407178|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
126576054|NCT03422276|455407179|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
126576055|NCT03422276|455407180|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
126576056|NCT03422276|455407177|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
126576057|NCT03422276|455407178|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
126576058|NCT03422276|455407179|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
126576059|NCT03422276|455407180|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
126576060|NCT03422276|455407177|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
126576061|NCT03422276|455407178|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
126576062|NCT03422276|455407179|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
126576063|NCT03422276|455407180|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
126576064|NCT05985044|455407181|FG000|Overall Study|Death|6|||
126576065|NCT05985044|455407181|FG000|Overall Study|Lost to Follow-up|4|||
126576066|NCT05985044|455407181|FG000|Overall Study|Incapacitation|3|||
126727514|NCT00479557|455951167|FG000|Overall Study|Investigator Request|0|||
126727515|NCT00479557|455951168|FG001|Overall Study|Investigator Request|0|||
126727516|NCT00479557|455951169|FG002|Overall Study|Investigator Request|1|||
126727517|NCT00479557|455951170|FG003|Overall Study|Investigator Request|0|||
126727518|NCT00479557|455951171|FG004|Overall Study|Investigator Request|0|||
126727519|NCT00479557|455951172|FG005|Overall Study|Investigator Request|0|||
126727520|NCT00479557|455951173|FG006|Overall Study|Investigator Request|0|||
126727521|NCT00479557|455951167|FG000|Overall Study|Subject Request|3|||
126727522|NCT00479557|455951168|FG001|Overall Study|Subject Request|0|||
126727523|NCT00479557|455951169|FG002|Overall Study|Subject Request|1|||
126727524|NCT00479557|455951170|FG003|Overall Study|Subject Request|1|||
126727525|NCT00479557|455951171|FG004|Overall Study|Subject Request|1|||
126727526|NCT00479557|455951172|FG005|Overall Study|Subject Request|4|||
126523821|NCT01434602|455210358|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
126523822|NCT01434602|455210359|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
126523823|NCT01434602|455210360|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
126523824|NCT01434602|455210361|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
126523825|NCT01434602|455210357|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
126523826|NCT01434602|455210358|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
126523827|NCT01434602|455210359|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
126523828|NCT01434602|455210360|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
126523829|NCT01434602|455210361|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
126523830|NCT01434602|455210357|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
126523831|NCT01434602|455210358|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
126523832|NCT01434602|455210359|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
126523833|NCT01434602|455210360|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
126523834|NCT01434602|455210361|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
126523835|NCT01434602|455210357|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
126523836|NCT01434602|455210358|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
126523837|NCT01434602|455210359|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
126523838|NCT01434602|455210360|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
126523839|NCT01434602|455210361|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
126523840|NCT00586105|455210368|FG000|Overall Study|Adverse Event|4|||
126523841|NCT00586105|455210368|FG000|Overall Study|Death|2|||
126523842|NCT00586105|455210368|FG000|Overall Study|Protocol Violation|1|||
126523843|NCT00586105|455210368|FG000|Overall Study|Withdrawal by Subject|3|||
126523844|NCT00586105|455210368|FG000|Overall Study|Disease progression|19|||
126523845|NCT00586105|455210368|FG000|Overall Study|Switched to commercial drug|9|||
126523846|NCT00586105|455210368|FG000|Overall Study|Reason not reported|1|||
126523847|NCT03835533|455210371|FG000|Overall Study|Death|5|||
126523848|NCT03835533|455210372|FG001|Overall Study|Death|10|||
126523849|NCT03835533|455210373|FG002|Overall Study|Death|9|||
126523850|NCT03835533|455210371|FG000|Overall Study|Withdrawal by Subject|2|||
126523851|NCT03835533|455210372|FG001|Overall Study|Withdrawal by Subject|2|||
126523852|NCT03835533|455210373|FG002|Overall Study|Withdrawal by Subject|2|||
126523853|NCT03835533|455210371|FG000|Overall Study|Lost to Follow-up|1|||
126523854|NCT03835533|455210372|FG001|Overall Study|Lost to Follow-up|0|||
126523855|NCT03835533|455210373|FG002|Overall Study|Lost to Follow-up|0|||
126523856|NCT01136291|455210374|FG000|Overall Study|Lost to Follow-up|1|||
126523857|NCT01136291|455210375|FG001|Overall Study|Lost to Follow-up|1|||
126523858|NCT02308033|455210378|FG000|Overall Study|Normal Gram stain at Baseline|13|||
126523859|NCT02308033|455210379|FG001|Overall Study|Normal Gram stain at Baseline|10|||
126523860|NCT02308033|455210378|FG000|Overall Study|Positive for STD at Baseline|7|||
126523861|NCT02308033|455210379|FG001|Overall Study|Positive for STD at Baseline|4|||
126523862|NCT02308033|455210378|FG000|Overall Study|Lost to Follow-up|6|||
126523863|NCT02308033|455210379|FG001|Overall Study|Lost to Follow-up|5|||
126523864|NCT00345397|455210380|FG000|Overall Study|Death|1|||
126523865|NCT01870843|455210381|FG000|Overall Study|Adverse Event|10|||
126523866|NCT01870843|455210381|FG000|Overall Study|Lost to Follow-up|24|||
126523867|NCT01870843|455210381|FG000|Overall Study|Death|1|||
126523868|NCT01870843|455210381|FG000|Overall Study|Withdrawal by Subject|18|||
126523869|NCT03021187|455210386|FG000|Overall Study|Death|0|||
126523870|NCT03021187|455210387|FG001|Overall Study|Death|0|||
126523871|NCT03021187|455210388|FG002|Overall Study|Death|3|||
126523872|NCT03021187|455210389|FG003|Overall Study|Death|0|||
126523873|NCT03021187|455210386|FG000|Overall Study|Withdrawal by Subject|0|||
126523874|NCT03021187|455210387|FG001|Overall Study|Withdrawal by Subject|6|||
126523875|NCT03021187|455210388|FG002|Overall Study|Withdrawal by Subject|2|||
126523876|NCT03021187|455210389|FG003|Overall Study|Withdrawal by Subject|5|||
126523877|NCT03021187|455210386|FG000|Overall Study|Lost to Follow-up|10|||
126523878|NCT03021187|455210387|FG001|Overall Study|Lost to Follow-up|3|||
126523879|NCT03021187|455210388|FG002|Overall Study|Lost to Follow-up|1|||
126523880|NCT03021187|455210389|FG003|Overall Study|Lost to Follow-up|4|||
126523881|NCT01664078|455210390|FG000|Overall Study|Death|9|||
126727527|NCT00479557|455951173|FG006|Overall Study|Subject Request|1|||
126727528|NCT00479557|455951167|FG000|Overall Study|Other|2|||
126727529|NCT00479557|455951168|FG001|Overall Study|Other|3|||
126727530|NCT00479557|455951169|FG002|Overall Study|Other|1|||
126727531|NCT00479557|455951170|FG003|Overall Study|Other|0|||
126727532|NCT00479557|455951171|FG004|Overall Study|Other|0|||
126576067|NCT05985044|455407181|FG000|Overall Study|Withdrawal by Subject|2|||
126576068|NCT02279095|455407184|FG000|Overall Study|Non-Compliance|1|||
126576069|NCT02279095|455407184|FG000|Overall Study|Withdrawal by Subject|8|||
126576070|NCT02279095|455407184|FG000|Overall Study|Adverse Event|2|||
126576071|NCT02279095|455407184|FG000|Overall Study|Other|7|||
126576072|NCT02279095|455407184|FG000|Overall Study|Lost to Follow-up|1|||
126576073|NCT05938413|455407185|FG000|Overall Study|Lost to Follow-up|1|||
126576074|NCT05938413|455407186|FG001|Overall Study|Lost to Follow-up|7|||
126576075|NCT05938413|455407185|FG000|Overall Study|Withdrawal by Subject|1|||
126576076|NCT05938413|455407186|FG001|Overall Study|Withdrawal by Subject|1|||
126576077|NCT05644444|455407191|FG000|Tolerance Phase|Adverse Event|0|||
126576078|NCT05644444|455407192|FG001|Tolerance Phase|Adverse Event|2|||
126576079|NCT05644444|455407191|FG000|Treatment Phase|Adverse Event|0|||
126576080|NCT05644444|455407192|FG001|Treatment Phase|Adverse Event|2|||
126576081|NCT04817670|455407193|FG000|Overall Study|Withdrawal by Subject|1|||
126576082|NCT04817670|455407194|FG001|Overall Study|Withdrawal by Subject|0|||
126576083|NCT04817670|455407195|FG002|Overall Study|Withdrawal by Subject|0|||
126576084|NCT04817670|455407196|FG003|Overall Study|Withdrawal by Subject|0|||
126576085|NCT04817670|455407197|FG004|Overall Study|Withdrawal by Subject|0|||
126576086|NCT04817670|455407193|FG000|Overall Study|Lost to Follow-up|0|||
126576087|NCT04817670|455407194|FG001|Overall Study|Lost to Follow-up|0|||
126576088|NCT04817670|455407195|FG002|Overall Study|Lost to Follow-up|1|||
126576089|NCT04817670|455407196|FG003|Overall Study|Lost to Follow-up|0|||
126576090|NCT04817670|455407197|FG004|Overall Study|Lost to Follow-up|0|||
126576091|NCT03312907|455407198|FG000|Overall Study|Adverse Event|1|||
126576092|NCT03312907|455407199|FG001|Overall Study|Adverse Event|6|||
126576093|NCT03312907|455407200|FG002|Overall Study|Adverse Event|1|||
126576094|NCT03312907|455407198|FG000|Overall Study|Protocol Violation|2|||
126576095|NCT03312907|455407199|FG001|Overall Study|Protocol Violation|3|||
126576096|NCT03312907|455407200|FG002|Overall Study|Protocol Violation|4|||
126576097|NCT03312907|455407198|FG000|Overall Study|Lost to Follow-up|2|||
126576098|NCT03312907|455407199|FG001|Overall Study|Lost to Follow-up|3|||
126576099|NCT03312907|455407200|FG002|Overall Study|Lost to Follow-up|2|||
126576100|NCT03312907|455407198|FG000|Overall Study|Physician Decision|3|||
126576101|NCT03312907|455407199|FG001|Overall Study|Physician Decision|4|||
126576102|NCT03312907|455407200|FG002|Overall Study|Physician Decision|2|||
126576103|NCT03312907|455407198|FG000|Overall Study|Withdrawal by Subject|9|||
126576104|NCT03312907|455407199|FG001|Overall Study|Withdrawal by Subject|14|||
126576105|NCT03312907|455407200|FG002|Overall Study|Withdrawal by Subject|10|||
126576106|NCT03936660|455407204|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
126576107|NCT03936660|455407205|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
126576108|NCT04056624|455407207|FG000|Overall Study|Withdrawal by Subject|0|||
126576109|NCT04056624|455407208|FG001|Overall Study|Withdrawal by Subject|0|||
126576110|NCT04056624|455407209|FG002|Overall Study|Withdrawal by Subject|1|||
126576111|NCT04056624|455407207|FG000|Overall Study|Protocol Violation|1|||
126576112|NCT04056624|455407208|FG001|Overall Study|Protocol Violation|2|||
126576113|NCT04056624|455407209|FG002|Overall Study|Protocol Violation|0|||
126576114|NCT02267824|455407210|FG000|Overall Study|Pregnancy|1|||
126576115|NCT02267824|455407211|FG001|Overall Study|Pregnancy|1|||
126727533|NCT00479557|455951172|FG005|Overall Study|Other|3|||
126576116|NCT02267824|455407210|FG000|Overall Study|Lost to Follow-up|4|||
126576117|NCT02267824|455407211|FG001|Overall Study|Lost to Follow-up|0|||
126576118|NCT02267824|455407210|FG000|Overall Study|Protocol Violation|3|||
126576119|NCT02267824|455407211|FG001|Overall Study|Protocol Violation|0|||
126576120|NCT02267824|455407210|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
126576121|NCT02267824|455407211|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
126576122|NCT00914589|455407212|FG000|Overall Study|Adverse Event|1|||
126576123|NCT00914589|455407213|FG001|Overall Study|Adverse Event|0|||
126576124|NCT00914589|455407214|FG002|Overall Study|Adverse Event|1|||
126576125|NCT00914589|455407212|FG000|Overall Study|Protocol Violation|8|||
126576126|NCT00914589|455407213|FG001|Overall Study|Protocol Violation|6|||
126727534|NCT00479557|455951173|FG006|Overall Study|Other|0|||
126727535|NCT02509494|455951176|FG000|Overall Study|Lost to Follow-up|8|||
126727536|NCT02509494|455951177|FG001|Overall Study|Lost to Follow-up|47|||
126727537|NCT02509494|455951178|FG002|Overall Study|Lost to Follow-up|19|||
126727538|NCT02509494|455951179|FG003|Overall Study|Lost to Follow-up|6|||
126727539|NCT02509494|455951180|FG004|Overall Study|Lost to Follow-up|3|||
126576127|NCT00914589|455407214|FG002|Overall Study|Protocol Violation|3|||
126576128|NCT00914589|455407212|FG000|Overall Study|unclassified|16|||
126576129|NCT00914589|455407213|FG001|Overall Study|unclassified|9|||
126576130|NCT00914589|455407214|FG002|Overall Study|unclassified|7|||
126576131|NCT00914589|455407212|FG000|Overall Study|Death|0|||
126576132|NCT00914589|455407213|FG001|Overall Study|Death|1|||
126576133|NCT00914589|455407214|FG002|Overall Study|Death|1|||
126727540|NCT02509494|455951181|FG005|Overall Study|Lost to Follow-up|3|||
126727541|NCT02509494|455951182|FG006|Overall Study|Lost to Follow-up|1|||
126727542|NCT02509494|455951183|FG007|Overall Study|Lost to Follow-up|3|||
126727543|NCT02509494|455951184|FG008|Overall Study|Lost to Follow-up|1|||
126727544|NCT02509494|455951176|FG000|Overall Study|Physician Decision|2|||
126727545|NCT02509494|455951177|FG001|Overall Study|Physician Decision|1|||
126727546|NCT02509494|455951178|FG002|Overall Study|Physician Decision|0|||
126727547|NCT02509494|455951179|FG003|Overall Study|Physician Decision|0|||
126727548|NCT02509494|455951180|FG004|Overall Study|Physician Decision|0|||
126727549|NCT02509494|455951181|FG005|Overall Study|Physician Decision|0|||
126727550|NCT02509494|455951182|FG006|Overall Study|Physician Decision|0|||
126727551|NCT02509494|455951183|FG007|Overall Study|Physician Decision|0|||
126727552|NCT02509494|455951184|FG008|Overall Study|Physician Decision|0|||
126727553|NCT02509494|455951176|FG000|Overall Study|Withdrawal by Subject|4|||
126727554|NCT02509494|455951177|FG001|Overall Study|Withdrawal by Subject|17|||
126727555|NCT02509494|455951178|FG002|Overall Study|Withdrawal by Subject|7|||
126727556|NCT02509494|455951179|FG003|Overall Study|Withdrawal by Subject|5|||
126727557|NCT02509494|455951180|FG004|Overall Study|Withdrawal by Subject|0|||
126727558|NCT02509494|455951181|FG005|Overall Study|Withdrawal by Subject|6|||
126727559|NCT02509494|455951182|FG006|Overall Study|Withdrawal by Subject|1|||
126727560|NCT02509494|455951183|FG007|Overall Study|Withdrawal by Subject|2|||
126727561|NCT02509494|455951184|FG008|Overall Study|Withdrawal by Subject|1|||
126727562|NCT02509494|455951176|FG000|Overall Study|Death|0|||
126727563|NCT02509494|455951177|FG001|Overall Study|Death|1|||
126727564|NCT02509494|455951178|FG002|Overall Study|Death|0|||
126727565|NCT02509494|455951179|FG003|Overall Study|Death|0|||
126727566|NCT02509494|455951180|FG004|Overall Study|Death|1|||
126727567|NCT02509494|455951181|FG005|Overall Study|Death|0|||
126727568|NCT02509494|455951182|FG006|Overall Study|Death|0|||
126727569|NCT02509494|455951183|FG007|Overall Study|Death|1|||
126727570|NCT02509494|455951184|FG008|Overall Study|Death|0|||
126727571|NCT02509494|455951176|FG000|Overall Study|Other|0|||
126727572|NCT02509494|455951177|FG001|Overall Study|Other|4|||
126727573|NCT02509494|455951178|FG002|Overall Study|Other|5|||
126727574|NCT02509494|455951179|FG003|Overall Study|Other|0|||
126727575|NCT02509494|455951180|FG004|Overall Study|Other|0|||
126727576|NCT02509494|455951181|FG005|Overall Study|Other|0|||
126727577|NCT02509494|455951182|FG006|Overall Study|Other|0|||
126727578|NCT02509494|455951183|FG007|Overall Study|Other|0|||
126727579|NCT02509494|455951184|FG008|Overall Study|Other|0|||
126576134|NCT01290341|455407215|FG000|Overall Study|Protocol Violation|7|||
126576135|NCT01290341|455407216|FG001|Overall Study|Protocol Violation|3|||
126576136|NCT01290341|455407215|FG000|Overall Study|Adverse Event|1|||
126576137|NCT01290341|455407216|FG001|Overall Study|Adverse Event|0|||
126576138|NCT01290341|455407215|FG000|Overall Study|Lost to Follow-up|21|||
126576139|NCT01290341|455407216|FG001|Overall Study|Lost to Follow-up|10|||
126576140|NCT01290341|455407215|FG000|Overall Study|Withdrawal by Subject|19|||
126576141|NCT01290341|455407216|FG001|Overall Study|Withdrawal by Subject|5|||
126576142|NCT01290341|455407215|FG000|Overall Study|Negative baseline culture and others|44|||
126576143|NCT01290341|455407216|FG001|Overall Study|Negative baseline culture and others|11|||
126576144|NCT03036813|455407221|FG000|Overall Study|Adverse Event|6|||
126727580|NCT02509494|455951176|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126727581|NCT02509494|455951177|FG001|Overall Study|Non-Compliance With Study Drug|11|||
126727582|NCT02509494|455951178|FG002|Overall Study|Non-Compliance With Study Drug|7|||
126727583|NCT02509494|455951179|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126727584|NCT02509494|455951180|FG004|Overall Study|Non-Compliance With Study Drug|1|||
126727585|NCT02509494|455951181|FG005|Overall Study|Non-Compliance With Study Drug|2|||
126727586|NCT02509494|455951182|FG006|Overall Study|Non-Compliance With Study Drug|1|||
126727587|NCT02509494|455951183|FG007|Overall Study|Non-Compliance With Study Drug|1|||
126727588|NCT02509494|455951184|FG008|Overall Study|Non-Compliance With Study Drug|0|||
126727589|NCT03003403|455951185|FG000|Overall Study|Ineligible|8|||
126727590|NCT03003403|455951186|FG001|Overall Study|Ineligible|7|||
126727591|NCT03003403|455951185|FG000|Overall Study|Withdrawal by Subject|3|||
126727592|NCT03003403|455951186|FG001|Overall Study|Withdrawal by Subject|1|||
126727593|NCT03073213|455952794|FG000|Multiple Dose Period|Protocol Violation|0|||
126727594|NCT03073213|455952795|FG001|Multiple Dose Period|Protocol Violation|0|||
126727595|NCT03073213|455952796|FG002|Multiple Dose Period|Protocol Violation|1|||
126727596|NCT00280150|455952800|FG000|Overall Study|Adverse Event|0|||
126727597|NCT00280150|455952801|FG001|Overall Study|Adverse Event|1|||
126727598|NCT00280150|455952802|FG002|Overall Study|Adverse Event|2|||
126727599|NCT00280150|455952803|FG003|Overall Study|Adverse Event|3|||
126727600|NCT00280150|455952800|FG000|Overall Study|Lack of Efficacy|0|||
126727601|NCT00280150|455952801|FG001|Overall Study|Lack of Efficacy|0|||
126576145|NCT03036813|455407222|FG001|Overall Study|Adverse Event|11|||
126576146|NCT03036813|455407223|FG002|Overall Study|Adverse Event|6|||
126727602|NCT00280150|455952802|FG002|Overall Study|Lack of Efficacy|0|||
126727603|NCT00280150|455952803|FG003|Overall Study|Lack of Efficacy|3|||
126727604|NCT00280150|455952800|FG000|Overall Study|Physician Decision|0|||
126727605|NCT00280150|455952801|FG001|Overall Study|Physician Decision|0|||
126727606|NCT00280150|455952802|FG002|Overall Study|Physician Decision|0|||
126576147|NCT03036813|455407221|FG000|Overall Study|Withdrawal by Subject|12|||
126576148|NCT03036813|455407222|FG001|Overall Study|Withdrawal by Subject|6|||
126576149|NCT03036813|455407223|FG002|Overall Study|Withdrawal by Subject|10|||
126576150|NCT03036813|455407221|FG000|Overall Study|Lost to Follow-up|1|||
126576151|NCT03036813|455407222|FG001|Overall Study|Lost to Follow-up|1|||
126576152|NCT03036813|455407223|FG002|Overall Study|Lost to Follow-up|0|||
126576153|NCT03036813|455407221|FG000|Overall Study|Physician Decision|2|||
126576154|NCT03036813|455407222|FG001|Overall Study|Physician Decision|1|||
126576155|NCT03036813|455407223|FG002|Overall Study|Physician Decision|1|||
126576156|NCT03036813|455407221|FG000|Overall Study|Non-Compliance|1|||
126576157|NCT03036813|455407222|FG001|Overall Study|Non-Compliance|5|||
126576158|NCT03036813|455407223|FG002|Overall Study|Non-Compliance|3|||
126576159|NCT03036813|455407221|FG000|Overall Study|Pregnancy|0|||
126576160|NCT03036813|455407222|FG001|Overall Study|Pregnancy|0|||
126576161|NCT03036813|455407223|FG002|Overall Study|Pregnancy|1|||
126576162|NCT03036813|455407221|FG000|Overall Study|Other|0|||
126576163|NCT03036813|455407222|FG001|Overall Study|Other|3|||
126576164|NCT03036813|455407223|FG002|Overall Study|Other|5|||
126576165|NCT01102231|455407224|FG000|Overall Study|Protocol Violation|3|||
126576166|NCT01102231|455407224|FG000|Overall Study|Lack of Efficacy|2|||
126576167|NCT01102231|455407224|FG000|Overall Study|Death|2|||
126576168|NCT01102231|455407224|FG000|Overall Study|Adverse Event|3|||
126576169|NCT01102231|455407224|FG000|Overall Study|Withdrawal by Subject|1|||
126576170|NCT01102231|455407224|FG000|Overall Study|Did not received the treatment|4|||
126576171|NCT03903822|455407225|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
126576172|NCT03903822|455407226|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
126576173|NCT03903822|455407227|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
126576174|NCT03903822|455407228|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
126576175|NCT03903822|455407229|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
126576176|NCT03903822|455407230|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
126576177|NCT03903822|455407231|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
126576178|NCT03903822|455407232|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
126576179|NCT03903822|455407225|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
126576180|NCT03903822|455407226|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
126576181|NCT03903822|455407227|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
126576182|NCT03903822|455407228|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
126576183|NCT03903822|455407229|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
126576184|NCT03903822|455407230|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
126576185|NCT03903822|455407231|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
126576186|NCT03903822|455407232|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
126576187|NCT03903822|455407225|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
126576188|NCT03903822|455407226|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
126576189|NCT03903822|455407227|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
126576190|NCT03903822|455407228|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
126576191|NCT03903822|455407229|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
126576192|NCT03903822|455407230|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
126576193|NCT03903822|455407231|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
126576194|NCT03903822|455407232|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
126576195|NCT03903822|455407225|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
126576196|NCT03903822|455407226|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
126576197|NCT03903822|455407227|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
126576198|NCT03903822|455407228|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
126576199|NCT03903822|455407229|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
126576200|NCT03903822|455407230|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
126727607|NCT00280150|455952803|FG003|Overall Study|Physician Decision|1|||
126727608|NCT00280150|455952800|FG000|Overall Study|Protocol Violation|0|||
126727609|NCT00280150|455952801|FG001|Overall Study|Protocol Violation|0|||
126727610|NCT00280150|455952802|FG002|Overall Study|Protocol Violation|0|||
126727611|NCT00280150|455952803|FG003|Overall Study|Protocol Violation|1|||
126576201|NCT03903822|455407231|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
126576202|NCT03903822|455407232|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
126576203|NCT03903822|455407225|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
126576204|NCT03903822|455407226|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
126576205|NCT03903822|455407227|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
126576206|NCT03903822|455407228|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
126576207|NCT03903822|455407229|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
126576208|NCT03903822|455407230|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
126576209|NCT03903822|455407231|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
126576210|NCT03903822|455407232|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
126576211|NCT03903822|455407225|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126576212|NCT03903822|455407226|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126576213|NCT03903822|455407227|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126576214|NCT03903822|455407228|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
126727612|NCT00280150|455952800|FG000|Overall Study|Withdrawal by Subject|0|||
126727613|NCT00280150|455952801|FG001|Overall Study|Withdrawal by Subject|0|||
126523882|NCT01664078|455210390|FG000|Overall Study|Withdrawal by Subject|4|||
126523883|NCT01664078|455210390|FG000|Overall Study|Lost to Follow-up|2|||
126523884|NCT01664078|455210390|FG000|Overall Study|missed 5 year visit|1|||
126523885|NCT01664078|455210390|FG000|Overall Study|Other|53|||
126523886|NCT03351049|455210393|FG000|Overall Study|Withdrawal|26|||
126523887|NCT03351049|455210394|FG001|Overall Study|Withdrawal|22|||
126523888|NCT03832192|455210399|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
126523889|NCT03832192|455210400|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
126523890|NCT03738150|455210401|FG000|Base Study|Withdrawal by Subject|1|||
126523891|NCT03738150|455210401|FG000|Extension Study|Withdrawal by Subject|1|||
126523892|NCT01307501|455210406|FG000|Overall Study|Treatment Failure|1|||
126523893|NCT01307501|455210406|FG000|Overall Study|Death|20|||
126523894|NCT01307501|455210406|FG000|Overall Study|Lost to Follow-up|1|||
126523895|NCT01307501|455210406|FG000|Overall Study|Starting Hospice|1|||
126523896|NCT02005471|455210407|FG000|Main Study|Adverse Event|0|||
126523897|NCT02005471|455210408|FG001|Main Study|Adverse Event|1|||
126523898|NCT02005471|455210409|FG002|Main Study|Adverse Event|0|||
126523899|NCT02005471|455210410|FG003|Main Study|Adverse Event|0|||
126523900|NCT02005471|455210407|FG000|Main Study|Death|83|||
126523901|NCT02005471|455210408|FG001|Main Study|Death|52|||
126523902|NCT02005471|455210409|FG002|Main Study|Death|0|||
126523903|NCT02005471|455210410|FG003|Main Study|Death|0|||
126523904|NCT02005471|455210407|FG000|Main Study|Lost to Follow-up|4|||
126523905|NCT02005471|455210408|FG001|Main Study|Lost to Follow-up|5|||
126523906|NCT02005471|455210409|FG002|Main Study|Lost to Follow-up|0|||
126523907|NCT02005471|455210410|FG003|Main Study|Lost to Follow-up|0|||
126523908|NCT02005471|455210407|FG000|Main Study|Physician Decision|3|||
126523909|NCT02005471|455210408|FG001|Main Study|Physician Decision|1|||
126523910|NCT02005471|455210409|FG002|Main Study|Physician Decision|0|||
126523911|NCT02005471|455210410|FG003|Main Study|Physician Decision|0|||
126523912|NCT02005471|455210407|FG000|Main Study|Withdrawal by Subject|26|||
126523913|NCT02005471|455210408|FG001|Main Study|Withdrawal by Subject|11|||
126523914|NCT02005471|455210409|FG002|Main Study|Withdrawal by Subject|0|||
126523915|NCT02005471|455210410|FG003|Main Study|Withdrawal by Subject|0|||
126523916|NCT02005471|455210407|FG000|Main Study|Reason not Specified|0|||
126523917|NCT02005471|455210408|FG001|Main Study|Reason not Specified|6|||
126523918|NCT02005471|455210409|FG002|Main Study|Reason not Specified|0|||
126523919|NCT02005471|455210410|FG003|Main Study|Reason not Specified|0|||
126523920|NCT02005471|455210407|FG000|Main Study|Randomized but not Dosed|8|||
126523921|NCT02005471|455210408|FG001|Main Study|Randomized but not Dosed|0|||
126523922|NCT02005471|455210409|FG002|Main Study|Randomized but not Dosed|0|||
126523923|NCT02005471|455210410|FG003|Main Study|Randomized but not Dosed|0|||
126523924|NCT02005471|455210407|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
126523925|NCT02005471|455210408|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
126523926|NCT02005471|455210409|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
126523927|NCT02005471|455210410|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
126523928|NCT02005471|455210407|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
126523929|NCT02005471|455210408|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
126523930|NCT02005471|455210409|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
126523931|NCT02005471|455210410|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
126523932|NCT02005471|455210407|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
126523933|NCT02005471|455210408|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
126523934|NCT02005471|455210409|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
126523935|NCT02005471|455210410|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
126523936|NCT00558285|455210411|FG000|Overall Study|Adverse Event|1|||
126523937|NCT00558285|455210412|FG001|Overall Study|Adverse Event|1|||
126523938|NCT00558285|455210413|FG002|Overall Study|Adverse Event|4|||
126523939|NCT00558285|455210414|FG003|Overall Study|Adverse Event|1|||
126523940|NCT00558285|455210415|FG004|Overall Study|Adverse Event|2|||
126523941|NCT00558285|455210411|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126523942|NCT00558285|455210412|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126523943|NCT00558285|455210413|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126523944|NCT00558285|455210414|FG003|Overall Study|Abnormal test procedure result(s)|0|||
126523945|NCT00558285|455210415|FG004|Overall Study|Abnormal test procedure result(s)|0|||
126523946|NCT00558285|455210411|FG000|Overall Study|Subject withdrew consent|2|||
126523947|NCT00558285|455210412|FG001|Overall Study|Subject withdrew consent|0|||
126523948|NCT00558285|455210413|FG002|Overall Study|Subject withdrew consent|1|||
126523949|NCT00558285|455210414|FG003|Overall Study|Subject withdrew consent|1|||
126523950|NCT00558285|455210415|FG004|Overall Study|Subject withdrew consent|1|||
126523951|NCT00558285|455210411|FG000|Overall Study|Lost to Follow-up|1|||
126523952|NCT00558285|455210412|FG001|Overall Study|Lost to Follow-up|1|||
126523953|NCT00558285|455210413|FG002|Overall Study|Lost to Follow-up|0|||
126523954|NCT00558285|455210414|FG003|Overall Study|Lost to Follow-up|0|||
126523955|NCT00558285|455210415|FG004|Overall Study|Lost to Follow-up|0|||
126576215|NCT03903822|455407229|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126523956|NCT00558285|455210411|FG000|Overall Study|Administrative problems|0|||
126523957|NCT00558285|455210412|FG001|Overall Study|Administrative problems|0|||
126576216|NCT03903822|455407230|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126576217|NCT03903822|455407231|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126576218|NCT03903822|455407232|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
126576219|NCT03903822|455407225|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
126576220|NCT03903822|455407226|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
126576221|NCT03903822|455407227|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
126576222|NCT03903822|455407228|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
126576223|NCT03903822|455407229|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
126576224|NCT03903822|455407230|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
126576225|NCT03903822|455407231|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
126576226|NCT03903822|455407232|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
126576227|NCT03903822|455407225|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
126576228|NCT03903822|455407226|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
126576229|NCT03903822|455407227|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
126576230|NCT03903822|455407228|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
126576231|NCT03903822|455407229|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
126576232|NCT03903822|455407230|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
126576233|NCT03903822|455407231|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
126576234|NCT03903822|455407232|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
126576235|NCT03903822|455407225|FG000|Treatment Phase (6 Weeks)|Other|2|||
126576236|NCT03903822|455407226|FG001|Treatment Phase (6 Weeks)|Other|1|||
126576237|NCT03903822|455407227|FG002|Treatment Phase (6 Weeks)|Other|0|||
126576238|NCT03903822|455407228|FG003|Treatment Phase (6 Weeks)|Other|0|||
126576239|NCT03903822|455407229|FG004|Treatment Phase (6 Weeks)|Other|1|||
126576240|NCT03903822|455407230|FG005|Treatment Phase (6 Weeks)|Other|1|||
126576241|NCT03903822|455407231|FG006|Treatment Phase (6 Weeks)|Other|0|||
126576242|NCT03903822|455407232|FG007|Treatment Phase (6 Weeks)|Other|0|||
126576243|NCT03903822|455407225|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
126576244|NCT03903822|455407226|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
126576245|NCT03903822|455407227|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
126576246|NCT03903822|455407228|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
126576247|NCT03903822|455407229|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
126576248|NCT03903822|455407230|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
126576249|NCT03903822|455407231|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
126576250|NCT03903822|455407232|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
126576251|NCT03903822|455407225|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126576252|NCT03903822|455407226|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126576253|NCT03903822|455407227|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126576254|NCT03903822|455407228|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126576255|NCT03903822|455407229|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
126576256|NCT03903822|455407230|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126576257|NCT03903822|455407231|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126576258|NCT03903822|455407232|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
126576259|NCT03903822|455407225|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
126576260|NCT03903822|455407226|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
126576261|NCT03903822|455407227|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
126576262|NCT03903822|455407228|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
126576263|NCT03903822|455407229|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
126576264|NCT03903822|455407230|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
126576265|NCT03903822|455407231|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
126576266|NCT03903822|455407232|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
126576267|NCT03903822|455407225|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
126576268|NCT03903822|455407226|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
126576269|NCT03903822|455407227|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
126576270|NCT03903822|455407228|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
126576271|NCT03903822|455407229|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
126576272|NCT03903822|455407230|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
126576273|NCT03903822|455407231|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
126727614|NCT00280150|455952802|FG002|Overall Study|Withdrawal by Subject|0|||
126727615|NCT00280150|455952803|FG003|Overall Study|Withdrawal by Subject|1|||
126727616|NCT00280150|455952800|FG000|Overall Study|Did not get consolidation therapy|3|||
126727617|NCT00280150|455952801|FG001|Overall Study|Did not get consolidation therapy|0|||
126727618|NCT00280150|455952802|FG002|Overall Study|Did not get consolidation therapy|3|||
126576274|NCT03903822|455407232|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
126576275|NCT03903822|455407225|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
126576276|NCT03903822|455407226|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
126576277|NCT03903822|455407227|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
126576278|NCT03903822|455407228|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
126576279|NCT03903822|455407229|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
126576280|NCT03903822|455407230|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
126727619|NCT00280150|455952803|FG003|Overall Study|Did not get consolidation therapy|0|||
126727620|NCT00280150|455952800|FG000|Overall Study|Declining Performance Status|0|||
126576281|NCT03903822|455407231|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
126576282|NCT03903822|455407232|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
126576283|NCT03903822|455407225|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126576284|NCT03903822|455407226|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126576285|NCT03903822|455407227|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126576286|NCT03903822|455407228|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126576287|NCT03903822|455407229|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126576288|NCT03903822|455407230|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
126576289|NCT03903822|455407231|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126576290|NCT03903822|455407232|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
126576291|NCT03903822|455407225|FG000|Follow up Phase (4 Weeks)|Other|1|||
126576292|NCT03903822|455407226|FG001|Follow up Phase (4 Weeks)|Other|1|||
126576293|NCT03903822|455407227|FG002|Follow up Phase (4 Weeks)|Other|0|||
126576294|NCT03903822|455407228|FG003|Follow up Phase (4 Weeks)|Other|0|||
126576295|NCT03903822|455407229|FG004|Follow up Phase (4 Weeks)|Other|0|||
126576296|NCT03903822|455407230|FG005|Follow up Phase (4 Weeks)|Other|0|||
126576297|NCT03903822|455407231|FG006|Follow up Phase (4 Weeks)|Other|0|||
126576298|NCT03903822|455407232|FG007|Follow up Phase (4 Weeks)|Other|0|||
126576299|NCT00785512|455407233|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
126576300|NCT00785512|455407234|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
126576301|NCT00785512|455407233|FG000|Overall Study|Adverse Event|0|||
126576302|NCT00785512|455407234|FG001|Overall Study|Adverse Event|0|||
126576303|NCT00785512|455407233|FG000|Overall Study|Lack of Efficacy|0|||
126576304|NCT00785512|455407234|FG001|Overall Study|Lack of Efficacy|2|||
126576305|NCT00785512|455407233|FG000|Overall Study|Withdrawal by Subject|0|||
126576306|NCT00785512|455407234|FG001|Overall Study|Withdrawal by Subject|1|||
126576307|NCT00785512|455407233|FG000|Overall Study|Lost to Follow-up|3|||
126576308|NCT00785512|455407234|FG001|Overall Study|Lost to Follow-up|0|||
126576309|NCT00785512|455407233|FG000|Overall Study|Precedure Refused|0|||
126576310|NCT00785512|455407234|FG001|Overall Study|Precedure Refused|0|||
126576311|NCT00785512|455407233|FG000|Overall Study|IVRS Programing Error|0|||
126523958|NCT00558285|455210413|FG002|Overall Study|Administrative problems|0|||
126523959|NCT00558285|455210414|FG003|Overall Study|Administrative problems|1|||
126523960|NCT00558285|455210415|FG004|Overall Study|Administrative problems|1|||
126523961|NCT00558285|455210411|FG000|Overall Study|Protocol deviation|1|||
126523962|NCT00558285|455210412|FG001|Overall Study|Protocol deviation|1|||
126523963|NCT00558285|455210413|FG002|Overall Study|Protocol deviation|0|||
126523964|NCT00558285|455210414|FG003|Overall Study|Protocol deviation|1|||
126523965|NCT00558285|455210415|FG004|Overall Study|Protocol deviation|0|||
126523966|NCT02730819|455210416|FG000|Overall Study|Lost to Follow-up|9|||
126523967|NCT01660906|455210417|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
126523968|NCT02121847|455210418|FG000|Overall Study|Administrative Reasons|1|||
126523969|NCT02121847|455210418|FG000|Overall Study|Adverse Event|2|||
126523970|NCT03478891|455210419|FG000|Overall Study|Enrolled, but product never administered|0|||
126523971|NCT03478891|455210420|FG001|Overall Study|Enrolled, but product never administered|0|||
126523972|NCT03478891|455210421|FG002|Overall Study|Enrolled, but product never administered|1|||
126523973|NCT03478891|455210419|FG000|Overall Study|Moved from area|0|||
126523974|NCT03478891|455210420|FG001|Overall Study|Moved from area|0|||
126523975|NCT03478891|455210421|FG002|Overall Study|Moved from area|1|||
126523976|NCT03478891|455210419|FG000|Overall Study|Lost to Follow-up|1|||
126523977|NCT03478891|455210420|FG001|Overall Study|Lost to Follow-up|0|||
126523978|NCT03478891|455210421|FG002|Overall Study|Lost to Follow-up|1|||
126523979|NCT00360529|455210422|FG000|Overall Study|Adverse Event|10|||
126523980|NCT00360529|455210423|FG001|Overall Study|Adverse Event|23|||
126576312|NCT00785512|455407234|FG001|Overall Study|IVRS Programing Error|0|||
126576313|NCT00785512|455407233|FG000|Overall Study|Physician Decision|0|||
126576314|NCT00785512|455407234|FG001|Overall Study|Physician Decision|0|||
126576315|NCT00785512|455407233|FG000|Overall Study|Lack of compliance|0|||
126576316|NCT00785512|455407234|FG001|Overall Study|Lack of compliance|1|||
126576317|NCT00529100|455407240|FG000|Overall Study|Adverse Event|0|||
126576318|NCT00529100|455407241|FG001|Overall Study|Adverse Event|5|||
126576319|NCT00529100|455407240|FG000|Overall Study|Protocol Violation|0|||
126576320|NCT00529100|455407241|FG001|Overall Study|Protocol Violation|1|||
126576321|NCT00529100|455407240|FG000|Overall Study|Progressive Disease|0|||
126576322|NCT00529100|455407241|FG001|Overall Study|Progressive Disease|1|||
126576323|NCT00529100|455407240|FG000|Overall Study|Withdrawal by Subject|0|||
126523981|NCT00360529|455210424|FG002|Overall Study|Adverse Event|33|||
126523982|NCT00360529|455210422|FG000|Overall Study|Protocol Violation|3|||
126576324|NCT00529100|455407241|FG001|Overall Study|Withdrawal by Subject|1|||
126576325|NCT00529100|455407240|FG000|Overall Study|Participant Ineligibility|0|||
126576326|NCT00529100|455407241|FG001|Overall Study|Participant Ineligibility|1|||
126576327|NCT03733119|455407242|FG000|Overall Study|Physician Decision|2|||
126523983|NCT00360529|455210423|FG001|Overall Study|Protocol Violation|3|||
126523984|NCT00360529|455210424|FG002|Overall Study|Protocol Violation|11|||
126523985|NCT00360529|455210422|FG000|Overall Study|Lost to Follow-up|14|||
126523986|NCT00360529|455210423|FG001|Overall Study|Lost to Follow-up|10|||
126576328|NCT03733119|455407243|FG001|Overall Study|Physician Decision|1|||
126576329|NCT03733119|455407242|FG000|Overall Study|ineligible to treat per protocol|0|||
126576330|NCT03733119|455407243|FG001|Overall Study|ineligible to treat per protocol|1|||
126576331|NCT00807937|455407250|FG000|Overall Study|Adverse Event|12|||
126576332|NCT00807937|455407251|FG001|Overall Study|Adverse Event|12|||
126576333|NCT00807937|455407252|FG002|Overall Study|Adverse Event|5|||
126576334|NCT00807937|455407253|FG003|Overall Study|Adverse Event|4|||
126576335|NCT00807937|455407250|FG000|Overall Study|Protocol Violation|4|||
126576336|NCT00807937|455407251|FG001|Overall Study|Protocol Violation|5|||
126576337|NCT00807937|455407252|FG002|Overall Study|Protocol Violation|3|||
126576338|NCT00807937|455407253|FG003|Overall Study|Protocol Violation|3|||
126576339|NCT00807937|455407250|FG000|Overall Study|Withdrawal by Subject|5|||
126576340|NCT00807937|455407251|FG001|Overall Study|Withdrawal by Subject|4|||
126576341|NCT00807937|455407252|FG002|Overall Study|Withdrawal by Subject|1|||
126576342|NCT00807937|455407253|FG003|Overall Study|Withdrawal by Subject|4|||
126576343|NCT00807937|455407250|FG000|Overall Study|Lost to Follow-up|4|||
126576344|NCT00807937|455407251|FG001|Overall Study|Lost to Follow-up|0|||
126576345|NCT00807937|455407252|FG002|Overall Study|Lost to Follow-up|2|||
126576346|NCT00807937|455407253|FG003|Overall Study|Lost to Follow-up|1|||
126576347|NCT00807937|455407250|FG000|Overall Study|Lack of Efficacy|0|||
126576348|NCT00807937|455407251|FG001|Overall Study|Lack of Efficacy|0|||
126576349|NCT00807937|455407252|FG002|Overall Study|Lack of Efficacy|1|||
126576350|NCT00807937|455407253|FG003|Overall Study|Lack of Efficacy|2|||
126576351|NCT00807937|455407250|FG000|Overall Study|Intake of prohibited medicine|0|||
126576352|NCT00807937|455407251|FG001|Overall Study|Intake of prohibited medicine|0|||
126576353|NCT00807937|455407252|FG002|Overall Study|Intake of prohibited medicine|2|||
126576354|NCT00807937|455407253|FG003|Overall Study|Intake of prohibited medicine|0|||
126576355|NCT00807937|455407250|FG000|Overall Study|All other reasons (not provided)|2|||
126576356|NCT00807937|455407251|FG001|Overall Study|All other reasons (not provided)|4|||
126576357|NCT00807937|455407252|FG002|Overall Study|All other reasons (not provided)|0|||
126576358|NCT00807937|455407253|FG003|Overall Study|All other reasons (not provided)|1|||
126576359|NCT00510887|455407256|FG000|Overall Study|Lost to Follow-up|1|||
126576360|NCT03485950|455407268|FG000|Overall Study|Adverse Event|1|||
126576361|NCT03485950|455407269|FG001|Overall Study|Adverse Event|0|||
126576362|NCT03485950|455407268|FG000|Overall Study|Death|3|||
126576363|NCT03485950|455407269|FG001|Overall Study|Death|2|||
126576364|NCT03485950|455407268|FG000|Overall Study|Withdrawal by Subject|3|||
126576365|NCT03485950|455407269|FG001|Overall Study|Withdrawal by Subject|0|||
126576366|NCT00390299|455407273|FG000|Overall Study|Cancellation|1|||
126576367|NCT00390299|455407274|FG001|Overall Study|Cancellation|0|||
126576368|NCT00390299|455407275|FG002|Overall Study|Cancellation|0|||
126576369|NCT00390299|455407276|FG003|Overall Study|Cancellation|0|||
126576370|NCT00390299|455407277|FG004|Overall Study|Cancellation|0|||
126576371|NCT00970359|455407282|FG000|Overall Study|Not Treated|4|||
126576372|NCT01565148|455407283|FG000|Overall Study|Withdrawal by Subject|1|||
126576373|NCT01565148|455407284|FG001|Overall Study|Withdrawal by Subject|1|||
126576374|NCT01565148|455407285|FG002|Overall Study|Withdrawal by Subject|1|||
126576375|NCT01565148|455407286|FG003|Overall Study|Withdrawal by Subject|2|||
126576376|NCT01565148|455407283|FG000|Overall Study|Lost to Follow-up|4|||
126576377|NCT01565148|455407284|FG001|Overall Study|Lost to Follow-up|4|||
126576378|NCT01565148|455407285|FG002|Overall Study|Lost to Follow-up|0|||
126576379|NCT01565148|455407286|FG003|Overall Study|Lost to Follow-up|3|||
126576380|NCT01565148|455407283|FG000|Overall Study|Rescue Therapy|8|||
126576381|NCT01565148|455407284|FG001|Overall Study|Rescue Therapy|5|||
126576382|NCT01565148|455407285|FG002|Overall Study|Rescue Therapy|5|||
126576383|NCT01565148|455407286|FG003|Overall Study|Rescue Therapy|8|||
126576384|NCT01565148|455407283|FG000|Overall Study|Death|0|||
126576385|NCT01565148|455407284|FG001|Overall Study|Death|0|||
126576386|NCT01565148|455407285|FG002|Overall Study|Death|1|||
126576387|NCT01565148|455407286|FG003|Overall Study|Death|0|||
126576388|NCT01565148|455407283|FG000|Overall Study|Physician Decision|2|||
126576389|NCT01565148|455407284|FG001|Overall Study|Physician Decision|5|||
126576390|NCT01565148|455407285|FG002|Overall Study|Physician Decision|0|||
126576391|NCT01565148|455407286|FG003|Overall Study|Physician Decision|0|||
126576392|NCT01061671|455407288|FG000|Overall Study|Withdrawal by Subject|16|||
126576393|NCT01061671|455407289|FG001|Overall Study|Withdrawal by Subject|20|||
126576394|NCT01061671|455407288|FG000|Overall Study|Lost to Follow-up|3|||
126576395|NCT01061671|455407289|FG001|Overall Study|Lost to Follow-up|5|||
126576396|NCT01061671|455407288|FG000|Overall Study|Death|28|||
126576397|NCT01061671|455407289|FG001|Overall Study|Death|30|||
126576398|NCT05368831|455407290|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
126576399|NCT01551355|455407291|FG000|Overall Study|Lost to Follow-up|51|||
126576400|NCT01551355|455407292|FG001|Overall Study|Lost to Follow-up|49|||
126576401|NCT01551355|455407293|FG002|Overall Study|Lost to Follow-up|34|||
126576402|NCT01551355|455407294|FG003|Overall Study|Lost to Follow-up|24|||
126576403|NCT01551355|455407295|FG004|Overall Study|Lost to Follow-up|9|||
126576404|NCT01551355|455407296|FG005|Overall Study|Lost to Follow-up|6|||
126576405|NCT03482635|455407299|FG000|Overall Study|Lack of Efficacy|0|||
126576406|NCT03482635|455407300|FG001|Overall Study|Lack of Efficacy|0|||
126576407|NCT03482635|455407301|FG002|Overall Study|Lack of Efficacy|1|||
126576408|NCT03482635|455407302|FG003|Overall Study|Lack of Efficacy|3|||
126576409|NCT03482635|455407299|FG000|Overall Study|Adverse Event|2|||
126576410|NCT03482635|455407300|FG001|Overall Study|Adverse Event|2|||
126576411|NCT03482635|455407301|FG002|Overall Study|Adverse Event|0|||
126576412|NCT03482635|455407302|FG003|Overall Study|Adverse Event|3|||
126576413|NCT03482635|455407299|FG000|Overall Study|Withdrawal by Subject|2|||
126576414|NCT03482635|455407300|FG001|Overall Study|Withdrawal by Subject|1|||
126576415|NCT03482635|455407301|FG002|Overall Study|Withdrawal by Subject|0|||
126576416|NCT03482635|455407302|FG003|Overall Study|Withdrawal by Subject|1|||
126576417|NCT03482635|455407299|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
126576418|NCT03482635|455407300|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
126576419|NCT03482635|455407301|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
126576420|NCT03482635|455407302|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
126576421|NCT03482635|455407299|FG000|Overall Study|Not treated|0|||
126576422|NCT03482635|455407300|FG001|Overall Study|Not treated|0|||
126576423|NCT03482635|455407301|FG002|Overall Study|Not treated|0|||
126576424|NCT03482635|455407302|FG003|Overall Study|Not treated|1|||
126576425|NCT01780298|455408453|FG000|Overall Study|Physician Decision|1|||
126576426|NCT01780298|455408454|FG001|Overall Study|Physician Decision|5|||
126576427|NCT01780298|455408455|FG002|Overall Study|Physician Decision|1|||
126576428|NCT01780298|455408456|FG003|Overall Study|Physician Decision|1|||
126576429|NCT01780298|455408453|FG000|Overall Study|Subject not matched|1|||
126576430|NCT01780298|455408454|FG001|Overall Study|Subject not matched|0|||
126576431|NCT01780298|455408455|FG002|Overall Study|Subject not matched|1|||
126576432|NCT01780298|455408456|FG003|Overall Study|Subject not matched|0|||
126576433|NCT01780298|455408453|FG000|Overall Study|Adverse Event|0|||
126576434|NCT01780298|455408454|FG001|Overall Study|Adverse Event|0|||
126576435|NCT01780298|455408455|FG002|Overall Study|Adverse Event|2|||
126576436|NCT01780298|455408456|FG003|Overall Study|Adverse Event|0|||
126576437|NCT04907474|455408461|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
126576438|NCT04907474|455408462|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
126576439|NCT04259450|455408465|FG000|Overall Study|Adverse event/ Toxicity|0|||
126576440|NCT04259450|455408466|FG001|Overall Study|Adverse event/ Toxicity|3|||
126576441|NCT04259450|455408467|FG002|Overall Study|Adverse event/ Toxicity|0|||
126576442|NCT04259450|455408468|FG003|Overall Study|Adverse event/ Toxicity|1|||
126576443|NCT04259450|455408469|FG004|Overall Study|Adverse event/ Toxicity|0|||
126576444|NCT04259450|455408470|FG005|Overall Study|Adverse event/ Toxicity|0|||
126576445|NCT04259450|455408471|FG006|Overall Study|Adverse event/ Toxicity|0|||
126576446|NCT04259450|455408472|FG007|Overall Study|Adverse event/ Toxicity|1|||
126576447|NCT04259450|455408473|FG008|Overall Study|Adverse event/ Toxicity|0|||
126576448|NCT04259450|455408474|FG009|Overall Study|Adverse event/ Toxicity|3|||
126576449|NCT04259450|455408465|FG000|Overall Study|Disease progression|2|||
126576450|NCT04259450|455408466|FG001|Overall Study|Disease progression|3|||
126576451|NCT04259450|455408467|FG002|Overall Study|Disease progression|4|||
126576452|NCT04259450|455408468|FG003|Overall Study|Disease progression|4|||
126576453|NCT04259450|455408469|FG004|Overall Study|Disease progression|6|||
126576454|NCT04259450|455408470|FG005|Overall Study|Disease progression|6|||
126576455|NCT04259450|455408471|FG006|Overall Study|Disease progression|6|||
126576456|NCT04259450|455408472|FG007|Overall Study|Disease progression|15|||
126576457|NCT04259450|455408473|FG008|Overall Study|Disease progression|6|||
126576458|NCT04259450|455408474|FG009|Overall Study|Disease progression|18|||
126576459|NCT04259450|455408465|FG000|Overall Study|Death|0|||
126576460|NCT04259450|455408466|FG001|Overall Study|Death|0|||
126576461|NCT04259450|455408467|FG002|Overall Study|Death|0|||
126576462|NCT04259450|455408468|FG003|Overall Study|Death|0|||
126576463|NCT04259450|455408469|FG004|Overall Study|Death|0|||
126576464|NCT04259450|455408470|FG005|Overall Study|Death|0|||
126576465|NCT04259450|455408471|FG006|Overall Study|Death|0|||
126576466|NCT04259450|455408472|FG007|Overall Study|Death|1|||
126576467|NCT04259450|455408473|FG008|Overall Study|Death|1|||
126576468|NCT04259450|455408474|FG009|Overall Study|Death|0|||
126576469|NCT04259450|455408465|FG000|Overall Study|Withdrawal by Subject|0|||
126777039|NCT02124746|456139166|FG002|Overall Study|Adverse Event|2|||
126576470|NCT04259450|455408466|FG001|Overall Study|Withdrawal by Subject|0|||
126576471|NCT04259450|455408467|FG002|Overall Study|Withdrawal by Subject|0|||
126576472|NCT04259450|455408468|FG003|Overall Study|Withdrawal by Subject|0|||
126576473|NCT04259450|455408469|FG004|Overall Study|Withdrawal by Subject|0|||
126576474|NCT04259450|455408470|FG005|Overall Study|Withdrawal by Subject|0|||
126576475|NCT04259450|455408471|FG006|Overall Study|Withdrawal by Subject|0|||
126576476|NCT04259450|455408472|FG007|Overall Study|Withdrawal by Subject|1|||
126576477|NCT04259450|455408473|FG008|Overall Study|Withdrawal by Subject|0|||
126576478|NCT04259450|455408474|FG009|Overall Study|Withdrawal by Subject|0|||
126576479|NCT04259450|455408465|FG000|Overall Study|Other than listed|0|||
126576480|NCT04259450|455408466|FG001|Overall Study|Other than listed|0|||
126576481|NCT04259450|455408467|FG002|Overall Study|Other than listed|0|||
126576482|NCT04259450|455408468|FG003|Overall Study|Other than listed|0|||
126576483|NCT04259450|455408469|FG004|Overall Study|Other than listed|0|||
126777040|NCT02124746|456139164|FG000|Overall Study|Death|2|||
126727621|NCT00280150|455952801|FG001|Overall Study|Declining Performance Status|0|||
126727622|NCT00280150|455952802|FG002|Overall Study|Declining Performance Status|0|||
126727623|NCT00280150|455952803|FG003|Overall Study|Declining Performance Status|1|||
126727624|NCT02871401|455952807|FG000|Overall Study|Adverse Event|1|||
126727625|NCT02871401|455952808|FG001|Overall Study|Adverse Event|0|||
126727626|NCT01120379|455952809|FG000|One Year Timepoint|Withdrawal by Subject|41|||
126727627|NCT01120379|455952809|FG000|One Year Timepoint|Lost to Follow-up|115|||
126727628|NCT01120379|455952809|FG000|One Year Timepoint|Death|108|||
126727629|NCT01120379|455952809|FG000|One Year Timepoint|Physician Decision|9|||
126727630|NCT01120379|455952809|FG000|One Year Timepoint|Any other reason for early termination|5|||
126727631|NCT01120379|455952809|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
126727632|NCT01120379|455952809|FG000|Two Year Timepoint|Lost to Follow-up|87|||
126727633|NCT01120379|455952809|FG000|Two Year Timepoint|Death|123|||
126727634|NCT01120379|455952809|FG000|Two Year Timepoint|Physician Decision|12|||
126727635|NCT01120379|455952809|FG000|Two Year Timepoint|Any other reason for early termination|4|||
126727636|NCT01120379|455952809|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
126727637|NCT01120379|455952809|FG000|Three Year Timepoint|Lost to Follow-up|43|||
126727638|NCT01120379|455952809|FG000|Three Year Timepoint|Death|120|||
126727639|NCT01120379|455952809|FG000|Three Year Timepoint|Physician Decision|9|||
126727640|NCT01120379|455952809|FG000|Three Year Timepoint|Any other reason for early termination|17|||
126727641|NCT01120379|455952809|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
126727642|NCT01120379|455952809|FG000|Four Year Timepoint|Lost to Follow-up|10|||
126727643|NCT01120379|455952809|FG000|Four Year Timepoint|Death|131|||
126727644|NCT01120379|455952809|FG000|Four Year Timepoint|Physician Decision|5|||
126727645|NCT01120379|455952809|FG000|Four Year Timepoint|Any other reason for early termination|217|||
126727646|NCT03162055|455952810|FG000|Overall Study|Adverse Event|6|||
126727647|NCT03162055|455952811|FG001|Overall Study|Adverse Event|5|||
126727648|NCT03162055|455952810|FG000|Overall Study|Death|3|||
126727649|NCT03162055|455952811|FG001|Overall Study|Death|3|||
126727650|NCT03162055|455952810|FG000|Overall Study|Lost to Follow-up|0|||
126727651|NCT03162055|455952811|FG001|Overall Study|Lost to Follow-up|1|||
126727652|NCT03162055|455952810|FG000|Overall Study|Study-specific withdrawal criteria|22|||
126727653|NCT03162055|455952811|FG001|Overall Study|Study-specific withdrawal criteria|14|||
126727654|NCT03162055|455952810|FG000|Overall Study|Withdrawal by Subject|17|||
126727655|NCT03162055|455952811|FG001|Overall Study|Withdrawal by Subject|2|||
126727656|NCT03162055|455952810|FG000|Overall Study|Did not receive treatment|2|||
126727657|NCT03162055|455952811|FG001|Overall Study|Did not receive treatment|0|||
126727658|NCT03162055|455952810|FG000|Overall Study|Incorrect randomization|4|||
126727659|NCT03162055|455952811|FG001|Overall Study|Incorrect randomization|3|||
126727660|NCT03162055|455952810|FG000|Overall Study|Other|8|||
126727661|NCT03162055|455952811|FG001|Overall Study|Other|15|||
126727662|NCT01993615|455952815|FG000|Overall Study|Death|1|||
126727663|NCT01993615|455952816|FG001|Overall Study|Death|0|||
126727664|NCT01617655|455952817|FG000|Overall Study|Adverse Event|2|||
126727665|NCT01617655|455952818|FG001|Overall Study|Adverse Event|3|||
126727666|NCT01617655|455952817|FG000|Overall Study|Poor compliance to protocol|1|||
126727667|NCT01617655|455952818|FG001|Overall Study|Poor compliance to protocol|4|||
126727668|NCT01617655|455952817|FG000|Overall Study|Participants moved|0|||
126523987|NCT00360529|455210424|FG002|Overall Study|Lost to Follow-up|13|||
126523988|NCT00360529|455210422|FG000|Overall Study|Withdrawal by Subject|22|||
126523989|NCT00360529|455210423|FG001|Overall Study|Withdrawal by Subject|14|||
126523990|NCT00360529|455210424|FG002|Overall Study|Withdrawal by Subject|18|||
126523991|NCT00360529|455210422|FG000|Overall Study|Lack of Efficacy|8|||
126523992|NCT00360529|455210423|FG001|Overall Study|Lack of Efficacy|6|||
126523993|NCT00360529|455210424|FG002|Overall Study|Lack of Efficacy|5|||
126523994|NCT00360529|455210422|FG000|Overall Study|Reason discontinued not explained above|4|||
126523995|NCT00360529|455210423|FG001|Overall Study|Reason discontinued not explained above|9|||
126523996|NCT00360529|455210424|FG002|Overall Study|Reason discontinued not explained above|11|||
126523997|NCT03712917|455210425|FG000|Overall Study|Pregnancy|0|||
126523998|NCT03712917|455210426|FG001|Overall Study|Pregnancy|0|||
126523999|NCT03712917|455210427|FG002|Overall Study|Pregnancy|1|||
126524000|NCT03712917|455210425|FG000|Overall Study|Adverse Event|0|||
126524001|NCT03712917|455210426|FG001|Overall Study|Adverse Event|4|||
126524002|NCT03712917|455210427|FG002|Overall Study|Adverse Event|3|||
126524003|NCT03712917|455210425|FG000|Overall Study|Lost to Follow-up|9|||
126524004|NCT03712917|455210426|FG001|Overall Study|Lost to Follow-up|4|||
126524005|NCT03712917|455210427|FG002|Overall Study|Lost to Follow-up|5|||
126524006|NCT03662750|455210428|FG000|Overall Study|Withdrawal by Subject|1|||
126524007|NCT00932893|455210429|FG000|Overall Study|Death|115|||
126524008|NCT00932893|455210430|FG001|Overall Study|Death|24|||
126524009|NCT00932893|455210429|FG000|Overall Study|Lost to Follow-up|8|||
126524010|NCT00932893|455210430|FG001|Overall Study|Lost to Follow-up|0|||
126524011|NCT00932893|455210429|FG000|Overall Study|Withdrawal by Subject|5|||
126524012|NCT00932893|455210430|FG001|Overall Study|Withdrawal by Subject|2|||
126524013|NCT00932893|455210429|FG000|Overall Study|Other|5|||
126524014|NCT00932893|455210430|FG001|Overall Study|Other|144|||
126524015|NCT05706506|455212279|FG000|Overall Study|Adverse Event|1|||
126524016|NCT05706506|455212279|FG000|Overall Study|Withdrawal by Subject|4|||
126727669|NCT01617655|455952818|FG001|Overall Study|Participants moved|4|||
126727670|NCT01617655|455952817|FG000|Overall Study|Consent withdrawn by participant|1|||
126727671|NCT01617655|455952818|FG001|Overall Study|Consent withdrawn by participant|1|||
126727672|NCT01617655|455952817|FG000|Overall Study|Last visit outside protocol visit window|1|||
126727673|NCT01617655|455952818|FG001|Overall Study|Last visit outside protocol visit window|10|||
126727674|NCT01617655|455952817|FG000|Overall Study|Site closure|3|||
126727675|NCT01617655|455952818|FG001|Overall Study|Site closure|5|||
126727676|NCT01617655|455952817|FG000|Overall Study|Other than specified above|1|||
126727677|NCT01617655|455952818|FG001|Overall Study|Other than specified above|2|||
126727678|NCT01175213|455952821|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
126727679|NCT01175213|455952822|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
126727680|NCT01175213|455952821|FG000|IGSC, 10%/rHuPH20|Death|1|||
126727681|NCT01175213|455952822|FG001|IGSC, 10%/rHuPH20|Death|0|||
126727682|NCT01175213|455952821|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
126727683|NCT01175213|455952822|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
126727684|NCT01175213|455952821|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
126727685|NCT01175213|455952822|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
126727686|NCT01175213|455952821|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
126727687|NCT01175213|455952822|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
126727688|NCT01175213|455952821|FG000|Safety Follow-up|Adverse Event|1|||
126727689|NCT01175213|455952822|FG001|Safety Follow-up|Adverse Event|0|||
126727690|NCT01245764|455952827|FG000|Study Phase A|Other|3|||
126727691|NCT01245764|455952828|FG001|Study Phase A|Other|2|||
126727692|NCT01245764|455952829|FG002|Study Phase A|Other|3|||
126727693|NCT01245764|455952830|FG003|Study Phase A|Other|1|||
126727694|NCT01245764|455952827|FG000|Study Phase A|Protocol Violation|6|||
126727695|NCT01245764|455952828|FG001|Study Phase A|Protocol Violation|3|||
126727696|NCT01245764|455952829|FG002|Study Phase A|Protocol Violation|2|||
126727697|NCT01245764|455952830|FG003|Study Phase A|Protocol Violation|2|||
126727698|NCT01245764|455952827|FG000|Study Phase A|Lost to Follow-up|0|||
126727699|NCT01245764|455952828|FG001|Study Phase A|Lost to Follow-up|0|||
126727700|NCT01245764|455952829|FG002|Study Phase A|Lost to Follow-up|5|||
126727701|NCT01245764|455952830|FG003|Study Phase A|Lost to Follow-up|0|||
126727702|NCT00003476|455952831|FG000|Overall Study|Not evaluable|1|||
126727703|NCT00781963|455952836|FG000|Overall Study|Death|3|||
126727704|NCT00781963|455952837|FG001|Overall Study|Death|0|||
126727705|NCT00781963|455952836|FG000|Overall Study|Lost to Follow-up|2|||
126727706|NCT00781963|455952837|FG001|Overall Study|Lost to Follow-up|1|||
126727707|NCT00781963|455952836|FG000|Overall Study|Withdrawal by Subject|3|||
126727708|NCT00781963|455952837|FG001|Overall Study|Withdrawal by Subject|1|||
126727709|NCT00781963|455952836|FG000|Overall Study|Refused follow-up|9|||
126727710|NCT00781963|455952837|FG001|Overall Study|Refused follow-up|0|||
126727711|NCT02064205|455952841|FG000|Overall Study|Withdrawal by Subject|1|||
126524017|NCT05706506|455212279|FG000|Overall Study|Lost to Follow-up|2|||
126524018|NCT05706506|455212279|FG000|Overall Study|Inadvertent Enrolment|12|||
126524019|NCT05706506|455212279|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
126524020|NCT05706506|455212279|FG000|Overall Study|Participant Moved Out of State|1|||
126524021|NCT01262651|455212280|FG000|Overall Study|Adverse Event|40|||
126524022|NCT01262651|455212281|FG001|Overall Study|Adverse Event|35|||
126524023|NCT01262651|455212280|FG000|Overall Study|Withdrawal by Subject|15|||
126524024|NCT01262651|455212281|FG001|Overall Study|Withdrawal by Subject|11|||
126727712|NCT03057951|455952842|FG000|Overall Study|Adverse Event|553|||
126727713|NCT03057951|455952843|FG001|Overall Study|Adverse Event|575|||
126727714|NCT03057951|455952842|FG000|Overall Study|Protocol Violation|30|||
126727715|NCT03057951|455952843|FG001|Overall Study|Protocol Violation|24|||
126727716|NCT03057951|455952842|FG000|Overall Study|Lost to Follow-up|6|||
126727717|NCT03057951|455952843|FG001|Overall Study|Lost to Follow-up|16|||
126727718|NCT03057951|455952842|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
126727719|NCT03057951|455952843|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
126727720|NCT03057951|455952842|FG000|Overall Study|Study drug stopped, reason missing|6|||
126524025|NCT01262651|455212280|FG000|Overall Study|Withdrawal by Investigator|2|||
126576484|NCT04259450|455408470|FG005|Overall Study|Other than listed|0|||
126727721|NCT03057951|455952843|FG001|Overall Study|Study drug stopped, reason missing|1|||
126727722|NCT03057951|455952842|FG000|Overall Study|Medical advice|6|||
126777041|NCT02124746|456139165|FG001|Overall Study|Death|1|||
126727723|NCT03057951|455952843|FG001|Overall Study|Medical advice|2|||
126727724|NCT03057951|455952842|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
126727725|NCT03057951|455952843|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
126727726|NCT03057951|455952842|FG000|Overall Study|Investigator decision|2|||
126727727|NCT03057951|455952843|FG001|Overall Study|Investigator decision|0|||
126727728|NCT03057951|455952842|FG000|Overall Study|Patient decision|5|||
126727729|NCT03057951|455952843|FG001|Overall Study|Patient decision|2|||
126727730|NCT03057951|455952842|FG000|Overall Study|Not attending study visits|3|||
126524026|NCT01262651|455212281|FG001|Overall Study|Withdrawal by Investigator|2|||
126524027|NCT01262651|455212280|FG000|Overall Study|Met Withdrawal Criteria|1|||
126524028|NCT01262651|455212281|FG001|Overall Study|Met Withdrawal Criteria|0|||
126727731|NCT03057951|455952843|FG001|Overall Study|Not attending study visits|0|||
126777042|NCT02124746|456139166|FG002|Overall Study|Death|3|||
126524029|NCT04743908|455212282|FG000|Overall Study|Death|1|||
126524030|NCT04743908|455212283|FG001|Overall Study|Death|0|||
126524031|NCT04743908|455212282|FG000|Overall Study|Lost to Follow-up|181|||
126524032|NCT04743908|455212283|FG001|Overall Study|Lost to Follow-up|180|||
126524033|NCT04743908|455212282|FG000|Overall Study|Withdrawal by Subject|1|||
126524034|NCT04743908|455212283|FG001|Overall Study|Withdrawal by Subject|2|||
126524035|NCT04969783|455212284|FG000|Overall Study|Lost to Follow-up|2|||
126524036|NCT04969783|455212285|FG001|Overall Study|Lost to Follow-up|0|||
126524037|NCT04969783|455212284|FG000|Overall Study|Withdrawal by Subject|4|||
126524038|NCT04969783|455212285|FG001|Overall Study|Withdrawal by Subject|0|||
126524039|NCT04969783|455212284|FG000|Overall Study|Physician Decision|6|||
126524040|NCT04969783|455212285|FG001|Overall Study|Physician Decision|0|||
126524041|NCT04837482|455212286|FG000|Period 2|Withdrawal by Subject|0|||
126524042|NCT04837482|455212287|FG001|Period 2|Withdrawal by Subject|1|||
126524043|NCT00407537|455212297|FG000|Overall Study|Death|5|||
126524044|NCT00407537|455212298|FG001|Overall Study|Death|2|||
126524045|NCT00407537|455212297|FG000|Overall Study|Adverse Event|36|||
126524046|NCT00407537|455212298|FG001|Overall Study|Adverse Event|0|||
126524047|NCT00407537|455212297|FG000|Overall Study|Lost to Follow-up|12|||
126524048|NCT00407537|455212298|FG001|Overall Study|Lost to Follow-up|19|||
126524049|NCT00407537|455212297|FG000|Overall Study|Other|6|||
126524050|NCT00407537|455212298|FG001|Overall Study|Other|7|||
126524051|NCT00407537|455212297|FG000|Overall Study|Withdrawal by Subject|34|||
126524052|NCT00407537|455212298|FG001|Overall Study|Withdrawal by Subject|16|||
126524053|NCT01519206|455212299|FG000|Overall Study|Lost to Follow-up|3|||
126524054|NCT01519206|455212299|FG000|Overall Study|Missed Visit|2|||
126524055|NCT06027216|455212300|FG000|Overall Study|Did not qualify|8|||
126524056|NCT03646513|455212304|FG000|Overall Study|Premature study termination|4|||
126524057|NCT00782340|455212305|FG000|Open Label Titration|Adverse Event|12|||
126524058|NCT00782340|455212306|FG001|Open Label Titration|Adverse Event|0|||
126524059|NCT00782340|455212307|FG002|Open Label Titration|Adverse Event|0|||
126524060|NCT00782340|455212305|FG000|Open Label Titration|Treatment failure|50|||
126524061|NCT00782340|455212306|FG001|Open Label Titration|Treatment failure|0|||
126524062|NCT00782340|455212307|FG002|Open Label Titration|Treatment failure|0|||
126524063|NCT00782340|455212305|FG000|Open Label Titration|Protocol Violation|5|||
126524064|NCT00782340|455212306|FG001|Open Label Titration|Protocol Violation|0|||
126524065|NCT00782340|455212307|FG002|Open Label Titration|Protocol Violation|0|||
126524066|NCT00782340|455212305|FG000|Open Label Titration|Withdrawal by Subject|5|||
126524067|NCT00782340|455212306|FG001|Open Label Titration|Withdrawal by Subject|0|||
126524068|NCT00782340|455212307|FG002|Open Label Titration|Withdrawal by Subject|0|||
126524069|NCT00782340|455212305|FG000|Open Label Titration|Enrollment capped|16|||
126524070|NCT00782340|455212306|FG001|Open Label Titration|Enrollment capped|0|||
126524071|NCT00782340|455212307|FG002|Open Label Titration|Enrollment capped|0|||
126524072|NCT00782340|455212305|FG000|Open Label Titration|Did not meet responder criteria|2|||
126524073|NCT00782340|455212306|FG001|Open Label Titration|Did not meet responder criteria|0|||
126524074|NCT00782340|455212307|FG002|Open Label Titration|Did not meet responder criteria|0|||
126524075|NCT00782340|455212305|FG000|Open Label Titration|Lost to Follow-up|5|||
126524076|NCT00782340|455212306|FG001|Open Label Titration|Lost to Follow-up|0|||
126524077|NCT00782340|455212307|FG002|Open Label Titration|Lost to Follow-up|0|||
126524078|NCT00782340|455212305|FG000|Open Label Titration|Randomized in error|6|||
126524079|NCT00782340|455212306|FG001|Open Label Titration|Randomized in error|0|||
126524080|NCT00782340|455212307|FG002|Open Label Titration|Randomized in error|0|||
126524081|NCT02219932|455212312|FG000|Overall Study|Other|5|||
126524082|NCT02219932|455212313|FG001|Overall Study|Other|11|||
126524083|NCT02219932|455212312|FG000|Overall Study|Death|1|||
126524084|NCT02219932|455212313|FG001|Overall Study|Death|1|||
126524085|NCT02219932|455212312|FG000|Overall Study|Investigator Decision|0|||
126524086|NCT02219932|455212313|FG001|Overall Study|Investigator Decision|1|||
126524087|NCT02219932|455212312|FG000|Overall Study|Consent Withdrawn|11|||
126524088|NCT02219932|455212313|FG001|Overall Study|Consent Withdrawn|7|||
126524089|NCT02219932|455212312|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
126524090|NCT02219932|455212313|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
126524091|NCT02219932|455212312|FG000|Overall Study|Protocol Violation|10|||
126524092|NCT02219932|455212313|FG001|Overall Study|Protocol Violation|6|||
126524093|NCT02219932|455212312|FG000|Overall Study|Pregnancy|1|||
126524094|NCT02219932|455212313|FG001|Overall Study|Pregnancy|0|||
126524095|NCT02219932|455212312|FG000|Overall Study|Lost to Follow-up|4|||
126524096|NCT02219932|455212313|FG001|Overall Study|Lost to Follow-up|2|||
126524097|NCT02219932|455212312|FG000|Overall Study|Adverse Event|23|||
126524098|NCT02219932|455212313|FG001|Overall Study|Adverse Event|21|||
126524099|NCT00093145|455212315|FG000|Overall Study|Unacceptable Toxicity Only|2|||
126524100|NCT00093145|455212315|FG000|Overall Study|Physician Decision|5|||
126524101|NCT00093145|455212315|FG000|Overall Study|Withdrawal by Subject|9|||
126524102|NCT00093145|455212315|FG000|Overall Study|Other|1|||
126524103|NCT04389840|455212316|FG000|Overall Study|Adverse Event|0|||
126524104|NCT04389840|455212317|FG001|Overall Study|Adverse Event|0|||
126524105|NCT04389840|455212318|FG002|Overall Study|Adverse Event|0|||
126524106|NCT04389840|455212319|FG003|Overall Study|Adverse Event|1|||
126524107|NCT04389840|455212320|FG004|Overall Study|Adverse Event|0|||
126524108|NCT04389840|455212321|FG005|Overall Study|Adverse Event|0|||
126524109|NCT04389840|455212316|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
126524110|NCT04389840|455212317|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
126524111|NCT04389840|455212318|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
126524112|NCT04389840|455212319|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
126524113|NCT04389840|455212320|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
126524114|NCT04389840|455212321|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
126524115|NCT04389840|455212316|FG000|Overall Study|Death|0|||
126524116|NCT04389840|455212317|FG001|Overall Study|Death|1|||
126524117|NCT04389840|455212318|FG002|Overall Study|Death|0|||
126524118|NCT04389840|455212319|FG003|Overall Study|Death|0|||
126524119|NCT04389840|455212320|FG004|Overall Study|Death|0|||
126524120|NCT04389840|455212321|FG005|Overall Study|Death|0|||
126524121|NCT02252211|455212322|FG000|Overall Study|Adverse Event|0|||
126524122|NCT02252211|455212323|FG001|Overall Study|Adverse Event|1|||
126524123|NCT02252211|455212324|FG002|Overall Study|Adverse Event|0|||
126524124|NCT02252211|455212322|FG000|Overall Study|Progressive disease|3|||
126524125|NCT02252211|455212323|FG001|Overall Study|Progressive disease|2|||
126524126|NCT02252211|455212324|FG002|Overall Study|Progressive disease|0|||
126524127|NCT02252211|455212322|FG000|Overall Study|Withdrawal by Subject|1|||
126524128|NCT02252211|455212323|FG001|Overall Study|Withdrawal by Subject|0|||
126524129|NCT02252211|455212324|FG002|Overall Study|Withdrawal by Subject|0|||
126524130|NCT02252211|455212322|FG000|Overall Study|Serious Adverse Event During Screening|1|||
126524131|NCT02252211|455212323|FG001|Overall Study|Serious Adverse Event During Screening|0|||
126524132|NCT02252211|455212324|FG002|Overall Study|Serious Adverse Event During Screening|1|||
126524133|NCT00968669|455212325|FG000|Overall Study|Lost to Follow-up|5|||
126524134|NCT00968669|455212326|FG001|Overall Study|Lost to Follow-up|2|||
126524135|NCT00968669|455212327|FG002|Overall Study|Lost to Follow-up|1|||
126524136|NCT00968669|455212328|FG003|Overall Study|Lost to Follow-up|4|||
126524137|NCT00968669|455212325|FG000|Overall Study|Withdrawal by Subject|9|||
126524138|NCT00968669|455212326|FG001|Overall Study|Withdrawal by Subject|7|||
126524139|NCT00968669|455212327|FG002|Overall Study|Withdrawal by Subject|5|||
126524140|NCT00968669|455212328|FG003|Overall Study|Withdrawal by Subject|3|||
126524141|NCT00968669|455212325|FG000|Overall Study|Pregnancy|0|||
126524142|NCT00968669|455212326|FG001|Overall Study|Pregnancy|0|||
126524143|NCT00968669|455212327|FG002|Overall Study|Pregnancy|2|||
126524144|NCT00968669|455212328|FG003|Overall Study|Pregnancy|0|||
126524145|NCT00968669|455212325|FG000|Overall Study|AE|1|||
126524146|NCT00968669|455212326|FG001|Overall Study|AE|0|||
126524147|NCT00968669|455212327|FG002|Overall Study|AE|0|||
126524148|NCT00968669|455212328|FG003|Overall Study|AE|0|||
126524149|NCT00968669|455212325|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
126524150|NCT00968669|455212326|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
126524151|NCT00968669|455212327|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
126524152|NCT00968669|455212328|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
126524153|NCT00968669|455212325|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
126524154|NCT00968669|455212326|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
126524155|NCT00968669|455212327|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
126524156|NCT00968669|455212328|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
126524157|NCT00968669|455212325|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
126524158|NCT00968669|455212326|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
126524159|NCT00968669|455212327|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
126524160|NCT00968669|455212328|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
126524161|NCT00968669|455212325|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
126576485|NCT04259450|455408471|FG006|Overall Study|Other than listed|0|||
126524162|NCT00968669|455212326|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
126524163|NCT00968669|455212327|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
126524164|NCT00968669|455212328|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
126524165|NCT00968669|455212325|FG000|Overall Study|EARLY WITHDRAWAL|0|||
126524166|NCT00968669|455212326|FG001|Overall Study|EARLY WITHDRAWAL|1|||
126524167|NCT00968669|455212327|FG002|Overall Study|EARLY WITHDRAWAL|0|||
126524168|NCT00968669|455212328|FG003|Overall Study|EARLY WITHDRAWAL|0|||
126524169|NCT00968669|455212325|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
126524170|NCT00968669|455212326|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
126524171|NCT00968669|455212327|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
126524172|NCT00968669|455212328|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
126524173|NCT00968669|455212325|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
126524174|NCT00968669|455212326|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
126524175|NCT00968669|455212327|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
126524176|NCT00968669|455212328|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
126524177|NCT00968669|455212325|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
126524178|NCT00968669|455212326|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
126524179|NCT00968669|455212327|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
126524180|NCT00968669|455212328|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
126524181|NCT00968669|455212325|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
126524182|NCT00968669|455212326|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
126524183|NCT00968669|455212327|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
126524184|NCT00968669|455212328|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
126524185|NCT00968669|455212325|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
126524186|NCT00968669|455212326|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
126524187|NCT00968669|455212327|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
126524188|NCT00968669|455212328|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
126524189|NCT00968669|455212325|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
126524190|NCT00968669|455212326|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
126524191|NCT00968669|455212327|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
126524192|NCT00968669|455212328|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
126524193|NCT00968669|455212325|FG000|Overall Study|SPONSOR DECISION|0|||
126524194|NCT00968669|455212326|FG001|Overall Study|SPONSOR DECISION|1|||
126524195|NCT00968669|455212327|FG002|Overall Study|SPONSOR DECISION|0|||
126524196|NCT00968669|455212328|FG003|Overall Study|SPONSOR DECISION|0|||
126524197|NCT00968669|455212325|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
126524198|NCT00968669|455212326|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
126524199|NCT00968669|455212327|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
126524200|NCT00968669|455212328|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
126524201|NCT00968669|455212325|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
126524202|NCT00968669|455212326|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
126524203|NCT00968669|455212327|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
126524204|NCT00968669|455212328|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
126524205|NCT00968669|455212325|FG000|Overall Study|SUBJECT INCARCERATED|0|||
126524206|NCT00968669|455212326|FG001|Overall Study|SUBJECT INCARCERATED|1|||
126524207|NCT00968669|455212327|FG002|Overall Study|SUBJECT INCARCERATED|0|||
126524208|NCT00968669|455212328|FG003|Overall Study|SUBJECT INCARCERATED|0|||
126524209|NCT00968669|455212325|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
126524210|NCT00968669|455212326|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
126524211|NCT00968669|455212327|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
126524212|NCT00968669|455212328|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
126524213|NCT00968669|455212325|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
126524214|NCT00968669|455212326|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
126524215|NCT00968669|455212327|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
126524216|NCT00968669|455212328|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
126524217|NCT00144339|455212329|FG000|Overall Study|Adverse Event|746|||
126524218|NCT00144339|455212330|FG001|Overall Study|Adverse Event|627|||
126524219|NCT00144339|455212329|FG000|Overall Study|Protocol Violation|75|||
126524220|NCT00144339|455212330|FG001|Overall Study|Protocol Violation|48|||
126524221|NCT00144339|455212329|FG000|Overall Study|Withdrawal by Subject|403|||
126524222|NCT00144339|455212330|FG001|Overall Study|Withdrawal by Subject|300|||
126524223|NCT00144339|455212329|FG000|Overall Study|Lost to Follow-up|76|||
126524224|NCT00144339|455212330|FG001|Overall Study|Lost to Follow-up|64|||
126524225|NCT00144339|455212329|FG000|Overall Study|Other|58|||
126524226|NCT00144339|455212330|FG001|Overall Study|Other|60|||
126524227|NCT01109992|455212331|FG000|Overall Study|Withdrawal by Subject|0|||
126524228|NCT01109992|455212332|FG001|Overall Study|Withdrawal by Subject|1|||
126524229|NCT01109992|455212331|FG000|Overall Study|Movement during rest scan.|0|||
126524230|NCT01109992|455212332|FG001|Overall Study|Movement during rest scan.|1|||
126524231|NCT02338362|455212335|FG000|Overall Study|Withdrawal by Subject|1|||
126524232|NCT02338362|455212336|FG001|Overall Study|Withdrawal by Subject|1|||
126524233|NCT00690755|455212337|FG000|Overall Study|Physician Decision|2|||
126524234|NCT00690755|455212338|FG001|Overall Study|Physician Decision|0|||
126524235|NCT00690755|455212339|FG002|Overall Study|Physician Decision|46|||
126524236|NCT00690755|455212340|FG003|Overall Study|Physician Decision|5|||
126524237|NCT00690755|455212341|FG004|Overall Study|Physician Decision|0|||
126524238|NCT00690755|455212342|FG005|Overall Study|Physician Decision|4|||
126524239|NCT00690755|455212343|FG006|Overall Study|Physician Decision|0|||
126524240|NCT01764945|455212347|FG000|Overall Study|Adverse Event|0|||
126524241|NCT01764945|455212348|FG001|Overall Study|Adverse Event|1|||
126524242|NCT01764945|455212349|FG002|Overall Study|Adverse Event|0|||
126524243|NCT01764945|455212350|FG003|Overall Study|Adverse Event|0|||
126524244|NCT01764945|455212351|FG004|Overall Study|Adverse Event|0|||
126524245|NCT01764945|455212352|FG005|Overall Study|Adverse Event|0|||
126524246|NCT01764945|455212353|FG006|Overall Study|Adverse Event|1|||
126524247|NCT01764945|455212354|FG007|Overall Study|Adverse Event|0|||
126524248|NCT05077267|455212355|FG000|Treatment Period|Lost to Follow-up|0|||
126524249|NCT05077267|455212356|FG001|Treatment Period|Lost to Follow-up|1|||
126524250|NCT05077267|455212357|FG002|Treatment Period|Lost to Follow-up|0|||
126524251|NCT05077267|455212355|FG000|Treatment Period|Withdrawal by Subject|0|||
126524252|NCT05077267|455212356|FG001|Treatment Period|Withdrawal by Subject|1|||
126524253|NCT05077267|455212357|FG002|Treatment Period|Withdrawal by Subject|0|||
126524254|NCT05077267|455212355|FG000|Follow-up Period|Lost to Follow-up|0|||
126524255|NCT05077267|455212356|FG001|Follow-up Period|Lost to Follow-up|5|||
126524256|NCT05077267|455212357|FG002|Follow-up Period|Lost to Follow-up|7|||
126524257|NCT05077267|455212355|FG000|Follow-up Period|Withdrawal by Subject|0|||
126524258|NCT05077267|455212356|FG001|Follow-up Period|Withdrawal by Subject|2|||
126524259|NCT05077267|455212357|FG002|Follow-up Period|Withdrawal by Subject|5|||
126524260|NCT05077267|455212355|FG000|Follow-up Period|Study terminated by sponsor|0|||
126524261|NCT05077267|455212356|FG001|Follow-up Period|Study terminated by sponsor|27|||
126524262|NCT05077267|455212357|FG002|Follow-up Period|Study terminated by sponsor|23|||
126524263|NCT05077267|455212355|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
126524264|NCT05077267|455212356|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
126524265|NCT05077267|455212357|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
126524266|NCT05077267|455212355|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
126524267|NCT05077267|455212356|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
126524268|NCT05077267|455212357|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
126524269|NCT02911948|455212358|FG000|Overall Study|Protocol Violation|0|||
126524270|NCT02911948|455212359|FG001|Overall Study|Protocol Violation|1|||
126524271|NCT02911948|455212358|FG000|Overall Study|Withdrawal by Subject|0|||
126524272|NCT02911948|455212359|FG001|Overall Study|Withdrawal by Subject|2|||
126524273|NCT02911948|455212358|FG000|Overall Study|Lack of Efficacy|0|||
126524274|NCT02911948|455212359|FG001|Overall Study|Lack of Efficacy|1|||
126524275|NCT02911948|455212358|FG000|Overall Study|Unclassified|0|||
126524276|NCT02911948|455212359|FG001|Overall Study|Unclassified|3|||
126524277|NCT03867734|455212360|FG000|Overall Study|Lost to Follow-up|2|||
126524278|NCT02276482|455212370|FG000|Overall Study|Adverse Event|1|||
126524279|NCT02276482|455212371|FG001|Overall Study|Adverse Event|0|||
126524280|NCT02276482|455212370|FG000|Overall Study|Withdrawal by Subject|1|||
126524281|NCT02276482|455212371|FG001|Overall Study|Withdrawal by Subject|0|||
126524282|NCT02276482|455212370|FG000|Overall Study|Gram-negative infection|1|||
126524283|NCT02276482|455212371|FG001|Overall Study|Gram-negative infection|0|||
126524284|NCT02276482|455212370|FG000|Overall Study|Reason not specified|0|||
126524285|NCT02276482|455212371|FG001|Overall Study|Reason not specified|1|||
126524286|NCT01165281|455212379|FG000|Overall Study|Adverse Event|12|||
126524287|NCT01165281|455212380|FG001|Overall Study|Adverse Event|14|||
126524288|NCT01165281|455212379|FG000|Overall Study|Death|3|||
126524289|NCT01165281|455212380|FG001|Overall Study|Death|4|||
126524290|NCT01165281|455212379|FG000|Overall Study|Lack of Efficacy|4|||
126524291|NCT01165281|455212380|FG001|Overall Study|Lack of Efficacy|1|||
126524292|NCT01165281|455212379|FG000|Overall Study|Lost to Follow-up|0|||
126524293|NCT01165281|455212380|FG001|Overall Study|Lost to Follow-up|1|||
126524294|NCT01165281|455212379|FG000|Overall Study|Physician Decision|8|||
126524295|NCT01165281|455212380|FG001|Overall Study|Physician Decision|1|||
126524296|NCT01165281|455212379|FG000|Overall Study|Protocol Violation|6|||
126524297|NCT01165281|455212380|FG001|Overall Study|Protocol Violation|5|||
126524298|NCT01165281|455212379|FG000|Overall Study|Withdrawal by Subject|8|||
126524299|NCT01165281|455212380|FG001|Overall Study|Withdrawal by Subject|7|||
126524300|NCT01165281|455212379|FG000|Overall Study|Noncompliance with Study Drug|1|||
126524301|NCT01165281|455212380|FG001|Overall Study|Noncompliance with Study Drug|4|||
126524302|NCT01165281|455212379|FG000|Overall Study|Progressive Disease|10|||
126524303|NCT01165281|455212380|FG001|Overall Study|Progressive Disease|14|||
126524304|NCT01165281|455212379|FG000|Overall Study|Other|6|||
126524305|NCT01165281|455212380|FG001|Overall Study|Other|0|||
126524306|NCT00364858|455212385|FG000|Overall Study|Adverse Event|1|||
126524307|NCT00364858|455212386|FG001|Overall Study|Adverse Event|5|||
126524308|NCT00364858|455212385|FG000|Overall Study|Withdrawal by Subject|1|||
126524309|NCT00364858|455212386|FG001|Overall Study|Withdrawal by Subject|1|||
126524310|NCT00364858|455212385|FG000|Overall Study|Pregnancy|1|||
126524311|NCT00364858|455212386|FG001|Overall Study|Pregnancy|1|||
126524312|NCT00364858|455212385|FG000|Overall Study|Clinical failure|2|||
126524313|NCT00364858|455212386|FG001|Overall Study|Clinical failure|13|||
126524314|NCT00364858|455212385|FG000|Overall Study|Discontinuation at baseline|1|||
126524315|NCT00364858|455212386|FG001|Overall Study|Discontinuation at baseline|0|||
126524316|NCT00364858|455212385|FG000|Overall Study|Non-compliant|1|||
126524317|NCT00364858|455212386|FG001|Overall Study|Non-compliant|0|||
126524318|NCT00364858|455212385|FG000|Overall Study|Return to Q2 regimen|0|||
126524319|NCT00364858|455212386|FG001|Overall Study|Return to Q2 regimen|1|||
126524320|NCT00364858|455212385|FG000|Overall Study|Clinical baseline issue|0|||
126524321|NCT00364858|455212386|FG001|Overall Study|Clinical baseline issue|1|||
126524322|NCT00363766|455212387|FG000|Overall Study|Progressive Disease|15|||
126524323|NCT00363766|455212388|FG001|Overall Study|Progressive Disease|9|||
126524324|NCT00363766|455212387|FG000|Overall Study|Adverse Event|10|||
126524325|NCT00363766|455212388|FG001|Overall Study|Adverse Event|2|||
126524326|NCT00363766|455212387|FG000|Overall Study|Disease Related Death|1|||
126524327|NCT00363766|455212388|FG001|Overall Study|Disease Related Death|3|||
126524328|NCT00363766|455212387|FG000|Overall Study|Not Disease Related Death|3|||
126524329|NCT00363766|455212388|FG001|Overall Study|Not Disease Related Death|4|||
126524330|NCT00363766|455212387|FG000|Overall Study|Withdrawal by Subject|2|||
126524331|NCT00363766|455212388|FG001|Overall Study|Withdrawal by Subject|0|||
126524332|NCT00363766|455212387|FG000|Overall Study|Physician Decision|1|||
126524333|NCT00363766|455212388|FG001|Overall Study|Physician Decision|2|||
126524334|NCT00627705|455212389|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
126524335|NCT00627705|455212390|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
126524336|NCT00627705|455212389|FG000|Overall Study|Adverse Event|1|||
126524337|NCT00627705|455212390|FG001|Overall Study|Adverse Event|0|||
126524338|NCT00627705|455212389|FG000|Overall Study|Withdrawal by Subject|0|||
126524339|NCT00627705|455212390|FG001|Overall Study|Withdrawal by Subject|2|||
126524340|NCT00627705|455212389|FG000|Overall Study|Lost to Follow-up|0|||
126524341|NCT00627705|455212390|FG001|Overall Study|Lost to Follow-up|1|||
126524342|NCT00809757|455212400|FG000|Overall Study|Adverse Event|2|||
126524343|NCT00809757|455212401|FG001|Overall Study|Adverse Event|3|||
126524344|NCT00809757|455212402|FG002|Overall Study|Adverse Event|3|||
126524345|NCT00809757|455212400|FG000|Overall Study|Lost to Follow-up|0|||
126524346|NCT00809757|455212401|FG001|Overall Study|Lost to Follow-up|0|||
126524347|NCT00809757|455212402|FG002|Overall Study|Lost to Follow-up|1|||
126524348|NCT00809757|455212400|FG000|Overall Study|Protocol Violation|1|||
126524349|NCT00809757|455212401|FG001|Overall Study|Protocol Violation|1|||
126524350|NCT00809757|455212402|FG002|Overall Study|Protocol Violation|1|||
126524351|NCT00809757|455212400|FG000|Overall Study|Withdrawal by Subject|2|||
126524352|NCT00809757|455212401|FG001|Overall Study|Withdrawal by Subject|1|||
126524353|NCT00809757|455212402|FG002|Overall Study|Withdrawal by Subject|3|||
126524354|NCT00809757|455212400|FG000|Overall Study|Subject Uncooperative|1|||
126524355|NCT00809757|455212401|FG001|Overall Study|Subject Uncooperative|0|||
126524356|NCT00809757|455212402|FG002|Overall Study|Subject Uncooperative|2|||
126524357|NCT00809757|455212400|FG000|Overall Study|Noncompliance with Medication|0|||
126524358|NCT00809757|455212401|FG001|Overall Study|Noncompliance with Medication|0|||
126524359|NCT00809757|455212402|FG002|Overall Study|Noncompliance with Medication|1|||
126524360|NCT00659334|455212403|FG000|Overall Study|Screen Failure|8|||
126524361|NCT00659334|455212404|FG001|Overall Study|Screen Failure|5|||
126524362|NCT00659334|455212405|FG002|Overall Study|Screen Failure|0|||
126524363|NCT00659334|455212406|FG003|Overall Study|Screen Failure|0|||
126524364|NCT00659334|455212407|FG004|Overall Study|Screen Failure|0|||
126524365|NCT00659334|455212408|FG005|Overall Study|Screen Failure|0|||
126524366|NCT00659334|455212409|FG006|Overall Study|Screen Failure|1|||
126524367|NCT00253864|455212410|FG000|Overall Study|Lost to Follow-up|5|||
126524368|NCT00253864|455212411|FG001|Overall Study|Lost to Follow-up|8|||
126524369|NCT01174342|455212415|FG000|Overall Study|Conversion to cesarean section|4|||
126524370|NCT01410448|455212416|FG000|Overall Study|No conversion to everolimus|0|||
126524371|NCT01410448|455212417|FG001|Overall Study|No conversion to everolimus|24|||
126524372|NCT01410448|455212416|FG000|Overall Study|Graft loss|4|||
126524373|NCT01410448|455212417|FG001|Overall Study|Graft loss|1|||
126524374|NCT01410448|455212416|FG000|Overall Study|Administrative issues|2|||
126524375|NCT01410448|455212417|FG001|Overall Study|Administrative issues|1|||
126524376|NCT01410448|455212416|FG000|Overall Study|Lost to Follow-up|1|||
126524377|NCT01410448|455212417|FG001|Overall Study|Lost to Follow-up|0|||
126524378|NCT01410448|455212416|FG000|Overall Study|Withdrawal by Subject|3|||
126524379|NCT01410448|455212417|FG001|Overall Study|Withdrawal by Subject|2|||
126524380|NCT01410448|455212416|FG000|Overall Study|Protocol Violation|0|||
126524381|NCT01410448|455212417|FG001|Overall Study|Protocol Violation|4|||
126576486|NCT04259450|455408472|FG007|Overall Study|Other than listed|1|||
126576487|NCT04259450|455408473|FG008|Overall Study|Other than listed|1|||
126576488|NCT04259450|455408474|FG009|Overall Study|Other than listed|2|||
126576489|NCT01534494|455408475|FG000|Overall Study|Withdrawal by Subject|1|||
126576490|NCT02724592|455408476|FG000|Overall Study|Lost to Follow-up|4|||
126576491|NCT02724592|455408477|FG001|Overall Study|Lost to Follow-up|1|||
126576492|NCT02584829|455408478|FG000|Overall Study|Physician Decision|1|||
126576493|NCT02584829|455408479|FG001|Overall Study|Physician Decision|0|||
126727732|NCT03057951|455952842|FG000|Overall Study|Patient moved away|3|||
126727733|NCT03057951|455952843|FG001|Overall Study|Patient moved away|4|||
126576494|NCT02584829|455408478|FG000|Overall Study|Withdrawal by Subject|0|||
126576495|NCT02584829|455408479|FG001|Overall Study|Withdrawal by Subject|1|||
126727734|NCT03057951|455952842|FG000|Overall Study|Other reason than stated above|23|||
126727735|NCT03057951|455952843|FG001|Overall Study|Other reason than stated above|29|||
126727736|NCT03057951|455952842|FG000|Overall Study|Not treated|2|||
126727737|NCT03057951|455952843|FG001|Overall Study|Not treated|1|||
126727738|NCT00696436|455952844|FG000|Overall Study|Adverse Event|7|||
126727739|NCT00696436|455952845|FG001|Overall Study|Adverse Event|9|||
126727740|NCT00696436|455952846|FG002|Overall Study|Adverse Event|8|||
126727741|NCT00696436|455952847|FG003|Overall Study|Adverse Event|6|||
126727742|NCT00696436|455952848|FG004|Overall Study|Adverse Event|4|||
126727743|NCT00696436|455952844|FG000|Overall Study|Protocol Violation|3|||
126576496|NCT02584829|455408478|FG000|Overall Study|Progressive Disease|0|||
126576497|NCT02584829|455408479|FG001|Overall Study|Progressive Disease|3|||
126727744|NCT00696436|455952845|FG001|Overall Study|Protocol Violation|2|||
126727745|NCT00696436|455952846|FG002|Overall Study|Protocol Violation|2|||
126524382|NCT01410448|455212416|FG000|Overall Study|Death|2|||
126524383|NCT01410448|455212417|FG001|Overall Study|Death|3|||
126524384|NCT01308580|455212418|FG000|Overall Study|Lost to Follow-up|12|||
126524385|NCT01308580|455212419|FG001|Overall Study|Lost to Follow-up|7|||
126524386|NCT01218438|455212420|FG000|Epoch 1|Physician Decision|2|||
126524387|NCT01218438|455212420|FG000|Epoch 1|Adverse Event|1|||
126524388|NCT01218438|455212420|FG000|Epoch 3|Withdrawal by Subject|3|||
126524389|NCT01218438|455212420|FG000|Epoch 3|Adverse Event|1|||
126524390|NCT01218438|455212420|FG000|Epoch 4|Physician Decision|1|||
126524391|NCT01218438|455212420|FG000|Epoch 4|Withdrawal by Subject|2|||
126524392|NCT01218646|455212422|FG000|Overall Study|Adverse Event|0|||
126524393|NCT01218646|455212423|FG001|Overall Study|Adverse Event|0|||
126524394|NCT01218646|455212424|FG002|Overall Study|Adverse Event|1|||
126524395|NCT01218646|455212425|FG003|Overall Study|Adverse Event|0|||
126524396|NCT01218646|455212422|FG000|Overall Study|Lost to Follow-up|1|||
126524397|NCT01218646|455212423|FG001|Overall Study|Lost to Follow-up|0|||
126524398|NCT01218646|455212424|FG002|Overall Study|Lost to Follow-up|0|||
126524399|NCT01218646|455212425|FG003|Overall Study|Lost to Follow-up|0|||
126524400|NCT01218646|455212422|FG000|Overall Study|Protocol Violation|0|||
126524401|NCT01218646|455212423|FG001|Overall Study|Protocol Violation|0|||
126524402|NCT01218646|455212424|FG002|Overall Study|Protocol Violation|1|||
126524403|NCT01218646|455212425|FG003|Overall Study|Protocol Violation|1|||
126524404|NCT04295564|455214452|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
126524405|NCT04295564|455214453|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
126524406|NCT01682460|455214454|FG000|Overall Study|Withdrawal by Subject|2|||
126524407|NCT01682460|455214454|FG000|Overall Study|Did not meet inclusion criteria|2|||
126524408|NCT00724282|455214456|FG000|Overall Study|Withdrawal by Subject|3|||
126524409|NCT00724282|455214456|FG000|Overall Study|Physician Decision|1|||
126524410|NCT01159691|455214459|FG000|Overall Study|Lost to Follow-up|2|||
126524411|NCT01159691|455214459|FG000|Overall Study|Unknown reasons|1|||
126524412|NCT01159691|455214459|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
126524413|NCT01159691|455214459|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
126524414|NCT01159691|455214459|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
126524415|NCT01159691|455214459|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
126524416|NCT01159691|455214459|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
126524417|NCT01159691|455214459|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
126524418|NCT01928719|455214460|FG000|Overall Study|Lost to Follow-up|26|||
126524419|NCT01928719|455214461|FG001|Overall Study|Lost to Follow-up|11|||
126524420|NCT01928719|455214460|FG000|Overall Study|Withdrawal by Subject|22|||
126524421|NCT01928719|455214461|FG001|Overall Study|Withdrawal by Subject|7|||
126524422|NCT01928719|455214460|FG000|Overall Study|Protocol Violation|3|||
126524423|NCT01928719|455214461|FG001|Overall Study|Protocol Violation|1|||
126524424|NCT01928719|455214460|FG000|Overall Study|Adverse Event|1|||
126524425|NCT01928719|455214461|FG001|Overall Study|Adverse Event|0|||
126524426|NCT00773968|455214467|FG000|Overall Study|Adverse Event|2|||
126524427|NCT00773968|455214467|FG000|Overall Study|Death|1|||
126524428|NCT00773968|455214467|FG000|Overall Study|Failure to Return|2|||
126524429|NCT00773968|455214467|FG000|Overall Study|Lack of Efficacy|3|||
126524430|NCT00773968|455214467|FG000|Overall Study|Protocol Violation|1|||
126524431|NCT00773968|455214467|FG000|Overall Study|Withdrawal by Subject|11|||
126524432|NCT00773968|455214467|FG000|Overall Study|Screen Failure|17|||
126524433|NCT00773968|455214467|FG000|Overall Study|Other|8|||
126524434|NCT00263666|455214468|FG000|Overall Study|Adverse Event|6|||
126524435|NCT00263666|455214469|FG001|Overall Study|Adverse Event|8|||
126524436|NCT00263666|455214468|FG000|Overall Study|Lost to Follow-up|1|||
126524437|NCT00263666|455214469|FG001|Overall Study|Lost to Follow-up|2|||
126524438|NCT00263666|455214468|FG000|Overall Study|Withdrawal by Subject|0|||
126524439|NCT00263666|455214469|FG001|Overall Study|Withdrawal by Subject|1|||
126524440|NCT05732454|455214470|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
126524441|NCT05732454|455214471|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
126524442|NCT05732454|455214470|FG000|Part 1: DB Period|Adverse Event|1|||
126524443|NCT05732454|455214471|FG001|Part 1: DB Period|Adverse Event|0|||
126524444|NCT05732454|455214470|FG000|Part 1: DB Period|Lost to Follow-up|1|||
126524445|NCT05732454|455214471|FG001|Part 1: DB Period|Lost to Follow-up|0|||
126524446|NCT05732454|455214470|FG000|Part 1: DB Period|Protocol Violation|0|||
126524447|NCT05732454|455214471|FG001|Part 1: DB Period|Protocol Violation|1|||
126524448|NCT05732454|455214470|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
126524449|NCT05732454|455214471|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
126524450|NCT05732454|455214470|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
126524451|NCT05732454|455214471|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
126524452|NCT05732454|455214470|FG000|Part 1: OLE Period|Adverse Event|0|||
126524453|NCT05732454|455214471|FG001|Part 1: OLE Period|Adverse Event|1|||
126524454|NCT05732454|455214470|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
126524455|NCT05732454|455214471|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
126524456|NCT00838110|455214474|FG000|Overall Study|Death|0|||
126524457|NCT00838110|455214475|FG001|Overall Study|Death|0|||
126524458|NCT00838110|455214476|FG002|Overall Study|Death|1|||
126524459|NCT00838110|455214477|FG003|Overall Study|Death|2|||
126524460|NCT00838110|455214474|FG000|Overall Study|Adverse Event|11|||
126524461|NCT00838110|455214475|FG001|Overall Study|Adverse Event|10|||
126524462|NCT00838110|455214476|FG002|Overall Study|Adverse Event|8|||
126576498|NCT01939899|455408481|FG000|Lead-in Dose Finding Phase|Death|0|||
126576499|NCT01939899|455408482|FG001|Lead-in Dose Finding Phase|Death|3|||
126576500|NCT01939899|455408483|FG002|Lead-in Dose Finding Phase|Death|1|||
126576501|NCT01939899|455408484|FG003|Lead-in Dose Finding Phase|Death|0|||
126524463|NCT00838110|455214477|FG003|Overall Study|Adverse Event|7|||
126524464|NCT00838110|455214474|FG000|Overall Study|Withdrawal by Subject|5|||
126524465|NCT00838110|455214475|FG001|Overall Study|Withdrawal by Subject|6|||
126524466|NCT00838110|455214476|FG002|Overall Study|Withdrawal by Subject|3|||
126524467|NCT00838110|455214477|FG003|Overall Study|Withdrawal by Subject|4|||
126524468|NCT00838110|455214474|FG000|Overall Study|Other|3|||
126524469|NCT00838110|455214475|FG001|Overall Study|Other|3|||
126524470|NCT00838110|455214476|FG002|Overall Study|Other|3|||
126524471|NCT00838110|455214477|FG003|Overall Study|Other|2|||
126524472|NCT00838110|455214474|FG000|Overall Study|Protocol Violation|0|||
126524473|NCT00838110|455214475|FG001|Overall Study|Protocol Violation|2|||
126524474|NCT00838110|455214476|FG002|Overall Study|Protocol Violation|1|||
126524475|NCT00838110|455214477|FG003|Overall Study|Protocol Violation|1|||
126524476|NCT00838110|455214474|FG000|Overall Study|Lost to Follow-up|3|||
126524477|NCT00838110|455214475|FG001|Overall Study|Lost to Follow-up|0|||
126524478|NCT00838110|455214476|FG002|Overall Study|Lost to Follow-up|0|||
126524479|NCT00838110|455214477|FG003|Overall Study|Lost to Follow-up|0|||
126524480|NCT00838110|455214474|FG000|Overall Study|Did not meet eligibility criteria|0|||
126524481|NCT00838110|455214475|FG001|Overall Study|Did not meet eligibility criteria|0|||
126524482|NCT00838110|455214476|FG002|Overall Study|Did not meet eligibility criteria|1|||
126524483|NCT00838110|455214477|FG003|Overall Study|Did not meet eligibility criteria|2|||
126524484|NCT00838110|455214474|FG000|Overall Study|Randomized but not treated|0|||
126524485|NCT00838110|455214475|FG001|Overall Study|Randomized but not treated|1|||
126524486|NCT00838110|455214476|FG002|Overall Study|Randomized but not treated|0|||
126524487|NCT00838110|455214477|FG003|Overall Study|Randomized but not treated|0|||
126524488|NCT00328510|455214481|FG000|Overall Study|Gag disorder, could not use frame|4|||
126524489|NCT00328510|455214482|FG001|Overall Study|Gag disorder, could not use frame|0|||
126524490|NCT00328510|455214481|FG000|Overall Study|Dentition problems, could not use frame|1|||
126524491|NCT00328510|455214482|FG001|Overall Study|Dentition problems, could not use frame|0|||
126524492|NCT00328510|455214481|FG000|Overall Study|Withdrawal by Subject|4|||
126524493|NCT00328510|455214482|FG001|Overall Study|Withdrawal by Subject|2|||
126524494|NCT00328510|455214481|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
126524495|NCT00328510|455214482|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
126524496|NCT00328510|455214481|FG000|Overall Study|Treatment changed to a single fraction|1|||
126524497|NCT00328510|455214482|FG001|Overall Study|Treatment changed to a single fraction|1|||
126524498|NCT03240588|455214484|FG000|Overall Study|Death|3|||
126524499|NCT03240588|455214485|FG001|Overall Study|Death|0|||
126524500|NCT03240588|455214486|FG002|Overall Study|Death|0|||
126524501|NCT03240588|455214484|FG000|Overall Study|Adverse Event|5|||
126524502|NCT03240588|455214485|FG001|Overall Study|Adverse Event|4|||
126524503|NCT03240588|455214486|FG002|Overall Study|Adverse Event|0|||
126524504|NCT03240588|455214484|FG000|Overall Study|Lost to Follow-up|9|||
126524505|NCT03240588|455214485|FG001|Overall Study|Lost to Follow-up|4|||
126524506|NCT03240588|455214486|FG002|Overall Study|Lost to Follow-up|0|||
126524507|NCT03240588|455214484|FG000|Overall Study|Physician Decision|3|||
126524508|NCT03240588|455214485|FG001|Overall Study|Physician Decision|2|||
126524509|NCT03240588|455214486|FG002|Overall Study|Physician Decision|0|||
126524510|NCT03240588|455214484|FG000|Overall Study|Did not meet eligibility criteria|0|||
126524511|NCT03240588|455214485|FG001|Overall Study|Did not meet eligibility criteria|6|||
126524512|NCT03240588|455214486|FG002|Overall Study|Did not meet eligibility criteria|0|||
126524513|NCT03240588|455214484|FG000|Overall Study|No longer meets protocol criteria|12|||
126524514|NCT03240588|455214485|FG001|Overall Study|No longer meets protocol criteria|7|||
126524515|NCT03240588|455214486|FG002|Overall Study|No longer meets protocol criteria|0|||
126524516|NCT03240588|455214484|FG000|Overall Study|Withdrawal by Subject|60|||
126524517|NCT03240588|455214485|FG001|Overall Study|Withdrawal by Subject|52|||
126524518|NCT03240588|455214486|FG002|Overall Study|Withdrawal by Subject|7|||
126524519|NCT03240588|455214484|FG000|Overall Study|Other, additional details not available.|0|||
126524520|NCT03240588|455214485|FG001|Overall Study|Other, additional details not available.|12|||
126524521|NCT03240588|455214486|FG002|Overall Study|Other, additional details not available.|1|||
126524522|NCT03240588|455214484|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
126524523|NCT03240588|455214485|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
126524524|NCT03240588|455214486|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
126524525|NCT03240588|455214484|FG000|Overall Study|Closure of study|55|||
126524526|NCT03240588|455214485|FG001|Overall Study|Closure of study|3|||
126524527|NCT03240588|455214486|FG002|Overall Study|Closure of study|0|||
126524528|NCT03240588|455214484|FG000|Overall Study|Subject non-compliance|23|||
126524529|NCT03240588|455214485|FG001|Overall Study|Subject non-compliance|2|||
126576502|NCT01939899|455408485|FG004|Lead-in Dose Finding Phase|Death|0|||
126576503|NCT01939899|455408481|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
126576504|NCT01939899|455408482|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
126576505|NCT01939899|455408483|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
126576506|NCT01939899|455408484|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
126576507|NCT01939899|455408485|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
126576508|NCT01939899|455408481|FG000|Lead-in Dose Finding Phase|Other|0|||
126576509|NCT01939899|455408482|FG001|Lead-in Dose Finding Phase|Other|0|||
126576510|NCT01939899|455408483|FG002|Lead-in Dose Finding Phase|Other|1|||
126576511|NCT01939899|455408484|FG003|Lead-in Dose Finding Phase|Other|0|||
126576512|NCT01939899|455408485|FG004|Lead-in Dose Finding Phase|Other|0|||
126576513|NCT01939899|455408481|FG000|Phase 2|Withdrawal by Subject|0|||
126576514|NCT01939899|455408482|FG001|Phase 2|Withdrawal by Subject|0|||
126576515|NCT01939899|455408483|FG002|Phase 2|Withdrawal by Subject|0|||
126576516|NCT01939899|455408484|FG003|Phase 2|Withdrawal by Subject|2|||
126576517|NCT01939899|455408485|FG004|Phase 2|Withdrawal by Subject|0|||
126576518|NCT01939899|455408481|FG000|Phase 2|Disease Progression|0|||
126576519|NCT01939899|455408482|FG001|Phase 2|Disease Progression|0|||
126576520|NCT01939899|455408483|FG002|Phase 2|Disease Progression|0|||
126576521|NCT01939899|455408484|FG003|Phase 2|Disease Progression|9|||
126576522|NCT01939899|455408485|FG004|Phase 2|Disease Progression|1|||
126576523|NCT00585052|455408486|FG000|Overall Study|Withdrawal by Subject|1|||
126576524|NCT05489484|455408490|FG000|Overall Study|withdrawn|1|||
126576525|NCT00444600|455408493|FG000|Overall Study|Death|7|||
126576526|NCT00444600|455408494|FG001|Overall Study|Death|5|||
126576527|NCT00444600|455408495|FG002|Overall Study|Death|3|||
126576528|NCT00444600|455408496|FG003|Overall Study|Death|2|||
126576529|NCT00444600|455408493|FG000|Overall Study|Dropped|11|||
126576530|NCT00444600|455408494|FG001|Overall Study|Dropped|11|||
126576531|NCT00444600|455408495|FG002|Overall Study|Dropped|7|||
126576532|NCT00444600|455408496|FG003|Overall Study|Dropped|7|||
126576533|NCT00444600|455408493|FG000|Overall Study|Missed visit|1|||
126576534|NCT00444600|455408494|FG001|Overall Study|Missed visit|0|||
126576535|NCT00444600|455408495|FG002|Overall Study|Missed visit|0|||
126576536|NCT00444600|455408496|FG003|Overall Study|Missed visit|1|||
126576537|NCT05132478|455408497|FG000|Overall Study|did not complete survey after consent|1|||
126576538|NCT05132478|455408498|FG001|Overall Study|did not complete survey after consent|1|||
126576539|NCT05132478|455408497|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
126576540|NCT05132478|455408498|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
126576541|NCT00106080|455408499|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
126576542|NCT00106080|455408500|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
126576543|NCT01414738|455408503|FG000|Overall Study|Death|26|||
126576544|NCT01414738|455408503|FG000|Overall Study|Refused testing|5|||
126576545|NCT01414738|455408503|FG000|Overall Study|Lost to Follow-up|2|||
126576546|NCT01414738|455408503|FG000|Overall Study|Refused, disease progression|8|||
126576547|NCT01414738|455408503|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
126576548|NCT01839331|455408504|FG000|Overall Study|Early Termination|3|||
126576549|NCT01839331|455408505|FG001|Overall Study|Early Termination|0|||
126576550|NCT01839331|455408506|FG002|Overall Study|Early Termination|1|||
126576551|NCT01839331|455408507|FG003|Overall Study|Early Termination|2|||
126576552|NCT01839331|455408504|FG000|Overall Study|Protocol Violation|1|||
126576553|NCT01839331|455408505|FG001|Overall Study|Protocol Violation|6|||
126576554|NCT01839331|455408506|FG002|Overall Study|Protocol Violation|4|||
126576555|NCT01839331|455408507|FG003|Overall Study|Protocol Violation|3|||
126576556|NCT00703820|455408508|FG000|Overall Study|Adverse Event|12|||
126576557|NCT00703820|455408509|FG001|Overall Study|Adverse Event|17|||
126576558|NCT00703820|455408508|FG000|Overall Study|Death|5|||
126576559|NCT00703820|455408509|FG001|Overall Study|Death|0|||
126576560|NCT00703820|455408508|FG000|Overall Study|Lack of Efficacy|11|||
126576561|NCT00703820|455408509|FG001|Overall Study|Lack of Efficacy|11|||
126576562|NCT00703820|455408508|FG000|Overall Study|Received non-protocol therapy|1|||
126576563|NCT00703820|455408509|FG001|Overall Study|Received non-protocol therapy|0|||
126576564|NCT00703820|455408508|FG000|Overall Study|Physician Decision|4|||
126576565|NCT00703820|455408509|FG001|Overall Study|Physician Decision|5|||
126576566|NCT00703820|455408508|FG000|Overall Study|Withdrawal by Subject|2|||
126576567|NCT00703820|455408509|FG001|Overall Study|Withdrawal by Subject|1|||
126576568|NCT03531840|455408514|FG000|Overall Study|Death on study|3|||
126576569|NCT03531840|455408515|FG001|Overall Study|Death on study|2|||
126576570|NCT03531840|455408516|FG002|Overall Study|Death on study|1|||
126576571|NCT03531840|455408517|FG003|Overall Study|Death on study|2|||
126576572|NCT03531840|455408514|FG000|Overall Study|Death during follow up|2|||
126576573|NCT03531840|455408515|FG001|Overall Study|Death during follow up|3|||
126576574|NCT03531840|455408516|FG002|Overall Study|Death during follow up|4|||
126576575|NCT03531840|455408517|FG003|Overall Study|Death during follow up|1|||
126576576|NCT00761605|455408519|FG000|Overall Study|Adverse Event|26|||
126576577|NCT00761605|455408519|FG000|Overall Study|Death|2|||
126576578|NCT00761605|455408519|FG000|Overall Study|Lack of Efficacy|26|||
126576579|NCT00761605|455408519|FG000|Overall Study|Lost to Follow-up|29|||
126576580|NCT00761605|455408519|FG000|Overall Study|Withdrawal by Subject|37|||
126576581|NCT00761605|455408519|FG000|Overall Study|Other|21|||
126576582|NCT03451721|455408520|FG000|Overall Study|Death|1|||
126524530|NCT03240588|455214486|FG002|Overall Study|Subject non-compliance|1|||
126524531|NCT03240588|455214484|FG000|Overall Study|Device Deficiency|1|||
126524532|NCT03240588|455214485|FG001|Overall Study|Device Deficiency|0|||
126727746|NCT00696436|455952847|FG003|Overall Study|Protocol Violation|0|||
126727747|NCT00696436|455952848|FG004|Overall Study|Protocol Violation|1|||
126727748|NCT00696436|455952844|FG000|Overall Study|Lost to Follow-up|1|||
126727749|NCT00696436|455952845|FG001|Overall Study|Lost to Follow-up|6|||
126727750|NCT00696436|455952846|FG002|Overall Study|Lost to Follow-up|2|||
126727751|NCT00696436|455952847|FG003|Overall Study|Lost to Follow-up|4|||
126727752|NCT00696436|455952848|FG004|Overall Study|Lost to Follow-up|3|||
126727753|NCT00696436|455952844|FG000|Overall Study|Withdrawal by Subject|4|||
126727754|NCT00696436|455952845|FG001|Overall Study|Withdrawal by Subject|11|||
126727755|NCT00696436|455952846|FG002|Overall Study|Withdrawal by Subject|5|||
126727756|NCT00696436|455952847|FG003|Overall Study|Withdrawal by Subject|7|||
126727757|NCT00696436|455952848|FG004|Overall Study|Withdrawal by Subject|1|||
126727758|NCT00696436|455952844|FG000|Overall Study|Lack of Efficacy|3|||
126727759|NCT00696436|455952845|FG001|Overall Study|Lack of Efficacy|1|||
126727760|NCT00696436|455952846|FG002|Overall Study|Lack of Efficacy|5|||
126727761|NCT00696436|455952847|FG003|Overall Study|Lack of Efficacy|2|||
126727762|NCT00696436|455952848|FG004|Overall Study|Lack of Efficacy|4|||
126727763|NCT00696436|455952844|FG000|Overall Study|Participant Unavailability|2|||
126727764|NCT00696436|455952845|FG001|Overall Study|Participant Unavailability|0|||
126727765|NCT00696436|455952846|FG002|Overall Study|Participant Unavailability|2|||
126727766|NCT00696436|455952847|FG003|Overall Study|Participant Unavailability|1|||
126727767|NCT00696436|455952848|FG004|Overall Study|Participant Unavailability|0|||
126727768|NCT00696436|455952844|FG000|Overall Study|Administrative Error|2|||
126727769|NCT00696436|455952845|FG001|Overall Study|Administrative Error|0|||
126727770|NCT00696436|455952846|FG002|Overall Study|Administrative Error|2|||
126727771|NCT00696436|455952847|FG003|Overall Study|Administrative Error|0|||
126727772|NCT00696436|455952848|FG004|Overall Study|Administrative Error|0|||
126727773|NCT00696436|455952844|FG000|Overall Study|Participant Non-compliance|0|||
126727774|NCT00696436|455952845|FG001|Overall Study|Participant Non-compliance|0|||
126727775|NCT00696436|455952846|FG002|Overall Study|Participant Non-compliance|1|||
126727776|NCT00696436|455952847|FG003|Overall Study|Participant Non-compliance|2|||
126727777|NCT00696436|455952848|FG004|Overall Study|Participant Non-compliance|0|||
126727778|NCT00696436|455952844|FG000|Overall Study|Administrative Decision|1|||
126727779|NCT00696436|455952845|FG001|Overall Study|Administrative Decision|0|||
126727780|NCT00696436|455952846|FG002|Overall Study|Administrative Decision|0|||
126727781|NCT00696436|455952847|FG003|Overall Study|Administrative Decision|0|||
126727782|NCT00696436|455952848|FG004|Overall Study|Administrative Decision|0|||
126727783|NCT00696436|455952844|FG000|Overall Study|Missing|0|||
126727784|NCT00696436|455952845|FG001|Overall Study|Missing|1|||
126727785|NCT00696436|455952846|FG002|Overall Study|Missing|1|||
126727786|NCT00696436|455952847|FG003|Overall Study|Missing|0|||
126727787|NCT00696436|455952848|FG004|Overall Study|Missing|0|||
126727788|NCT02282982|455952849|FG000|Overall Study|Lost to Follow-up|15|||
126727789|NCT02282982|455952849|FG000|Overall Study|Withdrew consent|2|||
126727790|NCT02282982|455952849|FG000|Overall Study|Death|4|||
126727791|NCT02282982|455952849|FG000|Overall Study|Lack of product|156|||
126727792|NCT02282982|455952849|FG000|Overall Study|Palivizumab is ended|11|||
126727793|NCT02282982|455952849|FG000|Overall Study|Other, not specified|18|||
126727794|NCT02062463|455952850|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
126727795|NCT02062463|455952851|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
126727796|NCT02062463|455952852|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
126727797|NCT02062463|455952853|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
126727798|NCT02062463|455952850|FG000|Stage 2|Adverse Event|0|||
126727799|NCT02062463|455952851|FG001|Stage 2|Adverse Event|0|||
126727800|NCT02062463|455952852|FG002|Stage 2|Adverse Event|12|||
126727801|NCT02062463|455952853|FG003|Stage 2|Adverse Event|20|||
126727802|NCT02062463|455952850|FG000|Stage 2|Lack of Efficacy|0|||
126727803|NCT02062463|455952851|FG001|Stage 2|Lack of Efficacy|0|||
126727804|NCT02062463|455952852|FG002|Stage 2|Lack of Efficacy|3|||
126727805|NCT02062463|455952853|FG003|Stage 2|Lack of Efficacy|4|||
126727806|NCT02062463|455952850|FG000|Stage 2|Lost to Follow-up|0|||
126727807|NCT02062463|455952851|FG001|Stage 2|Lost to Follow-up|0|||
126727808|NCT02062463|455952852|FG002|Stage 2|Lost to Follow-up|20|||
126524533|NCT03240588|455214486|FG002|Overall Study|Device Deficiency|0|||
126727809|NCT02062463|455952853|FG003|Stage 2|Lost to Follow-up|20|||
126727810|NCT02062463|455952850|FG000|Stage 2|Non-Compliance|0|||
126727811|NCT02062463|455952851|FG001|Stage 2|Non-Compliance|0|||
126727812|NCT02062463|455952852|FG002|Stage 2|Non-Compliance|0|||
126727813|NCT02062463|455952853|FG003|Stage 2|Non-Compliance|1|||
126727814|NCT02062463|455952850|FG000|Stage 2|Other than specified|0|||
126727815|NCT02062463|455952851|FG001|Stage 2|Other than specified|0|||
126727816|NCT02062463|455952852|FG002|Stage 2|Other than specified|3|||
126727817|NCT02062463|455952853|FG003|Stage 2|Other than specified|1|||
126727818|NCT02062463|455952850|FG000|Stage 2|Withdrawal by Subject|0|||
126727819|NCT02062463|455952851|FG001|Stage 2|Withdrawal by Subject|0|||
126727820|NCT02062463|455952852|FG002|Stage 2|Withdrawal by Subject|15|||
126576583|NCT00350792|455408521|FG000|Overall Study|Adverse Event|11|||
126576584|NCT00350792|455408521|FG000|Overall Study|Death from Study Disease|1|||
126576585|NCT00350792|455408521|FG000|Overall Study|Death from Study Drug Toxicity|1|||
126576586|NCT00350792|455408521|FG000|Overall Study|Death Not Study Drug Related|2|||
126576587|NCT00350792|455408521|FG000|Overall Study|Protocol Violation|1|||
126576588|NCT00350792|455408521|FG000|Overall Study|Withdrawal by Subject|4|||
126576589|NCT00350792|455408521|FG000|Overall Study|Physician Decision|2|||
126576590|NCT00350792|455408521|FG000|Overall Study|Lack of Efficacy|11|||
126576591|NCT01985334|455408522|FG000|Overall Study|Administrative problems|1|||
126576592|NCT01985334|455408523|FG001|Overall Study|Administrative problems|1|||
126576593|NCT01985334|455408524|FG002|Overall Study|Administrative problems|0|||
126576594|NCT01985334|455408525|FG003|Overall Study|Administrative problems|2|||
126576595|NCT01985334|455408526|FG004|Overall Study|Administrative problems|0|||
126576596|NCT01985334|455408527|FG005|Overall Study|Administrative problems|1|||
126576597|NCT01985334|455408528|FG006|Overall Study|Administrative problems|1|||
126576598|NCT01985334|455408529|FG007|Overall Study|Administrative problems|3|||
126576599|NCT01985334|455408522|FG000|Overall Study|Death|1|||
126576600|NCT01985334|455408523|FG001|Overall Study|Death|0|||
126576601|NCT01985334|455408524|FG002|Overall Study|Death|0|||
126576602|NCT01985334|455408525|FG003|Overall Study|Death|3|||
126576603|NCT01985334|455408526|FG004|Overall Study|Death|0|||
126576604|NCT01985334|455408527|FG005|Overall Study|Death|0|||
126576605|NCT01985334|455408528|FG006|Overall Study|Death|1|||
126576606|NCT01985334|455408529|FG007|Overall Study|Death|2|||
126576607|NCT01985334|455408522|FG000|Overall Study|Worsening of disease|0|||
126576608|NCT01985334|455408523|FG001|Overall Study|Worsening of disease|0|||
126576609|NCT01985334|455408524|FG002|Overall Study|Worsening of disease|0|||
126576610|NCT01985334|455408525|FG003|Overall Study|Worsening of disease|1|||
126576611|NCT01985334|455408526|FG004|Overall Study|Worsening of disease|0|||
126576612|NCT01985334|455408527|FG005|Overall Study|Worsening of disease|3|||
126576613|NCT01985334|455408528|FG006|Overall Study|Worsening of disease|0|||
126576614|NCT01985334|455408529|FG007|Overall Study|Worsening of disease|1|||
126576615|NCT01985334|455408522|FG000|Overall Study|Other|2|||
126576616|NCT01985334|455408523|FG001|Overall Study|Other|9|||
126576617|NCT01985334|455408524|FG002|Overall Study|Other|7|||
126576618|NCT01985334|455408525|FG003|Overall Study|Other|17|||
126576619|NCT01985334|455408526|FG004|Overall Study|Other|4|||
126576620|NCT01985334|455408527|FG005|Overall Study|Other|8|||
126576621|NCT01985334|455408528|FG006|Overall Study|Other|4|||
126576622|NCT01985334|455408529|FG007|Overall Study|Other|7|||
126576623|NCT01985334|455408522|FG000|Overall Study|Protocol deviation|6|||
126576624|NCT01985334|455408523|FG001|Overall Study|Protocol deviation|31|||
126576625|NCT01985334|455408524|FG002|Overall Study|Protocol deviation|25|||
126576626|NCT01985334|455408525|FG003|Overall Study|Protocol deviation|84|||
126576627|NCT01985334|455408526|FG004|Overall Study|Protocol deviation|17|||
126576628|NCT01985334|455408527|FG005|Overall Study|Protocol deviation|47|||
126576629|NCT01985334|455408528|FG006|Overall Study|Protocol deviation|15|||
126576630|NCT01985334|455408529|FG007|Overall Study|Protocol deviation|42|||
126576631|NCT01985334|455408522|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
126576632|NCT01985334|455408523|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
126576633|NCT01985334|455408524|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
126576634|NCT01985334|455408525|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
126576635|NCT01985334|455408526|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
126576636|NCT01985334|455408527|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
126576637|NCT01985334|455408528|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
126576638|NCT01985334|455408529|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
126576639|NCT01985334|455408522|FG000|Overall Study|Subject withdrawal of consent|3|||
126576640|NCT01985334|455408523|FG001|Overall Study|Subject withdrawal of consent|6|||
126576641|NCT01985334|455408524|FG002|Overall Study|Subject withdrawal of consent|2|||
126576642|NCT01985334|455408525|FG003|Overall Study|Subject withdrawal of consent|28|||
126576643|NCT01985334|455408526|FG004|Overall Study|Subject withdrawal of consent|4|||
126576644|NCT01985334|455408527|FG005|Overall Study|Subject withdrawal of consent|19|||
126576645|NCT01985334|455408528|FG006|Overall Study|Subject withdrawal of consent|0|||
126576646|NCT01985334|455408529|FG007|Overall Study|Subject withdrawal of consent|20|||
126576647|NCT01985334|455408522|FG000|Overall Study|Adverse Event|0|||
126576648|NCT01985334|455408523|FG001|Overall Study|Adverse Event|8|||
126576649|NCT01985334|455408524|FG002|Overall Study|Adverse Event|2|||
126576650|NCT01985334|455408525|FG003|Overall Study|Adverse Event|26|||
126576651|NCT01985334|455408526|FG004|Overall Study|Adverse Event|3|||
126576652|NCT01985334|455408527|FG005|Overall Study|Adverse Event|18|||
126576653|NCT01985334|455408528|FG006|Overall Study|Adverse Event|3|||
126576654|NCT01985334|455408529|FG007|Overall Study|Adverse Event|15|||
126576655|NCT01985334|455408522|FG000|Overall Study|Other|4|||
126576656|NCT01985334|455408523|FG001|Overall Study|Other|2|||
126576657|NCT01985334|455408524|FG002|Overall Study|Other|3|||
126576658|NCT01985334|455408525|FG003|Overall Study|Other|10|||
126576659|NCT01985334|455408526|FG004|Overall Study|Other|1|||
126576660|NCT01985334|455408527|FG005|Overall Study|Other|6|||
126576661|NCT01985334|455408528|FG006|Overall Study|Other|2|||
126727821|NCT02062463|455952853|FG003|Stage 2|Withdrawal by Subject|10|||
126727822|NCT03341923|455952856|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
126727823|NCT03341923|455952857|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
126727824|NCT03337152|455952860|FG000|Overall Study|Physician Decision|1|||
126727825|NCT03337152|455952861|FG001|Overall Study|Physician Decision|0|||
126727826|NCT03337152|455952860|FG000|Overall Study|Lost to Follow-up|1|||
126727827|NCT03337152|455952861|FG001|Overall Study|Lost to Follow-up|3|||
126727828|NCT03337152|455952860|FG000|Overall Study|Adverse Event|3|||
126727829|NCT03337152|455952861|FG001|Overall Study|Adverse Event|1|||
126727830|NCT03337152|455952860|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
126727831|NCT03337152|455952861|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
126727832|NCT02662985|455952862|FG000|Treatment Period 1|Adverse Event|0|||
126524534|NCT03240588|455214484|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
126524535|NCT03240588|455214485|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
126524536|NCT03240588|455214486|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
126524537|NCT00377819|455214489|FG000|Overall Study|Adverse Event|2|||
126524538|NCT00377819|455214490|FG001|Overall Study|Adverse Event|3|||
126524539|NCT00377819|455214489|FG000|Overall Study|Withdrawal by Subject|10|||
126524540|NCT00377819|455214490|FG001|Overall Study|Withdrawal by Subject|4|||
126524541|NCT00377819|455214489|FG000|Overall Study|Death|0|||
126524542|NCT00377819|455214490|FG001|Overall Study|Death|1|||
126524543|NCT00377819|455214489|FG000|Overall Study|Lost to Follow-up|0|||
126524544|NCT00377819|455214490|FG001|Overall Study|Lost to Follow-up|1|||
126524545|NCT00377819|455214489|FG000|Overall Study|Protocol Violation|1|||
126524546|NCT00377819|455214490|FG001|Overall Study|Protocol Violation|1|||
126524547|NCT02091726|455214491|FG000|Overall Study|Lost to Follow-up|6|||
126524548|NCT03727750|455214492|FG000|Overall Study|Death|45|||
126524549|NCT03727750|455214492|FG000|Overall Study|Withdrawal by Subject|2|||
126524550|NCT03727750|455214492|FG000|Overall Study|Lost to Follow-up|1|||
126524551|NCT03727750|455214492|FG000|Overall Study|Other|1|||
126524552|NCT01914926|455214494|FG000|Overall Study|Adverse Event|1|||
126524553|NCT01914926|455214495|FG001|Overall Study|Adverse Event|0|||
126524554|NCT01914926|455214494|FG000|Overall Study|uncooperative, agitated and removed|0|||
126524555|NCT01914926|455214495|FG001|Overall Study|uncooperative, agitated and removed|1|||
126524556|NCT00467870|455214496|FG000|Overall Study|Adverse Event|13|||
126524557|NCT00467870|455214497|FG001|Overall Study|Adverse Event|9|||
126524558|NCT00467870|455214498|FG002|Overall Study|Adverse Event|1|||
126524559|NCT00467870|455214499|FG003|Overall Study|Adverse Event|15|||
126524560|NCT00467870|455214500|FG004|Overall Study|Adverse Event|15|||
126524561|NCT00467870|455214501|FG005|Overall Study|Adverse Event|1|||
126524562|NCT00467870|455214496|FG000|Overall Study|Protocol Violation|2|||
126524563|NCT00467870|455214497|FG001|Overall Study|Protocol Violation|1|||
126524564|NCT00467870|455214498|FG002|Overall Study|Protocol Violation|1|||
126524565|NCT00467870|455214499|FG003|Overall Study|Protocol Violation|2|||
126524566|NCT00467870|455214500|FG004|Overall Study|Protocol Violation|0|||
126524567|NCT00467870|455214501|FG005|Overall Study|Protocol Violation|0|||
126524568|NCT00467870|455214496|FG000|Overall Study|Withdrawal by Subject|14|||
126524569|NCT00467870|455214497|FG001|Overall Study|Withdrawal by Subject|21|||
126524570|NCT00467870|455214498|FG002|Overall Study|Withdrawal by Subject|0|||
126524571|NCT00467870|455214499|FG003|Overall Study|Withdrawal by Subject|9|||
126524572|NCT00467870|455214500|FG004|Overall Study|Withdrawal by Subject|10|||
126524573|NCT00467870|455214501|FG005|Overall Study|Withdrawal by Subject|1|||
126524574|NCT00467870|455214496|FG000|Overall Study|Lost to Follow-up|5|||
126524575|NCT00467870|455214497|FG001|Overall Study|Lost to Follow-up|3|||
126524576|NCT00467870|455214498|FG002|Overall Study|Lost to Follow-up|1|||
126524577|NCT00467870|455214499|FG003|Overall Study|Lost to Follow-up|1|||
126524578|NCT00467870|455214500|FG004|Overall Study|Lost to Follow-up|3|||
126524579|NCT00467870|455214501|FG005|Overall Study|Lost to Follow-up|0|||
126524580|NCT00467870|455214496|FG000|Overall Study|Subject Non-compliance|3|||
126524581|NCT00467870|455214497|FG001|Overall Study|Subject Non-compliance|4|||
126524582|NCT00467870|455214498|FG002|Overall Study|Subject Non-compliance|0|||
126524583|NCT00467870|455214499|FG003|Overall Study|Subject Non-compliance|1|||
126524584|NCT00467870|455214500|FG004|Overall Study|Subject Non-compliance|5|||
126524585|NCT00467870|455214501|FG005|Overall Study|Subject Non-compliance|0|||
126524586|NCT00467870|455214496|FG000|Overall Study|Other/Unknown|8|||
126524587|NCT00467870|455214497|FG001|Overall Study|Other/Unknown|5|||
126524588|NCT00467870|455214498|FG002|Overall Study|Other/Unknown|1|||
126524589|NCT00467870|455214499|FG003|Overall Study|Other/Unknown|5|||
126727833|NCT02662985|455952863|FG001|Treatment Period 1|Adverse Event|2|||
126524590|NCT00467870|455214500|FG004|Overall Study|Other/Unknown|4|||
126524591|NCT00467870|455214501|FG005|Overall Study|Other/Unknown|0|||
126524592|NCT00321919|455214502|FG000|Overall Study|Adverse Event|17|||
126524593|NCT00321919|455214503|FG001|Overall Study|Adverse Event|10|||
126524594|NCT00321919|455214502|FG000|Overall Study|Death|21|||
126524595|NCT00321919|455214503|FG001|Overall Study|Death|17|||
126524596|NCT00321919|455214502|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126777043|NCT02124746|456139164|FG000|Overall Study|Lack of Efficacy|3|||
126576662|NCT01985334|455408529|FG007|Overall Study|Other|2|||
126576663|NCT01985334|455408522|FG000|Overall Study|Medication non-compliance|0|||
126576664|NCT01985334|455408523|FG001|Overall Study|Medication non-compliance|4|||
126576665|NCT01985334|455408524|FG002|Overall Study|Medication non-compliance|1|||
126576666|NCT01985334|455408525|FG003|Overall Study|Medication non-compliance|6|||
126576667|NCT01985334|455408526|FG004|Overall Study|Medication non-compliance|2|||
126576668|NCT01985334|455408527|FG005|Overall Study|Medication non-compliance|3|||
126576669|NCT01985334|455408528|FG006|Overall Study|Medication non-compliance|1|||
126576670|NCT01985334|455408529|FG007|Overall Study|Medication non-compliance|3|||
126576671|NCT01985334|455408522|FG000|Overall Study|Use of prohibited treatment|1|||
126576672|NCT01985334|455408523|FG001|Overall Study|Use of prohibited treatment|4|||
126576673|NCT01985334|455408524|FG002|Overall Study|Use of prohibited treatment|1|||
126576674|NCT01985334|455408525|FG003|Overall Study|Use of prohibited treatment|2|||
126576675|NCT01985334|455408526|FG004|Overall Study|Use of prohibited treatment|1|||
126576676|NCT01985334|455408527|FG005|Overall Study|Use of prohibited treatment|6|||
126576677|NCT01985334|455408528|FG006|Overall Study|Use of prohibited treatment|2|||
126576678|NCT01985334|455408529|FG007|Overall Study|Use of prohibited treatment|0|||
126576679|NCT01985334|455408522|FG000|Overall Study|Investigator decision|0|||
126576680|NCT01985334|455408523|FG001|Overall Study|Investigator decision|3|||
126576681|NCT01985334|455408524|FG002|Overall Study|Investigator decision|0|||
126576682|NCT01985334|455408525|FG003|Overall Study|Investigator decision|7|||
126576683|NCT01985334|455408526|FG004|Overall Study|Investigator decision|1|||
126576684|NCT01985334|455408527|FG005|Overall Study|Investigator decision|1|||
126576685|NCT01985334|455408528|FG006|Overall Study|Investigator decision|0|||
126576686|NCT01985334|455408529|FG007|Overall Study|Investigator decision|4|||
126576687|NCT01985334|455408522|FG000|Overall Study|Lost to Follow-up|0|||
126576688|NCT01985334|455408523|FG001|Overall Study|Lost to Follow-up|2|||
126576689|NCT01985334|455408524|FG002|Overall Study|Lost to Follow-up|0|||
126576690|NCT01985334|455408525|FG003|Overall Study|Lost to Follow-up|3|||
126576691|NCT01985334|455408526|FG004|Overall Study|Lost to Follow-up|1|||
126576692|NCT01985334|455408527|FG005|Overall Study|Lost to Follow-up|4|||
126576693|NCT01985334|455408528|FG006|Overall Study|Lost to Follow-up|0|||
126576694|NCT01985334|455408529|FG007|Overall Study|Lost to Follow-up|3|||
126576695|NCT03988023|455408530|FG000|Overall Study|Non-compliance|3|||
126576696|NCT03988023|455408531|FG001|Overall Study|Non-compliance|0|||
126576697|NCT03988023|455408530|FG000|Overall Study|Withdrawal by Subject|39|||
126576698|NCT03988023|455408531|FG001|Overall Study|Withdrawal by Subject|37|||
126576699|NCT03988023|455408530|FG000|Overall Study|Adverse Event|0|||
126576700|NCT03988023|455408531|FG001|Overall Study|Adverse Event|2|||
126576701|NCT03988023|455408530|FG000|Overall Study|Physician Decision|0|||
126576702|NCT03988023|455408531|FG001|Overall Study|Physician Decision|1|||
126576703|NCT03988023|455408530|FG000|Overall Study|Lost to Follow-up|5|||
126576704|NCT03988023|455408531|FG001|Overall Study|Lost to Follow-up|8|||
126576705|NCT03988023|455408530|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
126576706|NCT03988023|455408531|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
126576707|NCT03988023|455408530|FG000|Overall Study|Lack of Efficacy|3|||
126576708|NCT03988023|455408531|FG001|Overall Study|Lack of Efficacy|1|||
126576709|NCT03988023|455408530|FG000|Overall Study|COVID-19 pandemic|225|||
126576710|NCT03988023|455408531|FG001|Overall Study|COVID-19 pandemic|227|||
126576711|NCT00068601|455408532|FG000|Overall Study|Ineligible|11|||
126576712|NCT00068601|455408533|FG001|Overall Study|Ineligible|13|||
126576713|NCT00068601|455408532|FG000|Overall Study|Not evaluable: withdrew consent|5|||
126576714|NCT00068601|455408533|FG001|Overall Study|Not evaluable: withdrew consent|4|||
126576715|NCT00068601|455408532|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
126576716|NCT00068601|455408533|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
126576717|NCT00068601|455408532|FG000|Overall Study|Death|11|||
126576718|NCT00068601|455408533|FG001|Overall Study|Death|3|||
126576719|NCT00068601|455408532|FG000|Overall Study|Lost to Follow-up|3|||
126576720|NCT00068601|455408533|FG001|Overall Study|Lost to Follow-up|2|||
126576721|NCT00068601|455408532|FG000|Overall Study|Missing primary outcome data|30|||
126576722|NCT00068601|455408533|FG001|Overall Study|Missing primary outcome data|34|||
126576723|NCT01199575|455408539|FG000|Overall Study|Withdrawal by Subject|5|||
126576724|NCT00223795|455408544|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
126576725|NCT00223795|455408545|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
126576726|NCT00223795|455408544|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
126576727|NCT00223795|455408545|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
126576728|NCT04732338|455408547|FG000|Overall Study|Lost to Follow-up|3|||
126576729|NCT04732338|455408548|FG001|Overall Study|Lost to Follow-up|3|||
126576730|NCT01803555|455408552|FG000|Overall Study|Adverse Event|3|||
126727834|NCT02662985|455952862|FG000|Treatment Period 1|Protocol Violation|0|||
126576731|NCT01803555|455408553|FG001|Overall Study|Adverse Event|2|||
126576732|NCT01803555|455408552|FG000|Overall Study|Withdrawal by Subject|3|||
126576733|NCT01803555|455408553|FG001|Overall Study|Withdrawal by Subject|3|||
126576734|NCT01803555|455408552|FG000|Overall Study|Non-compliance|1|||
126727835|NCT02662985|455952863|FG001|Treatment Period 1|Protocol Violation|1|||
126576735|NCT01803555|455408553|FG001|Overall Study|Non-compliance|1|||
126576736|NCT01803555|455408552|FG000|Overall Study|Protocol Violation|3|||
126727836|NCT02662985|455952862|FG000|Treatment Period 1|Physician Decision|1|||
126727837|NCT02662985|455952863|FG001|Treatment Period 1|Physician Decision|0|||
126727838|NCT02662985|455952862|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126727839|NCT02662985|455952863|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126727840|NCT02662985|455952862|FG000|Treatment Period 2|Lack of Efficacy|0|||
126727841|NCT02662985|455952863|FG001|Treatment Period 2|Lack of Efficacy|1|||
126727842|NCT02662985|455952862|FG000|Treatment Period 2|Lost to Follow-up|1|||
126727843|NCT02662985|455952863|FG001|Treatment Period 2|Lost to Follow-up|0|||
126727844|NCT02662985|455952862|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
126727845|NCT02662985|455952863|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
126727846|NCT02662985|455952862|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
126727847|NCT02662985|455952863|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
126727848|NCT02662985|455952862|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
126727849|NCT02662985|455952863|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
126727850|NCT02662985|455952862|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
126727851|NCT02662985|455952863|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
126727852|NCT02662985|455952862|FG000|Treatment Period 3 (Extension Period)|Death|0|||
126727853|NCT02662985|455952863|FG001|Treatment Period 3 (Extension Period)|Death|1|||
126727854|NCT02493426|455952864|FG000|Overall Study|Withdrawal by Subject|0|||
126727855|NCT02493426|455952865|FG001|Overall Study|Withdrawal by Subject|1|||
126727856|NCT03491553|455952866|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
126727857|NCT03491553|455952867|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
126727858|NCT03491553|455952868|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
126727859|NCT03491553|455952869|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
126727860|NCT03491553|455952870|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
126727861|NCT03491553|455952871|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
126727862|NCT03491553|455952866|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
126727863|NCT03491553|455952867|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
126727864|NCT03491553|455952868|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
126727865|NCT03491553|455952869|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
126727866|NCT03491553|455952870|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
126727867|NCT03491553|455952871|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
126727868|NCT01025817|455952874|FG000|Completed Study Medication|Adverse Event|66|||
126727869|NCT01025817|455952875|FG001|Completed Study Medication|Adverse Event|39|||
126727870|NCT01025817|455952874|FG000|Completed Study Medication|Protocol Deviation|9|||
126727871|NCT01025817|455952875|FG001|Completed Study Medication|Protocol Deviation|8|||
126727872|NCT01025817|455952874|FG000|Completed Study Medication|Withdrawal by Subject|8|||
126727873|NCT01025817|455952875|FG001|Completed Study Medication|Withdrawal by Subject|9|||
126727874|NCT01025817|455952874|FG000|Completed Study Medication|Administrative problems|7|||
126727875|NCT01025817|455952875|FG001|Completed Study Medication|Administrative problems|5|||
126727876|NCT01025817|455952874|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
126727877|NCT01025817|455952875|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
126727878|NCT01025817|455952874|FG000|Completed Study Medication|Abnormal test procedure|4|||
126727879|NCT01025817|455952875|FG001|Completed Study Medication|Abnormal test procedure|0|||
126727880|NCT01025817|455952874|FG000|Completed Study Medication|Graft loss|2|||
126727881|NCT01025817|455952875|FG001|Completed Study Medication|Graft loss|5|||
126727882|NCT01025817|455952874|FG000|Completed Study Medication|Death|2|||
126727883|NCT01025817|455952875|FG001|Completed Study Medication|Death|2|||
126727884|NCT01025817|455952874|FG000|Completed Study Medication|Abnormal lab values|0|||
126727885|NCT01025817|455952875|FG001|Completed Study Medication|Abnormal lab values|2|||
126727886|NCT01025817|455952874|FG000|Completed Study Medication|Subject no longer required study drug|0|||
126727887|NCT01025817|455952875|FG001|Completed Study Medication|Subject no longer required study drug|1|||
126727888|NCT01025817|455952874|FG000|Completed Study Medication|Lost to Follow-up|0|||
126727889|NCT01025817|455952875|FG001|Completed Study Medication|Lost to Follow-up|1|||
126727890|NCT01025817|455952874|FG000|Completed Study|Withdrawal by Subject|8|||
126727891|NCT01025817|455952875|FG001|Completed Study|Withdrawal by Subject|16|||
126727892|NCT01025817|455952874|FG000|Completed Study|Death|6|||
126727893|NCT01025817|455952875|FG001|Completed Study|Death|5|||
126727894|NCT01025817|455952874|FG000|Completed Study|Missing|2|||
126727895|NCT01025817|455952875|FG001|Completed Study|Missing|0|||
126727896|NCT01025817|455952874|FG000|Completed Study|Lost to Follow-up|0|||
126727897|NCT01025817|455952875|FG001|Completed Study|Lost to Follow-up|1|||
126727898|NCT00973921|455952876|FG000|Overall Study|IVUS results were not available|9|||
126727899|NCT01599754|455952877|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
126727900|NCT01599754|455952878|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
126524597|NCT00321919|455214503|FG001|Overall Study|Insufficient Therapeutic Response|0|||
126524598|NCT00321919|455214502|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
126727901|NCT01599754|455952877|FG000|Overall Study|Participant noncompliance|4|||
126727902|NCT01599754|455952878|FG001|Overall Study|Participant noncompliance|4|||
126727903|NCT01599754|455952877|FG000|Overall Study|Lost to Follow-up|13|||
126576737|NCT01803555|455408553|FG001|Overall Study|Protocol Violation|5|||
126576738|NCT01803555|455408552|FG000|Overall Study|Lost to Follow-up|0|||
126576739|NCT01803555|455408553|FG001|Overall Study|Lost to Follow-up|2|||
126576740|NCT01803555|455408552|FG000|Overall Study|Other than specified|3|||
126576741|NCT01803555|455408553|FG001|Overall Study|Other than specified|5|||
126576742|NCT02409667|455408556|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
126576743|NCT02409667|455408557|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
126576744|NCT02409667|455408558|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
126576745|NCT02409667|455408559|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
126576746|NCT02409667|455408560|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
126576747|NCT02409667|455408556|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
126576748|NCT02409667|455408557|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
126576749|NCT02409667|455408558|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
126576750|NCT02409667|455408559|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
126576751|NCT02409667|455408560|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
126576752|NCT02409667|455408556|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
126576753|NCT02409667|455408557|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
126576754|NCT02409667|455408558|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
126576755|NCT02409667|455408559|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
126576756|NCT02409667|455408560|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
126576757|NCT02409667|455408556|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
126576758|NCT02409667|455408557|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
126576759|NCT02409667|455408558|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
126576760|NCT02409667|455408559|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
126576761|NCT02409667|455408560|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
126576762|NCT02409667|455408556|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
126576763|NCT02409667|455408557|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
126576764|NCT02409667|455408558|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
126576765|NCT02409667|455408559|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
126576766|NCT02409667|455408560|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
126576767|NCT02409667|455408556|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
126576768|NCT02409667|455408557|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
126576769|NCT02409667|455408558|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
126576770|NCT02409667|455408559|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
126576771|NCT02409667|455408560|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
126576772|NCT02409667|455408556|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
126576773|NCT02409667|455408557|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
126576774|NCT02409667|455408558|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
126576775|NCT02409667|455408559|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
126576776|NCT02409667|455408560|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
126576777|NCT02409667|455408556|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
126576778|NCT02409667|455408557|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
126576779|NCT02409667|455408558|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
126576780|NCT02409667|455408559|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
126576781|NCT02409667|455408560|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
126576782|NCT02409667|455408556|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
126576783|NCT02409667|455408557|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
126576784|NCT02409667|455408558|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
126576785|NCT02409667|455408559|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
126576786|NCT02409667|455408560|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
126576787|NCT02409667|455408556|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
126576788|NCT02409667|455408557|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
126576789|NCT02409667|455408558|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
126576790|NCT02409667|455408559|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
126576791|NCT02409667|455408560|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
126576792|NCT02409667|455408556|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
126576793|NCT02409667|455408557|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
126576794|NCT02409667|455408558|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
126576795|NCT02409667|455408559|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
126576796|NCT02409667|455408560|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
126576797|NCT02409667|455408556|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
126576798|NCT02409667|455408557|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
126576799|NCT02409667|455408558|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
126576800|NCT02409667|455408559|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
126576801|NCT02409667|455408560|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
126576802|NCT02409667|455408556|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
126576803|NCT02409667|455408557|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
126576804|NCT02409667|455408558|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
126576805|NCT02409667|455408559|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
126576806|NCT02409667|455408560|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
126576807|NCT02409667|455408556|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
126576808|NCT02409667|455408557|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
126576809|NCT02409667|455408558|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
126576810|NCT02409667|455408559|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
126576811|NCT02409667|455408560|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
126576812|NCT02409667|455408556|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
126576813|NCT02409667|455408557|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
126576814|NCT02409667|455408558|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
126576815|NCT02409667|455408559|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
126576816|NCT02409667|455408560|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
126576817|NCT02409667|455408556|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
126576818|NCT02409667|455408557|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
126576819|NCT02409667|455408558|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
126576820|NCT02409667|455408559|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
126576821|NCT02409667|455408560|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
126576822|NCT01925339|455408561|FG000|Overall Study|Adverse Event|2|||
126576823|NCT01925339|455408562|FG001|Overall Study|Adverse Event|0|||
126576824|NCT01538719|455408563|FG000|Overall Study|Lost to Follow-up|2|||
126576825|NCT01538719|455408564|FG001|Overall Study|Lost to Follow-up|0|||
126576826|NCT03664960|455408565|FG000|Overall Study|Adverse Event|0|||
126576827|NCT03664960|455408566|FG001|Overall Study|Adverse Event|3|||
126576828|NCT03664960|455408565|FG000|Overall Study|Lost to Follow-up|3|||
126576829|NCT03664960|455408566|FG001|Overall Study|Lost to Follow-up|2|||
126576830|NCT03664960|455408565|FG000|Overall Study|Physician Decision|1|||
126576831|NCT03664960|455408566|FG001|Overall Study|Physician Decision|0|||
126576832|NCT03664960|455408565|FG000|Overall Study|Withdrawal by Subject|3|||
126576833|NCT03664960|455408566|FG001|Overall Study|Withdrawal by Subject|14|||
126576834|NCT03664960|455408565|FG000|Overall Study|Sponsor Decision|1|||
126576835|NCT03664960|455408566|FG001|Overall Study|Sponsor Decision|1|||
126576836|NCT03664960|455408565|FG000|Overall Study|Other|1|||
126576837|NCT03664960|455408566|FG001|Overall Study|Other|2|||
126576838|NCT00774852|455408568|FG000|Overall Study|Adverse Event|9|||
126576839|NCT00774852|455408569|FG001|Overall Study|Adverse Event|6|||
126576840|NCT00774852|455408568|FG000|Overall Study|Death|2|||
126576841|NCT00774852|455408569|FG001|Overall Study|Death|1|||
126576842|NCT00774852|455408568|FG000|Overall Study|Lack of Efficacy|3|||
126576843|NCT00774852|455408569|FG001|Overall Study|Lack of Efficacy|7|||
126576844|NCT00774852|455408568|FG000|Overall Study|Lost to Follow-up|9|||
126576845|NCT00774852|455408569|FG001|Overall Study|Lost to Follow-up|5|||
126576846|NCT00774852|455408568|FG000|Overall Study|Physician Decision|2|||
126576847|NCT00774852|455408569|FG001|Overall Study|Physician Decision|6|||
126576848|NCT00774852|455408568|FG000|Overall Study|Pregnancy|1|||
126576849|NCT00774852|455408569|FG001|Overall Study|Pregnancy|2|||
126576850|NCT00774852|455408568|FG000|Overall Study|Withdrawal by Subject|2|||
126576851|NCT00774852|455408569|FG001|Overall Study|Withdrawal by Subject|2|||
126576852|NCT00774852|455408568|FG000|Overall Study|Non-responder|15|||
126576853|NCT00774852|455408569|FG001|Overall Study|Non-responder|11|||
126576854|NCT00774852|455408568|FG000|Overall Study|Subject non-compliance|0|||
126576855|NCT00774852|455408569|FG001|Overall Study|Subject non-compliance|1|||
126576856|NCT00774852|455408568|FG000|Overall Study|Protocol Violation|1|||
126576857|NCT00774852|455408569|FG001|Overall Study|Protocol Violation|0|||
126576858|NCT00774852|455408568|FG000|Overall Study|Subject received prohibited medication|1|||
126576859|NCT00774852|455408569|FG001|Overall Study|Subject received prohibited medication|0|||
126576860|NCT03997916|455408570|FG000|Overall Study|Protocol Violation|35|||
126576861|NCT05568615|455410089|FG000|Overall Study|Death|1|||
126576862|NCT05568615|455410089|FG000|Overall Study|Physician Decision|1|||
126576863|NCT03237481|455410092|FG000|Overall Study|Lost to Follow-up|1|||
126576864|NCT03237481|455410093|FG001|Overall Study|Lost to Follow-up|0|||
126576865|NCT03237481|455410094|FG002|Overall Study|Lost to Follow-up|0|||
126576866|NCT03237481|455410092|FG000|Overall Study|Protocol Violation|1|||
126576867|NCT03237481|455410093|FG001|Overall Study|Protocol Violation|0|||
126576868|NCT03237481|455410094|FG002|Overall Study|Protocol Violation|0|||
126576869|NCT03237481|455410092|FG000|Overall Study|Withdrawal by Subject|3|||
126576870|NCT03237481|455410093|FG001|Overall Study|Withdrawal by Subject|2|||
126576871|NCT03237481|455410094|FG002|Overall Study|Withdrawal by Subject|1|||
126576872|NCT02980276|455410098|FG000|Overall Study|Withdrawal by Subject|4|||
126576873|NCT02980276|455410099|FG001|Overall Study|Withdrawal by Subject|4|||
126576874|NCT02980276|455410098|FG000|Overall Study|Physician Decision|0|||
126576875|NCT02980276|455410099|FG001|Overall Study|Physician Decision|1|||
126576876|NCT02980276|455410098|FG000|Overall Study|Lost to Follow-up|18|||
126576877|NCT02980276|455410099|FG001|Overall Study|Lost to Follow-up|18|||
126576878|NCT02980276|455410098|FG000|Overall Study|Death|1|||
126576879|NCT02980276|455410099|FG001|Overall Study|Death|0|||
126576880|NCT02980276|455410098|FG000|Overall Study|Miscellaneous other|10|||
126576881|NCT02980276|455410099|FG001|Overall Study|Miscellaneous other|4|||
126576882|NCT04999085|455410101|FG000|Overall Study|Death|1|||
126576883|NCT03873779|455410103|FG000|Overall Study|Withdrawal by Subject|1|||
126576884|NCT02581215|455410104|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
126576885|NCT02581215|455410105|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
126576886|NCT02581215|455410104|FG000|Overall Study|Eligibility Criteria Not Met|0|||
126576887|NCT02581215|455410105|FG001|Overall Study|Eligibility Criteria Not Met|1|||
126576888|NCT03613740|455410108|FG000|Overall Study|Lost to Follow-up|1|||
126576889|NCT03613740|455410109|FG001|Overall Study|Lost to Follow-up|1|||
126576890|NCT04279574|455410110|FG000|Overall Study|Death|1|||
126576891|NCT04279574|455410111|FG001|Overall Study|Death|0|||
126576892|NCT04279574|455410110|FG000|Overall Study|lost restoration, tooth fracture|1|||
126576893|NCT04279574|455410111|FG001|Overall Study|lost restoration, tooth fracture|0|||
126576894|NCT04279574|455410110|FG000|Overall Study|Lost to Follow-up|0|||
126576895|NCT04279574|455410111|FG001|Overall Study|Lost to Follow-up|1|||
126576896|NCT04188379|455410112|FG000|Overall Study|Withdrawal by Subject|10|||
126576897|NCT04188379|455410113|FG001|Overall Study|Withdrawal by Subject|3|||
126576898|NCT04188379|455410112|FG000|Overall Study|Physician Decision|0|||
126576899|NCT04188379|455410113|FG001|Overall Study|Physician Decision|1|||
126576900|NCT04188379|455410112|FG000|Overall Study|Adverse Event|3|||
126576901|NCT04188379|455410113|FG001|Overall Study|Adverse Event|1|||
126576902|NCT04188379|455410112|FG000|Overall Study|Pregnancy|1|||
126576903|NCT04188379|455410113|FG001|Overall Study|Pregnancy|0|||
126576904|NCT04188379|455410112|FG000|Overall Study|Lack of Efficacy|8|||
126576905|NCT04188379|455410113|FG001|Overall Study|Lack of Efficacy|5|||
126576906|NCT04188379|455410112|FG000|Overall Study|Other|0|||
126576907|NCT04188379|455410113|FG001|Overall Study|Other|3|||
126576908|NCT02411084|455410116|FG000|Overall Study|Lack of Efficacy|6|||
126576909|NCT02411084|455410117|FG001|Overall Study|Lack of Efficacy|3|||
126576910|NCT02411084|455410116|FG000|Overall Study|Death|5|||
126576911|NCT02411084|455410117|FG001|Overall Study|Death|4|||
126576912|NCT02411084|455410116|FG000|Overall Study|Adverse Event|2|||
126576913|NCT02411084|455410117|FG001|Overall Study|Adverse Event|1|||
126576914|NCT02411084|455410116|FG000|Overall Study|Other reasons|0|||
126576915|NCT02411084|455410117|FG001|Overall Study|Other reasons|5|||
126576916|NCT03112174|455410120|FG000|Overall Study|Withdrawal by Subject|3|||
126576917|NCT03112174|455410121|FG001|Overall Study|Withdrawal by Subject|0|||
126576918|NCT03112174|455410122|FG002|Overall Study|Withdrawal by Subject|11|||
126576919|NCT03112174|455410123|FG003|Overall Study|Withdrawal by Subject|9|||
126524599|NCT00321919|455214503|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
126524600|NCT00321919|455214502|FG000|Overall Study|Refused Treatment|23|||
126524601|NCT00321919|455214503|FG001|Overall Study|Refused Treatment|14|||
126524602|NCT00321919|455214502|FG000|Overall Study|Other Protocol Violation|2|||
126524603|NCT00321919|455214503|FG001|Overall Study|Other Protocol Violation|3|||
126524604|NCT00321919|455214502|FG000|Overall Study|Failure to Return|3|||
126524605|NCT00321919|455214503|FG001|Overall Study|Failure to Return|1|||
126524606|NCT00321919|455214502|FG000|Overall Study|Other withdrawal reason|7|||
126524607|NCT00321919|455214503|FG001|Overall Study|Other withdrawal reason|6|||
126524608|NCT02261363|455214504|FG000|Overall Study|Lost to Follow-up|21|||
126524609|NCT01517802|455214505|FG000|Overall Study|Death|1|||
126524610|NCT02590354|455214506|FG000|Phase 1|Active hepatitis B or C infection|1|||
126524611|NCT02590354|455214506|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
126524612|NCT02590354|455214506|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
126524613|NCT02590354|455214506|FG000|Phase 1|Subject does not want to participate|20|||
126524614|NCT02590354|455214506|FG000|Phase 1|Lost to Follow-up|1|||
126524615|NCT02590354|455214506|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
126524616|NCT00760929|455214507|FG000|Overall Study|Adverse Event|2|||
126576920|NCT03112174|455410124|FG004|Overall Study|Withdrawal by Subject|7|||
126576921|NCT03112174|455410120|FG000|Overall Study|Lost to Follow-up|1|||
126576922|NCT03112174|455410121|FG001|Overall Study|Lost to Follow-up|1|||
126576923|NCT03112174|455410122|FG002|Overall Study|Lost to Follow-up|2|||
126576924|NCT03112174|455410123|FG003|Overall Study|Lost to Follow-up|3|||
126576925|NCT03112174|455410124|FG004|Overall Study|Lost to Follow-up|2|||
126576926|NCT03112174|455410120|FG000|Overall Study|Death|8|||
126576927|NCT03112174|455410121|FG001|Overall Study|Death|3|||
126524617|NCT00760929|455214508|FG001|Overall Study|Adverse Event|0|||
126524618|NCT00760929|455214509|FG002|Overall Study|Adverse Event|6|||
126524619|NCT00760929|455214510|FG003|Overall Study|Adverse Event|10|||
126524620|NCT00760929|455214507|FG000|Overall Study|Lack of Efficacy|0|||
126524621|NCT00760929|455214508|FG001|Overall Study|Lack of Efficacy|2|||
126524622|NCT00760929|455214509|FG002|Overall Study|Lack of Efficacy|1|||
126576928|NCT03112174|455410122|FG002|Overall Study|Death|67|||
126576929|NCT03112174|455410123|FG003|Overall Study|Death|73|||
126576930|NCT03112174|455410124|FG004|Overall Study|Death|18|||
126576931|NCT03112174|455410120|FG000|Overall Study|Other, Not Specified|1|||
126524623|NCT00760929|455214510|FG003|Overall Study|Lack of Efficacy|0|||
126524624|NCT00760929|455214507|FG000|Overall Study|Withdrawal by Subject|1|||
126524625|NCT00760929|455214508|FG001|Overall Study|Withdrawal by Subject|0|||
126524626|NCT00760929|455214509|FG002|Overall Study|Withdrawal by Subject|9|||
126524627|NCT00760929|455214510|FG003|Overall Study|Withdrawal by Subject|1|||
126524628|NCT00760929|455214507|FG000|Overall Study|Lost to Follow-up|0|||
126524629|NCT00760929|455214508|FG001|Overall Study|Lost to Follow-up|0|||
126524630|NCT00760929|455214509|FG002|Overall Study|Lost to Follow-up|1|||
126524631|NCT00760929|455214510|FG003|Overall Study|Lost to Follow-up|0|||
126524632|NCT00760929|455214507|FG000|Overall Study|Progression of Disease|21|||
126524633|NCT00760929|455214508|FG001|Overall Study|Progression of Disease|26|||
126524634|NCT00760929|455214509|FG002|Overall Study|Progression of Disease|38|||
126524635|NCT00760929|455214510|FG003|Overall Study|Progression of Disease|42|||
126524636|NCT00760929|455214507|FG000|Overall Study|Other|2|||
126524637|NCT00760929|455214508|FG001|Overall Study|Other|0|||
126524638|NCT00760929|455214509|FG002|Overall Study|Other|2|||
126524639|NCT00760929|455214510|FG003|Overall Study|Other|1|||
126524640|NCT00760929|455214507|FG000|Overall Study|Death|0|||
126524641|NCT00760929|455214508|FG001|Overall Study|Death|0|||
126524642|NCT00760929|455214509|FG002|Overall Study|Death|1|||
126524643|NCT00760929|455214510|FG003|Overall Study|Death|0|||
126524644|NCT00760929|455214507|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
126524645|NCT00760929|455214508|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
126524646|NCT00760929|455214509|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
126524647|NCT00760929|455214510|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
126524648|NCT02099838|455214511|FG000|Overall Study|Death|1|||
126524649|NCT02099838|455214512|FG001|Overall Study|Death|0|||
126524650|NCT02099838|455214511|FG000|Overall Study|Lost to Follow-up|3|||
126524651|NCT02099838|455214512|FG001|Overall Study|Lost to Follow-up|1|||
126524652|NCT02099838|455214511|FG000|Overall Study|Withdrawal by Subject|0|||
126524653|NCT02099838|455214512|FG001|Overall Study|Withdrawal by Subject|1|||
126524654|NCT02301143|455214513|FG000|Induction Period|Enrolled But Not Treated|1|||
126524655|NCT02301143|455214514|FG001|Induction Period|Enrolled But Not Treated|0|||
126524656|NCT02301143|455214513|FG000|Induction Period|Death|1|||
126524657|NCT02301143|455214514|FG001|Induction Period|Death|0|||
126524658|NCT02301143|455214513|FG000|Induction Period|Adverse Event|22|||
126524659|NCT02301143|455214514|FG001|Induction Period|Adverse Event|0|||
126524660|NCT02301143|455214513|FG000|Induction Period|Progressive Disease|8|||
126524661|NCT02301143|455214514|FG001|Induction Period|Progressive Disease|0|||
126524662|NCT02301143|455214513|FG000|Induction Period|Withdrawal by Subject|3|||
126524663|NCT02301143|455214514|FG001|Induction Period|Withdrawal by Subject|0|||
126524664|NCT02301143|455214513|FG000|Induction Period|Noncompliance with Study Drug|1|||
126524665|NCT02301143|455214514|FG001|Induction Period|Noncompliance with Study Drug|0|||
126524666|NCT02301143|455214513|FG000|Induction Period|Physician Decision|4|||
126524667|NCT02301143|455214514|FG001|Induction Period|Physician Decision|0|||
126524668|NCT02301143|455214513|FG000|Induction Period|Symptomatic Deterioration|2|||
126524669|NCT02301143|455214514|FG001|Induction Period|Symptomatic Deterioration|0|||
126524670|NCT02301143|455214513|FG000|Induction Period|Protocol Violation|2|||
126524671|NCT02301143|455214514|FG001|Induction Period|Protocol Violation|0|||
126524672|NCT02301143|455214513|FG000|Induction Period|Other|1|||
126524673|NCT02301143|455214514|FG001|Induction Period|Other|0|||
126524674|NCT02301143|455214513|FG000|Investigator's Choice|Adverse Event|0|||
126524675|NCT02301143|455214514|FG001|Investigator's Choice|Adverse Event|3|||
126524676|NCT02301143|455214513|FG000|Investigator's Choice|Progressive Disease|0|||
126524677|NCT02301143|455214514|FG001|Investigator's Choice|Progressive Disease|3|||
126524678|NCT02301143|455214513|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
126524679|NCT02301143|455214514|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
126524680|NCT02301143|455214513|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
126524681|NCT02301143|455214514|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
126524682|NCT02301143|455214513|FG000|Investigator's Choice|Other|0|||
126524683|NCT02301143|455214514|FG001|Investigator's Choice|Other|1|||
126524684|NCT02301143|455214513|FG000|Investigator's Choice|Unresectable Surgery|0|||
126524685|NCT02301143|455214514|FG001|Investigator's Choice|Unresectable Surgery|1|||
126524686|NCT02536508|455214517|FG000|Overall Study|Withdrawal by Subject|18|||
126524687|NCT02536508|455214518|FG001|Overall Study|Withdrawal by Subject|13|||
126524688|NCT02536508|455214519|FG002|Overall Study|Withdrawal by Subject|7|||
126524689|NCT02536508|455214517|FG000|Overall Study|Adverse Event|14|||
126524690|NCT02536508|455214518|FG001|Overall Study|Adverse Event|13|||
126524691|NCT02536508|455214519|FG002|Overall Study|Adverse Event|6|||
126524692|NCT02536508|455214517|FG000|Overall Study|Lost to Follow-up|12|||
126524693|NCT02536508|455214518|FG001|Overall Study|Lost to Follow-up|4|||
126524694|NCT02536508|455214519|FG002|Overall Study|Lost to Follow-up|0|||
126524695|NCT02536508|455214517|FG000|Overall Study|Lack of Efficacy|3|||
126524696|NCT02536508|455214518|FG001|Overall Study|Lack of Efficacy|5|||
126524697|NCT02536508|455214519|FG002|Overall Study|Lack of Efficacy|4|||
126524698|NCT02536508|455214517|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
126524699|NCT02536508|455214518|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
126576932|NCT03112174|455410121|FG001|Overall Study|Other, Not Specified|0|||
126576933|NCT03112174|455410122|FG002|Overall Study|Other, Not Specified|1|||
126576934|NCT03112174|455410123|FG003|Overall Study|Other, Not Specified|2|||
126576935|NCT03112174|455410124|FG004|Overall Study|Other, Not Specified|0|||
126576936|NCT05773313|455410127|FG000|Overall Study|Lost to Follow-up|3|||
126576937|NCT02748317|455410128|FG000|Overall Study|Withdrawal by Subject|14|||
126576938|NCT02748317|455410128|FG000|Overall Study|Lost to Follow-up|8|||
126576939|NCT02748317|455410128|FG000|Overall Study|Death|1|||
126576940|NCT00332241|455410131|FG000|Overall Study|Lack of Efficacy|6|||
126576941|NCT00332241|455410132|FG001|Overall Study|Lack of Efficacy|1|||
126576942|NCT00332241|455410131|FG000|Overall Study|Adverse Event|3|||
126576943|NCT00332241|455410132|FG001|Overall Study|Adverse Event|5|||
126576944|NCT00332241|455410131|FG000|Overall Study|Withdrawal by Subject|2|||
126576945|NCT00332241|455410132|FG001|Overall Study|Withdrawal by Subject|1|||
126576946|NCT00332241|455410131|FG000|Overall Study|Lost to Follow-up|4|||
126576947|NCT00332241|455410132|FG001|Overall Study|Lost to Follow-up|1|||
126576948|NCT00802464|455410134|FG000|Month 0 - Month 8|Adverse Event|0|||
126576949|NCT00802464|455410135|FG001|Month 0 - Month 8|Adverse Event|1|||
126576950|NCT00802464|455410136|FG002|Month 0 - Month 8|Adverse Event|1|||
126576951|NCT00802464|455410137|FG003|Month 0 - Month 8|Adverse Event|2|||
126576952|NCT00802464|455410134|FG000|Month 0 - Month 8|Protocol Violation|0|||
126576953|NCT00802464|455410135|FG001|Month 0 - Month 8|Protocol Violation|0|||
126576954|NCT00802464|455410136|FG002|Month 0 - Month 8|Protocol Violation|1|||
126576955|NCT00802464|455410137|FG003|Month 0 - Month 8|Protocol Violation|0|||
126576956|NCT00802464|455410134|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
126576957|NCT00802464|455410135|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
126576958|NCT00802464|455410136|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
126576959|NCT00802464|455410137|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
126576960|NCT00802464|455410134|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
126576961|NCT00802464|455410135|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
126576962|NCT00802464|455410136|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
126576963|NCT00802464|455410137|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
126576964|NCT00802464|455410134|FG000|Month 0 - Month 8|Other|0|||
126576965|NCT00802464|455410135|FG001|Month 0 - Month 8|Other|0|||
126576966|NCT00802464|455410136|FG002|Month 0 - Month 8|Other|1|||
126576967|NCT00802464|455410137|FG003|Month 0 - Month 8|Other|0|||
126576968|NCT00802464|455410134|FG000|Month 8 - Month 14|Adverse Event|0|||
126576969|NCT00802464|455410135|FG001|Month 8 - Month 14|Adverse Event|1|||
126576970|NCT00802464|455410136|FG002|Month 8 - Month 14|Adverse Event|0|||
126576971|NCT00802464|455410137|FG003|Month 8 - Month 14|Adverse Event|0|||
126576972|NCT00802464|455410134|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
126576973|NCT00802464|455410135|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
126576974|NCT00802464|455410136|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
126576975|NCT00802464|455410137|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
126576976|NCT00802464|455410134|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
126576977|NCT00802464|455410135|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
126576978|NCT00802464|455410136|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
126576979|NCT00802464|455410137|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
126576980|NCT00402246|455410138|FG000|Overall Study|Death|62|||
126576981|NCT00402246|455410139|FG001|Overall Study|Death|58|||
126576982|NCT00402246|455410138|FG000|Overall Study|Lost to Follow-up|20|||
126576983|NCT00402246|455410139|FG001|Overall Study|Lost to Follow-up|28|||
126576984|NCT00402246|455410138|FG000|Overall Study|Withdrawal by Subject|72|||
126576985|NCT00402246|455410139|FG001|Overall Study|Withdrawal by Subject|87|||
126576986|NCT00402246|455410138|FG000|Overall Study|Physician Decision|24|||
126727904|NCT01599754|455952878|FG001|Overall Study|Lost to Follow-up|6|||
126727905|NCT01599754|455952877|FG000|Overall Study|Death|31|||
126727906|NCT01599754|455952878|FG001|Overall Study|Death|33|||
126727907|NCT01599754|455952877|FG000|Overall Study|Adverse Event|3|||
126727908|NCT01599754|455952878|FG001|Overall Study|Adverse Event|2|||
126727909|NCT01599754|455952877|FG000|Overall Study|Investigator decision|1|||
126727910|NCT01599754|455952878|FG001|Overall Study|Investigator decision|3|||
126727911|NCT01599754|455952877|FG000|Overall Study|Withdrawal by Subject|24|||
126727912|NCT01599754|455952878|FG001|Overall Study|Withdrawal by Subject|25|||
126727913|NCT01599754|455952877|FG000|Overall Study|Study terminated by sponsor|282|||
126727914|NCT01599754|455952878|FG001|Overall Study|Study terminated by sponsor|285|||
126727915|NCT01551758|455952879|FG000|Overall Study|Adverse Event|29|||
126727916|NCT01551758|455952880|FG001|Overall Study|Adverse Event|43|||
126727917|NCT01551758|455952879|FG000|Overall Study|Lack of Efficacy|0|||
126576987|NCT00402246|455410139|FG001|Overall Study|Physician Decision|26|||
126576988|NCT00402246|455410138|FG000|Overall Study|Protocol Violation|25|||
126576989|NCT00402246|455410139|FG001|Overall Study|Protocol Violation|24|||
126727918|NCT01551758|455952880|FG001|Overall Study|Lack of Efficacy|1|||
126727919|NCT01551758|455952879|FG000|Overall Study|Protocol Violation|5|||
126727920|NCT01551758|455952880|FG001|Overall Study|Protocol Violation|6|||
126576990|NCT00402246|455410138|FG000|Overall Study|Missed Final Visit|1|||
126576991|NCT00402246|455410139|FG001|Overall Study|Missed Final Visit|2|||
126576992|NCT00402246|455410138|FG000|Overall Study|Insurance Issues|2|||
126727921|NCT01551758|455952879|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
126524700|NCT02536508|455214519|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
126524701|NCT02536508|455214517|FG000|Overall Study|Physician Decision|0|||
126524702|NCT02536508|455214518|FG001|Overall Study|Physician Decision|4|||
126524703|NCT02536508|455214519|FG002|Overall Study|Physician Decision|2|||
126524704|NCT02536508|455214517|FG000|Overall Study|Major Protocol Deviation|2|||
126524705|NCT02536508|455214518|FG001|Overall Study|Major Protocol Deviation|2|||
126524706|NCT02536508|455214519|FG002|Overall Study|Major Protocol Deviation|2|||
126727922|NCT01551758|455952880|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
126727923|NCT01551758|455952879|FG000|Overall Study|Lost to Follow-up|29|||
126524707|NCT02536508|455214517|FG000|Overall Study|Administrative Reasons|0|||
126524708|NCT02536508|455214518|FG001|Overall Study|Administrative Reasons|1|||
126524709|NCT02536508|455214519|FG002|Overall Study|Administrative Reasons|0|||
126524710|NCT02460991|455214523|FG000|Overall Study|Withdrawal by Subject|0|||
126524711|NCT02460991|455214524|FG001|Overall Study|Withdrawal by Subject|2|||
126524712|NCT00434057|455214525|FG000|Overall Study|Withdrawal by Subject|1|||
126524713|NCT02473952|455214526|FG000|Overall Study|Adverse Event|2|||
126524714|NCT02473952|455214527|FG001|Overall Study|Adverse Event|2|||
126524715|NCT02473952|455214526|FG000|Overall Study|Withdrawal by Subject|0|||
126524716|NCT02473952|455214527|FG001|Overall Study|Withdrawal by Subject|6|||
126524717|NCT00823719|455214528|FG000|Overall Study|Adverse Event|1|||
126524718|NCT00823719|455214529|FG001|Overall Study|Adverse Event|2|||
126524719|NCT00823719|455214528|FG000|Overall Study|Physician Decision|1|||
126524720|NCT00823719|455214529|FG001|Overall Study|Physician Decision|4|||
126524721|NCT00823719|455214528|FG000|Overall Study|Withdrawal by Subject|0|||
126524722|NCT00823719|455214529|FG001|Overall Study|Withdrawal by Subject|1|||
126524723|NCT00823719|455214528|FG000|Overall Study|Disease Progression|4|||
126524724|NCT00823719|455214529|FG001|Overall Study|Disease Progression|4|||
126524725|NCT00455195|455214530|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
126524726|NCT00455195|455214531|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
126524727|NCT00455195|455214530|FG000|Double-blind Study AGLU02704|Death|1|||
126524728|NCT00455195|455214531|FG001|Double-blind Study AGLU02704|Death|0|||
126524729|NCT00455195|455214530|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
126524730|NCT00455195|455214531|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
126524731|NCT00455195|455214530|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
126524732|NCT00455195|455214531|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
126524733|NCT02117570|455214532|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
126524734|NCT02117570|455214533|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
126524735|NCT02117570|455214534|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
126524736|NCT02117570|455214532|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
126524737|NCT02117570|455214533|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
126524738|NCT02117570|455214534|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
126524739|NCT02117570|455214532|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
126524740|NCT02117570|455214533|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
126524741|NCT02117570|455214534|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
126524742|NCT02117570|455214532|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
126524743|NCT02117570|455214533|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
126524744|NCT02117570|455214534|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
126524745|NCT02117570|455214532|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
126524746|NCT02117570|455214533|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
126524747|NCT02117570|455214534|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
126524748|NCT02117570|455214532|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
126524749|NCT02117570|455214533|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
126524750|NCT02117570|455214534|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
126524751|NCT02117570|455214532|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
126524752|NCT02117570|455214533|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
126524753|NCT02117570|455214534|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
126524754|NCT03701555|455214536|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
126524755|NCT03701555|455214537|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
126524756|NCT03701555|455214538|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
126524757|NCT03701555|455214539|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
126524758|NCT03701555|455214540|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
126524759|NCT03701555|455214541|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
126524760|NCT03701555|455214542|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
126524761|NCT03701555|455214543|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
126524762|NCT03701555|455214544|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
126524763|NCT03701555|455214545|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
126524764|NCT03701555|455214546|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
126524765|NCT03701555|455214547|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
126524766|NCT03701555|455214548|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
126524767|NCT03701555|455214549|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
126524768|NCT03701555|455214550|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
126727924|NCT01551758|455952880|FG001|Overall Study|Lost to Follow-up|25|||
126727925|NCT01551758|455952879|FG000|Overall Study|Physician Decision|9|||
126727926|NCT01551758|455952880|FG001|Overall Study|Physician Decision|3|||
126727927|NCT01551758|455952879|FG000|Overall Study|Withdrawal by Subject|14|||
126727928|NCT01551758|455952880|FG001|Overall Study|Withdrawal by Subject|17|||
126727929|NCT00101192|455952881|FG000|Overall Study|Ineligible|6|||
126727930|NCT00101192|455952881|FG000|Overall Study|Inevaluable|1|||
126727931|NCT02618928|455952884|FG000|Overall Study|Failure to Return|28|||
126727932|NCT02618928|455952884|FG000|Overall Study|Insufficient Virological Response|1|||
126727933|NCT02618928|455952884|FG000|Overall Study|Withdrawal by Subject|2|||
126727934|NCT02618928|455952884|FG000|Overall Study|Death|3|||
126727935|NCT02618928|455952884|FG000|Overall Study|Other|11|||
126727936|NCT02618928|455952884|FG000|Overall Study|Missing|6|||
126727937|NCT02618928|455952884|FG000|Overall Study|Treatment Never Started|7|||
126727938|NCT02128763|455952887|FG000|Overall Study|Death|1|||
126727939|NCT02128763|455952888|FG001|Overall Study|Death|0|||
126727940|NCT02128763|455952887|FG000|Overall Study|Lost to Follow-up|19|||
126727941|NCT02128763|455952888|FG001|Overall Study|Lost to Follow-up|16|||
126727942|NCT03282357|455952891|FG000|Overall Study|Lost to Follow-up|3|||
126727943|NCT03282357|455952891|FG000|Overall Study|Withdrawal by Subject|4|||
126727944|NCT03282357|455952891|FG000|Overall Study|Adverse Event|1|||
126727945|NCT03282357|455952891|FG000|Overall Study|Other|9|||
126727946|NCT01586156|455952892|FG000|Overall Study|Pregnancy|0|||
126727947|NCT01586156|455952893|FG001|Overall Study|Pregnancy|1|||
126727948|NCT01586156|455952894|FG002|Overall Study|Pregnancy|0|||
126727949|NCT00975195|455952895|FG000|Overall Study|Adverse Event|108|||
126727950|NCT00975195|455952896|FG001|Overall Study|Adverse Event|101|||
126576993|NCT00402246|455410139|FG001|Overall Study|Insurance Issues|1|||
126576994|NCT00402246|455410138|FG000|Overall Study|Heart Transplant|0|||
126576995|NCT00402246|455410139|FG001|Overall Study|Heart Transplant|1|||
126576996|NCT00402246|455410138|FG000|Overall Study|Patient's device explanted|6|||
126576997|NCT00402246|455410139|FG001|Overall Study|Patient's device explanted|2|||
126576998|NCT00402246|455410138|FG000|Overall Study|Center Closure|5|||
126576999|NCT00402246|455410139|FG001|Overall Study|Center Closure|3|||
126577000|NCT00402246|455410138|FG000|Overall Study|Deterioriating Condition|3|||
126577001|NCT00402246|455410139|FG001|Overall Study|Deterioriating Condition|2|||
126577002|NCT00434304|455410144|FG000|Overall Study|Adverse Event|14|||
126577003|NCT00434304|455410144|FG000|Overall Study|Lack of Efficacy|2|||
126577004|NCT00434304|455410144|FG000|Overall Study|Withdrawal by Subject|4|||
126577005|NCT05262738|455410145|FG000|Overall Study|Withdrawal by Subject|1|||
126577006|NCT05262738|455410146|FG001|Overall Study|Withdrawal by Subject|0|||
126577007|NCT02374463|455410148|FG000|Overall Study|Withdrawal by Subject|3|||
126577008|NCT02374463|455410149|FG001|Overall Study|Withdrawal by Subject|3|||
126577009|NCT01471691|455410152|FG000|Overall Study|Lack of Efficacy|0|||
126577010|NCT01471691|455410153|FG001|Overall Study|Lack of Efficacy|1|||
126577011|NCT01808339|455410154|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126577012|NCT01808339|455410155|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126577013|NCT01808339|455410156|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126577014|NCT01808339|455410157|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
126577015|NCT01808339|455410158|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
126577016|NCT01808339|455410159|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
126577017|NCT01808339|455410154|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126577018|NCT01808339|455410155|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126577019|NCT01808339|455410156|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126577020|NCT01808339|455410157|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
126727951|NCT00975195|455952895|FG000|Overall Study|Lack of Efficacy|6|||
126727952|NCT00975195|455952896|FG001|Overall Study|Lack of Efficacy|6|||
126727953|NCT00975195|455952895|FG000|Overall Study|Protocol Violation|27|||
126727954|NCT00975195|455952896|FG001|Overall Study|Protocol Violation|23|||
126727955|NCT00975195|455952895|FG000|Overall Study|Lost to Follow-up|9|||
126727956|NCT00975195|455952896|FG001|Overall Study|Lost to Follow-up|7|||
126577021|NCT01808339|455410158|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126577022|NCT01808339|455410159|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
126577023|NCT01808339|455410154|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126577024|NCT01808339|455410155|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126577025|NCT01808339|455410156|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
126577026|NCT01808339|455410157|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126577027|NCT01808339|455410158|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126727957|NCT00975195|455952895|FG000|Overall Study|Withdrawal by Subject|48|||
126727958|NCT00975195|455952896|FG001|Overall Study|Withdrawal by Subject|61|||
126727959|NCT00975195|455952895|FG000|Overall Study|Other reason not defined above|29|||
126727960|NCT00975195|455952896|FG001|Overall Study|Other reason not defined above|33|||
126727961|NCT00975195|455952895|FG000|Overall Study|Not treated|1|||
126727962|NCT00975195|455952896|FG001|Overall Study|Not treated|2|||
126727963|NCT04501679|455952900|FG000|Overall Study|Pregnancy|0|||
126727964|NCT04501679|455952901|FG001|Overall Study|Pregnancy|1|||
126727965|NCT04501679|455952900|FG000|Overall Study|Adverse Event|4|||
126727966|NCT04501679|455952901|FG001|Overall Study|Adverse Event|2|||
126727967|NCT04501679|455952900|FG000|Overall Study|Withdrawal by Subject|2|||
126727968|NCT04501679|455952901|FG001|Overall Study|Withdrawal by Subject|0|||
126727969|NCT04501679|455952900|FG000|Overall Study|Physician Decision|1|||
126727970|NCT04501679|455952901|FG001|Overall Study|Physician Decision|0|||
126727971|NCT04501679|455952900|FG000|Overall Study|Lost to Follow-up|2|||
126727972|NCT04501679|455952901|FG001|Overall Study|Lost to Follow-up|0|||
126727973|NCT00910429|455952904|FG000|Overall Study|Death|18|||
126727974|NCT00910429|455952905|FG001|Overall Study|Death|12|||
126727975|NCT00910429|455952904|FG000|Overall Study|Withdrawal by Subject|3|||
126727976|NCT00910429|455952905|FG001|Overall Study|Withdrawal by Subject|2|||
126727977|NCT00910429|455952904|FG000|Overall Study|Protocol Violation|1|||
126727978|NCT00910429|455952905|FG001|Overall Study|Protocol Violation|0|||
126727979|NCT00910429|455952904|FG000|Overall Study|Lost to Follow-up|2|||
126727980|NCT00910429|455952905|FG001|Overall Study|Lost to Follow-up|1|||
126727981|NCT00910429|455952904|FG000|Overall Study|Adverse Event|10|||
126727982|NCT00910429|455952905|FG001|Overall Study|Adverse Event|5|||
126727983|NCT00910429|455952904|FG000|Overall Study|Drug non-compliance|1|||
126727984|NCT00910429|455952905|FG001|Overall Study|Drug non-compliance|0|||
126727985|NCT00910429|455952904|FG000|Overall Study|Lack of Efficacy|4|||
126727986|NCT00910429|455952905|FG001|Overall Study|Lack of Efficacy|1|||
126727987|NCT02121756|455952907|FG000|Overall Study|Adverse Event|3|||
126727988|NCT02121756|455952908|FG001|Overall Study|Adverse Event|0|||
126727989|NCT02121756|455952907|FG000|Overall Study|Protocol Violation|1|||
126727990|NCT02121756|455952908|FG001|Overall Study|Protocol Violation|1|||
126727991|NCT02121756|455952907|FG000|Overall Study|Physician Decision|2|||
126727992|NCT02121756|455952908|FG001|Overall Study|Physician Decision|1|||
126727993|NCT02365584|455952912|FG000|Overall Study|Adverse Event|2|||
126727994|NCT02365584|455952913|FG001|Overall Study|Adverse Event|2|||
126727995|NCT02365584|455952912|FG000|Overall Study|Withdrawal by Subject|1|||
126727996|NCT02365584|455952913|FG001|Overall Study|Withdrawal by Subject|0|||
126727997|NCT02365584|455952912|FG000|Overall Study|Disease Progression|9|||
126727998|NCT02365584|455952913|FG001|Overall Study|Disease Progression|12|||
126727999|NCT00349752|455952914|FG000|Overall Study|Adverse Event|8|||
126728000|NCT00349752|455952915|FG001|Overall Study|Adverse Event|12|||
126728001|NCT00349752|455952914|FG000|Overall Study|Lack of Efficacy|37|||
126728002|NCT00349752|455952915|FG001|Overall Study|Lack of Efficacy|42|||
126728003|NCT00349752|455952914|FG000|Overall Study|Lost to Follow-up|4|||
126728004|NCT00349752|455952915|FG001|Overall Study|Lost to Follow-up|2|||
126728005|NCT00349752|455952914|FG000|Overall Study|Personal reasons|6|||
126728006|NCT00349752|455952915|FG001|Overall Study|Personal reasons|5|||
126728007|NCT00349752|455952914|FG000|Overall Study|Other: Required exclusionary medication|0|||
126728008|NCT00349752|455952915|FG001|Overall Study|Other: Required exclusionary medication|1|||
126728009|NCT00349752|455952914|FG000|Overall Study|Other: Non compliance|0|||
126728010|NCT00349752|455952915|FG001|Overall Study|Other: Non compliance|1|||
126728011|NCT00349752|455952914|FG000|Overall Study|Other: Patient stopped steroids|0|||
126728012|NCT00349752|455952915|FG001|Overall Study|Other: Patient stopped steroids|1|||
126728013|NCT00349752|455952914|FG000|Overall Study|Other: Patient's steroid use|1|||
126728014|NCT00349752|455952915|FG001|Overall Study|Other: Patient's steroid use|0|||
126728015|NCT00349752|455952914|FG000|Overall Study|Other: Ineligible|1|||
126728016|NCT00349752|455952915|FG001|Overall Study|Other: Ineligible|0|||
126728017|NCT00349752|455952914|FG000|Overall Study|Other: Inadvertently unblinded|1|||
126728018|NCT00349752|455952915|FG001|Overall Study|Other: Inadvertently unblinded|0|||
126728019|NCT00349752|455952914|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
126728020|NCT00349752|455952915|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
126728021|NCT01973452|455952916|FG000|Overall Study|Lack of Efficacy|0|||
126728022|NCT01973452|455952917|FG001|Overall Study|Lack of Efficacy|1|||
126728023|NCT01973452|455952916|FG000|Overall Study|Lost to Follow-up|1|||
126728024|NCT01973452|455952917|FG001|Overall Study|Lost to Follow-up|0|||
126728025|NCT01973452|455952916|FG000|Overall Study|Withdrawal by Subject|10|||
126728026|NCT01973452|455952917|FG001|Overall Study|Withdrawal by Subject|9|||
126728027|NCT01973452|455952916|FG000|Overall Study|Ineligible|1|||
126728028|NCT01973452|455952917|FG001|Overall Study|Ineligible|1|||
126728029|NCT01973452|455952916|FG000|Overall Study|Surgery canceled by participant|5|||
126640441|NCT00479882|455642776|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
126640442|NCT00479882|455642777|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
126640443|NCT00479882|455642774|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
126640444|NCT00479882|455642775|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
126640445|NCT00479882|455642776|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
126640446|NCT00479882|455642777|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
126640447|NCT00479882|455642774|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
126640448|NCT00479882|455642775|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
126640449|NCT00479882|455642776|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
126640450|NCT00479882|455642777|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
126728030|NCT01973452|455952917|FG001|Overall Study|Surgery canceled by participant|3|||
126728031|NCT00064350|455952923|FG000|Induction Treatment|Disease Progression|5|||
126728032|NCT00064350|455952924|FG001|Induction Treatment|Disease Progression|1|||
126728033|NCT00064350|455952925|FG002|Induction Treatment|Disease Progression|110|||
126728034|NCT00064350|455952923|FG000|Induction Treatment|Adverse Event|0|||
126728035|NCT00064350|455952924|FG001|Induction Treatment|Adverse Event|2|||
126728036|NCT00064350|455952925|FG002|Induction Treatment|Adverse Event|49|||
126728037|NCT00064350|455952923|FG000|Induction Treatment|Death|0|||
126524769|NCT03701555|455214551|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
126524770|NCT03701555|455214552|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
126524771|NCT03701555|455214553|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
126524772|NCT03701555|455214554|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
126524773|NCT03701555|455214555|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
126524774|NCT03701555|455214556|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
126524775|NCT03701555|455214557|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
126524776|NCT03701555|455214558|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
126524777|NCT03701555|455214559|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
126524778|NCT03701555|455214560|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
126524779|NCT03701555|455214561|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
126524780|NCT03701555|455214562|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
126524781|NCT03701555|455214563|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
126524782|NCT03701555|455214564|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
126524783|NCT03701555|455214565|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
126524784|NCT03701555|455214566|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
126524785|NCT03701555|455214567|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
126524786|NCT03701555|455214568|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
126524787|NCT03701555|455214569|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
126524788|NCT03701555|455214570|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
126524789|NCT03701555|455214571|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
126524790|NCT03701555|455214536|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
126524791|NCT03701555|455214537|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
126524792|NCT03701555|455214538|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
126524793|NCT03701555|455214539|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
126524794|NCT03701555|455214540|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
126524795|NCT03701555|455214541|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
126524796|NCT03701555|455214542|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
126524797|NCT03701555|455214543|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
126524798|NCT03701555|455214544|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
126524799|NCT03701555|455214545|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
126524800|NCT03701555|455214546|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
126524801|NCT03701555|455214547|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
126524802|NCT03701555|455214548|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
126524803|NCT03701555|455214549|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
126524804|NCT03701555|455214550|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
126524805|NCT03701555|455214551|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
126524806|NCT03701555|455214552|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
126524807|NCT03701555|455214553|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
126524808|NCT03701555|455214554|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
126524809|NCT03701555|455214555|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
126524810|NCT03701555|455214556|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
126524811|NCT03701555|455214557|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
126524812|NCT03701555|455214558|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
126524813|NCT03701555|455214559|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
126524814|NCT03701555|455214560|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
126524815|NCT03701555|455214561|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
126524816|NCT03701555|455214562|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
126524817|NCT03701555|455214563|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
126524818|NCT03701555|455214564|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
126524819|NCT03701555|455214565|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
126524820|NCT03701555|455214566|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
126524821|NCT03701555|455214567|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
126524822|NCT03701555|455214568|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
126524823|NCT03701555|455214569|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
126524824|NCT03701555|455214570|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
126524825|NCT03701555|455214571|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
126524826|NCT03701555|455214536|FG000|Part 2 (Day 1)|Other|0|||
126524827|NCT03701555|455214537|FG001|Part 2 (Day 1)|Other|0|||
126524828|NCT03701555|455214538|FG002|Part 2 (Day 1)|Other|0|||
126524829|NCT03701555|455214539|FG003|Part 2 (Day 1)|Other|0|||
126728038|NCT00064350|455952924|FG001|Induction Treatment|Death|0|||
126524830|NCT03701555|455214540|FG004|Part 2 (Day 1)|Other|0|||
126524831|NCT03701555|455214541|FG005|Part 2 (Day 1)|Other|0|||
126524832|NCT03701555|455214542|FG006|Part 2 (Day 1)|Other|0|||
126524833|NCT03701555|455214543|FG007|Part 2 (Day 1)|Other|0|||
126524834|NCT03701555|455214544|FG008|Part 2 (Day 1)|Other|0|||
126524835|NCT03701555|455214545|FG009|Part 2 (Day 1)|Other|0|||
126524836|NCT03701555|455214546|FG010|Part 2 (Day 1)|Other|3|||
126524837|NCT03701555|455214547|FG011|Part 2 (Day 1)|Other|1|||
126524838|NCT03701555|455214548|FG012|Part 2 (Day 1)|Other|0|||
126577028|NCT01808339|455410159|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
126577029|NCT02622568|455410168|FG000|Overall Study|Lost to Follow-up|5|||
126577030|NCT02622568|455410169|FG001|Overall Study|Lost to Follow-up|5|||
126577031|NCT00858117|455410170|FG000|Treatment on Study|Adverse Event|2|||
126577032|NCT00858117|455410170|FG000|Follow up for 5 Years|Death|4|||
126577033|NCT00858117|455410170|FG000|Follow up for 5 Years|No further data collected for study|9|||
126577034|NCT00371787|455410171|FG000|Overall Study|Withdrawal by Subject|3|||
126577035|NCT00371787|455410172|FG001|Overall Study|Withdrawal by Subject|1|||
126577036|NCT04425863|455410174|FG000|Overall Study|Death|0|||
126577037|NCT04425863|455410175|FG001|Overall Study|Death|0|||
126577038|NCT04425863|455410176|FG002|Overall Study|Death|1|||
126577039|NCT01854385|455410179|FG000|Pre-Treatment|Withdrawal by Subject|4|||
126577040|NCT01854385|455410179|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
126577041|NCT01854385|455410179|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
126577042|NCT01854385|455410179|FG000|Pre-Treatment|Unable to come for study visits|1|||
126577043|NCT01854385|455410179|FG000|Treatment|Lost to Follow-up|1|||
126577044|NCT00277355|455410182|FG000|Overall Study|Withdrawal by Subject|3|||
126577045|NCT00277355|455410183|FG001|Overall Study|Withdrawal by Subject|3|||
126577046|NCT00277355|455410182|FG000|Overall Study|Lost to Follow-up|2|||
126577047|NCT00277355|455410183|FG001|Overall Study|Lost to Follow-up|2|||
126577048|NCT00277355|455410182|FG000|Overall Study|Adverse Event|5|||
126577049|NCT00277355|455410183|FG001|Overall Study|Adverse Event|0|||
126577050|NCT00277355|455410182|FG000|Overall Study|Death|3|||
126577051|NCT00277355|455410183|FG001|Overall Study|Death|0|||
126577052|NCT00277355|455410182|FG000|Overall Study|Physician Decision|1|||
126577053|NCT00277355|455410183|FG001|Overall Study|Physician Decision|0|||
126577054|NCT02597920|455410186|FG000|Overall Study|Worsening of other pre-existing disease|0|||
126577055|NCT02597920|455410187|FG001|Overall Study|Worsening of other pre-existing disease|1|||
126577056|NCT02597920|455410188|FG002|Overall Study|Worsening of other pre-existing disease|0|||
126577057|NCT02597920|455410186|FG000|Overall Study|Other adverse event|20|||
126577058|NCT02597920|455410187|FG001|Overall Study|Other adverse event|30|||
126577059|NCT02597920|455410188|FG002|Overall Study|Other adverse event|0|||
126577060|NCT02597920|455410186|FG000|Overall Study|Lost to Follow-up|7|||
126577061|NCT02597920|455410187|FG001|Overall Study|Lost to Follow-up|9|||
126577062|NCT02597920|455410188|FG002|Overall Study|Lost to Follow-up|0|||
126577063|NCT02597920|455410186|FG000|Overall Study|Refuse to continue in the study|3|||
126577064|NCT02597920|455410187|FG001|Overall Study|Refuse to continue in the study|13|||
126577065|NCT02597920|455410188|FG002|Overall Study|Refuse to continue in the study|1|||
126577066|NCT02597920|455410186|FG000|Overall Study|Other than specified|10|||
126577067|NCT02597920|455410187|FG001|Overall Study|Other than specified|31|||
126577068|NCT02597920|455410188|FG002|Overall Study|Other than specified|5|||
126577069|NCT02597920|455410186|FG000|Overall Study|Other|1|||
126577070|NCT02597920|455410187|FG001|Overall Study|Other|0|||
126577071|NCT02597920|455410188|FG002|Overall Study|Other|0|||
126577072|NCT00642850|455410189|FG000|Overall Study|Death|7|||
126577073|NCT00642850|455410189|FG000|Overall Study|Adverse Event|2|||
126577074|NCT00642850|455410189|FG000|Overall Study|Lack of Efficacy|1|||
126577075|NCT00642850|455410189|FG000|Overall Study|Protocol Violation|2|||
126577076|NCT00642850|455410189|FG000|Overall Study|Kidney transplantation|8|||
126577077|NCT00642850|455410189|FG000|Overall Study|Blood transfusion|6|||
126577078|NCT00642850|455410189|FG000|Overall Study|Other reasons|7|||
126577079|NCT02549170|455410192|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
126577080|NCT02549170|455410193|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
126577081|NCT02549170|455410194|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
126577082|NCT02549170|455410195|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
126577083|NCT02549170|455410196|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
126577084|NCT02549170|455410192|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
126577085|NCT02549170|455410193|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
126577086|NCT02549170|455410194|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
126577087|NCT02549170|455410195|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
126577088|NCT02549170|455410196|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
126577089|NCT02549170|455410192|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
126577090|NCT02549170|455410193|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
126577091|NCT02549170|455410194|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
126577092|NCT02549170|455410195|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
126577093|NCT02549170|455410196|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
126577094|NCT01266122|455410198|FG000|Overall Study|Lost to Follow-up|6|||
126577095|NCT01266122|455410199|FG001|Overall Study|Lost to Follow-up|6|||
126577096|NCT03756571|455410200|FG000|Overall Study|Lost to Follow-up|1|||
126577097|NCT03756571|455410201|FG001|Overall Study|Lost to Follow-up|1|||
126577098|NCT00421889|455410202|FG000|Overall Study|Adverse Event|1|||
126577099|NCT00421889|455410203|FG001|Overall Study|Adverse Event|0|||
126577100|NCT00421889|455410204|FG002|Overall Study|Adverse Event|1|||
126577101|NCT00421889|455410205|FG003|Overall Study|Adverse Event|1|||
126577102|NCT00421889|455410206|FG004|Overall Study|Adverse Event|1|||
126577103|NCT00421889|455410207|FG005|Overall Study|Adverse Event|4|||
126577104|NCT00421889|455410208|FG006|Overall Study|Adverse Event|1|||
126577105|NCT00421889|455410209|FG007|Overall Study|Adverse Event|0|||
126577106|NCT00421889|455410210|FG008|Overall Study|Adverse Event|2|||
126577107|NCT00421889|455410202|FG000|Overall Study|Withdrawal by Subject|1|||
126577108|NCT00421889|455410203|FG001|Overall Study|Withdrawal by Subject|3|||
126577109|NCT00421889|455410204|FG002|Overall Study|Withdrawal by Subject|0|||
126577110|NCT00421889|455410205|FG003|Overall Study|Withdrawal by Subject|0|||
126577111|NCT00421889|455410206|FG004|Overall Study|Withdrawal by Subject|2|||
126577112|NCT00421889|455410207|FG005|Overall Study|Withdrawal by Subject|0|||
126577113|NCT00421889|455410208|FG006|Overall Study|Withdrawal by Subject|0|||
126577114|NCT00421889|455410209|FG007|Overall Study|Withdrawal by Subject|0|||
126577115|NCT00421889|455410210|FG008|Overall Study|Withdrawal by Subject|0|||
126577116|NCT00421889|455410202|FG000|Overall Study|Death|0|||
126577117|NCT00421889|455410203|FG001|Overall Study|Death|0|||
126577118|NCT00421889|455410204|FG002|Overall Study|Death|0|||
126577119|NCT00421889|455410205|FG003|Overall Study|Death|0|||
126577120|NCT00421889|455410206|FG004|Overall Study|Death|1|||
126577121|NCT00421889|455410207|FG005|Overall Study|Death|1|||
126577122|NCT00421889|455410208|FG006|Overall Study|Death|0|||
126577123|NCT00421889|455410209|FG007|Overall Study|Death|0|||
126577124|NCT00421889|455410210|FG008|Overall Study|Death|0|||
126577125|NCT00421889|455410202|FG000|Overall Study|Progressive disease|3|||
126577126|NCT00421889|455410203|FG001|Overall Study|Progressive disease|2|||
126577127|NCT00421889|455410204|FG002|Overall Study|Progressive disease|2|||
126577128|NCT00421889|455410205|FG003|Overall Study|Progressive disease|3|||
126577129|NCT00421889|455410206|FG004|Overall Study|Progressive disease|2|||
126577130|NCT00421889|455410207|FG005|Overall Study|Progressive disease|21|||
126577131|NCT00421889|455410208|FG006|Overall Study|Progressive disease|3|||
126577132|NCT00421889|455410209|FG007|Overall Study|Progressive disease|1|||
126577133|NCT00421889|455410210|FG008|Overall Study|Progressive disease|5|||
126577134|NCT00421889|455410202|FG000|Overall Study|Patient/Investigator request|0|||
126577135|NCT00421889|455410203|FG001|Overall Study|Patient/Investigator request|0|||
126577136|NCT00421889|455410204|FG002|Overall Study|Patient/Investigator request|0|||
126577137|NCT00421889|455410205|FG003|Overall Study|Patient/Investigator request|0|||
126577138|NCT00421889|455410206|FG004|Overall Study|Patient/Investigator request|0|||
126577139|NCT00421889|455410207|FG005|Overall Study|Patient/Investigator request|9|||
126577140|NCT00421889|455410208|FG006|Overall Study|Patient/Investigator request|0|||
126577141|NCT00421889|455410209|FG007|Overall Study|Patient/Investigator request|1|||
126577142|NCT00421889|455410210|FG008|Overall Study|Patient/Investigator request|3|||
126577143|NCT00421889|455410202|FG000|Overall Study|Lost to Follow-up|0|||
126577144|NCT00421889|455410203|FG001|Overall Study|Lost to Follow-up|0|||
126577145|NCT00421889|455410204|FG002|Overall Study|Lost to Follow-up|0|||
126577146|NCT00421889|455410205|FG003|Overall Study|Lost to Follow-up|0|||
126577147|NCT00421889|455410206|FG004|Overall Study|Lost to Follow-up|0|||
126577148|NCT00421889|455410207|FG005|Overall Study|Lost to Follow-up|0|||
126577149|NCT00421889|455410208|FG006|Overall Study|Lost to Follow-up|0|||
126577150|NCT00421889|455410209|FG007|Overall Study|Lost to Follow-up|0|||
126577151|NCT00421889|455410210|FG008|Overall Study|Lost to Follow-up|1|||
126577152|NCT00978042|455410211|FG000|Initial Treatment Period|Treated in Error|0|||
126577153|NCT00978042|455410212|FG001|Initial Treatment Period|Treated in Error|3|||
126577154|NCT00978042|455410211|FG000|Initial Treatment Period|Ineligibility|1|||
126577155|NCT00978042|455410212|FG001|Initial Treatment Period|Ineligibility|0|||
126577156|NCT00978042|455410211|FG000|Initial Treatment Period|Lost to Follow-up|21|||
126577157|NCT00978042|455410212|FG001|Initial Treatment Period|Lost to Follow-up|3|||
126577158|NCT00978042|455410211|FG000|Initial Treatment Period|Adverse Event|2|||
126577159|NCT00978042|455410212|FG001|Initial Treatment Period|Adverse Event|0|||
126577160|NCT00978042|455410211|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
126577161|NCT00978042|455410212|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
126577162|NCT00978042|455410211|FG000|Initial Treatment Period|Consent withdrawn|22|||
126577163|NCT00978042|455410212|FG001|Initial Treatment Period|Consent withdrawn|9|||
126577164|NCT00978042|455410211|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
126577165|NCT00978042|455410212|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
126577166|NCT00396084|455410217|FG000|Overall Study|Adverse Event|0|||
126577167|NCT00396084|455410218|FG001|Overall Study|Adverse Event|0|||
126577168|NCT00396084|455410219|FG002|Overall Study|Adverse Event|0|||
126577169|NCT00396084|455410220|FG003|Overall Study|Adverse Event|0|||
126577170|NCT00396084|455410221|FG004|Overall Study|Adverse Event|1|||
126728039|NCT00064350|455952925|FG002|Induction Treatment|Death|9|||
126577171|NCT00396084|455410222|FG005|Overall Study|Adverse Event|2|||
126577172|NCT00396084|455410217|FG000|Overall Study|Withdrawal by Subject|0|||
126577173|NCT00396084|455410218|FG001|Overall Study|Withdrawal by Subject|0|||
126577174|NCT00396084|455410219|FG002|Overall Study|Withdrawal by Subject|0|||
126728040|NCT00064350|455952923|FG000|Induction Treatment|Withdrawal by Subject|0|||
126728041|NCT00064350|455952924|FG001|Induction Treatment|Withdrawal by Subject|0|||
126728042|NCT00064350|455952925|FG002|Induction Treatment|Withdrawal by Subject|21|||
126728043|NCT00064350|455952923|FG000|Induction Treatment|Ineligible or never started treatment|3|||
126728044|NCT00064350|455952924|FG001|Induction Treatment|Ineligible or never started treatment|6|||
126577175|NCT00396084|455410220|FG003|Overall Study|Withdrawal by Subject|1|||
126577176|NCT00396084|455410221|FG004|Overall Study|Withdrawal by Subject|0|||
126577177|NCT00396084|455410222|FG005|Overall Study|Withdrawal by Subject|0|||
126577178|NCT02708108|455410223|FG000|Overall Study|Death|1|||
126577179|NCT02708108|455410224|FG001|Overall Study|Death|2|||
126577180|NCT02708108|455410223|FG000|Overall Study|Regimen change|1|||
126577181|NCT02708108|455410224|FG001|Overall Study|Regimen change|0|||
126577182|NCT02708108|455410223|FG000|Overall Study|No MRD and no imaging available|0|||
126577183|NCT02708108|455410224|FG001|Overall Study|No MRD and no imaging available|1|||
126577184|NCT02568683|455410225|FG000|Overall Study|Death|0|||
126577185|NCT02568683|455410226|FG001|Overall Study|Death|2|||
126577186|NCT02568683|455410225|FG000|Overall Study|Withdrew Consent|1|||
126577187|NCT02568683|455410226|FG001|Overall Study|Withdrew Consent|0|||
126577188|NCT02568683|455410225|FG000|Overall Study|Study Terminated By Sponsor|5|||
126577189|NCT02568683|455410226|FG001|Overall Study|Study Terminated By Sponsor|2|||
126577190|NCT01736215|455410227|FG000|Overall Study|Early termination of erythropoietin use|1|||
126577191|NCT01736215|455410227|FG000|Overall Study|Adverse Event|4|||
126577192|NCT01736215|455410227|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
126577193|NCT01736215|455410227|FG000|Overall Study|Insufficient data to perform analysis|8|||
126577194|NCT01248936|455410233|FG000|Overall Study|Sponsor Decision|259|||
126577195|NCT01248936|455410233|FG000|Overall Study|Progression of Disease|50|||
126577196|NCT01248936|455410233|FG000|Overall Study|Death|26|||
126577197|NCT01248936|455410233|FG000|Overall Study|Withdrawal of Consent|20|||
126577198|NCT01248936|455410233|FG000|Overall Study|Adverse Event|8|||
126577199|NCT01248936|455410233|FG000|Overall Study|Lost to Follow-up|7|||
126577200|NCT01248936|455410233|FG000|Overall Study|Refused Treatment|1|||
126577201|NCT01248936|455410233|FG000|Overall Study|Other reason|3|||
126577202|NCT03930420|455410234|FG000|Overall Study|Withdrawal by Subject|7|||
126577203|NCT03930420|455410235|FG001|Overall Study|Withdrawal by Subject|9|||
126577204|NCT04556981|455410236|FG000|Overall Study|Death|0|||
126577205|NCT04556981|455410237|FG001|Overall Study|Death|1|||
126577206|NCT04556981|455410236|FG000|Overall Study|Lost to Follow-up|2|||
126577207|NCT04556981|455410237|FG001|Overall Study|Lost to Follow-up|11|||
126577208|NCT04556981|455410236|FG000|Overall Study|Moved from the study area|1|||
126577209|NCT04556981|455410237|FG001|Overall Study|Moved from the study area|4|||
126577210|NCT04556981|455410236|FG000|Overall Study|Withdrawal by Subject|2|||
126577211|NCT04556981|455410237|FG001|Overall Study|Withdrawal by Subject|2|||
126577212|NCT04556981|455410236|FG000|Overall Study|Other|2|||
126577213|NCT04556981|455410237|FG001|Overall Study|Other|1|||
126577214|NCT00440011|455410249|FG000|Overall Study|Adverse Event|2|||
126577215|NCT00440011|455410250|FG001|Overall Study|Adverse Event|0|||
126577216|NCT00440011|455410249|FG000|Overall Study|Lost to Follow-up|0|||
126577217|NCT00440011|455410250|FG001|Overall Study|Lost to Follow-up|2|||
126577218|NCT00440011|455410249|FG000|Overall Study|Protocol Violation|1|||
126577219|NCT00440011|455410250|FG001|Overall Study|Protocol Violation|1|||
126577220|NCT00440011|455410249|FG000|Overall Study|Withdrawal by Subject|1|||
126577221|NCT00440011|455410250|FG001|Overall Study|Withdrawal by Subject|0|||
126577222|NCT00419341|455410251|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
126577223|NCT00419341|455410251|FG000|Wash in/Wash Out Period|Adverse Event|2|||
126577224|NCT00419341|455410251|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
126577225|NCT00419341|455410251|FG000|Efficacy Period|Withdrawal by Subject|6|||
126577226|NCT00419341|455410251|FG000|Efficacy Period|Protocol Violation|1|||
126577227|NCT00419341|455410251|FG000|Efficacy Period|Lost to Follow-up|1|||
126577228|NCT00419341|455410251|FG000|Efficacy Period|Non-compliance|1|||
126728045|NCT00064350|455952925|FG002|Induction Treatment|Ineligible or never started treatment|34|||
126728046|NCT00064350|455952923|FG000|Induction Treatment|Other|0|||
126728047|NCT00064350|455952924|FG001|Induction Treatment|Other|0|||
126577229|NCT00419341|455410251|FG000|Efficacy Period|Termination of study site|1|||
126577230|NCT03783026|455412541|FG000|Treatment Phase|Adverse Event|15|||
126728048|NCT00064350|455952925|FG002|Induction Treatment|Other|13|||
126728049|NCT00064350|455952923|FG000|Randomization|Adverse Event|8|||
126728050|NCT00064350|455952924|FG001|Randomization|Adverse Event|3|||
126577231|NCT03783026|455412541|FG000|Treatment Phase|Lack of Efficacy|11|||
126577232|NCT03783026|455412541|FG000|Treatment Phase|Withdrawal by Subject|6|||
126577233|NCT03783026|455412541|FG000|Treatment Phase|Lost to Follow-up|2|||
126577234|NCT03783026|455412541|FG000|Treatment Phase|Protocol Deviation|8|||
126577235|NCT03783026|455412541|FG000|Treatment Phase|Did Not Receive Treatment|1|||
126577236|NCT03783026|455412541|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
126577237|NCT04814186|455412545|FG000|Treatment Phase|Adverse Event|1|||
126577238|NCT04814186|455412545|FG000|Treatment Phase|Death|6|||
126577239|NCT04814186|455412545|FG000|Treatment Phase|Withdrawal by Subject|2|||
126577240|NCT04814186|455412545|FG000|Treatment Phase|Other|1|||
126577241|NCT04814186|455412545|FG000|Follow-Up Phase|Adverse Event|1|||
126577242|NCT04814186|455412545|FG000|Follow-Up Phase|Death|6|||
126577243|NCT04814186|455412545|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
126577244|NCT04814186|455412545|FG000|Follow-Up Phase|Other|1|||
126577245|NCT03960463|455412576|FG000|Overall Study|Withdrawal by Subject|2|||
126577246|NCT03960463|455412577|FG001|Overall Study|Withdrawal by Subject|0|||
126577247|NCT04043455|455412578|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
126577248|NCT04043455|455412579|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
126577249|NCT04043455|455412580|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
126577250|NCT04043455|455412581|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
126577251|NCT04043455|455412582|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
126577252|NCT04043455|455412583|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
126577253|NCT04043455|455412578|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
126577254|NCT04043455|455412579|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
126577255|NCT04043455|455412580|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
126577256|NCT04043455|455412581|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
126577257|NCT04043455|455412582|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
126577258|NCT04043455|455412583|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
126577259|NCT04043455|455412578|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
126577260|NCT04043455|455412579|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
126577261|NCT04043455|455412580|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
126577262|NCT04043455|455412581|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
126577263|NCT04043455|455412582|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
126577264|NCT04043455|455412583|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
126577265|NCT04043455|455412578|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
126577266|NCT04043455|455412579|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
126577267|NCT04043455|455412580|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
126577268|NCT04043455|455412581|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
126577269|NCT04043455|455412582|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
126577270|NCT04043455|455412583|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
126577271|NCT04043455|455412578|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
126577272|NCT04043455|455412579|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
126577273|NCT04043455|455412580|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
126577274|NCT04043455|455412581|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
126577275|NCT04043455|455412582|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
126577276|NCT04043455|455412583|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
126577277|NCT04043455|455412578|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
126577278|NCT04043455|455412579|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
126577279|NCT04043455|455412580|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
126577280|NCT04043455|455412581|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
126577281|NCT04043455|455412582|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
126577282|NCT04043455|455412583|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
126577283|NCT04043455|455412578|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
126577284|NCT04043455|455412579|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
126577285|NCT04043455|455412580|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
126577286|NCT04043455|455412581|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
126577287|NCT04043455|455412582|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
126577288|NCT04043455|455412583|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
126577289|NCT04043455|455412578|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
126577290|NCT04043455|455412579|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
126577291|NCT04043455|455412580|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
126577292|NCT04043455|455412581|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
126577293|NCT04043455|455412582|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
126577294|NCT04043455|455412583|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
126577295|NCT04043455|455412578|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
126577296|NCT04043455|455412579|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
126577297|NCT04043455|455412580|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
126577298|NCT04043455|455412581|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
126577299|NCT04043455|455412582|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
126577300|NCT04043455|455412583|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
126577301|NCT04043455|455412578|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
126577302|NCT04043455|455412579|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
126728051|NCT00064350|455952925|FG002|Randomization|Adverse Event|0|||
126728052|NCT00064350|455952923|FG000|Randomization|Death|3|||
126728053|NCT00064350|455952924|FG001|Randomization|Death|0|||
126524839|NCT03701555|455214549|FG013|Part 2 (Day 1)|Other|1|||
126524840|NCT03701555|455214550|FG014|Part 2 (Day 1)|Other|0|||
126524841|NCT03701555|455214551|FG015|Part 2 (Day 1)|Other|2|||
126524842|NCT03701555|455214552|FG016|Part 2 (Day 1)|Other|2|||
126524843|NCT03701555|455214553|FG017|Part 2 (Day 1)|Other|0|||
126524844|NCT03701555|455214554|FG018|Part 2 (Day 1)|Other|0|||
126524845|NCT03701555|455214555|FG019|Part 2 (Day 1)|Other|0|||
126524846|NCT03701555|455214556|FG020|Part 2 (Day 1)|Other|0|||
126524847|NCT03701555|455214557|FG021|Part 2 (Day 1)|Other|0|||
126524848|NCT03701555|455214558|FG022|Part 2 (Day 1)|Other|0|||
126524849|NCT03701555|455214559|FG023|Part 2 (Day 1)|Other|0|||
126524850|NCT03701555|455214560|FG024|Part 2 (Day 1)|Other|0|||
126524851|NCT03701555|455214561|FG025|Part 2 (Day 1)|Other|0|||
126524852|NCT03701555|455214562|FG026|Part 2 (Day 1)|Other|0|||
126524853|NCT03701555|455214563|FG027|Part 2 (Day 1)|Other|0|||
126524854|NCT03701555|455214564|FG028|Part 2 (Day 1)|Other|0|||
126524855|NCT03701555|455214565|FG029|Part 2 (Day 1)|Other|0|||
126524856|NCT03701555|455214566|FG030|Part 2 (Day 1)|Other|0|||
126524857|NCT03701555|455214567|FG031|Part 2 (Day 1)|Other|0|||
126524858|NCT03701555|455214568|FG032|Part 2 (Day 1)|Other|0|||
126524859|NCT03701555|455214569|FG033|Part 2 (Day 1)|Other|0|||
126524860|NCT03701555|455214570|FG034|Part 2 (Day 1)|Other|0|||
126524861|NCT03701555|455214571|FG035|Part 2 (Day 1)|Other|0|||
126524862|NCT03701555|455214536|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
126524863|NCT03701555|455214537|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
126524864|NCT03701555|455214538|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
126524865|NCT03701555|455214539|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
126524866|NCT03701555|455214540|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
126524867|NCT03701555|455214541|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
126524868|NCT03701555|455214542|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
126524869|NCT03701555|455214543|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
126524870|NCT03701555|455214544|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
126524871|NCT03701555|455214545|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
126524872|NCT03701555|455214546|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
126524873|NCT03701555|455214547|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
126524874|NCT03701555|455214548|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
126524875|NCT03701555|455214549|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
126524876|NCT03701555|455214550|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
126524877|NCT03701555|455214551|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
126524878|NCT03701555|455214552|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
126524879|NCT03701555|455214553|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
126524880|NCT03701555|455214554|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
126524881|NCT03701555|455214555|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
126524882|NCT03701555|455214556|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
126524883|NCT03701555|455214557|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
126524884|NCT03701555|455214558|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
126524885|NCT03701555|455214559|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
126524886|NCT03701555|455214560|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
126524887|NCT03701555|455214561|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
126524888|NCT03701555|455214562|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
126524889|NCT03701555|455214563|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
126524890|NCT03701555|455214564|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
126524891|NCT03701555|455214565|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
126524892|NCT03701555|455214566|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
126524893|NCT03701555|455214567|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
126524894|NCT03701555|455214568|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
126524895|NCT03701555|455214569|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
126524896|NCT03701555|455214570|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
126524897|NCT03701555|455214571|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
126524898|NCT03701555|455214536|FG000|Part 3 (Day 1)|Subject Decision|0|||
126524899|NCT03701555|455214537|FG001|Part 3 (Day 1)|Subject Decision|0|||
126524900|NCT03701555|455214538|FG002|Part 3 (Day 1)|Subject Decision|0|||
126524901|NCT03701555|455214539|FG003|Part 3 (Day 1)|Subject Decision|0|||
126577303|NCT04043455|455412580|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
126728054|NCT00064350|455952925|FG002|Randomization|Death|0|||
126524902|NCT03701555|455214540|FG004|Part 3 (Day 1)|Subject Decision|0|||
126524903|NCT03701555|455214541|FG005|Part 3 (Day 1)|Subject Decision|0|||
126524904|NCT03701555|455214542|FG006|Part 3 (Day 1)|Subject Decision|0|||
126524905|NCT03701555|455214543|FG007|Part 3 (Day 1)|Subject Decision|0|||
126524906|NCT03701555|455214544|FG008|Part 3 (Day 1)|Subject Decision|0|||
126524907|NCT03701555|455214545|FG009|Part 3 (Day 1)|Subject Decision|0|||
126524908|NCT03701555|455214546|FG010|Part 3 (Day 1)|Subject Decision|0|||
126524909|NCT03701555|455214547|FG011|Part 3 (Day 1)|Subject Decision|0|||
126524910|NCT03701555|455214548|FG012|Part 3 (Day 1)|Subject Decision|0|||
126524911|NCT03701555|455214549|FG013|Part 3 (Day 1)|Subject Decision|0|||
126524912|NCT03701555|455214550|FG014|Part 3 (Day 1)|Subject Decision|0|||
126524913|NCT03701555|455214551|FG015|Part 3 (Day 1)|Subject Decision|0|||
126524914|NCT03701555|455214552|FG016|Part 3 (Day 1)|Subject Decision|0|||
126524915|NCT03701555|455214553|FG017|Part 3 (Day 1)|Subject Decision|0|||
126524916|NCT03701555|455214554|FG018|Part 3 (Day 1)|Subject Decision|0|||
126577304|NCT04043455|455412581|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
126577305|NCT04043455|455412582|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
126577306|NCT04043455|455412583|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
126577307|NCT04043455|455412578|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
126577308|NCT04043455|455412579|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
126577309|NCT04043455|455412580|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
126577310|NCT04043455|455412581|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
126577311|NCT04043455|455412582|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
126577312|NCT04043455|455412583|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
126577313|NCT03529110|455412584|FG000|Overall Study|Progressive Disease|66|||
126577314|NCT03529110|455412585|FG001|Overall Study|Progressive Disease|158|||
126577315|NCT03529110|455412584|FG000|Overall Study|Clinical Progression|4|||
126577316|NCT03529110|455412585|FG001|Overall Study|Clinical Progression|12|||
126577317|NCT03529110|455412584|FG000|Overall Study|Adverse Event|35|||
126577318|NCT03529110|455412585|FG001|Overall Study|Adverse Event|17|||
126577319|NCT03529110|455412584|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
126577320|NCT03529110|455412585|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
126577321|NCT03529110|455412584|FG000|Overall Study|Lack of Efficacy|3|||
126577322|NCT03529110|455412585|FG001|Overall Study|Lack of Efficacy|3|||
126577323|NCT03529110|455412584|FG000|Overall Study|Physician Decision|2|||
126577324|NCT03529110|455412585|FG001|Overall Study|Physician Decision|8|||
126577325|NCT03529110|455412584|FG000|Overall Study|Miscellaneous|2|||
126577326|NCT03529110|455412585|FG001|Overall Study|Miscellaneous|5|||
126577327|NCT05194917|455412586|FG000|Overall Study|Lost to Follow-up|7|||
126577328|NCT05194917|455412587|FG001|Overall Study|Lost to Follow-up|5|||
126577329|NCT05194917|455412588|FG002|Overall Study|Lost to Follow-up|6|||
126577330|NCT05194917|455412589|FG003|Overall Study|Lost to Follow-up|5|||
126577331|NCT04922021|455412594|FG000|Overall Study|Withdrawal by Subject|4|||
126577332|NCT04922021|455412595|FG001|Overall Study|Withdrawal by Subject|10|||
126577333|NCT04922021|455412594|FG000|Overall Study|Adverse Event|2|||
126577334|NCT04922021|455412595|FG001|Overall Study|Adverse Event|2|||
126577335|NCT04922021|455412594|FG000|Overall Study|Lack of Efficacy|0|||
126577336|NCT04922021|455412595|FG001|Overall Study|Lack of Efficacy|1|||
126577337|NCT04922021|455412594|FG000|Overall Study|Multiple reasons|1|||
126577338|NCT04922021|455412595|FG001|Overall Study|Multiple reasons|0|||
126577339|NCT02544074|455412607|FG000|Overall Study|Withdrawal by Subject|0|||
126577340|NCT02544074|455412608|FG001|Overall Study|Withdrawal by Subject|1|||
126577341|NCT02544074|455412609|FG002|Overall Study|Withdrawal by Subject|0|||
126577342|NCT02544074|455412610|FG003|Overall Study|Withdrawal by Subject|0|||
126577343|NCT02544074|455412611|FG004|Overall Study|Withdrawal by Subject|0|||
126577344|NCT02544074|455412612|FG005|Overall Study|Withdrawal by Subject|0|||
126577345|NCT02544074|455412613|FG006|Overall Study|Withdrawal by Subject|0|||
126577346|NCT02544074|455412614|FG007|Overall Study|Withdrawal by Subject|0|||
126577347|NCT02544074|455412615|FG008|Overall Study|Withdrawal by Subject|0|||
126577348|NCT02544074|455412616|FG009|Overall Study|Withdrawal by Subject|0|||
126577349|NCT02544074|455412617|FG010|Overall Study|Withdrawal by Subject|0|||
126577350|NCT02544074|455412618|FG011|Overall Study|Withdrawal by Subject|0|||
126577351|NCT02544074|455412619|FG012|Overall Study|Withdrawal by Subject|0|||
126577352|NCT02544074|455412620|FG013|Overall Study|Withdrawal by Subject|0|||
126577353|NCT02544074|455412621|FG014|Overall Study|Withdrawal by Subject|0|||
126577354|NCT02544074|455412622|FG015|Overall Study|Withdrawal by Subject|0|||
126577355|NCT02544074|455412623|FG016|Overall Study|Withdrawal by Subject|0|||
126577356|NCT02544074|455412624|FG017|Overall Study|Withdrawal by Subject|0|||
126577357|NCT02544074|455412625|FG018|Overall Study|Withdrawal by Subject|0|||
126577358|NCT02544074|455412626|FG019|Overall Study|Withdrawal by Subject|0|||
126577359|NCT02544074|455412627|FG020|Overall Study|Withdrawal by Subject|0|||
126577360|NCT02544074|455412607|FG000|Overall Study|Tablet error|0|||
126577361|NCT02544074|455412608|FG001|Overall Study|Tablet error|0|||
126577362|NCT02544074|455412609|FG002|Overall Study|Tablet error|0|||
126577363|NCT02544074|455412610|FG003|Overall Study|Tablet error|0|||
126577364|NCT02544074|455412611|FG004|Overall Study|Tablet error|0|||
126577365|NCT02544074|455412612|FG005|Overall Study|Tablet error|1|||
126577366|NCT02544074|455412613|FG006|Overall Study|Tablet error|0|||
126577367|NCT02544074|455412614|FG007|Overall Study|Tablet error|0|||
126577368|NCT02544074|455412615|FG008|Overall Study|Tablet error|0|||
126577369|NCT02544074|455412616|FG009|Overall Study|Tablet error|1|||
126577370|NCT02544074|455412617|FG010|Overall Study|Tablet error|0|||
126577371|NCT02544074|455412618|FG011|Overall Study|Tablet error|0|||
126577372|NCT02544074|455412619|FG012|Overall Study|Tablet error|0|||
126577373|NCT02544074|455412620|FG013|Overall Study|Tablet error|0|||
126577374|NCT02544074|455412621|FG014|Overall Study|Tablet error|0|||
126577375|NCT02544074|455412622|FG015|Overall Study|Tablet error|0|||
126577376|NCT02544074|455412623|FG016|Overall Study|Tablet error|0|||
126577377|NCT02544074|455412624|FG017|Overall Study|Tablet error|0|||
126577378|NCT02544074|455412625|FG018|Overall Study|Tablet error|0|||
126577379|NCT02544074|455412626|FG019|Overall Study|Tablet error|0|||
126728055|NCT00064350|455952923|FG000|Randomization|Withdrawal by Subject|1|||
126728056|NCT00064350|455952924|FG001|Randomization|Withdrawal by Subject|0|||
126728057|NCT00064350|455952925|FG002|Randomization|Withdrawal by Subject|0|||
126728058|NCT00064350|455952923|FG000|Randomization|Ineligible or never started treatment|9|||
126728059|NCT00064350|455952924|FG001|Randomization|Ineligible or never started treatment|15|||
126728060|NCT00064350|455952925|FG002|Randomization|Ineligible or never started treatment|0|||
126728061|NCT00064350|455952923|FG000|Randomization|Other|5|||
126728062|NCT00064350|455952924|FG001|Randomization|Other|0|||
126524917|NCT03701555|455214555|FG019|Part 3 (Day 1)|Subject Decision|0|||
126524918|NCT03701555|455214556|FG020|Part 3 (Day 1)|Subject Decision|0|||
126524919|NCT03701555|455214557|FG021|Part 3 (Day 1)|Subject Decision|0|||
126524920|NCT03701555|455214558|FG022|Part 3 (Day 1)|Subject Decision|0|||
126524921|NCT03701555|455214559|FG023|Part 3 (Day 1)|Subject Decision|0|||
126524922|NCT03701555|455214560|FG024|Part 3 (Day 1)|Subject Decision|0|||
126524923|NCT03701555|455214561|FG025|Part 3 (Day 1)|Subject Decision|0|||
126524924|NCT03701555|455214562|FG026|Part 3 (Day 1)|Subject Decision|1|||
126524925|NCT03701555|455214563|FG027|Part 3 (Day 1)|Subject Decision|0|||
126524926|NCT03701555|455214564|FG028|Part 3 (Day 1)|Subject Decision|0|||
126524927|NCT03701555|455214565|FG029|Part 3 (Day 1)|Subject Decision|0|||
126524928|NCT03701555|455214566|FG030|Part 3 (Day 1)|Subject Decision|0|||
126524929|NCT03701555|455214567|FG031|Part 3 (Day 1)|Subject Decision|2|||
126524930|NCT03701555|455214568|FG032|Part 3 (Day 1)|Subject Decision|1|||
126524931|NCT03701555|455214569|FG033|Part 3 (Day 1)|Subject Decision|1|||
126524932|NCT03701555|455214570|FG034|Part 3 (Day 1)|Subject Decision|0|||
126524933|NCT03701555|455214571|FG035|Part 3 (Day 1)|Subject Decision|0|||
126524934|NCT03701555|455214536|FG000|Part 3 (Day 1)|Other|0|||
126524935|NCT03701555|455214537|FG001|Part 3 (Day 1)|Other|0|||
126524936|NCT03701555|455214538|FG002|Part 3 (Day 1)|Other|0|||
126524937|NCT03701555|455214539|FG003|Part 3 (Day 1)|Other|0|||
126524938|NCT03701555|455214540|FG004|Part 3 (Day 1)|Other|0|||
126524939|NCT03701555|455214541|FG005|Part 3 (Day 1)|Other|0|||
126524940|NCT03701555|455214542|FG006|Part 3 (Day 1)|Other|0|||
126524941|NCT03701555|455214543|FG007|Part 3 (Day 1)|Other|0|||
126524942|NCT03701555|455214544|FG008|Part 3 (Day 1)|Other|0|||
126524943|NCT03701555|455214545|FG009|Part 3 (Day 1)|Other|0|||
126524944|NCT03701555|455214546|FG010|Part 3 (Day 1)|Other|0|||
126524945|NCT03701555|455214547|FG011|Part 3 (Day 1)|Other|0|||
126524946|NCT03701555|455214548|FG012|Part 3 (Day 1)|Other|0|||
126524947|NCT03701555|455214549|FG013|Part 3 (Day 1)|Other|0|||
126524948|NCT03701555|455214550|FG014|Part 3 (Day 1)|Other|0|||
126524949|NCT03701555|455214551|FG015|Part 3 (Day 1)|Other|0|||
126524950|NCT03701555|455214552|FG016|Part 3 (Day 1)|Other|0|||
126777044|NCT02124746|456139165|FG001|Overall Study|Lack of Efficacy|2|||
126524951|NCT03701555|455214553|FG017|Part 3 (Day 1)|Other|0|||
126524952|NCT03701555|455214554|FG018|Part 3 (Day 1)|Other|0|||
126524953|NCT03701555|455214555|FG019|Part 3 (Day 1)|Other|0|||
126524954|NCT03701555|455214556|FG020|Part 3 (Day 1)|Other|0|||
126524955|NCT03701555|455214557|FG021|Part 3 (Day 1)|Other|0|||
126524956|NCT03701555|455214558|FG022|Part 3 (Day 1)|Other|0|||
126524957|NCT03701555|455214559|FG023|Part 3 (Day 1)|Other|0|||
126524958|NCT03701555|455214560|FG024|Part 3 (Day 1)|Other|1|||
126524959|NCT03701555|455214561|FG025|Part 3 (Day 1)|Other|1|||
126524960|NCT03701555|455214562|FG026|Part 3 (Day 1)|Other|0|||
126524961|NCT03701555|455214563|FG027|Part 3 (Day 1)|Other|0|||
126524962|NCT03701555|455214564|FG028|Part 3 (Day 1)|Other|0|||
126524963|NCT03701555|455214565|FG029|Part 3 (Day 1)|Other|1|||
126524964|NCT03701555|455214566|FG030|Part 3 (Day 1)|Other|1|||
126524965|NCT03701555|455214567|FG031|Part 3 (Day 1)|Other|0|||
126524966|NCT03701555|455214568|FG032|Part 3 (Day 1)|Other|1|||
126728063|NCT00064350|455952925|FG002|Randomization|Other|0|||
126524967|NCT03701555|455214569|FG033|Part 3 (Day 1)|Other|1|||
126524968|NCT03701555|455214570|FG034|Part 3 (Day 1)|Other|0|||
126524969|NCT03701555|455214571|FG035|Part 3 (Day 1)|Other|0|||
126524970|NCT04757649|455214574|FG000|Overall Study|Withdrawal by Subject|1|||
126524971|NCT04757649|455214574|FG000|Overall Study|Adverse Event|1|||
126728064|NCT00064350|455952923|FG000|Cross-Over|Adverse Event|0|||
126728065|NCT00064350|455952924|FG001|Cross-Over|Adverse Event|1|||
126728066|NCT00064350|455952925|FG002|Cross-Over|Adverse Event|0|||
126728067|NCT00064350|455952923|FG000|Cross-Over|Death|1|||
126728068|NCT00064350|455952924|FG001|Cross-Over|Death|3|||
126728069|NCT00064350|455952925|FG002|Cross-Over|Death|0|||
126524972|NCT01286779|455214575|FG000|Overall Study|Withdrawal by Subject|9|||
126577380|NCT02544074|455412627|FG020|Overall Study|Tablet error|0|||
126524973|NCT01286779|455214575|FG000|Overall Study|Protocol Violation|5|||
126524974|NCT01286779|455214575|FG000|Overall Study|Physician Decision|2|||
126524975|NCT01286779|455214575|FG000|Overall Study|Participant had scheduled surgery|1|||
126524976|NCT01286779|455214575|FG000|Overall Study|Participant moved to another country|1|||
126524977|NCT01286779|455214575|FG000|Overall Study|Discontinued by sponsor|1|||
126524978|NCT02896855|455214578|FG000|Overall Study|Death|50|||
126524979|NCT02896855|455214579|FG001|Overall Study|Death|40|||
126524980|NCT02896855|455214578|FG000|Overall Study|Lost to Follow-up|15|||
126524981|NCT02896855|455214579|FG001|Overall Study|Lost to Follow-up|9|||
126524982|NCT02896855|455214578|FG000|Overall Study|Withdrawal by Subject|7|||
126777045|NCT02124746|456139166|FG002|Overall Study|Lack of Efficacy|2|||
126728070|NCT00064350|455952923|FG000|Cross-Over|Withdrawal by Subject|2|||
126524983|NCT02896855|455214579|FG001|Overall Study|Withdrawal by Subject|4|||
126524984|NCT02508311|455214580|FG000|Overall Study|Withdrawal by Subject|1|||
126524985|NCT02508311|455214581|FG001|Overall Study|Withdrawal by Subject|0|||
126524986|NCT02169674|455214582|FG000|Overall Study|Withdrawal by Subject|2|||
126524987|NCT02169674|455214583|FG001|Overall Study|Withdrawal by Subject|1|||
126524988|NCT02169674|455214582|FG000|Overall Study|Seroprotected|30|||
126524989|NCT02169674|455214583|FG001|Overall Study|Seroprotected|76|||
126524990|NCT02169674|455214582|FG000|Overall Study|Lost to Follow-up|0|||
126524991|NCT02169674|455214583|FG001|Overall Study|Lost to Follow-up|1|||
126524992|NCT02370602|455214584|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
126524993|NCT02370602|455214585|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
126524994|NCT02370602|455214586|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
126524995|NCT02370602|455214587|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
126524996|NCT02370602|455214588|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
126524997|NCT02370602|455214589|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
126524998|NCT03349710|455214590|FG000|Treatment Period|Death|0|||
126524999|NCT03349710|455214591|FG001|Treatment Period|Death|0|||
126525000|NCT03349710|455214592|FG002|Treatment Period|Death|1|||
126525001|NCT03349710|455214593|FG003|Treatment Period|Death|0|||
126525002|NCT03349710|455214590|FG000|Treatment Period|Disease Progression|0|||
126525003|NCT03349710|455214591|FG001|Treatment Period|Disease Progression|2|||
126525004|NCT03349710|455214592|FG002|Treatment Period|Disease Progression|0|||
126525005|NCT03349710|455214593|FG003|Treatment Period|Disease Progression|1|||
126525006|NCT03349710|455214590|FG000|Treatment Period|Study Drug Toxicity|1|||
126525007|NCT03349710|455214591|FG001|Treatment Period|Study Drug Toxicity|0|||
126525008|NCT03349710|455214592|FG002|Treatment Period|Study Drug Toxicity|1|||
126525009|NCT03349710|455214593|FG003|Treatment Period|Study Drug Toxicity|1|||
126525010|NCT03349710|455214590|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
126525011|NCT03349710|455214591|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
126525012|NCT03349710|455214592|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
126525013|NCT03349710|455214593|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
126525014|NCT03349710|455214590|FG000|Treatment Period|admin reason by sponsor|0|||
126525015|NCT03349710|455214591|FG001|Treatment Period|admin reason by sponsor|7|||
126525016|NCT03349710|455214592|FG002|Treatment Period|admin reason by sponsor|0|||
126525017|NCT03349710|455214593|FG003|Treatment Period|admin reason by sponsor|19|||
126525018|NCT03349710|455214590|FG000|Treatment Period|Other Reason|2|||
126525019|NCT03349710|455214591|FG001|Treatment Period|Other Reason|0|||
126525020|NCT03349710|455214592|FG002|Treatment Period|Other Reason|2|||
126525021|NCT03349710|455214593|FG003|Treatment Period|Other Reason|1|||
126525022|NCT03349710|455214590|FG000|Treatment Period|completed|6|||
126525023|NCT03349710|455214591|FG001|Treatment Period|completed|0|||
126525024|NCT03349710|455214592|FG002|Treatment Period|completed|18|||
126525025|NCT03349710|455214593|FG003|Treatment Period|completed|1|||
126525026|NCT03349710|455214590|FG000|Treatment Period|participant request to discontinue|0|||
126525027|NCT03349710|455214591|FG001|Treatment Period|participant request to discontinue|0|||
126525028|NCT03349710|455214592|FG002|Treatment Period|participant request to discontinue|4|||
126525029|NCT03349710|455214593|FG003|Treatment Period|participant request to discontinue|0|||
126525030|NCT03349710|455214590|FG000|Treatment Period|participant withdrew consent|1|||
126525031|NCT03349710|455214591|FG001|Treatment Period|participant withdrew consent|0|||
126525032|NCT03349710|455214592|FG002|Treatment Period|participant withdrew consent|0|||
126525033|NCT03349710|455214593|FG003|Treatment Period|participant withdrew consent|0|||
126525034|NCT01296568|455214594|FG000|Continued Access Phase|Lost to Follow-up|1|||
126525035|NCT01296568|455214594|FG000|Continued Access Phase|Withdrawal by Subject|1|||
126525036|NCT01296568|455214594|FG000|Continued Access Phase|Disease Progression|1|||
126525037|NCT00237744|455214595|FG000|Overall Study|Withdrawal by Subject|3|||
126525038|NCT00237744|455214596|FG001|Overall Study|Withdrawal by Subject|1|||
126525039|NCT00237744|455214597|FG002|Overall Study|Withdrawal by Subject|0|||
126525040|NCT00574080|455214602|FG000|Overall Study|Death|10|||
126525041|NCT00574080|455214603|FG001|Overall Study|Death|10|||
126525042|NCT04258020|455214604|FG000|Overall Study|Withdrawal by Subject|1|||
126525043|NCT04258020|455214605|FG001|Overall Study|Withdrawal by Subject|0|||
126525044|NCT01380327|455214606|FG000|Overall Study|Lost to Follow-up|0|||
126525045|NCT01380327|455214607|FG001|Overall Study|Lost to Follow-up|1|||
126525046|NCT01380327|455214608|FG002|Overall Study|Lost to Follow-up|1|||
126525047|NCT01380327|455214606|FG000|Overall Study|Protocol Violation|3|||
126525048|NCT01380327|455214607|FG001|Overall Study|Protocol Violation|2|||
126525049|NCT01380327|455214608|FG002|Overall Study|Protocol Violation|3|||
126525050|NCT01380327|455214606|FG000|Overall Study|Withdrawal by Subject|0|||
126728071|NCT00064350|455952924|FG001|Cross-Over|Withdrawal by Subject|2|||
126525051|NCT01380327|455214607|FG001|Overall Study|Withdrawal by Subject|0|||
126525052|NCT01380327|455214608|FG002|Overall Study|Withdrawal by Subject|1|||
126525053|NCT01380327|455214606|FG000|Overall Study|Housing situation precluded ability to k|0|||
126525054|NCT01380327|455214607|FG001|Overall Study|Housing situation precluded ability to k|0|||
126525055|NCT01380327|455214608|FG002|Overall Study|Housing situation precluded ability to k|1|||
126577381|NCT03189524|455412628|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
126577382|NCT03189524|455412629|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
126577383|NCT03189524|455412630|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
126577384|NCT03189524|455412628|FG000|Overall Study|Death|2|||
126577385|NCT03189524|455412629|FG001|Overall Study|Death|2|||
126577386|NCT03189524|455412630|FG002|Overall Study|Death|1|||
126577387|NCT03189524|455412628|FG000|Overall Study|Lost to Follow-up|1|||
126577388|NCT03189524|455412629|FG001|Overall Study|Lost to Follow-up|0|||
126577389|NCT03189524|455412630|FG002|Overall Study|Lost to Follow-up|8|||
126577390|NCT03189524|455412628|FG000|Overall Study|Withdrawal by Subject|1|||
126577391|NCT03189524|455412629|FG001|Overall Study|Withdrawal by Subject|1|||
126577392|NCT03189524|455412630|FG002|Overall Study|Withdrawal by Subject|3|||
126577393|NCT03189524|455412628|FG000|Overall Study|Progressive Disease|0|||
126577394|NCT03189524|455412629|FG001|Overall Study|Progressive Disease|2|||
126577395|NCT03189524|455412630|FG002|Overall Study|Progressive Disease|0|||
126577396|NCT04139668|455412631|FG000|Overall Study|Withdrawal by Subject|1|||
126577397|NCT03025789|455412632|FG000|Overall Study|Lack of Efficacy|6|||
126577398|NCT03025789|455412633|FG001|Overall Study|Lack of Efficacy|1|||
126577399|NCT03025789|455412632|FG000|Overall Study|Death|1|||
126577400|NCT03025789|455412633|FG001|Overall Study|Death|0|||
126577401|NCT03025789|455412632|FG000|Overall Study|Withdrawal by Subject|0|||
126577402|NCT03025789|455412633|FG001|Overall Study|Withdrawal by Subject|2|||
126577403|NCT02723955|455412634|FG000|Escalation Phase|Death|1|||
126577404|NCT02723955|455412635|FG001|Escalation Phase|Death|1|||
126577405|NCT02723955|455412636|FG002|Escalation Phase|Death|2|||
126577406|NCT02723955|455412637|FG003|Escalation Phase|Death|7|||
126577407|NCT02723955|455412638|FG004|Escalation Phase|Death|18|||
126577408|NCT02723955|455412639|FG005|Escalation Phase|Death|17|||
126577409|NCT02723955|455412640|FG006|Escalation Phase|Death|11|||
126577410|NCT02723955|455412641|FG007|Escalation Phase|Death|21|||
126577411|NCT02723955|455412642|FG008|Escalation Phase|Death|3|||
126577412|NCT02723955|455412643|FG009|Escalation Phase|Death|0|||
126577413|NCT02723955|455412644|FG010|Escalation Phase|Death|0|||
126577414|NCT02723955|455412645|FG011|Escalation Phase|Death|0|||
126577415|NCT02723955|455412646|FG012|Escalation Phase|Death|2|||
126577416|NCT02723955|455412647|FG013|Escalation Phase|Death|4|||
126577417|NCT02723955|455412648|FG014|Escalation Phase|Death|5|||
126577418|NCT02723955|455412649|FG015|Escalation Phase|Death|6|||
126577419|NCT02723955|455412650|FG016|Escalation Phase|Death|6|||
126577420|NCT02723955|455412651|FG017|Escalation Phase|Death|7|||
126577421|NCT02723955|455412652|FG018|Escalation Phase|Death|1|||
126577422|NCT02723955|455412653|FG019|Escalation Phase|Death|3|||
126577423|NCT02723955|455412654|FG020|Escalation Phase|Death|13|||
126577424|NCT02723955|455412655|FG021|Escalation Phase|Death|3|||
126577425|NCT02723955|455412656|FG022|Escalation Phase|Death|2|||
126577426|NCT02723955|455412657|FG023|Escalation Phase|Death|4|||
126577427|NCT02723955|455412658|FG024|Escalation Phase|Death|31|||
126577428|NCT02723955|455412659|FG025|Escalation Phase|Death|7|||
126577429|NCT02723955|455412660|FG026|Escalation Phase|Death|13|||
126577430|NCT02723955|455412661|FG027|Escalation Phase|Death|0|||
126577431|NCT02723955|455412662|FG028|Escalation Phase|Death|1|||
126577432|NCT02723955|455412663|FG029|Escalation Phase|Death|0|||
126577433|NCT02723955|455412664|FG030|Escalation Phase|Death|0|||
126577434|NCT02723955|455412665|FG031|Escalation Phase|Death|0|||
126577435|NCT02723955|455412666|FG032|Escalation Phase|Death|0|||
126577436|NCT02723955|455412667|FG033|Escalation Phase|Death|0|||
126577437|NCT02723955|455412668|FG034|Escalation Phase|Death|0|||
126577438|NCT02723955|455412669|FG035|Escalation Phase|Death|0|||
126577439|NCT02723955|455412670|FG036|Escalation Phase|Death|0|||
126577440|NCT02723955|455412671|FG037|Escalation Phase|Death|0|||
126577441|NCT02723955|455412672|FG038|Escalation Phase|Death|0|||
126577442|NCT02723955|455412673|FG039|Escalation Phase|Death|0|||
126577443|NCT02723955|455412674|FG040|Escalation Phase|Death|0|||
126577444|NCT02723955|455412675|FG041|Escalation Phase|Death|0|||
126577445|NCT02723955|455412676|FG042|Escalation Phase|Death|0|||
126577446|NCT02723955|455412634|FG000|Escalation Phase|Lost to Follow-up|0|||
126577447|NCT02723955|455412635|FG001|Escalation Phase|Lost to Follow-up|0|||
126577448|NCT02723955|455412636|FG002|Escalation Phase|Lost to Follow-up|0|||
126577449|NCT02723955|455412637|FG003|Escalation Phase|Lost to Follow-up|0|||
126577450|NCT02723955|455412638|FG004|Escalation Phase|Lost to Follow-up|0|||
126577451|NCT02723955|455412639|FG005|Escalation Phase|Lost to Follow-up|2|||
126577452|NCT02723955|455412640|FG006|Escalation Phase|Lost to Follow-up|1|||
126577453|NCT02723955|455412641|FG007|Escalation Phase|Lost to Follow-up|1|||
126577454|NCT02723955|455412642|FG008|Escalation Phase|Lost to Follow-up|1|||
126577455|NCT02723955|455412643|FG009|Escalation Phase|Lost to Follow-up|0|||
126577456|NCT02723955|455412644|FG010|Escalation Phase|Lost to Follow-up|0|||
126577457|NCT02723955|455412645|FG011|Escalation Phase|Lost to Follow-up|0|||
126577458|NCT02723955|455412646|FG012|Escalation Phase|Lost to Follow-up|1|||
126577459|NCT02723955|455412647|FG013|Escalation Phase|Lost to Follow-up|0|||
126577460|NCT02723955|455412648|FG014|Escalation Phase|Lost to Follow-up|0|||
126577461|NCT02723955|455412649|FG015|Escalation Phase|Lost to Follow-up|0|||
126525056|NCT01380327|455214606|FG000|Overall Study|Questionable onset of epilepsy|0|||
126525057|NCT01380327|455214607|FG001|Overall Study|Questionable onset of epilepsy|0|||
126525058|NCT01380327|455214608|FG002|Overall Study|Questionable onset of epilepsy|1|||
126525059|NCT04139317|455214609|FG000|Overall Study|Adverse Event|10|||
126525060|NCT04139317|455214610|FG001|Overall Study|Adverse Event|2|||
126525061|NCT04139317|455214609|FG000|Overall Study|Death|6|||
126525062|NCT04139317|455214610|FG001|Overall Study|Death|4|||
126525063|NCT04139317|455214609|FG000|Overall Study|Lost to Follow-up|1|||
126525064|NCT04139317|455214610|FG001|Overall Study|Lost to Follow-up|0|||
126525065|NCT04139317|455214609|FG000|Overall Study|Physician Decision|3|||
126525066|NCT04139317|455214610|FG001|Overall Study|Physician Decision|1|||
126525067|NCT04139317|455214609|FG000|Overall Study|Progressive Disease|19|||
126525068|NCT04139317|455214610|FG001|Overall Study|Progressive Disease|9|||
126525069|NCT04139317|455214609|FG000|Overall Study|Subject Decision|2|||
126525070|NCT04139317|455214610|FG001|Overall Study|Subject Decision|2|||
126525071|NCT00214136|455214613|FG000|Overall Study|Death|5|||
126525072|NCT01272934|455214614|FG000|Overall Study|Adverse Event|0|||
126525073|NCT01272934|455214615|FG001|Overall Study|Adverse Event|1|||
126525074|NCT01272934|455214614|FG000|Overall Study|Abnormal Laboratory Value|0|||
126525075|NCT01272934|455214615|FG001|Overall Study|Abnormal Laboratory Value|1|||
126525076|NCT04287920|455214616|FG000|Overall Study|Lost to Follow-up|1|||
126525077|NCT04287920|455214617|FG001|Overall Study|Lost to Follow-up|1|||
126525078|NCT04287920|455214616|FG000|Overall Study|Withdrawal by Subject|0|||
126525079|NCT04287920|455214617|FG001|Overall Study|Withdrawal by Subject|3|||
126525080|NCT04313634|455214618|FG000|Overall Study|Adverse Event|2|||
126525081|NCT04313634|455214619|FG001|Overall Study|Adverse Event|2|||
126525082|NCT04313634|455214620|FG002|Overall Study|Adverse Event|0|||
126525083|NCT04313634|455214618|FG000|Overall Study|Withdrawal by Subject|1|||
126525084|NCT04313634|455214619|FG001|Overall Study|Withdrawal by Subject|0|||
126525085|NCT04313634|455214620|FG002|Overall Study|Withdrawal by Subject|1|||
126525086|NCT04313634|455214618|FG000|Overall Study|Protocol Violation|0|||
126525087|NCT04313634|455214619|FG001|Overall Study|Protocol Violation|0|||
126525088|NCT04313634|455214620|FG002|Overall Study|Protocol Violation|1|||
126525089|NCT01587651|455214625|FG000|Overall Study|Adverse Event|0|||
126525090|NCT01587651|455214626|FG001|Overall Study|Adverse Event|1|||
126525091|NCT01587651|455214627|FG002|Overall Study|Adverse Event|0|||
126525092|NCT01587651|455214625|FG000|Overall Study|Protocol Violation|0|||
126525093|NCT01587651|455214626|FG001|Overall Study|Protocol Violation|1|||
126525094|NCT01587651|455214627|FG002|Overall Study|Protocol Violation|1|||
126525095|NCT01587651|455214625|FG000|Overall Study|Withdrawal by Subject|0|||
126525096|NCT01587651|455214626|FG001|Overall Study|Withdrawal by Subject|1|||
126525097|NCT01587651|455214627|FG002|Overall Study|Withdrawal by Subject|0|||
126525098|NCT04323436|455214628|FG000|Overall Study|Adverse Event|7|||
126525099|NCT04323436|455214629|FG001|Overall Study|Adverse Event|0|||
126525100|NCT04323436|455214630|FG002|Overall Study|Adverse Event|0|||
126525101|NCT04323436|455214628|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
126525102|NCT04323436|455214629|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
126525103|NCT04323436|455214630|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
126525104|NCT04323436|455214628|FG000|Overall Study|Death|1|||
126525105|NCT04323436|455214629|FG001|Overall Study|Death|0|||
126525106|NCT04323436|455214630|FG002|Overall Study|Death|0|||
126525107|NCT04323436|455214628|FG000|Overall Study|Physician Decision|2|||
126525108|NCT04323436|455214629|FG001|Overall Study|Physician Decision|0|||
126525109|NCT04323436|455214630|FG002|Overall Study|Physician Decision|0|||
126525110|NCT04323436|455214628|FG000|Overall Study|Progressive disease|10|||
126525111|NCT04323436|455214629|FG001|Overall Study|Progressive disease|0|||
126525112|NCT04323436|455214630|FG002|Overall Study|Progressive disease|0|||
126525113|NCT04323436|455214628|FG000|Overall Study|Subject decision|3|||
126525114|NCT04323436|455214629|FG001|Overall Study|Subject decision|0|||
126525115|NCT04323436|455214630|FG002|Overall Study|Subject decision|0|||
126525116|NCT01660763|455214631|FG000|Overall Study|Lack of Efficacy|45|||
126525117|NCT01660763|455214632|FG001|Overall Study|Lack of Efficacy|50|||
126525118|NCT01660763|455214631|FG000|Overall Study|Adverse Event|22|||
126525119|NCT01660763|455214632|FG001|Overall Study|Adverse Event|7|||
126525120|NCT01660763|455214631|FG000|Overall Study|Protocol Violation|1|||
126525121|NCT01660763|455214632|FG001|Overall Study|Protocol Violation|0|||
126525122|NCT01660763|455214631|FG000|Overall Study|Withdrawal by Subject|4|||
126525123|NCT01660763|455214632|FG001|Overall Study|Withdrawal by Subject|0|||
126525124|NCT01660763|455214631|FG000|Overall Study|Patient ready for early discharge|28|||
126525125|NCT01660763|455214632|FG001|Overall Study|Patient ready for early discharge|4|||
126525126|NCT03325712|455214633|FG000|Overall Study|Protocol Violation|0|||
126525127|NCT03325712|455214634|FG001|Overall Study|Protocol Violation|0|||
126525128|NCT03325712|455214635|FG002|Overall Study|Protocol Violation|0|||
126525129|NCT03325712|455214636|FG003|Overall Study|Protocol Violation|0|||
126525130|NCT03325712|455214637|FG004|Overall Study|Protocol Violation|1|||
126525131|NCT03325712|455214638|FG005|Overall Study|Protocol Violation|0|||
126525132|NCT03325712|455214639|FG006|Overall Study|Protocol Violation|0|||
126525133|NCT03325712|455214640|FG007|Overall Study|Protocol Violation|0|||
126577462|NCT02723955|455412650|FG016|Escalation Phase|Lost to Follow-up|1|||
126577463|NCT02723955|455412651|FG017|Escalation Phase|Lost to Follow-up|2|||
126577464|NCT02723955|455412652|FG018|Escalation Phase|Lost to Follow-up|0|||
126577465|NCT02723955|455412653|FG019|Escalation Phase|Lost to Follow-up|1|||
126577466|NCT02723955|455412654|FG020|Escalation Phase|Lost to Follow-up|2|||
126577467|NCT02723955|455412655|FG021|Escalation Phase|Lost to Follow-up|1|||
126577468|NCT02723955|455412656|FG022|Escalation Phase|Lost to Follow-up|0|||
126577469|NCT02723955|455412657|FG023|Escalation Phase|Lost to Follow-up|0|||
126577470|NCT02723955|455412658|FG024|Escalation Phase|Lost to Follow-up|1|||
126577471|NCT02723955|455412659|FG025|Escalation Phase|Lost to Follow-up|1|||
126577472|NCT02723955|455412660|FG026|Escalation Phase|Lost to Follow-up|3|||
126577473|NCT02723955|455412661|FG027|Escalation Phase|Lost to Follow-up|0|||
126577474|NCT02723955|455412662|FG028|Escalation Phase|Lost to Follow-up|1|||
126577475|NCT02723955|455412663|FG029|Escalation Phase|Lost to Follow-up|0|||
126577476|NCT02723955|455412664|FG030|Escalation Phase|Lost to Follow-up|0|||
126577477|NCT02723955|455412665|FG031|Escalation Phase|Lost to Follow-up|0|||
126577478|NCT02723955|455412666|FG032|Escalation Phase|Lost to Follow-up|0|||
126577479|NCT02723955|455412667|FG033|Escalation Phase|Lost to Follow-up|0|||
126577480|NCT02723955|455412668|FG034|Escalation Phase|Lost to Follow-up|0|||
126577481|NCT02723955|455412669|FG035|Escalation Phase|Lost to Follow-up|0|||
126577482|NCT02723955|455412670|FG036|Escalation Phase|Lost to Follow-up|0|||
126577483|NCT02723955|455412671|FG037|Escalation Phase|Lost to Follow-up|0|||
126577484|NCT02723955|455412672|FG038|Escalation Phase|Lost to Follow-up|0|||
126577485|NCT02723955|455412673|FG039|Escalation Phase|Lost to Follow-up|0|||
126577486|NCT02723955|455412674|FG040|Escalation Phase|Lost to Follow-up|0|||
126577487|NCT02723955|455412675|FG041|Escalation Phase|Lost to Follow-up|0|||
126577488|NCT02723955|455412676|FG042|Escalation Phase|Lost to Follow-up|0|||
126577489|NCT02723955|455412634|FG000|Escalation Phase|Physician Decision|0|||
126577490|NCT02723955|455412635|FG001|Escalation Phase|Physician Decision|0|||
126577491|NCT02723955|455412636|FG002|Escalation Phase|Physician Decision|0|||
126577492|NCT02723955|455412637|FG003|Escalation Phase|Physician Decision|0|||
126577493|NCT02723955|455412638|FG004|Escalation Phase|Physician Decision|0|||
126577494|NCT02723955|455412639|FG005|Escalation Phase|Physician Decision|2|||
126577495|NCT02723955|455412640|FG006|Escalation Phase|Physician Decision|0|||
126577496|NCT02723955|455412641|FG007|Escalation Phase|Physician Decision|0|||
126577497|NCT02723955|455412642|FG008|Escalation Phase|Physician Decision|0|||
126577498|NCT02723955|455412643|FG009|Escalation Phase|Physician Decision|0|||
126577499|NCT02723955|455412644|FG010|Escalation Phase|Physician Decision|0|||
126577500|NCT02723955|455412645|FG011|Escalation Phase|Physician Decision|0|||
126577501|NCT02723955|455412646|FG012|Escalation Phase|Physician Decision|0|||
126577502|NCT02723955|455412647|FG013|Escalation Phase|Physician Decision|0|||
126577503|NCT02723955|455412648|FG014|Escalation Phase|Physician Decision|0|||
126577504|NCT02723955|455412649|FG015|Escalation Phase|Physician Decision|0|||
126577505|NCT02723955|455412650|FG016|Escalation Phase|Physician Decision|0|||
126577506|NCT02723955|455412651|FG017|Escalation Phase|Physician Decision|0|||
126577507|NCT02723955|455412652|FG018|Escalation Phase|Physician Decision|0|||
126577508|NCT02723955|455412653|FG019|Escalation Phase|Physician Decision|0|||
126577509|NCT02723955|455412654|FG020|Escalation Phase|Physician Decision|0|||
126577510|NCT02723955|455412655|FG021|Escalation Phase|Physician Decision|0|||
126577511|NCT02723955|455412656|FG022|Escalation Phase|Physician Decision|0|||
126577512|NCT02723955|455412657|FG023|Escalation Phase|Physician Decision|0|||
126577513|NCT02723955|455412658|FG024|Escalation Phase|Physician Decision|0|||
126577514|NCT02723955|455412659|FG025|Escalation Phase|Physician Decision|0|||
126577515|NCT02723955|455412660|FG026|Escalation Phase|Physician Decision|2|||
126577516|NCT02723955|455412661|FG027|Escalation Phase|Physician Decision|0|||
126577517|NCT02723955|455412662|FG028|Escalation Phase|Physician Decision|0|||
126577518|NCT02723955|455412663|FG029|Escalation Phase|Physician Decision|0|||
126577519|NCT02723955|455412664|FG030|Escalation Phase|Physician Decision|0|||
126577520|NCT02723955|455412665|FG031|Escalation Phase|Physician Decision|0|||
126577521|NCT02723955|455412666|FG032|Escalation Phase|Physician Decision|0|||
126577522|NCT02723955|455412667|FG033|Escalation Phase|Physician Decision|0|||
126577523|NCT02723955|455412668|FG034|Escalation Phase|Physician Decision|0|||
126577524|NCT02723955|455412669|FG035|Escalation Phase|Physician Decision|0|||
126577525|NCT02723955|455412670|FG036|Escalation Phase|Physician Decision|0|||
126577526|NCT02723955|455412671|FG037|Escalation Phase|Physician Decision|0|||
126577527|NCT02723955|455412672|FG038|Escalation Phase|Physician Decision|0|||
126577528|NCT02723955|455412673|FG039|Escalation Phase|Physician Decision|0|||
126577529|NCT02723955|455412674|FG040|Escalation Phase|Physician Decision|0|||
126577530|NCT02723955|455412675|FG041|Escalation Phase|Physician Decision|0|||
126577531|NCT02723955|455412676|FG042|Escalation Phase|Physician Decision|0|||
126577532|NCT02723955|455412634|FG000|Escalation Phase|Withdrawal by Subject|0|||
126577533|NCT02723955|455412635|FG001|Escalation Phase|Withdrawal by Subject|0|||
126577534|NCT02723955|455412636|FG002|Escalation Phase|Withdrawal by Subject|0|||
126577535|NCT02723955|455412637|FG003|Escalation Phase|Withdrawal by Subject|0|||
126577536|NCT02723955|455412638|FG004|Escalation Phase|Withdrawal by Subject|1|||
126577537|NCT02723955|455412639|FG005|Escalation Phase|Withdrawal by Subject|1|||
126577538|NCT02723955|455412640|FG006|Escalation Phase|Withdrawal by Subject|1|||
126577539|NCT02723955|455412641|FG007|Escalation Phase|Withdrawal by Subject|1|||
126577540|NCT02723955|455412642|FG008|Escalation Phase|Withdrawal by Subject|0|||
126577541|NCT02723955|455412643|FG009|Escalation Phase|Withdrawal by Subject|0|||
126577542|NCT02723955|455412644|FG010|Escalation Phase|Withdrawal by Subject|0|||
126577543|NCT02723955|455412645|FG011|Escalation Phase|Withdrawal by Subject|0|||
126577544|NCT02723955|455412646|FG012|Escalation Phase|Withdrawal by Subject|1|||
126577545|NCT02723955|455412647|FG013|Escalation Phase|Withdrawal by Subject|0|||
126577546|NCT02723955|455412648|FG014|Escalation Phase|Withdrawal by Subject|0|||
126777046|NCT02124746|456139164|FG000|Overall Study|Physician Decision|6|||
126777047|NCT02124746|456139165|FG001|Overall Study|Physician Decision|4|||
126777048|NCT02124746|456139166|FG002|Overall Study|Physician Decision|5|||
126777049|NCT02124746|456139164|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126777050|NCT02124746|456139165|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126525134|NCT03325712|455214633|FG000|Overall Study|Adverse Event|0|||
126525135|NCT03325712|455214634|FG001|Overall Study|Adverse Event|0|||
126577547|NCT02723955|455412649|FG015|Escalation Phase|Withdrawal by Subject|0|||
126577548|NCT02723955|455412650|FG016|Escalation Phase|Withdrawal by Subject|1|||
126577549|NCT02723955|455412651|FG017|Escalation Phase|Withdrawal by Subject|0|||
126577550|NCT02723955|455412652|FG018|Escalation Phase|Withdrawal by Subject|0|||
126577551|NCT02723955|455412653|FG019|Escalation Phase|Withdrawal by Subject|0|||
126577552|NCT02723955|455412654|FG020|Escalation Phase|Withdrawal by Subject|0|||
126577553|NCT02723955|455412655|FG021|Escalation Phase|Withdrawal by Subject|0|||
126577554|NCT02723955|455412656|FG022|Escalation Phase|Withdrawal by Subject|0|||
126577555|NCT02723955|455412657|FG023|Escalation Phase|Withdrawal by Subject|2|||
126577556|NCT02723955|455412658|FG024|Escalation Phase|Withdrawal by Subject|0|||
126525136|NCT03325712|455214635|FG002|Overall Study|Adverse Event|0|||
126525137|NCT03325712|455214636|FG003|Overall Study|Adverse Event|0|||
126525138|NCT03325712|455214637|FG004|Overall Study|Adverse Event|1|||
126525139|NCT03325712|455214638|FG005|Overall Study|Adverse Event|0|||
126525140|NCT03325712|455214639|FG006|Overall Study|Adverse Event|0|||
126525141|NCT03325712|455214640|FG007|Overall Study|Adverse Event|0|||
126525142|NCT02265237|455214642|FG000|As Treated (Overall Study)|Adverse Event|1|||
126525143|NCT02265237|455214643|FG001|As Treated (Overall Study)|Adverse Event|1|||
126525144|NCT02265237|455214644|FG002|As Treated (Overall Study)|Adverse Event|0|||
126525145|NCT02265237|455214645|FG003|As Treated (Overall Study)|Adverse Event|0|||
126525146|NCT02265237|455214642|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
126525147|NCT02265237|455214643|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
126525148|NCT02265237|455214644|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
126525149|NCT02265237|455214645|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
126525150|NCT02265237|455214642|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
126525151|NCT02265237|455214643|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
126525152|NCT02265237|455214644|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
126525153|NCT02265237|455214645|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
126525154|NCT02265237|455214642|FG000|As Treated (Overall Study)|Other|2|||
126525155|NCT02265237|455214643|FG001|As Treated (Overall Study)|Other|0|||
126525156|NCT02265237|455214644|FG002|As Treated (Overall Study)|Other|3|||
126525157|NCT02265237|455214645|FG003|As Treated (Overall Study)|Other|1|||
126525158|NCT01178853|455214647|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
126525159|NCT01178853|455214648|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
126525160|NCT01178853|455214647|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
126525161|NCT01178853|455214648|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
126525162|NCT01178853|455214647|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
126525163|NCT01178853|455214648|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
126525164|NCT01178853|455214647|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
126525165|NCT01178853|455214648|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
126525166|NCT01178853|455214647|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
126525167|NCT01178853|455214648|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
126525168|NCT03550313|455214649|FG000|Overall Study|Adverse Event|0|||
126525169|NCT03550313|455214650|FG001|Overall Study|Adverse Event|1|||
126525170|NCT03550313|455214651|FG002|Overall Study|Adverse Event|0|||
126525171|NCT03550313|455214649|FG000|Overall Study|Lost to Follow-up|5|||
126577557|NCT02723955|455412659|FG025|Escalation Phase|Withdrawal by Subject|1|||
126577558|NCT02723955|455412660|FG026|Escalation Phase|Withdrawal by Subject|0|||
126577559|NCT02723955|455412661|FG027|Escalation Phase|Withdrawal by Subject|0|||
126577560|NCT02723955|455412662|FG028|Escalation Phase|Withdrawal by Subject|1|||
126577561|NCT02723955|455412663|FG029|Escalation Phase|Withdrawal by Subject|0|||
126577562|NCT02723955|455412664|FG030|Escalation Phase|Withdrawal by Subject|0|||
126577563|NCT02723955|455412665|FG031|Escalation Phase|Withdrawal by Subject|0|||
126525172|NCT03550313|455214650|FG001|Overall Study|Lost to Follow-up|7|||
126525173|NCT03550313|455214651|FG002|Overall Study|Lost to Follow-up|12|||
126525174|NCT03550313|455214649|FG000|Overall Study|Study terminated by sponsor|44|||
126577564|NCT02723955|455412666|FG032|Escalation Phase|Withdrawal by Subject|0|||
126777051|NCT02124746|456139166|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126577565|NCT02723955|455412667|FG033|Escalation Phase|Withdrawal by Subject|0|||
126577566|NCT02723955|455412668|FG034|Escalation Phase|Withdrawal by Subject|0|||
126577567|NCT02723955|455412669|FG035|Escalation Phase|Withdrawal by Subject|0|||
126777052|NCT02124746|456139164|FG000|Overall Study|Withdrawal by Subject|3|||
126577568|NCT02723955|455412670|FG036|Escalation Phase|Withdrawal by Subject|0|||
126577569|NCT02723955|455412671|FG037|Escalation Phase|Withdrawal by Subject|0|||
126577570|NCT02723955|455412672|FG038|Escalation Phase|Withdrawal by Subject|0|||
126577571|NCT02723955|455412673|FG039|Escalation Phase|Withdrawal by Subject|0|||
126577572|NCT02723955|455412674|FG040|Escalation Phase|Withdrawal by Subject|0|||
126577573|NCT02723955|455412675|FG041|Escalation Phase|Withdrawal by Subject|0|||
126577574|NCT02723955|455412676|FG042|Escalation Phase|Withdrawal by Subject|0|||
126577575|NCT02723955|455412634|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577576|NCT02723955|455412635|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577577|NCT02723955|455412636|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577578|NCT02723955|455412637|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577579|NCT02723955|455412638|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
126577580|NCT02723955|455412639|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
126577581|NCT02723955|455412640|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
126577582|NCT02723955|455412641|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
126577583|NCT02723955|455412642|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
126577584|NCT02723955|455412643|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577585|NCT02723955|455412644|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577586|NCT02723955|455412645|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577587|NCT02723955|455412646|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577588|NCT02723955|455412647|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577589|NCT02723955|455412648|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577590|NCT02723955|455412649|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577591|NCT02723955|455412650|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577592|NCT02723955|455412651|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577593|NCT02723955|455412652|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577594|NCT02723955|455412653|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577595|NCT02723955|455412654|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577596|NCT02723955|455412655|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577597|NCT02723955|455412656|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577598|NCT02723955|455412657|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577599|NCT02723955|455412658|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577600|NCT02723955|455412659|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577601|NCT02723955|455412660|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577602|NCT02723955|455412661|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577603|NCT02723955|455412662|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577604|NCT02723955|455412663|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577605|NCT02723955|455412664|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577606|NCT02723955|455412665|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577607|NCT02723955|455412666|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577608|NCT02723955|455412667|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577609|NCT02723955|455412668|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577610|NCT02723955|455412669|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577611|NCT02723955|455412670|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577612|NCT02723955|455412671|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577613|NCT02723955|455412672|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577614|NCT02723955|455412673|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577615|NCT02723955|455412674|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577616|NCT02723955|455412675|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577617|NCT02723955|455412676|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
126577618|NCT02723955|455412634|FG000|Escalation Phase|Site Closed|0|||
126577619|NCT02723955|455412635|FG001|Escalation Phase|Site Closed|0|||
126525175|NCT03550313|455214650|FG001|Overall Study|Study terminated by sponsor|37|||
126525176|NCT03550313|455214651|FG002|Overall Study|Study terminated by sponsor|48|||
126525177|NCT03550313|455214649|FG000|Overall Study|No longer met eligibility criteria|3|||
126525178|NCT03550313|455214650|FG001|Overall Study|No longer met eligibility criteria|5|||
126525179|NCT03550313|455214651|FG002|Overall Study|No longer met eligibility criteria|6|||
126525180|NCT03550313|455214649|FG000|Overall Study|Withdrawal by parent/guardian|20|||
126525181|NCT03550313|455214650|FG001|Overall Study|Withdrawal by parent/guardian|18|||
126525182|NCT03550313|455214651|FG002|Overall Study|Withdrawal by parent/guardian|26|||
126525183|NCT03550313|455214649|FG000|Overall Study|Other|4|||
126728072|NCT00064350|455952925|FG002|Cross-Over|Withdrawal by Subject|0|||
126728073|NCT00064350|455952923|FG000|Cross-Over|Ineligible or never started treatment|3|||
126728074|NCT00064350|455952924|FG001|Cross-Over|Ineligible or never started treatment|6|||
126525184|NCT03550313|455214650|FG001|Overall Study|Other|2|||
126525185|NCT03550313|455214651|FG002|Overall Study|Other|2|||
126525186|NCT03550313|455214649|FG000|Overall Study|Randomized but not vaccinated|3|||
126525187|NCT03550313|455214650|FG001|Overall Study|Randomized but not vaccinated|23|||
126525188|NCT03550313|455214651|FG002|Overall Study|Randomized but not vaccinated|2|||
126525189|NCT03550313|455214649|FG000|Overall Study|Sites terminated due to quality issues|18|||
126525190|NCT03550313|455214650|FG001|Overall Study|Sites terminated due to quality issues|17|||
126525191|NCT03550313|455214651|FG002|Overall Study|Sites terminated due to quality issues|18|||
126525192|NCT00839072|455214652|FG000|First Intervention Period|Withdrawal by Subject|1|||
126525193|NCT00839072|455214653|FG001|First Intervention Period|Withdrawal by Subject|0|||
126525194|NCT00839072|455214652|FG000|First Intervention Period|Adverse Event|1|||
126525195|NCT00839072|455214653|FG001|First Intervention Period|Adverse Event|1|||
126525196|NCT00839072|455214652|FG000|Second Intervention Period|Withdrawal by Subject|1|||
126525197|NCT00839072|455214653|FG001|Second Intervention Period|Withdrawal by Subject|0|||
126525198|NCT00380068|455214654|FG000|Overall Study|Adverse Event|40|||
126525199|NCT00380068|455214654|FG000|Overall Study|Withdrawal by Subject|10|||
126525200|NCT00380068|455214654|FG000|Overall Study|Not compliant|6|||
126525201|NCT00380068|455214654|FG000|Overall Study|Lost to Follow-up|1|||
126525202|NCT00380068|455214654|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
126525203|NCT00380068|455214654|FG000|Overall Study|Lung transplant|3|||
126525204|NCT00380068|455214654|FG000|Overall Study|Physician Decision|2|||
126525205|NCT00380068|455214654|FG000|Overall Study|Partipant moved away|1|||
126525206|NCT00380068|455214654|FG000|Overall Study|Lack of Efficacy|5|||
126525207|NCT01297062|455214655|FG000|Overall Study|Adverse Event|2|||
126525208|NCT01297062|455214656|FG001|Overall Study|Adverse Event|0|||
126525209|NCT01297062|455214657|FG002|Overall Study|Adverse Event|1|||
126525210|NCT01297062|455214658|FG003|Overall Study|Adverse Event|0|||
126525211|NCT01297062|455214659|FG004|Overall Study|Adverse Event|0|||
126525212|NCT01297062|455214660|FG005|Overall Study|Adverse Event|0|||
126525213|NCT01297062|455214661|FG006|Overall Study|Adverse Event|0|||
126525214|NCT01297062|455214655|FG000|Overall Study|Physician Decision|1|||
126525215|NCT01297062|455214656|FG001|Overall Study|Physician Decision|0|||
126525216|NCT01297062|455214657|FG002|Overall Study|Physician Decision|1|||
126525217|NCT01297062|455214658|FG003|Overall Study|Physician Decision|0|||
126525218|NCT01297062|455214659|FG004|Overall Study|Physician Decision|0|||
126525219|NCT01297062|455214660|FG005|Overall Study|Physician Decision|0|||
126525220|NCT01297062|455214661|FG006|Overall Study|Physician Decision|6|||
126525221|NCT01297062|455214655|FG000|Overall Study|Protocol Violation|0|||
126525222|NCT01297062|455214656|FG001|Overall Study|Protocol Violation|0|||
126525223|NCT01297062|455214657|FG002|Overall Study|Protocol Violation|0|||
126525224|NCT01297062|455214658|FG003|Overall Study|Protocol Violation|0|||
126525225|NCT01297062|455214659|FG004|Overall Study|Protocol Violation|1|||
126525226|NCT01297062|455214660|FG005|Overall Study|Protocol Violation|0|||
126525227|NCT01297062|455214661|FG006|Overall Study|Protocol Violation|0|||
126525228|NCT01297062|455214655|FG000|Overall Study|Subject Decision|1|||
126525229|NCT01297062|455214656|FG001|Overall Study|Subject Decision|1|||
126525230|NCT01297062|455214657|FG002|Overall Study|Subject Decision|0|||
126525231|NCT01297062|455214658|FG003|Overall Study|Subject Decision|1|||
126525232|NCT01297062|455214659|FG004|Overall Study|Subject Decision|1|||
126728075|NCT00064350|455952925|FG002|Cross-Over|Ineligible or never started treatment|0|||
126525233|NCT01297062|455214660|FG005|Overall Study|Subject Decision|1|||
126525234|NCT01297062|455214661|FG006|Overall Study|Subject Decision|2|||
126525235|NCT01458574|455214662|FG000|Overall Study|Adverse Event|5|||
126525236|NCT01458574|455214663|FG001|Overall Study|Adverse Event|9|||
126525237|NCT01458574|455214664|FG002|Overall Study|Adverse Event|7|||
126525238|NCT01458574|455214662|FG000|Overall Study|Lack of Efficacy|70|||
126525239|NCT01458574|455214663|FG001|Overall Study|Lack of Efficacy|53|||
126525240|NCT01458574|455214664|FG002|Overall Study|Lack of Efficacy|132|||
126525241|NCT01458574|455214662|FG000|Overall Study|Lost to Follow-up|3|||
126525242|NCT01458574|455214663|FG001|Overall Study|Lost to Follow-up|2|||
126525243|NCT01458574|455214664|FG002|Overall Study|Lost to Follow-up|1|||
126525244|NCT01458574|455214662|FG000|Overall Study|Pregnancy|1|||
126525245|NCT01458574|455214663|FG001|Overall Study|Pregnancy|1|||
126525246|NCT01458574|455214664|FG002|Overall Study|Pregnancy|0|||
126525247|NCT01458574|455214662|FG000|Overall Study|Protocol Violation|0|||
126728076|NCT00064350|455952923|FG000|Cross-Over|Other|0|||
126728077|NCT00064350|455952924|FG001|Cross-Over|Other|2|||
126728078|NCT00064350|455952925|FG002|Cross-Over|Other|0|||
126728079|NCT00838916|455952926|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
126728080|NCT00838916|455952927|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
126728081|NCT00838916|455952926|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
126525248|NCT01458574|455214663|FG001|Overall Study|Protocol Violation|1|||
126525249|NCT01458574|455214664|FG002|Overall Study|Protocol Violation|0|||
126577620|NCT02723955|455412636|FG002|Escalation Phase|Site Closed|0|||
126577621|NCT02723955|455412637|FG003|Escalation Phase|Site Closed|0|||
126728082|NCT00838916|455952927|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
126728083|NCT00838916|455952926|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
126525250|NCT01458574|455214662|FG000|Overall Study|Withdrawal by Subject|6|||
126525251|NCT01458574|455214663|FG001|Overall Study|Withdrawal by Subject|3|||
126525252|NCT01458574|455214664|FG002|Overall Study|Withdrawal by Subject|5|||
126525253|NCT01458574|455214662|FG000|Overall Study|Other|2|||
126525254|NCT01458574|455214663|FG001|Overall Study|Other|1|||
126525255|NCT01458574|455214664|FG002|Overall Study|Other|0|||
126525256|NCT01458574|455214662|FG000|Overall Study|Randomized but not treated|0|||
126525257|NCT01458574|455214663|FG001|Overall Study|Randomized but not treated|1|||
126525258|NCT01458574|455214664|FG002|Overall Study|Randomized but not treated|0|||
126525259|NCT02125786|455214665|FG000|Overall Study|Still in Follow-up|3|||
126525260|NCT02125786|455214665|FG000|Overall Study|Screen Failure|2|||
126525261|NCT02125786|455214665|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
126525262|NCT02125786|455214665|FG000|Overall Study|Progressive Disease|44|||
126525263|NCT02125786|455214665|FG000|Overall Study|Death|8|||
126525264|NCT04964089|455214666|FG000|Overall Study|Adverse Event|8|||
126525265|NCT04964089|455214667|FG001|Overall Study|Adverse Event|6|||
126525266|NCT04964089|455214666|FG000|Overall Study|Non-compliance with study schedule|1|||
126525267|NCT04964089|455214667|FG001|Overall Study|Non-compliance with study schedule|0|||
126525268|NCT04964089|455214666|FG000|Overall Study|Withdrawal by Subject|6|||
126525269|NCT04964089|455214667|FG001|Overall Study|Withdrawal by Subject|5|||
126525270|NCT04964089|455214666|FG000|Overall Study|Lost to Follow-up|1|||
126525271|NCT04964089|455214667|FG001|Overall Study|Lost to Follow-up|1|||
126525272|NCT04964089|455214666|FG000|Overall Study|Progressive disease|4|||
126525273|NCT04964089|455214667|FG001|Overall Study|Progressive disease|0|||
126525274|NCT04964089|455214666|FG000|Overall Study|Physician Decision|1|||
126525275|NCT04964089|455214667|FG001|Overall Study|Physician Decision|0|||
126525276|NCT04964089|455214666|FG000|Overall Study|Participant did not want to continue study treatment|1|||
126525277|NCT04964089|455214667|FG001|Overall Study|Participant did not want to continue study treatment|0|||
126525278|NCT04964089|455214666|FG000|Overall Study|Participant moved to different state|1|||
126525279|NCT04964089|455214667|FG001|Overall Study|Participant moved to different state|0|||
126525280|NCT04964089|455214666|FG000|Overall Study|Participant decided to discontinue|0|||
126525281|NCT04964089|455214667|FG001|Overall Study|Participant decided to discontinue|1|||
126525282|NCT01682837|455214668|FG000|Baseline|Withdrawal by Subject|5|||
126525283|NCT05437510|455214669|FG000|Overall Study|Adverse Event|1|||
126525284|NCT05437510|455214670|FG001|Overall Study|Adverse Event|1|||
126525285|NCT05437510|455214669|FG000|Overall Study|Protocol Deviation|1|||
126525286|NCT05437510|455214670|FG001|Overall Study|Protocol Deviation|6|||
126525287|NCT05437510|455214669|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
126525288|NCT05437510|455214670|FG001|Overall Study|Withdrawal by Parent/Guardian|22|||
126525289|NCT05437510|455214669|FG000|Overall Study|Lost to Follow-up|219|||
126525290|NCT05437510|455214670|FG001|Overall Study|Lost to Follow-up|289|||
126525291|NCT05437510|455214669|FG000|Overall Study|Ongoing in the Study Extension|1387|||
126525292|NCT05437510|455214670|FG001|Overall Study|Ongoing in the Study Extension|1352|||
126525293|NCT02105116|455216749|FG000|Overall Study|not eligible for step 2 of trial|5|||
126525294|NCT02105116|455216749|FG000|Overall Study|Death|1|||
126525295|NCT02863926|455216750|FG000|Overall Study|Physician Decision|1|||
126577622|NCT02723955|455412638|FG004|Escalation Phase|Site Closed|0|||
126577623|NCT02723955|455412639|FG005|Escalation Phase|Site Closed|0|||
126728084|NCT00838916|455952927|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
126728085|NCT00838916|455952926|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
126525296|NCT02863926|455216751|FG001|Overall Study|Physician Decision|0|||
126525297|NCT02863926|455216750|FG000|Overall Study|Lost to Follow-up|1|||
126525298|NCT02863926|455216751|FG001|Overall Study|Lost to Follow-up|1|||
126525299|NCT03422250|455216752|FG000|Intervention|Adverse Event|0|||
126525300|NCT03422250|455216753|FG001|Intervention|Adverse Event|1|||
126525301|NCT03422250|455216754|FG002|Intervention|Adverse Event|0|||
126525302|NCT03422250|455216755|FG003|Intervention|Adverse Event|1|||
126525303|NCT03422250|455216752|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
126525304|NCT03422250|455216753|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
126525305|NCT03422250|455216754|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
126525306|NCT03422250|455216755|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
126525307|NCT03422250|455216752|FG000|Follow-up|Withdrawal by Subject|0|||
126525308|NCT03422250|455216753|FG001|Follow-up|Withdrawal by Subject|0|||
126577624|NCT02723955|455412640|FG006|Escalation Phase|Site Closed|0|||
126577625|NCT02723955|455412641|FG007|Escalation Phase|Site Closed|0|||
126577626|NCT02723955|455412642|FG008|Escalation Phase|Site Closed|0|||
126577627|NCT02723955|455412643|FG009|Escalation Phase|Site Closed|0|||
126577628|NCT02723955|455412644|FG010|Escalation Phase|Site Closed|0|||
126577629|NCT02723955|455412645|FG011|Escalation Phase|Site Closed|0|||
126577630|NCT02723955|455412646|FG012|Escalation Phase|Site Closed|0|||
126577631|NCT02723955|455412647|FG013|Escalation Phase|Site Closed|0|||
126577632|NCT02723955|455412648|FG014|Escalation Phase|Site Closed|0|||
126577633|NCT02723955|455412649|FG015|Escalation Phase|Site Closed|1|||
126577634|NCT02723955|455412650|FG016|Escalation Phase|Site Closed|0|||
126577635|NCT02723955|455412651|FG017|Escalation Phase|Site Closed|2|||
126577636|NCT02723955|455412652|FG018|Escalation Phase|Site Closed|0|||
126577637|NCT02723955|455412653|FG019|Escalation Phase|Site Closed|0|||
126577638|NCT02723955|455412654|FG020|Escalation Phase|Site Closed|1|||
126577639|NCT02723955|455412655|FG021|Escalation Phase|Site Closed|0|||
126577640|NCT02723955|455412656|FG022|Escalation Phase|Site Closed|0|||
126577641|NCT02723955|455412657|FG023|Escalation Phase|Site Closed|0|||
126577642|NCT02723955|455412658|FG024|Escalation Phase|Site Closed|3|||
126577643|NCT02723955|455412659|FG025|Escalation Phase|Site Closed|1|||
126577644|NCT02723955|455412660|FG026|Escalation Phase|Site Closed|3|||
126577645|NCT02723955|455412661|FG027|Escalation Phase|Site Closed|1|||
126577646|NCT02723955|455412662|FG028|Escalation Phase|Site Closed|1|||
126577647|NCT02723955|455412663|FG029|Escalation Phase|Site Closed|0|||
126577648|NCT02723955|455412664|FG030|Escalation Phase|Site Closed|0|||
126577649|NCT02723955|455412665|FG031|Escalation Phase|Site Closed|0|||
126577650|NCT02723955|455412666|FG032|Escalation Phase|Site Closed|0|||
126577651|NCT02723955|455412667|FG033|Escalation Phase|Site Closed|0|||
126577652|NCT02723955|455412668|FG034|Escalation Phase|Site Closed|0|||
126577653|NCT02723955|455412669|FG035|Escalation Phase|Site Closed|0|||
126577654|NCT02723955|455412670|FG036|Escalation Phase|Site Closed|0|||
126577655|NCT02723955|455412671|FG037|Escalation Phase|Site Closed|0|||
126577656|NCT02723955|455412672|FG038|Escalation Phase|Site Closed|0|||
126577657|NCT02723955|455412673|FG039|Escalation Phase|Site Closed|0|||
126577658|NCT02723955|455412674|FG040|Escalation Phase|Site Closed|0|||
126577659|NCT02723955|455412675|FG041|Escalation Phase|Site Closed|0|||
126577660|NCT02723955|455412676|FG042|Escalation Phase|Site Closed|0|||
126577661|NCT02723955|455412634|FG000|Expansion Phase|Death|0|||
126577662|NCT02723955|455412635|FG001|Expansion Phase|Death|0|||
126577663|NCT02723955|455412636|FG002|Expansion Phase|Death|0|||
126577664|NCT02723955|455412637|FG003|Expansion Phase|Death|0|||
126577665|NCT02723955|455412638|FG004|Expansion Phase|Death|0|||
126577666|NCT02723955|455412639|FG005|Expansion Phase|Death|0|||
126577667|NCT02723955|455412640|FG006|Expansion Phase|Death|0|||
126577668|NCT02723955|455412641|FG007|Expansion Phase|Death|0|||
126577669|NCT02723955|455412642|FG008|Expansion Phase|Death|0|||
126577670|NCT02723955|455412643|FG009|Expansion Phase|Death|25|||
126577671|NCT02723955|455412644|FG010|Expansion Phase|Death|69|||
126577672|NCT02723955|455412645|FG011|Expansion Phase|Death|48|||
126577673|NCT02723955|455412646|FG012|Expansion Phase|Death|0|||
126577674|NCT02723955|455412647|FG013|Expansion Phase|Death|0|||
126577675|NCT02723955|455412648|FG014|Expansion Phase|Death|0|||
126577676|NCT02723955|455412649|FG015|Expansion Phase|Death|0|||
126577677|NCT02723955|455412650|FG016|Expansion Phase|Death|0|||
126577678|NCT02723955|455412651|FG017|Expansion Phase|Death|0|||
126577679|NCT02723955|455412652|FG018|Expansion Phase|Death|0|||
126577680|NCT02723955|455412653|FG019|Expansion Phase|Death|0|||
126577681|NCT02723955|455412654|FG020|Expansion Phase|Death|0|||
126577682|NCT02723955|455412655|FG021|Expansion Phase|Death|0|||
126577683|NCT02723955|455412656|FG022|Expansion Phase|Death|0|||
126577684|NCT02723955|455412657|FG023|Expansion Phase|Death|0|||
126577685|NCT02723955|455412658|FG024|Expansion Phase|Death|0|||
126577686|NCT02723955|455412659|FG025|Expansion Phase|Death|0|||
126577687|NCT02723955|455412660|FG026|Expansion Phase|Death|0|||
126577688|NCT02723955|455412661|FG027|Expansion Phase|Death|0|||
126577689|NCT02723955|455412662|FG028|Expansion Phase|Death|0|||
126577690|NCT02723955|455412663|FG029|Expansion Phase|Death|12|||
126577691|NCT02723955|455412664|FG030|Expansion Phase|Death|202|||
126577692|NCT02723955|455412665|FG031|Expansion Phase|Death|31|||
126577693|NCT02723955|455412666|FG032|Expansion Phase|Death|17|||
126577694|NCT02723955|455412667|FG033|Expansion Phase|Death|2|||
126577695|NCT02723955|455412668|FG034|Expansion Phase|Death|3|||
126577696|NCT02723955|455412669|FG035|Expansion Phase|Death|3|||
126577697|NCT02723955|455412670|FG036|Expansion Phase|Death|1|||
126577698|NCT02723955|455412671|FG037|Expansion Phase|Death|0|||
126577699|NCT02723955|455412672|FG038|Expansion Phase|Death|0|||
126577700|NCT02723955|455412673|FG039|Expansion Phase|Death|0|||
126577701|NCT02723955|455412674|FG040|Expansion Phase|Death|0|||
126577702|NCT02723955|455412675|FG041|Expansion Phase|Death|0|||
126577703|NCT02723955|455412676|FG042|Expansion Phase|Death|0|||
126577704|NCT02723955|455412634|FG000|Expansion Phase|Lost to Follow-up|0|||
126577705|NCT02723955|455412635|FG001|Expansion Phase|Lost to Follow-up|0|||
126577706|NCT02723955|455412636|FG002|Expansion Phase|Lost to Follow-up|0|||
126577707|NCT02723955|455412637|FG003|Expansion Phase|Lost to Follow-up|0|||
126577708|NCT02723955|455412638|FG004|Expansion Phase|Lost to Follow-up|0|||
126577709|NCT02723955|455412639|FG005|Expansion Phase|Lost to Follow-up|0|||
126728086|NCT00838916|455952927|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
126728087|NCT00838916|455952926|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
126728088|NCT00838916|455952927|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
126728089|NCT00838916|455952926|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
126728090|NCT00838916|455952927|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
126728091|NCT00838916|455952926|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
126728092|NCT00838916|455952927|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
126728093|NCT00838916|455952926|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
126728094|NCT00838916|455952927|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
126728095|NCT00838916|455952926|FG000|Treatment Period (156 Weeks)|Missing|3|||
126728096|NCT00838916|455952927|FG001|Treatment Period (156 Weeks)|Missing|1|||
126728097|NCT00838916|455952926|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
126728098|NCT00838916|455952927|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
126728099|NCT00838916|455952926|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
126728100|NCT00838916|455952927|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
126728101|NCT00838916|455952926|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
126728102|NCT00838916|455952927|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
126728103|NCT00838916|455952926|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
126728104|NCT00838916|455952927|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
126728105|NCT00838916|455952926|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
126728106|NCT00838916|455952927|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
126728107|NCT00838916|455952926|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
126728108|NCT00838916|455952927|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
126728109|NCT00838916|455952926|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
126728110|NCT00838916|455952927|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
126728111|NCT00838916|455952926|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
126728112|NCT00838916|455952927|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
126728113|NCT00838916|455952926|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
126728114|NCT00838916|455952927|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
126728115|NCT00838916|455952926|FG000|Follow-up Period (8 Weeks)|Missing|3|||
126728116|NCT00838916|455952927|FG001|Follow-up Period (8 Weeks)|Missing|0|||
126728117|NCT02034474|455952928|FG000|Overall Study|Adverse Event|3|||
126728118|NCT02034474|455952929|FG001|Overall Study|Adverse Event|2|||
126728119|NCT02034474|455952928|FG000|Overall Study|Withdrawal by Subject|1|||
126728120|NCT02034474|455952929|FG001|Overall Study|Withdrawal by Subject|2|||
126728121|NCT00675103|455952930|FG000|Overall Study|Lack of Efficacy|2|||
126728122|NCT00675103|455952930|FG000|Overall Study|Adverse Event|1|||
126728123|NCT03600714|455952931|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
126728124|NCT02164513|455952932|FG000|Overall Study|Adverse Event|162|||
126728125|NCT02164513|455952933|FG001|Overall Study|Adverse Event|180|||
126728126|NCT02164513|455952934|FG002|Overall Study|Adverse Event|111|||
126728127|NCT02164513|455952932|FG000|Overall Study|Other: Study Closed or terminated|5|||
126728128|NCT02164513|455952933|FG001|Overall Study|Other: Study Closed or terminated|2|||
126728129|NCT02164513|455952934|FG002|Overall Study|Other: Study Closed or terminated|4|||
126728130|NCT02164513|455952932|FG000|Overall Study|Lost to Follow-up|30|||
126728131|NCT02164513|455952933|FG001|Overall Study|Lost to Follow-up|36|||
126728132|NCT02164513|455952934|FG002|Overall Study|Lost to Follow-up|22|||
126728133|NCT02164513|455952932|FG000|Overall Study|Physician Decision|47|||
126728134|NCT02164513|455952933|FG001|Overall Study|Physician Decision|57|||
126728135|NCT02164513|455952934|FG002|Overall Study|Physician Decision|28|||
126728136|NCT02164513|455952932|FG000|Overall Study|Withdrawal by Subject|192|||
126728137|NCT02164513|455952933|FG001|Overall Study|Withdrawal by Subject|261|||
126728138|NCT02164513|455952934|FG002|Overall Study|Withdrawal by Subject|130|||
126728139|NCT02164513|455952932|FG000|Overall Study|Other: Reason not provided by site|1|||
126728140|NCT02164513|455952933|FG001|Overall Study|Other: Reason not provided by site|0|||
126728141|NCT02164513|455952934|FG002|Overall Study|Other: Reason not provided by site|0|||
126728142|NCT02586077|455954152|FG000|Overall Study|Withdrawal by Subject|1|||
126525309|NCT03422250|455216754|FG002|Follow-up|Withdrawal by Subject|0|||
126525310|NCT03422250|455216755|FG003|Follow-up|Withdrawal by Subject|1|||
126525311|NCT03422250|455216752|FG000|Follow-up|Adverse Event|0|||
126525312|NCT03422250|455216753|FG001|Follow-up|Adverse Event|0|||
126525313|NCT03422250|455216754|FG002|Follow-up|Adverse Event|0|||
126525314|NCT03422250|455216755|FG003|Follow-up|Adverse Event|1|||
126525315|NCT01917526|455216764|FG000|Overall Study|Protocol Violation|1|||
126525316|NCT01917526|455216765|FG001|Overall Study|Protocol Violation|1|||
126525317|NCT04717596|455216766|FG000|Overall Study|Withdrawal by Subject|4|||
126525318|NCT01127178|455216767|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
126525319|NCT01127178|455216768|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
126525320|NCT01127178|455216767|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
126525321|NCT01127178|455216768|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
126525322|NCT01127178|455216767|FG000|Dose Escalation: Treatment Phase|Other|2|||
126525323|NCT01127178|455216768|FG001|Dose Escalation: Treatment Phase|Other|0|||
126525324|NCT01127178|455216767|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
126577710|NCT02723955|455412640|FG006|Expansion Phase|Lost to Follow-up|0|||
126577711|NCT02723955|455412641|FG007|Expansion Phase|Lost to Follow-up|0|||
126577712|NCT02723955|455412642|FG008|Expansion Phase|Lost to Follow-up|0|||
126577713|NCT02723955|455412643|FG009|Expansion Phase|Lost to Follow-up|0|||
126577714|NCT02723955|455412644|FG010|Expansion Phase|Lost to Follow-up|4|||
126577715|NCT02723955|455412645|FG011|Expansion Phase|Lost to Follow-up|1|||
126577716|NCT02723955|455412646|FG012|Expansion Phase|Lost to Follow-up|0|||
126577717|NCT02723955|455412647|FG013|Expansion Phase|Lost to Follow-up|0|||
126577718|NCT02723955|455412648|FG014|Expansion Phase|Lost to Follow-up|0|||
126577719|NCT02723955|455412649|FG015|Expansion Phase|Lost to Follow-up|0|||
126577720|NCT02723955|455412650|FG016|Expansion Phase|Lost to Follow-up|0|||
126577721|NCT02723955|455412651|FG017|Expansion Phase|Lost to Follow-up|0|||
126577722|NCT02723955|455412652|FG018|Expansion Phase|Lost to Follow-up|0|||
126577723|NCT02723955|455412653|FG019|Expansion Phase|Lost to Follow-up|0|||
126577724|NCT02723955|455412654|FG020|Expansion Phase|Lost to Follow-up|0|||
126577725|NCT02723955|455412655|FG021|Expansion Phase|Lost to Follow-up|0|||
126577726|NCT02723955|455412656|FG022|Expansion Phase|Lost to Follow-up|0|||
126577727|NCT02723955|455412657|FG023|Expansion Phase|Lost to Follow-up|0|||
126577728|NCT02723955|455412658|FG024|Expansion Phase|Lost to Follow-up|0|||
126577729|NCT02723955|455412659|FG025|Expansion Phase|Lost to Follow-up|0|||
126577730|NCT02723955|455412660|FG026|Expansion Phase|Lost to Follow-up|0|||
126577731|NCT02723955|455412661|FG027|Expansion Phase|Lost to Follow-up|0|||
126577732|NCT02723955|455412662|FG028|Expansion Phase|Lost to Follow-up|0|||
126577733|NCT02723955|455412663|FG029|Expansion Phase|Lost to Follow-up|1|||
126577734|NCT02723955|455412664|FG030|Expansion Phase|Lost to Follow-up|19|||
126577735|NCT02723955|455412665|FG031|Expansion Phase|Lost to Follow-up|2|||
126577736|NCT02723955|455412666|FG032|Expansion Phase|Lost to Follow-up|1|||
126577737|NCT02723955|455412667|FG033|Expansion Phase|Lost to Follow-up|0|||
126577738|NCT02723955|455412668|FG034|Expansion Phase|Lost to Follow-up|0|||
126577739|NCT02723955|455412669|FG035|Expansion Phase|Lost to Follow-up|0|||
126577740|NCT02723955|455412670|FG036|Expansion Phase|Lost to Follow-up|0|||
126577741|NCT02723955|455412671|FG037|Expansion Phase|Lost to Follow-up|0|||
126577742|NCT02723955|455412672|FG038|Expansion Phase|Lost to Follow-up|0|||
126577743|NCT02723955|455412673|FG039|Expansion Phase|Lost to Follow-up|0|||
126577744|NCT02723955|455412674|FG040|Expansion Phase|Lost to Follow-up|0|||
126577745|NCT02723955|455412675|FG041|Expansion Phase|Lost to Follow-up|0|||
126577746|NCT02723955|455412676|FG042|Expansion Phase|Lost to Follow-up|0|||
126728143|NCT02586077|455954152|FG000|Overall Study|Physician Decision|4|||
126728144|NCT02586077|455954152|FG000|Overall Study|Lost to Follow-up|3|||
126728145|NCT00363051|455954159|FG000|Overall Study|Adminstrative problems|1|||
126728146|NCT00363051|455954160|FG001|Overall Study|Adminstrative problems|1|||
126728147|NCT00363051|455954159|FG000|Overall Study|Adverse Event|21|||
126728148|NCT00363051|455954160|FG001|Overall Study|Adverse Event|12|||
126728149|NCT00363051|455954159|FG000|Overall Study|New Cancer Therapy|2|||
126728150|NCT00363051|455954160|FG001|Overall Study|New Cancer Therapy|1|||
126728151|NCT00363051|455954159|FG000|Overall Study|Withdrawal by Subject|11|||
126728152|NCT00363051|455954160|FG001|Overall Study|Withdrawal by Subject|3|||
126728153|NCT00363051|455954159|FG000|Overall Study|Lost to Follow-up|0|||
126728154|NCT00363051|455954160|FG001|Overall Study|Lost to Follow-up|1|||
126728155|NCT00363051|455954159|FG000|Overall Study|Protocol Violation|0|||
126728156|NCT00363051|455954160|FG001|Overall Study|Protocol Violation|2|||
126728157|NCT00363051|455954159|FG000|Overall Study|Death|3|||
126728158|NCT00363051|455954160|FG001|Overall Study|Death|2|||
126728159|NCT00205699|455954163|FG000|Overall Study|Lost to Follow-up|1|||
126577747|NCT02723955|455412634|FG000|Expansion Phase|Physician Decision|0|||
126577748|NCT02723955|455412635|FG001|Expansion Phase|Physician Decision|0|||
126577749|NCT02723955|455412636|FG002|Expansion Phase|Physician Decision|0|||
126728160|NCT00205699|455954164|FG001|Overall Study|Lost to Follow-up|3|||
126728161|NCT00205699|455954165|FG002|Overall Study|Lost to Follow-up|5|||
126728162|NCT00205699|455954163|FG000|Overall Study|Adverse Event|1|||
126577750|NCT02723955|455412637|FG003|Expansion Phase|Physician Decision|0|||
126577751|NCT02723955|455412638|FG004|Expansion Phase|Physician Decision|0|||
126577752|NCT02723955|455412639|FG005|Expansion Phase|Physician Decision|0|||
126577753|NCT02723955|455412640|FG006|Expansion Phase|Physician Decision|0|||
126577754|NCT02723955|455412641|FG007|Expansion Phase|Physician Decision|0|||
126577755|NCT02723955|455412642|FG008|Expansion Phase|Physician Decision|0|||
126577756|NCT02723955|455412643|FG009|Expansion Phase|Physician Decision|0|||
126577757|NCT02723955|455412644|FG010|Expansion Phase|Physician Decision|0|||
126577758|NCT02723955|455412645|FG011|Expansion Phase|Physician Decision|0|||
126728163|NCT00205699|455954164|FG001|Overall Study|Adverse Event|0|||
126728164|NCT00205699|455954165|FG002|Overall Study|Adverse Event|0|||
126728165|NCT00205699|455954163|FG000|Overall Study|Withdrawal by Subject|1|||
126728166|NCT00205699|455954164|FG001|Overall Study|Withdrawal by Subject|2|||
126728167|NCT00205699|455954165|FG002|Overall Study|Withdrawal by Subject|1|||
126577759|NCT02723955|455412646|FG012|Expansion Phase|Physician Decision|0|||
126577760|NCT02723955|455412647|FG013|Expansion Phase|Physician Decision|0|||
126577761|NCT02723955|455412648|FG014|Expansion Phase|Physician Decision|0|||
126577762|NCT02723955|455412649|FG015|Expansion Phase|Physician Decision|0|||
126728168|NCT00205699|455954163|FG000|Overall Study|Lack of Efficacy|0|||
126728169|NCT00205699|455954164|FG001|Overall Study|Lack of Efficacy|1|||
126577763|NCT02723955|455412650|FG016|Expansion Phase|Physician Decision|0|||
126577764|NCT02723955|455412651|FG017|Expansion Phase|Physician Decision|0|||
126577765|NCT02723955|455412652|FG018|Expansion Phase|Physician Decision|0|||
126577766|NCT02723955|455412653|FG019|Expansion Phase|Physician Decision|0|||
126577767|NCT02723955|455412654|FG020|Expansion Phase|Physician Decision|0|||
126577768|NCT02723955|455412655|FG021|Expansion Phase|Physician Decision|0|||
126577769|NCT02723955|455412656|FG022|Expansion Phase|Physician Decision|0|||
126577770|NCT02723955|455412657|FG023|Expansion Phase|Physician Decision|0|||
126577771|NCT02723955|455412658|FG024|Expansion Phase|Physician Decision|0|||
126577772|NCT02723955|455412659|FG025|Expansion Phase|Physician Decision|0|||
126577773|NCT02723955|455412660|FG026|Expansion Phase|Physician Decision|0|||
126577774|NCT02723955|455412661|FG027|Expansion Phase|Physician Decision|0|||
126577775|NCT02723955|455412662|FG028|Expansion Phase|Physician Decision|0|||
126577776|NCT02723955|455412663|FG029|Expansion Phase|Physician Decision|0|||
126577777|NCT02723955|455412664|FG030|Expansion Phase|Physician Decision|1|||
126577778|NCT02723955|455412665|FG031|Expansion Phase|Physician Decision|1|||
126577779|NCT02723955|455412666|FG032|Expansion Phase|Physician Decision|0|||
126577780|NCT02723955|455412667|FG033|Expansion Phase|Physician Decision|0|||
126577781|NCT02723955|455412668|FG034|Expansion Phase|Physician Decision|0|||
126577782|NCT02723955|455412669|FG035|Expansion Phase|Physician Decision|0|||
126577783|NCT02723955|455412670|FG036|Expansion Phase|Physician Decision|0|||
126577784|NCT02723955|455412671|FG037|Expansion Phase|Physician Decision|0|||
126577785|NCT02723955|455412672|FG038|Expansion Phase|Physician Decision|0|||
126577786|NCT02723955|455412673|FG039|Expansion Phase|Physician Decision|0|||
126577787|NCT02723955|455412674|FG040|Expansion Phase|Physician Decision|0|||
126577788|NCT02723955|455412675|FG041|Expansion Phase|Physician Decision|0|||
126577789|NCT02723955|455412676|FG042|Expansion Phase|Physician Decision|0|||
126577790|NCT02723955|455412634|FG000|Expansion Phase|Withdrawal by Subject|0|||
126577791|NCT02723955|455412635|FG001|Expansion Phase|Withdrawal by Subject|0|||
126577792|NCT02723955|455412636|FG002|Expansion Phase|Withdrawal by Subject|0|||
126577793|NCT02723955|455412637|FG003|Expansion Phase|Withdrawal by Subject|0|||
126577794|NCT02723955|455412638|FG004|Expansion Phase|Withdrawal by Subject|0|||
126577795|NCT02723955|455412639|FG005|Expansion Phase|Withdrawal by Subject|0|||
126577796|NCT02723955|455412640|FG006|Expansion Phase|Withdrawal by Subject|0|||
126577797|NCT02723955|455412641|FG007|Expansion Phase|Withdrawal by Subject|0|||
126577798|NCT02723955|455412642|FG008|Expansion Phase|Withdrawal by Subject|0|||
126577799|NCT02723955|455412643|FG009|Expansion Phase|Withdrawal by Subject|2|||
126577800|NCT02723955|455412644|FG010|Expansion Phase|Withdrawal by Subject|1|||
126577801|NCT02723955|455412645|FG011|Expansion Phase|Withdrawal by Subject|0|||
126728170|NCT00205699|455954165|FG002|Overall Study|Lack of Efficacy|0|||
126728171|NCT03225716|455954172|FG000|Overall Study|Withdrawal by Subject|2|||
126728172|NCT03225716|455954173|FG001|Overall Study|Withdrawal by Subject|2|||
126728173|NCT03225716|455954174|FG002|Overall Study|Withdrawal by Subject|0|||
126728174|NCT03225716|455954172|FG000|Overall Study|Lack of Efficacy|1|||
126728175|NCT03225716|455954173|FG001|Overall Study|Lack of Efficacy|0|||
126728176|NCT03225716|455954174|FG002|Overall Study|Lack of Efficacy|0|||
126728177|NCT03225716|455954172|FG000|Overall Study|Adverse Event|2|||
126728178|NCT03225716|455954173|FG001|Overall Study|Adverse Event|0|||
126728179|NCT03225716|455954174|FG002|Overall Study|Adverse Event|1|||
126728180|NCT03225716|455954172|FG000|Overall Study|Study early termination by Sponsor|0|||
126728181|NCT03225716|455954173|FG001|Overall Study|Study early termination by Sponsor|0|||
126728182|NCT03225716|455954174|FG002|Overall Study|Study early termination by Sponsor|2|||
126728183|NCT01170702|455954177|FG000|Overall Study|Exclusion criteria met after consent|1|||
126728184|NCT01170702|455954178|FG001|Overall Study|Exclusion criteria met after consent|2|||
126728185|NCT01170702|455954179|FG002|Overall Study|Exclusion criteria met after consent|0|||
126728186|NCT01170702|455954180|FG003|Overall Study|Exclusion criteria met after consent|2|||
126728187|NCT01677507|455954181|FG000|Initial Assignment|Adverse Event|0|||
126728188|NCT01677507|455954182|FG001|Initial Assignment|Adverse Event|1|||
126728189|NCT01677507|455954181|FG000|Initial Assignment|Protocol Violation|0|||
126728190|NCT01677507|455954182|FG001|Initial Assignment|Protocol Violation|1|||
126728191|NCT01677507|455954181|FG000|Second Assigment|Withdrawal by Subject|2|||
126728192|NCT01677507|455954182|FG001|Second Assigment|Withdrawal by Subject|2|||
126728193|NCT01677507|455954181|FG000|Second Assigment|Adverse Event|1|||
126728194|NCT01677507|455954182|FG001|Second Assigment|Adverse Event|3|||
126728195|NCT00571688|455954183|FG000|Overall Study|Lost to Follow-up|3|||
126728196|NCT00571688|455954184|FG001|Overall Study|Lost to Follow-up|6|||
126577802|NCT02723955|455412646|FG012|Expansion Phase|Withdrawal by Subject|0|||
126577803|NCT02723955|455412647|FG013|Expansion Phase|Withdrawal by Subject|0|||
126577804|NCT02723955|455412648|FG014|Expansion Phase|Withdrawal by Subject|0|||
126728197|NCT00571688|455954183|FG000|Overall Study|subject did not tolerate Consta|1|||
126728198|NCT00571688|455954184|FG001|Overall Study|subject did not tolerate Consta|0|||
126577805|NCT02723955|455412649|FG015|Expansion Phase|Withdrawal by Subject|0|||
126577806|NCT02723955|455412650|FG016|Expansion Phase|Withdrawal by Subject|0|||
126577807|NCT02723955|455412651|FG017|Expansion Phase|Withdrawal by Subject|0|||
126728199|NCT00571688|455954183|FG000|Overall Study|subject moved out of the area|1|||
126577808|NCT02723955|455412652|FG018|Expansion Phase|Withdrawal by Subject|0|||
126577809|NCT02723955|455412653|FG019|Expansion Phase|Withdrawal by Subject|0|||
126577810|NCT02723955|455412654|FG020|Expansion Phase|Withdrawal by Subject|0|||
126577811|NCT02723955|455412655|FG021|Expansion Phase|Withdrawal by Subject|0|||
126577812|NCT02723955|455412656|FG022|Expansion Phase|Withdrawal by Subject|0|||
126577813|NCT02723955|455412657|FG023|Expansion Phase|Withdrawal by Subject|0|||
126577814|NCT02723955|455412658|FG024|Expansion Phase|Withdrawal by Subject|0|||
126577815|NCT02723955|455412659|FG025|Expansion Phase|Withdrawal by Subject|0|||
126577816|NCT02723955|455412660|FG026|Expansion Phase|Withdrawal by Subject|0|||
126577817|NCT02723955|455412661|FG027|Expansion Phase|Withdrawal by Subject|0|||
126577818|NCT02723955|455412662|FG028|Expansion Phase|Withdrawal by Subject|0|||
126577819|NCT02723955|455412663|FG029|Expansion Phase|Withdrawal by Subject|0|||
126577820|NCT02723955|455412664|FG030|Expansion Phase|Withdrawal by Subject|8|||
126577821|NCT02723955|455412665|FG031|Expansion Phase|Withdrawal by Subject|4|||
126577822|NCT02723955|455412666|FG032|Expansion Phase|Withdrawal by Subject|0|||
126577823|NCT02723955|455412667|FG033|Expansion Phase|Withdrawal by Subject|0|||
126577824|NCT02723955|455412668|FG034|Expansion Phase|Withdrawal by Subject|0|||
126577825|NCT02723955|455412669|FG035|Expansion Phase|Withdrawal by Subject|1|||
126577826|NCT02723955|455412670|FG036|Expansion Phase|Withdrawal by Subject|0|||
126577827|NCT02723955|455412671|FG037|Expansion Phase|Withdrawal by Subject|0|||
126577828|NCT02723955|455412672|FG038|Expansion Phase|Withdrawal by Subject|0|||
126577829|NCT02723955|455412673|FG039|Expansion Phase|Withdrawal by Subject|0|||
126577830|NCT02723955|455412674|FG040|Expansion Phase|Withdrawal by Subject|0|||
126577831|NCT02723955|455412675|FG041|Expansion Phase|Withdrawal by Subject|0|||
126577832|NCT02723955|455412676|FG042|Expansion Phase|Withdrawal by Subject|0|||
126577833|NCT02723955|455412634|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577834|NCT02723955|455412635|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577835|NCT02723955|455412636|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577836|NCT02723955|455412637|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577837|NCT02723955|455412638|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577838|NCT02723955|455412639|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577839|NCT02723955|455412640|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577840|NCT02723955|455412641|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577841|NCT02723955|455412642|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577842|NCT02723955|455412643|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
126577843|NCT02723955|455412644|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
126577844|NCT02723955|455412645|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
126577845|NCT02723955|455412646|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577846|NCT02723955|455412647|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577847|NCT02723955|455412648|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577848|NCT02723955|455412649|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577849|NCT02723955|455412650|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577850|NCT02723955|455412651|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577851|NCT02723955|455412652|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577852|NCT02723955|455412653|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577853|NCT02723955|455412654|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577854|NCT02723955|455412655|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577855|NCT02723955|455412656|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577856|NCT02723955|455412657|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577857|NCT02723955|455412658|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577858|NCT02723955|455412659|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577859|NCT02723955|455412660|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577860|NCT02723955|455412661|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577861|NCT02723955|455412662|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577862|NCT02723955|455412663|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577863|NCT02723955|455412664|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
126577864|NCT02723955|455412665|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577865|NCT02723955|455412666|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577866|NCT02723955|455412667|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577867|NCT02723955|455412668|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126525325|NCT01127178|455216768|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
126525326|NCT01127178|455216767|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
126525327|NCT01127178|455216768|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
126525328|NCT01127178|455216767|FG000|Dose Escalation: Extension Phase|Other|1|||
126525329|NCT01127178|455216768|FG001|Dose Escalation: Extension Phase|Other|0|||
126525330|NCT05177770|455216769|FG000|Overall Study|Death|4|||
126525331|NCT05177770|455216769|FG000|Overall Study|Withdrawal by Subject|1|||
126525332|NCT05177770|455216769|FG000|Overall Study|Adverse Event prior to dosing|1|||
126525333|NCT02365467|455216770|FG000|Overall Study|Death|3|||
126525334|NCT02043782|455216771|FG000|Period 1|Adverse Event|0|||
126525335|NCT02043782|455216772|FG001|Period 1|Adverse Event|0|||
126525336|NCT02043782|455216773|FG002|Period 1|Adverse Event|1|||
126525337|NCT02043782|455216774|FG003|Period 1|Adverse Event|0|||
126525338|NCT02043782|455216775|FG004|Period 1|Adverse Event|0|||
126525339|NCT02043782|455216776|FG005|Period 1|Adverse Event|0|||
126525340|NCT04667117|455216777|FG000|Investigational Period|Lost to Follow-up|0|||
126525341|NCT04667117|455216778|FG001|Investigational Period|Lost to Follow-up|0|||
126525342|NCT04667117|455216779|FG002|Investigational Period|Lost to Follow-up|1|||
126525343|NCT04667117|455216777|FG000|Investigational Period|Protocol Deviation|0|||
126525344|NCT04667117|455216778|FG001|Investigational Period|Protocol Deviation|1|||
126525345|NCT04667117|455216779|FG002|Investigational Period|Protocol Deviation|0|||
126525346|NCT04667117|455216777|FG000|Extension Period|Lost to Follow-up|1|||
126525347|NCT04667117|455216778|FG001|Extension Period|Lost to Follow-up|0|||
126525348|NCT04667117|455216779|FG002|Extension Period|Lost to Follow-up|0|||
126525349|NCT01306162|455216780|FG000|Period 1|Adverse Event|0|||
126525350|NCT01306162|455216781|FG001|Period 1|Adverse Event|0|||
126525351|NCT01306162|455216782|FG002|Period 1|Adverse Event|0|||
126525352|NCT01306162|455216783|FG003|Period 1|Adverse Event|1|||
126525353|NCT01306162|455216780|FG000|Washout 1|Non-compliance to protocol|0|||
126525354|NCT01306162|455216781|FG001|Washout 1|Non-compliance to protocol|1|||
126525355|NCT01306162|455216782|FG002|Washout 1|Non-compliance to protocol|0|||
126525356|NCT01306162|455216783|FG003|Washout 1|Non-compliance to protocol|0|||
126525357|NCT02959437|455216789|FG000|Overall Study|Death|33|||
126525358|NCT02959437|455216790|FG001|Overall Study|Death|3|||
126525359|NCT02959437|455216791|FG002|Overall Study|Death|0|||
126525360|NCT02959437|455216792|FG003|Overall Study|Death|0|||
126525361|NCT02959437|455216789|FG000|Overall Study|Lost to Follow-up|3|||
126525362|NCT02959437|455216790|FG001|Overall Study|Lost to Follow-up|1|||
126525363|NCT02959437|455216791|FG002|Overall Study|Lost to Follow-up|0|||
126525364|NCT02959437|455216792|FG003|Overall Study|Lost to Follow-up|0|||
126525365|NCT02959437|455216789|FG000|Overall Study|Withdrawal by Subject|11|||
126525366|NCT02959437|455216790|FG001|Overall Study|Withdrawal by Subject|3|||
126525367|NCT02959437|455216791|FG002|Overall Study|Withdrawal by Subject|0|||
126525368|NCT02959437|455216792|FG003|Overall Study|Withdrawal by Subject|0|||
126525369|NCT02959437|455216789|FG000|Overall Study|Progressive Disease|9|||
126525370|NCT02959437|455216790|FG001|Overall Study|Progressive Disease|1|||
126525371|NCT02959437|455216791|FG002|Overall Study|Progressive Disease|0|||
126525372|NCT02959437|455216792|FG003|Overall Study|Progressive Disease|0|||
126525373|NCT02959437|455216789|FG000|Overall Study|Study Terminated by Sponsor|4|||
126525374|NCT02959437|455216790|FG001|Overall Study|Study Terminated by Sponsor|0|||
126525375|NCT02959437|455216791|FG002|Overall Study|Study Terminated by Sponsor|0|||
126525376|NCT02959437|455216792|FG003|Overall Study|Study Terminated by Sponsor|0|||
126525377|NCT02959437|455216789|FG000|Overall Study|Other Unspecified|2|||
126525378|NCT02959437|455216790|FG001|Overall Study|Other Unspecified|0|||
126525379|NCT02959437|455216791|FG002|Overall Study|Other Unspecified|0|||
126525380|NCT02959437|455216792|FG003|Overall Study|Other Unspecified|0|||
126525381|NCT00833989|455216802|FG000|Overall Study|Physician Decision|0|||
126525382|NCT00833989|455216803|FG001|Overall Study|Physician Decision|0|||
126525383|NCT00833989|455216804|FG002|Overall Study|Physician Decision|0|||
126525384|NCT00833989|455216805|FG003|Overall Study|Physician Decision|1|||
126525385|NCT00833989|455216802|FG000|Overall Study|Withdrawal by Subject|3|||
126525386|NCT00833989|455216803|FG001|Overall Study|Withdrawal by Subject|0|||
126525387|NCT00833989|455216804|FG002|Overall Study|Withdrawal by Subject|1|||
126525388|NCT00833989|455216805|FG003|Overall Study|Withdrawal by Subject|1|||
126525389|NCT01949480|455216807|FG000|Overall Study|Physician Decision|5|||
126525390|NCT01949480|455216808|FG001|Overall Study|Physician Decision|8|||
126525391|NCT02952924|455216815|FG000|Overall Study|Protocol Violation|0|||
126525392|NCT02952924|455216816|FG001|Overall Study|Protocol Violation|0|||
126525393|NCT02952924|455216817|FG002|Overall Study|Protocol Violation|0|||
126525394|NCT02952924|455216818|FG003|Overall Study|Protocol Violation|0|||
126525395|NCT02952924|455216819|FG004|Overall Study|Protocol Violation|0|||
126525396|NCT02952924|455216820|FG005|Overall Study|Protocol Violation|0|||
126525397|NCT02952924|455216821|FG006|Overall Study|Protocol Violation|0|||
126525398|NCT02952924|455216822|FG007|Overall Study|Protocol Violation|0|||
126525399|NCT02952924|455216823|FG008|Overall Study|Protocol Violation|0|||
126525400|NCT02952924|455216824|FG009|Overall Study|Protocol Violation|0|||
126525401|NCT02952924|455216825|FG010|Overall Study|Protocol Violation|0|||
126525402|NCT02952924|455216826|FG011|Overall Study|Protocol Violation|0|||
126525403|NCT02952924|455216827|FG012|Overall Study|Protocol Violation|0|||
126577868|NCT02723955|455412669|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577869|NCT02723955|455412670|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577870|NCT02723955|455412671|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577871|NCT02723955|455412672|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577872|NCT02723955|455412673|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577873|NCT02723955|455412674|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577874|NCT02723955|455412675|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577875|NCT02723955|455412676|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
126577876|NCT02723955|455412634|FG000|Expansion Phase|Site Closed|0|||
126577877|NCT02723955|455412635|FG001|Expansion Phase|Site Closed|0|||
126577878|NCT02723955|455412636|FG002|Expansion Phase|Site Closed|0|||
126577879|NCT02723955|455412637|FG003|Expansion Phase|Site Closed|0|||
126577880|NCT02723955|455412638|FG004|Expansion Phase|Site Closed|0|||
126577881|NCT02723955|455412639|FG005|Expansion Phase|Site Closed|0|||
126577882|NCT02723955|455412640|FG006|Expansion Phase|Site Closed|0|||
126577883|NCT02723955|455412641|FG007|Expansion Phase|Site Closed|0|||
126577884|NCT02723955|455412642|FG008|Expansion Phase|Site Closed|0|||
126577885|NCT02723955|455412643|FG009|Expansion Phase|Site Closed|1|||
126577886|NCT02723955|455412644|FG010|Expansion Phase|Site Closed|2|||
126577887|NCT02723955|455412645|FG011|Expansion Phase|Site Closed|6|||
126577888|NCT02723955|455412646|FG012|Expansion Phase|Site Closed|0|||
126577889|NCT02723955|455412647|FG013|Expansion Phase|Site Closed|0|||
126577890|NCT02723955|455412648|FG014|Expansion Phase|Site Closed|0|||
126577891|NCT02723955|455412649|FG015|Expansion Phase|Site Closed|0|||
126577892|NCT02723955|455412650|FG016|Expansion Phase|Site Closed|0|||
126577893|NCT02723955|455412651|FG017|Expansion Phase|Site Closed|0|||
126577894|NCT02723955|455412652|FG018|Expansion Phase|Site Closed|0|||
126577895|NCT02723955|455412653|FG019|Expansion Phase|Site Closed|0|||
126577896|NCT02723955|455412654|FG020|Expansion Phase|Site Closed|0|||
126577897|NCT02723955|455412655|FG021|Expansion Phase|Site Closed|0|||
126577898|NCT02723955|455412656|FG022|Expansion Phase|Site Closed|0|||
126577899|NCT02723955|455412657|FG023|Expansion Phase|Site Closed|0|||
126577900|NCT02723955|455412658|FG024|Expansion Phase|Site Closed|0|||
126577901|NCT02723955|455412659|FG025|Expansion Phase|Site Closed|0|||
126577902|NCT02723955|455412660|FG026|Expansion Phase|Site Closed|0|||
126577903|NCT02723955|455412661|FG027|Expansion Phase|Site Closed|0|||
126577904|NCT02723955|455412662|FG028|Expansion Phase|Site Closed|0|||
126577905|NCT02723955|455412663|FG029|Expansion Phase|Site Closed|0|||
126577906|NCT02723955|455412664|FG030|Expansion Phase|Site Closed|8|||
126577907|NCT02723955|455412665|FG031|Expansion Phase|Site Closed|4|||
126577908|NCT02723955|455412666|FG032|Expansion Phase|Site Closed|2|||
126577909|NCT02723955|455412667|FG033|Expansion Phase|Site Closed|2|||
126577910|NCT02723955|455412668|FG034|Expansion Phase|Site Closed|0|||
126577911|NCT02723955|455412669|FG035|Expansion Phase|Site Closed|0|||
126577912|NCT02723955|455412670|FG036|Expansion Phase|Site Closed|0|||
126577913|NCT02723955|455412671|FG037|Expansion Phase|Site Closed|0|||
126728200|NCT00571688|455954184|FG001|Overall Study|subject moved out of the area|0|||
126728201|NCT00190983|455954187|FG000|Overall Study|Inevaluable (never treated)|2|||
126728202|NCT02287402|455954188|FG000|Treatment Period|Adverse Event|17|||
126728203|NCT02287402|455954188|FG000|Treatment Period|Voluntary Withdrawal|10|||
126728204|NCT02287402|455954188|FG000|Follow-up|Lost to Follow-up|1|||
126728205|NCT02287402|455954188|FG000|Follow-up|Voluntary Withdrawal|2|||
126728206|NCT01844830|455954189|FG000|Overall Study|Withdrawal by Subject|1|||
126728207|NCT01844830|455954190|FG001|Overall Study|Withdrawal by Subject|0|||
126728208|NCT04247815|455954191|FG000|Overall Study|Adverse Event|1|||
126728209|NCT04247815|455954192|FG001|Overall Study|Adverse Event|0|||
126728210|NCT04247815|455954191|FG000|Overall Study|Withdrawal by Subject|1|||
126728211|NCT04247815|455954192|FG001|Overall Study|Withdrawal by Subject|0|||
126728212|NCT04247815|455954191|FG000|Overall Study|Protocol Violation|0|||
126728213|NCT04247815|455954192|FG001|Overall Study|Protocol Violation|1|||
126728214|NCT00502320|455954194|FG000|Overall Study|Lost to Follow-up|1|||
126577914|NCT02723955|455412672|FG038|Expansion Phase|Site Closed|0|||
126577915|NCT02723955|455412673|FG039|Expansion Phase|Site Closed|0|||
126577916|NCT02723955|455412674|FG040|Expansion Phase|Site Closed|0|||
126728215|NCT00502320|455954195|FG001|Overall Study|Lost to Follow-up|1|||
126728216|NCT00502320|455954194|FG000|Overall Study|Withdrew Consent|1|||
126728217|NCT00502320|455954195|FG001|Overall Study|Withdrew Consent|0|||
126728218|NCT00502320|455954194|FG000|Overall Study|No longer met criteria|1|||
126577917|NCT02723955|455412675|FG041|Expansion Phase|Site Closed|0|||
126577918|NCT02723955|455412676|FG042|Expansion Phase|Site Closed|0|||
126577919|NCT02723955|455412634|FG000|Crossover/ Re-treatment Phase|Death|0|||
126577920|NCT02723955|455412635|FG001|Crossover/ Re-treatment Phase|Death|0|||
126577921|NCT02723955|455412636|FG002|Crossover/ Re-treatment Phase|Death|0|||
126577922|NCT02723955|455412637|FG003|Crossover/ Re-treatment Phase|Death|0|||
126577923|NCT02723955|455412638|FG004|Crossover/ Re-treatment Phase|Death|0|||
126728219|NCT00502320|455954195|FG001|Overall Study|No longer met criteria|0|||
126577924|NCT02723955|455412639|FG005|Crossover/ Re-treatment Phase|Death|0|||
126577925|NCT02723955|455412640|FG006|Crossover/ Re-treatment Phase|Death|0|||
126577926|NCT02723955|455412641|FG007|Crossover/ Re-treatment Phase|Death|0|||
126577927|NCT02723955|455412642|FG008|Crossover/ Re-treatment Phase|Death|0|||
126577928|NCT02723955|455412643|FG009|Crossover/ Re-treatment Phase|Death|0|||
126577929|NCT02723955|455412644|FG010|Crossover/ Re-treatment Phase|Death|0|||
126577930|NCT02723955|455412645|FG011|Crossover/ Re-treatment Phase|Death|0|||
126577931|NCT02723955|455412646|FG012|Crossover/ Re-treatment Phase|Death|0|||
126577932|NCT02723955|455412647|FG013|Crossover/ Re-treatment Phase|Death|0|||
126777053|NCT02124746|456139165|FG001|Overall Study|Withdrawal by Subject|3|||
126777054|NCT02124746|456139166|FG002|Overall Study|Withdrawal by Subject|0|||
126777055|NCT02124746|456139164|FG000|Overall Study|Study Terminated by Sponsor|0|||
126777056|NCT02124746|456139165|FG001|Overall Study|Study Terminated by Sponsor|0|||
126777057|NCT02124746|456139166|FG002|Overall Study|Study Terminated by Sponsor|6|||
126777058|NCT02124746|456139164|FG000|Overall Study|Disease Progression|3|||
126777059|NCT02124746|456139165|FG001|Overall Study|Disease Progression|6|||
126777060|NCT02124746|456139166|FG002|Overall Study|Disease Progression|4|||
126777061|NCT00571922|456139167|FG000|Overall Study|Completion unknown|36|||
126777062|NCT00571922|456139168|FG001|Overall Study|Completion unknown|36|||
126777063|NCT02191579|456139175|FG000|Treatment 1|Multiple Reasons Specified|27|||
126777064|NCT02191579|456139176|FG001|Treatment 1|Multiple Reasons Specified|58|||
126777065|NCT02191579|456139175|FG000|Treatment 2|Multiple Reasons Specified|0|||
126777066|NCT02191579|456139176|FG001|Treatment 2|Multiple Reasons Specified|25|||
126777067|NCT03940586|456139179|FG000|Overall Study|Death|3|||
126777068|NCT03940586|456139180|FG001|Overall Study|Death|2|||
126777069|NCT03940586|456139181|FG002|Overall Study|Death|0|||
126777070|NCT03940586|456139179|FG000|Overall Study|Physician Decision|1|||
126777071|NCT03940586|456139180|FG001|Overall Study|Physician Decision|0|||
126777072|NCT03940586|456139181|FG002|Overall Study|Physician Decision|1|||
126777073|NCT03940586|456139179|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
126777074|NCT03940586|456139180|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
126777075|NCT03940586|456139181|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
126777076|NCT03940586|456139179|FG000|Overall Study|Not Treated|0|||
126777077|NCT03940586|456139180|FG001|Overall Study|Not Treated|2|||
126777078|NCT03940586|456139181|FG002|Overall Study|Not Treated|0|||
126777079|NCT00964223|456139182|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
126777080|NCT03077828|456139183|FG000|Treatment Cycles|Death|1|||
126777081|NCT03077828|456139183|FG000|Treatment Cycles|Withdrawal by Subject|1|||
126777082|NCT03077828|456139183|FG000|Treatment Cycles|Screen Fail|2|||
126525404|NCT02952924|455216828|FG013|Overall Study|Protocol Violation|0|||
126525405|NCT02952924|455216829|FG014|Overall Study|Protocol Violation|0|||
126525406|NCT02952924|455216830|FG015|Overall Study|Protocol Violation|0|||
126525407|NCT02952924|455216831|FG016|Overall Study|Protocol Violation|0|||
126525408|NCT02952924|455216832|FG017|Overall Study|Protocol Violation|0|||
126525409|NCT02952924|455216833|FG018|Overall Study|Protocol Violation|0|||
126525410|NCT02952924|455216834|FG019|Overall Study|Protocol Violation|1|||
126525411|NCT02952924|455216835|FG020|Overall Study|Protocol Violation|0|||
126525412|NCT02952924|455216836|FG021|Overall Study|Protocol Violation|0|||
126525413|NCT02952924|455216815|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
126525414|NCT02952924|455216816|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
126525415|NCT02952924|455216817|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
126525416|NCT02952924|455216818|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
126525417|NCT02952924|455216819|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
126525418|NCT02952924|455216820|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
126525419|NCT02952924|455216821|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
126525420|NCT02952924|455216822|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
126525421|NCT02952924|455216823|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
126525422|NCT02952924|455216824|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
126525423|NCT02952924|455216825|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
126525424|NCT02952924|455216826|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
126525425|NCT02952924|455216827|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
126525426|NCT02952924|455216828|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
126525427|NCT02952924|455216829|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
126525428|NCT02952924|455216830|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
126777083|NCT03077828|456139183|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
126777084|NCT03077828|456139183|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
126525429|NCT02952924|455216831|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
126577933|NCT02723955|455412648|FG014|Crossover/ Re-treatment Phase|Death|0|||
126777085|NCT03077828|456139183|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
126777086|NCT03077828|456139183|FG000|Follow-up|Patients still in follow-up|15|||
126777087|NCT00345683|456139187|FG000|Overall Study|Lost to Follow-up|19|||
126777088|NCT00345683|456139188|FG001|Overall Study|Lost to Follow-up|7|||
126777089|NCT00345683|456139187|FG000|Overall Study|Other|6|||
126728220|NCT00502320|455954194|FG000|Overall Study|Screen Failure|0|||
126728221|NCT00502320|455954195|FG001|Overall Study|Screen Failure|1|||
126728222|NCT00502320|455954194|FG000|Overall Study|Adverse Event|3|||
126728223|NCT00502320|455954195|FG001|Overall Study|Adverse Event|5|||
126728224|NCT03654755|455954202|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
126728225|NCT03654755|455954203|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
126728226|NCT03654755|455954204|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
126728227|NCT03654755|455954202|FG000|Overall Study|Withdrawal by Subject|2|||
126728228|NCT03654755|455954203|FG001|Overall Study|Withdrawal by Subject|4|||
126728229|NCT03654755|455954204|FG002|Overall Study|Withdrawal by Subject|8|||
126728230|NCT03654755|455954202|FG000|Overall Study|Lost to Follow-up|1|||
126728231|NCT03654755|455954203|FG001|Overall Study|Lost to Follow-up|3|||
126728232|NCT03654755|455954204|FG002|Overall Study|Lost to Follow-up|7|||
126728233|NCT03654755|455954202|FG000|Overall Study|Physician Decision|0|||
126728234|NCT03654755|455954203|FG001|Overall Study|Physician Decision|1|||
126728235|NCT03654755|455954204|FG002|Overall Study|Physician Decision|0|||
126728236|NCT03654755|455954202|FG000|Overall Study|Adverse Event|0|||
126728237|NCT03654755|455954203|FG001|Overall Study|Adverse Event|0|||
126728238|NCT03654755|455954204|FG002|Overall Study|Adverse Event|4|||
126728239|NCT03654755|455954202|FG000|Overall Study|Lack of Efficacy|0|||
126728240|NCT03654755|455954203|FG001|Overall Study|Lack of Efficacy|0|||
126728241|NCT03654755|455954204|FG002|Overall Study|Lack of Efficacy|1|||
126525430|NCT02952924|455216832|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
126525431|NCT02952924|455216833|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
126525432|NCT02952924|455216834|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
126525433|NCT02952924|455216835|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
126525434|NCT02952924|455216836|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
126525435|NCT02952924|455216815|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525436|NCT02952924|455216816|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525437|NCT02952924|455216817|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525438|NCT02952924|455216818|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525439|NCT02952924|455216819|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525440|NCT02952924|455216820|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525441|NCT02952924|455216821|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525442|NCT02952924|455216822|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525443|NCT02952924|455216823|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525444|NCT02952924|455216824|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525445|NCT02952924|455216825|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525446|NCT02952924|455216826|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525447|NCT02952924|455216827|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525448|NCT02952924|455216828|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525449|NCT02952924|455216829|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525450|NCT02952924|455216830|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525451|NCT02952924|455216831|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525452|NCT02952924|455216832|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525453|NCT02952924|455216833|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525454|NCT02952924|455216834|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525455|NCT02952924|455216835|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
126525456|NCT02952924|455216836|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
126525457|NCT02952924|455216815|FG000|Overall Study|Noncompliance with study drug|0|||
126525458|NCT02952924|455216816|FG001|Overall Study|Noncompliance with study drug|0|||
126525459|NCT02952924|455216817|FG002|Overall Study|Noncompliance with study drug|0|||
126525460|NCT02952924|455216818|FG003|Overall Study|Noncompliance with study drug|0|||
126525461|NCT02952924|455216819|FG004|Overall Study|Noncompliance with study drug|0|||
126525462|NCT02952924|455216820|FG005|Overall Study|Noncompliance with study drug|0|||
126525463|NCT02952924|455216821|FG006|Overall Study|Noncompliance with study drug|0|||
126525464|NCT02952924|455216822|FG007|Overall Study|Noncompliance with study drug|0|||
126525465|NCT02952924|455216823|FG008|Overall Study|Noncompliance with study drug|0|||
126525466|NCT02952924|455216824|FG009|Overall Study|Noncompliance with study drug|0|||
126525467|NCT02952924|455216825|FG010|Overall Study|Noncompliance with study drug|0|||
126525468|NCT02952924|455216826|FG011|Overall Study|Noncompliance with study drug|0|||
126525469|NCT02952924|455216827|FG012|Overall Study|Noncompliance with study drug|0|||
126525470|NCT02952924|455216828|FG013|Overall Study|Noncompliance with study drug|0|||
126525471|NCT02952924|455216829|FG014|Overall Study|Noncompliance with study drug|0|||
126525472|NCT02952924|455216830|FG015|Overall Study|Noncompliance with study drug|0|||
126728242|NCT02394808|455954205|FG000|Period 1|Unsatisfactory lens fitting|0|||
126728243|NCT02394808|455954206|FG001|Period 1|Unsatisfactory lens fitting|1|||
126525473|NCT02952924|455216831|FG016|Overall Study|Noncompliance with study drug|0|||
126525474|NCT02952924|455216832|FG017|Overall Study|Noncompliance with study drug|0|||
126525475|NCT02952924|455216833|FG018|Overall Study|Noncompliance with study drug|0|||
126525476|NCT02952924|455216834|FG019|Overall Study|Noncompliance with study drug|0|||
126525477|NCT02952924|455216835|FG020|Overall Study|Noncompliance with study drug|0|||
126525478|NCT02952924|455216836|FG021|Overall Study|Noncompliance with study drug|1|||
126525479|NCT01226745|455216839|FG000|Overall Study|Did not complete schedule of assessments|8|||
126525480|NCT01226745|455216840|FG001|Overall Study|Did not complete schedule of assessments|3|||
126525481|NCT01226745|455216841|FG002|Overall Study|Did not complete schedule of assessments|6|||
126525482|NCT01226745|455216842|FG003|Overall Study|Did not complete schedule of assessments|0|||
126525483|NCT01226745|455216843|FG004|Overall Study|Did not complete schedule of assessments|0|||
126525484|NCT01226745|455216844|FG005|Overall Study|Did not complete schedule of assessments|1|||
126525485|NCT01226745|455216839|FG000|Overall Study|Lost to Follow-up|2|||
126525486|NCT01226745|455216840|FG001|Overall Study|Lost to Follow-up|6|||
126525487|NCT01226745|455216841|FG002|Overall Study|Lost to Follow-up|6|||
126525488|NCT01226745|455216842|FG003|Overall Study|Lost to Follow-up|1|||
126525489|NCT01226745|455216843|FG004|Overall Study|Lost to Follow-up|1|||
126525490|NCT01226745|455216844|FG005|Overall Study|Lost to Follow-up|2|||
126525491|NCT01226745|455216839|FG000|Overall Study|Death|1|||
126525492|NCT01226745|455216840|FG001|Overall Study|Death|0|||
126525493|NCT01226745|455216841|FG002|Overall Study|Death|0|||
126525494|NCT01226745|455216842|FG003|Overall Study|Death|0|||
126525495|NCT01226745|455216843|FG004|Overall Study|Death|0|||
126525496|NCT01226745|455216844|FG005|Overall Study|Death|1|||
126525497|NCT01226745|455216839|FG000|Overall Study|Other|6|||
126525498|NCT01226745|455216840|FG001|Overall Study|Other|7|||
126525499|NCT01226745|455216841|FG002|Overall Study|Other|8|||
126525500|NCT01226745|455216842|FG003|Overall Study|Other|4|||
126525501|NCT01226745|455216843|FG004|Overall Study|Other|3|||
126525502|NCT01226745|455216844|FG005|Overall Study|Other|1|||
126525503|NCT01435577|455216845|FG000|Overall Study|Adverse Event|10|||
126525504|NCT01435577|455216846|FG001|Overall Study|Adverse Event|0|||
126525505|NCT01435577|455216845|FG000|Overall Study|Lack of Efficacy|7|||
126525506|NCT01435577|455216846|FG001|Overall Study|Lack of Efficacy|51|||
126525507|NCT01435577|455216845|FG000|Overall Study|Alternative treatment started|0|||
126525508|NCT01435577|455216846|FG001|Overall Study|Alternative treatment started|1|||
126525509|NCT02105948|455216849|FG000|Overall Study|Adverse Event|10|||
126525510|NCT02105948|455216850|FG001|Overall Study|Adverse Event|7|||
126525511|NCT02105948|455216851|FG002|Overall Study|Adverse Event|11|||
126525512|NCT02105948|455216852|FG003|Overall Study|Adverse Event|11|||
126525513|NCT02105948|455216849|FG000|Overall Study|Lack of Efficacy|0|||
126525514|NCT02105948|455216850|FG001|Overall Study|Lack of Efficacy|1|||
126525515|NCT02105948|455216851|FG002|Overall Study|Lack of Efficacy|3|||
126525516|NCT02105948|455216852|FG003|Overall Study|Lack of Efficacy|2|||
126525517|NCT02105948|455216849|FG000|Overall Study|Lost to Follow-up|0|||
126525518|NCT02105948|455216850|FG001|Overall Study|Lost to Follow-up|0|||
126525519|NCT02105948|455216851|FG002|Overall Study|Lost to Follow-up|2|||
126525520|NCT02105948|455216852|FG003|Overall Study|Lost to Follow-up|1|||
126525521|NCT02105948|455216849|FG000|Overall Study|Physician Decision|2|||
126525522|NCT02105948|455216850|FG001|Overall Study|Physician Decision|2|||
126525523|NCT02105948|455216851|FG002|Overall Study|Physician Decision|2|||
126525524|NCT02105948|455216852|FG003|Overall Study|Physician Decision|2|||
126525525|NCT02105948|455216849|FG000|Overall Study|Withdrawal by Subject|15|||
126525526|NCT02105948|455216850|FG001|Overall Study|Withdrawal by Subject|10|||
126525527|NCT02105948|455216851|FG002|Overall Study|Withdrawal by Subject|10|||
126525528|NCT02105948|455216852|FG003|Overall Study|Withdrawal by Subject|11|||
126525529|NCT01934218|455216853|FG000|Double-blind Phase|Adverse Event|8|||
126525530|NCT01934218|455216854|FG001|Double-blind Phase|Adverse Event|8|||
126525531|NCT01934218|455216853|FG000|Double-blind Phase|Lack of Efficacy|6|||
126525532|NCT01934218|455216854|FG001|Double-blind Phase|Lack of Efficacy|7|||
126525533|NCT01934218|455216853|FG000|Double-blind Phase|Lost to Follow-up|7|||
126525534|NCT01934218|455216854|FG001|Double-blind Phase|Lost to Follow-up|14|||
126525535|NCT01934218|455216853|FG000|Double-blind Phase|Physician Decision|1|||
126525536|NCT01934218|455216854|FG001|Double-blind Phase|Physician Decision|2|||
126525537|NCT01934218|455216853|FG000|Double-blind Phase|Protocol Violation|4|||
126525538|NCT01934218|455216854|FG001|Double-blind Phase|Protocol Violation|0|||
126525539|NCT01934218|455216853|FG000|Double-blind Phase|Withdrawal by Subject|16|||
126525540|NCT01934218|455216854|FG001|Double-blind Phase|Withdrawal by Subject|13|||
126525541|NCT01934218|455216853|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
126525542|NCT01934218|455216854|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
126525543|NCT01934218|455216853|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
126525544|NCT01934218|455216854|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
126525545|NCT01934218|455216853|FG000|Open-Label Phase|Adverse Event|2|||
126525546|NCT01934218|455216854|FG001|Open-Label Phase|Adverse Event|4|||
126525547|NCT01934218|455216853|FG000|Open-Label Phase|Lack of Efficacy|1|||
126525548|NCT01934218|455216854|FG001|Open-Label Phase|Lack of Efficacy|4|||
126525549|NCT01934218|455216853|FG000|Open-Label Phase|Lost to Follow-up|4|||
126525550|NCT01934218|455216854|FG001|Open-Label Phase|Lost to Follow-up|2|||
126525551|NCT01934218|455216853|FG000|Open-Label Phase|Physician Decision|1|||
126525552|NCT01934218|455216854|FG001|Open-Label Phase|Physician Decision|0|||
126525553|NCT01934218|455216853|FG000|Open-Label Phase|Protocol Violation|1|||
126525554|NCT01934218|455216854|FG001|Open-Label Phase|Protocol Violation|0|||
126525555|NCT01934218|455216853|FG000|Open-Label Phase|Withdrawal by Subject|13|||
126525556|NCT01934218|455216854|FG001|Open-Label Phase|Withdrawal by Subject|11|||
126525557|NCT01934218|455216853|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
126525558|NCT01934218|455216854|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
126525559|NCT01934218|455216853|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
126525560|NCT01934218|455216854|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
126525561|NCT02232893|455216855|FG000|Overall Study|Withdrawal by Subject|4|||
126525562|NCT02232893|455216856|FG001|Overall Study|Withdrawal by Subject|1|||
126525563|NCT02232893|455216855|FG000|Overall Study|Adverse Event|0|||
126525564|NCT02232893|455216856|FG001|Overall Study|Adverse Event|1|||
126525565|NCT02232893|455216855|FG000|Overall Study|Sponsor request early termination|0|||
126525566|NCT02232893|455216856|FG001|Overall Study|Sponsor request early termination|1|||
126525567|NCT02232893|455216855|FG000|Overall Study|Developed exclusion criteria|0|||
126525568|NCT02232893|455216856|FG001|Overall Study|Developed exclusion criteria|1|||
126525569|NCT02232893|455216855|FG000|Overall Study|Other|0|||
126525570|NCT02232893|455216856|FG001|Overall Study|Other|3|||
126525571|NCT01196975|455216861|FG000|Overall Study|Adverse Event|2|||
126525572|NCT01196975|455216862|FG001|Overall Study|Adverse Event|2|||
126525573|NCT01196975|455216863|FG002|Overall Study|Adverse Event|0|||
126525574|NCT01196975|455216864|FG003|Overall Study|Adverse Event|0|||
126525575|NCT01196975|455216865|FG004|Overall Study|Adverse Event|2|||
126525576|NCT01196975|455216861|FG000|Overall Study|Withdrawal by Subject|2|||
126525577|NCT01196975|455216862|FG001|Overall Study|Withdrawal by Subject|1|||
126525578|NCT01196975|455216863|FG002|Overall Study|Withdrawal by Subject|0|||
126525579|NCT01196975|455216864|FG003|Overall Study|Withdrawal by Subject|1|||
126525580|NCT01196975|455216865|FG004|Overall Study|Withdrawal by Subject|0|||
126525581|NCT01196975|455216861|FG000|Overall Study|Lost to Follow-up|11|||
126525582|NCT01196975|455216862|FG001|Overall Study|Lost to Follow-up|6|||
126525583|NCT01196975|455216863|FG002|Overall Study|Lost to Follow-up|5|||
126525584|NCT01196975|455216864|FG003|Overall Study|Lost to Follow-up|5|||
126525585|NCT01196975|455216865|FG004|Overall Study|Lost to Follow-up|11|||
126525586|NCT01365494|455216868|FG000|Overall Study|Adverse Event|1|||
126525587|NCT01365494|455216869|FG001|Overall Study|Adverse Event|0|||
126525588|NCT01365494|455216868|FG000|Overall Study|Withdrawal by Subject|0|||
126525589|NCT01365494|455216869|FG001|Overall Study|Withdrawal by Subject|1|||
126525590|NCT01365494|455216868|FG000|Overall Study|Lost to Follow-up|1|||
126525591|NCT01365494|455216869|FG001|Overall Study|Lost to Follow-up|2|||
126525592|NCT00718718|455216870|FG000|Prior to Week 12|Adverse Event|0|||
126525593|NCT00718718|455216871|FG001|Prior to Week 12|Adverse Event|0|||
126525594|NCT00718718|455216872|FG002|Prior to Week 12|Adverse Event|0|||
126525595|NCT00718718|455216873|FG003|Prior to Week 12|Adverse Event|0|||
126525596|NCT00718718|455216874|FG004|Prior to Week 12|Adverse Event|0|||
126525597|NCT00718718|455216875|FG005|Prior to Week 12|Adverse Event|0|||
126525598|NCT00718718|455216876|FG006|Prior to Week 12|Adverse Event|0|||
126525599|NCT00718718|455216877|FG007|Prior to Week 12|Adverse Event|1|||
126525600|NCT00718718|455216878|FG008|Prior to Week 12|Adverse Event|1|||
126525601|NCT00718718|455216879|FG009|Prior to Week 12|Adverse Event|0|||
126525602|NCT00718718|455216870|FG000|Prior to Week 12|Withdrawal by Subject|0|||
126525603|NCT00718718|455216871|FG001|Prior to Week 12|Withdrawal by Subject|0|||
126525604|NCT00718718|455216872|FG002|Prior to Week 12|Withdrawal by Subject|0|||
126525605|NCT00718718|455216873|FG003|Prior to Week 12|Withdrawal by Subject|0|||
126525606|NCT00718718|455216874|FG004|Prior to Week 12|Withdrawal by Subject|3|||
126525607|NCT00718718|455216875|FG005|Prior to Week 12|Withdrawal by Subject|0|||
126525608|NCT00718718|455216876|FG006|Prior to Week 12|Withdrawal by Subject|1|||
126525609|NCT00718718|455216877|FG007|Prior to Week 12|Withdrawal by Subject|1|||
126525610|NCT00718718|455216878|FG008|Prior to Week 12|Withdrawal by Subject|1|||
126525611|NCT00718718|455216879|FG009|Prior to Week 12|Withdrawal by Subject|0|||
126525612|NCT00718718|455216870|FG000|Prior to Week 12|Other|1|||
126525613|NCT00718718|455216871|FG001|Prior to Week 12|Other|0|||
126525614|NCT00718718|455216872|FG002|Prior to Week 12|Other|1|||
126525615|NCT00718718|455216873|FG003|Prior to Week 12|Other|0|||
126525616|NCT00718718|455216874|FG004|Prior to Week 12|Other|0|||
126525617|NCT00718718|455216875|FG005|Prior to Week 12|Other|0|||
126525618|NCT00718718|455216876|FG006|Prior to Week 12|Other|0|||
126525619|NCT00718718|455216877|FG007|Prior to Week 12|Other|0|||
126525620|NCT00718718|455216878|FG008|Prior to Week 12|Other|0|||
126525621|NCT00718718|455216879|FG009|Prior to Week 12|Other|0|||
126525622|NCT00718718|455216870|FG000|Week 12 to End of Study|Adverse Event|0|||
126525623|NCT00718718|455216871|FG001|Week 12 to End of Study|Adverse Event|0|||
126577934|NCT02723955|455412649|FG015|Crossover/ Re-treatment Phase|Death|0|||
126525624|NCT00718718|455216872|FG002|Week 12 to End of Study|Adverse Event|0|||
126525625|NCT00718718|455216873|FG003|Week 12 to End of Study|Adverse Event|0|||
126525626|NCT00718718|455216874|FG004|Week 12 to End of Study|Adverse Event|0|||
126525627|NCT00718718|455216875|FG005|Week 12 to End of Study|Adverse Event|0|||
126525628|NCT00718718|455216876|FG006|Week 12 to End of Study|Adverse Event|0|||
126525629|NCT00718718|455216877|FG007|Week 12 to End of Study|Adverse Event|1|||
126525630|NCT00718718|455216878|FG008|Week 12 to End of Study|Adverse Event|0|||
126525631|NCT00718718|455216879|FG009|Week 12 to End of Study|Adverse Event|0|||
126525632|NCT00718718|455216870|FG000|Week 12 to End of Study|Death|0|||
126525633|NCT00718718|455216871|FG001|Week 12 to End of Study|Death|0|||
126525634|NCT00718718|455216872|FG002|Week 12 to End of Study|Death|0|||
126525635|NCT00718718|455216873|FG003|Week 12 to End of Study|Death|0|||
126525636|NCT00718718|455216874|FG004|Week 12 to End of Study|Death|0|||
126525637|NCT00718718|455216875|FG005|Week 12 to End of Study|Death|1|||
126525638|NCT00718718|455216876|FG006|Week 12 to End of Study|Death|0|||
126525639|NCT00718718|455216877|FG007|Week 12 to End of Study|Death|0|||
126525640|NCT00718718|455216878|FG008|Week 12 to End of Study|Death|0|||
126525641|NCT00718718|455216879|FG009|Week 12 to End of Study|Death|0|||
126525642|NCT00718718|455216870|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
126525643|NCT00718718|455216871|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
126525644|NCT00718718|455216872|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
126525645|NCT00718718|455216873|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
126525646|NCT00718718|455216874|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
126525647|NCT00718718|455216875|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
126525648|NCT00718718|455216876|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
126525649|NCT00718718|455216877|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
126525650|NCT00718718|455216878|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
126525651|NCT00718718|455216879|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
126525652|NCT00718718|455216870|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
126577935|NCT02723955|455412650|FG016|Crossover/ Re-treatment Phase|Death|0|||
126577936|NCT02723955|455412651|FG017|Crossover/ Re-treatment Phase|Death|0|||
126577937|NCT02723955|455412652|FG018|Crossover/ Re-treatment Phase|Death|0|||
126728244|NCT02394808|455954205|FG000|Period 2|Lost to Follow-up|1|||
126728245|NCT02394808|455954206|FG001|Period 2|Lost to Follow-up|0|||
126728246|NCT04580394|455954210|FG000|First Intervention|Incorrectly Randomized|1|||
126728247|NCT04580394|455954210|FG000|First Intervention|Physician Decision|1|||
126728248|NCT04580394|455954210|FG000|First Intervention|Lost to Follow-up|1|||
126728249|NCT04580394|455954210|FG000|Washout (One Week)|Withdrawal by Subject|1|||
126728250|NCT04580394|455954210|FG000|Washout (One Week)|Adverse Event|1|||
126728251|NCT04580394|455954210|FG000|Washout (One Week)|Withdrawal by Subject|2|||
126728252|NCT04580394|455954210|FG000|Third Intervention|Adverse Event|1|||
126728253|NCT04580394|455954210|FG000|Third Intervention|Withdrawal by Subject|1|||
126728254|NCT04580394|455954210|FG000|Washout (One Week)|Withdrawal by Subject|2|||
126728255|NCT00642746|455954212|FG000|Overall Study|Patient unevaluable|1|||
126728256|NCT00642746|455954213|FG001|Overall Study|Patient unevaluable|0|||
126728257|NCT00077610|455954214|FG000|Overall Study|Adverse Event|9|||
126728258|NCT00077610|455954215|FG001|Overall Study|Adverse Event|7|||
126728259|NCT00077610|455954216|FG002|Overall Study|Adverse Event|1|||
126728260|NCT00077610|455954214|FG000|Overall Study|Lost to Follow-up|0|||
126728261|NCT00077610|455954215|FG001|Overall Study|Lost to Follow-up|1|||
126728262|NCT00077610|455954216|FG002|Overall Study|Lost to Follow-up|2|||
126728263|NCT00077610|455954214|FG000|Overall Study|Withdrawal by Subject|4|||
126728264|NCT00077610|455954215|FG001|Overall Study|Withdrawal by Subject|10|||
126728265|NCT00077610|455954216|FG002|Overall Study|Withdrawal by Subject|6|||
126728266|NCT00077610|455954214|FG000|Overall Study|Death|17|||
126728267|NCT00077610|455954215|FG001|Overall Study|Death|13|||
126728268|NCT00077610|455954216|FG002|Overall Study|Death|13|||
126728269|NCT00077610|455954214|FG000|Overall Study|Renal transplant|12|||
126728270|NCT00077610|455954215|FG001|Overall Study|Renal transplant|15|||
126728271|NCT00077610|455954216|FG002|Overall Study|Renal transplant|11|||
126728272|NCT00077610|455954214|FG000|Overall Study|Withdrew from dialysis care|5|||
126728273|NCT00077610|455954215|FG001|Overall Study|Withdrew from dialysis care|0|||
126728274|NCT00077610|455954216|FG002|Overall Study|Withdrew from dialysis care|3|||
126728275|NCT00077610|455954214|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126728276|NCT00077610|455954215|FG001|Overall Study|Insufficient Therapeutic Response|0|||
126728277|NCT00077610|455954216|FG002|Overall Study|Insufficient Therapeutic Response|0|||
126728278|NCT00077610|455954214|FG000|Overall Study|Multiple blood transfusions|0|||
126728279|NCT00077610|455954215|FG001|Overall Study|Multiple blood transfusions|0|||
126728280|NCT00077610|455954216|FG002|Overall Study|Multiple blood transfusions|1|||
126728281|NCT00077610|455954214|FG000|Overall Study|Principal Investigator's decision|1|||
126728282|NCT00077610|455954215|FG001|Overall Study|Principal Investigator's decision|0|||
126728283|NCT00077610|455954216|FG002|Overall Study|Principal Investigator's decision|1|||
126525653|NCT00718718|455216871|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
126577938|NCT02723955|455412653|FG019|Crossover/ Re-treatment Phase|Death|0|||
126525654|NCT00718718|455216872|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
126525655|NCT00718718|455216873|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
126525656|NCT00718718|455216874|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
126525657|NCT00718718|455216875|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
126525658|NCT00718718|455216876|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
126577939|NCT02723955|455412654|FG020|Crossover/ Re-treatment Phase|Death|0|||
126577940|NCT02723955|455412655|FG021|Crossover/ Re-treatment Phase|Death|0|||
126577941|NCT02723955|455412656|FG022|Crossover/ Re-treatment Phase|Death|0|||
126728284|NCT00077610|455954214|FG000|Overall Study|Worsening of health condition|1|||
126728285|NCT00077610|455954215|FG001|Overall Study|Worsening of health condition|1|||
126728286|NCT00077610|455954216|FG002|Overall Study|Worsening of health condition|0|||
126728287|NCT00077610|455954214|FG000|Overall Study|Given Epogen in hospital|1|||
126728288|NCT00077610|455954215|FG001|Overall Study|Given Epogen in hospital|0|||
126728289|NCT00077610|455954216|FG002|Overall Study|Given Epogen in hospital|0|||
126728290|NCT00077610|455954214|FG000|Overall Study|Transferred to other unit|0|||
126728291|NCT00077610|455954215|FG001|Overall Study|Transferred to other unit|0|||
126525659|NCT00718718|455216877|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
126525660|NCT00718718|455216878|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
126525661|NCT00718718|455216879|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
126525662|NCT00718718|455216870|FG000|Week 12 to End of Study|Other|0|||
126525663|NCT00718718|455216871|FG001|Week 12 to End of Study|Other|1|||
126525664|NCT00718718|455216872|FG002|Week 12 to End of Study|Other|0|||
126525665|NCT00718718|455216873|FG003|Week 12 to End of Study|Other|1|||
126525666|NCT00718718|455216874|FG004|Week 12 to End of Study|Other|0|||
126525667|NCT00718718|455216875|FG005|Week 12 to End of Study|Other|0|||
126525668|NCT00718718|455216876|FG006|Week 12 to End of Study|Other|1|||
126525669|NCT00718718|455216877|FG007|Week 12 to End of Study|Other|0|||
126525670|NCT00718718|455216878|FG008|Week 12 to End of Study|Other|0|||
126525671|NCT00718718|455216879|FG009|Week 12 to End of Study|Other|0|||
126525672|NCT04558346|455216890|FG000|Overall Study|Withdrawal by Subject|2|||
126525673|NCT04558346|455216891|FG001|Overall Study|Withdrawal by Subject|0|||
126525674|NCT04558346|455216890|FG000|Overall Study|Lost to Follow-up|0|||
126525675|NCT04558346|455216891|FG001|Overall Study|Lost to Follow-up|1|||
126525676|NCT04558346|455216890|FG000|Overall Study|Adverse Event|0|||
126525677|NCT04558346|455216891|FG001|Overall Study|Adverse Event|1|||
126525678|NCT01462344|455216892|FG000|Overall Study|Withdrawal by Subject|245|||
126525679|NCT01462344|455216893|FG001|Overall Study|Withdrawal by Subject|226|||
126525680|NCT01462344|455216892|FG000|Overall Study|Adverse Event|24|||
126525681|NCT01462344|455216893|FG001|Overall Study|Adverse Event|23|||
126525682|NCT01462344|455216892|FG000|Overall Study|Asthma Exacerbation|34|||
126525683|NCT01462344|455216893|FG001|Overall Study|Asthma Exacerbation|35|||
126525684|NCT01462344|455216892|FG000|Overall Study|Lack of Efficacy|5|||
126525685|NCT01462344|455216893|FG001|Overall Study|Lack of Efficacy|6|||
126525686|NCT01462344|455216892|FG000|Overall Study|Protocol Violation|68|||
126525687|NCT01462344|455216893|FG001|Overall Study|Protocol Violation|53|||
126525688|NCT01462344|455216892|FG000|Overall Study|Lost to Follow-up|7|||
126525689|NCT01462344|455216893|FG001|Overall Study|Lost to Follow-up|7|||
126525690|NCT00724971|455216894|FG000|Overall Study|Adverse Event|5|||
126525691|NCT00724971|455216894|FG000|Overall Study|Withdrawal by Subject|1|||
126525692|NCT01003249|455216895|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
126525693|NCT01003249|455216896|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
126525694|NCT01003249|455216895|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
126525695|NCT01003249|455216896|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
126525696|NCT01003249|455216895|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
126525697|NCT01003249|455216896|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
126525698|NCT01003249|455216895|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
126525699|NCT01003249|455216896|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
126525700|NCT01962974|455216899|FG000|Overall Study|Study termination|7|||
126525701|NCT01692197|455216900|FG000|Overall Study|Failed Screening|3|||
126525702|NCT03086447|455216902|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
126525703|NCT03086447|455216903|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
126525704|NCT03086447|455216902|FG000|Overall Study|Lost Lens|2|||
126525705|NCT03086447|455216903|FG001|Overall Study|Lost Lens|5|||
126525706|NCT03086447|455216902|FG000|Overall Study|Product quality complaint|0|||
126525707|NCT03086447|455216903|FG001|Overall Study|Product quality complaint|1|||
126525708|NCT03086447|455216902|FG000|Overall Study|Lens Damage|1|||
126525709|NCT03086447|455216903|FG001|Overall Study|Lens Damage|6|||
126525710|NCT03086447|455216902|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
126525711|NCT03086447|455216903|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
126577942|NCT02723955|455412657|FG023|Crossover/ Re-treatment Phase|Death|0|||
126577943|NCT02723955|455412658|FG024|Crossover/ Re-treatment Phase|Death|0|||
126728292|NCT00077610|455954216|FG002|Overall Study|Transferred to other unit|1|||
126728293|NCT00077610|455954214|FG000|Overall Study|Transferred to nursing home|0|||
126728294|NCT00077610|455954215|FG001|Overall Study|Transferred to nursing home|0|||
126777090|NCT00345683|456139188|FG001|Overall Study|Other|2|||
126525712|NCT03086447|455216902|FG000|Overall Study|Test Article No Longer Available|1|||
126525713|NCT03086447|455216903|FG001|Overall Study|Test Article No Longer Available|0|||
126525714|NCT03086447|455216902|FG000|Overall Study|Protocol Violation|2|||
126525715|NCT03086447|455216903|FG001|Overall Study|Protocol Violation|4|||
126525716|NCT03086447|455216902|FG000|Overall Study|Lost to Follow-up|0|||
126525717|NCT03086447|455216903|FG001|Overall Study|Lost to Follow-up|1|||
126577944|NCT02723955|455412659|FG025|Crossover/ Re-treatment Phase|Death|0|||
126577945|NCT02723955|455412660|FG026|Crossover/ Re-treatment Phase|Death|0|||
126577946|NCT02723955|455412661|FG027|Crossover/ Re-treatment Phase|Death|0|||
126577947|NCT02723955|455412662|FG028|Crossover/ Re-treatment Phase|Death|0|||
126577948|NCT02723955|455412663|FG029|Crossover/ Re-treatment Phase|Death|0|||
126577949|NCT02723955|455412664|FG030|Crossover/ Re-treatment Phase|Death|0|||
126577950|NCT02723955|455412665|FG031|Crossover/ Re-treatment Phase|Death|0|||
126577951|NCT02723955|455412666|FG032|Crossover/ Re-treatment Phase|Death|0|||
126577952|NCT02723955|455412667|FG033|Crossover/ Re-treatment Phase|Death|0|||
126577953|NCT02723955|455412668|FG034|Crossover/ Re-treatment Phase|Death|0|||
126577954|NCT02723955|455412669|FG035|Crossover/ Re-treatment Phase|Death|0|||
126577955|NCT02723955|455412670|FG036|Crossover/ Re-treatment Phase|Death|0|||
126577956|NCT02723955|455412671|FG037|Crossover/ Re-treatment Phase|Death|1|||
126577957|NCT02723955|455412672|FG038|Crossover/ Re-treatment Phase|Death|14|||
126577958|NCT02723955|455412673|FG039|Crossover/ Re-treatment Phase|Death|32|||
126577959|NCT02723955|455412674|FG040|Crossover/ Re-treatment Phase|Death|2|||
126577960|NCT02723955|455412675|FG041|Crossover/ Re-treatment Phase|Death|1|||
126577961|NCT02723955|455412676|FG042|Crossover/ Re-treatment Phase|Death|0|||
126577962|NCT02723955|455412634|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577963|NCT02723955|455412635|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577964|NCT02723955|455412636|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577965|NCT02723955|455412637|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577966|NCT02723955|455412638|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577967|NCT02723955|455412639|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577968|NCT02723955|455412640|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577969|NCT02723955|455412641|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577970|NCT02723955|455412642|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577971|NCT02723955|455412643|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577972|NCT02723955|455412644|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577973|NCT02723955|455412645|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577974|NCT02723955|455412646|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577975|NCT02723955|455412647|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577976|NCT02723955|455412648|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577977|NCT02723955|455412649|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577978|NCT02723955|455412650|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577979|NCT02723955|455412651|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577980|NCT02723955|455412652|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577981|NCT02723955|455412653|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577982|NCT02723955|455412654|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577983|NCT02723955|455412655|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577984|NCT02723955|455412656|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577985|NCT02723955|455412657|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577986|NCT02723955|455412658|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577987|NCT02723955|455412659|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577988|NCT02723955|455412660|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577989|NCT02723955|455412661|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577990|NCT02723955|455412662|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577991|NCT02723955|455412663|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577992|NCT02723955|455412664|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577993|NCT02723955|455412665|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577994|NCT02723955|455412666|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577995|NCT02723955|455412667|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577996|NCT02723955|455412668|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577997|NCT02723955|455412669|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577998|NCT02723955|455412670|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126577999|NCT02723955|455412671|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126578000|NCT02723955|455412672|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126578001|NCT02723955|455412673|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
126578002|NCT02723955|455412674|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126578003|NCT02723955|455412675|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126578004|NCT02723955|455412676|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
126578005|NCT02723955|455412634|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578006|NCT02723955|455412635|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578007|NCT02723955|455412636|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578008|NCT02723955|455412637|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578009|NCT02723955|455412638|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578010|NCT02723955|455412639|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578011|NCT02723955|455412640|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578012|NCT02723955|455412641|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578013|NCT02723955|455412642|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578014|NCT02723955|455412643|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578015|NCT02723955|455412644|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
126525718|NCT03086447|455216902|FG000|Overall Study|Adverse Event|3|||
126525719|NCT03086447|455216903|FG001|Overall Study|Adverse Event|0|||
126525720|NCT03086447|455216902|FG000|Overall Study|Lens Discomfort|2|||
126525721|NCT03086447|455216903|FG001|Overall Study|Lens Discomfort|1|||
126525722|NCT03394924|455216909|FG000|Overall Study|Adverse Event|0|||
126525723|NCT03394924|455216910|FG001|Overall Study|Adverse Event|5|||
126525724|NCT03394924|455216911|FG002|Overall Study|Adverse Event|0|||
126525725|NCT03394924|455216909|FG000|Overall Study|Withdrawal by Subject|2|||
126525726|NCT03394924|455216910|FG001|Overall Study|Withdrawal by Subject|0|||
126525727|NCT03394924|455216911|FG002|Overall Study|Withdrawal by Subject|0|||
126525728|NCT03394924|455216909|FG000|Overall Study|Lost to Follow-up|0|||
126525729|NCT03394924|455216910|FG001|Overall Study|Lost to Follow-up|1|||
126525730|NCT03394924|455216911|FG002|Overall Study|Lost to Follow-up|0|||
126525731|NCT03394924|455216909|FG000|Overall Study|Did not meet all inclusion criteria|1|||
126525732|NCT03394924|455216910|FG001|Overall Study|Did not meet all inclusion criteria|0|||
126525733|NCT03394924|455216911|FG002|Overall Study|Did not meet all inclusion criteria|0|||
126525734|NCT03588572|455216914|FG000|Visitation 1|Lack of Efficacy|1|||
126525735|NCT03588572|455216915|FG001|Visitation 1|Lack of Efficacy|1|||
126525736|NCT03588572|455216914|FG000|Visitation 2|Lost to Follow-up|1|||
126525737|NCT03588572|455216915|FG001|Visitation 2|Lost to Follow-up|1|||
126525738|NCT03588572|455216914|FG000|Visitation 2|Lack of Efficacy|0|||
126525739|NCT03588572|455216915|FG001|Visitation 2|Lack of Efficacy|1|||
126525740|NCT03588572|455216914|FG000|Visitation 2|Withdrawal by Subject|1|||
126525741|NCT03588572|455216915|FG001|Visitation 2|Withdrawal by Subject|0|||
126525742|NCT03588572|455216914|FG000|Visitation 3|Lost to Follow-up|1|||
126525743|NCT03588572|455216915|FG001|Visitation 3|Lost to Follow-up|1|||
126525744|NCT03588572|455216914|FG000|Visitation 3|Physician Decision|1|||
126525745|NCT03588572|455216915|FG001|Visitation 3|Physician Decision|1|||
126525746|NCT03588572|455216914|FG000|Visitation 3|Withdrawal by Subject|1|||
126525747|NCT03588572|455216915|FG001|Visitation 3|Withdrawal by Subject|0|||
126525748|NCT03387852|455216920|FG000|Overall Study|Adverse event (AE)|3|||
126525749|NCT03387852|455216921|FG001|Overall Study|Adverse event (AE)|0|||
126525750|NCT03387852|455216922|FG002|Overall Study|Adverse event (AE)|2|||
126525751|NCT03387852|455216923|FG003|Overall Study|Adverse event (AE)|0|||
126525752|NCT03387852|455216920|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
126525753|NCT03387852|455216921|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
126525754|NCT03387852|455216922|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
126525755|NCT03387852|455216923|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
126525756|NCT03387852|455216920|FG000|Overall Study|Withdrawal by participant|1|||
126525757|NCT03387852|455216921|FG001|Overall Study|Withdrawal by participant|1|||
126525758|NCT03387852|455216922|FG002|Overall Study|Withdrawal by participant|3|||
126525759|NCT03387852|455216923|FG003|Overall Study|Withdrawal by participant|2|||
126525760|NCT03387852|455216920|FG000|Overall Study|Other- Unspecified|1|||
126525761|NCT03387852|455216921|FG001|Overall Study|Other- Unspecified|1|||
126525762|NCT03387852|455216922|FG002|Overall Study|Other- Unspecified|2|||
126525763|NCT03387852|455216923|FG003|Overall Study|Other- Unspecified|1|||
126525764|NCT03387852|455216920|FG000|Overall Study|Poor compliance to protocol|0|||
126525765|NCT03387852|455216921|FG001|Overall Study|Poor compliance to protocol|0|||
126525766|NCT03387852|455216922|FG002|Overall Study|Poor compliance to protocol|0|||
126525767|NCT03387852|455216923|FG003|Overall Study|Poor compliance to protocol|1|||
126525768|NCT03387852|455216920|FG000|Overall Study|Randomized and not treated|0|||
126525769|NCT03387852|455216921|FG001|Overall Study|Randomized and not treated|0|||
126525770|NCT03387852|455216922|FG002|Overall Study|Randomized and not treated|0|||
126525771|NCT03387852|455216923|FG003|Overall Study|Randomized and not treated|1|||
126525772|NCT02535065|455216929|FG000|Overall Study|Death|13|||
126525773|NCT02535065|455216929|FG000|Overall Study|Lost to Follow-up|1|||
126525774|NCT02535065|455216929|FG000|Overall Study|Withdrawal by Subject|6|||
126525775|NCT00110617|455216930|FG000|Overall Study|Adverse Event|2|||
126525776|NCT00110617|455216931|FG001|Overall Study|Adverse Event|4|||
126525777|NCT00110617|455216930|FG000|Overall Study|Abnormal Laboratory Value|4|||
126525778|NCT00110617|455216931|FG001|Overall Study|Abnormal Laboratory Value|2|||
126525779|NCT00110617|455216930|FG000|Overall Study|Lack of Efficacy|1|||
126525780|NCT00110617|455216931|FG001|Overall Study|Lack of Efficacy|0|||
126525781|NCT00110617|455216930|FG000|Overall Study|Patient no longer requires study drug|1|||
126525782|NCT00110617|455216931|FG001|Overall Study|Patient no longer requires study drug|0|||
126525783|NCT00110617|455216930|FG000|Overall Study|Protocol Violation|5|||
126525784|NCT00110617|455216931|FG001|Overall Study|Protocol Violation|0|||
126525785|NCT00110617|455216930|FG000|Overall Study|Withdrawal by Subject|10|||
126525786|NCT00110617|455216931|FG001|Overall Study|Withdrawal by Subject|4|||
126525787|NCT00110617|455216930|FG000|Overall Study|Lost to Follow-up|9|||
126525788|NCT00110617|455216931|FG001|Overall Study|Lost to Follow-up|1|||
126525789|NCT00110617|455216930|FG000|Overall Study|Administrative problems|6|||
126525790|NCT00110617|455216931|FG001|Overall Study|Administrative problems|5|||
126525791|NCT00110617|455216930|FG000|Overall Study|Death|1|||
126525792|NCT00110617|455216931|FG001|Overall Study|Death|1|||
126525793|NCT00110617|455216930|FG000|Overall Study|Did not receive study drug|0|||
126525794|NCT00110617|455216931|FG001|Overall Study|Did not receive study drug|12|||
126578016|NCT02723955|455412645|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578017|NCT02723955|455412646|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578018|NCT02723955|455412647|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578019|NCT02723955|455412648|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578020|NCT02723955|455412649|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578021|NCT02723955|455412650|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578022|NCT02723955|455412651|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578023|NCT02723955|455412652|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578024|NCT02723955|455412653|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578025|NCT02723955|455412654|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578026|NCT02723955|455412655|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578027|NCT02723955|455412656|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578028|NCT02723955|455412657|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578029|NCT02723955|455412658|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578030|NCT02723955|455412659|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578031|NCT02723955|455412660|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578032|NCT02723955|455412661|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578033|NCT02723955|455412662|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578034|NCT02723955|455412663|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578035|NCT02723955|455412664|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578036|NCT02723955|455412665|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578037|NCT02723955|455412666|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578038|NCT02723955|455412667|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578039|NCT02723955|455412668|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578040|NCT02723955|455412669|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578041|NCT02723955|455412670|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578042|NCT02723955|455412671|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578043|NCT02723955|455412672|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
126578044|NCT02723955|455412673|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
126578045|NCT02723955|455412674|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578046|NCT02723955|455412675|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
126578047|NCT02723955|455412676|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
126578048|NCT02723955|455412634|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
126578049|NCT02723955|455412635|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
126578050|NCT02723955|455412636|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
126578051|NCT02723955|455412637|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
126578052|NCT02723955|455412638|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
126578053|NCT02723955|455412639|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
126578054|NCT02723955|455412640|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
126578055|NCT02723955|455412641|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
126578056|NCT02723955|455412642|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
126578057|NCT02723955|455412643|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
126578058|NCT02723955|455412644|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
126578059|NCT02723955|455412645|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
126578060|NCT02723955|455412646|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
126578061|NCT02723955|455412647|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
126578062|NCT02723955|455412648|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
126578063|NCT02723955|455412649|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
126578064|NCT02723955|455412650|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
126578065|NCT02723955|455412651|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
126578066|NCT02723955|455412652|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
126578067|NCT02723955|455412653|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
126578068|NCT02723955|455412654|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
126578069|NCT02723955|455412655|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
126578070|NCT02723955|455412656|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
126578071|NCT02723955|455412657|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
126578072|NCT02723955|455412658|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
126578073|NCT02723955|455412659|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
126578074|NCT02723955|455412660|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
126578075|NCT02723955|455412661|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
126578076|NCT02723955|455412662|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
126728295|NCT00077610|455954216|FG002|Overall Study|Transferred to nursing home|1|||
126728296|NCT00077610|455954214|FG000|Overall Study|Transfer to satellite unit|1|||
126728297|NCT00077610|455954215|FG001|Overall Study|Transfer to satellite unit|0|||
126728298|NCT00077610|455954216|FG002|Overall Study|Transfer to satellite unit|0|||
126728299|NCT00077610|455954214|FG000|Overall Study|Transfer to other center for surgery|1|||
126578077|NCT02723955|455412663|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
126578078|NCT02723955|455412664|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
126578079|NCT02723955|455412665|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
126578080|NCT02723955|455412666|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
126578081|NCT02723955|455412667|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
126578082|NCT02723955|455412668|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
126578083|NCT02723955|455412669|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
126728300|NCT00077610|455954215|FG001|Overall Study|Transfer to other center for surgery|0|||
126728301|NCT00077610|455954216|FG002|Overall Study|Transfer to other center for surgery|0|||
126728302|NCT00077610|455954214|FG000|Overall Study|Change in dialysis modality|1|||
126728303|NCT00077610|455954215|FG001|Overall Study|Change in dialysis modality|0|||
126728304|NCT00077610|455954216|FG002|Overall Study|Change in dialysis modality|0|||
126728305|NCT00077610|455954214|FG000|Overall Study|Relocation|0|||
126728306|NCT00077610|455954215|FG001|Overall Study|Relocation|8|||
126728307|NCT00077610|455954216|FG002|Overall Study|Relocation|5|||
126728308|NCT00077610|455954214|FG000|Overall Study|Financial issues|0|||
126728309|NCT00077610|455954215|FG001|Overall Study|Financial issues|1|||
126728310|NCT00077610|455954216|FG002|Overall Study|Financial issues|0|||
126728311|NCT00077610|455954214|FG000|Overall Study|Sponsors decision to withdraw|0|||
126728312|NCT00077610|455954215|FG001|Overall Study|Sponsors decision to withdraw|0|||
126525795|NCT01781572|455216932|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
126525796|NCT01781572|455216933|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
126525797|NCT01781572|455216934|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
126525798|NCT01781572|455216932|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
126525799|NCT01781572|455216933|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
126525800|NCT01781572|455216934|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
126525801|NCT01781572|455216932|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
126525802|NCT01781572|455216933|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
126525803|NCT01781572|455216934|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
126525804|NCT01781572|455216932|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
126525805|NCT01781572|455216933|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
126525806|NCT01781572|455216934|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
126525807|NCT01781572|455216932|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
126525808|NCT01781572|455216933|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
126525809|NCT01781572|455216934|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
126525810|NCT01781572|455216932|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
126525811|NCT01781572|455216933|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
126525812|NCT01781572|455216934|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
126525813|NCT01781572|455216932|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
126525814|NCT01781572|455216933|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
126525815|NCT01781572|455216934|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
126525816|NCT01781572|455216932|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
126525817|NCT01781572|455216933|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
126525818|NCT01781572|455216934|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
126525819|NCT01781572|455216932|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
126525820|NCT01781572|455216933|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
126525821|NCT01781572|455216934|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
126525822|NCT01781572|455216932|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
126525823|NCT01781572|455216933|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
126525824|NCT01781572|455216934|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
126525825|NCT01781572|455216932|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
126525826|NCT01781572|455216933|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
126525827|NCT01781572|455216934|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
126525828|NCT01781572|455216932|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
126525829|NCT01781572|455216933|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
126525830|NCT01781572|455216934|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
126525831|NCT01781572|455216932|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
126525832|NCT01781572|455216933|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
126525833|NCT01781572|455216934|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
126525834|NCT01781572|455216932|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
126525835|NCT01781572|455216933|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
126525836|NCT01781572|455216934|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
126525837|NCT01781572|455216932|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
126525838|NCT01781572|455216933|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
126525839|NCT01781572|455216934|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
126525840|NCT01781572|455216932|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
126525841|NCT01781572|455216933|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
126525842|NCT01781572|455216934|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
126525843|NCT01781572|455216932|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
126525844|NCT01781572|455216933|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
126525845|NCT01781572|455216934|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
126525846|NCT01781572|455216932|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
126525847|NCT01781572|455216933|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
126525848|NCT01781572|455216934|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
126728313|NCT00077610|455954216|FG002|Overall Study|Sponsors decision to withdraw|1|||
126525849|NCT00045110|455216935|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
126578084|NCT02723955|455412670|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
126578085|NCT02723955|455412671|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
126728314|NCT00976950|455954217|FG000|Overall Study|Adverse Event|3|||
126578086|NCT02723955|455412672|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
126578087|NCT02723955|455412673|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
126578088|NCT02723955|455412674|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
126578089|NCT02723955|455412675|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
126578090|NCT02723955|455412676|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
126578091|NCT02566902|455412678|FG000|Overall Study|Protocol Violation|2|||
126578092|NCT02566902|455412679|FG001|Overall Study|Protocol Violation|1|||
126578093|NCT02379819|455412680|FG000|Overall Study|Withdrawal by Subject|10|||
126578094|NCT02379819|455412680|FG000|Overall Study|Death|2|||
126578095|NCT02379819|455412680|FG000|Overall Study|Lack of Efficacy|1|||
126578096|NCT02379819|455412680|FG000|Overall Study|Lost to Follow-up|1|||
126578097|NCT00520546|455412681|FG000|Overall Study|Withdrawal by Subject|1|||
126578098|NCT00520546|455412681|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
126578099|NCT02101281|455412685|FG000|Overall Study|Adverse Event|0|||
126578100|NCT02101281|455412686|FG001|Overall Study|Adverse Event|1|||
126578101|NCT04452318|455412687|FG000|Overall Study|Physician Decision|1|||
126578102|NCT04452318|455412688|FG001|Overall Study|Physician Decision|2|||
126578103|NCT04452318|455412689|FG002|Overall Study|Physician Decision|0|||
126578104|NCT04452318|455412690|FG003|Overall Study|Physician Decision|2|||
126578105|NCT04452318|455412691|FG004|Overall Study|Physician Decision|0|||
126578106|NCT04452318|455412692|FG005|Overall Study|Physician Decision|2|||
126578107|NCT04452318|455412693|FG006|Overall Study|Physician Decision|5|||
126578108|NCT04452318|455412687|FG000|Overall Study|Death|2|||
126578109|NCT04452318|455412688|FG001|Overall Study|Death|3|||
126578110|NCT04452318|455412689|FG002|Overall Study|Death|0|||
126578111|NCT04452318|455412690|FG003|Overall Study|Death|0|||
126578112|NCT04452318|455412691|FG004|Overall Study|Death|0|||
126578113|NCT04452318|455412692|FG005|Overall Study|Death|0|||
126578114|NCT04452318|455412693|FG006|Overall Study|Death|0|||
126578115|NCT04452318|455412687|FG000|Overall Study|Lost to Follow-up|38|||
126578116|NCT04452318|455412688|FG001|Overall Study|Lost to Follow-up|28|||
126578117|NCT04452318|455412689|FG002|Overall Study|Lost to Follow-up|0|||
126578118|NCT04452318|455412690|FG003|Overall Study|Lost to Follow-up|3|||
126578119|NCT04452318|455412691|FG004|Overall Study|Lost to Follow-up|3|||
126578120|NCT04452318|455412692|FG005|Overall Study|Lost to Follow-up|2|||
126578121|NCT04452318|455412693|FG006|Overall Study|Lost to Follow-up|1|||
126578122|NCT04452318|455412687|FG000|Overall Study|Withdrawal by Subject|46|||
126578123|NCT04452318|455412688|FG001|Overall Study|Withdrawal by Subject|40|||
126578124|NCT04452318|455412689|FG002|Overall Study|Withdrawal by Subject|0|||
126578125|NCT04452318|455412690|FG003|Overall Study|Withdrawal by Subject|18|||
126578126|NCT04452318|455412691|FG004|Overall Study|Withdrawal by Subject|6|||
126578127|NCT04452318|455412692|FG005|Overall Study|Withdrawal by Subject|8|||
126578128|NCT04452318|455412693|FG006|Overall Study|Withdrawal by Subject|6|||
126578129|NCT03951805|455412695|FG000|Overall Study|Adverse Event|1|||
126578130|NCT03951805|455412696|FG001|Overall Study|Adverse Event|0|||
126578131|NCT03951805|455412697|FG002|Overall Study|Adverse Event|0|||
126578132|NCT03951805|455412698|FG003|Overall Study|Adverse Event|0|||
126578133|NCT00604669|455412699|FG000|Overall Study|lack of information in chart|7|||
126578134|NCT01695954|455412700|FG000|Overall Study|Withdrawal by Subject|4|||
126578135|NCT01695954|455412701|FG001|Overall Study|Withdrawal by Subject|0|||
126578136|NCT01695954|455412700|FG000|Overall Study|Adverse Event|0|||
126578137|NCT01695954|455412701|FG001|Overall Study|Adverse Event|2|||
126578138|NCT04328727|455412703|FG000|Overall Study|Guardian Decision|1|||
126578139|NCT04328727|455412703|FG000|Overall Study|Participant decision|4|||
126578140|NCT04328727|455412703|FG000|Overall Study|Death|3|||
126578141|NCT03684044|455412704|FG000|Overall Study|Adverse Event|3|||
126578142|NCT03684044|455412705|FG001|Overall Study|Adverse Event|0|||
126578143|NCT03684044|455412704|FG000|Overall Study|Death|4|||
126578144|NCT03684044|455412705|FG001|Overall Study|Death|7|||
126578145|NCT03684044|455412704|FG000|Overall Study|Lost to Follow-up|3|||
126578146|NCT03684044|455412705|FG001|Overall Study|Lost to Follow-up|2|||
126578147|NCT03684044|455412704|FG000|Overall Study|Patient Not Available|0|||
126578148|NCT03684044|455412705|FG001|Overall Study|Patient Not Available|2|||
126578149|NCT03684044|455412704|FG000|Overall Study|Physician Decision|1|||
126578150|NCT03684044|455412705|FG001|Overall Study|Physician Decision|0|||
126578151|NCT03684044|455412704|FG000|Overall Study|Withdrawal by Subject|11|||
126578152|NCT03684044|455412705|FG001|Overall Study|Withdrawal by Subject|9|||
126578153|NCT03703336|455412706|FG000|Overall Study|Parent withdrew consent|29|||
126578154|NCT03703336|455412707|FG001|Overall Study|Parent withdrew consent|8|||
126578155|NCT03703336|455412706|FG000|Overall Study|Migration|3|||
126578156|NCT03703336|455412707|FG001|Overall Study|Migration|3|||
126578157|NCT03703336|455412706|FG000|Overall Study|Protocol Violation|3|||
126777091|NCT04288115|456139189|FG000|Overall Study|Withdrawal by Subject|0|||
126578158|NCT03703336|455412707|FG001|Overall Study|Protocol Violation|1|||
126777092|NCT04288115|456139190|FG001|Overall Study|Withdrawal by Subject|1|||
126578159|NCT03703336|455412706|FG000|Overall Study|Physician Decision|2|||
126578160|NCT03703336|455412707|FG001|Overall Study|Physician Decision|0|||
126578161|NCT03703336|455412706|FG000|Overall Study|Adverse Event|0|||
126578162|NCT03703336|455412707|FG001|Overall Study|Adverse Event|2|||
126578163|NCT03703336|455412706|FG000|Overall Study|Lost to Follow-up|1|||
126525850|NCT00045110|455216936|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
126525851|NCT00045110|455216937|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
126525852|NCT00045110|455216935|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
126525853|NCT00045110|455216936|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
126525854|NCT00045110|455216937|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
126525855|NCT00045110|455216935|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
126525856|NCT00045110|455216936|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
126525857|NCT00045110|455216937|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
126525858|NCT00660010|455216938|FG000|Overall Study|Withdrawal by Subject|2|||
126525859|NCT00660010|455216938|FG000|Overall Study|Lost to Follow-up|3|||
126525860|NCT00660010|455216938|FG000|Overall Study|Adverse Event|1|||
126525861|NCT00660010|455216938|FG000|Overall Study|Noncompliance with visit schedule|3|||
126525862|NCT04827576|455219509|FG000|Overall Study|Death|5|||
126525863|NCT04827576|455219510|FG001|Overall Study|Death|17|||
126525864|NCT04827576|455219511|FG002|Overall Study|Death|17|||
126525865|NCT04827576|455219512|FG003|Overall Study|Death|32|||
126525866|NCT04827576|455219509|FG000|Overall Study|Study Terminated by Sponsor|2|||
126525867|NCT04827576|455219510|FG001|Overall Study|Study Terminated by Sponsor|9|||
126525868|NCT04827576|455219511|FG002|Overall Study|Study Terminated by Sponsor|7|||
126525869|NCT04827576|455219512|FG003|Overall Study|Study Terminated by Sponsor|5|||
126525870|NCT04827576|455219509|FG000|Overall Study|Investigator's Discretion|1|||
126525871|NCT04827576|455219510|FG001|Overall Study|Investigator's Discretion|0|||
126525872|NCT04827576|455219511|FG002|Overall Study|Investigator's Discretion|2|||
126525873|NCT04827576|455219512|FG003|Overall Study|Investigator's Discretion|5|||
126525874|NCT04827576|455219509|FG000|Overall Study|Withdrew Consent|0|||
126525875|NCT04827576|455219510|FG001|Overall Study|Withdrew Consent|3|||
126525876|NCT04827576|455219511|FG002|Overall Study|Withdrew Consent|0|||
126525877|NCT04827576|455219512|FG003|Overall Study|Withdrew Consent|0|||
126525878|NCT04827576|455219509|FG000|Overall Study|Lost to Follow-up|1|||
126525879|NCT04827576|455219510|FG001|Overall Study|Lost to Follow-up|0|||
126525880|NCT04827576|455219511|FG002|Overall Study|Lost to Follow-up|0|||
126525881|NCT04827576|455219512|FG003|Overall Study|Lost to Follow-up|0|||
126525882|NCT03069482|455219513|FG000|Overall Study|Lost to Follow-up|0|||
126525883|NCT03069482|455219514|FG001|Overall Study|Lost to Follow-up|1|||
126525884|NCT03069482|455219513|FG000|Overall Study|Physician Decision|1|||
126525885|NCT03069482|455219514|FG001|Overall Study|Physician Decision|0|||
126525886|NCT04537923|455219515|FG000|Overall Study|Adverse Event|2|||
126525887|NCT04537923|455219516|FG001|Overall Study|Adverse Event|1|||
126525888|NCT04537923|455219517|FG002|Overall Study|Adverse Event|2|||
126525889|NCT04537923|455219518|FG003|Overall Study|Adverse Event|4|||
126525890|NCT04537923|455219515|FG000|Overall Study|Death|3|||
126525891|NCT04537923|455219516|FG001|Overall Study|Death|3|||
126525892|NCT04537923|455219517|FG002|Overall Study|Death|1|||
126525893|NCT04537923|455219518|FG003|Overall Study|Death|11|||
126525894|NCT04537923|455219515|FG000|Overall Study|Lost to Follow-up|1|||
126525895|NCT04537923|455219516|FG001|Overall Study|Lost to Follow-up|2|||
126525896|NCT04537923|455219517|FG002|Overall Study|Lost to Follow-up|1|||
126525897|NCT04537923|455219518|FG003|Overall Study|Lost to Follow-up|6|||
126525898|NCT04537923|455219515|FG000|Overall Study|Physician Decision|1|||
126525899|NCT04537923|455219516|FG001|Overall Study|Physician Decision|0|||
126525900|NCT04537923|455219517|FG002|Overall Study|Physician Decision|2|||
126525901|NCT04537923|455219518|FG003|Overall Study|Physician Decision|5|||
126525902|NCT04537923|455219515|FG000|Overall Study|Pregnancy|1|||
126525903|NCT04537923|455219516|FG001|Overall Study|Pregnancy|0|||
126525904|NCT04537923|455219517|FG002|Overall Study|Pregnancy|0|||
126525905|NCT04537923|455219518|FG003|Overall Study|Pregnancy|0|||
126525906|NCT04537923|455219515|FG000|Overall Study|Withdrawal by Subject|4|||
126525907|NCT04537923|455219516|FG001|Overall Study|Withdrawal by Subject|4|||
126525908|NCT04537923|455219517|FG002|Overall Study|Withdrawal by Subject|4|||
126525909|NCT04537923|455219518|FG003|Overall Study|Withdrawal by Subject|58|||
126525910|NCT04537923|455219515|FG000|Overall Study|Missed study visits|2|||
126525911|NCT04537923|455219516|FG001|Overall Study|Missed study visits|0|||
126525912|NCT04537923|455219517|FG002|Overall Study|Missed study visits|0|||
126525913|NCT04537923|455219518|FG003|Overall Study|Missed study visits|3|||
126525914|NCT04537923|455219515|FG000|Overall Study|Sponsor's decision|0|||
126525915|NCT04537923|455219516|FG001|Overall Study|Sponsor's decision|0|||
126525916|NCT04537923|455219517|FG002|Overall Study|Sponsor's decision|1|||
126525917|NCT04537923|455219518|FG003|Overall Study|Sponsor's decision|1|||
126525918|NCT04537923|455219515|FG000|Overall Study|Safety reasons|1|||
126525919|NCT04537923|455219516|FG001|Overall Study|Safety reasons|0|||
126525920|NCT04537923|455219517|FG002|Overall Study|Safety reasons|0|||
126525921|NCT04537923|455219518|FG003|Overall Study|Safety reasons|0|||
126525922|NCT01261611|455219519|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
126525923|NCT01261611|455219520|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
126525924|NCT01261611|455219521|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
126525925|NCT01261611|455219519|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
126525926|NCT01261611|455219520|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
126525927|NCT01261611|455219521|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
126578164|NCT03703336|455412707|FG001|Overall Study|Lost to Follow-up|0|||
126578165|NCT00595413|455412708|FG000|Overall Study|Adverse Event|0|||
126578166|NCT00595413|455412709|FG001|Overall Study|Adverse Event|2|||
126578167|NCT00595413|455412710|FG002|Overall Study|Adverse Event|1|||
126578168|NCT00595413|455412711|FG003|Overall Study|Adverse Event|1|||
126578169|NCT00595413|455412708|FG000|Overall Study|Lost to Follow-up|2|||
126578170|NCT00595413|455412709|FG001|Overall Study|Lost to Follow-up|2|||
126578171|NCT00595413|455412710|FG002|Overall Study|Lost to Follow-up|1|||
126578172|NCT00595413|455412711|FG003|Overall Study|Lost to Follow-up|3|||
126578173|NCT00595413|455412708|FG000|Overall Study|Death|0|||
126578174|NCT00595413|455412709|FG001|Overall Study|Death|0|||
126578175|NCT00595413|455412710|FG002|Overall Study|Death|1|||
126578176|NCT00595413|455412711|FG003|Overall Study|Death|0|||
126578177|NCT00595413|455412708|FG000|Overall Study|Other|5|||
126578178|NCT00595413|455412709|FG001|Overall Study|Other|1|||
126578179|NCT00595413|455412710|FG002|Overall Study|Other|5|||
126578180|NCT00595413|455412711|FG003|Overall Study|Other|0|||
126578181|NCT04149002|455412712|FG000|Overall Study|Lost to Follow-up|1|||
126578182|NCT04149002|455412713|FG001|Overall Study|Lost to Follow-up|0|||
126578183|NCT04149002|455412712|FG000|Overall Study|Withdrawal by Subject|1|||
126578184|NCT04149002|455412713|FG001|Overall Study|Withdrawal by Subject|0|||
126578185|NCT04629950|455412714|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
126578186|NCT04629950|455412715|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
126578187|NCT04629950|455412716|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
126578188|NCT04629950|455412717|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
126578189|NCT04629950|455412714|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
126578190|NCT04629950|455412715|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
126578191|NCT04629950|455412716|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
126578192|NCT04629950|455412717|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
126578193|NCT04629950|455412714|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
126578194|NCT04629950|455412715|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
126578195|NCT04629950|455412716|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
126578196|NCT04629950|455412717|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
126578197|NCT04629950|455412714|FG000|Extension Study|Withdrawal by Subject|0|||
126578198|NCT04629950|455412715|FG001|Extension Study|Withdrawal by Subject|0|||
126578199|NCT04629950|455412716|FG002|Extension Study|Withdrawal by Subject|1|||
126578200|NCT04629950|455412717|FG003|Extension Study|Withdrawal by Subject|0|||
126578201|NCT04629950|455412714|FG000|Extension Study|Adverse Event|0|||
126578202|NCT04629950|455412715|FG001|Extension Study|Adverse Event|0|||
126578203|NCT04629950|455412716|FG002|Extension Study|Adverse Event|0|||
126578204|NCT04629950|455412717|FG003|Extension Study|Adverse Event|1|||
126578205|NCT03233633|455412718|FG000|Overall Study|Adverse Event|2|||
126578206|NCT03233633|455412718|FG000|Overall Study|Less Than 3 Days of Data|6|||
126578207|NCT02088853|455412719|FG000|Overall Study|Pregnancy|1|||
126578208|NCT02088853|455412720|FG001|Overall Study|Pregnancy|0|||
126578209|NCT01198145|455412722|FG000|Overall Study|Withdrawal by Subject|1|||
126578210|NCT01198145|455412723|FG001|Overall Study|Withdrawal by Subject|1|||
126578211|NCT01697969|455412726|FG000|Overall Study|Did not meet inc/exc criteria|3|||
126578212|NCT01561989|455412727|FG000|Overall Study|accural target not met.|5|||
126578213|NCT01561989|455412728|FG001|Overall Study|accural target not met.|6|||
126578214|NCT03447249|455412731|FG000|Overall Study|Adverse Event|1|||
126578215|NCT03447249|455412732|FG001|Overall Study|Adverse Event|0|||
126578216|NCT03447249|455412731|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
126578217|NCT03447249|455412732|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
126578218|NCT03447249|455412731|FG000|Overall Study|Other|3|||
126578219|NCT03447249|455412732|FG001|Overall Study|Other|0|||
126578220|NCT01388361|455412733|FG000|Overall Study|Adverse Event|0|||
126578221|NCT01388361|455412734|FG001|Overall Study|Adverse Event|5|||
126728315|NCT00976950|455954217|FG000|Overall Study|Events with no relationship to Aptivus|3|||
126728316|NCT00304915|455954218|FG000|Overall Study|Lost to Follow-up|11|||
126728317|NCT00304915|455954219|FG001|Overall Study|Lost to Follow-up|11|||
126728318|NCT00304915|455954218|FG000|Overall Study|Death|4|||
126578222|NCT01388361|455412735|FG002|Overall Study|Adverse Event|1|||
126578223|NCT01388361|455412733|FG000|Overall Study|Protocol Violation|0|||
126578224|NCT01388361|455412734|FG001|Overall Study|Protocol Violation|0|||
126578225|NCT01388361|455412735|FG002|Overall Study|Protocol Violation|2|||
126578226|NCT01388361|455412733|FG000|Overall Study|Withdrawal criteria|12|||
126578227|NCT01388361|455412734|FG001|Overall Study|Withdrawal criteria|7|||
126578228|NCT01388361|455412735|FG002|Overall Study|Withdrawal criteria|10|||
126578229|NCT01388361|455412733|FG000|Overall Study|Unclassified|0|||
126578230|NCT01388361|455412734|FG001|Overall Study|Unclassified|0|||
126578231|NCT01388361|455412735|FG002|Overall Study|Unclassified|1|||
126578232|NCT01070069|455412736|FG000|Overall Study|Death|1|||
126578233|NCT01070069|455412737|FG001|Overall Study|Death|0|||
126728319|NCT00304915|455954219|FG001|Overall Study|Death|5|||
126578234|NCT01070069|455412738|FG002|Overall Study|Death|2|||
126578235|NCT01070069|455412739|FG003|Overall Study|Death|0|||
126578236|NCT01070069|455412740|FG004|Overall Study|Death|1|||
126525928|NCT01261611|455219519|FG000|Treatment Cycle 1|Adverse Event|0|||
126525929|NCT01261611|455219520|FG001|Treatment Cycle 1|Adverse Event|1|||
126525930|NCT01261611|455219521|FG002|Treatment Cycle 1|Adverse Event|0|||
126578237|NCT01070069|455412736|FG000|Overall Study|Withdrawal by Subject|1|||
126578238|NCT01070069|455412737|FG001|Overall Study|Withdrawal by Subject|1|||
126578239|NCT01070069|455412738|FG002|Overall Study|Withdrawal by Subject|4|||
126578240|NCT01070069|455412739|FG003|Overall Study|Withdrawal by Subject|0|||
126578241|NCT01070069|455412740|FG004|Overall Study|Withdrawal by Subject|0|||
126578242|NCT01070069|455412736|FG000|Overall Study|Lost to Follow-up|4|||
126578243|NCT01070069|455412737|FG001|Overall Study|Lost to Follow-up|1|||
126578244|NCT01070069|455412738|FG002|Overall Study|Lost to Follow-up|0|||
126578245|NCT01070069|455412739|FG003|Overall Study|Lost to Follow-up|0|||
126578246|NCT01070069|455412740|FG004|Overall Study|Lost to Follow-up|3|||
126578247|NCT01499199|455412743|FG000|Overall Study|Adverse Event|1|||
126578248|NCT01499199|455412743|FG000|Overall Study|Lack of Efficacy|1|||
126578249|NCT02539225|455412749|FG000|Part A|Adverse Event|13|||
126578250|NCT02539225|455412750|FG001|Part A|Adverse Event|4|||
126578251|NCT02539225|455412749|FG000|Part A|Withdrawal by Subject|2|||
126578252|NCT02539225|455412750|FG001|Part A|Withdrawal by Subject|4|||
126578253|NCT02539225|455412749|FG000|Part A|Physician Decision|4|||
126578254|NCT02539225|455412750|FG001|Part A|Physician Decision|7|||
126578255|NCT02539225|455412749|FG000|Part A|Did Not Receive study Drug|1|||
126578256|NCT02539225|455412750|FG001|Part A|Did Not Receive study Drug|1|||
126578257|NCT02539225|455412749|FG000|Pre Treatment for Part B|Progressive disease|1|||
126578258|NCT02539225|455412750|FG001|Pre Treatment for Part B|Progressive disease|1|||
126578259|NCT02539225|455412749|FG000|Pre Treatment for Part B|Adverse Event|1|||
126578260|NCT02539225|455412750|FG001|Pre Treatment for Part B|Adverse Event|1|||
126578261|NCT02539225|455412749|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
126578262|NCT02539225|455412750|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
126578263|NCT02539225|455412749|FG000|Pre Treatment for Part B|Physician Decision|2|||
126578264|NCT02539225|455412750|FG001|Pre Treatment for Part B|Physician Decision|0|||
126578265|NCT02539225|455412749|FG000|Part B|Adverse Event|4|||
126578266|NCT02539225|455412750|FG001|Part B|Adverse Event|4|||
126578267|NCT02539225|455412749|FG000|Part B|Withdrawal by Subject|0|||
126578268|NCT02539225|455412750|FG001|Part B|Withdrawal by Subject|3|||
126578269|NCT02539225|455412749|FG000|Part B|Physician Decision|0|||
126578270|NCT02539225|455412750|FG001|Part B|Physician Decision|9|||
126578271|NCT02318134|455412751|FG000|Overall Study|Withdrawal by Subject|2|||
126578272|NCT02318134|455412752|FG001|Overall Study|Withdrawal by Subject|1|||
126578273|NCT04766034|455412753|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
126578274|NCT04766034|455412754|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
126578275|NCT04766034|455412755|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
126578276|NCT04766034|455412756|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
126578277|NCT04766034|455412757|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
126578278|NCT04766034|455412753|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
126578279|NCT04766034|455412754|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
126578280|NCT04766034|455412755|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
126578281|NCT04766034|455412756|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
126578282|NCT04766034|455412757|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
126578283|NCT04766034|455412753|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
126578284|NCT04766034|455412754|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
126578285|NCT04766034|455412755|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
126578286|NCT04766034|455412756|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
126578287|NCT04766034|455412757|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
126578288|NCT04766034|455412753|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
126578289|NCT04766034|455412754|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
126578290|NCT04766034|455412755|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
126578291|NCT04766034|455412756|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
126578292|NCT04766034|455412757|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
126525931|NCT01261611|455219519|FG000|Treatment Cycle 1|Protocol Violation|0|||
126525932|NCT01261611|455219520|FG001|Treatment Cycle 1|Protocol Violation|0|||
126525933|NCT01261611|455219521|FG002|Treatment Cycle 1|Protocol Violation|2|||
126525934|NCT01261611|455219519|FG000|Treatment Cycle 2|Completed study|4|||
126525935|NCT01261611|455219520|FG001|Treatment Cycle 2|Completed study|0|||
126525936|NCT01261611|455219521|FG002|Treatment Cycle 2|Completed study|0|||
126525937|NCT01261611|455219519|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
126525938|NCT01261611|455219520|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
126525939|NCT01261611|455219521|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
126525940|NCT01261611|455219519|FG000|Treatment Cycle 2|Adverse Event|1|||
126525941|NCT01261611|455219520|FG001|Treatment Cycle 2|Adverse Event|0|||
126525942|NCT01261611|455219521|FG002|Treatment Cycle 2|Adverse Event|0|||
126525943|NCT01261611|455219519|FG000|Treatment Cycle 2|Protocol Violation|2|||
126525944|NCT01261611|455219520|FG001|Treatment Cycle 2|Protocol Violation|0|||
126525945|NCT01261611|455219521|FG002|Treatment Cycle 2|Protocol Violation|0|||
126525946|NCT01261611|455219519|FG000|Treatment Cycle 2|Not otherwise specified|2|||
126525947|NCT01261611|455219520|FG001|Treatment Cycle 2|Not otherwise specified|0|||
126525948|NCT01261611|455219521|FG002|Treatment Cycle 2|Not otherwise specified|0|||
126525949|NCT01261611|455219519|FG000|Treatment Cycle 3|Completed study|24|||
126525950|NCT01261611|455219520|FG001|Treatment Cycle 3|Completed study|0|||
126525951|NCT01261611|455219521|FG002|Treatment Cycle 3|Completed study|0|||
126525952|NCT01261611|455219519|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
126525953|NCT01261611|455219520|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
126525954|NCT01261611|455219521|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
126525955|NCT01261611|455219519|FG000|Treatment Cycle 3|Adverse Event|1|||
126525956|NCT01261611|455219520|FG001|Treatment Cycle 3|Adverse Event|0|||
126525957|NCT01261611|455219521|FG002|Treatment Cycle 3|Adverse Event|0|||
126525958|NCT01261611|455219519|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
126525959|NCT01261611|455219520|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
126525960|NCT01261611|455219521|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
126525961|NCT01261611|455219519|FG000|Treatment Cycle 4|Completed study|87|||
126525962|NCT01261611|455219520|FG001|Treatment Cycle 4|Completed study|0|||
126525963|NCT01261611|455219521|FG002|Treatment Cycle 4|Completed study|0|||
126525964|NCT01261611|455219519|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
126525965|NCT01261611|455219520|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
126525966|NCT01261611|455219521|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
126525967|NCT01261611|455219519|FG000|Treatment Cycle 4|Adverse Event|1|||
126525968|NCT01261611|455219520|FG001|Treatment Cycle 4|Adverse Event|0|||
126525969|NCT01261611|455219521|FG002|Treatment Cycle 4|Adverse Event|0|||
126525970|NCT01261611|455219519|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
126525971|NCT01261611|455219520|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
126525972|NCT01261611|455219521|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
126525973|NCT01261611|455219519|FG000|Treatment Cycle 4|Not otherwise specified|3|||
126525974|NCT01261611|455219520|FG001|Treatment Cycle 4|Not otherwise specified|0|||
126525975|NCT01261611|455219521|FG002|Treatment Cycle 4|Not otherwise specified|0|||
126525976|NCT01261611|455219519|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
126525977|NCT01261611|455219520|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
126525978|NCT01261611|455219521|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
126525979|NCT01261611|455219519|FG000|Treatment Cycle 5|Adverse Event|1|||
126525980|NCT01261611|455219520|FG001|Treatment Cycle 5|Adverse Event|0|||
126525981|NCT01261611|455219521|FG002|Treatment Cycle 5|Adverse Event|0|||
126525982|NCT01261611|455219519|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
126525983|NCT01261611|455219520|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
126525984|NCT01261611|455219521|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
126525985|NCT02527798|455219522|FG000|Overall Study|Physician Decision|1|||
126525986|NCT02527798|455219523|FG001|Overall Study|Physician Decision|0|||
126525987|NCT02527798|455219524|FG002|Overall Study|Physician Decision|1|||
126525988|NCT02527798|455219525|FG003|Overall Study|Physician Decision|1|||
126525989|NCT02527798|455219526|FG004|Overall Study|Physician Decision|0|||
126525990|NCT02527798|455219527|FG005|Overall Study|Physician Decision|0|||
126525991|NCT02527798|455219522|FG000|Overall Study|Death|0|||
126525992|NCT02527798|455219523|FG001|Overall Study|Death|0|||
126525993|NCT02527798|455219524|FG002|Overall Study|Death|1|||
126525994|NCT02527798|455219525|FG003|Overall Study|Death|0|||
126525995|NCT02527798|455219526|FG004|Overall Study|Death|0|||
126525996|NCT02527798|455219527|FG005|Overall Study|Death|0|||
126525997|NCT02527798|455219522|FG000|Overall Study|Withdrawal by Subject|0|||
126525998|NCT02527798|455219523|FG001|Overall Study|Withdrawal by Subject|1|||
126525999|NCT02527798|455219524|FG002|Overall Study|Withdrawal by Subject|2|||
126526000|NCT02527798|455219525|FG003|Overall Study|Withdrawal by Subject|0|||
126526001|NCT02527798|455219526|FG004|Overall Study|Withdrawal by Subject|0|||
126526002|NCT02527798|455219527|FG005|Overall Study|Withdrawal by Subject|0|||
126526003|NCT02527798|455219522|FG000|Overall Study|Reason undisclosed|1|||
126526004|NCT02527798|455219523|FG001|Overall Study|Reason undisclosed|0|||
126526005|NCT02527798|455219524|FG002|Overall Study|Reason undisclosed|1|||
126526006|NCT02527798|455219525|FG003|Overall Study|Reason undisclosed|0|||
126526007|NCT02527798|455219526|FG004|Overall Study|Reason undisclosed|0|||
126526008|NCT02527798|455219527|FG005|Overall Study|Reason undisclosed|0|||
126526009|NCT02527798|455219522|FG000|Overall Study|Did not receive intervention|1|||
126526010|NCT02527798|455219523|FG001|Overall Study|Did not receive intervention|1|||
126526011|NCT02527798|455219524|FG002|Overall Study|Did not receive intervention|0|||
126526012|NCT02527798|455219525|FG003|Overall Study|Did not receive intervention|0|||
126526013|NCT02527798|455219526|FG004|Overall Study|Did not receive intervention|0|||
126526014|NCT02527798|455219527|FG005|Overall Study|Did not receive intervention|0|||
126526015|NCT02395120|455219528|FG000|Overall Study|Missed follow-up dental exam|57|||
126526016|NCT02395120|455219529|FG001|Overall Study|Missed follow-up dental exam|62|||
126526017|NCT02395120|455219530|FG002|Overall Study|Missed follow-up dental exam|6|||
126526018|NCT02395120|455219531|FG003|Overall Study|Missed follow-up dental exam|6|||
126526019|NCT02395120|455219532|FG004|Overall Study|Missed follow-up dental exam|51|||
126526020|NCT00674986|455219533|FG000|Overall Study|Adverse Event|2|||
126526021|NCT00674986|455219534|FG001|Overall Study|Adverse Event|1|||
126526022|NCT00674986|455219533|FG000|Overall Study|Subject withdrew consent|12|||
126526023|NCT00674986|455219534|FG001|Overall Study|Subject withdrew consent|19|||
126526024|NCT00674986|455219533|FG000|Overall Study|Lost to Follow-up|25|||
126526025|NCT00674986|455219534|FG001|Overall Study|Lost to Follow-up|53|||
126526026|NCT00674986|455219533|FG000|Overall Study|Other reasons|4|||
126526027|NCT00674986|455219534|FG001|Overall Study|Other reasons|8|||
126526028|NCT00896168|455219536|FG000|Overall Study|Adverse Event|4|||
126526029|NCT00896168|455219537|FG001|Overall Study|Adverse Event|7|||
126526030|NCT00896168|455219536|FG000|Overall Study|Treatment failure|8|||
126578293|NCT01976312|455412758|FG000|Overall Study|Pregnancy|0|||
126578294|NCT01976312|455412759|FG001|Overall Study|Pregnancy|1|||
126578295|NCT01976312|455412758|FG000|Overall Study|Lost to Follow-up|2|||
126578296|NCT01976312|455412759|FG001|Overall Study|Lost to Follow-up|0|||
126578297|NCT01976312|455412758|FG000|Overall Study|Withdrawal by Subject|7|||
126578298|NCT01976312|455412759|FG001|Overall Study|Withdrawal by Subject|2|||
126578299|NCT01976312|455412758|FG000|Overall Study|Adverse Event|6|||
126578300|NCT01976312|455412759|FG001|Overall Study|Adverse Event|6|||
126578301|NCT01976312|455412758|FG000|Overall Study|Protocol Violation|2|||
126578302|NCT01976312|455412759|FG001|Overall Study|Protocol Violation|0|||
126526031|NCT00896168|455219537|FG001|Overall Study|Treatment failure|10|||
126526032|NCT00896168|455219536|FG000|Overall Study|Lost to Follow-up|1|||
126526033|NCT00896168|455219537|FG001|Overall Study|Lost to Follow-up|1|||
126526034|NCT00896168|455219536|FG000|Overall Study|Other|1|||
126526035|NCT00896168|455219537|FG001|Overall Study|Other|1|||
126526036|NCT02492100|455219538|FG000|Overall Study|Death|1|||
126526037|NCT02332720|455219541|FG000|Part A and Part B|Lost to Follow-up|1|||
126526038|NCT02332720|455219542|FG001|Part A and Part B|Lost to Follow-up|0|||
126526039|NCT02332720|455219543|FG002|Part A and Part B|Lost to Follow-up|0|||
126526040|NCT02332720|455219544|FG003|Part A and Part B|Lost to Follow-up|0|||
126526041|NCT02332720|455219545|FG004|Part A and Part B|Lost to Follow-up|0|||
126526042|NCT02332720|455219546|FG005|Part A and Part B|Lost to Follow-up|2|||
126526043|NCT02332720|455219547|FG006|Part A and Part B|Lost to Follow-up|1|||
126526044|NCT02332720|455219548|FG007|Part A and Part B|Lost to Follow-up|1|||
126526045|NCT02332720|455219549|FG008|Part A and Part B|Lost to Follow-up|0|||
126526046|NCT02332720|455219550|FG009|Part A and Part B|Lost to Follow-up|0|||
126526047|NCT02332720|455219551|FG010|Part A and Part B|Lost to Follow-up|0|||
126526048|NCT02332720|455219552|FG011|Part A and Part B|Lost to Follow-up|0|||
126526049|NCT02332720|455219553|FG012|Part A and Part B|Lost to Follow-up|0|||
126526050|NCT02332720|455219554|FG013|Part A and Part B|Lost to Follow-up|0|||
126526051|NCT02332720|455219555|FG014|Part A and Part B|Lost to Follow-up|0|||
126526052|NCT02332720|455219556|FG015|Part A and Part B|Lost to Follow-up|1|||
126526053|NCT02332720|455219557|FG016|Part A and Part B|Lost to Follow-up|0|||
126526054|NCT02332720|455219558|FG017|Part A and Part B|Lost to Follow-up|0|||
126526055|NCT02332720|455219559|FG018|Part A and Part B|Lost to Follow-up|0|||
126526056|NCT02332720|455219560|FG019|Part A and Part B|Lost to Follow-up|0|||
126526057|NCT02332720|455219561|FG020|Part A and Part B|Lost to Follow-up|0|||
126526058|NCT02332720|455219562|FG021|Part A and Part B|Lost to Follow-up|0|||
126526059|NCT02332720|455219563|FG022|Part A and Part B|Lost to Follow-up|0|||
126526060|NCT02332720|455219541|FG000|Part A and Part B|Adverse Event|0|||
126526061|NCT02332720|455219542|FG001|Part A and Part B|Adverse Event|0|||
126526062|NCT02332720|455219543|FG002|Part A and Part B|Adverse Event|0|||
126526063|NCT02332720|455219544|FG003|Part A and Part B|Adverse Event|0|||
126526064|NCT02332720|455219545|FG004|Part A and Part B|Adverse Event|0|||
126526065|NCT02332720|455219546|FG005|Part A and Part B|Adverse Event|0|||
126526066|NCT02332720|455219547|FG006|Part A and Part B|Adverse Event|0|||
126526067|NCT02332720|455219548|FG007|Part A and Part B|Adverse Event|0|||
126526068|NCT02332720|455219549|FG008|Part A and Part B|Adverse Event|0|||
126578303|NCT04300647|455414002|FG000|Pre-Crossover|Death|19|||
126578304|NCT04300647|455414003|FG001|Pre-Crossover|Death|58|||
126578305|NCT04300647|455414004|FG002|Pre-Crossover|Death|0|||
126526069|NCT02332720|455219550|FG009|Part A and Part B|Adverse Event|0|||
126526070|NCT02332720|455219551|FG010|Part A and Part B|Adverse Event|0|||
126526071|NCT02332720|455219552|FG011|Part A and Part B|Adverse Event|0|||
126578306|NCT04300647|455414002|FG000|Pre-Crossover|Lost to Follow-up|0|||
126578307|NCT04300647|455414003|FG001|Pre-Crossover|Lost to Follow-up|3|||
126578308|NCT04300647|455414004|FG002|Pre-Crossover|Lost to Follow-up|0|||
126526072|NCT02332720|455219553|FG012|Part A and Part B|Adverse Event|0|||
126526073|NCT02332720|455219554|FG013|Part A and Part B|Adverse Event|0|||
126578309|NCT04300647|455414002|FG000|Pre-Crossover|Withdrawal by Subject|2|||
126578310|NCT04300647|455414003|FG001|Pre-Crossover|Withdrawal by Subject|4|||
126526074|NCT02332720|455219555|FG014|Part A and Part B|Adverse Event|0|||
126526075|NCT02332720|455219556|FG015|Part A and Part B|Adverse Event|0|||
126578311|NCT04300647|455414004|FG002|Pre-Crossover|Withdrawal by Subject|0|||
126526076|NCT02332720|455219557|FG016|Part A and Part B|Adverse Event|0|||
126526077|NCT02332720|455219558|FG017|Part A and Part B|Adverse Event|1|||
126526078|NCT02332720|455219559|FG018|Part A and Part B|Adverse Event|0|||
126526079|NCT02332720|455219560|FG019|Part A and Part B|Adverse Event|0|||
126526080|NCT02332720|455219561|FG020|Part A and Part B|Adverse Event|0|||
126526081|NCT02332720|455219562|FG021|Part A and Part B|Adverse Event|0|||
126526082|NCT02332720|455219563|FG022|Part A and Part B|Adverse Event|0|||
126526083|NCT02332720|455219541|FG000|Part A and Part B|Physician Decision|0|||
126526084|NCT02332720|455219542|FG001|Part A and Part B|Physician Decision|0|||
126526085|NCT02332720|455219543|FG002|Part A and Part B|Physician Decision|0|||
126526086|NCT02332720|455219544|FG003|Part A and Part B|Physician Decision|0|||
126526087|NCT02332720|455219545|FG004|Part A and Part B|Physician Decision|0|||
126526088|NCT02332720|455219546|FG005|Part A and Part B|Physician Decision|0|||
126526089|NCT02332720|455219547|FG006|Part A and Part B|Physician Decision|0|||
126526090|NCT02332720|455219548|FG007|Part A and Part B|Physician Decision|0|||
126526091|NCT02332720|455219549|FG008|Part A and Part B|Physician Decision|0|||
126526092|NCT02332720|455219550|FG009|Part A and Part B|Physician Decision|0|||
126526093|NCT02332720|455219551|FG010|Part A and Part B|Physician Decision|0|||
126526094|NCT02332720|455219552|FG011|Part A and Part B|Physician Decision|0|||
126526095|NCT02332720|455219553|FG012|Part A and Part B|Physician Decision|0|||
126526096|NCT02332720|455219554|FG013|Part A and Part B|Physician Decision|0|||
126526097|NCT02332720|455219555|FG014|Part A and Part B|Physician Decision|0|||
126526098|NCT02332720|455219556|FG015|Part A and Part B|Physician Decision|0|||
126526099|NCT02332720|455219557|FG016|Part A and Part B|Physician Decision|0|||
126526100|NCT02332720|455219558|FG017|Part A and Part B|Physician Decision|0|||
126526101|NCT02332720|455219559|FG018|Part A and Part B|Physician Decision|1|||
126526102|NCT02332720|455219560|FG019|Part A and Part B|Physician Decision|0|||
126526103|NCT02332720|455219561|FG020|Part A and Part B|Physician Decision|0|||
126526104|NCT02332720|455219562|FG021|Part A and Part B|Physician Decision|0|||
126526105|NCT02332720|455219563|FG022|Part A and Part B|Physician Decision|0|||
126526106|NCT02332720|455219541|FG000|Part A and Part B|Withdrawal by Subject|0|||
126526107|NCT02332720|455219542|FG001|Part A and Part B|Withdrawal by Subject|0|||
126526108|NCT02332720|455219543|FG002|Part A and Part B|Withdrawal by Subject|0|||
126526109|NCT02332720|455219544|FG003|Part A and Part B|Withdrawal by Subject|0|||
126526110|NCT02332720|455219545|FG004|Part A and Part B|Withdrawal by Subject|0|||
126526111|NCT02332720|455219546|FG005|Part A and Part B|Withdrawal by Subject|1|||
126526112|NCT02332720|455219547|FG006|Part A and Part B|Withdrawal by Subject|0|||
126526113|NCT02332720|455219548|FG007|Part A and Part B|Withdrawal by Subject|0|||
126526114|NCT02332720|455219549|FG008|Part A and Part B|Withdrawal by Subject|0|||
126526115|NCT02332720|455219550|FG009|Part A and Part B|Withdrawal by Subject|0|||
126526116|NCT02332720|455219551|FG010|Part A and Part B|Withdrawal by Subject|0|||
126526117|NCT02332720|455219552|FG011|Part A and Part B|Withdrawal by Subject|0|||
126526118|NCT02332720|455219553|FG012|Part A and Part B|Withdrawal by Subject|0|||
126526119|NCT02332720|455219554|FG013|Part A and Part B|Withdrawal by Subject|0|||
126526120|NCT02332720|455219555|FG014|Part A and Part B|Withdrawal by Subject|0|||
126526121|NCT02332720|455219556|FG015|Part A and Part B|Withdrawal by Subject|0|||
126526122|NCT02332720|455219557|FG016|Part A and Part B|Withdrawal by Subject|0|||
126526123|NCT02332720|455219558|FG017|Part A and Part B|Withdrawal by Subject|0|||
126526124|NCT02332720|455219559|FG018|Part A and Part B|Withdrawal by Subject|0|||
126526125|NCT02332720|455219560|FG019|Part A and Part B|Withdrawal by Subject|1|||
126526126|NCT02332720|455219561|FG020|Part A and Part B|Withdrawal by Subject|0|||
126526127|NCT02332720|455219562|FG021|Part A and Part B|Withdrawal by Subject|0|||
126526128|NCT02332720|455219563|FG022|Part A and Part B|Withdrawal by Subject|0|||
126526129|NCT03832010|455219564|FG000|Overall Study|Withdrawal by Subject|2|||
126526130|NCT03832010|455219565|FG001|Overall Study|Withdrawal by Subject|1|||
126526131|NCT03832010|455219566|FG002|Overall Study|Withdrawal by Subject|0|||
126526132|NCT03832010|455219564|FG000|Overall Study|Lost to Follow-up|2|||
126526133|NCT03832010|455219565|FG001|Overall Study|Lost to Follow-up|1|||
126526134|NCT03832010|455219566|FG002|Overall Study|Lost to Follow-up|1|||
126526135|NCT01003899|455219568|FG000|Overall Study|Other Adverse Event|8|||
126526136|NCT01003899|455219568|FG000|Overall Study|Not entered|4|||
126526137|NCT01003899|455219568|FG000|Overall Study|Not treated|1|||
126526138|NCT01003899|455219568|FG000|Overall Study|Progressive disease|34|||
126526139|NCT03822533|455219570|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
126526140|NCT03822533|455219571|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
126526141|NCT03822533|455219570|FG000|3 Month Follow-up|Lost to Follow-up|2|||
126526142|NCT03822533|455219571|FG001|3 Month Follow-up|Lost to Follow-up|2|||
126526143|NCT03822533|455219570|FG000|6 Month Follow-up|Lost to Follow-up|3|||
126526144|NCT03822533|455219571|FG001|6 Month Follow-up|Lost to Follow-up|0|||
126526145|NCT03822533|455219570|FG000|12 Month Follow-up|Lost to Follow-up|2|||
126526146|NCT03822533|455219571|FG001|12 Month Follow-up|Lost to Follow-up|3|||
126526147|NCT03822533|455219570|FG000|12 Month Follow-up|Pregnancy|0|||
126526148|NCT03822533|455219571|FG001|12 Month Follow-up|Pregnancy|1|||
126526149|NCT03822533|455219570|FG000|12 Month Follow-up|Surgery|2|||
126526150|NCT03822533|455219571|FG001|12 Month Follow-up|Surgery|0|||
126526151|NCT03822533|455219570|FG000|12 Month Follow-up|Wrong address|1|||
126526152|NCT03822533|455219571|FG001|12 Month Follow-up|Wrong address|0|||
126578312|NCT04300647|455414002|FG000|Pre-Crossover|On-going in Study|24|||
126578313|NCT04300647|455414003|FG001|Pre-Crossover|On-going in Study|61|||
126578314|NCT04300647|455414004|FG002|Pre-Crossover|On-going in Study|0|||
126578315|NCT04300647|455414002|FG000|Post-Crossover|Death|0|||
126578316|NCT04300647|455414003|FG001|Post-Crossover|Death|0|||
126578317|NCT04300647|455414004|FG002|Post-Crossover|Death|3|||
126578318|NCT04300647|455414002|FG000|Post-Crossover|Lost to Follow-up|0|||
126578319|NCT04300647|455414003|FG001|Post-Crossover|Lost to Follow-up|0|||
126578320|NCT04300647|455414004|FG002|Post-Crossover|Lost to Follow-up|1|||
126578321|NCT04300647|455414002|FG000|Post-Crossover|Withdrawal by Subject|0|||
126578322|NCT04300647|455414003|FG001|Post-Crossover|Withdrawal by Subject|0|||
126578323|NCT04300647|455414004|FG002|Post-Crossover|Withdrawal by Subject|1|||
126578324|NCT04300647|455414002|FG000|Post-Crossover|On-going in Study|0|||
126578325|NCT04300647|455414003|FG001|Post-Crossover|On-going in Study|0|||
126578326|NCT04300647|455414004|FG002|Post-Crossover|On-going in Study|8|||
126578327|NCT02824029|455414008|FG000|Overall Study|Didn't receive treatment|2|||
126578328|NCT02824029|455414008|FG000|Overall Study|Patient decision to discontinue treatment|3|||
126578329|NCT02824029|455414008|FG000|Overall Study|Non-compliant|5|||
126578330|NCT02824029|455414008|FG000|Overall Study|Progression of disease|15|||
126578331|NCT02824029|455414008|FG000|Overall Study|Inadequate response to therapy|2|||
126578332|NCT02824029|455414008|FG000|Overall Study|Possible progression per treating physician|1|||
126578333|NCT03990649|455414019|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
126578334|NCT03990649|455414020|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
126578335|NCT03990649|455414021|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
126578336|NCT03990649|455414019|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
126578337|NCT03990649|455414020|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
126578338|NCT03990649|455414021|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
126578339|NCT03990649|455414019|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
126578340|NCT03990649|455414020|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
126578341|NCT03990649|455414021|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
126578342|NCT03990649|455414019|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
126578343|NCT03990649|455414020|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
126578344|NCT03990649|455414021|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
126578345|NCT03990649|455414019|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
126578346|NCT03990649|455414020|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
126578347|NCT03990649|455414021|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
126578348|NCT03990649|455414019|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
126578349|NCT03990649|455414020|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
126578350|NCT03990649|455414021|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
126578351|NCT03990649|455414019|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
126578352|NCT03990649|455414020|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
126578353|NCT03990649|455414021|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
126578354|NCT00505934|455414022|FG000|Overall Study|Adverse Event|1|||
126578355|NCT00505934|455414022|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
126578356|NCT00505934|455414022|FG000|Overall Study|Other: IV dose needed to be changed|1|||
126578357|NCT01443845|455414023|FG000|Overall Study|Protocol Violation|43|||
126578358|NCT01443845|455414024|FG001|Overall Study|Protocol Violation|45|||
126578359|NCT01443845|455414023|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
126578360|NCT01443845|455414024|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
126578361|NCT01443845|455414023|FG000|Overall Study|Deterioration in pulmonary function|1|||
126578362|NCT01443845|455414024|FG001|Overall Study|Deterioration in pulmonary function|4|||
126578363|NCT01443845|455414023|FG000|Overall Study|Lack of Efficacy|10|||
126578364|NCT01443845|455414024|FG001|Overall Study|Lack of Efficacy|5|||
126578365|NCT01443845|455414023|FG000|Overall Study|Adverse Event|64|||
126578366|NCT01443845|455414024|FG001|Overall Study|Adverse Event|138|||
126578367|NCT01443845|455414023|FG000|Overall Study|Withdrawal by Subject|63|||
126578368|NCT01443845|455414024|FG001|Overall Study|Withdrawal by Subject|67|||
126578369|NCT01443845|455414023|FG000|Overall Study|Military Conflict - Site Terminated|20|||
126578370|NCT01443845|455414024|FG001|Overall Study|Military Conflict - Site Terminated|21|||
126578371|NCT01443845|455414023|FG000|Overall Study|Lost to Follow-up|9|||
126578372|NCT01443845|455414024|FG001|Overall Study|Lost to Follow-up|13|||
126578373|NCT00174382|455414026|FG000|Overall Study|Death|2|||
126526153|NCT03822533|455219570|FG000|12 Month Follow-up|No symptoms|1|||
126526154|NCT03822533|455219571|FG001|12 Month Follow-up|No symptoms|0|||
126526155|NCT03822533|455219570|FG000|12 Month Follow-up|Changed primary care center|0|||
126526156|NCT03822533|455219571|FG001|12 Month Follow-up|Changed primary care center|1|||
126526157|NCT02489500|455219574|FG000|Overall Study|Death|1|||
126526158|NCT02489500|455219575|FG001|Overall Study|Death|1|||
126526159|NCT02349295|455219577|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
126578374|NCT00174382|455414026|FG000|Overall Study|Adverse Event|19|||
126526160|NCT02349295|455219578|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
126578375|NCT00174382|455414026|FG000|Overall Study|Withdrawal by Subject|6|||
126578376|NCT00174382|455414026|FG000|Overall Study|Protocol Violation|3|||
126578377|NCT00174382|455414026|FG000|Overall Study|Arrived early for last visit in error|1|||
126578378|NCT00174382|455414026|FG000|Overall Study|Subject felt pill not effective enough|1|||
126578379|NCT00174382|455414026|FG000|Overall Study|Lost to Follow-up|1|||
126578380|NCT00296036|455414027|FG000|Overall Study|Withdrawal by Subject|1|||
126578381|NCT00296036|455414028|FG001|Overall Study|Withdrawal by Subject|0|||
126578382|NCT00296036|455414029|FG002|Overall Study|Withdrawal by Subject|2|||
126578383|NCT00296036|455414030|FG003|Overall Study|Withdrawal by Subject|1|||
126578384|NCT00296036|455414031|FG004|Overall Study|Withdrawal by Subject|2|||
126578385|NCT00296036|455414032|FG005|Overall Study|Withdrawal by Subject|1|||
126578386|NCT00296036|455414027|FG000|Overall Study|Protocol Violation|0|||
126578387|NCT00296036|455414028|FG001|Overall Study|Protocol Violation|0|||
126578388|NCT00296036|455414029|FG002|Overall Study|Protocol Violation|0|||
126578389|NCT00296036|455414030|FG003|Overall Study|Protocol Violation|0|||
126578390|NCT00296036|455414031|FG004|Overall Study|Protocol Violation|0|||
126578391|NCT00296036|455414032|FG005|Overall Study|Protocol Violation|3|||
126578392|NCT03403413|455414033|FG000|Overall Study|Lack of Efficacy|2|||
126578393|NCT03655262|455414034|FG000|Overall Study|Withdrawal by Subject|0|||
126578394|NCT03655262|455414035|FG001|Overall Study|Withdrawal by Subject|0|||
126578395|NCT03655262|455414036|FG002|Overall Study|Withdrawal by Subject|1|||
126578396|NCT04583423|455414039|FG000|Overall Study|Lost to Follow-up|0|||
126578397|NCT04583423|455414040|FG001|Overall Study|Lost to Follow-up|1|||
126578398|NCT04583423|455414041|FG002|Overall Study|Lost to Follow-up|0|||
126578399|NCT04583423|455414042|FG003|Overall Study|Lost to Follow-up|2|||
126578400|NCT04583423|455414039|FG000|Overall Study|Study Terminated by Sponsor|32|||
126578401|NCT04583423|455414040|FG001|Overall Study|Study Terminated by Sponsor|35|||
126578402|NCT04583423|455414041|FG002|Overall Study|Study Terminated by Sponsor|36|||
126578403|NCT04583423|455414042|FG003|Overall Study|Study Terminated by Sponsor|33|||
126578404|NCT04583423|455414039|FG000|Overall Study|Withdrawal by Subject|3|||
126578405|NCT04583423|455414040|FG001|Overall Study|Withdrawal by Subject|1|||
126578406|NCT04583423|455414041|FG002|Overall Study|Withdrawal by Subject|2|||
126578407|NCT04583423|455414042|FG003|Overall Study|Withdrawal by Subject|1|||
126578408|NCT00603954|455414045|FG000|Overall Study|Protocol Violation|1|||
126578409|NCT00603954|455414046|FG001|Overall Study|Protocol Violation|2|||
126578410|NCT00580866|455414048|FG000|Overall Study|Lost to Follow-up|2|||
126578411|NCT00580866|455414049|FG001|Overall Study|Lost to Follow-up|2|||
126578412|NCT00609336|455414050|FG000|Overall Study|Protocol Violation|3|||
126578413|NCT00609336|455414050|FG000|Overall Study|Death|1|||
126578414|NCT00609336|455414050|FG000|Overall Study|LA or Met at Surgery|9|||
126578415|NCT02238483|455414051|FG000|Overall Study|Withdrawal by Subject|2|||
126578416|NCT02238483|455414052|FG001|Overall Study|Withdrawal by Subject|7|||
126578417|NCT02238483|455414051|FG000|Overall Study|Lost to Follow-up|1|||
126578418|NCT02238483|455414052|FG001|Overall Study|Lost to Follow-up|1|||
126578419|NCT02238483|455414051|FG000|Overall Study|Protocol Violation|1|||
126578420|NCT02238483|455414052|FG001|Overall Study|Protocol Violation|2|||
126578421|NCT02238483|455414051|FG000|Overall Study|Death|1|||
126578422|NCT02238483|455414052|FG001|Overall Study|Death|0|||
126578423|NCT02238483|455414051|FG000|Overall Study|Adverse Event|7|||
126578424|NCT02238483|455414052|FG001|Overall Study|Adverse Event|3|||
126578425|NCT02238483|455414051|FG000|Overall Study|Withdrawn due to physician decision|1|||
126578426|NCT02238483|455414052|FG001|Overall Study|Withdrawn due to physician decision|0|||
126578427|NCT02238483|455414051|FG000|Overall Study|Completion status not recorded|1|||
126578428|NCT02238483|455414052|FG001|Overall Study|Completion status not recorded|1|||
126578429|NCT02238483|455414051|FG000|Overall Study|Illness in family member|1|||
126578430|NCT02238483|455414052|FG001|Overall Study|Illness in family member|0|||
126578431|NCT02477605|455414053|FG000|Overall Study|Discontinued prior to treatment|1|||
126728320|NCT00304915|455954218|FG000|Overall Study|Withdrawal by Subject|3|||
126728321|NCT00304915|455954219|FG001|Overall Study|Withdrawal by Subject|0|||
126728322|NCT03442829|455954228|FG000|Overall Study|Scheduling clash|3|||
126728323|NCT03442829|455954229|FG001|Overall Study|Scheduling clash|1|||
126578432|NCT02477605|455414054|FG001|Overall Study|Discontinued prior to treatment|0|||
126578433|NCT02477605|455414053|FG000|Overall Study|Lost to Follow-up|0|||
126578434|NCT02477605|455414054|FG001|Overall Study|Lost to Follow-up|2|||
126578435|NCT02477605|455414053|FG000|Overall Study|Withdrawal by Subject|0|||
126728324|NCT03442829|455954228|FG000|Overall Study|Illness unrelated to study|1|||
126578436|NCT02477605|455414054|FG001|Overall Study|Withdrawal by Subject|1|||
126578437|NCT02477605|455414053|FG000|Overall Study|Administered gas during surgery|0|||
126728325|NCT03442829|455954229|FG001|Overall Study|Illness unrelated to study|1|||
126728326|NCT01021852|455954232|FG000|Treatment Period 1|Adverse Event|3|||
126578438|NCT02477605|455414054|FG001|Overall Study|Administered gas during surgery|1|||
126578439|NCT02574455|455414055|FG000|Overall Study|Death|197|||
126578440|NCT02574455|455414056|FG001|Overall Study|Death|210|||
126578441|NCT02574455|455414055|FG000|Overall Study|Withdrawal of Consent|11|||
126578442|NCT02574455|455414056|FG001|Overall Study|Withdrawal of Consent|28|||
126578443|NCT02574455|455414055|FG000|Overall Study|Lost to Follow-up|4|||
126578444|NCT02574455|455414056|FG001|Overall Study|Lost to Follow-up|4|||
126578445|NCT02574455|455414055|FG000|Overall Study|Sponsor's Decision|55|||
126728327|NCT01021852|455954233|FG001|Treatment Period 1|Adverse Event|1|||
126526161|NCT02349295|455219579|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
126526162|NCT02349295|455219580|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
126526163|NCT02349295|455219581|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
126526164|NCT02349295|455219582|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
126526165|NCT02349295|455219583|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
126526166|NCT02349295|455219584|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
126526167|NCT02349295|455219585|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
126526168|NCT02349295|455219586|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
126526169|NCT02349295|455219587|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
126526170|NCT02349295|455219588|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
126526171|NCT02349295|455219589|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
126526172|NCT02349295|455219590|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
126526173|NCT02349295|455219577|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
126526174|NCT02349295|455219578|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
126526175|NCT02349295|455219579|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
126526176|NCT02349295|455219580|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
126526177|NCT02349295|455219581|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
126526178|NCT02349295|455219582|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
126526179|NCT02349295|455219583|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
126526180|NCT02349295|455219584|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
126526181|NCT02349295|455219585|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
126526182|NCT02349295|455219586|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
126526183|NCT02349295|455219587|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
126526184|NCT02349295|455219588|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
126526185|NCT02349295|455219589|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
126526186|NCT02349295|455219590|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
126526187|NCT02349295|455219577|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
126526188|NCT02349295|455219578|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
126526189|NCT02349295|455219579|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
126526190|NCT02349295|455219580|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
126526191|NCT02349295|455219581|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
126526192|NCT02349295|455219582|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
126526193|NCT02349295|455219583|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
126526194|NCT02349295|455219584|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
126526195|NCT02349295|455219585|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
126526196|NCT02349295|455219586|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
126526197|NCT02349295|455219587|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
126526198|NCT02349295|455219588|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
126526199|NCT02349295|455219589|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
126526200|NCT02349295|455219590|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
126526201|NCT02349295|455219577|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
126526202|NCT02349295|455219578|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
126526203|NCT02349295|455219579|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
126526204|NCT02349295|455219580|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
126526205|NCT02349295|455219581|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
126526206|NCT02349295|455219582|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
126526207|NCT02349295|455219583|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
126526208|NCT02349295|455219584|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
126526209|NCT02349295|455219585|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
126526210|NCT02349295|455219586|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
126526211|NCT02349295|455219587|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
126526212|NCT02349295|455219588|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
126526213|NCT02349295|455219589|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
126526214|NCT02349295|455219590|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
126526215|NCT02349295|455219577|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126526216|NCT02349295|455219578|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
126526217|NCT02349295|455219579|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
126526218|NCT02349295|455219580|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126526219|NCT02349295|455219581|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126526220|NCT02349295|455219582|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126526221|NCT02349295|455219583|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126526222|NCT02349295|455219584|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126526223|NCT02349295|455219585|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126526224|NCT02349295|455219586|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126728328|NCT01021852|455954234|FG002|Treatment Period 1|Adverse Event|1|||
126526225|NCT02349295|455219587|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126526226|NCT02349295|455219588|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126526227|NCT02349295|455219589|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126526228|NCT02349295|455219590|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
126526229|NCT02349295|455219577|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
126526230|NCT02349295|455219578|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
126526231|NCT02349295|455219579|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
126526232|NCT02349295|455219580|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
126526233|NCT02349295|455219581|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
126526234|NCT02349295|455219582|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
126526235|NCT02349295|455219583|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
126526236|NCT02349295|455219584|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
126526237|NCT02349295|455219585|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
126526238|NCT02349295|455219586|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
126526239|NCT02349295|455219587|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
126526240|NCT02349295|455219588|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
126526241|NCT02349295|455219589|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
126526242|NCT02349295|455219590|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
126526243|NCT02349295|455219577|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
126526244|NCT02349295|455219578|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
126526245|NCT02349295|455219579|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
126526246|NCT02349295|455219580|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
126526247|NCT02349295|455219581|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
126526248|NCT02349295|455219582|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
126526249|NCT02349295|455219583|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
126526250|NCT02349295|455219584|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
126526251|NCT02349295|455219585|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
126526252|NCT02349295|455219586|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
126526253|NCT02349295|455219587|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
126526254|NCT02349295|455219588|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
126526255|NCT02349295|455219589|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
126526256|NCT02349295|455219590|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
126526257|NCT02349295|455219577|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
126526258|NCT02349295|455219578|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
126526259|NCT02349295|455219579|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
126526260|NCT02349295|455219580|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
126526261|NCT02349295|455219581|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
126526262|NCT02349295|455219582|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
126526263|NCT02349295|455219583|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
126526264|NCT02349295|455219584|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
126526265|NCT02349295|455219585|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
126526266|NCT02349295|455219586|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
126526267|NCT02349295|455219587|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
126526268|NCT02349295|455219588|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
126526269|NCT02349295|455219589|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
126526270|NCT02349295|455219590|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
126526271|NCT02349295|455219577|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
126526272|NCT02349295|455219578|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
126526273|NCT02349295|455219579|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
126526274|NCT02349295|455219580|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
126526275|NCT02349295|455219581|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
126526276|NCT02349295|455219582|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
126526277|NCT02349295|455219583|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
126526278|NCT02349295|455219584|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
126526279|NCT02349295|455219585|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
126526280|NCT02349295|455219586|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
126526281|NCT02349295|455219587|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
126526282|NCT02349295|455219588|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
126526283|NCT02349295|455219589|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
126526284|NCT02349295|455219590|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
126526285|NCT02349295|455219577|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
126526286|NCT02349295|455219578|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
126526287|NCT02349295|455219579|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
126526288|NCT02349295|455219580|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
126526289|NCT02349295|455219581|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
126728329|NCT01021852|455954235|FG003|Treatment Period 1|Adverse Event|0|||
126728330|NCT01021852|455954236|FG004|Treatment Period 1|Adverse Event|2|||
126526290|NCT02349295|455219582|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
126728331|NCT01021852|455954237|FG005|Treatment Period 1|Adverse Event|2|||
126526291|NCT02349295|455219583|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
126526292|NCT02349295|455219584|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
126526293|NCT02349295|455219585|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
126526294|NCT02349295|455219586|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
126526295|NCT02349295|455219587|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
126526296|NCT02349295|455219588|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
126526297|NCT02349295|455219589|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
126526298|NCT02349295|455219590|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
126526299|NCT02349295|455219577|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
126526300|NCT02349295|455219578|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
126526301|NCT02349295|455219579|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
126526302|NCT02349295|455219580|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
126526303|NCT02349295|455219581|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
126526304|NCT02349295|455219582|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
126526305|NCT02349295|455219583|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
126526306|NCT02349295|455219584|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
126526307|NCT02349295|455219585|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
126526308|NCT02349295|455219586|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
126526309|NCT02349295|455219587|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
126526310|NCT02349295|455219588|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
126526311|NCT02349295|455219589|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
126526312|NCT02349295|455219590|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
126526313|NCT02349295|455219577|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
126526314|NCT02349295|455219578|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
126526315|NCT02349295|455219579|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
126526316|NCT02349295|455219580|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
126526317|NCT02349295|455219581|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
126526318|NCT02349295|455219582|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
126526319|NCT02349295|455219583|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
126526320|NCT02349295|455219584|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
126526321|NCT02349295|455219585|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
126526322|NCT02349295|455219586|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
126526323|NCT02349295|455219587|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
126526324|NCT02349295|455219588|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
126526325|NCT02349295|455219589|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
126526326|NCT02349295|455219590|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
126526327|NCT02349295|455219577|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
126526328|NCT02349295|455219578|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
126526329|NCT02349295|455219579|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
126526330|NCT02349295|455219580|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
126526331|NCT02349295|455219581|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
126526332|NCT02349295|455219582|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
126526333|NCT02349295|455219583|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
126526334|NCT02349295|455219584|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
126526335|NCT02349295|455219585|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
126526336|NCT02349295|455219586|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
126526337|NCT02349295|455219587|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
126526338|NCT02349295|455219588|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
126526339|NCT02349295|455219589|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
126526340|NCT02349295|455219590|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
126526341|NCT02349295|455219577|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
126526342|NCT02349295|455219578|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
126526343|NCT02349295|455219579|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
126526344|NCT02349295|455219580|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
126526345|NCT02349295|455219581|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
126526346|NCT02349295|455219582|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
126526347|NCT02349295|455219583|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
126526348|NCT02349295|455219584|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
126526349|NCT02349295|455219585|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
126526350|NCT02349295|455219586|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
126526351|NCT02349295|455219587|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
126526352|NCT02349295|455219588|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
126578446|NCT02574455|455414056|FG001|Overall Study|Sponsor's Decision|20|||
126728332|NCT01021852|455954238|FG006|Treatment Period 1|Adverse Event|0|||
126526353|NCT02349295|455219589|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
126526354|NCT02349295|455219590|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
126526355|NCT02349295|455219577|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
126526356|NCT02349295|455219578|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
126526357|NCT02349295|455219579|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
126526358|NCT02349295|455219580|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
126526359|NCT02349295|455219581|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
126526360|NCT02349295|455219582|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
126526361|NCT02349295|455219583|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
126526362|NCT02349295|455219584|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
126526363|NCT02349295|455219585|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
126526364|NCT02349295|455219586|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
126526365|NCT02349295|455219587|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
126526366|NCT02349295|455219588|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
126526367|NCT02349295|455219589|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
126526368|NCT02349295|455219590|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
126526369|NCT02349295|455219577|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126526370|NCT02349295|455219578|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126526371|NCT02349295|455219579|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126526372|NCT02349295|455219580|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126526373|NCT02349295|455219581|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126526374|NCT02349295|455219582|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126526375|NCT02349295|455219583|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126526376|NCT02349295|455219584|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126526377|NCT02349295|455219585|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126526378|NCT02349295|455219586|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126526379|NCT02349295|455219587|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126526380|NCT02349295|455219588|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
126526381|NCT02349295|455219589|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
126526382|NCT02349295|455219590|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
126526383|NCT02349295|455219577|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526384|NCT02349295|455219578|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526385|NCT02349295|455219579|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526386|NCT02349295|455219580|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526387|NCT02349295|455219581|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526388|NCT02349295|455219582|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526389|NCT02349295|455219583|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526390|NCT02349295|455219584|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526391|NCT02349295|455219585|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526392|NCT02349295|455219586|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526393|NCT02349295|455219587|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526394|NCT02349295|455219588|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
126526395|NCT02349295|455219589|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526396|NCT02349295|455219590|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
126526397|NCT02349295|455219577|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526398|NCT02349295|455219578|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526399|NCT02349295|455219579|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526400|NCT02349295|455219580|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526401|NCT02349295|455219581|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526402|NCT02349295|455219582|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526403|NCT02349295|455219583|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526404|NCT02349295|455219584|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526405|NCT02349295|455219585|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526406|NCT02349295|455219586|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526407|NCT02349295|455219587|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526408|NCT02349295|455219588|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
126526409|NCT02349295|455219589|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526410|NCT02349295|455219590|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
126526411|NCT01259713|455219592|FG000|Overall Study|Adverse Event|54|||
126526412|NCT01259713|455219593|FG001|Overall Study|Adverse Event|23|||
126526413|NCT01259713|455219592|FG000|Overall Study|Death Not Related to IFI|8|||
126526414|NCT01259713|455219593|FG001|Overall Study|Death Not Related to IFI|1|||
126526415|NCT01259713|455219592|FG000|Overall Study|Investigators Discretion|14|||
126526416|NCT01259713|455219593|FG001|Overall Study|Investigators Discretion|6|||
126728333|NCT01021852|455954239|FG007|Treatment Period 1|Adverse Event|0|||
126578447|NCT02677896|455414058|FG000|Double Blind Period (up to 35 Months)|Death|117|||
126578448|NCT02677896|455414059|FG001|Double Blind Period (up to 35 Months)|Death|197|||
126578449|NCT02677896|455414058|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
126578450|NCT02677896|455414059|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
126578451|NCT02677896|455414058|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
126578452|NCT02677896|455414059|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
126578453|NCT02677896|455414058|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
126578454|NCT02677896|455414059|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
126578455|NCT02677896|455414058|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
126578456|NCT02677896|455414059|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
126578457|NCT02677896|455414058|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
126578458|NCT02677896|455414059|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
126578459|NCT02677896|455414058|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
126578460|NCT02677896|455414059|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
126578461|NCT02677896|455414058|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
126578462|NCT02677896|455414059|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
126578463|NCT02677896|455414058|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
126578464|NCT02677896|455414059|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
126578465|NCT02677896|455414058|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
126578466|NCT02677896|455414059|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
126578467|NCT02677896|455414058|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
126578468|NCT02677896|455414059|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
126578469|NCT02677896|455414058|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
126578470|NCT02677896|455414059|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
126578471|NCT02677896|455414058|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
126578472|NCT02677896|455414059|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
126578473|NCT02677896|455414058|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
126578474|NCT02677896|455414059|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
126578475|NCT00567489|455414060|FG000|Overall Study|Adverse Event|6|||
126578476|NCT00567489|455414061|FG001|Overall Study|Adverse Event|14|||
126578477|NCT00567489|455414060|FG000|Overall Study|Physician Decision|0|||
126578478|NCT00567489|455414061|FG001|Overall Study|Physician Decision|4|||
126578479|NCT00567489|455414060|FG000|Overall Study|Withdrawal by Subject|0|||
126578480|NCT00567489|455414061|FG001|Overall Study|Withdrawal by Subject|2|||
126578481|NCT00567489|455414060|FG000|Overall Study|Renal Transplantation|0|||
126578482|NCT00567489|455414061|FG001|Overall Study|Renal Transplantation|3|||
126578483|NCT00567489|455414060|FG000|Overall Study|Other|1|||
126578484|NCT00567489|455414061|FG001|Overall Study|Other|0|||
126578485|NCT00539734|455414067|FG000|Overall Study|Protocol Violation|1|||
126578486|NCT03565315|455414072|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
126578487|NCT03565315|455414073|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
126578488|NCT03565315|455414074|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
126578489|NCT03565315|455414075|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
126578490|NCT01083316|455414076|FG000|Overall Study|Adverse Event|2|||
126578491|NCT01083316|455414076|FG000|Overall Study|Withdrawal by Subject|1|||
126578492|NCT04200365|455414077|FG000|Overall Study|Adverse Event|2|||
126578493|NCT04200365|455414077|FG000|Overall Study|Progressive Disease|4|||
126578494|NCT04200365|455414077|FG000|Overall Study|Lack of Efficacy|1|||
126578495|NCT04200365|455414077|FG000|Overall Study|Study Closure|4|||
126578496|NCT02692417|455414078|FG000|Overall Study|Withdrawal by Subject|5|||
126578497|NCT02692417|455414079|FG001|Overall Study|Withdrawal by Subject|1|||
126578498|NCT02692417|455414078|FG000|Overall Study|Adverse Event|1|||
126578499|NCT02692417|455414079|FG001|Overall Study|Adverse Event|0|||
126578500|NCT02372253|455414082|FG000|Overall Study|Non Compliance|2|||
126578501|NCT02372253|455414083|FG001|Overall Study|Non Compliance|0|||
126578502|NCT00065260|455414084|FG000|Overall Study|Death|0|||
126578503|NCT00065260|455414085|FG001|Overall Study|Death|1|||
126578504|NCT00001277|455414086|FG000|Overall Study|Adverse Event|0|||
126578505|NCT00001277|455414087|FG001|Overall Study|Adverse Event|0|||
126578506|NCT00001277|455414088|FG002|Overall Study|Adverse Event|1|||
126578507|NCT00001277|455414086|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
126578508|NCT00001277|455414087|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
126578509|NCT00001277|455414088|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
126578510|NCT04048382|455414102|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
126578511|NCT04048382|455414103|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
126578512|NCT04048382|455414102|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
126578513|NCT04048382|455414103|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
126578514|NCT04048382|455414102|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
126578515|NCT04048382|455414103|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
126777093|NCT04288115|456139189|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
126578516|NCT02556138|455414104|FG000|Overall Study|Withdrawal by Subject|1|||
126578517|NCT01205048|455414109|FG000|Overall Study|Withdrawal by Subject|14|||
126578518|NCT01205048|455414109|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
126578519|NCT01205048|455414109|FG000|Overall Study|Lost to Follow-up|4|||
126578520|NCT01205048|455414109|FG000|Overall Study|Other|2|||
126578521|NCT01255670|455414110|FG000|Overall Study|Adverse Event|10|||
126578522|NCT01255670|455414111|FG001|Overall Study|Adverse Event|10|||
126578523|NCT01255670|455414110|FG000|Overall Study|Lost to Follow-up|16|||
126578524|NCT01255670|455414111|FG001|Overall Study|Lost to Follow-up|10|||
126578525|NCT01037985|455414112|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
126578526|NCT01037985|455414113|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
126578527|NCT01037985|455414112|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
126578528|NCT01037985|455414113|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
126578529|NCT01037985|455414112|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
126578530|NCT01037985|455414113|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
126578531|NCT01037985|455414112|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
126728334|NCT01021852|455954232|FG000|Treatment Period 1|Pregnancy|0|||
126728335|NCT01021852|455954233|FG001|Treatment Period 1|Pregnancy|0|||
126728336|NCT01021852|455954234|FG002|Treatment Period 1|Pregnancy|1|||
126728337|NCT01021852|455954235|FG003|Treatment Period 1|Pregnancy|0|||
126728338|NCT01021852|455954236|FG004|Treatment Period 1|Pregnancy|0|||
126728339|NCT01021852|455954237|FG005|Treatment Period 1|Pregnancy|0|||
126728340|NCT01021852|455954238|FG006|Treatment Period 1|Pregnancy|0|||
126728341|NCT01021852|455954239|FG007|Treatment Period 1|Pregnancy|0|||
126728342|NCT01021852|455954232|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126728343|NCT01021852|455954233|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126728344|NCT01021852|455954234|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126728345|NCT01021852|455954235|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126728346|NCT01021852|455954236|FG004|Treatment Period 1|Withdrawal by Subject|1|||
126728347|NCT01021852|455954237|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126728348|NCT01021852|455954238|FG006|Treatment Period 1|Withdrawal by Subject|0|||
126728349|NCT01021852|455954239|FG007|Treatment Period 1|Withdrawal by Subject|1|||
126728350|NCT01021852|455954232|FG000|Treatment Period 1|Not Treated|0|||
126728351|NCT01021852|455954233|FG001|Treatment Period 1|Not Treated|0|||
126728352|NCT01021852|455954234|FG002|Treatment Period 1|Not Treated|0|||
126728353|NCT01021852|455954235|FG003|Treatment Period 1|Not Treated|2|||
126526417|NCT01259713|455219592|FG000|Overall Study|Lack of Efficacy|2|||
126526418|NCT01259713|455219593|FG001|Overall Study|Lack of Efficacy|0|||
126526419|NCT01259713|455219592|FG000|Overall Study|Protocol Violation|5|||
126526420|NCT01259713|455219593|FG001|Overall Study|Protocol Violation|4|||
126526421|NCT01259713|455219592|FG000|Overall Study|Subject Withdrew Consent|12|||
126526422|NCT01259713|455219593|FG001|Overall Study|Subject Withdrew Consent|7|||
126526423|NCT06111742|455219594|FG000|Overall Study|Did not receive intervention|1|||
126526424|NCT06111742|455219595|FG001|Overall Study|Did not receive intervention|0|||
126526425|NCT06111742|455219596|FG002|Overall Study|Did not receive intervention|0|||
126526426|NCT06111742|455219594|FG000|Overall Study|Withdrawal by Subject|2|||
126526427|NCT06111742|455219595|FG001|Overall Study|Withdrawal by Subject|0|||
126526428|NCT06111742|455219596|FG002|Overall Study|Withdrawal by Subject|0|||
126526429|NCT02148250|455219599|FG000|Screening|Withdrawal by Subject|5|||
126526430|NCT02148250|455219600|FG001|Screening|Withdrawal by Subject|0|||
126526431|NCT00695903|455219605|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
126526432|NCT00695903|455219606|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
126526433|NCT00695903|455219605|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
126526434|NCT00695903|455219606|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
126526435|NCT00695903|455219605|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
126526436|NCT00695903|455219606|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
126526437|NCT00695903|455219605|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
126526438|NCT00695903|455219606|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
126526439|NCT00695903|455219605|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
126578532|NCT01037985|455414113|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
126578533|NCT02269475|455414114|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
126578534|NCT02269475|455414115|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
126578535|NCT02269475|455414114|FG000|Overall Study|Withdrawal by Subject|0|||
126578536|NCT02269475|455414115|FG001|Overall Study|Withdrawal by Subject|1|||
126578537|NCT02730871|455414116|FG000|Overall Study|Adverse Event|6|||
126578538|NCT02730871|455414117|FG001|Overall Study|Adverse Event|0|||
126728354|NCT01021852|455954236|FG004|Treatment Period 1|Not Treated|0|||
126728355|NCT01021852|455954237|FG005|Treatment Period 1|Not Treated|0|||
126728356|NCT01021852|455954238|FG006|Treatment Period 1|Not Treated|0|||
126728357|NCT01021852|455954239|FG007|Treatment Period 1|Not Treated|0|||
126728358|NCT01021852|455954232|FG000|Washout Period-Placebo|Adverse Event|0|||
126526440|NCT00695903|455219606|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
126526441|NCT00695903|455219605|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
126526442|NCT00695903|455219606|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
126578539|NCT00823472|455414118|FG000|Overall Study|Physician Decision|24|||
126578540|NCT00823472|455414119|FG001|Overall Study|Physician Decision|28|||
126578541|NCT01609218|455414120|FG000|Period 1|Adverse Event|3|||
126578542|NCT01609218|455414121|FG001|Period 1|Adverse Event|5|||
126578543|NCT01609218|455414120|FG000|Period 1|Sponsor Decision|0|||
126578544|NCT01609218|455414121|FG001|Period 1|Sponsor Decision|1|||
126578545|NCT01609218|455414120|FG000|Period 2|Adverse Event|1|||
126578546|NCT01609218|455414121|FG001|Period 2|Adverse Event|0|||
126578547|NCT04428112|455414127|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
126578548|NCT04428112|455414128|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
126728359|NCT01021852|455954233|FG001|Washout Period-Placebo|Adverse Event|0|||
126526443|NCT00695903|455219605|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
126526444|NCT00695903|455219606|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
126526445|NCT00695903|455219605|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
126526446|NCT00695903|455219606|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
126526447|NCT00695903|455219605|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
126526448|NCT00695903|455219606|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
126526449|NCT04723576|455219607|FG000|Overall Study|Withdrawal by Subject|2133|||
126526450|NCT04723576|455219608|FG001|Overall Study|Withdrawal by Subject|3234|||
126526451|NCT02097472|455219609|FG000|Received Vaccination 2|Adverse Event|0|||
126526452|NCT02097472|455219610|FG001|Received Vaccination 2|Adverse Event|0|||
126526453|NCT02097472|455219611|FG002|Received Vaccination 2|Adverse Event|0|||
126526454|NCT02097472|455219612|FG003|Received Vaccination 2|Adverse Event|0|||
126526455|NCT02097472|455219613|FG004|Received Vaccination 2|Adverse Event|0|||
126526456|NCT02097472|455219614|FG005|Received Vaccination 2|Adverse Event|0|||
126526457|NCT02097472|455219615|FG006|Received Vaccination 2|Adverse Event|1|||
126526458|NCT02097472|455219616|FG007|Received Vaccination 2|Adverse Event|0|||
126526459|NCT03966157|455219617|FG000|Overall Study|Physician Decision|1|||
126526460|NCT03966157|455219618|FG001|Overall Study|Physician Decision|0|||
126526461|NCT03305016|455219619|FG000|Overall Study|Withdrawal by Subject|2|||
126526462|NCT02119416|455219620|FG000|Overall Study|Protocol Violation|1|||
126526463|NCT02119416|455219621|FG001|Overall Study|Protocol Violation|1|||
126526464|NCT02119416|455219622|FG002|Overall Study|Protocol Violation|1|||
126526465|NCT02119416|455219620|FG000|Overall Study|wrong pubertal stage|1|||
126526466|NCT02119416|455219621|FG001|Overall Study|wrong pubertal stage|0|||
126526467|NCT02119416|455219622|FG002|Overall Study|wrong pubertal stage|1|||
126526468|NCT03593655|455219625|FG000|First Product Use Period|Withdrawal by Subject|1|||
126526469|NCT03593655|455219626|FG001|First Product Use Period|Withdrawal by Subject|1|||
126526470|NCT03593655|455219625|FG000|First Product Use Period|Lost to Follow-up|1|||
126526471|NCT03593655|455219626|FG001|First Product Use Period|Lost to Follow-up|3|||
126526472|NCT03593655|455219625|FG000|Second Product Use Period|Withdrawal by Subject|1|||
126526473|NCT03593655|455219626|FG001|Second Product Use Period|Withdrawal by Subject|1|||
126526474|NCT03593655|455219625|FG000|Second Product Use Period|Lost to Follow-up|1|||
126526475|NCT03593655|455219626|FG001|Second Product Use Period|Lost to Follow-up|0|||
126526476|NCT03593655|455219625|FG000|Third Product Use Period|Lost to Follow-up|1|||
126526477|NCT03593655|455219626|FG001|Third Product Use Period|Lost to Follow-up|2|||
126526478|NCT03593655|455219625|FG000|Third Product Use Period|Physician Decision|0|||
126526479|NCT03593655|455219626|FG001|Third Product Use Period|Physician Decision|1|||
126526480|NCT03593655|455219625|FG000|Third Product Use Period|Withdrawal by Subject|0|||
126526481|NCT03593655|455219626|FG001|Third Product Use Period|Withdrawal by Subject|1|||
126526482|NCT03732209|455219627|FG000|Overall Study|Lost to Follow-up|4|||
126526483|NCT03732209|455219628|FG001|Overall Study|Lost to Follow-up|4|||
126526484|NCT03732209|455219627|FG000|Overall Study|Withdrawal by Subject|8|||
126526485|NCT03732209|455219628|FG001|Overall Study|Withdrawal by Subject|9|||
126526486|NCT05046795|455219629|FG000|Overall Study|Adverse Event|13|||
126526487|NCT05046795|455219630|FG001|Overall Study|Adverse Event|15|||
126526488|NCT05046795|455219629|FG000|Overall Study|Withdrawal by Subject|4|||
126526489|NCT05046795|455219630|FG001|Overall Study|Withdrawal by Subject|7|||
126526490|NCT05046795|455219629|FG000|Overall Study|Physician Decision|1|||
126526491|NCT05046795|455219630|FG001|Overall Study|Physician Decision|2|||
126526492|NCT05046795|455219629|FG000|Overall Study|Protocol Violation|1|||
126526493|NCT05046795|455219630|FG001|Overall Study|Protocol Violation|2|||
126526494|NCT05046795|455219629|FG000|Overall Study|Death|1|||
126526495|NCT05046795|455219630|FG001|Overall Study|Death|0|||
126526496|NCT05046795|455219629|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
126526497|NCT05046795|455219630|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
126526498|NCT02864082|455219631|FG000|Overall Study|Adverse Event|1|||
126526499|NCT02864082|455219632|FG001|Overall Study|Adverse Event|1|||
126526500|NCT02864082|455219631|FG000|Overall Study|Lost to Follow-up|0|||
126526501|NCT02864082|455219632|FG001|Overall Study|Lost to Follow-up|1|||
126526502|NCT02864082|455219631|FG000|Overall Study|Withdrawal by Subject|2|||
126526503|NCT02864082|455219632|FG001|Overall Study|Withdrawal by Subject|2|||
126526504|NCT03621696|455219633|FG000|Overall Study|Not eligible|0|||
126526505|NCT03621696|455219634|FG001|Overall Study|Not eligible|0|||
126578549|NCT04428112|455414127|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
126578550|NCT04428112|455414128|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
126578551|NCT04428112|455414127|FG000|Overall Study|Withdrawal by Subject|9|||
126578552|NCT04428112|455414128|FG001|Overall Study|Withdrawal by Subject|4|||
126578553|NCT04428112|455414127|FG000|Overall Study|Lost to Follow-up|27|||
126578554|NCT04428112|455414128|FG001|Overall Study|Lost to Follow-up|7|||
126578555|NCT01207492|455414129|FG000|Overall Study|Still on study|1|||
126578556|NCT01207492|455414129|FG000|Overall Study|Withdrawal by Subject|9|||
126578557|NCT01207492|455414129|FG000|Overall Study|Physician Decision|1|||
126578558|NCT01207492|455414129|FG000|Overall Study|Progressive disease|3|||
126578559|NCT01207492|455414129|FG000|Overall Study|Toxicity|1|||
126578560|NCT02769858|455414130|FG000|Overall Study|Withdrawal by Subject|2|||
126578561|NCT02807779|455414131|FG000|Overall Study|Lost to Follow-up|1|||
126578562|NCT02807779|455414132|FG001|Overall Study|Lost to Follow-up|0|||
126578563|NCT02807779|455414133|FG002|Overall Study|Lost to Follow-up|0|||
126578564|NCT02807779|455414131|FG000|Overall Study|Physician Decision|2|||
126578565|NCT02807779|455414132|FG001|Overall Study|Physician Decision|0|||
126578566|NCT02807779|455414133|FG002|Overall Study|Physician Decision|1|||
126578567|NCT02807779|455414131|FG000|Overall Study|Death|1|||
126578568|NCT02807779|455414132|FG001|Overall Study|Death|1|||
126578569|NCT02807779|455414133|FG002|Overall Study|Death|0|||
126578570|NCT01853748|455415736|FG000|Allocation|Withdrawal by Subject|1|||
126578571|NCT01853748|455415737|FG001|Allocation|Withdrawal by Subject|13|||
126578572|NCT01853748|455415736|FG000|Allocation|not sufficient to receive intervention|0|||
126578573|NCT01853748|455415737|FG001|Allocation|not sufficient to receive intervention|1|||
126578574|NCT01853748|455415736|FG000|Follow-Up|Withdrawal by Subject|7|||
126578575|NCT01853748|455415737|FG001|Follow-Up|Withdrawal by Subject|6|||
126578576|NCT01853748|455415736|FG000|Follow-Up|Adverse Event|67|||
126578577|NCT01853748|455415737|FG001|Follow-Up|Adverse Event|7|||
126578578|NCT01853748|455415736|FG000|Follow-Up|not available for data collection|16|||
126578579|NCT01853748|455415737|FG001|Follow-Up|not available for data collection|4|||
126578580|NCT04688450|455415742|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
126578581|NCT04688450|455415742|FG000|Overall Study|Withdrawal by Subject|1|||
126578582|NCT03346538|455415743|FG000|Overall Study|Physician Decision|0|||
126578583|NCT03346538|455415744|FG001|Overall Study|Physician Decision|1|||
126578584|NCT03346538|455415745|FG002|Overall Study|Physician Decision|0|||
126578585|NCT03346538|455415743|FG000|Overall Study|Withdrawal by Subject|3|||
126578586|NCT03346538|455415744|FG001|Overall Study|Withdrawal by Subject|2|||
126578587|NCT03346538|455415745|FG002|Overall Study|Withdrawal by Subject|0|||
126578588|NCT03346538|455415743|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
126578589|NCT03346538|455415744|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
126578590|NCT03346538|455415745|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
126578591|NCT01353313|455415746|FG000|Overall Study|Lost to Follow-up|22|||
126578592|NCT01353313|455415747|FG001|Overall Study|Lost to Follow-up|23|||
126578593|NCT01353313|455415746|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
126578594|NCT01353313|455415747|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
126578595|NCT04755660|455415748|FG000|Overall Study|Lost to Follow-up|1|||
126777094|NCT04288115|456139190|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
126777095|NCT00729365|456139192|FG000|Overall Study|Physician Decision|33|||
126777096|NCT00729365|456139193|FG001|Overall Study|Physician Decision|6|||
126777097|NCT00729365|456139194|FG002|Overall Study|Physician Decision|7|||
126777098|NCT02270983|456141274|FG000|Overall Study|Adverse Event|3|||
126777099|NCT02270983|456141275|FG001|Overall Study|Adverse Event|2|||
126777100|NCT02270983|456141276|FG002|Overall Study|Adverse Event|6|||
126777101|NCT02270983|456141274|FG000|Overall Study|Lack of Efficacy|2|||
126777102|NCT02270983|456141275|FG001|Overall Study|Lack of Efficacy|1|||
126777103|NCT02270983|456141276|FG002|Overall Study|Lack of Efficacy|1|||
126777104|NCT02270983|456141274|FG000|Overall Study|Withdrawal by Subject|1|||
126777105|NCT02270983|456141275|FG001|Overall Study|Withdrawal by Subject|0|||
126777106|NCT02270983|456141276|FG002|Overall Study|Withdrawal by Subject|2|||
126777107|NCT02270983|456141274|FG000|Overall Study|Lost to Follow-up|1|||
126777108|NCT02270983|456141275|FG001|Overall Study|Lost to Follow-up|1|||
126777109|NCT02270983|456141276|FG002|Overall Study|Lost to Follow-up|2|||
126777110|NCT02270983|456141274|FG000|Overall Study|Protocol Violation|1|||
126777111|NCT02270983|456141275|FG001|Overall Study|Protocol Violation|1|||
126777112|NCT02270983|456141276|FG002|Overall Study|Protocol Violation|1|||
126578596|NCT04755660|455415749|FG001|Overall Study|Lost to Follow-up|1|||
126578597|NCT04755660|455415750|FG002|Overall Study|Lost to Follow-up|0|||
126578598|NCT04755660|455415748|FG000|Overall Study|Withdrawal by Subject|0|||
126777113|NCT02270983|456141274|FG000|Overall Study|family emergency|0|||
126777114|NCT02270983|456141275|FG001|Overall Study|family emergency|1|||
126777115|NCT02270983|456141276|FG002|Overall Study|family emergency|0|||
126777116|NCT02270983|456141274|FG000|Overall Study|study procedure non-compliance|1|||
126777117|NCT02270983|456141275|FG001|Overall Study|study procedure non-compliance|0|||
126578599|NCT04755660|455415749|FG001|Overall Study|Withdrawal by Subject|1|||
126578600|NCT04755660|455415750|FG002|Overall Study|Withdrawal by Subject|1|||
126578601|NCT04755660|455415748|FG000|Overall Study|Physician Decision|0|||
126578602|NCT04755660|455415749|FG001|Overall Study|Physician Decision|0|||
126578603|NCT04755660|455415750|FG002|Overall Study|Physician Decision|1|||
126578604|NCT05672667|455415752|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
126578605|NCT04524390|455415753|FG000|Double Blind|Consent Withdrawal by subject|2|||
126578606|NCT04524390|455415754|FG001|Double Blind|Consent Withdrawal by subject|1|||
126578607|NCT04524390|455415755|FG002|Double Blind|Consent Withdrawal by subject|0|||
126578608|NCT04524390|455415753|FG000|Double Blind|Adverse Event|5|||
126578609|NCT04524390|455415754|FG001|Double Blind|Adverse Event|3|||
126578610|NCT04524390|455415755|FG002|Double Blind|Adverse Event|0|||
126578611|NCT04524390|455415753|FG000|Double Blind|Liver Transplant|5|||
126578612|NCT04524390|455415754|FG001|Double Blind|Liver Transplant|6|||
126578613|NCT04524390|455415755|FG002|Double Blind|Liver Transplant|0|||
126578614|NCT04524390|455415753|FG000|Double Blind|Disease Progression|0|||
126578615|NCT04524390|455415754|FG001|Double Blind|Disease Progression|1|||
126578616|NCT04524390|455415755|FG002|Double Blind|Disease Progression|0|||
126578617|NCT04524390|455415753|FG000|Open-Label|Drug interruption criteria|0|||
126578618|NCT04524390|455415754|FG001|Open-Label|Drug interruption criteria|0|||
126578619|NCT04524390|455415755|FG002|Open-Label|Drug interruption criteria|1|||
126578620|NCT04524390|455415753|FG000|Open-Label|Liver Transplant|0|||
126578621|NCT04524390|455415754|FG001|Open-Label|Liver Transplant|0|||
126578622|NCT04524390|455415755|FG002|Open-Label|Liver Transplant|1|||
126578623|NCT04524390|455415753|FG000|Open-Label|Disease Progression|0|||
126578624|NCT04524390|455415754|FG001|Open-Label|Disease Progression|0|||
126578625|NCT04524390|455415755|FG002|Open-Label|Disease Progression|1|||
126578626|NCT04524390|455415753|FG000|Open-Label|Adverse Event|0|||
126578627|NCT04524390|455415754|FG001|Open-Label|Adverse Event|0|||
126578628|NCT04524390|455415755|FG002|Open-Label|Adverse Event|3|||
126578629|NCT04524390|455415753|FG000|Open-Label|Study Termination by sponsor|0|||
126578630|NCT04524390|455415754|FG001|Open-Label|Study Termination by sponsor|0|||
126578631|NCT04524390|455415755|FG002|Open-Label|Study Termination by sponsor|45|||
126578632|NCT04540913|455415770|FG000|Overall Study|Withdrawal by Subject|14|||
126578633|NCT04540913|455415771|FG001|Overall Study|Withdrawal by Subject|3|||
126578634|NCT01693120|455415772|FG000|Enrollment|Lost to Follow-up|1|||
126578635|NCT01693120|455415772|FG000|Enrollment|Withdrawal by Subject|10|||
126578636|NCT01693120|455415772|FG000|Enrollment|Protocol Violation|46|||
126578637|NCT01693120|455415772|FG000|Enrollment|Physician Decision|3|||
126578638|NCT01693120|455415772|FG000|Enrollment|Adverse Event|1|||
126578639|NCT01693120|455415772|FG000|Enrollment|Study closed|8|||
126578640|NCT01693120|455415772|FG000|Enrollment|Other|1|||
126578641|NCT01693120|455415772|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
126578642|NCT01693120|455415772|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
126578643|NCT01693120|455415772|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
126578644|NCT01693120|455415772|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
126526506|NCT03621696|455219635|FG002|Overall Study|Not eligible|0|||
126526507|NCT03621696|455219636|FG003|Overall Study|Not eligible|5|||
126526508|NCT03621696|455219633|FG000|Overall Study|Withdrawal by Subject|1|||
126526509|NCT03621696|455219634|FG001|Overall Study|Withdrawal by Subject|1|||
126526510|NCT03621696|455219635|FG002|Overall Study|Withdrawal by Subject|1|||
126526511|NCT03621696|455219636|FG003|Overall Study|Withdrawal by Subject|0|||
126526512|NCT03621696|455219633|FG000|Overall Study|Physician Decision|0|||
126526513|NCT03621696|455219634|FG001|Overall Study|Physician Decision|0|||
126526514|NCT03621696|455219635|FG002|Overall Study|Physician Decision|1|||
126526515|NCT03621696|455219636|FG003|Overall Study|Physician Decision|0|||
126526516|NCT04349553|455219637|FG000|Overall Study|Withdrawal by Subject|1|||
126526517|NCT04349553|455219638|FG001|Overall Study|Withdrawal by Subject|0|||
126526518|NCT04349553|455219639|FG002|Overall Study|Withdrawal by Subject|1|||
126526519|NCT04349553|455219640|FG003|Overall Study|Withdrawal by Subject|0|||
126526520|NCT02063724|455219641|FG000|Overall Study|Disease progression|1|||
126526521|NCT01715805|455219642|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
126526522|NCT01715805|455219643|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
126526523|NCT01715805|455219644|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
126526524|NCT01715805|455219645|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
126526525|NCT01715805|455219642|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
126526526|NCT01715805|455219643|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
126526527|NCT01715805|455219644|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
126526528|NCT01715805|455219645|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
126526529|NCT01715805|455219642|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
126526530|NCT01715805|455219643|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
126526531|NCT01715805|455219644|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
126526532|NCT01715805|455219645|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
126578645|NCT01693120|455415772|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
126578646|NCT04153565|455415773|FG000|Overall Study|Death|13|||
126578647|NCT03050814|455415776|FG000|Overall Study|Screen failures|0|||
126578648|NCT03050814|455415777|FG001|Overall Study|Screen failures|0|||
126578649|NCT03050814|455415778|FG002|Overall Study|Screen failures|4|||
126578650|NCT05137236|455415782|FG000|Part A|Other than Specified|1|||
126578651|NCT05137236|455415783|FG001|Part A|Other than Specified|0|||
126578652|NCT05137236|455415784|FG002|Part A|Other than Specified|0|||
126578653|NCT05137236|455415785|FG003|Part A|Other than Specified|0|||
126578654|NCT05137236|455415786|FG004|Part A|Other than Specified|0|||
126578655|NCT05137236|455415787|FG005|Part A|Other than Specified|0|||
126578656|NCT05137236|455415788|FG006|Part A|Other than Specified|0|||
126578657|NCT05137236|455415789|FG007|Part A|Other than Specified|0|||
126578658|NCT05137236|455415782|FG000|Part A|Withdrawal by Subject|0|||
126578659|NCT05137236|455415783|FG001|Part A|Withdrawal by Subject|4|||
126578660|NCT05137236|455415784|FG002|Part A|Withdrawal by Subject|1|||
126578661|NCT05137236|455415785|FG003|Part A|Withdrawal by Subject|1|||
126578662|NCT05137236|455415786|FG004|Part A|Withdrawal by Subject|3|||
126578663|NCT05137236|455415787|FG005|Part A|Withdrawal by Subject|2|||
126578664|NCT05137236|455415788|FG006|Part A|Withdrawal by Subject|0|||
126578665|NCT05137236|455415789|FG007|Part A|Withdrawal by Subject|0|||
126578666|NCT05137236|455415782|FG000|Part A|Lost to Follow-up|5|||
126578667|NCT05137236|455415783|FG001|Part A|Lost to Follow-up|7|||
126578668|NCT05137236|455415784|FG002|Part A|Lost to Follow-up|1|||
126578669|NCT05137236|455415785|FG003|Part A|Lost to Follow-up|3|||
126578670|NCT05137236|455415786|FG004|Part A|Lost to Follow-up|3|||
126578671|NCT05137236|455415787|FG005|Part A|Lost to Follow-up|8|||
126578672|NCT05137236|455415788|FG006|Part A|Lost to Follow-up|0|||
126578673|NCT05137236|455415789|FG007|Part A|Lost to Follow-up|0|||
126578674|NCT05137236|455415782|FG000|Part B|Withdrawal by Subject|0|||
126578675|NCT05137236|455415783|FG001|Part B|Withdrawal by Subject|0|||
126578676|NCT05137236|455415784|FG002|Part B|Withdrawal by Subject|0|||
126578677|NCT05137236|455415785|FG003|Part B|Withdrawal by Subject|0|||
126578678|NCT05137236|455415786|FG004|Part B|Withdrawal by Subject|0|||
126578679|NCT05137236|455415787|FG005|Part B|Withdrawal by Subject|0|||
126578680|NCT05137236|455415788|FG006|Part B|Withdrawal by Subject|0|||
126578681|NCT05137236|455415789|FG007|Part B|Withdrawal by Subject|2|||
126578682|NCT05137236|455415782|FG000|Part B|Lost to Follow-up|0|||
126578683|NCT05137236|455415783|FG001|Part B|Lost to Follow-up|0|||
126578684|NCT05137236|455415784|FG002|Part B|Lost to Follow-up|0|||
126578685|NCT05137236|455415785|FG003|Part B|Lost to Follow-up|0|||
126578686|NCT05137236|455415786|FG004|Part B|Lost to Follow-up|0|||
126578687|NCT05137236|455415787|FG005|Part B|Lost to Follow-up|0|||
126578688|NCT05137236|455415788|FG006|Part B|Lost to Follow-up|5|||
126578689|NCT05137236|455415789|FG007|Part B|Lost to Follow-up|5|||
126578690|NCT05137236|455415782|FG000|Part B|Death|0|||
126578691|NCT05137236|455415783|FG001|Part B|Death|0|||
126578692|NCT05137236|455415784|FG002|Part B|Death|0|||
126578693|NCT05137236|455415785|FG003|Part B|Death|0|||
126578694|NCT05137236|455415786|FG004|Part B|Death|0|||
126578695|NCT05137236|455415787|FG005|Part B|Death|0|||
126578696|NCT05137236|455415788|FG006|Part B|Death|0|||
126578697|NCT05137236|455415789|FG007|Part B|Death|2|||
126578698|NCT02724956|455415790|FG000|Overall Study|Physician Decision|1|||
126578699|NCT02724956|455415791|FG001|Overall Study|Physician Decision|0|||
126578700|NCT02724956|455415790|FG000|Overall Study|Lack of Efficacy|0|||
126578701|NCT02724956|455415791|FG001|Overall Study|Lack of Efficacy|1|||
126578702|NCT02724956|455415790|FG000|Overall Study|Withdrawal by Subject|0|||
126578703|NCT02724956|455415791|FG001|Overall Study|Withdrawal by Subject|1|||
126578704|NCT02647905|455415794|FG000|Overall Study|Lost to Follow-up|1|||
126578705|NCT02647905|455415794|FG000|Overall Study|Withdrawal by Subject|2|||
126578706|NCT02015520|455415795|FG000|Overall Study|Lack of Efficacy|1|||
126578707|NCT02015520|455415796|FG001|Overall Study|Lack of Efficacy|0|||
126578708|NCT02015520|455415797|FG002|Overall Study|Lack of Efficacy|3|||
126578709|NCT02015520|455415798|FG003|Overall Study|Lack of Efficacy|2|||
126578710|NCT02015520|455415795|FG000|Overall Study|Adverse Event|0|||
126578711|NCT02015520|455415796|FG001|Overall Study|Adverse Event|0|||
126728360|NCT01021852|455954234|FG002|Washout Period-Placebo|Adverse Event|0|||
126728361|NCT01021852|455954235|FG003|Washout Period-Placebo|Adverse Event|1|||
126578712|NCT02015520|455415797|FG002|Overall Study|Adverse Event|0|||
126578713|NCT02015520|455415798|FG003|Overall Study|Adverse Event|1|||
126578714|NCT02015520|455415795|FG000|Overall Study|Withdrawal by Subject|2|||
126578715|NCT02015520|455415796|FG001|Overall Study|Withdrawal by Subject|2|||
126578716|NCT02015520|455415797|FG002|Overall Study|Withdrawal by Subject|1|||
126578717|NCT02015520|455415798|FG003|Overall Study|Withdrawal by Subject|0|||
126578718|NCT02015520|455415795|FG000|Overall Study|Death|1|||
126578719|NCT02015520|455415796|FG001|Overall Study|Death|0|||
126578720|NCT02015520|455415797|FG002|Overall Study|Death|0|||
126578721|NCT02015520|455415798|FG003|Overall Study|Death|0|||
126578722|NCT02015520|455415795|FG000|Overall Study|Lost to Follow-up|0|||
126728362|NCT01021852|455954236|FG004|Washout Period-Placebo|Adverse Event|0|||
126578723|NCT02015520|455415796|FG001|Overall Study|Lost to Follow-up|0|||
126578724|NCT02015520|455415797|FG002|Overall Study|Lost to Follow-up|1|||
126578725|NCT02015520|455415798|FG003|Overall Study|Lost to Follow-up|0|||
126578726|NCT02015520|455415795|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
126578727|NCT02015520|455415796|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
126578728|NCT02015520|455415797|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
126728363|NCT01021852|455954237|FG005|Washout Period-Placebo|Adverse Event|1|||
126728364|NCT01021852|455954238|FG006|Washout Period-Placebo|Adverse Event|0|||
126526533|NCT01715805|455219642|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
126526534|NCT01715805|455219643|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
126526535|NCT01715805|455219644|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
126526536|NCT01715805|455219645|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
126526537|NCT01715805|455219642|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
126526538|NCT01715805|455219643|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
126526539|NCT01715805|455219644|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
126526540|NCT01715805|455219645|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
126526541|NCT01715805|455219642|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
126526542|NCT01715805|455219643|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
126526543|NCT01715805|455219644|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
126526544|NCT01715805|455219645|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
126526545|NCT01715805|455219642|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
126526546|NCT01715805|455219643|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
126526547|NCT01715805|455219644|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
126526548|NCT01715805|455219645|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
126526549|NCT01715805|455219642|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
126526550|NCT01715805|455219643|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
126526551|NCT01715805|455219644|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
126526552|NCT01715805|455219645|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
126526553|NCT01715805|455219642|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
126526554|NCT01715805|455219643|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
126526555|NCT01715805|455219644|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
126526556|NCT01715805|455219645|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
126526557|NCT01715805|455219642|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
126526558|NCT01715805|455219643|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
126526559|NCT01715805|455219644|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
126526560|NCT01715805|455219645|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
126526561|NCT01715805|455219642|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
126526562|NCT01715805|455219643|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
126526563|NCT01715805|455219644|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
126526564|NCT01715805|455219645|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
126526565|NCT01715805|455219642|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
126526566|NCT01715805|455219643|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
126526567|NCT01715805|455219644|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
126526568|NCT01715805|455219645|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
126526569|NCT01715805|455219642|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
126526570|NCT01715805|455219643|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
126526571|NCT01715805|455219644|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
126526572|NCT01715805|455219645|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
126526573|NCT01715805|455219642|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
126526574|NCT01715805|455219643|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
126526575|NCT01715805|455219644|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
126526576|NCT01715805|455219645|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
126526577|NCT00709722|455219648|FG000|Overall Study|Adverse Event|1|||
126526578|NCT02372396|455219649|FG000|Overall Study|Lost to Follow-up|7|||
126526579|NCT02372396|455219650|FG001|Overall Study|Lost to Follow-up|9|||
126526580|NCT02310750|455219657|FG000|HP Period 1|Lost to Follow-up|0|||
126526581|NCT02310750|455219658|FG001|HP Period 1|Lost to Follow-up|0|||
126526582|NCT02310750|455219659|FG002|HP Period 1|Lost to Follow-up|0|||
126526583|NCT02310750|455219660|FG003|HP Period 1|Lost to Follow-up|0|||
126526584|NCT02310750|455219661|FG004|HP Period 1|Lost to Follow-up|0|||
126526585|NCT02310750|455219662|FG005|HP Period 1|Lost to Follow-up|0|||
126526586|NCT02310750|455219663|FG006|HP Period 1|Lost to Follow-up|1|||
126526587|NCT02310750|455219664|FG007|HP Period 1|Lost to Follow-up|0|||
126526588|NCT02310750|455219665|FG008|HP Period 1|Lost to Follow-up|0|||
126526589|NCT02310750|455219666|FG009|HP Period 1|Lost to Follow-up|0|||
126526590|NCT02310750|455219667|FG010|HP Period 1|Lost to Follow-up|0|||
126526591|NCT02310750|455219668|FG011|HP Period 1|Lost to Follow-up|0|||
126526592|NCT02310750|455219669|FG012|HP Period 1|Lost to Follow-up|0|||
126526593|NCT02310750|455219670|FG013|HP Period 1|Lost to Follow-up|0|||
126526594|NCT02310750|455219671|FG014|HP Period 1|Lost to Follow-up|0|||
126526595|NCT02310750|455219672|FG015|HP Period 1|Lost to Follow-up|0|||
126526596|NCT02310750|455219657|FG000|HP Period 1|Withdrawal by Subject|1|||
126526597|NCT02310750|455219658|FG001|HP Period 1|Withdrawal by Subject|0|||
126578729|NCT02015520|455415798|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
126578730|NCT02015520|455415795|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
126578731|NCT02015520|455415796|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
126578732|NCT02015520|455415797|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
126578733|NCT02015520|455415798|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
126578734|NCT05119855|455415799|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
126578735|NCT05119855|455415800|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
126578736|NCT05119855|455415799|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
126578737|NCT05119855|455415800|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
126578738|NCT05119855|455415799|FG000|Overall Study|Lost to Follow-up|6|||
126578739|NCT05119855|455415800|FG001|Overall Study|Lost to Follow-up|8|||
126578740|NCT02932579|455415801|FG000|Overall Study|Withdrawal by Subject|4|||
126578741|NCT02932579|455415802|FG001|Overall Study|Withdrawal by Subject|1|||
126578742|NCT01972724|455415803|FG000|Double-Blind|Rescue Criteria Met|1|||
126578743|NCT01972724|455415804|FG001|Double-Blind|Rescue Criteria Met|0|||
126578744|NCT01972724|455415805|FG002|Double-Blind|Rescue Criteria Met|0|||
126578745|NCT01972724|455415803|FG000|Double-Blind|Adverse Event|1|||
126578746|NCT01972724|455415804|FG001|Double-Blind|Adverse Event|0|||
126578747|NCT01972724|455415805|FG002|Double-Blind|Adverse Event|0|||
126578748|NCT01972724|455415803|FG000|Double-Blind|Withdrawal of Consent|2|||
126578749|NCT01972724|455415804|FG001|Double-Blind|Withdrawal of Consent|1|||
126578750|NCT01972724|455415805|FG002|Double-Blind|Withdrawal of Consent|0|||
126578751|NCT01972724|455415803|FG000|Double-Blind|Significant Protocol Deviation|5|||
126578752|NCT01972724|455415804|FG001|Double-Blind|Significant Protocol Deviation|8|||
126578753|NCT01972724|455415805|FG002|Double-Blind|Significant Protocol Deviation|0|||
126578754|NCT01972724|455415803|FG000|Open-Label|Withdrew Consent|0|||
126578755|NCT01972724|455415804|FG001|Open-Label|Withdrew Consent|0|||
126578756|NCT01972724|455415805|FG002|Open-Label|Withdrew Consent|3|||
126578757|NCT01972724|455415803|FG000|Open-Label|Significant Protocol Deviation|0|||
126578758|NCT01972724|455415804|FG001|Open-Label|Significant Protocol Deviation|0|||
126578759|NCT01972724|455415805|FG002|Open-Label|Significant Protocol Deviation|2|||
126578760|NCT00111813|455415812|FG000|Overall Study|Adverse Event|1|||
126578761|NCT00111813|455415813|FG001|Overall Study|Adverse Event|2|||
126578762|NCT00111813|455415814|FG002|Overall Study|Adverse Event|4|||
126578763|NCT00111813|455415815|FG003|Overall Study|Adverse Event|2|||
126578764|NCT00111813|455415816|FG004|Overall Study|Adverse Event|2|||
126578765|NCT00111813|455415817|FG005|Overall Study|Adverse Event|2|||
126578766|NCT00111813|455415812|FG000|Overall Study|Progressive disease|2|||
126578767|NCT00111813|455415813|FG001|Overall Study|Progressive disease|1|||
126578768|NCT00111813|455415814|FG002|Overall Study|Progressive disease|5|||
126578769|NCT00111813|455415815|FG003|Overall Study|Progressive disease|3|||
126578770|NCT00111813|455415816|FG004|Overall Study|Progressive disease|4|||
126578771|NCT00111813|455415817|FG005|Overall Study|Progressive disease|3|||
126578772|NCT00111813|455415812|FG000|Overall Study|Lack of Efficacy|0|||
126578773|NCT00111813|455415813|FG001|Overall Study|Lack of Efficacy|0|||
126578774|NCT00111813|455415814|FG002|Overall Study|Lack of Efficacy|0|||
126578775|NCT00111813|455415815|FG003|Overall Study|Lack of Efficacy|0|||
126578776|NCT00111813|455415816|FG004|Overall Study|Lack of Efficacy|0|||
126578777|NCT00111813|455415817|FG005|Overall Study|Lack of Efficacy|1|||
126578778|NCT00111813|455415812|FG000|Overall Study|Other|0|||
126578779|NCT00111813|455415813|FG001|Overall Study|Other|0|||
126578780|NCT00111813|455415814|FG002|Overall Study|Other|1|||
126578781|NCT00111813|455415815|FG003|Overall Study|Other|0|||
126578782|NCT00111813|455415816|FG004|Overall Study|Other|0|||
126578783|NCT00111813|455415817|FG005|Overall Study|Other|0|||
126578784|NCT02121002|455415819|FG000|Overall Study|Physician Decision|2|||
126578785|NCT02121002|455415820|FG001|Overall Study|Physician Decision|0|||
126578786|NCT02121002|455415821|FG002|Overall Study|Physician Decision|0|||
126578787|NCT02121002|455415819|FG000|Overall Study|Withdrawal by Subject|3|||
126578788|NCT02121002|455415820|FG001|Overall Study|Withdrawal by Subject|1|||
126578789|NCT02121002|455415821|FG002|Overall Study|Withdrawal by Subject|4|||
126578790|NCT02121002|455415819|FG000|Overall Study|Protocol Violation|1|||
126578791|NCT02121002|455415820|FG001|Overall Study|Protocol Violation|2|||
126578792|NCT02121002|455415821|FG002|Overall Study|Protocol Violation|4|||
126578793|NCT02121002|455415819|FG000|Overall Study|Concomitant therapy|0|||
126578794|NCT02121002|455415820|FG001|Overall Study|Concomitant therapy|1|||
126578795|NCT02121002|455415821|FG002|Overall Study|Concomitant therapy|1|||
126578796|NCT02121002|455415819|FG000|Overall Study|Others|1|||
126578797|NCT02121002|455415820|FG001|Overall Study|Others|0|||
126578798|NCT02121002|455415821|FG002|Overall Study|Others|1|||
126578799|NCT01000480|455415823|FG000|Induction Phase|Adverse Event|2|||
126578800|NCT01000480|455415823|FG000|Induction Phase|Lost to Follow-up|1|||
126578801|NCT01000480|455415823|FG000|Induction Phase|Physician Decision|1|||
126578802|NCT01000480|455415823|FG000|Induction Phase|Entry Criteria Not Met|3|||
126578803|NCT01000480|455415823|FG000|Concurrent Therapy Phase|Adverse Event|4|||
126578804|NCT01000480|455415823|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
126578805|NCT01000480|455415823|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
126578806|NCT01000480|455415823|FG000|Concurrent Therapy Phase|Physician Decision|1|||
126526598|NCT02310750|455219659|FG002|HP Period 1|Withdrawal by Subject|0|||
126526599|NCT02310750|455219660|FG003|HP Period 1|Withdrawal by Subject|1|||
126526600|NCT02310750|455219661|FG004|HP Period 1|Withdrawal by Subject|0|||
126526601|NCT02310750|455219662|FG005|HP Period 1|Withdrawal by Subject|0|||
126526602|NCT02310750|455219663|FG006|HP Period 1|Withdrawal by Subject|0|||
126526603|NCT02310750|455219664|FG007|HP Period 1|Withdrawal by Subject|0|||
126526604|NCT02310750|455219665|FG008|HP Period 1|Withdrawal by Subject|0|||
126526605|NCT02310750|455219666|FG009|HP Period 1|Withdrawal by Subject|0|||
126526606|NCT02310750|455219667|FG010|HP Period 1|Withdrawal by Subject|0|||
126526607|NCT02310750|455219668|FG011|HP Period 1|Withdrawal by Subject|0|||
126526608|NCT02310750|455219669|FG012|HP Period 1|Withdrawal by Subject|0|||
126526609|NCT02310750|455219670|FG013|HP Period 1|Withdrawal by Subject|0|||
126526610|NCT02310750|455219671|FG014|HP Period 1|Withdrawal by Subject|0|||
126526611|NCT02310750|455219672|FG015|HP Period 1|Withdrawal by Subject|0|||
126526612|NCT02310750|455219657|FG000|HP Washout 1|Lost to Follow-up|0|||
126526613|NCT02310750|455219658|FG001|HP Washout 1|Lost to Follow-up|0|||
126526614|NCT02310750|455219659|FG002|HP Washout 1|Lost to Follow-up|1|||
126526615|NCT02310750|455219660|FG003|HP Washout 1|Lost to Follow-up|1|||
126526616|NCT02310750|455219661|FG004|HP Washout 1|Lost to Follow-up|2|||
126526617|NCT02310750|455219662|FG005|HP Washout 1|Lost to Follow-up|2|||
126526618|NCT02310750|455219663|FG006|HP Washout 1|Lost to Follow-up|3|||
126526619|NCT02310750|455219664|FG007|HP Washout 1|Lost to Follow-up|0|||
126526620|NCT02310750|455219665|FG008|HP Washout 1|Lost to Follow-up|0|||
126526621|NCT02310750|455219666|FG009|HP Washout 1|Lost to Follow-up|0|||
126526622|NCT02310750|455219667|FG010|HP Washout 1|Lost to Follow-up|0|||
126526623|NCT02310750|455219668|FG011|HP Washout 1|Lost to Follow-up|0|||
126526624|NCT02310750|455219669|FG012|HP Washout 1|Lost to Follow-up|0|||
126526625|NCT02310750|455219670|FG013|HP Washout 1|Lost to Follow-up|0|||
126526626|NCT02310750|455219671|FG014|HP Washout 1|Lost to Follow-up|0|||
126526627|NCT02310750|455219672|FG015|HP Washout 1|Lost to Follow-up|0|||
126526628|NCT02310750|455219657|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126526629|NCT02310750|455219658|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126526630|NCT02310750|455219659|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126526631|NCT02310750|455219660|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
126526632|NCT02310750|455219661|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126526633|NCT02310750|455219662|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
126526634|NCT02310750|455219663|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126526635|NCT02310750|455219664|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126526636|NCT02310750|455219665|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
126526637|NCT02310750|455219666|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
126526638|NCT02310750|455219667|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126526639|NCT02310750|455219668|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126526640|NCT02310750|455219669|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126526641|NCT02310750|455219670|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126526642|NCT02310750|455219671|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126526643|NCT02310750|455219672|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
126526644|NCT02310750|455219657|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526645|NCT02310750|455219658|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526646|NCT02310750|455219659|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526647|NCT02310750|455219660|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526648|NCT02310750|455219661|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526649|NCT02310750|455219662|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526650|NCT02310750|455219663|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526651|NCT02310750|455219664|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526652|NCT02310750|455219665|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526653|NCT02310750|455219666|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
126526654|NCT02310750|455219667|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526655|NCT02310750|455219668|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526656|NCT02310750|455219669|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526657|NCT02310750|455219670|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526658|NCT02310750|455219671|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526659|NCT02310750|455219672|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
126526660|NCT02310750|455219657|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526661|NCT02310750|455219658|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526662|NCT02310750|455219659|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526663|NCT02310750|455219660|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526664|NCT02310750|455219661|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526665|NCT02310750|455219662|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526666|NCT02310750|455219663|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526667|NCT02310750|455219664|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
126526668|NCT02310750|455219665|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
126526669|NCT02310750|455219666|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
126578807|NCT05052996|455415824|FG000|Overall Study|Still on study|0|||
126526670|NCT02310750|455219667|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526671|NCT02310750|455219668|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526672|NCT02310750|455219669|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526673|NCT02310750|455219670|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526674|NCT02310750|455219671|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526675|NCT02310750|455219672|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
126526676|NCT02310750|455219657|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126578808|NCT05052996|455415825|FG001|Overall Study|Still on study|0|||
126578809|NCT05052996|455415826|FG002|Overall Study|Still on study|47|||
126578810|NCT05052996|455415827|FG003|Overall Study|Still on study|44|||
126578811|NCT05052996|455415824|FG000|Overall Study|Cohort terminated by sponsor|21|||
126526677|NCT02310750|455219658|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526678|NCT02310750|455219659|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526679|NCT02310750|455219660|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526680|NCT02310750|455219661|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526681|NCT02310750|455219662|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526682|NCT02310750|455219663|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526683|NCT02310750|455219664|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
126526684|NCT02310750|455219665|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
126526685|NCT02310750|455219666|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526686|NCT02310750|455219667|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526687|NCT02310750|455219668|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526688|NCT02310750|455219669|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526689|NCT02310750|455219670|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526690|NCT02310750|455219671|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526691|NCT02310750|455219672|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
126526692|NCT02310750|455219657|FG000|HP Washout 2|Lost to Follow-up|0|||
126526693|NCT02310750|455219658|FG001|HP Washout 2|Lost to Follow-up|0|||
126526694|NCT02310750|455219659|FG002|HP Washout 2|Lost to Follow-up|0|||
126526695|NCT02310750|455219660|FG003|HP Washout 2|Lost to Follow-up|0|||
126526696|NCT02310750|455219661|FG004|HP Washout 2|Lost to Follow-up|1|||
126526697|NCT02310750|455219662|FG005|HP Washout 2|Lost to Follow-up|0|||
126526698|NCT02310750|455219663|FG006|HP Washout 2|Lost to Follow-up|7|||
126526699|NCT02310750|455219664|FG007|HP Washout 2|Lost to Follow-up|0|||
126526700|NCT02310750|455219665|FG008|HP Washout 2|Lost to Follow-up|0|||
126526701|NCT02310750|455219666|FG009|HP Washout 2|Lost to Follow-up|0|||
126526702|NCT02310750|455219667|FG010|HP Washout 2|Lost to Follow-up|0|||
126526703|NCT02310750|455219668|FG011|HP Washout 2|Lost to Follow-up|0|||
126526704|NCT02310750|455219669|FG012|HP Washout 2|Lost to Follow-up|0|||
126526705|NCT02310750|455219670|FG013|HP Washout 2|Lost to Follow-up|0|||
126526706|NCT02310750|455219671|FG014|HP Washout 2|Lost to Follow-up|0|||
126526707|NCT02310750|455219672|FG015|HP Washout 2|Lost to Follow-up|0|||
126526708|NCT00355082|455219675|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
126526709|NCT00355082|455219676|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
126526710|NCT00355082|455219677|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
126526711|NCT00355082|455219675|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
126526712|NCT00355082|455219676|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
126526713|NCT00355082|455219677|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
126526714|NCT00355082|455219675|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
126526715|NCT00355082|455219676|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
126526716|NCT00355082|455219677|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
126526717|NCT00355082|455219675|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
126526718|NCT00355082|455219676|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
126526719|NCT00355082|455219677|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
126526720|NCT00355082|455219675|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
126526721|NCT00355082|455219676|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
126578812|NCT05052996|455415825|FG001|Overall Study|Cohort terminated by sponsor|12|||
126578813|NCT05052996|455415826|FG002|Overall Study|Cohort terminated by sponsor|0|||
126578814|NCT05052996|455415827|FG003|Overall Study|Cohort terminated by sponsor|0|||
126578815|NCT05052996|455415824|FG000|Overall Study|Withdrew consent|1|||
126578816|NCT05052996|455415825|FG001|Overall Study|Withdrew consent|0|||
126578817|NCT05052996|455415826|FG002|Overall Study|Withdrew consent|1|||
126578818|NCT05052996|455415827|FG003|Overall Study|Withdrew consent|2|||
126578819|NCT05052996|455415824|FG000|Overall Study|Lost to Follow-up|1|||
126578820|NCT05052996|455415825|FG001|Overall Study|Lost to Follow-up|0|||
126526722|NCT00355082|455219677|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
126526723|NCT00355082|455219675|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
126526724|NCT00355082|455219676|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
126526725|NCT00355082|455219677|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
126578821|NCT05052996|455415826|FG002|Overall Study|Lost to Follow-up|0|||
126728365|NCT01021852|455954239|FG007|Washout Period-Placebo|Adverse Event|0|||
126728366|NCT01021852|455954232|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
126728367|NCT01021852|455954233|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
126526726|NCT00355082|455219675|FG000|Continuation Phase|Adverse Event|2|||
126728368|NCT01021852|455954234|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
126728369|NCT01021852|455954235|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
126728370|NCT01021852|455954236|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
126728371|NCT01021852|455954237|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
126728372|NCT01021852|455954238|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
126728373|NCT01021852|455954239|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
126728374|NCT01021852|455954232|FG000|Washout Period-Placebo|Protocol Violation|0|||
126728375|NCT01021852|455954233|FG001|Washout Period-Placebo|Protocol Violation|0|||
126728376|NCT01021852|455954234|FG002|Washout Period-Placebo|Protocol Violation|0|||
126728377|NCT01021852|455954235|FG003|Washout Period-Placebo|Protocol Violation|0|||
126728378|NCT01021852|455954236|FG004|Washout Period-Placebo|Protocol Violation|0|||
126728379|NCT01021852|455954237|FG005|Washout Period-Placebo|Protocol Violation|0|||
126728380|NCT01021852|455954238|FG006|Washout Period-Placebo|Protocol Violation|1|||
126728381|NCT01021852|455954239|FG007|Washout Period-Placebo|Protocol Violation|0|||
126728382|NCT01021852|455954232|FG000|Washout Period-No Drug|Adverse Event|1|||
126728383|NCT01021852|455954233|FG001|Washout Period-No Drug|Adverse Event|0|||
126728384|NCT01021852|455954234|FG002|Washout Period-No Drug|Adverse Event|0|||
126728385|NCT01021852|455954235|FG003|Washout Period-No Drug|Adverse Event|0|||
126728386|NCT01021852|455954236|FG004|Washout Period-No Drug|Adverse Event|0|||
126728387|NCT01021852|455954237|FG005|Washout Period-No Drug|Adverse Event|1|||
126728388|NCT01021852|455954238|FG006|Washout Period-No Drug|Adverse Event|0|||
126728389|NCT01021852|455954239|FG007|Washout Period-No Drug|Adverse Event|0|||
126728390|NCT01021852|455954232|FG000|Treatment Period 2|Adverse Event|0|||
126728391|NCT01021852|455954233|FG001|Treatment Period 2|Adverse Event|1|||
126728392|NCT01021852|455954234|FG002|Treatment Period 2|Adverse Event|0|||
126728393|NCT01021852|455954235|FG003|Treatment Period 2|Adverse Event|0|||
126728394|NCT01021852|455954236|FG004|Treatment Period 2|Adverse Event|1|||
126728395|NCT01021852|455954237|FG005|Treatment Period 2|Adverse Event|0|||
126728396|NCT01021852|455954238|FG006|Treatment Period 2|Adverse Event|1|||
126728397|NCT01021852|455954239|FG007|Treatment Period 2|Adverse Event|0|||
126728398|NCT01021852|455954232|FG000|Treatment Period 2|Lack of Efficacy|0|||
126728399|NCT01021852|455954233|FG001|Treatment Period 2|Lack of Efficacy|0|||
126728400|NCT01021852|455954234|FG002|Treatment Period 2|Lack of Efficacy|0|||
126728401|NCT01021852|455954235|FG003|Treatment Period 2|Lack of Efficacy|0|||
126728402|NCT01021852|455954236|FG004|Treatment Period 2|Lack of Efficacy|0|||
126728403|NCT01021852|455954237|FG005|Treatment Period 2|Lack of Efficacy|1|||
126728404|NCT01021852|455954238|FG006|Treatment Period 2|Lack of Efficacy|0|||
126728405|NCT01021852|455954239|FG007|Treatment Period 2|Lack of Efficacy|0|||
126728406|NCT01021852|455954232|FG000|Treatment Period 2|Physician Decision|0|||
126777118|NCT02270983|456141276|FG002|Overall Study|study procedure non-compliance|0|||
126777119|NCT02270983|456141274|FG000|Overall Study|moved away from study site|0|||
126526727|NCT00355082|455219676|FG001|Continuation Phase|Adverse Event|0|||
126526728|NCT00355082|455219677|FG002|Continuation Phase|Adverse Event|1|||
126526729|NCT00355082|455219675|FG000|Continuation Phase|Lost to Follow-up|2|||
126526730|NCT00355082|455219676|FG001|Continuation Phase|Lost to Follow-up|0|||
126526731|NCT00355082|455219677|FG002|Continuation Phase|Lost to Follow-up|1|||
126526732|NCT00355082|455219675|FG000|Continuation Phase|Protocol Violation|1|||
126526733|NCT00355082|455219676|FG001|Continuation Phase|Protocol Violation|0|||
126526734|NCT00355082|455219677|FG002|Continuation Phase|Protocol Violation|1|||
126526735|NCT00355082|455219675|FG000|Continuation Phase|Withdrawal by Subject|4|||
126526736|NCT00355082|455219676|FG001|Continuation Phase|Withdrawal by Subject|0|||
126526737|NCT00355082|455219677|FG002|Continuation Phase|Withdrawal by Subject|0|||
126526738|NCT00355082|455219675|FG000|Continuation Phase|Lack of Efficacy|5|||
126526739|NCT00355082|455219676|FG001|Continuation Phase|Lack of Efficacy|0|||
126526740|NCT00355082|455219677|FG002|Continuation Phase|Lack of Efficacy|0|||
126526741|NCT00355082|455219675|FG000|Continuation Phase|Site Closed by Sponsor|8|||
126526742|NCT00355082|455219676|FG001|Continuation Phase|Site Closed by Sponsor|0|||
126526743|NCT00355082|455219677|FG002|Continuation Phase|Site Closed by Sponsor|0|||
126526744|NCT00355082|455219675|FG000|Continuation Phase|Scheduling Error|1|||
126526745|NCT00355082|455219676|FG001|Continuation Phase|Scheduling Error|0|||
126526746|NCT00355082|455219677|FG002|Continuation Phase|Scheduling Error|0|||
126728407|NCT01021852|455954233|FG001|Treatment Period 2|Physician Decision|0|||
126777120|NCT02270983|456141275|FG001|Overall Study|moved away from study site|1|||
126777121|NCT02270983|456141276|FG002|Overall Study|moved away from study site|0|||
126578822|NCT05052996|455415827|FG003|Overall Study|Lost to Follow-up|2|||
126728408|NCT01021852|455954234|FG002|Treatment Period 2|Physician Decision|1|||
126728409|NCT01021852|455954235|FG003|Treatment Period 2|Physician Decision|0|||
126728410|NCT01021852|455954236|FG004|Treatment Period 2|Physician Decision|0|||
126728411|NCT01021852|455954237|FG005|Treatment Period 2|Physician Decision|0|||
126728412|NCT01021852|455954238|FG006|Treatment Period 2|Physician Decision|0|||
126777122|NCT00854620|456141282|FG000|Overall Study|Adverse Event|1|||
126777123|NCT01623830|456141283|FG000|Overall Study|Withdrawal by Subject|6|||
126578823|NCT05052996|455415824|FG000|Overall Study|Adverse Event|0|||
126578824|NCT05052996|455415825|FG001|Overall Study|Adverse Event|0|||
126578825|NCT05052996|455415826|FG002|Overall Study|Adverse Event|2|||
126578826|NCT05052996|455415827|FG003|Overall Study|Adverse Event|0|||
126526747|NCT00355082|455219675|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
126526748|NCT00355082|455219676|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
126578827|NCT05052996|455415824|FG000|Overall Study|Randomized but never treated|0|||
126578828|NCT05052996|455415825|FG001|Overall Study|Randomized but never treated|0|||
126578829|NCT05052996|455415826|FG002|Overall Study|Randomized but never treated|1|||
126578830|NCT05052996|455415827|FG003|Overall Study|Randomized but never treated|1|||
126578831|NCT05052996|455415824|FG000|Overall Study|Protocol Violation|1|||
126578832|NCT05052996|455415825|FG001|Overall Study|Protocol Violation|0|||
126578833|NCT05052996|455415826|FG002|Overall Study|Protocol Violation|0|||
126578834|NCT05052996|455415827|FG003|Overall Study|Protocol Violation|0|||
126578835|NCT03101930|455415833|FG000|Overall Study|Withdrawal by Subject|2|||
126578836|NCT03101930|455415834|FG001|Overall Study|Withdrawal by Subject|1|||
126578837|NCT03101930|455415835|FG002|Overall Study|Withdrawal by Subject|2|||
126578838|NCT00087139|455415836|FG000|Overall Study|Adverse Event|18|||
126578839|NCT00087139|455415837|FG001|Overall Study|Adverse Event|17|||
126578840|NCT00087139|455415838|FG002|Overall Study|Adverse Event|13|||
126578841|NCT00087139|455415836|FG000|Overall Study|Death|2|||
126578842|NCT00087139|455415837|FG001|Overall Study|Death|1|||
126578843|NCT00087139|455415838|FG002|Overall Study|Death|0|||
126578844|NCT00087139|455415836|FG000|Overall Study|Withdrawal by Subject|3|||
126578845|NCT00087139|455415837|FG001|Overall Study|Withdrawal by Subject|2|||
126578846|NCT00087139|455415838|FG002|Overall Study|Withdrawal by Subject|2|||
126578847|NCT00087139|455415836|FG000|Overall Study|Physician Decision|1|||
126578848|NCT00087139|455415837|FG001|Overall Study|Physician Decision|1|||
126526749|NCT00355082|455219677|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
126526750|NCT04782323|455219678|FG000|Overall Study|Death|1|||
126526751|NCT04782323|455219679|FG001|Overall Study|Death|0|||
126526752|NCT04782323|455219680|FG002|Overall Study|Death|0|||
126526753|NCT04782323|455219681|FG003|Overall Study|Death|0|||
126526754|NCT04782323|455219682|FG004|Overall Study|Death|1|||
126526755|NCT04782323|455219683|FG005|Overall Study|Death|1|||
126526756|NCT04782323|455219684|FG006|Overall Study|Death|1|||
126526757|NCT04782323|455219685|FG007|Overall Study|Death|0|||
126526758|NCT04782323|455219678|FG000|Overall Study|Withdrawal by Subject|0|||
126526759|NCT04782323|455219679|FG001|Overall Study|Withdrawal by Subject|0|||
126526760|NCT04782323|455219680|FG002|Overall Study|Withdrawal by Subject|1|||
126526761|NCT04782323|455219681|FG003|Overall Study|Withdrawal by Subject|0|||
126526762|NCT04782323|455219682|FG004|Overall Study|Withdrawal by Subject|0|||
126526763|NCT04782323|455219683|FG005|Overall Study|Withdrawal by Subject|1|||
126526764|NCT04782323|455219684|FG006|Overall Study|Withdrawal by Subject|0|||
126526765|NCT04782323|455219685|FG007|Overall Study|Withdrawal by Subject|1|||
126526766|NCT04782323|455219678|FG000|Overall Study|Lost to Follow-up|0|||
126526767|NCT04782323|455219679|FG001|Overall Study|Lost to Follow-up|1|||
126526768|NCT04782323|455219680|FG002|Overall Study|Lost to Follow-up|1|||
126526769|NCT04782323|455219681|FG003|Overall Study|Lost to Follow-up|0|||
126526770|NCT04782323|455219682|FG004|Overall Study|Lost to Follow-up|0|||
126526771|NCT04782323|455219683|FG005|Overall Study|Lost to Follow-up|1|||
126526772|NCT04782323|455219684|FG006|Overall Study|Lost to Follow-up|1|||
126526773|NCT04782323|455219685|FG007|Overall Study|Lost to Follow-up|2|||
126526774|NCT04782323|455219678|FG000|Overall Study|randomization in error|1|||
126526775|NCT04782323|455219679|FG001|Overall Study|randomization in error|0|||
126526776|NCT04782323|455219680|FG002|Overall Study|randomization in error|0|||
126526777|NCT04782323|455219681|FG003|Overall Study|randomization in error|0|||
126526778|NCT04782323|455219682|FG004|Overall Study|randomization in error|0|||
126526779|NCT04782323|455219683|FG005|Overall Study|randomization in error|0|||
126526780|NCT04782323|455219684|FG006|Overall Study|randomization in error|0|||
126526781|NCT04782323|455219685|FG007|Overall Study|randomization in error|0|||
126526782|NCT02663128|455219690|FG000|Period 2|Physician Decision|0|||
126526783|NCT02663128|455219691|FG001|Period 2|Physician Decision|0|||
126578849|NCT00087139|455415838|FG002|Overall Study|Physician Decision|1|||
126578850|NCT00087139|455415836|FG000|Overall Study|Disease progression|9|||
126578851|NCT00087139|455415837|FG001|Overall Study|Disease progression|19|||
126578852|NCT00087139|455415838|FG002|Overall Study|Disease progression|12|||
126526784|NCT02663128|455219692|FG002|Period 2|Physician Decision|0|||
126526785|NCT02663128|455219693|FG003|Period 2|Physician Decision|0|||
126526786|NCT02663128|455219694|FG004|Period 2|Physician Decision|1|||
126526787|NCT02663128|455219695|FG005|Period 2|Physician Decision|0|||
126526788|NCT02715765|455219696|FG000|Overall Study|Study Termination|3|||
126526789|NCT02715765|455219697|FG001|Overall Study|Study Termination|0|||
126526790|NCT02715765|455219698|FG002|Overall Study|Study Termination|0|||
126526791|NCT03156023|455219709|FG000|Overall Study|Withdrawal by Subject|1|||
126526792|NCT03156023|455219710|FG001|Overall Study|Withdrawal by Subject|0|||
126578853|NCT00087139|455415836|FG000|Overall Study|Ineligible|4|||
126578854|NCT00087139|455415837|FG001|Overall Study|Ineligible|7|||
126578855|NCT00087139|455415838|FG002|Overall Study|Ineligible|4|||
126526793|NCT03156023|455219711|FG002|Overall Study|Withdrawal by Subject|2|||
126526794|NCT03156023|455219712|FG003|Overall Study|Withdrawal by Subject|1|||
126526795|NCT03156023|455219713|FG004|Overall Study|Withdrawal by Subject|1|||
126526796|NCT03156023|455219709|FG000|Overall Study|Lost to Follow-up|0|||
126526797|NCT03156023|455219710|FG001|Overall Study|Lost to Follow-up|0|||
126526798|NCT03156023|455219711|FG002|Overall Study|Lost to Follow-up|0|||
126526799|NCT03156023|455219712|FG003|Overall Study|Lost to Follow-up|0|||
126526800|NCT03156023|455219713|FG004|Overall Study|Lost to Follow-up|1|||
126526801|NCT00726752|455219714|FG000|Overall Study|Lack of Efficacy|6|||
126526802|NCT00156065|455221336|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
126526803|NCT00156065|455221337|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
126526804|NCT00156065|455221338|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
126526805|NCT00156065|455221336|FG000|Overall Study|Adverse Event|8|||
126526806|NCT00156065|455221337|FG001|Overall Study|Adverse Event|11|||
126526807|NCT00156065|455221338|FG002|Overall Study|Adverse Event|4|||
126526808|NCT00156065|455221336|FG000|Overall Study|Lack of Efficacy|2|||
126526809|NCT00156065|455221337|FG001|Overall Study|Lack of Efficacy|9|||
126526810|NCT00156065|455221338|FG002|Overall Study|Lack of Efficacy|3|||
126526811|NCT00156065|455221336|FG000|Overall Study|Withdrawal by Subject|13|||
126526812|NCT00156065|455221337|FG001|Overall Study|Withdrawal by Subject|26|||
126526813|NCT00156065|455221338|FG002|Overall Study|Withdrawal by Subject|16|||
126526814|NCT00156065|455221336|FG000|Overall Study|Lost to Follow-up|5|||
126526815|NCT00156065|455221337|FG001|Overall Study|Lost to Follow-up|7|||
126526816|NCT00156065|455221338|FG002|Overall Study|Lost to Follow-up|1|||
126526817|NCT00156065|455221336|FG000|Overall Study|Other|2|||
126526818|NCT00156065|455221337|FG001|Overall Study|Other|9|||
126526819|NCT00156065|455221338|FG002|Overall Study|Other|3|||
126526820|NCT04745169|455221339|FG000|Overall Study|Kidney transplantation|1|||
126526821|NCT04745169|455221339|FG000|Overall Study|Participant health problems|3|||
126526822|NCT04745169|455221339|FG000|Overall Study|Physician Decision|2|||
126526823|NCT00920426|455221340|FG000|ITZ111451|Adverse Event|1|||
126526824|NCT00920426|455221341|FG001|ITZ111451|Adverse Event|0|||
126526825|NCT00920426|455221342|FG002|ITZ111451|Adverse Event|0|||
126526826|NCT00920426|455221343|FG003|ITZ111451|Adverse Event|0|||
126526827|NCT01292603|455221344|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
126526828|NCT01292603|455221345|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
126526829|NCT01292603|455221346|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
126526830|NCT01292603|455221347|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
126526831|NCT01292603|455221348|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
126526832|NCT01292603|455221349|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
126526833|NCT01292603|455221344|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
126526834|NCT01292603|455221345|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
126526835|NCT01292603|455221346|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
126526836|NCT01292603|455221347|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
126526837|NCT01292603|455221348|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
126526838|NCT01292603|455221349|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
126526839|NCT01292603|455221344|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
126526840|NCT01292603|455221345|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
126526841|NCT01292603|455221346|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
126526842|NCT01292603|455221347|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
126526843|NCT01292603|455221348|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
126526844|NCT01292603|455221349|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
126526845|NCT01292603|455221344|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
126526846|NCT01292603|455221345|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
126526847|NCT01292603|455221346|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
126526848|NCT01292603|455221347|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
126526849|NCT01292603|455221348|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
126526850|NCT01292603|455221349|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
126526851|NCT01292603|455221344|FG000|Part 1: Regular Follow-Up Period|Death|3|||
126526852|NCT01292603|455221345|FG001|Part 1: Regular Follow-Up Period|Death|1|||
126526853|NCT01292603|455221346|FG002|Part 1: Regular Follow-Up Period|Death|3|||
126526854|NCT01292603|455221347|FG003|Part 1: Regular Follow-Up Period|Death|1|||
126526855|NCT01292603|455221348|FG004|Part 1: Regular Follow-Up Period|Death|0|||
126526856|NCT01292603|455221349|FG005|Part 1: Regular Follow-Up Period|Death|0|||
126526857|NCT01292603|455221344|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
126526858|NCT01292603|455221345|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
126526859|NCT01292603|455221346|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
126526860|NCT01292603|455221347|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
126578856|NCT00087139|455415836|FG000|Overall Study|Symptomatic deterioration|1|||
126526861|NCT01292603|455221348|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
126526862|NCT01292603|455221349|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
126526863|NCT01292603|455221344|FG000|Part 2: Dose Confirmation Period|Death|0|||
126526864|NCT01292603|455221345|FG001|Part 2: Dose Confirmation Period|Death|0|||
126526865|NCT01292603|455221346|FG002|Part 2: Dose Confirmation Period|Death|0|||
126526866|NCT01292603|455221347|FG003|Part 2: Dose Confirmation Period|Death|0|||
126526867|NCT01292603|455221348|FG004|Part 2: Dose Confirmation Period|Death|1|||
126526868|NCT01292603|455221349|FG005|Part 2: Dose Confirmation Period|Death|0|||
126526869|NCT01292603|455221344|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
126526870|NCT01292603|455221345|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
126526871|NCT01292603|455221346|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
126526872|NCT01292603|455221347|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
126526873|NCT01292603|455221348|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
126526874|NCT01292603|455221349|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
126526875|NCT01292603|455221344|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
126526876|NCT01292603|455221345|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
126526877|NCT01292603|455221346|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
126526878|NCT01292603|455221347|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
126526879|NCT01292603|455221348|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
126526880|NCT01292603|455221349|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
126526881|NCT01292603|455221344|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
126526882|NCT01292603|455221345|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
126526883|NCT01292603|455221346|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
126526884|NCT01292603|455221347|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
126526885|NCT01292603|455221348|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
126526886|NCT01292603|455221349|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
126526887|NCT01292603|455221344|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
126526888|NCT01292603|455221345|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
126526889|NCT01292603|455221346|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
126526890|NCT01292603|455221347|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
126526891|NCT01292603|455221348|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
126526892|NCT01292603|455221349|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
126526893|NCT01292603|455221344|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
126526894|NCT01292603|455221345|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
126526895|NCT01292603|455221346|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
126526896|NCT01292603|455221347|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
126526897|NCT01292603|455221348|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
126526898|NCT01292603|455221349|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
126526899|NCT01292603|455221344|FG000|Part 2: Regular Follow-Up|Death|0|||
126526900|NCT01292603|455221345|FG001|Part 2: Regular Follow-Up|Death|0|||
126526901|NCT01292603|455221346|FG002|Part 2: Regular Follow-Up|Death|0|||
126526902|NCT01292603|455221347|FG003|Part 2: Regular Follow-Up|Death|0|||
126526903|NCT01292603|455221348|FG004|Part 2: Regular Follow-Up|Death|6|||
126526904|NCT01292603|455221349|FG005|Part 2: Regular Follow-Up|Death|3|||
126526905|NCT01292603|455221344|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
126526906|NCT01292603|455221345|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
126526907|NCT01292603|455221346|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
126526908|NCT01292603|455221347|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
126526909|NCT01292603|455221348|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
126526910|NCT01292603|455221349|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
126526911|NCT01292603|455221344|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
126526912|NCT01292603|455221345|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
126526913|NCT01292603|455221346|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
126526914|NCT01292603|455221347|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
126526915|NCT01292603|455221348|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
126526916|NCT01292603|455221349|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
126526917|NCT01292603|455221344|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
126526918|NCT01292603|455221345|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
126526919|NCT01292603|455221346|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
126526920|NCT01292603|455221347|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
126526921|NCT01292603|455221348|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
126526922|NCT01292603|455221349|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
126526923|NCT01292603|455221344|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
126526924|NCT01292603|455221345|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
126526925|NCT01292603|455221346|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
126526926|NCT01292603|455221347|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
126526927|NCT01292603|455221348|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
126526928|NCT01292603|455221349|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
126526929|NCT01292603|455221344|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
126526930|NCT01292603|455221345|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
126526931|NCT01292603|455221346|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
126526932|NCT01292603|455221347|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
126526933|NCT01292603|455221348|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
126777124|NCT01623830|456141284|FG001|Overall Study|Withdrawal by Subject|7|||
126728413|NCT01021852|455954239|FG007|Treatment Period 2|Physician Decision|0|||
126728414|NCT01021852|455954232|FG000|Treatment Period 2|Protocol Violation|0|||
126728415|NCT01021852|455954233|FG001|Treatment Period 2|Protocol Violation|0|||
126728416|NCT01021852|455954234|FG002|Treatment Period 2|Protocol Violation|0|||
126526934|NCT01292603|455221349|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
126526935|NCT01292603|455221344|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
126526936|NCT01292603|455221345|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
126526937|NCT01292603|455221346|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
126526938|NCT01292603|455221347|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
126526939|NCT01292603|455221348|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
126526940|NCT01292603|455221349|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
126526941|NCT01292603|455221344|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
126526942|NCT01292603|455221345|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
126526943|NCT01292603|455221346|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
126526944|NCT01292603|455221347|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
126526945|NCT01292603|455221348|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
126526946|NCT01292603|455221349|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
126526947|NCT01292603|455221344|FG000|Overall Survival Status|Death|3|||
126526948|NCT01292603|455221345|FG001|Overall Survival Status|Death|1|||
126526949|NCT01292603|455221346|FG002|Overall Survival Status|Death|3|||
126526950|NCT01292603|455221347|FG003|Overall Survival Status|Death|1|||
126526951|NCT01292603|455221348|FG004|Overall Survival Status|Death|16|||
126526952|NCT01292603|455221349|FG005|Overall Survival Status|Death|10|||
126526953|NCT01432366|455221352|FG000|Overall Study|Non-Responder|7|||
126526954|NCT01432366|455221352|FG000|Overall Study|Adverse Event|8|||
126526955|NCT01432366|455221352|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
126526956|NCT01432366|455221352|FG000|Overall Study|Pregnancy|1|||
126526957|NCT01432366|455221352|FG000|Overall Study|Lost to Follow-up|13|||
126526958|NCT01432366|455221352|FG000|Overall Study|Lack of Efficacy|1|||
126526959|NCT01432366|455221352|FG000|Overall Study|Site Closed|20|||
126526960|NCT01432366|455221352|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
126526961|NCT01432366|455221352|FG000|Overall Study|Other|14|||
126526962|NCT01808690|455221353|FG000|Overall Study|Withdrawal by Subject|1|||
126526963|NCT01808690|455221354|FG001|Overall Study|Withdrawal by Subject|2|||
126526964|NCT03870763|455221355|FG000|Overall Study|Study terminated by sponsor|0|||
126526965|NCT03870763|455221356|FG001|Overall Study|Study terminated by sponsor|2|||
126526966|NCT03870763|455221357|FG002|Overall Study|Study terminated by sponsor|0|||
126526967|NCT03870763|455221355|FG000|Overall Study|Withdrawal by Subject|0|||
126526968|NCT03870763|455221356|FG001|Overall Study|Withdrawal by Subject|1|||
126526969|NCT03870763|455221357|FG002|Overall Study|Withdrawal by Subject|0|||
126526970|NCT03870763|455221355|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
126526971|NCT03870763|455221356|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
126526972|NCT03870763|455221357|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
126526973|NCT02891187|455221358|FG000|Overall Study|Lost to Follow-up|1|||
126526974|NCT02891187|455221359|FG001|Overall Study|Lost to Follow-up|2|||
126526975|NCT03586648|455221364|FG000|Period 1|Withdrawal by Subject|0|||
126526976|NCT03586648|455221365|FG001|Period 1|Withdrawal by Subject|1|||
126526977|NCT03586648|455221364|FG000|Period 1|Lost to Follow-up|1|||
126526978|NCT03586648|455221365|FG001|Period 1|Lost to Follow-up|1|||
126526979|NCT03586648|455221364|FG000|Period 1|Adverse Event|1|||
126526980|NCT03586648|455221365|FG001|Period 1|Adverse Event|0|||
126526981|NCT03586648|455221364|FG000|Period 1|Study related symptoms or complaints|2|||
126526982|NCT03586648|455221365|FG001|Period 1|Study related symptoms or complaints|1|||
126526983|NCT03586648|455221364|FG000|Period 1|Physician Decision|0|||
126526984|NCT03586648|455221365|FG001|Period 1|Physician Decision|1|||
126526985|NCT03586648|455221364|FG000|Period 2|Adverse Event|1|||
126526986|NCT03586648|455221365|FG001|Period 2|Adverse Event|0|||
126526987|NCT02041195|455221366|FG000|Overall Study|Adverse Event|1|||
126526988|NCT02041195|455221367|FG001|Overall Study|Adverse Event|2|||
126526989|NCT02041195|455221368|FG002|Overall Study|Adverse Event|0|||
126526990|NCT02041195|455221369|FG003|Overall Study|Adverse Event|0|||
126526991|NCT02041195|455221370|FG004|Overall Study|Adverse Event|0|||
126526992|NCT02041195|455221371|FG005|Overall Study|Adverse Event|0|||
126526993|NCT02041195|455221372|FG006|Overall Study|Adverse Event|3|||
126526994|NCT02041195|455221373|FG007|Overall Study|Adverse Event|0|||
126526995|NCT02041195|455221366|FG000|Overall Study|Withdrawal by Subject|1|||
126526996|NCT02041195|455221367|FG001|Overall Study|Withdrawal by Subject|0|||
126526997|NCT02041195|455221368|FG002|Overall Study|Withdrawal by Subject|0|||
126728417|NCT01021852|455954235|FG003|Treatment Period 2|Protocol Violation|0|||
126728418|NCT01021852|455954236|FG004|Treatment Period 2|Protocol Violation|1|||
126526998|NCT02041195|455221369|FG003|Overall Study|Withdrawal by Subject|0|||
126526999|NCT02041195|455221370|FG004|Overall Study|Withdrawal by Subject|0|||
126527000|NCT02041195|455221371|FG005|Overall Study|Withdrawal by Subject|0|||
126527001|NCT02041195|455221372|FG006|Overall Study|Withdrawal by Subject|4|||
126527002|NCT02041195|455221373|FG007|Overall Study|Withdrawal by Subject|3|||
126527003|NCT02041195|455221366|FG000|Overall Study|Unable to comply with study visits|0|||
126527004|NCT02041195|455221367|FG001|Overall Study|Unable to comply with study visits|1|||
126578857|NCT00087139|455415837|FG001|Overall Study|Symptomatic deterioration|1|||
126578858|NCT00087139|455415838|FG002|Overall Study|Symptomatic deterioration|3|||
126578859|NCT00087139|455415836|FG000|Overall Study|Use of coumadin|1|||
126578860|NCT00087139|455415837|FG001|Overall Study|Use of coumadin|0|||
126578861|NCT00087139|455415838|FG002|Overall Study|Use of coumadin|0|||
126578862|NCT00087139|455415836|FG000|Overall Study|Response achieved|0|||
126578863|NCT00087139|455415837|FG001|Overall Study|Response achieved|1|||
126578864|NCT00087139|455415838|FG002|Overall Study|Response achieved|0|||
126728419|NCT01021852|455954237|FG005|Treatment Period 2|Protocol Violation|0|||
126728420|NCT01021852|455954238|FG006|Treatment Period 2|Protocol Violation|1|||
126728421|NCT01021852|455954239|FG007|Treatment Period 2|Protocol Violation|0|||
126728422|NCT01021852|455954232|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126728423|NCT01021852|455954233|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126728424|NCT01021852|455954234|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126728425|NCT01021852|455954235|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126728426|NCT01021852|455954236|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126527005|NCT02041195|455221368|FG002|Overall Study|Unable to comply with study visits|0|||
126527006|NCT02041195|455221369|FG003|Overall Study|Unable to comply with study visits|0|||
126527007|NCT02041195|455221370|FG004|Overall Study|Unable to comply with study visits|1|||
126527008|NCT02041195|455221371|FG005|Overall Study|Unable to comply with study visits|0|||
126527009|NCT02041195|455221372|FG006|Overall Study|Unable to comply with study visits|0|||
126527010|NCT02041195|455221373|FG007|Overall Study|Unable to comply with study visits|0|||
126527011|NCT04546581|455221381|FG000|Overall Study|Adverse Event|9|||
126527012|NCT04546581|455221382|FG001|Overall Study|Adverse Event|3|||
126527013|NCT04546581|455221381|FG000|Overall Study|Physician Decision|0|||
126527014|NCT04546581|455221382|FG001|Overall Study|Physician Decision|1|||
126527015|NCT04546581|455221381|FG000|Overall Study|Protocol Violation|1|||
126527016|NCT04546581|455221382|FG001|Overall Study|Protocol Violation|2|||
126527017|NCT04546581|455221381|FG000|Overall Study|Withdrawal by Subject|3|||
126527018|NCT04546581|455221382|FG001|Overall Study|Withdrawal by Subject|7|||
126527019|NCT02526693|455221383|FG000|Overall Study|Physician Decision|3|||
126527020|NCT02526693|455221384|FG001|Overall Study|Physician Decision|1|||
126527021|NCT01983293|455221385|FG000|Overall Study|Withdrawal by Subject|29|||
126527022|NCT01983293|455221386|FG001|Overall Study|Withdrawal by Subject|15|||
126527023|NCT01983293|455221385|FG000|Overall Study|Missing 12-month visit|3|||
126527024|NCT01983293|455221386|FG001|Overall Study|Missing 12-month visit|3|||
126527025|NCT01983293|455221385|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
126527026|NCT01983293|455221386|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
126527027|NCT01275625|455221387|FG000|Overall Study|Death|1|||
126527028|NCT01275625|455221387|FG000|Overall Study|Lack of Efficacy|2|||
126527029|NCT01275625|455221387|FG000|Overall Study|Lost to Follow-up|1|||
126527030|NCT01275625|455221387|FG000|Overall Study|Withdrawal by Subject|3|||
126527031|NCT01275625|455221387|FG000|Overall Study|Protocol Violation|1|||
126527032|NCT01275625|455221387|FG000|Overall Study|Adverse Event|4|||
126527033|NCT01275625|455221387|FG000|Overall Study|Other|1|||
126527034|NCT01585103|455221389|FG000|Overall Study|Unable to swallow Cytosponge|6|||
126527035|NCT01349569|455221391|FG000|Overall Study|Lack of Efficacy|4|||
126527036|NCT03581305|455221392|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
126527037|NCT03581305|455221393|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
126527038|NCT03581305|455221392|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
126527039|NCT03581305|455221393|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
126527040|NCT03581305|455221392|FG000|Serotonergic Study|Withdrawal by Subject|5|||
126527041|NCT03581305|455221393|FG001|Serotonergic Study|Withdrawal by Subject|1|||
126527042|NCT01747772|455221396|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
126527043|NCT01798927|455221397|FG000|Overall Study|Withdrawal by Subject|1|||
126527044|NCT03750552|455221398|FG000|Overall Study|Adverse Event|5|||
126527045|NCT03750552|455221399|FG001|Overall Study|Adverse Event|1|||
126578865|NCT00087139|455415836|FG000|Overall Study|Extradural disease|0|||
126527046|NCT03750552|455221398|FG000|Overall Study|Withdrawal by Subject|1|||
126527047|NCT03750552|455221399|FG001|Overall Study|Withdrawal by Subject|1|||
126578866|NCT00087139|455415837|FG001|Overall Study|Extradural disease|0|||
126578867|NCT00087139|455415838|FG002|Overall Study|Extradural disease|1|||
126578868|NCT03201562|455415844|FG000|Overall Study|Physician Decision|0|||
126728427|NCT01021852|455954237|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126728428|NCT01021852|455954238|FG006|Treatment Period 2|Withdrawal by Subject|1|||
126728429|NCT01021852|455954239|FG007|Treatment Period 2|Withdrawal by Subject|2|||
126527048|NCT03750552|455221398|FG000|Overall Study|Other|2|||
126527049|NCT03750552|455221399|FG001|Overall Study|Other|0|||
126527050|NCT02062632|455221400|FG000|Overall Study|No treatment data|1|||
126527051|NCT00626522|455221403|FG000|Overall Study|Protocol Violation|0|||
126527052|NCT00626522|455221404|FG001|Overall Study|Protocol Violation|0|||
126527053|NCT00626522|455221405|FG002|Overall Study|Protocol Violation|0|||
126527054|NCT00626522|455221406|FG003|Overall Study|Protocol Violation|0|||
126527055|NCT00626522|455221407|FG004|Overall Study|Protocol Violation|1|||
126578869|NCT03201562|455415845|FG001|Overall Study|Physician Decision|0|||
126578870|NCT03201562|455415846|FG002|Overall Study|Physician Decision|1|||
126578871|NCT03201562|455415844|FG000|Overall Study|Adverse Event|0|||
126578872|NCT03201562|455415845|FG001|Overall Study|Adverse Event|0|||
126527056|NCT00626522|455221408|FG005|Overall Study|Protocol Violation|0|||
126527057|NCT00626522|455221403|FG000|Overall Study|Adverse Event|2|||
126527058|NCT00626522|455221404|FG001|Overall Study|Adverse Event|1|||
126527059|NCT00626522|455221405|FG002|Overall Study|Adverse Event|2|||
126527060|NCT00626522|455221406|FG003|Overall Study|Adverse Event|0|||
126527061|NCT00626522|455221407|FG004|Overall Study|Adverse Event|1|||
126527062|NCT00626522|455221408|FG005|Overall Study|Adverse Event|1|||
126527063|NCT00626522|455221403|FG000|Overall Study|Withdrawal by Subject|2|||
126527064|NCT00626522|455221404|FG001|Overall Study|Withdrawal by Subject|5|||
126527065|NCT00626522|455221405|FG002|Overall Study|Withdrawal by Subject|5|||
126527066|NCT00626522|455221406|FG003|Overall Study|Withdrawal by Subject|0|||
126527067|NCT00626522|455221407|FG004|Overall Study|Withdrawal by Subject|4|||
126527068|NCT00626522|455221408|FG005|Overall Study|Withdrawal by Subject|1|||
126527069|NCT00626522|455221403|FG000|Overall Study|COPD exacerbation|0|||
126527070|NCT00626522|455221404|FG001|Overall Study|COPD exacerbation|0|||
126527071|NCT00626522|455221405|FG002|Overall Study|COPD exacerbation|0|||
126527072|NCT00626522|455221406|FG003|Overall Study|COPD exacerbation|1|||
126527073|NCT00626522|455221407|FG004|Overall Study|COPD exacerbation|1|||
126527074|NCT00626522|455221408|FG005|Overall Study|COPD exacerbation|0|||
126527075|NCT00626522|455221403|FG000|Overall Study|Lost to Follow-up|0|||
126527076|NCT00626522|455221404|FG001|Overall Study|Lost to Follow-up|1|||
126527077|NCT00626522|455221405|FG002|Overall Study|Lost to Follow-up|0|||
126527078|NCT00626522|455221406|FG003|Overall Study|Lost to Follow-up|0|||
126527079|NCT00626522|455221407|FG004|Overall Study|Lost to Follow-up|0|||
126527080|NCT00626522|455221408|FG005|Overall Study|Lost to Follow-up|0|||
126527081|NCT00626522|455221403|FG000|Overall Study|Inconsistent reason reported|1|||
126527082|NCT00626522|455221404|FG001|Overall Study|Inconsistent reason reported|0|||
126527083|NCT00626522|455221405|FG002|Overall Study|Inconsistent reason reported|0|||
126527084|NCT00626522|455221406|FG003|Overall Study|Inconsistent reason reported|0|||
126527085|NCT00626522|455221407|FG004|Overall Study|Inconsistent reason reported|0|||
126527086|NCT00626522|455221408|FG005|Overall Study|Inconsistent reason reported|0|||
126527087|NCT00626522|455221403|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
126527088|NCT00626522|455221404|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
126527089|NCT00626522|455221405|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
126527090|NCT00626522|455221406|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
126527091|NCT00626522|455221407|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
126527092|NCT00626522|455221408|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
126527093|NCT02280044|455221409|FG000|Overall Study|Planned alternate|0|||
126527094|NCT02280044|455221410|FG001|Overall Study|Planned alternate|2|||
126527095|NCT01490632|455221414|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
126527096|NCT01490632|455221415|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
126527097|NCT01490632|455221416|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
126527098|NCT01490632|455221417|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
126527099|NCT01490632|455221418|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
126527100|NCT01490632|455221419|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
126527101|NCT01490632|455221420|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
126527102|NCT01490632|455221421|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
126527103|NCT01490632|455221422|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
126527104|NCT01490632|455221423|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
126527105|NCT01490632|455221424|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
126527106|NCT01490632|455221425|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
126527107|NCT01490632|455221426|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
126527108|NCT01490632|455221427|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
126527109|NCT01490632|455221428|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
126527110|NCT01490632|455221429|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
126527111|NCT01490632|455221430|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
126527112|NCT01490632|455221431|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
126527113|NCT01490632|455221432|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
126527114|NCT01490632|455221433|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
126578873|NCT03201562|455415846|FG002|Overall Study|Adverse Event|1|||
126578874|NCT03201562|455415844|FG000|Overall Study|Lost to Follow-up|0|||
126728430|NCT00712322|455954240|FG000|Overall Study|Protocol deviation|0|||
126728431|NCT00712322|455954241|FG001|Overall Study|Protocol deviation|1|||
126728432|NCT00712322|455954242|FG002|Overall Study|Protocol deviation|0|||
126527115|NCT01490632|455221414|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
126527116|NCT01490632|455221415|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
126527117|NCT01490632|455221416|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
126527118|NCT01490632|455221417|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
126578875|NCT03201562|455415845|FG001|Overall Study|Lost to Follow-up|1|||
126728433|NCT02802878|455954247|FG000|Overall Study|Withdrawal by Subject|3|||
126527119|NCT01490632|455221418|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527120|NCT01490632|455221419|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527121|NCT01490632|455221420|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527122|NCT01490632|455221421|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527123|NCT01490632|455221422|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527124|NCT01490632|455221423|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527125|NCT01490632|455221424|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527126|NCT01490632|455221425|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527127|NCT01490632|455221426|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527128|NCT01490632|455221427|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527129|NCT01490632|455221428|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527130|NCT01490632|455221429|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527131|NCT01490632|455221430|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527132|NCT01490632|455221431|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527133|NCT01490632|455221432|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527134|NCT01490632|455221433|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
126527135|NCT01490632|455221414|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527136|NCT01490632|455221415|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527137|NCT01490632|455221416|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
126527138|NCT01490632|455221417|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
126527139|NCT01490632|455221418|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
126527140|NCT01490632|455221419|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527141|NCT01490632|455221420|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527142|NCT01490632|455221421|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527143|NCT01490632|455221422|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527144|NCT01490632|455221423|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527145|NCT01490632|455221424|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527146|NCT01490632|455221425|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527147|NCT01490632|455221426|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527148|NCT01490632|455221427|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527149|NCT01490632|455221428|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527150|NCT01490632|455221429|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527151|NCT01490632|455221430|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527152|NCT01490632|455221431|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527153|NCT01490632|455221432|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527154|NCT01490632|455221433|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
126527155|NCT01490632|455221414|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
126527156|NCT01490632|455221415|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
126527157|NCT01490632|455221416|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
126527158|NCT01490632|455221417|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
126527159|NCT01490632|455221418|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
126527160|NCT01490632|455221419|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
126527161|NCT01490632|455221420|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
126527162|NCT01490632|455221421|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
126527163|NCT01490632|455221422|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
126578876|NCT03201562|455415846|FG002|Overall Study|Lost to Follow-up|2|||
126578877|NCT00393484|455415847|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
126578878|NCT00393484|455415848|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
126578879|NCT00393484|455415847|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
126578880|NCT00393484|455415848|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
126578881|NCT00393484|455415847|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
126578882|NCT00393484|455415848|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
126578883|NCT00393484|455415847|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
126578884|NCT00393484|455415848|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
126578885|NCT00393484|455415847|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
126578886|NCT00393484|455415848|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
126578887|NCT00393484|455415847|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
126578888|NCT00393484|455415848|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
126578889|NCT00393484|455415847|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
126578890|NCT00393484|455415848|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
126728434|NCT02802878|455954248|FG001|Overall Study|Withdrawal by Subject|3|||
126527164|NCT01490632|455221423|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
126527165|NCT01490632|455221424|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
126527166|NCT01490632|455221425|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
126527167|NCT01490632|455221426|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
126527168|NCT01490632|455221427|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
126527169|NCT01490632|455221428|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
126527170|NCT01490632|455221429|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
126527171|NCT01490632|455221430|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
126578891|NCT00393484|455415847|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
126578892|NCT00393484|455415848|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
126578893|NCT00393484|455415847|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
126578894|NCT00393484|455415848|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
126578895|NCT00393484|455415847|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
126578896|NCT00393484|455415848|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
126578897|NCT02178098|455415851|FG000|Overall Study|Withdrawal by Subject|0|||
126578898|NCT02178098|455415852|FG001|Overall Study|Withdrawal by Subject|6|||
126578899|NCT02178098|455415851|FG000|Overall Study|Adverse Event|1|||
126578900|NCT02178098|455415852|FG001|Overall Study|Adverse Event|2|||
126578901|NCT02178098|455415851|FG000|Overall Study|Protocol Violation|1|||
126578902|NCT02178098|455415852|FG001|Overall Study|Protocol Violation|1|||
126578903|NCT02178098|455415851|FG000|Overall Study|Lost to Follow-up|0|||
126578904|NCT02178098|455415852|FG001|Overall Study|Lost to Follow-up|1|||
126578905|NCT02178098|455415851|FG000|Overall Study|Sponsor Request|1|||
126578906|NCT02178098|455415852|FG001|Overall Study|Sponsor Request|0|||
126578907|NCT02178098|455415851|FG000|Overall Study|Other|2|||
126578908|NCT02178098|455415852|FG001|Overall Study|Other|2|||
126578909|NCT01109524|455415853|FG000|Overall Study|Disease Progression|29|||
126578910|NCT01109524|455415853|FG000|Overall Study|Study Drug toxicity|6|||
126578911|NCT01109524|455415853|FG000|Overall Study|Adverse Event|4|||
126578912|NCT01109524|455415853|FG000|Overall Study|Withdrawal by Subject|2|||
126578913|NCT01109524|455415853|FG000|Overall Study|Maximum clinical benefit|3|||
126578914|NCT01109524|455415853|FG000|Overall Study|Death|2|||
126578915|NCT01109524|455415853|FG000|Overall Study|No longer meets criteria|2|||
126578916|NCT01109524|455415853|FG000|Overall Study|Participant requested to end treatment|4|||
126578917|NCT01109524|455415853|FG000|Overall Study|Other|5|||
126578918|NCT03101371|455415863|FG000|Overall Study|Physician Decision|0|||
126578919|NCT03101371|455415864|FG001|Overall Study|Physician Decision|1|||
126578920|NCT03101371|455415863|FG000|Overall Study|Lost to Follow-up|1|||
126578921|NCT03101371|455415864|FG001|Overall Study|Lost to Follow-up|4|||
126578922|NCT03101371|455415863|FG000|Overall Study|Did not meet eligibility criteria|2|||
126578923|NCT03101371|455415864|FG001|Overall Study|Did not meet eligibility criteria|1|||
126578924|NCT00031694|455415871|FG000|Overall Study|Adverse Event|12|||
126578925|NCT00031694|455415871|FG000|Overall Study|Death|2|||
126578926|NCT00031694|455415871|FG000|Overall Study|Withdrawal by Subject|5|||
126578927|NCT04019444|455415872|FG000|Overall Study|Withdrawal by Subject|0|||
126578928|NCT04019444|455415873|FG001|Overall Study|Withdrawal by Subject|1|||
126578929|NCT04019444|455415874|FG002|Overall Study|Withdrawal by Subject|0|||
126578930|NCT04019444|455415875|FG003|Overall Study|Withdrawal by Subject|1|||
126578931|NCT04019444|455415872|FG000|Overall Study|Solicited Event|0|||
126578932|NCT04019444|455415873|FG001|Overall Study|Solicited Event|0|||
126578933|NCT04019444|455415874|FG002|Overall Study|Solicited Event|2|||
126578934|NCT04019444|455415875|FG003|Overall Study|Solicited Event|0|||
126578935|NCT04992390|455415882|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
126578936|NCT04992390|455415883|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
126578937|NCT04992390|455415884|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
126578938|NCT04992390|455415882|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
126578939|NCT04992390|455415883|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
126578940|NCT04992390|455415884|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
126578941|NCT04992390|455415882|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
126578942|NCT04992390|455415883|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
126578943|NCT04992390|455415884|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
126578944|NCT04992390|455415882|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
126578945|NCT04992390|455415883|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
126578946|NCT04992390|455415884|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
126578947|NCT04992390|455415882|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
126578948|NCT04992390|455415883|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
126728435|NCT02802878|455954247|FG000|Overall Study|Protocol Violation|1|||
126728436|NCT02802878|455954248|FG001|Overall Study|Protocol Violation|0|||
126728437|NCT01029002|455954249|FG000|Overall Study|Lost to Follow-up|2|||
126578949|NCT04992390|455415884|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
126578950|NCT04992390|455415882|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
126578951|NCT04992390|455415883|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
126578952|NCT04992390|455415884|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
126728438|NCT01029002|455954250|FG001|Overall Study|Lost to Follow-up|4|||
126728439|NCT00702052|455954251|FG000|Overall Study|Adverse Event|23|||
126728440|NCT00702052|455954251|FG000|Overall Study|Disease Progression|30|||
126578953|NCT04992390|455415882|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
126578954|NCT04992390|455415883|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
126578955|NCT04992390|455415884|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
126578956|NCT04992390|455415882|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
126728441|NCT00702052|455954251|FG000|Overall Study|Withdrawal by Subject|5|||
126728442|NCT01577160|455954252|FG000|Overall Study|Adverse Event|9|||
126728443|NCT01577160|455954252|FG000|Overall Study|Lack of Efficacy|15|||
126578957|NCT04992390|455415883|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
126578958|NCT04992390|455415884|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
126578959|NCT04992390|455415882|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
126578960|NCT04992390|455415883|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
126578961|NCT04992390|455415884|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
126578962|NCT04992390|455415882|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
126578963|NCT04992390|455415883|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
126578964|NCT04992390|455415884|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
126578965|NCT04992390|455415882|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
126578966|NCT04992390|455415883|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
126578967|NCT04992390|455415884|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
126578968|NCT04992390|455415882|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
126578969|NCT04992390|455415883|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
126578970|NCT04992390|455415884|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
126578971|NCT04992390|455415882|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
126578972|NCT04992390|455415883|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
126578973|NCT04992390|455415884|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
126578974|NCT04992390|455415882|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
126578975|NCT04992390|455415883|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
126578976|NCT04992390|455415884|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
126578977|NCT04992390|455415882|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
126578978|NCT04992390|455415883|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
126578979|NCT04992390|455415884|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
126578980|NCT04992390|455415882|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
126578981|NCT04992390|455415883|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
126578982|NCT04992390|455415884|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
126578983|NCT01303445|455415885|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
126578984|NCT01303445|455415886|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
126578985|NCT01303445|455415885|FG000|Second Intervention (7 Days)|Adverse Event|0|||
126578986|NCT01303445|455415886|FG001|Second Intervention (7 Days)|Adverse Event|2|||
126578987|NCT01303445|455415885|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
126578988|NCT01303445|455415886|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
126578989|NCT01303445|455415885|FG000|Washout (14 Days)|Protocol Violation|1|||
126578990|NCT01303445|455415886|FG001|Washout (14 Days)|Protocol Violation|0|||
126578991|NCT01303445|455415885|FG000|Washout (14 Days)|Lost to Follow-up|0|||
126578992|NCT01303445|455415886|FG001|Washout (14 Days)|Lost to Follow-up|2|||
126578993|NCT01303445|455415885|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
126578994|NCT01303445|455415886|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
126578995|NCT01303445|455415885|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
126578996|NCT01303445|455415886|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
126578997|NCT04939246|455415887|FG000|After Treatment|Death|4|||
126578998|NCT04939246|455415887|FG000|After Treatment|Lost to Follow-up|1|||
126578999|NCT04939246|455415887|FG000|After Treatment|Discharged to hospice|2|||
126579000|NCT04994509|455415888|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
126579001|NCT04994509|455415889|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
126579002|NCT04994509|455415890|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
126579003|NCT04994509|455415888|FG000|Overall Study|Withdrew Consent|73|||
126579004|NCT04994509|455415889|FG001|Overall Study|Withdrew Consent|72|||
126579005|NCT04994509|455415890|FG002|Overall Study|Withdrew Consent|46|||
126579006|NCT04994509|455415888|FG000|Overall Study|Lost to Follow-up|39|||
126579007|NCT04994509|455415889|FG001|Overall Study|Lost to Follow-up|36|||
126579008|NCT04994509|455415890|FG002|Overall Study|Lost to Follow-up|26|||
126579009|NCT04994509|455415888|FG000|Overall Study|HIV-1 Infection|4|||
126579010|NCT04994509|455415889|FG001|Overall Study|HIV-1 Infection|20|||
126579011|NCT04994509|455415890|FG002|Overall Study|HIV-1 Infection|12|||
126579012|NCT04994509|455415888|FG000|Overall Study|Investigator's Discretion|9|||
126579013|NCT04994509|455415889|FG001|Overall Study|Investigator's Discretion|8|||
126579014|NCT04994509|455415890|FG002|Overall Study|Investigator's Discretion|11|||
126579015|NCT04994509|455415888|FG000|Overall Study|Randomized but Never Treated|10|||
126579016|NCT04994509|455415889|FG001|Overall Study|Randomized but Never Treated|10|||
126579017|NCT04994509|455415890|FG002|Overall Study|Randomized but Never Treated|3|||
126579018|NCT04994509|455415888|FG000|Overall Study|Pregnancy|5|||
126728444|NCT01577160|455954252|FG000|Overall Study|Lost to Follow-up|40|||
126728445|NCT01577160|455954252|FG000|Overall Study|Withdrawal by Subject|18|||
126579019|NCT04994509|455415889|FG001|Overall Study|Pregnancy|5|||
126579020|NCT04994509|455415890|FG002|Overall Study|Pregnancy|0|||
126579021|NCT04994509|455415888|FG000|Overall Study|Death|0|||
126579022|NCT04994509|455415889|FG001|Overall Study|Death|5|||
126728446|NCT01577160|455954252|FG000|Overall Study|Subject Uncooperative|7|||
126527172|NCT01490632|455221431|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
126527173|NCT01490632|455221432|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
126527174|NCT01490632|455221433|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
126527175|NCT01490632|455221414|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
126527176|NCT01490632|455221415|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527177|NCT01490632|455221416|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527178|NCT01490632|455221417|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527179|NCT01490632|455221418|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527180|NCT01490632|455221419|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527181|NCT01490632|455221420|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527182|NCT01490632|455221421|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527183|NCT01490632|455221422|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527184|NCT01490632|455221423|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527185|NCT01490632|455221424|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527186|NCT01490632|455221425|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527187|NCT01490632|455221426|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527188|NCT01490632|455221427|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527189|NCT01490632|455221428|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527190|NCT01490632|455221429|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527191|NCT01490632|455221430|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527192|NCT01490632|455221431|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527193|NCT01490632|455221432|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527194|NCT01490632|455221433|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
126527195|NCT01490632|455221414|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
126527196|NCT01490632|455221415|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
126527197|NCT01490632|455221416|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527198|NCT01490632|455221417|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
126527199|NCT01490632|455221418|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
126527200|NCT01490632|455221419|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527201|NCT01490632|455221420|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527202|NCT01490632|455221421|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527203|NCT01490632|455221422|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527204|NCT01490632|455221423|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527205|NCT01490632|455221424|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527206|NCT01490632|455221425|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527207|NCT01490632|455221426|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527208|NCT01490632|455221427|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527209|NCT01490632|455221428|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527210|NCT01490632|455221429|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527211|NCT01490632|455221430|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527212|NCT01490632|455221431|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527213|NCT01490632|455221432|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527214|NCT01490632|455221433|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
126527215|NCT01490632|455221414|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527216|NCT01490632|455221415|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527217|NCT01490632|455221416|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527218|NCT01490632|455221417|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527219|NCT01490632|455221418|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
126527220|NCT01490632|455221419|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527221|NCT01490632|455221420|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527222|NCT01490632|455221421|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527223|NCT01490632|455221422|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527224|NCT01490632|455221423|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527225|NCT01490632|455221424|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527226|NCT01490632|455221425|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527227|NCT01490632|455221426|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527228|NCT01490632|455221427|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527229|NCT01490632|455221428|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527230|NCT01490632|455221429|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527231|NCT01490632|455221430|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527232|NCT01490632|455221431|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527233|NCT01490632|455221432|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126527234|NCT01490632|455221433|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
126777125|NCT01623830|456141283|FG000|Overall Study|Exclusion from Study|1|||
126527235|NCT01490632|455221414|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527236|NCT01490632|455221415|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527237|NCT01490632|455221416|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527238|NCT01490632|455221417|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527239|NCT01490632|455221418|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527240|NCT01490632|455221419|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
126527241|NCT01490632|455221420|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
126527242|NCT01490632|455221421|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527243|NCT01490632|455221422|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527244|NCT01490632|455221423|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
126527245|NCT01490632|455221424|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
126527246|NCT01490632|455221425|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
126527247|NCT01490632|455221426|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527248|NCT01490632|455221427|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527249|NCT01490632|455221428|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527250|NCT01490632|455221429|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527251|NCT01490632|455221430|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527252|NCT01490632|455221431|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527253|NCT01490632|455221432|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527254|NCT01490632|455221433|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
126527255|NCT01490632|455221414|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527256|NCT01490632|455221415|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527257|NCT01490632|455221416|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527258|NCT01490632|455221417|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527259|NCT01490632|455221418|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527260|NCT01490632|455221419|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527261|NCT01490632|455221420|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
126527262|NCT01490632|455221421|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527263|NCT01490632|455221422|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
126527264|NCT01490632|455221423|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
126527265|NCT01490632|455221424|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
126527266|NCT01490632|455221425|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527267|NCT01490632|455221426|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527268|NCT01490632|455221427|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527269|NCT01490632|455221428|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527270|NCT01490632|455221429|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527271|NCT01490632|455221430|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527272|NCT01490632|455221431|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527273|NCT01490632|455221432|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527274|NCT01490632|455221433|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
126527275|NCT01490632|455221414|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527276|NCT01490632|455221415|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527277|NCT01490632|455221416|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527278|NCT01490632|455221417|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527279|NCT01490632|455221418|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527280|NCT01490632|455221419|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527281|NCT01490632|455221420|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
126527282|NCT01490632|455221421|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527283|NCT01490632|455221422|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527284|NCT01490632|455221423|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
126527285|NCT01490632|455221424|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527286|NCT01490632|455221425|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527287|NCT01490632|455221426|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527288|NCT01490632|455221427|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527289|NCT01490632|455221428|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527290|NCT01490632|455221429|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527291|NCT01490632|455221430|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527292|NCT01490632|455221431|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527293|NCT01490632|455221432|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527294|NCT01490632|455221433|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
126527295|NCT01490632|455221414|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527296|NCT01490632|455221415|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527297|NCT01490632|455221416|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527298|NCT01490632|455221417|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527299|NCT01490632|455221418|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527300|NCT01490632|455221419|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527301|NCT01490632|455221420|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
126527302|NCT01490632|455221421|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527303|NCT01490632|455221422|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527304|NCT01490632|455221423|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527305|NCT01490632|455221424|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527306|NCT01490632|455221425|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527307|NCT01490632|455221426|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527308|NCT01490632|455221427|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527309|NCT01490632|455221428|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527310|NCT01490632|455221429|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527311|NCT01490632|455221430|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527312|NCT01490632|455221431|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527313|NCT01490632|455221432|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527314|NCT01490632|455221433|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
126527315|NCT01490632|455221414|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527316|NCT01490632|455221415|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527317|NCT01490632|455221416|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527318|NCT01490632|455221417|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527319|NCT01490632|455221418|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527320|NCT01490632|455221419|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
126527321|NCT01490632|455221420|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527322|NCT01490632|455221421|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527323|NCT01490632|455221422|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527324|NCT01490632|455221423|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527325|NCT01490632|455221424|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527326|NCT01490632|455221425|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527327|NCT01490632|455221426|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527328|NCT01490632|455221427|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527329|NCT01490632|455221428|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527330|NCT01490632|455221429|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527331|NCT01490632|455221430|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527332|NCT01490632|455221431|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527333|NCT01490632|455221432|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527334|NCT01490632|455221433|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
126527335|NCT01490632|455221414|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527336|NCT01490632|455221415|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527337|NCT01490632|455221416|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527338|NCT01490632|455221417|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527339|NCT01490632|455221418|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527340|NCT01490632|455221419|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527341|NCT01490632|455221420|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
126527342|NCT01490632|455221421|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527343|NCT01490632|455221422|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
126527344|NCT01490632|455221423|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527345|NCT01490632|455221424|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
126527346|NCT01490632|455221425|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
126527347|NCT01490632|455221426|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527348|NCT01490632|455221427|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527349|NCT01490632|455221428|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527350|NCT01490632|455221429|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527351|NCT01490632|455221430|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527352|NCT01490632|455221431|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527353|NCT01490632|455221432|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527354|NCT01490632|455221433|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
126527355|NCT01490632|455221414|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527356|NCT01490632|455221415|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527357|NCT01490632|455221416|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527358|NCT01490632|455221417|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527359|NCT01490632|455221418|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527360|NCT01490632|455221419|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
126527361|NCT01490632|455221420|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
126527362|NCT01490632|455221421|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
126527363|NCT01490632|455221422|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
126527364|NCT01490632|455221423|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
126579023|NCT04994509|455415890|FG002|Overall Study|Death|0|||
126527365|NCT01490632|455221424|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
126527366|NCT01490632|455221425|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
126527367|NCT01490632|455221426|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527368|NCT01490632|455221427|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527369|NCT01490632|455221428|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527370|NCT01490632|455221429|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527371|NCT01490632|455221430|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527372|NCT01490632|455221431|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527373|NCT01490632|455221432|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527374|NCT01490632|455221433|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
126527375|NCT01490632|455221414|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527376|NCT01490632|455221415|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527377|NCT01490632|455221416|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527378|NCT01490632|455221417|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527379|NCT01490632|455221418|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527380|NCT01490632|455221419|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527381|NCT01490632|455221420|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527382|NCT01490632|455221421|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527383|NCT01490632|455221422|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527384|NCT01490632|455221423|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527385|NCT01490632|455221424|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527386|NCT01490632|455221425|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527387|NCT01490632|455221426|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527388|NCT01490632|455221427|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527389|NCT01490632|455221428|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
126527390|NCT01490632|455221429|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
126527391|NCT01490632|455221430|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527392|NCT01490632|455221431|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527393|NCT01490632|455221432|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527394|NCT01490632|455221433|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
126527395|NCT01490632|455221414|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527396|NCT01490632|455221415|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527397|NCT01490632|455221416|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527398|NCT01490632|455221417|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527399|NCT01490632|455221418|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527400|NCT01490632|455221419|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527401|NCT01490632|455221420|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527402|NCT01490632|455221421|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527403|NCT01490632|455221422|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527404|NCT01490632|455221423|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527405|NCT01490632|455221424|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527406|NCT01490632|455221425|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527407|NCT01490632|455221426|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527408|NCT01490632|455221427|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
126527409|NCT01490632|455221428|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527410|NCT01490632|455221429|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527411|NCT01490632|455221430|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527412|NCT01490632|455221431|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527413|NCT01490632|455221432|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527414|NCT01490632|455221433|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
126527415|NCT01490632|455221414|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527416|NCT01490632|455221415|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527417|NCT01490632|455221416|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527418|NCT01490632|455221417|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527419|NCT01490632|455221418|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527420|NCT01490632|455221419|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527421|NCT01490632|455221420|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527422|NCT01490632|455221421|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527423|NCT01490632|455221422|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527424|NCT01490632|455221423|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527425|NCT01490632|455221424|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527426|NCT01490632|455221425|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527427|NCT01490632|455221426|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527428|NCT01490632|455221427|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527429|NCT01490632|455221428|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
126527430|NCT01490632|455221429|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
126527431|NCT01490632|455221430|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527432|NCT01490632|455221431|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527433|NCT01490632|455221432|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527434|NCT01490632|455221433|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
126527435|NCT01490632|455221414|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527436|NCT01490632|455221415|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527437|NCT01490632|455221416|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527438|NCT01490632|455221417|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527439|NCT01490632|455221418|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527440|NCT01490632|455221419|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527441|NCT01490632|455221420|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527442|NCT01490632|455221421|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527443|NCT01490632|455221422|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527444|NCT01490632|455221423|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527445|NCT01490632|455221424|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527446|NCT01490632|455221425|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126579024|NCT04994509|455415888|FG000|Overall Study|Adverse Event|2|||
126579025|NCT04994509|455415889|FG001|Overall Study|Adverse Event|1|||
126579026|NCT04994509|455415890|FG002|Overall Study|Adverse Event|0|||
126579027|NCT04994509|455415888|FG000|Overall Study|Non-compliance With Study Drug|1|||
126579028|NCT04994509|455415889|FG001|Overall Study|Non-compliance With Study Drug|1|||
126579029|NCT04994509|455415890|FG002|Overall Study|Non-compliance With Study Drug|1|||
126579030|NCT04994509|455415888|FG000|Overall Study|Withdrew Assent|3|||
126579031|NCT04994509|455415889|FG001|Overall Study|Withdrew Assent|0|||
126579032|NCT04994509|455415890|FG002|Overall Study|Withdrew Assent|0|||
126579033|NCT04994509|455415888|FG000|Overall Study|Protocol Violation|1|||
126579034|NCT04994509|455415889|FG001|Overall Study|Protocol Violation|0|||
126579035|NCT04994509|455415890|FG002|Overall Study|Protocol Violation|0|||
126579036|NCT02576509|455417294|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
126579037|NCT02576509|455417295|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
126579038|NCT02576509|455417294|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
126579039|NCT02576509|455417295|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
126579040|NCT02576509|455417294|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
126579041|NCT02576509|455417295|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
126579042|NCT02576509|455417294|FG000|Treatment Period|Disease progression|263|||
126579043|NCT02576509|455417295|FG001|Treatment Period|Disease progression|244|||
126579044|NCT02576509|455417294|FG000|Treatment Period|Study drug toxicity|37|||
126579045|NCT02576509|455417295|FG001|Treatment Period|Study drug toxicity|41|||
126579046|NCT02576509|455417294|FG000|Treatment Period|Death|1|||
126579047|NCT02576509|455417295|FG001|Treatment Period|Death|1|||
126579048|NCT02576509|455417294|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
126579049|NCT02576509|455417295|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
126579050|NCT02576509|455417294|FG000|Treatment Period|Participant request to stop treatment|8|||
126579051|NCT02576509|455417295|FG001|Treatment Period|Participant request to stop treatment|18|||
126579052|NCT02576509|455417294|FG000|Treatment Period|Participant withdrew consent|3|||
126579053|NCT02576509|455417295|FG001|Treatment Period|Participant withdrew consent|7|||
126579054|NCT02576509|455417294|FG000|Treatment Period|Lost to Follow-up|0|||
126579055|NCT02576509|455417295|FG001|Treatment Period|Lost to Follow-up|1|||
126579056|NCT02576509|455417294|FG000|Treatment Period|Maximum clinical benefit|1|||
126579057|NCT02576509|455417295|FG001|Treatment Period|Maximum clinical benefit|0|||
126579058|NCT02576509|455417294|FG000|Treatment Period|Poor/non-compliance|1|||
126579059|NCT02576509|455417295|FG001|Treatment Period|Poor/non-compliance|1|||
126527447|NCT01490632|455221426|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
126527448|NCT01490632|455221427|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
126579060|NCT02576509|455417294|FG000|Treatment Period|Participant no longer meets criteria|1|||
126579061|NCT02576509|455417295|FG001|Treatment Period|Participant no longer meets criteria|0|||
126579062|NCT02576509|455417294|FG000|Treatment Period|Other reason|12|||
126579063|NCT02576509|455417295|FG001|Treatment Period|Other reason|8|||
126579064|NCT02576509|455417294|FG000|Treatment Period|NOT REPORTED|1|||
126579065|NCT02576509|455417295|FG001|Treatment Period|NOT REPORTED|0|||
126579066|NCT02576509|455417294|FG000|Treatment Period|Administrative reason by sponsor|0|||
126579067|NCT02576509|455417295|FG001|Treatment Period|Administrative reason by sponsor|1|||
126579068|NCT05505045|455417297|FG000|Overall Study|Withdrawal by Subject|2|||
126579069|NCT05505045|455417298|FG001|Overall Study|Withdrawal by Subject|1|||
126579070|NCT01643070|455417299|FG000|Overall Study|Withdrawal by Subject|3|||
126579071|NCT01643070|455417300|FG001|Overall Study|Withdrawal by Subject|1|||
126579072|NCT01643070|455417299|FG000|Overall Study|Death|1|||
126579073|NCT01643070|455417300|FG001|Overall Study|Death|0|||
126579074|NCT01643070|455417299|FG000|Overall Study|Pregressive disease|0|||
126579075|NCT01643070|455417300|FG001|Overall Study|Pregressive disease|2|||
126579076|NCT04278586|455417301|FG000|Overall Study|Withdrawal by Subject|13|||
126579077|NCT04278586|455417302|FG001|Overall Study|Withdrawal by Subject|6|||
126579078|NCT04278586|455417301|FG000|Overall Study|Lost to Follow-up|37|||
126579079|NCT04278586|455417302|FG001|Overall Study|Lost to Follow-up|24|||
126579080|NCT04038957|455417310|FG000|Overall Study|Withdrawal by Subject|1|||
126579081|NCT04038957|455417310|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
126579082|NCT01998984|455417315|FG000|Overall Study|Adverse Event|0|||
126579083|NCT01998984|455417316|FG001|Overall Study|Adverse Event|0|||
126579084|NCT01998984|455417317|FG002|Overall Study|Adverse Event|0|||
126579085|NCT01998984|455417318|FG003|Overall Study|Adverse Event|1|||
126579086|NCT01998984|455417315|FG000|Overall Study|Lost to Follow-up|0|||
126579087|NCT01998984|455417316|FG001|Overall Study|Lost to Follow-up|1|||
126579088|NCT01998984|455417317|FG002|Overall Study|Lost to Follow-up|0|||
126579089|NCT01998984|455417318|FG003|Overall Study|Lost to Follow-up|1|||
126579090|NCT01998984|455417315|FG000|Overall Study|Withdrawal by Subject|0|||
126579091|NCT01998984|455417316|FG001|Overall Study|Withdrawal by Subject|0|||
126579092|NCT01998984|455417317|FG002|Overall Study|Withdrawal by Subject|1|||
126579093|NCT01998984|455417318|FG003|Overall Study|Withdrawal by Subject|0|||
126579094|NCT01998984|455417315|FG000|Overall Study|Other|0|||
126579095|NCT01998984|455417316|FG001|Overall Study|Other|0|||
126579096|NCT01998984|455417317|FG002|Overall Study|Other|0|||
126579097|NCT01998984|455417318|FG003|Overall Study|Other|1|||
126579098|NCT01843374|455417320|FG000|Overall Study|Death|155|||
126579099|NCT01843374|455417321|FG001|Overall Study|Death|313|||
126579100|NCT01843374|455417320|FG000|Overall Study|Withdrawal by Subject|14|||
126579101|NCT01843374|455417321|FG001|Overall Study|Withdrawal by Subject|20|||
126579102|NCT01843374|455417320|FG000|Overall Study|Withdrawing due to Other reason|20|||
126579103|NCT01843374|455417321|FG001|Overall Study|Withdrawing due to Other reason|46|||
126579104|NCT03397108|455417322|FG000|Overall Study|Lost to Follow-up|15|||
126579105|NCT03397108|455417323|FG001|Overall Study|Lost to Follow-up|0|||
126579106|NCT03397108|455417322|FG000|Overall Study|Insufficient milk production|3|||
126579107|NCT03397108|455417323|FG001|Overall Study|Insufficient milk production|2|||
126579108|NCT03397108|455417322|FG000|Overall Study|Withdrawal by Subject|2|||
126579109|NCT03397108|455417323|FG001|Overall Study|Withdrawal by Subject|0|||
126579110|NCT05386238|455417324|FG000|Overall Study|Lost to Follow-up|3|||
126579111|NCT05386238|455417325|FG001|Overall Study|Lost to Follow-up|2|||
126579112|NCT05386238|455417324|FG000|Overall Study|Withdrawal by Subject|0|||
126579113|NCT05386238|455417325|FG001|Overall Study|Withdrawal by Subject|1|||
126579114|NCT05057897|455417326|FG000|Overall Study|Site closure|2|||
126579115|NCT05057897|455417327|FG001|Overall Study|Site closure|2|||
126579116|NCT05057897|455417326|FG000|Overall Study|Death|1|||
126579117|NCT05057897|455417327|FG001|Overall Study|Death|0|||
126579118|NCT04714320|455417328|FG000|Overall Study|Voluntary Withdrawal|4|||
126579119|NCT04714320|455417329|FG001|Overall Study|Voluntary Withdrawal|1|||
126579120|NCT04714320|455417330|FG002|Overall Study|Voluntary Withdrawal|2|||
126579121|NCT04714320|455417328|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
126579122|NCT04714320|455417329|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
126579123|NCT04714320|455417330|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
126579124|NCT04714320|455417328|FG000|Overall Study|Reason Not Specified|1|||
126579125|NCT04714320|455417329|FG001|Overall Study|Reason Not Specified|3|||
126579126|NCT04714320|455417330|FG002|Overall Study|Reason Not Specified|3|||
126579127|NCT03438188|455417331|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
126579128|NCT03438188|455417332|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
126579129|NCT03438188|455417333|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
126579130|NCT03438188|455417331|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
126579131|NCT03438188|455417332|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
126579132|NCT03438188|455417333|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
126579133|NCT03438188|455417331|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
126579134|NCT03438188|455417332|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
126579135|NCT03438188|455417333|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
126579136|NCT03438188|455417331|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
126579137|NCT03438188|455417332|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
126579138|NCT03438188|455417333|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
126579139|NCT03438188|455417331|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
126579140|NCT03438188|455417332|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
126579141|NCT03438188|455417333|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
126579142|NCT00670046|455417334|FG000|Overall Study|Lost to Follow-up|1|||
126579143|NCT00670046|455417335|FG001|Overall Study|Lost to Follow-up|1|||
126579144|NCT00670046|455417334|FG000|Overall Study|Withdrawal by Subject|0|||
126579145|NCT00670046|455417335|FG001|Overall Study|Withdrawal by Subject|1|||
126579146|NCT03285763|455417336|FG000|Overall Study|Death|470|||
126728447|NCT01577160|455954252|FG000|Overall Study|Other|9|||
126527449|NCT01490632|455221428|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
126527450|NCT01490632|455221429|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
126527451|NCT01490632|455221430|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527452|NCT01490632|455221431|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527453|NCT01490632|455221432|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527454|NCT01490632|455221433|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
126527455|NCT01490632|455221414|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
126527456|NCT01490632|455221415|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
126527457|NCT01490632|455221416|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
126527458|NCT01490632|455221417|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
126527459|NCT01490632|455221418|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
126527460|NCT01490632|455221419|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
126527461|NCT01490632|455221420|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
126527462|NCT01490632|455221421|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
126527463|NCT01490632|455221422|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
126527464|NCT01490632|455221423|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
126527465|NCT01490632|455221424|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
126527466|NCT01490632|455221425|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
126527467|NCT01490632|455221426|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
126527468|NCT01490632|455221427|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
126527469|NCT01490632|455221428|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
126527470|NCT01490632|455221429|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
126527471|NCT01490632|455221430|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
126527472|NCT01490632|455221431|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
126527473|NCT01490632|455221432|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
126527474|NCT01490632|455221433|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
126527475|NCT01490632|455221414|FG000|Part D: Re-Treatment Period|Death|0|||
126527476|NCT01490632|455221415|FG001|Part D: Re-Treatment Period|Death|0|||
126527477|NCT01490632|455221416|FG002|Part D: Re-Treatment Period|Death|0|||
126527478|NCT01490632|455221417|FG003|Part D: Re-Treatment Period|Death|0|||
126527479|NCT01490632|455221418|FG004|Part D: Re-Treatment Period|Death|0|||
126527480|NCT01490632|455221419|FG005|Part D: Re-Treatment Period|Death|0|||
126527481|NCT01490632|455221420|FG006|Part D: Re-Treatment Period|Death|0|||
126527482|NCT01490632|455221421|FG007|Part D: Re-Treatment Period|Death|0|||
126527483|NCT01490632|455221422|FG008|Part D: Re-Treatment Period|Death|0|||
126527484|NCT01490632|455221423|FG009|Part D: Re-Treatment Period|Death|0|||
126527485|NCT01490632|455221424|FG010|Part D: Re-Treatment Period|Death|0|||
126527486|NCT01490632|455221425|FG011|Part D: Re-Treatment Period|Death|0|||
126527487|NCT01490632|455221426|FG012|Part D: Re-Treatment Period|Death|0|||
126527488|NCT01490632|455221427|FG013|Part D: Re-Treatment Period|Death|0|||
126527489|NCT01490632|455221428|FG014|Part D: Re-Treatment Period|Death|0|||
126527490|NCT01490632|455221429|FG015|Part D: Re-Treatment Period|Death|0|||
126527491|NCT01490632|455221430|FG016|Part D: Re-Treatment Period|Death|0|||
126527492|NCT01490632|455221431|FG017|Part D: Re-Treatment Period|Death|0|||
126527493|NCT01490632|455221432|FG018|Part D: Re-Treatment Period|Death|1|||
126527494|NCT01490632|455221433|FG019|Part D: Re-Treatment Period|Death|0|||
126527495|NCT01490632|455221414|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527496|NCT01490632|455221415|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527497|NCT01490632|455221416|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527498|NCT01490632|455221417|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527499|NCT01490632|455221418|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527500|NCT01490632|455221419|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527501|NCT01490632|455221420|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527502|NCT01490632|455221421|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527503|NCT01490632|455221422|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527504|NCT01490632|455221423|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527505|NCT01490632|455221424|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527506|NCT01490632|455221425|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527507|NCT01490632|455221426|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527508|NCT01490632|455221427|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527509|NCT01490632|455221428|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527510|NCT01490632|455221429|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527511|NCT01490632|455221430|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
126527512|NCT01490632|455221431|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
126527513|NCT01490632|455221432|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
126527514|NCT01490632|455221433|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
126527515|NCT01490632|455221414|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527516|NCT01490632|455221415|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527517|NCT01490632|455221416|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527518|NCT01490632|455221417|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527519|NCT01490632|455221418|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527520|NCT01490632|455221419|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126579147|NCT03285763|455417336|FG000|Overall Study|Lost to Follow-up|18|||
126527521|NCT01490632|455221420|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527522|NCT01490632|455221421|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527523|NCT01490632|455221422|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527524|NCT01490632|455221423|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527525|NCT01490632|455221424|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527526|NCT01490632|455221425|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527527|NCT01490632|455221426|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527528|NCT01490632|455221427|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527529|NCT01490632|455221428|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527530|NCT01490632|455221429|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527531|NCT01490632|455221430|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527532|NCT01490632|455221431|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527533|NCT01490632|455221432|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
126527534|NCT01490632|455221433|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
126527535|NCT01490632|455221414|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
126527536|NCT01490632|455221415|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
126527537|NCT01490632|455221416|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
126527538|NCT01490632|455221417|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
126527539|NCT01490632|455221418|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
126527540|NCT01490632|455221419|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
126527541|NCT01490632|455221420|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
126527542|NCT01490632|455221421|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
126527543|NCT01490632|455221422|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
126527544|NCT01490632|455221423|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
126527545|NCT01490632|455221424|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
126527546|NCT01490632|455221425|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
126527547|NCT01490632|455221426|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
126527548|NCT01490632|455221427|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
126527549|NCT01490632|455221428|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
126527550|NCT01490632|455221429|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
126527551|NCT01490632|455221430|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
126527552|NCT01490632|455221431|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
126527553|NCT01490632|455221432|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
126527554|NCT01490632|455221433|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
126527555|NCT01490632|455221414|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
126527556|NCT01490632|455221415|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
126527557|NCT01490632|455221416|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
126527558|NCT01490632|455221417|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
126527559|NCT01490632|455221418|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
126527560|NCT01490632|455221419|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
126527561|NCT01490632|455221420|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
126527562|NCT01490632|455221421|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
126527563|NCT01490632|455221422|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
126527564|NCT01490632|455221423|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
126527565|NCT01490632|455221424|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
126527566|NCT01490632|455221425|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
126527567|NCT01490632|455221426|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
126527568|NCT01490632|455221427|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
126527569|NCT01490632|455221428|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
126527570|NCT01490632|455221429|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
126527571|NCT01490632|455221430|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
126527572|NCT01490632|455221431|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
126527573|NCT01490632|455221432|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
126527574|NCT01490632|455221433|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
126527575|NCT01490632|455221414|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527576|NCT01490632|455221415|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527577|NCT01490632|455221416|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527578|NCT01490632|455221417|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527579|NCT01490632|455221418|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527580|NCT01490632|455221419|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527581|NCT01490632|455221420|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527582|NCT01490632|455221421|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527583|NCT01490632|455221422|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527584|NCT01490632|455221423|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527585|NCT01490632|455221424|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527586|NCT01490632|455221425|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527587|NCT01490632|455221426|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527588|NCT01490632|455221427|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527589|NCT01490632|455221428|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126579148|NCT03285763|455417336|FG000|Overall Study|Physician Decision|2|||
126527590|NCT01490632|455221429|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527591|NCT01490632|455221430|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
126527592|NCT01490632|455221431|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
126527593|NCT01490632|455221432|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
126527594|NCT01490632|455221433|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
126527595|NCT01944631|455221439|FG000|Overall Study|Adverse Event|1|||
126527596|NCT01944631|455221440|FG001|Overall Study|Adverse Event|0|||
126527597|NCT01944631|455221439|FG000|Overall Study|Lost to Follow-up|3|||
126527598|NCT01944631|455221440|FG001|Overall Study|Lost to Follow-up|1|||
126527599|NCT01944631|455221439|FG000|Overall Study|Withdrawal by Subject|0|||
126527600|NCT01944631|455221440|FG001|Overall Study|Withdrawal by Subject|1|||
126527601|NCT01412944|455221441|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
126527602|NCT01412944|455221442|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
126527603|NCT01412944|455221443|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
126527604|NCT01412944|455221444|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
126527605|NCT01412944|455221445|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
126527606|NCT01412944|455221446|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
126527607|NCT01412944|455221441|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
126527608|NCT01412944|455221442|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
126527609|NCT01412944|455221443|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
126527610|NCT01412944|455221444|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
126527611|NCT01412944|455221445|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
126527612|NCT01412944|455221446|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
126527613|NCT01412944|455221441|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
126527614|NCT01412944|455221442|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
126527615|NCT01412944|455221443|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
126527616|NCT01412944|455221444|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
126527617|NCT01412944|455221445|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
126527618|NCT01412944|455221446|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
126527619|NCT01412944|455221441|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
126527620|NCT01412944|455221442|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
126527621|NCT01412944|455221443|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
126527622|NCT01412944|455221444|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
126527623|NCT01412944|455221445|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
126527624|NCT01412944|455221446|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
126527625|NCT01412944|455221441|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
126527626|NCT01412944|455221442|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
126527627|NCT01412944|455221443|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
126527628|NCT01412944|455221444|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
126527629|NCT01412944|455221445|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
126527630|NCT01412944|455221446|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
126527631|NCT01412944|455221441|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
126527632|NCT01412944|455221442|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
126527633|NCT01412944|455221443|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
126527634|NCT01412944|455221444|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
126527635|NCT01412944|455221445|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
126527636|NCT01412944|455221446|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
126527637|NCT01412944|455221441|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
126527638|NCT01412944|455221442|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
126527639|NCT01412944|455221443|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
126527640|NCT01412944|455221444|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
126527641|NCT01412944|455221445|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
126527642|NCT01412944|455221446|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
126527643|NCT01412944|455221441|FG000|Entire: IV + Maintenance|Adverse Event|0|||
126527644|NCT01412944|455221442|FG001|Entire: IV + Maintenance|Adverse Event|0|||
126527645|NCT01412944|455221443|FG002|Entire: IV + Maintenance|Adverse Event|0|||
126527646|NCT01412944|455221444|FG003|Entire: IV + Maintenance|Adverse Event|0|||
126527647|NCT01412944|455221445|FG004|Entire: IV + Maintenance|Adverse Event|1|||
126527648|NCT01412944|455221446|FG005|Entire: IV + Maintenance|Adverse Event|0|||
126527649|NCT01412944|455221441|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
126527650|NCT01412944|455221442|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
126527651|NCT01412944|455221443|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
126527652|NCT01412944|455221444|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
126527653|NCT01412944|455221445|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
126527654|NCT01412944|455221446|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
126527655|NCT01412944|455221441|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
126527656|NCT01412944|455221442|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
126527657|NCT01412944|455221443|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
126527658|NCT01412944|455221444|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
126527659|NCT01412944|455221445|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
126579149|NCT03285763|455417336|FG000|Overall Study|Study Terminated By Sponsor|79|||
126579150|NCT03285763|455417336|FG000|Overall Study|Withdrawal by Subject|33|||
126579151|NCT03624972|455417337|FG000|Overall Study|Lost to Follow-up|2|||
126579152|NCT03624972|455417338|FG001|Overall Study|Lost to Follow-up|0|||
126579153|NCT03624972|455417339|FG002|Overall Study|Lost to Follow-up|0|||
126579154|NCT03624972|455417337|FG000|Overall Study|Withdrawal by Subject|0|||
126579155|NCT03624972|455417338|FG001|Overall Study|Withdrawal by Subject|2|||
126579156|NCT03624972|455417339|FG002|Overall Study|Withdrawal by Subject|0|||
126579157|NCT03456076|455417344|FG000|Overall Study|Withdrawal by Subject|5|||
126579158|NCT03456076|455417345|FG001|Overall Study|Withdrawal by Subject|9|||
126579159|NCT03456076|455417344|FG000|Overall Study|Protocol deviation|0|||
126579160|NCT03456076|455417345|FG001|Overall Study|Protocol deviation|1|||
126579161|NCT03456076|455417344|FG000|Overall Study|Lost to Follow-up|0|||
126579162|NCT03456076|455417345|FG001|Overall Study|Lost to Follow-up|1|||
126579163|NCT03456076|455417344|FG000|Overall Study|Death|2|||
126579164|NCT03456076|455417345|FG001|Overall Study|Death|5|||
126579165|NCT03456076|455417344|FG000|Overall Study|Study ongoing|123|||
126579166|NCT03456076|455417345|FG001|Overall Study|Study ongoing|111|||
126579167|NCT00431834|455417348|FG000|Overall Study|Withdrawal by Subject|7|||
126579168|NCT00431834|455417348|FG000|Overall Study|Death|3|||
126579169|NCT00431834|455417348|FG000|Overall Study|Missed Endpoint Visit|2|||
126579170|NCT00431834|455417348|FG000|Overall Study|Lost to Follow-up|1|||
126579171|NCT02461628|455417354|FG000|Overall Study|Refused to complete survey|4|||
126579172|NCT02461628|455417355|FG001|Overall Study|Refused to complete survey|7|||
126579173|NCT01610297|455417357|FG000|Overall Study|Lost to Follow-up|1|||
126579174|NCT01007396|455417361|FG000|Overall Study|Lost to Follow-up|47|||
126579175|NCT02590432|455417365|FG000|Open-label Treatment Period|Adverse Event|97|||
126579176|NCT02590432|455417366|FG001|Open-label Treatment Period|Adverse Event|79|||
126579177|NCT02590432|455417367|FG002|Open-label Treatment Period|Adverse Event|0|||
126579178|NCT02590432|455417368|FG003|Open-label Treatment Period|Adverse Event|0|||
126579179|NCT02590432|455417369|FG004|Open-label Treatment Period|Adverse Event|0|||
126579180|NCT02590432|455417370|FG005|Open-label Treatment Period|Adverse Event|0|||
126579181|NCT02590432|455417371|FG006|Open-label Treatment Period|Adverse Event|0|||
126579182|NCT02590432|455417372|FG007|Open-label Treatment Period|Adverse Event|0|||
126579183|NCT02590432|455417373|FG008|Open-label Treatment Period|Adverse Event|0|||
126579184|NCT02590432|455417365|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
126579185|NCT02590432|455417366|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
126579186|NCT02590432|455417367|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
126579187|NCT02590432|455417368|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
126579188|NCT02590432|455417369|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
126579189|NCT02590432|455417370|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
126579190|NCT02590432|455417371|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
126579191|NCT02590432|455417372|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
126579192|NCT02590432|455417373|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
126579193|NCT02590432|455417365|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
126579194|NCT02590432|455417366|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
126579195|NCT02590432|455417367|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
126579196|NCT02590432|455417368|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
126579197|NCT02590432|455417369|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
126579198|NCT02590432|455417370|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
126579199|NCT02590432|455417371|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
126579200|NCT02590432|455417372|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
126579201|NCT02590432|455417373|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
126579202|NCT02590432|455417365|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
126579203|NCT02590432|455417366|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
126579204|NCT02590432|455417367|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
126579205|NCT02590432|455417368|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
126579206|NCT02590432|455417369|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
126579207|NCT02590432|455417370|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
126579208|NCT02590432|455417371|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
126579209|NCT02590432|455417372|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
126579210|NCT02590432|455417373|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
126579211|NCT02590432|455417365|FG000|Open-label Treatment Period|Protocol Violation|10|||
126579212|NCT02590432|455417366|FG001|Open-label Treatment Period|Protocol Violation|4|||
126579213|NCT02590432|455417367|FG002|Open-label Treatment Period|Protocol Violation|0|||
126579214|NCT02590432|455417368|FG003|Open-label Treatment Period|Protocol Violation|0|||
126579215|NCT02590432|455417369|FG004|Open-label Treatment Period|Protocol Violation|0|||
126579216|NCT02590432|455417370|FG005|Open-label Treatment Period|Protocol Violation|0|||
126579217|NCT02590432|455417371|FG006|Open-label Treatment Period|Protocol Violation|0|||
126579218|NCT02590432|455417372|FG007|Open-label Treatment Period|Protocol Violation|0|||
126579219|NCT02590432|455417373|FG008|Open-label Treatment Period|Protocol Violation|0|||
126579220|NCT02590432|455417365|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
126579221|NCT02590432|455417366|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
126579222|NCT02590432|455417367|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126579223|NCT02590432|455417368|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126579224|NCT02590432|455417369|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126579225|NCT02590432|455417370|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126579226|NCT02590432|455417371|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126579227|NCT02590432|455417372|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126579228|NCT02590432|455417373|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
126579229|NCT02590432|455417365|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
126579230|NCT02590432|455417366|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
126579231|NCT02590432|455417367|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126579232|NCT02590432|455417368|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126579233|NCT02590432|455417369|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126579234|NCT02590432|455417370|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126579235|NCT02590432|455417371|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126579236|NCT02590432|455417372|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126579237|NCT02590432|455417373|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
126579238|NCT02590432|455417365|FG000|Double-blind Treatment Period|Adverse Event|0|||
126579239|NCT02590432|455417366|FG001|Double-blind Treatment Period|Adverse Event|0|||
126579240|NCT02590432|455417367|FG002|Double-blind Treatment Period|Adverse Event|14|||
126728448|NCT00536978|455954253|FG000|Overall Study|Not eligible for Adback Infusion|22|||
126728449|NCT00916370|455954256|FG000|Overall Study|Death|3|||
126728450|NCT00916370|455954257|FG001|Overall Study|Death|1|||
126728451|NCT00916370|455954256|FG000|Overall Study|Withdrawal by Subject|2|||
126728452|NCT00916370|455954257|FG001|Overall Study|Withdrawal by Subject|0|||
126728453|NCT00916370|455954256|FG000|Overall Study|Physician Decision|0|||
126728454|NCT00916370|455954257|FG001|Overall Study|Physician Decision|1|||
126728455|NCT03550131|455954258|FG000|Overall Study|Lost to Follow-up|16|||
126728456|NCT03550131|455954259|FG001|Overall Study|Lost to Follow-up|24|||
126728457|NCT03550131|455954258|FG000|Overall Study|Withdrawal by Subject|36|||
126728458|NCT03550131|455954259|FG001|Overall Study|Withdrawal by Subject|28|||
126728459|NCT03550131|455954258|FG000|Overall Study|Illness of dyad member|10|||
126728460|NCT03550131|455954259|FG001|Overall Study|Illness of dyad member|2|||
126728461|NCT03550131|455954258|FG000|Overall Study|Death of person with dementia|4|||
126728462|NCT03550131|455954259|FG001|Overall Study|Death of person with dementia|8|||
126728463|NCT01318512|455954260|FG000|Maintenance Period (6 Months)|Death|2|||
126728464|NCT01318512|455954260|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
126728465|NCT00717366|455954261|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
126728466|NCT00717366|455954262|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
126728467|NCT00717366|455954261|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
126728468|NCT00717366|455954262|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
126728469|NCT00717366|455954261|FG000|Core Study Period (20 Weeks)|Death|0|||
126728470|NCT00717366|455954262|FG001|Core Study Period (20 Weeks)|Death|1|||
126728471|NCT00717366|455954261|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
126728472|NCT00717366|455954262|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
126728473|NCT00717366|455954261|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
126728474|NCT00717366|455954262|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
126728475|NCT00717366|455954261|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
126728476|NCT00717366|455954262|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
126728477|NCT00717366|455954261|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
126728478|NCT00717366|455954262|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
126728479|NCT01317615|455954265|FG000|Overall Study|Disease progression|25|||
126728480|NCT01317615|455954265|FG000|Overall Study|New cancer therapy|5|||
126728481|NCT01317615|455954265|FG000|Overall Study|Death|6|||
126728482|NCT01317615|455954265|FG000|Overall Study|Withdrawal by Subject|5|||
126728483|NCT01317615|455954265|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126728484|NCT01317615|455954265|FG000|Overall Study|Adverse Event|7|||
126728485|NCT00255086|455954266|FG000|Overall Study|Adverse Event|1|||
126728486|NCT00255086|455954267|FG001|Overall Study|Adverse Event|1|||
126728487|NCT00255086|455954266|FG000|Overall Study|Protocol Violation|1|||
126728488|NCT00255086|455954267|FG001|Overall Study|Protocol Violation|1|||
126728489|NCT00438399|455954270|FG000|Overall Study|Lost to Follow-up|2|||
126728490|NCT00438399|455954271|FG001|Overall Study|Lost to Follow-up|2|||
126728491|NCT00438399|455954272|FG002|Overall Study|Lost to Follow-up|1|||
126728492|NCT00438399|455954273|FG003|Overall Study|Lost to Follow-up|1|||
126728493|NCT00438399|455954274|FG004|Overall Study|Lost to Follow-up|1|||
126728494|NCT00438399|455954275|FG005|Overall Study|Lost to Follow-up|1|||
126728495|NCT00438399|455954270|FG000|Overall Study|Adverse Event|0|||
126728496|NCT00438399|455954271|FG001|Overall Study|Adverse Event|0|||
126728497|NCT00438399|455954272|FG002|Overall Study|Adverse Event|1|||
126728498|NCT00438399|455954273|FG003|Overall Study|Adverse Event|1|||
126579241|NCT02590432|455417368|FG003|Double-blind Treatment Period|Adverse Event|12|||
126579242|NCT02590432|455417369|FG004|Double-blind Treatment Period|Adverse Event|6|||
126777126|NCT01623830|456141284|FG001|Overall Study|Exclusion from Study|2|||
126527660|NCT01412944|455221446|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
126527661|NCT01412944|455221441|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
126527662|NCT01412944|455221442|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
126527663|NCT01412944|455221443|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
126527664|NCT01412944|455221444|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
126527665|NCT01412944|455221445|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
126527666|NCT01412944|455221446|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
126527667|NCT01412944|455221441|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
126527668|NCT01412944|455221442|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
126527669|NCT01412944|455221443|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
126527670|NCT01412944|455221444|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
126527671|NCT01412944|455221445|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
126527672|NCT01412944|455221446|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
126527673|NCT01412944|455221441|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
126527674|NCT01412944|455221442|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
126527675|NCT01412944|455221443|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
126527676|NCT01412944|455221444|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
126527677|NCT01412944|455221445|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
126527678|NCT01412944|455221446|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
126527679|NCT01412944|455221441|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
126527680|NCT01412944|455221442|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
126527681|NCT01412944|455221443|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
126527682|NCT01412944|455221444|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
126527683|NCT01412944|455221445|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
126527684|NCT01412944|455221446|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
126527685|NCT01412944|455221441|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
126527686|NCT01412944|455221442|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
126527687|NCT01412944|455221443|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
126527688|NCT01412944|455221444|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
126527689|NCT01412944|455221445|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
126527690|NCT01412944|455221446|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
126527691|NCT01412944|455221441|FG000|Entire: IV + Maintenance|Adverse Event|0|||
126527692|NCT01412944|455221442|FG001|Entire: IV + Maintenance|Adverse Event|1|||
126527693|NCT01412944|455221443|FG002|Entire: IV + Maintenance|Adverse Event|0|||
126527694|NCT01412944|455221444|FG003|Entire: IV + Maintenance|Adverse Event|0|||
126527695|NCT01412944|455221445|FG004|Entire: IV + Maintenance|Adverse Event|0|||
126527696|NCT01412944|455221446|FG005|Entire: IV + Maintenance|Adverse Event|0|||
126527697|NCT01990950|455221447|FG000|Overall Study|Death|3|||
126527698|NCT01990950|455221447|FG000|Overall Study|Lost to Follow-up|2|||
126527699|NCT01990950|455221447|FG000|Overall Study|Withdrawal by Subject|6|||
126527700|NCT02388724|455221449|FG000|Overall Study|Reason not Specified|0|||
126527701|NCT02388724|455221450|FG001|Overall Study|Reason not Specified|1|||
126527702|NCT02388724|455221449|FG000|Overall Study|Major Protocol Deviation|3|||
126527703|NCT02388724|455221450|FG001|Overall Study|Major Protocol Deviation|3|||
126527704|NCT02388724|455221449|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
126527705|NCT02388724|455221450|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
126527706|NCT02388724|455221449|FG000|Overall Study|Voluntary Withdrawal|6|||
126527707|NCT02388724|455221450|FG001|Overall Study|Voluntary Withdrawal|5|||
126527708|NCT02388724|455221449|FG000|Overall Study|Randomized but not Treated|0|||
126527709|NCT02388724|455221450|FG001|Overall Study|Randomized but not Treated|2|||
126527710|NCT02605954|455221452|FG000|Overall Study|Adverse Event|5|||
126527711|NCT02605954|455221453|FG001|Overall Study|Adverse Event|1|||
126527712|NCT02605954|455221452|FG000|Overall Study|Investigator's Discretion|1|||
126527713|NCT02605954|455221453|FG001|Overall Study|Investigator's Discretion|0|||
126527714|NCT02605954|455221452|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126527715|NCT02605954|455221453|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126527716|NCT02605954|455221452|FG000|Overall Study|Withdrew Consent|2|||
126527717|NCT02605954|455221453|FG001|Overall Study|Withdrew Consent|2|||
126527718|NCT02605954|455221452|FG000|Overall Study|Lost to Follow-up|3|||
126527719|NCT02605954|455221453|FG001|Overall Study|Lost to Follow-up|0|||
126527720|NCT02605954|455221452|FG000|Overall Study|Randomized but not treated|0|||
126527721|NCT02605954|455221453|FG001|Overall Study|Randomized but not treated|1|||
126527722|NCT00856856|455221457|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
126527723|NCT00856856|455221457|FG000|4-year Clinical Follow-up|Missed visit|1|||
126527724|NCT00922428|455221460|FG000|Overall Study|retrospective/extremely implausible data|2|||
126527725|NCT00922428|455221460|FG000|Overall Study|no medication use or questionable use|13|||
126527726|NCT02696317|455221461|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
126527727|NCT02696317|455221462|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
126527728|NCT02696317|455221461|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
126527729|NCT02696317|455221462|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
126527730|NCT01343368|455221463|FG000|Overall Study|Death|1|||
126527731|NCT01343368|455221464|FG001|Overall Study|Death|0|||
126527732|NCT01343368|455221463|FG000|Overall Study|Lost to Follow-up|1|||
126579243|NCT02590432|455417370|FG005|Double-blind Treatment Period|Adverse Event|22|||
126579244|NCT02590432|455417371|FG006|Double-blind Treatment Period|Adverse Event|20|||
126579245|NCT02590432|455417372|FG007|Double-blind Treatment Period|Adverse Event|0|||
126579246|NCT02590432|455417373|FG008|Double-blind Treatment Period|Adverse Event|0|||
126579247|NCT02590432|455417365|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
126579248|NCT02590432|455417366|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
126579249|NCT02590432|455417367|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
126579250|NCT02590432|455417368|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
126579251|NCT02590432|455417369|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
126579252|NCT02590432|455417370|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
126579253|NCT02590432|455417371|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
126579254|NCT02590432|455417372|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
126579255|NCT02590432|455417373|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
126579256|NCT02590432|455417365|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
126579257|NCT02590432|455417366|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
126579258|NCT02590432|455417367|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
126579259|NCT02590432|455417368|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
126579260|NCT02590432|455417369|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
126579261|NCT02590432|455417370|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
126579262|NCT02590432|455417371|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
126579263|NCT02590432|455417372|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
126579264|NCT02590432|455417373|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
126579265|NCT02590432|455417365|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
126579266|NCT02590432|455417366|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
126579267|NCT02590432|455417367|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
126579268|NCT02590432|455417368|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
126579269|NCT02590432|455417369|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
126579270|NCT02590432|455417370|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
126579271|NCT02590432|455417371|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
126579272|NCT02590432|455417372|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
126579273|NCT02590432|455417373|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
126579274|NCT02590432|455417365|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126579275|NCT02590432|455417366|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126579276|NCT02590432|455417367|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126579277|NCT02590432|455417368|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126579278|NCT02590432|455417369|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126579279|NCT02590432|455417370|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
126579280|NCT02590432|455417371|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126579281|NCT02590432|455417372|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126579282|NCT02590432|455417373|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
126579283|NCT02590432|455417365|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126579284|NCT02590432|455417366|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126579285|NCT02590432|455417367|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126579286|NCT02590432|455417368|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126579287|NCT02590432|455417369|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126579288|NCT02590432|455417370|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126579289|NCT02590432|455417371|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
126579290|NCT02590432|455417372|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
126579291|NCT02590432|455417373|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
126579292|NCT02590432|455417365|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126579293|NCT02590432|455417366|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126579294|NCT02590432|455417367|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126579295|NCT02590432|455417368|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126579296|NCT02590432|455417369|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126579297|NCT02590432|455417370|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126579298|NCT02590432|455417371|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126579299|NCT02590432|455417372|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
126579300|NCT02590432|455417373|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
126579301|NCT02590432|455417365|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126579302|NCT02590432|455417366|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126579303|NCT02590432|455417367|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126579304|NCT02590432|455417368|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126579305|NCT02590432|455417369|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126579306|NCT02590432|455417370|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126579307|NCT02590432|455417371|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
126579308|NCT02590432|455417372|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
126527733|NCT01343368|455221464|FG001|Overall Study|Lost to Follow-up|0|||
126527734|NCT01939028|455221467|FG000|Overall Study|Withdrawal by Subject|5|||
126527735|NCT01939028|455221467|FG000|Overall Study|Physician Decision|7|||
126527736|NCT01220557|455221470|FG000|Overall Study|Lost to Follow-up|5|||
126527737|NCT01220557|455221471|FG001|Overall Study|Lost to Follow-up|3|||
126527738|NCT01220557|455221470|FG000|Overall Study|attended less than 6 lessons|1|||
126527739|NCT01220557|455221471|FG001|Overall Study|attended less than 6 lessons|2|||
126527740|NCT01358526|455221487|FG000|Open-label Titration Period|Adverse Event|95|||
126527741|NCT01358526|455221488|FG001|Open-label Titration Period|Adverse Event|0|||
126527742|NCT01358526|455221489|FG002|Open-label Titration Period|Adverse Event|0|||
126527743|NCT01358526|455221487|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
126527744|NCT01358526|455221488|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
126527745|NCT01358526|455221489|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
126527746|NCT01358526|455221487|FG000|Open-label Titration Period|Lost to Follow-up|25|||
126527747|NCT01358526|455221488|FG001|Open-label Titration Period|Lost to Follow-up|0|||
126527748|NCT01358526|455221489|FG002|Open-label Titration Period|Lost to Follow-up|0|||
126527749|NCT01358526|455221487|FG000|Open-label Titration Period|Lack of Efficacy|107|||
126527750|NCT01358526|455221488|FG001|Open-label Titration Period|Lack of Efficacy|0|||
126527751|NCT01358526|455221489|FG002|Open-label Titration Period|Lack of Efficacy|0|||
126527752|NCT01358526|455221487|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
126527753|NCT01358526|455221488|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
126527754|NCT01358526|455221489|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
126527755|NCT01358526|455221487|FG000|Open-label Titration Period|Administrative|8|||
126527756|NCT01358526|455221488|FG001|Open-label Titration Period|Administrative|0|||
126527757|NCT01358526|455221489|FG002|Open-label Titration Period|Administrative|0|||
126527758|NCT01358526|455221487|FG000|Open-label Titration Period|Did not qualify|178|||
126527759|NCT01358526|455221488|FG001|Open-label Titration Period|Did not qualify|0|||
126527760|NCT01358526|455221489|FG002|Open-label Titration Period|Did not qualify|0|||
126527761|NCT01358526|455221487|FG000|Double-blind Phase|Adverse Event|0|||
126527762|NCT01358526|455221488|FG001|Double-blind Phase|Adverse Event|24|||
126527763|NCT01358526|455221489|FG002|Double-blind Phase|Adverse Event|23|||
126527764|NCT01358526|455221487|FG000|Double-blind Phase|Withdrawal by Subject|0|||
126527765|NCT01358526|455221488|FG001|Double-blind Phase|Withdrawal by Subject|10|||
126527766|NCT01358526|455221489|FG002|Double-blind Phase|Withdrawal by Subject|8|||
126527767|NCT01358526|455221487|FG000|Double-blind Phase|Lost to Follow-up|0|||
126527768|NCT01358526|455221488|FG001|Double-blind Phase|Lost to Follow-up|4|||
126527769|NCT01358526|455221489|FG002|Double-blind Phase|Lost to Follow-up|1|||
126527770|NCT01358526|455221487|FG000|Double-blind Phase|Lack of Efficacy|0|||
126527771|NCT01358526|455221488|FG001|Double-blind Phase|Lack of Efficacy|31|||
126527772|NCT01358526|455221489|FG002|Double-blind Phase|Lack of Efficacy|73|||
126527773|NCT01358526|455221487|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
126527774|NCT01358526|455221488|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
126527775|NCT01358526|455221489|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
126527776|NCT01358526|455221487|FG000|Double-blind Phase|Administrative|0|||
126527777|NCT01358526|455221488|FG001|Double-blind Phase|Administrative|6|||
126527778|NCT01358526|455221489|FG002|Double-blind Phase|Administrative|10|||
126527779|NCT03277313|455221500|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
126527780|NCT03277313|455221501|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
126527781|NCT03277313|455221500|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
126527782|NCT03277313|455221501|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
126527783|NCT03277313|455221500|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
126527784|NCT03277313|455221501|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
126527785|NCT03277313|455221500|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
126527786|NCT03277313|455221501|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
126527787|NCT03277313|455221500|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
126527788|NCT03277313|455221501|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
126527789|NCT02132611|455221502|FG000|Overall Study|Death|2|||
126527790|NCT02194621|455221511|FG000|Overall Study|6 withdrew prior to randomization|2|||
126527791|NCT02194621|455221512|FG001|Overall Study|6 withdrew prior to randomization|2|||
126527792|NCT02194621|455221513|FG002|Overall Study|6 withdrew prior to randomization|2|||
126527793|NCT02194621|455221511|FG000|Overall Study|Withdrawal by Subject|4|||
126527794|NCT02194621|455221512|FG001|Overall Study|Withdrawal by Subject|4|||
126527795|NCT02194621|455221513|FG002|Overall Study|Withdrawal by Subject|7|||
126527796|NCT02763384|455221514|FG000|Overall Study|Physician Decision|1|||
126527797|NCT02763384|455221514|FG000|Overall Study|Rapid decline - went on hospice|1|||
126527798|NCT02493127|455221515|FG000|Overall Study|Lost to Follow-up|1|||
126527799|NCT02493127|455221516|FG001|Overall Study|Lost to Follow-up|1|||
126527800|NCT02096900|455221518|FG000|Overall Study|Did not receive medication|3|||
126527801|NCT02096900|455221519|FG001|Overall Study|Did not receive medication|1|||
126527802|NCT02096900|455221518|FG000|Overall Study|Surgery cancelled- medication received|1|||
126527803|NCT02096900|455221519|FG001|Overall Study|Surgery cancelled- medication received|1|||
126527804|NCT03034577|455221522|FG000|Overall Study|Withdrawal by Subject|6|||
126579309|NCT02590432|455417373|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
126579310|NCT02590432|455417365|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126579311|NCT02590432|455417366|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126579312|NCT02590432|455417367|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126579313|NCT02590432|455417368|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126579314|NCT02590432|455417369|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126579315|NCT02590432|455417370|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126579316|NCT02590432|455417371|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126579317|NCT02590432|455417372|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
126579318|NCT02590432|455417373|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
126579319|NCT02590432|455417365|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126579320|NCT02590432|455417366|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126579321|NCT02590432|455417367|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126579322|NCT02590432|455417368|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126579323|NCT02590432|455417369|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126579324|NCT02590432|455417370|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126579325|NCT02590432|455417371|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126579326|NCT02590432|455417372|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
126579327|NCT02590432|455417373|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
126579328|NCT02590432|455417365|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126579329|NCT02590432|455417366|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126579330|NCT02590432|455417367|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126579331|NCT02590432|455417368|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126527805|NCT03034577|455221523|FG001|Overall Study|Withdrawal by Subject|9|||
126527806|NCT03034577|455221522|FG000|Overall Study|Lost to Follow-up|25|||
126527807|NCT03034577|455221523|FG001|Overall Study|Lost to Follow-up|26|||
126527808|NCT04177758|455221524|FG000|Overall Study|Lost to Follow-up|19|||
126527809|NCT04177758|455221525|FG001|Overall Study|Lost to Follow-up|11|||
126527810|NCT00791765|455223431|FG000|Weeks 1 to 12|Adverse Event|0|||
126527811|NCT00791765|455223432|FG001|Weeks 1 to 12|Adverse Event|1|||
126527812|NCT00791765|455223431|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
126527813|NCT00791765|455223432|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
126527814|NCT00791765|455223431|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
126527815|NCT00791765|455223432|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
126527816|NCT00791765|455223431|FG000|Weeks 1 to 12|Physician Decision|1|||
126527817|NCT00791765|455223432|FG001|Weeks 1 to 12|Physician Decision|0|||
126527818|NCT00791765|455223431|FG000|Weeks 1 to 12|Disease progression|3|||
126527819|NCT00791765|455223432|FG001|Weeks 1 to 12|Disease progression|0|||
126527820|NCT00791765|455223431|FG000|Weeks 1 to 12|Ineligibility determined|0|||
126527821|NCT00791765|455223432|FG001|Weeks 1 to 12|Ineligibility determined|3|||
126527822|NCT00791765|455223431|FG000|Weeks 13 to 24|Protocol deviation|2|||
126527823|NCT00791765|455223432|FG001|Weeks 13 to 24|Protocol deviation|0|||
126527824|NCT00791765|455223431|FG000|Weeks 13 to 24|Adverse Event|0|||
126527825|NCT00791765|455223432|FG001|Weeks 13 to 24|Adverse Event|3|||
126527826|NCT00791765|455223431|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
126527827|NCT00791765|455223432|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
126527828|NCT00791765|455223431|FG000|Weeks 13 to 24|Disease progression|0|||
126527829|NCT00791765|455223432|FG001|Weeks 13 to 24|Disease progression|1|||
126527830|NCT00791765|455223431|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
126527831|NCT00791765|455223432|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
126527832|NCT00791765|455223431|FG000|Weeks 13 to 24|Other|0|||
126527833|NCT00791765|455223432|FG001|Weeks 13 to 24|Other|1|||
126527834|NCT01877408|455223441|FG000|Overall Study|Lost to Follow-up|0|||
126527835|NCT01877408|455223442|FG001|Overall Study|Lost to Follow-up|2|||
126527836|NCT00377234|455223446|FG000|Overall Study|Adverse Event|14|||
126527837|NCT00377234|455223447|FG001|Overall Study|Adverse Event|17|||
126527838|NCT00377234|455223446|FG000|Overall Study|Withdrawal by Subject|11|||
126527839|NCT00377234|455223447|FG001|Overall Study|Withdrawal by Subject|9|||
126527840|NCT00377234|455223446|FG000|Overall Study|Lost to Follow-up|4|||
126527841|NCT00377234|455223447|FG001|Overall Study|Lost to Follow-up|2|||
126527842|NCT00377234|455223446|FG000|Overall Study|Administrative|2|||
126579332|NCT02590432|455417369|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126579333|NCT02590432|455417370|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126579334|NCT02590432|455417371|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126527843|NCT00377234|455223447|FG001|Overall Study|Administrative|1|||
126527844|NCT00377234|455223446|FG000|Overall Study|Not assigned|3|||
126527845|NCT00377234|455223447|FG001|Overall Study|Not assigned|2|||
126728499|NCT00438399|455954274|FG004|Overall Study|Adverse Event|0|||
126527846|NCT01880424|455223448|FG000|Overall Study|Adverse Event|7|||
126527847|NCT01880424|455223449|FG001|Overall Study|Adverse Event|6|||
126527848|NCT01880424|455223448|FG000|Overall Study|Lack of Efficacy|1|||
126527849|NCT01880424|455223449|FG001|Overall Study|Lack of Efficacy|4|||
126527850|NCT01880424|455223448|FG000|Overall Study|Lost to Follow-up|3|||
126527851|NCT01880424|455223449|FG001|Overall Study|Lost to Follow-up|2|||
126527852|NCT01880424|455223448|FG000|Overall Study|Protocol Violation|11|||
126527853|NCT01880424|455223449|FG001|Overall Study|Protocol Violation|13|||
126527854|NCT01880424|455223448|FG000|Overall Study|Withdrawal by Subject|10|||
126527855|NCT01880424|455223449|FG001|Overall Study|Withdrawal by Subject|30|||
126527856|NCT01880424|455223448|FG000|Overall Study|Other|1|||
126527857|NCT01880424|455223449|FG001|Overall Study|Other|0|||
126527858|NCT00907153|455223450|FG000|Overall Study|Lost to Follow-up|1|||
126527859|NCT00907153|455223451|FG001|Overall Study|Lost to Follow-up|1|||
126527860|NCT00907153|455223450|FG000|Overall Study|Withdrawal by Subject|1|||
126527861|NCT00907153|455223451|FG001|Overall Study|Withdrawal by Subject|3|||
126527862|NCT03147248|455223452|FG000|Overall Study|Adverse Event|0|||
126527863|NCT03147248|455223453|FG001|Overall Study|Adverse Event|2|||
126527864|NCT03147248|455223454|FG002|Overall Study|Adverse Event|2|||
126527865|NCT03147248|455223455|FG003|Overall Study|Adverse Event|2|||
126527866|NCT03147248|455223456|FG004|Overall Study|Adverse Event|6|||
126527867|NCT03147248|455223457|FG005|Overall Study|Adverse Event|11|||
126527868|NCT03147248|455223452|FG000|Overall Study|Disease progression|1|||
126527869|NCT03147248|455223453|FG001|Overall Study|Disease progression|0|||
126527870|NCT03147248|455223454|FG002|Overall Study|Disease progression|0|||
126527871|NCT03147248|455223455|FG003|Overall Study|Disease progression|0|||
126527872|NCT03147248|455223456|FG004|Overall Study|Disease progression|0|||
126527873|NCT03147248|455223457|FG005|Overall Study|Disease progression|2|||
126527874|NCT03147248|455223452|FG000|Overall Study|Withdrawal by Subject|0|||
126527875|NCT03147248|455223453|FG001|Overall Study|Withdrawal by Subject|0|||
126527876|NCT03147248|455223454|FG002|Overall Study|Withdrawal by Subject|0|||
126527877|NCT03147248|455223455|FG003|Overall Study|Withdrawal by Subject|0|||
126527878|NCT03147248|455223456|FG004|Overall Study|Withdrawal by Subject|12|||
126527879|NCT03147248|455223457|FG005|Overall Study|Withdrawal by Subject|9|||
126527880|NCT03147248|455223452|FG000|Overall Study|Protocol Violation|0|||
126527881|NCT03147248|455223453|FG001|Overall Study|Protocol Violation|0|||
126527882|NCT03147248|455223454|FG002|Overall Study|Protocol Violation|0|||
126527883|NCT03147248|455223455|FG003|Overall Study|Protocol Violation|0|||
126527884|NCT03147248|455223456|FG004|Overall Study|Protocol Violation|2|||
126527885|NCT03147248|455223457|FG005|Overall Study|Protocol Violation|0|||
126527886|NCT03147248|455223452|FG000|Overall Study|Lost to Follow-up|0|||
126527887|NCT03147248|455223453|FG001|Overall Study|Lost to Follow-up|0|||
126527888|NCT03147248|455223454|FG002|Overall Study|Lost to Follow-up|0|||
126527889|NCT03147248|455223455|FG003|Overall Study|Lost to Follow-up|0|||
126527890|NCT03147248|455223456|FG004|Overall Study|Lost to Follow-up|2|||
126527891|NCT03147248|455223457|FG005|Overall Study|Lost to Follow-up|0|||
126527892|NCT03147248|455223452|FG000|Overall Study|Pregnancy|0|||
126527893|NCT03147248|455223453|FG001|Overall Study|Pregnancy|0|||
126527894|NCT03147248|455223454|FG002|Overall Study|Pregnancy|0|||
126527895|NCT03147248|455223455|FG003|Overall Study|Pregnancy|0|||
126527896|NCT03147248|455223456|FG004|Overall Study|Pregnancy|1|||
126527897|NCT03147248|455223457|FG005|Overall Study|Pregnancy|0|||
126527898|NCT03147248|455223452|FG000|Overall Study|Death|0|||
126527899|NCT03147248|455223453|FG001|Overall Study|Death|0|||
126527900|NCT03147248|455223454|FG002|Overall Study|Death|0|||
126527901|NCT03147248|455223455|FG003|Overall Study|Death|0|||
126527902|NCT03147248|455223456|FG004|Overall Study|Death|0|||
126527903|NCT03147248|455223457|FG005|Overall Study|Death|4|||
126527904|NCT03147248|455223452|FG000|Overall Study|Physician Decision|0|||
126527905|NCT03147248|455223453|FG001|Overall Study|Physician Decision|0|||
126527906|NCT03147248|455223454|FG002|Overall Study|Physician Decision|0|||
126527907|NCT03147248|455223455|FG003|Overall Study|Physician Decision|0|||
126527908|NCT03147248|455223456|FG004|Overall Study|Physician Decision|2|||
126527909|NCT03147248|455223457|FG005|Overall Study|Physician Decision|4|||
126527910|NCT03147248|455223452|FG000|Overall Study|Prolonged Dosing Interval|0|||
126527911|NCT03147248|455223453|FG001|Overall Study|Prolonged Dosing Interval|0|||
126527912|NCT03147248|455223454|FG002|Overall Study|Prolonged Dosing Interval|0|||
126527913|NCT03147248|455223455|FG003|Overall Study|Prolonged Dosing Interval|0|||
126527914|NCT03147248|455223456|FG004|Overall Study|Prolonged Dosing Interval|1|||
126527915|NCT03147248|455223457|FG005|Overall Study|Prolonged Dosing Interval|1|||
126527916|NCT00448539|455223462|FG000|Overall Study|Medication non-compliance|4|||
126527917|NCT00448539|455223463|FG001|Overall Study|Medication non-compliance|1|||
126527918|NCT00448539|455223462|FG000|Overall Study|Protocol Violation|1|||
126527919|NCT00448539|455223463|FG001|Overall Study|Protocol Violation|0|||
126527920|NCT00448539|455223462|FG000|Overall Study|Request of the investigator or sponsor|67|||
126527921|NCT00448539|455223463|FG001|Overall Study|Request of the investigator or sponsor|54|||
126527922|NCT00448539|455223462|FG000|Overall Study|Withdrawal by Subject|20|||
126527923|NCT00448539|455223463|FG001|Overall Study|Withdrawal by Subject|24|||
126527924|NCT00448539|455223462|FG000|Overall Study|Diary non-compliance|1|||
126527925|NCT00448539|455223463|FG001|Overall Study|Diary non-compliance|0|||
126527926|NCT00448539|455223462|FG000|Overall Study|Adverse Event|9|||
126527927|NCT00448539|455223463|FG001|Overall Study|Adverse Event|26|||
126527928|NCT00448539|455223462|FG000|Overall Study|Lack of Efficacy|27|||
126527929|NCT00448539|455223463|FG001|Overall Study|Lack of Efficacy|40|||
126728500|NCT00438399|455954275|FG005|Overall Study|Adverse Event|1|||
126728501|NCT00438399|455954270|FG000|Overall Study|Withdrawal by Subject|5|||
126728502|NCT00438399|455954271|FG001|Overall Study|Withdrawal by Subject|6|||
126728503|NCT00438399|455954272|FG002|Overall Study|Withdrawal by Subject|3|||
126728504|NCT00438399|455954273|FG003|Overall Study|Withdrawal by Subject|2|||
126728505|NCT00438399|455954274|FG004|Overall Study|Withdrawal by Subject|2|||
126728506|NCT00438399|455954275|FG005|Overall Study|Withdrawal by Subject|2|||
126728507|NCT00438399|455954270|FG000|Overall Study|Protocol Violation|0|||
126728508|NCT00438399|455954271|FG001|Overall Study|Protocol Violation|0|||
126728509|NCT00438399|455954272|FG002|Overall Study|Protocol Violation|1|||
126728510|NCT00438399|455954273|FG003|Overall Study|Protocol Violation|0|||
126728511|NCT00438399|455954274|FG004|Overall Study|Protocol Violation|0|||
126728512|NCT00438399|455954275|FG005|Overall Study|Protocol Violation|1|||
126728513|NCT00438399|455954270|FG000|Overall Study|Subje stopped study|0|||
126728514|NCT00438399|455954271|FG001|Overall Study|Subje stopped study|0|||
126728515|NCT00438399|455954272|FG002|Overall Study|Subje stopped study|1|||
126728516|NCT00438399|455954273|FG003|Overall Study|Subje stopped study|0|||
126728517|NCT00438399|455954274|FG004|Overall Study|Subje stopped study|0|||
126728518|NCT00438399|455954275|FG005|Overall Study|Subje stopped study|0|||
126728519|NCT00438399|455954270|FG000|Overall Study|Pregnancy|0|||
126728520|NCT00438399|455954271|FG001|Overall Study|Pregnancy|0|||
126728521|NCT00438399|455954272|FG002|Overall Study|Pregnancy|0|||
126728522|NCT00438399|455954273|FG003|Overall Study|Pregnancy|0|||
126728523|NCT00438399|455954274|FG004|Overall Study|Pregnancy|0|||
126728524|NCT00438399|455954275|FG005|Overall Study|Pregnancy|1|||
126579335|NCT02590432|455417372|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
126579336|NCT02590432|455417373|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
126579337|NCT02590432|455417365|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126579338|NCT02590432|455417366|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126579339|NCT02590432|455417367|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126579340|NCT02590432|455417368|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126579341|NCT02590432|455417369|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126579342|NCT02590432|455417370|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126579343|NCT02590432|455417371|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126579344|NCT02590432|455417372|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
126579345|NCT02590432|455417373|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
126579346|NCT04788641|455417374|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
126579347|NCT04788641|455417375|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
126579348|NCT04788641|455417376|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
126579349|NCT04788641|455417377|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
126579350|NCT04788641|455417374|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
126579351|NCT04788641|455417375|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
126579352|NCT04788641|455417376|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
126579353|NCT04788641|455417377|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
126579354|NCT04788641|455417374|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
126579355|NCT04788641|455417375|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
126579356|NCT04788641|455417376|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
126579357|NCT04788641|455417377|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
126579358|NCT03283371|455417378|FG000|Placebo-controlled|Adverse Event|1|||
126579359|NCT03283371|455417379|FG001|Placebo-controlled|Adverse Event|1|||
126579360|NCT03283371|455417380|FG002|Placebo-controlled|Adverse Event|0|||
126728525|NCT00438399|455954270|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
126728526|NCT00438399|455954271|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
126728527|NCT00438399|455954272|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
126728528|NCT00438399|455954273|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
126728529|NCT00438399|455954274|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
126728530|NCT00438399|455954275|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
126728531|NCT00632541|455954278|FG000|Overall Study|Adverse Event|7|||
126728532|NCT05294211|455954279|FG000|Overall Study|Withdrawal by Subject|3|||
126728533|NCT05294211|455954279|FG000|Overall Study|Physician Decision|2|||
126579361|NCT03283371|455417381|FG003|Placebo-controlled|Adverse Event|0|||
126579362|NCT03283371|455417378|FG000|Placebo-controlled|Lack of Efficacy|1|||
126728534|NCT05294211|455954279|FG000|Overall Study|Progressed to active labor|1|||
126728535|NCT05294211|455954279|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
126728536|NCT05294211|455954279|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
126728537|NCT01842607|455954281|FG000|Overall Study|Adverse Event|11|||
126728538|NCT01842607|455954281|FG000|Overall Study|Lack of Efficacy|19|||
126728539|NCT01842607|455954281|FG000|Overall Study|Protocol Violation|8|||
126579363|NCT03283371|455417379|FG001|Placebo-controlled|Lack of Efficacy|0|||
126728540|NCT01842607|455954281|FG000|Overall Study|Protocol defined stopping criteria|2|||
126728541|NCT01842607|455954281|FG000|Overall Study|Lost to Follow-up|3|||
126527930|NCT00448539|455223462|FG000|Overall Study|Miscellaneous|2|||
126527931|NCT00448539|455223463|FG001|Overall Study|Miscellaneous|1|||
126527932|NCT00448539|455223462|FG000|Overall Study|Change of meds|2|||
126527933|NCT00448539|455223463|FG001|Overall Study|Change of meds|3|||
126527934|NCT00448539|455223462|FG000|Overall Study|Lost to Follow-up|1|||
126527935|NCT00448539|455223463|FG001|Overall Study|Lost to Follow-up|3|||
126527936|NCT02103439|455223464|FG000|Overall Study|Adverse Event|0|||
126527937|NCT02103439|455223465|FG001|Overall Study|Adverse Event|2|||
126527938|NCT02103439|455223464|FG000|Overall Study|Withdrawal by Subject|3|||
126527939|NCT02103439|455223465|FG001|Overall Study|Withdrawal by Subject|1|||
126527940|NCT04955639|455223467|FG000|Overall Study|Withdrawal by Subject|2|||
126527941|NCT04955639|455223468|FG001|Overall Study|Withdrawal by Subject|2|||
126527942|NCT04955639|455223467|FG000|Overall Study|Week 26 survey not completed|2|||
126527943|NCT04955639|455223468|FG001|Overall Study|Week 26 survey not completed|2|||
126527944|NCT04447404|455223469|FG000|Overall Study|Death|2|||
126527945|NCT04447404|455223470|FG001|Overall Study|Death|0|||
126579364|NCT03283371|455417380|FG002|Placebo-controlled|Lack of Efficacy|0|||
126579365|NCT03283371|455417381|FG003|Placebo-controlled|Lack of Efficacy|0|||
126579366|NCT03283371|455417378|FG000|Placebo-controlled|Withdrawal by Subject|1|||
126579367|NCT03283371|455417379|FG001|Placebo-controlled|Withdrawal by Subject|1|||
126579368|NCT03283371|455417380|FG002|Placebo-controlled|Withdrawal by Subject|0|||
126579369|NCT03283371|455417381|FG003|Placebo-controlled|Withdrawal by Subject|0|||
126579370|NCT03283371|455417378|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
126579371|NCT03283371|455417379|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
126579372|NCT03283371|455417380|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
126579373|NCT03283371|455417381|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
126579374|NCT03283371|455417378|FG000|Open-label Phase|Adverse Event|0|||
126579375|NCT03283371|455417379|FG001|Open-label Phase|Adverse Event|0|||
126579376|NCT03283371|455417380|FG002|Open-label Phase|Adverse Event|2|||
126579377|NCT03283371|455417381|FG003|Open-label Phase|Adverse Event|0|||
126579378|NCT03283371|455417378|FG000|Open-label Phase|Withdrawal by Subject|0|||
126579379|NCT03283371|455417379|FG001|Open-label Phase|Withdrawal by Subject|0|||
126579380|NCT03283371|455417380|FG002|Open-label Phase|Withdrawal by Subject|1|||
126579381|NCT03283371|455417381|FG003|Open-label Phase|Withdrawal by Subject|0|||
126579382|NCT03283371|455417378|FG000|Open-label Phase|Other|0|||
126579383|NCT03283371|455417379|FG001|Open-label Phase|Other|0|||
126579384|NCT03283371|455417380|FG002|Open-label Phase|Other|1|||
126728542|NCT01842607|455954281|FG000|Overall Study|Physician Decision|9|||
126728543|NCT01842607|455954281|FG000|Overall Study|Withdrawal by Subject|14|||
126728544|NCT01179347|455956788|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
126728545|NCT01179347|455956789|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
126728546|NCT01179347|455956788|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
126728547|NCT01179347|455956789|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
126728548|NCT01179347|455956788|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
126728549|NCT01179347|455956789|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
126728550|NCT01179347|455956788|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
126728551|NCT01179347|455956789|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
126728552|NCT01179347|455956788|FG000|Double-blind Period (12 Weeks)|Other|2|||
126728553|NCT01179347|455956789|FG001|Double-blind Period (12 Weeks)|Other|4|||
126728554|NCT01179347|455956788|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
126728555|NCT01179347|455956789|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
126728556|NCT01179347|455956788|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
126527946|NCT00321854|455223471|FG000|Overall Study|Adverse Event|41|||
126527947|NCT00321854|455223472|FG001|Overall Study|Adverse Event|43|||
126527948|NCT00321854|455223471|FG000|Overall Study|Lack of Efficacy|9|||
126527949|NCT00321854|455223472|FG001|Overall Study|Lack of Efficacy|14|||
126527950|NCT00321854|455223471|FG000|Overall Study|Protocol Violation|6|||
126527951|NCT00321854|455223472|FG001|Overall Study|Protocol Violation|5|||
126579385|NCT03283371|455417381|FG003|Open-label Phase|Other|1|||
126579386|NCT02462759|455417382|FG000|Part 1: Double Blind|Death|1|||
126579387|NCT02462759|455417383|FG001|Part 1: Double Blind|Death|0|||
126579388|NCT02462759|455417384|FG002|Part 1: Double Blind|Death|0|||
126579389|NCT02740231|455417385|FG000|Overall Study|Withdrawal by Subject|1|||
126728557|NCT01179347|455956789|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
126728558|NCT01179347|455956788|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
126527952|NCT00321854|455223471|FG000|Overall Study|Lost to Follow-up|0|||
126527953|NCT00321854|455223472|FG001|Overall Study|Lost to Follow-up|2|||
126527954|NCT00321854|455223471|FG000|Overall Study|Withdrawal by Subject|6|||
126728559|NCT01179347|455956789|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
126728560|NCT01179347|455956788|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
126579390|NCT02740231|455417386|FG001|Overall Study|Withdrawal by Subject|1|||
126579391|NCT02740231|455417387|FG002|Overall Study|Withdrawal by Subject|1|||
126579392|NCT02740231|455417388|FG003|Overall Study|Withdrawal by Subject|0|||
126579393|NCT02740231|455417385|FG000|Overall Study|Lack of Efficacy|0|||
126579394|NCT02740231|455417386|FG001|Overall Study|Lack of Efficacy|1|||
126579395|NCT02740231|455417387|FG002|Overall Study|Lack of Efficacy|0|||
126527955|NCT00321854|455223472|FG001|Overall Study|Withdrawal by Subject|17|||
126527956|NCT00321854|455223471|FG000|Overall Study|Other|1|||
126527957|NCT00321854|455223472|FG001|Overall Study|Other|1|||
126527958|NCT03204279|455223473|FG000|Overall Study|Withdrawal by Subject|0|||
126527959|NCT03204279|455223474|FG001|Overall Study|Withdrawal by Subject|1|||
126527960|NCT02277106|455223475|FG000|Stage 2|Adverse Event|0|||
126527961|NCT02277106|455223476|FG001|Stage 2|Adverse Event|0|||
126527962|NCT02277106|455223477|FG002|Stage 2|Adverse Event|1|||
126527963|NCT02384759|455223479|FG000|Overall Study|Patients not treated|3|||
126527964|NCT02384759|455223480|FG001|Overall Study|Patients not treated|2|||
126527965|NCT03043664|455223481|FG000|Overall Study|Lost to Follow-up|1|||
126527966|NCT03759873|455223489|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
126527967|NCT03759873|455223490|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
126527968|NCT03759873|455223491|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
126527969|NCT03759873|455223492|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
126527970|NCT03759873|455223489|FG000|Overall Study|Moved outside eligible area|0|||
126527971|NCT03759873|455223490|FG001|Overall Study|Moved outside eligible area|2|||
126527972|NCT03759873|455223491|FG002|Overall Study|Moved outside eligible area|0|||
126527973|NCT03759873|455223492|FG003|Overall Study|Moved outside eligible area|0|||
126527974|NCT03759873|455223489|FG000|Overall Study|Withdrawal by Subject|0|||
126527975|NCT03759873|455223490|FG001|Overall Study|Withdrawal by Subject|0|||
126527976|NCT03759873|455223491|FG002|Overall Study|Withdrawal by Subject|1|||
126527977|NCT03759873|455223492|FG003|Overall Study|Withdrawal by Subject|0|||
126728561|NCT01179347|455956789|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
126728562|NCT01179347|455956788|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
126728563|NCT01179347|455956789|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
126728564|NCT01179347|455956788|FG000|Open-label Period (12 Weeks)|Other|7|||
126728565|NCT01179347|455956789|FG001|Open-label Period (12 Weeks)|Other|4|||
126728566|NCT00369967|455956790|FG000|Overall Study|Lost to Follow-up|23|||
126728567|NCT00369967|455956791|FG001|Overall Study|Lost to Follow-up|12|||
126728568|NCT00830115|455956794|FG000|Overall Study|Adverse Event|2|||
126728569|NCT00830115|455956794|FG000|Overall Study|Improvement/recovery|1|||
126728570|NCT01207388|455956796|FG000|Overall Study|Death|67|||
126728571|NCT01207388|455956796|FG000|Overall Study|Withdrawal by Subject|1|||
126728572|NCT01885078|455956797|FG000|Treatment Period|Adverse Event|52|||
126728573|NCT01885078|455956798|FG001|Treatment Period|Adverse Event|136|||
126728574|NCT01885078|455956799|FG002|Treatment Period|Adverse Event|30|||
126728575|NCT01885078|455956800|FG003|Treatment Period|Adverse Event|73|||
126728576|NCT01885078|455956801|FG004|Treatment Period|Adverse Event|17|||
126728577|NCT01885078|455956802|FG005|Treatment Period|Adverse Event|72|||
126728578|NCT01885078|455956803|FG006|Treatment Period|Adverse Event|24|||
126728579|NCT01885078|455956804|FG007|Treatment Period|Adverse Event|5|||
126728580|NCT01885078|455956805|FG008|Treatment Period|Adverse Event|0|||
126728581|NCT01885078|455956806|FG009|Treatment Period|Adverse Event|0|||
126527978|NCT03579563|455223493|FG000|Overall Study|Lost to Follow-up|0|||
126527979|NCT03579563|455223494|FG001|Overall Study|Lost to Follow-up|0|||
126527980|NCT03579563|455223495|FG002|Overall Study|Lost to Follow-up|0|||
126527981|NCT03579563|455223496|FG003|Overall Study|Lost to Follow-up|0|||
126527982|NCT03579563|455223497|FG004|Overall Study|Lost to Follow-up|1|||
126527983|NCT03579563|455223498|FG005|Overall Study|Lost to Follow-up|0|||
126527984|NCT03579563|455223493|FG000|Overall Study|Lack of Efficacy|1|||
126527985|NCT03579563|455223494|FG001|Overall Study|Lack of Efficacy|1|||
126527986|NCT03579563|455223495|FG002|Overall Study|Lack of Efficacy|4|||
126527987|NCT03579563|455223496|FG003|Overall Study|Lack of Efficacy|1|||
126728582|NCT01885078|455956797|FG000|Treatment Period|Death|13|||
126527988|NCT03579563|455223497|FG004|Overall Study|Lack of Efficacy|2|||
126527989|NCT03579563|455223498|FG005|Overall Study|Lack of Efficacy|3|||
126527990|NCT03579563|455223493|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
126527991|NCT03579563|455223494|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
126527992|NCT03579563|455223495|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
126527993|NCT03579563|455223496|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
126527994|NCT03579563|455223497|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
126527995|NCT03579563|455223498|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
126527996|NCT03579563|455223493|FG000|Overall Study|Time/distance concern|0|||
126527997|NCT03579563|455223494|FG001|Overall Study|Time/distance concern|0|||
126527998|NCT03579563|455223495|FG002|Overall Study|Time/distance concern|1|||
126527999|NCT03579563|455223496|FG003|Overall Study|Time/distance concern|0|||
126528000|NCT03579563|455223497|FG004|Overall Study|Time/distance concern|0|||
126528001|NCT03579563|455223498|FG005|Overall Study|Time/distance concern|1|||
126728583|NCT01885078|455956798|FG001|Treatment Period|Death|33|||
126728584|NCT01885078|455956799|FG002|Treatment Period|Death|5|||
126728585|NCT01885078|455956800|FG003|Treatment Period|Death|9|||
126728586|NCT01885078|455956801|FG004|Treatment Period|Death|2|||
126728587|NCT01885078|455956802|FG005|Treatment Period|Death|10|||
126728588|NCT01885078|455956803|FG006|Treatment Period|Death|3|||
126728589|NCT01885078|455956804|FG007|Treatment Period|Death|2|||
126728590|NCT01885078|455956805|FG008|Treatment Period|Death|0|||
126728591|NCT01885078|455956806|FG009|Treatment Period|Death|0|||
126728592|NCT01885078|455956797|FG000|Treatment Period|Lack of Efficacy|12|||
126528002|NCT03579563|455223493|FG000|Overall Study|COVID shutdown|2|||
126528003|NCT03579563|455223494|FG001|Overall Study|COVID shutdown|3|||
126528004|NCT03579563|455223495|FG002|Overall Study|COVID shutdown|4|||
126528005|NCT03579563|455223496|FG003|Overall Study|COVID shutdown|3|||
126528006|NCT03579563|455223497|FG004|Overall Study|COVID shutdown|1|||
126528007|NCT03579563|455223498|FG005|Overall Study|COVID shutdown|2|||
126528008|NCT03579563|455223493|FG000|Overall Study|Protocol administration error|1|||
126528009|NCT03579563|455223494|FG001|Overall Study|Protocol administration error|0|||
126528010|NCT03579563|455223495|FG002|Overall Study|Protocol administration error|1|||
126528011|NCT03579563|455223496|FG003|Overall Study|Protocol administration error|0|||
126528012|NCT03579563|455223497|FG004|Overall Study|Protocol administration error|1|||
126528013|NCT03579563|455223498|FG005|Overall Study|Protocol administration error|5|||
126528014|NCT03526250|455223499|FG000|Overall Study|Adverse Event|4|||
126528015|NCT03526250|455223499|FG000|Overall Study|Progressive Disease|16|||
126528016|NCT03526250|455223499|FG000|Overall Study|No Treatment|3|||
126528017|NCT02647359|455223500|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
126528018|NCT02647359|455223501|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
126528019|NCT02647359|455223500|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
126528020|NCT02647359|455223501|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
126528021|NCT02647359|455223500|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
126528022|NCT02647359|455223501|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
126528023|NCT02647359|455223500|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
126528024|NCT02647359|455223501|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
126528025|NCT02647359|455223500|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
126528026|NCT02647359|455223501|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
126528027|NCT02647359|455223500|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
126528028|NCT02647359|455223501|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
126528029|NCT01618864|455223502|FG000|Overall Study|Withdrawal by Subject|2|||
126528030|NCT01618864|455223502|FG000|Overall Study|Lost to Follow-up|2|||
126528031|NCT02513563|455223503|FG000|Overall Study|Death|4|||
126528032|NCT02513563|455223503|FG000|Overall Study|Withdrawal by Subject|4|||
126528033|NCT02513563|455223503|FG000|Overall Study|Physician Decision|1|||
126528034|NCT04818346|455223512|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
126528035|NCT04818346|455223513|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
126528036|NCT04818346|455223514|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
126528037|NCT04818346|455223515|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
126528038|NCT04818346|455223512|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
126528039|NCT04818346|455223513|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
126528040|NCT04818346|455223514|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
126528041|NCT04818346|455223515|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
126528042|NCT04818346|455223512|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
126528043|NCT04818346|455223513|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
126528044|NCT04818346|455223514|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
126528045|NCT04818346|455223515|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
126528046|NCT04818346|455223512|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
126528047|NCT04818346|455223513|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
126528048|NCT04818346|455223514|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
126528049|NCT04818346|455223515|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
126528050|NCT04818346|455223512|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
126528051|NCT04818346|455223513|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
126528052|NCT04818346|455223514|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
126528053|NCT04818346|455223515|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
126528054|NCT04818346|455223512|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
126528055|NCT04818346|455223513|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
126528056|NCT04818346|455223514|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
126528057|NCT04818346|455223515|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
126528058|NCT04818346|455223512|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
126528059|NCT04818346|455223513|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
126528060|NCT04818346|455223514|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
126528061|NCT04818346|455223515|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
126528062|NCT04818346|455223512|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
126528063|NCT04818346|455223513|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
126728593|NCT01885078|455956798|FG001|Treatment Period|Lack of Efficacy|33|||
126728594|NCT01885078|455956799|FG002|Treatment Period|Lack of Efficacy|10|||
126728595|NCT01885078|455956800|FG003|Treatment Period|Lack of Efficacy|23|||
126728596|NCT01885078|455956801|FG004|Treatment Period|Lack of Efficacy|24|||
126528064|NCT04818346|455223514|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
126579396|NCT02740231|455417388|FG003|Overall Study|Lack of Efficacy|4|||
126579397|NCT02740231|455417385|FG000|Overall Study|Lost to Follow-up|1|||
126579398|NCT02740231|455417386|FG001|Overall Study|Lost to Follow-up|3|||
126579399|NCT02740231|455417387|FG002|Overall Study|Lost to Follow-up|0|||
126579400|NCT02740231|455417388|FG003|Overall Study|Lost to Follow-up|3|||
126579401|NCT02740231|455417385|FG000|Overall Study|Adverse Event|0|||
126579402|NCT02740231|455417386|FG001|Overall Study|Adverse Event|1|||
126579403|NCT02740231|455417387|FG002|Overall Study|Adverse Event|0|||
126579404|NCT02740231|455417388|FG003|Overall Study|Adverse Event|1|||
126579405|NCT00243503|455417391|FG000|Overall Study|Adverse Event|11|||
126579406|NCT00243503|455417391|FG000|Overall Study|Withdrawal by Subject|1|||
126579407|NCT00243503|455417391|FG000|Overall Study|Lack of Efficacy|44|||
126579408|NCT00243503|455417391|FG000|Overall Study|Death|1|||
126579409|NCT00243503|455417391|FG000|Overall Study|Other|1|||
126579410|NCT04600752|455417396|FG000|Overall Study|Physician Decision|0|||
126579411|NCT04600752|455417397|FG001|Overall Study|Physician Decision|0|||
126579412|NCT04600752|455417398|FG002|Overall Study|Physician Decision|1|||
126728597|NCT01885078|455956802|FG005|Treatment Period|Lack of Efficacy|58|||
126528065|NCT04818346|455223515|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
126528066|NCT04818346|455223512|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
126528067|NCT04818346|455223513|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
126528068|NCT04818346|455223514|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
126528069|NCT04818346|455223515|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
126528070|NCT04818346|455223512|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
126528071|NCT04818346|455223513|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
126528072|NCT04818346|455223514|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
126528073|NCT04818346|455223515|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
126528074|NCT04818346|455223512|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
126528075|NCT04818346|455223513|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
126528076|NCT04818346|455223514|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
126528077|NCT04818346|455223515|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
126528078|NCT04818346|455223512|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
126528079|NCT04818346|455223513|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
126528080|NCT04818346|455223514|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
126528081|NCT04818346|455223515|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
126528082|NCT04818346|455223512|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
126528083|NCT04818346|455223513|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
126528084|NCT04818346|455223514|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
126528085|NCT04818346|455223515|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
126528086|NCT04818346|455223512|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
126528087|NCT04818346|455223513|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
126528088|NCT04818346|455223514|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
126528089|NCT04818346|455223515|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
126528090|NCT04818346|455223512|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
126528091|NCT04818346|455223513|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
126528092|NCT04818346|455223514|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
126528093|NCT04818346|455223515|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
126528094|NCT01672801|455223516|FG000|Overall Study|Screen Failure|0|||
126528095|NCT01672801|455223517|FG001|Overall Study|Screen Failure|1|||
126528096|NCT01362140|455223518|FG000|Overall Study|Noncompliance|1|||
126528097|NCT01362140|455223519|FG001|Overall Study|Noncompliance|0|||
126528098|NCT01362140|455223518|FG000|Overall Study|Adverse Event|2|||
126528099|NCT01362140|455223519|FG001|Overall Study|Adverse Event|2|||
126528100|NCT01362140|455223518|FG000|Overall Study|Withdrawal by Subject|3|||
126528101|NCT01362140|455223519|FG001|Overall Study|Withdrawal by Subject|3|||
126528102|NCT01362140|455223518|FG000|Overall Study|Administrative Decision|0|||
126528103|NCT01362140|455223519|FG001|Overall Study|Administrative Decision|1|||
126528104|NCT01362140|455223518|FG000|Overall Study|Death|2|||
126528105|NCT01362140|455223519|FG001|Overall Study|Death|1|||
126579413|NCT04600752|455417396|FG000|Overall Study|Adverse Event|0|||
126579414|NCT04600752|455417397|FG001|Overall Study|Adverse Event|1|||
126579415|NCT04600752|455417398|FG002|Overall Study|Adverse Event|0|||
126579416|NCT04600752|455417396|FG000|Overall Study|Withdrawal by Subject|2|||
126579417|NCT04600752|455417397|FG001|Overall Study|Withdrawal by Subject|1|||
126579418|NCT04600752|455417398|FG002|Overall Study|Withdrawal by Subject|0|||
126579419|NCT04600752|455417396|FG000|Overall Study|Lack of Efficacy|1|||
126579420|NCT04600752|455417397|FG001|Overall Study|Lack of Efficacy|0|||
126728598|NCT01885078|455956803|FG006|Treatment Period|Lack of Efficacy|9|||
126728599|NCT01885078|455956804|FG007|Treatment Period|Lack of Efficacy|5|||
126579421|NCT04600752|455417398|FG002|Overall Study|Lack of Efficacy|0|||
126579422|NCT03076515|455417399|FG000|Overall Study|DMC decision based on interim analysis|25|||
126579423|NCT03076515|455417400|FG001|Overall Study|DMC decision based on interim analysis|29|||
126579424|NCT02374307|455417401|FG000|3-months Follow-up|Lost to Follow-up|1|||
126579425|NCT02374307|455417402|FG001|3-months Follow-up|Lost to Follow-up|2|||
126579426|NCT02374307|455417401|FG000|3-months Follow-up|Withdrawal by Subject|1|||
126579427|NCT02374307|455417402|FG001|3-months Follow-up|Withdrawal by Subject|4|||
126579428|NCT02374307|455417401|FG000|3-months Follow-up|Death|1|||
126579429|NCT02374307|455417402|FG001|3-months Follow-up|Death|2|||
126579430|NCT02374307|455417401|FG000|3-months Follow-up|Missed first follow-up|5|||
126579431|NCT02374307|455417402|FG001|3-months Follow-up|Missed first follow-up|1|||
126579432|NCT02374307|455417401|FG000|6-months Follow-up|Lost to Follow-up|1|||
126579433|NCT02374307|455417402|FG001|6-months Follow-up|Lost to Follow-up|2|||
126579434|NCT02374307|455417401|FG000|6-months Follow-up|Death|2|||
126579435|NCT02374307|455417402|FG001|6-months Follow-up|Death|1|||
126579436|NCT02374307|455417401|FG000|6-months Follow-up|Withdrawal by Subject|0|||
126579437|NCT02374307|455417402|FG001|6-months Follow-up|Withdrawal by Subject|3|||
126579438|NCT00999167|455417403|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
126579439|NCT00999167|455417404|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
126579440|NCT00999167|455417405|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
126579441|NCT00999167|455417403|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
126579442|NCT00999167|455417404|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
126579443|NCT00999167|455417405|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
126579444|NCT00999167|455417403|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
126579445|NCT00999167|455417404|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
126579446|NCT00999167|455417405|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
126579447|NCT00999167|455417403|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
126579448|NCT00999167|455417404|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
126579449|NCT00999167|455417405|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
126579450|NCT00999167|455417403|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
126579451|NCT00999167|455417404|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
126579452|NCT00999167|455417405|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
126579453|NCT00999167|455417403|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
126579454|NCT00999167|455417404|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
126579455|NCT00999167|455417405|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
126579456|NCT00999167|455417403|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
126579457|NCT00999167|455417404|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
126579458|NCT00999167|455417405|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
126579459|NCT00999167|455417403|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
126579460|NCT00999167|455417404|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
126579461|NCT00999167|455417405|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
126579462|NCT02554786|455417406|FG000|Overall Study|Subject/guardian decision|29|||
126579463|NCT02554786|455417407|FG001|Overall Study|Subject/guardian decision|17|||
126579464|NCT02554786|455417408|FG002|Overall Study|Subject/guardian decision|18|||
126579465|NCT02554786|455417409|FG003|Overall Study|Subject/guardian decision|30|||
126579466|NCT02554786|455417410|FG004|Overall Study|Subject/guardian decision|20|||
126579467|NCT02554786|455417406|FG000|Overall Study|Lost to Follow-up|4|||
126579468|NCT02554786|455417407|FG001|Overall Study|Lost to Follow-up|3|||
126579469|NCT02554786|455417408|FG002|Overall Study|Lost to Follow-up|4|||
126579470|NCT02554786|455417409|FG003|Overall Study|Lost to Follow-up|2|||
126579471|NCT02554786|455417410|FG004|Overall Study|Lost to Follow-up|2|||
126579472|NCT02554786|455417406|FG000|Overall Study|Protocol deviation|1|||
126579473|NCT02554786|455417407|FG001|Overall Study|Protocol deviation|3|||
126579474|NCT02554786|455417408|FG002|Overall Study|Protocol deviation|3|||
126579475|NCT02554786|455417409|FG003|Overall Study|Protocol deviation|4|||
126579476|NCT02554786|455417410|FG004|Overall Study|Protocol deviation|2|||
126579477|NCT02554786|455417406|FG000|Overall Study|Technical problems|1|||
126579478|NCT02554786|455417407|FG001|Overall Study|Technical problems|1|||
126579479|NCT02554786|455417408|FG002|Overall Study|Technical problems|0|||
126728600|NCT01885078|455956805|FG008|Treatment Period|Lack of Efficacy|0|||
126728601|NCT01885078|455956806|FG009|Treatment Period|Lack of Efficacy|0|||
126728602|NCT01885078|455956797|FG000|Treatment Period|Lost to Follow-up|16|||
126728603|NCT01885078|455956798|FG001|Treatment Period|Lost to Follow-up|19|||
126579480|NCT02554786|455417409|FG003|Overall Study|Technical problems|2|||
126579481|NCT02554786|455417410|FG004|Overall Study|Technical problems|1|||
126579482|NCT02554786|455417406|FG000|Overall Study|Adverse Event|0|||
126579483|NCT02554786|455417407|FG001|Overall Study|Adverse Event|0|||
126579484|NCT02554786|455417408|FG002|Overall Study|Adverse Event|0|||
126579485|NCT02554786|455417409|FG003|Overall Study|Adverse Event|0|||
126579486|NCT02554786|455417410|FG004|Overall Study|Adverse Event|2|||
126579487|NCT02554786|455417406|FG000|Overall Study|Death|0|||
126579488|NCT02554786|455417407|FG001|Overall Study|Death|0|||
126579489|NCT02554786|455417408|FG002|Overall Study|Death|0|||
126528106|NCT01362140|455223518|FG000|Overall Study|Other|1|||
126528107|NCT01362140|455223519|FG001|Overall Study|Other|1|||
126528108|NCT01362140|455223518|FG000|Overall Study|Protocol-specified Criteria|1|||
126528109|NCT01362140|455223519|FG001|Overall Study|Protocol-specified Criteria|2|||
126528110|NCT01362140|455223518|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
126528111|NCT01362140|455223519|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
126528112|NCT06476366|455223521|FG000|Overall Study|Lost to Follow-up|1|||
126528113|NCT06476366|455223522|FG001|Overall Study|Lost to Follow-up|3|||
126528114|NCT06476366|455223521|FG000|Overall Study|Adverse Event|1|||
126528115|NCT06476366|455223522|FG001|Overall Study|Adverse Event|0|||
126528116|NCT03150056|455223523|FG000|Overall Study|Withdrawal by Subject|0|||
126528117|NCT03150056|455223524|FG001|Overall Study|Withdrawal by Subject|0|||
126528118|NCT03150056|455223525|FG002|Overall Study|Withdrawal by Subject|0|||
126528119|NCT03150056|455223526|FG003|Overall Study|Withdrawal by Subject|0|||
126528120|NCT03150056|455223527|FG004|Overall Study|Withdrawal by Subject|0|||
126528121|NCT03150056|455223528|FG005|Overall Study|Withdrawal by Subject|2|||
126528122|NCT03150056|455223523|FG000|Overall Study|Study terminated by Sponsor|1|||
126528123|NCT03150056|455223524|FG001|Overall Study|Study terminated by Sponsor|3|||
126528124|NCT03150056|455223525|FG002|Overall Study|Study terminated by Sponsor|1|||
126528125|NCT03150056|455223526|FG003|Overall Study|Study terminated by Sponsor|1|||
126528126|NCT03150056|455223527|FG004|Overall Study|Study terminated by Sponsor|5|||
126528127|NCT03150056|455223528|FG005|Overall Study|Study terminated by Sponsor|6|||
126528128|NCT03150056|455223523|FG000|Overall Study|Death|9|||
126528129|NCT03150056|455223524|FG001|Overall Study|Death|2|||
126528130|NCT03150056|455223525|FG002|Overall Study|Death|2|||
126528131|NCT03150056|455223526|FG003|Overall Study|Death|7|||
126528132|NCT03150056|455223527|FG004|Overall Study|Death|8|||
126528133|NCT03150056|455223528|FG005|Overall Study|Death|10|||
126528134|NCT00965523|455223529|FG000|Study 221|Progressive Disease|4|||
126528135|NCT00965523|455223529|FG000|Study 221|Physician Decision|3|||
126528136|NCT00965523|455223529|FG000|Study 224|Progressive Disease|5|||
126528137|NCT00965523|455223529|FG000|Study 224|Physician Decision|1|||
126528138|NCT00700401|455223535|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
126528139|NCT00700401|455223535|FG000|Overall Study|Adverse Event|5|||
126528140|NCT00700401|455223535|FG000|Overall Study|Refused Treatment|2|||
126528141|NCT00700401|455223535|FG000|Overall Study|Lost to Follow-up|1|||
126528142|NCT00700401|455223535|FG000|Overall Study|Treatment never started|1|||
126528143|NCT00700401|455223535|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
126528144|NCT00700401|455223535|FG000|Overall Study|Withdrawal by Subject|2|||
126528145|NCT01650259|455223536|FG000|Overall Study|Improvement|105|||
126528146|NCT01650259|455223537|FG001|Overall Study|Improvement|0|||
126528147|NCT01650259|455223536|FG000|Overall Study|Adverse Event|127|||
126528148|NCT01650259|455223537|FG001|Overall Study|Adverse Event|0|||
126528149|NCT01650259|455223536|FG000|Overall Study|Lack of Efficacy|143|||
126528150|NCT01650259|455223537|FG001|Overall Study|Lack of Efficacy|0|||
126528151|NCT01650259|455223536|FG000|Overall Study|Lost to Follow-up|435|||
126528152|NCT01650259|455223537|FG001|Overall Study|Lost to Follow-up|0|||
126528153|NCT01650259|455223536|FG000|Overall Study|Patients had no visit after entry|70|||
126528154|NCT01650259|455223537|FG001|Overall Study|Patients had no visit after entry|0|||
126528155|NCT01650259|455223536|FG000|Overall Study|CRF not collected|98|||
126528156|NCT01650259|455223537|FG001|Overall Study|CRF not collected|82|||
126528157|NCT01650259|455223536|FG000|Overall Study|Not treated|1|||
126528158|NCT01650259|455223537|FG001|Overall Study|Not treated|7|||
126528159|NCT01650259|455223536|FG000|Overall Study|Other than listed|64|||
126528160|NCT01650259|455223537|FG001|Overall Study|Other than listed|146|||
126528161|NCT00092131|455223538|FG000|Treatment Period I|Adverse Event|1|||
126528162|NCT00092131|455223539|FG001|Treatment Period I|Adverse Event|0|||
126528163|NCT00092131|455223538|FG000|Treatment Period II|Adverse Event|0|||
126528164|NCT00092131|455223539|FG001|Treatment Period II|Adverse Event|1|||
126528165|NCT02576067|455223540|FG000|Overall Study|Death|0|||
126528166|NCT02576067|455223541|FG001|Overall Study|Death|1|||
126528167|NCT02576067|455223540|FG000|Overall Study|Lack of Efficacy|1|||
126528168|NCT02576067|455223541|FG001|Overall Study|Lack of Efficacy|0|||
126528169|NCT02576067|455223540|FG000|Overall Study|Lost to Follow-up|11|||
126528170|NCT02576067|455223541|FG001|Overall Study|Lost to Follow-up|0|||
126528171|NCT02576067|455223540|FG000|Overall Study|Withdrawal by Subject|11|||
126528172|NCT02576067|455223541|FG001|Overall Study|Withdrawal by Subject|2|||
126528173|NCT02576067|455223540|FG000|Overall Study|study closure of main CIRT trial)|0|||
126528174|NCT02576067|455223541|FG001|Overall Study|study closure of main CIRT trial)|8|||
126528175|NCT02576067|455223540|FG000|Overall Study|not randomized, failed run-in|7|||
126528176|NCT02576067|455223541|FG001|Overall Study|not randomized, failed run-in|0|||
126528177|NCT02576067|455223540|FG000|Overall Study|screen failure/ re-enrolled|0|||
126528178|NCT02576067|455223541|FG001|Overall Study|screen failure/ re-enrolled|25|||
126528179|NCT02576067|455223540|FG000|Overall Study|Physician Decision|4|||
126528180|NCT02576067|455223541|FG001|Overall Study|Physician Decision|0|||
126528181|NCT02372409|455223542|FG000|Overall Study|Lost to Follow-up|1|||
126528182|NCT02372409|455223543|FG001|Overall Study|Lost to Follow-up|0|||
126528183|NCT02372409|455223542|FG000|Overall Study|Disease progression|1|||
126528184|NCT02372409|455223543|FG001|Overall Study|Disease progression|1|||
126528185|NCT03346759|455223545|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
126528186|NCT03346759|455223546|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
126528187|NCT03346759|455223545|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
126528188|NCT03346759|455223546|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
126528189|NCT03346759|455223545|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
126528190|NCT03346759|455223546|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
126528191|NCT01128413|455223550|FG000|Overall Study|Withdrawal by Subject|1|||
126528192|NCT01128413|455223551|FG001|Overall Study|Withdrawal by Subject|0|||
126528193|NCT01128413|455223550|FG000|Overall Study|NICOM Monitor Problems|2|||
126528194|NCT01128413|455223551|FG001|Overall Study|NICOM Monitor Problems|1|||
126528195|NCT01128413|455223550|FG000|Overall Study|Pt made DNR|1|||
126528196|NCT01128413|455223551|FG001|Overall Study|Pt made DNR|0|||
126528197|NCT00722761|455223552|FG000|Overall Study|Lost to Follow-up|1|||
126528198|NCT00722761|455223553|FG001|Overall Study|Lost to Follow-up|4|||
126528199|NCT00722761|455223552|FG000|Overall Study|Withdrawal by Subject|5|||
126528200|NCT00722761|455223553|FG001|Overall Study|Withdrawal by Subject|2|||
126528201|NCT02075593|455223555|FG000|Overall Study|Withdrawal by Subject|1|||
126528202|NCT02010060|455223557|FG000|Overall Study|Lost to Follow-up|1|||
126528203|NCT02010060|455223558|FG001|Overall Study|Lost to Follow-up|2|||
126528204|NCT02010060|455223559|FG002|Overall Study|Lost to Follow-up|2|||
126528205|NCT02010060|455223557|FG000|Overall Study|Injury|0|||
126528206|NCT02010060|455223558|FG001|Overall Study|Injury|1|||
126528207|NCT02010060|455223559|FG002|Overall Study|Injury|0|||
126528208|NCT05819749|455223560|FG000|Overall Study|Lost to Follow-up|1|||
126528209|NCT01369342|455225494|FG000|Overall Study|Withdrawal by Subject|7|||
126528210|NCT01369342|455225495|FG001|Overall Study|Withdrawal by Subject|7|||
126528211|NCT01369342|455225496|FG002|Overall Study|Withdrawal by Subject|2|||
126528212|NCT01369342|455225494|FG000|Overall Study|Lost to Follow-up|5|||
126528213|NCT01369342|455225495|FG001|Overall Study|Lost to Follow-up|2|||
126528214|NCT01369342|455225496|FG002|Overall Study|Lost to Follow-up|1|||
126528215|NCT01369342|455225494|FG000|Overall Study|Not Treated|1|||
126528216|NCT01369342|455225495|FG001|Overall Study|Not Treated|0|||
126528217|NCT01369342|455225496|FG002|Overall Study|Not Treated|0|||
126528218|NCT02566031|455225497|FG000|Overall Study|Patient/guardian decision|14|||
126528219|NCT02566031|455225498|FG001|Overall Study|Patient/guardian decision|7|||
126528220|NCT02566031|455225497|FG000|Overall Study|Protocol deviation|2|||
126528221|NCT02566031|455225498|FG001|Overall Study|Protocol deviation|3|||
126528222|NCT02566031|455225497|FG000|Overall Study|Adverse Event|3|||
126528223|NCT02566031|455225498|FG001|Overall Study|Adverse Event|1|||
126528224|NCT02566031|455225497|FG000|Overall Study|Lost to Follow-up|1|||
126528225|NCT02566031|455225498|FG001|Overall Study|Lost to Follow-up|1|||
126528226|NCT00413153|455225499|FG000|Overall Study|Withdrawal by Subject|1|||
126528227|NCT00413153|455225500|FG001|Overall Study|Withdrawal by Subject|1|||
126528228|NCT00413153|455225499|FG000|Overall Study|Adverse Event|1|||
126528229|NCT00413153|455225500|FG001|Overall Study|Adverse Event|0|||
126528230|NCT01064739|455225501|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
126528231|NCT02479412|455225504|FG000|Overall Study|Adverse Event|0|||
126528232|NCT02479412|455225505|FG001|Overall Study|Adverse Event|0|||
126528233|NCT02479412|455225506|FG002|Overall Study|Adverse Event|1|||
126528234|NCT02479412|455225507|FG003|Overall Study|Adverse Event|0|||
126528235|NCT02479412|455225508|FG004|Overall Study|Adverse Event|0|||
126528236|NCT02479412|455225509|FG005|Overall Study|Adverse Event|0|||
126528237|NCT02479412|455225510|FG006|Overall Study|Adverse Event|0|||
126528238|NCT02479412|455225511|FG007|Overall Study|Adverse Event|0|||
126528239|NCT02479412|455225512|FG008|Overall Study|Adverse Event|0|||
126528240|NCT02479412|455225504|FG000|Overall Study|Study-specific withdrawal criteria|0|||
126528241|NCT02479412|455225505|FG001|Overall Study|Study-specific withdrawal criteria|0|||
126528242|NCT02479412|455225506|FG002|Overall Study|Study-specific withdrawal criteria|1|||
126528243|NCT02479412|455225507|FG003|Overall Study|Study-specific withdrawal criteria|1|||
126528244|NCT02479412|455225508|FG004|Overall Study|Study-specific withdrawal criteria|0|||
126528245|NCT02479412|455225509|FG005|Overall Study|Study-specific withdrawal criteria|0|||
126528246|NCT02479412|455225510|FG006|Overall Study|Study-specific withdrawal criteria|0|||
126579490|NCT02554786|455417409|FG003|Overall Study|Death|1|||
126528247|NCT02479412|455225511|FG007|Overall Study|Study-specific withdrawal criteria|1|||
126528248|NCT02479412|455225512|FG008|Overall Study|Study-specific withdrawal criteria|1|||
126528249|NCT02479412|455225504|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
126528250|NCT02479412|455225505|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
126528251|NCT02479412|455225506|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
126528252|NCT02479412|455225507|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
126579491|NCT02554786|455417410|FG004|Overall Study|Death|0|||
126528253|NCT02479412|455225508|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
126528254|NCT02479412|455225509|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
126528255|NCT02479412|455225510|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
126528256|NCT02479412|455225511|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
126528257|NCT02479412|455225512|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
126528258|NCT01669629|455225514|FG000|Period 1|protocol deviation|1|||
126728604|NCT01885078|455956799|FG002|Treatment Period|Lost to Follow-up|7|||
126728605|NCT01885078|455956800|FG003|Treatment Period|Lost to Follow-up|9|||
126728606|NCT01885078|455956801|FG004|Treatment Period|Lost to Follow-up|2|||
126728607|NCT01885078|455956802|FG005|Treatment Period|Lost to Follow-up|8|||
126728608|NCT01885078|455956803|FG006|Treatment Period|Lost to Follow-up|2|||
126728609|NCT01885078|455956804|FG007|Treatment Period|Lost to Follow-up|0|||
126728610|NCT01885078|455956805|FG008|Treatment Period|Lost to Follow-up|0|||
126728611|NCT01885078|455956806|FG009|Treatment Period|Lost to Follow-up|0|||
126728612|NCT01885078|455956797|FG000|Treatment Period|Physician Decision|19|||
126728613|NCT01885078|455956798|FG001|Treatment Period|Physician Decision|21|||
126728614|NCT01885078|455956799|FG002|Treatment Period|Physician Decision|5|||
126728615|NCT01885078|455956800|FG003|Treatment Period|Physician Decision|12|||
126728616|NCT01885078|455956801|FG004|Treatment Period|Physician Decision|9|||
126728617|NCT01885078|455956802|FG005|Treatment Period|Physician Decision|24|||
126728618|NCT01885078|455956803|FG006|Treatment Period|Physician Decision|4|||
126728619|NCT01885078|455956804|FG007|Treatment Period|Physician Decision|3|||
126728620|NCT01885078|455956805|FG008|Treatment Period|Physician Decision|0|||
126728621|NCT01885078|455956806|FG009|Treatment Period|Physician Decision|0|||
126728622|NCT01885078|455956797|FG000|Treatment Period|Protocol Violation|3|||
126728623|NCT01885078|455956798|FG001|Treatment Period|Protocol Violation|5|||
126728624|NCT01885078|455956799|FG002|Treatment Period|Protocol Violation|0|||
126728625|NCT01885078|455956800|FG003|Treatment Period|Protocol Violation|3|||
126728626|NCT01885078|455956801|FG004|Treatment Period|Protocol Violation|1|||
126728627|NCT01885078|455956802|FG005|Treatment Period|Protocol Violation|6|||
126728628|NCT01885078|455956803|FG006|Treatment Period|Protocol Violation|0|||
126728629|NCT01885078|455956804|FG007|Treatment Period|Protocol Violation|0|||
126728630|NCT01885078|455956805|FG008|Treatment Period|Protocol Violation|0|||
126728631|NCT01885078|455956806|FG009|Treatment Period|Protocol Violation|0|||
126728632|NCT01885078|455956797|FG000|Treatment Period|Sponsor Decision|245|||
126528259|NCT01669629|455225515|FG001|Period 1|protocol deviation|2|||
126528260|NCT04969250|455225516|FG000|Overall Study|Protocol Violation|0|||
126528261|NCT04969250|455225517|FG001|Overall Study|Protocol Violation|2|||
126528262|NCT04969250|455225518|FG002|Overall Study|Protocol Violation|3|||
126528263|NCT04969250|455225519|FG003|Overall Study|Protocol Violation|8|||
126528264|NCT04969250|455225516|FG000|Overall Study|Withdrawal by Subject|0|||
126528265|NCT04969250|455225517|FG001|Overall Study|Withdrawal by Subject|1|||
126528266|NCT04969250|455225518|FG002|Overall Study|Withdrawal by Subject|0|||
126528267|NCT04969250|455225519|FG003|Overall Study|Withdrawal by Subject|0|||
126528268|NCT01221597|455225520|FG000|Overall Study|Adverse Event|4|||
126528269|NCT01221597|455225521|FG001|Overall Study|Adverse Event|1|||
126528270|NCT01221597|455225520|FG000|Overall Study|Withdrawal by Subject|20|||
126528271|NCT01221597|455225521|FG001|Overall Study|Withdrawal by Subject|6|||
126528272|NCT01221597|455225520|FG000|Overall Study|Lost to Follow-up|6|||
126528273|NCT01221597|455225521|FG001|Overall Study|Lost to Follow-up|5|||
126528274|NCT01221597|455225520|FG000|Overall Study|Protocol Violation|1|||
126528275|NCT01221597|455225521|FG001|Overall Study|Protocol Violation|0|||
126528276|NCT01221597|455225520|FG000|Overall Study|Other|3|||
126528277|NCT01221597|455225521|FG001|Overall Study|Other|4|||
126528278|NCT01221597|455225520|FG000|Overall Study|Death|2|||
126528279|NCT01221597|455225521|FG001|Overall Study|Death|0|||
126528280|NCT00487162|455225523|FG000|Overall Study|Adverse Event|0|||
126528281|NCT00487162|455225524|FG001|Overall Study|Adverse Event|1|||
126528282|NCT00487162|455225523|FG000|Overall Study|Physician Decision|0|||
126528283|NCT00487162|455225524|FG001|Overall Study|Physician Decision|1|||
126528284|NCT00487162|455225523|FG000|Overall Study|Withdrawal by Subject|2|||
126528285|NCT00487162|455225524|FG001|Overall Study|Withdrawal by Subject|3|||
126528286|NCT02278328|455225526|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
126528287|NCT02278328|455225527|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
126528288|NCT02278328|455225528|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
126528289|NCT02278328|455225526|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
126528290|NCT02278328|455225527|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
126528291|NCT02278328|455225528|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
126528292|NCT02278328|455225526|FG000|Neuropsych Screening|incomplete consent|0|||
126528293|NCT02278328|455225527|FG001|Neuropsych Screening|incomplete consent|0|||
126728633|NCT01885078|455956798|FG001|Treatment Period|Sponsor Decision|648|||
126728634|NCT01885078|455956799|FG002|Treatment Period|Sponsor Decision|49|||
126728635|NCT01885078|455956800|FG003|Treatment Period|Sponsor Decision|90|||
126728636|NCT01885078|455956801|FG004|Treatment Period|Sponsor Decision|20|||
126728637|NCT01885078|455956802|FG005|Treatment Period|Sponsor Decision|38|||
126728638|NCT01885078|455956803|FG006|Treatment Period|Sponsor Decision|162|||
126528294|NCT02278328|455225528|FG002|Neuropsych Screening|incomplete consent|2|||
126528295|NCT03834779|455225534|FG000|Overall Study|Death|1|||
126528296|NCT03834779|455225535|FG001|Overall Study|Death|2|||
126528297|NCT03834779|455225534|FG000|Overall Study|Lost to Follow-up|6|||
126728639|NCT01885078|455956804|FG007|Treatment Period|Sponsor Decision|3|||
126728640|NCT01885078|455956805|FG008|Treatment Period|Sponsor Decision|0|||
126528298|NCT03834779|455225535|FG001|Overall Study|Lost to Follow-up|4|||
126579492|NCT02554786|455417406|FG000|Overall Study|Non-compliance with study treatment|0|||
126579493|NCT02554786|455417407|FG001|Overall Study|Non-compliance with study treatment|1|||
126579494|NCT02554786|455417408|FG002|Overall Study|Non-compliance with study treatment|1|||
126579495|NCT02554786|455417409|FG003|Overall Study|Non-compliance with study treatment|0|||
126579496|NCT02554786|455417410|FG004|Overall Study|Non-compliance with study treatment|1|||
126579497|NCT02554786|455417406|FG000|Overall Study|Physician Decision|0|||
126579498|NCT02554786|455417407|FG001|Overall Study|Physician Decision|1|||
126579499|NCT02554786|455417408|FG002|Overall Study|Physician Decision|4|||
126579500|NCT02554786|455417409|FG003|Overall Study|Physician Decision|1|||
126579501|NCT02554786|455417410|FG004|Overall Study|Physician Decision|1|||
126579502|NCT02554786|455417406|FG000|Overall Study|Pregnancy|0|||
126579503|NCT02554786|455417407|FG001|Overall Study|Pregnancy|0|||
126579504|NCT02554786|455417408|FG002|Overall Study|Pregnancy|0|||
126579505|NCT02554786|455417409|FG003|Overall Study|Pregnancy|1|||
126579506|NCT02554786|455417410|FG004|Overall Study|Pregnancy|1|||
126579507|NCT04704284|455417411|FG000|Overall Study|Withdrawal by Subject|1|||
126579508|NCT01747486|455417415|FG000|Stage 1|Physician Decision|3|||
126579509|NCT01747486|455417416|FG001|Stage 1|Physician Decision|0|||
126579510|NCT01747486|455417415|FG000|Stage 1|Withdrawal by Subject|4|||
126579511|NCT01747486|455417416|FG001|Stage 1|Withdrawal by Subject|3|||
126579512|NCT01747486|455417415|FG000|Stage 1|Disease progression|4|||
126579513|NCT01747486|455417416|FG001|Stage 1|Disease progression|9|||
126579514|NCT01747486|455417415|FG000|Stage 1|Death|1|||
126579515|NCT01747486|455417416|FG001|Stage 1|Death|1|||
126579516|NCT01747486|455417415|FG000|Stage 2|Physician Decision|2|||
126579517|NCT01747486|455417416|FG001|Stage 2|Physician Decision|0|||
126579518|NCT01747486|455417415|FG000|Stage 2|Withdrawal by Subject|1|||
126579519|NCT01747486|455417416|FG001|Stage 2|Withdrawal by Subject|0|||
126579520|NCT01747486|455417415|FG000|Stage 2|New Cancer Therapy|3|||
126579521|NCT01747486|455417416|FG001|Stage 2|New Cancer Therapy|0|||
126579522|NCT01747486|455417415|FG000|Stage 2|Disease Progression|3|||
126579523|NCT01747486|455417416|FG001|Stage 2|Disease Progression|0|||
126579524|NCT00976495|455417417|FG000|Overall Study|Withdrawal by Subject|0|||
126579525|NCT00976495|455417418|FG001|Overall Study|Withdrawal by Subject|1|||
126579526|NCT00976495|455417419|FG002|Overall Study|Withdrawal by Subject|0|||
126579527|NCT00331136|455417420|FG000|Overall Study|Adverse Event|3|||
126579528|NCT00331136|455417421|FG001|Overall Study|Adverse Event|5|||
126579529|NCT00331136|455417422|FG002|Overall Study|Adverse Event|0|||
126579530|NCT00331136|455417423|FG003|Overall Study|Adverse Event|1|||
126579531|NCT00331136|455417420|FG000|Overall Study|Withdrawal by Subject|0|||
126579532|NCT00331136|455417421|FG001|Overall Study|Withdrawal by Subject|1|||
126579533|NCT00331136|455417422|FG002|Overall Study|Withdrawal by Subject|0|||
126579534|NCT00331136|455417423|FG003|Overall Study|Withdrawal by Subject|0|||
126579535|NCT00331136|455417420|FG000|Overall Study|Lost to Follow-up|0|||
126579536|NCT00331136|455417421|FG001|Overall Study|Lost to Follow-up|1|||
126579537|NCT00331136|455417422|FG002|Overall Study|Lost to Follow-up|0|||
126579538|NCT00331136|455417423|FG003|Overall Study|Lost to Follow-up|0|||
126579539|NCT00331136|455417420|FG000|Overall Study|Protocol Violation|1|||
126579540|NCT00331136|455417421|FG001|Overall Study|Protocol Violation|0|||
126579541|NCT00331136|455417422|FG002|Overall Study|Protocol Violation|0|||
126579542|NCT00331136|455417423|FG003|Overall Study|Protocol Violation|0|||
126579543|NCT00331136|455417420|FG000|Overall Study|Not treated|1|||
126579544|NCT00331136|455417421|FG001|Overall Study|Not treated|0|||
126579545|NCT00331136|455417422|FG002|Overall Study|Not treated|0|||
126579546|NCT00331136|455417423|FG003|Overall Study|Not treated|0|||
126579547|NCT02321514|455417424|FG000|Overall Study|Death|15|||
126579548|NCT02321514|455417424|FG000|Overall Study|Missed Visit|7|||
126579549|NCT02321514|455417424|FG000|Overall Study|Study Exit|3|||
126579550|NCT03432858|455417429|FG000|Overall Study|Protocol Violation|2|||
126579551|NCT03432858|455417430|FG001|Overall Study|Protocol Violation|1|||
126579552|NCT03432858|455417431|FG002|Overall Study|Protocol Violation|9|||
126579553|NCT03432858|455417429|FG000|Overall Study|Withdrawal by Subject|0|||
126579554|NCT03432858|455417430|FG001|Overall Study|Withdrawal by Subject|1|||
126579555|NCT03432858|455417431|FG002|Overall Study|Withdrawal by Subject|1|||
126579556|NCT03432858|455417429|FG000|Overall Study|Procedure canceled/rescheduled|0|||
126579557|NCT03432858|455417430|FG001|Overall Study|Procedure canceled/rescheduled|9|||
126579558|NCT03432858|455417431|FG002|Overall Study|Procedure canceled/rescheduled|6|||
126579559|NCT03432858|455417429|FG000|Overall Study|Required postop mobilization with splinting|0|||
126579560|NCT03432858|455417430|FG001|Overall Study|Required postop mobilization with splinting|0|||
126579561|NCT03432858|455417431|FG002|Overall Study|Required postop mobilization with splinting|1|||
126579562|NCT01044303|455417435|FG000|Overall Study|Lost to Follow-up|2|||
126579563|NCT01216176|455419449|FG000|Overall Study|Adverse Event|0|||
126579564|NCT01216176|455419450|FG001|Overall Study|Adverse Event|8|||
126579565|NCT01216176|455419451|FG002|Overall Study|Adverse Event|0|||
126579566|NCT01216176|455419449|FG000|Overall Study|Physician Decision|0|||
126579567|NCT01216176|455419450|FG001|Overall Study|Physician Decision|0|||
126579568|NCT01216176|455419451|FG002|Overall Study|Physician Decision|1|||
126579569|NCT03725722|455419454|FG000|Overall Study|Lack of Efficacy|2|||
126579570|NCT03725722|455419455|FG001|Overall Study|Lack of Efficacy|1|||
126579571|NCT03725722|455419456|FG002|Overall Study|Lack of Efficacy|2|||
126728641|NCT01885078|455956806|FG009|Treatment Period|Sponsor Decision|0|||
126528299|NCT01292928|455225536|FG000|Overall Study|Death|8|||
126528300|NCT01292928|455225536|FG000|Overall Study|Withdrawal by Subject|8|||
126528301|NCT01292928|455225536|FG000|Overall Study|Lost to Follow-up|6|||
126528302|NCT01292928|455225536|FG000|Overall Study|Physician Decision|2|||
126528303|NCT00130533|455225537|FG000|Overall Study|Withdrawal by Subject|33|||
126528304|NCT00130533|455225538|FG001|Overall Study|Withdrawal by Subject|6|||
126528305|NCT00130533|455225537|FG000|Overall Study|Adverse Event|34|||
126528306|NCT00130533|455225538|FG001|Overall Study|Adverse Event|1|||
126528307|NCT00130533|455225537|FG000|Overall Study|Disease relapse|9|||
126528308|NCT00130533|455225538|FG001|Overall Study|Disease relapse|13|||
126528309|NCT00130533|455225537|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
126528310|NCT00130533|455225538|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
126528311|NCT00130533|455225537|FG000|Overall Study|Death|4|||
126528312|NCT00130533|455225538|FG001|Overall Study|Death|2|||
126528313|NCT00130533|455225537|FG000|Overall Study|Protocol Violation|5|||
126528314|NCT00130533|455225538|FG001|Overall Study|Protocol Violation|1|||
126528315|NCT00130533|455225537|FG000|Overall Study|Lost to Follow-up|1|||
126528316|NCT00130533|455225538|FG001|Overall Study|Lost to Follow-up|1|||
126528317|NCT00130533|455225537|FG000|Overall Study|Sponsor´s decision|2|||
126528318|NCT00130533|455225538|FG001|Overall Study|Sponsor´s decision|0|||
126528319|NCT00130533|455225537|FG000|Overall Study|Second Primary Malignancy|0|||
126528320|NCT00130533|455225538|FG001|Overall Study|Second Primary Malignancy|1|||
126528321|NCT00130533|455225537|FG000|Overall Study|Other|12|||
126528322|NCT00130533|455225538|FG001|Overall Study|Other|5|||
126528323|NCT01059565|455225539|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
126528324|NCT01059565|455225540|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
126528325|NCT01059565|455225539|FG000|24-Week Randomized Phase|Adverse Event|5|||
126528326|NCT01059565|455225540|FG001|24-Week Randomized Phase|Adverse Event|0|||
126528327|NCT01059565|455225539|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
126528328|NCT01059565|455225540|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
126528329|NCT01059565|455225539|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
126528330|NCT01059565|455225540|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
126528331|NCT01059565|455225539|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
126528332|NCT01059565|455225540|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
126528333|NCT01059565|455225539|FG000|24-Week Open-Label Phase|Adverse Event|2|||
126528334|NCT01059565|455225540|FG001|24-Week Open-Label Phase|Adverse Event|0|||
126528335|NCT01059565|455225539|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
126528336|NCT01059565|455225540|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
126528337|NCT01059565|455225539|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
126528338|NCT01059565|455225540|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
126528339|NCT01059565|455225539|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
126528340|NCT01059565|455225540|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
126528341|NCT01059565|455225539|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
126528342|NCT01059565|455225540|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
126528343|NCT01059565|455225539|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
126528344|NCT01059565|455225540|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
126528345|NCT03263429|455225546|FG000|Overall Study|Withdrawal by Subject|0|||
126528346|NCT03263429|455225547|FG001|Overall Study|Withdrawal by Subject|1|||
126528347|NCT03263429|455225548|FG002|Overall Study|Withdrawal by Subject|0|||
126528348|NCT03263429|455225546|FG000|Overall Study|Follow-Up Period Completed|0|||
126528349|NCT03263429|455225547|FG001|Overall Study|Follow-Up Period Completed|2|||
126528350|NCT03263429|455225548|FG002|Overall Study|Follow-Up Period Completed|0|||
126528351|NCT03263429|455225546|FG000|Overall Study|Death|3|||
126528352|NCT03263429|455225547|FG001|Overall Study|Death|5|||
126528353|NCT03263429|455225548|FG002|Overall Study|Death|16|||
126528354|NCT03263429|455225546|FG000|Overall Study|Participant unable to return|0|||
126528355|NCT03263429|455225547|FG001|Overall Study|Participant unable to return|0|||
126528356|NCT03263429|455225548|FG002|Overall Study|Participant unable to return|1|||
126528357|NCT03263429|455225546|FG000|Overall Study|Study Closed|0|||
126528358|NCT03263429|455225547|FG001|Overall Study|Study Closed|0|||
126528359|NCT03263429|455225548|FG002|Overall Study|Study Closed|1|||
126528360|NCT01605617|455225549|FG000|First Intervention|Adverse Event|0|||
126528361|NCT01605617|455225550|FG001|First Intervention|Adverse Event|1|||
126528362|NCT01605617|455225549|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
126728642|NCT01885078|455956797|FG000|Treatment Period|Withdrawal by Subject|72|||
126728643|NCT01885078|455956798|FG001|Treatment Period|Withdrawal by Subject|132|||
126528363|NCT01605617|455225550|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
126528364|NCT01314118|455225556|FG000|Overall Study|Adverse Event|9|||
126528365|NCT01314118|455225556|FG000|Overall Study|Progressive disease|27|||
126528366|NCT01314118|455225556|FG000|Overall Study|Physician Decision|11|||
126528367|NCT01314118|455225556|FG000|Overall Study|Death|4|||
126528368|NCT01314118|455225556|FG000|Overall Study|Protocol Violation|5|||
126528369|NCT01314118|455225556|FG000|Overall Study|Withdrawal by Subject|11|||
126528370|NCT01314118|455225556|FG000|Overall Study|Other|2|||
126528371|NCT01314118|455225556|FG000|Overall Study|Ongoing|62|||
126528372|NCT05545072|455225562|FG000|Overall Study|Lost to Follow-up|1|||
126528373|NCT05545072|455225563|FG001|Overall Study|Lost to Follow-up|0|||
126528374|NCT05545072|455225562|FG000|Overall Study|Study ended prematurely due to funding|2|||
126528375|NCT05545072|455225563|FG001|Overall Study|Study ended prematurely due to funding|2|||
126528376|NCT03638141|455225564|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
126528377|NCT05585307|455225567|FG000|Overall Study|Lost to Follow-up|0|||
126528378|NCT05585307|455225568|FG001|Overall Study|Lost to Follow-up|0|||
126528379|NCT05585307|455225569|FG002|Overall Study|Lost to Follow-up|0|||
126528380|NCT05585307|455225570|FG003|Overall Study|Lost to Follow-up|0|||
126528381|NCT05585307|455225571|FG004|Overall Study|Lost to Follow-up|0|||
126528382|NCT05585307|455225572|FG005|Overall Study|Lost to Follow-up|0|||
126528383|NCT05585307|455225573|FG006|Overall Study|Lost to Follow-up|1|||
126528384|NCT05585307|455225574|FG007|Overall Study|Lost to Follow-up|0|||
126528385|NCT04420221|455225578|FG000|Overall Study|Withdrawal by Subject|0|||
126528386|NCT04420221|455225579|FG001|Overall Study|Withdrawal by Subject|0|||
126528387|NCT04420221|455225580|FG002|Overall Study|Withdrawal by Subject|0|||
126528388|NCT04420221|455225581|FG003|Overall Study|Withdrawal by Subject|0|||
126528389|NCT04420221|455225582|FG004|Overall Study|Withdrawal by Subject|0|||
126528390|NCT04420221|455225583|FG005|Overall Study|Withdrawal by Subject|20|||
126528391|NCT04420221|455225584|FG006|Overall Study|Withdrawal by Subject|5|||
126528392|NCT04420221|455225578|FG000|Overall Study|Other|0|||
126528393|NCT04420221|455225579|FG001|Overall Study|Other|0|||
126528394|NCT04420221|455225580|FG002|Overall Study|Other|0|||
126528395|NCT04420221|455225581|FG003|Overall Study|Other|0|||
126528396|NCT04420221|455225582|FG004|Overall Study|Other|0|||
126528397|NCT04420221|455225583|FG005|Overall Study|Other|1|||
126528398|NCT04420221|455225584|FG006|Overall Study|Other|1|||
126528399|NCT04420221|455225578|FG000|Overall Study|Lost to Follow-up|0|||
126528400|NCT04420221|455225579|FG001|Overall Study|Lost to Follow-up|0|||
126528401|NCT04420221|455225580|FG002|Overall Study|Lost to Follow-up|0|||
126528402|NCT04420221|455225581|FG003|Overall Study|Lost to Follow-up|0|||
126528403|NCT04420221|455225582|FG004|Overall Study|Lost to Follow-up|0|||
126528404|NCT04420221|455225583|FG005|Overall Study|Lost to Follow-up|3|||
126528405|NCT04420221|455225584|FG006|Overall Study|Lost to Follow-up|2|||
126528406|NCT04420221|455225578|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
126528407|NCT04420221|455225579|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
126528408|NCT04420221|455225580|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
126528409|NCT04420221|455225581|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
126528410|NCT04420221|455225582|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
126528411|NCT04420221|455225583|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
126528412|NCT04420221|455225584|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
126528413|NCT00511004|455225585|FG000|Overall Study|Lost to Follow-up|0|||
126528414|NCT00511004|455225586|FG001|Overall Study|Lost to Follow-up|0|||
126528415|NCT00511004|455225587|FG002|Overall Study|Lost to Follow-up|4|||
126528416|NCT00492284|455225593|FG000|Overall Study|Adverse Event|0|||
126528417|NCT00492284|455225594|FG001|Overall Study|Adverse Event|1|||
126528418|NCT00492284|455225595|FG002|Overall Study|Adverse Event|1|||
126528419|NCT00492284|455225596|FG003|Overall Study|Adverse Event|2|||
126579572|NCT03725722|455419457|FG003|Overall Study|Lack of Efficacy|0|||
126579573|NCT03725722|455419458|FG004|Overall Study|Lack of Efficacy|2|||
126579574|NCT03725722|455419454|FG000|Overall Study|Adverse Event|2|||
126579575|NCT03725722|455419455|FG001|Overall Study|Adverse Event|2|||
126579576|NCT03725722|455419456|FG002|Overall Study|Adverse Event|1|||
126579577|NCT03725722|455419457|FG003|Overall Study|Adverse Event|0|||
126579578|NCT03725722|455419458|FG004|Overall Study|Adverse Event|6|||
126579579|NCT03725722|455419454|FG000|Overall Study|Withdrawal by Subject|4|||
126579580|NCT03725722|455419455|FG001|Overall Study|Withdrawal by Subject|1|||
126528420|NCT00492284|455225593|FG000|Overall Study|Lost to Follow-up|0|||
126528421|NCT00492284|455225594|FG001|Overall Study|Lost to Follow-up|0|||
126528422|NCT00492284|455225595|FG002|Overall Study|Lost to Follow-up|3|||
126528423|NCT00492284|455225596|FG003|Overall Study|Lost to Follow-up|1|||
126528424|NCT00492284|455225593|FG000|Overall Study|Death|0|||
126528425|NCT00492284|455225594|FG001|Overall Study|Death|3|||
126528426|NCT00492284|455225595|FG002|Overall Study|Death|2|||
126528427|NCT00492284|455225596|FG003|Overall Study|Death|5|||
126528428|NCT00492284|455225593|FG000|Overall Study|Withdrawal by Subject|1|||
126528429|NCT00492284|455225594|FG001|Overall Study|Withdrawal by Subject|0|||
126579581|NCT03725722|455419456|FG002|Overall Study|Withdrawal by Subject|0|||
126579582|NCT03725722|455419457|FG003|Overall Study|Withdrawal by Subject|4|||
126528430|NCT00492284|455225595|FG002|Overall Study|Withdrawal by Subject|0|||
126528431|NCT00492284|455225596|FG003|Overall Study|Withdrawal by Subject|2|||
126528432|NCT01581281|455225598|FG000|Overall Study|Early Study Closure|15|||
126528433|NCT01581281|455225599|FG001|Overall Study|Early Study Closure|6|||
126579583|NCT03725722|455419458|FG004|Overall Study|Withdrawal by Subject|4|||
126579584|NCT03725722|455419454|FG000|Overall Study|Lost to Follow-up|3|||
126579585|NCT03725722|455419455|FG001|Overall Study|Lost to Follow-up|1|||
126777127|NCT00928252|456141285|FG000|Overall Study|Physician Decision|3|||
126728644|NCT01885078|455956799|FG002|Treatment Period|Withdrawal by Subject|25|||
126728645|NCT01885078|455956800|FG003|Treatment Period|Withdrawal by Subject|63|||
126728646|NCT01885078|455956801|FG004|Treatment Period|Withdrawal by Subject|15|||
126728647|NCT01885078|455956802|FG005|Treatment Period|Withdrawal by Subject|34|||
126728648|NCT01885078|455956803|FG006|Treatment Period|Withdrawal by Subject|17|||
126728649|NCT01885078|455956804|FG007|Treatment Period|Withdrawal by Subject|10|||
126728650|NCT01885078|455956805|FG008|Treatment Period|Withdrawal by Subject|0|||
126728651|NCT01885078|455956806|FG009|Treatment Period|Withdrawal by Subject|0|||
126728652|NCT01885078|455956797|FG000|Treatment Period|Other|0|||
126728653|NCT01885078|455956798|FG001|Treatment Period|Other|0|||
126728654|NCT01885078|455956799|FG002|Treatment Period|Other|0|||
126728655|NCT01885078|455956800|FG003|Treatment Period|Other|1|||
126728656|NCT01885078|455956801|FG004|Treatment Period|Other|0|||
126728657|NCT01885078|455956802|FG005|Treatment Period|Other|0|||
126728658|NCT01885078|455956803|FG006|Treatment Period|Other|0|||
126728659|NCT01885078|455956804|FG007|Treatment Period|Other|0|||
126728660|NCT01885078|455956805|FG008|Treatment Period|Other|0|||
126728661|NCT01885078|455956806|FG009|Treatment Period|Other|0|||
126728662|NCT01885078|455956797|FG000|Step-down Period|Sponsor Decision|0|||
126728663|NCT01885078|455956798|FG001|Step-down Period|Sponsor Decision|0|||
126728664|NCT01885078|455956799|FG002|Step-down Period|Sponsor Decision|0|||
126728665|NCT01885078|455956800|FG003|Step-down Period|Sponsor Decision|0|||
126728666|NCT01885078|455956801|FG004|Step-down Period|Sponsor Decision|0|||
126728667|NCT01885078|455956802|FG005|Step-down Period|Sponsor Decision|0|||
126728668|NCT01885078|455956803|FG006|Step-down Period|Sponsor Decision|0|||
126728669|NCT01885078|455956804|FG007|Step-down Period|Sponsor Decision|0|||
126728670|NCT01885078|455956805|FG008|Step-down Period|Sponsor Decision|1|||
126728671|NCT01885078|455956806|FG009|Step-down Period|Sponsor Decision|1|||
126728672|NCT01885078|455956797|FG000|Step-down Period|Adverse Event|0|||
126728673|NCT01885078|455956798|FG001|Step-down Period|Adverse Event|0|||
126728674|NCT01885078|455956799|FG002|Step-down Period|Adverse Event|0|||
126728675|NCT01885078|455956800|FG003|Step-down Period|Adverse Event|0|||
126728676|NCT01885078|455956801|FG004|Step-down Period|Adverse Event|0|||
126728677|NCT01885078|455956802|FG005|Step-down Period|Adverse Event|0|||
126728678|NCT01885078|455956803|FG006|Step-down Period|Adverse Event|0|||
126728679|NCT01885078|455956804|FG007|Step-down Period|Adverse Event|0|||
126728680|NCT01885078|455956805|FG008|Step-down Period|Adverse Event|29|||
126728681|NCT01885078|455956806|FG009|Step-down Period|Adverse Event|38|||
126728682|NCT01885078|455956797|FG000|Step-down Period|Withdrawal by Subject|0|||
126728683|NCT01885078|455956798|FG001|Step-down Period|Withdrawal by Subject|0|||
126728684|NCT01885078|455956799|FG002|Step-down Period|Withdrawal by Subject|0|||
126728685|NCT01885078|455956800|FG003|Step-down Period|Withdrawal by Subject|0|||
126728686|NCT01885078|455956801|FG004|Step-down Period|Withdrawal by Subject|0|||
126728687|NCT01885078|455956802|FG005|Step-down Period|Withdrawal by Subject|0|||
126728688|NCT01885078|455956803|FG006|Step-down Period|Withdrawal by Subject|0|||
126728689|NCT01885078|455956804|FG007|Step-down Period|Withdrawal by Subject|0|||
126728690|NCT01885078|455956805|FG008|Step-down Period|Withdrawal by Subject|25|||
126728691|NCT01885078|455956806|FG009|Step-down Period|Withdrawal by Subject|15|||
126528434|NCT01581281|455225600|FG002|Overall Study|Early Study Closure|12|||
126528435|NCT02187991|455225601|FG000|Overall Study|Adverse Event|13|||
126528436|NCT02187991|455225602|FG001|Overall Study|Adverse Event|14|||
126528437|NCT02187991|455225603|FG002|Overall Study|Adverse Event|3|||
126528438|NCT02187991|455225604|FG003|Overall Study|Adverse Event|2|||
126528439|NCT02187991|455225601|FG000|Overall Study|Withdrawal by Subject|9|||
126528440|NCT02187991|455225602|FG001|Overall Study|Withdrawal by Subject|6|||
126528441|NCT02187991|455225603|FG002|Overall Study|Withdrawal by Subject|3|||
126528442|NCT02187991|455225604|FG003|Overall Study|Withdrawal by Subject|2|||
126528443|NCT02187991|455225601|FG000|Overall Study|Physician Decision|4|||
126528444|NCT02187991|455225602|FG001|Overall Study|Physician Decision|4|||
126528445|NCT02187991|455225603|FG002|Overall Study|Physician Decision|0|||
126528446|NCT02187991|455225604|FG003|Overall Study|Physician Decision|2|||
126528447|NCT02187991|455225601|FG000|Overall Study|Other, unrelated complication|7|||
126728692|NCT01885078|455956797|FG000|Step-down Period|Physician Decision|0|||
126728693|NCT01885078|455956798|FG001|Step-down Period|Physician Decision|0|||
126728694|NCT01885078|455956799|FG002|Step-down Period|Physician Decision|0|||
126728695|NCT01885078|455956800|FG003|Step-down Period|Physician Decision|0|||
126728696|NCT01885078|455956801|FG004|Step-down Period|Physician Decision|0|||
126728697|NCT01885078|455956802|FG005|Step-down Period|Physician Decision|0|||
126728698|NCT01885078|455956803|FG006|Step-down Period|Physician Decision|0|||
126728699|NCT01885078|455956804|FG007|Step-down Period|Physician Decision|0|||
126728700|NCT01885078|455956805|FG008|Step-down Period|Physician Decision|7|||
126728701|NCT01885078|455956806|FG009|Step-down Period|Physician Decision|2|||
126528448|NCT02187991|455225602|FG001|Overall Study|Other, unrelated complication|1|||
126528449|NCT02187991|455225603|FG002|Overall Study|Other, unrelated complication|1|||
126528450|NCT02187991|455225604|FG003|Overall Study|Other, unrelated complication|2|||
126528451|NCT02187991|455225601|FG000|Overall Study|Death|1|||
126728702|NCT01885078|455956797|FG000|Step-down Period|Death|0|||
126728703|NCT01885078|455956798|FG001|Step-down Period|Death|0|||
126728704|NCT01885078|455956799|FG002|Step-down Period|Death|0|||
126528452|NCT02187991|455225602|FG001|Overall Study|Death|3|||
126579586|NCT03725722|455419456|FG002|Overall Study|Lost to Follow-up|2|||
126579587|NCT03725722|455419457|FG003|Overall Study|Lost to Follow-up|2|||
126579588|NCT03725722|455419458|FG004|Overall Study|Lost to Follow-up|1|||
126579589|NCT03725722|455419454|FG000|Overall Study|Personal reasons|0|||
126579590|NCT03725722|455419455|FG001|Overall Study|Personal reasons|0|||
126579591|NCT03725722|455419456|FG002|Overall Study|Personal reasons|1|||
126579592|NCT03725722|455419457|FG003|Overall Study|Personal reasons|0|||
126579593|NCT03725722|455419458|FG004|Overall Study|Personal reasons|1|||
126579594|NCT03725722|455419454|FG000|Overall Study|COVID-19 situation|0|||
126579595|NCT03725722|455419455|FG001|Overall Study|COVID-19 situation|1|||
126579596|NCT03725722|455419456|FG002|Overall Study|COVID-19 situation|0|||
126579597|NCT03725722|455419457|FG003|Overall Study|COVID-19 situation|0|||
126579598|NCT03725722|455419458|FG004|Overall Study|COVID-19 situation|0|||
126579599|NCT01600014|455419459|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
126579600|NCT01600014|455419460|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
126579601|NCT01600014|455419459|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
126579602|NCT01600014|455419460|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
126579603|NCT01600014|455419459|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
126579604|NCT01600014|455419460|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
126579605|NCT01600014|455419459|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
126579606|NCT01600014|455419460|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
126579607|NCT01600014|455419459|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
126579608|NCT01600014|455419460|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
126579609|NCT01600014|455419459|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
126579610|NCT01600014|455419460|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
126579611|NCT01600014|455419459|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
126579612|NCT01600014|455419460|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
126579613|NCT01600014|455419459|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
126579614|NCT01600014|455419460|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
126579615|NCT01600014|455419459|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
126579616|NCT01600014|455419460|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
126579617|NCT01600014|455419459|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
126579618|NCT01600014|455419460|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
126579619|NCT01600014|455419459|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
126579620|NCT01600014|455419460|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
126579621|NCT01600014|455419459|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
126579622|NCT01600014|455419460|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
126579623|NCT01600014|455419459|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
126579624|NCT01600014|455419460|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
126579625|NCT01600014|455419459|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
126579626|NCT01600014|455419460|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
126728705|NCT01885078|455956800|FG003|Step-down Period|Death|0|||
126528453|NCT02187991|455225603|FG002|Overall Study|Death|0|||
126528454|NCT02187991|455225604|FG003|Overall Study|Death|0|||
126528455|NCT03273946|455225612|FG000|Overall Study|Withdrawal by Subject|5|||
126528456|NCT03273946|455225612|FG000|Overall Study|Unwillingness of the guardian|1|||
126528457|NCT03273946|455225612|FG000|Overall Study|Participant refused to use the drug|2|||
126528458|NCT03273946|455225612|FG000|Overall Study|Participant relative refused to use drug|1|||
126528459|NCT00522275|455225613|FG000|Overall Study|Adverse Event|35|||
126528460|NCT00522275|455225613|FG000|Overall Study|Lack of Efficacy|80|||
126528461|NCT00522275|455225613|FG000|Overall Study|Subject withdrew consent|16|||
126528462|NCT00522275|455225613|FG000|Overall Study|Protocol deviation|1|||
126528463|NCT00522275|455225613|FG000|Overall Study|Unsatisfactory compliance|11|||
126528464|NCT00522275|455225613|FG000|Overall Study|Lost to Follow-up|8|||
126528465|NCT00522275|455225613|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
126528466|NCT00522275|455225613|FG000|Overall Study|Other: Subject is pregnant|2|||
126528467|NCT00522275|455225613|FG000|Overall Study|Other: Subject relocated|2|||
126528468|NCT00522275|455225613|FG000|Overall Study|Other: Subject arrested|1|||
126528469|NCT00522275|455225613|FG000|Overall Study|Other: Site / clinic closed|4|||
126528470|NCT00522275|455225613|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
126528471|NCT00522275|455225613|FG000|Overall Study|Other: Sponsor request|2|||
126528472|NCT00522275|455225613|FG000|Overall Study|Other: Subject ran out of medication|1|||
126728706|NCT01885078|455956801|FG004|Step-down Period|Death|0|||
126728707|NCT01885078|455956802|FG005|Step-down Period|Death|0|||
126528473|NCT00522275|455225613|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
126528474|NCT04773587|455225614|FG000|Overall Study|Lost to Follow-up|11|||
126528475|NCT04773587|455225615|FG001|Overall Study|Lost to Follow-up|3|||
126528476|NCT04773587|455225614|FG000|Overall Study|Adverse Event|6|||
126579627|NCT01600014|455419459|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
126728708|NCT01885078|455956803|FG006|Step-down Period|Death|0|||
126528477|NCT04773587|455225615|FG001|Overall Study|Adverse Event|3|||
126528478|NCT04773587|455225614|FG000|Overall Study|Lack of Efficacy|5|||
126528479|NCT04773587|455225615|FG001|Overall Study|Lack of Efficacy|2|||
126528480|NCT04773587|455225614|FG000|Overall Study|Withdrawal by Subject|4|||
126528481|NCT04773587|455225615|FG001|Overall Study|Withdrawal by Subject|5|||
126528482|NCT04773587|455225614|FG000|Overall Study|Noncompliance|1|||
126528483|NCT04773587|455225615|FG001|Overall Study|Noncompliance|0|||
126528484|NCT04773587|455225614|FG000|Overall Study|Protocol Violation|1|||
126528485|NCT04773587|455225615|FG001|Overall Study|Protocol Violation|0|||
126528486|NCT04773587|455225614|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
126528487|NCT04773587|455225615|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
126528488|NCT01808313|455225616|FG000|Overall Study|Adverse Event|5|||
126528489|NCT01808313|455225616|FG000|Overall Study|Protocol Violation|2|||
126528490|NCT01808313|455225616|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126528491|NCT01808313|455225616|FG000|Overall Study|Lost to Follow-up|1|||
126528492|NCT01808313|455225616|FG000|Overall Study|Physician Decision|1|||
126528493|NCT00622167|455225617|FG000|Overall Study|Did not meet angiographic criteria|20|||
126528494|NCT04598152|455225619|FG000|Overall Study|Lost to Follow-up|0|||
126528495|NCT04598152|455225620|FG001|Overall Study|Lost to Follow-up|1|||
126528496|NCT01954017|455225621|FG000|Overall Study|Adverse Event|0|||
126528497|NCT01954017|455225622|FG001|Overall Study|Adverse Event|0|||
126528498|NCT01954017|455225623|FG002|Overall Study|Adverse Event|1|||
126528499|NCT01954017|455225621|FG000|Overall Study|Death|2|||
126528500|NCT01954017|455225622|FG001|Overall Study|Death|1|||
126528501|NCT01954017|455225623|FG002|Overall Study|Death|1|||
126528502|NCT01954017|455225621|FG000|Overall Study|Withdrawal by Subject|0|||
126528503|NCT01954017|455225622|FG001|Overall Study|Withdrawal by Subject|1|||
126528504|NCT01954017|455225623|FG002|Overall Study|Withdrawal by Subject|0|||
126528505|NCT01954017|455225621|FG000|Overall Study|Protocol Violation|0|||
126528506|NCT01954017|455225622|FG001|Overall Study|Protocol Violation|3|||
126528507|NCT01954017|455225623|FG002|Overall Study|Protocol Violation|2|||
126528508|NCT01954017|455225621|FG000|Overall Study|Necrotizing enterocolitis|1|||
126528509|NCT01954017|455225622|FG001|Overall Study|Necrotizing enterocolitis|0|||
126528510|NCT01954017|455225623|FG002|Overall Study|Necrotizing enterocolitis|1|||
126528511|NCT01954017|455225621|FG000|Overall Study|Enteral intake stopped >7 days|0|||
126528512|NCT01954017|455225622|FG001|Overall Study|Enteral intake stopped >7 days|1|||
126528513|NCT01954017|455225623|FG002|Overall Study|Enteral intake stopped >7 days|1|||
126528514|NCT01954017|455225621|FG000|Overall Study|All other reasons|2|||
126528515|NCT01954017|455225622|FG001|Overall Study|All other reasons|2|||
126528516|NCT01954017|455225623|FG002|Overall Study|All other reasons|7|||
126528517|NCT03674177|455225631|FG000|Overall Study|Lost to Follow-up|2|||
126528518|NCT03674177|455225632|FG001|Overall Study|Lost to Follow-up|1|||
126528519|NCT03674177|455225633|FG002|Overall Study|Lost to Follow-up|0|||
126528520|NCT03674177|455225634|FG003|Overall Study|Lost to Follow-up|2|||
126528521|NCT00714168|455225635|FG000|Overall Study|Pregnancy|5|||
126528522|NCT00714168|455225636|FG001|Overall Study|Pregnancy|4|||
126528523|NCT00714168|455225635|FG000|Overall Study|Lost to Follow-up|32|||
126528524|NCT00714168|455225636|FG001|Overall Study|Lost to Follow-up|50|||
126528525|NCT00714168|455225635|FG000|Overall Study|Relocation|4|||
126528526|NCT00714168|455225636|FG001|Overall Study|Relocation|3|||
126528527|NCT00714168|455225635|FG000|Overall Study|Non-study medical condition|3|||
126528528|NCT00714168|455225636|FG001|Overall Study|Non-study medical condition|2|||
126528529|NCT02653482|455225637|FG000|Overall Study|Death|1|||
126528530|NCT02653482|455225638|FG001|Overall Study|Death|1|||
126528531|NCT03230916|455225641|FG000|Overall Study|Withdrawal by Subject|0|||
126528532|NCT03230916|455225642|FG001|Overall Study|Withdrawal by Subject|0|||
126528533|NCT03230916|455225643|FG002|Overall Study|Withdrawal by Subject|0|||
126528534|NCT03230916|455225644|FG003|Overall Study|Withdrawal by Subject|0|||
126528535|NCT03230916|455225645|FG004|Overall Study|Withdrawal by Subject|0|||
126528536|NCT03230916|455225646|FG005|Overall Study|Withdrawal by Subject|1|||
126528537|NCT03230916|455225647|FG006|Overall Study|Withdrawal by Subject|0|||
126528538|NCT03230916|455225648|FG007|Overall Study|Withdrawal by Subject|0|||
126528539|NCT03230916|455225649|FG008|Overall Study|Withdrawal by Subject|0|||
126528540|NCT03230916|455225650|FG009|Overall Study|Withdrawal by Subject|0|||
126528541|NCT03230916|455225651|FG010|Overall Study|Withdrawal by Subject|0|||
126528542|NCT03077724|455225654|FG000|Overall Study|Lost to Follow-up|5|||
126528543|NCT03077724|455225655|FG001|Overall Study|Lost to Follow-up|1|||
126528544|NCT03077724|455225654|FG000|Overall Study|Withdrawal by Subject|3|||
126528545|NCT03077724|455225655|FG001|Overall Study|Withdrawal by Subject|1|||
126528546|NCT04370054|455225658|FG000|Treatment Phase|Lost to Follow-up|1|||
126528547|NCT04370054|455225658|FG000|Treatment Phase|Withdrawal by Subject|1|||
126528548|NCT04370054|455225658|FG000|Follow-Up Phase|Ongoing|75|||
126528549|NCT00680407|455225662|FG000|Overall Study|Lost to Follow-up|3|||
126528550|NCT00680407|455225663|FG001|Overall Study|Lost to Follow-up|3|||
126528551|NCT00680407|455225664|FG002|Overall Study|Lost to Follow-up|1|||
126528552|NCT00680407|455225662|FG000|Overall Study|Withdrawal by Subject|5|||
126528553|NCT00680407|455225663|FG001|Overall Study|Withdrawal by Subject|2|||
126528554|NCT00680407|455225664|FG002|Overall Study|Withdrawal by Subject|2|||
126728709|NCT01885078|455956804|FG007|Step-down Period|Death|0|||
126528555|NCT06167031|455225665|FG000|Overall Study|Lost to Follow-up|5|||
126528556|NCT06167031|455225666|FG001|Overall Study|Lost to Follow-up|1|||
126528557|NCT01588184|455227489|FG000|Overall Study|Death|1|||
126528558|NCT01588184|455227490|FG001|Overall Study|Death|0|||
126528559|NCT01588184|455227491|FG002|Overall Study|Death|0|||
126528560|NCT01588184|455227492|FG003|Overall Study|Death|1|||
126528561|NCT01588184|455227493|FG004|Overall Study|Death|1|||
126528562|NCT01588184|455227494|FG005|Overall Study|Death|1|||
126528563|NCT01588184|455227489|FG000|Overall Study|Withdrawal by Subject|2|||
126528564|NCT01588184|455227490|FG001|Overall Study|Withdrawal by Subject|4|||
126528565|NCT01588184|455227491|FG002|Overall Study|Withdrawal by Subject|0|||
126528566|NCT01588184|455227492|FG003|Overall Study|Withdrawal by Subject|1|||
126528567|NCT01588184|455227493|FG004|Overall Study|Withdrawal by Subject|0|||
126528568|NCT01588184|455227494|FG005|Overall Study|Withdrawal by Subject|0|||
126528569|NCT01588184|455227489|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
126528570|NCT01588184|455227490|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
126528571|NCT01588184|455227491|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
126528572|NCT01588184|455227492|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
126528573|NCT01588184|455227493|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
126528574|NCT01588184|455227494|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
126528575|NCT01588184|455227489|FG000|Overall Study|multiple reasons|0|||
126528576|NCT01588184|455227490|FG001|Overall Study|multiple reasons|3|||
126528577|NCT01588184|455227491|FG002|Overall Study|multiple reasons|0|||
126528578|NCT01588184|455227492|FG003|Overall Study|multiple reasons|1|||
126528579|NCT01588184|455227493|FG004|Overall Study|multiple reasons|0|||
126528580|NCT01588184|455227494|FG005|Overall Study|multiple reasons|0|||
126528581|NCT05912400|455227496|FG000|Overall Study|Lost to Follow-up|1|||
126528582|NCT05912400|455227497|FG001|Overall Study|Lost to Follow-up|0|||
126528583|NCT05912400|455227496|FG000|Overall Study|Physician Decision|6|||
126528584|NCT05912400|455227497|FG001|Overall Study|Physician Decision|0|||
126528585|NCT05912400|455227496|FG000|Overall Study|Withdrawal by Subject|1|||
126528586|NCT05912400|455227497|FG001|Overall Study|Withdrawal by Subject|0|||
126528587|NCT02047045|455227502|FG000|Baseline|Withdrawal by Subject|3|||
126528588|NCT02047045|455227503|FG001|Baseline|Withdrawal by Subject|2|||
126528589|NCT02047045|455227502|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
126528590|NCT02047045|455227503|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
126528591|NCT02047045|455227502|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
126528592|NCT02047045|455227503|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
126528593|NCT02047045|455227502|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
126528594|NCT02047045|455227503|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
126528595|NCT02047045|455227502|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
126528596|NCT02047045|455227503|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
126528597|NCT02047045|455227502|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
126528598|NCT02047045|455227503|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
126528599|NCT02047045|455227502|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
126528600|NCT02047045|455227503|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
126528601|NCT02047045|455227502|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
126528602|NCT02047045|455227503|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
126528603|NCT02047045|455227502|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
126528604|NCT02047045|455227503|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
126528605|NCT03214367|455227504|FG000|Lead-in Period|Withdrawal by Subject|50|||
126528606|NCT03214367|455227505|FG001|Lead-in Period|Withdrawal by Subject|0|||
126528607|NCT03214367|455227506|FG002|Lead-in Period|Withdrawal by Subject|0|||
126528608|NCT03214367|455227507|FG003|Lead-in Period|Withdrawal by Subject|0|||
126528609|NCT03214367|455227508|FG004|Lead-in Period|Withdrawal by Subject|2|||
126528610|NCT03214367|455227509|FG005|Lead-in Period|Withdrawal by Subject|0|||
126528611|NCT03214367|455227510|FG006|Lead-in Period|Withdrawal by Subject|0|||
126528612|NCT03214367|455227511|FG007|Lead-in Period|Withdrawal by Subject|0|||
126528613|NCT03214367|455227504|FG000|Lead-in Period|Adverse Event|3|||
126528614|NCT03214367|455227505|FG001|Lead-in Period|Adverse Event|0|||
126528615|NCT03214367|455227506|FG002|Lead-in Period|Adverse Event|0|||
126528616|NCT03214367|455227507|FG003|Lead-in Period|Adverse Event|0|||
126528617|NCT03214367|455227508|FG004|Lead-in Period|Adverse Event|0|||
126528618|NCT03214367|455227509|FG005|Lead-in Period|Adverse Event|0|||
126528619|NCT03214367|455227510|FG006|Lead-in Period|Adverse Event|0|||
126528620|NCT03214367|455227511|FG007|Lead-in Period|Adverse Event|0|||
126528621|NCT03214367|455227504|FG000|Lead-in Period|Lost to Follow-up|12|||
126528622|NCT03214367|455227505|FG001|Lead-in Period|Lost to Follow-up|0|||
126528623|NCT03214367|455227506|FG002|Lead-in Period|Lost to Follow-up|0|||
126528624|NCT03214367|455227507|FG003|Lead-in Period|Lost to Follow-up|0|||
126528625|NCT03214367|455227508|FG004|Lead-in Period|Lost to Follow-up|0|||
126528626|NCT03214367|455227509|FG005|Lead-in Period|Lost to Follow-up|0|||
126528627|NCT03214367|455227510|FG006|Lead-in Period|Lost to Follow-up|0|||
126528628|NCT03214367|455227511|FG007|Lead-in Period|Lost to Follow-up|0|||
126528629|NCT03214367|455227504|FG000|Lead-in Period|Sponsor Decision|11|||
126728710|NCT01885078|455956805|FG008|Step-down Period|Death|4|||
126579628|NCT01600014|455419460|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
126579629|NCT01600014|455419459|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
126579630|NCT01600014|455419460|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
126579631|NCT01600014|455419459|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
126579632|NCT01600014|455419460|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
126579633|NCT04104321|455419470|FG000|Overall Study|didn't take the study drug|3|||
126579634|NCT03481777|455419471|FG000|Overall Study|Withdrawal by Subject|36|||
126579635|NCT03481777|455419472|FG001|Overall Study|Withdrawal by Subject|31|||
126579636|NCT03481777|455419471|FG000|Overall Study|Non stroke = non target population|277|||
126579637|NCT03481777|455419472|FG001|Overall Study|Non stroke = non target population|254|||
126579638|NCT05696080|455419473|FG000|Overall Study|Lost to Follow-up|2|||
126579639|NCT05696080|455419474|FG001|Overall Study|Lost to Follow-up|1|||
126579640|NCT05696080|455419473|FG000|Overall Study|Physician Decision|1|||
126579641|NCT05696080|455419474|FG001|Overall Study|Physician Decision|0|||
126579642|NCT05696080|455419473|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
126579643|NCT05696080|455419474|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
126579644|NCT05696080|455419473|FG000|Overall Study|Withdrawal by Subject|12|||
126579645|NCT05696080|455419474|FG001|Overall Study|Withdrawal by Subject|0|||
126579646|NCT03821844|455419482|FG000|Overall Study|Death|37|||
126579647|NCT03821844|455419483|FG001|Overall Study|Death|31|||
126579648|NCT03821844|455419482|FG000|Overall Study|Discharged|10|||
126579649|NCT03821844|455419483|FG001|Overall Study|Discharged|14|||
126579650|NCT03821844|455419482|FG000|Overall Study|Not present in facility at followup|2|||
126579651|NCT03821844|455419483|FG001|Overall Study|Not present in facility at followup|3|||
126579652|NCT03554265|455419484|FG000|Overall Study|Withdrawal by Subject|2|||
126579653|NCT03554265|455419485|FG001|Overall Study|Withdrawal by Subject|2|||
126579654|NCT03554265|455419486|FG002|Overall Study|Withdrawal by Subject|3|||
126579655|NCT03554265|455419484|FG000|Overall Study|Physician Decision|0|||
126579656|NCT03554265|455419485|FG001|Overall Study|Physician Decision|0|||
126579657|NCT03554265|455419486|FG002|Overall Study|Physician Decision|1|||
126579658|NCT02605837|455419487|FG000|Overall Study|Adverse Event|3|||
126579659|NCT02605837|455419488|FG001|Overall Study|Adverse Event|1|||
126579660|NCT02605837|455419487|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126579661|NCT02605837|455419488|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126579662|NCT02605837|455419487|FG000|Overall Study|Withdrawal by Subject|8|||
126579663|NCT02605837|455419488|FG001|Overall Study|Withdrawal by Subject|8|||
126579664|NCT02605837|455419487|FG000|Overall Study|Physician Decision|0|||
126579665|NCT02605837|455419488|FG001|Overall Study|Physician Decision|1|||
126579666|NCT05056246|455419489|FG000|Overall Study|Adverse Event|0|||
126579667|NCT05056246|455419490|FG001|Overall Study|Adverse Event|0|||
126579668|NCT05056246|455419491|FG002|Overall Study|Adverse Event|0|||
126579669|NCT05056246|455419492|FG003|Overall Study|Adverse Event|0|||
126579670|NCT05056246|455419493|FG004|Overall Study|Adverse Event|1|||
126579671|NCT05056246|455419489|FG000|Overall Study|Lost to Follow-up|0|||
126579672|NCT05056246|455419490|FG001|Overall Study|Lost to Follow-up|0|||
126728711|NCT01885078|455956806|FG009|Step-down Period|Death|3|||
126728712|NCT01885078|455956797|FG000|Step-down Period|Lost to Follow-up|0|||
126728713|NCT01885078|455956798|FG001|Step-down Period|Lost to Follow-up|0|||
126528630|NCT03214367|455227505|FG001|Lead-in Period|Sponsor Decision|0|||
126528631|NCT03214367|455227506|FG002|Lead-in Period|Sponsor Decision|0|||
126528632|NCT03214367|455227507|FG003|Lead-in Period|Sponsor Decision|0|||
126528633|NCT03214367|455227508|FG004|Lead-in Period|Sponsor Decision|0|||
126528634|NCT03214367|455227509|FG005|Lead-in Period|Sponsor Decision|0|||
126528635|NCT03214367|455227510|FG006|Lead-in Period|Sponsor Decision|0|||
126528636|NCT03214367|455227511|FG007|Lead-in Period|Sponsor Decision|0|||
126528637|NCT03214367|455227504|FG000|Lead-in Period|Physician Decision|12|||
126528638|NCT03214367|455227505|FG001|Lead-in Period|Physician Decision|0|||
126528639|NCT03214367|455227506|FG002|Lead-in Period|Physician Decision|0|||
126528640|NCT03214367|455227507|FG003|Lead-in Period|Physician Decision|0|||
126528641|NCT03214367|455227508|FG004|Lead-in Period|Physician Decision|0|||
126528642|NCT03214367|455227509|FG005|Lead-in Period|Physician Decision|0|||
126528643|NCT03214367|455227510|FG006|Lead-in Period|Physician Decision|0|||
126528644|NCT03214367|455227511|FG007|Lead-in Period|Physician Decision|0|||
126528645|NCT03214367|455227504|FG000|Lead-in Period|Protocol Violation|5|||
126528646|NCT03214367|455227505|FG001|Lead-in Period|Protocol Violation|0|||
126528647|NCT03214367|455227506|FG002|Lead-in Period|Protocol Violation|0|||
126528648|NCT03214367|455227507|FG003|Lead-in Period|Protocol Violation|0|||
126579673|NCT05056246|455419491|FG002|Overall Study|Lost to Follow-up|0|||
126579674|NCT05056246|455419492|FG003|Overall Study|Lost to Follow-up|2|||
126579675|NCT05056246|455419493|FG004|Overall Study|Lost to Follow-up|0|||
126579676|NCT05056246|455419489|FG000|Overall Study|Withdrawal by Subject|0|||
126579677|NCT05056246|455419490|FG001|Overall Study|Withdrawal by Subject|1|||
126579678|NCT05056246|455419491|FG002|Overall Study|Withdrawal by Subject|0|||
126579679|NCT05056246|455419492|FG003|Overall Study|Withdrawal by Subject|0|||
126528649|NCT03214367|455227508|FG004|Lead-in Period|Protocol Violation|0|||
126579680|NCT05056246|455419493|FG004|Overall Study|Withdrawal by Subject|0|||
126728714|NCT01885078|455956799|FG002|Step-down Period|Lost to Follow-up|0|||
126528650|NCT03214367|455227509|FG005|Lead-in Period|Protocol Violation|0|||
126528651|NCT03214367|455227510|FG006|Lead-in Period|Protocol Violation|0|||
126528652|NCT03214367|455227511|FG007|Lead-in Period|Protocol Violation|0|||
126528653|NCT03214367|455227504|FG000|Lead-in Period|Treatment Interruption|1|||
126528654|NCT03214367|455227505|FG001|Lead-in Period|Treatment Interruption|0|||
126528655|NCT03214367|455227506|FG002|Lead-in Period|Treatment Interruption|0|||
126528656|NCT03214367|455227507|FG003|Lead-in Period|Treatment Interruption|0|||
126528657|NCT03214367|455227508|FG004|Lead-in Period|Treatment Interruption|0|||
126528658|NCT03214367|455227509|FG005|Lead-in Period|Treatment Interruption|0|||
126528659|NCT03214367|455227510|FG006|Lead-in Period|Treatment Interruption|0|||
126528660|NCT03214367|455227511|FG007|Lead-in Period|Treatment Interruption|0|||
126528661|NCT03214367|455227504|FG000|Treatment Period|Adverse Event|0|||
126528662|NCT03214367|455227505|FG001|Treatment Period|Adverse Event|1|||
126528663|NCT03214367|455227506|FG002|Treatment Period|Adverse Event|4|||
126528664|NCT03214367|455227507|FG003|Treatment Period|Adverse Event|2|||
126528665|NCT03214367|455227508|FG004|Treatment Period|Adverse Event|0|||
126528666|NCT03214367|455227509|FG005|Treatment Period|Adverse Event|0|||
126528667|NCT03214367|455227510|FG006|Treatment Period|Adverse Event|0|||
126528668|NCT03214367|455227511|FG007|Treatment Period|Adverse Event|0|||
126528669|NCT03214367|455227504|FG000|Treatment Period|Death|0|||
126528670|NCT03214367|455227505|FG001|Treatment Period|Death|1|||
126528671|NCT03214367|455227506|FG002|Treatment Period|Death|1|||
126528672|NCT03214367|455227507|FG003|Treatment Period|Death|1|||
126528673|NCT03214367|455227508|FG004|Treatment Period|Death|0|||
126528674|NCT03214367|455227509|FG005|Treatment Period|Death|0|||
126528675|NCT03214367|455227510|FG006|Treatment Period|Death|0|||
126528676|NCT03214367|455227511|FG007|Treatment Period|Death|0|||
126528677|NCT03214367|455227504|FG000|Treatment Period|Lost to Follow-up|0|||
126528678|NCT03214367|455227505|FG001|Treatment Period|Lost to Follow-up|5|||
126528679|NCT03214367|455227506|FG002|Treatment Period|Lost to Follow-up|3|||
126528680|NCT03214367|455227507|FG003|Treatment Period|Lost to Follow-up|2|||
126528681|NCT03214367|455227508|FG004|Treatment Period|Lost to Follow-up|0|||
126528682|NCT03214367|455227509|FG005|Treatment Period|Lost to Follow-up|2|||
126528683|NCT03214367|455227510|FG006|Treatment Period|Lost to Follow-up|1|||
126528684|NCT03214367|455227511|FG007|Treatment Period|Lost to Follow-up|0|||
126528685|NCT03214367|455227504|FG000|Treatment Period|Sponsor Decision|0|||
126528686|NCT03214367|455227505|FG001|Treatment Period|Sponsor Decision|3|||
126528687|NCT03214367|455227506|FG002|Treatment Period|Sponsor Decision|0|||
126528688|NCT03214367|455227507|FG003|Treatment Period|Sponsor Decision|0|||
126528689|NCT03214367|455227508|FG004|Treatment Period|Sponsor Decision|0|||
126528690|NCT03214367|455227509|FG005|Treatment Period|Sponsor Decision|0|||
126528691|NCT03214367|455227510|FG006|Treatment Period|Sponsor Decision|0|||
126528692|NCT03214367|455227511|FG007|Treatment Period|Sponsor Decision|0|||
126528693|NCT03214367|455227504|FG000|Treatment Period|Physician Decision|0|||
126528694|NCT03214367|455227505|FG001|Treatment Period|Physician Decision|1|||
126528695|NCT03214367|455227506|FG002|Treatment Period|Physician Decision|2|||
126528696|NCT03214367|455227507|FG003|Treatment Period|Physician Decision|0|||
126528697|NCT03214367|455227508|FG004|Treatment Period|Physician Decision|0|||
126528698|NCT03214367|455227509|FG005|Treatment Period|Physician Decision|0|||
126528699|NCT03214367|455227510|FG006|Treatment Period|Physician Decision|0|||
126528700|NCT03214367|455227511|FG007|Treatment Period|Physician Decision|0|||
126528701|NCT03214367|455227504|FG000|Treatment Period|Protocol Violation|0|||
126528702|NCT03214367|455227505|FG001|Treatment Period|Protocol Violation|3|||
126528703|NCT03214367|455227506|FG002|Treatment Period|Protocol Violation|0|||
126528704|NCT03214367|455227507|FG003|Treatment Period|Protocol Violation|0|||
126528705|NCT03214367|455227508|FG004|Treatment Period|Protocol Violation|0|||
126528706|NCT03214367|455227509|FG005|Treatment Period|Protocol Violation|0|||
126528707|NCT03214367|455227510|FG006|Treatment Period|Protocol Violation|0|||
126528708|NCT03214367|455227511|FG007|Treatment Period|Protocol Violation|0|||
126528709|NCT03214367|455227504|FG000|Treatment Period|Withdrawal by Subject|0|||
126528710|NCT03214367|455227505|FG001|Treatment Period|Withdrawal by Subject|20|||
126528711|NCT03214367|455227506|FG002|Treatment Period|Withdrawal by Subject|23|||
126528712|NCT03214367|455227507|FG003|Treatment Period|Withdrawal by Subject|14|||
126528713|NCT03214367|455227508|FG004|Treatment Period|Withdrawal by Subject|0|||
126528714|NCT03214367|455227509|FG005|Treatment Period|Withdrawal by Subject|1|||
126528715|NCT03214367|455227510|FG006|Treatment Period|Withdrawal by Subject|1|||
126528716|NCT03214367|455227511|FG007|Treatment Period|Withdrawal by Subject|1|||
126528717|NCT03508843|455227512|FG000|Overall Study|Withdrawal by Subject|1|||
126528718|NCT03508843|455227512|FG000|Overall Study|technical difficulties|2|||
126528719|NCT00765843|455227513|FG000|Overall Study|Lost to Follow-up|1|||
126528720|NCT00765843|455227514|FG001|Overall Study|Lost to Follow-up|3|||
126528721|NCT00765843|455227515|FG002|Overall Study|Lost to Follow-up|2|||
126528722|NCT00765843|455227513|FG000|Overall Study|did not return to receive intervention|0|||
126528723|NCT00765843|455227514|FG001|Overall Study|did not return to receive intervention|1|||
126528724|NCT00765843|455227515|FG002|Overall Study|did not return to receive intervention|0|||
126528725|NCT00765843|455227513|FG000|Overall Study|Adverse Event|0|||
126528726|NCT00765843|455227514|FG001|Overall Study|Adverse Event|0|||
126528727|NCT00765843|455227515|FG002|Overall Study|Adverse Event|1|||
126579681|NCT05656911|455419504|FG000|Treatment Phase|Physician Decision|2|||
126579682|NCT05656911|455419505|FG001|Treatment Phase|Physician Decision|0|||
126579683|NCT05656911|455419504|FG000|Treatment Phase|Lack of Efficacy|6|||
126579684|NCT05656911|455419505|FG001|Treatment Phase|Lack of Efficacy|3|||
126579685|NCT05656911|455419504|FG000|Treatment Phase|Subject Decision|4|||
126579686|NCT05656911|455419505|FG001|Treatment Phase|Subject Decision|2|||
126579687|NCT05656911|455419504|FG000|Treatment Phase|Other Reasons|1|||
126579688|NCT05656911|455419505|FG001|Treatment Phase|Other Reasons|0|||
126579689|NCT05656911|455419504|FG000|Treatment Phase|Adverse Event|3|||
126579690|NCT05656911|455419505|FG001|Treatment Phase|Adverse Event|1|||
126579691|NCT05656911|455419504|FG000|Follow-up Phase|Subject Decision|0|||
126579692|NCT05656911|455419505|FG001|Follow-up Phase|Subject Decision|1|||
126579693|NCT05656911|455419504|FG000|Follow-up Phase|Missing|1|||
126579694|NCT05656911|455419505|FG001|Follow-up Phase|Missing|0|||
126579695|NCT03088813|455419506|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
126579696|NCT03088813|455419507|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
126579697|NCT03088813|455419508|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
126579698|NCT03088813|455419509|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
126579699|NCT03088813|455419506|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
126579700|NCT03088813|455419507|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
126579701|NCT03088813|455419508|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
126579702|NCT03088813|455419509|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
126579703|NCT03088813|455419506|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
126579704|NCT03088813|455419507|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
126579705|NCT03088813|455419508|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
126579706|NCT03088813|455419509|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
126579707|NCT03088813|455419506|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
126579708|NCT03088813|455419507|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
126579709|NCT03088813|455419508|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
126579710|NCT03088813|455419509|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
126579711|NCT03088813|455419506|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
126579712|NCT03088813|455419507|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
126579713|NCT03088813|455419508|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
126579714|NCT03088813|455419509|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
126579715|NCT03088813|455419506|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
126579716|NCT03088813|455419507|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
126579717|NCT03088813|455419508|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
126579718|NCT03088813|455419509|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
126579719|NCT03088813|455419506|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
126579720|NCT03088813|455419507|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
126579721|NCT03088813|455419508|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
126579722|NCT03088813|455419509|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
126579723|NCT02780388|455419510|FG000|Overall Study|Lost to Follow-up|0|||
126579724|NCT02780388|455419511|FG001|Overall Study|Lost to Follow-up|1|||
126579725|NCT02780388|455419512|FG002|Overall Study|Lost to Follow-up|0|||
126728715|NCT01885078|455956800|FG003|Step-down Period|Lost to Follow-up|0|||
126579726|NCT02780388|455419513|FG003|Overall Study|Lost to Follow-up|0|||
126579727|NCT02780388|455419514|FG004|Overall Study|Lost to Follow-up|0|||
126579728|NCT02780388|455419510|FG000|Overall Study|Withdrawal by Subject|1|||
126579729|NCT02780388|455419511|FG001|Overall Study|Withdrawal by Subject|1|||
126579730|NCT02780388|455419512|FG002|Overall Study|Withdrawal by Subject|0|||
126579731|NCT02780388|455419513|FG003|Overall Study|Withdrawal by Subject|0|||
126579732|NCT02780388|455419514|FG004|Overall Study|Withdrawal by Subject|0|||
126579733|NCT04527146|455419515|FG000|Overall Study|Withdrawal by Subject|12|||
126728716|NCT01885078|455956801|FG004|Step-down Period|Lost to Follow-up|0|||
126728717|NCT01885078|455956802|FG005|Step-down Period|Lost to Follow-up|0|||
126728718|NCT01885078|455956803|FG006|Step-down Period|Lost to Follow-up|0|||
126728719|NCT01885078|455956804|FG007|Step-down Period|Lost to Follow-up|0|||
126728720|NCT01885078|455956805|FG008|Step-down Period|Lost to Follow-up|1|||
126728721|NCT01885078|455956806|FG009|Step-down Period|Lost to Follow-up|1|||
126728722|NCT01885078|455956797|FG000|Step-down Period|Lack of Efficacy|0|||
126728723|NCT01885078|455956798|FG001|Step-down Period|Lack of Efficacy|0|||
126728724|NCT01885078|455956799|FG002|Step-down Period|Lack of Efficacy|0|||
126579734|NCT04527146|455419516|FG001|Overall Study|Withdrawal by Subject|15|||
126579735|NCT04527146|455419517|FG002|Overall Study|Withdrawal by Subject|7|||
126579736|NCT04527146|455419518|FG003|Overall Study|Withdrawal by Subject|16|||
126579737|NCT04527146|455419515|FG000|Overall Study|Lost to Follow-up|13|||
126579738|NCT04527146|455419516|FG001|Overall Study|Lost to Follow-up|9|||
126579739|NCT04527146|455419517|FG002|Overall Study|Lost to Follow-up|16|||
126579740|NCT04527146|455419518|FG003|Overall Study|Lost to Follow-up|13|||
126579741|NCT04527146|455419515|FG000|Overall Study|Death|0|||
126777128|NCT01605461|456141287|FG000|Overall Study|Lost to Follow-up|3|||
126528728|NCT03555396|455227516|FG000|Overall Study|Death|3|||
126528729|NCT03555396|455227517|FG001|Overall Study|Death|1|||
126528730|NCT03555396|455227516|FG000|Overall Study|Lost to Follow-up|0|||
126528731|NCT03555396|455227517|FG001|Overall Study|Lost to Follow-up|2|||
126528732|NCT01816594|455227525|FG000|Overall Study|Local Progress|0|||
126528733|NCT01816594|455227526|FG001|Overall Study|Local Progress|2|||
126528734|NCT01816594|455227525|FG000|Overall Study|Adverse Event|9|||
126528735|NCT01816594|455227526|FG001|Overall Study|Adverse Event|0|||
126528736|NCT01816594|455227525|FG000|Overall Study|Withdrawal by Subject|1|||
126528737|NCT01816594|455227526|FG001|Overall Study|Withdrawal by Subject|0|||
126528738|NCT01816594|455227525|FG000|Overall Study|Physician Decision|1|||
126528739|NCT01816594|455227526|FG001|Overall Study|Physician Decision|0|||
126528740|NCT03905655|455227527|FG000|Overall Study|Adverse Event|1|||
126528741|NCT03905655|455227528|FG001|Overall Study|Adverse Event|0|||
126528742|NCT03905655|455227529|FG002|Overall Study|Adverse Event|1|||
126528743|NCT03905655|455227530|FG003|Overall Study|Adverse Event|1|||
126528744|NCT01571362|455227533|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
126528745|NCT01571362|455227534|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
126528746|NCT01571362|455227535|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
126528747|NCT01571362|455227533|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
126528748|NCT01571362|455227534|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
126528749|NCT01571362|455227535|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
126528750|NCT01571362|455227533|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
126528751|NCT01571362|455227534|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
126528752|NCT01571362|455227535|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
126528753|NCT01571362|455227533|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
126528754|NCT01571362|455227534|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
126528755|NCT01571362|455227535|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
126528756|NCT01571362|455227533|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
126528757|NCT01571362|455227534|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
126528758|NCT01571362|455227535|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
126528759|NCT01571362|455227533|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
126528760|NCT01571362|455227534|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
126528761|NCT01571362|455227535|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
126528762|NCT01571362|455227533|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126528763|NCT01571362|455227534|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
126528764|NCT01571362|455227535|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
126528765|NCT01571362|455227533|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
126528766|NCT01571362|455227534|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
126528767|NCT01571362|455227535|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
126528768|NCT01571362|455227533|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126528769|NCT01571362|455227534|FG001|Double-Blind Treatment Period|Adverse Event|9|||
126528770|NCT01571362|455227535|FG002|Double-Blind Treatment Period|Adverse Event|14|||
126528771|NCT01571362|455227533|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126528772|NCT01571362|455227534|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
126528773|NCT01571362|455227535|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
126528774|NCT01571362|455227533|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
126528775|NCT01571362|455227534|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
126528776|NCT01571362|455227535|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
126528777|NCT01571362|455227533|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
126528778|NCT01571362|455227534|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
126528779|NCT01571362|455227535|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
126528780|NCT03667053|455227536|FG000|Overall Study|Withdrawal by Subject|1|||
126528781|NCT03667053|455227537|FG001|Overall Study|Withdrawal by Subject|0|||
126528782|NCT03667053|455227538|FG002|Overall Study|Withdrawal by Subject|0|||
126528783|NCT00121238|455227544|FG000|Overall Study|disease progression before intervention|1|||
126528784|NCT00121238|455227544|FG000|Overall Study|Protocol Violation|2|||
126528785|NCT01026974|455227556|FG000|Overall Study|Withdrawal by Subject|0|||
126528786|NCT01026974|455227557|FG001|Overall Study|Withdrawal by Subject|1|||
126528787|NCT01026974|455227558|FG002|Overall Study|Withdrawal by Subject|7|||
126528788|NCT01026974|455227559|FG003|Overall Study|Withdrawal by Subject|2|||
126528789|NCT01026974|455227556|FG000|Overall Study|Lost to Follow-up|1|||
126528790|NCT01026974|455227557|FG001|Overall Study|Lost to Follow-up|1|||
126528791|NCT01026974|455227558|FG002|Overall Study|Lost to Follow-up|4|||
126528792|NCT01026974|455227559|FG003|Overall Study|Lost to Follow-up|0|||
126528793|NCT01026974|455227556|FG000|Overall Study|Adverse Event|0|||
126528794|NCT01026974|455227557|FG001|Overall Study|Adverse Event|0|||
126528795|NCT01026974|455227558|FG002|Overall Study|Adverse Event|0|||
126528796|NCT01026974|455227559|FG003|Overall Study|Adverse Event|1|||
126528797|NCT01026974|455227556|FG000|Overall Study|Inappropriate enrollment|0|||
126528798|NCT01026974|455227557|FG001|Overall Study|Inappropriate enrollment|0|||
126579742|NCT04527146|455419516|FG001|Overall Study|Death|1|||
126579743|NCT04527146|455419517|FG002|Overall Study|Death|1|||
126579744|NCT04527146|455419518|FG003|Overall Study|Death|0|||
126579745|NCT04527146|455419515|FG000|Overall Study|Adverse Event|0|||
126579746|NCT04527146|455419516|FG001|Overall Study|Adverse Event|0|||
126579747|NCT04527146|455419517|FG002|Overall Study|Adverse Event|1|||
126579748|NCT04527146|455419518|FG003|Overall Study|Adverse Event|0|||
126579749|NCT04527146|455419515|FG000|Overall Study|Ineligible after randomization|2|||
126579750|NCT04527146|455419516|FG001|Overall Study|Ineligible after randomization|0|||
126579751|NCT04527146|455419517|FG002|Overall Study|Ineligible after randomization|2|||
126579752|NCT04527146|455419518|FG003|Overall Study|Ineligible after randomization|2|||
126579753|NCT04527146|455419515|FG000|Overall Study|Moved to a different group|6|||
126579754|NCT04527146|455419516|FG001|Overall Study|Moved to a different group|3|||
126579755|NCT04527146|455419517|FG002|Overall Study|Moved to a different group|0|||
126579756|NCT04527146|455419518|FG003|Overall Study|Moved to a different group|2|||
126579757|NCT05107401|455419519|FG000|Overall Study|Lost to Follow-up|13|||
126579758|NCT05107401|455419520|FG001|Overall Study|Lost to Follow-up|12|||
126579759|NCT01903811|455419532|FG000|Overall Study|No measurable disease|1|||
126579760|NCT01903811|455419533|FG001|Overall Study|No measurable disease|1|||
126579761|NCT01903811|455419532|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
126728725|NCT01885078|455956800|FG003|Step-down Period|Lack of Efficacy|0|||
126728726|NCT01885078|455956801|FG004|Step-down Period|Lack of Efficacy|0|||
126728727|NCT01885078|455956802|FG005|Step-down Period|Lack of Efficacy|0|||
126728728|NCT01885078|455956803|FG006|Step-down Period|Lack of Efficacy|0|||
126728729|NCT01885078|455956804|FG007|Step-down Period|Lack of Efficacy|0|||
126728730|NCT01885078|455956805|FG008|Step-down Period|Lack of Efficacy|1|||
126728731|NCT01885078|455956806|FG009|Step-down Period|Lack of Efficacy|0|||
126579762|NCT01903811|455419533|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
126579763|NCT01903811|455419532|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
126579764|NCT01903811|455419533|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
126579765|NCT01903811|455419532|FG000|Overall Study|Withdrawal by Subject|0|||
126579766|NCT01903811|455419533|FG001|Overall Study|Withdrawal by Subject|1|||
126579767|NCT04468776|455419534|FG000|Overall Study|Lost to Follow-up|4|||
126579768|NCT04468776|455419535|FG001|Overall Study|Lost to Follow-up|3|||
126579769|NCT04468776|455419536|FG002|Overall Study|Lost to Follow-up|4|||
126579770|NCT04468776|455419534|FG000|Overall Study|Withdrawal by Subject|1|||
126579771|NCT04468776|455419535|FG001|Overall Study|Withdrawal by Subject|10|||
126579772|NCT04468776|455419536|FG002|Overall Study|Withdrawal by Subject|4|||
126579773|NCT04468776|455419534|FG000|Overall Study|Physician Decision|0|||
126579774|NCT04468776|455419535|FG001|Overall Study|Physician Decision|1|||
126579775|NCT04468776|455419536|FG002|Overall Study|Physician Decision|1|||
126579776|NCT01704079|455419540|FG000|Overall Study|Withdrawal by Subject|5|||
126728732|NCT01885078|455956797|FG000|Step-down Period|Protocol Violation|0|||
126728733|NCT01885078|455956798|FG001|Step-down Period|Protocol Violation|0|||
126728734|NCT01885078|455956799|FG002|Step-down Period|Protocol Violation|0|||
126728735|NCT01885078|455956800|FG003|Step-down Period|Protocol Violation|0|||
126728736|NCT01885078|455956801|FG004|Step-down Period|Protocol Violation|0|||
126728737|NCT01885078|455956802|FG005|Step-down Period|Protocol Violation|0|||
126728738|NCT01885078|455956803|FG006|Step-down Period|Protocol Violation|0|||
126728739|NCT01885078|455956804|FG007|Step-down Period|Protocol Violation|0|||
126728740|NCT01885078|455956805|FG008|Step-down Period|Protocol Violation|1|||
126728741|NCT01885078|455956806|FG009|Step-down Period|Protocol Violation|1|||
126728742|NCT01114373|455956807|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
126728743|NCT01114373|455956808|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
126728744|NCT01114373|455956807|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
126728745|NCT01114373|455956808|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
126728746|NCT01114373|455956807|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
126728747|NCT01114373|455956808|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
126728748|NCT01114373|455956807|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
126728749|NCT01114373|455956808|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
126728750|NCT01895452|455956812|FG000|Overall Study|Adverse Event|1|||
126728751|NCT01895452|455956813|FG001|Overall Study|Adverse Event|4|||
126728752|NCT01895452|455956812|FG000|Overall Study|Lost to Follow-up|1|||
126728753|NCT01895452|455956813|FG001|Overall Study|Lost to Follow-up|5|||
126728754|NCT01895452|455956812|FG000|Overall Study|Pregnancy|0|||
126728755|NCT01895452|455956813|FG001|Overall Study|Pregnancy|1|||
126579777|NCT01704079|455419541|FG001|Overall Study|Withdrawal by Subject|7|||
126579778|NCT01704079|455419540|FG000|Overall Study|Lost to Follow-up|2|||
126579779|NCT01704079|455419541|FG001|Overall Study|Lost to Follow-up|5|||
126579780|NCT01704079|455419540|FG000|Overall Study|Adverse Event|4|||
126579781|NCT01704079|455419541|FG001|Overall Study|Adverse Event|7|||
126579782|NCT01704079|455419540|FG000|Overall Study|Protocol Violation|1|||
126579783|NCT01704079|455419541|FG001|Overall Study|Protocol Violation|0|||
126579784|NCT01704079|455419540|FG000|Overall Study|Subject noncompliance|2|||
126579785|NCT01704079|455419541|FG001|Overall Study|Subject noncompliance|3|||
126728756|NCT01895452|455956812|FG000|Overall Study|Withdrawal by Subject|2|||
126728757|NCT01895452|455956813|FG001|Overall Study|Withdrawal by Subject|14|||
126728758|NCT01895452|455956812|FG000|Overall Study|Underlying disease|0|||
126728759|NCT01895452|455956813|FG001|Overall Study|Underlying disease|3|||
126728760|NCT01895452|455956812|FG000|Overall Study|Noncompliance with study drug|0|||
126728761|NCT01895452|455956813|FG001|Overall Study|Noncompliance with study drug|1|||
126728762|NCT01653158|455956814|FG000|Overall Study|Death|0|||
126728763|NCT01653158|455956815|FG001|Overall Study|Death|0|||
126728764|NCT01653158|455956816|FG002|Overall Study|Death|0|||
126728765|NCT01653158|455956817|FG003|Overall Study|Death|1|||
126728766|NCT01653158|455956818|FG004|Overall Study|Death|0|||
126728767|NCT01653158|455956819|FG005|Overall Study|Death|0|||
126728768|NCT01653158|455956820|FG006|Overall Study|Death|0|||
126728769|NCT01653158|455956821|FG007|Overall Study|Death|2|||
126728770|NCT01653158|455956814|FG000|Overall Study|Adverse Event|0|||
126728771|NCT01653158|455956815|FG001|Overall Study|Adverse Event|0|||
126728772|NCT01653158|455956816|FG002|Overall Study|Adverse Event|0|||
126728773|NCT01653158|455956817|FG003|Overall Study|Adverse Event|1|||
126728774|NCT01653158|455956818|FG004|Overall Study|Adverse Event|0|||
126728775|NCT01653158|455956819|FG005|Overall Study|Adverse Event|0|||
126728776|NCT01653158|455956820|FG006|Overall Study|Adverse Event|0|||
126728777|NCT01653158|455956821|FG007|Overall Study|Adverse Event|3|||
126728778|NCT01653158|455956814|FG000|Overall Study|Other|0|||
126728779|NCT01653158|455956815|FG001|Overall Study|Other|0|||
126728780|NCT01653158|455956816|FG002|Overall Study|Other|0|||
126728781|NCT01653158|455956817|FG003|Overall Study|Other|0|||
126728782|NCT01653158|455956818|FG004|Overall Study|Other|0|||
126728783|NCT01653158|455956819|FG005|Overall Study|Other|0|||
126728784|NCT01653158|455956820|FG006|Overall Study|Other|0|||
126528799|NCT01026974|455227558|FG002|Overall Study|Inappropriate enrollment|1|||
126528800|NCT01026974|455227559|FG003|Overall Study|Inappropriate enrollment|0|||
126528801|NCT00325468|455227561|FG000|Overall Study|Adverse Event|1|||
126528802|NCT00325468|455227562|FG001|Overall Study|Adverse Event|1|||
126528803|NCT00325468|455227563|FG002|Overall Study|Adverse Event|0|||
126528804|NCT00325468|455227564|FG003|Overall Study|Adverse Event|5|||
126528805|NCT00325468|455227565|FG004|Overall Study|Adverse Event|1|||
126528806|NCT00325468|455227561|FG000|Overall Study|Death|2|||
126528807|NCT00325468|455227562|FG001|Overall Study|Death|0|||
126528808|NCT00325468|455227563|FG002|Overall Study|Death|2|||
126528809|NCT00325468|455227564|FG003|Overall Study|Death|4|||
126528810|NCT00325468|455227565|FG004|Overall Study|Death|0|||
126528811|NCT00325468|455227561|FG000|Overall Study|Lost to Follow-up|0|||
126528812|NCT00325468|455227562|FG001|Overall Study|Lost to Follow-up|0|||
126528813|NCT00325468|455227563|FG002|Overall Study|Lost to Follow-up|1|||
126528814|NCT00325468|455227564|FG003|Overall Study|Lost to Follow-up|2|||
126528815|NCT00325468|455227565|FG004|Overall Study|Lost to Follow-up|2|||
126528816|NCT00325468|455227561|FG000|Overall Study|Physician Decision|1|||
126528817|NCT00325468|455227562|FG001|Overall Study|Physician Decision|1|||
126528818|NCT00325468|455227563|FG002|Overall Study|Physician Decision|0|||
126528819|NCT00325468|455227564|FG003|Overall Study|Physician Decision|1|||
126528820|NCT00325468|455227565|FG004|Overall Study|Physician Decision|0|||
126528821|NCT00325468|455227561|FG000|Overall Study|Withdrawal by Subject|3|||
126528822|NCT00325468|455227562|FG001|Overall Study|Withdrawal by Subject|1|||
126528823|NCT00325468|455227563|FG002|Overall Study|Withdrawal by Subject|0|||
126528824|NCT00325468|455227564|FG003|Overall Study|Withdrawal by Subject|14|||
126528825|NCT00325468|455227565|FG004|Overall Study|Withdrawal by Subject|4|||
126528826|NCT00325468|455227561|FG000|Overall Study|site closure etc|4|||
126528827|NCT00325468|455227562|FG001|Overall Study|site closure etc|2|||
126528828|NCT00325468|455227563|FG002|Overall Study|site closure etc|1|||
126528829|NCT00325468|455227564|FG003|Overall Study|site closure etc|8|||
126528830|NCT00325468|455227565|FG004|Overall Study|site closure etc|1|||
126528831|NCT03280121|455227566|FG000|Overall Study|Physician Decision|1|||
126528832|NCT03280121|455227566|FG000|Overall Study|Lost to Follow-up|1|||
126528833|NCT03280121|455227566|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
126528834|NCT04642638|455227569|FG000|Overall Study|Withdrawal by Subject|23|||
126728785|NCT01653158|455956821|FG007|Overall Study|Other|1|||
126728786|NCT01653158|455956814|FG000|Overall Study|Progressive disease|0|||
126528835|NCT04642638|455227570|FG001|Overall Study|Withdrawal by Subject|29|||
126528836|NCT04642638|455227571|FG002|Overall Study|Withdrawal by Subject|9|||
126528837|NCT04642638|455227572|FG003|Overall Study|Withdrawal by Subject|7|||
126528838|NCT04642638|455227573|FG004|Overall Study|Withdrawal by Subject|61|||
126777129|NCT01605461|456141287|FG000|Overall Study|Withdrawal by Subject|1|||
126528839|NCT04642638|455227574|FG005|Overall Study|Withdrawal by Subject|27|||
126528840|NCT04642638|455227569|FG000|Overall Study|Lost to Follow-up|17|||
126528841|NCT04642638|455227570|FG001|Overall Study|Lost to Follow-up|18|||
126728787|NCT01653158|455956815|FG001|Overall Study|Progressive disease|0|||
126728788|NCT01653158|455956816|FG002|Overall Study|Progressive disease|0|||
126528842|NCT04642638|455227571|FG002|Overall Study|Lost to Follow-up|5|||
126528843|NCT04642638|455227572|FG003|Overall Study|Lost to Follow-up|5|||
126728789|NCT01653158|455956817|FG003|Overall Study|Progressive disease|0|||
126728790|NCT01653158|455956818|FG004|Overall Study|Progressive disease|1|||
126728791|NCT01653158|455956819|FG005|Overall Study|Progressive disease|1|||
126528844|NCT04642638|455227573|FG004|Overall Study|Lost to Follow-up|6|||
126728792|NCT01653158|455956820|FG006|Overall Study|Progressive disease|2|||
126728793|NCT01653158|455956821|FG007|Overall Study|Progressive disease|9|||
126728794|NCT01653158|455956814|FG000|Overall Study|Withdrawal by Subject|1|||
126728795|NCT01653158|455956815|FG001|Overall Study|Withdrawal by Subject|0|||
126728796|NCT01653158|455956816|FG002|Overall Study|Withdrawal by Subject|0|||
126728797|NCT01653158|455956817|FG003|Overall Study|Withdrawal by Subject|0|||
126728798|NCT01653158|455956818|FG004|Overall Study|Withdrawal by Subject|0|||
126728799|NCT01653158|455956819|FG005|Overall Study|Withdrawal by Subject|0|||
126728800|NCT01653158|455956820|FG006|Overall Study|Withdrawal by Subject|0|||
126728801|NCT01653158|455956821|FG007|Overall Study|Withdrawal by Subject|0|||
126728802|NCT03444870|455956826|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
126728803|NCT03444870|455956827|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
126728804|NCT03444870|455956828|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
126728805|NCT03444870|455956829|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
126728806|NCT03444870|455956830|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
126728807|NCT03444870|455956831|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
126728808|NCT03444870|455956826|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
126528845|NCT04642638|455227574|FG005|Overall Study|Lost to Follow-up|3|||
126528846|NCT04642638|455227569|FG000|Overall Study|Adverse Event|0|||
126528847|NCT04642638|455227570|FG001|Overall Study|Adverse Event|0|||
126528848|NCT04642638|455227571|FG002|Overall Study|Adverse Event|1|||
126528849|NCT04642638|455227572|FG003|Overall Study|Adverse Event|0|||
126528850|NCT04642638|455227573|FG004|Overall Study|Adverse Event|10|||
126528851|NCT04642638|455227574|FG005|Overall Study|Adverse Event|3|||
126528852|NCT04642638|455227569|FG000|Overall Study|Reason Not Specified|1|||
126528853|NCT04642638|455227570|FG001|Overall Study|Reason Not Specified|4|||
126528854|NCT04642638|455227571|FG002|Overall Study|Reason Not Specified|0|||
126528855|NCT04642638|455227572|FG003|Overall Study|Reason Not Specified|0|||
126528856|NCT04642638|455227573|FG004|Overall Study|Reason Not Specified|38|||
126528857|NCT04642638|455227574|FG005|Overall Study|Reason Not Specified|16|||
126528858|NCT04642638|455227569|FG000|Overall Study|Physician Decision|0|||
126528859|NCT04642638|455227570|FG001|Overall Study|Physician Decision|0|||
126528860|NCT04642638|455227571|FG002|Overall Study|Physician Decision|0|||
126528861|NCT04642638|455227572|FG003|Overall Study|Physician Decision|0|||
126528862|NCT04642638|455227573|FG004|Overall Study|Physician Decision|2|||
126528863|NCT04642638|455227574|FG005|Overall Study|Physician Decision|1|||
126528864|NCT04642638|455227569|FG000|Overall Study|Protocol Deviation|0|||
126528865|NCT04642638|455227570|FG001|Overall Study|Protocol Deviation|0|||
126528866|NCT04642638|455227571|FG002|Overall Study|Protocol Deviation|0|||
126528867|NCT04642638|455227572|FG003|Overall Study|Protocol Deviation|0|||
126528868|NCT04642638|455227573|FG004|Overall Study|Protocol Deviation|1|||
126528869|NCT04642638|455227574|FG005|Overall Study|Protocol Deviation|3|||
126528870|NCT04642638|455227569|FG000|Overall Study|Study Terminated|0|||
126528871|NCT04642638|455227570|FG001|Overall Study|Study Terminated|0|||
126528872|NCT04642638|455227571|FG002|Overall Study|Study Terminated|0|||
126528873|NCT04642638|455227572|FG003|Overall Study|Study Terminated|0|||
126528874|NCT04642638|455227573|FG004|Overall Study|Study Terminated|484|||
126528875|NCT04642638|455227574|FG005|Overall Study|Study Terminated|250|||
126528876|NCT04642638|455227569|FG000|Overall Study|Pregnancy|0|||
126528877|NCT04642638|455227570|FG001|Overall Study|Pregnancy|0|||
126528878|NCT04642638|455227571|FG002|Overall Study|Pregnancy|0|||
126528879|NCT04642638|455227572|FG003|Overall Study|Pregnancy|0|||
126528880|NCT04642638|455227573|FG004|Overall Study|Pregnancy|1|||
126528881|NCT04642638|455227574|FG005|Overall Study|Pregnancy|0|||
126528882|NCT00990652|455227575|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
126528883|NCT00990652|455227575|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
126528884|NCT02085408|455227576|FG000|Step 1: Induction|Disease Progression|19|||
126528885|NCT02085408|455227577|FG001|Step 1: Induction|Disease Progression|19|||
126528886|NCT02085408|455227576|FG000|Step 1: Induction|Adverse Event|18|||
126528887|NCT02085408|455227577|FG001|Step 1: Induction|Adverse Event|17|||
126528888|NCT02085408|455227576|FG000|Step 1: Induction|Death|33|||
126528889|NCT02085408|455227577|FG001|Step 1: Induction|Death|30|||
126528890|NCT02085408|455227576|FG000|Step 1: Induction|Withdrawal by Subject|16|||
126528891|NCT02085408|455227577|FG001|Step 1: Induction|Withdrawal by Subject|8|||
126528892|NCT02085408|455227576|FG000|Step 1: Induction|Alternative Therapy|15|||
126528893|NCT02085408|455227577|FG001|Step 1: Induction|Alternative Therapy|19|||
126528894|NCT02085408|455227576|FG000|Step 1: Induction|Complicating Disease|2|||
126528895|NCT02085408|455227577|FG001|Step 1: Induction|Complicating Disease|3|||
126528896|NCT02085408|455227576|FG000|Step 1: Induction|Other|27|||
126528897|NCT02085408|455227577|FG001|Step 1: Induction|Other|39|||
126528898|NCT02085408|455227576|FG000|Step 1: Induction|Never started treatment|6|||
126528899|NCT02085408|455227577|FG001|Step 1: Induction|Never started treatment|4|||
126579786|NCT01704079|455419540|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
126728809|NCT03444870|455956827|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
126528900|NCT02085408|455227576|FG000|Step 2: Consolidation|Disease Progression|5|||
126528901|NCT02085408|455227577|FG001|Step 2: Consolidation|Disease Progression|20|||
126579787|NCT01704079|455419541|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
126579788|NCT04300231|455419542|FG000|Overall Study|Protocol Violation|4|||
126579789|NCT04300231|455419543|FG001|Overall Study|Protocol Violation|3|||
126579790|NCT04300231|455419544|FG002|Overall Study|Protocol Violation|0|||
126579791|NCT04300231|455419545|FG003|Overall Study|Protocol Violation|2|||
126579792|NCT05986565|455419551|FG000|Overall Study|Lost to Follow-up|8|||
126579793|NCT05986565|455419552|FG001|Overall Study|Lost to Follow-up|3|||
126579794|NCT05986565|455419551|FG000|Overall Study|Withdrawal by Subject|0|||
126579795|NCT05986565|455419552|FG001|Overall Study|Withdrawal by Subject|1|||
126579796|NCT02991807|455419555|FG000|Overall Study|Withdrawal by Subject|2|||
126579797|NCT02991807|455419556|FG001|Overall Study|Withdrawal by Subject|1|||
126579798|NCT02991807|455419555|FG000|Overall Study|Physician Decision|0|||
126579799|NCT02991807|455419556|FG001|Overall Study|Physician Decision|1|||
126579800|NCT02991807|455419555|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
126579801|NCT02991807|455419556|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
126579802|NCT02300298|455419559|FG000|Disposition for Nintedanib|Progressive disease|10|||
126579803|NCT02300298|455419560|FG001|Disposition for Nintedanib|Progressive disease|0|||
126579804|NCT02300298|455419559|FG000|Disposition for Docetaxel|Progressive disease|0|||
126579805|NCT02300298|455419560|FG001|Disposition for Docetaxel|Progressive disease|6|||
126579806|NCT02300298|455419559|FG000|Disposition for Docetaxel|other adverse event|0|||
126579807|NCT02300298|455419560|FG001|Disposition for Docetaxel|other adverse event|4|||
126579808|NCT00792636|455419564|FG000|Overall Study|Protocol Violation|17|||
126579809|NCT00792636|455419565|FG001|Overall Study|Protocol Violation|23|||
126579810|NCT00792636|455419566|FG002|Overall Study|Protocol Violation|20|||
126579811|NCT00792636|455419564|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
126579812|NCT00792636|455419565|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
126579813|NCT00792636|455419566|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
126579814|NCT00792636|455419564|FG000|Overall Study|Lost to Follow-up|13|||
126579815|NCT00792636|455419565|FG001|Overall Study|Lost to Follow-up|19|||
126579816|NCT00792636|455419566|FG002|Overall Study|Lost to Follow-up|14|||
126579817|NCT00792636|455419564|FG000|Overall Study|Withdrew Consent|10|||
126579818|NCT00792636|455419565|FG001|Overall Study|Withdrew Consent|13|||
126579819|NCT00792636|455419566|FG002|Overall Study|Withdrew Consent|9|||
126579820|NCT00792636|455419564|FG000|Overall Study|Lack of Efficacy|3|||
126579821|NCT00792636|455419565|FG001|Overall Study|Lack of Efficacy|4|||
126579822|NCT00792636|455419566|FG002|Overall Study|Lack of Efficacy|13|||
126579823|NCT00792636|455419564|FG000|Overall Study|Adverse Event|4|||
126579824|NCT00792636|455419565|FG001|Overall Study|Adverse Event|2|||
126579825|NCT00792636|455419566|FG002|Overall Study|Adverse Event|3|||
126579826|NCT00792636|455419564|FG000|Overall Study|Investigator Discretion|2|||
126579827|NCT00792636|455419565|FG001|Overall Study|Investigator Discretion|0|||
126579828|NCT00792636|455419566|FG002|Overall Study|Investigator Discretion|2|||
126579829|NCT04579250|455419568|FG000|Overall Study|Withdrawal by Subject|1|||
126579830|NCT04579250|455419569|FG001|Overall Study|Withdrawal by Subject|1|||
126579831|NCT04579250|455419570|FG002|Overall Study|Withdrawal by Subject|0|||
126579832|NCT04579250|455419568|FG000|Overall Study|Lost to Follow-up|1|||
126579833|NCT04579250|455419569|FG001|Overall Study|Lost to Follow-up|1|||
126579834|NCT04579250|455419570|FG002|Overall Study|Lost to Follow-up|0|||
126579835|NCT04579250|455419568|FG000|Overall Study|Moved from area|0|||
126579836|NCT04579250|455419569|FG001|Overall Study|Moved from area|1|||
126579837|NCT04579250|455419570|FG002|Overall Study|Moved from area|2|||
126579838|NCT02058108|455419571|FG000|Overall Study|Abnormal Laboratory Values|0|||
126579839|NCT02058108|455419572|FG001|Overall Study|Abnormal Laboratory Values|1|||
126728810|NCT03444870|455956828|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
126728811|NCT03444870|455956829|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
126728812|NCT03444870|455956830|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
126728813|NCT03444870|455956831|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
126728814|NCT03444870|455956826|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
126728815|NCT03444870|455956827|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
126728816|NCT03444870|455956828|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
126728817|NCT03444870|455956829|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
126728818|NCT03444870|455956830|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
126728819|NCT03444870|455956831|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
126728820|NCT03444870|455956826|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
126728821|NCT03444870|455956827|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
126579840|NCT02058108|455419571|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
126579841|NCT02058108|455419572|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
126579842|NCT02058108|455419571|FG000|Overall Study|No longer requires study drug|0|||
126579843|NCT02058108|455419572|FG001|Overall Study|No longer requires study drug|1|||
126579844|NCT02058108|455419571|FG000|Overall Study|Withdrawal by Subject|1|||
126579845|NCT02058108|455419572|FG001|Overall Study|Withdrawal by Subject|0|||
126579846|NCT02058108|455419571|FG000|Overall Study|Administrative problems|3|||
126728822|NCT03444870|455956828|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
126528902|NCT02085408|455227576|FG000|Step 2: Consolidation|Adverse Event|9|||
126528903|NCT02085408|455227577|FG001|Step 2: Consolidation|Adverse Event|8|||
126528904|NCT02085408|455227576|FG000|Step 2: Consolidation|Death|4|||
126528905|NCT02085408|455227577|FG001|Step 2: Consolidation|Death|3|||
126528906|NCT02085408|455227576|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
126528907|NCT02085408|455227577|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
126528908|NCT02085408|455227576|FG000|Step 2: Consolidation|Alternative Therapy|9|||
126528909|NCT02085408|455227577|FG001|Step 2: Consolidation|Alternative Therapy|3|||
126528910|NCT02085408|455227576|FG000|Step 2: Consolidation|Complicating Disease|0|||
126528911|NCT02085408|455227577|FG001|Step 2: Consolidation|Complicating Disease|2|||
126528912|NCT02085408|455227576|FG000|Step 2: Consolidation|Other|6|||
126528913|NCT02085408|455227577|FG001|Step 2: Consolidation|Other|6|||
126528914|NCT02085408|455227576|FG000|Step 2: Consolidation|Never started treatment|4|||
126528915|NCT02085408|455227577|FG001|Step 2: Consolidation|Never started treatment|3|||
126728823|NCT03444870|455956829|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
126728824|NCT03444870|455956830|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
126728825|NCT03444870|455956831|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
126728826|NCT03444870|455956826|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
126728827|NCT03444870|455956827|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
126728828|NCT03444870|455956828|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
126728829|NCT03444870|455956829|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
126728830|NCT03444870|455956830|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
126728831|NCT03444870|455956831|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
126728832|NCT03444870|455956826|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
126728833|NCT03444870|455956827|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
126728834|NCT03444870|455956828|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
126728835|NCT03444870|455956829|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
126728836|NCT03444870|455956830|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
126728837|NCT03444870|455956831|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
126728838|NCT03444870|455956826|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
126728839|NCT03444870|455956827|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
126728840|NCT03444870|455956828|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
126728841|NCT03444870|455956829|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
126728842|NCT03444870|455956830|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
126728843|NCT03444870|455956831|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
126728844|NCT03444870|455956826|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
126728845|NCT03444870|455956827|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
126728846|NCT03444870|455956828|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
126728847|NCT03444870|455956829|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
126728848|NCT03444870|455956830|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
126728849|NCT03444870|455956831|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
126728850|NCT03444870|455956826|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
126728851|NCT03444870|455956827|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
126728852|NCT03444870|455956828|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
126728853|NCT03444870|455956829|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
126728854|NCT03444870|455956830|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
126728855|NCT03444870|455956831|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
126728856|NCT03444870|455956826|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126728857|NCT03444870|455956827|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126728858|NCT03444870|455956828|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126728859|NCT03444870|455956829|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126728860|NCT03444870|455956830|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
126728861|NCT03444870|455956831|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
126528916|NCT02085408|455227576|FG000|Step 3: Maintenance|Disease Progression|13|||
126528917|NCT02085408|455227577|FG001|Step 3: Maintenance|Disease Progression|11|||
126528918|NCT02085408|455227576|FG000|Step 3: Maintenance|Adverse Event|2|||
126528919|NCT02085408|455227577|FG001|Step 3: Maintenance|Adverse Event|4|||
126528920|NCT02085408|455227576|FG000|Step 3: Maintenance|Death|1|||
126528921|NCT02085408|455227577|FG001|Step 3: Maintenance|Death|2|||
126528922|NCT02085408|455227576|FG000|Step 3: Maintenance|Alternative Therapy|1|||
126528923|NCT02085408|455227577|FG001|Step 3: Maintenance|Alternative Therapy|1|||
126528924|NCT02085408|455227576|FG000|Step 3: Maintenance|Complicating Disease|0|||
126528925|NCT02085408|455227577|FG001|Step 3: Maintenance|Complicating Disease|1|||
126528926|NCT02085408|455227576|FG000|Step 3: Maintenance|Other|3|||
126528927|NCT02085408|455227577|FG001|Step 3: Maintenance|Other|2|||
126528928|NCT02085408|455227576|FG000|Step 3: Maintenance|Never started treatment|5|||
126528929|NCT02085408|455227577|FG001|Step 3: Maintenance|Never started treatment|1|||
126528930|NCT02273141|455227578|FG000|Overall Study|Adverse Event|0|||
126728862|NCT03444870|455956826|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
126728863|NCT03444870|455956827|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
126728864|NCT03444870|455956828|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
126728865|NCT03444870|455956829|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
126528931|NCT02273141|455227579|FG001|Overall Study|Adverse Event|1|||
126528932|NCT02273141|455227578|FG000|Overall Study|Lost to Follow-up|1|||
126528933|NCT02273141|455227579|FG001|Overall Study|Lost to Follow-up|3|||
126528934|NCT02273141|455227578|FG000|Overall Study|Withdrawal by Subject|10|||
126528935|NCT02273141|455227579|FG001|Overall Study|Withdrawal by Subject|15|||
126528936|NCT02273141|455227578|FG000|Overall Study|Various|6|||
126528937|NCT02273141|455227579|FG001|Overall Study|Various|6|||
126528938|NCT01556438|455227580|FG000|Overall Study|Adverse Event|4|||
126528939|NCT01556438|455227581|FG001|Overall Study|Adverse Event|2|||
126528940|NCT01556438|455227580|FG000|Overall Study|Sponsor Decision|0|||
126528941|NCT01556438|455227581|FG001|Overall Study|Sponsor Decision|2|||
126528942|NCT01556438|455227580|FG000|Overall Study|Progressive Disease|0|||
126528943|NCT01556438|455227581|FG001|Overall Study|Progressive Disease|6|||
126528944|NCT01556438|455227580|FG000|Overall Study|Death|0|||
126528945|NCT01556438|455227581|FG001|Overall Study|Death|1|||
126528946|NCT00529399|455227582|FG000|Overall Study|Lost to Follow-up|1|||
126528947|NCT00529399|455227583|FG001|Overall Study|Lost to Follow-up|0|||
126528948|NCT00529399|455227584|FG002|Overall Study|Lost to Follow-up|1|||
126528949|NCT00529399|455227582|FG000|Overall Study|Withdrawal by Subject|1|||
126528950|NCT00529399|455227583|FG001|Overall Study|Withdrawal by Subject|0|||
126528951|NCT00529399|455227584|FG002|Overall Study|Withdrawal by Subject|1|||
126528952|NCT00529399|455227582|FG000|Overall Study|Non-compliant|0|||
126528953|NCT00529399|455227583|FG001|Overall Study|Non-compliant|1|||
126528954|NCT00529399|455227584|FG002|Overall Study|Non-compliant|0|||
126528955|NCT03695172|455227585|FG000|Overall Study|Withdrawal by Subject|1|||
126528956|NCT03695172|455227586|FG001|Overall Study|Withdrawal by Subject|1|||
126528957|NCT03695172|455227587|FG002|Overall Study|Withdrawal by Subject|0|||
126528958|NCT02734212|455227591|FG000|Overall Study|Lost to Follow-up|5|||
126528959|NCT02734212|455227592|FG001|Overall Study|Lost to Follow-up|10|||
126528960|NCT04313881|455227593|FG000|Overall Study|Death|138|||
126528961|NCT04313881|455227594|FG001|Overall Study|Death|126|||
126528962|NCT04313881|455227593|FG000|Overall Study|Study terminated by sponsor|108|||
126528963|NCT04313881|455227594|FG001|Overall Study|Study terminated by sponsor|129|||
126528964|NCT04313881|455227593|FG000|Overall Study|Consent withdrawn|19|||
126528965|NCT04313881|455227594|FG001|Overall Study|Consent withdrawn|15|||
126528966|NCT04313881|455227593|FG000|Overall Study|Reason not Specified|3|||
126528967|NCT04313881|455227594|FG001|Overall Study|Reason not Specified|1|||
126528968|NCT00688636|455227597|FG000|Overall Study|Adverse Event|2|||
126528969|NCT00688636|455227598|FG001|Overall Study|Adverse Event|1|||
126528970|NCT01572727|455227599|FG000|Overall Study|Adverse Event|43|||
126528971|NCT01572727|455227600|FG001|Overall Study|Adverse Event|15|||
126528972|NCT01572727|455227599|FG000|Overall Study|Lost to Follow-up|1|||
126528973|NCT01572727|455227600|FG001|Overall Study|Lost to Follow-up|1|||
126528974|NCT01572727|455227599|FG000|Overall Study|Physician Decision|23|||
126528975|NCT01572727|455227600|FG001|Overall Study|Physician Decision|9|||
126528976|NCT01572727|455227599|FG000|Overall Study|Progressive disease|59|||
126528977|NCT01572727|455227600|FG001|Overall Study|Progressive disease|82|||
126528978|NCT01572727|455227599|FG000|Overall Study|Protocol Violation|0|||
126528979|NCT01572727|455227600|FG001|Overall Study|Protocol Violation|1|||
126528980|NCT01572727|455227599|FG000|Overall Study|Study terminated by sponsor|61|||
126528981|NCT01572727|455227600|FG001|Overall Study|Study terminated by sponsor|83|||
126528982|NCT01572727|455227599|FG000|Overall Study|Parent/guardian decision|14|||
126528983|NCT01572727|455227600|FG001|Overall Study|Parent/guardian decision|9|||
126528984|NCT01572727|455227599|FG000|Overall Study|Death|2|||
126528985|NCT01572727|455227600|FG001|Overall Study|Death|2|||
126528986|NCT01572727|455227599|FG000|Overall Study|Untreated|4|||
126528987|NCT01572727|455227600|FG001|Overall Study|Untreated|7|||
126528988|NCT04053764|455227601|FG000|Overall Study|Withdrawal by Subject|6|||
126528989|NCT04053764|455227602|FG001|Overall Study|Withdrawal by Subject|2|||
126528990|NCT04053764|455227601|FG000|Overall Study|Physician Decision|2|||
126528991|NCT04053764|455227602|FG001|Overall Study|Physician Decision|1|||
126528992|NCT04053764|455227601|FG000|Overall Study|Adverse Event|1|||
126528993|NCT04053764|455227602|FG001|Overall Study|Adverse Event|0|||
126528994|NCT04053764|455227601|FG000|Overall Study|Pregnancy|1|||
126528995|NCT04053764|455227602|FG001|Overall Study|Pregnancy|0|||
126528996|NCT04732286|455227606|FG000|Overall Study|Progressive Disease|2|||
126528997|NCT04732286|455227606|FG000|Overall Study|Physician Decision|1|||
126528998|NCT04732286|455227606|FG000|Overall Study|Study Terminated by Sponsor|31|||
126528999|NCT04732286|455227606|FG000|Overall Study|Withdrawal by Subject|10|||
126529000|NCT04732286|455227606|FG000|Overall Study|Non-compliance With Study Drug|1|||
126529001|NCT04732286|455227606|FG000|Overall Study|Lost to Follow-up|4|||
126529002|NCT04732286|455227606|FG000|Overall Study|Death|51|||
126529003|NCT01474681|455227610|FG000|Overall Study|Death|0|||
126529004|NCT01474681|455227611|FG001|Overall Study|Death|3|||
126529005|NCT01474681|455227612|FG002|Overall Study|Death|2|||
126728866|NCT03444870|455956830|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
126529006|NCT01474681|455227613|FG003|Overall Study|Death|6|||
126529007|NCT01910129|455227618|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
126579847|NCT02058108|455419572|FG001|Overall Study|Administrative problems|3|||
126579848|NCT02058108|455419571|FG000|Overall Study|Protocol Violation|0|||
126579849|NCT02058108|455419572|FG001|Overall Study|Protocol Violation|1|||
126579850|NCT04711135|455419577|FG000|Overall Study|Physician Decision|0|||
126579851|NCT04711135|455419578|FG001|Overall Study|Physician Decision|1|||
126579852|NCT04711135|455419577|FG000|Overall Study|Ongoing treatment|0|||
126579853|NCT04711135|455419578|FG001|Overall Study|Ongoing treatment|1|||
126579854|NCT00998881|455419579|FG000|Overall Study|Adverse Event|2|||
126579855|NCT00998881|455419580|FG001|Overall Study|Adverse Event|2|||
126579856|NCT00998881|455419579|FG000|Overall Study|Lack of Efficacy|1|||
126579857|NCT00998881|455419580|FG001|Overall Study|Lack of Efficacy|0|||
126579858|NCT00998881|455419579|FG000|Overall Study|Physician Decision|3|||
126579859|NCT00998881|455419580|FG001|Overall Study|Physician Decision|0|||
126579860|NCT00998881|455419579|FG000|Overall Study|Withdrawal by Subject|1|||
126579861|NCT00998881|455419580|FG001|Overall Study|Withdrawal by Subject|0|||
126579862|NCT00998881|455419579|FG000|Overall Study|Personal matter|1|||
126579863|NCT00998881|455419580|FG001|Overall Study|Personal matter|0|||
126579864|NCT02006758|455419581|FG000|Overall Study|Protocol Violation|1|||
126579865|NCT02006758|455419581|FG000|Overall Study|Death|1|||
126579866|NCT02006758|455419581|FG000|Overall Study|Lost to Follow-up|4|||
126579867|NCT02006758|455419581|FG000|Overall Study|Withdrawal by Subject|4|||
126579868|NCT02006758|455419581|FG000|Overall Study|Procedurally excluded|1|||
126579869|NCT02006758|455419581|FG000|Overall Study|Other|2|||
126579870|NCT00522951|455419589|FG000|Period 1|body motion|0|||
126579871|NCT00522951|455419590|FG001|Period 1|body motion|1|||
126579872|NCT00522951|455419589|FG000|Washout Period|Adverse Event|0|||
126579873|NCT00522951|455419590|FG001|Washout Period|Adverse Event|1|||
126579874|NCT00522951|455419589|FG000|Washout Period|Death|0|||
126579875|NCT00522951|455419590|FG001|Washout Period|Death|1|||
126579876|NCT00522951|455419589|FG000|Period 2|Withdrawal by Subject|1|||
126579877|NCT00522951|455419590|FG001|Period 2|Withdrawal by Subject|0|||
126579878|NCT00522951|455419589|FG000|Period 2|residual contrast medium|1|||
126579879|NCT00522951|455419590|FG001|Period 2|residual contrast medium|1|||
126579880|NCT01771731|455419591|FG000|Overall Study|Physician Decision|1|||
126579881|NCT01771731|455419592|FG001|Overall Study|Physician Decision|0|||
126579882|NCT01771731|455419591|FG000|Overall Study|Protocol Violation|0|||
126579883|NCT01771731|455419592|FG001|Overall Study|Protocol Violation|1|||
126579884|NCT01771731|455419591|FG000|Overall Study|Adverse event: Pain Crisis|1|||
126579885|NCT01771731|455419592|FG001|Overall Study|Adverse event: Pain Crisis|1|||
126579886|NCT04484935|455419593|FG000|Overall Study|Other|0|||
126579887|NCT04484935|455419594|FG001|Overall Study|Other|1|||
126579888|NCT04484935|455419593|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126579889|NCT04484935|455419594|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126579890|NCT04484935|455419593|FG000|Overall Study|Lost to Follow-up|1|||
126579891|NCT04484935|455419594|FG001|Overall Study|Lost to Follow-up|0|||
126579892|NCT04484935|455419593|FG000|Overall Study|Death|2|||
126579893|NCT04484935|455419594|FG001|Overall Study|Death|1|||
126579894|NCT01094184|455419595|FG000|Overall Study|Death|35|||
126579895|NCT01094184|455419596|FG001|Overall Study|Death|11|||
126579896|NCT03892564|455419597|FG000|Overall Study|Withdrawal by Subject|2|||
126579897|NCT03398148|455421701|FG000|Substudy 1 Period 1|Adverse Event|5|||
126579898|NCT03398148|455421702|FG001|Substudy 1 Period 1|Adverse Event|2|||
126579899|NCT03398148|455421703|FG002|Substudy 1 Period 1|Adverse Event|2|||
126579900|NCT03398148|455421704|FG003|Substudy 1 Period 1|Adverse Event|0|||
126579901|NCT03398148|455421705|FG004|Substudy 1 Period 1|Adverse Event|8|||
126579902|NCT03398148|455421706|FG005|Substudy 1 Period 1|Adverse Event|0|||
126579903|NCT03398148|455421707|FG006|Substudy 1 Period 1|Adverse Event|0|||
126579904|NCT03398148|455421708|FG007|Substudy 1 Period 1|Adverse Event|0|||
126579905|NCT03398148|455421709|FG008|Substudy 1 Period 1|Adverse Event|0|||
126579906|NCT03398148|455421710|FG009|Substudy 1 Period 1|Adverse Event|0|||
126579907|NCT03398148|455421711|FG010|Substudy 1 Period 1|Adverse Event|0|||
126579908|NCT03398148|455421712|FG011|Substudy 1 Period 1|Adverse Event|0|||
126579909|NCT03398148|455421713|FG012|Substudy 1 Period 1|Adverse Event|0|||
126579910|NCT03398148|455421714|FG013|Substudy 1 Period 1|Adverse Event|0|||
126579911|NCT03398148|455421715|FG014|Substudy 1 Period 1|Adverse Event|0|||
126579912|NCT03398148|455421701|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
126579913|NCT03398148|455421702|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
126579914|NCT03398148|455421703|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126579915|NCT03398148|455421704|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
126579916|NCT03398148|455421705|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
126579917|NCT03398148|455421706|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126579918|NCT03398148|455421707|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126579919|NCT03398148|455421708|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126579920|NCT03398148|455421709|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126579921|NCT03398148|455421710|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126579922|NCT03398148|455421711|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126579923|NCT03398148|455421712|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126579924|NCT03398148|455421713|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126579925|NCT03398148|455421714|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126579926|NCT03398148|455421715|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
126579927|NCT03398148|455421701|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
126579928|NCT03398148|455421702|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
126579929|NCT03398148|455421703|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
126579930|NCT03398148|455421704|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
126579931|NCT03398148|455421705|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
126579932|NCT03398148|455421706|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
126579933|NCT03398148|455421707|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
126579934|NCT03398148|455421708|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
126579935|NCT03398148|455421709|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
126579936|NCT03398148|455421710|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
126579937|NCT03398148|455421711|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
126579938|NCT03398148|455421712|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
126579939|NCT03398148|455421713|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
126579940|NCT03398148|455421714|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
126579941|NCT03398148|455421715|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
126579942|NCT03398148|455421701|FG000|Substudy 1 Period 1|Other|0|||
126579943|NCT03398148|455421702|FG001|Substudy 1 Period 1|Other|1|||
126579944|NCT03398148|455421703|FG002|Substudy 1 Period 1|Other|0|||
126579945|NCT03398148|455421704|FG003|Substudy 1 Period 1|Other|0|||
126728867|NCT03444870|455956831|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
126728868|NCT03444870|455956826|FG000|Open-Label Extension (OLE) Period|Death|0|||
126728869|NCT03444870|455956827|FG001|Open-Label Extension (OLE) Period|Death|0|||
126529008|NCT01910129|455227619|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
126529009|NCT01910129|455227620|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
126529010|NCT01910129|455227618|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
126529011|NCT01910129|455227619|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
126529012|NCT01910129|455227620|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
126529013|NCT00319098|455227621|FG000|Overall Study|Serious adverse event|3|||
126529014|NCT00319098|455227622|FG001|Overall Study|Serious adverse event|0|||
126529015|NCT00319098|455227621|FG000|Overall Study|Adverse Event|20|||
126529016|NCT00319098|455227622|FG001|Overall Study|Adverse Event|1|||
126529017|NCT00319098|455227621|FG000|Overall Study|Withdrawal by Subject|37|||
126529018|NCT00319098|455227622|FG001|Overall Study|Withdrawal by Subject|8|||
126529019|NCT00319098|455227621|FG000|Overall Study|Migrated/moved from study area|2|||
126529020|NCT00319098|455227622|FG001|Overall Study|Migrated/moved from study area|1|||
126529021|NCT00319098|455227621|FG000|Overall Study|Lost to Follow-up|37|||
126529022|NCT00319098|455227622|FG001|Overall Study|Lost to Follow-up|13|||
126529023|NCT00319098|455227621|FG000|Overall Study|Others|33|||
126529024|NCT00319098|455227622|FG001|Overall Study|Others|8|||
126529025|NCT00319098|455227621|FG000|Overall Study|Protocol Violation|3|||
126529026|NCT00319098|455227622|FG001|Overall Study|Protocol Violation|1|||
126529027|NCT03595904|455227625|FG000|Overall Study|Protocol Violation|3|||
126529028|NCT03595904|455227626|FG001|Overall Study|Protocol Violation|1|||
126529029|NCT03595904|455227625|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
126529030|NCT03595904|455227626|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
126529031|NCT03595904|455227625|FG000|Overall Study|Insurance complications|1|||
126529032|NCT03595904|455227626|FG001|Overall Study|Insurance complications|0|||
126529033|NCT03595904|455227625|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
126529034|NCT03595904|455227626|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
126529035|NCT01392560|455227627|FG000|Overall Study|Adverse Event|2|||
126529036|NCT01392560|455227627|FG000|Overall Study|not entered|8|||
126529037|NCT01392560|455227627|FG000|Overall Study|discontinued during placebo run-in|2|||
126529038|NCT02199028|455227637|FG000|Week 1|Adverse Event|1|||
126529039|NCT02199028|455227638|FG001|Week 1|Adverse Event|0|||
126529040|NCT02199028|455227637|FG000|Week 3|Adverse Event|1|||
126529041|NCT02199028|455227638|FG001|Week 3|Adverse Event|0|||
126529042|NCT01881126|455227639|FG000|Overall Study|Non-compliance|1|||
126529043|NCT01881126|455227640|FG001|Overall Study|Non-compliance|1|||
126529044|NCT01881126|455227639|FG000|Overall Study|Adverse Event|0|||
126529045|NCT01881126|455227640|FG001|Overall Study|Adverse Event|1|||
126529046|NCT02341417|455227641|FG000|Overall Study|Withdrawal by Subject|0|||
126529047|NCT02341417|455227642|FG001|Overall Study|Withdrawal by Subject|2|||
126529048|NCT02341417|455227643|FG002|Overall Study|Withdrawal by Subject|0|||
126529049|NCT02341417|455227641|FG000|Overall Study|Decision by sponsor|2|||
126529050|NCT02341417|455227642|FG001|Overall Study|Decision by sponsor|0|||
126529051|NCT02341417|455227643|FG002|Overall Study|Decision by sponsor|0|||
126529052|NCT02341417|455227641|FG000|Overall Study|Death|0|||
126529053|NCT02341417|455227642|FG001|Overall Study|Death|0|||
126529054|NCT02341417|455227643|FG002|Overall Study|Death|1|||
126579946|NCT03398148|455421705|FG004|Substudy 1 Period 1|Other|3|||
126579947|NCT03398148|455421706|FG005|Substudy 1 Period 1|Other|0|||
126728870|NCT03444870|455956828|FG002|Open-Label Extension (OLE) Period|Death|0|||
126529055|NCT04656847|455227650|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
126579948|NCT03398148|455421707|FG006|Substudy 1 Period 1|Other|0|||
126579949|NCT03398148|455421708|FG007|Substudy 1 Period 1|Other|0|||
126579950|NCT03398148|455421709|FG008|Substudy 1 Period 1|Other|0|||
126579951|NCT03398148|455421710|FG009|Substudy 1 Period 1|Other|0|||
126579952|NCT03398148|455421711|FG010|Substudy 1 Period 1|Other|0|||
126579953|NCT03398148|455421712|FG011|Substudy 1 Period 1|Other|0|||
126579954|NCT03398148|455421713|FG012|Substudy 1 Period 1|Other|0|||
126579955|NCT03398148|455421714|FG013|Substudy 1 Period 1|Other|0|||
126579956|NCT03398148|455421715|FG014|Substudy 1 Period 1|Other|0|||
126579957|NCT03398148|455421701|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579958|NCT03398148|455421702|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579959|NCT03398148|455421703|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579960|NCT03398148|455421704|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579961|NCT03398148|455421705|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
126579962|NCT03398148|455421706|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579963|NCT03398148|455421707|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579964|NCT03398148|455421708|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579965|NCT03398148|455421709|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579966|NCT03398148|455421710|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579967|NCT03398148|455421711|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579968|NCT03398148|455421712|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579969|NCT03398148|455421713|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579970|NCT03398148|455421714|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579971|NCT03398148|455421715|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
126579972|NCT03398148|455421701|FG000|Substudy 1 Period 2|Adverse Event|0|||
126579973|NCT03398148|455421702|FG001|Substudy 1 Period 2|Adverse Event|0|||
126579974|NCT03398148|455421703|FG002|Substudy 1 Period 2|Adverse Event|0|||
126579975|NCT03398148|455421704|FG003|Substudy 1 Period 2|Adverse Event|0|||
126579976|NCT03398148|455421705|FG004|Substudy 1 Period 2|Adverse Event|0|||
126579977|NCT03398148|455421706|FG005|Substudy 1 Period 2|Adverse Event|2|||
126579978|NCT03398148|455421707|FG006|Substudy 1 Period 2|Adverse Event|4|||
126579979|NCT03398148|455421708|FG007|Substudy 1 Period 2|Adverse Event|0|||
126579980|NCT03398148|455421709|FG008|Substudy 1 Period 2|Adverse Event|0|||
126579981|NCT03398148|455421710|FG009|Substudy 1 Period 2|Adverse Event|0|||
126579982|NCT03398148|455421711|FG010|Substudy 1 Period 2|Adverse Event|0|||
126579983|NCT03398148|455421712|FG011|Substudy 1 Period 2|Adverse Event|0|||
126579984|NCT03398148|455421713|FG012|Substudy 1 Period 2|Adverse Event|0|||
126579985|NCT03398148|455421714|FG013|Substudy 1 Period 2|Adverse Event|0|||
126579986|NCT03398148|455421715|FG014|Substudy 1 Period 2|Adverse Event|0|||
126579987|NCT03398148|455421701|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126579988|NCT03398148|455421702|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126579989|NCT03398148|455421703|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126579990|NCT03398148|455421704|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126579991|NCT03398148|455421705|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126579992|NCT03398148|455421706|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126579993|NCT03398148|455421707|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
126579994|NCT03398148|455421708|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
126579995|NCT03398148|455421709|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126579996|NCT03398148|455421710|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126579997|NCT03398148|455421711|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126579998|NCT03398148|455421712|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126579999|NCT03398148|455421713|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126580000|NCT03398148|455421714|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126580001|NCT03398148|455421715|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
126580002|NCT03398148|455421701|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
126580003|NCT03398148|455421702|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
126529056|NCT03301051|455227651|FG000|Overall Study|Adverse Event|0|||
126529057|NCT03301051|455227652|FG001|Overall Study|Adverse Event|4|||
126529058|NCT03301051|455227651|FG000|Overall Study|Withdrawal by Subject|59|||
126529059|NCT03301051|455227652|FG001|Overall Study|Withdrawal by Subject|65|||
126529060|NCT03301051|455227651|FG000|Overall Study|Lost to Follow-up|263|||
126529061|NCT03301051|455227652|FG001|Overall Study|Lost to Follow-up|282|||
126529062|NCT03301051|455227651|FG000|Overall Study|Protocol Violation|1|||
126529063|NCT03301051|455227652|FG001|Overall Study|Protocol Violation|3|||
126529064|NCT03301051|455227651|FG000|Overall Study|Physician Decision|1|||
126580004|NCT03398148|455421703|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
126580005|NCT03398148|455421704|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
126580006|NCT03398148|455421705|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
126580007|NCT03398148|455421706|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
126580008|NCT03398148|455421707|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
126580009|NCT03398148|455421708|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
126580010|NCT03398148|455421709|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
126580011|NCT03398148|455421710|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
126580012|NCT03398148|455421711|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
126580013|NCT03398148|455421712|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
126580014|NCT03398148|455421713|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
126580015|NCT03398148|455421714|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
126580016|NCT03398148|455421715|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
126580017|NCT03398148|455421701|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580018|NCT03398148|455421702|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580019|NCT03398148|455421703|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580020|NCT03398148|455421704|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580021|NCT03398148|455421705|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580022|NCT03398148|455421706|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580023|NCT03398148|455421707|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
126580024|NCT03398148|455421708|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580025|NCT03398148|455421709|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580026|NCT03398148|455421710|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580027|NCT03398148|455421711|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580028|NCT03398148|455421712|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580029|NCT03398148|455421713|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580030|NCT03398148|455421714|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580031|NCT03398148|455421715|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580032|NCT03398148|455421701|FG000|Substudy 1 Period 2|Other|0|||
126580033|NCT03398148|455421702|FG001|Substudy 1 Period 2|Other|0|||
126580034|NCT03398148|455421703|FG002|Substudy 1 Period 2|Other|0|||
126580035|NCT03398148|455421704|FG003|Substudy 1 Period 2|Other|0|||
126580036|NCT03398148|455421705|FG004|Substudy 1 Period 2|Other|0|||
126580037|NCT03398148|455421706|FG005|Substudy 1 Period 2|Other|0|||
126580038|NCT03398148|455421707|FG006|Substudy 1 Period 2|Other|1|||
126580039|NCT03398148|455421708|FG007|Substudy 1 Period 2|Other|0|||
126580040|NCT03398148|455421709|FG008|Substudy 1 Period 2|Other|0|||
126580041|NCT03398148|455421710|FG009|Substudy 1 Period 2|Other|0|||
126580042|NCT03398148|455421711|FG010|Substudy 1 Period 2|Other|0|||
126580043|NCT03398148|455421712|FG011|Substudy 1 Period 2|Other|0|||
126580044|NCT03398148|455421713|FG012|Substudy 1 Period 2|Other|0|||
126580045|NCT03398148|455421714|FG013|Substudy 1 Period 2|Other|0|||
126580046|NCT03398148|455421715|FG014|Substudy 1 Period 2|Other|0|||
126580047|NCT03398148|455421701|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580048|NCT03398148|455421702|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580049|NCT03398148|455421703|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580050|NCT03398148|455421704|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580051|NCT03398148|455421705|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580052|NCT03398148|455421706|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580053|NCT03398148|455421707|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
126580054|NCT03398148|455421708|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580055|NCT03398148|455421709|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580056|NCT03398148|455421710|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580057|NCT03398148|455421711|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580058|NCT03398148|455421712|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580059|NCT03398148|455421713|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580060|NCT03398148|455421714|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580061|NCT03398148|455421715|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
126580062|NCT03398148|455421701|FG000|Substudy 2 Period 1|Adverse Event|0|||
126580063|NCT03398148|455421702|FG001|Substudy 2 Period 1|Adverse Event|0|||
126580064|NCT03398148|455421703|FG002|Substudy 2 Period 1|Adverse Event|0|||
126580065|NCT03398148|455421704|FG003|Substudy 2 Period 1|Adverse Event|0|||
126580066|NCT03398148|455421705|FG004|Substudy 2 Period 1|Adverse Event|0|||
126580067|NCT03398148|455421706|FG005|Substudy 2 Period 1|Adverse Event|0|||
126580068|NCT03398148|455421707|FG006|Substudy 2 Period 1|Adverse Event|0|||
126580069|NCT03398148|455421708|FG007|Substudy 2 Period 1|Adverse Event|0|||
126580070|NCT03398148|455421709|FG008|Substudy 2 Period 1|Adverse Event|0|||
126580071|NCT03398148|455421710|FG009|Substudy 2 Period 1|Adverse Event|12|||
126580072|NCT03398148|455421711|FG010|Substudy 2 Period 1|Adverse Event|2|||
126580073|NCT03398148|455421712|FG011|Substudy 2 Period 1|Adverse Event|0|||
126580074|NCT03398148|455421713|FG012|Substudy 2 Period 1|Adverse Event|0|||
126580075|NCT03398148|455421714|FG013|Substudy 2 Period 1|Adverse Event|0|||
126580076|NCT03398148|455421715|FG014|Substudy 2 Period 1|Adverse Event|0|||
126580077|NCT03398148|455421701|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126580078|NCT03398148|455421702|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126580079|NCT03398148|455421703|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126728871|NCT03444870|455956829|FG003|Open-Label Extension (OLE) Period|Death|0|||
126728872|NCT03444870|455956830|FG004|Open-Label Extension (OLE) Period|Death|1|||
126580080|NCT03398148|455421704|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126580081|NCT03398148|455421705|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126580082|NCT03398148|455421706|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126580083|NCT03398148|455421707|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126580084|NCT03398148|455421708|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126580085|NCT03398148|455421709|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126580086|NCT03398148|455421710|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
126580087|NCT03398148|455421711|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
126580088|NCT03398148|455421712|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126580089|NCT03398148|455421713|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126580090|NCT03398148|455421714|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126728873|NCT03444870|455956831|FG005|Open-Label Extension (OLE) Period|Death|0|||
126728874|NCT01204697|455956832|FG000|Overall Study|Death|26|||
126728875|NCT01204697|455956833|FG001|Overall Study|Death|27|||
126728876|NCT01204697|455956832|FG000|Overall Study|Lost to Follow-up|3|||
126728877|NCT01204697|455956833|FG001|Overall Study|Lost to Follow-up|4|||
126728878|NCT01204697|455956832|FG000|Overall Study|Withdrawal by Subject|2|||
126728879|NCT01204697|455956833|FG001|Overall Study|Withdrawal by Subject|4|||
126728880|NCT01204697|455956832|FG000|Overall Study|Randomized, but not treated|0|||
126728881|NCT01204697|455956833|FG001|Overall Study|Randomized, but not treated|1|||
126728882|NCT01205451|455956834|FG000|Overall Study|Lost to Follow-up|1|||
126728883|NCT01205451|455956835|FG001|Overall Study|Lost to Follow-up|1|||
126728884|NCT01205451|455956834|FG000|Overall Study|Withdrawal by Subject|5|||
126728885|NCT01205451|455956835|FG001|Overall Study|Withdrawal by Subject|9|||
126529065|NCT03301051|455227652|FG001|Overall Study|Physician Decision|3|||
126529066|NCT03301051|455227651|FG000|Overall Study|Death|1|||
126529067|NCT03301051|455227652|FG001|Overall Study|Death|1|||
126529068|NCT03301051|455227651|FG000|Overall Study|Miscellaneous|8|||
126529069|NCT03301051|455227652|FG001|Overall Study|Miscellaneous|4|||
126529070|NCT03301051|455227651|FG000|Overall Study|Randomized, not vaccinated|13|||
126529071|NCT03301051|455227652|FG001|Overall Study|Randomized, not vaccinated|10|||
126529072|NCT00047879|455227653|FG000|Overall Study|Progressive disease|4|||
126529073|NCT00047879|455227654|FG001|Overall Study|Progressive disease|3|||
126529074|NCT04764396|455227664|FG000|Overall Study|Physician Decision|1|||
126529075|NCT04764396|455227665|FG001|Overall Study|Physician Decision|0|||
126529076|NCT04657211|455227668|FG000|Overall Study|Withdrawal by Subject|21|||
126529077|NCT04657211|455227668|FG000|Overall Study|Lost to Follow-up|113|||
126529078|NCT04657211|455227668|FG000|Overall Study|Death|47|||
126529079|NCT04657211|455227668|FG000|Overall Study|Transfer to another institution|21|||
126529080|NCT04657211|455227668|FG000|Overall Study|Other|29|||
126529081|NCT01962493|455227669|FG000|Overall Study|Adverse Event|1|||
126529082|NCT01962493|455227670|FG001|Overall Study|Adverse Event|2|||
126529083|NCT01962493|455227669|FG000|Overall Study|Protocol Violation|0|||
126529084|NCT01962493|455227670|FG001|Overall Study|Protocol Violation|1|||
126529085|NCT01962493|455227669|FG000|Overall Study|Withdrawal by Subject|4|||
126529086|NCT01962493|455227670|FG001|Overall Study|Withdrawal by Subject|2|||
126529087|NCT03776136|455227671|FG000|Overall Study|Death|85|||
126529088|NCT03776136|455227671|FG000|Overall Study|Withdrawal by Subject|3|||
126529089|NCT03776136|455227671|FG000|Overall Study|Sponsor Decision|15|||
126529090|NCT06273774|455227672|FG000|Overall Study|Participant was out of state.|0|||
126529091|NCT06273774|455227673|FG001|Overall Study|Participant was out of state.|0|||
126529092|NCT06273774|455227674|FG002|Overall Study|Participant was out of state.|0|||
126529093|NCT06273774|455227675|FG003|Overall Study|Participant was out of state.|0|||
126529094|NCT06273774|455227676|FG004|Overall Study|Participant was out of state.|0|||
126529095|NCT06273774|455227677|FG005|Overall Study|Participant was out of state.|1|||
126529096|NCT06273774|455227672|FG000|Overall Study|Lost to Follow-up|0|||
126529097|NCT06273774|455227673|FG001|Overall Study|Lost to Follow-up|0|||
126529098|NCT06273774|455227674|FG002|Overall Study|Lost to Follow-up|0|||
126529099|NCT06273774|455227675|FG003|Overall Study|Lost to Follow-up|0|||
126529100|NCT06273774|455227676|FG004|Overall Study|Lost to Follow-up|1|||
126529101|NCT06273774|455227677|FG005|Overall Study|Lost to Follow-up|0|||
126529102|NCT04414696|455227682|FG000|3-month Follow up|Withdrawal by Subject|1|||
126529103|NCT04414696|455227683|FG001|3-month Follow up|Withdrawal by Subject|0|||
126529104|NCT04414696|455227682|FG000|3-month Follow up|Lost to Follow-up|22|||
126529105|NCT04414696|455227683|FG001|3-month Follow up|Lost to Follow-up|23|||
126529106|NCT04414696|455227682|FG000|6-month Follow up|Withdrawal by Subject|1|||
126529107|NCT04414696|455227683|FG001|6-month Follow up|Withdrawal by Subject|2|||
126529108|NCT04414696|455227682|FG000|6-month Follow up|Lost to Follow-up|5|||
126529109|NCT04414696|455227683|FG001|6-month Follow up|Lost to Follow-up|2|||
126529110|NCT00924287|455229862|FG000|Overall Study|Death|1|||
126529111|NCT01625897|455229863|FG000|Overall Study|Adverse Event|27|||
126529112|NCT01625897|455229864|FG001|Overall Study|Adverse Event|10|||
126529113|NCT01625897|455229863|FG000|Overall Study|Physician Decision|0|||
126529114|NCT01625897|455229864|FG001|Overall Study|Physician Decision|1|||
126529115|NCT01625897|455229863|FG000|Overall Study|Withdrawal by Subject|25|||
126529116|NCT01625897|455229864|FG001|Overall Study|Withdrawal by Subject|3|||
126529117|NCT02621931|455229865|FG000|Overall Study|Death|0|||
126529118|NCT02621931|455229866|FG001|Overall Study|Death|1|||
126529119|NCT02621931|455229867|FG002|Overall Study|Death|0|||
126529120|NCT02621931|455229865|FG000|Overall Study|Adverse Event|8|||
126529121|NCT02621931|455229866|FG001|Overall Study|Adverse Event|5|||
126529122|NCT02621931|455229867|FG002|Overall Study|Adverse Event|7|||
126529123|NCT02621931|455229865|FG000|Overall Study|Withdrawal by Subject|12|||
126529124|NCT02621931|455229866|FG001|Overall Study|Withdrawal by Subject|10|||
126529125|NCT02621931|455229867|FG002|Overall Study|Withdrawal by Subject|11|||
126529126|NCT02621931|455229865|FG000|Overall Study|Protocol Violation|2|||
126529127|NCT02621931|455229866|FG001|Overall Study|Protocol Violation|2|||
126529128|NCT02621931|455229867|FG002|Overall Study|Protocol Violation|2|||
126728886|NCT01194869|455956836|FG000|Overall Study|Disease Progression|2|||
126728887|NCT01194869|455956836|FG000|Overall Study|Toxicity|2|||
126728888|NCT04321252|455956837|FG000|Overall Study|Withdrawal by Subject|0|||
126728889|NCT04321252|455956838|FG001|Overall Study|Withdrawal by Subject|0|||
126580091|NCT03398148|455421715|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
126580092|NCT03398148|455421701|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
126580093|NCT03398148|455421702|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
126580094|NCT03398148|455421703|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
126580095|NCT03398148|455421704|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
126580096|NCT03398148|455421705|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
126580097|NCT03398148|455421706|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
126580098|NCT03398148|455421707|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
126580099|NCT03398148|455421708|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
126580100|NCT03398148|455421709|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
126580101|NCT03398148|455421710|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
126580102|NCT03398148|455421711|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
126580103|NCT03398148|455421712|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
126580104|NCT03398148|455421713|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
126580105|NCT03398148|455421714|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
126580106|NCT03398148|455421715|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
126580107|NCT03398148|455421701|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580108|NCT03398148|455421702|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580109|NCT03398148|455421703|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580110|NCT03398148|455421704|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580111|NCT03398148|455421705|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580112|NCT03398148|455421706|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580113|NCT03398148|455421707|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580114|NCT03398148|455421708|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580115|NCT03398148|455421709|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580116|NCT03398148|455421710|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580117|NCT03398148|455421711|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
126580118|NCT03398148|455421712|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580119|NCT03398148|455421713|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580120|NCT03398148|455421714|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580121|NCT03398148|455421715|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
126580122|NCT03398148|455421701|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580123|NCT03398148|455421702|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580124|NCT03398148|455421703|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580125|NCT03398148|455421704|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580126|NCT03398148|455421705|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580127|NCT03398148|455421706|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580128|NCT03398148|455421707|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580129|NCT03398148|455421708|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580130|NCT03398148|455421709|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580131|NCT03398148|455421710|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580132|NCT03398148|455421711|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
126580133|NCT03398148|455421712|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580134|NCT03398148|455421713|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580135|NCT03398148|455421714|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580136|NCT03398148|455421715|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
126580137|NCT03398148|455421701|FG000|Substudy 2 Period 1|Other|0|||
126580138|NCT03398148|455421702|FG001|Substudy 2 Period 1|Other|0|||
126580139|NCT03398148|455421703|FG002|Substudy 2 Period 1|Other|0|||
126580140|NCT03398148|455421704|FG003|Substudy 2 Period 1|Other|0|||
126580141|NCT03398148|455421705|FG004|Substudy 2 Period 1|Other|0|||
126580142|NCT03398148|455421706|FG005|Substudy 2 Period 1|Other|0|||
126580143|NCT03398148|455421707|FG006|Substudy 2 Period 1|Other|0|||
126580144|NCT03398148|455421708|FG007|Substudy 2 Period 1|Other|0|||
126580145|NCT03398148|455421709|FG008|Substudy 2 Period 1|Other|0|||
126580146|NCT03398148|455421710|FG009|Substudy 2 Period 1|Other|4|||
126580147|NCT03398148|455421711|FG010|Substudy 2 Period 1|Other|4|||
126580148|NCT03398148|455421712|FG011|Substudy 2 Period 1|Other|0|||
126777130|NCT02024698|456141288|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
126580149|NCT03398148|455421713|FG012|Substudy 2 Period 1|Other|0|||
126580150|NCT03398148|455421714|FG013|Substudy 2 Period 1|Other|0|||
126580151|NCT03398148|455421715|FG014|Substudy 2 Period 1|Other|0|||
126580152|NCT03398148|455421701|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
126580153|NCT03398148|455421702|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
126580154|NCT03398148|455421703|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
126580155|NCT03398148|455421704|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
126580156|NCT03398148|455421705|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
126580157|NCT03398148|455421706|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
126580158|NCT03398148|455421707|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
126777131|NCT02024698|456141289|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
126580159|NCT03398148|455421708|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
126580160|NCT03398148|455421709|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
126580161|NCT03398148|455421710|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
126580162|NCT03398148|455421711|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
126529129|NCT02621931|455229865|FG000|Overall Study|Pregnancy|2|||
126529130|NCT02621931|455229866|FG001|Overall Study|Pregnancy|0|||
126529131|NCT02621931|455229867|FG002|Overall Study|Pregnancy|0|||
126529132|NCT02621931|455229865|FG000|Overall Study|Noncompliance to study procedures|0|||
126529133|NCT02621931|455229866|FG001|Overall Study|Noncompliance to study procedures|1|||
126529134|NCT02621931|455229867|FG002|Overall Study|Noncompliance to study procedures|2|||
126529135|NCT02621931|455229865|FG000|Overall Study|Lost to Follow-up|8|||
126529136|NCT02621931|455229866|FG001|Overall Study|Lost to Follow-up|7|||
126529137|NCT02621931|455229867|FG002|Overall Study|Lost to Follow-up|10|||
126529138|NCT02621931|455229865|FG000|Overall Study|Lack of Efficacy|0|||
126529139|NCT02621931|455229866|FG001|Overall Study|Lack of Efficacy|0|||
126529140|NCT02621931|455229867|FG002|Overall Study|Lack of Efficacy|1|||
126529141|NCT02621931|455229865|FG000|Overall Study|Other|1|||
126529142|NCT02621931|455229866|FG001|Overall Study|Other|1|||
126529143|NCT02621931|455229867|FG002|Overall Study|Other|3|||
126529144|NCT01912612|455229870|FG000|Overall Study|Adverse Event|4|||
126529145|NCT01912612|455229871|FG001|Overall Study|Adverse Event|0|||
126529146|NCT01912612|455229872|FG002|Overall Study|Adverse Event|0|||
126529147|NCT01912612|455229870|FG000|Overall Study|Withdrew consent|1|||
126529148|NCT01912612|455229871|FG001|Overall Study|Withdrew consent|0|||
126529149|NCT01912612|455229872|FG002|Overall Study|Withdrew consent|0|||
126529150|NCT01912612|455229870|FG000|Overall Study|Study design change|0|||
126529151|NCT01912612|455229871|FG001|Overall Study|Study design change|0|||
126529152|NCT01912612|455229872|FG002|Overall Study|Study design change|3|||
126529153|NCT02008890|455229873|FG000|Period 1|Withdrawal by Subject|7|||
126529154|NCT02008890|455229874|FG001|Period 1|Withdrawal by Subject|7|||
126529155|NCT02008890|455229875|FG002|Period 1|Withdrawal by Subject|5|||
126529156|NCT02008890|455229876|FG003|Period 1|Withdrawal by Subject|0|||
126529157|NCT02008890|455229877|FG004|Period 1|Withdrawal by Subject|0|||
126529158|NCT02008890|455229873|FG000|Period 1|Pregnancy|1|||
126529159|NCT02008890|455229874|FG001|Period 1|Pregnancy|0|||
126529160|NCT02008890|455229875|FG002|Period 1|Pregnancy|0|||
126529161|NCT02008890|455229876|FG003|Period 1|Pregnancy|0|||
126529162|NCT02008890|455229877|FG004|Period 1|Pregnancy|0|||
126529163|NCT02008890|455229873|FG000|Period 1|Physician Decision|1|||
126529164|NCT02008890|455229874|FG001|Period 1|Physician Decision|0|||
126529165|NCT02008890|455229875|FG002|Period 1|Physician Decision|1|||
126529166|NCT02008890|455229876|FG003|Period 1|Physician Decision|0|||
126529167|NCT02008890|455229877|FG004|Period 1|Physician Decision|0|||
126529168|NCT02008890|455229873|FG000|Period 1|Adverse Event|6|||
126529169|NCT02008890|455229874|FG001|Period 1|Adverse Event|8|||
126529170|NCT02008890|455229875|FG002|Period 1|Adverse Event|6|||
126529171|NCT02008890|455229876|FG003|Period 1|Adverse Event|0|||
126529172|NCT02008890|455229877|FG004|Period 1|Adverse Event|0|||
126529173|NCT02008890|455229873|FG000|Period 2|Adverse Event|12|||
126529174|NCT02008890|455229874|FG001|Period 2|Adverse Event|7|||
126529175|NCT02008890|455229875|FG002|Period 2|Adverse Event|0|||
126529176|NCT02008890|455229876|FG003|Period 2|Adverse Event|5|||
126529177|NCT02008890|455229877|FG004|Period 2|Adverse Event|5|||
126529178|NCT02008890|455229873|FG000|Period 2|Withdrawal by Subject|11|||
126529179|NCT02008890|455229874|FG001|Period 2|Withdrawal by Subject|8|||
126529180|NCT02008890|455229875|FG002|Period 2|Withdrawal by Subject|0|||
126529181|NCT02008890|455229876|FG003|Period 2|Withdrawal by Subject|7|||
126529182|NCT02008890|455229877|FG004|Period 2|Withdrawal by Subject|2|||
126529183|NCT02008890|455229873|FG000|Period 2|Physician Decision|4|||
126529184|NCT02008890|455229874|FG001|Period 2|Physician Decision|0|||
126529185|NCT02008890|455229875|FG002|Period 2|Physician Decision|0|||
126529186|NCT02008890|455229876|FG003|Period 2|Physician Decision|2|||
126529187|NCT02008890|455229877|FG004|Period 2|Physician Decision|1|||
126529188|NCT02008890|455229873|FG000|Period 2|Lost to Follow-up|0|||
126529189|NCT02008890|455229874|FG001|Period 2|Lost to Follow-up|0|||
126529190|NCT02008890|455229875|FG002|Period 2|Lost to Follow-up|1|||
126529191|NCT02008890|455229876|FG003|Period 2|Lost to Follow-up|0|||
126529192|NCT02008890|455229877|FG004|Period 2|Lost to Follow-up|0|||
126529193|NCT02008890|455229873|FG000|Extension Period|Withdrawal by Subject|3|||
126580163|NCT03398148|455421712|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
126529194|NCT02008890|455229874|FG001|Extension Period|Withdrawal by Subject|2|||
126529195|NCT02008890|455229875|FG002|Extension Period|Withdrawal by Subject|0|||
126529196|NCT02008890|455229876|FG003|Extension Period|Withdrawal by Subject|4|||
126529197|NCT02008890|455229877|FG004|Extension Period|Withdrawal by Subject|2|||
126529198|NCT02008890|455229873|FG000|Extension Period|Lost to Follow-up|1|||
126529199|NCT02008890|455229874|FG001|Extension Period|Lost to Follow-up|0|||
126529200|NCT02008890|455229875|FG002|Extension Period|Lost to Follow-up|0|||
126529201|NCT02008890|455229876|FG003|Extension Period|Lost to Follow-up|0|||
126529202|NCT02008890|455229877|FG004|Extension Period|Lost to Follow-up|0|||
126529203|NCT02008890|455229873|FG000|Extension Period|Adverse Event|1|||
126529204|NCT02008890|455229874|FG001|Extension Period|Adverse Event|3|||
126529205|NCT02008890|455229875|FG002|Extension Period|Adverse Event|0|||
126529206|NCT02008890|455229876|FG003|Extension Period|Adverse Event|0|||
126529207|NCT02008890|455229877|FG004|Extension Period|Adverse Event|2|||
126529208|NCT02207816|455229878|FG000|Overall Study|Serious Adverse Event|0|||
126529209|NCT02207816|455229879|FG001|Overall Study|Serious Adverse Event|5|||
126529210|NCT02207816|455229880|FG002|Overall Study|Serious Adverse Event|2|||
126529211|NCT02207816|455229878|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
126529212|NCT02207816|455229879|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
126529213|NCT02207816|455229880|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
126529214|NCT02207816|455229878|FG000|Overall Study|Withdrawal by Subject|4|||
126529215|NCT02207816|455229879|FG001|Overall Study|Withdrawal by Subject|9|||
126529216|NCT02207816|455229880|FG002|Overall Study|Withdrawal by Subject|7|||
126529217|NCT02207816|455229878|FG000|Overall Study|Migrated/Moved From Study Area|41|||
126529218|NCT02207816|455229879|FG001|Overall Study|Migrated/Moved From Study Area|60|||
126529219|NCT02207816|455229880|FG002|Overall Study|Migrated/Moved From Study Area|51|||
126529220|NCT02207816|455229878|FG000|Overall Study|Lost to Follow-up|3|||
126529221|NCT02207816|455229879|FG001|Overall Study|Lost to Follow-up|9|||
126529222|NCT02207816|455229880|FG002|Overall Study|Lost to Follow-up|1|||
126529223|NCT02207816|455229878|FG000|Overall Study|Other|1|||
126529224|NCT02207816|455229879|FG001|Overall Study|Other|2|||
126529225|NCT02207816|455229880|FG002|Overall Study|Other|4|||
126529226|NCT02522494|455229881|FG000|Overall Study|Lost to Follow-up|6|||
126529227|NCT02522494|455229882|FG001|Overall Study|Lost to Follow-up|2|||
126529228|NCT02522494|455229881|FG000|Overall Study|Withdrawal by Subject|1|||
126529229|NCT02522494|455229882|FG001|Overall Study|Withdrawal by Subject|0|||
126529230|NCT02522494|455229881|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
126529231|NCT02522494|455229882|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
126529232|NCT02522494|455229881|FG000|Overall Study|Participant did not watch the video|1|||
126529233|NCT02522494|455229882|FG001|Overall Study|Participant did not watch the video|0|||
126529234|NCT02522494|455229881|FG000|Overall Study|Death|0|||
126529235|NCT02522494|455229882|FG001|Overall Study|Death|1|||
126529236|NCT03461003|455229883|FG000|Overall Study|Lost to Follow-up|2|||
126529237|NCT03461003|455229884|FG001|Overall Study|Lost to Follow-up|2|||
126529238|NCT03461003|455229883|FG000|Overall Study|Withdrawal by Subject|3|||
126529239|NCT03461003|455229884|FG001|Overall Study|Withdrawal by Subject|1|||
126529240|NCT03489304|455229885|FG000|Overall Study|Lost to Follow-up|4|||
126529241|NCT02239679|455229889|FG000|Overall Study|Lost to Follow-up|1|||
126529242|NCT02239679|455229890|FG001|Overall Study|Lost to Follow-up|0|||
126529243|NCT02239679|455229891|FG002|Overall Study|Lost to Follow-up|0|||
126529244|NCT02239679|455229889|FG000|Overall Study|Withdrawal by Subject|2|||
126529245|NCT02239679|455229890|FG001|Overall Study|Withdrawal by Subject|3|||
126529246|NCT02239679|455229891|FG002|Overall Study|Withdrawal by Subject|1|||
126529247|NCT01217073|455229892|FG000|Base Period|Adverse Event|1|||
126529248|NCT01217073|455229893|FG001|Base Period|Adverse Event|0|||
126529249|NCT01217073|455229894|FG002|Base Period|Adverse Event|1|||
126529250|NCT01217073|455229895|FG003|Base Period|Adverse Event|0|||
126529251|NCT01217073|455229896|FG004|Base Period|Adverse Event|4|||
126529252|NCT01217073|455229897|FG005|Base Period|Adverse Event|1|||
126529253|NCT01217073|455229898|FG006|Base Period|Adverse Event|0|||
126529254|NCT01217073|455229899|FG007|Base Period|Adverse Event|0|||
126529255|NCT01217073|455229892|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
126529256|NCT01217073|455229893|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
126529257|NCT01217073|455229894|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
126529258|NCT01217073|455229895|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
126529259|NCT01217073|455229896|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
126529260|NCT01217073|455229897|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
126529261|NCT01217073|455229898|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
126529262|NCT01217073|455229899|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
126529263|NCT01217073|455229892|FG000|Base Period|Excluded medication|0|||
126529264|NCT01217073|455229893|FG001|Base Period|Excluded medication|0|||
126529265|NCT01217073|455229894|FG002|Base Period|Excluded medication|0|||
126529266|NCT01217073|455229895|FG003|Base Period|Excluded medication|0|||
126529267|NCT01217073|455229896|FG004|Base Period|Excluded medication|1|||
126529268|NCT01217073|455229897|FG005|Base Period|Excluded medication|0|||
126529269|NCT01217073|455229898|FG006|Base Period|Excluded medication|0|||
126529270|NCT01217073|455229899|FG007|Base Period|Excluded medication|0|||
126529271|NCT01217073|455229892|FG000|Base Period|Lack of Efficacy|0|||
126529272|NCT01217073|455229893|FG001|Base Period|Lack of Efficacy|0|||
126529273|NCT01217073|455229894|FG002|Base Period|Lack of Efficacy|0|||
126529274|NCT01217073|455229895|FG003|Base Period|Lack of Efficacy|0|||
126529275|NCT01217073|455229896|FG004|Base Period|Lack of Efficacy|0|||
126529276|NCT01217073|455229897|FG005|Base Period|Lack of Efficacy|1|||
126529277|NCT01217073|455229898|FG006|Base Period|Lack of Efficacy|0|||
126529278|NCT01217073|455229899|FG007|Base Period|Lack of Efficacy|0|||
126529279|NCT01217073|455229892|FG000|Base Period|Lost to Follow-up|0|||
126529280|NCT01217073|455229893|FG001|Base Period|Lost to Follow-up|0|||
126529281|NCT01217073|455229894|FG002|Base Period|Lost to Follow-up|1|||
126529282|NCT01217073|455229895|FG003|Base Period|Lost to Follow-up|1|||
126529283|NCT01217073|455229896|FG004|Base Period|Lost to Follow-up|3|||
126529284|NCT01217073|455229897|FG005|Base Period|Lost to Follow-up|0|||
126529285|NCT01217073|455229898|FG006|Base Period|Lost to Follow-up|0|||
126529286|NCT01217073|455229899|FG007|Base Period|Lost to Follow-up|0|||
126580164|NCT03398148|455421713|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
126580165|NCT03398148|455421714|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
126580166|NCT03398148|455421715|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
126580167|NCT03398148|455421701|FG000|Substudy 2 Period 2|Adverse Event|0|||
126580168|NCT03398148|455421702|FG001|Substudy 2 Period 2|Adverse Event|0|||
126580169|NCT03398148|455421703|FG002|Substudy 2 Period 2|Adverse Event|0|||
126580170|NCT03398148|455421704|FG003|Substudy 2 Period 2|Adverse Event|0|||
126580171|NCT03398148|455421705|FG004|Substudy 2 Period 2|Adverse Event|0|||
126580172|NCT03398148|455421706|FG005|Substudy 2 Period 2|Adverse Event|0|||
126580173|NCT03398148|455421707|FG006|Substudy 2 Period 2|Adverse Event|0|||
126580174|NCT03398148|455421708|FG007|Substudy 2 Period 2|Adverse Event|0|||
126580175|NCT03398148|455421709|FG008|Substudy 2 Period 2|Adverse Event|0|||
126580176|NCT03398148|455421710|FG009|Substudy 2 Period 2|Adverse Event|0|||
126580177|NCT03398148|455421711|FG010|Substudy 2 Period 2|Adverse Event|0|||
126580178|NCT03398148|455421712|FG011|Substudy 2 Period 2|Adverse Event|0|||
126580179|NCT03398148|455421713|FG012|Substudy 2 Period 2|Adverse Event|0|||
126580180|NCT03398148|455421714|FG013|Substudy 2 Period 2|Adverse Event|1|||
126580181|NCT03398148|455421715|FG014|Substudy 2 Period 2|Adverse Event|3|||
126580182|NCT03398148|455421701|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
126580183|NCT03398148|455421702|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
126580184|NCT03398148|455421703|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
126580185|NCT03398148|455421704|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
126580186|NCT03398148|455421705|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
126580187|NCT03398148|455421706|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
126580188|NCT03398148|455421707|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
126580189|NCT03398148|455421708|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
126580190|NCT03398148|455421709|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
126580191|NCT03398148|455421710|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
126580192|NCT03398148|455421711|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
126580193|NCT03398148|455421712|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
126580194|NCT03398148|455421713|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
126580195|NCT03398148|455421714|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
126580196|NCT03398148|455421715|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
126580197|NCT03398148|455421701|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126580198|NCT03398148|455421702|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126580199|NCT03398148|455421703|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126580200|NCT03398148|455421704|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126580201|NCT03398148|455421705|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126580202|NCT03398148|455421706|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126580203|NCT03398148|455421707|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126580204|NCT03398148|455421708|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126580205|NCT03398148|455421709|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126580206|NCT03398148|455421710|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126580207|NCT03398148|455421711|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126580208|NCT03398148|455421712|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
126580209|NCT03398148|455421713|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
126580210|NCT03398148|455421714|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
126580211|NCT03398148|455421715|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
126580212|NCT03398148|455421701|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
126580213|NCT03398148|455421702|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
126580214|NCT03398148|455421703|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
126580215|NCT03398148|455421704|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
126580216|NCT03398148|455421705|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
126580217|NCT03398148|455421706|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
126580218|NCT03398148|455421707|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
126580219|NCT03398148|455421708|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
126580220|NCT03398148|455421709|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
126580221|NCT03398148|455421710|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
126580222|NCT03398148|455421711|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
126580223|NCT03398148|455421712|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
126580224|NCT03398148|455421713|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
126580225|NCT03398148|455421714|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
126580226|NCT03398148|455421715|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
126580227|NCT03398148|455421701|FG000|Substudy 2 Period 2|Other|0|||
126580228|NCT03398148|455421702|FG001|Substudy 2 Period 2|Other|0|||
126580229|NCT03398148|455421703|FG002|Substudy 2 Period 2|Other|0|||
126580230|NCT03398148|455421704|FG003|Substudy 2 Period 2|Other|0|||
126580231|NCT03398148|455421705|FG004|Substudy 2 Period 2|Other|0|||
126580232|NCT03398148|455421706|FG005|Substudy 2 Period 2|Other|0|||
126580233|NCT03398148|455421707|FG006|Substudy 2 Period 2|Other|0|||
126580234|NCT03398148|455421708|FG007|Substudy 2 Period 2|Other|0|||
126580235|NCT03398148|455421709|FG008|Substudy 2 Period 2|Other|0|||
126580236|NCT03398148|455421710|FG009|Substudy 2 Period 2|Other|0|||
126728890|NCT04321252|455956839|FG002|Overall Study|Withdrawal by Subject|0|||
126580237|NCT03398148|455421711|FG010|Substudy 2 Period 2|Other|0|||
126580238|NCT03398148|455421712|FG011|Substudy 2 Period 2|Other|0|||
126580239|NCT03398148|455421713|FG012|Substudy 2 Period 2|Other|0|||
126580240|NCT03398148|455421714|FG013|Substudy 2 Period 2|Other|1|||
126529287|NCT01217073|455229892|FG000|Base Period|Physician Decision|0|||
126529288|NCT01217073|455229893|FG001|Base Period|Physician Decision|0|||
126529289|NCT01217073|455229894|FG002|Base Period|Physician Decision|0|||
126529290|NCT01217073|455229895|FG003|Base Period|Physician Decision|0|||
126529291|NCT01217073|455229896|FG004|Base Period|Physician Decision|1|||
126529292|NCT01217073|455229897|FG005|Base Period|Physician Decision|0|||
126529293|NCT01217073|455229898|FG006|Base Period|Physician Decision|0|||
126529294|NCT01217073|455229899|FG007|Base Period|Physician Decision|0|||
126529295|NCT01217073|455229892|FG000|Base Period|Protocol Violation|1|||
126529296|NCT01217073|455229893|FG001|Base Period|Protocol Violation|0|||
126529297|NCT01217073|455229894|FG002|Base Period|Protocol Violation|0|||
126529298|NCT01217073|455229895|FG003|Base Period|Protocol Violation|0|||
126529299|NCT01217073|455229896|FG004|Base Period|Protocol Violation|1|||
126529300|NCT01217073|455229897|FG005|Base Period|Protocol Violation|2|||
126529301|NCT01217073|455229898|FG006|Base Period|Protocol Violation|0|||
126529302|NCT01217073|455229899|FG007|Base Period|Protocol Violation|0|||
126529303|NCT01217073|455229892|FG000|Base Period|Withdrawal by Subject|4|||
126529304|NCT01217073|455229893|FG001|Base Period|Withdrawal by Subject|5|||
126529305|NCT01217073|455229894|FG002|Base Period|Withdrawal by Subject|5|||
126529306|NCT01217073|455229895|FG003|Base Period|Withdrawal by Subject|1|||
126529307|NCT01217073|455229896|FG004|Base Period|Withdrawal by Subject|5|||
126529308|NCT01217073|455229897|FG005|Base Period|Withdrawal by Subject|5|||
126529309|NCT01217073|455229898|FG006|Base Period|Withdrawal by Subject|0|||
126529310|NCT01217073|455229899|FG007|Base Period|Withdrawal by Subject|0|||
126529311|NCT01217073|455229892|FG000|Extension Period|Adverse Event|0|||
126529312|NCT01217073|455229893|FG001|Extension Period|Adverse Event|0|||
126529313|NCT01217073|455229894|FG002|Extension Period|Adverse Event|0|||
126529314|NCT01217073|455229895|FG003|Extension Period|Adverse Event|0|||
126529315|NCT01217073|455229896|FG004|Extension Period|Adverse Event|0|||
126529316|NCT01217073|455229897|FG005|Extension Period|Adverse Event|0|||
126529317|NCT01217073|455229898|FG006|Extension Period|Adverse Event|19|||
126529318|NCT01217073|455229899|FG007|Extension Period|Adverse Event|5|||
126529319|NCT01217073|455229892|FG000|Extension Period|ALT/AST|0|||
126529320|NCT01217073|455229893|FG001|Extension Period|ALT/AST|0|||
126529321|NCT01217073|455229894|FG002|Extension Period|ALT/AST|0|||
126529322|NCT01217073|455229895|FG003|Extension Period|ALT/AST|0|||
126529323|NCT01217073|455229896|FG004|Extension Period|ALT/AST|0|||
126529324|NCT01217073|455229897|FG005|Extension Period|ALT/AST|0|||
126529325|NCT01217073|455229898|FG006|Extension Period|ALT/AST|2|||
126529326|NCT01217073|455229899|FG007|Extension Period|ALT/AST|0|||
126529327|NCT01217073|455229892|FG000|Extension Period|Contraindication to study medication|0|||
126529328|NCT01217073|455229893|FG001|Extension Period|Contraindication to study medication|0|||
126529329|NCT01217073|455229894|FG002|Extension Period|Contraindication to study medication|0|||
126529330|NCT01217073|455229895|FG003|Extension Period|Contraindication to study medication|0|||
126529331|NCT01217073|455229896|FG004|Extension Period|Contraindication to study medication|0|||
126529332|NCT01217073|455229897|FG005|Extension Period|Contraindication to study medication|0|||
126529333|NCT01217073|455229898|FG006|Extension Period|Contraindication to study medication|1|||
126529334|NCT01217073|455229899|FG007|Extension Period|Contraindication to study medication|0|||
126529335|NCT01217073|455229892|FG000|Extension Period|Creatinine/eGFR|0|||
126529336|NCT01217073|455229893|FG001|Extension Period|Creatinine/eGFR|0|||
126529337|NCT01217073|455229894|FG002|Extension Period|Creatinine/eGFR|0|||
126529338|NCT01217073|455229895|FG003|Extension Period|Creatinine/eGFR|0|||
126529339|NCT01217073|455229896|FG004|Extension Period|Creatinine/eGFR|0|||
126529340|NCT01217073|455229897|FG005|Extension Period|Creatinine/eGFR|0|||
126529341|NCT01217073|455229898|FG006|Extension Period|Creatinine/eGFR|11|||
126529342|NCT01217073|455229899|FG007|Extension Period|Creatinine/eGFR|1|||
126529343|NCT01217073|455229892|FG000|Extension Period|Death|0|||
126529344|NCT01217073|455229893|FG001|Extension Period|Death|0|||
126529345|NCT01217073|455229894|FG002|Extension Period|Death|0|||
126529346|NCT01217073|455229895|FG003|Extension Period|Death|0|||
126529347|NCT01217073|455229896|FG004|Extension Period|Death|0|||
126529348|NCT01217073|455229897|FG005|Extension Period|Death|0|||
126529349|NCT01217073|455229898|FG006|Extension Period|Death|1|||
126529350|NCT01217073|455229899|FG007|Extension Period|Death|0|||
126529351|NCT01217073|455229892|FG000|Extension Period|Excluded medication|0|||
126529352|NCT01217073|455229893|FG001|Extension Period|Excluded medication|0|||
126529353|NCT01217073|455229894|FG002|Extension Period|Excluded medication|0|||
126529354|NCT01217073|455229895|FG003|Extension Period|Excluded medication|0|||
126529355|NCT01217073|455229896|FG004|Extension Period|Excluded medication|0|||
126529356|NCT01217073|455229897|FG005|Extension Period|Excluded medication|0|||
126529357|NCT01217073|455229898|FG006|Extension Period|Excluded medication|2|||
126529358|NCT01217073|455229899|FG007|Extension Period|Excluded medication|0|||
126529359|NCT01217073|455229892|FG000|Extension Period|Lack of Efficacy|0|||
126529360|NCT01217073|455229893|FG001|Extension Period|Lack of Efficacy|0|||
126529361|NCT01217073|455229894|FG002|Extension Period|Lack of Efficacy|0|||
126529362|NCT01217073|455229895|FG003|Extension Period|Lack of Efficacy|0|||
126529363|NCT01217073|455229896|FG004|Extension Period|Lack of Efficacy|0|||
126529364|NCT01217073|455229897|FG005|Extension Period|Lack of Efficacy|0|||
126529365|NCT01217073|455229898|FG006|Extension Period|Lack of Efficacy|3|||
126529366|NCT01217073|455229899|FG007|Extension Period|Lack of Efficacy|0|||
126580241|NCT03398148|455421715|FG014|Substudy 2 Period 2|Other|1|||
126580242|NCT03398148|455421701|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580243|NCT03398148|455421702|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580244|NCT03398148|455421703|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580245|NCT03398148|455421704|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580246|NCT03398148|455421705|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580247|NCT03398148|455421706|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580248|NCT03398148|455421707|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580249|NCT03398148|455421708|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580250|NCT03398148|455421709|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580251|NCT03398148|455421710|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580252|NCT03398148|455421711|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580253|NCT03398148|455421712|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580254|NCT03398148|455421713|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
126580255|NCT03398148|455421714|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
126580256|NCT03398148|455421715|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
126580257|NCT02791230|455421716|FG000|Overall Study|Adverse Event|10|||
126529367|NCT01217073|455229892|FG000|Extension Period|Lost to Follow-up|0|||
126529368|NCT01217073|455229893|FG001|Extension Period|Lost to Follow-up|0|||
126529369|NCT01217073|455229894|FG002|Extension Period|Lost to Follow-up|0|||
126529370|NCT01217073|455229895|FG003|Extension Period|Lost to Follow-up|0|||
126529371|NCT01217073|455229896|FG004|Extension Period|Lost to Follow-up|0|||
126529372|NCT01217073|455229897|FG005|Extension Period|Lost to Follow-up|0|||
126529373|NCT01217073|455229898|FG006|Extension Period|Lost to Follow-up|9|||
126529374|NCT01217073|455229899|FG007|Extension Period|Lost to Follow-up|1|||
126529375|NCT01217073|455229892|FG000|Extension Period|Non-compliance with study drug|0|||
126529376|NCT01217073|455229893|FG001|Extension Period|Non-compliance with study drug|0|||
126529377|NCT01217073|455229894|FG002|Extension Period|Non-compliance with study drug|0|||
126529378|NCT01217073|455229895|FG003|Extension Period|Non-compliance with study drug|0|||
126529379|NCT01217073|455229896|FG004|Extension Period|Non-compliance with study drug|0|||
126529380|NCT01217073|455229897|FG005|Extension Period|Non-compliance with study drug|0|||
126529381|NCT01217073|455229898|FG006|Extension Period|Non-compliance with study drug|0|||
126529382|NCT01217073|455229899|FG007|Extension Period|Non-compliance with study drug|1|||
126529383|NCT01217073|455229892|FG000|Extension Period|Physician Decision|0|||
126529384|NCT01217073|455229893|FG001|Extension Period|Physician Decision|0|||
126529385|NCT01217073|455229894|FG002|Extension Period|Physician Decision|0|||
126529386|NCT01217073|455229895|FG003|Extension Period|Physician Decision|0|||
126529387|NCT01217073|455229896|FG004|Extension Period|Physician Decision|0|||
126529388|NCT01217073|455229897|FG005|Extension Period|Physician Decision|0|||
126529389|NCT01217073|455229898|FG006|Extension Period|Physician Decision|4|||
126529390|NCT01217073|455229899|FG007|Extension Period|Physician Decision|1|||
126529391|NCT01217073|455229892|FG000|Extension Period|Protocol Violation|0|||
126529392|NCT01217073|455229893|FG001|Extension Period|Protocol Violation|0|||
126529393|NCT01217073|455229894|FG002|Extension Period|Protocol Violation|0|||
126529394|NCT01217073|455229895|FG003|Extension Period|Protocol Violation|0|||
126529395|NCT01217073|455229896|FG004|Extension Period|Protocol Violation|0|||
126529396|NCT01217073|455229897|FG005|Extension Period|Protocol Violation|0|||
126529397|NCT01217073|455229898|FG006|Extension Period|Protocol Violation|2|||
126529398|NCT01217073|455229899|FG007|Extension Period|Protocol Violation|1|||
126529399|NCT01217073|455229892|FG000|Extension Period|Site discontinued study participation|0|||
126529400|NCT01217073|455229893|FG001|Extension Period|Site discontinued study participation|0|||
126529401|NCT01217073|455229894|FG002|Extension Period|Site discontinued study participation|0|||
126529402|NCT01217073|455229895|FG003|Extension Period|Site discontinued study participation|0|||
126529403|NCT01217073|455229896|FG004|Extension Period|Site discontinued study participation|0|||
126529404|NCT01217073|455229897|FG005|Extension Period|Site discontinued study participation|0|||
126529405|NCT01217073|455229898|FG006|Extension Period|Site discontinued study participation|7|||
126580258|NCT02791230|455421717|FG001|Overall Study|Adverse Event|9|||
126580259|NCT02791230|455421718|FG002|Overall Study|Adverse Event|66|||
126580260|NCT02791230|455421716|FG000|Overall Study|Death|38|||
126580261|NCT02791230|455421717|FG001|Overall Study|Death|25|||
126580262|NCT02791230|455421718|FG002|Overall Study|Death|184|||
126529406|NCT01217073|455229899|FG007|Extension Period|Site discontinued study participation|2|||
126529407|NCT01217073|455229892|FG000|Extension Period|Withdrawal by Subject|0|||
126529408|NCT01217073|455229893|FG001|Extension Period|Withdrawal by Subject|0|||
126529409|NCT01217073|455229894|FG002|Extension Period|Withdrawal by Subject|0|||
126529410|NCT01217073|455229895|FG003|Extension Period|Withdrawal by Subject|0|||
126529411|NCT01217073|455229896|FG004|Extension Period|Withdrawal by Subject|0|||
126529412|NCT01217073|455229897|FG005|Extension Period|Withdrawal by Subject|0|||
126529413|NCT01217073|455229898|FG006|Extension Period|Withdrawal by Subject|30|||
126529414|NCT01217073|455229899|FG007|Extension Period|Withdrawal by Subject|8|||
126529415|NCT02564523|455229900|FG000|Overall Study|Withdrawal by Subject|3|||
126580263|NCT02791230|455421716|FG000|Overall Study|Lack of Efficacy|1|||
126777132|NCT01169649|456141290|FG000|Overall Study|Patient Not Treated|3|||
126529416|NCT02564523|455229901|FG001|Overall Study|Withdrawal by Subject|0|||
126529417|NCT02564523|455229902|FG002|Overall Study|Withdrawal by Subject|1|||
126529418|NCT02564523|455229903|FG003|Overall Study|Withdrawal by Subject|0|||
126529419|NCT02564523|455229904|FG004|Overall Study|Withdrawal by Subject|1|||
126529420|NCT02564523|455229905|FG005|Overall Study|Withdrawal by Subject|0|||
126529421|NCT02564523|455229906|FG006|Overall Study|Withdrawal by Subject|1|||
126580264|NCT02791230|455421717|FG001|Overall Study|Lack of Efficacy|0|||
126580265|NCT02791230|455421718|FG002|Overall Study|Lack of Efficacy|3|||
126580266|NCT02791230|455421716|FG000|Overall Study|Lost to Follow-up|0|||
126580267|NCT02791230|455421717|FG001|Overall Study|Lost to Follow-up|0|||
126580268|NCT02791230|455421718|FG002|Overall Study|Lost to Follow-up|10|||
126580269|NCT02791230|455421716|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
126580270|NCT02791230|455421717|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
126580271|NCT02791230|455421718|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
126580272|NCT02791230|455421716|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
126580273|NCT02791230|455421717|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
126580274|NCT02791230|455421718|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
126580275|NCT02791230|455421716|FG000|Overall Study|Study sites terminated by sponsor|1|||
126580276|NCT02791230|455421717|FG001|Overall Study|Study sites terminated by sponsor|0|||
126580277|NCT02791230|455421718|FG002|Overall Study|Study sites terminated by sponsor|5|||
126580278|NCT02791230|455421716|FG000|Overall Study|Other|9|||
126580279|NCT02791230|455421717|FG001|Overall Study|Other|1|||
126580280|NCT02791230|455421718|FG002|Overall Study|Other|28|||
126580281|NCT02791230|455421716|FG000|Overall Study|Protocol Violation|0|||
126580282|NCT02791230|455421717|FG001|Overall Study|Protocol Violation|0|||
126580283|NCT02791230|455421718|FG002|Overall Study|Protocol Violation|4|||
126580284|NCT02791230|455421716|FG000|Overall Study|Withdrawal by Subject|24|||
126580285|NCT02791230|455421717|FG001|Overall Study|Withdrawal by Subject|13|||
126580286|NCT02791230|455421718|FG002|Overall Study|Withdrawal by Subject|172|||
126580287|NCT02791230|455421716|FG000|Overall Study|Enrolled but not treated|0|||
126580288|NCT02791230|455421717|FG001|Overall Study|Enrolled but not treated|0|||
126580289|NCT02791230|455421718|FG002|Overall Study|Enrolled but not treated|5|||
126580290|NCT01259401|455421719|FG000|4-month Follow-up|Death|0|||
126529422|NCT02564523|455229907|FG007|Overall Study|Withdrawal by Subject|0|||
126580291|NCT01259401|455421720|FG001|4-month Follow-up|Death|1|||
126580292|NCT01259401|455421719|FG000|4-month Follow-up|Lost to Follow-up|0|||
126580293|NCT01259401|455421720|FG001|4-month Follow-up|Lost to Follow-up|1|||
126580294|NCT04201834|455421722|FG000|Overall Study|Screen fail|1|||
126580295|NCT00212355|455421723|FG000|Overall Study|Adverse Event|1|||
126580296|NCT00212355|455421723|FG000|Overall Study|Withdrawal by Subject|1|||
126580297|NCT00212355|455421723|FG000|Overall Study|A change of address|1|||
126580298|NCT04310735|455421726|FG000|Overall Study|Withdrawal by Subject|1|||
126580299|NCT04310735|455421727|FG001|Overall Study|Withdrawal by Subject|3|||
126580300|NCT04310735|455421728|FG002|Overall Study|Withdrawal by Subject|8|||
126580301|NCT04310735|455421726|FG000|Overall Study|Equipment malfunction|0|||
126580302|NCT04310735|455421727|FG001|Overall Study|Equipment malfunction|1|||
126580303|NCT04310735|455421728|FG002|Overall Study|Equipment malfunction|0|||
126580304|NCT03954184|455421729|FG000|Overall Study|Lost to Follow-up|500|||
126580305|NCT03954184|455421730|FG001|Overall Study|Lost to Follow-up|0|||
126580306|NCT03398200|455421731|FG000|Overall Study|Withdrawal by Subject|0|||
126580307|NCT03398200|455421732|FG001|Overall Study|Withdrawal by Subject|1|||
126580308|NCT05478525|455421733|FG000|Overall Study|Withdrawal by Subject|0|||
126580309|NCT05478525|455421734|FG001|Overall Study|Withdrawal by Subject|1|||
126580310|NCT05478525|455421735|FG002|Overall Study|Withdrawal by Subject|2|||
126580311|NCT05478525|455421736|FG003|Overall Study|Withdrawal by Subject|0|||
126728891|NCT04321252|455956840|FG003|Overall Study|Withdrawal by Subject|0|||
126728892|NCT04321252|455956841|FG004|Overall Study|Withdrawal by Subject|0|||
126728893|NCT04321252|455956842|FG005|Overall Study|Withdrawal by Subject|1|||
126728894|NCT04321252|455956843|FG006|Overall Study|Withdrawal by Subject|0|||
126728895|NCT04321252|455956844|FG007|Overall Study|Withdrawal by Subject|0|||
126728896|NCT04321252|455956845|FG008|Overall Study|Withdrawal by Subject|0|||
126728897|NCT03004469|455956846|FG000|Overall Study|Adverse Event|6|||
126777133|NCT02370784|456141294|FG000|Overall Study|Patient started prohibited medication|0|||
126529423|NCT02564523|455229908|FG008|Overall Study|Withdrawal by Subject|0|||
126529424|NCT02564523|455229909|FG009|Overall Study|Withdrawal by Subject|0|||
126580312|NCT05478525|455421733|FG000|Overall Study|COVID-19 Infection|2|||
126580313|NCT05478525|455421734|FG001|Overall Study|COVID-19 Infection|0|||
126580314|NCT05478525|455421735|FG002|Overall Study|COVID-19 Infection|1|||
126580315|NCT05478525|455421736|FG003|Overall Study|COVID-19 Infection|1|||
126580316|NCT01649271|455421737|FG000|Overall Study|Progressive disease|4|||
126580317|NCT01649271|455421738|FG001|Overall Study|Progressive disease|5|||
126580318|NCT01649271|455421737|FG000|Overall Study|Other Adverse Event|0|||
126580319|NCT01649271|455421738|FG001|Overall Study|Other Adverse Event|2|||
126580320|NCT01649271|455421737|FG000|Overall Study|Withdrawal by Subject|1|||
126728898|NCT03004469|455956847|FG001|Overall Study|Adverse Event|4|||
126728899|NCT03004469|455956848|FG002|Overall Study|Adverse Event|6|||
126580321|NCT01649271|455421738|FG001|Overall Study|Withdrawal by Subject|0|||
126580322|NCT01649271|455421737|FG000|Overall Study|Other than stated above|1|||
126580323|NCT01649271|455421738|FG001|Overall Study|Other than stated above|0|||
126580324|NCT05644002|455421741|FG000|Overall Study|Lost to Follow-up|1|||
126580325|NCT05644002|455421742|FG001|Overall Study|Lost to Follow-up|2|||
126580326|NCT05644002|455421741|FG000|Overall Study|Withdrawal by Subject|0|||
126580327|NCT05644002|455421742|FG001|Overall Study|Withdrawal by Subject|1|||
126580328|NCT04842500|455421743|FG000|Overall Study|Withdrawal by Subject|4|||
126580329|NCT04842500|455421744|FG001|Overall Study|Withdrawal by Subject|1|||
126580330|NCT04842500|455421745|FG002|Overall Study|Withdrawal by Subject|2|||
126580331|NCT04842500|455421746|FG003|Overall Study|Withdrawal by Subject|3|||
126580332|NCT04842500|455421743|FG000|Overall Study|Protocol Violation|1|||
126580333|NCT04842500|455421744|FG001|Overall Study|Protocol Violation|0|||
126580334|NCT04842500|455421745|FG002|Overall Study|Protocol Violation|0|||
126580335|NCT04842500|455421746|FG003|Overall Study|Protocol Violation|1|||
126580336|NCT05756075|455421749|FG000|Overall Study|Withdrawal by Subject|16|||
126580337|NCT05756075|455421750|FG001|Overall Study|Withdrawal by Subject|9|||
126580338|NCT02652260|455421751|FG000|Base Study|Pregnancy|0|||
126580339|NCT02652260|455421752|FG001|Base Study|Pregnancy|1|||
126580340|NCT02652260|455421751|FG000|Base Study|Withdrawal by Subject|0|||
126580341|NCT02652260|455421752|FG001|Base Study|Withdrawal by Subject|1|||
126580342|NCT02652260|455421751|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
126580343|NCT02652260|455421752|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
126580344|NCT02652260|455421751|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
126580345|NCT02652260|455421752|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
126580346|NCT02652260|455421751|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
126580347|NCT02652260|455421752|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
126580348|NCT02652260|455421751|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
126580349|NCT02652260|455421752|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
126580350|NCT02652260|455421751|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
126580351|NCT02652260|455421752|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
126580352|NCT02652260|455421751|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
126580353|NCT02652260|455421752|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
126580354|NCT02652260|455421751|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
126580355|NCT02652260|455421752|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
126580356|NCT02652260|455421751|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
126580357|NCT02652260|455421752|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
126580358|NCT02652260|455421751|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
126580359|NCT02652260|455421752|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
126580360|NCT02652260|455421751|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
126580361|NCT02652260|455421752|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
126580362|NCT02652260|455421751|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
126580363|NCT02652260|455421752|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
126580364|NCT02652260|455421751|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
126580365|NCT02652260|455421752|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
126580366|NCT03899961|455421753|FG000|Overall Study|-delivery prior to|2|||
126580367|NCT03899961|455421754|FG001|Overall Study|-delivery prior to|7|||
126580368|NCT03899961|455421753|FG000|Overall Study|req general anesth|1|||
126580369|NCT03899961|455421754|FG001|Overall Study|req general anesth|2|||
126580370|NCT03899961|455421753|FG000|Overall Study|capacity|5|||
126580371|NCT03899961|455421754|FG001|Overall Study|capacity|6|||
126580372|NCT03899961|455421753|FG000|Overall Study|Withdrawal by Subject|1|||
126580373|NCT03899961|455421754|FG001|Overall Study|Withdrawal by Subject|1|||
126580374|NCT02837510|455421755|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
126580375|NCT02837510|455421756|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
126580376|NCT02837510|455421755|FG000|Washout (2 Weeks)|Adverse Event|0|||
126580377|NCT02837510|455421756|FG001|Washout (2 Weeks)|Adverse Event|1|||
126580378|NCT02837510|455421755|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
126580379|NCT02837510|455421756|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
126728900|NCT03004469|455956846|FG000|Overall Study|Lack of Efficacy|1|||
126728901|NCT03004469|455956847|FG001|Overall Study|Lack of Efficacy|0|||
126728902|NCT03004469|455956848|FG002|Overall Study|Lack of Efficacy|1|||
126728903|NCT03004469|455956846|FG000|Overall Study|Lost to Follow-up|23|||
126580380|NCT02837510|455421755|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
126580381|NCT02837510|455421756|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
126580382|NCT02837510|455421755|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
126728904|NCT03004469|455956847|FG001|Overall Study|Lost to Follow-up|14|||
126728905|NCT03004469|455956848|FG002|Overall Study|Lost to Follow-up|6|||
126728906|NCT03004469|455956846|FG000|Overall Study|Non-Compliance with Study Drug|2|||
126580383|NCT02837510|455421756|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
126580384|NCT02837510|455421755|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
126580385|NCT02837510|455421756|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
126580386|NCT01064440|455421757|FG000|Overall Study|Lost to Follow-up|1|||
126580387|NCT01064440|455421758|FG001|Overall Study|Lost to Follow-up|1|||
126580388|NCT01064440|455421759|FG002|Overall Study|Lost to Follow-up|1|||
126580389|NCT01064440|455421757|FG000|Overall Study|Non-compliance|0|||
126580390|NCT01064440|455421758|FG001|Overall Study|Non-compliance|1|||
126580391|NCT01064440|455421759|FG002|Overall Study|Non-compliance|0|||
126580392|NCT01064440|455421757|FG000|Overall Study|Death|1|||
126580393|NCT01064440|455421758|FG001|Overall Study|Death|0|||
126580394|NCT01064440|455421759|FG002|Overall Study|Death|1|||
126580395|NCT01064440|455421757|FG000|Overall Study|Withdrawal by Subject|0|||
126580396|NCT01064440|455421758|FG001|Overall Study|Withdrawal by Subject|1|||
126580397|NCT01064440|455421759|FG002|Overall Study|Withdrawal by Subject|1|||
126580398|NCT01064440|455421757|FG000|Overall Study|Other: amputation|1|||
126580399|NCT01064440|455421758|FG001|Overall Study|Other: amputation|0|||
126580400|NCT01064440|455421759|FG002|Overall Study|Other: amputation|0|||
126580401|NCT06194214|455421761|FG000|Overall Study|Adverse Event|1|||
126580402|NCT04440176|455421766|FG000|Overall Study|Withdrawal by Subject|5|||
126580403|NCT04440176|455421767|FG001|Overall Study|Withdrawal by Subject|3|||
126580404|NCT04440176|455421766|FG000|Overall Study|Withdrawal by parent/guardian|4|||
126580405|NCT04440176|455421767|FG001|Overall Study|Withdrawal by parent/guardian|5|||
126580406|NCT04440176|455421766|FG000|Overall Study|Adverse Event|2|||
126580407|NCT04440176|455421767|FG001|Overall Study|Adverse Event|6|||
126580408|NCT04440176|455421766|FG000|Overall Study|Lost to Follow-up|22|||
126580409|NCT04440176|455421767|FG001|Overall Study|Lost to Follow-up|23|||
126580410|NCT04440176|455421766|FG000|Overall Study|Medication error without associated adverse event|0|||
126580411|NCT04440176|455421767|FG001|Overall Study|Medication error without associated adverse event|1|||
126580412|NCT04440176|455421766|FG000|Overall Study|No longer met eligibility criteria|7|||
126580413|NCT04440176|455421767|FG001|Overall Study|No longer met eligibility criteria|1|||
126580414|NCT04440176|455421766|FG000|Overall Study|Other|1|||
126580415|NCT04440176|455421767|FG001|Overall Study|Other|2|||
126580416|NCT04440176|455421766|FG000|Overall Study|Protocol deviation|6|||
126580417|NCT04440176|455421767|FG001|Overall Study|Protocol deviation|8|||
126580418|NCT04440176|455421766|FG000|Overall Study|Randomized but not vaccinated|6|||
126580419|NCT04440176|455421767|FG001|Overall Study|Randomized but not vaccinated|3|||
126580420|NCT04608045|455421772|FG000|Overall Study|Physician Decision|1|||
126580421|NCT03517553|455421774|FG000|Overall Study|Withdrawal by Subject|2|||
126580422|NCT03575052|455421775|FG000|Overall Study|Adverse Event|6|||
126580423|NCT03575052|455421776|FG001|Overall Study|Adverse Event|10|||
126580424|NCT03575052|455421775|FG000|Overall Study|Not further specified|5|||
126580425|NCT03575052|455421776|FG001|Overall Study|Not further specified|7|||
126580426|NCT03575052|455421775|FG000|Overall Study|Withdrawal by Subject|5|||
126580427|NCT03575052|455421776|FG001|Overall Study|Withdrawal by Subject|6|||
126580428|NCT03575052|455421775|FG000|Overall Study|Lost to Follow-up|3|||
126580429|NCT03575052|455421776|FG001|Overall Study|Lost to Follow-up|0|||
126580430|NCT03575052|455421775|FG000|Overall Study|Death|2|||
126580431|NCT03575052|455421776|FG001|Overall Study|Death|1|||
126580432|NCT03575052|455421775|FG000|Overall Study|Lack of Efficacy|2|||
126580433|NCT03575052|455421776|FG001|Overall Study|Lack of Efficacy|1|||
126580434|NCT03575052|455421775|FG000|Overall Study|Study drug noncompliance|1|||
126580435|NCT03575052|455421776|FG001|Overall Study|Study drug noncompliance|2|||
126580436|NCT03575052|455421775|FG000|Overall Study|Protocol Violation|0|||
126580437|NCT03575052|455421776|FG001|Overall Study|Protocol Violation|2|||
126580438|NCT03575052|455421775|FG000|Overall Study|Physician Decision|1|||
126580439|NCT03575052|455421776|FG001|Overall Study|Physician Decision|0|||
126580440|NCT03271151|455421777|FG000|Overall Study|Lost to Follow-up|1|||
126580441|NCT03271151|455421778|FG001|Overall Study|Lost to Follow-up|3|||
126580442|NCT03271151|455421777|FG000|Overall Study|Withdrawal by Subject|1|||
126728907|NCT03004469|455956847|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126728908|NCT03004469|455956848|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126728909|NCT03004469|455956846|FG000|Overall Study|Protocol Violation|0|||
126728910|NCT03004469|455956847|FG001|Overall Study|Protocol Violation|0|||
126728911|NCT03004469|455956848|FG002|Overall Study|Protocol Violation|1|||
126728912|NCT03004469|455956846|FG000|Overall Study|Withdrawal by Subject|29|||
126728913|NCT03004469|455956847|FG001|Overall Study|Withdrawal by Subject|27|||
126580443|NCT03271151|455421778|FG001|Overall Study|Withdrawal by Subject|0|||
126580444|NCT03103321|455421779|FG000|Overall Study|Protocol Violation|1|||
126580445|NCT03103321|455421780|FG001|Overall Study|Protocol Violation|1|||
126580446|NCT03103321|455421781|FG002|Overall Study|Protocol Violation|1|||
126580447|NCT03103321|455421782|FG003|Overall Study|Protocol Violation|0|||
126580448|NCT04247542|455421783|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
126728914|NCT03004469|455956848|FG002|Overall Study|Withdrawal by Subject|10|||
126580449|NCT04247542|455421784|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
126580450|NCT04247542|455421785|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
126580451|NCT04247542|455421783|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
126580452|NCT04247542|455421784|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
126580453|NCT04247542|455421785|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
126728915|NCT03004469|455956846|FG000|Overall Study|Other unspecified reason|0|||
126529425|NCT02564523|455229910|FG010|Overall Study|Withdrawal by Subject|1|||
126529426|NCT02564523|455229911|FG011|Overall Study|Withdrawal by Subject|0|||
126529427|NCT02564523|455229912|FG012|Overall Study|Withdrawal by Subject|1|||
126529428|NCT02564523|455229913|FG013|Overall Study|Withdrawal by Subject|0|||
126529429|NCT02564523|455229914|FG014|Overall Study|Withdrawal by Subject|0|||
126529430|NCT02564523|455229915|FG015|Overall Study|Withdrawal by Subject|0|||
126529431|NCT02564523|455229916|FG016|Overall Study|Withdrawal by Subject|0|||
126529432|NCT02564523|455229917|FG017|Overall Study|Withdrawal by Subject|0|||
126529433|NCT02564523|455229900|FG000|Overall Study|Adverse Event|0|||
126529434|NCT02564523|455229901|FG001|Overall Study|Adverse Event|0|||
126529435|NCT02564523|455229902|FG002|Overall Study|Adverse Event|0|||
126529436|NCT02564523|455229903|FG003|Overall Study|Adverse Event|0|||
126529437|NCT02564523|455229904|FG004|Overall Study|Adverse Event|0|||
126529438|NCT02564523|455229905|FG005|Overall Study|Adverse Event|0|||
126529439|NCT02564523|455229906|FG006|Overall Study|Adverse Event|0|||
126529440|NCT02564523|455229907|FG007|Overall Study|Adverse Event|0|||
126529441|NCT02564523|455229908|FG008|Overall Study|Adverse Event|0|||
126529442|NCT02564523|455229909|FG009|Overall Study|Adverse Event|0|||
126529443|NCT02564523|455229910|FG010|Overall Study|Adverse Event|0|||
126529444|NCT02564523|455229911|FG011|Overall Study|Adverse Event|0|||
126529445|NCT02564523|455229912|FG012|Overall Study|Adverse Event|0|||
126529446|NCT02564523|455229913|FG013|Overall Study|Adverse Event|0|||
126529447|NCT02564523|455229914|FG014|Overall Study|Adverse Event|0|||
126529448|NCT02564523|455229915|FG015|Overall Study|Adverse Event|0|||
126529449|NCT02564523|455229916|FG016|Overall Study|Adverse Event|0|||
126529450|NCT02564523|455229917|FG017|Overall Study|Adverse Event|1|||
126529451|NCT02564523|455229900|FG000|Overall Study|Death|0|||
126529452|NCT02564523|455229901|FG001|Overall Study|Death|0|||
126529453|NCT02564523|455229902|FG002|Overall Study|Death|0|||
126529454|NCT02564523|455229903|FG003|Overall Study|Death|0|||
126529455|NCT02564523|455229904|FG004|Overall Study|Death|0|||
126529456|NCT02564523|455229905|FG005|Overall Study|Death|0|||
126529457|NCT02564523|455229906|FG006|Overall Study|Death|1|||
126529458|NCT02564523|455229907|FG007|Overall Study|Death|0|||
126529459|NCT02564523|455229908|FG008|Overall Study|Death|0|||
126529460|NCT02564523|455229909|FG009|Overall Study|Death|0|||
126529461|NCT02564523|455229910|FG010|Overall Study|Death|1|||
126529462|NCT02564523|455229911|FG011|Overall Study|Death|0|||
126529463|NCT02564523|455229912|FG012|Overall Study|Death|0|||
126529464|NCT02564523|455229913|FG013|Overall Study|Death|0|||
126529465|NCT02564523|455229914|FG014|Overall Study|Death|0|||
126529466|NCT02564523|455229915|FG015|Overall Study|Death|0|||
126529467|NCT02564523|455229916|FG016|Overall Study|Death|0|||
126529468|NCT02564523|455229917|FG017|Overall Study|Death|0|||
126529469|NCT02564523|455229900|FG000|Overall Study|Lost to Follow-up|2|||
126529470|NCT02564523|455229901|FG001|Overall Study|Lost to Follow-up|1|||
126529471|NCT02564523|455229902|FG002|Overall Study|Lost to Follow-up|4|||
126529472|NCT02564523|455229903|FG003|Overall Study|Lost to Follow-up|0|||
126529473|NCT02564523|455229904|FG004|Overall Study|Lost to Follow-up|1|||
126529474|NCT02564523|455229905|FG005|Overall Study|Lost to Follow-up|0|||
126529475|NCT02564523|455229906|FG006|Overall Study|Lost to Follow-up|1|||
126529476|NCT02564523|455229907|FG007|Overall Study|Lost to Follow-up|0|||
126529477|NCT02564523|455229908|FG008|Overall Study|Lost to Follow-up|0|||
126529478|NCT02564523|455229909|FG009|Overall Study|Lost to Follow-up|0|||
126529479|NCT02564523|455229910|FG010|Overall Study|Lost to Follow-up|0|||
126529480|NCT02564523|455229911|FG011|Overall Study|Lost to Follow-up|1|||
126529481|NCT02564523|455229912|FG012|Overall Study|Lost to Follow-up|1|||
126529482|NCT02564523|455229913|FG013|Overall Study|Lost to Follow-up|0|||
126529483|NCT02564523|455229914|FG014|Overall Study|Lost to Follow-up|0|||
126529484|NCT02564523|455229915|FG015|Overall Study|Lost to Follow-up|0|||
126529485|NCT02564523|455229916|FG016|Overall Study|Lost to Follow-up|0|||
126529486|NCT02564523|455229917|FG017|Overall Study|Lost to Follow-up|0|||
126529487|NCT02564523|455229900|FG000|Overall Study|Physician Decision|0|||
126580454|NCT04118452|455421786|FG000|Overall Study|Lost to Follow-up|5|||
126580455|NCT04118452|455421787|FG001|Overall Study|Lost to Follow-up|5|||
126529488|NCT02564523|455229901|FG001|Overall Study|Physician Decision|0|||
126529489|NCT02564523|455229902|FG002|Overall Study|Physician Decision|0|||
126529490|NCT02564523|455229903|FG003|Overall Study|Physician Decision|0|||
126529491|NCT02564523|455229904|FG004|Overall Study|Physician Decision|1|||
126529492|NCT02564523|455229905|FG005|Overall Study|Physician Decision|0|||
126529493|NCT02564523|455229906|FG006|Overall Study|Physician Decision|0|||
126529494|NCT02564523|455229907|FG007|Overall Study|Physician Decision|0|||
126529495|NCT02564523|455229908|FG008|Overall Study|Physician Decision|0|||
126529496|NCT02564523|455229909|FG009|Overall Study|Physician Decision|0|||
126529497|NCT02564523|455229910|FG010|Overall Study|Physician Decision|1|||
126529498|NCT02564523|455229911|FG011|Overall Study|Physician Decision|0|||
126529499|NCT02564523|455229912|FG012|Overall Study|Physician Decision|0|||
126529500|NCT02564523|455229913|FG013|Overall Study|Physician Decision|0|||
126529501|NCT02564523|455229914|FG014|Overall Study|Physician Decision|0|||
126529502|NCT02564523|455229915|FG015|Overall Study|Physician Decision|0|||
126529503|NCT02564523|455229916|FG016|Overall Study|Physician Decision|0|||
126529504|NCT02564523|455229917|FG017|Overall Study|Physician Decision|0|||
126580456|NCT04118452|455421786|FG000|Overall Study|Withdrawal by Subject|17|||
126580457|NCT04118452|455421787|FG001|Overall Study|Withdrawal by Subject|17|||
126580458|NCT05288283|455421788|FG000|Overall Study|Study Terminated Early|1|||
126580459|NCT05288283|455421789|FG001|Overall Study|Study Terminated Early|1|||
126580460|NCT05086744|455421790|FG000|Part A|Adverse Event|0|||
126580461|NCT05086744|455421791|FG001|Part A|Adverse Event|1|||
126580462|NCT05086744|455421790|FG000|Part A|Lack of Efficacy|3|||
126580463|NCT05086744|455421791|FG001|Part A|Lack of Efficacy|0|||
126580464|NCT05086744|455421790|FG000|Part A|Protocol deviation|1|||
126580465|NCT05086744|455421791|FG001|Part A|Protocol deviation|0|||
126580466|NCT05086744|455421790|FG000|Part A|Subject decision|1|||
126580467|NCT05086744|455421791|FG001|Part A|Subject decision|0|||
126580468|NCT05086744|455421790|FG000|Part B|Adverse Event|0|||
126580469|NCT05086744|455421791|FG001|Part B|Adverse Event|1|||
126580470|NCT05086744|455421790|FG000|Part B|Lack of Efficacy|0|||
126580471|NCT05086744|455421791|FG001|Part B|Lack of Efficacy|1|||
126580472|NCT05086744|455421790|FG000|Part B|Study terminated by sponsor|1|||
126580473|NCT05086744|455421791|FG001|Part B|Study terminated by sponsor|6|||
126580474|NCT01046136|455421792|FG000|Overall Study|Withdrawal by Subject|0|||
126580475|NCT01046136|455421793|FG001|Overall Study|Withdrawal by Subject|4|||
126580476|NCT01046136|455421792|FG000|Overall Study|Physician Decision|1|||
126580477|NCT01046136|455421793|FG001|Overall Study|Physician Decision|1|||
126580478|NCT01046136|455421792|FG000|Overall Study|Lost to Follow-up|3|||
126580479|NCT01046136|455421793|FG001|Overall Study|Lost to Follow-up|3|||
126580480|NCT04759833|455421797|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
126580481|NCT04759833|455421798|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
126580482|NCT04759833|455421799|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
126580483|NCT04759833|455421800|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
126580484|NCT04759833|455421801|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
126580485|NCT04759833|455421797|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
126580486|NCT04759833|455421798|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
126580487|NCT04759833|455421799|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
126580488|NCT04759833|455421800|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
126580489|NCT04759833|455421801|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
126580490|NCT04759833|455421797|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
126580491|NCT04759833|455421798|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
126580492|NCT04759833|455421799|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
126580493|NCT04759833|455421800|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
126580494|NCT04759833|455421801|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
126580495|NCT04759833|455421797|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
126580496|NCT04759833|455421798|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
126580497|NCT04759833|455421799|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
126580498|NCT04759833|455421800|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
126580499|NCT04759833|455421801|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
126580500|NCT04759833|455421797|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
126580501|NCT04759833|455421798|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
126580502|NCT04759833|455421799|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
126580503|NCT04759833|455421800|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
126580504|NCT04759833|455421801|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
126580505|NCT04759833|455421797|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
126580506|NCT04759833|455421798|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
126580507|NCT04759833|455421799|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
126580508|NCT04759833|455421800|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
126580509|NCT04759833|455421801|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
126728916|NCT03004469|455956847|FG001|Overall Study|Other unspecified reason|4|||
126728917|NCT03004469|455956848|FG002|Overall Study|Other unspecified reason|1|||
126580510|NCT04759833|455421797|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
126580511|NCT04759833|455421798|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
126580512|NCT04759833|455421799|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
126580513|NCT04759833|455421800|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
126580514|NCT04759833|455421801|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
126580515|NCT04759833|455421797|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
126580516|NCT04759833|455421798|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
126580517|NCT04759833|455421799|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
126580518|NCT04759833|455421800|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
126580519|NCT04759833|455421801|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
126728918|NCT00259740|455956849|FG000|Overall Study|Physician Decision|1|||
126728919|NCT00259740|455956850|FG001|Overall Study|Physician Decision|1|||
126580520|NCT04759833|455421797|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
126580521|NCT04759833|455421798|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
126580522|NCT04759833|455421799|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
126580523|NCT04759833|455421800|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
126580524|NCT04759833|455421801|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
126580525|NCT04759833|455421797|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
126580526|NCT04759833|455421798|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
126580527|NCT04759833|455421799|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
126580528|NCT04759833|455421800|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
126580529|NCT04759833|455421801|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
126580530|NCT04759833|455421797|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
126580531|NCT04759833|455421798|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
126580532|NCT04759833|455421799|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
126580533|NCT04759833|455421800|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
126580534|NCT04759833|455421801|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
126580535|NCT04759833|455421797|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
126580536|NCT04759833|455421798|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
126580537|NCT04759833|455421799|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
126580538|NCT04759833|455421800|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
126580539|NCT04759833|455421801|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
126580540|NCT04759833|455421797|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
126580541|NCT04759833|455421798|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
126580542|NCT04759833|455421799|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
126580543|NCT04759833|455421800|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
126580544|NCT04759833|455421801|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
126580545|NCT03446157|455421802|FG000|Overall Study|Death|11|||
126580546|NCT03446157|455421803|FG001|Overall Study|Death|9|||
126580547|NCT03446157|455421802|FG000|Overall Study|Lost to Follow-up|0|||
126580548|NCT03446157|455421803|FG001|Overall Study|Lost to Follow-up|1|||
126580549|NCT03446157|455421802|FG000|Overall Study|Withdrawal by Subject|2|||
126580550|NCT03446157|455421803|FG001|Overall Study|Withdrawal by Subject|1|||
126580551|NCT00411151|455421804|FG000|Overall Study|Death|38|||
126580552|NCT00411151|455421804|FG000|Overall Study|Withdrawal by Subject|2|||
126580553|NCT00411151|455421804|FG000|Overall Study|Lost to Follow-up|2|||
126580554|NCT00411151|455421804|FG000|Overall Study|Protocol Violation|1|||
126580555|NCT00411151|455421804|FG000|Overall Study|Trial prematurely closed|4|||
126580556|NCT00818246|455421807|FG000|Overall Study|Impossible to match pictures|5|||
126580557|NCT01121991|455421808|FG000|Overall Study|Lack of Ovarian Response|2|||
126580558|NCT01121991|455421808|FG000|Overall Study|No Oocytes Retrieved|3|||
126580559|NCT01121991|455421808|FG000|Overall Study|No Fertilization|1|||
126580560|NCT00409838|455421809|FG000|Short-term Period|Adverse Event|0|||
126580561|NCT00409838|455421810|FG001|Short-term Period|Adverse Event|1|||
126580562|NCT00409838|455421809|FG000|Short-term Period|Lost to Follow-up|0|||
126580563|NCT00409838|455421810|FG001|Short-term Period|Lost to Follow-up|1|||
126580564|NCT00409838|455421809|FG000|Short-term Period|Withdrawal by Subject|2|||
126580565|NCT00409838|455421810|FG001|Short-term Period|Withdrawal by Subject|3|||
126580566|NCT00409838|455421809|FG000|Short-term Period|Never Treated|1|||
126580567|NCT00409838|455421810|FG001|Short-term Period|Never Treated|0|||
126580568|NCT00409838|455421809|FG000|Long-term Extension Period|Adverse Event|10|||
126580569|NCT00409838|455421810|FG001|Long-term Extension Period|Adverse Event|0|||
126580570|NCT00409838|455421809|FG000|Long-term Extension Period|Death|1|||
126580571|NCT00409838|455421810|FG001|Long-term Extension Period|Death|0|||
126580572|NCT00409838|455421809|FG000|Long-term Extension Period|Lack of Efficacy|2|||
126580573|NCT00409838|455421810|FG001|Long-term Extension Period|Lack of Efficacy|0|||
126580574|NCT00409838|455421809|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
126580575|NCT00409838|455421810|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
126580576|NCT00409838|455421809|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
126580577|NCT00409838|455421810|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
126580578|NCT00409838|455421809|FG000|Long-term Extension Period|Pregnancy|1|||
126580579|NCT00409838|455421810|FG001|Long-term Extension Period|Pregnancy|0|||
126580580|NCT01619410|455421811|FG000|Overall Study|Lost to Follow-up|7|||
126580581|NCT01619410|455421812|FG001|Overall Study|Lost to Follow-up|4|||
126580582|NCT01250769|455421813|FG000|Overall Study|Withdrawal by Subject|0|||
126580583|NCT01250769|455421814|FG001|Overall Study|Withdrawal by Subject|1|||
126580584|NCT01250769|455421815|FG002|Overall Study|Withdrawal by Subject|1|||
126580585|NCT01250769|455421816|FG003|Overall Study|Withdrawal by Subject|0|||
126580586|NCT01250769|455421813|FG000|Overall Study|Adverse Event|0|||
126580587|NCT01250769|455421814|FG001|Overall Study|Adverse Event|0|||
126580588|NCT01250769|455421815|FG002|Overall Study|Adverse Event|1|||
126580589|NCT01250769|455421816|FG003|Overall Study|Adverse Event|0|||
126580590|NCT04110054|455421817|FG000|Overall Study|COVID-19 reason other than AE|0|||
126580591|NCT04110054|455421818|FG001|Overall Study|COVID-19 reason other than AE|0|||
126580592|NCT04110054|455421819|FG002|Overall Study|COVID-19 reason other than AE|2|||
126580593|NCT04110054|455421820|FG003|Overall Study|COVID-19 reason other than AE|0|||
126580594|NCT04110054|455421817|FG000|Overall Study|Withdrawal by Subject|0|||
126580595|NCT04110054|455421818|FG001|Overall Study|Withdrawal by Subject|3|||
126580596|NCT04110054|455421819|FG002|Overall Study|Withdrawal by Subject|2|||
126580597|NCT04110054|455421820|FG003|Overall Study|Withdrawal by Subject|0|||
126580598|NCT04110054|455421817|FG000|Overall Study|Adverse Event|1|||
126580599|NCT04110054|455421818|FG001|Overall Study|Adverse Event|1|||
126580600|NCT04110054|455421819|FG002|Overall Study|Adverse Event|4|||
126580601|NCT04110054|455421820|FG003|Overall Study|Adverse Event|3|||
126580602|NCT00093015|455421821|FG000|Overall Study|Withdrawal by Subject|194|||
126580603|NCT00093015|455421822|FG001|Overall Study|Withdrawal by Subject|171|||
126580604|NCT00093015|455421821|FG000|Overall Study|Lost to Follow-up|96|||
126580605|NCT00093015|455421822|FG001|Overall Study|Lost to Follow-up|108|||
126580606|NCT00093015|455421821|FG000|Overall Study|Death|375|||
126580607|NCT00093015|455421822|FG001|Overall Study|Death|385|||
126580608|NCT02794480|455421830|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
126580609|NCT02794480|455421831|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
126580610|NCT02794480|455421832|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
126580611|NCT02794480|455421833|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
126580612|NCT02794480|455421830|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
126580613|NCT02794480|455421831|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
126580614|NCT02794480|455421832|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
126580615|NCT02794480|455421833|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
126580616|NCT02794480|455421830|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126580617|NCT02794480|455421831|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126580618|NCT02794480|455421832|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126580619|NCT02794480|455421833|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
126580620|NCT02794480|455421830|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126580621|NCT02794480|455421831|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
126580622|NCT02794480|455421832|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126580623|NCT02794480|455421833|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
126580624|NCT02794480|455421830|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
126580625|NCT02794480|455421831|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126580626|NCT02794480|455421832|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126580627|NCT02794480|455421833|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
126580628|NCT01017146|455421834|FG000|Overall Study|Adverse Event|11|||
126580629|NCT01017146|455421835|FG001|Overall Study|Adverse Event|1|||
126580630|NCT01017146|455421834|FG000|Overall Study|Lost to Follow-up|14|||
126580631|NCT01017146|455421835|FG001|Overall Study|Lost to Follow-up|14|||
126580632|NCT01017146|455421834|FG000|Overall Study|Noncompliance with Study Product|1|||
126580633|NCT01017146|455421835|FG001|Overall Study|Noncompliance with Study Product|1|||
126580634|NCT01017146|455421834|FG000|Overall Study|Withdrawal by Subject|32|||
126580635|NCT01017146|455421835|FG001|Overall Study|Withdrawal by Subject|16|||
126580636|NCT01017146|455421834|FG000|Overall Study|Relocation|0|||
126580637|NCT01017146|455421835|FG001|Overall Study|Relocation|4|||
126580638|NCT01017146|455421834|FG000|Overall Study|Pregnancy|2|||
126580639|NCT01017146|455421835|FG001|Overall Study|Pregnancy|1|||
126580640|NCT01017146|455421834|FG000|Overall Study|Protocol Violation|2|||
126580641|NCT01017146|455421835|FG001|Overall Study|Protocol Violation|0|||
126580642|NCT01017146|455421834|FG000|Overall Study|Took Excluded Medication|2|||
126580643|NCT01017146|455421835|FG001|Overall Study|Took Excluded Medication|0|||
126580644|NCT01017146|455421834|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
126580645|NCT01017146|455421835|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
126580646|NCT01017146|455421834|FG000|Overall Study|Change in Work Situation|1|||
126580647|NCT01017146|455421835|FG001|Overall Study|Change in Work Situation|0|||
126580648|NCT05171777|455421841|FG000|Treatment Crossover Period|Adverse Event|9|||
126580649|NCT05171777|455421842|FG001|Treatment Crossover Period|Adverse Event|6|||
126580650|NCT05171777|455421843|FG002|Treatment Crossover Period|Adverse Event|0|||
126580651|NCT05171777|455421844|FG003|Treatment Crossover Period|Adverse Event|0|||
126580652|NCT05171777|455421841|FG000|Treatment Crossover Period|Death|5|||
126580653|NCT05171777|455421842|FG001|Treatment Crossover Period|Death|5|||
126580654|NCT05171777|455421843|FG002|Treatment Crossover Period|Death|0|||
126580655|NCT05171777|455421844|FG003|Treatment Crossover Period|Death|0|||
126580656|NCT05171777|455421841|FG000|Treatment Crossover Period|Disease Relapse|0|||
126580657|NCT05171777|455421842|FG001|Treatment Crossover Period|Disease Relapse|1|||
126580658|NCT05171777|455421843|FG002|Treatment Crossover Period|Disease Relapse|0|||
126580659|NCT05171777|455421844|FG003|Treatment Crossover Period|Disease Relapse|0|||
126580660|NCT05171777|455421841|FG000|Treatment Crossover Period|Reason not Specified|2|||
126580661|NCT05171777|455421842|FG001|Treatment Crossover Period|Reason not Specified|1|||
126580662|NCT05171777|455421843|FG002|Treatment Crossover Period|Reason not Specified|0|||
126580663|NCT05171777|455421844|FG003|Treatment Crossover Period|Reason not Specified|0|||
126580664|NCT05171777|455421841|FG000|Treatment Crossover Period|Physician Decision|0|||
126580665|NCT05171777|455421842|FG001|Treatment Crossover Period|Physician Decision|1|||
126580666|NCT05171777|455421843|FG002|Treatment Crossover Period|Physician Decision|0|||
126580667|NCT05171777|455421844|FG003|Treatment Crossover Period|Physician Decision|0|||
126580668|NCT05171777|455421841|FG000|Treatment Crossover Period|Progressive Disease|13|||
126580669|NCT05171777|455421842|FG001|Treatment Crossover Period|Progressive Disease|9|||
126580670|NCT05171777|455421843|FG002|Treatment Crossover Period|Progressive Disease|0|||
126580671|NCT05171777|455421844|FG003|Treatment Crossover Period|Progressive Disease|0|||
126580672|NCT05171777|455421841|FG000|Treatment Crossover Period|Protocol Violation|0|||
126580673|NCT05171777|455421842|FG001|Treatment Crossover Period|Protocol Violation|2|||
126580674|NCT05171777|455421843|FG002|Treatment Crossover Period|Protocol Violation|0|||
126580675|NCT05171777|455421844|FG003|Treatment Crossover Period|Protocol Violation|0|||
126580676|NCT05171777|455421841|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
126580677|NCT05171777|455421842|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
126580678|NCT05171777|455421843|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
126580679|NCT05171777|455421844|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
126580680|NCT05171777|455421841|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
126580681|NCT05171777|455421842|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
126580682|NCT05171777|455421843|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
126580683|NCT05171777|455421844|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
126580684|NCT05171777|455421841|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
126580685|NCT05171777|455421842|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
126580686|NCT05171777|455421843|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
126580687|NCT05171777|455421844|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
126580688|NCT05171777|455421841|FG000|Treatment Continuation Period|Death|0|||
126580689|NCT05171777|455421842|FG001|Treatment Continuation Period|Death|0|||
126580690|NCT05171777|455421843|FG002|Treatment Continuation Period|Death|1|||
126580691|NCT05171777|455421844|FG003|Treatment Continuation Period|Death|6|||
126580692|NCT05171777|455421841|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
126580693|NCT05171777|455421842|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
126580694|NCT05171777|455421843|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
126580695|NCT05171777|455421844|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
126580696|NCT02538341|455421845|FG000|Overall Study|Lost to Follow-up|51|||
126580697|NCT02538341|455421846|FG001|Overall Study|Lost to Follow-up|46|||
126580698|NCT02538341|455421845|FG000|Overall Study|Withdrawal by Subject|3|||
126580699|NCT02538341|455421846|FG001|Overall Study|Withdrawal by Subject|1|||
126580700|NCT02538341|455421845|FG000|Overall Study|Death|2|||
126580701|NCT02538341|455421846|FG001|Overall Study|Death|0|||
126580702|NCT00632749|455421847|FG000|Overall Study|Progressive disease|3|||
126529505|NCT02564523|455229900|FG000|Overall Study|Protocol Violation|2|||
126529506|NCT02564523|455229901|FG001|Overall Study|Protocol Violation|2|||
126529507|NCT02564523|455229902|FG002|Overall Study|Protocol Violation|5|||
126529508|NCT02564523|455229903|FG003|Overall Study|Protocol Violation|0|||
126529509|NCT02564523|455229904|FG004|Overall Study|Protocol Violation|1|||
126529510|NCT02564523|455229905|FG005|Overall Study|Protocol Violation|0|||
126529511|NCT02564523|455229906|FG006|Overall Study|Protocol Violation|0|||
126529512|NCT02564523|455229907|FG007|Overall Study|Protocol Violation|0|||
126529513|NCT02564523|455229908|FG008|Overall Study|Protocol Violation|0|||
126529514|NCT02564523|455229909|FG009|Overall Study|Protocol Violation|0|||
126529515|NCT02564523|455229910|FG010|Overall Study|Protocol Violation|0|||
126529516|NCT02564523|455229911|FG011|Overall Study|Protocol Violation|0|||
126529517|NCT02564523|455229912|FG012|Overall Study|Protocol Violation|0|||
126529518|NCT02564523|455229913|FG013|Overall Study|Protocol Violation|0|||
126529519|NCT02564523|455229914|FG014|Overall Study|Protocol Violation|0|||
126529520|NCT02564523|455229915|FG015|Overall Study|Protocol Violation|0|||
126529521|NCT02564523|455229916|FG016|Overall Study|Protocol Violation|0|||
126580703|NCT00632749|455421848|FG001|Overall Study|Progressive disease|2|||
126580704|NCT00632749|455421849|FG002|Overall Study|Progressive disease|2|||
126580705|NCT00632749|455421850|FG003|Overall Study|Progressive disease|2|||
126580706|NCT00632749|455421851|FG004|Overall Study|Progressive disease|4|||
126580707|NCT00632749|455421852|FG005|Overall Study|Progressive disease|4|||
126529522|NCT02564523|455229917|FG017|Overall Study|Protocol Violation|0|||
126580708|NCT00632749|455421853|FG006|Overall Study|Progressive disease|3|||
126580709|NCT00632749|455421854|FG007|Overall Study|Progressive disease|2|||
126580710|NCT00632749|455421855|FG008|Overall Study|Progressive disease|3|||
126580711|NCT00632749|455421856|FG009|Overall Study|Progressive disease|2|||
126529523|NCT02564523|455229900|FG000|Overall Study|Other|3|||
126529524|NCT02564523|455229901|FG001|Overall Study|Other|0|||
126529525|NCT02564523|455229902|FG002|Overall Study|Other|0|||
126529526|NCT02564523|455229903|FG003|Overall Study|Other|1|||
126529527|NCT02564523|455229904|FG004|Overall Study|Other|0|||
126529528|NCT02564523|455229905|FG005|Overall Study|Other|0|||
126529529|NCT02564523|455229906|FG006|Overall Study|Other|0|||
126529530|NCT02564523|455229907|FG007|Overall Study|Other|0|||
126529531|NCT02564523|455229908|FG008|Overall Study|Other|0|||
126529532|NCT02564523|455229909|FG009|Overall Study|Other|0|||
126529533|NCT02564523|455229910|FG010|Overall Study|Other|0|||
126529534|NCT02564523|455229911|FG011|Overall Study|Other|0|||
126529535|NCT02564523|455229912|FG012|Overall Study|Other|0|||
126529536|NCT02564523|455229913|FG013|Overall Study|Other|0|||
126529537|NCT02564523|455229914|FG014|Overall Study|Other|0|||
126529538|NCT02564523|455229915|FG015|Overall Study|Other|0|||
126529539|NCT02564523|455229916|FG016|Overall Study|Other|0|||
126529540|NCT02564523|455229917|FG017|Overall Study|Other|0|||
126529541|NCT04862143|455229932|FG000|Overall Study|Adverse Event|1|||
126529542|NCT04862143|455229932|FG000|Overall Study|Study terminated by sponsor|1|||
126529543|NCT03031938|455229933|FG000|Overall Study|Death|1|||
126529544|NCT03031938|455229934|FG001|Overall Study|Death|0|||
126529545|NCT00454051|455229935|FG000|Overall Study|Adverse Event|1|||
126529546|NCT00454051|455229936|FG001|Overall Study|Adverse Event|2|||
126529547|NCT00454051|455229935|FG000|Overall Study|Withdrawal by Subject|1|||
126529548|NCT00454051|455229936|FG001|Overall Study|Withdrawal by Subject|0|||
126529549|NCT00454051|455229935|FG000|Overall Study|Protocol Violation|1|||
126529550|NCT00454051|455229936|FG001|Overall Study|Protocol Violation|1|||
126529551|NCT01491854|455229942|FG000|Overall Study|mainly due to premature termination|93|||
126529552|NCT01491854|455229942|FG000|Overall Study|Death|1|||
126529553|NCT01491854|455229942|FG000|Overall Study|Withdrawal by Subject|3|||
126529554|NCT01491854|455229942|FG000|Overall Study|Lost to Follow-up|33|||
126529555|NCT02384954|455229951|FG000|Phase 1|Progressive Disease|2|||
126529556|NCT02384954|455229952|FG001|Phase 1|Progressive Disease|0|||
126529557|NCT02384954|455229953|FG002|Phase 1|Progressive Disease|1|||
126529558|NCT02384954|455229954|FG003|Phase 1|Progressive Disease|1|||
126529559|NCT02384954|455229955|FG004|Phase 1|Progressive Disease|0|||
126529560|NCT02384954|455229956|FG005|Phase 1|Progressive Disease|0|||
126529561|NCT02384954|455229957|FG006|Phase 1|Progressive Disease|0|||
126529562|NCT02384954|455229958|FG007|Phase 1|Progressive Disease|0|||
126529563|NCT02384954|455229959|FG008|Phase 1|Progressive Disease|0|||
126529564|NCT02384954|455229951|FG000|Phase 1|Adverse Event|0|||
126529565|NCT02384954|455229952|FG001|Phase 1|Adverse Event|0|||
126728920|NCT00259740|455956849|FG000|Overall Study|Adverse Event|0|||
126728921|NCT00259740|455956850|FG001|Overall Study|Adverse Event|2|||
126728922|NCT00259740|455956849|FG000|Overall Study|Withdrawal by Subject|2|||
126728923|NCT00259740|455956850|FG001|Overall Study|Withdrawal by Subject|6|||
126529566|NCT02384954|455229953|FG002|Phase 1|Adverse Event|1|||
126529567|NCT02384954|455229954|FG003|Phase 1|Adverse Event|0|||
126529568|NCT02384954|455229955|FG004|Phase 1|Adverse Event|0|||
126529569|NCT02384954|455229956|FG005|Phase 1|Adverse Event|0|||
126529570|NCT02384954|455229957|FG006|Phase 1|Adverse Event|0|||
126529571|NCT02384954|455229958|FG007|Phase 1|Adverse Event|0|||
126529572|NCT02384954|455229959|FG008|Phase 1|Adverse Event|0|||
126529573|NCT02384954|455229951|FG000|Phase 2|Progressive Disease|0|||
126529574|NCT02384954|455229952|FG001|Phase 2|Progressive Disease|0|||
126529575|NCT02384954|455229953|FG002|Phase 2|Progressive Disease|0|||
126529576|NCT02384954|455229954|FG003|Phase 2|Progressive Disease|0|||
126529577|NCT02384954|455229955|FG004|Phase 2|Progressive Disease|0|||
126529578|NCT02384954|455229956|FG005|Phase 2|Progressive Disease|0|||
126529579|NCT02384954|455229957|FG006|Phase 2|Progressive Disease|0|||
126529580|NCT02384954|455229958|FG007|Phase 2|Progressive Disease|1|||
126529581|NCT02384954|455229959|FG008|Phase 2|Progressive Disease|2|||
126529582|NCT02384954|455229951|FG000|Phase 2|Adverse Event|0|||
126529583|NCT02384954|455229952|FG001|Phase 2|Adverse Event|0|||
126529584|NCT02384954|455229953|FG002|Phase 2|Adverse Event|0|||
126529585|NCT02384954|455229954|FG003|Phase 2|Adverse Event|0|||
126529586|NCT02384954|455229955|FG004|Phase 2|Adverse Event|0|||
126529587|NCT02384954|455229956|FG005|Phase 2|Adverse Event|0|||
126529588|NCT02384954|455229957|FG006|Phase 2|Adverse Event|0|||
126529589|NCT02384954|455229958|FG007|Phase 2|Adverse Event|1|||
126529590|NCT02384954|455229959|FG008|Phase 2|Adverse Event|1|||
126529591|NCT02384954|455229951|FG000|Phase 2|Failure to meet continuation criteria|0|||
126529592|NCT02384954|455229952|FG001|Phase 2|Failure to meet continuation criteria|0|||
126529593|NCT02384954|455229953|FG002|Phase 2|Failure to meet continuation criteria|0|||
126529594|NCT02384954|455229954|FG003|Phase 2|Failure to meet continuation criteria|0|||
126529595|NCT02384954|455229955|FG004|Phase 2|Failure to meet continuation criteria|0|||
126529596|NCT02384954|455229956|FG005|Phase 2|Failure to meet continuation criteria|0|||
126529597|NCT02384954|455229957|FG006|Phase 2|Failure to meet continuation criteria|0|||
126529598|NCT02384954|455229958|FG007|Phase 2|Failure to meet continuation criteria|1|||
126529599|NCT02384954|455229959|FG008|Phase 2|Failure to meet continuation criteria|0|||
126529600|NCT03998618|455229960|FG000|Overall Study|Death|7|||
126529601|NCT03998618|455229961|FG001|Overall Study|Death|11|||
126529602|NCT03998618|455229960|FG000|Overall Study|hospice enrollment|3|||
126529603|NCT03998618|455229961|FG001|Overall Study|hospice enrollment|3|||
126529604|NCT03998618|455229960|FG000|Overall Study|Not feeling well/health problems|3|||
126529605|NCT03998618|455229961|FG001|Overall Study|Not feeling well/health problems|5|||
126529606|NCT03998618|455229960|FG000|Overall Study|Lost to Follow-up|6|||
126529607|NCT03998618|455229961|FG001|Overall Study|Lost to Follow-up|6|||
126529608|NCT03998618|455229960|FG000|Overall Study|Withdrawal by Subject|0|||
126529609|NCT03998618|455229961|FG001|Overall Study|Withdrawal by Subject|4|||
126529610|NCT02415400|455229962|FG000|Overall Study|Adverse Event|0|||
126529611|NCT02415400|455229963|FG001|Overall Study|Adverse Event|1|||
126529612|NCT02415400|455229964|FG002|Overall Study|Adverse Event|1|||
126529613|NCT02415400|455229965|FG003|Overall Study|Adverse Event|2|||
126529614|NCT02415400|455229962|FG000|Overall Study|Participant request to stop therapy|4|||
126529615|NCT02415400|455229963|FG001|Overall Study|Participant request to stop therapy|3|||
126529616|NCT02415400|455229964|FG002|Overall Study|Participant request to stop therapy|8|||
126529617|NCT02415400|455229965|FG003|Overall Study|Participant request to stop therapy|6|||
126529618|NCT02415400|455229962|FG000|Overall Study|Participant withdrew consent|14|||
126529619|NCT02415400|455229963|FG001|Overall Study|Participant withdrew consent|12|||
126529620|NCT02415400|455229964|FG002|Overall Study|Participant withdrew consent|30|||
126529621|NCT02415400|455229965|FG003|Overall Study|Participant withdrew consent|21|||
126529622|NCT02415400|455229962|FG000|Overall Study|Death|39|||
126529623|NCT02415400|455229963|FG001|Overall Study|Death|41|||
126529624|NCT02415400|455229964|FG002|Overall Study|Death|35|||
126529625|NCT02415400|455229965|FG003|Overall Study|Death|42|||
126529626|NCT02415400|455229962|FG000|Overall Study|Lost to Follow-up|3|||
126529627|NCT02415400|455229963|FG001|Overall Study|Lost to Follow-up|3|||
126529628|NCT02415400|455229964|FG002|Overall Study|Lost to Follow-up|2|||
126529629|NCT02415400|455229965|FG003|Overall Study|Lost to Follow-up|5|||
126529630|NCT02415400|455229962|FG000|Overall Study|Poor/Non-Compliance|0|||
126529631|NCT02415400|455229963|FG001|Overall Study|Poor/Non-Compliance|1|||
126529632|NCT02415400|455229964|FG002|Overall Study|Poor/Non-Compliance|3|||
126529633|NCT02415400|455229965|FG003|Overall Study|Poor/Non-Compliance|4|||
126529634|NCT02415400|455229962|FG000|Overall Study|Participant no longer meets criteria|2|||
126529635|NCT02415400|455229963|FG001|Overall Study|Participant no longer meets criteria|0|||
126529636|NCT02415400|455229964|FG002|Overall Study|Participant no longer meets criteria|0|||
126529637|NCT02415400|455229965|FG003|Overall Study|Participant no longer meets criteria|1|||
126529638|NCT02415400|455229962|FG000|Overall Study|Participant doesn't answer phone|1|||
126529639|NCT02415400|455229963|FG001|Overall Study|Participant doesn't answer phone|0|||
126529640|NCT02415400|455229964|FG002|Overall Study|Participant doesn't answer phone|0|||
126529641|NCT02415400|455229965|FG003|Overall Study|Participant doesn't answer phone|0|||
126529642|NCT02415400|455229962|FG000|Overall Study|Participant wanted home visits|1|||
126529643|NCT02415400|455229963|FG001|Overall Study|Participant wanted home visits|0|||
126529644|NCT02415400|455229964|FG002|Overall Study|Participant wanted home visits|0|||
126529645|NCT02415400|455229965|FG003|Overall Study|Participant wanted home visits|0|||
126529646|NCT02415400|455229962|FG000|Overall Study|Randomized in error|2|||
126529647|NCT02415400|455229963|FG001|Overall Study|Randomized in error|0|||
126529648|NCT02415400|455229964|FG002|Overall Study|Randomized in error|0|||
126529649|NCT02415400|455229965|FG003|Overall Study|Randomized in error|0|||
126529650|NCT02415400|455229962|FG000|Overall Study|No study drug on site|0|||
126529651|NCT02415400|455229963|FG001|Overall Study|No study drug on site|1|||
126529652|NCT02415400|455229964|FG002|Overall Study|No study drug on site|0|||
126529653|NCT02415400|455229965|FG003|Overall Study|No study drug on site|0|||
126529654|NCT02415400|455229962|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
126529655|NCT02415400|455229963|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
126529656|NCT02415400|455229964|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
126529657|NCT02415400|455229965|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
126529658|NCT02415400|455229962|FG000|Overall Study|Coagulation values cannot be set|0|||
126529659|NCT02415400|455229963|FG001|Overall Study|Coagulation values cannot be set|0|||
126529660|NCT02415400|455229964|FG002|Overall Study|Coagulation values cannot be set|1|||
126580712|NCT00632749|455421857|FG010|Overall Study|Progressive disease|4|||
126529661|NCT02415400|455229965|FG003|Overall Study|Coagulation values cannot be set|0|||
126529662|NCT02415400|455229962|FG000|Overall Study|State regulations prevent participation|0|||
126529663|NCT02415400|455229963|FG001|Overall Study|State regulations prevent participation|0|||
126529664|NCT02415400|455229964|FG002|Overall Study|State regulations prevent participation|1|||
126529665|NCT02415400|455229965|FG003|Overall Study|State regulations prevent participation|0|||
126529666|NCT02415400|455229962|FG000|Overall Study|Poor treatment monitoring|0|||
126529667|NCT02415400|455229963|FG001|Overall Study|Poor treatment monitoring|0|||
126529668|NCT02415400|455229964|FG002|Overall Study|Poor treatment monitoring|1|||
126529669|NCT02415400|455229965|FG003|Overall Study|Poor treatment monitoring|0|||
126529670|NCT02415400|455229962|FG000|Overall Study|Participant in jail|0|||
126529671|NCT02415400|455229963|FG001|Overall Study|Participant in jail|0|||
126529672|NCT02415400|455229964|FG002|Overall Study|Participant in jail|1|||
126529673|NCT02415400|455229965|FG003|Overall Study|Participant in jail|0|||
126529674|NCT02415400|455229962|FG000|Overall Study|Investigator decision|0|||
126529675|NCT02415400|455229963|FG001|Overall Study|Investigator decision|0|||
126529676|NCT02415400|455229964|FG002|Overall Study|Investigator decision|1|||
126529677|NCT02415400|455229965|FG003|Overall Study|Investigator decision|1|||
126529678|NCT02415400|455229962|FG000|Overall Study|Site closure; participant won't transfer|0|||
126529679|NCT02415400|455229963|FG001|Overall Study|Site closure; participant won't transfer|0|||
126580713|NCT00632749|455421858|FG011|Overall Study|Progressive disease|3|||
126529680|NCT02415400|455229964|FG002|Overall Study|Site closure; participant won't transfer|0|||
126529681|NCT02415400|455229965|FG003|Overall Study|Site closure; participant won't transfer|1|||
126529682|NCT02270450|455229966|FG000|Overall Study|Refusal unrelated to adverse event|3|||
126529683|NCT02270450|455229967|FG001|Overall Study|Refusal unrelated to adverse event|1|||
126529684|NCT02270450|455229968|FG002|Overall Study|Refusal unrelated to adverse event|5|||
126529685|NCT02270450|455229969|FG003|Overall Study|Refusal unrelated to adverse event|14|||
126529686|NCT02270450|455229966|FG000|Overall Study|Progression/relapse|1|||
126529687|NCT02270450|455229967|FG001|Overall Study|Progression/relapse|2|||
126529688|NCT02270450|455229968|FG002|Overall Study|Progression/relapse|4|||
126529689|NCT02270450|455229969|FG003|Overall Study|Progression/relapse|9|||
126529690|NCT02270450|455229966|FG000|Overall Study|Death|19|||
126529691|NCT02270450|455229967|FG001|Overall Study|Death|19|||
126529692|NCT02270450|455229968|FG002|Overall Study|Death|31|||
126529693|NCT02270450|455229969|FG003|Overall Study|Death|59|||
126529694|NCT02363738|455229970|FG000|Overall Study|Adverse Event|5|||
126529695|NCT02363738|455229971|FG001|Overall Study|Adverse Event|2|||
126529696|NCT02363738|455229970|FG000|Overall Study|Lack of Efficacy|1|||
126529697|NCT02363738|455229971|FG001|Overall Study|Lack of Efficacy|2|||
126529698|NCT02363738|455229970|FG000|Overall Study|Lost to Follow-up|2|||
126529699|NCT02363738|455229971|FG001|Overall Study|Lost to Follow-up|1|||
126529700|NCT02081846|455229974|FG000|Overall Study|Withdrawal by Subject|1|||
126529701|NCT02081846|455229975|FG001|Overall Study|Withdrawal by Subject|0|||
126529702|NCT02081846|455229974|FG000|Overall Study|invalid consent|1|||
126529703|NCT02081846|455229975|FG001|Overall Study|invalid consent|0|||
126529704|NCT03282227|455229976|FG000|Overall Study|Exposure Goals Achieved|60|||
126529705|NCT03282227|455229976|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
126529706|NCT03282227|455229976|FG000|Overall Study|Adverse Event|15|||
126529707|NCT03282227|455229976|FG000|Overall Study|Lost to Follow-up|21|||
126529708|NCT03282227|455229976|FG000|Overall Study|Withdrawal by Subject|20|||
126529709|NCT03282227|455229976|FG000|Overall Study|Lack of Efficacy|12|||
126529710|NCT03282227|455229976|FG000|Overall Study|Sponsor decision|3|||
126529711|NCT03282227|455229976|FG000|Overall Study|Physician Decision|2|||
126529712|NCT03282227|455229976|FG000|Overall Study|Pregnancy|2|||
126529713|NCT03282227|455229976|FG000|Overall Study|Other|1|||
126529714|NCT02576678|455229977|FG000|Overall Study|Adverse Event|0|||
126529715|NCT02576678|455229978|FG001|Overall Study|Adverse Event|0|||
126529716|NCT02576678|455229979|FG002|Overall Study|Adverse Event|2|||
126529717|NCT02576678|455229977|FG000|Overall Study|Withdrawal by Subject|3|||
126529718|NCT02576678|455229978|FG001|Overall Study|Withdrawal by Subject|1|||
126529719|NCT02576678|455229979|FG002|Overall Study|Withdrawal by Subject|2|||
126529720|NCT02576678|455229977|FG000|Overall Study|Lost to Follow-up|0|||
126529721|NCT02576678|455229978|FG001|Overall Study|Lost to Follow-up|0|||
126529722|NCT02576678|455229979|FG002|Overall Study|Lost to Follow-up|1|||
126529723|NCT02576678|455229977|FG000|Overall Study|Miscellaneous|2|||
126529724|NCT02576678|455229978|FG001|Overall Study|Miscellaneous|0|||
126529725|NCT02576678|455229979|FG002|Overall Study|Miscellaneous|0|||
126529726|NCT02251990|455229983|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
126529727|NCT02251990|455229984|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
126529728|NCT02251990|455229983|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
126529729|NCT02251990|455229984|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
126529730|NCT02251990|455229983|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
126529731|NCT02251990|455229984|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
126529732|NCT02251990|455229983|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
126529733|NCT02251990|455229984|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
126529734|NCT02251990|455229983|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
126529735|NCT02251990|455229984|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
126529736|NCT02251990|455229983|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
126529737|NCT02251990|455229984|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
126529738|NCT03265600|455229985|FG000|Overall Study|Lost to Follow-up|17|||
126529739|NCT03265600|455229986|FG001|Overall Study|Lost to Follow-up|5|||
126529740|NCT03265600|455229985|FG000|Overall Study|Withdrawal by Subject|4|||
126529741|NCT03265600|455229986|FG001|Overall Study|Withdrawal by Subject|2|||
126529742|NCT03265600|455229985|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
126529743|NCT03265600|455229986|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
126529744|NCT04330638|455229987|FG000|Overall Study|Adverse Event|9|||
126529745|NCT04330638|455229988|FG001|Overall Study|Adverse Event|10|||
126529746|NCT04330638|455229989|FG002|Overall Study|Adverse Event|15|||
126529747|NCT04330638|455229990|FG003|Overall Study|Adverse Event|6|||
126529748|NCT04330638|455229991|FG004|Overall Study|Adverse Event|10|||
126529749|NCT04330638|455229992|FG005|Overall Study|Adverse Event|5|||
126529750|NCT04330638|455229987|FG000|Overall Study|Other|2|||
126529751|NCT04330638|455229988|FG001|Overall Study|Other|2|||
126529752|NCT04330638|455229989|FG002|Overall Study|Other|5|||
126529753|NCT04330638|455229990|FG003|Overall Study|Other|1|||
126529754|NCT04330638|455229991|FG004|Overall Study|Other|3|||
126529755|NCT04330638|455229992|FG005|Overall Study|Other|2|||
126529756|NCT04330638|455229987|FG000|Overall Study|Withdrawal by Subject|4|||
126529757|NCT04330638|455229988|FG001|Overall Study|Withdrawal by Subject|0|||
126529758|NCT04330638|455229989|FG002|Overall Study|Withdrawal by Subject|0|||
126529759|NCT04330638|455229990|FG003|Overall Study|Withdrawal by Subject|0|||
126529760|NCT04330638|455229991|FG004|Overall Study|Withdrawal by Subject|0|||
126529761|NCT04330638|455229992|FG005|Overall Study|Withdrawal by Subject|0|||
126529762|NCT04330638|455229987|FG000|Overall Study|Lost to Follow-up|3|||
126529763|NCT04330638|455229988|FG001|Overall Study|Lost to Follow-up|2|||
126529764|NCT04330638|455229989|FG002|Overall Study|Lost to Follow-up|3|||
126529765|NCT04330638|455229990|FG003|Overall Study|Lost to Follow-up|2|||
126529766|NCT04330638|455229991|FG004|Overall Study|Lost to Follow-up|3|||
126529767|NCT04330638|455229992|FG005|Overall Study|Lost to Follow-up|0|||
126529768|NCT02293538|455229993|FG000|Overall Study|Adverse Event|0|||
126529769|NCT02293538|455229994|FG001|Overall Study|Adverse Event|1|||
126529770|NCT02293538|455229993|FG000|Overall Study|Lost to Follow-up|1|||
126529771|NCT02293538|455229994|FG001|Overall Study|Lost to Follow-up|0|||
126529772|NCT02293538|455229993|FG000|Overall Study|Withdrawal by Subject|0|||
126529773|NCT02293538|455229994|FG001|Overall Study|Withdrawal by Subject|1|||
126529774|NCT00295750|455229996|FG000|Overall Study|Adverse Event|19|||
126529775|NCT00295750|455229997|FG001|Overall Study|Adverse Event|15|||
126529776|NCT00295750|455229998|FG002|Overall Study|Adverse Event|12|||
126529777|NCT00295750|455229996|FG000|Overall Study|Lack of Efficacy|1|||
126529778|NCT00295750|455229997|FG001|Overall Study|Lack of Efficacy|1|||
126529779|NCT00295750|455229998|FG002|Overall Study|Lack of Efficacy|0|||
126529780|NCT00295750|455229996|FG000|Overall Study|Lost to Follow-up|1|||
126529781|NCT00295750|455229997|FG001|Overall Study|Lost to Follow-up|4|||
126529782|NCT00295750|455229998|FG002|Overall Study|Lost to Follow-up|1|||
126529783|NCT00295750|455229996|FG000|Overall Study|Taking prohibited therapy|2|||
126529784|NCT00295750|455229997|FG001|Overall Study|Taking prohibited therapy|3|||
126529785|NCT00295750|455229998|FG002|Overall Study|Taking prohibited therapy|2|||
126529786|NCT00295750|455229996|FG000|Overall Study|Administrative errors|2|||
126529787|NCT00295750|455229997|FG001|Overall Study|Administrative errors|4|||
126529788|NCT00295750|455229998|FG002|Overall Study|Administrative errors|5|||
126529789|NCT00295750|455229996|FG000|Overall Study|Trial drug errors|1|||
126529790|NCT00295750|455229997|FG001|Overall Study|Trial drug errors|1|||
126529791|NCT00295750|455229998|FG002|Overall Study|Trial drug errors|0|||
126529792|NCT00295750|455229996|FG000|Overall Study|Disease progression|2|||
126529793|NCT00295750|455229997|FG001|Overall Study|Disease progression|1|||
126529794|NCT00295750|455229998|FG002|Overall Study|Disease progression|0|||
126529795|NCT00295750|455229996|FG000|Overall Study|Personal reasons|0|||
126529796|NCT00295750|455229997|FG001|Overall Study|Personal reasons|1|||
126529797|NCT00295750|455229998|FG002|Overall Study|Personal reasons|0|||
126529798|NCT00295750|455229996|FG000|Overall Study|Randomized but never received trial drug|4|||
126529799|NCT00295750|455229997|FG001|Overall Study|Randomized but never received trial drug|3|||
126529800|NCT00295750|455229998|FG002|Overall Study|Randomized but never received trial drug|3|||
126529801|NCT00295750|455229996|FG000|Overall Study|Withdrawal by Subject|9|||
126529802|NCT00295750|455229997|FG001|Overall Study|Withdrawal by Subject|4|||
126529803|NCT00295750|455229998|FG002|Overall Study|Withdrawal by Subject|7|||
126529804|NCT00295750|455229996|FG000|Overall Study|Protocol Violation|2|||
126529805|NCT00295750|455229997|FG001|Overall Study|Protocol Violation|4|||
126529806|NCT00295750|455229998|FG002|Overall Study|Protocol Violation|2|||
126529807|NCT00936858|455230002|FG000|Overall Study|Death|3|||
126529808|NCT00936858|455230002|FG000|Overall Study|Progression|29|||
126529809|NCT00936858|455230002|FG000|Overall Study|Withdrawal by Subject|5|||
126529810|NCT00936858|455230002|FG000|Overall Study|Adverse Event|1|||
126529811|NCT00936858|455230002|FG000|Overall Study|Physician Decision|7|||
126529812|NCT00936858|455230002|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
126529813|NCT00936858|455230002|FG000|Overall Study|Lost to Follow-up|1|||
126529814|NCT04899349|455230009|FG000|Overall Study|Study terminated by Sponsor|2|||
126529815|NCT04899349|455230010|FG001|Overall Study|Study terminated by Sponsor|0|||
126529816|NCT01857531|455230011|FG000|Overall Study|Withdrawal by Subject|4|||
126529817|NCT00435370|455230012|FG000|Overall Study|Adverse Event|8|||
126529818|NCT00435370|455230013|FG001|Overall Study|Adverse Event|8|||
126529819|NCT00435370|455230012|FG000|Overall Study|Withdrawal by Subject|10|||
126529820|NCT00435370|455230013|FG001|Overall Study|Withdrawal by Subject|10|||
126529821|NCT00435370|455230012|FG000|Overall Study|Antipsychotic medication changed|4|||
126529822|NCT00435370|455230013|FG001|Overall Study|Antipsychotic medication changed|2|||
126529823|NCT03943095|455230014|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
126529824|NCT03943095|455230015|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
126529825|NCT03943095|455230014|FG000|Overall Study|Withdrawal by Subject|1|||
126529826|NCT03943095|455230015|FG001|Overall Study|Withdrawal by Subject|0|||
126529827|NCT00744653|455230017|FG000|Overall Study|antineoplastic treatment|11|||
126529828|NCT00744653|455230017|FG000|Overall Study|Death|1|||
126580714|NCT00632749|455421859|FG012|Overall Study|Progressive disease|2|||
126529829|NCT00744653|455230017|FG000|Overall Study|Lost to Follow-up|1|||
126529830|NCT00744653|455230017|FG000|Overall Study|Physician Decision|3|||
126529831|NCT03826667|455230020|FG000|Overall Study|Protocol deviation|21|||
126529832|NCT00617344|455230021|FG000|Overall Study|Serious adverse event|1|||
126728924|NCT00259740|455956849|FG000|Overall Study|Death|1|||
126728925|NCT00259740|455956850|FG001|Overall Study|Death|1|||
126728926|NCT00259740|455956849|FG000|Overall Study|Disease progression|19|||
126728927|NCT00259740|455956850|FG001|Overall Study|Disease progression|36|||
126728928|NCT00259740|455956849|FG000|Overall Study|Ongoing|17|||
126728929|NCT00259740|455956850|FG001|Overall Study|Ongoing|3|||
126728930|NCT00259740|455956849|FG000|Overall Study|Other|3|||
126728931|NCT00259740|455956850|FG001|Overall Study|Other|0|||
126728932|NCT00259740|455956849|FG000|Overall Study|Requirement for alternative therapy|0|||
126728933|NCT00259740|455956850|FG001|Overall Study|Requirement for alternative therapy|4|||
126728934|NCT03495453|455956854|FG000|Overall Study|Withdrawal by Subject|0|||
126529833|NCT00617344|455230022|FG001|Overall Study|Serious adverse event|0|||
126529834|NCT00617344|455230023|FG002|Overall Study|Serious adverse event|0|||
126529835|NCT00617344|455230021|FG000|Overall Study|Other Adverse Event|1|||
126529836|NCT00617344|455230022|FG001|Overall Study|Other Adverse Event|1|||
126529837|NCT00617344|455230023|FG002|Overall Study|Other Adverse Event|0|||
126529838|NCT00617344|455230021|FG000|Overall Study|Protocol Violation|10|||
126529839|NCT00617344|455230022|FG001|Overall Study|Protocol Violation|8|||
126529840|NCT00617344|455230023|FG002|Overall Study|Protocol Violation|5|||
126529841|NCT00617344|455230021|FG000|Overall Study|Lost to Follow-up|5|||
126529842|NCT00617344|455230022|FG001|Overall Study|Lost to Follow-up|4|||
126529843|NCT00617344|455230023|FG002|Overall Study|Lost to Follow-up|1|||
126529844|NCT00617344|455230021|FG000|Overall Study|Withdrawal by Subject|8|||
126529845|NCT00617344|455230022|FG001|Overall Study|Withdrawal by Subject|9|||
126529846|NCT00617344|455230023|FG002|Overall Study|Withdrawal by Subject|2|||
126529847|NCT01864564|455230024|FG000|Overall Study|Lost to Follow-up|17|||
126529848|NCT01864564|455230025|FG001|Overall Study|Lost to Follow-up|23|||
126529849|NCT01864564|455230024|FG000|Overall Study|Withdrawal by Subject|20|||
126529850|NCT01864564|455230025|FG001|Overall Study|Withdrawal by Subject|11|||
126529851|NCT01864564|455230024|FG000|Overall Study|Protocol Violation|0|||
126529852|NCT01864564|455230025|FG001|Overall Study|Protocol Violation|27|||
126529853|NCT01864564|455230024|FG000|Overall Study|not reported|0|||
126529854|NCT01864564|455230025|FG001|Overall Study|not reported|34|||
126529855|NCT02269670|455230026|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
126529856|NCT00941330|455230027|FG000|Overall Study|Other|1|||
126529857|NCT00941330|455230028|FG001|Overall Study|Other|0|||
126529858|NCT00941330|455230027|FG000|Overall Study|Physician Decision|0|||
126529859|NCT00941330|455230028|FG001|Overall Study|Physician Decision|2|||
126529860|NCT02693665|455230029|FG000|Overall Study|Death|3|||
126529861|NCT02693665|455230030|FG001|Overall Study|Death|2|||
126529862|NCT02693665|455230029|FG000|Overall Study|Lost to Follow-up|7|||
126529863|NCT02693665|455230030|FG001|Overall Study|Lost to Follow-up|3|||
126529864|NCT02693665|455230029|FG000|Overall Study|Protocol Violation|1|||
126529865|NCT02693665|455230030|FG001|Overall Study|Protocol Violation|0|||
126529866|NCT02693665|455230029|FG000|Overall Study|Withdrawal by Subject|2|||
126529867|NCT02693665|455230030|FG001|Overall Study|Withdrawal by Subject|0|||
126529868|NCT02693665|455230029|FG000|Overall Study|patient wanted to leave it behind|1|||
126529869|NCT02693665|455230030|FG001|Overall Study|patient wanted to leave it behind|0|||
126529870|NCT02693665|455230029|FG000|Overall Study|anxiety|1|||
126529871|NCT02693665|455230030|FG001|Overall Study|anxiety|0|||
126529872|NCT02693665|455230029|FG000|Overall Study|family issues|1|||
126529873|NCT02693665|455230030|FG001|Overall Study|family issues|0|||
126529874|NCT02693665|455230029|FG000|Overall Study|no reason given|1|||
126529875|NCT02693665|455230030|FG001|Overall Study|no reason given|0|||
126529876|NCT00710424|455230035|FG000|Overall Study|Adverse Event|30|||
126529877|NCT00710424|455230036|FG001|Overall Study|Adverse Event|12|||
126529878|NCT00710424|455230035|FG000|Overall Study|Lack of Efficacy|4|||
126529879|NCT00710424|455230036|FG001|Overall Study|Lack of Efficacy|5|||
126529880|NCT00710424|455230035|FG000|Overall Study|Withdrawal by Subject|5|||
126529881|NCT00710424|455230036|FG001|Overall Study|Withdrawal by Subject|3|||
126529882|NCT00710424|455230035|FG000|Overall Study|Lost to Follow-up|0|||
126529883|NCT00710424|455230036|FG001|Overall Study|Lost to Follow-up|1|||
126529884|NCT00710424|455230035|FG000|Overall Study|Refused medication, no side effects|1|||
126529885|NCT00710424|455230036|FG001|Overall Study|Refused medication, no side effects|0|||
126529886|NCT00710424|455230035|FG000|Overall Study|Non-compliance with stable analgesia|1|||
126529887|NCT00710424|455230036|FG001|Overall Study|Non-compliance with stable analgesia|0|||
126529888|NCT00710424|455230035|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
126529889|NCT00710424|455230036|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
126529890|NCT00710424|455230035|FG000|Overall Study|Subject thought medication changed|1|||
126529891|NCT00710424|455230036|FG001|Overall Study|Subject thought medication changed|0|||
126529892|NCT00710424|455230035|FG000|Overall Study|Ceased treatment due to travel|1|||
126728935|NCT03495453|455956855|FG001|Overall Study|Withdrawal by Subject|1|||
126728936|NCT04724733|455956857|FG000|Overall Study|Lost to Follow-up|1|||
126728937|NCT04724733|455956858|FG001|Overall Study|Lost to Follow-up|1|||
126529893|NCT00710424|455230036|FG001|Overall Study|Ceased treatment due to travel|0|||
126529894|NCT00710424|455230035|FG000|Overall Study|Subject preferred paracetamol|0|||
126728938|NCT04724733|455956859|FG002|Overall Study|Lost to Follow-up|1|||
126728939|NCT04511819|455956860|FG000|Overall Study|Non-compliance with study drug|5|||
126580715|NCT00632749|455421860|FG013|Overall Study|Progressive disease|4|||
126580716|NCT00632749|455421847|FG000|Overall Study|Other Adverse event|1|||
126580717|NCT00632749|455421848|FG001|Overall Study|Other Adverse event|1|||
126580718|NCT00632749|455421849|FG002|Overall Study|Other Adverse event|1|||
126580719|NCT00632749|455421850|FG003|Overall Study|Other Adverse event|1|||
126580720|NCT00632749|455421851|FG004|Overall Study|Other Adverse event|2|||
126580721|NCT00632749|455421852|FG005|Overall Study|Other Adverse event|4|||
126580722|NCT00632749|455421853|FG006|Overall Study|Other Adverse event|1|||
126580723|NCT00632749|455421854|FG007|Overall Study|Other Adverse event|2|||
126580724|NCT00632749|455421855|FG008|Overall Study|Other Adverse event|2|||
126580725|NCT00632749|455421856|FG009|Overall Study|Other Adverse event|0|||
126580726|NCT00632749|455421857|FG010|Overall Study|Other Adverse event|1|||
126580727|NCT00632749|455421858|FG011|Overall Study|Other Adverse event|0|||
126580728|NCT00632749|455421859|FG012|Overall Study|Other Adverse event|1|||
126580729|NCT00632749|455421860|FG013|Overall Study|Other Adverse event|0|||
126580730|NCT00632749|455421847|FG000|Overall Study|Refuse to continue medication|0|||
126580731|NCT00632749|455421848|FG001|Overall Study|Refuse to continue medication|0|||
126580732|NCT00632749|455421849|FG002|Overall Study|Refuse to continue medication|0|||
126580733|NCT00632749|455421850|FG003|Overall Study|Refuse to continue medication|1|||
126580734|NCT00632749|455421851|FG004|Overall Study|Refuse to continue medication|0|||
126580735|NCT00632749|455421852|FG005|Overall Study|Refuse to continue medication|0|||
126580736|NCT00632749|455421853|FG006|Overall Study|Refuse to continue medication|0|||
126580737|NCT00632749|455421854|FG007|Overall Study|Refuse to continue medication|0|||
126580738|NCT00632749|455421855|FG008|Overall Study|Refuse to continue medication|0|||
126580739|NCT00632749|455421856|FG009|Overall Study|Refuse to continue medication|1|||
126529895|NCT00710424|455230036|FG001|Overall Study|Subject preferred paracetamol|1|||
126529896|NCT00710424|455230035|FG000|Overall Study|Felt good so stopped treatment|0|||
126529897|NCT00710424|455230036|FG001|Overall Study|Felt good so stopped treatment|1|||
126529898|NCT00613951|455230037|FG000|Overall Study|Adverse Event|1|||
126529899|NCT00613951|455230038|FG001|Overall Study|Adverse Event|0|||
126529900|NCT00613951|455230039|FG002|Overall Study|Adverse Event|1|||
126529901|NCT00613951|455230037|FG000|Overall Study|Lack of Efficacy|0|||
126529902|NCT00613951|455230038|FG001|Overall Study|Lack of Efficacy|1|||
126529903|NCT00613951|455230039|FG002|Overall Study|Lack of Efficacy|1|||
126529904|NCT00613951|455230037|FG000|Overall Study|Protocol Violation|1|||
126529905|NCT00613951|455230038|FG001|Overall Study|Protocol Violation|1|||
126529906|NCT00613951|455230039|FG002|Overall Study|Protocol Violation|1|||
126529907|NCT00613951|455230037|FG000|Overall Study|Unclassified|5|||
126529908|NCT00613951|455230038|FG001|Overall Study|Unclassified|3|||
126529909|NCT00613951|455230039|FG002|Overall Study|Unclassified|2|||
126529910|NCT01329029|455230042|FG000|Overall Study|Withdrawal by Subject|117|||
126529911|NCT01329029|455230043|FG001|Overall Study|Withdrawal by Subject|87|||
126529912|NCT01329029|455230042|FG000|Overall Study|Adverse Event|82|||
126529913|NCT01329029|455230043|FG001|Overall Study|Adverse Event|29|||
126529914|NCT01329029|455230042|FG000|Overall Study|Death|16|||
126529915|NCT01329029|455230043|FG001|Overall Study|Death|19|||
126529916|NCT01329029|455230042|FG000|Overall Study|Other|14|||
126529917|NCT01329029|455230043|FG001|Overall Study|Other|20|||
126529918|NCT01329029|455230042|FG000|Overall Study|COPD Exacerbation|11|||
126529919|NCT01329029|455230043|FG001|Overall Study|COPD Exacerbation|18|||
126529920|NCT01329029|455230042|FG000|Overall Study|Physician Decision|16|||
126529921|NCT01329029|455230043|FG001|Overall Study|Physician Decision|13|||
126529922|NCT01329029|455230042|FG000|Overall Study|Lost to Follow-up|8|||
126529923|NCT01329029|455230043|FG001|Overall Study|Lost to Follow-up|5|||
126529924|NCT01329029|455230042|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
126529925|NCT01329029|455230043|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
126529926|NCT01266642|455230044|FG000|Overall Study|Protocol Violation|0|||
126529927|NCT01266642|455230045|FG001|Overall Study|Protocol Violation|1|||
126529928|NCT02985866|455231888|FG000|Overall Study|Poor CGM data|1|||
126529929|NCT02985866|455231889|FG001|Overall Study|Poor CGM data|1|||
126580740|NCT00632749|455421857|FG010|Overall Study|Refuse to continue medication|0|||
126529930|NCT02811861|455231890|FG000|Overall Study|Radiological Disease Progression|123|||
126529931|NCT02811861|455231891|FG001|Overall Study|Radiological Disease Progression|97|||
126529932|NCT02811861|455231892|FG002|Overall Study|Radiological Disease Progression|174|||
126529933|NCT02811861|455231890|FG000|Overall Study|Clinical Disease Progression|20|||
126529934|NCT02811861|455231891|FG001|Overall Study|Clinical Disease Progression|19|||
126529935|NCT02811861|455231892|FG002|Overall Study|Clinical Disease Progression|22|||
126580741|NCT00632749|455421858|FG011|Overall Study|Refuse to continue medication|0|||
126580742|NCT00632749|455421859|FG012|Overall Study|Refuse to continue medication|0|||
126580743|NCT00632749|455421860|FG013|Overall Study|Refuse to continue medication|0|||
126580744|NCT00632749|455421847|FG000|Overall Study|Reason other than those specified above|0|||
126529936|NCT02811861|455231890|FG000|Overall Study|Adverse Event|63|||
126529937|NCT02811861|455231891|FG001|Overall Study|Adverse Event|60|||
126529938|NCT02811861|455231892|FG002|Overall Study|Adverse Event|41|||
126529939|NCT02811861|455231890|FG000|Overall Study|Lost to Follow-up|0|||
126529940|NCT02811861|455231891|FG001|Overall Study|Lost to Follow-up|0|||
126529941|NCT02811861|455231892|FG002|Overall Study|Lost to Follow-up|1|||
126728940|NCT04511819|455956861|FG001|Overall Study|Non-compliance with study drug|1|||
126728941|NCT04511819|455956860|FG000|Overall Study|Withdrawal by Subject|0|||
126728942|NCT04511819|455956861|FG001|Overall Study|Withdrawal by Subject|3|||
126728943|NCT04511819|455956860|FG000|Overall Study|Adverse Event|0|||
126728944|NCT04511819|455956861|FG001|Overall Study|Adverse Event|1|||
126728945|NCT04511819|455956860|FG000|Overall Study|Protocol deviation|1|||
126728946|NCT04511819|455956861|FG001|Overall Study|Protocol deviation|0|||
126728947|NCT01742078|455956862|FG000|Overall Study|Withdrawal by Subject|0|||
126728948|NCT01742078|455956863|FG001|Overall Study|Withdrawal by Subject|0|||
126728949|NCT01742078|455956864|FG002|Overall Study|Withdrawal by Subject|0|||
126728950|NCT01742078|455956865|FG003|Overall Study|Withdrawal by Subject|1|||
126728951|NCT01742078|455956866|FG004|Overall Study|Withdrawal by Subject|0|||
126728952|NCT01742078|455956867|FG005|Overall Study|Withdrawal by Subject|0|||
126728953|NCT01742078|455956868|FG006|Overall Study|Withdrawal by Subject|0|||
126728954|NCT01742078|455956869|FG007|Overall Study|Withdrawal by Subject|0|||
126777134|NCT02370784|456141295|FG001|Overall Study|Patient started prohibited medication|1|||
126529942|NCT02811861|455231890|FG000|Overall Study|Subject Choice|29|||
126529943|NCT02811861|455231891|FG001|Overall Study|Subject Choice|17|||
126529944|NCT02811861|455231892|FG002|Overall Study|Subject Choice|23|||
126529945|NCT02811861|455231890|FG000|Overall Study|Withdrawal by Subject|4|||
126529946|NCT02811861|455231891|FG001|Overall Study|Withdrawal by Subject|4|||
126529947|NCT02811861|455231892|FG002|Overall Study|Withdrawal by Subject|9|||
126529948|NCT02811861|455231890|FG000|Overall Study|Other|4|||
126529949|NCT02811861|455231891|FG001|Overall Study|Other|13|||
126529950|NCT02811861|455231892|FG002|Overall Study|Other|3|||
126529951|NCT02811861|455231890|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
126529952|NCT02811861|455231891|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
126529953|NCT02811861|455231892|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
126529954|NCT02811861|455231890|FG000|Overall Study|Randomized but not treated|2|||
126529955|NCT02811861|455231891|FG001|Overall Study|Randomized but not treated|3|||
126529956|NCT02811861|455231892|FG002|Overall Study|Randomized but not treated|17|||
126529957|NCT02925455|455231893|FG000|Overall Study|Withdrawal by Subject|2|||
126529958|NCT02925455|455231894|FG001|Overall Study|Withdrawal by Subject|0|||
126529959|NCT00360308|455231895|FG000|Overall Study|Adverse Event|15|||
126529960|NCT00360308|455231896|FG001|Overall Study|Adverse Event|14|||
126529961|NCT00360308|455231897|FG002|Overall Study|Adverse Event|25|||
126529962|NCT00360308|455231895|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
126529963|NCT00360308|455231896|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
126529964|NCT00360308|455231897|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
126529965|NCT00360308|455231895|FG000|Overall Study|Protocol Violation|2|||
126529966|NCT00360308|455231896|FG001|Overall Study|Protocol Violation|1|||
126529967|NCT00360308|455231897|FG002|Overall Study|Protocol Violation|2|||
126529968|NCT00360308|455231895|FG000|Overall Study|Withdrawal by Subject|11|||
126529969|NCT00360308|455231896|FG001|Overall Study|Withdrawal by Subject|7|||
126529970|NCT00360308|455231897|FG002|Overall Study|Withdrawal by Subject|14|||
126529971|NCT00360308|455231895|FG000|Overall Study|Lack of Efficacy|3|||
126529972|NCT00360308|455231896|FG001|Overall Study|Lack of Efficacy|0|||
126529973|NCT00360308|455231897|FG002|Overall Study|Lack of Efficacy|2|||
126529974|NCT00360308|455231895|FG000|Overall Study|Other|2|||
126529975|NCT00360308|455231896|FG001|Overall Study|Other|1|||
126529976|NCT00360308|455231897|FG002|Overall Study|Other|1|||
126529977|NCT00360308|455231895|FG000|Overall Study|Study termination by sponsor|43|||
126529978|NCT00360308|455231896|FG001|Overall Study|Study termination by sponsor|55|||
126529979|NCT00360308|455231897|FG002|Overall Study|Study termination by sponsor|44|||
126529980|NCT02732938|455231900|FG000|Overall Study|Death|0|||
126529981|NCT02732938|455231901|FG001|Overall Study|Death|11|||
126529982|NCT02732938|455231902|FG002|Overall Study|Death|0|||
126529983|NCT02732938|455231900|FG000|Overall Study|Randomized but did not receive treatment|0|||
126529984|NCT02732938|455231901|FG001|Overall Study|Randomized but did not receive treatment|1|||
126529985|NCT02732938|455231902|FG002|Overall Study|Randomized but did not receive treatment|0|||
126529986|NCT02732938|455231900|FG000|Overall Study|Refused further follow-up|1|||
126529987|NCT02732938|455231901|FG001|Overall Study|Refused further follow-up|0|||
126529988|NCT02732938|455231902|FG002|Overall Study|Refused further follow-up|0|||
126529989|NCT02732938|455231900|FG000|Overall Study|Study terminated by sponsor|3|||
126529990|NCT02732938|455231901|FG001|Overall Study|Study terminated by sponsor|6|||
126529991|NCT02732938|455231902|FG002|Overall Study|Study terminated by sponsor|0|||
126529992|NCT03927950|455231903|FG000|Overall Study|Adverse Event|9|||
126529993|NCT04530448|455231904|FG000|Overall Study|Physician Decision|3|||
126529994|NCT04530448|455231905|FG001|Overall Study|Physician Decision|0|||
126529995|NCT01433354|455231907|FG000|Overall Study|Adverse Event|6|||
126529996|NCT01433354|455231907|FG000|Overall Study|Lost to Follow-up|1|||
126529997|NCT01433354|455231907|FG000|Overall Study|Administrative problems|90|||
126529998|NCT01433354|455231907|FG000|Overall Study|Protocol Violation|2|||
126529999|NCT01433354|455231907|FG000|Overall Study|Lack of Efficacy|17|||
126530000|NCT01433354|455231907|FG000|Overall Study|Subject Withdrew Consent|3|||
126530001|NCT02015676|455231910|FG000|Overall Study|Adverse Event|2|||
126530002|NCT02015676|455231911|FG001|Overall Study|Adverse Event|18|||
126530003|NCT02015676|455231912|FG002|Overall Study|Adverse Event|0|||
126530004|NCT02015676|455231910|FG000|Overall Study|Lack of Efficacy|2|||
126530005|NCT02015676|455231911|FG001|Overall Study|Lack of Efficacy|4|||
126530006|NCT02015676|455231912|FG002|Overall Study|Lack of Efficacy|0|||
126530007|NCT02015676|455231910|FG000|Overall Study|Protocol Violation|1|||
126530008|NCT02015676|455231911|FG001|Overall Study|Protocol Violation|0|||
126530009|NCT02015676|455231912|FG002|Overall Study|Protocol Violation|0|||
126530010|NCT02015676|455231910|FG000|Overall Study|Withdrawal by Subject|1|||
126530011|NCT02015676|455231911|FG001|Overall Study|Withdrawal by Subject|7|||
126530012|NCT02015676|455231912|FG002|Overall Study|Withdrawal by Subject|1|||
126530013|NCT02015676|455231910|FG000|Overall Study|Administrative reasons|0|||
126530014|NCT02015676|455231911|FG001|Overall Study|Administrative reasons|3|||
126530015|NCT02015676|455231912|FG002|Overall Study|Administrative reasons|1|||
126530016|NCT02015676|455231910|FG000|Overall Study|Death|0|||
126728955|NCT01742078|455956870|FG008|Overall Study|Withdrawal by Subject|0|||
126728956|NCT00084929|455956873|FG000|Overall Study|ineligible - medical contraindication|1|||
126728957|NCT00084929|455956873|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
126728958|NCT00084929|455956873|FG000|Overall Study|Ineligible - Medical history|6|||
126728959|NCT00084929|455956873|FG000|Overall Study|Withdrawal by Subject|10|||
126728960|NCT00084929|455956873|FG000|Overall Study|Missing/incomplete CTC exam|9|||
126728961|NCT00084929|455956873|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
126728962|NCT03247413|455956874|FG000|Overall Study|Lost to Follow-up|28|||
126728963|NCT00424294|455956875|FG000|Overall Study|Adverse Event|4|||
126728964|NCT00424294|455956876|FG001|Overall Study|Adverse Event|10|||
126728965|NCT00424294|455956875|FG000|Overall Study|Lack of Efficacy|2|||
126728966|NCT00424294|455956876|FG001|Overall Study|Lack of Efficacy|1|||
126728967|NCT00424294|455956875|FG000|Overall Study|Withdrawal by Subject|1|||
126728968|NCT00424294|455956876|FG001|Overall Study|Withdrawal by Subject|2|||
126728969|NCT00424294|455956875|FG000|Overall Study|Other|0|||
126728970|NCT00424294|455956876|FG001|Overall Study|Other|2|||
126728971|NCT00424294|455956875|FG000|Overall Study|Randomized but not Treated|1|||
126728972|NCT00424294|455956876|FG001|Overall Study|Randomized but not Treated|0|||
126728973|NCT04397718|455956877|FG000|Overall Study|Death|7|||
126728974|NCT04397718|455956878|FG001|Overall Study|Death|11|||
126728975|NCT04397718|455956877|FG000|Overall Study|Lost to Follow-up|0|||
126728976|NCT04397718|455956878|FG001|Overall Study|Lost to Follow-up|4|||
126728977|NCT01797965|455956879|FG000|Overall Study|Adverse Event|104|||
126728978|NCT01797965|455956880|FG001|Overall Study|Adverse Event|129|||
126728979|NCT01797965|455956881|FG002|Overall Study|Adverse Event|4|||
126728980|NCT01797965|455956882|FG003|Overall Study|Adverse Event|21|||
126728981|NCT01797965|455956879|FG000|Overall Study|Lost to Follow-up|9|||
126728982|NCT01797965|455956880|FG001|Overall Study|Lost to Follow-up|8|||
126728983|NCT01797965|455956881|FG002|Overall Study|Lost to Follow-up|1|||
126530017|NCT02015676|455231911|FG001|Overall Study|Death|1|||
126530018|NCT02015676|455231912|FG002|Overall Study|Death|0|||
126530019|NCT02015676|455231910|FG000|Overall Study|Disease progression|3|||
126530020|NCT02015676|455231911|FG001|Overall Study|Disease progression|1|||
126530021|NCT02015676|455231912|FG002|Overall Study|Disease progression|1|||
126530022|NCT02701985|455231917|FG000|Overall Study|Withdrawal by Subject|1|||
126530023|NCT02701985|455231918|FG001|Overall Study|Withdrawal by Subject|1|||
126530024|NCT02701985|455231917|FG000|Overall Study|Lost to Follow-up|1|||
126530025|NCT02701985|455231918|FG001|Overall Study|Lost to Follow-up|0|||
126530026|NCT02701985|455231917|FG000|Overall Study|Death|1|||
126530027|NCT02701985|455231918|FG001|Overall Study|Death|0|||
126530028|NCT02701985|455231917|FG000|Overall Study|Adverse Event|0|||
126530029|NCT02701985|455231918|FG001|Overall Study|Adverse Event|5|||
126530030|NCT01640808|455231919|FG000|Overall Study|Unable to continue dynamic CT|14|||
126530031|NCT01640808|455231920|FG001|Overall Study|Unable to continue dynamic CT|4|||
126530032|NCT01640808|455231919|FG000|Overall Study|Withdrawal by Subject|12|||
126530033|NCT01640808|455231920|FG001|Overall Study|Withdrawal by Subject|4|||
126530034|NCT01640808|455231919|FG000|Overall Study|Lost to Follow-up|4|||
126530035|NCT01640808|455231920|FG001|Overall Study|Lost to Follow-up|0|||
126530036|NCT01640808|455231919|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
126728984|NCT01797965|455956882|FG003|Overall Study|Lost to Follow-up|2|||
126728985|NCT01797965|455956879|FG000|Overall Study|Consent withdrawn|130|||
126728986|NCT01797965|455956880|FG001|Overall Study|Consent withdrawn|117|||
126728987|NCT01797965|455956881|FG002|Overall Study|Consent withdrawn|3|||
126530037|NCT01640808|455231920|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
126530038|NCT01640808|455231919|FG000|Overall Study|Administration of anticancer drugs|2|||
126530039|NCT01640808|455231920|FG001|Overall Study|Administration of anticancer drugs|1|||
126728988|NCT01797965|455956882|FG003|Overall Study|Consent withdrawn|35|||
126728989|NCT01797965|455956879|FG000|Overall Study|Investigator decision|21|||
126777135|NCT00515073|456141298|FG000|Overall Study|Withdrawal by Subject|1|||
126530040|NCT01640808|455231919|FG000|Overall Study|Physician Decision|19|||
126530041|NCT01640808|455231920|FG001|Overall Study|Physician Decision|5|||
126530042|NCT01640808|455231919|FG000|Overall Study|Randomized but not treated|4|||
126530043|NCT01640808|455231920|FG001|Overall Study|Randomized but not treated|2|||
126530044|NCT04391023|455231921|FG000|Overall Study|Withdrawal by Subject|2|||
126728990|NCT01797965|455956880|FG001|Overall Study|Investigator decision|15|||
126728991|NCT01797965|455956881|FG002|Overall Study|Investigator decision|0|||
126728992|NCT01797965|455956882|FG003|Overall Study|Investigator decision|0|||
126728993|NCT01797965|455956879|FG000|Overall Study|Death|2|||
126728994|NCT01797965|455956880|FG001|Overall Study|Death|4|||
126728995|NCT01797965|455956881|FG002|Overall Study|Death|0|||
126728996|NCT01797965|455956882|FG003|Overall Study|Death|0|||
126728997|NCT01797965|455956879|FG000|Overall Study|Disease progression, defined by protocol|3|||
126728998|NCT01797965|455956880|FG001|Overall Study|Disease progression, defined by protocol|1|||
126728999|NCT01797965|455956881|FG002|Overall Study|Disease progression, defined by protocol|0|||
126729000|NCT01797965|455956882|FG003|Overall Study|Disease progression, defined by protocol|0|||
126729001|NCT01797965|455956879|FG000|Overall Study|Reason Not Specified|280|||
126729002|NCT01797965|455956880|FG001|Overall Study|Reason Not Specified|295|||
126729003|NCT01797965|455956881|FG002|Overall Study|Reason Not Specified|0|||
126729004|NCT01797965|455956882|FG003|Overall Study|Reason Not Specified|15|||
126729005|NCT02670330|455956884|FG000|Overall Study|Protocol Deviation|1|||
126729006|NCT02670330|455956885|FG001|Overall Study|Protocol Deviation|0|||
126729007|NCT02670330|455956884|FG000|Overall Study|Study Terminated By Sponsor|36|||
126729008|NCT02670330|455956885|FG001|Overall Study|Study Terminated By Sponsor|43|||
126729009|NCT02670330|455956884|FG000|Overall Study|Adverse Event|1|||
126729010|NCT02670330|455956885|FG001|Overall Study|Adverse Event|3|||
126729011|NCT02670330|455956884|FG000|Overall Study|Withdrawal by Subject|34|||
126729012|NCT02670330|455956885|FG001|Overall Study|Withdrawal by Subject|29|||
126729013|NCT02670330|455956884|FG000|Overall Study|Lost to Follow-up|3|||
126729014|NCT02670330|455956885|FG001|Overall Study|Lost to Follow-up|2|||
126729015|NCT04404010|455956886|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
126729016|NCT04404010|455956887|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
126729017|NCT02120157|455956888|FG000|Overall Study|Death|8|||
126729018|NCT00441103|455956892|FG000|Overall Study|Adverse Event|2|||
126777136|NCT00515073|456141298|FG000|Overall Study|Physician Decision|1|||
126777137|NCT01456052|456141299|FG000|Overall Study|Adverse Event|1|||
126777138|NCT01456052|456141300|FG001|Overall Study|Adverse Event|1|||
126777139|NCT01456052|456141301|FG002|Overall Study|Adverse Event|2|||
126530045|NCT04391023|455231922|FG001|Overall Study|Withdrawal by Subject|2|||
126530046|NCT01270347|455231923|FG000|Core Phase|Adverse Event|1|||
126530047|NCT01270347|455231924|FG001|Core Phase|Adverse Event|6|||
126580745|NCT00632749|455421848|FG001|Overall Study|Reason other than those specified above|2|||
126580746|NCT00632749|455421849|FG002|Overall Study|Reason other than those specified above|0|||
126580747|NCT00632749|455421850|FG003|Overall Study|Reason other than those specified above|0|||
126580748|NCT00632749|455421851|FG004|Overall Study|Reason other than those specified above|1|||
126580749|NCT00632749|455421852|FG005|Overall Study|Reason other than those specified above|0|||
126580750|NCT00632749|455421853|FG006|Overall Study|Reason other than those specified above|1|||
126580751|NCT00632749|455421854|FG007|Overall Study|Reason other than those specified above|0|||
126580752|NCT00632749|455421855|FG008|Overall Study|Reason other than those specified above|0|||
126580753|NCT00632749|455421856|FG009|Overall Study|Reason other than those specified above|0|||
126580754|NCT00632749|455421857|FG010|Overall Study|Reason other than those specified above|2|||
126580755|NCT00632749|455421858|FG011|Overall Study|Reason other than those specified above|1|||
126530048|NCT01270347|455231923|FG000|Core Phase|Withdrawal by Subject|1|||
126530049|NCT01270347|455231924|FG001|Core Phase|Withdrawal by Subject|2|||
126530050|NCT01270347|455231923|FG000|Core Phase|Lost to Follow-up|0|||
126530051|NCT01270347|455231924|FG001|Core Phase|Lost to Follow-up|1|||
126530052|NCT01270347|455231923|FG000|Core Phase|Miscellaneous|8|||
126530053|NCT01270347|455231924|FG001|Core Phase|Miscellaneous|14|||
126530054|NCT01270347|455231923|FG000|Extension Phase|Adverse Event|1|||
126530055|NCT01270347|455231924|FG001|Extension Phase|Adverse Event|3|||
126530056|NCT01270347|455231923|FG000|Extension Phase|Withdrawal by Subject|3|||
126530057|NCT01270347|455231924|FG001|Extension Phase|Withdrawal by Subject|4|||
126530058|NCT01270347|455231923|FG000|Extension Phase|Miscellaneous|2|||
126530059|NCT01270347|455231924|FG001|Extension Phase|Miscellaneous|2|||
126530060|NCT02189798|455231925|FG000|Extended Use Phase|Withdrawal by Subject|0|||
126530061|NCT02189798|455231926|FG001|Extended Use Phase|Withdrawal by Subject|4|||
126530062|NCT02189798|455231925|FG000|Extended Use Phase|Physician Decision|1|||
126580756|NCT00632749|455421859|FG012|Overall Study|Reason other than those specified above|0|||
126580757|NCT00632749|455421860|FG013|Overall Study|Reason other than those specified above|2|||
126580758|NCT04128319|455421861|FG000|Overall Study|Death|3|||
126777140|NCT01456052|456141299|FG000|Overall Study|Consent withdrawn|0|||
126580759|NCT05028582|455421865|FG000|Overall Study|Lost to Follow-up|11|||
126729019|NCT00441103|455956893|FG001|Overall Study|Adverse Event|1|||
126729020|NCT00441103|455956892|FG000|Overall Study|Death|1|||
126580760|NCT05028582|455421866|FG001|Overall Study|Lost to Follow-up|9|||
126777141|NCT01456052|456141300|FG001|Overall Study|Consent withdrawn|2|||
126530063|NCT02189798|455231926|FG001|Extended Use Phase|Physician Decision|0|||
126530064|NCT02189798|455231925|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
126530065|NCT02189798|455231926|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
126729021|NCT00441103|455956893|FG001|Overall Study|Death|0|||
126729022|NCT00441103|455956892|FG000|Overall Study|Disease Progression|2|||
126729023|NCT00441103|455956893|FG001|Overall Study|Disease Progression|0|||
126729024|NCT00441103|455956892|FG000|Overall Study|Lost to Follow-up|1|||
126729025|NCT00441103|455956893|FG001|Overall Study|Lost to Follow-up|0|||
126729026|NCT00441103|455956892|FG000|Overall Study|Protocol Violation|1|||
126729027|NCT00441103|455956893|FG001|Overall Study|Protocol Violation|0|||
126729028|NCT00441103|455956892|FG000|Overall Study|Participant unable to use Rebiject II|1|||
126729029|NCT00441103|455956893|FG001|Overall Study|Participant unable to use Rebiject II|0|||
126729030|NCT00441103|455956892|FG000|Overall Study|Participant refused MRI|1|||
126729031|NCT00441103|455956893|FG001|Overall Study|Participant refused MRI|0|||
126729032|NCT00441103|455956892|FG000|Overall Study|Inclusion criteria absent|1|||
126729033|NCT00441103|455956893|FG001|Overall Study|Inclusion criteria absent|0|||
126729034|NCT00441103|455956892|FG000|Overall Study|Non-compliant|0|||
126729035|NCT00441103|455956893|FG001|Overall Study|Non-compliant|1|||
126729036|NCT00441103|455956892|FG000|Overall Study|Participant decided to withdraw|1|||
126729037|NCT00441103|455956893|FG001|Overall Study|Participant decided to withdraw|0|||
126729038|NCT00441103|455956892|FG000|Overall Study|Participant's reason|0|||
126729039|NCT00441103|455956893|FG001|Overall Study|Participant's reason|1|||
126729040|NCT00441103|455956892|FG000|Overall Study|Participant decided to stop|0|||
126729041|NCT00441103|455956893|FG001|Overall Study|Participant decided to stop|1|||
126729042|NCT00239837|455956896|FG000|Overall Study|Lost to Follow-up|3|||
126729043|NCT00239837|455956897|FG001|Overall Study|Lost to Follow-up|7|||
126729044|NCT01153893|455956898|FG000|Overall Study|Adverse Event|1|||
126729045|NCT01153893|455956899|FG001|Overall Study|Adverse Event|0|||
126729046|NCT01838590|455956900|FG000|Overall Study|Lack of Efficacy|12|||
126729047|NCT01838590|455956901|FG001|Overall Study|Lack of Efficacy|4|||
126729048|NCT01838590|455956900|FG000|Overall Study|Lost to Follow-up|0|||
126729049|NCT01838590|455956901|FG001|Overall Study|Lost to Follow-up|1|||
126729050|NCT01354431|455956902|FG000|Pre-Treatment Period|Not reported|1|||
126729051|NCT01354431|455956903|FG001|Pre-Treatment Period|Not reported|0|||
126729052|NCT01354431|455956904|FG002|Pre-Treatment Period|Not reported|0|||
126729053|NCT01354431|455956902|FG000|Treatment Period|Disease Progression|50|||
126729054|NCT01354431|455956903|FG001|Treatment Period|Disease Progression|40|||
126729055|NCT01354431|455956904|FG002|Treatment Period|Disease Progression|44|||
126729056|NCT01354431|455956902|FG000|Treatment Period|Study Drug Toxicity|5|||
126729057|NCT01354431|455956903|FG001|Treatment Period|Study Drug Toxicity|8|||
126729058|NCT01354431|455956904|FG002|Treatment Period|Study Drug Toxicity|4|||
126729059|NCT01354431|455956902|FG000|Treatment Period|Death|0|||
126729060|NCT01354431|455956903|FG001|Treatment Period|Death|1|||
126729061|NCT01354431|455956904|FG002|Treatment Period|Death|0|||
126729062|NCT01354431|455956902|FG000|Treatment Period|AE unrelated to study drug|1|||
126729063|NCT01354431|455956903|FG001|Treatment Period|AE unrelated to study drug|2|||
126729064|NCT01354431|455956904|FG002|Treatment Period|AE unrelated to study drug|5|||
126729065|NCT01354431|455956902|FG000|Treatment Period|Participant request to discontinue|2|||
126729066|NCT01354431|455956903|FG001|Treatment Period|Participant request to discontinue|2|||
126729067|NCT01354431|455956904|FG002|Treatment Period|Participant request to discontinue|1|||
126729068|NCT01354431|455956902|FG000|Treatment Period|Participant withdrew consent|0|||
126530066|NCT02189798|455231925|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
126530067|NCT02189798|455231926|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
126530068|NCT02189798|455231925|FG000|Extended Use Phase|Travel Issues|2|||
126530069|NCT02189798|455231926|FG001|Extended Use Phase|Travel Issues|1|||
126530070|NCT02189798|455231925|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
126530071|NCT02189798|455231926|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
126530072|NCT00727272|455231933|FG000|Washout Period A|Adverse Event|0|||
126530073|NCT00727272|455231934|FG001|Washout Period A|Adverse Event|0|||
126530074|NCT00727272|455231935|FG002|Washout Period A|Adverse Event|1|||
126530075|NCT00727272|455231933|FG000|Washout Period B|Withdrawal by Subject|0|||
126530076|NCT00727272|455231934|FG001|Washout Period B|Withdrawal by Subject|0|||
126530077|NCT00727272|455231935|FG002|Washout Period B|Withdrawal by Subject|1|||
126729069|NCT01354431|455956903|FG001|Treatment Period|Participant withdrew consent|1|||
126729070|NCT01354431|455956904|FG002|Treatment Period|Participant withdrew consent|0|||
126729071|NCT01354431|455956902|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
126729072|NCT01354431|455956903|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
126729073|NCT01354431|455956904|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
126729074|NCT00878215|455956907|FG000|Overall Study|Determined to be ineligible|0|||
126729075|NCT00878215|455956908|FG001|Overall Study|Determined to be ineligible|10|||
126729076|NCT00878215|455956909|FG002|Overall Study|Determined to be ineligible|0|||
126729077|NCT00878215|455956910|FG003|Overall Study|Determined to be ineligible|0|||
126729078|NCT01364233|455956911|FG000|Overall Study|Lost to Follow-up|1|||
126729079|NCT00738374|455956913|FG000|Induction Treatment Phase|Adverse Event|14|||
126530078|NCT00651664|455231936|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
126530079|NCT00651664|455231937|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
126530080|NCT00651664|455231938|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
126580761|NCT05028582|455421865|FG000|Overall Study|Withdrawal by Subject|9|||
126580762|NCT05028582|455421866|FG001|Overall Study|Withdrawal by Subject|10|||
126580763|NCT05028582|455421865|FG000|Overall Study|Adverse Event|5|||
126580764|NCT05028582|455421866|FG001|Overall Study|Adverse Event|2|||
126530081|NCT00651664|455231939|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
126530082|NCT00651664|455231940|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
126530083|NCT00651664|455231941|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
126530084|NCT00651664|455231942|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
126530085|NCT00651664|455231943|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
126530086|NCT00651664|455231944|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
126530087|NCT00651664|455231945|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
126530088|NCT00651664|455231936|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
126530089|NCT00651664|455231937|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
126530090|NCT00651664|455231938|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
126530091|NCT00651664|455231939|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
126530092|NCT00651664|455231940|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
126530093|NCT00651664|455231941|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
126530094|NCT00651664|455231942|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
126530095|NCT00651664|455231943|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
126530096|NCT00651664|455231944|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
126530097|NCT00651664|455231945|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
126530098|NCT00651664|455231936|FG000|Overall Study|Progressive Disease|3|||
126530099|NCT00651664|455231937|FG001|Overall Study|Progressive Disease|3|||
126530100|NCT00651664|455231938|FG002|Overall Study|Progressive Disease|3|||
126530101|NCT00651664|455231939|FG003|Overall Study|Progressive Disease|12|||
126530102|NCT00651664|455231940|FG004|Overall Study|Progressive Disease|4|||
126580765|NCT05028582|455421865|FG000|Overall Study|Miscellaneous|3|||
126580766|NCT05028582|455421866|FG001|Overall Study|Miscellaneous|2|||
126580767|NCT05028582|455421865|FG000|Overall Study|Lack of Efficacy|3|||
126580768|NCT05028582|455421866|FG001|Overall Study|Lack of Efficacy|1|||
126580769|NCT05028582|455421865|FG000|Overall Study|Physician Decision|0|||
126580770|NCT05028582|455421866|FG001|Overall Study|Physician Decision|1|||
126580771|NCT01959698|455421867|FG000|Overall Study|Adverse Event|0|||
126580772|NCT01959698|455421868|FG001|Overall Study|Adverse Event|0|||
126580773|NCT01959698|455421869|FG002|Overall Study|Adverse Event|0|||
126580774|NCT01959698|455421870|FG003|Overall Study|Adverse Event|0|||
126580775|NCT01959698|455421871|FG004|Overall Study|Adverse Event|0|||
126580776|NCT01959698|455421872|FG005|Overall Study|Adverse Event|0|||
126580777|NCT01959698|455421873|FG006|Overall Study|Adverse Event|1|||
126580778|NCT01959698|455421867|FG000|Overall Study|Physician Decision|1|||
126580779|NCT01959698|455421868|FG001|Overall Study|Physician Decision|0|||
126580780|NCT01959698|455421869|FG002|Overall Study|Physician Decision|1|||
126580781|NCT01959698|455421870|FG003|Overall Study|Physician Decision|2|||
126580782|NCT01959698|455421871|FG004|Overall Study|Physician Decision|0|||
126580783|NCT01959698|455421872|FG005|Overall Study|Physician Decision|3|||
126580784|NCT01959698|455421873|FG006|Overall Study|Physician Decision|3|||
126580785|NCT04402294|455421874|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
126580786|NCT04402294|455421875|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
126580787|NCT04402294|455421874|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
126580788|NCT04402294|455421875|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
126580789|NCT03481660|455424030|FG000|Overall Study|Adverse Event|5|||
126580790|NCT03481660|455424031|FG001|Overall Study|Adverse Event|4|||
126580791|NCT03481660|455424030|FG000|Overall Study|Death|13|||
126580792|NCT03481660|455424031|FG001|Overall Study|Death|9|||
126580793|NCT03481660|455424030|FG000|Overall Study|Lost to Follow-up|2|||
126580794|NCT03481660|455424031|FG001|Overall Study|Lost to Follow-up|2|||
126580795|NCT03481660|455424030|FG000|Overall Study|Physician Decision|2|||
126580796|NCT03481660|455424031|FG001|Overall Study|Physician Decision|3|||
126580797|NCT03481660|455424030|FG000|Overall Study|Withdrawal by Subject|14|||
126580798|NCT03481660|455424031|FG001|Overall Study|Withdrawal by Subject|7|||
126580799|NCT00186992|455424034|FG000|Overall Study|Withdrawal by Subject|5|||
126580800|NCT00186992|455424034|FG000|Overall Study|Physician's discretion|13|||
126530103|NCT00651664|455231941|FG005|Overall Study|Progressive Disease|1|||
126530104|NCT00651664|455231942|FG006|Overall Study|Progressive Disease|3|||
126530105|NCT00651664|455231943|FG007|Overall Study|Progressive Disease|6|||
126530106|NCT00651664|455231944|FG008|Overall Study|Progressive Disease|5|||
126580801|NCT00186992|455424034|FG000|Overall Study|PI Discretion|4|||
126580802|NCT00186992|455424034|FG000|Overall Study|Ineligible|2|||
126580803|NCT00186992|455424034|FG000|Overall Study|Lost to Follow-up|2|||
126580804|NCT00186992|455424034|FG000|Overall Study|Still on Study|9|||
126580805|NCT03683069|455424035|FG000|Overall Study|see limitations|12|||
126777142|NCT01456052|456141301|FG002|Overall Study|Consent withdrawn|1|||
126530107|NCT00651664|455231945|FG009|Overall Study|Progressive Disease|5|||
126580806|NCT03683069|455424036|FG001|Overall Study|see limitations|13|||
126580807|NCT04065048|455424037|FG000|Overall Study|Withdrawal by Subject|1|||
126580808|NCT04065048|455424038|FG001|Overall Study|Withdrawal by Subject|2|||
126777143|NCT01456052|456141299|FG000|Overall Study|Protocol Violation|0|||
126729080|NCT00738374|455956914|FG001|Induction Treatment Phase|Adverse Event|0|||
126729081|NCT00738374|455956915|FG002|Induction Treatment Phase|Adverse Event|0|||
126729082|NCT00738374|455956916|FG003|Induction Treatment Phase|Adverse Event|0|||
126729083|NCT00738374|455956913|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
126729084|NCT00738374|455956914|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
126729085|NCT00738374|455956915|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
126729086|NCT00738374|455956916|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
126729087|NCT00738374|455956913|FG000|Induction Treatment Phase|Physician Decision|2|||
126530108|NCT00651664|455231936|FG000|Overall Study|Patient Declined Further Treatment|0|||
126530109|NCT00651664|455231937|FG001|Overall Study|Patient Declined Further Treatment|0|||
126530110|NCT00651664|455231938|FG002|Overall Study|Patient Declined Further Treatment|0|||
126530111|NCT00651664|455231939|FG003|Overall Study|Patient Declined Further Treatment|1|||
126530112|NCT00651664|455231940|FG004|Overall Study|Patient Declined Further Treatment|1|||
126530113|NCT00651664|455231941|FG005|Overall Study|Patient Declined Further Treatment|1|||
126530114|NCT00651664|455231942|FG006|Overall Study|Patient Declined Further Treatment|0|||
126530115|NCT00651664|455231943|FG007|Overall Study|Patient Declined Further Treatment|0|||
126530116|NCT00651664|455231944|FG008|Overall Study|Patient Declined Further Treatment|0|||
126530117|NCT00651664|455231945|FG009|Overall Study|Patient Declined Further Treatment|1|||
126530118|NCT00651664|455231936|FG000|Overall Study|Symptomatic Deterioration|0|||
126530119|NCT00651664|455231937|FG001|Overall Study|Symptomatic Deterioration|0|||
126530120|NCT00651664|455231938|FG002|Overall Study|Symptomatic Deterioration|0|||
126530121|NCT00651664|455231939|FG003|Overall Study|Symptomatic Deterioration|1|||
126530122|NCT00651664|455231940|FG004|Overall Study|Symptomatic Deterioration|0|||
126530123|NCT00651664|455231941|FG005|Overall Study|Symptomatic Deterioration|0|||
126530124|NCT00651664|455231942|FG006|Overall Study|Symptomatic Deterioration|1|||
126530125|NCT00651664|455231943|FG007|Overall Study|Symptomatic Deterioration|0|||
126530126|NCT00651664|455231944|FG008|Overall Study|Symptomatic Deterioration|1|||
126530127|NCT00651664|455231945|FG009|Overall Study|Symptomatic Deterioration|0|||
126530128|NCT00651664|455231936|FG000|Overall Study|Reason not Specified|0|||
126530129|NCT00651664|455231937|FG001|Overall Study|Reason not Specified|0|||
126530130|NCT00651664|455231938|FG002|Overall Study|Reason not Specified|0|||
126530131|NCT00651664|455231939|FG003|Overall Study|Reason not Specified|0|||
126530132|NCT00651664|455231940|FG004|Overall Study|Reason not Specified|0|||
126530133|NCT00651664|455231941|FG005|Overall Study|Reason not Specified|0|||
126530134|NCT00651664|455231942|FG006|Overall Study|Reason not Specified|1|||
126530135|NCT00651664|455231943|FG007|Overall Study|Reason not Specified|0|||
126530136|NCT00651664|455231944|FG008|Overall Study|Reason not Specified|0|||
126530137|NCT00651664|455231945|FG009|Overall Study|Reason not Specified|0|||
126530138|NCT02195986|455231948|FG000|Overall Study|Adverse Event|3|||
126530139|NCT02195986|455231949|FG001|Overall Study|Adverse Event|0|||
126530140|NCT02195986|455231950|FG002|Overall Study|Adverse Event|0|||
126530141|NCT02195986|455231948|FG000|Overall Study|Withdrawal by Subject|0|||
126530142|NCT02195986|455231949|FG001|Overall Study|Withdrawal by Subject|3|||
126530143|NCT02195986|455231950|FG002|Overall Study|Withdrawal by Subject|0|||
126530144|NCT02195986|455231948|FG000|Overall Study|Family Emergency|0|||
126530145|NCT02195986|455231949|FG001|Overall Study|Family Emergency|0|||
126530146|NCT02195986|455231950|FG002|Overall Study|Family Emergency|1|||
126530147|NCT02195986|455231948|FG000|Overall Study|Protocol Violation|0|||
126530148|NCT02195986|455231949|FG001|Overall Study|Protocol Violation|1|||
126530149|NCT02195986|455231950|FG002|Overall Study|Protocol Violation|1|||
126530150|NCT02195986|455231948|FG000|Overall Study|Non-compliance|0|||
126530151|NCT02195986|455231949|FG001|Overall Study|Non-compliance|1|||
126530152|NCT02195986|455231950|FG002|Overall Study|Non-compliance|0|||
126530153|NCT02834780|455231951|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
126530154|NCT02834780|455231952|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
126530155|NCT02834780|455231953|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
126530156|NCT02834780|455231954|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
126530157|NCT02834780|455231955|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
126530158|NCT02834780|455231956|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
126530159|NCT02834780|455231957|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
126530160|NCT02834780|455231958|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
126530161|NCT02834780|455231959|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
126530162|NCT02834780|455231960|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
126530163|NCT02834780|455231961|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
126530164|NCT02834780|455231962|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
126530165|NCT02834780|455231963|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
126530166|NCT02834780|455231951|FG000|Overall Study|Withdrawal by Subject|0|||
126530167|NCT02834780|455231952|FG001|Overall Study|Withdrawal by Subject|0|||
126530168|NCT02834780|455231953|FG002|Overall Study|Withdrawal by Subject|1|||
126530169|NCT02834780|455231954|FG003|Overall Study|Withdrawal by Subject|0|||
126729088|NCT00738374|455956914|FG001|Induction Treatment Phase|Physician Decision|0|||
126729089|NCT00738374|455956915|FG002|Induction Treatment Phase|Physician Decision|0|||
126729090|NCT00738374|455956916|FG003|Induction Treatment Phase|Physician Decision|0|||
126729091|NCT00738374|455956913|FG000|Induction Treatment Phase|Protocol Violation|2|||
126729092|NCT00738374|455956914|FG001|Induction Treatment Phase|Protocol Violation|0|||
126729093|NCT00738374|455956915|FG002|Induction Treatment Phase|Protocol Violation|0|||
126729094|NCT00738374|455956916|FG003|Induction Treatment Phase|Protocol Violation|0|||
126729095|NCT00738374|455956913|FG000|Induction Treatment Phase|Non-compliance|1|||
126729096|NCT00738374|455956914|FG001|Induction Treatment Phase|Non-compliance|0|||
126729097|NCT00738374|455956915|FG002|Induction Treatment Phase|Non-compliance|0|||
126729098|NCT00738374|455956916|FG003|Induction Treatment Phase|Non-compliance|0|||
126729099|NCT00738374|455956913|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
126729100|NCT00738374|455956914|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
126729101|NCT00738374|455956915|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
126777144|NCT01456052|456141300|FG001|Overall Study|Protocol Violation|1|||
126530170|NCT02834780|455231955|FG004|Overall Study|Withdrawal by Subject|0|||
126530171|NCT02834780|455231956|FG005|Overall Study|Withdrawal by Subject|0|||
126530172|NCT02834780|455231957|FG006|Overall Study|Withdrawal by Subject|0|||
126530173|NCT02834780|455231958|FG007|Overall Study|Withdrawal by Subject|0|||
126530174|NCT02834780|455231959|FG008|Overall Study|Withdrawal by Subject|0|||
126530175|NCT02834780|455231960|FG009|Overall Study|Withdrawal by Subject|0|||
126530176|NCT02834780|455231961|FG010|Overall Study|Withdrawal by Subject|1|||
126530177|NCT02834780|455231962|FG011|Overall Study|Withdrawal by Subject|0|||
126530178|NCT02834780|455231963|FG012|Overall Study|Withdrawal by Subject|0|||
126530179|NCT02834780|455231951|FG000|Overall Study|Adverse Event|0|||
126530180|NCT02834780|455231952|FG001|Overall Study|Adverse Event|0|||
126530181|NCT02834780|455231953|FG002|Overall Study|Adverse Event|0|||
126530182|NCT02834780|455231954|FG003|Overall Study|Adverse Event|0|||
126530183|NCT02834780|455231955|FG004|Overall Study|Adverse Event|1|||
126530184|NCT02834780|455231956|FG005|Overall Study|Adverse Event|0|||
126530185|NCT02834780|455231957|FG006|Overall Study|Adverse Event|1|||
126530186|NCT02834780|455231958|FG007|Overall Study|Adverse Event|1|||
126530187|NCT02834780|455231959|FG008|Overall Study|Adverse Event|0|||
126530188|NCT02834780|455231960|FG009|Overall Study|Adverse Event|2|||
126530189|NCT02834780|455231961|FG010|Overall Study|Adverse Event|0|||
126530190|NCT02834780|455231962|FG011|Overall Study|Adverse Event|3|||
126530191|NCT02834780|455231963|FG012|Overall Study|Adverse Event|2|||
126530192|NCT02834780|455231951|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
126530193|NCT02834780|455231952|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
126530194|NCT02834780|455231953|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
126530195|NCT02834780|455231954|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
126530196|NCT02834780|455231955|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
126530197|NCT02834780|455231956|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
126530198|NCT02834780|455231957|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
126530199|NCT02834780|455231958|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
126530200|NCT02834780|455231959|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
126530201|NCT02834780|455231960|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
126530202|NCT02834780|455231961|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
126530203|NCT02834780|455231962|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
126530204|NCT02834780|455231963|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
126530205|NCT02834780|455231951|FG000|Overall Study|Other|1|||
126530206|NCT02834780|455231952|FG001|Overall Study|Other|0|||
126530207|NCT02834780|455231953|FG002|Overall Study|Other|1|||
126530208|NCT02834780|455231954|FG003|Overall Study|Other|2|||
126530209|NCT02834780|455231955|FG004|Overall Study|Other|0|||
126530210|NCT02834780|455231956|FG005|Overall Study|Other|0|||
126530211|NCT02834780|455231957|FG006|Overall Study|Other|0|||
126530212|NCT02834780|455231958|FG007|Overall Study|Other|0|||
126530213|NCT02834780|455231959|FG008|Overall Study|Other|0|||
126530214|NCT02834780|455231960|FG009|Overall Study|Other|0|||
126530215|NCT02834780|455231961|FG010|Overall Study|Other|0|||
126530216|NCT02834780|455231962|FG011|Overall Study|Other|0|||
126530217|NCT02834780|455231963|FG012|Overall Study|Other|1|||
126530218|NCT02491671|455231968|FG000|Overall Study|Adverse Event|6|||
126530219|NCT02491671|455231969|FG001|Overall Study|Adverse Event|8|||
126530220|NCT02491671|455231968|FG000|Overall Study|Death|0|||
126530221|NCT02491671|455231969|FG001|Overall Study|Death|2|||
126530222|NCT02491671|455231968|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
126530223|NCT02491671|455231969|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
126530224|NCT00535730|455231970|FG000|Overall Study|Adverse Event|1|||
126530225|NCT00535730|455231971|FG001|Overall Study|Adverse Event|1|||
126530226|NCT00535730|455231970|FG000|Overall Study|Lost to Follow-up|0|||
126530227|NCT00535730|455231971|FG001|Overall Study|Lost to Follow-up|1|||
126729102|NCT00738374|455956916|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
126530228|NCT00535730|455231970|FG000|Overall Study|Physician Decision|0|||
126530229|NCT00535730|455231971|FG001|Overall Study|Physician Decision|1|||
126729103|NCT00738374|455956913|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
126729104|NCT00738374|455956914|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
126729105|NCT00738374|455956915|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
126729106|NCT00738374|455956916|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
126729107|NCT00738374|455956913|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
126530230|NCT00535730|455231970|FG000|Overall Study|Protocol Violation|1|||
126530231|NCT00535730|455231971|FG001|Overall Study|Protocol Violation|0|||
126530232|NCT00535730|455231970|FG000|Overall Study|Withdrawal by Subject|0|||
126530233|NCT00535730|455231971|FG001|Overall Study|Withdrawal by Subject|4|||
126530234|NCT00322348|455231972|FG000|Overall Study|Adverse Event|0|||
126530235|NCT00322348|455231973|FG001|Overall Study|Adverse Event|1|||
126530236|NCT00322348|455231972|FG000|Overall Study|Withdrawal by Subject|1|||
126530237|NCT00322348|455231973|FG001|Overall Study|Withdrawal by Subject|4|||
126530238|NCT00322348|455231972|FG000|Overall Study|Lost to Follow-up|1|||
126530239|NCT00322348|455231973|FG001|Overall Study|Lost to Follow-up|0|||
126530240|NCT00322348|455231972|FG000|Overall Study|Death|0|||
126530241|NCT00322348|455231973|FG001|Overall Study|Death|2|||
126530242|NCT00322348|455231972|FG000|Overall Study|Disease Progression|30|||
126530243|NCT00322348|455231973|FG001|Overall Study|Disease Progression|25|||
126530244|NCT00322348|455231972|FG000|Overall Study|Reasons not specified|5|||
126530245|NCT00322348|455231973|FG001|Overall Study|Reasons not specified|1|||
126530246|NCT01090453|455231986|FG000|Overall Study|Withdrawal by Subject|1|||
126530247|NCT01090453|455231987|FG001|Overall Study|Withdrawal by Subject|2|||
126530248|NCT01090453|455231986|FG000|Overall Study|Lost to Follow-up|7|||
126530249|NCT01090453|455231987|FG001|Overall Study|Lost to Follow-up|7|||
126530250|NCT01090453|455231986|FG000|Overall Study|Non serious AEs|1|||
126530251|NCT01090453|455231987|FG001|Overall Study|Non serious AEs|0|||
126530252|NCT01090453|455231986|FG000|Overall Study|Protocol Violation|2|||
126530253|NCT01090453|455231987|FG001|Overall Study|Protocol Violation|0|||
126530254|NCT01090453|455231986|FG000|Overall Study|Other|2|||
126530255|NCT01090453|455231987|FG001|Overall Study|Other|4|||
126530256|NCT01090453|455231986|FG000|Overall Study|Eligibility Criteria|0|||
126530257|NCT01090453|455231987|FG001|Overall Study|Eligibility Criteria|1|||
126530258|NCT04072159|455231988|FG000|Overall Study|Lost to Follow-up|6|||
126530259|NCT04072159|455231989|FG001|Overall Study|Lost to Follow-up|6|||
126530260|NCT04072159|455231988|FG000|Overall Study|Withdrawal by Subject|2|||
126530261|NCT04072159|455231989|FG001|Overall Study|Withdrawal by Subject|0|||
126530262|NCT00989287|455231995|FG000|Overall Study|Adverse Event|1|||
126530263|NCT00989287|455231996|FG001|Overall Study|Adverse Event|0|||
126530264|NCT00989287|455231995|FG000|Overall Study|Lost to Follow-up|0|||
126530265|NCT00989287|455231996|FG001|Overall Study|Lost to Follow-up|1|||
126530266|NCT00729833|455231997|FG000|Overall Study|Death|5|||
126530267|NCT00729833|455231998|FG001|Overall Study|Death|1|||
126530268|NCT00729833|455231999|FG002|Overall Study|Death|3|||
126530269|NCT00729833|455232000|FG003|Overall Study|Death|5|||
126530270|NCT00729833|455231997|FG000|Overall Study|Study Terminated by Sponsor|0|||
126530271|NCT00729833|455231998|FG001|Overall Study|Study Terminated by Sponsor|0|||
126530272|NCT00729833|455231999|FG002|Overall Study|Study Terminated by Sponsor|1|||
126530273|NCT00729833|455232000|FG003|Overall Study|Study Terminated by Sponsor|0|||
126530274|NCT00729833|455231997|FG000|Overall Study|Lost to Follow-up|1|||
126530275|NCT00729833|455231998|FG001|Overall Study|Lost to Follow-up|0|||
126530276|NCT00729833|455231999|FG002|Overall Study|Lost to Follow-up|0|||
126530277|NCT00729833|455232000|FG003|Overall Study|Lost to Follow-up|0|||
126530278|NCT00729833|455231997|FG000|Overall Study|Withdrawal by Subject|3|||
126530279|NCT00729833|455231998|FG001|Overall Study|Withdrawal by Subject|1|||
126530280|NCT00729833|455231999|FG002|Overall Study|Withdrawal by Subject|3|||
126530281|NCT00729833|455232000|FG003|Overall Study|Withdrawal by Subject|0|||
126530282|NCT00729833|455231997|FG000|Overall Study|Unspecified Reasons|11|||
126530283|NCT00729833|455231998|FG001|Overall Study|Unspecified Reasons|5|||
126530284|NCT00729833|455231999|FG002|Overall Study|Unspecified Reasons|5|||
126530285|NCT00729833|455232000|FG003|Overall Study|Unspecified Reasons|1|||
126530286|NCT00695669|455232001|FG000|Overall Study|Adverse Event|0|||
126530287|NCT00695669|455232002|FG001|Overall Study|Adverse Event|0|||
126530288|NCT00695669|455232003|FG002|Overall Study|Adverse Event|2|||
126530289|NCT00695669|455232004|FG003|Overall Study|Adverse Event|0|||
126530290|NCT00695669|455232001|FG000|Overall Study|Lost to Follow-up|4|||
126530291|NCT00695669|455232002|FG001|Overall Study|Lost to Follow-up|4|||
126530292|NCT00695669|455232003|FG002|Overall Study|Lost to Follow-up|1|||
126530293|NCT00695669|455232004|FG003|Overall Study|Lost to Follow-up|4|||
126729108|NCT00738374|455956914|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
126530294|NCT05045625|455232005|FG000|Overall Study|Lost to Follow-up|3|||
126530295|NCT00417079|455232006|FG000|Overall Study|Disease progression|267|||
126530296|NCT00417079|455232007|FG001|Overall Study|Disease progression|180|||
126729109|NCT00738374|455956915|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
126777145|NCT01456052|456141301|FG002|Overall Study|Protocol Violation|0|||
126530297|NCT00417079|455232006|FG000|Overall Study|Adverse Event|32|||
126530298|NCT00417079|455232007|FG001|Overall Study|Adverse Event|67|||
126530299|NCT00417079|455232006|FG000|Overall Study|Non-compliance to protocol|0|||
126530300|NCT00417079|455232007|FG001|Overall Study|Non-compliance to protocol|1|||
126729110|NCT00738374|455956916|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
126729111|NCT00738374|455956913|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
126729112|NCT00738374|455956914|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
126729113|NCT00738374|455956915|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
126729114|NCT00738374|455956916|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
126729115|NCT00738374|455956913|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
126729116|NCT00738374|455956914|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
126729117|NCT00738374|455956915|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
126729118|NCT00738374|455956916|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
126729119|NCT00738374|455956913|FG000|Maintenance Treatment/Observation Phase|Other|0|||
126729120|NCT00738374|455956914|FG001|Maintenance Treatment/Observation Phase|Other|1|||
126729121|NCT00738374|455956915|FG002|Maintenance Treatment/Observation Phase|Other|0|||
126729122|NCT00738374|455956916|FG003|Maintenance Treatment/Observation Phase|Other|0|||
126729123|NCT03334396|455956917|FG000|Overall Study|Adverse Event|1|||
126729124|NCT03334396|455956918|FG001|Overall Study|Adverse Event|0|||
126729125|NCT03334396|455956919|FG002|Overall Study|Adverse Event|1|||
126729126|NCT03334396|455956920|FG003|Overall Study|Adverse Event|0|||
126729127|NCT03334396|455956921|FG004|Overall Study|Adverse Event|0|||
126729128|NCT03334396|455956922|FG005|Overall Study|Adverse Event|0|||
126729129|NCT03334396|455956923|FG006|Overall Study|Adverse Event|0|||
126729130|NCT03334396|455956924|FG007|Overall Study|Adverse Event|0|||
126729131|NCT03334396|455956917|FG000|Overall Study|Lack of Efficacy|10|||
126729132|NCT03334396|455956918|FG001|Overall Study|Lack of Efficacy|4|||
126729133|NCT03334396|455956919|FG002|Overall Study|Lack of Efficacy|1|||
126729134|NCT03334396|455956920|FG003|Overall Study|Lack of Efficacy|3|||
126729135|NCT03334396|455956921|FG004|Overall Study|Lack of Efficacy|1|||
126729136|NCT03334396|455956922|FG005|Overall Study|Lack of Efficacy|0|||
126729137|NCT03334396|455956923|FG006|Overall Study|Lack of Efficacy|0|||
126729138|NCT03334396|455956924|FG007|Overall Study|Lack of Efficacy|1|||
126729139|NCT03334396|455956917|FG000|Overall Study|Lost to Follow-up|0|||
126729140|NCT03334396|455956918|FG001|Overall Study|Lost to Follow-up|0|||
126729141|NCT03334396|455956919|FG002|Overall Study|Lost to Follow-up|1|||
126729142|NCT03334396|455956920|FG003|Overall Study|Lost to Follow-up|0|||
126729143|NCT03334396|455956921|FG004|Overall Study|Lost to Follow-up|0|||
126729144|NCT03334396|455956922|FG005|Overall Study|Lost to Follow-up|0|||
126729145|NCT03334396|455956923|FG006|Overall Study|Lost to Follow-up|1|||
126729146|NCT03334396|455956924|FG007|Overall Study|Lost to Follow-up|0|||
126530301|NCT00417079|455232006|FG000|Overall Study|Lost to Follow-up|2|||
126530302|NCT00417079|455232007|FG001|Overall Study|Lost to Follow-up|0|||
126530303|NCT00417079|455232006|FG000|Overall Study|Withdrawal by Subject|17|||
126530304|NCT00417079|455232007|FG001|Overall Study|Withdrawal by Subject|8|||
126530305|NCT00417079|455232006|FG000|Overall Study|Not treated|6|||
126530306|NCT00417079|455232007|FG001|Overall Study|Not treated|7|||
126530307|NCT00417079|455232006|FG000|Overall Study|Screened failure|2|||
126530308|NCT00417079|455232007|FG001|Overall Study|Screened failure|1|||
126530309|NCT00417079|455232006|FG000|Overall Study|Investigator's decision|1|||
126530310|NCT00417079|455232007|FG001|Overall Study|Investigator's decision|4|||
126530311|NCT00417079|455232006|FG000|Overall Study|Non-confirmed Disease progression|1|||
126530312|NCT00417079|455232007|FG001|Overall Study|Non-confirmed Disease progression|1|||
126530313|NCT00417079|455232006|FG000|Overall Study|Clinical deterioration|1|||
126530314|NCT00417079|455232007|FG001|Overall Study|Clinical deterioration|0|||
126530315|NCT00417079|455232006|FG000|Overall Study|Screening error|2|||
126530316|NCT00417079|455232007|FG001|Overall Study|Screening error|1|||
126530317|NCT00417079|455232006|FG000|Overall Study|Withdrawal by subject's family|0|||
126530318|NCT00417079|455232007|FG001|Overall Study|Withdrawal by subject's family|1|||
126530319|NCT00417079|455232006|FG000|Overall Study|Patient unable to come to the clinic|0|||
126530320|NCT00417079|455232007|FG001|Overall Study|Patient unable to come to the clinic|1|||
126530321|NCT00417079|455232006|FG000|Overall Study|abnormal liver function tests|0|||
126530322|NCT00417079|455232007|FG001|Overall Study|abnormal liver function tests|1|||
126530323|NCT04403698|455232019|FG000|Overall Study|Adverse Event|1|||
126530324|NCT04403698|455232020|FG001|Overall Study|Adverse Event|1|||
126530325|NCT04403698|455232019|FG000|Overall Study|Lost to Follow-up|1|||
126530326|NCT04403698|455232020|FG001|Overall Study|Lost to Follow-up|0|||
126530327|NCT04403698|455232019|FG000|Overall Study|Protocol Violation|0|||
126530328|NCT04403698|455232020|FG001|Overall Study|Protocol Violation|1|||
126530329|NCT03152552|455232021|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
126530330|NCT03152552|455232022|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
126530331|NCT03152552|455232023|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
126530332|NCT03152552|455232024|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
126530333|NCT03152552|455232025|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
126729147|NCT03334396|455956917|FG000|Overall Study|Physician Decision|1|||
126729148|NCT03334396|455956918|FG001|Overall Study|Physician Decision|0|||
126729149|NCT03334396|455956919|FG002|Overall Study|Physician Decision|0|||
126530334|NCT03152552|455232021|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
126530335|NCT03152552|455232022|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
126530336|NCT03152552|455232023|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
126530337|NCT03152552|455232024|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
126530338|NCT03152552|455232025|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
126530339|NCT03152552|455232021|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
126530340|NCT03152552|455232022|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
126530341|NCT03152552|455232023|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
126530342|NCT03152552|455232024|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
126530343|NCT03152552|455232025|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
126530344|NCT03152552|455232021|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126530345|NCT03152552|455232022|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126530346|NCT03152552|455232023|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
126530347|NCT03152552|455232024|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126530348|NCT03152552|455232025|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126530349|NCT03152552|455232021|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
126530350|NCT03152552|455232022|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
126530351|NCT03152552|455232023|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
126530352|NCT03152552|455232024|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
126530353|NCT03152552|455232025|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
126530354|NCT03152552|455232021|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
126530355|NCT03152552|455232022|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
126530356|NCT03152552|455232023|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
126530357|NCT03152552|455232024|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
126530358|NCT03152552|455232025|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
126530359|NCT03152552|455232021|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
126530360|NCT03152552|455232022|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
126530361|NCT03152552|455232023|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
126530362|NCT03152552|455232024|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
126530363|NCT03152552|455232025|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
126530364|NCT03570619|455232026|FG000|Overall Study|Adverse Event|2|||
126530365|NCT03570619|455232027|FG001|Overall Study|Adverse Event|0|||
126530366|NCT03570619|455232028|FG002|Overall Study|Adverse Event|1|||
126530367|NCT03570619|455232026|FG000|Overall Study|new diagnosis of new malignancy|1|||
126530368|NCT03570619|455232027|FG001|Overall Study|new diagnosis of new malignancy|0|||
126530369|NCT03570619|455232028|FG002|Overall Study|new diagnosis of new malignancy|0|||
126530370|NCT03570619|455232026|FG000|Overall Study|Physician Decision|1|||
126530371|NCT03570619|455232027|FG001|Overall Study|Physician Decision|1|||
126530372|NCT03570619|455232028|FG002|Overall Study|Physician Decision|0|||
126530373|NCT03570619|455232026|FG000|Overall Study|Withdrawal by Subject|0|||
126530374|NCT03570619|455232027|FG001|Overall Study|Withdrawal by Subject|2|||
126530375|NCT03570619|455232028|FG002|Overall Study|Withdrawal by Subject|0|||
126530376|NCT01022762|455232030|FG000|Overall Study|Adverse Event|3|||
126530377|NCT01022762|455232031|FG001|Overall Study|Adverse Event|1|||
126530378|NCT01022762|455232030|FG000|Overall Study|Lack of Efficacy|0|||
126530379|NCT01022762|455232031|FG001|Overall Study|Lack of Efficacy|1|||
126530380|NCT01022762|455232030|FG000|Overall Study|Protocol Violation|7|||
126530381|NCT01022762|455232031|FG001|Overall Study|Protocol Violation|6|||
126530382|NCT01022762|455232030|FG000|Overall Study|Unclassified|12|||
126530383|NCT01022762|455232031|FG001|Overall Study|Unclassified|20|||
126530384|NCT01302119|455232032|FG000|Overall Study|Withdrawal by Subject|30|||
126530385|NCT01302119|455232033|FG001|Overall Study|Withdrawal by Subject|20|||
126530386|NCT01302119|455232032|FG000|Overall Study|Lost to Follow-up|10|||
126530387|NCT01302119|455232033|FG001|Overall Study|Lost to Follow-up|4|||
126530388|NCT01302119|455232032|FG000|Overall Study|Adverse Event|2|||
126530389|NCT01302119|455232033|FG001|Overall Study|Adverse Event|1|||
126530390|NCT01302119|455232032|FG000|Overall Study|Non-compliance|4|||
126530391|NCT01302119|455232033|FG001|Overall Study|Non-compliance|2|||
126530392|NCT01302119|455232032|FG000|Overall Study|Non-specific|4|||
126530393|NCT01302119|455232033|FG001|Overall Study|Non-specific|1|||
126530394|NCT03743038|455232034|FG000|Overall Study|Physician Decision|1|||
126530395|NCT03336619|455232035|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
126530396|NCT03336619|455232036|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
126530397|NCT03336619|455232035|FG000|Overall Study|Withdrawal by Subject|17|||
126530398|NCT03336619|455232036|FG001|Overall Study|Withdrawal by Subject|16|||
126530399|NCT03336619|455232035|FG000|Overall Study|Adverse Event|2|||
126530400|NCT03336619|455232036|FG001|Overall Study|Adverse Event|5|||
126530401|NCT03336619|455232035|FG000|Overall Study|Physician Decision|3|||
126530402|NCT03336619|455232036|FG001|Overall Study|Physician Decision|0|||
126530403|NCT01300546|455232037|FG000|Overall Study|Withdrawal by Subject|1|||
126530404|NCT01300546|455232038|FG001|Overall Study|Withdrawal by Subject|0|||
126530405|NCT01300546|455232037|FG000|Overall Study|Lost to Follow-up|0|||
126530406|NCT01300546|455232038|FG001|Overall Study|Lost to Follow-up|2|||
126530407|NCT01300546|455232037|FG000|Overall Study|Lack of Efficacy|0|||
126530408|NCT01300546|455232038|FG001|Overall Study|Lack of Efficacy|3|||
126530409|NCT01300546|455232037|FG000|Overall Study|Adverse Event|0|||
126530410|NCT01300546|455232038|FG001|Overall Study|Adverse Event|1|||
126530411|NCT02820623|455232039|FG000|Overall Study|Withdrawal by Subject|1|||
126530412|NCT02820623|455232040|FG001|Overall Study|Withdrawal by Subject|3|||
126530413|NCT02820623|455232041|FG002|Overall Study|Withdrawal by Subject|3|||
126530414|NCT02820623|455232039|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
126530415|NCT02820623|455232040|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
126530416|NCT02820623|455232041|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
126530417|NCT02820623|455232039|FG000|Overall Study|Therapist unable to enroll clients|1|||
126530418|NCT02820623|455232040|FG001|Overall Study|Therapist unable to enroll clients|1|||
126530419|NCT02820623|455232041|FG002|Overall Study|Therapist unable to enroll clients|3|||
126530420|NCT02820623|455232039|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
126530421|NCT02820623|455232040|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
126530422|NCT02820623|455232041|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
126530423|NCT01965834|455232042|FG000|Overall Study|Lack of Efficacy|4|||
126530424|NCT02298192|455232043|FG000|Overall Study|Unclassified|3|||
126530425|NCT02298192|455232044|FG001|Overall Study|Unclassified|2|||
126530426|NCT02298192|455232043|FG000|Overall Study|Withdrawal criteria|2|||
126530427|NCT02298192|455232044|FG001|Overall Study|Withdrawal criteria|0|||
126530428|NCT02298192|455232043|FG000|Overall Study|Withdrawal by Subject|6|||
126530429|NCT02298192|455232044|FG001|Overall Study|Withdrawal by Subject|1|||
126530430|NCT02298192|455232043|FG000|Overall Study|Lost to Follow-up|2|||
126530431|NCT02298192|455232044|FG001|Overall Study|Lost to Follow-up|1|||
126530432|NCT02298192|455232043|FG000|Overall Study|Adverse Event|6|||
126530433|NCT02298192|455232044|FG001|Overall Study|Adverse Event|2|||
126530434|NCT00679939|455232046|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
126530435|NCT00679939|455232047|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
126530436|NCT00679939|455232046|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
126530437|NCT00679939|455232047|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
126530438|NCT00679939|455232046|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
126530439|NCT00679939|455232047|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
126530440|NCT00679939|455232046|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
126530441|NCT00679939|455232047|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
126530442|NCT00679939|455232046|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
126530443|NCT00679939|455232047|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
126530444|NCT00679939|455232046|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
126530445|NCT00679939|455232047|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
126530446|NCT00679939|455232046|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
126530447|NCT00679939|455232047|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
126530448|NCT00679939|455232046|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
126530449|NCT00679939|455232047|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
126530450|NCT00679939|455232046|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
126530451|NCT00679939|455232047|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
126530452|NCT00679939|455232046|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
126530453|NCT00679939|455232047|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
126530454|NCT00655980|455232053|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
126530455|NCT00655980|455232054|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
126530456|NCT00655980|455232055|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
126530457|NCT04439110|455232056|FG000|Overall Study|Ineligible|2|||
126530458|NCT04439110|455232056|FG000|Overall Study|Adverse Event|4|||
126530459|NCT04439110|455232056|FG000|Overall Study|Death|2|||
126530460|NCT04439110|455232056|FG000|Overall Study|Disease proression|25|||
126530461|NCT04439110|455232056|FG000|Overall Study|Withdrawal by Subject|1|||
126530462|NCT04439110|455232056|FG000|Overall Study|Alternative therapy|1|||
126530463|NCT04439110|455232056|FG000|Overall Study|Other complicating disease|1|||
126530464|NCT04439110|455232056|FG000|Overall Study|Personal reasons|1|||
126530465|NCT04439110|455232056|FG000|Overall Study|Still on treatment|1|||
126530466|NCT00127608|455232059|FG000|Overall Study|VZV DNA negative|1|||
126530467|NCT05245864|455232060|FG000|Overall Study|Withdrawal by Subject|1|||
126530468|NCT05245864|455232061|FG001|Overall Study|Withdrawal by Subject|1|||
126530469|NCT00506493|455232067|FG000|Overall Study|Death|6|||
126530470|NCT00506493|455232067|FG000|Overall Study|Withdrawal by Subject|5|||
126530471|NCT00686166|455233732|FG000|Overall Study|Adverse Event|7|||
126530472|NCT00686166|455233732|FG000|Overall Study|Withdrawal by Subject|1|||
126530473|NCT00686166|455233732|FG000|Overall Study|Progression/Relapse|1|||
126530474|NCT00686166|455233732|FG000|Overall Study|Death|1|||
126530475|NCT00686166|455233732|FG000|Overall Study|Not Protocol Specified|1|||
126530476|NCT00686166|455233732|FG000|Overall Study|Ineligible|5|||
126530477|NCT00686166|455233732|FG000|Overall Study|Did not begin protocol therapy|4|||
126530478|NCT03912259|455233735|FG000|Overall Study|Adverse Event (AE)|2|||
126530479|NCT03912259|455233736|FG001|Overall Study|Adverse Event (AE)|4|||
126530480|NCT03912259|455233735|FG000|Overall Study|Lack of Efficacy|4|||
126530481|NCT03912259|455233736|FG001|Overall Study|Lack of Efficacy|1|||
126530482|NCT03912259|455233735|FG000|Overall Study|Withdrawal by Subject|11|||
126530483|NCT03912259|455233736|FG001|Overall Study|Withdrawal by Subject|1|||
126530484|NCT01549613|455233737|FG000|Overall Study|Lost to Follow-up|11|||
126530485|NCT01549613|455233738|FG001|Overall Study|Lost to Follow-up|11|||
126530486|NCT02216123|455233739|FG000|Overall Study|Lost to Follow-up|4|||
126530487|NCT02216123|455233740|FG001|Overall Study|Lost to Follow-up|2|||
126530488|NCT02216123|455233739|FG000|Overall Study|Withdrawal by Subject|2|||
126530489|NCT02216123|455233740|FG001|Overall Study|Withdrawal by Subject|0|||
126530490|NCT02131272|455233741|FG000|Overall Study|Withdrawal by parent|0|||
126530491|NCT02131272|455233742|FG001|Overall Study|Withdrawal by parent|1|||
126530492|NCT02131272|455233741|FG000|Overall Study|Withdrawal by Subject|0|||
126530493|NCT02131272|455233742|FG001|Overall Study|Withdrawal by Subject|1|||
126530494|NCT02131272|455233741|FG000|Overall Study|Withdrawal Criteria|1|||
126530495|NCT02131272|455233742|FG001|Overall Study|Withdrawal Criteria|0|||
126530496|NCT04066114|455233744|FG000|Overall Study|Adverse Event|1|||
126530497|NCT04066114|455233745|FG001|Overall Study|Adverse Event|0|||
126530498|NCT04066114|455233746|FG002|Overall Study|Adverse Event|0|||
126530499|NCT04066114|455233744|FG000|Overall Study|Withdrawal by Subject|1|||
126530500|NCT04066114|455233745|FG001|Overall Study|Withdrawal by Subject|0|||
126530501|NCT04066114|455233746|FG002|Overall Study|Withdrawal by Subject|0|||
126530502|NCT04066114|455233744|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
126530503|NCT04066114|455233745|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
126530504|NCT04066114|455233746|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
126530505|NCT00254982|455233747|FG000|Overall Study|Other|2|||
126530506|NCT00254982|455233748|FG001|Overall Study|Other|1|||
126530507|NCT00254982|455233747|FG000|Overall Study|Lack of Efficacy|5|||
126530508|NCT00254982|455233748|FG001|Overall Study|Lack of Efficacy|3|||
126530509|NCT00254982|455233747|FG000|Overall Study|Lost to Follow-up|5|||
126530510|NCT00254982|455233748|FG001|Overall Study|Lost to Follow-up|3|||
126530511|NCT00254982|455233747|FG000|Overall Study|Adverse Event|18|||
126530512|NCT00254982|455233748|FG001|Overall Study|Adverse Event|16|||
126530513|NCT00254982|455233747|FG000|Overall Study|Withdrawal by Subject|1|||
126530514|NCT00254982|455233748|FG001|Overall Study|Withdrawal by Subject|1|||
126530515|NCT00254982|455233747|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
126530516|NCT00254982|455233748|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
126530517|NCT00254982|455233747|FG000|Overall Study|Protocol deviation|1|||
126530518|NCT00254982|455233748|FG001|Overall Study|Protocol deviation|1|||
126530519|NCT00254982|455233747|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
126530520|NCT00254982|455233748|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
126530521|NCT00254982|455233747|FG000|Overall Study|Malignancy|0|||
126530522|NCT00254982|455233748|FG001|Overall Study|Malignancy|2|||
126530523|NCT00254982|455233747|FG000|Overall Study|Opportunistic infection|1|||
126530524|NCT00254982|455233748|FG001|Overall Study|Opportunistic infection|0|||
126530525|NCT00254982|455233747|FG000|Overall Study|Abnormal liver function tests|2|||
126530526|NCT00254982|455233748|FG001|Overall Study|Abnormal liver function tests|1|||
126530527|NCT03117738|455233750|FG000|Overall Study|Withdrawal by Subject|3|||
126530528|NCT03117738|455233751|FG001|Overall Study|Withdrawal by Subject|1|||
126530529|NCT03117738|455233750|FG000|Overall Study|Lost to Follow-up|1|||
126530530|NCT03117738|455233751|FG001|Overall Study|Lost to Follow-up|4|||
126530531|NCT04004611|455233752|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
126530532|NCT04004611|455233753|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
126530533|NCT04004611|455233754|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
126530534|NCT04004611|455233755|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
126530535|NCT04004611|455233756|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
126530536|NCT04004611|455233757|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
126530537|NCT04004611|455233758|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
126530538|NCT04004611|455233759|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
126530539|NCT04004611|455233760|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
126530540|NCT04004611|455233752|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
126530541|NCT04004611|455233753|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
126530542|NCT04004611|455233754|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
126530543|NCT04004611|455233755|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
126530544|NCT04004611|455233756|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
126530545|NCT04004611|455233757|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
126530546|NCT04004611|455233758|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
126530547|NCT04004611|455233759|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
126530548|NCT04004611|455233760|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
126530549|NCT04004611|455233752|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
126530550|NCT04004611|455233753|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
126530551|NCT04004611|455233754|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
126530552|NCT04004611|455233755|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
126530553|NCT04004611|455233756|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
126530554|NCT04004611|455233757|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
126530555|NCT04004611|455233758|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
126580809|NCT04065048|455424039|FG002|Overall Study|Withdrawal by Subject|1|||
126580810|NCT04065048|455424040|FG003|Overall Study|Withdrawal by Subject|1|||
126580811|NCT04065048|455424037|FG000|Overall Study|Adverse Event|1|||
126580812|NCT04065048|455424038|FG001|Overall Study|Adverse Event|0|||
126580813|NCT04065048|455424039|FG002|Overall Study|Adverse Event|1|||
126580814|NCT04065048|455424040|FG003|Overall Study|Adverse Event|0|||
126580815|NCT05104697|455424042|FG000|Overall Study|Withdrawal by Subject|0|||
126580816|NCT05104697|455424043|FG001|Overall Study|Withdrawal by Subject|1|||
126580817|NCT03845465|455424044|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
126580818|NCT03845465|455424045|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
126580819|NCT03845465|455424044|FG000|6-month Data Collection|Withdrawal by Subject|0|||
126580820|NCT03845465|455424045|FG001|6-month Data Collection|Withdrawal by Subject|2|||
126580821|NCT03845465|455424044|FG000|12-month Data Collection|Withdrawal by Subject|0|||
126580822|NCT03845465|455424045|FG001|12-month Data Collection|Withdrawal by Subject|2|||
126580823|NCT05307978|455424048|FG000|Overall Study|Lost to Follow-up|0|||
126580824|NCT05307978|455424049|FG001|Overall Study|Lost to Follow-up|1|||
126580825|NCT05307978|455424050|FG002|Overall Study|Lost to Follow-up|0|||
126580826|NCT05307978|455424051|FG003|Overall Study|Lost to Follow-up|4|||
126580827|NCT05307978|455424052|FG004|Overall Study|Lost to Follow-up|0|||
126580828|NCT05307978|455424053|FG005|Overall Study|Lost to Follow-up|0|||
126580829|NCT05307978|455424054|FG006|Overall Study|Lost to Follow-up|1|||
126580830|NCT03547908|455424055|FG000|Blinded Phase|Lost to Follow-up|3|||
126580831|NCT03547908|455424056|FG001|Blinded Phase|Lost to Follow-up|3|||
126580832|NCT03547908|455424057|FG002|Blinded Phase|Lost to Follow-up|0|||
126580833|NCT03547908|455424058|FG003|Blinded Phase|Lost to Follow-up|0|||
126580834|NCT03547908|455424055|FG000|Blinded Phase|Withdrew Consent|2|||
126580835|NCT03547908|455424056|FG001|Blinded Phase|Withdrew Consent|3|||
126580836|NCT03547908|455424057|FG002|Blinded Phase|Withdrew Consent|0|||
126580837|NCT03547908|455424058|FG003|Blinded Phase|Withdrew Consent|0|||
126580838|NCT03547908|455424055|FG000|Blinded Phase|Investigator's Discretion|2|||
126580839|NCT03547908|455424056|FG001|Blinded Phase|Investigator's Discretion|1|||
126580840|NCT03547908|455424057|FG002|Blinded Phase|Investigator's Discretion|0|||
126580841|NCT03547908|455424058|FG003|Blinded Phase|Investigator's Discretion|0|||
126580842|NCT03547908|455424055|FG000|Blinded Phase|Death|2|||
126580843|NCT03547908|455424056|FG001|Blinded Phase|Death|0|||
126580844|NCT03547908|455424057|FG002|Blinded Phase|Death|0|||
126580845|NCT03547908|455424058|FG003|Blinded Phase|Death|0|||
126580846|NCT03547908|455424055|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
126580847|NCT03547908|455424056|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
126580848|NCT03547908|455424057|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
126580849|NCT03547908|455424058|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
126580850|NCT03547908|455424055|FG000|Blinded Phase|Adverse Event|1|||
126580851|NCT03547908|455424056|FG001|Blinded Phase|Adverse Event|0|||
126580852|NCT03547908|455424057|FG002|Blinded Phase|Adverse Event|0|||
126580853|NCT03547908|455424058|FG003|Blinded Phase|Adverse Event|0|||
126580854|NCT03547908|455424055|FG000|Blinded Phase|Randomized But Never Treated|1|||
126580855|NCT03547908|455424056|FG001|Blinded Phase|Randomized But Never Treated|0|||
126580856|NCT03547908|455424057|FG002|Blinded Phase|Randomized But Never Treated|0|||
126580857|NCT03547908|455424058|FG003|Blinded Phase|Randomized But Never Treated|0|||
126580858|NCT03547908|455424055|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
126580859|NCT03547908|455424056|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
126580860|NCT03547908|455424057|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
126580861|NCT03547908|455424058|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
126580862|NCT03547908|455424055|FG000|Open-label Extension Phase|Death|0|||
126580863|NCT03547908|455424056|FG001|Open-label Extension Phase|Death|0|||
126580864|NCT03547908|455424057|FG002|Open-label Extension Phase|Death|1|||
126580865|NCT03547908|455424058|FG003|Open-label Extension Phase|Death|0|||
126580866|NCT05075408|455424065|FG000|Overall Study|Withdrawal by Subject|5|||
126580867|NCT05075408|455424066|FG001|Overall Study|Withdrawal by Subject|3|||
126580868|NCT05075408|455424067|FG002|Overall Study|Withdrawal by Subject|4|||
126580869|NCT05075408|455424065|FG000|Overall Study|Adverse Event|5|||
126580870|NCT05075408|455424066|FG001|Overall Study|Adverse Event|7|||
126580871|NCT05075408|455424067|FG002|Overall Study|Adverse Event|8|||
126580872|NCT05075408|455424065|FG000|Overall Study|Protocol Violation|0|||
126580873|NCT05075408|455424066|FG001|Overall Study|Protocol Violation|1|||
126580874|NCT05075408|455424067|FG002|Overall Study|Protocol Violation|0|||
126580875|NCT05075408|455424065|FG000|Overall Study|Lost to Follow-up|2|||
126580876|NCT05075408|455424066|FG001|Overall Study|Lost to Follow-up|1|||
126580877|NCT05075408|455424067|FG002|Overall Study|Lost to Follow-up|1|||
126580878|NCT05075408|455424065|FG000|Overall Study|Physician Decision|1|||
126580879|NCT05075408|455424066|FG001|Overall Study|Physician Decision|0|||
126580880|NCT05075408|455424067|FG002|Overall Study|Physician Decision|0|||
126580881|NCT05075408|455424065|FG000|Overall Study|Other-unspecified|3|||
126580882|NCT05075408|455424066|FG001|Overall Study|Other-unspecified|2|||
126580883|NCT05075408|455424067|FG002|Overall Study|Other-unspecified|0|||
126580884|NCT03416023|455424068|FG000|Overall Study|Exclusion criteria failure|1|||
126580885|NCT03416023|455424068|FG000|Overall Study|Withdrawal by Subject|6|||
126580886|NCT03416023|455424068|FG000|Overall Study|Explanted|7|||
126530556|NCT04004611|455233759|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
126530557|NCT04004611|455233760|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
126530558|NCT04004611|455233752|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
126530559|NCT04004611|455233753|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
126530560|NCT04004611|455233754|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
126530561|NCT04004611|455233755|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
126530562|NCT04004611|455233756|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
126530563|NCT04004611|455233757|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
126530564|NCT04004611|455233758|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
126530565|NCT04004611|455233759|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
126530566|NCT04004611|455233760|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
126530567|NCT04004611|455233752|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
126580887|NCT03416023|455424068|FG000|Overall Study|Physician Decision|1|||
126580888|NCT03416023|455424068|FG000|Overall Study|Lost to Follow-up|1|||
126580889|NCT03416023|455424068|FG000|Overall Study|Death|1|||
126580890|NCT05419505|455424069|FG000|Overall Study|Adverse Event|0|||
126580891|NCT05419505|455424070|FG001|Overall Study|Adverse Event|0|||
126580892|NCT05419505|455424071|FG002|Overall Study|Adverse Event|0|||
126580893|NCT05419505|455424072|FG003|Overall Study|Adverse Event|1|||
126580894|NCT05419505|455424073|FG004|Overall Study|Adverse Event|0|||
126580895|NCT05419505|455424074|FG005|Overall Study|Adverse Event|0|||
126580896|NCT05419505|455424075|FG006|Overall Study|Adverse Event|0|||
126580897|NCT05419505|455424076|FG007|Overall Study|Adverse Event|0|||
126580898|NCT05419505|455424069|FG000|Overall Study|Withdrawal by Subject|1|||
126530568|NCT04004611|455233753|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
126530569|NCT04004611|455233754|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
126530570|NCT04004611|455233755|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
126530571|NCT04004611|455233756|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
126530572|NCT04004611|455233757|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
126530573|NCT04004611|455233758|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
126530574|NCT04004611|455233759|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
126530575|NCT04004611|455233760|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
126530576|NCT04004611|455233752|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
126530577|NCT04004611|455233753|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
126530578|NCT04004611|455233754|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
126530579|NCT04004611|455233755|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
126530580|NCT04004611|455233756|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
126530581|NCT04004611|455233757|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
126580899|NCT05419505|455424070|FG001|Overall Study|Withdrawal by Subject|2|||
126580900|NCT05419505|455424071|FG002|Overall Study|Withdrawal by Subject|0|||
126580901|NCT05419505|455424072|FG003|Overall Study|Withdrawal by Subject|0|||
126580902|NCT05419505|455424073|FG004|Overall Study|Withdrawal by Subject|0|||
126580903|NCT05419505|455424074|FG005|Overall Study|Withdrawal by Subject|0|||
126580904|NCT05419505|455424075|FG006|Overall Study|Withdrawal by Subject|1|||
126580905|NCT05419505|455424076|FG007|Overall Study|Withdrawal by Subject|0|||
126580906|NCT05419505|455424069|FG000|Overall Study|Lost to Follow-up|2|||
126580907|NCT05419505|455424070|FG001|Overall Study|Lost to Follow-up|1|||
126580908|NCT05419505|455424071|FG002|Overall Study|Lost to Follow-up|0|||
126580909|NCT05419505|455424072|FG003|Overall Study|Lost to Follow-up|0|||
126580910|NCT05419505|455424073|FG004|Overall Study|Lost to Follow-up|1|||
126580911|NCT05419505|455424074|FG005|Overall Study|Lost to Follow-up|2|||
126580912|NCT05419505|455424075|FG006|Overall Study|Lost to Follow-up|0|||
126580913|NCT05419505|455424076|FG007|Overall Study|Lost to Follow-up|1|||
126580914|NCT03358875|455424079|FG000|Overall Study|Death|409|||
126580915|NCT03358875|455424080|FG001|Overall Study|Death|223|||
126580916|NCT03358875|455424079|FG000|Overall Study|Study Closed by Sponsor|66|||
126580917|NCT03358875|455424080|FG001|Overall Study|Study Closed by Sponsor|29|||
126580918|NCT03358875|455424079|FG000|Overall Study|Withdrawal by Subject|13|||
126580919|NCT03358875|455424080|FG001|Overall Study|Withdrawal by Subject|16|||
126580920|NCT03358875|455424079|FG000|Overall Study|Lost to Follow-up|13|||
126580921|NCT03358875|455424080|FG001|Overall Study|Lost to Follow-up|2|||
126580922|NCT03358875|455424079|FG000|Overall Study|Miscellaneous|33|||
126580923|NCT03358875|455424080|FG001|Overall Study|Miscellaneous|0|||
126580924|NCT03358875|455424079|FG000|Overall Study|Remained on Study|1|||
126580925|NCT03358875|455424080|FG001|Overall Study|Remained on Study|0|||
126729150|NCT03334396|455956920|FG003|Overall Study|Physician Decision|0|||
126729151|NCT03334396|455956921|FG004|Overall Study|Physician Decision|0|||
126729152|NCT03334396|455956922|FG005|Overall Study|Physician Decision|0|||
126729153|NCT03334396|455956923|FG006|Overall Study|Physician Decision|0|||
126729154|NCT03334396|455956924|FG007|Overall Study|Physician Decision|0|||
126580926|NCT04847999|455424085|FG000|Overall Study|Lost to Follow-up|0|||
126580927|NCT04847999|455424086|FG001|Overall Study|Lost to Follow-up|1|||
126580928|NCT02879448|455424087|FG000|Overall Study|Death|251|||
126729155|NCT03334396|455956917|FG000|Overall Study|Withdrawal by Subject|10|||
126580929|NCT02879448|455424088|FG001|Overall Study|Death|263|||
126580930|NCT02879448|455424087|FG000|Overall Study|Lost to Follow-up|23|||
126580931|NCT02879448|455424088|FG001|Overall Study|Lost to Follow-up|28|||
126580932|NCT02879448|455424087|FG000|Overall Study|Withdrawal by Subject|42|||
126580933|NCT02879448|455424088|FG001|Overall Study|Withdrawal by Subject|79|||
126580934|NCT02879448|455424087|FG000|Overall Study|Other Reasons|8|||
126580935|NCT02879448|455424088|FG001|Overall Study|Other Reasons|12|||
126580936|NCT03433339|455424089|FG000|Overall Study|Lost to Follow-up|2|||
126580937|NCT03433339|455424090|FG001|Overall Study|Lost to Follow-up|0|||
126580938|NCT03433339|455424089|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
126580939|NCT03433339|455424090|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
126580940|NCT03433339|455424089|FG000|Overall Study|Withdrawal by Subject|0|||
126580941|NCT03433339|455424090|FG001|Overall Study|Withdrawal by Subject|2|||
126580942|NCT05952076|455424091|FG000|Overall Study|Death|1|||
126580943|NCT05952076|455424092|FG001|Overall Study|Death|1|||
126580944|NCT05952076|455424091|FG000|Overall Study|Lost to Follow-up|0|||
126580945|NCT05952076|455424092|FG001|Overall Study|Lost to Follow-up|1|||
126580946|NCT02919449|455424093|FG000|Overall Study|Withdrawal by Subject|1|||
126580947|NCT02919449|455424093|FG000|Overall Study|Investigator decision|1|||
126580948|NCT00727909|455424094|FG000|Overall Study|Withdrawal by Subject|5|||
126580949|NCT00727909|455424095|FG001|Overall Study|Withdrawal by Subject|11|||
126580950|NCT00727909|455424096|FG002|Overall Study|Withdrawal by Subject|8|||
126580951|NCT00727909|455424097|FG003|Overall Study|Withdrawal by Subject|5|||
126580952|NCT00727909|455424094|FG000|Overall Study|Death|0|||
126580953|NCT00727909|455424095|FG001|Overall Study|Death|0|||
126580954|NCT00727909|455424096|FG002|Overall Study|Death|1|||
126580955|NCT00727909|455424097|FG003|Overall Study|Death|0|||
126580956|NCT02538900|455424098|FG000|Overall Study|Death|2|||
126580957|NCT02538900|455424099|FG001|Overall Study|Death|2|||
126580958|NCT02538900|455424100|FG002|Overall Study|Death|2|||
126580959|NCT02538900|455424098|FG000|Overall Study|Withdrawal by Subject|18|||
126580960|NCT02538900|455424099|FG001|Overall Study|Withdrawal by Subject|16|||
126580961|NCT02538900|455424100|FG002|Overall Study|Withdrawal by Subject|15|||
126580962|NCT02874534|455424101|FG000|Overall Study|Withdrawal by Subject|5|||
126580963|NCT02874534|455424102|FG001|Overall Study|Withdrawal by Subject|8|||
126580964|NCT02874534|455424101|FG000|Overall Study|Lost to Follow-up|2|||
126580965|NCT02874534|455424102|FG001|Overall Study|Lost to Follow-up|2|||
126580966|NCT02874534|455424101|FG000|Overall Study|Ongoing in study|1|||
126580967|NCT02874534|455424102|FG001|Overall Study|Ongoing in study|1|||
126580968|NCT02923180|455424104|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
126580969|NCT02923180|455424104|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
126580970|NCT01989455|455424107|FG000|Overall Study|Adverse Event|0|||
126580971|NCT01989455|455424108|FG001|Overall Study|Adverse Event|1|||
126580972|NCT01989455|455424109|FG002|Overall Study|Adverse Event|0|||
126580973|NCT01989455|455424110|FG003|Overall Study|Adverse Event|0|||
126580974|NCT01989455|455424111|FG004|Overall Study|Adverse Event|0|||
126580975|NCT01989455|455424107|FG000|Overall Study|Withdrawal by Subject|0|||
126580976|NCT01989455|455424108|FG001|Overall Study|Withdrawal by Subject|1|||
126580977|NCT01989455|455424109|FG002|Overall Study|Withdrawal by Subject|0|||
126580978|NCT01989455|455424110|FG003|Overall Study|Withdrawal by Subject|0|||
126580979|NCT01989455|455424111|FG004|Overall Study|Withdrawal by Subject|0|||
126580980|NCT01989455|455424107|FG000|Overall Study|Technical problems with infusion|0|||
126580981|NCT01989455|455424108|FG001|Overall Study|Technical problems with infusion|0|||
126580982|NCT01989455|455424109|FG002|Overall Study|Technical problems with infusion|1|||
126580983|NCT01989455|455424110|FG003|Overall Study|Technical problems with infusion|0|||
126580984|NCT01989455|455424111|FG004|Overall Study|Technical problems with infusion|1|||
126580985|NCT00632203|455424112|FG000|Overall Study|Did not start study treatment|1|||
126580986|NCT00632203|455424113|FG001|Overall Study|Did not start study treatment|0|||
126580987|NCT00448669|455424116|FG000|Overall Study|Lost to Follow-up|52|||
126580988|NCT00448669|455424117|FG001|Overall Study|Lost to Follow-up|63|||
126580989|NCT00448669|455424116|FG000|Overall Study|Withdrawal by Subject|90|||
126580990|NCT00448669|455424117|FG001|Overall Study|Withdrawal by Subject|74|||
126580991|NCT00448669|455424116|FG000|Overall Study|Relocated|49|||
126580992|NCT00448669|455424117|FG001|Overall Study|Relocated|36|||
126580993|NCT00448669|455424116|FG000|Overall Study|Were withdrawn by investigator|10|||
126580994|NCT00448669|455424117|FG001|Overall Study|Were withdrawn by investigator|6|||
126580995|NCT00448669|455424116|FG000|Overall Study|Death|2|||
126580996|NCT00448669|455424117|FG001|Overall Study|Death|4|||
126580997|NCT00448669|455424116|FG000|Overall Study|Had other reasons|5|||
126580998|NCT00448669|455424117|FG001|Overall Study|Had other reasons|6|||
126580999|NCT00448669|455424116|FG000|Overall Study|HIV-infected at enrollment|1|||
126581000|NCT00448669|455424117|FG001|Overall Study|HIV-infected at enrollment|2|||
126581001|NCT00448669|455424116|FG000|Overall Study|Never started drug|9|||
126581002|NCT00448669|455424117|FG001|Overall Study|Never started drug|7|||
126581003|NCT04287985|455424118|FG000|Overall Study|Adverse Event|1|||
126581004|NCT04287985|455424119|FG001|Overall Study|Adverse Event|0|||
126581005|NCT04287985|455424120|FG002|Overall Study|Adverse Event|0|||
126581006|NCT04287985|455424121|FG003|Overall Study|Adverse Event|0|||
126581007|NCT04287985|455424118|FG000|Overall Study|Protocol Violation|0|||
126581008|NCT04287985|455424119|FG001|Overall Study|Protocol Violation|1|||
126581009|NCT04287985|455424120|FG002|Overall Study|Protocol Violation|0|||
126581010|NCT04287985|455424121|FG003|Overall Study|Protocol Violation|0|||
126581011|NCT04287985|455424118|FG000|Overall Study|Physician Decision|0|||
126581012|NCT04287985|455424119|FG001|Overall Study|Physician Decision|0|||
126581013|NCT04287985|455424120|FG002|Overall Study|Physician Decision|0|||
126581014|NCT04287985|455424121|FG003|Overall Study|Physician Decision|1|||
126581015|NCT04287985|455424118|FG000|Overall Study|Withdrawal by Subject|2|||
126581016|NCT04287985|455424119|FG001|Overall Study|Withdrawal by Subject|1|||
126581017|NCT04287985|455424120|FG002|Overall Study|Withdrawal by Subject|1|||
126581018|NCT04287985|455424121|FG003|Overall Study|Withdrawal by Subject|2|||
126581019|NCT02638337|455424126|FG000|Overall Study|Adverse Event|6|||
126581020|NCT02638337|455424127|FG001|Overall Study|Adverse Event|10|||
126581021|NCT02638337|455424126|FG000|Overall Study|Protocol Violation|3|||
126581022|NCT02638337|455424127|FG001|Overall Study|Protocol Violation|0|||
126581023|NCT02638337|455424126|FG000|Overall Study|Withdrawal by Subject|13|||
126581024|NCT02638337|455424127|FG001|Overall Study|Withdrawal by Subject|16|||
126581025|NCT02638337|455424126|FG000|Overall Study|Lost to Follow-up|7|||
126581026|NCT02638337|455424127|FG001|Overall Study|Lost to Follow-up|7|||
126581027|NCT02638337|455424126|FG000|Overall Study|Other - Miscellaneous|4|||
126581028|NCT02638337|455424127|FG001|Overall Study|Other - Miscellaneous|3|||
126581029|NCT01340066|455424128|FG000|Placebo Run in Period|Screen Failures|27|||
126581030|NCT01340066|455424129|FG001|Placebo Run in Period|Screen Failures|0|||
126581031|NCT01340066|455424130|FG002|Placebo Run in Period|Screen Failures|0|||
126581032|NCT01340066|455424128|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
126581033|NCT01340066|455424129|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
126581034|NCT01340066|455424130|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
126581035|NCT01340066|455424128|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
126581036|NCT01340066|455424129|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
126581037|NCT01340066|455424130|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
126581038|NCT01340066|455424128|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
126581039|NCT01340066|455424129|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
126581040|NCT01340066|455424130|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
126581041|NCT02789020|455424131|FG000|Overall Study|Withdrawal by Subject|6|||
126581042|NCT02789020|455424132|FG001|Overall Study|Withdrawal by Subject|5|||
126581043|NCT03771352|455424147|FG000|Overall Study|Screen failure|2|||
126581044|NCT03771352|455424147|FG000|Overall Study|Withdrawal by Subject|2|||
126581045|NCT03338816|455424153|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
126581046|NCT03338816|455424154|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
126581047|NCT03338816|455424155|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
126581048|NCT03338816|455424156|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
126581049|NCT03338816|455424153|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
126530582|NCT04004611|455233758|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
126530583|NCT04004611|455233759|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
126530584|NCT04004611|455233760|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
126530585|NCT04420689|455233761|FG000|Overall Study|COVID-19 related hospitalization|0|||
126530586|NCT04420689|455233762|FG001|Overall Study|COVID-19 related hospitalization|0|||
126530587|NCT04420689|455233763|FG002|Overall Study|COVID-19 related hospitalization|0|||
126530588|NCT04420689|455233764|FG003|Overall Study|COVID-19 related hospitalization|0|||
126530589|NCT04420689|455233765|FG004|Overall Study|COVID-19 related hospitalization|1|||
126530590|NCT04420689|455233766|FG005|Overall Study|COVID-19 related hospitalization|0|||
126530591|NCT04420689|455233767|FG006|Overall Study|COVID-19 related hospitalization|0|||
126530592|NCT04420689|455233761|FG000|Overall Study|Physician Decision|0|||
126530593|NCT04420689|455233762|FG001|Overall Study|Physician Decision|0|||
126530594|NCT04420689|455233763|FG002|Overall Study|Physician Decision|0|||
126530595|NCT04420689|455233764|FG003|Overall Study|Physician Decision|0|||
126530596|NCT04420689|455233765|FG004|Overall Study|Physician Decision|0|||
126530597|NCT04420689|455233766|FG005|Overall Study|Physician Decision|1|||
126530598|NCT04420689|455233767|FG006|Overall Study|Physician Decision|0|||
126530599|NCT00515502|455233768|FG000|Treatment Period 1|Adverse Event|0|||
126581050|NCT03338816|455424154|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
126581051|NCT03338816|455424155|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
126581052|NCT03338816|455424156|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
126581053|NCT03338816|455424153|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
126581054|NCT03338816|455424154|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
126581055|NCT03338816|455424155|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
126530600|NCT00515502|455233769|FG001|Treatment Period 1|Adverse Event|0|||
126530601|NCT00515502|455233770|FG002|Treatment Period 1|Adverse Event|0|||
126530602|NCT00515502|455233771|FG003|Treatment Period 1|Adverse Event|0|||
126581056|NCT03338816|455424156|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
126581057|NCT03338816|455424153|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
126581058|NCT03338816|455424154|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
126581059|NCT03338816|455424155|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
126581060|NCT03338816|455424156|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
126581061|NCT03338816|455424153|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
126581062|NCT03338816|455424154|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
126581063|NCT03338816|455424155|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
126581064|NCT03338816|455424156|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
126581065|NCT03338816|455424153|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
126581066|NCT03338816|455424154|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
126581067|NCT03338816|455424155|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
126581068|NCT03338816|455424156|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
126581069|NCT03338816|455424153|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
126581070|NCT03338816|455424154|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
126581071|NCT03338816|455424155|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
126581072|NCT03338816|455424156|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
126581073|NCT04238247|455424161|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
126581074|NCT04238247|455424162|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
126581075|NCT04238247|455424163|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
126581076|NCT04238247|455424164|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
126581077|NCT04238247|455424161|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
126581078|NCT04238247|455424162|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
126581079|NCT04238247|455424163|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
126581080|NCT04238247|455424164|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
126581081|NCT04238247|455424161|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
126581082|NCT04238247|455424162|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
126581083|NCT04238247|455424163|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
126581084|NCT04238247|455424164|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
126581085|NCT04238247|455424161|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
126581086|NCT04238247|455424162|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
126581087|NCT04238247|455424163|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
126581088|NCT04238247|455424164|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
126581089|NCT03092726|455424165|FG000|Overall Study|Adverse Event|3|||
126581090|NCT03092726|455424166|FG001|Overall Study|Adverse Event|10|||
126581091|NCT03092726|455424165|FG000|Overall Study|Lack of Efficacy|0|||
126581092|NCT03092726|455424166|FG001|Overall Study|Lack of Efficacy|1|||
126581093|NCT03092726|455424165|FG000|Overall Study|Lost to Follow-up|1|||
126581094|NCT03092726|455424166|FG001|Overall Study|Lost to Follow-up|0|||
126581095|NCT03092726|455424165|FG000|Overall Study|Withdrawal by Subject|5|||
126581096|NCT03092726|455424166|FG001|Overall Study|Withdrawal by Subject|3|||
126581097|NCT04950127|455424167|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
126581098|NCT04950127|455424168|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
126581099|NCT04950127|455424169|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
126581100|NCT04950127|455424170|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
126581101|NCT04950127|455424171|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
126581102|NCT04950127|455424172|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
126581103|NCT04950127|455424167|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
126581104|NCT04950127|455424168|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
126581105|NCT04950127|455424169|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
126581106|NCT04950127|455424170|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
126581107|NCT04950127|455424171|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
126581108|NCT04950127|455424172|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
126581109|NCT04950127|455424167|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
126581110|NCT04950127|455424168|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
126581111|NCT04950127|455424169|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
126581112|NCT04950127|455424170|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
126581113|NCT04950127|455424171|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
126581114|NCT04950127|455424172|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
126581115|NCT04950127|455424167|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
126581116|NCT04950127|455424168|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
126581117|NCT04950127|455424169|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
126581118|NCT04950127|455424170|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
126581119|NCT04950127|455424171|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
126581120|NCT04950127|455424172|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
126581121|NCT04950127|455424167|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
126581122|NCT04950127|455424168|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
126581123|NCT04950127|455424169|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
126581124|NCT04950127|455424170|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
126729156|NCT03334396|455956918|FG001|Overall Study|Withdrawal by Subject|5|||
126729157|NCT03334396|455956919|FG002|Overall Study|Withdrawal by Subject|7|||
126530603|NCT00515502|455233772|FG004|Treatment Period 1|Adverse Event|0|||
126530604|NCT00515502|455233773|FG005|Treatment Period 1|Adverse Event|0|||
126530605|NCT00515502|455233774|FG006|Treatment Period 1|Adverse Event|1|||
126530606|NCT00515502|455233775|FG007|Treatment Period 1|Adverse Event|0|||
126530607|NCT00515502|455233776|FG008|Treatment Period 1|Adverse Event|1|||
126530608|NCT00515502|455233777|FG009|Treatment Period 1|Adverse Event|0|||
126530609|NCT00515502|455233778|FG010|Treatment Period 1|Adverse Event|0|||
126530610|NCT00515502|455233779|FG011|Treatment Period 1|Adverse Event|1|||
126530611|NCT00515502|455233768|FG000|Treatment Period 2|Adverse Event|0|||
126530612|NCT00515502|455233769|FG001|Treatment Period 2|Adverse Event|1|||
126530613|NCT00515502|455233770|FG002|Treatment Period 2|Adverse Event|0|||
126530614|NCT00515502|455233771|FG003|Treatment Period 2|Adverse Event|0|||
126530615|NCT00515502|455233772|FG004|Treatment Period 2|Adverse Event|0|||
126530616|NCT00515502|455233773|FG005|Treatment Period 2|Adverse Event|0|||
126530617|NCT00515502|455233774|FG006|Treatment Period 2|Adverse Event|0|||
126530618|NCT00515502|455233775|FG007|Treatment Period 2|Adverse Event|0|||
126530619|NCT00515502|455233776|FG008|Treatment Period 2|Adverse Event|0|||
126530620|NCT00515502|455233777|FG009|Treatment Period 2|Adverse Event|0|||
126530621|NCT00515502|455233778|FG010|Treatment Period 2|Adverse Event|0|||
126530622|NCT00515502|455233779|FG011|Treatment Period 2|Adverse Event|0|||
126530623|NCT03647501|455233783|FG000|Overall Study|Lost to Follow-up|1|||
126530624|NCT03647501|455233784|FG001|Overall Study|Lost to Follow-up|1|||
126530625|NCT03647501|455233783|FG000|Overall Study|Withdrawal by Subject|0|||
126530626|NCT03647501|455233784|FG001|Overall Study|Withdrawal by Subject|1|||
126530627|NCT01613248|455233785|FG000|Overall Study|Adverse Event|0|||
126530628|NCT01613248|455233786|FG001|Overall Study|Adverse Event|0|||
126530629|NCT01613248|455233787|FG002|Overall Study|Adverse Event|0|||
126530630|NCT01613248|455233788|FG003|Overall Study|Adverse Event|1|||
126530631|NCT01613248|455233789|FG004|Overall Study|Adverse Event|0|||
126530632|NCT01613248|455233790|FG005|Overall Study|Adverse Event|0|||
126530633|NCT01613248|455233785|FG000|Overall Study|Withdrawal by Subject|3|||
126530634|NCT01613248|455233786|FG001|Overall Study|Withdrawal by Subject|2|||
126530635|NCT01613248|455233787|FG002|Overall Study|Withdrawal by Subject|2|||
126530636|NCT01613248|455233788|FG003|Overall Study|Withdrawal by Subject|5|||
126530637|NCT01613248|455233789|FG004|Overall Study|Withdrawal by Subject|0|||
126530638|NCT01613248|455233790|FG005|Overall Study|Withdrawal by Subject|1|||
126530639|NCT01613248|455233785|FG000|Overall Study|Lost to Follow-up|5|||
126530640|NCT01613248|455233786|FG001|Overall Study|Lost to Follow-up|7|||
126530641|NCT01613248|455233787|FG002|Overall Study|Lost to Follow-up|4|||
126530642|NCT01613248|455233788|FG003|Overall Study|Lost to Follow-up|8|||
126530643|NCT01613248|455233789|FG004|Overall Study|Lost to Follow-up|4|||
126530644|NCT01613248|455233790|FG005|Overall Study|Lost to Follow-up|2|||
126530645|NCT01613248|455233785|FG000|Overall Study|Study Terminated by Sponsor|4|||
126530646|NCT01613248|455233786|FG001|Overall Study|Study Terminated by Sponsor|6|||
126530647|NCT01613248|455233787|FG002|Overall Study|Study Terminated by Sponsor|8|||
126530648|NCT01613248|455233788|FG003|Overall Study|Study Terminated by Sponsor|8|||
126530649|NCT01613248|455233789|FG004|Overall Study|Study Terminated by Sponsor|9|||
126530650|NCT01613248|455233790|FG005|Overall Study|Study Terminated by Sponsor|11|||
126530651|NCT01613248|455233785|FG000|Overall Study|Physician Decision|8|||
126530652|NCT01613248|455233786|FG001|Overall Study|Physician Decision|8|||
126530653|NCT01613248|455233787|FG002|Overall Study|Physician Decision|9|||
126530654|NCT01613248|455233788|FG003|Overall Study|Physician Decision|4|||
126530655|NCT01613248|455233789|FG004|Overall Study|Physician Decision|7|||
126530656|NCT01613248|455233790|FG005|Overall Study|Physician Decision|6|||
126530657|NCT01613248|455233785|FG000|Overall Study|Lack of Qualifying Event|9|||
126530658|NCT01613248|455233786|FG001|Overall Study|Lack of Qualifying Event|11|||
126530659|NCT01613248|455233787|FG002|Overall Study|Lack of Qualifying Event|10|||
126530660|NCT01613248|455233788|FG003|Overall Study|Lack of Qualifying Event|11|||
126530661|NCT01613248|455233789|FG004|Overall Study|Lack of Qualifying Event|15|||
126530662|NCT01613248|455233790|FG005|Overall Study|Lack of Qualifying Event|18|||
126530663|NCT01613248|455233785|FG000|Overall Study|Pregnancy|0|||
126530664|NCT01613248|455233786|FG001|Overall Study|Pregnancy|0|||
126530665|NCT01613248|455233787|FG002|Overall Study|Pregnancy|0|||
126530666|NCT01613248|455233788|FG003|Overall Study|Pregnancy|1|||
126530667|NCT01613248|455233789|FG004|Overall Study|Pregnancy|0|||
126530668|NCT01613248|455233790|FG005|Overall Study|Pregnancy|0|||
126530669|NCT02013622|455233796|FG000|Overall Study|Lost to Follow-up|10|||
126530670|NCT02013622|455233796|FG000|Overall Study|Adverse Event|3|||
126530671|NCT02013622|455233796|FG000|Overall Study|Met Withdrawal Criteria|3|||
126530672|NCT02013622|455233796|FG000|Overall Study|Withdrawal by Subject|6|||
126530673|NCT02013622|455233796|FG000|Overall Study|Protocol Deviation|1|||
126530674|NCT02013622|455233796|FG000|Overall Study|Lack of Efficacy|1|||
126530675|NCT04307004|455233804|FG000|Randomization 1|Withdrawal by Subject|25|||
126530676|NCT04307004|455233805|FG001|Randomization 1|Withdrawal by Subject|26|||
126530677|NCT04307004|455233806|FG002|Randomization 1|Withdrawal by Subject|0|||
126530678|NCT04307004|455233807|FG003|Randomization 1|Withdrawal by Subject|0|||
126530679|NCT04307004|455233804|FG000|Randomization 2|Withdrawal by Subject|0|||
126530680|NCT04307004|455233805|FG001|Randomization 2|Withdrawal by Subject|0|||
126530681|NCT04307004|455233806|FG002|Randomization 2|Withdrawal by Subject|28|||
126530682|NCT04307004|455233807|FG003|Randomization 2|Withdrawal by Subject|23|||
126530683|NCT01381692|455233808|FG000|Overall Study|Adverse Event|1|||
126530684|NCT01381692|455233809|FG001|Overall Study|Adverse Event|0|||
126530685|NCT01381692|455233810|FG002|Overall Study|Adverse Event|0|||
126530686|NCT01381692|455233811|FG003|Overall Study|Adverse Event|0|||
126530687|NCT01381692|455233812|FG004|Overall Study|Adverse Event|0|||
126530688|NCT01381692|455233813|FG005|Overall Study|Adverse Event|0|||
126530689|NCT04009291|455233814|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
126530690|NCT04009291|455233815|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
126530691|NCT04009291|455233816|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
126530692|NCT04009291|455233817|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
126530693|NCT04009291|455233818|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
126530694|NCT04009291|455233814|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
126530695|NCT04009291|455233815|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
126530696|NCT04009291|455233816|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
126530697|NCT04009291|455233817|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
126530698|NCT04009291|455233818|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
126530699|NCT03449030|455233823|FG000|Overall Study|Withdrawal by Subject|0|||
126530700|NCT03449030|455233824|FG001|Overall Study|Withdrawal by Subject|0|||
126530701|NCT03449030|455233825|FG002|Overall Study|Withdrawal by Subject|0|||
126530702|NCT03449030|455233826|FG003|Overall Study|Withdrawal by Subject|1|||
126530703|NCT03449030|455233827|FG004|Overall Study|Withdrawal by Subject|1|||
126530704|NCT03449030|455233828|FG005|Overall Study|Withdrawal by Subject|1|||
126530705|NCT03449030|455233829|FG006|Overall Study|Withdrawal by Subject|1|||
126530706|NCT03449030|455233830|FG007|Overall Study|Withdrawal by Subject|2|||
126530707|NCT03449030|455233831|FG008|Overall Study|Withdrawal by Subject|0|||
126530708|NCT03449030|455233832|FG009|Overall Study|Withdrawal by Subject|0|||
126530709|NCT03449030|455233823|FG000|Overall Study|Symptomatic Deterioration|0|||
126530710|NCT03449030|455233824|FG001|Overall Study|Symptomatic Deterioration|1|||
126530711|NCT03449030|455233825|FG002|Overall Study|Symptomatic Deterioration|0|||
126530712|NCT03449030|455233826|FG003|Overall Study|Symptomatic Deterioration|0|||
126530713|NCT03449030|455233827|FG004|Overall Study|Symptomatic Deterioration|0|||
126530714|NCT03449030|455233828|FG005|Overall Study|Symptomatic Deterioration|1|||
126530715|NCT03449030|455233829|FG006|Overall Study|Symptomatic Deterioration|1|||
126530716|NCT03449030|455233830|FG007|Overall Study|Symptomatic Deterioration|0|||
126530717|NCT03449030|455233831|FG008|Overall Study|Symptomatic Deterioration|2|||
126530718|NCT03449030|455233832|FG009|Overall Study|Symptomatic Deterioration|0|||
126530719|NCT03449030|455233823|FG000|Overall Study|Progressive Disease|1|||
126530720|NCT03449030|455233824|FG001|Overall Study|Progressive Disease|0|||
126530721|NCT03449030|455233825|FG002|Overall Study|Progressive Disease|1|||
126530722|NCT03449030|455233826|FG003|Overall Study|Progressive Disease|4|||
126530723|NCT03449030|455233827|FG004|Overall Study|Progressive Disease|5|||
126530724|NCT03449030|455233828|FG005|Overall Study|Progressive Disease|3|||
126530725|NCT03449030|455233829|FG006|Overall Study|Progressive Disease|0|||
126530726|NCT03449030|455233830|FG007|Overall Study|Progressive Disease|1|||
126530727|NCT03449030|455233831|FG008|Overall Study|Progressive Disease|1|||
126530728|NCT03449030|455233832|FG009|Overall Study|Progressive Disease|1|||
126530729|NCT03449030|455233823|FG000|Overall Study|Adverse Event|0|||
126530730|NCT03449030|455233824|FG001|Overall Study|Adverse Event|0|||
126530731|NCT03449030|455233825|FG002|Overall Study|Adverse Event|0|||
126530732|NCT03449030|455233826|FG003|Overall Study|Adverse Event|0|||
126530733|NCT03449030|455233827|FG004|Overall Study|Adverse Event|0|||
126530734|NCT03449030|455233828|FG005|Overall Study|Adverse Event|2|||
126530735|NCT03449030|455233829|FG006|Overall Study|Adverse Event|0|||
126530736|NCT03449030|455233830|FG007|Overall Study|Adverse Event|0|||
126530737|NCT03449030|455233831|FG008|Overall Study|Adverse Event|0|||
126530738|NCT03449030|455233832|FG009|Overall Study|Adverse Event|0|||
126530739|NCT03449030|455233823|FG000|Overall Study|Death|0|||
126530740|NCT03449030|455233824|FG001|Overall Study|Death|0|||
126530741|NCT03449030|455233825|FG002|Overall Study|Death|0|||
126530742|NCT03449030|455233826|FG003|Overall Study|Death|0|||
126530743|NCT03449030|455233827|FG004|Overall Study|Death|1|||
126530744|NCT03449030|455233828|FG005|Overall Study|Death|0|||
126530745|NCT03449030|455233829|FG006|Overall Study|Death|0|||
126729158|NCT03334396|455956920|FG003|Overall Study|Withdrawal by Subject|2|||
126729159|NCT03334396|455956921|FG004|Overall Study|Withdrawal by Subject|2|||
126530746|NCT03449030|455233830|FG007|Overall Study|Death|0|||
126530747|NCT03449030|455233831|FG008|Overall Study|Death|0|||
126530748|NCT03449030|455233832|FG009|Overall Study|Death|0|||
126530749|NCT04084314|455233842|FG000|Overall Study|Subject/guardian decision|91|||
126530750|NCT04084314|455233842|FG000|Overall Study|Adverse Event|24|||
126530751|NCT04084314|455233842|FG000|Overall Study|Lost to Follow-up|19|||
126530752|NCT04084314|455233842|FG000|Overall Study|New therapy for study indication|9|||
126530753|NCT04084314|455233842|FG000|Overall Study|Pregnancy|9|||
126530754|NCT04084314|455233842|FG000|Overall Study|Withdrawal of informed consent|8|||
126530755|NCT04084314|455233842|FG000|Overall Study|Physician Decision|4|||
126530756|NCT04084314|455233842|FG000|Overall Study|Protocol Deviation|3|||
126729160|NCT03334396|455956922|FG005|Overall Study|Withdrawal by Subject|1|||
126729161|NCT03334396|455956923|FG006|Overall Study|Withdrawal by Subject|2|||
126729162|NCT03334396|455956924|FG007|Overall Study|Withdrawal by Subject|0|||
126729163|NCT03334396|455956917|FG000|Overall Study|Pregnancy|0|||
126729164|NCT03334396|455956918|FG001|Overall Study|Pregnancy|1|||
126729165|NCT03334396|455956919|FG002|Overall Study|Pregnancy|0|||
126729166|NCT03334396|455956920|FG003|Overall Study|Pregnancy|0|||
126729167|NCT03334396|455956921|FG004|Overall Study|Pregnancy|0|||
126729168|NCT03334396|455956922|FG005|Overall Study|Pregnancy|0|||
126729169|NCT03334396|455956923|FG006|Overall Study|Pregnancy|0|||
126729170|NCT03334396|455956924|FG007|Overall Study|Pregnancy|0|||
126729171|NCT03334396|455956917|FG000|Overall Study|Ineligible|0|||
126729172|NCT03334396|455956918|FG001|Overall Study|Ineligible|1|||
126729173|NCT03334396|455956919|FG002|Overall Study|Ineligible|0|||
126729174|NCT03334396|455956920|FG003|Overall Study|Ineligible|0|||
126729175|NCT03334396|455956921|FG004|Overall Study|Ineligible|0|||
126729176|NCT03334396|455956922|FG005|Overall Study|Ineligible|0|||
126729177|NCT03334396|455956923|FG006|Overall Study|Ineligible|0|||
126729178|NCT03334396|455956924|FG007|Overall Study|Ineligible|0|||
126729179|NCT03334396|455956917|FG000|Overall Study|Started New Job|1|||
126729180|NCT03334396|455956918|FG001|Overall Study|Started New Job|0|||
126729181|NCT03334396|455956919|FG002|Overall Study|Started New Job|0|||
126729182|NCT03334396|455956920|FG003|Overall Study|Started New Job|0|||
126729183|NCT03334396|455956921|FG004|Overall Study|Started New Job|0|||
126729184|NCT03334396|455956922|FG005|Overall Study|Started New Job|0|||
126729185|NCT03334396|455956923|FG006|Overall Study|Started New Job|0|||
126729186|NCT03334396|455956924|FG007|Overall Study|Started New Job|0|||
126729187|NCT01969799|455956925|FG000|Overall Study|Adverse Event|0|||
126729188|NCT01969799|455956926|FG001|Overall Study|Adverse Event|1|||
126729189|NCT01969799|455956925|FG000|Overall Study|Death|16|||
126729190|NCT01969799|455956926|FG001|Overall Study|Death|11|||
126729191|NCT01969799|455956925|FG000|Overall Study|Lost to Follow-up|0|||
126729192|NCT01969799|455956926|FG001|Overall Study|Lost to Follow-up|2|||
126729193|NCT01969799|455956925|FG000|Overall Study|Physician Decision|1|||
126729194|NCT01969799|455956926|FG001|Overall Study|Physician Decision|0|||
126729195|NCT02927873|455956929|FG000|Overall Study|Lost to Follow-up|0|||
126729196|NCT02927873|455956930|FG001|Overall Study|Lost to Follow-up|1|||
126729197|NCT02927873|455956931|FG002|Overall Study|Lost to Follow-up|0|||
126729198|NCT02927873|455956932|FG003|Overall Study|Lost to Follow-up|0|||
126729199|NCT02927873|455956933|FG004|Overall Study|Lost to Follow-up|0|||
126729200|NCT02927873|455956934|FG005|Overall Study|Lost to Follow-up|0|||
126729201|NCT02927873|455956929|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126729202|NCT02927873|455956930|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
126729203|NCT02927873|455956931|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126729204|NCT02927873|455956932|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126729205|NCT02927873|455956933|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126729206|NCT02927873|455956934|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
126729207|NCT02927873|455956929|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126729208|NCT02927873|455956930|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126729209|NCT02927873|455956931|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126729210|NCT02927873|455956932|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126729211|NCT02927873|455956933|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126729212|NCT02927873|455956934|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126729213|NCT02927873|455956929|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
126729214|NCT02927873|455956930|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
126729215|NCT02927873|455956931|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
126729216|NCT02927873|455956932|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
126729217|NCT02927873|455956933|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
126729218|NCT02927873|455956934|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
126777146|NCT01456052|456141299|FG000|Overall Study|Physician Decision|1|||
126777147|NCT01456052|456141300|FG001|Overall Study|Physician Decision|0|||
126729219|NCT02927873|455956929|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
126729220|NCT02927873|455956930|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
126729221|NCT02927873|455956931|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
126729222|NCT02927873|455956932|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
126729223|NCT02927873|455956933|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
126777148|NCT01456052|456141301|FG002|Overall Study|Physician Decision|1|||
126777149|NCT01456052|456141299|FG000|Overall Study|Treatment Failure|0|||
126777150|NCT01456052|456141300|FG001|Overall Study|Treatment Failure|1|||
126729224|NCT02927873|455956934|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
126729225|NCT02927873|455956929|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
126729226|NCT02927873|455956930|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
126777151|NCT01456052|456141301|FG002|Overall Study|Treatment Failure|1|||
126777152|NCT01113710|456141302|FG000|Overall Study|Adverse Event|64|||
126777153|NCT01113710|456141302|FG000|Overall Study|Lack of Efficacy|41|||
126729227|NCT02927873|455956931|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
126729228|NCT02927873|455956932|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
126729229|NCT02927873|455956933|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
126729230|NCT02927873|455956934|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
126729231|NCT03629041|455956935|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
126729232|NCT03629041|455956936|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
126729233|NCT03629041|455956937|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
126729234|NCT03629041|455956938|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
126729235|NCT01927419|455956944|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126729236|NCT01927419|455956945|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
126729237|NCT01927419|455956944|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
126729238|NCT01927419|455956945|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
126729239|NCT01927419|455956944|FG000|Treatment Period|Disease progression|17|||
126729240|NCT01927419|455956945|FG001|Treatment Period|Disease progression|20|||
126729241|NCT01927419|455956944|FG000|Treatment Period|Study drug toxicity|48|||
126729242|NCT01927419|455956945|FG001|Treatment Period|Study drug toxicity|10|||
126729243|NCT01927419|455956944|FG000|Treatment Period|Death|0|||
126530757|NCT00802074|455233843|FG000|Overall Study|Adverse Event|1|||
126530758|NCT00802074|455233844|FG001|Overall Study|Adverse Event|1|||
126530759|NCT00802074|455233845|FG002|Overall Study|Adverse Event|1|||
126530760|NCT00802074|455233846|FG003|Overall Study|Adverse Event|0|||
126530761|NCT00802074|455233847|FG004|Overall Study|Adverse Event|0|||
126530762|NCT00802074|455233848|FG005|Overall Study|Adverse Event|0|||
126530763|NCT00802074|455233843|FG000|Overall Study|Withdrawal by Subject|1|||
126530764|NCT00802074|455233844|FG001|Overall Study|Withdrawal by Subject|0|||
126530765|NCT00802074|455233845|FG002|Overall Study|Withdrawal by Subject|0|||
126729244|NCT01927419|455956945|FG001|Treatment Period|Death|1|||
126729245|NCT01927419|455956944|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
126729246|NCT01927419|455956945|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
126729247|NCT01927419|455956944|FG000|Treatment Period|Participant request to discontinue|12|||
126729248|NCT01927419|455956945|FG001|Treatment Period|Participant request to discontinue|4|||
126729249|NCT01927419|455956944|FG000|Treatment Period|Withdrawal by Subject|1|||
126729250|NCT01927419|455956945|FG001|Treatment Period|Withdrawal by Subject|1|||
126530766|NCT00802074|455233846|FG003|Overall Study|Withdrawal by Subject|0|||
126530767|NCT00802074|455233847|FG004|Overall Study|Withdrawal by Subject|0|||
126530768|NCT00802074|455233848|FG005|Overall Study|Withdrawal by Subject|0|||
126530769|NCT01371851|455233855|FG000|Overall Study|Lost to Follow-up|5|||
126530770|NCT01371851|455233856|FG001|Overall Study|Lost to Follow-up|8|||
126530771|NCT01371851|455233855|FG000|Overall Study|was arrested and put in jail|0|||
126530772|NCT01371851|455233856|FG001|Overall Study|was arrested and put in jail|1|||
126530773|NCT01371851|455233855|FG000|Overall Study|non study related adverse event|1|||
126530774|NCT01371851|455233856|FG001|Overall Study|non study related adverse event|0|||
126530775|NCT01371851|455233855|FG000|Overall Study|Blood Pressure outside study parameters|2|||
126530776|NCT01371851|455233856|FG001|Overall Study|Blood Pressure outside study parameters|0|||
126530777|NCT00833638|455233857|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
126530778|NCT00833638|455233858|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
126530779|NCT00833638|455233859|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
126530780|NCT00833638|455233857|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
126530781|NCT00833638|455233858|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
126530782|NCT00833638|455233859|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
126530783|NCT00833638|455233857|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
126530784|NCT00833638|455233858|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
126530785|NCT00833638|455233859|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
126530786|NCT00833638|455233857|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
126530787|NCT00833638|455233858|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
126530788|NCT00833638|455233859|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
126530789|NCT00833638|455233857|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
126530790|NCT00833638|455233858|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
126530791|NCT00833638|455233859|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
126530792|NCT00833638|455233857|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
126530793|NCT00833638|455233858|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
126530794|NCT00833638|455233859|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
126530795|NCT00833638|455233857|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
126530796|NCT00833638|455233858|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
126530797|NCT00833638|455233859|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
126530798|NCT00833638|455233857|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
126530799|NCT00833638|455233858|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
126729251|NCT01927419|455956944|FG000|Treatment Period|Maximum Clinical Benefit|6|||
126729252|NCT01927419|455956945|FG001|Treatment Period|Maximum Clinical Benefit|2|||
126581125|NCT04950127|455424171|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
126581126|NCT04950127|455424172|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
126581127|NCT03833167|455424177|FG000|Overall Study|Withdrawal by Subject|4|||
126581128|NCT03833167|455424178|FG001|Overall Study|Withdrawal by Subject|6|||
126581129|NCT03833167|455424177|FG000|Overall Study|Ongoing|186|||
126581130|NCT03833167|455424178|FG001|Overall Study|Ongoing|194|||
126581131|NCT03833167|455424177|FG000|Overall Study|Lost to Follow-up|1|||
126581132|NCT03833167|455424178|FG001|Overall Study|Lost to Follow-up|1|||
126581133|NCT03833167|455424177|FG000|Overall Study|Physician Decision|0|||
126581134|NCT03833167|455424178|FG001|Overall Study|Physician Decision|2|||
126581135|NCT03833167|455424177|FG000|Overall Study|Death|34|||
126581136|NCT03833167|455424178|FG001|Overall Study|Death|22|||
126581137|NCT01948661|455424180|FG000|Overall Study|Withdrawal by Subject|2|||
126581138|NCT01948661|455424181|FG001|Overall Study|Withdrawal by Subject|4|||
126581139|NCT03271489|455424182|FG000|Double-Blind (DB) Period|Adverse Event|4|||
126581140|NCT03271489|455424183|FG001|Double-Blind (DB) Period|Adverse Event|1|||
126581141|NCT03271489|455424182|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
126581142|NCT03271489|455424183|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
126581143|NCT03271489|455424182|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
126581144|NCT03271489|455424183|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
126581145|NCT03271489|455424182|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
126581146|NCT03271489|455424183|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
126581147|NCT03271489|455424182|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
126581148|NCT03271489|455424183|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
126530800|NCT00833638|455233859|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
126530801|NCT00833638|455233857|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
126530802|NCT00833638|455233858|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
126530803|NCT00833638|455233859|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
126530804|NCT05608629|455233860|FG000|Overall Study|Lost to Follow-up|2|||
126530805|NCT01453595|455233862|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
126530806|NCT01453595|455233863|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
126530807|NCT01453595|455233864|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
126530808|NCT00983073|455233865|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
126530809|NCT00983073|455233865|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
126530810|NCT00983073|455233865|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
126530811|NCT00983073|455233865|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
126530812|NCT00983073|455233865|FG000|Titration and Optimal Dose Period|Other reason|4|||
126530813|NCT00983073|455233865|FG000|Maintenance Period|Adverse Event|5|||
126530814|NCT00983073|455233865|FG000|Maintenance Period|Withdrawal by Subject|2|||
126530815|NCT00983073|455233865|FG000|Maintenance Period|Lack of Efficacy|2|||
126530816|NCT00983073|455233865|FG000|Maintenance Period|Other Reason|7|||
126530817|NCT02962908|455233868|FG000|Overall Study|Lost to Follow-up|0|||
126530818|NCT02962908|455233869|FG001|Overall Study|Lost to Follow-up|3|||
126530819|NCT02962908|455233870|FG002|Overall Study|Lost to Follow-up|0|||
126530820|NCT02962908|455233871|FG003|Overall Study|Lost to Follow-up|1|||
126530821|NCT02962908|455233868|FG000|Overall Study|Withdrawal by Subject|0|||
126530822|NCT02962908|455233869|FG001|Overall Study|Withdrawal by Subject|3|||
126530823|NCT02962908|455233870|FG002|Overall Study|Withdrawal by Subject|0|||
126530824|NCT02962908|455233871|FG003|Overall Study|Withdrawal by Subject|2|||
126530825|NCT02962908|455233868|FG000|Overall Study|Protocol Violation|0|||
126530826|NCT02962908|455233869|FG001|Overall Study|Protocol Violation|1|||
126530827|NCT02962908|455233870|FG002|Overall Study|Protocol Violation|0|||
126530828|NCT02962908|455233871|FG003|Overall Study|Protocol Violation|0|||
126530829|NCT02962908|455233868|FG000|Overall Study|Physician Decision|0|||
126530830|NCT02962908|455233869|FG001|Overall Study|Physician Decision|1|||
126530831|NCT02962908|455233870|FG002|Overall Study|Physician Decision|0|||
126530832|NCT02962908|455233871|FG003|Overall Study|Physician Decision|0|||
126530833|NCT03543254|455233872|FG000|Overall Study|Lost to Follow-up|1|||
126530834|NCT01261338|455233873|FG000|Overall Study|Withdrawal by Subject|3|||
126530835|NCT01261338|455233874|FG001|Overall Study|Withdrawal by Subject|2|||
126530836|NCT05374421|455233875|FG000|Overall Study|Withdrawal by Subject|3|||
126530837|NCT05374421|455233876|FG001|Overall Study|Withdrawal by Subject|4|||
126581149|NCT03271489|455424182|FG000|Double-Blind (DB) Period|Other|6|||
126581150|NCT03271489|455424183|FG001|Double-Blind (DB) Period|Other|1|||
126581151|NCT03271489|455424182|FG000|Double-Blind (DB) Period|Missing|1|||
126729253|NCT01927419|455956944|FG000|Treatment Period|Other reasons|3|||
126729254|NCT01927419|455956945|FG001|Treatment Period|Other reasons|4|||
126729255|NCT01927419|455956944|FG000|Treatment Period|Not Reported|1|||
126729256|NCT01927419|455956945|FG001|Treatment Period|Not Reported|1|||
126729257|NCT00393913|455956946|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
126729258|NCT00393913|455956946|FG000|Initial Assessment|Withdrawal by Subject|16|||
126729259|NCT00393913|455956946|FG000|CPAP|Withdrawal by Subject|3|||
126729260|NCT00393913|455956946|FG000|CPAP|Physician Decision|1|||
126729261|NCT00393913|455956946|FG000|CPAP|TEchnical problem with CPAP|3|||
126581152|NCT03271489|455424183|FG001|Double-Blind (DB) Period|Missing|0|||
126581153|NCT03271489|455424182|FG000|Open-Label (OL) Period|Adverse Event|2|||
126581154|NCT03271489|455424183|FG001|Open-Label (OL) Period|Adverse Event|0|||
126581155|NCT03271489|455424182|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
126581156|NCT03271489|455424183|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
126581157|NCT03271489|455424182|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
126581158|NCT03271489|455424183|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
126581159|NCT03271489|455424182|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
126581160|NCT03271489|455424183|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
126581161|NCT03271489|455424182|FG000|Open-Label (OL) Period|No Specified|2|||
126581162|NCT03271489|455424183|FG001|Open-Label (OL) Period|No Specified|2|||
126581163|NCT03271489|455424182|FG000|Open-Label (OL) Period|Missing|2|||
126581164|NCT03271489|455424183|FG001|Open-Label (OL) Period|Missing|0|||
126581165|NCT03271489|455424182|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
126581166|NCT03271489|455424183|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
126581167|NCT03271489|455424182|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
126581168|NCT03271489|455424183|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
126581169|NCT03271489|455424182|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
126581170|NCT03271489|455424183|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
126581171|NCT03271489|455424182|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
126581172|NCT03271489|455424183|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
126581173|NCT03271489|455424182|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
126581174|NCT03271489|455424183|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
126581175|NCT03271489|455424182|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
126581176|NCT03271489|455424183|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
126581177|NCT03271489|455424182|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
126581178|NCT03271489|455424183|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
126581179|NCT03271489|455424182|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
126581180|NCT03271489|455424183|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
126581181|NCT02860130|455424184|FG000|Overall Study|Adverse Event|2|||
126581182|NCT02860130|455424185|FG001|Overall Study|Adverse Event|3|||
126581183|NCT02860130|455424184|FG000|Overall Study|Protocol Violation|1|||
126581184|NCT02860130|455424185|FG001|Overall Study|Protocol Violation|1|||
126581185|NCT02860130|455424184|FG000|Overall Study|Withdrawal by Subject|0|||
126581186|NCT02860130|455424185|FG001|Overall Study|Withdrawal by Subject|2|||
126581187|NCT02860130|455424184|FG000|Overall Study|Physician Decision|2|||
126581188|NCT02860130|455424185|FG001|Overall Study|Physician Decision|2|||
126581189|NCT02860130|455424184|FG000|Overall Study|Other|2|||
126581190|NCT02860130|455424185|FG001|Overall Study|Other|1|||
126581191|NCT03330795|455424186|FG000|Overall Study|Death|3|||
126581192|NCT03330795|455424186|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
126581193|NCT05064735|455424187|FG000|Overall Study|Withdrawal by Subject|7|||
126581194|NCT05064735|455424188|FG001|Overall Study|Withdrawal by Subject|8|||
126581195|NCT05064735|455424187|FG000|Overall Study|Lost to Follow-up|7|||
126581196|NCT05064735|455424188|FG001|Overall Study|Lost to Follow-up|2|||
126581197|NCT05064735|455424187|FG000|Overall Study|Physician Decision|2|||
126581198|NCT05064735|455424188|FG001|Overall Study|Physician Decision|1|||
126581199|NCT05064735|455424187|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
126581200|NCT05064735|455424188|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
126581201|NCT05064735|455424187|FG000|Overall Study|Site Closure|7|||
126581202|NCT05064735|455424188|FG001|Overall Study|Site Closure|2|||
126581203|NCT03380390|455424189|FG000|Overall Study|Adverse Event|3|||
126581204|NCT02886286|455424190|FG000|Overall Study|pump motor stall|0|||
126581205|NCT02886286|455424191|FG001|Overall Study|pump motor stall|1|||
126581206|NCT02376790|455424192|FG000|Overall Study|Withdrawal by Subject|43|||
126581207|NCT02376790|455424193|FG001|Overall Study|Withdrawal by Subject|36|||
126581208|NCT02376790|455424194|FG002|Overall Study|Withdrawal by Subject|37|||
126581209|NCT02376790|455424192|FG000|Overall Study|Decision by Sponsor|2|||
126581210|NCT02376790|455424193|FG001|Overall Study|Decision by Sponsor|1|||
126581211|NCT02376790|455424194|FG002|Overall Study|Decision by Sponsor|4|||
126581212|NCT02376790|455424192|FG000|Overall Study|Lost to Follow-up|15|||
126581213|NCT02376790|455424193|FG001|Overall Study|Lost to Follow-up|10|||
126581214|NCT02376790|455424194|FG002|Overall Study|Lost to Follow-up|12|||
126581215|NCT03014453|455424195|FG000|Overall Study|Lost to Follow-up|12|||
126581216|NCT03014453|455424195|FG000|Overall Study|Discontinued GER|3|||
126581217|NCT03014453|455424195|FG000|Overall Study|Excluded|19|||
126581218|NCT03014453|455424195|FG000|Overall Study|Refused to take part in|37|||
126581219|NCT05450458|455424196|FG000|Overall Study|Lost to Follow-up|4|||
126581220|NCT00262301|455424197|FG000|Double-blind Phase|Lost to Follow-up|1|||
126581221|NCT00262301|455424198|FG001|Double-blind Phase|Lost to Follow-up|0|||
126581222|NCT00262301|455424199|FG002|Double-blind Phase|Lost to Follow-up|0|||
126729262|NCT03488251|455956947|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
126530838|NCT05540522|455233879|FG000|Overall Study|Adverse Event|1|||
126581223|NCT00262301|455424197|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
126581224|NCT00262301|455424198|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
126581225|NCT00262301|455424199|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
126530839|NCT05540522|455233880|FG001|Overall Study|Adverse Event|0|||
126530840|NCT05540522|455233881|FG002|Overall Study|Adverse Event|2|||
126530841|NCT05540522|455233882|FG003|Overall Study|Adverse Event|5|||
126530842|NCT05540522|455233879|FG000|Overall Study|Lost to Follow-up|487|||
126530843|NCT05540522|455233880|FG001|Overall Study|Lost to Follow-up|427|||
126530844|NCT05540522|455233881|FG002|Overall Study|Lost to Follow-up|146|||
126530845|NCT05540522|455233882|FG003|Overall Study|Lost to Follow-up|166|||
126530846|NCT05540522|455233879|FG000|Overall Study|Physician Decision|11|||
126530847|NCT05540522|455233880|FG001|Overall Study|Physician Decision|19|||
126581226|NCT00901901|455424200|FG000|Treatment Period|Adverse Event|120|||
126581227|NCT00901901|455424201|FG001|Treatment Period|Adverse Event|128|||
126581228|NCT00901901|455424200|FG000|Treatment Period|Withdrawal by Subject|26|||
126581229|NCT00901901|455424201|FG001|Treatment Period|Withdrawal by Subject|24|||
126581230|NCT00901901|455424200|FG000|Treatment Period|Physician Decision|2|||
126581231|NCT00901901|455424201|FG001|Treatment Period|Physician Decision|2|||
126581232|NCT00901901|455424200|FG000|Treatment Period|Lost to Follow-up|3|||
126581233|NCT00901901|455424201|FG001|Treatment Period|Lost to Follow-up|5|||
126581234|NCT00901901|455424200|FG000|Treatment Period|Noncompliance with study medication|4|||
126581235|NCT00901901|455424201|FG001|Treatment Period|Noncompliance with study medication|1|||
126581236|NCT00901901|455424200|FG000|Treatment Period|Missing|1|||
126581237|NCT00901901|455424201|FG001|Treatment Period|Missing|0|||
126581238|NCT00901901|455424200|FG000|Treatment Period|Never treated|0|||
126581239|NCT00901901|455424201|FG001|Treatment Period|Never treated|3|||
126581240|NCT00901901|455424200|FG000|Treatment Period|Protocol driven decision point|0|||
126581241|NCT00901901|455424201|FG001|Treatment Period|Protocol driven decision point|2|||
126581242|NCT00901901|455424200|FG000|Treatment Period|Study terminated by sponsor|2|||
126581243|NCT00901901|455424201|FG001|Treatment Period|Study terminated by sponsor|0|||
126581244|NCT00901901|455424200|FG000|Treatment Period|Protocol Violation|5|||
126581245|NCT00901901|455424201|FG001|Treatment Period|Protocol Violation|9|||
126581246|NCT00901901|455424200|FG000|Treatment Period|Switch to commercial drug|1|||
126581247|NCT00901901|455424201|FG001|Treatment Period|Switch to commercial drug|1|||
126581248|NCT00901901|455424200|FG000|Treatment Period|Transfer to treatment continuation study|5|||
126581249|NCT00901901|455424201|FG001|Treatment Period|Transfer to treatment continuation study|2|||
126581250|NCT00901901|455424200|FG000|Follow-up Period|Death|181|||
126581251|NCT00901901|455424201|FG001|Follow-up Period|Death|208|||
126581252|NCT00901901|455424200|FG000|Follow-up Period|Protocol driven decision point|47|||
126581253|NCT00901901|455424201|FG001|Follow-up Period|Protocol driven decision point|36|||
126581254|NCT00901901|455424200|FG000|Follow-up Period|Withdrawal by Subject|6|||
126581255|NCT00901901|455424201|FG001|Follow-up Period|Withdrawal by Subject|9|||
126581256|NCT00901901|455424200|FG000|Follow-up Period|Lost to Follow-up|12|||
126581257|NCT00901901|455424201|FG001|Follow-up Period|Lost to Follow-up|8|||
126581258|NCT00901901|455424200|FG000|Follow-up Period|Missing|94|||
126581259|NCT00901901|455424201|FG001|Follow-up Period|Missing|80|||
126581260|NCT02272816|455424202|FG000|Overall Study|Adverse Event|1|||
126581261|NCT01136876|455424203|FG000|Overall Study|Lost to Follow-up|0|||
126581262|NCT01136876|455424204|FG001|Overall Study|Lost to Follow-up|1|||
126581263|NCT01136876|455424203|FG000|Overall Study|Physician Decision|3|||
126581264|NCT01136876|455424204|FG001|Overall Study|Physician Decision|5|||
126581265|NCT01136876|455424203|FG000|Overall Study|Missing NGAL measurement|2|||
126581266|NCT01136876|455424204|FG001|Overall Study|Missing NGAL measurement|5|||
126581267|NCT00976937|455424207|FG000|Overall Study|Adverse Event|4|||
126729263|NCT03488251|455956948|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
126729264|NCT03488251|455956949|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
126530848|NCT05540522|455233881|FG002|Overall Study|Physician Decision|8|||
126530849|NCT05540522|455233882|FG003|Overall Study|Physician Decision|13|||
126530850|NCT05540522|455233879|FG000|Overall Study|Pregnancy|1|||
126530851|NCT05540522|455233880|FG001|Overall Study|Pregnancy|0|||
126530852|NCT05540522|455233881|FG002|Overall Study|Pregnancy|0|||
126530853|NCT05540522|455233882|FG003|Overall Study|Pregnancy|0|||
126530854|NCT05540522|455233879|FG000|Overall Study|Protocol Violation|3|||
126530855|NCT05540522|455233880|FG001|Overall Study|Protocol Violation|1|||
126581268|NCT00976937|455424208|FG001|Overall Study|Adverse Event|5|||
126581269|NCT00976937|455424207|FG000|Overall Study|Lost to Follow-up|2|||
126581270|NCT00976937|455424208|FG001|Overall Study|Lost to Follow-up|1|||
126581271|NCT00976937|455424207|FG000|Overall Study|Withdrawal by Subject|5|||
126581272|NCT00976937|455424208|FG001|Overall Study|Withdrawal by Subject|3|||
126581273|NCT00976937|455424207|FG000|Overall Study|Poor compliance to protocol|3|||
126581274|NCT00976937|455424208|FG001|Overall Study|Poor compliance to protocol|0|||
126581275|NCT00976937|455424207|FG000|Overall Study|Personal and Familial Reason|2|||
126581276|NCT00976937|455424208|FG001|Overall Study|Personal and Familial Reason|2|||
126530856|NCT05540522|455233881|FG002|Overall Study|Protocol Violation|9|||
126530857|NCT05540522|455233882|FG003|Overall Study|Protocol Violation|7|||
126581277|NCT01011946|455424209|FG000|Overall Study|Transferred to another hospital|2|||
126581278|NCT01011946|455424209|FG000|Overall Study|No pathological lab value|1|||
126581279|NCT03988842|455424210|FG000|Overall Study|Death|1|||
126581280|NCT01227265|455424212|FG000|Overall Study|Did Not Receive Treatment|1|||
126581281|NCT01227265|455424213|FG001|Overall Study|Did Not Receive Treatment|2|||
126581282|NCT01227265|455424214|FG002|Overall Study|Did Not Receive Treatment|0|||
126581283|NCT01227265|455424212|FG000|Overall Study|Administrative|1|||
126581284|NCT01227265|455424213|FG001|Overall Study|Administrative|0|||
126581285|NCT01227265|455424214|FG002|Overall Study|Administrative|2|||
126581286|NCT01227265|455424212|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
126581287|NCT01227265|455424213|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
126581288|NCT01227265|455424214|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
126581289|NCT01227265|455424212|FG000|Overall Study|Protocol Violation|2|||
126581290|NCT01227265|455424213|FG001|Overall Study|Protocol Violation|1|||
126581291|NCT01227265|455424214|FG002|Overall Study|Protocol Violation|0|||
126581292|NCT01227265|455424212|FG000|Overall Study|Withdrawal by Subject|7|||
126581293|NCT01227265|455424213|FG001|Overall Study|Withdrawal by Subject|7|||
126581294|NCT01227265|455424214|FG002|Overall Study|Withdrawal by Subject|3|||
126581295|NCT01227265|455424212|FG000|Overall Study|Lost to Follow-up|2|||
126581296|NCT01227265|455424213|FG001|Overall Study|Lost to Follow-up|0|||
126581297|NCT01227265|455424214|FG002|Overall Study|Lost to Follow-up|3|||
126581298|NCT01227265|455424212|FG000|Overall Study|Adverse Event|6|||
126581299|NCT01227265|455424213|FG001|Overall Study|Adverse Event|10|||
126581300|NCT01227265|455424214|FG002|Overall Study|Adverse Event|5|||
126581301|NCT03690206|455424215|FG000|Overall Study|Withdrawal by Subject|2|||
126581302|NCT03690206|455424216|FG001|Overall Study|Withdrawal by Subject|0|||
126581303|NCT03690206|455424217|FG002|Overall Study|Withdrawal by Subject|0|||
126581304|NCT03690206|455424215|FG000|Overall Study|ICF withdrawal|2|||
126581305|NCT03690206|455424216|FG001|Overall Study|ICF withdrawal|0|||
126581306|NCT03690206|455424217|FG002|Overall Study|ICF withdrawal|0|||
126581307|NCT03012841|455425679|FG000|Overall Study|Protocol Violation|0|||
126581308|NCT03012841|455425680|FG001|Overall Study|Protocol Violation|10|||
126581309|NCT03012841|455425679|FG000|Overall Study|Lost to Follow-up|6|||
126581310|NCT03012841|455425680|FG001|Overall Study|Lost to Follow-up|1|||
126581311|NCT03012841|455425679|FG000|Overall Study|Withdrawal by Subject|6|||
126581312|NCT03012841|455425680|FG001|Overall Study|Withdrawal by Subject|0|||
126581313|NCT03012841|455425679|FG000|Overall Study|Unable to complete 12 month visit|6|||
126581314|NCT03012841|455425680|FG001|Overall Study|Unable to complete 12 month visit|0|||
126581315|NCT03012841|455425679|FG000|Overall Study|Subject relocation|1|||
126581316|NCT03012841|455425680|FG001|Overall Study|Subject relocation|0|||
126581317|NCT03012841|455425679|FG000|Overall Study|Seasonal winter travel|1|||
126581318|NCT03012841|455425680|FG001|Overall Study|Seasonal winter travel|0|||
126581319|NCT03012841|455425679|FG000|Overall Study|Physician Decision|0|||
126581320|NCT03012841|455425680|FG001|Overall Study|Physician Decision|2|||
126581321|NCT03012841|455425679|FG000|Overall Study|No ablation performed|0|||
126581322|NCT03012841|455425680|FG001|Overall Study|No ablation performed|2|||
126581323|NCT03012841|455425679|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
126581324|NCT03012841|455425680|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
126581325|NCT03012841|455425679|FG000|Overall Study|Insurance change|0|||
126581326|NCT03012841|455425680|FG001|Overall Study|Insurance change|1|||
126581327|NCT03769168|455425681|FG000|Overall Study|Adverse Event|0|||
126581328|NCT03769168|455425682|FG001|Overall Study|Adverse Event|1|||
126581329|NCT03769168|455425681|FG000|Overall Study|Lack of Efficacy|2|||
126581330|NCT03769168|455425682|FG001|Overall Study|Lack of Efficacy|4|||
126581331|NCT03769168|455425681|FG000|Overall Study|Post study access to treatment|3|||
126581332|NCT03769168|455425682|FG001|Overall Study|Post study access to treatment|11|||
126581333|NCT03769168|455425681|FG000|Overall Study|Physician Decision|1|||
126581334|NCT03769168|455425682|FG001|Overall Study|Physician Decision|4|||
126581335|NCT03769168|455425681|FG000|Overall Study|Subject Decision|2|||
126581336|NCT03769168|455425682|FG001|Overall Study|Subject Decision|4|||
126581337|NCT03769168|455425681|FG000|Overall Study|Guardian decision|1|||
126581338|NCT03769168|455425682|FG001|Overall Study|Guardian decision|0|||
126581339|NCT04941287|455425683|FG000|Overall Study|Rapid decline before starting treatment|3|||
126581340|NCT04941287|455425684|FG001|Overall Study|Rapid decline before starting treatment|1|||
126581341|NCT05096819|455425691|FG000|Overall Study|Withdrawal by Subject|3|||
126581342|NCT05096819|455425692|FG001|Overall Study|Withdrawal by Subject|0|||
126581343|NCT03324984|455425693|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
126581344|NCT03324984|455425694|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
126581345|NCT04607044|455425697|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
126581346|NCT04607044|455425697|FG000|Overall Study|Adverse Event|1|||
126581347|NCT04607044|455425697|FG000|Overall Study|Did not receive study device|3|||
126581348|NCT04607044|455425697|FG000|Overall Study|Death|1|||
126581349|NCT02152137|455425699|FG000|Overall Study|Withdrawal by Subject|1|||
126581350|NCT02152137|455425699|FG000|Overall Study|Originally assigned to Arm B|3|||
126581351|NCT04878354|455425700|FG000|Overall Study|Adverse Event|4|||
126581352|NCT04878354|455425701|FG001|Overall Study|Adverse Event|13|||
126581353|NCT04878354|455425700|FG000|Overall Study|Withdrawal by Subject|14|||
126729265|NCT03488251|455956950|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
126729266|NCT03488251|455956947|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
126729267|NCT03488251|455956948|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
126729268|NCT03488251|455956949|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
126729269|NCT03488251|455956950|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
126729270|NCT03488251|455956947|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
126729271|NCT03488251|455956948|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
126729272|NCT03488251|455956949|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
126729273|NCT03488251|455956950|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
126729274|NCT03488251|455956947|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
126729275|NCT03488251|455956948|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
126729276|NCT03488251|455956949|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
126729277|NCT03488251|455956950|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
126729278|NCT03488251|455956947|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
126729279|NCT03488251|455956948|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
126729280|NCT03488251|455956949|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
126729281|NCT03488251|455956950|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
126729282|NCT00592553|455956956|FG000|Overall Study|Protocol Noncompliance|1|||
126729283|NCT00592553|455956957|FG001|Overall Study|Protocol Noncompliance|0|||
126729284|NCT00592553|455956958|FG002|Overall Study|Protocol Noncompliance|0|||
126729285|NCT02379390|455956959|FG000|Overall Study|Adverse Event|1|||
126729286|NCT02379390|455956960|FG001|Overall Study|Adverse Event|1|||
126729287|NCT02379390|455956959|FG000|Overall Study|Investigator's decision|1|||
126729288|NCT02379390|455956960|FG001|Overall Study|Investigator's decision|0|||
126530858|NCT05540522|455233879|FG000|Overall Study|Withdrawal by Subject|168|||
126729289|NCT02379390|455956959|FG000|Overall Study|Study Termination|0|||
126729290|NCT02379390|455956960|FG001|Overall Study|Study Termination|1|||
126530859|NCT05540522|455233880|FG001|Overall Study|Withdrawal by Subject|134|||
126530860|NCT05540522|455233881|FG002|Overall Study|Withdrawal by Subject|331|||
126530861|NCT05540522|455233882|FG003|Overall Study|Withdrawal by Subject|322|||
126530862|NCT05540522|455233879|FG000|Overall Study|Death|7|||
126530863|NCT05540522|455233880|FG001|Overall Study|Death|9|||
126530864|NCT05540522|455233881|FG002|Overall Study|Death|49|||
126530865|NCT05540522|455233882|FG003|Overall Study|Death|46|||
126530866|NCT05540522|455233879|FG000|Overall Study|Not vaccinated|34|||
126530867|NCT05540522|455233880|FG001|Overall Study|Not vaccinated|53|||
126530868|NCT05540522|455233881|FG002|Overall Study|Not vaccinated|57|||
126530869|NCT05540522|455233882|FG003|Overall Study|Not vaccinated|50|||
126530870|NCT05540522|455233879|FG000|Overall Study|No longer meets eligibility criteria|0|||
126530871|NCT05540522|455233880|FG001|Overall Study|No longer meets eligibility criteria|0|||
126530872|NCT05540522|455233881|FG002|Overall Study|No longer meets eligibility criteria|3|||
126530873|NCT05540522|455233882|FG003|Overall Study|No longer meets eligibility criteria|2|||
126530874|NCT05540522|455233879|FG000|Overall Study|Other (Unspecified)|8|||
126530875|NCT05540522|455233880|FG001|Overall Study|Other (Unspecified)|10|||
126530876|NCT05540522|455233881|FG002|Overall Study|Other (Unspecified)|4|||
126530877|NCT05540522|455233882|FG003|Overall Study|Other (Unspecified)|2|||
126530878|NCT03754803|455233883|FG000|Overall Study|Withdrawal by Subject|2|||
126530879|NCT05239039|455233884|FG000|Overall Study|Withdrawal by Subject|0|||
126530880|NCT05239039|455233885|FG001|Overall Study|Withdrawal by Subject|1|||
126530881|NCT02119260|455235287|FG000|Overall Study|Adverse Event|1|||
126530882|NCT02119260|455235288|FG001|Overall Study|Adverse Event|0|||
126530883|NCT02119260|455235289|FG002|Overall Study|Adverse Event|0|||
126530884|NCT02119260|455235290|FG003|Overall Study|Adverse Event|0|||
126530885|NCT02119260|455235291|FG004|Overall Study|Adverse Event|0|||
126530886|NCT02119260|455235292|FG005|Overall Study|Adverse Event|0|||
126530887|NCT02119260|455235293|FG006|Overall Study|Adverse Event|0|||
126530888|NCT02119260|455235287|FG000|Overall Study|Withdrew consent|0|||
126530889|NCT02119260|455235288|FG001|Overall Study|Withdrew consent|1|||
126530890|NCT02119260|455235289|FG002|Overall Study|Withdrew consent|1|||
126530891|NCT02119260|455235290|FG003|Overall Study|Withdrew consent|0|||
126530892|NCT02119260|455235291|FG004|Overall Study|Withdrew consent|0|||
126530893|NCT02119260|455235292|FG005|Overall Study|Withdrew consent|0|||
126530894|NCT02119260|455235293|FG006|Overall Study|Withdrew consent|0|||
126530895|NCT00857207|455235294|FG000|Overall Study|Withdrawal by Subject|13|||
126530896|NCT00857207|455235295|FG001|Overall Study|Withdrawal by Subject|0|||
126530897|NCT00857207|455235294|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
126530898|NCT00857207|455235295|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
126530899|NCT00857207|455235294|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
126530900|NCT00857207|455235295|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
126530901|NCT00955357|455235296|FG000|Titration Phase|Adverse Event|9|||
126530902|NCT00955357|455235297|FG001|Titration Phase|Adverse Event|46|||
126530903|NCT00955357|455235296|FG000|Titration Phase|Lack of Efficacy|0|||
126729291|NCT01244191|455956961|FG000|Overall Study|Progressive disease|295|||
126729292|NCT01244191|455956962|FG001|Overall Study|Progressive disease|350|||
126729293|NCT01244191|455956961|FG000|Overall Study|Clinical disease progression|54|||
126530904|NCT00955357|455235297|FG001|Titration Phase|Lack of Efficacy|2|||
126530905|NCT00955357|455235296|FG000|Titration Phase|Protocol Violation|3|||
126530906|NCT00955357|455235297|FG001|Titration Phase|Protocol Violation|7|||
126530907|NCT00955357|455235296|FG000|Titration Phase|Lost to Follow-up|1|||
126530908|NCT00955357|455235297|FG001|Titration Phase|Lost to Follow-up|3|||
126530909|NCT00955357|455235296|FG000|Titration Phase|Withdrawal by Subject|3|||
126530910|NCT00955357|455235297|FG001|Titration Phase|Withdrawal by Subject|5|||
126530911|NCT00955357|455235296|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
126530912|NCT00955357|455235297|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
126530913|NCT00955357|455235296|FG000|Titration Phase|Study medication not tolerated|0|||
126530914|NCT00955357|455235297|FG001|Titration Phase|Study medication not tolerated|1|||
126530915|NCT00955357|455235296|FG000|Titration Phase|Non compliance to study procedures|0|||
126530916|NCT00955357|455235297|FG001|Titration Phase|Non compliance to study procedures|1|||
126530917|NCT00955357|455235296|FG000|Maintenance Phase|Adverse Event|3|||
126530918|NCT00955357|455235297|FG001|Maintenance Phase|Adverse Event|23|||
126530919|NCT00955357|455235296|FG000|Maintenance Phase|Lack of Efficacy|0|||
126530920|NCT00955357|455235297|FG001|Maintenance Phase|Lack of Efficacy|4|||
126530921|NCT00955357|455235296|FG000|Maintenance Phase|Protocol Violation|2|||
126530922|NCT00955357|455235297|FG001|Maintenance Phase|Protocol Violation|6|||
126530923|NCT00955357|455235296|FG000|Maintenance Phase|Lost to Follow-up|2|||
126530924|NCT00955357|455235297|FG001|Maintenance Phase|Lost to Follow-up|7|||
126530925|NCT00955357|455235296|FG000|Maintenance Phase|Withdrawal by Subject|4|||
126530926|NCT00955357|455235297|FG001|Maintenance Phase|Withdrawal by Subject|4|||
126530927|NCT00955357|455235296|FG000|Maintenance Phase|Patient moving out of area|0|||
126530928|NCT00955357|455235297|FG001|Maintenance Phase|Patient moving out of area|1|||
126530929|NCT00955357|455235296|FG000|Maintenance Phase|Non compliance to study procedures|1|||
126530930|NCT00955357|455235297|FG001|Maintenance Phase|Non compliance to study procedures|0|||
126530931|NCT00440531|455235302|FG000|Overall Study|Adverse Event|1|||
126530932|NCT00440531|455235303|FG001|Overall Study|Adverse Event|0|||
126530933|NCT00440531|455235304|FG002|Overall Study|Adverse Event|2|||
126530934|NCT00440531|455235302|FG000|Overall Study|Withdrawal by Subject|2|||
126530935|NCT00440531|455235303|FG001|Overall Study|Withdrawal by Subject|0|||
126530936|NCT00440531|455235304|FG002|Overall Study|Withdrawal by Subject|0|||
126530937|NCT00440531|455235302|FG000|Overall Study|Protocol Violation|1|||
126530938|NCT00440531|455235303|FG001|Overall Study|Protocol Violation|2|||
126530939|NCT00440531|455235304|FG002|Overall Study|Protocol Violation|0|||
126530940|NCT00440531|455235302|FG000|Overall Study|Lost to Follow-up|4|||
126530941|NCT00440531|455235303|FG001|Overall Study|Lost to Follow-up|3|||
126530942|NCT00440531|455235304|FG002|Overall Study|Lost to Follow-up|5|||
126530943|NCT00440531|455235302|FG000|Overall Study|see pre-assignment details|2|||
126530944|NCT00440531|455235303|FG001|Overall Study|see pre-assignment details|0|||
126530945|NCT00440531|455235304|FG002|Overall Study|see pre-assignment details|0|||
126530946|NCT02181803|455235311|FG000|Overall Study|Withdrawal by Subject|0|||
126530947|NCT02181803|455235312|FG001|Overall Study|Withdrawal by Subject|2|||
126530948|NCT02181803|455235313|FG002|Overall Study|Withdrawal by Subject|0|||
126530949|NCT02181803|455235314|FG003|Overall Study|Withdrawal by Subject|0|||
126530950|NCT02181803|455235315|FG004|Overall Study|Withdrawal by Subject|0|||
126530951|NCT02181803|455235316|FG005|Overall Study|Withdrawal by Subject|0|||
126530952|NCT02181803|455235317|FG006|Overall Study|Withdrawal by Subject|0|||
126530953|NCT02181803|455235318|FG007|Overall Study|Withdrawal by Subject|0|||
126530954|NCT02181803|455235319|FG008|Overall Study|Withdrawal by Subject|0|||
126530955|NCT02181803|455235311|FG000|Overall Study|Physician Decision|0|||
126530956|NCT02181803|455235312|FG001|Overall Study|Physician Decision|0|||
126530957|NCT02181803|455235313|FG002|Overall Study|Physician Decision|0|||
126530958|NCT02181803|455235314|FG003|Overall Study|Physician Decision|1|||
126530959|NCT02181803|455235315|FG004|Overall Study|Physician Decision|0|||
126530960|NCT02181803|455235316|FG005|Overall Study|Physician Decision|0|||
126530961|NCT02181803|455235317|FG006|Overall Study|Physician Decision|0|||
126530962|NCT02181803|455235318|FG007|Overall Study|Physician Decision|1|||
126530963|NCT02181803|455235319|FG008|Overall Study|Physician Decision|0|||
126530964|NCT02181803|455235311|FG000|Overall Study|Adverse Event|0|||
126530965|NCT02181803|455235312|FG001|Overall Study|Adverse Event|2|||
126530966|NCT02181803|455235313|FG002|Overall Study|Adverse Event|0|||
126530967|NCT02181803|455235314|FG003|Overall Study|Adverse Event|1|||
126530968|NCT02181803|455235315|FG004|Overall Study|Adverse Event|0|||
126530969|NCT02181803|455235316|FG005|Overall Study|Adverse Event|0|||
126530970|NCT02181803|455235317|FG006|Overall Study|Adverse Event|1|||
126530971|NCT02181803|455235318|FG007|Overall Study|Adverse Event|0|||
126530972|NCT02181803|455235319|FG008|Overall Study|Adverse Event|0|||
126530973|NCT04786444|455235320|FG000|Overall Study|Withdrawal by Subject|4|||
126530974|NCT04786444|455235321|FG001|Overall Study|Withdrawal by Subject|7|||
126530975|NCT04786444|455235322|FG002|Overall Study|Withdrawal by Subject|2|||
126530976|NCT04786444|455235320|FG000|Overall Study|Lost to Follow-up|11|||
126530977|NCT04786444|455235321|FG001|Overall Study|Lost to Follow-up|9|||
126530978|NCT04786444|455235322|FG002|Overall Study|Lost to Follow-up|10|||
126530979|NCT04786444|455235320|FG000|Overall Study|Subject would like to become pregnant|0|||
126530980|NCT04786444|455235321|FG001|Overall Study|Subject would like to become pregnant|1|||
126530981|NCT04786444|455235322|FG002|Overall Study|Subject would like to become pregnant|0|||
126530982|NCT02462876|455235323|FG000|Overall Study|Death|3|||
126530983|NCT02462876|455235323|FG000|Overall Study|Lost to Follow-up|7|||
126581354|NCT04878354|455425701|FG001|Overall Study|Withdrawal by Subject|12|||
126581355|NCT04878354|455425700|FG000|Overall Study|Lost to Follow-up|4|||
126581356|NCT04878354|455425701|FG001|Overall Study|Lost to Follow-up|1|||
126581357|NCT04878354|455425700|FG000|Overall Study|Lack of Efficacy|1|||
126581358|NCT04878354|455425701|FG001|Overall Study|Lack of Efficacy|0|||
126581359|NCT04878354|455425700|FG000|Overall Study|Protocol Violation|0|||
126581360|NCT04878354|455425701|FG001|Overall Study|Protocol Violation|1|||
126581361|NCT04878354|455425700|FG000|Overall Study|"Reason stated as other in CRF"|2|||
126581362|NCT04878354|455425701|FG001|Overall Study|"Reason stated as other in CRF"|3|||
126581363|NCT05510232|455425702|FG000|Overall Study|Withdrawal by Subject|2|||
126581364|NCT05510232|455425703|FG001|Overall Study|Withdrawal by Subject|7|||
126581365|NCT05510232|455425704|FG002|Overall Study|Withdrawal by Subject|6|||
126581366|NCT05307783|455425711|FG000|Overall Study|Death|7|||
126581367|NCT05307783|455425711|FG000|Overall Study|Lost to Follow-up|4|||
126581368|NCT04883645|455425712|FG000|Overall Study|Death|1|||
126581369|NCT05687903|455425713|FG000|Overall Study|Protocol Deviation|1|||
126581370|NCT05687903|455425714|FG001|Overall Study|Protocol Deviation|1|||
126581371|NCT05687903|455425715|FG002|Overall Study|Protocol Deviation|0|||
126581372|NCT05687903|455425716|FG003|Overall Study|Protocol Deviation|1|||
126581373|NCT05687903|455425717|FG004|Overall Study|Protocol Deviation|0|||
126581374|NCT04855760|455425718|FG000|Overall Study|Adverse Event|21|||
126581375|NCT04855760|455425718|FG000|Overall Study|Withdrawal by Subject|116|||
126581376|NCT04855760|455425718|FG000|Overall Study|Lack of Efficacy|21|||
126581377|NCT04855760|455425718|FG000|Overall Study|Lost to Follow-up|49|||
126581378|NCT04855760|455425718|FG000|Overall Study|Protocol Violation|2|||
126581379|NCT04855760|455425718|FG000|Overall Study|Physician Decision|5|||
126581380|NCT04855760|455425718|FG000|Overall Study|Pregnancy|1|||
126581381|NCT04855760|455425718|FG000|Overall Study|Non-Compliance with Study Drug|11|||
126581382|NCT04855760|455425718|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
126581383|NCT04855760|455425718|FG000|Overall Study|Study Completed by Sponsor|202|||
126581384|NCT04855760|455425718|FG000|Overall Study|Other|13|||
126581385|NCT01631214|455425724|FG000|Overall Study|Withdrawal by Subject|276|||
126581386|NCT01631214|455425725|FG001|Overall Study|Withdrawal by Subject|290|||
126581387|NCT01631214|455425724|FG000|Overall Study|Death|113|||
126581388|NCT01631214|455425725|FG001|Overall Study|Death|106|||
126530984|NCT02462876|455235323|FG000|Overall Study|Surgical Bypass|9|||
126530985|NCT02462876|455235323|FG000|Overall Study|Amputation Above the Metatarsals|1|||
126530986|NCT02462876|455235323|FG000|Overall Study|36 months follow-up visit missed|1|||
126530987|NCT02462876|455235323|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
126530988|NCT02462876|455235323|FG000|Overall Study|Patient did not come back to the vascular department|1|||
126530989|NCT02462876|455235323|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
126530990|NCT02462876|455235323|FG000|Overall Study|Patient refused to come back|1|||
126530991|NCT02462876|455235323|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
126530992|NCT02462876|455235323|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
126530993|NCT01786512|455235328|FG000|Overall Study|Lost to Follow-up|0|||
126530994|NCT01786512|455235329|FG001|Overall Study|Lost to Follow-up|0|||
126530995|NCT01786512|455235330|FG002|Overall Study|Lost to Follow-up|0|||
126530996|NCT01786512|455235331|FG003|Overall Study|Lost to Follow-up|0|||
126530997|NCT01786512|455235332|FG004|Overall Study|Lost to Follow-up|0|||
126530998|NCT01786512|455235333|FG005|Overall Study|Lost to Follow-up|0|||
126530999|NCT01786512|455235334|FG006|Overall Study|Lost to Follow-up|0|||
126531000|NCT01786512|455235335|FG007|Overall Study|Lost to Follow-up|0|||
126531001|NCT01786512|455235336|FG008|Overall Study|Lost to Follow-up|0|||
126531002|NCT01786512|455235337|FG009|Overall Study|Lost to Follow-up|1|||
126531003|NCT01786512|455235338|FG010|Overall Study|Lost to Follow-up|0|||
126531004|NCT01786512|455235328|FG000|Overall Study|Decision by sponsor|0|||
126531005|NCT01786512|455235329|FG001|Overall Study|Decision by sponsor|0|||
126531006|NCT01786512|455235330|FG002|Overall Study|Decision by sponsor|0|||
126531007|NCT01786512|455235331|FG003|Overall Study|Decision by sponsor|0|||
126531008|NCT01786512|455235332|FG004|Overall Study|Decision by sponsor|0|||
126531009|NCT01786512|455235333|FG005|Overall Study|Decision by sponsor|0|||
126531010|NCT01786512|455235334|FG006|Overall Study|Decision by sponsor|0|||
126531011|NCT01786512|455235335|FG007|Overall Study|Decision by sponsor|0|||
126531012|NCT01786512|455235336|FG008|Overall Study|Decision by sponsor|0|||
126531013|NCT01786512|455235337|FG009|Overall Study|Decision by sponsor|0|||
126531014|NCT01786512|455235338|FG010|Overall Study|Decision by sponsor|2|||
126531015|NCT01786512|455235328|FG000|Overall Study|Withdrawal by Subject|0|||
126531016|NCT01786512|455235329|FG001|Overall Study|Withdrawal by Subject|1|||
126581389|NCT01631214|455425724|FG000|Overall Study|Lost to Follow-up|54|||
126581390|NCT01631214|455425725|FG001|Overall Study|Lost to Follow-up|40|||
126729294|NCT01244191|455956962|FG001|Overall Study|Clinical disease progression|36|||
126729295|NCT01244191|455956961|FG000|Overall Study|Adverse Event|65|||
126729296|NCT01244191|455956962|FG001|Overall Study|Adverse Event|48|||
126729297|NCT01244191|455956961|FG000|Overall Study|Death|22|||
126729298|NCT01244191|455956962|FG001|Overall Study|Death|29|||
126729299|NCT01244191|455956961|FG000|Overall Study|Lost to Follow-up|0|||
126729300|NCT01244191|455956962|FG001|Overall Study|Lost to Follow-up|2|||
126729301|NCT01244191|455956961|FG000|Overall Study|Protocol Violation|1|||
126729302|NCT01244191|455956962|FG001|Overall Study|Protocol Violation|2|||
126729303|NCT01244191|455956961|FG000|Overall Study|Withdrawal by Subject|31|||
126729304|NCT01244191|455956962|FG001|Overall Study|Withdrawal by Subject|23|||
126729305|NCT01244191|455956961|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
126729306|NCT01244191|455956962|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
126729307|NCT01511107|455956964|FG000|Overall Study|Ineligible|3|||
126729308|NCT01511107|455956965|FG001|Overall Study|Ineligible|2|||
126729309|NCT01511107|455956964|FG000|Overall Study|Lost to Follow-up|10|||
126729310|NCT01511107|455956965|FG001|Overall Study|Lost to Follow-up|19|||
126729311|NCT01511107|455956964|FG000|Overall Study|Withdrawal by Subject|9|||
126729312|NCT01511107|455956965|FG001|Overall Study|Withdrawal by Subject|20|||
126729313|NCT01283997|455958368|FG000|Overall Study|Physician Decision|8|||
126729314|NCT01283997|455958369|FG001|Overall Study|Physician Decision|10|||
126729315|NCT01283997|455958368|FG000|Overall Study|Withdrawal by Subject|3|||
126729316|NCT01283997|455958369|FG001|Overall Study|Withdrawal by Subject|2|||
126729317|NCT01283997|455958368|FG000|Overall Study|Physically unable to continue|0|||
126729318|NCT01283997|455958369|FG001|Overall Study|Physically unable to continue|1|||
126729319|NCT01283997|455958368|FG000|Overall Study|Progressive disease|1|||
126729320|NCT01283997|455958369|FG001|Overall Study|Progressive disease|0|||
126729321|NCT01283997|455958368|FG000|Overall Study|Other|4|||
126729322|NCT01283997|455958369|FG001|Overall Study|Other|4|||
126729323|NCT02017899|455958370|FG000|Overall Study|Withdrawal by Subject|0|||
126729324|NCT02017899|455958371|FG001|Overall Study|Withdrawal by Subject|0|||
126729325|NCT02017899|455958372|FG002|Overall Study|Withdrawal by Subject|0|||
126729326|NCT02017899|455958373|FG003|Overall Study|Withdrawal by Subject|1|||
126729327|NCT02017899|455958374|FG004|Overall Study|Withdrawal by Subject|1|||
126729328|NCT02017899|455958375|FG005|Overall Study|Withdrawal by Subject|0|||
126729329|NCT01677624|455958380|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
126729330|NCT01747811|455958381|FG000|Overall Study|Lack of Efficacy|2|||
126729331|NCT01747811|455958382|FG001|Overall Study|Lack of Efficacy|4|||
126729332|NCT01337167|455958383|FG000|Infant Series|Adverse Event|1|||
126729333|NCT01337167|455958384|FG001|Infant Series|Adverse Event|1|||
126729334|NCT01337167|455958383|FG000|Infant Series|Death|1|||
126729335|NCT01337167|455958384|FG001|Infant Series|Death|1|||
126729336|NCT01337167|455958383|FG000|Infant Series|Lost to Follow-up|13|||
126729337|NCT01337167|455958384|FG001|Infant Series|Lost to Follow-up|7|||
126729338|NCT01337167|455958383|FG000|Infant Series|Non-compliance with study drug|2|||
126729339|NCT01337167|455958384|FG001|Infant Series|Non-compliance with study drug|1|||
126729340|NCT01337167|455958383|FG000|Infant Series|Physician Decision|3|||
126729341|NCT01337167|455958384|FG001|Infant Series|Physician Decision|1|||
126729342|NCT01337167|455958383|FG000|Infant Series|Protocol Violation|22|||
126729343|NCT01337167|455958384|FG001|Infant Series|Protocol Violation|9|||
126729344|NCT01337167|455958383|FG000|Infant Series|Withdrawal by Subject|15|||
126729345|NCT01337167|455958384|FG001|Infant Series|Withdrawal by Subject|4|||
126729346|NCT01337167|455958383|FG000|Infant Series|Randomized but not vaccinated|5|||
126729347|NCT01337167|455958384|FG001|Infant Series|Randomized but not vaccinated|3|||
126729348|NCT01337167|455958383|FG000|Interim Period|Lost to Follow-up|51|||
126729349|NCT01337167|455958384|FG001|Interim Period|Lost to Follow-up|23|||
126729350|NCT01337167|455958383|FG000|Interim Period|Non-compliance with study drug|1|||
126729351|NCT01337167|455958384|FG001|Interim Period|Non-compliance with study drug|0|||
126729352|NCT01337167|455958383|FG000|Interim Period|Physician Decision|6|||
126729353|NCT01337167|455958384|FG001|Interim Period|Physician Decision|3|||
126729354|NCT01337167|455958383|FG000|Interim Period|Protocol Violation|5|||
126531017|NCT01786512|455235330|FG002|Overall Study|Withdrawal by Subject|0|||
126531018|NCT01786512|455235331|FG003|Overall Study|Withdrawal by Subject|0|||
126729355|NCT01337167|455958384|FG001|Interim Period|Protocol Violation|3|||
126729356|NCT01337167|455958383|FG000|Interim Period|Withdrawal by Subject|18|||
126729357|NCT01337167|455958384|FG001|Interim Period|Withdrawal by Subject|10|||
126729358|NCT01337167|455958383|FG000|Interim Period|Other protocol criterion not met|0|||
126729359|NCT01337167|455958384|FG001|Interim Period|Other protocol criterion not met|1|||
126729360|NCT01337167|455958383|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
126729361|NCT01337167|455958384|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
126729362|NCT01337167|455958383|FG000|Toddler Vaccinations|Protocol Violation|0|||
126531019|NCT01786512|455235332|FG004|Overall Study|Withdrawal by Subject|0|||
126729363|NCT01337167|455958384|FG001|Toddler Vaccinations|Protocol Violation|1|||
126531020|NCT01786512|455235333|FG005|Overall Study|Withdrawal by Subject|0|||
126729364|NCT01337167|455958383|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
126729365|NCT01337167|455958384|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
126729366|NCT03833817|455958385|FG000|Overall Study|Withdrawal by Subject|3|||
126581391|NCT01631214|455425724|FG000|Overall Study|Adverse Event|45|||
126581392|NCT01631214|455425725|FG001|Overall Study|Adverse Event|45|||
126581393|NCT01631214|455425724|FG000|Overall Study|Other|22|||
126581394|NCT01631214|455425725|FG001|Overall Study|Other|19|||
126581395|NCT01631214|455425724|FG000|Overall Study|Noncompliance|16|||
126581396|NCT01631214|455425725|FG001|Overall Study|Noncompliance|15|||
126581397|NCT01631214|455425724|FG000|Overall Study|Requirement for Alternative Therapy|8|||
126581398|NCT01631214|455425725|FG001|Overall Study|Requirement for Alternative Therapy|3|||
126581399|NCT01631214|455425724|FG000|Overall Study|Protocol Deviation|4|||
126581400|NCT01631214|455425725|FG001|Overall Study|Protocol Deviation|3|||
126581401|NCT01631214|455425724|FG000|Overall Study|Ineligibility determined|5|||
126581402|NCT01631214|455425725|FG001|Overall Study|Ineligibility determined|2|||
126581403|NCT01631214|455425724|FG000|Overall Study|Administrative Decision|1|||
126581404|NCT01631214|455425725|FG001|Overall Study|Administrative Decision|0|||
126581405|NCT04112316|455425731|FG000|First Period (8 Weeks)|Protocol Violation|1|||
126581406|NCT04112316|455425732|FG001|First Period (8 Weeks)|Protocol Violation|0|||
126581407|NCT04112316|455425731|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
126581408|NCT04112316|455425732|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
126581409|NCT03857620|455425733|FG000|Overall Study|Death|4|||
126581410|NCT03857620|455425734|FG001|Overall Study|Death|5|||
126581411|NCT03857620|455425735|FG002|Overall Study|Death|7|||
126581412|NCT03857620|455425733|FG000|Overall Study|Lost to Follow-up|2|||
126581413|NCT03857620|455425734|FG001|Overall Study|Lost to Follow-up|5|||
126581414|NCT03857620|455425735|FG002|Overall Study|Lost to Follow-up|3|||
126581415|NCT03857620|455425733|FG000|Overall Study|Disease progression or relapse after study registration|1|||
126581416|NCT03857620|455425734|FG001|Overall Study|Disease progression or relapse after study registration|5|||
126581417|NCT03857620|455425735|FG002|Overall Study|Disease progression or relapse after study registration|1|||
126581418|NCT03857620|455425733|FG000|Overall Study|Ineligible|5|||
126581419|NCT03857620|455425734|FG001|Overall Study|Ineligible|0|||
126581420|NCT03857620|455425735|FG002|Overall Study|Ineligible|2|||
126581421|NCT03857620|455425733|FG000|Overall Study|No malignancy|1|||
126581422|NCT03857620|455425734|FG001|Overall Study|No malignancy|0|||
126581423|NCT03857620|455425735|FG002|Overall Study|No malignancy|1|||
126581424|NCT03857620|455425733|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
126581425|NCT03857620|455425734|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
126581426|NCT03857620|455425735|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
126581427|NCT03857620|455425733|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
126581428|NCT03857620|455425734|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
126581429|NCT03857620|455425735|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
126581430|NCT03857620|455425733|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
126581431|NCT03857620|455425734|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
126581432|NCT03857620|455425735|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
126581433|NCT03857620|455425733|FG000|Overall Study|Surgery not performed, patient decision|0|||
126581434|NCT03857620|455425734|FG001|Overall Study|Surgery not performed, patient decision|3|||
126581435|NCT03857620|455425735|FG002|Overall Study|Surgery not performed, patient decision|1|||
126581436|NCT03857620|455425733|FG000|Overall Study|Surgery not performed, other reason|3|||
126581437|NCT03857620|455425734|FG001|Overall Study|Surgery not performed, other reason|1|||
126581438|NCT03857620|455425735|FG002|Overall Study|Surgery not performed, other reason|4|||
126581439|NCT03857620|455425733|FG000|Overall Study|Worsening performance status after surgery performed|0|||
126581440|NCT03857620|455425734|FG001|Overall Study|Worsening performance status after surgery performed|1|||
126581441|NCT03857620|455425735|FG002|Overall Study|Worsening performance status after surgery performed|1|||
126581442|NCT02473250|455425736|FG000|Overall Study|Lost to Follow-up|10|||
126581443|NCT02473250|455425736|FG000|Overall Study|Physician Decision|5|||
126581444|NCT02473250|455425736|FG000|Overall Study|Did not tolerate medication washout|3|||
126581445|NCT02473250|455425736|FG000|Overall Study|Antidepressant effect of divalproex|2|||
126581446|NCT04093362|455425739|FG000|Overall Study|Study Termination|1|||
126581447|NCT04093362|455425740|FG001|Overall Study|Study Termination|1|||
126581448|NCT04093362|455425739|FG000|Overall Study|Withdrawal of Consent|1|||
126581449|NCT04093362|455425740|FG001|Overall Study|Withdrawal of Consent|0|||
126581450|NCT04093362|455425739|FG000|Overall Study|Death|1|||
126581451|NCT04093362|455425740|FG001|Overall Study|Death|3|||
126581452|NCT04093362|455425739|FG000|Overall Study|Reason not Specified|1|||
126581453|NCT04093362|455425740|FG001|Overall Study|Reason not Specified|2|||
126581454|NCT01898494|455425758|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
126581455|NCT01898494|455425759|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
126581456|NCT01898494|455425760|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
126581457|NCT01898494|455425761|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
126581458|NCT01898494|455425762|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
126581459|NCT01898494|455425758|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
126581460|NCT01898494|455425759|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
126581461|NCT01898494|455425760|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
126729367|NCT03833817|455958386|FG001|Overall Study|Withdrawal by Subject|3|||
126729368|NCT03833817|455958385|FG000|Overall Study|Lost to Follow-up|3|||
126729369|NCT03833817|455958386|FG001|Overall Study|Lost to Follow-up|3|||
126729370|NCT00884221|455958389|FG000|Overall Study|Withdrawal by Subject|0|||
126729371|NCT00884221|455958390|FG001|Overall Study|Withdrawal by Subject|3|||
126729372|NCT00884221|455958389|FG000|Overall Study|Adverse Event|6|||
126729373|NCT00884221|455958390|FG001|Overall Study|Adverse Event|3|||
126581462|NCT01898494|455425761|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
126581463|NCT01898494|455425762|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
126581464|NCT01898494|455425758|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
126581465|NCT01898494|455425759|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
126581466|NCT01898494|455425760|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
126581467|NCT01898494|455425761|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
126581468|NCT01898494|455425762|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
126581469|NCT01898494|455425758|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
126581470|NCT01898494|455425759|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
126581471|NCT01898494|455425760|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
126581472|NCT01898494|455425761|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
126729374|NCT00884221|455958389|FG000|Overall Study|Protocol Violation|16|||
126729375|NCT00884221|455958390|FG001|Overall Study|Protocol Violation|13|||
126531021|NCT01786512|455235334|FG006|Overall Study|Withdrawal by Subject|1|||
126531022|NCT01786512|455235335|FG007|Overall Study|Withdrawal by Subject|0|||
126531023|NCT01786512|455235336|FG008|Overall Study|Withdrawal by Subject|0|||
126531024|NCT01786512|455235337|FG009|Overall Study|Withdrawal by Subject|3|||
126531025|NCT01786512|455235338|FG010|Overall Study|Withdrawal by Subject|7|||
126531026|NCT01786512|455235328|FG000|Overall Study|Death|0|||
126531027|NCT01786512|455235329|FG001|Overall Study|Death|0|||
126531028|NCT01786512|455235330|FG002|Overall Study|Death|0|||
126531029|NCT01786512|455235331|FG003|Overall Study|Death|0|||
126531030|NCT01786512|455235332|FG004|Overall Study|Death|0|||
126531031|NCT01786512|455235333|FG005|Overall Study|Death|0|||
126531032|NCT01786512|455235334|FG006|Overall Study|Death|0|||
126531033|NCT01786512|455235335|FG007|Overall Study|Death|0|||
126531034|NCT01786512|455235336|FG008|Overall Study|Death|4|||
126531035|NCT01786512|455235337|FG009|Overall Study|Death|1|||
126531036|NCT01786512|455235338|FG010|Overall Study|Death|3|||
126531037|NCT03166618|455235339|FG000|Overall Study|Study was Terminated|0|||
126531038|NCT03166618|455235340|FG001|Overall Study|Study was Terminated|1|||
126531039|NCT01925950|455235341|FG000|Part 2|Withdrawal by Subject|1|||
126531040|NCT01925950|455235342|FG001|Part 2|Withdrawal by Subject|0|||
126531041|NCT00381940|455235345|FG000|Overall Study|Lack of Efficacy|3|||
126531042|NCT00381940|455235345|FG000|Overall Study|Protocol Violation|1|||
126531043|NCT00381940|455235345|FG000|Overall Study|Ineligible|1|||
126531044|NCT03162224|455235347|FG000|Overall Study|Death|4|||
126531045|NCT03162224|455235348|FG001|Overall Study|Death|5|||
126531046|NCT03162224|455235349|FG002|Overall Study|Death|8|||
126531047|NCT03162224|455235347|FG000|Overall Study|Withdrawal by Subject|1|||
126531048|NCT03162224|455235348|FG001|Overall Study|Withdrawal by Subject|0|||
126531049|NCT03162224|455235349|FG002|Overall Study|Withdrawal by Subject|1|||
126531050|NCT03162224|455235347|FG000|Overall Study|Lost to Follow-up|0|||
126531051|NCT03162224|455235348|FG001|Overall Study|Lost to Follow-up|1|||
126531052|NCT03162224|455235349|FG002|Overall Study|Lost to Follow-up|0|||
126531053|NCT03162224|455235347|FG000|Overall Study|Other|6|||
126531054|NCT03162224|455235348|FG001|Overall Study|Other|2|||
126531055|NCT03162224|455235349|FG002|Overall Study|Other|1|||
126531056|NCT03137303|455235350|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
126531057|NCT03137303|455235351|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
126531058|NCT03137303|455235350|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
126531059|NCT03137303|455235351|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
126531060|NCT03137303|455235350|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
126531061|NCT03137303|455235351|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
126531062|NCT03137303|455235350|FG000|T3: 9-month Follow-up|Death|1|||
126531063|NCT03137303|455235351|FG001|T3: 9-month Follow-up|Death|0|||
126531064|NCT03137303|455235350|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
126581473|NCT01898494|455425762|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
126729376|NCT00884221|455958389|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
126531065|NCT03137303|455235351|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
126531066|NCT03137303|455235350|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
126531067|NCT03137303|455235351|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
126729377|NCT00884221|455958390|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
126531068|NCT03137303|455235350|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
126531069|NCT03137303|455235351|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
126531070|NCT03561090|455235354|FG000|Overall Study|Adverse Event|11|||
126531071|NCT03561090|455235355|FG001|Overall Study|Adverse Event|7|||
126531072|NCT03561090|455235354|FG000|Overall Study|Non-Compliance With Study Drug|2|||
126531073|NCT03561090|455235355|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126531074|NCT03561090|455235354|FG000|Overall Study|Protocol Violation|2|||
126531075|NCT03561090|455235355|FG001|Overall Study|Protocol Violation|2|||
126531076|NCT03561090|455235354|FG000|Overall Study|Withdrawal by Subject|7|||
126531077|NCT03561090|455235355|FG001|Overall Study|Withdrawal by Subject|7|||
126531078|NCT03561090|455235354|FG000|Overall Study|Lost to Follow-up|7|||
126531079|NCT03561090|455235355|FG001|Overall Study|Lost to Follow-up|2|||
126531080|NCT03561090|455235354|FG000|Overall Study|Study Terminated by Sponsor|10|||
126531081|NCT03561090|455235355|FG001|Overall Study|Study Terminated by Sponsor|15|||
126531082|NCT03561090|455235354|FG000|Overall Study|Randomized by Mistake|1|||
126531083|NCT03561090|455235355|FG001|Overall Study|Randomized by Mistake|1|||
126531084|NCT03561090|455235354|FG000|Overall Study|Other Not Specified|0|||
126777154|NCT01113710|456141302|FG000|Overall Study|No Information Available|40|||
126777155|NCT01113710|456141302|FG000|Overall Study|Withdrawal by Subject|28|||
126531085|NCT03561090|455235355|FG001|Overall Study|Other Not Specified|2|||
126531086|NCT04162769|455235362|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
126531087|NCT04162769|455235363|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
126531088|NCT04162769|455235364|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
126531089|NCT04162769|455235365|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
126531090|NCT04162769|455235362|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
126531091|NCT04162769|455235363|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
126531092|NCT04162769|455235364|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
126531093|NCT04162769|455235365|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
126531094|NCT04162769|455235362|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
126531095|NCT04162769|455235363|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
126531096|NCT04162769|455235364|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
126531097|NCT04162769|455235365|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
126531098|NCT04162769|455235362|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
126531099|NCT04162769|455235363|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
126531100|NCT04162769|455235364|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
126531101|NCT04162769|455235365|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
126531102|NCT04162769|455235362|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
126531103|NCT04162769|455235363|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
126531104|NCT04162769|455235364|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
126531105|NCT04162769|455235365|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
126531106|NCT04162769|455235362|FG000|Double-blind Treatment (12-Week)|Other|0|||
126531107|NCT04162769|455235363|FG001|Double-blind Treatment (12-Week)|Other|1|||
126531108|NCT04162769|455235364|FG002|Double-blind Treatment (12-Week)|Other|1|||
126531109|NCT04162769|455235365|FG003|Double-blind Treatment (12-Week)|Other|0|||
126531110|NCT04162769|455235362|FG000|OLE Period (52-Week)|Adverse Event|0|||
126531111|NCT04162769|455235363|FG001|OLE Period (52-Week)|Adverse Event|0|||
126531112|NCT04162769|455235364|FG002|OLE Period (52-Week)|Adverse Event|0|||
126531113|NCT04162769|455235365|FG003|OLE Period (52-Week)|Adverse Event|5|||
126531114|NCT04162769|455235362|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
126531115|NCT04162769|455235363|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
126531116|NCT04162769|455235364|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
126531117|NCT04162769|455235365|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
126531118|NCT04162769|455235362|FG000|OLE Period (52-Week)|Physician Decision|0|||
126531119|NCT04162769|455235363|FG001|OLE Period (52-Week)|Physician Decision|0|||
126531120|NCT04162769|455235364|FG002|OLE Period (52-Week)|Physician Decision|0|||
126531121|NCT04162769|455235365|FG003|OLE Period (52-Week)|Physician Decision|1|||
126531122|NCT04162769|455235362|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
126531123|NCT04162769|455235363|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
126531124|NCT04162769|455235364|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
126531125|NCT04162769|455235365|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
126531126|NCT04162769|455235362|FG000|OLE Period (52-Week)|Protocol deviation|0|||
126531127|NCT04162769|455235363|FG001|OLE Period (52-Week)|Protocol deviation|0|||
126531128|NCT04162769|455235364|FG002|OLE Period (52-Week)|Protocol deviation|0|||
126531129|NCT04162769|455235365|FG003|OLE Period (52-Week)|Protocol deviation|2|||
126531130|NCT00476476|455235371|FG000|Overall Study|Adverse Event|2|||
126531131|NCT00476476|455235372|FG001|Overall Study|Adverse Event|7|||
126531132|NCT00476476|455235371|FG000|Overall Study|Progressive Disease|0|||
126777156|NCT01113710|456141302|FG000|Overall Study|Lost to Follow-up|20|||
126531133|NCT00476476|455235372|FG001|Overall Study|Progressive Disease|17|||
126531134|NCT00971048|455235380|FG000|Overall Study|Protocol Violation|1|||
126531135|NCT00971048|455235381|FG001|Overall Study|Protocol Violation|2|||
126531136|NCT00971048|455235382|FG002|Overall Study|Protocol Violation|0|||
126531137|NCT00971048|455235383|FG003|Overall Study|Protocol Violation|1|||
126531138|NCT00971048|455235380|FG000|Overall Study|Adverse Event|0|||
126531139|NCT00971048|455235381|FG001|Overall Study|Adverse Event|0|||
126531140|NCT00971048|455235382|FG002|Overall Study|Adverse Event|1|||
126531141|NCT00971048|455235383|FG003|Overall Study|Adverse Event|0|||
126531142|NCT00971048|455235380|FG000|Overall Study|Physician Decision|0|||
126531143|NCT00971048|455235381|FG001|Overall Study|Physician Decision|0|||
126531144|NCT00971048|455235382|FG002|Overall Study|Physician Decision|0|||
126531145|NCT00971048|455235383|FG003|Overall Study|Physician Decision|1|||
126531146|NCT01540851|455235388|FG000|Overall Study|Lost to Follow-up|14|||
126531147|NCT01540851|455235389|FG001|Overall Study|Lost to Follow-up|15|||
126531148|NCT01540851|455235388|FG000|Overall Study|Withdrawal by Subject|7|||
126531149|NCT01540851|455235389|FG001|Overall Study|Withdrawal by Subject|3|||
126531150|NCT00224874|455235392|FG000|Overall Study|Withdrawal by Subject|0|||
126531151|NCT00224874|455235393|FG001|Overall Study|Withdrawal by Subject|0|||
126531152|NCT00224874|455235394|FG002|Overall Study|Withdrawal by Subject|1|||
126531153|NCT00224874|455235395|FG003|Overall Study|Withdrawal by Subject|0|||
126531154|NCT02633137|455235396|FG000|Overall Study|Adverse Event|1|||
126531155|NCT02633137|455235396|FG000|Overall Study|Lack of Efficacy|2|||
126531156|NCT02633137|455235396|FG000|Overall Study|Withdrawal by Subject|1|||
126531157|NCT01324271|455235397|FG000|Overall Study|Lost to Follow-up|3|||
126531158|NCT01324271|455235398|FG001|Overall Study|Lost to Follow-up|0|||
126531159|NCT01324271|455235397|FG000|Overall Study|Physician Decision|1|||
126531160|NCT01324271|455235398|FG001|Overall Study|Physician Decision|0|||
126531161|NCT05130970|455235399|FG000|Overall Study|Adverse Event|1|||
126531162|NCT05130970|455235400|FG001|Overall Study|Adverse Event|1|||
126531163|NCT05130970|455235399|FG000|Overall Study|Death|0|||
126531164|NCT05130970|455235400|FG001|Overall Study|Death|1|||
126531165|NCT05130970|455235399|FG000|Overall Study|Lost to Follow-up|0|||
126531166|NCT05130970|455235400|FG001|Overall Study|Lost to Follow-up|1|||
126531167|NCT05130970|455235399|FG000|Overall Study|Physician Decision|0|||
126531168|NCT05130970|455235400|FG001|Overall Study|Physician Decision|1|||
126531169|NCT05130970|455235399|FG000|Overall Study|Withdrawal by Subject|1|||
126531170|NCT05130970|455235400|FG001|Overall Study|Withdrawal by Subject|1|||
126531171|NCT03996473|455235401|FG000|Treatment Assignment|Withdrawal by Subject|1|||
126531172|NCT03996473|455235401|FG000|Treatment Assignment|Progressive disease|6|||
126531173|NCT03996473|455235401|FG000|Treatment Assignment|Study drug never administered|1|||
126531174|NCT03996473|455235401|FG000|Active Follow-up|Death|1|||
126531175|NCT03996473|455235401|FG000|Long-term Follow-up|Death|5|||
126531176|NCT06116591|455235402|FG000|Overall Study|No longer met eligibility criteria|0|||
126531177|NCT06116591|455235403|FG001|Overall Study|No longer met eligibility criteria|1|||
126531178|NCT06116591|455235402|FG000|Overall Study|Other: Change in life situation|0|||
126531179|NCT06116591|455235403|FG001|Overall Study|Other: Change in life situation|1|||
126531180|NCT03644186|455235404|FG000|Overall Study|Withdrawal by Subject|1|||
126531181|NCT03644186|455235405|FG001|Overall Study|Withdrawal by Subject|1|||
126531182|NCT02192502|455235407|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
126531183|NCT02192502|455235408|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
126531184|NCT02192502|455235407|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
126531185|NCT02192502|455235408|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
126531186|NCT02192502|455235407|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
126531187|NCT02192502|455235408|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
126531188|NCT01869491|455235409|FG000|Overall Study|Adverse Event|3|||
126531189|NCT01869491|455235410|FG001|Overall Study|Adverse Event|5|||
126531190|NCT01869491|455235409|FG000|Overall Study|Lack of Efficacy|0|||
126531191|NCT01869491|455235410|FG001|Overall Study|Lack of Efficacy|3|||
126531192|NCT01869491|455235409|FG000|Overall Study|Withdrawal by Subject|6|||
126531193|NCT01869491|455235410|FG001|Overall Study|Withdrawal by Subject|7|||
126531194|NCT01869491|455235409|FG000|Overall Study|Lost to Follow-up|11|||
126531195|NCT01869491|455235410|FG001|Overall Study|Lost to Follow-up|9|||
126531196|NCT01869491|455235409|FG000|Overall Study|No further need of investigational product|1|||
126531197|NCT01869491|455235410|FG001|Overall Study|No further need of investigational product|0|||
126531198|NCT05553808|455235411|FG000|Overall Study|Death|25|||
126531199|NCT05553808|455235412|FG001|Overall Study|Death|62|||
126531200|NCT05553808|455235411|FG000|Overall Study|Site Closed|6|||
126531201|NCT05553808|455235412|FG001|Overall Study|Site Closed|6|||
126531202|NCT05553808|455235411|FG000|Overall Study|Lost to Follow-up|1|||
126531203|NCT05553808|455235412|FG001|Overall Study|Lost to Follow-up|0|||
126531204|NCT05553808|455235411|FG000|Overall Study|Withdrawal by Subject|3|||
126531205|NCT05553808|455235412|FG001|Overall Study|Withdrawal by Subject|2|||
126531206|NCT02308748|455235413|FG000|Period 1|Withdrawal by Subject|0|||
126531207|NCT02308748|455235414|FG001|Period 1|Withdrawal by Subject|0|||
126531208|NCT02308748|455235415|FG002|Period 1|Withdrawal by Subject|1|||
126531209|NCT02308748|455235416|FG003|Period 1|Withdrawal by Subject|0|||
126531210|NCT02308748|455235417|FG004|Period 1|Withdrawal by Subject|0|||
126531211|NCT02308748|455235418|FG005|Period 1|Withdrawal by Subject|0|||
126531212|NCT02308748|455235419|FG006|Period 1|Withdrawal by Subject|0|||
126531213|NCT02308748|455235420|FG007|Period 1|Withdrawal by Subject|0|||
126531214|NCT02308748|455235421|FG008|Period 1|Withdrawal by Subject|0|||
126531215|NCT02308748|455235422|FG009|Period 1|Withdrawal by Subject|0|||
126531216|NCT02308748|455235413|FG000|Period 2|Adverse Event|0|||
126531217|NCT02308748|455235414|FG001|Period 2|Adverse Event|0|||
126531218|NCT02308748|455235415|FG002|Period 2|Adverse Event|0|||
126531219|NCT02308748|455235416|FG003|Period 2|Adverse Event|0|||
126531220|NCT02308748|455235417|FG004|Period 2|Adverse Event|0|||
126531221|NCT02308748|455235418|FG005|Period 2|Adverse Event|0|||
126531222|NCT02308748|455235419|FG006|Period 2|Adverse Event|0|||
126581474|NCT01898494|455425758|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
126581475|NCT01898494|455425759|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
126581476|NCT01898494|455425760|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
126581477|NCT01898494|455425761|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
126581478|NCT01898494|455425762|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
126581479|NCT01898494|455425758|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
126581480|NCT01898494|455425759|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
126581481|NCT01898494|455425760|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
126581482|NCT01898494|455425761|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
126581483|NCT01898494|455425762|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
126581484|NCT01898494|455425758|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
126581485|NCT01898494|455425759|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
126581486|NCT01898494|455425760|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
126581487|NCT01898494|455425761|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
126581488|NCT01898494|455425762|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
126581489|NCT01898494|455425758|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
126581490|NCT01898494|455425759|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
126581491|NCT01898494|455425760|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
126581492|NCT01898494|455425761|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
126581493|NCT01898494|455425762|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
126581494|NCT01898494|455425758|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
126581495|NCT01898494|455425759|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
126581496|NCT01898494|455425760|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
126581497|NCT01898494|455425761|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
126581498|NCT01898494|455425762|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
126581499|NCT01898494|455425758|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
126581500|NCT01898494|455425759|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
126581501|NCT01898494|455425760|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
126581502|NCT01898494|455425761|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
126581503|NCT01898494|455425762|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
126581504|NCT01898494|455425758|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
126581505|NCT01898494|455425759|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
126581506|NCT01898494|455425760|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
126581507|NCT01898494|455425761|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
126581508|NCT01898494|455425762|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
126581509|NCT01898494|455425758|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
126581510|NCT01898494|455425759|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
126581511|NCT01898494|455425760|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
126581512|NCT01898494|455425761|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
126581513|NCT01898494|455425762|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
126581514|NCT01898494|455425758|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
126581515|NCT01898494|455425759|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
126581516|NCT01898494|455425760|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
126581517|NCT01898494|455425761|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
126581518|NCT01898494|455425762|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
126581519|NCT01898494|455425758|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
126581520|NCT01898494|455425759|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
126581521|NCT01898494|455425760|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
126581522|NCT01898494|455425761|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
126581523|NCT01898494|455425762|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
126581524|NCT01718743|455425763|FG000|Overall Study|Physician Decision|7|||
126581525|NCT01718743|455425763|FG000|Overall Study|Withdrawal by Subject|14|||
126581526|NCT01718743|455425763|FG000|Overall Study|Progressive Disease|22|||
126729378|NCT03363919|455958393|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
126729379|NCT03363919|455958394|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
126729380|NCT03363919|455958393|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
126729381|NCT03363919|455958394|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
126729382|NCT01646398|455958395|FG000|Overall Study|Withdrawal by Subject|1|||
126729383|NCT01646398|455958396|FG001|Overall Study|Withdrawal by Subject|0|||
126581527|NCT01718743|455425763|FG000|Overall Study|Toxicity|1|||
126581528|NCT01718743|455425763|FG000|Overall Study|Malignancy|1|||
126581529|NCT04905407|455425767|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
126581530|NCT04905407|455425768|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
126729384|NCT00255034|455958397|FG000|Overall Study|Withdrawal by Subject|15|||
126729385|NCT00255034|455958398|FG001|Overall Study|Withdrawal by Subject|38|||
126581531|NCT04905407|455425769|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
126581532|NCT04905407|455425770|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
126581533|NCT04905407|455425767|FG000|Part 1 and Part 2|Death|7|||
126581534|NCT04905407|455425768|FG001|Part 1 and Part 2|Death|7|||
126581535|NCT04905407|455425769|FG002|Part 1 and Part 2|Death|7|||
126729386|NCT00574119|455958399|FG000|Overall Study|Adverse Event|1|||
126531223|NCT02308748|455235420|FG007|Period 2|Adverse Event|1|||
126531224|NCT02308748|455235421|FG008|Period 2|Adverse Event|0|||
126531225|NCT02308748|455235422|FG009|Period 2|Adverse Event|0|||
126531226|NCT02308748|455235413|FG000|Period 3|Protocol Violation|0|||
126531227|NCT02308748|455235414|FG001|Period 3|Protocol Violation|0|||
126531228|NCT02308748|455235415|FG002|Period 3|Protocol Violation|0|||
126531229|NCT02308748|455235416|FG003|Period 3|Protocol Violation|0|||
126531230|NCT02308748|455235417|FG004|Period 3|Protocol Violation|0|||
126531231|NCT02308748|455235418|FG005|Period 3|Protocol Violation|0|||
126531232|NCT02308748|455235419|FG006|Period 3|Protocol Violation|0|||
126531233|NCT02308748|455235420|FG007|Period 3|Protocol Violation|0|||
126531234|NCT02308748|455235421|FG008|Period 3|Protocol Violation|0|||
126531235|NCT02308748|455235422|FG009|Period 3|Protocol Violation|1|||
126531236|NCT02308748|455235413|FG000|Period 5|Adverse Event|1|||
126531237|NCT02308748|455235414|FG001|Period 5|Adverse Event|0|||
126531238|NCT02308748|455235415|FG002|Period 5|Adverse Event|0|||
126531239|NCT02308748|455235416|FG003|Period 5|Adverse Event|0|||
126531240|NCT02308748|455235417|FG004|Period 5|Adverse Event|0|||
126531241|NCT02308748|455235418|FG005|Period 5|Adverse Event|0|||
126531242|NCT02308748|455235419|FG006|Period 5|Adverse Event|0|||
126531243|NCT02308748|455235420|FG007|Period 5|Adverse Event|0|||
126531244|NCT02308748|455235421|FG008|Period 5|Adverse Event|1|||
126531245|NCT02308748|455235422|FG009|Period 5|Adverse Event|0|||
126531246|NCT00808808|455235428|FG000|Overall Study|Vaccinated; survey not completed|131|||
126531247|NCT00808808|455235429|FG001|Overall Study|Vaccinated; survey not completed|169|||
126531248|NCT00808808|455235430|FG002|Overall Study|Vaccinated; survey not completed|302|||
126531249|NCT00808808|455235428|FG000|Overall Study|Employee was not vaccinated.|2686|||
126531250|NCT00808808|455235429|FG001|Overall Study|Employee was not vaccinated.|2268|||
126531251|NCT00808808|455235430|FG002|Overall Study|Employee was not vaccinated.|2255|||
126531252|NCT00490646|455235432|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
126531253|NCT00490646|455235433|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
126531254|NCT00490646|455235432|FG000|Overall Study|Never Treated (had an adverse event)|1|||
126531255|NCT00490646|455235433|FG001|Overall Study|Never Treated (had an adverse event)|0|||
126531256|NCT00490646|455235432|FG000|Overall Study|Never Treated (withdrew consent)|0|||
126531257|NCT00490646|455235433|FG001|Overall Study|Never Treated (withdrew consent)|1|||
126531258|NCT01178086|455235434|FG000|Overall Study|Participant refusal|7|||
126531259|NCT01178086|455235434|FG000|Overall Study|Physician Decision|44|||
126531260|NCT01178086|455235434|FG000|Overall Study|Switch to other CLL therapy|113|||
126531261|NCT01178086|455235434|FG000|Overall Study|Death|59|||
126531262|NCT01178086|455235434|FG000|Overall Study|Other unspecified|89|||
126531263|NCT01178086|455235434|FG000|Overall Study|Excluded from EAS|20|||
126531264|NCT01669122|455235435|FG000|Period I|Lost to Follow-up|1|||
126531265|NCT01669122|455235435|FG000|Washout Period II|Protocol Violation|2|||
126531266|NCT00234065|455235436|FG000|Overall Study|Adverse Event|268|||
126531267|NCT00234065|455235437|FG001|Overall Study|Adverse Event|166|||
126531268|NCT00234065|455235436|FG000|Overall Study|Withdrawal by Subject|73|||
126531269|NCT00234065|455235437|FG001|Overall Study|Withdrawal by Subject|56|||
126531270|NCT00234065|455235436|FG000|Overall Study|Physician Decision|23|||
126531271|NCT00234065|455235437|FG001|Overall Study|Physician Decision|22|||
126531272|NCT00234065|455235436|FG000|Overall Study|Not Classified|111|||
126531273|NCT00234065|455235437|FG001|Overall Study|Not Classified|112|||
126531274|NCT02313428|455235438|FG000|Overall Study|Lost to Follow-up|1|||
126531275|NCT02313428|455235439|FG001|Overall Study|Lost to Follow-up|1|||
126531276|NCT05132699|455235440|FG000|Overall Study|Withdrawal by Subject|3|||
126729387|NCT00574119|455958399|FG000|Overall Study|Protocol Violation|1|||
126729388|NCT00574119|455958399|FG000|Overall Study|Withdrawal by Subject|1|||
126531277|NCT05132699|455235441|FG001|Overall Study|Withdrawal by Subject|0|||
126531278|NCT02899728|455235442|FG000|Overall Study|Withdrawal by Subject|1|||
126531279|NCT02899728|455235443|FG001|Overall Study|Withdrawal by Subject|1|||
126531280|NCT05557942|455235444|FG000|Overall Study|Death|0|||
126531281|NCT05557942|455235445|FG001|Overall Study|Death|0|||
126531282|NCT05557942|455235446|FG002|Overall Study|Death|0|||
126531283|NCT05557942|455235447|FG003|Overall Study|Death|2|||
126531284|NCT05557942|455235448|FG004|Overall Study|Death|1|||
126531285|NCT05557942|455235449|FG005|Overall Study|Death|1|||
126531286|NCT05557942|455235444|FG000|Overall Study|Physician Decision|1|||
126729389|NCT00574119|455958399|FG000|Overall Study|Physician Decision|1|||
126729390|NCT03434418|455958400|FG000|Overall Study|Disease Progression|11|||
126531287|NCT05557942|455235445|FG001|Overall Study|Physician Decision|1|||
126531288|NCT05557942|455235446|FG002|Overall Study|Physician Decision|2|||
126531289|NCT05557942|455235447|FG003|Overall Study|Physician Decision|3|||
126531290|NCT05557942|455235448|FG004|Overall Study|Physician Decision|0|||
126531291|NCT05557942|455235449|FG005|Overall Study|Physician Decision|2|||
126531292|NCT05557942|455235444|FG000|Overall Study|Study terminated by sponsor|17|||
126531293|NCT05557942|455235445|FG001|Overall Study|Study terminated by sponsor|17|||
126531294|NCT05557942|455235446|FG002|Overall Study|Study terminated by sponsor|14|||
126531295|NCT05557942|455235447|FG003|Overall Study|Study terminated by sponsor|40|||
126531296|NCT05557942|455235448|FG004|Overall Study|Study terminated by sponsor|45|||
126581536|NCT04905407|455425770|FG003|Part 1 and Part 2|Death|0|||
126729391|NCT03434418|455958400|FG000|Overall Study|Adverse Event|2|||
126729392|NCT03434418|455958400|FG000|Overall Study|Physician Decision|1|||
126729393|NCT03434418|455958400|FG000|Overall Study|Decline in Performance Status (PS)|1|||
126729394|NCT00912340|455958403|FG000|Overall Study|Adverse Event|2|||
126729395|NCT00912340|455958404|FG001|Overall Study|Adverse Event|4|||
126729396|NCT00912340|455958405|FG002|Overall Study|Adverse Event|0|||
126729397|NCT00912340|455958403|FG000|Overall Study|Protocol revised to remove arm|0|||
126729398|NCT00912340|455958404|FG001|Overall Study|Protocol revised to remove arm|0|||
126729399|NCT00912340|455958405|FG002|Overall Study|Protocol revised to remove arm|4|||
126729400|NCT01517412|455958406|FG000|Overall Study|Adverse Event|10|||
126729401|NCT01517412|455958407|FG001|Overall Study|Adverse Event|11|||
126729402|NCT01517412|455958406|FG000|Overall Study|Lack of Efficacy|10|||
126729403|NCT01517412|455958407|FG001|Overall Study|Lack of Efficacy|5|||
126729404|NCT01517412|455958406|FG000|Overall Study|Poor compliance to protocol|8|||
126777157|NCT01113710|456141302|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
126777158|NCT01113710|456141302|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
126777159|NCT01113710|456141302|FG000|Overall Study|Lack of Patient's Compliance|8|||
126777160|NCT01113710|456141302|FG000|Overall Study|Other|7|||
126777161|NCT01113710|456141302|FG000|Overall Study|Adverse Event/Other|5|||
126777162|NCT01113710|456141302|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
126777163|NCT01113710|456141302|FG000|Overall Study|Lack of Efficacy/Other|4|||
126777164|NCT01113710|456141302|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
126777165|NCT01113710|456141302|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
126777166|NCT01113710|456141302|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
126777167|NCT01113710|456141302|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
126777168|NCT01113710|456141302|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
126777169|NCT01113710|456141302|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
126777170|NCT01113710|456141302|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
126777171|NCT01113710|456141302|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
126777172|NCT01113710|456141302|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
126777173|NCT01113710|456141302|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
126777174|NCT01113710|456141302|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
126777175|NCT01113710|456141302|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
126777176|NCT01113710|456141302|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
126777177|NCT00693784|456141303|FG000|Overall Study|Lost to Follow-up|2|||
126777178|NCT00693784|456141303|FG000|Overall Study|Withdrawal by Subject|2|||
126777179|NCT00326885|456141305|FG000|Overall Study|Adverse Event|1|||
126777180|NCT00326885|456141305|FG000|Overall Study|Withdrawal by Subject|3|||
126777181|NCT00326885|456141305|FG000|Overall Study|Physician Decision|1|||
126777182|NCT00326885|456141305|FG000|Overall Study|Hospice withdrew consent|2|||
126777183|NCT01473758|456141306|FG000|Cycle 1|Adverse Event|10|||
126777184|NCT01473758|456141307|FG001|Cycle 1|Adverse Event|2|||
126777185|NCT01473758|456141308|FG002|Cycle 1|Adverse Event|0|||
126777186|NCT01473758|456141309|FG003|Cycle 1|Adverse Event|0|||
126777187|NCT01473758|456141306|FG000|Cycle 1|Withdrawal by Subject|1|||
126777188|NCT01473758|456141307|FG001|Cycle 1|Withdrawal by Subject|1|||
126777189|NCT01473758|456141308|FG002|Cycle 1|Withdrawal by Subject|0|||
126777190|NCT01473758|456141309|FG003|Cycle 1|Withdrawal by Subject|0|||
126777191|NCT01473758|456141306|FG000|Cycle 2|Adverse Event|0|||
126777192|NCT01473758|456141307|FG001|Cycle 2|Adverse Event|0|||
126777193|NCT01473758|456141308|FG002|Cycle 2|Adverse Event|5|||
126777194|NCT01473758|456141309|FG003|Cycle 2|Adverse Event|0|||
126777195|NCT01677910|456141310|FG000|Double-Blind Treatment Period|Adverse Event|6|||
126777196|NCT01677910|456141311|FG001|Double-Blind Treatment Period|Adverse Event|2|||
126777197|NCT01677910|456141312|FG002|Double-Blind Treatment Period|Adverse Event|3|||
126777198|NCT01677910|456141313|FG003|Double-Blind Treatment Period|Adverse Event|0|||
126777199|NCT01677910|456141310|FG000|Double-Blind Treatment Period|Physician Decision|0|||
126777200|NCT01677910|456141311|FG001|Double-Blind Treatment Period|Physician Decision|0|||
126777201|NCT01677910|456141312|FG002|Double-Blind Treatment Period|Physician Decision|1|||
126777202|NCT01677910|456141313|FG003|Double-Blind Treatment Period|Physician Decision|0|||
126777203|NCT01677910|456141310|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
126777204|NCT01677910|456141311|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
126777205|NCT01677910|456141312|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
126777206|NCT01677910|456141313|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
126777207|NCT01677910|456141310|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
126777208|NCT01677910|456141311|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
126777209|NCT01677910|456141312|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
126777210|NCT01677910|456141313|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
126777211|NCT01677910|456141310|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
126777212|NCT01677910|456141311|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
126777213|NCT01677910|456141312|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
126777214|NCT01677910|456141313|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
126729405|NCT01517412|455958407|FG001|Overall Study|Poor compliance to protocol|3|||
126581537|NCT04905407|455425767|FG000|Part 1 and Part 2|Other than specified|0|||
126581538|NCT04905407|455425768|FG001|Part 1 and Part 2|Other than specified|0|||
126581539|NCT04905407|455425769|FG002|Part 1 and Part 2|Other than specified|1|||
126581540|NCT04905407|455425770|FG003|Part 1 and Part 2|Other than specified|0|||
126581541|NCT04905407|455425767|FG000|Part 3|Death|0|||
126581542|NCT04905407|455425768|FG001|Part 3|Death|0|||
126581543|NCT04905407|455425769|FG002|Part 3|Death|0|||
126581544|NCT04905407|455425770|FG003|Part 3|Death|2|||
126581545|NCT03263026|455425773|FG000|Overall Study|Withdrawal by Subject|1|||
126581546|NCT03263026|455425774|FG001|Overall Study|Withdrawal by Subject|0|||
126581547|NCT03263026|455425773|FG000|Overall Study|Death|1|||
126581548|NCT03263026|455425774|FG001|Overall Study|Death|0|||
126581549|NCT03263026|455425773|FG000|Overall Study|Other/ Various|41|||
126581550|NCT03263026|455425774|FG001|Overall Study|Other/ Various|29|||
126581551|NCT03739996|455425775|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
126581552|NCT03739996|455425775|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
126581553|NCT03739996|455425775|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
126581554|NCT03739996|455425775|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
126581555|NCT03739996|455425775|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
126581556|NCT03739996|455425775|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
126581557|NCT03739996|455425775|FG000|Step 3 (SOC ART)|Death|1|||
126581558|NCT03739996|455425775|FG000|Step 3 (SOC ART)|Participant moved|1|||
126581559|NCT01673984|455425776|FG000|Overall Study|Adverse Event|1|||
126581560|NCT01673984|455425777|FG001|Overall Study|Adverse Event|0|||
126581561|NCT01673984|455425776|FG000|Overall Study|Study termination|9|||
126581562|NCT01673984|455425777|FG001|Overall Study|Study termination|6|||
126581563|NCT02553642|455425778|FG000|Overall Study|Withdrawal by Subject|0|||
126581564|NCT02553642|455425779|FG001|Overall Study|Withdrawal by Subject|3|||
126581565|NCT02553642|455425778|FG000|Overall Study|Physician Decision|0|||
126581566|NCT02553642|455425779|FG001|Overall Study|Physician Decision|1|||
126581567|NCT02553642|455425778|FG000|Overall Study|Additional cancer dx|0|||
126581568|NCT02553642|455425779|FG001|Overall Study|Additional cancer dx|1|||
126581569|NCT02553642|455425778|FG000|Overall Study|Never started treatment|0|||
126581570|NCT02553642|455425779|FG001|Overall Study|Never started treatment|1|||
126581571|NCT00894543|455425782|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
126581572|NCT00894543|455425783|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
126581573|NCT00894543|455425782|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
126581574|NCT00894543|455425783|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
126581575|NCT02697136|455425784|FG000|Overall Study|Adverse Event|3|||
126581576|NCT02697136|455425785|FG001|Overall Study|Adverse Event|0|||
126581577|NCT05198310|455425788|FG000|Overall Study|Lost to Follow-up|0|||
126581578|NCT05198310|455425789|FG001|Overall Study|Lost to Follow-up|1|||
126581579|NCT05198310|455425790|FG002|Overall Study|Lost to Follow-up|0|||
126581580|NCT05198310|455425791|FG003|Overall Study|Lost to Follow-up|0|||
126581581|NCT05198310|455425792|FG004|Overall Study|Lost to Follow-up|0|||
126581582|NCT05198310|455425793|FG005|Overall Study|Lost to Follow-up|0|||
126581583|NCT05198310|455425794|FG006|Overall Study|Lost to Follow-up|0|||
126581584|NCT05198310|455425795|FG007|Overall Study|Lost to Follow-up|0|||
126581585|NCT05198310|455425788|FG000|Overall Study|Withdrawal by Subject|0|||
126531297|NCT05557942|455235449|FG005|Overall Study|Study terminated by sponsor|37|||
126531298|NCT05557942|455235444|FG000|Overall Study|Protocol Violation|0|||
126531299|NCT05557942|455235445|FG001|Overall Study|Protocol Violation|0|||
126531300|NCT05557942|455235446|FG002|Overall Study|Protocol Violation|0|||
126531301|NCT05557942|455235447|FG003|Overall Study|Protocol Violation|0|||
126531302|NCT05557942|455235448|FG004|Overall Study|Protocol Violation|0|||
126531303|NCT05557942|455235449|FG005|Overall Study|Protocol Violation|1|||
126531304|NCT05557942|455235444|FG000|Overall Study|Withdrawal by Subject|0|||
126531305|NCT05557942|455235445|FG001|Overall Study|Withdrawal by Subject|0|||
126531306|NCT05557942|455235446|FG002|Overall Study|Withdrawal by Subject|0|||
126531307|NCT05557942|455235447|FG003|Overall Study|Withdrawal by Subject|0|||
126531308|NCT05557942|455235448|FG004|Overall Study|Withdrawal by Subject|2|||
126531309|NCT05557942|455235449|FG005|Overall Study|Withdrawal by Subject|0|||
126531310|NCT02477618|455235450|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
126531311|NCT02477618|455235451|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
126581586|NCT05198310|455425789|FG001|Overall Study|Withdrawal by Subject|0|||
126581587|NCT05198310|455425790|FG002|Overall Study|Withdrawal by Subject|0|||
126581588|NCT05198310|455425791|FG003|Overall Study|Withdrawal by Subject|2|||
126581589|NCT05198310|455425792|FG004|Overall Study|Withdrawal by Subject|0|||
126581590|NCT05198310|455425793|FG005|Overall Study|Withdrawal by Subject|2|||
126581591|NCT05198310|455425794|FG006|Overall Study|Withdrawal by Subject|1|||
126581592|NCT05198310|455425795|FG007|Overall Study|Withdrawal by Subject|3|||
126581593|NCT01095796|455425796|FG000|Overall Study|Randomized but Not Treated|5|||
126581594|NCT01095796|455425797|FG001|Overall Study|Randomized but Not Treated|2|||
126581595|NCT01095796|455425796|FG000|Overall Study|Adverse Event|9|||
126531312|NCT02477618|455235450|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
126531313|NCT02477618|455235451|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
126729406|NCT01517412|455958406|FG000|Overall Study|Other than specified above|8|||
126729407|NCT01517412|455958407|FG001|Overall Study|Other than specified above|5|||
126729408|NCT01956240|455958410|FG000|Overall Study|Lost to Follow-up|6|||
126729409|NCT01956240|455958411|FG001|Overall Study|Lost to Follow-up|20|||
126729410|NCT01956240|455958410|FG000|Overall Study|Adverse Event|17|||
126729411|NCT01956240|455958411|FG001|Overall Study|Adverse Event|4|||
126729412|NCT00600028|455958414|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
126729413|NCT00600028|455958415|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
126729414|NCT00600028|455958414|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
126729415|NCT00600028|455958415|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
126729416|NCT00600028|455958414|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
126729417|NCT00600028|455958415|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
126729418|NCT01830816|455958419|FG000|Overall Study|Progressive Disease|12|||
126729419|NCT01830816|455958420|FG001|Overall Study|Progressive Disease|7|||
126729420|NCT01830816|455958421|FG002|Overall Study|Progressive Disease|7|||
126729421|NCT01830816|455958419|FG000|Overall Study|Adverse Event|3|||
126729422|NCT01830816|455958420|FG001|Overall Study|Adverse Event|4|||
126729423|NCT01830816|455958421|FG002|Overall Study|Adverse Event|0|||
126729424|NCT01830816|455958419|FG000|Overall Study|Study Terminated by Sponsor|1|||
126729425|NCT01830816|455958420|FG001|Overall Study|Study Terminated by Sponsor|1|||
126729426|NCT01830816|455958421|FG002|Overall Study|Study Terminated by Sponsor|0|||
126729427|NCT01830816|455958419|FG000|Overall Study|Withdrawal by Subject|1|||
126729428|NCT01830816|455958420|FG001|Overall Study|Withdrawal by Subject|1|||
126729429|NCT01830816|455958421|FG002|Overall Study|Withdrawal by Subject|0|||
126729430|NCT01830816|455958419|FG000|Overall Study|Lost to Follow-up|0|||
126729431|NCT01830816|455958420|FG001|Overall Study|Lost to Follow-up|1|||
126729432|NCT01830816|455958421|FG002|Overall Study|Lost to Follow-up|0|||
126729433|NCT01830816|455958419|FG000|Overall Study|Symptomatic Deterioration|1|||
126729434|NCT01830816|455958420|FG001|Overall Study|Symptomatic Deterioration|0|||
126729435|NCT01830816|455958421|FG002|Overall Study|Symptomatic Deterioration|0|||
126729436|NCT01830816|455958419|FG000|Overall Study|Reason not Specified|2|||
126729437|NCT01830816|455958420|FG001|Overall Study|Reason not Specified|0|||
126729438|NCT01830816|455958421|FG002|Overall Study|Reason not Specified|0|||
126729439|NCT03115112|455958431|FG000|Overall Study|Adverse Event|5|||
126729440|NCT03115112|455958432|FG001|Overall Study|Adverse Event|1|||
126729441|NCT03115112|455958431|FG000|Overall Study|Withdrawal by Subject|4|||
126729442|NCT03115112|455958432|FG001|Overall Study|Withdrawal by Subject|2|||
126729443|NCT03115112|455958431|FG000|Overall Study|Lost to Follow-up|0|||
126729444|NCT03115112|455958432|FG001|Overall Study|Lost to Follow-up|1|||
126729445|NCT03115112|455958431|FG000|Overall Study|Death|1|||
126729446|NCT03115112|455958432|FG001|Overall Study|Death|0|||
126729447|NCT03115112|455958431|FG000|Overall Study|Pregnancy|1|||
126729448|NCT03115112|455958432|FG001|Overall Study|Pregnancy|0|||
126729449|NCT03115112|455958431|FG000|Overall Study|Site closure|1|||
126729450|NCT03115112|455958432|FG001|Overall Study|Site closure|1|||
126729451|NCT04019795|455958433|FG000|Overall Study|Withdrawal by Subject|1|||
126729452|NCT04019795|455958434|FG001|Overall Study|Withdrawal by Subject|2|||
126729453|NCT04019795|455958435|FG002|Overall Study|Withdrawal by Subject|2|||
126729454|NCT04019795|455958436|FG003|Overall Study|Withdrawal by Subject|1|||
126729455|NCT04019795|455958433|FG000|Overall Study|Lost to Follow-up|0|||
126729456|NCT04019795|455958434|FG001|Overall Study|Lost to Follow-up|1|||
126729457|NCT04019795|455958435|FG002|Overall Study|Lost to Follow-up|1|||
126729458|NCT04019795|455958436|FG003|Overall Study|Lost to Follow-up|2|||
126729459|NCT04019795|455958433|FG000|Overall Study|Treatment non-compliance|3|||
126729460|NCT04019795|455958434|FG001|Overall Study|Treatment non-compliance|1|||
126729461|NCT04019795|455958435|FG002|Overall Study|Treatment non-compliance|2|||
126729462|NCT04019795|455958436|FG003|Overall Study|Treatment non-compliance|0|||
126729463|NCT04019795|455958433|FG000|Overall Study|Physician Decision|0|||
126729464|NCT04019795|455958434|FG001|Overall Study|Physician Decision|0|||
126729465|NCT04019795|455958435|FG002|Overall Study|Physician Decision|1|||
126729466|NCT04019795|455958436|FG003|Overall Study|Physician Decision|0|||
126729467|NCT04019795|455958433|FG000|Overall Study|Adverse Event|1|||
126729468|NCT04019795|455958434|FG001|Overall Study|Adverse Event|0|||
126729469|NCT04019795|455958435|FG002|Overall Study|Adverse Event|0|||
126729470|NCT04019795|455958436|FG003|Overall Study|Adverse Event|0|||
126729471|NCT01610076|455958437|FG000|Overall Study|Technical issue with video|0|||
126729472|NCT01610076|455958438|FG001|Overall Study|Technical issue with video|1|||
126729473|NCT01610076|455958437|FG000|Overall Study|Lost to Follow-up|3|||
126729474|NCT01610076|455958438|FG001|Overall Study|Lost to Follow-up|4|||
126729475|NCT02168803|455958439|FG000|Overall Study|Lost to Follow-up|1|||
126729476|NCT02168803|455958440|FG001|Overall Study|Lost to Follow-up|0|||
126729477|NCT02168803|455958441|FG002|Overall Study|Lost to Follow-up|1|||
126729478|NCT02168803|455958439|FG000|Overall Study|Withdrawal by Subject|1|||
126729479|NCT02168803|455958440|FG001|Overall Study|Withdrawal by Subject|1|||
126729480|NCT02168803|455958441|FG002|Overall Study|Withdrawal by Subject|2|||
126729481|NCT02168803|455958439|FG000|Overall Study|Physician Decision|0|||
126729482|NCT02168803|455958440|FG001|Overall Study|Physician Decision|1|||
126729483|NCT02168803|455958441|FG002|Overall Study|Physician Decision|0|||
126729484|NCT02168803|455958439|FG000|Overall Study|Adverse Event|0|||
126729485|NCT02168803|455958440|FG001|Overall Study|Adverse Event|1|||
126729486|NCT02168803|455958441|FG002|Overall Study|Adverse Event|1|||
126729487|NCT02168803|455958439|FG000|Overall Study|Death|0|||
126729488|NCT02168803|455958440|FG001|Overall Study|Death|0|||
126729489|NCT02168803|455958441|FG002|Overall Study|Death|1|||
126729490|NCT02168803|455958439|FG000|Overall Study|Sponsor Decision|0|||
126729491|NCT02168803|455958440|FG001|Overall Study|Sponsor Decision|0|||
126729492|NCT02168803|455958441|FG002|Overall Study|Sponsor Decision|1|||
126729493|NCT01107405|455958446|FG000|Overall Study|Adverse Event|1|||
126729494|NCT01107405|455958447|FG001|Overall Study|Adverse Event|1|||
126729495|NCT01107405|455958448|FG002|Overall Study|Adverse Event|0|||
126729496|NCT01107405|455958449|FG003|Overall Study|Adverse Event|0|||
126729497|NCT01107405|455958450|FG004|Overall Study|Adverse Event|2|||
126729498|NCT01107405|455958446|FG000|Overall Study|Withdrawal by Subject|1|||
126729499|NCT01107405|455958447|FG001|Overall Study|Withdrawal by Subject|0|||
126729500|NCT01107405|455958448|FG002|Overall Study|Withdrawal by Subject|1|||
126729501|NCT01107405|455958449|FG003|Overall Study|Withdrawal by Subject|2|||
126581596|NCT01095796|455425797|FG001|Overall Study|Adverse Event|19|||
126581597|NCT01095796|455425796|FG000|Overall Study|Death|3|||
126581598|NCT01095796|455425797|FG001|Overall Study|Death|2|||
126581599|NCT01095796|455425796|FG000|Overall Study|Pregnancy|2|||
126581600|NCT01095796|455425797|FG001|Overall Study|Pregnancy|0|||
126581601|NCT01095796|455425796|FG000|Overall Study|Lack of Efficacy|5|||
126581602|NCT01095796|455425797|FG001|Overall Study|Lack of Efficacy|3|||
126581603|NCT01095796|455425796|FG000|Overall Study|Investigator's Discretion|7|||
126581604|NCT01095796|455425797|FG001|Overall Study|Investigator's Discretion|2|||
126581605|NCT01095796|455425796|FG000|Overall Study|Withdrew Consent|16|||
126581606|NCT01095796|455425797|FG001|Overall Study|Withdrew Consent|22|||
126581607|NCT01095796|455425796|FG000|Overall Study|Lost to Follow-up|27|||
126581608|NCT01095796|455425797|FG001|Overall Study|Lost to Follow-up|29|||
126581609|NCT01095796|455425796|FG000|Overall Study|Participant Noncompliance|5|||
126581610|NCT01095796|455425797|FG001|Overall Study|Participant Noncompliance|10|||
126581611|NCT01095796|455425796|FG000|Overall Study|Protocol Violation|1|||
126581612|NCT01095796|455425797|FG001|Overall Study|Protocol Violation|0|||
126581613|NCT01095796|455425796|FG000|Overall Study|Participant Transferred to Another Study|215|||
126581614|NCT01095796|455425797|FG001|Overall Study|Participant Transferred to Another Study|200|||
126581615|NCT04820686|455425799|FG000|Overall Study|Withdrawal by Subject|5|||
126581616|NCT04820686|455425800|FG001|Overall Study|Withdrawal by Subject|2|||
126581617|NCT04820686|455425801|FG002|Overall Study|Withdrawal by Subject|3|||
126581618|NCT04820686|455425799|FG000|Overall Study|Study Termination|25|||
126581619|NCT04820686|455425800|FG001|Overall Study|Study Termination|13|||
126581620|NCT04820686|455425801|FG002|Overall Study|Study Termination|14|||
126581621|NCT04820686|455425799|FG000|Overall Study|Adverse Event|0|||
126581622|NCT04820686|455425800|FG001|Overall Study|Adverse Event|1|||
126581623|NCT04820686|455425801|FG002|Overall Study|Adverse Event|0|||
126581624|NCT01424670|455425802|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
126581625|NCT01424670|455425803|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
126581626|NCT01424670|455425802|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
126581627|NCT01424670|455425803|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
126581628|NCT01424670|455425802|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
126581629|NCT01424670|455425803|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
126581630|NCT01424670|455425802|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
126581631|NCT01424670|455425803|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
126581632|NCT01424670|455425802|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
126581633|NCT01424670|455425803|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
126581634|NCT01424670|455425802|FG000|Continuation Period|Adverse Event|13|||
126581635|NCT01424670|455425803|FG001|Continuation Period|Adverse Event|5|||
126581636|NCT01424670|455425802|FG000|Continuation Period|Lost to Follow-up|2|||
126581637|NCT01424670|455425803|FG001|Continuation Period|Lost to Follow-up|0|||
126581638|NCT01424670|455425802|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
126581639|NCT01424670|455425803|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
126581640|NCT01424670|455425802|FG000|Continuation Period|Physician Decision|5|||
126581641|NCT01424670|455425803|FG001|Continuation Period|Physician Decision|4|||
126729502|NCT01107405|455958450|FG004|Overall Study|Withdrawal by Subject|1|||
126729503|NCT01107405|455958446|FG000|Overall Study|Protocol Violation|0|||
126729504|NCT01107405|455958447|FG001|Overall Study|Protocol Violation|0|||
126581642|NCT01424670|455425802|FG000|Continuation Period|Withdrawal by Subject|13|||
126581643|NCT01424670|455425803|FG001|Continuation Period|Withdrawal by Subject|4|||
126581644|NCT02891915|455425808|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
126581645|NCT02891915|455425809|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
126581646|NCT02891915|455425808|FG000|Overall Study|Withdrawal by Subject|3|||
126581647|NCT02891915|455425809|FG001|Overall Study|Withdrawal by Subject|3|||
126581648|NCT02891915|455425808|FG000|Overall Study|Became Ineligible After Enrollment|2|||
126581649|NCT02891915|455425809|FG001|Overall Study|Became Ineligible After Enrollment|1|||
126729505|NCT01107405|455958448|FG002|Overall Study|Protocol Violation|1|||
126729506|NCT01107405|455958449|FG003|Overall Study|Protocol Violation|1|||
126729507|NCT01107405|455958450|FG004|Overall Study|Protocol Violation|0|||
126729508|NCT00980343|455958451|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
126729509|NCT00980343|455958452|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
126729510|NCT02310906|455958457|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
126729511|NCT02310906|455958458|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
126729512|NCT02310906|455958459|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
126729513|NCT02310906|455958460|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
126729514|NCT02310906|455958457|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
126729515|NCT02310906|455958458|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
126729516|NCT02310906|455958459|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
126729517|NCT02310906|455958460|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
126729518|NCT02310906|455958457|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
126729519|NCT02310906|455958458|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
126729520|NCT02310906|455958459|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
126531314|NCT02477618|455235450|FG000|Overall Study|Adverse Event|1|||
126531315|NCT02477618|455235451|FG001|Overall Study|Adverse Event|1|||
126531316|NCT02477618|455235450|FG000|Overall Study|Transferred Away from Study Site|1|||
126531317|NCT02477618|455235451|FG001|Overall Study|Transferred Away from Study Site|0|||
126531318|NCT02477618|455235450|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
126531319|NCT02477618|455235451|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
126531320|NCT00936390|455235453|FG000|Overall Study|Protocol Violation|21|||
126531321|NCT00936390|455235454|FG001|Overall Study|Protocol Violation|25|||
126531322|NCT04348604|455235455|FG000|Week 8|Withdrawal by Subject|1|||
126531323|NCT04348604|455235456|FG001|Week 8|Withdrawal by Subject|1|||
126531324|NCT04348604|455235455|FG000|Week 8|Lost to Follow-up|1|||
126531325|NCT04348604|455235456|FG001|Week 8|Lost to Follow-up|2|||
126531326|NCT04348604|455235455|FG000|Week 8|Suspended|0|||
126531327|NCT04348604|455235456|FG001|Week 8|Suspended|1|||
126531328|NCT04348604|455235455|FG000|Week 12|Lost to Follow-up|1|||
126531329|NCT04348604|455235456|FG001|Week 12|Lost to Follow-up|2|||
126531330|NCT04348604|455235455|FG000|Week 12|Withdrawal by Subject|1|||
126531331|NCT04348604|455235456|FG001|Week 12|Withdrawal by Subject|0|||
126531332|NCT04348604|455235455|FG000|Week 24|Lost to Follow-up|2|||
126531333|NCT04348604|455235456|FG001|Week 24|Lost to Follow-up|1|||
126531334|NCT02097108|455235457|FG000|Overall Study|Adverse Event|1|||
126531335|NCT02097108|455235457|FG000|Overall Study|patient was abroad for 6 months|1|||
126531336|NCT01738984|455237282|FG000|Overall Study|Pregnancy|4|||
126531337|NCT01738984|455237283|FG001|Overall Study|Pregnancy|0|||
126531338|NCT01738984|455237282|FG000|Overall Study|Withdrawal by Subject|1|||
126531339|NCT01738984|455237283|FG001|Overall Study|Withdrawal by Subject|0|||
126531340|NCT01738984|455237282|FG000|Overall Study|Lost to Follow-up|59|||
126531341|NCT01738984|455237283|FG001|Overall Study|Lost to Follow-up|39|||
126531342|NCT01258608|455237288|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
126531343|NCT01258608|455237289|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
126531344|NCT01258608|455237288|FG000|Overall Study|Clinical progression|1|||
126531345|NCT01258608|455237289|FG001|Overall Study|Clinical progression|0|||
126531346|NCT01258608|455237288|FG000|Overall Study|Sponsor decision|0|||
126531347|NCT01258608|455237289|FG001|Overall Study|Sponsor decision|1|||
126531348|NCT01258608|455237288|FG000|Overall Study|Physician Decision|6|||
126531349|NCT01258608|455237289|FG001|Overall Study|Physician Decision|1|||
126531350|NCT01258608|455237288|FG000|Overall Study|Lost to Follow-up|0|||
126531351|NCT01258608|455237289|FG001|Overall Study|Lost to Follow-up|1|||
126531352|NCT01258608|455237288|FG000|Overall Study|Lack of compliance|1|||
126531353|NCT01258608|455237289|FG001|Overall Study|Lack of compliance|0|||
126531354|NCT01258608|455237288|FG000|Overall Study|Lack of Efficacy|0|||
126531355|NCT01258608|455237289|FG001|Overall Study|Lack of Efficacy|1|||
126531356|NCT01258608|455237288|FG000|Overall Study|Adverse Event|6|||
126531357|NCT01258608|455237289|FG001|Overall Study|Adverse Event|10|||
126531358|NCT01258608|455237288|FG000|Overall Study|Withdrawal by Subject|6|||
126531359|NCT01258608|455237289|FG001|Overall Study|Withdrawal by Subject|5|||
126531360|NCT02943408|455237291|FG000|Overall Study|Lost to Follow-up|7|||
126531361|NCT02943408|455237292|FG001|Overall Study|Lost to Follow-up|1|||
126531362|NCT02943408|455237291|FG000|Overall Study|Withdrawal by Subject|0|||
126531363|NCT02943408|455237292|FG001|Overall Study|Withdrawal by Subject|1|||
126531364|NCT01843192|455237293|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
126531365|NCT01843192|455237294|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
126531366|NCT01843192|455237295|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
126531367|NCT02314624|455237296|FG000|Overall Study|No participating patient|16|||
126531368|NCT02314624|455237297|FG001|Overall Study|No participating patient|13|||
126531369|NCT02314624|455237296|FG000|Overall Study|Participant withdrew|7|||
126531370|NCT02314624|455237297|FG001|Overall Study|Participant withdrew|2|||
126531371|NCT02314624|455237296|FG000|Overall Study|Lost to Follow-up|2|||
126531372|NCT02314624|455237297|FG001|Overall Study|Lost to Follow-up|5|||
126531373|NCT02314624|455237296|FG000|Overall Study|Dropped/Excluded by PI|6|||
126729521|NCT02310906|455958460|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
126729522|NCT02310906|455958457|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
126729523|NCT02310906|455958458|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
126729524|NCT02310906|455958459|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
126729525|NCT02310906|455958460|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
126729526|NCT00098020|455958467|FG000|Overall Study|Adverse Event|2|||
126729527|NCT00098020|455958467|FG000|Overall Study|Lost to Follow-up|1|||
126729528|NCT00098020|455958467|FG000|Overall Study|elevated liver enzymes|1|||
126729529|NCT00098020|455958467|FG000|Overall Study|Low urine PCR|1|||
126729530|NCT00098020|455958467|FG000|Overall Study|Low epidermal growth factor receptor|1|||
126729531|NCT01840228|455958470|FG000|Overall Study|Lost to Follow-up|1|||
126729532|NCT01840228|455958471|FG001|Overall Study|Lost to Follow-up|1|||
126729533|NCT01879319|455958479|FG000|Overall Study|Withdrawal by Subject|1|||
126729534|NCT01879319|455958480|FG001|Overall Study|Withdrawal by Subject|0|||
126729535|NCT01879319|455958479|FG000|Overall Study|Lost to Follow-up|1|||
126729536|NCT01879319|455958480|FG001|Overall Study|Lost to Follow-up|5|||
126729537|NCT01360762|455958481|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
126729538|NCT01360762|455958481|FG000|Main Study Period (12-month Treatment)|Death|5|||
126729539|NCT01360762|455958481|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
126729540|NCT01360762|455958481|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
126729541|NCT01360762|455958481|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
126729542|NCT01360762|455958481|FG000|Whole Study Period|Lost to Follow-up|10|||
126729543|NCT01360762|455958481|FG000|Whole Study Period|Death|7|||
126729544|NCT01360762|455958481|FG000|Whole Study Period|Patient relapsed|18|||
126729545|NCT01360762|455958481|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
126729546|NCT03084718|455958482|FG000|Overall Study|Withdrawal by Subject|4|||
126729547|NCT03084718|455958483|FG001|Overall Study|Withdrawal by Subject|3|||
126729548|NCT03084718|455958484|FG002|Overall Study|Withdrawal by Subject|4|||
126729549|NCT03084718|455958485|FG003|Overall Study|Withdrawal by Subject|0|||
126729550|NCT03084718|455958486|FG004|Overall Study|Withdrawal by Subject|0|||
126729551|NCT03084718|455958482|FG000|Overall Study|Physician Decision|1|||
126729552|NCT03084718|455958483|FG001|Overall Study|Physician Decision|0|||
126729553|NCT03084718|455958484|FG002|Overall Study|Physician Decision|0|||
126729554|NCT03084718|455958485|FG003|Overall Study|Physician Decision|0|||
126729555|NCT03084718|455958486|FG004|Overall Study|Physician Decision|0|||
126729556|NCT03084718|455958482|FG000|Overall Study|Adverse Event|3|||
126729557|NCT03084718|455958483|FG001|Overall Study|Adverse Event|5|||
126729558|NCT03084718|455958484|FG002|Overall Study|Adverse Event|5|||
126729559|NCT03084718|455958485|FG003|Overall Study|Adverse Event|8|||
126729560|NCT03084718|455958486|FG004|Overall Study|Adverse Event|2|||
126729561|NCT03084718|455958482|FG000|Overall Study|Lack of Efficacy|2|||
126729562|NCT03084718|455958483|FG001|Overall Study|Lack of Efficacy|0|||
126729563|NCT03084718|455958484|FG002|Overall Study|Lack of Efficacy|1|||
126729564|NCT03084718|455958485|FG003|Overall Study|Lack of Efficacy|4|||
126729565|NCT03084718|455958486|FG004|Overall Study|Lack of Efficacy|0|||
126729566|NCT03084718|455958482|FG000|Overall Study|Lost to Follow-up|0|||
126729567|NCT03084718|455958483|FG001|Overall Study|Lost to Follow-up|1|||
126729568|NCT03084718|455958484|FG002|Overall Study|Lost to Follow-up|0|||
126729569|NCT03084718|455958485|FG003|Overall Study|Lost to Follow-up|0|||
126729570|NCT03084718|455958486|FG004|Overall Study|Lost to Follow-up|2|||
126531374|NCT02314624|455237297|FG001|Overall Study|Dropped/Excluded by PI|6|||
126531375|NCT03151005|455237298|FG000|Overall Study|Lost to Follow-up|5|||
126531376|NCT03151005|455237299|FG001|Overall Study|Lost to Follow-up|5|||
126531377|NCT00605293|455237300|FG000|Overall Study|Death|2|||
126531378|NCT00605293|455237301|FG001|Overall Study|Death|1|||
126531379|NCT00605293|455237300|FG000|Overall Study|Insufficient Therapeutic Response|2|||
126531380|NCT00605293|455237301|FG001|Overall Study|Insufficient Therapeutic Response|0|||
126531381|NCT00605293|455237300|FG000|Overall Study|Adverse Event|1|||
126531382|NCT00605293|455237301|FG001|Overall Study|Adverse Event|0|||
126531383|NCT00605293|455237300|FG000|Overall Study|Holidays Dialysis Out|1|||
126531384|NCT00605293|455237301|FG001|Overall Study|Holidays Dialysis Out|0|||
126729571|NCT03084718|455958482|FG000|Overall Study|Protocol Violation|0|||
126729572|NCT03084718|455958483|FG001|Overall Study|Protocol Violation|0|||
126729573|NCT03084718|455958484|FG002|Overall Study|Protocol Violation|1|||
126729574|NCT03084718|455958485|FG003|Overall Study|Protocol Violation|0|||
126777215|NCT01677910|456141310|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
126531385|NCT00605293|455237300|FG000|Overall Study|Blood Transfusion|7|||
126531386|NCT00605293|455237301|FG001|Overall Study|Blood Transfusion|1|||
126729575|NCT03084718|455958486|FG004|Overall Study|Protocol Violation|0|||
126729576|NCT03084718|455958482|FG000|Overall Study|Death|0|||
126729577|NCT03084718|455958483|FG001|Overall Study|Death|1|||
126729578|NCT03084718|455958484|FG002|Overall Study|Death|0|||
126729579|NCT03084718|455958485|FG003|Overall Study|Death|0|||
126729580|NCT03084718|455958486|FG004|Overall Study|Death|0|||
126729581|NCT03084718|455958482|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
126531387|NCT00605293|455237300|FG000|Overall Study|Renal Transplantation|3|||
126729582|NCT03084718|455958483|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
126729583|NCT03084718|455958484|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
126729584|NCT03084718|455958485|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
126729585|NCT03084718|455958486|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
126729586|NCT00844649|455958487|FG000|Overall Study|Progressive Disease|196|||
126729587|NCT00844649|455958488|FG001|Overall Study|Progressive Disease|245|||
126729588|NCT00844649|455958487|FG000|Overall Study|Adverse Event|128|||
126729589|NCT00844649|455958488|FG001|Overall Study|Adverse Event|73|||
126729590|NCT00844649|455958487|FG000|Overall Study|Physician Decision|25|||
126531388|NCT00605293|455237301|FG001|Overall Study|Renal Transplantation|1|||
126531389|NCT00605293|455237300|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
126531390|NCT00605293|455237301|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
126531391|NCT00605293|455237300|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
126531392|NCT00605293|455237301|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
126531393|NCT00605293|455237300|FG000|Overall Study|Principal Investigator Decision|0|||
126531394|NCT00605293|455237301|FG001|Overall Study|Principal Investigator Decision|1|||
126531395|NCT00725452|455237303|FG000|Overall Study|Adverse Event|3|||
126531396|NCT00725452|455237303|FG000|Overall Study|Lack of Efficacy|2|||
126531397|NCT00725452|455237303|FG000|Overall Study|Reason not specified|1|||
126531398|NCT00725452|455237303|FG000|Overall Study|Physician Decision|1|||
126531399|NCT00725452|455237303|FG000|Overall Study|Withdrawal by Subject|3|||
126531400|NCT00725452|455237303|FG000|Overall Study|Lost to Follow-up|1|||
126531401|NCT00620750|455237304|FG000|Overall Study|Lost to Follow-up|25|||
126531402|NCT02163733|455237305|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
126531403|NCT02163733|455237306|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
126531404|NCT02163733|455237307|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
126531405|NCT02163733|455237305|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
126531406|NCT02163733|455237306|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
126531407|NCT02163733|455237307|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
126531408|NCT04477187|455237308|FG000|Overall Study|Lost to Follow-up|2|||
126531409|NCT02633800|455237309|FG000|Overall Study|Death|3|||
126581650|NCT02891915|455425808|FG000|Overall Study|Lost to Follow-up|1|||
126581651|NCT02891915|455425809|FG001|Overall Study|Lost to Follow-up|4|||
126581652|NCT02891915|455425808|FG000|Overall Study|Physician Decision|1|||
126581653|NCT02891915|455425809|FG001|Overall Study|Physician Decision|0|||
126581654|NCT00709098|455425810|FG000|Double-blind Period|Withdrawal of consent|3|||
126581655|NCT00709098|455425811|FG001|Double-blind Period|Withdrawal of consent|3|||
126581656|NCT00709098|455425812|FG002|Double-blind Period|Withdrawal of consent|0|||
126581657|NCT00709098|455425810|FG000|Double-blind Period|Administrative reason|1|||
126581658|NCT00709098|455425811|FG001|Double-blind Period|Administrative reason|3|||
126581659|NCT00709098|455425812|FG002|Double-blind Period|Administrative reason|0|||
126581660|NCT00709098|455425810|FG000|Double-blind Period|Death|1|||
126581661|NCT00709098|455425811|FG001|Double-blind Period|Death|1|||
126581662|NCT00709098|455425812|FG002|Double-blind Period|Death|0|||
126581663|NCT00709098|455425810|FG000|Double-blind Period|Lost to Follow-up|1|||
126581664|NCT00709098|455425811|FG001|Double-blind Period|Lost to Follow-up|1|||
126581665|NCT00709098|455425812|FG002|Double-blind Period|Lost to Follow-up|0|||
126581666|NCT00709098|455425810|FG000|Open-label Period|Withdrawal of consent|0|||
126581667|NCT00709098|455425811|FG001|Open-label Period|Withdrawal of consent|0|||
126581668|NCT00709098|455425812|FG002|Open-label Period|Withdrawal of consent|7|||
126581669|NCT00709098|455425810|FG000|Open-label Period|Administrative reason|0|||
126581670|NCT00709098|455425811|FG001|Open-label Period|Administrative reason|0|||
126581671|NCT00709098|455425812|FG002|Open-label Period|Administrative reason|5|||
126581672|NCT00709098|455425810|FG000|Open-label Period|Death|0|||
126581673|NCT00709098|455425811|FG001|Open-label Period|Death|0|||
126581674|NCT00709098|455425812|FG002|Open-label Period|Death|1|||
126581675|NCT00709098|455425810|FG000|Open-label Period|Lost to Follow-up|0|||
126581676|NCT00709098|455425811|FG001|Open-label Period|Lost to Follow-up|0|||
126581677|NCT00709098|455425812|FG002|Open-label Period|Lost to Follow-up|1|||
126581678|NCT03481816|455425814|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
126531410|NCT02633800|455237310|FG001|Overall Study|Death|3|||
126581679|NCT03481816|455425815|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
126581680|NCT03481816|455425814|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
126581681|NCT03481816|455425815|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
126581682|NCT03481816|455425814|FG000|Dose Expansion|Withdrawal by Subject|0|||
126581683|NCT03481816|455425815|FG001|Dose Expansion|Withdrawal by Subject|2|||
126531411|NCT02633800|455237309|FG000|Overall Study|Reason not provided|1|||
126531412|NCT02633800|455237310|FG001|Overall Study|Reason not provided|0|||
126581684|NCT03481816|455425814|FG000|Dose Expansion|Physician Decision|0|||
126581685|NCT03481816|455425815|FG001|Dose Expansion|Physician Decision|5|||
126581686|NCT01091168|455425818|FG000|Overall Study|Progressive disease|250|||
126581687|NCT01091168|455425819|FG001|Overall Study|Progressive disease|234|||
126581688|NCT01091168|455425818|FG000|Overall Study|Adverse Event|21|||
126531413|NCT02633800|455237309|FG000|Overall Study|Radiologic(al) progression|23|||
126729591|NCT00844649|455958488|FG001|Overall Study|Physician Decision|18|||
126729592|NCT00844649|455958487|FG000|Overall Study|Protocol Violation|10|||
126729593|NCT00844649|455958488|FG001|Overall Study|Protocol Violation|6|||
126729594|NCT00844649|455958487|FG000|Overall Study|Withdrawal by Subject|28|||
126729595|NCT00844649|455958488|FG001|Overall Study|Withdrawal by Subject|39|||
126729596|NCT00844649|455958487|FG000|Overall Study|Other|7|||
126729597|NCT00844649|455958488|FG001|Overall Study|Other|10|||
126729598|NCT00844649|455958487|FG000|Overall Study|Withdrew prior to starting treatment|11|||
126729599|NCT00844649|455958488|FG001|Overall Study|Withdrew prior to starting treatment|27|||
126729600|NCT02767856|455958489|FG000|Overall Study|Lost to Follow-up|9|||
126729601|NCT02767856|455958490|FG001|Overall Study|Lost to Follow-up|1|||
126729602|NCT02767856|455958489|FG000|Overall Study|Withdrawal by Subject|2|||
126729603|NCT02767856|455958490|FG001|Overall Study|Withdrawal by Subject|1|||
126729604|NCT00091026|455958491|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
126531414|NCT02633800|455237310|FG001|Overall Study|Radiologic(al) progression|23|||
126531415|NCT02633800|455237309|FG000|Overall Study|Clinical progression|3|||
126729605|NCT00091026|455958492|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
126531416|NCT02633800|455237310|FG001|Overall Study|Clinical progression|6|||
126531417|NCT02633800|455237309|FG000|Overall Study|Study terminated by sponsor|6|||
126531418|NCT02633800|455237310|FG001|Overall Study|Study terminated by sponsor|5|||
126531419|NCT02633800|455237309|FG000|Overall Study|Adverse event, non-fatal|7|||
126531420|NCT02633800|455237310|FG001|Overall Study|Adverse event, non-fatal|2|||
126531421|NCT02633800|455237309|FG000|Overall Study|Withdrawal by Subject|0|||
126531422|NCT02633800|455237310|FG001|Overall Study|Withdrawal by Subject|3|||
126531423|NCT02633800|455237309|FG000|Overall Study|Patient Request|1|||
126531424|NCT02633800|455237310|FG001|Overall Study|Patient Request|1|||
126531425|NCT00082173|455237311|FG000|Overall Study|Withdrawal by Subject|3|||
126531426|NCT00082173|455237312|FG001|Overall Study|Withdrawal by Subject|5|||
126531427|NCT00082173|455237311|FG000|Overall Study|Lost to Follow-up|1|||
126531428|NCT00082173|455237312|FG001|Overall Study|Lost to Follow-up|0|||
126531429|NCT00082173|455237311|FG000|Overall Study|Adverse Event|1|||
126531430|NCT00082173|455237312|FG001|Overall Study|Adverse Event|0|||
126729606|NCT00091026|455958491|FG000|Overall Study|Patient withdrew and never received trea|0|||
126729607|NCT00091026|455958492|FG001|Overall Study|Patient withdrew and never received trea|2|||
126729608|NCT00091026|455958491|FG000|Overall Study|Unknown-never received treatment|0|||
126729609|NCT00091026|455958492|FG001|Overall Study|Unknown-never received treatment|1|||
126729610|NCT00589979|455958493|FG000|Run-In Period|Adverse Event|5|||
126531431|NCT00082173|455237311|FG000|Overall Study|Culture negative or resistant at baselin|5|||
126531432|NCT00082173|455237312|FG001|Overall Study|Culture negative or resistant at baselin|6|||
126531433|NCT01733732|455237313|FG000|Overall Study|Adverse Event|1|||
126531434|NCT01733732|455237314|FG001|Overall Study|Adverse Event|0|||
126531435|NCT01733732|455237313|FG000|Overall Study|Did not attend all study visits|1|||
126531436|NCT01733732|455237314|FG001|Overall Study|Did not attend all study visits|0|||
126531437|NCT00746590|455237315|FG000|Overall Study|Death|1|||
126531438|NCT00464815|455237319|FG000|Overall Study|Withdrawal by Subject|6|||
126531439|NCT00464815|455237320|FG001|Overall Study|Withdrawal by Subject|3|||
126531440|NCT04402866|455237331|FG000|Overall Study|Discontinued Prior to Treatment|0|||
126531441|NCT04402866|455237332|FG001|Overall Study|Discontinued Prior to Treatment|0|||
126531442|NCT04402866|455237333|FG002|Overall Study|Discontinued Prior to Treatment|0|||
126531443|NCT04402866|455237334|FG003|Overall Study|Discontinued Prior to Treatment|0|||
126531444|NCT04402866|455237335|FG004|Overall Study|Discontinued Prior to Treatment|2|||
126531445|NCT04402866|455237336|FG005|Overall Study|Discontinued Prior to Treatment|3|||
126531446|NCT04402866|455237331|FG000|Overall Study|Adverse Event|2|||
126531447|NCT04402866|455237332|FG001|Overall Study|Adverse Event|1|||
126531448|NCT04402866|455237333|FG002|Overall Study|Adverse Event|0|||
126531449|NCT04402866|455237334|FG003|Overall Study|Adverse Event|0|||
126531450|NCT04402866|455237335|FG004|Overall Study|Adverse Event|13|||
126531451|NCT04402866|455237336|FG005|Overall Study|Adverse Event|8|||
126531452|NCT04402866|455237331|FG000|Overall Study|Miscellaneous|0|||
126531453|NCT04402866|455237332|FG001|Overall Study|Miscellaneous|0|||
126531454|NCT04402866|455237333|FG002|Overall Study|Miscellaneous|1|||
126531455|NCT04402866|455237334|FG003|Overall Study|Miscellaneous|0|||
126531456|NCT04402866|455237335|FG004|Overall Study|Miscellaneous|0|||
126531457|NCT04402866|455237336|FG005|Overall Study|Miscellaneous|0|||
126531458|NCT04402866|455237331|FG000|Overall Study|Lost to Follow-up|0|||
126531459|NCT04402866|455237332|FG001|Overall Study|Lost to Follow-up|0|||
126531460|NCT04402866|455237333|FG002|Overall Study|Lost to Follow-up|0|||
126531461|NCT04402866|455237334|FG003|Overall Study|Lost to Follow-up|0|||
126531462|NCT04402866|455237335|FG004|Overall Study|Lost to Follow-up|0|||
126531463|NCT04402866|455237336|FG005|Overall Study|Lost to Follow-up|1|||
126531464|NCT04402866|455237331|FG000|Overall Study|Withdrawal by Subject|0|||
126531465|NCT04402866|455237332|FG001|Overall Study|Withdrawal by Subject|0|||
126531466|NCT04402866|455237333|FG002|Overall Study|Withdrawal by Subject|0|||
126531467|NCT04402866|455237334|FG003|Overall Study|Withdrawal by Subject|0|||
126531468|NCT04402866|455237335|FG004|Overall Study|Withdrawal by Subject|0|||
126581689|NCT01091168|455425819|FG001|Overall Study|Adverse Event|24|||
126729611|NCT00589979|455958494|FG001|Run-In Period|Adverse Event|0|||
126729612|NCT00589979|455958495|FG002|Run-In Period|Adverse Event|0|||
126729613|NCT00589979|455958493|FG000|Run-In Period|Protocol Violation|3|||
126729614|NCT00589979|455958494|FG001|Run-In Period|Protocol Violation|0|||
126729615|NCT00589979|455958495|FG002|Run-In Period|Protocol Violation|0|||
126729616|NCT00589979|455958493|FG000|Run-In Period|Did not qualify for randomization|54|||
126729617|NCT00589979|455958494|FG001|Run-In Period|Did not qualify for randomization|0|||
126729618|NCT00589979|455958495|FG002|Run-In Period|Did not qualify for randomization|0|||
126729619|NCT00589979|455958493|FG000|Run-In Period|Withdrawal by Subject|10|||
126729620|NCT00589979|455958494|FG001|Run-In Period|Withdrawal by Subject|0|||
126729621|NCT00589979|455958495|FG002|Run-In Period|Withdrawal by Subject|0|||
126729622|NCT00589979|455958493|FG000|Run-In Period|Informed Consent Withdrawn|4|||
126729623|NCT00589979|455958494|FG001|Run-In Period|Informed Consent Withdrawn|0|||
126729624|NCT00589979|455958495|FG002|Run-In Period|Informed Consent Withdrawn|0|||
126729625|NCT00589979|455958493|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
126729626|NCT00589979|455958494|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
126729627|NCT00589979|455958495|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
126729628|NCT00589979|455958493|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
126729629|NCT00589979|455958494|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
126729630|NCT00589979|455958495|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
126729631|NCT00589979|455958493|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
126729632|NCT00589979|455958494|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
126729633|NCT00589979|455958495|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
126729634|NCT00589979|455958493|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
126729635|NCT00589979|455958494|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
126729636|NCT00589979|455958495|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
126729637|NCT00589979|455958493|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
126729638|NCT00589979|455958494|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
126729639|NCT00589979|455958495|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
126581690|NCT01091168|455425818|FG000|Overall Study|Lost to Follow-up|0|||
126581691|NCT01091168|455425819|FG001|Overall Study|Lost to Follow-up|1|||
126581692|NCT01091168|455425818|FG000|Overall Study|Physician, patient's decision, other|27|||
126581693|NCT01091168|455425819|FG001|Overall Study|Physician, patient's decision, other|37|||
126581694|NCT03582722|455425822|FG000|Overall Study|Lost to Follow-up|1|||
126581695|NCT03582722|455425823|FG001|Overall Study|Lost to Follow-up|4|||
126581696|NCT03582722|455425822|FG000|Overall Study|Withdrawal by Subject|3|||
126581697|NCT03582722|455425823|FG001|Overall Study|Withdrawal by Subject|3|||
126581698|NCT06024174|455425824|FG000|Overall Study|Other Reasons|1|||
126581699|NCT06024174|455425824|FG000|Overall Study|Study terminated by Sponsor|4|||
126581700|NCT04567615|455425825|FG000|Randomization|Participant withdrew consent|1|||
126581701|NCT04567615|455425826|FG001|Randomization|Participant withdrew consent|0|||
126581702|NCT04567615|455425827|FG002|Randomization|Participant withdrew consent|0|||
126581703|NCT04567615|455425825|FG000|Randomization|Adverse event unrelated to study drug|0|||
126581704|NCT04567615|455425826|FG001|Randomization|Adverse event unrelated to study drug|1|||
126581705|NCT04567615|455425827|FG002|Randomization|Adverse event unrelated to study drug|0|||
126581706|NCT04567615|455425825|FG000|Treatment Period|Participant Withdrew Consent|2|||
126581707|NCT04567615|455425826|FG001|Treatment Period|Participant Withdrew Consent|5|||
126581708|NCT04567615|455425827|FG002|Treatment Period|Participant Withdrew Consent|1|||
126581709|NCT04567615|455425825|FG000|Treatment Period|Death|1|||
126581710|NCT04567615|455425826|FG001|Treatment Period|Death|2|||
126581711|NCT04567615|455425827|FG002|Treatment Period|Death|0|||
126581712|NCT04567615|455425825|FG000|Treatment Period|Lost to Follow-up|0|||
126581713|NCT04567615|455425826|FG001|Treatment Period|Lost to Follow-up|1|||
126581714|NCT04567615|455425827|FG002|Treatment Period|Lost to Follow-up|0|||
126581715|NCT04567615|455425825|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
126581716|NCT04567615|455425826|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
126581717|NCT04567615|455425827|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
126581718|NCT04567615|455425825|FG000|Treatment Period|Disease Progression|85|||
126581719|NCT04567615|455425826|FG001|Treatment Period|Disease Progression|63|||
126581720|NCT04567615|455425827|FG002|Treatment Period|Disease Progression|16|||
126581721|NCT04567615|455425825|FG000|Treatment Period|Study Drug Toxicity|3|||
126581722|NCT04567615|455425826|FG001|Treatment Period|Study Drug Toxicity|10|||
126729640|NCT00589979|455958493|FG000|Double-Blind Treatment Period 2|Other|0|||
126581723|NCT04567615|455425827|FG002|Treatment Period|Study Drug Toxicity|4|||
126581724|NCT04567615|455425825|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
126729641|NCT00589979|455958494|FG001|Double-Blind Treatment Period 2|Other|0|||
126581725|NCT04567615|455425826|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
126729642|NCT00589979|455958495|FG002|Double-Blind Treatment Period 2|Other|1|||
126581726|NCT04567615|455425827|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
126581727|NCT04567615|455425825|FG000|Treatment Period|Other Reasons|1|||
126581728|NCT04567615|455425826|FG001|Treatment Period|Other Reasons|2|||
126729643|NCT00589979|455958493|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
126729644|NCT00589979|455958494|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
126729645|NCT00589979|455958495|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
126729646|NCT00589979|455958493|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
126729647|NCT00589979|455958494|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
126729648|NCT00589979|455958495|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
126729649|NCT00302718|455958500|FG000|Overall Study|Participant left the hospital|1|||
126729650|NCT00302718|455958501|FG001|Overall Study|Participant left the hospital|0|||
126729651|NCT00302718|455958502|FG002|Overall Study|Participant left the hospital|0|||
126729652|NCT00302718|455958503|FG003|Overall Study|Participant left the hospital|1|||
126729653|NCT00302718|455958500|FG000|Overall Study|Withdrawal by Subject|0|||
126729654|NCT00302718|455958501|FG001|Overall Study|Withdrawal by Subject|1|||
126729655|NCT00302718|455958502|FG002|Overall Study|Withdrawal by Subject|0|||
126729656|NCT00302718|455958503|FG003|Overall Study|Withdrawal by Subject|0|||
126531469|NCT04402866|455237336|FG005|Overall Study|Withdrawal by Subject|2|||
126531470|NCT01358968|455237337|FG000|Period 2|Adverse Event|0|||
126531471|NCT01358968|455237338|FG001|Period 2|Adverse Event|1|||
126531472|NCT01358968|455237339|FG002|Period 2|Adverse Event|0|||
126531473|NCT01358968|455237340|FG003|Period 2|Adverse Event|0|||
126531474|NCT01358968|455237337|FG000|Continued Access Phase|Progression of Disease|0|||
126531475|NCT01358968|455237338|FG001|Continued Access Phase|Progression of Disease|0|||
126531476|NCT01358968|455237339|FG002|Continued Access Phase|Progression of Disease|8|||
126531477|NCT01358968|455237340|FG003|Continued Access Phase|Progression of Disease|4|||
126531478|NCT01358968|455237337|FG000|Continued Access Phase|Protocol Violation|0|||
126531479|NCT01358968|455237338|FG001|Continued Access Phase|Protocol Violation|0|||
126531480|NCT01358968|455237339|FG002|Continued Access Phase|Protocol Violation|0|||
126531481|NCT01358968|455237340|FG003|Continued Access Phase|Protocol Violation|2|||
126531482|NCT01358968|455237337|FG000|Continued Access Phase|Withdrawal by Subject|0|||
126531483|NCT01358968|455237338|FG001|Continued Access Phase|Withdrawal by Subject|0|||
126531484|NCT01358968|455237339|FG002|Continued Access Phase|Withdrawal by Subject|3|||
126531485|NCT01358968|455237340|FG003|Continued Access Phase|Withdrawal by Subject|0|||
126531486|NCT01358968|455237337|FG000|Continued Access Phase|Death|0|||
126531487|NCT01358968|455237338|FG001|Continued Access Phase|Death|0|||
126531488|NCT01358968|455237339|FG002|Continued Access Phase|Death|1|||
126531489|NCT01358968|455237340|FG003|Continued Access Phase|Death|1|||
126531490|NCT01814371|455237344|FG000|Overall Study|Lost to Follow-up|30|||
126531491|NCT01814371|455237345|FG001|Overall Study|Lost to Follow-up|27|||
126531492|NCT02794285|455237346|FG000|Overall Study|Adverse Event|11|||
126531493|NCT02794285|455237347|FG001|Overall Study|Adverse Event|4|||
126531494|NCT02794285|455237348|FG002|Overall Study|Adverse Event|5|||
126531495|NCT02794285|455237349|FG003|Overall Study|Adverse Event|8|||
126531496|NCT02794285|455237346|FG000|Overall Study|Condition Under Investigation Improved|1|||
126531497|NCT02794285|455237347|FG001|Overall Study|Condition Under Investigation Improved|0|||
126531498|NCT02794285|455237348|FG002|Overall Study|Condition Under Investigation Improved|0|||
126531499|NCT02794285|455237349|FG003|Overall Study|Condition Under Investigation Improved|0|||
126531500|NCT02794285|455237346|FG000|Overall Study|Condition Under Investigation Worsened|0|||
126531501|NCT02794285|455237347|FG001|Overall Study|Condition Under Investigation Worsened|2|||
126531502|NCT02794285|455237348|FG002|Overall Study|Condition Under Investigation Worsened|1|||
126531503|NCT02794285|455237349|FG003|Overall Study|Condition Under Investigation Worsened|0|||
126531504|NCT02794285|455237346|FG000|Overall Study|Death|2|||
126531505|NCT02794285|455237347|FG001|Overall Study|Death|1|||
126531506|NCT02794285|455237348|FG002|Overall Study|Death|2|||
126531507|NCT02794285|455237349|FG003|Overall Study|Death|0|||
126531508|NCT02794285|455237346|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
126531509|NCT02794285|455237347|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
126531510|NCT02794285|455237348|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
126531511|NCT02794285|455237349|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
126531512|NCT02794285|455237346|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
126531513|NCT02794285|455237347|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
126531514|NCT02794285|455237348|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
126531515|NCT02794285|455237349|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
126531516|NCT02794285|455237346|FG000|Overall Study|Lack of Efficacy|10|||
126531517|NCT02794285|455237347|FG001|Overall Study|Lack of Efficacy|6|||
126729657|NCT00302718|455958500|FG000|Overall Study|Participant left primary care setting|0|||
126729658|NCT00302718|455958501|FG001|Overall Study|Participant left primary care setting|0|||
126729659|NCT00302718|455958502|FG002|Overall Study|Participant left primary care setting|2|||
126531518|NCT02794285|455237348|FG002|Overall Study|Lack of Efficacy|3|||
126531519|NCT02794285|455237349|FG003|Overall Study|Lack of Efficacy|3|||
126531520|NCT02794285|455237346|FG000|Overall Study|Lost to Follow-up|5|||
126531521|NCT02794285|455237347|FG001|Overall Study|Lost to Follow-up|6|||
126531522|NCT02794285|455237348|FG002|Overall Study|Lost to Follow-up|3|||
126531523|NCT02794285|455237349|FG003|Overall Study|Lost to Follow-up|1|||
126531524|NCT02794285|455237346|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
126531525|NCT02794285|455237347|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
126581729|NCT04567615|455425827|FG002|Treatment Period|Other Reasons|0|||
126581730|NCT04567615|455425825|FG000|Treatment Period|Still On-going Treatment|21|||
126581731|NCT04567615|455425826|FG001|Treatment Period|Still On-going Treatment|22|||
126581732|NCT04567615|455425827|FG002|Treatment Period|Still On-going Treatment|2|||
126581733|NCT04059354|455427649|FG000|Overall Study|COVID-19 pandemic|3|||
126581734|NCT05403801|455427650|FG000|Overall Study|Withdrawal by Subject|2|||
126581735|NCT03651895|455427652|FG000|First Drug Assignment|Adverse Event|4|||
126581736|NCT03651895|455427653|FG001|First Drug Assignment|Adverse Event|5|||
126581737|NCT03651895|455427652|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
126581738|NCT03651895|455427653|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
126581739|NCT02525692|455427654|FG000|Overall Study|Withdrawal by Subject|1|||
126581740|NCT02525692|455427655|FG001|Overall Study|Withdrawal by Subject|1|||
126581741|NCT02525692|455427656|FG002|Overall Study|Withdrawal by Subject|0|||
126581742|NCT02525692|455427657|FG003|Overall Study|Withdrawal by Subject|5|||
126581743|NCT02525692|455427658|FG004|Overall Study|Withdrawal by Subject|0|||
126581744|NCT02525692|455427659|FG005|Overall Study|Withdrawal by Subject|1|||
126581745|NCT02525692|455427654|FG000|Overall Study|Death|16|||
126581746|NCT02525692|455427655|FG001|Overall Study|Death|18|||
126581747|NCT02525692|455427656|FG002|Overall Study|Death|7|||
126581748|NCT02525692|455427657|FG003|Overall Study|Death|20|||
126581749|NCT02525692|455427658|FG004|Overall Study|Death|3|||
126581750|NCT02525692|455427659|FG005|Overall Study|Death|6|||
126581751|NCT02525692|455427654|FG000|Overall Study|Lost to Follow-up|0|||
126581752|NCT02525692|455427655|FG001|Overall Study|Lost to Follow-up|0|||
126581753|NCT02525692|455427656|FG002|Overall Study|Lost to Follow-up|1|||
126581754|NCT02525692|455427657|FG003|Overall Study|Lost to Follow-up|5|||
126581755|NCT02525692|455427658|FG004|Overall Study|Lost to Follow-up|0|||
126581756|NCT02525692|455427659|FG005|Overall Study|Lost to Follow-up|0|||
126581757|NCT02396199|455427660|FG000|Overall Study|Lost to Follow-up|1|||
126581758|NCT02396199|455427660|FG000|Overall Study|Death|4|||
126581759|NCT05613205|455427664|FG000|Overall Study|Lost to Follow-up|0|||
126581760|NCT05613205|455427665|FG001|Overall Study|Lost to Follow-up|0|||
126581761|NCT05613205|455427666|FG002|Overall Study|Lost to Follow-up|1|||
126581762|NCT05613205|455427667|FG003|Overall Study|Lost to Follow-up|1|||
126581763|NCT05613205|455427668|FG004|Overall Study|Lost to Follow-up|0|||
126581764|NCT05613205|455427664|FG000|Overall Study|Withdrawal by Subject|0|||
126581765|NCT05613205|455427665|FG001|Overall Study|Withdrawal by Subject|0|||
126581766|NCT05613205|455427666|FG002|Overall Study|Withdrawal by Subject|1|||
126581767|NCT05613205|455427667|FG003|Overall Study|Withdrawal by Subject|1|||
126581768|NCT05613205|455427668|FG004|Overall Study|Withdrawal by Subject|0|||
126581769|NCT04869982|455427671|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
126581770|NCT04869982|455427672|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
126581771|NCT04869982|455427671|FG000|Overall Study|Migrated / moved from the study area|1|||
126581772|NCT04869982|455427672|FG001|Overall Study|Migrated / moved from the study area|1|||
126581773|NCT04869982|455427671|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
126581774|NCT04869982|455427672|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
126581775|NCT04869982|455427671|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
126581776|NCT04869982|455427672|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
126581777|NCT04869982|455427671|FG000|Overall Study|Solicited adverse event|2|||
126581778|NCT04869982|455427672|FG001|Overall Study|Solicited adverse event|1|||
126581779|NCT00567398|455427673|FG000|Overall Study|Adverse Event|6|||
126581780|NCT00567398|455427674|FG001|Overall Study|Adverse Event|14|||
126581781|NCT00567398|455427673|FG000|Overall Study|Physician Decision|0|||
126581782|NCT00567398|455427674|FG001|Overall Study|Physician Decision|4|||
126581783|NCT00567398|455427673|FG000|Overall Study|Withdrawal by Subject|0|||
126581784|NCT00567398|455427674|FG001|Overall Study|Withdrawal by Subject|2|||
126581785|NCT00567398|455427673|FG000|Overall Study|Renal Transplantation|0|||
126581786|NCT00567398|455427674|FG001|Overall Study|Renal Transplantation|3|||
126581787|NCT00567398|455427673|FG000|Overall Study|Other|1|||
126581788|NCT00567398|455427674|FG001|Overall Study|Other|0|||
126581789|NCT02201108|455427675|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
126581790|NCT02201108|455427676|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
126729660|NCT00302718|455958503|FG003|Overall Study|Participant left primary care setting|1|||
126581791|NCT02201108|455427677|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
126581792|NCT02201108|455427675|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
126581793|NCT02201108|455427676|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
126581794|NCT02201108|455427677|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
126581795|NCT02201108|455427675|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
126581796|NCT02201108|455427676|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
126729661|NCT00819585|455958504|FG000|Core Study|Adverse Event|2|||
126581797|NCT02201108|455427677|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
126581798|NCT02201108|455427675|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
126581799|NCT02201108|455427676|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
126581800|NCT02201108|455427677|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
126581801|NCT02201108|455427675|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
126531526|NCT02794285|455237348|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
126531527|NCT02794285|455237349|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
126729662|NCT00819585|455958505|FG001|Core Study|Adverse Event|1|||
126729663|NCT00819585|455958506|FG002|Core Study|Adverse Event|1|||
126729664|NCT00819585|455958507|FG003|Core Study|Adverse Event|4|||
126729665|NCT00819585|455958508|FG004|Core Study|Adverse Event|1|||
126729666|NCT00819585|455958509|FG005|Core Study|Adverse Event|0|||
126729667|NCT00819585|455958510|FG006|Core Study|Adverse Event|2|||
126729668|NCT00819585|455958511|FG007|Core Study|Adverse Event|0|||
126729669|NCT00819585|455958512|FG008|Core Study|Adverse Event|0|||
126729670|NCT00819585|455958513|FG009|Core Study|Adverse Event|0|||
126729671|NCT00819585|455958514|FG010|Core Study|Adverse Event|0|||
126729672|NCT00819585|455958504|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
126729673|NCT00819585|455958505|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
126729674|NCT00819585|455958506|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
126729675|NCT00819585|455958507|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
126729676|NCT00819585|455958508|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
126729677|NCT00819585|455958509|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
126777216|NCT01677910|456141311|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
126777217|NCT01677910|456141312|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
126777218|NCT01677910|456141313|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
126777219|NCT01677910|456141310|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
126777220|NCT01677910|456141311|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
126777221|NCT01677910|456141312|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
126777222|NCT01677910|456141313|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
126777223|NCT01677910|456141310|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
126777224|NCT01677910|456141311|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
126777225|NCT01677910|456141312|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
126777226|NCT01677910|456141313|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
126777227|NCT01677910|456141310|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
126777228|NCT01677910|456141311|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
126777229|NCT01677910|456141312|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
126777230|NCT01677910|456141313|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
126777231|NCT01677910|456141310|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
126777232|NCT01677910|456141311|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
126777233|NCT01677910|456141312|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
126777234|NCT01677910|456141313|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
126531528|NCT02794285|455237346|FG000|Overall Study|Withdrawal by Subject|38|||
126531529|NCT02794285|455237347|FG001|Overall Study|Withdrawal by Subject|29|||
126531530|NCT02794285|455237348|FG002|Overall Study|Withdrawal by Subject|20|||
126531531|NCT02794285|455237349|FG003|Overall Study|Withdrawal by Subject|12|||
126531532|NCT02794285|455237346|FG000|Overall Study|Missing|1|||
126531533|NCT02794285|455237347|FG001|Overall Study|Missing|0|||
126531534|NCT02794285|455237348|FG002|Overall Study|Missing|0|||
126531535|NCT02794285|455237349|FG003|Overall Study|Missing|0|||
126531536|NCT02794285|455237346|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
126531537|NCT02794285|455237347|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
126531538|NCT02794285|455237348|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
126531539|NCT02794285|455237349|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
126531540|NCT02794285|455237346|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
126531541|NCT02794285|455237347|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
126531542|NCT02794285|455237348|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
126531543|NCT02794285|455237349|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
126531544|NCT03252587|455237350|FG000|Overall Study|Adverse Event|3|||
126531545|NCT03252587|455237351|FG001|Overall Study|Adverse Event|8|||
126531546|NCT03252587|455237352|FG002|Overall Study|Adverse Event|6|||
126531547|NCT03252587|455237353|FG003|Overall Study|Adverse Event|12|||
126531548|NCT03252587|455237350|FG000|Overall Study|Lack of Efficacy|7|||
126531549|NCT03252587|455237351|FG001|Overall Study|Lack of Efficacy|2|||
126531550|NCT03252587|455237352|FG002|Overall Study|Lack of Efficacy|2|||
126531551|NCT03252587|455237353|FG003|Overall Study|Lack of Efficacy|4|||
126531552|NCT03252587|455237350|FG000|Overall Study|Lost to Follow-up|2|||
126531553|NCT03252587|455237351|FG001|Overall Study|Lost to Follow-up|0|||
126777235|NCT03341273|456141316|FG000|Overall Study|Lost to Follow-up|7|||
126777236|NCT03341273|456141317|FG001|Overall Study|Lost to Follow-up|7|||
126777237|NCT03341273|456141316|FG000|Overall Study|Withdrawal by Subject|4|||
126777238|NCT03341273|456141317|FG001|Overall Study|Withdrawal by Subject|2|||
126777239|NCT03341273|456141316|FG000|Overall Study|Physician Decision|1|||
126531554|NCT03252587|455237352|FG002|Overall Study|Lost to Follow-up|0|||
126531555|NCT03252587|455237353|FG003|Overall Study|Lost to Follow-up|2|||
126531556|NCT03252587|455237350|FG000|Overall Study|Pregnancy|2|||
126531557|NCT03252587|455237351|FG001|Overall Study|Pregnancy|1|||
126531558|NCT03252587|455237352|FG002|Overall Study|Pregnancy|0|||
126531559|NCT03252587|455237353|FG003|Overall Study|Pregnancy|1|||
126729678|NCT00819585|455958510|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
126729679|NCT00819585|455958511|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
126531560|NCT03252587|455237350|FG000|Overall Study|Withdrawal by Subject|8|||
126531561|NCT03252587|455237351|FG001|Overall Study|Withdrawal by Subject|4|||
126531562|NCT03252587|455237352|FG002|Overall Study|Withdrawal by Subject|4|||
126531563|NCT03252587|455237353|FG003|Overall Study|Withdrawal by Subject|4|||
126531564|NCT03252587|455237350|FG000|Overall Study|Other Reasons|2|||
126531565|NCT03252587|455237351|FG001|Overall Study|Other Reasons|5|||
126531566|NCT03252587|455237352|FG002|Overall Study|Other Reasons|5|||
126531567|NCT03252587|455237353|FG003|Overall Study|Other Reasons|4|||
126531568|NCT04052204|455237354|FG000|Overall Study|Death|1|||
126531569|NCT04052204|455237355|FG001|Overall Study|Death|0|||
126531570|NCT04052204|455237356|FG002|Overall Study|Death|0|||
126531571|NCT04052204|455237354|FG000|Overall Study|Progressive disease|1|||
126531572|NCT04052204|455237355|FG001|Overall Study|Progressive disease|0|||
126531573|NCT04052204|455237356|FG002|Overall Study|Progressive disease|0|||
126531574|NCT04052204|455237354|FG000|Overall Study|Other|1|||
126531575|NCT04052204|455237355|FG001|Overall Study|Other|0|||
126531576|NCT04052204|455237356|FG002|Overall Study|Other|0|||
126531577|NCT00868439|455237359|FG000|Overall Study|Adverse Event|4|||
126531578|NCT00868439|455237360|FG001|Overall Study|Adverse Event|3|||
126531579|NCT00868439|455237359|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
126581802|NCT02201108|455427676|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
126581803|NCT02201108|455427677|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
126581804|NCT02201108|455427675|FG000|Open Label Period (up to Week 192)|Other reason|4|||
126581805|NCT02201108|455427676|FG001|Open Label Period (up to Week 192)|Other reason|7|||
126581806|NCT02201108|455427677|FG002|Open Label Period (up to Week 192)|Other reason|0|||
126581807|NCT02201108|455427675|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
126581808|NCT02201108|455427676|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
126581809|NCT02201108|455427677|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
126581810|NCT02201108|455427675|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
126581811|NCT02201108|455427676|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
126581812|NCT02201108|455427677|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
126581813|NCT02201108|455427675|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
126581814|NCT02201108|455427676|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
126581815|NCT02201108|455427677|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
126581816|NCT03055377|455427687|FG000|Treatment Phase|Lost to Follow-up|28|||
126581817|NCT03055377|455427688|FG001|Treatment Phase|Lost to Follow-up|24|||
126581818|NCT03055377|455427687|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
126581819|NCT03055377|455427688|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
126581820|NCT05215847|455427689|FG000|Overall Study|Lost to Follow-up|1|||
126581821|NCT04143061|455427691|FG000|Overall Study|Protocol Deviation|0|||
126581822|NCT04143061|455427692|FG001|Overall Study|Protocol Deviation|0|||
126581823|NCT04143061|455427693|FG002|Overall Study|Protocol Deviation|0|||
126581824|NCT04143061|455427694|FG003|Overall Study|Protocol Deviation|0|||
126581825|NCT04143061|455427695|FG004|Overall Study|Protocol Deviation|0|||
126581826|NCT04143061|455427696|FG005|Overall Study|Protocol Deviation|0|||
126581827|NCT04143061|455427697|FG006|Overall Study|Protocol Deviation|5|||
126581828|NCT04143061|455427698|FG007|Overall Study|Protocol Deviation|5|||
126581829|NCT04143061|455427691|FG000|Overall Study|Withdrawal by Subject|2|||
126581830|NCT04143061|455427692|FG001|Overall Study|Withdrawal by Subject|0|||
126581831|NCT04143061|455427693|FG002|Overall Study|Withdrawal by Subject|0|||
126581832|NCT04143061|455427694|FG003|Overall Study|Withdrawal by Subject|0|||
126531580|NCT00868439|455237360|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
126531581|NCT00868439|455237359|FG000|Overall Study|Death|0|||
126531582|NCT00868439|455237360|FG001|Overall Study|Death|1|||
126531583|NCT00868439|455237359|FG000|Overall Study|Protocol Violation|1|||
126581833|NCT04143061|455427695|FG004|Overall Study|Withdrawal by Subject|0|||
126581834|NCT04143061|455427696|FG005|Overall Study|Withdrawal by Subject|1|||
126581835|NCT04143061|455427697|FG006|Overall Study|Withdrawal by Subject|0|||
126581836|NCT04143061|455427698|FG007|Overall Study|Withdrawal by Subject|0|||
126581837|NCT04143061|455427691|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126581838|NCT04143061|455427692|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126531584|NCT00868439|455237360|FG001|Overall Study|Protocol Violation|1|||
126531585|NCT00868439|455237359|FG000|Overall Study|Physician Decision|1|||
126531586|NCT00868439|455237360|FG001|Overall Study|Physician Decision|0|||
126531587|NCT00868439|455237359|FG000|Overall Study|Withdrawal by Subject|0|||
126531588|NCT00868439|455237360|FG001|Overall Study|Withdrawal by Subject|1|||
126581839|NCT04143061|455427693|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126531589|NCT03321396|455237364|FG000|Overall Study|Physician Decision|1|||
126531590|NCT01654549|455237365|FG000|Overall Study|H.pylori eradication not successful|0|||
126581840|NCT04143061|455427694|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126581841|NCT04143061|455427695|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
126581842|NCT04143061|455427696|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
126581843|NCT04143061|455427697|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
126581844|NCT04143061|455427698|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
126581845|NCT03602014|455427699|FG000|Overall Study|Lost to Follow-up|2|||
126729680|NCT00819585|455958512|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
126729681|NCT00819585|455958513|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
126729682|NCT00819585|455958514|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
126729683|NCT00819585|455958504|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
126729684|NCT00819585|455958505|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
126729685|NCT00819585|455958506|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
126729686|NCT00819585|455958507|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
126729687|NCT00819585|455958508|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
126729688|NCT00819585|455958509|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
126729689|NCT00819585|455958510|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
126729690|NCT00819585|455958511|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
126729691|NCT00819585|455958512|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
126729692|NCT00819585|455958513|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
126729693|NCT00819585|455958514|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
126729694|NCT00819585|455958504|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
126729695|NCT00819585|455958505|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
126729696|NCT00819585|455958506|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
126729697|NCT00819585|455958507|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
126729698|NCT00819585|455958508|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
126729699|NCT00819585|455958509|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
126729700|NCT00819585|455958510|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
126729701|NCT00819585|455958511|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
126729702|NCT00819585|455958512|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
126531591|NCT01654549|455237366|FG001|Overall Study|H.pylori eradication not successful|1|||
126531592|NCT00937924|455237367|FG000|Overall Study|Lost to Follow-up|44|||
126531593|NCT00937924|455237368|FG001|Overall Study|Lost to Follow-up|44|||
126531594|NCT00937924|455237369|FG002|Overall Study|Lost to Follow-up|41|||
126531595|NCT05072080|455237372|FG000|Overall Study|Death|0|||
126531596|NCT05072080|455237373|FG001|Overall Study|Death|0|||
126531597|NCT05072080|455237374|FG002|Overall Study|Death|1|||
126531598|NCT05072080|455237375|FG003|Overall Study|Death|0|||
126531599|NCT05072080|455237372|FG000|Overall Study|Lost to Follow-up|65|||
126531600|NCT05072080|455237373|FG001|Overall Study|Lost to Follow-up|70|||
126531601|NCT05072080|455237374|FG002|Overall Study|Lost to Follow-up|58|||
126531602|NCT05072080|455237375|FG003|Overall Study|Lost to Follow-up|23|||
126531603|NCT05072080|455237372|FG000|Overall Study|Physician Decision|2|||
126531604|NCT05072080|455237373|FG001|Overall Study|Physician Decision|1|||
126531605|NCT05072080|455237374|FG002|Overall Study|Physician Decision|1|||
126531606|NCT05072080|455237375|FG003|Overall Study|Physician Decision|0|||
126531607|NCT05072080|455237372|FG000|Overall Study|Withdrawal by Subject|45|||
126531608|NCT05072080|455237373|FG001|Overall Study|Withdrawal by Subject|30|||
126531609|NCT05072080|455237374|FG002|Overall Study|Withdrawal by Subject|27|||
126531610|NCT05072080|455237375|FG003|Overall Study|Withdrawal by Subject|7|||
126531611|NCT05072080|455237372|FG000|Overall Study|Sponsor Decision|0|||
126531612|NCT05072080|455237373|FG001|Overall Study|Sponsor Decision|1|||
126531613|NCT05072080|455237374|FG002|Overall Study|Sponsor Decision|0|||
126531614|NCT05072080|455237375|FG003|Overall Study|Sponsor Decision|0|||
126531615|NCT05072080|455237372|FG000|Overall Study|Subject moved|1|||
126531616|NCT05072080|455237373|FG001|Overall Study|Subject moved|3|||
126531617|NCT05072080|455237374|FG002|Overall Study|Subject moved|5|||
126531618|NCT05072080|455237375|FG003|Overall Study|Subject moved|2|||
126531619|NCT05072080|455237372|FG000|Overall Study|Withdrawal by parent|0|||
126531620|NCT05072080|455237373|FG001|Overall Study|Withdrawal by parent|0|||
126531621|NCT05072080|455237374|FG002|Overall Study|Withdrawal by parent|1|||
126531622|NCT05072080|455237375|FG003|Overall Study|Withdrawal by parent|0|||
126531623|NCT05072080|455237372|FG000|Overall Study|Subject was deployed|0|||
126531624|NCT05072080|455237373|FG001|Overall Study|Subject was deployed|1|||
126531625|NCT05072080|455237374|FG002|Overall Study|Subject was deployed|0|||
126531626|NCT05072080|455237375|FG003|Overall Study|Subject was deployed|0|||
126531627|NCT05072080|455237372|FG000|Overall Study|Subject left site without receiving dose|0|||
126777240|NCT03341273|456141317|FG001|Overall Study|Physician Decision|0|||
126777241|NCT03341273|456141316|FG000|Overall Study|Protocol Violation|0|||
126531628|NCT05072080|455237373|FG001|Overall Study|Subject left site without receiving dose|1|||
126531629|NCT05072080|455237374|FG002|Overall Study|Subject left site without receiving dose|0|||
126531630|NCT05072080|455237375|FG003|Overall Study|Subject left site without receiving dose|0|||
126531631|NCT05072080|455237372|FG000|Overall Study|Subject incarcerated|0|||
126531632|NCT05072080|455237373|FG001|Overall Study|Subject incarcerated|1|||
126777242|NCT03341273|456141317|FG001|Overall Study|Protocol Violation|1|||
126531633|NCT05072080|455237374|FG002|Overall Study|Subject incarcerated|0|||
126531634|NCT05072080|455237375|FG003|Overall Study|Subject incarcerated|1|||
126531635|NCT05072080|455237372|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
126531636|NCT05072080|455237373|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
126531637|NCT05072080|455237374|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
126729703|NCT00819585|455958513|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
126581846|NCT03602014|455427700|FG001|Overall Study|Lost to Follow-up|0|||
126581847|NCT03602014|455427701|FG002|Overall Study|Lost to Follow-up|0|||
126581848|NCT03289039|455427702|FG000|Overall Study|Withdrawal by Subject|0|||
126581849|NCT03289039|455427703|FG001|Overall Study|Withdrawal by Subject|1|||
126581850|NCT03289039|455427702|FG000|Overall Study|Became ineligible prior to treatment start|0|||
126581851|NCT03289039|455427703|FG001|Overall Study|Became ineligible prior to treatment start|1|||
126581852|NCT03289039|455427702|FG000|Overall Study|progressed before treatment start|1|||
126581853|NCT03289039|455427703|FG001|Overall Study|progressed before treatment start|0|||
126581854|NCT04732494|455427706|FG000|Overall Study|Death|39|||
126581855|NCT04732494|455427707|FG001|Overall Study|Death|36|||
126581856|NCT04732494|455427706|FG000|Overall Study|Study Closed by Sponsor|20|||
126581857|NCT04732494|455427707|FG001|Overall Study|Study Closed by Sponsor|15|||
126581858|NCT04732494|455427706|FG000|Overall Study|Withdrawal by Subject|2|||
126581859|NCT04732494|455427707|FG001|Overall Study|Withdrawal by Subject|7|||
126581860|NCT04732494|455427706|FG000|Overall Study|Lost to Follow-up|1|||
126581861|NCT04732494|455427707|FG001|Overall Study|Lost to Follow-up|5|||
126581862|NCT03897686|455427708|FG000|Overall Study|Protocol Violation|1|||
126581863|NCT03897686|455427709|FG001|Overall Study|Protocol Violation|1|||
126581864|NCT03897686|455427708|FG000|Overall Study|Withdrawal by Subject|1|||
126531638|NCT05072080|455237375|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
126531639|NCT05072080|455237372|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
126531640|NCT05072080|455237373|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
126531641|NCT05072080|455237374|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
126531642|NCT05072080|455237375|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
126531643|NCT01972841|455237382|FG000|Overall Study|Randomized but Never Received Treatment|2|||
126531644|NCT01972841|455237383|FG001|Overall Study|Randomized but Never Received Treatment|5|||
126531645|NCT01972841|455237384|FG002|Overall Study|Randomized but Never Received Treatment|4|||
126531646|NCT01972841|455237385|FG003|Overall Study|Randomized but Never Received Treatment|2|||
126531647|NCT01972841|455237386|FG004|Overall Study|Randomized but Never Received Treatment|6|||
126581865|NCT03897686|455427709|FG001|Overall Study|Withdrawal by Subject|1|||
126531648|NCT01972841|455237387|FG005|Overall Study|Randomized but Never Received Treatment|13|||
126531649|NCT01972841|455237382|FG000|Overall Study|Adverse Event|13|||
126531650|NCT01972841|455237383|FG001|Overall Study|Adverse Event|8|||
126531651|NCT01972841|455237384|FG002|Overall Study|Adverse Event|12|||
126531652|NCT01972841|455237385|FG003|Overall Study|Adverse Event|9|||
126531653|NCT01972841|455237386|FG004|Overall Study|Adverse Event|21|||
126531654|NCT01972841|455237387|FG005|Overall Study|Adverse Event|26|||
126531655|NCT01972841|455237382|FG000|Overall Study|Lack of Efficacy|1|||
126531656|NCT01972841|455237383|FG001|Overall Study|Lack of Efficacy|0|||
126531657|NCT01972841|455237384|FG002|Overall Study|Lack of Efficacy|0|||
126531658|NCT01972841|455237385|FG003|Overall Study|Lack of Efficacy|2|||
126531659|NCT01972841|455237386|FG004|Overall Study|Lack of Efficacy|4|||
126531660|NCT01972841|455237387|FG005|Overall Study|Lack of Efficacy|1|||
126531661|NCT01972841|455237382|FG000|Overall Study|Lost to Follow-up|4|||
126531662|NCT01972841|455237383|FG001|Overall Study|Lost to Follow-up|2|||
126531663|NCT01972841|455237384|FG002|Overall Study|Lost to Follow-up|4|||
126531664|NCT01972841|455237385|FG003|Overall Study|Lost to Follow-up|2|||
126531665|NCT01972841|455237386|FG004|Overall Study|Lost to Follow-up|9|||
126531666|NCT01972841|455237387|FG005|Overall Study|Lost to Follow-up|3|||
126531667|NCT01972841|455237382|FG000|Overall Study|Protocol Violation|2|||
126531668|NCT01972841|455237383|FG001|Overall Study|Protocol Violation|2|||
126531669|NCT01972841|455237384|FG002|Overall Study|Protocol Violation|3|||
126531670|NCT01972841|455237385|FG003|Overall Study|Protocol Violation|5|||
126531671|NCT01972841|455237386|FG004|Overall Study|Protocol Violation|9|||
126531672|NCT01972841|455237387|FG005|Overall Study|Protocol Violation|4|||
126531673|NCT01972841|455237382|FG000|Overall Study|Withdrawal by participants|21|||
126531674|NCT01972841|455237383|FG001|Overall Study|Withdrawal by participants|27|||
126531675|NCT01972841|455237384|FG002|Overall Study|Withdrawal by participants|23|||
126531676|NCT01972841|455237385|FG003|Overall Study|Withdrawal by participants|16|||
126531677|NCT01972841|455237386|FG004|Overall Study|Withdrawal by participants|33|||
126531678|NCT01972841|455237387|FG005|Overall Study|Withdrawal by participants|34|||
126531679|NCT01972841|455237382|FG000|Overall Study|Miscellaneous|0|||
126581866|NCT03157167|455427710|FG000|Overall Study|Withdrawal by Subject|1|||
126581867|NCT03157167|455427711|FG001|Overall Study|Withdrawal by Subject|0|||
126581868|NCT03157167|455427712|FG002|Overall Study|Withdrawal by Subject|0|||
126581869|NCT04437433|455427715|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
126531680|NCT01972841|455237383|FG001|Overall Study|Miscellaneous|0|||
126531681|NCT01972841|455237384|FG002|Overall Study|Miscellaneous|4|||
126531682|NCT01972841|455237385|FG003|Overall Study|Miscellaneous|1|||
126531683|NCT01972841|455237386|FG004|Overall Study|Miscellaneous|0|||
126531684|NCT01972841|455237387|FG005|Overall Study|Miscellaneous|4|||
126581870|NCT04437433|455427716|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
126581871|NCT04437433|455427715|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
126581872|NCT04437433|455427716|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
126581873|NCT04437433|455427715|FG000|Overall Study|Adverse Event|9|||
126729704|NCT00819585|455958514|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
126729705|NCT00819585|455958504|FG000|Core Study|Subject Withdrew Consent|0|||
126729706|NCT00819585|455958505|FG001|Core Study|Subject Withdrew Consent|3|||
126729707|NCT00819585|455958506|FG002|Core Study|Subject Withdrew Consent|2|||
126729708|NCT00819585|455958507|FG003|Core Study|Subject Withdrew Consent|1|||
126729709|NCT00819585|455958508|FG004|Core Study|Subject Withdrew Consent|0|||
126729710|NCT00819585|455958509|FG005|Core Study|Subject Withdrew Consent|0|||
126729711|NCT00819585|455958510|FG006|Core Study|Subject Withdrew Consent|3|||
126729712|NCT00819585|455958511|FG007|Core Study|Subject Withdrew Consent|0|||
126531685|NCT01972841|455237382|FG000|Overall Study|Did not have end of treatment page|0|||
126581874|NCT04437433|455427716|FG001|Overall Study|Adverse Event|0|||
126581875|NCT04437433|455427715|FG000|Overall Study|Lack of Efficacy|4|||
126581876|NCT04437433|455427716|FG001|Overall Study|Lack of Efficacy|0|||
126581877|NCT04437433|455427715|FG000|Overall Study|Withdrawal by Subject|4|||
126581878|NCT04437433|455427716|FG001|Overall Study|Withdrawal by Subject|1|||
126581879|NCT04437433|455427715|FG000|Overall Study|Protocol Deviation|0|||
126581880|NCT04437433|455427716|FG001|Overall Study|Protocol Deviation|1|||
126581881|NCT04437433|455427715|FG000|Overall Study|Other, not specified|0|||
126581882|NCT04437433|455427716|FG001|Overall Study|Other, not specified|1|||
126581883|NCT04048681|455427717|FG000|Overall Study|family emergency|0|||
126581884|NCT04048681|455427718|FG001|Overall Study|family emergency|0|||
126581885|NCT04048681|455427719|FG002|Overall Study|family emergency|0|||
126581886|NCT04048681|455427720|FG003|Overall Study|family emergency|1|||
126581887|NCT04048681|455427721|FG004|Overall Study|family emergency|0|||
126581888|NCT01532388|455427722|FG000|3-month Follow-up|Lost to Follow-up|68|||
126581889|NCT01532388|455427723|FG001|3-month Follow-up|Lost to Follow-up|68|||
126581890|NCT01532388|455427722|FG000|6-month Follow-up|Lost to Follow-up|74|||
126581891|NCT01532388|455427723|FG001|6-month Follow-up|Lost to Follow-up|66|||
126581892|NCT01532388|455427722|FG000|12-month Follow-up|Lost to Follow-up|69|||
126581893|NCT01532388|455427723|FG001|12-month Follow-up|Lost to Follow-up|67|||
126531686|NCT01972841|455237383|FG001|Overall Study|Did not have end of treatment page|0|||
126531687|NCT01972841|455237384|FG002|Overall Study|Did not have end of treatment page|0|||
126531688|NCT01972841|455237385|FG003|Overall Study|Did not have end of treatment page|0|||
126581894|NCT03578536|455427727|FG000|Overall Study|Lost to Follow-up|1|||
126581895|NCT04436107|455427728|FG000|Overall Study|Sponsor Ended Study|2|||
126581896|NCT04436107|455427729|FG001|Overall Study|Sponsor Ended Study|4|||
126581897|NCT04436107|455427730|FG002|Overall Study|Sponsor Ended Study|8|||
126581898|NCT04436107|455427731|FG003|Overall Study|Sponsor Ended Study|20|||
126581899|NCT04436107|455427728|FG000|Overall Study|Death|3|||
126531689|NCT01972841|455237386|FG004|Overall Study|Did not have end of treatment page|1|||
126531690|NCT01972841|455237387|FG005|Overall Study|Did not have end of treatment page|0|||
126531691|NCT04969198|455237390|FG000|Overall Study|Withdrawal by Subject|20|||
126531692|NCT04969198|455237390|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
126531693|NCT04969198|455237390|FG000|Overall Study|Lost to Follow-up|20|||
126531694|NCT01041638|455237401|FG000|Overall Study|Adverse Event|4|||
126531695|NCT01041638|455237401|FG000|Overall Study|Death|1|||
126531696|NCT01041638|455237401|FG000|Overall Study|Lack of Efficacy|7|||
126531697|NCT01041638|455237401|FG000|Overall Study|Physician Decision|4|||
126531698|NCT01041638|455237401|FG000|Overall Study|Withdrawal by Subject|11|||
126531699|NCT01687257|455237403|FG000|Overall Study|Efficacy Failure|6|||
126531700|NCT01687257|455237404|FG001|Overall Study|Efficacy Failure|0|||
126531701|NCT01687257|455237405|FG002|Overall Study|Efficacy Failure|5|||
126531702|NCT01687257|455237403|FG000|Overall Study|Subject Withdrew Consent|1|||
126531703|NCT01687257|455237404|FG001|Overall Study|Subject Withdrew Consent|1|||
126531704|NCT01687257|455237405|FG002|Overall Study|Subject Withdrew Consent|1|||
126531705|NCT01687257|455237403|FG000|Overall Study|Adverse Event|1|||
126531706|NCT01687257|455237404|FG001|Overall Study|Adverse Event|0|||
126531707|NCT01687257|455237405|FG002|Overall Study|Adverse Event|0|||
126531708|NCT01687257|455237403|FG000|Overall Study|Investigator's Discretion|0|||
126531709|NCT01687257|455237404|FG001|Overall Study|Investigator's Discretion|3|||
126531710|NCT01687257|455237405|FG002|Overall Study|Investigator's Discretion|0|||
126531711|NCT01922076|455237407|FG000|Overall Study|Adverse Event|0|||
126531712|NCT01922076|455237408|FG001|Overall Study|Adverse Event|0|||
126531713|NCT01922076|455237409|FG002|Overall Study|Adverse Event|0|||
126531714|NCT01922076|455237410|FG003|Overall Study|Adverse Event|0|||
126531715|NCT01922076|455237411|FG004|Overall Study|Adverse Event|1|||
126581900|NCT04436107|455427729|FG001|Overall Study|Death|5|||
126581901|NCT04436107|455427730|FG002|Overall Study|Death|3|||
126581902|NCT04436107|455427731|FG003|Overall Study|Death|18|||
126581903|NCT04436107|455427728|FG000|Overall Study|Withdrawal by Subject|1|||
126581904|NCT04436107|455427729|FG001|Overall Study|Withdrawal by Subject|1|||
126581905|NCT04436107|455427730|FG002|Overall Study|Withdrawal by Subject|0|||
126729713|NCT00819585|455958512|FG008|Core Study|Subject Withdrew Consent|0|||
126531716|NCT01922076|455237412|FG005|Overall Study|Adverse Event|0|||
126531717|NCT01922076|455237413|FG006|Overall Study|Adverse Event|0|||
126581906|NCT04436107|455427731|FG003|Overall Study|Withdrawal by Subject|1|||
126581907|NCT04116736|455427734|FG000|Overall Study|Withdrew consent during study|3|||
126531718|NCT01922076|455237407|FG000|Overall Study|Physician Decision|0|||
126531719|NCT01922076|455237408|FG001|Overall Study|Physician Decision|0|||
126531720|NCT01922076|455237409|FG002|Overall Study|Physician Decision|1|||
126531721|NCT01922076|455237410|FG003|Overall Study|Physician Decision|0|||
126531722|NCT01922076|455237411|FG004|Overall Study|Physician Decision|0|||
126531723|NCT01922076|455237412|FG005|Overall Study|Physician Decision|0|||
126531724|NCT01922076|455237413|FG006|Overall Study|Physician Decision|0|||
126531725|NCT01922076|455237407|FG000|Overall Study|Withdrawal by Subject|0|||
126531726|NCT01922076|455237408|FG001|Overall Study|Withdrawal by Subject|0|||
126531727|NCT01922076|455237409|FG002|Overall Study|Withdrawal by Subject|0|||
126531728|NCT01922076|455237410|FG003|Overall Study|Withdrawal by Subject|1|||
126531729|NCT01922076|455237411|FG004|Overall Study|Withdrawal by Subject|0|||
126531730|NCT01922076|455237412|FG005|Overall Study|Withdrawal by Subject|1|||
126531731|NCT01922076|455237413|FG006|Overall Study|Withdrawal by Subject|1|||
126729714|NCT00819585|455958513|FG009|Core Study|Subject Withdrew Consent|0|||
126531732|NCT01018394|455237416|FG000|Overall Study|Withdrawal by Subject|5|||
126531733|NCT01018394|455237417|FG001|Overall Study|Withdrawal by Subject|5|||
126531734|NCT01018394|455237416|FG000|Overall Study|Lost to Follow-up|4|||
126531735|NCT01018394|455237417|FG001|Overall Study|Lost to Follow-up|3|||
126531736|NCT00683644|455237418|FG000|Overall Study|Withdrawal by Subject|4|||
126531737|NCT00683644|455237419|FG001|Overall Study|Withdrawal by Subject|2|||
126531738|NCT00683644|455237418|FG000|Overall Study|Lost to Follow-up|1|||
126581908|NCT04116736|455427735|FG001|Overall Study|Withdrew consent during study|1|||
126581909|NCT04116736|455427734|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
126581910|NCT04116736|455427735|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
126581911|NCT04116736|455427734|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
126581912|NCT04116736|455427735|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
126581913|NCT04116736|455427734|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
126581914|NCT04116736|455427735|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
126729715|NCT00819585|455958514|FG010|Core Study|Subject Withdrew Consent|0|||
126729716|NCT00819585|455958504|FG000|Core Study|Lost to Follow-up|2|||
126729717|NCT00819585|455958505|FG001|Core Study|Lost to Follow-up|1|||
126729718|NCT00819585|455958506|FG002|Core Study|Lost to Follow-up|2|||
126729719|NCT00819585|455958507|FG003|Core Study|Lost to Follow-up|0|||
126729720|NCT00819585|455958508|FG004|Core Study|Lost to Follow-up|1|||
126729721|NCT00819585|455958509|FG005|Core Study|Lost to Follow-up|1|||
126729722|NCT00819585|455958510|FG006|Core Study|Lost to Follow-up|1|||
126729723|NCT00819585|455958511|FG007|Core Study|Lost to Follow-up|0|||
126729724|NCT00819585|455958512|FG008|Core Study|Lost to Follow-up|0|||
126729725|NCT00819585|455958513|FG009|Core Study|Lost to Follow-up|0|||
126729726|NCT00819585|455958514|FG010|Core Study|Lost to Follow-up|0|||
126729727|NCT00819585|455958504|FG000|Core Study|Administrative Problems|0|||
126729728|NCT00819585|455958505|FG001|Core Study|Administrative Problems|0|||
126729729|NCT00819585|455958506|FG002|Core Study|Administrative Problems|0|||
126729730|NCT00819585|455958507|FG003|Core Study|Administrative Problems|0|||
126729731|NCT00819585|455958508|FG004|Core Study|Administrative Problems|0|||
126729732|NCT00819585|455958509|FG005|Core Study|Administrative Problems|0|||
126729733|NCT00819585|455958510|FG006|Core Study|Administrative Problems|2|||
126729734|NCT00819585|455958511|FG007|Core Study|Administrative Problems|0|||
126729735|NCT00819585|455958512|FG008|Core Study|Administrative Problems|0|||
126729736|NCT00819585|455958513|FG009|Core Study|Administrative Problems|0|||
126729737|NCT00819585|455958514|FG010|Core Study|Administrative Problems|0|||
126729738|NCT00819585|455958504|FG000|Core Study|Death|0|||
126729739|NCT00819585|455958505|FG001|Core Study|Death|0|||
126729740|NCT00819585|455958506|FG002|Core Study|Death|0|||
126729741|NCT00819585|455958507|FG003|Core Study|Death|0|||
126581915|NCT04116736|455427734|FG000|Overall Study|Subject was enrolled in error|2|||
126581916|NCT04116736|455427735|FG001|Overall Study|Subject was enrolled in error|0|||
126581917|NCT04116736|455427734|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
126581918|NCT04116736|455427735|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
126581919|NCT04116736|455427734|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
126729742|NCT00819585|455958508|FG004|Core Study|Death|0|||
126729743|NCT00819585|455958509|FG005|Core Study|Death|0|||
126729744|NCT00819585|455958510|FG006|Core Study|Death|1|||
126729745|NCT00819585|455958511|FG007|Core Study|Death|0|||
126729746|NCT00819585|455958512|FG008|Core Study|Death|0|||
126531739|NCT00683644|455237419|FG001|Overall Study|Lost to Follow-up|4|||
126531740|NCT00683644|455237418|FG000|Overall Study|Adverse Event|1|||
126531741|NCT00683644|455237419|FG001|Overall Study|Adverse Event|2|||
126531742|NCT00683644|455237418|FG000|Overall Study|Low copper, other health problems,|7|||
126729747|NCT00819585|455958513|FG009|Core Study|Death|0|||
126729748|NCT00819585|455958514|FG010|Core Study|Death|0|||
126729749|NCT00819585|455958504|FG000|Core Study|Protocol Violation|0|||
126729750|NCT00819585|455958505|FG001|Core Study|Protocol Violation|0|||
126729751|NCT00819585|455958506|FG002|Core Study|Protocol Violation|1|||
126729752|NCT00819585|455958507|FG003|Core Study|Protocol Violation|0|||
126531743|NCT00683644|455237419|FG001|Overall Study|Low copper, other health problems,|6|||
126531744|NCT01565707|455237420|FG000|Overall Study|Adverse Event|1|||
126729753|NCT00819585|455958508|FG004|Core Study|Protocol Violation|0|||
126729754|NCT00819585|455958509|FG005|Core Study|Protocol Violation|1|||
126729755|NCT00819585|455958510|FG006|Core Study|Protocol Violation|3|||
126729756|NCT00819585|455958511|FG007|Core Study|Protocol Violation|0|||
126729757|NCT00819585|455958512|FG008|Core Study|Protocol Violation|0|||
126729758|NCT00819585|455958513|FG009|Core Study|Protocol Violation|0|||
126729759|NCT00819585|455958514|FG010|Core Study|Protocol Violation|0|||
126729760|NCT00819585|455958504|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
126729761|NCT00819585|455958505|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
126729762|NCT00819585|455958506|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
126729763|NCT00819585|455958507|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
126729764|NCT00819585|455958508|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
126729765|NCT00819585|455958509|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
126729766|NCT00819585|455958510|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
126729767|NCT00819585|455958511|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
126729768|NCT00819585|455958512|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
126729769|NCT00819585|455958513|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
126729770|NCT00819585|455958514|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
126729771|NCT00819585|455958504|FG000|Extension Study|Subject Withdrew Consent|0|||
126729772|NCT00819585|455958505|FG001|Extension Study|Subject Withdrew Consent|0|||
126729773|NCT00819585|455958506|FG002|Extension Study|Subject Withdrew Consent|0|||
126729774|NCT00819585|455958507|FG003|Extension Study|Subject Withdrew Consent|0|||
126729775|NCT00819585|455958508|FG004|Extension Study|Subject Withdrew Consent|0|||
126729776|NCT00819585|455958509|FG005|Extension Study|Subject Withdrew Consent|0|||
126729777|NCT00819585|455958510|FG006|Extension Study|Subject Withdrew Consent|0|||
126729778|NCT00819585|455958511|FG007|Extension Study|Subject Withdrew Consent|0|||
126729779|NCT00819585|455958512|FG008|Extension Study|Subject Withdrew Consent|3|||
126729780|NCT00819585|455958513|FG009|Extension Study|Subject Withdrew Consent|0|||
126729781|NCT00819585|455958514|FG010|Extension Study|Subject Withdrew Consent|1|||
126729782|NCT00819585|455958504|FG000|Extension Study|Lost to Follow-up|0|||
126729783|NCT00819585|455958505|FG001|Extension Study|Lost to Follow-up|0|||
126729784|NCT00819585|455958506|FG002|Extension Study|Lost to Follow-up|0|||
126729785|NCT00819585|455958507|FG003|Extension Study|Lost to Follow-up|0|||
126729786|NCT00819585|455958508|FG004|Extension Study|Lost to Follow-up|0|||
126729787|NCT00819585|455958509|FG005|Extension Study|Lost to Follow-up|0|||
126729788|NCT00819585|455958510|FG006|Extension Study|Lost to Follow-up|0|||
126729789|NCT00819585|455958511|FG007|Extension Study|Lost to Follow-up|0|||
126729790|NCT00819585|455958512|FG008|Extension Study|Lost to Follow-up|2|||
126729791|NCT00819585|455958513|FG009|Extension Study|Lost to Follow-up|1|||
126729792|NCT00819585|455958514|FG010|Extension Study|Lost to Follow-up|1|||
126729793|NCT00819585|455958504|FG000|Extension Study|Death|0|||
126729794|NCT00819585|455958505|FG001|Extension Study|Death|0|||
126729795|NCT00819585|455958506|FG002|Extension Study|Death|0|||
126729796|NCT00819585|455958507|FG003|Extension Study|Death|0|||
126729797|NCT00819585|455958508|FG004|Extension Study|Death|0|||
126729798|NCT00819585|455958509|FG005|Extension Study|Death|0|||
126729799|NCT00819585|455958510|FG006|Extension Study|Death|0|||
126729800|NCT00819585|455958511|FG007|Extension Study|Death|0|||
126729801|NCT00819585|455958512|FG008|Extension Study|Death|2|||
126729802|NCT00819585|455958513|FG009|Extension Study|Death|0|||
126729803|NCT00819585|455958514|FG010|Extension Study|Death|0|||
126729804|NCT02159469|455958515|FG000|Overall Study|Missing Completion status|1|||
126729805|NCT02159469|455958515|FG000|Overall Study|Adverse Event|5|||
126729806|NCT02159469|455958515|FG000|Overall Study|Non-compliance|2|||
126729807|NCT02159469|455958515|FG000|Overall Study|Withdrawal by Subject|9|||
126729808|NCT02159469|455958515|FG000|Overall Study|Lost to Follow-up|1|||
126729809|NCT02159469|455958515|FG000|Overall Study|Sponsor's request|2|||
126729810|NCT02159469|455958515|FG000|Overall Study|Met Stopping Criteria|3|||
126531745|NCT01565707|455237421|FG001|Overall Study|Adverse Event|6|||
126531746|NCT01565707|455237422|FG002|Overall Study|Adverse Event|2|||
126531747|NCT01565707|455237423|FG003|Overall Study|Adverse Event|1|||
126531748|NCT01565707|455237420|FG000|Overall Study|Lost to Follow-up|1|||
126729811|NCT02159469|455958515|FG000|Overall Study|Other|1|||
126729812|NCT02159469|455958515|FG000|Overall Study|Multiple|29|||
126729813|NCT00383721|455958517|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
126729814|NCT00383721|455958518|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
126531749|NCT01565707|455237421|FG001|Overall Study|Lost to Follow-up|0|||
126531750|NCT01565707|455237422|FG002|Overall Study|Lost to Follow-up|0|||
126581920|NCT04116736|455427735|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
126729815|NCT00383721|455958519|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
126729816|NCT00383721|455958520|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
126729817|NCT00383721|455958521|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
126729818|NCT00383721|455958517|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
126729819|NCT00383721|455958518|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
126729820|NCT00383721|455958519|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
126729821|NCT00383721|455958520|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
126729822|NCT00383721|455958521|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
126729823|NCT00383721|455958517|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
126729824|NCT00383721|455958518|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
126729825|NCT00383721|455958519|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
126729826|NCT00383721|455958520|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
126729827|NCT00383721|455958521|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
126729828|NCT00383721|455958517|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
126729829|NCT00383721|455958518|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
126729830|NCT00383721|455958519|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
126729831|NCT00383721|455958520|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
126729832|NCT00383721|455958521|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
126729833|NCT00383721|455958517|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
126729834|NCT00383721|455958518|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
126729835|NCT00383721|455958519|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
126729836|NCT00383721|455958520|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
126729837|NCT00383721|455958521|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
126729838|NCT00383721|455958517|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
126729839|NCT00383721|455958518|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
126729840|NCT00383721|455958519|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
126729841|NCT00383721|455958520|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
126729842|NCT00383721|455958521|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
126729843|NCT00383721|455958517|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
126729844|NCT00383721|455958518|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
126729845|NCT00383721|455958519|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
126729846|NCT00383721|455958520|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
126729847|NCT00383721|455958521|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
126729848|NCT00383721|455958517|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
126729849|NCT00383721|455958518|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
126729850|NCT00383721|455958519|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
126531751|NCT01565707|455237423|FG003|Overall Study|Lost to Follow-up|0|||
126531752|NCT01565707|455237420|FG000|Overall Study|Protocol Violation|1|||
126729851|NCT00383721|455958520|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
126729852|NCT00383721|455958521|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
126729853|NCT00383721|455958517|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
126729854|NCT00383721|455958518|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
126729855|NCT00383721|455958519|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
126729856|NCT00383721|455958520|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
126729857|NCT00383721|455958521|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
126729858|NCT00383721|455958517|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
126729859|NCT00383721|455958518|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
126729860|NCT00383721|455958519|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
126729861|NCT00383721|455958520|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
126729862|NCT00383721|455958521|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
126729863|NCT00383721|455958517|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
126729864|NCT00383721|455958518|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
126729865|NCT00383721|455958519|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
126729866|NCT00383721|455958520|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
126729867|NCT00383721|455958521|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
126729868|NCT00383721|455958517|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
126729869|NCT00383721|455958518|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
126729870|NCT00383721|455958519|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
126729871|NCT00383721|455958520|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
126729872|NCT00383721|455958521|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
126729873|NCT00383721|455958517|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
126531753|NCT01565707|455237421|FG001|Overall Study|Protocol Violation|0|||
126531754|NCT01565707|455237422|FG002|Overall Study|Protocol Violation|0|||
126531755|NCT01565707|455237423|FG003|Overall Study|Protocol Violation|1|||
126531756|NCT01565707|455237420|FG000|Overall Study|Withdrawal by Subject|3|||
126531757|NCT01565707|455237421|FG001|Overall Study|Withdrawal by Subject|1|||
126531758|NCT01565707|455237422|FG002|Overall Study|Withdrawal by Subject|1|||
126531759|NCT01565707|455237423|FG003|Overall Study|Withdrawal by Subject|1|||
126531760|NCT01565707|455237420|FG000|Overall Study|Randomized but not evaluable|2|||
126531761|NCT01565707|455237421|FG001|Overall Study|Randomized but not evaluable|0|||
126581921|NCT04116736|455427734|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
126729874|NCT00383721|455958518|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
126729875|NCT00383721|455958519|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
126729876|NCT00383721|455958520|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
126729877|NCT00383721|455958521|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
126729878|NCT00383721|455958517|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
126729879|NCT00383721|455958518|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
126729880|NCT00383721|455958519|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
126729881|NCT00383721|455958520|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
126729882|NCT00383721|455958521|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
126729883|NCT00383721|455958517|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
126729884|NCT00383721|455958518|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
126729885|NCT00383721|455958519|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
126729886|NCT00383721|455958520|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
126729887|NCT00383721|455958521|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
126729888|NCT00383721|455958517|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
126729889|NCT00383721|455958518|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
126729890|NCT00383721|455958519|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
126729891|NCT00383721|455958520|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
126729892|NCT00383721|455958521|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
126729893|NCT00383721|455958517|FG000|26-Week Treatment Safety Extension|Administrative|1|||
126729894|NCT00383721|455958518|FG001|26-Week Treatment Safety Extension|Administrative|2|||
126729895|NCT00383721|455958519|FG002|26-Week Treatment Safety Extension|Administrative|3|||
126729896|NCT00383721|455958520|FG003|26-Week Treatment Safety Extension|Administrative|1|||
126729897|NCT00383721|455958521|FG004|26-Week Treatment Safety Extension|Administrative|0|||
126756536|NCT01667731|456059467|FG002|Overall Study|Enrolled but not treated|0|||
126756537|NCT01667731|456059468|FG003|Overall Study|Enrolled but not treated|0|||
126756538|NCT01667731|456059469|FG004|Overall Study|Enrolled but not treated|1|||
126756539|NCT01667731|456059465|FG000|Overall Study|Efficacy Failure|1|||
126756540|NCT01667731|456059466|FG001|Overall Study|Efficacy Failure|12|||
126756541|NCT01667731|456059467|FG002|Overall Study|Efficacy Failure|0|||
126756542|NCT01667731|456059468|FG003|Overall Study|Efficacy Failure|1|||
126756543|NCT01667731|456059469|FG004|Overall Study|Efficacy Failure|24|||
126756544|NCT01667731|456059465|FG000|Overall Study|Lost to Follow-up|2|||
126756545|NCT01667731|456059466|FG001|Overall Study|Lost to Follow-up|3|||
126756546|NCT01667731|456059467|FG002|Overall Study|Lost to Follow-up|1|||
126756547|NCT01667731|456059468|FG003|Overall Study|Lost to Follow-up|1|||
126756548|NCT01667731|456059469|FG004|Overall Study|Lost to Follow-up|2|||
126756549|NCT01667731|456059465|FG000|Overall Study|Subject Withdrew Consent|2|||
126756550|NCT01667731|456059466|FG001|Overall Study|Subject Withdrew Consent|0|||
126756551|NCT01667731|456059467|FG002|Overall Study|Subject Withdrew Consent|1|||
126756552|NCT01667731|456059468|FG003|Overall Study|Subject Withdrew Consent|0|||
126756553|NCT01667731|456059469|FG004|Overall Study|Subject Withdrew Consent|1|||
126756554|NCT01667731|456059465|FG000|Overall Study|Death|0|||
126756555|NCT01667731|456059466|FG001|Overall Study|Death|1|||
126756556|NCT01667731|456059467|FG002|Overall Study|Death|0|||
126756557|NCT01667731|456059468|FG003|Overall Study|Death|0|||
126756558|NCT01667731|456059469|FG004|Overall Study|Death|0|||
126581922|NCT04116736|455427735|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
126581923|NCT05512962|455427738|FG000|Overall Study|Withdrawal by Subject|1|||
126581924|NCT05512962|455427739|FG001|Overall Study|Withdrawal by Subject|0|||
126581925|NCT05575076|455427741|FG000|Overall Study|Adverse Event|24|||
126581926|NCT05575076|455427741|FG000|Overall Study|Death|7|||
126581927|NCT05575076|455427741|FG000|Overall Study|Lost to Follow-up|16|||
126581928|NCT05575076|455427741|FG000|Overall Study|Non-Compliance|3|||
126581929|NCT05575076|455427741|FG000|Overall Study|Physician Decision|6|||
126581930|NCT05575076|455427741|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
126581931|NCT05575076|455427741|FG000|Overall Study|Withdrawal by Subject|71|||
126581932|NCT05575076|455427741|FG000|Overall Study|Study Terminated by Sponsor|630|||
126756559|NCT01425268|456059470|FG000|Overall Study|Withdrawal by Subject|2|||
126756560|NCT01425268|456059471|FG001|Overall Study|Withdrawal by Subject|0|||
126756561|NCT01425268|456059470|FG000|Overall Study|Sponsor Decision|5|||
126756562|NCT01425268|456059471|FG001|Overall Study|Sponsor Decision|0|||
126756563|NCT01425268|456059470|FG000|Overall Study|Physician Decision|1|||
126756564|NCT01425268|456059471|FG001|Overall Study|Physician Decision|0|||
126581933|NCT05575076|455427741|FG000|Overall Study|Other|17|||
126581934|NCT01127373|455427742|FG000|Overall Study|Not Treated|3|||
126756565|NCT03633461|456059472|FG000|Overall Study|Lost to Follow-up|0|||
126756566|NCT03633461|456059473|FG001|Overall Study|Lost to Follow-up|1|||
126756567|NCT01345162|456059478|FG000|Overall Study|Protocol Violation|2|||
126756568|NCT01345162|456059479|FG001|Overall Study|Protocol Violation|4|||
126756569|NCT01871870|456059480|FG000|Overall Study|Hardware issues|7|||
126581935|NCT01127373|455427742|FG000|Overall Study|Lost to Follow-up|7|||
126531762|NCT01565707|455237422|FG002|Overall Study|Randomized but not evaluable|0|||
126531763|NCT01565707|455237423|FG003|Overall Study|Randomized but not evaluable|0|||
126531764|NCT01565707|455237420|FG000|Overall Study|Miscellaneous|1|||
126531765|NCT01565707|455237421|FG001|Overall Study|Miscellaneous|1|||
126531766|NCT01565707|455237422|FG002|Overall Study|Miscellaneous|0|||
126531767|NCT01565707|455237423|FG003|Overall Study|Miscellaneous|2|||
126531768|NCT05207813|455237424|FG000|Overall Study|Lost to Follow-up|2|||
126531769|NCT04988308|455237425|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
126531770|NCT04988308|455237426|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
126531771|NCT04988308|455237427|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
126531772|NCT04988308|455237428|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
126531773|NCT04988308|455237429|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
126531774|NCT04988308|455237430|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
126531775|NCT04988308|455237425|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
126531776|NCT04988308|455237426|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
126531777|NCT04988308|455237427|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
126531778|NCT04988308|455237428|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
126531779|NCT04988308|455237429|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
126531780|NCT04988308|455237430|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
126531781|NCT04988308|455237425|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
126531782|NCT04988308|455237426|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
126531783|NCT04988308|455237427|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
126531784|NCT04988308|455237428|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
126531785|NCT04988308|455237429|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
126531786|NCT04988308|455237430|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
126531787|NCT04988308|455237425|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
126531788|NCT04988308|455237426|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
126531789|NCT04988308|455237427|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
126531790|NCT04988308|455237428|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
126531791|NCT04988308|455237429|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
126531792|NCT04988308|455237430|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
126531793|NCT04988308|455237425|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
126531794|NCT04988308|455237426|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
126531795|NCT04988308|455237427|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
126531796|NCT04988308|455237428|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
126531797|NCT04988308|455237429|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
126531798|NCT04988308|455237430|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
126531799|NCT04988308|455237425|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
126531800|NCT04988308|455237426|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
126531801|NCT04988308|455237427|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
126531802|NCT04988308|455237428|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
126531803|NCT04988308|455237429|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
126531804|NCT04988308|455237430|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
126531805|NCT04988308|455237425|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
126531806|NCT04988308|455237426|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
126531807|NCT04988308|455237427|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
126531808|NCT04988308|455237428|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
126531809|NCT04988308|455237429|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
126531810|NCT04988308|455237430|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
126531811|NCT04988308|455237425|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
126531812|NCT04988308|455237426|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
126531813|NCT04988308|455237427|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
126531814|NCT04988308|455237428|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
126531815|NCT04988308|455237429|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
126531816|NCT04988308|455237430|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
126531817|NCT04988308|455237425|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
126531818|NCT04988308|455237426|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
126531819|NCT04988308|455237427|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
126531820|NCT04988308|455237428|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
126531821|NCT04988308|455237429|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
126531822|NCT04988308|455237430|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
126581936|NCT01127373|455427742|FG000|Overall Study|Withdrawal by Subject|1|||
126581937|NCT01127373|455427742|FG000|Overall Study|Disease progression|1|||
126581938|NCT01426412|455427749|FG000|Overall Study|Withdrawal by Subject|1|||
126581939|NCT01426412|455427750|FG001|Overall Study|Withdrawal by Subject|0|||
126581940|NCT01426412|455427751|FG002|Overall Study|Withdrawal by Subject|0|||
126729898|NCT01255306|455960339|FG000|Overall Study|Physician Decision|1|||
126729899|NCT01255306|455960340|FG001|Overall Study|Physician Decision|1|||
126729900|NCT01146951|455960341|FG000|Overall Study|Adverse Event|4|||
126729901|NCT01146951|455960342|FG001|Overall Study|Adverse Event|1|||
126729902|NCT00804843|455960346|FG000|Overall Study|Protocol Violation|1|||
126729903|NCT00804843|455960347|FG001|Overall Study|Protocol Violation|0|||
126729904|NCT00804843|455960346|FG000|Overall Study|Adverse Event|8|||
126729905|NCT00804843|455960347|FG001|Overall Study|Adverse Event|5|||
126729906|NCT00804843|455960346|FG000|Overall Study|Withdrawal by Subject|1|||
126729907|NCT00804843|455960347|FG001|Overall Study|Withdrawal by Subject|2|||
126729908|NCT02126670|455960356|FG000|Overall Study|Withdrawal by Subject|1|||
126729909|NCT02126670|455960357|FG001|Overall Study|Withdrawal by Subject|0|||
126729910|NCT02126670|455960358|FG002|Overall Study|Withdrawal by Subject|0|||
126729911|NCT02126670|455960359|FG003|Overall Study|Withdrawal by Subject|1|||
126729912|NCT01975246|455960360|FG000|Overall Study|Adverse Event|2|||
126729913|NCT01975246|455960361|FG001|Overall Study|Adverse Event|1|||
126729914|NCT01975246|455960360|FG000|Overall Study|Lack of Efficacy|1|||
126729915|NCT01975246|455960361|FG001|Overall Study|Lack of Efficacy|0|||
126729916|NCT01975246|455960360|FG000|Overall Study|Protocol Violation|1|||
126729917|NCT01975246|455960361|FG001|Overall Study|Protocol Violation|0|||
126729918|NCT01975246|455960360|FG000|Overall Study|Other than stated|0|||
126729919|NCT01975246|455960361|FG001|Overall Study|Other than stated|1|||
126729920|NCT01263093|455960362|FG000|Washout|Physician Decision|1|||
126729921|NCT01263093|455960363|FG001|Washout|Physician Decision|0|||
126729922|NCT01263093|455960362|FG000|Period 2|Adverse Event|1|||
126729923|NCT01263093|455960363|FG001|Period 2|Adverse Event|0|||
126729924|NCT00424346|455960364|FG000|Core Study|Adverse Event|5|||
126729925|NCT00424346|455960365|FG001|Core Study|Adverse Event|3|||
126729926|NCT00424346|455960366|FG002|Core Study|Adverse Event|1|||
126729927|NCT00424346|455960367|FG003|Core Study|Adverse Event|1|||
126729928|NCT00424346|455960364|FG000|Core Study|Abnormal Laboratory Values|0|||
126729929|NCT00424346|455960365|FG001|Core Study|Abnormal Laboratory Values|1|||
126729930|NCT00424346|455960366|FG002|Core Study|Abnormal Laboratory Values|0|||
126729931|NCT00424346|455960367|FG003|Core Study|Abnormal Laboratory Values|0|||
126729932|NCT00424346|455960364|FG000|Core Study|Lack of Efficacy|1|||
126729933|NCT00424346|455960365|FG001|Core Study|Lack of Efficacy|3|||
126729934|NCT00424346|455960366|FG002|Core Study|Lack of Efficacy|0|||
126729935|NCT00424346|455960367|FG003|Core Study|Lack of Efficacy|4|||
126729936|NCT00424346|455960364|FG000|Core Study|Withdrawal by Subject|1|||
126729937|NCT00424346|455960365|FG001|Core Study|Withdrawal by Subject|0|||
126729938|NCT00424346|455960366|FG002|Core Study|Withdrawal by Subject|0|||
126729939|NCT00424346|455960367|FG003|Core Study|Withdrawal by Subject|2|||
126729940|NCT00424346|455960364|FG000|Core Study|Lost to Follow-up|1|||
126729941|NCT00424346|455960365|FG001|Core Study|Lost to Follow-up|1|||
126729942|NCT00424346|455960366|FG002|Core Study|Lost to Follow-up|0|||
126729943|NCT00424346|455960367|FG003|Core Study|Lost to Follow-up|0|||
126729944|NCT00424346|455960364|FG000|Core Study|Administrative Problems|1|||
126729945|NCT00424346|455960365|FG001|Core Study|Administrative Problems|0|||
126729946|NCT00424346|455960366|FG002|Core Study|Administrative Problems|1|||
126729947|NCT00424346|455960367|FG003|Core Study|Administrative Problems|0|||
126729948|NCT00424346|455960364|FG000|Core Study|Protocol Violation|0|||
126729949|NCT00424346|455960365|FG001|Core Study|Protocol Violation|0|||
126729950|NCT00424346|455960366|FG002|Core Study|Protocol Violation|2|||
126729951|NCT00424346|455960367|FG003|Core Study|Protocol Violation|0|||
126729952|NCT00424346|455960364|FG000|Extension Phase|Adverse Event|0|||
126729953|NCT00424346|455960365|FG001|Extension Phase|Adverse Event|9|||
126729954|NCT00424346|455960366|FG002|Extension Phase|Adverse Event|5|||
126729955|NCT00424346|455960367|FG003|Extension Phase|Adverse Event|4|||
126729956|NCT00424346|455960364|FG000|Extension Phase|Lack of Efficacy|0|||
126729957|NCT00424346|455960365|FG001|Extension Phase|Lack of Efficacy|16|||
126729958|NCT00424346|455960366|FG002|Extension Phase|Lack of Efficacy|14|||
126729959|NCT00424346|455960367|FG003|Extension Phase|Lack of Efficacy|11|||
126729960|NCT00424346|455960364|FG000|Extension Phase|Withdrawal by Subject|0|||
126729961|NCT00424346|455960365|FG001|Extension Phase|Withdrawal by Subject|5|||
126729962|NCT00424346|455960366|FG002|Extension Phase|Withdrawal by Subject|3|||
126729963|NCT00424346|455960367|FG003|Extension Phase|Withdrawal by Subject|4|||
126729964|NCT00424346|455960364|FG000|Extension Phase|Lost to Follow-up|0|||
126729965|NCT00424346|455960365|FG001|Extension Phase|Lost to Follow-up|2|||
126729966|NCT00424346|455960366|FG002|Extension Phase|Lost to Follow-up|0|||
126729967|NCT00424346|455960367|FG003|Extension Phase|Lost to Follow-up|0|||
126729968|NCT00424346|455960364|FG000|Extension Phase|Administrative Problems|0|||
126729969|NCT00424346|455960365|FG001|Extension Phase|Administrative Problems|69|||
126729970|NCT00424346|455960366|FG002|Extension Phase|Administrative Problems|32|||
126729971|NCT00424346|455960367|FG003|Extension Phase|Administrative Problems|35|||
126729972|NCT00424346|455960364|FG000|Extension Phase|Death|0|||
126729973|NCT00424346|455960365|FG001|Extension Phase|Death|0|||
126729974|NCT00424346|455960366|FG002|Extension Phase|Death|0|||
126729975|NCT00424346|455960367|FG003|Extension Phase|Death|1|||
126729976|NCT00424346|455960364|FG000|Extension Phase|Protocol Violation|0|||
126729977|NCT00424346|455960365|FG001|Extension Phase|Protocol Violation|1|||
126729978|NCT00424346|455960366|FG002|Extension Phase|Protocol Violation|1|||
126729979|NCT00424346|455960367|FG003|Extension Phase|Protocol Violation|0|||
126729980|NCT01827319|455960368|FG000|Overall Study|Lost to Follow-up|3|||
126729981|NCT00571519|455960369|FG000|Overall Study|Subject withdrew consent|0|||
126729982|NCT00571519|455960370|FG001|Overall Study|Subject withdrew consent|1|||
126729983|NCT00571519|455960371|FG002|Overall Study|Subject withdrew consent|0|||
126729984|NCT00571519|455960372|FG003|Overall Study|Subject withdrew consent|2|||
126729985|NCT00571519|455960373|FG004|Overall Study|Subject withdrew consent|1|||
126729986|NCT00571519|455960374|FG005|Overall Study|Subject withdrew consent|1|||
126729987|NCT00571519|455960375|FG006|Overall Study|Subject withdrew consent|2|||
126729988|NCT00571519|455960369|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
126729989|NCT00571519|455960370|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
126729990|NCT00571519|455960371|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
126729991|NCT00571519|455960372|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
126729992|NCT00571519|455960373|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
126729993|NCT00571519|455960374|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
126729994|NCT00571519|455960375|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
126729995|NCT00571519|455960369|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
126729996|NCT00571519|455960370|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
126729997|NCT00571519|455960371|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
126729998|NCT00571519|455960372|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
126729999|NCT00571519|455960373|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
126730000|NCT00571519|455960374|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
126730001|NCT00571519|455960375|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
126730002|NCT00571519|455960369|FG000|Overall Study|Termination of study by Sponsor|2|||
126730003|NCT00571519|455960370|FG001|Overall Study|Termination of study by Sponsor|7|||
126730004|NCT00571519|455960371|FG002|Overall Study|Termination of study by Sponsor|10|||
126730005|NCT00571519|455960372|FG003|Overall Study|Termination of study by Sponsor|24|||
126730006|NCT00571519|455960373|FG004|Overall Study|Termination of study by Sponsor|8|||
126730007|NCT00571519|455960374|FG005|Overall Study|Termination of study by Sponsor|9|||
126730008|NCT00571519|455960375|FG006|Overall Study|Termination of study by Sponsor|22|||
126730009|NCT00571519|455960369|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
126730010|NCT00571519|455960370|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
126730011|NCT00571519|455960371|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
126730012|NCT00571519|455960372|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
126730013|NCT00571519|455960373|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
126730014|NCT00571519|455960374|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
126730015|NCT00571519|455960375|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
126730016|NCT00562640|455960377|FG000|Overall Study|Death|0|||
126730017|NCT00562640|455960378|FG001|Overall Study|Death|1|||
126730018|NCT00562640|455960379|FG002|Overall Study|Death|1|||
126730019|NCT00562640|455960380|FG003|Overall Study|Death|0|||
126730020|NCT05263921|455960381|FG000|Overall Study|Other: family emergency.|0|||
126730021|NCT05263921|455960382|FG001|Overall Study|Other: family emergency.|0|||
126730022|NCT05263921|455960383|FG002|Overall Study|Other: family emergency.|1|||
126730023|NCT05263921|455960384|FG003|Overall Study|Other: family emergency.|0|||
126730024|NCT02499575|455960385|FG000|Overall Study|Protocol Violation|0|||
126730025|NCT02499575|455960386|FG001|Overall Study|Protocol Violation|1|||
126730026|NCT02658968|455960387|FG000|Received Rituximab|Adverse Event|0|||
126730027|NCT02658968|455960388|FG001|Received Rituximab|Adverse Event|0|||
126730028|NCT02658968|455960389|FG002|Received Rituximab|Adverse Event|0|||
126730029|NCT02658968|455960390|FG003|Received Rituximab|Adverse Event|0|||
126730030|NCT02658968|455960391|FG004|Received Rituximab|Adverse Event|1|||
126730031|NCT02658968|455960387|FG000|Received Rituximab|Progressive disease|0|||
126730032|NCT02658968|455960388|FG001|Received Rituximab|Progressive disease|0|||
126730033|NCT02658968|455960389|FG002|Received Rituximab|Progressive disease|0|||
126730034|NCT02658968|455960390|FG003|Received Rituximab|Progressive disease|0|||
126730035|NCT02658968|455960391|FG004|Received Rituximab|Progressive disease|1|||
126730036|NCT02658968|455960387|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
126730037|NCT02658968|455960388|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
126730038|NCT02658968|455960389|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
126730039|NCT02658968|455960390|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
126730040|NCT02658968|455960391|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
126730041|NCT02658968|455960387|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
126730042|NCT02658968|455960388|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
126730043|NCT02658968|455960389|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
126730044|NCT02658968|455960390|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
126756570|NCT01871870|456059480|FG000|Overall Study|hyperglycemia|2|||
126730045|NCT02658968|455960391|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
126730046|NCT02658968|455960387|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
126730047|NCT02658968|455960388|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
126730048|NCT02658968|455960389|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
126730049|NCT02658968|455960390|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
126730050|NCT02658968|455960391|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
126730051|NCT02658968|455960387|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
126730052|NCT02658968|455960388|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
126730053|NCT02658968|455960389|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
126730054|NCT02658968|455960390|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
126730055|NCT02658968|455960391|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
126730056|NCT02658968|455960387|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
126730057|NCT02658968|455960388|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
126730058|NCT02658968|455960389|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
126730059|NCT02658968|455960390|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
126730060|NCT02658968|455960391|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
126730061|NCT02667457|455960402|FG000|Overall Study|Withdrawal by Subject|1|||
126730062|NCT02667457|455960403|FG001|Overall Study|Withdrawal by Subject|0|||
126730063|NCT02667457|455960402|FG000|Overall Study|Other Reason|0|||
126581941|NCT01426412|455427752|FG003|Overall Study|Withdrawal by Subject|0|||
126581942|NCT01426412|455427753|FG004|Overall Study|Withdrawal by Subject|1|||
126581943|NCT01426412|455427754|FG005|Overall Study|Withdrawal by Subject|0|||
126581944|NCT01426412|455427755|FG006|Overall Study|Withdrawal by Subject|0|||
126581945|NCT01426412|455427756|FG007|Overall Study|Withdrawal by Subject|3|||
126581946|NCT01426412|455427757|FG008|Overall Study|Withdrawal by Subject|1|||
126581947|NCT04157348|455427759|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
126581948|NCT04157348|455427760|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
126581949|NCT04157348|455427759|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
126581950|NCT04157348|455427760|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
126581951|NCT04157348|455427759|FG000|Double-blind Treatment Period|Adverse Event|0|||
126581952|NCT04157348|455427760|FG001|Double-blind Treatment Period|Adverse Event|1|||
126581953|NCT04157348|455427759|FG000|Open-label Extension Period|Adverse Event|1|||
126581954|NCT04157348|455427760|FG001|Open-label Extension Period|Adverse Event|1|||
126581955|NCT04157348|455427759|FG000|Open-label Extension Period|Death|0|||
126581956|NCT04157348|455427760|FG001|Open-label Extension Period|Death|1|||
126581957|NCT04157348|455427759|FG000|Open-label Extension Period|Lack of Efficacy|2|||
126581958|NCT04157348|455427760|FG001|Open-label Extension Period|Lack of Efficacy|2|||
126581959|NCT04157348|455427759|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
126581960|NCT04157348|455427760|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
126581961|NCT04157348|455427759|FG000|Open-label Extension Period|Ongoing|60|||
126581962|NCT04157348|455427760|FG001|Open-label Extension Period|Ongoing|57|||
126581963|NCT04157348|455427759|FG000|Open-label Extension Period|other reasons|1|||
126581964|NCT04157348|455427760|FG001|Open-label Extension Period|other reasons|1|||
126581965|NCT02965846|455427761|FG000|Overall Study|Lost to Follow-up|1|||
126581966|NCT02965846|455427762|FG001|Overall Study|Lost to Follow-up|0|||
126581967|NCT02965846|455427763|FG002|Overall Study|Lost to Follow-up|0|||
126581968|NCT02965846|455427761|FG000|Overall Study|Withdrawal by Subject|0|||
126581969|NCT02965846|455427762|FG001|Overall Study|Withdrawal by Subject|1|||
126581970|NCT02965846|455427763|FG002|Overall Study|Withdrawal by Subject|0|||
126581971|NCT02965846|455427761|FG000|Overall Study|Study Terminated By Sponsor|4|||
126581972|NCT02965846|455427762|FG001|Overall Study|Study Terminated By Sponsor|4|||
126581973|NCT02965846|455427763|FG002|Overall Study|Study Terminated By Sponsor|0|||
126581974|NCT02965846|455427761|FG000|Overall Study|Participants not randomized|0|||
126581975|NCT02965846|455427762|FG001|Overall Study|Participants not randomized|0|||
126581976|NCT02965846|455427763|FG002|Overall Study|Participants not randomized|33|||
126581977|NCT01084707|455427764|FG000|Overall Study|Withdrawal by Subject|6|||
126581978|NCT00879333|455427767|FG000|Overall Study|Adverse Event|94|||
126581979|NCT00879333|455427768|FG001|Overall Study|Adverse Event|34|||
126581980|NCT00879333|455427767|FG000|Overall Study|Abnormal Laboratory Value|1|||
126730064|NCT02667457|455960403|FG001|Overall Study|Other Reason|2|||
126730065|NCT02475850|455960404|FG000|Overall Study|Death|155|||
126581981|NCT00879333|455427768|FG001|Overall Study|Abnormal Laboratory Value|0|||
126581982|NCT00879333|455427767|FG000|Overall Study|Withdrawal by Subject|20|||
126581983|NCT00879333|455427768|FG001|Overall Study|Withdrawal by Subject|7|||
126581984|NCT00879333|455427767|FG000|Overall Study|Lost to Follow-up|2|||
126581985|NCT00879333|455427768|FG001|Overall Study|Lost to Follow-up|1|||
126730066|NCT02475850|455960405|FG001|Overall Study|Death|141|||
126730067|NCT02475850|455960404|FG000|Overall Study|Lost to Follow-up|217|||
126730068|NCT02475850|455960405|FG001|Overall Study|Lost to Follow-up|188|||
126756571|NCT00883896|456059482|FG000|Overall Study|Lost to Follow-up|0|||
126581986|NCT00879333|455427767|FG000|Overall Study|Administrative Problems|2|||
126581987|NCT00879333|455427768|FG001|Overall Study|Administrative Problems|0|||
126581988|NCT00879333|455427767|FG000|Overall Study|Death|16|||
126581989|NCT00879333|455427768|FG001|Overall Study|Death|5|||
126581990|NCT00879333|455427767|FG000|Overall Study|Disease Progression|292|||
126581991|NCT00879333|455427768|FG001|Overall Study|Disease Progression|169|||
126581992|NCT00879333|455427767|FG000|Overall Study|Protocol Violation|1|||
126581993|NCT00879333|455427768|FG001|Overall Study|Protocol Violation|1|||
126581994|NCT02671435|455427771|FG000|Overall Study|Death|1|||
126581995|NCT02671435|455427772|FG001|Overall Study|Death|3|||
126581996|NCT02671435|455427773|FG002|Overall Study|Death|0|||
126581997|NCT02671435|455427774|FG003|Overall Study|Death|16|||
126581998|NCT02671435|455427775|FG004|Overall Study|Death|14|||
126581999|NCT02671435|455427776|FG005|Overall Study|Death|29|||
126582000|NCT02671435|455427777|FG006|Overall Study|Death|34|||
126582001|NCT02671435|455427778|FG007|Overall Study|Death|28|||
126582002|NCT02671435|455427779|FG008|Overall Study|Death|19|||
126582003|NCT02671435|455427780|FG009|Overall Study|Death|10|||
126582004|NCT02671435|455427781|FG010|Overall Study|Death|8|||
126582005|NCT02671435|455427782|FG011|Overall Study|Death|29|||
126582006|NCT02671435|455427783|FG012|Overall Study|Death|29|||
126582007|NCT02671435|455427784|FG013|Overall Study|Death|29|||
126582008|NCT02671435|455427785|FG014|Overall Study|Death|27|||
126582009|NCT02671435|455427771|FG000|Overall Study|Lost to Follow-up|0|||
126582010|NCT02671435|455427772|FG001|Overall Study|Lost to Follow-up|0|||
126582011|NCT02671435|455427773|FG002|Overall Study|Lost to Follow-up|1|||
126582012|NCT02671435|455427774|FG003|Overall Study|Lost to Follow-up|0|||
126582013|NCT02671435|455427775|FG004|Overall Study|Lost to Follow-up|1|||
126582014|NCT02671435|455427776|FG005|Overall Study|Lost to Follow-up|1|||
126582015|NCT02671435|455427777|FG006|Overall Study|Lost to Follow-up|2|||
126582016|NCT02671435|455427778|FG007|Overall Study|Lost to Follow-up|2|||
126582017|NCT02671435|455427779|FG008|Overall Study|Lost to Follow-up|0|||
126582018|NCT02671435|455427780|FG009|Overall Study|Lost to Follow-up|2|||
126582019|NCT02671435|455427781|FG010|Overall Study|Lost to Follow-up|0|||
126582020|NCT02671435|455427782|FG011|Overall Study|Lost to Follow-up|3|||
126582021|NCT02671435|455427783|FG012|Overall Study|Lost to Follow-up|3|||
126582022|NCT02671435|455427784|FG013|Overall Study|Lost to Follow-up|2|||
126582023|NCT02671435|455427785|FG014|Overall Study|Lost to Follow-up|0|||
126582024|NCT02671435|455427771|FG000|Overall Study|Withdrawal by Subject|2|||
126582025|NCT02671435|455427772|FG001|Overall Study|Withdrawal by Subject|0|||
126582026|NCT02671435|455427773|FG002|Overall Study|Withdrawal by Subject|2|||
126582027|NCT02671435|455427774|FG003|Overall Study|Withdrawal by Subject|2|||
126582028|NCT02671435|455427775|FG004|Overall Study|Withdrawal by Subject|2|||
126582029|NCT02671435|455427776|FG005|Overall Study|Withdrawal by Subject|7|||
126582030|NCT02671435|455427777|FG006|Overall Study|Withdrawal by Subject|2|||
126582031|NCT02671435|455427778|FG007|Overall Study|Withdrawal by Subject|7|||
126582032|NCT02671435|455427779|FG008|Overall Study|Withdrawal by Subject|1|||
126582033|NCT02671435|455427780|FG009|Overall Study|Withdrawal by Subject|1|||
126582034|NCT02671435|455427781|FG010|Overall Study|Withdrawal by Subject|2|||
126582035|NCT02671435|455427782|FG011|Overall Study|Withdrawal by Subject|4|||
126582036|NCT02671435|455427783|FG012|Overall Study|Withdrawal by Subject|4|||
126582037|NCT02671435|455427784|FG013|Overall Study|Withdrawal by Subject|4|||
126582038|NCT02671435|455427785|FG014|Overall Study|Withdrawal by Subject|2|||
126582039|NCT02671435|455427771|FG000|Overall Study|Un-specified|0|||
126582040|NCT02671435|455427772|FG001|Overall Study|Un-specified|0|||
126582041|NCT02671435|455427773|FG002|Overall Study|Un-specified|0|||
126582042|NCT02671435|455427774|FG003|Overall Study|Un-specified|0|||
126582043|NCT02671435|455427775|FG004|Overall Study|Un-specified|1|||
126582044|NCT02671435|455427776|FG005|Overall Study|Un-specified|3|||
126582045|NCT02671435|455427777|FG006|Overall Study|Un-specified|2|||
126582046|NCT02671435|455427778|FG007|Overall Study|Un-specified|3|||
126582047|NCT02671435|455427779|FG008|Overall Study|Un-specified|0|||
126582048|NCT02671435|455427780|FG009|Overall Study|Un-specified|5|||
126582049|NCT02671435|455427781|FG010|Overall Study|Un-specified|8|||
126582050|NCT02671435|455427782|FG011|Overall Study|Un-specified|4|||
126582051|NCT02671435|455427783|FG012|Overall Study|Un-specified|5|||
126582052|NCT02671435|455427784|FG013|Overall Study|Un-specified|9|||
126582053|NCT02671435|455427785|FG014|Overall Study|Un-specified|8|||
126582054|NCT02412748|455427788|FG000|Overall Study|Lost to Follow-up|38|||
126582055|NCT02412748|455427789|FG001|Overall Study|Lost to Follow-up|39|||
126582056|NCT03069313|455427790|FG000|Overall Study|Adverse Event|5|||
126582057|NCT01872078|455427794|FG000|Overall Study|Adverse Event|0|||
126582058|NCT01872078|455427795|FG001|Overall Study|Adverse Event|0|||
126582059|NCT01872078|455427796|FG002|Overall Study|Adverse Event|1|||
126582060|NCT01872078|455427797|FG003|Overall Study|Adverse Event|0|||
126582061|NCT01872078|455427794|FG000|Overall Study|Dose administration non-compliance|0|||
126582062|NCT01872078|455427795|FG001|Overall Study|Dose administration non-compliance|0|||
126582063|NCT01872078|455427796|FG002|Overall Study|Dose administration non-compliance|0|||
126582064|NCT01872078|455427797|FG003|Overall Study|Dose administration non-compliance|1|||
126582065|NCT01872078|455427794|FG000|Overall Study|Protocol Violation|0|||
126582066|NCT01872078|455427795|FG001|Overall Study|Protocol Violation|0|||
126582067|NCT01872078|455427796|FG002|Overall Study|Protocol Violation|1|||
126582068|NCT01872078|455427797|FG003|Overall Study|Protocol Violation|0|||
126582069|NCT01872078|455427794|FG000|Overall Study|Withdrawal by Subject|0|||
126582070|NCT01872078|455427795|FG001|Overall Study|Withdrawal by Subject|0|||
126582071|NCT01872078|455427796|FG002|Overall Study|Withdrawal by Subject|1|||
126582072|NCT01872078|455427797|FG003|Overall Study|Withdrawal by Subject|0|||
126582073|NCT01872078|455427794|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
126582074|NCT01872078|455427795|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
126582075|NCT01872078|455427796|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
126582076|NCT01872078|455427797|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
126582077|NCT00761189|455427798|FG000|Overall Study|Adverse Event|42|||
126582078|NCT00761189|455427798|FG000|Overall Study|Lack of Efficacy|45|||
126582079|NCT00761189|455427798|FG000|Overall Study|Lost to Follow-up|36|||
126582080|NCT00761189|455427798|FG000|Overall Study|Withdrawal by Subject|49|||
126582081|NCT00761189|455427798|FG000|Overall Study|Other|13|||
126582082|NCT01494922|455427799|FG000|Overall Study|Adverse Event|1|||
126582083|NCT02759016|455427800|FG000|Overall Study|Not treated with BI 836826|1|||
126582084|NCT02759016|455427801|FG001|Overall Study|Not treated with BI 836826|0|||
126582085|NCT02759016|455427800|FG000|Overall Study|Progressive disease|1|||
126582086|NCT02759016|455427801|FG001|Overall Study|Progressive disease|0|||
126582087|NCT02759016|455427800|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
126582088|NCT02759016|455427801|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
126582089|NCT02759016|455427800|FG000|Overall Study|Other not defined above|2|||
126582090|NCT02759016|455427801|FG001|Overall Study|Other not defined above|1|||
126582091|NCT03939312|455427802|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
126582092|NCT03939312|455427802|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
126582093|NCT03939312|455427802|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
126582094|NCT03939312|455427802|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
126582095|NCT03939312|455427802|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
126582096|NCT03939312|455427802|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
126582097|NCT03939312|455427802|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
126582098|NCT03939312|455427802|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
126582099|NCT03939312|455427802|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
126582100|NCT03939312|455427802|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
126582101|NCT03939312|455427802|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
126582102|NCT03939312|455427802|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
126582103|NCT02119650|455427803|FG000|Overall Study|Adverse Event|3|||
126582104|NCT02119650|455427804|FG001|Overall Study|Adverse Event|4|||
126582105|NCT02119650|455427803|FG000|Overall Study|Subject decision|2|||
126582106|NCT02119650|455427804|FG001|Overall Study|Subject decision|3|||
126582107|NCT02119650|455427803|FG000|Overall Study|Disease progression|11|||
126582108|NCT02119650|455427804|FG001|Overall Study|Disease progression|14|||
126582109|NCT02119650|455427803|FG000|Overall Study|Death|5|||
126582110|NCT02119650|455427804|FG001|Overall Study|Death|1|||
126582111|NCT02119650|455427803|FG000|Overall Study|Noncompliance with study treatment|1|||
126582112|NCT02119650|455427804|FG001|Overall Study|Noncompliance with study treatment|1|||
126582113|NCT02119650|455427803|FG000|Overall Study|Study terminated by the sponsor|1|||
126582114|NCT02119650|455427804|FG001|Overall Study|Study terminated by the sponsor|0|||
126582115|NCT02119650|455427803|FG000|Overall Study|Physician Decision|0|||
126582116|NCT02119650|455427804|FG001|Overall Study|Physician Decision|2|||
126582117|NCT02119650|455427803|FG000|Overall Study|Multiple reasons for termination|2|||
126582118|NCT02119650|455427804|FG001|Overall Study|Multiple reasons for termination|1|||
126582119|NCT01721291|455427805|FG000|Overall Study|Withdrawal by Subject|1|||
126582120|NCT01721291|455427806|FG001|Overall Study|Withdrawal by Subject|0|||
126582121|NCT01721291|455427805|FG000|Overall Study|did not like the treatment|1|||
126582122|NCT01721291|455427806|FG001|Overall Study|did not like the treatment|0|||
126582123|NCT03744312|455429120|FG000|Overall Study|Withdrawal by Subject|0|||
126582124|NCT03744312|455429121|FG001|Overall Study|Withdrawal by Subject|1|||
126582125|NCT03744312|455429120|FG000|Overall Study|Screen fail|0|||
126582126|NCT03744312|455429121|FG001|Overall Study|Screen fail|1|||
126582127|NCT05134337|455429122|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
126582128|NCT05134337|455429123|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
126582129|NCT04924062|455429124|FG000|Overall Study|Death|49|||
126582130|NCT04924062|455429125|FG001|Overall Study|Death|63|||
126730069|NCT02475850|455960404|FG000|Overall Study|Withdrawal by Subject|221|||
126582131|NCT04924062|455429124|FG000|Overall Study|Participant On-going|26|||
126582132|NCT04924062|455429125|FG001|Overall Study|Participant On-going|20|||
126582133|NCT02349412|455429130|FG000|Overall Study|Withdrawal by Subject|7|||
126582134|NCT02349412|455429131|FG001|Overall Study|Withdrawal by Subject|7|||
126582135|NCT04337372|455429132|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
126582136|NCT04337372|455429133|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
126582137|NCT04337372|455429134|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
126582138|NCT04337372|455429135|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
126582139|NCT04337372|455429132|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
126582140|NCT04337372|455429133|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
126730070|NCT02475850|455960405|FG001|Overall Study|Withdrawal by Subject|155|||
126582141|NCT04337372|455429134|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
126582142|NCT04337372|455429135|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
126582143|NCT04337372|455429132|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
126582144|NCT04337372|455429133|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
126582145|NCT04337372|455429134|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
126582146|NCT04337372|455429135|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
126582147|NCT04337372|455429132|FG000|Day 2: EEG Measures|Protocol Violation|6|||
126582148|NCT04337372|455429133|FG001|Day 2: EEG Measures|Protocol Violation|6|||
126582149|NCT04337372|455429134|FG002|Day 2: EEG Measures|Protocol Violation|5|||
126582150|NCT04337372|455429135|FG003|Day 2: EEG Measures|Protocol Violation|17|||
126582151|NCT03460236|455429136|FG000|Overall Study|failed radiographic screening|16|||
126582152|NCT03460236|455429136|FG000|Overall Study|Withdrawal by Subject|11|||
126582153|NCT00979576|455429139|FG000|Combination Treatment Phase|Progressive disease|3|||
126582154|NCT00979576|455429140|FG001|Combination Treatment Phase|Progressive disease|1|||
126582155|NCT00979576|455429141|FG002|Combination Treatment Phase|Progressive disease|5|||
126582156|NCT00979576|455429139|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
126582157|NCT00979576|455429140|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
126582158|NCT00979576|455429141|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
126582159|NCT00979576|455429139|FG000|Combination Treatment Phase|Adverse Event|0|||
126582160|NCT00979576|455429140|FG001|Combination Treatment Phase|Adverse Event|2|||
126582161|NCT00979576|455429141|FG002|Combination Treatment Phase|Adverse Event|2|||
126582162|NCT00979576|455429139|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
126582163|NCT00979576|455429140|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
126582164|NCT00979576|455429141|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
126582165|NCT04840199|455429142|FG000|Overall Study|Study Terminated by Sponsor|8|||
126582166|NCT04840199|455429143|FG001|Overall Study|Study Terminated by Sponsor|9|||
126582167|NCT04840199|455429142|FG000|Overall Study|Lost to Follow-up|0|||
126582168|NCT04840199|455429143|FG001|Overall Study|Lost to Follow-up|2|||
126582169|NCT04840199|455429142|FG000|Overall Study|Withdrawal by Subject|2|||
126582170|NCT04840199|455429143|FG001|Overall Study|Withdrawal by Subject|0|||
126582171|NCT04840199|455429142|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
126582172|NCT04840199|455429143|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
126582173|NCT06023082|455429150|FG000|Overall Study|Withdrawal by Subject|2|||
126582174|NCT06023082|455429150|FG000|Overall Study|Lost to Follow-up|15|||
126730071|NCT03297216|455960410|FG000|Overall Study|Death|0|||
126730072|NCT03297216|455960411|FG001|Overall Study|Death|1|||
126730073|NCT03297216|455960410|FG000|Overall Study|Miscarriage|0|||
126730074|NCT03297216|455960411|FG001|Overall Study|Miscarriage|2|||
126730075|NCT03297216|455960410|FG000|Overall Study|Lost to Follow-up|3|||
126730076|NCT03297216|455960411|FG001|Overall Study|Lost to Follow-up|2|||
126730077|NCT00603733|455960412|FG000|Active Phase ITT|Adverse Event|8|||
126730078|NCT00603733|455960413|FG001|Active Phase ITT|Adverse Event|7|||
126730079|NCT00603733|455960412|FG000|Active Phase ITT|Withdrawal by Subject|0|||
126730080|NCT00603733|455960413|FG001|Active Phase ITT|Withdrawal by Subject|3|||
126730081|NCT00603733|455960412|FG000|Active Phase ITT|Lost to Follow-up|0|||
126730082|NCT00603733|455960413|FG001|Active Phase ITT|Lost to Follow-up|1|||
126730083|NCT00603733|455960412|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
126730084|NCT00603733|455960413|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
126730085|NCT00603733|455960412|FG000|Active Phase ITT|Lack of Efficacy|1|||
126730086|NCT00603733|455960413|FG001|Active Phase ITT|Lack of Efficacy|2|||
126730087|NCT00603733|455960412|FG000|Active Phase ITT|Subject moved, site closed|1|||
126730088|NCT00603733|455960413|FG001|Active Phase ITT|Subject moved, site closed|1|||
126730089|NCT00603733|455960412|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
126730090|NCT00603733|455960413|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
126531823|NCT02625623|455237432|FG000|Overall Study|Participants randomized but not treated|9|||
126531824|NCT02625623|455237433|FG001|Overall Study|Participants randomized but not treated|1|||
126531825|NCT02352948|455237434|FG000|Overall Study|Death|47|||
126531826|NCT02352948|455237435|FG001|Overall Study|Death|48|||
126531827|NCT02352948|455237436|FG002|Overall Study|Death|114|||
126531828|NCT02352948|455237437|FG003|Overall Study|Death|74|||
126531829|NCT02352948|455237438|FG004|Overall Study|Death|77|||
126531830|NCT02352948|455237439|FG005|Overall Study|Death|44|||
126531831|NCT02352948|455237434|FG000|Overall Study|Lost to Follow-up|1|||
126531832|NCT02352948|455237435|FG001|Overall Study|Lost to Follow-up|0|||
126582175|NCT06023082|455429150|FG000|Overall Study|Side effects|5|||
126730091|NCT00603733|455960412|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
126730092|NCT00603733|455960413|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
126730093|NCT00603733|455960412|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
126531833|NCT02352948|455237436|FG002|Overall Study|Lost to Follow-up|2|||
126582176|NCT05136404|455429151|FG000|Period 1|Adverse Event|0|||
126582177|NCT05136404|455429152|FG001|Period 1|Adverse Event|1|||
126582178|NCT05136404|455429153|FG002|Period 1|Adverse Event|1|||
126730094|NCT00603733|455960413|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
126730095|NCT00603733|455960412|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
126531834|NCT02352948|455237437|FG003|Overall Study|Lost to Follow-up|1|||
126531835|NCT02352948|455237438|FG004|Overall Study|Lost to Follow-up|2|||
126730096|NCT00603733|455960413|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
126730097|NCT00603733|455960412|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
126730098|NCT00603733|455960413|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
126730099|NCT00603733|455960412|FG000|Maintenance Phase ITT|Adverse Event|3|||
126730100|NCT00603733|455960413|FG001|Maintenance Phase ITT|Adverse Event|6|||
126730101|NCT00603733|455960412|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
126730102|NCT00603733|455960413|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
126730103|NCT00603733|455960412|FG000|Maintenance Phase ITT|Protocol Violation|1|||
126730104|NCT00603733|455960413|FG001|Maintenance Phase ITT|Protocol Violation|1|||
126730105|NCT00603733|455960412|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
126730106|NCT00603733|455960413|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
126730107|NCT00603733|455960412|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
126730108|NCT00603733|455960413|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
126777243|NCT03341273|456141316|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
126777244|NCT03341273|456141317|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
126531836|NCT02352948|455237439|FG005|Overall Study|Lost to Follow-up|1|||
126531837|NCT02352948|455237434|FG000|Overall Study|Withdrawal by Subject|1|||
126531838|NCT02352948|455237435|FG001|Overall Study|Withdrawal by Subject|10|||
126531839|NCT02352948|455237436|FG002|Overall Study|Withdrawal by Subject|11|||
126531840|NCT02352948|455237437|FG003|Overall Study|Withdrawal by Subject|23|||
126531841|NCT02352948|455237438|FG004|Overall Study|Withdrawal by Subject|9|||
126531842|NCT02352948|455237439|FG005|Overall Study|Withdrawal by Subject|4|||
126531843|NCT02352948|455237434|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126531844|NCT02352948|455237435|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126531845|NCT02352948|455237436|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
126531846|NCT02352948|455237437|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
126531847|NCT02352948|455237438|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
126531848|NCT02352948|455237439|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
126531849|NCT02352948|455237434|FG000|Overall Study|Other|0|||
126531850|NCT02352948|455237435|FG001|Overall Study|Other|0|||
126531851|NCT02352948|455237436|FG002|Overall Study|Other|2|||
126531852|NCT02352948|455237437|FG003|Overall Study|Other|0|||
126531853|NCT02352948|455237438|FG004|Overall Study|Other|0|||
126531854|NCT02352948|455237439|FG005|Overall Study|Other|0|||
126531855|NCT03762473|455237440|FG000|Overall Study|Death|1|||
126531856|NCT03762473|455237441|FG001|Overall Study|Death|0|||
126531857|NCT00126438|455237442|FG000|Overall Study|Withdrawal due to adverse event|1|||
126531858|NCT00126438|455237443|FG001|Overall Study|Withdrawal due to adverse event|0|||
126531859|NCT00126438|455237442|FG000|Overall Study|Lost to Follow-up|22|||
126531860|NCT00126438|455237443|FG001|Overall Study|Lost to Follow-up|0|||
126531861|NCT00126438|455237442|FG000|Overall Study|Protocol Violation|8|||
126531862|NCT00126438|455237443|FG001|Overall Study|Protocol Violation|8|||
126531863|NCT00126438|455237442|FG000|Overall Study|Withdrawal by Subject|3|||
126531864|NCT00126438|455237443|FG001|Overall Study|Withdrawal by Subject|2|||
126531865|NCT02057874|455239963|FG000|Overall Study|participant did not return for scan|1|||
126531866|NCT01621126|455239966|FG000|Overall Study|Physician Decision|6|||
126531867|NCT00886340|455239968|FG000|Overall Study|Withdrawal by Subject|0|||
126531868|NCT00886340|455239969|FG001|Overall Study|Withdrawal by Subject|7|||
126531869|NCT01949311|455239970|FG000|Overall Study|Lost to Follow-up|73|||
126531870|NCT01949311|455239970|FG000|Overall Study|Terminated by Sponsor|708|||
126531871|NCT01949311|455239970|FG000|Overall Study|Withdrawal by Subject|375|||
126531872|NCT01949311|455239970|FG000|Overall Study|Lack of Efficacy|50|||
126531873|NCT01949311|455239970|FG000|Overall Study|Protocol Deviation|34|||
126531874|NCT01949311|455239970|FG000|Overall Study|Pregnancy|20|||
126531875|NCT01949311|455239970|FG000|Overall Study|Physician Decision|9|||
126531876|NCT01949311|455239970|FG000|Overall Study|Other|4|||
126531877|NCT01949311|455239970|FG000|Overall Study|Adverse Event|107|||
126531878|NCT02338154|455239971|FG000|Overall Study|Death|46|||
126531879|NCT02338154|455239971|FG000|Overall Study|Valve Implant Failure|17|||
126531880|NCT02338154|455239971|FG000|Overall Study|Valve Explant|11|||
126531881|NCT02338154|455239971|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
126531882|NCT02338154|455239971|FG000|Overall Study|Lost to Follow-up|8|||
126531883|NCT02338154|455239971|FG000|Overall Study|Other Reason|3|||
126531884|NCT02338154|455239971|FG000|Overall Study|Patients Without Exit Form|47|||
126531885|NCT02338154|455239971|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
126531886|NCT02120027|455239972|FG000|Overall Study|Adverse Event|4|||
126531887|NCT02120027|455239973|FG001|Overall Study|Adverse Event|5|||
126531888|NCT02120027|455239972|FG000|Overall Study|Lack of Efficacy|3|||
126531889|NCT02120027|455239973|FG001|Overall Study|Lack of Efficacy|5|||
126531890|NCT02120027|455239972|FG000|Overall Study|Lost to Follow-up|5|||
126531891|NCT02120027|455239973|FG001|Overall Study|Lost to Follow-up|13|||
126531892|NCT02120027|455239972|FG000|Overall Study|Other|4|||
126531893|NCT02120027|455239973|FG001|Overall Study|Other|0|||
126531894|NCT02120027|455239972|FG000|Overall Study|Physician Decision|4|||
126531895|NCT02120027|455239973|FG001|Overall Study|Physician Decision|3|||
126730109|NCT00603733|455960412|FG000|Maintenance Phase ITT|Physician Decision|0|||
126531896|NCT02120027|455239972|FG000|Overall Study|Protocol Violation|18|||
126531897|NCT02120027|455239973|FG001|Overall Study|Protocol Violation|21|||
126531898|NCT02120027|455239972|FG000|Overall Study|Study terminated by Sponsor|45|||
126531899|NCT02120027|455239973|FG001|Overall Study|Study terminated by Sponsor|47|||
126531900|NCT02120027|455239972|FG000|Overall Study|Withdrawal by Subject|33|||
126531901|NCT02120027|455239973|FG001|Overall Study|Withdrawal by Subject|25|||
126531902|NCT00447057|455239980|FG000|Overall Study|Adverse Event|4|||
126531903|NCT00447057|455239981|FG001|Overall Study|Adverse Event|10|||
126531904|NCT00447057|455239982|FG002|Overall Study|Adverse Event|0|||
126531905|NCT00447057|455239983|FG003|Overall Study|Adverse Event|3|||
126531906|NCT00447057|455239980|FG000|Overall Study|Death due to study disease|6|||
126531907|NCT00447057|455239981|FG001|Overall Study|Death due to study disease|4|||
126531908|NCT00447057|455239982|FG002|Overall Study|Death due to study disease|1|||
126531909|NCT00447057|455239983|FG003|Overall Study|Death due to study disease|1|||
126531910|NCT00447057|455239980|FG000|Overall Study|Lost to Follow-up|0|||
126531911|NCT00447057|455239981|FG001|Overall Study|Lost to Follow-up|1|||
126531912|NCT00447057|455239982|FG002|Overall Study|Lost to Follow-up|0|||
126531913|NCT00447057|455239983|FG003|Overall Study|Lost to Follow-up|0|||
126531914|NCT00447057|455239980|FG000|Overall Study|Entry criteria not met|1|||
126531915|NCT00447057|455239981|FG001|Overall Study|Entry criteria not met|1|||
126531916|NCT00447057|455239982|FG002|Overall Study|Entry criteria not met|0|||
126531917|NCT00447057|455239983|FG003|Overall Study|Entry criteria not met|0|||
126531918|NCT00447057|455239980|FG000|Overall Study|Protocol Violation|0|||
126531919|NCT00447057|455239981|FG001|Overall Study|Protocol Violation|1|||
126531920|NCT00447057|455239982|FG002|Overall Study|Protocol Violation|0|||
126531921|NCT00447057|455239983|FG003|Overall Study|Protocol Violation|0|||
126531922|NCT00447057|455239980|FG000|Overall Study|Withdrawal by Subject|4|||
126531923|NCT00447057|455239981|FG001|Overall Study|Withdrawal by Subject|5|||
126531924|NCT00447057|455239982|FG002|Overall Study|Withdrawal by Subject|1|||
126531925|NCT00447057|455239983|FG003|Overall Study|Withdrawal by Subject|1|||
126531926|NCT00447057|455239980|FG000|Overall Study|Physician Decision|9|||
126531927|NCT00447057|455239981|FG001|Overall Study|Physician Decision|6|||
126531928|NCT00447057|455239982|FG002|Overall Study|Physician Decision|3|||
126531929|NCT00447057|455239983|FG003|Overall Study|Physician Decision|1|||
126531930|NCT00447057|455239980|FG000|Overall Study|Sponsor decision|1|||
126531931|NCT00447057|455239981|FG001|Overall Study|Sponsor decision|1|||
126531932|NCT00447057|455239982|FG002|Overall Study|Sponsor decision|0|||
126531933|NCT00447057|455239983|FG003|Overall Study|Sponsor decision|0|||
126531934|NCT00447057|455239980|FG000|Overall Study|Progressive disease|58|||
126531935|NCT00447057|455239981|FG001|Overall Study|Progressive disease|43|||
126531936|NCT00447057|455239982|FG002|Overall Study|Progressive disease|13|||
126531937|NCT00447057|455239983|FG003|Overall Study|Progressive disease|18|||
126531938|NCT00447057|455239980|FG000|Overall Study|Death due to adverse event|0|||
126531939|NCT00447057|455239981|FG001|Overall Study|Death due to adverse event|0|||
126531940|NCT00447057|455239982|FG002|Overall Study|Death due to adverse event|1|||
126531941|NCT00447057|455239983|FG003|Overall Study|Death due to adverse event|2|||
126531942|NCT00447057|455239980|FG000|Overall Study|Death, study drug related|0|||
126531943|NCT00447057|455239981|FG001|Overall Study|Death, study drug related|1|||
126531944|NCT00447057|455239982|FG002|Overall Study|Death, study drug related|0|||
126531945|NCT00447057|455239983|FG003|Overall Study|Death, study drug related|0|||
126531946|NCT03393000|455239988|FG000|Overall Study|Death|11|||
126531947|NCT03393000|455239988|FG000|Overall Study|Withdrawal by Subject|2|||
126531948|NCT03393000|455239988|FG000|Overall Study|Physician Decision|1|||
126531949|NCT01773070|455239989|FG000|Overall Study|Withdrawal by Subject|24|||
126531950|NCT01773070|455239989|FG000|Overall Study|Lost to Follow-up|39|||
126531951|NCT01773070|455239989|FG000|Overall Study|Other|15|||
126531952|NCT01773070|455239989|FG000|Overall Study|Death (unrelated to study procedures)|3|||
126531953|NCT01471054|455239990|FG000|Overall Study|Study terminated prematurely|4|||
126531954|NCT01471054|455239991|FG001|Overall Study|Study terminated prematurely|0|||
126531955|NCT04493216|455239992|FG000|Overall Study|Study terminated by sponsor|30|||
126531956|NCT04493216|455239993|FG001|Overall Study|Study terminated by sponsor|33|||
126531957|NCT04493216|455239994|FG002|Overall Study|Study terminated by sponsor|28|||
126531958|NCT04493216|455239995|FG003|Overall Study|Study terminated by sponsor|27|||
126531959|NCT04493216|455239992|FG000|Overall Study|Withdrawal by Subject|2|||
126531960|NCT04493216|455239993|FG001|Overall Study|Withdrawal by Subject|1|||
126531961|NCT04493216|455239994|FG002|Overall Study|Withdrawal by Subject|1|||
126531962|NCT04493216|455239995|FG003|Overall Study|Withdrawal by Subject|2|||
126531963|NCT04493216|455239992|FG000|Overall Study|Protocol Violation|1|||
126531964|NCT04493216|455239993|FG001|Overall Study|Protocol Violation|2|||
126531965|NCT04493216|455239994|FG002|Overall Study|Protocol Violation|0|||
126582179|NCT05136404|455429151|FG000|Period 2|Inappropriate Behavior|0|||
126531966|NCT04493216|455239995|FG003|Overall Study|Protocol Violation|2|||
126531967|NCT04493216|455239992|FG000|Overall Study|Physician Decision|0|||
126531968|NCT04493216|455239993|FG001|Overall Study|Physician Decision|0|||
126531969|NCT04493216|455239994|FG002|Overall Study|Physician Decision|1|||
126531970|NCT04493216|455239995|FG003|Overall Study|Physician Decision|0|||
126531971|NCT04493216|455239992|FG000|Overall Study|Lost to Follow-up|2|||
126531972|NCT04493216|455239993|FG001|Overall Study|Lost to Follow-up|1|||
126582180|NCT05136404|455429152|FG001|Period 2|Inappropriate Behavior|0|||
126582181|NCT05136404|455429153|FG002|Period 2|Inappropriate Behavior|1|||
126582182|NCT05136404|455429151|FG000|Period 3|Adverse Event|0|||
126582183|NCT05136404|455429152|FG001|Period 3|Adverse Event|0|||
126582184|NCT05136404|455429153|FG002|Period 3|Adverse Event|1|||
126582185|NCT03584516|455429154|FG000|Part 1|Death|2|||
126582186|NCT03584516|455429155|FG001|Part 1|Death|3|||
126582187|NCT03584516|455429156|FG002|Part 1|Death|0|||
126582188|NCT03584516|455429157|FG003|Part 1|Death|0|||
126582189|NCT03584516|455429158|FG004|Part 1|Death|0|||
126582190|NCT03584516|455429159|FG005|Part 1|Death|0|||
126582191|NCT03584516|455429154|FG000|Part 1|Withdrawal by Subject|2|||
126582192|NCT03584516|455429155|FG001|Part 1|Withdrawal by Subject|0|||
126582193|NCT03584516|455429156|FG002|Part 1|Withdrawal by Subject|0|||
126582194|NCT03584516|455429157|FG003|Part 1|Withdrawal by Subject|0|||
126582195|NCT03584516|455429158|FG004|Part 1|Withdrawal by Subject|0|||
126582196|NCT03584516|455429159|FG005|Part 1|Withdrawal by Subject|0|||
126582197|NCT03584516|455429154|FG000|Part 1|Lost to Follow-up|1|||
126582198|NCT03584516|455429155|FG001|Part 1|Lost to Follow-up|0|||
126582199|NCT03584516|455429156|FG002|Part 1|Lost to Follow-up|0|||
126582200|NCT03584516|455429157|FG003|Part 1|Lost to Follow-up|0|||
126582201|NCT03584516|455429158|FG004|Part 1|Lost to Follow-up|0|||
126582202|NCT03584516|455429159|FG005|Part 1|Lost to Follow-up|0|||
126582203|NCT03584516|455429154|FG000|Part 1|Study Terminated by Sponsor|0|||
126582204|NCT03584516|455429155|FG001|Part 1|Study Terminated by Sponsor|2|||
126582205|NCT03584516|455429156|FG002|Part 1|Study Terminated by Sponsor|0|||
126582206|NCT03584516|455429157|FG003|Part 1|Study Terminated by Sponsor|0|||
126582207|NCT03584516|455429158|FG004|Part 1|Study Terminated by Sponsor|0|||
126582208|NCT03584516|455429159|FG005|Part 1|Study Terminated by Sponsor|0|||
126582209|NCT03584516|455429154|FG000|Part 1 Expansion|Death|0|||
126582210|NCT03584516|455429155|FG001|Part 1 Expansion|Death|0|||
126582211|NCT03584516|455429156|FG002|Part 1 Expansion|Death|9|||
126582212|NCT03584516|455429157|FG003|Part 1 Expansion|Death|8|||
126582213|NCT03584516|455429158|FG004|Part 1 Expansion|Death|4|||
126582214|NCT03584516|455429159|FG005|Part 1 Expansion|Death|5|||
126582215|NCT03584516|455429154|FG000|Part 1 Expansion|Lost to Follow-up|0|||
126582216|NCT03584516|455429155|FG001|Part 1 Expansion|Lost to Follow-up|0|||
126582217|NCT03584516|455429156|FG002|Part 1 Expansion|Lost to Follow-up|0|||
126582218|NCT03584516|455429157|FG003|Part 1 Expansion|Lost to Follow-up|1|||
126582219|NCT03584516|455429158|FG004|Part 1 Expansion|Lost to Follow-up|0|||
126582220|NCT03584516|455429159|FG005|Part 1 Expansion|Lost to Follow-up|0|||
126582221|NCT03584516|455429154|FG000|Part 1 Expansion|Physician Decision|0|||
126582222|NCT03584516|455429155|FG001|Part 1 Expansion|Physician Decision|0|||
126582223|NCT03584516|455429156|FG002|Part 1 Expansion|Physician Decision|4|||
126582224|NCT03584516|455429157|FG003|Part 1 Expansion|Physician Decision|3|||
126582225|NCT03584516|455429158|FG004|Part 1 Expansion|Physician Decision|2|||
126582226|NCT03584516|455429159|FG005|Part 1 Expansion|Physician Decision|3|||
126582227|NCT03584516|455429154|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
126582228|NCT03584516|455429155|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
126582229|NCT03584516|455429156|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
126582230|NCT03584516|455429157|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
126582231|NCT03584516|455429158|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
126582232|NCT03584516|455429159|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
126582233|NCT03584516|455429154|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
126582234|NCT03584516|455429155|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
126582235|NCT03584516|455429156|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
126582236|NCT03584516|455429157|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
126582237|NCT03584516|455429158|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
126582238|NCT03584516|455429159|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
126582239|NCT03584516|455429154|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
126777245|NCT03341273|456141316|FG000|Overall Study|Became ineligible after enrollment|1|||
126777246|NCT03341273|456141317|FG001|Overall Study|Became ineligible after enrollment|0|||
126777247|NCT03341273|456141316|FG000|Overall Study|Not Eligible at Enrollment|0|||
126582240|NCT03584516|455429155|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
126582241|NCT03584516|455429156|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
126582242|NCT03584516|455429157|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
126582243|NCT03584516|455429158|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
126582244|NCT03584516|455429159|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
126582245|NCT03584516|455429154|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
126582246|NCT03584516|455429155|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
126582247|NCT03584516|455429156|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
126582248|NCT03584516|455429157|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
126582249|NCT03584516|455429158|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
126582250|NCT03584516|455429159|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
126582251|NCT04868110|455429161|FG000|Overall Study|Withdrawal by Subject|3|||
126582252|NCT04868110|455429162|FG001|Overall Study|Withdrawal by Subject|4|||
126582253|NCT04823611|455429163|FG000|Overall Study|Adverse Event|2|||
126531973|NCT04493216|455239994|FG002|Overall Study|Lost to Follow-up|0|||
126531974|NCT04493216|455239995|FG003|Overall Study|Lost to Follow-up|1|||
126531975|NCT04493216|455239992|FG000|Overall Study|Adverse Event|1|||
126531976|NCT04493216|455239993|FG001|Overall Study|Adverse Event|4|||
126531977|NCT04493216|455239994|FG002|Overall Study|Adverse Event|5|||
126531978|NCT04493216|455239995|FG003|Overall Study|Adverse Event|2|||
126531979|NCT04493216|455239992|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
126531980|NCT04493216|455239993|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
126531981|NCT04493216|455239994|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
126531982|NCT04493216|455239995|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
126531983|NCT01559844|455239996|FG000|Overall Study|Consent Withdrawn|7|||
126531984|NCT01559844|455239996|FG000|Overall Study|Death|5|||
126531985|NCT01559844|455239996|FG000|Overall Study|Efficacy Failure|10|||
126531986|NCT01559844|455239996|FG000|Overall Study|No Longer A Transplant Candidate|3|||
126531987|NCT00951041|455239997|FG000|Overall Study|Withdrawal by Subject|1|||
126531988|NCT00951041|455239998|FG001|Overall Study|Withdrawal by Subject|1|||
126531989|NCT00951041|455239997|FG000|Overall Study|Lost to Follow-up|1|||
126730110|NCT00603733|455960413|FG001|Maintenance Phase ITT|Physician Decision|1|||
126730111|NCT00603733|455960412|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
126730112|NCT00603733|455960413|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
126730113|NCT02700919|455960414|FG000|Overall Study|Physician Decision|1|||
126730114|NCT02700919|455960415|FG001|Overall Study|Physician Decision|0|||
126730115|NCT02700919|455960416|FG002|Overall Study|Physician Decision|0|||
126730116|NCT02700919|455960414|FG000|Overall Study|Protocol Violation|1|||
126730117|NCT02700919|455960415|FG001|Overall Study|Protocol Violation|0|||
126730118|NCT02700919|455960416|FG002|Overall Study|Protocol Violation|0|||
126531990|NCT00951041|455239998|FG001|Overall Study|Lost to Follow-up|0|||
126531991|NCT00951041|455239997|FG000|Overall Study|Other|3|||
126531992|NCT00951041|455239998|FG001|Overall Study|Other|0|||
126531993|NCT01514448|455239999|FG000|Overall Study|Death|7|||
126531994|NCT01514448|455240000|FG001|Overall Study|Death|8|||
126582254|NCT04823611|455429164|FG001|Overall Study|Adverse Event|0|||
126582255|NCT04823611|455429165|FG002|Overall Study|Adverse Event|1|||
126582256|NCT04823611|455429166|FG003|Overall Study|Adverse Event|0|||
126582257|NCT04823611|455429167|FG004|Overall Study|Adverse Event|0|||
126582258|NCT04823611|455429168|FG005|Overall Study|Adverse Event|0|||
126582259|NCT04823611|455429169|FG006|Overall Study|Adverse Event|0|||
126582260|NCT04511702|455429175|FG000|Overall Study|Lost to Follow-up|3|||
126582261|NCT04511702|455429176|FG001|Overall Study|Lost to Follow-up|0|||
126582262|NCT04511702|455429177|FG002|Overall Study|Lost to Follow-up|4|||
126582263|NCT04511702|455429175|FG000|Overall Study|Withdrawal by Subject|17|||
126582264|NCT04511702|455429176|FG001|Overall Study|Withdrawal by Subject|1|||
126582265|NCT04511702|455429177|FG002|Overall Study|Withdrawal by Subject|8|||
126582266|NCT01894061|455429178|FG000|Overall Study|Screen failure|1|||
126582267|NCT01894061|455429178|FG000|Overall Study|Withdrawal by Subject|1|||
126582268|NCT02840474|455429181|FG000|Overall Study|Lost to Follow-up|1|||
126582269|NCT02840474|455429182|FG001|Overall Study|Lost to Follow-up|0|||
126582270|NCT05444192|455429183|FG000|Overall Study|Lost to Follow-up|1|||
126582271|NCT05444192|455429184|FG001|Overall Study|Lost to Follow-up|0|||
126582272|NCT05623345|455429186|FG000|Overall Study|Withdrawal by Subject|14|||
126582273|NCT05623345|455429187|FG001|Overall Study|Withdrawal by Subject|0|||
126582274|NCT05623345|455429188|FG002|Overall Study|Withdrawal by Subject|9|||
126582275|NCT05623345|455429189|FG003|Overall Study|Withdrawal by Subject|20|||
126582276|NCT05623345|455429186|FG000|Overall Study|Lost to Follow-up|3|||
126582277|NCT05623345|455429187|FG001|Overall Study|Lost to Follow-up|0|||
126730119|NCT02700919|455960414|FG000|Overall Study|Adverse Event|1|||
126730120|NCT02700919|455960415|FG001|Overall Study|Adverse Event|3|||
126582278|NCT05623345|455429188|FG002|Overall Study|Lost to Follow-up|7|||
126582279|NCT05623345|455429189|FG003|Overall Study|Lost to Follow-up|2|||
126582280|NCT05623345|455429186|FG000|Overall Study|Termination of Study By Sponsor|37|||
126582281|NCT05623345|455429187|FG001|Overall Study|Termination of Study By Sponsor|4|||
126582282|NCT05623345|455429188|FG002|Overall Study|Termination of Study By Sponsor|40|||
126582283|NCT05623345|455429189|FG003|Overall Study|Termination of Study By Sponsor|38|||
126730121|NCT02700919|455960416|FG002|Overall Study|Adverse Event|1|||
126730122|NCT02700919|455960414|FG000|Overall Study|Withdrawal by Subject|5|||
126730123|NCT02700919|455960415|FG001|Overall Study|Withdrawal by Subject|8|||
126531995|NCT01514448|455239999|FG000|Overall Study|Withdrawal by Subject|2|||
126531996|NCT01514448|455240000|FG001|Overall Study|Withdrawal by Subject|0|||
126531997|NCT01514448|455239999|FG000|Overall Study|Lost to Follow-up|2|||
126531998|NCT01514448|455240000|FG001|Overall Study|Lost to Follow-up|0|||
126582284|NCT01385176|455429190|FG000|Randomization Phase|Death|1|||
126582285|NCT01385176|455429191|FG001|Randomization Phase|Death|2|||
126582286|NCT01385176|455429190|FG000|6-18 Month All VNS Active|Death|1|||
126531999|NCT01514448|455239999|FG000|Overall Study|New Cancer Therapy|1|||
126532000|NCT01514448|455240000|FG001|Overall Study|New Cancer Therapy|0|||
126532001|NCT00713648|455240003|FG000|Overall Study|Adverse Event|1|||
126532002|NCT00713648|455240003|FG000|Overall Study|Unclassified|2|||
126582287|NCT01385176|455429191|FG001|6-18 Month All VNS Active|Death|2|||
126582288|NCT01385176|455429190|FG000|6-18 Month All VNS Active|Physician Decision|0|||
126582289|NCT01385176|455429191|FG001|6-18 Month All VNS Active|Physician Decision|1|||
126582290|NCT01385176|455429190|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
126582291|NCT01385176|455429191|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
126582292|NCT01385176|455429190|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
126582293|NCT01385176|455429191|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
126582294|NCT05384730|455429192|FG000|Overall Study|Adverse Event|1|||
126582295|NCT05384730|455429193|FG001|Overall Study|Adverse Event|0|||
126582296|NCT05384730|455429192|FG000|Overall Study|Lack of social support|2|||
126582297|NCT05384730|455429193|FG001|Overall Study|Lack of social support|0|||
126582298|NCT05384730|455429192|FG000|Overall Study|Hospital readmission|2|||
126582299|NCT05384730|455429193|FG001|Overall Study|Hospital readmission|0|||
126582300|NCT05384730|455429192|FG000|Overall Study|Disease progression|5|||
126582301|NCT05384730|455429193|FG001|Overall Study|Disease progression|0|||
126582302|NCT05384730|455429192|FG000|Overall Study|Overwhelmed with College commitments|0|||
126582303|NCT05384730|455429193|FG001|Overall Study|Overwhelmed with College commitments|2|||
126582304|NCT01772472|455429194|FG000|Overall Study|Death|126|||
126582305|NCT01772472|455429195|FG001|Overall Study|Death|94|||
126582306|NCT01772472|455429194|FG000|Overall Study|Lost to Follow-up|51|||
126582307|NCT01772472|455429195|FG001|Overall Study|Lost to Follow-up|50|||
126582308|NCT01772472|455429194|FG000|Overall Study|Other|9|||
126582309|NCT01772472|455429195|FG001|Overall Study|Other|7|||
126582310|NCT01772472|455429194|FG000|Overall Study|Physician Decision|1|||
126582311|NCT01772472|455429195|FG001|Overall Study|Physician Decision|7|||
126582312|NCT01772472|455429194|FG000|Overall Study|Withdrawal by Subject|115|||
126582313|NCT01772472|455429195|FG001|Overall Study|Withdrawal by Subject|90|||
126582314|NCT01772472|455429194|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
126582315|NCT01772472|455429195|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
126582316|NCT04431726|455429204|FG000|Overall Study|Ongoing in the Study|55|||
126582317|NCT04093752|455429206|FG000|Overall Study|Adverse Event|7|||
126582318|NCT04093752|455429207|FG001|Overall Study|Adverse Event|19|||
126582319|NCT04093752|455429208|FG002|Overall Study|Adverse Event|18|||
126582320|NCT04093752|455429209|FG003|Overall Study|Adverse Event|4|||
126582321|NCT04093752|455429206|FG000|Overall Study|Withdrawal by Subject|6|||
126582322|NCT04093752|455429207|FG001|Overall Study|Withdrawal by Subject|6|||
126582323|NCT04093752|455429208|FG002|Overall Study|Withdrawal by Subject|8|||
126582324|NCT04093752|455429209|FG003|Overall Study|Withdrawal by Subject|20|||
126582325|NCT04093752|455429206|FG000|Overall Study|Lost to Follow-up|2|||
126582326|NCT04093752|455429207|FG001|Overall Study|Lost to Follow-up|1|||
126582327|NCT04093752|455429208|FG002|Overall Study|Lost to Follow-up|1|||
126582328|NCT04093752|455429209|FG003|Overall Study|Lost to Follow-up|1|||
126582329|NCT04093752|455429206|FG000|Overall Study|Death|0|||
126582330|NCT04093752|455429207|FG001|Overall Study|Death|0|||
126582331|NCT04093752|455429208|FG002|Overall Study|Death|1|||
126582332|NCT04093752|455429209|FG003|Overall Study|Death|2|||
126582333|NCT04093752|455429206|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
126582334|NCT04093752|455429207|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
126582335|NCT04093752|455429208|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
126582336|NCT04093752|455429209|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
126582337|NCT04093752|455429206|FG000|Overall Study|Covid 19|0|||
126582338|NCT04093752|455429207|FG001|Overall Study|Covid 19|0|||
126582339|NCT04093752|455429208|FG002|Overall Study|Covid 19|0|||
126582340|NCT04093752|455429209|FG003|Overall Study|Covid 19|1|||
126582341|NCT04093752|455429206|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
126582342|NCT04093752|455429207|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
126582343|NCT04093752|455429208|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
126582344|NCT04093752|455429209|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
126582345|NCT04093752|455429206|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
126582346|NCT04093752|455429207|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
126582347|NCT04093752|455429208|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
126582348|NCT04093752|455429209|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
126582349|NCT04093752|455429206|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
126582350|NCT04093752|455429207|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
126582351|NCT04093752|455429208|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
126582352|NCT04093752|455429209|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
126582353|NCT01101451|455429210|FG000|Overall Study|Eligible and never treated|0|||
126730124|NCT02700919|455960416|FG002|Overall Study|Withdrawal by Subject|2|||
126730125|NCT02700919|455960414|FG000|Overall Study|Lost to Follow-up|2|||
126582354|NCT01101451|455429211|FG001|Overall Study|Eligible and never treated|5|||
126582355|NCT01101451|455429210|FG000|Overall Study|Ineligible and treated|12|||
126582356|NCT01101451|455429211|FG001|Overall Study|Ineligible and treated|8|||
126582357|NCT01101451|455429210|FG000|Overall Study|Ineligible and never treated|2|||
126582358|NCT01101451|455429211|FG001|Overall Study|Ineligible and never treated|2|||
126582359|NCT04854096|455429212|FG000|Overall Study|Adverse Event|1|||
126532003|NCT00713648|455240003|FG000|Overall Study|According to Protocol|2|||
126532004|NCT00713648|455240003|FG000|Overall Study|Development of antibodies|3|||
126532005|NCT01260350|455240006|FG000|Overall Study|Lack of Efficacy|0|||
126532006|NCT01260350|455240007|FG001|Overall Study|Lack of Efficacy|0|||
126532007|NCT01260350|455240008|FG002|Overall Study|Lack of Efficacy|0|||
126532008|NCT01260350|455240009|FG003|Overall Study|Lack of Efficacy|0|||
126532009|NCT01260350|455240010|FG004|Overall Study|Lack of Efficacy|0|||
126532010|NCT01260350|455240011|FG005|Overall Study|Lack of Efficacy|0|||
126532011|NCT01260350|455240012|FG006|Overall Study|Lack of Efficacy|0|||
126532012|NCT01260350|455240013|FG007|Overall Study|Lack of Efficacy|0|||
126532013|NCT01260350|455240014|FG008|Overall Study|Lack of Efficacy|0|||
126532014|NCT01260350|455240015|FG009|Overall Study|Lack of Efficacy|0|||
126532015|NCT01260350|455240016|FG010|Overall Study|Lack of Efficacy|0|||
126532016|NCT01260350|455240017|FG011|Overall Study|Lack of Efficacy|0|||
126532017|NCT01260350|455240018|FG012|Overall Study|Lack of Efficacy|0|||
126532018|NCT01260350|455240019|FG013|Overall Study|Lack of Efficacy|0|||
126532019|NCT01260350|455240020|FG014|Overall Study|Lack of Efficacy|0|||
126532020|NCT01260350|455240021|FG015|Overall Study|Lack of Efficacy|0|||
126532021|NCT01260350|455240022|FG016|Overall Study|Lack of Efficacy|0|||
126532022|NCT01260350|455240023|FG017|Overall Study|Lack of Efficacy|1|||
126532023|NCT01260350|455240024|FG018|Overall Study|Lack of Efficacy|0|||
126532024|NCT01260350|455240025|FG019|Overall Study|Lack of Efficacy|0|||
126532025|NCT01260350|455240026|FG020|Overall Study|Lack of Efficacy|3|||
126532026|NCT01260350|455240027|FG021|Overall Study|Lack of Efficacy|0|||
126532027|NCT01260350|455240006|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532028|NCT01260350|455240007|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532029|NCT01260350|455240008|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532030|NCT01260350|455240009|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532031|NCT01260350|455240010|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532032|NCT01260350|455240011|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532033|NCT01260350|455240012|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532034|NCT01260350|455240013|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532035|NCT01260350|455240014|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
126532036|NCT01260350|455240015|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532037|NCT01260350|455240016|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532038|NCT01260350|455240017|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532039|NCT01260350|455240018|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532040|NCT01260350|455240019|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532041|NCT01260350|455240020|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532042|NCT01260350|455240021|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532043|NCT01260350|455240022|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532044|NCT01260350|455240023|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532045|NCT01260350|455240024|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532046|NCT01260350|455240025|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532047|NCT01260350|455240026|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532048|NCT01260350|455240027|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
126532049|NCT00423176|455240046|FG000|Overall Study|Adverse Event|4|||
126532050|NCT00423176|455240047|FG001|Overall Study|Adverse Event|6|||
126532051|NCT00423176|455240046|FG000|Overall Study|Treatment Failure|1|||
126532052|NCT00423176|455240047|FG001|Overall Study|Treatment Failure|6|||
126532053|NCT00423176|455240046|FG000|Overall Study|Lost to Follow-up|4|||
126532054|NCT00423176|455240047|FG001|Overall Study|Lost to Follow-up|7|||
126532055|NCT00423176|455240046|FG000|Overall Study|Withdrawal by Subject|4|||
126532056|NCT00423176|455240047|FG001|Overall Study|Withdrawal by Subject|3|||
126532057|NCT00423176|455240046|FG000|Overall Study|Protocol Violation|1|||
126532058|NCT00423176|455240047|FG001|Overall Study|Protocol Violation|3|||
126532059|NCT00423176|455240046|FG000|Overall Study|Did not meet protocol eligibility|2|||
126532060|NCT00423176|455240047|FG001|Overall Study|Did not meet protocol eligibility|4|||
126532061|NCT04867369|455240048|FG000|Overall Study|Withdrawal by Subject|1|||
126532062|NCT04867369|455240049|FG001|Overall Study|Withdrawal by Subject|0|||
126532063|NCT05554237|455240050|FG000|Part 2 (7 Days)|Adverse Event|0|||
126532064|NCT05554237|455240051|FG001|Part 2 (7 Days)|Adverse Event|0|||
126532065|NCT05554237|455240052|FG002|Part 2 (7 Days)|Adverse Event|0|||
126532066|NCT05554237|455240053|FG003|Part 2 (7 Days)|Adverse Event|0|||
126532067|NCT05554237|455240054|FG004|Part 2 (7 Days)|Adverse Event|2|||
126532068|NCT05554237|455240055|FG005|Part 2 (7 Days)|Adverse Event|0|||
126532069|NCT05554237|455240056|FG006|Part 2 (7 Days)|Adverse Event|0|||
126532070|NCT05554237|455240057|FG007|Part 2 (7 Days)|Adverse Event|0|||
126532071|NCT05554237|455240058|FG008|Part 2 (7 Days)|Adverse Event|0|||
126532072|NCT05554237|455240059|FG009|Part 2 (7 Days)|Adverse Event|1|||
126532073|NCT05554237|455240060|FG010|Part 2 (7 Days)|Adverse Event|0|||
126532074|NCT05554237|455240061|FG011|Part 2 (7 Days)|Adverse Event|0|||
126532075|NCT05554237|455240062|FG012|Part 2 (7 Days)|Adverse Event|1|||
126532076|NCT05554237|455240063|FG013|Part 2 (7 Days)|Adverse Event|0|||
126532077|NCT02395042|455240064|FG000|Treatment 1 Period|Adverse Event|1|||
126532078|NCT02395042|455240065|FG001|Treatment 1 Period|Adverse Event|3|||
126532079|NCT02395042|455240066|FG002|Treatment 1 Period|Adverse Event|1|||
126532080|NCT02395042|455240064|FG000|Treatment 1 Period|Lack of Efficacy|1|||
126532081|NCT02395042|455240065|FG001|Treatment 1 Period|Lack of Efficacy|1|||
126532082|NCT02395042|455240066|FG002|Treatment 1 Period|Lack of Efficacy|0|||
126532083|NCT02395042|455240064|FG000|Treatment 1 Period|Lost to Follow-up|1|||
126532084|NCT02395042|455240065|FG001|Treatment 1 Period|Lost to Follow-up|0|||
126532085|NCT02395042|455240066|FG002|Treatment 1 Period|Lost to Follow-up|0|||
126532086|NCT02395042|455240064|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
126532087|NCT02395042|455240065|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
126532088|NCT02395042|455240066|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
126532089|NCT02395042|455240064|FG000|Treatment 2 Period|Lack of Efficacy|1|||
126532090|NCT02395042|455240065|FG001|Treatment 2 Period|Lack of Efficacy|1|||
126532091|NCT02395042|455240066|FG002|Treatment 2 Period|Lack of Efficacy|0|||
126532092|NCT02807558|455240067|FG000|Overall Study|Consent withdrawn by participant|4|||
126532093|NCT02807558|455240068|FG001|Overall Study|Consent withdrawn by participant|0|||
126532094|NCT02807558|455240069|FG002|Overall Study|Consent withdrawn by participant|4|||
126532095|NCT02807558|455240070|FG003|Overall Study|Consent withdrawn by participant|2|||
126532096|NCT02807558|455240071|FG004|Overall Study|Consent withdrawn by participant|1|||
126532097|NCT02807558|455240072|FG005|Overall Study|Consent withdrawn by participant|0|||
126532098|NCT02807558|455240067|FG000|Overall Study|Non-compliance with Study Drug|0|||
126532099|NCT02807558|455240068|FG001|Overall Study|Non-compliance with Study Drug|0|||
126532100|NCT02807558|455240069|FG002|Overall Study|Non-compliance with Study Drug|1|||
126532101|NCT02807558|455240070|FG003|Overall Study|Non-compliance with Study Drug|0|||
126532102|NCT02807558|455240071|FG004|Overall Study|Non-compliance with Study Drug|0|||
126532103|NCT02807558|455240072|FG005|Overall Study|Non-compliance with Study Drug|0|||
126532104|NCT02807558|455240067|FG000|Overall Study|Adverse Event|0|||
126532105|NCT02807558|455240068|FG001|Overall Study|Adverse Event|0|||
126532106|NCT02807558|455240069|FG002|Overall Study|Adverse Event|9|||
126532107|NCT02807558|455240070|FG003|Overall Study|Adverse Event|0|||
126532108|NCT02807558|455240071|FG004|Overall Study|Adverse Event|0|||
126532109|NCT02807558|455240072|FG005|Overall Study|Adverse Event|0|||
126532110|NCT02807558|455240067|FG000|Overall Study|Death|23|||
126532111|NCT02807558|455240068|FG001|Overall Study|Death|2|||
126532112|NCT02807558|455240069|FG002|Overall Study|Death|3|||
126532113|NCT02807558|455240070|FG003|Overall Study|Death|43|||
126532114|NCT02807558|455240071|FG004|Overall Study|Death|24|||
126532115|NCT02807558|455240072|FG005|Overall Study|Death|15|||
126532116|NCT02807558|455240067|FG000|Overall Study|Progressive Disease|0|||
126532117|NCT02807558|455240068|FG001|Overall Study|Progressive Disease|0|||
126532118|NCT02807558|455240069|FG002|Overall Study|Progressive Disease|1|||
126532119|NCT02807558|455240070|FG003|Overall Study|Progressive Disease|0|||
126532120|NCT02807558|455240071|FG004|Overall Study|Progressive Disease|0|||
126532121|NCT02807558|455240072|FG005|Overall Study|Progressive Disease|0|||
126532122|NCT02807558|455240067|FG000|Overall Study|Other than specified|1|||
126532123|NCT02807558|455240068|FG001|Overall Study|Other than specified|0|||
126532124|NCT02807558|455240069|FG002|Overall Study|Other than specified|2|||
126532125|NCT02807558|455240070|FG003|Overall Study|Other than specified|0|||
126532126|NCT02807558|455240071|FG004|Overall Study|Other than specified|1|||
126532127|NCT02807558|455240072|FG005|Overall Study|Other than specified|1|||
126532128|NCT02807558|455240067|FG000|Overall Study|Lack of Efficacy|0|||
126532129|NCT02807558|455240068|FG001|Overall Study|Lack of Efficacy|0|||
126532130|NCT02807558|455240069|FG002|Overall Study|Lack of Efficacy|9|||
126532131|NCT02807558|455240070|FG003|Overall Study|Lack of Efficacy|0|||
126532132|NCT02807558|455240071|FG004|Overall Study|Lack of Efficacy|0|||
126532133|NCT02807558|455240072|FG005|Overall Study|Lack of Efficacy|0|||
126532134|NCT02477111|455240073|FG000|Overall Study|Death|28|||
126532135|NCT02477111|455240073|FG000|Overall Study|Withdrawal by Subject|19|||
126532136|NCT02477111|455240073|FG000|Overall Study|Lost to Follow-up|4|||
126532137|NCT03492281|455240078|FG000|Overall Study|Withdrawal by Subject|21|||
126532138|NCT03492281|455240079|FG001|Overall Study|Withdrawal by Subject|14|||
126532139|NCT03492281|455240080|FG002|Overall Study|Withdrawal by Subject|13|||
126532140|NCT03492281|455240078|FG000|Overall Study|Lost to Follow-up|14|||
126532141|NCT03492281|455240079|FG001|Overall Study|Lost to Follow-up|15|||
126532142|NCT03492281|455240080|FG002|Overall Study|Lost to Follow-up|10|||
126532143|NCT03492281|455240078|FG000|Overall Study|Adverse Event|6|||
126532144|NCT03492281|455240079|FG001|Overall Study|Adverse Event|8|||
126532145|NCT03492281|455240080|FG002|Overall Study|Adverse Event|13|||
126532146|NCT03492281|455240078|FG000|Overall Study|Lack of Efficacy|3|||
126532147|NCT03492281|455240079|FG001|Overall Study|Lack of Efficacy|0|||
126532148|NCT03492281|455240080|FG002|Overall Study|Lack of Efficacy|1|||
126730126|NCT02700919|455960415|FG001|Overall Study|Lost to Follow-up|0|||
126730127|NCT02700919|455960416|FG002|Overall Study|Lost to Follow-up|0|||
126532149|NCT03492281|455240078|FG000|Overall Study|Physician Decision|1|||
126532150|NCT03492281|455240079|FG001|Overall Study|Physician Decision|0|||
126532151|NCT03492281|455240080|FG002|Overall Study|Physician Decision|3|||
126532152|NCT03492281|455240078|FG000|Overall Study|Protocol Violation|0|||
126532153|NCT03492281|455240079|FG001|Overall Study|Protocol Violation|2|||
126532154|NCT03492281|455240080|FG002|Overall Study|Protocol Violation|1|||
126532155|NCT03492281|455240078|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
126582360|NCT04854096|455429213|FG001|Overall Study|Adverse Event|0|||
126582361|NCT04854096|455429212|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
126582362|NCT04854096|455429213|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
126582363|NCT04854096|455429212|FG000|Overall Study|Withdrawal by Subject|1|||
126582364|NCT04854096|455429213|FG001|Overall Study|Withdrawal by Subject|0|||
126582365|NCT04854096|455429212|FG000|Overall Study|Other reasons|1|||
126582366|NCT04854096|455429213|FG001|Overall Study|Other reasons|0|||
126582367|NCT04757610|455429214|FG000|Overall Study|Adverse Event|13|||
126582368|NCT04757610|455429215|FG001|Overall Study|Adverse Event|10|||
126582369|NCT04757610|455429216|FG002|Overall Study|Adverse Event|5|||
126582370|NCT04757610|455429214|FG000|Overall Study|Death|5|||
126582371|NCT04757610|455429215|FG001|Overall Study|Death|13|||
126582372|NCT04757610|455429216|FG002|Overall Study|Death|8|||
126582373|NCT04757610|455429214|FG000|Overall Study|Lack of Efficacy|1|||
126582374|NCT04757610|455429215|FG001|Overall Study|Lack of Efficacy|2|||
126582375|NCT04757610|455429216|FG002|Overall Study|Lack of Efficacy|3|||
126582376|NCT04757610|455429214|FG000|Overall Study|Lost to Follow-up|7|||
126582377|NCT04757610|455429215|FG001|Overall Study|Lost to Follow-up|2|||
126582378|NCT04757610|455429216|FG002|Overall Study|Lost to Follow-up|7|||
126582379|NCT04757610|455429214|FG000|Overall Study|Physician Decision|4|||
126582380|NCT04757610|455429215|FG001|Overall Study|Physician Decision|1|||
126582381|NCT04757610|455429216|FG002|Overall Study|Physician Decision|2|||
126582382|NCT04757610|455429214|FG000|Overall Study|Withdrawal by Subject|26|||
126582383|NCT04757610|455429215|FG001|Overall Study|Withdrawal by Subject|25|||
126582384|NCT04757610|455429216|FG002|Overall Study|Withdrawal by Subject|25|||
126582385|NCT04757610|455429214|FG000|Overall Study|Study Terminated by Sponsor|105|||
126582386|NCT04757610|455429215|FG001|Overall Study|Study Terminated by Sponsor|105|||
126582387|NCT04757610|455429216|FG002|Overall Study|Study Terminated by Sponsor|110|||
126582388|NCT04757610|455429214|FG000|Overall Study|Randomized in Error|1|||
126582389|NCT04757610|455429215|FG001|Overall Study|Randomized in Error|0|||
126582390|NCT04757610|455429216|FG002|Overall Study|Randomized in Error|0|||
126582391|NCT00073749|455429217|FG000|Overall Study|Disease Progression|2|||
126582392|NCT00073749|455429218|FG001|Overall Study|Disease Progression|0|||
126582393|NCT00073749|455429219|FG002|Overall Study|Disease Progression|3|||
126582394|NCT00073749|455429220|FG003|Overall Study|Disease Progression|2|||
126582395|NCT00073749|455429221|FG004|Overall Study|Disease Progression|3|||
126582396|NCT00073749|455429222|FG005|Overall Study|Disease Progression|1|||
126582397|NCT00073749|455429223|FG006|Overall Study|Disease Progression|3|||
126582398|NCT00073749|455429217|FG000|Overall Study|Death|0|||
126582399|NCT00073749|455429218|FG001|Overall Study|Death|1|||
126582400|NCT00073749|455429219|FG002|Overall Study|Death|1|||
126582401|NCT00073749|455429220|FG003|Overall Study|Death|0|||
126582402|NCT00073749|455429221|FG004|Overall Study|Death|0|||
126730128|NCT02700919|455960414|FG000|Overall Study|Other|2|||
126730129|NCT02700919|455960415|FG001|Overall Study|Other|1|||
126730130|NCT02700919|455960416|FG002|Overall Study|Other|1|||
126730131|NCT01253187|455960420|FG000|Period 2|Withdrawal by Subject|0|||
126730132|NCT01253187|455960421|FG001|Period 2|Withdrawal by Subject|0|||
126582403|NCT00073749|455429222|FG005|Overall Study|Death|0|||
126582404|NCT00073749|455429223|FG006|Overall Study|Death|29|||
126582405|NCT00073749|455429217|FG000|Overall Study|Adverse Event|0|||
126582406|NCT00073749|455429218|FG001|Overall Study|Adverse Event|3|||
126582407|NCT00073749|455429219|FG002|Overall Study|Adverse Event|6|||
126582408|NCT00073749|455429220|FG003|Overall Study|Adverse Event|4|||
126582409|NCT00073749|455429221|FG004|Overall Study|Adverse Event|2|||
126582410|NCT00073749|455429222|FG005|Overall Study|Adverse Event|1|||
126582411|NCT00073749|455429223|FG006|Overall Study|Adverse Event|0|||
126582412|NCT00073749|455429217|FG000|Overall Study|Physician Decision|0|||
126582413|NCT00073749|455429218|FG001|Overall Study|Physician Decision|0|||
126582414|NCT00073749|455429219|FG002|Overall Study|Physician Decision|1|||
126582415|NCT00073749|455429220|FG003|Overall Study|Physician Decision|0|||
126582416|NCT00073749|455429221|FG004|Overall Study|Physician Decision|0|||
126582417|NCT00073749|455429222|FG005|Overall Study|Physician Decision|2|||
126582418|NCT00073749|455429223|FG006|Overall Study|Physician Decision|0|||
126582419|NCT00073749|455429217|FG000|Overall Study|Withdrawal by Subject|0|||
126582420|NCT00073749|455429218|FG001|Overall Study|Withdrawal by Subject|1|||
126582421|NCT00073749|455429219|FG002|Overall Study|Withdrawal by Subject|0|||
126582422|NCT00073749|455429220|FG003|Overall Study|Withdrawal by Subject|0|||
126582423|NCT00073749|455429221|FG004|Overall Study|Withdrawal by Subject|1|||
126582424|NCT00073749|455429222|FG005|Overall Study|Withdrawal by Subject|0|||
126582425|NCT00073749|455429223|FG006|Overall Study|Withdrawal by Subject|2|||
126582426|NCT00073749|455429217|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
126582427|NCT00073749|455429218|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
126582428|NCT00073749|455429219|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
126582429|NCT00073749|455429220|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
126582430|NCT00073749|455429221|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
126582431|NCT00073749|455429222|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
126582432|NCT00073749|455429223|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
126582433|NCT00073749|455429217|FG000|Overall Study|Lost to Follow-up|0|||
126777248|NCT03341273|456141317|FG001|Overall Study|Not Eligible at Enrollment|1|||
126777249|NCT03341273|456141316|FG000|Overall Study|Participant incarcerated|1|||
126777250|NCT03341273|456141317|FG001|Overall Study|Participant incarcerated|0|||
126777251|NCT00685919|456141318|FG000|Overall Study|Withdrawal by Subject|0|||
126777252|NCT00685919|456141319|FG001|Overall Study|Withdrawal by Subject|0|||
126777253|NCT00685919|456141320|FG002|Overall Study|Withdrawal by Subject|1|||
126777254|NCT00685919|456141321|FG003|Overall Study|Withdrawal by Subject|0|||
126777255|NCT00685919|456141318|FG000|Overall Study|Physician Decision|1|||
126777256|NCT00685919|456141319|FG001|Overall Study|Physician Decision|0|||
126777257|NCT00685919|456141320|FG002|Overall Study|Physician Decision|0|||
126777258|NCT00685919|456141321|FG003|Overall Study|Physician Decision|0|||
126777259|NCT01717456|456141322|FG000|End of Treatment|Physician Decision|0|||
126777260|NCT01717456|456141323|FG001|End of Treatment|Physician Decision|1|||
126777261|NCT01717456|456141322|FG000|End of Treatment|Lost to Follow-up|0|||
126777262|NCT01717456|456141323|FG001|End of Treatment|Lost to Follow-up|1|||
126777263|NCT01717456|456141322|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
126777264|NCT01717456|456141323|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
126730133|NCT01253187|455960422|FG002|Period 2|Withdrawal by Subject|0|||
126730134|NCT01253187|455960423|FG003|Period 2|Withdrawal by Subject|0|||
126730135|NCT01253187|455960424|FG004|Period 2|Withdrawal by Subject|1|||
126730136|NCT01253187|455960425|FG005|Period 2|Withdrawal by Subject|0|||
126730137|NCT01253187|455960420|FG000|Period 3|Pregnancy|1|||
126730138|NCT01253187|455960421|FG001|Period 3|Pregnancy|0|||
126730139|NCT01253187|455960422|FG002|Period 3|Pregnancy|0|||
126730140|NCT01253187|455960423|FG003|Period 3|Pregnancy|0|||
126730141|NCT01253187|455960424|FG004|Period 3|Pregnancy|0|||
126730142|NCT01253187|455960425|FG005|Period 3|Pregnancy|0|||
126730143|NCT01253187|455960420|FG000|Period 3|difficulty with blood sampling|0|||
126730144|NCT01253187|455960421|FG001|Period 3|difficulty with blood sampling|1|||
126730145|NCT01253187|455960422|FG002|Period 3|difficulty with blood sampling|0|||
126730146|NCT01253187|455960423|FG003|Period 3|difficulty with blood sampling|0|||
126730147|NCT01253187|455960424|FG004|Period 3|difficulty with blood sampling|0|||
126730148|NCT01253187|455960425|FG005|Period 3|difficulty with blood sampling|0|||
126730149|NCT01253187|455960420|FG000|Period 3|non-compliance|0|||
126730150|NCT01253187|455960421|FG001|Period 3|non-compliance|0|||
126730151|NCT01253187|455960422|FG002|Period 3|non-compliance|0|||
126730152|NCT01253187|455960423|FG003|Period 3|non-compliance|0|||
126582434|NCT00073749|455429218|FG001|Overall Study|Lost to Follow-up|0|||
126582435|NCT00073749|455429219|FG002|Overall Study|Lost to Follow-up|0|||
126582436|NCT00073749|455429220|FG003|Overall Study|Lost to Follow-up|0|||
126582437|NCT00073749|455429221|FG004|Overall Study|Lost to Follow-up|0|||
126582438|NCT00073749|455429222|FG005|Overall Study|Lost to Follow-up|0|||
126582439|NCT00073749|455429223|FG006|Overall Study|Lost to Follow-up|2|||
126582440|NCT00073749|455429217|FG000|Overall Study|Other|0|||
126582441|NCT00073749|455429218|FG001|Overall Study|Other|0|||
126582442|NCT00073749|455429219|FG002|Overall Study|Other|0|||
126582443|NCT00073749|455429220|FG003|Overall Study|Other|0|||
126582444|NCT00073749|455429221|FG004|Overall Study|Other|0|||
126582445|NCT00073749|455429222|FG005|Overall Study|Other|2|||
126582446|NCT00073749|455429223|FG006|Overall Study|Other|0|||
126730153|NCT01253187|455960424|FG004|Period 3|non-compliance|1|||
126730154|NCT01253187|455960425|FG005|Period 3|non-compliance|0|||
126730155|NCT03172481|455960426|FG000|Double-blind|Withdrawal by Subject|1|||
126730156|NCT03172481|455960427|FG001|Double-blind|Withdrawal by Subject|0|||
126730157|NCT01957709|455960428|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
126730158|NCT01149343|455960432|FG000|Overall Study|Withdrawal by Subject|1|||
126730159|NCT01149343|455960433|FG001|Overall Study|Withdrawal by Subject|1|||
126730160|NCT01149343|455960434|FG002|Overall Study|Withdrawal by Subject|1|||
126730161|NCT01149343|455960435|FG003|Overall Study|Withdrawal by Subject|5|||
126730162|NCT01149343|455960432|FG000|Overall Study|Death|10|||
126730163|NCT01149343|455960433|FG001|Overall Study|Death|13|||
126730164|NCT01149343|455960434|FG002|Overall Study|Death|18|||
126730165|NCT01149343|455960435|FG003|Overall Study|Death|18|||
126730166|NCT01149343|455960432|FG000|Overall Study|Lost to Follow-up|1|||
126730167|NCT01149343|455960433|FG001|Overall Study|Lost to Follow-up|0|||
126730168|NCT01149343|455960434|FG002|Overall Study|Lost to Follow-up|0|||
126730169|NCT01149343|455960435|FG003|Overall Study|Lost to Follow-up|1|||
126777265|NCT03751020|456141324|FG000|Overall Study|Withdrawal by Subject|2|||
126777266|NCT03751020|456141325|FG001|Overall Study|Withdrawal by Subject|0|||
126777267|NCT03751020|456141326|FG002|Overall Study|Withdrawal by Subject|0|||
126777268|NCT03751020|456141324|FG000|Overall Study|Lost to Follow-up|7|||
126582447|NCT04154384|455429224|FG000|Overall Study|Lost to Follow-up|24|||
126582448|NCT04154384|455429225|FG001|Overall Study|Lost to Follow-up|33|||
126582449|NCT04154384|455429226|FG002|Overall Study|Lost to Follow-up|0|||
126582450|NCT04154384|455429224|FG000|Overall Study|Withdrawal by Subject|7|||
126582451|NCT04154384|455429225|FG001|Overall Study|Withdrawal by Subject|18|||
126582452|NCT04154384|455429226|FG002|Overall Study|Withdrawal by Subject|0|||
126582453|NCT04154384|455429224|FG000|Overall Study|Missing outcome data|1|||
126582454|NCT04154384|455429225|FG001|Overall Study|Missing outcome data|0|||
126582455|NCT04154384|455429226|FG002|Overall Study|Missing outcome data|0|||
126730170|NCT01149343|455960432|FG000|Overall Study|Other|8|||
126730171|NCT01149343|455960433|FG001|Overall Study|Other|10|||
126730172|NCT01149343|455960434|FG002|Overall Study|Other|2|||
126730173|NCT01149343|455960435|FG003|Overall Study|Other|14|||
126730174|NCT01149343|455960432|FG000|Overall Study|Sponsor study termination|0|||
126730175|NCT01149343|455960433|FG001|Overall Study|Sponsor study termination|0|||
126532156|NCT03492281|455240079|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
126532157|NCT03492281|455240080|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
126532158|NCT03492281|455240078|FG000|Overall Study|Death|0|||
126532159|NCT03492281|455240079|FG001|Overall Study|Death|0|||
126532160|NCT03492281|455240080|FG002|Overall Study|Death|1|||
126532161|NCT03492281|455240078|FG000|Overall Study|Captured as Other in Database|8|||
126532162|NCT03492281|455240079|FG001|Overall Study|Captured as Other in Database|6|||
126532163|NCT03492281|455240080|FG002|Overall Study|Captured as Other in Database|3|||
126532164|NCT01506193|455240081|FG000|Overall Study|Protocol Violation|1|||
126532165|NCT01506193|455240082|FG001|Overall Study|Protocol Violation|0|||
126532166|NCT01506193|455240083|FG002|Overall Study|Protocol Violation|1|||
126532167|NCT01506193|455240081|FG000|Overall Study|Migrated/moved from study area|0|||
126532168|NCT01506193|455240082|FG001|Overall Study|Migrated/moved from study area|0|||
126532169|NCT01506193|455240083|FG002|Overall Study|Migrated/moved from study area|1|||
126532170|NCT01506193|455240081|FG000|Overall Study|Adverse event, non-fatal|0|||
126532171|NCT01506193|455240082|FG001|Overall Study|Adverse event, non-fatal|0|||
126532172|NCT01506193|455240083|FG002|Overall Study|Adverse event, non-fatal|1|||
126532173|NCT01506193|455240081|FG000|Overall Study|Withdrawal by Subject|5|||
126532174|NCT01506193|455240082|FG001|Overall Study|Withdrawal by Subject|1|||
126532175|NCT01506193|455240083|FG002|Overall Study|Withdrawal by Subject|8|||
126532176|NCT01506193|455240081|FG000|Overall Study|Lost to Follow-up|8|||
126532177|NCT01506193|455240082|FG001|Overall Study|Lost to Follow-up|3|||
126532178|NCT01506193|455240083|FG002|Overall Study|Lost to Follow-up|3|||
126532179|NCT04575467|455240087|FG000|Overall Study|Adverse Event|0|||
126532180|NCT04575467|455240088|FG001|Overall Study|Adverse Event|1|||
126532181|NCT04575467|455240089|FG002|Overall Study|Adverse Event|0|||
126532182|NCT04575467|455240090|FG003|Overall Study|Adverse Event|0|||
126532183|NCT01328574|455240091|FG000|Overall Study|Refused further treatment|1|||
126532184|NCT01483924|455240092|FG000|Overall Study|Withdrawal by Subject|2|||
126532185|NCT01483924|455240093|FG001|Overall Study|Withdrawal by Subject|0|||
126532186|NCT01483924|455240094|FG002|Overall Study|Withdrawal by Subject|0|||
126532187|NCT01483924|455240095|FG003|Overall Study|Withdrawal by Subject|1|||
126532188|NCT01483924|455240096|FG004|Overall Study|Withdrawal by Subject|1|||
126532189|NCT01483924|455240092|FG000|Overall Study|Adverse Event|0|||
126532190|NCT01483924|455240093|FG001|Overall Study|Adverse Event|0|||
126532191|NCT01483924|455240094|FG002|Overall Study|Adverse Event|1|||
126532192|NCT01483924|455240095|FG003|Overall Study|Adverse Event|1|||
126532193|NCT01483924|455240096|FG004|Overall Study|Adverse Event|0|||
126532194|NCT01483924|455240092|FG000|Overall Study|Non-compliance|0|||
126532195|NCT01483924|455240093|FG001|Overall Study|Non-compliance|0|||
126532196|NCT01483924|455240094|FG002|Overall Study|Non-compliance|0|||
126532197|NCT01483924|455240095|FG003|Overall Study|Non-compliance|1|||
126532198|NCT01483924|455240096|FG004|Overall Study|Non-compliance|1|||
126532199|NCT01483924|455240092|FG000|Overall Study|Sponsor concern over ECG result|0|||
126532200|NCT01483924|455240093|FG001|Overall Study|Sponsor concern over ECG result|0|||
126532201|NCT01483924|455240094|FG002|Overall Study|Sponsor concern over ECG result|0|||
126532202|NCT01483924|455240095|FG003|Overall Study|Sponsor concern over ECG result|1|||
126532203|NCT01483924|455240096|FG004|Overall Study|Sponsor concern over ECG result|0|||
126532204|NCT00003298|455240097|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
126532205|NCT00003298|455240097|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
126532206|NCT00003298|455240097|FG000|Surgery|Unresectable at surgery|3|||
126532207|NCT00003298|455240097|FG000|Surgery|Progression before surgery|2|||
126532208|NCT00003298|455240097|FG000|Surgery|Unevaluable and off study|2|||
126532209|NCT00003298|455240097|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
126532210|NCT00003298|455240097|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
126532211|NCT00003298|455240097|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
126532212|NCT00003298|455240097|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
126532213|NCT00003298|455240097|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
126532214|NCT00003298|455240097|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
126532215|NCT00003298|455240097|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
126730176|NCT01149343|455960434|FG002|Overall Study|Sponsor study termination|0|||
126532216|NCT00003298|455240097|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
126532217|NCT00003298|455240097|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
126532218|NCT00003298|455240097|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
126532219|NCT03565887|455240105|FG000|Overall Study|Adverse Event|1|||
126532220|NCT03565887|455240106|FG001|Overall Study|Adverse Event|0|||
126532221|NCT03565887|455240105|FG000|Overall Study|Withdrawal by Subject|0|||
126532222|NCT03565887|455240106|FG001|Overall Study|Withdrawal by Subject|2|||
126730177|NCT01149343|455960435|FG003|Overall Study|Sponsor study termination|2|||
126730178|NCT01149343|455960432|FG000|Overall Study|Recurrence / Progressive disease|0|||
126730179|NCT01149343|455960433|FG001|Overall Study|Recurrence / Progressive disease|0|||
126730180|NCT01149343|455960434|FG002|Overall Study|Recurrence / Progressive disease|1|||
126730181|NCT01149343|455960435|FG003|Overall Study|Recurrence / Progressive disease|0|||
126730182|NCT01061736|455960436|FG000|Overall Study|Dose regimen not selected|0|||
126730183|NCT01061736|455960437|FG001|Overall Study|Dose regimen not selected|0|||
126730184|NCT01061736|455960438|FG002|Overall Study|Dose regimen not selected|0|||
126730185|NCT01061736|455960439|FG003|Overall Study|Dose regimen not selected|0|||
126730186|NCT01061736|455960440|FG004|Overall Study|Dose regimen not selected|0|||
126730187|NCT01061736|455960441|FG005|Overall Study|Dose regimen not selected|0|||
126730188|NCT01061736|455960442|FG006|Overall Study|Dose regimen not selected|79|||
126730189|NCT01061736|455960443|FG007|Overall Study|Dose regimen not selected|0|||
126730190|NCT01061736|455960444|FG008|Overall Study|Dose regimen not selected|0|||
126730191|NCT01061736|455960445|FG009|Overall Study|Dose regimen not selected|0|||
126730192|NCT01061736|455960436|FG000|Overall Study|Adverse Event|13|||
126730193|NCT01061736|455960437|FG001|Overall Study|Adverse Event|1|||
126730194|NCT01061736|455960438|FG002|Overall Study|Adverse Event|3|||
126730195|NCT01061736|455960439|FG003|Overall Study|Adverse Event|2|||
126730196|NCT01061736|455960440|FG004|Overall Study|Adverse Event|4|||
126730197|NCT01061736|455960441|FG005|Overall Study|Adverse Event|1|||
126730198|NCT01061736|455960442|FG006|Overall Study|Adverse Event|4|||
126730199|NCT01061736|455960443|FG007|Overall Study|Adverse Event|63|||
126730200|NCT01061736|455960444|FG008|Overall Study|Adverse Event|67|||
126730201|NCT01061736|455960445|FG009|Overall Study|Adverse Event|34|||
126730202|NCT01061736|455960436|FG000|Overall Study|Lack of Efficacy|0|||
126582456|NCT05048186|455429227|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
126582457|NCT05048186|455429228|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
126582458|NCT05048186|455429227|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
126582459|NCT05048186|455429228|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
126582460|NCT00951379|455429229|FG000|Overall Study|Adverse Event|4|||
126582461|NCT00951379|455429230|FG001|Overall Study|Adverse Event|1|||
126582462|NCT00951379|455429229|FG000|Overall Study|Withdrawal by Subject|1|||
126582463|NCT00951379|455429230|FG001|Overall Study|Withdrawal by Subject|0|||
126582464|NCT00951379|455429229|FG000|Overall Study|Noncompliance|1|||
126582465|NCT00951379|455429230|FG001|Overall Study|Noncompliance|0|||
126582466|NCT00951379|455429229|FG000|Overall Study|Disease Progression|0|||
126582467|NCT00951379|455429230|FG001|Overall Study|Disease Progression|1|||
126582468|NCT04218266|455429231|FG000|Overall Study|Death|1|||
126582469|NCT04218266|455429232|FG001|Overall Study|Death|2|||
126582470|NCT04218266|455429233|FG002|Overall Study|Death|3|||
126582471|NCT04218266|455429231|FG000|Overall Study|Adverse Event|13|||
126582472|NCT04218266|455429232|FG001|Overall Study|Adverse Event|14|||
126582473|NCT04218266|455429233|FG002|Overall Study|Adverse Event|11|||
126582474|NCT04218266|455429231|FG000|Overall Study|Other|7|||
126582475|NCT04218266|455429232|FG001|Overall Study|Other|5|||
126582476|NCT04218266|455429233|FG002|Overall Study|Other|14|||
126582477|NCT04218266|455429231|FG000|Overall Study|Physician Decision|1|||
126582478|NCT04218266|455429232|FG001|Overall Study|Physician Decision|3|||
126582479|NCT04218266|455429233|FG002|Overall Study|Physician Decision|2|||
126582480|NCT04218266|455429231|FG000|Overall Study|Non-compliance with study drug|0|||
126582481|NCT04218266|455429232|FG001|Overall Study|Non-compliance with study drug|0|||
126582482|NCT04218266|455429233|FG002|Overall Study|Non-compliance with study drug|1|||
126582483|NCT04218266|455429231|FG000|Overall Study|Withdrawal by Subject|1|||
126582484|NCT04218266|455429232|FG001|Overall Study|Withdrawal by Subject|3|||
126582485|NCT04218266|455429233|FG002|Overall Study|Withdrawal by Subject|1|||
126582486|NCT04218266|455429231|FG000|Overall Study|Study drug never administered|2|||
126582487|NCT04218266|455429232|FG001|Overall Study|Study drug never administered|0|||
126582488|NCT04218266|455429233|FG002|Overall Study|Study drug never administered|0|||
126582489|NCT02742519|455429235|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
126582490|NCT02742519|455429236|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
126582491|NCT02742519|455429237|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
126582492|NCT02742519|455429235|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
126582493|NCT02742519|455429236|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
126582494|NCT02742519|455429237|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
126582495|NCT02742519|455429235|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
126582496|NCT02742519|455429236|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
126582497|NCT02742519|455429237|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
126582498|NCT04377308|455429238|FG000|Overall Study|Withdrawal by Subject|0|||
126582499|NCT04377308|455429239|FG001|Overall Study|Withdrawal by Subject|1|||
126730203|NCT01061736|455960437|FG001|Overall Study|Lack of Efficacy|2|||
126730204|NCT01061736|455960438|FG002|Overall Study|Lack of Efficacy|1|||
126730205|NCT01061736|455960439|FG003|Overall Study|Lack of Efficacy|1|||
126730206|NCT01061736|455960440|FG004|Overall Study|Lack of Efficacy|1|||
126730207|NCT01061736|455960441|FG005|Overall Study|Lack of Efficacy|2|||
126730208|NCT01061736|455960442|FG006|Overall Study|Lack of Efficacy|1|||
126532223|NCT01994954|455240110|FG000|Overall Study|Death|1|||
126532224|NCT01994954|455240111|FG001|Overall Study|Death|0|||
126532225|NCT01994954|455240110|FG000|Overall Study|Withdrawal by Subject|9|||
126532226|NCT01994954|455240111|FG001|Overall Study|Withdrawal by Subject|14|||
126532227|NCT01994954|455240110|FG000|Overall Study|Physician Decision|2|||
126532228|NCT01994954|455240111|FG001|Overall Study|Physician Decision|2|||
126532229|NCT01994954|455240110|FG000|Overall Study|Lost to Follow-up|8|||
126532230|NCT01994954|455240111|FG001|Overall Study|Lost to Follow-up|10|||
126532231|NCT01994954|455240110|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
126532232|NCT01994954|455240111|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
126532233|NCT00449176|455240112|FG000|Overall Study|Withdrawal by Subject|39|||
126532234|NCT00449176|455240113|FG001|Overall Study|Withdrawal by Subject|43|||
126532235|NCT00449176|455240114|FG002|Overall Study|Withdrawal by Subject|59|||
126532236|NCT00449176|455240112|FG000|Overall Study|Lost to Follow-up|13|||
126532237|NCT00449176|455240113|FG001|Overall Study|Lost to Follow-up|8|||
126532238|NCT00449176|455240114|FG002|Overall Study|Lost to Follow-up|12|||
126532239|NCT00449176|455240112|FG000|Overall Study|Adverse Event|51|||
126532240|NCT00449176|455240113|FG001|Overall Study|Adverse Event|107|||
126532241|NCT00449176|455240114|FG002|Overall Study|Adverse Event|15|||
126532242|NCT00449176|455240112|FG000|Overall Study|Lack of Efficacy|13|||
126532243|NCT00449176|455240113|FG001|Overall Study|Lack of Efficacy|7|||
126532244|NCT00449176|455240114|FG002|Overall Study|Lack of Efficacy|50|||
126532245|NCT00449176|455240112|FG000|Overall Study|Study drug non-compliant|14|||
126532246|NCT00449176|455240113|FG001|Overall Study|Study drug non-compliant|11|||
126532247|NCT00449176|455240114|FG002|Overall Study|Study drug non-compliant|11|||
126532248|NCT00449176|455240112|FG000|Overall Study|all other|22|||
126532249|NCT00449176|455240113|FG001|Overall Study|all other|19|||
126532250|NCT00449176|455240114|FG002|Overall Study|all other|20|||
126532251|NCT01454583|455240121|FG000|1st Year|Lost to Follow-up|1057|||
126532252|NCT01454583|455240122|FG001|1st Year|Lost to Follow-up|318|||
126532253|NCT01454583|455240123|FG002|1st Year|Lost to Follow-up|180|||
126532254|NCT01454583|455240121|FG000|2nd Year|Lost to Follow-up|3965|||
126532255|NCT01454583|455240122|FG001|2nd Year|Lost to Follow-up|1049|||
126532256|NCT01454583|455240123|FG002|2nd Year|Lost to Follow-up|737|||
126532257|NCT01454583|455240121|FG000|3rd Year|Lost to Follow-up|1959|||
126532258|NCT01454583|455240122|FG001|3rd Year|Lost to Follow-up|512|||
126532259|NCT01454583|455240123|FG002|3rd Year|Lost to Follow-up|297|||
126532260|NCT02677116|455240126|FG000|Overall Study|Adverse Event|0|||
126532261|NCT02677116|455240127|FG001|Overall Study|Adverse Event|1|||
126532262|NCT02677116|455240128|FG002|Overall Study|Adverse Event|0|||
126532263|NCT02677116|455240129|FG003|Overall Study|Adverse Event|0|||
126532264|NCT02677116|455240130|FG004|Overall Study|Adverse Event|0|||
126532265|NCT02677116|455240131|FG005|Overall Study|Adverse Event|1|||
126532266|NCT02677116|455240132|FG006|Overall Study|Adverse Event|1|||
126532267|NCT02677116|455240133|FG007|Overall Study|Adverse Event|0|||
126532268|NCT02677116|455240134|FG008|Overall Study|Adverse Event|0|||
126532269|NCT02677116|455240126|FG000|Overall Study|Physician Decision|0|||
126532270|NCT02677116|455240127|FG001|Overall Study|Physician Decision|2|||
126532271|NCT02677116|455240128|FG002|Overall Study|Physician Decision|3|||
126532272|NCT02677116|455240129|FG003|Overall Study|Physician Decision|2|||
126532273|NCT02677116|455240130|FG004|Overall Study|Physician Decision|1|||
126582500|NCT04774237|455429250|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
126582501|NCT04774237|455429251|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
126582502|NCT04774237|455429252|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
126582503|NCT04774237|455429253|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
126582504|NCT04774237|455429254|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
126582505|NCT04774237|455429255|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
126582506|NCT02728557|455430768|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
126582507|NCT02728557|455430769|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
126582508|NCT02728557|455430768|FG000|Overall Study|Dissatisfaction with research tasks|0|||
126532274|NCT02677116|455240131|FG005|Overall Study|Physician Decision|3|||
126532275|NCT02677116|455240132|FG006|Overall Study|Physician Decision|1|||
126532276|NCT02677116|455240133|FG007|Overall Study|Physician Decision|1|||
126532277|NCT02677116|455240134|FG008|Overall Study|Physician Decision|2|||
126532278|NCT02677116|455240126|FG000|Overall Study|Withdrawal by parent or guardian|2|||
126532279|NCT02677116|455240127|FG001|Overall Study|Withdrawal by parent or guardian|1|||
126532280|NCT02677116|455240128|FG002|Overall Study|Withdrawal by parent or guardian|0|||
126582509|NCT02728557|455430769|FG001|Overall Study|Dissatisfaction with research tasks|1|||
126582510|NCT02728557|455430768|FG000|Overall Study|Scheduling or change in availability|1|||
126582511|NCT02728557|455430769|FG001|Overall Study|Scheduling or change in availability|1|||
126532281|NCT02677116|455240129|FG003|Overall Study|Withdrawal by parent or guardian|1|||
126532282|NCT02677116|455240130|FG004|Overall Study|Withdrawal by parent or guardian|0|||
126532283|NCT02677116|455240131|FG005|Overall Study|Withdrawal by parent or guardian|0|||
126532284|NCT02677116|455240132|FG006|Overall Study|Withdrawal by parent or guardian|2|||
126532285|NCT02677116|455240133|FG007|Overall Study|Withdrawal by parent or guardian|1|||
126532286|NCT02677116|455240134|FG008|Overall Study|Withdrawal by parent or guardian|0|||
126532287|NCT02677116|455240126|FG000|Overall Study|Withdrawal by Subject|1|||
126582512|NCT04052516|455430770|FG000|Overall Study|Withdrawal by Subject|4|||
126582513|NCT04052516|455430771|FG001|Overall Study|Withdrawal by Subject|5|||
126582514|NCT04052516|455430772|FG002|Overall Study|Withdrawal by Subject|6|||
126582515|NCT04052516|455430770|FG000|Overall Study|Adverse Event|3|||
126582516|NCT04052516|455430771|FG001|Overall Study|Adverse Event|2|||
126582517|NCT04052516|455430772|FG002|Overall Study|Adverse Event|8|||
126582518|NCT04052516|455430770|FG000|Overall Study|Lost to Follow-up|2|||
126582519|NCT04052516|455430771|FG001|Overall Study|Lost to Follow-up|5|||
126582520|NCT04052516|455430772|FG002|Overall Study|Lost to Follow-up|3|||
126582521|NCT04052516|455430770|FG000|Overall Study|Protocol Violation|1|||
126582522|NCT04052516|455430771|FG001|Overall Study|Protocol Violation|1|||
126582523|NCT04052516|455430772|FG002|Overall Study|Protocol Violation|0|||
126582524|NCT04052516|455430770|FG000|Overall Study|Death|1|||
126582525|NCT04052516|455430771|FG001|Overall Study|Death|0|||
126582526|NCT04052516|455430772|FG002|Overall Study|Death|0|||
126582527|NCT04052516|455430770|FG000|Overall Study|Physician Decision|0|||
126582528|NCT04052516|455430771|FG001|Overall Study|Physician Decision|1|||
126582529|NCT04052516|455430772|FG002|Overall Study|Physician Decision|0|||
126582530|NCT04052516|455430770|FG000|Overall Study|Pregnancy|1|||
126582531|NCT04052516|455430771|FG001|Overall Study|Pregnancy|0|||
126582532|NCT04052516|455430772|FG002|Overall Study|Pregnancy|0|||
126532288|NCT02677116|455240127|FG001|Overall Study|Withdrawal by Subject|0|||
126532289|NCT02677116|455240128|FG002|Overall Study|Withdrawal by Subject|0|||
126532290|NCT02677116|455240129|FG003|Overall Study|Withdrawal by Subject|0|||
126532291|NCT02677116|455240130|FG004|Overall Study|Withdrawal by Subject|0|||
126532292|NCT02677116|455240131|FG005|Overall Study|Withdrawal by Subject|0|||
126532293|NCT02677116|455240132|FG006|Overall Study|Withdrawal by Subject|0|||
126532294|NCT02677116|455240133|FG007|Overall Study|Withdrawal by Subject|0|||
126532295|NCT02677116|455240134|FG008|Overall Study|Withdrawal by Subject|0|||
126532296|NCT03182868|455240135|FG000|Overall Study|Protocol Violation|3|||
126532297|NCT03182868|455240136|FG001|Overall Study|Protocol Violation|0|||
126532298|NCT03182868|455240137|FG002|Overall Study|Protocol Violation|4|||
126532299|NCT03182868|455240138|FG003|Overall Study|Protocol Violation|1|||
126532300|NCT03182868|455240139|FG004|Overall Study|Protocol Violation|8|||
126532301|NCT02363946|455240141|FG000|Overall Study|Lost to Follow-up|0|||
126532302|NCT02363946|455240142|FG001|Overall Study|Lost to Follow-up|0|||
126532303|NCT02363946|455240143|FG002|Overall Study|Lost to Follow-up|0|||
126532304|NCT02363946|455240144|FG003|Overall Study|Lost to Follow-up|0|||
126532305|NCT02363946|455240145|FG004|Overall Study|Lost to Follow-up|0|||
126532306|NCT02363946|455240146|FG005|Overall Study|Lost to Follow-up|0|||
126532307|NCT02363946|455240147|FG006|Overall Study|Lost to Follow-up|0|||
126532308|NCT02363946|455240148|FG007|Overall Study|Lost to Follow-up|1|||
126532309|NCT02363946|455240149|FG008|Overall Study|Lost to Follow-up|0|||
126532310|NCT02363946|455240150|FG009|Overall Study|Lost to Follow-up|0|||
126532311|NCT02363946|455240151|FG010|Overall Study|Lost to Follow-up|0|||
126532312|NCT02363946|455240152|FG011|Overall Study|Lost to Follow-up|0|||
126532313|NCT02363946|455240153|FG012|Overall Study|Lost to Follow-up|0|||
126532314|NCT01967732|455240154|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
126532315|NCT01967732|455240155|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
126532316|NCT01967732|455240156|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
126532317|NCT01967732|455240157|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
126532318|NCT01967732|455240154|FG000|First Intervention (Day 1)|Poor venous access|0|||
126532319|NCT01967732|455240155|FG001|First Intervention (Day 1)|Poor venous access|1|||
126532320|NCT01967732|455240156|FG002|First Intervention (Day 1)|Poor venous access|0|||
126532321|NCT01967732|455240157|FG003|First Intervention (Day 1)|Poor venous access|0|||
126532322|NCT03342638|455240158|FG000|Overall Study|Withdrawal by Subject|1|||
126532323|NCT03342638|455240159|FG001|Overall Study|Withdrawal by Subject|0|||
126532324|NCT03342638|455240158|FG000|Overall Study|Physician Decision|0|||
126532325|NCT03342638|455240159|FG001|Overall Study|Physician Decision|1|||
126532326|NCT01292239|455240175|FG000|Overall Study|Other|1|||
126532327|NCT01292239|455240176|FG001|Overall Study|Other|1|||
126532328|NCT01292239|455240175|FG000|Overall Study|Withdrawal by Subject|3|||
126532329|NCT01292239|455240176|FG001|Overall Study|Withdrawal by Subject|6|||
126532330|NCT00113568|455240177|FG000|Overall Study|Adverse Event|97|||
126582533|NCT04052516|455430770|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
126582534|NCT04052516|455430771|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
126730209|NCT01061736|455960443|FG007|Overall Study|Lack of Efficacy|9|||
126532331|NCT00113568|455240177|FG000|Overall Study|Death|1|||
126532332|NCT00113568|455240177|FG000|Overall Study|Lack of Efficacy|30|||
126532333|NCT00113568|455240177|FG000|Overall Study|Lost to Follow-up|156|||
126532334|NCT00113568|455240177|FG000|Overall Study|Protocol Violation|32|||
126532335|NCT00113568|455240177|FG000|Overall Study|Withdrawal by Subject|117|||
126532336|NCT00113568|455240177|FG000|Overall Study|Other|112|||
126532337|NCT00262821|455240178|FG000|Overall Study|Ineligible - wrong stage|0|||
126730210|NCT01061736|455960444|FG008|Overall Study|Lack of Efficacy|9|||
126532338|NCT00262821|455240179|FG001|Overall Study|Ineligible - wrong stage|3|||
126582535|NCT04052516|455430772|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
126582536|NCT04052516|455430770|FG000|Overall Study|Reason not recorded|0|||
126532339|NCT00262821|455240178|FG000|Overall Study|Ineligible - wrong cell type|2|||
126532340|NCT00262821|455240179|FG001|Overall Study|Ineligible - wrong cell type|2|||
126532341|NCT00262821|455240178|FG000|Overall Study|Ineligible - wrong primary|0|||
126532342|NCT00262821|455240179|FG001|Overall Study|Ineligible - wrong primary|1|||
126532343|NCT00262821|455240178|FG000|Overall Study|Ineligible - inadequate pathology|1|||
126532344|NCT00262821|455240179|FG001|Overall Study|Ineligible - inadequate pathology|3|||
126532345|NCT00262821|455240178|FG000|Overall Study|Ineligible - elevated creatinine|0|||
126532346|NCT00262821|455240179|FG001|Overall Study|Ineligible - elevated creatinine|2|||
126532347|NCT00262821|455240178|FG000|Overall Study|Ineligible - required test not done|1|||
126532348|NCT00262821|455240179|FG001|Overall Study|Ineligible - required test not done|4|||
126532349|NCT00262821|455240178|FG000|Overall Study|Inevaluable - inadequate data|0|||
126532350|NCT00262821|455240179|FG001|Overall Study|Inevaluable - inadequate data|4|||
126532351|NCT01988779|455240181|FG000|Overall Study|Withdrawal by Subject|2|||
126532352|NCT01988779|455240182|FG001|Overall Study|Withdrawal by Subject|2|||
126532353|NCT01988779|455240181|FG000|Overall Study|Protocol Violation|1|||
126532354|NCT01988779|455240182|FG001|Overall Study|Protocol Violation|0|||
126532355|NCT00584727|455240183|FG000|First Intervention|Discontinuation|0|||
126532356|NCT00584727|455240184|FG001|First Intervention|Discontinuation|0|||
126532357|NCT00584727|455240185|FG002|First Intervention|Discontinuation|1|||
126532358|NCT00584727|455240186|FG003|First Intervention|Discontinuation|0|||
126532359|NCT00584727|455240187|FG004|First Intervention|Discontinuation|0|||
126532360|NCT00584727|455240188|FG005|First Intervention|Discontinuation|0|||
126532361|NCT00584727|455240183|FG000|Third Intervention|Protocol Violation|0|||
126532362|NCT00584727|455240184|FG001|Third Intervention|Protocol Violation|0|||
126532363|NCT00584727|455240185|FG002|Third Intervention|Protocol Violation|1|||
126532364|NCT00584727|455240186|FG003|Third Intervention|Protocol Violation|0|||
126532365|NCT00584727|455240187|FG004|Third Intervention|Protocol Violation|4|||
126532366|NCT00584727|455240188|FG005|Third Intervention|Protocol Violation|2|||
126532367|NCT00377403|455240190|FG000|Overall Study|Unable to contact for telephone intervie|4|||
126532368|NCT00377403|455240191|FG001|Overall Study|Unable to contact for telephone intervie|7|||
126532369|NCT02858895|455240194|FG000|Overall Study|Disease progression|31|||
126532370|NCT02858895|455240194|FG000|Overall Study|Death|2|||
126532371|NCT02858895|455240194|FG000|Overall Study|Adverse Event|1|||
126532372|NCT02858895|455240194|FG000|Overall Study|Withdrawal by Subject|3|||
126532373|NCT02858895|455240194|FG000|Overall Study|hospice,|1|||
126532374|NCT02858895|455240194|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
126532375|NCT02277444|455240206|FG000|Overall Study|Adverse Event|10|||
126532376|NCT02277444|455240206|FG000|Overall Study|Withdrawal by Subject|3|||
126532377|NCT02277444|455240206|FG000|Overall Study|Other|1|||
126532378|NCT02277444|455240206|FG000|Overall Study|Enrolled and not Treated|3|||
126532379|NCT02277444|455240206|FG000|Overall Study|Ongoing|113|||
126532380|NCT04918784|455242315|FG000|Overall Study|Amputation - no longer eligible|1|||
126532381|NCT04918784|455242316|FG001|Overall Study|Amputation - no longer eligible|2|||
126532382|NCT04918784|455242315|FG000|Overall Study|Death|1|||
126532383|NCT04918784|455242316|FG001|Overall Study|Death|0|||
126532384|NCT04918784|455242315|FG000|Overall Study|patient non-compliance|3|||
126532385|NCT04918784|455242316|FG001|Overall Study|patient non-compliance|1|||
126532386|NCT04918784|455242315|FG000|Overall Study|Adverse Event|1|||
126532387|NCT04918784|455242316|FG001|Overall Study|Adverse Event|0|||
126532388|NCT01712009|455242317|FG000|Overall Study|Withdrawal by Subject|24|||
126532389|NCT01712009|455242318|FG001|Overall Study|Withdrawal by Subject|15|||
126532390|NCT01712009|455242319|FG002|Overall Study|Withdrawal by Subject|8|||
126532391|NCT01712009|455242317|FG000|Overall Study|Lost to Follow-up|2|||
126532392|NCT01712009|455242318|FG001|Overall Study|Lost to Follow-up|0|||
126532393|NCT01712009|455242319|FG002|Overall Study|Lost to Follow-up|1|||
126532394|NCT01712009|455242317|FG000|Overall Study|Decision by Sponsor|12|||
126532395|NCT01712009|455242318|FG001|Overall Study|Decision by Sponsor|14|||
126532396|NCT01712009|455242319|FG002|Overall Study|Decision by Sponsor|12|||
126532397|NCT02160314|455242320|FG000|Overall Study|Adverse Event|0|||
126532398|NCT02160314|455242321|FG001|Overall Study|Adverse Event|6|||
126532399|NCT02160314|455242320|FG000|Overall Study|Protocol Violation|0|||
126532400|NCT02160314|455242321|FG001|Overall Study|Protocol Violation|4|||
126532401|NCT02160314|455242320|FG000|Overall Study|Withdrawal by Subject|1|||
126532402|NCT02160314|455242321|FG001|Overall Study|Withdrawal by Subject|2|||
126532403|NCT02160314|455242320|FG000|Overall Study|Lost to Follow-up|0|||
126532404|NCT02160314|455242321|FG001|Overall Study|Lost to Follow-up|1|||
126532405|NCT00593567|455242325|FG000|Overall Study|Adverse Event|2|||
126532406|NCT00593567|455242326|FG001|Overall Study|Adverse Event|0|||
126532407|NCT00593567|455242325|FG000|Overall Study|Physician Decision|2|||
126532408|NCT00593567|455242326|FG001|Overall Study|Physician Decision|0|||
126532409|NCT00593567|455242325|FG000|Overall Study|Protocol Violation|13|||
126532410|NCT00593567|455242326|FG001|Overall Study|Protocol Violation|7|||
126532411|NCT00593567|455242325|FG000|Overall Study|Lack of Efficacy|2|||
126532412|NCT00593567|455242326|FG001|Overall Study|Lack of Efficacy|1|||
126532413|NCT00593567|455242325|FG000|Overall Study|Withdrawal by Subject|1|||
126532414|NCT00593567|455242326|FG001|Overall Study|Withdrawal by Subject|2|||
126532415|NCT00590902|455242331|FG000|Overall Study|Death|1|||
126532416|NCT00785291|455242333|FG000|Overall Study|Never began treatment|8|||
126532417|NCT00785291|455242334|FG001|Overall Study|Never began treatment|4|||
126532418|NCT00785291|455242335|FG002|Overall Study|Never began treatment|4|||
126532419|NCT00785291|455242333|FG000|Overall Study|Adverse Event|39|||
126532420|NCT00785291|455242334|FG001|Overall Study|Adverse Event|70|||
126582537|NCT04052516|455430771|FG001|Overall Study|Reason not recorded|1|||
126582538|NCT04052516|455430772|FG002|Overall Study|Reason not recorded|0|||
126582539|NCT03416010|455430773|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
126582540|NCT03416010|455430774|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
126582541|NCT03416010|455430773|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
126582542|NCT03416010|455430774|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
126582543|NCT03416010|455430773|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
126582544|NCT03416010|455430774|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
126582545|NCT03416010|455430773|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
126582546|NCT03416010|455430774|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
126582547|NCT03416010|455430773|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
126582548|NCT03416010|455430774|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
126582549|NCT03416010|455430773|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
126582550|NCT03416010|455430774|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
126582551|NCT03416010|455430773|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
126582552|NCT03416010|455430774|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
126582553|NCT05415436|455430775|FG000|Overall Study|Surgeon cancelled procedure|1|||
126582554|NCT05415436|455430776|FG001|Overall Study|Surgeon cancelled procedure|0|||
126582555|NCT05415436|455430775|FG000|Overall Study|Death|1|||
126582556|NCT05415436|455430776|FG001|Overall Study|Death|0|||
126582557|NCT03948763|455430780|FG000|Overall Study|Sponsor's decision|0|||
126582558|NCT03948763|455430781|FG001|Overall Study|Sponsor's decision|2|||
126582559|NCT03948763|455430782|FG002|Overall Study|Sponsor's decision|6|||
126582560|NCT03948763|455430783|FG003|Overall Study|Sponsor's decision|4|||
126582561|NCT03948763|455430784|FG004|Overall Study|Sponsor's decision|0|||
126582562|NCT03948763|455430780|FG000|Overall Study|Physician Decision|0|||
126582563|NCT03948763|455430781|FG001|Overall Study|Physician Decision|0|||
126730211|NCT01061736|455960445|FG009|Overall Study|Lack of Efficacy|10|||
126730212|NCT01061736|455960436|FG000|Overall Study|Poor compliance to protocol|0|||
126730213|NCT01061736|455960437|FG001|Overall Study|Poor compliance to protocol|0|||
126730214|NCT01061736|455960438|FG002|Overall Study|Poor compliance to protocol|0|||
126730215|NCT01061736|455960439|FG003|Overall Study|Poor compliance to protocol|0|||
126730216|NCT01061736|455960440|FG004|Overall Study|Poor compliance to protocol|0|||
126730217|NCT01061736|455960441|FG005|Overall Study|Poor compliance to protocol|0|||
126730218|NCT01061736|455960442|FG006|Overall Study|Poor compliance to protocol|0|||
126730219|NCT01061736|455960443|FG007|Overall Study|Poor compliance to protocol|2|||
126730220|NCT01061736|455960444|FG008|Overall Study|Poor compliance to protocol|5|||
126730221|NCT01061736|455960445|FG009|Overall Study|Poor compliance to protocol|9|||
126730222|NCT01061736|455960436|FG000|Overall Study|Not treated|0|||
126730223|NCT01061736|455960437|FG001|Overall Study|Not treated|0|||
126730224|NCT01061736|455960438|FG002|Overall Study|Not treated|0|||
126730225|NCT01061736|455960439|FG003|Overall Study|Not treated|0|||
126730226|NCT01061736|455960440|FG004|Overall Study|Not treated|1|||
126730227|NCT01061736|455960441|FG005|Overall Study|Not treated|0|||
126730228|NCT01061736|455960442|FG006|Overall Study|Not treated|0|||
126730229|NCT01061736|455960443|FG007|Overall Study|Not treated|2|||
126730230|NCT01061736|455960444|FG008|Overall Study|Not treated|1|||
126730231|NCT01061736|455960445|FG009|Overall Study|Not treated|0|||
126730232|NCT01061736|455960436|FG000|Overall Study|Other than specified above|0|||
126730233|NCT01061736|455960437|FG001|Overall Study|Other than specified above|1|||
126730234|NCT01061736|455960438|FG002|Overall Study|Other than specified above|2|||
126730235|NCT01061736|455960439|FG003|Overall Study|Other than specified above|0|||
126730236|NCT01061736|455960440|FG004|Overall Study|Other than specified above|1|||
126532421|NCT00785291|455242335|FG002|Overall Study|Adverse Event|56|||
126532422|NCT00785291|455242333|FG000|Overall Study|Death|7|||
126532423|NCT00785291|455242334|FG001|Overall Study|Death|4|||
126532424|NCT00785291|455242335|FG002|Overall Study|Death|3|||
126582564|NCT03948763|455430782|FG002|Overall Study|Physician Decision|1|||
126532425|NCT00785291|455242333|FG000|Overall Study|Withdrawal by Subject|35|||
126582565|NCT03948763|455430783|FG003|Overall Study|Physician Decision|0|||
126582566|NCT03948763|455430784|FG004|Overall Study|Physician Decision|0|||
126582567|NCT03948763|455430780|FG000|Overall Study|Lost to Follow-up|0|||
126730237|NCT01061736|455960441|FG005|Overall Study|Other than specified above|0|||
126730238|NCT01061736|455960442|FG006|Overall Study|Other than specified above|0|||
126730239|NCT01061736|455960443|FG007|Overall Study|Other than specified above|18|||
126730240|NCT01061736|455960444|FG008|Overall Study|Other than specified above|15|||
126730241|NCT01061736|455960445|FG009|Overall Study|Other than specified above|21|||
126730242|NCT01093755|455960446|FG000|Overall Study|Withdrawal by Subject|3|||
126730243|NCT01093755|455960447|FG001|Overall Study|Withdrawal by Subject|4|||
126532426|NCT00785291|455242334|FG001|Overall Study|Withdrawal by Subject|36|||
126730244|NCT02680587|455960450|FG000|Overall Study|Withdrawal by Subject|1|||
126730245|NCT02680587|455960451|FG001|Overall Study|Withdrawal by Subject|0|||
126730246|NCT02899377|455960452|FG000|Overall Study|Adverse Event|1|||
126730247|NCT02899377|455960453|FG001|Overall Study|Adverse Event|0|||
126730248|NCT00469209|455960454|FG000|Overall Study|Adverse Event|1|||
126730249|NCT00469209|455960455|FG001|Overall Study|Adverse Event|0|||
126730250|NCT00469209|455960456|FG002|Overall Study|Adverse Event|1|||
126730251|NCT00712933|455960460|FG000|Overall Study|Adverse Event|69|||
126730252|NCT00712933|455960460|FG000|Overall Study|Lack of Efficacy|6|||
126730253|NCT00712933|455960460|FG000|Overall Study|Lost to Follow-up|22|||
126730254|NCT00712933|455960460|FG000|Overall Study|Non-compliance with study drug|13|||
126730255|NCT00712933|455960460|FG000|Overall Study|Other Pregnancy|37|||
126730256|NCT00712933|455960460|FG000|Overall Study|Sponsor decision|14|||
126730257|NCT00712933|455960460|FG000|Overall Study|Withdrew consent|4|||
126730258|NCT00712933|455960460|FG000|Overall Study|Hip replacement surgery|1|||
126730259|NCT00712933|455960460|FG000|Overall Study|Involved in Clinical research|3|||
126730260|NCT00712933|455960460|FG000|Overall Study|Participant hospitalized|1|||
126730261|NCT00712933|455960460|FG000|Overall Study|Participant travelled overseas|2|||
126730262|NCT00712933|455960460|FG000|Overall Study|Death of patient|1|||
126730263|NCT00712933|455960460|FG000|Overall Study|Other Physician decision|1|||
126730264|NCT00712933|455960460|FG000|Overall Study|Not committed to contraception|1|||
126730265|NCT00712933|455960460|FG000|Overall Study|Participant received medication|1|||
126730266|NCT00712933|455960460|FG000|Overall Study|Physician Decision|36|||
126730267|NCT00712933|455960460|FG000|Overall Study|Protocol Violation|4|||
126730268|NCT00712933|455960460|FG000|Overall Study|Withdrawal by Subject|151|||
126730269|NCT01295580|455960463|FG000|Overall Study|Protocol Violation|4|||
126730270|NCT01295580|455960464|FG001|Overall Study|Protocol Violation|2|||
126730271|NCT01295580|455960463|FG000|Overall Study|Withdrawal by Subject|1|||
126730272|NCT01295580|455960464|FG001|Overall Study|Withdrawal by Subject|4|||
126730273|NCT01295580|455960463|FG000|Overall Study|Adverse Event|2|||
126730274|NCT01295580|455960464|FG001|Overall Study|Adverse Event|1|||
126730275|NCT01295580|455960463|FG000|Overall Study|Lost to Follow-up|1|||
126730276|NCT01295580|455960464|FG001|Overall Study|Lost to Follow-up|0|||
126730277|NCT01295580|455960463|FG000|Overall Study|Lack of Efficacy|1|||
126730278|NCT01295580|455960464|FG001|Overall Study|Lack of Efficacy|0|||
126730279|NCT01295580|455960463|FG000|Overall Study|Other: inconvenience|1|||
126730280|NCT01295580|455960464|FG001|Overall Study|Other: inconvenience|0|||
126730281|NCT01295580|455960463|FG000|Overall Study|Other: family objection|0|||
126730282|NCT01295580|455960464|FG001|Overall Study|Other: family objection|1|||
126730283|NCT02022033|455960468|FG000|Overall Study|Physician Decision|1|||
126730284|NCT01103778|455960469|FG000|Overall Study|Lost to Follow-up|1|||
126730285|NCT01103778|455960469|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
126730286|NCT01103778|455960469|FG000|Overall Study|Screen failure|1|||
126730287|NCT03067129|455960470|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
126730288|NCT03067129|455960471|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
126730289|NCT03067129|455960472|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
126730290|NCT03067129|455960473|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
126730291|NCT03067129|455960470|FG000|Overall Study|Withdrawal by Subject|0|||
126730292|NCT03067129|455960471|FG001|Overall Study|Withdrawal by Subject|0|||
126730293|NCT03067129|455960472|FG002|Overall Study|Withdrawal by Subject|1|||
126730294|NCT03067129|455960473|FG003|Overall Study|Withdrawal by Subject|2|||
126730295|NCT03067129|455960470|FG000|Overall Study|Lost to Follow-up|5|||
126730296|NCT03067129|455960471|FG001|Overall Study|Lost to Follow-up|5|||
126730297|NCT03067129|455960472|FG002|Overall Study|Lost to Follow-up|4|||
126730298|NCT03067129|455960473|FG003|Overall Study|Lost to Follow-up|3|||
126730299|NCT03986190|455960474|FG000|Overall Study|Withdrawal by Subject|12|||
126532427|NCT00785291|455242335|FG002|Overall Study|Withdrawal by Subject|17|||
126532428|NCT00785291|455242333|FG000|Overall Study|Alternative Therapy|12|||
126532429|NCT00785291|455242334|FG001|Overall Study|Alternative Therapy|6|||
126532430|NCT00785291|455242335|FG002|Overall Study|Alternative Therapy|7|||
126532431|NCT00785291|455242333|FG000|Overall Study|Complicating illness|6|||
126532432|NCT00785291|455242334|FG001|Overall Study|Complicating illness|4|||
126532433|NCT00785291|455242335|FG002|Overall Study|Complicating illness|4|||
126532434|NCT00785291|455242333|FG000|Overall Study|Other Medical Reasons|29|||
126532435|NCT00785291|455242334|FG001|Overall Study|Other Medical Reasons|25|||
126532436|NCT00785291|455242335|FG002|Overall Study|Other Medical Reasons|15|||
126532437|NCT00844857|455242336|FG000|Overall Study|Adverse Event|24|||
126532438|NCT00844857|455242337|FG001|Overall Study|Adverse Event|5|||
126532439|NCT00844857|455242336|FG000|Overall Study|Sponsor Decision|1|||
126730300|NCT03986190|455960475|FG001|Overall Study|Withdrawal by Subject|0|||
126730301|NCT04929613|455960476|FG000|Overall Study|Withdrawal by Subject|12|||
126730302|NCT01464788|455960480|FG000|Overall Study|Lost to Follow-up|0|||
126730303|NCT01464788|455960481|FG001|Overall Study|Lost to Follow-up|1|||
126730304|NCT01464788|455960482|FG002|Overall Study|Lost to Follow-up|0|||
126730305|NCT01464788|455960480|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
126730306|NCT01464788|455960481|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
126730307|NCT01464788|455960482|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
126582568|NCT03948763|455430781|FG001|Overall Study|Lost to Follow-up|0|||
126582569|NCT03948763|455430782|FG002|Overall Study|Lost to Follow-up|0|||
126582570|NCT03948763|455430783|FG003|Overall Study|Lost to Follow-up|0|||
126582571|NCT03948763|455430784|FG004|Overall Study|Lost to Follow-up|1|||
126532440|NCT00844857|455242337|FG001|Overall Study|Sponsor Decision|1|||
126582572|NCT03948763|455430780|FG000|Overall Study|Death|2|||
126582573|NCT03948763|455430781|FG001|Overall Study|Death|12|||
126582574|NCT03948763|455430782|FG002|Overall Study|Death|13|||
126582575|NCT03948763|455430783|FG003|Overall Study|Death|10|||
126582576|NCT03948763|455430784|FG004|Overall Study|Death|11|||
126582577|NCT03948763|455430780|FG000|Overall Study|Withdrawal by Subject|1|||
126582578|NCT03948763|455430781|FG001|Overall Study|Withdrawal by Subject|1|||
126582579|NCT03948763|455430782|FG002|Overall Study|Withdrawal by Subject|0|||
126582580|NCT03948763|455430783|FG003|Overall Study|Withdrawal by Subject|2|||
126582581|NCT03948763|455430784|FG004|Overall Study|Withdrawal by Subject|4|||
126582582|NCT03819686|455430789|FG000|Overall Study|Lost to Follow-up|2|||
126582583|NCT03819686|455430790|FG001|Overall Study|Lost to Follow-up|3|||
126582584|NCT03192891|455430803|FG000|Overall Study|Lost to Follow-up|55|||
126532441|NCT00844857|455242336|FG000|Overall Study|Physician Decision|2|||
126532442|NCT00844857|455242337|FG001|Overall Study|Physician Decision|0|||
126532443|NCT00844857|455242336|FG000|Overall Study|Parent/Caregiver Decision|6|||
126532444|NCT00844857|455242337|FG001|Overall Study|Parent/Caregiver Decision|2|||
126532445|NCT00844857|455242336|FG000|Overall Study|Withdrawal by Subject|8|||
126532446|NCT00844857|455242337|FG001|Overall Study|Withdrawal by Subject|7|||
126532447|NCT00844857|455242336|FG000|Overall Study|Protocol Violation|6|||
126532448|NCT00844857|455242337|FG001|Overall Study|Protocol Violation|0|||
126532449|NCT00844857|455242336|FG000|Overall Study|Lack of Efficacy|5|||
126532450|NCT00844857|455242337|FG001|Overall Study|Lack of Efficacy|5|||
126532451|NCT00844857|455242336|FG000|Overall Study|Clinical Relapse|0|||
126532452|NCT00844857|455242337|FG001|Overall Study|Clinical Relapse|1|||
126532453|NCT00844857|455242336|FG000|Overall Study|Entry Criteria Not Met|0|||
126532454|NCT00844857|455242337|FG001|Overall Study|Entry Criteria Not Met|1|||
126532455|NCT00844857|455242336|FG000|Overall Study|Lost to Follow-up|2|||
126532456|NCT00844857|455242337|FG001|Overall Study|Lost to Follow-up|3|||
126532457|NCT00844857|455242336|FG000|Overall Study|Did Not Take Study Drug|3|||
126532458|NCT00844857|455242337|FG001|Overall Study|Did Not Take Study Drug|1|||
126532459|NCT00844857|455242336|FG000|Overall Study|Good Clinical Practice Violations|21|||
126532460|NCT00844857|455242337|FG001|Overall Study|Good Clinical Practice Violations|11|||
126532461|NCT00570674|455242338|FG000|Overall Study|Withdrawal by Subject|0|||
126532462|NCT00570674|455242339|FG001|Overall Study|Withdrawal by Subject|0|||
126532463|NCT00570674|455242340|FG002|Overall Study|Withdrawal by Subject|1|||
126532464|NCT00570674|455242341|FG003|Overall Study|Withdrawal by Subject|0|||
126532465|NCT00570674|455242342|FG004|Overall Study|Withdrawal by Subject|0|||
126532466|NCT00570674|455242343|FG005|Overall Study|Withdrawal by Subject|0|||
126532467|NCT00570674|455242344|FG006|Overall Study|Withdrawal by Subject|0|||
126532468|NCT02979639|455242346|FG000|Overall Study|Withdrawal based on medical judgement|1|||
126532469|NCT02979639|455242346|FG000|Overall Study|Lost to Follow-up|8|||
126582585|NCT05141903|455430804|FG000|Overall Study|Withdrawal by Subject|0|||
126582586|NCT05141903|455430805|FG001|Overall Study|Withdrawal by Subject|1|||
126582587|NCT05141903|455430806|FG002|Overall Study|Withdrawal by Subject|1|||
126582588|NCT05141903|455430807|FG003|Overall Study|Withdrawal by Subject|0|||
126582589|NCT05141903|455430808|FG004|Overall Study|Withdrawal by Subject|0|||
126582590|NCT05141903|455430804|FG000|Overall Study|Other|1|||
126582591|NCT05141903|455430805|FG001|Overall Study|Other|1|||
126582592|NCT05141903|455430806|FG002|Overall Study|Other|0|||
126582593|NCT05141903|455430807|FG003|Overall Study|Other|0|||
126582594|NCT05141903|455430808|FG004|Overall Study|Other|0|||
126582595|NCT03089398|455430811|FG000|Overall Study|Death|4|||
126582596|NCT03089398|455430812|FG001|Overall Study|Death|9|||
126582597|NCT03089398|455430811|FG000|Overall Study|Lost to Follow-up|21|||
126582598|NCT03089398|455430812|FG001|Overall Study|Lost to Follow-up|30|||
126532470|NCT02979639|455242346|FG000|Overall Study|Withdrawal by Subject|3|||
126532471|NCT02979639|455242346|FG000|Overall Study|Adverse Event|2|||
126532472|NCT04050865|455242349|FG000|Overall Study|Adverse Event|1|||
126532473|NCT04050865|455242350|FG001|Overall Study|Adverse Event|0|||
126582599|NCT03089398|455430811|FG000|Overall Study|Withdrawal by Subject|2|||
126582600|NCT03089398|455430812|FG001|Overall Study|Withdrawal by Subject|2|||
126582601|NCT05062265|455430813|FG000|Overall Study|Withdrawal by Subject|1|||
126582602|NCT05062265|455430814|FG001|Overall Study|Withdrawal by Subject|0|||
126582603|NCT05439603|455430815|FG000|Overall Study|met withdrawal criteria|2|||
126582604|NCT02682316|455430822|FG000|Overall Study|Benign Final Pathology|27|||
126582605|NCT02682316|455430823|FG001|Overall Study|Benign Final Pathology|26|||
126730308|NCT00843843|455960485|FG000|Overall Study|Physician Decision|1|||
126582606|NCT02682316|455430822|FG000|Overall Study|Reoperation before 30 days|7|||
126532474|NCT04050865|455242349|FG000|Overall Study|no insert|1|||
126532475|NCT04050865|455242350|FG001|Overall Study|no insert|0|||
126582607|NCT02682316|455430823|FG001|Overall Study|Reoperation before 30 days|6|||
126582608|NCT02682316|455430822|FG000|Overall Study|Ineligible|1|||
126582609|NCT02682316|455430823|FG001|Overall Study|Ineligible|0|||
126532476|NCT04050865|455242349|FG000|Overall Study|Only 1 insert|2|||
126532477|NCT04050865|455242350|FG001|Overall Study|Only 1 insert|3|||
126532478|NCT04050865|455242349|FG000|Overall Study|Physician Decision|0|||
126532479|NCT04050865|455242350|FG001|Overall Study|Physician Decision|1|||
126582610|NCT02682316|455430822|FG000|Overall Study|Death|1|||
126582611|NCT02682316|455430823|FG001|Overall Study|Death|0|||
126582612|NCT02682316|455430822|FG000|Overall Study|Lost to Follow-up|7|||
126582613|NCT02682316|455430823|FG001|Overall Study|Lost to Follow-up|3|||
126582614|NCT00150813|455430825|FG000|Overall Study|Adverse Event|1|||
126582615|NCT00150813|455430825|FG000|Overall Study|Lack of Efficacy|1|||
126582616|NCT00150813|455430825|FG000|Overall Study|Lost to Follow-up|5|||
126582617|NCT00150813|455430825|FG000|Overall Study|Withdrawal by Subject|5|||
126582618|NCT00150813|455430825|FG000|Overall Study|Remission|3|||
126582619|NCT00150813|455430825|FG000|Overall Study|Planned pregancy|1|||
126582620|NCT00150813|455430825|FG000|Overall Study|Switch to commercially available LEV|2|||
126582621|NCT03052608|455430827|FG000|Treatment Phase|Adverse Event|10|||
126582622|NCT03052608|455430828|FG001|Treatment Phase|Adverse Event|12|||
126582623|NCT03052608|455430827|FG000|Treatment Phase|Death|6|||
126582624|NCT03052608|455430828|FG001|Treatment Phase|Death|4|||
126582625|NCT03052608|455430827|FG000|Treatment Phase|Withdrawal by Subject|4|||
126582626|NCT03052608|455430828|FG001|Treatment Phase|Withdrawal by Subject|12|||
126582627|NCT03052608|455430827|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
126582628|NCT03052608|455430828|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
126582629|NCT03052608|455430827|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
126582630|NCT03052608|455430828|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
126582631|NCT03052608|455430827|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
126532480|NCT04050865|455242349|FG000|Overall Study|Withdrawal by Subject|0|||
126582632|NCT03052608|455430828|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
126582633|NCT03052608|455430827|FG000|Treatment Phase|Ongoing|103|||
126582634|NCT03052608|455430828|FG001|Treatment Phase|Ongoing|31|||
126582635|NCT03052608|455430827|FG000|Long-Term Follow-up Phase|Death|23|||
126582636|NCT03052608|455430828|FG001|Long-Term Follow-up Phase|Death|28|||
126582637|NCT03052608|455430827|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
126582638|NCT03052608|455430828|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
126582639|NCT03052608|455430827|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
126532481|NCT04050865|455242350|FG001|Overall Study|Withdrawal by Subject|1|||
126532482|NCT04205630|455242355|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
126532483|NCT04205630|455242355|FG000|Overall Study|Disease clinical progression|7|||
126532484|NCT04205630|455242355|FG000|Overall Study|Withdrawal by Subject|2|||
126532485|NCT04205630|455242355|FG000|Overall Study|Adverse Event|17|||
126532486|NCT04205630|455242355|FG000|Overall Study|Other|1|||
126532487|NCT03643952|455242361|FG000|Overall Study|Lack of Efficacy|1|||
126532488|NCT01597050|455242362|FG000|Overall Study|Withdrawal by Subject|1|||
126532489|NCT01597050|455242363|FG001|Overall Study|Withdrawal by Subject|0|||
126532490|NCT00483184|455242364|FG000|Overall Study|Withdrawal by Subject|2|||
126532491|NCT00483184|455242365|FG001|Overall Study|Withdrawal by Subject|2|||
126532492|NCT00483184|455242366|FG002|Overall Study|Withdrawal by Subject|0|||
126582640|NCT03052608|455430828|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
126582641|NCT03052608|455430827|FG000|Long-Term Follow-up Phase|Ongoing|122|||
126582642|NCT03052608|455430828|FG001|Long-Term Follow-up Phase|Ongoing|99|||
126582643|NCT03113500|455430829|FG000|Overall Study|Withdrawal by Subject|1|||
126582644|NCT05249439|455430833|FG000|Overall Study|Withdrawal by Subject|2|||
126582645|NCT05249439|455430834|FG001|Overall Study|Withdrawal by Subject|5|||
126582646|NCT05249439|455430833|FG000|Overall Study|Physician Decision|3|||
126582647|NCT05249439|455430834|FG001|Overall Study|Physician Decision|1|||
126582648|NCT01707030|455430835|FG000|Overall Study|Death|1|||
126582649|NCT01707030|455430836|FG001|Overall Study|Death|1|||
126582650|NCT01707030|455430835|FG000|Overall Study|Withdrawal by Subject|2|||
126532493|NCT00483184|455242364|FG000|Overall Study|Lost to Follow-up|1|||
126582651|NCT01707030|455430836|FG001|Overall Study|Withdrawal by Subject|3|||
126582652|NCT01707030|455430835|FG000|Overall Study|Lost to Follow-up|8|||
126532494|NCT00483184|455242365|FG001|Overall Study|Lost to Follow-up|0|||
126582653|NCT01707030|455430836|FG001|Overall Study|Lost to Follow-up|13|||
126582654|NCT04820855|455430837|FG000|Overall Study|Lost to Follow-up|6|||
126582655|NCT04820855|455430838|FG001|Overall Study|Lost to Follow-up|9|||
126582656|NCT02140645|455430851|FG000|Overall Study|Not linked|5489|||
126582657|NCT02140645|455430852|FG001|Overall Study|Not linked|61654|||
126582658|NCT02140645|455430853|FG002|Overall Study|Not linked|4236|||
126582659|NCT02140645|455430854|FG003|Overall Study|Not linked|13833|||
126582660|NCT02140645|455430855|FG004|Overall Study|Not linked|3286|||
126532495|NCT00483184|455242366|FG002|Overall Study|Lost to Follow-up|0|||
126532496|NCT00483184|455242364|FG000|Overall Study|Adverse Event|1|||
126532497|NCT00483184|455242365|FG001|Overall Study|Adverse Event|2|||
126582661|NCT02140645|455430856|FG005|Overall Study|Not linked|70896|||
126582662|NCT00593489|455430863|FG000|Allocation|did not attend workshop; allocation not|2|||
126582663|NCT00593489|455430864|FG001|Allocation|did not attend workshop; allocation not|1|||
126582664|NCT00611559|455430865|FG000|Overall Study|Lost to Follow-up|0|||
126730309|NCT00843843|455960486|FG001|Overall Study|Physician Decision|1|||
126730310|NCT00843843|455960485|FG000|Overall Study|Protocol Violation|1|||
126730311|NCT00843843|455960486|FG001|Overall Study|Protocol Violation|1|||
126730312|NCT01397448|455960487|FG000|Overall Study|Adverse Event|4|||
126730313|NCT01397448|455960488|FG001|Overall Study|Adverse Event|4|||
126730314|NCT01397448|455960489|FG002|Overall Study|Adverse Event|6|||
126730315|NCT01397448|455960487|FG000|Overall Study|Withdrawal by Subject|4|||
126730316|NCT01397448|455960488|FG001|Overall Study|Withdrawal by Subject|4|||
126730317|NCT01397448|455960489|FG002|Overall Study|Withdrawal by Subject|3|||
126730318|NCT01397448|455960487|FG000|Overall Study|Lack of Efficacy|2|||
126730319|NCT01397448|455960488|FG001|Overall Study|Lack of Efficacy|0|||
126730320|NCT01397448|455960489|FG002|Overall Study|Lack of Efficacy|5|||
126730321|NCT01397448|455960487|FG000|Overall Study|Other|8|||
126730322|NCT01397448|455960488|FG001|Overall Study|Other|7|||
126730323|NCT01397448|455960489|FG002|Overall Study|Other|4|||
126730324|NCT02180217|455960490|FG000|Overall Study|Adverse Event|3|||
126730325|NCT02180217|455960491|FG001|Overall Study|Adverse Event|2|||
126730326|NCT02180217|455960492|FG002|Overall Study|Adverse Event|22|||
126532498|NCT00483184|455242366|FG002|Overall Study|Adverse Event|2|||
126532499|NCT00483184|455242364|FG000|Overall Study|Protocol Violation|1|||
126532500|NCT00483184|455242365|FG001|Overall Study|Protocol Violation|0|||
126532501|NCT00483184|455242366|FG002|Overall Study|Protocol Violation|1|||
126532502|NCT00558428|455242367|FG000|Overall Study|Adverse Event|6|||
126532503|NCT00558428|455242368|FG001|Overall Study|Adverse Event|22|||
126532504|NCT00558428|455242369|FG002|Overall Study|Adverse Event|3|||
126532505|NCT00558428|455242370|FG003|Overall Study|Adverse Event|4|||
126532506|NCT00558428|455242367|FG000|Overall Study|Lost to Follow-up|0|||
126532507|NCT00558428|455242368|FG001|Overall Study|Lost to Follow-up|1|||
126532508|NCT00558428|455242369|FG002|Overall Study|Lost to Follow-up|0|||
126532509|NCT00558428|455242370|FG003|Overall Study|Lost to Follow-up|0|||
126532510|NCT00558428|455242367|FG000|Overall Study|Lack of Efficacy|0|||
126532511|NCT00558428|455242368|FG001|Overall Study|Lack of Efficacy|0|||
126532512|NCT00558428|455242369|FG002|Overall Study|Lack of Efficacy|1|||
126532513|NCT00558428|455242370|FG003|Overall Study|Lack of Efficacy|2|||
126532514|NCT00558428|455242367|FG000|Overall Study|Non compliant with protocol|1|||
126532515|NCT00558428|455242368|FG001|Overall Study|Non compliant with protocol|0|||
126532516|NCT00558428|455242369|FG002|Overall Study|Non compliant with protocol|0|||
126532517|NCT00558428|455242370|FG003|Overall Study|Non compliant with protocol|3|||
126532518|NCT00558428|455242367|FG000|Overall Study|Consent withdrawn|2|||
126532519|NCT00558428|455242368|FG001|Overall Study|Consent withdrawn|1|||
126532520|NCT00558428|455242369|FG002|Overall Study|Consent withdrawn|0|||
126532521|NCT00558428|455242370|FG003|Overall Study|Consent withdrawn|1|||
126532522|NCT00558428|455242367|FG000|Overall Study|Other|3|||
126532523|NCT00558428|455242368|FG001|Overall Study|Other|0|||
126532524|NCT00558428|455242369|FG002|Overall Study|Other|0|||
126532525|NCT00558428|455242370|FG003|Overall Study|Other|1|||
126532526|NCT00815295|455242371|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
126532527|NCT00815295|455242372|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
126532528|NCT00815295|455242373|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
126532529|NCT00530855|455242374|FG000|Overall Study|Lack of Efficacy|20|||
126532530|NCT00530855|455242374|FG000|Overall Study|Withdrawal by Subject|30|||
126532531|NCT00530855|455242374|FG000|Overall Study|Fatal Serious AE|3|||
126532532|NCT00530855|455242374|FG000|Overall Study|Non Fatal Serious AE|7|||
126532533|NCT00530855|455242374|FG000|Overall Study|Non Fatal Non Serious AE|12|||
126532534|NCT00530855|455242374|FG000|Overall Study|Protocol Violation|3|||
126532535|NCT00530855|455242374|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
126532536|NCT00530855|455242374|FG000|Overall Study|Lost to Follow-up|9|||
126532537|NCT00530855|455242374|FG000|Overall Study|Other reason for premature termination|17|||
126532538|NCT05224050|455242375|FG000|Overall Study|Withdrawal by Subject|9|||
126532539|NCT05224050|455242375|FG000|Overall Study|Lost to Follow-up|3|||
126532540|NCT01292876|455242376|FG000|Overall Study|Physician Decision|4|||
126532541|NCT01627327|455242377|FG000|Overall Study|Adverse Event|6|||
126532542|NCT01627327|455242378|FG001|Overall Study|Adverse Event|12|||
126532543|NCT01627327|455242377|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
126532544|NCT01627327|455242378|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
126532545|NCT01627327|455242377|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
126532546|NCT01627327|455242378|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
126532547|NCT01627327|455242377|FG000|Overall Study|Protocol Violation|4|||
126532548|NCT01627327|455242378|FG001|Overall Study|Protocol Violation|10|||
126532549|NCT01627327|455242377|FG000|Overall Study|Lost to Follow-up|1|||
126532550|NCT01627327|455242378|FG001|Overall Study|Lost to Follow-up|3|||
126532551|NCT01627327|455242377|FG000|Overall Study|Physician Decision|1|||
126532552|NCT01627327|455242378|FG001|Overall Study|Physician Decision|0|||
126532553|NCT01627327|455242377|FG000|Overall Study|Withdrawal by Subject|3|||
126532554|NCT01627327|455242378|FG001|Overall Study|Withdrawal by Subject|3|||
126730327|NCT02180217|455960490|FG000|Overall Study|Death|1|||
126730328|NCT02180217|455960491|FG001|Overall Study|Death|1|||
126532555|NCT04528069|455242384|FG000|Overall Study|Adverse Event|1|||
126730329|NCT02180217|455960492|FG002|Overall Study|Death|0|||
126532556|NCT04528069|455242384|FG000|Overall Study|Lost to Follow-up|1|||
126532557|NCT04528069|455242384|FG000|Overall Study|Patient Unable to Come|1|||
126532558|NCT04528069|455242384|FG000|Overall Study|Patient Unable to Attend|1|||
126532559|NCT02525874|455242387|FG000|Overall Study|Other|1|||
126532560|NCT02525874|455242387|FG000|Overall Study|Investigator Decision|1|||
126532561|NCT02525874|455242387|FG000|Overall Study|Consent withdrawn|22|||
126532562|NCT02525874|455242387|FG000|Overall Study|Non-compliance with study drug|3|||
126532563|NCT02525874|455242387|FG000|Overall Study|Adverse Event|17|||
126532564|NCT02525874|455242387|FG000|Overall Study|Lost to Follow-up|7|||
126532565|NCT02525874|455242387|FG000|Overall Study|Disease progression, defined by protocol|2|||
126532566|NCT02525874|455242387|FG000|Overall Study|Disease relapse|4|||
126532567|NCT02525874|455242387|FG000|Overall Study|Alternative Treatment for MS|2|||
126582665|NCT00611559|455430866|FG001|Overall Study|Lost to Follow-up|1|||
126582666|NCT00611559|455430867|FG002|Overall Study|Lost to Follow-up|0|||
126582667|NCT00611559|455430865|FG000|Overall Study|Protocol Violation|1|||
126582668|NCT00611559|455430866|FG001|Overall Study|Protocol Violation|0|||
126582669|NCT00611559|455430867|FG002|Overall Study|Protocol Violation|1|||
126582670|NCT04095104|455430868|FG000|Overall Study|Withdrawal by Subject|0|||
126582671|NCT04095104|455430869|FG001|Overall Study|Withdrawal by Subject|1|||
126582672|NCT03580369|455430871|FG000|Overall Study|No treatment due to mis-randomization|1|||
126582673|NCT03580369|455430872|FG001|Overall Study|No treatment due to mis-randomization|0|||
126582674|NCT03580369|455430873|FG002|Overall Study|No treatment due to mis-randomization|0|||
126582675|NCT03580369|455430874|FG003|Overall Study|No treatment due to mis-randomization|0|||
126582676|NCT03580369|455430875|FG004|Overall Study|No treatment due to mis-randomization|3|||
126582677|NCT03580369|455430876|FG005|Overall Study|No treatment due to mis-randomization|0|||
126582678|NCT03580369|455430877|FG006|Overall Study|No treatment due to mis-randomization|0|||
126582679|NCT03580369|455430878|FG007|Overall Study|No treatment due to mis-randomization|0|||
126582680|NCT03580369|455430871|FG000|Overall Study|Reason unknown|0|||
126582681|NCT03580369|455430872|FG001|Overall Study|Reason unknown|0|||
126582682|NCT03580369|455430873|FG002|Overall Study|Reason unknown|1|||
126582683|NCT03580369|455430874|FG003|Overall Study|Reason unknown|0|||
126582684|NCT03580369|455430875|FG004|Overall Study|Reason unknown|0|||
126582685|NCT03580369|455430876|FG005|Overall Study|Reason unknown|0|||
126582686|NCT03580369|455430877|FG006|Overall Study|Reason unknown|0|||
126582687|NCT03580369|455430878|FG007|Overall Study|Reason unknown|0|||
126582688|NCT03580369|455430871|FG000|Overall Study|Technical problems|0|||
126582689|NCT03580369|455430872|FG001|Overall Study|Technical problems|0|||
126582690|NCT03580369|455430873|FG002|Overall Study|Technical problems|0|||
126582691|NCT03580369|455430874|FG003|Overall Study|Technical problems|0|||
126582692|NCT03580369|455430875|FG004|Overall Study|Technical problems|1|||
126582693|NCT03580369|455430876|FG005|Overall Study|Technical problems|0|||
126730330|NCT02180217|455960490|FG000|Overall Study|Withdrawal by Subject|1|||
126730331|NCT02180217|455960491|FG001|Overall Study|Withdrawal by Subject|1|||
126730332|NCT02180217|455960492|FG002|Overall Study|Withdrawal by Subject|4|||
126730333|NCT02180217|455960490|FG000|Overall Study|Subject/Guardian decision|5|||
126730334|NCT02180217|455960491|FG001|Overall Study|Subject/Guardian decision|3|||
126730335|NCT02180217|455960492|FG002|Overall Study|Subject/Guardian decision|6|||
126730336|NCT02180217|455960490|FG000|Overall Study|Physician Decision|1|||
126730337|NCT02180217|455960491|FG001|Overall Study|Physician Decision|1|||
126730338|NCT02180217|455960492|FG002|Overall Study|Physician Decision|6|||
126730339|NCT02180217|455960490|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126730340|NCT02180217|455960491|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126730341|NCT02180217|455960492|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
126730342|NCT02475395|455960500|FG000|Overall Study|Protocol Violation|30|||
126730343|NCT02475395|455960501|FG001|Overall Study|Protocol Violation|3|||
126730344|NCT00995670|455960502|FG000|Overall Study|Failed arterial cannulation|1|||
126730345|NCT00995670|455960503|FG001|Overall Study|Failed arterial cannulation|0|||
126730346|NCT00995670|455960504|FG002|Overall Study|Failed arterial cannulation|3|||
126730347|NCT03784027|455960512|FG000|Period 1|Withdrawal by Subject|0|||
126730348|NCT03784027|455960513|FG001|Period 1|Withdrawal by Subject|1|||
126730349|NCT01297309|455962922|FG000|Overall Study|Eligibility failure|2|||
126532568|NCT02525874|455242387|FG000|Overall Study|New lesions in Brain|1|||
126730350|NCT01297309|455962922|FG000|Overall Study|Screen failure|2|||
126532569|NCT01692782|455242390|FG000|Overall Study|Adverse Event|12|||
126532570|NCT01692782|455242391|FG001|Overall Study|Adverse Event|32|||
126532571|NCT01692782|455242392|FG002|Overall Study|Adverse Event|2|||
126582694|NCT03580369|455430877|FG006|Overall Study|Technical problems|2|||
126582695|NCT03580369|455430878|FG007|Overall Study|Technical problems|0|||
126582696|NCT03580369|455430871|FG000|Overall Study|Pregnancy|2|||
126582697|NCT03580369|455430872|FG001|Overall Study|Pregnancy|0|||
126582698|NCT03580369|455430873|FG002|Overall Study|Pregnancy|3|||
126582699|NCT03580369|455430874|FG003|Overall Study|Pregnancy|0|||
126582700|NCT03580369|455430875|FG004|Overall Study|Pregnancy|2|||
126730351|NCT01297309|455962922|FG000|Overall Study|Withdrawal by Subject|5|||
126730352|NCT01297309|455962922|FG000|Overall Study|Adverse Event|1|||
126532572|NCT01692782|455242390|FG000|Overall Study|Lack of Efficacy|1|||
126532573|NCT01692782|455242391|FG001|Overall Study|Lack of Efficacy|2|||
126730353|NCT01297309|455962922|FG000|Overall Study|Investigator Decision|2|||
126730354|NCT01297309|455962922|FG000|Overall Study|Death|1|||
126730355|NCT01297309|455962922|FG000|Overall Study|Participant not entering extensionperiod|1|||
126730356|NCT03039738|455962923|FG000|Overall Study|Incomplete data sets|54|||
126730357|NCT03039738|455962924|FG001|Overall Study|Incomplete data sets|0|||
126730358|NCT00085917|455962932|FG000|Overall Study|Adverse Event|4|||
126730359|NCT00085917|455962933|FG001|Overall Study|Adverse Event|3|||
126730360|NCT01429077|455962934|FG000|Overall Study|Lost to Follow-up|0|||
126730361|NCT01429077|455962935|FG001|Overall Study|Lost to Follow-up|3|||
126777269|NCT03751020|456141325|FG001|Overall Study|Lost to Follow-up|4|||
126777270|NCT03751020|456141326|FG002|Overall Study|Lost to Follow-up|10|||
126777271|NCT00033631|456141327|FG000|Overall Study|Protocol Violation|14|||
126777272|NCT00033631|456141328|FG001|Overall Study|Protocol Violation|11|||
126777273|NCT00033631|456141327|FG000|Overall Study|Withdrawal by Subject|4|||
126777274|NCT00033631|456141328|FG001|Overall Study|Withdrawal by Subject|4|||
126777275|NCT00528879|456141329|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
126777276|NCT00528879|456141330|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
126777277|NCT00528879|456141331|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
126777278|NCT00528879|456141332|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
126777279|NCT00528879|456141329|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
126777280|NCT00528879|456141330|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
126777281|NCT00528879|456141331|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
126777282|NCT00528879|456141332|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
126777283|NCT00528879|456141329|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
126777284|NCT00528879|456141330|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
126777285|NCT00528879|456141331|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
126777286|NCT00528879|456141332|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
126777287|NCT00528879|456141329|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
126777288|NCT00528879|456141330|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
126777289|NCT00528879|456141331|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
126777290|NCT00528879|456141332|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
126777291|NCT00528879|456141329|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
126777292|NCT00528879|456141330|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
126777293|NCT00528879|456141331|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
126777294|NCT00528879|456141332|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
126777295|NCT00528879|456141329|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
126777296|NCT00528879|456141330|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
126777297|NCT00528879|456141331|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
126777298|NCT00528879|456141332|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
126777299|NCT00528879|456141329|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
126777300|NCT00528879|456141330|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
126777301|NCT00528879|456141331|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
126777302|NCT00528879|456141332|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
126777303|NCT00528879|456141329|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
126777304|NCT00528879|456141330|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
126777305|NCT00528879|456141331|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
126777306|NCT00528879|456141332|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
126777307|NCT00528879|456141329|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
126777308|NCT00528879|456141330|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
126777309|NCT00528879|456141331|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
126777310|NCT00528879|456141332|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
126777311|NCT00528879|456141329|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
126777312|NCT00528879|456141330|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
126777313|NCT00528879|456141331|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
126777314|NCT00528879|456141332|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
126777315|NCT00528879|456141329|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
126777316|NCT00528879|456141330|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
126777317|NCT00528879|456141331|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
126777318|NCT00528879|456141332|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
126777319|NCT00528879|456141329|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
126777320|NCT00528879|456141330|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
126777321|NCT00528879|456141331|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
126777322|NCT00528879|456141332|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
126730362|NCT03372603|455962936|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
126532574|NCT01692782|455242392|FG002|Overall Study|Lack of Efficacy|0|||
126532575|NCT01692782|455242390|FG000|Overall Study|Lost to Follow-up|2|||
126730363|NCT03372603|455962937|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
126730364|NCT03372603|455962936|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
126730365|NCT03372603|455962937|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
126730366|NCT02806947|455962938|FG000|Overall Study|Withdrawal by Subject|5|||
126730367|NCT02806947|455962939|FG001|Overall Study|Withdrawal by Subject|1|||
126730368|NCT00865189|455962943|FG000|Overall Study|Other|1|||
126730369|NCT00865189|455962944|FG001|Overall Study|Other|2|||
126730370|NCT00865189|455962943|FG000|Overall Study|Death|4|||
126730371|NCT00865189|455962944|FG001|Overall Study|Death|11|||
126730372|NCT00865189|455962943|FG000|Overall Study|Lost to Follow-up|6|||
126730373|NCT00865189|455962944|FG001|Overall Study|Lost to Follow-up|6|||
126730374|NCT00865189|455962943|FG000|Overall Study|Withdrawal by Subject|1|||
126730375|NCT00865189|455962944|FG001|Overall Study|Withdrawal by Subject|0|||
126730376|NCT00418379|455962958|FG000|Year 1|Adverse Event|9|||
126532576|NCT01692782|455242391|FG001|Overall Study|Lost to Follow-up|7|||
126532577|NCT01692782|455242392|FG002|Overall Study|Lost to Follow-up|1|||
126532578|NCT01692782|455242390|FG000|Overall Study|Pregnancy|1|||
126532579|NCT01692782|455242391|FG001|Overall Study|Pregnancy|0|||
126532580|NCT01692782|455242392|FG002|Overall Study|Pregnancy|0|||
126532581|NCT01692782|455242390|FG000|Overall Study|Protocol Violation|1|||
126532582|NCT01692782|455242391|FG001|Overall Study|Protocol Violation|0|||
126532583|NCT01692782|455242392|FG002|Overall Study|Protocol Violation|2|||
126532584|NCT01692782|455242390|FG000|Overall Study|Non-complance with study drug|0|||
126532585|NCT01692782|455242391|FG001|Overall Study|Non-complance with study drug|4|||
126532586|NCT01692782|455242392|FG002|Overall Study|Non-complance with study drug|1|||
126532587|NCT01692782|455242390|FG000|Overall Study|Non-compliant with study visits|0|||
126532588|NCT01692782|455242391|FG001|Overall Study|Non-compliant with study visits|0|||
126532589|NCT01692782|455242392|FG002|Overall Study|Non-compliant with study visits|1|||
126532590|NCT01692782|455242390|FG000|Overall Study|SAE not related to study drug|0|||
126532591|NCT01692782|455242391|FG001|Overall Study|SAE not related to study drug|1|||
126532592|NCT01692782|455242392|FG002|Overall Study|SAE not related to study drug|0|||
126532593|NCT01692782|455242390|FG000|Overall Study|Withdrawal by Subject|3|||
126532594|NCT01692782|455242391|FG001|Overall Study|Withdrawal by Subject|10|||
126532595|NCT01692782|455242392|FG002|Overall Study|Withdrawal by Subject|3|||
126532596|NCT03945188|455242393|FG000|Overall Study|Protocol Violation|1|||
126532597|NCT03945188|455242394|FG001|Overall Study|Protocol Violation|0|||
126532598|NCT03945188|455242393|FG000|Overall Study|Disease worsening|79|||
126532599|NCT03945188|455242394|FG001|Overall Study|Disease worsening|73|||
126532600|NCT03945188|455242393|FG000|Overall Study|Physician Decision|2|||
126532601|NCT03945188|455242394|FG001|Overall Study|Physician Decision|2|||
126532602|NCT03945188|455242393|FG000|Overall Study|Lack of Efficacy|7|||
126532603|NCT03945188|455242394|FG001|Overall Study|Lack of Efficacy|4|||
126532604|NCT03945188|455242393|FG000|Overall Study|Pregnancy|2|||
126532605|NCT03945188|455242394|FG001|Overall Study|Pregnancy|0|||
126532606|NCT03945188|455242393|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
126532607|NCT03945188|455242394|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
126532608|NCT03945188|455242393|FG000|Overall Study|Adverse Event|10|||
126532609|NCT03945188|455242394|FG001|Overall Study|Adverse Event|5|||
126532610|NCT03945188|455242393|FG000|Overall Study|Other|2|||
126532611|NCT03945188|455242394|FG001|Overall Study|Other|2|||
126532612|NCT03945188|455242393|FG000|Overall Study|Lost to Follow-up|1|||
126532613|NCT03945188|455242394|FG001|Overall Study|Lost to Follow-up|2|||
126532614|NCT02219048|455242395|FG000|Overall Study|Adverse Event|2|||
126532615|NCT02219048|455242396|FG001|Overall Study|Adverse Event|5|||
126532616|NCT02219048|455242395|FG000|Overall Study|No longer meets eligibility criteria|1|||
126532617|NCT02219048|455242396|FG001|Overall Study|No longer meets eligibility criteria|0|||
126532618|NCT02219048|455242395|FG000|Overall Study|Study terminated by sponsor|16|||
126532619|NCT02219048|455242396|FG001|Overall Study|Study terminated by sponsor|15|||
126532620|NCT02219048|455242395|FG000|Overall Study|Withdrawal by Subject|2|||
126532621|NCT02219048|455242396|FG001|Overall Study|Withdrawal by Subject|0|||
126532622|NCT02219048|455242395|FG000|Overall Study|Other|0|||
126532623|NCT02219048|455242396|FG001|Overall Study|Other|1|||
126532624|NCT01618162|455242411|FG000|Overall Study|Protocol Violation|13|||
126532625|NCT01618162|455242412|FG001|Overall Study|Protocol Violation|10|||
126532626|NCT01618162|455242411|FG000|Overall Study|Adverse Event|9|||
126532627|NCT01618162|455242412|FG001|Overall Study|Adverse Event|2|||
126532628|NCT01618162|455242411|FG000|Overall Study|Withdrawal Criteria|2|||
126532629|NCT01618162|455242412|FG001|Overall Study|Withdrawal Criteria|10|||
126532630|NCT01618162|455242411|FG000|Overall Study|Unclassified|14|||
126532631|NCT01618162|455242412|FG001|Overall Study|Unclassified|13|||
126532632|NCT04124926|455242413|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
126532633|NCT04124926|455242414|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
126532634|NCT04124926|455242415|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
126532635|NCT04124926|455242416|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
126582701|NCT03580369|455430876|FG005|Overall Study|Pregnancy|0|||
126730377|NCT00418379|455962959|FG001|Year 1|Adverse Event|15|||
126730378|NCT00418379|455962960|FG002|Year 1|Adverse Event|3|||
126730379|NCT00418379|455962958|FG000|Year 1|Withdrawal by Subject|7|||
126582702|NCT03580369|455430877|FG006|Overall Study|Pregnancy|0|||
126582703|NCT03580369|455430878|FG007|Overall Study|Pregnancy|0|||
126582704|NCT03580369|455430871|FG000|Overall Study|Lost to Follow-up|2|||
126582705|NCT03580369|455430872|FG001|Overall Study|Lost to Follow-up|0|||
126582706|NCT03580369|455430873|FG002|Overall Study|Lost to Follow-up|2|||
126582707|NCT03580369|455430874|FG003|Overall Study|Lost to Follow-up|0|||
126582708|NCT03580369|455430875|FG004|Overall Study|Lost to Follow-up|3|||
126582709|NCT03580369|455430876|FG005|Overall Study|Lost to Follow-up|0|||
126582710|NCT03580369|455430877|FG006|Overall Study|Lost to Follow-up|1|||
126582711|NCT03580369|455430878|FG007|Overall Study|Lost to Follow-up|0|||
126582712|NCT03580369|455430871|FG000|Overall Study|Physician Decision|4|||
126582713|NCT03580369|455430872|FG001|Overall Study|Physician Decision|0|||
126582714|NCT03580369|455430873|FG002|Overall Study|Physician Decision|4|||
126730380|NCT00418379|455962959|FG001|Year 1|Withdrawal by Subject|8|||
126532636|NCT04124926|455242417|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
126532637|NCT04124926|455242413|FG000|Healing Phase|Protocol Violation|0|||
126532638|NCT04124926|455242414|FG001|Healing Phase|Protocol Violation|1|||
126532639|NCT04124926|455242415|FG002|Healing Phase|Protocol Violation|0|||
126532640|NCT04124926|455242416|FG003|Healing Phase|Protocol Violation|0|||
126532641|NCT04124926|455242417|FG004|Healing Phase|Protocol Violation|0|||
126532642|NCT04124926|455242413|FG000|Healing Phase|Lost to Follow-up|5|||
126532643|NCT04124926|455242414|FG001|Healing Phase|Lost to Follow-up|4|||
126532644|NCT04124926|455242415|FG002|Healing Phase|Lost to Follow-up|0|||
126532645|NCT04124926|455242416|FG003|Healing Phase|Lost to Follow-up|0|||
126532646|NCT04124926|455242417|FG004|Healing Phase|Lost to Follow-up|0|||
126532647|NCT04124926|455242413|FG000|Healing Phase|Voluntary Withdrawal|10|||
126532648|NCT04124926|455242414|FG001|Healing Phase|Voluntary Withdrawal|7|||
126532649|NCT04124926|455242415|FG002|Healing Phase|Voluntary Withdrawal|0|||
126532650|NCT04124926|455242416|FG003|Healing Phase|Voluntary Withdrawal|0|||
126532651|NCT04124926|455242417|FG004|Healing Phase|Voluntary Withdrawal|0|||
126532652|NCT04124926|455242413|FG000|Healing Phase|Withdrawal of Consent|5|||
126532653|NCT04124926|455242414|FG001|Healing Phase|Withdrawal of Consent|3|||
126532654|NCT04124926|455242415|FG002|Healing Phase|Withdrawal of Consent|0|||
126532655|NCT04124926|455242416|FG003|Healing Phase|Withdrawal of Consent|0|||
126532656|NCT04124926|455242417|FG004|Healing Phase|Withdrawal of Consent|0|||
126532657|NCT04124926|455242413|FG000|Healing Phase|Miscellaneous|8|||
126532658|NCT04124926|455242414|FG001|Healing Phase|Miscellaneous|7|||
126532659|NCT04124926|455242415|FG002|Healing Phase|Miscellaneous|0|||
126532660|NCT04124926|455242416|FG003|Healing Phase|Miscellaneous|0|||
126532661|NCT04124926|455242417|FG004|Healing Phase|Miscellaneous|0|||
126532662|NCT04124926|455242413|FG000|Healing Phase|Randomized but not Treated|0|||
126532663|NCT04124926|455242414|FG001|Healing Phase|Randomized but not Treated|3|||
126532664|NCT04124926|455242415|FG002|Healing Phase|Randomized but not Treated|0|||
126532665|NCT04124926|455242416|FG003|Healing Phase|Randomized but not Treated|0|||
126532666|NCT04124926|455242417|FG004|Healing Phase|Randomized but not Treated|0|||
126532667|NCT04124926|455242413|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
126532668|NCT04124926|455242414|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
126532669|NCT04124926|455242415|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
126532670|NCT04124926|455242416|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
126532671|NCT04124926|455242417|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
126532672|NCT04124926|455242413|FG000|Maintenance Phase|Protocol Violation|0|||
126532673|NCT04124926|455242414|FG001|Maintenance Phase|Protocol Violation|0|||
126532674|NCT04124926|455242415|FG002|Maintenance Phase|Protocol Violation|3|||
126532675|NCT04124926|455242416|FG003|Maintenance Phase|Protocol Violation|0|||
126532676|NCT04124926|455242417|FG004|Maintenance Phase|Protocol Violation|0|||
126532677|NCT04124926|455242413|FG000|Maintenance Phase|Lost to Follow-up|0|||
126532678|NCT04124926|455242414|FG001|Maintenance Phase|Lost to Follow-up|0|||
126532679|NCT04124926|455242415|FG002|Maintenance Phase|Lost to Follow-up|7|||
126532680|NCT04124926|455242416|FG003|Maintenance Phase|Lost to Follow-up|8|||
126532681|NCT04124926|455242417|FG004|Maintenance Phase|Lost to Follow-up|9|||
126532682|NCT04124926|455242413|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
126532683|NCT04124926|455242414|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
126532684|NCT04124926|455242415|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
126582715|NCT03580369|455430874|FG003|Overall Study|Physician Decision|1|||
126582716|NCT03580369|455430875|FG004|Overall Study|Physician Decision|1|||
126582717|NCT03580369|455430876|FG005|Overall Study|Physician Decision|0|||
126582718|NCT03580369|455430877|FG006|Overall Study|Physician Decision|0|||
126582719|NCT03580369|455430878|FG007|Overall Study|Physician Decision|0|||
126582720|NCT03580369|455430871|FG000|Overall Study|Lack of Efficacy|3|||
126582721|NCT03580369|455430872|FG001|Overall Study|Lack of Efficacy|0|||
126582722|NCT03580369|455430873|FG002|Overall Study|Lack of Efficacy|7|||
126582723|NCT03580369|455430874|FG003|Overall Study|Lack of Efficacy|0|||
126532685|NCT04124926|455242416|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
126532686|NCT04124926|455242417|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
126532687|NCT04124926|455242413|FG000|Maintenance Phase|Pregnancy|0|||
126532688|NCT04124926|455242414|FG001|Maintenance Phase|Pregnancy|0|||
126582724|NCT03580369|455430875|FG004|Overall Study|Lack of Efficacy|2|||
126582725|NCT03580369|455430876|FG005|Overall Study|Lack of Efficacy|0|||
126582726|NCT03580369|455430877|FG006|Overall Study|Lack of Efficacy|3|||
126582727|NCT03580369|455430878|FG007|Overall Study|Lack of Efficacy|0|||
126582728|NCT03580369|455430871|FG000|Overall Study|Protocol Violation|6|||
126582729|NCT03580369|455430872|FG001|Overall Study|Protocol Violation|0|||
126582730|NCT03580369|455430873|FG002|Overall Study|Protocol Violation|6|||
126582731|NCT03580369|455430874|FG003|Overall Study|Protocol Violation|1|||
126582732|NCT03580369|455430875|FG004|Overall Study|Protocol Violation|8|||
126582733|NCT03580369|455430876|FG005|Overall Study|Protocol Violation|2|||
126582734|NCT03580369|455430877|FG006|Overall Study|Protocol Violation|1|||
126582735|NCT03580369|455430878|FG007|Overall Study|Protocol Violation|0|||
126582736|NCT03580369|455430871|FG000|Overall Study|Adverse Event|7|||
126582737|NCT03580369|455430872|FG001|Overall Study|Adverse Event|0|||
126582738|NCT03580369|455430873|FG002|Overall Study|Adverse Event|14|||
126582739|NCT03580369|455430874|FG003|Overall Study|Adverse Event|1|||
126582740|NCT03580369|455430875|FG004|Overall Study|Adverse Event|6|||
126582741|NCT03580369|455430876|FG005|Overall Study|Adverse Event|0|||
126582742|NCT03580369|455430877|FG006|Overall Study|Adverse Event|1|||
126582743|NCT03580369|455430878|FG007|Overall Study|Adverse Event|0|||
126582744|NCT03580369|455430871|FG000|Overall Study|Withdrawal by Subject|19|||
126582745|NCT03580369|455430872|FG001|Overall Study|Withdrawal by Subject|0|||
126582746|NCT03580369|455430873|FG002|Overall Study|Withdrawal by Subject|17|||
126582747|NCT03580369|455430874|FG003|Overall Study|Withdrawal by Subject|0|||
126582748|NCT03580369|455430875|FG004|Overall Study|Withdrawal by Subject|16|||
126582749|NCT03580369|455430876|FG005|Overall Study|Withdrawal by Subject|1|||
126582750|NCT03580369|455430877|FG006|Overall Study|Withdrawal by Subject|7|||
126582751|NCT03580369|455430878|FG007|Overall Study|Withdrawal by Subject|0|||
126582752|NCT03912831|455430879|FG000|Overall Study|Death|1|||
126582753|NCT03912831|455430880|FG001|Overall Study|Death|1|||
126582754|NCT03912831|455430881|FG002|Overall Study|Death|1|||
126582755|NCT03912831|455430882|FG003|Overall Study|Death|1|||
126582756|NCT03912831|455430883|FG004|Overall Study|Death|1|||
126582757|NCT03912831|455430884|FG005|Overall Study|Death|1|||
126582758|NCT03912831|455430879|FG000|Overall Study|Reason not Specified|0|||
126582759|NCT03912831|455430880|FG001|Overall Study|Reason not Specified|0|||
126582760|NCT03912831|455430881|FG002|Overall Study|Reason not Specified|0|||
126582761|NCT03912831|455430882|FG003|Overall Study|Reason not Specified|0|||
126582762|NCT03912831|455430883|FG004|Overall Study|Reason not Specified|1|||
126582763|NCT03912831|455430884|FG005|Overall Study|Reason not Specified|0|||
126582764|NCT03912831|455430879|FG000|Overall Study|Withdrawal by Participant|0|||
126582765|NCT03912831|455430880|FG001|Overall Study|Withdrawal by Participant|0|||
126582766|NCT03912831|455430881|FG002|Overall Study|Withdrawal by Participant|0|||
126582767|NCT03912831|455430882|FG003|Overall Study|Withdrawal by Participant|0|||
126582768|NCT03912831|455430883|FG004|Overall Study|Withdrawal by Participant|1|||
126582769|NCT03912831|455430884|FG005|Overall Study|Withdrawal by Participant|0|||
126582770|NCT04442126|455430890|FG000|Overall Study|Withdrawal by Subject|0|||
126582771|NCT04442126|455430891|FG001|Overall Study|Withdrawal by Subject|0|||
126582772|NCT04442126|455430892|FG002|Overall Study|Withdrawal by Subject|0|||
126582773|NCT04442126|455430893|FG003|Overall Study|Withdrawal by Subject|2|||
126582774|NCT04442126|455430894|FG004|Overall Study|Withdrawal by Subject|1|||
126582775|NCT04442126|455430895|FG005|Overall Study|Withdrawal by Subject|0|||
126582776|NCT04442126|455430896|FG006|Overall Study|Withdrawal by Subject|1|||
126582777|NCT04442126|455430897|FG007|Overall Study|Withdrawal by Subject|1|||
126582778|NCT04442126|455430898|FG008|Overall Study|Withdrawal by Subject|3|||
126582779|NCT04442126|455430890|FG000|Overall Study|Death|1|||
126582780|NCT04442126|455430891|FG001|Overall Study|Death|0|||
126582781|NCT04442126|455430892|FG002|Overall Study|Death|0|||
126582782|NCT04442126|455430893|FG003|Overall Study|Death|1|||
126582783|NCT04442126|455430894|FG004|Overall Study|Death|2|||
126582784|NCT04442126|455430895|FG005|Overall Study|Death|2|||
126582785|NCT04442126|455430896|FG006|Overall Study|Death|4|||
126582786|NCT04442126|455430897|FG007|Overall Study|Death|1|||
126582787|NCT04442126|455430898|FG008|Overall Study|Death|5|||
126582788|NCT04442126|455430890|FG000|Overall Study|Study Terminated by Sponsor|0|||
126582789|NCT04442126|455430891|FG001|Overall Study|Study Terminated by Sponsor|0|||
126582790|NCT04442126|455430892|FG002|Overall Study|Study Terminated by Sponsor|0|||
126582791|NCT04442126|455430893|FG003|Overall Study|Study Terminated by Sponsor|0|||
126582792|NCT04442126|455430894|FG004|Overall Study|Study Terminated by Sponsor|0|||
126582793|NCT04442126|455430895|FG005|Overall Study|Study Terminated by Sponsor|1|||
126582794|NCT04442126|455430896|FG006|Overall Study|Study Terminated by Sponsor|4|||
126582795|NCT04442126|455430897|FG007|Overall Study|Study Terminated by Sponsor|2|||
126582796|NCT04442126|455430898|FG008|Overall Study|Study Terminated by Sponsor|10|||
126582797|NCT04442126|455430890|FG000|Overall Study|Lost to Follow-up|0|||
126582798|NCT04442126|455430891|FG001|Overall Study|Lost to Follow-up|0|||
126582799|NCT04442126|455430892|FG002|Overall Study|Lost to Follow-up|0|||
126582800|NCT04442126|455430893|FG003|Overall Study|Lost to Follow-up|0|||
126582801|NCT04442126|455430894|FG004|Overall Study|Lost to Follow-up|0|||
126582802|NCT04442126|455430895|FG005|Overall Study|Lost to Follow-up|0|||
126582803|NCT04442126|455430896|FG006|Overall Study|Lost to Follow-up|0|||
126582804|NCT04442126|455430897|FG007|Overall Study|Lost to Follow-up|1|||
126532689|NCT04124926|455242415|FG002|Maintenance Phase|Pregnancy|0|||
126532690|NCT04124926|455242416|FG003|Maintenance Phase|Pregnancy|1|||
126532691|NCT04124926|455242417|FG004|Maintenance Phase|Pregnancy|0|||
126532692|NCT04124926|455242413|FG000|Maintenance Phase|Lack of Efficacy|0|||
126532693|NCT04124926|455242414|FG001|Maintenance Phase|Lack of Efficacy|0|||
126532694|NCT04124926|455242415|FG002|Maintenance Phase|Lack of Efficacy|0|||
126532695|NCT04124926|455242416|FG003|Maintenance Phase|Lack of Efficacy|0|||
126532696|NCT04124926|455242417|FG004|Maintenance Phase|Lack of Efficacy|1|||
126532697|NCT04124926|455242413|FG000|Maintenance Phase|Withdrawal of Consent|0|||
126532698|NCT04124926|455242414|FG001|Maintenance Phase|Withdrawal of Consent|0|||
126532699|NCT04124926|455242415|FG002|Maintenance Phase|Withdrawal of Consent|5|||
126532700|NCT04124926|455242416|FG003|Maintenance Phase|Withdrawal of Consent|5|||
126532701|NCT04124926|455242417|FG004|Maintenance Phase|Withdrawal of Consent|5|||
126532702|NCT04124926|455242413|FG000|Maintenance Phase|Miscellaneous|0|||
126532703|NCT04124926|455242414|FG001|Maintenance Phase|Miscellaneous|0|||
126532704|NCT04124926|455242415|FG002|Maintenance Phase|Miscellaneous|1|||
126532705|NCT04124926|455242416|FG003|Maintenance Phase|Miscellaneous|2|||
126532706|NCT04124926|455242417|FG004|Maintenance Phase|Miscellaneous|4|||
126532707|NCT04124926|455242413|FG000|Maintenance Phase|Randomized but not Treated|0|||
126532708|NCT04124926|455242414|FG001|Maintenance Phase|Randomized but not Treated|0|||
126532709|NCT04124926|455242415|FG002|Maintenance Phase|Randomized but not Treated|2|||
126532710|NCT04124926|455242416|FG003|Maintenance Phase|Randomized but not Treated|2|||
126532711|NCT04124926|455242417|FG004|Maintenance Phase|Randomized but not Treated|0|||
126532712|NCT03152526|455242420|FG000|Overall Study|Withdrawal by Subject|0|||
126532713|NCT03152526|455242421|FG001|Overall Study|Withdrawal by Subject|1|||
126532714|NCT04435366|455242422|FG000|Year 1 (12 Months)|Adverse Event|3|||
126532715|NCT04435366|455242423|FG001|Year 1 (12 Months)|Adverse Event|0|||
126532716|NCT04435366|455242424|FG002|Year 1 (12 Months)|Adverse Event|2|||
126532717|NCT04435366|455242422|FG000|Year 1 (12 Months)|Death|2|||
126532718|NCT04435366|455242423|FG001|Year 1 (12 Months)|Death|0|||
126532719|NCT04435366|455242424|FG002|Year 1 (12 Months)|Death|1|||
126532720|NCT04435366|455242422|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
126532721|NCT04435366|455242423|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
126532722|NCT04435366|455242424|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
126532723|NCT04435366|455242422|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
126532724|NCT04435366|455242423|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
126532725|NCT04435366|455242424|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
126532726|NCT04435366|455242422|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
126532727|NCT04435366|455242423|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
126532728|NCT04435366|455242424|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
126532729|NCT04435366|455242422|FG000|Year 1 (12 Months)|Not treated|0|||
126532730|NCT04435366|455242423|FG001|Year 1 (12 Months)|Not treated|0|||
126532731|NCT04435366|455242424|FG002|Year 1 (12 Months)|Not treated|1|||
126532732|NCT04435366|455242422|FG000|Year 2 (12 Months)|Death|1|||
126532733|NCT04435366|455242423|FG001|Year 2 (12 Months)|Death|4|||
126532734|NCT04435366|455242424|FG002|Year 2 (12 Months)|Death|6|||
126532735|NCT04435366|455242422|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
126532736|NCT04435366|455242423|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
126532737|NCT04435366|455242424|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
126532738|NCT04435366|455242422|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
126532739|NCT04435366|455242423|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
126532740|NCT04435366|455242424|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
126532741|NCT04435366|455242422|FG000|Year 2 (12 Months)|Adverse Event|2|||
126532742|NCT04435366|455242423|FG001|Year 2 (12 Months)|Adverse Event|1|||
126532743|NCT04435366|455242424|FG002|Year 2 (12 Months)|Adverse Event|6|||
126532744|NCT00736645|455242425|FG000|Overall Study|Adverse Event|0|||
126532745|NCT00736645|455242426|FG001|Overall Study|Adverse Event|2|||
126532746|NCT00736645|455242427|FG002|Overall Study|Adverse Event|0|||
126532747|NCT00736645|455242428|FG003|Overall Study|Adverse Event|0|||
126532748|NCT00295022|455242431|FG000|Overall Study|Adverse Event|1|||
126532749|NCT00295022|455242432|FG001|Overall Study|Adverse Event|1|||
126532750|NCT00295022|455242433|FG002|Overall Study|Adverse Event|2|||
126532751|NCT00295022|455242431|FG000|Overall Study|Lost to Follow-up|0|||
126532752|NCT00295022|455242432|FG001|Overall Study|Lost to Follow-up|0|||
126532753|NCT00295022|455242433|FG002|Overall Study|Lost to Follow-up|1|||
126532754|NCT00295022|455242431|FG000|Overall Study|Withdrawal by Subject|0|||
126532755|NCT00295022|455242432|FG001|Overall Study|Withdrawal by Subject|0|||
126532756|NCT00295022|455242433|FG002|Overall Study|Withdrawal by Subject|2|||
126532757|NCT00734630|455242434|FG000|Overall Study|Lack of Efficacy|4|||
126532758|NCT00734630|455242435|FG001|Overall Study|Lack of Efficacy|4|||
126532759|NCT00734630|455242434|FG000|Overall Study|Withdrawal by Subject|7|||
126532760|NCT00734630|455242435|FG001|Overall Study|Withdrawal by Subject|9|||
126532761|NCT00734630|455242434|FG000|Overall Study|Lost to Follow-up|13|||
126532762|NCT00734630|455242435|FG001|Overall Study|Lost to Follow-up|7|||
126532763|NCT00734630|455242434|FG000|Overall Study|Protocol Violation|0|||
126532764|NCT00734630|455242435|FG001|Overall Study|Protocol Violation|3|||
126532765|NCT00734630|455242434|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
126532766|NCT00734630|455242435|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
126730381|NCT00418379|455962960|FG002|Year 1|Withdrawal by Subject|5|||
126730382|NCT00418379|455962958|FG000|Year 1|Any other reason not above-mentioned|2|||
126730383|NCT00418379|455962959|FG001|Year 1|Any other reason not above-mentioned|5|||
126730384|NCT00418379|455962960|FG002|Year 1|Any other reason not above-mentioned|7|||
126730385|NCT00418379|455962958|FG000|Year 2|Adverse Event|5|||
126532767|NCT00734630|455242434|FG000|Overall Study|Adverse Event|3|||
126532768|NCT00734630|455242435|FG001|Overall Study|Adverse Event|6|||
126532769|NCT00734630|455242434|FG000|Overall Study|Randomized in Error|0|||
126532770|NCT00734630|455242435|FG001|Overall Study|Randomized in Error|1|||
126532771|NCT00734630|455242434|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
126532772|NCT00734630|455242435|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
126532773|NCT00734630|455242434|FG000|Overall Study|Poor Compliance|1|||
126532774|NCT00734630|455242435|FG001|Overall Study|Poor Compliance|1|||
126532775|NCT03792126|455242437|FG000|Overall Study|Adverse Event|1|||
126532776|NCT03792126|455242438|FG001|Overall Study|Adverse Event|2|||
126532777|NCT03792126|455242437|FG000|Overall Study|Death|0|||
126532778|NCT03792126|455242438|FG001|Overall Study|Death|1|||
126532779|NCT03792126|455242437|FG000|Overall Study|Lost to Follow-up|1|||
126532780|NCT03792126|455242438|FG001|Overall Study|Lost to Follow-up|0|||
126532781|NCT03792126|455242437|FG000|Overall Study|Withdrawal by Subject|0|||
126532782|NCT03792126|455242438|FG001|Overall Study|Withdrawal by Subject|1|||
126532783|NCT03792126|455242437|FG000|Overall Study|COVID-19 Restrictions|1|||
126532784|NCT03792126|455242438|FG001|Overall Study|COVID-19 Restrictions|3|||
126532785|NCT03792126|455242437|FG000|Overall Study|Symptoms resolved|0|||
126532786|NCT03792126|455242438|FG001|Overall Study|Symptoms resolved|3|||
126532787|NCT03240692|455242439|FG000|Overall Study|Physician Decision|1|||
126532788|NCT03240692|455242439|FG000|Overall Study|Withdrawal by Subject|1|||
126532789|NCT02300220|455242440|FG000|Overall Study|Lost to Follow-up|1|||
126532790|NCT02300220|455242441|FG001|Overall Study|Lost to Follow-up|2|||
126532791|NCT02300220|455242440|FG000|Overall Study|Death|1|||
126532792|NCT02300220|455242441|FG001|Overall Study|Death|1|||
126532793|NCT02300220|455242440|FG000|Overall Study|Adverse Event|1|||
126532794|NCT02300220|455242441|FG001|Overall Study|Adverse Event|1|||
126532795|NCT02300220|455242440|FG000|Overall Study|Protocol Violation|1|||
126532796|NCT02300220|455242441|FG001|Overall Study|Protocol Violation|0|||
126532797|NCT02300220|455242440|FG000|Overall Study|Withdrawal by Subject|0|||
126532798|NCT02300220|455242441|FG001|Overall Study|Withdrawal by Subject|2|||
126532799|NCT02300220|455242440|FG000|Overall Study|Did not tolerate IMP|0|||
126532800|NCT02300220|455242441|FG001|Overall Study|Did not tolerate IMP|1|||
126532801|NCT02238379|455242443|FG000|Overall Study|Lost to Follow-up|1|||
126532802|NCT02238379|455242444|FG001|Overall Study|Lost to Follow-up|0|||
126532803|NCT04123067|455242445|FG000|Overall Study|Lost to Follow-up|0|||
126532804|NCT04123067|455242446|FG001|Overall Study|Lost to Follow-up|1|||
126532805|NCT00441090|455242447|FG000|Overall Study|Adverse Event|0|||
126532806|NCT00441090|455242448|FG001|Overall Study|Adverse Event|1|||
126532807|NCT00441090|455242449|FG002|Overall Study|Adverse Event|1|||
126532808|NCT00441090|455242450|FG003|Overall Study|Adverse Event|0|||
126532809|NCT00441090|455242451|FG004|Overall Study|Adverse Event|0|||
126532810|NCT00441090|455242447|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
126532811|NCT00441090|455242448|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
126532812|NCT00441090|455242449|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
126532813|NCT00441090|455242450|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
126532814|NCT00441090|455242451|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
126532815|NCT00441090|455242447|FG000|Overall Study|Withdrawal by Subject|1|||
126532816|NCT00441090|455242448|FG001|Overall Study|Withdrawal by Subject|0|||
126532817|NCT00441090|455242449|FG002|Overall Study|Withdrawal by Subject|1|||
126532818|NCT00441090|455242450|FG003|Overall Study|Withdrawal by Subject|0|||
126532819|NCT00441090|455242451|FG004|Overall Study|Withdrawal by Subject|0|||
126532820|NCT00441090|455242447|FG000|Overall Study|Lack of Efficacy|1|||
126532821|NCT00441090|455242448|FG001|Overall Study|Lack of Efficacy|0|||
126532822|NCT00441090|455242449|FG002|Overall Study|Lack of Efficacy|0|||
126532823|NCT00441090|455242450|FG003|Overall Study|Lack of Efficacy|0|||
126532824|NCT00441090|455242451|FG004|Overall Study|Lack of Efficacy|0|||
126532825|NCT01441102|455242452|FG000|Overall Study|Adverse Event|1|||
126532826|NCT01441102|455242452|FG000|Overall Study|Withdrawal by Subject|2|||
126532827|NCT03085485|455242453|FG000|Overall Study|Death|1|||
126532828|NCT03085485|455242454|FG001|Overall Study|Death|0|||
126532829|NCT03085485|455242453|FG000|Overall Study|Lost to Follow-up|1|||
126532830|NCT03085485|455242454|FG001|Overall Study|Lost to Follow-up|0|||
126532831|NCT01775904|455242458|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
126532832|NCT01775904|455242458|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
126532833|NCT00518115|455242459|FG000|Overall Study|Adverse Event|6|||
126532834|NCT00518115|455242460|FG001|Overall Study|Adverse Event|1|||
126532835|NCT00518115|455242461|FG002|Overall Study|Adverse Event|5|||
126532836|NCT00518115|455242462|FG003|Overall Study|Adverse Event|6|||
126532837|NCT00518115|455242463|FG004|Overall Study|Adverse Event|5|||
126532838|NCT00518115|455242464|FG005|Overall Study|Adverse Event|5|||
126532839|NCT00518115|455242465|FG006|Overall Study|Adverse Event|5|||
126582805|NCT04442126|455430898|FG008|Overall Study|Lost to Follow-up|2|||
126582806|NCT04442126|455430890|FG000|Overall Study|Progressive Disease|0|||
126582807|NCT04442126|455430891|FG001|Overall Study|Progressive Disease|1|||
126582808|NCT04442126|455430892|FG002|Overall Study|Progressive Disease|3|||
126582809|NCT04442126|455430893|FG003|Overall Study|Progressive Disease|0|||
126582810|NCT04442126|455430894|FG004|Overall Study|Progressive Disease|3|||
126582811|NCT04442126|455430895|FG005|Overall Study|Progressive Disease|0|||
126582812|NCT04442126|455430896|FG006|Overall Study|Progressive Disease|0|||
126582813|NCT04442126|455430897|FG007|Overall Study|Progressive Disease|0|||
126582814|NCT04442126|455430898|FG008|Overall Study|Progressive Disease|0|||
126582815|NCT04442126|455430890|FG000|Overall Study|Other|0|||
126582816|NCT04442126|455430891|FG001|Overall Study|Other|0|||
126582817|NCT04442126|455430892|FG002|Overall Study|Other|0|||
126582818|NCT04442126|455430893|FG003|Overall Study|Other|0|||
126582819|NCT04442126|455430894|FG004|Overall Study|Other|0|||
126582820|NCT04442126|455430895|FG005|Overall Study|Other|0|||
126582821|NCT04442126|455430896|FG006|Overall Study|Other|0|||
126582822|NCT04442126|455430897|FG007|Overall Study|Other|0|||
126582823|NCT04442126|455430898|FG008|Overall Study|Other|1|||
126582824|NCT06450405|455430899|FG000|Overall Study|Study funding terminated.|0|||
126582825|NCT06450405|455430900|FG001|Overall Study|Study funding terminated.|2|||
126582826|NCT03152786|455432155|FG000|Overall Study|Withdrawal by Subject|2|||
126582827|NCT03152786|455432156|FG001|Overall Study|Withdrawal by Subject|1|||
126582828|NCT04923347|455432157|FG000|Overall Study|Withdrawal by Subject|14|||
126582829|NCT03424811|455432158|FG000|Overall Study|Lost to Follow-up|9|||
126582830|NCT03424811|455432159|FG001|Overall Study|Lost to Follow-up|0|||
126582831|NCT00753090|455432171|FG000|Overall Study|Withdrawal by Subject|10|||
126582832|NCT00753090|455432172|FG001|Overall Study|Withdrawal by Subject|10|||
126582833|NCT00753090|455432171|FG000|Overall Study|Death|17|||
126582834|NCT00753090|455432172|FG001|Overall Study|Death|6|||
126582835|NCT00753090|455432171|FG000|Overall Study|Study Prosthesis Removed|12|||
126582836|NCT00753090|455432172|FG001|Overall Study|Study Prosthesis Removed|3|||
126582837|NCT00753090|455432171|FG000|Overall Study|Lost to Follow-up|2|||
126582838|NCT00753090|455432172|FG001|Overall Study|Lost to Follow-up|2|||
126582839|NCT00753090|455432171|FG000|Overall Study|Other|127|||
126582840|NCT00753090|455432172|FG001|Overall Study|Other|75|||
126582841|NCT06066541|455432179|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
126582842|NCT06066541|455432180|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
126582843|NCT06066541|455432181|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
126582844|NCT06066541|455432182|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
126582845|NCT06066541|455432183|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
126582846|NCT06066541|455432184|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
126582847|NCT06066541|455432185|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
126582848|NCT06066541|455432179|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
126582849|NCT06066541|455432180|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
126582850|NCT06066541|455432181|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
126582851|NCT06066541|455432182|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
126582852|NCT06066541|455432183|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
126582853|NCT06066541|455432184|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
126582854|NCT06066541|455432185|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
126582855|NCT02819843|455432186|FG000|Overall Study|Disease progression before RT|0|||
126582856|NCT02819843|455432187|FG001|Overall Study|Disease progression before RT|1|||
126582857|NCT03055858|455432189|FG000|Overall Study|Death|9|||
126582858|NCT03055858|455432189|FG000|Overall Study|Withdrawal by Subject|11|||
126582859|NCT03055858|455432189|FG000|Overall Study|Lost to Follow-up|6|||
126582860|NCT03055858|455432189|FG000|Overall Study|Missed Follow-Up Visits|18|||
126582861|NCT04586920|455432190|FG000|Overall Study|Lost to Follow-up|0|||
126582862|NCT04586920|455432191|FG001|Overall Study|Lost to Follow-up|0|||
126582863|NCT04586920|455432192|FG002|Overall Study|Lost to Follow-up|0|||
126582864|NCT04586920|455432193|FG003|Overall Study|Lost to Follow-up|0|||
126582865|NCT04586920|455432194|FG004|Overall Study|Lost to Follow-up|0|||
126582866|NCT04586920|455432195|FG005|Overall Study|Lost to Follow-up|0|||
126582867|NCT04586920|455432196|FG006|Overall Study|Lost to Follow-up|1|||
126582868|NCT04586920|455432197|FG007|Overall Study|Lost to Follow-up|1|||
126582869|NCT04586920|455432198|FG008|Overall Study|Lost to Follow-up|0|||
126582870|NCT04586920|455432199|FG009|Overall Study|Lost to Follow-up|1|||
126582871|NCT04586920|455432200|FG010|Overall Study|Lost to Follow-up|0|||
126582872|NCT04586920|455432201|FG011|Overall Study|Lost to Follow-up|0|||
126582873|NCT04586920|455432202|FG012|Overall Study|Lost to Follow-up|0|||
126582874|NCT04586920|455432203|FG013|Overall Study|Lost to Follow-up|1|||
126582875|NCT04586920|455432204|FG014|Overall Study|Lost to Follow-up|0|||
126582876|NCT04586920|455432205|FG015|Overall Study|Lost to Follow-up|0|||
126582877|NCT04586920|455432206|FG016|Overall Study|Lost to Follow-up|0|||
126582878|NCT04586920|455432207|FG017|Overall Study|Lost to Follow-up|0|||
126582879|NCT04586920|455432190|FG000|Overall Study|Withdrawal by Subject|0|||
126582880|NCT04586920|455432191|FG001|Overall Study|Withdrawal by Subject|0|||
126582881|NCT04586920|455432192|FG002|Overall Study|Withdrawal by Subject|0|||
126582882|NCT04586920|455432193|FG003|Overall Study|Withdrawal by Subject|0|||
126582883|NCT04586920|455432194|FG004|Overall Study|Withdrawal by Subject|0|||
126582884|NCT04586920|455432195|FG005|Overall Study|Withdrawal by Subject|0|||
126582885|NCT04586920|455432196|FG006|Overall Study|Withdrawal by Subject|0|||
126582886|NCT04586920|455432197|FG007|Overall Study|Withdrawal by Subject|1|||
126582887|NCT04586920|455432198|FG008|Overall Study|Withdrawal by Subject|0|||
126582888|NCT04586920|455432199|FG009|Overall Study|Withdrawal by Subject|1|||
126582889|NCT04586920|455432200|FG010|Overall Study|Withdrawal by Subject|0|||
126582890|NCT04586920|455432201|FG011|Overall Study|Withdrawal by Subject|1|||
126582891|NCT04586920|455432202|FG012|Overall Study|Withdrawal by Subject|0|||
126582892|NCT04586920|455432203|FG013|Overall Study|Withdrawal by Subject|0|||
126582893|NCT04586920|455432204|FG014|Overall Study|Withdrawal by Subject|0|||
126582894|NCT04586920|455432205|FG015|Overall Study|Withdrawal by Subject|0|||
126582895|NCT04586920|455432206|FG016|Overall Study|Withdrawal by Subject|0|||
126582896|NCT04586920|455432207|FG017|Overall Study|Withdrawal by Subject|0|||
126582897|NCT06143670|455432208|FG000|Overall Study|Lost to Follow-up|0|||
126582898|NCT06143670|455432209|FG001|Overall Study|Lost to Follow-up|1|||
126582899|NCT06143670|455432208|FG000|Overall Study|Withdrawal by Subject|3|||
126582900|NCT06143670|455432209|FG001|Overall Study|Withdrawal by Subject|0|||
126582901|NCT02597946|455432213|FG000|Overall Study|Withdrawal by Subject|1|||
126582902|NCT02597946|455432213|FG000|Overall Study|Progressive disease|16|||
126582903|NCT02597946|455432213|FG000|Overall Study|Other than above|1|||
126582904|NCT05058391|455432221|FG000|Overall Study|Adverse Event|1|||
126582905|NCT01938547|455432233|FG000|Overall Study|Physician Decision|1|||
126582906|NCT05038566|455432236|FG000|Overall Study|Technical Difficulties with the Device|0|||
126582907|NCT05038566|455432237|FG001|Overall Study|Technical Difficulties with the Device|1|||
126582908|NCT04842643|455432238|FG000|Overall Study|Physician Decision|1|||
126582909|NCT04842643|455432238|FG000|Overall Study|Other|1|||
126582910|NCT05110495|455432241|FG000|Overall Study|Lost to Follow-up|1|||
126582911|NCT05110495|455432241|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
126582912|NCT04716634|455432243|FG000|Overall Study|Death|24|||
126582913|NCT04716634|455432244|FG001|Overall Study|Death|24|||
126582914|NCT04716634|455432245|FG002|Overall Study|Death|8|||
126582915|NCT04716634|455432243|FG000|Overall Study|Closed by Sponsor|4|||
126582916|NCT04716634|455432244|FG001|Overall Study|Closed by Sponsor|4|||
126582917|NCT04716634|455432245|FG002|Overall Study|Closed by Sponsor|5|||
126582918|NCT04716634|455432243|FG000|Overall Study|Lost to Follow-up|1|||
126582919|NCT04716634|455432244|FG001|Overall Study|Lost to Follow-up|0|||
126582920|NCT04716634|455432245|FG002|Overall Study|Lost to Follow-up|1|||
126582921|NCT04716634|455432243|FG000|Overall Study|Withdrawal by Subject|0|||
126582922|NCT04716634|455432244|FG001|Overall Study|Withdrawal by Subject|0|||
126582923|NCT04716634|455432245|FG002|Overall Study|Withdrawal by Subject|1|||
126582924|NCT05387447|455432249|FG000|Overall Study|Participants changed their minds about study participation.|3|||
126582925|NCT05387447|455432250|FG001|Overall Study|Participants changed their minds about study participation.|5|||
126582926|NCT03391466|455432253|FG000|Overall Study|Death|82|||
126582927|NCT03391466|455432254|FG001|Overall Study|Death|85|||
126582928|NCT03391466|455432253|FG000|Overall Study|Still on study|93|||
126582929|NCT03391466|455432254|FG001|Overall Study|Still on study|74|||
126582930|NCT03391466|455432253|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
126582931|NCT03391466|455432254|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
126532840|NCT00518115|455242466|FG007|Overall Study|Adverse Event|10|||
126532841|NCT00518115|455242467|FG008|Overall Study|Adverse Event|2|||
126532842|NCT00518115|455242468|FG009|Overall Study|Adverse Event|9|||
126532843|NCT00518115|455242459|FG000|Overall Study|Lost to Follow-up|0|||
126532844|NCT00518115|455242460|FG001|Overall Study|Lost to Follow-up|0|||
126532845|NCT00518115|455242461|FG002|Overall Study|Lost to Follow-up|2|||
126532846|NCT00518115|455242462|FG003|Overall Study|Lost to Follow-up|3|||
126532847|NCT00518115|455242463|FG004|Overall Study|Lost to Follow-up|1|||
126532848|NCT00518115|455242464|FG005|Overall Study|Lost to Follow-up|3|||
126532849|NCT00518115|455242465|FG006|Overall Study|Lost to Follow-up|0|||
126532850|NCT00518115|455242466|FG007|Overall Study|Lost to Follow-up|1|||
126532851|NCT00518115|455242467|FG008|Overall Study|Lost to Follow-up|1|||
126532852|NCT00518115|455242468|FG009|Overall Study|Lost to Follow-up|1|||
126532853|NCT00518115|455242459|FG000|Overall Study|Protocol Violation|1|||
126532854|NCT00518115|455242460|FG001|Overall Study|Protocol Violation|3|||
126532855|NCT00518115|455242461|FG002|Overall Study|Protocol Violation|1|||
126532856|NCT00518115|455242462|FG003|Overall Study|Protocol Violation|0|||
126582932|NCT03391466|455432253|FG000|Overall Study|Lost to Follow-up|5|||
126582933|NCT03391466|455432254|FG001|Overall Study|Lost to Follow-up|5|||
126582934|NCT03391466|455432253|FG000|Overall Study|Investigator decision|0|||
126582935|NCT03391466|455432254|FG001|Overall Study|Investigator decision|1|||
126582936|NCT03391466|455432253|FG000|Overall Study|Other|0|||
126532857|NCT00518115|455242463|FG004|Overall Study|Protocol Violation|0|||
126532858|NCT00518115|455242464|FG005|Overall Study|Protocol Violation|0|||
126532859|NCT00518115|455242465|FG006|Overall Study|Protocol Violation|0|||
126532860|NCT00518115|455242466|FG007|Overall Study|Protocol Violation|0|||
126532861|NCT00518115|455242467|FG008|Overall Study|Protocol Violation|0|||
126532862|NCT00518115|455242468|FG009|Overall Study|Protocol Violation|0|||
126532863|NCT00518115|455242459|FG000|Overall Study|Withdrawal by Subject|1|||
126532864|NCT00518115|455242460|FG001|Overall Study|Withdrawal by Subject|1|||
126532865|NCT00518115|455242461|FG002|Overall Study|Withdrawal by Subject|5|||
126532866|NCT00518115|455242462|FG003|Overall Study|Withdrawal by Subject|0|||
126532867|NCT00518115|455242463|FG004|Overall Study|Withdrawal by Subject|2|||
126532868|NCT00518115|455242464|FG005|Overall Study|Withdrawal by Subject|1|||
126532869|NCT00518115|455242465|FG006|Overall Study|Withdrawal by Subject|0|||
126532870|NCT00518115|455242466|FG007|Overall Study|Withdrawal by Subject|2|||
126532871|NCT00518115|455242467|FG008|Overall Study|Withdrawal by Subject|1|||
126532872|NCT00518115|455242468|FG009|Overall Study|Withdrawal by Subject|3|||
126532873|NCT00518115|455242459|FG000|Overall Study|Lack of Efficacy|1|||
126532874|NCT00518115|455242460|FG001|Overall Study|Lack of Efficacy|0|||
126532875|NCT00518115|455242461|FG002|Overall Study|Lack of Efficacy|1|||
126532876|NCT00518115|455242462|FG003|Overall Study|Lack of Efficacy|1|||
126532877|NCT00518115|455242463|FG004|Overall Study|Lack of Efficacy|0|||
126532878|NCT00518115|455242464|FG005|Overall Study|Lack of Efficacy|0|||
126582937|NCT03391466|455432254|FG001|Overall Study|Other|1|||
126582938|NCT03655132|455432255|FG000|Overall Study|Lost to Follow-up|2|||
126582939|NCT03655132|455432256|FG001|Overall Study|Lost to Follow-up|1|||
126582940|NCT03655132|455432255|FG000|Overall Study|Withdrawal by Subject|0|||
126582941|NCT03655132|455432256|FG001|Overall Study|Withdrawal by Subject|1|||
126582942|NCT03655132|455432255|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
126582943|NCT03655132|455432256|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
126582944|NCT05919082|455432260|FG000|Overall Study|Adverse Event|3|||
126582945|NCT05919082|455432261|FG001|Overall Study|Adverse Event|0|||
126582946|NCT05919082|455432260|FG000|Overall Study|Lost to Follow-up|0|||
126582947|NCT05919082|455432261|FG001|Overall Study|Lost to Follow-up|1|||
126582948|NCT05919082|455432260|FG000|Overall Study|Withdrawal by Subject|8|||
126582949|NCT05919082|455432261|FG001|Overall Study|Withdrawal by Subject|9|||
126582950|NCT05919082|455432260|FG000|Overall Study|Lack of Efficacy|0|||
126582951|NCT05919082|455432261|FG001|Overall Study|Lack of Efficacy|1|||
126582952|NCT05919082|455432260|FG000|Overall Study|Investigator Decision|1|||
126582953|NCT05919082|455432261|FG001|Overall Study|Investigator Decision|0|||
126582954|NCT01376700|455432263|FG000|Overall Study|Sponsor terminated study early|8|||
126582955|NCT01376700|455432263|FG000|Overall Study|Low or high titer inhibitor|8|||
126582956|NCT00601900|455432267|FG000|Overall Study|Withdrawal by Subject|0|||
126582957|NCT00601900|455432268|FG001|Overall Study|Withdrawal by Subject|3|||
126582958|NCT02500758|455432270|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
126582959|NCT02500758|455432271|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
126582960|NCT02500758|455432270|FG000|Washout (1 Week)|Lost to Follow-up|2|||
126582961|NCT02500758|455432271|FG001|Washout (1 Week)|Lost to Follow-up|2|||
126582962|NCT02500758|455432270|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
126582963|NCT02500758|455432271|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
126582964|NCT02500758|455432270|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
126582965|NCT02500758|455432271|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
126582966|NCT02500758|455432270|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
126582967|NCT02500758|455432271|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
126582968|NCT00274469|455432273|FG000|Overall Study|Death|63|||
126582969|NCT00274469|455432274|FG001|Overall Study|Death|74|||
126582970|NCT00274469|455432273|FG000|Overall Study|Did not consent to OS follow-up|16|||
126582971|NCT00274469|455432274|FG001|Overall Study|Did not consent to OS follow-up|19|||
126582972|NCT04999592|455432280|FG000|Overall Study|Withdrawal by Subject|1|||
126582973|NCT04999592|455432281|FG001|Overall Study|Withdrawal by Subject|0|||
126582974|NCT03527160|455432283|FG000|Overall Study|No urine collected|13|||
126582975|NCT03527160|455432283|FG000|Overall Study|No clinical serum creatinine collected|6|||
126582976|NCT03527160|455432283|FG000|Overall Study|Did not meet inclusion|2|||
126582977|NCT02910713|455432284|FG000|Overall Study|Protocol Violation|2|||
126582978|NCT02910713|455432284|FG000|Overall Study|Subject Choice|4|||
126582979|NCT02910713|455432284|FG000|Overall Study|Received One Application|10|||
126582980|NCT02910713|455432284|FG000|Overall Study|Received Neither Application|18|||
126582981|NCT02910713|455432284|FG000|Overall Study|Enrollment cap|7|||
126582982|NCT02910713|455432284|FG000|Overall Study|Investigator Discretion|1|||
126582983|NCT05179395|455432285|FG000|Overall Study|Lack of Efficacy|1|||
126582984|NCT03767517|455432289|FG000|Overall Study|Lost to Follow-up|16|||
126532879|NCT00518115|455242465|FG006|Overall Study|Lack of Efficacy|0|||
126532880|NCT00518115|455242466|FG007|Overall Study|Lack of Efficacy|1|||
126532881|NCT00518115|455242467|FG008|Overall Study|Lack of Efficacy|0|||
126532882|NCT00518115|455242468|FG009|Overall Study|Lack of Efficacy|0|||
126532883|NCT00518115|455242459|FG000|Overall Study|Non-Compliance|1|||
126532884|NCT00518115|455242460|FG001|Overall Study|Non-Compliance|0|||
126532885|NCT00518115|455242461|FG002|Overall Study|Non-Compliance|1|||
126532886|NCT00518115|455242462|FG003|Overall Study|Non-Compliance|0|||
126532887|NCT00518115|455242463|FG004|Overall Study|Non-Compliance|1|||
126532888|NCT00518115|455242464|FG005|Overall Study|Non-Compliance|1|||
126532889|NCT00518115|455242465|FG006|Overall Study|Non-Compliance|1|||
126532890|NCT00518115|455242466|FG007|Overall Study|Non-Compliance|1|||
126532891|NCT00518115|455242467|FG008|Overall Study|Non-Compliance|0|||
126532892|NCT00518115|455242468|FG009|Overall Study|Non-Compliance|1|||
126532893|NCT00518115|455242459|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
126532894|NCT00518115|455242460|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
126532895|NCT00518115|455242461|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
126532896|NCT00518115|455242462|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
126532897|NCT00518115|455242463|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
126532898|NCT00518115|455242464|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
126532899|NCT00518115|455242465|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
126532900|NCT00518115|455242466|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
126532901|NCT00518115|455242467|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
126532902|NCT00518115|455242468|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
126532903|NCT00518115|455242459|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
126532904|NCT00518115|455242460|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
126532905|NCT00518115|455242461|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
126532906|NCT00518115|455242462|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
126532907|NCT00518115|455242463|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
126532908|NCT00518115|455242464|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
126532909|NCT00518115|455242465|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
126532910|NCT00518115|455242466|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
126532911|NCT00518115|455242467|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
126532912|NCT00518115|455242468|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
126532913|NCT00518115|455242459|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
126532914|NCT00518115|455242460|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
126532915|NCT00518115|455242461|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
126532916|NCT00518115|455242462|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
126532917|NCT00518115|455242463|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
126532918|NCT00518115|455242464|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
126532919|NCT00518115|455242465|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
126532920|NCT00518115|455242466|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
126532921|NCT00518115|455242467|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
126532922|NCT00518115|455242468|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
126532923|NCT00518115|455242459|FG000|Overall Study|Wrong Monotherapy Administered|0|||
126730386|NCT00418379|455962959|FG001|Year 2|Adverse Event|2|||
126730387|NCT00418379|455962960|FG002|Year 2|Adverse Event|1|||
126730388|NCT00418379|455962958|FG000|Year 2|Withdrawal by Subject|1|||
126730389|NCT00418379|455962959|FG001|Year 2|Withdrawal by Subject|1|||
126730390|NCT00418379|455962960|FG002|Year 2|Withdrawal by Subject|3|||
126730391|NCT00418379|455962958|FG000|Year 2|Any other reason not above-mentioned|2|||
126730392|NCT00418379|455962959|FG001|Year 2|Any other reason not above-mentioned|1|||
126730393|NCT00418379|455962960|FG002|Year 2|Any other reason not above-mentioned|6|||
126730394|NCT00418379|455962958|FG000|Year 3|Withdrawal by Subject|1|||
126730395|NCT00418379|455962959|FG001|Year 3|Withdrawal by Subject|1|||
126730396|NCT00418379|455962960|FG002|Year 3|Withdrawal by Subject|2|||
126730397|NCT00418379|455962958|FG000|Year 3|Any other reason not above-mentioned|2|||
126730398|NCT00418379|455962959|FG001|Year 3|Any other reason not above-mentioned|1|||
126730399|NCT00418379|455962960|FG002|Year 3|Any other reason not above-mentioned|1|||
126532924|NCT00518115|455242460|FG001|Overall Study|Wrong Monotherapy Administered|0|||
126532925|NCT00518115|455242461|FG002|Overall Study|Wrong Monotherapy Administered|1|||
126532926|NCT00518115|455242462|FG003|Overall Study|Wrong Monotherapy Administered|0|||
126532927|NCT00518115|455242463|FG004|Overall Study|Wrong Monotherapy Administered|0|||
126532928|NCT00518115|455242464|FG005|Overall Study|Wrong Monotherapy Administered|0|||
126532929|NCT00518115|455242465|FG006|Overall Study|Wrong Monotherapy Administered|1|||
126532930|NCT00518115|455242466|FG007|Overall Study|Wrong Monotherapy Administered|0|||
126532931|NCT00518115|455242467|FG008|Overall Study|Wrong Monotherapy Administered|0|||
126532932|NCT00518115|455242468|FG009|Overall Study|Wrong Monotherapy Administered|0|||
126730400|NCT00418379|455962958|FG000|Year 4|Adverse Event|0|||
126532933|NCT00518115|455242459|FG000|Overall Study|Violation of Exclusion Criteria|0|||
126532934|NCT00518115|455242460|FG001|Overall Study|Violation of Exclusion Criteria|0|||
126532935|NCT00518115|455242461|FG002|Overall Study|Violation of Exclusion Criteria|0|||
126532936|NCT00518115|455242462|FG003|Overall Study|Violation of Exclusion Criteria|1|||
126532937|NCT00518115|455242463|FG004|Overall Study|Violation of Exclusion Criteria|0|||
126532938|NCT00518115|455242464|FG005|Overall Study|Violation of Exclusion Criteria|0|||
126532939|NCT00518115|455242465|FG006|Overall Study|Violation of Exclusion Criteria|1|||
126730401|NCT00418379|455962959|FG001|Year 4|Adverse Event|1|||
126730402|NCT00418379|455962960|FG002|Year 4|Adverse Event|0|||
126730403|NCT00418379|455962958|FG000|Year 4|Withdrawal by Subject|2|||
126730404|NCT00418379|455962959|FG001|Year 4|Withdrawal by Subject|3|||
126582985|NCT03767517|455432290|FG001|Overall Study|Lost to Follow-up|10|||
126582986|NCT03767517|455432289|FG000|Overall Study|Death|2|||
126582987|NCT03767517|455432290|FG001|Overall Study|Death|3|||
126582988|NCT04533022|455433349|FG000|Overall Study|Withdrawal by Subject|15|||
126582989|NCT04533022|455433349|FG000|Overall Study|Adverse Event|6|||
126582990|NCT04533022|455433349|FG000|Overall Study|Death|1|||
126582991|NCT04533022|455433349|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
126582992|NCT04533022|455433349|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
126582993|NCT02163447|455433350|FG000|Overall Study|Withdrawal by Subject|2|||
126582994|NCT02163447|455433351|FG001|Overall Study|Withdrawal by Subject|0|||
126582995|NCT02163447|455433352|FG002|Overall Study|Withdrawal by Subject|1|||
126582996|NCT02163447|455433350|FG000|Overall Study|Lost to Follow-up|1|||
126582997|NCT02163447|455433351|FG001|Overall Study|Lost to Follow-up|3|||
126582998|NCT02163447|455433352|FG002|Overall Study|Lost to Follow-up|0|||
126582999|NCT02163447|455433350|FG000|Overall Study|Moved out of study area|2|||
126583000|NCT02163447|455433351|FG001|Overall Study|Moved out of study area|3|||
126583001|NCT02163447|455433352|FG002|Overall Study|Moved out of study area|2|||
126583002|NCT02163447|455433350|FG000|Overall Study|Became HIV infected at time of delivery|1|||
126583003|NCT02163447|455433351|FG001|Overall Study|Became HIV infected at time of delivery|0|||
126583004|NCT02163447|455433352|FG002|Overall Study|Became HIV infected at time of delivery|0|||
126583005|NCT05113966|455433354|FG000|Overall Study|Death|21|||
126583006|NCT05113966|455433354|FG000|Overall Study|Study Terminated by Sponsor|9|||
126583007|NCT05386355|455433355|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
126583008|NCT05386355|455433356|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
126583009|NCT05386355|455433357|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
126583010|NCT05386355|455433358|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
126583011|NCT03747484|455433359|FG000|Overall Study|Lack of Efficacy|0|||
126583012|NCT03747484|455433360|FG001|Overall Study|Lack of Efficacy|1|||
126583013|NCT03747484|455433361|FG002|Overall Study|Lack of Efficacy|1|||
126532940|NCT00518115|455242466|FG007|Overall Study|Violation of Exclusion Criteria|0|||
126532941|NCT00518115|455242467|FG008|Overall Study|Violation of Exclusion Criteria|0|||
126532942|NCT00518115|455242468|FG009|Overall Study|Violation of Exclusion Criteria|0|||
126532943|NCT00518115|455242459|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
126532944|NCT00518115|455242460|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
126532945|NCT00518115|455242461|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
126532946|NCT00518115|455242462|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
126532947|NCT00518115|455242463|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
126532948|NCT00518115|455242464|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
126532949|NCT00518115|455242465|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
126532950|NCT00518115|455242466|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
126532951|NCT00518115|455242467|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
126532952|NCT00518115|455242468|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
126532953|NCT00518115|455242459|FG000|Overall Study|Withdrew Consent|0|||
126532954|NCT00518115|455242460|FG001|Overall Study|Withdrew Consent|0|||
126532955|NCT00518115|455242461|FG002|Overall Study|Withdrew Consent|0|||
126532956|NCT00518115|455242462|FG003|Overall Study|Withdrew Consent|0|||
126532957|NCT00518115|455242463|FG004|Overall Study|Withdrew Consent|0|||
126532958|NCT00518115|455242464|FG005|Overall Study|Withdrew Consent|1|||
126532959|NCT00518115|455242465|FG006|Overall Study|Withdrew Consent|0|||
126532960|NCT00518115|455242466|FG007|Overall Study|Withdrew Consent|0|||
126532961|NCT00518115|455242467|FG008|Overall Study|Withdrew Consent|0|||
126532962|NCT00518115|455242468|FG009|Overall Study|Withdrew Consent|0|||
126532963|NCT00518115|455242459|FG000|Overall Study|Moved Out of State|0|||
126532964|NCT00518115|455242460|FG001|Overall Study|Moved Out of State|0|||
126532965|NCT00518115|455242461|FG002|Overall Study|Moved Out of State|0|||
126532966|NCT00518115|455242462|FG003|Overall Study|Moved Out of State|0|||
126532967|NCT00518115|455242463|FG004|Overall Study|Moved Out of State|0|||
126532968|NCT00518115|455242464|FG005|Overall Study|Moved Out of State|0|||
126532969|NCT00518115|455242465|FG006|Overall Study|Moved Out of State|0|||
126532970|NCT00518115|455242466|FG007|Overall Study|Moved Out of State|0|||
126532971|NCT00518115|455242467|FG008|Overall Study|Moved Out of State|0|||
126532972|NCT00518115|455242468|FG009|Overall Study|Moved Out of State|1|||
126532973|NCT04891419|455242469|FG000|Overall Study|Withdrawal by Subject|4|||
126532974|NCT04891419|455242470|FG001|Overall Study|Withdrawal by Subject|0|||
126532975|NCT04891419|455242469|FG000|Overall Study|Lost to Follow-up|1|||
126532976|NCT04891419|455242470|FG001|Overall Study|Lost to Follow-up|3|||
126532977|NCT00827918|455242471|FG000|Overall Study|Adverse Event|4|||
126532978|NCT00827918|455242472|FG001|Overall Study|Adverse Event|0|||
126583014|NCT03747484|455433362|FG003|Overall Study|Lack of Efficacy|2|||
126583015|NCT03747484|455433363|FG004|Overall Study|Lack of Efficacy|2|||
126583016|NCT04521478|455433364|FG000|Overall Study|Protocol Violation|2|||
126532979|NCT00827918|455242473|FG002|Overall Study|Adverse Event|0|||
126532980|NCT00827918|455242471|FG000|Overall Study|Lack of Efficacy|16|||
126583017|NCT04521478|455433365|FG001|Overall Study|Protocol Violation|0|||
126583018|NCT04521478|455433366|FG002|Overall Study|Protocol Violation|1|||
126583019|NCT04521478|455433367|FG003|Overall Study|Protocol Violation|0|||
126583020|NCT04521478|455433368|FG004|Overall Study|Protocol Violation|0|||
126583021|NCT04521478|455433369|FG005|Overall Study|Protocol Violation|0|||
126583022|NCT04521478|455433364|FG000|Overall Study|Technical Problems|0|||
126583023|NCT04521478|455433365|FG001|Overall Study|Technical Problems|0|||
126583024|NCT04521478|455433366|FG002|Overall Study|Technical Problems|0|||
126583025|NCT04521478|455433367|FG003|Overall Study|Technical Problems|1|||
126583026|NCT04521478|455433368|FG004|Overall Study|Technical Problems|0|||
126583027|NCT04521478|455433369|FG005|Overall Study|Technical Problems|0|||
126583028|NCT04521478|455433364|FG000|Overall Study|Burden of Study Procedures|1|||
126583029|NCT04521478|455433365|FG001|Overall Study|Burden of Study Procedures|0|||
126583030|NCT04521478|455433366|FG002|Overall Study|Burden of Study Procedures|0|||
126583031|NCT04521478|455433367|FG003|Overall Study|Burden of Study Procedures|1|||
126583032|NCT04521478|455433368|FG004|Overall Study|Burden of Study Procedures|0|||
126583033|NCT04521478|455433369|FG005|Overall Study|Burden of Study Procedures|1|||
126583034|NCT04521478|455433364|FG000|Overall Study|Lack of Efficacy|0|||
126583035|NCT04521478|455433365|FG001|Overall Study|Lack of Efficacy|0|||
126583036|NCT04521478|455433366|FG002|Overall Study|Lack of Efficacy|0|||
126583037|NCT04521478|455433367|FG003|Overall Study|Lack of Efficacy|0|||
126583038|NCT04521478|455433368|FG004|Overall Study|Lack of Efficacy|1|||
126583039|NCT04521478|455433369|FG005|Overall Study|Lack of Efficacy|1|||
126583040|NCT04521478|455433364|FG000|Overall Study|Adverse Event|7|||
126583041|NCT04521478|455433365|FG001|Overall Study|Adverse Event|0|||
126583042|NCT04521478|455433366|FG002|Overall Study|Adverse Event|2|||
126583043|NCT04521478|455433367|FG003|Overall Study|Adverse Event|1|||
126583044|NCT04521478|455433368|FG004|Overall Study|Adverse Event|2|||
126583045|NCT04521478|455433369|FG005|Overall Study|Adverse Event|7|||
126583046|NCT04521478|455433364|FG000|Overall Study|No Reason Available|0|||
126583047|NCT04521478|455433365|FG001|Overall Study|No Reason Available|2|||
126583048|NCT04521478|455433366|FG002|Overall Study|No Reason Available|0|||
126583049|NCT04521478|455433367|FG003|Overall Study|No Reason Available|0|||
126583050|NCT04521478|455433368|FG004|Overall Study|No Reason Available|1|||
126583051|NCT04521478|455433369|FG005|Overall Study|No Reason Available|0|||
126583052|NCT04521478|455433364|FG000|Overall Study|Other than listed|3|||
126583053|NCT04521478|455433365|FG001|Overall Study|Other than listed|3|||
126583054|NCT04521478|455433366|FG002|Overall Study|Other than listed|3|||
126583055|NCT04521478|455433367|FG003|Overall Study|Other than listed|2|||
126583056|NCT04521478|455433368|FG004|Overall Study|Other than listed|3|||
126583057|NCT04521478|455433369|FG005|Overall Study|Other than listed|3|||
126583058|NCT04521478|455433364|FG000|Overall Study|Not treated|0|||
126583059|NCT04521478|455433365|FG001|Overall Study|Not treated|0|||
126583060|NCT04521478|455433366|FG002|Overall Study|Not treated|0|||
126583061|NCT04521478|455433367|FG003|Overall Study|Not treated|0|||
126583062|NCT04521478|455433368|FG004|Overall Study|Not treated|0|||
126583063|NCT04521478|455433369|FG005|Overall Study|Not treated|1|||
126583064|NCT03833245|455433373|FG000|Overall Study|Death|0|||
126583065|NCT03833245|455433374|FG001|Overall Study|Death|1|||
126583066|NCT03775109|455433375|FG000|Overall Study|Adverse Event|1|||
126583067|NCT03775109|455433376|FG001|Overall Study|Adverse Event|0|||
126583068|NCT03775109|455433375|FG000|Overall Study|COVID-19 outbreak|2|||
126583069|NCT03775109|455433376|FG001|Overall Study|COVID-19 outbreak|0|||
126583070|NCT03775109|455433375|FG000|Overall Study|Lost to Follow-up|0|||
126583071|NCT03775109|455433376|FG001|Overall Study|Lost to Follow-up|2|||
126583072|NCT03775109|455433375|FG000|Overall Study|Withdrawal by Subject|1|||
126583073|NCT03775109|455433376|FG001|Overall Study|Withdrawal by Subject|1|||
126583074|NCT03775109|455433375|FG000|Overall Study|Death|0|||
126583075|NCT03775109|455433376|FG001|Overall Study|Death|1|||
126583076|NCT03775109|455433375|FG000|Overall Study|Lack of Efficacy|1|||
126583077|NCT03775109|455433376|FG001|Overall Study|Lack of Efficacy|0|||
126583078|NCT03347383|455433377|FG000|Overall Study|Death|39|||
126583079|NCT03347383|455433377|FG000|Overall Study|Withdrawal by Subject|3|||
126583080|NCT03347383|455433377|FG000|Overall Study|Lost to Follow-up|9|||
126583081|NCT05691452|455433379|FG000|Overall Study|Withdrawal by Subject|1|||
126583082|NCT05691452|455433380|FG001|Overall Study|Withdrawal by Subject|1|||
126730405|NCT00418379|455962960|FG002|Year 4|Withdrawal by Subject|2|||
126730406|NCT00418379|455962958|FG000|Year 4|Any other reason not above-mentioned|1|||
126583083|NCT05691452|455433381|FG002|Overall Study|Withdrawal by Subject|0|||
126583084|NCT05691452|455433379|FG000|Overall Study|Physician Decision|1|||
126583085|NCT05691452|455433380|FG001|Overall Study|Physician Decision|0|||
126583086|NCT05691452|455433381|FG002|Overall Study|Physician Decision|0|||
126583087|NCT05691452|455433379|FG000|Overall Study|Lost to Follow-up|0|||
126583088|NCT05691452|455433380|FG001|Overall Study|Lost to Follow-up|0|||
126730407|NCT00418379|455962959|FG001|Year 4|Any other reason not above-mentioned|1|||
126583089|NCT05691452|455433381|FG002|Overall Study|Lost to Follow-up|1|||
126583090|NCT05691452|455433379|FG000|Overall Study|Adverse Event|0|||
126583091|NCT05691452|455433380|FG001|Overall Study|Adverse Event|0|||
126583092|NCT05691452|455433381|FG002|Overall Study|Adverse Event|1|||
126583093|NCT00739648|455433384|FG000|Overall Study|Adverse Event|3|||
126583094|NCT00739648|455433385|FG001|Overall Study|Adverse Event|15|||
126532981|NCT00827918|455242472|FG001|Overall Study|Lack of Efficacy|4|||
126532982|NCT00827918|455242473|FG002|Overall Study|Lack of Efficacy|15|||
126532983|NCT00827918|455242471|FG000|Overall Study|Physician Decision|1|||
126532984|NCT00827918|455242472|FG001|Overall Study|Physician Decision|0|||
126532985|NCT00827918|455242473|FG002|Overall Study|Physician Decision|0|||
126532986|NCT00827918|455242471|FG000|Overall Study|Pregnancy|0|||
126532987|NCT00827918|455242472|FG001|Overall Study|Pregnancy|1|||
126532988|NCT00827918|455242473|FG002|Overall Study|Pregnancy|0|||
126532989|NCT00827918|455242471|FG000|Overall Study|Progressive Disease|1|||
126532990|NCT00827918|455242472|FG001|Overall Study|Progressive Disease|1|||
126532991|NCT00827918|455242473|FG002|Overall Study|Progressive Disease|0|||
126583095|NCT00739648|455433384|FG000|Overall Study|Withdrawal by Subject|13|||
126583096|NCT00739648|455433385|FG001|Overall Study|Withdrawal by Subject|25|||
126583097|NCT00739648|455433384|FG000|Overall Study|Lost to Follow-up|4|||
126583098|NCT00739648|455433385|FG001|Overall Study|Lost to Follow-up|7|||
126583099|NCT00739648|455433384|FG000|Overall Study|Death|2|||
126583100|NCT00739648|455433385|FG001|Overall Study|Death|0|||
126583101|NCT00739648|455433384|FG000|Overall Study|Do not know|4|||
126583102|NCT00739648|455433385|FG001|Overall Study|Do not know|6|||
126583103|NCT04173663|455433386|FG000|Overall Study|Withdrawal by Subject|1|||
126583104|NCT04173663|455433387|FG001|Overall Study|Withdrawal by Subject|6|||
126583105|NCT04173663|455433386|FG000|Overall Study|Lost to Follow-up|17|||
126583106|NCT04173663|455433387|FG001|Overall Study|Lost to Follow-up|24|||
126583107|NCT01757665|455433388|FG000|Overall Study|Still on Study - Visit Completed|240|||
126583108|NCT01757665|455433389|FG001|Overall Study|Still on Study - Visit Completed|30|||
126583109|NCT01757665|455433388|FG000|Overall Study|Still on Study - Visit Pending|398|||
126583110|NCT01757665|455433389|FG001|Overall Study|Still on Study - Visit Pending|40|||
126583111|NCT01757665|455433388|FG000|Overall Study|Still on Study - Missed Visit|14|||
126583112|NCT01757665|455433389|FG001|Overall Study|Still on Study - Missed Visit|1|||
126583113|NCT01757665|455433388|FG000|Overall Study|Death|25|||
126583114|NCT01757665|455433389|FG001|Overall Study|Death|8|||
126583115|NCT01757665|455433388|FG000|Overall Study|Explant|1|||
126583116|NCT01757665|455433389|FG001|Overall Study|Explant|2|||
126583117|NCT01757665|455433388|FG000|Overall Study|Withdrawal by Subject|10|||
126583118|NCT01757665|455433389|FG001|Overall Study|Withdrawal by Subject|0|||
126583119|NCT01757665|455433388|FG000|Overall Study|Lost to Follow-up|1|||
126583120|NCT01757665|455433389|FG001|Overall Study|Lost to Follow-up|1|||
126583121|NCT01757665|455433388|FG000|Overall Study|Not Implanted with Device|5|||
126583122|NCT01757665|455433389|FG001|Overall Study|Not Implanted with Device|1|||
126583123|NCT02630823|455433397|FG000|Overall Study|Withdrawal by Subject|1|||
126583124|NCT02630823|455433397|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
126583125|NCT06311084|455433410|FG000|Overall Study|Lost to Follow-up|14|||
126583126|NCT03526861|455433419|FG000|Initial Treatment Period|Not dosed|1|||
126583127|NCT03526861|455433420|FG001|Initial Treatment Period|Not dosed|1|||
126583128|NCT03526861|455433421|FG002|Initial Treatment Period|Not dosed|1|||
126583129|NCT03526861|455433422|FG003|Initial Treatment Period|Not dosed|0|||
126583130|NCT03526861|455433423|FG004|Initial Treatment Period|Not dosed|0|||
126583131|NCT03526861|455433424|FG005|Initial Treatment Period|Not dosed|0|||
126583132|NCT03526861|455433425|FG006|Initial Treatment Period|Not dosed|0|||
126583133|NCT03526861|455433426|FG007|Initial Treatment Period|Not dosed|0|||
126583134|NCT03526861|455433427|FG008|Initial Treatment Period|Not dosed|0|||
126583135|NCT03526861|455433419|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
126583136|NCT03526861|455433420|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
126583137|NCT03526861|455433421|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
126583138|NCT03526861|455433422|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583139|NCT03526861|455433423|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583140|NCT03526861|455433424|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583141|NCT03526861|455433425|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583142|NCT03526861|455433426|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583143|NCT03526861|455433427|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126730408|NCT00418379|455962960|FG002|Year 4|Any other reason not above-mentioned|0|||
126532992|NCT00827918|455242471|FG000|Overall Study|Protocol Violation|0|||
126583144|NCT03526861|455433419|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
126583145|NCT03526861|455433420|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
126583146|NCT03526861|455433421|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
126583147|NCT03526861|455433422|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
126730409|NCT00418379|455962958|FG000|Year 5|Adverse Event|0|||
126532993|NCT00827918|455242472|FG001|Overall Study|Protocol Violation|1|||
126532994|NCT00827918|455242473|FG002|Overall Study|Protocol Violation|0|||
126532995|NCT00827918|455242471|FG000|Overall Study|Withdrawal by Subject|6|||
126583148|NCT03526861|455433423|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
126583149|NCT03526861|455433424|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
126583150|NCT03526861|455433425|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
126583151|NCT03526861|455433426|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
126583152|NCT03526861|455433427|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
126583153|NCT03526861|455433419|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583154|NCT03526861|455433420|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583155|NCT03526861|455433421|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583156|NCT03526861|455433422|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
126583157|NCT03526861|455433423|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
126583158|NCT03526861|455433424|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583159|NCT03526861|455433425|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
126583160|NCT03526861|455433426|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583161|NCT03526861|455433427|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583162|NCT03526861|455433419|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
126583163|NCT03526861|455433420|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
126583164|NCT03526861|455433421|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
126583165|NCT03526861|455433422|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
126583166|NCT03526861|455433423|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
126583167|NCT03526861|455433424|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
126583168|NCT03526861|455433425|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
126583169|NCT03526861|455433426|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
126583170|NCT03526861|455433427|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
126583171|NCT03526861|455433419|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583172|NCT03526861|455433420|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583173|NCT03526861|455433421|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583174|NCT03526861|455433422|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
126583175|NCT03526861|455433423|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583176|NCT03526861|455433424|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583177|NCT03526861|455433425|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583178|NCT03526861|455433426|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583179|NCT03526861|455433427|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583180|NCT03526861|455433419|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583181|NCT03526861|455433420|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583182|NCT03526861|455433421|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583183|NCT03526861|455433422|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583184|NCT03526861|455433423|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583185|NCT03526861|455433424|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583186|NCT03526861|455433425|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583187|NCT03526861|455433426|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
126583188|NCT03526861|455433427|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
126583189|NCT03526861|455433419|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126583190|NCT03526861|455433420|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126583191|NCT03526861|455433421|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126583192|NCT03526861|455433422|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126583193|NCT03526861|455433423|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126583194|NCT03526861|455433424|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126583195|NCT03526861|455433425|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126583196|NCT03526861|455433426|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
126583197|NCT03526861|455433427|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
126730410|NCT00418379|455962959|FG001|Year 5|Adverse Event|1|||
126583198|NCT03526861|455433419|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126730411|NCT00418379|455962960|FG002|Year 5|Adverse Event|0|||
126730412|NCT00418379|455962958|FG000|Year 5|Any other reason not above-mentioned|2|||
126730413|NCT00418379|455962959|FG001|Year 5|Any other reason not above-mentioned|4|||
126730414|NCT00418379|455962960|FG002|Year 5|Any other reason not above-mentioned|3|||
126730415|NCT01594333|455962962|FG000|Overall Study|Death|96|||
126532996|NCT00827918|455242472|FG001|Overall Study|Withdrawal by Subject|2|||
126532997|NCT00827918|455242473|FG002|Overall Study|Withdrawal by Subject|6|||
126532998|NCT00127101|455242474|FG000|Base Protocol|Adverse Event|0|||
126532999|NCT00127101|455242475|FG001|Base Protocol|Adverse Event|2|||
126533000|NCT00127101|455242476|FG002|Base Protocol|Adverse Event|1|||
126533001|NCT00127101|455242477|FG003|Base Protocol|Adverse Event|0|||
126533002|NCT00127101|455242478|FG004|Base Protocol|Adverse Event|0|||
126533003|NCT00127101|455242479|FG005|Base Protocol|Adverse Event|0|||
126533004|NCT00127101|455242474|FG000|Base Protocol|Lack of Efficacy|1|||
126533005|NCT00127101|455242475|FG001|Base Protocol|Lack of Efficacy|0|||
126533006|NCT00127101|455242476|FG002|Base Protocol|Lack of Efficacy|0|||
126533007|NCT00127101|455242477|FG003|Base Protocol|Lack of Efficacy|0|||
126533008|NCT00127101|455242478|FG004|Base Protocol|Lack of Efficacy|2|||
126533009|NCT00127101|455242479|FG005|Base Protocol|Lack of Efficacy|0|||
126533010|NCT00127101|455242474|FG000|Base Protocol|Withdrawal by Subject|1|||
126533011|NCT00127101|455242475|FG001|Base Protocol|Withdrawal by Subject|2|||
126533012|NCT00127101|455242476|FG002|Base Protocol|Withdrawal by Subject|1|||
126533013|NCT00127101|455242477|FG003|Base Protocol|Withdrawal by Subject|0|||
126533014|NCT00127101|455242478|FG004|Base Protocol|Withdrawal by Subject|0|||
126533015|NCT00127101|455242479|FG005|Base Protocol|Withdrawal by Subject|1|||
126533016|NCT00127101|455242474|FG000|Continuation Phase|Adverse Event|0|||
126533017|NCT00127101|455242475|FG001|Continuation Phase|Adverse Event|0|||
126533018|NCT00127101|455242476|FG002|Continuation Phase|Adverse Event|0|||
126533019|NCT00127101|455242477|FG003|Continuation Phase|Adverse Event|0|||
126533020|NCT00127101|455242478|FG004|Continuation Phase|Adverse Event|1|||
126533021|NCT00127101|455242479|FG005|Continuation Phase|Adverse Event|1|||
126533022|NCT00127101|455242474|FG000|Continuation Phase|Lack of Efficacy|0|||
126533023|NCT00127101|455242475|FG001|Continuation Phase|Lack of Efficacy|0|||
126533024|NCT00127101|455242476|FG002|Continuation Phase|Lack of Efficacy|0|||
126533025|NCT00127101|455242477|FG003|Continuation Phase|Lack of Efficacy|0|||
126533026|NCT00127101|455242478|FG004|Continuation Phase|Lack of Efficacy|0|||
126533027|NCT00127101|455242479|FG005|Continuation Phase|Lack of Efficacy|1|||
126533028|NCT00127101|455242474|FG000|Continuation Phase|Withdrawal by Subject|0|||
126533029|NCT00127101|455242475|FG001|Continuation Phase|Withdrawal by Subject|0|||
126533030|NCT00127101|455242476|FG002|Continuation Phase|Withdrawal by Subject|1|||
126533031|NCT00127101|455242477|FG003|Continuation Phase|Withdrawal by Subject|0|||
126533032|NCT00127101|455242478|FG004|Continuation Phase|Withdrawal by Subject|2|||
126533033|NCT00127101|455242479|FG005|Continuation Phase|Withdrawal by Subject|1|||
126533034|NCT00843167|455242480|FG000|Treatment Period|Adverse Event|1|||
126533035|NCT00843167|455242481|FG001|Treatment Period|Adverse Event|5|||
126533036|NCT00843167|455242480|FG000|Treatment Period|Withdrawal by Subject|2|||
126533037|NCT00843167|455242481|FG001|Treatment Period|Withdrawal by Subject|3|||
126533038|NCT02291614|455242484|FG000|Overall Study|Lost to Follow-up|0|||
126533039|NCT02291614|455242485|FG001|Overall Study|Lost to Follow-up|0|||
126533040|NCT02291614|455242486|FG002|Overall Study|Lost to Follow-up|0|||
126533041|NCT02291614|455242487|FG003|Overall Study|Lost to Follow-up|0|||
126533042|NCT02291614|455242488|FG004|Overall Study|Lost to Follow-up|0|||
126533043|NCT02291614|455242489|FG005|Overall Study|Lost to Follow-up|0|||
126533044|NCT02291614|455242490|FG006|Overall Study|Lost to Follow-up|0|||
126533045|NCT02291614|455242491|FG007|Overall Study|Lost to Follow-up|1|||
126533046|NCT02291614|455242492|FG008|Overall Study|Lost to Follow-up|0|||
126533047|NCT02291614|455242493|FG009|Overall Study|Lost to Follow-up|0|||
126533048|NCT02291614|455242494|FG010|Overall Study|Lost to Follow-up|0|||
126533049|NCT02291614|455242484|FG000|Overall Study|Withdrawal by Subject|0|||
126533050|NCT02291614|455242485|FG001|Overall Study|Withdrawal by Subject|1|||
126533051|NCT02291614|455242486|FG002|Overall Study|Withdrawal by Subject|0|||
126533052|NCT02291614|455242487|FG003|Overall Study|Withdrawal by Subject|0|||
126533053|NCT02291614|455242488|FG004|Overall Study|Withdrawal by Subject|0|||
126533054|NCT02291614|455242489|FG005|Overall Study|Withdrawal by Subject|0|||
126533055|NCT02291614|455242490|FG006|Overall Study|Withdrawal by Subject|0|||
126533056|NCT02291614|455242491|FG007|Overall Study|Withdrawal by Subject|0|||
126533057|NCT02291614|455242492|FG008|Overall Study|Withdrawal by Subject|0|||
126533058|NCT02291614|455242493|FG009|Overall Study|Withdrawal by Subject|2|||
126533059|NCT02291614|455242494|FG010|Overall Study|Withdrawal by Subject|2|||
126533060|NCT02291614|455242484|FG000|Overall Study|Decision by sponsor|0|||
126533061|NCT02291614|455242485|FG001|Overall Study|Decision by sponsor|0|||
126533062|NCT02291614|455242486|FG002|Overall Study|Decision by sponsor|0|||
126533063|NCT02291614|455242487|FG003|Overall Study|Decision by sponsor|1|||
126533064|NCT02291614|455242488|FG004|Overall Study|Decision by sponsor|0|||
126533065|NCT02291614|455242489|FG005|Overall Study|Decision by sponsor|0|||
126533066|NCT02291614|455242490|FG006|Overall Study|Decision by sponsor|0|||
126730416|NCT01594333|455962963|FG001|Overall Study|Death|83|||
126730417|NCT01594333|455962962|FG000|Overall Study|Lost to Follow-up|5|||
126730418|NCT01594333|455962963|FG001|Overall Study|Lost to Follow-up|5|||
126730419|NCT01594333|455962962|FG000|Overall Study|Withdrawal by Subject|60|||
126730420|NCT01594333|455962963|FG001|Overall Study|Withdrawal by Subject|63|||
126730421|NCT00565058|455962964|FG000|Overall Study|Adverse Event|1|||
126533067|NCT02291614|455242491|FG007|Overall Study|Decision by sponsor|0|||
126533068|NCT02291614|455242492|FG008|Overall Study|Decision by sponsor|0|||
126533069|NCT02291614|455242493|FG009|Overall Study|Decision by sponsor|0|||
126533070|NCT02291614|455242494|FG010|Overall Study|Decision by sponsor|0|||
126533071|NCT02291614|455242484|FG000|Overall Study|Death|0|||
126533072|NCT02291614|455242485|FG001|Overall Study|Death|0|||
126533073|NCT02291614|455242486|FG002|Overall Study|Death|1|||
126533074|NCT02291614|455242487|FG003|Overall Study|Death|0|||
126533075|NCT02291614|455242488|FG004|Overall Study|Death|1|||
126533076|NCT02291614|455242489|FG005|Overall Study|Death|1|||
126533077|NCT02291614|455242490|FG006|Overall Study|Death|1|||
126533078|NCT02291614|455242491|FG007|Overall Study|Death|0|||
126533079|NCT02291614|455242492|FG008|Overall Study|Death|0|||
126533080|NCT02291614|455242493|FG009|Overall Study|Death|0|||
126533081|NCT02291614|455242494|FG010|Overall Study|Death|0|||
126533082|NCT02137369|455242495|FG000|Overall Study|Withdrawal by Subject|3|||
126533083|NCT02137369|455242496|FG001|Overall Study|Withdrawal by Subject|2|||
126533084|NCT02137369|455242495|FG000|Overall Study|Adverse Event|2|||
126533085|NCT02137369|455242496|FG001|Overall Study|Adverse Event|0|||
126533086|NCT02137369|455242495|FG000|Overall Study|Lost to Follow-up|1|||
126533087|NCT02137369|455242496|FG001|Overall Study|Lost to Follow-up|0|||
126533088|NCT02137369|455242495|FG000|Overall Study|Moved away|2|||
126533089|NCT02137369|455242496|FG001|Overall Study|Moved away|0|||
126533090|NCT01389973|455242502|FG000|Overall Study|Lost to Follow-up|1|||
126533091|NCT01389973|455242502|FG000|Overall Study|Trial Stopped by Sponsor|9|||
126533092|NCT01389973|455242502|FG000|Overall Study|Other|10|||
126533093|NCT02626780|455242503|FG000|Overall Study|Withdrawal by Subject|3|||
126533094|NCT03456700|455242504|FG000|Overall Study|Withdrawal by Subject|1|||
126533095|NCT04154787|455242505|FG000|Overall Study|Adverse Event|0|||
126533096|NCT04154787|455242506|FG001|Overall Study|Adverse Event|1|||
126533097|NCT04154787|455242507|FG002|Overall Study|Adverse Event|0|||
126533098|NCT04154787|455242505|FG000|Overall Study|Patient Requires Other Treatment|0|||
126533099|NCT04154787|455242506|FG001|Overall Study|Patient Requires Other Treatment|1|||
126533100|NCT04154787|455242507|FG002|Overall Study|Patient Requires Other Treatment|0|||
126533101|NCT04154787|455242505|FG000|Overall Study|Study Terminated By Sponsor|0|||
126533102|NCT04154787|455242506|FG001|Overall Study|Study Terminated By Sponsor|6|||
126533103|NCT04154787|455242507|FG002|Overall Study|Study Terminated By Sponsor|1|||
126533104|NCT04154787|455242505|FG000|Overall Study|Subject Decision|0|||
126533105|NCT04154787|455242506|FG001|Overall Study|Subject Decision|1|||
126533106|NCT04154787|455242507|FG002|Overall Study|Subject Decision|0|||
126533107|NCT04154787|455242505|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
126533108|NCT04154787|455242506|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
126533109|NCT04154787|455242507|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
126533110|NCT02586025|455244391|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
126533111|NCT02586025|455244392|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
126533112|NCT02586025|455244391|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
126533113|NCT02586025|455244392|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
126533114|NCT02586025|455244391|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
126533115|NCT02586025|455244392|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
126533116|NCT02586025|455244391|FG000|Neoadjuvant Treatment|Death|1|||
126533117|NCT02586025|455244392|FG001|Neoadjuvant Treatment|Death|0|||
126533118|NCT02586025|455244391|FG000|Neoadjuvant Treatment|Adverse Event|1|||
126533119|NCT02586025|455244392|FG001|Neoadjuvant Treatment|Adverse Event|0|||
126533120|NCT02586025|455244391|FG000|Neoadjuvant Treatment|Physician Decision|2|||
126533121|NCT02586025|455244392|FG001|Neoadjuvant Treatment|Physician Decision|1|||
126730422|NCT00565058|455962965|FG001|Overall Study|Adverse Event|0|||
126777323|NCT00528879|456141329|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
126533122|NCT02586025|455244391|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
126533123|NCT02586025|455244392|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
126533124|NCT02586025|455244391|FG000|Adjuvant Treatment|Recurrent Disease|4|||
126533125|NCT02586025|455244392|FG001|Adjuvant Treatment|Recurrent Disease|5|||
126533126|NCT02586025|455244391|FG000|Adjuvant Treatment|Physician Decision|0|||
126777324|NCT00528879|456141330|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
126533127|NCT02586025|455244392|FG001|Adjuvant Treatment|Physician Decision|1|||
126533128|NCT02586025|455244391|FG000|Adjuvant Treatment|Pregnancy|1|||
126533129|NCT02586025|455244392|FG001|Adjuvant Treatment|Pregnancy|0|||
126533130|NCT02586025|455244391|FG000|Treatment-Free Follow-Up|Death|11|||
126533131|NCT02586025|455244392|FG001|Treatment-Free Follow-Up|Death|11|||
126730423|NCT00830804|455962968|FG000|Overall Study|Lost to Follow-up|4|||
126533132|NCT02586025|455244391|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
126533133|NCT02586025|455244392|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
126533134|NCT02586025|455244391|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
126533135|NCT02586025|455244392|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
126533136|NCT02586025|455244391|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
126533137|NCT02586025|455244392|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
126533138|NCT02586025|455244391|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
126533139|NCT02586025|455244392|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
126533140|NCT00175825|455244393|FG000|Overall Study|Adverse Event|3|||
126533141|NCT00175825|455244394|FG001|Overall Study|Adverse Event|2|||
126533142|NCT00175825|455244395|FG002|Overall Study|Adverse Event|1|||
126533143|NCT00175825|455244396|FG003|Overall Study|Adverse Event|1|||
126533144|NCT00175825|455244393|FG000|Overall Study|Lost to Follow-up|1|||
126533145|NCT00175825|455244394|FG001|Overall Study|Lost to Follow-up|2|||
126533146|NCT00175825|455244395|FG002|Overall Study|Lost to Follow-up|0|||
126533147|NCT00175825|455244396|FG003|Overall Study|Lost to Follow-up|0|||
126533148|NCT00175825|455244393|FG000|Overall Study|Withdrawal by Subject|1|||
126533149|NCT00175825|455244394|FG001|Overall Study|Withdrawal by Subject|0|||
126533150|NCT00175825|455244395|FG002|Overall Study|Withdrawal by Subject|0|||
126533151|NCT00175825|455244396|FG003|Overall Study|Withdrawal by Subject|0|||
126533152|NCT00608582|455244397|FG000|Overall Study|Lost to Follow-up|2|||
126533153|NCT00608582|455244398|FG001|Overall Study|Lost to Follow-up|0|||
126533154|NCT00608582|455244397|FG000|Overall Study|No Best Response in Phase 1 located|1|||
126533155|NCT00608582|455244398|FG001|Overall Study|No Best Response in Phase 1 located|1|||
126533156|NCT00608582|455244397|FG000|Overall Study|Illicit Drug Use|1|||
126533157|NCT00608582|455244398|FG001|Overall Study|Illicit Drug Use|0|||
126533158|NCT00608582|455244397|FG000|Overall Study|Early stage Design Change|0|||
126533159|NCT00608582|455244398|FG001|Overall Study|Early stage Design Change|3|||
126533160|NCT02450331|455244403|FG000|Overall Study|Death|162|||
126533161|NCT02450331|455244404|FG001|Overall Study|Death|171|||
126533162|NCT02450331|455244403|FG000|Overall Study|Lost to Follow-up|14|||
126533163|NCT02450331|455244404|FG001|Overall Study|Lost to Follow-up|12|||
126533164|NCT02450331|455244403|FG000|Overall Study|Withdrawal by Subject|55|||
126533165|NCT02450331|455244404|FG001|Overall Study|Withdrawal by Subject|44|||
126533166|NCT02450331|455244403|FG000|Overall Study|Non-specified other|1|||
126533167|NCT02450331|455244404|FG001|Overall Study|Non-specified other|1|||
126533168|NCT03232983|455244405|FG000|Period 1|Physician Decision|0|||
126533169|NCT03232983|455244406|FG001|Period 1|Physician Decision|0|||
126533170|NCT03232983|455244407|FG002|Period 1|Physician Decision|1|||
126533171|NCT03232983|455244408|FG003|Period 1|Physician Decision|0|||
126533172|NCT03232983|455244405|FG000|Washout Period 2|Physician Decision|0|||
126533173|NCT03232983|455244406|FG001|Washout Period 2|Physician Decision|0|||
126533174|NCT03232983|455244407|FG002|Washout Period 2|Physician Decision|1|||
126533175|NCT03232983|455244408|FG003|Washout Period 2|Physician Decision|0|||
126533176|NCT03232983|455244405|FG000|Washout Period 2|Withdrawal by Subject|0|||
126533177|NCT03232983|455244406|FG001|Washout Period 2|Withdrawal by Subject|0|||
126533178|NCT03232983|455244407|FG002|Washout Period 2|Withdrawal by Subject|0|||
126533179|NCT03232983|455244408|FG003|Washout Period 2|Withdrawal by Subject|1|||
126533180|NCT03232983|455244405|FG000|Period 4|Withdrawal by Subject|1|||
126533181|NCT03232983|455244406|FG001|Period 4|Withdrawal by Subject|0|||
126533182|NCT03232983|455244407|FG002|Period 4|Withdrawal by Subject|0|||
126533183|NCT03232983|455244408|FG003|Period 4|Withdrawal by Subject|0|||
126533184|NCT01137474|455244415|FG000|Overall Study|Adverse Event|3|||
126533185|NCT01137474|455244416|FG001|Overall Study|Adverse Event|5|||
126533186|NCT01137474|455244417|FG002|Overall Study|Adverse Event|1|||
126533187|NCT01137474|455244418|FG003|Overall Study|Adverse Event|3|||
126533188|NCT01137474|455244415|FG000|Overall Study|Withdrawal by Subject|7|||
126533189|NCT01137474|455244416|FG001|Overall Study|Withdrawal by Subject|2|||
126533190|NCT01137474|455244417|FG002|Overall Study|Withdrawal by Subject|6|||
126533191|NCT01137474|455244418|FG003|Overall Study|Withdrawal by Subject|9|||
126533192|NCT01137474|455244415|FG000|Overall Study|No longer met study criteria|6|||
126533193|NCT01137474|455244416|FG001|Overall Study|No longer met study criteria|1|||
126533194|NCT01137474|455244417|FG002|Overall Study|No longer met study criteria|0|||
126533195|NCT01137474|455244418|FG003|Overall Study|No longer met study criteria|5|||
126533196|NCT01137474|455244415|FG000|Overall Study|Lost to Follow-up|5|||
126533197|NCT01137474|455244416|FG001|Overall Study|Lost to Follow-up|1|||
126533198|NCT01137474|455244417|FG002|Overall Study|Lost to Follow-up|0|||
126533199|NCT01137474|455244418|FG003|Overall Study|Lost to Follow-up|2|||
126533200|NCT01137474|455244415|FG000|Overall Study|Lack of Efficacy|0|||
126533201|NCT01137474|455244416|FG001|Overall Study|Lack of Efficacy|0|||
126533202|NCT01137474|455244417|FG002|Overall Study|Lack of Efficacy|0|||
126533203|NCT01137474|455244418|FG003|Overall Study|Lack of Efficacy|2|||
126533204|NCT01137474|455244415|FG000|Overall Study|Other|3|||
126533205|NCT01137474|455244416|FG001|Overall Study|Other|1|||
126533206|NCT01137474|455244417|FG002|Overall Study|Other|0|||
126533207|NCT01137474|455244418|FG003|Overall Study|Other|0|||
126533208|NCT01137474|455244415|FG000|Overall Study|Pregnancy|0|||
126533209|NCT01137474|455244416|FG001|Overall Study|Pregnancy|1|||
126533210|NCT01137474|455244417|FG002|Overall Study|Pregnancy|0|||
126533211|NCT01137474|455244418|FG003|Overall Study|Pregnancy|0|||
126533212|NCT01137474|455244415|FG000|Overall Study|Administrative reason by sponsor|0|||
126730424|NCT00830804|455962968|FG000|Overall Study|Death|1|||
126730425|NCT00830804|455962968|FG000|Overall Study|Unable to get to clinic|7|||
126730426|NCT00830804|455962968|FG000|Overall Study|Consent withdrawn|2|||
126730427|NCT00830804|455962968|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
126730428|NCT03428997|455962976|FG000|Overall Study|Sponsor decision.|1|||
126730429|NCT03428997|455962976|FG000|Overall Study|Withdrawal by Subject|3|||
126730430|NCT03428997|455962976|FG000|Overall Study|Lost to Follow-up|4|||
126730431|NCT00510068|455962977|FG000|Double-blind Period|Disease progression|98|||
126730432|NCT00510068|455962978|FG001|Double-blind Period|Disease progression|169|||
126730433|NCT00510068|455962977|FG000|Double-blind Period|Final primary analysis|52|||
126730434|NCT00510068|455962978|FG001|Double-blind Period|Final primary analysis|18|||
126730435|NCT00510068|455962977|FG000|Double-blind Period|Adverse Event|37|||
126730436|NCT00510068|455962978|FG001|Double-blind Period|Adverse Event|7|||
126730437|NCT00510068|455962977|FG000|Double-blind Period|Withdrawal by Subject|8|||
126730438|NCT00510068|455962978|FG001|Double-blind Period|Withdrawal by Subject|6|||
126730439|NCT00510068|455962977|FG000|Double-blind Period|Death|4|||
126730440|NCT00510068|455962978|FG001|Double-blind Period|Death|3|||
126730441|NCT00510068|455962977|FG000|Double-blind Period|Abnormal test result (s)|1|||
126730442|NCT00510068|455962978|FG001|Double-blind Period|Abnormal test result (s)|0|||
126730443|NCT00510068|455962977|FG000|Double-blind Period|Lost to Follow-up|1|||
126730444|NCT00510068|455962978|FG001|Double-blind Period|Lost to Follow-up|0|||
126730445|NCT00510068|455962977|FG000|Double-blind Period|Protocol Violation|6|||
126730446|NCT00510068|455962978|FG001|Double-blind Period|Protocol Violation|0|||
126730447|NCT00510068|455962977|FG000|Open-label Period|Disease Progression|124|||
126730448|NCT00510068|455962978|FG001|Open-label Period|Disease Progression|0|||
126730449|NCT00510068|455962977|FG000|Open-label Period|Adverse Event|46|||
126730450|NCT00510068|455962978|FG001|Open-label Period|Adverse Event|0|||
126730451|NCT00510068|455962977|FG000|Open-label Period|Withdrawal by Subject|21|||
126730452|NCT00510068|455962978|FG001|Open-label Period|Withdrawal by Subject|0|||
126730453|NCT00510068|455962977|FG000|Open-label Period|Administrative problems|17|||
126730454|NCT00510068|455962978|FG001|Open-label Period|Administrative problems|0|||
126730455|NCT00510068|455962977|FG000|Open-label Period|Death|7|||
126730456|NCT00510068|455962978|FG001|Open-label Period|Death|0|||
126730457|NCT00510068|455962977|FG000|Open-label Period|New cancer therapy|7|||
126730458|NCT00510068|455962978|FG001|Open-label Period|New cancer therapy|0|||
126730459|NCT00510068|455962977|FG000|Open-label Period|Protocol Violation|2|||
126730460|NCT00510068|455962978|FG001|Open-label Period|Protocol Violation|0|||
126730461|NCT00510068|455962977|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
126730462|NCT00510068|455962978|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
126730463|NCT02563925|455962979|FG000|Overall Study|Withdrawal by Subject|2|||
126730464|NCT00400712|455962980|FG000|Overall Study|Death|1|||
126730465|NCT00400712|455962981|FG001|Overall Study|Death|0|||
126730466|NCT00400712|455962980|FG000|Overall Study|Withdrawal by Subject|11|||
126730467|NCT00400712|455962981|FG001|Overall Study|Withdrawal by Subject|12|||
126730468|NCT00400712|455962980|FG000|Overall Study|Physician Decision|5|||
126730469|NCT00400712|455962981|FG001|Overall Study|Physician Decision|4|||
126730470|NCT03691610|455962984|FG000|Overall Study|Adverse Event|0|||
126730471|NCT03691610|455962985|FG001|Overall Study|Adverse Event|1|||
126730472|NCT03691610|455962986|FG002|Overall Study|Adverse Event|0|||
126730473|NCT03691610|455962987|FG003|Overall Study|Adverse Event|0|||
126730474|NCT03691610|455962984|FG000|Overall Study|Protocol Deviation|15|||
126533213|NCT01137474|455244416|FG001|Overall Study|Administrative reason by sponsor|1|||
126730475|NCT03691610|455962985|FG001|Overall Study|Protocol Deviation|8|||
126730476|NCT03691610|455962986|FG002|Overall Study|Protocol Deviation|1|||
126730477|NCT03691610|455962987|FG003|Overall Study|Protocol Deviation|2|||
126730478|NCT03691610|455962984|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
126730479|NCT03691610|455962985|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
126730480|NCT03691610|455962986|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
126730481|NCT03691610|455962987|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
126730482|NCT03691610|455962984|FG000|Overall Study|Lost to Follow-up|20|||
126730483|NCT03691610|455962985|FG001|Overall Study|Lost to Follow-up|11|||
126730484|NCT03691610|455962986|FG002|Overall Study|Lost to Follow-up|5|||
126730485|NCT03691610|455962987|FG003|Overall Study|Lost to Follow-up|2|||
126730486|NCT00622869|455962988|FG000|Overall Study|Subject Withdrew Consent|13|||
126730487|NCT00622869|455962989|FG001|Overall Study|Subject Withdrew Consent|17|||
126730488|NCT00622869|455962990|FG002|Overall Study|Subject Withdrew Consent|11|||
126533214|NCT01137474|455244417|FG002|Overall Study|Administrative reason by sponsor|0|||
126533215|NCT01137474|455244418|FG003|Overall Study|Administrative reason by sponsor|0|||
126533216|NCT04794803|455244419|FG000|Overall Study|Death|1|||
126730489|NCT00622869|455962988|FG000|Overall Study|Administrative Problems|11|||
126533217|NCT04794803|455244420|FG001|Overall Study|Death|3|||
126533218|NCT04794803|455244419|FG000|Overall Study|Lost to Follow-up|2|||
126730490|NCT00622869|455962989|FG001|Overall Study|Administrative Problems|17|||
126533219|NCT04794803|455244420|FG001|Overall Study|Lost to Follow-up|2|||
126730491|NCT00622869|455962990|FG002|Overall Study|Administrative Problems|13|||
126730492|NCT00622869|455962988|FG000|Overall Study|Death|12|||
126730493|NCT00622869|455962989|FG001|Overall Study|Death|15|||
126730494|NCT00622869|455962990|FG002|Overall Study|Death|10|||
126583199|NCT03526861|455433420|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583200|NCT03526861|455433421|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583201|NCT03526861|455433422|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583202|NCT03526861|455433423|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583203|NCT03526861|455433424|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583204|NCT03526861|455433425|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583205|NCT03526861|455433426|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
126583206|NCT03526861|455433427|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
126583207|NCT05862870|455433428|FG000|Overall Study|Lost to Follow-up|3|||
126583208|NCT00650104|455433436|FG000|Overall Study|Adverse Event|17|||
126583209|NCT00650104|455433436|FG000|Overall Study|Death|2|||
126583210|NCT00650104|455433436|FG000|Overall Study|Withdrawal by Subject|11|||
126583211|NCT00650104|455433436|FG000|Overall Study|Physician Decision|7|||
126583212|NCT00650104|455433436|FG000|Overall Study|Lost to Follow-up|1|||
126583213|NCT00650104|455433436|FG000|Overall Study|Non-compliance|2|||
126583214|NCT00650104|455433436|FG000|Overall Study|Sponsor Terminated Dosing|1|||
126730495|NCT00622869|455962988|FG000|Overall Study|Lost to Follow-up|2|||
126730496|NCT00622869|455962989|FG001|Overall Study|Lost to Follow-up|4|||
126730497|NCT00622869|455962990|FG002|Overall Study|Lost to Follow-up|2|||
126583215|NCT00931710|455433437|FG000|Overall Study|Adverse Event|16|||
126583216|NCT00931710|455433438|FG001|Overall Study|Adverse Event|10|||
126583217|NCT00931710|455433437|FG000|Overall Study|Abnormal test procedure results|2|||
126583218|NCT00931710|455433438|FG001|Overall Study|Abnormal test procedure results|0|||
126583219|NCT00931710|455433437|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
126583220|NCT00931710|455433438|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
126583221|NCT00931710|455433437|FG000|Overall Study|Patient withdrew consent|4|||
126583222|NCT00931710|455433438|FG001|Overall Study|Patient withdrew consent|9|||
126583223|NCT00931710|455433437|FG000|Overall Study|Lost to Follow-up|6|||
126583224|NCT00931710|455433438|FG001|Overall Study|Lost to Follow-up|5|||
126583225|NCT00931710|455433437|FG000|Overall Study|Protocol deviation|1|||
126583226|NCT00931710|455433438|FG001|Overall Study|Protocol deviation|2|||
126583227|NCT05792423|455433439|FG000|Overall Study|Withdrawal by Subject|2|||
126583228|NCT02471638|455433440|FG000|Overall Study|Early Term Withdrawal|10|||
126583229|NCT05338086|455434688|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
126583230|NCT05338086|455434689|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
126583231|NCT05338086|455434690|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
126583232|NCT05338086|455434691|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
126583233|NCT05338086|455434692|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
126583234|NCT05338086|455434688|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
126583235|NCT05338086|455434689|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
126583236|NCT05338086|455434690|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
126583237|NCT05338086|455434691|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
126583238|NCT05338086|455434692|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
126583239|NCT05338086|455434688|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
126583240|NCT05338086|455434689|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
126583241|NCT05338086|455434690|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
126583242|NCT05338086|455434691|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
126583243|NCT05338086|455434692|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
126583244|NCT05338086|455434688|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
126583245|NCT05338086|455434689|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
126583246|NCT05338086|455434690|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
126583247|NCT05338086|455434691|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
126583248|NCT05338086|455434692|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
126583249|NCT05338086|455434688|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
126583250|NCT05338086|455434689|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
126583251|NCT05338086|455434690|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
126583252|NCT05338086|455434691|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
126583253|NCT05338086|455434692|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
126583254|NCT05338086|455434688|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
126730498|NCT00622869|455962988|FG000|Overall Study|Graft Loss|5|||
126730499|NCT00622869|455962989|FG001|Overall Study|Graft Loss|3|||
126730500|NCT00622869|455962990|FG002|Overall Study|Graft Loss|2|||
126730501|NCT00622869|455962988|FG000|Overall Study|Missing|0|||
126583255|NCT05338086|455434689|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
126583256|NCT05338086|455434690|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
126583257|NCT05338086|455434691|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
126583258|NCT05338086|455434692|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
126583259|NCT05338086|455434688|FG000|Transition Period (M12 to M18)|Death|0|||
126583260|NCT05338086|455434689|FG001|Transition Period (M12 to M18)|Death|0|||
126583261|NCT05338086|455434690|FG002|Transition Period (M12 to M18)|Death|1|||
126583262|NCT05338086|455434691|FG003|Transition Period (M12 to M18)|Death|0|||
126583263|NCT05338086|455434692|FG004|Transition Period (M12 to M18)|Death|0|||
126583264|NCT05338086|455434688|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
126583265|NCT05338086|455434689|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
126583266|NCT05338086|455434690|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
126583267|NCT05338086|455434691|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
126583268|NCT05338086|455434692|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
126583269|NCT05338086|455434688|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
126583270|NCT05338086|455434689|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
126583271|NCT05338086|455434690|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
126583272|NCT05338086|455434691|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
126583273|NCT05338086|455434692|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
126583274|NCT05338086|455434688|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
126583275|NCT05338086|455434689|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
126583276|NCT05338086|455434690|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
126583277|NCT05338086|455434691|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
126583278|NCT05338086|455434692|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
126583279|NCT03940703|455434693|FG000|Overall Study|Still under treatment|31|||
126583280|NCT03940703|455434694|FG001|Overall Study|Still under treatment|0|||
126583281|NCT03625882|455434695|FG000|Overall Study|Protocol Violation|3|||
126583282|NCT05320432|455434700|FG000|Overall Study|Withdrawal by Subject|0|||
126583283|NCT05320432|455434701|FG001|Overall Study|Withdrawal by Subject|2|||
126583284|NCT03484702|455434702|FG000|Treatment Period|Death|3|||
126583285|NCT03484702|455434703|FG001|Treatment Period|Death|1|||
126730502|NCT00622869|455962989|FG001|Overall Study|Missing|1|||
126730503|NCT00622869|455962990|FG002|Overall Study|Missing|1|||
126730504|NCT00645567|455962991|FG000|Overall Study|Adverse Event|1|||
126730505|NCT03730194|455962995|FG000|First Stage Treatment|Withdrawal by Subject|1|||
126730506|NCT03730194|455962996|FG001|First Stage Treatment|Withdrawal by Subject|1|||
126730507|NCT03730194|455962997|FG002|First Stage Treatment|Withdrawal by Subject|0|||
126730508|NCT03730194|455962998|FG003|First Stage Treatment|Withdrawal by Subject|0|||
126730509|NCT03730194|455962999|FG004|First Stage Treatment|Withdrawal by Subject|0|||
126730510|NCT03730194|455963000|FG005|First Stage Treatment|Withdrawal by Subject|0|||
126730511|NCT03730194|455962995|FG000|First Stage Treatment|Protocol Violation|3|||
126730512|NCT03730194|455962996|FG001|First Stage Treatment|Protocol Violation|3|||
126730513|NCT03730194|455962997|FG002|First Stage Treatment|Protocol Violation|0|||
126730514|NCT03730194|455962998|FG003|First Stage Treatment|Protocol Violation|0|||
126730515|NCT03730194|455962999|FG004|First Stage Treatment|Protocol Violation|0|||
126730516|NCT03730194|455963000|FG005|First Stage Treatment|Protocol Violation|0|||
126730517|NCT00115765|455963001|FG000|Overall Study|Withdrawal by Subject|22|||
126730518|NCT00115765|455963002|FG001|Overall Study|Withdrawal by Subject|53|||
126730519|NCT00115765|455963003|FG002|Overall Study|Withdrawal by Subject|76|||
126730520|NCT00115765|455963004|FG003|Overall Study|Withdrawal by Subject|15|||
126730521|NCT00115765|455963001|FG000|Overall Study|Physician Decision|4|||
126730522|NCT00115765|455963002|FG001|Overall Study|Physician Decision|15|||
126730523|NCT00115765|455963003|FG002|Overall Study|Physician Decision|18|||
126730524|NCT00115765|455963004|FG003|Overall Study|Physician Decision|13|||
126730525|NCT00115765|455963001|FG000|Overall Study|Lost to Follow-up|3|||
126730526|NCT00115765|455963002|FG001|Overall Study|Lost to Follow-up|20|||
126730527|NCT00115765|455963003|FG002|Overall Study|Lost to Follow-up|18|||
126730528|NCT00115765|455963004|FG003|Overall Study|Lost to Follow-up|1|||
126730529|NCT00115765|455963001|FG000|Overall Study|Other|6|||
126730530|NCT00115765|455963002|FG001|Overall Study|Other|12|||
126730531|NCT00115765|455963003|FG002|Overall Study|Other|9|||
126730532|NCT00115765|455963004|FG003|Overall Study|Other|2|||
126730533|NCT03543358|455963005|FG000|Overall Study|Death|1|||
126730534|NCT03543358|455963006|FG001|Overall Study|Death|0|||
126777325|NCT00528879|456141331|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
126583286|NCT03484702|455434704|FG002|Treatment Period|Death|0|||
126583287|NCT03484702|455434705|FG003|Treatment Period|Death|0|||
126583288|NCT03484702|455434706|FG004|Treatment Period|Death|0|||
126583289|NCT03484702|455434707|FG005|Treatment Period|Death|0|||
126730535|NCT03543358|455963005|FG000|Overall Study|Disease Progression|1|||
126730536|NCT03543358|455963006|FG001|Overall Study|Disease Progression|0|||
126730537|NCT03543358|455963005|FG000|Overall Study|Parent Study Closure|1|||
126730538|NCT03543358|455963006|FG001|Overall Study|Parent Study Closure|0|||
126730539|NCT00870818|455963009|FG000|Overall Study|Lost to Follow-up|3|||
126730540|NCT00870818|455963010|FG001|Overall Study|Lost to Follow-up|2|||
126533220|NCT04794803|455244419|FG000|Overall Study|Withdrawal by Subject|1|||
126533221|NCT04794803|455244420|FG001|Overall Study|Withdrawal by Subject|0|||
126533222|NCT04794803|455244419|FG000|Overall Study|Physician Decision|1|||
126533223|NCT04794803|455244420|FG001|Overall Study|Physician Decision|1|||
126533224|NCT04794803|455244419|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
126533225|NCT04794803|455244420|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
126533226|NCT04794803|455244419|FG000|Overall Study|Refused to continue the treatment|1|||
126533227|NCT04794803|455244420|FG001|Overall Study|Refused to continue the treatment|0|||
126533228|NCT04794803|455244419|FG000|Overall Study|Patient admitted to ICU|0|||
126533229|NCT04794803|455244420|FG001|Overall Study|Patient admitted to ICU|1|||
126533230|NCT00911534|455244421|FG000|Overall Study|Adverse Event|4|||
126533231|NCT00911534|455244422|FG001|Overall Study|Adverse Event|4|||
126533232|NCT00911534|455244421|FG000|Overall Study|Lost to Follow-up|2|||
126533233|NCT00911534|455244422|FG001|Overall Study|Lost to Follow-up|4|||
126533234|NCT00911534|455244421|FG000|Overall Study|Withdrawal by Subject|2|||
126533235|NCT00911534|455244422|FG001|Overall Study|Withdrawal by Subject|1|||
126533236|NCT00911534|455244421|FG000|Overall Study|Lack of Efficacy|4|||
126533237|NCT00911534|455244422|FG001|Overall Study|Lack of Efficacy|1|||
126533238|NCT00911534|455244421|FG000|Overall Study|Withdrawal of consent|1|||
126533239|NCT00911534|455244422|FG001|Overall Study|Withdrawal of consent|4|||
126533240|NCT00911534|455244421|FG000|Overall Study|Other|2|||
126533241|NCT00911534|455244422|FG001|Overall Study|Other|2|||
126533242|NCT04040751|455244423|FG000|Overall Study|Withdrawal by Subject|2|||
126533243|NCT04040751|455244424|FG001|Overall Study|Withdrawal by Subject|0|||
126533244|NCT04040751|455244425|FG002|Overall Study|Withdrawal by Subject|2|||
126533245|NCT04040751|455244426|FG003|Overall Study|Withdrawal by Subject|0|||
126533246|NCT03896035|455244427|FG000|Overall Study|Lost to Follow-up|2|||
126533247|NCT03896035|455244428|FG001|Overall Study|Lost to Follow-up|6|||
126533248|NCT03896035|455244427|FG000|Overall Study|Withdrawal by Subject|0|||
126533249|NCT03896035|455244428|FG001|Overall Study|Withdrawal by Subject|1|||
126533250|NCT03896035|455244427|FG000|Overall Study|Health/family health issues during COVID|0|||
126533251|NCT03896035|455244428|FG001|Overall Study|Health/family health issues during COVID|4|||
126533252|NCT01388816|455244429|FG000|Overall Study|Adverse Event|0|||
126533253|NCT01388816|455244430|FG001|Overall Study|Adverse Event|2|||
126533254|NCT01388816|455244431|FG002|Overall Study|Adverse Event|0|||
126533255|NCT01388816|455244432|FG003|Overall Study|Adverse Event|0|||
126533256|NCT01388816|455244429|FG000|Overall Study|Lost to Follow-up|0|||
126533257|NCT01388816|455244430|FG001|Overall Study|Lost to Follow-up|1|||
126533258|NCT01388816|455244431|FG002|Overall Study|Lost to Follow-up|0|||
126533259|NCT01388816|455244432|FG003|Overall Study|Lost to Follow-up|0|||
126533260|NCT01388816|455244429|FG000|Overall Study|Withdrawal by Subject|2|||
126533261|NCT01388816|455244430|FG001|Overall Study|Withdrawal by Subject|1|||
126583290|NCT03484702|455434702|FG000|Treatment Period|Adverse Event|1|||
126583291|NCT03484702|455434703|FG001|Treatment Period|Adverse Event|0|||
126583292|NCT03484702|455434704|FG002|Treatment Period|Adverse Event|0|||
126583293|NCT03484702|455434705|FG003|Treatment Period|Adverse Event|0|||
126583294|NCT03484702|455434706|FG004|Treatment Period|Adverse Event|0|||
126583295|NCT03484702|455434707|FG005|Treatment Period|Adverse Event|0|||
126583296|NCT03484702|455434702|FG000|Treatment Period|Participant Withdrew from Study|0|||
126583297|NCT03484702|455434703|FG001|Treatment Period|Participant Withdrew from Study|1|||
126583298|NCT03484702|455434704|FG002|Treatment Period|Participant Withdrew from Study|0|||
126583299|NCT03484702|455434705|FG003|Treatment Period|Participant Withdrew from Study|0|||
126583300|NCT03484702|455434706|FG004|Treatment Period|Participant Withdrew from Study|0|||
126583301|NCT03484702|455434707|FG005|Treatment Period|Participant Withdrew from Study|0|||
126583302|NCT03484702|455434702|FG000|Treatment Period|Physician Decision|0|||
126583303|NCT03484702|455434703|FG001|Treatment Period|Physician Decision|1|||
126583304|NCT03484702|455434704|FG002|Treatment Period|Physician Decision|0|||
126583305|NCT03484702|455434705|FG003|Treatment Period|Physician Decision|0|||
126583306|NCT03484702|455434706|FG004|Treatment Period|Physician Decision|0|||
126583307|NCT03484702|455434707|FG005|Treatment Period|Physician Decision|1|||
126583308|NCT02187003|455434715|FG000|Overall Study|Adverse Event|2|||
126583309|NCT02187003|455434716|FG001|Overall Study|Adverse Event|0|||
126730541|NCT00870818|455963011|FG002|Overall Study|Lost to Follow-up|1|||
126730542|NCT00870818|455963012|FG003|Overall Study|Lost to Follow-up|0|||
126533262|NCT01388816|455244431|FG002|Overall Study|Withdrawal by Subject|1|||
126533263|NCT01388816|455244432|FG003|Overall Study|Withdrawal by Subject|0|||
126533264|NCT01388816|455244429|FG000|Overall Study|Protocol Violation|0|||
126533265|NCT01388816|455244430|FG001|Overall Study|Protocol Violation|0|||
126533266|NCT01388816|455244431|FG002|Overall Study|Protocol Violation|2|||
126533267|NCT01388816|455244432|FG003|Overall Study|Protocol Violation|0|||
126533268|NCT00743366|455244433|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
126533269|NCT00743366|455244434|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
126533270|NCT03206203|455244435|FG000|Treatment|Death|38|||
126533271|NCT03206203|455244436|FG001|Treatment|Death|26|||
126533272|NCT03206203|455244437|FG002|Treatment|Death|0|||
126583310|NCT02187003|455434715|FG000|Overall Study|Lost to Follow-up|14|||
126730543|NCT00870818|455963013|FG004|Overall Study|Lost to Follow-up|0|||
126730544|NCT00870818|455963009|FG000|Overall Study|Withdrawal by Subject|0|||
126730545|NCT00870818|455963010|FG001|Overall Study|Withdrawal by Subject|0|||
126730546|NCT00870818|455963011|FG002|Overall Study|Withdrawal by Subject|1|||
126730547|NCT00870818|455963012|FG003|Overall Study|Withdrawal by Subject|2|||
126730548|NCT00870818|455963013|FG004|Overall Study|Withdrawal by Subject|0|||
126730549|NCT00870818|455963009|FG000|Overall Study|Terminated by sponsor|29|||
126730550|NCT00870818|455963010|FG001|Overall Study|Terminated by sponsor|70|||
126730551|NCT00870818|455963011|FG002|Overall Study|Terminated by sponsor|36|||
126730552|NCT00870818|455963012|FG003|Overall Study|Terminated by sponsor|36|||
126730553|NCT00870818|455963013|FG004|Overall Study|Terminated by sponsor|38|||
126730554|NCT00870818|455963009|FG000|Overall Study|Other|0|||
126730555|NCT00870818|455963010|FG001|Overall Study|Other|1|||
126730556|NCT00870818|455963011|FG002|Overall Study|Other|0|||
126730557|NCT00870818|455963012|FG003|Overall Study|Other|0|||
126730558|NCT00870818|455963013|FG004|Overall Study|Other|0|||
126730559|NCT00178464|455963014|FG000|Overall Study|Withdrawal by Subject|1|||
126730560|NCT00178464|455963014|FG000|Overall Study|Physician Decision|1|||
126730561|NCT02227108|455963015|FG000|Overall Study|Did not receive treatment|2|||
126730562|NCT02227108|455963015|FG000|Overall Study|Other|3|||
126730563|NCT02227108|455963015|FG000|Overall Study|Progressive disease|17|||
126730564|NCT02227108|455963015|FG000|Overall Study|Initiation of alternative therapy|2|||
126730565|NCT02227108|455963015|FG000|Overall Study|Investigator discretion|1|||
126730566|NCT02227108|455963015|FG000|Overall Study|Adverse Event|6|||
126730567|NCT04900038|455963016|FG000|Overall Study|Adverse Event|1|||
126730568|NCT04900038|455963017|FG001|Overall Study|Adverse Event|0|||
126730569|NCT04900038|455963018|FG002|Overall Study|Adverse Event|1|||
126730570|NCT04900038|455963019|FG003|Overall Study|Adverse Event|1|||
126730571|NCT04900038|455963016|FG000|Overall Study|Withdrawal by Subject|0|||
126730572|NCT04900038|455963017|FG001|Overall Study|Withdrawal by Subject|1|||
126730573|NCT04900038|455963018|FG002|Overall Study|Withdrawal by Subject|0|||
126730574|NCT04900038|455963019|FG003|Overall Study|Withdrawal by Subject|0|||
126730575|NCT04900038|455963016|FG000|Overall Study|Study terminated by sponsor|18|||
126730576|NCT04900038|455963017|FG001|Overall Study|Study terminated by sponsor|15|||
126730577|NCT04900038|455963018|FG002|Overall Study|Study terminated by sponsor|17|||
126730578|NCT04900038|455963019|FG003|Overall Study|Study terminated by sponsor|14|||
126730579|NCT04900038|455963016|FG000|Overall Study|Protocol Deviation|1|||
126730580|NCT04900038|455963017|FG001|Overall Study|Protocol Deviation|1|||
126730581|NCT04900038|455963018|FG002|Overall Study|Protocol Deviation|0|||
126730582|NCT04900038|455963019|FG003|Overall Study|Protocol Deviation|0|||
126730583|NCT04900038|455963016|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
126730584|NCT04900038|455963017|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
126730585|NCT04900038|455963018|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
126730586|NCT04900038|455963019|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
126730587|NCT04900038|455963016|FG000|Overall Study|Lost to Follow-up|0|||
126730588|NCT04900038|455963017|FG001|Overall Study|Lost to Follow-up|0|||
126730589|NCT04900038|455963018|FG002|Overall Study|Lost to Follow-up|0|||
126730590|NCT04900038|455963019|FG003|Overall Study|Lost to Follow-up|1|||
126730591|NCT02486952|455963020|FG000|Overall Study|Not Started Induction Therapy|3|||
126730592|NCT02486952|455963020|FG000|Overall Study|Adverse Event|1|||
126730593|NCT02486952|455963020|FG000|Overall Study|Death|15|||
126730594|NCT02486952|455963020|FG000|Overall Study|Lack of Efficacy|3|||
126730595|NCT02486952|455963020|FG000|Overall Study|Lost to Follow-up|26|||
126730596|NCT02486952|455963020|FG000|Overall Study|Other|2|||
126730597|NCT01928485|455963021|FG000|Overall Study|Physician Decision|0|||
126730598|NCT01928485|455963022|FG001|Overall Study|Physician Decision|1|||
126730599|NCT04111107|455963023|FG000|Overall Study|Withdrawal by Subject|6|||
126730600|NCT04111107|455963023|FG000|Overall Study|Declining Health|5|||
126730601|NCT03814590|455963024|FG000|Overall Study|Adverse Event|0|||
126730602|NCT03814590|455963025|FG001|Overall Study|Adverse Event|0|||
126730603|NCT03814590|455963026|FG002|Overall Study|Adverse Event|0|||
126730604|NCT03814590|455963027|FG003|Overall Study|Adverse Event|0|||
126730605|NCT03814590|455963028|FG004|Overall Study|Adverse Event|0|||
126730606|NCT03814590|455963029|FG005|Overall Study|Adverse Event|1|||
126730607|NCT03814590|455963030|FG006|Overall Study|Adverse Event|1|||
126730608|NCT03814590|455963031|FG007|Overall Study|Adverse Event|1|||
126730609|NCT03814590|455963032|FG008|Overall Study|Adverse Event|0|||
126730610|NCT03814590|455963033|FG009|Overall Study|Adverse Event|0|||
126730611|NCT03814590|455963034|FG010|Overall Study|Adverse Event|1|||
126730612|NCT03814590|455963035|FG011|Overall Study|Adverse Event|0|||
126730613|NCT03814590|455963036|FG012|Overall Study|Adverse Event|3|||
126730614|NCT03814590|455963037|FG013|Overall Study|Adverse Event|0|||
126730615|NCT03814590|455963024|FG000|Overall Study|Lost to Follow-up|0|||
126730616|NCT03814590|455963025|FG001|Overall Study|Lost to Follow-up|2|||
126730617|NCT03814590|455963026|FG002|Overall Study|Lost to Follow-up|1|||
126730618|NCT03814590|455963027|FG003|Overall Study|Lost to Follow-up|0|||
126730619|NCT03814590|455963028|FG004|Overall Study|Lost to Follow-up|1|||
126730620|NCT03814590|455963029|FG005|Overall Study|Lost to Follow-up|1|||
126730621|NCT03814590|455963030|FG006|Overall Study|Lost to Follow-up|1|||
126583311|NCT02187003|455434716|FG001|Overall Study|Lost to Follow-up|10|||
126583312|NCT02187003|455434715|FG000|Overall Study|Withdrawal by Subject|3|||
126583313|NCT02187003|455434716|FG001|Overall Study|Withdrawal by Subject|7|||
126583314|NCT02187003|455434715|FG000|Overall Study|Protocol Violation|2|||
126583315|NCT02187003|455434716|FG001|Overall Study|Protocol Violation|4|||
126583316|NCT02187003|455434715|FG000|Overall Study|Other|5|||
126583317|NCT02187003|455434716|FG001|Overall Study|Other|5|||
126583318|NCT02187003|455434715|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126583319|NCT02187003|455434716|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
126583320|NCT05816551|455434717|FG000|Overall Study|Withdrawal by Subject|0|||
126583321|NCT05816551|455434718|FG001|Overall Study|Withdrawal by Subject|1|||
126583322|NCT05816551|455434717|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
126583323|NCT05816551|455434718|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
126583324|NCT02651324|455434723|FG000|Overall Study|drug not administered, due dispensing issue|1|||
126583325|NCT02651324|455434724|FG001|Overall Study|drug not administered, due dispensing issue|0|||
126583326|NCT05461131|455434725|FG000|Overall Study|Lost to Follow-up|0|||
126583327|NCT05461131|455434726|FG001|Overall Study|Lost to Follow-up|2|||
126583328|NCT03101904|455434728|FG000|Wash Out (10 Days)|Adverse Event|1|||
126583329|NCT03101904|455434729|FG001|Wash Out (10 Days)|Adverse Event|0|||
126583330|NCT03101904|455434728|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
126583331|NCT03101904|455434729|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
126583332|NCT04538417|455434730|FG000|Overall Study|Withdrawal by Subject|2|||
126583333|NCT04703322|455434734|FG000|Overall Study|Ongoing|8|||
126583334|NCT04703322|455434734|FG000|Overall Study|Withdrawal by Subject|1|||
126583335|NCT04549168|455434735|FG000|Randomization Phase|Adverse Event|0|||
126583336|NCT04549168|455434736|FG001|Randomization Phase|Adverse Event|0|||
126583337|NCT04549168|455434737|FG002|Randomization Phase|Adverse Event|1|||
126583338|NCT04549168|455434735|FG000|Randomization Phase|Other|0|||
126583339|NCT04549168|455434736|FG001|Randomization Phase|Other|2|||
126583340|NCT04549168|455434737|FG002|Randomization Phase|Other|0|||
126583341|NCT04549168|455434735|FG000|Randomization Phase|Withdrawal by Subject|0|||
126583342|NCT04549168|455434736|FG001|Randomization Phase|Withdrawal by Subject|2|||
126583343|NCT04549168|455434737|FG002|Randomization Phase|Withdrawal by Subject|1|||
126583344|NCT02662062|455434745|FG000|Overall Study|Withdrawal by Subject|1|||
126583345|NCT03988634|455434746|FG000|Double-Blind|Adverse Event|4|||
126583346|NCT03988634|455434747|FG001|Double-Blind|Adverse Event|0|||
126583347|NCT03988634|455434748|FG002|Double-Blind|Adverse Event|0|||
126583348|NCT03988634|455434746|FG000|Double-Blind|Death|18|||
126583349|NCT03988634|455434747|FG001|Double-Blind|Death|26|||
126583350|NCT03988634|455434748|FG002|Double-Blind|Death|0|||
126583351|NCT03988634|455434746|FG000|Double-Blind|Lost to Follow-up|6|||
126583352|NCT03988634|455434747|FG001|Double-Blind|Lost to Follow-up|7|||
126583353|NCT03988634|455434748|FG002|Double-Blind|Lost to Follow-up|0|||
126583354|NCT03988634|455434746|FG000|Double-Blind|Physician Decision|9|||
126583355|NCT03988634|455434747|FG001|Double-Blind|Physician Decision|5|||
126583356|NCT03988634|455434748|FG002|Double-Blind|Physician Decision|0|||
126583357|NCT03988634|455434746|FG000|Double-Blind|Subject decision|24|||
126583358|NCT03988634|455434747|FG001|Double-Blind|Subject decision|13|||
126583359|NCT03988634|455434748|FG002|Double-Blind|Subject decision|0|||
126583360|NCT03988634|455434746|FG000|Open-Label|Adverse Event|0|||
126583361|NCT03988634|455434747|FG001|Open-Label|Adverse Event|0|||
126583362|NCT03988634|455434748|FG002|Open-Label|Adverse Event|7|||
126583363|NCT03988634|455434746|FG000|Open-Label|Physician Decision|0|||
126583364|NCT03988634|455434747|FG001|Open-Label|Physician Decision|0|||
126583365|NCT03988634|455434748|FG002|Open-Label|Physician Decision|1|||
126583366|NCT03988634|455434746|FG000|Open-Label|Technical problems|0|||
126583367|NCT03988634|455434747|FG001|Open-Label|Technical problems|0|||
126583368|NCT03988634|455434748|FG002|Open-Label|Technical problems|1|||
126583369|NCT04725240|455434749|FG000|Overall Study|Adverse Event|2|||
126583370|NCT00676715|455434756|FG000|Treatment Period (TP)|Adverse Event|0|||
126583371|NCT00676715|455434757|FG001|Treatment Period (TP)|Adverse Event|3|||
126583372|NCT00676715|455434758|FG002|Treatment Period (TP)|Adverse Event|2|||
126583373|NCT00676715|455434759|FG003|Treatment Period (TP)|Adverse Event|2|||
126583374|NCT00676715|455434756|FG000|Treatment Period (TP)|Death|0|||
126583375|NCT00676715|455434757|FG001|Treatment Period (TP)|Death|0|||
126583376|NCT00676715|455434758|FG002|Treatment Period (TP)|Death|1|||
126583377|NCT00676715|455434759|FG003|Treatment Period (TP)|Death|0|||
126583378|NCT00676715|455434756|FG000|Treatment Period (TP)|Failure to return|1|||
126583379|NCT00676715|455434757|FG001|Treatment Period (TP)|Failure to return|0|||
126583380|NCT00676715|455434758|FG002|Treatment Period (TP)|Failure to return|0|||
126583381|NCT00676715|455434759|FG003|Treatment Period (TP)|Failure to return|0|||
126583382|NCT00676715|455434756|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
126583383|NCT00676715|455434757|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
126583384|NCT00676715|455434758|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
126583385|NCT00676715|455434759|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
126583386|NCT00676715|455434756|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
126583387|NCT00676715|455434757|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
126730622|NCT03814590|455963031|FG007|Overall Study|Lost to Follow-up|1|||
126533273|NCT03206203|455244435|FG000|Treatment|Withdrawal by Subject|1|||
126533274|NCT03206203|455244436|FG001|Treatment|Withdrawal by Subject|0|||
126533275|NCT03206203|455244437|FG002|Treatment|Withdrawal by Subject|0|||
126533276|NCT03206203|455244435|FG000|Treatment|Lost to Follow-up|4|||
126533277|NCT03206203|455244436|FG001|Treatment|Lost to Follow-up|0|||
126533278|NCT03206203|455244437|FG002|Treatment|Lost to Follow-up|0|||
126533279|NCT03206203|455244435|FG000|Treatment|N/A in Follow-Up|8|||
126533280|NCT03206203|455244436|FG001|Treatment|N/A in Follow-Up|1|||
126533281|NCT03206203|455244437|FG002|Treatment|N/A in Follow-Up|0|||
126533282|NCT03206203|455244435|FG000|Treatment|Disease progression|0|||
126533283|NCT03206203|455244436|FG001|Treatment|Disease progression|1|||
126533284|NCT03206203|455244437|FG002|Treatment|Disease progression|0|||
126533285|NCT03206203|455244435|FG000|Treatment|Refused follow-up|0|||
126583388|NCT00676715|455434758|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
126583389|NCT00676715|455434759|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
126583390|NCT00676715|455434756|FG000|Treatment Period (TP)|Withdrew consent|3|||
126583391|NCT00676715|455434757|FG001|Treatment Period (TP)|Withdrew consent|3|||
126583392|NCT00676715|455434758|FG002|Treatment Period (TP)|Withdrew consent|3|||
126583393|NCT00676715|455434759|FG003|Treatment Period (TP)|Withdrew consent|3|||
126583394|NCT00676715|455434756|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
126583395|NCT00676715|455434757|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
126583396|NCT00676715|455434758|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
126583397|NCT00676715|455434759|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
126583398|NCT00676715|455434756|FG000|Treatment Period (TP)|Administrative|0|||
126583399|NCT00676715|455434757|FG001|Treatment Period (TP)|Administrative|0|||
126583400|NCT00676715|455434758|FG002|Treatment Period (TP)|Administrative|0|||
126583401|NCT00676715|455434759|FG003|Treatment Period (TP)|Administrative|1|||
126583402|NCT00676715|455434756|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
126583403|NCT00676715|455434757|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
126583404|NCT00676715|455434758|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
126583405|NCT00676715|455434759|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
126583406|NCT00676715|455434756|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
126583407|NCT00676715|455434757|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
126583408|NCT00676715|455434758|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
126583409|NCT00676715|455434759|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
126583410|NCT00676715|455434756|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
126583411|NCT00676715|455434757|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
126583412|NCT00676715|455434758|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
126583413|NCT00676715|455434759|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
126583414|NCT00676715|455434756|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
126583415|NCT00676715|455434757|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
126583416|NCT00676715|455434758|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
126583417|NCT00676715|455434759|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
126583418|NCT00676715|455434756|FG000|Treatment-free Period (TFP)|Death|1|||
126583419|NCT00676715|455434757|FG001|Treatment-free Period (TFP)|Death|1|||
126583420|NCT00676715|455434758|FG002|Treatment-free Period (TFP)|Death|1|||
126583421|NCT00676715|455434759|FG003|Treatment-free Period (TFP)|Death|0|||
126583422|NCT00676715|455434756|FG000|Open Label Extension (OLE)|Reason not provided|3|||
126583423|NCT00676715|455434757|FG001|Open Label Extension (OLE)|Reason not provided|4|||
126583424|NCT00676715|455434758|FG002|Open Label Extension (OLE)|Reason not provided|1|||
126583425|NCT00676715|455434759|FG003|Open Label Extension (OLE)|Reason not provided|4|||
126583426|NCT00676715|455434756|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
126583427|NCT00676715|455434757|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
126583428|NCT00676715|455434758|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
126583429|NCT00676715|455434759|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
126533286|NCT03206203|455244436|FG001|Treatment|Refused follow-up|1|||
126533287|NCT03206203|455244437|FG002|Treatment|Refused follow-up|0|||
126533288|NCT03206203|455244435|FG000|Treatment|Cross over to Arm 1|0|||
126533289|NCT03206203|455244436|FG001|Treatment|Cross over to Arm 1|19|||
126533290|NCT03206203|455244437|FG002|Treatment|Cross over to Arm 1|0|||
126533291|NCT03206203|455244435|FG000|Optional Cross-Over|Death|0|||
126583430|NCT00676715|455434756|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
126583431|NCT00676715|455434757|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
126583432|NCT00676715|455434758|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
126583433|NCT00676715|455434759|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
126583434|NCT00676715|455434756|FG000|Open Label Extension (OLE)|Adverse Event|0|||
126583435|NCT00676715|455434757|FG001|Open Label Extension (OLE)|Adverse Event|3|||
126583436|NCT00676715|455434758|FG002|Open Label Extension (OLE)|Adverse Event|1|||
126583437|NCT00676715|455434759|FG003|Open Label Extension (OLE)|Adverse Event|0|||
126583438|NCT00676715|455434756|FG000|Open Label Extension (OLE)|Death|2|||
126583439|NCT00676715|455434757|FG001|Open Label Extension (OLE)|Death|0|||
126583440|NCT00676715|455434758|FG002|Open Label Extension (OLE)|Death|2|||
126533292|NCT03206203|455244436|FG001|Optional Cross-Over|Death|0|||
126533293|NCT03206203|455244437|FG002|Optional Cross-Over|Death|14|||
126533294|NCT03206203|455244435|FG000|Optional Cross-Over|Refused follow-up|0|||
126533295|NCT03206203|455244436|FG001|Optional Cross-Over|Refused follow-up|0|||
126533296|NCT03206203|455244437|FG002|Optional Cross-Over|Refused follow-up|2|||
126533297|NCT00335322|455244438|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
126533298|NCT00335322|455244439|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
126533299|NCT00335322|455244440|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
126533300|NCT01152580|455244443|FG000|Overall Study|Withdrawal by Subject|0|||
126533301|NCT01152580|455244444|FG001|Overall Study|Withdrawal by Subject|1|||
126533302|NCT03364751|455244445|FG000|Overall Study|Withdrawal by Subject|1|||
126533303|NCT03364751|455244446|FG001|Overall Study|Withdrawal by Subject|0|||
126583441|NCT00676715|455434759|FG003|Open Label Extension (OLE)|Death|2|||
126583442|NCT01820260|455434760|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583443|NCT01820260|455434761|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583444|NCT01820260|455434762|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583445|NCT01820260|455434763|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583446|NCT01820260|455434764|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583447|NCT01820260|455434765|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583448|NCT01820260|455434766|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
126583449|NCT01820260|455434767|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583450|NCT01820260|455434768|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583451|NCT01820260|455434769|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583452|NCT01820260|455434770|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583453|NCT01820260|455434771|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583454|NCT01820260|455434772|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583455|NCT01820260|455434773|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
126583456|NCT01820260|455434760|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583457|NCT01820260|455434761|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583458|NCT01820260|455434762|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583459|NCT01820260|455434763|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583460|NCT01820260|455434764|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583461|NCT01820260|455434765|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583462|NCT01820260|455434766|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583463|NCT01820260|455434767|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583464|NCT01820260|455434768|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583465|NCT01820260|455434769|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
126583466|NCT01820260|455434770|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583467|NCT01820260|455434771|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583468|NCT01820260|455434772|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583469|NCT01820260|455434773|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
126583470|NCT04831281|455434775|FG000|Overall Study|Adverse Event|1|||
126583471|NCT04831281|455434776|FG001|Overall Study|Adverse Event|0|||
126583472|NCT04831281|455434777|FG002|Overall Study|Adverse Event|3|||
126583473|NCT04831281|455434775|FG000|Overall Study|Withdrawal by Subject|0|||
126583474|NCT04831281|455434776|FG001|Overall Study|Withdrawal by Subject|1|||
126583475|NCT04831281|455434777|FG002|Overall Study|Withdrawal by Subject|2|||
126583476|NCT04831281|455434775|FG000|Overall Study|Undetermined|1|||
126583477|NCT04831281|455434776|FG001|Overall Study|Undetermined|1|||
126583478|NCT04831281|455434777|FG002|Overall Study|Undetermined|0|||
126583479|NCT02249949|455434778|FG000|Overall Study|Cancelled prior to treatment|2|||
126583480|NCT02097420|455434779|FG000|Overall Study|Death|6|||
126583481|NCT02097420|455434779|FG000|Overall Study|Valve explanted|13|||
126583482|NCT02097420|455434779|FG000|Overall Study|Other Reason|1|||
126583483|NCT02867384|455434780|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
126583484|NCT02867384|455434781|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
126583485|NCT02867384|455434782|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
126583486|NCT02867384|455434780|FG000|Overall Study|Progression/ Relapse|15|||
126583487|NCT02867384|455434781|FG001|Overall Study|Progression/ Relapse|19|||
126583488|NCT02867384|455434782|FG002|Overall Study|Progression/ Relapse|0|||
126583489|NCT02867384|455434780|FG000|Overall Study|Adverse Event|13|||
126583490|NCT02867384|455434781|FG001|Overall Study|Adverse Event|1|||
126583491|NCT02867384|455434782|FG002|Overall Study|Adverse Event|0|||
126583492|NCT02867384|455434780|FG000|Overall Study|Withdrawal by Subject|6|||
126583493|NCT02867384|455434781|FG001|Overall Study|Withdrawal by Subject|5|||
126583494|NCT02867384|455434782|FG002|Overall Study|Withdrawal by Subject|0|||
126583495|NCT02867384|455434780|FG000|Overall Study|Physician Decision|1|||
126583496|NCT02867384|455434781|FG001|Overall Study|Physician Decision|2|||
126533304|NCT03364751|455244447|FG002|Overall Study|Withdrawal by Subject|0|||
126533305|NCT03364751|455244448|FG003|Overall Study|Withdrawal by Subject|0|||
126533306|NCT03364751|455244445|FG000|Overall Study|Lost to Follow-up|0|||
126583497|NCT02867384|455434782|FG002|Overall Study|Physician Decision|0|||
126583498|NCT02867384|455434780|FG000|Overall Study|Patient compliance|1|||
126533307|NCT03364751|455244446|FG001|Overall Study|Lost to Follow-up|1|||
126533308|NCT03364751|455244447|FG002|Overall Study|Lost to Follow-up|0|||
126533309|NCT03364751|455244448|FG003|Overall Study|Lost to Follow-up|0|||
126533310|NCT00675766|455244449|FG000|Overall Study|Lost to Follow-up|6|||
126533311|NCT00675766|455244450|FG001|Overall Study|Lost to Follow-up|5|||
126533312|NCT00675766|455244451|FG002|Overall Study|Lost to Follow-up|21|||
126533313|NCT00675766|455244452|FG003|Overall Study|Lost to Follow-up|26|||
126533314|NCT02275065|455244454|FG000|Overall Study|Randomized but not treated|1|||
126533315|NCT02275065|455244455|FG001|Overall Study|Randomized but not treated|0|||
126533316|NCT02275065|455244456|FG002|Overall Study|Randomized but not treated|1|||
126533317|NCT02275065|455244457|FG003|Overall Study|Randomized but not treated|1|||
126533318|NCT02275065|455244458|FG004|Overall Study|Randomized but not treated|0|||
126533319|NCT03015402|455244459|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
126533320|NCT03015402|455244460|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
126533321|NCT03015402|455244459|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
126533322|NCT03015402|455244460|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
126533323|NCT03213158|455244461|FG000|Overall Study|Withdrawal by Subject|1|||
126533324|NCT03213158|455244461|FG000|Overall Study|Physician Decision|2|||
126533325|NCT01995461|455244464|FG000|Overall Study|Death|1|||
126533326|NCT01995461|455244464|FG000|Overall Study|Lost to Follow-up|2|||
126533327|NCT01995461|455244464|FG000|Overall Study|Withdrawal by Subject|2|||
126533328|NCT04322682|455244471|FG000|Overall Study|Withdrawal by Subject|33|||
126533329|NCT04322682|455244472|FG001|Overall Study|Withdrawal by Subject|47|||
126533330|NCT04322682|455244471|FG000|Overall Study|Death|5|||
126533331|NCT04322682|455244472|FG001|Overall Study|Death|9|||
126533332|NCT04322682|455244471|FG000|Overall Study|Lost to Follow-up|4|||
126533333|NCT04322682|455244472|FG001|Overall Study|Lost to Follow-up|8|||
126533334|NCT04322682|455244471|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
126533335|NCT04322682|455244472|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
126533336|NCT00605280|455244473|FG000|Year 1|Protocol Violation|0|||
126533337|NCT00605280|455244474|FG001|Year 1|Protocol Violation|0|||
126533338|NCT00605280|455244475|FG002|Year 1|Protocol Violation|0|||
126533339|NCT00605280|455244476|FG003|Year 1|Protocol Violation|1|||
126533340|NCT00605280|455244473|FG000|Year 1|Adverse Event|3|||
126533341|NCT00605280|455244474|FG001|Year 1|Adverse Event|1|||
126533342|NCT00605280|455244475|FG002|Year 1|Adverse Event|1|||
126533343|NCT00605280|455244476|FG003|Year 1|Adverse Event|5|||
126533344|NCT00605280|455244473|FG000|Year 1|Physician Decision|7|||
126533345|NCT00605280|455244474|FG001|Year 1|Physician Decision|4|||
126533346|NCT00605280|455244475|FG002|Year 1|Physician Decision|0|||
126533347|NCT00605280|455244476|FG003|Year 1|Physician Decision|6|||
126533348|NCT00605280|455244473|FG000|Year 1|Withdrawal by Subject|2|||
126533349|NCT00605280|455244474|FG001|Year 1|Withdrawal by Subject|4|||
126533350|NCT00605280|455244475|FG002|Year 1|Withdrawal by Subject|0|||
126533351|NCT00605280|455244476|FG003|Year 1|Withdrawal by Subject|4|||
126533352|NCT00605280|455244473|FG000|Year 1|Other|2|||
126533353|NCT00605280|455244474|FG001|Year 1|Other|1|||
126533354|NCT00605280|455244475|FG002|Year 1|Other|0|||
126533355|NCT00605280|455244476|FG003|Year 1|Other|1|||
126533356|NCT00605280|455244473|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
126533357|NCT00605280|455244474|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
126533358|NCT00605280|455244475|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
126533359|NCT00605280|455244476|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
126533360|NCT00605280|455244473|FG000|Year 2|Adverse Event|4|||
126533361|NCT00605280|455244474|FG001|Year 2|Adverse Event|0|||
126533362|NCT00605280|455244475|FG002|Year 2|Adverse Event|2|||
126533363|NCT00605280|455244476|FG003|Year 2|Adverse Event|4|||
126533364|NCT00605280|455244473|FG000|Year 2|Physician Decision|11|||
126533365|NCT00605280|455244474|FG001|Year 2|Physician Decision|6|||
126533366|NCT00605280|455244475|FG002|Year 2|Physician Decision|4|||
126533367|NCT00605280|455244476|FG003|Year 2|Physician Decision|11|||
126533368|NCT00605280|455244473|FG000|Year 2|Withdrawal by Subject|4|||
126533369|NCT00605280|455244474|FG001|Year 2|Withdrawal by Subject|0|||
126533370|NCT00605280|455244475|FG002|Year 2|Withdrawal by Subject|0|||
126533371|NCT00605280|455244476|FG003|Year 2|Withdrawal by Subject|4|||
126533372|NCT00605280|455244473|FG000|Year 2|Other|1|||
126533373|NCT00605280|455244474|FG001|Year 2|Other|0|||
126533374|NCT00605280|455244475|FG002|Year 2|Other|0|||
126533375|NCT00605280|455244476|FG003|Year 2|Other|1|||
126533376|NCT00605280|455244473|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
126533377|NCT00605280|455244474|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
126533378|NCT00605280|455244475|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
126533379|NCT00605280|455244476|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
126533380|NCT00605280|455244473|FG000|Year 3 Extension|Adverse Event|2|||
126533381|NCT00605280|455244474|FG001|Year 3 Extension|Adverse Event|0|||
126533382|NCT00605280|455244475|FG002|Year 3 Extension|Adverse Event|0|||
126533383|NCT00605280|455244476|FG003|Year 3 Extension|Adverse Event|2|||
126533384|NCT00605280|455244473|FG000|Year 3 Extension|Physician Decision|0|||
126533385|NCT00605280|455244474|FG001|Year 3 Extension|Physician Decision|0|||
126533386|NCT00605280|455244475|FG002|Year 3 Extension|Physician Decision|0|||
126533387|NCT00605280|455244476|FG003|Year 3 Extension|Physician Decision|2|||
126583499|NCT02867384|455434781|FG001|Overall Study|Patient compliance|0|||
126583500|NCT02867384|455434782|FG002|Overall Study|Patient compliance|0|||
126583501|NCT02867384|455434780|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
126583502|NCT02867384|455434781|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
126583503|NCT02867384|455434782|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
126583504|NCT02867384|455434780|FG000|Overall Study|Never start treatment|0|||
126583505|NCT02867384|455434781|FG001|Overall Study|Never start treatment|0|||
126583506|NCT02867384|455434782|FG002|Overall Study|Never start treatment|3|||
126583507|NCT03161379|455434785|FG000|Overall Study|Withdrawal by Subject|4|||
126583508|NCT03161379|455434785|FG000|Overall Study|disease progression during chemotherapy|5|||
126583509|NCT03161379|455434785|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
126583510|NCT03161379|455434785|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
126583511|NCT02728076|455434786|FG000|Overall Study|Physician Decision|4|||
126583512|NCT05054374|455434787|FG000|Overall Study|Withdrawal by Subject|1|||
126583513|NCT05054374|455434788|FG001|Overall Study|Withdrawal by Subject|0|||
126583514|NCT05054374|455434789|FG002|Overall Study|Withdrawal by Subject|0|||
126583515|NCT05054374|455434790|FG003|Overall Study|Withdrawal by Subject|0|||
126583516|NCT05054374|455434787|FG000|Overall Study|Progressive Disease|5|||
126583517|NCT05054374|455434788|FG001|Overall Study|Progressive Disease|0|||
126583518|NCT05054374|455434789|FG002|Overall Study|Progressive Disease|0|||
126583519|NCT05054374|455434790|FG003|Overall Study|Progressive Disease|0|||
126583520|NCT04089371|455434791|FG000|Overall Study|Withdrawal by Subject|0|||
126583521|NCT04089371|455434792|FG001|Overall Study|Withdrawal by Subject|1|||
126583522|NCT04089371|455434791|FG000|Overall Study|Study terminated early|0|||
126583523|NCT04089371|455434792|FG001|Overall Study|Study terminated early|9|||
126583524|NCT03453619|455434793|FG000|Core Study (Part A)|Physician Decision|0|||
126583525|NCT03453619|455434794|FG001|Core Study (Part A)|Physician Decision|0|||
126583526|NCT03453619|455434795|FG002|Core Study (Part A)|Physician Decision|2|||
126583527|NCT03453619|455434796|FG003|Core Study (Part A)|Physician Decision|0|||
126583528|NCT03453619|455434793|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
126583529|NCT03453619|455434794|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
126583530|NCT03453619|455434795|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
126583531|NCT03453619|455434796|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
126583532|NCT03453619|455434793|FG000|Core Study (Part A)|Other|0|||
126583533|NCT03453619|455434794|FG001|Core Study (Part A)|Other|1|||
126583534|NCT03453619|455434795|FG002|Core Study (Part A)|Other|0|||
126583535|NCT03453619|455434796|FG003|Core Study (Part A)|Other|0|||
126583536|NCT03453619|455434793|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
126583537|NCT03453619|455434794|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
126583538|NCT03453619|455434795|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
126583539|NCT03453619|455434796|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
126583540|NCT03453619|455434793|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
126583541|NCT03453619|455434794|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
126583542|NCT03453619|455434795|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
126583543|NCT03453619|455434796|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
126583544|NCT03453619|455434793|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
126583545|NCT03453619|455434794|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
126583546|NCT03453619|455434795|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
126583547|NCT03453619|455434796|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
126583548|NCT03453619|455434793|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
126583549|NCT03453619|455434794|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
126583550|NCT03453619|455434795|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
126583551|NCT03453619|455434796|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
126583552|NCT04936035|455434800|FG000|Overall Study|Adverse Event|0|||
126583553|NCT04936035|455434801|FG001|Overall Study|Adverse Event|1|||
126583554|NCT04936035|455434802|FG002|Overall Study|Adverse Event|0|||
126583555|NCT04936035|455434803|FG003|Overall Study|Adverse Event|0|||
126583556|NCT04936035|455434804|FG004|Overall Study|Adverse Event|0|||
126583557|NCT04936035|455434800|FG000|Overall Study|Death|0|||
126583558|NCT04936035|455434801|FG001|Overall Study|Death|0|||
126583559|NCT04936035|455434802|FG002|Overall Study|Death|0|||
126583560|NCT04936035|455434803|FG003|Overall Study|Death|1|||
126583561|NCT04936035|455434804|FG004|Overall Study|Death|0|||
126730623|NCT03814590|455963032|FG008|Overall Study|Lost to Follow-up|0|||
126730624|NCT03814590|455963033|FG009|Overall Study|Lost to Follow-up|0|||
126583562|NCT04936035|455434800|FG000|Overall Study|Lost to Follow-up|0|||
126583563|NCT04936035|455434801|FG001|Overall Study|Lost to Follow-up|1|||
126583564|NCT04936035|455434802|FG002|Overall Study|Lost to Follow-up|1|||
126583565|NCT04936035|455434803|FG003|Overall Study|Lost to Follow-up|2|||
126583566|NCT04936035|455434804|FG004|Overall Study|Lost to Follow-up|1|||
126730625|NCT03814590|455963034|FG010|Overall Study|Lost to Follow-up|1|||
126730626|NCT03814590|455963035|FG011|Overall Study|Lost to Follow-up|0|||
126583567|NCT04936035|455434800|FG000|Overall Study|Physician Decision|0|||
126583568|NCT04936035|455434801|FG001|Overall Study|Physician Decision|1|||
126583569|NCT04936035|455434802|FG002|Overall Study|Physician Decision|0|||
126583570|NCT04936035|455434803|FG003|Overall Study|Physician Decision|0|||
126583571|NCT04936035|455434804|FG004|Overall Study|Physician Decision|0|||
126583572|NCT04936035|455434800|FG000|Overall Study|Protocol Deviation|0|||
126583573|NCT04936035|455434801|FG001|Overall Study|Protocol Deviation|0|||
126583574|NCT04936035|455434802|FG002|Overall Study|Protocol Deviation|1|||
126583575|NCT04936035|455434803|FG003|Overall Study|Protocol Deviation|0|||
126583576|NCT04936035|455434804|FG004|Overall Study|Protocol Deviation|0|||
126583577|NCT04936035|455434800|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
126583578|NCT04936035|455434801|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
126583579|NCT04936035|455434802|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
126583580|NCT04936035|455434803|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
126583581|NCT04936035|455434804|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
126583582|NCT04936035|455434800|FG000|Overall Study|Reason Unknown|0|||
126583583|NCT04936035|455434801|FG001|Overall Study|Reason Unknown|0|||
126583584|NCT04936035|455434802|FG002|Overall Study|Reason Unknown|0|||
126583585|NCT04936035|455434803|FG003|Overall Study|Reason Unknown|0|||
126583586|NCT04936035|455434804|FG004|Overall Study|Reason Unknown|1|||
126583587|NCT04936035|455434800|FG000|Overall Study|Withdrawal by Subject|1|||
126583588|NCT04936035|455434801|FG001|Overall Study|Withdrawal by Subject|0|||
126583589|NCT04936035|455434802|FG002|Overall Study|Withdrawal by Subject|0|||
126583590|NCT04936035|455434803|FG003|Overall Study|Withdrawal by Subject|0|||
126583591|NCT04936035|455434804|FG004|Overall Study|Withdrawal by Subject|0|||
126583592|NCT04936035|455434800|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
126583593|NCT04936035|455434801|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
126583594|NCT04936035|455434802|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
126583595|NCT04936035|455434803|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
126583596|NCT04936035|455434804|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
126583597|NCT04936035|455434800|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
126583598|NCT04936035|455434801|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
126583599|NCT04936035|455434802|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
126583600|NCT04936035|455434803|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
126730627|NCT03814590|455963036|FG012|Overall Study|Lost to Follow-up|0|||
126730628|NCT03814590|455963037|FG013|Overall Study|Lost to Follow-up|1|||
126756572|NCT00883896|456059483|FG001|Overall Study|Lost to Follow-up|0|||
126583601|NCT04936035|455434804|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
126640451|NCT00479882|455642774|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
126640452|NCT00479882|455642775|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
126640453|NCT00479882|455642776|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
126640454|NCT00479882|455642777|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
126640455|NCT00479882|455642774|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
126640456|NCT00479882|455642775|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
126640457|NCT00479882|455642776|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
126640458|NCT00479882|455642777|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
126640459|NCT00479882|455642774|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
126640460|NCT00479882|455642775|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
126640461|NCT00479882|455642776|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
126640462|NCT00479882|455642777|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
126640463|NCT00479882|455642774|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
126640464|NCT00479882|455642775|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
126640465|NCT00479882|455642776|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
126640466|NCT00479882|455642777|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
126640467|NCT00479882|455642774|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
126640468|NCT00479882|455642775|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
126640469|NCT00479882|455642776|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
126640470|NCT00479882|455642777|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
126640471|NCT00479882|455642774|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
126640472|NCT00479882|455642775|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
126640473|NCT00479882|455642776|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
126640474|NCT00479882|455642777|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
126640475|NCT00479882|455642774|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
126640476|NCT00479882|455642775|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
126640477|NCT00479882|455642776|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
126640478|NCT00479882|455642777|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
126640479|NCT03738475|455642778|FG000|Overall Study|Participant Non-Compliance|1|||
126640480|NCT03738475|455642779|FG001|Overall Study|Participant Non-Compliance|0|||
126583602|NCT04936035|455434800|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
126583603|NCT04936035|455434801|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
126583604|NCT04936035|455434802|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
126583605|NCT04936035|455434803|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
126583606|NCT04936035|455434804|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
126583607|NCT05633407|455434810|FG000|Overall Study|Physician Decision|2|||
126583608|NCT05633407|455434811|FG001|Overall Study|Physician Decision|0|||
126583609|NCT05633407|455434810|FG000|Overall Study|Adverse Event|1|||
126583610|NCT05633407|455434811|FG001|Overall Study|Adverse Event|0|||
126583611|NCT05633407|455434810|FG000|Overall Study|Withdrawal by Subject|1|||
126583612|NCT05633407|455434811|FG001|Overall Study|Withdrawal by Subject|0|||
126583613|NCT05633407|455434810|FG000|Overall Study|Other|1|||
126583614|NCT05633407|455434811|FG001|Overall Study|Other|1|||
126583615|NCT04850807|455436093|FG000|Overall Study|Death|50|||
126583616|NCT04850807|455436094|FG001|Overall Study|Death|55|||
126583617|NCT04850807|455436093|FG000|Overall Study|Discharged|17|||
126583618|NCT04850807|455436094|FG001|Overall Study|Discharged|13|||
126583619|NCT04850807|455436093|FG000|Overall Study|Incomplete baseline data|3|||
126583620|NCT04850807|455436094|FG001|Overall Study|Incomplete baseline data|2|||
126583621|NCT04593472|455436095|FG000|Overall Study|Death|31|||
126583622|NCT04593472|455436096|FG001|Overall Study|Death|27|||
126583623|NCT04593472|455436095|FG000|Overall Study|Withdrawal by Subject|12|||
126583624|NCT04593472|455436096|FG001|Overall Study|Withdrawal by Subject|12|||
126583625|NCT04593472|455436095|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
126583626|NCT04593472|455436096|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
126583627|NCT04593472|455436095|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
126583628|NCT04593472|455436096|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
126583629|NCT04593472|455436095|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
126583630|NCT04593472|455436096|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
126583631|NCT04593472|455436095|FG000|Overall Study|Lost to Follow-up|0|||
126583632|NCT04593472|455436096|FG001|Overall Study|Lost to Follow-up|2|||
126583633|NCT04593472|455436095|FG000|Overall Study|Still collecting 24-month assessment|17|||
126583634|NCT04593472|455436096|FG001|Overall Study|Still collecting 24-month assessment|10|||
126583635|NCT04178733|455436097|FG000|Overall Study|Investigator Decision|0|||
126583636|NCT04178733|455436098|FG001|Overall Study|Investigator Decision|0|||
126583637|NCT04178733|455436099|FG002|Overall Study|Investigator Decision|0|||
126583638|NCT04178733|455436100|FG003|Overall Study|Investigator Decision|1|||
126583639|NCT04178733|455436101|FG004|Overall Study|Investigator Decision|2|||
126583640|NCT04833777|455436106|FG000|Overall Study|Lost to Follow-up|1|||
126583641|NCT04833777|455436107|FG001|Overall Study|Lost to Follow-up|0|||
126583642|NCT03896516|455436108|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
126583643|NCT03896516|455436109|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
126583644|NCT03896516|455436108|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
126583645|NCT03896516|455436109|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
126583646|NCT03896516|455436108|FG000|Washout Period|Physician Decision|3|||
126583647|NCT03896516|455436109|FG001|Washout Period|Physician Decision|1|||
126583648|NCT03896516|455436108|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
126583649|NCT03896516|455436109|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
126583650|NCT03648840|455436114|FG000|First IV Infusion Session|Adverse Event|0|||
126583651|NCT03648840|455436115|FG001|First IV Infusion Session|Adverse Event|2|||
126583652|NCT03648840|455436114|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
126583653|NCT03648840|455436115|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
126583654|NCT03648840|455436114|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
126583655|NCT03648840|455436115|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
126583656|NCT03648840|455436114|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
126583657|NCT03648840|455436115|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
126583658|NCT05382936|455436118|FG000|Overall Study|Progressive Disease|3|||
126583659|NCT05382936|455436119|FG001|Overall Study|Progressive Disease|5|||
126583660|NCT05382936|455436120|FG002|Overall Study|Progressive Disease|2|||
126583661|NCT05382936|455436121|FG003|Overall Study|Progressive Disease|5|||
126583662|NCT05382936|455436118|FG000|Overall Study|Adverse Event|0|||
126583663|NCT05382936|455436119|FG001|Overall Study|Adverse Event|1|||
126583664|NCT05382936|455436120|FG002|Overall Study|Adverse Event|1|||
126583665|NCT05382936|455436121|FG003|Overall Study|Adverse Event|0|||
126583666|NCT05382936|455436118|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
126583667|NCT05382936|455436119|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
126583668|NCT05382936|455436120|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
126583669|NCT05382936|455436121|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
126583670|NCT05382936|455436118|FG000|Overall Study|Withdrawal by Subject|0|||
126583671|NCT05382936|455436119|FG001|Overall Study|Withdrawal by Subject|0|||
126583672|NCT05382936|455436120|FG002|Overall Study|Withdrawal by Subject|1|||
126583673|NCT05382936|455436121|FG003|Overall Study|Withdrawal by Subject|1|||
126583674|NCT01195831|455436125|FG000|Overall Study|Lost to Follow-up|2|||
126583675|NCT01195831|455436126|FG001|Overall Study|Lost to Follow-up|4|||
126583676|NCT01195831|455436125|FG000|Overall Study|Withdrawal by Subject|2|||
126583677|NCT01195831|455436126|FG001|Overall Study|Withdrawal by Subject|2|||
126583678|NCT01195831|455436125|FG000|Overall Study|Adverse Event|4|||
126583679|NCT01195831|455436126|FG001|Overall Study|Adverse Event|2|||
126583680|NCT01195831|455436125|FG000|Overall Study|Protocol Violation|0|||
126583681|NCT01195831|455436126|FG001|Overall Study|Protocol Violation|2|||
126583682|NCT01857934|455436127|FG000|Overall Study|Relapse or progression|2|||
126583683|NCT01857934|455436127|FG000|Overall Study|Unacceptable toxicity|3|||
126583684|NCT01857934|455436127|FG000|Overall Study|Unwillingness or inability to comply|2|||
126583685|NCT01857934|455436127|FG000|Overall Study|Physician Decision|3|||
126583686|NCT03713086|455436130|FG000|Overall Study|Withdrawal by Subject|0|||
126583687|NCT03713086|455436131|FG001|Overall Study|Withdrawal by Subject|2|||
126583688|NCT03713086|455436132|FG002|Overall Study|Withdrawal by Subject|1|||
126583689|NCT03713086|455436133|FG003|Overall Study|Withdrawal by Subject|0|||
126583690|NCT03713086|455436130|FG000|Overall Study|Lost to Follow-up|0|||
126583691|NCT03713086|455436131|FG001|Overall Study|Lost to Follow-up|1|||
126583692|NCT03713086|455436132|FG002|Overall Study|Lost to Follow-up|0|||
126583693|NCT03713086|455436133|FG003|Overall Study|Lost to Follow-up|1|||
126583694|NCT02307565|455436141|FG000|Overall Study|Adverse Event|3|||
126583695|NCT02307565|455436142|FG001|Overall Study|Adverse Event|2|||
126583696|NCT02307565|455436141|FG000|Overall Study|Withdrawal by Subject|2|||
126583697|NCT02307565|455436142|FG001|Overall Study|Withdrawal by Subject|2|||
126583698|NCT03385629|455436143|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
126583699|NCT03385629|455436144|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
126583700|NCT03385629|455436143|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
126583701|NCT03385629|455436144|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
126583702|NCT03385629|455436143|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
126583703|NCT03385629|455436144|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
126583704|NCT02913872|455436149|FG000|Overall Study|Withdrawal by Subject|1|||
126583705|NCT03978871|455436150|FG000|Overall Study|Lost to Follow-up|11|||
126583706|NCT03978871|455436151|FG001|Overall Study|Lost to Follow-up|12|||
126583707|NCT04072822|455436152|FG000|Treatment|Adverse Event|9|||
126583708|NCT04072822|455436153|FG001|Treatment|Adverse Event|5|||
126583709|NCT04072822|455436152|FG000|Treatment|Met Stopping Criteria|13|||
126583710|NCT04072822|455436153|FG001|Treatment|Met Stopping Criteria|24|||
126583711|NCT04072822|455436152|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
126583712|NCT04072822|455436153|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
126583713|NCT04072822|455436152|FG000|Treatment|Withdrawal by Subject|0|||
126583714|NCT04072822|455436153|FG001|Treatment|Withdrawal by Subject|2|||
126583715|NCT04072822|455436152|FG000|Treatment|Death|0|||
126583716|NCT04072822|455436153|FG001|Treatment|Death|2|||
126583717|NCT04072822|455436152|FG000|Treatment|Lost to Follow-up|11|||
126583718|NCT04072822|455436153|FG001|Treatment|Lost to Follow-up|3|||
126583719|NCT04072822|455436152|FG000|Treatment|Physician Decision|1|||
126583720|NCT04072822|455436153|FG001|Treatment|Physician Decision|0|||
126583721|NCT04072822|455436152|FG000|Treatment|Other|7|||
126583722|NCT04072822|455436153|FG001|Treatment|Other|9|||
126583723|NCT04072822|455436152|FG000|Follow-up|Withdrawal by Subject|1|||
126583724|NCT04072822|455436153|FG001|Follow-up|Withdrawal by Subject|0|||
126583725|NCT04072822|455436152|FG000|Follow-up|Lost to Follow-up|5|||
126583726|NCT04072822|455436153|FG001|Follow-up|Lost to Follow-up|4|||
126583727|NCT02323321|455436158|FG000|Overall Study|Re-Transplant|1|||
126583728|NCT02323321|455436158|FG000|Overall Study|Death|12|||
126583729|NCT00446225|455436159|FG000|Overall Study|Protocol Violation|1|||
126583730|NCT00446225|455436160|FG001|Overall Study|Protocol Violation|0|||
126583731|NCT04450342|455436161|FG000|Overall Study|Adverse Event|1|||
126583732|NCT04450342|455436162|FG001|Overall Study|Adverse Event|1|||
126583733|NCT04450342|455436163|FG002|Overall Study|Adverse Event|0|||
126583734|NCT04450342|455436161|FG000|Overall Study|Device not used|1|||
126583735|NCT04450342|455436162|FG001|Overall Study|Device not used|0|||
126583736|NCT04450342|455436163|FG002|Overall Study|Device not used|0|||
126583737|NCT04450342|455436161|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
126583738|NCT04450342|455436162|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
126583739|NCT04450342|455436163|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
126583740|NCT04450342|455436161|FG000|Overall Study|Physician Decision|1|||
126583741|NCT04450342|455436162|FG001|Overall Study|Physician Decision|0|||
126583742|NCT04450342|455436163|FG002|Overall Study|Physician Decision|1|||
126583743|NCT04450342|455436161|FG000|Overall Study|Protocol Deviation|0|||
126583744|NCT04450342|455436162|FG001|Overall Study|Protocol Deviation|1|||
126583745|NCT04450342|455436163|FG002|Overall Study|Protocol Deviation|0|||
126583746|NCT04450342|455436161|FG000|Overall Study|Reoperation|1|||
126583747|NCT04450342|455436162|FG001|Overall Study|Reoperation|1|||
126583748|NCT04450342|455436163|FG002|Overall Study|Reoperation|0|||
126583749|NCT04450342|455436161|FG000|Overall Study|Screen Failures|0|||
126583750|NCT04450342|455436162|FG001|Overall Study|Screen Failures|0|||
126583751|NCT04450342|455436163|FG002|Overall Study|Screen Failures|2|||
126583752|NCT04450342|455436161|FG000|Overall Study|Site Terminated by Sponsor|1|||
126583753|NCT04450342|455436162|FG001|Overall Study|Site Terminated by Sponsor|1|||
126583754|NCT04450342|455436163|FG002|Overall Study|Site Terminated by Sponsor|1|||
126583755|NCT04450342|455436161|FG000|Overall Study|Study Terminated by Sponsor|31|||
126583756|NCT04450342|455436162|FG001|Overall Study|Study Terminated by Sponsor|29|||
126583757|NCT04450342|455436163|FG002|Overall Study|Study Terminated by Sponsor|6|||
126583758|NCT04450342|455436161|FG000|Overall Study|Withdrawal by Subject|0|||
126583759|NCT04450342|455436162|FG001|Overall Study|Withdrawal by Subject|1|||
126583760|NCT04450342|455436163|FG002|Overall Study|Withdrawal by Subject|2|||
126583761|NCT00220740|455436164|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
126583762|NCT00220740|455436165|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
126583763|NCT00220740|455436164|FG000|Efficacy Period|Adverse Event|1|||
126583764|NCT00220740|455436165|FG001|Efficacy Period|Adverse Event|1|||
126583765|NCT00220740|455436164|FG000|Efficacy Period|Withdrawal by Subject|1|||
126583766|NCT00220740|455436165|FG001|Efficacy Period|Withdrawal by Subject|0|||
126583767|NCT00220740|455436164|FG000|Efficacy Period|Protocol Violation|1|||
126583768|NCT00220740|455436165|FG001|Efficacy Period|Protocol Violation|0|||
126583769|NCT00220740|455436164|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
126583770|NCT00220740|455436165|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
126583771|NCT02811679|455436166|FG000|Overall Study|Adverse Event|1|||
126583772|NCT02811679|455436166|FG000|Overall Study|Lack of Efficacy|6|||
126583773|NCT02811679|455436166|FG000|Overall Study|Early study closure due to slow accrual|3|||
126583774|NCT04314895|455436169|FG000|Overall Study|Lost to Follow-up|1|||
126583775|NCT04314895|455436169|FG000|Overall Study|Death|10|||
126583776|NCT04314895|455436169|FG000|Overall Study|Physician Decision|2|||
126583777|NCT03941860|455436170|FG000|Overall Study|Withdrawal by Subject|0|||
126583778|NCT03941860|455436171|FG001|Overall Study|Withdrawal by Subject|1|||
126583779|NCT03361748|455436172|FG000|Overall Study|Death|77|||
126583780|NCT03361748|455436172|FG000|Overall Study|Lost to Follow-up|4|||
126583781|NCT03361748|455436172|FG000|Overall Study|Withdrawal by Subject|20|||
126583782|NCT02814838|455436175|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
126583783|NCT02814838|455436176|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
126583784|NCT02814838|455436175|FG000|Overall Study|Consent withdrawal|1|||
126583785|NCT02814838|455436176|FG001|Overall Study|Consent withdrawal|1|||
126583786|NCT01361711|455436178|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
126583787|NCT01361711|455436178|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
126583788|NCT01361711|455436178|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
126583789|NCT01361711|455436178|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
126583790|NCT01361711|455436178|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
126583791|NCT01361711|455436178|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
126583792|NCT01361711|455436178|FG000|Completed Week 18 of Treatment|Other|9|||
126583793|NCT01361711|455436178|FG000|10 Year Follow-up|Still in follow-up|22|||
126583794|NCT01361711|455436178|FG000|10 Year Follow-up|Death|7|||
126583795|NCT01361711|455436178|FG000|10 Year Follow-up|Developed new cancer|1|||
126583796|NCT01361711|455436178|FG000|10 Year Follow-up|Lost to Follow-up|2|||
126583797|NCT01361711|455436178|FG000|10 Year Follow-up|New treatment started|6|||
126583798|NCT01361711|455436178|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
126583799|NCT01361711|455436178|FG000|10 Year Follow-up|Progressive Disease|1|||
126583800|NCT02596126|455436179|FG000|Overall Study|Lost to Follow-up|12|||
126583801|NCT02596126|455436180|FG001|Overall Study|Lost to Follow-up|21|||
126583802|NCT02596126|455436179|FG000|Overall Study|Protocol Violation|7|||
126583803|NCT02596126|455436180|FG001|Overall Study|Protocol Violation|9|||
126583804|NCT03396588|455436181|FG000|Overall Study|Physician Decision|2|||
126583805|NCT03396588|455436182|FG001|Overall Study|Physician Decision|3|||
126583806|NCT00812461|455436183|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
126583807|NCT00812461|455436184|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
126583808|NCT00812461|455436183|FG000|All Treated Patients|Adverse Event|8|||
126583809|NCT00812461|455436184|FG001|All Treated Patients|Adverse Event|15|||
126583810|NCT00812461|455436183|FG000|All Treated Patients|Lack of Efficacy|13|||
126583811|NCT00812461|455436184|FG001|All Treated Patients|Lack of Efficacy|7|||
126583812|NCT00812461|455436183|FG000|All Treated Patients|Non-compliance|6|||
126583813|NCT00812461|455436184|FG001|All Treated Patients|Non-compliance|9|||
126583814|NCT00812461|455436183|FG000|All Treated Patients|Protocol Violation|36|||
126583815|NCT00812461|455436184|FG001|All Treated Patients|Protocol Violation|27|||
126583816|NCT00812461|455436183|FG000|All Treated Patients|Withdrawal by Subject|45|||
126583817|NCT00812461|455436184|FG001|All Treated Patients|Withdrawal by Subject|54|||
126583818|NCT00812461|455436183|FG000|All Treated Patients|Lost to Follow-up|11|||
126583819|NCT00812461|455436184|FG001|All Treated Patients|Lost to Follow-up|14|||
126583820|NCT00812461|455436183|FG000|All Treated Patients|Other Reason|13|||
126583821|NCT00812461|455436184|FG001|All Treated Patients|Other Reason|21|||
126583822|NCT04402489|455437916|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
126583823|NCT04402489|455437917|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
126640481|NCT00737477|455642780|FG000|Overall Study|Adverse Event|9|||
126583824|NCT04402489|455437918|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
126583825|NCT04402489|455437919|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
126583826|NCT04402489|455437920|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
126583827|NCT04402489|455437916|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
126583828|NCT04402489|455437917|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
126583829|NCT04402489|455437918|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
126730629|NCT03814590|455963024|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126730630|NCT03814590|455963025|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126730631|NCT03814590|455963026|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126730632|NCT03814590|455963027|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126730633|NCT03814590|455963028|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126730634|NCT03814590|455963029|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126730635|NCT03814590|455963030|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126756573|NCT00883896|456059484|FG002|Overall Study|Lost to Follow-up|0|||
126533388|NCT00605280|455244473|FG000|Year 3 Extension|Withdrawal by Subject|2|||
126533389|NCT00605280|455244474|FG001|Year 3 Extension|Withdrawal by Subject|0|||
126533390|NCT00605280|455244475|FG002|Year 3 Extension|Withdrawal by Subject|0|||
126533391|NCT00605280|455244476|FG003|Year 3 Extension|Withdrawal by Subject|5|||
126533392|NCT00605280|455244473|FG000|Year 3 Extension|Other|2|||
126533393|NCT00605280|455244474|FG001|Year 3 Extension|Other|0|||
126533394|NCT00605280|455244475|FG002|Year 3 Extension|Other|0|||
126533395|NCT00605280|455244476|FG003|Year 3 Extension|Other|0|||
126533396|NCT00605280|455244473|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
126533397|NCT00605280|455244474|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
126533398|NCT00605280|455244475|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
126533399|NCT00605280|455244476|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
126533400|NCT01662310|455244477|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
126533401|NCT01662310|455244478|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
126533402|NCT01662310|455244479|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
126533403|NCT01662310|455244480|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
126533404|NCT01662310|455244481|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
126533405|NCT01662310|455244477|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
126533406|NCT01662310|455244478|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
126533407|NCT01662310|455244479|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
126533408|NCT01662310|455244480|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
126533409|NCT01662310|455244481|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
126533410|NCT01662310|455244477|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
126533411|NCT01662310|455244478|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
126583830|NCT04402489|455437919|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
126583831|NCT04402489|455437920|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
126583832|NCT04402489|455437916|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
126583833|NCT04402489|455437917|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
126583834|NCT04402489|455437918|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
126583835|NCT04402489|455437919|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
126583836|NCT04402489|455437920|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
126583837|NCT04402489|455437916|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
126583838|NCT04402489|455437917|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
126583839|NCT04402489|455437918|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
126583840|NCT04402489|455437919|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
126583841|NCT04402489|455437920|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
126583842|NCT04402489|455437916|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
126583843|NCT04402489|455437917|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
126583844|NCT04402489|455437918|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
126583845|NCT04402489|455437919|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
126583846|NCT04402489|455437920|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
126583847|NCT04402489|455437916|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
126583848|NCT04402489|455437917|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
126583849|NCT04402489|455437918|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
126583850|NCT04402489|455437919|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
126583851|NCT04402489|455437920|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
126583852|NCT02287311|455437927|FG000|Cohort 1: Dose Level 1|Death|2|||
126583853|NCT02287311|455437928|FG001|Cohort 1: Dose Level 1|Death|0|||
126583854|NCT02287311|455437929|FG002|Cohort 1: Dose Level 1|Death|0|||
126583855|NCT02287311|455437930|FG003|Cohort 1: Dose Level 1|Death|3|||
126533412|NCT01662310|455244479|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
126533413|NCT01662310|455244480|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
126533414|NCT01662310|455244481|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
126730636|NCT03814590|455963031|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126730637|NCT03814590|455963032|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126730638|NCT03814590|455963033|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
126730639|NCT03814590|455963034|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126730640|NCT03814590|455963035|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126730641|NCT03814590|455963036|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126730642|NCT03814590|455963037|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
126730643|NCT03814590|455963024|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126730644|NCT03814590|455963025|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126730645|NCT03814590|455963026|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126730646|NCT03814590|455963027|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126730647|NCT03814590|455963028|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126730648|NCT03814590|455963029|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
126730649|NCT03814590|455963030|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
126730650|NCT03814590|455963031|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
126730651|NCT03814590|455963032|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126730652|NCT03814590|455963033|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
126730653|NCT03814590|455963034|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
126730654|NCT03814590|455963035|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
126730655|NCT03814590|455963036|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
126730656|NCT03814590|455963037|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
126730657|NCT03814590|455963024|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126730658|NCT03814590|455963025|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126730659|NCT03814590|455963026|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126730660|NCT03814590|455963027|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126730661|NCT03814590|455963028|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126730662|NCT03814590|455963029|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126730663|NCT03814590|455963030|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126730664|NCT03814590|455963031|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126730665|NCT03814590|455963032|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126730666|NCT03814590|455963033|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
126730667|NCT03814590|455963034|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126730668|NCT03814590|455963035|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126730669|NCT03814590|455963036|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126730670|NCT03814590|455963037|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
126730671|NCT03814590|455963024|FG000|Overall Study|UNKNOWN REASON|0|||
126730672|NCT03814590|455963025|FG001|Overall Study|UNKNOWN REASON|0|||
126730673|NCT03814590|455963026|FG002|Overall Study|UNKNOWN REASON|0|||
126730674|NCT03814590|455963027|FG003|Overall Study|UNKNOWN REASON|0|||
126730675|NCT03814590|455963028|FG004|Overall Study|UNKNOWN REASON|0|||
126730676|NCT03814590|455963029|FG005|Overall Study|UNKNOWN REASON|0|||
126730677|NCT03814590|455963030|FG006|Overall Study|UNKNOWN REASON|0|||
126730678|NCT03814590|455963031|FG007|Overall Study|UNKNOWN REASON|1|||
126730679|NCT03814590|455963032|FG008|Overall Study|UNKNOWN REASON|0|||
126730680|NCT03814590|455963033|FG009|Overall Study|UNKNOWN REASON|0|||
126730681|NCT03814590|455963034|FG010|Overall Study|UNKNOWN REASON|0|||
126730682|NCT03814590|455963035|FG011|Overall Study|UNKNOWN REASON|0|||
126730683|NCT03814590|455963036|FG012|Overall Study|UNKNOWN REASON|0|||
126730684|NCT03814590|455963037|FG013|Overall Study|UNKNOWN REASON|0|||
126730685|NCT00567541|455963041|FG000|Overall Study|Adverse Event|0|||
126730686|NCT00567541|455963042|FG001|Overall Study|Adverse Event|1|||
126730687|NCT03519516|455963045|FG000|Overall Study|Adverse Event|0|||
126730688|NCT03519516|455963046|FG001|Overall Study|Adverse Event|1|||
126730689|NCT01890512|455963047|FG000|Overall Study|Physician Decision|1|||
126730690|NCT01890512|455963047|FG000|Overall Study|Withdrawal by Subject|1|||
126730691|NCT01890512|455963047|FG000|Overall Study|Protocol Violation|1|||
126730692|NCT01935336|455963048|FG000|Overall Study|Adverse Event|1|||
126730693|NCT01935336|455963049|FG001|Overall Study|Adverse Event|0|||
126730694|NCT01935336|455963050|FG002|Overall Study|Adverse Event|0|||
126730695|NCT01935336|455963051|FG003|Overall Study|Adverse Event|0|||
126730696|NCT01935336|455963048|FG000|Overall Study|Progressive disease|5|||
126730697|NCT01935336|455963049|FG001|Overall Study|Progressive disease|3|||
126730698|NCT01935336|455963050|FG002|Overall Study|Progressive disease|47|||
126730699|NCT01935336|455963051|FG003|Overall Study|Progressive disease|66|||
126730700|NCT01529385|455963052|FG000|Overall Study|Lost to Follow-up|2|||
126583856|NCT02287311|455437931|FG004|Cohort 1: Dose Level 1|Death|0|||
126583857|NCT02287311|455437932|FG005|Cohort 1: Dose Level 1|Death|0|||
126583858|NCT02287311|455437933|FG006|Cohort 1: Dose Level 1|Death|1|||
126583859|NCT02287311|455437934|FG007|Cohort 1: Dose Level 1|Death|0|||
126583860|NCT02287311|455437935|FG008|Cohort 1: Dose Level 1|Death|0|||
126583861|NCT02287311|455437927|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126583862|NCT02287311|455437928|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126583863|NCT02287311|455437929|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126583864|NCT02287311|455437930|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
126583865|NCT02287311|455437931|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126583866|NCT02287311|455437932|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126583867|NCT02287311|455437933|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
126583868|NCT02287311|455437934|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126583869|NCT02287311|455437935|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
126583870|NCT02287311|455437927|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
126583871|NCT02287311|455437928|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
126583872|NCT02287311|455437929|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
126583873|NCT02287311|455437930|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
126583874|NCT02287311|455437931|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
126583875|NCT02287311|455437932|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
126583876|NCT02287311|455437933|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
126583877|NCT02287311|455437934|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
126583878|NCT02287311|455437935|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
126583879|NCT02287311|455437927|FG000|Cohort 2: Dose Level 2|Death|0|||
126583880|NCT02287311|455437928|FG001|Cohort 2: Dose Level 2|Death|2|||
126583881|NCT02287311|455437929|FG002|Cohort 2: Dose Level 2|Death|0|||
126583882|NCT02287311|455437930|FG003|Cohort 2: Dose Level 2|Death|0|||
126583883|NCT02287311|455437931|FG004|Cohort 2: Dose Level 2|Death|2|||
126583884|NCT02287311|455437932|FG005|Cohort 2: Dose Level 2|Death|0|||
126583885|NCT02287311|455437933|FG006|Cohort 2: Dose Level 2|Death|0|||
126583886|NCT02287311|455437934|FG007|Cohort 2: Dose Level 2|Death|2|||
126583887|NCT02287311|455437935|FG008|Cohort 2: Dose Level 2|Death|0|||
126583888|NCT02287311|455437927|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126583889|NCT02287311|455437928|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126583890|NCT02287311|455437929|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126583891|NCT02287311|455437930|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126583892|NCT02287311|455437931|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
126583893|NCT02287311|455437932|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126583894|NCT02287311|455437933|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126583895|NCT02287311|455437934|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126583896|NCT02287311|455437935|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
126583897|NCT02287311|455437927|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
126583898|NCT02287311|455437928|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
126583899|NCT02287311|455437929|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
126583900|NCT02287311|455437930|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
126533415|NCT01662310|455244477|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
126533416|NCT01662310|455244478|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
126533417|NCT01662310|455244479|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
126533418|NCT01662310|455244480|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
126533419|NCT01662310|455244481|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
126533420|NCT01662310|455244477|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
126533421|NCT01662310|455244478|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
126533422|NCT01662310|455244479|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
126533423|NCT01662310|455244480|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
126533424|NCT01662310|455244481|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
126533425|NCT01662310|455244477|FG000|Run-In or Stabilization Phase|Other|1|||
126533426|NCT01662310|455244478|FG001|Run-In or Stabilization Phase|Other|0|||
126533427|NCT01662310|455244479|FG002|Run-In or Stabilization Phase|Other|0|||
126533428|NCT01662310|455244480|FG003|Run-In or Stabilization Phase|Other|0|||
126533429|NCT01662310|455244481|FG004|Run-In or Stabilization Phase|Other|0|||
126533430|NCT01662310|455244477|FG000|Double-Blind Phase|Adverse Event|0|||
126533431|NCT01662310|455244478|FG001|Double-Blind Phase|Adverse Event|0|||
126533432|NCT01662310|455244479|FG002|Double-Blind Phase|Adverse Event|1|||
126533433|NCT01662310|455244480|FG003|Double-Blind Phase|Adverse Event|0|||
126533434|NCT01662310|455244481|FG004|Double-Blind Phase|Adverse Event|0|||
126533435|NCT01662310|455244477|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126533436|NCT01662310|455244478|FG001|Double-Blind Phase|Lost to Follow-up|3|||
126533437|NCT01662310|455244479|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126533438|NCT01662310|455244480|FG003|Double-Blind Phase|Lost to Follow-up|0|||
126533439|NCT01662310|455244481|FG004|Double-Blind Phase|Lost to Follow-up|0|||
126583901|NCT02287311|455437931|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
126583902|NCT02287311|455437932|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
126533440|NCT01662310|455244477|FG000|Double-Blind Phase|Pregnancy|0|||
126533441|NCT01662310|455244478|FG001|Double-Blind Phase|Pregnancy|2|||
126583903|NCT02287311|455437933|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
126583904|NCT02287311|455437934|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
126583905|NCT02287311|455437935|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
126583906|NCT02287311|455437927|FG000|Cohort 3: Dose Level 3|Death|0|||
126583907|NCT02287311|455437928|FG001|Cohort 3: Dose Level 3|Death|0|||
126583908|NCT02287311|455437929|FG002|Cohort 3: Dose Level 3|Death|4|||
126583909|NCT02287311|455437930|FG003|Cohort 3: Dose Level 3|Death|0|||
126583910|NCT02287311|455437931|FG004|Cohort 3: Dose Level 3|Death|0|||
126583911|NCT02287311|455437932|FG005|Cohort 3: Dose Level 3|Death|4|||
126583912|NCT02287311|455437933|FG006|Cohort 3: Dose Level 3|Death|0|||
126583913|NCT02287311|455437934|FG007|Cohort 3: Dose Level 3|Death|0|||
126583914|NCT02287311|455437935|FG008|Cohort 3: Dose Level 3|Death|2|||
126533442|NCT01662310|455244479|FG002|Double-Blind Phase|Pregnancy|0|||
126583915|NCT02287311|455437927|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126583916|NCT02287311|455437928|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126583917|NCT02287311|455437929|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
126583918|NCT02287311|455437930|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126583919|NCT02287311|455437931|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126583920|NCT02287311|455437932|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
126583921|NCT02287311|455437933|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126583922|NCT02287311|455437934|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126583923|NCT02287311|455437935|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
126583924|NCT02287311|455437927|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126583925|NCT02287311|455437928|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126583926|NCT02287311|455437929|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126583927|NCT02287311|455437930|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126583928|NCT02287311|455437931|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126583929|NCT02287311|455437932|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
126583930|NCT02287311|455437933|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126583931|NCT02287311|455437934|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
126583932|NCT02287311|455437935|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
126583933|NCT05418296|455437938|FG000|Overall Study|Withdrawal by Subject|4|||
126583934|NCT05418296|455437939|FG001|Overall Study|Withdrawal by Subject|1|||
126583935|NCT04630262|455437941|FG000|Overall Study|Intraoperative Screen Failure|5|||
126583936|NCT04630262|455437941|FG000|Overall Study|Study terminated prematurely|71|||
126583937|NCT04630262|455437941|FG000|Overall Study|Withdrawal by Subject|2|||
126583938|NCT04630262|455437941|FG000|Overall Study|Physician Decision|2|||
126583939|NCT03692676|455437947|FG000|Overall Study|exclude patients with prior use|4424|||
126533443|NCT01662310|455244480|FG003|Double-Blind Phase|Pregnancy|0|||
126533444|NCT01662310|455244481|FG004|Double-Blind Phase|Pregnancy|0|||
126533445|NCT01662310|455244477|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
126533446|NCT01662310|455244478|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
126533447|NCT01662310|455244479|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
126533448|NCT01662310|455244480|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
126533449|NCT01662310|455244481|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
126533450|NCT01662310|455244477|FG000|Double-Blind Phase|Other|0|||
126533451|NCT01662310|455244478|FG001|Double-Blind Phase|Other|0|||
126533452|NCT01662310|455244479|FG002|Double-Blind Phase|Other|1|||
126533453|NCT01662310|455244480|FG003|Double-Blind Phase|Other|0|||
126533454|NCT01662310|455244481|FG004|Double-Blind Phase|Other|0|||
126533455|NCT01662310|455244477|FG000|Double-Blind Phase|Randomized but not treated|0|||
126533456|NCT01662310|455244478|FG001|Double-Blind Phase|Randomized but not treated|1|||
126533457|NCT01662310|455244479|FG002|Double-Blind Phase|Randomized but not treated|0|||
126533458|NCT01662310|455244480|FG003|Double-Blind Phase|Randomized but not treated|0|||
126533459|NCT01662310|455244481|FG004|Double-Blind Phase|Randomized but not treated|0|||
126533460|NCT01662310|455244477|FG000|Open-Label Extension Phase|Adverse Event|0|||
126533461|NCT01662310|455244478|FG001|Open-Label Extension Phase|Adverse Event|0|||
126533462|NCT01662310|455244479|FG002|Open-Label Extension Phase|Adverse Event|0|||
126533463|NCT01662310|455244480|FG003|Open-Label Extension Phase|Adverse Event|3|||
126533464|NCT01662310|455244481|FG004|Open-Label Extension Phase|Adverse Event|0|||
126533465|NCT01662310|455244477|FG000|Open-Label Extension Phase|Death|0|||
126533466|NCT01662310|455244478|FG001|Open-Label Extension Phase|Death|0|||
126533467|NCT01662310|455244479|FG002|Open-Label Extension Phase|Death|0|||
126533468|NCT01662310|455244480|FG003|Open-Label Extension Phase|Death|1|||
126533469|NCT01662310|455244481|FG004|Open-Label Extension Phase|Death|0|||
126533470|NCT01662310|455244477|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
126583940|NCT03692676|455437948|FG001|Overall Study|exclude patients with prior use|24726|||
126583941|NCT03692676|455437949|FG002|Overall Study|exclude patients with prior use|0|||
126533471|NCT01662310|455244478|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
126533472|NCT01662310|455244479|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
126533473|NCT01662310|455244480|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
126533474|NCT01662310|455244481|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
126533475|NCT01662310|455244477|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
126583942|NCT03692676|455437950|FG003|Overall Study|exclude patients with prior use|0|||
126583943|NCT03692676|455437947|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
126583944|NCT03692676|455437948|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
126583945|NCT03692676|455437949|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
126730701|NCT01529385|455963053|FG001|Overall Study|Lost to Follow-up|1|||
126730702|NCT00964158|455963056|FG000|Overall Study|Lost to Follow-up|0|||
126730703|NCT00964158|455963057|FG001|Overall Study|Lost to Follow-up|1|||
126730704|NCT00964158|455963058|FG002|Overall Study|Lost to Follow-up|2|||
126730705|NCT00964158|455963056|FG000|Overall Study|Withdrawal by Subject|0|||
126730706|NCT00964158|455963057|FG001|Overall Study|Withdrawal by Subject|0|||
126730707|NCT00964158|455963058|FG002|Overall Study|Withdrawal by Subject|6|||
126730708|NCT01763866|455963065|FG000|Overall Study|Withdrawal by Subject|2|||
126730709|NCT01763866|455963066|FG001|Overall Study|Withdrawal by Subject|1|||
126730710|NCT01763866|455963067|FG002|Overall Study|Withdrawal by Subject|4|||
126730711|NCT01763866|455963068|FG003|Overall Study|Withdrawal by Subject|0|||
126730712|NCT01763866|455963069|FG004|Overall Study|Withdrawal by Subject|0|||
126730713|NCT01763866|455963070|FG005|Overall Study|Withdrawal by Subject|3|||
126730714|NCT01763866|455963071|FG006|Overall Study|Withdrawal by Subject|4|||
126730715|NCT01763866|455963072|FG007|Overall Study|Withdrawal by Subject|0|||
126730716|NCT01763866|455963073|FG008|Overall Study|Withdrawal by Subject|1|||
126730717|NCT01763866|455963074|FG009|Overall Study|Withdrawal by Subject|1|||
126730718|NCT01763866|455963075|FG010|Overall Study|Withdrawal by Subject|2|||
126730719|NCT01763866|455963076|FG011|Overall Study|Withdrawal by Subject|2|||
126730720|NCT01763866|455963077|FG012|Overall Study|Withdrawal by Subject|2|||
126730721|NCT01763866|455963078|FG013|Overall Study|Withdrawal by Subject|0|||
126730722|NCT01763866|455963079|FG014|Overall Study|Withdrawal by Subject|6|||
126730723|NCT01763866|455963080|FG015|Overall Study|Withdrawal by Subject|3|||
126730724|NCT01763866|455963081|FG016|Overall Study|Withdrawal by Subject|0|||
126730725|NCT01763866|455963082|FG017|Overall Study|Withdrawal by Subject|1|||
126730726|NCT01763866|455963083|FG018|Overall Study|Withdrawal by Subject|1|||
126730727|NCT01763866|455963084|FG019|Overall Study|Withdrawal by Subject|1|||
126533476|NCT01662310|455244478|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
126533477|NCT01662310|455244479|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
126730728|NCT01763866|455963085|FG020|Overall Study|Withdrawal by Subject|2|||
126730729|NCT01763866|455963086|FG021|Overall Study|Withdrawal by Subject|1|||
126730730|NCT01763866|455963087|FG022|Overall Study|Withdrawal by Subject|2|||
126730731|NCT01763866|455963088|FG023|Overall Study|Withdrawal by Subject|1|||
126730732|NCT01763866|455963065|FG000|Overall Study|Decision by sponsor|0|||
126730733|NCT01763866|455963066|FG001|Overall Study|Decision by sponsor|0|||
126730734|NCT01763866|455963067|FG002|Overall Study|Decision by sponsor|1|||
126730735|NCT01763866|455963068|FG003|Overall Study|Decision by sponsor|0|||
126730736|NCT01763866|455963069|FG004|Overall Study|Decision by sponsor|2|||
126730737|NCT01763866|455963070|FG005|Overall Study|Decision by sponsor|0|||
126730738|NCT01763866|455963071|FG006|Overall Study|Decision by sponsor|2|||
126730739|NCT01763866|455963072|FG007|Overall Study|Decision by sponsor|0|||
126730740|NCT01763866|455963073|FG008|Overall Study|Decision by sponsor|2|||
126730741|NCT01763866|455963074|FG009|Overall Study|Decision by sponsor|0|||
126730742|NCT01763866|455963075|FG010|Overall Study|Decision by sponsor|6|||
126730743|NCT01763866|455963076|FG011|Overall Study|Decision by sponsor|0|||
126730744|NCT01763866|455963077|FG012|Overall Study|Decision by sponsor|1|||
126730745|NCT01763866|455963078|FG013|Overall Study|Decision by sponsor|0|||
126730746|NCT01763866|455963079|FG014|Overall Study|Decision by sponsor|5|||
126730747|NCT01763866|455963080|FG015|Overall Study|Decision by sponsor|0|||
126730748|NCT01763866|455963081|FG016|Overall Study|Decision by sponsor|0|||
126730749|NCT01763866|455963082|FG017|Overall Study|Decision by sponsor|0|||
126730750|NCT01763866|455963083|FG018|Overall Study|Decision by sponsor|4|||
126730751|NCT01763866|455963084|FG019|Overall Study|Decision by sponsor|0|||
126730752|NCT01763866|455963085|FG020|Overall Study|Decision by sponsor|2|||
126730753|NCT01763866|455963086|FG021|Overall Study|Decision by sponsor|0|||
126730754|NCT01763866|455963087|FG022|Overall Study|Decision by sponsor|1|||
126730755|NCT01763866|455963088|FG023|Overall Study|Decision by sponsor|0|||
126730756|NCT01763866|455963065|FG000|Overall Study|Lost to Follow-up|0|||
126730757|NCT01763866|455963066|FG001|Overall Study|Lost to Follow-up|0|||
126730758|NCT01763866|455963067|FG002|Overall Study|Lost to Follow-up|0|||
126730759|NCT01763866|455963068|FG003|Overall Study|Lost to Follow-up|0|||
126730760|NCT01763866|455963069|FG004|Overall Study|Lost to Follow-up|0|||
126730761|NCT01763866|455963070|FG005|Overall Study|Lost to Follow-up|0|||
126730762|NCT01763866|455963071|FG006|Overall Study|Lost to Follow-up|1|||
126730763|NCT01763866|455963072|FG007|Overall Study|Lost to Follow-up|0|||
126730764|NCT01763866|455963073|FG008|Overall Study|Lost to Follow-up|0|||
126730765|NCT01763866|455963074|FG009|Overall Study|Lost to Follow-up|0|||
126730766|NCT01763866|455963075|FG010|Overall Study|Lost to Follow-up|0|||
126730767|NCT01763866|455963076|FG011|Overall Study|Lost to Follow-up|0|||
126730768|NCT01763866|455963077|FG012|Overall Study|Lost to Follow-up|1|||
126533478|NCT01662310|455244480|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
126730769|NCT01763866|455963078|FG013|Overall Study|Lost to Follow-up|0|||
126730770|NCT01763866|455963079|FG014|Overall Study|Lost to Follow-up|1|||
126730771|NCT01763866|455963080|FG015|Overall Study|Lost to Follow-up|0|||
126533479|NCT01662310|455244481|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
126730772|NCT01763866|455963081|FG016|Overall Study|Lost to Follow-up|0|||
126730773|NCT01763866|455963082|FG017|Overall Study|Lost to Follow-up|0|||
126730774|NCT01763866|455963083|FG018|Overall Study|Lost to Follow-up|1|||
126583946|NCT03692676|455437950|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
126583947|NCT03692676|455437947|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
126583948|NCT03692676|455437948|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
126583949|NCT03692676|455437949|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
126583950|NCT03692676|455437950|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
126583951|NCT03692676|455437947|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
126583952|NCT03692676|455437948|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
126583953|NCT03692676|455437949|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
126583954|NCT03692676|455437950|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
126583955|NCT03692676|455437947|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
126583956|NCT03692676|455437948|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
126583957|NCT03692676|455437949|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
126583958|NCT03692676|455437950|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
126583959|NCT03692676|455437947|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
126583960|NCT03692676|455437948|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
126583961|NCT03692676|455437949|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
126583962|NCT03692676|455437950|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
126583963|NCT03692676|455437947|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
126583964|NCT03692676|455437948|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
126583965|NCT03692676|455437949|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
126583966|NCT03692676|455437950|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
126583967|NCT03692676|455437947|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
126583968|NCT03692676|455437948|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
126583969|NCT03692676|455437949|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
126583970|NCT03692676|455437950|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
126583971|NCT03692676|455437947|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
126583972|NCT03692676|455437948|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
126583973|NCT03692676|455437949|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
126730775|NCT01763866|455963084|FG019|Overall Study|Lost to Follow-up|1|||
126730776|NCT01763866|455963085|FG020|Overall Study|Lost to Follow-up|0|||
126730777|NCT01763866|455963086|FG021|Overall Study|Lost to Follow-up|0|||
126730778|NCT01763866|455963087|FG022|Overall Study|Lost to Follow-up|0|||
126730779|NCT01763866|455963088|FG023|Overall Study|Lost to Follow-up|1|||
126730780|NCT01763866|455963065|FG000|Overall Study|Death|0|||
126730781|NCT01763866|455963066|FG001|Overall Study|Death|0|||
126730782|NCT01763866|455963067|FG002|Overall Study|Death|0|||
126730783|NCT01763866|455963068|FG003|Overall Study|Death|0|||
126730784|NCT01763866|455963069|FG004|Overall Study|Death|0|||
126730785|NCT01763866|455963070|FG005|Overall Study|Death|0|||
126730786|NCT01763866|455963071|FG006|Overall Study|Death|0|||
126730787|NCT01763866|455963072|FG007|Overall Study|Death|0|||
126730788|NCT01763866|455963073|FG008|Overall Study|Death|0|||
126730789|NCT01763866|455963074|FG009|Overall Study|Death|0|||
126730790|NCT01763866|455963075|FG010|Overall Study|Death|0|||
126730791|NCT01763866|455963076|FG011|Overall Study|Death|0|||
126730792|NCT01763866|455963077|FG012|Overall Study|Death|0|||
126730793|NCT01763866|455963078|FG013|Overall Study|Death|0|||
126533480|NCT01662310|455244477|FG000|Open-Label Extension Phase|Pregnancy|0|||
126533481|NCT01662310|455244478|FG001|Open-Label Extension Phase|Pregnancy|0|||
126533482|NCT01662310|455244479|FG002|Open-Label Extension Phase|Pregnancy|0|||
126533483|NCT01662310|455244480|FG003|Open-Label Extension Phase|Pregnancy|1|||
126533484|NCT01662310|455244481|FG004|Open-Label Extension Phase|Pregnancy|0|||
126533485|NCT01662310|455244477|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
126533486|NCT01662310|455244478|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
126533487|NCT01662310|455244479|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
126533488|NCT01662310|455244480|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
126533489|NCT01662310|455244481|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
126533490|NCT01302847|455244485|FG000|Overall Study|Death|0|||
126533491|NCT01302847|455244486|FG001|Overall Study|Death|1|||
126533492|NCT01302847|455244487|FG002|Overall Study|Death|0|||
126533493|NCT01302847|455244488|FG003|Overall Study|Death|0|||
126533494|NCT01302847|455244489|FG004|Overall Study|Death|0|||
126533495|NCT01302847|455244490|FG005|Overall Study|Death|1|||
126533496|NCT01302847|455244491|FG006|Overall Study|Death|1|||
126730794|NCT01763866|455963079|FG014|Overall Study|Death|0|||
126533497|NCT01302847|455244492|FG007|Overall Study|Death|0|||
126533498|NCT01302847|455244485|FG000|Overall Study|Pregnancy|2|||
126533499|NCT01302847|455244486|FG001|Overall Study|Pregnancy|0|||
126533500|NCT01302847|455244487|FG002|Overall Study|Pregnancy|0|||
126533501|NCT01302847|455244488|FG003|Overall Study|Pregnancy|0|||
126533502|NCT01302847|455244489|FG004|Overall Study|Pregnancy|0|||
126533503|NCT01302847|455244490|FG005|Overall Study|Pregnancy|0|||
126533504|NCT01302847|455244491|FG006|Overall Study|Pregnancy|0|||
126533505|NCT01302847|455244492|FG007|Overall Study|Pregnancy|0|||
126533506|NCT01302847|455244485|FG000|Overall Study|Virologic failure|0|||
126533507|NCT01302847|455244486|FG001|Overall Study|Virologic failure|2|||
126533508|NCT01302847|455244487|FG002|Overall Study|Virologic failure|0|||
126533509|NCT01302847|455244488|FG003|Overall Study|Virologic failure|2|||
126533510|NCT01302847|455244489|FG004|Overall Study|Virologic failure|1|||
126533511|NCT01302847|455244490|FG005|Overall Study|Virologic failure|3|||
126533512|NCT01302847|455244491|FG006|Overall Study|Virologic failure|1|||
126533513|NCT01302847|455244492|FG007|Overall Study|Virologic failure|2|||
126533514|NCT01302847|455244485|FG000|Overall Study|Severe debilitation, unable to continue|0|||
126533515|NCT01302847|455244486|FG001|Overall Study|Severe debilitation, unable to continue|0|||
126533516|NCT01302847|455244487|FG002|Overall Study|Severe debilitation, unable to continue|0|||
126533517|NCT01302847|455244488|FG003|Overall Study|Severe debilitation, unable to continue|0|||
126533518|NCT01302847|455244489|FG004|Overall Study|Severe debilitation, unable to continue|0|||
126533519|NCT01302847|455244490|FG005|Overall Study|Severe debilitation, unable to continue|1|||
126533520|NCT01302847|455244491|FG006|Overall Study|Severe debilitation, unable to continue|1|||
126533521|NCT01302847|455244492|FG007|Overall Study|Severe debilitation, unable to continue|0|||
126533522|NCT01302847|455244485|FG000|Overall Study|Not able to get to clinic|1|||
126533523|NCT01302847|455244486|FG001|Overall Study|Not able to get to clinic|1|||
126533524|NCT01302847|455244487|FG002|Overall Study|Not able to get to clinic|0|||
126533525|NCT01302847|455244488|FG003|Overall Study|Not able to get to clinic|0|||
126533526|NCT01302847|455244489|FG004|Overall Study|Not able to get to clinic|0|||
126533527|NCT01302847|455244490|FG005|Overall Study|Not able to get to clinic|0|||
126533528|NCT01302847|455244491|FG006|Overall Study|Not able to get to clinic|0|||
126533529|NCT01302847|455244492|FG007|Overall Study|Not able to get to clinic|0|||
126533530|NCT01302847|455244485|FG000|Overall Study|Site closing|2|||
126533531|NCT01302847|455244486|FG001|Overall Study|Site closing|2|||
126533532|NCT01302847|455244487|FG002|Overall Study|Site closing|0|||
126533533|NCT01302847|455244488|FG003|Overall Study|Site closing|0|||
126533534|NCT01302847|455244489|FG004|Overall Study|Site closing|0|||
126533535|NCT01302847|455244490|FG005|Overall Study|Site closing|0|||
126533536|NCT01302847|455244491|FG006|Overall Study|Site closing|0|||
126533537|NCT01302847|455244492|FG007|Overall Study|Site closing|0|||
126533538|NCT01302847|455244485|FG000|Overall Study|Withdrawal by Subject|1|||
126533539|NCT01302847|455244486|FG001|Overall Study|Withdrawal by Subject|0|||
126533540|NCT01302847|455244487|FG002|Overall Study|Withdrawal by Subject|0|||
126533541|NCT01302847|455244488|FG003|Overall Study|Withdrawal by Subject|0|||
126533542|NCT01302847|455244489|FG004|Overall Study|Withdrawal by Subject|1|||
126533543|NCT01302847|455244490|FG005|Overall Study|Withdrawal by Subject|0|||
126533544|NCT01302847|455244491|FG006|Overall Study|Withdrawal by Subject|0|||
126533545|NCT01302847|455244492|FG007|Overall Study|Withdrawal by Subject|1|||
126533546|NCT01302847|455244485|FG000|Overall Study|Not willing to adhere to requirements|5|||
126533547|NCT01302847|455244486|FG001|Overall Study|Not willing to adhere to requirements|0|||
126533548|NCT01302847|455244487|FG002|Overall Study|Not willing to adhere to requirements|1|||
126533549|NCT01302847|455244488|FG003|Overall Study|Not willing to adhere to requirements|0|||
126533550|NCT01302847|455244489|FG004|Overall Study|Not willing to adhere to requirements|0|||
126533551|NCT01302847|455244490|FG005|Overall Study|Not willing to adhere to requirements|0|||
126533552|NCT01302847|455244491|FG006|Overall Study|Not willing to adhere to requirements|0|||
126533553|NCT01302847|455244492|FG007|Overall Study|Not willing to adhere to requirements|2|||
126533554|NCT01302847|455244485|FG000|Overall Study|Site unable to contact participant|2|||
126533555|NCT01302847|455244486|FG001|Overall Study|Site unable to contact participant|1|||
126533556|NCT01302847|455244487|FG002|Overall Study|Site unable to contact participant|0|||
126533557|NCT01302847|455244488|FG003|Overall Study|Site unable to contact participant|0|||
126533558|NCT01302847|455244489|FG004|Overall Study|Site unable to contact participant|0|||
126533559|NCT01302847|455244490|FG005|Overall Study|Site unable to contact participant|0|||
126533560|NCT01302847|455244491|FG006|Overall Study|Site unable to contact participant|2|||
126533561|NCT01302847|455244492|FG007|Overall Study|Site unable to contact participant|0|||
126533562|NCT04302350|455244495|FG000|Overall Study|Physician Decision|1|||
126533563|NCT04302350|455244496|FG001|Overall Study|Physician Decision|1|||
126533564|NCT04302350|455244497|FG002|Overall Study|Physician Decision|2|||
126533565|NCT04302350|455244495|FG000|Overall Study|Lack of Efficacy|1|||
126533566|NCT04302350|455244496|FG001|Overall Study|Lack of Efficacy|1|||
126730795|NCT01763866|455963080|FG015|Overall Study|Death|0|||
126730796|NCT01763866|455963081|FG016|Overall Study|Death|1|||
126730797|NCT01763866|455963082|FG017|Overall Study|Death|0|||
126730798|NCT01763866|455963083|FG018|Overall Study|Death|0|||
126533567|NCT04302350|455244497|FG002|Overall Study|Lack of Efficacy|4|||
126533568|NCT04302350|455244495|FG000|Overall Study|Adverse Event|0|||
126533569|NCT04302350|455244496|FG001|Overall Study|Adverse Event|1|||
126533570|NCT04302350|455244497|FG002|Overall Study|Adverse Event|2|||
126730799|NCT01763866|455963084|FG019|Overall Study|Death|0|||
126730800|NCT01763866|455963085|FG020|Overall Study|Death|0|||
126533571|NCT00374322|455244500|FG000|Overall Study|Lost to Follow-up|92|||
126533572|NCT00374322|455244501|FG001|Overall Study|Lost to Follow-up|90|||
126730801|NCT01763866|455963086|FG021|Overall Study|Death|0|||
126730802|NCT01763866|455963087|FG022|Overall Study|Death|0|||
126730803|NCT01763866|455963088|FG023|Overall Study|Death|0|||
126730804|NCT03245723|455963091|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
126730805|NCT03245723|455963092|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
126730806|NCT03245723|455963091|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
126730807|NCT03245723|455963092|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
126730808|NCT03245723|455963091|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
126730809|NCT03245723|455963092|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
126730810|NCT03245723|455963091|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
126730811|NCT03245723|455963092|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
126730812|NCT03337139|455963093|FG000|Phase I|Withdrawal by Subject|10|||
126730813|NCT03337139|455963094|FG001|Phase I|Withdrawal by Subject|0|||
126730814|NCT02554253|455963095|FG000|Overall Study|ineligible after enrollment|1|||
126730815|NCT02554253|455963096|FG001|Overall Study|ineligible after enrollment|0|||
126730816|NCT02554253|455963095|FG000|Overall Study|converted to transcatheter procedure|0|||
126730817|NCT02554253|455963096|FG001|Overall Study|converted to transcatheter procedure|1|||
126730818|NCT02554253|455963095|FG000|Overall Study|received both drugs|0|||
126730819|NCT02554253|455963096|FG001|Overall Study|received both drugs|1|||
126730820|NCT03288493|455963097|FG000|Overall Study|Withdrawal by Subject|4|||
126730821|NCT03288493|455963098|FG001|Overall Study|Withdrawal by Subject|0|||
126730822|NCT03288493|455963099|FG002|Overall Study|Withdrawal by Subject|0|||
126730823|NCT03288493|455963100|FG003|Overall Study|Withdrawal by Subject|0|||
126730824|NCT03288493|455963101|FG004|Overall Study|Withdrawal by Subject|0|||
126730825|NCT03288493|455963102|FG005|Overall Study|Withdrawal by Subject|2|||
126730826|NCT03288493|455963103|FG006|Overall Study|Withdrawal by Subject|0|||
126730827|NCT03288493|455963097|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
126730828|NCT03288493|455963098|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
126730829|NCT03288493|455963099|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
126730830|NCT03288493|455963100|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
126730831|NCT03288493|455963101|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
126730832|NCT03288493|455963102|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
126730833|NCT03288493|455963103|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
126730834|NCT03288493|455963097|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
126730835|NCT03288493|455963098|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
126730836|NCT03288493|455963099|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
126730837|NCT03288493|455963100|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
126730838|NCT03288493|455963101|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
126730839|NCT03288493|455963102|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
126730840|NCT03288493|455963103|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
126730841|NCT03288493|455963097|FG000|Overall Study|Death|2|||
126730842|NCT03288493|455963098|FG001|Overall Study|Death|0|||
126730843|NCT03288493|455963099|FG002|Overall Study|Death|0|||
126730844|NCT03288493|455963100|FG003|Overall Study|Death|0|||
126730845|NCT03288493|455963101|FG004|Overall Study|Death|0|||
126730846|NCT03288493|455963102|FG005|Overall Study|Death|0|||
126730847|NCT03288493|455963103|FG006|Overall Study|Death|0|||
126730848|NCT03288493|455963097|FG000|Overall Study|other reason not listed above|2|||
126730849|NCT03288493|455963098|FG001|Overall Study|other reason not listed above|0|||
126730850|NCT03288493|455963099|FG002|Overall Study|other reason not listed above|0|||
126730851|NCT03288493|455963100|FG003|Overall Study|other reason not listed above|0|||
126730852|NCT03288493|455963101|FG004|Overall Study|other reason not listed above|0|||
126730853|NCT03288493|455963102|FG005|Overall Study|other reason not listed above|0|||
126730854|NCT03288493|455963103|FG006|Overall Study|other reason not listed above|0|||
126730855|NCT01736254|455963105|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
126730856|NCT01736254|455963105|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
126730857|NCT02559206|455963106|FG000|Overall Study|Adverse Event|0|||
126730858|NCT02559206|455963107|FG001|Overall Study|Adverse Event|4|||
126730859|NCT02559206|455963108|FG002|Overall Study|Adverse Event|1|||
126730860|NCT02559206|455963109|FG003|Overall Study|Adverse Event|5|||
126730861|NCT02559206|455963110|FG004|Overall Study|Adverse Event|3|||
126730862|NCT02559206|455963111|FG005|Overall Study|Adverse Event|0|||
126533573|NCT00374322|455244500|FG000|Overall Study|Protocol Violation|8|||
126533574|NCT00374322|455244501|FG001|Overall Study|Protocol Violation|3|||
126583974|NCT03692676|455437950|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
126583975|NCT03692676|455437947|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
126583976|NCT03692676|455437948|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
126583977|NCT03692676|455437949|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
126583978|NCT03692676|455437950|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
126583979|NCT03692676|455437947|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
126583980|NCT03692676|455437948|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
126583981|NCT03692676|455437949|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
126583982|NCT03692676|455437950|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
126583983|NCT03692676|455437947|FG000|Overall Study|Other|0|||
126583984|NCT03692676|455437948|FG001|Overall Study|Other|805|||
126583985|NCT03692676|455437949|FG002|Overall Study|Other|758|||
126583986|NCT03692676|455437950|FG003|Overall Study|Other|277|||
126583987|NCT03692676|455437947|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
126583988|NCT03692676|455437948|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
126583989|NCT03692676|455437949|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
126583990|NCT03692676|455437950|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
126583991|NCT04638998|455437951|FG000|Overall Study|Withdrawal by Subject|1|||
126583992|NCT04638998|455437952|FG001|Overall Study|Withdrawal by Subject|3|||
126583993|NCT01180634|455437953|FG000|Overall Study|Adverse Event|4|||
126583994|NCT01180634|455437954|FG001|Overall Study|Adverse Event|1|||
126583995|NCT01180634|455437953|FG000|Overall Study|Miscellaneous|2|||
126583996|NCT01180634|455437954|FG001|Overall Study|Miscellaneous|0|||
126583997|NCT01180634|455437953|FG000|Overall Study|Withdrawal by Subject|4|||
126583998|NCT01180634|455437954|FG001|Overall Study|Withdrawal by Subject|0|||
126583999|NCT03692611|455437956|FG000|Overall Study|Found to be ineligible postrandomization|3|||
126584000|NCT03692611|455437957|FG001|Overall Study|Found to be ineligible postrandomization|0|||
126584001|NCT04419168|455437958|FG000|Overall Study|Protocol Violation|1|||
126584002|NCT04419168|455437959|FG001|Overall Study|Protocol Violation|1|||
126584003|NCT04419168|455437958|FG000|Overall Study|Lost to Follow-up|7|||
126584004|NCT04419168|455437959|FG001|Overall Study|Lost to Follow-up|7|||
126730863|NCT02559206|455963112|FG006|Overall Study|Adverse Event|1|||
126730864|NCT02559206|455963113|FG007|Overall Study|Adverse Event|0|||
126730865|NCT02559206|455963106|FG000|Overall Study|Protocol Violation|1|||
126730866|NCT02559206|455963107|FG001|Overall Study|Protocol Violation|0|||
126730867|NCT02559206|455963108|FG002|Overall Study|Protocol Violation|1|||
126730868|NCT02559206|455963109|FG003|Overall Study|Protocol Violation|0|||
126730869|NCT02559206|455963110|FG004|Overall Study|Protocol Violation|0|||
126730870|NCT02559206|455963111|FG005|Overall Study|Protocol Violation|2|||
126730871|NCT02559206|455963112|FG006|Overall Study|Protocol Violation|0|||
126730872|NCT02559206|455963113|FG007|Overall Study|Protocol Violation|0|||
126730873|NCT02559206|455963106|FG000|Overall Study|Withdrawal by Subject|3|||
126730874|NCT02559206|455963107|FG001|Overall Study|Withdrawal by Subject|3|||
126730875|NCT02559206|455963108|FG002|Overall Study|Withdrawal by Subject|1|||
126730876|NCT02559206|455963109|FG003|Overall Study|Withdrawal by Subject|3|||
126730877|NCT02559206|455963110|FG004|Overall Study|Withdrawal by Subject|5|||
126730878|NCT02559206|455963111|FG005|Overall Study|Withdrawal by Subject|4|||
126730879|NCT02559206|455963112|FG006|Overall Study|Withdrawal by Subject|1|||
126730880|NCT02559206|455963113|FG007|Overall Study|Withdrawal by Subject|2|||
126730881|NCT02559206|455963106|FG000|Overall Study|Lost to Follow-up|3|||
126730882|NCT02559206|455963107|FG001|Overall Study|Lost to Follow-up|5|||
126584005|NCT04419168|455437958|FG000|Overall Study|Missed 6-month Visit|48|||
126584006|NCT04419168|455437959|FG001|Overall Study|Missed 6-month Visit|45|||
126640482|NCT00737477|455642780|FG000|Overall Study|Death|9|||
126640483|NCT00737477|455642780|FG000|Overall Study|Treatment Refusal|1|||
126640484|NCT00737477|455642780|FG000|Overall Study|Withdrawal by Subject|1|||
126640485|NCT00737477|455642780|FG000|Overall Study|Renal Transplantation|10|||
126640486|NCT00737477|455642780|FG000|Overall Study|Other|4|||
126640487|NCT01370655|455642781|FG000|Period 1|Adverse Event|2|||
126640488|NCT01370655|455642782|FG001|Period 1|Adverse Event|0|||
126640489|NCT01370655|455642783|FG002|Period 1|Adverse Event|0|||
126640490|NCT01370655|455642784|FG003|Period 1|Adverse Event|0|||
126640491|NCT01370655|455642785|FG004|Period 1|Adverse Event|0|||
126640492|NCT01370655|455642786|FG005|Period 1|Adverse Event|0|||
126640493|NCT01370655|455642787|FG006|Period 1|Adverse Event|1|||
126640494|NCT01370655|455642788|FG007|Period 1|Adverse Event|0|||
126640495|NCT01370655|455642789|FG008|Period 1|Adverse Event|0|||
126640496|NCT01370655|455642790|FG009|Period 1|Adverse Event|0|||
126640497|NCT01370655|455642791|FG010|Period 1|Adverse Event|0|||
126640498|NCT01370655|455642792|FG011|Period 1|Adverse Event|0|||
126640499|NCT01370655|455642781|FG000|Period 2|Adverse Event|0|||
126640500|NCT01370655|455642782|FG001|Period 2|Adverse Event|0|||
126533575|NCT00374322|455244500|FG000|Overall Study|Withdrawal by Subject|235|||
126533576|NCT00374322|455244501|FG001|Overall Study|Withdrawal by Subject|167|||
126533577|NCT00374322|455244500|FG000|Overall Study|Sponsor Terminated Study|866|||
126533578|NCT00374322|455244501|FG001|Overall Study|Sponsor Terminated Study|990|||
126533579|NCT00374322|455244500|FG000|Overall Study|Physician Decision|36|||
126533580|NCT00374322|455244501|FG001|Overall Study|Physician Decision|32|||
126533581|NCT00374322|455244500|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
126533582|NCT00374322|455244501|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
126533583|NCT00374322|455244500|FG000|Overall Study|Sponsor Decision|2|||
126533584|NCT00374322|455244501|FG001|Overall Study|Sponsor Decision|3|||
126533585|NCT00374322|455244500|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
126533586|NCT00374322|455244501|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
126533587|NCT00374322|455244500|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
126533588|NCT00374322|455244501|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
126533589|NCT00374322|455244500|FG000|Overall Study|Severe Toxicity|1|||
126533590|NCT00374322|455244501|FG001|Overall Study|Severe Toxicity|0|||
126533591|NCT00374322|455244500|FG000|Overall Study|Site Closed|2|||
126533592|NCT00374322|455244501|FG001|Overall Study|Site Closed|2|||
126533593|NCT00374322|455244500|FG000|Overall Study|Participant Changed Physician|1|||
126533594|NCT00374322|455244501|FG001|Overall Study|Participant Changed Physician|0|||
126533595|NCT00374322|455244500|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
126533596|NCT00374322|455244501|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
126533597|NCT00374322|455244500|FG000|Overall Study|Noncompliance with Study Requirements|0|||
126533598|NCT00374322|455244501|FG001|Overall Study|Noncompliance with Study Requirements|1|||
126533599|NCT00374322|455244500|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
126533600|NCT00374322|455244501|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
126533601|NCT00374322|455244500|FG000|Overall Study|Did Not Receive Study Medication|8|||
126533602|NCT00374322|455244501|FG001|Overall Study|Did Not Receive Study Medication|6|||
126533603|NCT02012491|455244502|FG000|Overall Study|Lost to Follow-up|1|||
126533604|NCT02012491|455244503|FG001|Overall Study|Lost to Follow-up|0|||
126533605|NCT02012491|455244502|FG000|Overall Study|Protocol Violation|0|||
126533606|NCT02012491|455244503|FG001|Overall Study|Protocol Violation|1|||
126533607|NCT02012491|455244502|FG000|Overall Study|Withdrawal by Subject|1|||
126533608|NCT02012491|455244503|FG001|Overall Study|Withdrawal by Subject|0|||
126533609|NCT00450411|455244504|FG000|Overall Study|Protocol Violation|6|||
126533610|NCT00450411|455244504|FG000|Overall Study|No protocol treatment|2|||
126533611|NCT03969719|455244515|FG000|Overall Study|Other reasons not specified|1|||
126533612|NCT03969719|455244516|FG001|Overall Study|Other reasons not specified|1|||
126533613|NCT03969719|455244517|FG002|Overall Study|Other reasons not specified|3|||
126533614|NCT03969719|455244515|FG000|Overall Study|Withdrawal by Subject|2|||
126533615|NCT03969719|455244516|FG001|Overall Study|Withdrawal by Subject|3|||
126533616|NCT03969719|455244517|FG002|Overall Study|Withdrawal by Subject|2|||
126533617|NCT03969719|455244515|FG000|Overall Study|Protocol Violation|1|||
126533618|NCT03969719|455244516|FG001|Overall Study|Protocol Violation|2|||
126533619|NCT03969719|455244517|FG002|Overall Study|Protocol Violation|0|||
126533620|NCT03969719|455244515|FG000|Overall Study|Adverse Event|0|||
126533621|NCT03969719|455244516|FG001|Overall Study|Adverse Event|2|||
126533622|NCT03969719|455244517|FG002|Overall Study|Adverse Event|0|||
126533623|NCT03969719|455244515|FG000|Overall Study|Lost to Follow-up|0|||
126533624|NCT03969719|455244516|FG001|Overall Study|Lost to Follow-up|1|||
126533625|NCT03969719|455244517|FG002|Overall Study|Lost to Follow-up|0|||
126533626|NCT02130193|455244521|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
126533627|NCT02130193|455244522|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
126533628|NCT02130193|455244523|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
126533629|NCT02130193|455244521|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
126533630|NCT02130193|455244522|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
126533631|NCT02130193|455244523|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
126533632|NCT02130193|455244521|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
126533633|NCT02130193|455244522|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
126533634|NCT02130193|455244523|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
126533635|NCT02130193|455244521|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
126533636|NCT02130193|455244522|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
126533637|NCT02130193|455244523|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
126533638|NCT01297959|455244524|FG000|Overall Study|Adverse Event|0|||
126533639|NCT01297959|455244525|FG001|Overall Study|Adverse Event|1|||
126533640|NCT01297959|455244524|FG000|Overall Study|Protocol Violation|2|||
126533641|NCT01297959|455244525|FG001|Overall Study|Protocol Violation|1|||
126533642|NCT01297959|455244524|FG000|Overall Study|Withdrawal by Subject|5|||
126533643|NCT01297959|455244525|FG001|Overall Study|Withdrawal by Subject|4|||
126533644|NCT01297959|455244524|FG000|Overall Study|Physician Decision|0|||
126533645|NCT01297959|455244525|FG001|Overall Study|Physician Decision|1|||
126533646|NCT01297959|455244524|FG000|Overall Study|Unrelated medical illness / complication|0|||
126533647|NCT01297959|455244525|FG001|Overall Study|Unrelated medical illness / complication|2|||
126533648|NCT01297959|455244524|FG000|Overall Study|Other|13|||
126584007|NCT04490915|455437960|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
126584008|NCT04490915|455437961|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
126584009|NCT04490915|455437960|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126584010|NCT04490915|455437961|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126584011|NCT04490915|455437960|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126584012|NCT04490915|455437961|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
126584013|NCT04490915|455437960|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
126584014|NCT04490915|455437961|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
126584015|NCT04490915|455437960|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
126584016|NCT04490915|455437961|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
126584017|NCT04490915|455437960|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
126584018|NCT04490915|455437961|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
126584019|NCT04490915|455437960|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
126584020|NCT04490915|455437961|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
126584021|NCT05009251|455437962|FG000|Overall Study|Protocol Violation|100|||
126584022|NCT05009251|455437963|FG001|Overall Study|Protocol Violation|105|||
126584023|NCT05009251|455437964|FG002|Overall Study|Protocol Violation|119|||
126584024|NCT05009251|455437965|FG003|Overall Study|Protocol Violation|120|||
126584025|NCT05009251|455437966|FG004|Overall Study|Protocol Violation|119|||
126584026|NCT05009251|455437962|FG000|Overall Study|Death|25|||
126584027|NCT05009251|455437963|FG001|Overall Study|Death|22|||
126584028|NCT05009251|455437964|FG002|Overall Study|Death|24|||
126584029|NCT05009251|455437965|FG003|Overall Study|Death|19|||
126584030|NCT05009251|455437966|FG004|Overall Study|Death|15|||
126584031|NCT05374837|455437967|FG000|Overall Study|Lost to Follow-up|17|||
126584032|NCT05374837|455437968|FG001|Overall Study|Lost to Follow-up|18|||
126584033|NCT05406921|455437970|FG000|Overall Study|Withdrawal by Subject|25|||
126584034|NCT05406921|455437971|FG001|Overall Study|Withdrawal by Subject|0|||
126584035|NCT05406921|455437972|FG002|Overall Study|Withdrawal by Subject|25|||
126584036|NCT05406921|455437970|FG000|Overall Study|Protocol Violation|0|||
126584037|NCT05406921|455437971|FG001|Overall Study|Protocol Violation|12|||
126584038|NCT05406921|455437972|FG002|Overall Study|Protocol Violation|0|||
126584039|NCT05059262|455437977|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
126584040|NCT05059262|455437978|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
126584041|NCT05059262|455437977|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
126584042|NCT05059262|455437978|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
126584043|NCT05059262|455437977|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
126584044|NCT05059262|455437978|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
126584045|NCT05059262|455437977|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
126584046|NCT05059262|455437978|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
126584047|NCT05059262|455437977|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
126584048|NCT05059262|455437978|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
126584049|NCT05059262|455437977|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
126584050|NCT05059262|455437978|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
126584051|NCT05059262|455437977|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
126584052|NCT05059262|455437978|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
126584053|NCT05059262|455437977|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
126584054|NCT05059262|455437978|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
126584055|NCT05059262|455437977|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
126584056|NCT05059262|455437978|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
126584057|NCT03393975|455437993|FG000|Urgent Treatment Period|Physician Decision|0|||
126584058|NCT03393975|455437994|FG001|Urgent Treatment Period|Physician Decision|0|||
126584059|NCT03393975|455437995|FG002|Urgent Treatment Period|Physician Decision|0|||
126584060|NCT03393975|455437996|FG003|Urgent Treatment Period|Physician Decision|1|||
126584061|NCT03393975|455437993|FG000|Prophylaxis Period 1|Reason not Specified|0|||
126584062|NCT03393975|455437994|FG001|Prophylaxis Period 1|Reason not Specified|1|||
126584063|NCT03393975|455437995|FG002|Prophylaxis Period 1|Reason not Specified|0|||
126584064|NCT03393975|455437996|FG003|Prophylaxis Period 1|Reason not Specified|0|||
126584065|NCT03393975|455437993|FG000|Prophylaxis Period 2|Reason not Specified|0|||
126584066|NCT03393975|455437994|FG001|Prophylaxis Period 2|Reason not Specified|1|||
126584067|NCT03393975|455437995|FG002|Prophylaxis Period 2|Reason not Specified|0|||
126584068|NCT03393975|455437996|FG003|Prophylaxis Period 2|Reason not Specified|0|||
126584069|NCT02312960|455438001|FG000|Overall Study|Death|24|||
126584070|NCT02312960|455438002|FG001|Overall Study|Death|32|||
126584071|NCT02312960|455438003|FG002|Overall Study|Death|25|||
126584072|NCT02312960|455438004|FG003|Overall Study|Death|11|||
126584073|NCT02312960|455438005|FG004|Overall Study|Death|5|||
126584074|NCT02312960|455438006|FG005|Overall Study|Death|5|||
126584075|NCT02312960|455438007|FG006|Overall Study|Death|8|||
126584076|NCT02312960|455438008|FG007|Overall Study|Death|5|||
126584077|NCT02312960|455438009|FG008|Overall Study|Death|7|||
126584078|NCT02312960|455438010|FG009|Overall Study|Death|3|||
126584079|NCT02312960|455438011|FG010|Overall Study|Death|3|||
126584080|NCT02312960|455438012|FG011|Overall Study|Death|1|||
126533649|NCT01297959|455244525|FG001|Overall Study|Other|7|||
126533650|NCT01667432|455244528|FG000|Overall Study|Premature Study Termination|26|||
126533651|NCT01667432|455244528|FG000|Overall Study|Failure to Return|10|||
126533652|NCT01667432|455244528|FG000|Overall Study|Moved to Another Center|3|||
126533653|NCT01667432|455244528|FG000|Overall Study|Lost to Follow-up|3|||
126533654|NCT01667432|455244528|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
126533655|NCT01667432|455244528|FG000|Overall Study|Insufficient Therapeutic Response|4|||
126533656|NCT01667432|455244528|FG000|Overall Study|Adverse Event|1|||
126533657|NCT01667432|455244528|FG000|Overall Study|Protocol Deviation|2|||
126533658|NCT01667432|455244528|FG000|Overall Study|Principal Investigator Decision|1|||
126533659|NCT01667432|455244528|FG000|Overall Study|Reason Not Specified|2|||
126533660|NCT01667432|455244528|FG000|Overall Study|Missing Information|4|||
126533661|NCT02077166|455244531|FG000|Overall Study|Death|6|||
126533662|NCT02077166|455244532|FG001|Overall Study|Death|7|||
126533663|NCT02077166|455244533|FG002|Overall Study|Death|5|||
126533664|NCT02077166|455244534|FG003|Overall Study|Death|6|||
126533665|NCT02077166|455244535|FG004|Overall Study|Death|4|||
126533666|NCT02077166|455244536|FG005|Overall Study|Death|32|||
126533667|NCT02077166|455244537|FG006|Overall Study|Death|22|||
126533668|NCT02077166|455244531|FG000|Overall Study|Study Closure by Sponsor|3|||
126533669|NCT02077166|455244532|FG001|Overall Study|Study Closure by Sponsor|0|||
126533670|NCT02077166|455244533|FG002|Overall Study|Study Closure by Sponsor|2|||
126533671|NCT02077166|455244534|FG003|Overall Study|Study Closure by Sponsor|2|||
126533672|NCT02077166|455244535|FG004|Overall Study|Study Closure by Sponsor|2|||
126533673|NCT02077166|455244536|FG005|Overall Study|Study Closure by Sponsor|12|||
126533674|NCT02077166|455244537|FG006|Overall Study|Study Closure by Sponsor|4|||
126533675|NCT02077166|455244531|FG000|Overall Study|Lost to Follow-up|0|||
126533676|NCT02077166|455244532|FG001|Overall Study|Lost to Follow-up|0|||
126533677|NCT02077166|455244533|FG002|Overall Study|Lost to Follow-up|0|||
126533678|NCT02077166|455244534|FG003|Overall Study|Lost to Follow-up|0|||
126533679|NCT02077166|455244535|FG004|Overall Study|Lost to Follow-up|0|||
126533680|NCT02077166|455244536|FG005|Overall Study|Lost to Follow-up|1|||
126533681|NCT02077166|455244537|FG006|Overall Study|Lost to Follow-up|0|||
126533682|NCT02077166|455244531|FG000|Overall Study|Withdrawal by Subject|3|||
126533683|NCT02077166|455244532|FG001|Overall Study|Withdrawal by Subject|0|||
126533684|NCT02077166|455244533|FG002|Overall Study|Withdrawal by Subject|1|||
126533685|NCT02077166|455244534|FG003|Overall Study|Withdrawal by Subject|1|||
126533686|NCT02077166|455244535|FG004|Overall Study|Withdrawal by Subject|1|||
126533687|NCT02077166|455244536|FG005|Overall Study|Withdrawal by Subject|3|||
126533688|NCT02077166|455244537|FG006|Overall Study|Withdrawal by Subject|0|||
126533689|NCT02077166|455244531|FG000|Overall Study|Other, Not Specified|0|||
126533690|NCT02077166|455244532|FG001|Overall Study|Other, Not Specified|0|||
126533691|NCT02077166|455244533|FG002|Overall Study|Other, Not Specified|1|||
126533692|NCT02077166|455244534|FG003|Overall Study|Other, Not Specified|0|||
126533693|NCT02077166|455244535|FG004|Overall Study|Other, Not Specified|1|||
126533694|NCT02077166|455244536|FG005|Overall Study|Other, Not Specified|7|||
126533695|NCT02077166|455244537|FG006|Overall Study|Other, Not Specified|8|||
126533696|NCT00707031|455244538|FG000|Overall Study|Adverse Event|45|||
126533697|NCT00707031|455244539|FG001|Overall Study|Adverse Event|45|||
126533698|NCT00707031|455244538|FG000|Overall Study|Lack of Efficacy|19|||
126533699|NCT00707031|455244539|FG001|Overall Study|Lack of Efficacy|6|||
126533700|NCT00707031|455244538|FG000|Overall Study|Lost to Follow-up|2|||
126533701|NCT00707031|455244539|FG001|Overall Study|Lost to Follow-up|1|||
126533702|NCT00707031|455244538|FG000|Overall Study|Protocol Violation|1|||
126533703|NCT00707031|455244539|FG001|Overall Study|Protocol Violation|0|||
126533704|NCT00707031|455244538|FG000|Overall Study|Withdrawal by Subject|7|||
126533705|NCT00707031|455244539|FG001|Overall Study|Withdrawal by Subject|8|||
126533706|NCT00707031|455244538|FG000|Overall Study|Poor Compliance to Protocol|7|||
126533707|NCT00707031|455244539|FG001|Overall Study|Poor Compliance to Protocol|13|||
126533708|NCT00707031|455244538|FG000|Overall Study|Familial or Personal Reasons|12|||
126533709|NCT00707031|455244539|FG001|Overall Study|Familial or Personal Reasons|15|||
126533710|NCT00707031|455244538|FG000|Overall Study|Serious Noncompliance|2|||
126533711|NCT00707031|455244539|FG001|Overall Study|Serious Noncompliance|3|||
126533712|NCT00707031|455244538|FG000|Overall Study|Sponsor Decision|9|||
126533713|NCT00707031|455244539|FG001|Overall Study|Sponsor Decision|8|||
126730883|NCT02559206|455963108|FG002|Overall Study|Lost to Follow-up|3|||
126730884|NCT02559206|455963109|FG003|Overall Study|Lost to Follow-up|3|||
126730885|NCT02559206|455963110|FG004|Overall Study|Lost to Follow-up|2|||
126730886|NCT02559206|455963111|FG005|Overall Study|Lost to Follow-up|5|||
126533714|NCT03519854|455244540|FG000|Overall Study|Technical Error|0|||
126533715|NCT03519854|455244541|FG001|Overall Study|Technical Error|0|||
126730887|NCT02559206|455963112|FG006|Overall Study|Lost to Follow-up|1|||
126730888|NCT02559206|455963113|FG007|Overall Study|Lost to Follow-up|4|||
126533716|NCT03519854|455244542|FG002|Overall Study|Technical Error|1|||
126533717|NCT03519854|455244543|FG003|Overall Study|Technical Error|0|||
126533718|NCT03519854|455244544|FG004|Overall Study|Technical Error|0|||
126533719|NCT03519854|455244545|FG005|Overall Study|Technical Error|0|||
126533720|NCT03519854|455244546|FG006|Overall Study|Technical Error|0|||
126533721|NCT03519854|455244547|FG007|Overall Study|Technical Error|0|||
126533722|NCT03519854|455244548|FG008|Overall Study|Technical Error|0|||
126533723|NCT03519854|455244549|FG009|Overall Study|Technical Error|0|||
126533724|NCT03519854|455244550|FG010|Overall Study|Technical Error|0|||
126533725|NCT03519854|455244551|FG011|Overall Study|Technical Error|0|||
126533726|NCT03519854|455244552|FG012|Overall Study|Technical Error|0|||
126533727|NCT03519854|455244553|FG013|Overall Study|Technical Error|0|||
126533728|NCT03519854|455244554|FG014|Overall Study|Technical Error|0|||
126533729|NCT03519854|455244555|FG015|Overall Study|Technical Error|0|||
126533730|NCT03519854|455244556|FG016|Overall Study|Technical Error|0|||
126533731|NCT03519854|455244557|FG017|Overall Study|Technical Error|0|||
126533732|NCT02747238|455244562|FG000|Overall Study|Lack of Efficacy|0|||
126533733|NCT02747238|455244563|FG001|Overall Study|Lack of Efficacy|1|||
126533734|NCT02747238|455244562|FG000|Overall Study|Data lost|3|||
126533735|NCT02747238|455244563|FG001|Overall Study|Data lost|5|||
126533736|NCT02085252|455244566|FG000|Overall Study|Withdrawal of Consent|1|||
126533737|NCT02085252|455244567|FG001|Overall Study|Withdrawal of Consent|0|||
126533738|NCT02085252|455244566|FG000|Overall Study|Adverse Event|0|||
126533739|NCT02085252|455244567|FG001|Overall Study|Adverse Event|1|||
126533740|NCT02085252|455244566|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
126533741|NCT02085252|455244567|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
126533742|NCT02085252|455244566|FG000|Overall Study|Reason Not Specified|0|||
126533743|NCT02085252|455244567|FG001|Overall Study|Reason Not Specified|1|||
126533744|NCT02085252|455244566|FG000|Overall Study|Reason Unknown|0|||
126533745|NCT02085252|455244567|FG001|Overall Study|Reason Unknown|1|||
126533746|NCT00951275|455244568|FG000|Overall Study|Administrative Reason|1|||
126533747|NCT00951275|455244568|FG000|Overall Study|Adverse Event|7|||
126533748|NCT00951275|455244568|FG000|Overall Study|Withdrawal by Subject|4|||
126533749|NCT00951275|455244568|FG000|Overall Study|Protocol Violation|1|||
126533750|NCT01112579|455244573|FG000|Overall Study|Missed Visit|1|||
126533751|NCT01112579|455244574|FG001|Overall Study|Missed Visit|1|||
126533752|NCT01112579|455244573|FG000|Overall Study|Death|0|||
126533753|NCT01112579|455244574|FG001|Overall Study|Death|2|||
126533754|NCT00818753|455244575|FG000|Overall Study|Protocol Violation|1|||
126533755|NCT00818753|455244576|FG001|Overall Study|Protocol Violation|0|||
126533756|NCT00818753|455244577|FG002|Overall Study|Protocol Violation|0|||
126533757|NCT00818753|455244575|FG000|Overall Study|Other reason (not specified)|0|||
126533758|NCT00818753|455244576|FG001|Overall Study|Other reason (not specified)|0|||
126533759|NCT00818753|455244577|FG002|Overall Study|Other reason (not specified)|1|||
126533760|NCT00818753|455244575|FG000|Overall Study|Randomised and not treated|2|||
126533761|NCT00818753|455244576|FG001|Overall Study|Randomised and not treated|0|||
126533762|NCT00818753|455244577|FG002|Overall Study|Randomised and not treated|0|||
126584081|NCT02312960|455438013|FG012|Overall Study|Death|25|||
126584082|NCT02312960|455438014|FG013|Overall Study|Death|19|||
126584083|NCT02312960|455438001|FG000|Overall Study|Missing|0|||
126584084|NCT02312960|455438002|FG001|Overall Study|Missing|0|||
126584085|NCT02312960|455438003|FG002|Overall Study|Missing|2|||
126584086|NCT02312960|455438004|FG003|Overall Study|Missing|0|||
126584087|NCT02312960|455438005|FG004|Overall Study|Missing|0|||
126584088|NCT02312960|455438006|FG005|Overall Study|Missing|0|||
126584089|NCT02312960|455438007|FG006|Overall Study|Missing|0|||
126584090|NCT02312960|455438008|FG007|Overall Study|Missing|0|||
126584091|NCT02312960|455438009|FG008|Overall Study|Missing|0|||
126584092|NCT02312960|455438010|FG009|Overall Study|Missing|0|||
126584093|NCT02312960|455438011|FG010|Overall Study|Missing|0|||
126584094|NCT02312960|455438012|FG011|Overall Study|Missing|0|||
126584095|NCT02312960|455438013|FG012|Overall Study|Missing|0|||
126584096|NCT02312960|455438014|FG013|Overall Study|Missing|0|||
126584097|NCT02312960|455438001|FG000|Overall Study|Lost to Follow-up|0|||
126584098|NCT02312960|455438002|FG001|Overall Study|Lost to Follow-up|0|||
126584099|NCT02312960|455438003|FG002|Overall Study|Lost to Follow-up|1|||
126584100|NCT02312960|455438004|FG003|Overall Study|Lost to Follow-up|0|||
126584101|NCT02312960|455438005|FG004|Overall Study|Lost to Follow-up|0|||
126584102|NCT02312960|455438006|FG005|Overall Study|Lost to Follow-up|0|||
126584103|NCT02312960|455438007|FG006|Overall Study|Lost to Follow-up|1|||
126584104|NCT02312960|455438008|FG007|Overall Study|Lost to Follow-up|1|||
126584105|NCT02312960|455438009|FG008|Overall Study|Lost to Follow-up|0|||
126584106|NCT02312960|455438010|FG009|Overall Study|Lost to Follow-up|1|||
126584107|NCT02312960|455438011|FG010|Overall Study|Lost to Follow-up|0|||
126730889|NCT02559206|455963106|FG000|Overall Study|Lack of Efficacy|1|||
126584108|NCT02312960|455438012|FG011|Overall Study|Lost to Follow-up|0|||
126584109|NCT02312960|455438013|FG012|Overall Study|Lost to Follow-up|1|||
126584110|NCT02312960|455438014|FG013|Overall Study|Lost to Follow-up|0|||
126584111|NCT02312960|455438001|FG000|Overall Study|Withdrawal by Subject|1|||
126584112|NCT02312960|455438002|FG001|Overall Study|Withdrawal by Subject|2|||
126584113|NCT02312960|455438003|FG002|Overall Study|Withdrawal by Subject|0|||
126584114|NCT02312960|455438004|FG003|Overall Study|Withdrawal by Subject|0|||
126584115|NCT02312960|455438005|FG004|Overall Study|Withdrawal by Subject|1|||
126584116|NCT02312960|455438006|FG005|Overall Study|Withdrawal by Subject|0|||
126584117|NCT02312960|455438007|FG006|Overall Study|Withdrawal by Subject|1|||
126584118|NCT02312960|455438008|FG007|Overall Study|Withdrawal by Subject|2|||
126777326|NCT00528879|456141332|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
126777327|NCT00528879|456141329|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
126777328|NCT00528879|456141330|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
126777329|NCT00528879|456141331|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
126777330|NCT00528879|456141332|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
126777331|NCT00528879|456141329|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
126777332|NCT00528879|456141330|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
126777333|NCT00528879|456141331|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
126777334|NCT00528879|456141332|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
126777335|NCT00528879|456141329|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
126777336|NCT00528879|456141330|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
126777337|NCT00528879|456141331|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
126777338|NCT00528879|456141332|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
126777339|NCT00078819|456141333|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
126777340|NCT00078819|456141334|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
126777341|NCT00078819|456141335|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
126777342|NCT00078819|456141336|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
126777343|NCT00078819|456141333|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
126777344|NCT00078819|456141334|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
126777345|NCT00078819|456141335|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
126777346|NCT00078819|456141336|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
126777347|NCT00078819|456141333|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
126777348|NCT00078819|456141334|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
126777349|NCT00078819|456141335|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
126777350|NCT00078819|456141336|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
126777351|NCT00078819|456141333|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
126777352|NCT00078819|456141334|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
126777353|NCT00078819|456141335|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
126777354|NCT00078819|456141336|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
126777355|NCT00078819|456141333|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
126777356|NCT00078819|456141334|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
126777357|NCT00078819|456141335|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
126777358|NCT00078819|456141336|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
126777359|NCT00078819|456141333|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
126777360|NCT00078819|456141334|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
126777361|NCT00078819|456141335|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
126777362|NCT00078819|456141336|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
126777363|NCT00078819|456141333|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
126640501|NCT01370655|455642783|FG002|Period 2|Adverse Event|1|||
126640502|NCT01370655|455642784|FG003|Period 2|Adverse Event|0|||
126640503|NCT01370655|455642785|FG004|Period 2|Adverse Event|1|||
126640504|NCT01370655|455642786|FG005|Period 2|Adverse Event|0|||
126640505|NCT01370655|455642787|FG006|Period 2|Adverse Event|0|||
126640506|NCT01370655|455642788|FG007|Period 2|Adverse Event|1|||
126640507|NCT01370655|455642789|FG008|Period 2|Adverse Event|0|||
126640508|NCT01370655|455642790|FG009|Period 2|Adverse Event|0|||
126640509|NCT01370655|455642791|FG010|Period 2|Adverse Event|0|||
126640510|NCT01370655|455642792|FG011|Period 2|Adverse Event|0|||
126640511|NCT01370655|455642781|FG000|Period 2|met protocol specified stopping criteria|0|||
126640512|NCT01370655|455642782|FG001|Period 2|met protocol specified stopping criteria|0|||
126640513|NCT01370655|455642783|FG002|Period 2|met protocol specified stopping criteria|1|||
126640514|NCT01370655|455642784|FG003|Period 2|met protocol specified stopping criteria|0|||
126640515|NCT01370655|455642785|FG004|Period 2|met protocol specified stopping criteria|0|||
126640516|NCT01370655|455642786|FG005|Period 2|met protocol specified stopping criteria|0|||
126640517|NCT01370655|455642787|FG006|Period 2|met protocol specified stopping criteria|1|||
126640518|NCT01370655|455642788|FG007|Period 2|met protocol specified stopping criteria|0|||
126640519|NCT01370655|455642789|FG008|Period 2|met protocol specified stopping criteria|1|||
126640520|NCT01370655|455642790|FG009|Period 2|met protocol specified stopping criteria|0|||
126640521|NCT01370655|455642791|FG010|Period 2|met protocol specified stopping criteria|1|||
126640522|NCT01370655|455642792|FG011|Period 2|met protocol specified stopping criteria|0|||
126640523|NCT01370655|455642781|FG000|Period 2|Withdrawal by Subject|0|||
126640524|NCT01370655|455642782|FG001|Period 2|Withdrawal by Subject|0|||
126640525|NCT01370655|455642783|FG002|Period 2|Withdrawal by Subject|0|||
126640526|NCT01370655|455642784|FG003|Period 2|Withdrawal by Subject|0|||
126640527|NCT01370655|455642785|FG004|Period 2|Withdrawal by Subject|0|||
126640528|NCT01370655|455642786|FG005|Period 2|Withdrawal by Subject|0|||
126640529|NCT01370655|455642787|FG006|Period 2|Withdrawal by Subject|0|||
126640530|NCT01370655|455642788|FG007|Period 2|Withdrawal by Subject|0|||
126730890|NCT02559206|455963107|FG001|Overall Study|Lack of Efficacy|0|||
126730891|NCT02559206|455963108|FG002|Overall Study|Lack of Efficacy|3|||
126730892|NCT02559206|455963109|FG003|Overall Study|Lack of Efficacy|2|||
126730893|NCT02559206|455963110|FG004|Overall Study|Lack of Efficacy|2|||
126730894|NCT02559206|455963111|FG005|Overall Study|Lack of Efficacy|3|||
126730895|NCT02559206|455963112|FG006|Overall Study|Lack of Efficacy|3|||
126730896|NCT02559206|455963113|FG007|Overall Study|Lack of Efficacy|3|||
126730897|NCT02559206|455963106|FG000|Overall Study|Other Not Specified|0|||
126730898|NCT02559206|455963107|FG001|Overall Study|Other Not Specified|0|||
126730899|NCT02559206|455963108|FG002|Overall Study|Other Not Specified|0|||
126730900|NCT02559206|455963109|FG003|Overall Study|Other Not Specified|1|||
126730901|NCT02559206|455963110|FG004|Overall Study|Other Not Specified|0|||
126730902|NCT02559206|455963111|FG005|Overall Study|Other Not Specified|0|||
126730903|NCT02559206|455963112|FG006|Overall Study|Other Not Specified|0|||
126730904|NCT02559206|455963113|FG007|Overall Study|Other Not Specified|0|||
126730905|NCT01561560|455963114|FG000|First Two Weeks of Wear|Time/job conflict|0|||
126730906|NCT01561560|455963115|FG001|First Two Weeks of Wear|Time/job conflict|1|||
126730907|NCT01561560|455963114|FG000|First Two Weeks of Wear|Adverse Event|0|||
126730908|NCT01561560|455963115|FG001|First Two Weeks of Wear|Adverse Event|1|||
126730909|NCT01561560|455963114|FG000|Second Two Weeks of Wear|Adverse Event|0|||
126730910|NCT01561560|455963115|FG001|Second Two Weeks of Wear|Adverse Event|1|||
126730911|NCT00646113|455964396|FG000|Overall Study|Lost to Follow-up|5|||
126730912|NCT00646113|455964396|FG000|Overall Study|Adverse Event|3|||
126730913|NCT02109744|455964397|FG000|Overall Study|Death|1|||
126730914|NCT02109744|455964398|FG001|Overall Study|Death|1|||
126730915|NCT02109744|455964397|FG000|Overall Study|no marrow exam|1|||
126730916|NCT02109744|455964398|FG001|Overall Study|no marrow exam|0|||
126730917|NCT04095442|455964399|FG000|Overall Study|Lost to Follow-up|0|||
126730918|NCT04095442|455964400|FG001|Overall Study|Lost to Follow-up|1|||
126730919|NCT04095442|455964399|FG000|Overall Study|Screen failure|1|||
126730920|NCT04095442|455964400|FG001|Overall Study|Screen failure|0|||
126730921|NCT03947255|455964403|FG000|Overall Study|Study Closure by Sponsor|2|||
126730922|NCT03947255|455964404|FG001|Overall Study|Study Closure by Sponsor|2|||
126730923|NCT03947255|455964403|FG000|Overall Study|Withdrawal by Subject|2|||
126730924|NCT03947255|455964404|FG001|Overall Study|Withdrawal by Subject|2|||
126730925|NCT03947255|455964403|FG000|Overall Study|Lost to Follow-up|2|||
126730926|NCT03947255|455964404|FG001|Overall Study|Lost to Follow-up|0|||
126730927|NCT03947255|455964403|FG000|Overall Study|Death|0|||
126730928|NCT03947255|455964404|FG001|Overall Study|Death|2|||
126730929|NCT04656418|455964405|FG000|Overall Study|Withdrawal by Subject|1|||
126730930|NCT04656418|455964406|FG001|Overall Study|Withdrawal by Subject|3|||
126584119|NCT02312960|455438009|FG008|Overall Study|Withdrawal by Subject|2|||
126584120|NCT02312960|455438010|FG009|Overall Study|Withdrawal by Subject|3|||
126584121|NCT02312960|455438011|FG010|Overall Study|Withdrawal by Subject|0|||
126584122|NCT02312960|455438012|FG011|Overall Study|Withdrawal by Subject|0|||
126584123|NCT02312960|455438013|FG012|Overall Study|Withdrawal by Subject|2|||
126584124|NCT02312960|455438014|FG013|Overall Study|Withdrawal by Subject|0|||
126584125|NCT05458011|455438015|FG000|DB Period (12 Weeks)|Adverse Event|2|||
126584126|NCT05458011|455438016|FG001|DB Period (12 Weeks)|Adverse Event|1|||
126584127|NCT05458011|455438017|FG002|DB Period (12 Weeks)|Adverse Event|1|||
126584128|NCT05458011|455438015|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
126584129|NCT05458011|455438016|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
126584130|NCT05458011|455438017|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
126584131|NCT05458011|455438015|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
126584132|NCT05458011|455438016|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
126584133|NCT05458011|455438017|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
126584134|NCT05458011|455438015|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
126584135|NCT05458011|455438016|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
126584136|NCT05458011|455438017|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
126584137|NCT05458011|455438015|FG000|OL Period (12 Weeks)|Adverse Event|1|||
126584138|NCT05458011|455438016|FG001|OL Period (12 Weeks)|Adverse Event|2|||
126584139|NCT05458011|455438017|FG002|OL Period (12 Weeks)|Adverse Event|1|||
126584140|NCT05458011|455438015|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
126584141|NCT05458011|455438016|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
126584142|NCT05458011|455438017|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
126584143|NCT02724878|455438034|FG000|Overall Study|Still on Active Therapy|15|||
126584144|NCT02724878|455438034|FG000|Overall Study|Disease Progression|31|||
126584145|NCT02724878|455438034|FG000|Overall Study|Toxicity|5|||
126584146|NCT02724878|455438034|FG000|Overall Study|Death|1|||
126584147|NCT02724878|455438034|FG000|Overall Study|Withdrawal by Subject|4|||
126584148|NCT02724878|455438034|FG000|Overall Study|Lost to Follow-up|2|||
126584149|NCT02724878|455438034|FG000|Overall Study|Protocol Violation|1|||
126584150|NCT02724878|455438034|FG000|Overall Study|Ineligible for Study Drug|5|||
126584151|NCT02724878|455438034|FG000|Overall Study|not started|1|||
126584152|NCT04838262|455438036|FG000|Overall Study|Withdrawal by Subject|9|||
126584153|NCT04838262|455438037|FG001|Overall Study|Withdrawal by Subject|4|||
126730931|NCT03287245|455964407|FG000|Overall Study|Study terminated by sponsor|3|||
126584154|NCT03175029|455438040|FG000|Overall Study|Withdrawal by Subject|2|||
126584155|NCT03175029|455438041|FG001|Overall Study|Withdrawal by Subject|1|||
126584156|NCT03175029|455438040|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
126584157|NCT03175029|455438041|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
126584158|NCT02900924|455438048|FG000|Overall Study|Death|52|||
126584159|NCT02900924|455438048|FG000|Overall Study|Lost to Follow-up|4|||
126584160|NCT02900924|455438048|FG000|Overall Study|Withdrawal by Subject|20|||
126584161|NCT02900924|455438048|FG000|Overall Study|Missed Visit|33|||
126584162|NCT02365766|455438068|FG000|Overall Study|Withdrawal by Subject|0|||
126584163|NCT02365766|455438069|FG001|Overall Study|Withdrawal by Subject|0|||
126584164|NCT02365766|455438070|FG002|Overall Study|Withdrawal by Subject|1|||
126584165|NCT02365766|455438068|FG000|Overall Study|Eligibility Criteria Not Met|0|||
126584166|NCT02365766|455438069|FG001|Overall Study|Eligibility Criteria Not Met|0|||
126584167|NCT02365766|455438070|FG002|Overall Study|Eligibility Criteria Not Met|1|||
126584168|NCT05956002|455438072|FG000|Treatment Period 3|Adverse Event|0|||
126584169|NCT05956002|455438073|FG001|Treatment Period 3|Adverse Event|0|||
126584170|NCT05956002|455438074|FG002|Treatment Period 3|Adverse Event|1|||
126584171|NCT05956002|455438075|FG003|Treatment Period 3|Adverse Event|0|||
126584172|NCT04391894|455438080|FG000|Overall Study|Adverse Event|1|||
126584173|NCT04391894|455438081|FG001|Overall Study|Adverse Event|1|||
126584174|NCT04391894|455438082|FG002|Overall Study|Adverse Event|1|||
126584175|NCT04391894|455438083|FG003|Overall Study|Adverse Event|1|||
126584176|NCT04391894|455438084|FG004|Overall Study|Adverse Event|1|||
126584177|NCT04391894|455438080|FG000|Overall Study|Lost to Follow-up|1|||
126584178|NCT04391894|455438081|FG001|Overall Study|Lost to Follow-up|0|||
126584179|NCT04391894|455438082|FG002|Overall Study|Lost to Follow-up|0|||
126584180|NCT04391894|455438083|FG003|Overall Study|Lost to Follow-up|0|||
126584181|NCT04391894|455438084|FG004|Overall Study|Lost to Follow-up|0|||
126584182|NCT04391894|455438080|FG000|Overall Study|Protocol Violation|0|||
126584183|NCT04391894|455438081|FG001|Overall Study|Protocol Violation|0|||
126584184|NCT04391894|455438082|FG002|Overall Study|Protocol Violation|0|||
126584185|NCT04391894|455438083|FG003|Overall Study|Protocol Violation|1|||
126584186|NCT04391894|455438084|FG004|Overall Study|Protocol Violation|0|||
126584187|NCT04391894|455438080|FG000|Overall Study|Withdrawal by Subject|2|||
126584188|NCT04391894|455438081|FG001|Overall Study|Withdrawal by Subject|0|||
126584189|NCT04391894|455438082|FG002|Overall Study|Withdrawal by Subject|3|||
126584190|NCT04391894|455438083|FG003|Overall Study|Withdrawal by Subject|0|||
126584191|NCT04391894|455438084|FG004|Overall Study|Withdrawal by Subject|1|||
126584192|NCT04391894|455438080|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
126584193|NCT04391894|455438081|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
126584194|NCT04391894|455438082|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
126584195|NCT04391894|455438083|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
126584196|NCT04391894|455438084|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
126584197|NCT01057433|455438089|FG000|Overall Study|Adverse Event|1|||
126584198|NCT05268302|455438090|FG000|Overall Study|Death|0|||
126584199|NCT05268302|455438091|FG001|Overall Study|Death|1|||
126584200|NCT04285567|455438092|FG000|Overall Study|Death|3|||
126584201|NCT04285567|455438093|FG001|Overall Study|Death|3|||
126584202|NCT04285567|455438092|FG000|Overall Study|Lost to Follow-up|1|||
126584203|NCT04285567|455438093|FG001|Overall Study|Lost to Follow-up|1|||
126584204|NCT04285567|455438092|FG000|Overall Study|Reason Not Specified|1|||
126584205|NCT04285567|455438093|FG001|Overall Study|Reason Not Specified|1|||
126584206|NCT04285567|455438092|FG000|Overall Study|Physician Decision|2|||
126584207|NCT04285567|455438093|FG001|Overall Study|Physician Decision|1|||
126584208|NCT04285567|455438092|FG000|Overall Study|Withdrawal by Subject|2|||
126584209|NCT04285567|455438093|FG001|Overall Study|Withdrawal by Subject|6|||
126730932|NCT03287245|455964408|FG001|Overall Study|Study terminated by sponsor|0|||
126730933|NCT03287245|455964409|FG002|Overall Study|Study terminated by sponsor|3|||
126730934|NCT03287245|455964410|FG003|Overall Study|Study terminated by sponsor|1|||
126730935|NCT03287245|455964407|FG000|Overall Study|Adverse Event|1|||
126730936|NCT03287245|455964408|FG001|Overall Study|Adverse Event|0|||
126730937|NCT03287245|455964409|FG002|Overall Study|Adverse Event|0|||
126730938|NCT03287245|455964410|FG003|Overall Study|Adverse Event|0|||
126584210|NCT04285567|455438092|FG000|Overall Study|Adverse Event|1|||
126584211|NCT04285567|455438093|FG001|Overall Study|Adverse Event|0|||
126584212|NCT04285567|455438092|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
126584213|NCT04285567|455438093|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
126584214|NCT05319860|455438095|FG000|Overall Study|Death|1|||
126584215|NCT05319860|455438096|FG001|Overall Study|Death|1|||
126584216|NCT05319860|455438095|FG000|Overall Study|Lost to Follow-up|3|||
126584217|NCT05319860|455438096|FG001|Overall Study|Lost to Follow-up|1|||
126584218|NCT05319860|455438095|FG000|Overall Study|Withdrawal by Subject|1|||
126584219|NCT05319860|455438096|FG001|Overall Study|Withdrawal by Subject|7|||
126584220|NCT05063994|455439684|FG000|Cortef Run-In|Withdrawal of Consent|1|||
126584221|NCT05063994|455439685|FG001|Cortef Run-In|Withdrawal of Consent|0|||
126584222|NCT05063994|455439686|FG002|Cortef Run-In|Withdrawal of Consent|0|||
126730939|NCT03287245|455964407|FG000|Overall Study|Withdrawal by Subject|8|||
126584223|NCT05063994|455439684|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
126584224|NCT05063994|455439685|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
126584225|NCT05063994|455439686|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
126584226|NCT05063994|455439684|FG000|Treatment|Physician Decision|0|||
126584227|NCT05063994|455439685|FG001|Treatment|Physician Decision|0|||
126584228|NCT05063994|455439686|FG002|Treatment|Physician Decision|1|||
126584229|NCT05063994|455439684|FG000|Treatment|Withdrawal by Subject|0|||
126584230|NCT05063994|455439685|FG001|Treatment|Withdrawal by Subject|0|||
126584231|NCT05063994|455439686|FG002|Treatment|Withdrawal by Subject|1|||
126584232|NCT05063994|455439684|FG000|Treatment|Withdrawal of Consent|0|||
126584233|NCT05063994|455439685|FG001|Treatment|Withdrawal of Consent|0|||
126584234|NCT05063994|455439686|FG002|Treatment|Withdrawal of Consent|1|||
126584235|NCT03786783|455439687|FG000|Overall Study|Death|1|||
126584236|NCT03786783|455439687|FG000|Overall Study|Physician Decision|6|||
126584237|NCT03786783|455439687|FG000|Overall Study|Withdrawal by Subject|2|||
126584238|NCT03786783|455439687|FG000|Overall Study|Disease Progression|7|||
126584239|NCT03786783|455439687|FG000|Overall Study|Patient/Parent Refusal|4|||
126584240|NCT00616967|455439688|FG000|Overall Study|Withdrawal by Subject|0|||
126584241|NCT00616967|455439689|FG001|Overall Study|Withdrawal by Subject|0|||
126584242|NCT00616967|455439690|FG002|Overall Study|Withdrawal by Subject|1|||
126584243|NCT02910583|455439691|FG000|Overall Study|Death|7|||
126584244|NCT02910583|455439692|FG001|Overall Study|Death|3|||
126584245|NCT02910583|455439691|FG000|Overall Study|Lost to Follow-up|1|||
126584246|NCT02910583|455439692|FG001|Overall Study|Lost to Follow-up|0|||
126584247|NCT02910583|455439691|FG000|Overall Study|Withdrawal by Subject|12|||
126584248|NCT02910583|455439692|FG001|Overall Study|Withdrawal by Subject|8|||
126584249|NCT02910583|455439691|FG000|Overall Study|Other, Not Specified|6|||
126584250|NCT02910583|455439692|FG001|Overall Study|Other, Not Specified|3|||
126584251|NCT01331005|455439694|FG000|Overall Study|Lost to Follow-up|2|||
126584252|NCT01331005|455439695|FG001|Overall Study|Lost to Follow-up|1|||
126584253|NCT01331005|455439694|FG000|Overall Study|Withdrawal by Subject|2|||
126584254|NCT01331005|455439695|FG001|Overall Study|Withdrawal by Subject|3|||
126584255|NCT02029443|455439698|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
126584256|NCT02029443|455439699|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
126584257|NCT02029443|455439700|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
126584258|NCT02029443|455439701|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
126584259|NCT02029443|455439702|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
126584260|NCT02029443|455439698|FG000|Overall Study|Death|13|||
126584261|NCT02029443|455439699|FG001|Overall Study|Death|2|||
126584262|NCT02029443|455439700|FG002|Overall Study|Death|2|||
126584263|NCT02029443|455439701|FG003|Overall Study|Death|11|||
126584264|NCT02029443|455439702|FG004|Overall Study|Death|2|||
126584265|NCT02029443|455439698|FG000|Overall Study|Lost to Follow-up|1|||
126584266|NCT02029443|455439699|FG001|Overall Study|Lost to Follow-up|0|||
126584267|NCT02029443|455439700|FG002|Overall Study|Lost to Follow-up|1|||
126584268|NCT02029443|455439701|FG003|Overall Study|Lost to Follow-up|1|||
126584269|NCT02029443|455439702|FG004|Overall Study|Lost to Follow-up|0|||
126584270|NCT02029443|455439698|FG000|Overall Study|Started other anti-cancer therapy|17|||
126584271|NCT02029443|455439699|FG001|Overall Study|Started other anti-cancer therapy|4|||
126584272|NCT02029443|455439700|FG002|Overall Study|Started other anti-cancer therapy|7|||
126730940|NCT03287245|455964408|FG001|Overall Study|Withdrawal by Subject|3|||
126584273|NCT02029443|455439701|FG003|Overall Study|Started other anti-cancer therapy|9|||
126584274|NCT02029443|455439702|FG004|Overall Study|Started other anti-cancer therapy|3|||
126584275|NCT02029443|455439698|FG000|Overall Study|Withdrawal by Subject|3|||
126584276|NCT02029443|455439699|FG001|Overall Study|Withdrawal by Subject|1|||
126584277|NCT02029443|455439700|FG002|Overall Study|Withdrawal by Subject|1|||
126584278|NCT02029443|455439701|FG003|Overall Study|Withdrawal by Subject|1|||
126584279|NCT02029443|455439702|FG004|Overall Study|Withdrawal by Subject|0|||
126584280|NCT02029443|455439698|FG000|Overall Study|Other|6|||
126584281|NCT02029443|455439699|FG001|Overall Study|Other|6|||
126584282|NCT02029443|455439700|FG002|Overall Study|Other|4|||
126584283|NCT02029443|455439701|FG003|Overall Study|Other|2|||
126584284|NCT02029443|455439702|FG004|Overall Study|Other|0|||
126584285|NCT04083235|455439709|FG000|Overall Study|Death|252|||
126584286|NCT04083235|455439710|FG001|Overall Study|Death|277|||
126584287|NCT04083235|455439709|FG000|Overall Study|Withdrawal by Subject|13|||
126584288|NCT04083235|455439710|FG001|Overall Study|Withdrawal by Subject|17|||
126584289|NCT04083235|455439709|FG000|Overall Study|Lost to Follow-up|1|||
126730941|NCT03287245|455964409|FG002|Overall Study|Withdrawal by Subject|3|||
126584290|NCT04083235|455439710|FG001|Overall Study|Lost to Follow-up|1|||
126584291|NCT04083235|455439709|FG000|Overall Study|Does not meet entry criteria|1|||
126584292|NCT04083235|455439710|FG001|Overall Study|Does not meet entry criteria|0|||
126584293|NCT04083235|455439709|FG000|Overall Study|Did not receive treatment|13|||
126584294|NCT04083235|455439710|FG001|Overall Study|Did not receive treatment|8|||
126584295|NCT04083235|455439709|FG000|Overall Study|Ongoing at the time of DCO|44|||
126584296|NCT04083235|455439710|FG001|Overall Study|Ongoing at the time of DCO|7|||
126730942|NCT03287245|455964410|FG003|Overall Study|Withdrawal by Subject|0|||
126584297|NCT02549339|455439711|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
126584298|NCT02549339|455439712|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
126584299|NCT02549339|455439711|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
126584300|NCT02549339|455439712|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
126584301|NCT02549339|455439711|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
126584302|NCT02549339|455439712|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
126584303|NCT02549339|455439711|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
126584304|NCT02549339|455439712|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
126584305|NCT02549339|455439711|FG000|12-month Follow-up|Lack of Efficacy|0|||
126584306|NCT02549339|455439712|FG001|12-month Follow-up|Lack of Efficacy|2|||
126584307|NCT02549339|455439711|FG000|12-month Follow-up|Withdrawal by Subject|8|||
126584308|NCT02549339|455439712|FG001|12-month Follow-up|Withdrawal by Subject|3|||
126584309|NCT02549339|455439711|FG000|12-month Follow-up|Lost to Follow-up|1|||
126584310|NCT02549339|455439712|FG001|12-month Follow-up|Lost to Follow-up|3|||
126584311|NCT02549339|455439711|FG000|12-month Follow-up|Other|0|||
126584312|NCT02549339|455439712|FG001|12-month Follow-up|Other|3|||
126584313|NCT03016169|455439713|FG000|Overall Study|Lost to Follow-up|4|||
126584314|NCT03016169|455439713|FG000|Overall Study|Death|54|||
126584315|NCT03016169|455439713|FG000|Overall Study|Device Explant|11|||
126584316|NCT03016169|455439713|FG000|Overall Study|Withdrawal by Subject|19|||
126584317|NCT03016169|455439713|FG000|Overall Study|Other Reasons|1|||
126584318|NCT05227209|455439718|FG000|Overall Study|Adverse Event|11|||
126584319|NCT05227209|455439718|FG000|Overall Study|Lost to Follow-up|1|||
126584320|NCT05227209|455439718|FG000|Overall Study|Withdrawal by Subject|7|||
126584321|NCT05227209|455439718|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
126584322|NCT03281291|455439721|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
126584323|NCT03281291|455439722|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
126584324|NCT03281291|455439723|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
126584325|NCT03281291|455439724|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
126584326|NCT03281291|455439725|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
126584327|NCT03281291|455439721|FG000|Overall Study|Protocol Deviation|2|||
126584328|NCT03281291|455439722|FG001|Overall Study|Protocol Deviation|0|||
126584329|NCT03281291|455439723|FG002|Overall Study|Protocol Deviation|1|||
126584330|NCT03281291|455439724|FG003|Overall Study|Protocol Deviation|2|||
126584331|NCT03281291|455439725|FG004|Overall Study|Protocol Deviation|1|||
126584332|NCT03281291|455439721|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
126584333|NCT03281291|455439722|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
126584334|NCT03281291|455439723|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
126584335|NCT03281291|455439724|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
126584336|NCT03281291|455439725|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
126584337|NCT03281291|455439721|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
126584338|NCT03281291|455439722|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
126584339|NCT03281291|455439723|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
126584340|NCT03281291|455439724|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
126584341|NCT03281291|455439725|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
126584342|NCT03281291|455439721|FG000|Overall Study|Lost to Follow-up|10|||
126584343|NCT03281291|455439722|FG001|Overall Study|Lost to Follow-up|10|||
126584344|NCT03281291|455439723|FG002|Overall Study|Lost to Follow-up|4|||
126584345|NCT03281291|455439724|FG003|Overall Study|Lost to Follow-up|6|||
126584346|NCT03281291|455439725|FG004|Overall Study|Lost to Follow-up|10|||
126584347|NCT03281291|455439721|FG000|Overall Study|Other|0|||
126730943|NCT03287245|455964407|FG000|Overall Study|Physician Decision|3|||
126730944|NCT03287245|455964408|FG001|Overall Study|Physician Decision|2|||
126730945|NCT03287245|455964409|FG002|Overall Study|Physician Decision|0|||
126584348|NCT03281291|455439722|FG001|Overall Study|Other|2|||
126584349|NCT03281291|455439723|FG002|Overall Study|Other|0|||
126584350|NCT03281291|455439724|FG003|Overall Study|Other|2|||
126584351|NCT03281291|455439725|FG004|Overall Study|Other|1|||
126584352|NCT00512070|455439726|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
126584353|NCT00512070|455439727|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
126584354|NCT00512070|455439728|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
126584355|NCT00512070|455439726|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
126584356|NCT00512070|455439727|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
126584357|NCT00512070|455439728|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
126584358|NCT05524233|455439729|FG000|Overall Study|Lost to Follow-up|2|||
126584359|NCT05524233|455439729|FG000|Overall Study|Adverse Event|2|||
126584360|NCT05524233|455439729|FG000|Overall Study|Withdrawal by Subject|1|||
126584361|NCT02506959|455439730|FG000|Overall Study|Physician Decision|2|||
126584362|NCT02506959|455439731|FG001|Overall Study|Physician Decision|1|||
126584363|NCT04382898|455439733|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
126584364|NCT04382898|455439734|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
126584365|NCT04382898|455439735|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
126584366|NCT04382898|455439736|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
126584367|NCT04382898|455439737|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
126584368|NCT04382898|455439733|FG000|Part 1: Dose Titration|Death|6|||
126584369|NCT04382898|455439734|FG001|Part 1: Dose Titration|Death|0|||
126584370|NCT04382898|455439735|FG002|Part 1: Dose Titration|Death|0|||
126584371|NCT04382898|455439736|FG003|Part 1: Dose Titration|Death|0|||
126584372|NCT04382898|455439737|FG004|Part 1: Dose Titration|Death|0|||
126584373|NCT04382898|455439733|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126584374|NCT04382898|455439734|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126584375|NCT04382898|455439735|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
126584376|NCT04382898|455439736|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126584377|NCT04382898|455439737|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
126730946|NCT03287245|455964410|FG003|Overall Study|Physician Decision|0|||
126584378|NCT04382898|455439733|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
126584379|NCT04382898|455439734|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
126584380|NCT04382898|455439735|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
126584381|NCT04382898|455439736|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
126584382|NCT04382898|455439737|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
126584383|NCT04382898|455439733|FG000|Part 2: Dose Expansion|Death|0|||
126584384|NCT04382898|455439734|FG001|Part 2: Dose Expansion|Death|17|||
126584385|NCT04382898|455439735|FG002|Part 2: Dose Expansion|Death|13|||
126584386|NCT04382898|455439736|FG003|Part 2: Dose Expansion|Death|1|||
126584387|NCT04382898|455439737|FG004|Part 2: Dose Expansion|Death|0|||
126584388|NCT04382898|455439733|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
126584389|NCT04382898|455439734|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
126584390|NCT04382898|455439735|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
126584391|NCT04382898|455439736|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
126584392|NCT04382898|455439737|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
126584393|NCT04382898|455439733|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
126584394|NCT04382898|455439734|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
126584395|NCT04382898|455439735|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
126584396|NCT04382898|455439736|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
126584397|NCT04382898|455439737|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
126584398|NCT04382898|455439733|FG000|Part 2: Dose Expansion|Other|0|||
126584399|NCT04382898|455439734|FG001|Part 2: Dose Expansion|Other|0|||
126584400|NCT04382898|455439735|FG002|Part 2: Dose Expansion|Other|1|||
126584401|NCT04382898|455439736|FG003|Part 2: Dose Expansion|Other|0|||
126584402|NCT04382898|455439737|FG004|Part 2: Dose Expansion|Other|0|||
126584403|NCT05229120|455439738|FG000|Overall Study|Withdrawal by Subject|8|||
126584404|NCT03932682|455439741|FG000|Overall Study|Death|1|||
126584405|NCT03932682|455439742|FG001|Overall Study|Death|2|||
126584406|NCT03932682|455439741|FG000|Overall Study|Withdrawal by Subject|37|||
126584407|NCT03932682|455439742|FG001|Overall Study|Withdrawal by Subject|45|||
126584408|NCT03932682|455439741|FG000|Overall Study|Lost to Follow-up|19|||
126584409|NCT03932682|455439742|FG001|Overall Study|Lost to Follow-up|25|||
126584410|NCT03932682|455439741|FG000|Overall Study|Protocol Violation|0|||
126584411|NCT03932682|455439742|FG001|Overall Study|Protocol Violation|2|||
126584412|NCT03932682|455439741|FG000|Overall Study|Other|9|||
126584413|NCT03932682|455439742|FG001|Overall Study|Other|23|||
126584414|NCT02530671|455439745|FG000|Overall Study|Lost to Follow-up|2|||
126584415|NCT02530671|455439746|FG001|Overall Study|Lost to Follow-up|0|||
126584416|NCT02530671|455439745|FG000|Overall Study|Withdrawal by Subject|1|||
126584417|NCT02530671|455439746|FG001|Overall Study|Withdrawal by Subject|0|||
126584418|NCT04390048|455439747|FG000|Overall Study|Withdrawal by Subject|1|||
126584419|NCT04390048|455439748|FG001|Overall Study|Withdrawal by Subject|3|||
126584420|NCT03126019|455439749|FG000|Overall Study|Death|5|||
126584421|NCT03126019|455439750|FG001|Overall Study|Death|27|||
126584422|NCT03126019|455439749|FG000|Overall Study|Lost to Follow-up|2|||
126584423|NCT03126019|455439750|FG001|Overall Study|Lost to Follow-up|4|||
126584424|NCT03126019|455439749|FG000|Overall Study|Withdrawal by Subject|1|||
126584425|NCT03126019|455439750|FG001|Overall Study|Withdrawal by Subject|9|||
126584426|NCT03126019|455439749|FG000|Overall Study|Physician Decision|1|||
126584427|NCT03126019|455439750|FG001|Overall Study|Physician Decision|0|||
126584428|NCT03126019|455439749|FG000|Overall Study|Transitioned to Rollover Study|0|||
126584429|NCT03126019|455439750|FG001|Overall Study|Transitioned to Rollover Study|11|||
126584430|NCT03126019|455439749|FG000|Overall Study|Did Not Return to Site for Care|0|||
126584431|NCT03126019|455439750|FG001|Overall Study|Did Not Return to Site for Care|1|||
126584432|NCT03126019|455439749|FG000|Overall Study|Site Closed|0|||
126730947|NCT02701192|455964411|FG000|Overall Study|Protocol Violation|2|||
126730948|NCT02701192|455964411|FG000|Overall Study|Lost to Follow-up|4|||
126584433|NCT03126019|455439750|FG001|Overall Study|Site Closed|1|||
126584434|NCT01566695|455439751|FG000|Overall Study|Lack of Efficacy|1|||
126584435|NCT01566695|455439752|FG001|Overall Study|Lack of Efficacy|0|||
126584436|NCT01566695|455439751|FG000|Overall Study|Adverse Event|3|||
126584437|NCT01566695|455439752|FG001|Overall Study|Adverse Event|0|||
126584438|NCT01566695|455439751|FG000|Overall Study|Death|79|||
126584439|NCT01566695|455439752|FG001|Overall Study|Death|86|||
126584440|NCT01566695|455439751|FG000|Overall Study|Withdrawal by Subject|13|||
126584441|NCT01566695|455439752|FG001|Overall Study|Withdrawal by Subject|12|||
126584442|NCT01566695|455439751|FG000|Overall Study|Lost to Follow-up|0|||
126584443|NCT01566695|455439752|FG001|Overall Study|Lost to Follow-up|3|||
126584444|NCT01566695|455439751|FG000|Overall Study|Other reasons|11|||
126584445|NCT01566695|455439752|FG001|Overall Study|Other reasons|8|||
126584446|NCT03763708|455439753|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
126584447|NCT03763708|455439754|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126584448|NCT03763708|455439755|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126584449|NCT03763708|455439756|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126584450|NCT03763708|455439757|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126584451|NCT03763708|455439758|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126584452|NCT03763708|455439759|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126584453|NCT03763708|455439760|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126584454|NCT03763708|455439761|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
126584455|NCT03763708|455439753|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126584456|NCT03763708|455439754|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126584457|NCT03763708|455439755|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
126584458|NCT03763708|455439756|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126584459|NCT03763708|455439757|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126584460|NCT03763708|455439758|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126584461|NCT03763708|455439759|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126584462|NCT03763708|455439760|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126584463|NCT03763708|455439761|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
126584464|NCT03763708|455439753|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126584465|NCT03763708|455439754|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126584466|NCT03763708|455439755|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126584467|NCT03763708|455439756|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
126584468|NCT03763708|455439757|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126584469|NCT03763708|455439758|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126584470|NCT03763708|455439759|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126584471|NCT03763708|455439760|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126584472|NCT03763708|455439761|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
126584473|NCT03763708|455439753|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126584474|NCT03763708|455439754|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126584475|NCT03763708|455439755|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126584476|NCT03763708|455439756|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126584477|NCT03763708|455439757|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
126584478|NCT03763708|455439758|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126584479|NCT03763708|455439759|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126584480|NCT03763708|455439760|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126584481|NCT03763708|455439761|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
126584482|NCT03763708|455439753|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126584483|NCT03763708|455439754|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126584484|NCT03763708|455439755|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126584485|NCT03763708|455439756|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126584486|NCT03763708|455439757|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126584487|NCT03763708|455439758|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
126584488|NCT03763708|455439759|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126584489|NCT03763708|455439760|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126584490|NCT03763708|455439761|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
126584491|NCT03763708|455439753|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126584492|NCT03763708|455439754|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126584493|NCT03763708|455439755|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126584494|NCT03763708|455439756|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126584495|NCT03763708|455439757|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126584496|NCT03763708|455439758|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126584497|NCT03763708|455439759|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
126584498|NCT03763708|455439760|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126584499|NCT03763708|455439761|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
126584500|NCT03763708|455439753|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
126584501|NCT03763708|455439754|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
126584502|NCT03763708|455439755|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
126584503|NCT03763708|455439756|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
126584504|NCT03763708|455439757|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
126640531|NCT01370655|455642789|FG008|Period 2|Withdrawal by Subject|1|||
126640532|NCT01370655|455642790|FG009|Period 2|Withdrawal by Subject|0|||
126640533|NCT01370655|455642791|FG010|Period 2|Withdrawal by Subject|0|||
126640534|NCT01370655|455642792|FG011|Period 2|Withdrawal by Subject|0|||
126640535|NCT00581477|455642793|FG000|Overall Study|Physician Decision|2|||
126584505|NCT03763708|455439758|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
126584506|NCT03763708|455439759|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
126584507|NCT03763708|455439760|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
126584508|NCT03763708|455439761|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
126584509|NCT03763708|455439753|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
126584510|NCT03763708|455439754|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
126584511|NCT03763708|455439755|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
126584512|NCT03763708|455439756|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
126584513|NCT03763708|455439757|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
126584514|NCT03763708|455439758|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
126584515|NCT03763708|455439759|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
126584516|NCT03763708|455439760|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
126584517|NCT03763708|455439761|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
126584518|NCT03763708|455439753|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
126584519|NCT03763708|455439754|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
126584520|NCT03763708|455439755|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
126584521|NCT03763708|455439756|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
126584522|NCT03763708|455439757|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
126584523|NCT03763708|455439758|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
126584524|NCT03763708|455439759|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
126584525|NCT03763708|455439760|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
126584526|NCT03763708|455439761|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
126584527|NCT05470400|455439764|FG000|Overall Study|Lost to Follow-up|0|||
126584528|NCT05470400|455439765|FG001|Overall Study|Lost to Follow-up|0|||
126584529|NCT05470400|455439766|FG002|Overall Study|Lost to Follow-up|0|||
126584530|NCT05470400|455439767|FG003|Overall Study|Lost to Follow-up|0|||
126584531|NCT05470400|455439768|FG004|Overall Study|Lost to Follow-up|0|||
126584532|NCT05470400|455439769|FG005|Overall Study|Lost to Follow-up|0|||
126584533|NCT05470400|455439770|FG006|Overall Study|Lost to Follow-up|0|||
126584534|NCT05470400|455439771|FG007|Overall Study|Lost to Follow-up|1|||
126584535|NCT05470400|455439764|FG000|Overall Study|Withdrawal by Subject|1|||
126584536|NCT05470400|455439765|FG001|Overall Study|Withdrawal by Subject|0|||
126584537|NCT05470400|455439766|FG002|Overall Study|Withdrawal by Subject|0|||
126584538|NCT05470400|455439767|FG003|Overall Study|Withdrawal by Subject|0|||
126584539|NCT05470400|455439768|FG004|Overall Study|Withdrawal by Subject|0|||
126584540|NCT05470400|455439769|FG005|Overall Study|Withdrawal by Subject|1|||
126584541|NCT05470400|455439770|FG006|Overall Study|Withdrawal by Subject|0|||
126584542|NCT05470400|455439771|FG007|Overall Study|Withdrawal by Subject|2|||
126584543|NCT05323084|455439775|FG000|Period 2 - Washout|Lost to Follow-up|0|||
126584544|NCT05323084|455439776|FG001|Period 2 - Washout|Lost to Follow-up|1|||
126584545|NCT04382404|455439777|FG000|Overall Study|Adverse Event|1|||
126584546|NCT04382404|455439777|FG000|Overall Study|Lost to Follow-up|2|||
126584547|NCT02960893|455439779|FG000|Randomization Phase (8-week)|Adverse Event|5|||
126584548|NCT02960893|455439780|FG001|Randomization Phase (8-week)|Adverse Event|0|||
126584549|NCT02960893|455439779|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
126584550|NCT02960893|455439780|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
126584551|NCT02960893|455439779|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
126584552|NCT02960893|455439780|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
126584553|NCT02960893|455439779|FG000|Extension Phase (48-week)|Adverse Event|2|||
126584554|NCT02960893|455439780|FG001|Extension Phase (48-week)|Adverse Event|3|||
126584555|NCT02960893|455439779|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
126584556|NCT02960893|455439780|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
126584557|NCT02960893|455439779|FG000|Extension Phase (48-week)|Other Reason|2|||
126584558|NCT02960893|455439780|FG001|Extension Phase (48-week)|Other Reason|1|||
126584559|NCT02960893|455439779|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
126584560|NCT02960893|455439780|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
126584561|NCT02960893|455439779|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
126584562|NCT02960893|455439780|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
126584563|NCT05687916|455439782|FG000|Overall Study|Adverse Event|1|||
126584564|NCT05687916|455439783|FG001|Overall Study|Adverse Event|2|||
126584565|NCT05687916|455439784|FG002|Overall Study|Adverse Event|0|||
126584566|NCT05687916|455439782|FG000|Overall Study|Withdrawal by Subject|1|||
126584567|NCT05687916|455439783|FG001|Overall Study|Withdrawal by Subject|0|||
126584568|NCT05687916|455439784|FG002|Overall Study|Withdrawal by Subject|1|||
126584569|NCT05687916|455439782|FG000|Overall Study|Protocol Violation|0|||
126584570|NCT05687916|455439783|FG001|Overall Study|Protocol Violation|2|||
126584571|NCT05687916|455439784|FG002|Overall Study|Protocol Violation|1|||
126584572|NCT05687916|455439782|FG000|Overall Study|Reason not Specified|1|||
126584573|NCT05687916|455439783|FG001|Overall Study|Reason not Specified|0|||
126584574|NCT05687916|455439784|FG002|Overall Study|Reason not Specified|0|||
126584575|NCT01809691|455439787|FG000|Overall Study|Currently on Treatment|192|||
126584576|NCT01809691|455439788|FG001|Overall Study|Currently on Treatment|100|||
126584577|NCT01809691|455439787|FG000|Overall Study|No Protocol Treatment|10|||
126584578|NCT01809691|455439788|FG001|Overall Study|No Protocol Treatment|11|||
126584579|NCT01809691|455439787|FG000|Overall Study|Adverse Event|80|||
126584580|NCT01809691|455439788|FG001|Overall Study|Adverse Event|21|||
126584581|NCT01809691|455439787|FG000|Overall Study|Disease Progression|226|||
126584582|NCT01809691|455439788|FG001|Overall Study|Disease Progression|372|||
126584583|NCT01809691|455439787|FG000|Overall Study|Death|26|||
126584584|NCT01809691|455439788|FG001|Overall Study|Death|13|||
126584585|NCT01809691|455439787|FG000|Overall Study|Participant Refusal|70|||
126584586|NCT01809691|455439788|FG001|Overall Study|Participant Refusal|72|||
126584587|NCT01809691|455439787|FG000|Overall Study|Other, Not Specified|34|||
126584588|NCT01809691|455439788|FG001|Overall Study|Other, Not Specified|52|||
126584589|NCT02281955|455439793|FG000|Overall Study|Death|1|||
126584590|NCT03892616|455439799|FG000|Washout Period 2|Met discontinuation criterion|0|||
126584591|NCT03892616|455439800|FG001|Washout Period 2|Met discontinuation criterion|0|||
126584592|NCT03892616|455439801|FG002|Washout Period 2|Met discontinuation criterion|0|||
126584593|NCT03892616|455439802|FG003|Washout Period 2|Met discontinuation criterion|0|||
126584594|NCT03892616|455439803|FG004|Washout Period 2|Met discontinuation criterion|0|||
126584595|NCT03892616|455439804|FG005|Washout Period 2|Met discontinuation criterion|0|||
126584596|NCT03892616|455439805|FG006|Washout Period 2|Met discontinuation criterion|0|||
126584597|NCT03892616|455439806|FG007|Washout Period 2|Met discontinuation criterion|0|||
126584598|NCT03892616|455439807|FG008|Washout Period 2|Met discontinuation criterion|1|||
126584599|NCT03892616|455439808|FG009|Washout Period 2|Met discontinuation criterion|0|||
126584600|NCT03892616|455439809|FG010|Washout Period 2|Met discontinuation criterion|0|||
126584601|NCT03892616|455439810|FG011|Washout Period 2|Met discontinuation criterion|0|||
126584602|NCT00378105|455439811|FG000|Overall Study|Adverse Event|3|||
126584603|NCT00378105|455439812|FG001|Overall Study|Adverse Event|1|||
126584604|NCT00378105|455439811|FG000|Overall Study|Withdrawal by Subject|3|||
126584605|NCT00378105|455439812|FG001|Overall Study|Withdrawal by Subject|3|||
126584606|NCT00378105|455439811|FG000|Overall Study|Death|1|||
126584607|NCT00378105|455439812|FG001|Overall Study|Death|0|||
126584608|NCT00378105|455439811|FG000|Overall Study|Going to transplant|7|||
126584609|NCT00378105|455439812|FG001|Overall Study|Going to transplant|8|||
126584610|NCT00378105|455439811|FG000|Overall Study|Progressive disease|3|||
126584611|NCT00378105|455439812|FG001|Overall Study|Progressive disease|3|||
126584612|NCT00378105|455439811|FG000|Overall Study|remain on study|3|||
126584613|NCT00378105|455439812|FG001|Overall Study|remain on study|11|||
126584614|NCT00378105|455439811|FG000|Overall Study|Physician Decision|0|||
126584615|NCT00378105|455439812|FG001|Overall Study|Physician Decision|2|||
126584616|NCT00378105|455439811|FG000|Overall Study|Going non-protocol therapy|0|||
126584617|NCT00378105|455439812|FG001|Overall Study|Going non-protocol therapy|1|||
126584618|NCT00378105|455439811|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
126584619|NCT00378105|455439812|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
126584620|NCT05192200|455439813|FG000|Treatment Period|Other|1|||
126584621|NCT05192200|455439813|FG000|Treatment Period|Lack of Efficacy|1|||
126584622|NCT05192200|455439813|FG000|Treatment Period|Withdrawal by Subject|1|||
126584623|NCT05192200|455439813|FG000|Follow-up|Withdrawal by Subject|1|||
126584624|NCT04533347|455439816|FG000|Overall Study|Adverse Event|1|||
126584625|NCT04533347|455439817|FG001|Overall Study|Adverse Event|2|||
126584626|NCT04533347|455439816|FG000|Overall Study|Lost to Follow-up|2|||
126584627|NCT04533347|455439817|FG001|Overall Study|Lost to Follow-up|0|||
126584628|NCT04533347|455439816|FG000|Overall Study|Withdrawal by Subject|1|||
126584629|NCT04533347|455439817|FG001|Overall Study|Withdrawal by Subject|0|||
126584630|NCT03907397|455439818|FG000|Overall Study|Lost to Follow-up|0|||
126584631|NCT03907397|455439819|FG001|Overall Study|Lost to Follow-up|1|||
126584632|NCT03907397|455439818|FG000|Overall Study|Physician Decision|2|||
126584633|NCT03907397|455439819|FG001|Overall Study|Physician Decision|1|||
126584634|NCT03907397|455439818|FG000|Overall Study|Withdrawal by Subject|5|||
126584635|NCT03907397|455439819|FG001|Overall Study|Withdrawal by Subject|4|||
126584636|NCT03907397|455439818|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
126584637|NCT03907397|455439819|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
126584638|NCT05021640|455442022|FG000|Overall Study|Lost to Follow-up|0|||
126584639|NCT05021640|455442023|FG001|Overall Study|Lost to Follow-up|0|||
126584640|NCT05021640|455442024|FG002|Overall Study|Lost to Follow-up|0|||
126584641|NCT05021640|455442025|FG003|Overall Study|Lost to Follow-up|0|||
126584642|NCT05021640|455442026|FG004|Overall Study|Lost to Follow-up|1|||
126584643|NCT04737772|455442027|FG000|Phase 2 Study|Lost to Follow-up|15|||
126584644|NCT04737772|455442028|FG001|Phase 2 Study|Lost to Follow-up|15|||
126584645|NCT04737772|455442027|FG000|Phase 2 Study|Withdrawal by Subject|0|||
126584646|NCT04737772|455442028|FG001|Phase 2 Study|Withdrawal by Subject|1|||
126584647|NCT04737772|455442027|FG000|Phase 2 Study|Did not take any coaching calls|4|||
126584648|NCT04737772|455442028|FG001|Phase 2 Study|Did not take any coaching calls|0|||
126584649|NCT04737772|455442027|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
126584650|NCT04737772|455442028|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
126584651|NCT04737772|455442027|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
126584652|NCT04737772|455442028|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
126584653|NCT05691309|455442030|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
126584654|NCT05691309|455442030|FG000|Overall Study|vancomycin levels not evaluable|2|||
126584655|NCT04421378|455442031|FG000|Overall Study|Adverse Event|2|||
126584656|NCT04421378|455442032|FG001|Overall Study|Adverse Event|7|||
126584657|NCT04421378|455442033|FG002|Overall Study|Adverse Event|0|||
126584658|NCT04421378|455442034|FG003|Overall Study|Adverse Event|1|||
126584659|NCT04421378|455442035|FG004|Overall Study|Adverse Event|0|||
126584660|NCT04421378|455442031|FG000|Overall Study|Physician Decision|1|||
126584661|NCT04421378|455442032|FG001|Overall Study|Physician Decision|2|||
126584662|NCT04421378|455442033|FG002|Overall Study|Physician Decision|0|||
126584663|NCT04421378|455442034|FG003|Overall Study|Physician Decision|0|||
126584664|NCT04421378|455442035|FG004|Overall Study|Physician Decision|0|||
126584665|NCT04421378|455442031|FG000|Overall Study|Progressive Disease|16|||
126584666|NCT04421378|455442032|FG001|Overall Study|Progressive Disease|4|||
126584667|NCT04421378|455442033|FG002|Overall Study|Progressive Disease|18|||
126584668|NCT04421378|455442034|FG003|Overall Study|Progressive Disease|11|||
126584669|NCT04421378|455442035|FG004|Overall Study|Progressive Disease|3|||
126584670|NCT04421378|455442031|FG000|Overall Study|Study Terminated by Sponsor|0|||
126584671|NCT04421378|455442032|FG001|Overall Study|Study Terminated by Sponsor|1|||
126584672|NCT04421378|455442033|FG002|Overall Study|Study Terminated by Sponsor|1|||
126584673|NCT04421378|455442034|FG003|Overall Study|Study Terminated by Sponsor|0|||
126584674|NCT04421378|455442035|FG004|Overall Study|Study Terminated by Sponsor|0|||
126584675|NCT04421378|455442031|FG000|Overall Study|Withdrawal by Subject|3|||
126584676|NCT04421378|455442032|FG001|Overall Study|Withdrawal by Subject|1|||
126584677|NCT04421378|455442033|FG002|Overall Study|Withdrawal by Subject|0|||
126584678|NCT04421378|455442034|FG003|Overall Study|Withdrawal by Subject|2|||
126584679|NCT04421378|455442035|FG004|Overall Study|Withdrawal by Subject|0|||
126584680|NCT04421378|455442031|FG000|Overall Study|Other|1|||
126584681|NCT04421378|455442032|FG001|Overall Study|Other|0|||
126584682|NCT04421378|455442033|FG002|Overall Study|Other|0|||
126584683|NCT04421378|455442034|FG003|Overall Study|Other|0|||
126584684|NCT04421378|455442035|FG004|Overall Study|Other|0|||
126584685|NCT03958955|455442036|FG000|Overall Study|Adverse Event|1|||
126584686|NCT02927769|455442038|FG000|Induction Phase|Study drug toxicity|1|||
126584687|NCT02927769|455442039|FG001|Induction Phase|Study drug toxicity|1|||
126584688|NCT02927769|455442038|FG000|Induction Phase|Disease progression|0|||
126584689|NCT02927769|455442039|FG001|Induction Phase|Disease progression|1|||
126584690|NCT02927769|455442038|FG000|Intensification Phase|Study drug toxicity|1|||
126584691|NCT02927769|455442039|FG001|Intensification Phase|Study drug toxicity|0|||
126584692|NCT02807636|455442042|FG000|Overall Study|Lost to Follow-up|10|||
126584693|NCT02807636|455442043|FG001|Overall Study|Lost to Follow-up|13|||
126584694|NCT02807636|455442044|FG002|Overall Study|Lost to Follow-up|6|||
126584695|NCT02807636|455442042|FG000|Overall Study|Protocol Deviation|1|||
126584696|NCT02807636|455442043|FG001|Overall Study|Protocol Deviation|0|||
126584697|NCT02807636|455442044|FG002|Overall Study|Protocol Deviation|0|||
126584698|NCT02807636|455442042|FG000|Overall Study|Symptomatic Deterioration|0|||
126584699|NCT02807636|455442043|FG001|Overall Study|Symptomatic Deterioration|1|||
126584700|NCT02807636|455442044|FG002|Overall Study|Symptomatic Deterioration|0|||
126584701|NCT02807636|455442042|FG000|Overall Study|Withdrawal by Subject|39|||
126584702|NCT02807636|455442043|FG001|Overall Study|Withdrawal by Subject|28|||
126584703|NCT02807636|455442044|FG002|Overall Study|Withdrawal by Subject|24|||
126584704|NCT02807636|455442042|FG000|Overall Study|Death|303|||
126584705|NCT02807636|455442043|FG001|Overall Study|Death|332|||
126584706|NCT02807636|455442044|FG002|Overall Study|Death|272|||
126584707|NCT02807636|455442042|FG000|Overall Study|Study Terminated By Sponsor|47|||
126584708|NCT02807636|455442043|FG001|Overall Study|Study Terminated By Sponsor|76|||
126584709|NCT02807636|455442044|FG002|Overall Study|Study Terminated By Sponsor|60|||
126584710|NCT02807636|455442042|FG000|Overall Study|Physician Decision|0|||
126584711|NCT02807636|455442043|FG001|Overall Study|Physician Decision|1|||
126584712|NCT02807636|455442044|FG002|Overall Study|Physician Decision|0|||
126584713|NCT05082909|455442045|FG000|Overall Study|Protocol Violation|0|||
126584714|NCT05082909|455442046|FG001|Overall Study|Protocol Violation|0|||
126584715|NCT05082909|455442047|FG002|Overall Study|Protocol Violation|1|||
126584716|NCT05082909|455442048|FG003|Overall Study|Protocol Violation|0|||
126584717|NCT05082909|455442049|FG004|Overall Study|Protocol Violation|0|||
126584718|NCT05082909|455442050|FG005|Overall Study|Protocol Violation|0|||
126584719|NCT04088630|455442051|FG000|Overall Study|Lost to Follow-up|3|||
126584720|NCT04088630|455442052|FG001|Overall Study|Lost to Follow-up|2|||
126584721|NCT04088630|455442053|FG002|Overall Study|Lost to Follow-up|6|||
126584722|NCT04088630|455442051|FG000|Overall Study|Death|3|||
126584723|NCT04088630|455442052|FG001|Overall Study|Death|1|||
126584724|NCT04088630|455442053|FG002|Overall Study|Death|1|||
126584725|NCT04088630|455442051|FG000|Overall Study|Physician Decision|0|||
126730949|NCT00949910|455964412|FG000|Overall Study|Progressive Disease|3750|||
126584726|NCT04088630|455442052|FG001|Overall Study|Physician Decision|1|||
126584727|NCT04088630|455442053|FG002|Overall Study|Physician Decision|1|||
126584728|NCT03315754|455442054|FG000|Overall Study|COVID-19 complications leading to death|1|||
126584729|NCT03315754|455442054|FG000|Overall Study|insurance coverage issue|1|||
126584730|NCT02954341|455442055|FG000|Overall Study|Attempted Implant unsuccessful|5|||
126584731|NCT02954341|455442055|FG000|Overall Study|Death|90|||
126584732|NCT02954341|455442055|FG000|Overall Study|Withdrawal by Subject|4|||
126584733|NCT02954341|455442055|FG000|Overall Study|Physician Decision|13|||
126584734|NCT02954341|455442055|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
126730950|NCT00949910|455964412|FG000|Overall Study|Symptomatic Deterioration|1088|||
126730951|NCT00949910|455964412|FG000|Overall Study|Lost to Follow-up|100|||
126730952|NCT00949910|455964412|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
126730953|NCT00949910|455964412|FG000|Overall Study|Participant Refusal|390|||
126730954|NCT00949910|455964412|FG000|Overall Study|Death Due to Malignant Disease|456|||
126730955|NCT00949910|455964412|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
126730956|NCT00949910|455964412|FG000|Overall Study|Death Due to Adverse Event|115|||
126730957|NCT00949910|455964412|FG000|Overall Study|Death Due to Toxicity|3|||
126730958|NCT00949910|455964412|FG000|Overall Study|Death from Unknown Cause|5|||
126584735|NCT02954341|455442055|FG000|Overall Study|Not implanted due to physician's decision|1|||
126584736|NCT02954341|455442055|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
126584737|NCT04024813|455442057|FG000|Overall Study|Study terminated by Sponsor|1|||
126584738|NCT04950660|455442058|FG000|Overall Study|Protocol Violation|4|||
126584739|NCT04950660|455442059|FG001|Overall Study|Protocol Violation|2|||
126584740|NCT04950660|455442058|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
126584741|NCT04950660|455442059|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
126584742|NCT04950660|455442058|FG000|Overall Study|Withdrawal by Subject|0|||
126584743|NCT04950660|455442059|FG001|Overall Study|Withdrawal by Subject|1|||
126584744|NCT04950660|455442058|FG000|Overall Study|Hypotension|1|||
126584745|NCT04950660|455442059|FG001|Overall Study|Hypotension|0|||
126584746|NCT02437318|455442076|FG000|Overall Study|Progressive disease|207|||
126584747|NCT02437318|455442077|FG001|Overall Study|Progressive disease|240|||
126584748|NCT02437318|455442076|FG000|Overall Study|Subject/guardian decision|24|||
126584749|NCT02437318|455442077|FG001|Overall Study|Subject/guardian decision|11|||
126584750|NCT02437318|455442076|FG000|Overall Study|Physician Decision|29|||
126584751|NCT02437318|455442077|FG001|Overall Study|Physician Decision|22|||
126584752|NCT02437318|455442076|FG000|Overall Study|Adverse Event|14|||
126584753|NCT02437318|455442077|FG001|Overall Study|Adverse Event|4|||
126584754|NCT02437318|455442076|FG000|Overall Study|Death|4|||
126584755|NCT02437318|455442077|FG001|Overall Study|Death|4|||
126584756|NCT02437318|455442076|FG000|Overall Study|Protocol deviation|5|||
126584757|NCT02437318|455442077|FG001|Overall Study|Protocol deviation|7|||
126584758|NCT02437318|455442076|FG000|Overall Study|Sponsor decision|1|||
126584759|NCT02437318|455442077|FG001|Overall Study|Sponsor decision|0|||
126584760|NCT00920621|455442080|FG000|Overall Study|Lost to Follow-up|16|||
126584761|NCT00920621|455442081|FG001|Overall Study|Lost to Follow-up|17|||
126584762|NCT00920621|455442082|FG002|Overall Study|Lost to Follow-up|19|||
126584763|NCT00920621|455442083|FG003|Overall Study|Lost to Follow-up|21|||
126584764|NCT00920621|455442080|FG000|Overall Study|Fetal/neonatal deaths|16|||
126584765|NCT00920621|455442081|FG001|Overall Study|Fetal/neonatal deaths|14|||
126584766|NCT00920621|455442082|FG002|Overall Study|Fetal/neonatal deaths|16|||
126584767|NCT00920621|455442083|FG003|Overall Study|Fetal/neonatal deaths|14|||
126584768|NCT00920621|455442080|FG000|Overall Study|Blood sample not collected|22|||
126584769|NCT00920621|455442081|FG001|Overall Study|Blood sample not collected|14|||
126584770|NCT00920621|455442082|FG002|Overall Study|Blood sample not collected|0|||
126584771|NCT00920621|455442083|FG003|Overall Study|Blood sample not collected|0|||
126584772|NCT04245501|455442084|FG000|Overall Study|Adverse Event|2|||
126584773|NCT04245501|455442085|FG001|Overall Study|Adverse Event|0|||
126584774|NCT04245501|455442084|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
126584775|NCT04245501|455442085|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
126584776|NCT01426425|455442086|FG000|Overall Study|Exited prior to EP study|22|||
126584777|NCT01426425|455442086|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
126584778|NCT01426425|455442086|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
126584779|NCT00961571|455442094|FG000|Overall Study|Physician Decision|39|||
126584780|NCT04321031|455442100|FG000|Overall Study|Adverse Event|0|||
126584781|NCT04321031|455442101|FG001|Overall Study|Adverse Event|2|||
126584782|NCT04321031|455442102|FG002|Overall Study|Adverse Event|2|||
126584783|NCT04321031|455442103|FG003|Overall Study|Adverse Event|2|||
126584784|NCT04321031|455442104|FG004|Overall Study|Adverse Event|2|||
126584785|NCT04321031|455442105|FG005|Overall Study|Adverse Event|2|||
126584786|NCT04321031|455442106|FG006|Overall Study|Adverse Event|0|||
126584787|NCT04321031|455442100|FG000|Overall Study|Lost to Follow-up|0|||
126584788|NCT04321031|455442101|FG001|Overall Study|Lost to Follow-up|0|||
126584789|NCT04321031|455442102|FG002|Overall Study|Lost to Follow-up|0|||
126730959|NCT00949910|455964412|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
126730960|NCT00949910|455964412|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
126584790|NCT04321031|455442103|FG003|Overall Study|Lost to Follow-up|1|||
126584791|NCT04321031|455442104|FG004|Overall Study|Lost to Follow-up|0|||
126584792|NCT04321031|455442105|FG005|Overall Study|Lost to Follow-up|2|||
126584793|NCT04321031|455442106|FG006|Overall Study|Lost to Follow-up|1|||
126584794|NCT04321031|455442100|FG000|Overall Study|Withdrawal by Subject|2|||
126584795|NCT04321031|455442101|FG001|Overall Study|Withdrawal by Subject|2|||
126584796|NCT04321031|455442102|FG002|Overall Study|Withdrawal by Subject|1|||
126584797|NCT04321031|455442103|FG003|Overall Study|Withdrawal by Subject|3|||
126584798|NCT04321031|455442104|FG004|Overall Study|Withdrawal by Subject|1|||
126756574|NCT00883896|456059485|FG003|Overall Study|Lost to Follow-up|2|||
126756575|NCT00883896|456059482|FG000|Overall Study|Withdrawal by Subject|5|||
126584799|NCT04321031|455442105|FG005|Overall Study|Withdrawal by Subject|0|||
126584800|NCT04321031|455442106|FG006|Overall Study|Withdrawal by Subject|1|||
126584801|NCT04321031|455442100|FG000|Overall Study|Non-compliance with study drug|0|||
126584802|NCT04321031|455442101|FG001|Overall Study|Non-compliance with study drug|0|||
126584803|NCT04321031|455442102|FG002|Overall Study|Non-compliance with study drug|0|||
126584804|NCT04321031|455442103|FG003|Overall Study|Non-compliance with study drug|0|||
126584805|NCT04321031|455442104|FG004|Overall Study|Non-compliance with study drug|0|||
126584806|NCT04321031|455442105|FG005|Overall Study|Non-compliance with study drug|1|||
126584807|NCT04321031|455442106|FG006|Overall Study|Non-compliance with study drug|0|||
126584808|NCT04321031|455442100|FG000|Overall Study|Other|0|||
126584809|NCT04321031|455442101|FG001|Overall Study|Other|0|||
126584810|NCT04321031|455442102|FG002|Overall Study|Other|0|||
126584811|NCT04321031|455442103|FG003|Overall Study|Other|1|||
126584812|NCT04321031|455442104|FG004|Overall Study|Other|0|||
126584813|NCT04321031|455442105|FG005|Overall Study|Other|0|||
126584814|NCT04321031|455442106|FG006|Overall Study|Other|0|||
126584815|NCT01415154|455442112|FG000|Overall Study|Lack of Efficacy|4|||
126584816|NCT01415154|455442113|FG001|Overall Study|Lack of Efficacy|5|||
126584817|NCT01415154|455442112|FG000|Overall Study|Withdrawal by Subject|7|||
126584818|NCT01415154|455442113|FG001|Overall Study|Withdrawal by Subject|8|||
126584819|NCT01415154|455442112|FG000|Overall Study|Lost to Follow-up|1|||
126584820|NCT01415154|455442113|FG001|Overall Study|Lost to Follow-up|4|||
126584821|NCT01415154|455442112|FG000|Overall Study|Protocol Violation|0|||
126584822|NCT01415154|455442113|FG001|Overall Study|Protocol Violation|1|||
126584823|NCT01415154|455442112|FG000|Overall Study|Satisfactory Response|0|||
126584824|NCT01415154|455442113|FG001|Overall Study|Satisfactory Response|1|||
126584825|NCT01415154|455442112|FG000|Overall Study|Adverse Event|1|||
126584826|NCT01415154|455442113|FG001|Overall Study|Adverse Event|1|||
126584827|NCT04556656|455442116|FG000|Overall Study|Withdrawal by Subject|14|||
126584828|NCT04556656|455442117|FG001|Overall Study|Withdrawal by Subject|12|||
126584829|NCT04556656|455442116|FG000|Overall Study|Physician Decision|1|||
126584830|NCT04556656|455442117|FG001|Overall Study|Physician Decision|0|||
126584831|NCT04556656|455442116|FG000|Overall Study|Adverse Event|4|||
126584832|NCT04556656|455442117|FG001|Overall Study|Adverse Event|7|||
126584833|NCT04556656|455442116|FG000|Overall Study|Death|4|||
126584834|NCT04556656|455442117|FG001|Overall Study|Death|0|||
126584835|NCT04556656|455442116|FG000|Overall Study|Lost to Follow-up|3|||
126584836|NCT04556656|455442117|FG001|Overall Study|Lost to Follow-up|2|||
126584837|NCT04556656|455442116|FG000|Overall Study|Not further specified|2|||
126584838|NCT04556656|455442117|FG001|Overall Study|Not further specified|1|||
126584839|NCT03138512|455442125|FG000|Randomization|Participants withdrew consent|0|||
126584840|NCT03138512|455442126|FG001|Randomization|Participants withdrew consent|1|||
126584841|NCT03138512|455442127|FG002|Randomization|Participants withdrew consent|1|||
126584842|NCT03138512|455442128|FG003|Randomization|Participants withdrew consent|0|||
126584843|NCT03138512|455442129|FG004|Randomization|Participants withdrew consent|0|||
126584844|NCT03138512|455442125|FG000|Randomization|Participant no longer meets study criteria|0|||
126584845|NCT03138512|455442126|FG001|Randomization|Participant no longer meets study criteria|3|||
126584846|NCT03138512|455442127|FG002|Randomization|Participant no longer meets study criteria|1|||
126584847|NCT03138512|455442128|FG003|Randomization|Participant no longer meets study criteria|1|||
126584848|NCT03138512|455442129|FG004|Randomization|Participant no longer meets study criteria|3|||
126584849|NCT03138512|455442125|FG000|Randomization|Other reasons|1|||
126584850|NCT03138512|455442126|FG001|Randomization|Other reasons|0|||
126584851|NCT03138512|455442127|FG002|Randomization|Other reasons|0|||
126584852|NCT03138512|455442128|FG003|Randomization|Other reasons|0|||
126584853|NCT03138512|455442129|FG004|Randomization|Other reasons|0|||
126584854|NCT03138512|455442125|FG000|Treatment Part A|Disease recurrence|10|||
126584855|NCT03138512|455442126|FG001|Treatment Part A|Disease recurrence|20|||
126584856|NCT03138512|455442127|FG002|Treatment Part A|Disease recurrence|0|||
126584857|NCT03138512|455442128|FG003|Treatment Part A|Disease recurrence|0|||
126584858|NCT03138512|455442129|FG004|Treatment Part A|Disease recurrence|0|||
126584859|NCT03138512|455442125|FG000|Treatment Part A|Study Drug Toxicity|132|||
126584860|NCT03138512|455442126|FG001|Treatment Part A|Study Drug Toxicity|5|||
126584861|NCT03138512|455442127|FG002|Treatment Part A|Study Drug Toxicity|0|||
126584862|NCT03138512|455442128|FG003|Treatment Part A|Study Drug Toxicity|0|||
126584863|NCT03138512|455442129|FG004|Treatment Part A|Study Drug Toxicity|0|||
126584864|NCT03138512|455442125|FG000|Treatment Part A|Death|1|||
126584865|NCT03138512|455442126|FG001|Treatment Part A|Death|0|||
126584866|NCT03138512|455442127|FG002|Treatment Part A|Death|0|||
126584867|NCT03138512|455442128|FG003|Treatment Part A|Death|0|||
126584868|NCT03138512|455442129|FG004|Treatment Part A|Death|0|||
126584869|NCT03138512|455442125|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
126584870|NCT03138512|455442126|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
126584871|NCT03138512|455442127|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
126584872|NCT03138512|455442128|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
126584873|NCT03138512|455442129|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
126584874|NCT03138512|455442125|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
126730961|NCT00949910|455964412|FG000|Overall Study|Switched to Commercial Treatment|4|||
126730962|NCT00949910|455964412|FG000|Overall Study|Violation of Eligibility|23|||
126730963|NCT00949910|455964412|FG000|Overall Study|Logistical Reasons|13|||
126730964|NCT00949910|455964412|FG000|Overall Study|Non-Compliance|10|||
126730965|NCT00949910|455964412|FG000|Overall Study|Prolonged Dosing Interruption|4|||
126730966|NCT00949910|455964412|FG000|Overall Study|Adverse Event|83|||
126730967|NCT00949910|455964412|FG000|Overall Study|Serious Adverse Event|6|||
126730968|NCT00949910|455964412|FG000|Overall Study|Physician/Participant Decision|7|||
126730969|NCT00949910|455964412|FG000|Overall Study|Other|4|||
126730970|NCT00949910|455964412|FG000|Overall Study|No Data|9|||
126730971|NCT03097614|455964413|FG000|Overall Study|Adverse Event|3|||
126730972|NCT02150213|455964415|FG000|Overall Study|Lost to Follow-up|1|||
126730973|NCT02150213|455964415|FG000|Overall Study|Withdrawal by Subject|1|||
126730974|NCT02678312|455964419|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
126730975|NCT02678312|455964420|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
126730976|NCT02678312|455964421|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
126730977|NCT02678312|455964422|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
126730978|NCT02678312|455964423|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
126730979|NCT02678312|455964419|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
126730980|NCT02678312|455964420|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
126730981|NCT02678312|455964421|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
126730982|NCT02678312|455964422|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
126730983|NCT02678312|455964423|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
126730984|NCT02678312|455964419|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
126730985|NCT02678312|455964420|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
126730986|NCT02678312|455964421|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
126730987|NCT02678312|455964422|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
126730988|NCT02678312|455964423|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
126730989|NCT02678312|455964419|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
126730990|NCT02678312|455964420|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
126730991|NCT02678312|455964421|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
126730992|NCT02678312|455964422|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
126730993|NCT02678312|455964423|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
126730994|NCT02678312|455964419|FG000|Part 2 Double Blind Epoch|Death|0|||
126730995|NCT02678312|455964420|FG001|Part 2 Double Blind Epoch|Death|0|||
126730996|NCT02678312|455964421|FG002|Part 2 Double Blind Epoch|Death|0|||
126730997|NCT02678312|455964422|FG003|Part 2 Double Blind Epoch|Death|8|||
126730998|NCT02678312|455964423|FG004|Part 2 Double Blind Epoch|Death|12|||
126730999|NCT02678312|455964419|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
126731000|NCT02678312|455964420|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
126731001|NCT02678312|455964421|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
126731002|NCT02678312|455964422|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
126584875|NCT03138512|455442126|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
126584876|NCT03138512|455442127|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
126584877|NCT03138512|455442128|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
126584878|NCT03138512|455442129|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
126584879|NCT03138512|455442125|FG000|Treatment Part A|Participant withdrew consent|2|||
126584880|NCT03138512|455442126|FG001|Treatment Part A|Participant withdrew consent|4|||
126584881|NCT03138512|455442127|FG002|Treatment Part A|Participant withdrew consent|0|||
126584882|NCT03138512|455442128|FG003|Treatment Part A|Participant withdrew consent|0|||
126584883|NCT03138512|455442129|FG004|Treatment Part A|Participant withdrew consent|0|||
126584884|NCT03138512|455442125|FG000|Treatment Part A|Lost to Follow-up|0|||
126584885|NCT03138512|455442126|FG001|Treatment Part A|Lost to Follow-up|1|||
126584886|NCT03138512|455442127|FG002|Treatment Part A|Lost to Follow-up|0|||
126584887|NCT03138512|455442128|FG003|Treatment Part A|Lost to Follow-up|0|||
126584888|NCT03138512|455442129|FG004|Treatment Part A|Lost to Follow-up|0|||
126584889|NCT03138512|455442125|FG000|Treatment Part A|Poor/non-compliance|1|||
126584890|NCT03138512|455442126|FG001|Treatment Part A|Poor/non-compliance|0|||
126584891|NCT03138512|455442127|FG002|Treatment Part A|Poor/non-compliance|0|||
126584892|NCT03138512|455442128|FG003|Treatment Part A|Poor/non-compliance|0|||
126584893|NCT03138512|455442129|FG004|Treatment Part A|Poor/non-compliance|0|||
126584894|NCT03138512|455442125|FG000|Treatment Part A|Pregnancy|0|||
126584895|NCT03138512|455442126|FG001|Treatment Part A|Pregnancy|1|||
126584896|NCT03138512|455442127|FG002|Treatment Part A|Pregnancy|0|||
126584897|NCT03138512|455442128|FG003|Treatment Part A|Pregnancy|0|||
126584898|NCT03138512|455442129|FG004|Treatment Part A|Pregnancy|0|||
126584899|NCT03138512|455442125|FG000|Treatment Part A|Other reasons|11|||
126731003|NCT02678312|455964423|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
126731004|NCT02678312|455964419|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
126731005|NCT02678312|455964420|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
126731006|NCT02678312|455964421|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
126731007|NCT02678312|455964422|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
126731008|NCT02678312|455964423|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
126584900|NCT03138512|455442126|FG001|Treatment Part A|Other reasons|8|||
126584901|NCT03138512|455442127|FG002|Treatment Part A|Other reasons|0|||
126584902|NCT03138512|455442128|FG003|Treatment Part A|Other reasons|0|||
126584903|NCT03138512|455442129|FG004|Treatment Part A|Other reasons|0|||
126584904|NCT03138512|455442125|FG000|Treatment Part B|Disease recurrence|0|||
126584905|NCT03138512|455442126|FG001|Treatment Part B|Disease recurrence|0|||
126584906|NCT03138512|455442127|FG002|Treatment Part B|Disease recurrence|6|||
126584907|NCT03138512|455442128|FG003|Treatment Part B|Disease recurrence|12|||
126584908|NCT03138512|455442129|FG004|Treatment Part B|Disease recurrence|10|||
126584909|NCT03138512|455442125|FG000|Treatment Part B|Study drug toxicity|0|||
126584910|NCT03138512|455442126|FG001|Treatment Part B|Study drug toxicity|0|||
126584911|NCT03138512|455442127|FG002|Treatment Part B|Study drug toxicity|63|||
126584912|NCT03138512|455442128|FG003|Treatment Part B|Study drug toxicity|3|||
126584913|NCT03138512|455442129|FG004|Treatment Part B|Study drug toxicity|45|||
126584914|NCT03138512|455442125|FG000|Treatment Part B|Death|0|||
126584915|NCT03138512|455442126|FG001|Treatment Part B|Death|0|||
126584916|NCT03138512|455442127|FG002|Treatment Part B|Death|1|||
126584917|NCT03138512|455442128|FG003|Treatment Part B|Death|0|||
126584918|NCT03138512|455442129|FG004|Treatment Part B|Death|0|||
126584919|NCT03138512|455442125|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
126584920|NCT03138512|455442126|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
126584921|NCT03138512|455442127|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
126584922|NCT03138512|455442128|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
126584923|NCT03138512|455442129|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
126584924|NCT03138512|455442125|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
126584925|NCT03138512|455442126|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
126584926|NCT03138512|455442127|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
126584927|NCT03138512|455442128|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
126584928|NCT03138512|455442129|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
126584929|NCT03138512|455442125|FG000|Treatment Part B|Participant withdrew consent|0|||
126584930|NCT03138512|455442126|FG001|Treatment Part B|Participant withdrew consent|0|||
126584931|NCT03138512|455442127|FG002|Treatment Part B|Participant withdrew consent|1|||
126584932|NCT03138512|455442128|FG003|Treatment Part B|Participant withdrew consent|1|||
126584933|NCT03138512|455442129|FG004|Treatment Part B|Participant withdrew consent|2|||
126584934|NCT03138512|455442125|FG000|Treatment Part B|Lost to Follow-up|0|||
126584935|NCT03138512|455442126|FG001|Treatment Part B|Lost to Follow-up|0|||
126584936|NCT03138512|455442127|FG002|Treatment Part B|Lost to Follow-up|0|||
126584937|NCT03138512|455442128|FG003|Treatment Part B|Lost to Follow-up|1|||
126584938|NCT03138512|455442129|FG004|Treatment Part B|Lost to Follow-up|0|||
126584939|NCT03138512|455442125|FG000|Treatment Part B|Poor/non-compliance|0|||
126584940|NCT03138512|455442126|FG001|Treatment Part B|Poor/non-compliance|0|||
126584941|NCT03138512|455442127|FG002|Treatment Part B|Poor/non-compliance|1|||
126584942|NCT03138512|455442128|FG003|Treatment Part B|Poor/non-compliance|1|||
126584943|NCT03138512|455442129|FG004|Treatment Part B|Poor/non-compliance|1|||
126584944|NCT03138512|455442125|FG000|Treatment Part B|Other reasons|0|||
126584945|NCT03138512|455442126|FG001|Treatment Part B|Other reasons|0|||
126584946|NCT03138512|455442127|FG002|Treatment Part B|Other reasons|3|||
126584947|NCT03138512|455442128|FG003|Treatment Part B|Other reasons|1|||
126584948|NCT03138512|455442129|FG004|Treatment Part B|Other reasons|5|||
126584949|NCT03332017|455442130|FG000|Overall Study|Lost to Follow-up|1|||
126584950|NCT03332017|455442131|FG001|Overall Study|Lost to Follow-up|2|||
126584951|NCT03332017|455442130|FG000|Overall Study|Death|17|||
126584952|NCT03332017|455442131|FG001|Overall Study|Death|16|||
126584953|NCT03332017|455442130|FG000|Overall Study|Withdrawal by Subject|6|||
126584954|NCT03332017|455442131|FG001|Overall Study|Withdrawal by Subject|14|||
126584955|NCT03332017|455442130|FG000|Overall Study|Other|1|||
126584956|NCT03332017|455442131|FG001|Overall Study|Other|3|||
126584957|NCT03332017|455442130|FG000|Overall Study|Remained in Study (Ongoing)|47|||
126584958|NCT03332017|455442131|FG001|Overall Study|Remained in Study (Ongoing)|110|||
126584959|NCT01261312|455442132|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
126584960|NCT01261312|455442133|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
126584961|NCT01261312|455442134|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
126584962|NCT01261312|455442135|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126584963|NCT01261312|455442136|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126584964|NCT01261312|455442137|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126584965|NCT01261312|455442138|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126584966|NCT01261312|455442139|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126584967|NCT01261312|455442140|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126731009|NCT02678312|455964419|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
126731010|NCT02678312|455964420|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
126584968|NCT01261312|455442141|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126584969|NCT01261312|455442142|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126777364|NCT00078819|456141334|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
126777365|NCT00078819|456141335|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
126777366|NCT00078819|456141336|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
126777367|NCT00078819|456141333|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
126777368|NCT00078819|456141334|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
126777369|NCT00078819|456141335|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
126777370|NCT00078819|456141336|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
126777371|NCT00323609|456141337|FG000|Overall Study|Death|16|||
126777372|NCT00323609|456141338|FG001|Overall Study|Death|21|||
126777373|NCT00323609|456141339|FG002|Overall Study|Death|0|||
126777374|NCT00323609|456141340|FG003|Overall Study|Death|0|||
126777375|NCT00323609|456141337|FG000|Overall Study|Lost to Follow-up|9|||
126777376|NCT00323609|456141338|FG001|Overall Study|Lost to Follow-up|10|||
126777377|NCT00323609|456141339|FG002|Overall Study|Lost to Follow-up|0|||
126777378|NCT00323609|456141340|FG003|Overall Study|Lost to Follow-up|0|||
126777379|NCT00323609|456141337|FG000|Overall Study|Physician Decision|2|||
126777380|NCT00323609|456141338|FG001|Overall Study|Physician Decision|0|||
126777381|NCT00323609|456141339|FG002|Overall Study|Physician Decision|0|||
126777382|NCT00323609|456141340|FG003|Overall Study|Physician Decision|1|||
126777383|NCT00323609|456141337|FG000|Overall Study|Withdrawal by Subject|11|||
126777384|NCT00323609|456141338|FG001|Overall Study|Withdrawal by Subject|23|||
126777385|NCT00323609|456141339|FG002|Overall Study|Withdrawal by Subject|4|||
126777386|NCT00323609|456141340|FG003|Overall Study|Withdrawal by Subject|4|||
126777387|NCT00323609|456141337|FG000|Overall Study|Other non-VCF-related medical condition|3|||
126777388|NCT00323609|456141338|FG001|Overall Study|Other non-VCF-related medical condition|2|||
126777389|NCT00323609|456141339|FG002|Overall Study|Other non-VCF-related medical condition|0|||
126777390|NCT00323609|456141340|FG003|Overall Study|Other non-VCF-related medical condition|0|||
126777391|NCT00323609|456141337|FG000|Overall Study|Sponsor discontinued trial|29|||
126777392|NCT00323609|456141338|FG001|Overall Study|Sponsor discontinued trial|29|||
126777393|NCT00323609|456141339|FG002|Overall Study|Sponsor discontinued trial|0|||
126777394|NCT00323609|456141340|FG003|Overall Study|Sponsor discontinued trial|0|||
126777395|NCT00323609|456141337|FG000|Overall Study|Unrelenting or severe back pain|1|||
126777396|NCT00323609|456141338|FG001|Overall Study|Unrelenting or severe back pain|1|||
126777397|NCT00323609|456141339|FG002|Overall Study|Unrelenting or severe back pain|0|||
126777398|NCT00323609|456141340|FG003|Overall Study|Unrelenting or severe back pain|0|||
126777399|NCT00323609|456141337|FG000|Overall Study|Logistical withdrawal|9|||
126777400|NCT00323609|456141338|FG001|Overall Study|Logistical withdrawal|5|||
126777401|NCT00323609|456141339|FG002|Overall Study|Logistical withdrawal|0|||
126777402|NCT00323609|456141340|FG003|Overall Study|Logistical withdrawal|1|||
126777403|NCT00323609|456141337|FG000|Overall Study|Other reason|11|||
126777404|NCT00323609|456141338|FG001|Overall Study|Other reason|8|||
126777405|NCT00323609|456141339|FG002|Overall Study|Other reason|4|||
126777406|NCT00323609|456141340|FG003|Overall Study|Other reason|9|||
126777407|NCT02217345|456141341|FG000|Overall Study|Lost to Follow-up|2|||
126584970|NCT01261312|455442143|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126584971|NCT01261312|455442144|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
126584972|NCT01261312|455442132|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
126584973|NCT01261312|455442133|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
126584974|NCT01261312|455442134|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126584975|NCT01261312|455442135|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126584976|NCT01261312|455442136|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126584977|NCT01261312|455442137|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126584978|NCT01261312|455442138|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126584979|NCT01261312|455442139|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126584980|NCT01261312|455442140|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126584981|NCT01261312|455442141|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126584982|NCT01261312|455442142|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126584983|NCT01261312|455442143|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126584984|NCT01261312|455442144|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
126584985|NCT01261312|455442132|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
126584986|NCT01261312|455442133|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
126584987|NCT01261312|455442134|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126584988|NCT01261312|455442135|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126584989|NCT01261312|455442136|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126584990|NCT01261312|455442137|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126777408|NCT02217345|456141342|FG001|Overall Study|Lost to Follow-up|1|||
126777409|NCT02217345|456141341|FG000|Overall Study|Withdrawal by Subject|3|||
126777410|NCT02217345|456141342|FG001|Overall Study|Withdrawal by Subject|2|||
126777411|NCT02217345|456141341|FG000|Overall Study|Adverse Event|2|||
126584991|NCT01261312|455442138|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126584992|NCT01261312|455442139|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126584993|NCT01261312|455442140|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126584994|NCT01261312|455442141|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126731011|NCT02678312|455964421|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
126731012|NCT02678312|455964422|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
126731013|NCT02678312|455964423|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
126731014|NCT02254551|455964429|FG000|Dose Escalation|Physician Decision|1|||
126731015|NCT02254551|455964429|FG000|Dose Escalation|Dose-limiting toxicity|2|||
126731016|NCT02716194|455964432|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
126731017|NCT02716194|455964433|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
126731018|NCT02716194|455964434|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
126731019|NCT00971425|455964438|FG000|Overall Study|Adverse Event|1|||
126731020|NCT00971425|455964439|FG001|Overall Study|Adverse Event|1|||
126731021|NCT00971425|455964438|FG000|Overall Study|Withdrawal by Subject|0|||
126731022|NCT00971425|455964439|FG001|Overall Study|Withdrawal by Subject|1|||
126731023|NCT03587584|455964445|FG000|Overall Study|SOC deviations|4|||
126731024|NCT03587584|455964446|FG001|Overall Study|SOC deviations|6|||
126731025|NCT03587584|455964445|FG000|Overall Study|Incomplete data|0|||
126731026|NCT03587584|455964446|FG001|Overall Study|Incomplete data|3|||
126731027|NCT00387348|455964447|FG000|Overall Study|Death|1|||
126731028|NCT00387348|455964448|FG001|Overall Study|Death|1|||
126731029|NCT00387348|455964449|FG002|Overall Study|Death|0|||
126731030|NCT00387348|455964447|FG000|Overall Study|Physician Decision|1|||
126731031|NCT00387348|455964448|FG001|Overall Study|Physician Decision|0|||
126731032|NCT00387348|455964449|FG002|Overall Study|Physician Decision|1|||
126731033|NCT00387348|455964447|FG000|Overall Study|Withdrawal by Subject|0|||
126731034|NCT00387348|455964448|FG001|Overall Study|Withdrawal by Subject|2|||
126731035|NCT00387348|455964449|FG002|Overall Study|Withdrawal by Subject|2|||
126731036|NCT00387348|455964447|FG000|Overall Study|Adverse Event|1|||
126731037|NCT00387348|455964448|FG001|Overall Study|Adverse Event|0|||
126731038|NCT00387348|455964449|FG002|Overall Study|Adverse Event|1|||
126731039|NCT02685995|455964450|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
126731040|NCT02685995|455964451|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
126731041|NCT03819218|455964456|FG000|Overall Study|Protocol Violation|1|||
126731042|NCT02267278|455964457|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
126731043|NCT02267278|455964457|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
126731044|NCT02267278|455964457|FG000|Overall Study|Developed new cancer diagnoses|2|||
126731045|NCT02267278|455964457|FG000|Overall Study|prescribed prohibited medication|1|||
126731046|NCT00650091|455964458|FG000|Amended Study Design|Withdrawal by Subject|12|||
126731047|NCT00650091|455964459|FG001|Amended Study Design|Withdrawal by Subject|11|||
126731048|NCT00650091|455964460|FG002|Amended Study Design|Withdrawal by Subject|0|||
126731049|NCT00650091|455964458|FG000|Amended Study Design|Physician Decision|5|||
126731050|NCT00650091|455964459|FG001|Amended Study Design|Physician Decision|0|||
126731051|NCT00650091|455964460|FG002|Amended Study Design|Physician Decision|0|||
126584995|NCT01261312|455442142|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126584996|NCT01261312|455442143|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126584997|NCT01261312|455442144|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
126584998|NCT01261312|455442132|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
126584999|NCT01261312|455442133|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
126585000|NCT01261312|455442134|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126585001|NCT01261312|455442135|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126585002|NCT01261312|455442136|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126585003|NCT01261312|455442137|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126585004|NCT01261312|455442138|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126585005|NCT01261312|455442139|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126585006|NCT01261312|455442140|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126585007|NCT01261312|455442141|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126585008|NCT01261312|455442142|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126731052|NCT00650091|455964458|FG000|Amended Study Design|Adverse Event|1|||
126731053|NCT00650091|455964459|FG001|Amended Study Design|Adverse Event|4|||
126731054|NCT00650091|455964460|FG002|Amended Study Design|Adverse Event|0|||
126585009|NCT01261312|455442143|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126731055|NCT00650091|455964458|FG000|Amended Study Design|Lung transplantation|4|||
126731056|NCT00650091|455964459|FG001|Amended Study Design|Lung transplantation|2|||
126731057|NCT00650091|455964460|FG002|Amended Study Design|Lung transplantation|0|||
126731058|NCT00650091|455964458|FG000|Amended Study Design|Other|1|||
126731059|NCT00650091|455964459|FG001|Amended Study Design|Other|3|||
126585010|NCT01261312|455442144|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
126585011|NCT01261312|455442132|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
126731060|NCT00650091|455964460|FG002|Amended Study Design|Other|0|||
126731061|NCT02988219|455964464|FG000|Overall Study|Lack of Efficacy|1|||
126731062|NCT02988219|455964465|FG001|Overall Study|Lack of Efficacy|1|||
126731063|NCT02988219|455964464|FG000|Overall Study|Withdrawal by Subject|0|||
126731064|NCT02988219|455964465|FG001|Overall Study|Withdrawal by Subject|2|||
126585012|NCT01261312|455442133|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
126585013|NCT01261312|455442134|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
126585014|NCT01261312|455442135|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126585015|NCT01261312|455442136|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126585016|NCT01261312|455442137|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126585017|NCT01261312|455442138|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126585018|NCT01261312|455442139|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126585019|NCT01261312|455442140|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126585020|NCT01261312|455442141|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126585021|NCT01261312|455442142|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126585022|NCT01261312|455442143|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126585023|NCT01261312|455442144|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
126585024|NCT01261312|455442132|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
126585025|NCT01261312|455442133|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
126585026|NCT01261312|455442134|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
126585027|NCT01261312|455442135|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126585028|NCT01261312|455442136|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126585029|NCT01261312|455442137|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126585030|NCT01261312|455442138|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126585031|NCT01261312|455442139|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126585032|NCT01261312|455442140|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126585033|NCT01261312|455442141|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126585034|NCT01261312|455442142|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126585035|NCT01261312|455442143|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126585036|NCT01261312|455442144|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
126585037|NCT01261312|455442132|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
126585038|NCT01261312|455442133|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126585039|NCT01261312|455442134|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
126585040|NCT01261312|455442135|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126585041|NCT01261312|455442136|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126585042|NCT01261312|455442137|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126585043|NCT01261312|455442138|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126585044|NCT01261312|455442139|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126585045|NCT01261312|455442140|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126585046|NCT01261312|455442141|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126585047|NCT01261312|455442142|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126585048|NCT01261312|455442143|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126585049|NCT01261312|455442144|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
126585050|NCT01261312|455442132|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126585051|NCT01261312|455442133|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126585052|NCT01261312|455442134|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126585053|NCT01261312|455442135|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
126585054|NCT01261312|455442136|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
126585055|NCT01261312|455442137|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
126585056|NCT01261312|455442138|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126585057|NCT01261312|455442139|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126585058|NCT01261312|455442140|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126585059|NCT01261312|455442141|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126585060|NCT01261312|455442142|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126585061|NCT01261312|455442143|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126585062|NCT01261312|455442144|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
126585063|NCT01261312|455442132|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126585064|NCT01261312|455442133|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126585065|NCT01261312|455442134|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126585066|NCT01261312|455442135|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126585067|NCT01261312|455442136|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
126585068|NCT01261312|455442137|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
126585069|NCT01261312|455442138|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126585070|NCT01261312|455442139|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126585071|NCT01261312|455442140|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126585072|NCT01261312|455442141|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126585073|NCT01261312|455442142|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126777412|NCT02217345|456141342|FG001|Overall Study|Adverse Event|1|||
126777413|NCT02217345|456141341|FG000|Overall Study|Physician Decision|0|||
126777414|NCT02217345|456141342|FG001|Overall Study|Physician Decision|1|||
126777415|NCT00950599|456141346|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126777416|NCT00950599|456141347|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126777417|NCT00950599|456141348|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126777418|NCT00950599|456141349|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
126777419|NCT00950599|456141350|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126777420|NCT00950599|456141351|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126777421|NCT00950599|456141352|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126777422|NCT00950599|456141353|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126777423|NCT00950599|456141354|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126777424|NCT00950599|456141355|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
126777425|NCT00950599|456141346|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126777426|NCT00950599|456141347|FG001|Double-Blind Treatment Period|Adverse Event|1|||
126777427|NCT00950599|456141348|FG002|Double-Blind Treatment Period|Adverse Event|1|||
126777428|NCT00950599|456141349|FG003|Double-Blind Treatment Period|Adverse Event|1|||
126777429|NCT00950599|456141350|FG004|Double-Blind Treatment Period|Adverse Event|1|||
126777430|NCT00950599|456141351|FG005|Double-Blind Treatment Period|Adverse Event|1|||
126777431|NCT00950599|456141352|FG006|Double-Blind Treatment Period|Adverse Event|0|||
126777432|NCT00950599|456141353|FG007|Double-Blind Treatment Period|Adverse Event|0|||
126777433|NCT00950599|456141354|FG008|Double-Blind Treatment Period|Adverse Event|0|||
126777434|NCT00950599|456141355|FG009|Double-Blind Treatment Period|Adverse Event|0|||
126777435|NCT00950599|456141346|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
126777436|NCT00950599|456141347|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
126777437|NCT00950599|456141348|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
126777438|NCT00950599|456141349|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
126777439|NCT00950599|456141350|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
126777440|NCT00950599|456141351|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
126777441|NCT00950599|456141352|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
126777442|NCT00950599|456141353|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
126777443|NCT00950599|456141354|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
126777444|NCT00950599|456141355|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
126777445|NCT00950599|456141346|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126777446|NCT00950599|456141347|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
126777447|NCT00950599|456141348|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
126777448|NCT00950599|456141349|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
126777449|NCT00950599|456141350|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
126777450|NCT00950599|456141351|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
126777451|NCT00950599|456141352|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
126777452|NCT00950599|456141353|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
126777453|NCT00950599|456141354|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
126777454|NCT00950599|456141355|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
126777455|NCT00950599|456141346|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
126777456|NCT00950599|456141347|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
126777457|NCT00950599|456141348|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126777458|NCT00950599|456141349|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126777459|NCT00950599|456141350|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126777460|NCT00950599|456141351|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126777461|NCT00950599|456141352|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126777462|NCT00950599|456141353|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
126777463|NCT00950599|456141354|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126777464|NCT00950599|456141355|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
126777465|NCT00950599|456141346|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126777466|NCT00950599|456141347|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126777467|NCT00950599|456141348|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126777468|NCT00950599|456141349|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126777469|NCT00950599|456141350|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
126777470|NCT00950599|456141351|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
126777471|NCT00950599|456141352|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126777472|NCT00950599|456141353|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126777473|NCT00950599|456141354|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126585074|NCT01261312|455442143|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126585075|NCT01261312|455442144|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
126585076|NCT01261312|455442132|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126585077|NCT01261312|455442133|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126585078|NCT01261312|455442134|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126731065|NCT00664209|455964466|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
126731066|NCT00664209|455964466|FG000|Study Treatment Period|Physician Decision|4|||
126731067|NCT00664209|455964466|FG000|Study Treatment Period|Withdrawal by Subject|2|||
126731068|NCT00065442|455964467|FG000|Overall Study|Lost to Follow-up|1|||
126731069|NCT00065442|455964468|FG001|Overall Study|Lost to Follow-up|1|||
126731070|NCT00065442|455964467|FG000|Overall Study|Death|121|||
126731071|NCT00065442|455964468|FG001|Overall Study|Death|210|||
126731072|NCT00065442|455964467|FG000|Overall Study|Withdrawal by Subject|3|||
126731073|NCT00065442|455964468|FG001|Overall Study|Withdrawal by Subject|9|||
126731074|NCT01764256|455964469|FG000|Received All Vaccinations|Adverse Event|1|||
126731075|NCT01764256|455964470|FG001|Received All Vaccinations|Adverse Event|1|||
126731076|NCT01764256|455964471|FG002|Received All Vaccinations|Adverse Event|0|||
126731077|NCT01764256|455964472|FG003|Received All Vaccinations|Adverse Event|0|||
126731078|NCT01764256|455964469|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
126731079|NCT01764256|455964470|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
126731080|NCT01764256|455964471|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
126731081|NCT01764256|455964472|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
126731082|NCT01764256|455964469|FG000|Received All Vaccinations|Lost to Follow-up|1|||
126731083|NCT01764256|455964470|FG001|Received All Vaccinations|Lost to Follow-up|0|||
126731084|NCT01764256|455964471|FG002|Received All Vaccinations|Lost to Follow-up|0|||
126731085|NCT01764256|455964472|FG003|Received All Vaccinations|Lost to Follow-up|0|||
126731086|NCT01764256|455964469|FG000|Completed Study|Lost to Follow-up|0|||
126731087|NCT01764256|455964470|FG001|Completed Study|Lost to Follow-up|0|||
126731088|NCT01764256|455964471|FG002|Completed Study|Lost to Follow-up|0|||
126731089|NCT01764256|455964472|FG003|Completed Study|Lost to Follow-up|1|||
126731090|NCT02029638|455964473|FG000|Overall Study|Death|0|||
126731091|NCT02029638|455964474|FG001|Overall Study|Death|0|||
126731092|NCT02029638|455964475|FG002|Overall Study|Death|1|||
126731093|NCT02029638|455964473|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
126731094|NCT02029638|455964474|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
126731095|NCT02029638|455964475|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
126731096|NCT01153841|455964476|FG000|Overall Study|Adverse Event|1|||
126731097|NCT01153841|455964477|FG001|Overall Study|Adverse Event|0|||
126731098|NCT01153841|455964476|FG000|Overall Study|Withdrawal by Subject|1|||
126731099|NCT01153841|455964477|FG001|Overall Study|Withdrawal by Subject|0|||
126731100|NCT01153841|455964476|FG000|Overall Study|Protocol Violation|2|||
126731101|NCT01153841|455964477|FG001|Overall Study|Protocol Violation|0|||
126731102|NCT01153841|455964476|FG000|Overall Study|Lost to Follow-up|2|||
126731103|NCT01153841|455964477|FG001|Overall Study|Lost to Follow-up|0|||
126731104|NCT02553317|455964483|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
126731105|NCT02553317|455964484|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
126731106|NCT02553317|455964483|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
126731107|NCT02553317|455964484|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
126731108|NCT02553317|455964483|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
126731109|NCT02553317|455964484|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
126731110|NCT02553317|455964483|FG000|Overall Treatment Period + Follow-up|Death|1|||
126731111|NCT02553317|455964484|FG001|Overall Treatment Period + Follow-up|Death|3|||
126731112|NCT02553317|455964483|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
126731113|NCT02553317|455964484|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
126731114|NCT02553317|455964483|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
126731115|NCT02553317|455964484|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
126731116|NCT02553317|455964483|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
126731117|NCT02553317|455964484|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
126731118|NCT02553317|455964483|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
126731119|NCT02553317|455964484|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
126731120|NCT02553317|455964483|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
126731121|NCT02553317|455964484|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
126731122|NCT02553317|455964483|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
126731123|NCT02553317|455964484|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
126731124|NCT04664855|455964486|FG000|Overall Study|Withdrawal by Subject|0|||
126731125|NCT04664855|455964487|FG001|Overall Study|Withdrawal by Subject|2|||
126731126|NCT02219087|455964488|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
126731127|NCT02219087|455964489|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
126731128|NCT03454412|455964492|FG000|Baseline Assesment|Physician Decision|12|||
126731129|NCT03956225|455964493|FG000|Overall Study|Lack of Efficacy|1|||
126731130|NCT03956225|455964494|FG001|Overall Study|Lack of Efficacy|1|||
126731131|NCT03956225|455964493|FG000|Overall Study|Lost to Follow-up|0|||
126731132|NCT03956225|455964494|FG001|Overall Study|Lost to Follow-up|1|||
126731133|NCT03956225|455964493|FG000|Overall Study|Withdrawal by Subject|2|||
126731134|NCT03956225|455964494|FG001|Overall Study|Withdrawal by Subject|1|||
126731135|NCT03956225|455964493|FG000|Overall Study|Other Reasons|2|||
126731136|NCT03956225|455964494|FG001|Overall Study|Other Reasons|1|||
126731137|NCT04093258|455964495|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
126731138|NCT04093258|455964496|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
126731139|NCT00594204|455964497|FG000|Overall Study|Adverse Event|15|||
126731140|NCT00594204|455964498|FG001|Overall Study|Adverse Event|3|||
126731141|NCT00594204|455964497|FG000|Overall Study|Lost to Follow-up|9|||
126731142|NCT00594204|455964498|FG001|Overall Study|Lost to Follow-up|5|||
126731143|NCT00594204|455964497|FG000|Overall Study|Withdrawal by Subject|23|||
126731144|NCT00594204|455964498|FG001|Overall Study|Withdrawal by Subject|29|||
126731145|NCT00594204|455964497|FG000|Overall Study|Other|4|||
126731146|NCT00594204|455964498|FG001|Overall Study|Other|3|||
126731147|NCT00594204|455964497|FG000|Overall Study|Lack of Efficacy|3|||
126731148|NCT00594204|455964498|FG001|Overall Study|Lack of Efficacy|4|||
126731149|NCT00594204|455964497|FG000|Overall Study|Randomized but not treated|4|||
126731150|NCT00594204|455964498|FG001|Overall Study|Randomized but not treated|1|||
126731151|NCT01401465|455964499|FG000|Treatment Period 1|Adverse Event|4|||
126731152|NCT01401465|455964500|FG001|Treatment Period 1|Adverse Event|1|||
126731153|NCT01401465|455964499|FG000|Treatment Period 1|Pregnancy|0|||
126731154|NCT01401465|455964500|FG001|Treatment Period 1|Pregnancy|1|||
126731155|NCT01401465|455964499|FG000|Treatment Period 1|Protocol Violation|5|||
126731156|NCT01401465|455964500|FG001|Treatment Period 1|Protocol Violation|0|||
126731157|NCT01401465|455964499|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126731158|NCT01401465|455964500|FG001|Treatment Period 1|Withdrawal by Subject|4|||
126731159|NCT01401465|455964499|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
126731160|NCT01401465|455964500|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
126731161|NCT01401465|455964499|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
126731162|NCT01401465|455964500|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
126731163|NCT01401465|455964499|FG000|Treatment Period 1|Scheduling Difficulties|1|||
126731164|NCT01401465|455964500|FG001|Treatment Period 1|Scheduling Difficulties|1|||
126731165|NCT01401465|455964499|FG000|Treatment Period 2|Lost to Follow-up|0|||
126731166|NCT01401465|455964500|FG001|Treatment Period 2|Lost to Follow-up|1|||
126731167|NCT01401465|455964499|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126731168|NCT01401465|455964500|FG001|Treatment Period 2|Withdrawal by Subject|1|||
126731169|NCT00986427|455964501|FG000|Overall Study|Lost to Follow-up|2|||
126731170|NCT00986427|455964502|FG001|Overall Study|Lost to Follow-up|0|||
126731171|NCT00986427|455964501|FG000|Overall Study|Lack of Efficacy|1|||
126731172|NCT00986427|455964502|FG001|Overall Study|Lack of Efficacy|0|||
126731173|NCT00986427|455964501|FG000|Overall Study|Withdrawal by Subject|1|||
126731174|NCT00986427|455964502|FG001|Overall Study|Withdrawal by Subject|0|||
126731175|NCT01115738|455964503|FG000|Overall Study|Death|1|||
126731176|NCT01115738|455964504|FG001|Overall Study|Death|0|||
126731177|NCT01115738|455964505|FG002|Overall Study|Death|0|||
126731178|NCT01115738|455964503|FG000|Overall Study|Lost to Follow-up|0|||
126731179|NCT01115738|455964504|FG001|Overall Study|Lost to Follow-up|0|||
126731180|NCT01115738|455964505|FG002|Overall Study|Lost to Follow-up|1|||
126731181|NCT01115738|455964503|FG000|Overall Study|Physician Decision|18|||
126731182|NCT01115738|455964504|FG001|Overall Study|Physician Decision|15|||
126731183|NCT01115738|455964505|FG002|Overall Study|Physician Decision|17|||
126731184|NCT01115738|455964503|FG000|Overall Study|Withdrawal by Subject|6|||
126731185|NCT01115738|455964504|FG001|Overall Study|Withdrawal by Subject|6|||
126731186|NCT01115738|455964505|FG002|Overall Study|Withdrawal by Subject|9|||
126731187|NCT01054976|455964511|FG000|Overall Study|Adverse Event|16|||
126731188|NCT01054976|455964511|FG000|Overall Study|Uncooperative participations to study|7|||
126731189|NCT01054976|455964511|FG000|Overall Study|Withdrawal by Subject|4|||
126731190|NCT01054976|455964511|FG000|Overall Study|Other|8|||
126731191|NCT01669811|455964516|FG000|Overall Study|Investigator decision|0|||
126731192|NCT01669811|455964517|FG001|Overall Study|Investigator decision|1|||
126731193|NCT01669811|455964516|FG000|Overall Study|Withdrawal by Subject|1|||
126731194|NCT01669811|455964517|FG001|Overall Study|Withdrawal by Subject|2|||
126731195|NCT01669811|455964516|FG000|Overall Study|Adverse Event|2|||
126731196|NCT01669811|455964517|FG001|Overall Study|Adverse Event|6|||
126731197|NCT01669811|455964516|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
126731198|NCT01669811|455964517|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
126731199|NCT00077376|455964518|FG000|Overall Study|Adverse Event|8|||
126731200|NCT00077376|455964518|FG000|Overall Study|Withdrawal by Subject|2|||
126731201|NCT00077376|455964518|FG000|Overall Study|Death|1|||
126731202|NCT00077376|455964518|FG000|Overall Study|Physician Decision|1|||
126731203|NCT00077376|455964518|FG000|Overall Study|Alternative therapy|5|||
126731204|NCT00077376|455964518|FG000|Overall Study|Complicating disease|1|||
126731205|NCT00077376|455964518|FG000|Overall Study|Still on treatment|1|||
126731206|NCT00077376|455964518|FG000|Overall Study|Symptomatic deterioration|1|||
126731207|NCT00077376|455964518|FG000|Overall Study|Surgery|1|||
126731208|NCT00077376|455964518|FG000|Overall Study|Insurance ran out|1|||
126731209|NCT02759562|455966021|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
126731210|NCT02759562|455966022|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
126731211|NCT02759562|455966021|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
126731212|NCT02759562|455966022|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
126585079|NCT01261312|455442135|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126585080|NCT01261312|455442136|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
126585081|NCT01261312|455442137|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
126585082|NCT01261312|455442138|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126585083|NCT01261312|455442139|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126585084|NCT01261312|455442140|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126585085|NCT01261312|455442141|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126585086|NCT01261312|455442142|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126585087|NCT01261312|455442143|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126585088|NCT01261312|455442144|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
126585089|NCT01261312|455442132|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
126585090|NCT01261312|455442133|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
126585091|NCT01261312|455442134|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
126585092|NCT01261312|455442135|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
126585093|NCT01261312|455442136|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
126585094|NCT01261312|455442137|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
126585095|NCT01261312|455442138|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
126585096|NCT01261312|455442139|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
126585097|NCT01261312|455442140|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
126585098|NCT01261312|455442141|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
126585099|NCT01261312|455442142|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
126585100|NCT01261312|455442143|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
126585101|NCT01261312|455442144|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
126585102|NCT01261312|455442132|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126585103|NCT01261312|455442133|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126585104|NCT01261312|455442134|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126585105|NCT01261312|455442135|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126585106|NCT01261312|455442136|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126585107|NCT01261312|455442137|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
126585108|NCT01261312|455442138|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126585109|NCT01261312|455442139|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126585110|NCT01261312|455442140|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126585111|NCT01261312|455442141|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126585112|NCT01261312|455442142|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126585113|NCT01261312|455442143|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126585114|NCT01261312|455442144|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
126585115|NCT01261312|455442132|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126585116|NCT01261312|455442133|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126585117|NCT01261312|455442134|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126585118|NCT01261312|455442135|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
126585119|NCT01261312|455442136|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
126585120|NCT01261312|455442137|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
126585121|NCT01261312|455442138|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126585122|NCT01261312|455442139|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126585123|NCT01261312|455442140|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126585124|NCT01261312|455442141|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126585125|NCT01261312|455442142|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126585126|NCT01261312|455442143|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126585127|NCT01261312|455442144|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
126585128|NCT01261312|455442132|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126585129|NCT01261312|455442133|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126585130|NCT01261312|455442134|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126585131|NCT01261312|455442135|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
126585132|NCT01261312|455442136|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
126585133|NCT01261312|455442137|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
126585134|NCT01261312|455442138|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126585135|NCT01261312|455442139|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126585136|NCT01261312|455442140|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126585137|NCT01261312|455442141|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126585138|NCT01261312|455442142|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126585139|NCT01261312|455442143|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126585140|NCT01261312|455442144|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
126585141|NCT01261312|455442132|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126585142|NCT01261312|455442133|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126640536|NCT02159040|455642796|FG000|Overall Study|Death|1|||
126640537|NCT02803593|455642799|FG000|Overall Study|Lost to Follow-up|17|||
126640538|NCT02803593|455642800|FG001|Overall Study|Lost to Follow-up|35|||
126640539|NCT05143138|455642801|FG000|Overall Study|Death|5|||
126640540|NCT05143138|455642802|FG001|Overall Study|Death|35|||
126640541|NCT05143138|455642803|FG002|Overall Study|Death|1|||
126640542|NCT05143138|455642801|FG000|Overall Study|Lost to Follow-up|2|||
126585143|NCT01261312|455442134|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126585144|NCT01261312|455442135|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126585145|NCT01261312|455442136|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126585146|NCT01261312|455442137|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126585147|NCT01261312|455442138|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
126585148|NCT01261312|455442139|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
126585149|NCT01261312|455442140|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
126585150|NCT01261312|455442141|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126585151|NCT01261312|455442142|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126585152|NCT01261312|455442143|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126585153|NCT01261312|455442144|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
126585154|NCT01261312|455442132|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126585155|NCT01261312|455442133|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126585156|NCT01261312|455442134|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126585157|NCT01261312|455442135|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126585158|NCT01261312|455442136|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126585159|NCT01261312|455442137|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126585160|NCT01261312|455442138|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126585161|NCT01261312|455442139|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
126585162|NCT01261312|455442140|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
126585163|NCT01261312|455442141|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126585164|NCT01261312|455442142|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126585165|NCT01261312|455442143|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126585166|NCT01261312|455442144|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
126585167|NCT01261312|455442132|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126585168|NCT01261312|455442133|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126585169|NCT01261312|455442134|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126585170|NCT01261312|455442135|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126585171|NCT01261312|455442136|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126585172|NCT01261312|455442137|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126585173|NCT01261312|455442138|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
126585174|NCT01261312|455442139|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
126585175|NCT01261312|455442140|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
126585176|NCT01261312|455442141|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126585177|NCT01261312|455442142|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126585178|NCT01261312|455442143|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126585179|NCT01261312|455442144|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
126585180|NCT01261312|455442132|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
126585181|NCT01261312|455442133|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
126585182|NCT01261312|455442134|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
126585183|NCT01261312|455442135|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
126585184|NCT01261312|455442136|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
126585185|NCT01261312|455442137|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
126585186|NCT01261312|455442138|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
126585187|NCT01261312|455442139|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
126585188|NCT01261312|455442140|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
126585189|NCT01261312|455442141|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
126585190|NCT01261312|455442142|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
126585191|NCT01261312|455442143|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
126585192|NCT01261312|455442144|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
126585193|NCT01261312|455442132|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126585194|NCT01261312|455442133|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126585195|NCT01261312|455442134|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126585196|NCT01261312|455442135|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126585197|NCT01261312|455442136|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126585198|NCT01261312|455442137|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126585199|NCT01261312|455442138|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
126585200|NCT01261312|455442139|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
126585201|NCT01261312|455442140|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
126585202|NCT01261312|455442141|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126585203|NCT01261312|455442142|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126585204|NCT01261312|455442143|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126585205|NCT01261312|455442144|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
126585206|NCT01261312|455442132|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126585207|NCT01261312|455442133|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126585208|NCT01261312|455442134|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126585209|NCT01261312|455442135|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126585210|NCT01261312|455442136|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126585211|NCT01261312|455442137|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126585212|NCT01261312|455442138|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
126585213|NCT01261312|455442139|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
126585214|NCT01261312|455442140|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
126585215|NCT01261312|455442141|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126585216|NCT01261312|455442142|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126585217|NCT01261312|455442143|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126585218|NCT01261312|455442144|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
126585219|NCT01261312|455442132|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126585220|NCT01261312|455442133|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126585221|NCT01261312|455442134|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126585222|NCT01261312|455442135|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126585223|NCT01261312|455442136|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126585224|NCT01261312|455442137|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126585225|NCT01261312|455442138|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
126585226|NCT01261312|455442139|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
126585227|NCT01261312|455442140|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
126585228|NCT01261312|455442141|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126585229|NCT01261312|455442142|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126585230|NCT01261312|455442143|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126585231|NCT01261312|455442144|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
126585232|NCT01261312|455442132|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126585233|NCT01261312|455442133|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126585234|NCT01261312|455442134|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126585235|NCT01261312|455442135|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126585236|NCT01261312|455442136|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126585237|NCT01261312|455442137|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126585238|NCT01261312|455442138|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126585239|NCT01261312|455442139|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126585240|NCT01261312|455442140|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
126585241|NCT01261312|455442141|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
126585242|NCT01261312|455442142|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
126585243|NCT01261312|455442143|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
126585244|NCT01261312|455442144|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
126585245|NCT01261312|455442132|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126585246|NCT01261312|455442133|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126585247|NCT01261312|455442134|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126585248|NCT01261312|455442135|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126585249|NCT01261312|455442136|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126585250|NCT01261312|455442137|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126585251|NCT01261312|455442138|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126585252|NCT01261312|455442139|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126585253|NCT01261312|455442140|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126585254|NCT01261312|455442141|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
126585255|NCT01261312|455442142|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
126585256|NCT01261312|455442143|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
126585257|NCT01261312|455442144|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
126585258|NCT01261312|455442132|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126585259|NCT01261312|455442133|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126585260|NCT01261312|455442134|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126585261|NCT01261312|455442135|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126585262|NCT01261312|455442136|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126585263|NCT01261312|455442137|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126585264|NCT01261312|455442138|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126585265|NCT01261312|455442139|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126585266|NCT01261312|455442140|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
126585267|NCT01261312|455442141|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
126585268|NCT01261312|455442142|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
126585269|NCT01261312|455442143|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
126585270|NCT01261312|455442144|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
126585271|NCT01261312|455442132|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126585272|NCT01261312|455442133|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126585273|NCT01261312|455442134|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126731213|NCT00505752|455966025|FG000|Overall Study|Adverse Event|1|||
126777474|NCT00950599|456141355|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
126777475|NCT00950599|456141346|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
126777476|NCT00950599|456141347|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
126777477|NCT00950599|456141348|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
126777478|NCT00950599|456141349|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
126777479|NCT00950599|456141350|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
126777480|NCT00950599|456141351|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
126777481|NCT00950599|456141352|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
126777482|NCT00950599|456141353|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
126777483|NCT00950599|456141354|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
126777484|NCT00950599|456141355|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
126777485|NCT00950599|456141346|FG000|Follow-Up Period|Adverse Event|0|||
126585274|NCT01261312|455442135|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126585275|NCT01261312|455442136|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126585276|NCT01261312|455442137|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126585277|NCT01261312|455442138|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126777486|NCT00950599|456141347|FG001|Follow-Up Period|Adverse Event|0|||
126777487|NCT00950599|456141348|FG002|Follow-Up Period|Adverse Event|0|||
126777488|NCT00950599|456141349|FG003|Follow-Up Period|Adverse Event|0|||
126777489|NCT00950599|456141350|FG004|Follow-Up Period|Adverse Event|0|||
126777490|NCT00950599|456141351|FG005|Follow-Up Period|Adverse Event|0|||
126777491|NCT00950599|456141352|FG006|Follow-Up Period|Adverse Event|0|||
126777492|NCT00950599|456141353|FG007|Follow-Up Period|Adverse Event|0|||
126777493|NCT00950599|456141354|FG008|Follow-Up Period|Adverse Event|1|||
126777494|NCT00950599|456141355|FG009|Follow-Up Period|Adverse Event|0|||
126777495|NCT00950599|456141346|FG000|Follow-Up Period|Lack of Efficacy|0|||
126777496|NCT00950599|456141347|FG001|Follow-Up Period|Lack of Efficacy|0|||
126777497|NCT00950599|456141348|FG002|Follow-Up Period|Lack of Efficacy|0|||
126777498|NCT00950599|456141349|FG003|Follow-Up Period|Lack of Efficacy|0|||
126777499|NCT00950599|456141350|FG004|Follow-Up Period|Lack of Efficacy|0|||
126777500|NCT00950599|456141351|FG005|Follow-Up Period|Lack of Efficacy|0|||
126777501|NCT00950599|456141352|FG006|Follow-Up Period|Lack of Efficacy|0|||
126777502|NCT00950599|456141353|FG007|Follow-Up Period|Lack of Efficacy|0|||
126777503|NCT00950599|456141354|FG008|Follow-Up Period|Lack of Efficacy|3|||
126777504|NCT00950599|456141355|FG009|Follow-Up Period|Lack of Efficacy|0|||
126777505|NCT00950599|456141346|FG000|Follow-Up Period|Lost to Follow-up|0|||
126777506|NCT00950599|456141347|FG001|Follow-Up Period|Lost to Follow-up|0|||
126777507|NCT00950599|456141348|FG002|Follow-Up Period|Lost to Follow-up|0|||
126777508|NCT00950599|456141349|FG003|Follow-Up Period|Lost to Follow-up|0|||
126777509|NCT00950599|456141350|FG004|Follow-Up Period|Lost to Follow-up|0|||
126777510|NCT00950599|456141351|FG005|Follow-Up Period|Lost to Follow-up|0|||
126777511|NCT00950599|456141352|FG006|Follow-Up Period|Lost to Follow-up|0|||
126777512|NCT00950599|456141353|FG007|Follow-Up Period|Lost to Follow-up|0|||
126777513|NCT00950599|456141354|FG008|Follow-Up Period|Lost to Follow-up|5|||
126777514|NCT00950599|456141355|FG009|Follow-Up Period|Lost to Follow-up|1|||
126777515|NCT00950599|456141346|FG000|Follow-Up Period|Physician Decision|0|||
126777516|NCT00950599|456141347|FG001|Follow-Up Period|Physician Decision|0|||
126777517|NCT00950599|456141348|FG002|Follow-Up Period|Physician Decision|0|||
126777518|NCT00950599|456141349|FG003|Follow-Up Period|Physician Decision|0|||
126777519|NCT00950599|456141350|FG004|Follow-Up Period|Physician Decision|0|||
126777520|NCT00950599|456141351|FG005|Follow-Up Period|Physician Decision|0|||
126777521|NCT00950599|456141352|FG006|Follow-Up Period|Physician Decision|0|||
126777522|NCT00950599|456141353|FG007|Follow-Up Period|Physician Decision|0|||
126777523|NCT00950599|456141354|FG008|Follow-Up Period|Physician Decision|1|||
126777524|NCT00950599|456141355|FG009|Follow-Up Period|Physician Decision|0|||
126777525|NCT00950599|456141346|FG000|Follow-Up Period|Poor/Noncompliance|0|||
126777526|NCT00950599|456141347|FG001|Follow-Up Period|Poor/Noncompliance|0|||
126777527|NCT00950599|456141348|FG002|Follow-Up Period|Poor/Noncompliance|0|||
126777528|NCT00950599|456141349|FG003|Follow-Up Period|Poor/Noncompliance|0|||
126777529|NCT00950599|456141350|FG004|Follow-Up Period|Poor/Noncompliance|0|||
126777530|NCT00950599|456141351|FG005|Follow-Up Period|Poor/Noncompliance|0|||
126777531|NCT00950599|456141352|FG006|Follow-Up Period|Poor/Noncompliance|0|||
126777532|NCT00950599|456141353|FG007|Follow-Up Period|Poor/Noncompliance|0|||
126777533|NCT00950599|456141354|FG008|Follow-Up Period|Poor/Noncompliance|1|||
126585278|NCT01261312|455442139|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126777534|NCT00950599|456141355|FG009|Follow-Up Period|Poor/Noncompliance|0|||
126777535|NCT00950599|456141346|FG000|Follow-Up Period|Subject withdrew Consent|0|||
126777536|NCT00950599|456141347|FG001|Follow-Up Period|Subject withdrew Consent|0|||
126777537|NCT00950599|456141348|FG002|Follow-Up Period|Subject withdrew Consent|0|||
126777538|NCT00950599|456141349|FG003|Follow-Up Period|Subject withdrew Consent|0|||
126777539|NCT00950599|456141350|FG004|Follow-Up Period|Subject withdrew Consent|0|||
126777540|NCT00950599|456141351|FG005|Follow-Up Period|Subject withdrew Consent|0|||
126777541|NCT00950599|456141352|FG006|Follow-Up Period|Subject withdrew Consent|0|||
126777542|NCT00950599|456141353|FG007|Follow-Up Period|Subject withdrew Consent|0|||
126731214|NCT00505752|455966026|FG001|Overall Study|Adverse Event|0|||
126731215|NCT00505752|455966027|FG002|Overall Study|Adverse Event|1|||
126731216|NCT00505752|455966028|FG003|Overall Study|Adverse Event|0|||
126731217|NCT00505752|455966025|FG000|Overall Study|Lost to Follow-up|1|||
126731218|NCT00505752|455966026|FG001|Overall Study|Lost to Follow-up|0|||
126731219|NCT00505752|455966027|FG002|Overall Study|Lost to Follow-up|0|||
126731220|NCT00505752|455966028|FG003|Overall Study|Lost to Follow-up|0|||
126731221|NCT00505752|455966025|FG000|Overall Study|Lack of ovarian response|1|||
126585279|NCT01261312|455442140|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
126585280|NCT01261312|455442141|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
126585281|NCT01261312|455442142|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
126585282|NCT01261312|455442143|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
126585283|NCT01261312|455442144|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
126731222|NCT00505752|455966026|FG001|Overall Study|Lack of ovarian response|3|||
126731223|NCT00505752|455966027|FG002|Overall Study|Lack of ovarian response|0|||
126731224|NCT00505752|455966028|FG003|Overall Study|Lack of ovarian response|0|||
126731225|NCT00505752|455966025|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
126731226|NCT00505752|455966026|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
126731227|NCT00505752|455966027|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
126731228|NCT00505752|455966028|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
126731229|NCT00505752|455966025|FG000|Overall Study|No oocytes retrieved|0|||
126731230|NCT00505752|455966026|FG001|Overall Study|No oocytes retrieved|2|||
126731231|NCT00505752|455966027|FG002|Overall Study|No oocytes retrieved|0|||
126731232|NCT00505752|455966028|FG003|Overall Study|No oocytes retrieved|1|||
126731233|NCT00505752|455966025|FG000|Overall Study|No Fertilization|1|||
126731234|NCT00505752|455966026|FG001|Overall Study|No Fertilization|1|||
126731235|NCT00505752|455966027|FG002|Overall Study|No Fertilization|2|||
126731236|NCT00505752|455966028|FG003|Overall Study|No Fertilization|1|||
126731237|NCT00505752|455966025|FG000|Overall Study|All embryos/blastocysts discarded|0|||
126731238|NCT00505752|455966026|FG001|Overall Study|All embryos/blastocysts discarded|0|||
126731239|NCT00505752|455966027|FG002|Overall Study|All embryos/blastocysts discarded|1|||
126731240|NCT00505752|455966028|FG003|Overall Study|All embryos/blastocysts discarded|1|||
126731241|NCT00505752|455966025|FG000|Overall Study|Other|1|||
126731242|NCT00505752|455966026|FG001|Overall Study|Other|2|||
126731243|NCT00505752|455966027|FG002|Overall Study|Other|1|||
126731244|NCT00505752|455966028|FG003|Overall Study|Other|2|||
126731245|NCT01925612|455966031|FG000|Overall Study|Progressive Disease|1|||
126731246|NCT01925612|455966032|FG001|Overall Study|Progressive Disease|1|||
126731247|NCT01925612|455966033|FG002|Overall Study|Progressive Disease|1|||
126731248|NCT01925612|455966034|FG003|Overall Study|Progressive Disease|0|||
126731249|NCT01925612|455966035|FG004|Overall Study|Progressive Disease|0|||
126731250|NCT01925612|455966031|FG000|Overall Study|Adverse Event|3|||
126731251|NCT01925612|455966032|FG001|Overall Study|Adverse Event|3|||
126731252|NCT01925612|455966033|FG002|Overall Study|Adverse Event|0|||
126731253|NCT01925612|455966034|FG003|Overall Study|Adverse Event|1|||
126731254|NCT01925612|455966035|FG004|Overall Study|Adverse Event|2|||
126731255|NCT04624672|455966039|FG000|Overall Study|Early Study Closure|2|||
126731256|NCT04624672|455966040|FG001|Overall Study|Early Study Closure|1|||
126731257|NCT03472040|455966041|FG000|Overall Study|Physician Decision|0|||
126731258|NCT03472040|455966042|FG001|Overall Study|Physician Decision|3|||
126731259|NCT03472040|455966041|FG000|Overall Study|Withdrawal by Subject|10|||
126731260|NCT03472040|455966042|FG001|Overall Study|Withdrawal by Subject|23|||
126731261|NCT03472040|455966041|FG000|Overall Study|Perceived Lack of Efficacy|29|||
126731262|NCT03472040|455966042|FG001|Overall Study|Perceived Lack of Efficacy|30|||
126731263|NCT03472040|455966041|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
126731264|NCT03472040|455966042|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
126731265|NCT03472040|455966041|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
126777543|NCT00950599|456141354|FG008|Follow-Up Period|Subject withdrew Consent|2|||
126777544|NCT00950599|456141355|FG009|Follow-Up Period|Subject withdrew Consent|1|||
126585284|NCT01261312|455442132|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126585285|NCT01261312|455442133|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126585286|NCT01261312|455442134|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126585287|NCT01261312|455442135|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126585288|NCT01261312|455442136|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126585289|NCT01261312|455442137|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126585290|NCT01261312|455442138|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126585291|NCT01261312|455442139|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126585292|NCT01261312|455442140|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
126731266|NCT03472040|455966042|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
126731267|NCT03472040|455966041|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
126731268|NCT03472040|455966042|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
126731269|NCT03472040|455966041|FG000|Overall Study|Subject Non-compliance|2|||
126731270|NCT03472040|455966042|FG001|Overall Study|Subject Non-compliance|5|||
126585293|NCT01261312|455442141|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
126585294|NCT01261312|455442142|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
126585295|NCT01261312|455442143|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
126585296|NCT01261312|455442144|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
126585297|NCT01261312|455442132|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126585298|NCT01261312|455442133|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126585299|NCT01261312|455442134|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126585300|NCT01261312|455442135|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126585301|NCT01261312|455442136|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126585302|NCT01261312|455442137|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126585303|NCT01261312|455442138|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126585304|NCT01261312|455442139|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126585305|NCT01261312|455442140|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
126585306|NCT01261312|455442141|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
126585307|NCT01261312|455442142|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
126585308|NCT01261312|455442143|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
126585309|NCT01261312|455442144|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
126585310|NCT01261312|455442132|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126585311|NCT01261312|455442133|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126585312|NCT01261312|455442134|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126585313|NCT01261312|455442135|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126585314|NCT01261312|455442136|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126585315|NCT01261312|455442137|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126585316|NCT01261312|455442138|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126585317|NCT01261312|455442139|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126585318|NCT01261312|455442140|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
126585319|NCT01261312|455442141|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
126585320|NCT01261312|455442142|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
126585321|NCT01261312|455442143|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
126585322|NCT01261312|455442144|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
126585323|NCT04401800|455442152|FG000|Overall Study|Death|17|||
126585324|NCT04401800|455442152|FG000|Overall Study|Lost to Follow-up|5|||
126585325|NCT04401800|455442152|FG000|Overall Study|Withdrawal by Subject|4|||
126585326|NCT04485039|455442160|FG000|TPOXX Only|Adverse Event|2|||
126585327|NCT04485039|455442160|FG000|TPOXX Only|Physician Decision|1|||
126585328|NCT04485039|455442160|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
126585329|NCT04485039|455442160|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
126585330|NCT02783300|455442163|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585331|NCT02783300|455442164|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585332|NCT02783300|455442165|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585333|NCT02783300|455442166|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585334|NCT02783300|455442167|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585335|NCT02783300|455442168|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585336|NCT02783300|455442169|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
126585337|NCT02783300|455442170|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585338|NCT02783300|455442171|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585339|NCT02783300|455442172|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585340|NCT02783300|455442173|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585341|NCT02783300|455442174|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585342|NCT02783300|455442175|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585343|NCT02783300|455442176|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585344|NCT02783300|455442177|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585345|NCT02783300|455442178|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585346|NCT02783300|455442179|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585347|NCT02783300|455442180|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585348|NCT02783300|455442181|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585349|NCT02783300|455442182|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585350|NCT02783300|455442183|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585351|NCT02783300|455442184|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585352|NCT02783300|455442185|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585353|NCT02783300|455442186|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585354|NCT02783300|455442187|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585355|NCT02783300|455442188|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585356|NCT02783300|455442189|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
126585357|NCT02783300|455442163|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126777545|NCT00971204|456141357|FG000|Overall Study|Did not meet all criteria-not treated|14|||
126777546|NCT00971204|456141357|FG000|Overall Study|Lost to Follow-up|10|||
126731271|NCT03472040|455966041|FG000|Overall Study|Discontinuation due to Rash|0|||
126731272|NCT03472040|455966042|FG001|Overall Study|Discontinuation due to Rash|1|||
126731273|NCT03472040|455966041|FG000|Overall Study|Subsequent Ineligibility|0|||
126731274|NCT03472040|455966042|FG001|Overall Study|Subsequent Ineligibility|2|||
126731275|NCT03472040|455966041|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
126731276|NCT03472040|455966042|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
126731277|NCT00225147|455966047|FG000|Open-label Phase|Lost to Follow-up|0|||
126731278|NCT00225147|455966048|FG001|Open-label Phase|Lost to Follow-up|0|||
126731279|NCT00225147|455966049|FG002|Open-label Phase|Lost to Follow-up|0|||
126731280|NCT00225147|455966050|FG003|Open-label Phase|Lost to Follow-up|4|||
126731281|NCT00225147|455966047|FG000|Open-label Phase|Withdrawal by Subject|0|||
126731282|NCT00225147|455966048|FG001|Open-label Phase|Withdrawal by Subject|0|||
126731283|NCT00225147|455966049|FG002|Open-label Phase|Withdrawal by Subject|0|||
126731284|NCT00225147|455966050|FG003|Open-label Phase|Withdrawal by Subject|6|||
126731285|NCT03625141|455966053|FG000|Overall Study|Adverse Event|0|||
126731286|NCT03625141|455966054|FG001|Overall Study|Adverse Event|2|||
126731287|NCT03625141|455966053|FG000|Overall Study|Study Terminated By Sponsor|1|||
126731288|NCT03625141|455966054|FG001|Overall Study|Study Terminated By Sponsor|13|||
126731289|NCT03625141|455966053|FG000|Overall Study|Withdrawal by Subject|3|||
126731290|NCT03625141|455966054|FG001|Overall Study|Withdrawal by Subject|0|||
126731291|NCT03625141|455966053|FG000|Overall Study|Withdrawal Of Consent|0|||
126731292|NCT03625141|455966054|FG001|Overall Study|Withdrawal Of Consent|1|||
126731293|NCT03625141|455966053|FG000|Overall Study|Death|11|||
126731294|NCT03625141|455966054|FG001|Overall Study|Death|47|||
126731295|NCT03625141|455966053|FG000|Overall Study|Progressive Disease|0|||
126731296|NCT03625141|455966054|FG001|Overall Study|Progressive Disease|2|||
126731297|NCT00868166|455966056|FG000|Overall Study|Death|58|||
126731298|NCT00868166|455966057|FG001|Overall Study|Death|65|||
126731299|NCT00868166|455966056|FG000|Overall Study|Withdrawal by Subject|33|||
126731300|NCT00868166|455966057|FG001|Overall Study|Withdrawal by Subject|25|||
126731301|NCT00868166|455966056|FG000|Overall Study|Protocol Violation|1|||
126731302|NCT00868166|455966057|FG001|Overall Study|Protocol Violation|0|||
126731303|NCT00868166|455966056|FG000|Overall Study|Lost to Follow-up|1|||
126731304|NCT00868166|455966057|FG001|Overall Study|Lost to Follow-up|3|||
126731305|NCT00868166|455966056|FG000|Overall Study|Adverse Event|9|||
126731306|NCT00868166|455966057|FG001|Overall Study|Adverse Event|10|||
126731307|NCT00868166|455966056|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
126731308|NCT00868166|455966057|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
126731309|NCT00868166|455966056|FG000|Overall Study|Non-compliance with IMP|1|||
126731310|NCT00868166|455966057|FG001|Overall Study|Non-compliance with IMP|1|||
126731311|NCT00433446|455966060|FG000|Overall Study|Adverse Event|4|||
126731312|NCT00433446|455966060|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
126731313|NCT00433446|455966060|FG000|Overall Study|Progression|44|||
126731314|NCT00433446|455966060|FG000|Overall Study|Other - Not Protocol specified|3|||
126731315|NCT00433446|455966060|FG000|Overall Study|Ineligible|9|||
126731316|NCT01188538|455966061|FG000|Overall Study|Lost to Follow-up|0|||
126731317|NCT01188538|455966062|FG001|Overall Study|Lost to Follow-up|1|||
126731318|NCT01231607|455966066|FG000|Overall Study|Adverse Event|0|||
126731319|NCT01231607|455966067|FG001|Overall Study|Adverse Event|8|||
126731320|NCT01231607|455966068|FG002|Overall Study|Adverse Event|4|||
126731321|NCT01231607|455966069|FG003|Overall Study|Adverse Event|4|||
126731322|NCT01231607|455966070|FG004|Overall Study|Adverse Event|5|||
126731323|NCT01231607|455966066|FG000|Overall Study|Lost to Follow-up|13|||
126731324|NCT01231607|455966067|FG001|Overall Study|Lost to Follow-up|11|||
126731325|NCT01231607|455966068|FG002|Overall Study|Lost to Follow-up|10|||
126731326|NCT01231607|455966069|FG003|Overall Study|Lost to Follow-up|10|||
126731327|NCT01231607|455966070|FG004|Overall Study|Lost to Follow-up|4|||
126777547|NCT02729194|456141358|FG000|Overall Study|Withdrawal by Subject|3|||
126585358|NCT02783300|455442164|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126731328|NCT01231607|455966066|FG000|Overall Study|Physician Decision|4|||
126731329|NCT01231607|455966067|FG001|Overall Study|Physician Decision|4|||
126731330|NCT01231607|455966068|FG002|Overall Study|Physician Decision|3|||
126731331|NCT01231607|455966069|FG003|Overall Study|Physician Decision|5|||
126731332|NCT01231607|455966070|FG004|Overall Study|Physician Decision|4|||
126731333|NCT01231607|455966066|FG000|Overall Study|Protocol Violation|3|||
126731334|NCT01231607|455966067|FG001|Overall Study|Protocol Violation|2|||
126731335|NCT01231607|455966068|FG002|Overall Study|Protocol Violation|0|||
126731336|NCT01231607|455966069|FG003|Overall Study|Protocol Violation|2|||
126585359|NCT02783300|455442165|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126731337|NCT01231607|455966070|FG004|Overall Study|Protocol Violation|2|||
126731338|NCT01231607|455966066|FG000|Overall Study|Withdrawal by Subject|9|||
126731339|NCT01231607|455966067|FG001|Overall Study|Withdrawal by Subject|9|||
126731340|NCT01231607|455966068|FG002|Overall Study|Withdrawal by Subject|14|||
126585360|NCT02783300|455442166|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
126777548|NCT01401478|456141359|FG000|Overall Study|Study drug not available|6|||
126585361|NCT02783300|455442167|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585362|NCT02783300|455442168|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585363|NCT02783300|455442169|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585364|NCT02783300|455442170|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585365|NCT02783300|455442171|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585366|NCT02783300|455442172|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585367|NCT02783300|455442173|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585368|NCT02783300|455442174|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585369|NCT02783300|455442175|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585370|NCT02783300|455442176|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585371|NCT02783300|455442177|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585372|NCT02783300|455442178|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585373|NCT02783300|455442179|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585374|NCT02783300|455442180|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585375|NCT02783300|455442181|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585376|NCT02783300|455442182|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585377|NCT02783300|455442183|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585378|NCT02783300|455442184|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585379|NCT02783300|455442185|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585380|NCT02783300|455442186|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585381|NCT02783300|455442187|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585382|NCT02783300|455442188|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585383|NCT02783300|455442189|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
126585384|NCT02783300|455442163|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
126585385|NCT02783300|455442164|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
126585386|NCT02783300|455442165|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
126585387|NCT02783300|455442166|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
126585388|NCT02783300|455442167|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
126585389|NCT02783300|455442168|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
126585390|NCT02783300|455442169|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
126585391|NCT02783300|455442170|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
126585392|NCT02783300|455442171|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
126585393|NCT02783300|455442172|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
126585394|NCT02783300|455442173|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
126585395|NCT02783300|455442174|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
126585396|NCT02783300|455442175|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
126585397|NCT02783300|455442176|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
126585398|NCT02783300|455442177|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
126585399|NCT02783300|455442178|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
126585400|NCT02783300|455442179|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
126585401|NCT02783300|455442180|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
126585402|NCT02783300|455442181|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
126585403|NCT02783300|455442182|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
126585404|NCT02783300|455442183|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
126585405|NCT02783300|455442184|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
126585406|NCT02783300|455442185|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
126585407|NCT02783300|455442186|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
126585408|NCT02783300|455442187|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
126585409|NCT02783300|455442188|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
126585410|NCT02783300|455442189|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
126585411|NCT02783300|455442163|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585412|NCT02783300|455442164|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585413|NCT02783300|455442165|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585414|NCT02783300|455442166|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585415|NCT02783300|455442167|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585416|NCT02783300|455442168|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585417|NCT02783300|455442169|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
126585418|NCT02783300|455442170|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585419|NCT02783300|455442171|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585420|NCT02783300|455442172|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585421|NCT02783300|455442173|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585422|NCT02783300|455442174|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585423|NCT02783300|455442175|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
126585424|NCT02783300|455442176|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126731341|NCT01231607|455966069|FG003|Overall Study|Withdrawal by Subject|17|||
126731342|NCT01231607|455966070|FG004|Overall Study|Withdrawal by Subject|9|||
126585425|NCT02783300|455442177|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585426|NCT02783300|455442178|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585427|NCT02783300|455442179|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126731343|NCT01797445|455966073|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
126731344|NCT01797445|455966074|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
126731345|NCT01797445|455966073|FG000|Double-Blind Phase|Adverse Event|3|||
126731346|NCT01797445|455966074|FG001|Double-Blind Phase|Adverse Event|0|||
126731347|NCT01797445|455966073|FG000|Double-Blind Phase|Death|5|||
126731348|NCT01797445|455966074|FG001|Double-Blind Phase|Death|4|||
126731349|NCT01797445|455966073|FG000|Double-Blind Phase|Pregnancy|0|||
126731350|NCT01797445|455966074|FG001|Double-Blind Phase|Pregnancy|1|||
126731351|NCT01797445|455966073|FG000|Double-Blind Phase|Lack of Efficacy|1|||
126731352|NCT01797445|455966074|FG001|Double-Blind Phase|Lack of Efficacy|2|||
126731353|NCT01797445|455966073|FG000|Double-Blind Phase|Investigator's Discretion|15|||
126731354|NCT01797445|455966074|FG001|Double-Blind Phase|Investigator's Discretion|17|||
126731355|NCT01797445|455966073|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
126731356|NCT01797445|455966074|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
126731357|NCT01797445|455966073|FG000|Double-Blind Phase|Protocol Violation|0|||
126731358|NCT01797445|455966074|FG001|Double-Blind Phase|Protocol Violation|1|||
126731359|NCT01797445|455966073|FG000|Double-Blind Phase|Withdrew Consent|20|||
126731360|NCT01797445|455966074|FG001|Double-Blind Phase|Withdrew Consent|35|||
126731361|NCT01797445|455966073|FG000|Double-Blind Phase|Lost to Follow-up|34|||
126731362|NCT01797445|455966074|FG001|Double-Blind Phase|Lost to Follow-up|26|||
126731363|NCT01797445|455966073|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
126731364|NCT01797445|455966074|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
126731365|NCT01280266|455966083|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
126731366|NCT01280266|455966084|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
126731367|NCT01280266|455966083|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
126731368|NCT01280266|455966084|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
126731369|NCT04116073|455966091|FG000|Overall Study|Withdrawal by Subject|2|||
126731370|NCT04116073|455966091|FG000|Overall Study|failed to maintained eligibility|1|||
126731371|NCT00881361|455966096|FG000|Overall Study|Terminated prior to surgery|27|||
126731372|NCT00881361|455966097|FG001|Overall Study|Terminated prior to surgery|7|||
126731373|NCT00881361|455966098|FG002|Overall Study|Terminated prior to surgery|0|||
126731374|NCT00881361|455966096|FG000|Overall Study|Ineligible|17|||
126731375|NCT00881361|455966097|FG001|Overall Study|Ineligible|2|||
126731376|NCT00881361|455966098|FG002|Overall Study|Ineligible|2|||
126731377|NCT01413542|455966101|FG000|Overall Study|Physician Decision|1|||
126731378|NCT01413542|455966102|FG001|Overall Study|Physician Decision|0|||
126731379|NCT01413542|455966103|FG002|Overall Study|Physician Decision|3|||
126731380|NCT01413542|455966104|FG003|Overall Study|Physician Decision|0|||
126731381|NCT01413542|455966101|FG000|Overall Study|Adverse Event|0|||
126731382|NCT01413542|455966102|FG001|Overall Study|Adverse Event|0|||
126731383|NCT01413542|455966103|FG002|Overall Study|Adverse Event|0|||
126731384|NCT01413542|455966104|FG003|Overall Study|Adverse Event|1|||
126731385|NCT02505542|455966105|FG000|Part A: Open-Label Period|Adverse Event|31|||
126731386|NCT02505542|455966106|FG001|Part A: Open-Label Period|Adverse Event|0|||
126731387|NCT02505542|455966107|FG002|Part A: Open-Label Period|Adverse Event|0|||
126731388|NCT02505542|455966108|FG003|Part A: Open-Label Period|Adverse Event|0|||
126731389|NCT02505542|455966105|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
126731390|NCT02505542|455966106|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
126731391|NCT02505542|455966107|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
126731392|NCT02505542|455966108|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
126731393|NCT02505542|455966105|FG000|Part A: Open-Label Period|Protocol Violation|1|||
126731394|NCT02505542|455966106|FG001|Part A: Open-Label Period|Protocol Violation|0|||
126731395|NCT02505542|455966107|FG002|Part A: Open-Label Period|Protocol Violation|0|||
126731396|NCT02505542|455966108|FG003|Part A: Open-Label Period|Protocol Violation|0|||
126731397|NCT02505542|455966105|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
126731398|NCT02505542|455966106|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
126731399|NCT02505542|455966107|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
126731400|NCT02505542|455966108|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
126731401|NCT02505542|455966105|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
126731402|NCT02505542|455966106|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
126731403|NCT02505542|455966107|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
126731404|NCT02505542|455966108|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
126731405|NCT02505542|455966105|FG000|Part A: Open-Label Period|New medical history available|1|||
126731406|NCT02505542|455966106|FG001|Part A: Open-Label Period|New medical history available|0|||
126731407|NCT02505542|455966107|FG002|Part A: Open-Label Period|New medical history available|0|||
126731408|NCT02505542|455966108|FG003|Part A: Open-Label Period|New medical history available|0|||
126731409|NCT02505542|455966105|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
126731410|NCT02505542|455966106|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
126731411|NCT02505542|455966107|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
126731412|NCT02505542|455966108|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
126731413|NCT02505542|455966105|FG000|Part A: Open-Label Period|Pregnancy|2|||
126731414|NCT02505542|455966106|FG001|Part A: Open-Label Period|Pregnancy|0|||
126731415|NCT02505542|455966107|FG002|Part A: Open-Label Period|Pregnancy|0|||
126585428|NCT02783300|455442180|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585429|NCT02783300|455442181|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585430|NCT02783300|455442182|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585431|NCT02783300|455442183|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585432|NCT02783300|455442184|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585433|NCT02783300|455442185|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585434|NCT02783300|455442186|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585435|NCT02783300|455442187|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585436|NCT02783300|455442188|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585437|NCT02783300|455442189|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
126585438|NCT02783300|455442163|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585439|NCT02783300|455442164|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585440|NCT02783300|455442165|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585441|NCT02783300|455442166|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585442|NCT02783300|455442167|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
126585443|NCT02783300|455442168|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585444|NCT02783300|455442169|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
126585445|NCT02783300|455442170|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585446|NCT02783300|455442171|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585447|NCT02783300|455442172|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
126585448|NCT02783300|455442173|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585449|NCT02783300|455442174|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585450|NCT02783300|455442175|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
126585451|NCT02783300|455442176|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585452|NCT02783300|455442177|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585453|NCT02783300|455442178|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585454|NCT02783300|455442179|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585455|NCT02783300|455442180|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585456|NCT02783300|455442181|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585457|NCT02783300|455442182|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585458|NCT02783300|455442183|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585459|NCT02783300|455442184|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585460|NCT02783300|455442185|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585461|NCT02783300|455442186|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585462|NCT02783300|455442187|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585463|NCT02783300|455442188|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585464|NCT02783300|455442189|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
126585465|NCT02783300|455442163|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585466|NCT02783300|455442164|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585467|NCT02783300|455442165|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585468|NCT02783300|455442166|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585469|NCT02783300|455442167|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585470|NCT02783300|455442168|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585471|NCT02783300|455442169|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585472|NCT02783300|455442170|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585473|NCT02783300|455442171|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585474|NCT02783300|455442172|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585475|NCT02783300|455442173|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585476|NCT02783300|455442174|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585477|NCT02783300|455442175|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585478|NCT02783300|455442176|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585479|NCT02783300|455442177|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585480|NCT02783300|455442178|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
126585481|NCT02783300|455442179|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585482|NCT02783300|455442180|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
126585483|NCT02783300|455442181|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
126585484|NCT02783300|455442182|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
126585485|NCT02783300|455442183|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585486|NCT02783300|455442184|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585487|NCT02783300|455442185|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585488|NCT02783300|455442186|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585489|NCT02783300|455442187|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
126585490|NCT02783300|455442188|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126585491|NCT02783300|455442189|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
126777549|NCT01401478|456141359|FG000|Overall Study|Adverse Event|5|||
126777550|NCT01401478|456141359|FG000|Overall Study|Hyperphosphatemia|5|||
126777551|NCT01401478|456141359|FG000|Overall Study|Lost to Follow-up|5|||
126585492|NCT02783300|455442163|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585493|NCT02783300|455442164|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585494|NCT02783300|455442165|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585495|NCT02783300|455442166|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585496|NCT02783300|455442167|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585497|NCT02783300|455442168|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585498|NCT02783300|455442169|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585499|NCT02783300|455442170|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585500|NCT02783300|455442171|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585501|NCT02783300|455442172|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585502|NCT02783300|455442173|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585503|NCT02783300|455442174|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585504|NCT02783300|455442175|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585505|NCT02783300|455442176|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585506|NCT02783300|455442177|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585507|NCT02783300|455442178|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585508|NCT02783300|455442179|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
126585509|NCT02783300|455442180|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585510|NCT02783300|455442181|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
126585511|NCT02783300|455442182|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
126585512|NCT02783300|455442183|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585513|NCT02783300|455442184|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585514|NCT02783300|455442185|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585515|NCT02783300|455442186|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585516|NCT02783300|455442187|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585517|NCT02783300|455442188|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585518|NCT02783300|455442189|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
126585519|NCT02783300|455442163|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585520|NCT02783300|455442164|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585521|NCT02783300|455442165|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585522|NCT02783300|455442166|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585523|NCT02783300|455442167|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585524|NCT02783300|455442168|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585525|NCT02783300|455442169|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585526|NCT02783300|455442170|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585527|NCT02783300|455442171|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585528|NCT02783300|455442172|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585529|NCT02783300|455442173|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585530|NCT02783300|455442174|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585531|NCT02783300|455442175|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585532|NCT02783300|455442176|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585533|NCT02783300|455442177|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585534|NCT02783300|455442178|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585535|NCT02783300|455442179|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
126585536|NCT02783300|455442180|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585537|NCT02783300|455442181|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
126585538|NCT02783300|455442182|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
126585539|NCT02783300|455442183|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
126585540|NCT02783300|455442184|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585541|NCT02783300|455442185|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585542|NCT02783300|455442186|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585543|NCT02783300|455442187|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585544|NCT02783300|455442188|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585545|NCT02783300|455442189|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
126585546|NCT02783300|455442163|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585547|NCT02783300|455442164|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585548|NCT02783300|455442165|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126777552|NCT01401478|456141359|FG000|Overall Study|Kidney transplantation|3|||
126777553|NCT01401478|456141359|FG000|Overall Study|Withdrawal by Subject|3|||
126777554|NCT01401478|456141359|FG000|Overall Study|Blood samples not available|1|||
126585549|NCT02783300|455442166|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585550|NCT02783300|455442167|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585551|NCT02783300|455442168|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585552|NCT02783300|455442169|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585553|NCT02783300|455442170|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585554|NCT02783300|455442171|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585555|NCT02783300|455442172|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585556|NCT02783300|455442173|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585557|NCT02783300|455442174|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585558|NCT02783300|455442175|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585559|NCT02783300|455442176|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585560|NCT02783300|455442177|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585561|NCT02783300|455442178|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
126585562|NCT02783300|455442179|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585563|NCT02783300|455442180|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585564|NCT02783300|455442181|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585565|NCT02783300|455442182|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585566|NCT02783300|455442183|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585567|NCT02783300|455442184|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585568|NCT02783300|455442185|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
126585569|NCT02783300|455442186|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585570|NCT02783300|455442187|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585571|NCT02783300|455442188|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585572|NCT02783300|455442189|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
126585573|NCT02783300|455442163|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585574|NCT02783300|455442164|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585575|NCT02783300|455442165|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585576|NCT02783300|455442166|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585577|NCT02783300|455442167|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585578|NCT02783300|455442168|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585579|NCT02783300|455442169|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585580|NCT02783300|455442170|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585581|NCT02783300|455442171|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585582|NCT02783300|455442172|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585583|NCT02783300|455442173|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585584|NCT02783300|455442174|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585585|NCT02783300|455442175|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585586|NCT02783300|455442176|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
126585587|NCT02783300|455442177|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
126585588|NCT02783300|455442178|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
126585589|NCT02783300|455442179|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
126585590|NCT02783300|455442180|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585591|NCT02783300|455442181|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
126585592|NCT02783300|455442182|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
126585593|NCT02783300|455442183|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585594|NCT02783300|455442184|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585595|NCT02783300|455442185|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585596|NCT02783300|455442186|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585597|NCT02783300|455442187|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585598|NCT02783300|455442188|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585599|NCT02783300|455442189|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
126585600|NCT02783300|455442163|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585601|NCT02783300|455442164|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585602|NCT02783300|455442165|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585603|NCT02783300|455442166|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126731416|NCT02505542|455966108|FG003|Part A: Open-Label Period|Pregnancy|0|||
126731417|NCT02505542|455966105|FG000|Part A: Open-Label Period|Sponsor directive|1|||
126731418|NCT02505542|455966106|FG001|Part A: Open-Label Period|Sponsor directive|0|||
126731419|NCT02505542|455966107|FG002|Part A: Open-Label Period|Sponsor directive|0|||
126585604|NCT02783300|455442167|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585605|NCT02783300|455442168|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585606|NCT02783300|455442169|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585607|NCT02783300|455442170|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585608|NCT02783300|455442171|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585609|NCT02783300|455442172|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585610|NCT02783300|455442173|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585611|NCT02783300|455442174|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585612|NCT02783300|455442175|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585613|NCT02783300|455442176|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
126585614|NCT02783300|455442177|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
126585615|NCT02783300|455442178|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
126585616|NCT02783300|455442179|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
126585617|NCT02783300|455442180|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
126585618|NCT02783300|455442181|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
126585619|NCT02783300|455442182|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
126585620|NCT02783300|455442183|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
126585621|NCT02783300|455442184|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
126585622|NCT02783300|455442185|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
126585623|NCT02783300|455442186|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
126585624|NCT02783300|455442187|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
126585625|NCT02783300|455442188|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
126585626|NCT02783300|455442189|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
126585627|NCT02783300|455442163|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585628|NCT02783300|455442164|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585629|NCT02783300|455442165|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585630|NCT02783300|455442166|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585631|NCT02783300|455442167|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585632|NCT02783300|455442168|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585633|NCT02783300|455442169|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585634|NCT02783300|455442170|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585635|NCT02783300|455442171|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585636|NCT02783300|455442172|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585637|NCT02783300|455442173|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585638|NCT02783300|455442174|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585639|NCT02783300|455442175|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585640|NCT02783300|455442176|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585641|NCT02783300|455442177|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585642|NCT02783300|455442178|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585643|NCT02783300|455442179|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585644|NCT02783300|455442180|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585645|NCT02783300|455442181|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585646|NCT02783300|455442182|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585647|NCT02783300|455442183|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585648|NCT02783300|455442184|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585649|NCT02783300|455442185|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585650|NCT02783300|455442186|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585651|NCT02783300|455442187|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585652|NCT02783300|455442188|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
126585653|NCT02783300|455442189|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
126585654|NCT02783300|455442163|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585655|NCT02783300|455442164|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585656|NCT02783300|455442165|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585657|NCT02783300|455442166|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585658|NCT02783300|455442167|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585659|NCT02783300|455442168|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585660|NCT02783300|455442169|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585661|NCT02783300|455442170|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585662|NCT02783300|455442171|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585663|NCT02783300|455442172|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585664|NCT02783300|455442173|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585665|NCT02783300|455442174|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585666|NCT02783300|455442175|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585667|NCT02783300|455442176|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585668|NCT02783300|455442177|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585669|NCT02783300|455442178|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585670|NCT02783300|455442179|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585671|NCT02783300|455442180|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585672|NCT02783300|455442181|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585673|NCT02783300|455442182|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585674|NCT02783300|455442183|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585675|NCT02783300|455442184|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585676|NCT02783300|455442185|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585677|NCT02783300|455442186|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585678|NCT02783300|455442187|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585679|NCT02783300|455442188|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
126585680|NCT02783300|455442189|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
126585681|NCT03535272|455442190|FG000|Overall Study|Lost to Follow-up|71|||
126585682|NCT03535272|455442191|FG001|Overall Study|Lost to Follow-up|73|||
126585683|NCT04831216|455442196|FG000|Overall Study|Lost to Follow-up|32|||
126585684|NCT03930342|455442201|FG000|Overall Study|Lost to Follow-up|70|||
126585685|NCT03930342|455442202|FG001|Overall Study|Lost to Follow-up|77|||
126585686|NCT03376321|455443731|FG000|Overall Study|Other|5|||
126585687|NCT03376321|455443732|FG001|Overall Study|Other|1|||
126585688|NCT03376321|455443731|FG000|Overall Study|Withdrawal by Subject|8|||
126585689|NCT03376321|455443732|FG001|Overall Study|Withdrawal by Subject|14|||
126585690|NCT03376321|455443731|FG000|Overall Study|Lost to Follow-up|1|||
126585691|NCT03376321|455443732|FG001|Overall Study|Lost to Follow-up|7|||
126731420|NCT02505542|455966108|FG003|Part A: Open-Label Period|Sponsor directive|0|||
126731421|NCT02505542|455966105|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
126731422|NCT02505542|455966106|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
126731423|NCT02505542|455966107|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
126731424|NCT02505542|455966108|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
126731425|NCT02505542|455966105|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
126731426|NCT02505542|455966106|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
126731427|NCT02505542|455966107|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
126731428|NCT02505542|455966108|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
126731429|NCT02505542|455966105|FG000|Part A: Open-Label Period|Non-compliance|1|||
126731430|NCT02505542|455966106|FG001|Part A: Open-Label Period|Non-compliance|0|||
126731431|NCT02505542|455966107|FG002|Part A: Open-Label Period|Non-compliance|0|||
126731432|NCT02505542|455966108|FG003|Part A: Open-Label Period|Non-compliance|0|||
126731433|NCT02505542|455966105|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
126731434|NCT02505542|455966106|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
126731435|NCT02505542|455966107|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
126731436|NCT02505542|455966108|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
126731437|NCT02505542|455966105|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
126731438|NCT02505542|455966106|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
126731439|NCT02505542|455966107|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
126731440|NCT02505542|455966108|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
126731441|NCT02505542|455966105|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
126731442|NCT02505542|455966106|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
126731443|NCT02505542|455966107|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
126731444|NCT02505542|455966108|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
126731445|NCT02505542|455966105|FG000|Part B: Double-Blind Period|Adverse Event|0|||
126731446|NCT02505542|455966106|FG001|Part B: Double-Blind Period|Adverse Event|0|||
126731447|NCT02505542|455966107|FG002|Part B: Double-Blind Period|Adverse Event|1|||
126731448|NCT02505542|455966108|FG003|Part B: Double-Blind Period|Adverse Event|3|||
126731449|NCT02505542|455966105|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
126731450|NCT02505542|455966106|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
126731451|NCT02505542|455966107|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
126731452|NCT02505542|455966108|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
126731453|NCT02505542|455966105|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
126731454|NCT02505542|455966106|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
126731455|NCT02505542|455966107|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
126731456|NCT02505542|455966108|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
126731457|NCT02505542|455966105|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
126731458|NCT02505542|455966106|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
126731459|NCT02505542|455966107|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
126731460|NCT02505542|455966108|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
126731461|NCT02505542|455966105|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
126731462|NCT02505542|455966106|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
126731463|NCT02505542|455966107|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
126731464|NCT02505542|455966108|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
126731465|NCT02505542|455966105|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
126731466|NCT02505542|455966106|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
126777555|NCT01401478|456141359|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
126777556|NCT01401478|456141359|FG000|Overall Study|Low intact parathyroid hormone|1|||
126777557|NCT01401478|456141359|FG000|Overall Study|Serious adverse event|1|||
126585692|NCT03376321|455443731|FG000|Overall Study|Death|4|||
126585693|NCT03376321|455443732|FG001|Overall Study|Death|0|||
126585694|NCT03376321|455443731|FG000|Overall Study|Randomized, not treated|5|||
126585695|NCT03376321|455443732|FG001|Overall Study|Randomized, not treated|3|||
126585696|NCT02992925|455443737|FG000|Cohort 2|Physician Decision|0|||
126585697|NCT02992925|455443738|FG001|Cohort 2|Physician Decision|0|||
126585698|NCT02992925|455443739|FG002|Cohort 2|Physician Decision|1|||
126585699|NCT02992925|455443740|FG003|Cohort 2|Physician Decision|0|||
126585700|NCT02992925|455443737|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
126585701|NCT02992925|455443738|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
126585702|NCT02992925|455443739|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
126585703|NCT02992925|455443740|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
126585704|NCT01804816|455443741|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
126585705|NCT01804816|455443741|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
126585706|NCT04263311|455443747|FG000|Overall Study|Lost to Follow-up|1|||
126585707|NCT04263311|455443748|FG001|Overall Study|Lost to Follow-up|2|||
126585708|NCT04263311|455443749|FG002|Overall Study|Lost to Follow-up|0|||
126585709|NCT04263311|455443747|FG000|Overall Study|Health Issues|1|||
126585710|NCT04263311|455443748|FG001|Overall Study|Health Issues|0|||
126585711|NCT04263311|455443749|FG002|Overall Study|Health Issues|0|||
126585712|NCT04263311|455443747|FG000|Overall Study|Left the country|1|||
126585713|NCT04263311|455443748|FG001|Overall Study|Left the country|0|||
126585714|NCT04263311|455443749|FG002|Overall Study|Left the country|0|||
126585715|NCT04263311|455443747|FG000|Overall Study|Unable to maintain time commitment|1|||
126585716|NCT04263311|455443748|FG001|Overall Study|Unable to maintain time commitment|0|||
126585717|NCT04263311|455443749|FG002|Overall Study|Unable to maintain time commitment|0|||
126585718|NCT04263311|455443747|FG000|Overall Study|No longer interested|1|||
126585719|NCT04263311|455443748|FG001|Overall Study|No longer interested|0|||
126585720|NCT04263311|455443749|FG002|Overall Study|No longer interested|0|||
126585721|NCT04263311|455443747|FG000|Overall Study|Ineligible post consent|0|||
126585722|NCT04263311|455443748|FG001|Overall Study|Ineligible post consent|0|||
126585723|NCT04263311|455443749|FG002|Overall Study|Ineligible post consent|5|||
126585724|NCT02592330|455443750|FG000|Overall Study|Withdrawal by Subject|1|||
126585725|NCT02592330|455443751|FG001|Overall Study|Withdrawal by Subject|0|||
126585726|NCT02592330|455443750|FG000|Overall Study|Failed Biopsy|1|||
126585727|NCT02592330|455443751|FG001|Overall Study|Failed Biopsy|0|||
126585728|NCT03090152|455443752|FG000|Overall Study|Withdrawal by Subject|0|||
126585729|NCT03090152|455443753|FG001|Overall Study|Withdrawal by Subject|2|||
126585730|NCT03090152|455443754|FG002|Overall Study|Withdrawal by Subject|1|||
126585731|NCT03090152|455443752|FG000|Overall Study|Surgery Canceled|1|||
126585732|NCT03090152|455443753|FG001|Overall Study|Surgery Canceled|0|||
126585733|NCT03090152|455443754|FG002|Overall Study|Surgery Canceled|0|||
126585734|NCT03090152|455443752|FG000|Overall Study|Epidural catheter could not be placed|0|||
126585735|NCT03090152|455443753|FG001|Overall Study|Epidural catheter could not be placed|2|||
126585736|NCT03090152|455443754|FG002|Overall Study|Epidural catheter could not be placed|0|||
126585737|NCT04673929|455443755|FG000|Overall Study|Death|73|||
126585738|NCT04673929|455443755|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
126585739|NCT05034952|455443756|FG000|Overall Study|Adverse Event|1|||
126585740|NCT05034952|455443757|FG001|Overall Study|Adverse Event|0|||
126585741|NCT05034952|455443758|FG002|Overall Study|Adverse Event|0|||
126585742|NCT05034952|455443759|FG003|Overall Study|Adverse Event|0|||
126585743|NCT05034952|455443756|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
126585744|NCT05034952|455443757|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
126585745|NCT05034952|455443758|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
126585746|NCT05034952|455443759|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
126585747|NCT05034952|455443756|FG000|Overall Study|Lost to Follow-up|1|||
126585748|NCT05034952|455443757|FG001|Overall Study|Lost to Follow-up|4|||
126585749|NCT05034952|455443758|FG002|Overall Study|Lost to Follow-up|3|||
126585750|NCT05034952|455443759|FG003|Overall Study|Lost to Follow-up|3|||
126585751|NCT05034952|455443756|FG000|Overall Study|Other|0|||
126585752|NCT05034952|455443757|FG001|Overall Study|Other|0|||
126585753|NCT05034952|455443758|FG002|Overall Study|Other|0|||
126585754|NCT05034952|455443759|FG003|Overall Study|Other|1|||
126585755|NCT04783935|455443760|FG000|Overall Study|Withdrawal by Subject|6|||
126585756|NCT04783935|455443760|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
126585757|NCT04783935|455443760|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
126585758|NCT04783935|455443760|FG000|Overall Study|Lost to Follow-up|3|||
126585759|NCT04783935|455443760|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
126777558|NCT01684722|456141360|FG000|Overall Study|Lost to Follow-up|78|||
126585760|NCT06074523|455443764|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
126585761|NCT06074523|455443764|FG000|Overall Study|Withdrawal by Subject|1|||
126585762|NCT05337748|455443765|FG000|Overall Study|Withdrawal by Subject|1|||
126585763|NCT05337748|455443766|FG001|Overall Study|Withdrawal by Subject|0|||
126777559|NCT01684722|456141361|FG001|Overall Study|Lost to Follow-up|56|||
126777560|NCT01684722|456141362|FG002|Overall Study|Lost to Follow-up|75|||
126777561|NCT01684722|456141363|FG003|Overall Study|Lost to Follow-up|89|||
126777562|NCT01684722|456141360|FG000|Overall Study|Death|19|||
126777563|NCT01684722|456141361|FG001|Overall Study|Death|21|||
126777564|NCT01684722|456141362|FG002|Overall Study|Death|19|||
126777565|NCT01684722|456141363|FG003|Overall Study|Death|21|||
126777566|NCT03063632|456141366|FG000|Overall Study|Death|4|||
126777567|NCT03063632|456141367|FG001|Overall Study|Death|6|||
126777568|NCT03063632|456141366|FG000|Overall Study|Lost to Follow-up|0|||
126777569|NCT03063632|456141367|FG001|Overall Study|Lost to Follow-up|1|||
126777570|NCT03063632|456141366|FG000|Overall Study|Withdrawal by Subject|0|||
126585764|NCT05337748|455443765|FG000|Overall Study|Death|1|||
126585765|NCT05337748|455443766|FG001|Overall Study|Death|0|||
126585766|NCT04806594|455443770|FG000|Overall Study|Withdrawal by Subject|2|||
126585767|NCT04806594|455443770|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
126585768|NCT02543281|455443771|FG000|Overall Study|Lost to Follow-up|0|||
126585769|NCT02543281|455443772|FG001|Overall Study|Lost to Follow-up|0|||
126585770|NCT02543281|455443773|FG002|Overall Study|Lost to Follow-up|1|||
126585771|NCT03143153|455443774|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
126585772|NCT03143153|455443775|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
126585773|NCT03143153|455443776|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
126585774|NCT03143153|455443774|FG000|Pre-Treatment|Participant withdrew consent|0|||
126585775|NCT03143153|455443775|FG001|Pre-Treatment|Participant withdrew consent|1|||
126585776|NCT03143153|455443776|FG002|Pre-Treatment|Participant withdrew consent|12|||
126585777|NCT03143153|455443774|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
126585778|NCT03143153|455443775|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
126585779|NCT03143153|455443776|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
126585780|NCT03143153|455443774|FG000|Pre-Treatment|Other Reasons|1|||
126585781|NCT03143153|455443775|FG001|Pre-Treatment|Other Reasons|2|||
126585782|NCT03143153|455443776|FG002|Pre-Treatment|Other Reasons|1|||
126585783|NCT03143153|455443774|FG000|Pre-Treatment|Disease Progression|1|||
126585784|NCT03143153|455443775|FG001|Pre-Treatment|Disease Progression|1|||
126585785|NCT03143153|455443776|FG002|Pre-Treatment|Disease Progression|2|||
126585786|NCT03143153|455443774|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
126585787|NCT03143153|455443775|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
126585788|NCT03143153|455443776|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
126585789|NCT03143153|455443774|FG000|Treatment|Disease progression|174|||
126585790|NCT03143153|455443775|FG001|Treatment|Disease progression|184|||
126585791|NCT03143153|455443776|FG002|Treatment|Disease progression|193|||
126585792|NCT03143153|455443774|FG000|Treatment|Study drug toxicity|59|||
126585793|NCT03143153|455443775|FG001|Treatment|Study drug toxicity|33|||
126585794|NCT03143153|455443776|FG002|Treatment|Study drug toxicity|40|||
126585795|NCT03143153|455443774|FG000|Treatment|Death|5|||
126585796|NCT03143153|455443775|FG001|Treatment|Death|3|||
126585797|NCT03143153|455443776|FG002|Treatment|Death|4|||
126585798|NCT03143153|455443774|FG000|Treatment|Adverse event unrelated to study drug|19|||
126585799|NCT03143153|455443775|FG001|Treatment|Adverse event unrelated to study drug|28|||
126585800|NCT03143153|455443776|FG002|Treatment|Adverse event unrelated to study drug|12|||
126585801|NCT03143153|455443774|FG000|Treatment|Participant request to discontinue study treatment|13|||
126585802|NCT03143153|455443775|FG001|Treatment|Participant request to discontinue study treatment|15|||
126585803|NCT03143153|455443776|FG002|Treatment|Participant request to discontinue study treatment|20|||
126585804|NCT03143153|455443774|FG000|Treatment|Participant withdrew consent|3|||
126585805|NCT03143153|455443775|FG001|Treatment|Participant withdrew consent|4|||
126585806|NCT03143153|455443776|FG002|Treatment|Participant withdrew consent|12|||
126585807|NCT03143153|455443774|FG000|Treatment|Pregnancy|1|||
126585808|NCT03143153|455443775|FG001|Treatment|Pregnancy|0|||
126585809|NCT03143153|455443776|FG002|Treatment|Pregnancy|0|||
126585810|NCT03143153|455443774|FG000|Treatment|Maximum clinical benefit|1|||
126585811|NCT03143153|455443775|FG001|Treatment|Maximum clinical benefit|3|||
126585812|NCT03143153|455443776|FG002|Treatment|Maximum clinical benefit|4|||
126585813|NCT03143153|455443774|FG000|Treatment|Completed treatment as per Protocol|13|||
126585814|NCT03143153|455443775|FG001|Treatment|Completed treatment as per Protocol|8|||
126585815|NCT03143153|455443776|FG002|Treatment|Completed treatment as per Protocol|0|||
126585816|NCT03143153|455443774|FG000|Treatment|Other reasons|12|||
126585817|NCT03143153|455443775|FG001|Treatment|Other reasons|7|||
126585818|NCT03143153|455443776|FG002|Treatment|Other reasons|15|||
126585819|NCT03143153|455443774|FG000|Treatment|Not reported|1|||
126585820|NCT03143153|455443775|FG001|Treatment|Not reported|0|||
126585821|NCT03143153|455443776|FG002|Treatment|Not reported|0|||
126585822|NCT02312557|455443777|FG000|Overall Study|Survival follow-up|4|||
126585823|NCT04237298|455443778|FG000|Overall Study|Lost to Follow-up|4|||
126585824|NCT04237298|455443779|FG001|Overall Study|Lost to Follow-up|5|||
126777571|NCT03063632|456141367|FG001|Overall Study|Withdrawal by Subject|2|||
126777572|NCT03063632|456141366|FG000|Overall Study|Physician Decision|2|||
126777573|NCT03063632|456141367|FG001|Overall Study|Physician Decision|0|||
126777574|NCT03063632|456141366|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
126777575|NCT03063632|456141367|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
126777576|NCT02570165|456141370|FG000|Overall Study|Adverse Event|1|||
126777577|NCT02570165|456141371|FG001|Overall Study|Adverse Event|0|||
126777578|NCT02570165|456141372|FG002|Overall Study|Adverse Event|2|||
126777579|NCT02570165|456141373|FG003|Overall Study|Adverse Event|0|||
126777580|NCT02570165|456141374|FG004|Overall Study|Adverse Event|0|||
126777581|NCT02570165|456141375|FG005|Overall Study|Adverse Event|0|||
126777582|NCT02570165|456141376|FG006|Overall Study|Adverse Event|0|||
126777583|NCT02570165|456141370|FG000|Overall Study|Lack of Efficacy|0|||
126777584|NCT02570165|456141371|FG001|Overall Study|Lack of Efficacy|1|||
126777585|NCT02570165|456141372|FG002|Overall Study|Lack of Efficacy|0|||
126777586|NCT02570165|456141373|FG003|Overall Study|Lack of Efficacy|0|||
126777587|NCT02570165|456141374|FG004|Overall Study|Lack of Efficacy|4|||
126777588|NCT02570165|456141375|FG005|Overall Study|Lack of Efficacy|0|||
126777589|NCT02570165|456141376|FG006|Overall Study|Lack of Efficacy|0|||
126777590|NCT02570165|456141370|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
126777591|NCT02570165|456141371|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
126777592|NCT02570165|456141372|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
126585825|NCT02736409|455443780|FG000|Overall Study|Withdrawal by Subject|4|||
126585826|NCT02736409|455443781|FG001|Overall Study|Withdrawal by Subject|2|||
126585827|NCT02736409|455443782|FG002|Overall Study|Withdrawal by Subject|17|||
126585828|NCT02736409|455443783|FG003|Overall Study|Withdrawal by Subject|3|||
126585829|NCT02736409|455443780|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126585830|NCT02736409|455443781|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126585831|NCT02736409|455443782|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126585832|NCT02736409|455443783|FG003|Overall Study|Non-Compliance with Study Drug|1|||
126585833|NCT02736409|455443780|FG000|Overall Study|Adverse Event|0|||
126585834|NCT02736409|455443781|FG001|Overall Study|Adverse Event|1|||
126585835|NCT02736409|455443782|FG002|Overall Study|Adverse Event|5|||
126585836|NCT02736409|455443783|FG003|Overall Study|Adverse Event|4|||
126585837|NCT02736409|455443780|FG000|Overall Study|Other|0|||
126585838|NCT02736409|455443781|FG001|Overall Study|Other|0|||
126585839|NCT02736409|455443782|FG002|Overall Study|Other|1|||
126585840|NCT02736409|455443783|FG003|Overall Study|Other|1|||
126585841|NCT02736409|455443780|FG000|Overall Study|Pregnancy|0|||
126585842|NCT02736409|455443781|FG001|Overall Study|Pregnancy|0|||
126585843|NCT02736409|455443782|FG002|Overall Study|Pregnancy|1|||
126585844|NCT02736409|455443783|FG003|Overall Study|Pregnancy|0|||
126585845|NCT02736409|455443780|FG000|Overall Study|Lost to Follow-up|0|||
126585846|NCT02736409|455443781|FG001|Overall Study|Lost to Follow-up|0|||
126585847|NCT02736409|455443782|FG002|Overall Study|Lost to Follow-up|2|||
126585848|NCT02736409|455443783|FG003|Overall Study|Lost to Follow-up|1|||
126585849|NCT02736409|455443780|FG000|Overall Study|Physician Decision|0|||
126585850|NCT02736409|455443781|FG001|Overall Study|Physician Decision|0|||
126585851|NCT02736409|455443782|FG002|Overall Study|Physician Decision|0|||
126585852|NCT02736409|455443783|FG003|Overall Study|Physician Decision|2|||
126585853|NCT00170573|455443788|FG000|Overall Study|Violation of inclusion criteria|13|||
126585854|NCT05536440|455443803|FG000|Overall Study|Adverse Event|0|||
126585855|NCT05536440|455443804|FG001|Overall Study|Adverse Event|0|||
126585856|NCT05536440|455443805|FG002|Overall Study|Adverse Event|0|||
126585857|NCT05536440|455443806|FG003|Overall Study|Adverse Event|0|||
126585858|NCT05536440|455443807|FG004|Overall Study|Adverse Event|0|||
126585859|NCT05536440|455443808|FG005|Overall Study|Adverse Event|0|||
126585860|NCT05536440|455443809|FG006|Overall Study|Adverse Event|0|||
126585861|NCT05536440|455443810|FG007|Overall Study|Adverse Event|0|||
126585862|NCT05536440|455443811|FG008|Overall Study|Adverse Event|1|||
126585863|NCT06283173|455443812|FG000|Overall Study|Did not show for first visit|10|||
126585864|NCT06283173|455443812|FG000|Overall Study|Lost to Follow-up|12|||
126585865|NCT06283173|455443812|FG000|Overall Study|Physician Decision|7|||
126585866|NCT04784559|455443815|FG000|Overall Study|Withdrawal by Subject|3|||
126585867|NCT04784559|455443816|FG001|Overall Study|Withdrawal by Subject|2|||
126585868|NCT04784559|455443817|FG002|Overall Study|Withdrawal by Subject|1|||
126585869|NCT04784559|455443815|FG000|Overall Study|Death|2|||
126585870|NCT04784559|455443816|FG001|Overall Study|Death|1|||
126585871|NCT04784559|455443817|FG002|Overall Study|Death|2|||
126585872|NCT04784559|455443815|FG000|Overall Study|Lost to Follow-up|0|||
126585873|NCT04784559|455443816|FG001|Overall Study|Lost to Follow-up|0|||
126585874|NCT04784559|455443817|FG002|Overall Study|Lost to Follow-up|2|||
126585875|NCT04784559|455443815|FG000|Overall Study|Participant worsened, PI decision|1|||
126585876|NCT04784559|455443816|FG001|Overall Study|Participant worsened, PI decision|0|||
126585877|NCT04784559|455443817|FG002|Overall Study|Participant worsened, PI decision|0|||
126585878|NCT04784559|455443815|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
126585879|NCT04784559|455443816|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
126585880|NCT04784559|455443817|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
126585881|NCT04784559|455443815|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
126777593|NCT02570165|456141373|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
126777594|NCT02570165|456141374|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
126585882|NCT04784559|455443816|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
126585883|NCT04784559|455443817|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
126585884|NCT04784559|455443815|FG000|Overall Study|Did not meet all inclusion criteria|0|||
126585885|NCT04784559|455443816|FG001|Overall Study|Did not meet all inclusion criteria|1|||
126585886|NCT04784559|455443817|FG002|Overall Study|Did not meet all inclusion criteria|0|||
126585887|NCT04784559|455443815|FG000|Overall Study|The participant was transferred to IRCU|0|||
126585888|NCT04784559|455443816|FG001|Overall Study|The participant was transferred to IRCU|1|||
126585889|NCT04784559|455443817|FG002|Overall Study|The participant was transferred to IRCU|0|||
126585890|NCT04784559|455443815|FG000|Overall Study|SAE|0|||
126585891|NCT04784559|455443816|FG001|Overall Study|SAE|1|||
126585892|NCT04784559|455443817|FG002|Overall Study|SAE|0|||
126585893|NCT04784559|455443815|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
126585894|NCT04784559|455443816|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
126585895|NCT04784559|455443817|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
126585896|NCT01580488|455443819|FG000|Overall Study|Withdrawal by Subject|1|||
126585897|NCT03338790|455443825|FG000|Overall Study|Disease Progression|65|||
126585898|NCT03338790|455443826|FG001|Overall Study|Disease Progression|43|||
126585899|NCT03338790|455443827|FG002|Overall Study|Disease Progression|50|||
126585900|NCT03338790|455443828|FG003|Overall Study|Disease Progression|37|||
126585901|NCT03338790|455443825|FG000|Overall Study|Study Drug Toxicity|9|||
126585902|NCT03338790|455443826|FG001|Overall Study|Study Drug Toxicity|8|||
126585903|NCT03338790|455443827|FG002|Overall Study|Study Drug Toxicity|15|||
126585904|NCT03338790|455443828|FG003|Overall Study|Study Drug Toxicity|0|||
126585905|NCT03338790|455443825|FG000|Overall Study|Death|1|||
126585906|NCT03338790|455443826|FG001|Overall Study|Death|1|||
126585907|NCT03338790|455443827|FG002|Overall Study|Death|1|||
126585908|NCT03338790|455443828|FG003|Overall Study|Death|0|||
126585909|NCT03338790|455443825|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
126585910|NCT03338790|455443826|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
126585911|NCT03338790|455443827|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
126585912|NCT03338790|455443828|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
126585913|NCT03338790|455443825|FG000|Overall Study|Participant request to discontinue study treatment|3|||
126585914|NCT03338790|455443826|FG001|Overall Study|Participant request to discontinue study treatment|3|||
126585915|NCT03338790|455443827|FG002|Overall Study|Participant request to discontinue study treatment|2|||
126585916|NCT03338790|455443828|FG003|Overall Study|Participant request to discontinue study treatment|1|||
126585917|NCT03338790|455443825|FG000|Overall Study|Poor/non-compliance|0|||
126585918|NCT03338790|455443826|FG001|Overall Study|Poor/non-compliance|1|||
126585919|NCT03338790|455443827|FG002|Overall Study|Poor/non-compliance|0|||
126585920|NCT03338790|455443828|FG003|Overall Study|Poor/non-compliance|0|||
126585921|NCT03338790|455443825|FG000|Overall Study|Participant withdrew consent|1|||
126585922|NCT03338790|455443826|FG001|Overall Study|Participant withdrew consent|0|||
126585923|NCT03338790|455443827|FG002|Overall Study|Participant withdrew consent|1|||
126585924|NCT03338790|455443828|FG003|Overall Study|Participant withdrew consent|1|||
126585925|NCT03338790|455443825|FG000|Overall Study|Other reasons|0|||
126585926|NCT03338790|455443826|FG001|Overall Study|Other reasons|5|||
126585927|NCT03338790|455443827|FG002|Overall Study|Other reasons|0|||
126585928|NCT03338790|455443828|FG003|Overall Study|Other reasons|2|||
126585929|NCT03338790|455443825|FG000|Overall Study|Not reported|0|||
126585930|NCT03338790|455443826|FG001|Overall Study|Not reported|0|||
126585931|NCT03338790|455443827|FG002|Overall Study|Not reported|1|||
126585932|NCT03338790|455443828|FG003|Overall Study|Not reported|0|||
126585933|NCT03338790|455443825|FG000|Overall Study|Completed treatment period|1|||
126585934|NCT03338790|455443826|FG001|Overall Study|Completed treatment period|2|||
126585935|NCT03338790|455443827|FG002|Overall Study|Completed treatment period|0|||
126585936|NCT03338790|455443828|FG003|Overall Study|Completed treatment period|0|||
126585937|NCT04588298|455443830|FG000|Overall Study|Adverse Event|0|||
126585938|NCT04588298|455443831|FG001|Overall Study|Adverse Event|0|||
126585939|NCT04588298|455443832|FG002|Overall Study|Adverse Event|1|||
126585940|NCT04588298|455443833|FG003|Overall Study|Adverse Event|0|||
126585941|NCT04588298|455443834|FG004|Overall Study|Adverse Event|2|||
126585942|NCT04588298|455443830|FG000|Overall Study|Withdrawal by Subject|1|||
126585943|NCT04588298|455443831|FG001|Overall Study|Withdrawal by Subject|0|||
126585944|NCT04588298|455443832|FG002|Overall Study|Withdrawal by Subject|0|||
126585945|NCT04588298|455443833|FG003|Overall Study|Withdrawal by Subject|1|||
126585946|NCT04588298|455443834|FG004|Overall Study|Withdrawal by Subject|0|||
126585947|NCT03846505|455443835|FG000|Treatment Phase|Withdrawal by Subject|9|||
126585948|NCT03846505|455443836|FG001|Treatment Phase|Withdrawal by Subject|11|||
126585949|NCT03846505|455443835|FG000|Treatment Phase|Lost to Follow-up|6|||
126585950|NCT03846505|455443836|FG001|Treatment Phase|Lost to Follow-up|2|||
126585951|NCT03846505|455443835|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
126585952|NCT03846505|455443836|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
126585953|NCT03846505|455443835|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
126585954|NCT03846505|455443836|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
126585955|NCT04005716|455443840|FG000|Overall Study|Death|175|||
126777595|NCT02570165|456141375|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
126777596|NCT02570165|456141376|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
126777597|NCT02570165|456141370|FG000|Overall Study|Lost to Follow-up|0|||
126777598|NCT02570165|456141371|FG001|Overall Study|Lost to Follow-up|0|||
126777599|NCT02570165|456141372|FG002|Overall Study|Lost to Follow-up|1|||
126777600|NCT02570165|456141373|FG003|Overall Study|Lost to Follow-up|1|||
126777601|NCT02570165|456141374|FG004|Overall Study|Lost to Follow-up|0|||
126777602|NCT02570165|456141375|FG005|Overall Study|Lost to Follow-up|0|||
126777603|NCT02570165|456141376|FG006|Overall Study|Lost to Follow-up|0|||
126777604|NCT02570165|456141370|FG000|Overall Study|Physician Decision|0|||
126777605|NCT02570165|456141371|FG001|Overall Study|Physician Decision|1|||
126777606|NCT02570165|456141372|FG002|Overall Study|Physician Decision|0|||
126777607|NCT02570165|456141373|FG003|Overall Study|Physician Decision|0|||
126777608|NCT02570165|456141374|FG004|Overall Study|Physician Decision|0|||
126777609|NCT02570165|456141375|FG005|Overall Study|Physician Decision|0|||
126777610|NCT02570165|456141376|FG006|Overall Study|Physician Decision|0|||
126777611|NCT02570165|456141370|FG000|Overall Study|Withdrawal by Subject|0|||
126777612|NCT02570165|456141371|FG001|Overall Study|Withdrawal by Subject|0|||
126777613|NCT02570165|456141372|FG002|Overall Study|Withdrawal by Subject|0|||
126777614|NCT02570165|456141373|FG003|Overall Study|Withdrawal by Subject|2|||
126777615|NCT02570165|456141374|FG004|Overall Study|Withdrawal by Subject|1|||
126777616|NCT02570165|456141375|FG005|Overall Study|Withdrawal by Subject|0|||
126777617|NCT02570165|456141376|FG006|Overall Study|Withdrawal by Subject|0|||
126777618|NCT02570165|456141370|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
126777619|NCT02570165|456141371|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
126777620|NCT02570165|456141372|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
126777621|NCT02570165|456141373|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
126777622|NCT02570165|456141374|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
126777623|NCT02570165|456141375|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
126777624|NCT02570165|456141376|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
126777625|NCT02570165|456141370|FG000|Overall Study|Withdrawal Request by GSK|0|||
126777626|NCT02570165|456141371|FG001|Overall Study|Withdrawal Request by GSK|0|||
126777627|NCT02570165|456141372|FG002|Overall Study|Withdrawal Request by GSK|2|||
126777628|NCT02570165|456141373|FG003|Overall Study|Withdrawal Request by GSK|0|||
126777629|NCT02570165|456141374|FG004|Overall Study|Withdrawal Request by GSK|0|||
126777630|NCT02570165|456141375|FG005|Overall Study|Withdrawal Request by GSK|0|||
126777631|NCT02570165|456141376|FG006|Overall Study|Withdrawal Request by GSK|0|||
126777632|NCT02862535|456141385|FG000|Overall Study|Death|7|||
126777633|NCT02862535|456141386|FG001|Overall Study|Death|3|||
126777634|NCT02862535|456141387|FG002|Overall Study|Death|2|||
126777635|NCT02862535|456141388|FG003|Overall Study|Death|5|||
126777636|NCT02862535|456141385|FG000|Overall Study|Study Terminated by Sponsor|1|||
126777637|NCT02862535|456141386|FG001|Overall Study|Study Terminated by Sponsor|3|||
126777638|NCT02862535|456141387|FG002|Overall Study|Study Terminated by Sponsor|8|||
126777639|NCT02862535|456141388|FG003|Overall Study|Study Terminated by Sponsor|5|||
126777640|NCT02862535|456141385|FG000|Overall Study|Enrolled, not Treated|1|||
126777641|NCT02862535|456141386|FG001|Overall Study|Enrolled, not Treated|0|||
126777642|NCT02862535|456141387|FG002|Overall Study|Enrolled, not Treated|0|||
126777643|NCT02862535|456141388|FG003|Overall Study|Enrolled, not Treated|1|||
126777644|NCT04304950|456141391|FG000|Overall Study|Lost to Follow-up|1|||
126777645|NCT04304950|456141392|FG001|Overall Study|Lost to Follow-up|1|||
126777646|NCT05478603|456141393|FG000|Overall Study|Withdrawal by Subject|0|||
126777647|NCT05478603|456141394|FG001|Overall Study|Withdrawal by Subject|1|||
126777648|NCT05478603|456141395|FG002|Overall Study|Withdrawal by Subject|0|||
126777649|NCT05478603|456141396|FG003|Overall Study|Withdrawal by Subject|0|||
126777650|NCT02418910|456141397|FG000|Overall Study|Lost to Follow-up|3|||
126777651|NCT02418910|456141397|FG000|Overall Study|Withdrawal by Subject|4|||
126777652|NCT03634488|456141399|FG000|Overall Study|Death|1|||
126777653|NCT03634488|456141400|FG001|Overall Study|Death|0|||
126777654|NCT03634488|456141401|FG002|Overall Study|Death|0|||
126777655|NCT03634488|456141399|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
126777656|NCT03634488|456141400|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
126777657|NCT03634488|456141401|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
126777658|NCT03182686|456141402|FG000|Overall Study|Lost to Follow-up|2|||
126585956|NCT04005716|455443841|FG001|Overall Study|Death|196|||
126777659|NCT03182686|456141403|FG001|Overall Study|Lost to Follow-up|0|||
126777660|NCT03182686|456141402|FG000|Overall Study|Adverse Event|2|||
126777661|NCT03182686|456141403|FG001|Overall Study|Adverse Event|0|||
126777662|NCT03182686|456141402|FG000|Overall Study|Withdrawal by Subject|3|||
126777663|NCT03182686|456141403|FG001|Overall Study|Withdrawal by Subject|0|||
126777664|NCT01154127|456141404|FG000|Period 1 (21 Days)|Adverse Event|3|||
126777665|NCT01154127|456141405|FG001|Period 1 (21 Days)|Adverse Event|4|||
126777666|NCT01154127|456141404|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
126777667|NCT01154127|456141405|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
126585957|NCT04005716|455443840|FG000|Overall Study|Withdrawal by Subject|1|||
126585958|NCT04005716|455443841|FG001|Overall Study|Withdrawal by Subject|6|||
126585959|NCT04005716|455443840|FG000|Overall Study|Lost to Follow-up|2|||
126585960|NCT04005716|455443841|FG001|Overall Study|Lost to Follow-up|2|||
126585961|NCT04021602|455443842|FG000|Overall Study|Lost to Follow-up|3|||
126585962|NCT04021602|455443843|FG001|Overall Study|Lost to Follow-up|3|||
126585963|NCT04021602|455443844|FG002|Overall Study|Lost to Follow-up|1|||
126585964|NCT04021602|455443842|FG000|Overall Study|Adverse Event|1|||
126585965|NCT04021602|455443843|FG001|Overall Study|Adverse Event|0|||
126585966|NCT04021602|455443844|FG002|Overall Study|Adverse Event|1|||
126585967|NCT03445988|455443850|FG000|Overall Study|Lost to Follow-up|14|||
126585968|NCT03445988|455443851|FG001|Overall Study|Lost to Follow-up|26|||
126585969|NCT03445988|455443852|FG002|Overall Study|Lost to Follow-up|27|||
126585970|NCT03445988|455443853|FG003|Overall Study|Lost to Follow-up|66|||
126585971|NCT03445988|455443850|FG000|Overall Study|Withdrawal by Subject|7|||
126585972|NCT03445988|455443851|FG001|Overall Study|Withdrawal by Subject|4|||
126585973|NCT03445988|455443852|FG002|Overall Study|Withdrawal by Subject|3|||
126585974|NCT03445988|455443853|FG003|Overall Study|Withdrawal by Subject|5|||
126585975|NCT03445988|455443850|FG000|Overall Study|Death (unrelated to study)|5|||
126585976|NCT03445988|455443851|FG001|Overall Study|Death (unrelated to study)|1|||
126585977|NCT03445988|455443852|FG002|Overall Study|Death (unrelated to study)|2|||
126585978|NCT03445988|455443853|FG003|Overall Study|Death (unrelated to study)|4|||
126585979|NCT03988608|455443854|FG000|Overall Study|Adverse Event|1|||
126585980|NCT03988608|455443854|FG000|Overall Study|Lost to Follow-up|1|||
126585981|NCT03988608|455443854|FG000|Overall Study|Withdrawal by Subject|3|||
126585982|NCT03988608|455443854|FG000|Overall Study|Death|1|||
126585983|NCT02689284|455443861|FG000|Overall Study|Adverse Event|1|||
126585984|NCT02689284|455443862|FG001|Overall Study|Adverse Event|8|||
126585985|NCT02689284|455443861|FG000|Overall Study|Death|0|||
126585986|NCT02689284|455443862|FG001|Overall Study|Death|1|||
126585987|NCT02689284|455443861|FG000|Overall Study|Physician Decision|1|||
126585988|NCT02689284|455443862|FG001|Overall Study|Physician Decision|2|||
126585989|NCT02689284|455443861|FG000|Overall Study|Withdrawal by Subject|0|||
126585990|NCT02689284|455443862|FG001|Overall Study|Withdrawal by Subject|1|||
126585991|NCT02689284|455443861|FG000|Overall Study|progression of cancer|1|||
126585992|NCT02689284|455443862|FG001|Overall Study|progression of cancer|72|||
126585993|NCT02689284|455443861|FG000|Overall Study|decreased heart function|0|||
126585994|NCT02689284|455443862|FG001|Overall Study|decreased heart function|1|||
126585995|NCT02689284|455443861|FG000|Overall Study|concern for anemia|0|||
126585996|NCT02689284|455443862|FG001|Overall Study|concern for anemia|1|||
126585997|NCT02689284|455443861|FG000|Overall Study|no measurable cancer for evaluation|0|||
126585998|NCT02689284|455443862|FG001|Overall Study|no measurable cancer for evaluation|1|||
126585999|NCT05592418|455443863|FG000|Overall Study|Adverse Event|1|||
126586000|NCT05592418|455443864|FG001|Overall Study|Adverse Event|0|||
126586001|NCT05592418|455443863|FG000|Overall Study|Lost to Follow-up|1|||
126586002|NCT05592418|455443864|FG001|Overall Study|Lost to Follow-up|3|||
126586003|NCT05592418|455443863|FG000|Overall Study|Withdrawal by Subject|2|||
126586004|NCT05592418|455443864|FG001|Overall Study|Withdrawal by Subject|7|||
126586005|NCT03110315|455443867|FG000|Overall Study|Withdrawal by Subject|1|||
126586006|NCT03110315|455443868|FG001|Overall Study|Withdrawal by Subject|0|||
126586007|NCT04727554|455443874|FG000|Overall Study|Lost to Follow-up|0|||
126586008|NCT04727554|455443875|FG001|Overall Study|Lost to Follow-up|1|||
126586009|NCT04727554|455443874|FG000|Overall Study|Death|2|||
126586010|NCT04727554|455443875|FG001|Overall Study|Death|6|||
126586011|NCT04727554|455443874|FG000|Overall Study|Withdrawal by Subject|1|||
126586012|NCT04727554|455443875|FG001|Overall Study|Withdrawal by Subject|0|||
126586013|NCT04150718|455445339|FG000|Overall Study|Withdrawal by Subject|2|||
126586014|NCT04150718|455445340|FG001|Overall Study|Withdrawal by Subject|7|||
126586015|NCT04150718|455445341|FG002|Overall Study|Withdrawal by Subject|1|||
126586016|NCT04150718|455445339|FG000|Overall Study|Lost to Follow-up|1|||
126586017|NCT04150718|455445340|FG001|Overall Study|Lost to Follow-up|2|||
126586018|NCT04150718|455445341|FG002|Overall Study|Lost to Follow-up|0|||
126586019|NCT04150718|455445339|FG000|Overall Study|Ineligible|1|||
126586020|NCT04150718|455445340|FG001|Overall Study|Ineligible|0|||
126586021|NCT04150718|455445341|FG002|Overall Study|Ineligible|10|||
126586022|NCT02729311|455445342|FG000|Overall Study|Withdrawal by Subject|8|||
126586023|NCT02729311|455445343|FG001|Overall Study|Withdrawal by Subject|2|||
126586024|NCT04956861|455445345|FG000|Overall Study|Withdrawal by Subject|4|||
126586025|NCT04956861|455445346|FG001|Overall Study|Withdrawal by Subject|4|||
126586026|NCT04956861|455445347|FG002|Overall Study|Withdrawal by Subject|2|||
126586027|NCT04956861|455445345|FG000|Overall Study|Physician Decision|4|||
126586028|NCT04956861|455445346|FG001|Overall Study|Physician Decision|5|||
126586029|NCT04956861|455445347|FG002|Overall Study|Physician Decision|1|||
126586030|NCT04812535|455445350|FG000|Overall Study|Withdrawal by Subject|0|||
126586031|NCT04812535|455445351|FG001|Overall Study|Withdrawal by Subject|0|||
126586032|NCT04812535|455445352|FG002|Overall Study|Withdrawal by Subject|0|||
126586033|NCT04812535|455445353|FG003|Overall Study|Withdrawal by Subject|1|||
126586034|NCT04812535|455445350|FG000|Overall Study|Death|7|||
126586035|NCT04812535|455445351|FG001|Overall Study|Death|2|||
126586036|NCT04812535|455445352|FG002|Overall Study|Death|4|||
126586037|NCT04812535|455445353|FG003|Overall Study|Death|1|||
126586038|NCT04812535|455445350|FG000|Overall Study|Due to premature study termination by sponsor|2|||
126586039|NCT04812535|455445351|FG001|Overall Study|Due to premature study termination by sponsor|0|||
126586040|NCT04812535|455445352|FG002|Overall Study|Due to premature study termination by sponsor|1|||
126586041|NCT04812535|455445353|FG003|Overall Study|Due to premature study termination by sponsor|3|||
126586042|NCT03436745|455445354|FG000|Overall Study|Ineligible|0|||
126586043|NCT03436745|455445355|FG001|Overall Study|Ineligible|0|||
126586044|NCT03436745|455445356|FG002|Overall Study|Ineligible|1|||
126586045|NCT03738228|455445359|FG000|Overall Study|Never received study treatment|2|||
126586046|NCT03738228|455445360|FG001|Overall Study|Never received study treatment|2|||
126586047|NCT03406871|455445364|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
126586048|NCT03406871|455445365|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
126586049|NCT03406871|455445366|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
126586050|NCT03406871|455445364|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
126586051|NCT03406871|455445365|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
126586052|NCT03406871|455445366|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
126586053|NCT03406871|455445364|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
126586054|NCT03406871|455445365|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
126586055|NCT03406871|455445366|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
126586056|NCT03406871|455445364|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
126586057|NCT03406871|455445365|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
126586058|NCT03406871|455445366|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
126586059|NCT03406871|455445364|FG000|Expansion Cohort(Final Analysis)|Death|0|||
126586060|NCT03406871|455445365|FG001|Expansion Cohort(Final Analysis)|Death|1|||
126586061|NCT03406871|455445366|FG002|Expansion Cohort(Final Analysis)|Death|0|||
126586062|NCT03406871|455445364|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
126586063|NCT03406871|455445365|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
126586064|NCT03406871|455445366|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
126586065|NCT03366649|455445367|FG000|Overall Study|Failed preoperative screening|4|||
126586066|NCT03366649|455445368|FG001|Overall Study|Failed preoperative screening|0|||
126586067|NCT03366649|455445369|FG002|Overall Study|Failed preoperative screening|0|||
126586068|NCT03366649|455445367|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
126586069|NCT03366649|455445368|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
126586070|NCT03366649|455445369|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
126586071|NCT03673111|455445370|FG000|Overall Study|Protocol Violation|0|||
126586072|NCT03673111|455445371|FG001|Overall Study|Protocol Violation|0|||
126586073|NCT03673111|455445372|FG002|Overall Study|Protocol Violation|0|||
126586074|NCT03673111|455445373|FG003|Overall Study|Protocol Violation|0|||
126586075|NCT03673111|455445374|FG004|Overall Study|Protocol Violation|0|||
126586076|NCT03673111|455445375|FG005|Overall Study|Protocol Violation|0|||
126586077|NCT03673111|455445376|FG006|Overall Study|Protocol Violation|0|||
126586078|NCT03673111|455445377|FG007|Overall Study|Protocol Violation|0|||
126586079|NCT03673111|455445378|FG008|Overall Study|Protocol Violation|0|||
126586080|NCT03673111|455445379|FG009|Overall Study|Protocol Violation|0|||
126586081|NCT03673111|455445380|FG010|Overall Study|Protocol Violation|1|||
126586082|NCT03673111|455445381|FG011|Overall Study|Protocol Violation|0|||
126586083|NCT03673111|455445382|FG012|Overall Study|Protocol Violation|0|||
126586084|NCT03673111|455445383|FG013|Overall Study|Protocol Violation|0|||
126586085|NCT03673111|455445370|FG000|Overall Study|Adverse Event|1|||
126586086|NCT03673111|455445371|FG001|Overall Study|Adverse Event|0|||
126586087|NCT03673111|455445372|FG002|Overall Study|Adverse Event|0|||
126586088|NCT03673111|455445373|FG003|Overall Study|Adverse Event|0|||
126586089|NCT03673111|455445374|FG004|Overall Study|Adverse Event|0|||
126586090|NCT03673111|455445375|FG005|Overall Study|Adverse Event|0|||
126586091|NCT03673111|455445376|FG006|Overall Study|Adverse Event|0|||
126586092|NCT03673111|455445377|FG007|Overall Study|Adverse Event|0|||
126586093|NCT03673111|455445378|FG008|Overall Study|Adverse Event|0|||
126586094|NCT03673111|455445379|FG009|Overall Study|Adverse Event|0|||
126586095|NCT03673111|455445380|FG010|Overall Study|Adverse Event|0|||
126586096|NCT03673111|455445381|FG011|Overall Study|Adverse Event|0|||
126586097|NCT03673111|455445382|FG012|Overall Study|Adverse Event|0|||
126586098|NCT03673111|455445383|FG013|Overall Study|Adverse Event|0|||
126586099|NCT03792555|455445386|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
126586100|NCT03792555|455445387|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
126586101|NCT03792555|455445388|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
126586102|NCT03792555|455445386|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
126586103|NCT03792555|455445387|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
126586104|NCT03792555|455445388|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
126586105|NCT03792555|455445386|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
126586106|NCT03792555|455445387|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
126777668|NCT01154127|456141404|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
126777669|NCT01154127|456141405|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
126777670|NCT01154127|456141404|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
126586107|NCT03792555|455445388|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
126586108|NCT01744782|455445392|FG000|Overall Study|Death|1|||
126586109|NCT02120456|455445394|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126586110|NCT02120456|455445395|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126586111|NCT02120456|455445396|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126586112|NCT02120456|455445397|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126586113|NCT02120456|455445398|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126586114|NCT02120456|455445399|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126586115|NCT02120456|455445400|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
126586116|NCT02120456|455445401|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126586117|NCT02120456|455445402|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
126586118|NCT02120456|455445394|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126586119|NCT02120456|455445395|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126586120|NCT02120456|455445396|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126586121|NCT02120456|455445397|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126586122|NCT02120456|455445398|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126586123|NCT02120456|455445399|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126586124|NCT02120456|455445400|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
126586125|NCT02120456|455445401|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126586126|NCT02120456|455445402|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
126586127|NCT02120456|455445394|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126586128|NCT02120456|455445395|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126586129|NCT02120456|455445396|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126586130|NCT02120456|455445397|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126586131|NCT02120456|455445398|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126586132|NCT02120456|455445399|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126586133|NCT02120456|455445400|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126586134|NCT02120456|455445401|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
126586135|NCT02120456|455445402|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
126586136|NCT03623321|455445403|FG000|Overall Study|Adverse Event|32|||
126586137|NCT03623321|455445403|FG000|Overall Study|Death|9|||
126586138|NCT03623321|455445403|FG000|Overall Study|Lack of Efficacy|9|||
126586139|NCT03623321|455445403|FG000|Overall Study|Lost to Follow-up|6|||
126586140|NCT03623321|455445403|FG000|Overall Study|Noncompliance with study drug|6|||
126586141|NCT03623321|455445403|FG000|Overall Study|Use of prohibited medication|3|||
126586142|NCT03623321|455445403|FG000|Overall Study|Physician Decision|5|||
126586143|NCT03623321|455445403|FG000|Overall Study|Protocol Violation|1|||
126586144|NCT03623321|455445403|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
126586145|NCT03623321|455445403|FG000|Overall Study|Not further specified|43|||
126586146|NCT02243709|455445405|FG000|Phase 1|Lost to Follow-up|0|||
126586147|NCT02243709|455445406|FG001|Phase 1|Lost to Follow-up|1|||
126586148|NCT02243709|455445405|FG000|Phase 1|Withdrawal by Subject|1|||
126586149|NCT02243709|455445406|FG001|Phase 1|Withdrawal by Subject|0|||
126586150|NCT02243709|455445405|FG000|Phase 1|Protocol Violation|0|||
126586151|NCT02243709|455445406|FG001|Phase 1|Protocol Violation|1|||
126586152|NCT02243709|455445405|FG000|Phase 1|Adverse Event|0|||
126586153|NCT02243709|455445406|FG001|Phase 1|Adverse Event|1|||
126586154|NCT01785719|455445407|FG000|4-week Baseline Evaluation|Physician Decision|1|||
126586155|NCT01785719|455445408|FG001|4-week Baseline Evaluation|Physician Decision|0|||
126586156|NCT01785719|455445407|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
126586157|NCT01785719|455445408|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
126586158|NCT01785719|455445407|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
126586159|NCT01785719|455445408|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
126586160|NCT01785719|455445407|FG000|4-week Baseline Evaluation|Pregnancy|0|||
126586161|NCT01785719|455445408|FG001|4-week Baseline Evaluation|Pregnancy|2|||
126586162|NCT01785719|455445407|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
126586163|NCT01785719|455445408|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
126586164|NCT01785719|455445407|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
126586165|NCT01785719|455445408|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
126586166|NCT01785719|455445407|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
126586167|NCT01785719|455445408|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
126586168|NCT01785719|455445407|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
126586169|NCT01785719|455445408|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
126586170|NCT01785719|455445407|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
126586171|NCT01785719|455445408|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
126777671|NCT01154127|456141405|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
126777672|NCT01154127|456141404|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
126586172|NCT01785719|455445407|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
126586173|NCT01785719|455445408|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
126586174|NCT01785719|455445407|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
126586175|NCT01785719|455445408|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
126586176|NCT01785719|455445407|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
126586177|NCT01785719|455445408|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
126586178|NCT01785719|455445407|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
126586179|NCT01785719|455445408|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
126586180|NCT01785719|455445407|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
126586181|NCT01785719|455445408|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
126586182|NCT01785719|455445407|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
126586183|NCT01785719|455445408|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
126586184|NCT03443323|455445409|FG000|Overall Study|Lost to Follow-up|2|||
126586185|NCT03443323|455445410|FG001|Overall Study|Lost to Follow-up|2|||
126586186|NCT03443323|455445409|FG000|Overall Study|PI withdrawal|1|||
126586187|NCT03443323|455445410|FG001|Overall Study|PI withdrawal|0|||
126586188|NCT04610892|455445418|FG000|Overall Study|Adverse Event|1|||
126586189|NCT04610892|455445419|FG001|Overall Study|Adverse Event|0|||
126586190|NCT04610892|455445420|FG002|Overall Study|Adverse Event|0|||
126586191|NCT04610892|455445421|FG003|Overall Study|Adverse Event|1|||
126586192|NCT04610892|455445422|FG004|Overall Study|Adverse Event|3|||
126586193|NCT04610892|455445418|FG000|Overall Study|Death|0|||
126586194|NCT04610892|455445419|FG001|Overall Study|Death|1|||
126586195|NCT04610892|455445420|FG002|Overall Study|Death|0|||
126586196|NCT04610892|455445421|FG003|Overall Study|Death|1|||
126586197|NCT04610892|455445422|FG004|Overall Study|Death|0|||
126586198|NCT04610892|455445418|FG000|Overall Study|Withdrawal by Subject|3|||
126586199|NCT04610892|455445419|FG001|Overall Study|Withdrawal by Subject|2|||
126586200|NCT04610892|455445420|FG002|Overall Study|Withdrawal by Subject|0|||
126586201|NCT04610892|455445421|FG003|Overall Study|Withdrawal by Subject|6|||
126586202|NCT04610892|455445422|FG004|Overall Study|Withdrawal by Subject|6|||
126586203|NCT04610892|455445418|FG000|Overall Study|Subjects who did not receive treatment|1|||
126586204|NCT04610892|455445419|FG001|Overall Study|Subjects who did not receive treatment|0|||
126586205|NCT04610892|455445420|FG002|Overall Study|Subjects who did not receive treatment|0|||
126586206|NCT04610892|455445421|FG003|Overall Study|Subjects who did not receive treatment|0|||
126586207|NCT04610892|455445422|FG004|Overall Study|Subjects who did not receive treatment|2|||
126586208|NCT05520190|455445423|FG000|Overall Study|Lost to Follow-up|7|||
126586209|NCT05520190|455445423|FG000|Overall Study|Withdrawal by Subject|2|||
126586210|NCT03683719|455445424|FG000|Overall Study|Lack of Efficacy|1|||
126586211|NCT03683719|455445425|FG001|Overall Study|Lack of Efficacy|3|||
126586212|NCT03683719|455445426|FG002|Overall Study|Lack of Efficacy|4|||
126586213|NCT03683719|455445427|FG003|Overall Study|Lack of Efficacy|0|||
126586214|NCT03683719|455445428|FG004|Overall Study|Lack of Efficacy|4|||
126586215|NCT03683719|455445424|FG000|Overall Study|Adverse Event|6|||
126586216|NCT03683719|455445425|FG001|Overall Study|Adverse Event|6|||
126586217|NCT03683719|455445426|FG002|Overall Study|Adverse Event|0|||
126586218|NCT03683719|455445427|FG003|Overall Study|Adverse Event|1|||
126586219|NCT03683719|455445428|FG004|Overall Study|Adverse Event|3|||
126586220|NCT03683719|455445424|FG000|Overall Study|Withdrawal by Subject|4|||
126586221|NCT03683719|455445425|FG001|Overall Study|Withdrawal by Subject|4|||
126586222|NCT03683719|455445426|FG002|Overall Study|Withdrawal by Subject|3|||
126586223|NCT03683719|455445427|FG003|Overall Study|Withdrawal by Subject|5|||
126586224|NCT03683719|455445428|FG004|Overall Study|Withdrawal by Subject|5|||
126586225|NCT03683719|455445424|FG000|Overall Study|Lost to Follow-up|1|||
126586226|NCT03683719|455445425|FG001|Overall Study|Lost to Follow-up|0|||
126586227|NCT03683719|455445426|FG002|Overall Study|Lost to Follow-up|0|||
126586228|NCT03683719|455445427|FG003|Overall Study|Lost to Follow-up|1|||
126586229|NCT03683719|455445428|FG004|Overall Study|Lost to Follow-up|1|||
126586230|NCT03683719|455445424|FG000|Overall Study|Other personal reasons|0|||
126586231|NCT03683719|455445425|FG001|Overall Study|Other personal reasons|0|||
126586232|NCT03683719|455445426|FG002|Overall Study|Other personal reasons|1|||
126586233|NCT03683719|455445427|FG003|Overall Study|Other personal reasons|0|||
126586234|NCT03683719|455445428|FG004|Overall Study|Other personal reasons|1|||
126586235|NCT04896476|455445437|FG000|Overall Study|Withdrawal by Subject|1|||
126586236|NCT04896476|455445437|FG000|Overall Study|Lost to Follow-up|2|||
126586237|NCT03476187|455445438|FG000|Overall Study|Protocol Violation|7|||
126586238|NCT03476187|455445438|FG000|Overall Study|Physician Decision|5|||
126586239|NCT03135548|455445439|FG000|Overall Study|Lost to Follow-up|3|||
126586240|NCT03135548|455445440|FG001|Overall Study|Lost to Follow-up|0|||
126586241|NCT03135548|455445441|FG002|Overall Study|Lost to Follow-up|0|||
126586242|NCT03135548|455445439|FG000|Overall Study|Withdrawal by Subject|2|||
126586243|NCT03135548|455445440|FG001|Overall Study|Withdrawal by Subject|2|||
126586244|NCT03135548|455445441|FG002|Overall Study|Withdrawal by Subject|1|||
126586245|NCT03135548|455445439|FG000|Overall Study|Other than listed|0|||
126586246|NCT03135548|455445440|FG001|Overall Study|Other than listed|2|||
126586247|NCT03135548|455445441|FG002|Overall Study|Other than listed|2|||
126586248|NCT03924986|455445442|FG000|Overall Study|Death|57|||
126586249|NCT03924986|455445443|FG001|Overall Study|Death|66|||
126586250|NCT03924986|455445442|FG000|Overall Study|Study Concluded by Sponsor|51|||
126586251|NCT03924986|455445443|FG001|Overall Study|Study Concluded by Sponsor|41|||
126586252|NCT03924986|455445442|FG000|Overall Study|Withdrawal by Subject|15|||
126586253|NCT03924986|455445443|FG001|Overall Study|Withdrawal by Subject|20|||
126586254|NCT03924986|455445442|FG000|Overall Study|Lost to Follow-up|7|||
126586255|NCT03924986|455445443|FG001|Overall Study|Lost to Follow-up|5|||
126586256|NCT03924986|455445442|FG000|Overall Study|Miscellaneous|1|||
126586257|NCT03924986|455445443|FG001|Overall Study|Miscellaneous|0|||
126586258|NCT05368103|455445444|FG000|Overall Study|Withdrawal by Subject|4|||
126586259|NCT05368103|455445444|FG000|Overall Study|Lost to Follow-up|1|||
126586260|NCT05368103|455445444|FG000|Overall Study|Lack of Efficacy|3|||
126586261|NCT05569252|455445445|FG000|Overall Study|Adverse event (central vision loss)|1|||
126586262|NCT05569252|455445446|FG001|Overall Study|Adverse event (central vision loss)|0|||
126586263|NCT05569252|455445447|FG002|Overall Study|Adverse event (central vision loss)|0|||
126586264|NCT05569252|455445448|FG003|Overall Study|Adverse event (central vision loss)|0|||
126586265|NCT03665597|455445449|FG000|Period 1|Adverse Event|1|||
126586266|NCT03665597|455445450|FG001|Period 1|Adverse Event|0|||
126586267|NCT03665597|455445451|FG002|Period 1|Adverse Event|0|||
126586268|NCT03665597|455445452|FG003|Period 1|Adverse Event|1|||
126586269|NCT03665597|455445453|FG004|Period 1|Adverse Event|0|||
126586270|NCT03665597|455445454|FG005|Period 1|Adverse Event|0|||
126586271|NCT03665597|455445455|FG006|Period 1|Adverse Event|0|||
126586272|NCT03665597|455445449|FG000|Period 1|Screen Failure|0|||
126586273|NCT03665597|455445450|FG001|Period 1|Screen Failure|0|||
126586274|NCT03665597|455445451|FG002|Period 1|Screen Failure|0|||
126586275|NCT03665597|455445452|FG003|Period 1|Screen Failure|1|||
126586276|NCT03665597|455445453|FG004|Period 1|Screen Failure|0|||
126586277|NCT03665597|455445454|FG005|Period 1|Screen Failure|0|||
126586278|NCT03665597|455445455|FG006|Period 1|Screen Failure|0|||
126586279|NCT03665597|455445449|FG000|Period 1|Death|0|||
126586280|NCT03665597|455445450|FG001|Period 1|Death|0|||
126586281|NCT03665597|455445451|FG002|Period 1|Death|0|||
126586282|NCT03665597|455445452|FG003|Period 1|Death|0|||
126586283|NCT03665597|455445453|FG004|Period 1|Death|0|||
126586284|NCT03665597|455445454|FG005|Period 1|Death|0|||
126586285|NCT03665597|455445455|FG006|Period 1|Death|45|||
126586286|NCT03665597|455445449|FG000|Period 1|Withdrawal by Subject|0|||
126586287|NCT03665597|455445450|FG001|Period 1|Withdrawal by Subject|0|||
126586288|NCT03665597|455445451|FG002|Period 1|Withdrawal by Subject|0|||
126586289|NCT03665597|455445452|FG003|Period 1|Withdrawal by Subject|0|||
126586290|NCT03665597|455445453|FG004|Period 1|Withdrawal by Subject|0|||
126586291|NCT03665597|455445454|FG005|Period 1|Withdrawal by Subject|0|||
126586292|NCT03665597|455445455|FG006|Period 1|Withdrawal by Subject|5|||
126586293|NCT03665597|455445449|FG000|Period 2|Adverse Event|0|||
126586294|NCT03665597|455445450|FG001|Period 2|Adverse Event|0|||
126586295|NCT03665597|455445451|FG002|Period 2|Adverse Event|0|||
126586296|NCT03665597|455445452|FG003|Period 2|Adverse Event|0|||
126586297|NCT03665597|455445453|FG004|Period 2|Adverse Event|0|||
126586298|NCT03665597|455445454|FG005|Period 2|Adverse Event|1|||
126586299|NCT03665597|455445455|FG006|Period 2|Adverse Event|0|||
126586300|NCT03665597|455445449|FG000|Period 3|Adverse Event|0|||
126586301|NCT03665597|455445450|FG001|Period 3|Adverse Event|1|||
126586302|NCT03665597|455445451|FG002|Period 3|Adverse Event|0|||
126586303|NCT03665597|455445452|FG003|Period 3|Adverse Event|0|||
126586304|NCT03665597|455445453|FG004|Period 3|Adverse Event|0|||
126586305|NCT03665597|455445454|FG005|Period 3|Adverse Event|0|||
126586306|NCT03665597|455445455|FG006|Period 3|Adverse Event|0|||
126586307|NCT03665597|455445449|FG000|Period 3|Death|0|||
126586308|NCT03665597|455445450|FG001|Period 3|Death|0|||
126586309|NCT03665597|455445451|FG002|Period 3|Death|0|||
126586310|NCT03665597|455445452|FG003|Period 3|Death|0|||
126586311|NCT03665597|455445453|FG004|Period 3|Death|1|||
126586312|NCT03665597|455445454|FG005|Period 3|Death|0|||
126586313|NCT03665597|455445455|FG006|Period 3|Death|0|||
126586314|NCT03665597|455445449|FG000|Period 4|Adverse Event|2|||
126586315|NCT03665597|455445450|FG001|Period 4|Adverse Event|2|||
126586316|NCT03665597|455445451|FG002|Period 4|Adverse Event|2|||
126777673|NCT01154127|456141405|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
126586317|NCT03665597|455445452|FG003|Period 4|Adverse Event|2|||
126586318|NCT03665597|455445453|FG004|Period 4|Adverse Event|1|||
126586319|NCT03665597|455445454|FG005|Period 4|Adverse Event|0|||
126586320|NCT03665597|455445455|FG006|Period 4|Adverse Event|0|||
126586321|NCT03665597|455445449|FG000|Period 4|Death|0|||
126586322|NCT03665597|455445450|FG001|Period 4|Death|0|||
126586323|NCT03665597|455445451|FG002|Period 4|Death|2|||
126586324|NCT03665597|455445452|FG003|Period 4|Death|0|||
126586325|NCT03665597|455445453|FG004|Period 4|Death|0|||
126586326|NCT03665597|455445454|FG005|Period 4|Death|0|||
126586327|NCT03665597|455445455|FG006|Period 4|Death|0|||
126586328|NCT03665597|455445449|FG000|Period 4|Physician Decision|1|||
126586329|NCT03665597|455445450|FG001|Period 4|Physician Decision|2|||
126586330|NCT03665597|455445451|FG002|Period 4|Physician Decision|0|||
126586331|NCT03665597|455445452|FG003|Period 4|Physician Decision|0|||
126586332|NCT03665597|455445453|FG004|Period 4|Physician Decision|0|||
126586333|NCT03665597|455445454|FG005|Period 4|Physician Decision|0|||
126586334|NCT03665597|455445455|FG006|Period 4|Physician Decision|0|||
126586335|NCT00450658|455445458|FG000|Overall Study|Adverse Event|24|||
126586336|NCT00450658|455445459|FG001|Overall Study|Adverse Event|15|||
126586337|NCT00450658|455445458|FG000|Overall Study|Withdrawal by Subject|43|||
126586338|NCT00450658|455445459|FG001|Overall Study|Withdrawal by Subject|26|||
126586339|NCT00450658|455445458|FG000|Overall Study|Lost to Follow-up|22|||
126586340|NCT00450658|455445459|FG001|Overall Study|Lost to Follow-up|5|||
126586341|NCT00450658|455445458|FG000|Overall Study|UGI ulcer|33|||
126586342|NCT00450658|455445459|FG001|Overall Study|UGI ulcer|34|||
126586343|NCT00450658|455445458|FG000|Overall Study|misc|21|||
126586344|NCT00450658|455445459|FG001|Overall Study|misc|10|||
126586345|NCT05371652|455445460|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
126586346|NCT05371652|455445460|FG000|Overall Study|Withdrawal by Subject|12|||
126586347|NCT05371652|455445460|FG000|Overall Study|Adverse Event|1|||
126586348|NCT05371652|455445460|FG000|Overall Study|Other|11|||
126586349|NCT04410042|455445464|FG000|Overall Study|Not Eligible|1|||
126586350|NCT04410042|455445465|FG001|Overall Study|Not Eligible|1|||
126586351|NCT03720795|455445468|FG000|Phase 1|Lost to Follow-up|4|||
126586352|NCT03720795|455445468|FG000|Phase 1|Withdrawal by Subject|6|||
126586353|NCT03720795|455445468|FG000|Phase 1|Protocol Violation|1|||
126586354|NCT03720795|455445468|FG000|Phase 1|Other|1|||
126586355|NCT03720795|455445468|FG000|Phase 2|Lost to Follow-up|5|||
126586356|NCT03720795|455445468|FG000|Phase 2|Withdrawal by Subject|10|||
126586357|NCT03720795|455445468|FG000|Phase 2|Protocol Violation|2|||
126586358|NCT03720795|455445468|FG000|3 Month Follow Up|Lost to Follow-up|2|||
126586359|NCT03302494|455445469|FG000|Overall Study|Other|7|||
126586360|NCT03302494|455445470|FG001|Overall Study|Other|4|||
126586361|NCT03302494|455445471|FG002|Overall Study|Other|6|||
126586362|NCT03302494|455445469|FG000|Overall Study|Withdrawal by Subject|10|||
126586363|NCT03302494|455445470|FG001|Overall Study|Withdrawal by Subject|2|||
126586364|NCT03302494|455445471|FG002|Overall Study|Withdrawal by Subject|9|||
126586365|NCT03302494|455445469|FG000|Overall Study|Study Terminated by Sponsor|32|||
126586366|NCT03302494|455445470|FG001|Overall Study|Study Terminated by Sponsor|29|||
126586367|NCT03302494|455445471|FG002|Overall Study|Study Terminated by Sponsor|30|||
126586368|NCT03302494|455445469|FG000|Overall Study|Physician Decision|1|||
126586369|NCT03302494|455445470|FG001|Overall Study|Physician Decision|0|||
126586370|NCT03302494|455445471|FG002|Overall Study|Physician Decision|1|||
126586371|NCT03302494|455445469|FG000|Overall Study|Lost to Follow-up|1|||
126586372|NCT03302494|455445470|FG001|Overall Study|Lost to Follow-up|3|||
126586373|NCT03302494|455445471|FG002|Overall Study|Lost to Follow-up|3|||
126586374|NCT03302494|455445469|FG000|Overall Study|Death|13|||
126586375|NCT03302494|455445470|FG001|Overall Study|Death|11|||
126586376|NCT03302494|455445471|FG002|Overall Study|Death|4|||
126586377|NCT03302494|455445469|FG000|Overall Study|Adverse Event|1|||
126586378|NCT03302494|455445470|FG001|Overall Study|Adverse Event|2|||
126586379|NCT03302494|455445471|FG002|Overall Study|Adverse Event|0|||
126586380|NCT03302494|455445469|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
126586381|NCT03302494|455445470|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
126586382|NCT03302494|455445471|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
126586383|NCT05134233|455445472|FG000|Overall Study|Pregnancy|1|||
126586384|NCT05134233|455445472|FG000|Overall Study|MEP value too low|2|||
126586385|NCT05134233|455445472|FG000|Overall Study|Lost to Follow-up|1|||
126586386|NCT01573442|455445473|FG000|Overall Study|Cancels|9|||
126586387|NCT01573442|455445474|FG001|Overall Study|Cancels|10|||
126586388|NCT02724631|455445477|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
126586389|NCT04763265|455445481|FG000|Overall Study|Adverse Event|1|||
126586390|NCT04763265|455445482|FG001|Overall Study|Adverse Event|0|||
126586391|NCT04763265|455445481|FG000|Overall Study|Lost to Follow-up|2|||
126586392|NCT04763265|455445482|FG001|Overall Study|Lost to Follow-up|4|||
126586393|NCT04763265|455445481|FG000|Overall Study|Withdrawal by Subject|0|||
126586394|NCT04763265|455445482|FG001|Overall Study|Withdrawal by Subject|1|||
126586395|NCT05609760|455445495|FG000|Overall Study|Lost to Follow-up|0|||
126586396|NCT05609760|455445496|FG001|Overall Study|Lost to Follow-up|1|||
126586397|NCT05609760|455445495|FG000|Overall Study|Withdrawal by Subject|1|||
126586398|NCT05609760|455445496|FG001|Overall Study|Withdrawal by Subject|0|||
126586399|NCT04049643|455445497|FG000|Overall Study|Lack of Efficacy|1|||
126586400|NCT04049643|455445498|FG001|Overall Study|Lack of Efficacy|1|||
126586401|NCT04049643|455445499|FG002|Overall Study|Lack of Efficacy|0|||
126586402|NCT04049643|455445497|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
126586403|NCT04049643|455445498|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
126586404|NCT04049643|455445499|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
126586405|NCT05089734|455445500|FG000|Overall Study|Still on study|122|||
126586406|NCT05089734|455445501|FG001|Overall Study|Still on study|101|||
126586407|NCT05089734|455445500|FG000|Overall Study|Death|161|||
126586408|NCT05089734|455445501|FG001|Overall Study|Death|179|||
126586409|NCT05089734|455445500|FG000|Overall Study|Withdrew consent|11|||
126586410|NCT05089734|455445501|FG001|Overall Study|Withdrew consent|24|||
126586411|NCT05089734|455445500|FG000|Overall Study|Lost to Follow-up|5|||
126586412|NCT05089734|455445501|FG001|Overall Study|Lost to Follow-up|0|||
126586413|NCT05302596|455445502|FG000|Overall Study|Withdrawal by Subject|1|||
126586414|NCT05302596|455445503|FG001|Overall Study|Withdrawal by Subject|1|||
126586415|NCT04060355|455447078|FG000|Overall Study|Lost to Follow-up|41|||
126586416|NCT01140880|455447083|FG000|Overall Study|Death|0|||
126586417|NCT01140880|455447084|FG001|Overall Study|Death|1|||
126586418|NCT01140880|455447083|FG000|Overall Study|Withdrawal by Subject|6|||
126586419|NCT01140880|455447084|FG001|Overall Study|Withdrawal by Subject|3|||
126586420|NCT01140880|455447083|FG000|Overall Study|Lost to Follow-up|8|||
126586421|NCT01140880|455447084|FG001|Overall Study|Lost to Follow-up|10|||
126586422|NCT01140880|455447083|FG000|Overall Study|Protocol Violation|0|||
126731467|NCT02505542|455966107|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
126731468|NCT02505542|455966108|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
126731469|NCT02505542|455966105|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
126731470|NCT02505542|455966106|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
126731471|NCT02505542|455966107|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
126731472|NCT02505542|455966108|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
126731473|NCT02505542|455966105|FG000|Part B: Double-Blind Period|Miscalculation|0|||
126731474|NCT02505542|455966106|FG001|Part B: Double-Blind Period|Miscalculation|1|||
126731475|NCT02505542|455966107|FG002|Part B: Double-Blind Period|Miscalculation|0|||
126731476|NCT02505542|455966108|FG003|Part B: Double-Blind Period|Miscalculation|0|||
126731477|NCT02505542|455966105|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
126731478|NCT02505542|455966106|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
126731479|NCT02505542|455966107|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
126731480|NCT02505542|455966108|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
126731481|NCT00618995|455966111|FG000|Period 1|Adverse Event|0|||
126731482|NCT00618995|455966112|FG001|Period 1|Adverse Event|0|||
126731483|NCT00618995|455966113|FG002|Period 1|Adverse Event|1|||
126731484|NCT00618995|455966114|FG003|Period 1|Adverse Event|0|||
126731485|NCT00618995|455966111|FG000|Period 1|Protocol Violation|0|||
126731486|NCT00618995|455966112|FG001|Period 1|Protocol Violation|1|||
126731487|NCT00618995|455966113|FG002|Period 1|Protocol Violation|1|||
126731488|NCT00618995|455966114|FG003|Period 1|Protocol Violation|0|||
126731489|NCT00618995|455966111|FG000|Period 2|Protocol Violation|0|||
126731490|NCT00618995|455966112|FG001|Period 2|Protocol Violation|0|||
126731491|NCT00618995|455966113|FG002|Period 2|Protocol Violation|1|||
126731492|NCT00618995|455966114|FG003|Period 2|Protocol Violation|0|||
126731493|NCT00618995|455966111|FG000|Period 4|Adverse Event|1|||
126731494|NCT00618995|455966112|FG001|Period 4|Adverse Event|0|||
126731495|NCT00618995|455966113|FG002|Period 4|Adverse Event|0|||
126731496|NCT00618995|455966114|FG003|Period 4|Adverse Event|0|||
126731497|NCT01522443|455966115|FG000|Overall Study|No longer receiving clinical benefit|36|||
126731498|NCT01522443|455966116|FG001|Overall Study|No longer receiving clinical benefit|28|||
126731499|NCT01522443|455966115|FG000|Overall Study|Adverse Event|10|||
126731500|NCT01522443|455966116|FG001|Overall Study|Adverse Event|15|||
126731501|NCT01522443|455966115|FG000|Overall Study|Withdrawal by Subject|5|||
126731502|NCT01522443|455966116|FG001|Overall Study|Withdrawal by Subject|8|||
126731503|NCT01522443|455966115|FG000|Overall Study|No study treatment given|1|||
126731504|NCT01522443|455966116|FG001|Overall Study|No study treatment given|1|||
126731505|NCT01522443|455966115|FG000|Overall Study|Other|1|||
126731506|NCT01522443|455966116|FG001|Overall Study|Other|3|||
126731507|NCT00776555|455966117|FG000|Overall Study|Study terminated|3|||
126731508|NCT00776555|455966118|FG001|Overall Study|Study terminated|0|||
126731509|NCT03176277|455966119|FG000|Part A Dose Escalation Study|Adverse Event|1|||
126731510|NCT03176277|455966120|FG001|Part A Dose Escalation Study|Adverse Event|0|||
126731511|NCT03176277|455966121|FG002|Part A Dose Escalation Study|Adverse Event|1|||
126731512|NCT03176277|455966122|FG003|Part A Dose Escalation Study|Adverse Event|0|||
126731513|NCT03176277|455966119|FG000|Part A Dose Escalation Study|Physician Decision|1|||
126731514|NCT03176277|455966120|FG001|Part A Dose Escalation Study|Physician Decision|1|||
126731515|NCT03176277|455966121|FG002|Part A Dose Escalation Study|Physician Decision|2|||
126731516|NCT03176277|455966122|FG003|Part A Dose Escalation Study|Physician Decision|0|||
126731517|NCT03176277|455966119|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
126731518|NCT03176277|455966120|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
126731519|NCT03176277|455966121|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
126731520|NCT03176277|455966122|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
126731521|NCT03176277|455966119|FG000|Part A Dose Escalation Study|Progressive disease|3|||
126731522|NCT03176277|455966120|FG001|Part A Dose Escalation Study|Progressive disease|1|||
126731523|NCT03176277|455966121|FG002|Part A Dose Escalation Study|Progressive disease|3|||
126731524|NCT03176277|455966122|FG003|Part A Dose Escalation Study|Progressive disease|0|||
126731525|NCT00634114|455966123|FG000|Overall Study|Adverse Event|6|||
126731526|NCT00634114|455966124|FG001|Overall Study|Adverse Event|8|||
126731527|NCT00634114|455966125|FG002|Overall Study|Adverse Event|3|||
126731528|NCT00634114|455966123|FG000|Overall Study|Withdrawal by Subject|9|||
126586423|NCT01140880|455447084|FG001|Overall Study|Protocol Violation|30|||
126731529|NCT00634114|455966124|FG001|Overall Study|Withdrawal by Subject|6|||
126731530|NCT00634114|455966125|FG002|Overall Study|Withdrawal by Subject|11|||
126731531|NCT00634114|455966123|FG000|Overall Study|Lost to Follow-up|0|||
126731532|NCT00634114|455966124|FG001|Overall Study|Lost to Follow-up|0|||
126731533|NCT00634114|455966125|FG002|Overall Study|Lost to Follow-up|1|||
126731534|NCT00634114|455966123|FG000|Overall Study|Protocol Violation|3|||
126731535|NCT00634114|455966124|FG001|Overall Study|Protocol Violation|3|||
126731536|NCT00634114|455966125|FG002|Overall Study|Protocol Violation|1|||
126731537|NCT00634114|455966123|FG000|Overall Study|Pregnancy|1|||
126731538|NCT00634114|455966124|FG001|Overall Study|Pregnancy|0|||
126731539|NCT00634114|455966125|FG002|Overall Study|Pregnancy|0|||
126731540|NCT00634114|455966123|FG000|Overall Study|Incorrect enrolment|0|||
126731541|NCT00634114|455966124|FG001|Overall Study|Incorrect enrolment|1|||
126731542|NCT00634114|455966125|FG002|Overall Study|Incorrect enrolment|0|||
126731543|NCT00634114|455966123|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
126731544|NCT00634114|455966124|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
126731545|NCT00634114|455966125|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
126731546|NCT00634114|455966123|FG000|Overall Study|Difficult to continue|3|||
126731547|NCT00634114|455966124|FG001|Overall Study|Difficult to continue|1|||
126731548|NCT00634114|455966125|FG002|Overall Study|Difficult to continue|1|||
126731549|NCT00634114|455966123|FG000|Overall Study|Other reason|1|||
126731550|NCT00634114|455966124|FG001|Overall Study|Other reason|1|||
126731551|NCT00634114|455966125|FG002|Overall Study|Other reason|1|||
126731552|NCT02940626|455966126|FG000|Overall Study|Death|40|||
126731553|NCT02940626|455966127|FG001|Overall Study|Death|32|||
126731554|NCT02940626|455966126|FG000|Overall Study|Lost to Follow-up|5|||
126731555|NCT02940626|455966127|FG001|Overall Study|Lost to Follow-up|2|||
126731556|NCT02940626|455966126|FG000|Overall Study|Withdrawal by Subject|1|||
126731557|NCT02940626|455966127|FG001|Overall Study|Withdrawal by Subject|0|||
126731558|NCT02940626|455966126|FG000|Overall Study|Transfer to Hospice Care|1|||
126731559|NCT02940626|455966127|FG001|Overall Study|Transfer to Hospice Care|0|||
126731560|NCT02940626|455966126|FG000|Overall Study|Prohibited Concomitant Medication|0|||
126731561|NCT02940626|455966127|FG001|Overall Study|Prohibited Concomitant Medication|1|||
126731562|NCT00585923|455966128|FG000|Overall Study|Physician decided not to continue|31|||
126731563|NCT00585923|455966129|FG001|Overall Study|Physician decided not to continue|33|||
126731564|NCT01441115|455966130|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
126731565|NCT00574496|455966133|FG000|Overall Study|Withdrawal by Subject|1|||
126731566|NCT01167582|455966134|FG000|Overall Study|Lost to Follow-up|0|||
126731567|NCT01167582|455966135|FG001|Overall Study|Lost to Follow-up|1|||
126731568|NCT01681576|455966138|FG000|Period 1|Adverse Event|1|||
126731569|NCT01681576|455966139|FG001|Period 1|Adverse Event|0|||
126731570|NCT01681576|455966138|FG000|Period 1|Protocol Deviation|1|||
126731571|NCT01681576|455966139|FG001|Period 1|Protocol Deviation|0|||
126731572|NCT01681576|455966138|FG000|Period 2|subject/guardian decision|3|||
126731573|NCT01681576|455966139|FG001|Period 2|subject/guardian decision|1|||
126731574|NCT01681576|455966138|FG000|Period 2|Non-compliance with study treatment|1|||
126731575|NCT01681576|455966139|FG001|Period 2|Non-compliance with study treatment|0|||
126731576|NCT01518244|455966140|FG000|Overall Study|Adverse Event|3|||
126731577|NCT01766817|455966142|FG000|Overall Study|Drug-related adverse event|1|||
126731578|NCT01766817|455966143|FG001|Overall Study|Drug-related adverse event|2|||
126731579|NCT01766817|455966144|FG002|Overall Study|Drug-related adverse event|1|||
126731580|NCT01766817|455966142|FG000|Overall Study|Drug-unrelated adverse event|3|||
126731581|NCT01766817|455966143|FG001|Overall Study|Drug-unrelated adverse event|3|||
126731582|NCT01766817|455966144|FG002|Overall Study|Drug-unrelated adverse event|3|||
126731583|NCT01766817|455966142|FG000|Overall Study|Death|1|||
126731584|NCT01766817|455966143|FG001|Overall Study|Death|1|||
126731585|NCT01766817|455966144|FG002|Overall Study|Death|0|||
126731586|NCT01766817|455966142|FG000|Overall Study|Unable to take study drug|0|||
126731587|NCT01766817|455966143|FG001|Overall Study|Unable to take study drug|1|||
126731588|NCT01766817|455966144|FG002|Overall Study|Unable to take study drug|0|||
126731589|NCT01766817|455966142|FG000|Overall Study|Withdrawal by Subject|2|||
126731590|NCT01766817|455966143|FG001|Overall Study|Withdrawal by Subject|0|||
126731591|NCT01766817|455966144|FG002|Overall Study|Withdrawal by Subject|3|||
126731592|NCT01766817|455966142|FG000|Overall Study|Subject non-compliance|0|||
126731593|NCT01766817|455966143|FG001|Overall Study|Subject non-compliance|1|||
126731594|NCT01766817|455966144|FG002|Overall Study|Subject non-compliance|2|||
126731595|NCT01766817|455966142|FG000|Overall Study|Physician Decision|3|||
126731596|NCT01766817|455966143|FG001|Overall Study|Physician Decision|3|||
126731597|NCT01766817|455966144|FG002|Overall Study|Physician Decision|4|||
126731598|NCT01766817|455966142|FG000|Overall Study|Other|1|||
126731599|NCT01766817|455966143|FG001|Overall Study|Other|0|||
126731600|NCT01766817|455966144|FG002|Overall Study|Other|0|||
126731601|NCT02260648|455966148|FG000|Overall Study|Adverse Event|3|||
126731602|NCT02260648|455966149|FG001|Overall Study|Adverse Event|0|||
126731603|NCT02260648|455966150|FG002|Overall Study|Adverse Event|1|||
126731604|NCT02260648|455966148|FG000|Overall Study|Withdrawal by Subject|1|||
126731605|NCT02260648|455966149|FG001|Overall Study|Withdrawal by Subject|1|||
126731606|NCT02260648|455966150|FG002|Overall Study|Withdrawal by Subject|0|||
126586424|NCT03131648|455447086|FG000|Initial Treatment Period|Not dosed|2|||
126586425|NCT03131648|455447087|FG001|Initial Treatment Period|Not dosed|2|||
126586426|NCT03131648|455447088|FG002|Initial Treatment Period|Not dosed|0|||
126586427|NCT03131648|455447089|FG003|Initial Treatment Period|Not dosed|0|||
126586428|NCT03131648|455447090|FG004|Initial Treatment Period|Not dosed|0|||
126586429|NCT03131648|455447091|FG005|Initial Treatment Period|Not dosed|0|||
126586430|NCT03131648|455447092|FG006|Initial Treatment Period|Not dosed|0|||
126586431|NCT03131648|455447093|FG007|Initial Treatment Period|Not dosed|0|||
126586432|NCT03131648|455447086|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
126586433|NCT03131648|455447087|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
126586434|NCT03131648|455447088|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126586435|NCT03131648|455447089|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126586436|NCT03131648|455447090|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126586437|NCT03131648|455447091|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126586438|NCT03131648|455447092|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126586439|NCT03131648|455447093|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126586440|NCT03131648|455447086|FG000|Open-label Treatment|Discontinued IMP|0|||
126586441|NCT03131648|455447087|FG001|Open-label Treatment|Discontinued IMP|0|||
126586442|NCT03131648|455447088|FG002|Open-label Treatment|Discontinued IMP|0|||
126586443|NCT03131648|455447089|FG003|Open-label Treatment|Discontinued IMP|0|||
126586444|NCT03131648|455447090|FG004|Open-label Treatment|Discontinued IMP|0|||
126586445|NCT03131648|455447091|FG005|Open-label Treatment|Discontinued IMP|0|||
126586446|NCT03131648|455447092|FG006|Open-label Treatment|Discontinued IMP|112|||
126586447|NCT03131648|455447093|FG007|Open-label Treatment|Discontinued IMP|0|||
126586448|NCT03131648|455447086|FG000|Open-label Treatment|Completed Week 50|0|||
126586449|NCT03131648|455447087|FG001|Open-label Treatment|Completed Week 50|0|||
126586450|NCT03131648|455447088|FG002|Open-label Treatment|Completed Week 50|0|||
126586451|NCT03131648|455447089|FG003|Open-label Treatment|Completed Week 50|0|||
126586452|NCT03131648|455447090|FG004|Open-label Treatment|Completed Week 50|0|||
126586453|NCT03131648|455447091|FG005|Open-label Treatment|Completed Week 50|0|||
126586454|NCT03131648|455447092|FG006|Open-label Treatment|Completed Week 50|6|||
126586455|NCT03131648|455447093|FG007|Open-label Treatment|Completed Week 50|0|||
126586456|NCT03131648|455447086|FG000|Maintenance Treatment Period|Not dosed|0|||
126586457|NCT03131648|455447087|FG001|Maintenance Treatment Period|Not dosed|0|||
126586458|NCT03131648|455447088|FG002|Maintenance Treatment Period|Not dosed|3|||
126586459|NCT03131648|455447089|FG003|Maintenance Treatment Period|Not dosed|2|||
126586460|NCT03131648|455447090|FG004|Maintenance Treatment Period|Not dosed|1|||
126586461|NCT03131648|455447091|FG005|Maintenance Treatment Period|Not dosed|0|||
126586462|NCT03131648|455447092|FG006|Maintenance Treatment Period|Not dosed|0|||
126586463|NCT03131648|455447093|FG007|Maintenance Treatment Period|Not dosed|0|||
126586464|NCT03131648|455447086|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
126586465|NCT03131648|455447087|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
126586466|NCT03131648|455447088|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
126586467|NCT03131648|455447089|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
126586468|NCT03131648|455447090|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
126586469|NCT03131648|455447091|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
126586470|NCT03131648|455447092|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
126586471|NCT03131648|455447093|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
126586472|NCT03131648|455447086|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126586473|NCT03131648|455447087|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126586474|NCT03131648|455447088|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
126586475|NCT03131648|455447089|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
126586476|NCT03131648|455447090|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
126586477|NCT03131648|455447091|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
126586478|NCT03131648|455447092|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126586479|NCT03131648|455447093|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126586480|NCT03131648|455447086|FG000|Maintenance Treatment Period|Completed Week 50|0|||
126586481|NCT03131648|455447087|FG001|Maintenance Treatment Period|Completed Week 50|0|||
126586482|NCT03131648|455447088|FG002|Maintenance Treatment Period|Completed Week 50|0|||
126586483|NCT03131648|455447089|FG003|Maintenance Treatment Period|Completed Week 50|0|||
126586484|NCT03131648|455447090|FG004|Maintenance Treatment Period|Completed Week 50|1|||
126777674|NCT01697449|456141406|FG000|Overall Study|Disease progression|47|||
126586485|NCT03131648|455447091|FG005|Maintenance Treatment Period|Completed Week 50|0|||
126586486|NCT03131648|455447092|FG006|Maintenance Treatment Period|Completed Week 50|0|||
126586487|NCT03131648|455447093|FG007|Maintenance Treatment Period|Completed Week 50|0|||
126586488|NCT03131648|455447086|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
126586489|NCT03131648|455447087|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
126777675|NCT01697449|456141406|FG000|Overall Study|Adverse Event|7|||
126586490|NCT03131648|455447088|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
126586491|NCT03131648|455447089|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
126777676|NCT01697449|456141406|FG000|Overall Study|Lost to Follow-up|5|||
126586492|NCT03131648|455447090|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
126586493|NCT03131648|455447091|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
126586494|NCT03131648|455447092|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
126586495|NCT03131648|455447093|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
126586496|NCT02671903|455447094|FG000|Period 0 (Run-In)|Death|0|||
126586497|NCT02671903|455447095|FG001|Period 0 (Run-In)|Death|0|||
126586498|NCT02671903|455447096|FG002|Period 0 (Run-In)|Death|3|||
126586499|NCT02671903|455447094|FG000|Period 0 (Run-In)|Physician Decision|0|||
126586500|NCT02671903|455447095|FG001|Period 0 (Run-In)|Physician Decision|0|||
126586501|NCT02671903|455447096|FG002|Period 0 (Run-In)|Physician Decision|4|||
126586502|NCT02671903|455447094|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
126586503|NCT02671903|455447095|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
126586504|NCT02671903|455447096|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
126586505|NCT02671903|455447094|FG000|Period 0 (Run-In)|Protocol Violation|0|||
126586506|NCT02671903|455447095|FG001|Period 0 (Run-In)|Protocol Violation|0|||
126586507|NCT02671903|455447096|FG002|Period 0 (Run-In)|Protocol Violation|1|||
126586508|NCT02671903|455447094|FG000|Period 0 (Run-In)|Adverse Event|0|||
126586509|NCT02671903|455447095|FG001|Period 0 (Run-In)|Adverse Event|0|||
126586510|NCT02671903|455447096|FG002|Period 0 (Run-In)|Adverse Event|1|||
126586511|NCT02671903|455447094|FG000|Period 0 (Run-In)|Implantation Failure|0|||
126586512|NCT02671903|455447095|FG001|Period 0 (Run-In)|Implantation Failure|0|||
126586513|NCT02671903|455447096|FG002|Period 0 (Run-In)|Implantation Failure|2|||
126586514|NCT02671903|455447094|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
126586515|NCT02671903|455447095|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
126586516|NCT02671903|455447096|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
126586517|NCT03779204|455447097|FG000|Overall Study|Lost to Follow-up|2|||
126586518|NCT03779204|455447098|FG001|Overall Study|Lost to Follow-up|0|||
126586519|NCT04258709|455447099|FG000|Overall Study|Lost to Follow-up|10|||
126586520|NCT04258709|455447100|FG001|Overall Study|Lost to Follow-up|4|||
126586521|NCT04258709|455447099|FG000|Overall Study|Withdrawal by Subject|1|||
126586522|NCT04258709|455447100|FG001|Overall Study|Withdrawal by Subject|0|||
126586523|NCT04258709|455447099|FG000|Overall Study|Fetal demise|0|||
126586524|NCT04258709|455447100|FG001|Overall Study|Fetal demise|1|||
126586525|NCT04258709|455447099|FG000|Overall Study|Protocol Violation|1|||
126586526|NCT04258709|455447100|FG001|Overall Study|Protocol Violation|1|||
126586527|NCT05633953|455447101|FG000|Overall Study|Adverse Event|7|||
126586528|NCT05633953|455447101|FG000|Overall Study|Death|30|||
126586529|NCT05633953|455447101|FG000|Overall Study|Lost to Follow-up|1|||
126586530|NCT05633953|455447101|FG000|Overall Study|Osilodrostat discontinued|4|||
126586531|NCT05633953|455447101|FG000|Overall Study|Physician Decision|1|||
126586532|NCT05633953|455447101|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
126586533|NCT05633953|455447101|FG000|Overall Study|Progressive disease|2|||
126586534|NCT03047928|455447102|FG000|Overall Study|Adverse Event|0|||
126586535|NCT03047928|455447103|FG001|Overall Study|Adverse Event|2|||
126586536|NCT03047928|455447104|FG002|Overall Study|Adverse Event|0|||
126586537|NCT03047928|455447102|FG000|Overall Study|Protocol Violation|0|||
126586538|NCT03047928|455447103|FG001|Overall Study|Protocol Violation|1|||
126586539|NCT03047928|455447104|FG002|Overall Study|Protocol Violation|0|||
126586540|NCT03047928|455447102|FG000|Overall Study|included in another protocol|0|||
126586541|NCT03047928|455447103|FG001|Overall Study|included in another protocol|1|||
126586542|NCT03047928|455447104|FG002|Overall Study|included in another protocol|0|||
126586543|NCT05324124|455447105|FG000|Period 1|Withdrawal by Subject|1|||
126586544|NCT05324124|455447106|FG001|Period 1|Withdrawal by Subject|0|||
126586545|NCT05324124|455447105|FG000|Period 1|Physician Decision|0|||
126586546|NCT05324124|455447106|FG001|Period 1|Physician Decision|1|||
126586547|NCT04034251|455447107|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
126586548|NCT04034251|455447108|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
126586549|NCT04034251|455447109|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
126586550|NCT02287610|455447110|FG000|Overall Study|Lost to Follow-up|3|||
126586551|NCT02287610|455447110|FG000|Overall Study|Withdrawal by Subject|8|||
126586552|NCT02287610|455447110|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
126586553|NCT05273749|455447111|FG000|Overall Study|Adverse Event|14|||
126586554|NCT05273749|455447112|FG001|Overall Study|Adverse Event|8|||
126586555|NCT05273749|455447111|FG000|Overall Study|Lack of Efficacy|2|||
126586556|NCT05273749|455447112|FG001|Overall Study|Lack of Efficacy|8|||
126586557|NCT05273749|455447111|FG000|Overall Study|Physician Decision|0|||
126586558|NCT05273749|455447112|FG001|Overall Study|Physician Decision|2|||
126586559|NCT05273749|455447111|FG000|Overall Study|Withdrawal by Subject|14|||
126731607|NCT02260648|455966148|FG000|Overall Study|Protocol Violation|1|||
126731608|NCT02260648|455966149|FG001|Overall Study|Protocol Violation|0|||
126586560|NCT05273749|455447112|FG001|Overall Study|Withdrawal by Subject|16|||
126586561|NCT05273749|455447111|FG000|Overall Study|Lost to Follow-up|10|||
126586562|NCT05273749|455447112|FG001|Overall Study|Lost to Follow-up|10|||
126586563|NCT05273749|455447111|FG000|Overall Study|Pregnancy|1|||
126586564|NCT05273749|455447112|FG001|Overall Study|Pregnancy|0|||
126586565|NCT05273749|455447111|FG000|Overall Study|Non-Compliance|3|||
126586566|NCT05273749|455447112|FG001|Overall Study|Non-Compliance|2|||
126586567|NCT05273749|455447111|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
126586568|NCT05273749|455447112|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
126586569|NCT05247489|455447124|FG000|Overall Study|Lost to Follow-up|5|||
126586570|NCT05247489|455447125|FG001|Overall Study|Lost to Follow-up|1|||
126586571|NCT05247489|455447124|FG000|Overall Study|Withdrawal by Subject|6|||
126586572|NCT05247489|455447125|FG001|Overall Study|Withdrawal by Subject|7|||
126586573|NCT05247489|455447124|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
126586574|NCT05247489|455447125|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
126586575|NCT05247489|455447124|FG000|Overall Study|Left Country|1|||
126586576|NCT05247489|455447125|FG001|Overall Study|Left Country|0|||
126586577|NCT05247489|455447124|FG000|Overall Study|Noncompliance with Investigational Product|1|||
126586578|NCT05247489|455447125|FG001|Overall Study|Noncompliance with Investigational Product|0|||
126586579|NCT05247489|455447124|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
126586580|NCT05247489|455447125|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
126586581|NCT03771898|455447126|FG000|Overall Study|Adverse Event|1|||
126586582|NCT03771898|455447127|FG001|Overall Study|Adverse Event|0|||
126586583|NCT03771898|455447128|FG002|Overall Study|Adverse Event|0|||
126586584|NCT03771898|455447129|FG003|Overall Study|Adverse Event|0|||
126586585|NCT03771898|455447130|FG004|Overall Study|Adverse Event|0|||
126586586|NCT03771898|455447126|FG000|Overall Study|Lost to Follow-up|1|||
126586587|NCT03771898|455447127|FG001|Overall Study|Lost to Follow-up|1|||
126586588|NCT03771898|455447128|FG002|Overall Study|Lost to Follow-up|1|||
126586589|NCT03771898|455447129|FG003|Overall Study|Lost to Follow-up|0|||
126586590|NCT03771898|455447130|FG004|Overall Study|Lost to Follow-up|0|||
126586591|NCT03771898|455447126|FG000|Overall Study|Withdrawal by parent/guardian|1|||
126586592|NCT03771898|455447127|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126586593|NCT03771898|455447128|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126586594|NCT03771898|455447129|FG003|Overall Study|Withdrawal by parent/guardian|0|||
126586595|NCT03771898|455447130|FG004|Overall Study|Withdrawal by parent/guardian|0|||
126586596|NCT03771898|455447126|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
126586597|NCT03771898|455447127|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
126586598|NCT03771898|455447128|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
126586599|NCT03771898|455447129|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
126586600|NCT03771898|455447130|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
126586601|NCT04541706|455447131|FG000|Overall Study|Withdrawal by Subject|3|||
126586602|NCT04541706|455447131|FG000|Overall Study|Progressive disease|33|||
126586603|NCT04541706|455447131|FG000|Overall Study|Physician Decision|1|||
126586604|NCT04541706|455447131|FG000|Overall Study|Lost to Follow-up|2|||
126586605|NCT04541706|455447131|FG000|Overall Study|Death|5|||
126586606|NCT04541706|455447131|FG000|Overall Study|Adverse Event|1|||
126586607|NCT05563246|455447132|FG000|Overall Study|Withdrawal by Subject|1|||
126586608|NCT05563246|455447133|FG001|Overall Study|Withdrawal by Subject|2|||
126586609|NCT05563246|455447134|FG002|Overall Study|Withdrawal by Subject|0|||
126586610|NCT05563246|455447135|FG003|Overall Study|Withdrawal by Subject|0|||
126586611|NCT05563246|455447132|FG000|Overall Study|Protocol Deviation|0|||
126586612|NCT05563246|455447133|FG001|Overall Study|Protocol Deviation|1|||
126586613|NCT05563246|455447134|FG002|Overall Study|Protocol Deviation|0|||
126586614|NCT05563246|455447135|FG003|Overall Study|Protocol Deviation|0|||
126586615|NCT05563246|455447132|FG000|Overall Study|Physician Decision|0|||
126586616|NCT05563246|455447133|FG001|Overall Study|Physician Decision|1|||
126586617|NCT05563246|455447134|FG002|Overall Study|Physician Decision|0|||
126586618|NCT05563246|455447135|FG003|Overall Study|Physician Decision|0|||
126586619|NCT05563246|455447132|FG000|Overall Study|Adverse Event|0|||
126586620|NCT05563246|455447133|FG001|Overall Study|Adverse Event|0|||
126586621|NCT05563246|455447134|FG002|Overall Study|Adverse Event|2|||
126586622|NCT05563246|455447135|FG003|Overall Study|Adverse Event|0|||
126586623|NCT05563246|455447132|FG000|Overall Study|Lost to Follow-up|0|||
126586624|NCT05563246|455447133|FG001|Overall Study|Lost to Follow-up|0|||
126586625|NCT05563246|455447134|FG002|Overall Study|Lost to Follow-up|1|||
126586626|NCT05563246|455447135|FG003|Overall Study|Lost to Follow-up|0|||
126586627|NCT01416831|455447138|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
126586628|NCT01416831|455447139|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
126586629|NCT05215314|455447140|FG000|Overall Study|Lost to Follow-up|2|||
126586630|NCT05215314|455447141|FG001|Overall Study|Lost to Follow-up|2|||
126586631|NCT05215314|455447140|FG000|Overall Study|Withdrawal by Subject|2|||
126586632|NCT05215314|455447141|FG001|Overall Study|Withdrawal by Subject|0|||
126586633|NCT05215314|455447140|FG000|Overall Study|Physician Decision|1|||
126586634|NCT05215314|455447141|FG001|Overall Study|Physician Decision|0|||
126586635|NCT04294225|455447146|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
126586636|NCT04294225|455447146|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
126586637|NCT04294225|455447146|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
126586638|NCT04294225|455447146|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
126586639|NCT04294225|455447146|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
126586640|NCT03336333|455447147|FG000|Overall Study|Remained on study at time of data cut-off|202|||
126586641|NCT03336333|455447148|FG001|Overall Study|Remained on study at time of data cut-off|219|||
126586642|NCT03336333|455447149|FG002|Overall Study|Remained on study at time of data cut-off|102|||
126586643|NCT03336333|455447147|FG000|Overall Study|Death|14|||
126586644|NCT03336333|455447148|FG001|Overall Study|Death|16|||
126586645|NCT03336333|455447149|FG002|Overall Study|Death|8|||
126586646|NCT03336333|455447147|FG000|Overall Study|Withdrawal by Subject|16|||
126586647|NCT03336333|455447148|FG001|Overall Study|Withdrawal by Subject|5|||
126586648|NCT03336333|455447149|FG002|Overall Study|Withdrawal by Subject|1|||
126586649|NCT03336333|455447147|FG000|Overall Study|Physician Decision|5|||
126586650|NCT03336333|455447148|FG001|Overall Study|Physician Decision|1|||
126586651|NCT03336333|455447149|FG002|Overall Study|Physician Decision|0|||
126586652|NCT03336333|455447147|FG000|Overall Study|Lost to Follow-up|1|||
126586653|NCT03336333|455447148|FG001|Overall Study|Lost to Follow-up|0|||
126586654|NCT03336333|455447149|FG002|Overall Study|Lost to Follow-up|0|||
126586655|NCT04927065|455447150|FG000|First Booster|Adverse Event|1|||
126586656|NCT04927065|455447151|FG001|First Booster|Adverse Event|0|||
126586657|NCT04927065|455447152|FG002|First Booster|Adverse Event|0|||
126586658|NCT04927065|455447153|FG003|First Booster|Adverse Event|0|||
126586659|NCT04927065|455447154|FG004|First Booster|Adverse Event|0|||
126586660|NCT04927065|455447155|FG005|First Booster|Adverse Event|0|||
126586661|NCT04927065|455447156|FG006|First Booster|Adverse Event|0|||
126586662|NCT04927065|455447157|FG007|First Booster|Adverse Event|1|||
126586663|NCT04927065|455447158|FG008|First Booster|Adverse Event|0|||
126586664|NCT04927065|455447159|FG009|First Booster|Adverse Event|0|||
126586665|NCT04927065|455447160|FG010|First Booster|Adverse Event|0|||
126586666|NCT04927065|455447161|FG011|First Booster|Adverse Event|0|||
126586667|NCT04927065|455447162|FG012|First Booster|Adverse Event|0|||
126586668|NCT04927065|455447163|FG013|First Booster|Adverse Event|0|||
126586669|NCT04927065|455447164|FG014|First Booster|Adverse Event|0|||
126586670|NCT04927065|455447165|FG015|First Booster|Adverse Event|0|||
126586671|NCT04927065|455447150|FG000|First Booster|Death|1|||
126586672|NCT04927065|455447151|FG001|First Booster|Death|0|||
126586673|NCT04927065|455447152|FG002|First Booster|Death|0|||
126586674|NCT04927065|455447153|FG003|First Booster|Death|1|||
126586675|NCT04927065|455447154|FG004|First Booster|Death|0|||
126586676|NCT04927065|455447155|FG005|First Booster|Death|1|||
126586677|NCT04927065|455447156|FG006|First Booster|Death|0|||
126586678|NCT04927065|455447157|FG007|First Booster|Death|0|||
126586679|NCT04927065|455447158|FG008|First Booster|Death|0|||
126586680|NCT04927065|455447159|FG009|First Booster|Death|0|||
126586681|NCT04927065|455447160|FG010|First Booster|Death|0|||
126586682|NCT04927065|455447161|FG011|First Booster|Death|0|||
126586683|NCT04927065|455447162|FG012|First Booster|Death|0|||
126586684|NCT04927065|455447163|FG013|First Booster|Death|0|||
126586685|NCT04927065|455447164|FG014|First Booster|Death|0|||
126586686|NCT04927065|455447165|FG015|First Booster|Death|0|||
126586687|NCT04927065|455447150|FG000|First Booster|Lost to Follow-up|8|||
126586688|NCT04927065|455447151|FG001|First Booster|Lost to Follow-up|20|||
126586689|NCT04927065|455447152|FG002|First Booster|Lost to Follow-up|0|||
126586690|NCT04927065|455447153|FG003|First Booster|Lost to Follow-up|11|||
126586691|NCT04927065|455447154|FG004|First Booster|Lost to Follow-up|43|||
126586692|NCT04927065|455447155|FG005|First Booster|Lost to Follow-up|30|||
126586693|NCT04927065|455447156|FG006|First Booster|Lost to Follow-up|28|||
126586694|NCT04927065|455447157|FG007|First Booster|Lost to Follow-up|23|||
126586695|NCT04927065|455447158|FG008|First Booster|Lost to Follow-up|4|||
126586696|NCT04927065|455447159|FG009|First Booster|Lost to Follow-up|15|||
126586697|NCT04927065|455447160|FG010|First Booster|Lost to Follow-up|0|||
126586698|NCT04927065|455447161|FG011|First Booster|Lost to Follow-up|0|||
126586699|NCT04927065|455447162|FG012|First Booster|Lost to Follow-up|0|||
126586700|NCT04927065|455447163|FG013|First Booster|Lost to Follow-up|0|||
126731609|NCT02260648|455966150|FG002|Overall Study|Protocol Violation|0|||
126731610|NCT02260648|455966148|FG000|Overall Study|Discontinue Due to Study Termination|13|||
126731611|NCT02260648|455966149|FG001|Overall Study|Discontinue Due to Study Termination|12|||
126586701|NCT04927065|455447164|FG014|First Booster|Lost to Follow-up|0|||
126586702|NCT04927065|455447165|FG015|First Booster|Lost to Follow-up|0|||
126586703|NCT04927065|455447150|FG000|First Booster|Physician Decision|1|||
126586704|NCT04927065|455447151|FG001|First Booster|Physician Decision|0|||
126586705|NCT04927065|455447152|FG002|First Booster|Physician Decision|0|||
126586706|NCT04927065|455447153|FG003|First Booster|Physician Decision|3|||
126586707|NCT04927065|455447154|FG004|First Booster|Physician Decision|1|||
126586708|NCT04927065|455447155|FG005|First Booster|Physician Decision|1|||
126586709|NCT04927065|455447156|FG006|First Booster|Physician Decision|0|||
126586710|NCT04927065|455447157|FG007|First Booster|Physician Decision|3|||
126586711|NCT04927065|455447158|FG008|First Booster|Physician Decision|0|||
126586712|NCT04927065|455447159|FG009|First Booster|Physician Decision|0|||
126586713|NCT04927065|455447160|FG010|First Booster|Physician Decision|0|||
126731612|NCT02260648|455966150|FG002|Overall Study|Discontinue Due to Study Termination|7|||
126586714|NCT04927065|455447161|FG011|First Booster|Physician Decision|0|||
126586715|NCT04927065|455447162|FG012|First Booster|Physician Decision|0|||
126586716|NCT04927065|455447163|FG013|First Booster|Physician Decision|0|||
126586717|NCT04927065|455447164|FG014|First Booster|Physician Decision|0|||
126586718|NCT04927065|455447165|FG015|First Booster|Physician Decision|0|||
126586719|NCT04927065|455447150|FG000|First Booster|Protocol Violation|4|||
126586720|NCT04927065|455447151|FG001|First Booster|Protocol Violation|4|||
126586721|NCT04927065|455447152|FG002|First Booster|Protocol Violation|0|||
126586722|NCT04927065|455447153|FG003|First Booster|Protocol Violation|3|||
126586723|NCT04927065|455447154|FG004|First Booster|Protocol Violation|0|||
126586724|NCT04927065|455447155|FG005|First Booster|Protocol Violation|0|||
126586725|NCT04927065|455447156|FG006|First Booster|Protocol Violation|0|||
126586726|NCT04927065|455447157|FG007|First Booster|Protocol Violation|2|||
126586727|NCT04927065|455447158|FG008|First Booster|Protocol Violation|0|||
126586728|NCT04927065|455447159|FG009|First Booster|Protocol Violation|0|||
126586729|NCT04927065|455447160|FG010|First Booster|Protocol Violation|0|||
126586730|NCT04927065|455447161|FG011|First Booster|Protocol Violation|0|||
126586731|NCT04927065|455447162|FG012|First Booster|Protocol Violation|0|||
126586732|NCT04927065|455447163|FG013|First Booster|Protocol Violation|0|||
126586733|NCT04927065|455447164|FG014|First Booster|Protocol Violation|0|||
126586734|NCT04927065|455447165|FG015|First Booster|Protocol Violation|0|||
126586735|NCT04927065|455447150|FG000|First Booster|Withdrawal by Subject|8|||
126586736|NCT04927065|455447151|FG001|First Booster|Withdrawal by Subject|23|||
126586737|NCT04927065|455447152|FG002|First Booster|Withdrawal by Subject|0|||
126586738|NCT04927065|455447153|FG003|First Booster|Withdrawal by Subject|19|||
126586739|NCT04927065|455447154|FG004|First Booster|Withdrawal by Subject|20|||
126586740|NCT04927065|455447155|FG005|First Booster|Withdrawal by Subject|15|||
126586741|NCT04927065|455447156|FG006|First Booster|Withdrawal by Subject|6|||
126586742|NCT04927065|455447157|FG007|First Booster|Withdrawal by Subject|24|||
126586743|NCT04927065|455447158|FG008|First Booster|Withdrawal by Subject|0|||
126586744|NCT04927065|455447159|FG009|First Booster|Withdrawal by Subject|4|||
126586745|NCT04927065|455447160|FG010|First Booster|Withdrawal by Subject|0|||
126586746|NCT04927065|455447161|FG011|First Booster|Withdrawal by Subject|0|||
126586747|NCT04927065|455447162|FG012|First Booster|Withdrawal by Subject|0|||
126586748|NCT04927065|455447163|FG013|First Booster|Withdrawal by Subject|0|||
126586749|NCT04927065|455447164|FG014|First Booster|Withdrawal by Subject|0|||
126586750|NCT04927065|455447165|FG015|First Booster|Withdrawal by Subject|0|||
126586751|NCT04927065|455447150|FG000|First Booster|Other Than Specified|1|||
126586752|NCT04927065|455447151|FG001|First Booster|Other Than Specified|1|||
126586753|NCT04927065|455447152|FG002|First Booster|Other Than Specified|0|||
126586754|NCT04927065|455447153|FG003|First Booster|Other Than Specified|1|||
126586755|NCT04927065|455447154|FG004|First Booster|Other Than Specified|2|||
126586756|NCT04927065|455447155|FG005|First Booster|Other Than Specified|3|||
126586757|NCT04927065|455447156|FG006|First Booster|Other Than Specified|2|||
126586758|NCT04927065|455447157|FG007|First Booster|Other Than Specified|6|||
126586759|NCT04927065|455447158|FG008|First Booster|Other Than Specified|0|||
126586760|NCT04927065|455447159|FG009|First Booster|Other Than Specified|4|||
126586761|NCT04927065|455447160|FG010|First Booster|Other Than Specified|0|||
126586762|NCT04927065|455447161|FG011|First Booster|Other Than Specified|0|||
126586763|NCT04927065|455447162|FG012|First Booster|Other Than Specified|0|||
126586764|NCT04927065|455447163|FG013|First Booster|Other Than Specified|0|||
126586765|NCT04927065|455447164|FG014|First Booster|Other Than Specified|0|||
126586766|NCT04927065|455447165|FG015|First Booster|Other Than Specified|0|||
126586767|NCT04927065|455447150|FG000|Second Booster|Death|0|||
126586768|NCT04927065|455447151|FG001|Second Booster|Death|0|||
126586769|NCT04927065|455447152|FG002|Second Booster|Death|0|||
126586770|NCT04927065|455447153|FG003|Second Booster|Death|0|||
126586771|NCT04927065|455447154|FG004|Second Booster|Death|0|||
126586772|NCT04927065|455447155|FG005|Second Booster|Death|0|||
126586773|NCT04927065|455447156|FG006|Second Booster|Death|0|||
126586774|NCT04927065|455447157|FG007|Second Booster|Death|0|||
126586775|NCT04927065|455447158|FG008|Second Booster|Death|0|||
126586776|NCT04927065|455447159|FG009|Second Booster|Death|0|||
126586777|NCT04927065|455447160|FG010|Second Booster|Death|2|||
126586778|NCT04927065|455447161|FG011|Second Booster|Death|0|||
126777677|NCT01697449|456141406|FG000|Overall Study|Withdrawal by Subject|2|||
126586779|NCT04927065|455447162|FG012|Second Booster|Death|2|||
126586780|NCT04927065|455447163|FG013|Second Booster|Death|2|||
126586781|NCT04927065|455447164|FG014|Second Booster|Death|0|||
126586782|NCT04927065|455447165|FG015|Second Booster|Death|0|||
126586783|NCT04927065|455447150|FG000|Second Booster|Lost to Follow-up|0|||
126586784|NCT04927065|455447151|FG001|Second Booster|Lost to Follow-up|0|||
126586785|NCT04927065|455447152|FG002|Second Booster|Lost to Follow-up|3|||
126586786|NCT04927065|455447153|FG003|Second Booster|Lost to Follow-up|0|||
126586787|NCT04927065|455447154|FG004|Second Booster|Lost to Follow-up|0|||
126586788|NCT04927065|455447155|FG005|Second Booster|Lost to Follow-up|0|||
126586789|NCT04927065|455447156|FG006|Second Booster|Lost to Follow-up|0|||
126586790|NCT04927065|455447157|FG007|Second Booster|Lost to Follow-up|0|||
126586791|NCT04927065|455447158|FG008|Second Booster|Lost to Follow-up|0|||
126586792|NCT04927065|455447159|FG009|Second Booster|Lost to Follow-up|0|||
126586793|NCT04927065|455447160|FG010|Second Booster|Lost to Follow-up|14|||
126586794|NCT04927065|455447161|FG011|Second Booster|Lost to Follow-up|10|||
126586795|NCT04927065|455447162|FG012|Second Booster|Lost to Follow-up|13|||
126586796|NCT04927065|455447163|FG013|Second Booster|Lost to Follow-up|16|||
126586797|NCT04927065|455447164|FG014|Second Booster|Lost to Follow-up|0|||
126586798|NCT04927065|455447165|FG015|Second Booster|Lost to Follow-up|0|||
126586799|NCT04927065|455447150|FG000|Second Booster|Physician Decision|0|||
126586800|NCT04927065|455447151|FG001|Second Booster|Physician Decision|0|||
126586801|NCT04927065|455447152|FG002|Second Booster|Physician Decision|0|||
126586802|NCT04927065|455447153|FG003|Second Booster|Physician Decision|0|||
126586803|NCT04927065|455447154|FG004|Second Booster|Physician Decision|0|||
126586804|NCT04927065|455447155|FG005|Second Booster|Physician Decision|0|||
126586805|NCT04927065|455447156|FG006|Second Booster|Physician Decision|0|||
126586806|NCT04927065|455447157|FG007|Second Booster|Physician Decision|0|||
126586807|NCT04927065|455447158|FG008|Second Booster|Physician Decision|0|||
126586808|NCT04927065|455447159|FG009|Second Booster|Physician Decision|0|||
126586809|NCT04927065|455447160|FG010|Second Booster|Physician Decision|0|||
126586810|NCT04927065|455447161|FG011|Second Booster|Physician Decision|3|||
126586811|NCT04927065|455447162|FG012|Second Booster|Physician Decision|0|||
126586812|NCT04927065|455447163|FG013|Second Booster|Physician Decision|1|||
126586813|NCT04927065|455447164|FG014|Second Booster|Physician Decision|0|||
126586814|NCT04927065|455447165|FG015|Second Booster|Physician Decision|0|||
126586815|NCT04927065|455447150|FG000|Second Booster|Withdrawal by Subject|0|||
126586816|NCT04927065|455447151|FG001|Second Booster|Withdrawal by Subject|0|||
126586817|NCT04927065|455447152|FG002|Second Booster|Withdrawal by Subject|4|||
126586818|NCT04927065|455447153|FG003|Second Booster|Withdrawal by Subject|0|||
126586819|NCT04927065|455447154|FG004|Second Booster|Withdrawal by Subject|0|||
126586820|NCT04927065|455447155|FG005|Second Booster|Withdrawal by Subject|0|||
126586821|NCT04927065|455447156|FG006|Second Booster|Withdrawal by Subject|0|||
126586822|NCT04927065|455447157|FG007|Second Booster|Withdrawal by Subject|0|||
126586823|NCT04927065|455447158|FG008|Second Booster|Withdrawal by Subject|0|||
126586824|NCT04927065|455447159|FG009|Second Booster|Withdrawal by Subject|0|||
126586825|NCT04927065|455447160|FG010|Second Booster|Withdrawal by Subject|3|||
126586826|NCT04927065|455447161|FG011|Second Booster|Withdrawal by Subject|16|||
126586827|NCT04927065|455447162|FG012|Second Booster|Withdrawal by Subject|13|||
126586828|NCT04927065|455447163|FG013|Second Booster|Withdrawal by Subject|9|||
126586829|NCT04927065|455447164|FG014|Second Booster|Withdrawal by Subject|0|||
126586830|NCT04927065|455447165|FG015|Second Booster|Withdrawal by Subject|0|||
126586831|NCT04927065|455447150|FG000|Second Booster|Other Than Specified|0|||
126586832|NCT04927065|455447151|FG001|Second Booster|Other Than Specified|0|||
126586833|NCT04927065|455447152|FG002|Second Booster|Other Than Specified|0|||
126586834|NCT04927065|455447153|FG003|Second Booster|Other Than Specified|0|||
126586835|NCT04927065|455447154|FG004|Second Booster|Other Than Specified|0|||
126586836|NCT04927065|455447155|FG005|Second Booster|Other Than Specified|0|||
126586837|NCT04927065|455447156|FG006|Second Booster|Other Than Specified|0|||
126586838|NCT04927065|455447157|FG007|Second Booster|Other Than Specified|0|||
126586839|NCT04927065|455447158|FG008|Second Booster|Other Than Specified|0|||
126586840|NCT04927065|455447159|FG009|Second Booster|Other Than Specified|0|||
126586841|NCT04927065|455447160|FG010|Second Booster|Other Than Specified|1|||
126586842|NCT04927065|455447161|FG011|Second Booster|Other Than Specified|1|||
126586843|NCT04927065|455447162|FG012|Second Booster|Other Than Specified|4|||
126586844|NCT04927065|455447163|FG013|Second Booster|Other Than Specified|0|||
126586845|NCT04927065|455447164|FG014|Second Booster|Other Than Specified|0|||
126586846|NCT04927065|455447165|FG015|Second Booster|Other Than Specified|0|||
126586847|NCT04927065|455447150|FG000|Third Booster|Lost to Follow-up|0|||
126586848|NCT04927065|455447151|FG001|Third Booster|Lost to Follow-up|0|||
126586849|NCT04927065|455447152|FG002|Third Booster|Lost to Follow-up|0|||
126586850|NCT04927065|455447153|FG003|Third Booster|Lost to Follow-up|0|||
126586851|NCT04927065|455447154|FG004|Third Booster|Lost to Follow-up|0|||
126586852|NCT04927065|455447155|FG005|Third Booster|Lost to Follow-up|0|||
126586853|NCT04927065|455447156|FG006|Third Booster|Lost to Follow-up|0|||
126586854|NCT04927065|455447157|FG007|Third Booster|Lost to Follow-up|0|||
126586855|NCT04927065|455447158|FG008|Third Booster|Lost to Follow-up|0|||
126586856|NCT04927065|455447159|FG009|Third Booster|Lost to Follow-up|0|||
126586857|NCT04927065|455447160|FG010|Third Booster|Lost to Follow-up|0|||
126586858|NCT04927065|455447161|FG011|Third Booster|Lost to Follow-up|0|||
126586859|NCT04927065|455447162|FG012|Third Booster|Lost to Follow-up|0|||
126586860|NCT04927065|455447163|FG013|Third Booster|Lost to Follow-up|0|||
126586861|NCT04927065|455447164|FG014|Third Booster|Lost to Follow-up|0|||
126586862|NCT04927065|455447165|FG015|Third Booster|Lost to Follow-up|1|||
126586863|NCT04927065|455447150|FG000|Third Booster|Withdrawal by Subject|0|||
126586864|NCT04927065|455447151|FG001|Third Booster|Withdrawal by Subject|0|||
126586865|NCT04927065|455447152|FG002|Third Booster|Withdrawal by Subject|0|||
126586866|NCT04927065|455447153|FG003|Third Booster|Withdrawal by Subject|0|||
126586867|NCT04927065|455447154|FG004|Third Booster|Withdrawal by Subject|0|||
126586868|NCT04927065|455447155|FG005|Third Booster|Withdrawal by Subject|0|||
126586869|NCT04927065|455447156|FG006|Third Booster|Withdrawal by Subject|0|||
126586870|NCT04927065|455447157|FG007|Third Booster|Withdrawal by Subject|0|||
126586871|NCT04927065|455447158|FG008|Third Booster|Withdrawal by Subject|0|||
126586872|NCT04927065|455447159|FG009|Third Booster|Withdrawal by Subject|0|||
126586873|NCT04927065|455447160|FG010|Third Booster|Withdrawal by Subject|0|||
126586874|NCT04927065|455447161|FG011|Third Booster|Withdrawal by Subject|0|||
126586875|NCT04927065|455447162|FG012|Third Booster|Withdrawal by Subject|0|||
126586876|NCT04927065|455447163|FG013|Third Booster|Withdrawal by Subject|0|||
126586877|NCT04927065|455447164|FG014|Third Booster|Withdrawal by Subject|0|||
126586878|NCT04927065|455447165|FG015|Third Booster|Withdrawal by Subject|1|||
126586879|NCT04347161|455447174|FG000|Overall Study|Death|0|||
126586880|NCT04347161|455447175|FG001|Overall Study|Death|2|||
126586881|NCT04347161|455447174|FG000|Overall Study|Withdrawal by Subject|1|||
126586882|NCT04347161|455447175|FG001|Overall Study|Withdrawal by Subject|0|||
126586883|NCT04347161|455447174|FG000|Overall Study|Lost to Follow-up|0|||
126586884|NCT04347161|455447175|FG001|Overall Study|Lost to Follow-up|1|||
126586885|NCT04347161|455447174|FG000|Overall Study|No longer on study medication|1|||
126586886|NCT04347161|455447175|FG001|Overall Study|No longer on study medication|1|||
126586887|NCT04169373|455447176|FG000|Week 1 to Week 14|Adverse Event|1|||
126586888|NCT04169373|455447177|FG001|Week 1 to Week 14|Adverse Event|0|||
126586889|NCT04169373|455447178|FG002|Week 1 to Week 14|Adverse Event|1|||
126586890|NCT04169373|455447179|FG003|Week 1 to Week 14|Adverse Event|2|||
126586891|NCT04169373|455447176|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
126586892|NCT04169373|455447177|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
126586893|NCT04169373|455447178|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
126586894|NCT04169373|455447179|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
126586895|NCT04169373|455447176|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
126586896|NCT04169373|455447177|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
126586897|NCT04169373|455447178|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
126586898|NCT04169373|455447179|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
126586899|NCT04169373|455447176|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
126586900|NCT04169373|455447177|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
126586901|NCT04169373|455447178|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
126586902|NCT04169373|455447179|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
126586903|NCT04169373|455447176|FG000|Week 1 to Week 14|Other|1|||
126586904|NCT04169373|455447177|FG001|Week 1 to Week 14|Other|3|||
126586905|NCT04169373|455447178|FG002|Week 1 to Week 14|Other|3|||
126586906|NCT04169373|455447179|FG003|Week 1 to Week 14|Other|5|||
126586907|NCT04169373|455447176|FG000|Week 14 to Week 52|Adverse Event|1|||
126586908|NCT04169373|455447177|FG001|Week 14 to Week 52|Adverse Event|0|||
126586909|NCT04169373|455447178|FG002|Week 14 to Week 52|Adverse Event|0|||
126586910|NCT04169373|455447179|FG003|Week 14 to Week 52|Adverse Event|1|||
126586911|NCT04169373|455447176|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
126586912|NCT04169373|455447177|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
126586913|NCT04169373|455447178|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
126586914|NCT04169373|455447179|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
126586915|NCT04169373|455447176|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
126586916|NCT04169373|455447177|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
126586917|NCT04169373|455447178|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
126586918|NCT04169373|455447179|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
126586919|NCT04169373|455447176|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
126586920|NCT04169373|455447177|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
126586921|NCT04169373|455447178|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
126586922|NCT04169373|455447179|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
126586923|NCT04169373|455447176|FG000|Week 14 to Week 52|Other|4|||
126586924|NCT04169373|455447177|FG001|Week 14 to Week 52|Other|5|||
126586925|NCT04169373|455447178|FG002|Week 14 to Week 52|Other|4|||
126586926|NCT04169373|455447179|FG003|Week 14 to Week 52|Other|5|||
126586927|NCT04169373|455447176|FG000|Week 14 to Week 52|Ongoing|0|||
126586928|NCT04169373|455447177|FG001|Week 14 to Week 52|Ongoing|1|||
126586929|NCT04169373|455447178|FG002|Week 14 to Week 52|Ongoing|0|||
126586930|NCT04169373|455447179|FG003|Week 14 to Week 52|Ongoing|0|||
126586931|NCT01999075|455447180|FG000|Overall Study|Lost to Follow-up|0|||
126586932|NCT01999075|455447181|FG001|Overall Study|Lost to Follow-up|2|||
126586933|NCT01999075|455447180|FG000|Overall Study|Withdrawal by Subject|2|||
126586934|NCT01999075|455447181|FG001|Overall Study|Withdrawal by Subject|7|||
126586935|NCT01999075|455447180|FG000|Overall Study|Enrolled in drug trial|3|||
126586936|NCT01999075|455447181|FG001|Overall Study|Enrolled in drug trial|1|||
126586937|NCT01999075|455447180|FG000|Overall Study|Became ineligible|0|||
126586938|NCT01999075|455447181|FG001|Overall Study|Became ineligible|2|||
126586939|NCT05948670|455447184|FG000|Overall Study|Protocol Violation|6|||
126586940|NCT05948670|455447185|FG001|Overall Study|Protocol Violation|8|||
126586941|NCT05948670|455447184|FG000|Overall Study|Withdrawal by Subject|0|||
126586942|NCT05948670|455447185|FG001|Overall Study|Withdrawal by Subject|1|||
126586943|NCT03699709|455447186|FG000|Overall Study|Death|1|||
126586944|NCT03699709|455447187|FG001|Overall Study|Death|2|||
126586945|NCT03699709|455447186|FG000|Overall Study|Lost to Follow-up|10|||
126586946|NCT03699709|455447187|FG001|Overall Study|Lost to Follow-up|3|||
126586947|NCT03699709|455447186|FG000|Overall Study|Withdrawal by Subject|5|||
126586948|NCT03699709|455447187|FG001|Overall Study|Withdrawal by Subject|0|||
126586949|NCT03699709|455447186|FG000|Overall Study|incarcerated|1|||
126586950|NCT03699709|455447187|FG001|Overall Study|incarcerated|0|||
126586951|NCT03699709|455447186|FG000|Overall Study|scheduled, but no show|0|||
126586952|NCT03699709|455447187|FG001|Overall Study|scheduled, but no show|1|||
126586953|NCT04562649|455447189|FG000|Overall Study|Withdrawal by Subject|11|||
126586954|NCT04562649|455447190|FG001|Overall Study|Withdrawal by Subject|8|||
126586955|NCT04562649|455447189|FG000|Overall Study|Lost to Follow-up|26|||
126586956|NCT04562649|455447190|FG001|Overall Study|Lost to Follow-up|20|||
126586957|NCT03675282|455447193|FG000|Overall Study|Lost to Follow-up|4|||
126586958|NCT03675282|455447194|FG001|Overall Study|Lost to Follow-up|8|||
126586959|NCT03675282|455447195|FG002|Overall Study|Lost to Follow-up|1|||
126586960|NCT03675282|455447196|FG003|Overall Study|Lost to Follow-up|0|||
126586961|NCT03675282|455447197|FG004|Overall Study|Lost to Follow-up|2|||
126586962|NCT03675282|455447198|FG005|Overall Study|Lost to Follow-up|7|||
126586963|NCT03675282|455447193|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
126586964|NCT03675282|455447194|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
126586965|NCT03675282|455447195|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
126586966|NCT03675282|455447196|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
126586967|NCT03675282|455447197|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
126586968|NCT03675282|455447198|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
126586969|NCT03675282|455447193|FG000|Overall Study|Physician Decision|1|||
126586970|NCT03675282|455447194|FG001|Overall Study|Physician Decision|0|||
126586971|NCT03675282|455447195|FG002|Overall Study|Physician Decision|0|||
126586972|NCT03675282|455447196|FG003|Overall Study|Physician Decision|0|||
126586973|NCT03675282|455447197|FG004|Overall Study|Physician Decision|0|||
126586974|NCT03675282|455447198|FG005|Overall Study|Physician Decision|0|||
126586975|NCT03056040|455447205|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
126586976|NCT03056040|455447206|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
126586977|NCT03056040|455447205|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
126586978|NCT03056040|455447206|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
126586979|NCT03056040|455447205|FG000|Primary Evaluation Period|Pregnancy|0|||
126586980|NCT03056040|455447206|FG001|Primary Evaluation Period|Pregnancy|1|||
126586981|NCT03056040|455447205|FG000|Primary Evaluation Period|Randomized, not treated|1|||
126586982|NCT03056040|455447206|FG001|Primary Evaluation Period|Randomized, not treated|1|||
126586983|NCT03056040|455447205|FG000|Extension Period|Physician Decision|3|||
126586984|NCT03056040|455447206|FG001|Extension Period|Physician Decision|3|||
126586985|NCT03056040|455447205|FG000|Extension Period|Lost to Follow-up|0|||
126586986|NCT03056040|455447206|FG001|Extension Period|Lost to Follow-up|1|||
126586987|NCT03056040|455447205|FG000|Extension Period|Death|0|||
126586988|NCT03056040|455447206|FG001|Extension Period|Death|3|||
126586989|NCT03056040|455447205|FG000|Extension Period|Withdrawal by Subject|1|||
126586990|NCT03056040|455447206|FG001|Extension Period|Withdrawal by Subject|0|||
126586991|NCT04029688|455447209|FG000|Overall Study|Death|8|||
126586992|NCT04029688|455447210|FG001|Overall Study|Death|3|||
126586993|NCT04029688|455447211|FG002|Overall Study|Death|6|||
126586994|NCT04029688|455447212|FG003|Overall Study|Death|2|||
126586995|NCT04029688|455447213|FG004|Overall Study|Death|5|||
126586996|NCT04029688|455447214|FG005|Overall Study|Death|0|||
126586997|NCT04029688|455447215|FG006|Overall Study|Death|2|||
126586998|NCT04029688|455447216|FG007|Overall Study|Death|3|||
126586999|NCT04029688|455447209|FG000|Overall Study|Study Terminated by Sponsor|0|||
126587000|NCT04029688|455447210|FG001|Overall Study|Study Terminated by Sponsor|0|||
126587001|NCT04029688|455447211|FG002|Overall Study|Study Terminated by Sponsor|0|||
126587002|NCT04029688|455447212|FG003|Overall Study|Study Terminated by Sponsor|0|||
126587003|NCT04029688|455447213|FG004|Overall Study|Study Terminated by Sponsor|1|||
126587004|NCT04029688|455447214|FG005|Overall Study|Study Terminated by Sponsor|3|||
126587005|NCT04029688|455447215|FG006|Overall Study|Study Terminated by Sponsor|1|||
126587006|NCT04029688|455447216|FG007|Overall Study|Study Terminated by Sponsor|3|||
126587007|NCT04029688|455447209|FG000|Overall Study|Withdrawal by Subject|0|||
126587008|NCT04029688|455447210|FG001|Overall Study|Withdrawal by Subject|0|||
126587009|NCT04029688|455447211|FG002|Overall Study|Withdrawal by Subject|0|||
126587010|NCT04029688|455447212|FG003|Overall Study|Withdrawal by Subject|1|||
126587011|NCT04029688|455447213|FG004|Overall Study|Withdrawal by Subject|0|||
126587012|NCT04029688|455447214|FG005|Overall Study|Withdrawal by Subject|0|||
126587013|NCT04029688|455447215|FG006|Overall Study|Withdrawal by Subject|0|||
126587014|NCT04029688|455447216|FG007|Overall Study|Withdrawal by Subject|0|||
126587015|NCT05763823|455447217|FG000|Overall Study|Death|6|||
126587016|NCT05763823|455447217|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126587017|NCT05763823|455447217|FG000|Overall Study|Withdrawal by Subject|6|||
126587018|NCT01494662|455447223|FG000|Overall Study|Withdrawal by Subject|0|||
126587019|NCT01494662|455447224|FG001|Overall Study|Withdrawal by Subject|0|||
126587020|NCT01494662|455447225|FG002|Overall Study|Withdrawal by Subject|1|||
126587021|NCT01494662|455447226|FG003|Overall Study|Withdrawal by Subject|0|||
126587022|NCT01494662|455447227|FG004|Overall Study|Withdrawal by Subject|0|||
126587023|NCT01494662|455447228|FG005|Overall Study|Withdrawal by Subject|0|||
126587024|NCT01494662|455447229|FG006|Overall Study|Withdrawal by Subject|0|||
126587025|NCT01494662|455447223|FG000|Overall Study|Physician Decision|0|||
126731613|NCT02721251|455966151|FG000|Overall Study|Withdrawal by Subject|8|||
126731614|NCT02721251|455966152|FG001|Overall Study|Withdrawal by Subject|7|||
126731615|NCT02721251|455966153|FG002|Overall Study|Withdrawal by Subject|9|||
126731616|NCT02721251|455966151|FG000|Overall Study|poor adherence|2|||
126731617|NCT02721251|455966152|FG001|Overall Study|poor adherence|2|||
126731618|NCT02721251|455966153|FG002|Overall Study|poor adherence|2|||
126731619|NCT01714817|455966154|FG000|Year 1 Period|Lack of Efficacy|11|||
126731620|NCT01714817|455966155|FG001|Year 1 Period|Lack of Efficacy|9|||
126731621|NCT01714817|455966154|FG000|Year 1 Period|Adverse Event|20|||
126731622|NCT01714817|455966155|FG001|Year 1 Period|Adverse Event|17|||
126731623|NCT01714817|455966154|FG000|Year 1 Period|Withdrawal by Subject|6|||
126731624|NCT01714817|455966155|FG001|Year 1 Period|Withdrawal by Subject|7|||
126731625|NCT01714817|455966154|FG000|Year 1 Period|Death|1|||
126731626|NCT01714817|455966155|FG001|Year 1 Period|Death|1|||
126731627|NCT01714817|455966154|FG000|Year 1 Period|Lost to Follow-up|0|||
126731628|NCT01714817|455966155|FG001|Year 1 Period|Lost to Follow-up|2|||
126731629|NCT01714817|455966154|FG000|Year 1 Period|Poor / non-compliance|0|||
126731630|NCT01714817|455966155|FG001|Year 1 Period|Poor / non-compliance|1|||
126731631|NCT01714817|455966154|FG000|Year 1 Period|Pregnancy|2|||
126731632|NCT01714817|455966155|FG001|Year 1 Period|Pregnancy|0|||
126731633|NCT01714817|455966154|FG000|Year 1 Period|Participant no longer meets criteria|6|||
126731634|NCT01714817|455966155|FG001|Year 1 Period|Participant no longer meets criteria|2|||
126731635|NCT01714817|455966154|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
126731636|NCT01714817|455966155|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
126731637|NCT01714817|455966154|FG000|Year 1 Period|Change in Concomitant Medication|0|||
126731638|NCT01714817|455966155|FG001|Year 1 Period|Change in Concomitant Medication|1|||
126731639|NCT01714817|455966154|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
126731640|NCT01714817|455966155|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
126731641|NCT01714817|455966154|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
126731642|NCT01714817|455966155|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
126731643|NCT01714817|455966154|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
126731644|NCT01714817|455966155|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
126731645|NCT01714817|455966154|FG000|Year 2 Period|Lack of Efficacy|4|||
126731646|NCT01714817|455966155|FG001|Year 2 Period|Lack of Efficacy|12|||
126731647|NCT01714817|455966154|FG000|Year 2 Period|Adverse Event|7|||
126731648|NCT01714817|455966155|FG001|Year 2 Period|Adverse Event|6|||
126731649|NCT01714817|455966154|FG000|Year 2 Period|Participant request to stop treatment|4|||
126731650|NCT01714817|455966155|FG001|Year 2 Period|Participant request to stop treatment|4|||
126731651|NCT01714817|455966154|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
126731652|NCT01714817|455966155|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
126731653|NCT01714817|455966154|FG000|Year 2 Period|Participant withdrew consent|1|||
126731654|NCT01714817|455966155|FG001|Year 2 Period|Participant withdrew consent|5|||
126731655|NCT01714817|455966154|FG000|Year 2 Period|Participant no longer meets criteria|1|||
126731656|NCT01714817|455966155|FG001|Year 2 Period|Participant no longer meets criteria|4|||
126731657|NCT01714817|455966154|FG000|Year 2 Period|Lost to Follow-up|2|||
126731658|NCT01714817|455966155|FG001|Year 2 Period|Lost to Follow-up|0|||
126731659|NCT01714817|455966154|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
126731660|NCT01714817|455966155|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
126731661|NCT01714817|455966154|FG000|Year 2 Period|Pregnancy|1|||
126731662|NCT01714817|455966155|FG001|Year 2 Period|Pregnancy|1|||
126731663|NCT01714817|455966154|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
126731664|NCT01714817|455966155|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
126731665|NCT01714817|455966154|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
126731666|NCT01714817|455966155|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
126731667|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
126587026|NCT01494662|455447224|FG001|Overall Study|Physician Decision|0|||
126587027|NCT01494662|455447225|FG002|Overall Study|Physician Decision|1|||
126587028|NCT01494662|455447226|FG003|Overall Study|Physician Decision|0|||
126587029|NCT01494662|455447227|FG004|Overall Study|Physician Decision|0|||
126587030|NCT01494662|455447228|FG005|Overall Study|Physician Decision|0|||
126587031|NCT01494662|455447229|FG006|Overall Study|Physician Decision|0|||
126587032|NCT05311384|455447230|FG000|Overall Study|Uncontrolled health conditions|2|||
126587033|NCT05311384|455447230|FG000|Overall Study|Withdrawal by Subject|1|||
126587034|NCT04322643|455447231|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
126587035|NCT03891667|455447232|FG000|Overall Study|Physician Decision|1|||
126587036|NCT03891667|455447233|FG001|Overall Study|Physician Decision|1|||
126731668|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
126731669|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
126731670|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
126587037|NCT03891667|455447232|FG000|Overall Study|COVID related pause|1|||
126587038|NCT03891667|455447233|FG001|Overall Study|COVID related pause|0|||
126587039|NCT03891667|455447232|FG000|Overall Study|Withdrawal by Subject|0|||
126587040|NCT03891667|455447233|FG001|Overall Study|Withdrawal by Subject|1|||
126587041|NCT03891667|455447232|FG000|Overall Study|Adverse Event|0|||
126587042|NCT03891667|455447233|FG001|Overall Study|Adverse Event|1|||
126587043|NCT05710107|455447234|FG000|Overall Study|Withdrawal by Subject|1|||
126587044|NCT05710107|455447235|FG001|Overall Study|Withdrawal by Subject|1|||
126587045|NCT05710107|455447234|FG000|Overall Study|Lost to Follow-up|8|||
126587046|NCT05710107|455447235|FG001|Overall Study|Lost to Follow-up|9|||
126587047|NCT05710107|455447234|FG000|Overall Study|Unable to place assigned block|2|||
126587048|NCT05710107|455447235|FG001|Overall Study|Unable to place assigned block|0|||
126587049|NCT05710107|455447234|FG000|Overall Study|Withdrawn by study team|0|||
126587050|NCT05710107|455447235|FG001|Overall Study|Withdrawn by study team|1|||
126587051|NCT05076708|455447236|FG000|Overall Study|Withdrawal by Subject|4|||
126587052|NCT05076708|455447236|FG000|Overall Study|Lost to study during switch phase|8|||
126587053|NCT04055090|455447238|FG000|Overall Study|screen failure|1|||
126587054|NCT04055090|455447239|FG001|Overall Study|screen failure|0|||
126587055|NCT04055090|455447238|FG000|Overall Study|Withdrawal by Subject|1|||
126587056|NCT04055090|455447239|FG001|Overall Study|Withdrawal by Subject|0|||
126587057|NCT05071807|455447240|FG000|Overall Study|Withdrawal by Subject|4|||
126587058|NCT05071807|455447241|FG001|Overall Study|Withdrawal by Subject|0|||
126587059|NCT05071807|455447240|FG000|Overall Study|Unrelated medical issues|3|||
126587060|NCT05071807|455447241|FG001|Overall Study|Unrelated medical issues|0|||
126587061|NCT05071807|455447240|FG000|Overall Study|Relocated|0|||
126587062|NCT05071807|455447241|FG001|Overall Study|Relocated|1|||
126777678|NCT01697449|456141406|FG000|Overall Study|Physician Decision|1|||
126777679|NCT01697449|456141406|FG000|Overall Study|Death|2|||
126777680|NCT01697449|456141406|FG000|Overall Study|Other|1|||
126777681|NCT01697449|456141406|FG000|Overall Study|Missing|25|||
126777682|NCT02390219|456141407|FG000|Overall Study|Death|1|||
126777683|NCT02390219|456141407|FG000|Overall Study|Physician Decision|1|||
126777684|NCT02390219|456141407|FG000|Overall Study|Adverse Event|6|||
126777685|NCT02390219|456141407|FG000|Overall Study|Withdrawal by Subject|1|||
126777686|NCT02390219|456141407|FG000|Overall Study|Lost to Follow-up|2|||
126777687|NCT02390219|456141407|FG000|Overall Study|Other|2|||
126777688|NCT01169844|456141408|FG000|Overall Study|Adverse Event|0|||
126777689|NCT01169844|456141409|FG001|Overall Study|Adverse Event|1|||
126777690|NCT01169844|456141408|FG000|Overall Study|Patient withdrew consent|4|||
126777691|NCT01169844|456141409|FG001|Overall Study|Patient withdrew consent|0|||
126777692|NCT01169844|456141408|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126777693|NCT01169844|456141409|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126777694|NCT05037409|456141410|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
126777695|NCT05037409|456141411|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
126777696|NCT05037409|456141412|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
126777697|NCT00529568|456141413|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
126777698|NCT00529568|456141414|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
126777699|NCT00529568|456141415|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
126777700|NCT00529568|456141413|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
126777701|NCT00529568|456141414|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
126587063|NCT05551637|455447242|FG000|Overall Study|Lack of Efficacy|0|||
126587064|NCT05551637|455447243|FG001|Overall Study|Lack of Efficacy|6|||
126587065|NCT05551637|455447242|FG000|Overall Study|Lost to Follow-up|1|||
126587066|NCT05551637|455447243|FG001|Overall Study|Lost to Follow-up|1|||
126587067|NCT05282173|455447244|FG000|Overall Study|Missed|3|||
126587068|NCT05282173|455447245|FG001|Overall Study|Missed|2|||
126587069|NCT05282173|455447246|FG002|Overall Study|Missed|4|||
126587070|NCT04353661|455449379|FG000|Overall Study|Protocol Violation|0|||
126587071|NCT04353661|455449380|FG001|Overall Study|Protocol Violation|0|||
126587072|NCT04353661|455449381|FG002|Overall Study|Protocol Violation|1|||
126587073|NCT04353661|455449379|FG000|Overall Study|Study termination by the Sponsor|1|||
126587074|NCT04353661|455449380|FG001|Overall Study|Study termination by the Sponsor|1|||
126587075|NCT04353661|455449381|FG002|Overall Study|Study termination by the Sponsor|1|||
126587076|NCT00667251|455449382|FG000|Overall Study|Disease progression|232|||
126587077|NCT00667251|455449383|FG001|Overall Study|Disease progression|203|||
126587078|NCT00667251|455449382|FG000|Overall Study|Toxicity|44|||
126587079|NCT00667251|455449383|FG001|Overall Study|Toxicity|23|||
126587080|NCT00667251|455449382|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
126587081|NCT00667251|455449383|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
126587082|NCT00667251|455449382|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
126587083|NCT00667251|455449383|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
126587084|NCT00667251|455449382|FG000|Overall Study|Symptomatic progression|8|||
126587085|NCT00667251|455449383|FG001|Overall Study|Symptomatic progression|4|||
126777702|NCT00529568|456141415|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
126587086|NCT00667251|455449382|FG000|Overall Study|Death|6|||
126587087|NCT00667251|455449383|FG001|Overall Study|Death|11|||
126587088|NCT00667251|455449382|FG000|Overall Study|Intercurrent illness|5|||
126587089|NCT00667251|455449383|FG001|Overall Study|Intercurrent illness|6|||
126587090|NCT00667251|455449382|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
126587091|NCT00667251|455449383|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
126587092|NCT00667251|455449382|FG000|Overall Study|Randomized not Treated|4|||
126587093|NCT00667251|455449383|FG001|Overall Study|Randomized not Treated|1|||
126587094|NCT02727699|455449384|FG000|Overall Study|Adverse Event|2|||
126587095|NCT02727699|455449385|FG001|Overall Study|Adverse Event|0|||
126587096|NCT02727699|455449384|FG000|Overall Study|Withdrawal by Subject|5|||
126587097|NCT02727699|455449385|FG001|Overall Study|Withdrawal by Subject|3|||
126587098|NCT02727699|455449384|FG000|Overall Study|Protocol Violation|0|||
126587099|NCT02727699|455449385|FG001|Overall Study|Protocol Violation|1|||
126587100|NCT02727699|455449384|FG000|Overall Study|Physician Decision|0|||
126587101|NCT02727699|455449385|FG001|Overall Study|Physician Decision|1|||
126587102|NCT02727699|455449384|FG000|Overall Study|Lost to Follow-up|1|||
126587103|NCT02727699|455449385|FG001|Overall Study|Lost to Follow-up|0|||
126587104|NCT02727699|455449384|FG000|Overall Study|Sponsor Decision|1|||
126587105|NCT02727699|455449385|FG001|Overall Study|Sponsor Decision|0|||
126587106|NCT02995434|455449386|FG000|Overall Study|Adverse Event|1|||
126587107|NCT02995434|455449387|FG001|Overall Study|Adverse Event|0|||
126587108|NCT02995434|455449386|FG000|Overall Study|Withdrawal by Subject|6|||
126587109|NCT02995434|455449387|FG001|Overall Study|Withdrawal by Subject|3|||
126587110|NCT04318548|455449388|FG000|Overall Study|Adverse Event|0|||
126587111|NCT04318548|455449389|FG001|Overall Study|Adverse Event|0|||
126587112|NCT04318548|455449390|FG002|Overall Study|Adverse Event|1|||
126587113|NCT04318548|455449388|FG000|Overall Study|Lost to Follow-up|6|||
126587114|NCT04318548|455449389|FG001|Overall Study|Lost to Follow-up|13|||
126587115|NCT04318548|455449390|FG002|Overall Study|Lost to Follow-up|9|||
126587116|NCT04318548|455449388|FG000|Overall Study|Protocol Violation|1|||
126587117|NCT04318548|455449389|FG001|Overall Study|Protocol Violation|0|||
126587118|NCT04318548|455449390|FG002|Overall Study|Protocol Violation|2|||
126587119|NCT04318548|455449388|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
126587120|NCT04318548|455449389|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
126587121|NCT04318548|455449390|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
126587122|NCT04318548|455449388|FG000|Overall Study|Migrated / moved from the study area|0|||
126587123|NCT04318548|455449389|FG001|Overall Study|Migrated / moved from the study area|0|||
126587124|NCT04318548|455449390|FG002|Overall Study|Migrated / moved from the study area|1|||
126587125|NCT04318548|455449388|FG000|Overall Study|Other|1|||
126587126|NCT04318548|455449389|FG001|Overall Study|Other|2|||
126587127|NCT04318548|455449390|FG002|Overall Study|Other|3|||
126587128|NCT04179500|455449391|FG000|Treatment|Withdrawal by Subject|1|||
126587129|NCT04179500|455449391|FG000|Treatment|Adverse Event|2|||
126587130|NCT04179500|455449391|FG000|Treatment|pyrazinamide resistance|1|||
126587131|NCT04241068|455449392|FG000|Core Treatment Period|Adverse Event|91|||
126587132|NCT04241068|455449392|FG000|Core Treatment Period|Change of Treatment|4|||
126587133|NCT04241068|455449392|FG000|Core Treatment Period|Consent Withdrawn|143|||
126587134|NCT04241068|455449392|FG000|Core Treatment Period|Death|26|||
126587135|NCT04241068|455449392|FG000|Core Treatment Period|Disease Progression|67|||
126587136|NCT04241068|455449392|FG000|Core Treatment Period|Investigator Decision|40|||
126587137|NCT04241068|455449392|FG000|Core Treatment Period|Loss of Capacity|9|||
126587138|NCT04241068|455449392|FG000|Core Treatment Period|Lost to Follow-up|11|||
126587139|NCT04241068|455449392|FG000|Core Treatment Period|Relocation|4|||
126587140|NCT04241068|455449392|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
126587141|NCT04241068|455449392|FG000|Core Treatment Period|Study Visit Burden|40|||
126587142|NCT04241068|455449392|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
126587143|NCT04241068|455449392|FG000|Core Treatment Period|Missing|2|||
126587144|NCT04241068|455449392|FG000|Core Treatment Period|Reason Not Specified|41|||
126587145|NCT04241068|455449392|FG000|LTE Period|Adverse Event|19|||
126587146|NCT04241068|455449392|FG000|LTE Period|Change of Treatment|1|||
126587147|NCT04241068|455449392|FG000|LTE Period|Consent Withdrawn|71|||
126587148|NCT04241068|455449392|FG000|LTE Period|Death|8|||
126587149|NCT04241068|455449392|FG000|LTE Period|Disease Progression|11|||
126587150|NCT04241068|455449392|FG000|LTE Period|Investigator Decision|12|||
126587151|NCT04241068|455449392|FG000|LTE Period|Loss of Capacity|2|||
126587152|NCT04241068|455449392|FG000|LTE Period|Lost to Follow-up|7|||
126587153|NCT04241068|455449392|FG000|LTE Period|Relocation|6|||
126587154|NCT04241068|455449392|FG000|LTE Period|Site Terminated by Sponsor|26|||
126587155|NCT04241068|455449392|FG000|LTE Period|Study Terminated by Sponsor|276|||
126587156|NCT04241068|455449392|FG000|LTE Period|Study Visit Burden|10|||
126587157|NCT04241068|455449392|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
126587158|NCT04241068|455449392|FG000|LTE Period|Reason Not Specified|65|||
126587159|NCT04492007|455449393|FG000|Overall Study|Lost to Follow-up|1|||
126587160|NCT04492007|455449394|FG001|Overall Study|Lost to Follow-up|1|||
126777703|NCT00529568|456141413|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
126777704|NCT00529568|456141414|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
126587161|NCT04492007|455449395|FG002|Overall Study|Lost to Follow-up|2|||
126587162|NCT04492007|455449396|FG003|Overall Study|Lost to Follow-up|2|||
126587163|NCT04492007|455449393|FG000|Overall Study|Protocol Violation|1|||
126587164|NCT04492007|455449394|FG001|Overall Study|Protocol Violation|1|||
126587165|NCT04492007|455449395|FG002|Overall Study|Protocol Violation|1|||
126587166|NCT04492007|455449396|FG003|Overall Study|Protocol Violation|1|||
126587167|NCT04492007|455449393|FG000|Overall Study|Withdrawal by Subject|0|||
126587168|NCT04492007|455449394|FG001|Overall Study|Withdrawal by Subject|0|||
126587169|NCT04492007|455449395|FG002|Overall Study|Withdrawal by Subject|1|||
126587170|NCT04492007|455449396|FG003|Overall Study|Withdrawal by Subject|1|||
126587171|NCT01413100|455449397|FG000|Overall Study|Withdrawal by Subject|1|||
126587172|NCT05369403|455449398|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
126587173|NCT05369403|455449399|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
126587174|NCT05369403|455449400|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
126587175|NCT05369403|455449398|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
126587176|NCT05369403|455449399|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
126587177|NCT05369403|455449400|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
126587178|NCT05369403|455449398|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
126587179|NCT05369403|455449399|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
126587180|NCT05369403|455449400|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
126587181|NCT05369403|455449398|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
126587182|NCT05369403|455449399|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
126587183|NCT05369403|455449400|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
126587184|NCT05369403|455449398|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
126587185|NCT05369403|455449399|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
126587186|NCT05369403|455449400|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
126587187|NCT05369403|455449398|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
126587188|NCT05369403|455449399|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
126587189|NCT05369403|455449400|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
126587190|NCT05369403|455449398|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
126587191|NCT05369403|455449399|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
126587192|NCT05369403|455449400|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
126587193|NCT05369403|455449398|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
126587194|NCT05369403|455449399|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
126587195|NCT05369403|455449400|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
126587196|NCT05369403|455449398|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
126587197|NCT05369403|455449399|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
126587198|NCT05369403|455449400|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
126587199|NCT05369403|455449398|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
126587200|NCT05369403|455449399|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
126587201|NCT05369403|455449400|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
126587202|NCT05369403|455449398|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
126587203|NCT05369403|455449399|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
126587204|NCT05369403|455449400|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
126587205|NCT03792256|455449404|FG000|Overall Study|Death|0|||
126587206|NCT03792256|455449405|FG001|Overall Study|Death|1|||
126587207|NCT03792256|455449404|FG000|Overall Study|Lack of Efficacy|0|||
126587208|NCT03792256|455449405|FG001|Overall Study|Lack of Efficacy|1|||
126587209|NCT03792256|455449404|FG000|Overall Study|Withdrawal by Subject|0|||
126587210|NCT03792256|455449405|FG001|Overall Study|Withdrawal by Subject|1|||
126587211|NCT04977947|455449408|FG000|Overall Study|Lost to Follow-up|1|||
126587212|NCT04977947|455449409|FG001|Overall Study|Lost to Follow-up|1|||
126587213|NCT05875142|455449410|FG000|Overall Study|Lost to Follow-up|0|||
126587214|NCT05875142|455449411|FG001|Overall Study|Lost to Follow-up|1|||
126587215|NCT05875142|455449412|FG002|Overall Study|Lost to Follow-up|1|||
126587216|NCT05784662|455449413|FG000|Overall Study|Lost to Follow-up|21|||
126587217|NCT05784662|455449414|FG001|Overall Study|Lost to Follow-up|17|||
126587218|NCT04274764|455449425|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
126587219|NCT04274764|455449426|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
126587220|NCT02677298|455449427|FG000|Double Blind Phase|Adverse Event|2|||
126587221|NCT02677298|455449428|FG001|Double Blind Phase|Adverse Event|1|||
126587222|NCT02677298|455449429|FG002|Double Blind Phase|Adverse Event|0|||
126587223|NCT02677298|455449427|FG000|Double Blind Phase|Physician Decision|5|||
126587224|NCT02677298|455449428|FG001|Double Blind Phase|Physician Decision|0|||
126587225|NCT02677298|455449429|FG002|Double Blind Phase|Physician Decision|0|||
126587226|NCT02677298|455449427|FG000|Double Blind Phase|Lost to Follow-up|11|||
126587227|NCT02677298|455449428|FG001|Double Blind Phase|Lost to Follow-up|7|||
126731671|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
126731672|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
126731673|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
126731674|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
126731675|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
126731676|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
126756576|NCT00883896|456059483|FG001|Overall Study|Withdrawal by Subject|0|||
126587228|NCT02677298|455449429|FG002|Double Blind Phase|Lost to Follow-up|0|||
126587229|NCT02677298|455449427|FG000|Double Blind Phase|Withdrawal by Subject|11|||
126587230|NCT02677298|455449428|FG001|Double Blind Phase|Withdrawal by Subject|8|||
126587231|NCT02677298|455449429|FG002|Double Blind Phase|Withdrawal by Subject|0|||
126587232|NCT02677298|455449427|FG000|Double Blind Phase|No study drug available at site|0|||
126587233|NCT02677298|455449428|FG001|Double Blind Phase|No study drug available at site|1|||
126587234|NCT02677298|455449429|FG002|Double Blind Phase|No study drug available at site|0|||
126587235|NCT02677298|455449427|FG000|Open Label Phase|Adverse Event|0|||
126587236|NCT02677298|455449428|FG001|Open Label Phase|Adverse Event|0|||
126587237|NCT02677298|455449429|FG002|Open Label Phase|Adverse Event|4|||
126587238|NCT02677298|455449427|FG000|Open Label Phase|Physician Decision|0|||
126587239|NCT02677298|455449428|FG001|Open Label Phase|Physician Decision|0|||
126587240|NCT02677298|455449429|FG002|Open Label Phase|Physician Decision|1|||
126587241|NCT02677298|455449427|FG000|Open Label Phase|Lost to Follow-up|0|||
126587242|NCT02677298|455449428|FG001|Open Label Phase|Lost to Follow-up|0|||
126587243|NCT02677298|455449429|FG002|Open Label Phase|Lost to Follow-up|17|||
126587244|NCT02677298|455449427|FG000|Open Label Phase|Withdrawal by Subject|0|||
126587245|NCT02677298|455449428|FG001|Open Label Phase|Withdrawal by Subject|0|||
126587246|NCT02677298|455449429|FG002|Open Label Phase|Withdrawal by Subject|38|||
126587247|NCT03611621|455449443|FG000|Overall Study|Graft loss|3|||
126587248|NCT03611621|455449443|FG000|Overall Study|Death|3|||
126587249|NCT03611621|455449443|FG000|Overall Study|Lost to Follow-up|1|||
126587250|NCT03039023|455449444|FG000|Overall Study|Withdrawal by Subject|1|||
126587251|NCT03039023|455449445|FG001|Overall Study|Withdrawal by Subject|0|||
126587252|NCT03039023|455449446|FG002|Overall Study|Withdrawal by Subject|1|||
126587253|NCT03039023|455449447|FG003|Overall Study|Withdrawal by Subject|1|||
126587254|NCT03039023|455449448|FG004|Overall Study|Withdrawal by Subject|0|||
126587255|NCT03039023|455449444|FG000|Overall Study|Physician Decision|0|||
126587256|NCT03039023|455449445|FG001|Overall Study|Physician Decision|0|||
126587257|NCT03039023|455449446|FG002|Overall Study|Physician Decision|0|||
126587258|NCT03039023|455449447|FG003|Overall Study|Physician Decision|1|||
126587259|NCT03039023|455449448|FG004|Overall Study|Physician Decision|0|||
126587260|NCT04130438|455449449|FG000|Overall Study|Lost to Follow-up|0|||
126587261|NCT04130438|455449450|FG001|Overall Study|Lost to Follow-up|0|||
126587262|NCT04130438|455449451|FG002|Overall Study|Lost to Follow-up|1|||
126587263|NCT03232138|455449453|FG000|Overall Study|Physician Decision|1|||
126587264|NCT03232138|455449454|FG001|Overall Study|Physician Decision|0|||
126587265|NCT03232138|455449453|FG000|Overall Study|Adverse Event|2|||
126587266|NCT03232138|455449454|FG001|Overall Study|Adverse Event|0|||
126587267|NCT03232138|455449453|FG000|Overall Study|Withdrawal by Subject|1|||
126587268|NCT03232138|455449454|FG001|Overall Study|Withdrawal by Subject|2|||
126587269|NCT04142788|455449455|FG000|Overall Study|Trial terminated prematurely|2|||
126587270|NCT04142788|455449456|FG001|Overall Study|Trial terminated prematurely|2|||
126587271|NCT04739956|455449460|FG000|Overall Study|Withdrawal by Subject|1|||
126587272|NCT04739956|455449461|FG001|Overall Study|Withdrawal by Subject|1|||
126587273|NCT03920111|455449462|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
126587274|NCT03920111|455449463|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
126587275|NCT03920111|455449464|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
126587276|NCT03519581|455449467|FG000|Overall Study|Lost to Follow-up|3|||
126587277|NCT03519581|455449468|FG001|Overall Study|Lost to Follow-up|2|||
126587278|NCT03519581|455449467|FG000|Overall Study|Adverse Event|5|||
126587279|NCT03519581|455449468|FG001|Overall Study|Adverse Event|2|||
126587280|NCT03519581|455449467|FG000|Overall Study|Withdrawal by Subject|2|||
126587281|NCT03519581|455449468|FG001|Overall Study|Withdrawal by Subject|0|||
126587282|NCT03519581|455449467|FG000|Overall Study|Change to insurance|2|||
126587283|NCT03519581|455449468|FG001|Overall Study|Change to insurance|1|||
126587284|NCT03519581|455449467|FG000|Overall Study|Other|2|||
126587285|NCT03519581|455449468|FG001|Overall Study|Other|4|||
126587286|NCT05268393|455449469|FG000|Overall Study|Withdrawal by Subject|2|||
126587287|NCT05268393|455449470|FG001|Overall Study|Withdrawal by Subject|1|||
126587288|NCT03396926|455449471|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
126587289|NCT03396926|455449472|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
126587290|NCT04764448|455449473|FG000|Overall Study|Study terminated by sponsor|2|||
126587291|NCT04764448|455449474|FG001|Overall Study|Study terminated by sponsor|2|||
126587292|NCT04764448|455449475|FG002|Overall Study|Study terminated by sponsor|5|||
126587293|NCT04764448|455449473|FG000|Overall Study|Withdrawal by Subject|3|||
126587294|NCT04764448|455449474|FG001|Overall Study|Withdrawal by Subject|3|||
126587295|NCT04764448|455449475|FG002|Overall Study|Withdrawal by Subject|1|||
126587296|NCT05256706|455449476|FG000|Overall Study|Lost to Follow-up|9|||
126587297|NCT05256706|455449477|FG001|Overall Study|Lost to Follow-up|3|||
126587298|NCT05256706|455449476|FG000|Overall Study|Withdrawal by Subject|7|||
126587299|NCT05256706|455449477|FG001|Overall Study|Withdrawal by Subject|11|||
126587300|NCT05256706|455449476|FG000|Overall Study|Screen Failures|3|||
126587301|NCT05256706|455449477|FG001|Overall Study|Screen Failures|0|||
126587302|NCT01997840|455449478|FG000|Overall Study|Lost to Follow-up|0|||
126587303|NCT01997840|455449479|FG001|Overall Study|Lost to Follow-up|0|||
126587304|NCT01997840|455449480|FG002|Overall Study|Lost to Follow-up|1|||
126587305|NCT01997840|455449481|FG003|Overall Study|Lost to Follow-up|0|||
126587306|NCT01997840|455449478|FG000|Overall Study|Withdrawal by participant|0|||
126587307|NCT01997840|455449479|FG001|Overall Study|Withdrawal by participant|0|||
126587308|NCT01997840|455449480|FG002|Overall Study|Withdrawal by participant|8|||
126587309|NCT01997840|455449481|FG003|Overall Study|Withdrawal by participant|1|||
126587310|NCT01997840|455449478|FG000|Overall Study|Physician Decision|0|||
126731677|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
126587311|NCT01997840|455449479|FG001|Overall Study|Physician Decision|0|||
126587312|NCT01997840|455449480|FG002|Overall Study|Physician Decision|3|||
126587313|NCT01997840|455449481|FG003|Overall Study|Physician Decision|0|||
126587314|NCT01997840|455449478|FG000|Overall Study|Progressive disease|3|||
126587315|NCT01997840|455449479|FG001|Overall Study|Progressive disease|4|||
126587316|NCT01997840|455449480|FG002|Overall Study|Progressive disease|57|||
126587317|NCT01997840|455449481|FG003|Overall Study|Progressive disease|8|||
126587318|NCT01997840|455449478|FG000|Overall Study|Other reasons|0|||
126587319|NCT01997840|455449479|FG001|Overall Study|Other reasons|0|||
126587320|NCT01997840|455449480|FG002|Overall Study|Other reasons|1|||
126587321|NCT01997840|455449481|FG003|Overall Study|Other reasons|0|||
126587322|NCT01997840|455449478|FG000|Overall Study|Adverse Event|0|||
126587323|NCT01997840|455449479|FG001|Overall Study|Adverse Event|0|||
126587324|NCT01997840|455449480|FG002|Overall Study|Adverse Event|15|||
126587325|NCT01997840|455449481|FG003|Overall Study|Adverse Event|2|||
126587326|NCT03850678|455449482|FG000|Overall Study|Withdrawal by Subject|3|||
126587327|NCT03850678|455449483|FG001|Overall Study|Withdrawal by Subject|0|||
126587328|NCT03850678|455449482|FG000|Overall Study|Experimenter Error|1|||
126587329|NCT03850678|455449483|FG001|Overall Study|Experimenter Error|1|||
126587330|NCT03850678|455449482|FG000|Overall Study|Did Not Condition To Experiment|7|||
126587331|NCT03850678|455449483|FG001|Overall Study|Did Not Condition To Experiment|2|||
126587332|NCT04166773|455449504|FG000|Overall Study|Adverse Event|2|||
126587333|NCT04166773|455449505|FG001|Overall Study|Adverse Event|0|||
126587334|NCT04166773|455449506|FG002|Overall Study|Adverse Event|2|||
126587335|NCT04166773|455449507|FG003|Overall Study|Adverse Event|1|||
126587336|NCT04166773|455449504|FG000|Overall Study|Lost to Follow-up|4|||
126587337|NCT04166773|455449505|FG001|Overall Study|Lost to Follow-up|2|||
126587338|NCT04166773|455449506|FG002|Overall Study|Lost to Follow-up|1|||
126587339|NCT04166773|455449507|FG003|Overall Study|Lost to Follow-up|3|||
126587340|NCT04166773|455449504|FG000|Overall Study|Physician Decision|0|||
126587341|NCT04166773|455449505|FG001|Overall Study|Physician Decision|0|||
126587342|NCT04166773|455449506|FG002|Overall Study|Physician Decision|0|||
126587343|NCT04166773|455449507|FG003|Overall Study|Physician Decision|1|||
126587344|NCT04166773|455449504|FG000|Overall Study|Withdrawal by Subject|1|||
126587345|NCT04166773|455449505|FG001|Overall Study|Withdrawal by Subject|1|||
126587346|NCT04166773|455449506|FG002|Overall Study|Withdrawal by Subject|2|||
126587347|NCT04166773|455449507|FG003|Overall Study|Withdrawal by Subject|5|||
126587348|NCT03269136|455449510|FG000|Part 1: Dose Escalation|Other|0|||
126587349|NCT03269136|455449511|FG001|Part 1: Dose Escalation|Other|0|||
126587350|NCT03269136|455449512|FG002|Part 1: Dose Escalation|Other|0|||
126587351|NCT03269136|455449513|FG003|Part 1: Dose Escalation|Other|0|||
126587352|NCT03269136|455449514|FG004|Part 1: Dose Escalation|Other|0|||
126587353|NCT03269136|455449515|FG005|Part 1: Dose Escalation|Other|0|||
126587354|NCT03269136|455449516|FG006|Part 1: Dose Escalation|Other|0|||
126587355|NCT03269136|455449517|FG007|Part 1: Dose Escalation|Other|0|||
126587356|NCT03269136|455449518|FG008|Part 1: Dose Escalation|Other|0|||
126587357|NCT03269136|455449519|FG009|Part 1: Dose Escalation|Other|0|||
126587358|NCT03269136|455449520|FG010|Part 1: Dose Escalation|Other|1|||
126587359|NCT03269136|455449521|FG011|Part 1: Dose Escalation|Other|1|||
126587360|NCT03269136|455449522|FG012|Part 1: Dose Escalation|Other|1|||
126587361|NCT03269136|455449523|FG013|Part 1: Dose Escalation|Other|0|||
126587362|NCT03269136|455449524|FG014|Part 1: Dose Escalation|Other|3|||
126731678|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
126731679|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
126731680|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
126731681|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
126731682|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
126587363|NCT03269136|455449525|FG015|Part 1: Dose Escalation|Other|1|||
126587364|NCT03269136|455449526|FG016|Part 1: Dose Escalation|Other|1|||
126587365|NCT03269136|455449527|FG017|Part 1: Dose Escalation|Other|0|||
126587366|NCT03269136|455449510|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587367|NCT03269136|455449511|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587368|NCT03269136|455449512|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587369|NCT03269136|455449513|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587370|NCT03269136|455449514|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587371|NCT03269136|455449515|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587372|NCT03269136|455449516|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
126587373|NCT03269136|455449517|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587374|NCT03269136|455449518|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
126587375|NCT03269136|455449519|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587376|NCT03269136|455449520|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587377|NCT03269136|455449521|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587378|NCT03269136|455449522|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
126587379|NCT03269136|455449523|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587380|NCT03269136|455449524|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587381|NCT03269136|455449525|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587382|NCT03269136|455449526|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587383|NCT03269136|455449527|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
126587384|NCT03269136|455449510|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587385|NCT03269136|455449511|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587386|NCT03269136|455449512|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587387|NCT03269136|455449513|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587388|NCT03269136|455449514|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587389|NCT03269136|455449515|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587390|NCT03269136|455449516|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587391|NCT03269136|455449517|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
126587392|NCT03269136|455449518|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587393|NCT03269136|455449519|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587394|NCT03269136|455449520|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587395|NCT03269136|455449521|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587396|NCT03269136|455449522|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587397|NCT03269136|455449523|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587398|NCT03269136|455449524|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587399|NCT03269136|455449525|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587400|NCT03269136|455449526|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587401|NCT03269136|455449527|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
126587402|NCT03269136|455449510|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587403|NCT03269136|455449511|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587404|NCT03269136|455449512|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587405|NCT03269136|455449513|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587406|NCT03269136|455449514|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587407|NCT03269136|455449515|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587408|NCT03269136|455449516|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587409|NCT03269136|455449517|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587410|NCT03269136|455449518|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587411|NCT03269136|455449519|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
126587412|NCT03269136|455449520|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587413|NCT03269136|455449521|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587414|NCT03269136|455449522|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587415|NCT03269136|455449523|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587416|NCT03269136|455449524|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587417|NCT03269136|455449525|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587418|NCT03269136|455449526|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587419|NCT03269136|455449527|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
126587420|NCT03269136|455449510|FG000|Part 1: Dose Escalation|Death|0|||
126587421|NCT03269136|455449511|FG001|Part 1: Dose Escalation|Death|0|||
126587422|NCT03269136|455449512|FG002|Part 1: Dose Escalation|Death|0|||
126587423|NCT03269136|455449513|FG003|Part 1: Dose Escalation|Death|0|||
126587424|NCT03269136|455449514|FG004|Part 1: Dose Escalation|Death|0|||
126587425|NCT03269136|455449515|FG005|Part 1: Dose Escalation|Death|0|||
126587426|NCT03269136|455449516|FG006|Part 1: Dose Escalation|Death|0|||
126587427|NCT03269136|455449517|FG007|Part 1: Dose Escalation|Death|0|||
126587428|NCT03269136|455449518|FG008|Part 1: Dose Escalation|Death|0|||
126587429|NCT03269136|455449519|FG009|Part 1: Dose Escalation|Death|1|||
126587430|NCT03269136|455449520|FG010|Part 1: Dose Escalation|Death|0|||
126587431|NCT03269136|455449521|FG011|Part 1: Dose Escalation|Death|1|||
126587432|NCT03269136|455449522|FG012|Part 1: Dose Escalation|Death|0|||
126587433|NCT03269136|455449523|FG013|Part 1: Dose Escalation|Death|1|||
126587434|NCT03269136|455449524|FG014|Part 1: Dose Escalation|Death|0|||
126587435|NCT03269136|455449525|FG015|Part 1: Dose Escalation|Death|0|||
126587436|NCT03269136|455449526|FG016|Part 1: Dose Escalation|Death|2|||
126587437|NCT03269136|455449527|FG017|Part 1: Dose Escalation|Death|0|||
126587438|NCT03269136|455449510|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
126587439|NCT03269136|455449511|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
126587440|NCT03269136|455449512|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
126587441|NCT03269136|455449513|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
126587442|NCT03269136|455449514|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
126587443|NCT03269136|455449515|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
126777705|NCT00529568|456141415|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
126587444|NCT03269136|455449516|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
126587445|NCT03269136|455449517|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
126587446|NCT03269136|455449518|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
126587447|NCT03269136|455449519|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
126587448|NCT03269136|455449520|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
126587449|NCT03269136|455449521|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
126587450|NCT03269136|455449522|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
126587451|NCT03269136|455449523|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
126587452|NCT03269136|455449524|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
126587453|NCT03269136|455449525|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
126587454|NCT03269136|455449526|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
126587455|NCT03269136|455449527|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
126587456|NCT03269136|455449510|FG000|Part 1: Dose Escalation|Adverse Event|0|||
126587457|NCT03269136|455449511|FG001|Part 1: Dose Escalation|Adverse Event|0|||
126587458|NCT03269136|455449512|FG002|Part 1: Dose Escalation|Adverse Event|0|||
126587459|NCT03269136|455449513|FG003|Part 1: Dose Escalation|Adverse Event|0|||
126587460|NCT03269136|455449514|FG004|Part 1: Dose Escalation|Adverse Event|0|||
126587461|NCT03269136|455449515|FG005|Part 1: Dose Escalation|Adverse Event|0|||
126587462|NCT03269136|455449516|FG006|Part 1: Dose Escalation|Adverse Event|2|||
126587463|NCT03269136|455449517|FG007|Part 1: Dose Escalation|Adverse Event|0|||
126587464|NCT03269136|455449518|FG008|Part 1: Dose Escalation|Adverse Event|0|||
126587465|NCT03269136|455449519|FG009|Part 1: Dose Escalation|Adverse Event|0|||
126587466|NCT03269136|455449520|FG010|Part 1: Dose Escalation|Adverse Event|1|||
126587467|NCT03269136|455449521|FG011|Part 1: Dose Escalation|Adverse Event|2|||
126587468|NCT03269136|455449522|FG012|Part 1: Dose Escalation|Adverse Event|0|||
126587469|NCT03269136|455449523|FG013|Part 1: Dose Escalation|Adverse Event|1|||
126587470|NCT03269136|455449524|FG014|Part 1: Dose Escalation|Adverse Event|0|||
126587471|NCT03269136|455449525|FG015|Part 1: Dose Escalation|Adverse Event|0|||
126587472|NCT03269136|455449526|FG016|Part 1: Dose Escalation|Adverse Event|1|||
126587473|NCT03269136|455449527|FG017|Part 1: Dose Escalation|Adverse Event|0|||
126587474|NCT03269136|455449510|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
126587475|NCT03269136|455449511|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
126587476|NCT03269136|455449512|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
126587477|NCT03269136|455449513|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
126587478|NCT03269136|455449514|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
126587479|NCT03269136|455449515|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
126587480|NCT03269136|455449516|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
126587481|NCT03269136|455449517|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
126587482|NCT03269136|455449518|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
126587483|NCT03269136|455449519|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
126587484|NCT03269136|455449520|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
126587485|NCT03269136|455449521|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
126587486|NCT03269136|455449522|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
126587487|NCT03269136|455449523|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
126587488|NCT03269136|455449524|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
126587489|NCT03269136|455449525|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
126587490|NCT03269136|455449526|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
126587491|NCT03269136|455449527|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
126587492|NCT03269136|455449510|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587493|NCT03269136|455449511|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587494|NCT03269136|455449512|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587495|NCT03269136|455449513|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587496|NCT03269136|455449514|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587497|NCT03269136|455449515|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587498|NCT03269136|455449516|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587499|NCT03269136|455449517|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587500|NCT03269136|455449518|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587501|NCT03269136|455449519|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587502|NCT03269136|455449520|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587503|NCT03269136|455449521|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587504|NCT03269136|455449522|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
126587505|NCT03269136|455449523|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
126587506|NCT03269136|455449524|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
126587507|NCT03269136|455449525|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587508|NCT03269136|455449526|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
126587509|NCT03269136|455449527|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
126587510|NCT03269136|455449510|FG000|Part 2A: Dose Expansion|Other|0|||
126587511|NCT03269136|455449511|FG001|Part 2A: Dose Expansion|Other|0|||
126587512|NCT03269136|455449512|FG002|Part 2A: Dose Expansion|Other|0|||
126587513|NCT03269136|455449513|FG003|Part 2A: Dose Expansion|Other|0|||
126587514|NCT03269136|455449514|FG004|Part 2A: Dose Expansion|Other|0|||
126587515|NCT03269136|455449515|FG005|Part 2A: Dose Expansion|Other|0|||
126587516|NCT03269136|455449516|FG006|Part 2A: Dose Expansion|Other|0|||
126587517|NCT03269136|455449517|FG007|Part 2A: Dose Expansion|Other|0|||
126587518|NCT03269136|455449518|FG008|Part 2A: Dose Expansion|Other|0|||
126587519|NCT03269136|455449519|FG009|Part 2A: Dose Expansion|Other|0|||
126587520|NCT03269136|455449520|FG010|Part 2A: Dose Expansion|Other|0|||
126587521|NCT03269136|455449521|FG011|Part 2A: Dose Expansion|Other|0|||
126587522|NCT03269136|455449522|FG012|Part 2A: Dose Expansion|Other|0|||
126587523|NCT03269136|455449523|FG013|Part 2A: Dose Expansion|Other|0|||
126587524|NCT03269136|455449524|FG014|Part 2A: Dose Expansion|Other|0|||
126587525|NCT03269136|455449525|FG015|Part 2A: Dose Expansion|Other|0|||
126587526|NCT03269136|455449526|FG016|Part 2A: Dose Expansion|Other|0|||
126587527|NCT03269136|455449527|FG017|Part 2A: Dose Expansion|Other|1|||
126587528|NCT03269136|455449510|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587529|NCT03269136|455449511|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587530|NCT03269136|455449512|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587531|NCT03269136|455449513|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587532|NCT03269136|455449514|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587533|NCT03269136|455449515|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587534|NCT03269136|455449516|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587535|NCT03269136|455449517|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587536|NCT03269136|455449518|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587537|NCT03269136|455449519|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587538|NCT03269136|455449520|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587539|NCT03269136|455449521|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587540|NCT03269136|455449522|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587541|NCT03269136|455449523|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587542|NCT03269136|455449524|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587543|NCT03269136|455449525|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587544|NCT03269136|455449526|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
126587545|NCT03269136|455449527|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
126587546|NCT03269136|455449510|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
126587547|NCT03269136|455449511|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
126587548|NCT03269136|455449512|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
126587549|NCT03269136|455449513|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
126587550|NCT03269136|455449514|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
126587551|NCT03269136|455449515|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
126587552|NCT03269136|455449516|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
126587553|NCT03269136|455449517|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
126587554|NCT03269136|455449518|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
126587555|NCT03269136|455449519|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
126587556|NCT03269136|455449520|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
126587557|NCT03269136|455449521|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
126587558|NCT03269136|455449522|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
126587559|NCT03269136|455449523|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
126587560|NCT03269136|455449524|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
126587561|NCT03269136|455449525|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
126587562|NCT03269136|455449526|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
126587563|NCT03269136|455449527|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
126587564|NCT03269136|455449510|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
126587565|NCT03269136|455449511|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
126587566|NCT03269136|455449512|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
126587567|NCT03269136|455449513|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
126587568|NCT03269136|455449514|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
126587569|NCT03269136|455449515|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
126587570|NCT03269136|455449516|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
126587571|NCT03269136|455449517|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
126587572|NCT03269136|455449518|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
126587573|NCT03269136|455449519|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
126587574|NCT03269136|455449520|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
126587575|NCT03269136|455449521|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
126587576|NCT03269136|455449522|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
126587577|NCT03269136|455449523|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
126587578|NCT03269136|455449524|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
126587579|NCT03269136|455449525|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
126587580|NCT03269136|455449526|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
126587581|NCT03269136|455449527|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
126587582|NCT03269136|455449510|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
126587583|NCT03269136|455449511|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
126587584|NCT03269136|455449512|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
126587585|NCT03269136|455449513|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
126587586|NCT03269136|455449514|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
126587587|NCT03269136|455449515|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
126587588|NCT03269136|455449516|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
126587589|NCT03269136|455449517|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
126587590|NCT03269136|455449518|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
126587591|NCT03269136|455449519|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
126587592|NCT03269136|455449520|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
126587593|NCT03269136|455449521|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
126587594|NCT03269136|455449522|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
126587595|NCT03269136|455449523|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
126587596|NCT03269136|455449524|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
126587597|NCT03269136|455449525|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
126587598|NCT03269136|455449526|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
126587599|NCT03269136|455449527|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
126587600|NCT04717492|455449528|FG000|Overall Study|Withdrawal by Subject|2|||
126587601|NCT04717492|455449529|FG001|Overall Study|Withdrawal by Subject|13|||
126587602|NCT04717492|455449528|FG000|Overall Study|Lost to Follow-up|2|||
126587603|NCT04717492|455449529|FG001|Overall Study|Lost to Follow-up|9|||
126587604|NCT04456517|455449530|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
126587605|NCT04456517|455449531|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
126587606|NCT04072380|455449533|FG000|Overall Study|Adverse Event|4|||
126587607|NCT04072380|455449534|FG001|Overall Study|Adverse Event|6|||
126587608|NCT04072380|455449535|FG002|Overall Study|Adverse Event|0|||
126587609|NCT04072380|455449533|FG000|Overall Study|Withdrawal by Subject|3|||
126587610|NCT04072380|455449534|FG001|Overall Study|Withdrawal by Subject|1|||
126587611|NCT04072380|455449535|FG002|Overall Study|Withdrawal by Subject|1|||
126587612|NCT04072380|455449533|FG000|Overall Study|Physician Decision|2|||
126587613|NCT04072380|455449534|FG001|Overall Study|Physician Decision|0|||
126587614|NCT04072380|455449535|FG002|Overall Study|Physician Decision|0|||
126587615|NCT04072380|455449533|FG000|Overall Study|Protocol Violation|0|||
126587616|NCT04072380|455449534|FG001|Overall Study|Protocol Violation|2|||
126587617|NCT04072380|455449535|FG002|Overall Study|Protocol Violation|3|||
126587618|NCT04072380|455449533|FG000|Overall Study|Intercurrent Illness and Others|3|||
126587619|NCT04072380|455449534|FG001|Overall Study|Intercurrent Illness and Others|5|||
126587620|NCT04072380|455449535|FG002|Overall Study|Intercurrent Illness and Others|6|||
126587621|NCT05351554|455449539|FG000|Overall Study|Study terminated by sponsor|1|||
126587622|NCT03774082|455449540|FG000|Overall Study|Death|6|||
126587623|NCT03774082|455449541|FG001|Overall Study|Death|3|||
126587624|NCT03774082|455449542|FG002|Overall Study|Death|2|||
126587625|NCT03774082|455449540|FG000|Overall Study|Subject decision|0|||
126587626|NCT03774082|455449541|FG001|Overall Study|Subject decision|3|||
126587627|NCT03774082|455449542|FG002|Overall Study|Subject decision|0|||
126587628|NCT03774082|455449540|FG000|Overall Study|Lost to Follow-up|2|||
126587629|NCT03774082|455449541|FG001|Overall Study|Lost to Follow-up|0|||
126587630|NCT03774082|455449542|FG002|Overall Study|Lost to Follow-up|0|||
126587631|NCT03774082|455449540|FG000|Overall Study|Guardian decision|0|||
126587632|NCT03774082|455449541|FG001|Overall Study|Guardian decision|0|||
126587633|NCT03774082|455449542|FG002|Overall Study|Guardian decision|1|||
126587634|NCT03774082|455449540|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
126587635|NCT03774082|455449541|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
126587636|NCT03774082|455449542|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
126587637|NCT05093829|455449543|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
126587638|NCT05093829|455449544|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
126587639|NCT05093829|455449545|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
126587640|NCT05093829|455449546|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
126587641|NCT05093829|455449547|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
126587642|NCT04177823|455451040|FG000|Overall Study|Physician Decision|1|||
126587643|NCT04177823|455451040|FG000|Overall Study|Withdrawal by Subject|1|||
126587644|NCT05178316|455451041|FG000|Overall Study|Adverse Event|5|||
126587645|NCT05178316|455451042|FG001|Overall Study|Adverse Event|4|||
126587646|NCT05178316|455451043|FG002|Overall Study|Adverse Event|9|||
126587647|NCT05178316|455451041|FG000|Overall Study|Enrolled in Error|1|||
126587648|NCT05178316|455451042|FG001|Overall Study|Enrolled in Error|2|||
126587649|NCT05178316|455451043|FG002|Overall Study|Enrolled in Error|1|||
126587650|NCT05178316|455451041|FG000|Overall Study|Lost to Follow-up|3|||
126587651|NCT05178316|455451042|FG001|Overall Study|Lost to Follow-up|15|||
126587652|NCT05178316|455451043|FG002|Overall Study|Lost to Follow-up|11|||
126587653|NCT05178316|455451041|FG000|Overall Study|Noncompliance|1|||
126587654|NCT05178316|455451042|FG001|Overall Study|Noncompliance|3|||
126587655|NCT05178316|455451043|FG002|Overall Study|Noncompliance|1|||
126587656|NCT05178316|455451041|FG000|Overall Study|Other|0|||
126587657|NCT05178316|455451042|FG001|Overall Study|Other|1|||
126587658|NCT05178316|455451043|FG002|Overall Study|Other|0|||
126587659|NCT05178316|455451041|FG000|Overall Study|Physician Decision|0|||
126587660|NCT05178316|455451042|FG001|Overall Study|Physician Decision|3|||
126587661|NCT05178316|455451043|FG002|Overall Study|Physician Decision|2|||
126587662|NCT05178316|455451041|FG000|Overall Study|Protocol deviation|1|||
126587663|NCT05178316|455451042|FG001|Overall Study|Protocol deviation|0|||
126587664|NCT05178316|455451043|FG002|Overall Study|Protocol deviation|1|||
126587665|NCT05178316|455451041|FG000|Overall Study|Sponsor decision|1|||
126587666|NCT05178316|455451042|FG001|Overall Study|Sponsor decision|0|||
126587667|NCT05178316|455451043|FG002|Overall Study|Sponsor decision|1|||
126587668|NCT05178316|455451041|FG000|Overall Study|Withdrawal by Subject|5|||
126587669|NCT05178316|455451042|FG001|Overall Study|Withdrawal by Subject|11|||
126587670|NCT05178316|455451043|FG002|Overall Study|Withdrawal by Subject|5|||
126587671|NCT03457142|455451044|FG000|Overall Study|Death|1|||
126587672|NCT04760678|455451047|FG000|Overall Study|Death|13|||
126587673|NCT04760678|455451047|FG000|Overall Study|Lost to Follow-up|48|||
126587674|NCT04760678|455451047|FG000|Overall Study|Withdrawal by Subject|1|||
126587675|NCT01748448|455451048|FG000|Treatment Period|Consent withdrawn by subject|1|||
126587676|NCT01748448|455451049|FG001|Treatment Period|Consent withdrawn by subject|0|||
126587677|NCT01748448|455451048|FG000|Treatment Period|Adverse Event|1|||
126587678|NCT01748448|455451049|FG001|Treatment Period|Adverse Event|0|||
126587679|NCT01748448|455451048|FG000|Treatment Period|Personal|0|||
126587680|NCT01748448|455451049|FG001|Treatment Period|Personal|1|||
126587681|NCT02907099|455451050|FG000|Overall Study|Adverse Event|1|||
126587682|NCT02907099|455451050|FG000|Overall Study|Withdrawal by Subject|2|||
126587683|NCT02907099|455451050|FG000|Overall Study|Screen Fail|2|||
126587684|NCT05516147|455451052|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
126587685|NCT03853746|455451056|FG000|Overall Study|Withdrawal by Subject|1|||
126587686|NCT00999804|455451057|FG000|Overall Study|Lack of Efficacy|9|||
126587687|NCT00999804|455451058|FG001|Overall Study|Lack of Efficacy|2|||
126587688|NCT00999804|455451057|FG000|Overall Study|Adverse Event|4|||
126587689|NCT00999804|455451058|FG001|Overall Study|Adverse Event|3|||
126587690|NCT00999804|455451057|FG000|Overall Study|Withdrawal by Subject|4|||
126587691|NCT00999804|455451058|FG001|Overall Study|Withdrawal by Subject|0|||
126587692|NCT00999804|455451057|FG000|Overall Study|Death|1|||
126587693|NCT00999804|455451058|FG001|Overall Study|Death|0|||
126587694|NCT00999804|455451057|FG000|Overall Study|Ineligible|3|||
126587695|NCT00999804|455451058|FG001|Overall Study|Ineligible|0|||
126587696|NCT04952909|455451071|FG000|Overall Study|Death|3|||
126587697|NCT03150810|455451078|FG000|Overall Study|Death|4|||
126587698|NCT03150810|455451079|FG001|Overall Study|Death|8|||
126587699|NCT03150810|455451080|FG002|Overall Study|Death|7|||
126587700|NCT03150810|455451081|FG003|Overall Study|Death|2|||
126587701|NCT03150810|455451082|FG004|Overall Study|Death|2|||
126587702|NCT03150810|455451083|FG005|Overall Study|Death|10|||
126587703|NCT03150810|455451084|FG006|Overall Study|Death|8|||
126587704|NCT03150810|455451085|FG007|Overall Study|Death|6|||
126587705|NCT03150810|455451086|FG008|Overall Study|Death|18|||
126587706|NCT03150810|455451087|FG009|Overall Study|Death|3|||
126587707|NCT03150810|455451088|FG010|Overall Study|Death|19|||
126587708|NCT03150810|455451089|FG011|Overall Study|Death|1|||
126587709|NCT03150810|455451090|FG012|Overall Study|Death|19|||
126587710|NCT03150810|455451078|FG000|Overall Study|Withdrawal by Subject|0|||
126587711|NCT03150810|455451079|FG001|Overall Study|Withdrawal by Subject|1|||
126587712|NCT03150810|455451080|FG002|Overall Study|Withdrawal by Subject|1|||
126587713|NCT03150810|455451081|FG003|Overall Study|Withdrawal by Subject|1|||
126587714|NCT03150810|455451082|FG004|Overall Study|Withdrawal by Subject|0|||
126587715|NCT03150810|455451083|FG005|Overall Study|Withdrawal by Subject|0|||
126587716|NCT03150810|455451084|FG006|Overall Study|Withdrawal by Subject|2|||
126587717|NCT03150810|455451085|FG007|Overall Study|Withdrawal by Subject|0|||
126587718|NCT03150810|455451086|FG008|Overall Study|Withdrawal by Subject|2|||
126587719|NCT03150810|455451087|FG009|Overall Study|Withdrawal by Subject|0|||
126587720|NCT03150810|455451088|FG010|Overall Study|Withdrawal by Subject|1|||
126587721|NCT03150810|455451089|FG011|Overall Study|Withdrawal by Subject|0|||
126587722|NCT03150810|455451090|FG012|Overall Study|Withdrawal by Subject|1|||
126587723|NCT03150810|455451078|FG000|Overall Study|Sponsor Decision|0|||
126587724|NCT03150810|455451079|FG001|Overall Study|Sponsor Decision|2|||
126587725|NCT03150810|455451080|FG002|Overall Study|Sponsor Decision|0|||
126587726|NCT03150810|455451081|FG003|Overall Study|Sponsor Decision|0|||
126587727|NCT03150810|455451082|FG004|Overall Study|Sponsor Decision|1|||
126587728|NCT03150810|455451083|FG005|Overall Study|Sponsor Decision|1|||
126587729|NCT03150810|455451084|FG006|Overall Study|Sponsor Decision|0|||
126587730|NCT03150810|455451085|FG007|Overall Study|Sponsor Decision|0|||
126587731|NCT03150810|455451086|FG008|Overall Study|Sponsor Decision|1|||
126587732|NCT03150810|455451087|FG009|Overall Study|Sponsor Decision|0|||
126587733|NCT03150810|455451088|FG010|Overall Study|Sponsor Decision|0|||
126587734|NCT03150810|455451089|FG011|Overall Study|Sponsor Decision|0|||
126587735|NCT03150810|455451090|FG012|Overall Study|Sponsor Decision|5|||
126587736|NCT03150810|455451078|FG000|Overall Study|Lost to Follow-up|0|||
126587737|NCT03150810|455451079|FG001|Overall Study|Lost to Follow-up|1|||
126587738|NCT03150810|455451080|FG002|Overall Study|Lost to Follow-up|1|||
126587739|NCT03150810|455451081|FG003|Overall Study|Lost to Follow-up|0|||
126587740|NCT03150810|455451082|FG004|Overall Study|Lost to Follow-up|0|||
126587741|NCT03150810|455451083|FG005|Overall Study|Lost to Follow-up|0|||
126587742|NCT03150810|455451084|FG006|Overall Study|Lost to Follow-up|1|||
126587743|NCT03150810|455451085|FG007|Overall Study|Lost to Follow-up|0|||
126587744|NCT03150810|455451086|FG008|Overall Study|Lost to Follow-up|0|||
126587745|NCT03150810|455451087|FG009|Overall Study|Lost to Follow-up|0|||
126587746|NCT03150810|455451088|FG010|Overall Study|Lost to Follow-up|1|||
126587747|NCT03150810|455451089|FG011|Overall Study|Lost to Follow-up|0|||
126587748|NCT03150810|455451090|FG012|Overall Study|Lost to Follow-up|0|||
126587749|NCT03150810|455451078|FG000|Overall Study|Physician Decision|0|||
126587750|NCT03150810|455451079|FG001|Overall Study|Physician Decision|0|||
126587751|NCT03150810|455451080|FG002|Overall Study|Physician Decision|0|||
126587752|NCT03150810|455451081|FG003|Overall Study|Physician Decision|0|||
126587753|NCT03150810|455451082|FG004|Overall Study|Physician Decision|0|||
126587754|NCT03150810|455451083|FG005|Overall Study|Physician Decision|1|||
126587755|NCT03150810|455451084|FG006|Overall Study|Physician Decision|1|||
126587756|NCT03150810|455451085|FG007|Overall Study|Physician Decision|0|||
126587757|NCT03150810|455451086|FG008|Overall Study|Physician Decision|0|||
126587758|NCT03150810|455451087|FG009|Overall Study|Physician Decision|0|||
126587759|NCT03150810|455451088|FG010|Overall Study|Physician Decision|0|||
126587760|NCT03150810|455451089|FG011|Overall Study|Physician Decision|0|||
126587761|NCT03150810|455451090|FG012|Overall Study|Physician Decision|0|||
126587762|NCT03150810|455451078|FG000|Overall Study|Site withdrawal from study|0|||
126587763|NCT03150810|455451079|FG001|Overall Study|Site withdrawal from study|1|||
126587764|NCT03150810|455451080|FG002|Overall Study|Site withdrawal from study|0|||
126587765|NCT03150810|455451081|FG003|Overall Study|Site withdrawal from study|0|||
126587766|NCT03150810|455451082|FG004|Overall Study|Site withdrawal from study|0|||
126587767|NCT03150810|455451083|FG005|Overall Study|Site withdrawal from study|0|||
126587768|NCT03150810|455451084|FG006|Overall Study|Site withdrawal from study|0|||
126587769|NCT03150810|455451085|FG007|Overall Study|Site withdrawal from study|0|||
126587770|NCT03150810|455451086|FG008|Overall Study|Site withdrawal from study|0|||
126587771|NCT03150810|455451087|FG009|Overall Study|Site withdrawal from study|1|||
126587772|NCT03150810|455451088|FG010|Overall Study|Site withdrawal from study|1|||
126587773|NCT03150810|455451089|FG011|Overall Study|Site withdrawal from study|0|||
126587774|NCT03150810|455451090|FG012|Overall Study|Site withdrawal from study|0|||
126587775|NCT03150810|455451078|FG000|Overall Study|Hospice|0|||
126587776|NCT03150810|455451079|FG001|Overall Study|Hospice|0|||
126587777|NCT03150810|455451080|FG002|Overall Study|Hospice|0|||
126587778|NCT03150810|455451081|FG003|Overall Study|Hospice|0|||
126587779|NCT03150810|455451082|FG004|Overall Study|Hospice|0|||
126587780|NCT03150810|455451083|FG005|Overall Study|Hospice|1|||
126587781|NCT03150810|455451084|FG006|Overall Study|Hospice|0|||
126587782|NCT03150810|455451085|FG007|Overall Study|Hospice|0|||
126587783|NCT03150810|455451086|FG008|Overall Study|Hospice|0|||
126587784|NCT03150810|455451087|FG009|Overall Study|Hospice|0|||
126587785|NCT03150810|455451088|FG010|Overall Study|Hospice|0|||
126587786|NCT03150810|455451089|FG011|Overall Study|Hospice|0|||
126587787|NCT03150810|455451090|FG012|Overall Study|Hospice|0|||
126587788|NCT03150810|455451078|FG000|Overall Study|Participant relocated abroad.|0|||
126587789|NCT03150810|455451079|FG001|Overall Study|Participant relocated abroad.|0|||
126587790|NCT03150810|455451080|FG002|Overall Study|Participant relocated abroad.|0|||
126587791|NCT03150810|455451081|FG003|Overall Study|Participant relocated abroad.|0|||
126587792|NCT03150810|455451082|FG004|Overall Study|Participant relocated abroad.|0|||
126587793|NCT03150810|455451083|FG005|Overall Study|Participant relocated abroad.|1|||
126587794|NCT03150810|455451084|FG006|Overall Study|Participant relocated abroad.|0|||
126587795|NCT03150810|455451085|FG007|Overall Study|Participant relocated abroad.|0|||
126587796|NCT03150810|455451086|FG008|Overall Study|Participant relocated abroad.|0|||
126587797|NCT03150810|455451087|FG009|Overall Study|Participant relocated abroad.|0|||
126587798|NCT03150810|455451088|FG010|Overall Study|Participant relocated abroad.|0|||
126587799|NCT03150810|455451089|FG011|Overall Study|Participant relocated abroad.|0|||
126587800|NCT03150810|455451090|FG012|Overall Study|Participant relocated abroad.|0|||
126587801|NCT03150810|455451078|FG000|Overall Study|Transferred care to oncologist|0|||
126587802|NCT03150810|455451079|FG001|Overall Study|Transferred care to oncologist|0|||
126587803|NCT03150810|455451080|FG002|Overall Study|Transferred care to oncologist|0|||
126587804|NCT03150810|455451081|FG003|Overall Study|Transferred care to oncologist|0|||
126587805|NCT03150810|455451082|FG004|Overall Study|Transferred care to oncologist|0|||
126587806|NCT03150810|455451083|FG005|Overall Study|Transferred care to oncologist|0|||
126587807|NCT03150810|455451084|FG006|Overall Study|Transferred care to oncologist|2|||
126587808|NCT03150810|455451085|FG007|Overall Study|Transferred care to oncologist|0|||
126587809|NCT03150810|455451086|FG008|Overall Study|Transferred care to oncologist|0|||
126587810|NCT03150810|455451087|FG009|Overall Study|Transferred care to oncologist|0|||
126587811|NCT03150810|455451088|FG010|Overall Study|Transferred care to oncologist|0|||
126587812|NCT03150810|455451089|FG011|Overall Study|Transferred care to oncologist|0|||
126587813|NCT03150810|455451090|FG012|Overall Study|Transferred care to oncologist|0|||
126587814|NCT05116787|455451091|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
126587815|NCT05116787|455451092|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
126587816|NCT05116787|455451091|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
126587817|NCT05116787|455451092|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
126587818|NCT05116787|455451091|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
126587819|NCT05116787|455451092|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
126587820|NCT05116787|455451091|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
126587821|NCT05116787|455451092|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
126587822|NCT06393088|455451094|FG000|Overall Study|Withdrawal by Subject|0|||
126587823|NCT06393088|455451095|FG001|Overall Study|Withdrawal by Subject|2|||
126587824|NCT02515773|455451096|FG000|Overall Study|Withdrawal by Subject|12|||
126587825|NCT02515773|455451097|FG001|Overall Study|Withdrawal by Subject|2|||
126587826|NCT02515773|455451096|FG000|Overall Study|Lost to Follow-up|119|||
126587827|NCT02515773|455451097|FG001|Overall Study|Lost to Follow-up|126|||
126587828|NCT02515773|455451096|FG000|Overall Study|Discharged from Clinic Services|53|||
126587829|NCT02515773|455451097|FG001|Overall Study|Discharged from Clinic Services|84|||
126587830|NCT02515773|455451096|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
126587831|NCT02515773|455451097|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
126587832|NCT02515773|455451096|FG000|Overall Study|Follow-up at non-study site|8|||
126587833|NCT02515773|455451097|FG001|Overall Study|Follow-up at non-study site|16|||
126587834|NCT02515773|455451096|FG000|Overall Study|Moved from area|9|||
126587835|NCT02515773|455451097|FG001|Overall Study|Moved from area|14|||
126587836|NCT03903146|455451098|FG000|Overall Study|Lost to Follow-up|6|||
126587837|NCT03903146|455451099|FG001|Overall Study|Lost to Follow-up|4|||
126587838|NCT03903146|455451098|FG000|Overall Study|Withdrawal by Subject|0|||
126587839|NCT03903146|455451099|FG001|Overall Study|Withdrawal by Subject|1|||
126587840|NCT04176965|455451100|FG000|Overall Study|Death|1|||
126587841|NCT04176965|455451101|FG001|Overall Study|Death|2|||
126587842|NCT04176965|455451100|FG000|Overall Study|Lost to Follow-up|10|||
126587843|NCT04176965|455451101|FG001|Overall Study|Lost to Follow-up|2|||
126587844|NCT04176965|455451100|FG000|Overall Study|Withdrawal by Subject|6|||
126587845|NCT04176965|455451101|FG001|Overall Study|Withdrawal by Subject|1|||
126587846|NCT02919683|455451102|FG000|Post-Surgery Follow-Up|Death|2|||
126587847|NCT02919683|455451103|FG001|Post-Surgery Follow-Up|Death|2|||
126587848|NCT02919683|455451102|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
126587849|NCT02919683|455451103|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
126587850|NCT03033576|455451104|FG000|Overall Study|Ineligible|1|||
126587851|NCT03033576|455451105|FG001|Overall Study|Ineligible|1|||
126587852|NCT03033576|455451104|FG000|Overall Study|Adverse Event|4|||
126587853|NCT03033576|455451105|FG001|Overall Study|Adverse Event|20|||
126587854|NCT03033576|455451104|FG000|Overall Study|Progression/relapse|9|||
126587855|NCT03033576|455451105|FG001|Overall Study|Progression/relapse|36|||
126587856|NCT03033576|455451104|FG000|Overall Study|Death|1|||
126587857|NCT03033576|455451105|FG001|Overall Study|Death|1|||
126587858|NCT03033576|455451104|FG000|Overall Study|Patient refusal|1|||
126587859|NCT03033576|455451105|FG001|Overall Study|Patient refusal|6|||
126587860|NCT03033576|455451104|FG000|Overall Study|Other, unspecified reasons|0|||
126587861|NCT03033576|455451105|FG001|Overall Study|Other, unspecified reasons|4|||
126587862|NCT03033576|455451104|FG000|Overall Study|Currently on protocol therapy|0|||
126587863|NCT03033576|455451105|FG001|Overall Study|Currently on protocol therapy|2|||
126587864|NCT05179837|455451106|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
126587865|NCT05179837|455451106|FG000|Overall Study|Device malfunctioned|1|||
126587866|NCT05179837|455451106|FG000|Overall Study|Image quality too low|2|||
126587867|NCT05051124|455451107|FG000|Overall Study|Lost to Follow-up|2|||
126587868|NCT05051124|455451107|FG000|Overall Study|Withdrawal by Subject|1|||
126587869|NCT05051124|455451107|FG000|Overall Study|Residential relocation|2|||
126587870|NCT05051124|455451107|FG000|Overall Study|Death|1|||
126587871|NCT04782973|455451108|FG000|Overall Study|Withdrawal by Subject|5|||
126587872|NCT04782973|455451108|FG000|Overall Study|Protocol Violation|6|||
126587873|NCT04782973|455451108|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
126587874|NCT04924660|455451109|FG000|United States|Death|29|||
126587875|NCT04924660|455451110|FG001|United States|Death|32|||
126587876|NCT04924660|455451111|FG002|United States|Death|34|||
126587877|NCT04924660|455451112|FG003|United States|Death|25|||
126587878|NCT04924660|455451113|FG004|United States|Death|26|||
126587879|NCT04924660|455451114|FG005|United States|Death|23|||
126587880|NCT04924660|455451109|FG000|United States|Lost to Follow-up|15|||
126587881|NCT04924660|455451110|FG001|United States|Lost to Follow-up|10|||
126587882|NCT04924660|455451111|FG002|United States|Lost to Follow-up|13|||
126587883|NCT04924660|455451112|FG003|United States|Lost to Follow-up|5|||
126587884|NCT04924660|455451113|FG004|United States|Lost to Follow-up|19|||
126587885|NCT04924660|455451114|FG005|United States|Lost to Follow-up|20|||
126587886|NCT04924660|455451109|FG000|United States|Withdrawal by Subject|8|||
126587887|NCT04924660|455451110|FG001|United States|Withdrawal by Subject|3|||
126587888|NCT04924660|455451111|FG002|United States|Withdrawal by Subject|3|||
126587889|NCT04924660|455451112|FG003|United States|Withdrawal by Subject|3|||
126587890|NCT04924660|455451113|FG004|United States|Withdrawal by Subject|8|||
126587891|NCT04924660|455451114|FG005|United States|Withdrawal by Subject|4|||
126587892|NCT04924660|455451109|FG000|Spain|Death|0|||
126587893|NCT04924660|455451110|FG001|Spain|Death|0|||
126587894|NCT04924660|455451111|FG002|Spain|Death|0|||
126587895|NCT04924660|455451112|FG003|Spain|Death|0|||
126587896|NCT04924660|455451113|FG004|Spain|Death|0|||
126587897|NCT04924660|455451114|FG005|Spain|Death|2|||
126587898|NCT04924660|455451109|FG000|Spain|Lost to Follow-up|0|||
126587899|NCT04924660|455451110|FG001|Spain|Lost to Follow-up|0|||
126587900|NCT04924660|455451111|FG002|Spain|Lost to Follow-up|0|||
126587901|NCT04924660|455451112|FG003|Spain|Lost to Follow-up|0|||
126587902|NCT04924660|455451113|FG004|Spain|Lost to Follow-up|1|||
126587903|NCT04924660|455451114|FG005|Spain|Lost to Follow-up|0|||
126587904|NCT04924660|455451109|FG000|Brazil|Death|0|||
126587905|NCT04924660|455451110|FG001|Brazil|Death|0|||
126587906|NCT04924660|455451111|FG002|Brazil|Death|0|||
126587907|NCT04924660|455451112|FG003|Brazil|Death|0|||
126587908|NCT04924660|455451113|FG004|Brazil|Death|1|||
126587909|NCT04924660|455451114|FG005|Brazil|Death|0|||
126587910|NCT04924660|455451109|FG000|Italy|Lost to Follow-up|0|||
126587911|NCT04924660|455451110|FG001|Italy|Lost to Follow-up|0|||
126587912|NCT04924660|455451111|FG002|Italy|Lost to Follow-up|0|||
126587913|NCT04924660|455451112|FG003|Italy|Lost to Follow-up|0|||
126587914|NCT04924660|455451113|FG004|Italy|Lost to Follow-up|0|||
126587915|NCT04924660|455451114|FG005|Italy|Lost to Follow-up|1|||
126587916|NCT04924660|455451109|FG000|South Africa|Death|0|||
126587917|NCT04924660|455451110|FG001|South Africa|Death|0|||
126587918|NCT04924660|455451111|FG002|South Africa|Death|0|||
126587919|NCT04924660|455451112|FG003|South Africa|Death|0|||
126587920|NCT04924660|455451113|FG004|South Africa|Death|0|||
126587921|NCT04924660|455451114|FG005|South Africa|Death|1|||
126587922|NCT04924660|455451109|FG000|South Africa|Lost to Follow-up|0|||
126587923|NCT04924660|455451110|FG001|South Africa|Lost to Follow-up|0|||
126587924|NCT04924660|455451111|FG002|South Africa|Lost to Follow-up|0|||
126587925|NCT04924660|455451112|FG003|South Africa|Lost to Follow-up|0|||
126587926|NCT04924660|455451113|FG004|South Africa|Lost to Follow-up|0|||
126587927|NCT04924660|455451114|FG005|South Africa|Lost to Follow-up|1|||
126587928|NCT06205407|455451115|FG000|Period 2|Withdrawal by Subject|0|||
126587929|NCT06205407|455451116|FG001|Period 2|Withdrawal by Subject|1|||
126587930|NCT06205407|455451115|FG000|Period 2|Adverse Event|2|||
126587931|NCT06205407|455451116|FG001|Period 2|Adverse Event|1|||
126587932|NCT03557697|455451117|FG000|Overall Study|Withdrawal by Subject|2|||
126587933|NCT03557697|455451118|FG001|Overall Study|Withdrawal by Subject|4|||
126587934|NCT06491433|455451119|FG000|Overall Study|Protocol Violation|51|||
126587935|NCT06491433|455451119|FG000|Overall Study|consent withdrawal|2|||
126587936|NCT06491433|455451119|FG000|Overall Study|screen failure|1|||
126777706|NCT00529568|456141413|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
126587937|NCT05478499|455451126|FG000|Overall Study|Adverse Event|4|||
126587938|NCT05478499|455451127|FG001|Overall Study|Adverse Event|2|||
126587939|NCT05478499|455451126|FG000|Overall Study|Withdrawal by Subject|3|||
126587940|NCT05478499|455451127|FG001|Overall Study|Withdrawal by Subject|2|||
126587941|NCT05478499|455451126|FG000|Overall Study|Lack of Efficacy|1|||
126587942|NCT05478499|455451127|FG001|Overall Study|Lack of Efficacy|0|||
126587943|NCT05478499|455451126|FG000|Overall Study|Lost to Follow-up|1|||
126587944|NCT05478499|455451127|FG001|Overall Study|Lost to Follow-up|0|||
126587945|NCT05478499|455451126|FG000|Overall Study|Other reasons|0|||
126587946|NCT05478499|455451127|FG001|Overall Study|Other reasons|1|||
126587947|NCT02962895|455451128|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
126587948|NCT02962895|455451129|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
126587949|NCT02962895|455451130|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
126587950|NCT02962895|455451131|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
126587951|NCT02962895|455451132|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
126587952|NCT02962895|455451133|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
126587953|NCT02962895|455451134|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
126587954|NCT02962895|455451128|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
126587955|NCT02962895|455451129|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
126587956|NCT02962895|455451130|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
126587957|NCT02962895|455451131|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
126587958|NCT02962895|455451132|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
126587959|NCT02962895|455451133|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
126587960|NCT02962895|455451134|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
126587961|NCT02962895|455451128|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
126587962|NCT02962895|455451129|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
126587963|NCT02962895|455451130|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
126587964|NCT02962895|455451131|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
126587965|NCT02962895|455451132|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
126587966|NCT02962895|455451133|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
126587967|NCT02962895|455451134|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
126587968|NCT02962895|455451128|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
126587969|NCT02962895|455451129|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
126587970|NCT02962895|455451130|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
126587971|NCT02962895|455451131|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
126640543|NCT05143138|455642802|FG001|Overall Study|Lost to Follow-up|4|||
126587972|NCT02962895|455451132|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
126587973|NCT02962895|455451133|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
126587974|NCT02962895|455451134|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
126587975|NCT02962895|455451128|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
126587976|NCT02962895|455451129|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
126587977|NCT02962895|455451130|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
126587978|NCT02962895|455451131|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
126587979|NCT02962895|455451132|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
126587980|NCT02962895|455451133|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
126587981|NCT02962895|455451134|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
126587982|NCT02962895|455451128|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
126587983|NCT02962895|455451129|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
126587984|NCT02962895|455451130|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
126587985|NCT02962895|455451131|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
126587986|NCT02962895|455451132|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
126587987|NCT02962895|455451133|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
126587988|NCT02962895|455451134|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
126587989|NCT02962895|455451128|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
126587990|NCT02962895|455451129|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
126587991|NCT02962895|455451130|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
126587992|NCT02962895|455451131|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
126587993|NCT02962895|455451132|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
126587994|NCT02962895|455451133|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
126587995|NCT02962895|455451134|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
126587996|NCT02962895|455451128|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
126587997|NCT02962895|455451129|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
126587998|NCT02962895|455451130|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
126587999|NCT02962895|455451131|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
126588000|NCT02962895|455451132|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
126588001|NCT02962895|455451133|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
126588002|NCT02962895|455451134|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
126588003|NCT02962895|455451128|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
126588004|NCT02962895|455451129|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
126588005|NCT02962895|455451130|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
126588006|NCT02962895|455451131|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
126588007|NCT02962895|455451132|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
126588008|NCT02962895|455451133|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
126588009|NCT02962895|455451134|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
126588010|NCT02962895|455451128|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
126588011|NCT02962895|455451129|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
126588012|NCT02962895|455451130|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
126588013|NCT02962895|455451131|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
126588014|NCT02962895|455451132|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
126588015|NCT02962895|455451133|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
126588016|NCT02962895|455451134|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
126588017|NCT02962895|455451128|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
126588018|NCT02962895|455451129|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
126588019|NCT02962895|455451130|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
126588020|NCT02962895|455451131|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
126588021|NCT02962895|455451132|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
126588022|NCT02962895|455451133|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
126588023|NCT02962895|455451134|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
126588024|NCT02962895|455451128|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
126588025|NCT02962895|455451129|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
126588026|NCT02962895|455451130|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
126588027|NCT02962895|455451131|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
126588028|NCT02962895|455451132|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
126588029|NCT02962895|455451133|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
126588030|NCT02962895|455451134|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
126588031|NCT02962895|455451128|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
126588032|NCT02962895|455451129|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
126588033|NCT02962895|455451130|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
126588034|NCT02962895|455451131|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
126588035|NCT02962895|455451132|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
126588036|NCT02962895|455451133|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
126588037|NCT02962895|455451134|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
126588038|NCT02962895|455451128|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
126588039|NCT02962895|455451129|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
126588040|NCT02962895|455451130|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
126588041|NCT02962895|455451131|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
126588042|NCT02962895|455451132|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
126588043|NCT02962895|455451133|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
126588044|NCT02962895|455451134|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
126588045|NCT03364647|455451136|FG000|Overall Study|Withdrawal by Subject|3|||
126588046|NCT03364647|455451137|FG001|Overall Study|Withdrawal by Subject|1|||
126588047|NCT03476460|455451140|FG000|Overall Study|Withdrawal by Subject|3|||
126588048|NCT03476460|455451141|FG001|Overall Study|Withdrawal by Subject|2|||
126588049|NCT03476460|455451140|FG000|Overall Study|Non-compliance with treatment|3|||
126588050|NCT03476460|455451141|FG001|Overall Study|Non-compliance with treatment|0|||
126588051|NCT03476460|455451140|FG000|Overall Study|Missing laboratory tests|5|||
126588052|NCT03476460|455451141|FG001|Overall Study|Missing laboratory tests|5|||
126588053|NCT03476460|455451140|FG000|Overall Study|Adverse Event|0|||
126588054|NCT03476460|455451141|FG001|Overall Study|Adverse Event|1|||
126588055|NCT01606215|455451149|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
126588056|NCT01606215|455451150|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
126588057|NCT04592549|455451151|FG000|Overall Study|Withdrawal by Subject|0|||
126588058|NCT04592549|455451152|FG001|Overall Study|Withdrawal by Subject|1|||
126588059|NCT04592549|455451153|FG002|Overall Study|Withdrawal by Subject|0|||
126588060|NCT04592549|455451154|FG003|Overall Study|Withdrawal by Subject|1|||
126588061|NCT04592549|455451155|FG004|Overall Study|Withdrawal by Subject|1|||
126588062|NCT04592549|455451156|FG005|Overall Study|Withdrawal by Subject|0|||
126588063|NCT04592549|455451151|FG000|Overall Study|Lost to Follow-up|2|||
126588064|NCT04592549|455451152|FG001|Overall Study|Lost to Follow-up|0|||
126588065|NCT04592549|455451153|FG002|Overall Study|Lost to Follow-up|0|||
126588066|NCT04592549|455451154|FG003|Overall Study|Lost to Follow-up|1|||
126588067|NCT04592549|455451155|FG004|Overall Study|Lost to Follow-up|1|||
126588068|NCT04592549|455451156|FG005|Overall Study|Lost to Follow-up|1|||
126588069|NCT05184192|455451157|FG000|Overall Study|Lost to Follow-up|4|||
126588070|NCT05184192|455451158|FG001|Overall Study|Lost to Follow-up|7|||
126588071|NCT05184192|455451157|FG000|Overall Study|Adverse Event|1|||
126588072|NCT05184192|455451158|FG001|Overall Study|Adverse Event|4|||
126588073|NCT05184192|455451157|FG000|Overall Study|PI withdrawal|1|||
126588074|NCT05184192|455451158|FG001|Overall Study|PI withdrawal|2|||
126588075|NCT05184192|455451157|FG000|Overall Study|Withdrew due to adverse effect|1|||
126588076|NCT05184192|455451158|FG001|Overall Study|Withdrew due to adverse effect|0|||
126588077|NCT05184192|455451157|FG000|Overall Study|Medication schedule|1|||
126588078|NCT05184192|455451158|FG001|Overall Study|Medication schedule|0|||
126588079|NCT05184192|455451157|FG000|Overall Study|Concern for adverse effects|0|||
126588080|NCT05184192|455451158|FG001|Overall Study|Concern for adverse effects|4|||
126588081|NCT02921230|455452892|FG000|Overall Study|Withdrawal by Subject|20|||
126588082|NCT02921230|455452893|FG001|Overall Study|Withdrawal by Subject|8|||
126588083|NCT02921230|455452892|FG000|Overall Study|Death|12|||
126588084|NCT02921230|455452893|FG001|Overall Study|Death|3|||
126588085|NCT02921230|455452892|FG000|Overall Study|Protocol Violation|17|||
126588086|NCT02921230|455452893|FG001|Overall Study|Protocol Violation|6|||
126588087|NCT02921230|455452892|FG000|Overall Study|Early completion|5|||
126588088|NCT02921230|455452893|FG001|Overall Study|Early completion|1|||
126588089|NCT02921230|455452892|FG000|Overall Study|Pending data entry|1|||
126588090|NCT02921230|455452893|FG001|Overall Study|Pending data entry|0|||
126588091|NCT03436290|455452894|FG000|Overall Study|Post-randomization Exclusion|1|||
126588092|NCT03436290|455452895|FG001|Overall Study|Post-randomization Exclusion|0|||
126588093|NCT03436290|455452894|FG000|Overall Study|Death|6|||
126588094|NCT03436290|455452895|FG001|Overall Study|Death|0|||
126588095|NCT03436290|455452894|FG000|Overall Study|Withdrawal by Subject|4|||
126588096|NCT03436290|455452895|FG001|Overall Study|Withdrawal by Subject|0|||
126588097|NCT03436290|455452894|FG000|Overall Study|Protocol Violation|30|||
126588098|NCT03436290|455452895|FG001|Overall Study|Protocol Violation|0|||
126588099|NCT03338933|455452904|FG000|Screening Visit|Lost to Follow-up|1|||
126588100|NCT03338933|455452905|FG001|Screening Visit|Lost to Follow-up|3|||
126588101|NCT03338933|455452906|FG002|Screening Visit|Lost to Follow-up|1|||
126588102|NCT03338933|455452907|FG003|Screening Visit|Lost to Follow-up|4|||
126588103|NCT03338933|455452904|FG000|Screening Visit|Screen fail after consent|2|||
126588104|NCT03338933|455452905|FG001|Screening Visit|Screen fail after consent|7|||
126588105|NCT03338933|455452906|FG002|Screening Visit|Screen fail after consent|1|||
126588106|NCT03338933|455452907|FG003|Screening Visit|Screen fail after consent|4|||
126588107|NCT03338933|455452904|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
126588108|NCT03338933|455452905|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
126588109|NCT03338933|455452906|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
126588110|NCT03338933|455452907|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
126588111|NCT03338933|455452904|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
126588112|NCT03338933|455452905|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
126588113|NCT03338933|455452906|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
126588114|NCT03338933|455452907|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
126588115|NCT03338933|455452904|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
126588116|NCT03338933|455452905|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
126588117|NCT03338933|455452906|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
126588118|NCT03338933|455452907|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
126588119|NCT02924272|455452911|FG000|Overall Study|Site Terminated by Sponsor|4|||
126588120|NCT02924272|455452912|FG001|Overall Study|Site Terminated by Sponsor|1|||
126588121|NCT02924272|455452911|FG000|Overall Study|Withdrawal by Subject|2|||
126588122|NCT02924272|455452912|FG001|Overall Study|Withdrawal by Subject|0|||
126588123|NCT02924272|455452911|FG000|Overall Study|Adverse Event|3|||
126588124|NCT02924272|455452912|FG001|Overall Study|Adverse Event|0|||
126588125|NCT02924272|455452911|FG000|Overall Study|Progressive Disease|11|||
126588126|NCT02924272|455452912|FG001|Overall Study|Progressive Disease|8|||
126588127|NCT02924272|455452911|FG000|Overall Study|Clinical Deterioration|1|||
126588128|NCT02924272|455452912|FG001|Overall Study|Clinical Deterioration|0|||
126588129|NCT02924272|455452911|FG000|Overall Study|Death|1|||
126588130|NCT02924272|455452912|FG001|Overall Study|Death|0|||
126588131|NCT02924272|455452911|FG000|Overall Study|Reason Not Specified|1|||
126588132|NCT02924272|455452912|FG001|Overall Study|Reason Not Specified|0|||
126588133|NCT02100813|455452917|FG000|Overall Study|Adverse Event|0|||
126588134|NCT02100813|455452918|FG001|Overall Study|Adverse Event|0|||
126588135|NCT02100813|455452919|FG002|Overall Study|Adverse Event|0|||
126588136|NCT02100813|455452920|FG003|Overall Study|Adverse Event|0|||
126588137|NCT02100813|455452921|FG004|Overall Study|Adverse Event|0|||
126588138|NCT02100813|455452922|FG005|Overall Study|Adverse Event|0|||
126588139|NCT02100813|455452923|FG006|Overall Study|Adverse Event|0|||
126588140|NCT02100813|455452924|FG007|Overall Study|Adverse Event|1|||
126588141|NCT03575897|455452926|FG000|Overall Study|Lost to Follow-up|12|||
126588142|NCT03575897|455452927|FG001|Overall Study|Lost to Follow-up|13|||
126588143|NCT04359108|455452928|FG000|Overall Study|Withdrawal by Subject|1|||
126588144|NCT04359108|455452929|FG001|Overall Study|Withdrawal by Subject|0|||
126588145|NCT04359108|455452928|FG000|Overall Study|Unable or too feeble to walk independently|0|||
126588146|NCT04359108|455452929|FG001|Overall Study|Unable or too feeble to walk independently|2|||
126588147|NCT04359108|455452928|FG000|Overall Study|Argus II system stopped functioning|0|||
126588148|NCT04359108|455452929|FG001|Overall Study|Argus II system stopped functioning|1|||
126588149|NCT04359108|455452928|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
126588150|NCT04359108|455452929|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
126588151|NCT03652688|455452930|FG000|Baseline|Withdrawal by Subject|0|||
126588152|NCT03652688|455452931|FG001|Baseline|Withdrawal by Subject|3|||
126588153|NCT03652688|455452930|FG000|Follow-up|Lost to Follow-up|56|||
126588154|NCT03652688|455452931|FG001|Follow-up|Lost to Follow-up|54|||
126588155|NCT03468218|455452932|FG000|Overall Study|Adverse Event|5|||
126588156|NCT03468218|455452932|FG000|Overall Study|Progressive Disease|16|||
126588157|NCT03468218|455452932|FG000|Overall Study|Death|1|||
126588158|NCT03468218|455452932|FG000|Overall Study|Alternate therapy|1|||
126588159|NCT03468218|455452932|FG000|Overall Study|Withdrawal by Subject|2|||
126588160|NCT03829410|455452934|FG000|Overall Study|Adverse Event|1|||
126588161|NCT03829410|455452935|FG001|Overall Study|Adverse Event|0|||
126588162|NCT03829410|455452936|FG002|Overall Study|Adverse Event|1|||
126588163|NCT03829410|455452937|FG003|Overall Study|Adverse Event|4|||
126588164|NCT03829410|455452934|FG000|Overall Study|Physician Decision|0|||
126588165|NCT03829410|455452935|FG001|Overall Study|Physician Decision|0|||
126588166|NCT03829410|455452936|FG002|Overall Study|Physician Decision|0|||
126588167|NCT03829410|455452937|FG003|Overall Study|Physician Decision|2|||
126588168|NCT03829410|455452934|FG000|Overall Study|Disease Progressing|3|||
126588169|NCT03829410|455452935|FG001|Overall Study|Disease Progressing|4|||
126588170|NCT03829410|455452936|FG002|Overall Study|Disease Progressing|2|||
126588171|NCT03829410|455452937|FG003|Overall Study|Disease Progressing|31|||
126588172|NCT03829410|455452934|FG000|Overall Study|Miscellaneous|2|||
126588173|NCT03829410|455452935|FG001|Overall Study|Miscellaneous|4|||
126588174|NCT03829410|455452936|FG002|Overall Study|Miscellaneous|3|||
126588175|NCT03829410|455452937|FG003|Overall Study|Miscellaneous|10|||
126588176|NCT03719443|455452938|FG000|Overall Study|Lost to Follow-up|0|||
126588177|NCT03719443|455452939|FG001|Overall Study|Lost to Follow-up|0|||
126588178|NCT03719443|455452940|FG002|Overall Study|Lost to Follow-up|1|||
126588179|NCT03719443|455452941|FG003|Overall Study|Lost to Follow-up|0|||
126588180|NCT03719443|455452942|FG004|Overall Study|Lost to Follow-up|1|||
126588181|NCT03719443|455452943|FG005|Overall Study|Lost to Follow-up|0|||
126588182|NCT03719443|455452944|FG006|Overall Study|Lost to Follow-up|1|||
126588183|NCT03719443|455452938|FG000|Overall Study|Withdrawal by Subject|0|||
126588184|NCT03719443|455452939|FG001|Overall Study|Withdrawal by Subject|0|||
126588185|NCT03719443|455452940|FG002|Overall Study|Withdrawal by Subject|1|||
126588186|NCT03719443|455452941|FG003|Overall Study|Withdrawal by Subject|0|||
126588187|NCT03719443|455452942|FG004|Overall Study|Withdrawal by Subject|0|||
126588188|NCT03719443|455452943|FG005|Overall Study|Withdrawal by Subject|0|||
126588189|NCT03719443|455452944|FG006|Overall Study|Withdrawal by Subject|0|||
126588190|NCT04749615|455452945|FG000|Overall Study|Lost to Follow-up|6|||
126588191|NCT04749615|455452946|FG001|Overall Study|Lost to Follow-up|10|||
126588192|NCT03611491|455452947|FG000|Overall Study|Lost to Follow-up|1|||
126588193|NCT04676022|455452948|FG000|Overall Study|Screen Failure/|1|||
126588194|NCT04676022|455452949|FG001|Overall Study|Screen Failure/|1|||
126588195|NCT04676022|455452950|FG002|Overall Study|Screen Failure/|85|||
126588196|NCT04676022|455452948|FG000|Overall Study|Lost to Follow-up|1|||
126588197|NCT04676022|455452949|FG001|Overall Study|Lost to Follow-up|1|||
126588198|NCT04676022|455452950|FG002|Overall Study|Lost to Follow-up|0|||
126588199|NCT04676022|455452948|FG000|Overall Study|Adverse Event|2|||
126588200|NCT04676022|455452949|FG001|Overall Study|Adverse Event|0|||
126588201|NCT04676022|455452950|FG002|Overall Study|Adverse Event|1|||
126588202|NCT04676022|455452948|FG000|Overall Study|Physician Decision|2|||
126588203|NCT04676022|455452949|FG001|Overall Study|Physician Decision|0|||
126588204|NCT04676022|455452950|FG002|Overall Study|Physician Decision|1|||
126588205|NCT04676022|455452948|FG000|Overall Study|Withdrawal by Subject|3|||
126588206|NCT04676022|455452949|FG001|Overall Study|Withdrawal by Subject|1|||
126588207|NCT04676022|455452950|FG002|Overall Study|Withdrawal by Subject|6|||
126588208|NCT04676022|455452948|FG000|Overall Study|Will not move forward with permanent implant|6|||
126588209|NCT04676022|455452949|FG001|Overall Study|Will not move forward with permanent implant|0|||
126588210|NCT04676022|455452950|FG002|Overall Study|Will not move forward with permanent implant|0|||
126588211|NCT04676022|455452948|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
126588212|NCT04676022|455452949|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
126588213|NCT04676022|455452950|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
126588214|NCT03194217|455452965|FG000|Overall Study|Adverse Event|0|||
126588215|NCT03194217|455452966|FG001|Overall Study|Adverse Event|2|||
126588216|NCT03194217|455452967|FG002|Overall Study|Adverse Event|3|||
126588217|NCT03194217|455452968|FG003|Overall Study|Adverse Event|3|||
126588218|NCT03194217|455452965|FG000|Overall Study|Failure to meet randomisation criteria|0|||
126588219|NCT03194217|455452966|FG001|Overall Study|Failure to meet randomisation criteria|0|||
126588220|NCT03194217|455452967|FG002|Overall Study|Failure to meet randomisation criteria|0|||
126588221|NCT03194217|455452968|FG003|Overall Study|Failure to meet randomisation criteria|1|||
126588222|NCT03194217|455452965|FG000|Overall Study|Other|0|||
126588223|NCT03194217|455452966|FG001|Overall Study|Other|1|||
126588224|NCT03194217|455452967|FG002|Overall Study|Other|1|||
126588225|NCT03194217|455452968|FG003|Overall Study|Other|0|||
126588226|NCT05481320|455452969|FG000|Overall Study|Withdrawal by Subject|1|||
126588227|NCT05481320|455452970|FG001|Overall Study|Withdrawal by Subject|1|||
126588228|NCT05481320|455452969|FG000|Overall Study|Care recipent passed away|0|||
126588229|NCT05481320|455452970|FG001|Overall Study|Care recipent passed away|1|||
126588230|NCT05481320|455452969|FG000|Overall Study|Out-of-window assessment|0|||
126588231|NCT05481320|455452970|FG001|Overall Study|Out-of-window assessment|1|||
126588232|NCT05481320|455452969|FG000|Overall Study|No longer a primary caregiver|3|||
126588233|NCT05481320|455452970|FG001|Overall Study|No longer a primary caregiver|0|||
126588234|NCT05481320|455452969|FG000|Overall Study|Unable to contact|1|||
126588235|NCT05481320|455452970|FG001|Overall Study|Unable to contact|0|||
126588236|NCT05894577|455452971|FG000|Overall Study|No receipt of study drug|14|||
126588237|NCT05894577|455452972|FG001|Overall Study|No receipt of study drug|13|||
126588238|NCT05894577|455452971|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
126588239|NCT05894577|455452972|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
126588240|NCT05894577|455452971|FG000|Overall Study|Screen Fail|2|||
126588241|NCT05894577|455452972|FG001|Overall Study|Screen Fail|0|||
126588242|NCT05894577|455452971|FG000|Overall Study|Study drug recall|86|||
126588243|NCT05894577|455452972|FG001|Overall Study|Study drug recall|63|||
126588244|NCT04509674|455452974|FG000|Overall Study|Not treated|33|||
126588245|NCT04509674|455452975|FG001|Overall Study|Not treated|26|||
126588246|NCT04509674|455452974|FG000|Overall Study|Protocol Violation|9|||
126588247|NCT04509674|455452975|FG001|Overall Study|Protocol Violation|10|||
126588248|NCT04509674|455452974|FG000|Overall Study|Lost to Follow-up|31|||
126588249|NCT04509674|455452975|FG001|Overall Study|Lost to Follow-up|39|||
126588250|NCT04509674|455452974|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
126588251|NCT04509674|455452975|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
126588252|NCT04509674|455452974|FG000|Overall Study|Adverse event, serious fatal event|11|||
126588253|NCT04509674|455452975|FG001|Overall Study|Adverse event, serious fatal event|4|||
126588254|NCT04509674|455452974|FG000|Overall Study|Adverse event, non-fatal event|107|||
126588255|NCT04509674|455452975|FG001|Overall Study|Adverse event, non-fatal event|118|||
126588256|NCT04509674|455452974|FG000|Overall Study|Other reason than listed|106|||
126588257|NCT04509674|455452975|FG001|Overall Study|Other reason than listed|95|||
126777707|NCT00529568|456141414|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
126777708|NCT00529568|456141415|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
126777709|NCT00529568|456141413|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
126777710|NCT00529568|456141414|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
126777711|NCT00529568|456141415|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
126777712|NCT00529568|456141413|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
126777713|NCT00529568|456141414|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
126777714|NCT00529568|456141415|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
126777715|NCT00529568|456141413|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
126777716|NCT00529568|456141414|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
126777717|NCT00529568|456141415|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
126777718|NCT00529568|456141413|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
126777719|NCT00529568|456141414|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
126777720|NCT00529568|456141415|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
126777721|NCT00529568|456141413|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
126777722|NCT00529568|456141414|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
126777723|NCT00529568|456141415|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
126777724|NCT00529568|456141413|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
126777725|NCT00529568|456141414|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
126777726|NCT00529568|456141415|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
126777727|NCT00529568|456141413|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
126777728|NCT00529568|456141414|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
126777729|NCT00529568|456141415|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
126777730|NCT00931385|456141416|FG000|Overall Study|Adverse Event|2|||
126588258|NCT03197662|455452976|FG000|Overall Study|Withdrawn by family|0|||
126588259|NCT03197662|455452977|FG001|Overall Study|Withdrawn by family|2|||
126588260|NCT01214616|455452978|FG000|Overall Study|Progressive disease|2|||
126588261|NCT01214616|455452979|FG001|Overall Study|Progressive disease|2|||
126588262|NCT01214616|455452980|FG002|Overall Study|Progressive disease|2|||
126588263|NCT01214616|455452981|FG003|Overall Study|Progressive disease|4|||
126588264|NCT01214616|455452978|FG000|Overall Study|Dose limiting toxicity|0|||
126588265|NCT01214616|455452979|FG001|Overall Study|Dose limiting toxicity|2|||
126588266|NCT01214616|455452980|FG002|Overall Study|Dose limiting toxicity|0|||
126588267|NCT01214616|455452981|FG003|Overall Study|Dose limiting toxicity|0|||
126588268|NCT01214616|455452978|FG000|Overall Study|Other adverse events|0|||
126588269|NCT01214616|455452979|FG001|Overall Study|Other adverse events|1|||
126588270|NCT01214616|455452980|FG002|Overall Study|Other adverse events|1|||
126588271|NCT01214616|455452981|FG003|Overall Study|Other adverse events|1|||
126588272|NCT01214616|455452978|FG000|Overall Study|Withdrawal by Subject|1|||
126588273|NCT01214616|455452979|FG001|Overall Study|Withdrawal by Subject|0|||
126588274|NCT01214616|455452980|FG002|Overall Study|Withdrawal by Subject|0|||
126588275|NCT01214616|455452981|FG003|Overall Study|Withdrawal by Subject|1|||
126588276|NCT03721952|455452982|FG000|Overall Study|Lost to Follow-up|0|||
126588277|NCT03721952|455452983|FG001|Overall Study|Lost to Follow-up|0|||
126588278|NCT03721952|455452984|FG002|Overall Study|Lost to Follow-up|2|||
126588279|NCT03721952|455452985|FG003|Overall Study|Lost to Follow-up|0|||
126588280|NCT03721952|455452986|FG004|Overall Study|Lost to Follow-up|0|||
126588281|NCT03721952|455452982|FG000|Overall Study|Protocol Violation|0|||
126588282|NCT03721952|455452983|FG001|Overall Study|Protocol Violation|1|||
126588283|NCT03721952|455452984|FG002|Overall Study|Protocol Violation|0|||
126588284|NCT03721952|455452985|FG003|Overall Study|Protocol Violation|0|||
126588285|NCT03721952|455452986|FG004|Overall Study|Protocol Violation|0|||
126588286|NCT03721952|455452982|FG000|Overall Study|Withdrawal by Subject|1|||
126588287|NCT03721952|455452983|FG001|Overall Study|Withdrawal by Subject|0|||
126588288|NCT03721952|455452984|FG002|Overall Study|Withdrawal by Subject|40|||
126588289|NCT03721952|455452985|FG003|Overall Study|Withdrawal by Subject|28|||
126588290|NCT03721952|455452986|FG004|Overall Study|Withdrawal by Subject|0|||
126588291|NCT05292365|455452989|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
126588292|NCT05292365|455452990|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
126588293|NCT05292365|455452991|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
126588294|NCT05292365|455452992|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
126588295|NCT04495894|455452996|FG000|Overall Study|Withdrawal by Subject|2|||
126588296|NCT04495894|455452997|FG001|Overall Study|Withdrawal by Subject|0|||
126588297|NCT04495894|455452998|FG002|Overall Study|Withdrawal by Subject|2|||
126588298|NCT04495894|455452999|FG003|Overall Study|Withdrawal by Subject|3|||
126588299|NCT04495894|455452996|FG000|Overall Study|Early termination|0|||
126588300|NCT04495894|455452997|FG001|Overall Study|Early termination|0|||
126588301|NCT04495894|455452998|FG002|Overall Study|Early termination|3|||
126588302|NCT04495894|455452999|FG003|Overall Study|Early termination|0|||
126588303|NCT05579899|455453001|FG000|Overall Study|Lost to Follow-up|3|||
126588304|NCT05579899|455453002|FG001|Overall Study|Lost to Follow-up|1|||
126588305|NCT05579899|455453001|FG000|Overall Study|Adverse Event|0|||
126588306|NCT05579899|455453002|FG001|Overall Study|Adverse Event|3|||
126588307|NCT05579899|455453001|FG000|Overall Study|Pregnancy|0|||
126588308|NCT05579899|455453002|FG001|Overall Study|Pregnancy|1|||
126588309|NCT05579899|455453001|FG000|Overall Study|Withdrawal by Subject|0|||
126588310|NCT05579899|455453002|FG001|Overall Study|Withdrawal by Subject|3|||
126588311|NCT01000961|455453004|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
126588312|NCT01000961|455453005|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126588313|NCT01000961|455453004|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
126588314|NCT01000961|455453005|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
126588315|NCT04185298|455453006|FG000|Overall Study|Lost to Follow-up|1|||
126588316|NCT04185298|455453007|FG001|Overall Study|Lost to Follow-up|3|||
126588317|NCT04185298|455453006|FG000|Overall Study|Withdrawal by Subject|0|||
126588318|NCT04185298|455453007|FG001|Overall Study|Withdrawal by Subject|3|||
126588319|NCT03896789|455453008|FG000|Baseline|Lost to Follow-up|1|||
126588320|NCT03896789|455453009|FG001|Baseline|Lost to Follow-up|2|||
126588321|NCT03896789|455453008|FG000|Baseline|Death|3|||
126588322|NCT03896789|455453009|FG001|Baseline|Death|6|||
126588323|NCT03896789|455453008|FG000|Post-Randomization|Lost to Follow-up|12|||
126777731|NCT00931385|456141417|FG001|Overall Study|Adverse Event|1|||
126777732|NCT00931385|456141418|FG002|Overall Study|Adverse Event|0|||
126777733|NCT00931385|456141419|FG003|Overall Study|Adverse Event|3|||
126777734|NCT00931385|456141416|FG000|Overall Study|Protocol Violation|0|||
126777735|NCT00931385|456141417|FG001|Overall Study|Protocol Violation|0|||
126777736|NCT00931385|456141418|FG002|Overall Study|Protocol Violation|1|||
126777737|NCT00931385|456141419|FG003|Overall Study|Protocol Violation|0|||
126777738|NCT00931385|456141416|FG000|Overall Study|Withdrawal by Subject|0|||
126777739|NCT00931385|456141417|FG001|Overall Study|Withdrawal by Subject|1|||
126777740|NCT00931385|456141418|FG002|Overall Study|Withdrawal by Subject|0|||
126777741|NCT00931385|456141419|FG003|Overall Study|Withdrawal by Subject|1|||
126588324|NCT03896789|455453009|FG001|Post-Randomization|Lost to Follow-up|11|||
126588325|NCT03896789|455453008|FG000|Post-Randomization|Death|12|||
126588326|NCT03896789|455453009|FG001|Post-Randomization|Death|13|||
126588327|NCT04015167|455453021|FG000|Overall Study|Lost to Follow-up|40|||
126588328|NCT04015167|455453021|FG000|Overall Study|Adverse Event|5|||
126588329|NCT04015167|455453021|FG000|Overall Study|Withdrawal by Subject|2|||
126588330|NCT04015167|455453021|FG000|Overall Study|Subject went to jail|1|||
126588331|NCT03640312|455453022|FG000|Overall Study|Lost to Follow-up|3|||
126588332|NCT03640312|455453023|FG001|Overall Study|Lost to Follow-up|6|||
126588333|NCT03382652|455453024|FG000|Overall Study|Lost to Follow-up|6|||
126588334|NCT03382652|455453024|FG000|Overall Study|Death|4|||
126588335|NCT03382652|455453024|FG000|Overall Study|Revision|5|||
126588336|NCT03382652|455453024|FG000|Overall Study|Patient withdrew|3|||
126588337|NCT03382652|455453024|FG000|Overall Study|Other reasons|21|||
126588338|NCT04810650|455453028|FG000|Overall Study|Disenrolled in error|0|||
126588339|NCT04810650|455453029|FG001|Overall Study|Disenrolled in error|0|||
126588340|NCT04810650|455453030|FG002|Overall Study|Disenrolled in error|0|||
126588341|NCT04810650|455453031|FG003|Overall Study|Disenrolled in error|0|||
126588342|NCT04810650|455453032|FG004|Overall Study|Disenrolled in error|0|||
126588343|NCT04810650|455453033|FG005|Overall Study|Disenrolled in error|0|||
126588344|NCT04810650|455453034|FG006|Overall Study|Disenrolled in error|0|||
126588345|NCT04810650|455453035|FG007|Overall Study|Disenrolled in error|0|||
126588346|NCT04810650|455453036|FG008|Overall Study|Disenrolled in error|1|||
126588347|NCT04810650|455453037|FG009|Overall Study|Disenrolled in error|0|||
126588348|NCT04810650|455453038|FG010|Overall Study|Disenrolled in error|0|||
126588349|NCT04810650|455453039|FG011|Overall Study|Disenrolled in error|0|||
126588350|NCT04810650|455453040|FG012|Overall Study|Disenrolled in error|0|||
126588351|NCT04810650|455453041|FG013|Overall Study|Disenrolled in error|0|||
126588352|NCT04810650|455453028|FG000|Overall Study|Death|0|||
126588353|NCT04810650|455453029|FG001|Overall Study|Death|0|||
126588354|NCT04810650|455453030|FG002|Overall Study|Death|0|||
126588355|NCT04810650|455453031|FG003|Overall Study|Death|0|||
126588356|NCT04810650|455453032|FG004|Overall Study|Death|0|||
126588357|NCT04810650|455453033|FG005|Overall Study|Death|0|||
126588358|NCT04810650|455453034|FG006|Overall Study|Death|2|||
126588359|NCT04810650|455453035|FG007|Overall Study|Death|2|||
126777742|NCT00931385|456141416|FG000|Overall Study|Lost to Follow-up|0|||
126777743|NCT00931385|456141417|FG001|Overall Study|Lost to Follow-up|0|||
126777744|NCT00931385|456141418|FG002|Overall Study|Lost to Follow-up|0|||
126777745|NCT00931385|456141419|FG003|Overall Study|Lost to Follow-up|1|||
126777746|NCT01201356|456141420|FG000|Overall Study|Adverse Event|170|||
126777747|NCT01201356|456141420|FG000|Overall Study|Abnormal laboratory value(s)|51|||
126588360|NCT04810650|455453036|FG008|Overall Study|Death|0|||
126588361|NCT04810650|455453037|FG009|Overall Study|Death|1|||
126588362|NCT04810650|455453038|FG010|Overall Study|Death|0|||
126588363|NCT04810650|455453039|FG011|Overall Study|Death|0|||
126588364|NCT04810650|455453040|FG012|Overall Study|Death|2|||
126777748|NCT01201356|456141420|FG000|Overall Study|Abnormal test procedure result(s)|3|||
126777749|NCT01201356|456141420|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
126777750|NCT01201356|456141420|FG000|Overall Study|Condition no longer requires study drug|12|||
126777751|NCT01201356|456141420|FG000|Overall Study|Withdrawal by Subject|144|||
126777752|NCT01201356|456141420|FG000|Overall Study|Lost to Follow-up|50|||
126777753|NCT01201356|456141420|FG000|Overall Study|administrative problems|74|||
126777754|NCT01201356|456141420|FG000|Overall Study|Death|16|||
126777755|NCT01201356|456141420|FG000|Overall Study|Protocol Violation|12|||
126777756|NCT00738920|456141422|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
126777757|NCT00738920|456141423|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
126777758|NCT00738920|456141424|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
126777759|NCT00738920|456141422|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
126777760|NCT00738920|456141423|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
126777761|NCT00738920|456141424|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
126777762|NCT00738920|456141422|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
126777763|NCT00738920|456141423|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
126777764|NCT00738920|456141424|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
126777765|NCT00738920|456141422|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
126777766|NCT00738920|456141423|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
126777767|NCT00738920|456141424|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
126777768|NCT00738920|456141422|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
126777769|NCT00738920|456141423|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
126777770|NCT00738920|456141424|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
126777771|NCT00738920|456141422|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
126777772|NCT00738920|456141423|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
126777773|NCT00738920|456141424|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
126777774|NCT00738920|456141422|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
126777775|NCT00738920|456141423|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
126777776|NCT00738920|456141424|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
126777777|NCT00738920|456141422|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
126777778|NCT00738920|456141423|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
126777779|NCT00738920|456141424|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
126777780|NCT00738920|456141422|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
126777781|NCT00738920|456141423|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
126777782|NCT00738920|456141424|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
126777783|NCT00738920|456141422|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
126588365|NCT04810650|455453041|FG013|Overall Study|Death|1|||
126588366|NCT04810650|455453028|FG000|Overall Study|Moved/transferred care|0|||
126588367|NCT04810650|455453029|FG001|Overall Study|Moved/transferred care|0|||
126588368|NCT04810650|455453030|FG002|Overall Study|Moved/transferred care|0|||
126588369|NCT04810650|455453031|FG003|Overall Study|Moved/transferred care|0|||
126588370|NCT04810650|455453032|FG004|Overall Study|Moved/transferred care|0|||
126588371|NCT04810650|455453033|FG005|Overall Study|Moved/transferred care|0|||
126588372|NCT04810650|455453034|FG006|Overall Study|Moved/transferred care|0|||
126588373|NCT04810650|455453035|FG007|Overall Study|Moved/transferred care|1|||
126588374|NCT04810650|455453036|FG008|Overall Study|Moved/transferred care|12|||
126588375|NCT04810650|455453037|FG009|Overall Study|Moved/transferred care|10|||
126588376|NCT04810650|455453038|FG010|Overall Study|Moved/transferred care|0|||
126588377|NCT04810650|455453039|FG011|Overall Study|Moved/transferred care|0|||
126588378|NCT04810650|455453040|FG012|Overall Study|Moved/transferred care|0|||
126588379|NCT04810650|455453041|FG013|Overall Study|Moved/transferred care|0|||
126588380|NCT04810650|455453028|FG000|Overall Study|Lost to Follow-up|15|||
126777784|NCT00738920|456141423|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
126777785|NCT00738920|456141424|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
126588381|NCT04810650|455453029|FG001|Overall Study|Lost to Follow-up|12|||
126588382|NCT04810650|455453030|FG002|Overall Study|Lost to Follow-up|7|||
126588383|NCT04810650|455453031|FG003|Overall Study|Lost to Follow-up|9|||
126588384|NCT04810650|455453032|FG004|Overall Study|Lost to Follow-up|10|||
126588385|NCT04810650|455453033|FG005|Overall Study|Lost to Follow-up|6|||
126588386|NCT04810650|455453034|FG006|Overall Study|Lost to Follow-up|0|||
126588387|NCT04810650|455453035|FG007|Overall Study|Lost to Follow-up|0|||
126588388|NCT04810650|455453036|FG008|Overall Study|Lost to Follow-up|0|||
126588389|NCT04810650|455453037|FG009|Overall Study|Lost to Follow-up|0|||
126588390|NCT04810650|455453038|FG010|Overall Study|Lost to Follow-up|1|||
126588391|NCT04810650|455453039|FG011|Overall Study|Lost to Follow-up|0|||
126588392|NCT04810650|455453040|FG012|Overall Study|Lost to Follow-up|3|||
126588393|NCT04810650|455453041|FG013|Overall Study|Lost to Follow-up|9|||
126588394|NCT04810650|455453028|FG000|Overall Study|Participant declined|0|||
126777786|NCT00811070|456141425|FG000|Overall Study|Death|0|||
126777787|NCT00811070|456141426|FG001|Overall Study|Death|0|||
126777788|NCT00811070|456141427|FG002|Overall Study|Death|0|||
126588395|NCT04810650|455453029|FG001|Overall Study|Participant declined|0|||
126588396|NCT04810650|455453030|FG002|Overall Study|Participant declined|0|||
126588397|NCT04810650|455453031|FG003|Overall Study|Participant declined|0|||
126588398|NCT04810650|455453032|FG004|Overall Study|Participant declined|0|||
126588399|NCT04810650|455453033|FG005|Overall Study|Participant declined|0|||
126588400|NCT04810650|455453034|FG006|Overall Study|Participant declined|0|||
126588401|NCT04810650|455453035|FG007|Overall Study|Participant declined|0|||
126588402|NCT04810650|455453036|FG008|Overall Study|Participant declined|0|||
126588403|NCT04810650|455453037|FG009|Overall Study|Participant declined|0|||
126588404|NCT04810650|455453038|FG010|Overall Study|Participant declined|2|||
126588405|NCT04810650|455453039|FG011|Overall Study|Participant declined|0|||
126588406|NCT04810650|455453040|FG012|Overall Study|Participant declined|0|||
126588407|NCT04810650|455453041|FG013|Overall Study|Participant declined|0|||
126588408|NCT05794243|455453042|FG000|Overall Study|Withdrawal by Subject|1|||
126588409|NCT05794243|455453043|FG001|Overall Study|Withdrawal by Subject|0|||
126588410|NCT05794243|455453044|FG002|Overall Study|Withdrawal by Subject|1|||
126588411|NCT05794243|455453042|FG000|Overall Study|Physician Decision|0|||
126588412|NCT05794243|455453043|FG001|Overall Study|Physician Decision|3|||
126588413|NCT05794243|455453044|FG002|Overall Study|Physician Decision|1|||
126588414|NCT02761057|455453050|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
126588415|NCT02761057|455453051|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
126588416|NCT02761057|455453052|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
126588417|NCT02761057|455453053|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
126588418|NCT02761057|455453050|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
126588419|NCT02761057|455453051|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
126588420|NCT02761057|455453052|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
126588421|NCT02761057|455453053|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
126588422|NCT02761057|455453050|FG000|Overall Study|Currently On Study Treatment|0|||
126588423|NCT02761057|455453051|FG001|Overall Study|Currently On Study Treatment|3|||
126588424|NCT02761057|455453052|FG002|Overall Study|Currently On Study Treatment|0|||
126588425|NCT02761057|455453053|FG003|Overall Study|Currently On Study Treatment|0|||
126588426|NCT02761057|455453050|FG000|Overall Study|Adverse Event|11|||
126588427|NCT02761057|455453051|FG001|Overall Study|Adverse Event|9|||
126588428|NCT02761057|455453052|FG002|Overall Study|Adverse Event|5|||
126588429|NCT02761057|455453053|FG003|Overall Study|Adverse Event|3|||
126588430|NCT02761057|455453050|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
126588431|NCT02761057|455453051|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
126588432|NCT02761057|455453052|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
126588433|NCT02761057|455453053|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
126777789|NCT00811070|456141428|FG003|Overall Study|Death|2|||
126777790|NCT00811070|456141429|FG004|Overall Study|Death|5|||
126777791|NCT00811070|456141430|FG005|Overall Study|Death|0|||
126777792|NCT00811070|456141425|FG000|Overall Study|Other|1|||
126777793|NCT00811070|456141426|FG001|Overall Study|Other|0|||
126777794|NCT00811070|456141427|FG002|Overall Study|Other|0|||
126777795|NCT00811070|456141428|FG003|Overall Study|Other|0|||
126777796|NCT00811070|456141429|FG004|Overall Study|Other|0|||
126777797|NCT00811070|456141430|FG005|Overall Study|Other|0|||
126777798|NCT00811070|456141425|FG000|Overall Study|Withdrawal by Subject|0|||
126777799|NCT00811070|456141426|FG001|Overall Study|Withdrawal by Subject|1|||
126777800|NCT00811070|456141427|FG002|Overall Study|Withdrawal by Subject|0|||
126777801|NCT00811070|456141428|FG003|Overall Study|Withdrawal by Subject|0|||
126777802|NCT00811070|456141429|FG004|Overall Study|Withdrawal by Subject|0|||
126777803|NCT00811070|456141430|FG005|Overall Study|Withdrawal by Subject|0|||
126777804|NCT00811070|456141425|FG000|Overall Study|Physician Decision|0|||
126777805|NCT00811070|456141426|FG001|Overall Study|Physician Decision|0|||
126777806|NCT00811070|456141427|FG002|Overall Study|Physician Decision|0|||
126777807|NCT00811070|456141428|FG003|Overall Study|Physician Decision|0|||
126777808|NCT00811070|456141429|FG004|Overall Study|Physician Decision|0|||
126777809|NCT00811070|456141430|FG005|Overall Study|Physician Decision|1|||
126777810|NCT01025193|456141434|FG000|Overall Study|Protocol Violation|1|||
126777811|NCT01025193|456141434|FG000|Overall Study|Adverse Event|3|||
126777812|NCT04079842|456141435|FG000|Overall Study|Request of subject|2|||
126777813|NCT04079842|456141435|FG000|Overall Study|Unable to draw Arterial samples|1|||
126777814|NCT02904200|456141436|FG000|Overall Study|Withdrawal by Subject|1|||
126588434|NCT02761057|455453050|FG000|Overall Study|Progression/Relapse|29|||
126588435|NCT02761057|455453051|FG001|Overall Study|Progression/Relapse|27|||
126777815|NCT02904200|456141437|FG001|Overall Study|Withdrawal by Subject|0|||
126777816|NCT04444752|456141438|FG000|Overall Study|Adverse Event|1|||
126777817|NCT04444752|456141439|FG001|Overall Study|Adverse Event|0|||
126777818|NCT04444752|456141440|FG002|Overall Study|Adverse Event|0|||
126777819|NCT04444752|456141441|FG003|Overall Study|Adverse Event|2|||
126777820|NCT04444752|456141438|FG000|Overall Study|Lost to Follow-up|2|||
126588436|NCT02761057|455453052|FG002|Overall Study|Progression/Relapse|20|||
126777821|NCT04444752|456141439|FG001|Overall Study|Lost to Follow-up|6|||
126777822|NCT04444752|456141440|FG002|Overall Study|Lost to Follow-up|2|||
126777823|NCT04444752|456141441|FG003|Overall Study|Lost to Follow-up|5|||
126777824|NCT04444752|456141438|FG000|Overall Study|Physician Decision|0|||
126777825|NCT04444752|456141439|FG001|Overall Study|Physician Decision|0|||
126777826|NCT04444752|456141440|FG002|Overall Study|Physician Decision|0|||
126777827|NCT04444752|456141441|FG003|Overall Study|Physician Decision|2|||
126777828|NCT04444752|456141438|FG000|Overall Study|Pregnancy|0|||
126777829|NCT04444752|456141439|FG001|Overall Study|Pregnancy|0|||
126777830|NCT04444752|456141440|FG002|Overall Study|Pregnancy|0|||
126777831|NCT04444752|456141441|FG003|Overall Study|Pregnancy|1|||
126777832|NCT04444752|456141438|FG000|Overall Study|Withdrawal by Subject|6|||
126777833|NCT04444752|456141439|FG001|Overall Study|Withdrawal by Subject|5|||
126777834|NCT04444752|456141440|FG002|Overall Study|Withdrawal by Subject|3|||
126777835|NCT04444752|456141441|FG003|Overall Study|Withdrawal by Subject|4|||
126777836|NCT04444752|456141438|FG000|Overall Study|Protocol Violation|1|||
126777837|NCT04444752|456141439|FG001|Overall Study|Protocol Violation|1|||
126777838|NCT04444752|456141440|FG002|Overall Study|Protocol Violation|0|||
126777839|NCT04444752|456141441|FG003|Overall Study|Protocol Violation|0|||
126777840|NCT04444752|456141438|FG000|Overall Study|Patient moving out of town|1|||
126777841|NCT04444752|456141439|FG001|Overall Study|Patient moving out of town|0|||
126777842|NCT04444752|456141440|FG002|Overall Study|Patient moving out of town|0|||
126588437|NCT02761057|455453053|FG003|Overall Study|Progression/Relapse|23|||
126588438|NCT02761057|455453050|FG000|Overall Study|Death|2|||
126588439|NCT02761057|455453051|FG001|Overall Study|Death|2|||
126588440|NCT02761057|455453052|FG002|Overall Study|Death|1|||
126588441|NCT02761057|455453053|FG003|Overall Study|Death|1|||
126588442|NCT02761057|455453050|FG000|Overall Study|Other - Not Protocol Specified|2|||
126588443|NCT02761057|455453051|FG001|Overall Study|Other - Not Protocol Specified|1|||
126588444|NCT02761057|455453052|FG002|Overall Study|Other - Not Protocol Specified|2|||
126588445|NCT02761057|455453053|FG003|Overall Study|Other - Not Protocol Specified|0|||
126588446|NCT06037369|455453056|FG000|Overall Study|Lost to Follow-up|0|||
126588447|NCT06037369|455453057|FG001|Overall Study|Lost to Follow-up|1|||
126588448|NCT04209465|455453058|FG000|Overall Study|Adverse Event|0|||
126588449|NCT04209465|455453059|FG001|Overall Study|Adverse Event|0|||
126588450|NCT04209465|455453060|FG002|Overall Study|Adverse Event|0|||
126588451|NCT04209465|455453061|FG003|Overall Study|Adverse Event|0|||
126588452|NCT04209465|455453062|FG004|Overall Study|Adverse Event|0|||
126588453|NCT04209465|455453063|FG005|Overall Study|Adverse Event|1|||
126588454|NCT04209465|455453064|FG006|Overall Study|Adverse Event|0|||
126588455|NCT04209465|455453065|FG007|Overall Study|Adverse Event|0|||
126588456|NCT04209465|455453066|FG008|Overall Study|Adverse Event|1|||
126588457|NCT04209465|455453067|FG009|Overall Study|Adverse Event|0|||
126588458|NCT04209465|455453068|FG010|Overall Study|Adverse Event|2|||
126588459|NCT04209465|455453069|FG011|Overall Study|Adverse Event|1|||
126588460|NCT04209465|455453070|FG012|Overall Study|Adverse Event|1|||
126588461|NCT04209465|455453058|FG000|Overall Study|Death|1|||
126588462|NCT04209465|455453059|FG001|Overall Study|Death|0|||
126588463|NCT04209465|455453060|FG002|Overall Study|Death|0|||
126588464|NCT04209465|455453061|FG003|Overall Study|Death|0|||
126588465|NCT04209465|455453062|FG004|Overall Study|Death|2|||
126588466|NCT04209465|455453063|FG005|Overall Study|Death|7|||
126588467|NCT04209465|455453064|FG006|Overall Study|Death|2|||
126588468|NCT04209465|455453065|FG007|Overall Study|Death|2|||
126588469|NCT04209465|455453066|FG008|Overall Study|Death|1|||
126588470|NCT04209465|455453067|FG009|Overall Study|Death|1|||
126588471|NCT04209465|455453068|FG010|Overall Study|Death|1|||
126588472|NCT04209465|455453069|FG011|Overall Study|Death|0|||
126588473|NCT04209465|455453070|FG012|Overall Study|Death|10|||
126588474|NCT04209465|455453058|FG000|Overall Study|Physician Decision|0|||
126588475|NCT04209465|455453059|FG001|Overall Study|Physician Decision|1|||
126588476|NCT04209465|455453060|FG002|Overall Study|Physician Decision|0|||
126777843|NCT04444752|456141441|FG003|Overall Study|Patient moving out of town|1|||
126777844|NCT04444752|456141438|FG000|Overall Study|Lack of Efficacy|0|||
126777845|NCT04444752|456141439|FG001|Overall Study|Lack of Efficacy|0|||
126777846|NCT04444752|456141440|FG002|Overall Study|Lack of Efficacy|0|||
126588477|NCT04209465|455453061|FG003|Overall Study|Physician Decision|0|||
126588478|NCT04209465|455453062|FG004|Overall Study|Physician Decision|0|||
126588479|NCT04209465|455453063|FG005|Overall Study|Physician Decision|0|||
126588480|NCT04209465|455453064|FG006|Overall Study|Physician Decision|0|||
126588481|NCT04209465|455453065|FG007|Overall Study|Physician Decision|0|||
126588482|NCT04209465|455453066|FG008|Overall Study|Physician Decision|0|||
126588483|NCT04209465|455453067|FG009|Overall Study|Physician Decision|0|||
126588484|NCT04209465|455453068|FG010|Overall Study|Physician Decision|0|||
126588485|NCT04209465|455453069|FG011|Overall Study|Physician Decision|0|||
126588486|NCT04209465|455453070|FG012|Overall Study|Physician Decision|0|||
126588487|NCT04209465|455453058|FG000|Overall Study|Progressive Disease|0|||
126588488|NCT04209465|455453059|FG001|Overall Study|Progressive Disease|0|||
126588489|NCT04209465|455453060|FG002|Overall Study|Progressive Disease|1|||
126588490|NCT04209465|455453061|FG003|Overall Study|Progressive Disease|2|||
126588491|NCT04209465|455453062|FG004|Overall Study|Progressive Disease|8|||
126588492|NCT04209465|455453063|FG005|Overall Study|Progressive Disease|5|||
126588493|NCT04209465|455453064|FG006|Overall Study|Progressive Disease|3|||
126588494|NCT04209465|455453065|FG007|Overall Study|Progressive Disease|4|||
126777847|NCT04444752|456141441|FG003|Overall Study|Lack of Efficacy|1|||
126777848|NCT04444752|456141438|FG000|Overall Study|Death|0|||
126777849|NCT04444752|456141439|FG001|Overall Study|Death|0|||
126588495|NCT04209465|455453066|FG008|Overall Study|Progressive Disease|1|||
126588496|NCT04209465|455453067|FG009|Overall Study|Progressive Disease|3|||
126588497|NCT04209465|455453068|FG010|Overall Study|Progressive Disease|2|||
126588498|NCT04209465|455453069|FG011|Overall Study|Progressive Disease|1|||
126588499|NCT04209465|455453070|FG012|Overall Study|Progressive Disease|0|||
126588500|NCT04209465|455453058|FG000|Overall Study|Withdrawal by Subject|0|||
126588501|NCT04209465|455453059|FG001|Overall Study|Withdrawal by Subject|0|||
126588502|NCT04209465|455453060|FG002|Overall Study|Withdrawal by Subject|0|||
126588503|NCT04209465|455453061|FG003|Overall Study|Withdrawal by Subject|0|||
126588504|NCT04209465|455453062|FG004|Overall Study|Withdrawal by Subject|0|||
126588505|NCT04209465|455453063|FG005|Overall Study|Withdrawal by Subject|1|||
126588506|NCT04209465|455453064|FG006|Overall Study|Withdrawal by Subject|2|||
126588507|NCT04209465|455453065|FG007|Overall Study|Withdrawal by Subject|0|||
126588508|NCT04209465|455453066|FG008|Overall Study|Withdrawal by Subject|1|||
126588509|NCT04209465|455453067|FG009|Overall Study|Withdrawal by Subject|0|||
126588510|NCT04209465|455453068|FG010|Overall Study|Withdrawal by Subject|0|||
126588511|NCT04209465|455453069|FG011|Overall Study|Withdrawal by Subject|2|||
126588512|NCT04209465|455453070|FG012|Overall Study|Withdrawal by Subject|2|||
126588513|NCT04209465|455453058|FG000|Overall Study|Lost to Follow-up|0|||
126588514|NCT04209465|455453059|FG001|Overall Study|Lost to Follow-up|0|||
126588515|NCT04209465|455453060|FG002|Overall Study|Lost to Follow-up|0|||
126588516|NCT04209465|455453061|FG003|Overall Study|Lost to Follow-up|0|||
126588517|NCT04209465|455453062|FG004|Overall Study|Lost to Follow-up|0|||
126588518|NCT04209465|455453063|FG005|Overall Study|Lost to Follow-up|1|||
126588519|NCT04209465|455453064|FG006|Overall Study|Lost to Follow-up|0|||
126588520|NCT04209465|455453065|FG007|Overall Study|Lost to Follow-up|0|||
126588521|NCT04209465|455453066|FG008|Overall Study|Lost to Follow-up|1|||
126588522|NCT04209465|455453067|FG009|Overall Study|Lost to Follow-up|0|||
126588523|NCT04209465|455453068|FG010|Overall Study|Lost to Follow-up|0|||
126588524|NCT04209465|455453069|FG011|Overall Study|Lost to Follow-up|1|||
126588525|NCT04209465|455453070|FG012|Overall Study|Lost to Follow-up|0|||
126588526|NCT04209465|455453058|FG000|Overall Study|Started new therapy|0|||
126588527|NCT04209465|455453059|FG001|Overall Study|Started new therapy|0|||
126588528|NCT04209465|455453060|FG002|Overall Study|Started new therapy|0|||
126588529|NCT04209465|455453061|FG003|Overall Study|Started new therapy|0|||
126588530|NCT04209465|455453062|FG004|Overall Study|Started new therapy|0|||
126588531|NCT04209465|455453063|FG005|Overall Study|Started new therapy|1|||
126588532|NCT04209465|455453064|FG006|Overall Study|Started new therapy|0|||
126588533|NCT04209465|455453065|FG007|Overall Study|Started new therapy|0|||
126588534|NCT04209465|455453066|FG008|Overall Study|Started new therapy|0|||
126588535|NCT04209465|455453067|FG009|Overall Study|Started new therapy|0|||
126588536|NCT04209465|455453068|FG010|Overall Study|Started new therapy|0|||
126588537|NCT04209465|455453069|FG011|Overall Study|Started new therapy|0|||
126588538|NCT04209465|455453070|FG012|Overall Study|Started new therapy|0|||
126588539|NCT04209465|455453058|FG000|Overall Study|Study terminated early by sponsor|0|||
126588540|NCT04209465|455453059|FG001|Overall Study|Study terminated early by sponsor|0|||
126588541|NCT04209465|455453060|FG002|Overall Study|Study terminated early by sponsor|0|||
126588542|NCT04209465|455453061|FG003|Overall Study|Study terminated early by sponsor|0|||
126588543|NCT04209465|455453062|FG004|Overall Study|Study terminated early by sponsor|0|||
126588544|NCT04209465|455453063|FG005|Overall Study|Study terminated early by sponsor|0|||
126588545|NCT04209465|455453064|FG006|Overall Study|Study terminated early by sponsor|3|||
126588546|NCT04209465|455453065|FG007|Overall Study|Study terminated early by sponsor|0|||
126588547|NCT04209465|455453066|FG008|Overall Study|Study terminated early by sponsor|0|||
126588548|NCT04209465|455453067|FG009|Overall Study|Study terminated early by sponsor|0|||
126588549|NCT04209465|455453068|FG010|Overall Study|Study terminated early by sponsor|0|||
126588550|NCT04209465|455453069|FG011|Overall Study|Study terminated early by sponsor|0|||
126588551|NCT04209465|455453070|FG012|Overall Study|Study terminated early by sponsor|3|||
126588552|NCT04209465|455453058|FG000|Overall Study|Other|0|||
126588553|NCT04209465|455453059|FG001|Overall Study|Other|0|||
126588554|NCT04209465|455453060|FG002|Overall Study|Other|0|||
126588555|NCT04209465|455453061|FG003|Overall Study|Other|0|||
126588556|NCT04209465|455453062|FG004|Overall Study|Other|0|||
126588557|NCT04209465|455453063|FG005|Overall Study|Other|0|||
126588558|NCT04209465|455453064|FG006|Overall Study|Other|0|||
126588559|NCT04209465|455453065|FG007|Overall Study|Other|0|||
126588560|NCT04209465|455453066|FG008|Overall Study|Other|1|||
126588561|NCT04209465|455453067|FG009|Overall Study|Other|0|||
126588562|NCT04209465|455453068|FG010|Overall Study|Other|0|||
126588563|NCT04209465|455453069|FG011|Overall Study|Other|0|||
126588564|NCT04209465|455453070|FG012|Overall Study|Other|0|||
126588565|NCT04277442|455453078|FG000|Overall Study|Death|1|||
126588566|NCT04876118|455453079|FG000|Overall Study|Pregnancy|1|||
126588567|NCT04876118|455453079|FG000|Overall Study|Withdrawal by Subject|14|||
126588568|NCT04948697|455453082|FG000|Overall Study|Progressive disease|27|||
126588569|NCT04948697|455453083|FG001|Overall Study|Progressive disease|18|||
126588570|NCT04948697|455453082|FG000|Overall Study|Adverse Event|14|||
126588571|NCT04948697|455453083|FG001|Overall Study|Adverse Event|4|||
126588572|NCT04948697|455453082|FG000|Overall Study|Participant moved to long term extension study|7|||
126588573|NCT04948697|455453083|FG001|Overall Study|Participant moved to long term extension study|4|||
126588574|NCT04948697|455453082|FG000|Overall Study|Withdrawal by Subject|10|||
126588575|NCT04948697|455453083|FG001|Overall Study|Withdrawal by Subject|0|||
126588576|NCT04948697|455453082|FG000|Overall Study|Closed by Sponsor|3|||
126588577|NCT04948697|455453083|FG001|Overall Study|Closed by Sponsor|2|||
126588578|NCT04948697|455453082|FG000|Overall Study|Physician Decision|0|||
126588579|NCT04948697|455453083|FG001|Overall Study|Physician Decision|2|||
126731683|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
126731684|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
126588580|NCT04948697|455453082|FG000|Overall Study|Lost to Follow-up|0|||
126588581|NCT04948697|455453083|FG001|Overall Study|Lost to Follow-up|1|||
126588582|NCT04948697|455453082|FG000|Overall Study|Other-Miscellaneous|1|||
126588583|NCT04948697|455453083|FG001|Overall Study|Other-Miscellaneous|0|||
126588584|NCT04948697|455453082|FG000|Overall Study|Randomized but not treated|0|||
126588585|NCT04948697|455453083|FG001|Overall Study|Randomized but not treated|1|||
126588586|NCT04338061|455453084|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
126588587|NCT04338061|455453085|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
126588588|NCT04338061|455453084|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
126588589|NCT04338061|455453085|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
126588590|NCT04338061|455453084|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
126588591|NCT04338061|455453085|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
126588592|NCT04338061|455453084|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
126588593|NCT04338061|455453085|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
126588594|NCT04338061|455453084|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
126588595|NCT04338061|455453085|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
126588596|NCT04338061|455453084|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
126588597|NCT04338061|455453085|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
126588598|NCT04338061|455453084|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
126588599|NCT04338061|455453085|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
126588600|NCT04338061|455453084|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
126588601|NCT04338061|455453085|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
126588602|NCT04338061|455453084|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
126588603|NCT04338061|455453085|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
126588604|NCT04338061|455453084|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
126588605|NCT04338061|455453085|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
126588606|NCT04338061|455453084|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
126588607|NCT04338061|455453085|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
126588608|NCT04338061|455453084|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
126588609|NCT04338061|455453085|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
126588610|NCT03365882|455453086|FG000|Randomization|Still Receiving Protocol Treatment|2|||
126588611|NCT03365882|455453087|FG001|Randomization|Still Receiving Protocol Treatment|0|||
126588612|NCT03365882|455453086|FG000|Randomization|Adverse Event|1|||
126588613|NCT03365882|455453087|FG001|Randomization|Adverse Event|2|||
126588614|NCT03365882|455453086|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
126588615|NCT03365882|455453087|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
126588616|NCT03365882|455453086|FG000|Randomization|Progression/Relapse|21|||
126588617|NCT03365882|455453087|FG001|Randomization|Progression/Relapse|3|||
126588618|NCT03365882|455453086|FG000|Randomization|Death|1|||
126588619|NCT03365882|455453087|FG001|Randomization|Death|0|||
126588620|NCT03365882|455453086|FG000|Randomization|Other - Not Protocol Specified|1|||
126588621|NCT03365882|455453087|FG001|Randomization|Other - Not Protocol Specified|1|||
126588622|NCT03365882|455453086|FG000|Randomization|Major Protocol Deviation|0|||
126588623|NCT03365882|455453087|FG001|Randomization|Major Protocol Deviation|1|||
126588624|NCT03365882|455453086|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
126588625|NCT03365882|455453087|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
126588626|NCT03365882|455453086|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
126588627|NCT03365882|455453087|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
126588628|NCT03365882|455453086|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
126588629|NCT03365882|455453087|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
126588630|NCT03365882|455453086|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
126588631|NCT03365882|455453087|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
126588632|NCT04229992|455455571|FG000|Overall Study|Withdrawal by Subject|0|||
126588633|NCT04229992|455455572|FG001|Overall Study|Withdrawal by Subject|2|||
126588634|NCT04229992|455455573|FG002|Overall Study|Withdrawal by Subject|1|||
126588635|NCT04229992|455455574|FG003|Overall Study|Withdrawal by Subject|1|||
126588636|NCT04229992|455455571|FG000|Overall Study|Adverse Event|1|||
126588637|NCT04229992|455455572|FG001|Overall Study|Adverse Event|1|||
126588638|NCT04229992|455455573|FG002|Overall Study|Adverse Event|3|||
126588639|NCT04229992|455455574|FG003|Overall Study|Adverse Event|1|||
126588640|NCT04229992|455455571|FG000|Overall Study|Lost to Follow-up|0|||
126588641|NCT04229992|455455572|FG001|Overall Study|Lost to Follow-up|0|||
126588642|NCT04229992|455455573|FG002|Overall Study|Lost to Follow-up|0|||
126588643|NCT04229992|455455574|FG003|Overall Study|Lost to Follow-up|1|||
126588644|NCT03770273|455455575|FG000|Overall Study|Adverse Event|2|||
126588645|NCT03770273|455455576|FG001|Overall Study|Adverse Event|0|||
126588646|NCT03770273|455455575|FG000|Overall Study|Lost to Follow-up|1|||
126588647|NCT03770273|455455576|FG001|Overall Study|Lost to Follow-up|1|||
126588648|NCT00418886|455455577|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
126588649|NCT00418886|455455578|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
126588650|NCT00418886|455455577|FG000|Randomized Period|Death|122|||
126588651|NCT00418886|455455578|FG001|Randomized Period|Death|147|||
126588652|NCT00418886|455455577|FG000|Randomized Period|Withdrawal by Subject|9|||
126588653|NCT00418886|455455578|FG001|Randomized Period|Withdrawal by Subject|10|||
126588654|NCT00418886|455455577|FG000|Randomized Period|Lost to Follow-up|4|||
126588655|NCT00418886|455455578|FG001|Randomized Period|Lost to Follow-up|6|||
126588656|NCT00418886|455455577|FG000|Randomized Period|withdrawn due to other reason|1|||
126588657|NCT00418886|455455578|FG001|Randomized Period|withdrawn due to other reason|0|||
126588658|NCT00418886|455455577|FG000|Randomized Period|randomised but no treatment received|0|||
126588659|NCT00418886|455455578|FG001|Randomized Period|randomised but no treatment received|1|||
126588660|NCT04060654|455455579|FG000|Overall Study|Withdrawal by Subject|1|||
126588661|NCT04060654|455455579|FG000|Overall Study|Lost to Follow-up|5|||
126588662|NCT03707951|455455580|FG000|Overall Study|Lost to Follow-up|8|||
126588663|NCT03707951|455455581|FG001|Overall Study|Lost to Follow-up|17|||
126588664|NCT03707951|455455580|FG000|Overall Study|Withdrawal by Subject|6|||
126588665|NCT03707951|455455581|FG001|Overall Study|Withdrawal by Subject|6|||
126588666|NCT04887129|455455582|FG000|Overall Study|Lost to Follow-up|0|||
126588667|NCT04887129|455455583|FG001|Overall Study|Lost to Follow-up|24|||
126588668|NCT04887129|455455582|FG000|Overall Study|Withdrawal by Subject|9|||
126588669|NCT04887129|455455583|FG001|Overall Study|Withdrawal by Subject|57|||
126588670|NCT04887129|455455582|FG000|Overall Study|Other|2|||
126588671|NCT04887129|455455583|FG001|Overall Study|Other|9|||
126588672|NCT05177848|455455584|FG000|Overall Study|Lost to Follow-up|1|||
126588673|NCT05177848|455455585|FG001|Overall Study|Lost to Follow-up|4|||
126588674|NCT05177848|455455584|FG000|Overall Study|Discontinued|2|||
126588675|NCT05177848|455455585|FG001|Overall Study|Discontinued|1|||
126588676|NCT01084876|455455586|FG000|Main Study Treatment Period|Adverse Event|12|||
126588677|NCT01084876|455455587|FG001|Main Study Treatment Period|Adverse Event|7|||
126588678|NCT01084876|455455586|FG000|Main Study Treatment Period|Disease Progression|41|||
126588679|NCT01084876|455455587|FG001|Main Study Treatment Period|Disease Progression|24|||
126588680|NCT01084876|455455586|FG000|Main Study Treatment Period|Physician Decision|2|||
126588681|NCT01084876|455455587|FG001|Main Study Treatment Period|Physician Decision|0|||
126588682|NCT01084876|455455586|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
126588683|NCT01084876|455455587|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
126588684|NCT01084876|455455586|FG000|Main Study Treatment Period|Other Reason|0|||
126588685|NCT01084876|455455587|FG001|Main Study Treatment Period|Other Reason|1|||
126588686|NCT01084876|455455586|FG000|Main Study Treatment Period|Other|0|||
126588687|NCT01084876|455455587|FG001|Main Study Treatment Period|Other|1|||
126588688|NCT01084876|455455586|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
126588689|NCT01084876|455455587|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
126588690|NCT01084876|455455586|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
126588691|NCT01084876|455455587|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
126588692|NCT01084876|455455586|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
126588693|NCT01084876|455455587|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
126588694|NCT01084876|455455586|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
126588695|NCT01084876|455455587|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
126588696|NCT01084876|455455586|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
126588697|NCT01084876|455455587|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
126588698|NCT01084876|455455586|FG000|Treatment Period Beyond Cycle 8|Other|6|||
126588699|NCT01084876|455455587|FG001|Treatment Period Beyond Cycle 8|Other|9|||
126588700|NCT05308004|455455592|FG000|Overall Study|Not seen by Palliative Care NP|0|||
126588701|NCT05308004|455455593|FG001|Overall Study|Not seen by Palliative Care NP|1|||
126588702|NCT05409183|455455596|FG000|Complete Study|Adverse Event|1|||
126588703|NCT05409183|455455597|FG001|Complete Study|Adverse Event|2|||
126588704|NCT05409183|455455596|FG000|Complete Study|Withdrawal by Subject|3|||
126588705|NCT05409183|455455597|FG001|Complete Study|Withdrawal by Subject|0|||
126588706|NCT02274662|455455598|FG000|Overall Study|Death|1|||
126588707|NCT02274662|455455598|FG000|Overall Study|Lost to Follow-up|3|||
126588708|NCT02936752|455455599|FG000|Overall Study|Death|2|||
126588709|NCT02936752|455455600|FG001|Overall Study|Death|1|||
126588710|NCT02936752|455455599|FG000|Overall Study|Physician Decision|4|||
126588711|NCT02936752|455455600|FG001|Overall Study|Physician Decision|0|||
126588712|NCT02936752|455455599|FG000|Overall Study|Withdrawal by Subject|0|||
126588713|NCT02936752|455455600|FG001|Overall Study|Withdrawal by Subject|2|||
126588714|NCT04489771|455455601|FG000|Overall Study|Death|27|||
126588715|NCT04489771|455455602|FG001|Overall Study|Death|25|||
126588716|NCT04489771|455455601|FG000|Overall Study|Withdrawal by Subject|1|||
126640544|NCT05143138|455642803|FG002|Overall Study|Lost to Follow-up|0|||
126588717|NCT04489771|455455602|FG001|Overall Study|Withdrawal by Subject|0|||
126588718|NCT04489771|455455601|FG000|Overall Study|Participants Ongoing in Study|50|||
126588719|NCT04489771|455455602|FG001|Overall Study|Participants Ongoing in Study|51|||
126588720|NCT04064164|455455616|FG000|Overall Study|Withdrawal by Subject|8|||
126588721|NCT04064164|455455617|FG001|Overall Study|Withdrawal by Subject|8|||
126588722|NCT04059484|455455618|FG000|Overall Study|Adverse Event|2|||
126588723|NCT04059484|455455619|FG001|Overall Study|Adverse Event|5|||
126588724|NCT04059484|455455618|FG000|Overall Study|Withdrawal by Subject|5|||
126588725|NCT04059484|455455619|FG001|Overall Study|Withdrawal by Subject|3|||
126588726|NCT04059484|455455618|FG000|Overall Study|Progressive disease|112|||
126588727|NCT04059484|455455619|FG001|Overall Study|Progressive disease|112|||
126588728|NCT04059484|455455618|FG000|Overall Study|Other|8|||
126588729|NCT04059484|455455619|FG001|Overall Study|Other|3|||
126588730|NCT04059484|455455618|FG000|Overall Study|Ongoing|20|||
126588731|NCT04059484|455455619|FG001|Overall Study|Ongoing|20|||
126588732|NCT02949362|455455620|FG000|Retrospective Period|Inform consent not signed by participant|4|||
126588733|NCT02949362|455455621|FG001|Retrospective Period|Inform consent not signed by participant|1|||
126588734|NCT02949362|455455622|FG002|Retrospective Period|Inform consent not signed by participant|0|||
126588735|NCT02949362|455455623|FG003|Retrospective Period|Inform consent not signed by participant|0|||
126588736|NCT02949362|455455620|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
126588737|NCT02949362|455455621|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
126588738|NCT02949362|455455622|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
126588739|NCT02949362|455455623|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
126588740|NCT02949362|455455620|FG000|Prospective Period|Other|0|||
126588741|NCT02949362|455455621|FG001|Prospective Period|Other|0|||
126588742|NCT02949362|455455622|FG002|Prospective Period|Other|0|||
126588743|NCT02949362|455455623|FG003|Prospective Period|Other|4|||
126588744|NCT04633122|455455627|FG000|Overall Study|Remained on treatment|19|||
126588745|NCT04633122|455455628|FG001|Overall Study|Remained on treatment|14|||
126588746|NCT04633122|455455627|FG000|Overall Study|Survival follow-up stopped|22|||
126588747|NCT04633122|455455628|FG001|Overall Study|Survival follow-up stopped|25|||
126588748|NCT03307343|455455629|FG000|Overall Study|Withdrawal by Subject|1|||
126588749|NCT03307343|455455630|FG001|Overall Study|Withdrawal by Subject|2|||
126588750|NCT03307343|455455629|FG000|Overall Study|Pregnancy|0|||
126588751|NCT03307343|455455630|FG001|Overall Study|Pregnancy|2|||
126588752|NCT03307343|455455629|FG000|Overall Study|Physician Decision|1|||
126588753|NCT03307343|455455630|FG001|Overall Study|Physician Decision|0|||
126588754|NCT03307343|455455629|FG000|Overall Study|Lost to Follow-up|0|||
126588755|NCT03307343|455455630|FG001|Overall Study|Lost to Follow-up|2|||
126588756|NCT01798498|455455631|FG000|Overall Study|Lost to Follow-up|1|||
126588757|NCT03447470|455455632|FG000|Overall Study|Death|0|||
126588758|NCT03447470|455455633|FG001|Overall Study|Death|1|||
126588759|NCT03447470|455455634|FG002|Overall Study|Death|3|||
126588760|NCT03447470|455455635|FG003|Overall Study|Death|0|||
126588761|NCT03447470|455455636|FG004|Overall Study|Death|1|||
126588762|NCT03447470|455455637|FG005|Overall Study|Death|0|||
126588763|NCT03447470|455455638|FG006|Overall Study|Death|3|||
126588764|NCT03447470|455455639|FG007|Overall Study|Death|3|||
126588765|NCT03447470|455455640|FG008|Overall Study|Death|1|||
126588766|NCT03447470|455455632|FG000|Overall Study|Withdrawal by Subject|1|||
126588767|NCT03447470|455455633|FG001|Overall Study|Withdrawal by Subject|0|||
126588768|NCT03447470|455455634|FG002|Overall Study|Withdrawal by Subject|0|||
126588769|NCT03447470|455455635|FG003|Overall Study|Withdrawal by Subject|0|||
126588770|NCT03447470|455455636|FG004|Overall Study|Withdrawal by Subject|1|||
126588771|NCT03447470|455455637|FG005|Overall Study|Withdrawal by Subject|0|||
126588772|NCT03447470|455455638|FG006|Overall Study|Withdrawal by Subject|1|||
126588773|NCT03447470|455455639|FG007|Overall Study|Withdrawal by Subject|1|||
126588774|NCT03447470|455455640|FG008|Overall Study|Withdrawal by Subject|3|||
126588775|NCT03447470|455455632|FG000|Overall Study|Treatment discontinued|3|||
126588776|NCT03447470|455455633|FG001|Overall Study|Treatment discontinued|2|||
126588777|NCT03447470|455455634|FG002|Overall Study|Treatment discontinued|4|||
126588778|NCT03447470|455455635|FG003|Overall Study|Treatment discontinued|6|||
126588779|NCT03447470|455455636|FG004|Overall Study|Treatment discontinued|2|||
126588780|NCT03447470|455455637|FG005|Overall Study|Treatment discontinued|1|||
126588781|NCT03447470|455455638|FG006|Overall Study|Treatment discontinued|2|||
126588782|NCT03447470|455455639|FG007|Overall Study|Treatment discontinued|4|||
126588783|NCT03447470|455455640|FG008|Overall Study|Treatment discontinued|3|||
126777850|NCT04444752|456141440|FG002|Overall Study|Death|1|||
126588784|NCT00227344|455455641|FG000|Overall Study|study terminated early|12|||
126588785|NCT00227344|455455642|FG001|Overall Study|study terminated early|5|||
126588786|NCT01987895|455455643|FG000|Overall Study|Withdrawal by Subject|12|||
126588787|NCT01987895|455455644|FG001|Overall Study|Withdrawal by Subject|7|||
126588788|NCT01987895|455455643|FG000|Overall Study|Physician Decision|8|||
126588789|NCT01987895|455455644|FG001|Overall Study|Physician Decision|10|||
126588790|NCT01987895|455455643|FG000|Overall Study|Death|7|||
126588791|NCT01987895|455455644|FG001|Overall Study|Death|7|||
126588792|NCT01987895|455455643|FG000|Overall Study|Lost to Follow-up|3|||
126588793|NCT01987895|455455644|FG001|Overall Study|Lost to Follow-up|5|||
126588794|NCT01987895|455455643|FG000|Overall Study|randomized before giving IC|0|||
126588795|NCT01987895|455455644|FG001|Overall Study|randomized before giving IC|1|||
126588796|NCT05256017|455455645|FG000|Treatment Period|Withdrawal by Subject|1|||
126588797|NCT05256017|455455646|FG001|Treatment Period|Withdrawal by Subject|1|||
126588798|NCT05256017|455455645|FG000|Follow-up|Lost to Follow-up|7|||
126588799|NCT05256017|455455646|FG001|Follow-up|Lost to Follow-up|1|||
126588800|NCT05256017|455455645|FG000|Follow-up|Withdrawal by Subject|1|||
126588801|NCT05256017|455455646|FG001|Follow-up|Withdrawal by Subject|0|||
126588802|NCT05256017|455455645|FG000|Follow-up|Death|0|||
126588803|NCT05256017|455455646|FG001|Follow-up|Death|1|||
126588804|NCT05780437|455455649|FG000|Overall Study|Withdrawal by Subject|22|||
126588805|NCT05780437|455455650|FG001|Overall Study|Withdrawal by Subject|16|||
126588806|NCT03452579|455455651|FG000|Overall Study|Death|0|||
126588807|NCT03452579|455455652|FG001|Overall Study|Death|1|||
126588808|NCT03452579|455455651|FG000|Overall Study|Withdrawal by Subject|2|||
126588809|NCT03452579|455455652|FG001|Overall Study|Withdrawal by Subject|0|||
126588810|NCT03452579|455455651|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
126588811|NCT03452579|455455652|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
126588812|NCT03452579|455455651|FG000|Overall Study|Physician Decision|1|||
126588813|NCT03452579|455455652|FG001|Overall Study|Physician Decision|1|||
126588814|NCT03452579|455455651|FG000|Overall Study|Adverse Event|1|||
126588815|NCT03452579|455455652|FG001|Overall Study|Adverse Event|4|||
126588816|NCT04858321|455455656|FG000|Overall Study|Withdrawal by Subject|3|||
126588817|NCT05057247|455455657|FG000|Overall Study|Death|4|||
126588818|NCT05057247|455455657|FG000|Overall Study|Physician Decision|3|||
126588819|NCT05057247|455455657|FG000|Overall Study|Progressive Disease|7|||
126588820|NCT05057247|455455657|FG000|Overall Study|Withdrawal by Subject|3|||
126588821|NCT05057247|455455657|FG000|Overall Study|Adverse Event|6|||
126588822|NCT05057247|455455657|FG000|Overall Study|Subject Non-Compliance|1|||
126588823|NCT05057247|455455657|FG000|Overall Study|On treatment|2|||
126588824|NCT04788511|455455668|FG000|Overall Study|Withdrawal by Subject|2|||
126588825|NCT04788511|455455669|FG001|Overall Study|Withdrawal by Subject|1|||
126588826|NCT04788511|455455668|FG000|Overall Study|Lost to Follow-up|2|||
126588827|NCT04788511|455455669|FG001|Overall Study|Lost to Follow-up|7|||
126588828|NCT04788511|455455668|FG000|Overall Study|Death|3|||
126588829|NCT04788511|455455669|FG001|Overall Study|Death|4|||
126588830|NCT04652700|455455672|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
126588831|NCT04652700|455455673|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
126588832|NCT04652700|455455672|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
126588833|NCT04652700|455455673|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
126588834|NCT04652700|455455672|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
126588835|NCT04652700|455455673|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
126588836|NCT04652700|455455672|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
126588837|NCT04652700|455455673|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
126588838|NCT04652700|455455672|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
126588839|NCT04652700|455455673|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
126588840|NCT04652700|455455672|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
126588841|NCT04652700|455455673|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
126588842|NCT04652700|455455672|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
126588843|NCT04652700|455455673|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
126588844|NCT04652700|455455672|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
126588845|NCT04652700|455455673|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
126588846|NCT04652700|455455672|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
126588847|NCT04652700|455455673|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
126588848|NCT05603143|455455674|FG000|Overall Study|Withdrew consent|6|||
126588849|NCT05603143|455455675|FG001|Overall Study|Withdrew consent|2|||
126588850|NCT05603143|455455674|FG000|Overall Study|Randomized but never treated|0|||
126588851|NCT05603143|455455675|FG001|Overall Study|Randomized but never treated|3|||
126588852|NCT05603143|455455674|FG000|Overall Study|Adverse Event|2|||
126588853|NCT05603143|455455675|FG001|Overall Study|Adverse Event|0|||
126588854|NCT05603143|455455674|FG000|Overall Study|Death|0|||
126588855|NCT05603143|455455675|FG001|Overall Study|Death|1|||
126588856|NCT05603143|455455674|FG000|Overall Study|Investigator's discretion|1|||
126588857|NCT05603143|455455675|FG001|Overall Study|Investigator's discretion|0|||
126588858|NCT05603143|455455674|FG000|Overall Study|Lost to Follow-up|0|||
126588859|NCT05603143|455455675|FG001|Overall Study|Lost to Follow-up|1|||
126588860|NCT05603143|455455674|FG000|Overall Study|Protocol Violation|0|||
126588861|NCT05603143|455455675|FG001|Overall Study|Protocol Violation|1|||
126588862|NCT05783102|455455676|FG000|Overall Study|Lost to Follow-up|1|||
126588863|NCT05783102|455455676|FG000|Overall Study|Withdrawal by Subject|2|||
126588864|NCT05647304|455455677|FG000|Overall Study|Withdrawal by Subject|1|||
126588865|NCT05647304|455455678|FG001|Overall Study|Withdrawal by Subject|0|||
126588866|NCT05008835|455455679|FG000|Overall Study|Adverse Event|5|||
126588867|NCT05008835|455455680|FG001|Overall Study|Adverse Event|2|||
126588868|NCT05008835|455455681|FG002|Overall Study|Adverse Event|1|||
126588869|NCT05008835|455455679|FG000|Overall Study|Lack of Efficacy|0|||
126588870|NCT05008835|455455680|FG001|Overall Study|Lack of Efficacy|0|||
126588871|NCT05008835|455455681|FG002|Overall Study|Lack of Efficacy|1|||
126588872|NCT05008835|455455679|FG000|Overall Study|Study terminated by sponsor|0|||
126588873|NCT05008835|455455680|FG001|Overall Study|Study terminated by sponsor|0|||
126588874|NCT05008835|455455681|FG002|Overall Study|Study terminated by sponsor|1|||
126588875|NCT05008835|455455679|FG000|Overall Study|Not further specified|3|||
126588876|NCT05008835|455455680|FG001|Overall Study|Not further specified|2|||
126588877|NCT05008835|455455681|FG002|Overall Study|Not further specified|1|||
126588878|NCT04171999|455455682|FG000|Overall Study|deemed ineligible after randomization|2|||
126588879|NCT04171999|455455683|FG001|Overall Study|deemed ineligible after randomization|1|||
126588880|NCT04505904|455455684|FG000|Overall Study|Withdrawal by Subject|1|||
126588881|NCT04505904|455455685|FG001|Overall Study|Withdrawal by Subject|2|||
126588882|NCT04505904|455455686|FG002|Overall Study|Withdrawal by Subject|0|||
126588883|NCT04505904|455455687|FG003|Overall Study|Withdrawal by Subject|0|||
126588884|NCT04505904|455455684|FG000|Overall Study|Physician Decision|1|||
126588885|NCT04505904|455455685|FG001|Overall Study|Physician Decision|0|||
126588886|NCT04505904|455455686|FG002|Overall Study|Physician Decision|0|||
126588887|NCT04505904|455455687|FG003|Overall Study|Physician Decision|0|||
126588888|NCT04505904|455455684|FG000|Overall Study|Adverse Event|0|||
126588889|NCT04505904|455455685|FG001|Overall Study|Adverse Event|1|||
126588890|NCT04505904|455455686|FG002|Overall Study|Adverse Event|0|||
126588891|NCT04505904|455455687|FG003|Overall Study|Adverse Event|0|||
126588892|NCT03544281|455455688|FG000|Main Study Phase|Death|3|||
126588893|NCT03544281|455455689|FG001|Main Study Phase|Death|2|||
126588894|NCT03544281|455455690|FG002|Main Study Phase|Death|6|||
126588895|NCT03544281|455455691|FG003|Main Study Phase|Death|8|||
126588896|NCT03544281|455455692|FG004|Main Study Phase|Death|4|||
126588897|NCT03544281|455455693|FG005|Main Study Phase|Death|2|||
126588898|NCT03544281|455455694|FG006|Main Study Phase|Death|4|||
126588899|NCT03544281|455455695|FG007|Main Study Phase|Death|5|||
126588900|NCT03544281|455455696|FG008|Main Study Phase|Death|5|||
126588901|NCT03544281|455455697|FG009|Main Study Phase|Death|8|||
126588902|NCT03544281|455455698|FG010|Main Study Phase|Death|6|||
126588903|NCT03544281|455455699|FG011|Main Study Phase|Death|4|||
126588904|NCT03544281|455455700|FG012|Main Study Phase|Death|0|||
126588905|NCT03544281|455455701|FG013|Main Study Phase|Death|0|||
126588906|NCT03544281|455455702|FG014|Main Study Phase|Death|0|||
126588907|NCT03544281|455455703|FG015|Main Study Phase|Death|0|||
126588908|NCT03544281|455455704|FG016|Main Study Phase|Death|0|||
126588909|NCT03544281|455455705|FG017|Main Study Phase|Death|0|||
126588910|NCT03544281|455455706|FG018|Main Study Phase|Death|0|||
126588911|NCT03544281|455455707|FG019|Main Study Phase|Death|0|||
126588912|NCT03544281|455455708|FG020|Main Study Phase|Death|0|||
126588913|NCT03544281|455455709|FG021|Main Study Phase|Death|0|||
126588914|NCT03544281|455455688|FG000|Main Study Phase|Lost to Follow-up|0|||
126588915|NCT03544281|455455689|FG001|Main Study Phase|Lost to Follow-up|0|||
126588916|NCT03544281|455455690|FG002|Main Study Phase|Lost to Follow-up|0|||
126588917|NCT03544281|455455691|FG003|Main Study Phase|Lost to Follow-up|0|||
126588918|NCT03544281|455455692|FG004|Main Study Phase|Lost to Follow-up|0|||
126588919|NCT03544281|455455693|FG005|Main Study Phase|Lost to Follow-up|0|||
126588920|NCT03544281|455455694|FG006|Main Study Phase|Lost to Follow-up|0|||
126588921|NCT03544281|455455695|FG007|Main Study Phase|Lost to Follow-up|0|||
126588922|NCT03544281|455455696|FG008|Main Study Phase|Lost to Follow-up|0|||
126588923|NCT03544281|455455697|FG009|Main Study Phase|Lost to Follow-up|0|||
126588924|NCT03544281|455455698|FG010|Main Study Phase|Lost to Follow-up|1|||
126588925|NCT03544281|455455699|FG011|Main Study Phase|Lost to Follow-up|0|||
126588926|NCT03544281|455455700|FG012|Main Study Phase|Lost to Follow-up|0|||
126588927|NCT03544281|455455701|FG013|Main Study Phase|Lost to Follow-up|0|||
126588928|NCT03544281|455455702|FG014|Main Study Phase|Lost to Follow-up|0|||
126588929|NCT03544281|455455703|FG015|Main Study Phase|Lost to Follow-up|0|||
126588930|NCT03544281|455455704|FG016|Main Study Phase|Lost to Follow-up|0|||
126588931|NCT03544281|455455705|FG017|Main Study Phase|Lost to Follow-up|0|||
126588932|NCT03544281|455455706|FG018|Main Study Phase|Lost to Follow-up|0|||
126588933|NCT03544281|455455707|FG019|Main Study Phase|Lost to Follow-up|0|||
126588934|NCT03544281|455455708|FG020|Main Study Phase|Lost to Follow-up|0|||
126588935|NCT03544281|455455709|FG021|Main Study Phase|Lost to Follow-up|0|||
126588936|NCT03544281|455455688|FG000|Main Study Phase|Physician Decision|0|||
126588937|NCT03544281|455455689|FG001|Main Study Phase|Physician Decision|0|||
126588938|NCT03544281|455455690|FG002|Main Study Phase|Physician Decision|0|||
126588939|NCT03544281|455455691|FG003|Main Study Phase|Physician Decision|0|||
126588940|NCT03544281|455455692|FG004|Main Study Phase|Physician Decision|0|||
126588941|NCT03544281|455455693|FG005|Main Study Phase|Physician Decision|0|||
126588942|NCT03544281|455455694|FG006|Main Study Phase|Physician Decision|0|||
126588943|NCT03544281|455455695|FG007|Main Study Phase|Physician Decision|1|||
126588944|NCT03544281|455455696|FG008|Main Study Phase|Physician Decision|0|||
126588945|NCT03544281|455455697|FG009|Main Study Phase|Physician Decision|0|||
126588946|NCT03544281|455455698|FG010|Main Study Phase|Physician Decision|0|||
126588947|NCT03544281|455455699|FG011|Main Study Phase|Physician Decision|0|||
126588948|NCT03544281|455455700|FG012|Main Study Phase|Physician Decision|0|||
126588949|NCT03544281|455455701|FG013|Main Study Phase|Physician Decision|0|||
126588950|NCT03544281|455455702|FG014|Main Study Phase|Physician Decision|0|||
126588951|NCT03544281|455455703|FG015|Main Study Phase|Physician Decision|0|||
126588952|NCT03544281|455455704|FG016|Main Study Phase|Physician Decision|0|||
126588953|NCT03544281|455455705|FG017|Main Study Phase|Physician Decision|0|||
126588954|NCT03544281|455455706|FG018|Main Study Phase|Physician Decision|0|||
126588955|NCT03544281|455455707|FG019|Main Study Phase|Physician Decision|0|||
126588956|NCT03544281|455455708|FG020|Main Study Phase|Physician Decision|0|||
126588957|NCT03544281|455455709|FG021|Main Study Phase|Physician Decision|0|||
126588958|NCT03544281|455455688|FG000|Main Study Phase|Withdrawal by Subject|2|||
126588959|NCT03544281|455455689|FG001|Main Study Phase|Withdrawal by Subject|0|||
126588960|NCT03544281|455455690|FG002|Main Study Phase|Withdrawal by Subject|1|||
126588961|NCT03544281|455455691|FG003|Main Study Phase|Withdrawal by Subject|2|||
126588962|NCT03544281|455455692|FG004|Main Study Phase|Withdrawal by Subject|0|||
126588963|NCT03544281|455455693|FG005|Main Study Phase|Withdrawal by Subject|0|||
126588964|NCT03544281|455455694|FG006|Main Study Phase|Withdrawal by Subject|0|||
126588965|NCT03544281|455455695|FG007|Main Study Phase|Withdrawal by Subject|0|||
126588966|NCT03544281|455455696|FG008|Main Study Phase|Withdrawal by Subject|2|||
126588967|NCT03544281|455455697|FG009|Main Study Phase|Withdrawal by Subject|3|||
126588968|NCT03544281|455455698|FG010|Main Study Phase|Withdrawal by Subject|0|||
126588969|NCT03544281|455455699|FG011|Main Study Phase|Withdrawal by Subject|4|||
126588970|NCT03544281|455455700|FG012|Main Study Phase|Withdrawal by Subject|0|||
126588971|NCT03544281|455455701|FG013|Main Study Phase|Withdrawal by Subject|0|||
126588972|NCT03544281|455455702|FG014|Main Study Phase|Withdrawal by Subject|0|||
126588973|NCT03544281|455455703|FG015|Main Study Phase|Withdrawal by Subject|0|||
126588974|NCT03544281|455455704|FG016|Main Study Phase|Withdrawal by Subject|0|||
126588975|NCT03544281|455455705|FG017|Main Study Phase|Withdrawal by Subject|0|||
126588976|NCT03544281|455455706|FG018|Main Study Phase|Withdrawal by Subject|0|||
126588977|NCT03544281|455455707|FG019|Main Study Phase|Withdrawal by Subject|0|||
126588978|NCT03544281|455455708|FG020|Main Study Phase|Withdrawal by Subject|0|||
126588979|NCT03544281|455455709|FG021|Main Study Phase|Withdrawal by Subject|0|||
126588980|NCT03544281|455455688|FG000|Main Study Phase|Ongoing|3|||
126588981|NCT03544281|455455689|FG001|Main Study Phase|Ongoing|1|||
126588982|NCT03544281|455455690|FG002|Main Study Phase|Ongoing|2|||
126588983|NCT03544281|455455691|FG003|Main Study Phase|Ongoing|4|||
126588984|NCT03544281|455455692|FG004|Main Study Phase|Ongoing|2|||
126588985|NCT03544281|455455693|FG005|Main Study Phase|Ongoing|4|||
126588986|NCT03544281|455455694|FG006|Main Study Phase|Ongoing|4|||
126588987|NCT03544281|455455695|FG007|Main Study Phase|Ongoing|0|||
126588988|NCT03544281|455455696|FG008|Main Study Phase|Ongoing|2|||
126588989|NCT03544281|455455697|FG009|Main Study Phase|Ongoing|2|||
126588990|NCT03544281|455455698|FG010|Main Study Phase|Ongoing|1|||
126588991|NCT03544281|455455699|FG011|Main Study Phase|Ongoing|0|||
126588992|NCT03544281|455455700|FG012|Main Study Phase|Ongoing|0|||
126588993|NCT03544281|455455701|FG013|Main Study Phase|Ongoing|0|||
126588994|NCT03544281|455455702|FG014|Main Study Phase|Ongoing|0|||
126588995|NCT03544281|455455703|FG015|Main Study Phase|Ongoing|0|||
126588996|NCT03544281|455455704|FG016|Main Study Phase|Ongoing|0|||
126588997|NCT03544281|455455705|FG017|Main Study Phase|Ongoing|0|||
126588998|NCT03544281|455455706|FG018|Main Study Phase|Ongoing|0|||
126588999|NCT03544281|455455707|FG019|Main Study Phase|Ongoing|0|||
126589000|NCT03544281|455455708|FG020|Main Study Phase|Ongoing|0|||
126589001|NCT03544281|455455709|FG021|Main Study Phase|Ongoing|0|||
126589002|NCT03544281|455455688|FG000|Main Study Phase|Investigator Site Closed|0|||
126589003|NCT03544281|455455689|FG001|Main Study Phase|Investigator Site Closed|0|||
126589004|NCT03544281|455455690|FG002|Main Study Phase|Investigator Site Closed|0|||
126589005|NCT03544281|455455691|FG003|Main Study Phase|Investigator Site Closed|0|||
126589006|NCT03544281|455455692|FG004|Main Study Phase|Investigator Site Closed|0|||
126589007|NCT03544281|455455693|FG005|Main Study Phase|Investigator Site Closed|0|||
126589008|NCT03544281|455455694|FG006|Main Study Phase|Investigator Site Closed|0|||
126589009|NCT03544281|455455695|FG007|Main Study Phase|Investigator Site Closed|0|||
126589010|NCT03544281|455455696|FG008|Main Study Phase|Investigator Site Closed|0|||
126589011|NCT03544281|455455697|FG009|Main Study Phase|Investigator Site Closed|1|||
126589012|NCT03544281|455455698|FG010|Main Study Phase|Investigator Site Closed|0|||
126589013|NCT03544281|455455699|FG011|Main Study Phase|Investigator Site Closed|0|||
126589014|NCT03544281|455455700|FG012|Main Study Phase|Investigator Site Closed|0|||
126589015|NCT03544281|455455701|FG013|Main Study Phase|Investigator Site Closed|0|||
126589016|NCT03544281|455455702|FG014|Main Study Phase|Investigator Site Closed|0|||
126589017|NCT03544281|455455703|FG015|Main Study Phase|Investigator Site Closed|0|||
126589018|NCT03544281|455455704|FG016|Main Study Phase|Investigator Site Closed|0|||
126589019|NCT03544281|455455705|FG017|Main Study Phase|Investigator Site Closed|0|||
126589020|NCT03544281|455455706|FG018|Main Study Phase|Investigator Site Closed|0|||
126589021|NCT03544281|455455707|FG019|Main Study Phase|Investigator Site Closed|0|||
126589022|NCT03544281|455455708|FG020|Main Study Phase|Investigator Site Closed|0|||
126589023|NCT03544281|455455709|FG021|Main Study Phase|Investigator Site Closed|0|||
126589024|NCT03544281|455455688|FG000|Main Study Phase|Did not receive study treatment|0|||
126589025|NCT03544281|455455689|FG001|Main Study Phase|Did not receive study treatment|0|||
126589026|NCT03544281|455455690|FG002|Main Study Phase|Did not receive study treatment|0|||
126589027|NCT03544281|455455691|FG003|Main Study Phase|Did not receive study treatment|0|||
126589028|NCT03544281|455455692|FG004|Main Study Phase|Did not receive study treatment|0|||
126589029|NCT03544281|455455693|FG005|Main Study Phase|Did not receive study treatment|0|||
126589030|NCT03544281|455455694|FG006|Main Study Phase|Did not receive study treatment|1|||
126589031|NCT03544281|455455695|FG007|Main Study Phase|Did not receive study treatment|0|||
126589032|NCT03544281|455455696|FG008|Main Study Phase|Did not receive study treatment|0|||
126589033|NCT03544281|455455697|FG009|Main Study Phase|Did not receive study treatment|0|||
126589034|NCT03544281|455455698|FG010|Main Study Phase|Did not receive study treatment|0|||
126589035|NCT03544281|455455699|FG011|Main Study Phase|Did not receive study treatment|0|||
126589036|NCT03544281|455455700|FG012|Main Study Phase|Did not receive study treatment|0|||
126589037|NCT03544281|455455701|FG013|Main Study Phase|Did not receive study treatment|0|||
126589038|NCT03544281|455455702|FG014|Main Study Phase|Did not receive study treatment|0|||
126589039|NCT03544281|455455703|FG015|Main Study Phase|Did not receive study treatment|0|||
126589040|NCT03544281|455455704|FG016|Main Study Phase|Did not receive study treatment|0|||
126589041|NCT03544281|455455705|FG017|Main Study Phase|Did not receive study treatment|0|||
126589042|NCT03544281|455455706|FG018|Main Study Phase|Did not receive study treatment|0|||
126589043|NCT03544281|455455707|FG019|Main Study Phase|Did not receive study treatment|0|||
126589044|NCT03544281|455455708|FG020|Main Study Phase|Did not receive study treatment|0|||
126589045|NCT03544281|455455709|FG021|Main Study Phase|Did not receive study treatment|0|||
126589046|NCT03544281|455455688|FG000|PACT Phase|Adverse Event|0|||
126589047|NCT03544281|455455689|FG001|PACT Phase|Adverse Event|0|||
126589048|NCT03544281|455455690|FG002|PACT Phase|Adverse Event|0|||
126589049|NCT03544281|455455691|FG003|PACT Phase|Adverse Event|0|||
126589050|NCT03544281|455455692|FG004|PACT Phase|Adverse Event|0|||
126589051|NCT03544281|455455693|FG005|PACT Phase|Adverse Event|0|||
126589052|NCT03544281|455455694|FG006|PACT Phase|Adverse Event|0|||
126589053|NCT03544281|455455695|FG007|PACT Phase|Adverse Event|0|||
126589054|NCT03544281|455455696|FG008|PACT Phase|Adverse Event|0|||
126589055|NCT03544281|455455697|FG009|PACT Phase|Adverse Event|0|||
126589056|NCT03544281|455455698|FG010|PACT Phase|Adverse Event|0|||
126589057|NCT03544281|455455699|FG011|PACT Phase|Adverse Event|0|||
126589058|NCT03544281|455455700|FG012|PACT Phase|Adverse Event|1|||
126589059|NCT03544281|455455701|FG013|PACT Phase|Adverse Event|0|||
126589060|NCT03544281|455455702|FG014|PACT Phase|Adverse Event|0|||
126589061|NCT03544281|455455703|FG015|PACT Phase|Adverse Event|0|||
126589062|NCT03544281|455455704|FG016|PACT Phase|Adverse Event|0|||
126589063|NCT03544281|455455705|FG017|PACT Phase|Adverse Event|1|||
126589064|NCT03544281|455455706|FG018|PACT Phase|Adverse Event|1|||
126589065|NCT03544281|455455707|FG019|PACT Phase|Adverse Event|0|||
126589066|NCT03544281|455455708|FG020|PACT Phase|Adverse Event|0|||
126589067|NCT03544281|455455709|FG021|PACT Phase|Adverse Event|0|||
126589068|NCT03092518|455455711|FG000|Overall Study|Ineligible|2|||
126589069|NCT02547987|455455714|FG000|Overall Study|Withdrawal by Subject|1|||
126589070|NCT02547987|455455714|FG000|Overall Study|Adverse Event|2|||
126589071|NCT04282148|455455715|FG000|Overall Study|Death|7|||
126589072|NCT04282148|455455715|FG000|Overall Study|Withdrawal by Subject|1|||
126589073|NCT04282148|455455715|FG000|Overall Study|Physician Decision|1|||
126589074|NCT04925986|455455716|FG000|Overall Study|Death|0|||
126589075|NCT04925986|455455717|FG001|Overall Study|Death|0|||
126589076|NCT04925986|455455718|FG002|Overall Study|Death|2|||
126589077|NCT04925986|455455719|FG003|Overall Study|Death|0|||
126589078|NCT04925986|455455716|FG000|Overall Study|Lack of Efficacy|1|||
126589079|NCT04925986|455455717|FG001|Overall Study|Lack of Efficacy|2|||
126589080|NCT04925986|455455718|FG002|Overall Study|Lack of Efficacy|0|||
126589081|NCT04925986|455455719|FG003|Overall Study|Lack of Efficacy|1|||
126589082|NCT04925986|455455716|FG000|Overall Study|Withdrawal by Subject|0|||
126589083|NCT04925986|455455717|FG001|Overall Study|Withdrawal by Subject|0|||
126589084|NCT04925986|455455718|FG002|Overall Study|Withdrawal by Subject|1|||
126589085|NCT04925986|455455719|FG003|Overall Study|Withdrawal by Subject|2|||
126589086|NCT06181760|455455720|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
126589087|NCT06181760|455455721|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
126589088|NCT06181760|455455722|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
126589089|NCT06181760|455455723|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
126589090|NCT04770532|455455724|FG000|Overall Study|Withdrawal by Subject|0|||
126589091|NCT04770532|455455725|FG001|Overall Study|Withdrawal by Subject|3|||
126589092|NCT04770532|455455724|FG000|Overall Study|Physician Decision|1|||
126589093|NCT04770532|455455725|FG001|Overall Study|Physician Decision|0|||
126589094|NCT04770532|455455724|FG000|Overall Study|Death|2|||
126589095|NCT04770532|455455725|FG001|Overall Study|Death|2|||
126589096|NCT04938492|455455726|FG000|Overall Study|Lost to Follow-up|17|||
126589097|NCT04938492|455455727|FG001|Overall Study|Lost to Follow-up|18|||
126589098|NCT04025554|455455728|FG000|Overall Study|Adverse Event|3|||
126589099|NCT05084508|455455729|FG000|Overall Study|Lost to Follow-up|6|||
126589100|NCT05084508|455455730|FG001|Overall Study|Lost to Follow-up|3|||
126589101|NCT05084508|455455731|FG002|Overall Study|Lost to Follow-up|7|||
126589102|NCT05084508|455455732|FG003|Overall Study|Lost to Follow-up|3|||
126589103|NCT05084508|455455729|FG000|Overall Study|Withdrawal by Subject|0|||
126589104|NCT05084508|455455730|FG001|Overall Study|Withdrawal by Subject|2|||
126589105|NCT05084508|455455731|FG002|Overall Study|Withdrawal by Subject|3|||
126589106|NCT05084508|455455732|FG003|Overall Study|Withdrawal by Subject|1|||
126589107|NCT05084508|455455729|FG000|Overall Study|Other|0|||
126589108|NCT05084508|455455730|FG001|Overall Study|Other|0|||
126589109|NCT05084508|455455731|FG002|Overall Study|Other|0|||
126589110|NCT05084508|455455732|FG003|Overall Study|Other|1|||
126589111|NCT05296525|455455733|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
126589112|NCT05296525|455455734|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
126589113|NCT05296525|455455735|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
126589114|NCT05296525|455455736|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
126589115|NCT04065841|455455741|FG000|Overall Study|Adverse Event|4|||
126589116|NCT04065841|455455742|FG001|Overall Study|Adverse Event|2|||
126589117|NCT04065841|455455743|FG002|Overall Study|Adverse Event|10|||
126589118|NCT04065841|455455744|FG003|Overall Study|Adverse Event|1|||
126589119|NCT04065841|455455741|FG000|Overall Study|Lost to Follow-up|1|||
126589120|NCT04065841|455455742|FG001|Overall Study|Lost to Follow-up|2|||
126589121|NCT04065841|455455743|FG002|Overall Study|Lost to Follow-up|2|||
126589122|NCT04065841|455455744|FG003|Overall Study|Lost to Follow-up|2|||
126589123|NCT04065841|455455741|FG000|Overall Study|Physician Decision|1|||
126589124|NCT04065841|455455742|FG001|Overall Study|Physician Decision|0|||
126589125|NCT04065841|455455743|FG002|Overall Study|Physician Decision|0|||
126589126|NCT04065841|455455744|FG003|Overall Study|Physician Decision|0|||
126589127|NCT04065841|455455741|FG000|Overall Study|Protocol Violation|0|||
126589128|NCT04065841|455455742|FG001|Overall Study|Protocol Violation|1|||
126589129|NCT04065841|455455743|FG002|Overall Study|Protocol Violation|0|||
126589130|NCT04065841|455455744|FG003|Overall Study|Protocol Violation|0|||
126589131|NCT04065841|455455741|FG000|Overall Study|Study terminated by Sponsor|22|||
126589132|NCT04065841|455455742|FG001|Overall Study|Study terminated by Sponsor|16|||
126589133|NCT04065841|455455743|FG002|Overall Study|Study terminated by Sponsor|28|||
126589134|NCT04065841|455455744|FG003|Overall Study|Study terminated by Sponsor|17|||
126589135|NCT04065841|455455741|FG000|Overall Study|Withdrawal by Subject|1|||
126589136|NCT04065841|455455742|FG001|Overall Study|Withdrawal by Subject|1|||
126589137|NCT04065841|455455743|FG002|Overall Study|Withdrawal by Subject|2|||
126589138|NCT04065841|455455744|FG003|Overall Study|Withdrawal by Subject|0|||
126589139|NCT01420237|455455745|FG000|Overall Study|Death|13|||
126589140|NCT01420237|455455745|FG000|Overall Study|Withdrawal by Subject|41|||
126589141|NCT01420237|455455745|FG000|Overall Study|Lost to Follow-up|32|||
126589142|NCT01420237|455455745|FG000|Overall Study|Adverse Event|10|||
126589143|NCT01420237|455455745|FG000|Overall Study|Investigative Site Termination|43|||
126589144|NCT01420237|455455745|FG000|Overall Study|Censored because study device not implanted|21|||
126589145|NCT01420237|455455745|FG000|Overall Study|Censored because surgery not performed|2|||
126589146|NCT01420237|455455745|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
126589147|NCT01420237|455455745|FG000|Overall Study|Sponsor terminated study early|127|||
126589148|NCT03631784|455455747|FG000|Overall Study|Participants Ongoing|1|||
126589149|NCT03631784|455455748|FG001|Overall Study|Participants Ongoing|0|||
126589150|NCT03631784|455455747|FG000|Overall Study|Withdrawal by Subject|3|||
126589151|NCT03631784|455455748|FG001|Overall Study|Withdrawal by Subject|3|||
126589152|NCT03631784|455455747|FG000|Overall Study|Sponsor's Decision|36|||
126589153|NCT03631784|455455748|FG001|Overall Study|Sponsor's Decision|52|||
126589154|NCT03631784|455455747|FG000|Overall Study|Lost to Follow-up|1|||
126589155|NCT03631784|455455748|FG001|Overall Study|Lost to Follow-up|0|||
126589156|NCT03631784|455455747|FG000|Overall Study|Death|71|||
126589157|NCT03631784|455455748|FG001|Overall Study|Death|49|||
126589158|NCT05030233|455455753|FG000|Overall Study|withdrawn for transfer|1|||
126589159|NCT05030233|455455754|FG001|Overall Study|withdrawn for transfer|0|||
126589160|NCT04437615|455455756|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
126589161|NCT02035787|455457834|FG000|Overall Study- 12 Months|Adverse Event|3|||
126589162|NCT02035787|455457835|FG001|Overall Study- 12 Months|Adverse Event|0|||
126589163|NCT02035787|455457834|FG000|Overall Study- 12 Months|Complete response|4|||
126589164|NCT02035787|455457835|FG001|Overall Study- 12 Months|Complete response|1|||
126589165|NCT02035787|455457834|FG000|Overall Study- 12 Months|Protocol Violation|1|||
126589166|NCT02035787|455457835|FG001|Overall Study- 12 Months|Protocol Violation|1|||
126589167|NCT06414213|455457836|FG000|Overall Study|Lost to Follow-up|1|||
126589168|NCT06414213|455457837|FG001|Overall Study|Lost to Follow-up|1|||
126589169|NCT06414213|455457838|FG002|Overall Study|Lost to Follow-up|3|||
126589170|NCT01396278|455457839|FG000|Overall Study|Adverse Event|0|||
126589171|NCT01396278|455457840|FG001|Overall Study|Adverse Event|0|||
126589172|NCT01396278|455457841|FG002|Overall Study|Adverse Event|0|||
126589173|NCT01396278|455457842|FG003|Overall Study|Adverse Event|2|||
126589174|NCT01396278|455457843|FG004|Overall Study|Adverse Event|0|||
126589175|NCT01396278|455457839|FG000|Overall Study|Withdraw due to trial termination|2|||
126589176|NCT01396278|455457840|FG001|Overall Study|Withdraw due to trial termination|1|||
126589177|NCT01396278|455457841|FG002|Overall Study|Withdraw due to trial termination|1|||
126589178|NCT01396278|455457842|FG003|Overall Study|Withdraw due to trial termination|0|||
126589179|NCT01396278|455457843|FG004|Overall Study|Withdraw due to trial termination|2|||
126589180|NCT04515576|455457846|FG000|Overall Study|Withdrawal by Subject|0|||
126589181|NCT04515576|455457847|FG001|Overall Study|Withdrawal by Subject|0|||
126589182|NCT04515576|455457848|FG002|Overall Study|Withdrawal by Subject|0|||
126589183|NCT04515576|455457849|FG003|Overall Study|Withdrawal by Subject|0|||
126589184|NCT04515576|455457850|FG004|Overall Study|Withdrawal by Subject|0|||
126589185|NCT04515576|455457851|FG005|Overall Study|Withdrawal by Subject|1|||
126589186|NCT05028634|455457852|FG000|Overall Study|Withdrawal by Subject|0|||
126589187|NCT05028634|455457853|FG001|Overall Study|Withdrawal by Subject|1|||
126589188|NCT05653427|455457854|FG000|Overall Study|Study Terminated by Sponsor|13|||
126589189|NCT04971395|455457858|FG000|Overall Study|Withdrawal by Subject|0|||
126589190|NCT04971395|455457859|FG001|Overall Study|Withdrawal by Subject|1|||
126589191|NCT04971395|455457860|FG002|Overall Study|Withdrawal by Subject|0|||
126589192|NCT03771417|455457861|FG000|Overall Study|Withdrawal by Subject|1|||
126589193|NCT03771417|455457862|FG001|Overall Study|Withdrawal by Subject|0|||
126589194|NCT03771417|455457863|FG002|Overall Study|Withdrawal by Subject|0|||
126589195|NCT03771417|455457861|FG000|Overall Study|Covid-19 Shutdown|0|||
126589196|NCT03771417|455457862|FG001|Overall Study|Covid-19 Shutdown|1|||
126589197|NCT03771417|455457863|FG002|Overall Study|Covid-19 Shutdown|0|||
126589198|NCT00881621|455457867|FG000|Overall Study|Physician Decision|34|||
126589199|NCT03936322|455457872|FG000|Overall Study|Lost to Follow-up|1|||
126589200|NCT03936322|455457872|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
126589201|NCT05434078|455457874|FG000|Overall Study|Lost to Follow-up|2|||
126589202|NCT05434078|455457875|FG001|Overall Study|Lost to Follow-up|1|||
126589203|NCT05434078|455457874|FG000|Overall Study|Withdrawal by Subject|1|||
126589204|NCT05434078|455457875|FG001|Overall Study|Withdrawal by Subject|0|||
126589205|NCT01160211|455457876|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
126589206|NCT01160211|455457877|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
126589207|NCT01160211|455457878|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
126589208|NCT01160211|455457876|FG000|Overall Study|Lost to Follow-up|4|||
126589209|NCT01160211|455457877|FG001|Overall Study|Lost to Follow-up|8|||
126589210|NCT01160211|455457878|FG002|Overall Study|Lost to Follow-up|4|||
126589211|NCT01160211|455457876|FG000|Overall Study|Physician Decision|1|||
126589212|NCT01160211|455457877|FG001|Overall Study|Physician Decision|0|||
126589213|NCT01160211|455457878|FG002|Overall Study|Physician Decision|0|||
126589214|NCT01160211|455457876|FG000|Overall Study|Withdrawal by Subject|4|||
126589215|NCT01160211|455457877|FG001|Overall Study|Withdrawal by Subject|2|||
126589216|NCT01160211|455457878|FG002|Overall Study|Withdrawal by Subject|2|||
126589217|NCT01160211|455457876|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
126589218|NCT01160211|455457877|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
126589219|NCT01160211|455457878|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
126589220|NCT02734290|455457882|FG000|Overall Study|Adverse Event|1|||
126589221|NCT02734290|455457883|FG001|Overall Study|Adverse Event|0|||
126589222|NCT02734290|455457882|FG000|Overall Study|Death|1|||
126589223|NCT02734290|455457883|FG001|Overall Study|Death|0|||
126589224|NCT03158129|455457884|FG000|Overall Study|Adverse Event|0|||
126589225|NCT03158129|455457885|FG001|Overall Study|Adverse Event|1|||
126589226|NCT03158129|455457886|FG002|Overall Study|Adverse Event|0|||
126589227|NCT03158129|455457887|FG003|Overall Study|Adverse Event|0|||
126589228|NCT03158129|455457884|FG000|Overall Study|Death|0|||
126589229|NCT03158129|455457885|FG001|Overall Study|Death|0|||
126589230|NCT03158129|455457886|FG002|Overall Study|Death|0|||
126589231|NCT03158129|455457887|FG003|Overall Study|Death|1|||
126589232|NCT03158129|455457884|FG000|Overall Study|High surgical risk|1|||
126589233|NCT03158129|455457885|FG001|Overall Study|High surgical risk|1|||
126589234|NCT03158129|455457886|FG002|Overall Study|High surgical risk|0|||
126589235|NCT03158129|455457887|FG003|Overall Study|High surgical risk|0|||
126589236|NCT03158129|455457884|FG000|Overall Study|Progression|1|||
126589237|NCT03158129|455457885|FG001|Overall Study|Progression|1|||
126589238|NCT03158129|455457886|FG002|Overall Study|Progression|0|||
126589239|NCT03158129|455457887|FG003|Overall Study|Progression|0|||
126589240|NCT03158129|455457884|FG000|Overall Study|Lack of resectability|0|||
126589241|NCT03158129|455457885|FG001|Overall Study|Lack of resectability|1|||
126589242|NCT03158129|455457886|FG002|Overall Study|Lack of resectability|0|||
126589243|NCT03158129|455457887|FG003|Overall Study|Lack of resectability|0|||
126589244|NCT03158129|455457884|FG000|Overall Study|Declined surgery|0|||
126589245|NCT03158129|455457885|FG001|Overall Study|Declined surgery|1|||
126589246|NCT03158129|455457886|FG002|Overall Study|Declined surgery|0|||
126589247|NCT03158129|455457887|FG003|Overall Study|Declined surgery|0|||
126589248|NCT03158129|455457884|FG000|Overall Study|No longer surgical candidate|0|||
126589249|NCT03158129|455457885|FG001|Overall Study|No longer surgical candidate|0|||
126589250|NCT03158129|455457886|FG002|Overall Study|No longer surgical candidate|0|||
126589251|NCT03158129|455457887|FG003|Overall Study|No longer surgical candidate|1|||
126589252|NCT02577835|455457888|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
126589253|NCT04342494|455457889|FG000|Overall Study|Questionnaire partially completed|1|||
126589254|NCT04342494|455457890|FG001|Overall Study|Questionnaire partially completed|0|||
126589255|NCT04342494|455457891|FG002|Overall Study|Questionnaire partially completed|2|||
126589256|NCT04342494|455457892|FG003|Overall Study|Questionnaire partially completed|0|||
126589257|NCT04342494|455457893|FG004|Overall Study|Questionnaire partially completed|1|||
126589258|NCT04342494|455457889|FG000|Overall Study|Lost to Follow-up|49|||
126589259|NCT04342494|455457890|FG001|Overall Study|Lost to Follow-up|38|||
126589260|NCT04342494|455457891|FG002|Overall Study|Lost to Follow-up|34|||
126589261|NCT04342494|455457892|FG003|Overall Study|Lost to Follow-up|34|||
126589262|NCT04342494|455457893|FG004|Overall Study|Lost to Follow-up|35|||
126589263|NCT04806451|455457894|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
126589264|NCT04806451|455457895|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
126589265|NCT04806451|455457894|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
126589266|NCT04806451|455457895|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
126589267|NCT04806451|455457894|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
126589268|NCT04806451|455457895|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
126589269|NCT05835336|455457896|FG000|Overall Study|Withdrawal by Subject|5|||
126589270|NCT05835336|455457896|FG000|Overall Study|Did not complete the personalization process|3|||
126589271|NCT02979522|455457897|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
126589272|NCT02979522|455457898|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
126589273|NCT02979522|455457897|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
126589274|NCT02979522|455457898|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
126589275|NCT03199469|455457902|FG000|Overall Study|Randomized, not treated|0|||
126589276|NCT03199469|455457903|FG001|Overall Study|Randomized, not treated|3|||
126589277|NCT03199469|455457902|FG000|Overall Study|Withdrawal by Subject|1|||
126589278|NCT03199469|455457903|FG001|Overall Study|Withdrawal by Subject|0|||
126589279|NCT03199469|455457902|FG000|Overall Study|Death|1|||
126589280|NCT03199469|455457903|FG001|Overall Study|Death|3|||
126589281|NCT03199469|455457902|FG000|Overall Study|Ongoing|5|||
126589282|NCT03199469|455457903|FG001|Overall Study|Ongoing|14|||
126589283|NCT05453773|455457907|FG000|Overall Study|Withdrawal by Subject|3|||
126589284|NCT05453773|455457907|FG000|Overall Study|Lost to Follow-up|3|||
126589285|NCT05453773|455457907|FG000|Overall Study|Difficult Blood Draw|3|||
126589286|NCT02023866|455457910|FG000|Overall Study|Non-compliance|2|||
126589287|NCT02023866|455457910|FG000|Overall Study|Adverse Event|3|||
126589288|NCT02023866|455457910|FG000|Overall Study|Withdrawal by Subject|1|||
126589289|NCT04683744|455457911|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
126589290|NCT04683744|455457912|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
126589291|NCT04683744|455457913|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
126589292|NCT04963270|455457915|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
126589293|NCT04963270|455457916|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
126589294|NCT04963270|455457917|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
126589295|NCT04963270|455457918|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
126589296|NCT04963270|455457915|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126589297|NCT04963270|455457916|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
126589298|NCT04963270|455457917|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126589299|NCT04963270|455457918|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
126589300|NCT04963270|455457915|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
126589301|NCT04963270|455457916|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126589302|NCT04963270|455457917|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126589303|NCT04963270|455457918|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
126589304|NCT04963270|455457915|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
126589305|NCT04963270|455457916|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
126589306|NCT04963270|455457917|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
126589307|NCT04963270|455457918|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
126589308|NCT04963270|455457915|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
126589309|NCT04963270|455457916|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
126589310|NCT04963270|455457917|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
126589311|NCT04963270|455457918|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
126589312|NCT04963270|455457915|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
126589313|NCT04963270|455457916|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
126589314|NCT04963270|455457917|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
126589315|NCT04963270|455457918|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
126589316|NCT04963270|455457915|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
126589317|NCT04963270|455457916|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
126589318|NCT04963270|455457917|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
126589319|NCT04963270|455457918|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
126589320|NCT04963270|455457915|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
126589321|NCT04963270|455457916|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
126589322|NCT04963270|455457917|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
126589323|NCT04963270|455457918|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
126589324|NCT04963270|455457915|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
126589325|NCT04963270|455457916|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
126589326|NCT04963270|455457917|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
126589327|NCT04963270|455457918|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
126589328|NCT04963270|455457915|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
126589329|NCT04963270|455457916|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
126589330|NCT04963270|455457917|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
126589331|NCT04963270|455457918|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
126589332|NCT04963270|455457915|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
126589333|NCT04963270|455457916|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
126589334|NCT04963270|455457917|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
126589335|NCT04963270|455457918|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
126589336|NCT04963270|455457915|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
126589337|NCT04963270|455457916|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
126589338|NCT04963270|455457917|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
126589339|NCT04963270|455457918|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
126589340|NCT04963270|455457915|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
126589341|NCT04963270|455457916|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
126589342|NCT04963270|455457917|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
126589343|NCT04963270|455457918|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
126589344|NCT04963270|455457915|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
126589345|NCT04963270|455457916|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
126589346|NCT04963270|455457917|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
126589347|NCT04963270|455457918|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
126589348|NCT04624633|455457923|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
126589349|NCT04624633|455457924|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
126589350|NCT04624633|455457923|FG000|Overall Study|Death|1|||
126589351|NCT04624633|455457924|FG001|Overall Study|Death|0|||
126589352|NCT04316871|455457925|FG000|Overall Study|Protocol Violation|2|||
126589353|NCT04316871|455457926|FG001|Overall Study|Protocol Violation|2|||
126589354|NCT04316871|455457927|FG002|Overall Study|Protocol Violation|2|||
126589355|NCT04316871|455457928|FG003|Overall Study|Protocol Violation|2|||
126589356|NCT05087992|455457929|FG000|Overall Study|Adverse Event|0|||
126589357|NCT05087992|455457930|FG001|Overall Study|Adverse Event|1|||
126589358|NCT05087992|455457931|FG002|Overall Study|Adverse Event|0|||
126589359|NCT05087992|455457929|FG000|Overall Study|Withdrawal by Subject|2|||
126589360|NCT05087992|455457930|FG001|Overall Study|Withdrawal by Subject|0|||
126589361|NCT05087992|455457931|FG002|Overall Study|Withdrawal by Subject|0|||
126589362|NCT05087992|455457929|FG000|Overall Study|clinical disease progression|3|||
126589363|NCT05087992|455457930|FG001|Overall Study|clinical disease progression|1|||
126589364|NCT05087992|455457931|FG002|Overall Study|clinical disease progression|0|||
126589365|NCT05087992|455457929|FG000|Overall Study|objective disease progression|4|||
126589366|NCT05087992|455457930|FG001|Overall Study|objective disease progression|1|||
126589367|NCT05087992|455457931|FG002|Overall Study|objective disease progression|0|||
126589368|NCT01842542|455457932|FG000|Overall Study|Withdrawal by Subject|2|||
126589369|NCT01842542|455457932|FG000|Overall Study|Lack of Efficacy|1|||
126589370|NCT01842542|455457932|FG000|Overall Study|Protocol Non-compliance|2|||
126589371|NCT01842542|455457932|FG000|Overall Study|Lost to Follow-up|1|||
126589372|NCT01369355|455457939|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
126589373|NCT01369355|455457940|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
126589374|NCT01369355|455457941|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
126589375|NCT01369355|455457942|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
126589376|NCT01369355|455457943|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
126589377|NCT01369355|455457944|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
126589378|NCT01369355|455457945|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
126589379|NCT01369355|455457946|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
126589380|NCT01369355|455457947|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
126589381|NCT01369355|455457939|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
126589382|NCT01369355|455457940|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
126589383|NCT01369355|455457941|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
126589384|NCT01369355|455457942|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
126589385|NCT01369355|455457943|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
126589386|NCT01369355|455457944|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
126589387|NCT01369355|455457945|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
126589388|NCT01369355|455457946|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
126589389|NCT01369355|455457947|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
126589390|NCT01369355|455457939|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
126589391|NCT01369355|455457940|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
126589392|NCT01369355|455457941|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
126640545|NCT05143138|455642801|FG000|Overall Study|withdrawal|1|||
126589393|NCT01369355|455457942|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
126589394|NCT01369355|455457943|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
126589395|NCT01369355|455457944|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
126589396|NCT01369355|455457945|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
126589397|NCT01369355|455457946|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
126589398|NCT01369355|455457947|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
126589399|NCT01369355|455457939|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
126589400|NCT01369355|455457940|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
126589401|NCT01369355|455457941|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
126589402|NCT01369355|455457942|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
126589403|NCT01369355|455457943|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
126589404|NCT01369355|455457944|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
126589405|NCT01369355|455457945|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
126589406|NCT01369355|455457946|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
126589407|NCT01369355|455457947|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
126589408|NCT01369355|455457939|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
126589409|NCT01369355|455457940|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
126589410|NCT01369355|455457941|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
126589411|NCT01369355|455457942|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
126589412|NCT01369355|455457943|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
126589413|NCT01369355|455457944|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
126589414|NCT01369355|455457945|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
126589415|NCT01369355|455457946|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
126589416|NCT01369355|455457947|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
126589417|NCT01369355|455457939|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
126589418|NCT01369355|455457940|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
126589419|NCT01369355|455457941|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
126589420|NCT01369355|455457942|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
126589421|NCT01369355|455457943|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
126589422|NCT01369355|455457944|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
126589423|NCT01369355|455457945|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
126589424|NCT01369355|455457946|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
126589425|NCT01369355|455457947|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
126589426|NCT01369355|455457939|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
126589427|NCT01369355|455457940|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
126589428|NCT01369355|455457941|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
126589429|NCT01369355|455457942|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
126589430|NCT01369355|455457943|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
126589431|NCT01369355|455457944|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
126589432|NCT01369355|455457945|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
126589433|NCT01369355|455457946|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
126589434|NCT01369355|455457947|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
126589435|NCT01369355|455457939|FG000|Long-term Extension (Week 44-272)|Death|0|||
126589436|NCT01369355|455457940|FG001|Long-term Extension (Week 44-272)|Death|0|||
126589437|NCT01369355|455457941|FG002|Long-term Extension (Week 44-272)|Death|0|||
126589438|NCT01369355|455457942|FG003|Long-term Extension (Week 44-272)|Death|0|||
126589439|NCT01369355|455457943|FG004|Long-term Extension (Week 44-272)|Death|0|||
126589440|NCT01369355|455457944|FG005|Long-term Extension (Week 44-272)|Death|0|||
126589441|NCT01369355|455457945|FG006|Long-term Extension (Week 44-272)|Death|0|||
126589442|NCT01369355|455457946|FG007|Long-term Extension (Week 44-272)|Death|1|||
126589443|NCT01369355|455457947|FG008|Long-term Extension (Week 44-272)|Death|3|||
126589444|NCT01369355|455457939|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
126589445|NCT01369355|455457940|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
126589446|NCT01369355|455457941|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
126589447|NCT01369355|455457942|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
126589448|NCT01369355|455457943|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
126589449|NCT01369355|455457944|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
126589450|NCT01369355|455457945|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
126589451|NCT01369355|455457946|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
126589452|NCT01369355|455457947|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
126589453|NCT01369355|455457939|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126589454|NCT01369355|455457940|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126589455|NCT01369355|455457941|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126589456|NCT01369355|455457942|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126589457|NCT01369355|455457943|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126589458|NCT01369355|455457944|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126589459|NCT01369355|455457945|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
126589460|NCT01369355|455457946|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
126589461|NCT01369355|455457947|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
126589462|NCT01369355|455457939|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
126589463|NCT01369355|455457940|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
126589464|NCT01369355|455457941|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
126589465|NCT01369355|455457942|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
126589466|NCT01369355|455457943|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
126589467|NCT01369355|455457944|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
126589468|NCT01369355|455457945|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
126589469|NCT01369355|455457946|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
126589470|NCT01369355|455457947|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
126589471|NCT01369355|455457939|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
126589472|NCT01369355|455457940|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
126589473|NCT01369355|455457941|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
126589474|NCT01369355|455457942|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
126589475|NCT01369355|455457943|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
126589476|NCT01369355|455457944|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
126589477|NCT01369355|455457945|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
126589478|NCT01369355|455457946|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
126589479|NCT01369355|455457947|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
126589480|NCT01369355|455457939|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
126589481|NCT01369355|455457940|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
126589482|NCT01369355|455457941|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
126589483|NCT01369355|455457942|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
126589484|NCT01369355|455457943|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
126589485|NCT01369355|455457944|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
126589486|NCT01369355|455457945|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
126589487|NCT01369355|455457946|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
126589488|NCT01369355|455457947|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
126589489|NCT01369355|455457939|FG000|Long-term Extension (Week 44-272)|Other|0|||
126589490|NCT01369355|455457940|FG001|Long-term Extension (Week 44-272)|Other|0|||
126589491|NCT01369355|455457941|FG002|Long-term Extension (Week 44-272)|Other|0|||
126589492|NCT01369355|455457942|FG003|Long-term Extension (Week 44-272)|Other|0|||
126589493|NCT01369355|455457943|FG004|Long-term Extension (Week 44-272)|Other|0|||
126589494|NCT01369355|455457944|FG005|Long-term Extension (Week 44-272)|Other|0|||
126589495|NCT01369355|455457945|FG006|Long-term Extension (Week 44-272)|Other|110|||
126589496|NCT01369355|455457946|FG007|Long-term Extension (Week 44-272)|Other|9|||
126589497|NCT01369355|455457947|FG008|Long-term Extension (Week 44-272)|Other|17|||
126589498|NCT01824394|455457950|FG000|Overall Study|Early Termination|1|||
126589499|NCT01824394|455457951|FG001|Overall Study|Early Termination|1|||
126589500|NCT01824394|455457952|FG002|Overall Study|Early Termination|3|||
126589501|NCT01824394|455457950|FG000|Overall Study|Withdrawn due to Study Termination|91|||
126589502|NCT01824394|455457951|FG001|Overall Study|Withdrawn due to Study Termination|83|||
126589503|NCT01824394|455457952|FG002|Overall Study|Withdrawn due to Study Termination|41|||
126589504|NCT01824394|455457950|FG000|Overall Study|Lost to Follow-up|0|||
126589505|NCT01824394|455457951|FG001|Overall Study|Lost to Follow-up|9|||
126589506|NCT01824394|455457952|FG002|Overall Study|Lost to Follow-up|3|||
126589507|NCT01824394|455457950|FG000|Overall Study|Death|3|||
126589508|NCT01824394|455457951|FG001|Overall Study|Death|2|||
126589509|NCT01824394|455457952|FG002|Overall Study|Death|4|||
126589510|NCT01824394|455457950|FG000|Overall Study|Discontinued Subjects|1|||
126589511|NCT01824394|455457951|FG001|Overall Study|Discontinued Subjects|1|||
126589512|NCT01824394|455457952|FG002|Overall Study|Discontinued Subjects|2|||
126589513|NCT01824394|455457950|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
126589514|NCT01824394|455457951|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
126589515|NCT01824394|455457952|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
126589516|NCT05364671|455457953|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
126589517|NCT05364671|455457954|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
126589518|NCT05364671|455457953|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
126589519|NCT05364671|455457954|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
126589520|NCT05364671|455457953|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
126589521|NCT05364671|455457954|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
126589522|NCT05364671|455457953|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
126589523|NCT05364671|455457954|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
126589524|NCT05364671|455457953|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
126589525|NCT05364671|455457954|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
126589526|NCT02359890|455457955|FG000|Overall Study|Not meeting eligibility|4|||
126589527|NCT02359890|455457955|FG000|Overall Study|Never treated with study catheter|6|||
126589528|NCT03536754|455457958|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
126589529|NCT03536754|455457959|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
126589530|NCT03536754|455457960|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
126589531|NCT03536754|455457961|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
126589532|NCT03536754|455457962|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
126589533|NCT03536754|455457958|FG000|Open Label Extension|Other|0|||
126589534|NCT03536754|455457959|FG001|Open Label Extension|Other|0|||
126589535|NCT03536754|455457960|FG002|Open Label Extension|Other|0|||
126589536|NCT03536754|455457961|FG003|Open Label Extension|Other|0|||
126589537|NCT03536754|455457962|FG004|Open Label Extension|Other|1|||
126589538|NCT04187833|455457963|FG000|Overall Study|Withdrawal by Subject|1|||
126589539|NCT03097549|455457964|FG000|Overall Study|Withdrawal by Subject|1|||
126589540|NCT03097549|455457965|FG001|Overall Study|Withdrawal by Subject|0|||
126589541|NCT03097549|455457964|FG000|Overall Study|Lost to Follow-up|1|||
126589542|NCT03097549|455457965|FG001|Overall Study|Lost to Follow-up|0|||
126589543|NCT02547233|455457966|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
126589544|NCT02547233|455457967|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
126589545|NCT02547233|455457966|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
126589546|NCT02547233|455457967|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
126589547|NCT02547233|455457966|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
126589548|NCT02547233|455457967|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
126589549|NCT02547233|455457966|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
126589550|NCT02547233|455457967|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
126589551|NCT02547233|455457966|FG000|12-month Follow-up|Withdrawal by Subject|10|||
126589552|NCT02547233|455457967|FG001|12-month Follow-up|Withdrawal by Subject|10|||
126589553|NCT02547233|455457966|FG000|12-month Follow-up|Lost to Follow-up|3|||
126589554|NCT02547233|455457967|FG001|12-month Follow-up|Lost to Follow-up|3|||
126589555|NCT02547233|455457966|FG000|12-month Follow-up|Lack of Efficacy|1|||
126589556|NCT02547233|455457967|FG001|12-month Follow-up|Lack of Efficacy|2|||
126589557|NCT02547233|455457966|FG000|12-month Follow-up|Protocol Violation|0|||
126589558|NCT02547233|455457967|FG001|12-month Follow-up|Protocol Violation|1|||
126589559|NCT02547233|455457966|FG000|12-month Follow-up|Other|0|||
126589560|NCT02547233|455457967|FG001|12-month Follow-up|Other|1|||
126589561|NCT02146378|455457968|FG000|Overall Study|No information of administration|2|||
126589562|NCT03603600|455457969|FG000|Overall Study|Withdrawal by Subject|5|||
126589563|NCT03603600|455457970|FG001|Overall Study|Withdrawal by Subject|7|||
126589564|NCT03603600|455457969|FG000|Overall Study|Lost to Follow-up|2|||
126589565|NCT03603600|455457970|FG001|Overall Study|Lost to Follow-up|3|||
126589566|NCT03603600|455457969|FG000|Overall Study|Death|3|||
126589567|NCT03603600|455457970|FG001|Overall Study|Death|1|||
126589568|NCT03603600|455457969|FG000|Overall Study|Physician Decision|2|||
126589569|NCT03603600|455457970|FG001|Overall Study|Physician Decision|1|||
126589570|NCT03603600|455457969|FG000|Overall Study|Other reason|1|||
126589571|NCT03603600|455457970|FG001|Overall Study|Other reason|0|||
126589572|NCT05170009|455457971|FG000|Overall Study|Physician Decision|0|||
126589573|NCT05170009|455457972|FG001|Overall Study|Physician Decision|1|||
126589574|NCT03524612|455457978|FG000|Overall Study|Lack of Efficacy|10|||
126589575|NCT03524612|455457978|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
126589576|NCT03524612|455457978|FG000|Overall Study|Adverse Event|10|||
126589577|NCT03524612|455457978|FG000|Overall Study|Withdrawal by Subject|7|||
126589578|NCT03524612|455457978|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
126589579|NCT03524612|455457978|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
126589580|NCT03524612|455457978|FG000|Overall Study|New therapy for study indication|6|||
126589581|NCT03524612|455457978|FG000|Overall Study|Death|3|||
126589582|NCT03524612|455457978|FG000|Overall Study|Lost to Follow-up|2|||
126589583|NCT03524612|455457978|FG000|Overall Study|Protocol Violation|1|||
126589584|NCT05457647|455457979|FG000|Overall Study|Lost to Follow-up|3|||
126589585|NCT02683447|455457980|FG000|Overall Study|Lost to Follow-up|2|||
126589586|NCT03448107|455457981|FG000|Overall Study|Lost to Follow-up|229|||
126589587|NCT03448107|455457982|FG001|Overall Study|Lost to Follow-up|258|||
126589588|NCT03115476|455457983|FG000|LP0084-1369|Death|1|||
126589589|NCT03115476|455457984|FG001|LP0084-1369|Death|0|||
126589590|NCT03115476|455457985|FG002|LP0084-1369|Death|2|||
126589591|NCT03115476|455457983|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
126589592|NCT03115476|455457984|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
126589593|NCT03115476|455457985|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
126589594|NCT02489903|455457986|FG000|Screening|Screen Failure|24|||
126589595|NCT02489903|455457987|FG001|Screening|Screen Failure|0|||
126589596|NCT02489903|455457988|FG002|Screening|Screen Failure|0|||
126589597|NCT02489903|455457989|FG003|Screening|Screen Failure|8|||
126589598|NCT02489903|455457986|FG000|Randomized and Received Treatment|Protocol Violation|0|||
126589599|NCT02489903|455457987|FG001|Randomized and Received Treatment|Protocol Violation|1|||
126589600|NCT02489903|455457988|FG002|Randomized and Received Treatment|Protocol Violation|0|||
126589601|NCT02489903|455457989|FG003|Randomized and Received Treatment|Protocol Violation|0|||
126589602|NCT02489903|455457986|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
126589603|NCT02489903|455457987|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
126589604|NCT02489903|455457988|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
126589605|NCT02489903|455457989|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
126589606|NCT02489903|455457986|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
126589607|NCT02489903|455457987|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
126589608|NCT02489903|455457988|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
126589609|NCT02489903|455457989|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
126589610|NCT02489903|455457986|FG000|Randomized and Received Treatment|Death|10|||
126589611|NCT02489903|455457987|FG001|Randomized and Received Treatment|Death|1|||
126589612|NCT02489903|455457988|FG002|Randomized and Received Treatment|Death|0|||
126589613|NCT02489903|455457989|FG003|Randomized and Received Treatment|Death|0|||
126589614|NCT03976362|455457993|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
126589615|NCT03976362|455457994|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
126589616|NCT03976362|455457995|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
126589617|NCT03976362|455457993|FG000|Induction Phase|Death|62|||
126589618|NCT03976362|455457994|FG001|Induction Phase|Death|0|||
126589619|NCT03976362|455457995|FG002|Induction Phase|Death|0|||
126589620|NCT03976362|455457993|FG000|Maintenance Phase|Participants Ongoing|0|||
126589621|NCT03976362|455457994|FG001|Maintenance Phase|Participants Ongoing|106|||
126589622|NCT03976362|455457995|FG002|Maintenance Phase|Participants Ongoing|103|||
126589623|NCT03976362|455457993|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126589624|NCT03976362|455457994|FG001|Maintenance Phase|Withdrawal by Subject|4|||
126589625|NCT03976362|455457995|FG002|Maintenance Phase|Withdrawal by Subject|4|||
126589626|NCT03976362|455457993|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
126589627|NCT03976362|455457994|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
126589628|NCT03976362|455457995|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
126589629|NCT03976362|455457993|FG000|Maintenance Phase|Death|0|||
126589630|NCT03976362|455457994|FG001|Maintenance Phase|Death|186|||
126589631|NCT03976362|455457995|FG002|Maintenance Phase|Death|187|||
126589632|NCT00613106|455457996|FG000|Overall Study|Adverse Event|3|||
126589633|NCT00613106|455457997|FG001|Overall Study|Adverse Event|1|||
126589634|NCT00613106|455457996|FG000|Overall Study|Withdrawal by Subject|6|||
126589635|NCT00613106|455457997|FG001|Overall Study|Withdrawal by Subject|3|||
126589636|NCT00613106|455457996|FG000|Overall Study|Lost to Follow-up|7|||
126589637|NCT00613106|455457997|FG001|Overall Study|Lost to Follow-up|2|||
126589638|NCT00613106|455457996|FG000|Overall Study|misc|4|||
126589639|NCT00613106|455457997|FG001|Overall Study|misc|3|||
126589640|NCT04492722|455458007|FG000|Overall Study|Adverse Event|7|||
126589641|NCT04492722|455458008|FG001|Overall Study|Adverse Event|2|||
126589642|NCT04492722|455458009|FG002|Overall Study|Adverse Event|3|||
126589643|NCT04492722|455458010|FG003|Overall Study|Adverse Event|0|||
126589644|NCT04492722|455458007|FG000|Overall Study|Death|0|||
126589645|NCT04492722|455458008|FG001|Overall Study|Death|0|||
126589646|NCT04492722|455458009|FG002|Overall Study|Death|0|||
126589647|NCT04492722|455458010|FG003|Overall Study|Death|1|||
126589648|NCT04492722|455458007|FG000|Overall Study|Lost to Follow-up|0|||
126589649|NCT04492722|455458008|FG001|Overall Study|Lost to Follow-up|1|||
126589650|NCT04492722|455458009|FG002|Overall Study|Lost to Follow-up|0|||
126589651|NCT04492722|455458010|FG003|Overall Study|Lost to Follow-up|1|||
126589652|NCT04492722|455458007|FG000|Overall Study|Physician Decision|0|||
126589653|NCT04492722|455458008|FG001|Overall Study|Physician Decision|3|||
126589654|NCT04492722|455458009|FG002|Overall Study|Physician Decision|1|||
126589655|NCT04492722|455458010|FG003|Overall Study|Physician Decision|1|||
126589656|NCT04492722|455458007|FG000|Overall Study|Withdrawal by Subject|6|||
126589657|NCT04492722|455458008|FG001|Overall Study|Withdrawal by Subject|6|||
126589658|NCT04492722|455458009|FG002|Overall Study|Withdrawal by Subject|0|||
126589659|NCT04492722|455458010|FG003|Overall Study|Withdrawal by Subject|3|||
126589660|NCT04492722|455458007|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
126589661|NCT04492722|455458008|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
126589662|NCT04492722|455458009|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
126589663|NCT04492722|455458010|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
126589664|NCT04492722|455458007|FG000|Overall Study|Due to Covid-19 pandemic|7|||
126589665|NCT04492722|455458008|FG001|Overall Study|Due to Covid-19 pandemic|3|||
126589666|NCT04492722|455458009|FG002|Overall Study|Due to Covid-19 pandemic|7|||
126589667|NCT04492722|455458010|FG003|Overall Study|Due to Covid-19 pandemic|6|||
126589668|NCT04492722|455458007|FG000|Overall Study|Failure to meet randomisation criteria|2|||
126589669|NCT04492722|455458008|FG001|Overall Study|Failure to meet randomisation criteria|3|||
126589670|NCT04492722|455458009|FG002|Overall Study|Failure to meet randomisation criteria|4|||
126589671|NCT04492722|455458010|FG003|Overall Study|Failure to meet randomisation criteria|2|||
126589672|NCT04492722|455458007|FG000|Overall Study|Early termination from the study|54|||
126589673|NCT04492722|455458008|FG001|Overall Study|Early termination from the study|51|||
126589674|NCT04492722|455458009|FG002|Overall Study|Early termination from the study|50|||
126589675|NCT04492722|455458010|FG003|Overall Study|Early termination from the study|50|||
126589676|NCT04492722|455458007|FG000|Overall Study|Missing|3|||
126589677|NCT04492722|455458008|FG001|Overall Study|Missing|0|||
126589678|NCT04492722|455458009|FG002|Overall Study|Missing|0|||
126589679|NCT04492722|455458010|FG003|Overall Study|Missing|5|||
126589680|NCT04492722|455458007|FG000|Overall Study|Participants who did not receive treatment|0|||
126589681|NCT04492722|455458008|FG001|Overall Study|Participants who did not receive treatment|1|||
126589682|NCT04492722|455458009|FG002|Overall Study|Participants who did not receive treatment|4|||
126589683|NCT04492722|455458010|FG003|Overall Study|Participants who did not receive treatment|0|||
126589684|NCT04256941|455459906|FG000|Overall Study|Withdrawal by Subject|0|||
126589685|NCT04256941|455459907|FG001|Overall Study|Withdrawal by Subject|1|||
126589686|NCT04256941|455459906|FG000|Overall Study|Death|1|||
126589687|NCT04256941|455459907|FG001|Overall Study|Death|0|||
126589688|NCT04256941|455459906|FG000|Overall Study|Disease Progession|0|||
126589689|NCT04256941|455459907|FG001|Overall Study|Disease Progession|2|||
126589690|NCT02908477|455459914|FG000|Overall Study|Withdrawal by Subject|8|||
126589691|NCT02908477|455459915|FG001|Overall Study|Withdrawal by Subject|28|||
126589692|NCT02140554|455459916|FG000|Overall Study|Withdrawal of consent|1|||
126589693|NCT02140554|455459917|FG001|Overall Study|Withdrawal of consent|0|||
126589694|NCT02140554|455459918|FG002|Overall Study|Withdrawal of consent|4|||
126589695|NCT02140554|455459916|FG000|Overall Study|Physician Decision|1|||
126589696|NCT02140554|455459917|FG001|Overall Study|Physician Decision|0|||
126589697|NCT02140554|455459918|FG002|Overall Study|Physician Decision|2|||
126589698|NCT02140554|455459916|FG000|Overall Study|Death|0|||
126589699|NCT02140554|455459917|FG001|Overall Study|Death|0|||
126589700|NCT02140554|455459918|FG002|Overall Study|Death|1|||
126589701|NCT02140554|455459916|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
126589702|NCT02140554|455459917|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
126589703|NCT02140554|455459918|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
126589704|NCT05659537|455459919|FG000|Overall Study|Adverse Event|5|||
126589705|NCT05659537|455459919|FG000|Overall Study|Lost to Follow-up|4|||
126589706|NCT05659537|455459919|FG000|Overall Study|Withdrawal by Subject|13|||
126589707|NCT05659537|455459919|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
126589708|NCT05659537|455459919|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
126589709|NCT05659537|455459919|FG000|Overall Study|Participant was suffering from anaemia|1|||
126589710|NCT04728347|455459920|FG000|Overall Study|Sponsor decision|0|||
126589711|NCT04728347|455459921|FG001|Overall Study|Sponsor decision|0|||
126589712|NCT04728347|455459922|FG002|Overall Study|Sponsor decision|1|||
126589713|NCT04728347|455459923|FG003|Overall Study|Sponsor decision|0|||
126589714|NCT03953508|455459925|FG000|Baseline|Lost to Follow-up|3|||
126589715|NCT03953508|455459926|FG001|Baseline|Lost to Follow-up|2|||
126589716|NCT03953508|455459925|FG000|6-month Follow-up|Lost to Follow-up|62|||
126589717|NCT03953508|455459926|FG001|6-month Follow-up|Lost to Follow-up|70|||
126589718|NCT04856163|455459927|FG000|Overall Study|Lost to Follow-up|97|||
126589719|NCT04856163|455459928|FG001|Overall Study|Lost to Follow-up|100|||
126589720|NCT04526704|455459937|FG000|Overall Study|Adverse Event|1|||
126589721|NCT04526704|455459938|FG001|Overall Study|Adverse Event|0|||
126589722|NCT04526704|455459937|FG000|Overall Study|Physician Decision|1|||
126589723|NCT04526704|455459938|FG001|Overall Study|Physician Decision|0|||
126589724|NCT04526704|455459937|FG000|Overall Study|Withdrawal by Subject|2|||
126589725|NCT04526704|455459938|FG001|Overall Study|Withdrawal by Subject|0|||
126589726|NCT02105766|455459943|FG000|Overall Study|Physician Decision|1|||
126589727|NCT02105766|455459944|FG001|Overall Study|Physician Decision|1|||
126589728|NCT02105766|455459945|FG002|Overall Study|Physician Decision|0|||
126589729|NCT02105766|455459943|FG000|Overall Study|Lost to Follow-up|2|||
126589730|NCT02105766|455459944|FG001|Overall Study|Lost to Follow-up|0|||
126589731|NCT02105766|455459945|FG002|Overall Study|Lost to Follow-up|0|||
126589732|NCT02105766|455459943|FG000|Overall Study|Death|1|||
126589733|NCT02105766|455459944|FG001|Overall Study|Death|1|||
126589734|NCT02105766|455459945|FG002|Overall Study|Death|0|||
126589735|NCT03867500|455459946|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
126589736|NCT03897465|455459947|FG000|Overall Study|Lost to Follow-up|2|||
126589737|NCT03897465|455459948|FG001|Overall Study|Lost to Follow-up|1|||
126589738|NCT03897465|455459947|FG000|Overall Study|Adverse Event|2|||
126589739|NCT03897465|455459948|FG001|Overall Study|Adverse Event|0|||
126589740|NCT03897465|455459947|FG000|Overall Study|complete healing by V2|1|||
126589741|NCT03897465|455459948|FG001|Overall Study|complete healing by V2|0|||
126589742|NCT03897465|455459947|FG000|Overall Study|occurence of exclusion criterion|1|||
126589743|NCT03897465|455459948|FG001|Overall Study|occurence of exclusion criterion|1|||
126589744|NCT03897465|455459947|FG000|Overall Study|Other|1|||
126589745|NCT03897465|455459948|FG001|Overall Study|Other|0|||
126589746|NCT05119023|455459949|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
126589747|NCT05119023|455459949|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
126589748|NCT05119023|455459949|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
126589749|NCT06516705|455459964|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
126589750|NCT06516705|455459965|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
126589751|NCT06516705|455459964|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
126589752|NCT06516705|455459965|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
126589753|NCT06516705|455459964|FG000|T3 ( 3 Month After Education)|covid-19|1|||
126589754|NCT06516705|455459965|FG001|T3 ( 3 Month After Education)|covid-19|2|||
126589755|NCT06516705|455459964|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
126589756|NCT06516705|455459965|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
126589757|NCT06516705|455459964|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
126589758|NCT06516705|455459965|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
126589759|NCT06516705|455459964|FG000|T4 ( 6 Month After Education)|covid-19|3|||
126589760|NCT06516705|455459965|FG001|T4 ( 6 Month After Education)|covid-19|2|||
126589761|NCT06516705|455459964|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
126589762|NCT06516705|455459965|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
126589763|NCT04292223|455459966|FG000|Overall Study|Adverse Event|1|||
126589764|NCT04292223|455459966|FG000|Overall Study|Lost to Follow-up|1|||
126589765|NCT04292223|455459966|FG000|Overall Study|Noncompliance with study drug|2|||
126589766|NCT04292223|455459966|FG000|Overall Study|Patient moved out of the state|1|||
126589767|NCT04719390|455459967|FG000|Overall Study|Withdrawal by Subject|1|||
126589768|NCT00753545|455459968|FG000|Overall Study|Death|98|||
126589769|NCT00753545|455459969|FG001|Overall Study|Death|112|||
126589770|NCT00753545|455459968|FG000|Overall Study|Lost to Follow-up|2|||
126589771|NCT00753545|455459969|FG001|Overall Study|Lost to Follow-up|3|||
126589772|NCT00753545|455459968|FG000|Overall Study|Protocol Violation|1|||
126589773|NCT00753545|455459969|FG001|Overall Study|Protocol Violation|0|||
126589774|NCT00753545|455459968|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
126589775|NCT00753545|455459969|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
126589776|NCT06190691|455459970|FG000|Overall Study|Adverse Event|2|||
126589777|NCT06190691|455459971|FG001|Overall Study|Adverse Event|0|||
126589778|NCT06190691|455459972|FG002|Overall Study|Adverse Event|0|||
126589779|NCT06190691|455459973|FG003|Overall Study|Adverse Event|0|||
126589780|NCT05746455|455459974|FG000|Overall Study|Discharged from Clinical Service|1|||
126589781|NCT05746455|455459974|FG000|Overall Study|Lost to Follow-up|1|||
126589782|NCT02485938|455459976|FG000|Overall Study|Withdrawal of consent|2|||
126589783|NCT02485938|455459977|FG001|Overall Study|Withdrawal of consent|0|||
126589784|NCT03016754|455459978|FG000|Overall Study|Death|5|||
126589785|NCT03016754|455459979|FG001|Overall Study|Death|4|||
126589786|NCT03016754|455459980|FG002|Overall Study|Death|5|||
126589787|NCT03016754|455459981|FG003|Overall Study|Death|1|||
126589788|NCT03016754|455459978|FG000|Overall Study|Lost to Follow-up|23|||
126589789|NCT03016754|455459979|FG001|Overall Study|Lost to Follow-up|17|||
126589790|NCT03016754|455459980|FG002|Overall Study|Lost to Follow-up|4|||
126589791|NCT03016754|455459981|FG003|Overall Study|Lost to Follow-up|2|||
126589792|NCT03016754|455459978|FG000|Overall Study|Withdrawal by Subject|6|||
126589793|NCT03016754|455459979|FG001|Overall Study|Withdrawal by Subject|6|||
126589794|NCT03016754|455459980|FG002|Overall Study|Withdrawal by Subject|2|||
126589795|NCT03016754|455459981|FG003|Overall Study|Withdrawal by Subject|2|||
126589796|NCT03016754|455459978|FG000|Overall Study|Other/Unknown|2|||
126589797|NCT03016754|455459979|FG001|Overall Study|Other/Unknown|4|||
126589798|NCT03016754|455459980|FG002|Overall Study|Other/Unknown|2|||
126589799|NCT03016754|455459981|FG003|Overall Study|Other/Unknown|1|||
126589800|NCT03016754|455459978|FG000|Overall Study|Protocol Violation|0|||
126589801|NCT03016754|455459979|FG001|Overall Study|Protocol Violation|0|||
126589802|NCT03016754|455459980|FG002|Overall Study|Protocol Violation|0|||
126589803|NCT03016754|455459981|FG003|Overall Study|Protocol Violation|4|||
126589804|NCT03839940|455459982|FG000|Overall Study|Withdrawal by Subject|3|||
126589805|NCT03839940|455459983|FG001|Overall Study|Withdrawal by Subject|0|||
126589806|NCT03839940|455459982|FG000|Overall Study|Protocol Violation|0|||
126589807|NCT03839940|455459983|FG001|Overall Study|Protocol Violation|1|||
126589808|NCT03839940|455459982|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
126589809|NCT03839940|455459983|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
126589810|NCT03241745|455459984|FG000|Overall Study|Adverse Event|7|||
126589811|NCT03241745|455459984|FG000|Overall Study|Death|1|||
126589812|NCT03241745|455459984|FG000|Overall Study|Withdrawal by Subject|5|||
126589813|NCT03241745|455459984|FG000|Overall Study|Treatment delay >28 days|2|||
126589814|NCT03241745|455459984|FG000|Overall Study|Lack of Efficacy|14|||
126589815|NCT03023410|455459985|FG000|Overall Study|study termination|0|||
126589816|NCT03023410|455459986|FG001|Overall Study|study termination|1|||
126589817|NCT04799899|455459987|FG000|Overall Study|Lost to Follow-up|2|||
126589818|NCT04799899|455459988|FG001|Overall Study|Lost to Follow-up|4|||
126589819|NCT00470704|455459989|FG000|Overall Study|Withdrawal by Subject|4|||
126589820|NCT00470704|455459990|FG001|Overall Study|Withdrawal by Subject|3|||
126589821|NCT00470704|455459989|FG000|Overall Study|Relapse/Progression|37|||
126589822|NCT00470704|455459990|FG001|Overall Study|Relapse/Progression|42|||
126589823|NCT00470704|455459989|FG000|Overall Study|toxicity|0|||
126589824|NCT00470704|455459990|FG001|Overall Study|toxicity|1|||
126589825|NCT04019873|455459991|FG000|Overall Study|Discontinued from the treatment|1|||
126589826|NCT04019873|455459992|FG001|Overall Study|Discontinued from the treatment|39|||
126589827|NCT04019873|455459993|FG002|Overall Study|Discontinued from the treatment|2|||
126589828|NCT04927364|455460003|FG000|Overall Study|Withdrawal by Subject|3|||
126589829|NCT04927364|455460003|FG000|Overall Study|Unable to complete preassessment MRI|1|||
126589830|NCT04091750|455460006|FG000|Overall Study|Adverse Event|4|||
126589831|NCT04091750|455460006|FG000|Overall Study|Withdrawal by Subject|1|||
126589832|NCT02919306|455460007|FG000|Overall Study|Withdrawal by Subject|1|||
126589833|NCT02919306|455460008|FG001|Overall Study|Withdrawal by Subject|0|||
126589834|NCT02919306|455460007|FG000|Overall Study|Protocol Violation|1|||
126589835|NCT02919306|455460008|FG001|Overall Study|Protocol Violation|0|||
126589836|NCT04473222|455460009|FG000|Overall Study|Lost to Follow-up|13|||
126589837|NCT04473222|455460010|FG001|Overall Study|Lost to Follow-up|13|||
126589838|NCT04473222|455460009|FG000|Overall Study|Withdrawal by Subject|0|||
126777851|NCT04444752|456141441|FG003|Overall Study|Death|0|||
126589839|NCT04473222|455460010|FG001|Overall Study|Withdrawal by Subject|1|||
126589840|NCT04473222|455460009|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
126589841|NCT04473222|455460010|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
126589842|NCT04293055|455460011|FG000|Overall Study|Lost to Follow-up|1|||
126589843|NCT04293055|455460012|FG001|Overall Study|Lost to Follow-up|1|||
126589844|NCT04293055|455460011|FG000|Overall Study|Did not trigger randomization|6|||
126589845|NCT04293055|455460012|FG001|Overall Study|Did not trigger randomization|5|||
126589846|NCT03560609|455460013|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
126589847|NCT03560609|455460014|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
126589848|NCT04195698|455460023|FG000|Overall Study|Adverse Event|4|||
126589849|NCT04195698|455460024|FG001|Overall Study|Adverse Event|11|||
126589850|NCT04195698|455460023|FG000|Overall Study|Withdrawal by Subject|9|||
126589851|NCT04195698|455460024|FG001|Overall Study|Withdrawal by Subject|10|||
126589852|NCT04195698|455460023|FG000|Overall Study|Lost to Follow-up|5|||
126589853|NCT04195698|455460024|FG001|Overall Study|Lost to Follow-up|4|||
126589854|NCT04195698|455460023|FG000|Overall Study|Lack of Efficacy|2|||
126589855|NCT04195698|455460024|FG001|Overall Study|Lack of Efficacy|10|||
126589856|NCT04195698|455460023|FG000|Overall Study|Other|5|||
126589857|NCT04195698|455460024|FG001|Overall Study|Other|4|||
126589858|NCT01902173|455460025|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
126589859|NCT01902173|455460026|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
126589860|NCT01902173|455460027|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
126589861|NCT01902173|455460028|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
126589862|NCT01902173|455460029|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
126589863|NCT01902173|455460030|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
126589864|NCT01902173|455460025|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
126589865|NCT01902173|455460026|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
126589866|NCT01902173|455460027|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
126589867|NCT01902173|455460028|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
126589868|NCT01902173|455460029|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
126589869|NCT01902173|455460030|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
126589870|NCT01902173|455460025|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
126589871|NCT01902173|455460026|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
126589872|NCT01902173|455460027|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
126589873|NCT01902173|455460028|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
126589874|NCT01902173|455460029|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
126589875|NCT01902173|455460030|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
126589876|NCT01902173|455460025|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
126589877|NCT01902173|455460026|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
126589878|NCT01902173|455460027|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
126589879|NCT01902173|455460028|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
126589880|NCT01902173|455460029|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
126589881|NCT01902173|455460030|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
126589882|NCT01902173|455460025|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
126589883|NCT01902173|455460026|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
126589884|NCT01902173|455460027|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
126589885|NCT01902173|455460028|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
126589886|NCT01902173|455460029|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
126589887|NCT01902173|455460030|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
126589888|NCT01902173|455460025|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
126589889|NCT01902173|455460026|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
126589890|NCT01902173|455460027|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
126589891|NCT01902173|455460028|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
126777852|NCT00185211|456141442|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
126589892|NCT01902173|455460029|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
126777853|NCT00185211|456141443|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
126777854|NCT00185211|456141442|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
126589893|NCT01902173|455460030|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
126589894|NCT01902173|455460025|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
126589895|NCT01902173|455460026|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
126589896|NCT01902173|455460027|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
126589897|NCT01902173|455460028|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
126589898|NCT01902173|455460029|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
126589899|NCT01902173|455460030|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
126589900|NCT01902173|455460025|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
126589901|NCT01902173|455460026|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
126589902|NCT01902173|455460027|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
126589903|NCT01902173|455460028|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
126589904|NCT01902173|455460029|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
126589905|NCT01902173|455460030|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
126589906|NCT01902173|455460025|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
126589907|NCT01902173|455460026|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
126589908|NCT01902173|455460027|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
126589909|NCT01902173|455460028|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
126589910|NCT01902173|455460029|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
126589911|NCT01902173|455460030|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
126589912|NCT01902173|455460025|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
126589913|NCT01902173|455460026|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
126589914|NCT01902173|455460027|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
126589915|NCT01902173|455460028|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
126589916|NCT01902173|455460029|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
126589917|NCT01902173|455460030|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
126589918|NCT01902173|455460025|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
126589919|NCT01902173|455460026|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
126589920|NCT01902173|455460027|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
126589921|NCT01902173|455460028|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
126589922|NCT01902173|455460029|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
126589923|NCT01902173|455460030|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
126589924|NCT01902173|455460025|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
126589925|NCT01902173|455460026|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
126589926|NCT01902173|455460027|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
126589927|NCT01902173|455460028|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
126589928|NCT01902173|455460029|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
126589929|NCT01902173|455460030|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
126589930|NCT01902173|455460025|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
126589931|NCT01902173|455460026|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
126589932|NCT01902173|455460027|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
126589933|NCT01902173|455460028|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
126589934|NCT01902173|455460029|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
126589935|NCT01902173|455460030|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
126589936|NCT01902173|455460025|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
126589937|NCT01902173|455460026|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
126589938|NCT01902173|455460027|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
126589939|NCT01902173|455460028|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
126589940|NCT01902173|455460029|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
126589941|NCT01902173|455460030|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
126589942|NCT02262728|455460032|FG000|Follow-up Phase (3 Years)|Death|0|||
126589943|NCT02262728|455460033|FG001|Follow-up Phase (3 Years)|Death|1|||
126589944|NCT02262728|455460032|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
126589945|NCT02262728|455460033|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
126589946|NCT02262728|455460032|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
126589947|NCT02262728|455460033|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
126589948|NCT05540665|455460034|FG000|Overall Study|Study terminated by sponsor|6|||
126777855|NCT00185211|456141443|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
126589949|NCT05540665|455460035|FG001|Overall Study|Study terminated by sponsor|6|||
126589950|NCT05540665|455460036|FG002|Overall Study|Study terminated by sponsor|7|||
126589951|NCT02619838|455460037|FG000|Overall Study|Lost to Follow-up|9|||
126589952|NCT02619838|455460037|FG000|Overall Study|Withdrawal by Subject|15|||
126589953|NCT04066244|455460040|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
126589954|NCT04066244|455460041|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
126589955|NCT04066244|455460042|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
126589956|NCT04066244|455460043|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
126589957|NCT04066244|455460044|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
126589958|NCT04066244|455460045|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
126589959|NCT04066244|455460040|FG000|Part 2 (Cohort 5)|Death|0|||
126589960|NCT04066244|455460041|FG001|Part 2 (Cohort 5)|Death|0|||
126589961|NCT04066244|455460042|FG002|Part 2 (Cohort 5)|Death|0|||
126589962|NCT04066244|455460043|FG003|Part 2 (Cohort 5)|Death|0|||
126589963|NCT04066244|455460044|FG004|Part 2 (Cohort 5)|Death|0|||
126589964|NCT04066244|455460045|FG005|Part 2 (Cohort 5)|Death|2|||
126589965|NCT04066244|455460040|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
126589966|NCT04066244|455460041|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
126777856|NCT00185211|456141442|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
126589967|NCT04066244|455460042|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
126589968|NCT04066244|455460043|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
126589969|NCT04066244|455460044|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
126589970|NCT04066244|455460045|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
126589971|NCT04066244|455460040|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
126589972|NCT04066244|455460041|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
126589973|NCT04066244|455460042|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
126589974|NCT04066244|455460043|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
126589975|NCT04066244|455460044|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
126589976|NCT04066244|455460045|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
126589977|NCT01073566|455460046|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
126589978|NCT01073566|455460047|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
126589979|NCT04632992|455460049|FG000|Overall Study|Adverse Event|0|||
126589980|NCT04632992|455460050|FG001|Overall Study|Adverse Event|0|||
126589981|NCT04632992|455460051|FG002|Overall Study|Adverse Event|0|||
126589982|NCT04632992|455460052|FG003|Overall Study|Adverse Event|0|||
126589983|NCT04632992|455460053|FG004|Overall Study|Adverse Event|0|||
126589984|NCT04632992|455460054|FG005|Overall Study|Adverse Event|0|||
126589985|NCT04632992|455460055|FG006|Overall Study|Adverse Event|0|||
126589986|NCT04632992|455460056|FG007|Overall Study|Adverse Event|0|||
126589987|NCT04632992|455460057|FG008|Overall Study|Adverse Event|0|||
126589988|NCT04632992|455460058|FG009|Overall Study|Adverse Event|0|||
126589989|NCT04632992|455460059|FG010|Overall Study|Adverse Event|0|||
126589990|NCT04632992|455460060|FG011|Overall Study|Adverse Event|0|||
126589991|NCT04632992|455460061|FG012|Overall Study|Adverse Event|1|||
126589992|NCT04632992|455460062|FG013|Overall Study|Adverse Event|0|||
126589993|NCT04632992|455460049|FG000|Overall Study|Death|17|||
126589994|NCT04632992|455460050|FG001|Overall Study|Death|1|||
126589995|NCT04632992|455460051|FG002|Overall Study|Death|14|||
126589996|NCT04632992|455460052|FG003|Overall Study|Death|14|||
126589997|NCT04632992|455460053|FG004|Overall Study|Death|13|||
126589998|NCT04632992|455460054|FG005|Overall Study|Death|6|||
126589999|NCT04632992|455460055|FG006|Overall Study|Death|7|||
126590000|NCT04632992|455460056|FG007|Overall Study|Death|12|||
126590001|NCT04632992|455460057|FG008|Overall Study|Death|15|||
126590002|NCT04632992|455460058|FG009|Overall Study|Death|20|||
126590003|NCT04632992|455460059|FG010|Overall Study|Death|8|||
126590004|NCT04632992|455460060|FG011|Overall Study|Death|2|||
126590005|NCT04632992|455460061|FG012|Overall Study|Death|10|||
126590006|NCT04632992|455460062|FG013|Overall Study|Death|1|||
126590007|NCT04632992|455460049|FG000|Overall Study|Lost to Follow-up|1|||
126590008|NCT04632992|455460050|FG001|Overall Study|Lost to Follow-up|0|||
126590009|NCT04632992|455460051|FG002|Overall Study|Lost to Follow-up|1|||
126590010|NCT04632992|455460052|FG003|Overall Study|Lost to Follow-up|0|||
126590011|NCT04632992|455460053|FG004|Overall Study|Lost to Follow-up|2|||
126590012|NCT04632992|455460054|FG005|Overall Study|Lost to Follow-up|0|||
126590013|NCT04632992|455460055|FG006|Overall Study|Lost to Follow-up|1|||
126590014|NCT04632992|455460056|FG007|Overall Study|Lost to Follow-up|1|||
126590015|NCT04632992|455460057|FG008|Overall Study|Lost to Follow-up|1|||
126590016|NCT04632992|455460058|FG009|Overall Study|Lost to Follow-up|1|||
126590017|NCT04632992|455460059|FG010|Overall Study|Lost to Follow-up|2|||
126590018|NCT04632992|455460060|FG011|Overall Study|Lost to Follow-up|0|||
126590019|NCT04632992|455460061|FG012|Overall Study|Lost to Follow-up|0|||
126590020|NCT04632992|455460062|FG013|Overall Study|Lost to Follow-up|0|||
126590021|NCT04632992|455460049|FG000|Overall Study|Reason not Specified|2|||
126590022|NCT04632992|455460050|FG001|Overall Study|Reason not Specified|0|||
126590023|NCT04632992|455460051|FG002|Overall Study|Reason not Specified|1|||
126590024|NCT04632992|455460052|FG003|Overall Study|Reason not Specified|1|||
126590025|NCT04632992|455460053|FG004|Overall Study|Reason not Specified|0|||
126590026|NCT04632992|455460054|FG005|Overall Study|Reason not Specified|0|||
126590027|NCT04632992|455460055|FG006|Overall Study|Reason not Specified|0|||
126590028|NCT04632992|455460056|FG007|Overall Study|Reason not Specified|0|||
126590029|NCT04632992|455460057|FG008|Overall Study|Reason not Specified|0|||
126590030|NCT04632992|455460058|FG009|Overall Study|Reason not Specified|0|||
126590031|NCT04632992|455460059|FG010|Overall Study|Reason not Specified|1|||
126590032|NCT04632992|455460060|FG011|Overall Study|Reason not Specified|0|||
126590033|NCT04632992|455460061|FG012|Overall Study|Reason not Specified|0|||
126590034|NCT04632992|455460062|FG013|Overall Study|Reason not Specified|0|||
126590035|NCT04632992|455460049|FG000|Overall Study|Physician Decision|0|||
126590036|NCT04632992|455460050|FG001|Overall Study|Physician Decision|0|||
126590037|NCT04632992|455460051|FG002|Overall Study|Physician Decision|0|||
126590038|NCT04632992|455460052|FG003|Overall Study|Physician Decision|2|||
126590039|NCT04632992|455460053|FG004|Overall Study|Physician Decision|1|||
126590040|NCT04632992|455460054|FG005|Overall Study|Physician Decision|0|||
126590041|NCT04632992|455460055|FG006|Overall Study|Physician Decision|0|||
126590042|NCT04632992|455460056|FG007|Overall Study|Physician Decision|0|||
126590043|NCT04632992|455460057|FG008|Overall Study|Physician Decision|0|||
126590044|NCT04632992|455460058|FG009|Overall Study|Physician Decision|0|||
126590045|NCT04632992|455460059|FG010|Overall Study|Physician Decision|0|||
126590046|NCT04632992|455460060|FG011|Overall Study|Physician Decision|0|||
126590047|NCT04632992|455460061|FG012|Overall Study|Physician Decision|3|||
126590048|NCT04632992|455460062|FG013|Overall Study|Physician Decision|0|||
126590049|NCT04632992|455460049|FG000|Overall Study|Progressive Disease|0|||
126590050|NCT04632992|455460050|FG001|Overall Study|Progressive Disease|0|||
126590051|NCT04632992|455460051|FG002|Overall Study|Progressive Disease|0|||
126590052|NCT04632992|455460052|FG003|Overall Study|Progressive Disease|0|||
126590053|NCT04632992|455460053|FG004|Overall Study|Progressive Disease|1|||
126590054|NCT04632992|455460054|FG005|Overall Study|Progressive Disease|0|||
126590055|NCT04632992|455460055|FG006|Overall Study|Progressive Disease|0|||
126590056|NCT04632992|455460056|FG007|Overall Study|Progressive Disease|0|||
126590057|NCT04632992|455460057|FG008|Overall Study|Progressive Disease|0|||
126590058|NCT04632992|455460058|FG009|Overall Study|Progressive Disease|1|||
126590059|NCT04632992|455460059|FG010|Overall Study|Progressive Disease|1|||
126590060|NCT04632992|455460060|FG011|Overall Study|Progressive Disease|0|||
126590061|NCT04632992|455460061|FG012|Overall Study|Progressive Disease|2|||
126590062|NCT04632992|455460062|FG013|Overall Study|Progressive Disease|0|||
126590063|NCT04632992|455460049|FG000|Overall Study|Withdrawal by Subject|4|||
126590064|NCT04632992|455460050|FG001|Overall Study|Withdrawal by Subject|1|||
126590065|NCT04632992|455460051|FG002|Overall Study|Withdrawal by Subject|5|||
126590066|NCT04632992|455460052|FG003|Overall Study|Withdrawal by Subject|4|||
126590067|NCT04632992|455460053|FG004|Overall Study|Withdrawal by Subject|3|||
126590068|NCT04632992|455460054|FG005|Overall Study|Withdrawal by Subject|3|||
126590069|NCT04632992|455460055|FG006|Overall Study|Withdrawal by Subject|0|||
126590070|NCT04632992|455460056|FG007|Overall Study|Withdrawal by Subject|5|||
126590071|NCT04632992|455460057|FG008|Overall Study|Withdrawal by Subject|0|||
126590072|NCT04632992|455460058|FG009|Overall Study|Withdrawal by Subject|2|||
126590073|NCT04632992|455460059|FG010|Overall Study|Withdrawal by Subject|8|||
126590074|NCT04632992|455460060|FG011|Overall Study|Withdrawal by Subject|0|||
126590075|NCT04632992|455460061|FG012|Overall Study|Withdrawal by Subject|1|||
126590076|NCT04632992|455460062|FG013|Overall Study|Withdrawal by Subject|1|||
126590077|NCT05257486|455460064|FG000|Overall Study|Protocol Violation|3|||
126590078|NCT04542317|455460065|FG000|Overall Study|Care recipients passed away|18|||
126590079|NCT04542317|455460066|FG001|Overall Study|Care recipients passed away|13|||
126590080|NCT04542317|455460065|FG000|Overall Study|No longer a primary caregiver|5|||
126590081|NCT04542317|455460066|FG001|Overall Study|No longer a primary caregiver|1|||
126590082|NCT04542317|455460065|FG000|Overall Study|Withdrawal by Subject|4|||
126590083|NCT04542317|455460066|FG001|Overall Study|Withdrawal by Subject|2|||
126590084|NCT04542317|455460065|FG000|Overall Study|Caregivers passed away|0|||
126590085|NCT04542317|455460066|FG001|Overall Study|Caregivers passed away|2|||
126590086|NCT04700163|455460067|FG000|Overall Study|Lost to Follow-up|0|||
126590087|NCT04700163|455460068|FG001|Overall Study|Lost to Follow-up|0|||
126590088|NCT04700163|455460069|FG002|Overall Study|Lost to Follow-up|0|||
126590089|NCT04700163|455460070|FG003|Overall Study|Lost to Follow-up|0|||
126590090|NCT04700163|455460071|FG004|Overall Study|Lost to Follow-up|0|||
126590091|NCT04700163|455460072|FG005|Overall Study|Lost to Follow-up|1|||
126590092|NCT03865498|455460075|FG000|Overall Study|Lack of Efficacy|12|||
126590093|NCT03865498|455460076|FG001|Overall Study|Lack of Efficacy|11|||
126590094|NCT03865498|455460075|FG000|Overall Study|Lost to Follow-up|125|||
126590095|NCT03865498|455460076|FG001|Overall Study|Lost to Follow-up|133|||
126590096|NCT03865498|455460075|FG000|Overall Study|Withdrawal by Subject|2|||
126590097|NCT03865498|455460076|FG001|Overall Study|Withdrawal by Subject|4|||
126590098|NCT05126433|455460083|FG000|Overall Study|Withdrawal by Subject|3|||
126590099|NCT05126433|455460084|FG001|Overall Study|Withdrawal by Subject|0|||
126590100|NCT05126433|455460085|FG002|Overall Study|Withdrawal by Subject|4|||
126590101|NCT05126433|455460083|FG000|Overall Study|Death|9|||
126590102|NCT05126433|455460084|FG001|Overall Study|Death|3|||
126590103|NCT05126433|455460085|FG002|Overall Study|Death|5|||
126590104|NCT05126433|455460083|FG000|Overall Study|Study Terminated by sponsor|0|||
126590105|NCT05126433|455460084|FG001|Overall Study|Study Terminated by sponsor|1|||
126590106|NCT05126433|455460085|FG002|Overall Study|Study Terminated by sponsor|2|||
126590107|NCT05126433|455460083|FG000|Overall Study|Progressive Disease|1|||
126590108|NCT05126433|455460084|FG001|Overall Study|Progressive Disease|4|||
126590109|NCT05126433|455460085|FG002|Overall Study|Progressive Disease|3|||
126590110|NCT05126433|455460083|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
126590111|NCT05126433|455460084|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
126590112|NCT05126433|455460085|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
126590113|NCT03270501|455460086|FG000|Overall Study|Screen failure|6|||
126590114|NCT03270501|455460086|FG000|Overall Study|Lost to Follow-up|2|||
126590115|NCT03270501|455460086|FG000|Overall Study|Adverse Event|1|||
126590116|NCT04137289|455460087|FG000|Overall Study|Death|0|||
126590117|NCT04137289|455460088|FG001|Overall Study|Death|0|||
126590118|NCT04137289|455460089|FG002|Overall Study|Death|0|||
126590119|NCT04137289|455460090|FG003|Overall Study|Death|0|||
126590120|NCT04137289|455460091|FG004|Overall Study|Death|0|||
126590121|NCT04137289|455460092|FG005|Overall Study|Death|0|||
126590122|NCT04137289|455460093|FG006|Overall Study|Death|1|||
126590123|NCT04137289|455460094|FG007|Overall Study|Death|0|||
126590124|NCT04137289|455460095|FG008|Overall Study|Death|0|||
126640546|NCT05143138|455642802|FG001|Overall Study|withdrawal|1|||
126590125|NCT04137289|455460087|FG000|Overall Study|Clinical disease progression|0|||
126590126|NCT04137289|455460088|FG001|Overall Study|Clinical disease progression|0|||
126590127|NCT04137289|455460089|FG002|Overall Study|Clinical disease progression|0|||
126590128|NCT04137289|455460090|FG003|Overall Study|Clinical disease progression|4|||
126590129|NCT04137289|455460091|FG004|Overall Study|Clinical disease progression|4|||
126590130|NCT04137289|455460092|FG005|Overall Study|Clinical disease progression|2|||
126590131|NCT04137289|455460093|FG006|Overall Study|Clinical disease progression|5|||
126590132|NCT04137289|455460094|FG007|Overall Study|Clinical disease progression|1|||
126590133|NCT04137289|455460095|FG008|Overall Study|Clinical disease progression|0|||
126590134|NCT04137289|455460087|FG000|Overall Study|Lost to Follow-up|0|||
126590135|NCT04137289|455460088|FG001|Overall Study|Lost to Follow-up|0|||
126590136|NCT04137289|455460089|FG002|Overall Study|Lost to Follow-up|0|||
126590137|NCT04137289|455460090|FG003|Overall Study|Lost to Follow-up|1|||
126590138|NCT04137289|455460091|FG004|Overall Study|Lost to Follow-up|0|||
126590139|NCT04137289|455460092|FG005|Overall Study|Lost to Follow-up|0|||
126590140|NCT04137289|455460093|FG006|Overall Study|Lost to Follow-up|0|||
126590141|NCT04137289|455460094|FG007|Overall Study|Lost to Follow-up|0|||
126590142|NCT04137289|455460095|FG008|Overall Study|Lost to Follow-up|0|||
126590143|NCT04137289|455460087|FG000|Overall Study|Adverse Event|0|||
126590144|NCT04137289|455460088|FG001|Overall Study|Adverse Event|0|||
126590145|NCT04137289|455460089|FG002|Overall Study|Adverse Event|1|||
126590146|NCT04137289|455460090|FG003|Overall Study|Adverse Event|0|||
126590147|NCT04137289|455460091|FG004|Overall Study|Adverse Event|0|||
126590148|NCT04137289|455460092|FG005|Overall Study|Adverse Event|1|||
126590149|NCT04137289|455460093|FG006|Overall Study|Adverse Event|0|||
126590150|NCT04137289|455460094|FG007|Overall Study|Adverse Event|0|||
126590151|NCT04137289|455460095|FG008|Overall Study|Adverse Event|0|||
126590152|NCT04137289|455460087|FG000|Overall Study|Lack of clinical benefit|0|||
126590153|NCT04137289|455460088|FG001|Overall Study|Lack of clinical benefit|0|||
126590154|NCT04137289|455460089|FG002|Overall Study|Lack of clinical benefit|0|||
126590155|NCT04137289|455460090|FG003|Overall Study|Lack of clinical benefit|0|||
126590156|NCT04137289|455460091|FG004|Overall Study|Lack of clinical benefit|0|||
126590157|NCT04137289|455460092|FG005|Overall Study|Lack of clinical benefit|0|||
126590158|NCT04137289|455460093|FG006|Overall Study|Lack of clinical benefit|0|||
126590159|NCT04137289|455460094|FG007|Overall Study|Lack of clinical benefit|0|||
126590160|NCT04137289|455460095|FG008|Overall Study|Lack of clinical benefit|1|||
126590161|NCT04137289|455460087|FG000|Overall Study|Objective disease progression|1|||
126590162|NCT04137289|455460088|FG001|Overall Study|Objective disease progression|1|||
126590163|NCT04137289|455460089|FG002|Overall Study|Objective disease progression|6|||
126590164|NCT04137289|455460090|FG003|Overall Study|Objective disease progression|18|||
126590165|NCT04137289|455460091|FG004|Overall Study|Objective disease progression|12|||
126590166|NCT04137289|455460092|FG005|Overall Study|Objective disease progression|20|||
126590167|NCT04137289|455460093|FG006|Overall Study|Objective disease progression|18|||
126590168|NCT04137289|455460094|FG007|Overall Study|Objective disease progression|7|||
126590169|NCT04137289|455460095|FG008|Overall Study|Objective disease progression|6|||
126640547|NCT05143138|455642803|FG002|Overall Study|withdrawal|0|||
126640548|NCT03443414|455642806|FG000|Overall Study|Adverse Event|6|||
126640549|NCT03443414|455642807|FG001|Overall Study|Adverse Event|0|||
126640550|NCT03443414|455642808|FG002|Overall Study|Adverse Event|4|||
126640551|NCT03443414|455642809|FG003|Overall Study|Adverse Event|2|||
126640552|NCT03443414|455642810|FG004|Overall Study|Adverse Event|3|||
126640553|NCT03443414|455642806|FG000|Overall Study|Withdrawal by Subject|3|||
126640554|NCT03443414|455642807|FG001|Overall Study|Withdrawal by Subject|2|||
126640555|NCT03443414|455642808|FG002|Overall Study|Withdrawal by Subject|2|||
126640556|NCT03443414|455642809|FG003|Overall Study|Withdrawal by Subject|2|||
126640557|NCT03443414|455642810|FG004|Overall Study|Withdrawal by Subject|1|||
126640558|NCT03443414|455642806|FG000|Overall Study|Death|0|||
126640559|NCT03443414|455642807|FG001|Overall Study|Death|1|||
126640560|NCT03443414|455642808|FG002|Overall Study|Death|0|||
126640561|NCT03443414|455642809|FG003|Overall Study|Death|1|||
126640562|NCT03443414|455642810|FG004|Overall Study|Death|0|||
126640563|NCT03443414|455642806|FG000|Overall Study|Reason not specified|2|||
126640564|NCT03443414|455642807|FG001|Overall Study|Reason not specified|0|||
126640565|NCT03443414|455642808|FG002|Overall Study|Reason not specified|0|||
126640566|NCT03443414|455642809|FG003|Overall Study|Reason not specified|0|||
126640567|NCT03443414|455642810|FG004|Overall Study|Reason not specified|1|||
126640568|NCT00732992|455642811|FG000|Overall Study|Adverse Event|1|||
126731685|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
126731686|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
126731687|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
126731688|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
126731689|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
126640569|NCT00732992|455642812|FG001|Overall Study|Adverse Event|1|||
126640570|NCT00732992|455642811|FG000|Overall Study|Objective Progression or Relapse|3|||
126640571|NCT00732992|455642812|FG001|Overall Study|Objective Progression or Relapse|5|||
126590170|NCT03812679|455461937|FG000|Overall Study|Adverse Event|2|||
126590171|NCT03812679|455461937|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
126590172|NCT03812679|455461937|FG000|Overall Study|Renal transplant|1|||
126590173|NCT03812679|455461937|FG000|Overall Study|Withdrawal by Subject|1|||
126590174|NCT03812679|455461937|FG000|Overall Study|Termination of study|2|||
126590175|NCT03812679|455461937|FG000|Overall Study|Water device replacement|1|||
126590176|NCT05486078|455461938|FG000|Overall Study|4 drop out and one withdrawn|5|||
126590177|NCT05590403|455461939|FG000|Overall Study|Lost to Follow-up|13|||
126590178|NCT05590403|455461940|FG001|Overall Study|Lost to Follow-up|1|||
126590179|NCT05590403|455461941|FG002|Overall Study|Lost to Follow-up|7|||
126590180|NCT05590403|455461942|FG003|Overall Study|Lost to Follow-up|3|||
126590181|NCT05590403|455461943|FG004|Overall Study|Lost to Follow-up|4|||
126590182|NCT05590403|455461939|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
126590183|NCT05590403|455461940|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
126590184|NCT05590403|455461941|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
126590185|NCT05590403|455461942|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
126590186|NCT05590403|455461943|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
126590187|NCT05590403|455461939|FG000|Overall Study|Other|2|||
126590188|NCT05590403|455461940|FG001|Overall Study|Other|0|||
126590189|NCT05590403|455461941|FG002|Overall Study|Other|2|||
126590190|NCT05590403|455461942|FG003|Overall Study|Other|2|||
126590191|NCT05590403|455461943|FG004|Overall Study|Other|0|||
126590192|NCT05590403|455461939|FG000|Overall Study|Migrated / moved from the study area|1|||
126590193|NCT05590403|455461940|FG001|Overall Study|Migrated / moved from the study area|1|||
126590194|NCT05590403|455461941|FG002|Overall Study|Migrated / moved from the study area|0|||
126590195|NCT05590403|455461942|FG003|Overall Study|Migrated / moved from the study area|3|||
126590196|NCT05590403|455461943|FG004|Overall Study|Migrated / moved from the study area|1|||
126590197|NCT05590403|455461939|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
126590198|NCT05590403|455461940|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
126590199|NCT05590403|455461941|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
126590200|NCT05590403|455461942|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
126590201|NCT05590403|455461943|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
126590202|NCT03766009|455461944|FG000|Usual Care|Death|0|||
126590203|NCT03766009|455461945|FG001|Usual Care|Death|0|||
126590204|NCT03766009|455461946|FG002|Usual Care|Death|0|||
126590205|NCT03766009|455461947|FG003|Usual Care|Death|1|||
126590206|NCT03766009|455461948|FG004|Usual Care|Death|0|||
126590207|NCT03766009|455461949|FG005|Usual Care|Death|0|||
126590208|NCT03766009|455461944|FG000|Usual Care|Lost to Follow-up|0|||
126590209|NCT03766009|455461945|FG001|Usual Care|Lost to Follow-up|0|||
126590210|NCT03766009|455461946|FG002|Usual Care|Lost to Follow-up|0|||
126590211|NCT03766009|455461947|FG003|Usual Care|Lost to Follow-up|1|||
126590212|NCT03766009|455461948|FG004|Usual Care|Lost to Follow-up|0|||
126590213|NCT03766009|455461949|FG005|Usual Care|Lost to Follow-up|0|||
126590214|NCT03766009|455461944|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
126590215|NCT03766009|455461945|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
126590216|NCT03766009|455461946|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
126590217|NCT03766009|455461947|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
126590218|NCT03766009|455461948|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
126590219|NCT03766009|455461949|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
126590220|NCT03766009|455461944|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
126590221|NCT03766009|455461945|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
126590222|NCT03766009|455461946|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
126590223|NCT03766009|455461947|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
126590224|NCT03766009|455461948|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
126590225|NCT03766009|455461949|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
126590226|NCT03766009|455461944|FG000|Usual Care|No treatment or declined surgery|0|||
126590227|NCT03766009|455461945|FG001|Usual Care|No treatment or declined surgery|0|||
126590228|NCT03766009|455461946|FG002|Usual Care|No treatment or declined surgery|0|||
126590229|NCT03766009|455461947|FG003|Usual Care|No treatment or declined surgery|2|||
126590230|NCT03766009|455461948|FG004|Usual Care|No treatment or declined surgery|0|||
126590231|NCT03766009|455461949|FG005|Usual Care|No treatment or declined surgery|0|||
126590232|NCT03766009|455461944|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
126590233|NCT03766009|455461945|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
126590234|NCT03766009|455461946|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
126590235|NCT03766009|455461947|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
126590236|NCT03766009|455461948|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
126590237|NCT03766009|455461949|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
126590238|NCT03766009|455461944|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
126590239|NCT03766009|455461945|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
126590240|NCT03766009|455461946|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
126590241|NCT03766009|455461947|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
126590242|NCT03766009|455461948|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
126590243|NCT03766009|455461949|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
126590244|NCT03766009|455461944|FG000|Usual Care|Ineligible|0|||
126590245|NCT03766009|455461945|FG001|Usual Care|Ineligible|1|||
126590246|NCT03766009|455461946|FG002|Usual Care|Ineligible|0|||
126590247|NCT03766009|455461947|FG003|Usual Care|Ineligible|0|||
126590248|NCT03766009|455461948|FG004|Usual Care|Ineligible|0|||
126590249|NCT03766009|455461949|FG005|Usual Care|Ineligible|0|||
126590250|NCT03766009|455461944|FG000|Usual Care|Other: Staff turnover|0|||
126590251|NCT03766009|455461945|FG001|Usual Care|Other: Staff turnover|0|||
126590252|NCT03766009|455461946|FG002|Usual Care|Other: Staff turnover|0|||
126590253|NCT03766009|455461947|FG003|Usual Care|Other: Staff turnover|0|||
126590254|NCT03766009|455461948|FG004|Usual Care|Other: Staff turnover|0|||
126590255|NCT03766009|455461949|FG005|Usual Care|Other: Staff turnover|2|||
126590256|NCT04552223|455461950|FG000|Overall Study|Withdrawal by Subject|1|||
126590257|NCT02737436|455461951|FG000|Washout Period|Lost to Follow-up|5|||
126590258|NCT02737436|455461952|FG001|Washout Period|Lost to Follow-up|11|||
126590259|NCT02737436|455461951|FG000|Data Analysis|Scanning data problems|5|||
126590260|NCT02737436|455461952|FG001|Data Analysis|Scanning data problems|8|||
126590261|NCT03701399|455461953|FG000|Overall Study|Adverse Event|3|||
126590262|NCT03701399|455461954|FG001|Overall Study|Adverse Event|5|||
126590263|NCT03701399|455461953|FG000|Overall Study|Withdrawal by Subject|6|||
126590264|NCT03701399|455461954|FG001|Overall Study|Withdrawal by Subject|3|||
126590265|NCT03701399|455461953|FG000|Overall Study|Investigators decision|1|||
126590266|NCT03701399|455461954|FG001|Overall Study|Investigators decision|2|||
126590267|NCT03701399|455461953|FG000|Overall Study|Lost to Follow-up|1|||
126590268|NCT03701399|455461954|FG001|Overall Study|Lost to Follow-up|2|||
126590269|NCT03701399|455461953|FG000|Overall Study|Death|1|||
126590270|NCT03701399|455461954|FG001|Overall Study|Death|1|||
126590271|NCT03701399|455461953|FG000|Overall Study|Randomized but not treated|1|||
126590272|NCT03701399|455461954|FG001|Overall Study|Randomized but not treated|0|||
126590273|NCT00554788|455461955|FG000|Overall Study|Adverse Event|0|||
126590274|NCT00554788|455461956|FG001|Overall Study|Adverse Event|1|||
126590275|NCT00554788|455461957|FG002|Overall Study|Adverse Event|2|||
126590276|NCT00554788|455461955|FG000|Overall Study|Lost to Follow-up|4|||
126590277|NCT00554788|455461956|FG001|Overall Study|Lost to Follow-up|3|||
126590278|NCT00554788|455461957|FG002|Overall Study|Lost to Follow-up|3|||
126590279|NCT00554788|455461955|FG000|Overall Study|Physician Decision|1|||
126590280|NCT00554788|455461956|FG001|Overall Study|Physician Decision|1|||
126590281|NCT00554788|455461957|FG002|Overall Study|Physician Decision|3|||
126590282|NCT00554788|455461955|FG000|Overall Study|Withdrawal by Subject|0|||
126590283|NCT00554788|455461956|FG001|Overall Study|Withdrawal by Subject|0|||
126590284|NCT00554788|455461957|FG002|Overall Study|Withdrawal by Subject|1|||
126590285|NCT00554788|455461955|FG000|Overall Study|Refusal of further protocol therapy|0|||
126590286|NCT00554788|455461956|FG001|Overall Study|Refusal of further protocol therapy|1|||
126590287|NCT00554788|455461957|FG002|Overall Study|Refusal of further protocol therapy|1|||
126590288|NCT00554788|455461955|FG000|Overall Study|Progressive disease|0|||
126590289|NCT00554788|455461956|FG001|Overall Study|Progressive disease|0|||
126590290|NCT00554788|455461957|FG002|Overall Study|Progressive disease|3|||
126590291|NCT00554788|455461955|FG000|Overall Study|Ineligible|2|||
126590292|NCT00554788|455461956|FG001|Overall Study|Ineligible|0|||
126590293|NCT00554788|455461957|FG002|Overall Study|Ineligible|1|||
126590294|NCT03134196|455461971|FG000|Overall Study|Death|2|||
126590295|NCT03134196|455461972|FG001|Overall Study|Death|1|||
126590296|NCT03134196|455461971|FG000|Overall Study|Lost to Follow-up|13|||
126590297|NCT03134196|455461972|FG001|Overall Study|Lost to Follow-up|15|||
126590298|NCT03134196|455461971|FG000|Overall Study|Physician Decision|0|||
126590299|NCT03134196|455461972|FG001|Overall Study|Physician Decision|1|||
126590300|NCT03134196|455461971|FG000|Overall Study|Withdrawal by Subject|19|||
126590301|NCT03134196|455461972|FG001|Overall Study|Withdrawal by Subject|12|||
126590302|NCT03134196|455461971|FG000|Overall Study|Site Unable to Contact Participant|2|||
126590303|NCT03134196|455461972|FG001|Overall Study|Site Unable to Contact Participant|0|||
126590304|NCT03134196|455461971|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
126590305|NCT03134196|455461972|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
126590306|NCT03134196|455461971|FG000|Overall Study|Scheduling Conflict|1|||
126590307|NCT03134196|455461972|FG001|Overall Study|Scheduling Conflict|0|||
126590308|NCT04295798|455461977|FG000|Overall Study|Lost to Follow-up|1|||
126590309|NCT04650269|455461983|FG000|Overall Study|Death|3|||
126590310|NCT04650269|455461983|FG000|Overall Study|Lost to Follow-up|6|||
126590311|NCT01437709|455461984|FG000|Overall Study|Adverse Event|0|||
126590312|NCT01437709|455461985|FG001|Overall Study|Adverse Event|1|||
126590313|NCT01437709|455461986|FG002|Overall Study|Adverse Event|0|||
126590314|NCT01437709|455461984|FG000|Overall Study|Pt trasnferred care|0|||
126590315|NCT01437709|455461985|FG001|Overall Study|Pt trasnferred care|1|||
126590316|NCT01437709|455461986|FG002|Overall Study|Pt trasnferred care|0|||
126590317|NCT05459688|455461987|FG000|Overall Study|Lost to Follow-up|6|||
126590318|NCT05459688|455461987|FG000|Overall Study|Physician Decision|1|||
126590319|NCT05459688|455461987|FG000|Overall Study|Withdrawal by Subject|19|||
126590320|NCT05459688|455461987|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
126590321|NCT04908722|455461988|FG000|Overall Study|Protocol deviation|1|||
126590322|NCT04908722|455461989|FG001|Overall Study|Protocol deviation|0|||
126590323|NCT04908722|455461990|FG002|Overall Study|Protocol deviation|0|||
126590324|NCT04908722|455461991|FG003|Overall Study|Protocol deviation|0|||
126590325|NCT04908722|455461992|FG004|Overall Study|Protocol deviation|0|||
126590326|NCT04908722|455461993|FG005|Overall Study|Protocol deviation|1|||
126590327|NCT04908722|455461988|FG000|Overall Study|Lost to Follow-up|33|||
126590328|NCT04908722|455461989|FG001|Overall Study|Lost to Follow-up|33|||
126590329|NCT04908722|455461990|FG002|Overall Study|Lost to Follow-up|36|||
126590330|NCT04908722|455461991|FG003|Overall Study|Lost to Follow-up|30|||
126590331|NCT04908722|455461992|FG004|Overall Study|Lost to Follow-up|32|||
126590332|NCT04908722|455461993|FG005|Overall Study|Lost to Follow-up|34|||
126590333|NCT04908722|455461988|FG000|Overall Study|Physician Decision|1|||
126590334|NCT04908722|455461989|FG001|Overall Study|Physician Decision|1|||
126590335|NCT04908722|455461990|FG002|Overall Study|Physician Decision|1|||
126590336|NCT04908722|455461991|FG003|Overall Study|Physician Decision|2|||
126590337|NCT04908722|455461992|FG004|Overall Study|Physician Decision|0|||
126590338|NCT04908722|455461993|FG005|Overall Study|Physician Decision|0|||
126590339|NCT04908722|455461988|FG000|Overall Study|Death|1|||
126590340|NCT04908722|455461989|FG001|Overall Study|Death|0|||
126590341|NCT04908722|455461990|FG002|Overall Study|Death|0|||
126590342|NCT04908722|455461991|FG003|Overall Study|Death|0|||
126590343|NCT04908722|455461992|FG004|Overall Study|Death|0|||
126590344|NCT04908722|455461993|FG005|Overall Study|Death|1|||
126590345|NCT04908722|455461988|FG000|Overall Study|Withdrawal by Subject|12|||
126590346|NCT04908722|455461989|FG001|Overall Study|Withdrawal by Subject|8|||
126590347|NCT04908722|455461990|FG002|Overall Study|Withdrawal by Subject|7|||
126590348|NCT04908722|455461991|FG003|Overall Study|Withdrawal by Subject|6|||
126590349|NCT04908722|455461992|FG004|Overall Study|Withdrawal by Subject|12|||
126590350|NCT04908722|455461993|FG005|Overall Study|Withdrawal by Subject|14|||
126590351|NCT04908722|455461988|FG000|Overall Study|Other|3|||
126590352|NCT04908722|455461989|FG001|Overall Study|Other|1|||
126590353|NCT04908722|455461990|FG002|Overall Study|Other|3|||
126590354|NCT04908722|455461991|FG003|Overall Study|Other|2|||
126590355|NCT04908722|455461992|FG004|Overall Study|Other|4|||
126590356|NCT04908722|455461993|FG005|Overall Study|Other|1|||
126590357|NCT04908722|455461988|FG000|Overall Study|Initiated prohibited medication|0|||
126590358|NCT04908722|455461989|FG001|Overall Study|Initiated prohibited medication|0|||
126590359|NCT04908722|455461990|FG002|Overall Study|Initiated prohibited medication|0|||
126590360|NCT04908722|455461991|FG003|Overall Study|Initiated prohibited medication|1|||
126590361|NCT04908722|455461992|FG004|Overall Study|Initiated prohibited medication|0|||
126590362|NCT04908722|455461993|FG005|Overall Study|Initiated prohibited medication|1|||
126590363|NCT04908722|455461988|FG000|Overall Study|Randomized but not vaccinated|3|||
126590364|NCT04908722|455461989|FG001|Overall Study|Randomized but not vaccinated|1|||
126590365|NCT04908722|455461990|FG002|Overall Study|Randomized but not vaccinated|2|||
126590366|NCT04908722|455461991|FG003|Overall Study|Randomized but not vaccinated|2|||
126590367|NCT04908722|455461992|FG004|Overall Study|Randomized but not vaccinated|3|||
126590368|NCT04908722|455461993|FG005|Overall Study|Randomized but not vaccinated|4|||
126590369|NCT02319759|455461994|FG000|Week 0 - 16|Lack of Efficacy|1|||
126590370|NCT02319759|455461995|FG001|Week 0 - 16|Lack of Efficacy|0|||
126590371|NCT02319759|455461996|FG002|Week 0 - 16|Lack of Efficacy|0|||
126590372|NCT02319759|455461997|FG003|Week 0 - 16|Lack of Efficacy|0|||
126590373|NCT02319759|455461998|FG004|Week 0 - 16|Lack of Efficacy|0|||
126590374|NCT02319759|455461994|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
126590375|NCT02319759|455461995|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
126590376|NCT02319759|455461996|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
126590377|NCT02319759|455461997|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
126590378|NCT02319759|455461998|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
126590379|NCT02319759|455461994|FG000|Week 16 - 24|Lack of Efficacy|1|||
126590380|NCT02319759|455461995|FG001|Week 16 - 24|Lack of Efficacy|0|||
126590381|NCT02319759|455461996|FG002|Week 16 - 24|Lack of Efficacy|1|||
126590382|NCT02319759|455461997|FG003|Week 16 - 24|Lack of Efficacy|0|||
126590383|NCT02319759|455461998|FG004|Week 16 - 24|Lack of Efficacy|0|||
126590384|NCT02319759|455461994|FG000|Week 16 - 24|Lost to Follow-up|1|||
126590385|NCT02319759|455461995|FG001|Week 16 - 24|Lost to Follow-up|0|||
126590386|NCT02319759|455461996|FG002|Week 16 - 24|Lost to Follow-up|0|||
126590387|NCT02319759|455461997|FG003|Week 16 - 24|Lost to Follow-up|0|||
126590388|NCT02319759|455461998|FG004|Week 16 - 24|Lost to Follow-up|0|||
126590389|NCT02319759|455461994|FG000|Week 16 - 24|Withdrawal by Subject|0|||
126590390|NCT02319759|455461995|FG001|Week 16 - 24|Withdrawal by Subject|0|||
126590391|NCT02319759|455461996|FG002|Week 16 - 24|Withdrawal by Subject|2|||
126590392|NCT02319759|455461997|FG003|Week 16 - 24|Withdrawal by Subject|0|||
126590393|NCT02319759|455461998|FG004|Week 16 - 24|Withdrawal by Subject|0|||
126590394|NCT02319759|455461994|FG000|Week 24 - 56|Adverse Event|0|||
126590395|NCT02319759|455461995|FG001|Week 24 - 56|Adverse Event|0|||
126590396|NCT02319759|455461996|FG002|Week 24 - 56|Adverse Event|2|||
126590397|NCT02319759|455461997|FG003|Week 24 - 56|Adverse Event|0|||
126590398|NCT02319759|455461998|FG004|Week 24 - 56|Adverse Event|0|||
126590399|NCT02319759|455461994|FG000|Week 24 - 56|Lack of Efficacy|0|||
126590400|NCT02319759|455461995|FG001|Week 24 - 56|Lack of Efficacy|0|||
126590401|NCT02319759|455461996|FG002|Week 24 - 56|Lack of Efficacy|0|||
126590402|NCT02319759|455461997|FG003|Week 24 - 56|Lack of Efficacy|2|||
126590403|NCT02319759|455461998|FG004|Week 24 - 56|Lack of Efficacy|1|||
126590404|NCT02319759|455461994|FG000|Week 24 - 56|Withdrawal by Subject|0|||
126590405|NCT02319759|455461995|FG001|Week 24 - 56|Withdrawal by Subject|1|||
126590406|NCT02319759|455461996|FG002|Week 24 - 56|Withdrawal by Subject|0|||
126590407|NCT02319759|455461997|FG003|Week 24 - 56|Withdrawal by Subject|0|||
126590408|NCT02319759|455461998|FG004|Week 24 - 56|Withdrawal by Subject|0|||
126590409|NCT02319759|455461994|FG000|Week 24 - 56|Lost to Follow-up|0|||
126590410|NCT02319759|455461995|FG001|Week 24 - 56|Lost to Follow-up|0|||
126590411|NCT02319759|455461996|FG002|Week 24 - 56|Lost to Follow-up|0|||
126590412|NCT02319759|455461997|FG003|Week 24 - 56|Lost to Follow-up|0|||
126590413|NCT02319759|455461998|FG004|Week 24 - 56|Lost to Follow-up|1|||
126590414|NCT06424236|455462001|FG000|Overall Study|Adverse Event|0|||
126590415|NCT06424236|455462002|FG001|Overall Study|Adverse Event|1|||
126590416|NCT06424236|455462003|FG002|Overall Study|Adverse Event|0|||
126590417|NCT06424236|455462001|FG000|Overall Study|Withdrawal by Subject|3|||
126590418|NCT06424236|455462002|FG001|Overall Study|Withdrawal by Subject|1|||
126590419|NCT06424236|455462003|FG002|Overall Study|Withdrawal by Subject|2|||
126590420|NCT06424236|455462001|FG000|Overall Study|Physician Decision|0|||
126590421|NCT06424236|455462002|FG001|Overall Study|Physician Decision|1|||
126590422|NCT06424236|455462003|FG002|Overall Study|Physician Decision|0|||
126590423|NCT06424236|455462001|FG000|Overall Study|Study Terminated by Sponsor|11|||
126590424|NCT06424236|455462002|FG001|Overall Study|Study Terminated by Sponsor|20|||
126590425|NCT06424236|455462003|FG002|Overall Study|Study Terminated by Sponsor|16|||
126590426|NCT06424236|455462001|FG000|Overall Study|Lost to Follow-up|0|||
126590427|NCT06424236|455462002|FG001|Overall Study|Lost to Follow-up|1|||
126590428|NCT06424236|455462003|FG002|Overall Study|Lost to Follow-up|0|||
126590429|NCT06424236|455462001|FG000|Overall Study|Disease Progression|0|||
126590430|NCT06424236|455462002|FG001|Overall Study|Disease Progression|1|||
126590431|NCT06424236|455462003|FG002|Overall Study|Disease Progression|2|||
126590432|NCT06424236|455462001|FG000|Overall Study|Other|0|||
126590433|NCT06424236|455462002|FG001|Overall Study|Other|0|||
126590434|NCT06424236|455462003|FG002|Overall Study|Other|1|||
126590435|NCT03339713|455462005|FG000|Overall Study|Lost to Follow-up|2|||
126590436|NCT03339713|455462006|FG001|Overall Study|Lost to Follow-up|1|||
126590437|NCT03339713|455462005|FG000|Overall Study|Protocol Violation|1|||
126590438|NCT03339713|455462006|FG001|Overall Study|Protocol Violation|0|||
126590439|NCT03339713|455462005|FG000|Overall Study|Withdrawal by Subject|1|||
126590440|NCT03339713|455462006|FG001|Overall Study|Withdrawal by Subject|1|||
126590441|NCT01959425|455462007|FG000|Overall Study|Withdrawal by Subject|5|||
126590442|NCT01959425|455462008|FG001|Overall Study|Withdrawal by Subject|4|||
126590443|NCT01959425|455462007|FG000|Overall Study|Lost to Follow-up|1|||
126590444|NCT01959425|455462008|FG001|Overall Study|Lost to Follow-up|0|||
126590445|NCT01959425|455462007|FG000|Overall Study|Discontinued Subjects|6|||
126590446|NCT01959425|455462008|FG001|Overall Study|Discontinued Subjects|4|||
126590447|NCT04625283|455462009|FG000|Overall Study|post randomization exclusion|28|||
126590448|NCT04625283|455462010|FG001|Overall Study|post randomization exclusion|20|||
126590449|NCT02817776|455462011|FG000|Overall Study|Excluded|33|||
126590450|NCT02817776|455462011|FG000|Overall Study|Lost to Follow-up|20|||
126590451|NCT02817776|455462011|FG000|Overall Study|Withdrawal by Subject|33|||
126590452|NCT02817776|455462011|FG000|Overall Study|Death|2|||
126590453|NCT01715285|455462012|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
126590454|NCT01715285|455462013|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
126590455|NCT01715285|455462014|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
126590456|NCT01715285|455462012|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
126590457|NCT01715285|455462013|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
126590458|NCT01715285|455462014|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
126590459|NCT01715285|455462012|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
126590460|NCT01715285|455462013|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
126590461|NCT01715285|455462014|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
126590462|NCT01715285|455462012|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
126590463|NCT01715285|455462013|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
126590464|NCT01715285|455462014|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
126590465|NCT01715285|455462012|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
126590466|NCT01715285|455462013|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
126590467|NCT01715285|455462014|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
126590468|NCT01715285|455462012|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
126590469|NCT01715285|455462013|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
126590470|NCT01715285|455462014|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
126590471|NCT01715285|455462012|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
126590472|NCT01715285|455462013|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
126590473|NCT01715285|455462014|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
126590474|NCT01715285|455462012|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
126590475|NCT01715285|455462013|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
126590476|NCT01715285|455462014|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
126590477|NCT01715285|455462012|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
126590478|NCT01715285|455462013|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
126590479|NCT01715285|455462014|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
126590480|NCT01715285|455462012|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
126590481|NCT01715285|455462013|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
126590482|NCT01715285|455462014|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
126590483|NCT01715285|455462012|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
126590484|NCT01715285|455462013|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
126590485|NCT01715285|455462014|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
126590486|NCT01715285|455462012|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
126590487|NCT01715285|455462013|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
126590488|NCT01715285|455462014|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
126590489|NCT01715285|455462012|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
126590490|NCT01715285|455462013|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
126590491|NCT01715285|455462014|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
126590492|NCT01715285|455462012|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
126590493|NCT01715285|455462013|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
126590494|NCT01715285|455462014|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
126590495|NCT02598388|455462015|FG000|Overall Study|Lost to Follow-up|1|||
126590496|NCT02598388|455462016|FG001|Overall Study|Lost to Follow-up|0|||
126590497|NCT02598388|455462017|FG002|Overall Study|Lost to Follow-up|1|||
126590498|NCT02598388|455462018|FG003|Overall Study|Lost to Follow-up|0|||
126590499|NCT02598388|455462019|FG004|Overall Study|Lost to Follow-up|5|||
126590500|NCT02598388|455462020|FG005|Overall Study|Lost to Follow-up|1|||
126590501|NCT02598388|455462021|FG006|Overall Study|Lost to Follow-up|2|||
126590502|NCT02598388|455462022|FG007|Overall Study|Lost to Follow-up|1|||
126590503|NCT02598388|455462023|FG008|Overall Study|Lost to Follow-up|0|||
126590504|NCT02598388|455462024|FG009|Overall Study|Lost to Follow-up|0|||
126590505|NCT02598388|455462025|FG010|Overall Study|Lost to Follow-up|1|||
126590506|NCT02598388|455462026|FG011|Overall Study|Lost to Follow-up|0|||
126590507|NCT02598388|455462015|FG000|Overall Study|Withdrawal by Subject|0|||
126590508|NCT02598388|455462016|FG001|Overall Study|Withdrawal by Subject|0|||
126590509|NCT02598388|455462017|FG002|Overall Study|Withdrawal by Subject|0|||
126590510|NCT02598388|455462018|FG003|Overall Study|Withdrawal by Subject|0|||
126590511|NCT02598388|455462019|FG004|Overall Study|Withdrawal by Subject|2|||
126590512|NCT02598388|455462020|FG005|Overall Study|Withdrawal by Subject|0|||
126590513|NCT02598388|455462021|FG006|Overall Study|Withdrawal by Subject|2|||
126590514|NCT02598388|455462022|FG007|Overall Study|Withdrawal by Subject|0|||
126590515|NCT02598388|455462023|FG008|Overall Study|Withdrawal by Subject|0|||
126590516|NCT02598388|455462024|FG009|Overall Study|Withdrawal by Subject|1|||
126590517|NCT02598388|455462025|FG010|Overall Study|Withdrawal by Subject|0|||
126590518|NCT02598388|455462026|FG011|Overall Study|Withdrawal by Subject|0|||
126590519|NCT02598388|455462015|FG000|Overall Study|Other|0|||
126590520|NCT02598388|455462016|FG001|Overall Study|Other|0|||
126590521|NCT02598388|455462017|FG002|Overall Study|Other|1|||
126590522|NCT02598388|455462018|FG003|Overall Study|Other|0|||
126590523|NCT02598388|455462019|FG004|Overall Study|Other|3|||
126590524|NCT02598388|455462020|FG005|Overall Study|Other|0|||
126590525|NCT02598388|455462021|FG006|Overall Study|Other|1|||
126590526|NCT02598388|455462022|FG007|Overall Study|Other|0|||
126590527|NCT02598388|455462023|FG008|Overall Study|Other|0|||
126590528|NCT02598388|455462024|FG009|Overall Study|Other|0|||
126590529|NCT02598388|455462025|FG010|Overall Study|Other|0|||
126590530|NCT02598388|455462026|FG011|Overall Study|Other|0|||
126590531|NCT05006872|455462037|FG000|Overall Study|Lost to Follow-up|37|||
126590532|NCT05006872|455462038|FG001|Overall Study|Lost to Follow-up|31|||
126590533|NCT04971681|455462046|FG000|Followup|Lost to Follow-up|1|||
126590534|NCT04971681|455462047|FG001|Followup|Lost to Follow-up|0|||
126590535|NCT00686335|455462048|FG000|Run-in Period|Adverse Event|1|||
126590536|NCT00686335|455462048|FG000|Run-in Period|asthma exacerbation|1|||
126590537|NCT00686335|455462048|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
126590538|NCT04350463|455462055|FG000|Overall Study|Other reason|0|||
126590539|NCT04350463|455462056|FG001|Overall Study|Other reason|0|||
126590540|NCT04350463|455462057|FG002|Overall Study|Other reason|0|||
126590541|NCT04350463|455462058|FG003|Overall Study|Other reason|1|||
126590542|NCT04350463|455462055|FG000|Overall Study|Lost to Follow-up|0|||
126590543|NCT04350463|455462056|FG001|Overall Study|Lost to Follow-up|0|||
126590544|NCT04350463|455462057|FG002|Overall Study|Lost to Follow-up|0|||
126590545|NCT04350463|455462058|FG003|Overall Study|Lost to Follow-up|2|||
126590546|NCT04350463|455462055|FG000|Overall Study|Withdrawal by Subject|4|||
126731690|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
126731691|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
126731692|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
126731693|NCT01714817|455966154|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
126731694|NCT01714817|455966155|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
126731695|NCT02921763|455966156|FG000|Overall Study|Adverse Event|4|||
126731696|NCT02921763|455966156|FG000|Overall Study|Lost to Follow-up|4|||
126731697|NCT02921763|455966156|FG000|Overall Study|Lack of Efficacy|3|||
126731698|NCT02921763|455966156|FG000|Overall Study|Protocol Violation|2|||
126731699|NCT02921763|455966156|FG000|Overall Study|Withdrawal by Subject|2|||
126731700|NCT02921763|455966156|FG000|Overall Study|Physician Decision|1|||
126731701|NCT02921763|455966156|FG000|Overall Study|No data obtained|2|||
126731702|NCT04142216|455966157|FG000|Overall Study|Hospitalization|0|||
126731703|NCT04142216|455966158|FG001|Overall Study|Hospitalization|2|||
126731704|NCT04142216|455966157|FG000|Overall Study|Death|3|||
126731705|NCT04142216|455966158|FG001|Overall Study|Death|1|||
126731706|NCT04142216|455966157|FG000|Overall Study|Referral to another hemodialysis unit|3|||
126731707|NCT04142216|455966158|FG001|Overall Study|Referral to another hemodialysis unit|2|||
126731708|NCT04142216|455966157|FG000|Overall Study|Use of clove|0|||
126731709|NCT04142216|455966158|FG001|Overall Study|Use of clove|1|||
126731710|NCT01582971|455966159|FG000|Overall Study|Death|2|||
126731711|NCT01582971|455966160|FG001|Overall Study|Death|1|||
126731712|NCT01582971|455966159|FG000|Overall Study|Lost to Follow-up|18|||
126731713|NCT01582971|455966160|FG001|Overall Study|Lost to Follow-up|21|||
126731714|NCT01582971|455966159|FG000|Overall Study|Withdrawal by Subject|4|||
126731715|NCT01582971|455966160|FG001|Overall Study|Withdrawal by Subject|2|||
126731716|NCT01582971|455966159|FG000|Overall Study|Other|15|||
126731717|NCT01582971|455966160|FG001|Overall Study|Other|13|||
126731718|NCT02007954|455966161|FG000|Overall Study|Received liver transplant|3|||
126731719|NCT02007954|455966161|FG000|Overall Study|Switch in treatment modality|2|||
126731720|NCT02007954|455966161|FG000|Overall Study|Disease progression and unrelated AE|1|||
126731721|NCT02007954|455966161|FG000|Overall Study|Death|1|||
126731722|NCT01195363|455966167|FG000|Overall Study|Lost to Follow-up|7|||
126731723|NCT01195363|455966168|FG001|Overall Study|Lost to Follow-up|4|||
126731724|NCT01195363|455966167|FG000|Overall Study|Adverse Event|3|||
126731725|NCT01195363|455966168|FG001|Overall Study|Adverse Event|1|||
126731726|NCT01195363|455966167|FG000|Overall Study|Lack of Efficacy|0|||
126731727|NCT01195363|455966168|FG001|Overall Study|Lack of Efficacy|4|||
126731728|NCT01195363|455966167|FG000|Overall Study|incarceration|1|||
126731729|NCT01195363|455966168|FG001|Overall Study|incarceration|0|||
126731730|NCT01871896|455966179|FG000|Overall Study|Lost to Follow-up|1|||
126731731|NCT06025396|455968257|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
126731732|NCT06025396|455968258|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
126731733|NCT06025396|455968259|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
126731734|NCT06025396|455968260|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
126731735|NCT06025396|455968261|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
126731736|NCT06025396|455968257|FG000|Overall Study|Withdrawal by Subject|0|||
126731737|NCT06025396|455968258|FG001|Overall Study|Withdrawal by Subject|1|||
126731738|NCT06025396|455968259|FG002|Overall Study|Withdrawal by Subject|1|||
126731739|NCT06025396|455968260|FG003|Overall Study|Withdrawal by Subject|0|||
126731740|NCT06025396|455968261|FG004|Overall Study|Withdrawal by Subject|0|||
126731741|NCT05691829|455968262|FG000|Overall Study|Physician Decision|2|||
126731742|NCT05691829|455968262|FG000|Overall Study|Eligibility criteria not met|3|||
126731743|NCT06422377|455968268|FG000|Overall Study|Study Terminated by Sponsor|1|||
126731744|NCT02843178|455968269|FG000|Overall Study|Lost to Follow-up|8|||
126731745|NCT02843178|455968270|FG001|Overall Study|Lost to Follow-up|8|||
126731746|NCT02843178|455968271|FG002|Overall Study|Lost to Follow-up|6|||
126731747|NCT02843178|455968272|FG003|Overall Study|Lost to Follow-up|3|||
126731748|NCT02843178|455968269|FG000|Overall Study|Withdrawal by Subject|0|||
126731749|NCT02843178|455968270|FG001|Overall Study|Withdrawal by Subject|0|||
126731750|NCT02843178|455968271|FG002|Overall Study|Withdrawal by Subject|1|||
126731751|NCT02843178|455968272|FG003|Overall Study|Withdrawal by Subject|1|||
126731752|NCT00453180|455968280|FG000|Overall Study|Lost to Follow-up|2|||
126731753|NCT00453180|455968281|FG001|Overall Study|Lost to Follow-up|1|||
126731754|NCT00453180|455968280|FG000|Overall Study|Adverse Event|1|||
126731755|NCT00453180|455968281|FG001|Overall Study|Adverse Event|2|||
126731756|NCT02420795|455968288|FG000|Overall Study|Withdrawal by Subject|1|||
126731757|NCT02420795|455968289|FG001|Overall Study|Withdrawal by Subject|0|||
126731758|NCT02420795|455968290|FG002|Overall Study|Withdrawal by Subject|0|||
126731759|NCT02420795|455968288|FG000|Overall Study|Adverse Event|1|||
126731760|NCT02420795|455968289|FG001|Overall Study|Adverse Event|0|||
126731761|NCT02420795|455968290|FG002|Overall Study|Adverse Event|0|||
126731762|NCT02420795|455968288|FG000|Overall Study|Progressive disease|2|||
126731763|NCT02420795|455968289|FG001|Overall Study|Progressive disease|2|||
126731764|NCT02420795|455968290|FG002|Overall Study|Progressive disease|4|||
126731765|NCT02420795|455968288|FG000|Overall Study|Death|0|||
126731766|NCT02420795|455968289|FG001|Overall Study|Death|0|||
126590547|NCT04350463|455462056|FG001|Overall Study|Withdrawal by Subject|0|||
126590548|NCT04350463|455462057|FG002|Overall Study|Withdrawal by Subject|1|||
126590549|NCT04350463|455462058|FG003|Overall Study|Withdrawal by Subject|4|||
126590550|NCT04350463|455462055|FG000|Overall Study|Adverse Event|0|||
126590551|NCT04350463|455462056|FG001|Overall Study|Adverse Event|0|||
126590552|NCT04350463|455462057|FG002|Overall Study|Adverse Event|0|||
126590553|NCT04350463|455462058|FG003|Overall Study|Adverse Event|2|||
126590554|NCT04350463|455462055|FG000|Overall Study|Death|27|||
126590555|NCT04350463|455462056|FG001|Overall Study|Death|2|||
126590556|NCT04350463|455462057|FG002|Overall Study|Death|13|||
126590557|NCT04350463|455462058|FG003|Overall Study|Death|26|||
126590558|NCT04111536|455462059|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
126590559|NCT04111536|455462060|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
126590560|NCT04111536|455462059|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
126590561|NCT04111536|455462060|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
126590562|NCT04111536|455462059|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
126590563|NCT04111536|455462060|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
126590564|NCT04111536|455462059|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
126590565|NCT04111536|455462060|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
126590566|NCT02268253|455462061|FG000|Stage 1|Withdrawal by Subject|1|||
126590567|NCT02268253|455462062|FG001|Stage 1|Withdrawal by Subject|0|||
126590568|NCT02268253|455462063|FG002|Stage 1|Withdrawal by Subject|0|||
126590569|NCT02268253|455462064|FG003|Stage 1|Withdrawal by Subject|0|||
126590570|NCT02268253|455462065|FG004|Stage 1|Withdrawal by Subject|0|||
126590571|NCT02268253|455462066|FG005|Stage 1|Withdrawal by Subject|0|||
126590572|NCT02268253|455462067|FG006|Stage 1|Withdrawal by Subject|0|||
126590573|NCT02268253|455462061|FG000|Stage 1|Death|0|||
126590574|NCT02268253|455462062|FG001|Stage 1|Death|2|||
126590575|NCT02268253|455462063|FG002|Stage 1|Death|2|||
126590576|NCT02268253|455462064|FG003|Stage 1|Death|2|||
126590577|NCT02268253|455462065|FG004|Stage 1|Death|1|||
126590578|NCT02268253|455462066|FG005|Stage 1|Death|1|||
126590579|NCT02268253|455462067|FG006|Stage 1|Death|0|||
126590580|NCT02268253|455462061|FG000|Stage 2|Disease Recurrence/ Progression|0|||
126590581|NCT02268253|455462062|FG001|Stage 2|Disease Recurrence/ Progression|0|||
126590582|NCT02268253|455462063|FG002|Stage 2|Disease Recurrence/ Progression|1|||
126590583|NCT02268253|455462064|FG003|Stage 2|Disease Recurrence/ Progression|0|||
126590584|NCT02268253|455462065|FG004|Stage 2|Disease Recurrence/ Progression|0|||
126590585|NCT02268253|455462066|FG005|Stage 2|Disease Recurrence/ Progression|0|||
126590586|NCT02268253|455462067|FG006|Stage 2|Disease Recurrence/ Progression|0|||
126590587|NCT02268253|455462061|FG000|Stage 2|Withdrawal by Subject|0|||
126590588|NCT02268253|455462062|FG001|Stage 2|Withdrawal by Subject|0|||
126590589|NCT02268253|455462063|FG002|Stage 2|Withdrawal by Subject|2|||
126590590|NCT02268253|455462064|FG003|Stage 2|Withdrawal by Subject|0|||
126590591|NCT02268253|455462065|FG004|Stage 2|Withdrawal by Subject|0|||
126590592|NCT02268253|455462066|FG005|Stage 2|Withdrawal by Subject|2|||
126590593|NCT02268253|455462067|FG006|Stage 2|Withdrawal by Subject|0|||
126590594|NCT02268253|455462061|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
126590595|NCT02268253|455462062|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
126590596|NCT02268253|455462063|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
126590597|NCT02268253|455462064|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
126590598|NCT02268253|455462065|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
126590599|NCT02268253|455462066|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
126590600|NCT02268253|455462067|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
126590601|NCT02268253|455462061|FG000|Stage 2|Death|0|||
126590602|NCT02268253|455462062|FG001|Stage 2|Death|0|||
126590603|NCT02268253|455462063|FG002|Stage 2|Death|19|||
126590604|NCT02268253|455462064|FG003|Stage 2|Death|0|||
126590605|NCT02268253|455462065|FG004|Stage 2|Death|0|||
126590606|NCT02268253|455462066|FG005|Stage 2|Death|20|||
126590607|NCT02268253|455462067|FG006|Stage 2|Death|1|||
126590608|NCT02268253|455462061|FG000|Stage 2|Lost to Follow-up|0|||
126590609|NCT02268253|455462062|FG001|Stage 2|Lost to Follow-up|0|||
126590610|NCT02268253|455462063|FG002|Stage 2|Lost to Follow-up|0|||
126590611|NCT02268253|455462064|FG003|Stage 2|Lost to Follow-up|0|||
126590612|NCT02268253|455462065|FG004|Stage 2|Lost to Follow-up|0|||
126590613|NCT02268253|455462066|FG005|Stage 2|Lost to Follow-up|4|||
126590614|NCT02268253|455462067|FG006|Stage 2|Lost to Follow-up|0|||
126590615|NCT02268253|455462061|FG000|Stage 2|Transferred to Hospice|0|||
126590616|NCT02268253|455462062|FG001|Stage 2|Transferred to Hospice|0|||
126590617|NCT02268253|455462063|FG002|Stage 2|Transferred to Hospice|0|||
126590618|NCT02268253|455462064|FG003|Stage 2|Transferred to Hospice|0|||
126590619|NCT02268253|455462065|FG004|Stage 2|Transferred to Hospice|0|||
126590620|NCT02268253|455462066|FG005|Stage 2|Transferred to Hospice|2|||
126590621|NCT02268253|455462067|FG006|Stage 2|Transferred to Hospice|0|||
126590622|NCT02268253|455462061|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
126590623|NCT02268253|455462062|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
126590624|NCT02268253|455462063|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
126590625|NCT02268253|455462064|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
126590626|NCT02268253|455462065|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
126590627|NCT02268253|455462066|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
126590628|NCT02268253|455462067|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
126590629|NCT02268253|455462061|FG000|Stage 3A|Withdrawal by Subject|0|||
126590630|NCT02268253|455462062|FG001|Stage 3A|Withdrawal by Subject|0|||
126590631|NCT02268253|455462063|FG002|Stage 3A|Withdrawal by Subject|2|||
126590632|NCT02268253|455462064|FG003|Stage 3A|Withdrawal by Subject|0|||
126590633|NCT02268253|455462065|FG004|Stage 3A|Withdrawal by Subject|0|||
126590634|NCT02268253|455462066|FG005|Stage 3A|Withdrawal by Subject|0|||
126590635|NCT02268253|455462067|FG006|Stage 3A|Withdrawal by Subject|0|||
126590636|NCT02268253|455462061|FG000|Stage 3A|Physician Decision|0|||
126590637|NCT02268253|455462062|FG001|Stage 3A|Physician Decision|0|||
126590638|NCT02268253|455462063|FG002|Stage 3A|Physician Decision|2|||
126590639|NCT02268253|455462064|FG003|Stage 3A|Physician Decision|0|||
126590640|NCT02268253|455462065|FG004|Stage 3A|Physician Decision|0|||
126590641|NCT02268253|455462066|FG005|Stage 3A|Physician Decision|0|||
126590642|NCT02268253|455462067|FG006|Stage 3A|Physician Decision|0|||
126590643|NCT02268253|455462061|FG000|Stage 3A|Study Terminated by Sponsor|0|||
126590644|NCT02268253|455462062|FG001|Stage 3A|Study Terminated by Sponsor|0|||
126590645|NCT02268253|455462063|FG002|Stage 3A|Study Terminated by Sponsor|2|||
126590646|NCT02268253|455462064|FG003|Stage 3A|Study Terminated by Sponsor|0|||
126590647|NCT02268253|455462065|FG004|Stage 3A|Study Terminated by Sponsor|0|||
126590648|NCT02268253|455462066|FG005|Stage 3A|Study Terminated by Sponsor|0|||
126590649|NCT02268253|455462067|FG006|Stage 3A|Study Terminated by Sponsor|0|||
126590650|NCT02268253|455462061|FG000|Stage 3A|Lost to Follow-up|0|||
126590651|NCT02268253|455462062|FG001|Stage 3A|Lost to Follow-up|0|||
126590652|NCT02268253|455462063|FG002|Stage 3A|Lost to Follow-up|1|||
126590653|NCT02268253|455462064|FG003|Stage 3A|Lost to Follow-up|0|||
126590654|NCT02268253|455462065|FG004|Stage 3A|Lost to Follow-up|0|||
126590655|NCT02268253|455462066|FG005|Stage 3A|Lost to Follow-up|0|||
126590656|NCT02268253|455462067|FG006|Stage 3A|Lost to Follow-up|0|||
126590657|NCT02268253|455462061|FG000|Stage 3A|Death|0|||
126590658|NCT02268253|455462062|FG001|Stage 3A|Death|0|||
126590659|NCT02268253|455462063|FG002|Stage 3A|Death|5|||
126590660|NCT02268253|455462064|FG003|Stage 3A|Death|0|||
126590661|NCT02268253|455462065|FG004|Stage 3A|Death|0|||
126590662|NCT02268253|455462066|FG005|Stage 3A|Death|0|||
126590663|NCT02268253|455462067|FG006|Stage 3A|Death|0|||
126590664|NCT05362487|455462071|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
126590665|NCT04096040|455462072|FG000|Overall Study|Protocol Violation|12|||
126590666|NCT04096040|455462072|FG000|Overall Study|Non-compliant site|4|||
126590667|NCT04973254|455462075|FG000|Overall Study|Not adherent|0|||
126590668|NCT04973254|455462076|FG001|Overall Study|Not adherent|1|||
126590669|NCT04973254|455462077|FG002|Overall Study|Not adherent|0|||
126590670|NCT04629716|455462078|FG000|Overall Study|Lost to Follow-up|7|||
126590671|NCT04629716|455462079|FG001|Overall Study|Lost to Follow-up|3|||
126590672|NCT04537715|455462080|FG000|Overall Study|Death|3|||
126590673|NCT04537715|455462081|FG001|Overall Study|Death|1|||
126590674|NCT04537715|455462080|FG000|Overall Study|Withdrawal by Subject|3|||
126590675|NCT04537715|455462081|FG001|Overall Study|Withdrawal by Subject|1|||
126590676|NCT04537715|455462080|FG000|Overall Study|Other|4|||
126590677|NCT04537715|455462081|FG001|Overall Study|Other|3|||
126590678|NCT04537715|455462080|FG000|Overall Study|Progressive disease|1|||
126590679|NCT04537715|455462081|FG001|Overall Study|Progressive disease|0|||
126590680|NCT03461276|455462082|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
126590681|NCT03461276|455462083|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
126590682|NCT03461276|455462082|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
126590683|NCT03461276|455462083|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
126590684|NCT03461276|455462082|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
126590685|NCT03461276|455462083|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
126590686|NCT03461276|455462082|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
126590687|NCT03461276|455462083|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
126590688|NCT03461276|455462082|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
126590689|NCT03461276|455462083|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
126590690|NCT03461276|455462082|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
126590691|NCT03461276|455462083|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
126590692|NCT03461276|455462082|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
126590693|NCT03461276|455462083|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
126590694|NCT03461276|455462082|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
126590695|NCT03461276|455462083|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
126590696|NCT03461276|455462082|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
126590697|NCT03461276|455462083|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
126590698|NCT03461276|455462082|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
126590699|NCT03461276|455462083|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
126590700|NCT04663737|455462084|FG000|Overall Study|Withdrawal by Subject|2|||
126590701|NCT04663737|455462085|FG001|Overall Study|Withdrawal by Subject|0|||
126590702|NCT03848065|455462086|FG000|Overall Study|Death|0|||
126590703|NCT03848065|455462087|FG001|Overall Study|Death|1|||
126777857|NCT00185211|456141443|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
126777858|NCT00185211|456141442|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
126777859|NCT00185211|456141443|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
126777860|NCT00185211|456141442|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
126777861|NCT00185211|456141443|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
126777862|NCT00185211|456141442|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
126777863|NCT00185211|456141443|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
126777864|NCT00185211|456141442|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
126777865|NCT00185211|456141443|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
126777866|NCT00185211|456141442|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
126777867|NCT00185211|456141443|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
126777868|NCT00185211|456141442|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
126777869|NCT00185211|456141443|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
126777870|NCT00185211|456141442|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
126777871|NCT00185211|456141443|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
126777872|NCT00185211|456141442|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
126777873|NCT00185211|456141443|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
126777874|NCT00185211|456141442|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
126777875|NCT00185211|456141443|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
126777876|NCT01759537|456141444|FG000|Overall Study|Death|1|||
126777877|NCT01759537|456141445|FG001|Overall Study|Death|1|||
126777878|NCT01759537|456141444|FG000|Overall Study|Pregnancy|1|||
126777879|NCT01759537|456141445|FG001|Overall Study|Pregnancy|1|||
126777880|NCT01759537|456141444|FG000|Overall Study|Lost to Follow-up|9|||
126777881|NCT01759537|456141445|FG001|Overall Study|Lost to Follow-up|9|||
126777882|NCT01759537|456141444|FG000|Overall Study|Accident involving jaw fracture|1|||
126777883|NCT01759537|456141445|FG001|Overall Study|Accident involving jaw fracture|1|||
126777884|NCT01759537|456141444|FG000|Overall Study|Subcrestal implant too coronal|1|||
126777885|NCT01759537|456141445|FG001|Overall Study|Subcrestal implant too coronal|1|||
126777886|NCT02544633|456143032|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
126777887|NCT02544633|456143033|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
126777888|NCT02544633|456143034|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
126777889|NCT02544633|456143035|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
126777890|NCT02544633|456143032|FG000|Treatment Period|Adverse Event|7|||
126777891|NCT02544633|456143033|FG001|Treatment Period|Adverse Event|4|||
126777892|NCT02544633|456143034|FG002|Treatment Period|Adverse Event|0|||
126777893|NCT02544633|456143035|FG003|Treatment Period|Adverse Event|5|||
126777894|NCT02544633|456143032|FG000|Treatment Period|Lack of Efficacy|17|||
126777895|NCT02544633|456143033|FG001|Treatment Period|Lack of Efficacy|11|||
126777896|NCT02544633|456143034|FG002|Treatment Period|Lack of Efficacy|5|||
126777897|NCT02544633|456143035|FG003|Treatment Period|Lack of Efficacy|5|||
126777898|NCT02544633|456143032|FG000|Treatment Period|Global Deterioration of Health|3|||
126777899|NCT02544633|456143033|FG001|Treatment Period|Global Deterioration of Health|3|||
126777900|NCT02544633|456143034|FG002|Treatment Period|Global Deterioration of Health|0|||
126777901|NCT02544633|456143035|FG003|Treatment Period|Global Deterioration of Health|1|||
126777902|NCT02544633|456143032|FG000|Treatment Period|Withdrawal by Subject|1|||
126777903|NCT02544633|456143033|FG001|Treatment Period|Withdrawal by Subject|0|||
126777904|NCT02544633|456143034|FG002|Treatment Period|Withdrawal by Subject|0|||
126777905|NCT02544633|456143035|FG003|Treatment Period|Withdrawal by Subject|0|||
126777906|NCT02544633|456143032|FG000|Treatment Period|Lost to Follow-up|0|||
126777907|NCT02544633|456143033|FG001|Treatment Period|Lost to Follow-up|1|||
126777908|NCT02544633|456143034|FG002|Treatment Period|Lost to Follow-up|0|||
126777909|NCT02544633|456143035|FG003|Treatment Period|Lost to Follow-up|0|||
126777910|NCT02544633|456143032|FG000|Treatment Period|Death|0|||
126777911|NCT02544633|456143033|FG001|Treatment Period|Death|0|||
126777912|NCT02544633|456143034|FG002|Treatment Period|Death|1|||
126777913|NCT02544633|456143035|FG003|Treatment Period|Death|0|||
126777914|NCT02544633|456143032|FG000|Treatment Period|Non-compliance|0|||
126777915|NCT02544633|456143033|FG001|Treatment Period|Non-compliance|0|||
126777916|NCT02544633|456143034|FG002|Treatment Period|Non-compliance|1|||
126777917|NCT02544633|456143035|FG003|Treatment Period|Non-compliance|0|||
126777918|NCT02544633|456143032|FG000|Treatment Period|Clinical Disease Progression|0|||
126590704|NCT03848065|455462088|FG002|Overall Study|Death|0|||
126590705|NCT03848065|455462086|FG000|Overall Study|Lost to Follow-up|0|||
126590706|NCT03848065|455462087|FG001|Overall Study|Lost to Follow-up|0|||
126590707|NCT03848065|455462088|FG002|Overall Study|Lost to Follow-up|1|||
126777919|NCT02544633|456143033|FG001|Treatment Period|Clinical Disease Progression|0|||
126777920|NCT02544633|456143034|FG002|Treatment Period|Clinical Disease Progression|0|||
126590708|NCT03848065|455462086|FG000|Overall Study|Physician Decision|0|||
126590709|NCT03848065|455462087|FG001|Overall Study|Physician Decision|0|||
126777921|NCT02544633|456143035|FG003|Treatment Period|Clinical Disease Progression|1|||
126777922|NCT02544633|456143032|FG000|Survival Follow-up Period|Death|12|||
126777923|NCT02544633|456143033|FG001|Survival Follow-up Period|Death|14|||
126590710|NCT03848065|455462088|FG002|Overall Study|Physician Decision|1|||
126590711|NCT04137367|455462089|FG000|Overall Study|Lost to Follow-up|8|||
126590712|NCT04137367|455462090|FG001|Overall Study|Lost to Follow-up|6|||
126590713|NCT04137367|455462091|FG002|Overall Study|Lost to Follow-up|4|||
126590714|NCT03907878|455462092|FG000|Treatment Period|Withdrawal by Subject|5|||
126590715|NCT03907878|455462092|FG000|Treatment Period|Adverse Event|4|||
126590716|NCT03907878|455462092|FG000|Treatment Period|Lack of Efficacy|1|||
126590717|NCT03907878|455462092|FG000|Treatment Period|Protocol Violation|1|||
126590718|NCT03907878|455462092|FG000|Follow-up Period|Adverse Event|3|||
126590719|NCT03907878|455462092|FG000|Follow-up Period|Withdrawal by Subject|3|||
126590720|NCT05144009|455462093|FG000|Overall Study|Lost to Follow-up|0|||
126590721|NCT05144009|455462094|FG001|Overall Study|Lost to Follow-up|1|||
126590722|NCT05144009|455462093|FG000|Overall Study|Study Termination by the Sponsor|11|||
126590723|NCT05144009|455462094|FG001|Overall Study|Study Termination by the Sponsor|11|||
126590724|NCT05144009|455462093|FG000|Overall Study|Disease Progression|1|||
126590725|NCT05144009|455462094|FG001|Overall Study|Disease Progression|0|||
126590726|NCT05144009|455462093|FG000|Overall Study|Participant Decision|0|||
126590727|NCT05144009|455462094|FG001|Overall Study|Participant Decision|2|||
126590728|NCT05144009|455462093|FG000|Overall Study|Death|5|||
126590729|NCT05144009|455462094|FG001|Overall Study|Death|10|||
126590730|NCT04499924|455462095|FG000|Overall Study|Study termination by sponsor|4|||
126590731|NCT04499924|455462096|FG001|Overall Study|Study termination by sponsor|6|||
126590732|NCT04499924|455462095|FG000|Overall Study|Withdrawal by Subject|1|||
126590733|NCT04499924|455462096|FG001|Overall Study|Withdrawal by Subject|3|||
126590734|NCT05329220|455462101|FG000|Active Trial Period|Adverse Event|0|||
126590735|NCT05329220|455462102|FG001|Active Trial Period|Adverse Event|0|||
126590736|NCT05329220|455462103|FG002|Active Trial Period|Adverse Event|0|||
126590737|NCT05329220|455462104|FG003|Active Trial Period|Adverse Event|0|||
126590738|NCT05329220|455462105|FG004|Active Trial Period|Adverse Event|1|||
126590739|NCT05329220|455462106|FG005|Active Trial Period|Adverse Event|0|||
126590740|NCT05329220|455462101|FG000|Active Trial Period|Lost to Follow-up|0|||
126590741|NCT05329220|455462102|FG001|Active Trial Period|Lost to Follow-up|0|||
126590742|NCT05329220|455462103|FG002|Active Trial Period|Lost to Follow-up|0|||
126590743|NCT05329220|455462104|FG003|Active Trial Period|Lost to Follow-up|0|||
126590744|NCT05329220|455462105|FG004|Active Trial Period|Lost to Follow-up|32|||
126590745|NCT05329220|455462106|FG005|Active Trial Period|Lost to Follow-up|28|||
126590746|NCT05329220|455462101|FG000|Active Trial Period|Physician Decision|0|||
126590747|NCT05329220|455462102|FG001|Active Trial Period|Physician Decision|0|||
126590748|NCT05329220|455462103|FG002|Active Trial Period|Physician Decision|0|||
126590749|NCT05329220|455462104|FG003|Active Trial Period|Physician Decision|0|||
126590750|NCT05329220|455462105|FG004|Active Trial Period|Physician Decision|2|||
126590751|NCT05329220|455462106|FG005|Active Trial Period|Physician Decision|0|||
126590752|NCT05329220|455462101|FG000|Active Trial Period|Protocol Violation|0|||
126590753|NCT05329220|455462102|FG001|Active Trial Period|Protocol Violation|0|||
126590754|NCT05329220|455462103|FG002|Active Trial Period|Protocol Violation|0|||
126590755|NCT05329220|455462104|FG003|Active Trial Period|Protocol Violation|0|||
126590756|NCT05329220|455462105|FG004|Active Trial Period|Protocol Violation|1|||
126590757|NCT05329220|455462106|FG005|Active Trial Period|Protocol Violation|3|||
126590758|NCT05329220|455462101|FG000|Active Trial Period|Withdrawal by Subject|0|||
126590759|NCT05329220|455462102|FG001|Active Trial Period|Withdrawal by Subject|0|||
126590760|NCT05329220|455462103|FG002|Active Trial Period|Withdrawal by Subject|0|||
126590761|NCT05329220|455462104|FG003|Active Trial Period|Withdrawal by Subject|1|||
126590762|NCT05329220|455462105|FG004|Active Trial Period|Withdrawal by Subject|12|||
126590763|NCT05329220|455462106|FG005|Active Trial Period|Withdrawal by Subject|13|||
126590764|NCT05329220|455462101|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
126590765|NCT05329220|455462102|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
126590766|NCT05329220|455462103|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
126590767|NCT05329220|455462104|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
126590768|NCT05329220|455462105|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
126590769|NCT05329220|455462106|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
126590770|NCT05329220|455462101|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
126590771|NCT05329220|455462102|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
126590772|NCT05329220|455462103|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
126590773|NCT05329220|455462104|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
126590774|NCT05329220|455462105|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
126590775|NCT05329220|455462106|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
126590776|NCT05329220|455462101|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
126590777|NCT05329220|455462102|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
126590778|NCT05329220|455462103|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
126777924|NCT02544633|456143034|FG002|Survival Follow-up Period|Death|3|||
126777925|NCT02544633|456143035|FG003|Survival Follow-up Period|Death|9|||
126590779|NCT05329220|455462104|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
126590780|NCT05329220|455462105|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
126590781|NCT05329220|455462106|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
126590782|NCT05329220|455462101|FG000|Follow-up Period|Adverse Event|0|||
126590783|NCT05329220|455462102|FG001|Follow-up Period|Adverse Event|0|||
126590784|NCT05329220|455462103|FG002|Follow-up Period|Adverse Event|0|||
126590785|NCT05329220|455462104|FG003|Follow-up Period|Adverse Event|0|||
126590786|NCT05329220|455462105|FG004|Follow-up Period|Adverse Event|2|||
126590787|NCT05329220|455462106|FG005|Follow-up Period|Adverse Event|1|||
126590788|NCT05329220|455462101|FG000|Follow-up Period|Death|0|||
126590789|NCT05329220|455462102|FG001|Follow-up Period|Death|0|||
126590790|NCT05329220|455462103|FG002|Follow-up Period|Death|1|||
126590791|NCT05329220|455462104|FG003|Follow-up Period|Death|1|||
126590792|NCT05329220|455462105|FG004|Follow-up Period|Death|0|||
126590793|NCT05329220|455462106|FG005|Follow-up Period|Death|1|||
126590794|NCT05329220|455462101|FG000|Follow-up Period|Lost to Follow-up|0|||
126590795|NCT05329220|455462102|FG001|Follow-up Period|Lost to Follow-up|1|||
126590796|NCT05329220|455462103|FG002|Follow-up Period|Lost to Follow-up|2|||
126590797|NCT05329220|455462104|FG003|Follow-up Period|Lost to Follow-up|2|||
126590798|NCT05329220|455462105|FG004|Follow-up Period|Lost to Follow-up|113|||
126590799|NCT05329220|455462106|FG005|Follow-up Period|Lost to Follow-up|89|||
126590800|NCT05329220|455462101|FG000|Follow-up Period|Physician Decision|0|||
126590801|NCT05329220|455462102|FG001|Follow-up Period|Physician Decision|0|||
126590802|NCT05329220|455462103|FG002|Follow-up Period|Physician Decision|0|||
126590803|NCT05329220|455462104|FG003|Follow-up Period|Physician Decision|0|||
126590804|NCT05329220|455462105|FG004|Follow-up Period|Physician Decision|2|||
126590805|NCT05329220|455462106|FG005|Follow-up Period|Physician Decision|2|||
126590806|NCT05329220|455462101|FG000|Follow-up Period|Protocol Violation|0|||
126590807|NCT05329220|455462102|FG001|Follow-up Period|Protocol Violation|0|||
126590808|NCT05329220|455462103|FG002|Follow-up Period|Protocol Violation|0|||
126590809|NCT05329220|455462104|FG003|Follow-up Period|Protocol Violation|0|||
126590810|NCT05329220|455462105|FG004|Follow-up Period|Protocol Violation|0|||
126590811|NCT05329220|455462106|FG005|Follow-up Period|Protocol Violation|1|||
126590812|NCT05329220|455462101|FG000|Follow-up Period|Withdrawal by Subject|0|||
126590813|NCT05329220|455462102|FG001|Follow-up Period|Withdrawal by Subject|0|||
126590814|NCT05329220|455462103|FG002|Follow-up Period|Withdrawal by Subject|1|||
126590815|NCT05329220|455462104|FG003|Follow-up Period|Withdrawal by Subject|1|||
126590816|NCT05329220|455462105|FG004|Follow-up Period|Withdrawal by Subject|34|||
126590817|NCT05329220|455462106|FG005|Follow-up Period|Withdrawal by Subject|35|||
126590818|NCT05329220|455462101|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
126590819|NCT05329220|455462102|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
126590820|NCT05329220|455462103|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
126590821|NCT05329220|455462104|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
126590822|NCT05329220|455462105|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
126590823|NCT05329220|455462106|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
126590824|NCT05329220|455462101|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
126590825|NCT05329220|455462102|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
126590826|NCT05329220|455462103|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
126590827|NCT05329220|455462104|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
126590828|NCT05329220|455462105|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
126590829|NCT05329220|455462106|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
126590830|NCT05329220|455462101|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
126590831|NCT05329220|455462102|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
126590832|NCT05329220|455462103|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
126590833|NCT05329220|455462104|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
126590834|NCT05329220|455462105|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
126590835|NCT05329220|455462106|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
126590836|NCT05329220|455462101|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
126590837|NCT05329220|455462102|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
126590838|NCT05329220|455462103|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
126590839|NCT05329220|455462104|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
126590840|NCT05329220|455462105|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
126590841|NCT05329220|455462106|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
126590842|NCT05329220|455462101|FG000|Follow-up Period|EARLY TERMINATION|0|||
126590843|NCT05329220|455462102|FG001|Follow-up Period|EARLY TERMINATION|0|||
126590844|NCT05329220|455462103|FG002|Follow-up Period|EARLY TERMINATION|0|||
126590845|NCT05329220|455462104|FG003|Follow-up Period|EARLY TERMINATION|0|||
126590846|NCT05329220|455462105|FG004|Follow-up Period|EARLY TERMINATION|0|||
126590847|NCT05329220|455462106|FG005|Follow-up Period|EARLY TERMINATION|1|||
126640572|NCT00732992|455642811|FG000|Overall Study|Global Deterioration of Health Status|1|||
126590848|NCT05329220|455462101|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
126590849|NCT05329220|455462102|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
126590850|NCT05329220|455462103|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
126590851|NCT05329220|455462104|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
126590852|NCT05329220|455462105|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
126590853|NCT05329220|455462106|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
126590854|NCT05329220|455462101|FG000|Follow-up Period|DROPPED|0|||
126590855|NCT05329220|455462102|FG001|Follow-up Period|DROPPED|0|||
126590856|NCT05329220|455462103|FG002|Follow-up Period|DROPPED|0|||
126590857|NCT05329220|455462104|FG003|Follow-up Period|DROPPED|0|||
126590858|NCT05329220|455462105|FG004|Follow-up Period|DROPPED|0|||
126590859|NCT05329220|455462106|FG005|Follow-up Period|DROPPED|1|||
126590860|NCT05329220|455462101|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
126590861|NCT05329220|455462102|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
126590862|NCT05329220|455462103|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
126590863|NCT05329220|455462104|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
126590864|NCT05329220|455462105|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
126590865|NCT05329220|455462106|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
126590866|NCT02601313|455462107|FG000|Overall Study|Death|2|||
126590867|NCT02601313|455462108|FG001|Overall Study|Death|41|||
126590868|NCT02601313|455462109|FG002|Overall Study|Death|6|||
126590869|NCT02601313|455462107|FG000|Overall Study|Enrolled but never treated|0|||
126590870|NCT02601313|455462108|FG001|Overall Study|Enrolled but never treated|6|||
126590871|NCT02601313|455462109|FG002|Overall Study|Enrolled but never treated|3|||
126590872|NCT02601313|455462107|FG000|Overall Study|Enrolled, did not initiate AC|4|||
126590873|NCT02601313|455462108|FG001|Overall Study|Enrolled, did not initiate AC|0|||
126590874|NCT02601313|455462109|FG002|Overall Study|Enrolled, did not initiate AC|0|||
126590875|NCT02601313|455462107|FG000|Overall Study|Full consent withdrawal|0|||
126590876|NCT02601313|455462108|FG001|Overall Study|Full consent withdrawal|3|||
126590877|NCT02601313|455462109|FG002|Overall Study|Full consent withdrawal|2|||
126590878|NCT02601313|455462107|FG000|Overall Study|Lost to Follow-up|0|||
126590879|NCT02601313|455462108|FG001|Overall Study|Lost to Follow-up|1|||
126590880|NCT02601313|455462109|FG002|Overall Study|Lost to Follow-up|1|||
126590881|NCT03869866|455463817|FG000|Overall Study|Protocol Violation|1|||
126590882|NCT03869866|455463817|FG000|Overall Study|Withdrawal by Subject|3|||
126590883|NCT00506519|455463819|FG000|Overall Study|Death|4|||
126590884|NCT00506519|455463820|FG001|Overall Study|Death|6|||
126590885|NCT00506519|455463821|FG002|Overall Study|Death|0|||
126590886|NCT00506519|455463819|FG000|Overall Study|Adverse Event|1|||
126590887|NCT00506519|455463820|FG001|Overall Study|Adverse Event|0|||
126590888|NCT00506519|455463821|FG002|Overall Study|Adverse Event|0|||
126590889|NCT01186367|455463822|FG000|Overall Study|Lost to Follow-up|7|||
126590890|NCT01186367|455463823|FG001|Overall Study|Lost to Follow-up|4|||
126590891|NCT01186367|455463824|FG002|Overall Study|Lost to Follow-up|7|||
126590892|NCT01186367|455463822|FG000|Overall Study|Did not receive study treatment|0|||
126590893|NCT01186367|455463823|FG001|Overall Study|Did not receive study treatment|1|||
126590894|NCT01186367|455463824|FG002|Overall Study|Did not receive study treatment|0|||
126590895|NCT02975882|455463825|FG000|Overall Study|Adverse Event|1|||
126590896|NCT02975882|455463826|FG001|Overall Study|Adverse Event|2|||
126590897|NCT02975882|455463827|FG002|Overall Study|Adverse Event|1|||
126590898|NCT02975882|455463828|FG003|Overall Study|Adverse Event|1|||
126590899|NCT02975882|455463825|FG000|Overall Study|Death|0|||
126590900|NCT02975882|455463826|FG001|Overall Study|Death|1|||
126590901|NCT02975882|455463827|FG002|Overall Study|Death|0|||
126590902|NCT02975882|455463828|FG003|Overall Study|Death|0|||
126590903|NCT02975882|455463825|FG000|Overall Study|Lack of Efficacy|3|||
126590904|NCT02975882|455463826|FG001|Overall Study|Lack of Efficacy|7|||
126590905|NCT02975882|455463827|FG002|Overall Study|Lack of Efficacy|4|||
126590906|NCT02975882|455463828|FG003|Overall Study|Lack of Efficacy|3|||
126590907|NCT02975882|455463825|FG000|Overall Study|Physician Decision|0|||
126590908|NCT02975882|455463826|FG001|Overall Study|Physician Decision|2|||
126590909|NCT02975882|455463827|FG002|Overall Study|Physician Decision|4|||
126590910|NCT02975882|455463828|FG003|Overall Study|Physician Decision|2|||
126590911|NCT02975882|455463825|FG000|Overall Study|Ineligible|0|||
126590912|NCT02975882|455463826|FG001|Overall Study|Ineligible|1|||
126590913|NCT02975882|455463827|FG002|Overall Study|Ineligible|0|||
126590914|NCT02975882|455463828|FG003|Overall Study|Ineligible|0|||
126590915|NCT02985957|455463829|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126590916|NCT02985957|455463830|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126590917|NCT02985957|455463831|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126590918|NCT02985957|455463832|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126590919|NCT02985957|455463833|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126590920|NCT02985957|455463834|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126590921|NCT02985957|455463835|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126590922|NCT02985957|455463829|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
126590923|NCT02985957|455463830|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
126731767|NCT02420795|455968290|FG002|Overall Study|Death|1|||
126731768|NCT01002742|455968293|FG000|Overall Study|Determined to be ineligible|0|||
126731769|NCT01002742|455968294|FG001|Overall Study|Determined to be ineligible|1|||
126731770|NCT02862548|455968306|FG000|Randomized Phase (Up to Week 48)|Death|0|||
126731771|NCT02862548|455968307|FG001|Randomized Phase (Up to Week 48)|Death|1|||
126731772|NCT02862548|455968306|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
126731773|NCT02862548|455968307|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
126731774|NCT02862548|455968306|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
126731775|NCT02862548|455968307|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
126731776|NCT02862548|455968306|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
126731777|NCT02862548|455968307|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
126731778|NCT00880763|455968308|FG000|Extension Period (Part 2)|Adverse Event|0|||
126731779|NCT00880763|455968309|FG001|Extension Period (Part 2)|Adverse Event|0|||
126731780|NCT00880763|455968310|FG002|Extension Period (Part 2)|Adverse Event|1|||
126731781|NCT00880763|455968311|FG003|Extension Period (Part 2)|Adverse Event|1|||
126731782|NCT00880763|455968308|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
126731783|NCT00880763|455968309|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
126731784|NCT00880763|455968310|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
126731785|NCT00880763|455968311|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
126731786|NCT00880763|455968308|FG000|Extension Period (Part 2)|Physician Decision|0|||
126731787|NCT00880763|455968309|FG001|Extension Period (Part 2)|Physician Decision|1|||
126731788|NCT00880763|455968310|FG002|Extension Period (Part 2)|Physician Decision|1|||
126731789|NCT00880763|455968311|FG003|Extension Period (Part 2)|Physician Decision|0|||
126731790|NCT00880763|455968308|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
126731791|NCT00880763|455968309|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
126731792|NCT00880763|455968310|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
126731793|NCT00880763|455968311|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
126731794|NCT02670928|455968313|FG000|Overall Study|Adverse Event|3|||
126731795|NCT02670928|455968314|FG001|Overall Study|Adverse Event|1|||
126731796|NCT02670928|455968313|FG000|Overall Study|Withdrawal by Subject|4|||
126731797|NCT02670928|455968314|FG001|Overall Study|Withdrawal by Subject|0|||
126731798|NCT02670928|455968313|FG000|Overall Study|Lost to Follow-up|1|||
126731799|NCT02670928|455968314|FG001|Overall Study|Lost to Follow-up|0|||
126731800|NCT02670928|455968313|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
126731801|NCT02670928|455968314|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
126731802|NCT01293006|455968315|FG000|Period 2|Lost to Follow-up|1|||
126731803|NCT01293006|455968316|FG001|Period 2|Lost to Follow-up|0|||
126731804|NCT01293006|455968317|FG002|Period 2|Lost to Follow-up|0|||
126731805|NCT01293006|455968318|FG003|Period 2|Lost to Follow-up|0|||
126731806|NCT01494987|455968319|FG000|Overall Study|Adverse Event|6|||
126731807|NCT01494987|455968320|FG001|Overall Study|Adverse Event|5|||
126731808|NCT01494987|455968319|FG000|Overall Study|Hyperglycemia|6|||
126731809|NCT01494987|455968320|FG001|Overall Study|Hyperglycemia|4|||
126731810|NCT01494987|455968319|FG000|Overall Study|Investigator's Discretion|1|||
126731811|NCT01494987|455968320|FG001|Overall Study|Investigator's Discretion|2|||
126731812|NCT01494987|455968319|FG000|Overall Study|Lost to Follow-up|1|||
126731813|NCT01494987|455968320|FG001|Overall Study|Lost to Follow-up|1|||
126731814|NCT01494987|455968319|FG000|Overall Study|Protocol Violation|3|||
126731815|NCT01494987|455968320|FG001|Overall Study|Protocol Violation|3|||
126731816|NCT01494987|455968319|FG000|Overall Study|Subject Non-Compliance|9|||
126731817|NCT01494987|455968320|FG001|Overall Study|Subject Non-Compliance|10|||
126731818|NCT01494987|455968319|FG000|Overall Study|Subject Withdrew Consent|2|||
126731819|NCT01494987|455968320|FG001|Overall Study|Subject Withdrew Consent|3|||
126731820|NCT00436982|455968323|FG000|Overall Study|Withdrawal by Subject|3|||
126731821|NCT00436982|455968324|FG001|Overall Study|Withdrawal by Subject|1|||
126731822|NCT00436982|455968323|FG000|Overall Study|Did not receive allocated intervention|0|||
126731823|NCT00436982|455968324|FG001|Overall Study|Did not receive allocated intervention|1|||
126731824|NCT00436982|455968323|FG000|Overall Study|no RSA data|1|||
126731825|NCT00436982|455968324|FG001|Overall Study|no RSA data|2|||
126731826|NCT02215616|455968328|FG000|Overall Study|Sponsor requested to stop study drug|0|||
126731827|NCT02215616|455968329|FG001|Overall Study|Sponsor requested to stop study drug|0|||
126731828|NCT02215616|455968330|FG002|Overall Study|Sponsor requested to stop study drug|1|||
126731829|NCT02215616|455968331|FG003|Overall Study|Sponsor requested to stop study drug|4|||
126731830|NCT02215616|455968328|FG000|Overall Study|Death|1|||
126731831|NCT02215616|455968329|FG001|Overall Study|Death|0|||
126731832|NCT02215616|455968330|FG002|Overall Study|Death|0|||
126731833|NCT02215616|455968331|FG003|Overall Study|Death|0|||
126731834|NCT02215616|455968328|FG000|Overall Study|Adverse Event|7|||
126731835|NCT02215616|455968329|FG001|Overall Study|Adverse Event|4|||
126731836|NCT02215616|455968330|FG002|Overall Study|Adverse Event|9|||
126731837|NCT02215616|455968331|FG003|Overall Study|Adverse Event|2|||
126590924|NCT02985957|455463831|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
126590925|NCT02985957|455463832|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
126590926|NCT02985957|455463833|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
126590927|NCT02985957|455463834|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
126590928|NCT02985957|455463835|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
126590929|NCT02985957|455463829|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126590930|NCT02985957|455463830|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126590931|NCT02985957|455463831|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126590932|NCT02985957|455463832|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126590933|NCT02985957|455463833|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126590934|NCT02985957|455463834|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
126590935|NCT02985957|455463835|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
126590936|NCT02985957|455463829|FG000|Treatment Period|Death|0|||
126590937|NCT02985957|455463830|FG001|Treatment Period|Death|0|||
126590938|NCT02985957|455463831|FG002|Treatment Period|Death|0|||
126590939|NCT02985957|455463832|FG003|Treatment Period|Death|0|||
126590940|NCT02985957|455463833|FG004|Treatment Period|Death|1|||
126590941|NCT02985957|455463834|FG005|Treatment Period|Death|0|||
126590942|NCT02985957|455463835|FG006|Treatment Period|Death|0|||
126590943|NCT02985957|455463829|FG000|Treatment Period|Participant withdrew consent|0|||
126590944|NCT02985957|455463830|FG001|Treatment Period|Participant withdrew consent|0|||
126590945|NCT02985957|455463831|FG002|Treatment Period|Participant withdrew consent|0|||
126590946|NCT02985957|455463832|FG003|Treatment Period|Participant withdrew consent|1|||
126590947|NCT02985957|455463833|FG004|Treatment Period|Participant withdrew consent|3|||
126590948|NCT02985957|455463834|FG005|Treatment Period|Participant withdrew consent|0|||
126590949|NCT02985957|455463835|FG006|Treatment Period|Participant withdrew consent|1|||
126590950|NCT02985957|455463829|FG000|Treatment Period|Lost to Follow-up|0|||
126590951|NCT02985957|455463830|FG001|Treatment Period|Lost to Follow-up|0|||
126590952|NCT02985957|455463831|FG002|Treatment Period|Lost to Follow-up|0|||
126590953|NCT02985957|455463832|FG003|Treatment Period|Lost to Follow-up|0|||
126590954|NCT02985957|455463833|FG004|Treatment Period|Lost to Follow-up|1|||
126590955|NCT02985957|455463834|FG005|Treatment Period|Lost to Follow-up|0|||
126590956|NCT02985957|455463835|FG006|Treatment Period|Lost to Follow-up|0|||
126590957|NCT02985957|455463829|FG000|Treatment Period|Other reasons|0|||
126590958|NCT02985957|455463830|FG001|Treatment Period|Other reasons|0|||
126590959|NCT02985957|455463831|FG002|Treatment Period|Other reasons|1|||
126590960|NCT02985957|455463832|FG003|Treatment Period|Other reasons|3|||
126590961|NCT02985957|455463833|FG004|Treatment Period|Other reasons|6|||
126590962|NCT02985957|455463834|FG005|Treatment Period|Other reasons|0|||
126590963|NCT02985957|455463835|FG006|Treatment Period|Other reasons|1|||
126590964|NCT02985957|455463829|FG000|Treatment Period|Not reported|0|||
126590965|NCT02985957|455463830|FG001|Treatment Period|Not reported|1|||
126590966|NCT02985957|455463831|FG002|Treatment Period|Not reported|2|||
126590967|NCT02985957|455463832|FG003|Treatment Period|Not reported|5|||
126590968|NCT02985957|455463833|FG004|Treatment Period|Not reported|0|||
126590969|NCT02985957|455463834|FG005|Treatment Period|Not reported|0|||
126590970|NCT02985957|455463835|FG006|Treatment Period|Not reported|0|||
126590971|NCT02985957|455463829|FG000|Treatment Period|Maximum clinical benefit|0|||
126590972|NCT02985957|455463830|FG001|Treatment Period|Maximum clinical benefit|0|||
126590973|NCT02985957|455463831|FG002|Treatment Period|Maximum clinical benefit|1|||
126590974|NCT02985957|455463832|FG003|Treatment Period|Maximum clinical benefit|1|||
126590975|NCT02985957|455463833|FG004|Treatment Period|Maximum clinical benefit|0|||
126590976|NCT02985957|455463834|FG005|Treatment Period|Maximum clinical benefit|0|||
126590977|NCT02985957|455463835|FG006|Treatment Period|Maximum clinical benefit|2|||
126590978|NCT02985957|455463829|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
126590979|NCT02985957|455463830|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
126590980|NCT02985957|455463831|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
126590981|NCT02985957|455463832|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
126590982|NCT02985957|455463833|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
126590983|NCT02985957|455463834|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
126590984|NCT02985957|455463835|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
126590985|NCT02985957|455463829|FG000|Treatment Period|Study drug toxicity|1|||
126590986|NCT02985957|455463830|FG001|Treatment Period|Study drug toxicity|23|||
126590987|NCT02985957|455463831|FG002|Treatment Period|Study drug toxicity|20|||
126590988|NCT02985957|455463832|FG003|Treatment Period|Study drug toxicity|11|||
126590989|NCT02985957|455463833|FG004|Treatment Period|Study drug toxicity|19|||
126590990|NCT02985957|455463834|FG005|Treatment Period|Study drug toxicity|3|||
126590991|NCT02985957|455463835|FG006|Treatment Period|Study drug toxicity|5|||
126590992|NCT02985957|455463829|FG000|Treatment Period|Disease progression|0|||
126590993|NCT02985957|455463830|FG001|Treatment Period|Disease progression|16|||
126590994|NCT02985957|455463831|FG002|Treatment Period|Disease progression|20|||
126731838|NCT02215616|455968328|FG000|Overall Study|Withdrawal by Subject|1|||
126731839|NCT02215616|455968329|FG001|Overall Study|Withdrawal by Subject|8|||
126731840|NCT02215616|455968330|FG002|Overall Study|Withdrawal by Subject|2|||
126590995|NCT02985957|455463832|FG003|Treatment Period|Disease progression|39|||
126590996|NCT02985957|455463833|FG004|Treatment Period|Disease progression|29|||
126590997|NCT02985957|455463834|FG005|Treatment Period|Disease progression|11|||
126590998|NCT02985957|455463835|FG006|Treatment Period|Disease progression|28|||
126590999|NCT02985957|455463829|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
126591000|NCT02985957|455463830|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
126591001|NCT02985957|455463831|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
126591002|NCT02985957|455463832|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
126591003|NCT02985957|455463833|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
126591004|NCT02985957|455463834|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
126591005|NCT02985957|455463835|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
126591006|NCT02985957|455463829|FG000|Treatment Period|Poor/Non-Compliance|0|||
126591007|NCT02985957|455463830|FG001|Treatment Period|Poor/Non-Compliance|0|||
126591008|NCT02985957|455463831|FG002|Treatment Period|Poor/Non-Compliance|0|||
126591009|NCT02985957|455463832|FG003|Treatment Period|Poor/Non-Compliance|0|||
126591010|NCT02985957|455463833|FG004|Treatment Period|Poor/Non-Compliance|1|||
126591011|NCT02985957|455463834|FG005|Treatment Period|Poor/Non-Compliance|1|||
126591012|NCT02985957|455463835|FG006|Treatment Period|Poor/Non-Compliance|0|||
126591013|NCT02985957|455463829|FG000|Treatment Period|Continuing in Treatment Period|0|||
126591014|NCT02985957|455463830|FG001|Treatment Period|Continuing in Treatment Period|1|||
126591015|NCT02985957|455463831|FG002|Treatment Period|Continuing in Treatment Period|0|||
126591016|NCT02985957|455463832|FG003|Treatment Period|Continuing in Treatment Period|4|||
126591017|NCT02985957|455463833|FG004|Treatment Period|Continuing in Treatment Period|4|||
126591018|NCT02985957|455463834|FG005|Treatment Period|Continuing in Treatment Period|0|||
126591019|NCT02985957|455463835|FG006|Treatment Period|Continuing in Treatment Period|0|||
126591020|NCT04802967|455463842|FG000|Part B|Withdrawal by Subject|0|||
126591021|NCT04802967|455463843|FG001|Part B|Withdrawal by Subject|0|||
126591022|NCT04802967|455463844|FG002|Part B|Withdrawal by Subject|0|||
126591023|NCT04802967|455463845|FG003|Part B|Withdrawal by Subject|0|||
126591024|NCT04802967|455463846|FG004|Part B|Withdrawal by Subject|0|||
126591025|NCT04802967|455463847|FG005|Part B|Withdrawal by Subject|1|||
126591026|NCT04802967|455463848|FG006|Part B|Withdrawal by Subject|0|||
126591027|NCT04802967|455463849|FG007|Part B|Withdrawal by Subject|0|||
126591028|NCT04802967|455463850|FG008|Part B|Withdrawal by Subject|0|||
126591029|NCT04802967|455463851|FG009|Part B|Withdrawal by Subject|0|||
126591030|NCT00085735|455463860|FG000|Overall Study|Adverse Event|1|||
126591031|NCT00085735|455463861|FG001|Overall Study|Adverse Event|0|||
126591032|NCT00085735|455463862|FG002|Overall Study|Adverse Event|0|||
126591033|NCT00085735|455463863|FG003|Overall Study|Adverse Event|0|||
126591034|NCT00085735|455463864|FG004|Overall Study|Adverse Event|0|||
126591035|NCT00085735|455463865|FG005|Overall Study|Adverse Event|0|||
126591036|NCT00085735|455463860|FG000|Overall Study|Lack of Efficacy|2|||
126591037|NCT00085735|455463861|FG001|Overall Study|Lack of Efficacy|4|||
126591038|NCT00085735|455463862|FG002|Overall Study|Lack of Efficacy|6|||
126591039|NCT00085735|455463863|FG003|Overall Study|Lack of Efficacy|3|||
126591040|NCT00085735|455463864|FG004|Overall Study|Lack of Efficacy|4|||
126591041|NCT00085735|455463865|FG005|Overall Study|Lack of Efficacy|3|||
126591042|NCT00085735|455463860|FG000|Overall Study|Lost to Follow-up|0|||
126591043|NCT00085735|455463861|FG001|Overall Study|Lost to Follow-up|1|||
126591044|NCT00085735|455463862|FG002|Overall Study|Lost to Follow-up|0|||
126591045|NCT00085735|455463863|FG003|Overall Study|Lost to Follow-up|0|||
126591046|NCT00085735|455463864|FG004|Overall Study|Lost to Follow-up|1|||
126591047|NCT00085735|455463865|FG005|Overall Study|Lost to Follow-up|0|||
126591048|NCT00085735|455463860|FG000|Overall Study|Physician Decision|2|||
126591049|NCT00085735|455463861|FG001|Overall Study|Physician Decision|3|||
126591050|NCT00085735|455463862|FG002|Overall Study|Physician Decision|2|||
126591051|NCT00085735|455463863|FG003|Overall Study|Physician Decision|3|||
126591052|NCT00085735|455463864|FG004|Overall Study|Physician Decision|11|||
126591053|NCT00085735|455463865|FG005|Overall Study|Physician Decision|8|||
126591054|NCT00085735|455463860|FG000|Overall Study|Protocol Violation|1|||
126591055|NCT00085735|455463861|FG001|Overall Study|Protocol Violation|0|||
126591056|NCT00085735|455463862|FG002|Overall Study|Protocol Violation|0|||
126591057|NCT00085735|455463863|FG003|Overall Study|Protocol Violation|0|||
126591058|NCT00085735|455463864|FG004|Overall Study|Protocol Violation|0|||
126591059|NCT00085735|455463865|FG005|Overall Study|Protocol Violation|0|||
126591060|NCT00085735|455463860|FG000|Overall Study|Withdrawal by Subject|1|||
126591061|NCT00085735|455463861|FG001|Overall Study|Withdrawal by Subject|0|||
126591062|NCT00085735|455463862|FG002|Overall Study|Withdrawal by Subject|4|||
126591063|NCT00085735|455463863|FG003|Overall Study|Withdrawal by Subject|5|||
126591064|NCT00085735|455463864|FG004|Overall Study|Withdrawal by Subject|7|||
126591065|NCT00085735|455463865|FG005|Overall Study|Withdrawal by Subject|8|||
126591066|NCT00085735|455463860|FG000|Overall Study|Patient ineligible|1|||
126591067|NCT00085735|455463861|FG001|Overall Study|Patient ineligible|0|||
126591068|NCT00085735|455463862|FG002|Overall Study|Patient ineligible|3|||
126591069|NCT00085735|455463863|FG003|Overall Study|Patient ineligible|7|||
126591070|NCT00085735|455463864|FG004|Overall Study|Patient ineligible|17|||
126591071|NCT00085735|455463865|FG005|Overall Study|Patient ineligible|8|||
126591072|NCT00085735|455463860|FG000|Overall Study|Excess residual disease|2|||
126591073|NCT00085735|455463861|FG001|Overall Study|Excess residual disease|2|||
126591074|NCT00085735|455463862|FG002|Overall Study|Excess residual disease|1|||
126591075|NCT00085735|455463863|FG003|Overall Study|Excess residual disease|1|||
126591076|NCT00085735|455463864|FG004|Overall Study|Excess residual disease|1|||
126591077|NCT00085735|455463865|FG005|Overall Study|Excess residual disease|4|||
126591078|NCT00085735|455463860|FG000|Overall Study|Reason not documented|1|||
126591079|NCT00085735|455463861|FG001|Overall Study|Reason not documented|0|||
126591080|NCT00085735|455463862|FG002|Overall Study|Reason not documented|1|||
126591081|NCT00085735|455463863|FG003|Overall Study|Reason not documented|0|||
126591082|NCT00085735|455463864|FG004|Overall Study|Reason not documented|1|||
126591083|NCT00085735|455463865|FG005|Overall Study|Reason not documented|0|||
126591084|NCT00085735|455463860|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
126591085|NCT00085735|455463861|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
126591086|NCT00085735|455463862|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
126591087|NCT00085735|455463863|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
126591088|NCT00085735|455463864|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
126591089|NCT00085735|455463865|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
126591090|NCT01824875|455463866|FG000|Overall Study|Disease progression|22|||
126591091|NCT01824875|455463867|FG001|Overall Study|Disease progression|15|||
126591092|NCT01824875|455463866|FG000|Overall Study|Withdrawal by Subject|5|||
126591093|NCT01824875|455463867|FG001|Overall Study|Withdrawal by Subject|4|||
126591094|NCT01824875|455463866|FG000|Overall Study|Adverse Event|4|||
126591095|NCT01824875|455463867|FG001|Overall Study|Adverse Event|10|||
126591096|NCT01824875|455463866|FG000|Overall Study|Alternative therapy|3|||
126591097|NCT01824875|455463867|FG001|Overall Study|Alternative therapy|0|||
126591098|NCT01824875|455463866|FG000|Overall Study|Complicating disease|1|||
126591099|NCT01824875|455463867|FG001|Overall Study|Complicating disease|0|||
126591100|NCT01824875|455463866|FG000|Overall Study|Physician Decision|0|||
126777926|NCT02544633|456143032|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
126591101|NCT01824875|455463867|FG001|Overall Study|Physician Decision|1|||
126591102|NCT01824875|455463866|FG000|Overall Study|Non-compliance|1|||
126591103|NCT01824875|455463867|FG001|Overall Study|Non-compliance|1|||
126591104|NCT01824875|455463866|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
126591105|NCT01824875|455463867|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
126591106|NCT01824875|455463866|FG000|Overall Study|Administrative issues|0|||
126591107|NCT01824875|455463867|FG001|Overall Study|Administrative issues|2|||
126591108|NCT01824875|455463866|FG000|Overall Study|Ineligible or never started treatment|9|||
126591109|NCT01824875|455463867|FG001|Overall Study|Ineligible or never started treatment|5|||
126591110|NCT01824875|455463866|FG000|Overall Study|Other|0|||
126591111|NCT01824875|455463867|FG001|Overall Study|Other|2|||
126591112|NCT04149704|455463879|FG000|Three Month Follow-up|Death|2|||
126591113|NCT04149704|455463880|FG001|Three Month Follow-up|Death|0|||
126591114|NCT04149704|455463881|FG002|Three Month Follow-up|Death|0|||
126591115|NCT04149704|455463882|FG003|Three Month Follow-up|Death|0|||
126591116|NCT04149704|455463879|FG000|Three Month Follow-up|Lost to Follow-up|1|||
126591117|NCT04149704|455463880|FG001|Three Month Follow-up|Lost to Follow-up|4|||
126591118|NCT04149704|455463881|FG002|Three Month Follow-up|Lost to Follow-up|5|||
126591119|NCT04149704|455463882|FG003|Three Month Follow-up|Lost to Follow-up|5|||
126591120|NCT04149704|455463879|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
126591121|NCT04149704|455463880|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
126591122|NCT04149704|455463881|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
126591123|NCT04149704|455463882|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
126591124|NCT04149704|455463879|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
126591125|NCT04149704|455463880|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
126591126|NCT04149704|455463881|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
126591127|NCT04149704|455463882|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
126591128|NCT02677805|455463887|FG000|Double Blind Phase|Lost to Follow-up|8|||
126591129|NCT02677805|455463888|FG001|Double Blind Phase|Lost to Follow-up|3|||
126591130|NCT02677805|455463889|FG002|Double Blind Phase|Lost to Follow-up|0|||
126591131|NCT02677805|455463887|FG000|Double Blind Phase|Withdrawal by Subject|5|||
126591132|NCT02677805|455463888|FG001|Double Blind Phase|Withdrawal by Subject|2|||
126591133|NCT02677805|455463889|FG002|Double Blind Phase|Withdrawal by Subject|0|||
126591134|NCT02677805|455463887|FG000|Open Label Phase|Lost to Follow-up|0|||
126591135|NCT02677805|455463888|FG001|Open Label Phase|Lost to Follow-up|0|||
126591136|NCT02677805|455463889|FG002|Open Label Phase|Lost to Follow-up|10|||
126777927|NCT02544633|456143033|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
126591137|NCT02677805|455463887|FG000|Open Label Phase|Withdrawal by Subject|0|||
126591138|NCT02677805|455463888|FG001|Open Label Phase|Withdrawal by Subject|0|||
126591139|NCT02677805|455463889|FG002|Open Label Phase|Withdrawal by Subject|6|||
126591140|NCT05714761|455463890|FG000|Overall Study|Lost to Follow-up|3|||
126591141|NCT05714761|455463890|FG000|Overall Study|Withdrawal by Subject|3|||
126591142|NCT05714761|455463890|FG000|Overall Study|unblinding of sensor data|1|||
126591143|NCT05714761|455463890|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
126591144|NCT05714761|455463890|FG000|Overall Study|did not return second CGM sensor|4|||
126591145|NCT05949788|455463891|FG000|Overall Study|severe birth deformity|2|||
126591146|NCT05949788|455463892|FG001|Overall Study|severe birth deformity|7|||
126591147|NCT05949788|455463891|FG000|Overall Study|twin-twin transfusion syndrome|2|||
126591148|NCT05949788|455463892|FG001|Overall Study|twin-twin transfusion syndrome|7|||
126591149|NCT05949788|455463891|FG000|Overall Study|neonatal hemolytic disease|3|||
126591150|NCT05949788|455463892|FG001|Overall Study|neonatal hemolytic disease|8|||
126591151|NCT05949788|455463891|FG000|Overall Study|death within 14 days after birth|2|||
126591152|NCT05949788|455463892|FG001|Overall Study|death within 14 days after birth|6|||
126591153|NCT05949788|455463891|FG000|Overall Study|transfer to another hospital|2|||
126591154|NCT05949788|455463892|FG001|Overall Study|transfer to another hospital|6|||
126591155|NCT05213390|455463893|FG000|Overall Study|Withdrawal by Subject|2|||
126591156|NCT05213390|455463893|FG000|Overall Study|Lost to Follow-up|12|||
126591157|NCT05213390|455463893|FG000|Overall Study|Protocol Violation|9|||
126591158|NCT01824537|455463894|FG000|Overall Study|Lost to Follow-up|78|||
126591159|NCT01824537|455463895|FG001|Overall Study|Lost to Follow-up|87|||
126591160|NCT05415722|455463909|FG000|Overall Study|Lost to Follow-up|0|||
126591161|NCT05415722|455463910|FG001|Overall Study|Lost to Follow-up|2|||
126591162|NCT05415722|455463911|FG002|Overall Study|Lost to Follow-up|0|||
126591163|NCT05415722|455463912|FG003|Overall Study|Lost to Follow-up|1|||
126591164|NCT05415722|455463913|FG004|Overall Study|Lost to Follow-up|0|||
126591165|NCT05415722|455463914|FG005|Overall Study|Lost to Follow-up|0|||
126591166|NCT05415722|455463915|FG006|Overall Study|Lost to Follow-up|1|||
126591167|NCT05415722|455463909|FG000|Overall Study|Physician Decision|0|||
126591168|NCT05415722|455463910|FG001|Overall Study|Physician Decision|0|||
126591169|NCT05415722|455463911|FG002|Overall Study|Physician Decision|0|||
126591170|NCT05415722|455463912|FG003|Overall Study|Physician Decision|1|||
126591171|NCT05415722|455463913|FG004|Overall Study|Physician Decision|0|||
126591172|NCT05415722|455463914|FG005|Overall Study|Physician Decision|0|||
126591173|NCT05415722|455463915|FG006|Overall Study|Physician Decision|1|||
126591174|NCT05415722|455463909|FG000|Overall Study|Protocol Violation|0|||
126591175|NCT05415722|455463910|FG001|Overall Study|Protocol Violation|0|||
126591176|NCT05415722|455463911|FG002|Overall Study|Protocol Violation|0|||
126591177|NCT05415722|455463912|FG003|Overall Study|Protocol Violation|1|||
126591178|NCT05415722|455463913|FG004|Overall Study|Protocol Violation|0|||
126591179|NCT05415722|455463914|FG005|Overall Study|Protocol Violation|0|||
126591180|NCT05415722|455463915|FG006|Overall Study|Protocol Violation|0|||
126591181|NCT05415722|455463909|FG000|Overall Study|Sponsor Discretion|0|||
126591182|NCT05415722|455463910|FG001|Overall Study|Sponsor Discretion|0|||
126591183|NCT05415722|455463911|FG002|Overall Study|Sponsor Discretion|0|||
126591184|NCT05415722|455463912|FG003|Overall Study|Sponsor Discretion|0|||
126591185|NCT05415722|455463913|FG004|Overall Study|Sponsor Discretion|1|||
126591186|NCT05415722|455463914|FG005|Overall Study|Sponsor Discretion|1|||
126591187|NCT05415722|455463915|FG006|Overall Study|Sponsor Discretion|0|||
126591188|NCT05415722|455463909|FG000|Overall Study|Withdrawal by Subject|0|||
126591189|NCT05415722|455463910|FG001|Overall Study|Withdrawal by Subject|1|||
126591190|NCT05415722|455463911|FG002|Overall Study|Withdrawal by Subject|0|||
126591191|NCT05415722|455463912|FG003|Overall Study|Withdrawal by Subject|1|||
126591192|NCT05415722|455463913|FG004|Overall Study|Withdrawal by Subject|1|||
126591193|NCT05415722|455463914|FG005|Overall Study|Withdrawal by Subject|0|||
126591194|NCT05415722|455463915|FG006|Overall Study|Withdrawal by Subject|1|||
126591195|NCT02191618|455463922|FG000|Overall Study|Withdrawal by Subject|3|||
126591196|NCT02191618|455463922|FG000|Overall Study|Missed Visit|4|||
126591197|NCT03031470|455463925|FG000|Overall Study|Adverse Event|3|||
126591198|NCT03031470|455463926|FG001|Overall Study|Adverse Event|0|||
126591199|NCT03031470|455463925|FG000|Overall Study|Death|3|||
126591200|NCT03031470|455463926|FG001|Overall Study|Death|1|||
126591201|NCT03031470|455463925|FG000|Overall Study|Lost to Follow-up|1|||
126591202|NCT03031470|455463926|FG001|Overall Study|Lost to Follow-up|1|||
126591203|NCT03031470|455463925|FG000|Overall Study|Withdrawal by Subject|1|||
126591204|NCT03031470|455463926|FG001|Overall Study|Withdrawal by Subject|0|||
126591205|NCT03031470|455463925|FG000|Overall Study|Protocol entry criteria not met|0|||
126591206|NCT03031470|455463926|FG001|Overall Study|Protocol entry criteria not met|1|||
126591207|NCT03031470|455463925|FG000|Overall Study|Cancel the operation|0|||
126591208|NCT03031470|455463926|FG001|Overall Study|Cancel the operation|1|||
126591209|NCT04623671|455463930|FG000|Overall Study|Adverse Event|0|||
126591210|NCT04623671|455463931|FG001|Overall Study|Adverse Event|1|||
126591211|NCT04623671|455463930|FG000|Overall Study|Lost to Follow-up|2|||
126591212|NCT04623671|455463931|FG001|Overall Study|Lost to Follow-up|1|||
126591213|NCT04623671|455463930|FG000|Overall Study|Death|5|||
126591214|NCT04623671|455463931|FG001|Overall Study|Death|5|||
126591215|NCT01943409|455463935|FG000|Overall Study|resumed oral/entral|24|||
126591216|NCT01943409|455463936|FG001|Overall Study|resumed oral/entral|20|||
126591217|NCT01943409|455463935|FG000|Overall Study|Protocol Violation|14|||
126591218|NCT01943409|455463936|FG001|Overall Study|Protocol Violation|24|||
126591219|NCT01943409|455463935|FG000|Overall Study|Death|3|||
126591220|NCT01943409|455463936|FG001|Overall Study|Death|1|||
126591221|NCT01943409|455463935|FG000|Overall Study|Withdrawal by Subject|4|||
126591222|NCT01943409|455463936|FG001|Overall Study|Withdrawal by Subject|3|||
126591223|NCT02310646|455463937|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
126591224|NCT02310646|455463938|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
126591225|NCT02310646|455463937|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
126591226|NCT02310646|455463938|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
126591227|NCT03496168|455463945|FG000|Overall Study|Other Reasons|1|||
126591228|NCT03496168|455463945|FG000|Overall Study|Adverse Event|1|||
126591229|NCT05869383|455463946|FG000|Overall Study|Withdrawal by Subject|2|||
126591230|NCT05869383|455463947|FG001|Overall Study|Withdrawal by Subject|0|||
126591231|NCT01648023|455463952|FG000|Overall Study|Screen Fail Post Randomization|1|||
126591232|NCT01648023|455463953|FG001|Overall Study|Screen Fail Post Randomization|2|||
126591233|NCT04599062|455463959|FG000|Overall Study|Physician Decision|1|||
126591234|NCT04599062|455463960|FG001|Overall Study|Physician Decision|0|||
126591235|NCT04074759|455463962|FG000|Overall Study|Withdrawal by Subject|0|||
126591236|NCT04074759|455463963|FG001|Overall Study|Withdrawal by Subject|0|||
126591237|NCT04074759|455463964|FG002|Overall Study|Withdrawal by Subject|0|||
126591238|NCT04074759|455463965|FG003|Overall Study|Withdrawal by Subject|0|||
126591239|NCT04074759|455463966|FG004|Overall Study|Withdrawal by Subject|0|||
126591240|NCT04074759|455463967|FG005|Overall Study|Withdrawal by Subject|2|||
126591241|NCT04074759|455463968|FG006|Overall Study|Withdrawal by Subject|0|||
126591242|NCT04074759|455463969|FG007|Overall Study|Withdrawal by Subject|2|||
126591243|NCT04074759|455463970|FG008|Overall Study|Withdrawal by Subject|1|||
126591244|NCT04074759|455463971|FG009|Overall Study|Withdrawal by Subject|2|||
126591245|NCT04074759|455463972|FG010|Overall Study|Withdrawal by Subject|9|||
126591246|NCT04074759|455463973|FG011|Overall Study|Withdrawal by Subject|2|||
126591247|NCT04074759|455463974|FG012|Overall Study|Withdrawal by Subject|1|||
126591248|NCT04074759|455463975|FG013|Overall Study|Withdrawal by Subject|3|||
126591249|NCT04074759|455463976|FG014|Overall Study|Withdrawal by Subject|2|||
126591250|NCT04074759|455463977|FG015|Overall Study|Withdrawal by Subject|0|||
126591251|NCT04074759|455463978|FG016|Overall Study|Withdrawal by Subject|0|||
126591252|NCT04074759|455463979|FG017|Overall Study|Withdrawal by Subject|3|||
126591253|NCT04074759|455463980|FG018|Overall Study|Withdrawal by Subject|1|||
126591254|NCT04074759|455463962|FG000|Overall Study|Death|1|||
126591255|NCT04074759|455463963|FG001|Overall Study|Death|0|||
126591256|NCT04074759|455463964|FG002|Overall Study|Death|1|||
126591257|NCT04074759|455463965|FG003|Overall Study|Death|1|||
126591258|NCT04074759|455463966|FG004|Overall Study|Death|2|||
126591259|NCT04074759|455463967|FG005|Overall Study|Death|0|||
126591260|NCT04074759|455463968|FG006|Overall Study|Death|1|||
126591261|NCT04074759|455463969|FG007|Overall Study|Death|0|||
126591262|NCT04074759|455463970|FG008|Overall Study|Death|3|||
126591263|NCT04074759|455463971|FG009|Overall Study|Death|2|||
126591264|NCT04074759|455463972|FG010|Overall Study|Death|4|||
126591265|NCT04074759|455463973|FG011|Overall Study|Death|1|||
126591266|NCT04074759|455463974|FG012|Overall Study|Death|0|||
126591267|NCT04074759|455463975|FG013|Overall Study|Death|2|||
126591268|NCT04074759|455463976|FG014|Overall Study|Death|1|||
126591269|NCT04074759|455463977|FG015|Overall Study|Death|0|||
126591270|NCT04074759|455463978|FG016|Overall Study|Death|1|||
126591271|NCT04074759|455463979|FG017|Overall Study|Death|0|||
126591272|NCT04074759|455463980|FG018|Overall Study|Death|1|||
126591273|NCT04074759|455463962|FG000|Overall Study|Lost to Follow-up|0|||
126591274|NCT04074759|455463963|FG001|Overall Study|Lost to Follow-up|0|||
126591275|NCT04074759|455463964|FG002|Overall Study|Lost to Follow-up|0|||
126591276|NCT04074759|455463965|FG003|Overall Study|Lost to Follow-up|0|||
126591277|NCT04074759|455463966|FG004|Overall Study|Lost to Follow-up|0|||
126591278|NCT04074759|455463967|FG005|Overall Study|Lost to Follow-up|0|||
126777928|NCT02544633|456143034|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
126777929|NCT02544633|456143035|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
126777930|NCT02544633|456143032|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
126777931|NCT02544633|456143033|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
126591279|NCT04074759|455463968|FG006|Overall Study|Lost to Follow-up|0|||
126591280|NCT04074759|455463969|FG007|Overall Study|Lost to Follow-up|0|||
126591281|NCT04074759|455463970|FG008|Overall Study|Lost to Follow-up|0|||
126591282|NCT04074759|455463971|FG009|Overall Study|Lost to Follow-up|0|||
126591283|NCT04074759|455463972|FG010|Overall Study|Lost to Follow-up|1|||
126591284|NCT04074759|455463973|FG011|Overall Study|Lost to Follow-up|0|||
126591285|NCT04074759|455463974|FG012|Overall Study|Lost to Follow-up|0|||
126591286|NCT04074759|455463975|FG013|Overall Study|Lost to Follow-up|0|||
126591287|NCT04074759|455463976|FG014|Overall Study|Lost to Follow-up|0|||
126591288|NCT04074759|455463977|FG015|Overall Study|Lost to Follow-up|0|||
126591289|NCT04074759|455463978|FG016|Overall Study|Lost to Follow-up|1|||
126591290|NCT04074759|455463979|FG017|Overall Study|Lost to Follow-up|0|||
126591291|NCT04074759|455463980|FG018|Overall Study|Lost to Follow-up|1|||
126591292|NCT04074759|455463962|FG000|Overall Study|Other|0|||
126591293|NCT04074759|455463963|FG001|Overall Study|Other|1|||
126591294|NCT04074759|455463964|FG002|Overall Study|Other|1|||
126591295|NCT04074759|455463965|FG003|Overall Study|Other|0|||
126591296|NCT04074759|455463966|FG004|Overall Study|Other|2|||
126591297|NCT04074759|455463967|FG005|Overall Study|Other|1|||
126591298|NCT04074759|455463968|FG006|Overall Study|Other|2|||
126591299|NCT04074759|455463969|FG007|Overall Study|Other|1|||
126591300|NCT04074759|455463970|FG008|Overall Study|Other|1|||
126591301|NCT04074759|455463971|FG009|Overall Study|Other|4|||
126591302|NCT04074759|455463972|FG010|Overall Study|Other|4|||
126591303|NCT04074759|455463973|FG011|Overall Study|Other|2|||
126591304|NCT04074759|455463974|FG012|Overall Study|Other|0|||
126591305|NCT04074759|455463975|FG013|Overall Study|Other|0|||
126591306|NCT04074759|455463976|FG014|Overall Study|Other|0|||
126591307|NCT04074759|455463977|FG015|Overall Study|Other|1|||
126591308|NCT04074759|455463978|FG016|Overall Study|Other|0|||
126591309|NCT04074759|455463979|FG017|Overall Study|Other|0|||
126591310|NCT04074759|455463980|FG018|Overall Study|Other|0|||
126591311|NCT04074759|455463962|FG000|Overall Study|Missing end of study status|0|||
126591312|NCT04074759|455463963|FG001|Overall Study|Missing end of study status|0|||
126591313|NCT04074759|455463964|FG002|Overall Study|Missing end of study status|0|||
126591314|NCT04074759|455463965|FG003|Overall Study|Missing end of study status|0|||
126591315|NCT04074759|455463966|FG004|Overall Study|Missing end of study status|0|||
126591316|NCT04074759|455463967|FG005|Overall Study|Missing end of study status|0|||
126591317|NCT04074759|455463968|FG006|Overall Study|Missing end of study status|0|||
126591318|NCT04074759|455463969|FG007|Overall Study|Missing end of study status|0|||
126591319|NCT04074759|455463970|FG008|Overall Study|Missing end of study status|0|||
126591320|NCT04074759|455463971|FG009|Overall Study|Missing end of study status|0|||
126591321|NCT04074759|455463972|FG010|Overall Study|Missing end of study status|2|||
126591322|NCT04074759|455463973|FG011|Overall Study|Missing end of study status|0|||
126591323|NCT04074759|455463974|FG012|Overall Study|Missing end of study status|0|||
126591324|NCT04074759|455463975|FG013|Overall Study|Missing end of study status|0|||
126591325|NCT04074759|455463976|FG014|Overall Study|Missing end of study status|0|||
126591326|NCT04074759|455463977|FG015|Overall Study|Missing end of study status|0|||
126591327|NCT04074759|455463978|FG016|Overall Study|Missing end of study status|1|||
126591328|NCT04074759|455463979|FG017|Overall Study|Missing end of study status|0|||
126591329|NCT04074759|455463980|FG018|Overall Study|Missing end of study status|0|||
126591330|NCT02231164|455463983|FG000|Overall Study|Adverse Event|1|||
126591331|NCT02231164|455463984|FG001|Overall Study|Adverse Event|1|||
126591332|NCT02231164|455463983|FG000|Overall Study|Lack of Efficacy|4|||
126591333|NCT02231164|455463984|FG001|Overall Study|Lack of Efficacy|3|||
126591334|NCT02231164|455463983|FG000|Overall Study|Withdrawal by Subject|1|||
126591335|NCT02231164|455463984|FG001|Overall Study|Withdrawal by Subject|2|||
126591336|NCT03931174|455463985|FG000|Providers|Staff left organization|26|||
126591337|NCT03931174|455463986|FG001|Providers|Staff left organization|25|||
126591338|NCT03931174|455463985|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
126591339|NCT03931174|455463986|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
126591340|NCT03931174|455463985|FG000|Providers|Lost to Follow-up|4|||
126591341|NCT03931174|455463986|FG001|Providers|Lost to Follow-up|4|||
126591342|NCT03931174|455463985|FG000|Patients|Post-consent screening failure|1|||
126591343|NCT03931174|455463986|FG001|Patients|Post-consent screening failure|1|||
126591344|NCT03931174|455463985|FG000|Patients|Death|1|||
126591345|NCT03931174|455463986|FG001|Patients|Death|1|||
126591346|NCT03931174|455463985|FG000|Patients|Lost to Follow-up|60|||
126591347|NCT03931174|455463986|FG001|Patients|Lost to Follow-up|89|||
126591348|NCT03322267|455463987|FG000|Overall Study|Lack of Efficacy|11|||
126591349|NCT03322267|455463987|FG000|Overall Study|Adverse Event|1|||
126591350|NCT03322267|455463987|FG000|Overall Study|Withdrawal by Subject|2|||
126591351|NCT03852472|455463997|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
126591352|NCT03852472|455463998|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
126591353|NCT03852472|455463999|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
126591354|NCT03852472|455464000|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
126591355|NCT03852472|455464001|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
126591356|NCT03852472|455463997|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
126591357|NCT03852472|455463998|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
126591358|NCT03852472|455463999|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
126591359|NCT03852472|455464000|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
126591360|NCT03852472|455464001|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
126591361|NCT03852472|455463997|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
126591362|NCT03852472|455463998|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
126591363|NCT03852472|455463999|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
126591364|NCT03852472|455464000|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
126591365|NCT03852472|455464001|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
126591366|NCT03852472|455463997|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
126591367|NCT03852472|455463998|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
126591368|NCT03852472|455463999|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
126591369|NCT03852472|455464000|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
126591370|NCT03852472|455464001|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
126591371|NCT03852472|455463997|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
126591372|NCT03852472|455463998|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
126591373|NCT03852472|455463999|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
126591374|NCT03852472|455464000|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
126591375|NCT03852472|455464001|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
126591376|NCT03852472|455463997|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
126591377|NCT03852472|455463998|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
126591378|NCT03852472|455463999|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
126591379|NCT03852472|455464000|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
126591380|NCT03852472|455464001|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
126591381|NCT03852472|455463997|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
126591382|NCT03852472|455463998|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
126591383|NCT03852472|455463999|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
126591384|NCT03852472|455464000|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
126591385|NCT03852472|455464001|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
126591386|NCT03852472|455463997|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
126591387|NCT03852472|455463998|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
126591388|NCT03852472|455463999|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
126591389|NCT03852472|455464000|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
126591390|NCT03852472|455464001|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
126591391|NCT03852472|455463997|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
126591392|NCT03852472|455463998|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
126591393|NCT03852472|455463999|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
126591394|NCT03852472|455464000|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
126591395|NCT03852472|455464001|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
126591396|NCT03852472|455463997|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
126591397|NCT03852472|455463998|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
126591398|NCT03852472|455463999|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
126591399|NCT03852472|455464000|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
126591400|NCT03852472|455464001|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
126591401|NCT03852472|455463997|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
126591402|NCT03852472|455463998|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
126591403|NCT03852472|455463999|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
126591404|NCT03852472|455464000|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
126591405|NCT03852472|455464001|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
126591406|NCT03852472|455463997|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
126591407|NCT03852472|455463998|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
126591408|NCT03852472|455463999|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
126591409|NCT03852472|455464000|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
126591410|NCT03852472|455464001|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
126591411|NCT03852472|455463997|FG000|Period 2 - Week 44|Adverse Event|0|||
126591412|NCT03852472|455463998|FG001|Period 2 - Week 44|Adverse Event|3|||
126591413|NCT03852472|455463999|FG002|Period 2 - Week 44|Adverse Event|1|||
126591414|NCT03852472|455464000|FG003|Period 2 - Week 44|Adverse Event|2|||
126591415|NCT03852472|455464001|FG004|Period 2 - Week 44|Adverse Event|2|||
126591416|NCT03852472|455463997|FG000|Period 2 - Week 44|COVID-19 Related|0|||
126591417|NCT03852472|455463998|FG001|Period 2 - Week 44|COVID-19 Related|0|||
126591418|NCT03852472|455463999|FG002|Period 2 - Week 44|COVID-19 Related|0|||
126591419|NCT03852472|455464000|FG003|Period 2 - Week 44|COVID-19 Related|1|||
126591420|NCT03852472|455464001|FG004|Period 2 - Week 44|COVID-19 Related|0|||
126591421|NCT03852472|455463997|FG000|Period 2 - Week 44|Reason not stated|0|||
126591422|NCT03852472|455463998|FG001|Period 2 - Week 44|Reason not stated|0|||
126591423|NCT03852472|455463999|FG002|Period 2 - Week 44|Reason not stated|0|||
126591424|NCT03852472|455464000|FG003|Period 2 - Week 44|Reason not stated|0|||
126591425|NCT03852472|455464001|FG004|Period 2 - Week 44|Reason not stated|1|||
126591426|NCT06457802|455464002|FG000|Overall Study|Early termination of study prior to participant completion|2|||
126591427|NCT06457802|455464003|FG001|Overall Study|Early termination of study prior to participant completion|2|||
126591428|NCT01467427|455464004|FG000|Overall Study|Withdrawal by Subject|1|||
126591429|NCT01467427|455464005|FG001|Overall Study|Withdrawal by Subject|0|||
126591430|NCT01467427|455464004|FG000|Overall Study|Not continuing in extension phase|0|||
126591431|NCT01467427|455464005|FG001|Overall Study|Not continuing in extension phase|2|||
126591432|NCT01467427|455464004|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
126591433|NCT01467427|455464005|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
126591434|NCT01467427|455464004|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
126591435|NCT01467427|455464005|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
126591436|NCT01467427|455464004|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
126591437|NCT01467427|455464005|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
126591438|NCT01467427|455464004|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
126591439|NCT01467427|455464005|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
126591440|NCT03161028|455464006|FG000|Overall Study|Withdrawal by Subject|6|||
126591441|NCT03161028|455464007|FG001|Overall Study|Withdrawal by Subject|4|||
126591442|NCT03161028|455464006|FG000|Overall Study|Adverse Event|5|||
126591443|NCT03161028|455464007|FG001|Overall Study|Adverse Event|1|||
126591444|NCT03161028|455464006|FG000|Overall Study|Study drug side effects|2|||
126591445|NCT03161028|455464007|FG001|Overall Study|Study drug side effects|2|||
126591446|NCT03161028|455464006|FG000|Overall Study|Administrative PD/UP|4|||
126591447|NCT03161028|455464007|FG001|Overall Study|Administrative PD/UP|2|||
126591448|NCT03161028|455464006|FG000|Overall Study|Lost to Follow-up|2|||
126591449|NCT03161028|455464007|FG001|Overall Study|Lost to Follow-up|0|||
126591450|NCT03161028|455464006|FG000|Overall Study|Unable to comply with procedures|1|||
126591451|NCT03161028|455464007|FG001|Overall Study|Unable to comply with procedures|1|||
126591452|NCT00736723|455464008|FG000|Overall Study|Withdrawal by Subject|4|||
126591453|NCT00736723|455464009|FG001|Overall Study|Withdrawal by Subject|3|||
126591454|NCT03492216|455464010|FG000|Overall Study|Death|1|||
126591455|NCT03492216|455464011|FG001|Overall Study|Death|0|||
126591456|NCT03492216|455464012|FG002|Overall Study|Death|4|||
126591457|NCT03492216|455464013|FG003|Overall Study|Death|0|||
126591458|NCT03492216|455464010|FG000|Overall Study|Withdrawal by Subject|5|||
126591459|NCT03492216|455464011|FG001|Overall Study|Withdrawal by Subject|3|||
126591460|NCT03492216|455464012|FG002|Overall Study|Withdrawal by Subject|1|||
126591461|NCT03492216|455464013|FG003|Overall Study|Withdrawal by Subject|1|||
126591462|NCT03492216|455464010|FG000|Overall Study|Lost to Follow-up|9|||
126591463|NCT03492216|455464011|FG001|Overall Study|Lost to Follow-up|2|||
126591464|NCT03492216|455464012|FG002|Overall Study|Lost to Follow-up|7|||
126591465|NCT03492216|455464013|FG003|Overall Study|Lost to Follow-up|8|||
126591466|NCT03492216|455464010|FG000|Overall Study|Moved|5|||
126591467|NCT03492216|455464011|FG001|Overall Study|Moved|3|||
126591468|NCT03492216|455464012|FG002|Overall Study|Moved|3|||
126591469|NCT03492216|455464013|FG003|Overall Study|Moved|5|||
126591470|NCT03492216|455464010|FG000|Overall Study|Too ill|0|||
126591471|NCT03492216|455464011|FG001|Overall Study|Too ill|1|||
126591472|NCT03492216|455464012|FG002|Overall Study|Too ill|0|||
126591473|NCT03492216|455464013|FG003|Overall Study|Too ill|0|||
126591474|NCT03492216|455464010|FG000|Overall Study|Incarcerated|0|||
126591475|NCT03492216|455464011|FG001|Overall Study|Incarcerated|0|||
126591476|NCT03492216|455464012|FG002|Overall Study|Incarcerated|2|||
126591477|NCT03492216|455464013|FG003|Overall Study|Incarcerated|0|||
126591478|NCT03945292|455466198|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
126591479|NCT03945292|455466199|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
126591480|NCT03945292|455466200|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
126591481|NCT03945292|455466201|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
126591482|NCT03945292|455466202|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
126591483|NCT03945292|455466203|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
126591484|NCT03945292|455466204|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
126591485|NCT03945292|455466205|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
126591486|NCT03945292|455466198|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126591487|NCT03945292|455466199|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126591488|NCT03945292|455466200|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
126591489|NCT03945292|455466201|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126591490|NCT03945292|455466202|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126591491|NCT03945292|455466203|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126591492|NCT03945292|455466204|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126591493|NCT03945292|455466205|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
126591494|NCT03945292|455466198|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126591495|NCT03945292|455466199|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126591496|NCT03945292|455466200|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126591497|NCT03945292|455466201|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126591498|NCT03945292|455466202|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126591499|NCT03945292|455466203|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126591500|NCT03945292|455466204|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
126591501|NCT03945292|455466205|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
126591502|NCT03524118|455466207|FG000|Overall Study|Lost to Follow-up|0|||
126591503|NCT03524118|455466208|FG001|Overall Study|Lost to Follow-up|0|||
126591504|NCT03524118|455466209|FG002|Overall Study|Lost to Follow-up|0|||
126591505|NCT03524118|455466210|FG003|Overall Study|Lost to Follow-up|0|||
126591506|NCT03524118|455466211|FG004|Overall Study|Lost to Follow-up|1|||
126591507|NCT03524118|455466212|FG005|Overall Study|Lost to Follow-up|0|||
126591508|NCT03524118|455466207|FG000|Overall Study|Other|0|||
126591509|NCT03524118|455466208|FG001|Overall Study|Other|1|||
126591510|NCT03524118|455466209|FG002|Overall Study|Other|0|||
126591511|NCT03524118|455466210|FG003|Overall Study|Other|0|||
126591512|NCT03524118|455466211|FG004|Overall Study|Other|1|||
126591513|NCT03524118|455466212|FG005|Overall Study|Other|1|||
126591514|NCT03524118|455466207|FG000|Overall Study|Physician Decision|0|||
126591515|NCT03524118|455466208|FG001|Overall Study|Physician Decision|0|||
126591516|NCT03524118|455466209|FG002|Overall Study|Physician Decision|0|||
126591517|NCT03524118|455466210|FG003|Overall Study|Physician Decision|0|||
126591518|NCT03524118|455466211|FG004|Overall Study|Physician Decision|1|||
126591519|NCT03524118|455466212|FG005|Overall Study|Physician Decision|0|||
126591520|NCT03524118|455466207|FG000|Overall Study|Protocol Violation|0|||
126591521|NCT03524118|455466208|FG001|Overall Study|Protocol Violation|0|||
126591522|NCT03524118|455466209|FG002|Overall Study|Protocol Violation|1|||
126591523|NCT03524118|455466210|FG003|Overall Study|Protocol Violation|0|||
126591524|NCT03524118|455466211|FG004|Overall Study|Protocol Violation|1|||
126591525|NCT03524118|455466212|FG005|Overall Study|Protocol Violation|0|||
126591526|NCT03524118|455466207|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126591527|NCT03524118|455466208|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126591528|NCT03524118|455466209|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126591529|NCT03524118|455466210|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
126591530|NCT03524118|455466211|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
126591531|NCT03524118|455466212|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126591532|NCT04987320|455466213|FG000|Overall Study|Withdrawal by Subject|0|||
126591533|NCT04987320|455466214|FG001|Overall Study|Withdrawal by Subject|1|||
126591534|NCT00433329|455466217|FG000|Overall Study|Adverse Event|9|||
126591535|NCT00433329|455466217|FG000|Overall Study|Death|4|||
126591536|NCT00433329|455466217|FG000|Overall Study|Withdrew consent|3|||
126591537|NCT00433329|455466217|FG000|Overall Study|Discontinued sildenafil|2|||
126591538|NCT00433329|455466217|FG000|Overall Study|Moved out of state|1|||
126591539|NCT00433329|455466217|FG000|Overall Study|Lost to Follow-up|1|||
126591540|NCT00433329|455466217|FG000|Overall Study|Physician Decision|1|||
126591541|NCT01098812|455466218|FG000|Overall Study|Death|2|||
126591542|NCT01098812|455466219|FG001|Overall Study|Death|0|||
126591543|NCT01098812|455466220|FG002|Overall Study|Death|1|||
126591544|NCT01098812|455466218|FG000|Overall Study|Lost to Follow-up|0|||
126591545|NCT01098812|455466219|FG001|Overall Study|Lost to Follow-up|1|||
126591546|NCT01098812|455466220|FG002|Overall Study|Lost to Follow-up|0|||
126591547|NCT01129102|455466221|FG000|Overall Study|No study drug treatment|2|||
126591548|NCT01129102|455466222|FG001|Overall Study|No study drug treatment|3|||
126591549|NCT01129102|455466223|FG002|Overall Study|No study drug treatment|1|||
126591550|NCT01129102|455466221|FG000|Overall Study|Withdrawal by Subject|2|||
126591551|NCT01129102|455466222|FG001|Overall Study|Withdrawal by Subject|0|||
126591552|NCT01129102|455466223|FG002|Overall Study|Withdrawal by Subject|3|||
126591553|NCT01129102|455466221|FG000|Overall Study|Protocol Violation|0|||
126591554|NCT01129102|455466222|FG001|Overall Study|Protocol Violation|1|||
126591555|NCT01129102|455466223|FG002|Overall Study|Protocol Violation|1|||
126591556|NCT01129102|455466221|FG000|Overall Study|Pregnancy|0|||
126591557|NCT01129102|455466222|FG001|Overall Study|Pregnancy|0|||
126591558|NCT01129102|455466223|FG002|Overall Study|Pregnancy|1|||
126591559|NCT01129102|455466221|FG000|Overall Study|Adverse Event|2|||
126591560|NCT01129102|455466222|FG001|Overall Study|Adverse Event|2|||
126591561|NCT01129102|455466223|FG002|Overall Study|Adverse Event|1|||
126591562|NCT01129102|455466221|FG000|Overall Study|Lost to Follow-up|2|||
126591563|NCT01129102|455466222|FG001|Overall Study|Lost to Follow-up|0|||
126591564|NCT01129102|455466223|FG002|Overall Study|Lost to Follow-up|0|||
126591565|NCT03379675|455466228|FG000|Overall Study|Lost to Follow-up|0|||
126591566|NCT03379675|455466229|FG001|Overall Study|Lost to Follow-up|1|||
126591567|NCT03379675|455466230|FG002|Overall Study|Lost to Follow-up|0|||
126591568|NCT03379675|455466228|FG000|Overall Study|Adverse Event|2|||
126591569|NCT03379675|455466229|FG001|Overall Study|Adverse Event|0|||
126591570|NCT03379675|455466230|FG002|Overall Study|Adverse Event|0|||
126591571|NCT03379675|455466228|FG000|Overall Study|Withdrawal by Subject|2|||
126591572|NCT03379675|455466229|FG001|Overall Study|Withdrawal by Subject|1|||
126591573|NCT03379675|455466230|FG002|Overall Study|Withdrawal by Subject|2|||
126591574|NCT03462030|455466234|FG000|Overall Study|Withdrawal by Subject|1|||
126591575|NCT03462030|455466235|FG001|Overall Study|Withdrawal by Subject|1|||
126591576|NCT02675751|455466236|FG000|Overall Study|Lost to Follow-up|16|||
126591577|NCT03371381|455466237|FG000|Overall Study|Death|5|||
126591578|NCT03371381|455466237|FG000|Overall Study|Study terminated by sponsor|3|||
126591579|NCT03371381|455466237|FG000|Overall Study|Other|4|||
126591580|NCT02979327|455466238|FG000|First Intervention|Protocol Violation|1|||
126591581|NCT02979327|455466239|FG001|First Intervention|Protocol Violation|0|||
126591582|NCT05020249|455466240|FG000|Overall Study|Protocol Violation|1|||
126591583|NCT05020249|455466241|FG001|Overall Study|Protocol Violation|0|||
126591584|NCT03628924|455466250|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
126591585|NCT03628924|455466251|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
126591586|NCT03628924|455466252|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
126591587|NCT03628924|455466253|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
126591588|NCT03628924|455466254|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
126591589|NCT03628924|455466255|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
126591590|NCT03628924|455466256|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
126591591|NCT03628924|455466250|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126591592|NCT03628924|455466251|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126591593|NCT03628924|455466252|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
126591594|NCT03628924|455466253|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126591595|NCT03628924|455466254|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126591596|NCT03628924|455466255|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126591597|NCT03628924|455466256|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
126591598|NCT03628924|455466250|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
126591599|NCT03628924|455466251|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
126591600|NCT03628924|455466252|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
126591601|NCT03628924|455466253|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
126591602|NCT03628924|455466254|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
126591603|NCT03628924|455466255|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
126591604|NCT03628924|455466256|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
126591605|NCT03628924|455466250|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126591606|NCT03628924|455466251|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
126591607|NCT03628924|455466252|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126591608|NCT03628924|455466253|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126591609|NCT03628924|455466254|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126591610|NCT03628924|455466255|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126591611|NCT03628924|455466256|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126591612|NCT03628924|455466250|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
126591613|NCT03628924|455466251|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
126591614|NCT03628924|455466252|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
126591615|NCT03628924|455466253|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
126591616|NCT03628924|455466254|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
126591617|NCT03628924|455466255|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
126591618|NCT03628924|455466256|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
126591619|NCT03628924|455466250|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
126591620|NCT03628924|455466251|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
126591621|NCT03628924|455466252|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
126591622|NCT03628924|455466253|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
126591623|NCT03628924|455466254|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
126591624|NCT03628924|455466255|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
126591625|NCT03628924|455466256|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
126591626|NCT03628924|455466250|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
126591627|NCT03628924|455466251|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
126591628|NCT03628924|455466252|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
126591629|NCT03628924|455466253|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
126591630|NCT03628924|455466254|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
126591631|NCT03628924|455466255|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
126591632|NCT03628924|455466256|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
126591633|NCT03628924|455466250|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
126591634|NCT03628924|455466251|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
126591635|NCT03628924|455466252|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
126591636|NCT03628924|455466253|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
126591637|NCT03628924|455466254|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
126591638|NCT03628924|455466255|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
126591639|NCT03628924|455466256|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
126591640|NCT03628924|455466250|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
126591641|NCT03628924|455466251|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
126591642|NCT03628924|455466252|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
126591643|NCT03628924|455466253|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
126591644|NCT03628924|455466254|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
126591645|NCT03628924|455466255|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
126591646|NCT03628924|455466256|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
126591647|NCT03628924|455466250|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
126591648|NCT03628924|455466251|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
126591649|NCT03628924|455466252|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
126591650|NCT03628924|455466253|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
126591651|NCT03628924|455466254|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
126591652|NCT03628924|455466255|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
126591653|NCT03628924|455466256|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
126591654|NCT03474679|455466263|FG000|Overall Study|Death|7|||
126591655|NCT03474679|455466263|FG000|Overall Study|Withdrawal by Subject|1|||
126591656|NCT05499377|455466266|FG000|Overall Study|Withdrawal by Subject|2|||
126591657|NCT05499377|455466267|FG001|Overall Study|Withdrawal by Subject|0|||
126591658|NCT05499377|455466266|FG000|Overall Study|Physician Decision|1|||
126591659|NCT05499377|455466267|FG001|Overall Study|Physician Decision|0|||
126591660|NCT02573493|455466268|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
126591661|NCT02573493|455466269|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
126591662|NCT02573493|455466270|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
126591663|NCT02573493|455466271|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
126591664|NCT04332926|455466272|FG000|Overall Study|Withdrawal by Subject|6|||
126591665|NCT04332926|455466272|FG000|Overall Study|Physician Decision|6|||
126591666|NCT05672069|455466274|FG000|Overall Study|Implant removal|1|||
126591667|NCT05672069|455466274|FG000|Overall Study|Lost to Follow-up|2|||
126591668|NCT06019559|455466275|FG000|Overall Study|Withdrawal by Subject|7|||
126591669|NCT06019559|455466276|FG001|Overall Study|Withdrawal by Subject|6|||
126591670|NCT06019559|455466277|FG002|Overall Study|Withdrawal by Subject|5|||
126591671|NCT06019559|455466275|FG000|Overall Study|Lost to Follow-up|2|||
126591672|NCT06019559|455466276|FG001|Overall Study|Lost to Follow-up|0|||
126591673|NCT06019559|455466277|FG002|Overall Study|Lost to Follow-up|3|||
126591674|NCT06215521|455466278|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
126591675|NCT06215521|455466279|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
126591676|NCT06215521|455466280|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
126591677|NCT06215521|455466281|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
126591678|NCT06215521|455466282|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
126591679|NCT06215521|455466283|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
126591680|NCT03858634|455466287|FG000|Overall Study|Withdrawal by Subject|1|||
126591681|NCT03858634|455466288|FG001|Overall Study|Withdrawal by Subject|0|||
126591682|NCT03858634|455466287|FG000|Overall Study|Adverse Event|1|||
126591683|NCT03858634|455466288|FG001|Overall Study|Adverse Event|0|||
126591684|NCT03858634|455466287|FG000|Overall Study|Lost to Follow-up|0|||
126591685|NCT03858634|455466288|FG001|Overall Study|Lost to Follow-up|1|||
126591686|NCT03858634|455466287|FG000|Overall Study|Other, Not Specified|1|||
126591687|NCT03858634|455466288|FG001|Overall Study|Other, Not Specified|1|||
126591688|NCT03808818|455466289|FG000|Overall Study|Death|6|||
126591689|NCT03808818|455466290|FG001|Overall Study|Death|6|||
126591690|NCT03808818|455466289|FG000|Overall Study|Withdrawal by Subject|7|||
126591691|NCT03808818|455466290|FG001|Overall Study|Withdrawal by Subject|18|||
126591692|NCT03808818|455466289|FG000|Overall Study|Lost to Follow-up|31|||
126591693|NCT03808818|455466290|FG001|Overall Study|Lost to Follow-up|33|||
126591694|NCT04676763|455466291|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
126591695|NCT04676763|455466292|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
126591696|NCT04676763|455466293|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
126591697|NCT04676763|455466291|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
126591698|NCT04676763|455466292|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
126591699|NCT04676763|455466293|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
126591700|NCT04676763|455466291|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
126591701|NCT04676763|455466292|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
126591702|NCT04676763|455466293|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
126591703|NCT03150173|455466294|FG000|Overall Study|Lost to Follow-up|13|||
126591704|NCT03150173|455466295|FG001|Overall Study|Lost to Follow-up|5|||
126591705|NCT02547363|455466304|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
126591706|NCT02547363|455466305|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
126591707|NCT02547363|455466304|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
126591708|NCT02547363|455466305|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
126591709|NCT02547363|455466304|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
126591710|NCT02547363|455466305|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
126591711|NCT02547363|455466304|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
126591712|NCT02547363|455466305|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
126591713|NCT02547363|455466304|FG000|12-month Follow-up|Withdrawal by Subject|4|||
126591714|NCT02547363|455466305|FG001|12-month Follow-up|Withdrawal by Subject|3|||
126591715|NCT02547363|455466304|FG000|12-month Follow-up|Lost to Follow-up|4|||
126591716|NCT02547363|455466305|FG001|12-month Follow-up|Lost to Follow-up|1|||
126591717|NCT02547363|455466304|FG000|12-month Follow-up|Lack of Efficacy|1|||
126591718|NCT02547363|455466305|FG001|12-month Follow-up|Lack of Efficacy|1|||
126591719|NCT02547363|455466304|FG000|12-month Follow-up|Other|1|||
126591720|NCT02547363|455466305|FG001|12-month Follow-up|Other|0|||
126591721|NCT05281562|455466308|FG000|Overall Study|Ineligible patient|1|||
126591722|NCT05281562|455466309|FG001|Overall Study|Ineligible patient|0|||
126591723|NCT04436276|455466310|FG000|Overall Study|Adverse Event|0|||
126591724|NCT04436276|455466311|FG001|Overall Study|Adverse Event|0|||
126591725|NCT04436276|455466312|FG002|Overall Study|Adverse Event|0|||
126591726|NCT04436276|455466313|FG003|Overall Study|Adverse Event|0|||
126591727|NCT04436276|455466314|FG004|Overall Study|Adverse Event|0|||
126591728|NCT04436276|455466315|FG005|Overall Study|Adverse Event|0|||
126591729|NCT04436276|455466316|FG006|Overall Study|Adverse Event|0|||
126591730|NCT04436276|455466317|FG007|Overall Study|Adverse Event|0|||
126591731|NCT04436276|455466318|FG008|Overall Study|Adverse Event|0|||
126591732|NCT04436276|455466319|FG009|Overall Study|Adverse Event|0|||
126591733|NCT04436276|455466320|FG010|Overall Study|Adverse Event|0|||
126591734|NCT04436276|455466321|FG011|Overall Study|Adverse Event|0|||
126591735|NCT04436276|455466322|FG012|Overall Study|Adverse Event|0|||
126591736|NCT04436276|455466323|FG013|Overall Study|Adverse Event|0|||
126591737|NCT04436276|455466324|FG014|Overall Study|Adverse Event|0|||
126591738|NCT04436276|455466325|FG015|Overall Study|Adverse Event|0|||
126591739|NCT04436276|455466326|FG016|Overall Study|Adverse Event|1|||
126591740|NCT04436276|455466327|FG017|Overall Study|Adverse Event|0|||
126591741|NCT04436276|455466328|FG018|Overall Study|Adverse Event|0|||
126591742|NCT04436276|455466329|FG019|Overall Study|Adverse Event|0|||
126591743|NCT04436276|455466330|FG020|Overall Study|Adverse Event|0|||
126591744|NCT04436276|455466331|FG021|Overall Study|Adverse Event|0|||
126591745|NCT04436276|455466332|FG022|Overall Study|Adverse Event|0|||
126591746|NCT04436276|455466310|FG000|Overall Study|Death|0|||
126591747|NCT04436276|455466311|FG001|Overall Study|Death|0|||
126591748|NCT04436276|455466312|FG002|Overall Study|Death|0|||
126591749|NCT04436276|455466313|FG003|Overall Study|Death|0|||
126591750|NCT04436276|455466314|FG004|Overall Study|Death|0|||
126591751|NCT04436276|455466315|FG005|Overall Study|Death|0|||
126591752|NCT04436276|455466316|FG006|Overall Study|Death|0|||
126591753|NCT04436276|455466317|FG007|Overall Study|Death|0|||
126591754|NCT04436276|455466318|FG008|Overall Study|Death|0|||
126591755|NCT04436276|455466319|FG009|Overall Study|Death|0|||
126591756|NCT04436276|455466320|FG010|Overall Study|Death|0|||
126591757|NCT04436276|455466321|FG011|Overall Study|Death|0|||
126591758|NCT04436276|455466322|FG012|Overall Study|Death|1|||
126591759|NCT04436276|455466323|FG013|Overall Study|Death|0|||
126591760|NCT04436276|455466324|FG014|Overall Study|Death|1|||
126591761|NCT04436276|455466325|FG015|Overall Study|Death|0|||
126591762|NCT04436276|455466326|FG016|Overall Study|Death|0|||
126591763|NCT04436276|455466327|FG017|Overall Study|Death|0|||
126591764|NCT04436276|455466328|FG018|Overall Study|Death|0|||
126591765|NCT04436276|455466329|FG019|Overall Study|Death|2|||
126591766|NCT04436276|455466330|FG020|Overall Study|Death|0|||
126591767|NCT04436276|455466331|FG021|Overall Study|Death|1|||
126591768|NCT04436276|455466332|FG022|Overall Study|Death|0|||
126591769|NCT04436276|455466310|FG000|Overall Study|Lost to Follow-up|0|||
126591770|NCT04436276|455466311|FG001|Overall Study|Lost to Follow-up|2|||
126591771|NCT04436276|455466312|FG002|Overall Study|Lost to Follow-up|2|||
126591772|NCT04436276|455466313|FG003|Overall Study|Lost to Follow-up|1|||
126591773|NCT04436276|455466314|FG004|Overall Study|Lost to Follow-up|4|||
126591774|NCT04436276|455466315|FG005|Overall Study|Lost to Follow-up|1|||
126591775|NCT04436276|455466316|FG006|Overall Study|Lost to Follow-up|0|||
126591776|NCT04436276|455466317|FG007|Overall Study|Lost to Follow-up|0|||
126591777|NCT04436276|455466318|FG008|Overall Study|Lost to Follow-up|1|||
126591778|NCT04436276|455466319|FG009|Overall Study|Lost to Follow-up|0|||
126591779|NCT04436276|455466320|FG010|Overall Study|Lost to Follow-up|5|||
126591780|NCT04436276|455466321|FG011|Overall Study|Lost to Follow-up|5|||
126591781|NCT04436276|455466322|FG012|Overall Study|Lost to Follow-up|4|||
126591782|NCT04436276|455466323|FG013|Overall Study|Lost to Follow-up|1|||
126591783|NCT04436276|455466324|FG014|Overall Study|Lost to Follow-up|7|||
126591784|NCT04436276|455466325|FG015|Overall Study|Lost to Follow-up|7|||
126591785|NCT04436276|455466326|FG016|Overall Study|Lost to Follow-up|1|||
126591786|NCT04436276|455466327|FG017|Overall Study|Lost to Follow-up|0|||
126591787|NCT04436276|455466328|FG018|Overall Study|Lost to Follow-up|1|||
126591788|NCT04436276|455466329|FG019|Overall Study|Lost to Follow-up|1|||
126591789|NCT04436276|455466330|FG020|Overall Study|Lost to Follow-up|2|||
126591790|NCT04436276|455466331|FG021|Overall Study|Lost to Follow-up|1|||
126591791|NCT04436276|455466332|FG022|Overall Study|Lost to Follow-up|1|||
126591792|NCT04436276|455466310|FG000|Overall Study|Physician Decision|1|||
126591793|NCT04436276|455466311|FG001|Overall Study|Physician Decision|0|||
126591794|NCT04436276|455466312|FG002|Overall Study|Physician Decision|2|||
126591795|NCT04436276|455466313|FG003|Overall Study|Physician Decision|1|||
126591796|NCT04436276|455466314|FG004|Overall Study|Physician Decision|0|||
126591797|NCT04436276|455466315|FG005|Overall Study|Physician Decision|0|||
126591798|NCT04436276|455466316|FG006|Overall Study|Physician Decision|0|||
126591799|NCT04436276|455466317|FG007|Overall Study|Physician Decision|0|||
126591800|NCT04436276|455466318|FG008|Overall Study|Physician Decision|0|||
126591801|NCT04436276|455466319|FG009|Overall Study|Physician Decision|0|||
126591802|NCT04436276|455466320|FG010|Overall Study|Physician Decision|0|||
126591803|NCT04436276|455466321|FG011|Overall Study|Physician Decision|1|||
126591804|NCT04436276|455466322|FG012|Overall Study|Physician Decision|2|||
126591805|NCT04436276|455466323|FG013|Overall Study|Physician Decision|0|||
126591806|NCT04436276|455466324|FG014|Overall Study|Physician Decision|0|||
126591807|NCT04436276|455466325|FG015|Overall Study|Physician Decision|0|||
126591808|NCT04436276|455466326|FG016|Overall Study|Physician Decision|0|||
126591809|NCT04436276|455466327|FG017|Overall Study|Physician Decision|0|||
126591810|NCT04436276|455466328|FG018|Overall Study|Physician Decision|0|||
126591811|NCT04436276|455466329|FG019|Overall Study|Physician Decision|0|||
126591812|NCT04436276|455466330|FG020|Overall Study|Physician Decision|1|||
126591813|NCT04436276|455466331|FG021|Overall Study|Physician Decision|2|||
126591814|NCT04436276|455466332|FG022|Overall Study|Physician Decision|0|||
126591815|NCT04436276|455466310|FG000|Overall Study|Protocol Violation|0|||
126591816|NCT04436276|455466311|FG001|Overall Study|Protocol Violation|0|||
126591817|NCT04436276|455466312|FG002|Overall Study|Protocol Violation|0|||
126591818|NCT04436276|455466313|FG003|Overall Study|Protocol Violation|0|||
126591819|NCT04436276|455466314|FG004|Overall Study|Protocol Violation|0|||
126591820|NCT04436276|455466315|FG005|Overall Study|Protocol Violation|0|||
126591821|NCT04436276|455466316|FG006|Overall Study|Protocol Violation|0|||
126591822|NCT04436276|455466317|FG007|Overall Study|Protocol Violation|0|||
126591823|NCT04436276|455466318|FG008|Overall Study|Protocol Violation|0|||
126591824|NCT04436276|455466319|FG009|Overall Study|Protocol Violation|0|||
126591825|NCT04436276|455466320|FG010|Overall Study|Protocol Violation|0|||
126591826|NCT04436276|455466321|FG011|Overall Study|Protocol Violation|0|||
126591827|NCT04436276|455466322|FG012|Overall Study|Protocol Violation|0|||
126591828|NCT04436276|455466323|FG013|Overall Study|Protocol Violation|1|||
126591829|NCT04436276|455466324|FG014|Overall Study|Protocol Violation|0|||
126591830|NCT04436276|455466325|FG015|Overall Study|Protocol Violation|1|||
126591831|NCT04436276|455466326|FG016|Overall Study|Protocol Violation|0|||
126591832|NCT04436276|455466327|FG017|Overall Study|Protocol Violation|0|||
126591833|NCT04436276|455466328|FG018|Overall Study|Protocol Violation|0|||
126591834|NCT04436276|455466329|FG019|Overall Study|Protocol Violation|0|||
126591835|NCT04436276|455466330|FG020|Overall Study|Protocol Violation|0|||
126591836|NCT04436276|455466331|FG021|Overall Study|Protocol Violation|0|||
126591837|NCT04436276|455466332|FG022|Overall Study|Protocol Violation|0|||
126591838|NCT04436276|455466310|FG000|Overall Study|Withdrawal by Subject|25|||
126591839|NCT04436276|455466311|FG001|Overall Study|Withdrawal by Subject|22|||
126591840|NCT04436276|455466312|FG002|Overall Study|Withdrawal by Subject|24|||
126591841|NCT04436276|455466313|FG003|Overall Study|Withdrawal by Subject|23|||
126591842|NCT04436276|455466314|FG004|Overall Study|Withdrawal by Subject|14|||
126591843|NCT04436276|455466315|FG005|Overall Study|Withdrawal by Subject|0|||
126591844|NCT04436276|455466316|FG006|Overall Study|Withdrawal by Subject|0|||
126591845|NCT04436276|455466317|FG007|Overall Study|Withdrawal by Subject|1|||
126591846|NCT04436276|455466318|FG008|Overall Study|Withdrawal by Subject|0|||
126591847|NCT04436276|455466319|FG009|Overall Study|Withdrawal by Subject|1|||
126591848|NCT04436276|455466320|FG010|Overall Study|Withdrawal by Subject|17|||
126591849|NCT04436276|455466321|FG011|Overall Study|Withdrawal by Subject|7|||
126591850|NCT04436276|455466322|FG012|Overall Study|Withdrawal by Subject|10|||
126591851|NCT04436276|455466323|FG013|Overall Study|Withdrawal by Subject|6|||
126591852|NCT04436276|455466324|FG014|Overall Study|Withdrawal by Subject|20|||
126591853|NCT04436276|455466325|FG015|Overall Study|Withdrawal by Subject|6|||
126591854|NCT04436276|455466326|FG016|Overall Study|Withdrawal by Subject|11|||
126591855|NCT04436276|455466327|FG017|Overall Study|Withdrawal by Subject|4|||
126591856|NCT04436276|455466328|FG018|Overall Study|Withdrawal by Subject|14|||
126591857|NCT04436276|455466329|FG019|Overall Study|Withdrawal by Subject|24|||
126591858|NCT04436276|455466330|FG020|Overall Study|Withdrawal by Subject|24|||
126591859|NCT04436276|455466331|FG021|Overall Study|Withdrawal by Subject|16|||
126591860|NCT04436276|455466332|FG022|Overall Study|Withdrawal by Subject|14|||
126591861|NCT04436276|455466310|FG000|Overall Study|Other|3|||
126591862|NCT04436276|455466311|FG001|Overall Study|Other|2|||
126591863|NCT04436276|455466312|FG002|Overall Study|Other|5|||
126591864|NCT04436276|455466313|FG003|Overall Study|Other|9|||
126591865|NCT04436276|455466314|FG004|Overall Study|Other|23|||
126591866|NCT04436276|455466315|FG005|Overall Study|Other|1|||
126591867|NCT04436276|455466316|FG006|Overall Study|Other|0|||
126591868|NCT04436276|455466317|FG007|Overall Study|Other|0|||
126591869|NCT04436276|455466318|FG008|Overall Study|Other|0|||
126591870|NCT04436276|455466319|FG009|Overall Study|Other|0|||
126777932|NCT02544633|456143034|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
126777933|NCT02544633|456143035|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
126591871|NCT04436276|455466320|FG010|Overall Study|Other|3|||
126591872|NCT04436276|455466321|FG011|Overall Study|Other|1|||
126591873|NCT04436276|455466322|FG012|Overall Study|Other|1|||
126591874|NCT04436276|455466323|FG013|Overall Study|Other|2|||
126591875|NCT04436276|455466324|FG014|Overall Study|Other|3|||
126591876|NCT04436276|455466325|FG015|Overall Study|Other|0|||
126591877|NCT04436276|455466326|FG016|Overall Study|Other|0|||
126591878|NCT04436276|455466327|FG017|Overall Study|Other|6|||
126591879|NCT04436276|455466328|FG018|Overall Study|Other|1|||
126591880|NCT04436276|455466329|FG019|Overall Study|Other|0|||
126591881|NCT04436276|455466330|FG020|Overall Study|Other|2|||
126591882|NCT04436276|455466331|FG021|Overall Study|Other|2|||
126591883|NCT04436276|455466332|FG022|Overall Study|Other|60|||
126591884|NCT05977530|455466334|FG000|Overall Study|Withdrawal by Subject|1|||
126591885|NCT05977530|455466334|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
126591886|NCT04797897|455466341|FG000|Overall Study|Study Termination by Sponsor|1|||
126777934|NCT02544633|456143032|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
126777935|NCT02544633|456143033|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
126777936|NCT02544633|456143034|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
126777937|NCT02544633|456143035|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
126777938|NCT01977352|456143036|FG000|Overall Study|Lost to Follow-up|1|||
126777939|NCT01977352|456143037|FG001|Overall Study|Lost to Follow-up|2|||
126777940|NCT02257632|456143039|FG000|Overall Study|Withdrawal by Subject|0|||
126777941|NCT02257632|456143040|FG001|Overall Study|Withdrawal by Subject|1|||
126777942|NCT02257632|456143039|FG000|Overall Study|Adverse Event|1|||
126777943|NCT02257632|456143040|FG001|Overall Study|Adverse Event|2|||
126777944|NCT00331630|456143041|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
126777945|NCT00331630|456143041|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
126777946|NCT00331630|456143041|FG000|Follow up for 5 Years|Death|5|||
126777947|NCT00331630|456143041|FG000|Follow up for 5 Years|Data collection was stopped|24|||
126777948|NCT01059071|456143042|FG000|Overall Study|Lack of Efficacy|1|||
126777949|NCT01059071|456143043|FG001|Overall Study|Lack of Efficacy|4|||
126777950|NCT01059071|456143044|FG002|Overall Study|Lack of Efficacy|2|||
126777951|NCT01059071|456143045|FG003|Overall Study|Lack of Efficacy|3|||
126777952|NCT01059071|456143042|FG000|Overall Study|Withdrawal by Subject|1|||
126777953|NCT01059071|456143043|FG001|Overall Study|Withdrawal by Subject|0|||
126777954|NCT01059071|456143044|FG002|Overall Study|Withdrawal by Subject|0|||
126777955|NCT01059071|456143045|FG003|Overall Study|Withdrawal by Subject|2|||
126777956|NCT01059071|456143042|FG000|Overall Study|Physician Decision|0|||
126777957|NCT01059071|456143043|FG001|Overall Study|Physician Decision|0|||
126777958|NCT01059071|456143044|FG002|Overall Study|Physician Decision|0|||
126777959|NCT01059071|456143045|FG003|Overall Study|Physician Decision|1|||
126777960|NCT03763331|456143046|FG000|Overall Study|Lost to Follow-up|1|||
126777961|NCT03763331|456143047|FG001|Overall Study|Lost to Follow-up|0|||
126777962|NCT03763331|456143046|FG000|Overall Study|Withdrawal by Subject|1|||
126777963|NCT03763331|456143047|FG001|Overall Study|Withdrawal by Subject|0|||
126777964|NCT03763331|456143046|FG000|Overall Study|Non-compliance|0|||
126777965|NCT03763331|456143047|FG001|Overall Study|Non-compliance|3|||
126777966|NCT00936884|456143048|FG000|Double-blind|Withdrawal by Subject|6|||
126777967|NCT00936884|456143049|FG001|Double-blind|Withdrawal by Subject|4|||
126777968|NCT00936884|456143050|FG002|Double-blind|Withdrawal by Subject|0|||
126777969|NCT00936884|456143048|FG000|Double-blind|Death|2|||
126777970|NCT00936884|456143049|FG001|Double-blind|Death|1|||
126777971|NCT00936884|456143050|FG002|Double-blind|Death|0|||
126777972|NCT00936884|456143048|FG000|Double-blind|Lack of Efficacy|1|||
126777973|NCT00936884|456143049|FG001|Double-blind|Lack of Efficacy|1|||
126777974|NCT00936884|456143050|FG002|Double-blind|Lack of Efficacy|0|||
126777975|NCT00936884|456143048|FG000|Double-blind|Adverse Event|1|||
126777976|NCT00936884|456143049|FG001|Double-blind|Adverse Event|0|||
126777977|NCT00936884|456143050|FG002|Double-blind|Adverse Event|0|||
126777978|NCT00936884|456143048|FG000|Double-blind|Physician Decision|1|||
126777979|NCT00936884|456143049|FG001|Double-blind|Physician Decision|0|||
126777980|NCT00936884|456143050|FG002|Double-blind|Physician Decision|0|||
126777981|NCT00936884|456143048|FG000|Double-blind|No post baseline diary entry|1|||
126777982|NCT00936884|456143049|FG001|Double-blind|No post baseline diary entry|0|||
126777983|NCT00936884|456143050|FG002|Double-blind|No post baseline diary entry|0|||
126777984|NCT00936884|456143048|FG000|Double-blind|Did not receive study drug|0|||
126777985|NCT00936884|456143049|FG001|Double-blind|Did not receive study drug|1|||
126777986|NCT00936884|456143050|FG002|Double-blind|Did not receive study drug|0|||
126777987|NCT04741503|456143051|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
126777988|NCT04741503|456143052|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
126777989|NCT04741503|456143053|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
126777990|NCT04741503|456143051|FG000|Initial Enrollment|Overquotas removed|0|||
126777991|NCT04741503|456143052|FG001|Initial Enrollment|Overquotas removed|0|||
126777992|NCT04741503|456143053|FG002|Initial Enrollment|Overquotas removed|186|||
126591887|NCT04797897|455466342|FG001|Overall Study|Study Termination by Sponsor|1|||
126777993|NCT04741503|456143051|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
126777994|NCT04741503|456143052|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
126777995|NCT04741503|456143053|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
126777996|NCT02280421|456143054|FG000|Washout (2 Weeks)|Adverse Event|0|||
126777997|NCT02280421|456143055|FG001|Washout (2 Weeks)|Adverse Event|1|||
126777998|NCT02280421|456143054|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
126777999|NCT02280421|456143055|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
126778000|NCT01859390|456143062|FG000|Overall Study|Insufficient Sputum Collected|1|||
126778001|NCT01859390|456143063|FG001|Overall Study|Insufficient Sputum Collected|3|||
126778002|NCT01859390|456143062|FG000|Overall Study|Sample Missing Collection Date|0|||
126778003|NCT01859390|456143063|FG001|Overall Study|Sample Missing Collection Date|1|||
126778004|NCT01859390|456143062|FG000|Overall Study|Tube Cracked|0|||
126591888|NCT03024437|455466347|FG000|Overall Study|Adverse Event|0|||
126591889|NCT03024437|455466348|FG001|Overall Study|Adverse Event|1|||
126778005|NCT01859390|456143063|FG001|Overall Study|Tube Cracked|2|||
126591890|NCT03024437|455466349|FG002|Overall Study|Adverse Event|3|||
126591891|NCT03024437|455466350|FG003|Overall Study|Adverse Event|5|||
126591892|NCT03024437|455466351|FG004|Overall Study|Adverse Event|0|||
126591893|NCT03024437|455466347|FG000|Overall Study|Physician Decision|1|||
126591894|NCT03024437|455466348|FG001|Overall Study|Physician Decision|0|||
126591895|NCT03024437|455466349|FG002|Overall Study|Physician Decision|0|||
126591896|NCT03024437|455466350|FG003|Overall Study|Physician Decision|1|||
126591897|NCT03024437|455466351|FG004|Overall Study|Physician Decision|0|||
126591898|NCT03024437|455466347|FG000|Overall Study|Disease progression, relapse|1|||
126591899|NCT03024437|455466348|FG001|Overall Study|Disease progression, relapse|0|||
126591900|NCT03024437|455466349|FG002|Overall Study|Disease progression, relapse|0|||
126591901|NCT03024437|455466350|FG003|Overall Study|Disease progression, relapse|3|||
126591902|NCT03024437|455466351|FG004|Overall Study|Disease progression, relapse|0|||
126591903|NCT03024437|455466347|FG000|Overall Study|Disease progression, refractory disease|4|||
126591904|NCT03024437|455466348|FG001|Overall Study|Disease progression, refractory disease|4|||
126591905|NCT03024437|455466349|FG002|Overall Study|Disease progression, refractory disease|2|||
126591906|NCT03024437|455466350|FG003|Overall Study|Disease progression, refractory disease|2|||
126591907|NCT03024437|455466351|FG004|Overall Study|Disease progression, refractory disease|1|||
126591908|NCT03024437|455466347|FG000|Overall Study|Newly diagnosed cancer|0|||
126591909|NCT03024437|455466348|FG001|Overall Study|Newly diagnosed cancer|0|||
126591910|NCT03024437|455466349|FG002|Overall Study|Newly diagnosed cancer|0|||
126591911|NCT03024437|455466350|FG003|Overall Study|Newly diagnosed cancer|1|||
126591912|NCT03024437|455466351|FG004|Overall Study|Newly diagnosed cancer|0|||
126591913|NCT03024437|455466347|FG000|Overall Study|Moved out of state|0|||
126591914|NCT03024437|455466348|FG001|Overall Study|Moved out of state|1|||
126591915|NCT03024437|455466349|FG002|Overall Study|Moved out of state|0|||
126591916|NCT03024437|455466350|FG003|Overall Study|Moved out of state|0|||
126591917|NCT03024437|455466351|FG004|Overall Study|Moved out of state|0|||
126591918|NCT03024437|455466347|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
126591919|NCT03024437|455466348|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
126591920|NCT03024437|455466349|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
126591921|NCT03024437|455466350|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
126591922|NCT03024437|455466351|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
126591923|NCT05239455|455466353|FG000|Overall Study|Adverse Event|1|||
126591924|NCT05239455|455466353|FG000|Overall Study|Sponsor Decision|5|||
126591925|NCT05239455|455466353|FG000|Overall Study|Incomplete Blood Collection|1|||
126591926|NCT01799265|455466354|FG000|Overall Study|Lost to Follow-up|1|||
126591927|NCT01799265|455466355|FG001|Overall Study|Lost to Follow-up|0|||
126591928|NCT01799265|455466354|FG000|Overall Study|Protocol Violation|2|||
126591929|NCT01799265|455466355|FG001|Overall Study|Protocol Violation|1|||
126591930|NCT01799265|455466354|FG000|Overall Study|inadequate sleep study|0|||
126591931|NCT01799265|455466355|FG001|Overall Study|inadequate sleep study|2|||
126591932|NCT03459729|455466356|FG000|Overall Study|Physician Decision|2|||
126591933|NCT02364557|455466360|FG000|Overall Study|Protocol Violation|3|||
126591934|NCT02364557|455466361|FG001|Overall Study|Protocol Violation|1|||
126591935|NCT04200456|455466363|FG000|Overall Study|Physician Decision|0|||
126591936|NCT04200456|455466364|FG001|Overall Study|Physician Decision|1|||
126591937|NCT04200456|455466363|FG000|Overall Study|Withdrawal by Subject|2|||
126591938|NCT04200456|455466364|FG001|Overall Study|Withdrawal by Subject|2|||
126591939|NCT04200456|455466363|FG000|Overall Study|Lack of Efficacy|1|||
126591940|NCT04200456|455466364|FG001|Overall Study|Lack of Efficacy|1|||
126591941|NCT04200456|455466363|FG000|Overall Study|Adverse event, non-fatal|0|||
126591942|NCT04200456|455466364|FG001|Overall Study|Adverse event, non-fatal|1|||
126591943|NCT04200456|455466363|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
126591944|NCT04200456|455466364|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
126591945|NCT04828005|455466365|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
126591946|NCT04828005|455466366|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
126591947|NCT04828005|455466367|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
126591948|NCT04828005|455466368|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
126591949|NCT04828005|455466365|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
126591950|NCT04828005|455466366|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
126591951|NCT04828005|455466367|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
126591952|NCT04828005|455466368|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
126591953|NCT04828005|455466365|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
126591954|NCT04828005|455466366|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
126591955|NCT04828005|455466367|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
126591956|NCT04828005|455466368|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
126591957|NCT04828005|455466365|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
126591958|NCT04828005|455466366|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
126591959|NCT04828005|455466367|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
126591960|NCT04828005|455466368|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
126591961|NCT04828005|455466365|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
126778006|NCT01859390|456143062|FG000|Overall Study|Shipment Error|0|||
126778007|NCT01859390|456143063|FG001|Overall Study|Shipment Error|1|||
126778008|NCT02764489|456143068|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
126778009|NCT02764489|456143069|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
126778010|NCT02764489|456143068|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
126778011|NCT02764489|456143069|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
126778012|NCT02764489|456143068|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
126778013|NCT02764489|456143069|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
126778014|NCT02764489|456143068|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
126778015|NCT02764489|456143069|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
126778016|NCT02038634|456143070|FG000|Overall Study|Lost to Follow-up|0|||
126778017|NCT02038634|456143071|FG001|Overall Study|Lost to Follow-up|1|||
126778018|NCT01664052|456143072|FG000|Phase 1|No device placement|6|||
126778019|NCT01664052|456143073|FG001|Phase 1|No device placement|0|||
126778020|NCT01664052|456143072|FG000|Phase 1|No HSG 1 hr post placement|1|||
126778021|NCT01664052|456143073|FG001|Phase 1|No HSG 1 hr post placement|0|||
126778022|NCT01664052|456143072|FG000|Phase 2|No device placement|0|||
126778023|NCT01664052|456143073|FG001|Phase 2|No device placement|4|||
126778024|NCT01706198|456143076|FG000|Overall Study|Adverse Event|12|||
126778025|NCT01706198|456143077|FG001|Overall Study|Adverse Event|15|||
126778026|NCT01706198|456143076|FG000|Overall Study|Protocol Violation|7|||
126778027|NCT01706198|456143077|FG001|Overall Study|Protocol Violation|5|||
126778028|NCT01706198|456143076|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
126778029|NCT01706198|456143077|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
126778030|NCT01706198|456143076|FG000|Overall Study|Lost to Follow-up|97|||
126778031|NCT01706198|456143077|FG001|Overall Study|Lost to Follow-up|93|||
126778032|NCT01706198|456143076|FG000|Overall Study|Physician Decision|23|||
126778033|NCT01706198|456143077|FG001|Overall Study|Physician Decision|37|||
126778034|NCT01706198|456143076|FG000|Overall Study|Withdrawal by Subject|23|||
126778035|NCT01706198|456143077|FG001|Overall Study|Withdrawal by Subject|31|||
126778036|NCT04313283|456143079|FG000|Overall Study|did not complete intervention|4|||
126778037|NCT00606684|456143093|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
126778038|NCT00606684|456143094|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
126778039|NCT00606684|456143095|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
126778040|NCT00606684|456143096|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
126778041|NCT00606684|456143097|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
126778042|NCT00606684|456143098|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
126778043|NCT00606684|456143099|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
126778044|NCT00606684|456143093|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
126778045|NCT00606684|456143094|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
126778046|NCT00606684|456143095|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
126778047|NCT00606684|456143096|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
126778048|NCT00606684|456143097|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
126778049|NCT00606684|456143098|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
126778050|NCT00606684|456143099|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
126778051|NCT00606684|456143093|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
126778052|NCT00606684|456143094|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
126778053|NCT00606684|456143095|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
126778054|NCT00606684|456143096|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
126778055|NCT00606684|456143097|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
126778056|NCT00606684|456143098|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
126778057|NCT00606684|456143099|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
126778058|NCT00606684|456143093|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
126778059|NCT00606684|456143094|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
126778060|NCT00606684|456143095|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
126778061|NCT00606684|456143096|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
126778062|NCT00606684|456143097|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
126778063|NCT00606684|456143098|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
126778064|NCT00606684|456143099|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
126778065|NCT00606684|456143093|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
126778066|NCT00606684|456143094|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
126778067|NCT00606684|456143095|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
126778068|NCT00606684|456143096|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
126778069|NCT00606684|456143097|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
126778070|NCT00606684|456143098|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
126778071|NCT00606684|456143099|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
126778072|NCT00606684|456143093|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
126778073|NCT00606684|456143094|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
126778074|NCT00606684|456143095|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
126591962|NCT04828005|455466366|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
126591963|NCT04828005|455466367|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
126591964|NCT04828005|455466368|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
126591965|NCT04828005|455466365|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
126591966|NCT04828005|455466366|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
126591967|NCT04828005|455466367|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
126591968|NCT04828005|455466368|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
126591969|NCT04828005|455466365|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
126591970|NCT04828005|455466366|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
126591971|NCT04828005|455466367|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
126591972|NCT04828005|455466368|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
126591973|NCT04828005|455466365|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
126591974|NCT04828005|455466366|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
126591975|NCT04828005|455466367|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
126591976|NCT04828005|455466368|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
126591977|NCT04828005|455466365|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
126591978|NCT04828005|455466366|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
126591979|NCT04828005|455466367|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
126591980|NCT04828005|455466368|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
126591981|NCT03381196|455467978|FG000|Overall Study|Withdrawal by Subject|7|||
126591982|NCT03381196|455467979|FG001|Overall Study|Withdrawal by Subject|7|||
126591983|NCT03381196|455467978|FG000|Overall Study|Other|0|||
126591984|NCT03381196|455467979|FG001|Overall Study|Other|1|||
126591985|NCT03381196|455467978|FG000|Overall Study|Lost to Follow-up|5|||
126591986|NCT03381196|455467979|FG001|Overall Study|Lost to Follow-up|4|||
126591987|NCT03381196|455467978|FG000|Overall Study|Death|0|||
126591988|NCT03381196|455467979|FG001|Overall Study|Death|1|||
126591989|NCT03381196|455467978|FG000|Overall Study|Adverse Event|1|||
126591990|NCT03381196|455467979|FG001|Overall Study|Adverse Event|0|||
126591991|NCT03381196|455467978|FG000|Overall Study|Randomized, not treated|3|||
126591992|NCT03381196|455467979|FG001|Overall Study|Randomized, not treated|6|||
126591993|NCT01539083|455467980|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
126591994|NCT01539083|455467981|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
126591995|NCT01539083|455467982|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
126591996|NCT01539083|455467980|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
126591997|NCT01539083|455467981|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
126591998|NCT01539083|455467982|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
126591999|NCT01539083|455467980|FG000|Before Randomization (VCD Induction)|Death|6|||
126592000|NCT01539083|455467981|FG001|Before Randomization (VCD Induction)|Death|0|||
126592001|NCT01539083|455467982|FG002|Before Randomization (VCD Induction)|Death|0|||
126592002|NCT01539083|455467980|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
126592003|NCT01539083|455467981|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
126592004|NCT01539083|455467982|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
126592005|NCT01539083|455467980|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
126592006|NCT01539083|455467981|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
126592007|NCT01539083|455467982|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
126592008|NCT01539083|455467980|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
126592009|NCT01539083|455467981|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
126592010|NCT01539083|455467982|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
126592011|NCT01539083|455467980|FG000|Before Randomization (VCD Induction)|Other|5|||
126592012|NCT01539083|455467981|FG001|Before Randomization (VCD Induction)|Other|0|||
126778075|NCT00606684|456143096|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
126592013|NCT01539083|455467982|FG002|Before Randomization (VCD Induction)|Other|0|||
126592014|NCT01539083|455467980|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
126592015|NCT01539083|455467981|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
126592016|NCT01539083|455467982|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
126592017|NCT01539083|455467980|FG000|After Randomization (TP and VTP)|Other|0|||
126592018|NCT01539083|455467981|FG001|After Randomization (TP and VTP)|Other|1|||
126592019|NCT01539083|455467982|FG002|After Randomization (TP and VTP)|Other|1|||
126592020|NCT01539083|455467980|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
126778076|NCT00606684|456143097|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
126778077|NCT00606684|456143098|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
126592021|NCT01539083|455467981|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
126592022|NCT01539083|455467982|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
126778078|NCT00606684|456143099|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
126592023|NCT01539083|455467980|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
126592024|NCT01539083|455467981|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
126592025|NCT01539083|455467982|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
126592026|NCT01539083|455467980|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
126592027|NCT01539083|455467981|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
126778079|NCT00606684|456143093|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
126778080|NCT00606684|456143094|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
126778081|NCT00606684|456143095|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
126778082|NCT00606684|456143096|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
126778083|NCT00606684|456143097|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
126778084|NCT00606684|456143098|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
126778085|NCT00606684|456143099|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
126778086|NCT00606684|456143093|FG000|Double-Blind Treatment Period|Adverse Event|0|||
126778087|NCT00606684|456143094|FG001|Double-Blind Treatment Period|Adverse Event|3|||
126778088|NCT00606684|456143095|FG002|Double-Blind Treatment Period|Adverse Event|2|||
126778089|NCT00606684|456143096|FG003|Double-Blind Treatment Period|Adverse Event|4|||
126778090|NCT00606684|456143097|FG004|Double-Blind Treatment Period|Adverse Event|2|||
126778091|NCT00606684|456143098|FG005|Double-Blind Treatment Period|Adverse Event|0|||
126778092|NCT00606684|456143099|FG006|Double-Blind Treatment Period|Adverse Event|1|||
126778093|NCT00606684|456143093|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
126778094|NCT00606684|456143094|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
126778095|NCT00606684|456143095|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
126778096|NCT00606684|456143096|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
126778097|NCT00606684|456143097|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
126778098|NCT00606684|456143098|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
126778099|NCT00606684|456143099|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
126778100|NCT00606684|456143093|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
126778101|NCT00606684|456143094|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
126778102|NCT00606684|456143095|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
126778103|NCT00606684|456143096|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
126778104|NCT00606684|456143097|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
126778105|NCT00606684|456143098|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
126778106|NCT00606684|456143099|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
126778107|NCT00606684|456143093|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
126778108|NCT00606684|456143094|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
126778109|NCT00606684|456143095|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
126778110|NCT00606684|456143096|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
126778111|NCT00606684|456143097|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
126778112|NCT00606684|456143098|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
126778113|NCT00606684|456143099|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
126778114|NCT00606684|456143093|FG000|Double-Blind Treatment Period|Physician Decision|0|||
126778115|NCT00606684|456143094|FG001|Double-Blind Treatment Period|Physician Decision|5|||
126778116|NCT00606684|456143095|FG002|Double-Blind Treatment Period|Physician Decision|1|||
126778117|NCT00606684|456143096|FG003|Double-Blind Treatment Period|Physician Decision|0|||
126778118|NCT00606684|456143097|FG004|Double-Blind Treatment Period|Physician Decision|3|||
126778119|NCT00606684|456143098|FG005|Double-Blind Treatment Period|Physician Decision|1|||
126778120|NCT00606684|456143099|FG006|Double-Blind Treatment Period|Physician Decision|2|||
126778121|NCT00606684|456143093|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126778122|NCT00606684|456143094|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126778123|NCT00606684|456143095|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126778124|NCT00606684|456143096|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126778125|NCT00606684|456143097|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126778126|NCT00606684|456143098|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
126778127|NCT00606684|456143099|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126778128|NCT02763579|456143100|FG000|Global Period|Death|167|||
126778129|NCT02763579|456143101|FG001|Global Period|Death|151|||
126778130|NCT02763579|456143102|FG002|Global Period|Death|0|||
126778131|NCT02763579|456143103|FG003|Global Period|Death|0|||
126778132|NCT02763579|456143100|FG000|Global Period|Lost to Follow-up|2|||
126778133|NCT02763579|456143101|FG001|Global Period|Lost to Follow-up|4|||
126778134|NCT02763579|456143102|FG002|Global Period|Lost to Follow-up|0|||
126778135|NCT02763579|456143103|FG003|Global Period|Lost to Follow-up|0|||
126778136|NCT02763579|456143100|FG000|Global Period|Physician Decision|0|||
126778137|NCT02763579|456143101|FG001|Global Period|Physician Decision|2|||
126778138|NCT02763579|456143102|FG002|Global Period|Physician Decision|0|||
126592028|NCT01539083|455467982|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
126592029|NCT01539083|455467980|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
126592030|NCT01539083|455467981|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
126778139|NCT02763579|456143103|FG003|Global Period|Physician Decision|0|||
126778140|NCT02763579|456143100|FG000|Global Period|Study Terminated By Sponsor|21|||
126778141|NCT02763579|456143101|FG001|Global Period|Study Terminated By Sponsor|26|||
126778142|NCT02763579|456143102|FG002|Global Period|Study Terminated By Sponsor|0|||
126778143|NCT02763579|456143103|FG003|Global Period|Study Terminated By Sponsor|0|||
126778144|NCT02763579|456143100|FG000|Global Period|Withdrawal by Subject|12|||
126592031|NCT01539083|455467982|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
126592032|NCT01539083|455467980|FG000|After Randomization (TP and VTP)|Death|0|||
126592033|NCT01539083|455467981|FG001|After Randomization (TP and VTP)|Death|6|||
126592034|NCT01539083|455467982|FG002|After Randomization (TP and VTP)|Death|11|||
126592035|NCT04016662|455467983|FG000|Run-In Phase|Death|1|||
126592036|NCT04016662|455467983|FG000|Run-In Phase|Withdrawal by Subject|11|||
126592037|NCT04016662|455467983|FG000|Run-In Phase|Not meeting screening eligibility|9|||
126592038|NCT04016662|455467983|FG000|Run-In Phase|Physician Decision|3|||
126592039|NCT04016662|455467983|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
126592040|NCT04016662|455467983|FG000|PLGS (12 Weeks)|Death|1|||
126592041|NCT04016662|455467983|FG000|SAP (12 Weeks)|Death|1|||
126592042|NCT01802788|455467984|FG000|Overall Study|Withdrawal by Subject|102|||
126592043|NCT01802788|455467985|FG001|Overall Study|Withdrawal by Subject|5|||
126592044|NCT01802788|455467984|FG000|Overall Study|Death|382|||
126592045|NCT01802788|455467985|FG001|Overall Study|Death|18|||
126592046|NCT01802788|455467984|FG000|Overall Study|Lost to Follow-up|31|||
126592047|NCT01802788|455467985|FG001|Overall Study|Lost to Follow-up|2|||
126592048|NCT01802788|455467984|FG000|Overall Study|Physician Decision|3|||
126592049|NCT01802788|455467985|FG001|Overall Study|Physician Decision|0|||
126592050|NCT01802788|455467984|FG000|Overall Study|Patient Non-Compliance|1|||
126592051|NCT01802788|455467985|FG001|Overall Study|Patient Non-Compliance|0|||
126592052|NCT01802788|455467984|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
126592053|NCT01802788|455467985|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
126592054|NCT01802788|455467984|FG000|Overall Study|Other Reasons|19|||
126592055|NCT01802788|455467985|FG001|Overall Study|Other Reasons|0|||
126592056|NCT03021096|455467986|FG000|Overall Study|Lost to Follow-up|4|||
126592057|NCT03021096|455467986|FG000|Overall Study|Protocol Violation|2|||
126592058|NCT03904147|455467991|FG000|Overall Study|Death|15|||
126592059|NCT03904147|455467992|FG001|Overall Study|Death|13|||
126592060|NCT03904147|455467993|FG002|Overall Study|Death|15|||
126592061|NCT03904147|455467991|FG000|Overall Study|Withdrawal by Subject|7|||
126592062|NCT03904147|455467992|FG001|Overall Study|Withdrawal by Subject|12|||
126592063|NCT03904147|455467993|FG002|Overall Study|Withdrawal by Subject|1|||
126592064|NCT03904147|455467991|FG000|Overall Study|1Y visit completed after 365 days|1|||
126592065|NCT03904147|455467992|FG001|Overall Study|1Y visit completed after 365 days|1|||
126592066|NCT03904147|455467993|FG002|Overall Study|1Y visit completed after 365 days|0|||
126592067|NCT00764751|455468001|FG000|Overall Study|Adverse Event|1|||
126592068|NCT00764751|455468002|FG001|Overall Study|Adverse Event|1|||
126592069|NCT00764751|455468001|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
126592070|NCT00764751|455468002|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
126592071|NCT03011333|455468008|FG000|Overall Study|Lost to Follow-up|0|||
126592072|NCT03011333|455468009|FG001|Overall Study|Lost to Follow-up|1|||
126592073|NCT03011333|455468010|FG002|Overall Study|Lost to Follow-up|0|||
126592074|NCT03011333|455468011|FG003|Overall Study|Lost to Follow-up|1|||
126592075|NCT03011333|455468012|FG004|Overall Study|Lost to Follow-up|4|||
126592076|NCT03011333|455468013|FG005|Overall Study|Lost to Follow-up|4|||
126592077|NCT03011333|455468014|FG006|Overall Study|Lost to Follow-up|5|||
126592078|NCT02998268|455468018|FG000|Overall Study|Adverse Event|0|||
126592079|NCT02998268|455468019|FG001|Overall Study|Adverse Event|2|||
126592080|NCT02998268|455468018|FG000|Overall Study|Withdrawal by Subject|0|||
126592081|NCT02998268|455468019|FG001|Overall Study|Withdrawal by Subject|1|||
126592082|NCT05269667|455468020|FG000|Overall Study|Study Terminated by Sponsor|4|||
126592083|NCT04413708|455468021|FG000|Overall Study|Lost to Follow-up|1|||
126592084|NCT04413708|455468022|FG001|Overall Study|Lost to Follow-up|2|||
126592085|NCT03133546|455468023|FG000|Overall Study|Death|46|||
126592086|NCT03133546|455468024|FG001|Overall Study|Death|43|||
126592087|NCT03133546|455468023|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
126592088|NCT03133546|455468024|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
126592089|NCT05399459|455468027|FG000|Overall Study|Randomized but not treated|29|||
126592090|NCT05399459|455468028|FG001|Overall Study|Randomized but not treated|30|||
126592091|NCT05399459|455468029|FG002|Overall Study|Randomized but not treated|38|||
126592092|NCT05399459|455468027|FG000|Overall Study|Lost to Follow-up|1|||
126778145|NCT02763579|456143101|FG001|Global Period|Withdrawal by Subject|18|||
126778146|NCT02763579|456143102|FG002|Global Period|Withdrawal by Subject|0|||
126592093|NCT05399459|455468028|FG001|Overall Study|Lost to Follow-up|0|||
126592094|NCT05399459|455468029|FG002|Overall Study|Lost to Follow-up|0|||
126592095|NCT06103188|455468030|FG000|Overall Study|Lost to Follow-up|1|||
126592096|NCT06103188|455468031|FG001|Overall Study|Lost to Follow-up|6|||
126592097|NCT06103188|455468032|FG002|Overall Study|Lost to Follow-up|4|||
126592098|NCT01175356|455468037|FG000|Overall Study|Death|1|||
126592099|NCT01175356|455468037|FG000|Overall Study|Lack of Efficacy|12|||
126592100|NCT01175356|455468037|FG000|Overall Study|Lost to Follow-up|1|||
126592101|NCT01175356|455468037|FG000|Overall Study|Physician Decision|23|||
126592102|NCT01175356|455468037|FG000|Overall Study|Ineligible|1|||
126592103|NCT01175356|455468037|FG000|Overall Study|Treatment Slot Not Available|18|||
126592104|NCT01175356|455468037|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
126592105|NCT01175356|455468037|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
126592106|NCT01175356|455468037|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
126592107|NCT01175356|455468037|FG000|Overall Study|Inadequate stem cell for transplant|1|||
126592108|NCT01175356|455468037|FG000|Overall Study|Initiation other tx prior to completion|9|||
126592109|NCT05583578|455468038|FG000|Overall Study|Withdrawal by Subject|2|||
126592110|NCT05583578|455468039|FG001|Overall Study|Withdrawal by Subject|0|||
126592111|NCT05201079|455468052|FG000|Overall Study|Adverse Event|7|||
126592112|NCT05201079|455468053|FG001|Overall Study|Adverse Event|11|||
126592113|NCT05201079|455468052|FG000|Overall Study|Death|1|||
126592114|NCT05201079|455468053|FG001|Overall Study|Death|1|||
126592115|NCT05201079|455468052|FG000|Overall Study|Lack of Efficacy|0|||
126592116|NCT05201079|455468053|FG001|Overall Study|Lack of Efficacy|2|||
126592117|NCT05201079|455468052|FG000|Overall Study|Lost to Follow-up|0|||
126592118|NCT05201079|455468053|FG001|Overall Study|Lost to Follow-up|1|||
126592119|NCT05201079|455468052|FG000|Overall Study|Physician Decision|1|||
126592120|NCT05201079|455468053|FG001|Overall Study|Physician Decision|1|||
126592121|NCT05201079|455468052|FG000|Overall Study|Protocol Violation|1|||
126592122|NCT05201079|455468053|FG001|Overall Study|Protocol Violation|0|||
126592123|NCT05201079|455468052|FG000|Overall Study|Withdrawal by Subject|1|||
126592124|NCT05201079|455468053|FG001|Overall Study|Withdrawal by Subject|0|||
126592125|NCT05201079|455468052|FG000|Overall Study|Forbidden medication|9|||
126592126|NCT05201079|455468053|FG001|Overall Study|Forbidden medication|5|||
126592127|NCT05201079|455468052|FG000|Overall Study|Transfer to another hospital|0|||
126592128|NCT05201079|455468053|FG001|Overall Study|Transfer to another hospital|1|||
126592129|NCT05201079|455468052|FG000|Overall Study|Clinical condition|1|||
126592130|NCT05201079|455468053|FG001|Overall Study|Clinical condition|0|||
126592131|NCT05201079|455468052|FG000|Overall Study|SAE and sepsis|1|||
126592132|NCT05201079|455468053|FG001|Overall Study|SAE and sepsis|0|||
126592133|NCT04907851|455468054|FG000|Overall Study|Consent withdrawn|1|||
126592134|NCT04907851|455468055|FG001|Overall Study|Consent withdrawn|2|||
126592135|NCT04907851|455468056|FG002|Overall Study|Consent withdrawn|0|||
126592136|NCT04907851|455468054|FG000|Overall Study|Death|5|||
126592137|NCT04907851|455468055|FG001|Overall Study|Death|15|||
126592138|NCT04907851|455468056|FG002|Overall Study|Death|10|||
126592139|NCT01210807|455468063|FG000|Overall Study|Lost to Follow-up|1|||
126592140|NCT01210807|455468064|FG001|Overall Study|Lost to Follow-up|2|||
126592141|NCT01210807|455468063|FG000|Overall Study|Not implanted bilaterally|2|||
126592142|NCT01210807|455468064|FG001|Overall Study|Not implanted bilaterally|1|||
126592143|NCT05477186|455468069|FG000|Overall Study|Vaccine not administered|0|||
126592144|NCT05477186|455468070|FG001|Overall Study|Vaccine not administered|2|||
126592145|NCT05477186|455468071|FG002|Overall Study|Vaccine not administered|1|||
126592146|NCT05477186|455468072|FG003|Overall Study|Vaccine not administered|0|||
126592147|NCT05477186|455468073|FG004|Overall Study|Vaccine not administered|1|||
126592148|NCT05477186|455468074|FG005|Overall Study|Vaccine not administered|0|||
126592149|NCT05477186|455468075|FG006|Overall Study|Vaccine not administered|0|||
126592150|NCT05477186|455468069|FG000|Overall Study|Withdrawal by Subject|1|||
126592151|NCT05477186|455468070|FG001|Overall Study|Withdrawal by Subject|0|||
126592152|NCT05477186|455468071|FG002|Overall Study|Withdrawal by Subject|0|||
126592153|NCT05477186|455468072|FG003|Overall Study|Withdrawal by Subject|0|||
126592154|NCT05477186|455468073|FG004|Overall Study|Withdrawal by Subject|0|||
126592155|NCT05477186|455468074|FG005|Overall Study|Withdrawal by Subject|1|||
126592156|NCT05477186|455468075|FG006|Overall Study|Withdrawal by Subject|0|||
126592157|NCT05477186|455468069|FG000|Overall Study|Lost to Follow-up|1|||
126592158|NCT05477186|455468070|FG001|Overall Study|Lost to Follow-up|0|||
126592159|NCT05477186|455468071|FG002|Overall Study|Lost to Follow-up|2|||
126592160|NCT05477186|455468072|FG003|Overall Study|Lost to Follow-up|1|||
126592161|NCT05477186|455468073|FG004|Overall Study|Lost to Follow-up|1|||
126592162|NCT05477186|455468074|FG005|Overall Study|Lost to Follow-up|0|||
126592163|NCT05477186|455468075|FG006|Overall Study|Lost to Follow-up|2|||
126592164|NCT00324805|455468076|FG000|Overall Study|Adverse Event|62|||
126592165|NCT00324805|455468077|FG001|Overall Study|Adverse Event|203|||
126592166|NCT00324805|455468076|FG000|Overall Study|Progression|7|||
126592167|NCT00324805|455468077|FG001|Overall Study|Progression|35|||
126592168|NCT00324805|455468076|FG000|Overall Study|Withdrawal by Subject|51|||
126592169|NCT00324805|455468077|FG001|Overall Study|Withdrawal by Subject|174|||
126592170|NCT00324805|455468076|FG000|Overall Study|Death|6|||
126592171|NCT00324805|455468077|FG001|Overall Study|Death|9|||
126592172|NCT00324805|455468076|FG000|Overall Study|Alternative therapy|4|||
126592173|NCT00324805|455468077|FG001|Overall Study|Alternative therapy|8|||
126592174|NCT00324805|455468076|FG000|Overall Study|Other complicating disease|1|||
126592175|NCT00324805|455468077|FG001|Overall Study|Other complicating disease|9|||
126592176|NCT00324805|455468076|FG000|Overall Study|Other reasons|7|||
126592177|NCT00324805|455468077|FG001|Overall Study|Other reasons|26|||
126592178|NCT00324805|455468076|FG000|Overall Study|Other|0|||
126592179|NCT00324805|455468077|FG001|Overall Study|Other|2|||
126592180|NCT00324805|455468076|FG000|Overall Study|Did not start therapy|12|||
126592181|NCT00324805|455468077|FG001|Overall Study|Did not start therapy|17|||
126592182|NCT05792085|455468079|FG000|Overall Study|Death|0|||
126592183|NCT05792085|455468080|FG001|Overall Study|Death|0|||
126592184|NCT05792085|455468081|FG002|Overall Study|Death|0|||
126592185|NCT05792085|455468082|FG003|Overall Study|Death|0|||
126592186|NCT05792085|455468083|FG004|Overall Study|Death|1|||
126778147|NCT02763579|456143103|FG003|Global Period|Withdrawal by Subject|0|||
126778148|NCT02763579|456143100|FG000|China Period|Death|0|||
126778149|NCT02763579|456143101|FG001|China Period|Death|0|||
126778150|NCT02763579|456143102|FG002|China Period|Death|46|||
126778151|NCT02763579|456143103|FG003|China Period|Death|48|||
126778152|NCT02763579|456143100|FG000|China Period|Lost to Follow-up|0|||
126778153|NCT02763579|456143101|FG001|China Period|Lost to Follow-up|0|||
126778154|NCT02763579|456143102|FG002|China Period|Lost to Follow-up|1|||
126778155|NCT02763579|456143103|FG003|China Period|Lost to Follow-up|1|||
126778156|NCT02763579|456143100|FG000|China Period|Physician Decision|0|||
126778157|NCT02763579|456143101|FG001|China Period|Physician Decision|0|||
126778158|NCT02763579|456143102|FG002|China Period|Physician Decision|0|||
126778159|NCT02763579|456143103|FG003|China Period|Physician Decision|1|||
126778160|NCT02763579|456143100|FG000|China Period|Study Terminated By Sponsor|0|||
126778161|NCT02763579|456143101|FG001|China Period|Study Terminated By Sponsor|0|||
126778162|NCT02763579|456143102|FG002|China Period|Study Terminated By Sponsor|3|||
126778163|NCT02763579|456143103|FG003|China Period|Study Terminated By Sponsor|4|||
126778164|NCT02763579|456143100|FG000|China Period|Withdrawal by Subject|0|||
126778165|NCT02763579|456143101|FG001|China Period|Withdrawal by Subject|0|||
126778166|NCT02763579|456143102|FG002|China Period|Withdrawal by Subject|3|||
126778167|NCT02763579|456143103|FG003|China Period|Withdrawal by Subject|3|||
126778168|NCT00910858|456143108|FG000|Pharmacokinetic Phase|Adverse Event|1|||
126778169|NCT00910858|456143109|FG001|Pharmacokinetic Phase|Adverse Event|0|||
126778170|NCT00910858|456143110|FG002|Pharmacokinetic Phase|Adverse Event|0|||
126778171|NCT00910858|456143108|FG000|Monotherapy Phase|Adverse Event|3|||
126592187|NCT01919554|455468084|FG000|Overall Study|Withdrawal by Subject|0|||
126592188|NCT01919554|455468085|FG001|Overall Study|Withdrawal by Subject|0|||
126592189|NCT01919554|455468086|FG002|Overall Study|Withdrawal by Subject|1|||
126592190|NCT01919554|455468087|FG003|Overall Study|Withdrawal by Subject|1|||
126592191|NCT01544114|455468091|FG000|Overall Study|Withdrawal by Subject|0|||
126592192|NCT01544114|455468092|FG001|Overall Study|Withdrawal by Subject|0|||
126592193|NCT01544114|455468093|FG002|Overall Study|Withdrawal by Subject|3|||
126592194|NCT01544114|455468091|FG000|Overall Study|Lost to Follow-up|0|||
126592195|NCT01544114|455468092|FG001|Overall Study|Lost to Follow-up|2|||
126592196|NCT01544114|455468093|FG002|Overall Study|Lost to Follow-up|0|||
126592197|NCT01544114|455468091|FG000|Overall Study|Adverse Event|1|||
126592198|NCT01544114|455468092|FG001|Overall Study|Adverse Event|1|||
126592199|NCT01544114|455468093|FG002|Overall Study|Adverse Event|2|||
126592200|NCT01544114|455468091|FG000|Overall Study|Protocol Violation|0|||
126592201|NCT01544114|455468092|FG001|Overall Study|Protocol Violation|1|||
126592202|NCT01544114|455468093|FG002|Overall Study|Protocol Violation|0|||
126592203|NCT01733316|455468098|FG000|RP103 Phase|Non-compliance|1|||
126592204|NCT01733316|455468098|FG000|Long Term Extension Phase|Adverse Event|1|||
126592205|NCT01733316|455468098|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
126592206|NCT01733316|455468098|FG000|Long Term Extension Phase|Sponsor Decision|2|||
126592207|NCT03058289|455468105|FG000|Overall Study|Radiographic Deterioration|0|||
126592208|NCT03058289|455468106|FG001|Overall Study|Radiographic Deterioration|3|||
126592209|NCT03058289|455468107|FG002|Overall Study|Radiographic Deterioration|1|||
126592210|NCT03058289|455468108|FG003|Overall Study|Radiographic Deterioration|2|||
126592211|NCT03058289|455468109|FG004|Overall Study|Radiographic Deterioration|6|||
126592212|NCT03058289|455468110|FG005|Overall Study|Radiographic Deterioration|3|||
126592213|NCT03058289|455468111|FG006|Overall Study|Radiographic Deterioration|0|||
126592214|NCT03058289|455468112|FG007|Overall Study|Radiographic Deterioration|4|||
126592215|NCT03058289|455468113|FG008|Overall Study|Radiographic Deterioration|2|||
126592216|NCT03058289|455468105|FG000|Overall Study|Adverse Event|2|||
126592217|NCT03058289|455468106|FG001|Overall Study|Adverse Event|0|||
126592218|NCT03058289|455468107|FG002|Overall Study|Adverse Event|1|||
126592219|NCT03058289|455468108|FG003|Overall Study|Adverse Event|3|||
126592220|NCT03058289|455468109|FG004|Overall Study|Adverse Event|1|||
126592221|NCT03058289|455468110|FG005|Overall Study|Adverse Event|0|||
126778172|NCT00910858|456143109|FG001|Monotherapy Phase|Adverse Event|2|||
126778173|NCT00910858|456143110|FG002|Monotherapy Phase|Adverse Event|0|||
126778174|NCT00910858|456143108|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
126778175|NCT00910858|456143109|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
126778176|NCT00910858|456143110|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
126778177|NCT00910858|456143108|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
126778178|NCT00910858|456143109|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
126778179|NCT00910858|456143110|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
126592222|NCT03058289|455468111|FG006|Overall Study|Adverse Event|1|||
126592223|NCT03058289|455468112|FG007|Overall Study|Adverse Event|3|||
126592224|NCT03058289|455468113|FG008|Overall Study|Adverse Event|0|||
126592225|NCT03058289|455468105|FG000|Overall Study|Withdrawal by Subject|0|||
126592226|NCT03058289|455468106|FG001|Overall Study|Withdrawal by Subject|0|||
126592227|NCT03058289|455468107|FG002|Overall Study|Withdrawal by Subject|0|||
126592228|NCT03058289|455468108|FG003|Overall Study|Withdrawal by Subject|2|||
126592229|NCT03058289|455468109|FG004|Overall Study|Withdrawal by Subject|0|||
126778180|NCT00910858|456143108|FG000|Monotherapy Phase|Protocol Violation|1|||
126778181|NCT00910858|456143109|FG001|Monotherapy Phase|Protocol Violation|0|||
126592230|NCT03058289|455468110|FG005|Overall Study|Withdrawal by Subject|2|||
126592231|NCT03058289|455468111|FG006|Overall Study|Withdrawal by Subject|0|||
126592232|NCT03058289|455468112|FG007|Overall Study|Withdrawal by Subject|4|||
126592233|NCT03058289|455468113|FG008|Overall Study|Withdrawal by Subject|1|||
126592234|NCT03058289|455468105|FG000|Overall Study|Physician Decision|1|||
126592235|NCT03058289|455468106|FG001|Overall Study|Physician Decision|0|||
126592236|NCT03058289|455468107|FG002|Overall Study|Physician Decision|0|||
126592237|NCT03058289|455468108|FG003|Overall Study|Physician Decision|2|||
126592238|NCT03058289|455468109|FG004|Overall Study|Physician Decision|1|||
126592239|NCT03058289|455468110|FG005|Overall Study|Physician Decision|0|||
126592240|NCT03058289|455468111|FG006|Overall Study|Physician Decision|2|||
126592241|NCT03058289|455468112|FG007|Overall Study|Physician Decision|3|||
126592242|NCT03058289|455468113|FG008|Overall Study|Physician Decision|0|||
126592243|NCT03058289|455468105|FG000|Overall Study|Clinical Deterioration|2|||
126592244|NCT03058289|455468106|FG001|Overall Study|Clinical Deterioration|0|||
126592245|NCT03058289|455468107|FG002|Overall Study|Clinical Deterioration|0|||
126592246|NCT03058289|455468108|FG003|Overall Study|Clinical Deterioration|2|||
126592247|NCT03058289|455468109|FG004|Overall Study|Clinical Deterioration|1|||
126592248|NCT03058289|455468110|FG005|Overall Study|Clinical Deterioration|1|||
126592249|NCT03058289|455468111|FG006|Overall Study|Clinical Deterioration|0|||
126592250|NCT03058289|455468112|FG007|Overall Study|Clinical Deterioration|3|||
126592251|NCT03058289|455468113|FG008|Overall Study|Clinical Deterioration|2|||
126592252|NCT03058289|455468105|FG000|Overall Study|Lost to Follow-up|0|||
126592253|NCT03058289|455468106|FG001|Overall Study|Lost to Follow-up|0|||
126592254|NCT03058289|455468107|FG002|Overall Study|Lost to Follow-up|0|||
126592255|NCT03058289|455468108|FG003|Overall Study|Lost to Follow-up|0|||
126592256|NCT03058289|455468109|FG004|Overall Study|Lost to Follow-up|1|||
126592257|NCT03058289|455468110|FG005|Overall Study|Lost to Follow-up|0|||
126592258|NCT03058289|455468111|FG006|Overall Study|Lost to Follow-up|0|||
126592259|NCT03058289|455468112|FG007|Overall Study|Lost to Follow-up|0|||
126592260|NCT03058289|455468113|FG008|Overall Study|Lost to Follow-up|0|||
126592261|NCT03058289|455468105|FG000|Overall Study|Refused Further Treatment|0|||
126592262|NCT03058289|455468106|FG001|Overall Study|Refused Further Treatment|0|||
126592263|NCT03058289|455468107|FG002|Overall Study|Refused Further Treatment|1|||
126592264|NCT03058289|455468108|FG003|Overall Study|Refused Further Treatment|0|||
126592265|NCT03058289|455468109|FG004|Overall Study|Refused Further Treatment|1|||
126592266|NCT03058289|455468110|FG005|Overall Study|Refused Further Treatment|0|||
126592267|NCT03058289|455468111|FG006|Overall Study|Refused Further Treatment|0|||
126592268|NCT03058289|455468112|FG007|Overall Study|Refused Further Treatment|0|||
126592269|NCT03058289|455468113|FG008|Overall Study|Refused Further Treatment|0|||
126592270|NCT03058289|455468105|FG000|Overall Study|Rapid Progression of Disease|0|||
126592271|NCT03058289|455468106|FG001|Overall Study|Rapid Progression of Disease|0|||
126592272|NCT03058289|455468107|FG002|Overall Study|Rapid Progression of Disease|0|||
126592273|NCT03058289|455468108|FG003|Overall Study|Rapid Progression of Disease|1|||
126592274|NCT03058289|455468109|FG004|Overall Study|Rapid Progression of Disease|0|||
126592275|NCT03058289|455468110|FG005|Overall Study|Rapid Progression of Disease|0|||
126592276|NCT03058289|455468111|FG006|Overall Study|Rapid Progression of Disease|0|||
126592277|NCT03058289|455468112|FG007|Overall Study|Rapid Progression of Disease|0|||
126592278|NCT03058289|455468113|FG008|Overall Study|Rapid Progression of Disease|0|||
126592279|NCT05546411|455468116|FG000|Overall Study|Progressive Disease|1|||
126592280|NCT05546411|455468117|FG001|Overall Study|Progressive Disease|0|||
126592281|NCT05546411|455468116|FG000|Overall Study|Adverse Event|0|||
126592282|NCT05546411|455468117|FG001|Overall Study|Adverse Event|1|||
126592283|NCT05546411|455468116|FG000|Overall Study|Metastatic disease|1|||
126592284|NCT05546411|455468117|FG001|Overall Study|Metastatic disease|0|||
126592285|NCT02606422|455468118|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
126592286|NCT02606422|455468119|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
126592287|NCT02606422|455468118|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
126592288|NCT02606422|455468119|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
126592289|NCT02606422|455468118|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
126592290|NCT02606422|455468119|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
126592291|NCT02606422|455468118|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
126592292|NCT02606422|455468119|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
126592293|NCT04625465|455468120|FG000|Overall Study|Lost to Follow-up|2|||
126592294|NCT04625465|455468121|FG001|Overall Study|Lost to Follow-up|2|||
126592295|NCT04625465|455468122|FG002|Overall Study|Lost to Follow-up|1|||
126592296|NCT04625465|455468123|FG003|Overall Study|Lost to Follow-up|0|||
126592297|NCT04625465|455468124|FG004|Overall Study|Lost to Follow-up|0|||
126592298|NCT04625465|455468125|FG005|Overall Study|Lost to Follow-up|2|||
126592299|NCT04625465|455468126|FG006|Overall Study|Lost to Follow-up|0|||
126592300|NCT04625465|455468127|FG007|Overall Study|Lost to Follow-up|0|||
126592301|NCT04625465|455468120|FG000|Overall Study|Death|1|||
126592302|NCT04625465|455468121|FG001|Overall Study|Death|0|||
126592303|NCT04625465|455468122|FG002|Overall Study|Death|0|||
126592304|NCT04625465|455468123|FG003|Overall Study|Death|0|||
126778182|NCT00910858|456143110|FG002|Monotherapy Phase|Protocol Violation|0|||
126778183|NCT00910858|456143108|FG000|Monotherapy Phase|Other|3|||
126778184|NCT00910858|456143109|FG001|Monotherapy Phase|Other|4|||
126778185|NCT00910858|456143110|FG002|Monotherapy Phase|Other|2|||
126778186|NCT00910858|456143108|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
126778187|NCT00910858|456143109|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
126778188|NCT00910858|456143110|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
126778189|NCT00910858|456143108|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
126778190|NCT00910858|456143109|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
126778191|NCT00910858|456143110|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
126778192|NCT00910858|456143108|FG000|Combined Treatment Phase|Protocol Violation|1|||
126778193|NCT00910858|456143109|FG001|Combined Treatment Phase|Protocol Violation|0|||
126778194|NCT00910858|456143110|FG002|Combined Treatment Phase|Protocol Violation|0|||
126778195|NCT00910858|456143108|FG000|Combined Treatment Phase|Other|0|||
126778196|NCT00910858|456143109|FG001|Combined Treatment Phase|Other|2|||
126778197|NCT00910858|456143110|FG002|Combined Treatment Phase|Other|1|||
126778198|NCT01703741|456143118|FG000|Overall Study|Withdrawal by Subject|6|||
126778199|NCT01703741|456143118|FG000|Overall Study|Adverse Event|2|||
126778200|NCT01703741|456143118|FG000|Overall Study|Physician Decision|2|||
126778201|NCT01703741|456143118|FG000|Overall Study|Protocol Violation|1|||
126778202|NCT01703741|456143118|FG000|Overall Study|Lost to Follow-up|3|||
126778203|NCT01703741|456143118|FG000|Overall Study|Subject did not want to continue|2|||
126778204|NCT01703741|456143118|FG000|Overall Study|Subject cannot comply with study visits|1|||
126778205|NCT01703741|456143118|FG000|Overall Study|Subject started testosterone injections|1|||
126778206|NCT01170364|456143119|FG000|Overall Study|Protocol Violation|4|||
126778207|NCT01170364|456143120|FG001|Overall Study|Protocol Violation|1|||
126778208|NCT01381900|456143121|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
126778209|NCT01381900|456143122|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
126778210|NCT01381900|456143123|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
126778211|NCT01381900|456143121|FG000|Overall Study|Adverse Event|4|||
126778212|NCT01381900|456143122|FG001|Overall Study|Adverse Event|6|||
126778213|NCT01381900|456143123|FG002|Overall Study|Adverse Event|7|||
126778214|NCT01381900|456143121|FG000|Overall Study|Noncompliance with study drug|0|||
126778215|NCT01381900|456143122|FG001|Overall Study|Noncompliance with study drug|0|||
126778216|NCT01381900|456143123|FG002|Overall Study|Noncompliance with study drug|1|||
126778217|NCT01381900|456143121|FG000|Overall Study|Physician Decision|0|||
126778218|NCT01381900|456143122|FG001|Overall Study|Physician Decision|1|||
126778219|NCT01381900|456143123|FG002|Overall Study|Physician Decision|1|||
126778220|NCT01381900|456143121|FG000|Overall Study|Protocol Violation|0|||
126778221|NCT01381900|456143122|FG001|Overall Study|Protocol Violation|1|||
126778222|NCT01381900|456143123|FG002|Overall Study|Protocol Violation|1|||
126778223|NCT01381900|456143121|FG000|Overall Study|Withdrawal by Subject|0|||
126778224|NCT01381900|456143122|FG001|Overall Study|Withdrawal by Subject|0|||
126778225|NCT01381900|456143123|FG002|Overall Study|Withdrawal by Subject|1|||
126778226|NCT01381900|456143121|FG000|Overall Study|Early withdraw|3|||
126778227|NCT01381900|456143122|FG001|Overall Study|Early withdraw|1|||
126778228|NCT01381900|456143123|FG002|Overall Study|Early withdraw|1|||
126778229|NCT02041494|456143124|FG000|Overall Study|Death|1|||
126778230|NCT02041494|456143125|FG001|Overall Study|Death|3|||
126778231|NCT02041494|456143124|FG000|Overall Study|Lost to Follow-up|2|||
126778232|NCT02041494|456143125|FG001|Overall Study|Lost to Follow-up|6|||
126778233|NCT02041494|456143124|FG000|Overall Study|study terminated|16|||
126778234|NCT02041494|456143125|FG001|Overall Study|study terminated|11|||
126778235|NCT02965820|456143127|FG000|Period 2, Second 30 Days|Adverse Event|1|||
126778236|NCT02965820|456143128|FG001|Period 2, Second 30 Days|Adverse Event|1|||
126778237|NCT03870997|456143131|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
126778238|NCT03870997|456143132|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
126778239|NCT03870997|456143133|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
126778240|NCT03870997|456143134|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
126778241|NCT03870997|456143135|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
126592305|NCT04625465|455468124|FG004|Overall Study|Death|0|||
126592306|NCT04625465|455468125|FG005|Overall Study|Death|0|||
126592307|NCT04625465|455468126|FG006|Overall Study|Death|0|||
126592308|NCT04625465|455468127|FG007|Overall Study|Death|0|||
126592309|NCT04625465|455468120|FG000|Overall Study|Withdrawal by Subject|1|||
126778242|NCT03870997|456143136|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
126778243|NCT00667719|456143139|FG000|Overall Study|Adverse Event|39|||
126778244|NCT00667719|456143139|FG000|Overall Study|Abnormal Test Procedure|1|||
126778245|NCT00667719|456143139|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
126778246|NCT00667719|456143139|FG000|Overall Study|Protocol Violation|3|||
126778247|NCT00667719|456143139|FG000|Overall Study|Withdrawal by Subject|17|||
126778248|NCT00667719|456143139|FG000|Overall Study|Lost to Follow-up|8|||
126592310|NCT04625465|455468121|FG001|Overall Study|Withdrawal by Subject|0|||
126592311|NCT04625465|455468122|FG002|Overall Study|Withdrawal by Subject|4|||
126592312|NCT04625465|455468123|FG003|Overall Study|Withdrawal by Subject|4|||
126778249|NCT00863057|456143144|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
126778250|NCT00863057|456143145|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
126592313|NCT04625465|455468124|FG004|Overall Study|Withdrawal by Subject|4|||
126592314|NCT04625465|455468125|FG005|Overall Study|Withdrawal by Subject|0|||
126592315|NCT04625465|455468126|FG006|Overall Study|Withdrawal by Subject|0|||
126592316|NCT04625465|455468127|FG007|Overall Study|Withdrawal by Subject|0|||
126592317|NCT05566639|455468130|FG000|Overall Study|Adverse Event|1|||
126592318|NCT05566639|455468131|FG001|Overall Study|Adverse Event|1|||
126592319|NCT05566639|455468130|FG000|Overall Study|Serious Adverse Event|1|||
126592320|NCT05566639|455468131|FG001|Overall Study|Serious Adverse Event|3|||
126592321|NCT05566639|455468130|FG000|Overall Study|Death|44|||
126592322|NCT05566639|455468131|FG001|Overall Study|Death|45|||
126592323|NCT05566639|455468130|FG000|Overall Study|Lost to Follow-up|467|||
126592324|NCT05566639|455468131|FG001|Overall Study|Lost to Follow-up|461|||
126592325|NCT05566639|455468130|FG000|Overall Study|Physician Decision|45|||
126592326|NCT05566639|455468131|FG001|Overall Study|Physician Decision|44|||
126592327|NCT05566639|455468130|FG000|Overall Study|Protocol Deviation|4|||
126592328|NCT05566639|455468131|FG001|Overall Study|Protocol Deviation|4|||
126592329|NCT05566639|455468130|FG000|Overall Study|Withdrawal by Subject|277|||
126592330|NCT05566639|455468131|FG001|Overall Study|Withdrawal by Subject|271|||
126592331|NCT05566639|455468130|FG000|Overall Study|Other Than Specified|52|||
126592332|NCT05566639|455468131|FG001|Overall Study|Other Than Specified|64|||
126592333|NCT02589522|455468133|FG000|Overall Study|Physician Decision|1|||
126592334|NCT02589522|455468134|FG001|Overall Study|Physician Decision|2|||
126592335|NCT02589522|455468135|FG002|Overall Study|Physician Decision|0|||
126592336|NCT02589522|455468133|FG000|Overall Study|Did not start treatment|1|||
126592337|NCT02589522|455468134|FG001|Overall Study|Did not start treatment|0|||
126592338|NCT02589522|455468135|FG002|Overall Study|Did not start treatment|0|||
126592339|NCT04159415|455468136|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
126592340|NCT04159415|455468137|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
126592341|NCT04159415|455468138|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
126592342|NCT04159415|455468139|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
126592343|NCT04159415|455468140|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
126592344|NCT04159415|455468141|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
126592345|NCT04159415|455468142|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
126592346|NCT04159415|455468143|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
126592347|NCT03800654|455468144|FG000|Overall Study|Time constraints|3|||
126592348|NCT03800654|455468145|FG001|Overall Study|Time constraints|3|||
126592349|NCT03800654|455468146|FG002|Overall Study|Time constraints|3|||
126592350|NCT03800654|455468144|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
126592351|NCT03800654|455468145|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
126592352|NCT03800654|455468146|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
126592353|NCT03800654|455468144|FG000|Overall Study|Lost to Follow-up|2|||
126592354|NCT03800654|455468145|FG001|Overall Study|Lost to Follow-up|1|||
126592355|NCT03800654|455468146|FG002|Overall Study|Lost to Follow-up|6|||
126592356|NCT03800654|455468144|FG000|Overall Study|Medical Health Issue|0|||
126592357|NCT03800654|455468145|FG001|Overall Study|Medical Health Issue|0|||
126592358|NCT03800654|455468146|FG002|Overall Study|Medical Health Issue|1|||
126592359|NCT03800654|455468144|FG000|Overall Study|Personal Issues|0|||
126592360|NCT03800654|455468145|FG001|Overall Study|Personal Issues|2|||
126592361|NCT03800654|455468146|FG002|Overall Study|Personal Issues|0|||
126592362|NCT03800654|455468144|FG000|Overall Study|Protocol Violation|0|||
126592363|NCT03800654|455468145|FG001|Overall Study|Protocol Violation|1|||
126592364|NCT03800654|455468146|FG002|Overall Study|Protocol Violation|0|||
126592365|NCT06182033|455468147|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
126592366|NCT06182033|455468148|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
126592367|NCT06182033|455468147|FG000|Overall Study|Target child relocation|1|||
126592368|NCT06182033|455468148|FG001|Overall Study|Target child relocation|1|||
126592369|NCT06182033|455468147|FG000|Overall Study|Withdrawal by Subject|1|||
126592370|NCT06182033|455468148|FG001|Overall Study|Withdrawal by Subject|0|||
126592371|NCT05309291|455468150|FG000|Overall Study|Adverse Event|0|||
126592372|NCT05309291|455468151|FG001|Overall Study|Adverse Event|1|||
126592373|NCT05209152|455468154|FG000|Overall Study|Sponsor decision|1|||
126592374|NCT05209152|455468155|FG001|Overall Study|Sponsor decision|2|||
126592375|NCT05209152|455468154|FG000|Overall Study|Death|3|||
126592376|NCT05209152|455468155|FG001|Overall Study|Death|1|||
126592377|NCT04044768|455469665|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
126592378|NCT04044768|455469666|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
126592379|NCT01574274|455469667|FG000|Overall Study|Ineligible|0|||
126778251|NCT00863057|456143146|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
126592380|NCT01574274|455469668|FG001|Overall Study|Ineligible|1|||
126592381|NCT01574274|455469667|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
126778252|NCT00863057|456143147|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
126592382|NCT01574274|455469668|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
126592383|NCT01574274|455469667|FG000|Overall Study|Ph+ B-ALL|3|||
126592384|NCT01574274|455469668|FG001|Overall Study|Ph+ B-ALL|4|||
126592385|NCT01574274|455469667|FG000|Overall Study|Induction Death|2|||
126592386|NCT01574274|455469668|FG001|Overall Study|Induction Death|0|||
126592387|NCT01574274|455469667|FG000|Overall Study|Induction Failure|4|||
126592388|NCT01574274|455469668|FG001|Overall Study|Induction Failure|1|||
126592389|NCT01574274|455469667|FG000|Overall Study|Adverse Event|16|||
126592390|NCT01574274|455469668|FG001|Overall Study|Adverse Event|13|||
126592391|NCT01574274|455469667|FG000|Overall Study|Remission Death|1|||
126592392|NCT01574274|455469668|FG001|Overall Study|Remission Death|0|||
126592393|NCT01574274|455469667|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
126592394|NCT01574274|455469668|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
126592395|NCT01574274|455469667|FG000|Overall Study|Other, unknown|3|||
126592396|NCT01574274|455469668|FG001|Overall Study|Other, unknown|2|||
126592397|NCT05089019|455469669|FG000|Period 1|Withdrawal by Subject|0|||
126592398|NCT05089019|455469670|FG001|Period 1|Withdrawal by Subject|1|||
126592399|NCT05089019|455469669|FG000|Washout Period|Adverse Event|3|||
126592400|NCT05089019|455469670|FG001|Washout Period|Adverse Event|4|||
126592401|NCT05089019|455469669|FG000|Washout Period|Lost to Follow-up|1|||
126592402|NCT05089019|455469670|FG001|Washout Period|Lost to Follow-up|0|||
126592403|NCT05089019|455469669|FG000|Washout Period|Physician Decision|2|||
126592404|NCT05089019|455469670|FG001|Washout Period|Physician Decision|0|||
126592405|NCT05089019|455469669|FG000|Washout Period|Withdrawal by Subject|6|||
126592406|NCT05089019|455469670|FG001|Washout Period|Withdrawal by Subject|3|||
126592407|NCT05089019|455469669|FG000|Period 2|Adverse Event|4|||
126592408|NCT05089019|455469670|FG001|Period 2|Adverse Event|2|||
126592409|NCT05089019|455469669|FG000|Period 2|Lost to Follow-up|1|||
126592410|NCT05089019|455469670|FG001|Period 2|Lost to Follow-up|0|||
126592411|NCT05089019|455469669|FG000|Period 2|Withdrawal by Subject|0|||
126592412|NCT05089019|455469670|FG001|Period 2|Withdrawal by Subject|1|||
126592413|NCT01593917|455469675|FG000|Overall Study|Death|67|||
126592414|NCT01593917|455469675|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
126592415|NCT01593917|455469675|FG000|Overall Study|Withdrawal by Subject|23|||
126592416|NCT01593917|455469675|FG000|Overall Study|Lost to Follow-up|12|||
126592417|NCT01593917|455469675|FG000|Overall Study|Protocol Violation|5|||
126592418|NCT01593917|455469675|FG000|Overall Study|Physician Decision|3|||
126592419|NCT02043678|455469680|FG000|Overall Study|Never treated|11|||
126592420|NCT02043678|455469681|FG001|Overall Study|Never treated|9|||
126592421|NCT02043678|455469680|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
126592422|NCT02043678|455469681|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
126592423|NCT02043678|455469680|FG000|Overall Study|AE without clinical PD|54|||
126592424|NCT02043678|455469681|FG001|Overall Study|AE without clinical PD|36|||
126592425|NCT02043678|455469680|FG000|Overall Study|Lost to Follow-up|1|||
126592426|NCT02043678|455469681|FG001|Overall Study|Lost to Follow-up|1|||
126592427|NCT02043678|455469680|FG000|Overall Study|Other|10|||
126592428|NCT02043678|455469681|FG001|Overall Study|Other|14|||
126592429|NCT02043678|455469680|FG000|Overall Study|Clinical PD|114|||
126592430|NCT02043678|455469681|FG001|Overall Study|Clinical PD|148|||
126592431|NCT02043678|455469680|FG000|Overall Study|Radiological PD|100|||
126592432|NCT02043678|455469681|FG001|Overall Study|Radiological PD|90|||
126592433|NCT02043678|455469680|FG000|Overall Study|Protocol-driven decision point|59|||
126592434|NCT02043678|455469681|FG001|Overall Study|Protocol-driven decision point|58|||
126592435|NCT02043678|455469680|FG000|Overall Study|Withdrawal by Subject|16|||
126592436|NCT02043678|455469681|FG001|Overall Study|Withdrawal by Subject|20|||
126592437|NCT02043678|455469680|FG000|Overall Study|Protocol Violation|1|||
126592438|NCT02043678|455469681|FG001|Overall Study|Protocol Violation|0|||
126592439|NCT02043678|455469680|FG000|Overall Study|Deterioration of general conditions|1|||
126592440|NCT02043678|455469681|FG001|Overall Study|Deterioration of general conditions|1|||
126592441|NCT02043678|455469680|FG000|Overall Study|Logistical difficulties|2|||
126592442|NCT02043678|455469681|FG001|Overall Study|Logistical difficulties|0|||
126592443|NCT02043678|455469680|FG000|Overall Study|Non-compliance with study drug|3|||
126592444|NCT02043678|455469681|FG001|Overall Study|Non-compliance with study drug|1|||
126592445|NCT02043678|455469680|FG000|Overall Study|Physician Decision|4|||
126592446|NCT02043678|455469681|FG001|Overall Study|Physician Decision|3|||
126592447|NCT02043678|455469680|FG000|Overall Study|Subject decision|0|||
126592448|NCT02043678|455469681|FG001|Overall Study|Subject decision|1|||
126592449|NCT02043678|455469680|FG000|Overall Study|Switching to other therapy|3|||
126592450|NCT02043678|455469681|FG001|Overall Study|Switching to other therapy|2|||
126592451|NCT02043678|455469680|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
126592452|NCT02043678|455469681|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
126592453|NCT02043678|455469680|FG000|Overall Study|Missing|1|||
126592454|NCT02043678|455469681|FG001|Overall Study|Missing|0|||
126592455|NCT02043678|455469680|FG000|Overall Study|Adverse Event|0|||
126592456|NCT02043678|455469681|FG001|Overall Study|Adverse Event|1|||
126592457|NCT05543629|455469682|FG000|Overall Study|Death|1|||
126592458|NCT05543629|455469683|FG001|Overall Study|Death|0|||
126778253|NCT00863057|456143144|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
126592459|NCT05543629|455469684|FG002|Overall Study|Death|1|||
126592460|NCT05543629|455469685|FG003|Overall Study|Death|0|||
126592461|NCT05543629|455469686|FG004|Overall Study|Death|0|||
126592462|NCT05543629|455469687|FG005|Overall Study|Death|1|||
126592463|NCT05543629|455469688|FG006|Overall Study|Death|2|||
126592464|NCT05543629|455469689|FG007|Overall Study|Death|2|||
126592465|NCT05543629|455469682|FG000|Overall Study|Other Reasons|0|||
126592466|NCT05543629|455469683|FG001|Overall Study|Other Reasons|0|||
126592467|NCT05543629|455469684|FG002|Overall Study|Other Reasons|0|||
126592468|NCT05543629|455469685|FG003|Overall Study|Other Reasons|0|||
126592469|NCT05543629|455469686|FG004|Overall Study|Other Reasons|1|||
126592470|NCT05543629|455469687|FG005|Overall Study|Other Reasons|0|||
126592471|NCT05543629|455469688|FG006|Overall Study|Other Reasons|0|||
126592472|NCT05543629|455469689|FG007|Overall Study|Other Reasons|0|||
126592473|NCT05543629|455469682|FG000|Overall Study|Physician Decision|0|||
126592474|NCT05543629|455469683|FG001|Overall Study|Physician Decision|0|||
126592475|NCT05543629|455469684|FG002|Overall Study|Physician Decision|3|||
126592476|NCT05543629|455469685|FG003|Overall Study|Physician Decision|0|||
126592477|NCT05543629|455469686|FG004|Overall Study|Physician Decision|0|||
126592478|NCT05543629|455469687|FG005|Overall Study|Physician Decision|0|||
126592479|NCT05543629|455469688|FG006|Overall Study|Physician Decision|1|||
126592480|NCT05543629|455469689|FG007|Overall Study|Physician Decision|0|||
126592481|NCT05543629|455469682|FG000|Overall Study|Study terminated by Sponsor|1|||
126592482|NCT05543629|455469683|FG001|Overall Study|Study terminated by Sponsor|0|||
126592483|NCT05543629|455469684|FG002|Overall Study|Study terminated by Sponsor|0|||
126592484|NCT05543629|455469685|FG003|Overall Study|Study terminated by Sponsor|1|||
126592485|NCT05543629|455469686|FG004|Overall Study|Study terminated by Sponsor|0|||
126592486|NCT05543629|455469687|FG005|Overall Study|Study terminated by Sponsor|4|||
126592487|NCT05543629|455469688|FG006|Overall Study|Study terminated by Sponsor|1|||
126592488|NCT05543629|455469689|FG007|Overall Study|Study terminated by Sponsor|0|||
126592489|NCT05543629|455469682|FG000|Overall Study|Withdrawal by Subject|1|||
126592490|NCT05543629|455469683|FG001|Overall Study|Withdrawal by Subject|1|||
126592491|NCT05543629|455469684|FG002|Overall Study|Withdrawal by Subject|0|||
126592492|NCT05543629|455469685|FG003|Overall Study|Withdrawal by Subject|2|||
126592493|NCT05543629|455469686|FG004|Overall Study|Withdrawal by Subject|1|||
126592494|NCT05543629|455469687|FG005|Overall Study|Withdrawal by Subject|1|||
126592495|NCT05543629|455469688|FG006|Overall Study|Withdrawal by Subject|1|||
126592496|NCT05543629|455469689|FG007|Overall Study|Withdrawal by Subject|1|||
126592497|NCT05543629|455469682|FG000|Overall Study|Not Reported|2|||
126592498|NCT05543629|455469683|FG001|Overall Study|Not Reported|2|||
126592499|NCT05543629|455469684|FG002|Overall Study|Not Reported|0|||
126592500|NCT05543629|455469685|FG003|Overall Study|Not Reported|0|||
126592501|NCT05543629|455469686|FG004|Overall Study|Not Reported|1|||
126592502|NCT05543629|455469687|FG005|Overall Study|Not Reported|1|||
126592503|NCT05543629|455469688|FG006|Overall Study|Not Reported|3|||
126592504|NCT05543629|455469689|FG007|Overall Study|Not Reported|0|||
126592505|NCT03216057|455469690|FG000|Overall Study|Lost to Follow-up|2|||
126592506|NCT03216057|455469691|FG001|Overall Study|Lost to Follow-up|2|||
126592507|NCT04568603|455469692|FG000|Overall Study|Physician Decision|1|||
126592508|NCT04564742|455469693|FG000|Overall Study|Lost to Follow-up|1|||
126592509|NCT04564742|455469694|FG001|Overall Study|Lost to Follow-up|0|||
126592510|NCT04564742|455469693|FG000|Overall Study|Consent Withdrawal|4|||
126592511|NCT04564742|455469694|FG001|Overall Study|Consent Withdrawal|4|||
126592512|NCT03313076|455469698|FG000|Overall Study|Withdrawal by Subject|2|||
126592513|NCT03313076|455469699|FG001|Overall Study|Withdrawal by Subject|0|||
126592514|NCT03313076|455469700|FG002|Overall Study|Withdrawal by Subject|0|||
126592515|NCT03313076|455469701|FG003|Overall Study|Withdrawal by Subject|0|||
126592516|NCT03313076|455469698|FG000|Overall Study|Lost to Follow-up|0|||
126592517|NCT03313076|455469699|FG001|Overall Study|Lost to Follow-up|2|||
126592518|NCT03313076|455469700|FG002|Overall Study|Lost to Follow-up|2|||
126592519|NCT03313076|455469701|FG003|Overall Study|Lost to Follow-up|2|||
126592520|NCT04307355|455469707|FG000|Overall Study|Non-Compliance|3|||
126592521|NCT04307355|455469708|FG001|Overall Study|Non-Compliance|3|||
126592522|NCT04307355|455469709|FG002|Overall Study|Non-Compliance|0|||
126592523|NCT04225273|455469711|FG000|Overall Study|Lost to Follow-up|3|||
126592524|NCT05270408|455469713|FG000|Started Treatment|Withdrawal by Subject|0|||
126592525|NCT05270408|455469714|FG001|Started Treatment|Withdrawal by Subject|0|||
126592526|NCT05270408|455469715|FG002|Started Treatment|Withdrawal by Subject|3|||
126592527|NCT05270408|455469713|FG000|Started Treatment|Adverse Event|0|||
126592528|NCT05270408|455469714|FG001|Started Treatment|Adverse Event|0|||
126592529|NCT05270408|455469715|FG002|Started Treatment|Adverse Event|1|||
126592530|NCT05270408|455469713|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
126592531|NCT05270408|455469714|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
126592532|NCT05270408|455469715|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
126592533|NCT02465268|455469717|FG000|Overall Study|Withdrawal by Subject|4|||
126592534|NCT02465268|455469718|FG001|Overall Study|Withdrawal by Subject|3|||
126592535|NCT02465268|455469719|FG002|Overall Study|Withdrawal by Subject|1|||
126592536|NCT02465268|455469717|FG000|Overall Study|Not evaluable per protocol criteria|3|||
126592537|NCT02465268|455469718|FG001|Overall Study|Not evaluable per protocol criteria|2|||
126592538|NCT02465268|455469719|FG002|Overall Study|Not evaluable per protocol criteria|1|||
126778254|NCT00863057|456143145|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
126592539|NCT02465268|455469717|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
126592540|NCT02465268|455469718|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
126778255|NCT00863057|456143146|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
126778256|NCT00863057|456143147|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
126778257|NCT00863057|456143144|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
126778258|NCT00863057|456143145|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
126778259|NCT00863057|456143146|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
126778260|NCT00863057|456143147|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
126778261|NCT00863057|456143144|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
126778262|NCT00863057|456143145|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
126778263|NCT00863057|456143146|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
126778264|NCT00863057|456143147|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
126778265|NCT03412019|456143148|FG000|Overall Study|Withdrawal by Subject|1|||
126778266|NCT03412019|456143149|FG001|Overall Study|Withdrawal by Subject|1|||
126778267|NCT00947011|456143152|FG000|Overall Study|Study was terminated,PI left institution|12|||
126778268|NCT05266456|456143153|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
126778269|NCT05266456|456143154|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
126778270|NCT05266456|456143155|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
126778271|NCT05266456|456143156|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
126778272|NCT05266456|456143153|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
126778273|NCT05266456|456143154|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
126778274|NCT05266456|456143155|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
126778275|NCT05266456|456143156|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
126778276|NCT05266456|456143153|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
126778277|NCT05266456|456143154|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
126778278|NCT05266456|456143155|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
126778279|NCT05266456|456143156|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
126778280|NCT05266456|456143153|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
126778281|NCT05266456|456143154|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
126778282|NCT05266456|456143155|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
126778283|NCT05266456|456143156|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
126778284|NCT05266456|456143153|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
126778285|NCT05266456|456143154|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
126778286|NCT05266456|456143155|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
126778287|NCT05266456|456143156|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
126778288|NCT01141283|456143157|FG000|Overall Study|Adverse Event|56|||
126778289|NCT01141283|456143157|FG000|Overall Study|Lost to Follow-up|4|||
126778290|NCT01141283|456143157|FG000|Overall Study|Withdrawal by Subject|14|||
126778291|NCT01141283|456143157|FG000|Overall Study|Administrative|4|||
126592541|NCT02465268|455469719|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
126592542|NCT02465268|455469717|FG000|Overall Study|Study drug did not pass QA/QC|1|||
126592543|NCT02465268|455469718|FG001|Overall Study|Study drug did not pass QA/QC|0|||
126592544|NCT02465268|455469719|FG002|Overall Study|Study drug did not pass QA/QC|0|||
126592545|NCT02465268|455469717|FG000|Overall Study|Adverse Event|0|||
126592546|NCT02465268|455469718|FG001|Overall Study|Adverse Event|1|||
126592547|NCT02465268|455469719|FG002|Overall Study|Adverse Event|0|||
126592548|NCT02465268|455469717|FG000|Overall Study|Physician Decision|0|||
126592549|NCT02465268|455469718|FG001|Overall Study|Physician Decision|1|||
126592550|NCT02465268|455469719|FG002|Overall Study|Physician Decision|0|||
126592551|NCT03020199|455469726|FG000|Treatment Period|Adverse Event|0|||
126592552|NCT03020199|455469727|FG001|Treatment Period|Adverse Event|2|||
126592553|NCT03020199|455469726|FG000|Treatment Period|Lack of Efficacy|1|||
126592554|NCT03020199|455469727|FG001|Treatment Period|Lack of Efficacy|6|||
126592555|NCT03020199|455469726|FG000|Treatment Period|Lost to Follow-up|1|||
126592556|NCT03020199|455469727|FG001|Treatment Period|Lost to Follow-up|6|||
126592557|NCT03020199|455469726|FG000|Treatment Period|Physician Decision|0|||
126592558|NCT03020199|455469727|FG001|Treatment Period|Physician Decision|1|||
126592559|NCT03020199|455469726|FG000|Treatment Period|Subject/guardian decision|8|||
126592560|NCT03020199|455469727|FG001|Treatment Period|Subject/guardian decision|15|||
126592561|NCT03020199|455469726|FG000|Treatment Period|Subjects not treated|3|||
126778292|NCT01141283|456143157|FG000|Overall Study|Lack of Efficacy|10|||
126778293|NCT00479401|456143161|FG000|Overall Study|Adverse Event|24|||
126778294|NCT00479401|456143162|FG001|Overall Study|Adverse Event|20|||
126592562|NCT03020199|455469727|FG001|Treatment Period|Subjects not treated|4|||
126592563|NCT03020199|455469726|FG000|Follow-up Period|Disease relapse|32|||
126592564|NCT03020199|455469727|FG001|Follow-up Period|Disease relapse|7|||
126592565|NCT03020199|455469726|FG000|Follow-up Period|Lack of Efficacy|1|||
126778295|NCT00479401|456143163|FG002|Overall Study|Adverse Event|4|||
126778296|NCT00479401|456143161|FG000|Overall Study|Lack of Efficacy|2|||
126778297|NCT00479401|456143162|FG001|Overall Study|Lack of Efficacy|2|||
126778298|NCT00479401|456143163|FG002|Overall Study|Lack of Efficacy|4|||
126778299|NCT00479401|456143161|FG000|Overall Study|Protocol Violation|2|||
126778300|NCT00479401|456143162|FG001|Overall Study|Protocol Violation|1|||
126592566|NCT03020199|455469727|FG001|Follow-up Period|Lack of Efficacy|2|||
126592567|NCT03020199|455469726|FG000|Follow-up Period|Lost to Follow-up|4|||
126592568|NCT03020199|455469727|FG001|Follow-up Period|Lost to Follow-up|6|||
126592569|NCT03020199|455469726|FG000|Follow-up Period|Physician Decision|2|||
126592570|NCT03020199|455469727|FG001|Follow-up Period|Physician Decision|2|||
126592571|NCT03020199|455469726|FG000|Follow-up Period|Protocol Violation|1|||
126592572|NCT03020199|455469727|FG001|Follow-up Period|Protocol Violation|2|||
126592573|NCT03020199|455469726|FG000|Follow-up Period|Study terminated by Sponsor|6|||
126592574|NCT03020199|455469727|FG001|Follow-up Period|Study terminated by Sponsor|3|||
126592575|NCT03020199|455469726|FG000|Follow-up Period|Subject/guardian decision|14|||
126592576|NCT03020199|455469727|FG001|Follow-up Period|Subject/guardian decision|9|||
126592577|NCT04005794|455469730|FG000|Overall Study|Lost to Follow-up|0|||
126592578|NCT04005794|455469731|FG001|Overall Study|Lost to Follow-up|4|||
126592579|NCT04005794|455469732|FG002|Overall Study|Lost to Follow-up|0|||
126592580|NCT04313972|455469733|FG000|Overall Study|Withdrawal by Subject|0|||
126592581|NCT04313972|455469734|FG001|Overall Study|Withdrawal by Subject|1|||
126592582|NCT05808257|455469736|FG000|Overall Study|Lost to Follow-up|8|||
126592583|NCT05808257|455469737|FG001|Overall Study|Lost to Follow-up|8|||
126592584|NCT04568486|455469738|FG000|Overall Study|Withdrawal by Subject|26|||
126592585|NCT04568486|455469738|FG000|Overall Study|Lost to Follow-up|7|||
126592586|NCT04042233|455469739|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
126592587|NCT04042233|455469740|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
126592588|NCT04042233|455469739|FG000|Overall Study|Protocol Violation|0|||
126592589|NCT04042233|455469740|FG001|Overall Study|Protocol Violation|2|||
126592590|NCT05386030|455469746|FG000|Overall Study|Death|1|||
126592591|NCT05386030|455469747|FG001|Overall Study|Death|0|||
126592592|NCT05386030|455469746|FG000|Overall Study|Physician Decision|2|||
126592593|NCT05386030|455469747|FG001|Overall Study|Physician Decision|1|||
126592594|NCT05386030|455469746|FG000|Overall Study|Lost to Follow-up|19|||
126592595|NCT05386030|455469747|FG001|Overall Study|Lost to Follow-up|7|||
126592596|NCT05386030|455469746|FG000|Overall Study|Withdrawal by Subject|20|||
126592597|NCT05386030|455469747|FG001|Overall Study|Withdrawal by Subject|10|||
126592598|NCT05386030|455469746|FG000|Overall Study|Eligibility criteria violation|1|||
126592599|NCT05386030|455469747|FG001|Overall Study|Eligibility criteria violation|1|||
126592600|NCT05386030|455469746|FG000|Overall Study|Personal Reasons|1|||
126592601|NCT05386030|455469747|FG001|Overall Study|Personal Reasons|0|||
126592602|NCT04524442|455469748|FG000|Overall Study|Subject Decision|1|||
126592603|NCT04719832|455469749|FG000|Overall Study|Adverse Event|2|||
126592604|NCT04719832|455469750|FG001|Overall Study|Adverse Event|0|||
126592605|NCT04719832|455469749|FG000|Overall Study|Lack of Efficacy|2|||
126731841|NCT02215616|455968331|FG003|Overall Study|Withdrawal by Subject|5|||
126731842|NCT02215616|455968328|FG000|Overall Study|Non-compliance|0|||
126731843|NCT02215616|455968329|FG001|Overall Study|Non-compliance|2|||
126731844|NCT02215616|455968330|FG002|Overall Study|Non-compliance|1|||
126731845|NCT02215616|455968331|FG003|Overall Study|Non-compliance|0|||
126731846|NCT02215616|455968328|FG000|Overall Study|Protocol Violation|0|||
126731847|NCT02215616|455968329|FG001|Overall Study|Protocol Violation|2|||
126778301|NCT00479401|456143163|FG002|Overall Study|Protocol Violation|1|||
126778302|NCT00479401|456143161|FG000|Overall Study|Lost to Follow-up|1|||
126778303|NCT00479401|456143162|FG001|Overall Study|Lost to Follow-up|1|||
126592606|NCT04719832|455469750|FG001|Overall Study|Lack of Efficacy|4|||
126592607|NCT04719832|455469749|FG000|Overall Study|Lost to Follow-up|0|||
126592608|NCT04719832|455469750|FG001|Overall Study|Lost to Follow-up|2|||
126592609|NCT04719832|455469749|FG000|Overall Study|Physician Decision|0|||
126592610|NCT04719832|455469750|FG001|Overall Study|Physician Decision|1|||
126592611|NCT04719832|455469749|FG000|Overall Study|Pregnancy|1|||
126592612|NCT04719832|455469750|FG001|Overall Study|Pregnancy|1|||
126592613|NCT04719832|455469749|FG000|Overall Study|Withdrawal by Subject|5|||
126592614|NCT04719832|455469750|FG001|Overall Study|Withdrawal by Subject|5|||
126592615|NCT04719832|455469749|FG000|Overall Study|Randomized, not treated|0|||
126592616|NCT04719832|455469750|FG001|Overall Study|Randomized, not treated|2|||
126592617|NCT04719832|455469749|FG000|Overall Study|GCP violations|4|||
126592618|NCT04719832|455469750|FG001|Overall Study|GCP violations|7|||
126592619|NCT05228457|455469751|FG000|Overall Study|Withdrawal by Subject|1|||
126592620|NCT05228457|455469752|FG001|Overall Study|Withdrawal by Subject|1|||
126592621|NCT04880863|455469757|FG000|Overall Study|Adverse Event|1|||
126592622|NCT04880863|455469757|FG000|Overall Study|Patient decision|2|||
126592623|NCT04880863|455469757|FG000|Overall Study|Confirmed Disease Progression|15|||
126592624|NCT04880863|455469757|FG000|Overall Study|Death|3|||
126592625|NCT04880863|455469757|FG000|Overall Study|Physician Decision|4|||
126592626|NCT04880863|455469757|FG000|Overall Study|Unconfirmed Disease Progression|4|||
126592627|NCT04880863|455469757|FG000|Overall Study|Withdrawal by Subject|2|||
126592628|NCT04880863|455469757|FG000|Overall Study|Study discontinuation by the sponsor|4|||
126592629|NCT04880863|455469757|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
126592630|NCT04880863|455469757|FG000|Overall Study|Not received study drug NAP|2|||
126731848|NCT02215616|455968330|FG002|Overall Study|Protocol Violation|0|||
126778304|NCT00479401|456143163|FG002|Overall Study|Lost to Follow-up|1|||
126592631|NCT03213691|455469758|FG000|Overall Study|Adverse Event|2|||
126592632|NCT03213691|455469758|FG000|Overall Study|Death|3|||
126731849|NCT02215616|455968331|FG003|Overall Study|Protocol Violation|0|||
126592633|NCT03213691|455469758|FG000|Overall Study|Physician Decision|1|||
126592634|NCT03213691|455469758|FG000|Overall Study|Progressive Disease|14|||
126592635|NCT03213691|455469758|FG000|Overall Study|Ineligible|1|||
126592636|NCT04898673|455469759|FG000|Overall Study|Screenfail|1|||
126592637|NCT04898673|455469760|FG001|Overall Study|Screenfail|0|||
126592638|NCT03899259|455469763|FG000|Overall Study|Adverse Event|5|||
126592639|NCT03899259|455469764|FG001|Overall Study|Adverse Event|4|||
126592640|NCT03899259|455469765|FG002|Overall Study|Adverse Event|6|||
126592641|NCT03899259|455469763|FG000|Overall Study|Lack of Efficacy|5|||
126592642|NCT03899259|455469764|FG001|Overall Study|Lack of Efficacy|0|||
126592643|NCT03899259|455469765|FG002|Overall Study|Lack of Efficacy|2|||
126592644|NCT03899259|455469763|FG000|Overall Study|Pregnancy|3|||
126592645|NCT03899259|455469764|FG001|Overall Study|Pregnancy|0|||
126592646|NCT03899259|455469765|FG002|Overall Study|Pregnancy|1|||
126592647|NCT03899259|455469763|FG000|Overall Study|Physician Decision|0|||
126592648|NCT03899259|455469764|FG001|Overall Study|Physician Decision|1|||
126592649|NCT03899259|455469765|FG002|Overall Study|Physician Decision|0|||
126592650|NCT03899259|455469763|FG000|Overall Study|Protocol Deviation|1|||
126592651|NCT03899259|455469764|FG001|Overall Study|Protocol Deviation|1|||
126592652|NCT03899259|455469765|FG002|Overall Study|Protocol Deviation|1|||
126592653|NCT03899259|455469763|FG000|Overall Study|Withdrawal by Subject|8|||
126592654|NCT03899259|455469764|FG001|Overall Study|Withdrawal by Subject|10|||
126592655|NCT03899259|455469765|FG002|Overall Study|Withdrawal by Subject|12|||
126592656|NCT03899259|455469763|FG000|Overall Study|Lost to Follow-up|5|||
126592657|NCT03899259|455469764|FG001|Overall Study|Lost to Follow-up|6|||
126592658|NCT03899259|455469765|FG002|Overall Study|Lost to Follow-up|2|||
126592659|NCT03899259|455469763|FG000|Overall Study|Lack of Adherence|1|||
126592660|NCT03899259|455469764|FG001|Overall Study|Lack of Adherence|0|||
126592661|NCT03899259|455469765|FG002|Overall Study|Lack of Adherence|0|||
126592662|NCT03899259|455469763|FG000|Overall Study|Screen Failure|1|||
126592663|NCT03899259|455469764|FG001|Overall Study|Screen Failure|0|||
126592664|NCT03899259|455469765|FG002|Overall Study|Screen Failure|0|||
126592665|NCT03899259|455469763|FG000|Overall Study|Ongoing Study Participation|127|||
126592666|NCT03899259|455469764|FG001|Overall Study|Ongoing Study Participation|134|||
126592667|NCT03899259|455469765|FG002|Overall Study|Ongoing Study Participation|210|||
126592668|NCT01152450|455469768|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
126592669|NCT01152450|455469769|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
126592670|NCT01152450|455469770|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
126592671|NCT01152450|455469771|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
126592672|NCT01152450|455469772|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
126592673|NCT01152450|455469773|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
126592674|NCT01152450|455469768|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
126592675|NCT01152450|455469769|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
126592676|NCT01152450|455469770|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
126592677|NCT01152450|455469771|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
126592678|NCT01152450|455469772|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
126592679|NCT01152450|455469773|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
126592680|NCT01152450|455469768|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126592681|NCT01152450|455469769|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
126592682|NCT01152450|455469770|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
126592683|NCT01152450|455469771|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126592684|NCT01152450|455469772|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126592685|NCT01152450|455469773|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
126592686|NCT05670587|455469774|FG000|Overall Study|Withdrawal by Subject|3|||
126592687|NCT01197378|455469775|FG000|Overall Study|Adverse Event|3|||
126592688|NCT01197378|455469775|FG000|Overall Study|Withdrawal by Subject|1|||
126592689|NCT01197378|455469775|FG000|Overall Study|Physician Decision|1|||
126592690|NCT01197378|455469775|FG000|Overall Study|Other|2|||
126592691|NCT02723591|455469778|FG000|Overall Study|Adverse Event|48|||
126592692|NCT02723591|455469779|FG001|Overall Study|Adverse Event|40|||
126592693|NCT02723591|455469778|FG000|Overall Study|Death|2|||
126592694|NCT02723591|455469779|FG001|Overall Study|Death|2|||
126592695|NCT02723591|455469778|FG000|Overall Study|Lack of Efficacy|4|||
126592696|NCT02723591|455469779|FG001|Overall Study|Lack of Efficacy|3|||
126592697|NCT02723591|455469778|FG000|Overall Study|Lost to Follow-up|1|||
126592698|NCT02723591|455469779|FG001|Overall Study|Lost to Follow-up|7|||
126592699|NCT02723591|455469778|FG000|Overall Study|Protocol Violation|20|||
126592700|NCT02723591|455469779|FG001|Overall Study|Protocol Violation|23|||
126592701|NCT02723591|455469778|FG000|Overall Study|Withdrawal by Subject|4|||
126592702|NCT02723591|455469779|FG001|Overall Study|Withdrawal by Subject|8|||
126592703|NCT02723591|455469778|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
126592704|NCT02723591|455469779|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
126592705|NCT02723591|455469778|FG000|Overall Study|Miscellaneous|5|||
126592706|NCT02723591|455469779|FG001|Overall Study|Miscellaneous|6|||
126592707|NCT03691935|455469780|FG000|Overall Study|Physician Decision|2|||
126592708|NCT03691935|455469781|FG001|Overall Study|Physician Decision|1|||
126592709|NCT03691935|455469780|FG000|Overall Study|Adverse Event|3|||
126592710|NCT03691935|455469781|FG001|Overall Study|Adverse Event|0|||
126592711|NCT02151981|455469782|FG000|Overall Study|Death|184|||
126592712|NCT02151981|455469783|FG001|Overall Study|Death|88|||
126778305|NCT00479401|456143161|FG000|Overall Study|Withdrawal by Subject|16|||
126778306|NCT00479401|456143162|FG001|Overall Study|Withdrawal by Subject|10|||
126778307|NCT00479401|456143163|FG002|Overall Study|Withdrawal by Subject|2|||
126778308|NCT00479401|456143161|FG000|Overall Study|Exclusion criteria, relocation|4|||
126778309|NCT00479401|456143162|FG001|Overall Study|Exclusion criteria, relocation|3|||
126778310|NCT00479401|456143163|FG002|Overall Study|Exclusion criteria, relocation|0|||
126778311|NCT01430104|456143166|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
126778312|NCT01571635|456143167|FG000|Overall Study|Adverse Event|3|||
126778313|NCT01571635|456143168|FG001|Overall Study|Adverse Event|0|||
126778314|NCT01571635|456143169|FG002|Overall Study|Adverse Event|2|||
126778315|NCT01571635|456143170|FG003|Overall Study|Adverse Event|3|||
126778316|NCT01571635|456143171|FG004|Overall Study|Adverse Event|5|||
126778317|NCT01571635|456143167|FG000|Overall Study|Other reasons|2|||
126778318|NCT01571635|456143168|FG001|Overall Study|Other reasons|1|||
126778319|NCT01571635|456143169|FG002|Overall Study|Other reasons|2|||
126778320|NCT01571635|456143170|FG003|Overall Study|Other reasons|2|||
126778321|NCT01571635|456143171|FG004|Overall Study|Other reasons|1|||
126778322|NCT01571635|456143167|FG000|Overall Study|Study terminated by sponsor|0|||
126778323|NCT01571635|456143168|FG001|Overall Study|Study terminated by sponsor|4|||
126778324|NCT01571635|456143169|FG002|Overall Study|Study terminated by sponsor|1|||
126778325|NCT01571635|456143170|FG003|Overall Study|Study terminated by sponsor|3|||
126778326|NCT01571635|456143171|FG004|Overall Study|Study terminated by sponsor|1|||
126778327|NCT01571635|456143167|FG000|Overall Study|Withdrew consent|1|||
126778328|NCT01571635|456143168|FG001|Overall Study|Withdrew consent|1|||
126778329|NCT01571635|456143169|FG002|Overall Study|Withdrew consent|2|||
126778330|NCT01571635|456143170|FG003|Overall Study|Withdrew consent|3|||
126778331|NCT01571635|456143171|FG004|Overall Study|Withdrew consent|0|||
126778332|NCT01571635|456143167|FG000|Overall Study|Lack of Efficacy|0|||
126778333|NCT01571635|456143168|FG001|Overall Study|Lack of Efficacy|2|||
126778334|NCT01571635|456143169|FG002|Overall Study|Lack of Efficacy|0|||
126778335|NCT01571635|456143170|FG003|Overall Study|Lack of Efficacy|1|||
126778336|NCT01571635|456143171|FG004|Overall Study|Lack of Efficacy|2|||
126778337|NCT01722266|456143172|FG000|Overall Study|Withdrawal by Subject|1|||
126778338|NCT01722266|456143173|FG001|Overall Study|Withdrawal by Subject|2|||
126778339|NCT01722266|456143174|FG002|Overall Study|Withdrawal by Subject|0|||
126778340|NCT01722266|456143175|FG003|Overall Study|Withdrawal by Subject|0|||
126778341|NCT01722266|456143172|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
126778342|NCT01722266|456143173|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
126778343|NCT01722266|456143174|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
126778344|NCT01722266|456143175|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
126778345|NCT01722266|456143172|FG000|Overall Study|Dropped out due to Nausea|0|||
126778346|NCT01722266|456143173|FG001|Overall Study|Dropped out due to Nausea|0|||
126778347|NCT01722266|456143174|FG002|Overall Study|Dropped out due to Nausea|2|||
126778348|NCT01722266|456143175|FG003|Overall Study|Dropped out due to Nausea|0|||
126592713|NCT02151981|455469782|FG000|Overall Study|Lost to Follow-up|7|||
126592714|NCT02151981|455469783|FG001|Overall Study|Lost to Follow-up|1|||
126592715|NCT02151981|455469782|FG000|Overall Study|Withdrawal by Subject|27|||
126592716|NCT02151981|455469783|FG001|Overall Study|Withdrawal by Subject|21|||
126592717|NCT02151981|455469782|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126592718|NCT02151981|455469783|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
126592719|NCT02151981|455469782|FG000|Overall Study|Other reasons|1|||
126592720|NCT02151981|455469783|FG001|Overall Study|Other reasons|2|||
126592721|NCT01946789|455469787|FG000|Overall Study|Death|0|||
126592722|NCT01946789|455469788|FG001|Overall Study|Death|2|||
126592723|NCT01946789|455469789|FG002|Overall Study|Death|1|||
126592724|NCT01946789|455469790|FG003|Overall Study|Death|1|||
126592725|NCT01946789|455469791|FG004|Overall Study|Death|1|||
126592726|NCT01946789|455469792|FG005|Overall Study|Death|1|||
126592727|NCT01946789|455469793|FG006|Overall Study|Death|3|||
126592728|NCT01946789|455469794|FG007|Overall Study|Death|1|||
126592729|NCT01946789|455469795|FG008|Overall Study|Death|2|||
126592730|NCT01946789|455469787|FG000|Overall Study|Progressive Disease|0|||
126778349|NCT03124381|456143176|FG000|Overall Study|Lost to Follow-up|1|||
126778350|NCT03124381|456143177|FG001|Overall Study|Lost to Follow-up|1|||
126778351|NCT03124381|456143176|FG000|Overall Study|Withdrawal by Subject|6|||
126778352|NCT03124381|456143177|FG001|Overall Study|Withdrawal by Subject|3|||
126778353|NCT03124381|456143176|FG000|Overall Study|Protocol Violation|0|||
126778354|NCT03124381|456143177|FG001|Overall Study|Protocol Violation|1|||
126778355|NCT03124381|456143176|FG000|Overall Study|Adverse Event|1|||
126778356|NCT03124381|456143177|FG001|Overall Study|Adverse Event|1|||
126778357|NCT03124381|456143176|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
126778358|NCT03124381|456143177|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
126778359|NCT02533999|456143180|FG000|Overall Study|Lost to Follow-up|3|||
126778360|NCT02533999|456143181|FG001|Overall Study|Lost to Follow-up|5|||
126592731|NCT01946789|455469788|FG001|Overall Study|Progressive Disease|0|||
126592732|NCT01946789|455469789|FG002|Overall Study|Progressive Disease|1|||
126592733|NCT01946789|455469790|FG003|Overall Study|Progressive Disease|0|||
126592734|NCT01946789|455469791|FG004|Overall Study|Progressive Disease|0|||
126778361|NCT02533999|456143180|FG000|Overall Study|Protocol Violation|3|||
126778362|NCT02533999|456143181|FG001|Overall Study|Protocol Violation|0|||
126778363|NCT02533999|456143180|FG000|Overall Study|Adverse Event|0|||
126778364|NCT02533999|456143181|FG001|Overall Study|Adverse Event|1|||
126778365|NCT02533999|456143180|FG000|Overall Study|Randomized but intervention not received|0|||
126778366|NCT02533999|456143181|FG001|Overall Study|Randomized but intervention not received|1|||
126778367|NCT01875445|456143182|FG000|Overall Study|Lost to Follow-up|5|||
126778368|NCT01875445|456143183|FG001|Overall Study|Lost to Follow-up|0|||
126778369|NCT01875445|456143182|FG000|Overall Study|Withdrawal by Subject|2|||
126778370|NCT01875445|456143183|FG001|Overall Study|Withdrawal by Subject|0|||
126778371|NCT02472977|456143187|FG000|Overall Study|Disease progression|4|||
126778372|NCT02472977|456143188|FG001|Overall Study|Disease progression|25|||
126778373|NCT02472977|456143189|FG002|Overall Study|Disease progression|6|||
126778374|NCT02472977|456143187|FG000|Overall Study|Withdrawal by Subject|0|||
126778375|NCT02472977|456143188|FG001|Overall Study|Withdrawal by Subject|1|||
126778376|NCT02472977|456143189|FG002|Overall Study|Withdrawal by Subject|0|||
126778377|NCT02472977|456143187|FG000|Overall Study|Study drug toxicity|2|||
126778378|NCT02472977|456143188|FG001|Overall Study|Study drug toxicity|0|||
126778379|NCT02472977|456143189|FG002|Overall Study|Study drug toxicity|2|||
126778380|NCT02472977|456143187|FG000|Overall Study|Subject request to discontinue treatment|0|||
126778381|NCT02472977|456143188|FG001|Overall Study|Subject request to discontinue treatment|1|||
126778382|NCT02472977|456143189|FG002|Overall Study|Subject request to discontinue treatment|0|||
126778383|NCT02378506|456143198|FG000|Overall Study|Lack of Efficacy|3|||
126778384|NCT02378506|456143198|FG000|Overall Study|Withdrawal by Subject|4|||
126778385|NCT02378506|456143198|FG000|Overall Study|Protocol Violation|2|||
126778386|NCT02378506|456143198|FG000|Overall Study|Death|1|||
126778387|NCT02378506|456143198|FG000|Overall Study|Adverse Event|14|||
126778388|NCT02378506|456143198|FG000|Overall Study|Randomized But Not Treated|1|||
126778389|NCT01606137|456143199|FG000|Overall Study|Adverse Event|85|||
126778390|NCT01606137|456143199|FG000|Overall Study|Withdrawal by Subject|74|||
126778391|NCT01606137|456143199|FG000|Overall Study|Lack of Efficacy|56|||
126778392|NCT01606137|456143199|FG000|Overall Study|Lost to Follow-up|15|||
126778393|NCT01606137|456143199|FG000|Overall Study|Protocol Violation|1|||
126778394|NCT01606137|456143199|FG000|Overall Study|Patient non-compliance|9|||
126778395|NCT01606137|456143199|FG000|Overall Study|Death|1|||
126778396|NCT01606137|456143199|FG000|Overall Study|Decreased/no pain|4|||
126778397|NCT01606137|456143199|FG000|Overall Study|Issues with driving|4|||
126778398|NCT01606137|456143199|FG000|Overall Study|multiple sclerosis less stable|1|||
126778399|NCT01606137|456143199|FG000|Overall Study|Increased bilirubin|1|||
126778400|NCT01606137|456143199|FG000|Overall Study|Spray causes nausea|1|||
126778401|NCT01606137|456143199|FG000|Overall Study|Not enough improvement|4|||
126778402|NCT01606137|456143199|FG000|Overall Study|Wanted to try another treatment|1|||
126778403|NCT01606137|456143199|FG000|Overall Study|Patient leaving country|1|||
126778404|NCT01606137|456143199|FG000|Overall Study|Personal reasons|1|||
126592735|NCT01946789|455469792|FG005|Overall Study|Progressive Disease|2|||
126592736|NCT01946789|455469793|FG006|Overall Study|Progressive Disease|0|||
126592737|NCT01946789|455469794|FG007|Overall Study|Progressive Disease|0|||
126592738|NCT01946789|455469795|FG008|Overall Study|Progressive Disease|0|||
126592739|NCT01946789|455469787|FG000|Overall Study|Withdrawal by Subject|0|||
126592740|NCT01946789|455469788|FG001|Overall Study|Withdrawal by Subject|0|||
126592741|NCT01946789|455469789|FG002|Overall Study|Withdrawal by Subject|0|||
126592742|NCT01946789|455469790|FG003|Overall Study|Withdrawal by Subject|2|||
126592743|NCT01946789|455469791|FG004|Overall Study|Withdrawal by Subject|1|||
126592744|NCT01946789|455469792|FG005|Overall Study|Withdrawal by Subject|0|||
126592745|NCT01946789|455469793|FG006|Overall Study|Withdrawal by Subject|1|||
126592746|NCT01946789|455469794|FG007|Overall Study|Withdrawal by Subject|0|||
126592747|NCT01946789|455469795|FG008|Overall Study|Withdrawal by Subject|0|||
126592748|NCT05374798|455469796|FG000|Overall Study|Lost to Follow-up|2|||
126592749|NCT05374798|455469796|FG000|Overall Study|Withdrawal by Subject|2|||
126592750|NCT05374798|455469796|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
126592751|NCT05576155|455469797|FG000|Overall Study|Withdrawal by Subject|1|||
126592752|NCT05576155|455469798|FG001|Overall Study|Withdrawal by Subject|1|||
126592753|NCT01275677|455469802|FG000|Overall Study|Not at risk for recurrence.|1|||
126778405|NCT01606137|456143199|FG000|Overall Study|Unable to tolerate study med. taste|1|||
126778406|NCT01606137|456143199|FG000|Overall Study|Patient moving|1|||
126778407|NCT01606137|456143199|FG000|Overall Study|Unable to collect consistent data|1|||
126778408|NCT02266706|456144927|FG000|Overall Study|Withdrawal by Subject|0|||
126778409|NCT02266706|456144928|FG001|Overall Study|Withdrawal by Subject|1|||
126778410|NCT02266706|456144929|FG002|Overall Study|Withdrawal by Subject|1|||
126778411|NCT02266706|456144930|FG003|Overall Study|Withdrawal by Subject|0|||
126778412|NCT02266706|456144931|FG004|Overall Study|Withdrawal by Subject|0|||
126778413|NCT02266706|456144932|FG005|Overall Study|Withdrawal by Subject|1|||
126778414|NCT02266706|456144933|FG006|Overall Study|Withdrawal by Subject|0|||
126592754|NCT01275677|455469803|FG001|Overall Study|Not at risk for recurrence.|1|||
126592755|NCT01275677|455469802|FG000|Overall Study|No follow-up|26|||
126592756|NCT01275677|455469803|FG001|Overall Study|No follow-up|37|||
126592757|NCT01275677|455469802|FG000|Overall Study|No clinical follow up.|1|||
126778415|NCT02266706|456144934|FG007|Overall Study|Withdrawal by Subject|0|||
126778416|NCT02266706|456144935|FG008|Overall Study|Withdrawal by Subject|0|||
126778417|NCT02266706|456144927|FG000|Overall Study|Screen failure|0|||
126778418|NCT02266706|456144928|FG001|Overall Study|Screen failure|0|||
126778419|NCT02266706|456144929|FG002|Overall Study|Screen failure|0|||
126778420|NCT02266706|456144930|FG003|Overall Study|Screen failure|0|||
126778421|NCT02266706|456144931|FG004|Overall Study|Screen failure|0|||
126778422|NCT02266706|456144932|FG005|Overall Study|Screen failure|1|||
126592758|NCT01275677|455469803|FG001|Overall Study|No clinical follow up.|4|||
126592759|NCT04409353|455469808|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
126592760|NCT04409353|455469809|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
126592761|NCT04409353|455469810|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
126592762|NCT04409353|455469808|FG000|Overall Study|Lost to Follow-up|6|||
126592763|NCT04409353|455469809|FG001|Overall Study|Lost to Follow-up|8|||
126592764|NCT04409353|455469810|FG002|Overall Study|Lost to Follow-up|7|||
126592765|NCT04409353|455469808|FG000|Overall Study|Major surgery during participation window|4|||
126592766|NCT04409353|455469809|FG001|Overall Study|Major surgery during participation window|3|||
126592767|NCT04409353|455469810|FG002|Overall Study|Major surgery during participation window|3|||
126592768|NCT04409353|455469808|FG000|Overall Study|Life event occurred during participation window|3|||
126592769|NCT04409353|455469809|FG001|Overall Study|Life event occurred during participation window|2|||
126592770|NCT04409353|455469810|FG002|Overall Study|Life event occurred during participation window|4|||
126592771|NCT04409353|455469808|FG000|Overall Study|Lack of Efficacy|4|||
126592772|NCT04409353|455469809|FG001|Overall Study|Lack of Efficacy|1|||
126592773|NCT04409353|455469810|FG002|Overall Study|Lack of Efficacy|3|||
126592774|NCT04409353|455469808|FG000|Overall Study|Adverse Event|2|||
126592775|NCT04409353|455469809|FG001|Overall Study|Adverse Event|1|||
126592776|NCT04409353|455469810|FG002|Overall Study|Adverse Event|1|||
126592777|NCT04409353|455469808|FG000|Overall Study|Disease burden - unable to participate|0|||
126592778|NCT04409353|455469809|FG001|Overall Study|Disease burden - unable to participate|1|||
126592779|NCT04409353|455469810|FG002|Overall Study|Disease burden - unable to participate|1|||
126592780|NCT04409353|455469808|FG000|Overall Study|Intervention too complicated|1|||
126592781|NCT04409353|455469809|FG001|Overall Study|Intervention too complicated|0|||
126592782|NCT04409353|455469810|FG002|Overall Study|Intervention too complicated|1|||
126592783|NCT04081103|455469811|FG000|Overall Study|Adverse Event|1|||
126592784|NCT04081103|455469812|FG001|Overall Study|Adverse Event|1|||
126592785|NCT04081103|455469813|FG002|Overall Study|Adverse Event|1|||
126592786|NCT04081103|455469811|FG000|Overall Study|Physician Decision|0|||
126592787|NCT04081103|455469812|FG001|Overall Study|Physician Decision|0|||
126592788|NCT04081103|455469813|FG002|Overall Study|Physician Decision|1|||
126592789|NCT03287817|455471852|FG000|Overall Study|Progressive disease|4|||
126592790|NCT03287817|455471853|FG001|Overall Study|Progressive disease|2|||
126592791|NCT03287817|455471854|FG002|Overall Study|Progressive disease|3|||
126592792|NCT03287817|455471855|FG003|Overall Study|Progressive disease|10|||
126592793|NCT03287817|455471856|FG004|Overall Study|Progressive disease|8|||
126592794|NCT03287817|455471852|FG000|Overall Study|Death|0|||
126592795|NCT03287817|455471853|FG001|Overall Study|Death|0|||
126592796|NCT03287817|455471854|FG002|Overall Study|Death|2|||
126592797|NCT03287817|455471855|FG003|Overall Study|Death|3|||
126592798|NCT03287817|455471856|FG004|Overall Study|Death|4|||
126592799|NCT03287817|455471852|FG000|Overall Study|Physician Decision|0|||
126592800|NCT03287817|455471853|FG001|Overall Study|Physician Decision|0|||
126592801|NCT03287817|455471854|FG002|Overall Study|Physician Decision|0|||
126592802|NCT03287817|455471855|FG003|Overall Study|Physician Decision|1|||
126592803|NCT03287817|455471856|FG004|Overall Study|Physician Decision|0|||
126592804|NCT03287817|455471852|FG000|Overall Study|Withdrawal by Subject|0|||
126592805|NCT03287817|455471853|FG001|Overall Study|Withdrawal by Subject|0|||
126592806|NCT03287817|455471854|FG002|Overall Study|Withdrawal by Subject|0|||
126592807|NCT03287817|455471855|FG003|Overall Study|Withdrawal by Subject|0|||
126592808|NCT03287817|455471856|FG004|Overall Study|Withdrawal by Subject|4|||
126592809|NCT02696707|455471857|FG000|Per Protocol Population|Physician Decision|2|||
126592810|NCT02696707|455471858|FG001|Per Protocol Population|Physician Decision|1|||
126592811|NCT02696707|455471857|FG000|Per Protocol Population|Participant Decision|0|||
126592812|NCT02696707|455471858|FG001|Per Protocol Population|Participant Decision|2|||
126592813|NCT02696707|455471857|FG000|Completed Study as Planned|Reason = LVEF|2|||
126592814|NCT02696707|455471858|FG001|Completed Study as Planned|Reason = LVEF|2|||
126592815|NCT02696707|455471857|FG000|Completed Study as Planned|Protocol Violation|2|||
126731850|NCT02215616|455968328|FG000|Overall Study|Lost to Follow-up|1|||
126731851|NCT02215616|455968329|FG001|Overall Study|Lost to Follow-up|1|||
126731852|NCT02215616|455968330|FG002|Overall Study|Lost to Follow-up|0|||
126731853|NCT02215616|455968331|FG003|Overall Study|Lost to Follow-up|1|||
126731854|NCT02215616|455968328|FG000|Overall Study|Other than specified|1|||
126731855|NCT02215616|455968329|FG001|Overall Study|Other than specified|0|||
126731856|NCT02215616|455968330|FG002|Overall Study|Other than specified|1|||
126731857|NCT02215616|455968331|FG003|Overall Study|Other than specified|1|||
126731858|NCT01352845|455968334|FG000|Overall Study|Lost to Follow-up|313|||
126592816|NCT02696707|455471858|FG001|Completed Study as Planned|Protocol Violation|6|||
126592817|NCT02696707|455471857|FG000|Completed Study as Planned|Metastatic disease|3|||
126592818|NCT02696707|455471858|FG001|Completed Study as Planned|Metastatic disease|0|||
126592819|NCT02696707|455471857|FG000|Completed Study as Planned|Location|1|||
126592820|NCT02696707|455471858|FG001|Completed Study as Planned|Location|1|||
126592821|NCT06181227|455471859|FG000|Overall Study|Study terminated by sponsor|7|||
126592822|NCT06181227|455471860|FG001|Overall Study|Study terminated by sponsor|9|||
126592823|NCT03854227|455471864|FG000|Overall Study|Adverse Event|0|||
126592824|NCT03854227|455471865|FG001|Overall Study|Adverse Event|0|||
126592825|NCT03854227|455471866|FG002|Overall Study|Adverse Event|0|||
126592826|NCT03854227|455471867|FG003|Overall Study|Adverse Event|1|||
126592827|NCT03854227|455471868|FG004|Overall Study|Adverse Event|0|||
126592828|NCT03854227|455471869|FG005|Overall Study|Adverse Event|0|||
126592829|NCT03854227|455471870|FG006|Overall Study|Adverse Event|1|||
126592830|NCT03854227|455471871|FG007|Overall Study|Adverse Event|0|||
126592831|NCT03854227|455471872|FG008|Overall Study|Adverse Event|0|||
126592832|NCT03854227|455471873|FG009|Overall Study|Adverse Event|3|||
126592833|NCT03854227|455471874|FG010|Overall Study|Adverse Event|0|||
126592834|NCT03854227|455471875|FG011|Overall Study|Adverse Event|1|||
126592835|NCT03854227|455471864|FG000|Overall Study|Death|0|||
126592836|NCT03854227|455471865|FG001|Overall Study|Death|0|||
126592837|NCT03854227|455471866|FG002|Overall Study|Death|0|||
126592838|NCT03854227|455471867|FG003|Overall Study|Death|0|||
126592839|NCT03854227|455471868|FG004|Overall Study|Death|0|||
126592840|NCT03854227|455471869|FG005|Overall Study|Death|1|||
126592841|NCT03854227|455471870|FG006|Overall Study|Death|0|||
126592842|NCT03854227|455471871|FG007|Overall Study|Death|0|||
126592843|NCT03854227|455471872|FG008|Overall Study|Death|0|||
126592844|NCT03854227|455471873|FG009|Overall Study|Death|1|||
126592845|NCT03854227|455471874|FG010|Overall Study|Death|0|||
126592846|NCT03854227|455471875|FG011|Overall Study|Death|1|||
126592847|NCT03854227|455471864|FG000|Overall Study|Physician Decision|0|||
126592848|NCT03854227|455471865|FG001|Overall Study|Physician Decision|0|||
126592849|NCT03854227|455471866|FG002|Overall Study|Physician Decision|0|||
126592850|NCT03854227|455471867|FG003|Overall Study|Physician Decision|0|||
126592851|NCT03854227|455471868|FG004|Overall Study|Physician Decision|0|||
126592852|NCT03854227|455471869|FG005|Overall Study|Physician Decision|1|||
126592853|NCT03854227|455471870|FG006|Overall Study|Physician Decision|0|||
126592854|NCT03854227|455471871|FG007|Overall Study|Physician Decision|0|||
126592855|NCT03854227|455471872|FG008|Overall Study|Physician Decision|1|||
126592856|NCT03854227|455471873|FG009|Overall Study|Physician Decision|1|||
126592857|NCT03854227|455471874|FG010|Overall Study|Physician Decision|0|||
126592858|NCT03854227|455471875|FG011|Overall Study|Physician Decision|1|||
126592859|NCT03854227|455471864|FG000|Overall Study|Progressive disease|1|||
126592860|NCT03854227|455471865|FG001|Overall Study|Progressive disease|1|||
126592861|NCT03854227|455471866|FG002|Overall Study|Progressive disease|1|||
126592862|NCT03854227|455471867|FG003|Overall Study|Progressive disease|2|||
126592863|NCT03854227|455471868|FG004|Overall Study|Progressive disease|3|||
126592864|NCT03854227|455471869|FG005|Overall Study|Progressive disease|1|||
126592865|NCT03854227|455471870|FG006|Overall Study|Progressive disease|2|||
126592866|NCT03854227|455471871|FG007|Overall Study|Progressive disease|5|||
126592867|NCT03854227|455471872|FG008|Overall Study|Progressive disease|2|||
126592868|NCT03854227|455471873|FG009|Overall Study|Progressive disease|5|||
126592869|NCT03854227|455471874|FG010|Overall Study|Progressive disease|1|||
126592870|NCT03854227|455471875|FG011|Overall Study|Progressive disease|6|||
126592871|NCT03854227|455471864|FG000|Overall Study|Study terminated by sponsor|0|||
126592872|NCT03854227|455471865|FG001|Overall Study|Study terminated by sponsor|0|||
126592873|NCT03854227|455471866|FG002|Overall Study|Study terminated by sponsor|0|||
126592874|NCT03854227|455471867|FG003|Overall Study|Study terminated by sponsor|0|||
126592875|NCT03854227|455471868|FG004|Overall Study|Study terminated by sponsor|0|||
126592876|NCT03854227|455471869|FG005|Overall Study|Study terminated by sponsor|0|||
126592877|NCT03854227|455471870|FG006|Overall Study|Study terminated by sponsor|0|||
126592878|NCT03854227|455471871|FG007|Overall Study|Study terminated by sponsor|0|||
126592879|NCT03854227|455471872|FG008|Overall Study|Study terminated by sponsor|0|||
126592880|NCT03854227|455471873|FG009|Overall Study|Study terminated by sponsor|1|||
126592881|NCT03854227|455471874|FG010|Overall Study|Study terminated by sponsor|0|||
126731859|NCT01352845|455968335|FG001|Overall Study|Lost to Follow-up|92|||
126592882|NCT03854227|455471875|FG011|Overall Study|Study terminated by sponsor|0|||
126592883|NCT03854227|455471864|FG000|Overall Study|Withdrawal by Subject|0|||
126592884|NCT03854227|455471865|FG001|Overall Study|Withdrawal by Subject|0|||
126592885|NCT03854227|455471866|FG002|Overall Study|Withdrawal by Subject|1|||
126592886|NCT03854227|455471867|FG003|Overall Study|Withdrawal by Subject|0|||
126592887|NCT03854227|455471868|FG004|Overall Study|Withdrawal by Subject|0|||
126592888|NCT03854227|455471869|FG005|Overall Study|Withdrawal by Subject|0|||
126592889|NCT03854227|455471870|FG006|Overall Study|Withdrawal by Subject|0|||
126592890|NCT03854227|455471871|FG007|Overall Study|Withdrawal by Subject|0|||
126592891|NCT03854227|455471872|FG008|Overall Study|Withdrawal by Subject|0|||
126592892|NCT03854227|455471873|FG009|Overall Study|Withdrawal by Subject|1|||
126592893|NCT03854227|455471874|FG010|Overall Study|Withdrawal by Subject|1|||
126592894|NCT03854227|455471875|FG011|Overall Study|Withdrawal by Subject|0|||
126592895|NCT03854227|455471864|FG000|Overall Study|Disease relapse|0|||
126592896|NCT03854227|455471865|FG001|Overall Study|Disease relapse|0|||
126592897|NCT03854227|455471866|FG002|Overall Study|Disease relapse|0|||
126592898|NCT03854227|455471867|FG003|Overall Study|Disease relapse|0|||
126592899|NCT03854227|455471868|FG004|Overall Study|Disease relapse|0|||
126592900|NCT03854227|455471869|FG005|Overall Study|Disease relapse|0|||
126592901|NCT03854227|455471870|FG006|Overall Study|Disease relapse|0|||
126592902|NCT03854227|455471871|FG007|Overall Study|Disease relapse|0|||
126592903|NCT03854227|455471872|FG008|Overall Study|Disease relapse|1|||
126592904|NCT03854227|455471873|FG009|Overall Study|Disease relapse|0|||
126592905|NCT03854227|455471874|FG010|Overall Study|Disease relapse|0|||
126592906|NCT03854227|455471875|FG011|Overall Study|Disease relapse|0|||
126592907|NCT03854227|455471864|FG000|Overall Study|Global deterioration of health status|0|||
126592908|NCT03854227|455471865|FG001|Overall Study|Global deterioration of health status|0|||
126592909|NCT03854227|455471866|FG002|Overall Study|Global deterioration of health status|0|||
126592910|NCT03854227|455471867|FG003|Overall Study|Global deterioration of health status|0|||
126592911|NCT03854227|455471868|FG004|Overall Study|Global deterioration of health status|0|||
126592912|NCT03854227|455471869|FG005|Overall Study|Global deterioration of health status|1|||
126592913|NCT03854227|455471870|FG006|Overall Study|Global deterioration of health status|0|||
126592914|NCT03854227|455471871|FG007|Overall Study|Global deterioration of health status|1|||
126592915|NCT03854227|455471872|FG008|Overall Study|Global deterioration of health status|0|||
126592916|NCT03854227|455471873|FG009|Overall Study|Global deterioration of health status|0|||
126592917|NCT03854227|455471874|FG010|Overall Study|Global deterioration of health status|0|||
126592918|NCT03854227|455471875|FG011|Overall Study|Global deterioration of health status|0|||
126592919|NCT03854227|455471864|FG000|Overall Study|Refused further treatment|0|||
126592920|NCT03854227|455471865|FG001|Overall Study|Refused further treatment|0|||
126592921|NCT03854227|455471866|FG002|Overall Study|Refused further treatment|0|||
126592922|NCT03854227|455471867|FG003|Overall Study|Refused further treatment|0|||
126592923|NCT03854227|455471868|FG004|Overall Study|Refused further treatment|0|||
126592924|NCT03854227|455471869|FG005|Overall Study|Refused further treatment|0|||
126592925|NCT03854227|455471870|FG006|Overall Study|Refused further treatment|0|||
126592926|NCT03854227|455471871|FG007|Overall Study|Refused further treatment|0|||
126592927|NCT03854227|455471872|FG008|Overall Study|Refused further treatment|0|||
126592928|NCT03854227|455471873|FG009|Overall Study|Refused further treatment|1|||
126592929|NCT03854227|455471874|FG010|Overall Study|Refused further treatment|0|||
126592930|NCT03854227|455471875|FG011|Overall Study|Refused further treatment|1|||
126592931|NCT03854227|455471864|FG000|Overall Study|Other|0|||
126592932|NCT03854227|455471865|FG001|Overall Study|Other|0|||
126592933|NCT03854227|455471866|FG002|Overall Study|Other|0|||
126592934|NCT03854227|455471867|FG003|Overall Study|Other|0|||
126592935|NCT03854227|455471868|FG004|Overall Study|Other|0|||
126592936|NCT03854227|455471869|FG005|Overall Study|Other|0|||
126592937|NCT03854227|455471870|FG006|Overall Study|Other|0|||
126592938|NCT03854227|455471871|FG007|Overall Study|Other|0|||
126592939|NCT03854227|455471872|FG008|Overall Study|Other|1|||
126592940|NCT03854227|455471873|FG009|Overall Study|Other|1|||
126592941|NCT03854227|455471874|FG010|Overall Study|Other|0|||
126592942|NCT03854227|455471875|FG011|Overall Study|Other|0|||
126592943|NCT03668236|455471876|FG000|90-day Follow-up|Withdrawal by Subject|3|||
126592944|NCT03668236|455471877|FG001|90-day Follow-up|Withdrawal by Subject|2|||
126592945|NCT03668236|455471876|FG000|90-day Follow-up|Lost to Follow-up|3|||
126592946|NCT03668236|455471877|FG001|90-day Follow-up|Lost to Follow-up|1|||
126592947|NCT03668236|455471876|FG000|Baseline Characteristics|Lost to Follow-up|9|||
126592948|NCT03668236|455471877|FG001|Baseline Characteristics|Lost to Follow-up|5|||
126592949|NCT03668236|455471876|FG000|1-year Follow-up|Withdrawal by Subject|17|||
126592950|NCT03668236|455471877|FG001|1-year Follow-up|Withdrawal by Subject|15|||
126592951|NCT06132282|455471883|FG000|Overall Study|Lost to Follow-up|31|||
126592952|NCT04376502|455471889|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
126592953|NCT03748953|455471890|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
126592954|NCT03748953|455471891|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
126592955|NCT03748953|455471890|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
126731860|NCT01352845|455968334|FG000|Overall Study|No Longer Willing to Participate|205|||
126731861|NCT01352845|455968335|FG001|Overall Study|No Longer Willing to Participate|58|||
126592956|NCT03748953|455471891|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
126592957|NCT03748953|455471890|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
126592958|NCT03748953|455471891|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
126592959|NCT03748953|455471890|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
126592960|NCT03748953|455471891|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
126592961|NCT03748953|455471890|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
126592962|NCT03748953|455471891|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
126592963|NCT04119843|455471892|FG000|Overall Study|Adverse Event|3|||
126592964|NCT04119843|455471892|FG000|Overall Study|Death|1|||
126592965|NCT02841579|455471893|FG000|Overall Study|Death|1|||
126592966|NCT02841579|455471893|FG000|Overall Study|Adverse Event|1|||
126592967|NCT02841579|455471893|FG000|Overall Study|Lack of Efficacy|9|||
126592968|NCT03768505|455471896|FG000|Overall Study|sponsor decision|76|||
126592969|NCT03768505|455471896|FG000|Overall Study|Death|35|||
126592970|NCT03768505|455471896|FG000|Overall Study|Other -Various|30|||
126592971|NCT03768505|455471896|FG000|Overall Study|Withdrawal by Subject|22|||
126592972|NCT03768505|455471896|FG000|Overall Study|Lost to Follow-up|6|||
126592973|NCT02815566|455471897|FG000|Overall Study|Adverse Event|1|||
126592974|NCT02815566|455471898|FG001|Overall Study|Adverse Event|1|||
126592975|NCT02815566|455471897|FG000|Overall Study|Withdrawal by Subject|1|||
126592976|NCT02815566|455471898|FG001|Overall Study|Withdrawal by Subject|0|||
126592977|NCT02815566|455471897|FG000|Overall Study|Lost to Follow-up|0|||
126592978|NCT02815566|455471898|FG001|Overall Study|Lost to Follow-up|1|||
126592979|NCT04032704|455471901|FG000|Part A|Withdrawal by Subject|0|||
126592980|NCT04032704|455471902|FG001|Part A|Withdrawal by Subject|0|||
126592981|NCT04032704|455471903|FG002|Part A|Withdrawal by Subject|3|||
126592982|NCT04032704|455471904|FG003|Part A|Withdrawal by Subject|0|||
126592983|NCT04032704|455471905|FG004|Part A|Withdrawal by Subject|1|||
126592984|NCT04032704|455471906|FG005|Part A|Withdrawal by Subject|7|||
126592985|NCT04032704|455471907|FG006|Part A|Withdrawal by Subject|0|||
126592986|NCT04032704|455471908|FG007|Part A|Withdrawal by Subject|0|||
126592987|NCT04032704|455471909|FG008|Part A|Withdrawal by Subject|0|||
126592988|NCT04032704|455471910|FG009|Part A|Withdrawal by Subject|0|||
126592989|NCT04032704|455471911|FG010|Part A|Withdrawal by Subject|0|||
126592990|NCT04032704|455471912|FG011|Part A|Withdrawal by Subject|0|||
126592991|NCT04032704|455471913|FG012|Part A|Withdrawal by Subject|0|||
126592992|NCT04032704|455471914|FG013|Part A|Withdrawal by Subject|0|||
126592993|NCT04032704|455471915|FG014|Part A|Withdrawal by Subject|0|||
126592994|NCT04032704|455471916|FG015|Part A|Withdrawal by Subject|0|||
126592995|NCT04032704|455471917|FG016|Part A|Withdrawal by Subject|0|||
126592996|NCT04032704|455471918|FG017|Part A|Withdrawal by Subject|0|||
126592997|NCT04032704|455471901|FG000|Part A|Lost to Follow-up|1|||
126592998|NCT04032704|455471902|FG001|Part A|Lost to Follow-up|0|||
126592999|NCT04032704|455471903|FG002|Part A|Lost to Follow-up|0|||
126593000|NCT04032704|455471904|FG003|Part A|Lost to Follow-up|0|||
126593001|NCT04032704|455471905|FG004|Part A|Lost to Follow-up|0|||
126593002|NCT04032704|455471906|FG005|Part A|Lost to Follow-up|0|||
126593003|NCT04032704|455471907|FG006|Part A|Lost to Follow-up|0|||
126593004|NCT04032704|455471908|FG007|Part A|Lost to Follow-up|0|||
126593005|NCT04032704|455471909|FG008|Part A|Lost to Follow-up|0|||
126593006|NCT04032704|455471910|FG009|Part A|Lost to Follow-up|0|||
126593007|NCT04032704|455471911|FG010|Part A|Lost to Follow-up|0|||
126593008|NCT04032704|455471912|FG011|Part A|Lost to Follow-up|0|||
126593009|NCT04032704|455471913|FG012|Part A|Lost to Follow-up|0|||
126593010|NCT04032704|455471914|FG013|Part A|Lost to Follow-up|0|||
126593011|NCT04032704|455471915|FG014|Part A|Lost to Follow-up|0|||
126593012|NCT04032704|455471916|FG015|Part A|Lost to Follow-up|0|||
126593013|NCT04032704|455471917|FG016|Part A|Lost to Follow-up|0|||
126593014|NCT04032704|455471918|FG017|Part A|Lost to Follow-up|0|||
126593015|NCT04032704|455471901|FG000|Part A|Death|9|||
126593016|NCT04032704|455471902|FG001|Part A|Death|2|||
126593017|NCT04032704|455471903|FG002|Part A|Death|10|||
126593018|NCT04032704|455471904|FG003|Part A|Death|7|||
126593019|NCT04032704|455471905|FG004|Part A|Death|4|||
126593020|NCT04032704|455471906|FG005|Part A|Death|5|||
126593021|NCT04032704|455471907|FG006|Part A|Death|0|||
126593022|NCT04032704|455471908|FG007|Part A|Death|0|||
126593023|NCT04032704|455471909|FG008|Part A|Death|0|||
126593024|NCT04032704|455471910|FG009|Part A|Death|0|||
126593025|NCT04032704|455471911|FG010|Part A|Death|0|||
126593026|NCT04032704|455471912|FG011|Part A|Death|0|||
126593027|NCT04032704|455471913|FG012|Part A|Death|0|||
126593028|NCT04032704|455471914|FG013|Part A|Death|0|||
126593029|NCT04032704|455471915|FG014|Part A|Death|0|||
126593030|NCT04032704|455471916|FG015|Part A|Death|0|||
126593031|NCT04032704|455471917|FG016|Part A|Death|0|||
126593032|NCT04032704|455471918|FG017|Part A|Death|0|||
126593033|NCT04032704|455471901|FG000|Part B|Other|0|||
126593034|NCT04032704|455471902|FG001|Part B|Other|0|||
126593035|NCT04032704|455471903|FG002|Part B|Other|0|||
126593036|NCT04032704|455471904|FG003|Part B|Other|0|||
126593037|NCT04032704|455471905|FG004|Part B|Other|0|||
126593038|NCT04032704|455471906|FG005|Part B|Other|0|||
126593039|NCT04032704|455471907|FG006|Part B|Other|0|||
126593040|NCT04032704|455471908|FG007|Part B|Other|1|||
126593041|NCT04032704|455471909|FG008|Part B|Other|2|||
126593042|NCT04032704|455471910|FG009|Part B|Other|1|||
126593043|NCT04032704|455471911|FG010|Part B|Other|1|||
126593044|NCT04032704|455471912|FG011|Part B|Other|1|||
126593045|NCT04032704|455471913|FG012|Part B|Other|5|||
126593046|NCT04032704|455471914|FG013|Part B|Other|13|||
126593047|NCT04032704|455471915|FG014|Part B|Other|0|||
126593048|NCT04032704|455471916|FG015|Part B|Other|0|||
126593049|NCT04032704|455471917|FG016|Part B|Other|0|||
126593050|NCT04032704|455471918|FG017|Part B|Other|0|||
126593051|NCT04032704|455471901|FG000|Part B|Study termination by Sponsor|0|||
126593052|NCT04032704|455471902|FG001|Part B|Study termination by Sponsor|0|||
126593053|NCT04032704|455471903|FG002|Part B|Study termination by Sponsor|0|||
126593054|NCT04032704|455471904|FG003|Part B|Study termination by Sponsor|0|||
126593055|NCT04032704|455471905|FG004|Part B|Study termination by Sponsor|0|||
126593056|NCT04032704|455471906|FG005|Part B|Study termination by Sponsor|0|||
126593057|NCT04032704|455471907|FG006|Part B|Study termination by Sponsor|0|||
126593058|NCT04032704|455471908|FG007|Part B|Study termination by Sponsor|0|||
126593059|NCT04032704|455471909|FG008|Part B|Study termination by Sponsor|1|||
126731862|NCT01352845|455968334|FG000|Overall Study|Withdrawal by Subject|48|||
126731863|NCT01352845|455968335|FG001|Overall Study|Withdrawal by Subject|16|||
126731864|NCT01352845|455968334|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
126731865|NCT01352845|455968335|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
126731866|NCT01352845|455968334|FG000|Overall Study|Pregnancy|27|||
126731867|NCT01352845|455968335|FG001|Overall Study|Pregnancy|7|||
126731868|NCT01352845|455968334|FG000|Overall Study|Adverse Event|22|||
126731869|NCT01352845|455968335|FG001|Overall Study|Adverse Event|6|||
126731870|NCT01352845|455968334|FG000|Overall Study|Other|17|||
126731871|NCT01352845|455968335|FG001|Overall Study|Other|7|||
126731872|NCT01352845|455968334|FG000|Overall Study|Protocol Violation|12|||
126731873|NCT01352845|455968335|FG001|Overall Study|Protocol Violation|6|||
126731874|NCT01352845|455968334|FG000|Overall Study|Death|3|||
126731875|NCT01352845|455968335|FG001|Overall Study|Death|0|||
126731876|NCT02769832|455968340|FG000|Overall Study|Death|30|||
126731877|NCT02501902|455968348|FG000|Overall Study|Subject Refused Further Follow-up|0|||
126731878|NCT02501902|455968349|FG001|Overall Study|Subject Refused Further Follow-up|0|||
126731879|NCT02501902|455968350|FG002|Overall Study|Subject Refused Further Follow-up|0|||
126731880|NCT02501902|455968351|FG003|Overall Study|Subject Refused Further Follow-up|0|||
126731881|NCT02501902|455968352|FG004|Overall Study|Subject Refused Further Follow-up|0|||
126731882|NCT02501902|455968353|FG005|Overall Study|Subject Refused Further Follow-up|0|||
126731883|NCT02501902|455968354|FG006|Overall Study|Subject Refused Further Follow-up|0|||
126731884|NCT02501902|455968355|FG007|Overall Study|Subject Refused Further Follow-up|1|||
126731885|NCT02501902|455968348|FG000|Overall Study|Study Terminated by Sponsor|0|||
126731886|NCT02501902|455968349|FG001|Overall Study|Study Terminated by Sponsor|3|||
126731887|NCT02501902|455968350|FG002|Overall Study|Study Terminated by Sponsor|0|||
126778423|NCT02266706|456144933|FG006|Overall Study|Screen failure|1|||
126593060|NCT04032704|455471910|FG009|Part B|Study termination by Sponsor|0|||
126593061|NCT04032704|455471911|FG010|Part B|Study termination by Sponsor|0|||
126593062|NCT04032704|455471912|FG011|Part B|Study termination by Sponsor|0|||
126593063|NCT04032704|455471913|FG012|Part B|Study termination by Sponsor|0|||
126593064|NCT04032704|455471914|FG013|Part B|Study termination by Sponsor|0|||
126593065|NCT04032704|455471915|FG014|Part B|Study termination by Sponsor|0|||
126593066|NCT04032704|455471916|FG015|Part B|Study termination by Sponsor|0|||
126593067|NCT04032704|455471917|FG016|Part B|Study termination by Sponsor|0|||
126593068|NCT04032704|455471918|FG017|Part B|Study termination by Sponsor|0|||
126593069|NCT04032704|455471901|FG000|Part B|Withdrawal by Subject|0|||
126593070|NCT04032704|455471902|FG001|Part B|Withdrawal by Subject|0|||
126593071|NCT04032704|455471903|FG002|Part B|Withdrawal by Subject|0|||
126593072|NCT04032704|455471904|FG003|Part B|Withdrawal by Subject|0|||
126593073|NCT04032704|455471905|FG004|Part B|Withdrawal by Subject|0|||
126593074|NCT04032704|455471906|FG005|Part B|Withdrawal by Subject|0|||
126593075|NCT04032704|455471907|FG006|Part B|Withdrawal by Subject|3|||
126593076|NCT04032704|455471908|FG007|Part B|Withdrawal by Subject|2|||
126593077|NCT04032704|455471909|FG008|Part B|Withdrawal by Subject|2|||
126593078|NCT04032704|455471910|FG009|Part B|Withdrawal by Subject|1|||
126593079|NCT04032704|455471911|FG010|Part B|Withdrawal by Subject|4|||
126593080|NCT04032704|455471912|FG011|Part B|Withdrawal by Subject|6|||
126593081|NCT04032704|455471913|FG012|Part B|Withdrawal by Subject|2|||
126593082|NCT04032704|455471914|FG013|Part B|Withdrawal by Subject|1|||
126593083|NCT04032704|455471915|FG014|Part B|Withdrawal by Subject|0|||
126593084|NCT04032704|455471916|FG015|Part B|Withdrawal by Subject|1|||
126593085|NCT04032704|455471917|FG016|Part B|Withdrawal by Subject|0|||
126593086|NCT04032704|455471918|FG017|Part B|Withdrawal by Subject|0|||
126593087|NCT04032704|455471901|FG000|Part B|Lost to Follow-up|0|||
126593088|NCT04032704|455471902|FG001|Part B|Lost to Follow-up|0|||
126593089|NCT04032704|455471903|FG002|Part B|Lost to Follow-up|0|||
126593090|NCT04032704|455471904|FG003|Part B|Lost to Follow-up|0|||
126731888|NCT02501902|455968351|FG003|Overall Study|Study Terminated by Sponsor|1|||
126731889|NCT02501902|455968352|FG004|Overall Study|Study Terminated by Sponsor|1|||
126731890|NCT02501902|455968353|FG005|Overall Study|Study Terminated by Sponsor|0|||
126731891|NCT02501902|455968354|FG006|Overall Study|Study Terminated by Sponsor|2|||
126731892|NCT02501902|455968355|FG007|Overall Study|Study Terminated by Sponsor|4|||
126731893|NCT02501902|455968348|FG000|Overall Study|Death|3|||
126778424|NCT02266706|456144934|FG007|Overall Study|Screen failure|0|||
126593091|NCT04032704|455471905|FG004|Part B|Lost to Follow-up|0|||
126593092|NCT04032704|455471906|FG005|Part B|Lost to Follow-up|0|||
126593093|NCT04032704|455471907|FG006|Part B|Lost to Follow-up|0|||
126593094|NCT04032704|455471908|FG007|Part B|Lost to Follow-up|0|||
126593095|NCT04032704|455471909|FG008|Part B|Lost to Follow-up|0|||
126593096|NCT04032704|455471910|FG009|Part B|Lost to Follow-up|0|||
126593097|NCT04032704|455471911|FG010|Part B|Lost to Follow-up|0|||
126593098|NCT04032704|455471912|FG011|Part B|Lost to Follow-up|1|||
126593099|NCT04032704|455471913|FG012|Part B|Lost to Follow-up|0|||
126778425|NCT02266706|456144935|FG008|Overall Study|Screen failure|0|||
126778426|NCT02266706|456144927|FG000|Overall Study|Enrollment in another study|0|||
126778427|NCT02266706|456144928|FG001|Overall Study|Enrollment in another study|0|||
126778428|NCT02266706|456144929|FG002|Overall Study|Enrollment in another study|0|||
126593100|NCT04032704|455471914|FG013|Part B|Lost to Follow-up|0|||
126593101|NCT04032704|455471915|FG014|Part B|Lost to Follow-up|0|||
126593102|NCT04032704|455471916|FG015|Part B|Lost to Follow-up|0|||
126593103|NCT04032704|455471917|FG016|Part B|Lost to Follow-up|0|||
126593104|NCT04032704|455471918|FG017|Part B|Lost to Follow-up|0|||
126593105|NCT04032704|455471901|FG000|Part B|Death|0|||
126593106|NCT04032704|455471902|FG001|Part B|Death|0|||
126593107|NCT04032704|455471903|FG002|Part B|Death|0|||
126593108|NCT04032704|455471904|FG003|Part B|Death|0|||
126593109|NCT04032704|455471905|FG004|Part B|Death|0|||
126593110|NCT04032704|455471906|FG005|Part B|Death|0|||
126593111|NCT04032704|455471907|FG006|Part B|Death|13|||
126593112|NCT04032704|455471908|FG007|Part B|Death|13|||
126593113|NCT04032704|455471909|FG008|Part B|Death|14|||
126593114|NCT04032704|455471910|FG009|Part B|Death|12|||
126593115|NCT04032704|455471911|FG010|Part B|Death|12|||
126593116|NCT04032704|455471912|FG011|Part B|Death|13|||
126593117|NCT04032704|455471913|FG012|Part B|Death|7|||
126593118|NCT04032704|455471914|FG013|Part B|Death|17|||
126593119|NCT04032704|455471915|FG014|Part B|Death|2|||
126593120|NCT04032704|455471916|FG015|Part B|Death|1|||
126593121|NCT04032704|455471917|FG016|Part B|Death|2|||
126593122|NCT04032704|455471918|FG017|Part B|Death|2|||
126593123|NCT02861300|455471919|FG000|Overall Study|Death|0|||
126593124|NCT02861300|455471920|FG001|Overall Study|Death|0|||
126593125|NCT02861300|455471921|FG002|Overall Study|Death|0|||
126593126|NCT02861300|455471922|FG003|Overall Study|Death|0|||
126593127|NCT02861300|455471923|FG004|Overall Study|Death|0|||
126593128|NCT02861300|455471924|FG005|Overall Study|Death|0|||
126593129|NCT02861300|455471925|FG006|Overall Study|Death|24|||
126593130|NCT02861300|455471919|FG000|Overall Study|Delay in treatment|0|||
126593131|NCT02861300|455471920|FG001|Overall Study|Delay in treatment|0|||
126593132|NCT02861300|455471921|FG002|Overall Study|Delay in treatment|0|||
126593133|NCT02861300|455471922|FG003|Overall Study|Delay in treatment|0|||
126593134|NCT02861300|455471923|FG004|Overall Study|Delay in treatment|0|||
126593135|NCT02861300|455471924|FG005|Overall Study|Delay in treatment|1|||
126593136|NCT02861300|455471925|FG006|Overall Study|Delay in treatment|0|||
126593137|NCT02861300|455471919|FG000|Overall Study|Disease Progression|0|||
126593138|NCT02861300|455471920|FG001|Overall Study|Disease Progression|1|||
126593139|NCT02861300|455471921|FG002|Overall Study|Disease Progression|0|||
126593140|NCT02861300|455471922|FG003|Overall Study|Disease Progression|0|||
126593141|NCT02861300|455471923|FG004|Overall Study|Disease Progression|0|||
126593142|NCT02861300|455471924|FG005|Overall Study|Disease Progression|0|||
126593143|NCT02861300|455471925|FG006|Overall Study|Disease Progression|2|||
126593144|NCT02861300|455471919|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
126593145|NCT02861300|455471920|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
126593146|NCT02861300|455471921|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
126593147|NCT02861300|455471922|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
126593148|NCT02861300|455471923|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
126593149|NCT02861300|455471924|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
126593150|NCT02861300|455471925|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
126593151|NCT02861300|455471919|FG000|Overall Study|Clinical Complications|0|||
126593152|NCT02861300|455471920|FG001|Overall Study|Clinical Complications|0|||
126593153|NCT02861300|455471921|FG002|Overall Study|Clinical Complications|0|||
126593154|NCT02861300|455471922|FG003|Overall Study|Clinical Complications|0|||
126593155|NCT02861300|455471923|FG004|Overall Study|Clinical Complications|0|||
126731894|NCT02501902|455968349|FG001|Overall Study|Death|4|||
126731895|NCT02501902|455968350|FG002|Overall Study|Death|4|||
126731896|NCT02501902|455968351|FG003|Overall Study|Death|10|||
126731897|NCT02501902|455968352|FG004|Overall Study|Death|10|||
126731898|NCT02501902|455968353|FG005|Overall Study|Death|11|||
126593156|NCT02861300|455471924|FG005|Overall Study|Clinical Complications|0|||
126731899|NCT02501902|455968354|FG006|Overall Study|Death|7|||
126731900|NCT02501902|455968355|FG007|Overall Study|Death|15|||
126731901|NCT02513771|455968356|FG000|Overall Study|Lost to Follow-up|1|||
126731902|NCT02513771|455968357|FG001|Overall Study|Lost to Follow-up|1|||
126731903|NCT02513771|455968356|FG000|Overall Study|Not being able to get to clinic|1|||
126593157|NCT02861300|455471925|FG006|Overall Study|Clinical Complications|1|||
126593158|NCT03252847|455471926|FG000|Overall Study|Withdrawal by Subject|0|||
126731904|NCT02513771|455968357|FG001|Overall Study|Not being able to get to clinic|0|||
126593159|NCT03252847|455471927|FG001|Overall Study|Withdrawal by Subject|0|||
126593160|NCT03252847|455471928|FG002|Overall Study|Withdrawal by Subject|1|||
126593161|NCT03252847|455471929|FG003|Overall Study|Withdrawal by Subject|0|||
126593162|NCT03252847|455471930|FG004|Overall Study|Withdrawal by Subject|0|||
126593163|NCT03252847|455471931|FG005|Overall Study|Withdrawal by Subject|0|||
126593164|NCT03252847|455471932|FG006|Overall Study|Withdrawal by Subject|0|||
126593165|NCT03252847|455471926|FG000|Overall Study|Other: Patient decision|0|||
126593166|NCT03252847|455471927|FG001|Overall Study|Other: Patient decision|0|||
126731905|NCT01595438|455968358|FG000|Overall Study|Lost to Follow-up|20|||
126593167|NCT03252847|455471928|FG002|Overall Study|Other: Patient decision|0|||
126593168|NCT03252847|455471929|FG003|Overall Study|Other: Patient decision|0|||
126593169|NCT03252847|455471930|FG004|Overall Study|Other: Patient decision|1|||
126593170|NCT03252847|455471931|FG005|Overall Study|Other: Patient decision|0|||
126593171|NCT03252847|455471932|FG006|Overall Study|Other: Patient decision|0|||
126593172|NCT01501955|455471935|FG000|Overall Study|Withdrawal by Subject|1|||
126593173|NCT01501955|455471936|FG001|Overall Study|Withdrawal by Subject|0|||
126593174|NCT01501955|455471935|FG000|Overall Study|Adverse Event|1|||
126593175|NCT01501955|455471936|FG001|Overall Study|Adverse Event|3|||
126593176|NCT02993159|455471937|FG000|Overall Study|Withdrawal by Subject|1|||
126593177|NCT02993159|455471938|FG001|Overall Study|Withdrawal by Subject|3|||
126593178|NCT02993159|455471937|FG000|Overall Study|Protocol Violation|1|||
126593179|NCT02993159|455471938|FG001|Overall Study|Protocol Violation|0|||
126593180|NCT02993159|455471937|FG000|Overall Study|Opted out of surgery|2|||
126593181|NCT02993159|455471938|FG001|Overall Study|Opted out of surgery|0|||
126593182|NCT02993159|455471937|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
126593183|NCT02993159|455471938|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
126593184|NCT02993159|455471937|FG000|Overall Study|Physician Decision|0|||
126593185|NCT02993159|455471938|FG001|Overall Study|Physician Decision|1|||
126593186|NCT04992520|455471940|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
126593187|NCT04992520|455471941|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
126593188|NCT04992520|455471942|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
126593189|NCT04992520|455471943|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
126593190|NCT04992520|455471944|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
126593191|NCT04992520|455471945|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
126593192|NCT04992520|455471940|FG000|Part A: First Challenge|Non-compliance|0|||
126593193|NCT04992520|455471941|FG001|Part A: First Challenge|Non-compliance|0|||
126593194|NCT04992520|455471942|FG002|Part A: First Challenge|Non-compliance|0|||
126593195|NCT04992520|455471943|FG003|Part A: First Challenge|Non-compliance|1|||
126593196|NCT04992520|455471944|FG004|Part A: First Challenge|Non-compliance|0|||
126593197|NCT04992520|455471945|FG005|Part A: First Challenge|Non-compliance|0|||
126593198|NCT04992520|455471940|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
126593199|NCT04992520|455471941|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
126593200|NCT04992520|455471942|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
126593201|NCT04992520|455471943|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
126593202|NCT04992520|455471944|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
126593203|NCT04992520|455471945|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
126593204|NCT04992520|455471940|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
126593205|NCT04992520|455471941|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
126593206|NCT04992520|455471942|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
126593207|NCT04992520|455471943|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
126593208|NCT04992520|455471944|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
126593209|NCT04992520|455471945|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
126593210|NCT02714257|455471948|FG000|Overall Study|Withdrawal by Subject|6|||
126593211|NCT02714257|455471949|FG001|Overall Study|Withdrawal by Subject|11|||
126593212|NCT02714257|455471948|FG000|Overall Study|Death|3|||
126593213|NCT02714257|455471949|FG001|Overall Study|Death|4|||
126593214|NCT02714257|455471948|FG000|Overall Study|Lost to Follow-up|1|||
126593215|NCT02714257|455471949|FG001|Overall Study|Lost to Follow-up|6|||
126593216|NCT04103580|455471952|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
126593217|NCT04103580|455471953|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
126593218|NCT04103580|455471952|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
126593219|NCT04103580|455471953|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
126593220|NCT04103580|455471952|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
126593221|NCT04103580|455471953|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
126593222|NCT04103580|455471952|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
126593223|NCT04103580|455471953|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
126593224|NCT04103580|455471952|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
126593225|NCT04103580|455471953|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
126593226|NCT04103580|455471952|FG000|Phase 1 Active Caregiving|Other|3|||
126593227|NCT04103580|455471953|FG001|Phase 1 Active Caregiving|Other|3|||
126731906|NCT01595438|455968359|FG001|Overall Study|Lost to Follow-up|20|||
126731907|NCT01595438|455968358|FG000|Overall Study|Withdrawal by Subject|12|||
126731908|NCT01595438|455968359|FG001|Overall Study|Withdrawal by Subject|12|||
126593228|NCT04103580|455471952|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
126593229|NCT04103580|455471953|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
126593230|NCT04103580|455471952|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
126593231|NCT04103580|455471953|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
126593232|NCT04103580|455471952|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
126731909|NCT01595438|455968358|FG000|Overall Study|Other Eligibility criteria|11|||
126778429|NCT02266706|456144930|FG003|Overall Study|Enrollment in another study|1|||
126778430|NCT02266706|456144931|FG004|Overall Study|Enrollment in another study|0|||
126778431|NCT02266706|456144932|FG005|Overall Study|Enrollment in another study|0|||
126778432|NCT02266706|456144933|FG006|Overall Study|Enrollment in another study|0|||
126778433|NCT02266706|456144934|FG007|Overall Study|Enrollment in another study|0|||
126778434|NCT02266706|456144935|FG008|Overall Study|Enrollment in another study|0|||
126778435|NCT01084005|456144938|FG000|Overall Study|Adverse Event|1|||
126778436|NCT01084005|456144939|FG001|Overall Study|Adverse Event|8|||
126778437|NCT01084005|456144938|FG000|Overall Study|Protocol Violation|3|||
126778438|NCT01084005|456144939|FG001|Overall Study|Protocol Violation|7|||
126778439|NCT01084005|456144938|FG000|Overall Study|Withdrawal by Subject|1|||
126778440|NCT01084005|456144939|FG001|Overall Study|Withdrawal by Subject|1|||
126778441|NCT02480010|456144940|FG000|Overall Study|Adverse Event|3|||
126778442|NCT02480010|456144941|FG001|Overall Study|Adverse Event|1|||
126778443|NCT02480010|456144940|FG000|Overall Study|Death|1|||
126778444|NCT02480010|456144941|FG001|Overall Study|Death|0|||
126778445|NCT02480010|456144940|FG000|Overall Study|Insufficient therapeutic response|31|||
126778446|NCT02480010|456144941|FG001|Overall Study|Insufficient therapeutic response|29|||
126778447|NCT02480010|456144940|FG000|Overall Study|Refused Treatment|0|||
126778448|NCT02480010|456144941|FG001|Overall Study|Refused Treatment|3|||
126778449|NCT01034137|456144945|FG000|Overall Study|Adverse Event|9|||
126778450|NCT01034137|456144946|FG001|Overall Study|Adverse Event|10|||
126778451|NCT01034137|456144947|FG002|Overall Study|Adverse Event|8|||
126778452|NCT01034137|456144945|FG000|Overall Study|Withdrawal by Subject|4|||
126778453|NCT01034137|456144946|FG001|Overall Study|Withdrawal by Subject|3|||
126778454|NCT01034137|456144947|FG002|Overall Study|Withdrawal by Subject|3|||
126778455|NCT01034137|456144945|FG000|Overall Study|Lack of Efficacy|9|||
126778456|NCT01034137|456144946|FG001|Overall Study|Lack of Efficacy|4|||
126778457|NCT01034137|456144947|FG002|Overall Study|Lack of Efficacy|13|||
126778458|NCT01034137|456144945|FG000|Overall Study|Protocol Violation|2|||
126778459|NCT01034137|456144946|FG001|Overall Study|Protocol Violation|2|||
126778460|NCT01034137|456144947|FG002|Overall Study|Protocol Violation|1|||
126778461|NCT01034137|456144945|FG000|Overall Study|Refused treatment or did not cooperate|2|||
126778462|NCT01034137|456144946|FG001|Overall Study|Refused treatment or did not cooperate|0|||
126778463|NCT01034137|456144947|FG002|Overall Study|Refused treatment or did not cooperate|1|||
126778464|NCT01034137|456144945|FG000|Overall Study|Administrative or other|2|||
126778465|NCT01034137|456144946|FG001|Overall Study|Administrative or other|3|||
126778466|NCT01034137|456144947|FG002|Overall Study|Administrative or other|4|||
126778467|NCT01764854|456144951|FG000|Overall Study|Adverse Event|0|||
126778468|NCT01764854|456144952|FG001|Overall Study|Adverse Event|0|||
126778469|NCT01764854|456144953|FG002|Overall Study|Adverse Event|2|||
126778470|NCT01764854|456144954|FG003|Overall Study|Adverse Event|0|||
126778471|NCT01764854|456144951|FG000|Overall Study|Withdrawal by Subject|0|||
126778472|NCT01764854|456144952|FG001|Overall Study|Withdrawal by Subject|0|||
126778473|NCT01764854|456144953|FG002|Overall Study|Withdrawal by Subject|1|||
126778474|NCT01764854|456144954|FG003|Overall Study|Withdrawal by Subject|0|||
126778475|NCT01764854|456144951|FG000|Overall Study|relocation|0|||
126778476|NCT01764854|456144952|FG001|Overall Study|relocation|0|||
126778477|NCT01764854|456144953|FG002|Overall Study|relocation|2|||
126778478|NCT01764854|456144954|FG003|Overall Study|relocation|0|||
126778479|NCT01764854|456144951|FG000|Overall Study|Protocol Violation|0|||
126778480|NCT01764854|456144952|FG001|Overall Study|Protocol Violation|0|||
126778481|NCT01764854|456144953|FG002|Overall Study|Protocol Violation|1|||
126778482|NCT01764854|456144954|FG003|Overall Study|Protocol Violation|2|||
126731910|NCT01595438|455968359|FG001|Overall Study|Other Eligibility criteria|9|||
126731911|NCT05590767|455968362|FG000|Overall Study|Protocol Violation|1|||
126731912|NCT05590767|455968362|FG000|Overall Study|surgery canceled|1|||
126731913|NCT05590767|455968362|FG000|Overall Study|interscalene brachial block not performed|1|||
126731914|NCT03483116|455968374|FG000|Overall Study|Adverse Event|0|||
126731915|NCT03483116|455968375|FG001|Overall Study|Adverse Event|1|||
126731916|NCT03483116|455968376|FG002|Overall Study|Adverse Event|0|||
126731917|NCT03483116|455968377|FG003|Overall Study|Adverse Event|1|||
126731918|NCT03483116|455968374|FG000|Overall Study|Protocol Violation|1|||
126731919|NCT03483116|455968375|FG001|Overall Study|Protocol Violation|0|||
126731920|NCT03483116|455968376|FG002|Overall Study|Protocol Violation|0|||
126731921|NCT03483116|455968377|FG003|Overall Study|Protocol Violation|7|||
126731922|NCT03483116|455968374|FG000|Overall Study|Lost to Follow-up|9|||
126731923|NCT03483116|455968375|FG001|Overall Study|Lost to Follow-up|4|||
126731924|NCT03483116|455968376|FG002|Overall Study|Lost to Follow-up|9|||
126731925|NCT03483116|455968377|FG003|Overall Study|Lost to Follow-up|5|||
126731926|NCT03483116|455968374|FG000|Overall Study|Death|1|||
126731927|NCT03483116|455968375|FG001|Overall Study|Death|0|||
126778483|NCT03377556|456144963|FG000|Overall Study|Adverse Event|5|||
126778484|NCT03377556|456144963|FG000|Overall Study|Refusal unrelated to adverse events|1|||
126731928|NCT03483116|455968376|FG002|Overall Study|Death|2|||
126731929|NCT03483116|455968377|FG003|Overall Study|Death|1|||
126731930|NCT03483116|455968374|FG000|Overall Study|Withdrawal by Subject|14|||
126731931|NCT03483116|455968375|FG001|Overall Study|Withdrawal by Subject|16|||
126731932|NCT03483116|455968376|FG002|Overall Study|Withdrawal by Subject|14|||
126593233|NCT04103580|455471953|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
126593234|NCT04103580|455471952|FG000|Phase 2 Bereavement|Other|8|||
126593235|NCT04103580|455471953|FG001|Phase 2 Bereavement|Other|6|||
126593236|NCT04145440|455471954|FG000|Overall Study|Physician Decision|3|||
126593237|NCT04145440|455471955|FG001|Overall Study|Physician Decision|0|||
126593238|NCT04145440|455471954|FG000|Overall Study|Use of prohibited therapy|2|||
126593239|NCT04145440|455471955|FG001|Overall Study|Use of prohibited therapy|3|||
126593240|NCT00104676|455471956|FG000|Overall Study|Death|3|||
126593241|NCT00104676|455471957|FG001|Overall Study|Death|2|||
126593242|NCT00104676|455471956|FG000|Overall Study|Withdrawal by Subject|0|||
126593243|NCT00104676|455471957|FG001|Overall Study|Withdrawal by Subject|2|||
126593244|NCT00104676|455471956|FG000|Overall Study|treatment interruption|4|||
126593245|NCT00104676|455471957|FG001|Overall Study|treatment interruption|10|||
126593246|NCT05139810|455471958|FG000|Overall Study|Voluntary Withdrawal|2|||
126593247|NCT05139810|455471959|FG001|Overall Study|Voluntary Withdrawal|1|||
126593248|NCT05139810|455471960|FG002|Overall Study|Voluntary Withdrawal|0|||
126593249|NCT05139810|455471958|FG000|Overall Study|Pregnancy|1|||
126593250|NCT05139810|455471959|FG001|Overall Study|Pregnancy|0|||
126593251|NCT05139810|455471960|FG002|Overall Study|Pregnancy|0|||
126593252|NCT05139810|455471958|FG000|Overall Study|Roll Over to CS7|19|||
126593253|NCT05139810|455471959|FG001|Overall Study|Roll Over to CS7|44|||
126593254|NCT05139810|455471960|FG002|Overall Study|Roll Over to CS7|20|||
126593255|NCT04054193|455471972|FG000|Cycle 1|Physician Decision|1|||
126593256|NCT04054193|455471972|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
126593257|NCT04054193|455471972|FG000|Cycle 1|Allocated but not treated|3|||
126593258|NCT04054193|455471972|FG000|Cycles 2-3|Physician Decision|2|||
126593259|NCT04054193|455471972|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
126731933|NCT03483116|455968377|FG003|Overall Study|Withdrawal by Subject|16|||
126731934|NCT03483116|455968374|FG000|Overall Study|Unknown other reason|3|||
126731935|NCT03483116|455968375|FG001|Overall Study|Unknown other reason|2|||
126593260|NCT04054193|455471972|FG000|Cycles 2-3|Various reasons|17|||
126593261|NCT02966873|455471973|FG000|Overall Study|Lost to Follow-up|16|||
126593262|NCT02966873|455471974|FG001|Overall Study|Lost to Follow-up|15|||
126593263|NCT03084536|455471975|FG000|Overall Study|Determined to be ineligible|0|||
126593264|NCT03084536|455471976|FG001|Overall Study|Determined to be ineligible|0|||
126593265|NCT03084536|455471977|FG002|Overall Study|Determined to be ineligible|16|||
126593266|NCT03084536|455471975|FG000|Overall Study|Withdrawal by Subject|0|||
126593267|NCT03084536|455471976|FG001|Overall Study|Withdrawal by Subject|0|||
126593268|NCT03084536|455471977|FG002|Overall Study|Withdrawal by Subject|4|||
126593269|NCT03084536|455471975|FG000|Overall Study|Physician Decision|0|||
126593270|NCT03084536|455471976|FG001|Overall Study|Physician Decision|0|||
126593271|NCT03084536|455471977|FG002|Overall Study|Physician Decision|3|||
126593272|NCT03084536|455471975|FG000|Overall Study|Death|0|||
126593273|NCT03084536|455471976|FG001|Overall Study|Death|0|||
126593274|NCT03084536|455471977|FG002|Overall Study|Death|1|||
126593275|NCT03084536|455471975|FG000|Overall Study|Lost to Follow-up|0|||
126593276|NCT03084536|455471976|FG001|Overall Study|Lost to Follow-up|0|||
126593277|NCT03084536|455471977|FG002|Overall Study|Lost to Follow-up|1|||
126731936|NCT03483116|455968376|FG002|Overall Study|Unknown other reason|1|||
126731937|NCT03483116|455968377|FG003|Overall Study|Unknown other reason|1|||
126731938|NCT01181102|455968378|FG000|Overall Study|Adverse Event|28|||
126731939|NCT01181102|455968379|FG001|Overall Study|Adverse Event|26|||
126731940|NCT01181102|455968378|FG000|Overall Study|Lack of Efficacy|3|||
126731941|NCT01181102|455968379|FG001|Overall Study|Lack of Efficacy|1|||
126731942|NCT01181102|455968378|FG000|Overall Study|Lost to Follow-up|2|||
126731943|NCT01181102|455968379|FG001|Overall Study|Lost to Follow-up|0|||
126731944|NCT01181102|455968378|FG000|Overall Study|Physician Decision|3|||
126731945|NCT01181102|455968379|FG001|Overall Study|Physician Decision|1|||
126731946|NCT01181102|455968378|FG000|Overall Study|Protocol Violation|5|||
126731947|NCT01181102|455968379|FG001|Overall Study|Protocol Violation|6|||
126731948|NCT01181102|455968378|FG000|Overall Study|Withdrawal by Subject|10|||
126731949|NCT01181102|455968379|FG001|Overall Study|Withdrawal by Subject|12|||
126731950|NCT00936117|455968380|FG000|Overall Study|Adverse Event|7|||
126731951|NCT00936117|455968380|FG000|Overall Study|Unable to continue oral medication|3|||
126731952|NCT04685499|455968393|FG000|Overall Study|Study Terminated Early|1|||
126731953|NCT03699631|455968394|FG000|Overall Study|Adverse Event|3|||
126731954|NCT01996904|455968395|FG000|Overall Study|Lost to Follow-up|38|||
126778485|NCT03377556|456144963|FG000|Overall Study|Progression/relapse|38|||
126778486|NCT03377556|456144963|FG000|Overall Study|Death|3|||
126593278|NCT03084536|455471975|FG000|Overall Study|Protocol Violation|0|||
126593279|NCT03084536|455471976|FG001|Overall Study|Protocol Violation|0|||
126593280|NCT03084536|455471977|FG002|Overall Study|Protocol Violation|1|||
126593281|NCT03084536|455471975|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
126593282|NCT03084536|455471976|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
126593283|NCT03084536|455471977|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
126731955|NCT01996904|455968396|FG001|Overall Study|Lost to Follow-up|27|||
126731956|NCT01324622|455968397|FG000|Overall Study|Lost to Follow-up|7|||
126731957|NCT01324622|455968398|FG001|Overall Study|Lost to Follow-up|7|||
126593284|NCT05704543|455471978|FG000|Overall Study|Withdrawal by Subject|1|||
126593285|NCT05704543|455471979|FG001|Overall Study|Withdrawal by Subject|1|||
126593286|NCT05704543|455471980|FG002|Overall Study|Withdrawal by Subject|0|||
126593287|NCT05704543|455471981|FG003|Overall Study|Withdrawal by Subject|2|||
126593288|NCT05704543|455471978|FG000|Overall Study|Lost to Follow-up|1|||
126593289|NCT05704543|455471979|FG001|Overall Study|Lost to Follow-up|2|||
126593290|NCT05704543|455471980|FG002|Overall Study|Lost to Follow-up|0|||
126593291|NCT05704543|455471981|FG003|Overall Study|Lost to Follow-up|0|||
126593292|NCT04830800|455471988|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
126593293|NCT04830800|455471989|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
126593294|NCT04830800|455471990|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
126593295|NCT04830800|455471991|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
126593296|NCT04830800|455471992|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
126593297|NCT03816332|455471995|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
126593298|NCT03816332|455471995|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
126593299|NCT03710603|455471996|FG000|Overall Study|Adverse Event|1|||
126593300|NCT03710603|455471997|FG001|Overall Study|Adverse Event|0|||
126593301|NCT03710603|455471996|FG000|Overall Study|Death|44|||
126593302|NCT03710603|455471997|FG001|Overall Study|Death|34|||
126593303|NCT03710603|455471996|FG000|Overall Study|Lost to Follow-up|3|||
126593304|NCT03710603|455471997|FG001|Overall Study|Lost to Follow-up|5|||
126593305|NCT03710603|455471996|FG000|Overall Study|Withdrawal by Subject|11|||
126593306|NCT03710603|455471997|FG001|Overall Study|Withdrawal by Subject|10|||
126593307|NCT02626533|455471998|FG000|Overall Study|Protocol Violation|14|||
126593308|NCT02626533|455471998|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
126593309|NCT02626533|455471998|FG000|Overall Study|Withdrawal by Subject|1|||
126593310|NCT04753697|455471999|FG000|Induction Phase|Withdrawal by Subject|12|||
126593311|NCT04753697|455472000|FG001|Induction Phase|Withdrawal by Subject|5|||
126593312|NCT04753697|455472001|FG002|Induction Phase|Withdrawal by Subject|6|||
126593313|NCT04753697|455471999|FG000|Induction Phase|Physician Decision|1|||
126593314|NCT04753697|455472000|FG001|Induction Phase|Physician Decision|0|||
126593315|NCT04753697|455472001|FG002|Induction Phase|Physician Decision|0|||
126593316|NCT04753697|455471999|FG000|Induction Phase|Lost to Follow-up|2|||
126593317|NCT04753697|455472000|FG001|Induction Phase|Lost to Follow-up|2|||
126593318|NCT04753697|455472001|FG002|Induction Phase|Lost to Follow-up|1|||
126593319|NCT04753697|455471999|FG000|Induction Phase|Lack of Efficacy|1|||
126593320|NCT04753697|455472000|FG001|Induction Phase|Lack of Efficacy|0|||
126593321|NCT04753697|455472001|FG002|Induction Phase|Lack of Efficacy|0|||
126593322|NCT04753697|455471999|FG000|Maintenance Phase|Physician Decision|0|||
126593323|NCT04753697|455472000|FG001|Maintenance Phase|Physician Decision|0|||
126593324|NCT04753697|455472001|FG002|Maintenance Phase|Physician Decision|1|||
126593325|NCT04753697|455471999|FG000|Maintenance Phase|Withdrawal by Subject|3|||
126593326|NCT04753697|455472000|FG001|Maintenance Phase|Withdrawal by Subject|4|||
126593327|NCT04753697|455472001|FG002|Maintenance Phase|Withdrawal by Subject|6|||
126593328|NCT04753697|455471999|FG000|Maintenance Phase|Lost to Follow-up|2|||
126593329|NCT04753697|455472000|FG001|Maintenance Phase|Lost to Follow-up|2|||
126593330|NCT04753697|455472001|FG002|Maintenance Phase|Lost to Follow-up|0|||
126593331|NCT04753697|455471999|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
126593332|NCT04753697|455472000|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
126593333|NCT04753697|455472001|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
126593334|NCT04753697|455471999|FG000|Maintenance Phase|Adverse Event|0|||
126593335|NCT04753697|455472000|FG001|Maintenance Phase|Adverse Event|1|||
126593336|NCT04753697|455472001|FG002|Maintenance Phase|Adverse Event|1|||
126593337|NCT04753697|455471999|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
126593338|NCT04753697|455472000|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
126593339|NCT04753697|455472001|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
126593340|NCT03034356|455472027|FG000|Baseline|Lost to Follow-up|2|||
126593341|NCT03034356|455472028|FG001|Baseline|Lost to Follow-up|4|||
126593342|NCT03034356|455472027|FG000|Baseline|Withdrawal by Subject|2|||
126593343|NCT03034356|455472028|FG001|Baseline|Withdrawal by Subject|0|||
126593344|NCT03034356|455472027|FG000|Baseline|Physician Decision|0|||
126593345|NCT03034356|455472028|FG001|Baseline|Physician Decision|1|||
126593346|NCT03034356|455472027|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
126593347|NCT03034356|455472028|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
126731958|NCT01324622|455968397|FG000|Overall Study|Death|1|||
126731959|NCT01324622|455968398|FG001|Overall Study|Death|0|||
126593348|NCT03034356|455472027|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
126593349|NCT03034356|455472028|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
126593350|NCT03034356|455472027|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
126593351|NCT03034356|455472028|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
126593352|NCT03034356|455472027|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
126593353|NCT03034356|455472028|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
126731960|NCT01324622|455968397|FG000|Overall Study|Lack of Efficacy|1|||
126593354|NCT03221426|455472029|FG000|Overall Study|Ongoing in study|212|||
126593355|NCT03221426|455472030|FG001|Overall Study|Ongoing in study|193|||
126593356|NCT03221426|455472031|FG002|Overall Study|Ongoing in study|61|||
126593357|NCT03221426|455472032|FG003|Overall Study|Ongoing in study|55|||
126593358|NCT03221426|455472029|FG000|Overall Study|Withdrawal by Subject|12|||
126593359|NCT03221426|455472030|FG001|Overall Study|Withdrawal by Subject|4|||
126593360|NCT03221426|455472031|FG002|Overall Study|Withdrawal by Subject|2|||
126731961|NCT01324622|455968398|FG001|Overall Study|Lack of Efficacy|0|||
126731962|NCT00618449|455968399|FG000|Overall Study|Lost to Follow-up|98|||
126731963|NCT00618449|455968400|FG001|Overall Study|Lost to Follow-up|110|||
126731964|NCT05127421|455968401|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
126731965|NCT05127421|455968402|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
126731966|NCT05127421|455968403|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
126731967|NCT05127421|455968404|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
126731968|NCT05127421|455968401|FG000|4-Week Double-Blind Period|Physician Decision|1|||
126731969|NCT05127421|455968402|FG001|4-Week Double-Blind Period|Physician Decision|0|||
126731970|NCT05127421|455968403|FG002|4-Week Double-Blind Period|Physician Decision|0|||
126731971|NCT05127421|455968404|FG003|4-Week Double-Blind Period|Physician Decision|0|||
126731972|NCT05127421|455968401|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
126731973|NCT05127421|455968402|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
126731974|NCT05127421|455968403|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
126731975|NCT05127421|455968404|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
126731976|NCT05127421|455968401|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
126731977|NCT05127421|455968402|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
126731978|NCT05127421|455968403|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
126731979|NCT05127421|455968404|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
126731980|NCT05127421|455968401|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
126731981|NCT05127421|455968402|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
126731982|NCT05127421|455968403|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
126731983|NCT05127421|455968404|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
126731984|NCT05127421|455968401|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
126731985|NCT05127421|455968402|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
126731986|NCT05127421|455968403|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
126731987|NCT05127421|455968404|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
126731988|NCT05127421|455968401|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
126731989|NCT05127421|455968402|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
126731990|NCT05127421|455968403|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
126731991|NCT05127421|455968404|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
126731992|NCT05127421|455968401|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
126731993|NCT05127421|455968402|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
126731994|NCT05127421|455968403|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
126731995|NCT05127421|455968404|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
126731996|NCT00138424|455968407|FG000|Overall Study|Physician Decision|0|||
126731997|NCT00138424|455968408|FG001|Overall Study|Physician Decision|1|||
126731998|NCT00138424|455968409|FG002|Overall Study|Physician Decision|0|||
126731999|NCT00138424|455968410|FG003|Overall Study|Physician Decision|0|||
126732000|NCT04311177|455968411|FG000|Overall Study|Adverse Event|3|||
126732001|NCT04311177|455968412|FG001|Overall Study|Adverse Event|1|||
126732002|NCT04311177|455968411|FG000|Overall Study|Physician Decision|4|||
126732003|NCT04311177|455968412|FG001|Overall Study|Physician Decision|3|||
126732004|NCT04311177|455968411|FG000|Overall Study|Withdrawal by Subject|1|||
126732005|NCT04311177|455968412|FG001|Overall Study|Withdrawal by Subject|0|||
126732006|NCT00413062|455968415|FG000|Overall Study|Adverse event/serious adverse event|289|||
126732007|NCT00413062|455968416|FG001|Overall Study|Adverse event/serious adverse event|56|||
126732008|NCT00413062|455968415|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
126732009|NCT00413062|455968416|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
126732010|NCT00413062|455968415|FG000|Overall Study|Withdrawal of informed consent|111|||
126732011|NCT00413062|455968416|FG001|Overall Study|Withdrawal of informed consent|36|||
126732012|NCT00413062|455968415|FG000|Overall Study|Pregnancy|15|||
126732013|NCT00413062|455968416|FG001|Overall Study|Pregnancy|5|||
126732014|NCT00413062|455968415|FG000|Overall Study|Pregnancy wish|17|||
126732015|NCT00413062|455968416|FG001|Overall Study|Pregnancy wish|6|||
126593361|NCT03221426|455472032|FG003|Overall Study|Withdrawal by Subject|3|||
126732016|NCT00413062|455968415|FG000|Overall Study|Lost to Follow-up|175|||
126732017|NCT00413062|455968416|FG001|Overall Study|Lost to Follow-up|73|||
126732018|NCT00413062|455968415|FG000|Overall Study|Other reason|70|||
126593362|NCT03221426|455472029|FG000|Overall Study|Lost to Follow-up|4|||
126732019|NCT00413062|455968416|FG001|Overall Study|Other reason|34|||
126732020|NCT02176291|455968417|FG000|Overall Study|Death|1|||
126732021|NCT02176291|455968418|FG001|Overall Study|Death|0|||
126732022|NCT02176291|455968417|FG000|Overall Study|non compliance with protocol|2|||
126732023|NCT02176291|455968418|FG001|Overall Study|non compliance with protocol|0|||
126732024|NCT02176291|455968417|FG000|Overall Study|Withdrawal by Subject|2|||
126593363|NCT03221426|455472030|FG001|Overall Study|Lost to Follow-up|1|||
126778487|NCT01967888|456144968|FG000|Overall Study|Lost to Follow-up|6|||
126778488|NCT01967888|456144969|FG001|Overall Study|Lost to Follow-up|4|||
126778489|NCT01967888|456144968|FG000|Overall Study|Withdrawal by Subject|1|||
126778490|NCT01967888|456144969|FG001|Overall Study|Withdrawal by Subject|1|||
126778491|NCT01967888|456144968|FG000|Overall Study|Did Not Have Transplant|1|||
126778492|NCT01967888|456144969|FG001|Overall Study|Did Not Have Transplant|0|||
126778493|NCT01967888|456144968|FG000|Overall Study|Research visit not done, data recorded|1|||
126778494|NCT01967888|456144969|FG001|Overall Study|Research visit not done, data recorded|0|||
126778495|NCT01967888|456144968|FG000|Overall Study|Subject excluded after randomization|1|||
126778496|NCT01967888|456144969|FG001|Overall Study|Subject excluded after randomization|0|||
126778497|NCT01967888|456144968|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
126778498|NCT01967888|456144969|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
126778499|NCT01967888|456144968|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
126778500|NCT01967888|456144969|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
126778501|NCT00553540|456144970|FG000|Overall Study|discharged after first visit|2|||
126778502|NCT00553540|456144971|FG001|Overall Study|discharged after first visit|5|||
126778503|NCT02622074|456144972|FG000|Overall Study|Death|4|||
126778504|NCT02622074|456144973|FG001|Overall Study|Death|0|||
126778505|NCT02622074|456144974|FG002|Overall Study|Death|0|||
126778506|NCT02622074|456144975|FG003|Overall Study|Death|1|||
126778507|NCT02622074|456144976|FG004|Overall Study|Death|1|||
126778508|NCT02622074|456144977|FG005|Overall Study|Death|0|||
126778509|NCT02622074|456144972|FG000|Overall Study|Withdrawal by Subject|0|||
126778510|NCT02622074|456144973|FG001|Overall Study|Withdrawal by Subject|1|||
126778511|NCT02622074|456144974|FG002|Overall Study|Withdrawal by Subject|0|||
126778512|NCT02622074|456144975|FG003|Overall Study|Withdrawal by Subject|0|||
126778513|NCT02622074|456144976|FG004|Overall Study|Withdrawal by Subject|0|||
126778514|NCT02622074|456144977|FG005|Overall Study|Withdrawal by Subject|0|||
126778515|NCT02114931|456144978|FG000|Overall Study|Withdrawal by Subject|15|||
126778516|NCT02114931|456144979|FG001|Overall Study|Withdrawal by Subject|18|||
126778517|NCT02114931|456144978|FG000|Overall Study|Adverse Event|4|||
126778518|NCT02114931|456144979|FG001|Overall Study|Adverse Event|6|||
126778519|NCT02114931|456144978|FG000|Overall Study|Lost to Follow-up|3|||
126778520|NCT02114931|456144979|FG001|Overall Study|Lost to Follow-up|3|||
126778521|NCT02114931|456144978|FG000|Overall Study|Physician Decision|1|||
126778522|NCT02114931|456144979|FG001|Overall Study|Physician Decision|2|||
126778523|NCT02114931|456144978|FG000|Overall Study|Other|2|||
126778524|NCT02114931|456144979|FG001|Overall Study|Other|1|||
126778525|NCT03565211|456144981|FG000|Overall Study|Withdrawal by Subject|2|||
126778526|NCT03565211|456144981|FG000|Overall Study|Lost to Follow-up|1|||
126778527|NCT03565211|456144981|FG000|Overall Study|Adverse Event|44|||
126778528|NCT03565211|456144981|FG000|Overall Study|Personal issues|1|||
126778529|NCT01894984|456144985|FG000|Overall Study|Other|314|||
126778530|NCT01894984|456144986|FG001|Overall Study|Other|175|||
126778531|NCT03840135|456144988|FG000|Overall Study|Protocol Violation|6|||
126778532|NCT03840135|456144989|FG001|Overall Study|Protocol Violation|1|||
126778533|NCT03840135|456144988|FG000|Overall Study|Withdrawal by Subject|1|||
126778534|NCT03840135|456144989|FG001|Overall Study|Withdrawal by Subject|0|||
126778535|NCT01827371|456144990|FG000|Overall Study|Adverse Event|0|||
126778536|NCT01827371|456144991|FG001|Overall Study|Adverse Event|0|||
126778537|NCT01827371|456144992|FG002|Overall Study|Adverse Event|4|||
126778538|NCT01827371|456144993|FG003|Overall Study|Adverse Event|2|||
126778539|NCT01827371|456144990|FG000|Overall Study|Lost to Follow-up|0|||
126778540|NCT01827371|456144991|FG001|Overall Study|Lost to Follow-up|2|||
126778541|NCT01827371|456144992|FG002|Overall Study|Lost to Follow-up|0|||
126778542|NCT01827371|456144993|FG003|Overall Study|Lost to Follow-up|4|||
126778543|NCT01827371|456144990|FG000|Overall Study|Protocol Violation|1|||
126778544|NCT01827371|456144991|FG001|Overall Study|Protocol Violation|0|||
126778545|NCT01827371|456144992|FG002|Overall Study|Protocol Violation|0|||
126778546|NCT01827371|456144993|FG003|Overall Study|Protocol Violation|0|||
126778547|NCT01827371|456144990|FG000|Overall Study|Withdrawal by Subject|1|||
126778548|NCT01827371|456144991|FG001|Overall Study|Withdrawal by Subject|2|||
126778549|NCT01827371|456144992|FG002|Overall Study|Withdrawal by Subject|2|||
126778550|NCT01827371|456144993|FG003|Overall Study|Withdrawal by Subject|3|||
126778551|NCT01827371|456144990|FG000|Overall Study|Physician Decision|0|||
126778552|NCT01827371|456144991|FG001|Overall Study|Physician Decision|1|||
126778553|NCT01827371|456144992|FG002|Overall Study|Physician Decision|0|||
126778554|NCT01827371|456144993|FG003|Overall Study|Physician Decision|1|||
126778555|NCT01827371|456144990|FG000|Overall Study|Temporary study halt to vaccinations|11|||
126778556|NCT01827371|456144991|FG001|Overall Study|Temporary study halt to vaccinations|2|||
126778557|NCT01827371|456144992|FG002|Overall Study|Temporary study halt to vaccinations|5|||
126778558|NCT01827371|456144993|FG003|Overall Study|Temporary study halt to vaccinations|13|||
126778559|NCT01361607|456144996|FG000|Overall Study|Adverse Event|38|||
126778560|NCT01361607|456144997|FG001|Overall Study|Adverse Event|29|||
126778561|NCT01361607|456144996|FG000|Overall Study|Withdrawal by Subject|19|||
126778562|NCT01361607|456144997|FG001|Overall Study|Withdrawal by Subject|8|||
126778563|NCT01361607|456144996|FG000|Overall Study|Withdrawal by Investigator|5|||
126778564|NCT01361607|456144997|FG001|Overall Study|Withdrawal by Investigator|3|||
126593364|NCT03221426|455472031|FG002|Overall Study|Lost to Follow-up|1|||
126593365|NCT03221426|455472032|FG003|Overall Study|Lost to Follow-up|0|||
126593366|NCT03221426|455472029|FG000|Overall Study|Death|174|||
126593367|NCT03221426|455472030|FG001|Overall Study|Death|204|||
126593368|NCT03221426|455472031|FG002|Overall Study|Death|36|||
126593369|NCT03221426|455472032|FG003|Overall Study|Death|45|||
126778565|NCT01361607|456144996|FG000|Overall Study|Lost to Follow-up|1|||
126778566|NCT01361607|456144997|FG001|Overall Study|Lost to Follow-up|0|||
126593370|NCT05809453|455473986|FG000|Overall Study|Withdrawal by Subject|1|||
126593371|NCT05809453|455473987|FG001|Overall Study|Withdrawal by Subject|0|||
126593372|NCT05809453|455473988|FG002|Overall Study|Withdrawal by Subject|0|||
126593373|NCT05809453|455473989|FG003|Overall Study|Withdrawal by Subject|0|||
126593374|NCT05251909|455473994|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
126593375|NCT05251909|455473995|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
126593376|NCT05543915|455473996|FG000|Overall Study|Lost to Follow-up|0|||
126593377|NCT05543915|455473997|FG001|Overall Study|Lost to Follow-up|1|||
126593378|NCT04171141|455473999|FG000|Overall Study|Adverse Event|0|||
126593379|NCT04171141|455474000|FG001|Overall Study|Adverse Event|0|||
126593380|NCT04171141|455474001|FG002|Overall Study|Adverse Event|2|||
126593381|NCT04171141|455474002|FG003|Overall Study|Adverse Event|0|||
126593382|NCT04171141|455474003|FG004|Overall Study|Adverse Event|0|||
126593383|NCT04171141|455474004|FG005|Overall Study|Adverse Event|0|||
126593384|NCT04171141|455474005|FG006|Overall Study|Adverse Event|0|||
126593385|NCT04171141|455474006|FG007|Overall Study|Adverse Event|0|||
126593386|NCT04171141|455474007|FG008|Overall Study|Adverse Event|0|||
126593387|NCT04171141|455474008|FG009|Overall Study|Adverse Event|0|||
126593388|NCT04171141|455474009|FG010|Overall Study|Adverse Event|0|||
126593389|NCT04171141|455474010|FG011|Overall Study|Adverse Event|0|||
126593390|NCT04171141|455474011|FG012|Overall Study|Adverse Event|0|||
126593391|NCT04171141|455474012|FG013|Overall Study|Adverse Event|2|||
126593392|NCT04171141|455474013|FG014|Overall Study|Adverse Event|0|||
126593393|NCT04171141|455474014|FG015|Overall Study|Adverse Event|0|||
126593394|NCT04171141|455473999|FG000|Overall Study|Physician Decision|0|||
126593395|NCT04171141|455474000|FG001|Overall Study|Physician Decision|0|||
126593396|NCT04171141|455474001|FG002|Overall Study|Physician Decision|0|||
126593397|NCT04171141|455474002|FG003|Overall Study|Physician Decision|0|||
126593398|NCT04171141|455474003|FG004|Overall Study|Physician Decision|1|||
126593399|NCT04171141|455474004|FG005|Overall Study|Physician Decision|0|||
126593400|NCT04171141|455474005|FG006|Overall Study|Physician Decision|0|||
126593401|NCT04171141|455474006|FG007|Overall Study|Physician Decision|0|||
126593402|NCT04171141|455474007|FG008|Overall Study|Physician Decision|0|||
126593403|NCT04171141|455474008|FG009|Overall Study|Physician Decision|0|||
126593404|NCT04171141|455474009|FG010|Overall Study|Physician Decision|0|||
126593405|NCT04171141|455474010|FG011|Overall Study|Physician Decision|0|||
126593406|NCT04171141|455474011|FG012|Overall Study|Physician Decision|0|||
126593407|NCT04171141|455474012|FG013|Overall Study|Physician Decision|0|||
126593408|NCT04171141|455474013|FG014|Overall Study|Physician Decision|0|||
126593409|NCT04171141|455474014|FG015|Overall Study|Physician Decision|1|||
126593410|NCT04171141|455473999|FG000|Overall Study|Progressive disease|2|||
126593411|NCT04171141|455474000|FG001|Overall Study|Progressive disease|3|||
126593412|NCT04171141|455474001|FG002|Overall Study|Progressive disease|4|||
126593413|NCT04171141|455474002|FG003|Overall Study|Progressive disease|7|||
126593414|NCT04171141|455474003|FG004|Overall Study|Progressive disease|1|||
126593415|NCT04171141|455474004|FG005|Overall Study|Progressive disease|8|||
126593416|NCT04171141|455474005|FG006|Overall Study|Progressive disease|4|||
126593417|NCT04171141|455474006|FG007|Overall Study|Progressive disease|6|||
126593418|NCT04171141|455474007|FG008|Overall Study|Progressive disease|7|||
126593419|NCT04171141|455474008|FG009|Overall Study|Progressive disease|3|||
126593420|NCT04171141|455474009|FG010|Overall Study|Progressive disease|4|||
126593421|NCT04171141|455474010|FG011|Overall Study|Progressive disease|3|||
126593422|NCT04171141|455474011|FG012|Overall Study|Progressive disease|4|||
126593423|NCT04171141|455474012|FG013|Overall Study|Progressive disease|2|||
126593424|NCT04171141|455474013|FG014|Overall Study|Progressive disease|4|||
126593425|NCT04171141|455474014|FG015|Overall Study|Progressive disease|1|||
126593426|NCT04171141|455473999|FG000|Overall Study|Withdrawal by Subject|0|||
126593427|NCT04171141|455474000|FG001|Overall Study|Withdrawal by Subject|0|||
126593428|NCT04171141|455474001|FG002|Overall Study|Withdrawal by Subject|0|||
126593429|NCT04171141|455474002|FG003|Overall Study|Withdrawal by Subject|1|||
126593430|NCT04171141|455474003|FG004|Overall Study|Withdrawal by Subject|0|||
126593431|NCT04171141|455474004|FG005|Overall Study|Withdrawal by Subject|0|||
126778567|NCT01361607|456144996|FG000|Overall Study|Met Withdrawal Criteria|1|||
126593432|NCT04171141|455474005|FG006|Overall Study|Withdrawal by Subject|1|||
126593433|NCT04171141|455474006|FG007|Overall Study|Withdrawal by Subject|0|||
126593434|NCT04171141|455474007|FG008|Overall Study|Withdrawal by Subject|0|||
126593435|NCT04171141|455474008|FG009|Overall Study|Withdrawal by Subject|1|||
126593436|NCT04171141|455474009|FG010|Overall Study|Withdrawal by Subject|0|||
126593437|NCT04171141|455474010|FG011|Overall Study|Withdrawal by Subject|0|||
126593438|NCT04171141|455474011|FG012|Overall Study|Withdrawal by Subject|0|||
126593439|NCT04171141|455474012|FG013|Overall Study|Withdrawal by Subject|0|||
126732025|NCT02176291|455968418|FG001|Overall Study|Withdrawal by Subject|0|||
126732026|NCT02815293|455968421|FG000|Overall Study|Study termination by sponsor|10|||
126732027|NCT02815293|455968422|FG001|Overall Study|Study termination by sponsor|7|||
126732028|NCT02815293|455968423|FG002|Overall Study|Study termination by sponsor|0|||
126732029|NCT02815293|455968421|FG000|Overall Study|Participants not randomized|0|||
126732030|NCT02815293|455968422|FG001|Overall Study|Participants not randomized|0|||
126732031|NCT02815293|455968423|FG002|Overall Study|Participants not randomized|18|||
126732032|NCT02815293|455968421|FG000|Overall Study|Adverse Event|0|||
126732033|NCT02815293|455968422|FG001|Overall Study|Adverse Event|1|||
126732034|NCT02815293|455968423|FG002|Overall Study|Adverse Event|0|||
126732035|NCT00006604|455968426|FG000|Overall Study|Met study objective - no further FU|1|||
126732036|NCT00006604|455968427|FG001|Overall Study|Met study objective - no further FU|0|||
126732037|NCT00006604|455968428|FG002|Overall Study|Met study objective - no further FU|0|||
126732038|NCT00006604|455968429|FG003|Overall Study|Met study objective - no further FU|0|||
126732039|NCT00006604|455968430|FG004|Overall Study|Met study objective - no further FU|0|||
126732040|NCT00006604|455968431|FG005|Overall Study|Met study objective - no further FU|0|||
126732041|NCT00006604|455968432|FG006|Overall Study|Met study objective - no further FU|0|||
126732042|NCT00006604|455968433|FG007|Overall Study|Met study objective - no further FU|0|||
126732043|NCT00006604|455968434|FG008|Overall Study|Met study objective - no further FU|0|||
126732044|NCT00006604|455968435|FG009|Overall Study|Met study objective - no further FU|0|||
126732045|NCT00006604|455968436|FG010|Overall Study|Met study objective - no further FU|0|||
126732046|NCT00006604|455968437|FG011|Overall Study|Met study objective - no further FU|0|||
126732047|NCT00006604|455968438|FG012|Overall Study|Met study objective - no further FU|0|||
126732048|NCT00006604|455968439|FG013|Overall Study|Met study objective - no further FU|0|||
126732049|NCT00006604|455968440|FG014|Overall Study|Met study objective - no further FU|1|||
126732050|NCT00006604|455968441|FG015|Overall Study|Met study objective - no further FU|1|||
126732051|NCT00006604|455968442|FG016|Overall Study|Met study objective - no further FU|0|||
126732052|NCT00006604|455968426|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
126732053|NCT00006604|455968427|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
126732054|NCT00006604|455968428|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
126732055|NCT00006604|455968429|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
126732056|NCT00006604|455968430|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
126732057|NCT00006604|455968431|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
126732058|NCT00006604|455968432|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
126732059|NCT00006604|455968433|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
126732060|NCT00006604|455968434|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
126732061|NCT00006604|455968435|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
126732062|NCT00006604|455968436|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
126732063|NCT00006604|455968437|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
126732064|NCT00006604|455968438|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
126732065|NCT00006604|455968439|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
126732066|NCT00006604|455968440|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
126732067|NCT00006604|455968441|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
126732068|NCT00006604|455968442|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
126732069|NCT00006604|455968426|FG000|Overall Study|Death|0|||
126732070|NCT00006604|455968427|FG001|Overall Study|Death|0|||
126732071|NCT00006604|455968428|FG002|Overall Study|Death|0|||
126732072|NCT00006604|455968429|FG003|Overall Study|Death|0|||
126732073|NCT00006604|455968430|FG004|Overall Study|Death|0|||
126732074|NCT00006604|455968431|FG005|Overall Study|Death|0|||
126732075|NCT00006604|455968432|FG006|Overall Study|Death|0|||
126732076|NCT00006604|455968433|FG007|Overall Study|Death|0|||
126732077|NCT00006604|455968434|FG008|Overall Study|Death|0|||
126732078|NCT00006604|455968435|FG009|Overall Study|Death|1|||
126732079|NCT00006604|455968436|FG010|Overall Study|Death|1|||
126732080|NCT00006604|455968437|FG011|Overall Study|Death|1|||
126732081|NCT00006604|455968438|FG012|Overall Study|Death|0|||
126732082|NCT00006604|455968439|FG013|Overall Study|Death|0|||
126732083|NCT00006604|455968440|FG014|Overall Study|Death|0|||
126732084|NCT00006604|455968441|FG015|Overall Study|Death|0|||
126732085|NCT00006604|455968442|FG016|Overall Study|Death|0|||
126732086|NCT00006604|455968426|FG000|Overall Study|Severe debilitation, unable to continue|0|||
126732087|NCT00006604|455968427|FG001|Overall Study|Severe debilitation, unable to continue|0|||
126732088|NCT00006604|455968428|FG002|Overall Study|Severe debilitation, unable to continue|0|||
126732089|NCT00006604|455968429|FG003|Overall Study|Severe debilitation, unable to continue|0|||
126732090|NCT00006604|455968430|FG004|Overall Study|Severe debilitation, unable to continue|0|||
126732091|NCT00006604|455968431|FG005|Overall Study|Severe debilitation, unable to continue|0|||
126732092|NCT00006604|455968432|FG006|Overall Study|Severe debilitation, unable to continue|3|||
126732093|NCT00006604|455968433|FG007|Overall Study|Severe debilitation, unable to continue|0|||
126732094|NCT00006604|455968434|FG008|Overall Study|Severe debilitation, unable to continue|0|||
126778568|NCT01361607|456144997|FG001|Overall Study|Met Withdrawal Criteria|1|||
126778569|NCT01809314|456144998|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
126778570|NCT01809314|456144998|FG000|Overall Study|Adverse Event|6|||
126778571|NCT01809314|456144998|FG000|Overall Study|Insufficient Therapeutic Response|14|||
126778572|NCT01809314|456144998|FG000|Overall Study|Lost to Follow-up|724|||
126593440|NCT04171141|455474013|FG014|Overall Study|Withdrawal by Subject|0|||
126593441|NCT04171141|455474014|FG015|Overall Study|Withdrawal by Subject|0|||
126593442|NCT04171141|455473999|FG000|Overall Study|Global deterioration of health status|0|||
126593443|NCT04171141|455474000|FG001|Overall Study|Global deterioration of health status|0|||
126593444|NCT04171141|455474001|FG002|Overall Study|Global deterioration of health status|0|||
126593445|NCT04171141|455474002|FG003|Overall Study|Global deterioration of health status|1|||
126593446|NCT04171141|455474003|FG004|Overall Study|Global deterioration of health status|0|||
126593447|NCT04171141|455474004|FG005|Overall Study|Global deterioration of health status|2|||
126593448|NCT04171141|455474005|FG006|Overall Study|Global deterioration of health status|1|||
126593449|NCT04171141|455474006|FG007|Overall Study|Global deterioration of health status|0|||
126593450|NCT04171141|455474007|FG008|Overall Study|Global deterioration of health status|1|||
126593451|NCT04171141|455474008|FG009|Overall Study|Global deterioration of health status|0|||
126593452|NCT04171141|455474009|FG010|Overall Study|Global deterioration of health status|0|||
126593453|NCT04171141|455474010|FG011|Overall Study|Global deterioration of health status|0|||
126593454|NCT04171141|455474011|FG012|Overall Study|Global deterioration of health status|0|||
126593455|NCT04171141|455474012|FG013|Overall Study|Global deterioration of health status|0|||
126593456|NCT04171141|455474013|FG014|Overall Study|Global deterioration of health status|1|||
126593457|NCT04171141|455474014|FG015|Overall Study|Global deterioration of health status|1|||
126593458|NCT04858451|455474017|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
126593459|NCT04858451|455474018|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126593460|NCT04858451|455474019|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126593461|NCT04858451|455474020|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126593462|NCT04858451|455474021|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126593463|NCT04858451|455474022|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126593464|NCT04858451|455474023|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126593465|NCT04858451|455474024|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126593466|NCT04858451|455474025|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
126593467|NCT04858451|455474017|FG000|Part 2|Discontinued|0|||
126593468|NCT04858451|455474018|FG001|Part 2|Discontinued|0|||
126593469|NCT04858451|455474019|FG002|Part 2|Discontinued|0|||
126593470|NCT04858451|455474020|FG003|Part 2|Discontinued|0|||
126593471|NCT04858451|455474021|FG004|Part 2|Discontinued|0|||
126593472|NCT04858451|455474022|FG005|Part 2|Discontinued|0|||
126593473|NCT04858451|455474023|FG006|Part 2|Discontinued|0|||
126593474|NCT04858451|455474024|FG007|Part 2|Discontinued|0|||
126593475|NCT04858451|455474025|FG008|Part 2|Discontinued|63|||
126593476|NCT03314454|455474026|FG000|Overall Study|Protocol Violation|1|||
126593477|NCT04233216|455474028|FG000|Overall Study|Lost to Follow-up|1|||
126593478|NCT04233216|455474029|FG001|Overall Study|Lost to Follow-up|0|||
126593479|NCT04233216|455474030|FG002|Overall Study|Lost to Follow-up|2|||
126593480|NCT04233216|455474031|FG003|Overall Study|Lost to Follow-up|0|||
126593481|NCT04233216|455474028|FG000|Overall Study|Physician Decision|0|||
126593482|NCT04233216|455474029|FG001|Overall Study|Physician Decision|3|||
126593483|NCT04233216|455474030|FG002|Overall Study|Physician Decision|0|||
126593484|NCT04233216|455474031|FG003|Overall Study|Physician Decision|2|||
126593485|NCT04233216|455474028|FG000|Overall Study|Withdrawal by Subject|0|||
126593486|NCT04233216|455474029|FG001|Overall Study|Withdrawal by Subject|2|||
126593487|NCT04233216|455474030|FG002|Overall Study|Withdrawal by Subject|1|||
126593488|NCT04233216|455474031|FG003|Overall Study|Withdrawal by Subject|0|||
126593489|NCT03652389|455474032|FG000|Overall Study|Lost to Follow-up|1|||
126593490|NCT03652389|455474033|FG001|Overall Study|Lost to Follow-up|5|||
126593491|NCT03652389|455474032|FG000|Overall Study|Withdrawal by Subject|5|||
126593492|NCT03652389|455474033|FG001|Overall Study|Withdrawal by Subject|1|||
126593493|NCT03652389|455474032|FG000|Overall Study|New diagnosis|2|||
126593494|NCT03652389|455474033|FG001|Overall Study|New diagnosis|0|||
126593495|NCT05034328|455474037|FG000|Overall Study|Protocol Violation|1|||
126593496|NCT05034328|455474038|FG001|Overall Study|Protocol Violation|0|||
126593497|NCT05034328|455474037|FG000|Overall Study|Lost to Follow-up|0|||
126593498|NCT05034328|455474038|FG001|Overall Study|Lost to Follow-up|10|||
126593499|NCT03625167|455474041|FG000|Overall Study|Protocol Violation|5|||
126593500|NCT02969707|455474044|FG000|Overall Study|Withdrawal by Subject|6|||
126593501|NCT02969707|455474045|FG001|Overall Study|Withdrawal by Subject|5|||
126593502|NCT02969707|455474044|FG000|Overall Study|Severe anxiety|0|||
126593503|NCT02969707|455474045|FG001|Overall Study|Severe anxiety|1|||
126593504|NCT02969707|455474044|FG000|Overall Study|Positive toxicology screen|0|||
126593505|NCT02969707|455474045|FG001|Overall Study|Positive toxicology screen|2|||
126593506|NCT02969707|455474044|FG000|Overall Study|Claustrophobia|2|||
126593507|NCT02969707|455474045|FG001|Overall Study|Claustrophobia|2|||
126593508|NCT02969707|455474044|FG000|Overall Study|Non-compliance|1|||
126593509|NCT02969707|455474045|FG001|Overall Study|Non-compliance|2|||
126593510|NCT04314713|455474046|FG000|Overall Study|Lost to Follow-up|0|||
126593511|NCT04314713|455474047|FG001|Overall Study|Lost to Follow-up|0|||
126593512|NCT04314713|455474048|FG002|Overall Study|Lost to Follow-up|0|||
126593513|NCT04314713|455474049|FG003|Overall Study|Lost to Follow-up|1|||
126593514|NCT04314713|455474050|FG004|Overall Study|Lost to Follow-up|0|||
126593515|NCT04314713|455474051|FG005|Overall Study|Lost to Follow-up|0|||
126593516|NCT00248287|455474056|FG000|Overall Study|Adverse Event|11|||
126593517|NCT00248287|455474057|FG001|Overall Study|Adverse Event|10|||
126593518|NCT00248287|455474056|FG000|Overall Study|Death|1|||
126593519|NCT00248287|455474057|FG001|Overall Study|Death|0|||
126593520|NCT00248287|455474056|FG000|Overall Study|Lost to Follow-up|0|||
126593521|NCT00248287|455474057|FG001|Overall Study|Lost to Follow-up|1|||
126593522|NCT00248287|455474056|FG000|Overall Study|Investigator Request|4|||
126593523|NCT00248287|455474057|FG001|Overall Study|Investigator Request|3|||
126593524|NCT00248287|455474056|FG000|Overall Study|Patient Request|5|||
126593525|NCT00248287|455474057|FG001|Overall Study|Patient Request|3|||
126593526|NCT00248287|455474056|FG000|Overall Study|Other|3|||
126593527|NCT00248287|455474057|FG001|Overall Study|Other|2|||
126593528|NCT03766685|455474077|FG000|Overall Study|Lost to Follow-up|1|||
126593529|NCT03766685|455474078|FG001|Overall Study|Lost to Follow-up|1|||
126593530|NCT03766685|455474079|FG002|Overall Study|Lost to Follow-up|0|||
126593531|NCT03766685|455474080|FG003|Overall Study|Lost to Follow-up|0|||
126593532|NCT03766685|455474077|FG000|Overall Study|Adverse Event, not fatal|0|||
126593533|NCT03766685|455474078|FG001|Overall Study|Adverse Event, not fatal|1|||
126593534|NCT03766685|455474079|FG002|Overall Study|Adverse Event, not fatal|0|||
126593535|NCT03766685|455474080|FG003|Overall Study|Adverse Event, not fatal|1|||
126593536|NCT03766685|455474077|FG000|Overall Study|Withdrawal by Subject|0|||
126593537|NCT03766685|455474078|FG001|Overall Study|Withdrawal by Subject|2|||
126593538|NCT03766685|455474079|FG002|Overall Study|Withdrawal by Subject|0|||
126593539|NCT03766685|455474080|FG003|Overall Study|Withdrawal by Subject|0|||
126593540|NCT03766685|455474077|FG000|Overall Study|Protocol Violation|0|||
126593541|NCT03766685|455474078|FG001|Overall Study|Protocol Violation|1|||
126593542|NCT03766685|455474079|FG002|Overall Study|Protocol Violation|0|||
126593543|NCT03766685|455474080|FG003|Overall Study|Protocol Violation|0|||
126593544|NCT03766685|455474077|FG000|Overall Study|Non-compliance|0|||
126593545|NCT03766685|455474078|FG001|Overall Study|Non-compliance|2|||
126593546|NCT03766685|455474079|FG002|Overall Study|Non-compliance|0|||
126593547|NCT03766685|455474080|FG003|Overall Study|Non-compliance|0|||
126593548|NCT05297565|455474083|FG000|Overall Study|Other Reasons|0|||
126593549|NCT05297565|455474084|FG001|Overall Study|Other Reasons|1|||
126593550|NCT05297565|455474083|FG000|Overall Study|Physician Decision|0|||
126593551|NCT05297565|455474084|FG001|Overall Study|Physician Decision|1|||
126593552|NCT05297565|455474083|FG000|Overall Study|Disease recurrence|1|||
126593553|NCT05297565|455474084|FG001|Overall Study|Disease recurrence|0|||
126593554|NCT05940194|455474104|FG000|Overall Study|Adverse Event|0|||
126593555|NCT05940194|455474105|FG001|Overall Study|Adverse Event|1|||
126593556|NCT05940194|455474106|FG002|Overall Study|Adverse Event|0|||
126593557|NCT05940194|455474104|FG000|Overall Study|Migrated/Moved from the study area|2|||
126593558|NCT05940194|455474105|FG001|Overall Study|Migrated/Moved from the study area|2|||
126593559|NCT05940194|455474106|FG002|Overall Study|Migrated/Moved from the study area|4|||
126593560|NCT03085810|455474107|FG000|Main Study|Withdrawal by Subject|77|||
126593561|NCT03085810|455474108|FG001|Main Study|Withdrawal by Subject|0|||
126593562|NCT03085810|455474109|FG002|Main Study|Withdrawal by Subject|0|||
126593563|NCT03085810|455474107|FG000|Main Study|Terminated By Sponsor|14|||
126593564|NCT03085810|455474108|FG001|Main Study|Terminated By Sponsor|0|||
126593565|NCT03085810|455474109|FG002|Main Study|Terminated By Sponsor|0|||
126593566|NCT03085810|455474107|FG000|Main Study|Protocol Violation|15|||
126593567|NCT03085810|455474108|FG001|Main Study|Protocol Violation|0|||
126593568|NCT03085810|455474109|FG002|Main Study|Protocol Violation|0|||
126593569|NCT03085810|455474107|FG000|Main Study|Physician Decision|13|||
126593570|NCT03085810|455474108|FG001|Main Study|Physician Decision|0|||
126593571|NCT03085810|455474109|FG002|Main Study|Physician Decision|0|||
126593572|NCT03085810|455474107|FG000|Main Study|Lost to Follow-up|17|||
126593573|NCT03085810|455474108|FG001|Main Study|Lost to Follow-up|0|||
126593574|NCT03085810|455474109|FG002|Main Study|Lost to Follow-up|0|||
126593575|NCT03085810|455474107|FG000|Main Study|Adverse Event|25|||
126593576|NCT03085810|455474108|FG001|Main Study|Adverse Event|0|||
126593577|NCT03085810|455474109|FG002|Main Study|Adverse Event|0|||
126593578|NCT03085810|455474107|FG000|Main Study|Pregnancy|7|||
126593579|NCT03085810|455474108|FG001|Main Study|Pregnancy|0|||
126593580|NCT03085810|455474109|FG002|Main Study|Pregnancy|0|||
126593581|NCT03085810|455474107|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
126593582|NCT03085810|455474108|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
126593583|NCT03085810|455474109|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
126593584|NCT03085810|455474107|FG000|Main Study|Lack of Efficacy|10|||
126593585|NCT03085810|455474108|FG001|Main Study|Lack of Efficacy|0|||
126593586|NCT03085810|455474109|FG002|Main Study|Lack of Efficacy|0|||
126593587|NCT03085810|455474107|FG000|Main Study|Death|12|||
126593588|NCT03085810|455474108|FG001|Main Study|Death|0|||
126593589|NCT03085810|455474109|FG002|Main Study|Death|0|||
126593590|NCT03085810|455474107|FG000|Main Study|Disease progression|1|||
126593591|NCT03085810|455474108|FG001|Main Study|Disease progression|0|||
126593592|NCT03085810|455474109|FG002|Main Study|Disease progression|0|||
126593593|NCT03085810|455474107|FG000|Main Study|Site Closure|3|||
126593594|NCT03085810|455474108|FG001|Main Study|Site Closure|0|||
126593595|NCT03085810|455474109|FG002|Main Study|Site Closure|0|||
126593596|NCT03085810|455474107|FG000|Main Study|Planned pregnancy|17|||
126593597|NCT03085810|455474108|FG001|Main Study|Planned pregnancy|0|||
126593598|NCT03085810|455474109|FG002|Main Study|Planned pregnancy|0|||
126593599|NCT03085810|455474107|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
126593600|NCT03085810|455474108|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
126593601|NCT03085810|455474109|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
126593602|NCT03085810|455474107|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
126593603|NCT03085810|455474108|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
126593604|NCT03085810|455474109|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
126593605|NCT03085810|455474107|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
126593606|NCT03085810|455474108|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
126593607|NCT03085810|455474109|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
126593608|NCT03085810|455474107|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
126593609|NCT03085810|455474108|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
126593610|NCT03085810|455474109|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
126593611|NCT01959607|455474110|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
126593612|NCT01959607|455474111|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
126593613|NCT01959607|455474112|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
126593614|NCT01959607|455474113|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
126593615|NCT03235544|455474119|FG000|Overall Study|Death|11|||
126593616|NCT03235544|455474120|FG001|Overall Study|Death|31|||
126593617|NCT03235544|455474121|FG002|Overall Study|Death|19|||
126593618|NCT03235544|455474122|FG003|Overall Study|Death|34|||
126593619|NCT03235544|455474119|FG000|Overall Study|Lost to Follow-up|0|||
126593620|NCT03235544|455474120|FG001|Overall Study|Lost to Follow-up|1|||
126593621|NCT03235544|455474121|FG002|Overall Study|Lost to Follow-up|1|||
126593622|NCT03235544|455474122|FG003|Overall Study|Lost to Follow-up|1|||
126593623|NCT03235544|455474119|FG000|Overall Study|Withdrawal by Subject|0|||
126593624|NCT03235544|455474120|FG001|Overall Study|Withdrawal by Subject|3|||
126593625|NCT03235544|455474121|FG002|Overall Study|Withdrawal by Subject|1|||
126593626|NCT03235544|455474122|FG003|Overall Study|Withdrawal by Subject|5|||
126593627|NCT03235544|455474119|FG000|Overall Study|Disease Progression|0|||
126593628|NCT03235544|455474120|FG001|Overall Study|Disease Progression|1|||
126593629|NCT03235544|455474121|FG002|Overall Study|Disease Progression|0|||
126593630|NCT03235544|455474122|FG003|Overall Study|Disease Progression|2|||
126593631|NCT03235544|455474119|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
126593632|NCT03235544|455474120|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
126593633|NCT03235544|455474121|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
126593634|NCT03235544|455474122|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
126593635|NCT03235544|455474119|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
126593636|NCT03235544|455474120|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
126593637|NCT03235544|455474121|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
126593638|NCT03235544|455474122|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
126593639|NCT01456949|455474123|FG000|Enrollment|PI death- incomplete data|6|||
126593640|NCT01456949|455474123|FG000|Enrollment|Death|1|||
126593641|NCT01456949|455474123|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
126593642|NCT01456949|455474123|FG000|Enrollment|Physician Decision|10|||
126593643|NCT01456949|455474123|FG000|Enrollment|Withdrawal by Subject|7|||
126593644|NCT01456949|455474123|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
126593645|NCT01456949|455474123|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
126732095|NCT00006604|455968435|FG009|Overall Study|Severe debilitation, unable to continue|5|||
126732096|NCT00006604|455968436|FG010|Overall Study|Severe debilitation, unable to continue|0|||
126732097|NCT00006604|455968437|FG011|Overall Study|Severe debilitation, unable to continue|2|||
126732098|NCT00006604|455968438|FG012|Overall Study|Severe debilitation, unable to continue|1|||
126732099|NCT00006604|455968439|FG013|Overall Study|Severe debilitation, unable to continue|0|||
126732100|NCT00006604|455968440|FG014|Overall Study|Severe debilitation, unable to continue|2|||
126732101|NCT00006604|455968441|FG015|Overall Study|Severe debilitation, unable to continue|0|||
126593646|NCT01456949|455474123|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
126593647|NCT01456949|455474123|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
126593648|NCT01456949|455474123|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
126593649|NCT01456949|455474123|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
126593650|NCT01456949|455474123|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
126593651|NCT01456949|455474123|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
126732102|NCT00006604|455968442|FG016|Overall Study|Severe debilitation, unable to continue|0|||
126732103|NCT00006604|455968426|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
126732104|NCT00006604|455968427|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
126593652|NCT03701763|455474124|FG000|Placebo-controlled Phase|Adverse Event|1|||
126593653|NCT03701763|455474125|FG001|Placebo-controlled Phase|Adverse Event|5|||
126593654|NCT03701763|455474126|FG002|Placebo-controlled Phase|Adverse Event|0|||
126593655|NCT03701763|455474127|FG003|Placebo-controlled Phase|Adverse Event|0|||
126593656|NCT03701763|455474124|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
126593657|NCT03701763|455474125|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
126593658|NCT03701763|455474126|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
126593659|NCT03701763|455474127|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
126593660|NCT03701763|455474124|FG000|Placebo-controlled Phase|Miscellaneous|2|||
126593661|NCT03701763|455474125|FG001|Placebo-controlled Phase|Miscellaneous|0|||
126593662|NCT03701763|455474126|FG002|Placebo-controlled Phase|Miscellaneous|0|||
126593663|NCT03701763|455474127|FG003|Placebo-controlled Phase|Miscellaneous|0|||
126593664|NCT03701763|455474124|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
126593665|NCT03701763|455474125|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
126593666|NCT03701763|455474126|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
126593667|NCT03701763|455474127|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
126593668|NCT03701763|455474124|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
126593669|NCT03701763|455474125|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
126593670|NCT03701763|455474126|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
126593671|NCT03701763|455474127|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
126593672|NCT03701763|455474124|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
126593673|NCT03701763|455474125|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
126593674|NCT03701763|455474126|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
126593675|NCT03701763|455474127|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
126593676|NCT03701763|455474124|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
126593677|NCT03701763|455474125|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
126593678|NCT03701763|455474126|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
126593679|NCT03701763|455474127|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
126593680|NCT03701763|455474124|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
126593681|NCT03701763|455474125|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
126593682|NCT03701763|455474126|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
126593683|NCT03701763|455474127|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
126593684|NCT03701763|455474124|FG000|Apremilast Extension Phase|Adverse Event|0|||
126593685|NCT03701763|455474125|FG001|Apremilast Extension Phase|Adverse Event|0|||
126593686|NCT03701763|455474126|FG002|Apremilast Extension Phase|Adverse Event|3|||
126593687|NCT03701763|455474127|FG003|Apremilast Extension Phase|Adverse Event|1|||
126593688|NCT03701763|455474124|FG000|Apremilast Extension Phase|Miscellaneous|0|||
126593689|NCT03701763|455474125|FG001|Apremilast Extension Phase|Miscellaneous|0|||
126593690|NCT03701763|455474126|FG002|Apremilast Extension Phase|Miscellaneous|2|||
126593691|NCT03701763|455474127|FG003|Apremilast Extension Phase|Miscellaneous|1|||
126593692|NCT03701763|455474124|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
126593693|NCT03701763|455474125|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
126593694|NCT03701763|455474126|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
126593695|NCT03701763|455474127|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
126593696|NCT03701763|455474124|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
126593697|NCT03701763|455474125|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
126593698|NCT03701763|455474126|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
126593699|NCT03701763|455474127|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
126593700|NCT03701763|455474124|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
126593701|NCT03701763|455474125|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
126593702|NCT03701763|455474126|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
126593703|NCT03701763|455474127|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
126593704|NCT03701763|455474124|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
126593705|NCT03701763|455474125|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
126593706|NCT03701763|455474126|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
126593707|NCT03701763|455474127|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
126593708|NCT03701763|455474124|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
126593709|NCT03701763|455474125|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
126593710|NCT03701763|455474126|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
126593711|NCT03701763|455474127|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
126593712|NCT03701763|455474124|FG000|14-Week Observational Follow-up Phase|Other|0|||
126593713|NCT03701763|455474125|FG001|14-Week Observational Follow-up Phase|Other|0|||
126593714|NCT03701763|455474126|FG002|14-Week Observational Follow-up Phase|Other|1|||
126732105|NCT00006604|455968428|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
126732106|NCT00006604|455968429|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
126593715|NCT03701763|455474127|FG003|14-Week Observational Follow-up Phase|Other|0|||
126732107|NCT00006604|455968430|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
126593716|NCT03701763|455474124|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
126593717|NCT03701763|455474125|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
126593718|NCT03701763|455474126|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
126593719|NCT03701763|455474127|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
126593720|NCT03701763|455474124|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
126593721|NCT03701763|455474125|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
126593722|NCT03701763|455474126|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
126593723|NCT03701763|455474127|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
126593724|NCT03785964|455474129|FG000|Overall Study|Adverse Event|14|||
126593725|NCT03785964|455474130|FG001|Overall Study|Adverse Event|1|||
126593726|NCT03785964|455474129|FG000|Overall Study|Unqualified Clinical Progression|1|||
126593727|NCT03785964|455474130|FG001|Overall Study|Unqualified Clinical Progression|1|||
126593728|NCT03785964|455474129|FG000|Overall Study|Participant non-compliance|1|||
126593729|NCT03785964|455474130|FG001|Overall Study|Participant non-compliance|1|||
126593730|NCT03785964|455474129|FG000|Overall Study|Not treated|1|||
126593731|NCT03785964|455474130|FG001|Overall Study|Not treated|0|||
126593732|NCT03785964|455474129|FG000|Overall Study|Other reason|5|||
126593733|NCT03785964|455474130|FG001|Overall Study|Other reason|11|||
126593734|NCT03785964|455474129|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
126593735|NCT03785964|455474130|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
126593736|NCT04117347|455474131|FG000|Overall Study|Adverse Event|0|||
126593737|NCT04117347|455474132|FG001|Overall Study|Adverse Event|0|||
126593738|NCT04117347|455474133|FG002|Overall Study|Adverse Event|1|||
126593739|NCT04117347|455474131|FG000|Overall Study|No time for study|0|||
126593740|NCT04117347|455474132|FG001|Overall Study|No time for study|2|||
126593741|NCT04117347|455474133|FG002|Overall Study|No time for study|0|||
126593742|NCT04117347|455474131|FG000|Overall Study|Family emergency|1|||
126593743|NCT04117347|455474132|FG001|Overall Study|Family emergency|0|||
126593744|NCT04117347|455474133|FG002|Overall Study|Family emergency|0|||
126593745|NCT02505984|455474134|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
126593746|NCT02505984|455474135|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
126593747|NCT02505984|455474134|FG000|Overall Study|Unreliable self-report data|1|||
126593748|NCT02505984|455474135|FG001|Overall Study|Unreliable self-report data|0|||
126593749|NCT02505984|455474134|FG000|Overall Study|Study blind opened during assessment|0|||
126593750|NCT02505984|455474135|FG001|Overall Study|Study blind opened during assessment|1|||
126593751|NCT02505984|455474134|FG000|Overall Study|Noncompliance with study protocol|0|||
126593752|NCT02505984|455474135|FG001|Overall Study|Noncompliance with study protocol|1|||
126593753|NCT05194956|455474136|FG000|Washout Period|Withdrawal by Subject|0|||
126593754|NCT05194956|455474137|FG001|Washout Period|Withdrawal by Subject|2|||
126593755|NCT03687086|455474138|FG000|Overall Study|Withdrawal by Subject|3|||
126593756|NCT03687086|455474139|FG001|Overall Study|Withdrawal by Subject|4|||
126593757|NCT03687086|455474138|FG000|Overall Study|Lost to Follow-up|1|||
126593758|NCT03687086|455474139|FG001|Overall Study|Lost to Follow-up|1|||
126593759|NCT03687086|455474138|FG000|Overall Study|Death|1|||
126593760|NCT03687086|455474139|FG001|Overall Study|Death|0|||
126593761|NCT03687086|455474138|FG000|Overall Study|Incomplete assessment|0|||
126593762|NCT03687086|455474139|FG001|Overall Study|Incomplete assessment|2|||
126593763|NCT04201262|455474140|FG000|Overall Study|Adverse Event|1|||
126593764|NCT04201262|455474141|FG001|Overall Study|Adverse Event|2|||
126593765|NCT04201262|455474140|FG000|Overall Study|Continuing in the study|57|||
126593766|NCT04201262|455474141|FG001|Overall Study|Continuing in the study|0|||
126593767|NCT04201262|455474140|FG000|Overall Study|Withdrawal by Subject|0|||
126593768|NCT04201262|455474141|FG001|Overall Study|Withdrawal by Subject|1|||
126593769|NCT05446168|455474142|FG000|Overall Study|Physician Decision|0|||
126593770|NCT05446168|455474143|FG001|Overall Study|Physician Decision|1|||
126593771|NCT03511664|455474145|FG000|Overall Study|Death|457|||
126593772|NCT03511664|455474146|FG001|Overall Study|Death|201|||
126593773|NCT03511664|455474147|FG002|Overall Study|Death|21|||
126593774|NCT03511664|455474145|FG000|Overall Study|Withdrew consent|40|||
126593775|NCT03511664|455474146|FG001|Overall Study|Withdrew consent|63|||
126593776|NCT03511664|455474147|FG002|Overall Study|Withdrew consent|3|||
126593777|NCT03511664|455474145|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
126593778|NCT03511664|455474146|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
126593779|NCT03511664|455474147|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
126593780|NCT03511664|455474145|FG000|Overall Study|Lost to Follow-up|8|||
126593781|NCT03511664|455474146|FG001|Overall Study|Lost to Follow-up|5|||
126593782|NCT03511664|455474147|FG002|Overall Study|Lost to Follow-up|0|||
126593783|NCT03511664|455474145|FG000|Overall Study|Physician Decision|2|||
126593784|NCT03511664|455474146|FG001|Overall Study|Physician Decision|1|||
126593785|NCT03511664|455474147|FG002|Overall Study|Physician Decision|0|||
126593786|NCT03511664|455474145|FG000|Overall Study|Patient non-compliance|1|||
126593787|NCT03511664|455474146|FG001|Overall Study|Patient non-compliance|0|||
126593788|NCT03511664|455474147|FG002|Overall Study|Patient non-compliance|0|||
126593789|NCT02823145|455474148|FG000|Enrollment|Other|1|||
126593790|NCT02823145|455474149|FG001|Enrollment|Other|0|||
126593791|NCT02823145|455474148|FG000|Treatment|Adverse Event|0|||
126593792|NCT02823145|455474149|FG001|Treatment|Adverse Event|11|||
126593793|NCT02823145|455474148|FG000|Treatment|Death|0|||
126593794|NCT02823145|455474149|FG001|Treatment|Death|3|||
126593795|NCT02823145|455474148|FG000|Treatment|Family Decision|0|||
126593796|NCT02823145|455474149|FG001|Treatment|Family Decision|1|||
126593797|NCT02823145|455474148|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
126593798|NCT02823145|455474149|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
126593799|NCT02823145|455474148|FG000|Treatment|Lack of Efficacy|0|||
126593800|NCT02823145|455474149|FG001|Treatment|Lack of Efficacy|48|||
126593801|NCT02823145|455474148|FG000|Treatment|Non-Compliance With E-Diary|0|||
126593802|NCT02823145|455474149|FG001|Treatment|Non-Compliance With E-Diary|1|||
126593803|NCT02823145|455474148|FG000|Treatment|Physician Decision|0|||
126593804|NCT02823145|455474149|FG001|Treatment|Physician Decision|2|||
126593805|NCT02823145|455474148|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
126593806|NCT02823145|455474149|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
126593807|NCT02823145|455474148|FG000|Treatment|Subject needed to take prohibited medication|0|||
126593808|NCT02823145|455474149|FG001|Treatment|Subject needed to take prohibited medication|1|||
126593809|NCT02823145|455474148|FG000|Treatment|Subject transferred to direct access programme|0|||
126593810|NCT02823145|455474149|FG001|Treatment|Subject transferred to direct access programme|1|||
126593811|NCT02823145|455474148|FG000|Treatment|Switching to commercially available drug|0|||
126593812|NCT02823145|455474149|FG001|Treatment|Switching to commercially available drug|11|||
126593813|NCT02823145|455474148|FG000|Treatment|Transitioned to commercial supply of medication|0|||
126593814|NCT02823145|455474149|FG001|Treatment|Transitioned to commercial supply of medication|1|||
126593815|NCT02823145|455474148|FG000|Treatment|Withdrawal By Caregiver|0|||
126593816|NCT02823145|455474149|FG001|Treatment|Withdrawal By Caregiver|1|||
126593817|NCT02823145|455474148|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
126593818|NCT02823145|455474149|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
126593819|NCT02823145|455474148|FG000|Treatment|Withdrawal by Subject|0|||
126593820|NCT02823145|455474149|FG001|Treatment|Withdrawal by Subject|16|||
126593821|NCT02823145|455474148|FG000|Treatment|Reason unknown|0|||
126593822|NCT02823145|455474149|FG001|Treatment|Reason unknown|1|||
126593823|NCT05292391|455474150|FG000|Overall Study|Lost to Follow-up|0|||
126593824|NCT05292391|455474151|FG001|Overall Study|Lost to Follow-up|0|||
126593825|NCT05292391|455474152|FG002|Overall Study|Lost to Follow-up|0|||
126593826|NCT05292391|455474153|FG003|Overall Study|Lost to Follow-up|1|||
126593827|NCT05292391|455474154|FG004|Overall Study|Lost to Follow-up|0|||
126593828|NCT04857723|455474155|FG000|Overall Study|Withdrawal by Subject|2|||
126593829|NCT02276885|455475606|FG000|Overall Study|Withdrawal by Subject|2|||
126593830|NCT02276885|455475607|FG001|Overall Study|Withdrawal by Subject|0|||
126593831|NCT02276885|455475606|FG000|Overall Study|Lost to Follow-up|5|||
126593832|NCT02276885|455475607|FG001|Overall Study|Lost to Follow-up|2|||
126593833|NCT04979442|455475611|FG000|Overall Study|Death|43|||
126593834|NCT04979442|455475612|FG001|Overall Study|Death|30|||
126593835|NCT04979442|455475611|FG000|Overall Study|Withdrawal by Subject|8|||
126593836|NCT04979442|455475612|FG001|Overall Study|Withdrawal by Subject|13|||
126593837|NCT04979442|455475611|FG000|Overall Study|Physician Decision|1|||
126593838|NCT04979442|455475612|FG001|Overall Study|Physician Decision|1|||
126593839|NCT04979442|455475611|FG000|Overall Study|Lost to Follow-up|0|||
126593840|NCT04979442|455475612|FG001|Overall Study|Lost to Follow-up|2|||
126593841|NCT04979442|455475611|FG000|Overall Study|do not want to continue|0|||
126593842|NCT04979442|455475612|FG001|Overall Study|do not want to continue|1|||
126593843|NCT02427464|455475615|FG000|Overall Study|Adverse Event|6|||
126593844|NCT02427464|455475616|FG001|Overall Study|Adverse Event|1|||
126593845|NCT02427464|455475615|FG000|Overall Study|Lost to Follow-up|16|||
126593846|NCT02427464|455475616|FG001|Overall Study|Lost to Follow-up|5|||
126593847|NCT02427464|455475615|FG000|Overall Study|Physician Decision|2|||
126593848|NCT02427464|455475616|FG001|Overall Study|Physician Decision|0|||
126593849|NCT02427464|455475615|FG000|Overall Study|Withdrawal by Subject|10|||
126593850|NCT02427464|455475616|FG001|Overall Study|Withdrawal by Subject|8|||
126778573|NCT01814137|456144999|FG000|Overall Study|Adverse Event|0|||
126593851|NCT02427464|455475615|FG000|Overall Study|Noncompliance|16|||
126593852|NCT02427464|455475616|FG001|Overall Study|Noncompliance|10|||
126593853|NCT02927236|455475617|FG000|Characterization Phase|Physician Decision|0|||
126593854|NCT02927236|455475618|FG001|Characterization Phase|Physician Decision|3|||
126593855|NCT02927236|455475619|FG002|Characterization Phase|Physician Decision|0|||
126593856|NCT02927236|455475620|FG003|Characterization Phase|Physician Decision|2|||
126593857|NCT02927236|455475617|FG000|Characterization Phase|Lost to Follow-up|0|||
126593858|NCT02927236|455475618|FG001|Characterization Phase|Lost to Follow-up|0|||
126593859|NCT02927236|455475619|FG002|Characterization Phase|Lost to Follow-up|0|||
126593860|NCT02927236|455475620|FG003|Characterization Phase|Lost to Follow-up|3|||
126593861|NCT02927236|455475617|FG000|Characterization Phase|Withdrawal by Subject|1|||
126593862|NCT02927236|455475618|FG001|Characterization Phase|Withdrawal by Subject|0|||
126593863|NCT02927236|455475619|FG002|Characterization Phase|Withdrawal by Subject|0|||
126593864|NCT02927236|455475620|FG003|Characterization Phase|Withdrawal by Subject|1|||
126593865|NCT02927236|455475617|FG000|Treatment Phase|Adverse Event|1|||
126593866|NCT02927236|455475618|FG001|Treatment Phase|Adverse Event|0|||
126593867|NCT02927236|455475619|FG002|Treatment Phase|Adverse Event|1|||
126593868|NCT02927236|455475620|FG003|Treatment Phase|Adverse Event|1|||
126593869|NCT02927236|455475617|FG000|Treatment Phase|Protocol Violation|3|||
126593870|NCT02927236|455475618|FG001|Treatment Phase|Protocol Violation|0|||
126593871|NCT02927236|455475619|FG002|Treatment Phase|Protocol Violation|0|||
126593872|NCT02927236|455475620|FG003|Treatment Phase|Protocol Violation|1|||
126593873|NCT02927236|455475617|FG000|Treatment Phase|Lost to Follow-up|1|||
126593874|NCT02927236|455475618|FG001|Treatment Phase|Lost to Follow-up|0|||
126593875|NCT02927236|455475619|FG002|Treatment Phase|Lost to Follow-up|0|||
126593876|NCT02927236|455475620|FG003|Treatment Phase|Lost to Follow-up|0|||
126593877|NCT02927236|455475617|FG000|Follow-up Phase|Lost to Follow-up|1|||
126593878|NCT02927236|455475618|FG001|Follow-up Phase|Lost to Follow-up|0|||
126593879|NCT02927236|455475619|FG002|Follow-up Phase|Lost to Follow-up|1|||
126593880|NCT02927236|455475620|FG003|Follow-up Phase|Lost to Follow-up|0|||
126593881|NCT05496231|455475626|FG000|Overall Study|Adverse Event|1|||
126593882|NCT05496231|455475627|FG001|Overall Study|Adverse Event|1|||
126593883|NCT05496231|455475628|FG002|Overall Study|Adverse Event|0|||
126593884|NCT05496231|455475629|FG003|Overall Study|Adverse Event|4|||
126593885|NCT05496231|455475626|FG000|Overall Study|Withdrawal by Subject|5|||
126593886|NCT05496231|455475627|FG001|Overall Study|Withdrawal by Subject|5|||
126593887|NCT05496231|455475628|FG002|Overall Study|Withdrawal by Subject|4|||
126593888|NCT05496231|455475629|FG003|Overall Study|Withdrawal by Subject|11|||
126593889|NCT05496231|455475626|FG000|Overall Study|Migrated/moved from the study area|3|||
126593890|NCT05496231|455475627|FG001|Overall Study|Migrated/moved from the study area|5|||
126593891|NCT05496231|455475628|FG002|Overall Study|Migrated/moved from the study area|3|||
126593892|NCT05496231|455475629|FG003|Overall Study|Migrated/moved from the study area|3|||
126593893|NCT05496231|455475626|FG000|Overall Study|Lost to Follow-up|13|||
126593894|NCT05496231|455475627|FG001|Overall Study|Lost to Follow-up|6|||
126593895|NCT05496231|455475628|FG002|Overall Study|Lost to Follow-up|11|||
126593896|NCT05496231|455475629|FG003|Overall Study|Lost to Follow-up|6|||
126593897|NCT05496231|455475626|FG000|Overall Study|Other|9|||
126593898|NCT05496231|455475627|FG001|Overall Study|Other|7|||
126593899|NCT05496231|455475628|FG002|Overall Study|Other|7|||
126593900|NCT05496231|455475629|FG003|Overall Study|Other|8|||
126593901|NCT05029622|455475632|FG000|Overall Study|Lost to Follow-up|1|||
126593902|NCT03974178|455475633|FG000|Overall Study|Death|0|||
126593903|NCT03974178|455475634|FG001|Overall Study|Death|1|||
126593904|NCT04508309|455475635|FG000|Overall Study|Death|0|||
126593905|NCT04508309|455475636|FG001|Overall Study|Death|0|||
126593906|NCT04508309|455475637|FG002|Overall Study|Death|0|||
126593907|NCT04508309|455475638|FG003|Overall Study|Death|0|||
126593908|NCT04508309|455475639|FG004|Overall Study|Death|1|||
126593909|NCT04508309|455475635|FG000|Overall Study|Lost to Follow-up|0|||
126593910|NCT04508309|455475636|FG001|Overall Study|Lost to Follow-up|0|||
126593911|NCT04508309|455475637|FG002|Overall Study|Lost to Follow-up|1|||
126593912|NCT04508309|455475638|FG003|Overall Study|Lost to Follow-up|1|||
126593913|NCT04508309|455475639|FG004|Overall Study|Lost to Follow-up|0|||
126593914|NCT04508309|455475635|FG000|Overall Study|Withdrawal by Subject|0|||
126593915|NCT04508309|455475636|FG001|Overall Study|Withdrawal by Subject|0|||
126593916|NCT04508309|455475637|FG002|Overall Study|Withdrawal by Subject|0|||
126593917|NCT04508309|455475638|FG003|Overall Study|Withdrawal by Subject|0|||
126593918|NCT04508309|455475639|FG004|Overall Study|Withdrawal by Subject|1|||
126593919|NCT05526430|455475640|FG000|Overall Study|Withdrawal by Subject|0|||
126593920|NCT05526430|455475641|FG001|Overall Study|Withdrawal by Subject|2|||
126593921|NCT05526430|455475642|FG002|Overall Study|Withdrawal by Subject|0|||
126593922|NCT05526430|455475643|FG003|Overall Study|Withdrawal by Subject|0|||
126593923|NCT05200403|455475649|FG000|Overall Study|Withdrawal by Subject|4|||
126593924|NCT05200403|455475650|FG001|Overall Study|Withdrawal by Subject|2|||
126593925|NCT05200403|455475651|FG002|Overall Study|Withdrawal by Subject|6|||
126593926|NCT05073458|455475653|FG000|24-week Double-blind Period|Adverse Event|1|||
126593927|NCT05073458|455475654|FG001|24-week Double-blind Period|Adverse Event|0|||
126593928|NCT05073458|455475653|FG000|24-week Double-blind Period|Physician Decision|1|||
126593929|NCT05073458|455475654|FG001|24-week Double-blind Period|Physician Decision|0|||
126593930|NCT05073458|455475653|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
126593931|NCT05073458|455475654|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
126593932|NCT05073458|455475653|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
126593933|NCT05073458|455475654|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
126593934|NCT05073458|455475653|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
126593935|NCT05073458|455475654|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
126593936|NCT05073458|455475653|FG000|24-week Open-label Period|Adverse Event|1|||
126593937|NCT05073458|455475654|FG001|24-week Open-label Period|Adverse Event|2|||
126593938|NCT00950742|455475655|FG000|Overall Study|Other Adverse Event|1|||
126593939|NCT00950742|455475656|FG001|Overall Study|Other Adverse Event|0|||
126593940|NCT00950742|455475655|FG000|Overall Study|Withdrawal by Subject|3|||
126593941|NCT00950742|455475656|FG001|Overall Study|Withdrawal by Subject|0|||
126593942|NCT00950742|455475655|FG000|Overall Study|Progressive Disease|6|||
126778574|NCT01814137|456145000|FG001|Overall Study|Adverse Event|1|||
126778575|NCT01814137|456144999|FG000|Overall Study|Withdrawal by Subject|2|||
126778576|NCT01814137|456145000|FG001|Overall Study|Withdrawal by Subject|2|||
126778577|NCT01814137|456144999|FG000|Overall Study|Physician Decision|1|||
126778578|NCT01814137|456145000|FG001|Overall Study|Physician Decision|1|||
126778579|NCT01814137|456144999|FG000|Overall Study|Unclassified|2|||
126778580|NCT01814137|456145000|FG001|Overall Study|Unclassified|1|||
126778581|NCT00219557|456145001|FG000|Phase 1|Lack of Efficacy|3|||
126778582|NCT00219557|456145002|FG001|Phase 1|Lack of Efficacy|0|||
126778583|NCT00219557|456145003|FG002|Phase 1|Lack of Efficacy|0|||
126778584|NCT00219557|456145001|FG000|Phase 1|Adverse Event|2|||
126778585|NCT00219557|456145002|FG001|Phase 1|Adverse Event|0|||
126778586|NCT00219557|456145003|FG002|Phase 1|Adverse Event|0|||
126778587|NCT00219557|456145001|FG000|Phase 1|Withdrawal by Subject|1|||
126778588|NCT00219557|456145002|FG001|Phase 1|Withdrawal by Subject|0|||
126778589|NCT00219557|456145003|FG002|Phase 1|Withdrawal by Subject|0|||
126778590|NCT00219557|456145001|FG000|Phase 1|Started chemotherapy at other institute|1|||
126778591|NCT00219557|456145002|FG001|Phase 1|Started chemotherapy at other institute|0|||
126778592|NCT00219557|456145003|FG002|Phase 1|Started chemotherapy at other institute|0|||
126778593|NCT00219557|456145001|FG000|Phase 2|Lack of Efficacy|0|||
126778594|NCT00219557|456145002|FG001|Phase 2|Lack of Efficacy|21|||
126778595|NCT00219557|456145003|FG002|Phase 2|Lack of Efficacy|15|||
126778596|NCT00219557|456145001|FG000|Phase 2|Adverse Event|0|||
126778597|NCT00219557|456145002|FG001|Phase 2|Adverse Event|22|||
126778598|NCT00219557|456145003|FG002|Phase 2|Adverse Event|2|||
126778599|NCT00219557|456145001|FG000|Phase 2|Death|0|||
126778600|NCT00219557|456145002|FG001|Phase 2|Death|8|||
126778601|NCT00219557|456145003|FG002|Phase 2|Death|2|||
126778602|NCT00219557|456145001|FG000|Phase 2|Other|0|||
126778603|NCT00219557|456145002|FG001|Phase 2|Other|8|||
126778604|NCT00219557|456145003|FG002|Phase 2|Other|6|||
126778605|NCT00219557|456145001|FG000|Phase 2|Withdrawal by Subject|0|||
126778606|NCT00219557|456145002|FG001|Phase 2|Withdrawal by Subject|9|||
126778607|NCT00219557|456145003|FG002|Phase 2|Withdrawal by Subject|5|||
126778608|NCT00219557|456145001|FG000|Phase 2|Treatment not received|0|||
126778609|NCT00219557|456145002|FG001|Phase 2|Treatment not received|1|||
126778610|NCT00219557|456145003|FG002|Phase 2|Treatment not received|3|||
126778611|NCT01427803|456145008|FG000|Overall Study|Lost to Follow-up|32|||
126778612|NCT01427803|456145009|FG001|Overall Study|Lost to Follow-up|26|||
126778613|NCT01427803|456145008|FG000|Overall Study|Withdrawal by Subject|20|||
126778614|NCT01427803|456145009|FG001|Overall Study|Withdrawal by Subject|0|||
126778615|NCT01427803|456145008|FG000|Overall Study|Unable to complete full treatment period|6|||
126778616|NCT01427803|456145009|FG001|Overall Study|Unable to complete full treatment period|0|||
126778617|NCT01427803|456145008|FG000|Overall Study|Protocol Violation|1|||
126778618|NCT01427803|456145009|FG001|Overall Study|Protocol Violation|0|||
126778619|NCT01427803|456145008|FG000|Overall Study|Physician Decision|3|||
126778620|NCT01427803|456145009|FG001|Overall Study|Physician Decision|0|||
126778621|NCT01427803|456145008|FG000|Overall Study|did not take product|1|||
126778622|NCT01427803|456145009|FG001|Overall Study|did not take product|0|||
126778623|NCT02741271|456145014|FG000|Overall Study|Lost to Follow-up|2|||
126778624|NCT02741271|456145015|FG001|Overall Study|Lost to Follow-up|0|||
126778625|NCT02741271|456145014|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126778626|NCT02741271|456145015|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
126778627|NCT01612156|456145016|FG000|Overall Study|Protocol Violation|2|||
126778628|NCT01612156|456145017|FG001|Overall Study|Protocol Violation|0|||
126778629|NCT00410410|456145018|FG000|Induction Period (IP)|Death|1|||
126778630|NCT00410410|456145019|FG001|Induction Period (IP)|Death|0|||
126778631|NCT00410410|456145020|FG002|Induction Period (IP)|Death|0|||
126778632|NCT00410410|456145021|FG003|Induction Period (IP)|Death|0|||
126778633|NCT00410410|456145022|FG004|Induction Period (IP)|Death|0|||
126778634|NCT00410410|456145023|FG005|Induction Period (IP)|Death|0|||
126778635|NCT00410410|456145024|FG006|Induction Period (IP)|Death|0|||
126778636|NCT00410410|456145025|FG007|Induction Period (IP)|Death|0|||
126778637|NCT00410410|456145026|FG008|Induction Period (IP)|Death|0|||
126778638|NCT00410410|456145018|FG000|Induction Period (IP)|Adverse Event|3|||
126778639|NCT00410410|456145019|FG001|Induction Period (IP)|Adverse Event|4|||
126778640|NCT00410410|456145020|FG002|Induction Period (IP)|Adverse Event|2|||
126778641|NCT00410410|456145021|FG003|Induction Period (IP)|Adverse Event|4|||
126778642|NCT00410410|456145022|FG004|Induction Period (IP)|Adverse Event|1|||
126778643|NCT00410410|456145023|FG005|Induction Period (IP)|Adverse Event|0|||
126778644|NCT00410410|456145024|FG006|Induction Period (IP)|Adverse Event|0|||
126778645|NCT00410410|456145025|FG007|Induction Period (IP)|Adverse Event|0|||
126593943|NCT00950742|455475656|FG001|Overall Study|Progressive Disease|2|||
126778646|NCT00410410|456145026|FG008|Induction Period (IP)|Adverse Event|0|||
126778647|NCT00410410|456145018|FG000|Induction Period (IP)|Lack of Efficacy|26|||
126778648|NCT00410410|456145019|FG001|Induction Period (IP)|Lack of Efficacy|24|||
126778649|NCT00410410|456145020|FG002|Induction Period (IP)|Lack of Efficacy|8|||
126778650|NCT00410410|456145021|FG003|Induction Period (IP)|Lack of Efficacy|8|||
126778651|NCT00410410|456145022|FG004|Induction Period (IP)|Lack of Efficacy|7|||
126778652|NCT00410410|456145023|FG005|Induction Period (IP)|Lack of Efficacy|7|||
126593944|NCT00950742|455475655|FG000|Overall Study|Dose limiting toxicity|6|||
126593945|NCT00950742|455475656|FG001|Overall Study|Dose limiting toxicity|0|||
126593946|NCT00592852|455475660|FG000|Overall Study|Non-compliance|1|||
126593947|NCT00592852|455475660|FG000|Overall Study|Adverse Event|3|||
126593948|NCT00592852|455475660|FG000|Overall Study|Found ineligible|1|||
126593949|NCT00592852|455475660|FG000|Overall Study|Withdrawal by Subject|1|||
126593950|NCT05002088|455475662|FG000|Overall Study|Withdrawal by Subject|9|||
126593951|NCT05002088|455475663|FG001|Overall Study|Withdrawal by Subject|0|||
126593952|NCT05002088|455475662|FG000|Overall Study|Lost to Follow-up|0|||
126593953|NCT05002088|455475663|FG001|Overall Study|Lost to Follow-up|1|||
126593954|NCT05002088|455475662|FG000|Overall Study|Death|16|||
126593955|NCT05002088|455475663|FG001|Overall Study|Death|2|||
126593956|NCT05002088|455475662|FG000|Overall Study|Protocol Violation|25|||
126593957|NCT05002088|455475663|FG001|Overall Study|Protocol Violation|7|||
126593958|NCT04068181|455475664|FG000|Overall Study|Death|17|||
126593959|NCT04068181|455475665|FG001|Overall Study|Death|12|||
126593960|NCT04068181|455475666|FG002|Overall Study|Death|4|||
126593961|NCT04068181|455475667|FG003|Overall Study|Death|7|||
126593962|NCT04068181|455475664|FG000|Overall Study|Lost to Follow-up|1|||
126593963|NCT04068181|455475665|FG001|Overall Study|Lost to Follow-up|0|||
126593964|NCT04068181|455475666|FG002|Overall Study|Lost to Follow-up|0|||
126593965|NCT04068181|455475667|FG003|Overall Study|Lost to Follow-up|0|||
126593966|NCT04068181|455475664|FG000|Overall Study|Withdrawal of consent from study|3|||
126593967|NCT04068181|455475665|FG001|Overall Study|Withdrawal of consent from study|0|||
126593968|NCT04068181|455475666|FG002|Overall Study|Withdrawal of consent from study|0|||
126593969|NCT04068181|455475667|FG003|Overall Study|Withdrawal of consent from study|0|||
126593970|NCT05070728|455475670|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
126593971|NCT05070728|455475671|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
126593972|NCT04770402|455475678|FG000|Overall Study|Lost to Follow-up|1|||
126593973|NCT04770402|455475679|FG001|Overall Study|Lost to Follow-up|2|||
126593974|NCT04770402|455475678|FG000|Overall Study|Non-compliance|1|||
126593975|NCT04770402|455475679|FG001|Overall Study|Non-compliance|0|||
126593976|NCT04770402|455475678|FG000|Overall Study|Withdrawal by Subject|0|||
126593977|NCT04770402|455475679|FG001|Overall Study|Withdrawal by Subject|1|||
126593978|NCT02589795|455475680|FG000|Overall Study|Lost to Follow-up|1|||
126593979|NCT02589795|455475681|FG001|Overall Study|Lost to Follow-up|0|||
126593980|NCT02589795|455475682|FG002|Overall Study|Lost to Follow-up|0|||
126593981|NCT02589795|455475680|FG000|Overall Study|Withdrawal by Subject|0|||
126593982|NCT02589795|455475681|FG001|Overall Study|Withdrawal by Subject|0|||
126593983|NCT02589795|455475682|FG002|Overall Study|Withdrawal by Subject|2|||
126732108|NCT00006604|455968431|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
126732109|NCT00006604|455968432|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
126732110|NCT00006604|455968433|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
126732111|NCT00006604|455968434|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
126732112|NCT00006604|455968435|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
126732113|NCT00006604|455968436|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
126732114|NCT00006604|455968437|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
126732115|NCT00006604|455968438|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
126732116|NCT00006604|455968439|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
126732117|NCT00006604|455968440|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
126732118|NCT00006604|455968441|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
126732119|NCT00006604|455968442|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
126732120|NCT00006604|455968426|FG000|Overall Study|Site closing|0|||
126732121|NCT00006604|455968427|FG001|Overall Study|Site closing|0|||
126732122|NCT00006604|455968428|FG002|Overall Study|Site closing|1|||
126732123|NCT00006604|455968429|FG003|Overall Study|Site closing|1|||
126732124|NCT00006604|455968430|FG004|Overall Study|Site closing|0|||
126732125|NCT00006604|455968431|FG005|Overall Study|Site closing|0|||
126732126|NCT00006604|455968432|FG006|Overall Study|Site closing|0|||
126732127|NCT00006604|455968433|FG007|Overall Study|Site closing|1|||
126732128|NCT00006604|455968434|FG008|Overall Study|Site closing|0|||
126732129|NCT00006604|455968435|FG009|Overall Study|Site closing|0|||
126732130|NCT00006604|455968436|FG010|Overall Study|Site closing|0|||
126732131|NCT00006604|455968437|FG011|Overall Study|Site closing|1|||
126732132|NCT00006604|455968438|FG012|Overall Study|Site closing|1|||
126732133|NCT00006604|455968439|FG013|Overall Study|Site closing|1|||
126732134|NCT00006604|455968440|FG014|Overall Study|Site closing|0|||
126732135|NCT00006604|455968441|FG015|Overall Study|Site closing|0|||
126593984|NCT02589795|455475680|FG000|Overall Study|Protocol Violation|0|||
126593985|NCT02589795|455475681|FG001|Overall Study|Protocol Violation|0|||
126593986|NCT02589795|455475682|FG002|Overall Study|Protocol Violation|1|||
126593987|NCT03599661|455475684|FG000|Overall Study|Lost to Follow-up|9|||
126593988|NCT04909801|455475685|FG000|Overall Study|Lack of Efficacy|2|||
126593989|NCT04909801|455475686|FG001|Overall Study|Lack of Efficacy|1|||
126593990|NCT04909801|455475685|FG000|Overall Study|Adverse Event|1|||
126593991|NCT04909801|455475686|FG001|Overall Study|Adverse Event|2|||
126778653|NCT00410410|456145024|FG006|Induction Period (IP)|Lack of Efficacy|0|||
126778654|NCT00410410|456145025|FG007|Induction Period (IP)|Lack of Efficacy|0|||
126778655|NCT00410410|456145026|FG008|Induction Period (IP)|Lack of Efficacy|0|||
126778656|NCT00410410|456145018|FG000|Induction Period (IP)|Lost to Follow-up|2|||
126778657|NCT00410410|456145019|FG001|Induction Period (IP)|Lost to Follow-up|2|||
126778658|NCT00410410|456145020|FG002|Induction Period (IP)|Lost to Follow-up|2|||
126778659|NCT00410410|456145021|FG003|Induction Period (IP)|Lost to Follow-up|3|||
126778660|NCT00410410|456145022|FG004|Induction Period (IP)|Lost to Follow-up|0|||
126778661|NCT00410410|456145023|FG005|Induction Period (IP)|Lost to Follow-up|1|||
126778662|NCT00410410|456145024|FG006|Induction Period (IP)|Lost to Follow-up|0|||
126778663|NCT00410410|456145025|FG007|Induction Period (IP)|Lost to Follow-up|0|||
126778664|NCT00410410|456145026|FG008|Induction Period (IP)|Lost to Follow-up|0|||
126778665|NCT00410410|456145018|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
126593992|NCT04909801|455475685|FG000|Overall Study|Participant request to discontinue study treatment|1|||
126593993|NCT04909801|455475686|FG001|Overall Study|Participant request to discontinue study treatment|2|||
126593994|NCT04909801|455475685|FG000|Overall Study|Withdrawal by Subject|2|||
126732136|NCT00006604|455968442|FG016|Overall Study|Site closing|1|||
126732137|NCT00006604|455968426|FG000|Overall Study|Withdrawal by Subject|1|||
126732138|NCT00006604|455968427|FG001|Overall Study|Withdrawal by Subject|0|||
126732139|NCT00006604|455968428|FG002|Overall Study|Withdrawal by Subject|2|||
126732140|NCT00006604|455968429|FG003|Overall Study|Withdrawal by Subject|0|||
126732141|NCT00006604|455968430|FG004|Overall Study|Withdrawal by Subject|1|||
126732142|NCT00006604|455968431|FG005|Overall Study|Withdrawal by Subject|2|||
126732143|NCT00006604|455968432|FG006|Overall Study|Withdrawal by Subject|2|||
126732144|NCT00006604|455968433|FG007|Overall Study|Withdrawal by Subject|0|||
126732145|NCT00006604|455968434|FG008|Overall Study|Withdrawal by Subject|1|||
126732146|NCT00006604|455968435|FG009|Overall Study|Withdrawal by Subject|3|||
126732147|NCT00006604|455968436|FG010|Overall Study|Withdrawal by Subject|2|||
126732148|NCT00006604|455968437|FG011|Overall Study|Withdrawal by Subject|0|||
126732149|NCT00006604|455968438|FG012|Overall Study|Withdrawal by Subject|1|||
126732150|NCT00006604|455968439|FG013|Overall Study|Withdrawal by Subject|2|||
126732151|NCT00006604|455968440|FG014|Overall Study|Withdrawal by Subject|1|||
126732152|NCT00006604|455968441|FG015|Overall Study|Withdrawal by Subject|0|||
126732153|NCT00006604|455968442|FG016|Overall Study|Withdrawal by Subject|1|||
126732154|NCT00006604|455968426|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
126732155|NCT00006604|455968427|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
126732156|NCT00006604|455968428|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
126732157|NCT00006604|455968429|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
126732158|NCT00006604|455968430|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
126732159|NCT00006604|455968431|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
126732160|NCT00006604|455968432|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
126732161|NCT00006604|455968433|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
126732162|NCT00006604|455968434|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
126732163|NCT00006604|455968435|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
126732164|NCT00006604|455968436|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
126732165|NCT00006604|455968437|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
126732166|NCT00006604|455968438|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
126732167|NCT00006604|455968439|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
126732168|NCT00006604|455968440|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
126732169|NCT00006604|455968441|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
126732170|NCT00006604|455968442|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
126732171|NCT00006604|455968426|FG000|Overall Study|Lost to Follow-up|0|||
126732172|NCT00006604|455968427|FG001|Overall Study|Lost to Follow-up|0|||
126732173|NCT00006604|455968428|FG002|Overall Study|Lost to Follow-up|0|||
126732174|NCT00006604|455968429|FG003|Overall Study|Lost to Follow-up|0|||
126732175|NCT00006604|455968430|FG004|Overall Study|Lost to Follow-up|0|||
126732176|NCT00006604|455968431|FG005|Overall Study|Lost to Follow-up|0|||
126732177|NCT00006604|455968432|FG006|Overall Study|Lost to Follow-up|0|||
126732178|NCT00006604|455968433|FG007|Overall Study|Lost to Follow-up|1|||
126732179|NCT00006604|455968434|FG008|Overall Study|Lost to Follow-up|0|||
126732180|NCT00006604|455968435|FG009|Overall Study|Lost to Follow-up|2|||
126732181|NCT00006604|455968436|FG010|Overall Study|Lost to Follow-up|0|||
126732182|NCT00006604|455968437|FG011|Overall Study|Lost to Follow-up|0|||
126732183|NCT00006604|455968438|FG012|Overall Study|Lost to Follow-up|0|||
126732184|NCT00006604|455968439|FG013|Overall Study|Lost to Follow-up|0|||
126732185|NCT00006604|455968440|FG014|Overall Study|Lost to Follow-up|0|||
126732186|NCT00006604|455968441|FG015|Overall Study|Lost to Follow-up|1|||
126732187|NCT00006604|455968442|FG016|Overall Study|Lost to Follow-up|3|||
126732188|NCT00006604|455968426|FG000|Overall Study|Other Reason|0|||
126732189|NCT00006604|455968427|FG001|Overall Study|Other Reason|0|||
126778666|NCT00410410|456145019|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
126778667|NCT00410410|456145020|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
126778668|NCT00410410|456145021|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
126593995|NCT04909801|455475686|FG001|Overall Study|Withdrawal by Subject|1|||
126593996|NCT04909801|455475685|FG000|Overall Study|other reasons|1|||
126593997|NCT04909801|455475686|FG001|Overall Study|other reasons|1|||
126593998|NCT05192109|455475698|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
126593999|NCT05192109|455475699|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
126594000|NCT05192109|455475700|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126594001|NCT05192109|455475701|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126594002|NCT05192109|455475698|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
126594003|NCT05192109|455475699|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
126594004|NCT05192109|455475700|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126594005|NCT05192109|455475701|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
126594006|NCT04498390|455475702|FG000|Overall Study|Adverse Event|0|||
126594007|NCT04498390|455475703|FG001|Overall Study|Adverse Event|0|||
126594008|NCT04498390|455475704|FG002|Overall Study|Adverse Event|1|||
126594009|NCT04498390|455475705|FG003|Overall Study|Adverse Event|0|||
126594010|NCT04498390|455475706|FG004|Overall Study|Adverse Event|0|||
126594011|NCT04498390|455475702|FG000|Overall Study|Withdrawal by Subject|0|||
126594012|NCT04498390|455475703|FG001|Overall Study|Withdrawal by Subject|0|||
126594013|NCT04498390|455475704|FG002|Overall Study|Withdrawal by Subject|0|||
126594014|NCT04498390|455475705|FG003|Overall Study|Withdrawal by Subject|1|||
126594015|NCT04498390|455475706|FG004|Overall Study|Withdrawal by Subject|0|||
126594016|NCT04515849|455475711|FG000|Overall Study|Adverse Event|0|||
126594017|NCT04515849|455475712|FG001|Overall Study|Adverse Event|0|||
126594018|NCT04515849|455475713|FG002|Overall Study|Adverse Event|0|||
126594019|NCT04515849|455475714|FG003|Overall Study|Adverse Event|1|||
126594020|NCT04515849|455475715|FG004|Overall Study|Adverse Event|2|||
126594021|NCT04515849|455475711|FG000|Overall Study|Death|2|||
126594022|NCT04515849|455475712|FG001|Overall Study|Death|0|||
126594023|NCT04515849|455475713|FG002|Overall Study|Death|0|||
126594024|NCT04515849|455475714|FG003|Overall Study|Death|0|||
126594025|NCT04515849|455475715|FG004|Overall Study|Death|0|||
126594026|NCT04515849|455475711|FG000|Overall Study|Other:family emergency|0|||
126594027|NCT04515849|455475712|FG001|Overall Study|Other:family emergency|0|||
126594028|NCT04515849|455475713|FG002|Overall Study|Other:family emergency|0|||
126594029|NCT04515849|455475714|FG003|Overall Study|Other:family emergency|1|||
126594030|NCT04515849|455475715|FG004|Overall Study|Other:family emergency|0|||
126594031|NCT04515849|455475711|FG000|Overall Study|Other:randomised by error|0|||
126594032|NCT04515849|455475712|FG001|Overall Study|Other:randomised by error|1|||
126594033|NCT04515849|455475713|FG002|Overall Study|Other:randomised by error|0|||
126594034|NCT04515849|455475714|FG003|Overall Study|Other:randomised by error|0|||
126594035|NCT04515849|455475715|FG004|Overall Study|Other:randomised by error|0|||
126594036|NCT04515849|455475711|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
126594037|NCT04515849|455475712|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
126594038|NCT04515849|455475713|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
126594039|NCT04515849|455475714|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
126594040|NCT04515849|455475715|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
126594041|NCT04515849|455475711|FG000|Overall Study|Physician Decision|0|||
126594042|NCT04515849|455475712|FG001|Overall Study|Physician Decision|1|||
126594043|NCT04515849|455475713|FG002|Overall Study|Physician Decision|0|||
126594044|NCT04515849|455475714|FG003|Overall Study|Physician Decision|0|||
126594045|NCT04515849|455475715|FG004|Overall Study|Physician Decision|0|||
126594046|NCT04515849|455475711|FG000|Overall Study|Withdrawal by Subject|1|||
126594047|NCT04515849|455475712|FG001|Overall Study|Withdrawal by Subject|2|||
126594048|NCT04515849|455475713|FG002|Overall Study|Withdrawal by Subject|1|||
126594049|NCT04515849|455475714|FG003|Overall Study|Withdrawal by Subject|0|||
126594050|NCT04515849|455475715|FG004|Overall Study|Withdrawal by Subject|0|||
126594051|NCT05370040|455475718|FG000|Overall Study|Lost to Follow-up|0|||
126594052|NCT05370040|455475719|FG001|Overall Study|Lost to Follow-up|0|||
126594053|NCT05370040|455475720|FG002|Overall Study|Lost to Follow-up|1|||
126594054|NCT05370040|455475721|FG003|Overall Study|Lost to Follow-up|0|||
126594055|NCT05370040|455475722|FG004|Overall Study|Lost to Follow-up|1|||
126594056|NCT05370040|455475723|FG005|Overall Study|Lost to Follow-up|0|||
126594057|NCT04577963|455475727|FG000|Part 2|Death|0|||
126594058|NCT04577963|455475728|FG001|Part 2|Death|1|||
126594059|NCT04577963|455475729|FG002|Part 2|Death|8|||
126594060|NCT04577963|455475730|FG003|Part 2|Death|0|||
126594061|NCT04577963|455475731|FG004|Part 2|Death|20|||
126594062|NCT04577963|455475727|FG000|Part 2|Lost to Follow-up|0|||
126594063|NCT04577963|455475728|FG001|Part 2|Lost to Follow-up|0|||
126594064|NCT04577963|455475729|FG002|Part 2|Lost to Follow-up|0|||
126594065|NCT04577963|455475730|FG003|Part 2|Lost to Follow-up|0|||
126594066|NCT04577963|455475731|FG004|Part 2|Lost to Follow-up|2|||
126594067|NCT04577963|455475727|FG000|Part 2|Withdrawal by Subject|0|||
126594068|NCT04577963|455475728|FG001|Part 2|Withdrawal by Subject|0|||
126594069|NCT04577963|455475729|FG002|Part 2|Withdrawal by Subject|0|||
126594070|NCT04577963|455475730|FG003|Part 2|Withdrawal by Subject|0|||
126594071|NCT04577963|455475731|FG004|Part 2|Withdrawal by Subject|10|||
126594072|NCT04577963|455475727|FG000|Part 2|Progressive disease|0|||
126594073|NCT04577963|455475728|FG001|Part 2|Progressive disease|0|||
126594074|NCT04577963|455475729|FG002|Part 2|Progressive disease|0|||
126594075|NCT04577963|455475730|FG003|Part 2|Progressive disease|0|||
126594076|NCT04577963|455475731|FG004|Part 2|Progressive disease|2|||
126594077|NCT04577963|455475727|FG000|Part 2|Investigator decision|0|||
126594078|NCT04577963|455475728|FG001|Part 2|Investigator decision|0|||
126594079|NCT04577963|455475729|FG002|Part 2|Investigator decision|0|||
126594080|NCT04577963|455475730|FG003|Part 2|Investigator decision|0|||
126594081|NCT04577963|455475731|FG004|Part 2|Investigator decision|1|||
126594082|NCT04577963|455475727|FG000|Part 2|Sponsor terminated study|0|||
126594083|NCT04577963|455475728|FG001|Part 2|Sponsor terminated study|0|||
126594084|NCT04577963|455475729|FG002|Part 2|Sponsor terminated study|3|||
126594085|NCT04577963|455475730|FG003|Part 2|Sponsor terminated study|1|||
126594086|NCT04577963|455475731|FG004|Part 2|Sponsor terminated study|4|||
126594087|NCT02709161|455475734|FG000|Overall Study|Withdrawal by Subject|1|||
126594088|NCT02709161|455475735|FG001|Overall Study|Withdrawal by Subject|0|||
126594089|NCT03257410|455477868|FG000|Overall Study|Adverse Event|2|||
126594090|NCT03257410|455477869|FG001|Overall Study|Adverse Event|3|||
126594091|NCT03257410|455477868|FG000|Overall Study|Protocol Violation|1|||
126594092|NCT03257410|455477869|FG001|Overall Study|Protocol Violation|2|||
126594093|NCT03257410|455477868|FG000|Overall Study|Lost to Follow-up|1|||
126594094|NCT03257410|455477869|FG001|Overall Study|Lost to Follow-up|0|||
126594095|NCT03257410|455477868|FG000|Overall Study|Withdrawal by Subject|1|||
126594096|NCT03257410|455477869|FG001|Overall Study|Withdrawal by Subject|2|||
126594097|NCT03257410|455477868|FG000|Overall Study|Physician Decision|1|||
126594098|NCT03257410|455477869|FG001|Overall Study|Physician Decision|1|||
126594099|NCT03257410|455477868|FG000|Overall Study|Renal transplantation|2|||
126594100|NCT03257410|455477869|FG001|Overall Study|Renal transplantation|0|||
126594101|NCT03257410|455477868|FG000|Overall Study|Switch to peritoneal dialysis|1|||
126594102|NCT03257410|455477869|FG001|Overall Study|Switch to peritoneal dialysis|0|||
126594103|NCT03257410|455477868|FG000|Overall Study|Death|3|||
126594104|NCT03257410|455477869|FG001|Overall Study|Death|2|||
126594105|NCT03257410|455477868|FG000|Overall Study|Change to another dialysis center|2|||
126594106|NCT03257410|455477869|FG001|Overall Study|Change to another dialysis center|2|||
126594107|NCT03257410|455477868|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
126594108|NCT03257410|455477869|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
126594109|NCT03257410|455477868|FG000|Overall Study|Miscellaneous|2|||
126594110|NCT03257410|455477869|FG001|Overall Study|Miscellaneous|2|||
126594111|NCT03257410|455477868|FG000|Overall Study|Other|0|||
126594112|NCT03257410|455477869|FG001|Overall Study|Other|1|||
126594113|NCT02561247|455477870|FG000|Overall Study|Protocol Violation|1|||
126594114|NCT02561247|455477870|FG000|Overall Study|Withdrawal by Subject|1|||
126594115|NCT02561247|455477870|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
126594116|NCT04231149|455477871|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
126594117|NCT04231149|455477872|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
126594118|NCT04231149|455477873|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
126594119|NCT04231149|455477874|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
126594120|NCT04231149|455477875|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
126594121|NCT04298983|455477876|FG000|Overall Study|Adverse Event|4|||
126594122|NCT04298983|455477876|FG000|Overall Study|Lack of Efficacy|3|||
126594123|NCT02116530|455477878|FG000|Overall Study|Withdrawal by Subject|1|||
126594124|NCT02116530|455477879|FG001|Overall Study|Withdrawal by Subject|2|||
126594125|NCT02116530|455477878|FG000|Overall Study|Adverse Event|4|||
126594126|NCT02116530|455477879|FG001|Overall Study|Adverse Event|0|||
126594127|NCT02116530|455477878|FG000|Overall Study|Physician Decision|1|||
126594128|NCT02116530|455477879|FG001|Overall Study|Physician Decision|0|||
126594129|NCT02116530|455477878|FG000|Overall Study|Lost to Follow-up|1|||
126594130|NCT02116530|455477879|FG001|Overall Study|Lost to Follow-up|0|||
126594131|NCT02116530|455477878|FG000|Overall Study|Other Medical Problems|2|||
126594132|NCT02116530|455477879|FG001|Overall Study|Other Medical Problems|2|||
126594133|NCT03656510|455477881|FG000|Overall Study|Lost to Follow-up|1|||
126594134|NCT03656510|455477882|FG001|Overall Study|Lost to Follow-up|0|||
126594135|NCT03656510|455477883|FG002|Overall Study|Lost to Follow-up|0|||
126594136|NCT03656510|455477884|FG003|Overall Study|Lost to Follow-up|0|||
126594137|NCT03656510|455477885|FG004|Overall Study|Lost to Follow-up|0|||
126594138|NCT03656510|455477886|FG005|Overall Study|Lost to Follow-up|0|||
126594139|NCT03656510|455477881|FG000|Overall Study|Withdrawal by Subject|1|||
126594140|NCT03656510|455477882|FG001|Overall Study|Withdrawal by Subject|1|||
126594141|NCT03656510|455477883|FG002|Overall Study|Withdrawal by Subject|0|||
126594142|NCT03656510|455477884|FG003|Overall Study|Withdrawal by Subject|1|||
126594143|NCT03656510|455477885|FG004|Overall Study|Withdrawal by Subject|0|||
126594144|NCT03656510|455477886|FG005|Overall Study|Withdrawal by Subject|0|||
126594145|NCT05671653|455477887|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
126594146|NCT05671653|455477888|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
126594147|NCT05671653|455477889|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
126594148|NCT05671653|455477890|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
126594149|NCT05671653|455477891|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
126594150|NCT05671653|455477892|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
126594151|NCT05671653|455477893|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
126594152|NCT05671653|455477894|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
126594153|NCT05671653|455477895|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
126594154|NCT05671653|455477896|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
126594155|NCT05671653|455477897|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
126594156|NCT05671653|455477898|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
126594157|NCT05671653|455477899|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
126594158|NCT05671653|455477887|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126594159|NCT05671653|455477888|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126594160|NCT05671653|455477889|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126594161|NCT05671653|455477890|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126594162|NCT05671653|455477891|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126594163|NCT05671653|455477892|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
126594164|NCT05671653|455477893|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126594165|NCT05671653|455477894|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126594166|NCT05671653|455477895|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126594167|NCT05671653|455477896|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126594168|NCT05671653|455477897|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126594169|NCT05671653|455477898|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126594170|NCT05671653|455477899|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
126594171|NCT05671653|455477887|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126594172|NCT05671653|455477888|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126594173|NCT05671653|455477889|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126594174|NCT05671653|455477890|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126594175|NCT05671653|455477891|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126594176|NCT05671653|455477892|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
126594177|NCT05671653|455477893|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126594178|NCT05671653|455477894|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126594179|NCT05671653|455477895|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126594180|NCT05671653|455477896|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126594181|NCT05671653|455477897|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126594182|NCT05671653|455477898|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126594183|NCT05671653|455477899|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
126594184|NCT05671653|455477887|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126594185|NCT05671653|455477888|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126594186|NCT05671653|455477889|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126594187|NCT05671653|455477890|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126594188|NCT05671653|455477891|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126594189|NCT05671653|455477892|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126594190|NCT05671653|455477893|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126594191|NCT05671653|455477894|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126594192|NCT05671653|455477895|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
126594193|NCT05671653|455477896|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126594194|NCT05671653|455477897|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126594195|NCT05671653|455477898|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126594196|NCT05671653|455477899|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
126594197|NCT05671653|455477887|FG000|Cohort 2 Period 2|Adverse Event|0|||
126594198|NCT05671653|455477888|FG001|Cohort 2 Period 2|Adverse Event|0|||
126594199|NCT05671653|455477889|FG002|Cohort 2 Period 2|Adverse Event|0|||
126594200|NCT05671653|455477890|FG003|Cohort 2 Period 2|Adverse Event|0|||
126594201|NCT05671653|455477891|FG004|Cohort 2 Period 2|Adverse Event|0|||
126594202|NCT05671653|455477892|FG005|Cohort 2 Period 2|Adverse Event|0|||
126594203|NCT05671653|455477893|FG006|Cohort 2 Period 2|Adverse Event|0|||
126594204|NCT05671653|455477894|FG007|Cohort 2 Period 2|Adverse Event|0|||
126594205|NCT05671653|455477895|FG008|Cohort 2 Period 2|Adverse Event|0|||
126594206|NCT05671653|455477896|FG009|Cohort 2 Period 2|Adverse Event|0|||
126594207|NCT05671653|455477897|FG010|Cohort 2 Period 2|Adverse Event|1|||
126594208|NCT05671653|455477898|FG011|Cohort 2 Period 2|Adverse Event|0|||
126594209|NCT05671653|455477899|FG012|Cohort 2 Period 2|Adverse Event|0|||
126594210|NCT05671653|455477887|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
126594211|NCT05671653|455477888|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
126594212|NCT05671653|455477889|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
126594213|NCT05671653|455477890|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
126594214|NCT05671653|455477891|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
126594215|NCT05671653|455477892|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
126594216|NCT05671653|455477893|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
126594217|NCT05671653|455477894|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
126594218|NCT05671653|455477895|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
126594219|NCT05671653|455477896|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
126778669|NCT00410410|456145022|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
126778670|NCT00410410|456145023|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
126778671|NCT00410410|456145024|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
126778672|NCT00410410|456145025|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
126778673|NCT00410410|456145026|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
126778674|NCT00410410|456145018|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126778675|NCT00410410|456145019|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126778676|NCT00410410|456145020|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
126778677|NCT00410410|456145021|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126778678|NCT00410410|456145022|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126778679|NCT00410410|456145023|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126778680|NCT00410410|456145024|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126778681|NCT00410410|456145025|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126778682|NCT00410410|456145026|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
126778683|NCT00410410|456145018|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126778684|NCT00410410|456145019|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126778685|NCT00410410|456145020|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126778686|NCT00410410|456145021|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126778687|NCT00410410|456145022|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
126778688|NCT00410410|456145023|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
126778689|NCT00410410|456145024|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126778690|NCT00410410|456145025|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126778691|NCT00410410|456145026|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
126778692|NCT00410410|456145018|FG000|Induction Period (IP)|Other|0|||
126778693|NCT00410410|456145019|FG001|Induction Period (IP)|Other|0|||
126778694|NCT00410410|456145020|FG002|Induction Period (IP)|Other|1|||
126778695|NCT00410410|456145021|FG003|Induction Period (IP)|Other|0|||
126778696|NCT00410410|456145022|FG004|Induction Period (IP)|Other|0|||
126778697|NCT00410410|456145023|FG005|Induction Period (IP)|Other|0|||
126778698|NCT00410410|456145024|FG006|Induction Period (IP)|Other|0|||
126778699|NCT00410410|456145025|FG007|Induction Period (IP)|Other|0|||
126778700|NCT00410410|456145026|FG008|Induction Period (IP)|Other|0|||
126778701|NCT00410410|456145018|FG000|Maintenance Period (MP)|Death|0|||
126778702|NCT00410410|456145019|FG001|Maintenance Period (MP)|Death|0|||
126778703|NCT00410410|456145020|FG002|Maintenance Period (MP)|Death|0|||
126778704|NCT00410410|456145021|FG003|Maintenance Period (MP)|Death|0|||
126594220|NCT05671653|455477897|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
126594221|NCT05671653|455477898|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
126778705|NCT00410410|456145022|FG004|Maintenance Period (MP)|Death|0|||
126778706|NCT00410410|456145023|FG005|Maintenance Period (MP)|Death|0|||
126778707|NCT00410410|456145024|FG006|Maintenance Period (MP)|Death|1|||
126778708|NCT00410410|456145025|FG007|Maintenance Period (MP)|Death|0|||
126778709|NCT00410410|456145026|FG008|Maintenance Period (MP)|Death|0|||
126778710|NCT00410410|456145018|FG000|Maintenance Period (MP)|Adverse Event|0|||
126778711|NCT00410410|456145019|FG001|Maintenance Period (MP)|Adverse Event|0|||
126778712|NCT00410410|456145020|FG002|Maintenance Period (MP)|Adverse Event|0|||
126778713|NCT00410410|456145021|FG003|Maintenance Period (MP)|Adverse Event|0|||
126778714|NCT00410410|456145022|FG004|Maintenance Period (MP)|Adverse Event|0|||
126778715|NCT00410410|456145023|FG005|Maintenance Period (MP)|Adverse Event|0|||
126778716|NCT00410410|456145024|FG006|Maintenance Period (MP)|Adverse Event|1|||
126778717|NCT00410410|456145025|FG007|Maintenance Period (MP)|Adverse Event|3|||
126778718|NCT00410410|456145026|FG008|Maintenance Period (MP)|Adverse Event|0|||
126778719|NCT00410410|456145018|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
126778720|NCT00410410|456145019|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
126778721|NCT00410410|456145020|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
126778722|NCT00410410|456145021|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
126778723|NCT00410410|456145022|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
126778724|NCT00410410|456145023|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
126594222|NCT05671653|455477899|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
126594223|NCT05671653|455477887|FG000|Cohort 2 Period 2|Pregnancy|0|||
126594224|NCT05671653|455477888|FG001|Cohort 2 Period 2|Pregnancy|0|||
126778725|NCT00410410|456145024|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
126778726|NCT00410410|456145025|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
126778727|NCT00410410|456145026|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
126778728|NCT00410410|456145018|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
126778729|NCT00410410|456145019|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
126594225|NCT05671653|455477889|FG002|Cohort 2 Period 2|Pregnancy|0|||
126594226|NCT05671653|455477890|FG003|Cohort 2 Period 2|Pregnancy|0|||
126594227|NCT05671653|455477891|FG004|Cohort 2 Period 2|Pregnancy|0|||
126594228|NCT05671653|455477892|FG005|Cohort 2 Period 2|Pregnancy|0|||
126778730|NCT00410410|456145020|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
126778731|NCT00410410|456145021|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
126778732|NCT00410410|456145022|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
126594229|NCT05671653|455477893|FG006|Cohort 2 Period 2|Pregnancy|0|||
126594230|NCT05671653|455477894|FG007|Cohort 2 Period 2|Pregnancy|0|||
126594231|NCT05671653|455477895|FG008|Cohort 2 Period 2|Pregnancy|0|||
126594232|NCT05671653|455477896|FG009|Cohort 2 Period 2|Pregnancy|0|||
126594233|NCT05671653|455477897|FG010|Cohort 2 Period 2|Pregnancy|1|||
126594234|NCT05671653|455477898|FG011|Cohort 2 Period 2|Pregnancy|0|||
126594235|NCT05671653|455477899|FG012|Cohort 2 Period 2|Pregnancy|0|||
126594236|NCT05671653|455477887|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
126594237|NCT05671653|455477888|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
126594238|NCT05671653|455477889|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
126732190|NCT00006604|455968428|FG002|Overall Study|Other Reason|0|||
126732191|NCT00006604|455968429|FG003|Overall Study|Other Reason|0|||
126732192|NCT00006604|455968430|FG004|Overall Study|Other Reason|0|||
126732193|NCT00006604|455968431|FG005|Overall Study|Other Reason|1|||
126732194|NCT00006604|455968432|FG006|Overall Study|Other Reason|0|||
126732195|NCT00006604|455968433|FG007|Overall Study|Other Reason|0|||
126594239|NCT05671653|455477890|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
126594240|NCT05671653|455477891|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
126594241|NCT05671653|455477892|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
126594242|NCT05671653|455477893|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
126594243|NCT05671653|455477894|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
126594244|NCT05671653|455477895|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
126594245|NCT05671653|455477896|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
126594246|NCT05671653|455477897|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
126594247|NCT05671653|455477898|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
126594248|NCT05671653|455477899|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
126594249|NCT05671653|455477887|FG000|Cohort 2 Period 2|Other|0|||
126594250|NCT05671653|455477888|FG001|Cohort 2 Period 2|Other|0|||
126594251|NCT05671653|455477889|FG002|Cohort 2 Period 2|Other|0|||
126594252|NCT05671653|455477890|FG003|Cohort 2 Period 2|Other|0|||
126594253|NCT05671653|455477891|FG004|Cohort 2 Period 2|Other|0|||
126594254|NCT05671653|455477892|FG005|Cohort 2 Period 2|Other|0|||
126594255|NCT05671653|455477893|FG006|Cohort 2 Period 2|Other|0|||
126594256|NCT05671653|455477894|FG007|Cohort 2 Period 2|Other|0|||
126594257|NCT05671653|455477895|FG008|Cohort 2 Period 2|Other|0|||
126594258|NCT05671653|455477896|FG009|Cohort 2 Period 2|Other|0|||
126594259|NCT05671653|455477897|FG010|Cohort 2 Period 2|Other|1|||
126594260|NCT05671653|455477898|FG011|Cohort 2 Period 2|Other|0|||
126594261|NCT05671653|455477899|FG012|Cohort 2 Period 2|Other|0|||
126594262|NCT05671653|455477887|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126594263|NCT05671653|455477888|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126594264|NCT05671653|455477889|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126594265|NCT05671653|455477890|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126594266|NCT05671653|455477891|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126594267|NCT05671653|455477892|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126594268|NCT05671653|455477893|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126594269|NCT05671653|455477894|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126594270|NCT05671653|455477895|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126594271|NCT05671653|455477896|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126594272|NCT05671653|455477897|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126594273|NCT05671653|455477898|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
126594274|NCT05671653|455477899|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
126594275|NCT02305888|455477900|FG000|Overall Study|Lost to Follow-up|0|||
126594276|NCT02305888|455477901|FG001|Overall Study|Lost to Follow-up|0|||
126594277|NCT02305888|455477902|FG002|Overall Study|Lost to Follow-up|1|||
126594278|NCT02305888|455477900|FG000|Overall Study|Adverse Event|0|||
126732196|NCT00006604|455968434|FG008|Overall Study|Other Reason|0|||
126732197|NCT00006604|455968435|FG009|Overall Study|Other Reason|1|||
126732198|NCT00006604|455968436|FG010|Overall Study|Other Reason|0|||
126732199|NCT00006604|455968437|FG011|Overall Study|Other Reason|0|||
126732200|NCT00006604|455968438|FG012|Overall Study|Other Reason|0|||
126732201|NCT00006604|455968439|FG013|Overall Study|Other Reason|0|||
126732202|NCT00006604|455968440|FG014|Overall Study|Other Reason|0|||
126732203|NCT00006604|455968441|FG015|Overall Study|Other Reason|0|||
126732204|NCT00006604|455968442|FG016|Overall Study|Other Reason|0|||
126732205|NCT01056341|455968443|FG000|Overall Study|Treatment Intolerance|0|||
126732206|NCT01056341|455968444|FG001|Overall Study|Treatment Intolerance|2|||
126594279|NCT02305888|455477901|FG001|Overall Study|Adverse Event|1|||
126594280|NCT02305888|455477902|FG002|Overall Study|Adverse Event|0|||
126594281|NCT06232590|455477903|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
126732207|NCT01056341|455968445|FG002|Overall Study|Treatment Intolerance|0|||
126732208|NCT01056341|455968446|FG003|Overall Study|Treatment Intolerance|2|||
126732209|NCT01056341|455968447|FG004|Overall Study|Treatment Intolerance|0|||
126732210|NCT01056341|455968443|FG000|Overall Study|Lack of Efficacy|32|||
126732211|NCT01056341|455968444|FG001|Overall Study|Lack of Efficacy|30|||
126594282|NCT06232590|455477904|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
126594283|NCT04914676|455477905|FG000|Overall Study|Study termination|3|||
126732212|NCT01056341|455968445|FG002|Overall Study|Lack of Efficacy|7|||
126594284|NCT04914676|455477906|FG001|Overall Study|Study termination|0|||
126594285|NCT05436262|455477908|FG000|Pre-Randomization|Withdrawal by Subject|1|||
126594286|NCT05436262|455477909|FG001|Pre-Randomization|Withdrawal by Subject|0|||
126594287|NCT05436262|455477910|FG002|Pre-Randomization|Withdrawal by Subject|0|||
126594288|NCT05436262|455477908|FG000|Randomization|Withdrawal by Subject|0|||
126594289|NCT05436262|455477909|FG001|Randomization|Withdrawal by Subject|1|||
126594290|NCT05436262|455477910|FG002|Randomization|Withdrawal by Subject|0|||
126594291|NCT05299073|455477911|FG000|Overall Study|Withdrawal by Subject|0|||
126594292|NCT05299073|455477912|FG001|Overall Study|Withdrawal by Subject|0|||
126594293|NCT05299073|455477913|FG002|Overall Study|Withdrawal by Subject|1|||
126594294|NCT05299073|455477911|FG000|Overall Study|Adverse Event|0|||
126594295|NCT05299073|455477912|FG001|Overall Study|Adverse Event|1|||
126594296|NCT05299073|455477913|FG002|Overall Study|Adverse Event|0|||
126594297|NCT05299073|455477911|FG000|Overall Study|Lost to Follow-up|0|||
126594298|NCT05299073|455477912|FG001|Overall Study|Lost to Follow-up|1|||
126594299|NCT05299073|455477913|FG002|Overall Study|Lost to Follow-up|0|||
126594300|NCT03952338|455477914|FG000|Overall Study|Lost to Follow-up|11|||
126594301|NCT03952338|455477915|FG001|Overall Study|Lost to Follow-up|17|||
126594302|NCT03952338|455477914|FG000|Overall Study|Withdrawal by Subject|1|||
126594303|NCT03952338|455477915|FG001|Overall Study|Withdrawal by Subject|1|||
126594304|NCT03952338|455477914|FG000|Overall Study|Protocol Violation|1|||
126594305|NCT03952338|455477915|FG001|Overall Study|Protocol Violation|0|||
126594306|NCT04850898|455477916|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
126594307|NCT04850898|455477917|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
126594308|NCT04550221|455477919|FG000|Overall Study|Lost to Follow-up|0|||
126594309|NCT04550221|455477920|FG001|Overall Study|Lost to Follow-up|4|||
126594310|NCT04550221|455477919|FG000|Overall Study|Withdrawn|3|||
126594311|NCT04550221|455477920|FG001|Overall Study|Withdrawn|0|||
126594312|NCT04550221|455477919|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
126594313|NCT04550221|455477920|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
126594314|NCT05274074|455477921|FG000|Overall Study|Lost to Follow-up|2|||
126594315|NCT05274074|455477922|FG001|Overall Study|Lost to Follow-up|3|||
126594316|NCT05274074|455477921|FG000|Overall Study|Withdrawal by Subject|1|||
126594317|NCT05274074|455477922|FG001|Overall Study|Withdrawal by Subject|2|||
126594318|NCT04811040|455477923|FG000|Overall Study|Lost to Follow-up|2|||
126594319|NCT04811040|455477924|FG001|Overall Study|Lost to Follow-up|0|||
126594320|NCT04811040|455477925|FG002|Overall Study|Lost to Follow-up|0|||
126594321|NCT04811040|455477926|FG003|Overall Study|Lost to Follow-up|0|||
126594322|NCT04811040|455477923|FG000|Overall Study|Withdrew consent|1|||
126594323|NCT04811040|455477924|FG001|Overall Study|Withdrew consent|1|||
126594324|NCT04811040|455477925|FG002|Overall Study|Withdrew consent|0|||
126594325|NCT04811040|455477926|FG003|Overall Study|Withdrew consent|0|||
126594326|NCT01828099|455477933|FG000|Treatment Period|Adverse Event|24|||
126594327|NCT01828099|455477934|FG001|Treatment Period|Adverse Event|23|||
126594328|NCT01828099|455477933|FG000|Treatment Period|Death|10|||
126594329|NCT01828099|455477934|FG001|Treatment Period|Death|12|||
126594330|NCT01828099|455477933|FG000|Treatment Period|Lost to Follow-up|2|||
126594331|NCT01828099|455477934|FG001|Treatment Period|Lost to Follow-up|1|||
126594332|NCT01828099|455477933|FG000|Treatment Period|Non-compliance with study treatment|1|||
126594333|NCT01828099|455477934|FG001|Treatment Period|Non-compliance with study treatment|0|||
126594334|NCT01828099|455477933|FG000|Treatment Period|Physician Decision|17|||
126594335|NCT01828099|455477934|FG001|Treatment Period|Physician Decision|16|||
126594336|NCT01828099|455477933|FG000|Treatment Period|Progressive disease|99|||
126594337|NCT01828099|455477934|FG001|Treatment Period|Progressive disease|107|||
126594338|NCT01828099|455477933|FG000|Treatment Period|Subject/guardian decision|22|||
126594339|NCT01828099|455477934|FG001|Treatment Period|Subject/guardian decision|26|||
126594340|NCT01828099|455477933|FG000|Treatment Period|Study terminated by Sponsor|13|||
126594341|NCT01828099|455477934|FG001|Treatment Period|Study terminated by Sponsor|1|||
126594342|NCT01828099|455477933|FG000|Treatment Period|Protocol deviation|1|||
126594343|NCT01828099|455477934|FG001|Treatment Period|Protocol deviation|0|||
126594344|NCT01828099|455477933|FG000|Treatment Period|No longer requires treatment|0|||
126594345|NCT01828099|455477934|FG001|Treatment Period|No longer requires treatment|1|||
126594346|NCT01828099|455477933|FG000|Extension-treatment Phase|Adverse Event|0|||
126594347|NCT01828099|455477934|FG001|Extension-treatment Phase|Adverse Event|17|||
126594348|NCT01828099|455477933|FG000|Extension-treatment Phase|Death|0|||
126594349|NCT01828099|455477934|FG001|Extension-treatment Phase|Death|11|||
126594350|NCT01828099|455477933|FG000|Extension-treatment Phase|Physician Decision|0|||
126594351|NCT01828099|455477934|FG001|Extension-treatment Phase|Physician Decision|5|||
126594352|NCT01828099|455477933|FG000|Extension-treatment Phase|Progressive disease|0|||
126594353|NCT01828099|455477934|FG001|Extension-treatment Phase|Progressive disease|54|||
126594354|NCT01828099|455477933|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
126594355|NCT01828099|455477934|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
126594356|NCT01828099|455477933|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
126594357|NCT01828099|455477934|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
126594358|NCT04362254|455477954|FG000|Overall Study|Adverse Event|1|||
126594359|NCT04362254|455477954|FG000|Overall Study|Protocol Violation|1|||
126594360|NCT04362254|455477954|FG000|Overall Study|Due to early termination of the trial|10|||
126594361|NCT04568434|455477957|FG000|Overall Study|Voluntary Withdrawal|0|||
126594362|NCT04568434|455477958|FG001|Overall Study|Voluntary Withdrawal|1|||
126594363|NCT04568434|455477959|FG002|Overall Study|Voluntary Withdrawal|1|||
126594364|NCT04568434|455477957|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
126594365|NCT04568434|455477958|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
126594366|NCT04568434|455477959|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
126594367|NCT04568434|455477957|FG000|Overall Study|Investigator Judgement|1|||
126594368|NCT04568434|455477958|FG001|Overall Study|Investigator Judgement|0|||
126594369|NCT04568434|455477959|FG002|Overall Study|Investigator Judgement|0|||
126594370|NCT05469464|455477960|FG000|Overall Study|Withdrawal by Subject|8|||
126594371|NCT05469464|455477961|FG001|Overall Study|Withdrawal by Subject|7|||
126594372|NCT05469464|455477962|FG002|Overall Study|Withdrawal by Subject|4|||
126594373|NCT05469464|455477963|FG003|Overall Study|Withdrawal by Subject|5|||
126594374|NCT05469464|455477960|FG000|Overall Study|Adverse Event|8|||
126594375|NCT05469464|455477961|FG001|Overall Study|Adverse Event|14|||
126594376|NCT05469464|455477962|FG002|Overall Study|Adverse Event|13|||
126594377|NCT05469464|455477963|FG003|Overall Study|Adverse Event|2|||
126594378|NCT05469464|455477960|FG000|Overall Study|Lost to Follow-up|2|||
126594379|NCT05469464|455477961|FG001|Overall Study|Lost to Follow-up|5|||
126594380|NCT05469464|455477962|FG002|Overall Study|Lost to Follow-up|3|||
126594381|NCT05469464|455477963|FG003|Overall Study|Lost to Follow-up|3|||
126594382|NCT05469464|455477960|FG000|Overall Study|Lack of Efficacy|4|||
126594383|NCT05469464|455477961|FG001|Overall Study|Lack of Efficacy|1|||
126594384|NCT05469464|455477962|FG002|Overall Study|Lack of Efficacy|2|||
126594385|NCT05469464|455477963|FG003|Overall Study|Lack of Efficacy|2|||
126594386|NCT05469464|455477960|FG000|Overall Study|Physician Decision|0|||
126594387|NCT05469464|455477961|FG001|Overall Study|Physician Decision|0|||
126594388|NCT05469464|455477962|FG002|Overall Study|Physician Decision|0|||
126594389|NCT05469464|455477963|FG003|Overall Study|Physician Decision|1|||
126594390|NCT03905798|455477964|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
126594391|NCT06473662|455477965|FG000|Overall Study|Withdrawal by Subject|1|||
126594392|NCT06473662|455477966|FG001|Overall Study|Withdrawal by Subject|6|||
126594393|NCT06473662|455477967|FG002|Overall Study|Withdrawal by Subject|5|||
126594394|NCT06473662|455477965|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
126594395|NCT06473662|455477966|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
126594396|NCT06473662|455477967|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
126594397|NCT06473662|455477965|FG000|Overall Study|Starting HbA1c below 7%|0|||
126594398|NCT06473662|455477966|FG001|Overall Study|Starting HbA1c below 7%|1|||
126594399|NCT06473662|455477967|FG002|Overall Study|Starting HbA1c below 7%|1|||
126594400|NCT06473662|455477965|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
126594401|NCT06473662|455477966|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
126594402|NCT06473662|455477967|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
126594403|NCT06473662|455477965|FG000|Overall Study|Did not take medication|2|||
126594404|NCT06473662|455477966|FG001|Overall Study|Did not take medication|3|||
126594405|NCT06473662|455477967|FG002|Overall Study|Did not take medication|2|||
126594406|NCT05485779|455477968|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
126594407|NCT05485779|455477969|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
126594408|NCT05485779|455477970|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
126594409|NCT05485779|455477971|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
126594410|NCT05485779|455477972|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
126594411|NCT05485779|455477973|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
126594412|NCT05485779|455477974|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
126594413|NCT05485779|455477975|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
126594414|NCT05485779|455477976|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
126594415|NCT05485779|455477977|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
126594416|NCT05485779|455477978|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
126594417|NCT05485779|455477968|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
126594418|NCT05485779|455477969|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
126594419|NCT05485779|455477970|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
126594420|NCT05485779|455477971|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
126594421|NCT05485779|455477972|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
126594422|NCT05485779|455477973|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
126594423|NCT05485779|455477974|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
126594424|NCT05485779|455477975|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
126594425|NCT05485779|455477976|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
126594426|NCT05485779|455477977|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
126594427|NCT05485779|455477978|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
126594428|NCT05485779|455477968|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126594429|NCT05485779|455477969|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126594430|NCT05485779|455477970|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126594431|NCT05485779|455477971|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
126594432|NCT05485779|455477972|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126594433|NCT05485779|455477973|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126594434|NCT05485779|455477974|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126594435|NCT05485779|455477975|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126594436|NCT05485779|455477976|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126594437|NCT05485779|455477977|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126594438|NCT05485779|455477978|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
126594439|NCT03463044|455477979|FG000|Overall Study|Lost to Follow-up|0|||
126594440|NCT03463044|455477980|FG001|Overall Study|Lost to Follow-up|0|||
126594441|NCT03463044|455477981|FG002|Overall Study|Lost to Follow-up|0|||
126594442|NCT03463044|455477982|FG003|Overall Study|Lost to Follow-up|0|||
126594443|NCT03463044|455477983|FG004|Overall Study|Lost to Follow-up|0|||
126594444|NCT03463044|455477984|FG005|Overall Study|Lost to Follow-up|0|||
126594445|NCT03463044|455477985|FG006|Overall Study|Lost to Follow-up|0|||
126594446|NCT03463044|455477986|FG007|Overall Study|Lost to Follow-up|1|||
126594447|NCT03463044|455477987|FG008|Overall Study|Lost to Follow-up|0|||
126594448|NCT04971109|455477988|FG000|Overall Study|Adverse Event|4|||
126594449|NCT04971109|455477989|FG001|Overall Study|Adverse Event|3|||
126594450|NCT04971109|455477988|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
126594451|NCT04971109|455477989|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
126594452|NCT04971109|455477988|FG000|Overall Study|Lost to Follow-up|8|||
126594453|NCT04971109|455477989|FG001|Overall Study|Lost to Follow-up|2|||
126594454|NCT04971109|455477988|FG000|Overall Study|Physician Decision|5|||
126594455|NCT04971109|455477989|FG001|Overall Study|Physician Decision|0|||
126594456|NCT04971109|455477988|FG000|Overall Study|Protocol Violation|0|||
126594457|NCT04971109|455477989|FG001|Overall Study|Protocol Violation|1|||
126594458|NCT04971109|455477988|FG000|Overall Study|Withdrawal by Subject|18|||
126594459|NCT04971109|455477989|FG001|Overall Study|Withdrawal by Subject|3|||
126594460|NCT04971109|455477988|FG000|Overall Study|Subject was randomized in error|1|||
126594461|NCT04971109|455477989|FG001|Overall Study|Subject was randomized in error|0|||
126594462|NCT04066205|455477991|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
126594463|NCT04066205|455477992|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
126594464|NCT04066205|455477991|FG000|T2 Immediate Post-Intervention|did not respond|5|||
126594465|NCT04066205|455477992|FG001|T2 Immediate Post-Intervention|did not respond|3|||
126594466|NCT01712490|455477995|FG000|Overall Study|Ongoing|601|||
126594467|NCT01712490|455477996|FG001|Overall Study|Ongoing|586|||
126594468|NCT01712490|455477995|FG000|Overall Study|Other|11|||
126594469|NCT01712490|455477996|FG001|Overall Study|Other|11|||
126732213|NCT01056341|455968446|FG003|Overall Study|Lack of Efficacy|25|||
126732214|NCT01056341|455968447|FG004|Overall Study|Lack of Efficacy|9|||
126732215|NCT01056341|455968443|FG000|Overall Study|Other reasons|4|||
126732216|NCT01056341|455968444|FG001|Overall Study|Other reasons|4|||
126732217|NCT01056341|455968445|FG002|Overall Study|Other reasons|8|||
126732218|NCT01056341|455968446|FG003|Overall Study|Other reasons|9|||
126732219|NCT01056341|455968447|FG004|Overall Study|Other reasons|5|||
126732220|NCT01086150|455968448|FG000|Overall Study|Withdrawal by Subject|0|||
126732221|NCT01086150|455968449|FG001|Overall Study|Withdrawal by Subject|4|||
126732222|NCT01086150|455968450|FG002|Overall Study|Withdrawal by Subject|1|||
126732223|NCT01086150|455968448|FG000|Overall Study|Lost to Follow-up|0|||
126732224|NCT01086150|455968449|FG001|Overall Study|Lost to Follow-up|1|||
126732225|NCT01086150|455968450|FG002|Overall Study|Lost to Follow-up|0|||
126732226|NCT01086150|455968448|FG000|Overall Study|Screen Failure|0|||
126732227|NCT01086150|455968449|FG001|Overall Study|Screen Failure|1|||
126732228|NCT01086150|455968450|FG002|Overall Study|Screen Failure|0|||
126594470|NCT01712490|455477995|FG000|Overall Study|Withdrawal by Subject|36|||
126594471|NCT01712490|455477996|FG001|Overall Study|Withdrawal by Subject|44|||
126594472|NCT01712490|455477995|FG000|Overall Study|Lost to Follow-up|16|||
126594473|NCT01712490|455477996|FG001|Overall Study|Lost to Follow-up|29|||
126594474|NCT03987022|455477997|FG000|Overall Study|Lost to Follow-up|2|||
126594475|NCT03987022|455477998|FG001|Overall Study|Lost to Follow-up|2|||
126594476|NCT03987022|455477997|FG000|Overall Study|Withdrawal by Subject|1|||
126594477|NCT03987022|455477998|FG001|Overall Study|Withdrawal by Subject|0|||
126594478|NCT03478956|455477999|FG000|Randomized Treatment Period|Adverse Event|1|||
126594479|NCT03478956|455478000|FG001|Randomized Treatment Period|Adverse Event|0|||
126594480|NCT03478956|455478001|FG002|Randomized Treatment Period|Adverse Event|0|||
126594481|NCT03478956|455478002|FG003|Randomized Treatment Period|Adverse Event|0|||
126732229|NCT01182337|455968453|FG000|Overall Study|Withdrawal by Subject|3|||
126732230|NCT01182337|455968454|FG001|Overall Study|Withdrawal by Subject|1|||
126732231|NCT01182337|455968453|FG000|Overall Study|Lost to Follow-up|0|||
126732232|NCT01182337|455968454|FG001|Overall Study|Lost to Follow-up|1|||
126594482|NCT03478956|455477999|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
126594483|NCT03478956|455478000|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
126594484|NCT03478956|455478001|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
126594485|NCT03478956|455478002|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
126594486|NCT03478956|455477999|FG000|Open Label Extension Period|Adverse Event|0|||
126594487|NCT03478956|455478000|FG001|Open Label Extension Period|Adverse Event|0|||
126594488|NCT03478956|455478001|FG002|Open Label Extension Period|Adverse Event|4|||
126594489|NCT03478956|455478002|FG003|Open Label Extension Period|Adverse Event|0|||
126594490|NCT03478956|455477999|FG000|Open Label Extension Period|Lack of Efficacy|0|||
126594491|NCT03478956|455478000|FG001|Open Label Extension Period|Lack of Efficacy|0|||
126594492|NCT03478956|455478001|FG002|Open Label Extension Period|Lack of Efficacy|8|||
126594493|NCT03478956|455478002|FG003|Open Label Extension Period|Lack of Efficacy|0|||
126594494|NCT03478956|455477999|FG000|Open Label Extension Period|Reason Not Provided|0|||
126594495|NCT03478956|455478000|FG001|Open Label Extension Period|Reason Not Provided|0|||
126594496|NCT03478956|455478001|FG002|Open Label Extension Period|Reason Not Provided|1|||
126594497|NCT03478956|455478002|FG003|Open Label Extension Period|Reason Not Provided|0|||
126594498|NCT03478956|455477999|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
126594499|NCT03478956|455478000|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
126594500|NCT03478956|455478001|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
126594501|NCT03478956|455478002|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
126594502|NCT03478956|455477999|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
126594503|NCT03478956|455478000|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
126594504|NCT03478956|455478001|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
126594505|NCT03478956|455478002|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
126594506|NCT03478956|455477999|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
126594507|NCT03478956|455478000|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
126594508|NCT03478956|455478001|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
126594509|NCT03478956|455478002|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
126594510|NCT04800211|455478003|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
126594511|NCT04800211|455478004|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
126594512|NCT04800211|455478005|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
126594513|NCT04800211|455478003|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
126594514|NCT04800211|455478004|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
126594515|NCT04800211|455478005|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
126594516|NCT04800211|455478003|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
126594517|NCT04800211|455478004|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
126594518|NCT04800211|455478005|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
126594519|NCT04800211|455478003|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
126594520|NCT04800211|455478004|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
126594521|NCT04800211|455478005|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
126594522|NCT04800211|455478003|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
126594523|NCT04800211|455478004|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
126594524|NCT04800211|455478005|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
126594525|NCT04800211|455478003|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
126594526|NCT04800211|455478004|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
126594527|NCT04800211|455478005|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
126594528|NCT04800211|455478003|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
126594529|NCT04800211|455478004|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
126594530|NCT04800211|455478005|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
126594531|NCT04800211|455478003|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
126594532|NCT04800211|455478004|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
126594533|NCT04800211|455478005|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
126594534|NCT04800211|455478003|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
126594535|NCT04800211|455478004|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
126594536|NCT04800211|455478005|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
126594537|NCT04800211|455478003|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
126594538|NCT04800211|455478004|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
126594539|NCT04800211|455478005|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
126594540|NCT04800211|455478003|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
126594541|NCT04800211|455478004|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
126594542|NCT04800211|455478005|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
126594543|NCT05170841|455478006|FG000|Single Dose Phase|Adverse Event|1|||
126594544|NCT05170841|455478007|FG001|Single Dose Phase|Adverse Event|2|||
126594545|NCT05170841|455478008|FG002|Single Dose Phase|Adverse Event|0|||
126594546|NCT05170841|455478009|FG003|Single Dose Phase|Adverse Event|2|||
126594547|NCT05170841|455478006|FG000|Multiple Dose Phase|Adverse Event|1|||
126594548|NCT05170841|455478007|FG001|Multiple Dose Phase|Adverse Event|2|||
126594549|NCT05170841|455478008|FG002|Multiple Dose Phase|Adverse Event|1|||
126594550|NCT05170841|455478009|FG003|Multiple Dose Phase|Adverse Event|4|||
126594551|NCT05170841|455478006|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
126594552|NCT05170841|455478007|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
126594553|NCT05170841|455478008|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
126594554|NCT05170841|455478009|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
126594555|NCT05123586|455478012|FG000|Overall Study|Physician Decision|1|||
126594556|NCT05123586|455478013|FG001|Overall Study|Physician Decision|1|||
126594557|NCT05123586|455478012|FG000|Overall Study|Withdrawal by Subject|0|||
126594558|NCT05123586|455478013|FG001|Overall Study|Withdrawal by Subject|3|||
126594559|NCT04865289|455478014|FG000|Overall Study|Participant ongoing in study|47|||
126594560|NCT04865289|455478015|FG001|Overall Study|Participant ongoing in study|35|||
126594561|NCT04865289|455478014|FG000|Overall Study|Death|27|||
126594562|NCT04865289|455478015|FG001|Overall Study|Death|21|||
126594563|NCT02733159|455478018|FG000|Overall Study|Adverse Event|1|||
126594564|NCT02733159|455478018|FG000|Overall Study|Lack of disease progression|1|||
126594565|NCT06122194|455478019|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
126594566|NCT06122194|455478020|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
126594567|NCT06122194|455478021|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
126594568|NCT06122194|455478022|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
126594569|NCT03626220|455478031|FG000|Overall Study|Withdrawal by Subject|2|||
126594570|NCT03626220|455478032|FG001|Overall Study|Withdrawal by Subject|0|||
126594571|NCT03663569|455479075|FG000|Overall Study|Discontinuation of study|11|||
126594572|NCT03663569|455479075|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
126594573|NCT03663569|455479075|FG000|Overall Study|Deceased patient|6|||
126594574|NCT03663569|455479075|FG000|Overall Study|Lost to Follow-up|18|||
126594575|NCT03663569|455479075|FG000|Overall Study|Withdrawal of consent|5|||
126594576|NCT03663569|455479075|FG000|Overall Study|Patient's request|11|||
126594577|NCT03663569|455479075|FG000|Overall Study|Adverse Event|4|||
126594578|NCT03663569|455479075|FG000|Overall Study|Not come to second visit|3|||
126594579|NCT03663569|455479075|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
126594580|NCT03663569|455479075|FG000|Overall Study|Serious adverse event|1|||
126594581|NCT05877976|455479076|FG000|Overall Study|Lost to Follow-up|31|||
126594582|NCT04248725|455479077|FG000|Post-Treatment|Lost to Follow-up|6|||
126594583|NCT04248725|455479078|FG001|Post-Treatment|Lost to Follow-up|5|||
126594584|NCT04248725|455479077|FG000|6-Month Follow Up|Lost to Follow-up|9|||
126594585|NCT04248725|455479078|FG001|6-Month Follow Up|Lost to Follow-up|8|||
126594586|NCT05622812|455479079|FG000|Overall Study|Withdrawal by Subject|1|||
126594587|NCT05622812|455479080|FG001|Overall Study|Withdrawal by Subject|4|||
126594588|NCT05622812|455479079|FG000|Overall Study|Lost to Follow-up|2|||
126594589|NCT05622812|455479080|FG001|Overall Study|Lost to Follow-up|1|||
126594590|NCT03916185|455479081|FG000|Overall Study|Lost to Follow-up|0|||
126594591|NCT03916185|455479082|FG001|Overall Study|Lost to Follow-up|1|||
126594592|NCT03916185|455479083|FG002|Overall Study|Lost to Follow-up|0|||
126594593|NCT03916185|455479084|FG003|Overall Study|Lost to Follow-up|0|||
126594594|NCT03916185|455479081|FG000|Overall Study|Moved|1|||
126594595|NCT03916185|455479082|FG001|Overall Study|Moved|0|||
126594596|NCT03916185|455479083|FG002|Overall Study|Moved|0|||
126594597|NCT03916185|455479084|FG003|Overall Study|Moved|1|||
126594598|NCT03916185|455479081|FG000|Overall Study|Not Able to Get to Clinic|1|||
126594599|NCT03916185|455479082|FG001|Overall Study|Not Able to Get to Clinic|0|||
126594600|NCT03916185|455479083|FG002|Overall Study|Not Able to Get to Clinic|0|||
126594601|NCT03916185|455479084|FG003|Overall Study|Not Able to Get to Clinic|0|||
126594602|NCT02844465|455479091|FG000|Overall Study|Screen Failure|36|||
126594603|NCT02844465|455479091|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
126594604|NCT02844465|455479091|FG000|Overall Study|Withdrawal by Subject|5|||
126594605|NCT02844465|455479091|FG000|Overall Study|Lost to Follow-up|1|||
126594606|NCT02844465|455479091|FG000|Overall Study|Retreatment|1|||
126594607|NCT03819153|455479093|FG000|Overall Study|Withdrawal by Subject|20|||
126594608|NCT03819153|455479094|FG001|Overall Study|Withdrawal by Subject|28|||
126594609|NCT03819153|455479093|FG000|Overall Study|Lost to Follow-up|23|||
126594610|NCT03819153|455479094|FG001|Overall Study|Lost to Follow-up|30|||
126594611|NCT03240016|455479101|FG000|Overall Study|Adverse Event|9|||
126594612|NCT03240016|455479101|FG000|Overall Study|Withdrawal by Subject|7|||
126594613|NCT03240016|455479101|FG000|Overall Study|Death|1|||
126594614|NCT03240016|455479101|FG000|Overall Study|Physician Decision|2|||
126732233|NCT03448224|455968455|FG000|Overall Study|Provided same answer to every question|1|||
126732234|NCT03448224|455968456|FG001|Overall Study|Provided same answer to every question|0|||
126732235|NCT03103906|455968457|FG000|Overall Study|Adverse Event|2|||
126732236|NCT03103906|455968458|FG001|Overall Study|Adverse Event|3|||
126732237|NCT03103906|455968457|FG000|Overall Study|Other|2|||
126732238|NCT03103906|455968458|FG001|Overall Study|Other|0|||
126732239|NCT03571256|455968459|FG000|Overall Study|Adverse Event|3|||
126732240|NCT03571256|455968460|FG001|Overall Study|Adverse Event|0|||
126732241|NCT03571256|455968461|FG002|Overall Study|Adverse Event|1|||
126594615|NCT03913442|455479102|FG000|Overall Study|Adverse Event|0|||
126594616|NCT03913442|455479103|FG001|Overall Study|Adverse Event|3|||
126594617|NCT03913442|455479102|FG000|Overall Study|Withdrawal by Subject|5|||
126594618|NCT03913442|455479103|FG001|Overall Study|Withdrawal by Subject|5|||
126594619|NCT03913442|455479102|FG000|Overall Study|Terminations|2|||
126594620|NCT03913442|455479103|FG001|Overall Study|Terminations|1|||
126594621|NCT03913442|455479102|FG000|Overall Study|Lost to Follow-up|2|||
126594622|NCT03913442|455479103|FG001|Overall Study|Lost to Follow-up|2|||
126594623|NCT02460458|455479104|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
126594624|NCT02460458|455479104|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
126594625|NCT02460458|455479104|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
126594626|NCT02460458|455479104|FG000|First Prospective Phase|Lost to Follow-up|84|||
126594627|NCT02460458|455479104|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
126594628|NCT02593773|455479107|FG000|Overall Study|Voluntary Withdrawal|3|||
126594629|NCT02593773|455479107|FG000|Overall Study|Study Terminated by Sponsor|31|||
126594630|NCT02593773|455479107|FG000|Overall Study|Death|1|||
126594631|NCT05452460|455479111|FG000|Overall Study|Lost to Follow-up|3|||
126594632|NCT05452460|455479112|FG001|Overall Study|Lost to Follow-up|3|||
126594633|NCT05452460|455479111|FG000|Overall Study|Did not receive intervention|1|||
126594634|NCT05452460|455479112|FG001|Overall Study|Did not receive intervention|0|||
126594635|NCT01208662|455479115|FG000|Induction and Consolidation|Disease Progression|23|||
126594636|NCT01208662|455479116|FG001|Induction and Consolidation|Disease Progression|13|||
126594637|NCT01208662|455479117|FG002|Induction and Consolidation|Disease Progression|0|||
126594638|NCT01208662|455479115|FG000|Induction and Consolidation|Adverse Event|16|||
126594639|NCT01208662|455479116|FG001|Induction and Consolidation|Adverse Event|18|||
126594640|NCT01208662|455479117|FG002|Induction and Consolidation|Adverse Event|2|||
126594641|NCT01208662|455479115|FG000|Induction and Consolidation|MD or Participant Decision|16|||
126594642|NCT01208662|455479116|FG001|Induction and Consolidation|MD or Participant Decision|34|||
126594643|NCT01208662|455479117|FG002|Induction and Consolidation|MD or Participant Decision|4|||
126594644|NCT01208662|455479115|FG000|Induction and Consolidation|Death|1|||
126594645|NCT01208662|455479116|FG001|Induction and Consolidation|Death|3|||
126594646|NCT01208662|455479117|FG002|Induction and Consolidation|Death|1|||
126594647|NCT01208662|455479115|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
126594648|NCT01208662|455479116|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
126594649|NCT01208662|455479117|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
126594650|NCT01208662|455479115|FG000|Maintenance|Disease Progression|156|||
126594651|NCT01208662|455479116|FG001|Maintenance|Disease Progression|102|||
126594652|NCT01208662|455479117|FG002|Maintenance|Disease Progression|0|||
126594653|NCT01208662|455479115|FG000|Maintenance|Adverse Event|12|||
126594654|NCT01208662|455479116|FG001|Maintenance|Adverse Event|28|||
126594655|NCT01208662|455479117|FG002|Maintenance|Adverse Event|0|||
126594656|NCT01208662|455479115|FG000|Maintenance|MD or Participant Decision|24|||
126594657|NCT01208662|455479116|FG001|Maintenance|MD or Participant Decision|36|||
126594658|NCT01208662|455479117|FG002|Maintenance|MD or Participant Decision|0|||
126594659|NCT01208662|455479115|FG000|Maintenance|Death|0|||
126594660|NCT01208662|455479116|FG001|Maintenance|Death|3|||
126594661|NCT01208662|455479117|FG002|Maintenance|Death|0|||
126594662|NCT01208662|455479115|FG000|Maintenance|Discontinued for other reasons|21|||
126594663|NCT01208662|455479116|FG001|Maintenance|Discontinued for other reasons|31|||
126594664|NCT01208662|455479117|FG002|Maintenance|Discontinued for other reasons|0|||
126594665|NCT01208662|455479115|FG000|Maintenance|Still on Treatment|78|||
126594666|NCT01208662|455479116|FG001|Maintenance|Still on Treatment|89|||
126594667|NCT01208662|455479117|FG002|Maintenance|Still on Treatment|0|||
126594668|NCT04707625|455479118|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
126594669|NCT00321048|455479119|FG000|Overall Study|Withdrawal by Subject|6|||
126594670|NCT00321048|455479120|FG001|Overall Study|Withdrawal by Subject|8|||
126594671|NCT04471246|455479123|FG000|Overall Study|Lost to Follow-up|2|||
126594672|NCT04471246|455479124|FG001|Overall Study|Lost to Follow-up|2|||
126594673|NCT05764525|455479125|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
126594674|NCT05764525|455479126|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
126594675|NCT05764525|455479125|FG000|Overall Study|Withdrawal by Subject|4|||
126594676|NCT05764525|455479126|FG001|Overall Study|Withdrawal by Subject|8|||
126594677|NCT05764525|455479125|FG000|Overall Study|Physician Decision|1|||
126594678|NCT05764525|455479126|FG001|Overall Study|Physician Decision|0|||
126594679|NCT03334630|455479127|FG000|Overall Study|Withdrawal by Subject|7|||
126594680|NCT03334630|455479128|FG001|Overall Study|Withdrawal by Subject|7|||
126594681|NCT03334630|455479127|FG000|Overall Study|Lost to Follow-up|3|||
126732242|NCT03571256|455968459|FG000|Overall Study|Withdrawal by Subject|3|||
126732243|NCT03571256|455968460|FG001|Overall Study|Withdrawal by Subject|1|||
126732244|NCT03571256|455968461|FG002|Overall Study|Withdrawal by Subject|1|||
126732245|NCT03571256|455968459|FG000|Overall Study|Other than specified|0|||
126732246|NCT03571256|455968460|FG001|Overall Study|Other than specified|1|||
126732247|NCT03571256|455968461|FG002|Overall Study|Other than specified|1|||
126732248|NCT03571256|455968459|FG000|Overall Study|Protocol Violation|0|||
126594682|NCT03334630|455479128|FG001|Overall Study|Lost to Follow-up|1|||
126594683|NCT03334630|455479127|FG000|Overall Study|Adverse Event|0|||
126594684|NCT03334630|455479128|FG001|Overall Study|Adverse Event|1|||
126594685|NCT03334630|455479127|FG000|Overall Study|Physician Decision|1|||
126732249|NCT03571256|455968460|FG001|Overall Study|Protocol Violation|1|||
126594686|NCT03334630|455479128|FG001|Overall Study|Physician Decision|1|||
126594687|NCT03334630|455479127|FG000|Overall Study|Enrollment closed|2|||
126594688|NCT03334630|455479128|FG001|Overall Study|Enrollment closed|1|||
126594689|NCT03334630|455479127|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
126594690|NCT03334630|455479128|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
126594691|NCT03334630|455479127|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
126594692|NCT03334630|455479128|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
126594693|NCT03030261|455479133|FG000|Overall Study|Still receiving continuation therapy|5|||
126594694|NCT05907174|455479137|FG000|3-Month Assessment|Withdrawal by Subject|0|||
126594695|NCT05907174|455479138|FG001|3-Month Assessment|Withdrawal by Subject|0|||
126594696|NCT05907174|455479139|FG002|3-Month Assessment|Withdrawal by Subject|0|||
126594697|NCT05907174|455479140|FG003|3-Month Assessment|Withdrawal by Subject|1|||
126594698|NCT05907174|455479137|FG000|3-Month Assessment|Lost to Follow-up|1|||
126594699|NCT05907174|455479138|FG001|3-Month Assessment|Lost to Follow-up|1|||
126594700|NCT05907174|455479139|FG002|3-Month Assessment|Lost to Follow-up|1|||
126594701|NCT05907174|455479140|FG003|3-Month Assessment|Lost to Follow-up|1|||
126594702|NCT05907174|455479137|FG000|6-Month Assessment|Death|0|||
126594703|NCT05907174|455479138|FG001|6-Month Assessment|Death|0|||
126594704|NCT05907174|455479139|FG002|6-Month Assessment|Death|3|||
126594705|NCT05907174|455479140|FG003|6-Month Assessment|Death|0|||
126594706|NCT05907174|455479137|FG000|6-Month Assessment|Withdrawal by Subject|0|||
126594707|NCT05907174|455479138|FG001|6-Month Assessment|Withdrawal by Subject|0|||
126594708|NCT05907174|455479139|FG002|6-Month Assessment|Withdrawal by Subject|1|||
126594709|NCT05907174|455479140|FG003|6-Month Assessment|Withdrawal by Subject|1|||
126594710|NCT05907174|455479137|FG000|6-Month Assessment|Lost to Follow-up|0|||
126594711|NCT05907174|455479138|FG001|6-Month Assessment|Lost to Follow-up|1|||
126594712|NCT05907174|455479139|FG002|6-Month Assessment|Lost to Follow-up|1|||
126594713|NCT05907174|455479140|FG003|6-Month Assessment|Lost to Follow-up|1|||
126594714|NCT05093842|455479143|FG000|Overall Study|Pregnancy loss|1|||
126594715|NCT05093842|455479144|FG001|Overall Study|Pregnancy loss|1|||
126594716|NCT05093842|455479143|FG000|Overall Study|Lost to Follow-up|6|||
126594717|NCT05093842|455479144|FG001|Overall Study|Lost to Follow-up|0|||
126594718|NCT05093842|455479143|FG000|Overall Study|Physician Decision|0|||
126594719|NCT05093842|455479144|FG001|Overall Study|Physician Decision|1|||
126594720|NCT03910478|455479145|FG000|Overall Study|Death|13|||
126594721|NCT03910478|455479146|FG001|Overall Study|Death|6|||
126594722|NCT03910478|455479145|FG000|Overall Study|Withdrawal by Subject|23|||
126594723|NCT03910478|455479146|FG001|Overall Study|Withdrawal by Subject|2|||
126594724|NCT03910478|455479145|FG000|Overall Study|Physician Decision|5|||
126594725|NCT03910478|455479146|FG001|Overall Study|Physician Decision|0|||
126594726|NCT03910478|455479145|FG000|Overall Study|Protocol Violation|1|||
126594727|NCT03910478|455479146|FG001|Overall Study|Protocol Violation|0|||
126594728|NCT03910478|455479145|FG000|Overall Study|Failure to meet continuation criteria|2|||
126594729|NCT03910478|455479146|FG001|Overall Study|Failure to meet continuation criteria|0|||
126594730|NCT03910478|455479145|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
126594731|NCT03910478|455479146|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
126594732|NCT05293171|455479147|FG000|Washout 5 to 7 Days|Adverse Event|1|||
126594733|NCT05293171|455479148|FG001|Washout 5 to 7 Days|Adverse Event|1|||
126594734|NCT05293171|455479149|FG002|Washout 5 to 7 Days|Adverse Event|0|||
126594735|NCT05293171|455479150|FG003|Washout 5 to 7 Days|Adverse Event|0|||
126594736|NCT05293171|455479151|FG004|Washout 5 to 7 Days|Adverse Event|0|||
126594737|NCT05293171|455479152|FG005|Washout 5 to 7 Days|Adverse Event|0|||
126594738|NCT05293171|455479153|FG006|Washout 5 to 7 Days|Adverse Event|0|||
126594739|NCT05293171|455479154|FG007|Washout 5 to 7 Days|Adverse Event|0|||
126594740|NCT05293171|455479155|FG008|Washout 5 to 7 Days|Adverse Event|0|||
126594741|NCT05293171|455479156|FG009|Washout 5 to 7 Days|Adverse Event|0|||
126594742|NCT05293171|455479157|FG010|Washout 5 to 7 Days|Adverse Event|0|||
126594743|NCT05293171|455479158|FG011|Washout 5 to 7 Days|Adverse Event|0|||
126594744|NCT05293171|455479147|FG000|Washout 5 to 7 Days|Adverse Event|0|||
126594745|NCT05293171|455479148|FG001|Washout 5 to 7 Days|Adverse Event|0|||
126594746|NCT05293171|455479149|FG002|Washout 5 to 7 Days|Adverse Event|0|||
126594747|NCT05293171|455479150|FG003|Washout 5 to 7 Days|Adverse Event|0|||
126594748|NCT05293171|455479151|FG004|Washout 5 to 7 Days|Adverse Event|0|||
126594749|NCT05293171|455479152|FG005|Washout 5 to 7 Days|Adverse Event|1|||
126594750|NCT05293171|455479153|FG006|Washout 5 to 7 Days|Adverse Event|0|||
126732250|NCT03571256|455968461|FG002|Overall Study|Protocol Violation|1|||
126732251|NCT00575094|455968462|FG000|Overall Study|Adverse Event|2|||
126732252|NCT00575094|455968462|FG000|Overall Study|Withdrawal by Subject|1|||
126732253|NCT00772382|455968468|FG000|Overall Study|Adverse Event|19|||
126732254|NCT00772382|455968468|FG000|Overall Study|Death|6|||
126594751|NCT05293171|455479154|FG007|Washout 5 to 7 Days|Adverse Event|0|||
126594752|NCT05293171|455479155|FG008|Washout 5 to 7 Days|Adverse Event|0|||
126594753|NCT05293171|455479156|FG009|Washout 5 to 7 Days|Adverse Event|0|||
126594754|NCT05293171|455479157|FG010|Washout 5 to 7 Days|Adverse Event|0|||
126594755|NCT05293171|455479158|FG011|Washout 5 to 7 Days|Adverse Event|0|||
126732255|NCT00772382|455968468|FG000|Overall Study|Lack of Efficacy|4|||
126732256|NCT00772382|455968468|FG000|Overall Study|Physician Decision|5|||
126594756|NCT03734679|455479169|FG000|Overall Study|Missed Visit|1|||
126594757|NCT02887521|455479177|FG000|Overall Study|Withdrawal by Subject|0|||
126594758|NCT02887521|455479178|FG001|Overall Study|Withdrawal by Subject|3|||
126594759|NCT05299723|455480462|FG000|Overall Study|Withdrawal by Subject|0|||
126594760|NCT05299723|455480463|FG001|Overall Study|Withdrawal by Subject|2|||
126594761|NCT05299723|455480464|FG002|Overall Study|Withdrawal by Subject|0|||
126594762|NCT03220035|455480465|FG000|Overall Study|Adverse Event|1|||
126594763|NCT03220035|455480465|FG000|Overall Study|Protocol Violation|1|||
126594764|NCT03220035|455480465|FG000|Overall Study|Progressive Disease|2|||
126594765|NCT05934942|455480471|FG000|Run-in Period|Not treated|1|||
126594766|NCT05934942|455480471|FG000|Run-in Period|Withdrawal by Subject|1|||
126594767|NCT04447040|455480472|FG000|Overall Study|Lost to Follow-up|2|||
126594768|NCT04447040|455480473|FG001|Overall Study|Lost to Follow-up|1|||
126594769|NCT04447040|455480474|FG002|Overall Study|Lost to Follow-up|3|||
126594770|NCT04447040|455480475|FG003|Overall Study|Lost to Follow-up|3|||
126594771|NCT04447040|455480476|FG004|Overall Study|Lost to Follow-up|1|||
126594772|NCT04447040|455480477|FG005|Overall Study|Lost to Follow-up|3|||
126594773|NCT04447040|455480472|FG000|Overall Study|Withdrawal by Subject|0|||
126594774|NCT04447040|455480473|FG001|Overall Study|Withdrawal by Subject|1|||
126594775|NCT04447040|455480474|FG002|Overall Study|Withdrawal by Subject|1|||
126594776|NCT04447040|455480475|FG003|Overall Study|Withdrawal by Subject|1|||
126594777|NCT04447040|455480476|FG004|Overall Study|Withdrawal by Subject|0|||
126594778|NCT04447040|455480477|FG005|Overall Study|Withdrawal by Subject|0|||
126594779|NCT04076618|455480478|FG000|Overall Study|Lost to Follow-up|2|||
126594780|NCT04076618|455480479|FG001|Overall Study|Lost to Follow-up|1|||
126594781|NCT04076618|455480480|FG002|Overall Study|Lost to Follow-up|3|||
126594782|NCT04076618|455480478|FG000|Overall Study|Withdrawal by Subject|3|||
126594783|NCT04076618|455480479|FG001|Overall Study|Withdrawal by Subject|1|||
126594784|NCT04076618|455480480|FG002|Overall Study|Withdrawal by Subject|2|||
126594785|NCT04076618|455480478|FG000|Overall Study|Relocated out of state|0|||
126594786|NCT04076618|455480479|FG001|Overall Study|Relocated out of state|2|||
126594787|NCT04076618|455480480|FG002|Overall Study|Relocated out of state|0|||
126594788|NCT04076618|455480478|FG000|Overall Study|COVID concerns|0|||
126594789|NCT04076618|455480479|FG001|Overall Study|COVID concerns|1|||
126594790|NCT04076618|455480480|FG002|Overall Study|COVID concerns|0|||
126594791|NCT04076618|455480478|FG000|Overall Study|Adverse Event|0|||
126594792|NCT04076618|455480479|FG001|Overall Study|Adverse Event|0|||
126594793|NCT04076618|455480480|FG002|Overall Study|Adverse Event|2|||
126594794|NCT01928394|455480481|FG000|Treatment Period|Disease progression|17|||
126594795|NCT01928394|455480482|FG001|Treatment Period|Disease progression|2|||
126594796|NCT01928394|455480483|FG002|Treatment Period|Disease progression|12|||
126594797|NCT01928394|455480484|FG003|Treatment Period|Disease progression|48|||
126594798|NCT01928394|455480485|FG004|Treatment Period|Disease progression|3|||
126594799|NCT01928394|455480486|FG005|Treatment Period|Disease progression|25|||
126594800|NCT01928394|455480487|FG006|Treatment Period|Disease progression|38|||
126594801|NCT01928394|455480488|FG007|Treatment Period|Disease progression|16|||
126594802|NCT01928394|455480489|FG008|Treatment Period|Disease progression|3|||
126594803|NCT01928394|455480490|FG009|Treatment Period|Disease progression|11|||
126594804|NCT01928394|455480491|FG010|Treatment Period|Disease progression|22|||
126594805|NCT01928394|455480492|FG011|Treatment Period|Disease progression|73|||
126594806|NCT01928394|455480493|FG012|Treatment Period|Disease progression|38|||
126594807|NCT01928394|455480494|FG013|Treatment Period|Disease progression|118|||
126594808|NCT01928394|455480495|FG014|Treatment Period|Disease progression|59|||
126594809|NCT01928394|455480496|FG015|Treatment Period|Disease progression|1|||
126594810|NCT01928394|455480497|FG016|Treatment Period|Disease progression|43|||
126594811|NCT01928394|455480498|FG017|Treatment Period|Disease progression|56|||
126594812|NCT01928394|455480499|FG018|Treatment Period|Disease progression|50|||
126594813|NCT01928394|455480500|FG019|Treatment Period|Disease progression|71|||
126594814|NCT01928394|455480501|FG020|Treatment Period|Disease progression|30|||
126594815|NCT01928394|455480502|FG021|Treatment Period|Disease progression|31|||
126594816|NCT01928394|455480503|FG022|Treatment Period|Disease progression|31|||
126594817|NCT01928394|455480481|FG000|Treatment Period|Study drug toxicity|1|||
126594818|NCT01928394|455480482|FG001|Treatment Period|Study drug toxicity|1|||
126594819|NCT01928394|455480483|FG002|Treatment Period|Study drug toxicity|3|||
126594820|NCT01928394|455480484|FG003|Treatment Period|Study drug toxicity|3|||
126594821|NCT01928394|455480485|FG004|Treatment Period|Study drug toxicity|0|||
126594822|NCT01928394|455480486|FG005|Treatment Period|Study drug toxicity|9|||
126594823|NCT01928394|455480487|FG006|Treatment Period|Study drug toxicity|7|||
126594824|NCT01928394|455480488|FG007|Treatment Period|Study drug toxicity|1|||
126594825|NCT01928394|455480489|FG008|Treatment Period|Study drug toxicity|0|||
126594826|NCT01928394|455480490|FG009|Treatment Period|Study drug toxicity|5|||
126594827|NCT01928394|455480491|FG010|Treatment Period|Study drug toxicity|2|||
126594828|NCT01928394|455480492|FG011|Treatment Period|Study drug toxicity|3|||
126594829|NCT01928394|455480493|FG012|Treatment Period|Study drug toxicity|7|||
126594830|NCT01928394|455480494|FG013|Treatment Period|Study drug toxicity|5|||
126594831|NCT01928394|455480495|FG014|Treatment Period|Study drug toxicity|12|||
126594832|NCT01928394|455480496|FG015|Treatment Period|Study drug toxicity|0|||
126778733|NCT00410410|456145023|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
126778734|NCT00410410|456145024|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
126778735|NCT00410410|456145025|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
126778736|NCT00410410|456145026|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
126778737|NCT00410410|456145018|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
126778738|NCT00410410|456145019|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
126778739|NCT00410410|456145020|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
126778740|NCT00410410|456145021|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
126778741|NCT00410410|456145022|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
126778742|NCT00410410|456145023|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
126778743|NCT00410410|456145024|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
126778744|NCT00410410|456145025|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
126778745|NCT00410410|456145026|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
126778746|NCT00410410|456145018|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126778747|NCT00410410|456145019|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126778748|NCT00410410|456145020|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126778749|NCT00410410|456145021|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126778750|NCT00410410|456145022|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126778751|NCT00410410|456145023|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126778752|NCT00410410|456145024|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
126778753|NCT00410410|456145025|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
126778754|NCT00410410|456145026|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
126778755|NCT00410410|456145018|FG000|Open-Label Period (OL)|Death|0|||
126778756|NCT00410410|456145019|FG001|Open-Label Period (OL)|Death|0|||
126778757|NCT00410410|456145020|FG002|Open-Label Period (OL)|Death|0|||
126778758|NCT00410410|456145021|FG003|Open-Label Period (OL)|Death|0|||
126778759|NCT00410410|456145022|FG004|Open-Label Period (OL)|Death|0|||
126778760|NCT00410410|456145023|FG005|Open-Label Period (OL)|Death|0|||
126778761|NCT00410410|456145024|FG006|Open-Label Period (OL)|Death|0|||
126778762|NCT00410410|456145025|FG007|Open-Label Period (OL)|Death|0|||
126778763|NCT00410410|456145026|FG008|Open-Label Period (OL)|Death|1|||
126778764|NCT00410410|456145018|FG000|Open-Label Period (OL)|Adverse Event|0|||
126778765|NCT00410410|456145019|FG001|Open-Label Period (OL)|Adverse Event|0|||
126778766|NCT00410410|456145020|FG002|Open-Label Period (OL)|Adverse Event|0|||
126778767|NCT00410410|456145021|FG003|Open-Label Period (OL)|Adverse Event|0|||
126778768|NCT00410410|456145022|FG004|Open-Label Period (OL)|Adverse Event|0|||
126778769|NCT00410410|456145023|FG005|Open-Label Period (OL)|Adverse Event|0|||
126778770|NCT00410410|456145024|FG006|Open-Label Period (OL)|Adverse Event|0|||
126778771|NCT00410410|456145025|FG007|Open-Label Period (OL)|Adverse Event|0|||
126778772|NCT00410410|456145026|FG008|Open-Label Period (OL)|Adverse Event|10|||
126778773|NCT00410410|456145018|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
126778774|NCT00410410|456145019|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
126778775|NCT00410410|456145020|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
126778776|NCT00410410|456145021|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
126778777|NCT00410410|456145022|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
126778778|NCT00410410|456145023|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
126778779|NCT00410410|456145024|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
126778780|NCT00410410|456145025|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
126778781|NCT00410410|456145026|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
126778782|NCT00410410|456145018|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
126778783|NCT00410410|456145019|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
126778784|NCT00410410|456145020|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
126778785|NCT00410410|456145021|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
126778786|NCT00410410|456145022|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
126778787|NCT00410410|456145023|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
126778788|NCT00410410|456145024|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
126778789|NCT00410410|456145025|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
126778790|NCT00410410|456145026|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
126778791|NCT00410410|456145018|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
126778792|NCT00410410|456145019|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
126778793|NCT00410410|456145020|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
126594833|NCT01928394|455480497|FG016|Treatment Period|Study drug toxicity|3|||
126594834|NCT01928394|455480498|FG017|Treatment Period|Study drug toxicity|3|||
126594835|NCT01928394|455480499|FG018|Treatment Period|Study drug toxicity|12|||
126778794|NCT00410410|456145021|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
126778795|NCT00410410|456145022|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
126778796|NCT00410410|456145023|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
126778797|NCT00410410|456145024|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
126594836|NCT01928394|455480500|FG019|Treatment Period|Study drug toxicity|15|||
126778798|NCT00410410|456145025|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
126778799|NCT00410410|456145026|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
126778800|NCT00410410|456145018|FG000|Open-Label Period (OL)|Pregnancy|0|||
126778801|NCT00410410|456145019|FG001|Open-Label Period (OL)|Pregnancy|0|||
126732257|NCT00772382|455968468|FG000|Overall Study|Protocol Violation|1|||
126732258|NCT00772382|455968468|FG000|Overall Study|Withdrawal by Subject|10|||
126732259|NCT00772382|455968468|FG000|Overall Study|Other Reasons|10|||
126732260|NCT01512108|455969766|FG000|Overall Study|Adverse Event|9|||
126732261|NCT01512108|455969767|FG001|Overall Study|Adverse Event|4|||
126732262|NCT01512108|455969766|FG000|Overall Study|Protocol Violation|1|||
126732263|NCT01512108|455969767|FG001|Overall Study|Protocol Violation|2|||
126732264|NCT01512108|455969766|FG000|Overall Study|Withdrawal Criteria|1|||
126732265|NCT01512108|455969767|FG001|Overall Study|Withdrawal Criteria|0|||
126732266|NCT01512108|455969766|FG000|Overall Study|Unclassified|11|||
126732267|NCT01512108|455969767|FG001|Overall Study|Unclassified|3|||
126732268|NCT01824693|455969768|FG000|Overall Study|Death|0|||
126732269|NCT01824693|455969769|FG001|Overall Study|Death|1|||
126732270|NCT01824693|455969770|FG002|Overall Study|Death|0|||
126732271|NCT01824693|455969768|FG000|Overall Study|Physician Decision|1|||
126732272|NCT01824693|455969769|FG001|Overall Study|Physician Decision|1|||
126732273|NCT01824693|455969770|FG002|Overall Study|Physician Decision|1|||
126732274|NCT01824693|455969768|FG000|Overall Study|Withdrawal by Subject|0|||
126732275|NCT01824693|455969769|FG001|Overall Study|Withdrawal by Subject|0|||
126732276|NCT01824693|455969770|FG002|Overall Study|Withdrawal by Subject|1|||
126732277|NCT01824693|455969768|FG000|Overall Study|Progressive Disease|0|||
126732278|NCT01824693|455969769|FG001|Overall Study|Progressive Disease|5|||
126732279|NCT01824693|455969770|FG002|Overall Study|Progressive Disease|0|||
126732280|NCT01824693|455969768|FG000|Overall Study|Ineligible|0|||
126732281|NCT01824693|455969769|FG001|Overall Study|Ineligible|0|||
126732282|NCT01824693|455969770|FG002|Overall Study|Ineligible|3|||
126732283|NCT01824693|455969768|FG000|Overall Study|No Transplant Planned|0|||
126732284|NCT01824693|455969769|FG001|Overall Study|No Transplant Planned|0|||
126732285|NCT01824693|455969770|FG002|Overall Study|No Transplant Planned|10|||
126732286|NCT03287869|455969773|FG000|Overall Study|Adverse Event|14|||
126732287|NCT03287869|455969774|FG001|Overall Study|Adverse Event|12|||
126732288|NCT03287869|455969773|FG000|Overall Study|Lack of Efficacy|1|||
126732289|NCT03287869|455969774|FG001|Overall Study|Lack of Efficacy|0|||
126732290|NCT03287869|455969773|FG000|Overall Study|Lost to Follow-up|13|||
126732291|NCT03287869|455969774|FG001|Overall Study|Lost to Follow-up|19|||
126732292|NCT03287869|455969773|FG000|Overall Study|Non-Compliance With Study Drug|5|||
126732293|NCT03287869|455969774|FG001|Overall Study|Non-Compliance With Study Drug|9|||
126732294|NCT03287869|455969773|FG000|Overall Study|Progressive Disease|1|||
126732295|NCT03287869|455969774|FG001|Overall Study|Progressive Disease|0|||
126732296|NCT03287869|455969773|FG000|Overall Study|Protocol Deviation|2|||
126732297|NCT03287869|455969774|FG001|Overall Study|Protocol Deviation|1|||
126732298|NCT03287869|455969773|FG000|Overall Study|Withdrawal by Subject|36|||
126732299|NCT03287869|455969774|FG001|Overall Study|Withdrawal by Subject|43|||
126732300|NCT03287869|455969773|FG000|Overall Study|Early Closure of the Site|0|||
126732301|NCT03287869|455969774|FG001|Overall Study|Early Closure of the Site|1|||
126732302|NCT03287869|455969773|FG000|Overall Study|Physician Decision|5|||
126732303|NCT03287869|455969774|FG001|Overall Study|Physician Decision|5|||
126732304|NCT03287869|455969773|FG000|Overall Study|Reason not Specified|6|||
126732305|NCT03287869|455969774|FG001|Overall Study|Reason not Specified|3|||
126732306|NCT03488238|455969775|FG000|Overall Study|Equipment malfunction|1|||
126732307|NCT03488238|455969775|FG000|Overall Study|Adverse Event|1|||
126732308|NCT00656084|455969776|FG000|Overall Study|Adverse Event|4|||
126732309|NCT00656084|455969776|FG000|Overall Study|Withdrawal by Subject|1|||
126732310|NCT00656084|455969776|FG000|Overall Study|Patient Request|1|||
126732311|NCT00656084|455969776|FG000|Overall Study|Investigator Request|1|||
126732312|NCT02591238|455969777|FG000|Overall Study|Pregnancy|1|||
126732313|NCT02591238|455969778|FG001|Overall Study|Pregnancy|0|||
126732314|NCT02591238|455969779|FG002|Overall Study|Pregnancy|0|||
126732315|NCT02591238|455969780|FG003|Overall Study|Pregnancy|0|||
126732316|NCT02591238|455969777|FG000|Overall Study|Withdrawal by Subject|0|||
126732317|NCT02591238|455969778|FG001|Overall Study|Withdrawal by Subject|0|||
126732318|NCT02591238|455969779|FG002|Overall Study|Withdrawal by Subject|0|||
126732319|NCT02591238|455969780|FG003|Overall Study|Withdrawal by Subject|1|||
126732320|NCT02591238|455969777|FG000|Overall Study|influenza|0|||
126732321|NCT02591238|455969778|FG001|Overall Study|influenza|0|||
126732322|NCT02591238|455969779|FG002|Overall Study|influenza|0|||
126732323|NCT02591238|455969780|FG003|Overall Study|influenza|1|||
126732324|NCT02591238|455969777|FG000|Overall Study|personal circumstances|0|||
126732325|NCT02591238|455969778|FG001|Overall Study|personal circumstances|0|||
126732326|NCT02591238|455969779|FG002|Overall Study|personal circumstances|0|||
126732327|NCT02591238|455969780|FG003|Overall Study|personal circumstances|1|||
126732328|NCT02591238|455969777|FG000|Overall Study|personal circumstances|0|||
126732329|NCT02591238|455969778|FG001|Overall Study|personal circumstances|1|||
126732330|NCT02591238|455969779|FG002|Overall Study|personal circumstances|0|||
126732331|NCT02591238|455969780|FG003|Overall Study|personal circumstances|0|||
126732332|NCT00953225|455969781|FG000|Overall Study|Withdrawal by Subject|2|||
126732333|NCT00953225|455969782|FG001|Overall Study|Withdrawal by Subject|0|||
126732334|NCT00640146|455969786|FG000|Overall Study|Adverse Event|2|||
126732335|NCT00640146|455969787|FG001|Overall Study|Adverse Event|0|||
126732336|NCT00640146|455969786|FG000|Overall Study|Lost to Follow-up|0|||
126594837|NCT01928394|455480501|FG020|Treatment Period|Study drug toxicity|4|||
126594838|NCT01928394|455480502|FG021|Treatment Period|Study drug toxicity|7|||
126594839|NCT01928394|455480503|FG022|Treatment Period|Study drug toxicity|4|||
126594840|NCT01928394|455480481|FG000|Treatment Period|AE unrelated to study drug|0|||
126594841|NCT01928394|455480482|FG001|Treatment Period|AE unrelated to study drug|0|||
126594842|NCT01928394|455480483|FG002|Treatment Period|AE unrelated to study drug|2|||
126594843|NCT01928394|455480484|FG003|Treatment Period|AE unrelated to study drug|3|||
126594844|NCT01928394|455480485|FG004|Treatment Period|AE unrelated to study drug|0|||
126594845|NCT01928394|455480486|FG005|Treatment Period|AE unrelated to study drug|5|||
126594846|NCT01928394|455480487|FG006|Treatment Period|AE unrelated to study drug|1|||
126594847|NCT01928394|455480488|FG007|Treatment Period|AE unrelated to study drug|0|||
126594848|NCT01928394|455480489|FG008|Treatment Period|AE unrelated to study drug|0|||
126594849|NCT01928394|455480490|FG009|Treatment Period|AE unrelated to study drug|2|||
126594850|NCT01928394|455480491|FG010|Treatment Period|AE unrelated to study drug|0|||
126594851|NCT01928394|455480492|FG011|Treatment Period|AE unrelated to study drug|12|||
126594852|NCT01928394|455480493|FG012|Treatment Period|AE unrelated to study drug|6|||
126594853|NCT01928394|455480494|FG013|Treatment Period|AE unrelated to study drug|13|||
126594854|NCT01928394|455480495|FG014|Treatment Period|AE unrelated to study drug|6|||
126594855|NCT01928394|455480496|FG015|Treatment Period|AE unrelated to study drug|1|||
126594856|NCT01928394|455480497|FG016|Treatment Period|AE unrelated to study drug|1|||
126594857|NCT01928394|455480498|FG017|Treatment Period|AE unrelated to study drug|6|||
126594858|NCT01928394|455480499|FG018|Treatment Period|AE unrelated to study drug|3|||
126594859|NCT01928394|455480500|FG019|Treatment Period|AE unrelated to study drug|5|||
126594860|NCT01928394|455480501|FG020|Treatment Period|AE unrelated to study drug|1|||
126594861|NCT01928394|455480502|FG021|Treatment Period|AE unrelated to study drug|1|||
126594862|NCT01928394|455480503|FG022|Treatment Period|AE unrelated to study drug|0|||
126594863|NCT01928394|455480481|FG000|Treatment Period|Participant request to stop therapy|0|||
126594864|NCT01928394|455480482|FG001|Treatment Period|Participant request to stop therapy|0|||
126594865|NCT01928394|455480483|FG002|Treatment Period|Participant request to stop therapy|0|||
126594866|NCT01928394|455480484|FG003|Treatment Period|Participant request to stop therapy|0|||
126594867|NCT01928394|455480485|FG004|Treatment Period|Participant request to stop therapy|0|||
126594868|NCT01928394|455480486|FG005|Treatment Period|Participant request to stop therapy|3|||
126594869|NCT01928394|455480487|FG006|Treatment Period|Participant request to stop therapy|3|||
126594870|NCT01928394|455480488|FG007|Treatment Period|Participant request to stop therapy|0|||
126594871|NCT01928394|455480489|FG008|Treatment Period|Participant request to stop therapy|0|||
126594872|NCT01928394|455480490|FG009|Treatment Period|Participant request to stop therapy|0|||
126594873|NCT01928394|455480491|FG010|Treatment Period|Participant request to stop therapy|3|||
126594874|NCT01928394|455480492|FG011|Treatment Period|Participant request to stop therapy|2|||
126594875|NCT01928394|455480493|FG012|Treatment Period|Participant request to stop therapy|1|||
126594876|NCT01928394|455480494|FG013|Treatment Period|Participant request to stop therapy|2|||
126594877|NCT01928394|455480495|FG014|Treatment Period|Participant request to stop therapy|4|||
126594878|NCT01928394|455480496|FG015|Treatment Period|Participant request to stop therapy|0|||
126594879|NCT01928394|455480497|FG016|Treatment Period|Participant request to stop therapy|1|||
126594880|NCT01928394|455480498|FG017|Treatment Period|Participant request to stop therapy|3|||
126594881|NCT01928394|455480499|FG018|Treatment Period|Participant request to stop therapy|1|||
126594882|NCT01928394|455480500|FG019|Treatment Period|Participant request to stop therapy|1|||
126594883|NCT01928394|455480501|FG020|Treatment Period|Participant request to stop therapy|3|||
126594884|NCT01928394|455480502|FG021|Treatment Period|Participant request to stop therapy|1|||
126594885|NCT01928394|455480503|FG022|Treatment Period|Participant request to stop therapy|3|||
126594886|NCT01928394|455480481|FG000|Treatment Period|Participant withdrew consent|0|||
126594887|NCT01928394|455480482|FG001|Treatment Period|Participant withdrew consent|0|||
126594888|NCT01928394|455480483|FG002|Treatment Period|Participant withdrew consent|1|||
126594889|NCT01928394|455480484|FG003|Treatment Period|Participant withdrew consent|1|||
126594890|NCT01928394|455480485|FG004|Treatment Period|Participant withdrew consent|0|||
126594891|NCT01928394|455480486|FG005|Treatment Period|Participant withdrew consent|1|||
126594892|NCT01928394|455480487|FG006|Treatment Period|Participant withdrew consent|0|||
126594893|NCT01928394|455480488|FG007|Treatment Period|Participant withdrew consent|1|||
126594894|NCT01928394|455480489|FG008|Treatment Period|Participant withdrew consent|0|||
126594895|NCT01928394|455480490|FG009|Treatment Period|Participant withdrew consent|0|||
126594896|NCT01928394|455480491|FG010|Treatment Period|Participant withdrew consent|1|||
126594897|NCT01928394|455480492|FG011|Treatment Period|Participant withdrew consent|1|||
126594898|NCT01928394|455480493|FG012|Treatment Period|Participant withdrew consent|1|||
126594899|NCT01928394|455480494|FG013|Treatment Period|Participant withdrew consent|0|||
126594900|NCT01928394|455480495|FG014|Treatment Period|Participant withdrew consent|2|||
126594901|NCT01928394|455480496|FG015|Treatment Period|Participant withdrew consent|0|||
126594902|NCT01928394|455480497|FG016|Treatment Period|Participant withdrew consent|2|||
126594903|NCT01928394|455480498|FG017|Treatment Period|Participant withdrew consent|1|||
126594904|NCT01928394|455480499|FG018|Treatment Period|Participant withdrew consent|1|||
126594905|NCT01928394|455480500|FG019|Treatment Period|Participant withdrew consent|1|||
126778802|NCT00410410|456145020|FG002|Open-Label Period (OL)|Pregnancy|0|||
126778803|NCT00410410|456145021|FG003|Open-Label Period (OL)|Pregnancy|0|||
126778804|NCT00410410|456145022|FG004|Open-Label Period (OL)|Pregnancy|0|||
126778805|NCT00410410|456145023|FG005|Open-Label Period (OL)|Pregnancy|0|||
126778806|NCT00410410|456145024|FG006|Open-Label Period (OL)|Pregnancy|0|||
126778807|NCT00410410|456145025|FG007|Open-Label Period (OL)|Pregnancy|0|||
126778808|NCT00410410|456145026|FG008|Open-Label Period (OL)|Pregnancy|1|||
126778809|NCT00410410|456145018|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126778810|NCT00410410|456145019|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126778811|NCT00410410|456145020|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126778812|NCT00410410|456145021|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126778813|NCT00410410|456145022|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126778814|NCT00410410|456145023|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126778815|NCT00410410|456145024|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126778816|NCT00410410|456145025|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
126778817|NCT00410410|456145026|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
126778818|NCT00410410|456145018|FG000|Open-Label Period (OL)|Other|0|||
126778819|NCT00410410|456145019|FG001|Open-Label Period (OL)|Other|0|||
126778820|NCT00410410|456145020|FG002|Open-Label Period (OL)|Other|0|||
126778821|NCT00410410|456145021|FG003|Open-Label Period (OL)|Other|0|||
126778822|NCT00410410|456145022|FG004|Open-Label Period (OL)|Other|0|||
126778823|NCT00410410|456145023|FG005|Open-Label Period (OL)|Other|0|||
126778824|NCT00410410|456145024|FG006|Open-Label Period (OL)|Other|0|||
126778825|NCT00410410|456145025|FG007|Open-Label Period (OL)|Other|0|||
126778826|NCT00410410|456145026|FG008|Open-Label Period (OL)|Other|7|||
126778827|NCT01023269|456145027|FG000|Overall Study|early termination of the study|2|||
126778828|NCT01023269|456145028|FG001|Overall Study|early termination of the study|0|||
126778829|NCT00814658|456145030|FG000|Overall Study|Lost to Follow-up|0|||
126778830|NCT00814658|456145031|FG001|Overall Study|Lost to Follow-up|1|||
126778831|NCT00814658|456145030|FG000|Overall Study|Physician Decision|1|||
126778832|NCT00814658|456145031|FG001|Overall Study|Physician Decision|0|||
126778833|NCT00814658|456145030|FG000|Overall Study|Adverse Event|3|||
126778834|NCT00814658|456145031|FG001|Overall Study|Adverse Event|3|||
126778835|NCT02868281|456145032|FG000|Overall Study|Adverse Event|2|||
126778836|NCT02868281|456145033|FG001|Overall Study|Adverse Event|2|||
126778837|NCT02868281|456145032|FG000|Overall Study|Protocol Violation|13|||
126778838|NCT02868281|456145033|FG001|Overall Study|Protocol Violation|10|||
126778839|NCT02868281|456145032|FG000|Overall Study|Lost to Follow-up|3|||
126778840|NCT02868281|456145033|FG001|Overall Study|Lost to Follow-up|6|||
126778841|NCT02868281|456145032|FG000|Overall Study|Withdrawal by Subject|11|||
126778842|NCT02868281|456145033|FG001|Overall Study|Withdrawal by Subject|15|||
126778843|NCT02868281|456145032|FG000|Overall Study|Physician Decision|2|||
126778844|NCT02868281|456145033|FG001|Overall Study|Physician Decision|0|||
126778845|NCT02868281|456145032|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
126778846|NCT02868281|456145033|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
126778847|NCT02868281|456145032|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
126778848|NCT02868281|456145033|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
126778849|NCT02868281|456145032|FG000|Overall Study|Long journey/moving away|1|||
126778850|NCT02868281|456145033|FG001|Overall Study|Long journey/moving away|1|||
126778851|NCT01783730|456145037|FG000|Overall Study|Failed to meet inclusion criteria|6|||
126778852|NCT01841359|456145038|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
126778853|NCT01841359|456145038|FG000|Overall Study|Concommitant medical issues|2|||
126778854|NCT01841359|456145038|FG000|Overall Study|Adverse Event|3|||
126778855|NCT01841359|456145038|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
126778856|NCT02151461|456145039|FG000|Overall Study|Adverse Event|5|||
126778857|NCT02151461|456145040|FG001|Overall Study|Adverse Event|1|||
126778858|NCT02151461|456145041|FG002|Overall Study|Adverse Event|0|||
126778859|NCT02151461|456145042|FG003|Overall Study|Adverse Event|2|||
126778860|NCT02151461|456145039|FG000|Overall Study|Lost to Follow-up|0|||
126778861|NCT02151461|456145040|FG001|Overall Study|Lost to Follow-up|0|||
126778862|NCT02151461|456145041|FG002|Overall Study|Lost to Follow-up|1|||
126778863|NCT02151461|456145042|FG003|Overall Study|Lost to Follow-up|1|||
126778864|NCT02151461|456145039|FG000|Overall Study|Withdrawal by Subject|1|||
126778865|NCT02151461|456145040|FG001|Overall Study|Withdrawal by Subject|0|||
126778866|NCT02151461|456145041|FG002|Overall Study|Withdrawal by Subject|1|||
126778867|NCT02151461|456145042|FG003|Overall Study|Withdrawal by Subject|1|||
126778868|NCT02151461|456145039|FG000|Overall Study|Treatment discontinuation|0|||
126778869|NCT02151461|456145040|FG001|Overall Study|Treatment discontinuation|0|||
126778870|NCT02151461|456145041|FG002|Overall Study|Treatment discontinuation|1|||
126778871|NCT02151461|456145042|FG003|Overall Study|Treatment discontinuation|0|||
126778872|NCT02168270|456145043|FG000|Overall Study|Lack of Efficacy|4|||
126778873|NCT01102777|456145044|FG000|Overall Study|Death|2|||
126778874|NCT01102777|456145045|FG001|Overall Study|Death|6|||
126778875|NCT01102777|456145044|FG000|Overall Study|Lost to Follow-up|7|||
126778876|NCT01102777|456145045|FG001|Overall Study|Lost to Follow-up|10|||
126778877|NCT00771901|456145046|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
126778878|NCT00771901|456145047|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
126778879|NCT00771901|456145048|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
126778880|NCT01965652|456145049|FG000|Overall Study|Adverse Event|40|||
126778881|NCT01965652|456145050|FG001|Overall Study|Adverse Event|37|||
126778882|NCT01965652|456145049|FG000|Overall Study|Withdrawal by Subject|62|||
126778883|NCT01965652|456145050|FG001|Overall Study|Withdrawal by Subject|69|||
126778884|NCT01965652|456145049|FG000|Overall Study|Lost to Follow-up|53|||
126778885|NCT01965652|456145050|FG001|Overall Study|Lost to Follow-up|40|||
126778886|NCT01965652|456145049|FG000|Overall Study|Protocol Violation|34|||
126778887|NCT01965652|456145050|FG001|Overall Study|Protocol Violation|38|||
126778888|NCT01965652|456145049|FG000|Overall Study|Death|3|||
126778889|NCT01965652|456145050|FG001|Overall Study|Death|4|||
126778890|NCT01965652|456145049|FG000|Overall Study|Other - Miscellaneous|18|||
126778891|NCT01965652|456145050|FG001|Overall Study|Other - Miscellaneous|21|||
126778892|NCT01965652|456145049|FG000|Overall Study|Pregnancy|0|||
126778893|NCT01965652|456145050|FG001|Overall Study|Pregnancy|1|||
126778894|NCT01121900|456145051|FG000|First Intervention Period|Adverse Event|1|||
126778895|NCT01121900|456145052|FG001|First Intervention Period|Adverse Event|1|||
126778896|NCT01121900|456145051|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
126778897|NCT01121900|456145052|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126778898|NCT01328054|456145053|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
126778899|NCT01328054|456145054|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
126778900|NCT01328054|456145053|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
126778901|NCT01328054|456145054|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
126778902|NCT01328054|456145053|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
126778903|NCT01328054|456145054|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
126778904|NCT03493698|456145055|FG000|Treatment Period C|Adverse Event|1|||
126778905|NCT03493698|456145055|FG000|Treatment Period C|Withdrawal by Subject|1|||
126778906|NCT03760510|456145056|FG000|Overall Study|Not ventilated for 24 hours|105|||
126732337|NCT00640146|455969787|FG001|Overall Study|Lost to Follow-up|1|||
126732338|NCT00640146|455969786|FG000|Overall Study|Lack of Efficacy|0|||
126732339|NCT00640146|455969787|FG001|Overall Study|Lack of Efficacy|1|||
126732340|NCT00640146|455969786|FG000|Overall Study|Withdrawal by Subject|1|||
126732341|NCT00640146|455969787|FG001|Overall Study|Withdrawal by Subject|1|||
126732342|NCT00640146|455969786|FG000|Overall Study|Randomized but not treated|1|||
126732343|NCT00640146|455969787|FG001|Overall Study|Randomized but not treated|3|||
126732344|NCT00520299|455969788|FG000|Overall Study|Withdrawal by Subject|0|||
126732345|NCT00520299|455969789|FG001|Overall Study|Withdrawal by Subject|0|||
126732346|NCT00520299|455969790|FG002|Overall Study|Withdrawal by Subject|2|||
126732347|NCT00520299|455969788|FG000|Overall Study|Progressive disease|0|||
126732348|NCT00520299|455969789|FG001|Overall Study|Progressive disease|3|||
126732349|NCT00520299|455969790|FG002|Overall Study|Progressive disease|4|||
126732350|NCT01357980|455969792|FG000|Overall Study|Lack of Efficacy|0|||
126732351|NCT01357980|455969793|FG001|Overall Study|Lack of Efficacy|1|||
126732352|NCT01357980|455969794|FG002|Overall Study|Lack of Efficacy|0|||
126732353|NCT01357980|455969795|FG003|Overall Study|Lack of Efficacy|0|||
126732354|NCT01357980|455969792|FG000|Overall Study|Consent withdrawn|0|||
126732355|NCT01357980|455969793|FG001|Overall Study|Consent withdrawn|0|||
126732356|NCT01357980|455969794|FG002|Overall Study|Consent withdrawn|1|||
126732357|NCT01357980|455969795|FG003|Overall Study|Consent withdrawn|0|||
126732358|NCT02293993|455969797|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
126732359|NCT02293993|455969798|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
126732360|NCT02293993|455969799|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
126732361|NCT02293993|455969800|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
126732362|NCT02293993|455969797|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
126732363|NCT02293993|455969798|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
126732364|NCT02293993|455969799|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
126732365|NCT02293993|455969800|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
126732366|NCT02293993|455969797|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
126732367|NCT02293993|455969798|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
126732368|NCT02293993|455969799|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
126732369|NCT02293993|455969800|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
126732370|NCT02293993|455969797|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
126732371|NCT02293993|455969798|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
126732372|NCT02293993|455969799|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
126732373|NCT02293993|455969800|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
126778907|NCT03760510|456145057|FG001|Overall Study|Not ventilated for 24 hours|97|||
126778908|NCT00291330|456145060|FG000|Overall Study|Adverse Event|47|||
126778909|NCT00291330|456145061|FG001|Overall Study|Adverse Event|40|||
126778910|NCT00291330|456145060|FG000|Overall Study|Protocol Violation|13|||
126778911|NCT00291330|456145061|FG001|Overall Study|Protocol Violation|20|||
126778912|NCT00291330|456145060|FG000|Overall Study|Lost to Follow-up|16|||
126778913|NCT00291330|456145061|FG001|Overall Study|Lost to Follow-up|11|||
126778914|NCT00291330|456145060|FG000|Overall Study|Withdrawal by Subject|22|||
126778915|NCT00291330|456145061|FG001|Overall Study|Withdrawal by Subject|25|||
126778916|NCT00291330|456145060|FG000|Overall Study|Other|3|||
126778917|NCT00291330|456145061|FG001|Overall Study|Other|1|||
126778918|NCT00566709|456145064|FG000|Overall Study|Protocol Violation|5|||
126778919|NCT00566709|456145065|FG001|Overall Study|Protocol Violation|0|||
126778920|NCT01829295|456145066|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
126778921|NCT01829295|456145067|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
126778922|NCT01829295|456145068|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
126778923|NCT01829295|456145069|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
126778924|NCT01829295|456145066|FG000|6-12 Months|Adverse Event|0|||
126778925|NCT01829295|456145067|FG001|6-12 Months|Adverse Event|0|||
126778926|NCT01829295|456145068|FG002|6-12 Months|Adverse Event|3|||
126778927|NCT01829295|456145069|FG003|6-12 Months|Adverse Event|2|||
126778928|NCT01829295|456145066|FG000|6-12 Months|Lost to Follow-up|2|||
126778929|NCT01829295|456145067|FG001|6-12 Months|Lost to Follow-up|0|||
126778930|NCT01829295|456145068|FG002|6-12 Months|Lost to Follow-up|0|||
126778931|NCT01829295|456145069|FG003|6-12 Months|Lost to Follow-up|0|||
126778932|NCT01829295|456145066|FG000|6-12 Months|Withdrawal by Subject|2|||
126778933|NCT01829295|456145067|FG001|6-12 Months|Withdrawal by Subject|2|||
126778934|NCT01829295|456145068|FG002|6-12 Months|Withdrawal by Subject|0|||
126778935|NCT01829295|456145069|FG003|6-12 Months|Withdrawal by Subject|0|||
126778936|NCT03443869|456145070|FG000|Overall Study|Death|3|||
126778937|NCT03443869|456145071|FG001|Overall Study|Death|3|||
126778938|NCT03443869|456145070|FG000|Overall Study|Withdrawal by Subject|34|||
126778939|NCT03443869|456145071|FG001|Overall Study|Withdrawal by Subject|22|||
126778940|NCT03443869|456145070|FG000|Overall Study|Lost to Follow-up|1|||
126778941|NCT03443869|456145071|FG001|Overall Study|Lost to Follow-up|2|||
126778942|NCT03443869|456145070|FG000|Overall Study|Physician Decision|3|||
126778943|NCT03443869|456145071|FG001|Overall Study|Physician Decision|3|||
126778944|NCT03443869|456145070|FG000|Overall Study|Other|4|||
126778945|NCT03443869|456145071|FG001|Overall Study|Other|4|||
126778946|NCT00299728|456145072|FG000|Overall Study|Lost to Follow-up|0|||
126778947|NCT00299728|456145073|FG001|Overall Study|Lost to Follow-up|1|||
126778948|NCT00299728|456145072|FG000|Overall Study|Withdrawal by Subject|0|||
126778949|NCT00299728|456145073|FG001|Overall Study|Withdrawal by Subject|1|||
126778950|NCT00299728|456145072|FG000|Overall Study|Progressive disease|0|||
126778951|NCT00299728|456145073|FG001|Overall Study|Progressive disease|1|||
126594906|NCT01928394|455480501|FG020|Treatment Period|Participant withdrew consent|0|||
126594907|NCT01928394|455480502|FG021|Treatment Period|Participant withdrew consent|2|||
126594908|NCT01928394|455480503|FG022|Treatment Period|Participant withdrew consent|0|||
126778952|NCT02826603|456145074|FG000|Overall Study|Adverse Event|17|||
126778953|NCT02826603|456145075|FG001|Overall Study|Adverse Event|9|||
126778954|NCT02826603|456145074|FG000|Overall Study|Lack of Efficacy|4|||
126778955|NCT02826603|456145075|FG001|Overall Study|Lack of Efficacy|9|||
126778956|NCT02826603|456145074|FG000|Overall Study|Lost to Follow-up|13|||
126778957|NCT02826603|456145075|FG001|Overall Study|Lost to Follow-up|12|||
126778958|NCT02826603|456145074|FG000|Overall Study|Noncompliance with treatment|0|||
126778959|NCT02826603|456145075|FG001|Overall Study|Noncompliance with treatment|2|||
126778960|NCT02826603|456145074|FG000|Overall Study|Physician Decision|1|||
126778961|NCT02826603|456145075|FG001|Overall Study|Physician Decision|7|||
126778962|NCT02826603|456145074|FG000|Overall Study|Pregnancy|1|||
126778963|NCT02826603|456145075|FG001|Overall Study|Pregnancy|2|||
126778964|NCT02826603|456145074|FG000|Overall Study|Protocol Violation|3|||
126778965|NCT02826603|456145075|FG001|Overall Study|Protocol Violation|3|||
126778966|NCT02826603|456145074|FG000|Overall Study|Withdrawal by Subject|20|||
126778967|NCT02826603|456145075|FG001|Overall Study|Withdrawal by Subject|19|||
126778968|NCT02826603|456145074|FG000|Overall Study|Death|2|||
126778969|NCT02826603|456145075|FG001|Overall Study|Death|0|||
126778970|NCT02826603|456145074|FG000|Overall Study|New therapy for study indication|0|||
126778971|NCT02826603|456145075|FG001|Overall Study|New therapy for study indication|1|||
126778972|NCT00409188|456146827|FG000|Overall Study|Ongoing at data cut-off|383|||
126778973|NCT00409188|456146828|FG001|Overall Study|Ongoing at data cut-off|175|||
126594909|NCT01928394|455480481|FG000|Treatment Period|Poor/non-compliance|0|||
126594910|NCT01928394|455480482|FG001|Treatment Period|Poor/non-compliance|0|||
126594911|NCT01928394|455480483|FG002|Treatment Period|Poor/non-compliance|0|||
126594912|NCT01928394|455480484|FG003|Treatment Period|Poor/non-compliance|1|||
126778974|NCT01393990|456146832|FG000|Overall Study|Adverse Event|0|||
126778975|NCT01393990|456146833|FG001|Overall Study|Adverse Event|0|||
126778976|NCT01393990|456146834|FG002|Overall Study|Adverse Event|0|||
126778977|NCT01393990|456146835|FG003|Overall Study|Adverse Event|0|||
126778978|NCT01393990|456146836|FG004|Overall Study|Adverse Event|0|||
126778979|NCT01393990|456146837|FG005|Overall Study|Adverse Event|0|||
126778980|NCT01393990|456146838|FG006|Overall Study|Adverse Event|0|||
126778981|NCT01393990|456146839|FG007|Overall Study|Adverse Event|0|||
126778982|NCT01393990|456146840|FG008|Overall Study|Adverse Event|0|||
126778983|NCT01393990|456146841|FG009|Overall Study|Adverse Event|0|||
126778984|NCT01393990|456146842|FG010|Overall Study|Adverse Event|0|||
126778985|NCT01393990|456146843|FG011|Overall Study|Adverse Event|0|||
126778986|NCT01393990|456146844|FG012|Overall Study|Adverse Event|0|||
126778987|NCT01393990|456146845|FG013|Overall Study|Adverse Event|0|||
126778988|NCT01393990|456146846|FG014|Overall Study|Adverse Event|1|||
126778989|NCT01393990|456146847|FG015|Overall Study|Adverse Event|1|||
126594913|NCT01928394|455480485|FG004|Treatment Period|Poor/non-compliance|0|||
126594914|NCT01928394|455480486|FG005|Treatment Period|Poor/non-compliance|0|||
126594915|NCT01928394|455480487|FG006|Treatment Period|Poor/non-compliance|0|||
126594916|NCT01928394|455480488|FG007|Treatment Period|Poor/non-compliance|0|||
126594917|NCT01928394|455480489|FG008|Treatment Period|Poor/non-compliance|0|||
126594918|NCT01928394|455480490|FG009|Treatment Period|Poor/non-compliance|0|||
126594919|NCT01928394|455480491|FG010|Treatment Period|Poor/non-compliance|0|||
126594920|NCT01928394|455480492|FG011|Treatment Period|Poor/non-compliance|0|||
126594921|NCT01928394|455480493|FG012|Treatment Period|Poor/non-compliance|1|||
126594922|NCT01928394|455480494|FG013|Treatment Period|Poor/non-compliance|0|||
126594923|NCT01928394|455480495|FG014|Treatment Period|Poor/non-compliance|1|||
126594924|NCT01928394|455480496|FG015|Treatment Period|Poor/non-compliance|0|||
126594925|NCT01928394|455480497|FG016|Treatment Period|Poor/non-compliance|0|||
126594926|NCT01928394|455480498|FG017|Treatment Period|Poor/non-compliance|1|||
126594927|NCT01928394|455480499|FG018|Treatment Period|Poor/non-compliance|0|||
126594928|NCT01928394|455480500|FG019|Treatment Period|Poor/non-compliance|1|||
126594929|NCT01928394|455480501|FG020|Treatment Period|Poor/non-compliance|0|||
126594930|NCT01928394|455480502|FG021|Treatment Period|Poor/non-compliance|0|||
126594931|NCT01928394|455480503|FG022|Treatment Period|Poor/non-compliance|0|||
126594932|NCT01928394|455480481|FG000|Treatment Period|other reason|0|||
126594933|NCT01928394|455480482|FG001|Treatment Period|other reason|0|||
126594934|NCT01928394|455480483|FG002|Treatment Period|other reason|0|||
126594935|NCT01928394|455480484|FG003|Treatment Period|other reason|0|||
126594936|NCT01928394|455480485|FG004|Treatment Period|other reason|0|||
126594937|NCT01928394|455480486|FG005|Treatment Period|other reason|0|||
126594938|NCT01928394|455480487|FG006|Treatment Period|other reason|0|||
126594939|NCT01928394|455480488|FG007|Treatment Period|other reason|0|||
126594940|NCT01928394|455480489|FG008|Treatment Period|other reason|0|||
126594941|NCT01928394|455480490|FG009|Treatment Period|other reason|0|||
126594942|NCT01928394|455480491|FG010|Treatment Period|other reason|1|||
126594943|NCT01928394|455480492|FG011|Treatment Period|other reason|1|||
126594944|NCT01928394|455480493|FG012|Treatment Period|other reason|1|||
126594945|NCT01928394|455480494|FG013|Treatment Period|other reason|0|||
126594946|NCT01928394|455480495|FG014|Treatment Period|other reason|1|||
126594947|NCT01928394|455480496|FG015|Treatment Period|other reason|0|||
126594948|NCT01928394|455480497|FG016|Treatment Period|other reason|0|||
126594949|NCT01928394|455480498|FG017|Treatment Period|other reason|0|||
126594950|NCT01928394|455480499|FG018|Treatment Period|other reason|2|||
126594951|NCT01928394|455480500|FG019|Treatment Period|other reason|2|||
126778990|NCT01393990|456146848|FG016|Overall Study|Adverse Event|0|||
126778991|NCT01393990|456146849|FG017|Overall Study|Adverse Event|0|||
126594952|NCT01928394|455480501|FG020|Treatment Period|other reason|0|||
126594953|NCT01928394|455480502|FG021|Treatment Period|other reason|0|||
126594954|NCT01928394|455480503|FG022|Treatment Period|other reason|0|||
126594955|NCT01928394|455480481|FG000|Treatment Period|Maximum clinical benefit|0|||
126594956|NCT01928394|455480482|FG001|Treatment Period|Maximum clinical benefit|0|||
126594957|NCT01928394|455480483|FG002|Treatment Period|Maximum clinical benefit|0|||
126594958|NCT01928394|455480484|FG003|Treatment Period|Maximum clinical benefit|0|||
126594959|NCT01928394|455480485|FG004|Treatment Period|Maximum clinical benefit|0|||
126594960|NCT01928394|455480486|FG005|Treatment Period|Maximum clinical benefit|0|||
126594961|NCT01928394|455480487|FG006|Treatment Period|Maximum clinical benefit|0|||
126594962|NCT01928394|455480488|FG007|Treatment Period|Maximum clinical benefit|0|||
126778992|NCT01393990|456146832|FG000|Overall Study|Progressive Disease|1|||
126778993|NCT01393990|456146833|FG001|Overall Study|Progressive Disease|0|||
126778994|NCT01393990|456146834|FG002|Overall Study|Progressive Disease|0|||
126594963|NCT01928394|455480489|FG008|Treatment Period|Maximum clinical benefit|0|||
126594964|NCT01928394|455480490|FG009|Treatment Period|Maximum clinical benefit|0|||
126594965|NCT01928394|455480491|FG010|Treatment Period|Maximum clinical benefit|1|||
126594966|NCT01928394|455480492|FG011|Treatment Period|Maximum clinical benefit|1|||
126594967|NCT01928394|455480493|FG012|Treatment Period|Maximum clinical benefit|0|||
126594968|NCT01928394|455480494|FG013|Treatment Period|Maximum clinical benefit|0|||
126594969|NCT01928394|455480495|FG014|Treatment Period|Maximum clinical benefit|1|||
126594970|NCT01928394|455480496|FG015|Treatment Period|Maximum clinical benefit|0|||
126594971|NCT01928394|455480497|FG016|Treatment Period|Maximum clinical benefit|0|||
126594972|NCT01928394|455480498|FG017|Treatment Period|Maximum clinical benefit|1|||
126778995|NCT01393990|456146835|FG003|Overall Study|Progressive Disease|1|||
126594973|NCT01928394|455480499|FG018|Treatment Period|Maximum clinical benefit|1|||
126594974|NCT01928394|455480500|FG019|Treatment Period|Maximum clinical benefit|0|||
126594975|NCT01928394|455480501|FG020|Treatment Period|Maximum clinical benefit|2|||
126594976|NCT01928394|455480502|FG021|Treatment Period|Maximum clinical benefit|0|||
126778996|NCT01393990|456146836|FG004|Overall Study|Progressive Disease|1|||
126594977|NCT01928394|455480503|FG022|Treatment Period|Maximum clinical benefit|0|||
126594978|NCT01928394|455480481|FG000|Treatment Period|Lost to Follow-up|0|||
126594979|NCT01928394|455480482|FG001|Treatment Period|Lost to Follow-up|0|||
126594980|NCT01928394|455480483|FG002|Treatment Period|Lost to Follow-up|0|||
126594981|NCT01928394|455480484|FG003|Treatment Period|Lost to Follow-up|0|||
126594982|NCT01928394|455480485|FG004|Treatment Period|Lost to Follow-up|0|||
126594983|NCT01928394|455480486|FG005|Treatment Period|Lost to Follow-up|0|||
126594984|NCT01928394|455480487|FG006|Treatment Period|Lost to Follow-up|0|||
126594985|NCT01928394|455480488|FG007|Treatment Period|Lost to Follow-up|0|||
126594986|NCT01928394|455480489|FG008|Treatment Period|Lost to Follow-up|0|||
126594987|NCT01928394|455480490|FG009|Treatment Period|Lost to Follow-up|0|||
126594988|NCT01928394|455480491|FG010|Treatment Period|Lost to Follow-up|0|||
126594989|NCT01928394|455480492|FG011|Treatment Period|Lost to Follow-up|0|||
126594990|NCT01928394|455480493|FG012|Treatment Period|Lost to Follow-up|0|||
126594991|NCT01928394|455480494|FG013|Treatment Period|Lost to Follow-up|0|||
126594992|NCT01928394|455480495|FG014|Treatment Period|Lost to Follow-up|0|||
126594993|NCT01928394|455480496|FG015|Treatment Period|Lost to Follow-up|0|||
126594994|NCT01928394|455480497|FG016|Treatment Period|Lost to Follow-up|0|||
126594995|NCT01928394|455480498|FG017|Treatment Period|Lost to Follow-up|0|||
126594996|NCT01928394|455480499|FG018|Treatment Period|Lost to Follow-up|0|||
126594997|NCT01928394|455480500|FG019|Treatment Period|Lost to Follow-up|0|||
126594998|NCT01928394|455480501|FG020|Treatment Period|Lost to Follow-up|0|||
126594999|NCT01928394|455480502|FG021|Treatment Period|Lost to Follow-up|0|||
126595000|NCT01928394|455480503|FG022|Treatment Period|Lost to Follow-up|1|||
126595001|NCT01928394|455480481|FG000|Treatment Period|Death|0|||
126595002|NCT01928394|455480482|FG001|Treatment Period|Death|0|||
126595003|NCT01928394|455480483|FG002|Treatment Period|Death|0|||
126595004|NCT01928394|455480484|FG003|Treatment Period|Death|0|||
126595005|NCT01928394|455480485|FG004|Treatment Period|Death|0|||
126595006|NCT01928394|455480486|FG005|Treatment Period|Death|0|||
126595007|NCT01928394|455480487|FG006|Treatment Period|Death|0|||
126595008|NCT01928394|455480488|FG007|Treatment Period|Death|0|||
126595009|NCT01928394|455480489|FG008|Treatment Period|Death|0|||
126595010|NCT01928394|455480490|FG009|Treatment Period|Death|0|||
126595011|NCT01928394|455480491|FG010|Treatment Period|Death|0|||
126595012|NCT01928394|455480492|FG011|Treatment Period|Death|0|||
126595013|NCT01928394|455480493|FG012|Treatment Period|Death|0|||
126595014|NCT01928394|455480494|FG013|Treatment Period|Death|1|||
126595015|NCT01928394|455480495|FG014|Treatment Period|Death|2|||
126595016|NCT01928394|455480496|FG015|Treatment Period|Death|0|||
126595017|NCT01928394|455480497|FG016|Treatment Period|Death|0|||
126595018|NCT01928394|455480498|FG017|Treatment Period|Death|0|||
126595019|NCT01928394|455480499|FG018|Treatment Period|Death|0|||
126595020|NCT01928394|455480500|FG019|Treatment Period|Death|0|||
126595021|NCT01928394|455480501|FG020|Treatment Period|Death|0|||
126595022|NCT01928394|455480502|FG021|Treatment Period|Death|0|||
126595023|NCT01928394|455480503|FG022|Treatment Period|Death|0|||
126595024|NCT01928394|455480481|FG000|Follow-up Period|Participant withdrew consent|3|||
126595025|NCT01928394|455480482|FG001|Follow-up Period|Participant withdrew consent|0|||
126595026|NCT01928394|455480483|FG002|Follow-up Period|Participant withdrew consent|1|||
126595027|NCT01928394|455480484|FG003|Follow-up Period|Participant withdrew consent|4|||
126595028|NCT01928394|455480485|FG004|Follow-up Period|Participant withdrew consent|0|||
126595029|NCT01928394|455480486|FG005|Follow-up Period|Participant withdrew consent|2|||
126595030|NCT01928394|455480487|FG006|Follow-up Period|Participant withdrew consent|5|||
126595031|NCT01928394|455480488|FG007|Follow-up Period|Participant withdrew consent|1|||
126595032|NCT01928394|455480489|FG008|Follow-up Period|Participant withdrew consent|0|||
126595033|NCT01928394|455480490|FG009|Follow-up Period|Participant withdrew consent|0|||
126595034|NCT01928394|455480491|FG010|Follow-up Period|Participant withdrew consent|5|||
126595035|NCT01928394|455480492|FG011|Follow-up Period|Participant withdrew consent|8|||
126595036|NCT01928394|455480493|FG012|Follow-up Period|Participant withdrew consent|2|||
126595037|NCT01928394|455480494|FG013|Follow-up Period|Participant withdrew consent|12|||
126595038|NCT01928394|455480495|FG014|Follow-up Period|Participant withdrew consent|7|||
126595039|NCT01928394|455480496|FG015|Follow-up Period|Participant withdrew consent|0|||
126595040|NCT01928394|455480497|FG016|Follow-up Period|Participant withdrew consent|5|||
126595041|NCT01928394|455480498|FG017|Follow-up Period|Participant withdrew consent|3|||
126595042|NCT01928394|455480499|FG018|Follow-up Period|Participant withdrew consent|2|||
126595043|NCT01928394|455480500|FG019|Follow-up Period|Participant withdrew consent|7|||
126595044|NCT01928394|455480501|FG020|Follow-up Period|Participant withdrew consent|4|||
126595045|NCT01928394|455480502|FG021|Follow-up Period|Participant withdrew consent|6|||
126595046|NCT01928394|455480503|FG022|Follow-up Period|Participant withdrew consent|2|||
126595047|NCT01928394|455480481|FG000|Follow-up Period|Death|0|||
126595048|NCT01928394|455480482|FG001|Follow-up Period|Death|0|||
126595049|NCT01928394|455480483|FG002|Follow-up Period|Death|2|||
126595050|NCT01928394|455480484|FG003|Follow-up Period|Death|6|||
126595051|NCT01928394|455480485|FG004|Follow-up Period|Death|0|||
126595052|NCT01928394|455480486|FG005|Follow-up Period|Death|6|||
126595053|NCT01928394|455480487|FG006|Follow-up Period|Death|6|||
126595054|NCT01928394|455480488|FG007|Follow-up Period|Death|2|||
126595055|NCT01928394|455480489|FG008|Follow-up Period|Death|1|||
126595056|NCT01928394|455480490|FG009|Follow-up Period|Death|2|||
126595057|NCT01928394|455480491|FG010|Follow-up Period|Death|4|||
126595058|NCT01928394|455480492|FG011|Follow-up Period|Death|12|||
126595059|NCT01928394|455480493|FG012|Follow-up Period|Death|11|||
126595060|NCT01928394|455480494|FG013|Follow-up Period|Death|25|||
126595061|NCT01928394|455480495|FG014|Follow-up Period|Death|18|||
126595062|NCT01928394|455480496|FG015|Follow-up Period|Death|0|||
126595063|NCT01928394|455480497|FG016|Follow-up Period|Death|6|||
126595064|NCT01928394|455480498|FG017|Follow-up Period|Death|5|||
126595065|NCT01928394|455480499|FG018|Follow-up Period|Death|13|||
126595066|NCT01928394|455480500|FG019|Follow-up Period|Death|13|||
126595067|NCT01928394|455480501|FG020|Follow-up Period|Death|5|||
126595068|NCT01928394|455480502|FG021|Follow-up Period|Death|3|||
126595069|NCT01928394|455480503|FG022|Follow-up Period|Death|2|||
126595070|NCT01928394|455480481|FG000|Follow-up Period|other reason|0|||
126595071|NCT01928394|455480482|FG001|Follow-up Period|other reason|0|||
126595072|NCT01928394|455480483|FG002|Follow-up Period|other reason|0|||
126595073|NCT01928394|455480484|FG003|Follow-up Period|other reason|0|||
126595074|NCT01928394|455480485|FG004|Follow-up Period|other reason|0|||
126595075|NCT01928394|455480486|FG005|Follow-up Period|other reason|0|||
126595076|NCT01928394|455480487|FG006|Follow-up Period|other reason|1|||
126595077|NCT01928394|455480488|FG007|Follow-up Period|other reason|3|||
126595078|NCT01928394|455480489|FG008|Follow-up Period|other reason|0|||
126595079|NCT01928394|455480490|FG009|Follow-up Period|other reason|0|||
126595080|NCT01928394|455480491|FG010|Follow-up Period|other reason|2|||
126595081|NCT01928394|455480492|FG011|Follow-up Period|other reason|1|||
126595082|NCT01928394|455480493|FG012|Follow-up Period|other reason|0|||
126595083|NCT01928394|455480494|FG013|Follow-up Period|other reason|1|||
126595084|NCT01928394|455480495|FG014|Follow-up Period|other reason|4|||
126595085|NCT01928394|455480496|FG015|Follow-up Period|other reason|0|||
126595086|NCT01928394|455480497|FG016|Follow-up Period|other reason|2|||
126595087|NCT01928394|455480498|FG017|Follow-up Period|other reason|0|||
126595088|NCT01928394|455480499|FG018|Follow-up Period|other reason|1|||
126595089|NCT01928394|455480500|FG019|Follow-up Period|other reason|1|||
126595090|NCT01928394|455480501|FG020|Follow-up Period|other reason|0|||
126595091|NCT01928394|455480502|FG021|Follow-up Period|other reason|0|||
126595092|NCT01928394|455480503|FG022|Follow-up Period|other reason|1|||
126595093|NCT01928394|455480481|FG000|Follow-up Period|Lost to Follow-up|0|||
126595094|NCT01928394|455480482|FG001|Follow-up Period|Lost to Follow-up|0|||
126595095|NCT01928394|455480483|FG002|Follow-up Period|Lost to Follow-up|0|||
126595096|NCT01928394|455480484|FG003|Follow-up Period|Lost to Follow-up|0|||
126595097|NCT01928394|455480485|FG004|Follow-up Period|Lost to Follow-up|0|||
126595098|NCT01928394|455480486|FG005|Follow-up Period|Lost to Follow-up|0|||
126595099|NCT01928394|455480487|FG006|Follow-up Period|Lost to Follow-up|0|||
126595100|NCT01928394|455480488|FG007|Follow-up Period|Lost to Follow-up|0|||
126595101|NCT01928394|455480489|FG008|Follow-up Period|Lost to Follow-up|0|||
126595102|NCT01928394|455480490|FG009|Follow-up Period|Lost to Follow-up|0|||
126595103|NCT01928394|455480491|FG010|Follow-up Period|Lost to Follow-up|0|||
126595104|NCT01928394|455480492|FG011|Follow-up Period|Lost to Follow-up|1|||
126595105|NCT01928394|455480493|FG012|Follow-up Period|Lost to Follow-up|1|||
126595106|NCT01928394|455480494|FG013|Follow-up Period|Lost to Follow-up|0|||
126595107|NCT01928394|455480495|FG014|Follow-up Period|Lost to Follow-up|1|||
126595108|NCT01928394|455480496|FG015|Follow-up Period|Lost to Follow-up|0|||
126595109|NCT01928394|455480497|FG016|Follow-up Period|Lost to Follow-up|1|||
126595110|NCT01928394|455480498|FG017|Follow-up Period|Lost to Follow-up|0|||
126595111|NCT01928394|455480499|FG018|Follow-up Period|Lost to Follow-up|0|||
126595112|NCT01928394|455480500|FG019|Follow-up Period|Lost to Follow-up|0|||
126595113|NCT01928394|455480501|FG020|Follow-up Period|Lost to Follow-up|0|||
126595114|NCT01928394|455480502|FG021|Follow-up Period|Lost to Follow-up|0|||
126595115|NCT01928394|455480503|FG022|Follow-up Period|Lost to Follow-up|1|||
126595116|NCT04433208|455480504|FG000|Overall Study|Withdrawal by Subject|0|||
126595117|NCT04433208|455480505|FG001|Overall Study|Withdrawal by Subject|1|||
126595118|NCT04433208|455480506|FG002|Overall Study|Withdrawal by Subject|1|||
126595119|NCT04433208|455480507|FG003|Overall Study|Withdrawal by Subject|0|||
126595120|NCT04433208|455480508|FG004|Overall Study|Withdrawal by Subject|2|||
126595121|NCT04433208|455480509|FG005|Overall Study|Withdrawal by Subject|1|||
126595122|NCT04433208|455480504|FG000|Overall Study|Lost to Follow-up|0|||
126595123|NCT04433208|455480505|FG001|Overall Study|Lost to Follow-up|0|||
126595124|NCT04433208|455480506|FG002|Overall Study|Lost to Follow-up|0|||
126595125|NCT04433208|455480507|FG003|Overall Study|Lost to Follow-up|0|||
126595126|NCT04433208|455480508|FG004|Overall Study|Lost to Follow-up|0|||
126595127|NCT04433208|455480509|FG005|Overall Study|Lost to Follow-up|1|||
126595128|NCT04299464|455480512|FG000|Overall Study|Adverse Event|1|||
126595129|NCT04299464|455480513|FG001|Overall Study|Adverse Event|0|||
126595130|NCT04299464|455480514|FG002|Overall Study|Adverse Event|2|||
126595131|NCT04299464|455480512|FG000|Overall Study|Non-compliance with Study Drug|1|||
126595132|NCT04299464|455480513|FG001|Overall Study|Non-compliance with Study Drug|0|||
126595133|NCT04299464|455480514|FG002|Overall Study|Non-compliance with Study Drug|0|||
126595134|NCT04299464|455480512|FG000|Overall Study|Reason not Specified|0|||
126778997|NCT01393990|456146837|FG005|Overall Study|Progressive Disease|1|||
126778998|NCT01393990|456146838|FG006|Overall Study|Progressive Disease|1|||
126778999|NCT01393990|456146839|FG007|Overall Study|Progressive Disease|1|||
126779000|NCT01393990|456146840|FG008|Overall Study|Progressive Disease|3|||
126779001|NCT01393990|456146841|FG009|Overall Study|Progressive Disease|1|||
126779002|NCT01393990|456146842|FG010|Overall Study|Progressive Disease|0|||
126779003|NCT01393990|456146843|FG011|Overall Study|Progressive Disease|0|||
126779004|NCT01393990|456146844|FG012|Overall Study|Progressive Disease|0|||
126779005|NCT01393990|456146845|FG013|Overall Study|Progressive Disease|1|||
126779006|NCT01393990|456146846|FG014|Overall Study|Progressive Disease|6|||
126779007|NCT01393990|456146847|FG015|Overall Study|Progressive Disease|1|||
126779008|NCT01393990|456146848|FG016|Overall Study|Progressive Disease|0|||
126779009|NCT01393990|456146849|FG017|Overall Study|Progressive Disease|0|||
126779010|NCT01393990|456146832|FG000|Overall Study|Death|0|||
126779011|NCT01393990|456146833|FG001|Overall Study|Death|0|||
126779012|NCT01393990|456146834|FG002|Overall Study|Death|0|||
126779013|NCT01393990|456146835|FG003|Overall Study|Death|0|||
126779014|NCT01393990|456146836|FG004|Overall Study|Death|1|||
126779015|NCT01393990|456146837|FG005|Overall Study|Death|0|||
126779016|NCT01393990|456146838|FG006|Overall Study|Death|0|||
126779017|NCT01393990|456146839|FG007|Overall Study|Death|0|||
126779018|NCT01393990|456146840|FG008|Overall Study|Death|0|||
126779019|NCT01393990|456146841|FG009|Overall Study|Death|0|||
126779020|NCT01393990|456146842|FG010|Overall Study|Death|0|||
126779021|NCT01393990|456146843|FG011|Overall Study|Death|0|||
126779022|NCT01393990|456146844|FG012|Overall Study|Death|0|||
126779023|NCT01393990|456146845|FG013|Overall Study|Death|1|||
126779024|NCT01393990|456146846|FG014|Overall Study|Death|1|||
126779025|NCT01393990|456146847|FG015|Overall Study|Death|0|||
126779026|NCT01393990|456146848|FG016|Overall Study|Death|0|||
126779027|NCT01393990|456146849|FG017|Overall Study|Death|0|||
126779028|NCT01393990|456146832|FG000|Overall Study|Withdrawal by Subject|0|||
126779029|NCT01393990|456146833|FG001|Overall Study|Withdrawal by Subject|0|||
126779030|NCT01393990|456146834|FG002|Overall Study|Withdrawal by Subject|0|||
126779031|NCT01393990|456146835|FG003|Overall Study|Withdrawal by Subject|0|||
126779032|NCT01393990|456146836|FG004|Overall Study|Withdrawal by Subject|0|||
126779033|NCT01393990|456146837|FG005|Overall Study|Withdrawal by Subject|0|||
126779034|NCT01393990|456146838|FG006|Overall Study|Withdrawal by Subject|0|||
126779035|NCT01393990|456146839|FG007|Overall Study|Withdrawal by Subject|0|||
126779036|NCT01393990|456146840|FG008|Overall Study|Withdrawal by Subject|0|||
126779037|NCT01393990|456146841|FG009|Overall Study|Withdrawal by Subject|0|||
126779038|NCT01393990|456146842|FG010|Overall Study|Withdrawal by Subject|0|||
126779039|NCT01393990|456146843|FG011|Overall Study|Withdrawal by Subject|0|||
126779040|NCT01393990|456146844|FG012|Overall Study|Withdrawal by Subject|0|||
126779041|NCT01393990|456146845|FG013|Overall Study|Withdrawal by Subject|0|||
126779042|NCT01393990|456146846|FG014|Overall Study|Withdrawal by Subject|1|||
126779043|NCT01393990|456146847|FG015|Overall Study|Withdrawal by Subject|1|||
126779044|NCT01393990|456146848|FG016|Overall Study|Withdrawal by Subject|0|||
126779045|NCT01393990|456146849|FG017|Overall Study|Withdrawal by Subject|0|||
126779046|NCT00275028|456146850|FG000|Overall Study|Withdrew consent before treatment began|1|||
126779047|NCT00275028|456146850|FG000|Overall Study|Withdrawal by Subject|5|||
126779048|NCT00275028|456146850|FG000|Overall Study|Adverse Event|9|||
126779049|NCT00275028|456146850|FG000|Overall Study|Progressive Disease|30|||
126779050|NCT00275028|456146850|FG000|Overall Study|Physician Decision|2|||
126779051|NCT00720798|456146852|FG000|Overall Study|Adverse Event|304|||
126779052|NCT00720798|456146852|FG000|Overall Study|Death|39|||
126779053|NCT00720798|456146852|FG000|Overall Study|Insufficient Therapeutic Response|129|||
126779054|NCT00720798|456146852|FG000|Overall Study|Protocol Violation|4|||
126779055|NCT00720798|456146852|FG000|Overall Study|Refused Treatment|151|||
126779056|NCT00720798|456146852|FG000|Overall Study|Failure to Return|46|||
126779057|NCT00720798|456146852|FG000|Overall Study|Reason not Specified|83|||
126779058|NCT00433381|456146853|FG000|Overall Study|Ineligible / no protocol treatment|3|||
126779059|NCT00433381|456146854|FG001|Overall Study|Ineligible / no protocol treatment|3|||
126779060|NCT00549198|456146859|FG000|Overall Study|Adverse Event|28|||
126779061|NCT00549198|456146860|FG001|Overall Study|Adverse Event|26|||
126779062|NCT00549198|456146859|FG000|Overall Study|Insufficient Viral Load Response|4|||
126779063|NCT00549198|456146860|FG001|Overall Study|Insufficient Viral Load Response|2|||
126779064|NCT00549198|456146859|FG000|Overall Study|Protocol-defined Virological Failure|7|||
126779065|NCT00549198|456146860|FG001|Overall Study|Protocol-defined Virological Failure|0|||
126779066|NCT00549198|456146859|FG000|Overall Study|Non-compliance|2|||
126779067|NCT00549198|456146860|FG001|Overall Study|Non-compliance|4|||
126779068|NCT00549198|456146859|FG000|Overall Study|Lost to Follow-up|7|||
126779069|NCT00549198|456146860|FG001|Overall Study|Lost to Follow-up|8|||
126779070|NCT00549198|456146859|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
126779071|NCT00549198|456146860|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
126779072|NCT00549198|456146859|FG000|Overall Study|Protocol Violation|7|||
126779073|NCT00549198|456146860|FG001|Overall Study|Protocol Violation|2|||
126779074|NCT00549198|456146859|FG000|Overall Study|Investigator Decision|4|||
126779075|NCT00549198|456146860|FG001|Overall Study|Investigator Decision|3|||
126779076|NCT00549198|456146859|FG000|Overall Study|Withdrawal by Subject|7|||
126595135|NCT04299464|455480513|FG001|Overall Study|Reason not Specified|1|||
126595136|NCT04299464|455480514|FG002|Overall Study|Reason not Specified|3|||
126595137|NCT04299464|455480512|FG000|Overall Study|Physician Decision|0|||
126595138|NCT04299464|455480513|FG001|Overall Study|Physician Decision|1|||
126595139|NCT04299464|455480514|FG002|Overall Study|Physician Decision|1|||
126595140|NCT04299464|455480512|FG000|Overall Study|Withdrawal by Subject|0|||
126595141|NCT04299464|455480513|FG001|Overall Study|Withdrawal by Subject|2|||
126595142|NCT04299464|455480514|FG002|Overall Study|Withdrawal by Subject|1|||
126595143|NCT03386578|455480516|FG000|PK Component|Lost to Follow-up|0|||
126595144|NCT03386578|455480517|FG001|PK Component|Lost to Follow-up|1|||
126595145|NCT03386578|455480518|FG002|PK Component|Lost to Follow-up|0|||
126595146|NCT03386578|455480519|FG003|PK Component|Lost to Follow-up|0|||
126595147|NCT03386578|455480520|FG004|PK Component|Lost to Follow-up|0|||
126595148|NCT03386578|455480521|FG005|PK Component|Lost to Follow-up|0|||
126595149|NCT03386578|455480522|FG006|PK Component|Lost to Follow-up|1|||
126595150|NCT03386578|455480523|FG007|PK Component|Lost to Follow-up|0|||
126595151|NCT03386578|455480524|FG008|PK Component|Lost to Follow-up|0|||
126595152|NCT03386578|455480525|FG009|PK Component|Lost to Follow-up|0|||
126595153|NCT03386578|455480516|FG000|PK Component|Stillbirth/Abortion|0|||
126595154|NCT03386578|455480517|FG001|PK Component|Stillbirth/Abortion|0|||
126595155|NCT03386578|455480518|FG002|PK Component|Stillbirth/Abortion|0|||
126595156|NCT03386578|455480519|FG003|PK Component|Stillbirth/Abortion|0|||
126595157|NCT03386578|455480520|FG004|PK Component|Stillbirth/Abortion|0|||
126595158|NCT03386578|455480521|FG005|PK Component|Stillbirth/Abortion|2|||
126595159|NCT03386578|455480522|FG006|PK Component|Stillbirth/Abortion|0|||
126595160|NCT03386578|455480523|FG007|PK Component|Stillbirth/Abortion|0|||
126595161|NCT03386578|455480524|FG008|PK Component|Stillbirth/Abortion|0|||
126595162|NCT03386578|455480525|FG009|PK Component|Stillbirth/Abortion|0|||
126595163|NCT03386578|455480516|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
126595164|NCT03386578|455480517|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
126595165|NCT03386578|455480518|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
126595166|NCT03386578|455480519|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
126595167|NCT03386578|455480520|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
126595168|NCT03386578|455480521|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
126595169|NCT03386578|455480522|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
126595170|NCT03386578|455480523|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
126595171|NCT03386578|455480524|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
126595172|NCT03386578|455480525|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
126595173|NCT03386578|455480516|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
126595174|NCT03386578|455480517|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
126595175|NCT03386578|455480518|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
126595176|NCT03386578|455480519|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
126595177|NCT03386578|455480520|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
126595178|NCT03386578|455480521|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
126595179|NCT03386578|455480522|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
126595180|NCT03386578|455480523|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
126595181|NCT03386578|455480524|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
126595182|NCT03386578|455480525|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
126595183|NCT03386578|455480516|FG000|PrEP Comparison Component Step 1|Death|0|||
126595184|NCT03386578|455480517|FG001|PrEP Comparison Component Step 1|Death|0|||
126595185|NCT03386578|455480518|FG002|PrEP Comparison Component Step 1|Death|1|||
126595186|NCT03386578|455480519|FG003|PrEP Comparison Component Step 1|Death|0|||
126732374|NCT02293993|455969797|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
126732375|NCT02293993|455969798|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
126732376|NCT02293993|455969799|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
126732377|NCT02293993|455969800|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
126732378|NCT00094835|455969801|FG000|Overall Study|Physician Decision|1|||
126732379|NCT00094835|455969802|FG001|Overall Study|Physician Decision|0|||
126732380|NCT00094835|455969803|FG002|Overall Study|Physician Decision|0|||
126732381|NCT00094835|455969804|FG003|Overall Study|Physician Decision|0|||
126732382|NCT00094835|455969805|FG004|Overall Study|Physician Decision|0|||
126732383|NCT00094835|455969806|FG005|Overall Study|Physician Decision|1|||
126732384|NCT00094835|455969807|FG006|Overall Study|Physician Decision|0|||
126779077|NCT00549198|456146860|FG001|Overall Study|Withdrawal by Subject|7|||
126595187|NCT03386578|455480520|FG004|PrEP Comparison Component Step 1|Death|0|||
126779078|NCT00549198|456146859|FG000|Overall Study|Disease Progression|1|||
126595188|NCT03386578|455480521|FG005|PrEP Comparison Component Step 1|Death|0|||
126595189|NCT03386578|455480522|FG006|PrEP Comparison Component Step 1|Death|0|||
126595190|NCT03386578|455480523|FG007|PrEP Comparison Component Step 1|Death|9|||
126595191|NCT03386578|455480524|FG008|PrEP Comparison Component Step 1|Death|5|||
126595192|NCT03386578|455480525|FG009|PrEP Comparison Component Step 1|Death|0|||
126595193|NCT03386578|455480516|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126732385|NCT00094835|455969801|FG000|Overall Study|Withdrawal by Subject|0|||
126732386|NCT00094835|455969802|FG001|Overall Study|Withdrawal by Subject|0|||
126732387|NCT00094835|455969803|FG002|Overall Study|Withdrawal by Subject|0|||
126732388|NCT00094835|455969804|FG003|Overall Study|Withdrawal by Subject|0|||
126732389|NCT00094835|455969805|FG004|Overall Study|Withdrawal by Subject|0|||
126732390|NCT00094835|455969806|FG005|Overall Study|Withdrawal by Subject|0|||
126732391|NCT00094835|455969807|FG006|Overall Study|Withdrawal by Subject|1|||
126732392|NCT00094835|455969801|FG000|Overall Study|Lost to Follow-up|0|||
126732393|NCT00094835|455969802|FG001|Overall Study|Lost to Follow-up|0|||
126732394|NCT00094835|455969803|FG002|Overall Study|Lost to Follow-up|0|||
126732395|NCT00094835|455969804|FG003|Overall Study|Lost to Follow-up|0|||
126732396|NCT00094835|455969805|FG004|Overall Study|Lost to Follow-up|1|||
126732397|NCT00094835|455969806|FG005|Overall Study|Lost to Follow-up|0|||
126732398|NCT00094835|455969807|FG006|Overall Study|Lost to Follow-up|0|||
126732399|NCT00094835|455969801|FG000|Overall Study|Death|1|||
126732400|NCT00094835|455969802|FG001|Overall Study|Death|0|||
126732401|NCT00094835|455969803|FG002|Overall Study|Death|0|||
126732402|NCT00094835|455969804|FG003|Overall Study|Death|0|||
126732403|NCT00094835|455969805|FG004|Overall Study|Death|1|||
126732404|NCT00094835|455969806|FG005|Overall Study|Death|0|||
126732405|NCT00094835|455969807|FG006|Overall Study|Death|0|||
126732406|NCT00094835|455969801|FG000|Overall Study|Non-compliance|1|||
126732407|NCT00094835|455969802|FG001|Overall Study|Non-compliance|2|||
126732408|NCT00094835|455969803|FG002|Overall Study|Non-compliance|2|||
126732409|NCT00094835|455969804|FG003|Overall Study|Non-compliance|0|||
126732410|NCT00094835|455969805|FG004|Overall Study|Non-compliance|2|||
126732411|NCT00094835|455969806|FG005|Overall Study|Non-compliance|2|||
126732412|NCT00094835|455969807|FG006|Overall Study|Non-compliance|1|||
126732413|NCT00094835|455969801|FG000|Overall Study|Other|1|||
126732414|NCT00094835|455969802|FG001|Overall Study|Other|1|||
126732415|NCT00094835|455969803|FG002|Overall Study|Other|1|||
126732416|NCT00094835|455969804|FG003|Overall Study|Other|1|||
126732417|NCT00094835|455969805|FG004|Overall Study|Other|0|||
126732418|NCT00094835|455969806|FG005|Overall Study|Other|0|||
126732419|NCT00094835|455969807|FG006|Overall Study|Other|0|||
126732420|NCT03024255|455969810|FG000|Overall Study|Adverse Event|1|||
126732421|NCT03024255|455969811|FG001|Overall Study|Adverse Event|4|||
126732422|NCT03024255|455969812|FG002|Overall Study|Adverse Event|8|||
126732423|NCT03024255|455969813|FG003|Overall Study|Adverse Event|0|||
126732424|NCT03024255|455969810|FG000|Overall Study|Withdrawal by Subject|3|||
126732425|NCT03024255|455969811|FG001|Overall Study|Withdrawal by Subject|1|||
126732426|NCT03024255|455969812|FG002|Overall Study|Withdrawal by Subject|0|||
126732427|NCT03024255|455969813|FG003|Overall Study|Withdrawal by Subject|3|||
126732428|NCT03024255|455969810|FG000|Overall Study|Protocol Violation|0|||
126732429|NCT03024255|455969811|FG001|Overall Study|Protocol Violation|0|||
126732430|NCT03024255|455969812|FG002|Overall Study|Protocol Violation|2|||
126732431|NCT03024255|455969813|FG003|Overall Study|Protocol Violation|0|||
126732432|NCT03024255|455969810|FG000|Overall Study|Lost to Follow-up|1|||
126732433|NCT03024255|455969811|FG001|Overall Study|Lost to Follow-up|2|||
126732434|NCT03024255|455969812|FG002|Overall Study|Lost to Follow-up|1|||
126732435|NCT03024255|455969813|FG003|Overall Study|Lost to Follow-up|1|||
126732436|NCT03024255|455969810|FG000|Overall Study|Lack of Efficacy|1|||
126732437|NCT03024255|455969811|FG001|Overall Study|Lack of Efficacy|0|||
126732438|NCT03024255|455969812|FG002|Overall Study|Lack of Efficacy|0|||
126732439|NCT03024255|455969813|FG003|Overall Study|Lack of Efficacy|0|||
126732440|NCT03024255|455969810|FG000|Overall Study|Protocol Noncompliance|1|||
126732441|NCT03024255|455969811|FG001|Overall Study|Protocol Noncompliance|1|||
126732442|NCT03024255|455969812|FG002|Overall Study|Protocol Noncompliance|0|||
126732443|NCT03024255|455969813|FG003|Overall Study|Protocol Noncompliance|1|||
126732444|NCT00126581|455969818|FG000|Overall Study|Adverse Event|3|||
126732445|NCT00126581|455969819|FG001|Overall Study|Adverse Event|7|||
126732446|NCT00126581|455969818|FG000|Overall Study|Death|3|||
126732447|NCT00126581|455969819|FG001|Overall Study|Death|2|||
126732448|NCT00126581|455969818|FG000|Overall Study|Withdrawal by Subject|1|||
126732449|NCT00126581|455969819|FG001|Overall Study|Withdrawal by Subject|4|||
126732450|NCT00126581|455969818|FG000|Overall Study|Alternative therapy|3|||
126732451|NCT00126581|455969819|FG001|Overall Study|Alternative therapy|3|||
126732452|NCT00126581|455969818|FG000|Overall Study|Other illness/MD discretion|3|||
126732453|NCT00126581|455969819|FG001|Overall Study|Other illness/MD discretion|4|||
126732454|NCT00793182|455969820|FG000|Overall Study|Adverse Event|0|||
126732455|NCT00793182|455969821|FG001|Overall Study|Adverse Event|1|||
126732456|NCT03728140|455969823|FG000|Overall Study|Abnormal embryo transfer operation|10|||
126732457|NCT03728140|455969824|FG001|Overall Study|Abnormal embryo transfer operation|7|||
126732458|NCT02197897|455969825|FG000|Overall Study|not eligible|1|||
126732459|NCT02384395|455969826|FG000|Overall Study|Physician Decision|4|||
126732460|NCT02384395|455969826|FG000|Overall Study|Withdrawal by Subject|3|||
126732461|NCT02384395|455969826|FG000|Overall Study|Lost to Follow-up|3|||
126732462|NCT04295356|455969828|FG000|Overall Study|Physician Decision|1|||
126732463|NCT04295356|455969829|FG001|Overall Study|Physician Decision|0|||
126779079|NCT00549198|456146860|FG001|Overall Study|Disease Progression|0|||
126779080|NCT00549198|456146859|FG000|Overall Study|Participant Moved|2|||
126779081|NCT00549198|456146860|FG001|Overall Study|Participant Moved|0|||
126779082|NCT00549198|456146859|FG000|Overall Study|Participant not able to perform Week 96|1|||
126779083|NCT00549198|456146860|FG001|Overall Study|Participant not able to perform Week 96|0|||
126779084|NCT00549198|456146859|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
126779085|NCT00549198|456146860|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
126779086|NCT00549198|456146859|FG000|Overall Study|Prohibited Medication|1|||
126779087|NCT00549198|456146860|FG001|Overall Study|Prohibited Medication|2|||
126779088|NCT00549198|456146859|FG000|Overall Study|Participant planning pregnancy|1|||
126779089|NCT00549198|456146860|FG001|Overall Study|Participant planning pregnancy|0|||
126779090|NCT00549198|456146859|FG000|Overall Study|Participant overweight, no scan possible|1|||
126779091|NCT00549198|456146860|FG001|Overall Study|Participant overweight, no scan possible|0|||
126779092|NCT00549198|456146859|FG000|Overall Study|No scan facilities|0|||
126779093|NCT00549198|456146860|FG001|Overall Study|No scan facilities|2|||
126779094|NCT00549198|456146859|FG000|Overall Study|Pregnancy|0|||
126779095|NCT00549198|456146860|FG001|Overall Study|Pregnancy|3|||
126779096|NCT00549198|456146859|FG000|Overall Study|Not Exposed to Study Drug|3|||
126779097|NCT00549198|456146860|FG001|Overall Study|Not Exposed to Study Drug|4|||
126779098|NCT00472446|456146861|FG000|Overall Study|Protocol Violation|0|||
126779099|NCT00472446|456146862|FG001|Overall Study|Protocol Violation|0|||
126779100|NCT00472446|456146863|FG002|Overall Study|Protocol Violation|0|||
126779101|NCT00472446|456146864|FG003|Overall Study|Protocol Violation|1|||
126779102|NCT00472446|456146861|FG000|Overall Study|Reintervention|0|||
126779103|NCT00472446|456146862|FG001|Overall Study|Reintervention|0|||
126779104|NCT00472446|456146863|FG002|Overall Study|Reintervention|1|||
126779105|NCT00472446|456146864|FG003|Overall Study|Reintervention|1|||
126779106|NCT00472446|456146861|FG000|Overall Study|Questionnaires not returned|5|||
126779107|NCT00472446|456146862|FG001|Overall Study|Questionnaires not returned|6|||
126779108|NCT00472446|456146863|FG002|Overall Study|Questionnaires not returned|6|||
126779109|NCT00472446|456146864|FG003|Overall Study|Questionnaires not returned|4|||
126779110|NCT01165684|456146865|FG000|Overall Study|Adverse Event|1|||
126779111|NCT01165684|456146866|FG001|Overall Study|Adverse Event|1|||
126779112|NCT01165684|456146865|FG000|Overall Study|Lack of Efficacy|2|||
126779113|NCT01165684|456146866|FG001|Overall Study|Lack of Efficacy|1|||
126779114|NCT01165684|456146865|FG000|Overall Study|Protocol Violation|7|||
126779115|NCT01165684|456146866|FG001|Overall Study|Protocol Violation|15|||
126779116|NCT01165684|456146865|FG000|Overall Study|Withdrawal Criteria|2|||
126779117|NCT01165684|456146866|FG001|Overall Study|Withdrawal Criteria|13|||
126779118|NCT01165684|456146865|FG000|Overall Study|Unclassified|16|||
126779119|NCT01165684|456146866|FG001|Overall Study|Unclassified|22|||
126779120|NCT00671879|456146869|FG000|Overall Study|Withdrawal by Subject|0|||
126779121|NCT00671879|456146870|FG001|Overall Study|Withdrawal by Subject|4|||
126779122|NCT00671879|456146871|FG002|Overall Study|Withdrawal by Subject|6|||
126779123|NCT04633837|456146872|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
126779124|NCT04633837|456146873|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
126779125|NCT00901628|456146874|FG000|Overall Study|disconnection of catheter|4|||
126779126|NCT00901628|456146875|FG001|Overall Study|disconnection of catheter|8|||
126779127|NCT00901628|456146874|FG000|Overall Study|disconnection of drain|0|||
126779128|NCT00901628|456146875|FG001|Overall Study|disconnection of drain|1|||
126779129|NCT00901628|456146874|FG000|Overall Study|peroneal nerve palsy|0|||
126779130|NCT00901628|456146875|FG001|Overall Study|peroneal nerve palsy|1|||
126779131|NCT00608205|456146878|FG000|Overall Study|Adverse Event|3|||
126779132|NCT00608205|456146879|FG001|Overall Study|Adverse Event|2|||
126779133|NCT00608205|456146878|FG000|Overall Study|Patient non-compliant|0|||
126779134|NCT00608205|456146879|FG001|Overall Study|Patient non-compliant|1|||
126779135|NCT01797120|456146880|FG000|Overall Study|Disesae progression|37|||
126779136|NCT01797120|456146881|FG001|Overall Study|Disesae progression|49|||
126779137|NCT01797120|456146880|FG000|Overall Study|Adverse Event|13|||
126779138|NCT01797120|456146881|FG001|Overall Study|Adverse Event|5|||
126779139|NCT01797120|456146880|FG000|Overall Study|Withdrawal by Subject|6|||
126779140|NCT01797120|456146881|FG001|Overall Study|Withdrawal by Subject|6|||
126779141|NCT01797120|456146880|FG000|Overall Study|Symptomatic progression|2|||
126779142|NCT01797120|456146881|FG001|Overall Study|Symptomatic progression|1|||
126779143|NCT01797120|456146880|FG000|Overall Study|Non-compliance|1|||
126779144|NCT01797120|456146881|FG001|Overall Study|Non-compliance|0|||
126779145|NCT01797120|456146880|FG000|Overall Study|Physician Decision|3|||
126779146|NCT01797120|456146881|FG001|Overall Study|Physician Decision|0|||
126779147|NCT01797120|456146880|FG000|Overall Study|still on treatment|2|||
126779148|NCT01797120|456146881|FG001|Overall Study|still on treatment|4|||
126779149|NCT01797120|456146880|FG000|Overall Study|never start protocol therapy|2|||
126779150|NCT01797120|456146881|FG001|Overall Study|never start protocol therapy|0|||
126779151|NCT01909466|456146887|FG000|Overall Study|Lost to Follow-up|5|||
126779152|NCT01909466|456146888|FG001|Overall Study|Lost to Follow-up|7|||
126779153|NCT01909466|456146887|FG000|Overall Study|Adverse Event|3|||
126779154|NCT01909466|456146888|FG001|Overall Study|Adverse Event|4|||
126595194|NCT03386578|455480517|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126595195|NCT03386578|455480518|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126595196|NCT03386578|455480519|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
126595197|NCT03386578|455480520|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126595198|NCT03386578|455480521|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126595199|NCT03386578|455480522|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126595200|NCT03386578|455480523|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126595201|NCT03386578|455480524|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
126595202|NCT03386578|455480525|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
126595203|NCT03386578|455480516|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126595204|NCT03386578|455480517|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126595205|NCT03386578|455480518|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126595206|NCT03386578|455480519|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126595207|NCT03386578|455480520|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126595208|NCT03386578|455480521|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126595209|NCT03386578|455480522|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126595210|NCT03386578|455480523|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
126595211|NCT03386578|455480524|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
126595212|NCT03386578|455480525|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
126595213|NCT03386578|455480516|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126595214|NCT03386578|455480517|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126595215|NCT03386578|455480518|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126595216|NCT03386578|455480519|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126595217|NCT03386578|455480520|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126595218|NCT03386578|455480521|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126595219|NCT03386578|455480522|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126595220|NCT03386578|455480523|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
126595221|NCT03386578|455480524|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
126595222|NCT03386578|455480525|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
126595223|NCT02724969|455480530|FG000|Overall Study|Lost to Follow-up|12|||
126595224|NCT02724969|455480531|FG001|Overall Study|Lost to Follow-up|6|||
126595225|NCT02724969|455480530|FG000|Overall Study|Withdrawal by Subject|3|||
126595226|NCT02724969|455480531|FG001|Overall Study|Withdrawal by Subject|3|||
126595227|NCT02724969|455480530|FG000|Overall Study|Infant demise|0|||
126595228|NCT02724969|455480531|FG001|Overall Study|Infant demise|2|||
126595229|NCT03362476|455480532|FG000|Overall Study|Withdrawal by Subject|0|||
126595230|NCT03362476|455480533|FG001|Overall Study|Withdrawal by Subject|1|||
126595231|NCT05974501|455480534|FG000|Overall Study|Physician Decision|0|||
126595232|NCT05974501|455480535|FG001|Overall Study|Physician Decision|1|||
126595233|NCT04270942|455480536|FG000|Overall Study|Death|1|||
126595234|NCT05147116|455480543|FG000|Overall Study|Withdrawal by Subject|0|||
126595235|NCT05147116|455480544|FG001|Overall Study|Withdrawal by Subject|1|||
126595236|NCT03672916|455480545|FG000|Overall Study|Death|6|||
126595237|NCT03672916|455480545|FG000|Overall Study|Lost to Follow-up|29|||
126595238|NCT03672916|455480545|FG000|Overall Study|Adverse Event|6|||
126595239|NCT03672916|455480545|FG000|Overall Study|Withdrawal by Subject|11|||
126595240|NCT04197336|455480546|FG000|Overall Study|Withdrawal by Subject|1|||
126595241|NCT04585815|455480547|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
126595242|NCT04585815|455480548|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
126595243|NCT04585815|455480549|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
126595244|NCT04585815|455480550|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
126595245|NCT04585815|455480551|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
126595246|NCT04585815|455480552|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
126595247|NCT04585815|455480553|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
126595248|NCT04585815|455480547|FG000|Sub-study A- Treatment Phase|Death|0|||
126595249|NCT04585815|455480548|FG001|Sub-study A- Treatment Phase|Death|1|||
126595250|NCT04585815|455480549|FG002|Sub-study A- Treatment Phase|Death|0|||
126595251|NCT04585815|455480550|FG003|Sub-study A- Treatment Phase|Death|0|||
126595252|NCT04585815|455480551|FG004|Sub-study A- Treatment Phase|Death|0|||
126595253|NCT04585815|455480552|FG005|Sub-study A- Treatment Phase|Death|0|||
126595254|NCT04585815|455480553|FG006|Sub-study A- Treatment Phase|Death|0|||
126595255|NCT04585815|455480547|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
126595256|NCT04585815|455480548|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
126595257|NCT04585815|455480549|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
126595258|NCT04585815|455480550|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
126732464|NCT04295356|455969828|FG000|Overall Study|Lost to Follow-up|0|||
126732465|NCT04295356|455969829|FG001|Overall Study|Lost to Follow-up|3|||
126732466|NCT04295356|455969828|FG000|Overall Study|Protocol Violation|0|||
126732467|NCT04295356|455969829|FG001|Overall Study|Protocol Violation|1|||
126595259|NCT04585815|455480551|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
126595260|NCT04585815|455480552|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
126595261|NCT04585815|455480553|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
126595262|NCT04585815|455480547|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
126595263|NCT04585815|455480548|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
126595264|NCT04585815|455480549|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
126595265|NCT04585815|455480550|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
126595266|NCT04585815|455480551|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
126595267|NCT04585815|455480552|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
126595268|NCT04585815|455480553|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
126595269|NCT04585815|455480547|FG000|Sub-study A- Treatment Phase|Other|1|||
126595270|NCT04585815|455480548|FG001|Sub-study A- Treatment Phase|Other|0|||
126595271|NCT04585815|455480549|FG002|Sub-study A- Treatment Phase|Other|0|||
126595272|NCT04585815|455480550|FG003|Sub-study A- Treatment Phase|Other|0|||
126595273|NCT04585815|455480551|FG004|Sub-study A- Treatment Phase|Other|0|||
126595274|NCT04585815|455480552|FG005|Sub-study A- Treatment Phase|Other|0|||
126595275|NCT04585815|455480553|FG006|Sub-study A- Treatment Phase|Other|0|||
126595276|NCT04585815|455480547|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
126595277|NCT04585815|455480548|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
126595278|NCT04585815|455480549|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
126595279|NCT04585815|455480550|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
126595280|NCT04585815|455480551|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
126595281|NCT04585815|455480552|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
126595282|NCT04585815|455480553|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
126595283|NCT04585815|455480547|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
126595284|NCT04585815|455480548|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
126595285|NCT04585815|455480549|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
126595286|NCT04585815|455480550|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
126595287|NCT04585815|455480551|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
126595288|NCT04585815|455480552|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
126595289|NCT04585815|455480553|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
126595290|NCT04585815|455480547|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
126595291|NCT04585815|455480548|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
126595292|NCT04585815|455480549|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
126595293|NCT04585815|455480550|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
126595294|NCT04585815|455480551|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
126595295|NCT04585815|455480552|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
126595296|NCT04585815|455480553|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
126595297|NCT04585815|455480547|FG000|Sub-study B- Treatment Phase|Death|0|||
126595298|NCT04585815|455480548|FG001|Sub-study B- Treatment Phase|Death|0|||
126595299|NCT04585815|455480549|FG002|Sub-study B- Treatment Phase|Death|0|||
126595300|NCT04585815|455480550|FG003|Sub-study B- Treatment Phase|Death|1|||
126595301|NCT04585815|455480551|FG004|Sub-study B- Treatment Phase|Death|0|||
126595302|NCT04585815|455480552|FG005|Sub-study B- Treatment Phase|Death|0|||
126595303|NCT04585815|455480553|FG006|Sub-study B- Treatment Phase|Death|0|||
126595304|NCT04585815|455480547|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
126595305|NCT04585815|455480548|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
126595306|NCT04585815|455480549|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
126595307|NCT04585815|455480550|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
126595308|NCT04585815|455480551|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
126595309|NCT04585815|455480552|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
126595310|NCT04585815|455480553|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
126595311|NCT04585815|455480547|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
126595312|NCT04585815|455480548|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
126595313|NCT04585815|455480549|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
126595314|NCT04585815|455480550|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
126595315|NCT04585815|455480551|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
126595316|NCT04585815|455480552|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
126595317|NCT04585815|455480553|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
126595318|NCT04585815|455480547|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
126595319|NCT04585815|455480548|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
126595320|NCT04585815|455480549|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
126595321|NCT04585815|455480550|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
126595322|NCT04585815|455480551|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
126595323|NCT04585815|455480552|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
126595324|NCT04585815|455480553|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
126595325|NCT04585815|455480547|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
126595326|NCT04585815|455480548|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
126595327|NCT04585815|455480549|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
126595328|NCT04585815|455480550|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
126595329|NCT04585815|455480551|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
126595330|NCT04585815|455480552|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
126595331|NCT04585815|455480553|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
126595332|NCT04585815|455480547|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
126595333|NCT04585815|455480548|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
126595334|NCT04585815|455480549|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
126595335|NCT04585815|455480550|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
126595336|NCT04585815|455480551|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
126595337|NCT04585815|455480552|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
126595338|NCT04585815|455480553|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
126595339|NCT04585815|455480547|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
126595340|NCT04585815|455480548|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
126595341|NCT04585815|455480549|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
126595342|NCT04585815|455480550|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
126595343|NCT04585815|455480551|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
126595344|NCT04585815|455480552|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
126595345|NCT04585815|455480553|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
126595346|NCT04585815|455480547|FG000|Sub-study B- Follow-up Phase|Death|0|||
126595347|NCT04585815|455480548|FG001|Sub-study B- Follow-up Phase|Death|0|||
126595348|NCT04585815|455480549|FG002|Sub-study B- Follow-up Phase|Death|1|||
126595349|NCT04585815|455480550|FG003|Sub-study B- Follow-up Phase|Death|3|||
126595350|NCT04585815|455480551|FG004|Sub-study B- Follow-up Phase|Death|0|||
126595351|NCT04585815|455480552|FG005|Sub-study B- Follow-up Phase|Death|0|||
126595352|NCT04585815|455480553|FG006|Sub-study B- Follow-up Phase|Death|1|||
126595353|NCT04295512|455480561|FG000|Overall Study|Lack of family response to schedule assessment|0|||
126595354|NCT04295512|455480562|FG001|Overall Study|Lack of family response to schedule assessment|0|||
126595355|NCT04295512|455480563|FG002|Overall Study|Lack of family response to schedule assessment|0|||
126595356|NCT04295512|455480564|FG003|Overall Study|Lack of family response to schedule assessment|2|||
126595357|NCT04295512|455480561|FG000|Overall Study|Therapist did not refer eligible family|7|||
126595358|NCT04295512|455480562|FG001|Overall Study|Therapist did not refer eligible family|7|||
126595359|NCT04295512|455480563|FG002|Overall Study|Therapist did not refer eligible family|0|||
126595360|NCT04295512|455480564|FG003|Overall Study|Therapist did not refer eligible family|0|||
126595361|NCT04587453|455480569|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
126595362|NCT04587453|455480570|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
126595363|NCT03571581|455480573|FG000|Overall Study|Death|2|||
126595364|NCT03571581|455480573|FG000|Overall Study|Withdrawal by Subject|2|||
126595365|NCT01309672|455480575|FG000|Overall Study|Lack of Efficacy|20|||
126595366|NCT01309672|455480575|FG000|Overall Study|Other|9|||
126595367|NCT01309672|455480575|FG000|Overall Study|Adverse Event|5|||
126595368|NCT01309672|455480575|FG000|Overall Study|Withdrawal by Subject|3|||
126595369|NCT05623228|455480576|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
126595370|NCT05623228|455480577|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126595371|NCT05623228|455480578|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126595372|NCT05623228|455480579|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126595373|NCT05623228|455480580|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126595374|NCT05623228|455480581|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126595375|NCT05623228|455480582|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126595376|NCT05623228|455480583|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
126595377|NCT05623228|455480576|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
126595378|NCT05623228|455480577|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
126779155|NCT01909466|456146887|FG000|Overall Study|Met Withdrawal Criteria|0|||
126595379|NCT05623228|455480578|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
126595380|NCT05623228|455480579|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
126595381|NCT05623228|455480580|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
126595382|NCT05623228|455480581|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
126595383|NCT05623228|455480582|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
126595384|NCT05623228|455480583|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
126595385|NCT04141891|455480585|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
126595386|NCT04141891|455480586|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
126779156|NCT01909466|456146888|FG001|Overall Study|Met Withdrawal Criteria|3|||
126595387|NCT04141891|455480585|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
126595388|NCT04141891|455480586|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
126595389|NCT04141891|455480585|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
126595390|NCT04141891|455480586|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
126595391|NCT04141891|455480585|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
126595392|NCT04141891|455480586|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
126595393|NCT04141891|455480585|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
126779157|NCT01909466|456146887|FG000|Overall Study|Physician Decision|2|||
126779158|NCT01909466|456146888|FG001|Overall Study|Physician Decision|0|||
126779159|NCT01909466|456146887|FG000|Overall Study|Withdrawal by Subject|11|||
126779160|NCT01909466|456146888|FG001|Overall Study|Withdrawal by Subject|9|||
126779161|NCT01909466|456146887|FG000|Overall Study|Lack of Efficacy|1|||
126779162|NCT01909466|456146888|FG001|Overall Study|Lack of Efficacy|0|||
126779163|NCT01339910|456146889|FG000|Overall Study|Withdrawal by Subject|1|||
126779164|NCT01339910|456146890|FG001|Overall Study|Withdrawal by Subject|0|||
126779165|NCT01339910|456146889|FG000|Overall Study|Physician Decision|1|||
126779166|NCT01339910|456146890|FG001|Overall Study|Physician Decision|0|||
126779167|NCT01339910|456146889|FG000|Overall Study|Disease relapse|1|||
126779168|NCT01339910|456146890|FG001|Overall Study|Disease relapse|4|||
126779169|NCT01567306|456146892|FG000|Overall Study|Protocol Violation|2|||
126779170|NCT01567306|456146893|FG001|Overall Study|Protocol Violation|2|||
126779171|NCT01567306|456146894|FG002|Overall Study|Protocol Violation|0|||
126779172|NCT01567306|456146895|FG003|Overall Study|Protocol Violation|3|||
126779173|NCT01567306|456146896|FG004|Overall Study|Protocol Violation|1|||
126779174|NCT01567306|456146897|FG005|Overall Study|Protocol Violation|1|||
126779175|NCT01567306|456146892|FG000|Overall Study|Change site living|1|||
126779176|NCT01567306|456146893|FG001|Overall Study|Change site living|0|||
126779177|NCT01567306|456146894|FG002|Overall Study|Change site living|0|||
126779178|NCT01567306|456146895|FG003|Overall Study|Change site living|0|||
126779179|NCT01567306|456146896|FG004|Overall Study|Change site living|0|||
126779180|NCT01567306|456146897|FG005|Overall Study|Change site living|0|||
126779181|NCT01567306|456146892|FG000|Overall Study|Adverse Event|0|||
126779182|NCT01567306|456146893|FG001|Overall Study|Adverse Event|0|||
126779183|NCT01567306|456146894|FG002|Overall Study|Adverse Event|0|||
126779184|NCT01567306|456146895|FG003|Overall Study|Adverse Event|2|||
126779185|NCT01567306|456146896|FG004|Overall Study|Adverse Event|4|||
126779186|NCT01567306|456146897|FG005|Overall Study|Adverse Event|1|||
126779187|NCT01567306|456146892|FG000|Overall Study|Lost to Follow-up|0|||
126779188|NCT01567306|456146893|FG001|Overall Study|Lost to Follow-up|0|||
126779189|NCT01567306|456146894|FG002|Overall Study|Lost to Follow-up|0|||
126779190|NCT01567306|456146895|FG003|Overall Study|Lost to Follow-up|0|||
126779191|NCT01567306|456146896|FG004|Overall Study|Lost to Follow-up|2|||
126779192|NCT01567306|456146897|FG005|Overall Study|Lost to Follow-up|0|||
126779193|NCT01567306|456146892|FG000|Overall Study|Withdrawal by Subject|0|||
126779194|NCT01567306|456146893|FG001|Overall Study|Withdrawal by Subject|0|||
126779195|NCT01567306|456146894|FG002|Overall Study|Withdrawal by Subject|0|||
126779196|NCT01567306|456146895|FG003|Overall Study|Withdrawal by Subject|0|||
126779197|NCT01567306|456146896|FG004|Overall Study|Withdrawal by Subject|0|||
126779198|NCT01567306|456146897|FG005|Overall Study|Withdrawal by Subject|1|||
126779199|NCT00738673|456146902|FG000|Overall Study|Adverse Event|1|||
126779200|NCT00738673|456146903|FG001|Overall Study|Adverse Event|0|||
126779201|NCT00738673|456146902|FG000|Overall Study|Lack of Efficacy|19|||
126779202|NCT00738673|456146903|FG001|Overall Study|Lack of Efficacy|8|||
126779203|NCT00738673|456146902|FG000|Overall Study|Protocol Violation|1|||
126779204|NCT00738673|456146903|FG001|Overall Study|Protocol Violation|2|||
126779205|NCT00738673|456146902|FG000|Overall Study|Withdrawal by Subject|3|||
126779206|NCT00738673|456146903|FG001|Overall Study|Withdrawal by Subject|1|||
126779207|NCT02736227|456146906|FG000|Overall Study|Withdrawal by Subject|0|||
126595394|NCT04141891|455480586|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
126595395|NCT04141891|455480585|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
126595396|NCT04141891|455480586|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
126595397|NCT04141891|455480585|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
126595398|NCT04141891|455480586|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
126595399|NCT04141891|455480585|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
126595400|NCT04141891|455480586|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
126595401|NCT04141891|455480585|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
126595402|NCT04141891|455480586|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
126595403|NCT04141891|455480585|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
126595404|NCT04141891|455480586|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
126595405|NCT04141891|455480585|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
126779208|NCT02736227|456146907|FG001|Overall Study|Withdrawal by Subject|0|||
126779209|NCT02736227|456146908|FG002|Overall Study|Withdrawal by Subject|1|||
126779210|NCT02736227|456146906|FG000|Overall Study|Physician Decision|0|||
126779211|NCT02736227|456146907|FG001|Overall Study|Physician Decision|0|||
126779212|NCT02736227|456146908|FG002|Overall Study|Physician Decision|5|||
126779213|NCT02736227|456146906|FG000|Overall Study|Non Compliant|0|||
126779214|NCT02736227|456146907|FG001|Overall Study|Non Compliant|0|||
126779215|NCT02736227|456146908|FG002|Overall Study|Non Compliant|2|||
126779216|NCT04120194|456146909|FG000|Overall Study|Lost to Follow-up|11|||
126779217|NCT04120194|456146910|FG001|Overall Study|Lost to Follow-up|8|||
126779218|NCT04120194|456146909|FG000|Overall Study|Adverse Event|4|||
126779219|NCT04120194|456146910|FG001|Overall Study|Adverse Event|5|||
126779220|NCT04120194|456146909|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
126595406|NCT04141891|455480586|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
126595407|NCT04141891|455480585|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
126595408|NCT04141891|455480586|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
126595409|NCT04141891|455480585|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
126595410|NCT04141891|455480586|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
126595411|NCT04141891|455480585|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
126595412|NCT04141891|455480586|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
126595413|NCT04737330|455480587|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
126595414|NCT04737330|455480588|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
126595415|NCT04737330|455480587|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
126595416|NCT04737330|455480588|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
126595417|NCT04737330|455480587|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
126595418|NCT04737330|455480588|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
126595419|NCT04737330|455480587|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
126595420|NCT04737330|455480588|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
126595421|NCT04737330|455480587|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
126595422|NCT04737330|455480588|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
126595423|NCT04737330|455480587|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
126595424|NCT04737330|455480588|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
126595425|NCT04625725|455480589|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
126595426|NCT04625725|455480590|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
126595427|NCT04625725|455480591|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
126595428|NCT04625725|455480592|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
126595429|NCT04625725|455480593|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
126595430|NCT04625725|455480594|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
126595431|NCT04625725|455480589|FG000|Provent Main Study|Withdrawal by Subject|242|||
126595432|NCT04625725|455480590|FG001|Provent Main Study|Withdrawal by Subject|144|||
126595433|NCT04625725|455480591|FG002|Provent Main Study|Withdrawal by Subject|0|||
126595434|NCT04625725|455480592|FG003|Provent Main Study|Withdrawal by Subject|0|||
126595435|NCT04625725|455480593|FG004|Provent Main Study|Withdrawal by Subject|0|||
126595436|NCT04625725|455480594|FG005|Provent Main Study|Withdrawal by Subject|0|||
126595437|NCT04625725|455480589|FG000|Provent Main Study|Physician Decision|5|||
126595438|NCT04625725|455480590|FG001|Provent Main Study|Physician Decision|0|||
126595439|NCT04625725|455480591|FG002|Provent Main Study|Physician Decision|0|||
126595440|NCT04625725|455480592|FG003|Provent Main Study|Physician Decision|0|||
126595441|NCT04625725|455480593|FG004|Provent Main Study|Physician Decision|0|||
126595442|NCT04625725|455480594|FG005|Provent Main Study|Physician Decision|0|||
126595443|NCT04625725|455480589|FG000|Provent Main Study|Protocol Violation|1|||
126595444|NCT04625725|455480590|FG001|Provent Main Study|Protocol Violation|0|||
126595445|NCT04625725|455480591|FG002|Provent Main Study|Protocol Violation|0|||
126595446|NCT04625725|455480592|FG003|Provent Main Study|Protocol Violation|0|||
126595447|NCT04625725|455480593|FG004|Provent Main Study|Protocol Violation|0|||
126595448|NCT04625725|455480594|FG005|Provent Main Study|Protocol Violation|0|||
126595449|NCT04625725|455480589|FG000|Provent Main Study|Lost to Follow-up|357|||
126732468|NCT01106391|455969830|FG000|Overall Study|Death|12|||
126732469|NCT01106391|455969830|FG000|Overall Study|Withdrawal by Subject|7|||
126732470|NCT04268004|455969833|FG000|Overall Study|Excluded from analyses|0|||
126732471|NCT04268004|455969834|FG001|Overall Study|Excluded from analyses|1|||
126732472|NCT03783442|455969835|FG000|Overall Study|Death|252|||
126732473|NCT03783442|455969836|FG001|Overall Study|Death|268|||
126732474|NCT03783442|455969835|FG000|Overall Study|Withdrawal by Subject|19|||
126732475|NCT03783442|455969836|FG001|Overall Study|Withdrawal by Subject|21|||
126732476|NCT03783442|455969835|FG000|Overall Study|Lost to Follow-up|7|||
126732477|NCT03783442|455969836|FG001|Overall Study|Lost to Follow-up|6|||
126732478|NCT03783442|455969835|FG000|Overall Study|Sponsor Ended Study|48|||
126732479|NCT03783442|455969836|FG001|Overall Study|Sponsor Ended Study|28|||
126732480|NCT04190186|455969837|FG000|Overall Study|ILR is no longer functioning|0|||
126732481|NCT04190186|455969838|FG001|Overall Study|ILR is no longer functioning|1|||
126732482|NCT04190186|455969837|FG000|Overall Study|Lost to Follow-up|0|||
126732483|NCT04190186|455969838|FG001|Overall Study|Lost to Follow-up|1|||
126732484|NCT04190186|455969837|FG000|Overall Study|Withdrawal by Subject|2|||
126732485|NCT04190186|455969838|FG001|Overall Study|Withdrawal by Subject|0|||
126732486|NCT04190186|455969837|FG000|Overall Study|Subject choice to explant|1|||
126732487|NCT04190186|455969838|FG001|Overall Study|Subject choice to explant|0|||
126732488|NCT04190186|455969837|FG000|Overall Study|Physician Decision|0|||
126732489|NCT04190186|455969838|FG001|Overall Study|Physician Decision|1|||
126595450|NCT04625725|455480590|FG001|Provent Main Study|Lost to Follow-up|200|||
126595451|NCT04625725|455480591|FG002|Provent Main Study|Lost to Follow-up|0|||
126595452|NCT04625725|455480592|FG003|Provent Main Study|Lost to Follow-up|0|||
126595453|NCT04625725|455480593|FG004|Provent Main Study|Lost to Follow-up|0|||
126595454|NCT04625725|455480594|FG005|Provent Main Study|Lost to Follow-up|0|||
126595455|NCT04625725|455480589|FG000|Provent Main Study|Death|22|||
126595456|NCT04625725|455480590|FG001|Provent Main Study|Death|10|||
126595457|NCT04625725|455480591|FG002|Provent Main Study|Death|0|||
126595458|NCT04625725|455480592|FG003|Provent Main Study|Death|0|||
126595459|NCT04625725|455480593|FG004|Provent Main Study|Death|0|||
126595460|NCT04625725|455480594|FG005|Provent Main Study|Death|0|||
126595461|NCT04625725|455480589|FG000|Provent Main Study|Adverse Event|2|||
126595462|NCT04625725|455480590|FG001|Provent Main Study|Adverse Event|1|||
126595463|NCT04625725|455480591|FG002|Provent Main Study|Adverse Event|0|||
126595464|NCT04625725|455480592|FG003|Provent Main Study|Adverse Event|0|||
126595465|NCT04625725|455480593|FG004|Provent Main Study|Adverse Event|0|||
126595466|NCT04625725|455480594|FG005|Provent Main Study|Adverse Event|0|||
126595467|NCT04625725|455480589|FG000|Provent Main Study|Participants dosed in sub-study|310|||
126595468|NCT04625725|455480590|FG001|Provent Main Study|Participants dosed in sub-study|193|||
126595469|NCT04625725|455480591|FG002|Provent Main Study|Participants dosed in sub-study|0|||
126595470|NCT04625725|455480592|FG003|Provent Main Study|Participants dosed in sub-study|0|||
126595471|NCT04625725|455480593|FG004|Provent Main Study|Participants dosed in sub-study|0|||
126595472|NCT04625725|455480594|FG005|Provent Main Study|Participants dosed in sub-study|0|||
126595473|NCT04625725|455480589|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
126595474|NCT04625725|455480590|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
126595475|NCT04625725|455480591|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
126595476|NCT04625725|455480592|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
126595477|NCT04625725|455480593|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
126595478|NCT04625725|455480594|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
126595479|NCT04625725|455480589|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
126595480|NCT04625725|455480590|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
126595481|NCT04625725|455480591|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
126595482|NCT04625725|455480592|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
126595483|NCT04625725|455480593|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
126595484|NCT04625725|455480594|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
126595485|NCT04625725|455480589|FG000|Provent Main Study|INCARCERATION|3|||
126595486|NCT04625725|455480590|FG001|Provent Main Study|INCARCERATION|0|||
126595487|NCT04625725|455480591|FG002|Provent Main Study|INCARCERATION|0|||
126595488|NCT04625725|455480592|FG003|Provent Main Study|INCARCERATION|0|||
126595489|NCT04625725|455480593|FG004|Provent Main Study|INCARCERATION|0|||
126595490|NCT04625725|455480594|FG005|Provent Main Study|INCARCERATION|0|||
126595491|NCT04625725|455480589|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
126595492|NCT04625725|455480590|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
126595493|NCT04625725|455480591|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
126595494|NCT04625725|455480592|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
126595495|NCT04625725|455480593|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
126595496|NCT04625725|455480594|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
126595497|NCT04625725|455480589|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
126595498|NCT04625725|455480590|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
126595499|NCT04625725|455480591|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
126595500|NCT04625725|455480592|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
126595501|NCT04625725|455480593|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
126595502|NCT04625725|455480594|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
126595503|NCT04625725|455480589|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
126595504|NCT04625725|455480590|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
126595505|NCT04625725|455480591|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
126595506|NCT04625725|455480592|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
126595507|NCT04625725|455480593|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
126595508|NCT04625725|455480594|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
126595509|NCT04625725|455480589|FG000|Provent Main Study|MISSING REASON|0|||
126595510|NCT04625725|455480590|FG001|Provent Main Study|MISSING REASON|1|||
126595511|NCT04625725|455480591|FG002|Provent Main Study|MISSING REASON|0|||
126595512|NCT04625725|455480592|FG003|Provent Main Study|MISSING REASON|0|||
126595513|NCT04625725|455480593|FG004|Provent Main Study|MISSING REASON|0|||
126779221|NCT04120194|456146910|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
126779222|NCT04120194|456146909|FG000|Overall Study|Miscellaneous|4|||
126779223|NCT04120194|456146910|FG001|Overall Study|Miscellaneous|5|||
126779224|NCT00827359|456146914|FG000|Overall Study|Progressive Diseas|19|||
126779225|NCT00827359|456146914|FG000|Overall Study|Unacceptable Toxicity|5|||
126779226|NCT00827359|456146914|FG000|Overall Study|Ineligible|1|||
126595514|NCT04625725|455480594|FG005|Provent Main Study|MISSING REASON|0|||
126595515|NCT04625725|455480589|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
126595516|NCT04625725|455480590|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
126595517|NCT04625725|455480591|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
126595518|NCT04625725|455480592|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
126595519|NCT04625725|455480593|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
126595520|NCT04625725|455480594|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
126595521|NCT04625725|455480589|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
126595522|NCT04625725|455480590|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
126779227|NCT01159769|456146915|FG000|Overall Study|Adverse Event|1|||
126779228|NCT02555618|456146916|FG000|Overall Study|Sponsor's Circumstances|1|||
126779229|NCT02555618|456146917|FG001|Overall Study|Sponsor's Circumstances|0|||
126779230|NCT02063698|456146918|FG000|Overall Study|did not complete booklet for days 2-8|1|||
126779231|NCT02063698|456146919|FG001|Overall Study|did not complete booklet for days 2-8|2|||
126779232|NCT01953783|456146920|FG000|Overall Study|Progressive disease|2|||
126779233|NCT01271933|456146924|FG000|Single-Blind Phase|Lack of Efficacy|37|||
126779234|NCT01271933|456146925|FG001|Single-Blind Phase|Lack of Efficacy|0|||
126779235|NCT01271933|456146926|FG002|Single-Blind Phase|Lack of Efficacy|0|||
126779236|NCT01271933|456146924|FG000|Single-Blind Phase|Lost to Follow-up|10|||
126779237|NCT01271933|456146925|FG001|Single-Blind Phase|Lost to Follow-up|0|||
126779238|NCT01271933|456146926|FG002|Single-Blind Phase|Lost to Follow-up|0|||
126779239|NCT01271933|456146924|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
126779240|NCT01271933|456146925|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
126779241|NCT01271933|456146926|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
126779242|NCT01271933|456146924|FG000|Single-Blind Phase|Protocol Violation|3|||
126779243|NCT01271933|456146925|FG001|Single-Blind Phase|Protocol Violation|0|||
126779244|NCT01271933|456146926|FG002|Single-Blind Phase|Protocol Violation|0|||
126779245|NCT01271933|456146924|FG000|Single-Blind Phase|Adverse Event|52|||
126779246|NCT01271933|456146925|FG001|Single-Blind Phase|Adverse Event|0|||
126779247|NCT01271933|456146926|FG002|Single-Blind Phase|Adverse Event|0|||
126779248|NCT01271933|456146924|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
126779249|NCT01271933|456146925|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
126779250|NCT01271933|456146926|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
126779251|NCT01271933|456146924|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
126779252|NCT01271933|456146925|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
126779253|NCT01271933|456146926|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
126779254|NCT01271933|456146924|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
126779255|NCT01271933|456146925|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
126779256|NCT01271933|456146926|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
126779257|NCT01271933|456146924|FG000|Double-Blind Phase|Randomized but not treated|0|||
126779258|NCT01271933|456146925|FG001|Double-Blind Phase|Randomized but not treated|0|||
126779259|NCT01271933|456146926|FG002|Double-Blind Phase|Randomized but not treated|1|||
126779260|NCT01271933|456146924|FG000|Double-Blind Phase|Lack of Efficacy|0|||
126779261|NCT01271933|456146925|FG001|Double-Blind Phase|Lack of Efficacy|6|||
126779262|NCT01271933|456146926|FG002|Double-Blind Phase|Lack of Efficacy|9|||
126779263|NCT01271933|456146924|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126779264|NCT01271933|456146925|FG001|Double-Blind Phase|Lost to Follow-up|1|||
126779265|NCT01271933|456146926|FG002|Double-Blind Phase|Lost to Follow-up|1|||
126779266|NCT01271933|456146924|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
126779267|NCT01271933|456146925|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
126779268|NCT01271933|456146926|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
126779269|NCT01271933|456146924|FG000|Double-Blind Phase|Adverse Event|0|||
126779270|NCT01271933|456146925|FG001|Double-Blind Phase|Adverse Event|3|||
126779271|NCT01271933|456146926|FG002|Double-Blind Phase|Adverse Event|0|||
126595523|NCT04625725|455480591|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
126595524|NCT04625725|455480592|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
126595525|NCT04625725|455480593|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
126595526|NCT04625725|455480594|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
126595527|NCT04625725|455480589|FG000|Provent Sub Study|Lost to Follow-up|0|||
126595528|NCT04625725|455480590|FG001|Provent Sub Study|Lost to Follow-up|0|||
126595529|NCT04625725|455480591|FG002|Provent Sub Study|Lost to Follow-up|20|||
126595530|NCT04625725|455480592|FG003|Provent Sub Study|Lost to Follow-up|10|||
126595531|NCT04625725|455480593|FG004|Provent Sub Study|Lost to Follow-up|6|||
126595532|NCT04625725|455480594|FG005|Provent Sub Study|Lost to Follow-up|4|||
126595533|NCT04625725|455480589|FG000|Provent Sub Study|Death|0|||
126595534|NCT04625725|455480590|FG001|Provent Sub Study|Death|0|||
126779272|NCT01271933|456146924|FG000|Double-Blind Phase|Participant request-personal reason|0|||
126779273|NCT01271933|456146925|FG001|Double-Blind Phase|Participant request-personal reason|1|||
126779274|NCT01271933|456146926|FG002|Double-Blind Phase|Participant request-personal reason|0|||
126595535|NCT04625725|455480591|FG002|Provent Sub Study|Death|8|||
126595536|NCT04625725|455480592|FG003|Provent Sub Study|Death|5|||
126595537|NCT04625725|455480593|FG004|Provent Sub Study|Death|0|||
126595538|NCT04625725|455480594|FG005|Provent Sub Study|Death|1|||
126595539|NCT04625725|455480589|FG000|Provent Sub Study|Adverse Event|0|||
126779275|NCT01138150|456146927|FG000|Overall Study|blood unable to be processed|0|||
126779276|NCT01138150|456146928|FG001|Overall Study|blood unable to be processed|1|||
126779277|NCT01138150|456146927|FG000|Overall Study|Physician Decision|1|||
126779278|NCT01138150|456146928|FG001|Overall Study|Physician Decision|0|||
126779279|NCT05085964|456146929|FG000|Overall Study|Premature termination of study|21|||
126779280|NCT05085964|456146930|FG001|Overall Study|Premature termination of study|0|||
126779281|NCT03156270|456146933|FG000|Overall Study|Failed pre-treatment screening|1|||
126595540|NCT04625725|455480590|FG001|Provent Sub Study|Adverse Event|0|||
126595541|NCT04625725|455480591|FG002|Provent Sub Study|Adverse Event|0|||
126595542|NCT04625725|455480592|FG003|Provent Sub Study|Adverse Event|0|||
126595543|NCT04625725|455480593|FG004|Provent Sub Study|Adverse Event|0|||
126595544|NCT04625725|455480594|FG005|Provent Sub Study|Adverse Event|1|||
126595545|NCT04625725|455480589|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
126595546|NCT04625725|455480590|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
126595547|NCT04625725|455480591|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
126595548|NCT04625725|455480592|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
126595549|NCT04625725|455480593|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
126595550|NCT04625725|455480594|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
126595551|NCT04625725|455480589|FG000|Provent Sub Study|Withdrawal by Subject|0|||
126595552|NCT04625725|455480590|FG001|Provent Sub Study|Withdrawal by Subject|0|||
126595553|NCT04625725|455480591|FG002|Provent Sub Study|Withdrawal by Subject|11|||
126595554|NCT04625725|455480592|FG003|Provent Sub Study|Withdrawal by Subject|13|||
126595555|NCT04625725|455480593|FG004|Provent Sub Study|Withdrawal by Subject|5|||
126595556|NCT04625725|455480594|FG005|Provent Sub Study|Withdrawal by Subject|6|||
126595557|NCT04625725|455480589|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
126595558|NCT04625725|455480590|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
126595559|NCT04625725|455480591|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
126595560|NCT04625725|455480592|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
126595561|NCT04625725|455480593|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
126595562|NCT04625725|455480594|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
126595563|NCT03298451|455480598|FG000|Overall Study|Death|275|||
126595564|NCT03298451|455480599|FG001|Overall Study|Death|260|||
126595565|NCT03298451|455480600|FG002|Overall Study|Death|122|||
126595566|NCT03298451|455480601|FG003|Overall Study|Death|280|||
126595567|NCT03298451|455480598|FG000|Overall Study|Lost to Follow-up|1|||
126595568|NCT03298451|455480599|FG001|Overall Study|Lost to Follow-up|1|||
126595569|NCT03298451|455480600|FG002|Overall Study|Lost to Follow-up|0|||
126595570|NCT03298451|455480601|FG003|Overall Study|Lost to Follow-up|7|||
126595571|NCT03298451|455480598|FG000|Overall Study|Withdrawal by Subject|9|||
126595572|NCT03298451|455480599|FG001|Overall Study|Withdrawal by Subject|7|||
126595573|NCT03298451|455480600|FG002|Overall Study|Withdrawal by Subject|1|||
126595574|NCT03298451|455480601|FG003|Overall Study|Withdrawal by Subject|20|||
126595575|NCT01651403|455480609|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
126595576|NCT01651403|455480610|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
126595577|NCT01651403|455480609|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
126595578|NCT01651403|455480610|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
126595579|NCT01651403|455480609|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
126595580|NCT01651403|455480610|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
126595581|NCT01651403|455480609|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
126595582|NCT01651403|455480610|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
126595583|NCT01651403|455480609|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
126595584|NCT01651403|455480610|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
126595585|NCT01651403|455480609|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
126595586|NCT01651403|455480610|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
126595587|NCT04032847|455480613|FG000|Overall Study|Study termination by sponsor|8|||
126595588|NCT04032847|455480614|FG001|Overall Study|Study termination by sponsor|0|||
126595589|NCT04032847|455480615|FG002|Overall Study|Study termination by sponsor|4|||
126595590|NCT04032847|455480613|FG000|Overall Study|Death|12|||
126595591|NCT04032847|455480614|FG001|Overall Study|Death|0|||
126595592|NCT04032847|455480615|FG002|Overall Study|Death|0|||
126595593|NCT04032847|455480613|FG000|Overall Study|Progressive disease|2|||
126595594|NCT04032847|455480614|FG001|Overall Study|Progressive disease|0|||
126595595|NCT04032847|455480615|FG002|Overall Study|Progressive disease|1|||
126595596|NCT03213665|455480616|FG000|Overall Study|Adverse Event|1|||
126595597|NCT03213665|455480616|FG000|Overall Study|Physician Decision|2|||
126595598|NCT03213665|455480616|FG000|Overall Study|Withdrawal by Subject|3|||
126595599|NCT03213665|455480616|FG000|Overall Study|Progressive Disease|13|||
126595600|NCT03056573|455480617|FG000|Overall Study|Death|2|||
126595601|NCT03056573|455480618|FG001|Overall Study|Death|4|||
126595602|NCT03056573|455480617|FG000|Overall Study|Withdrawal by Subject|2|||
126595603|NCT03056573|455480618|FG001|Overall Study|Withdrawal by Subject|0|||
126595604|NCT03056573|455480617|FG000|Overall Study|Lost to Follow-up|1|||
126595605|NCT03056573|455480618|FG001|Overall Study|Lost to Follow-up|1|||
126595606|NCT05873556|455480619|FG000|Overall Study|Lost to Follow-up|4|||
126595607|NCT05873556|455480620|FG001|Overall Study|Lost to Follow-up|1|||
126595608|NCT03381586|455480621|FG000|Overall Study|Adverse Event|1|||
126595609|NCT03381586|455480622|FG001|Overall Study|Adverse Event|1|||
126595610|NCT03381586|455480621|FG000|Overall Study|Protocol Violation|1|||
126595611|NCT03381586|455480622|FG001|Overall Study|Protocol Violation|0|||
126595612|NCT03381586|455480621|FG000|Overall Study|Withdrawal by Subject|1|||
126595613|NCT03381586|455480622|FG001|Overall Study|Withdrawal by Subject|2|||
126595614|NCT00696111|455482217|FG000|Overall Study|Withdrawal by Subject|17|||
126595615|NCT02433379|455482218|FG000|Overall Study|Screen Failures|55|||
126595616|NCT02433379|455482218|FG000|Overall Study|Death|57|||
126595617|NCT02433379|455482218|FG000|Overall Study|Total Withdrawals|209|||
126595618|NCT02038777|455482221|FG000|Overall Study|Death|0|||
126595619|NCT02038777|455482222|FG001|Overall Study|Death|2|||
126595620|NCT02038777|455482223|FG002|Overall Study|Death|0|||
126595621|NCT02038777|455482224|FG003|Overall Study|Death|1|||
126595622|NCT02038777|455482225|FG004|Overall Study|Death|2|||
126595623|NCT02038777|455482226|FG005|Overall Study|Death|4|||
126595624|NCT02038777|455482227|FG006|Overall Study|Death|0|||
126595625|NCT02038777|455482228|FG007|Overall Study|Death|11|||
126595626|NCT02038777|455482221|FG000|Overall Study|Lost to Follow-up|0|||
126595627|NCT02038777|455482222|FG001|Overall Study|Lost to Follow-up|0|||
126595628|NCT02038777|455482223|FG002|Overall Study|Lost to Follow-up|0|||
126595629|NCT02038777|455482224|FG003|Overall Study|Lost to Follow-up|1|||
126595630|NCT02038777|455482225|FG004|Overall Study|Lost to Follow-up|0|||
126595631|NCT02038777|455482226|FG005|Overall Study|Lost to Follow-up|0|||
126595632|NCT02038777|455482227|FG006|Overall Study|Lost to Follow-up|0|||
126595633|NCT02038777|455482228|FG007|Overall Study|Lost to Follow-up|0|||
126595634|NCT02038777|455482221|FG000|Overall Study|Other|0|||
126595635|NCT02038777|455482222|FG001|Overall Study|Other|1|||
126595636|NCT02038777|455482223|FG002|Overall Study|Other|0|||
126595637|NCT02038777|455482224|FG003|Overall Study|Other|2|||
126595638|NCT02038777|455482225|FG004|Overall Study|Other|1|||
126595639|NCT02038777|455482226|FG005|Overall Study|Other|0|||
126595640|NCT02038777|455482227|FG006|Overall Study|Other|0|||
126595641|NCT02038777|455482228|FG007|Overall Study|Other|0|||
126595642|NCT02038777|455482221|FG000|Overall Study|Randomized but not treated|0|||
126595643|NCT02038777|455482222|FG001|Overall Study|Randomized but not treated|1|||
126595644|NCT02038777|455482223|FG002|Overall Study|Randomized but not treated|0|||
126595645|NCT02038777|455482224|FG003|Overall Study|Randomized but not treated|0|||
126595646|NCT02038777|455482225|FG004|Overall Study|Randomized but not treated|0|||
126595647|NCT02038777|455482226|FG005|Overall Study|Randomized but not treated|0|||
126595648|NCT02038777|455482227|FG006|Overall Study|Randomized but not treated|0|||
126595649|NCT02038777|455482228|FG007|Overall Study|Randomized but not treated|0|||
126595650|NCT02038777|455482221|FG000|Overall Study|Started Chemotherapy|1|||
126595651|NCT02038777|455482222|FG001|Overall Study|Started Chemotherapy|0|||
126595652|NCT02038777|455482223|FG002|Overall Study|Started Chemotherapy|3|||
126595653|NCT02038777|455482224|FG003|Overall Study|Started Chemotherapy|0|||
126595654|NCT02038777|455482225|FG004|Overall Study|Started Chemotherapy|0|||
126595655|NCT02038777|455482226|FG005|Overall Study|Started Chemotherapy|0|||
126595656|NCT02038777|455482227|FG006|Overall Study|Started Chemotherapy|0|||
126595657|NCT02038777|455482228|FG007|Overall Study|Started Chemotherapy|0|||
126595658|NCT02038777|455482221|FG000|Overall Study|participation terminated by sponsor|0|||
126595659|NCT02038777|455482222|FG001|Overall Study|participation terminated by sponsor|0|||
126595660|NCT02038777|455482223|FG002|Overall Study|participation terminated by sponsor|0|||
126595661|NCT02038777|455482224|FG003|Overall Study|participation terminated by sponsor|0|||
126595662|NCT02038777|455482225|FG004|Overall Study|participation terminated by sponsor|0|||
126595663|NCT02038777|455482226|FG005|Overall Study|participation terminated by sponsor|0|||
126595664|NCT02038777|455482227|FG006|Overall Study|participation terminated by sponsor|1|||
126595665|NCT02038777|455482228|FG007|Overall Study|participation terminated by sponsor|1|||
126595666|NCT03676192|455482229|FG000|Induction Study Period|Adverse Event|21|||
126595667|NCT03676192|455482230|FG001|Induction Study Period|Adverse Event|20|||
126595668|NCT03676192|455482229|FG000|Induction Study Period|Death|23|||
126595669|NCT03676192|455482230|FG001|Induction Study Period|Death|20|||
126595670|NCT03676192|455482229|FG000|Induction Study Period|Lost to Follow-up|3|||
126595671|NCT03676192|455482230|FG001|Induction Study Period|Lost to Follow-up|3|||
126595672|NCT03676192|455482229|FG000|Induction Study Period|Physician Decision|6|||
126595673|NCT03676192|455482230|FG001|Induction Study Period|Physician Decision|3|||
126595674|NCT03676192|455482229|FG000|Induction Study Period|Progressive Disease|32|||
126595675|NCT03676192|455482230|FG001|Induction Study Period|Progressive Disease|21|||
126595676|NCT03676192|455482229|FG000|Induction Study Period|Protocol Violation|1|||
126732490|NCT04190186|455969837|FG000|Overall Study|Study was stopped|4|||
126595677|NCT03676192|455482230|FG001|Induction Study Period|Protocol Violation|2|||
126732491|NCT04190186|455969838|FG001|Overall Study|Study was stopped|5|||
126595678|NCT03676192|455482229|FG000|Induction Study Period|Withdrawal by Subject|20|||
126595679|NCT03676192|455482230|FG001|Induction Study Period|Withdrawal by Subject|15|||
126595680|NCT04766892|455482234|FG000|Overall Study|Withdrawal by Subject|1|||
126595681|NCT04766892|455482234|FG000|Overall Study|Lost to Follow-up|1|||
126595682|NCT04766892|455482234|FG000|Overall Study|Adverse Event|3|||
126595683|NCT04766892|455482234|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
126595684|NCT04778397|455482235|FG000|Overall Study|Death|59|||
126595685|NCT04778397|455482236|FG001|Overall Study|Death|54|||
126779282|NCT03156270|456146933|FG000|Overall Study|Lost to Follow-up|1|||
126779283|NCT00591253|456146936|FG000|Overall Study|Adverse Event|3|||
126779284|NCT00591253|456146937|FG001|Overall Study|Adverse Event|3|||
126779285|NCT00591253|456146938|FG002|Overall Study|Adverse Event|1|||
126779286|NCT00591253|456146936|FG000|Overall Study|Protocol Violation|2|||
126779287|NCT00591253|456146937|FG001|Overall Study|Protocol Violation|2|||
126779288|NCT00591253|456146938|FG002|Overall Study|Protocol Violation|2|||
126779289|NCT00591253|456146936|FG000|Overall Study|Lost to Follow-up|2|||
126779290|NCT00591253|456146937|FG001|Overall Study|Lost to Follow-up|4|||
126779291|NCT00591253|456146938|FG002|Overall Study|Lost to Follow-up|0|||
126779292|NCT00591253|456146936|FG000|Overall Study|Withdrawal by Subject|1|||
126779293|NCT00591253|456146937|FG001|Overall Study|Withdrawal by Subject|7|||
126779294|NCT00591253|456146938|FG002|Overall Study|Withdrawal by Subject|6|||
126779295|NCT00591253|456146936|FG000|Overall Study|Lack of Efficacy|1|||
126779296|NCT00591253|456146937|FG001|Overall Study|Lack of Efficacy|0|||
126779297|NCT00591253|456146938|FG002|Overall Study|Lack of Efficacy|3|||
126779298|NCT00591253|456146936|FG000|Overall Study|Other|5|||
126779299|NCT00591253|456146937|FG001|Overall Study|Other|5|||
126779300|NCT00591253|456146938|FG002|Overall Study|Other|3|||
126779301|NCT00871169|456146939|FG000|Overall Study|Protocol Violation|1|||
126779302|NCT00871169|456146939|FG000|Overall Study|Patient did not receive study treatment|2|||
126779303|NCT02110706|456146943|FG000|Overall Study|Adverse Event|2|||
126779304|NCT02110706|456146944|FG001|Overall Study|Adverse Event|3|||
126779305|NCT02110706|456146943|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
126779306|NCT02110706|456146944|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
126779307|NCT03210259|456146945|FG000|12-Week Run-in Period|Adverse Event|1|||
126779308|NCT03210259|456146946|FG001|12-Week Run-in Period|Adverse Event|0|||
126779309|NCT03210259|456146947|FG002|12-Week Run-in Period|Adverse Event|0|||
126779310|NCT03210259|456146945|FG000|12-Week Run-in Period|Death|1|||
126779311|NCT03210259|456146946|FG001|12-Week Run-in Period|Death|0|||
126779312|NCT03210259|456146947|FG002|12-Week Run-in Period|Death|0|||
126779313|NCT03210259|456146945|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
126779314|NCT03210259|456146946|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
126779315|NCT03210259|456146947|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
126779316|NCT03210259|456146945|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
126779317|NCT03210259|456146946|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
126779318|NCT03210259|456146947|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
126779319|NCT03210259|456146945|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
126779320|NCT03210259|456146946|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
126779321|NCT03210259|456146947|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
126779322|NCT03210259|456146945|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
126779323|NCT03210259|456146946|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
126779324|NCT03210259|456146947|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
126779325|NCT03210259|456146945|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
126779326|NCT03210259|456146946|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
126779327|NCT03210259|456146947|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
126779328|NCT03210259|456146945|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
126779329|NCT03210259|456146946|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
126779330|NCT03210259|456146947|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
126779331|NCT03210259|456146945|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
126779332|NCT03210259|456146946|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
126779333|NCT03210259|456146947|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
126779334|NCT03210259|456146945|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
126779335|NCT03210259|456146946|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
126779336|NCT03210259|456146947|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
126779337|NCT03210259|456146945|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
126779338|NCT03210259|456146946|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
126779339|NCT03210259|456146947|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
126779340|NCT02087059|456146948|FG000|Overall Study|Disease Progression|1|||
126779341|NCT02087059|456146948|FG000|Overall Study|Adverse Event|5|||
126779342|NCT02087059|456146948|FG000|Overall Study|Lost to Follow-up|1|||
126779343|NCT00252187|456146949|FG000|Overall Study|Adverse Event|3|||
126779344|NCT00252187|456146950|FG001|Overall Study|Adverse Event|1|||
126779345|NCT00252187|456146949|FG000|Overall Study|Withdrawal by Subject|1|||
126779346|NCT00252187|456146950|FG001|Overall Study|Withdrawal by Subject|0|||
126779347|NCT00706706|456146953|FG000|Overall Study|Death|53|||
126779348|NCT00706706|456146953|FG000|Overall Study|Lost to Follow-up|7|||
126779349|NCT00706706|456146953|FG000|Overall Study|Study endpoint had reached|45|||
126779350|NCT05017493|456146954|FG000|Overall Study|Withdrawal by Subject|26|||
126779351|NCT05017493|456146955|FG001|Overall Study|Withdrawal by Subject|0|||
126779352|NCT05017493|456146954|FG000|Overall Study|Physician Decision|15|||
126779353|NCT05017493|456146955|FG001|Overall Study|Physician Decision|0|||
126779354|NCT05017493|456146954|FG000|Overall Study|Protocol Violation|81|||
126779355|NCT05017493|456146955|FG001|Overall Study|Protocol Violation|0|||
126779356|NCT01261325|456146966|FG000|Overall Study|Lack of Efficacy|1|||
126595686|NCT04778397|455482237|FG002|Overall Study|Death|11|||
126595687|NCT04778397|455482238|FG003|Overall Study|Death|9|||
126595688|NCT04778397|455482235|FG000|Overall Study|Study Terminated by Sponsor|34|||
126595689|NCT04778397|455482236|FG001|Overall Study|Study Terminated by Sponsor|42|||
126595690|NCT04778397|455482237|FG002|Overall Study|Study Terminated by Sponsor|15|||
126595691|NCT04778397|455482238|FG003|Overall Study|Study Terminated by Sponsor|12|||
126595692|NCT04778397|455482235|FG000|Overall Study|Withdrew Consent|5|||
126595693|NCT04778397|455482236|FG001|Overall Study|Withdrew Consent|4|||
126595694|NCT04778397|455482237|FG002|Overall Study|Withdrew Consent|1|||
126595695|NCT04778397|455482238|FG003|Overall Study|Withdrew Consent|1|||
126595696|NCT04778397|455482235|FG000|Overall Study|Reason Not Specified|1|||
126595697|NCT04778397|455482236|FG001|Overall Study|Reason Not Specified|3|||
126595698|NCT04778397|455482237|FG002|Overall Study|Reason Not Specified|0|||
126595699|NCT04778397|455482238|FG003|Overall Study|Reason Not Specified|2|||
126595700|NCT04778397|455482235|FG000|Overall Study|Lost to Follow-up|2|||
126595701|NCT04778397|455482236|FG001|Overall Study|Lost to Follow-up|1|||
126595702|NCT04778397|455482237|FG002|Overall Study|Lost to Follow-up|0|||
126595703|NCT04778397|455482238|FG003|Overall Study|Lost to Follow-up|1|||
126595704|NCT05906784|455482240|FG000|Overall Study|Lost to Follow-up|2|||
126595705|NCT05906784|455482241|FG001|Overall Study|Lost to Follow-up|1|||
126595706|NCT05906784|455482242|FG002|Overall Study|Lost to Follow-up|1|||
126595707|NCT05906784|455482243|FG003|Overall Study|Lost to Follow-up|1|||
126595708|NCT02668692|455482244|FG000|Overall Study|Adverse Event|1|||
126595709|NCT02668692|455482245|FG001|Overall Study|Adverse Event|0|||
126595710|NCT01627574|455482248|FG000|Overall Study|Withdrawal by Subject|8|||
126595711|NCT01627574|455482249|FG001|Overall Study|Withdrawal by Subject|5|||
126595712|NCT01627574|455482248|FG000|Overall Study|Lost to Follow-up|13|||
126595713|NCT01627574|455482249|FG001|Overall Study|Lost to Follow-up|13|||
126595714|NCT04730739|455482250|FG000|Overall Study|Death|1|||
126595715|NCT04707469|455482256|FG000|Overall Study|Site closure|0|||
126595716|NCT04707469|455482257|FG001|Overall Study|Site closure|2|||
126595717|NCT04707469|455482258|FG002|Overall Study|Site closure|0|||
126595718|NCT04707469|455482256|FG000|Overall Study|Physician Decision|2|||
126595719|NCT04707469|455482257|FG001|Overall Study|Physician Decision|2|||
126595720|NCT04707469|455482258|FG002|Overall Study|Physician Decision|2|||
126595721|NCT04707469|455482256|FG000|Overall Study|Death|1|||
126595722|NCT04707469|455482257|FG001|Overall Study|Death|6|||
126595723|NCT04707469|455482258|FG002|Overall Study|Death|2|||
126595724|NCT04707469|455482256|FG000|Overall Study|Lost to Follow-up|9|||
126595725|NCT04707469|455482257|FG001|Overall Study|Lost to Follow-up|19|||
126595726|NCT04707469|455482258|FG002|Overall Study|Lost to Follow-up|14|||
126595727|NCT04707469|455482256|FG000|Overall Study|Withdrawal by Subject|17|||
126595728|NCT04707469|455482257|FG001|Overall Study|Withdrawal by Subject|16|||
126595729|NCT04707469|455482258|FG002|Overall Study|Withdrawal by Subject|12|||
126595730|NCT04677738|455482259|FG000|Overall Study|Withdrawal by Subject|4|||
126595731|NCT04677738|455482260|FG001|Overall Study|Withdrawal by Subject|2|||
126595732|NCT03249090|455482263|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
126595733|NCT03249090|455482264|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
126595734|NCT03249090|455482263|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
126595735|NCT03249090|455482264|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
126595736|NCT03249090|455482263|FG000|3 Month Time Point|Voluntary withdrawal|6|||
126595737|NCT03249090|455482264|FG001|3 Month Time Point|Voluntary withdrawal|3|||
126595738|NCT03249090|455482263|FG000|3 Month Time Point|Changed oncology practice|4|||
126595739|NCT03249090|455482264|FG001|3 Month Time Point|Changed oncology practice|2|||
126595740|NCT03249090|455482263|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
126595741|NCT03249090|455482264|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
126595742|NCT03249090|455482263|FG000|12 Month Time Point|Voluntary withdrawal|35|||
126595743|NCT03249090|455482264|FG001|12 Month Time Point|Voluntary withdrawal|4|||
126595744|NCT03249090|455482263|FG000|12 Month Time Point|Changed oncology practice|20|||
126595745|NCT03249090|455482264|FG001|12 Month Time Point|Changed oncology practice|9|||
126595746|NCT04685135|455482265|FG000|Overall Study|Death|126|||
126595747|NCT04685135|455482266|FG001|Overall Study|Death|53|||
126595748|NCT04685135|455482265|FG000|Overall Study|Withdrawal by Subject|12|||
126732492|NCT01381718|455969839|FG000|Overall Study|Withdrawal by Subject|2|||
126732493|NCT01381718|455969840|FG001|Overall Study|Withdrawal by Subject|5|||
126595749|NCT04685135|455482266|FG001|Overall Study|Withdrawal by Subject|16|||
126595750|NCT03476343|455482267|FG000|Overall Study|Clinical exam moved to another scanner|7|||
126595751|NCT03476343|455482267|FG000|Overall Study|Clinical order cancelled|4|||
126595752|NCT03476343|455482267|FG000|Overall Study|Neonate did not settle down for the scan|1|||
126595753|NCT03088878|455482268|FG000|Overall Study|Adverse Event|0|||
126595754|NCT03088878|455482269|FG001|Overall Study|Adverse Event|0|||
126595755|NCT03088878|455482270|FG002|Overall Study|Adverse Event|0|||
126595756|NCT03088878|455482271|FG003|Overall Study|Adverse Event|0|||
126595757|NCT03088878|455482272|FG004|Overall Study|Adverse Event|4|||
126595758|NCT03088878|455482273|FG005|Overall Study|Adverse Event|2|||
126595759|NCT03088878|455482274|FG006|Overall Study|Adverse Event|1|||
126595760|NCT03088878|455482275|FG007|Overall Study|Adverse Event|0|||
126595761|NCT03088878|455482276|FG008|Overall Study|Adverse Event|0|||
126595762|NCT03088878|455482277|FG009|Overall Study|Adverse Event|0|||
126595763|NCT03088878|455482278|FG010|Overall Study|Adverse Event|0|||
126595764|NCT03088878|455482279|FG011|Overall Study|Adverse Event|0|||
126595765|NCT03088878|455482280|FG012|Overall Study|Adverse Event|5|||
126595766|NCT03088878|455482281|FG013|Overall Study|Adverse Event|3|||
126595767|NCT03088878|455482268|FG000|Overall Study|Clinical Progression|0|||
126595768|NCT03088878|455482269|FG001|Overall Study|Clinical Progression|0|||
126595769|NCT03088878|455482270|FG002|Overall Study|Clinical Progression|0|||
126595770|NCT03088878|455482271|FG003|Overall Study|Clinical Progression|0|||
126595771|NCT03088878|455482272|FG004|Overall Study|Clinical Progression|2|||
126595772|NCT03088878|455482273|FG005|Overall Study|Clinical Progression|0|||
126595773|NCT03088878|455482274|FG006|Overall Study|Clinical Progression|0|||
126595774|NCT03088878|455482275|FG007|Overall Study|Clinical Progression|0|||
126595775|NCT03088878|455482276|FG008|Overall Study|Clinical Progression|0|||
126595776|NCT03088878|455482277|FG009|Overall Study|Clinical Progression|0|||
126595777|NCT03088878|455482278|FG010|Overall Study|Clinical Progression|0|||
126595778|NCT03088878|455482279|FG011|Overall Study|Clinical Progression|0|||
126595779|NCT03088878|455482280|FG012|Overall Study|Clinical Progression|0|||
126595780|NCT03088878|455482281|FG013|Overall Study|Clinical Progression|0|||
126595781|NCT03088878|455482268|FG000|Overall Study|Death|0|||
126595782|NCT03088878|455482269|FG001|Overall Study|Death|0|||
126595783|NCT03088878|455482270|FG002|Overall Study|Death|0|||
126595784|NCT03088878|455482271|FG003|Overall Study|Death|0|||
126595785|NCT03088878|455482272|FG004|Overall Study|Death|2|||
126595786|NCT03088878|455482273|FG005|Overall Study|Death|0|||
126595787|NCT03088878|455482274|FG006|Overall Study|Death|0|||
126595788|NCT03088878|455482275|FG007|Overall Study|Death|0|||
126595789|NCT03088878|455482276|FG008|Overall Study|Death|0|||
126595790|NCT03088878|455482277|FG009|Overall Study|Death|0|||
126595791|NCT03088878|455482278|FG010|Overall Study|Death|0|||
126595792|NCT03088878|455482279|FG011|Overall Study|Death|1|||
126595793|NCT03088878|455482280|FG012|Overall Study|Death|0|||
126595794|NCT03088878|455482281|FG013|Overall Study|Death|0|||
126595795|NCT03088878|455482268|FG000|Overall Study|Disease Progression|1|||
126595796|NCT03088878|455482269|FG001|Overall Study|Disease Progression|2|||
126595797|NCT03088878|455482270|FG002|Overall Study|Disease Progression|3|||
126595798|NCT03088878|455482271|FG003|Overall Study|Disease Progression|0|||
126595799|NCT03088878|455482272|FG004|Overall Study|Disease Progression|3|||
126595800|NCT03088878|455482273|FG005|Overall Study|Disease Progression|0|||
126595801|NCT03088878|455482274|FG006|Overall Study|Disease Progression|0|||
126595802|NCT03088878|455482275|FG007|Overall Study|Disease Progression|0|||
126595803|NCT03088878|455482276|FG008|Overall Study|Disease Progression|0|||
126595804|NCT03088878|455482277|FG009|Overall Study|Disease Progression|0|||
126595805|NCT03088878|455482278|FG010|Overall Study|Disease Progression|0|||
126595806|NCT03088878|455482279|FG011|Overall Study|Disease Progression|0|||
126595807|NCT03088878|455482280|FG012|Overall Study|Disease Progression|1|||
126595808|NCT03088878|455482281|FG013|Overall Study|Disease Progression|1|||
126595809|NCT03088878|455482268|FG000|Overall Study|Initiation of Alternative Treatment|0|||
126595810|NCT03088878|455482269|FG001|Overall Study|Initiation of Alternative Treatment|0|||
126595811|NCT03088878|455482270|FG002|Overall Study|Initiation of Alternative Treatment|0|||
126595812|NCT03088878|455482271|FG003|Overall Study|Initiation of Alternative Treatment|1|||
126732494|NCT01381718|455969839|FG000|Overall Study|Lost to Follow-up|3|||
126732495|NCT01381718|455969840|FG001|Overall Study|Lost to Follow-up|5|||
126732496|NCT01381718|455969839|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
126732497|NCT01381718|455969840|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
126732498|NCT02759861|455969843|FG000|Overall Study|Death|1|||
126732499|NCT00992186|455969846|FG000|Overall Study|Withdrawal by Subject|2|||
126732500|NCT00992186|455969846|FG000|Overall Study|Protocol Violation|1|||
126595813|NCT03088878|455482272|FG004|Overall Study|Initiation of Alternative Treatment|0|||
126595814|NCT03088878|455482273|FG005|Overall Study|Initiation of Alternative Treatment|0|||
126595815|NCT03088878|455482274|FG006|Overall Study|Initiation of Alternative Treatment|0|||
126732501|NCT00992186|455969846|FG000|Overall Study|Physician Decision|1|||
126732502|NCT00992186|455969846|FG000|Overall Study|Adverse Event|9|||
126732503|NCT00992186|455969846|FG000|Overall Study|Progressive Disease|30|||
126732504|NCT00992186|455969846|FG000|Overall Study|Refusal To Receive Study Agent|3|||
126595816|NCT03088878|455482275|FG007|Overall Study|Initiation of Alternative Treatment|1|||
126595817|NCT03088878|455482276|FG008|Overall Study|Initiation of Alternative Treatment|1|||
126595818|NCT03088878|455482277|FG009|Overall Study|Initiation of Alternative Treatment|0|||
126732505|NCT02677220|455969847|FG000|Overall Study|Adverse Event|1|||
126732506|NCT00965146|455969848|FG000|Overall Study|Death|7|||
126732507|NCT00965146|455969848|FG000|Overall Study|Lost to Follow-up|22|||
126732508|NCT00965146|455969848|FG000|Overall Study|Withdrawal by Subject|17|||
126595819|NCT03088878|455482278|FG010|Overall Study|Initiation of Alternative Treatment|0|||
126595820|NCT03088878|455482279|FG011|Overall Study|Initiation of Alternative Treatment|0|||
126595821|NCT03088878|455482280|FG012|Overall Study|Initiation of Alternative Treatment|0|||
126595822|NCT03088878|455482281|FG013|Overall Study|Initiation of Alternative Treatment|0|||
126732509|NCT00965146|455969848|FG000|Overall Study|Unable to return|1|||
126595823|NCT03088878|455482268|FG000|Overall Study|Withdrawal by Subject|0|||
126595824|NCT03088878|455482269|FG001|Overall Study|Withdrawal by Subject|0|||
126595825|NCT03088878|455482270|FG002|Overall Study|Withdrawal by Subject|0|||
126595826|NCT03088878|455482271|FG003|Overall Study|Withdrawal by Subject|1|||
126595827|NCT03088878|455482272|FG004|Overall Study|Withdrawal by Subject|4|||
126595828|NCT03088878|455482273|FG005|Overall Study|Withdrawal by Subject|1|||
126595829|NCT03088878|455482274|FG006|Overall Study|Withdrawal by Subject|1|||
126595830|NCT03088878|455482275|FG007|Overall Study|Withdrawal by Subject|0|||
126595831|NCT03088878|455482276|FG008|Overall Study|Withdrawal by Subject|1|||
126595832|NCT03088878|455482277|FG009|Overall Study|Withdrawal by Subject|2|||
126595833|NCT03088878|455482278|FG010|Overall Study|Withdrawal by Subject|0|||
126595834|NCT03088878|455482279|FG011|Overall Study|Withdrawal by Subject|2|||
126595835|NCT03088878|455482280|FG012|Overall Study|Withdrawal by Subject|1|||
126595836|NCT03088878|455482281|FG013|Overall Study|Withdrawal by Subject|0|||
126595837|NCT03088878|455482268|FG000|Overall Study|Terminated by Sponsor|2|||
126595838|NCT03088878|455482269|FG001|Overall Study|Terminated by Sponsor|1|||
126595839|NCT03088878|455482270|FG002|Overall Study|Terminated by Sponsor|0|||
126595840|NCT03088878|455482271|FG003|Overall Study|Terminated by Sponsor|1|||
126595841|NCT03088878|455482272|FG004|Overall Study|Terminated by Sponsor|6|||
126595842|NCT03088878|455482273|FG005|Overall Study|Terminated by Sponsor|0|||
126595843|NCT03088878|455482274|FG006|Overall Study|Terminated by Sponsor|0|||
126595844|NCT03088878|455482275|FG007|Overall Study|Terminated by Sponsor|0|||
126595845|NCT03088878|455482276|FG008|Overall Study|Terminated by Sponsor|0|||
126595846|NCT03088878|455482277|FG009|Overall Study|Terminated by Sponsor|0|||
126595847|NCT03088878|455482278|FG010|Overall Study|Terminated by Sponsor|3|||
126595848|NCT03088878|455482279|FG011|Overall Study|Terminated by Sponsor|13|||
126595849|NCT03088878|455482280|FG012|Overall Study|Terminated by Sponsor|2|||
126595850|NCT03088878|455482281|FG013|Overall Study|Terminated by Sponsor|1|||
126595851|NCT03088878|455482268|FG000|Overall Study|Completed 2 years of Treatment|0|||
126595852|NCT03088878|455482269|FG001|Overall Study|Completed 2 years of Treatment|0|||
126595853|NCT03088878|455482270|FG002|Overall Study|Completed 2 years of Treatment|0|||
126595854|NCT03088878|455482271|FG003|Overall Study|Completed 2 years of Treatment|0|||
126595855|NCT03088878|455482272|FG004|Overall Study|Completed 2 years of Treatment|0|||
126595856|NCT03088878|455482273|FG005|Overall Study|Completed 2 years of Treatment|0|||
126595857|NCT03088878|455482274|FG006|Overall Study|Completed 2 years of Treatment|1|||
126595858|NCT03088878|455482275|FG007|Overall Study|Completed 2 years of Treatment|0|||
126595859|NCT03088878|455482276|FG008|Overall Study|Completed 2 years of Treatment|0|||
126595860|NCT03088878|455482277|FG009|Overall Study|Completed 2 years of Treatment|1|||
126595861|NCT03088878|455482278|FG010|Overall Study|Completed 2 years of Treatment|0|||
126595862|NCT03088878|455482279|FG011|Overall Study|Completed 2 years of Treatment|0|||
126595863|NCT03088878|455482280|FG012|Overall Study|Completed 2 years of Treatment|8|||
126595864|NCT03088878|455482281|FG013|Overall Study|Completed 2 years of Treatment|3|||
126595865|NCT03088878|455482268|FG000|Overall Study|Physician Decision|0|||
126595866|NCT03088878|455482269|FG001|Overall Study|Physician Decision|0|||
126595867|NCT03088878|455482270|FG002|Overall Study|Physician Decision|0|||
126595868|NCT03088878|455482271|FG003|Overall Study|Physician Decision|0|||
126595869|NCT03088878|455482272|FG004|Overall Study|Physician Decision|0|||
126595870|NCT03088878|455482273|FG005|Overall Study|Physician Decision|0|||
126595871|NCT03088878|455482274|FG006|Overall Study|Physician Decision|0|||
126595872|NCT03088878|455482275|FG007|Overall Study|Physician Decision|2|||
126595873|NCT03088878|455482276|FG008|Overall Study|Physician Decision|1|||
126595874|NCT03088878|455482277|FG009|Overall Study|Physician Decision|0|||
126595875|NCT03088878|455482278|FG010|Overall Study|Physician Decision|0|||
126595876|NCT03088878|455482279|FG011|Overall Study|Physician Decision|0|||
126595877|NCT03088878|455482280|FG012|Overall Study|Physician Decision|0|||
126595878|NCT03088878|455482281|FG013|Overall Study|Physician Decision|1|||
126595879|NCT03088878|455482268|FG000|Overall Study|COVID Related noncompliance|0|||
126595880|NCT03088878|455482269|FG001|Overall Study|COVID Related noncompliance|0|||
126595881|NCT03088878|455482270|FG002|Overall Study|COVID Related noncompliance|0|||
126595882|NCT03088878|455482271|FG003|Overall Study|COVID Related noncompliance|0|||
126595883|NCT03088878|455482272|FG004|Overall Study|COVID Related noncompliance|0|||
126595884|NCT03088878|455482273|FG005|Overall Study|COVID Related noncompliance|0|||
126595885|NCT03088878|455482274|FG006|Overall Study|COVID Related noncompliance|0|||
126595886|NCT03088878|455482275|FG007|Overall Study|COVID Related noncompliance|0|||
126595887|NCT03088878|455482276|FG008|Overall Study|COVID Related noncompliance|0|||
126595888|NCT03088878|455482277|FG009|Overall Study|COVID Related noncompliance|0|||
126595889|NCT03088878|455482278|FG010|Overall Study|COVID Related noncompliance|0|||
126595890|NCT03088878|455482279|FG011|Overall Study|COVID Related noncompliance|0|||
126595891|NCT03088878|455482280|FG012|Overall Study|COVID Related noncompliance|0|||
126595892|NCT03088878|455482281|FG013|Overall Study|COVID Related noncompliance|1|||
126595893|NCT03088878|455482268|FG000|Overall Study|Drug or Study Noncompliance|0|||
126595894|NCT03088878|455482269|FG001|Overall Study|Drug or Study Noncompliance|0|||
126595895|NCT03088878|455482270|FG002|Overall Study|Drug or Study Noncompliance|0|||
126595896|NCT03088878|455482271|FG003|Overall Study|Drug or Study Noncompliance|0|||
126595897|NCT03088878|455482272|FG004|Overall Study|Drug or Study Noncompliance|0|||
126595898|NCT03088878|455482273|FG005|Overall Study|Drug or Study Noncompliance|0|||
126595899|NCT03088878|455482274|FG006|Overall Study|Drug or Study Noncompliance|0|||
126595900|NCT03088878|455482275|FG007|Overall Study|Drug or Study Noncompliance|0|||
126595901|NCT03088878|455482276|FG008|Overall Study|Drug or Study Noncompliance|0|||
126595902|NCT03088878|455482277|FG009|Overall Study|Drug or Study Noncompliance|0|||
126595903|NCT03088878|455482278|FG010|Overall Study|Drug or Study Noncompliance|0|||
126595904|NCT03088878|455482279|FG011|Overall Study|Drug or Study Noncompliance|0|||
126595905|NCT03088878|455482280|FG012|Overall Study|Drug or Study Noncompliance|1|||
126595906|NCT03088878|455482281|FG013|Overall Study|Drug or Study Noncompliance|0|||
126595907|NCT01346540|455482293|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
126595908|NCT01346540|455482294|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
126595909|NCT01346540|455482293|FG000|Overall Study|Adverse Event|0|||
126595910|NCT01346540|455482294|FG001|Overall Study|Adverse Event|4|||
126595911|NCT01221948|455482306|FG000|Overall Study|Physician Decision|5|||
126595912|NCT01221948|455482306|FG000|Overall Study|Withdrawal by Subject|2|||
126595913|NCT01221948|455482306|FG000|Overall Study|not disclosed|2|||
126595914|NCT01221948|455482306|FG000|Overall Study|Death|1|||
126595915|NCT01221948|455482306|FG000|Overall Study|Protocol Violation|4|||
126595916|NCT00746096|455482307|FG000|Overall Study|Adverse Event|1|||
126595917|NCT00746096|455482308|FG001|Overall Study|Adverse Event|0|||
126595918|NCT00746096|455482307|FG000|Overall Study|Withdrawal by Subject|5|||
126595919|NCT00746096|455482308|FG001|Overall Study|Withdrawal by Subject|1|||
126595920|NCT00746096|455482307|FG000|Overall Study|Lost to Follow-up|2|||
126595921|NCT00746096|455482308|FG001|Overall Study|Lost to Follow-up|1|||
126595922|NCT00746096|455482307|FG000|Overall Study|Protocol Violation|1|||
126595923|NCT00746096|455482308|FG001|Overall Study|Protocol Violation|0|||
126595924|NCT00746096|455482307|FG000|Overall Study|No study drug treatment|1|||
126595925|NCT00746096|455482308|FG001|Overall Study|No study drug treatment|1|||
126595926|NCT04059185|455482309|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
126595927|NCT04059185|455482310|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
126595928|NCT04059185|455482311|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
126595929|NCT04059185|455482309|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
126595930|NCT04059185|455482310|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
126595931|NCT04059185|455482311|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
126595932|NCT04059185|455482309|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
126595933|NCT04059185|455482310|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
126595934|NCT04059185|455482311|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
126595935|NCT04059185|455482309|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
126595936|NCT04059185|455482310|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
126595937|NCT04059185|455482311|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
126595938|NCT04059185|455482309|FG000|Longitudinal Assessment-Adults Only|Death|4|||
126595939|NCT04059185|455482310|FG001|Longitudinal Assessment-Adults Only|Death|4|||
126595940|NCT04059185|455482311|FG002|Longitudinal Assessment-Adults Only|Death|3|||
126595941|NCT03756662|455482312|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
126595942|NCT03295721|455482320|FG000|Overall Study|Adverse Event|1|||
126595943|NCT03295721|455482321|FG001|Overall Study|Adverse Event|0|||
126595944|NCT03295721|455482322|FG002|Overall Study|Adverse Event|0|||
126595945|NCT03295721|455482320|FG000|Overall Study|Lost to Follow-up|1|||
126595946|NCT03295721|455482321|FG001|Overall Study|Lost to Follow-up|1|||
126595947|NCT03295721|455482322|FG002|Overall Study|Lost to Follow-up|1|||
126595948|NCT03295721|455482320|FG000|Overall Study|Withdrawal by Subject|1|||
126595949|NCT03295721|455482321|FG001|Overall Study|Withdrawal by Subject|0|||
126595950|NCT03295721|455482322|FG002|Overall Study|Withdrawal by Subject|1|||
126595951|NCT03295721|455482320|FG000|Overall Study|Death|0|||
126595952|NCT03295721|455482321|FG001|Overall Study|Death|0|||
126595953|NCT03295721|455482322|FG002|Overall Study|Death|1|||
126595954|NCT05090683|455482327|FG000|Overall Study|Lost to Follow-up|10|||
126595955|NCT05090683|455482328|FG001|Overall Study|Lost to Follow-up|2|||
126595956|NCT05090683|455482327|FG000|Overall Study|Withdrawal by Subject|15|||
126595957|NCT05090683|455482328|FG001|Overall Study|Withdrawal by Subject|0|||
126595958|NCT03325985|455482329|FG000|Overall Study|Lost to Follow-up|122|||
126595959|NCT03325985|455482330|FG001|Overall Study|Lost to Follow-up|26|||
126595960|NCT03325985|455482331|FG002|Overall Study|Lost to Follow-up|141|||
126595961|NCT03325985|455482332|FG003|Overall Study|Lost to Follow-up|28|||
126595962|NCT03325985|455482329|FG000|Overall Study|Death|99|||
126595963|NCT03325985|455482330|FG001|Overall Study|Death|36|||
126595964|NCT03325985|455482331|FG002|Overall Study|Death|94|||
126595965|NCT03325985|455482332|FG003|Overall Study|Death|32|||
126595966|NCT02684227|455482334|FG000|Overall Study|Adverse Event|1|||
126595967|NCT02684227|455482335|FG001|Overall Study|Adverse Event|7|||
126595968|NCT02684227|455482334|FG000|Overall Study|Death|0|||
126595969|NCT02684227|455482335|FG001|Overall Study|Death|2|||
126595970|NCT02684227|455482334|FG000|Overall Study|Withdrawal by Subject|0|||
126595971|NCT02684227|455482335|FG001|Overall Study|Withdrawal by Subject|1|||
126595972|NCT02684227|455482334|FG000|Overall Study|Progressive Disease|0|||
126595973|NCT02684227|455482335|FG001|Overall Study|Progressive Disease|2|||
126595974|NCT03606408|455482336|FG000|Overall Study|Adverse Event|13|||
126595975|NCT03606408|455482336|FG000|Overall Study|Withdrawal by Subject|7|||
126595976|NCT03606408|455482336|FG000|Overall Study|Physician Decision|4|||
126595977|NCT03606408|455482336|FG000|Overall Study|Lack of Efficacy|2|||
126595978|NCT03606408|455482336|FG000|Overall Study|Death|1|||
126595979|NCT03606408|455482336|FG000|Overall Study|new therapy for study indication|1|||
126595980|NCT04689256|455482337|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
126595981|NCT04689256|455482338|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
126595982|NCT05104463|455482341|FG000|Overall Study|Adverse Event|1|||
126595983|NCT05104463|455482342|FG001|Overall Study|Adverse Event|1|||
126595984|NCT05104463|455482341|FG000|Overall Study|Lost to Follow-up|1|||
126595985|NCT05104463|455482342|FG001|Overall Study|Lost to Follow-up|1|||
126595986|NCT05104463|455482341|FG000|Overall Study|Physician Decision|1|||
126595987|NCT05104463|455482342|FG001|Overall Study|Physician Decision|0|||
126595988|NCT05104463|455482341|FG000|Overall Study|Protocol Violation|0|||
126595989|NCT05104463|455482342|FG001|Overall Study|Protocol Violation|2|||
126595990|NCT05104463|455482341|FG000|Overall Study|Withdrawal by Subject|1|||
126595991|NCT05104463|455482342|FG001|Overall Study|Withdrawal by Subject|1|||
126595992|NCT05267470|455482344|FG000|Overall Study|Decision by sponsor|0|||
126595993|NCT05267470|455482345|FG001|Overall Study|Decision by sponsor|3|||
126595994|NCT05267470|455482346|FG002|Overall Study|Decision by sponsor|19|||
126595995|NCT05267470|455482347|FG003|Overall Study|Decision by sponsor|7|||
126595996|NCT05267470|455482348|FG004|Overall Study|Decision by sponsor|3|||
126595997|NCT05267470|455482344|FG000|Overall Study|Withdrawal by Subject|1|||
126595998|NCT05267470|455482345|FG001|Overall Study|Withdrawal by Subject|1|||
126595999|NCT05267470|455482346|FG002|Overall Study|Withdrawal by Subject|2|||
126596000|NCT05267470|455482347|FG003|Overall Study|Withdrawal by Subject|2|||
126596001|NCT05267470|455482348|FG004|Overall Study|Withdrawal by Subject|0|||
126596002|NCT05267470|455482344|FG000|Overall Study|Death|3|||
126596003|NCT05267470|455482345|FG001|Overall Study|Death|5|||
126596004|NCT05267470|455482346|FG002|Overall Study|Death|8|||
126596005|NCT05267470|455482347|FG003|Overall Study|Death|18|||
126596006|NCT05267470|455482348|FG004|Overall Study|Death|1|||
126596007|NCT05267470|455482344|FG000|Overall Study|Lost to Follow-up|0|||
126596008|NCT05267470|455482345|FG001|Overall Study|Lost to Follow-up|0|||
126596009|NCT05267470|455482346|FG002|Overall Study|Lost to Follow-up|0|||
126596010|NCT05267470|455482347|FG003|Overall Study|Lost to Follow-up|1|||
126596011|NCT05267470|455482348|FG004|Overall Study|Lost to Follow-up|0|||
126596012|NCT04230681|455482355|FG000|Overall Study|Physician Decision|2|||
126596013|NCT04230681|455482356|FG001|Overall Study|Physician Decision|3|||
126596014|NCT04230681|455482355|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
126596015|NCT04230681|455482356|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
126596016|NCT04230681|455482355|FG000|Overall Study|IV inadvertently removed|0|||
126596017|NCT04230681|455482356|FG001|Overall Study|IV inadvertently removed|1|||
126596018|NCT04079218|455484281|FG000|Overall Study|Death|1|||
126596019|NCT04079218|455484282|FG001|Overall Study|Death|0|||
126596020|NCT04079218|455484281|FG000|Overall Study|Withdrawal by Subject|3|||
126596021|NCT04079218|455484282|FG001|Overall Study|Withdrawal by Subject|0|||
126596022|NCT04079218|455484281|FG000|Overall Study|Physician Decision|4|||
126596023|NCT04079218|455484282|FG001|Overall Study|Physician Decision|0|||
126596024|NCT04079218|455484281|FG000|Overall Study|Lost to Follow-up|0|||
126596025|NCT04079218|455484282|FG001|Overall Study|Lost to Follow-up|1|||
126596026|NCT02424617|455484287|FG000|Overall Study|Adverse Event|0|||
126596027|NCT02424617|455484288|FG001|Overall Study|Adverse Event|1|||
126596028|NCT02424617|455484289|FG002|Overall Study|Adverse Event|0|||
126596029|NCT02424617|455484290|FG003|Overall Study|Adverse Event|0|||
126596030|NCT02424617|455484287|FG000|Overall Study|Investigator Decision|0|||
126596031|NCT02424617|455484288|FG001|Overall Study|Investigator Decision|0|||
126596032|NCT02424617|455484289|FG002|Overall Study|Investigator Decision|0|||
126596033|NCT02424617|455484290|FG003|Overall Study|Investigator Decision|1|||
126596034|NCT02424617|455484287|FG000|Overall Study|Withdrawal by Subject|1|||
126596035|NCT02424617|455484288|FG001|Overall Study|Withdrawal by Subject|1|||
126596036|NCT02424617|455484289|FG002|Overall Study|Withdrawal by Subject|0|||
126596037|NCT02424617|455484290|FG003|Overall Study|Withdrawal by Subject|1|||
126596038|NCT02424617|455484287|FG000|Overall Study|Progressive Disease|7|||
126596039|NCT02424617|455484288|FG001|Overall Study|Progressive Disease|6|||
126596040|NCT02424617|455484289|FG002|Overall Study|Progressive Disease|11|||
126596041|NCT02424617|455484290|FG003|Overall Study|Progressive Disease|10|||
126596042|NCT02424617|455484287|FG000|Overall Study|Other|0|||
126596043|NCT02424617|455484288|FG001|Overall Study|Other|0|||
126596044|NCT02424617|455484289|FG002|Overall Study|Other|0|||
126596045|NCT02424617|455484290|FG003|Overall Study|Other|1|||
126596046|NCT02694822|455484291|FG000|Phase 1|Death|2|||
126596047|NCT02694822|455484292|FG001|Phase 1|Death|1|||
126596048|NCT02694822|455484293|FG002|Phase 1|Death|6|||
126596049|NCT02694822|455484294|FG003|Phase 1|Death|6|||
126596050|NCT02694822|455484295|FG004|Phase 1|Death|3|||
126596051|NCT02694822|455484296|FG005|Phase 1|Death|0|||
126596052|NCT02694822|455484291|FG000|Phase 1|Withdrawal by Subject|2|||
126596053|NCT02694822|455484292|FG001|Phase 1|Withdrawal by Subject|2|||
126596054|NCT02694822|455484293|FG002|Phase 1|Withdrawal by Subject|4|||
126596055|NCT02694822|455484294|FG003|Phase 1|Withdrawal by Subject|8|||
126596056|NCT02694822|455484295|FG004|Phase 1|Withdrawal by Subject|1|||
126596057|NCT02694822|455484296|FG005|Phase 1|Withdrawal by Subject|0|||
126596058|NCT02694822|455484291|FG000|Phase 2|Death|0|||
126596059|NCT02694822|455484292|FG001|Phase 2|Death|0|||
126596060|NCT02694822|455484293|FG002|Phase 2|Death|0|||
126596061|NCT02694822|455484294|FG003|Phase 2|Death|0|||
126596062|NCT02694822|455484295|FG004|Phase 2|Death|0|||
126596063|NCT02694822|455484296|FG005|Phase 2|Death|26|||
126596064|NCT02694822|455484291|FG000|Phase 2|Withdrawal by Subject|0|||
126596065|NCT02694822|455484292|FG001|Phase 2|Withdrawal by Subject|0|||
126596066|NCT02694822|455484293|FG002|Phase 2|Withdrawal by Subject|0|||
126596067|NCT02694822|455484294|FG003|Phase 2|Withdrawal by Subject|0|||
126596068|NCT02694822|455484295|FG004|Phase 2|Withdrawal by Subject|0|||
126596069|NCT02694822|455484296|FG005|Phase 2|Withdrawal by Subject|13|||
126596070|NCT02694822|455484291|FG000|Phase 2|Administrative Study Closure|0|||
126596071|NCT02694822|455484292|FG001|Phase 2|Administrative Study Closure|0|||
126596072|NCT02694822|455484293|FG002|Phase 2|Administrative Study Closure|0|||
126596073|NCT02694822|455484294|FG003|Phase 2|Administrative Study Closure|0|||
126596074|NCT02694822|455484295|FG004|Phase 2|Administrative Study Closure|0|||
126596075|NCT02694822|455484296|FG005|Phase 2|Administrative Study Closure|2|||
126596076|NCT02694822|455484291|FG000|Phase 2|Lost to Follow-up|0|||
126596077|NCT02694822|455484292|FG001|Phase 2|Lost to Follow-up|0|||
126596078|NCT02694822|455484293|FG002|Phase 2|Lost to Follow-up|0|||
126596079|NCT02694822|455484294|FG003|Phase 2|Lost to Follow-up|0|||
126596080|NCT02694822|455484295|FG004|Phase 2|Lost to Follow-up|0|||
126596081|NCT02694822|455484296|FG005|Phase 2|Lost to Follow-up|1|||
126596082|NCT02694822|455484291|FG000|Phase 2|Participant Transferred to Another Site|0|||
126596083|NCT02694822|455484292|FG001|Phase 2|Participant Transferred to Another Site|0|||
126596084|NCT02694822|455484293|FG002|Phase 2|Participant Transferred to Another Site|0|||
126596085|NCT02694822|455484294|FG003|Phase 2|Participant Transferred to Another Site|0|||
126596086|NCT02694822|455484295|FG004|Phase 2|Participant Transferred to Another Site|0|||
126596087|NCT02694822|455484296|FG005|Phase 2|Participant Transferred to Another Site|1|||
126596088|NCT01868997|455484297|FG000|Overall Study|Adverse Event|2|||
126596089|NCT01868997|455484298|FG001|Overall Study|Adverse Event|5|||
126596090|NCT01868997|455484297|FG000|Overall Study|Lack of Efficacy|2|||
126596091|NCT01868997|455484298|FG001|Overall Study|Lack of Efficacy|0|||
126596092|NCT01868997|455484297|FG000|Overall Study|Other|3|||
126596093|NCT01868997|455484298|FG001|Overall Study|Other|1|||
126596094|NCT02052882|455484306|FG000|Overall Study|Not treated|11|||
126596095|NCT02052882|455484306|FG000|Overall Study|Protocol Violation|1|||
126596096|NCT02052882|455484306|FG000|Overall Study|Inadequate testing|1|||
126596097|NCT04294641|455484307|FG000|Overall Study|Screen failure|4|||
126596098|NCT03308877|455484308|FG000|Overall Study|Lost to Follow-up|32|||
126596099|NCT03308877|455484309|FG001|Overall Study|Lost to Follow-up|28|||
126596100|NCT04359654|455484331|FG000|Overall Study|Withdrawal by Subject|1|||
126596101|NCT04359654|455484332|FG001|Overall Study|Withdrawal by Subject|0|||
126596102|NCT04359654|455484331|FG000|Overall Study|Adverse Event|0|||
126596103|NCT04359654|455484332|FG001|Overall Study|Adverse Event|1|||
126596104|NCT04314778|455484336|FG000|Overall Study|Lost to Follow-up|5|||
126596105|NCT04314778|455484337|FG001|Overall Study|Lost to Follow-up|3|||
126596106|NCT04024020|455484340|FG000|Overall Study|Withdrawal by Subject|2|||
126596107|NCT04024020|455484341|FG001|Overall Study|Withdrawal by Subject|2|||
126596108|NCT05646355|455484342|FG000|Overall Study|Lost to Follow-up|1|||
126596109|NCT05646355|455484343|FG001|Overall Study|Lost to Follow-up|0|||
126596110|NCT05646355|455484342|FG000|Overall Study|translated materials not available for pilot|2|||
126596111|NCT05646355|455484343|FG001|Overall Study|translated materials not available for pilot|0|||
126596112|NCT05646355|455484342|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
126596113|NCT05646355|455484343|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
126596114|NCT03523572|455484346|FG000|Dose Escalation|Progressive disease|1|||
126596115|NCT03523572|455484347|FG001|Dose Escalation|Progressive disease|0|||
126596116|NCT03523572|455484348|FG002|Dose Escalation|Progressive disease|0|||
126596117|NCT03523572|455484349|FG003|Dose Escalation|Progressive disease|0|||
126596118|NCT03523572|455484350|FG004|Dose Escalation|Progressive disease|0|||
126596119|NCT03523572|455484351|FG005|Dose Escalation|Progressive disease|0|||
126596120|NCT03523572|455484346|FG000|Dose Escalation|Clinical Progression|0|||
126596121|NCT03523572|455484347|FG001|Dose Escalation|Clinical Progression|1|||
126596122|NCT03523572|455484348|FG002|Dose Escalation|Clinical Progression|0|||
126596123|NCT03523572|455484349|FG003|Dose Escalation|Clinical Progression|0|||
126596124|NCT03523572|455484350|FG004|Dose Escalation|Clinical Progression|0|||
126596125|NCT03523572|455484351|FG005|Dose Escalation|Clinical Progression|0|||
126596126|NCT03523572|455484346|FG000|Dose Escalation|Adverse Event|2|||
126596127|NCT03523572|455484347|FG001|Dose Escalation|Adverse Event|0|||
126596128|NCT03523572|455484348|FG002|Dose Escalation|Adverse Event|0|||
126596129|NCT03523572|455484349|FG003|Dose Escalation|Adverse Event|0|||
126596130|NCT03523572|455484350|FG004|Dose Escalation|Adverse Event|0|||
126596131|NCT03523572|455484351|FG005|Dose Escalation|Adverse Event|0|||
126596132|NCT03523572|455484346|FG000|Dose Escalation|Physician Decision|1|||
126596133|NCT03523572|455484347|FG001|Dose Escalation|Physician Decision|1|||
126596134|NCT03523572|455484348|FG002|Dose Escalation|Physician Decision|0|||
126596135|NCT03523572|455484349|FG003|Dose Escalation|Physician Decision|0|||
126596136|NCT03523572|455484350|FG004|Dose Escalation|Physician Decision|0|||
126596137|NCT03523572|455484351|FG005|Dose Escalation|Physician Decision|0|||
126596138|NCT03523572|455484346|FG000|Dose Expansion|Progressive Disease|0|||
126596139|NCT03523572|455484347|FG001|Dose Expansion|Progressive Disease|0|||
126596140|NCT03523572|455484348|FG002|Dose Expansion|Progressive Disease|9|||
126596141|NCT03523572|455484349|FG003|Dose Expansion|Progressive Disease|11|||
126596142|NCT03523572|455484350|FG004|Dose Expansion|Progressive Disease|15|||
126596143|NCT03523572|455484351|FG005|Dose Expansion|Progressive Disease|2|||
126596144|NCT03523572|455484346|FG000|Dose Expansion|Clinical Progression|0|||
126596145|NCT03523572|455484347|FG001|Dose Expansion|Clinical Progression|0|||
126596146|NCT03523572|455484348|FG002|Dose Expansion|Clinical Progression|2|||
126596147|NCT03523572|455484349|FG003|Dose Expansion|Clinical Progression|2|||
126596148|NCT03523572|455484350|FG004|Dose Expansion|Clinical Progression|2|||
126596149|NCT03523572|455484351|FG005|Dose Expansion|Clinical Progression|0|||
126596150|NCT03523572|455484346|FG000|Dose Expansion|Adverse Event|0|||
126596151|NCT03523572|455484347|FG001|Dose Expansion|Adverse Event|0|||
126596152|NCT03523572|455484348|FG002|Dose Expansion|Adverse Event|10|||
126596153|NCT03523572|455484349|FG003|Dose Expansion|Adverse Event|1|||
126596154|NCT03523572|455484350|FG004|Dose Expansion|Adverse Event|5|||
126596155|NCT03523572|455484351|FG005|Dose Expansion|Adverse Event|2|||
126596156|NCT03523572|455484346|FG000|Dose Expansion|Withdrawal by Subject|0|||
126596157|NCT03523572|455484347|FG001|Dose Expansion|Withdrawal by Subject|0|||
126596158|NCT03523572|455484348|FG002|Dose Expansion|Withdrawal by Subject|1|||
126596159|NCT03523572|455484349|FG003|Dose Expansion|Withdrawal by Subject|1|||
126596160|NCT03523572|455484350|FG004|Dose Expansion|Withdrawal by Subject|0|||
126596161|NCT03523572|455484351|FG005|Dose Expansion|Withdrawal by Subject|0|||
126596162|NCT03523572|455484346|FG000|Dose Expansion|Physician Decision|0|||
126596163|NCT03523572|455484347|FG001|Dose Expansion|Physician Decision|0|||
126596164|NCT03523572|455484348|FG002|Dose Expansion|Physician Decision|1|||
126596165|NCT03523572|455484349|FG003|Dose Expansion|Physician Decision|0|||
126596166|NCT03523572|455484350|FG004|Dose Expansion|Physician Decision|1|||
126596167|NCT03523572|455484351|FG005|Dose Expansion|Physician Decision|0|||
126596168|NCT03523572|455484346|FG000|Dose Expansion|Miscellaneous|0|||
126596169|NCT03523572|455484347|FG001|Dose Expansion|Miscellaneous|0|||
126596170|NCT03523572|455484348|FG002|Dose Expansion|Miscellaneous|0|||
126596171|NCT03523572|455484349|FG003|Dose Expansion|Miscellaneous|0|||
126596172|NCT03523572|455484350|FG004|Dose Expansion|Miscellaneous|3|||
126596173|NCT03523572|455484351|FG005|Dose Expansion|Miscellaneous|0|||
126596174|NCT05269966|455484352|FG000|Overall Study|Adverse Event|4|||
126596175|NCT05269966|455484352|FG000|Overall Study|Withdrawal by Subject|1|||
126596176|NCT05269966|455484352|FG000|Overall Study|Lost to Follow-up|4|||
126596177|NCT05269966|455484352|FG000|Overall Study|Physician Decision|1|||
126596178|NCT03519178|455484368|FG000|PF-06873600 Treatment|Adverse Event|0|||
126596179|NCT03519178|455484369|FG001|PF-06873600 Treatment|Adverse Event|0|||
126596180|NCT03519178|455484370|FG002|PF-06873600 Treatment|Adverse Event|0|||
126596181|NCT03519178|455484371|FG003|PF-06873600 Treatment|Adverse Event|0|||
126596182|NCT03519178|455484372|FG004|PF-06873600 Treatment|Adverse Event|0|||
126596183|NCT03519178|455484373|FG005|PF-06873600 Treatment|Adverse Event|0|||
126596184|NCT03519178|455484374|FG006|PF-06873600 Treatment|Adverse Event|0|||
126596185|NCT03519178|455484375|FG007|PF-06873600 Treatment|Adverse Event|2|||
126596186|NCT03519178|455484376|FG008|PF-06873600 Treatment|Adverse Event|1|||
126596187|NCT03519178|455484377|FG009|PF-06873600 Treatment|Adverse Event|0|||
126596188|NCT03519178|455484378|FG010|PF-06873600 Treatment|Adverse Event|0|||
126596189|NCT03519178|455484379|FG011|PF-06873600 Treatment|Adverse Event|0|||
126596190|NCT03519178|455484380|FG012|PF-06873600 Treatment|Adverse Event|1|||
126596191|NCT03519178|455484381|FG013|PF-06873600 Treatment|Adverse Event|3|||
126596192|NCT03519178|455484382|FG014|PF-06873600 Treatment|Adverse Event|2|||
126596193|NCT03519178|455484368|FG000|PF-06873600 Treatment|Death|0|||
126596194|NCT03519178|455484369|FG001|PF-06873600 Treatment|Death|0|||
126596195|NCT03519178|455484370|FG002|PF-06873600 Treatment|Death|0|||
126596196|NCT03519178|455484371|FG003|PF-06873600 Treatment|Death|0|||
126596197|NCT03519178|455484372|FG004|PF-06873600 Treatment|Death|0|||
126596198|NCT03519178|455484373|FG005|PF-06873600 Treatment|Death|0|||
126596199|NCT03519178|455484374|FG006|PF-06873600 Treatment|Death|0|||
126596200|NCT03519178|455484375|FG007|PF-06873600 Treatment|Death|0|||
126596201|NCT03519178|455484376|FG008|PF-06873600 Treatment|Death|1|||
126596202|NCT03519178|455484377|FG009|PF-06873600 Treatment|Death|1|||
126596203|NCT03519178|455484378|FG010|PF-06873600 Treatment|Death|0|||
126596204|NCT03519178|455484379|FG011|PF-06873600 Treatment|Death|0|||
126596205|NCT03519178|455484380|FG012|PF-06873600 Treatment|Death|0|||
126596206|NCT03519178|455484381|FG013|PF-06873600 Treatment|Death|0|||
126596207|NCT03519178|455484382|FG014|PF-06873600 Treatment|Death|1|||
126596208|NCT03519178|455484368|FG000|PF-06873600 Treatment|Physician Decision|0|||
126732510|NCT00965146|455969848|FG000|Overall Study|Unwilling to return|11|||
126732511|NCT00965146|455969848|FG000|Overall Study|Intercurrent illness|1|||
126596209|NCT03519178|455484369|FG001|PF-06873600 Treatment|Physician Decision|0|||
126596210|NCT03519178|455484370|FG002|PF-06873600 Treatment|Physician Decision|0|||
126596211|NCT03519178|455484371|FG003|PF-06873600 Treatment|Physician Decision|0|||
126596212|NCT03519178|455484372|FG004|PF-06873600 Treatment|Physician Decision|0|||
126596213|NCT03519178|455484373|FG005|PF-06873600 Treatment|Physician Decision|0|||
126596214|NCT03519178|455484374|FG006|PF-06873600 Treatment|Physician Decision|0|||
126596215|NCT03519178|455484375|FG007|PF-06873600 Treatment|Physician Decision|1|||
126596216|NCT03519178|455484376|FG008|PF-06873600 Treatment|Physician Decision|0|||
126596217|NCT03519178|455484377|FG009|PF-06873600 Treatment|Physician Decision|0|||
126596218|NCT03519178|455484378|FG010|PF-06873600 Treatment|Physician Decision|1|||
126596219|NCT03519178|455484379|FG011|PF-06873600 Treatment|Physician Decision|0|||
126596220|NCT03519178|455484380|FG012|PF-06873600 Treatment|Physician Decision|0|||
126596221|NCT03519178|455484381|FG013|PF-06873600 Treatment|Physician Decision|4|||
126596222|NCT03519178|455484382|FG014|PF-06873600 Treatment|Physician Decision|1|||
126596223|NCT03519178|455484368|FG000|PF-06873600 Treatment|Progressive disease|1|||
126596224|NCT03519178|455484369|FG001|PF-06873600 Treatment|Progressive disease|1|||
126596225|NCT03519178|455484370|FG002|PF-06873600 Treatment|Progressive disease|1|||
126596226|NCT03519178|455484371|FG003|PF-06873600 Treatment|Progressive disease|1|||
126596227|NCT03519178|455484372|FG004|PF-06873600 Treatment|Progressive disease|6|||
126596228|NCT03519178|455484373|FG005|PF-06873600 Treatment|Progressive disease|7|||
126596229|NCT03519178|455484374|FG006|PF-06873600 Treatment|Progressive disease|3|||
126596230|NCT03519178|455484375|FG007|PF-06873600 Treatment|Progressive disease|7|||
126596231|NCT03519178|455484376|FG008|PF-06873600 Treatment|Progressive disease|3|||
126596232|NCT03519178|455484377|FG009|PF-06873600 Treatment|Progressive disease|5|||
126596233|NCT03519178|455484378|FG010|PF-06873600 Treatment|Progressive disease|4|||
126596234|NCT03519178|455484379|FG011|PF-06873600 Treatment|Progressive disease|3|||
126596235|NCT03519178|455484380|FG012|PF-06873600 Treatment|Progressive disease|4|||
126596236|NCT03519178|455484381|FG013|PF-06873600 Treatment|Progressive disease|28|||
126596237|NCT03519178|455484382|FG014|PF-06873600 Treatment|Progressive disease|7|||
126596238|NCT03519178|455484368|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
126596239|NCT03519178|455484369|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
126596240|NCT03519178|455484370|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
126596241|NCT03519178|455484371|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
126596242|NCT03519178|455484372|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
126596243|NCT03519178|455484373|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
126596244|NCT03519178|455484374|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
126596245|NCT03519178|455484375|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
126596246|NCT03519178|455484376|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
126596247|NCT03519178|455484377|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
126596248|NCT03519178|455484378|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
126596249|NCT03519178|455484379|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
126596250|NCT03519178|455484380|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
126596251|NCT03519178|455484381|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
126596252|NCT03519178|455484382|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
126596253|NCT03519178|455484368|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
126596254|NCT03519178|455484369|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
126596255|NCT03519178|455484370|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
126596256|NCT03519178|455484371|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
126596257|NCT03519178|455484372|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
126596258|NCT03519178|455484373|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
126596259|NCT03519178|455484374|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
126596260|NCT03519178|455484375|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
126596261|NCT03519178|455484376|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
126596262|NCT03519178|455484377|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
126596263|NCT03519178|455484378|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
126596264|NCT03519178|455484379|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
126732512|NCT00965146|455969848|FG000|Overall Study|Revision / Removal of Study Implant|6|||
126732513|NCT00965146|455969848|FG000|Overall Study|Overall Study Termination|145|||
126596265|NCT03519178|455484380|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
126596266|NCT03519178|455484381|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
126596267|NCT03519178|455484382|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
126596268|NCT03519178|455484368|FG000|PF-06873600 Treatment|Refused further treatment|0|||
126596269|NCT03519178|455484369|FG001|PF-06873600 Treatment|Refused further treatment|1|||
126596270|NCT03519178|455484370|FG002|PF-06873600 Treatment|Refused further treatment|0|||
126596271|NCT03519178|455484371|FG003|PF-06873600 Treatment|Refused further treatment|0|||
126596272|NCT03519178|455484372|FG004|PF-06873600 Treatment|Refused further treatment|1|||
126596273|NCT03519178|455484373|FG005|PF-06873600 Treatment|Refused further treatment|0|||
126596274|NCT03519178|455484374|FG006|PF-06873600 Treatment|Refused further treatment|0|||
126596275|NCT03519178|455484375|FG007|PF-06873600 Treatment|Refused further treatment|0|||
126596276|NCT03519178|455484376|FG008|PF-06873600 Treatment|Refused further treatment|0|||
126596277|NCT03519178|455484377|FG009|PF-06873600 Treatment|Refused further treatment|0|||
126596278|NCT03519178|455484378|FG010|PF-06873600 Treatment|Refused further treatment|0|||
126596279|NCT03519178|455484379|FG011|PF-06873600 Treatment|Refused further treatment|0|||
126596280|NCT03519178|455484380|FG012|PF-06873600 Treatment|Refused further treatment|0|||
126596281|NCT03519178|455484381|FG013|PF-06873600 Treatment|Refused further treatment|0|||
126596282|NCT03519178|455484382|FG014|PF-06873600 Treatment|Refused further treatment|1|||
126596283|NCT03519178|455484368|FG000|PF-06873600 Treatment|Other|0|||
126596284|NCT03519178|455484369|FG001|PF-06873600 Treatment|Other|0|||
126596285|NCT03519178|455484370|FG002|PF-06873600 Treatment|Other|0|||
126596286|NCT03519178|455484371|FG003|PF-06873600 Treatment|Other|0|||
126596287|NCT03519178|455484372|FG004|PF-06873600 Treatment|Other|0|||
126596288|NCT03519178|455484373|FG005|PF-06873600 Treatment|Other|0|||
126596289|NCT03519178|455484374|FG006|PF-06873600 Treatment|Other|0|||
126596290|NCT03519178|455484375|FG007|PF-06873600 Treatment|Other|0|||
126596291|NCT03519178|455484376|FG008|PF-06873600 Treatment|Other|1|||
126596292|NCT03519178|455484377|FG009|PF-06873600 Treatment|Other|0|||
126596293|NCT03519178|455484378|FG010|PF-06873600 Treatment|Other|0|||
126596294|NCT03519178|455484379|FG011|PF-06873600 Treatment|Other|0|||
126596295|NCT03519178|455484380|FG012|PF-06873600 Treatment|Other|0|||
126596296|NCT03519178|455484381|FG013|PF-06873600 Treatment|Other|1|||
126596297|NCT03519178|455484382|FG014|PF-06873600 Treatment|Other|3|||
126596298|NCT03519178|455484368|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
126596299|NCT03519178|455484369|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
126596300|NCT03519178|455484370|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
126596301|NCT03519178|455484371|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
126596302|NCT03519178|455484372|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
126596303|NCT03519178|455484373|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
126596304|NCT03519178|455484374|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
126596305|NCT03519178|455484375|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
126596306|NCT03519178|455484376|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
126596307|NCT03519178|455484377|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
126596308|NCT03519178|455484378|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
126596309|NCT03519178|455484379|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
126596310|NCT03519178|455484380|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
126596311|NCT03519178|455484381|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
126596312|NCT03519178|455484382|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
126596313|NCT03519178|455484368|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596314|NCT03519178|455484369|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596315|NCT03519178|455484370|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596316|NCT03519178|455484371|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596317|NCT03519178|455484372|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596318|NCT03519178|455484373|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596319|NCT03519178|455484374|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596320|NCT03519178|455484375|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596321|NCT03519178|455484376|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596322|NCT03519178|455484377|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596323|NCT03519178|455484378|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596324|NCT03519178|455484379|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596325|NCT03519178|455484380|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
126596326|NCT03519178|455484381|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
126596327|NCT03519178|455484382|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
126596328|NCT03519178|455484368|FG000|PF-06873600 Treatment|Ongoing|0|||
126596329|NCT03519178|455484369|FG001|PF-06873600 Treatment|Ongoing|0|||
126596330|NCT03519178|455484370|FG002|PF-06873600 Treatment|Ongoing|0|||
126596331|NCT03519178|455484371|FG003|PF-06873600 Treatment|Ongoing|0|||
126732514|NCT00830960|455969849|FG000|Overall Study|Death|5|||
126596332|NCT03519178|455484372|FG004|PF-06873600 Treatment|Ongoing|0|||
126596333|NCT03519178|455484373|FG005|PF-06873600 Treatment|Ongoing|0|||
126596334|NCT03519178|455484374|FG006|PF-06873600 Treatment|Ongoing|0|||
126596335|NCT03519178|455484375|FG007|PF-06873600 Treatment|Ongoing|0|||
126596336|NCT03519178|455484376|FG008|PF-06873600 Treatment|Ongoing|0|||
126596337|NCT03519178|455484377|FG009|PF-06873600 Treatment|Ongoing|0|||
126596338|NCT03519178|455484378|FG010|PF-06873600 Treatment|Ongoing|0|||
126596339|NCT03519178|455484379|FG011|PF-06873600 Treatment|Ongoing|0|||
126596340|NCT03519178|455484380|FG012|PF-06873600 Treatment|Ongoing|0|||
126596341|NCT03519178|455484381|FG013|PF-06873600 Treatment|Ongoing|1|||
126596342|NCT03519178|455484382|FG014|PF-06873600 Treatment|Ongoing|6|||
126596343|NCT03519178|455484368|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126732515|NCT00830960|455969850|FG001|Overall Study|Death|4|||
126596344|NCT03519178|455484369|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126596345|NCT03519178|455484370|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126596346|NCT03519178|455484371|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126596347|NCT03519178|455484372|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126732516|NCT00830960|455969851|FG002|Overall Study|Death|3|||
126732517|NCT00830960|455969852|FG003|Overall Study|Death|2|||
126732518|NCT00830960|455969853|FG004|Overall Study|Death|6|||
126732519|NCT00830960|455969854|FG005|Overall Study|Death|1|||
126732520|NCT00830960|455969849|FG000|Overall Study|Lost to Follow-up|1|||
126732521|NCT00830960|455969850|FG001|Overall Study|Lost to Follow-up|1|||
126732522|NCT00830960|455969851|FG002|Overall Study|Lost to Follow-up|1|||
126732523|NCT00830960|455969852|FG003|Overall Study|Lost to Follow-up|0|||
126732524|NCT00830960|455969853|FG004|Overall Study|Lost to Follow-up|0|||
126732525|NCT00830960|455969854|FG005|Overall Study|Lost to Follow-up|1|||
126732526|NCT00830960|455969849|FG000|Overall Study|Withdrawal by Subject|19|||
126732527|NCT00830960|455969850|FG001|Overall Study|Withdrawal by Subject|19|||
126732528|NCT00830960|455969851|FG002|Overall Study|Withdrawal by Subject|18|||
126732529|NCT00830960|455969852|FG003|Overall Study|Withdrawal by Subject|23|||
126732530|NCT00830960|455969853|FG004|Overall Study|Withdrawal by Subject|16|||
126732531|NCT00830960|455969854|FG005|Overall Study|Withdrawal by Subject|21|||
126732532|NCT00830960|455969849|FG000|Overall Study|Sponsor Decision|1|||
126732533|NCT00830960|455969850|FG001|Overall Study|Sponsor Decision|2|||
126732534|NCT00830960|455969851|FG002|Overall Study|Sponsor Decision|3|||
126732535|NCT00830960|455969852|FG003|Overall Study|Sponsor Decision|4|||
126732536|NCT00830960|455969853|FG004|Overall Study|Sponsor Decision|5|||
126732537|NCT00830960|455969854|FG005|Overall Study|Sponsor Decision|7|||
126732538|NCT00830960|455969849|FG000|Overall Study|No study drug received|7|||
126732539|NCT00830960|455969850|FG001|Overall Study|No study drug received|2|||
126732540|NCT00830960|455969851|FG002|Overall Study|No study drug received|4|||
126732541|NCT00830960|455969852|FG003|Overall Study|No study drug received|3|||
126732542|NCT00830960|455969853|FG004|Overall Study|No study drug received|5|||
126732543|NCT00830960|455969854|FG005|Overall Study|No study drug received|7|||
126732544|NCT02855450|455969855|FG000|Overall Study|Adverse Event|1|||
126732545|NCT02855450|455969856|FG001|Overall Study|Adverse Event|0|||
126732546|NCT02855450|455969855|FG000|Overall Study|Lost to Follow-up|4|||
126732547|NCT02855450|455969856|FG001|Overall Study|Lost to Follow-up|0|||
126732548|NCT01504971|455969857|FG000|Overall Study|Physician Decision|13|||
126732549|NCT00426556|455969860|FG000|Phase I - Core Phase|Disease Progression|0|||
126732550|NCT00426556|455969861|FG001|Phase I - Core Phase|Disease Progression|6|||
126732551|NCT00426556|455969862|FG002|Phase I - Core Phase|Disease Progression|2|||
126732552|NCT00426556|455969863|FG003|Phase I - Core Phase|Disease Progression|0|||
126732553|NCT00426556|455969860|FG000|Phase I - Core Phase|Adverse Event|1|||
126732554|NCT00426556|455969861|FG001|Phase I - Core Phase|Adverse Event|3|||
126732555|NCT00426556|455969862|FG002|Phase I - Core Phase|Adverse Event|1|||
126732556|NCT00426556|455969863|FG003|Phase I - Core Phase|Adverse Event|0|||
126732557|NCT00426556|455969860|FG000|Phase I - Core Phase|Death|0|||
126732558|NCT00426556|455969861|FG001|Phase I - Core Phase|Death|1|||
126732559|NCT00426556|455969862|FG002|Phase I - Core Phase|Death|0|||
126732560|NCT00426556|455969863|FG003|Phase I - Core Phase|Death|0|||
126732561|NCT00426556|455969860|FG000|Phase I - Extension Phase|Adverse Event|0|||
126732562|NCT00426556|455969861|FG001|Phase I - Extension Phase|Adverse Event|1|||
126732563|NCT00426556|455969862|FG002|Phase I - Extension Phase|Adverse Event|1|||
126732564|NCT00426556|455969863|FG003|Phase I - Extension Phase|Adverse Event|0|||
126732565|NCT00426556|455969860|FG000|Phase I - Extension Phase|Disease Progression|5|||
126732566|NCT00426556|455969861|FG001|Phase I - Extension Phase|Disease Progression|5|||
126732567|NCT00426556|455969862|FG002|Phase I - Extension Phase|Disease Progression|6|||
126732568|NCT00426556|455969863|FG003|Phase I - Extension Phase|Disease Progression|0|||
126732569|NCT00426556|455969860|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
126732570|NCT00426556|455969861|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
126732571|NCT00426556|455969862|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
126732572|NCT00426556|455969863|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
126732573|NCT00426556|455969860|FG000|Phase II - Core Phase|Disease Progression|0|||
126732574|NCT00426556|455969861|FG001|Phase II - Core Phase|Disease Progression|0|||
126732575|NCT00426556|455969862|FG002|Phase II - Core Phase|Disease Progression|0|||
126732576|NCT00426556|455969863|FG003|Phase II - Core Phase|Disease Progression|16|||
126732577|NCT00426556|455969860|FG000|Phase II - Core Phase|Adverse Event|0|||
126732578|NCT00426556|455969861|FG001|Phase II - Core Phase|Adverse Event|0|||
126732579|NCT00426556|455969862|FG002|Phase II - Core Phase|Adverse Event|0|||
126732580|NCT00426556|455969863|FG003|Phase II - Core Phase|Adverse Event|8|||
126732581|NCT00426556|455969860|FG000|Phase II - Extension Phase|Disease Progression|0|||
126732582|NCT00426556|455969861|FG001|Phase II - Extension Phase|Disease Progression|0|||
126732583|NCT00426556|455969862|FG002|Phase II - Extension Phase|Disease Progression|0|||
126732584|NCT00426556|455969863|FG003|Phase II - Extension Phase|Disease Progression|21|||
126732585|NCT00426556|455969860|FG000|Phase II - Extension Phase|Adverse Event|0|||
126732586|NCT00426556|455969861|FG001|Phase II - Extension Phase|Adverse Event|0|||
126732587|NCT00426556|455969862|FG002|Phase II - Extension Phase|Adverse Event|0|||
126732588|NCT00426556|455969863|FG003|Phase II - Extension Phase|Adverse Event|2|||
126732589|NCT00225212|455969865|FG000|Overall Study|Disease progression|2|||
126732590|NCT00225212|455969865|FG000|Overall Study|Death|1|||
126732591|NCT00225212|455969865|FG000|Overall Study|Adverse Event|2|||
126732592|NCT00225212|455969865|FG000|Overall Study|Intercurrent illness|1|||
126732593|NCT01309841|455969866|FG000|Overall Study|Other|0|||
126732594|NCT01309841|455969867|FG001|Overall Study|Other|1|||
126732595|NCT01309841|455969868|FG002|Overall Study|Other|1|||
126732596|NCT01309841|455969866|FG000|Overall Study|Lost to Follow-up|7|||
126732597|NCT01309841|455969867|FG001|Overall Study|Lost to Follow-up|6|||
126732598|NCT01309841|455969868|FG002|Overall Study|Lost to Follow-up|4|||
126732599|NCT01309841|455969866|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
126732600|NCT01309841|455969867|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
126732601|NCT01309841|455969868|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
126732602|NCT01309841|455969866|FG000|Overall Study|Lack of Efficacy|0|||
126732603|NCT01309841|455969867|FG001|Overall Study|Lack of Efficacy|0|||
126732604|NCT01309841|455969868|FG002|Overall Study|Lack of Efficacy|2|||
126732605|NCT01309841|455969866|FG000|Overall Study|Adverse Event|9|||
126732606|NCT01309841|455969867|FG001|Overall Study|Adverse Event|22|||
126732607|NCT01309841|455969868|FG002|Overall Study|Adverse Event|11|||
126732608|NCT01309841|455969866|FG000|Overall Study|Death|1|||
126732609|NCT01309841|455969867|FG001|Overall Study|Death|0|||
126732610|NCT01309841|455969868|FG002|Overall Study|Death|0|||
126732611|NCT01309841|455969866|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
126732612|NCT01309841|455969867|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
126732613|NCT01309841|455969868|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
126732614|NCT01309841|455969866|FG000|Overall Study|Withdrawal by Subject|17|||
126732615|NCT01309841|455969867|FG001|Overall Study|Withdrawal by Subject|6|||
126732616|NCT01309841|455969868|FG002|Overall Study|Withdrawal by Subject|13|||
126732617|NCT01309841|455969866|FG000|Overall Study|Did Not Receive Treatment|2|||
126732618|NCT01309841|455969867|FG001|Overall Study|Did Not Receive Treatment|0|||
126732619|NCT01309841|455969868|FG002|Overall Study|Did Not Receive Treatment|1|||
126732620|NCT01309841|455969866|FG000|Overall Study|Severe non-compliance with protocol|0|||
126732621|NCT01309841|455969867|FG001|Overall Study|Severe non-compliance with protocol|5|||
126732622|NCT01309841|455969868|FG002|Overall Study|Severe non-compliance with protocol|2|||
126732623|NCT00050960|455969869|FG000|Overall Study|Progressive Disease|137|||
126732624|NCT00050960|455969870|FG001|Overall Study|Progressive Disease|93|||
126732625|NCT00050960|455969869|FG000|Overall Study|Stable Disease|19|||
126732626|NCT00050960|455969870|FG001|Overall Study|Stable Disease|48|||
126732627|NCT00050960|455969869|FG000|Overall Study|Partial Response|14|||
126732628|NCT00050960|455969870|FG001|Overall Study|Partial Response|19|||
126732629|NCT00050960|455969869|FG000|Overall Study|Complete Response|0|||
126732630|NCT00050960|455969870|FG001|Overall Study|Complete Response|2|||
126732631|NCT00050960|455969869|FG000|Overall Study|Adverse Event|62|||
126732632|NCT00050960|455969870|FG001|Overall Study|Adverse Event|61|||
126732633|NCT00050960|455969869|FG000|Overall Study|Lost to Follow-up|0|||
126732634|NCT00050960|455969870|FG001|Overall Study|Lost to Follow-up|1|||
126732635|NCT00050960|455969869|FG000|Overall Study|Withdrawal by Subject|23|||
126732636|NCT00050960|455969870|FG001|Overall Study|Withdrawal by Subject|18|||
126732637|NCT00050960|455969869|FG000|Overall Study|Administrative|31|||
126732638|NCT00050960|455969870|FG001|Overall Study|Administrative|46|||
126732639|NCT00050960|455969869|FG000|Overall Study|Non-compliance|3|||
126732640|NCT00050960|455969870|FG001|Overall Study|Non-compliance|1|||
126732641|NCT00050960|455969869|FG000|Overall Study|Death|13|||
126732642|NCT00050960|455969870|FG001|Overall Study|Death|15|||
126732643|NCT00643604|455969871|FG000|Overall Study|Death|1|||
126732644|NCT02702011|455969874|FG000|Overall Study|Withdrawal by Subject|0|||
126732645|NCT02702011|455969875|FG001|Overall Study|Withdrawal by Subject|1|||
126732646|NCT02702011|455969876|FG002|Overall Study|Withdrawal by Subject|0|||
126732647|NCT02702011|455969877|FG003|Overall Study|Withdrawal by Subject|0|||
126732648|NCT01740388|455969879|FG000|Overall Study|Withdrawal by Subject|1|||
126732649|NCT01740388|455969880|FG001|Overall Study|Withdrawal by Subject|2|||
126732650|NCT01740388|455969879|FG000|Overall Study|Lost to Follow-up|2|||
126732651|NCT01740388|455969880|FG001|Overall Study|Lost to Follow-up|0|||
126732652|NCT01740388|455969879|FG000|Overall Study|Physician Decision|2|||
126732653|NCT01740388|455969880|FG001|Overall Study|Physician Decision|6|||
126732654|NCT01740388|455969879|FG000|Overall Study|Subjects missing data, completed|41|||
126732655|NCT01740388|455969880|FG001|Overall Study|Subjects missing data, completed|36|||
126732656|NCT00862121|455969883|FG000|Overall Study|Adverse Event|1|||
126732657|NCT00862121|455969884|FG001|Overall Study|Adverse Event|2|||
126596348|NCT03519178|455484373|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126596349|NCT03519178|455484374|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126596350|NCT03519178|455484375|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126596351|NCT03519178|455484376|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126732658|NCT00862121|455969883|FG000|Overall Study|Lack of Efficacy|0|||
126596352|NCT03519178|455484377|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126596353|NCT03519178|455484378|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126732659|NCT00862121|455969884|FG001|Overall Study|Lack of Efficacy|3|||
126732660|NCT00862121|455969883|FG000|Overall Study|Protocol Violation|0|||
126732661|NCT00862121|455969884|FG001|Overall Study|Protocol Violation|1|||
126732662|NCT00862121|455969883|FG000|Overall Study|Exclusion criterion violation|0|||
126732663|NCT00862121|455969884|FG001|Overall Study|Exclusion criterion violation|1|||
126596354|NCT03519178|455484379|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126596355|NCT03519178|455484380|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126596356|NCT03519178|455484381|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
126596357|NCT03519178|455484382|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
126596358|NCT03519178|455484368|FG000|Disposition for Fluvestrant Treatment|Death|0|||
126596359|NCT03519178|455484369|FG001|Disposition for Fluvestrant Treatment|Death|0|||
126596360|NCT03519178|455484370|FG002|Disposition for Fluvestrant Treatment|Death|0|||
126596361|NCT03519178|455484371|FG003|Disposition for Fluvestrant Treatment|Death|0|||
126596362|NCT03519178|455484372|FG004|Disposition for Fluvestrant Treatment|Death|0|||
126596363|NCT03519178|455484373|FG005|Disposition for Fluvestrant Treatment|Death|0|||
126596364|NCT03519178|455484374|FG006|Disposition for Fluvestrant Treatment|Death|0|||
126596365|NCT03519178|455484375|FG007|Disposition for Fluvestrant Treatment|Death|0|||
126596366|NCT03519178|455484376|FG008|Disposition for Fluvestrant Treatment|Death|0|||
126596367|NCT03519178|455484377|FG009|Disposition for Fluvestrant Treatment|Death|1|||
126596368|NCT03519178|455484378|FG010|Disposition for Fluvestrant Treatment|Death|0|||
126596369|NCT03519178|455484379|FG011|Disposition for Fluvestrant Treatment|Death|0|||
126596370|NCT03519178|455484380|FG012|Disposition for Fluvestrant Treatment|Death|0|||
126596371|NCT03519178|455484381|FG013|Disposition for Fluvestrant Treatment|Death|0|||
126596372|NCT03519178|455484382|FG014|Disposition for Fluvestrant Treatment|Death|1|||
126596373|NCT03519178|455484368|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596374|NCT03519178|455484369|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596375|NCT03519178|455484370|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596376|NCT03519178|455484371|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596377|NCT03519178|455484372|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596378|NCT03519178|455484373|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596379|NCT03519178|455484374|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596380|NCT03519178|455484375|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596381|NCT03519178|455484376|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596382|NCT03519178|455484377|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596383|NCT03519178|455484378|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596384|NCT03519178|455484379|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596385|NCT03519178|455484380|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596386|NCT03519178|455484381|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
126596387|NCT03519178|455484382|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
126596388|NCT03519178|455484368|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596389|NCT03519178|455484369|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596390|NCT03519178|455484370|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596391|NCT03519178|455484371|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596392|NCT03519178|455484372|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596393|NCT03519178|455484373|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596394|NCT03519178|455484374|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596395|NCT03519178|455484375|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596396|NCT03519178|455484376|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596397|NCT03519178|455484377|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596398|NCT03519178|455484378|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596399|NCT03519178|455484379|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596400|NCT03519178|455484380|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
126596401|NCT03519178|455484381|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
126596402|NCT03519178|455484382|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
126596403|NCT03519178|455484368|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126596404|NCT03519178|455484369|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126596405|NCT03519178|455484370|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126596406|NCT03519178|455484371|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126596407|NCT03519178|455484372|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126596408|NCT03519178|455484373|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126596409|NCT03519178|455484374|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126596410|NCT03519178|455484375|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126596411|NCT03519178|455484376|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126596412|NCT03519178|455484377|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
126596413|NCT03519178|455484378|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126596414|NCT03519178|455484379|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126596415|NCT03519178|455484380|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
126596416|NCT03519178|455484381|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
126596417|NCT03519178|455484382|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
126596418|NCT03519178|455484368|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126596419|NCT03519178|455484369|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126779357|NCT01261325|456146967|FG001|Overall Study|Lack of Efficacy|1|||
126596420|NCT03519178|455484370|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126596421|NCT03519178|455484371|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126596422|NCT03519178|455484372|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126596423|NCT03519178|455484373|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126596424|NCT03519178|455484374|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126596425|NCT03519178|455484375|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126596426|NCT03519178|455484376|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126779358|NCT01261325|456146968|FG002|Overall Study|Lack of Efficacy|0|||
126596427|NCT03519178|455484377|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126596428|NCT03519178|455484378|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126596429|NCT03519178|455484379|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126596430|NCT03519178|455484380|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
126596431|NCT03519178|455484381|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
126596432|NCT03519178|455484382|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
126596433|NCT03519178|455484368|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126596434|NCT03519178|455484369|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126596435|NCT03519178|455484370|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126596436|NCT03519178|455484371|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126596437|NCT03519178|455484372|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126596438|NCT03519178|455484373|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126596439|NCT03519178|455484374|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126596440|NCT03519178|455484375|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126596441|NCT03519178|455484376|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126596442|NCT03519178|455484377|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
126596443|NCT03519178|455484378|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126596444|NCT03519178|455484379|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126596445|NCT03519178|455484380|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
126596446|NCT03519178|455484381|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
126596447|NCT03519178|455484382|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
126596448|NCT03519178|455484368|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596449|NCT03519178|455484369|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596450|NCT03519178|455484370|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596451|NCT03519178|455484371|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596452|NCT03519178|455484372|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596453|NCT03519178|455484373|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596454|NCT03519178|455484374|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596455|NCT03519178|455484375|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596456|NCT03519178|455484376|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596457|NCT03519178|455484377|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
126596458|NCT03519178|455484378|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596459|NCT03519178|455484379|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596460|NCT03519178|455484380|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596461|NCT03519178|455484381|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
126596462|NCT03519178|455484382|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
126596463|NCT03519178|455484368|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596464|NCT03519178|455484369|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596465|NCT03519178|455484370|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596466|NCT03519178|455484371|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596467|NCT03519178|455484372|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596468|NCT03519178|455484373|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596469|NCT03519178|455484374|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596470|NCT03519178|455484375|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596471|NCT03519178|455484376|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596472|NCT03519178|455484377|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596473|NCT03519178|455484378|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596474|NCT03519178|455484379|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596475|NCT03519178|455484380|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596476|NCT03519178|455484381|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
126596477|NCT03519178|455484382|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
126596478|NCT03519178|455484368|FG000|Disposition for Fluvestrant Treatment|Other|0|||
126596479|NCT03519178|455484369|FG001|Disposition for Fluvestrant Treatment|Other|0|||
126596480|NCT03519178|455484370|FG002|Disposition for Fluvestrant Treatment|Other|0|||
126596481|NCT03519178|455484371|FG003|Disposition for Fluvestrant Treatment|Other|0|||
126596482|NCT03519178|455484372|FG004|Disposition for Fluvestrant Treatment|Other|0|||
126596483|NCT03519178|455484373|FG005|Disposition for Fluvestrant Treatment|Other|0|||
126596484|NCT03519178|455484374|FG006|Disposition for Fluvestrant Treatment|Other|0|||
126596485|NCT03519178|455484375|FG007|Disposition for Fluvestrant Treatment|Other|0|||
126596486|NCT03519178|455484376|FG008|Disposition for Fluvestrant Treatment|Other|0|||
126596487|NCT03519178|455484377|FG009|Disposition for Fluvestrant Treatment|Other|0|||
126596488|NCT03519178|455484378|FG010|Disposition for Fluvestrant Treatment|Other|0|||
126596489|NCT03519178|455484379|FG011|Disposition for Fluvestrant Treatment|Other|0|||
126596490|NCT03519178|455484380|FG012|Disposition for Fluvestrant Treatment|Other|0|||
126596491|NCT03519178|455484381|FG013|Disposition for Fluvestrant Treatment|Other|1|||
126596492|NCT03519178|455484382|FG014|Disposition for Fluvestrant Treatment|Other|3|||
126596493|NCT03519178|455484368|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596494|NCT03519178|455484369|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596495|NCT03519178|455484370|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596496|NCT03519178|455484371|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596497|NCT03519178|455484372|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596498|NCT03519178|455484373|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596499|NCT03519178|455484374|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596500|NCT03519178|455484375|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596501|NCT03519178|455484376|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596502|NCT03519178|455484377|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596503|NCT03519178|455484378|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596504|NCT03519178|455484379|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596505|NCT03519178|455484380|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
126596506|NCT03519178|455484381|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
126596507|NCT03519178|455484382|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
126596508|NCT03519178|455484368|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
126596509|NCT03519178|455484369|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
126596510|NCT03519178|455484370|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
126596511|NCT03519178|455484371|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
126596512|NCT03519178|455484372|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
126596513|NCT03519178|455484373|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
126596514|NCT03519178|455484374|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
126596515|NCT03519178|455484375|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
126596516|NCT03519178|455484376|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
126596517|NCT03519178|455484377|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
126596518|NCT03519178|455484378|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
126596519|NCT03519178|455484379|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
126596520|NCT03519178|455484380|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
126596521|NCT03519178|455484381|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
126596522|NCT03519178|455484382|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
126596523|NCT03519178|455484368|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
126596524|NCT03519178|455484369|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
126596525|NCT03519178|455484370|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
126596526|NCT03519178|455484371|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
126596527|NCT03519178|455484372|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
126596528|NCT03519178|455484373|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
126596529|NCT03519178|455484374|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
126596530|NCT03519178|455484375|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
126596531|NCT03519178|455484376|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
126596532|NCT03519178|455484377|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
126596533|NCT03519178|455484378|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
126596534|NCT03519178|455484379|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
126596535|NCT03519178|455484380|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
126596536|NCT03519178|455484381|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
126596537|NCT03519178|455484382|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
126596538|NCT03519178|455484368|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596539|NCT03519178|455484369|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596540|NCT03519178|455484370|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126732664|NCT00862121|455969883|FG000|Overall Study|Incorrect randomisation|0|||
126732665|NCT00862121|455969884|FG001|Overall Study|Incorrect randomisation|1|||
126732666|NCT00171314|455969889|FG000|Overall Study|Adverse Event|44|||
126732667|NCT00171314|455969890|FG001|Overall Study|Adverse Event|41|||
126732668|NCT00171314|455969889|FG000|Overall Study|Lack of Efficacy|19|||
126596541|NCT03519178|455484371|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596542|NCT03519178|455484372|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596543|NCT03519178|455484373|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596544|NCT03519178|455484374|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596545|NCT03519178|455484375|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596546|NCT03519178|455484376|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596547|NCT03519178|455484377|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596548|NCT03519178|455484378|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
126596549|NCT03519178|455484379|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596550|NCT03519178|455484380|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596551|NCT03519178|455484381|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596552|NCT03519178|455484382|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
126596553|NCT03519178|455484368|FG000|Follow-Up|Death|0|||
126596554|NCT03519178|455484369|FG001|Follow-Up|Death|0|||
126596555|NCT03519178|455484370|FG002|Follow-Up|Death|1|||
126596556|NCT03519178|455484371|FG003|Follow-Up|Death|0|||
126596557|NCT03519178|455484372|FG004|Follow-Up|Death|0|||
126596558|NCT03519178|455484373|FG005|Follow-Up|Death|0|||
126596559|NCT03519178|455484374|FG006|Follow-Up|Death|0|||
126596560|NCT03519178|455484375|FG007|Follow-Up|Death|0|||
126596561|NCT03519178|455484376|FG008|Follow-Up|Death|3|||
126596562|NCT03519178|455484377|FG009|Follow-Up|Death|1|||
126596563|NCT03519178|455484378|FG010|Follow-Up|Death|0|||
126596564|NCT03519178|455484379|FG011|Follow-Up|Death|0|||
126596565|NCT03519178|455484380|FG012|Follow-Up|Death|2|||
126596566|NCT03519178|455484381|FG013|Follow-Up|Death|0|||
126596567|NCT03519178|455484382|FG014|Follow-Up|Death|0|||
126596568|NCT03519178|455484368|FG000|Follow-Up|Lost to Follow-up|0|||
126596569|NCT03519178|455484369|FG001|Follow-Up|Lost to Follow-up|0|||
126596570|NCT03519178|455484370|FG002|Follow-Up|Lost to Follow-up|0|||
126596571|NCT03519178|455484371|FG003|Follow-Up|Lost to Follow-up|0|||
126596572|NCT03519178|455484372|FG004|Follow-Up|Lost to Follow-up|0|||
126596573|NCT03519178|455484373|FG005|Follow-Up|Lost to Follow-up|3|||
126596574|NCT03519178|455484374|FG006|Follow-Up|Lost to Follow-up|1|||
126596575|NCT03519178|455484375|FG007|Follow-Up|Lost to Follow-up|4|||
126596576|NCT03519178|455484376|FG008|Follow-Up|Lost to Follow-up|1|||
126596577|NCT03519178|455484377|FG009|Follow-Up|Lost to Follow-up|0|||
126596578|NCT03519178|455484378|FG010|Follow-Up|Lost to Follow-up|0|||
126596579|NCT03519178|455484379|FG011|Follow-Up|Lost to Follow-up|0|||
126596580|NCT03519178|455484380|FG012|Follow-Up|Lost to Follow-up|0|||
126596581|NCT03519178|455484381|FG013|Follow-Up|Lost to Follow-up|0|||
126596582|NCT03519178|455484382|FG014|Follow-Up|Lost to Follow-up|0|||
126596583|NCT03519178|455484368|FG000|Follow-Up|Withdrawal by Subject|1|||
126596584|NCT03519178|455484369|FG001|Follow-Up|Withdrawal by Subject|2|||
126596585|NCT03519178|455484370|FG002|Follow-Up|Withdrawal by Subject|2|||
126596586|NCT03519178|455484371|FG003|Follow-Up|Withdrawal by Subject|3|||
126596587|NCT03519178|455484372|FG004|Follow-Up|Withdrawal by Subject|5|||
126596588|NCT03519178|455484373|FG005|Follow-Up|Withdrawal by Subject|1|||
126596589|NCT03519178|455484374|FG006|Follow-Up|Withdrawal by Subject|2|||
126596590|NCT03519178|455484375|FG007|Follow-Up|Withdrawal by Subject|6|||
126596591|NCT03519178|455484376|FG008|Follow-Up|Withdrawal by Subject|5|||
126596592|NCT03519178|455484377|FG009|Follow-Up|Withdrawal by Subject|2|||
126596593|NCT03519178|455484378|FG010|Follow-Up|Withdrawal by Subject|3|||
126596594|NCT03519178|455484379|FG011|Follow-Up|Withdrawal by Subject|5|||
126596595|NCT03519178|455484380|FG012|Follow-Up|Withdrawal by Subject|2|||
126596596|NCT03519178|455484381|FG013|Follow-Up|Withdrawal by Subject|0|||
126596597|NCT03519178|455484382|FG014|Follow-Up|Withdrawal by Subject|0|||
126596598|NCT03519178|455484368|FG000|Follow-Up|Other|0|||
126596599|NCT03519178|455484369|FG001|Follow-Up|Other|0|||
126596600|NCT03519178|455484370|FG002|Follow-Up|Other|0|||
126596601|NCT03519178|455484371|FG003|Follow-Up|Other|0|||
126596602|NCT03519178|455484372|FG004|Follow-Up|Other|0|||
126596603|NCT03519178|455484373|FG005|Follow-Up|Other|0|||
126596604|NCT03519178|455484374|FG006|Follow-Up|Other|0|||
126596605|NCT03519178|455484375|FG007|Follow-Up|Other|1|||
126596606|NCT03519178|455484376|FG008|Follow-Up|Other|0|||
126596607|NCT03519178|455484377|FG009|Follow-Up|Other|0|||
126596608|NCT03519178|455484378|FG010|Follow-Up|Other|0|||
126596609|NCT03519178|455484379|FG011|Follow-Up|Other|0|||
126596610|NCT03519178|455484380|FG012|Follow-Up|Other|0|||
126596611|NCT03519178|455484381|FG013|Follow-Up|Other|0|||
126596612|NCT03519178|455484382|FG014|Follow-Up|Other|0|||
126596613|NCT03519178|455484368|FG000|Long-term Follow-up|Death|0|||
126596614|NCT03519178|455484369|FG001|Long-term Follow-up|Death|0|||
126596615|NCT03519178|455484370|FG002|Long-term Follow-up|Death|0|||
126596616|NCT03519178|455484371|FG003|Long-term Follow-up|Death|0|||
126596617|NCT03519178|455484372|FG004|Long-term Follow-up|Death|0|||
126596618|NCT03519178|455484373|FG005|Long-term Follow-up|Death|0|||
126596619|NCT03519178|455484374|FG006|Long-term Follow-up|Death|0|||
126596620|NCT03519178|455484375|FG007|Long-term Follow-up|Death|0|||
126596621|NCT03519178|455484376|FG008|Long-term Follow-up|Death|0|||
126596622|NCT03519178|455484377|FG009|Long-term Follow-up|Death|0|||
126779359|NCT01261325|456146966|FG000|Overall Study|Withdrawal by Subject|2|||
126779360|NCT01261325|456146967|FG001|Overall Study|Withdrawal by Subject|2|||
126779361|NCT01261325|456146968|FG002|Overall Study|Withdrawal by Subject|4|||
126779362|NCT01261325|456146966|FG000|Overall Study|SAE, non-fatal|1|||
126779363|NCT01261325|456146967|FG001|Overall Study|SAE, non-fatal|5|||
126779364|NCT01261325|456146968|FG002|Overall Study|SAE, non-fatal|1|||
126779365|NCT01261325|456146966|FG000|Overall Study|AE, non-serious non-fatal|9|||
126779366|NCT01261325|456146967|FG001|Overall Study|AE, non-serious non-fatal|15|||
126779367|NCT01261325|456146968|FG002|Overall Study|AE, non-serious non-fatal|13|||
126779368|NCT01261325|456146966|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
126779369|NCT01261325|456146967|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126779370|NCT01261325|456146968|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
126779371|NCT01261325|456146966|FG000|Overall Study|Non Compliance|2|||
126779372|NCT01261325|456146967|FG001|Overall Study|Non Compliance|0|||
126779373|NCT01261325|456146968|FG002|Overall Study|Non Compliance|0|||
126779374|NCT01261325|456146966|FG000|Overall Study|Patient Randomized by Mistake|0|||
126779375|NCT01261325|456146967|FG001|Overall Study|Patient Randomized by Mistake|1|||
126779376|NCT01261325|456146968|FG002|Overall Study|Patient Randomized by Mistake|0|||
126779377|NCT01261325|456146966|FG000|Overall Study|Erroneously Randomized|1|||
126779378|NCT01261325|456146967|FG001|Overall Study|Erroneously Randomized|0|||
126779379|NCT01261325|456146968|FG002|Overall Study|Erroneously Randomized|0|||
126596623|NCT03519178|455484378|FG010|Long-term Follow-up|Death|0|||
126596624|NCT03519178|455484379|FG011|Long-term Follow-up|Death|0|||
126596625|NCT03519178|455484380|FG012|Long-term Follow-up|Death|0|||
126596626|NCT03519178|455484381|FG013|Long-term Follow-up|Death|4|||
126596627|NCT03519178|455484382|FG014|Long-term Follow-up|Death|4|||
126596628|NCT03519178|455484368|FG000|Long-term Follow-up|Lost to Follow-up|0|||
126596629|NCT03519178|455484369|FG001|Long-term Follow-up|Lost to Follow-up|0|||
126596630|NCT03519178|455484370|FG002|Long-term Follow-up|Lost to Follow-up|0|||
126596631|NCT03519178|455484371|FG003|Long-term Follow-up|Lost to Follow-up|0|||
126596632|NCT03519178|455484372|FG004|Long-term Follow-up|Lost to Follow-up|0|||
126596633|NCT03519178|455484373|FG005|Long-term Follow-up|Lost to Follow-up|0|||
126596634|NCT03519178|455484374|FG006|Long-term Follow-up|Lost to Follow-up|0|||
126596635|NCT03519178|455484375|FG007|Long-term Follow-up|Lost to Follow-up|0|||
126596636|NCT03519178|455484376|FG008|Long-term Follow-up|Lost to Follow-up|0|||
126596637|NCT03519178|455484377|FG009|Long-term Follow-up|Lost to Follow-up|0|||
126596638|NCT03519178|455484378|FG010|Long-term Follow-up|Lost to Follow-up|0|||
126596639|NCT03519178|455484379|FG011|Long-term Follow-up|Lost to Follow-up|0|||
126596640|NCT03519178|455484380|FG012|Long-term Follow-up|Lost to Follow-up|0|||
126596641|NCT03519178|455484381|FG013|Long-term Follow-up|Lost to Follow-up|1|||
126596642|NCT03519178|455484382|FG014|Long-term Follow-up|Lost to Follow-up|1|||
126596643|NCT03519178|455484368|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
126596644|NCT03519178|455484369|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
126596645|NCT03519178|455484370|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
126596646|NCT03519178|455484371|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
126596647|NCT03519178|455484372|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
126596648|NCT03519178|455484373|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
126596649|NCT03519178|455484374|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
126596650|NCT03519178|455484375|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
126596651|NCT03519178|455484376|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
126596652|NCT03519178|455484377|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
126596653|NCT03519178|455484378|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
126596654|NCT03519178|455484379|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
126596655|NCT03519178|455484380|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
126596656|NCT03519178|455484381|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
126596657|NCT03519178|455484382|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
126596658|NCT03519178|455484368|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
126596659|NCT03519178|455484369|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
126596660|NCT03519178|455484370|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
126596661|NCT03519178|455484371|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
126596662|NCT03519178|455484372|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
126596663|NCT03519178|455484373|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
126596664|NCT03519178|455484374|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
126596665|NCT03519178|455484375|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
126596666|NCT03519178|455484376|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
126596667|NCT03519178|455484377|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
126596668|NCT03519178|455484378|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
126596669|NCT03519178|455484379|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
126596670|NCT03519178|455484380|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
126596671|NCT03519178|455484381|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
126596672|NCT03519178|455484382|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
126596673|NCT03519178|455484368|FG000|Long-term Follow-up|Other|0|||
126779380|NCT01261325|456146966|FG000|Overall Study|Screen Failure|1|||
126779381|NCT01261325|456146967|FG001|Overall Study|Screen Failure|0|||
126779382|NCT01261325|456146968|FG002|Overall Study|Screen Failure|0|||
126596674|NCT03519178|455484369|FG001|Long-term Follow-up|Other|0|||
126596675|NCT03519178|455484370|FG002|Long-term Follow-up|Other|0|||
126596676|NCT03519178|455484371|FG003|Long-term Follow-up|Other|0|||
126596677|NCT03519178|455484372|FG004|Long-term Follow-up|Other|0|||
126596678|NCT03519178|455484373|FG005|Long-term Follow-up|Other|0|||
126596679|NCT03519178|455484374|FG006|Long-term Follow-up|Other|0|||
126596680|NCT03519178|455484375|FG007|Long-term Follow-up|Other|0|||
126596681|NCT03519178|455484376|FG008|Long-term Follow-up|Other|0|||
126596682|NCT03519178|455484377|FG009|Long-term Follow-up|Other|0|||
126596683|NCT03519178|455484378|FG010|Long-term Follow-up|Other|0|||
126596684|NCT03519178|455484379|FG011|Long-term Follow-up|Other|0|||
126596685|NCT03519178|455484380|FG012|Long-term Follow-up|Other|0|||
126596686|NCT03519178|455484381|FG013|Long-term Follow-up|Other|0|||
126596687|NCT03519178|455484382|FG014|Long-term Follow-up|Other|1|||
126596688|NCT03519178|455484368|FG000|Long-term Follow-up|Ongoing|0|||
126596689|NCT03519178|455484369|FG001|Long-term Follow-up|Ongoing|0|||
126596690|NCT03519178|455484370|FG002|Long-term Follow-up|Ongoing|0|||
126596691|NCT03519178|455484371|FG003|Long-term Follow-up|Ongoing|0|||
126596692|NCT03519178|455484372|FG004|Long-term Follow-up|Ongoing|0|||
126596693|NCT03519178|455484373|FG005|Long-term Follow-up|Ongoing|0|||
126596694|NCT03519178|455484374|FG006|Long-term Follow-up|Ongoing|0|||
126596695|NCT03519178|455484375|FG007|Long-term Follow-up|Ongoing|0|||
126596696|NCT03519178|455484376|FG008|Long-term Follow-up|Ongoing|0|||
126596697|NCT03519178|455484377|FG009|Long-term Follow-up|Ongoing|0|||
126596698|NCT03519178|455484378|FG010|Long-term Follow-up|Ongoing|0|||
126596699|NCT03519178|455484379|FG011|Long-term Follow-up|Ongoing|0|||
126596700|NCT03519178|455484380|FG012|Long-term Follow-up|Ongoing|0|||
126596701|NCT03519178|455484381|FG013|Long-term Follow-up|Ongoing|1|||
126596702|NCT03519178|455484382|FG014|Long-term Follow-up|Ongoing|0|||
126596703|NCT02240238|455484383|FG000|Phase 1|Adverse Event|0|||
126596704|NCT02240238|455484384|FG001|Phase 1|Adverse Event|0|||
126596705|NCT02240238|455484385|FG002|Phase 1|Adverse Event|0|||
126596706|NCT02240238|455484386|FG003|Phase 1|Adverse Event|0|||
126596707|NCT02240238|455484387|FG004|Phase 1|Adverse Event|0|||
126596708|NCT02240238|455484388|FG005|Phase 1|Adverse Event|0|||
126596709|NCT02240238|455484389|FG006|Phase 1|Adverse Event|3|||
126596710|NCT02240238|455484390|FG007|Phase 1|Adverse Event|1|||
126596711|NCT02240238|455484391|FG008|Phase 1|Adverse Event|0|||
126596712|NCT02240238|455484392|FG009|Phase 1|Adverse Event|0|||
126596713|NCT02240238|455484393|FG010|Phase 1|Adverse Event|0|||
126596714|NCT02240238|455484394|FG011|Phase 1|Adverse Event|0|||
126596715|NCT02240238|455484383|FG000|Phase 1|Death|0|||
126596716|NCT02240238|455484384|FG001|Phase 1|Death|0|||
126596717|NCT02240238|455484385|FG002|Phase 1|Death|0|||
126596718|NCT02240238|455484386|FG003|Phase 1|Death|0|||
126596719|NCT02240238|455484387|FG004|Phase 1|Death|0|||
126596720|NCT02240238|455484388|FG005|Phase 1|Death|1|||
126596721|NCT02240238|455484389|FG006|Phase 1|Death|0|||
126596722|NCT02240238|455484390|FG007|Phase 1|Death|0|||
126596723|NCT02240238|455484391|FG008|Phase 1|Death|0|||
126596724|NCT02240238|455484392|FG009|Phase 1|Death|0|||
126596725|NCT02240238|455484393|FG010|Phase 1|Death|0|||
126596726|NCT02240238|455484394|FG011|Phase 1|Death|0|||
126596727|NCT02240238|455484383|FG000|Phase 1|Sponsor termination|0|||
126596728|NCT02240238|455484384|FG001|Phase 1|Sponsor termination|0|||
126596729|NCT02240238|455484385|FG002|Phase 1|Sponsor termination|0|||
126596730|NCT02240238|455484386|FG003|Phase 1|Sponsor termination|0|||
126596731|NCT02240238|455484387|FG004|Phase 1|Sponsor termination|0|||
126596732|NCT02240238|455484388|FG005|Phase 1|Sponsor termination|1|||
126596733|NCT02240238|455484389|FG006|Phase 1|Sponsor termination|0|||
126596734|NCT02240238|455484390|FG007|Phase 1|Sponsor termination|0|||
126596735|NCT02240238|455484391|FG008|Phase 1|Sponsor termination|0|||
126596736|NCT02240238|455484392|FG009|Phase 1|Sponsor termination|0|||
126596737|NCT02240238|455484393|FG010|Phase 1|Sponsor termination|0|||
126596738|NCT02240238|455484394|FG011|Phase 1|Sponsor termination|0|||
126596739|NCT02240238|455484383|FG000|Phase 1|Withdrawal by Subject|0|||
126596740|NCT02240238|455484384|FG001|Phase 1|Withdrawal by Subject|0|||
126596741|NCT02240238|455484385|FG002|Phase 1|Withdrawal by Subject|0|||
126596742|NCT02240238|455484386|FG003|Phase 1|Withdrawal by Subject|0|||
126596743|NCT02240238|455484387|FG004|Phase 1|Withdrawal by Subject|0|||
126596744|NCT02240238|455484388|FG005|Phase 1|Withdrawal by Subject|2|||
126596745|NCT02240238|455484389|FG006|Phase 1|Withdrawal by Subject|0|||
126596746|NCT02240238|455484390|FG007|Phase 1|Withdrawal by Subject|0|||
126596747|NCT02240238|455484391|FG008|Phase 1|Withdrawal by Subject|0|||
126596748|NCT02240238|455484392|FG009|Phase 1|Withdrawal by Subject|0|||
126596749|NCT02240238|455484393|FG010|Phase 1|Withdrawal by Subject|0|||
126596750|NCT02240238|455484394|FG011|Phase 1|Withdrawal by Subject|0|||
126596751|NCT02240238|455484383|FG000|Phase 1|Physician Decision|0|||
126596752|NCT02240238|455484384|FG001|Phase 1|Physician Decision|0|||
126596753|NCT02240238|455484385|FG002|Phase 1|Physician Decision|0|||
126596754|NCT02240238|455484386|FG003|Phase 1|Physician Decision|0|||
126596755|NCT02240238|455484387|FG004|Phase 1|Physician Decision|0|||
126596756|NCT02240238|455484388|FG005|Phase 1|Physician Decision|2|||
126596757|NCT02240238|455484389|FG006|Phase 1|Physician Decision|0|||
126596758|NCT02240238|455484390|FG007|Phase 1|Physician Decision|0|||
126596759|NCT02240238|455484391|FG008|Phase 1|Physician Decision|0|||
126596760|NCT02240238|455484392|FG009|Phase 1|Physician Decision|0|||
126596761|NCT02240238|455484393|FG010|Phase 1|Physician Decision|0|||
126596762|NCT02240238|455484394|FG011|Phase 1|Physician Decision|0|||
126596763|NCT02240238|455484383|FG000|Phase 2|Adverse Event|0|||
126596764|NCT02240238|455484384|FG001|Phase 2|Adverse Event|0|||
126596765|NCT02240238|455484385|FG002|Phase 2|Adverse Event|0|||
126596766|NCT02240238|455484386|FG003|Phase 2|Adverse Event|0|||
126596767|NCT02240238|455484387|FG004|Phase 2|Adverse Event|0|||
126596768|NCT02240238|455484388|FG005|Phase 2|Adverse Event|0|||
126596769|NCT02240238|455484389|FG006|Phase 2|Adverse Event|0|||
126596770|NCT02240238|455484390|FG007|Phase 2|Adverse Event|0|||
126596771|NCT02240238|455484391|FG008|Phase 2|Adverse Event|0|||
126596772|NCT02240238|455484392|FG009|Phase 2|Adverse Event|7|||
126596773|NCT02240238|455484393|FG010|Phase 2|Adverse Event|14|||
126596774|NCT02240238|455484394|FG011|Phase 2|Adverse Event|2|||
126596775|NCT02240238|455484383|FG000|Phase 2|Death|0|||
126596776|NCT02240238|455484384|FG001|Phase 2|Death|0|||
126596777|NCT02240238|455484385|FG002|Phase 2|Death|0|||
126596778|NCT02240238|455484386|FG003|Phase 2|Death|0|||
126596779|NCT02240238|455484387|FG004|Phase 2|Death|0|||
126596780|NCT02240238|455484388|FG005|Phase 2|Death|0|||
126596781|NCT02240238|455484389|FG006|Phase 2|Death|0|||
126596782|NCT02240238|455484390|FG007|Phase 2|Death|0|||
126596783|NCT02240238|455484391|FG008|Phase 2|Death|0|||
126596784|NCT02240238|455484392|FG009|Phase 2|Death|3|||
126596785|NCT02240238|455484393|FG010|Phase 2|Death|2|||
126596786|NCT02240238|455484394|FG011|Phase 2|Death|1|||
126596787|NCT02240238|455484383|FG000|Phase 2|Disease progression|0|||
126596788|NCT02240238|455484384|FG001|Phase 2|Disease progression|0|||
126596789|NCT02240238|455484385|FG002|Phase 2|Disease progression|0|||
126596790|NCT02240238|455484386|FG003|Phase 2|Disease progression|0|||
126596791|NCT02240238|455484387|FG004|Phase 2|Disease progression|0|||
126596792|NCT02240238|455484388|FG005|Phase 2|Disease progression|0|||
126596793|NCT02240238|455484389|FG006|Phase 2|Disease progression|0|||
126596794|NCT02240238|455484390|FG007|Phase 2|Disease progression|0|||
126596795|NCT02240238|455484391|FG008|Phase 2|Disease progression|0|||
126596796|NCT02240238|455484392|FG009|Phase 2|Disease progression|5|||
126596797|NCT02240238|455484393|FG010|Phase 2|Disease progression|11|||
126596798|NCT02240238|455484394|FG011|Phase 2|Disease progression|1|||
126596799|NCT02240238|455484383|FG000|Phase 2|Withdrawal by Subject|0|||
126596800|NCT02240238|455484384|FG001|Phase 2|Withdrawal by Subject|0|||
126596801|NCT02240238|455484385|FG002|Phase 2|Withdrawal by Subject|0|||
126596802|NCT02240238|455484386|FG003|Phase 2|Withdrawal by Subject|0|||
126596803|NCT02240238|455484387|FG004|Phase 2|Withdrawal by Subject|0|||
126596804|NCT02240238|455484388|FG005|Phase 2|Withdrawal by Subject|0|||
126596805|NCT02240238|455484389|FG006|Phase 2|Withdrawal by Subject|0|||
126596806|NCT02240238|455484390|FG007|Phase 2|Withdrawal by Subject|0|||
126596807|NCT02240238|455484391|FG008|Phase 2|Withdrawal by Subject|0|||
126596808|NCT02240238|455484392|FG009|Phase 2|Withdrawal by Subject|1|||
126596809|NCT02240238|455484393|FG010|Phase 2|Withdrawal by Subject|1|||
126596810|NCT02240238|455484394|FG011|Phase 2|Withdrawal by Subject|0|||
126596811|NCT02240238|455484383|FG000|Phase 2|Physician Decision|0|||
126596812|NCT02240238|455484384|FG001|Phase 2|Physician Decision|0|||
126596813|NCT02240238|455484385|FG002|Phase 2|Physician Decision|0|||
126596814|NCT02240238|455484386|FG003|Phase 2|Physician Decision|0|||
126596815|NCT02240238|455484387|FG004|Phase 2|Physician Decision|0|||
126596816|NCT02240238|455484388|FG005|Phase 2|Physician Decision|0|||
126596817|NCT02240238|455484389|FG006|Phase 2|Physician Decision|0|||
126596818|NCT02240238|455484390|FG007|Phase 2|Physician Decision|0|||
126596819|NCT02240238|455484391|FG008|Phase 2|Physician Decision|0|||
126596820|NCT02240238|455484392|FG009|Phase 2|Physician Decision|1|||
126596821|NCT02240238|455484393|FG010|Phase 2|Physician Decision|3|||
126596822|NCT02240238|455484394|FG011|Phase 2|Physician Decision|0|||
126596823|NCT02240238|455484383|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126596824|NCT02240238|455484384|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126596825|NCT02240238|455484385|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126596826|NCT02240238|455484386|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126596827|NCT02240238|455484387|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126596828|NCT02240238|455484388|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126596829|NCT02240238|455484389|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126596830|NCT02240238|455484390|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126596831|NCT02240238|455484391|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126596832|NCT02240238|455484392|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
126596833|NCT02240238|455484393|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126596834|NCT02240238|455484394|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
126596835|NCT02240238|455484383|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126596836|NCT02240238|455484384|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126596837|NCT02240238|455484385|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126596838|NCT02240238|455484386|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126596839|NCT02240238|455484387|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126596840|NCT02240238|455484388|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126732669|NCT00171314|455969890|FG001|Overall Study|Lack of Efficacy|14|||
126732670|NCT00171314|455969889|FG000|Overall Study|Withdrawal by Subject|9|||
126732671|NCT00171314|455969890|FG001|Overall Study|Withdrawal by Subject|6|||
126732672|NCT00171314|455969889|FG000|Overall Study|Abnormal Test Procedure Results|9|||
126732673|NCT00171314|455969890|FG001|Overall Study|Abnormal Test Procedure Results|3|||
126732674|NCT00171314|455969889|FG000|Overall Study|Protocol Violation|3|||
126732675|NCT00171314|455969890|FG001|Overall Study|Protocol Violation|7|||
126732676|NCT00171314|455969889|FG000|Overall Study|Administrative Problems|4|||
126732677|NCT00171314|455969890|FG001|Overall Study|Administrative Problems|3|||
126732678|NCT00171314|455969889|FG000|Overall Study|Lost to Follow-up|1|||
126732679|NCT00171314|455969890|FG001|Overall Study|Lost to Follow-up|3|||
126732680|NCT00171314|455969889|FG000|Overall Study|Death|2|||
126732681|NCT00171314|455969890|FG001|Overall Study|Death|1|||
126732682|NCT00475540|455969891|FG000|36 Months|Lost to Follow-up|4|||
126732683|NCT00475540|455969892|FG001|36 Months|Lost to Follow-up|4|||
126732684|NCT00475540|455969891|FG000|36 Months|Death|1|||
126732685|NCT00475540|455969892|FG001|36 Months|Death|2|||
126732686|NCT00475540|455969891|FG000|36 Months|Censored due to reoperation|3|||
126732687|NCT00475540|455969892|FG001|36 Months|Censored due to reoperation|0|||
126732688|NCT00377429|455969893|FG000|Overall Study|Withdrawal by Subject|5|||
126732689|NCT00377429|455969893|FG000|Overall Study|Adverse Event|8|||
126732690|NCT00377429|455969893|FG000|Overall Study|Physician Decision|1|||
126732691|NCT00377429|455969893|FG000|Overall Study|Patient non-compliance|1|||
126732692|NCT01033487|455969899|FG000|Fourth Intervention Period|Adverse Event|0|||
126732693|NCT01033487|455969900|FG001|Fourth Intervention Period|Adverse Event|0|||
126732694|NCT01033487|455969901|FG002|Fourth Intervention Period|Adverse Event|0|||
126732695|NCT01033487|455969902|FG003|Fourth Intervention Period|Adverse Event|0|||
126732696|NCT01033487|455969903|FG004|Fourth Intervention Period|Adverse Event|0|||
126732697|NCT01033487|455969904|FG005|Fourth Intervention Period|Adverse Event|0|||
126732698|NCT01033487|455969905|FG006|Fourth Intervention Period|Adverse Event|0|||
126732699|NCT01033487|455969906|FG007|Fourth Intervention Period|Adverse Event|0|||
126732700|NCT01033487|455969907|FG008|Fourth Intervention Period|Adverse Event|1|||
126732701|NCT01033487|455969908|FG009|Fourth Intervention Period|Adverse Event|0|||
126732702|NCT02939599|455969909|FG000|Overall Study|Adverse Event|1|||
126732703|NCT02939599|455969910|FG001|Overall Study|Adverse Event|0|||
126732704|NCT02939599|455969909|FG000|Overall Study|Study Terminated By Sponsor|2|||
126732705|NCT02939599|455969910|FG001|Overall Study|Study Terminated By Sponsor|2|||
126732706|NCT02148211|455969911|FG000|Overall Study|Lost to Follow-up|352|||
126732707|NCT02726113|455969912|FG000|Total Enrollment|Physician Decision|0|||
126732708|NCT02726113|455969913|FG001|Total Enrollment|Physician Decision|1|||
126732709|NCT02726113|455969912|FG000|Total Enrollment|Protocol Violation|1|||
126732710|NCT02726113|455969913|FG001|Total Enrollment|Protocol Violation|0|||
126732711|NCT02726113|455969912|FG000|Total Enrollment|Withdrawal by Subject|2|||
126732712|NCT02726113|455969913|FG001|Total Enrollment|Withdrawal by Subject|1|||
126732713|NCT02726113|455969912|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
126732714|NCT02726113|455969913|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
126732715|NCT02726113|455969912|FG000|Genomic Analysis|Protocol Violation|1|||
126732716|NCT02726113|455969913|FG001|Genomic Analysis|Protocol Violation|0|||
126732717|NCT02726113|455969912|FG000|Genomic Analysis|Withdrawal by Subject|2|||
126732718|NCT02726113|455969913|FG001|Genomic Analysis|Withdrawal by Subject|1|||
126732719|NCT02726113|455969912|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
126732720|NCT02726113|455969913|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
126732721|NCT03326869|455972232|FG000|Overall Study|Study data has been lost to natural disa|1|||
126732722|NCT03326869|455972233|FG001|Overall Study|Study data has been lost to natural disa|1|||
126732723|NCT03788967|455972234|FG000|Overall Study|Lost to Follow-up|14|||
126732724|NCT03788967|455972235|FG001|Overall Study|Lost to Follow-up|10|||
126732725|NCT03788967|455972234|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
126732726|NCT03788967|455972235|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
126732727|NCT03788967|455972234|FG000|Overall Study|Participant Withdrawal of Consent|13|||
126732728|NCT03788967|455972235|FG001|Overall Study|Participant Withdrawal of Consent|5|||
126732729|NCT03788967|455972234|FG000|Overall Study|Adverse Event|1|||
126732730|NCT03788967|455972235|FG001|Overall Study|Adverse Event|1|||
126732731|NCT03788967|455972234|FG000|Overall Study|COVID-19|1|||
126779383|NCT01261325|456146966|FG000|Overall Study|Randomized in Error|0|||
126732732|NCT03788967|455972235|FG001|Overall Study|COVID-19|2|||
126732733|NCT03927911|455972236|FG000|Overall Study|problems with eDiary|0|||
126732734|NCT03927911|455972237|FG001|Overall Study|problems with eDiary|1|||
126732735|NCT03927911|455972238|FG002|Overall Study|problems with eDiary|0|||
126779384|NCT01261325|456146967|FG001|Overall Study|Randomized in Error|0|||
126779385|NCT01261325|456146968|FG002|Overall Study|Randomized in Error|1|||
126596841|NCT02240238|455484389|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126596842|NCT02240238|455484390|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126596843|NCT02240238|455484391|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126596844|NCT02240238|455484392|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
126596845|NCT02240238|455484393|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126596846|NCT02240238|455484394|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
126596847|NCT02240238|455484383|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126596848|NCT02240238|455484384|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126596849|NCT02240238|455484385|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126596850|NCT02240238|455484386|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126596851|NCT02240238|455484387|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126596852|NCT02240238|455484388|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126596853|NCT02240238|455484389|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126596854|NCT02240238|455484390|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126596855|NCT02240238|455484391|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126596856|NCT02240238|455484392|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126596857|NCT02240238|455484393|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
126596858|NCT02240238|455484394|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
126596859|NCT02240238|455484383|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126596860|NCT02240238|455484384|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126596861|NCT02240238|455484385|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126596862|NCT02240238|455484386|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126596863|NCT02240238|455484387|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126596864|NCT02240238|455484388|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126596865|NCT02240238|455484389|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126596866|NCT02240238|455484390|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126596867|NCT02240238|455484391|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126596868|NCT02240238|455484392|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126596869|NCT02240238|455484393|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
126596870|NCT02240238|455484394|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
126596871|NCT02240238|455484383|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126596872|NCT02240238|455484384|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126596873|NCT02240238|455484385|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126596874|NCT02240238|455484386|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126596875|NCT02240238|455484387|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126596876|NCT02240238|455484388|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126596877|NCT02240238|455484389|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126596878|NCT02240238|455484390|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126596879|NCT02240238|455484391|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126596880|NCT02240238|455484392|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126596881|NCT02240238|455484393|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
126596882|NCT02240238|455484394|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
126596883|NCT02240238|455484383|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126596884|NCT02240238|455484384|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126596885|NCT02240238|455484385|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126596886|NCT02240238|455484386|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126596887|NCT02240238|455484387|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126596888|NCT02240238|455484388|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126596889|NCT02240238|455484389|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126596890|NCT02240238|455484390|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126596891|NCT02240238|455484391|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126596892|NCT02240238|455484392|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126596893|NCT02240238|455484393|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
126596894|NCT02240238|455484394|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
126596895|NCT02240238|455484383|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126596896|NCT02240238|455484384|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126779386|NCT01261325|456146966|FG000|Overall Study|Protocol Violation|0|||
126779387|NCT01261325|456146967|FG001|Overall Study|Protocol Violation|3|||
126779388|NCT01261325|456146968|FG002|Overall Study|Protocol Violation|1|||
126779389|NCT01261325|456146966|FG000|Overall Study|Lost to Follow-up|0|||
126779390|NCT01261325|456146967|FG001|Overall Study|Lost to Follow-up|1|||
126596897|NCT02240238|455484385|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126596898|NCT02240238|455484386|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126596899|NCT02240238|455484387|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126596900|NCT02240238|455484388|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126596901|NCT02240238|455484389|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126596902|NCT02240238|455484390|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126596903|NCT02240238|455484391|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126596904|NCT02240238|455484392|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126596905|NCT02240238|455484393|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
126596906|NCT02240238|455484394|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
126596907|NCT02240238|455484383|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126596908|NCT02240238|455484384|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126596909|NCT02240238|455484385|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126596910|NCT02240238|455484386|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126596911|NCT02240238|455484387|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126596912|NCT02240238|455484388|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126596913|NCT02240238|455484389|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126596914|NCT02240238|455484390|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126596915|NCT02240238|455484391|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126596916|NCT02240238|455484392|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126596917|NCT02240238|455484393|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
126596918|NCT02240238|455484394|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
126596919|NCT02315703|455484395|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
126596920|NCT02315703|455484396|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
126596921|NCT02315703|455484397|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
126596922|NCT02315703|455484398|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
126596923|NCT02315703|455484399|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
126596924|NCT02315703|455484400|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
126596925|NCT02315703|455484401|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
126596926|NCT02315703|455484402|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
126596927|NCT02315703|455484395|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
126596928|NCT02315703|455484396|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
126596929|NCT02315703|455484397|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
126596930|NCT02315703|455484398|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
126596931|NCT02315703|455484399|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
126596932|NCT02315703|455484400|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
126596933|NCT02315703|455484401|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
126596934|NCT02315703|455484402|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
126596935|NCT02315703|455484395|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
126596936|NCT02315703|455484396|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
126596937|NCT02315703|455484397|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
126596938|NCT02315703|455484398|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
126596939|NCT02315703|455484399|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
126596940|NCT02315703|455484400|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
126596941|NCT02315703|455484401|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
126596942|NCT02315703|455484402|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
126596943|NCT02315703|455484395|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126596944|NCT02315703|455484396|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126596945|NCT02315703|455484397|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126596946|NCT02315703|455484398|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126596947|NCT02315703|455484399|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126596948|NCT02315703|455484400|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126596949|NCT02315703|455484401|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
126596950|NCT02315703|455484402|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
126596951|NCT02315703|455484395|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
126596952|NCT02315703|455484396|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
126596953|NCT02315703|455484397|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
126732736|NCT03927911|455972239|FG003|Overall Study|problems with eDiary|1|||
126732737|NCT03927911|455972240|FG004|Overall Study|problems with eDiary|0|||
126732738|NCT03927911|455972241|FG005|Overall Study|problems with eDiary|4|||
126596954|NCT02315703|455484398|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
126596955|NCT02315703|455484399|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
126596956|NCT02315703|455484400|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
126732739|NCT03927911|455972236|FG000|Overall Study|Adverse Event|0|||
126732740|NCT03927911|455972237|FG001|Overall Study|Adverse Event|0|||
126732741|NCT03927911|455972238|FG002|Overall Study|Adverse Event|0|||
126596957|NCT02315703|455484401|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
126596958|NCT02315703|455484402|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
126596959|NCT02315703|455484395|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
126596960|NCT02315703|455484396|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
126596961|NCT02315703|455484397|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
126596962|NCT02315703|455484398|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
126596963|NCT02315703|455484399|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
126596964|NCT02315703|455484400|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
126596965|NCT02315703|455484401|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
126596966|NCT02315703|455484402|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
126596967|NCT02315703|455484395|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
126596968|NCT02315703|455484396|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
126596969|NCT02315703|455484397|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
126596970|NCT02315703|455484398|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
126596971|NCT02315703|455484399|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
126596972|NCT02315703|455484400|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
126596973|NCT02315703|455484401|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
126596974|NCT02315703|455484402|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
126596975|NCT02315703|455484395|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126596976|NCT02315703|455484396|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
126596977|NCT02315703|455484397|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126596978|NCT02315703|455484398|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126596979|NCT02315703|455484399|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126596980|NCT02315703|455484400|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126596981|NCT02315703|455484401|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126596982|NCT02315703|455484402|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
126596983|NCT02315703|455484395|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
126596984|NCT02315703|455484396|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
126596985|NCT02315703|455484397|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
126596986|NCT02315703|455484398|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
126596987|NCT02315703|455484399|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
126596988|NCT02315703|455484400|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
126596989|NCT02315703|455484401|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
126596990|NCT02315703|455484402|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
126596991|NCT05863156|455484412|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
126596992|NCT05863156|455484413|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
126596993|NCT05863156|455484414|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
126596994|NCT05216406|455484417|FG000|Overall Study|Lost to Follow-up|8|||
126596995|NCT05216406|455484418|FG001|Overall Study|Lost to Follow-up|9|||
126596996|NCT03711474|455484419|FG000|Overall Study|Physician Decision|2|||
126596997|NCT03711474|455484420|FG001|Overall Study|Physician Decision|0|||
126596998|NCT04690582|455484421|FG000|Overall Study|Withdrawal by Subject|6|||
126596999|NCT04690582|455484422|FG001|Overall Study|Withdrawal by Subject|4|||
126597000|NCT03625115|455484425|FG000|Overall Study|Withdrawal by Subject|4|||
126597001|NCT03625115|455484426|FG001|Overall Study|Withdrawal by Subject|7|||
126597002|NCT03625115|455484425|FG000|Overall Study|Lost to Follow-up|17|||
126597003|NCT03625115|455484426|FG001|Overall Study|Lost to Follow-up|24|||
126597004|NCT04101357|455484428|FG000|Overall Study|Death|1|||
126597005|NCT04101357|455484429|FG001|Overall Study|Death|1|||
126597006|NCT04101357|455484430|FG002|Overall Study|Death|1|||
126597007|NCT04101357|455484431|FG003|Overall Study|Death|2|||
126597008|NCT04101357|455484432|FG004|Overall Study|Death|4|||
126597009|NCT04101357|455484433|FG005|Overall Study|Death|11|||
126597010|NCT04101357|455484434|FG006|Overall Study|Death|4|||
126597011|NCT04101357|455484435|FG007|Overall Study|Death|4|||
126597012|NCT04101357|455484436|FG008|Overall Study|Death|5|||
126597013|NCT04101357|455484437|FG009|Overall Study|Death|2|||
126597014|NCT04101357|455484438|FG010|Overall Study|Death|3|||
126597015|NCT04101357|455484428|FG000|Overall Study|Trial closure|0|||
126597016|NCT04101357|455484429|FG001|Overall Study|Trial closure|0|||
126597017|NCT04101357|455484430|FG002|Overall Study|Trial closure|0|||
126732742|NCT03927911|455972239|FG003|Overall Study|Adverse Event|0|||
126732743|NCT03927911|455972240|FG004|Overall Study|Adverse Event|0|||
126732744|NCT03927911|455972241|FG005|Overall Study|Adverse Event|1|||
126732745|NCT03927911|455972236|FG000|Overall Study|not treated -study terminated by sponsor|0|||
126597018|NCT04101357|455484431|FG003|Overall Study|Trial closure|0|||
126597019|NCT04101357|455484432|FG004|Overall Study|Trial closure|0|||
126597020|NCT04101357|455484433|FG005|Overall Study|Trial closure|2|||
126597021|NCT04101357|455484434|FG006|Overall Study|Trial closure|2|||
126597022|NCT04101357|455484435|FG007|Overall Study|Trial closure|0|||
126597023|NCT04101357|455484436|FG008|Overall Study|Trial closure|0|||
126597024|NCT04101357|455484437|FG009|Overall Study|Trial closure|0|||
126597025|NCT04101357|455484438|FG010|Overall Study|Trial closure|1|||
126779391|NCT01261325|456146968|FG002|Overall Study|Lost to Follow-up|3|||
126779392|NCT01261325|456146966|FG000|Overall Study|AE, serious fatal|0|||
126779393|NCT01261325|456146967|FG001|Overall Study|AE, serious fatal|0|||
126779394|NCT01261325|456146968|FG002|Overall Study|AE, serious fatal|2|||
126779395|NCT03469271|456146973|FG000|Overall Study|Withdrawal by Subject|2|||
126779396|NCT03469271|456146974|FG001|Overall Study|Withdrawal by Subject|0|||
126779397|NCT03469271|456146975|FG002|Overall Study|Withdrawal by Subject|0|||
126779398|NCT03469271|456146976|FG003|Overall Study|Withdrawal by Subject|1|||
126779399|NCT01337050|456146984|FG000|Overall Study|Death|0|||
126779400|NCT01337050|456146985|FG001|Overall Study|Death|0|||
126779401|NCT01337050|456146986|FG002|Overall Study|Death|4|||
126779402|NCT01337050|456146984|FG000|Overall Study|Other|4|||
126779403|NCT01337050|456146985|FG001|Overall Study|Other|6|||
126779404|NCT01337050|456146986|FG002|Overall Study|Other|8|||
126779405|NCT01337050|456146984|FG000|Overall Study|Participants refused further follow-up|0|||
126779406|NCT01337050|456146985|FG001|Overall Study|Participants refused further follow-up|7|||
126779407|NCT01337050|456146986|FG002|Overall Study|Participants refused further follow-up|7|||
126779408|NCT00003102|456146987|FG000|Overall Study|Physician Decision|1|||
126779409|NCT00003102|456146988|FG001|Overall Study|Physician Decision|1|||
126779410|NCT00003102|456146989|FG002|Overall Study|Physician Decision|0|||
126779411|NCT00003102|456146987|FG000|Overall Study|Progressive Disease|0|||
126779412|NCT00003102|456146988|FG001|Overall Study|Progressive Disease|1|||
126779413|NCT00003102|456146989|FG002|Overall Study|Progressive Disease|0|||
126779414|NCT00003102|456146987|FG000|Overall Study|Adverse Event|0|||
126779415|NCT00003102|456146988|FG001|Overall Study|Adverse Event|1|||
126779416|NCT00003102|456146989|FG002|Overall Study|Adverse Event|1|||
126779417|NCT00003102|456146987|FG000|Overall Study|Death|0|||
126779418|NCT00003102|456146988|FG001|Overall Study|Death|0|||
126779419|NCT00003102|456146989|FG002|Overall Study|Death|1|||
126779420|NCT00583596|456146990|FG000|Overall Study|Lost to Follow-up|110|||
126779421|NCT00583596|456146990|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
126779422|NCT00583596|456146990|FG000|Overall Study|Death|2|||
126779423|NCT00583596|456146990|FG000|Overall Study|Withdrawal by Subject|6|||
126779424|NCT00583596|456146990|FG000|Overall Study|Lost to Follow-up|94|||
126779425|NCT00583596|456146990|FG000|Overall Study|Data not complete|1|||
126779426|NCT00583596|456146990|FG000|Overall Study|Not consented|15|||
126779427|NCT00583596|456146990|FG000|Overall Study|Outside f-up window|26|||
126779428|NCT00656019|456146991|FG000|Overall Study|Not Eligible|10|||
126779429|NCT00656019|456146992|FG001|Overall Study|Not Eligible|0|||
126779430|NCT00656019|456146993|FG002|Overall Study|Not Eligible|0|||
126779431|NCT00656019|456146994|FG003|Overall Study|Not Eligible|0|||
126779432|NCT00656019|456146991|FG000|Overall Study|Withdrawal by Subject|2|||
126779433|NCT00656019|456146992|FG001|Overall Study|Withdrawal by Subject|0|||
126779434|NCT00656019|456146993|FG002|Overall Study|Withdrawal by Subject|0|||
126779435|NCT00656019|456146994|FG003|Overall Study|Withdrawal by Subject|0|||
126779436|NCT00656019|456146991|FG000|Overall Study|Lost to Follow-up|2|||
126779437|NCT00656019|456146992|FG001|Overall Study|Lost to Follow-up|1|||
126779438|NCT00656019|456146993|FG002|Overall Study|Lost to Follow-up|0|||
126779439|NCT00656019|456146994|FG003|Overall Study|Lost to Follow-up|0|||
126779440|NCT00096486|456146995|FG000|Overall Study|Withdrawal by Subject|0|||
126779441|NCT00096486|456146996|FG001|Overall Study|Withdrawal by Subject|0|||
126779442|NCT00096486|456146997|FG002|Overall Study|Withdrawal by Subject|1|||
126779443|NCT00096486|456146998|FG003|Overall Study|Withdrawal by Subject|1|||
126779444|NCT00096486|456146995|FG000|Overall Study|Not Treated|0|||
126779445|NCT00096486|456146996|FG001|Overall Study|Not Treated|0|||
126779446|NCT00096486|456146997|FG002|Overall Study|Not Treated|1|||
126779447|NCT00096486|456146998|FG003|Overall Study|Not Treated|1|||
126779448|NCT03558997|456146999|FG000|Overall Study|Adverse Event|0|||
126779449|NCT03558997|456147000|FG001|Overall Study|Adverse Event|2|||
126779450|NCT03558997|456147001|FG002|Overall Study|Adverse Event|5|||
126779451|NCT03558997|456147002|FG003|Overall Study|Adverse Event|1|||
126779452|NCT03558997|456146999|FG000|Overall Study|Physician Decision|0|||
126779453|NCT03558997|456147000|FG001|Overall Study|Physician Decision|0|||
126779454|NCT03558997|456147001|FG002|Overall Study|Physician Decision|1|||
126779455|NCT03558997|456147002|FG003|Overall Study|Physician Decision|0|||
126597026|NCT04101357|455484428|FG000|Overall Study|Lost to Follow-up|0|||
126597027|NCT04101357|455484429|FG001|Overall Study|Lost to Follow-up|0|||
126779456|NCT03558997|456146999|FG000|Overall Study|Withdrawal by Subject|1|||
126779457|NCT03558997|456147000|FG001|Overall Study|Withdrawal by Subject|0|||
126779458|NCT03558997|456147001|FG002|Overall Study|Withdrawal by Subject|1|||
126779459|NCT03558997|456147002|FG003|Overall Study|Withdrawal by Subject|1|||
126779460|NCT03558997|456146999|FG000|Overall Study|Lost to Follow-up|0|||
126779461|NCT03558997|456147000|FG001|Overall Study|Lost to Follow-up|0|||
126779462|NCT03558997|456147001|FG002|Overall Study|Lost to Follow-up|1|||
126779463|NCT03558997|456147002|FG003|Overall Study|Lost to Follow-up|0|||
126779464|NCT02230085|456147005|FG000|Overall Study|Physician Decision|1|||
126779465|NCT02230085|456147005|FG000|Overall Study|Withdrawal by Subject|3|||
126779466|NCT01360632|456147011|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
126779467|NCT01360632|456147012|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
126779468|NCT01360632|456147013|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
126597028|NCT04101357|455484430|FG002|Overall Study|Lost to Follow-up|0|||
126597029|NCT04101357|455484431|FG003|Overall Study|Lost to Follow-up|1|||
126597030|NCT04101357|455484432|FG004|Overall Study|Lost to Follow-up|0|||
126597031|NCT04101357|455484433|FG005|Overall Study|Lost to Follow-up|0|||
126597032|NCT04101357|455484434|FG006|Overall Study|Lost to Follow-up|0|||
126597033|NCT04101357|455484435|FG007|Overall Study|Lost to Follow-up|1|||
126597034|NCT04101357|455484436|FG008|Overall Study|Lost to Follow-up|0|||
126597035|NCT04101357|455484437|FG009|Overall Study|Lost to Follow-up|0|||
126597036|NCT04101357|455484438|FG010|Overall Study|Lost to Follow-up|0|||
126597037|NCT04101357|455484428|FG000|Overall Study|Withdrawal by Subject|1|||
126597038|NCT04101357|455484429|FG001|Overall Study|Withdrawal by Subject|0|||
126732746|NCT03927911|455972237|FG001|Overall Study|not treated -study terminated by sponsor|1|||
126732747|NCT03927911|455972238|FG002|Overall Study|not treated -study terminated by sponsor|0|||
126732748|NCT03927911|455972239|FG003|Overall Study|not treated -study terminated by sponsor|0|||
126732749|NCT03927911|455972240|FG004|Overall Study|not treated -study terminated by sponsor|0|||
126732750|NCT03927911|455972241|FG005|Overall Study|not treated -study terminated by sponsor|0|||
126732751|NCT03927911|455972236|FG000|Overall Study|Surgery cancelled|0|||
126732752|NCT03927911|455972237|FG001|Overall Study|Surgery cancelled|0|||
126732753|NCT03927911|455972238|FG002|Overall Study|Surgery cancelled|0|||
126732754|NCT03927911|455972239|FG003|Overall Study|Surgery cancelled|1|||
126732755|NCT03927911|455972240|FG004|Overall Study|Surgery cancelled|0|||
126732756|NCT03927911|455972241|FG005|Overall Study|Surgery cancelled|1|||
126732757|NCT03927911|455972236|FG000|Overall Study|Protocol Violation|0|||
126732758|NCT03927911|455972237|FG001|Overall Study|Protocol Violation|0|||
126732759|NCT03927911|455972238|FG002|Overall Study|Protocol Violation|0|||
126732760|NCT03927911|455972239|FG003|Overall Study|Protocol Violation|0|||
126732761|NCT03927911|455972240|FG004|Overall Study|Protocol Violation|0|||
126732762|NCT03927911|455972241|FG005|Overall Study|Protocol Violation|1|||
126732763|NCT04432376|455972242|FG000|Double-blind Treatment Period|Adverse Event|2|||
126732764|NCT04432376|455972243|FG001|Double-blind Treatment Period|Adverse Event|6|||
126732765|NCT04432376|455972244|FG002|Double-blind Treatment Period|Adverse Event|0|||
126732766|NCT04432376|455972242|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
126732767|NCT04432376|455972243|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
126732768|NCT04432376|455972244|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
126732769|NCT04432376|455972242|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
126732770|NCT04432376|455972243|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
126732771|NCT04432376|455972244|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126732772|NCT04432376|455972242|FG000|Double-blind Treatment Period|Protocol Violation|0|||
126732773|NCT04432376|455972243|FG001|Double-blind Treatment Period|Protocol Violation|1|||
126732774|NCT04432376|455972244|FG002|Double-blind Treatment Period|Protocol Violation|0|||
126732775|NCT04432376|455972242|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
126732776|NCT04432376|455972243|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
126732777|NCT04432376|455972244|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
126732778|NCT04847141|455972245|FG000|Overall Study|Adverse Event|1|||
126732779|NCT04847141|455972246|FG001|Overall Study|Adverse Event|0|||
126732780|NCT04847141|455972247|FG002|Overall Study|Adverse Event|1|||
126732781|NCT04847141|455972245|FG000|Overall Study|Withdrawal by Subject|2|||
126732782|NCT04847141|455972246|FG001|Overall Study|Withdrawal by Subject|4|||
126732783|NCT04847141|455972247|FG002|Overall Study|Withdrawal by Subject|3|||
126732784|NCT04847141|455972245|FG000|Overall Study|Lost to Follow-up|7|||
126732785|NCT04847141|455972246|FG001|Overall Study|Lost to Follow-up|5|||
126732786|NCT04847141|455972247|FG002|Overall Study|Lost to Follow-up|7|||
126732787|NCT04847141|455972245|FG000|Overall Study|Reason not Specified|0|||
126732788|NCT04847141|455972246|FG001|Overall Study|Reason not Specified|1|||
126732789|NCT04847141|455972247|FG002|Overall Study|Reason not Specified|0|||
126732790|NCT04058158|455972248|FG000|Period 1|Death|1|||
126732791|NCT04058158|455972249|FG001|Period 1|Death|0|||
126732792|NCT04058158|455972248|FG000|Period 1|Adverse Event|1|||
126732793|NCT04058158|455972249|FG001|Period 1|Adverse Event|1|||
126732794|NCT04058158|455972248|FG000|Period 1|Pregnancy|0|||
126732795|NCT04058158|455972249|FG001|Period 1|Pregnancy|1|||
126732796|NCT01634113|455972250|FG000|Overall Study|Not treated|0|||
126732797|NCT01634113|455972251|FG001|Overall Study|Not treated|0|||
126732798|NCT01634113|455972252|FG002|Overall Study|Not treated|1|||
126732799|NCT00324740|455972253|FG000|Overall Study|Withdrawal by Subject|1|||
126732800|NCT00324740|455972254|FG001|Overall Study|Withdrawal by Subject|0|||
126732801|NCT00324740|455972255|FG002|Overall Study|Withdrawal by Subject|1|||
126732802|NCT02528253|455972258|FG000|Overall Study|Adverse Event|3|||
126732803|NCT02528253|455972259|FG001|Overall Study|Adverse Event|4|||
126732804|NCT02528253|455972260|FG002|Overall Study|Adverse Event|4|||
126597039|NCT04101357|455484430|FG002|Overall Study|Withdrawal by Subject|0|||
126597040|NCT04101357|455484431|FG003|Overall Study|Withdrawal by Subject|0|||
126732805|NCT02528253|455972261|FG003|Overall Study|Adverse Event|8|||
126732806|NCT02528253|455972262|FG004|Overall Study|Adverse Event|18|||
126732807|NCT02528253|455972258|FG000|Overall Study|Death|2|||
126597041|NCT04101357|455484432|FG004|Overall Study|Withdrawal by Subject|0|||
126597042|NCT04101357|455484433|FG005|Overall Study|Withdrawal by Subject|0|||
126597043|NCT04101357|455484434|FG006|Overall Study|Withdrawal by Subject|0|||
126597044|NCT04101357|455484435|FG007|Overall Study|Withdrawal by Subject|0|||
126597045|NCT04101357|455484436|FG008|Overall Study|Withdrawal by Subject|1|||
126597046|NCT04101357|455484437|FG009|Overall Study|Withdrawal by Subject|1|||
126597047|NCT04101357|455484438|FG010|Overall Study|Withdrawal by Subject|0|||
126597048|NCT04101357|455484428|FG000|Overall Study|Other|0|||
126597049|NCT04101357|455484429|FG001|Overall Study|Other|0|||
126597050|NCT04101357|455484430|FG002|Overall Study|Other|0|||
126597051|NCT04101357|455484431|FG003|Overall Study|Other|0|||
126597052|NCT04101357|455484432|FG004|Overall Study|Other|0|||
126597053|NCT04101357|455484433|FG005|Overall Study|Other|1|||
126597054|NCT04101357|455484434|FG006|Overall Study|Other|2|||
126597055|NCT04101357|455484435|FG007|Overall Study|Other|1|||
126597056|NCT04101357|455484436|FG008|Overall Study|Other|0|||
126597057|NCT04101357|455484437|FG009|Overall Study|Other|0|||
126597058|NCT04101357|455484438|FG010|Overall Study|Other|0|||
126597059|NCT04101357|455484428|FG000|Overall Study|Enrolled but not treated|0|||
126597060|NCT04101357|455484429|FG001|Overall Study|Enrolled but not treated|0|||
126597061|NCT04101357|455484430|FG002|Overall Study|Enrolled but not treated|0|||
126597062|NCT04101357|455484431|FG003|Overall Study|Enrolled but not treated|0|||
126597063|NCT04101357|455484432|FG004|Overall Study|Enrolled but not treated|0|||
126597064|NCT04101357|455484433|FG005|Overall Study|Enrolled but not treated|1|||
126597065|NCT04101357|455484434|FG006|Overall Study|Enrolled but not treated|1|||
126597066|NCT04101357|455484435|FG007|Overall Study|Enrolled but not treated|0|||
126597067|NCT04101357|455484436|FG008|Overall Study|Enrolled but not treated|0|||
126597068|NCT04101357|455484437|FG009|Overall Study|Enrolled but not treated|0|||
126597069|NCT04101357|455484438|FG010|Overall Study|Enrolled but not treated|0|||
126597070|NCT05868382|455484439|FG000|Overall Study|Lost to Follow-up|5|||
126597071|NCT05868382|455484440|FG001|Overall Study|Lost to Follow-up|0|||
126597072|NCT05868382|455484441|FG002|Overall Study|Lost to Follow-up|6|||
126597073|NCT05868382|455484442|FG003|Overall Study|Lost to Follow-up|4|||
126597074|NCT05868382|455484443|FG004|Overall Study|Lost to Follow-up|2|||
126597075|NCT05868382|455484444|FG005|Overall Study|Lost to Follow-up|6|||
126597076|NCT05868382|455484439|FG000|Overall Study|Withdrawal by Subject|1|||
126597077|NCT05868382|455484440|FG001|Overall Study|Withdrawal by Subject|0|||
126597078|NCT05868382|455484441|FG002|Overall Study|Withdrawal by Subject|0|||
126597079|NCT05868382|455484442|FG003|Overall Study|Withdrawal by Subject|0|||
126597080|NCT05868382|455484443|FG004|Overall Study|Withdrawal by Subject|1|||
126597081|NCT05868382|455484444|FG005|Overall Study|Withdrawal by Subject|0|||
126597082|NCT02497950|455484445|FG000|Overall Study|Death|209|||
126597083|NCT02497950|455484445|FG000|Overall Study|Transplanted|85|||
126597084|NCT02497950|455484445|FG000|Overall Study|Explanted|8|||
126597085|NCT02497950|455484445|FG000|Overall Study|Device Permanently Deactivated|4|||
126597086|NCT02497950|455484445|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
126597087|NCT02497950|455484445|FG000|Overall Study|Lost to Follow-up|6|||
126597088|NCT02497950|455484445|FG000|Overall Study|Withdrawal by Subject|2|||
126597089|NCT02497950|455484445|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
126597090|NCT02497950|455484445|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
126597091|NCT01236781|455484446|FG000|Overall Study|Ineligible|2|||
126597092|NCT01236781|455484447|FG001|Overall Study|Ineligible|1|||
126597093|NCT01236781|455484446|FG000|Overall Study|Did not complete study imaging|5|||
126597094|NCT01236781|455484447|FG001|Overall Study|Did not complete study imaging|0|||
126597095|NCT01009788|455484460|FG000|Overall Study|Withdrawal by Subject|1|||
126597096|NCT01009788|455484461|FG001|Overall Study|Withdrawal by Subject|0|||
126597097|NCT04308681|455484462|FG000|Pre-Treatment|Not reported|1|||
126597098|NCT04308681|455484463|FG001|Pre-Treatment|Not reported|1|||
126597099|NCT04308681|455484464|FG002|Pre-Treatment|Not reported|0|||
126597100|NCT04308681|455484465|FG003|Pre-Treatment|Not reported|0|||
126597101|NCT04308681|455484466|FG004|Pre-Treatment|Not reported|0|||
126597102|NCT04308681|455484467|FG005|Pre-Treatment|Not reported|2|||
126597103|NCT04308681|455484468|FG006|Pre-Treatment|Not reported|0|||
126597104|NCT04308681|455484469|FG007|Pre-Treatment|Not reported|0|||
126597105|NCT04308681|455484462|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
126597106|NCT04308681|455484463|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
126597107|NCT04308681|455484464|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
126597108|NCT04308681|455484465|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
126597109|NCT04308681|455484466|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
126597110|NCT04308681|455484467|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
126597111|NCT04308681|455484468|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
126597112|NCT04308681|455484469|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
126597113|NCT04308681|455484462|FG000|Treatment up to Week 26|Other reasons|2|||
126597114|NCT04308681|455484463|FG001|Treatment up to Week 26|Other reasons|0|||
126597115|NCT04308681|455484464|FG002|Treatment up to Week 26|Other reasons|0|||
126597116|NCT04308681|455484465|FG003|Treatment up to Week 26|Other reasons|0|||
126597117|NCT04308681|455484466|FG004|Treatment up to Week 26|Other reasons|1|||
126597118|NCT04308681|455484467|FG005|Treatment up to Week 26|Other reasons|1|||
126597119|NCT04308681|455484468|FG006|Treatment up to Week 26|Other reasons|0|||
126597120|NCT04308681|455484469|FG007|Treatment up to Week 26|Other reasons|0|||
126597121|NCT04308681|455484462|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
126597122|NCT04308681|455484463|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
126597123|NCT04308681|455484464|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
126597124|NCT04308681|455484465|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
126597125|NCT04308681|455484466|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
126597126|NCT04308681|455484467|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
126597127|NCT04308681|455484468|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
126597128|NCT04308681|455484469|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
126597129|NCT04308681|455484462|FG000|Treatment up to Week 26|Adverse Event|6|||
126597130|NCT04308681|455484463|FG001|Treatment up to Week 26|Adverse Event|5|||
126597131|NCT04308681|455484464|FG002|Treatment up to Week 26|Adverse Event|5|||
126597132|NCT04308681|455484465|FG003|Treatment up to Week 26|Adverse Event|0|||
126597133|NCT04308681|455484466|FG004|Treatment up to Week 26|Adverse Event|6|||
126597134|NCT04308681|455484467|FG005|Treatment up to Week 26|Adverse Event|1|||
126597135|NCT04308681|455484468|FG006|Treatment up to Week 26|Adverse Event|0|||
126597136|NCT04308681|455484469|FG007|Treatment up to Week 26|Adverse Event|0|||
126597137|NCT04308681|455484462|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
126597138|NCT04308681|455484463|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
126597139|NCT04308681|455484464|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
126597140|NCT04308681|455484465|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
126597141|NCT04308681|455484466|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
126597142|NCT04308681|455484467|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
126597143|NCT04308681|455484468|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
126597144|NCT04308681|455484469|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
126597145|NCT04308681|455484462|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
126597146|NCT04308681|455484463|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
126597147|NCT04308681|455484464|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
126597148|NCT04308681|455484465|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
126597149|NCT04308681|455484466|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
126597150|NCT04308681|455484467|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
126597151|NCT04308681|455484468|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
126597152|NCT04308681|455484469|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
126597153|NCT04308681|455484462|FG000|OTE - 26 Weeks|Death|0|||
126597154|NCT04308681|455484463|FG001|OTE - 26 Weeks|Death|1|||
126597155|NCT04308681|455484464|FG002|OTE - 26 Weeks|Death|0|||
126597156|NCT04308681|455484465|FG003|OTE - 26 Weeks|Death|0|||
126597157|NCT04308681|455484466|FG004|OTE - 26 Weeks|Death|0|||
126597158|NCT04308681|455484467|FG005|OTE - 26 Weeks|Death|0|||
126597159|NCT04308681|455484468|FG006|OTE - 26 Weeks|Death|1|||
126597160|NCT04308681|455484469|FG007|OTE - 26 Weeks|Death|0|||
126597161|NCT04308681|455484462|FG000|OTE - 26 Weeks|Adverse Event|0|||
126597162|NCT04308681|455484463|FG001|OTE - 26 Weeks|Adverse Event|2|||
126597163|NCT04308681|455484464|FG002|OTE - 26 Weeks|Adverse Event|8|||
126597164|NCT04308681|455484465|FG003|OTE - 26 Weeks|Adverse Event|3|||
126597165|NCT04308681|455484466|FG004|OTE - 26 Weeks|Adverse Event|0|||
126597166|NCT04308681|455484467|FG005|OTE - 26 Weeks|Adverse Event|1|||
126597167|NCT04308681|455484468|FG006|OTE - 26 Weeks|Adverse Event|2|||
126597168|NCT04308681|455484469|FG007|OTE - 26 Weeks|Adverse Event|0|||
126597169|NCT04308681|455484462|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
126597170|NCT04308681|455484463|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
126597171|NCT04308681|455484464|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
126597172|NCT04308681|455484465|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
126597173|NCT04308681|455484466|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
126597174|NCT04308681|455484467|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
126597175|NCT04308681|455484468|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
126597176|NCT04308681|455484469|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
126597177|NCT05565820|455484470|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
126597178|NCT05565820|455484471|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
126597179|NCT05565820|455484470|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
126597180|NCT05565820|455484471|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
126597181|NCT03556293|455484473|FG000|Overall Study|Ineligible for analysis|1904|||
126597182|NCT03556293|455484474|FG001|Overall Study|Ineligible for analysis|1471|||
126597183|NCT03556293|455484475|FG002|Overall Study|Ineligible for analysis|1091|||
126597184|NCT03556293|455484476|FG003|Overall Study|Ineligible for analysis|1269|||
126597185|NCT05828017|455484477|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
126597186|NCT03209973|455485577|FG000|Overall Study|Withdrawal by Subject|7|||
126597187|NCT03209973|455485577|FG000|Overall Study|Lost to Follow-up|2|||
126597188|NCT03209973|455485577|FG000|Overall Study|Death|8|||
126597189|NCT03209973|455485577|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
126597190|NCT03209973|455485577|FG000|Overall Study|Sponsor Decision|18|||
126597191|NCT03209973|455485577|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
126597192|NCT03209973|455485577|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
126597193|NCT04797195|455485578|FG000|Overall Study|Death|8|||
126597194|NCT04797195|455485579|FG001|Overall Study|Death|15|||
126597195|NCT04797195|455485578|FG000|Overall Study|Change from PD|15|||
126597196|NCT04797195|455485579|FG001|Overall Study|Change from PD|15|||
126597197|NCT04797195|455485578|FG000|Overall Study|Withdrawal by Subject|3|||
126597198|NCT04797195|455485579|FG001|Overall Study|Withdrawal by Subject|2|||
126597199|NCT02296684|455485580|FG000|Overall Study|Withdrawal by Subject|0|||
126597200|NCT02296684|455485581|FG001|Overall Study|Withdrawal by Subject|1|||
126597201|NCT02296684|455485582|FG002|Overall Study|Withdrawal by Subject|1|||
126597202|NCT02296684|455485580|FG000|Overall Study|Death|2|||
126597203|NCT02296684|455485581|FG001|Overall Study|Death|0|||
126597204|NCT02296684|455485582|FG002|Overall Study|Death|0|||
126597205|NCT00429364|455485585|FG000|Overall Study|Withdrawal by Subject|11|||
126597206|NCT00429364|455485586|FG001|Overall Study|Withdrawal by Subject|5|||
126597207|NCT00429364|455485585|FG000|Overall Study|Physician Decision|4|||
126597208|NCT00429364|455485586|FG001|Overall Study|Physician Decision|2|||
126597209|NCT00429364|455485585|FG000|Overall Study|Lost to Follow-up|7|||
126597210|NCT00429364|455485586|FG001|Overall Study|Lost to Follow-up|6|||
126597211|NCT00429364|455485585|FG000|Overall Study|Death|0|||
126597212|NCT00429364|455485586|FG001|Overall Study|Death|1|||
126597213|NCT00429364|455485585|FG000|Overall Study|Underwent aortic root surgery|10|||
126597214|NCT00429364|455485586|FG001|Overall Study|Underwent aortic root surgery|18|||
126597215|NCT00429364|455485585|FG000|Overall Study|Pregnancy|0|||
126597216|NCT00429364|455485586|FG001|Overall Study|Pregnancy|1|||
126597217|NCT04871529|455485587|FG000|Overall Study|Withdrawal by Subject|0|||
126597218|NCT04871529|455485588|FG001|Overall Study|Withdrawal by Subject|1|||
126597219|NCT04871529|455485587|FG000|Overall Study|Death|0|||
126597220|NCT04871529|455485588|FG001|Overall Study|Death|1|||
126597221|NCT04871529|455485587|FG000|Overall Study|Not protocol specified|0|||
126597222|NCT04871529|455485588|FG001|Overall Study|Not protocol specified|1|||
126597223|NCT04786119|455485589|FG000|Overall Study|Withdrawal by Subject|2|||
126597224|NCT05012163|455485596|FG000|Overall Study|Protocol Violation|0|||
126597225|NCT05012163|455485597|FG001|Overall Study|Protocol Violation|0|||
126597226|NCT05012163|455485598|FG002|Overall Study|Protocol Violation|1|||
126597227|NCT05012163|455485599|FG003|Overall Study|Protocol Violation|1|||
126597228|NCT05076266|455485600|FG000|Overall Study|Survey not complete - Participant refusal|2|||
126597229|NCT05076266|455485601|FG001|Overall Study|Survey not complete - Participant refusal|0|||
126597230|NCT04003246|455485604|FG000|Overall Study|Death|9|||
126597231|NCT04132518|455485612|FG000|Overall Study|Prematurely withdrawn from the study|0|||
126597232|NCT04132518|455485613|FG001|Overall Study|Prematurely withdrawn from the study|9|||
126597233|NCT04132518|455485614|FG002|Overall Study|Prematurely withdrawn from the study|1|||
126597234|NCT05524402|455485616|FG000|Overall Study|Withdrawal by Subject|3|||
126597235|NCT05524402|455485617|FG001|Overall Study|Withdrawal by Subject|1|||
126597236|NCT05524402|455485616|FG000|Overall Study|Lost to Follow-up|2|||
126597237|NCT05524402|455485617|FG001|Overall Study|Lost to Follow-up|1|||
126597238|NCT04428203|455485618|FG000|Overall Study|Adverse Event|1|||
126597239|NCT04428203|455485619|FG001|Overall Study|Adverse Event|0|||
126597240|NCT04428203|455485620|FG002|Overall Study|Adverse Event|0|||
126597241|NCT04428203|455485618|FG000|Overall Study|Withdrawal by Subject|1|||
126597242|NCT04428203|455485619|FG001|Overall Study|Withdrawal by Subject|0|||
126597243|NCT04428203|455485620|FG002|Overall Study|Withdrawal by Subject|1|||
126597244|NCT05237284|455485625|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
126597245|NCT05237284|455485626|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
126597246|NCT05237284|455485627|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
126597247|NCT05237284|455485628|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
126597248|NCT05237284|455485625|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
126597249|NCT05237284|455485626|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
126597250|NCT05237284|455485627|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
126597251|NCT05237284|455485628|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
126597252|NCT05237284|455485625|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
126597253|NCT05237284|455485626|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
126597254|NCT05237284|455485627|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
126597255|NCT05237284|455485628|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
126597256|NCT05237284|455485625|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
126597257|NCT05237284|455485626|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
126597258|NCT05237284|455485627|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
126597259|NCT05237284|455485628|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
126597260|NCT05237284|455485625|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
126597261|NCT05237284|455485626|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
126597262|NCT05237284|455485627|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
126597263|NCT05237284|455485628|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
126597264|NCT05237284|455485625|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
126597265|NCT05237284|455485626|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
126597266|NCT05237284|455485627|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
126597267|NCT05237284|455485628|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
126597268|NCT05237284|455485625|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
126597269|NCT05237284|455485626|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
126597270|NCT05237284|455485627|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
126597271|NCT05237284|455485628|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
126597272|NCT05237284|455485625|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
126597273|NCT05237284|455485626|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
126597274|NCT05237284|455485627|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
126597275|NCT05237284|455485628|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
126597276|NCT05237284|455485625|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
126597277|NCT05237284|455485626|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
126597278|NCT05237284|455485627|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
126597279|NCT05237284|455485628|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
126597280|NCT03733925|455485632|FG000|Overall Study|Lost to Follow-up|1|||
126597281|NCT03733925|455485632|FG000|Overall Study|Withdrawal by Subject|2|||
126597282|NCT03733925|455485632|FG000|Overall Study|Adverse Event|2|||
126597283|NCT03733925|455485632|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126597284|NCT03213873|455485633|FG000|Overall Study|Withdrawal by Subject|8|||
126597285|NCT03213873|455485634|FG001|Overall Study|Withdrawal by Subject|9|||
126597286|NCT03213873|455485633|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
126597287|NCT03213873|455485634|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
126597288|NCT03213873|455485633|FG000|Overall Study|Lost to Follow-up|0|||
126597289|NCT03213873|455485634|FG001|Overall Study|Lost to Follow-up|2|||
126597290|NCT02361216|455485640|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
126597291|NCT02361216|455485641|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
126597292|NCT02361216|455485640|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
126597293|NCT02361216|455485641|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
126597294|NCT02361216|455485640|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
126597295|NCT02361216|455485641|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
126597296|NCT02361216|455485640|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
126597297|NCT02361216|455485641|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
126597298|NCT02361216|455485640|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
126597299|NCT02361216|455485641|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
126597300|NCT02361216|455485640|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
126597301|NCT02361216|455485641|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
126597302|NCT02852655|455485649|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
126597303|NCT02852655|455485650|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
126597304|NCT02852655|455485651|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
126597305|NCT02852655|455485649|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
126597306|NCT02852655|455485650|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
126597307|NCT02852655|455485651|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
126597308|NCT02852655|455485649|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
126597309|NCT02852655|455485650|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
126597310|NCT02852655|455485651|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
126597311|NCT02852655|455485649|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
126597312|NCT02852655|455485650|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
126597313|NCT02852655|455485651|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
126597314|NCT02852655|455485649|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
126597315|NCT02852655|455485650|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
126597316|NCT02852655|455485651|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
126597317|NCT02852655|455485649|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
126597318|NCT02852655|455485650|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
126597319|NCT02852655|455485651|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
126597320|NCT02852655|455485649|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
126597321|NCT02852655|455485650|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
126597322|NCT02852655|455485651|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
126597323|NCT02852655|455485649|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
126597324|NCT02852655|455485650|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
126779469|NCT01360632|456147014|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
126779470|NCT01360632|456147015|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
126779471|NCT01360632|456147011|FG000|Phase A (8 Weeks)|Adverse Event|60|||
126779472|NCT01360632|456147012|FG001|Phase A (8 Weeks)|Adverse Event|0|||
126779473|NCT01360632|456147013|FG002|Phase A (8 Weeks)|Adverse Event|0|||
126779474|NCT01360632|456147014|FG003|Phase A (8 Weeks)|Adverse Event|0|||
126779475|NCT01360632|456147015|FG004|Phase A (8 Weeks)|Adverse Event|0|||
126779476|NCT01360632|456147011|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
126779477|NCT01360632|456147012|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
126779478|NCT01360632|456147013|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
126779479|NCT01360632|456147014|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
126779480|NCT01360632|456147015|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
126779481|NCT01360632|456147011|FG000|Phase A (8 Weeks)|Physician Decision|10|||
126779482|NCT01360632|456147012|FG001|Phase A (8 Weeks)|Physician Decision|0|||
126779483|NCT01360632|456147013|FG002|Phase A (8 Weeks)|Physician Decision|0|||
126779484|NCT01360632|456147014|FG003|Phase A (8 Weeks)|Physician Decision|0|||
126779485|NCT01360632|456147015|FG004|Phase A (8 Weeks)|Physician Decision|0|||
126779486|NCT01360632|456147011|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
126779487|NCT01360632|456147012|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
126779488|NCT01360632|456147013|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
126779489|NCT01360632|456147014|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
126779490|NCT01360632|456147015|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
126779491|NCT01360632|456147011|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
126779492|NCT01360632|456147012|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
126779493|NCT01360632|456147013|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
126779494|NCT01360632|456147014|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
126779495|NCT01360632|456147015|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
126779496|NCT01360632|456147011|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
126779497|NCT01360632|456147012|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
126779498|NCT01360632|456147013|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
126779499|NCT01360632|456147014|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
126779500|NCT01360632|456147015|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
126779501|NCT01360632|456147011|FG000|Phase B (6 Weeks)|Adverse Event|0|||
126779502|NCT01360632|456147012|FG001|Phase B (6 Weeks)|Adverse Event|3|||
126779503|NCT01360632|456147013|FG002|Phase B (6 Weeks)|Adverse Event|9|||
126779504|NCT01360632|456147014|FG003|Phase B (6 Weeks)|Adverse Event|3|||
126779505|NCT01360632|456147015|FG004|Phase B (6 Weeks)|Adverse Event|0|||
126779506|NCT01360632|456147011|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
126779507|NCT01360632|456147012|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
126779508|NCT01360632|456147013|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
126779509|NCT01360632|456147014|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
126597325|NCT02852655|455485651|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
126597326|NCT02852655|455485649|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
126597327|NCT02852655|455485650|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
126779510|NCT01360632|456147015|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
126779511|NCT01360632|456147011|FG000|Phase B (6 Weeks)|Physician Decision|0|||
126779512|NCT01360632|456147012|FG001|Phase B (6 Weeks)|Physician Decision|0|||
126779513|NCT01360632|456147013|FG002|Phase B (6 Weeks)|Physician Decision|0|||
126779514|NCT01360632|456147014|FG003|Phase B (6 Weeks)|Physician Decision|1|||
126779515|NCT01360632|456147015|FG004|Phase B (6 Weeks)|Physician Decision|0|||
126779516|NCT01360632|456147011|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
126779517|NCT01360632|456147012|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
126779518|NCT01360632|456147013|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
126779519|NCT01360632|456147014|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
126779520|NCT01360632|456147015|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
126779521|NCT01360632|456147011|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
126779522|NCT01360632|456147012|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
126779523|NCT01360632|456147013|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
126779524|NCT01360632|456147014|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
126779525|NCT01360632|456147015|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
126597328|NCT02852655|455485651|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
126597329|NCT04544007|455485656|FG000|Overall Study|Withdrawal by Subject|1|||
126597330|NCT04544007|455485656|FG000|Overall Study|Confirmed Progressive Disease|1|||
126597331|NCT02988661|455485657|FG000|Overall Study|Death|2|||
126779526|NCT01360632|456147011|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
126597332|NCT02988661|455485658|FG001|Overall Study|Death|18|||
126597333|NCT02988661|455485657|FG000|Overall Study|Lost to Follow-up|0|||
126597334|NCT02988661|455485658|FG001|Overall Study|Lost to Follow-up|33|||
126779527|NCT01360632|456147012|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
126779528|NCT01360632|456147013|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
126779529|NCT01360632|456147014|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
126779530|NCT01360632|456147015|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
126779531|NCT01360632|456147011|FG000|Phase A+|Lost to Follow-up|0|||
126779532|NCT01360632|456147012|FG001|Phase A+|Lost to Follow-up|0|||
126779533|NCT01360632|456147013|FG002|Phase A+|Lost to Follow-up|0|||
126779534|NCT01360632|456147014|FG003|Phase A+|Lost to Follow-up|0|||
126779535|NCT01360632|456147015|FG004|Phase A+|Lost to Follow-up|2|||
126597335|NCT02988661|455485657|FG000|Overall Study|Withdrawal by Subject|0|||
126597336|NCT02988661|455485658|FG001|Overall Study|Withdrawal by Subject|6|||
126597337|NCT02988661|455485657|FG000|Overall Study|Unable to complete the 18-month survey|1|||
126597338|NCT02988661|455485658|FG001|Overall Study|Unable to complete the 18-month survey|27|||
126597339|NCT02413489|455485675|FG000|Overall Study|Death|11|||
126597340|NCT02413489|455485676|FG001|Overall Study|Death|3|||
126597341|NCT02413489|455485677|FG002|Overall Study|Death|4|||
126597342|NCT02413489|455485675|FG000|Overall Study|Withdrawal by Subject|2|||
126597343|NCT02413489|455485676|FG001|Overall Study|Withdrawal by Subject|0|||
126597344|NCT02413489|455485677|FG002|Overall Study|Withdrawal by Subject|0|||
126597345|NCT02413489|455485675|FG000|Overall Study|Study Terminated By Sponsor|2|||
126597346|NCT02413489|455485676|FG001|Overall Study|Study Terminated By Sponsor|13|||
126597347|NCT02413489|455485677|FG002|Overall Study|Study Terminated By Sponsor|1|||
126597348|NCT02575950|455485678|FG000|Overall Study|Withdrawal by Subject|0|||
126597349|NCT02575950|455485679|FG001|Overall Study|Withdrawal by Subject|0|||
126597350|NCT02575950|455485680|FG002|Overall Study|Withdrawal by Subject|0|||
126597351|NCT02575950|455485681|FG003|Overall Study|Withdrawal by Subject|2|||
126597352|NCT02575950|455485678|FG000|Overall Study|Lost to Follow-up|0|||
126597353|NCT02575950|455485679|FG001|Overall Study|Lost to Follow-up|1|||
126597354|NCT02575950|455485680|FG002|Overall Study|Lost to Follow-up|0|||
126597355|NCT02575950|455485681|FG003|Overall Study|Lost to Follow-up|3|||
126597356|NCT05645757|455487958|FG000|Overall Study|Enrolled but treatment not administered|0|||
126597357|NCT05645757|455487959|FG001|Overall Study|Enrolled but treatment not administered|0|||
126597358|NCT05645757|455487960|FG002|Overall Study|Enrolled but treatment not administered|0|||
126597359|NCT05645757|455487961|FG003|Overall Study|Enrolled but treatment not administered|0|||
126597360|NCT05645757|455487962|FG004|Overall Study|Enrolled but treatment not administered|1|||
126597361|NCT05645757|455487963|FG005|Overall Study|Enrolled but treatment not administered|1|||
126597362|NCT05645757|455487964|FG006|Overall Study|Enrolled but treatment not administered|0|||
126597363|NCT05645757|455487965|FG007|Overall Study|Enrolled but treatment not administered|0|||
126597364|NCT03924635|455487966|FG000|Overall Study|Withdrawal by Subject|2|||
126597365|NCT03924635|455487967|FG001|Overall Study|Withdrawal by Subject|4|||
126597366|NCT00539591|455487968|FG000|Overall Study|Toxicity|3|||
126597367|NCT00539591|455487969|FG001|Overall Study|Toxicity|0|||
126597368|NCT00539591|455487970|FG002|Overall Study|Toxicity|0|||
126597369|NCT00539591|455487968|FG000|Overall Study|Disease progression|2|||
126597370|NCT00539591|455487969|FG001|Overall Study|Disease progression|2|||
126597371|NCT00539591|455487970|FG002|Overall Study|Disease progression|3|||
126597372|NCT01960452|455487971|FG000|Overall Study|Withdrawal by Subject|2|||
126597373|NCT01960452|455487972|FG001|Overall Study|Withdrawal by Subject|1|||
126597374|NCT01960452|455487971|FG000|Overall Study|Sleep apnea in Night 1|1|||
126597375|NCT01960452|455487972|FG001|Overall Study|Sleep apnea in Night 1|0|||
126597376|NCT01960452|455487971|FG000|Overall Study|Poor Sleep in Night 1|0|||
126597377|NCT01960452|455487972|FG001|Overall Study|Poor Sleep in Night 1|2|||
126597378|NCT01960452|455487971|FG000|Overall Study|No Sex/Age Match Night 1|1|||
126597379|NCT01960452|455487972|FG001|Overall Study|No Sex/Age Match Night 1|0|||
126597380|NCT01960452|455487971|FG000|Overall Study|No Sex/Age Match Night 2|0|||
126597381|NCT01960452|455487972|FG001|Overall Study|No Sex/Age Match Night 2|2|||
126597382|NCT01960452|455487971|FG000|Overall Study|Technical Difficulties Night 2|2|||
126597383|NCT01960452|455487972|FG001|Overall Study|Technical Difficulties Night 2|0|||
126597384|NCT04414722|455487973|FG000|Overall Study|Lost to Follow-up|3|||
126597385|NCT04414722|455487974|FG001|Overall Study|Lost to Follow-up|4|||
126597386|NCT04414722|455487975|FG002|Overall Study|Lost to Follow-up|3|||
126597387|NCT04414722|455487976|FG003|Overall Study|Lost to Follow-up|2|||
126597388|NCT04414722|455487977|FG004|Overall Study|Lost to Follow-up|3|||
126597389|NCT04414722|455487973|FG000|Overall Study|Withdrawal by Subject|6|||
126597390|NCT04414722|455487974|FG001|Overall Study|Withdrawal by Subject|3|||
126597391|NCT04414722|455487975|FG002|Overall Study|Withdrawal by Subject|1|||
126732808|NCT02528253|455972259|FG001|Overall Study|Death|2|||
126732809|NCT02528253|455972260|FG002|Overall Study|Death|1|||
126732810|NCT02528253|455972261|FG003|Overall Study|Death|0|||
126732811|NCT02528253|455972262|FG004|Overall Study|Death|1|||
126732812|NCT02528253|455972258|FG000|Overall Study|Insufficient clinical response|7|||
126732813|NCT02528253|455972259|FG001|Overall Study|Insufficient clinical response|10|||
126732814|NCT02528253|455972260|FG002|Overall Study|Insufficient clinical response|13|||
126732815|NCT02528253|455972261|FG003|Overall Study|Insufficient clinical response|12|||
126732816|NCT02528253|455972262|FG004|Overall Study|Insufficient clinical response|16|||
126597392|NCT04414722|455487976|FG003|Overall Study|Withdrawal by Subject|5|||
126732817|NCT02528253|455972258|FG000|Overall Study|Lost to Follow-up|16|||
126597393|NCT04414722|455487977|FG004|Overall Study|Withdrawal by Subject|1|||
126597394|NCT04414722|455487973|FG000|Overall Study|Physician Decision|0|||
126597395|NCT04414722|455487974|FG001|Overall Study|Physician Decision|1|||
126597396|NCT04414722|455487975|FG002|Overall Study|Physician Decision|2|||
126597397|NCT04414722|455487976|FG003|Overall Study|Physician Decision|0|||
126597398|NCT04414722|455487977|FG004|Overall Study|Physician Decision|0|||
126597399|NCT04414722|455487973|FG000|Overall Study|Non-participatory|0|||
126597400|NCT04414722|455487974|FG001|Overall Study|Non-participatory|1|||
126597401|NCT04414722|455487975|FG002|Overall Study|Non-participatory|1|||
126597402|NCT04414722|455487976|FG003|Overall Study|Non-participatory|0|||
126597403|NCT04414722|455487977|FG004|Overall Study|Non-participatory|0|||
126597404|NCT05218096|455487978|FG000|Primary Evaluation|Withdrawal by Subject|0|||
126597405|NCT05218096|455487979|FG001|Primary Evaluation|Withdrawal by Subject|0|||
126597406|NCT05218096|455487980|FG002|Primary Evaluation|Withdrawal by Subject|2|||
126597407|NCT05218096|455487981|FG003|Primary Evaluation|Withdrawal by Subject|0|||
126597408|NCT05218096|455487982|FG004|Primary Evaluation|Withdrawal by Subject|0|||
126597409|NCT05218096|455487978|FG000|Primary Evaluation|Physician Decision|1|||
126597410|NCT05218096|455487979|FG001|Primary Evaluation|Physician Decision|0|||
126597411|NCT05218096|455487980|FG002|Primary Evaluation|Physician Decision|0|||
126597412|NCT05218096|455487981|FG003|Primary Evaluation|Physician Decision|0|||
126597413|NCT05218096|455487982|FG004|Primary Evaluation|Physician Decision|0|||
126597414|NCT05218096|455487978|FG000|Extended Treatment|Clinical Deterioration|1|||
126597415|NCT05218096|455487979|FG001|Extended Treatment|Clinical Deterioration|1|||
126597416|NCT05218096|455487980|FG002|Extended Treatment|Clinical Deterioration|0|||
126597417|NCT05218096|455487981|FG003|Extended Treatment|Clinical Deterioration|0|||
126597418|NCT05218096|455487982|FG004|Extended Treatment|Clinical Deterioration|0|||
126597419|NCT05218096|455487978|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
126597420|NCT05218096|455487979|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
126597421|NCT05218096|455487980|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
126597422|NCT05218096|455487981|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
126597423|NCT05218096|455487982|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
126597424|NCT05218096|455487978|FG000|Extended Treatment|Withdrawal by Subject|1|||
126597425|NCT05218096|455487979|FG001|Extended Treatment|Withdrawal by Subject|3|||
126597426|NCT05218096|455487980|FG002|Extended Treatment|Withdrawal by Subject|0|||
126597427|NCT05218096|455487981|FG003|Extended Treatment|Withdrawal by Subject|2|||
126597428|NCT05218096|455487982|FG004|Extended Treatment|Withdrawal by Subject|2|||
126597429|NCT05218096|455487978|FG000|Extended Treatment|Lack of Efficacy|3|||
126597430|NCT05218096|455487979|FG001|Extended Treatment|Lack of Efficacy|0|||
126597431|NCT05218096|455487980|FG002|Extended Treatment|Lack of Efficacy|0|||
126597432|NCT05218096|455487981|FG003|Extended Treatment|Lack of Efficacy|0|||
126597433|NCT05218096|455487982|FG004|Extended Treatment|Lack of Efficacy|0|||
126597434|NCT05218096|455487978|FG000|Extended Treatment|Physician Decision|0|||
126597435|NCT05218096|455487979|FG001|Extended Treatment|Physician Decision|1|||
126597436|NCT05218096|455487980|FG002|Extended Treatment|Physician Decision|0|||
126597437|NCT05218096|455487981|FG003|Extended Treatment|Physician Decision|0|||
126597438|NCT05218096|455487982|FG004|Extended Treatment|Physician Decision|0|||
126597439|NCT05218096|455487978|FG000|Open-label Extension|Adverse Event|1|||
126597440|NCT05218096|455487979|FG001|Open-label Extension|Adverse Event|0|||
126597441|NCT05218096|455487980|FG002|Open-label Extension|Adverse Event|0|||
126597442|NCT05218096|455487981|FG003|Open-label Extension|Adverse Event|0|||
126597443|NCT05218096|455487982|FG004|Open-label Extension|Adverse Event|1|||
126597444|NCT05218096|455487978|FG000|Open-label Extension|Pregnancy|0|||
126597445|NCT05218096|455487979|FG001|Open-label Extension|Pregnancy|0|||
126597446|NCT05218096|455487980|FG002|Open-label Extension|Pregnancy|0|||
126597447|NCT05218096|455487981|FG003|Open-label Extension|Pregnancy|0|||
126597448|NCT05218096|455487982|FG004|Open-label Extension|Pregnancy|1|||
126597449|NCT05218096|455487978|FG000|Open-label Extension|Lack of Efficacy|1|||
126597450|NCT05218096|455487979|FG001|Open-label Extension|Lack of Efficacy|2|||
126597451|NCT05218096|455487980|FG002|Open-label Extension|Lack of Efficacy|0|||
126597452|NCT05218096|455487981|FG003|Open-label Extension|Lack of Efficacy|0|||
126597453|NCT05218096|455487982|FG004|Open-label Extension|Lack of Efficacy|0|||
126597454|NCT05218096|455487978|FG000|Open-label Extension|Lost to Follow-up|1|||
126597455|NCT05218096|455487979|FG001|Open-label Extension|Lost to Follow-up|0|||
126597456|NCT05218096|455487980|FG002|Open-label Extension|Lost to Follow-up|0|||
126597457|NCT05218096|455487981|FG003|Open-label Extension|Lost to Follow-up|0|||
126597458|NCT05218096|455487982|FG004|Open-label Extension|Lost to Follow-up|0|||
126597459|NCT05218096|455487978|FG000|Open-label Extension|Death|0|||
126597460|NCT05218096|455487979|FG001|Open-label Extension|Death|0|||
126597461|NCT05218096|455487980|FG002|Open-label Extension|Death|0|||
126597462|NCT05218096|455487981|FG003|Open-label Extension|Death|1|||
126597463|NCT05218096|455487982|FG004|Open-label Extension|Death|0|||
126597464|NCT05218096|455487978|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
126597465|NCT05218096|455487979|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
126597466|NCT05218096|455487980|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
126597467|NCT05218096|455487981|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
126597468|NCT05218096|455487982|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
126597469|NCT04660539|455487993|FG000|Overall Study|Adverse Event|10|||
126597470|NCT04660539|455487993|FG000|Overall Study|Lack of Efficacy|4|||
126597471|NCT04660539|455487993|FG000|Overall Study|Lost to Follow-up|5|||
126597472|NCT04660539|455487993|FG000|Overall Study|Non-Compliance With Study Drug|3|||
126597473|NCT04660539|455487993|FG000|Overall Study|Reason not Specified|12|||
126597474|NCT04660539|455487993|FG000|Overall Study|Pregnancy|2|||
126597475|NCT04660539|455487993|FG000|Overall Study|Protocol Violation|2|||
126597476|NCT04660539|455487993|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
126597477|NCT04660539|455487993|FG000|Overall Study|Withdrawal by Subject|21|||
126597478|NCT03655028|455487996|FG000|12-weeks Follow up|Death|1|||
126597479|NCT03655028|455487997|FG001|12-weeks Follow up|Death|0|||
126597480|NCT03655028|455487996|FG000|12-weeks Follow up|Physician Decision|3|||
126597481|NCT03655028|455487997|FG001|12-weeks Follow up|Physician Decision|3|||
126597482|NCT03655028|455487996|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
126597483|NCT03655028|455487997|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
126597484|NCT03655028|455487996|FG000|12-weeks Follow up|Lost to Follow-up|4|||
126597485|NCT03655028|455487997|FG001|12-weeks Follow up|Lost to Follow-up|4|||
126597486|NCT03655028|455487996|FG000|24-weeks|Lost to Follow-up|1|||
126597487|NCT03655028|455487997|FG001|24-weeks|Lost to Follow-up|1|||
126597488|NCT03655028|455487996|FG000|24-weeks|Death|0|||
126597489|NCT03655028|455487997|FG001|24-weeks|Death|1|||
126597490|NCT03513302|455487998|FG000|First Intervention (14 Days)|Screen failure|15|||
126597491|NCT03513302|455487999|FG001|First Intervention (14 Days)|Screen failure|16|||
126597492|NCT05256654|455488000|FG000|Overall Study|Adverse Event|0|||
126597493|NCT05256654|455488001|FG001|Overall Study|Adverse Event|0|||
126597494|NCT05256654|455488002|FG002|Overall Study|Adverse Event|1|||
126597495|NCT05256654|455488003|FG003|Overall Study|Adverse Event|0|||
126597496|NCT05256654|455488000|FG000|Overall Study|Lost to Follow-up|0|||
126597497|NCT05256654|455488001|FG001|Overall Study|Lost to Follow-up|0|||
126597498|NCT05256654|455488002|FG002|Overall Study|Lost to Follow-up|0|||
126597499|NCT05256654|455488003|FG003|Overall Study|Lost to Follow-up|1|||
126597500|NCT05256654|455488000|FG000|Overall Study|Withdrawal by Subject|1|||
126597501|NCT05256654|455488001|FG001|Overall Study|Withdrawal by Subject|2|||
126597502|NCT05256654|455488002|FG002|Overall Study|Withdrawal by Subject|1|||
126597503|NCT05256654|455488003|FG003|Overall Study|Withdrawal by Subject|3|||
126597504|NCT05256654|455488000|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
126597505|NCT05256654|455488001|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
126597506|NCT05256654|455488002|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
126597507|NCT05256654|455488003|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
126597508|NCT05256654|455488000|FG000|Overall Study|Other|0|||
126597509|NCT05256654|455488001|FG001|Overall Study|Other|0|||
126597510|NCT05256654|455488002|FG002|Overall Study|Other|0|||
126597511|NCT05256654|455488003|FG003|Overall Study|Other|1|||
126597512|NCT05618587|455488004|FG000|Overall Study|Lost to Follow-up|2|||
126597513|NCT05618587|455488005|FG001|Overall Study|Lost to Follow-up|0|||
126597514|NCT05167864|455488012|FG000|Overall Study|Lost to Follow-up|7|||
126597515|NCT05167864|455488013|FG001|Overall Study|Lost to Follow-up|6|||
126597516|NCT05167864|455488014|FG002|Overall Study|Lost to Follow-up|7|||
126597517|NCT05167864|455488015|FG003|Overall Study|Lost to Follow-up|9|||
126597518|NCT04862416|455488016|FG000|Overall Study|Withdrawal by Subject|0|||
126597519|NCT04862416|455488017|FG001|Overall Study|Withdrawal by Subject|1|||
126597520|NCT04862416|455488018|FG002|Overall Study|Withdrawal by Subject|0|||
126597521|NCT04862416|455488019|FG003|Overall Study|Withdrawal by Subject|1|||
126597522|NCT04862416|455488020|FG004|Overall Study|Withdrawal by Subject|0|||
126597523|NCT04862416|455488021|FG005|Overall Study|Withdrawal by Subject|0|||
126597524|NCT04862416|455488022|FG006|Overall Study|Withdrawal by Subject|0|||
126597525|NCT04862416|455488023|FG007|Overall Study|Withdrawal by Subject|0|||
126597526|NCT03442309|455488024|FG000|Overall Study|Lost to Follow-up|1676|||
126597527|NCT03442309|455488025|FG001|Overall Study|Lost to Follow-up|1642|||
126597528|NCT03852550|455488026|FG000|Overall Study|Lost to Follow-up|4|||
126597529|NCT03852550|455488027|FG001|Overall Study|Lost to Follow-up|3|||
126597530|NCT03852550|455488026|FG000|Overall Study|Only parent outcomes completed|0|||
126597531|NCT03852550|455488027|FG001|Overall Study|Only parent outcomes completed|1|||
126597532|NCT03852550|455488026|FG000|Overall Study|Withdrawal by Subject|1|||
126597533|NCT03852550|455488027|FG001|Overall Study|Withdrawal by Subject|0|||
126597534|NCT05204654|455488028|FG000|Overall Study|Study terminated due to time restraint|2|||
126732818|NCT02528253|455972259|FG001|Overall Study|Lost to Follow-up|9|||
126732819|NCT02528253|455972260|FG002|Overall Study|Lost to Follow-up|31|||
126732820|NCT02528253|455972261|FG003|Overall Study|Lost to Follow-up|16|||
126732821|NCT02528253|455972262|FG004|Overall Study|Lost to Follow-up|34|||
126732822|NCT02528253|455972258|FG000|Overall Study|Other|21|||
126597535|NCT05204654|455488029|FG001|Overall Study|Study terminated due to time restraint|2|||
126732823|NCT02528253|455972259|FG001|Overall Study|Other|22|||
126597536|NCT05207956|455488044|FG000|Overall Study|Lost to follow up|1|||
126597537|NCT05207956|455488045|FG001|Overall Study|Lost to follow up|2|||
126597538|NCT01254864|455488046|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
126597539|NCT01254864|455488047|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
126597540|NCT01254864|455488048|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
126597541|NCT01254864|455488046|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
126597542|NCT01254864|455488047|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
126597543|NCT01254864|455488048|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
126597544|NCT01254864|455488046|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
126597545|NCT01254864|455488047|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
126732824|NCT02528253|455972260|FG002|Overall Study|Other|58|||
126779536|NCT01360632|456147011|FG000|Phase A+|Adverse Event|0|||
126779537|NCT01360632|456147012|FG001|Phase A+|Adverse Event|0|||
126779538|NCT01360632|456147013|FG002|Phase A+|Adverse Event|0|||
126779539|NCT01360632|456147014|FG003|Phase A+|Adverse Event|0|||
126779540|NCT01360632|456147015|FG004|Phase A+|Adverse Event|2|||
126779541|NCT01360632|456147011|FG000|Phase A+|Met Withdrawal Criteria|0|||
126779542|NCT01360632|456147012|FG001|Phase A+|Met Withdrawal Criteria|0|||
126779543|NCT01360632|456147013|FG002|Phase A+|Met Withdrawal Criteria|0|||
126779544|NCT01360632|456147014|FG003|Phase A+|Met Withdrawal Criteria|0|||
126779545|NCT01360632|456147015|FG004|Phase A+|Met Withdrawal Criteria|7|||
126597546|NCT01254864|455488048|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
126597547|NCT01254864|455488046|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
126597548|NCT01254864|455488047|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
126597549|NCT01254864|455488048|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
126597550|NCT01254864|455488046|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
126597551|NCT01254864|455488047|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
126597552|NCT01254864|455488048|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
126597553|NCT01254864|455488046|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
126597554|NCT01254864|455488047|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
126597555|NCT01254864|455488048|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
126597556|NCT01254864|455488046|FG000|Randomization Phase|Adverse Event|0|||
126732825|NCT02528253|455972261|FG003|Overall Study|Other|52|||
126732826|NCT02528253|455972262|FG004|Overall Study|Other|76|||
126732827|NCT02528253|455972258|FG000|Overall Study|Withdrawal by Subject|25|||
126732828|NCT02528253|455972259|FG001|Overall Study|Withdrawal by Subject|20|||
126732829|NCT02528253|455972260|FG002|Overall Study|Withdrawal by Subject|29|||
126732830|NCT02528253|455972261|FG003|Overall Study|Withdrawal by Subject|48|||
126732831|NCT02528253|455972262|FG004|Overall Study|Withdrawal by Subject|73|||
126732832|NCT02528253|455972258|FG000|Overall Study|Protocol Violation|1|||
126732833|NCT02528253|455972259|FG001|Overall Study|Protocol Violation|2|||
126732834|NCT02528253|455972260|FG002|Overall Study|Protocol Violation|4|||
126732835|NCT02528253|455972261|FG003|Overall Study|Protocol Violation|0|||
126732836|NCT02528253|455972262|FG004|Overall Study|Protocol Violation|4|||
126732837|NCT02528253|455972258|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
126732838|NCT02528253|455972259|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
126732839|NCT02528253|455972260|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
126732840|NCT02528253|455972261|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
126732841|NCT02528253|455972262|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
126779546|NCT01360632|456147011|FG000|Phase A+|Physician Decision|0|||
126779547|NCT01360632|456147012|FG001|Phase A+|Physician Decision|0|||
126597557|NCT01254864|455488047|FG001|Randomization Phase|Adverse Event|5|||
126597558|NCT01254864|455488048|FG002|Randomization Phase|Adverse Event|17|||
126597559|NCT01254864|455488046|FG000|Randomization Phase|Death|0|||
126597560|NCT01254864|455488047|FG001|Randomization Phase|Death|1|||
126597561|NCT01254864|455488048|FG002|Randomization Phase|Death|0|||
126597562|NCT01254864|455488046|FG000|Randomization Phase|Lost to Follow-up|0|||
126597563|NCT01254864|455488047|FG001|Randomization Phase|Lost to Follow-up|0|||
126597564|NCT01254864|455488048|FG002|Randomization Phase|Lost to Follow-up|1|||
126597565|NCT01254864|455488046|FG000|Randomization Phase|Physician Decision|0|||
126597566|NCT01254864|455488047|FG001|Randomization Phase|Physician Decision|20|||
126597567|NCT01254864|455488048|FG002|Randomization Phase|Physician Decision|25|||
126597568|NCT01254864|455488046|FG000|Randomization Phase|Withdrawal by Subject|0|||
126597569|NCT01254864|455488047|FG001|Randomization Phase|Withdrawal by Subject|4|||
126597570|NCT01254864|455488048|FG002|Randomization Phase|Withdrawal by Subject|2|||
126597571|NCT01254864|455488046|FG000|Randomization Phase|Non-Compliance|0|||
126597572|NCT01254864|455488047|FG001|Randomization Phase|Non-Compliance|1|||
126597573|NCT01254864|455488048|FG002|Randomization Phase|Non-Compliance|0|||
126597574|NCT01254864|455488046|FG000|Randomization Phase|Comorbidities|0|||
126597575|NCT01254864|455488047|FG001|Randomization Phase|Comorbidities|2|||
126597576|NCT01254864|455488048|FG002|Randomization Phase|Comorbidities|1|||
126597577|NCT01828112|455488053|FG000|Treatment Phase|Adverse Event|7|||
126732842|NCT04507776|455972263|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
126779548|NCT01360632|456147013|FG002|Phase A+|Physician Decision|0|||
126732843|NCT03628599|455972264|FG000|Overall Study|Adverse Event|0|||
126732844|NCT03628599|455972265|FG001|Overall Study|Adverse Event|1|||
126732845|NCT01624506|455972266|FG000|Overall Study|Lost to Follow-up|29|||
126779549|NCT01360632|456147014|FG003|Phase A+|Physician Decision|0|||
126779550|NCT01360632|456147015|FG004|Phase A+|Physician Decision|3|||
126779551|NCT01360632|456147011|FG000|Phase A+|Withdrawal by Subject|0|||
126597578|NCT01828112|455488054|FG001|Treatment Phase|Adverse Event|8|||
126597579|NCT01828112|455488055|FG002|Treatment Phase|Adverse Event|0|||
126597580|NCT01828112|455488053|FG000|Treatment Phase|Death|9|||
126597581|NCT01828112|455488054|FG001|Treatment Phase|Death|5|||
126597582|NCT01828112|455488055|FG002|Treatment Phase|Death|0|||
126597583|NCT01828112|455488053|FG000|Treatment Phase|No longer required treatment|0|||
126732846|NCT01624506|455972267|FG001|Overall Study|Lost to Follow-up|15|||
126779552|NCT01360632|456147012|FG001|Phase A+|Withdrawal by Subject|0|||
126597584|NCT01828112|455488054|FG001|Treatment Phase|No longer required treatment|1|||
126597585|NCT01828112|455488055|FG002|Treatment Phase|No longer required treatment|0|||
126597586|NCT01828112|455488053|FG000|Treatment Phase|Physician Decision|6|||
126597587|NCT01828112|455488054|FG001|Treatment Phase|Physician Decision|7|||
126597588|NCT01828112|455488055|FG002|Treatment Phase|Physician Decision|0|||
126597589|NCT01828112|455488053|FG000|Treatment Phase|Pregnancy|1|||
126597590|NCT01828112|455488054|FG001|Treatment Phase|Pregnancy|0|||
126597591|NCT01828112|455488055|FG002|Treatment Phase|Pregnancy|0|||
126597592|NCT01828112|455488053|FG000|Treatment Phase|Progressive disease|79|||
126597593|NCT01828112|455488054|FG001|Treatment Phase|Progressive disease|87|||
126597594|NCT01828112|455488055|FG002|Treatment Phase|Progressive disease|0|||
126597595|NCT01828112|455488053|FG000|Treatment Phase|Study terminated by sponsor|1|||
126597596|NCT01828112|455488054|FG001|Treatment Phase|Study terminated by sponsor|0|||
126597597|NCT01828112|455488055|FG002|Treatment Phase|Study terminated by sponsor|0|||
126597598|NCT01828112|455488053|FG000|Treatment Phase|Subject/guardian decision|12|||
126597599|NCT01828112|455488054|FG001|Treatment Phase|Subject/guardian decision|8|||
126597600|NCT01828112|455488055|FG002|Treatment Phase|Subject/guardian decision|0|||
126597601|NCT01828112|455488053|FG000|Extension Treatment Phase|Adverse Event|0|||
126597602|NCT01828112|455488054|FG001|Extension Treatment Phase|Adverse Event|0|||
126597603|NCT01828112|455488055|FG002|Extension Treatment Phase|Adverse Event|6|||
126597604|NCT01828112|455488053|FG000|Extension Treatment Phase|Death|0|||
126597605|NCT01828112|455488054|FG001|Extension Treatment Phase|Death|0|||
126597606|NCT01828112|455488055|FG002|Extension Treatment Phase|Death|17|||
126597607|NCT01828112|455488053|FG000|Extension Treatment Phase|Physician Decision|0|||
126597608|NCT01828112|455488054|FG001|Extension Treatment Phase|Physician Decision|0|||
126597609|NCT01828112|455488055|FG002|Extension Treatment Phase|Physician Decision|5|||
126597610|NCT01828112|455488053|FG000|Extension Treatment Phase|Progressive disease|0|||
126597611|NCT01828112|455488054|FG001|Extension Treatment Phase|Progressive disease|0|||
126597612|NCT01828112|455488055|FG002|Extension Treatment Phase|Progressive disease|46|||
126597613|NCT01828112|455488053|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
126597614|NCT01828112|455488054|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
126597615|NCT01828112|455488055|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
126597616|NCT01828112|455488053|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
126597617|NCT01828112|455488054|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
126597618|NCT01828112|455488055|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
126597619|NCT02446236|455488063|FG000|Overall Study|Screen Failure|1|||
126597620|NCT02446236|455488064|FG001|Overall Study|Screen Failure|0|||
126597621|NCT02446236|455488065|FG002|Overall Study|Screen Failure|1|||
126597622|NCT02446236|455488063|FG000|Overall Study|Actively Receiving Therapy|0|||
126597623|NCT02446236|455488064|FG001|Overall Study|Actively Receiving Therapy|0|||
126597624|NCT02446236|455488065|FG002|Overall Study|Actively Receiving Therapy|1|||
126597625|NCT05184452|455488066|FG000|Overall Study|Lost to Follow-up|0|||
126597626|NCT05184452|455488067|FG001|Overall Study|Lost to Follow-up|0|||
126597627|NCT05184452|455488068|FG002|Overall Study|Lost to Follow-up|0|||
126597628|NCT05184452|455488069|FG003|Overall Study|Lost to Follow-up|0|||
126597629|NCT05184452|455488070|FG004|Overall Study|Lost to Follow-up|0|||
126597630|NCT05184452|455488071|FG005|Overall Study|Lost to Follow-up|2|||
126597631|NCT05184452|455488072|FG006|Overall Study|Lost to Follow-up|0|||
126597632|NCT05184452|455488073|FG007|Overall Study|Lost to Follow-up|0|||
126597633|NCT05184452|455488074|FG008|Overall Study|Lost to Follow-up|0|||
126597634|NCT05184452|455488075|FG009|Overall Study|Lost to Follow-up|1|||
126597635|NCT05184452|455488066|FG000|Overall Study|Withdrawal by Subject|0|||
126597636|NCT05184452|455488067|FG001|Overall Study|Withdrawal by Subject|0|||
126597637|NCT05184452|455488068|FG002|Overall Study|Withdrawal by Subject|0|||
126597638|NCT05184452|455488069|FG003|Overall Study|Withdrawal by Subject|0|||
126597639|NCT05184452|455488070|FG004|Overall Study|Withdrawal by Subject|0|||
126597640|NCT05184452|455488071|FG005|Overall Study|Withdrawal by Subject|1|||
126597641|NCT05184452|455488072|FG006|Overall Study|Withdrawal by Subject|0|||
126597642|NCT05184452|455488073|FG007|Overall Study|Withdrawal by Subject|0|||
126597643|NCT05184452|455488074|FG008|Overall Study|Withdrawal by Subject|0|||
126597644|NCT05184452|455488075|FG009|Overall Study|Withdrawal by Subject|1|||
126597645|NCT05586490|455488076|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
126597646|NCT05586490|455488077|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
126597647|NCT05586490|455488078|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
126597648|NCT05586490|455488079|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
126597649|NCT05586490|455488080|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
126597650|NCT05586490|455488076|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
126597651|NCT05586490|455488077|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
126597652|NCT05586490|455488078|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
126597653|NCT05586490|455488079|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
126597654|NCT05586490|455488080|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
126597655|NCT05586490|455488076|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
126597656|NCT05586490|455488077|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
126597657|NCT05586490|455488078|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
126597658|NCT05586490|455488079|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
126597659|NCT05586490|455488080|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
126597660|NCT04862234|455488086|FG000|Overall Study|Surgery cancellation|1|||
126597661|NCT04862234|455488087|FG001|Overall Study|Surgery cancellation|2|||
126597662|NCT04862234|455488086|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
126597663|NCT04862234|455488087|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
126597664|NCT04862234|455488086|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
126597665|NCT04862234|455488087|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
126597666|NCT03292484|455488088|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
126597667|NCT03292484|455488088|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
126597668|NCT03292484|455488088|FG000|Overall Study|Protocol Violation|2|||
126597669|NCT03292484|455488088|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
126597670|NCT03292484|455488088|FG000|Overall Study|Sponsor decision|349|||
126597671|NCT03292484|455488088|FG000|Overall Study|Lost to Follow-up|7|||
126597672|NCT03292484|455488088|FG000|Overall Study|Coronavirus Disease 2019|1|||
126597673|NCT03292484|455488088|FG000|Overall Study|Other|20|||
126597674|NCT05290493|455488089|FG000|Overall Study|Withdrawal by Subject|2|||
126597675|NCT05290493|455488090|FG001|Overall Study|Withdrawal by Subject|2|||
126597676|NCT05290493|455488089|FG000|Overall Study|Adverse Event|1|||
126597677|NCT05290493|455488090|FG001|Overall Study|Adverse Event|0|||
126597678|NCT03677141|455488094|FG000|Overall Study|Death|2|||
126597679|NCT03677141|455488095|FG001|Overall Study|Death|1|||
126597680|NCT03677141|455488096|FG002|Overall Study|Death|6|||
126597681|NCT03677141|455488097|FG003|Overall Study|Death|9|||
126597682|NCT03677141|455488098|FG004|Overall Study|Death|5|||
126597683|NCT03677141|455488099|FG005|Overall Study|Death|3|||
126597684|NCT03677141|455488094|FG000|Overall Study|Lost to Follow-up|0|||
126597685|NCT03677141|455488095|FG001|Overall Study|Lost to Follow-up|0|||
126597686|NCT03677141|455488096|FG002|Overall Study|Lost to Follow-up|0|||
126597687|NCT03677141|455488097|FG003|Overall Study|Lost to Follow-up|2|||
126597688|NCT03677141|455488098|FG004|Overall Study|Lost to Follow-up|0|||
126597689|NCT03677141|455488099|FG005|Overall Study|Lost to Follow-up|0|||
126597690|NCT03677141|455488094|FG000|Overall Study|Screen failure or enrolled in error|0|||
126597691|NCT03677141|455488095|FG001|Overall Study|Screen failure or enrolled in error|0|||
126597692|NCT03677141|455488096|FG002|Overall Study|Screen failure or enrolled in error|0|||
126597693|NCT03677141|455488097|FG003|Overall Study|Screen failure or enrolled in error|0|||
126597694|NCT03677141|455488098|FG004|Overall Study|Screen failure or enrolled in error|2|||
126597695|NCT03677141|455488099|FG005|Overall Study|Screen failure or enrolled in error|0|||
126597696|NCT03677141|455488094|FG000|Overall Study|Physician Decision|0|||
126597697|NCT03677141|455488095|FG001|Overall Study|Physician Decision|0|||
126597698|NCT03677141|455488096|FG002|Overall Study|Physician Decision|0|||
126597699|NCT03677141|455488097|FG003|Overall Study|Physician Decision|0|||
126597700|NCT03677141|455488098|FG004|Overall Study|Physician Decision|1|||
126597701|NCT03677141|455488099|FG005|Overall Study|Physician Decision|0|||
126597702|NCT03677141|455488094|FG000|Overall Study|Withdrawal by Subject|0|||
126597703|NCT03677141|455488095|FG001|Overall Study|Withdrawal by Subject|0|||
126597704|NCT03677141|455488096|FG002|Overall Study|Withdrawal by Subject|1|||
126597705|NCT03677141|455488097|FG003|Overall Study|Withdrawal by Subject|1|||
126597706|NCT03677141|455488098|FG004|Overall Study|Withdrawal by Subject|1|||
126597707|NCT03677141|455488099|FG005|Overall Study|Withdrawal by Subject|0|||
126597708|NCT05425420|455488100|FG000|Overall Study|Physician Decision|1|||
126597709|NCT05425420|455488100|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
126597710|NCT05280574|455488101|FG000|Overall Study|Withdrawal by Subject|0|||
126597711|NCT05280574|455488102|FG001|Overall Study|Withdrawal by Subject|2|||
126597712|NCT05280574|455488103|FG002|Overall Study|Withdrawal by Subject|0|||
126597713|NCT04056611|455488104|FG000|Overall Study|Physician Decision|1|||
126597714|NCT02631746|455488107|FG000|Overall Study|Lack of Efficacy|3|||
126597715|NCT04571619|455488108|FG000|Phase 1|Death|22|||
126597716|NCT04571619|455488109|FG001|Phase 1|Death|18|||
126597717|NCT04571619|455488108|FG000|Phase 1|Withdrawal by Subject|7|||
126597718|NCT04571619|455488109|FG001|Phase 1|Withdrawal by Subject|2|||
126597719|NCT04571619|455488108|FG000|Phase 2|Death|13|||
126597720|NCT04571619|455488109|FG001|Phase 2|Death|16|||
126779553|NCT01360632|456147013|FG002|Phase A+|Withdrawal by Subject|0|||
126779554|NCT01360632|456147014|FG003|Phase A+|Withdrawal by Subject|0|||
126597721|NCT04571619|455488108|FG000|Phase 2|Withdrawal by Subject|6|||
126597722|NCT04571619|455488109|FG001|Phase 2|Withdrawal by Subject|4|||
126597723|NCT02224144|455488110|FG000|Overall Study|Lost to Follow-up|3|||
126597724|NCT02224144|455488111|FG001|Overall Study|Lost to Follow-up|1|||
126597725|NCT02224144|455488110|FG000|Overall Study|Death|2|||
126597726|NCT02224144|455488111|FG001|Overall Study|Death|0|||
126597727|NCT02224144|455488110|FG000|Overall Study|Withdrawal by Subject|0|||
126597728|NCT02224144|455488111|FG001|Overall Study|Withdrawal by Subject|1|||
126597729|NCT03505008|455488112|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
126779555|NCT01360632|456147015|FG004|Phase A+|Withdrawal by Subject|8|||
126779556|NCT01360632|456147011|FG000|Phase A+|Protocol Deviation|0|||
126597730|NCT03505008|455488113|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
126597731|NCT03505008|455488114|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
126597732|NCT03505008|455488115|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
126597733|NCT03505008|455488112|FG000|Before Week 24 Randomization|Adverse Event|10|||
126597734|NCT03505008|455488113|FG001|Before Week 24 Randomization|Adverse Event|0|||
126597735|NCT03505008|455488114|FG002|Before Week 24 Randomization|Adverse Event|0|||
126597736|NCT03505008|455488115|FG003|Before Week 24 Randomization|Adverse Event|0|||
126597737|NCT03505008|455488112|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
126597738|NCT03505008|455488113|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
126597739|NCT03505008|455488114|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
126597740|NCT03505008|455488115|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
126597741|NCT03505008|455488112|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
126597742|NCT03505008|455488113|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
126597743|NCT03505008|455488114|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
126597744|NCT03505008|455488115|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
126597745|NCT03505008|455488112|FG000|Before Week 24 Randomization|Physician Decision|2|||
126597746|NCT03505008|455488113|FG001|Before Week 24 Randomization|Physician Decision|0|||
126597747|NCT03505008|455488114|FG002|Before Week 24 Randomization|Physician Decision|0|||
126597748|NCT03505008|455488115|FG003|Before Week 24 Randomization|Physician Decision|0|||
126597749|NCT03505008|455488112|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
126597750|NCT03505008|455488113|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
126597751|NCT03505008|455488114|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
126597752|NCT03505008|455488115|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
126597753|NCT03505008|455488112|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
126597754|NCT03505008|455488113|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
126597755|NCT03505008|455488114|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
126597756|NCT03505008|455488115|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
126597757|NCT03505008|455488112|FG000|Before Week 24 Randomization|Complication|1|||
126597758|NCT03505008|455488113|FG001|Before Week 24 Randomization|Complication|0|||
126597759|NCT03505008|455488114|FG002|Before Week 24 Randomization|Complication|0|||
126597760|NCT03505008|455488115|FG003|Before Week 24 Randomization|Complication|0|||
126597761|NCT03505008|455488112|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
126597762|NCT03505008|455488113|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
126597763|NCT03505008|455488114|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
126597764|NCT03505008|455488115|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
126597765|NCT03505008|455488112|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
126597766|NCT03505008|455488113|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
126597767|NCT03505008|455488114|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
126597768|NCT03505008|455488115|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
126597769|NCT03505008|455488112|FG000|After Week 24 Randomization|Adverse Event|0|||
126597770|NCT03505008|455488113|FG001|After Week 24 Randomization|Adverse Event|1|||
126597771|NCT03505008|455488114|FG002|After Week 24 Randomization|Adverse Event|2|||
126597772|NCT03505008|455488115|FG003|After Week 24 Randomization|Adverse Event|2|||
126597773|NCT03505008|455488112|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
126597774|NCT03505008|455488113|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
126597775|NCT03505008|455488114|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
126597776|NCT03505008|455488115|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
126597777|NCT03505008|455488112|FG000|After Week 24 Randomization|Protocol Violation|0|||
126597778|NCT03505008|455488113|FG001|After Week 24 Randomization|Protocol Violation|0|||
126597779|NCT03505008|455488114|FG002|After Week 24 Randomization|Protocol Violation|1|||
126597780|NCT03505008|455488115|FG003|After Week 24 Randomization|Protocol Violation|0|||
126597781|NCT02780700|455488125|FG000|Overall Study|Progressive disease|1|||
126597782|NCT04820322|455488130|FG000|Overall Study|Adverse Event|1|||
126597783|NCT04820322|455488131|FG001|Overall Study|Adverse Event|0|||
126597784|NCT02834390|455488136|FG000|Induction Phase|Progressive disease|0|||
126597785|NCT02834390|455488137|FG001|Induction Phase|Progressive disease|1|||
126597786|NCT02834390|455488136|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
126597787|NCT02834390|455488137|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
126597788|NCT02834390|455488136|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
126597789|NCT02834390|455488137|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
126597790|NCT02834390|455488136|FG000|Consolidation Phase|Physician Decision|1|||
126597791|NCT02834390|455488137|FG001|Consolidation Phase|Physician Decision|1|||
126597792|NCT02998528|455488138|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
126597793|NCT02998528|455488139|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
126597794|NCT02998528|455488140|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
126597795|NCT02998528|455488138|FG000|Randomization Period|Participant withdrew consent|0|||
126597796|NCT02998528|455488139|FG001|Randomization Period|Participant withdrew consent|3|||
126779557|NCT01360632|456147012|FG001|Phase A+|Protocol Deviation|0|||
126779558|NCT01360632|456147013|FG002|Phase A+|Protocol Deviation|0|||
126779559|NCT01360632|456147014|FG003|Phase A+|Protocol Deviation|0|||
126597797|NCT02998528|455488140|FG002|Randomization Period|Participant withdrew consent|0|||
126597798|NCT02998528|455488138|FG000|Randomization Period|Participant no longer meets study criteria|1|||
126597799|NCT02998528|455488139|FG001|Randomization Period|Participant no longer meets study criteria|3|||
126597800|NCT02998528|455488140|FG002|Randomization Period|Participant no longer meets study criteria|2|||
126597801|NCT02998528|455488138|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
126597802|NCT02998528|455488139|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
126597803|NCT02998528|455488140|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
126597804|NCT02998528|455488138|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
126597805|NCT02998528|455488139|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
126597806|NCT02998528|455488140|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
126597807|NCT02998528|455488138|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
126597808|NCT02998528|455488139|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
126597809|NCT02998528|455488140|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
126597810|NCT02998528|455488138|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
126597811|NCT02998528|455488139|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
126597812|NCT02998528|455488140|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
126597813|NCT02998528|455488138|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
126597814|NCT02998528|455488139|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
126597815|NCT02998528|455488140|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
126597816|NCT02998528|455488138|FG000|Neoadjuvant Treatment Period|Death|1|||
126597817|NCT02998528|455488139|FG001|Neoadjuvant Treatment Period|Death|0|||
126597818|NCT02998528|455488140|FG002|Neoadjuvant Treatment Period|Death|0|||
126597819|NCT02998528|455488138|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
126597820|NCT02998528|455488139|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
126597821|NCT02998528|455488140|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
126597822|NCT02998528|455488138|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
126597823|NCT02998528|455488139|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
126597824|NCT02998528|455488140|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
126597825|NCT02998528|455488138|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
126597826|NCT02998528|455488139|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
126597827|NCT02998528|455488140|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
126597828|NCT02998528|455488138|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
126597829|NCT02998528|455488139|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
126597830|NCT02998528|455488140|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
126597831|NCT02998528|455488138|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
126597832|NCT02998528|455488139|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
126597833|NCT02998528|455488140|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
126597834|NCT02998528|455488138|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
126597835|NCT02998528|455488139|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
126597836|NCT02998528|455488140|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
126597837|NCT03213678|455488146|FG000|Overall Study|Death|1|||
126597838|NCT03213678|455488146|FG000|Overall Study|Physician Decision|1|||
126597839|NCT03213678|455488146|FG000|Overall Study|Progressive disease|16|||
126597840|NCT04218851|455488147|FG000|Overall Study|Death|1|||
126597841|NCT04218851|455488148|FG001|Overall Study|Death|3|||
126597842|NCT03174275|455488149|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
126597843|NCT03174275|455488149|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
126597844|NCT03174275|455488149|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
126597845|NCT03174275|455488149|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
126597846|NCT03174275|455488149|FG000|Adjuvant Chemotherapy|Progression|1|||
126597847|NCT03174275|455488149|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
126597848|NCT03174275|455488149|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
126597849|NCT03174275|455488149|FG000|Adjuvant Durvalumab|Progression|1|||
126597850|NCT03174275|455488149|FG000|Adjuvant Durvalumab|Adverse Event|3|||
126597851|NCT03174275|455488149|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
126597852|NCT03174275|455488149|FG000|Adjuvant Radiotherapy|Progression|1|||
126597853|NCT03174275|455488149|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
126597854|NCT04456296|455488150|FG000|Overall Study|Withdrawal by Subject|14|||
126597855|NCT04456296|455488151|FG001|Overall Study|Withdrawal by Subject|21|||
126597856|NCT04456296|455488152|FG002|Overall Study|Withdrawal by Subject|21|||
126597857|NCT04456296|455488150|FG000|Overall Study|Adverse Event|2|||
126732847|NCT01624506|455972266|FG000|Overall Study|Withdrawal by Subject|9|||
126732848|NCT01624506|455972267|FG001|Overall Study|Withdrawal by Subject|2|||
126732849|NCT01624506|455972266|FG000|Overall Study|Death|1|||
126597858|NCT04456296|455488151|FG001|Overall Study|Adverse Event|2|||
126597859|NCT04456296|455488152|FG002|Overall Study|Adverse Event|2|||
126597860|NCT04456296|455488150|FG000|Overall Study|Death|1|||
126732850|NCT01624506|455972267|FG001|Overall Study|Death|0|||
126597861|NCT04456296|455488151|FG001|Overall Study|Death|0|||
126597862|NCT04456296|455488152|FG002|Overall Study|Death|0|||
126597863|NCT04456296|455488150|FG000|Overall Study|Lost to Follow-up|3|||
126597864|NCT04456296|455488151|FG001|Overall Study|Lost to Follow-up|5|||
126597865|NCT04456296|455488152|FG002|Overall Study|Lost to Follow-up|6|||
126597866|NCT04456296|455488150|FG000|Overall Study|Other than specified|0|||
126597867|NCT04456296|455488151|FG001|Overall Study|Other than specified|1|||
126597868|NCT04456296|455488152|FG002|Overall Study|Other than specified|4|||
126597869|NCT04456296|455488150|FG000|Overall Study|Randomized, not treated|2|||
126597870|NCT04456296|455488151|FG001|Overall Study|Randomized, not treated|1|||
126597871|NCT04456296|455488152|FG002|Overall Study|Randomized, not treated|0|||
126597872|NCT04247802|455488153|FG000|Overall Study|Withdrawal by Subject|1|||
126597873|NCT04247802|455488154|FG001|Overall Study|Withdrawal by Subject|3|||
126597874|NCT04247802|455488153|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
126597875|NCT04247802|455488154|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
126597876|NCT04271046|455488155|FG000|Overall Study|Death|0|||
126597877|NCT04271046|455488156|FG001|Overall Study|Death|2|||
126597878|NCT04271046|455488157|FG002|Overall Study|Death|0|||
126597879|NCT04271046|455488158|FG003|Overall Study|Death|2|||
126597880|NCT04271046|455488155|FG000|Overall Study|Lost to Follow-up|12|||
126597881|NCT04271046|455488156|FG001|Overall Study|Lost to Follow-up|12|||
126597882|NCT04271046|455488157|FG002|Overall Study|Lost to Follow-up|11|||
126597883|NCT04271046|455488158|FG003|Overall Study|Lost to Follow-up|11|||
126597884|NCT04271046|455488155|FG000|Overall Study|Patient with Dementia Died|2|||
126597885|NCT04271046|455488156|FG001|Overall Study|Patient with Dementia Died|0|||
126597886|NCT04271046|455488157|FG002|Overall Study|Patient with Dementia Died|2|||
126597887|NCT04271046|455488158|FG003|Overall Study|Patient with Dementia Died|0|||
126597888|NCT04271046|455488155|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
126597889|NCT04271046|455488156|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
126597890|NCT04271046|455488157|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
126597891|NCT04271046|455488158|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
126597892|NCT04826471|455490270|FG000|Overall Study|Lost to Follow-up|2|||
126597893|NCT04826471|455490270|FG000|Overall Study|Protocol Violation|3|||
126597894|NCT04826471|455490270|FG000|Overall Study|Withdrawal by Subject|1|||
126597895|NCT04304144|455490272|FG000|DLT Observation Period|Physician Decision|0|||
126597896|NCT04304144|455490273|FG001|DLT Observation Period|Physician Decision|1|||
126597897|NCT04304144|455490274|FG002|DLT Observation Period|Physician Decision|0|||
126597898|NCT04304144|455490275|FG003|DLT Observation Period|Physician Decision|0|||
126597899|NCT04304144|455490272|FG000|Continued Treatment Period|Adverse Event|0|||
126597900|NCT04304144|455490273|FG001|Continued Treatment Period|Adverse Event|1|||
126597901|NCT04304144|455490274|FG002|Continued Treatment Period|Adverse Event|0|||
126597902|NCT04304144|455490275|FG003|Continued Treatment Period|Adverse Event|0|||
126597903|NCT04304144|455490272|FG000|Continued Treatment Period|Death|0|||
126597904|NCT04304144|455490273|FG001|Continued Treatment Period|Death|0|||
126597905|NCT04304144|455490274|FG002|Continued Treatment Period|Death|1|||
126597906|NCT04304144|455490275|FG003|Continued Treatment Period|Death|2|||
126597907|NCT04304144|455490272|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
126597908|NCT04304144|455490273|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
126597909|NCT04304144|455490274|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
126597910|NCT04304144|455490275|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
126597911|NCT04304144|455490272|FG000|Continued Treatment Period|Other than specified|2|||
126597912|NCT04304144|455490273|FG001|Continued Treatment Period|Other than specified|0|||
126597913|NCT04304144|455490274|FG002|Continued Treatment Period|Other than specified|1|||
126597914|NCT04304144|455490275|FG003|Continued Treatment Period|Other than specified|1|||
126597915|NCT04615273|455490278|FG000|Overall Study|Withdrawal by Subject|3|||
126597916|NCT04615273|455490279|FG001|Overall Study|Withdrawal by Subject|1|||
126597917|NCT04615273|455490280|FG002|Overall Study|Withdrawal by Subject|2|||
126597918|NCT04615273|455490278|FG000|Overall Study|Adverse Event|1|||
126597919|NCT04615273|455490279|FG001|Overall Study|Adverse Event|0|||
126597920|NCT04615273|455490280|FG002|Overall Study|Adverse Event|1|||
126597921|NCT04615273|455490278|FG000|Overall Study|Lost to Follow-up|0|||
126597922|NCT04615273|455490279|FG001|Overall Study|Lost to Follow-up|1|||
126597923|NCT04615273|455490280|FG002|Overall Study|Lost to Follow-up|0|||
126597924|NCT04615273|455490278|FG000|Overall Study|Physician Decision|0|||
126597925|NCT04615273|455490279|FG001|Overall Study|Physician Decision|0|||
126597926|NCT04615273|455490280|FG002|Overall Study|Physician Decision|1|||
126597927|NCT04615273|455490278|FG000|Overall Study|Other|0|||
126597928|NCT04615273|455490279|FG001|Overall Study|Other|1|||
126597929|NCT04615273|455490280|FG002|Overall Study|Other|0|||
126597930|NCT04615273|455490278|FG000|Overall Study|Randomized but not treated|1|||
126597931|NCT04615273|455490279|FG001|Overall Study|Randomized but not treated|3|||
126597932|NCT04615273|455490280|FG002|Overall Study|Randomized but not treated|1|||
126597933|NCT03673501|455490286|FG000|Overall Study|Participants ongoing.|36|||
126597934|NCT03673501|455490287|FG001|Overall Study|Participants ongoing.|24|||
126597935|NCT05838027|455490288|FG000|Overall Study|Lost to Follow-up|5|||
126597936|NCT05838027|455490289|FG001|Overall Study|Lost to Follow-up|1|||
126597937|NCT05838027|455490288|FG000|Overall Study|Withdrawal by Subject|1|||
126597938|NCT05838027|455490289|FG001|Overall Study|Withdrawal by Subject|0|||
126597939|NCT04599634|455490293|FG000|Overall Study|Dose limiting toxicity|0|||
126597940|NCT04599634|455490294|FG001|Overall Study|Dose limiting toxicity|0|||
126597941|NCT04599634|455490295|FG002|Overall Study|Dose limiting toxicity|2|||
126597942|NCT04599634|455490296|FG003|Overall Study|Dose limiting toxicity|0|||
126597943|NCT03714815|455490297|FG000|Overall Study|Physician Decision|2|||
126597944|NCT03714815|455490297|FG000|Overall Study|Withdrawal by Subject|2|||
126597945|NCT03714815|455490297|FG000|Overall Study|Death|11|||
126597946|NCT04709419|455490299|FG000|Overall Study|Physician Decision|1|||
126597947|NCT04709419|455490300|FG001|Overall Study|Physician Decision|0|||
126597948|NCT05683340|455490301|FG000|Overall Study|Adverse Event|1|||
126597949|NCT05683340|455490302|FG001|Overall Study|Adverse Event|1|||
126597950|NCT05683340|455490301|FG000|Overall Study|Protocol Violation|1|||
126597951|NCT05683340|455490302|FG001|Overall Study|Protocol Violation|0|||
126597952|NCT05683340|455490301|FG000|Overall Study|Withdrawal by Subject|0|||
126597953|NCT05683340|455490302|FG001|Overall Study|Withdrawal by Subject|2|||
126597954|NCT02962076|455490305|FG000|Overall Study|MHED tracer not available|5|||
126597955|NCT02962076|455490305|FG000|Overall Study|Protocol Violation|1|||
126597956|NCT02962076|455490305|FG000|Overall Study|Physician Decision|1|||
126597957|NCT04741776|455490306|FG000|Overall Study|Withdrawal by Subject|7|||
126597958|NCT04741776|455490307|FG001|Overall Study|Withdrawal by Subject|10|||
126597959|NCT04741776|455490308|FG002|Overall Study|Withdrawal by Subject|10|||
126597960|NCT04741776|455490309|FG003|Overall Study|Withdrawal by Subject|17|||
126597961|NCT04741776|455490306|FG000|Overall Study|Death|0|||
126597962|NCT04741776|455490307|FG001|Overall Study|Death|0|||
126597963|NCT04741776|455490308|FG002|Overall Study|Death|1|||
126597964|NCT04741776|455490309|FG003|Overall Study|Death|0|||
126597965|NCT04089865|455490310|FG000|Overall Study|Withdrawal by Subject|2|||
126597966|NCT04089865|455490311|FG001|Overall Study|Withdrawal by Subject|2|||
126597967|NCT04089865|455490312|FG002|Overall Study|Withdrawal by Subject|7|||
126597968|NCT04089865|455490313|FG003|Overall Study|Withdrawal by Subject|2|||
126597969|NCT03824366|455490319|FG000|Overall Study|Death|1|||
126597970|NCT03824366|455490319|FG000|Overall Study|Previously unidentified metal artifact|1|||
126597971|NCT03824366|455490319|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
126597972|NCT03824366|455490319|FG000|Overall Study|Withdrawal by Subject|1|||
126597973|NCT05069896|455490324|FG000|Overall Study|Adverse Event|0|||
126597974|NCT05069896|455490325|FG001|Overall Study|Adverse Event|1|||
126597975|NCT05069896|455490326|FG002|Overall Study|Adverse Event|1|||
126597976|NCT05069896|455490327|FG003|Overall Study|Adverse Event|0|||
126597977|NCT05069896|455490328|FG004|Overall Study|Adverse Event|0|||
126597978|NCT05069896|455490329|FG005|Overall Study|Adverse Event|0|||
126597979|NCT05069896|455490324|FG000|Overall Study|Lost to Follow-up|0|||
126597980|NCT05069896|455490325|FG001|Overall Study|Lost to Follow-up|0|||
126597981|NCT05069896|455490326|FG002|Overall Study|Lost to Follow-up|1|||
126597982|NCT05069896|455490327|FG003|Overall Study|Lost to Follow-up|0|||
126597983|NCT05069896|455490328|FG004|Overall Study|Lost to Follow-up|1|||
126597984|NCT05069896|455490329|FG005|Overall Study|Lost to Follow-up|2|||
126597985|NCT04068831|455490330|FG000|Overall Study|Disease Progression|10|||
126597986|NCT04068831|455490331|FG001|Overall Study|Disease Progression|8|||
126597987|NCT00323856|455490332|FG000|Overall Study|Withdrawal by Subject|1|||
126597988|NCT00323856|455490332|FG000|Overall Study|Was uncooperative and noncompliant|1|||
126597989|NCT00323856|455490332|FG000|Overall Study|Reason not specified|1|||
126597990|NCT00323856|455490332|FG000|Overall Study|Missing|2|||
126597991|NCT03156465|455490338|FG000|Overall Study|Withdrawal by Subject|2|||
126597992|NCT04086121|455490347|FG000|Overall Study|Other than listed|8|||
126597993|NCT04086121|455490347|FG000|Overall Study|Withdrawal by Subject|3|||
126597994|NCT04086121|455490347|FG000|Overall Study|Lost to Follow-up|2|||
126597995|NCT04086121|455490347|FG000|Overall Study|Adverse Event|1|||
126597996|NCT04580914|455490350|FG000|Overall Study|Withdrawal by Subject|6|||
126597997|NCT04580914|455490350|FG000|Overall Study|Lost to Follow-up|2|||
126597998|NCT03580356|455490352|FG000|Treatment Period|Withdrawal by Subject|13|||
126597999|NCT03580356|455490353|FG001|Treatment Period|Withdrawal by Subject|0|||
126779560|NCT01360632|456147015|FG004|Phase A+|Protocol Deviation|3|||
126779561|NCT02173301|456147016|FG000|Overall Study|Adverse Event|7|||
126779562|NCT02173301|456147017|FG001|Overall Study|Adverse Event|8|||
126598000|NCT03580356|455490354|FG002|Treatment Period|Withdrawal by Subject|13|||
126598001|NCT03580356|455490355|FG003|Treatment Period|Withdrawal by Subject|1|||
126598002|NCT03580356|455490356|FG004|Treatment Period|Withdrawal by Subject|17|||
126598003|NCT03580356|455490357|FG005|Treatment Period|Withdrawal by Subject|0|||
126598004|NCT03580356|455490358|FG006|Treatment Period|Withdrawal by Subject|5|||
126598005|NCT03580356|455490359|FG007|Treatment Period|Withdrawal by Subject|0|||
126598006|NCT03580356|455490352|FG000|Treatment Period|Adverse Event|10|||
126598007|NCT03580356|455490353|FG001|Treatment Period|Adverse Event|0|||
126598008|NCT03580356|455490354|FG002|Treatment Period|Adverse Event|13|||
126598009|NCT03580356|455490355|FG003|Treatment Period|Adverse Event|0|||
126598010|NCT03580356|455490356|FG004|Treatment Period|Adverse Event|5|||
126779563|NCT02173301|456147018|FG002|Overall Study|Adverse Event|13|||
126779564|NCT02173301|456147019|FG003|Overall Study|Adverse Event|5|||
126779565|NCT02173301|456147016|FG000|Overall Study|Withdrawal by Subject|8|||
126598011|NCT03580356|455490357|FG005|Treatment Period|Adverse Event|0|||
126598012|NCT03580356|455490358|FG006|Treatment Period|Adverse Event|8|||
126598013|NCT03580356|455490359|FG007|Treatment Period|Adverse Event|0|||
126598014|NCT03580356|455490352|FG000|Treatment Period|Protocol Violation|5|||
126598015|NCT03580356|455490353|FG001|Treatment Period|Protocol Violation|0|||
126598016|NCT03580356|455490354|FG002|Treatment Period|Protocol Violation|6|||
126598017|NCT03580356|455490355|FG003|Treatment Period|Protocol Violation|1|||
126598018|NCT03580356|455490356|FG004|Treatment Period|Protocol Violation|9|||
126598019|NCT03580356|455490357|FG005|Treatment Period|Protocol Violation|1|||
126598020|NCT03580356|455490358|FG006|Treatment Period|Protocol Violation|1|||
126598021|NCT03580356|455490359|FG007|Treatment Period|Protocol Violation|0|||
126598022|NCT03580356|455490352|FG000|Treatment Period|Lack of Efficacy|6|||
126598023|NCT03580356|455490353|FG001|Treatment Period|Lack of Efficacy|0|||
126598024|NCT03580356|455490354|FG002|Treatment Period|Lack of Efficacy|2|||
126598025|NCT03580356|455490355|FG003|Treatment Period|Lack of Efficacy|0|||
126598026|NCT03580356|455490356|FG004|Treatment Period|Lack of Efficacy|3|||
126598027|NCT03580356|455490357|FG005|Treatment Period|Lack of Efficacy|0|||
126598028|NCT03580356|455490358|FG006|Treatment Period|Lack of Efficacy|3|||
126598029|NCT03580356|455490359|FG007|Treatment Period|Lack of Efficacy|0|||
126598030|NCT03580356|455490352|FG000|Treatment Period|Pregnancy|1|||
126598031|NCT03580356|455490353|FG001|Treatment Period|Pregnancy|0|||
126598032|NCT03580356|455490354|FG002|Treatment Period|Pregnancy|7|||
126598033|NCT03580356|455490355|FG003|Treatment Period|Pregnancy|0|||
126598034|NCT03580356|455490356|FG004|Treatment Period|Pregnancy|2|||
126598035|NCT03580356|455490357|FG005|Treatment Period|Pregnancy|0|||
126598036|NCT03580356|455490358|FG006|Treatment Period|Pregnancy|1|||
126598037|NCT03580356|455490359|FG007|Treatment Period|Pregnancy|0|||
126598038|NCT03580356|455490352|FG000|Treatment Period|Physician Decision|2|||
126598039|NCT03580356|455490353|FG001|Treatment Period|Physician Decision|0|||
126598040|NCT03580356|455490354|FG002|Treatment Period|Physician Decision|1|||
126598041|NCT03580356|455490355|FG003|Treatment Period|Physician Decision|0|||
126598042|NCT03580356|455490356|FG004|Treatment Period|Physician Decision|4|||
126598043|NCT03580356|455490357|FG005|Treatment Period|Physician Decision|0|||
126598044|NCT03580356|455490358|FG006|Treatment Period|Physician Decision|2|||
126598045|NCT03580356|455490359|FG007|Treatment Period|Physician Decision|0|||
126598046|NCT03580356|455490352|FG000|Treatment Period|Lost to Follow-up|1|||
126598047|NCT03580356|455490353|FG001|Treatment Period|Lost to Follow-up|1|||
126598048|NCT03580356|455490354|FG002|Treatment Period|Lost to Follow-up|1|||
126598049|NCT03580356|455490355|FG003|Treatment Period|Lost to Follow-up|0|||
126598050|NCT03580356|455490356|FG004|Treatment Period|Lost to Follow-up|3|||
126598051|NCT03580356|455490357|FG005|Treatment Period|Lost to Follow-up|0|||
126598052|NCT03580356|455490358|FG006|Treatment Period|Lost to Follow-up|1|||
126598053|NCT03580356|455490359|FG007|Treatment Period|Lost to Follow-up|0|||
126598054|NCT03580356|455490352|FG000|Treatment Period|Death|0|||
126598055|NCT03580356|455490353|FG001|Treatment Period|Death|0|||
126598056|NCT03580356|455490354|FG002|Treatment Period|Death|1|||
126598057|NCT03580356|455490355|FG003|Treatment Period|Death|0|||
126598058|NCT03580356|455490356|FG004|Treatment Period|Death|0|||
126598059|NCT03580356|455490357|FG005|Treatment Period|Death|0|||
126732851|NCT01624506|455972266|FG000|Overall Study|LINX explants|23|||
126732852|NCT01624506|455972267|FG001|Overall Study|LINX explants|0|||
126732853|NCT01624506|455972266|FG000|Overall Study|Adverse Event|3|||
126732854|NCT01624506|455972267|FG001|Overall Study|Adverse Event|0|||
126732855|NCT00132314|455972270|FG000|Overall Study|Lost to Follow-up|70|||
126732856|NCT00132314|455972271|FG001|Overall Study|Lost to Follow-up|62|||
126732857|NCT00132314|455972270|FG000|Overall Study|Lacked SSN|1|||
126732858|NCT00132314|455972271|FG001|Overall Study|Lacked SSN|3|||
126732859|NCT00132314|455972270|FG000|Overall Study|Refused intervention at baseline|2|||
126732860|NCT00132314|455972271|FG001|Overall Study|Refused intervention at baseline|7|||
126732861|NCT05905601|455972272|FG000|Overall Study|Lost to Follow-up|1|||
126732862|NCT05905601|455972273|FG001|Overall Study|Lost to Follow-up|3|||
126732863|NCT02514772|455972274|FG000|Overall Study|Adverse Event|1|||
126732864|NCT02514772|455972275|FG001|Overall Study|Adverse Event|0|||
126732865|NCT02514772|455972274|FG000|Overall Study|Death|0|||
126732866|NCT02514772|455972275|FG001|Overall Study|Death|1|||
126732867|NCT02514772|455972274|FG000|Overall Study|Withdrawal by Subject|2|||
126732868|NCT02514772|455972275|FG001|Overall Study|Withdrawal by Subject|1|||
126732869|NCT03583606|455972276|FG000|Overall Study|Lost to Follow-up|0|||
126732870|NCT03583606|455972277|FG001|Overall Study|Lost to Follow-up|1|||
126732871|NCT03583606|455972278|FG002|Overall Study|Lost to Follow-up|0|||
126732872|NCT03583606|455972276|FG000|Overall Study|Ineligible at baseline|1|||
126732873|NCT03583606|455972277|FG001|Overall Study|Ineligible at baseline|0|||
126598060|NCT03580356|455490358|FG006|Treatment Period|Death|0|||
126732874|NCT03583606|455972278|FG002|Overall Study|Ineligible at baseline|0|||
126732875|NCT03250377|455972279|FG000|Overall Study|Adverse Event|2|||
126732876|NCT03250377|455972280|FG001|Overall Study|Adverse Event|4|||
126732877|NCT03250377|455972281|FG002|Overall Study|Adverse Event|0|||
126732878|NCT03250377|455972282|FG003|Overall Study|Adverse Event|4|||
126732879|NCT03250377|455972279|FG000|Overall Study|Lack of Efficacy|5|||
126598061|NCT03580356|455490359|FG007|Treatment Period|Death|0|||
126598062|NCT03580356|455490352|FG000|Treatment Period|Technical problems|0|||
126598063|NCT03580356|455490353|FG001|Treatment Period|Technical problems|0|||
126598064|NCT03580356|455490354|FG002|Treatment Period|Technical problems|0|||
126598065|NCT03580356|455490355|FG003|Treatment Period|Technical problems|0|||
126598066|NCT03580356|455490356|FG004|Treatment Period|Technical problems|1|||
126598067|NCT03580356|455490357|FG005|Treatment Period|Technical problems|0|||
126598068|NCT03580356|455490358|FG006|Treatment Period|Technical problems|0|||
126598069|NCT03580356|455490359|FG007|Treatment Period|Technical problems|0|||
126598070|NCT03580356|455490352|FG000|Treatment Period|Misrandomized, no treatment|0|||
126598071|NCT03580356|455490353|FG001|Treatment Period|Misrandomized, no treatment|0|||
126598072|NCT03580356|455490354|FG002|Treatment Period|Misrandomized, no treatment|1|||
126598073|NCT03580356|455490355|FG003|Treatment Period|Misrandomized, no treatment|0|||
126598074|NCT03580356|455490356|FG004|Treatment Period|Misrandomized, no treatment|2|||
126598075|NCT03580356|455490357|FG005|Treatment Period|Misrandomized, no treatment|0|||
126598076|NCT03580356|455490358|FG006|Treatment Period|Misrandomized, no treatment|0|||
126598077|NCT03580356|455490359|FG007|Treatment Period|Misrandomized, no treatment|0|||
126598078|NCT03580356|455490352|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
126598079|NCT03580356|455490353|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
126598080|NCT03580356|455490354|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
126598081|NCT03580356|455490355|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
126598082|NCT03580356|455490356|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
126598083|NCT03580356|455490357|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
126598084|NCT03580356|455490358|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
126598085|NCT03580356|455490359|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
126598086|NCT03580356|455490352|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
126598087|NCT03580356|455490353|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
126598088|NCT03580356|455490354|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
126598089|NCT03580356|455490355|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
126598090|NCT03580356|455490356|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
126598091|NCT03580356|455490357|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
126598092|NCT03580356|455490358|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
126598093|NCT03580356|455490359|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
126598094|NCT03580356|455490352|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
126598095|NCT03580356|455490353|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
126598096|NCT03580356|455490354|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
126598097|NCT03580356|455490355|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
126598098|NCT03580356|455490356|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
126598099|NCT03580356|455490357|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
126598100|NCT03580356|455490358|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
126598101|NCT03580356|455490359|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
126598102|NCT03580356|455490352|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
126598103|NCT03580356|455490353|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
126598104|NCT03580356|455490354|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
126598105|NCT03580356|455490355|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
126598106|NCT03580356|455490356|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
126598107|NCT03580356|455490357|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
126598108|NCT03580356|455490358|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
126598109|NCT03580356|455490359|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
126598110|NCT03580356|455490352|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
126598111|NCT03580356|455490353|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
126598112|NCT03580356|455490354|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
126598113|NCT03580356|455490355|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
126598114|NCT03580356|455490356|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
126598115|NCT03580356|455490357|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
126598116|NCT03580356|455490358|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
126598117|NCT03580356|455490359|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
126598118|NCT03580356|455490352|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
126598119|NCT03580356|455490353|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
126598120|NCT03580356|455490354|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
126598121|NCT03580356|455490355|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
126598122|NCT03580356|455490356|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
126598123|NCT03580356|455490357|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
126598124|NCT03580356|455490358|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
126598125|NCT03580356|455490359|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
126598126|NCT03580356|455490352|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
126598127|NCT03580356|455490353|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
126598128|NCT03580356|455490354|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
126732880|NCT03250377|455972280|FG001|Overall Study|Lack of Efficacy|14|||
126732881|NCT03250377|455972281|FG002|Overall Study|Lack of Efficacy|1|||
126598129|NCT03580356|455490355|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
126598130|NCT03580356|455490356|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
126598131|NCT03580356|455490357|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
126598132|NCT03580356|455490358|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
126598133|NCT03580356|455490359|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
126598134|NCT05715528|455490360|FG000|Overall Study|Randomized but never treated|11|||
126598135|NCT05715528|455490361|FG001|Overall Study|Randomized but never treated|13|||
126598136|NCT05715528|455490360|FG000|Overall Study|Withdrew consent|7|||
126598137|NCT05715528|455490361|FG001|Overall Study|Withdrew consent|15|||
126598138|NCT05715528|455490360|FG000|Overall Study|Lost to Follow-up|5|||
126598139|NCT05715528|455490361|FG001|Overall Study|Lost to Follow-up|13|||
126598140|NCT05715528|455490360|FG000|Overall Study|Investigator's discretion|3|||
126598141|NCT05715528|455490361|FG001|Overall Study|Investigator's discretion|1|||
126598142|NCT05715528|455490360|FG000|Overall Study|Protocol Violation|2|||
126598143|NCT05715528|455490361|FG001|Overall Study|Protocol Violation|0|||
126598144|NCT05715528|455490360|FG000|Overall Study|Non-compliance with study drug|0|||
126598145|NCT05715528|455490361|FG001|Overall Study|Non-compliance with study drug|1|||
126598146|NCT03118518|455490362|FG000|Overall Study|Early Exit after treatment|2|||
126598147|NCT03118518|455490363|FG001|Overall Study|Early Exit after treatment|8|||
126598148|NCT03118518|455490362|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
126598149|NCT03118518|455490363|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
126598150|NCT03536884|455490369|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
126598151|NCT03536884|455490370|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
126598152|NCT03536884|455490371|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126598153|NCT03536884|455490372|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126598154|NCT03536884|455490373|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126598155|NCT03536884|455490374|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126598156|NCT03536884|455490375|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126598157|NCT03536884|455490376|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126598158|NCT03536884|455490377|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126598159|NCT03536884|455490378|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126598160|NCT03536884|455490379|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126598161|NCT03536884|455490380|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
126598162|NCT03536884|455490369|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126598163|NCT03536884|455490370|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
126598164|NCT03536884|455490371|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126598165|NCT03536884|455490372|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126598166|NCT03536884|455490373|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126598167|NCT03536884|455490374|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126598168|NCT03536884|455490375|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126598169|NCT03536884|455490376|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126598170|NCT03536884|455490377|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126598171|NCT03536884|455490378|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126598172|NCT03536884|455490379|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126598173|NCT03536884|455490380|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
126598174|NCT03536884|455490369|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
126598175|NCT03536884|455490370|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
126598176|NCT03536884|455490371|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126598177|NCT03536884|455490372|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126598178|NCT03536884|455490373|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126598179|NCT03536884|455490374|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126598180|NCT03536884|455490375|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126598181|NCT03536884|455490376|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126598182|NCT03536884|455490377|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126598183|NCT03536884|455490378|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126598184|NCT03536884|455490379|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126598185|NCT03536884|455490380|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
126598186|NCT03536884|455490369|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126598187|NCT03536884|455490370|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
126598188|NCT03536884|455490371|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126598189|NCT03536884|455490372|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126598190|NCT03536884|455490373|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126598191|NCT03536884|455490374|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126598192|NCT03536884|455490375|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126598193|NCT03536884|455490376|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126598194|NCT03536884|455490377|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126598195|NCT03536884|455490378|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126598196|NCT03536884|455490379|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126598197|NCT03536884|455490380|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
126598198|NCT03536884|455490369|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126598199|NCT03536884|455490370|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
126598200|NCT03536884|455490371|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126598201|NCT03536884|455490372|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126598202|NCT03536884|455490373|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126598203|NCT03536884|455490374|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126598204|NCT03536884|455490375|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126598205|NCT03536884|455490376|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126598206|NCT03536884|455490377|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126598207|NCT03536884|455490378|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126598208|NCT03536884|455490379|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126598209|NCT03536884|455490380|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
126598210|NCT03536884|455490369|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126598211|NCT03536884|455490370|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
126598212|NCT03536884|455490371|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126598213|NCT03536884|455490372|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126598214|NCT03536884|455490373|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126598215|NCT03536884|455490374|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126598216|NCT03536884|455490375|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126732882|NCT03250377|455972282|FG003|Overall Study|Lack of Efficacy|3|||
126732883|NCT03250377|455972279|FG000|Overall Study|Protocol Violation|0|||
126732884|NCT03250377|455972280|FG001|Overall Study|Protocol Violation|2|||
126732885|NCT03250377|455972281|FG002|Overall Study|Protocol Violation|0|||
126732886|NCT03250377|455972282|FG003|Overall Study|Protocol Violation|1|||
126732887|NCT03250377|455972279|FG000|Overall Study|Lost to Follow-up|0|||
126732888|NCT03250377|455972280|FG001|Overall Study|Lost to Follow-up|1|||
126732889|NCT03250377|455972281|FG002|Overall Study|Lost to Follow-up|0|||
126732890|NCT03250377|455972282|FG003|Overall Study|Lost to Follow-up|0|||
126732891|NCT03250377|455972279|FG000|Overall Study|Withdrawal by Subject|7|||
126732892|NCT03250377|455972280|FG001|Overall Study|Withdrawal by Subject|7|||
126732893|NCT03250377|455972281|FG002|Overall Study|Withdrawal by Subject|0|||
126732894|NCT03250377|455972282|FG003|Overall Study|Withdrawal by Subject|4|||
126732895|NCT03250377|455972279|FG000|Overall Study|Investigator's Judgment|1|||
126732896|NCT03250377|455972280|FG001|Overall Study|Investigator's Judgment|0|||
126732897|NCT03250377|455972281|FG002|Overall Study|Investigator's Judgment|0|||
126732898|NCT03250377|455972282|FG003|Overall Study|Investigator's Judgment|0|||
126732899|NCT03250377|455972279|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
126732900|NCT03250377|455972280|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
126732901|NCT03250377|455972281|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
126732902|NCT03250377|455972282|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
126732903|NCT03250377|455972279|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
126732904|NCT03250377|455972280|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
126732905|NCT03250377|455972281|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
126732906|NCT03250377|455972282|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
126732907|NCT03250377|455972279|FG000|Overall Study|Epilepsy Surgery|0|||
126732908|NCT03250377|455972280|FG001|Overall Study|Epilepsy Surgery|1|||
126732909|NCT03250377|455972281|FG002|Overall Study|Epilepsy Surgery|2|||
126732910|NCT03250377|455972282|FG003|Overall Study|Epilepsy Surgery|0|||
126732911|NCT03250377|455972279|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
126732912|NCT03250377|455972280|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
126732913|NCT03250377|455972281|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
126732914|NCT03250377|455972282|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
126732915|NCT03250377|455972279|FG000|Overall Study|Request From The Sponsor|0|||
126732916|NCT03250377|455972280|FG001|Overall Study|Request From The Sponsor|1|||
126732917|NCT03250377|455972281|FG002|Overall Study|Request From The Sponsor|0|||
126732918|NCT03250377|455972282|FG003|Overall Study|Request From The Sponsor|0|||
126732919|NCT03250377|455972279|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
126732920|NCT03250377|455972280|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
126732921|NCT03250377|455972281|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
126732922|NCT03250377|455972282|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
126732923|NCT03250377|455972279|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
126732924|NCT03250377|455972280|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
126598217|NCT03536884|455490376|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126598218|NCT03536884|455490377|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126598219|NCT03536884|455490378|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126598220|NCT03536884|455490379|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126598221|NCT03536884|455490380|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
126598222|NCT03536884|455490369|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
126598223|NCT03536884|455490370|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
126598224|NCT03536884|455490371|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
126598225|NCT03536884|455490372|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
126598226|NCT03536884|455490373|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
126598227|NCT03536884|455490374|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
126598228|NCT03536884|455490375|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
126598229|NCT03536884|455490376|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
126598230|NCT03536884|455490377|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
126598231|NCT03536884|455490378|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
126598232|NCT03536884|455490379|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
126598233|NCT03536884|455490380|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
126598234|NCT03536884|455490369|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126598235|NCT03536884|455490370|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126598236|NCT03536884|455490371|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
126598237|NCT03536884|455490372|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
126598238|NCT03536884|455490373|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
126598239|NCT03536884|455490374|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126598240|NCT03536884|455490375|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126598241|NCT03536884|455490376|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126598242|NCT03536884|455490377|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126598243|NCT03536884|455490378|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126598244|NCT03536884|455490379|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126598245|NCT03536884|455490380|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
126598246|NCT03536884|455490369|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126598247|NCT03536884|455490370|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126598248|NCT03536884|455490371|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126598249|NCT03536884|455490372|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
126598250|NCT03536884|455490373|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
126598251|NCT03536884|455490374|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126598252|NCT03536884|455490375|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126598253|NCT03536884|455490376|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126598254|NCT03536884|455490377|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126598255|NCT03536884|455490378|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126598256|NCT03536884|455490379|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126598257|NCT03536884|455490380|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
126598258|NCT03536884|455490369|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126598259|NCT03536884|455490370|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126598260|NCT03536884|455490371|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
126598261|NCT03536884|455490372|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
126598262|NCT03536884|455490373|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
126598263|NCT03536884|455490374|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126598264|NCT03536884|455490375|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126598265|NCT03536884|455490376|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126598266|NCT03536884|455490377|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126598267|NCT03536884|455490378|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126779566|NCT02173301|456147017|FG001|Overall Study|Withdrawal by Subject|10|||
126779567|NCT02173301|456147018|FG002|Overall Study|Withdrawal by Subject|4|||
126779568|NCT02173301|456147019|FG003|Overall Study|Withdrawal by Subject|8|||
126779569|NCT02173301|456147016|FG000|Overall Study|Lost to Follow-up|4|||
126779570|NCT02173301|456147017|FG001|Overall Study|Lost to Follow-up|4|||
126779571|NCT02173301|456147018|FG002|Overall Study|Lost to Follow-up|2|||
126598268|NCT03536884|455490379|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126598269|NCT03536884|455490380|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
126598270|NCT03536884|455490369|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126598271|NCT03536884|455490370|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126598272|NCT03536884|455490371|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
126598273|NCT03536884|455490372|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
126598274|NCT03536884|455490373|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
126598275|NCT03536884|455490374|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126598276|NCT03536884|455490375|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126779572|NCT02173301|456147019|FG003|Overall Study|Lost to Follow-up|2|||
126598277|NCT03536884|455490376|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126598278|NCT03536884|455490377|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126779573|NCT02173301|456147016|FG000|Overall Study|Protocol Violation|0|||
126779574|NCT02173301|456147017|FG001|Overall Study|Protocol Violation|1|||
126779575|NCT02173301|456147018|FG002|Overall Study|Protocol Violation|0|||
126779576|NCT02173301|456147019|FG003|Overall Study|Protocol Violation|0|||
126779577|NCT02173301|456147016|FG000|Overall Study|Physician Decision|0|||
126779578|NCT02173301|456147017|FG001|Overall Study|Physician Decision|0|||
126779579|NCT02173301|456147018|FG002|Overall Study|Physician Decision|1|||
126779580|NCT02173301|456147019|FG003|Overall Study|Physician Decision|0|||
126779581|NCT02173301|456147016|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
126779582|NCT02173301|456147017|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
126779583|NCT02173301|456147018|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
126779584|NCT02173301|456147019|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
126779585|NCT03016078|456147021|FG000|Overall Study|Protocol Violation|1|||
126779586|NCT03016078|456147021|FG000|Overall Study|Protocol Violation|1|||
126779587|NCT03372083|456149544|FG000|Overall Study|Adverse Event|3|||
126779588|NCT03372083|456149544|FG000|Overall Study|Physician Decision|1|||
126779589|NCT03372083|456149544|FG000|Overall Study|Withdrawal by Subject|1|||
126779590|NCT00827827|456149545|FG000|Overall Study|Lost to Follow-up|3|||
126779591|NCT00827827|456149546|FG001|Overall Study|Lost to Follow-up|0|||
126779592|NCT00827827|456149545|FG000|Overall Study|Fall at home- hospitalization|1|||
126779593|NCT00827827|456149546|FG001|Overall Study|Fall at home- hospitalization|0|||
126779594|NCT00827827|456149545|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
126779595|NCT00827827|456149546|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
126779596|NCT00827827|456149545|FG000|Overall Study|Gout|1|||
126779597|NCT00827827|456149546|FG001|Overall Study|Gout|0|||
126779598|NCT00827827|456149545|FG000|Overall Study|Transportation issues|1|||
126779599|NCT00827827|456149546|FG001|Overall Study|Transportation issues|0|||
126779600|NCT00827827|456149545|FG000|Overall Study|Burned with water at home|1|||
126779601|NCT00827827|456149546|FG001|Overall Study|Burned with water at home|0|||
126779602|NCT02884206|456149547|FG000|Valsartan Run-in Period|Death|1|||
126779603|NCT02884206|456149548|FG001|Valsartan Run-in Period|Death|0|||
126779604|NCT02884206|456149549|FG002|Valsartan Run-in Period|Death|0|||
126779605|NCT02884206|456149547|FG000|Valsartan Run-in Period|Adverse Event|31|||
126779606|NCT02884206|456149548|FG001|Valsartan Run-in Period|Adverse Event|0|||
126779607|NCT02884206|456149549|FG002|Valsartan Run-in Period|Adverse Event|0|||
126779608|NCT02884206|456149547|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
126779609|NCT02884206|456149548|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
126779610|NCT02884206|456149549|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
126779611|NCT02884206|456149547|FG000|Valsartan Run-in Period|Protocol deviation|4|||
126779612|NCT02884206|456149548|FG001|Valsartan Run-in Period|Protocol deviation|0|||
126779613|NCT02884206|456149549|FG002|Valsartan Run-in Period|Protocol deviation|0|||
126779614|NCT02884206|456149547|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
126779615|NCT02884206|456149548|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
126779616|NCT02884206|456149549|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
126779617|NCT02884206|456149547|FG000|Valsartan Run-in Period|Physician Decision|1|||
126779618|NCT02884206|456149548|FG001|Valsartan Run-in Period|Physician Decision|0|||
126779619|NCT02884206|456149549|FG002|Valsartan Run-in Period|Physician Decision|0|||
126779620|NCT02884206|456149547|FG000|LCZ696 Run-in Period|Adverse Event|38|||
126779621|NCT02884206|456149548|FG001|LCZ696 Run-in Period|Adverse Event|0|||
126779622|NCT02884206|456149549|FG002|LCZ696 Run-in Period|Adverse Event|0|||
126779623|NCT02884206|456149547|FG000|LCZ696 Run-in Period|Death|2|||
126779624|NCT02884206|456149548|FG001|LCZ696 Run-in Period|Death|0|||
126779625|NCT02884206|456149549|FG002|LCZ696 Run-in Period|Death|0|||
126779626|NCT02884206|456149547|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
126779627|NCT02884206|456149548|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
126779628|NCT02884206|456149549|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
126779629|NCT02884206|456149547|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
126779630|NCT02884206|456149548|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
126779631|NCT02884206|456149549|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
126779632|NCT02884206|456149547|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
126779633|NCT02884206|456149548|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
126779634|NCT02884206|456149549|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
126779635|NCT02884206|456149547|FG000|LCZ696 Run-in Period|Physician Decision|1|||
126779636|NCT02884206|456149548|FG001|LCZ696 Run-in Period|Physician Decision|0|||
126779637|NCT02884206|456149549|FG002|LCZ696 Run-in Period|Physician Decision|0|||
126779638|NCT02884206|456149547|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
126779639|NCT02884206|456149548|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
126779640|NCT02884206|456149549|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
126779641|NCT02884206|456149547|FG000|Double-Blind Period|Death|0|||
126779642|NCT02884206|456149548|FG001|Double-Blind Period|Death|28|||
126779643|NCT02884206|456149549|FG002|Double-Blind Period|Death|39|||
126779644|NCT02884206|456149547|FG000|Double-Blind Period|Patient/guardian decision|0|||
126732925|NCT03250377|455972281|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
126732926|NCT03250377|455972282|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
126732927|NCT03250377|455972279|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
126732928|NCT03250377|455972280|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
126732929|NCT03250377|455972281|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
126732930|NCT03250377|455972282|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
126732931|NCT03250377|455972279|FG000|Overall Study|Pregnancy Event|0|||
126732932|NCT03250377|455972280|FG001|Overall Study|Pregnancy Event|1|||
126732933|NCT03250377|455972281|FG002|Overall Study|Pregnancy Event|0|||
126732934|NCT03250377|455972282|FG003|Overall Study|Pregnancy Event|0|||
126732935|NCT03250377|455972279|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
126732936|NCT03250377|455972280|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
126732937|NCT03250377|455972281|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
126732938|NCT03250377|455972282|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
126732939|NCT03250377|455972279|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
126732940|NCT03250377|455972280|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
126732941|NCT03250377|455972281|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
126732942|NCT03250377|455972282|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
126732943|NCT03250377|455972279|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
126732944|NCT03250377|455972280|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
126732945|NCT03250377|455972281|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
126732946|NCT03250377|455972282|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
126732947|NCT03250377|455972279|FG000|Overall Study|Patient requested to change hospital|0|||
126732948|NCT03250377|455972280|FG001|Overall Study|Patient requested to change hospital|0|||
126732949|NCT03250377|455972281|FG002|Overall Study|Patient requested to change hospital|0|||
126732950|NCT03250377|455972282|FG003|Overall Study|Patient requested to change hospital|1|||
126732951|NCT03250377|455972279|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
126732952|NCT03250377|455972280|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
126732953|NCT03250377|455972281|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
126732954|NCT03250377|455972282|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
126732955|NCT00817206|455972283|FG000|Overall Study|Adverse Event|10|||
126732956|NCT00817206|455972284|FG001|Overall Study|Adverse Event|3|||
126732957|NCT00817206|455972283|FG000|Overall Study|Protocol Violation|0|||
126732958|NCT00817206|455972284|FG001|Overall Study|Protocol Violation|2|||
126732959|NCT00817206|455972283|FG000|Overall Study|Lost to Follow-up|0|||
126732960|NCT00817206|455972284|FG001|Overall Study|Lost to Follow-up|1|||
126732961|NCT00817206|455972283|FG000|Overall Study|Death|2|||
126732962|NCT00817206|455972284|FG001|Overall Study|Death|0|||
126732963|NCT00817206|455972283|FG000|Overall Study|Withdrawal by Subject|7|||
126732964|NCT00817206|455972284|FG001|Overall Study|Withdrawal by Subject|3|||
126732965|NCT00817206|455972283|FG000|Overall Study|Physician Decision|2|||
126732966|NCT00817206|455972284|FG001|Overall Study|Physician Decision|0|||
126732967|NCT03657810|455972287|FG000|Overall Study|Adverse Event|0|||
126732968|NCT03657810|455972288|FG001|Overall Study|Adverse Event|1|||
126732969|NCT03657810|455972289|FG002|Overall Study|Adverse Event|0|||
126732970|NCT03657810|455972287|FG000|Overall Study|Lack of Efficacy|4|||
126732971|NCT03657810|455972288|FG001|Overall Study|Lack of Efficacy|1|||
126732972|NCT03657810|455972289|FG002|Overall Study|Lack of Efficacy|3|||
126732973|NCT03657810|455972287|FG000|Overall Study|Protocol Violation|1|||
126732974|NCT03657810|455972288|FG001|Overall Study|Protocol Violation|0|||
126732975|NCT03657810|455972289|FG002|Overall Study|Protocol Violation|0|||
126732976|NCT03657810|455972287|FG000|Overall Study|Lost to Follow-up|0|||
126732977|NCT03657810|455972288|FG001|Overall Study|Lost to Follow-up|1|||
126732978|NCT03657810|455972289|FG002|Overall Study|Lost to Follow-up|0|||
126732979|NCT03657810|455972287|FG000|Overall Study|Not provided|0|||
126732980|NCT03657810|455972288|FG001|Overall Study|Not provided|1|||
126732981|NCT03657810|455972289|FG002|Overall Study|Not provided|0|||
126732982|NCT03939637|455972298|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
126732983|NCT03939637|455972299|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
126732984|NCT03939637|455972298|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
126732985|NCT03939637|455972299|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
126732986|NCT05224076|455972300|FG000|Overall Study|Lost to Follow-up|24|||
126732987|NCT01082367|455972301|FG000|Double-blind Period|Administrative problems|0|||
126732988|NCT01082367|455972302|FG001|Double-blind Period|Administrative problems|1|||
126732989|NCT01082367|455972301|FG000|Double-blind Period|Lack of Efficacy|5|||
126732990|NCT01082367|455972302|FG001|Double-blind Period|Lack of Efficacy|11|||
126732991|NCT01082367|455972301|FG000|Double-blind Period|Adverse Event|0|||
126732992|NCT01082367|455972302|FG001|Double-blind Period|Adverse Event|1|||
126779645|NCT02884206|456149548|FG001|Double-Blind Period|Patient/guardian decision|10|||
126779646|NCT02884206|456149549|FG002|Double-Blind Period|Patient/guardian decision|13|||
126598279|NCT03536884|455490378|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126598280|NCT03536884|455490379|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126598281|NCT03536884|455490380|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
126598282|NCT03536884|455490369|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
126598283|NCT03536884|455490370|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
126598284|NCT03536884|455490371|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
126598285|NCT03536884|455490372|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
126598286|NCT03536884|455490373|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
126732993|NCT01082367|455972301|FG000|Follow-up (F-U) Period|Administrative problems|1|||
126732994|NCT01082367|455972302|FG001|Follow-up (F-U) Period|Administrative problems|0|||
126732995|NCT01082367|455972301|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
126732996|NCT01082367|455972302|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
126732997|NCT01082367|455972301|FG000|Follow-up (F-U) Period|Adverse Event|0|||
126732998|NCT01082367|455972302|FG001|Follow-up (F-U) Period|Adverse Event|1|||
126732999|NCT02016898|455972303|FG000|Overall Study|Death|1|||
126733000|NCT02016898|455972304|FG001|Overall Study|Death|1|||
126733001|NCT02016898|455972303|FG000|Overall Study|Lost to Follow-up|4|||
126733002|NCT02016898|455972304|FG001|Overall Study|Lost to Follow-up|4|||
126733003|NCT01665768|455972305|FG000|Overall Study|Adverse Event|3|||
126733004|NCT01665768|455972305|FG000|Overall Study|Lack of Efficacy|19|||
126733005|NCT01665768|455972305|FG000|Overall Study|Withdrawal by Subject|1|||
126733006|NCT01329341|455972306|FG000|Overall Study|Withdrawal by Subject|44|||
126733007|NCT03017846|455972307|FG000|Overall Study|Lost to Follow-up|3|||
126733008|NCT03017846|455972307|FG000|Overall Study|Adverse Event|2|||
126733009|NCT04603391|455972308|FG000|First Intervention (4 Days)|Adverse Event|1|||
126733010|NCT04603391|455972309|FG001|First Intervention (4 Days)|Adverse Event|0|||
126733011|NCT04603391|455972308|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
126733012|NCT04603391|455972309|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
126733013|NCT02151682|455972310|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
126733014|NCT02151682|455972311|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
126733015|NCT02151682|455972312|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
126733016|NCT02151682|455972313|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
126733017|NCT02151682|455972314|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
126733018|NCT02151682|455972315|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
126733019|NCT02151682|455972310|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
126733020|NCT02151682|455972311|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
126733021|NCT02151682|455972312|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
126733022|NCT02151682|455972313|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
126733023|NCT02151682|455972314|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
126733024|NCT02151682|455972315|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
126733025|NCT02151682|455972310|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
126733026|NCT02151682|455972311|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
126733027|NCT02151682|455972312|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
126733028|NCT02151682|455972313|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
126733029|NCT02151682|455972314|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
126733030|NCT02151682|455972315|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
126733031|NCT02151682|455972310|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
126733032|NCT02151682|455972311|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
126733033|NCT02151682|455972312|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
126733034|NCT02151682|455972313|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
126733035|NCT02151682|455972314|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
126733036|NCT02151682|455972315|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
126733037|NCT02151682|455972310|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
126733038|NCT02151682|455972311|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
126733039|NCT02151682|455972312|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
126733040|NCT02151682|455972313|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
126733041|NCT02151682|455972314|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
126733042|NCT02151682|455972315|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
126733043|NCT02151682|455972310|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
126733044|NCT02151682|455972311|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
126733045|NCT02151682|455972312|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
126733046|NCT02151682|455972313|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
126733047|NCT02151682|455972314|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
126733048|NCT02151682|455972315|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
126733049|NCT02151682|455972310|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
126733050|NCT02151682|455972311|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
126733051|NCT02151682|455972312|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
126733052|NCT02151682|455972313|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
126733053|NCT02151682|455972314|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
126598287|NCT03536884|455490374|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
126598288|NCT03536884|455490375|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
126598289|NCT03536884|455490376|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
126598290|NCT03536884|455490377|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
126598291|NCT03536884|455490378|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
126598292|NCT03536884|455490379|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
126598293|NCT03536884|455490380|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
126598294|NCT03536884|455490369|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126598295|NCT03536884|455490370|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126598296|NCT03536884|455490371|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126598297|NCT03536884|455490372|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126598298|NCT03536884|455490373|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126598299|NCT03536884|455490374|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
126598300|NCT03536884|455490375|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
126598301|NCT03536884|455490376|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
126598302|NCT03536884|455490377|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
126598303|NCT03536884|455490378|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126598304|NCT03536884|455490379|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126598305|NCT03536884|455490380|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
126598306|NCT03536884|455490369|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126598307|NCT03536884|455490370|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126598308|NCT03536884|455490371|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126598309|NCT03536884|455490372|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126598310|NCT03536884|455490373|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126598311|NCT03536884|455490374|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
126598312|NCT03536884|455490375|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126598313|NCT03536884|455490376|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
126598314|NCT03536884|455490377|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126733054|NCT02151682|455972315|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
126733055|NCT02151682|455972310|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
126733056|NCT02151682|455972311|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
126733057|NCT02151682|455972312|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
126733058|NCT02151682|455972313|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
126733059|NCT02151682|455972314|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
126733060|NCT02151682|455972315|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
126733061|NCT02151682|455972310|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
126733062|NCT02151682|455972311|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
126733063|NCT02151682|455972312|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
126733064|NCT02151682|455972313|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
126733065|NCT02151682|455972314|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
126733066|NCT02151682|455972315|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
126733067|NCT02151682|455972310|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
126733068|NCT02151682|455972311|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
126733069|NCT02151682|455972312|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
126733070|NCT02151682|455972313|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
126733071|NCT02151682|455972314|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
126733072|NCT02151682|455972315|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
126733073|NCT02151682|455972310|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
126733074|NCT02151682|455972311|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
126733075|NCT02151682|455972312|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
126733076|NCT02151682|455972313|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
126733077|NCT02151682|455972314|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
126733078|NCT02151682|455972315|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
126733079|NCT02151682|455972310|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
126733080|NCT02151682|455972311|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
126733081|NCT02151682|455972312|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
126733082|NCT02151682|455972313|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
126733083|NCT02151682|455972314|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
126733084|NCT02151682|455972315|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
126733085|NCT02151682|455972310|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
126733086|NCT02151682|455972311|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
126733087|NCT02151682|455972312|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
126733088|NCT02151682|455972313|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
126733089|NCT02151682|455972314|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
126733090|NCT02151682|455972315|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
126598315|NCT03536884|455490378|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126598316|NCT03536884|455490379|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126598317|NCT03536884|455490380|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
126598318|NCT03536884|455490369|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126598319|NCT03536884|455490370|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126598320|NCT03536884|455490371|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126598321|NCT03536884|455490372|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126598322|NCT03536884|455490373|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126598323|NCT03536884|455490374|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
126598324|NCT03536884|455490375|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126598325|NCT03536884|455490376|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
126598326|NCT03536884|455490377|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
126598327|NCT03536884|455490378|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126598328|NCT03536884|455490379|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126598329|NCT03536884|455490380|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
126598330|NCT03536884|455490369|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126598331|NCT03536884|455490370|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126598332|NCT03536884|455490371|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126598333|NCT03536884|455490372|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126598334|NCT03536884|455490373|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126598335|NCT03536884|455490374|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
126598336|NCT03536884|455490375|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
126598337|NCT03536884|455490376|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
126598338|NCT03536884|455490377|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
126598339|NCT03536884|455490378|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126598340|NCT03536884|455490379|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126598341|NCT03536884|455490380|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
126733091|NCT02151682|455972310|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
126733092|NCT02151682|455972311|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
126733093|NCT02151682|455972312|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
126733094|NCT02151682|455972313|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
126733095|NCT02151682|455972314|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
126733096|NCT02151682|455972315|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
126733097|NCT02151682|455972310|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
126733098|NCT02151682|455972311|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
126733099|NCT02151682|455972312|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
126733100|NCT02151682|455972313|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
126733101|NCT02151682|455972314|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
126733102|NCT02151682|455972315|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
126733103|NCT02151682|455972310|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
126733104|NCT02151682|455972311|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
126733105|NCT02151682|455972312|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
126733106|NCT02151682|455972313|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
126733107|NCT02151682|455972314|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
126733108|NCT02151682|455972315|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
126733109|NCT02151682|455972310|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
126733110|NCT02151682|455972311|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
126733111|NCT02151682|455972312|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
126733112|NCT02151682|455972313|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
126733113|NCT02151682|455972314|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
126733114|NCT02151682|455972315|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
126733115|NCT02151682|455972310|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
126733116|NCT02151682|455972311|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
126733117|NCT02151682|455972312|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
126733118|NCT02151682|455972313|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
126733119|NCT02151682|455972314|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
126733120|NCT02151682|455972315|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
126733121|NCT01306032|455972316|FG000|First Intervention|Adverse Event|1|||
126733122|NCT01306032|455972317|FG001|First Intervention|Adverse Event|0|||
126733123|NCT01306032|455972318|FG002|First Intervention|Adverse Event|1|||
126733124|NCT01306032|455972319|FG003|First Intervention|Adverse Event|0|||
126733125|NCT01306032|455972320|FG004|First Intervention|Adverse Event|0|||
126733126|NCT01306032|455972321|FG005|First Intervention|Adverse Event|1|||
126733127|NCT01306032|455972316|FG000|First Intervention|Withdrawal by Subject|0|||
126733128|NCT01306032|455972317|FG001|First Intervention|Withdrawal by Subject|2|||
126733129|NCT01306032|455972318|FG002|First Intervention|Withdrawal by Subject|0|||
126733130|NCT01306032|455972319|FG003|First Intervention|Withdrawal by Subject|1|||
126733131|NCT01306032|455972320|FG004|First Intervention|Withdrawal by Subject|0|||
126733132|NCT01306032|455972321|FG005|First Intervention|Withdrawal by Subject|0|||
126733133|NCT01306032|455972316|FG000|First Intervention|Death|0|||
126733134|NCT01306032|455972317|FG001|First Intervention|Death|0|||
126733135|NCT01306032|455972318|FG002|First Intervention|Death|1|||
126733136|NCT01306032|455972319|FG003|First Intervention|Death|0|||
126598342|NCT03536884|455490369|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126598343|NCT03536884|455490370|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126598344|NCT03536884|455490371|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126598345|NCT03536884|455490372|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126598346|NCT03536884|455490373|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126598347|NCT03536884|455490374|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
126598348|NCT03536884|455490375|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126598349|NCT03536884|455490376|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126598350|NCT03536884|455490377|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126598351|NCT03536884|455490378|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126598352|NCT03536884|455490379|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126598353|NCT03536884|455490380|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
126598354|NCT03536884|455490369|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126598355|NCT03536884|455490370|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126598356|NCT03536884|455490371|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126598357|NCT03536884|455490372|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126598358|NCT03536884|455490373|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126598359|NCT03536884|455490374|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126598360|NCT03536884|455490375|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
126598361|NCT03536884|455490376|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126598362|NCT03536884|455490377|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126598363|NCT03536884|455490378|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126598364|NCT03536884|455490379|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126598365|NCT03536884|455490380|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
126598366|NCT03536884|455490369|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126598367|NCT03536884|455490370|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126598368|NCT03536884|455490371|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126598369|NCT03536884|455490372|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126598370|NCT03536884|455490373|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126598371|NCT03536884|455490374|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126598372|NCT03536884|455490375|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
126598373|NCT03536884|455490376|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126598374|NCT03536884|455490377|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126598375|NCT03536884|455490378|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126598376|NCT03536884|455490379|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126598377|NCT03536884|455490380|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
126598378|NCT03536884|455490369|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
126598379|NCT03536884|455490370|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
126598380|NCT03536884|455490371|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
126598381|NCT03536884|455490372|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
126598382|NCT03536884|455490373|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
126598383|NCT03536884|455490374|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
126598384|NCT03536884|455490375|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
126598385|NCT03536884|455490376|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
126598386|NCT03536884|455490377|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
126598387|NCT03536884|455490378|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
126598388|NCT03536884|455490379|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
126598389|NCT03536884|455490380|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
126598390|NCT03536884|455490369|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126598391|NCT03536884|455490370|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126598392|NCT03536884|455490371|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126598393|NCT03536884|455490372|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126598394|NCT03536884|455490373|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126598395|NCT03536884|455490374|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126598396|NCT03536884|455490375|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126598397|NCT03536884|455490376|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126598398|NCT03536884|455490377|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
126598399|NCT03536884|455490378|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126598400|NCT03536884|455490379|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126598401|NCT03536884|455490380|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
126598402|NCT03536884|455490369|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126598403|NCT03536884|455490370|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126598404|NCT03536884|455490371|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126598405|NCT03536884|455490372|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126598406|NCT03536884|455490373|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126598407|NCT03536884|455490374|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126598408|NCT03536884|455490375|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126598409|NCT03536884|455490376|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126598410|NCT03536884|455490377|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
126598411|NCT03536884|455490378|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
126598412|NCT03536884|455490379|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
126598413|NCT03536884|455490380|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
126598414|NCT03536884|455490369|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126598415|NCT03536884|455490370|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126598416|NCT03536884|455490371|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126598417|NCT03536884|455490372|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126598418|NCT03536884|455490373|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126598419|NCT03536884|455490374|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126598420|NCT03536884|455490375|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126598421|NCT03536884|455490376|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126598422|NCT03536884|455490377|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
126598423|NCT03536884|455490378|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
126598424|NCT03536884|455490379|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
126598425|NCT03536884|455490380|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
126598426|NCT03536884|455490369|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126598427|NCT03536884|455490370|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126598428|NCT03536884|455490371|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126598429|NCT03536884|455490372|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126598430|NCT03536884|455490373|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126598431|NCT03536884|455490374|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126598432|NCT03536884|455490375|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126598433|NCT03536884|455490376|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126598434|NCT03536884|455490377|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126598435|NCT03536884|455490378|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126598436|NCT03536884|455490379|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
126598437|NCT03536884|455490380|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
126598438|NCT03536884|455490369|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126598439|NCT03536884|455490370|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126598440|NCT03536884|455490371|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126598441|NCT03536884|455490372|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126598442|NCT03536884|455490373|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126598443|NCT03536884|455490374|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126598444|NCT03536884|455490375|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126598445|NCT03536884|455490376|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126598446|NCT03536884|455490377|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126598447|NCT03536884|455490378|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126598448|NCT03536884|455490379|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
126598449|NCT03536884|455490380|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
126598450|NCT03536884|455490369|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126598451|NCT03536884|455490370|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126598452|NCT03536884|455490371|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126598453|NCT03536884|455490372|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126598454|NCT03536884|455490373|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126598455|NCT03536884|455490374|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126598456|NCT03536884|455490375|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126598457|NCT03536884|455490376|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126598458|NCT03536884|455490377|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126598459|NCT03536884|455490378|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126733137|NCT01306032|455972320|FG004|First Intervention|Death|0|||
126733138|NCT01306032|455972321|FG005|First Intervention|Death|0|||
126733139|NCT01306032|455972316|FG000|First Intervention|Ineligible|0|||
126733140|NCT01306032|455972317|FG001|First Intervention|Ineligible|0|||
126733141|NCT01306032|455972318|FG002|First Intervention|Ineligible|0|||
126733142|NCT01306032|455972319|FG003|First Intervention|Ineligible|0|||
126598460|NCT03536884|455490379|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
126598461|NCT03536884|455490380|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
126598462|NCT03485729|455490396|FG000|Overall Study|Withdrawal by Subject|0|||
126598463|NCT03485729|455490397|FG001|Overall Study|Withdrawal by Subject|0|||
126598464|NCT03485729|455490398|FG002|Overall Study|Withdrawal by Subject|1|||
126598465|NCT03485729|455490396|FG000|Overall Study|Disease progression|8|||
126598466|NCT03485729|455490397|FG001|Overall Study|Disease progression|13|||
126598467|NCT03485729|455490398|FG002|Overall Study|Disease progression|1|||
126598468|NCT03485729|455490396|FG000|Overall Study|Hospice care|1|||
126598469|NCT03485729|455490397|FG001|Overall Study|Hospice care|0|||
126598470|NCT03485729|455490398|FG002|Overall Study|Hospice care|0|||
126598471|NCT03485729|455490396|FG000|Overall Study|Poor performance status|1|||
126598472|NCT03485729|455490397|FG001|Overall Study|Poor performance status|0|||
126598473|NCT03485729|455490398|FG002|Overall Study|Poor performance status|0|||
126598474|NCT03485729|455490396|FG000|Overall Study|Illness|0|||
126598475|NCT03485729|455490397|FG001|Overall Study|Illness|1|||
126598476|NCT03485729|455490398|FG002|Overall Study|Illness|0|||
126598477|NCT05035654|455490400|FG000|Overall Study|Physician Decision|0|||
126598478|NCT05035654|455490401|FG001|Overall Study|Physician Decision|1|||
126598479|NCT05035654|455490402|FG002|Overall Study|Physician Decision|0|||
126598480|NCT05035654|455490400|FG000|Overall Study|Adverse Event|0|||
126598481|NCT05035654|455490401|FG001|Overall Study|Adverse Event|1|||
126598482|NCT05035654|455490402|FG002|Overall Study|Adverse Event|0|||
126598483|NCT05035654|455490400|FG000|Overall Study|Withdrawal by Subject|0|||
126598484|NCT05035654|455490401|FG001|Overall Study|Withdrawal by Subject|0|||
126598485|NCT05035654|455490402|FG002|Overall Study|Withdrawal by Subject|4|||
126598486|NCT05035654|455490400|FG000|Overall Study|Bilateral Dislodgement|1|||
126598487|NCT05035654|455490401|FG001|Overall Study|Bilateral Dislodgement|0|||
126598488|NCT05035654|455490402|FG002|Overall Study|Bilateral Dislodgement|0|||
126598489|NCT04880733|455490403|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
126598490|NCT04880733|455490404|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
126598491|NCT04880733|455490405|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
126598492|NCT04880733|455490403|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
126598493|NCT04880733|455490404|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
126598494|NCT04880733|455490405|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
126598495|NCT04880733|455490403|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
126598496|NCT04880733|455490404|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
126598497|NCT04880733|455490405|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
126598498|NCT04880733|455490403|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
126598499|NCT04880733|455490404|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
126598500|NCT04880733|455490405|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
126598501|NCT04880733|455490403|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
126598502|NCT04880733|455490404|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
126598503|NCT04880733|455490405|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
126598504|NCT02367040|455490412|FG000|Overall Study|Lost to Follow-up|1|||
126598505|NCT02367040|455490413|FG001|Overall Study|Lost to Follow-up|1|||
126598506|NCT02367040|455490412|FG000|Overall Study|Lack of Efficacy|1|||
126598507|NCT02367040|455490413|FG001|Overall Study|Lack of Efficacy|0|||
126598508|NCT02367040|455490412|FG000|Overall Study|Additional primary malignancy|0|||
126598509|NCT02367040|455490413|FG001|Overall Study|Additional primary malignancy|1|||
126598510|NCT02367040|455490412|FG000|Overall Study|AE not associated with clinical disease progression|114|||
126598511|NCT02367040|455490413|FG001|Overall Study|AE not associated with clinical disease progression|11|||
126598512|NCT02367040|455490412|FG000|Overall Study|AE associated with clinical disease progression|1|||
126598513|NCT02367040|455490413|FG001|Overall Study|AE associated with clinical disease progression|3|||
126598514|NCT02367040|455490412|FG000|Overall Study|Physician Decision|2|||
126598515|NCT02367040|455490413|FG001|Overall Study|Physician Decision|8|||
126598516|NCT02367040|455490412|FG000|Overall Study|Non-compliance with study drug|1|||
126598517|NCT02367040|455490413|FG001|Overall Study|Non-compliance with study drug|0|||
126598518|NCT02367040|455490412|FG000|Overall Study|Failure to meet continuation criteria|1|||
126598519|NCT02367040|455490413|FG001|Overall Study|Failure to meet continuation criteria|0|||
126598520|NCT02367040|455490412|FG000|Overall Study|Switching to other therapy|2|||
126733143|NCT01306032|455972320|FG004|First Intervention|Ineligible|0|||
126733144|NCT01306032|455972321|FG005|First Intervention|Ineligible|1|||
126733145|NCT01306032|455972316|FG000|First Intervention|Progressive disease|0|||
126733146|NCT01306032|455972317|FG001|First Intervention|Progressive disease|0|||
126598521|NCT02367040|455490413|FG001|Overall Study|Switching to other therapy|0|||
126598522|NCT02367040|455490412|FG000|Overall Study|Withdrawal by Subject|46|||
126598523|NCT02367040|455490413|FG001|Overall Study|Withdrawal by Subject|16|||
126598524|NCT02367040|455490412|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
126598525|NCT02367040|455490413|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
126733147|NCT01306032|455972318|FG002|First Intervention|Progressive disease|0|||
126598526|NCT02367040|455490412|FG000|Overall Study|Patient decision|39|||
126598527|NCT02367040|455490413|FG001|Overall Study|Patient decision|14|||
126598528|NCT02367040|455490412|FG000|Overall Study|Required procedure failed|1|||
126598529|NCT02367040|455490413|FG001|Overall Study|Required procedure failed|0|||
126598530|NCT02367040|455490412|FG000|Overall Study|Randomized by mistake with study treatment|1|||
126598531|NCT02367040|455490413|FG001|Overall Study|Randomized by mistake with study treatment|0|||
126598532|NCT02367040|455490412|FG000|Overall Study|Protocol Violation|1|||
126598533|NCT02367040|455490413|FG001|Overall Study|Protocol Violation|0|||
126598534|NCT02367040|455490412|FG000|Overall Study|Progressive disease - radiological progression|51|||
126598535|NCT02367040|455490413|FG001|Overall Study|Progressive disease - radiological progression|78|||
126598536|NCT02367040|455490412|FG000|Overall Study|Progressive disease - clinical progression|6|||
126598537|NCT02367040|455490413|FG001|Overall Study|Progressive disease - clinical progression|6|||
126598538|NCT02367040|455490412|FG000|Overall Study|Drug not administered|3|||
126598539|NCT02367040|455490413|FG001|Overall Study|Drug not administered|2|||
126598540|NCT02367040|455490412|FG000|Overall Study|Progressive disease|0|||
126598541|NCT02367040|455490413|FG001|Overall Study|Progressive disease|1|||
126598542|NCT02367040|455490412|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
126598543|NCT02367040|455490413|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
126598544|NCT02367040|455490412|FG000|Overall Study|Death|2|||
126598545|NCT02367040|455490413|FG001|Overall Study|Death|0|||
126598546|NCT05856435|455490425|FG000|Overall Study|Lost to Follow-up|6|||
126598547|NCT02323880|455490426|FG000|Overall Study|Adverse Event|2|||
126598548|NCT02323880|455490427|FG001|Overall Study|Adverse Event|0|||
126598549|NCT02323880|455490428|FG002|Overall Study|Adverse Event|1|||
126598550|NCT02323880|455490429|FG003|Overall Study|Adverse Event|1|||
126598551|NCT02323880|455490430|FG004|Overall Study|Adverse Event|1|||
126598552|NCT02323880|455490431|FG005|Overall Study|Adverse Event|0|||
126598553|NCT02323880|455490432|FG006|Overall Study|Adverse Event|1|||
126598554|NCT02323880|455490433|FG007|Overall Study|Adverse Event|0|||
126598555|NCT02323880|455490426|FG000|Overall Study|Death|0|||
126598556|NCT02323880|455490427|FG001|Overall Study|Death|0|||
126598557|NCT02323880|455490428|FG002|Overall Study|Death|0|||
126598558|NCT02323880|455490429|FG003|Overall Study|Death|0|||
126598559|NCT02323880|455490430|FG004|Overall Study|Death|0|||
126598560|NCT02323880|455490431|FG005|Overall Study|Death|1|||
126598561|NCT02323880|455490432|FG006|Overall Study|Death|0|||
126598562|NCT02323880|455490433|FG007|Overall Study|Death|0|||
126598563|NCT02323880|455490426|FG000|Overall Study|Lack of Efficacy|4|||
126598564|NCT02323880|455490427|FG001|Overall Study|Lack of Efficacy|11|||
126598565|NCT02323880|455490428|FG002|Overall Study|Lack of Efficacy|5|||
126598566|NCT02323880|455490429|FG003|Overall Study|Lack of Efficacy|5|||
126598567|NCT02323880|455490430|FG004|Overall Study|Lack of Efficacy|4|||
126598568|NCT02323880|455490431|FG005|Overall Study|Lack of Efficacy|8|||
126598569|NCT02323880|455490432|FG006|Overall Study|Lack of Efficacy|4|||
126598570|NCT02323880|455490433|FG007|Overall Study|Lack of Efficacy|6|||
126598571|NCT02323880|455490426|FG000|Overall Study|Physician Decision|0|||
126598572|NCT02323880|455490427|FG001|Overall Study|Physician Decision|0|||
126598573|NCT02323880|455490428|FG002|Overall Study|Physician Decision|0|||
126598574|NCT02323880|455490429|FG003|Overall Study|Physician Decision|0|||
126598575|NCT02323880|455490430|FG004|Overall Study|Physician Decision|1|||
126598576|NCT02323880|455490431|FG005|Overall Study|Physician Decision|1|||
126598577|NCT02323880|455490432|FG006|Overall Study|Physician Decision|1|||
126598578|NCT02323880|455490433|FG007|Overall Study|Physician Decision|0|||
126598579|NCT02323880|455490426|FG000|Overall Study|Withdrawal by Subject|0|||
126598580|NCT02323880|455490427|FG001|Overall Study|Withdrawal by Subject|2|||
126598581|NCT02323880|455490428|FG002|Overall Study|Withdrawal by Subject|0|||
126598582|NCT02323880|455490429|FG003|Overall Study|Withdrawal by Subject|0|||
126598583|NCT02323880|455490430|FG004|Overall Study|Withdrawal by Subject|0|||
126598584|NCT02323880|455490431|FG005|Overall Study|Withdrawal by Subject|0|||
126598585|NCT02323880|455490432|FG006|Overall Study|Withdrawal by Subject|0|||
126598586|NCT02323880|455490433|FG007|Overall Study|Withdrawal by Subject|0|||
126598587|NCT04934072|455490435|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
126598588|NCT04934072|455490436|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
126598589|NCT04934072|455490437|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
126598590|NCT04934072|455490438|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
126598591|NCT04934072|455490439|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
126598592|NCT04934072|455490435|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
126598593|NCT04934072|455490436|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
126598594|NCT04934072|455490437|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
126598595|NCT04934072|455490438|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
126598596|NCT04934072|455490439|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
126598597|NCT04934072|455490435|FG000|Day 0 to Week 52|Other|3|||
126598598|NCT04934072|455490436|FG001|Day 0 to Week 52|Other|1|||
126598599|NCT04934072|455490437|FG002|Day 0 to Week 52|Other|0|||
126598600|NCT04934072|455490438|FG003|Day 0 to Week 52|Other|0|||
126598601|NCT04934072|455490439|FG004|Day 0 to Week 52|Other|0|||
126598602|NCT04934072|455490435|FG000|Day 0 to Week 52|Adverse Event|1|||
126598603|NCT04934072|455490436|FG001|Day 0 to Week 52|Adverse Event|3|||
126779647|NCT02884206|456149547|FG000|Double-Blind Period|Lost to Follow-up|0|||
126779648|NCT02884206|456149548|FG001|Double-Blind Period|Lost to Follow-up|4|||
126779649|NCT02884206|456149549|FG002|Double-Blind Period|Lost to Follow-up|4|||
126779650|NCT02884206|456149547|FG000|Double-Blind Period|Physician Decision|0|||
126779651|NCT02884206|456149548|FG001|Double-Blind Period|Physician Decision|2|||
126779652|NCT02884206|456149549|FG002|Double-Blind Period|Physician Decision|0|||
126779653|NCT02884206|456149547|FG000|Double-Blind Period|Adverse Event|0|||
126779654|NCT02884206|456149548|FG001|Double-Blind Period|Adverse Event|0|||
126779655|NCT02884206|456149549|FG002|Double-Blind Period|Adverse Event|3|||
126779656|NCT02884206|456149547|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
126779657|NCT02884206|456149548|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
126779658|NCT02884206|456149549|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
126779659|NCT03038113|456149550|FG000|Overall Study|Withdrawal by Subject|0|||
126779660|NCT03038113|456149551|FG001|Overall Study|Withdrawal by Subject|0|||
126779661|NCT03038113|456149552|FG002|Overall Study|Withdrawal by Subject|1|||
126779662|NCT03038113|456149553|FG003|Overall Study|Withdrawal by Subject|0|||
126779663|NCT03038113|456149554|FG004|Overall Study|Withdrawal by Subject|0|||
126598604|NCT04934072|455490437|FG002|Day 0 to Week 52|Adverse Event|0|||
126598605|NCT04934072|455490438|FG003|Day 0 to Week 52|Adverse Event|0|||
126598606|NCT04934072|455490439|FG004|Day 0 to Week 52|Adverse Event|0|||
126598607|NCT04934072|455490435|FG000|Week 52 to Week 78|Adverse Event|0|||
126598608|NCT04934072|455490436|FG001|Week 52 to Week 78|Adverse Event|0|||
126598609|NCT04934072|455490437|FG002|Week 52 to Week 78|Adverse Event|0|||
126598610|NCT04934072|455490438|FG003|Week 52 to Week 78|Adverse Event|1|||
126598611|NCT04934072|455490439|FG004|Week 52 to Week 78|Adverse Event|1|||
126598612|NCT04934072|455490435|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
126598613|NCT04934072|455490436|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
126598614|NCT04934072|455490437|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
126598615|NCT04934072|455490438|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
126598616|NCT04934072|455490439|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
126598617|NCT04934072|455490435|FG000|Week 52 to Week 78|Other|0|||
126598618|NCT04934072|455490436|FG001|Week 52 to Week 78|Other|0|||
126598619|NCT04934072|455490437|FG002|Week 52 to Week 78|Other|1|||
126598620|NCT04934072|455490438|FG003|Week 52 to Week 78|Other|0|||
126598621|NCT04934072|455490439|FG004|Week 52 to Week 78|Other|0|||
126598622|NCT05660434|455490443|FG000|Overall Study|Never obtained study materials|2|||
126598623|NCT05660434|455490444|FG001|Overall Study|Never obtained study materials|1|||
126598624|NCT01820611|455490451|FG000|Overall Study|Death|8|||
126598625|NCT01820611|455490451|FG000|Overall Study|Adverse Event|1|||
126598626|NCT01820611|455490451|FG000|Overall Study|Withdrawal by Subject|9|||
126598627|NCT05736458|455490452|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
126598628|NCT05736458|455490453|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
126598629|NCT05736458|455490454|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
126598630|NCT05736458|455490452|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
126598631|NCT05736458|455490453|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
126598632|NCT05736458|455490454|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
126598633|NCT05736458|455490452|FG000|TMS/fMRI #1|Physician Decision|0|||
126598634|NCT05736458|455490453|FG001|TMS/fMRI #1|Physician Decision|0|||
126598635|NCT05736458|455490454|FG002|TMS/fMRI #1|Physician Decision|2|||
126598636|NCT05736458|455490452|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
126598637|NCT05736458|455490453|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
126598638|NCT05736458|455490454|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
126598639|NCT02990338|455490455|FG000|Overall Study|Randomized and not treated|4|||
126598640|NCT02990338|455490456|FG001|Overall Study|Randomized and not treated|2|||
126598641|NCT02990338|455490455|FG000|Overall Study|Adverse Event|23|||
126598642|NCT02990338|455490456|FG001|Overall Study|Adverse Event|22|||
126598643|NCT02990338|455490455|FG000|Overall Study|Progressive disease|118|||
126598644|NCT02990338|455490456|FG001|Overall Study|Progressive disease|107|||
126598645|NCT02990338|455490455|FG000|Overall Study|Poor compliance to protocol|0|||
126598646|NCT02990338|455490456|FG001|Overall Study|Poor compliance to protocol|1|||
126598647|NCT02990338|455490455|FG000|Overall Study|Withdrawal by Subject|6|||
126598648|NCT02990338|455490456|FG001|Overall Study|Withdrawal by Subject|8|||
126779664|NCT03038113|456149555|FG005|Overall Study|Withdrawal by Subject|0|||
126779665|NCT03038113|456149556|FG006|Overall Study|Withdrawal by Subject|0|||
126598649|NCT02990338|455490455|FG000|Overall Study|Physician's decision|2|||
126598650|NCT02990338|455490456|FG001|Overall Study|Physician's decision|6|||
126598651|NCT02990338|455490455|FG000|Overall Study|Treatment extension study|0|||
126598652|NCT02990338|455490456|FG001|Overall Study|Treatment extension study|6|||
126598653|NCT02990338|455490455|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
126598654|NCT02990338|455490456|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
126598655|NCT02990338|455490455|FG000|Overall Study|Continue with therapy available commercially|0|||
126598656|NCT02990338|455490456|FG001|Overall Study|Continue with therapy available commercially|1|||
126598657|NCT02997202|455490457|FG000|Overall Study|Miscellaneous|2|||
126598658|NCT02997202|455490458|FG001|Overall Study|Miscellaneous|2|||
126598659|NCT02997202|455490457|FG000|Overall Study|Withdrawal by Subject|8|||
126598660|NCT02997202|455490458|FG001|Overall Study|Withdrawal by Subject|12|||
126598661|NCT02997202|455490457|FG000|Overall Study|Lost to Follow-up|5|||
126598662|NCT02997202|455490458|FG001|Overall Study|Lost to Follow-up|3|||
126598663|NCT02997202|455490457|FG000|Overall Study|Death|41|||
126598664|NCT02997202|455490458|FG001|Overall Study|Death|45|||
126598665|NCT05900154|455490459|FG000|Follow-Up Period|Lost to Follow-up|1|||
126598666|NCT05900154|455490460|FG001|Follow-Up Period|Lost to Follow-up|2|||
126598667|NCT05900154|455490461|FG002|Follow-Up Period|Lost to Follow-up|1|||
126598668|NCT05900154|455490462|FG003|Follow-Up Period|Lost to Follow-up|0|||
126598669|NCT05900154|455490463|FG004|Follow-Up Period|Lost to Follow-up|1|||
126598670|NCT05900154|455490464|FG005|Follow-Up Period|Lost to Follow-up|1|||
126598671|NCT00303459|455490465|FG000|Overall Study|Death|33|||
126598672|NCT00303459|455490466|FG001|Overall Study|Death|44|||
126598673|NCT00303459|455490465|FG000|Overall Study|Withdrawal of consent|32|||
126598674|NCT00303459|455490466|FG001|Overall Study|Withdrawal of consent|26|||
126598675|NCT00303459|455490465|FG000|Overall Study|Lost to Follow-up|5|||
126598676|NCT00303459|455490466|FG001|Overall Study|Lost to Follow-up|4|||
126598677|NCT00303459|455490465|FG000|Overall Study|Administrative reason|7|||
126598678|NCT00303459|455490466|FG001|Overall Study|Administrative reason|7|||
126598679|NCT00303459|455490465|FG000|Overall Study|Decision by the investigator|5|||
126598680|NCT00303459|455490466|FG001|Overall Study|Decision by the investigator|7|||
126598681|NCT00303459|455490465|FG000|Overall Study|Lung transplantation|1|||
126598682|NCT00303459|455490466|FG001|Overall Study|Lung transplantation|1|||
126598683|NCT01570361|455490467|FG000|Overall Study|Subject discontinued|1|||
126598684|NCT01570361|455490468|FG001|Overall Study|Subject discontinued|2|||
126598685|NCT01570361|455490467|FG000|Overall Study|Sponsor closing the study|51|||
126598686|NCT01570361|455490468|FG001|Overall Study|Sponsor closing the study|50|||
126598687|NCT01570361|455490467|FG000|Overall Study|Subject excluded|5|||
126598688|NCT01570361|455490468|FG001|Overall Study|Subject excluded|3|||
126598689|NCT01570361|455490467|FG000|Overall Study|Subject withdrew consent|14|||
126598690|NCT01570361|455490468|FG001|Overall Study|Subject withdrew consent|9|||
126598691|NCT01570361|455490467|FG000|Overall Study|Adverse Event|2|||
126598692|NCT01570361|455490468|FG001|Overall Study|Adverse Event|1|||
126598693|NCT01570361|455490467|FG000|Overall Study|Lost to Follow-up|4|||
126598694|NCT01570361|455490468|FG001|Overall Study|Lost to Follow-up|4|||
126598695|NCT01570361|455490467|FG000|Overall Study|Death|5|||
126598696|NCT01570361|455490468|FG001|Overall Study|Death|4|||
126598697|NCT01570361|455490467|FG000|Overall Study|Other|0|||
126598698|NCT01570361|455490468|FG001|Overall Study|Other|2|||
126598699|NCT05962814|455490478|FG000|Overall Study|failed eligibility|1|||
126598700|NCT02865538|455490479|FG000|Overall Study|Withdrawal by Subject|0|||
126598701|NCT02865538|455490480|FG001|Overall Study|Withdrawal by Subject|0|||
126598702|NCT02865538|455490481|FG002|Overall Study|Withdrawal by Subject|1|||
126733148|NCT01306032|455972319|FG003|First Intervention|Progressive disease|0|||
126733149|NCT01306032|455972320|FG004|First Intervention|Progressive disease|2|||
126733150|NCT01306032|455972321|FG005|First Intervention|Progressive disease|0|||
126733151|NCT01306032|455972316|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
126733152|NCT01306032|455972317|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
126733153|NCT01306032|455972318|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
126733154|NCT01306032|455972319|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
126733155|NCT01306032|455972320|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
126733156|NCT01306032|455972321|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
126733157|NCT01306032|455972316|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
126733158|NCT01306032|455972317|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
126733159|NCT01306032|455972318|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
126733160|NCT01306032|455972319|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
126733161|NCT01306032|455972320|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
126733162|NCT01306032|455972321|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
126733163|NCT03260894|455972323|FG000|Overall Study|Death|6|||
126733164|NCT03260894|455972324|FG001|Overall Study|Death|8|||
126733165|NCT03260894|455972323|FG000|Overall Study|Withdrawal by Subject|4|||
126598703|NCT02865538|455490482|FG003|Overall Study|Withdrawal by Subject|0|||
126598704|NCT02865538|455490483|FG004|Overall Study|Withdrawal by Subject|0|||
126598705|NCT02865538|455490479|FG000|Overall Study|Lost to Follow-up|1|||
126598706|NCT02865538|455490480|FG001|Overall Study|Lost to Follow-up|0|||
126598707|NCT02865538|455490481|FG002|Overall Study|Lost to Follow-up|0|||
126598708|NCT02865538|455490482|FG003|Overall Study|Lost to Follow-up|0|||
126598709|NCT02865538|455490483|FG004|Overall Study|Lost to Follow-up|0|||
126598710|NCT03106740|455492123|FG000|Overall Study|Lost to Follow-up|2|||
126598711|NCT03106740|455492124|FG001|Overall Study|Lost to Follow-up|2|||
126598712|NCT03106740|455492123|FG000|Overall Study|Withdrawal by Subject|2|||
126598713|NCT03106740|455492124|FG001|Overall Study|Withdrawal by Subject|4|||
126598714|NCT03106740|455492123|FG000|Overall Study|Physician Decision|0|||
126598715|NCT03106740|455492124|FG001|Overall Study|Physician Decision|1|||
126598716|NCT03106740|455492123|FG000|Overall Study|Partial data|1|||
126598717|NCT03106740|455492124|FG001|Overall Study|Partial data|0|||
126598718|NCT04565990|455492125|FG000|Overall Study|Death|5|||
126598719|NCT04565990|455492125|FG000|Overall Study|Lost to Follow-up|1|||
126598720|NCT04565990|455492125|FG000|Overall Study|Withdrawal by Subject|1|||
126598721|NCT04797858|455492126|FG000|Overall Study|Withdrawal by Subject|0|||
126598722|NCT04797858|455492127|FG001|Overall Study|Withdrawal by Subject|1|||
126598723|NCT04797858|455492126|FG000|Overall Study|Excluded due to administrative error|7|||
126598724|NCT04797858|455492127|FG001|Overall Study|Excluded due to administrative error|8|||
126598725|NCT05363163|455492137|FG000|Overall Study|Withdrawal by Subject|13|||
126598726|NCT04999111|455492138|FG000|Overall Study|Lost to Follow-up|21|||
126598727|NCT04999111|455492139|FG001|Overall Study|Lost to Follow-up|16|||
126598728|NCT04999111|455492140|FG002|Overall Study|Lost to Follow-up|2|||
126598729|NCT04999111|455492141|FG003|Overall Study|Lost to Follow-up|26|||
126598730|NCT04999111|455492142|FG004|Overall Study|Lost to Follow-up|30|||
126598731|NCT04999111|455492143|FG005|Overall Study|Lost to Follow-up|6|||
126598732|NCT04999111|455492138|FG000|Overall Study|Physician Decision|1|||
126598733|NCT04999111|455492139|FG001|Overall Study|Physician Decision|3|||
126598734|NCT04999111|455492140|FG002|Overall Study|Physician Decision|0|||
126598735|NCT04999111|455492141|FG003|Overall Study|Physician Decision|1|||
126598736|NCT04999111|455492142|FG004|Overall Study|Physician Decision|2|||
126598737|NCT04999111|455492143|FG005|Overall Study|Physician Decision|0|||
126598738|NCT04999111|455492138|FG000|Overall Study|Withdrawal by Subject|23|||
126598739|NCT04999111|455492139|FG001|Overall Study|Withdrawal by Subject|29|||
126598740|NCT04999111|455492140|FG002|Overall Study|Withdrawal by Subject|15|||
126598741|NCT04999111|455492141|FG003|Overall Study|Withdrawal by Subject|30|||
126598742|NCT04999111|455492142|FG004|Overall Study|Withdrawal by Subject|35|||
126598743|NCT04999111|455492143|FG005|Overall Study|Withdrawal by Subject|10|||
126598744|NCT04999111|455492138|FG000|Overall Study|Other|6|||
126598745|NCT04999111|455492139|FG001|Overall Study|Other|6|||
126598746|NCT04999111|455492140|FG002|Overall Study|Other|3|||
126598747|NCT04999111|455492141|FG003|Overall Study|Other|8|||
126598748|NCT04999111|455492142|FG004|Overall Study|Other|8|||
126598749|NCT04999111|455492143|FG005|Overall Study|Other|5|||
126598750|NCT04999111|455492138|FG000|Overall Study|Non-compliance with study schedule|1|||
126598751|NCT04999111|455492139|FG001|Overall Study|Non-compliance with study schedule|0|||
126598752|NCT04999111|455492140|FG002|Overall Study|Non-compliance with study schedule|0|||
126598753|NCT04999111|455492141|FG003|Overall Study|Non-compliance with study schedule|1|||
126598754|NCT04999111|455492142|FG004|Overall Study|Non-compliance with study schedule|1|||
126598755|NCT04999111|455492143|FG005|Overall Study|Non-compliance with study schedule|1|||
126598756|NCT04999111|455492138|FG000|Overall Study|Randomized but not vaccinated|1|||
126598757|NCT04999111|455492139|FG001|Overall Study|Randomized but not vaccinated|2|||
126598758|NCT04999111|455492140|FG002|Overall Study|Randomized but not vaccinated|0|||
126598759|NCT04999111|455492141|FG003|Overall Study|Randomized but not vaccinated|3|||
126598760|NCT04999111|455492142|FG004|Overall Study|Randomized but not vaccinated|3|||
126598761|NCT04999111|455492143|FG005|Overall Study|Randomized but not vaccinated|0|||
126598762|NCT04999111|455492138|FG000|Overall Study|Adverse Event|1|||
126598763|NCT04999111|455492139|FG001|Overall Study|Adverse Event|1|||
126598764|NCT04999111|455492140|FG002|Overall Study|Adverse Event|0|||
126598765|NCT04999111|455492141|FG003|Overall Study|Adverse Event|0|||
126598766|NCT04999111|455492142|FG004|Overall Study|Adverse Event|0|||
126598767|NCT04999111|455492143|FG005|Overall Study|Adverse Event|0|||
126598768|NCT04999111|455492138|FG000|Overall Study|Initiated prohibited medication|0|||
126598769|NCT04999111|455492139|FG001|Overall Study|Initiated prohibited medication|0|||
126598770|NCT04999111|455492140|FG002|Overall Study|Initiated prohibited medication|0|||
126598771|NCT04999111|455492141|FG003|Overall Study|Initiated prohibited medication|0|||
126598772|NCT04999111|455492142|FG004|Overall Study|Initiated prohibited medication|1|||
126598773|NCT04999111|455492143|FG005|Overall Study|Initiated prohibited medication|0|||
126598774|NCT01314105|455492147|FG000|Overall Study|Progressive Disease|6|||
126598775|NCT01314105|455492148|FG001|Overall Study|Progressive Disease|10|||
126598776|NCT01314105|455492147|FG000|Overall Study|Refused to continue taking medication|0|||
126598777|NCT01314105|455492148|FG001|Overall Study|Refused to continue taking medication|1|||
126598778|NCT01314105|455492147|FG000|Overall Study|Other Adverse Event|1|||
126598779|NCT01314105|455492148|FG001|Overall Study|Other Adverse Event|1|||
126598780|NCT02056834|455492149|FG000|Overall Study|Lost to Follow-up|7|||
126598781|NCT06106022|455492150|FG000|Overall Study|Lost to Follow-up|1|||
126598782|NCT06106022|455492151|FG001|Overall Study|Lost to Follow-up|0|||
126598783|NCT06106022|455492150|FG000|Overall Study|Voluntary Withdrawal|0|||
126598784|NCT06106022|455492151|FG001|Overall Study|Voluntary Withdrawal|2|||
126598785|NCT03276676|455492153|FG000|Overall Study|Withdrawal by Subject|2|||
126598786|NCT03276676|455492154|FG001|Overall Study|Withdrawal by Subject|1|||
126598787|NCT03583333|455492157|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
126598788|NCT03583333|455492158|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
126598789|NCT03583333|455492157|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
126598790|NCT03583333|455492158|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
126598791|NCT03583333|455492157|FG000|Overall Study|Withdrawal by Subject|9|||
126598792|NCT03583333|455492158|FG001|Overall Study|Withdrawal by Subject|5|||
126598793|NCT03583333|455492157|FG000|Overall Study|Physician Decision|3|||
126598794|NCT03583333|455492158|FG001|Overall Study|Physician Decision|2|||
126598795|NCT03583333|455492157|FG000|Overall Study|Death|12|||
126598796|NCT03583333|455492158|FG001|Overall Study|Death|7|||
126598797|NCT03926130|455492159|FG000|Overall Study|Adverse Event|9|||
126598798|NCT03926130|455492160|FG001|Overall Study|Adverse Event|11|||
126598799|NCT03926130|455492161|FG002|Overall Study|Adverse Event|2|||
126598800|NCT03926130|455492162|FG003|Overall Study|Adverse Event|0|||
126598801|NCT03926130|455492159|FG000|Overall Study|Death|2|||
126598802|NCT03926130|455492160|FG001|Overall Study|Death|0|||
126598803|NCT03926130|455492161|FG002|Overall Study|Death|1|||
126598804|NCT03926130|455492162|FG003|Overall Study|Death|0|||
126598805|NCT03926130|455492159|FG000|Overall Study|Lack of Efficacy|14|||
126598806|NCT03926130|455492160|FG001|Overall Study|Lack of Efficacy|11|||
126598807|NCT03926130|455492161|FG002|Overall Study|Lack of Efficacy|7|||
126598808|NCT03926130|455492162|FG003|Overall Study|Lack of Efficacy|1|||
126598809|NCT03926130|455492159|FG000|Overall Study|Lost to Follow-up|0|||
126598810|NCT03926130|455492160|FG001|Overall Study|Lost to Follow-up|7|||
126598811|NCT03926130|455492161|FG002|Overall Study|Lost to Follow-up|1|||
126598812|NCT03926130|455492162|FG003|Overall Study|Lost to Follow-up|0|||
126598813|NCT03926130|455492159|FG000|Overall Study|As Reported by Investigator|2|||
126598814|NCT03926130|455492160|FG001|Overall Study|As Reported by Investigator|6|||
126598815|NCT03926130|455492161|FG002|Overall Study|As Reported by Investigator|6|||
126598816|NCT03926130|455492162|FG003|Overall Study|As Reported by Investigator|0|||
126598817|NCT03926130|455492159|FG000|Overall Study|Physician Decision|3|||
126598818|NCT03926130|455492160|FG001|Overall Study|Physician Decision|2|||
126598819|NCT03926130|455492161|FG002|Overall Study|Physician Decision|1|||
126598820|NCT03926130|455492162|FG003|Overall Study|Physician Decision|0|||
126598821|NCT03926130|455492159|FG000|Overall Study|Pregnancy|2|||
126598822|NCT03926130|455492160|FG001|Overall Study|Pregnancy|2|||
126598823|NCT03926130|455492161|FG002|Overall Study|Pregnancy|1|||
126598824|NCT03926130|455492162|FG003|Overall Study|Pregnancy|0|||
126598825|NCT03926130|455492159|FG000|Overall Study|Withdrawal by Subject|20|||
126598826|NCT03926130|455492160|FG001|Overall Study|Withdrawal by Subject|28|||
126598827|NCT03926130|455492161|FG002|Overall Study|Withdrawal by Subject|18|||
126598828|NCT03926130|455492162|FG003|Overall Study|Withdrawal by Subject|1|||
126598829|NCT03926130|455492159|FG000|Overall Study|Non-Compliance|1|||
126598830|NCT03926130|455492160|FG001|Overall Study|Non-Compliance|1|||
126598831|NCT03926130|455492161|FG002|Overall Study|Non-Compliance|0|||
126598832|NCT03926130|455492162|FG003|Overall Study|Non-Compliance|0|||
126598833|NCT03926130|455492159|FG000|Overall Study|Disposition Not Captured|0|||
126598834|NCT03926130|455492160|FG001|Overall Study|Disposition Not Captured|2|||
126598835|NCT03926130|455492161|FG002|Overall Study|Disposition Not Captured|1|||
126598836|NCT03926130|455492162|FG003|Overall Study|Disposition Not Captured|0|||
126598837|NCT01730937|455492163|FG000|Overall Study|Protocol Violation|5|||
126598838|NCT01730937|455492164|FG001|Overall Study|Protocol Violation|11|||
126598839|NCT04469270|455492175|FG000|Overall Study|Adverse Event|2|||
126598840|NCT04469270|455492176|FG001|Overall Study|Adverse Event|0|||
126598841|NCT04469270|455492175|FG000|Overall Study|Lost to Follow-up|4|||
126598842|NCT04469270|455492176|FG001|Overall Study|Lost to Follow-up|3|||
126598843|NCT04469270|455492175|FG000|Overall Study|Withdrawal by Subject|7|||
126598844|NCT04469270|455492176|FG001|Overall Study|Withdrawal by Subject|3|||
126598845|NCT04469270|455492175|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
126733166|NCT03260894|455972324|FG001|Overall Study|Withdrawal by Subject|11|||
126733167|NCT03260894|455972323|FG000|Overall Study|On-going at clinical cut off date|36|||
126733168|NCT03260894|455972324|FG001|Overall Study|On-going at clinical cut off date|31|||
126733169|NCT00168064|455972325|FG000|Overall Study|Adverse Event|26|||
126733170|NCT00168064|455972326|FG001|Overall Study|Adverse Event|22|||
126733171|NCT00168064|455972325|FG000|Overall Study|Withdrawal by Subject|3|||
126733172|NCT00168064|455972326|FG001|Overall Study|Withdrawal by Subject|4|||
126733173|NCT00168064|455972325|FG000|Overall Study|Lack of Efficacy|4|||
126733174|NCT00168064|455972326|FG001|Overall Study|Lack of Efficacy|4|||
126598846|NCT04469270|455492176|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
126598847|NCT04469270|455492175|FG000|Overall Study|missing|1|||
126598848|NCT04469270|455492176|FG001|Overall Study|missing|0|||
126598849|NCT02839265|455492183|FG000|Overall Study|Screen Failure|2|||
126598850|NCT02839265|455492183|FG000|Overall Study|Death|1|||
126598851|NCT02839265|455492183|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
126598852|NCT05424380|455492188|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
126598853|NCT05424380|455492189|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
126598854|NCT05424380|455492190|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
126598855|NCT05424380|455492191|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
126598856|NCT05424380|455492192|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
126598857|NCT05424380|455492193|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
126598858|NCT05424380|455492188|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
126598859|NCT05424380|455492189|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
126598860|NCT05424380|455492190|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
126779666|NCT03038113|456149557|FG007|Overall Study|Withdrawal by Subject|0|||
126779667|NCT03038113|456149558|FG008|Overall Study|Withdrawal by Subject|0|||
126779668|NCT03038113|456149559|FG009|Overall Study|Withdrawal by Subject|0|||
126779669|NCT03038113|456149560|FG010|Overall Study|Withdrawal by Subject|0|||
126779670|NCT03038113|456149561|FG011|Overall Study|Withdrawal by Subject|0|||
126779671|NCT03038113|456149562|FG012|Overall Study|Withdrawal by Subject|0|||
126779672|NCT03038113|456149563|FG013|Overall Study|Withdrawal by Subject|1|||
126779673|NCT03038113|456149550|FG000|Overall Study|Lost to Follow-up|0|||
126779674|NCT03038113|456149551|FG001|Overall Study|Lost to Follow-up|0|||
126779675|NCT03038113|456149552|FG002|Overall Study|Lost to Follow-up|0|||
126779676|NCT03038113|456149553|FG003|Overall Study|Lost to Follow-up|0|||
126779677|NCT03038113|456149554|FG004|Overall Study|Lost to Follow-up|0|||
126779678|NCT03038113|456149555|FG005|Overall Study|Lost to Follow-up|0|||
126779679|NCT03038113|456149556|FG006|Overall Study|Lost to Follow-up|1|||
126779680|NCT03038113|456149557|FG007|Overall Study|Lost to Follow-up|0|||
126779681|NCT03038113|456149558|FG008|Overall Study|Lost to Follow-up|0|||
126779682|NCT03038113|456149559|FG009|Overall Study|Lost to Follow-up|0|||
126779683|NCT03038113|456149560|FG010|Overall Study|Lost to Follow-up|0|||
126779684|NCT03038113|456149561|FG011|Overall Study|Lost to Follow-up|0|||
126779685|NCT03038113|456149562|FG012|Overall Study|Lost to Follow-up|0|||
126779686|NCT03038113|456149563|FG013|Overall Study|Lost to Follow-up|0|||
126779687|NCT01418352|456149566|FG000|Overall Study|Lost to Follow-up|2|||
126779688|NCT01418352|456149567|FG001|Overall Study|Lost to Follow-up|0|||
126779689|NCT01418352|456149568|FG002|Overall Study|Lost to Follow-up|0|||
126779690|NCT01418352|456149569|FG003|Overall Study|Lost to Follow-up|0|||
126779691|NCT01418352|456149566|FG000|Overall Study|Adverse Event|0|||
126779692|NCT01418352|456149567|FG001|Overall Study|Adverse Event|1|||
126779693|NCT01418352|456149568|FG002|Overall Study|Adverse Event|0|||
126779694|NCT01418352|456149569|FG003|Overall Study|Adverse Event|0|||
126779695|NCT01418352|456149566|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
126779696|NCT01418352|456149567|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
126779697|NCT01418352|456149568|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
126779698|NCT01418352|456149569|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
126779699|NCT01418352|456149566|FG000|Overall Study|Subject Withdrew Consent|0|||
126779700|NCT01418352|456149567|FG001|Overall Study|Subject Withdrew Consent|1|||
126779701|NCT01418352|456149568|FG002|Overall Study|Subject Withdrew Consent|2|||
126779702|NCT01418352|456149569|FG003|Overall Study|Subject Withdrew Consent|1|||
126779703|NCT01418352|456149566|FG000|Overall Study|Protocol Deviation|0|||
126779704|NCT01418352|456149567|FG001|Overall Study|Protocol Deviation|0|||
126779705|NCT01418352|456149568|FG002|Overall Study|Protocol Deviation|1|||
126779706|NCT01418352|456149569|FG003|Overall Study|Protocol Deviation|0|||
126779707|NCT01418352|456149566|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
126779708|NCT01418352|456149567|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
126779709|NCT01418352|456149568|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
126779710|NCT01418352|456149569|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
126779711|NCT00619619|456149570|FG000|Overall Study|Physician Decision|0|||
126779712|NCT00619619|456149571|FG001|Overall Study|Physician Decision|0|||
126779713|NCT00619619|456149572|FG002|Overall Study|Physician Decision|1|||
126779714|NCT00619619|456149573|FG003|Overall Study|Physician Decision|0|||
126779715|NCT00619619|456149574|FG004|Overall Study|Physician Decision|0|||
126779716|NCT00619619|456149575|FG005|Overall Study|Physician Decision|0|||
126779717|NCT00619619|456149576|FG006|Overall Study|Physician Decision|0|||
126779718|NCT00619619|456149577|FG007|Overall Study|Physician Decision|0|||
126779719|NCT00619619|456149570|FG000|Overall Study|Protocol Violation|0|||
126779720|NCT00619619|456149571|FG001|Overall Study|Protocol Violation|0|||
126779721|NCT00619619|456149572|FG002|Overall Study|Protocol Violation|0|||
126779722|NCT00619619|456149573|FG003|Overall Study|Protocol Violation|1|||
126779723|NCT00619619|456149574|FG004|Overall Study|Protocol Violation|0|||
126779724|NCT00619619|456149575|FG005|Overall Study|Protocol Violation|0|||
126779725|NCT00619619|456149576|FG006|Overall Study|Protocol Violation|1|||
126779726|NCT00619619|456149577|FG007|Overall Study|Protocol Violation|1|||
126779727|NCT00619619|456149570|FG000|Overall Study|Adverse Event|0|||
126779728|NCT00619619|456149571|FG001|Overall Study|Adverse Event|0|||
126779729|NCT00619619|456149572|FG002|Overall Study|Adverse Event|0|||
126779730|NCT00619619|456149573|FG003|Overall Study|Adverse Event|0|||
126779731|NCT00619619|456149574|FG004|Overall Study|Adverse Event|2|||
126779732|NCT00619619|456149575|FG005|Overall Study|Adverse Event|0|||
126779733|NCT00619619|456149576|FG006|Overall Study|Adverse Event|0|||
126779734|NCT00619619|456149577|FG007|Overall Study|Adverse Event|2|||
126779735|NCT01092702|456149578|FG000|Overall Study|Withdrawal by Subject|7|||
126779736|NCT01092702|456149578|FG000|Overall Study|Lost to Follow-up|2|||
126779737|NCT03263819|456149579|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
126779738|NCT03263819|456149580|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
126779739|NCT03652961|456149582|FG000|Overall Study|Lost to Follow-up|3|||
126779740|NCT03652961|456149582|FG000|Overall Study|Screen Failure|1|||
126779741|NCT01783496|456149583|FG000|Overall Study|Lost to Follow-up|0|||
126779742|NCT01783496|456149584|FG001|Overall Study|Lost to Follow-up|0|||
126779743|NCT01783496|456149585|FG002|Overall Study|Lost to Follow-up|0|||
126779744|NCT01783496|456149586|FG003|Overall Study|Lost to Follow-up|2|||
126779745|NCT01783496|456149587|FG004|Overall Study|Lost to Follow-up|0|||
126779746|NCT01783496|456149588|FG005|Overall Study|Lost to Follow-up|1|||
126779747|NCT01783496|456149583|FG000|Overall Study|Withdrawal by Subject|1|||
126779748|NCT01783496|456149584|FG001|Overall Study|Withdrawal by Subject|0|||
126598861|NCT05424380|455492191|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
126598862|NCT05424380|455492192|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
126779749|NCT01783496|456149585|FG002|Overall Study|Withdrawal by Subject|0|||
126779750|NCT01783496|456149586|FG003|Overall Study|Withdrawal by Subject|0|||
126779751|NCT01783496|456149587|FG004|Overall Study|Withdrawal by Subject|0|||
126779752|NCT01783496|456149588|FG005|Overall Study|Withdrawal by Subject|0|||
126779753|NCT00686920|456149592|FG000|Overall Study|Death|45|||
126598863|NCT05424380|455492193|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
126598864|NCT05424380|455492188|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
126598865|NCT05424380|455492189|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
126598866|NCT05424380|455492190|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
126598867|NCT05424380|455492191|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
126598868|NCT05424380|455492192|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
126598869|NCT05424380|455492193|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
126598870|NCT05424380|455492188|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
126598871|NCT05424380|455492189|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
126598872|NCT05424380|455492190|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
126598873|NCT05424380|455492191|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
126598874|NCT05424380|455492192|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
126598875|NCT05424380|455492193|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
126598876|NCT05424380|455492188|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
126598877|NCT05424380|455492189|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
126598878|NCT05424380|455492190|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
126598879|NCT05424380|455492191|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
126598880|NCT05424380|455492192|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
126598881|NCT05424380|455492193|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
126598882|NCT05424380|455492188|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
126598883|NCT05424380|455492189|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
126598884|NCT05424380|455492190|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
126598885|NCT05424380|455492191|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
126598886|NCT05424380|455492192|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
126598887|NCT05424380|455492193|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
126598888|NCT05424380|455492188|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
126598889|NCT05424380|455492189|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
126779754|NCT00686920|456149593|FG001|Overall Study|Death|14|||
126779755|NCT00686920|456149592|FG000|Overall Study|Liver Transplant|23|||
126779756|NCT00686920|456149593|FG001|Overall Study|Liver Transplant|8|||
126598890|NCT05424380|455492190|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
126598891|NCT05424380|455492191|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
126598892|NCT05424380|455492192|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
126598893|NCT05424380|455492193|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
126598894|NCT05424380|455492188|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
126598895|NCT05424380|455492189|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
126598896|NCT05424380|455492190|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
126598897|NCT05424380|455492191|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
126598898|NCT05424380|455492192|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
126598899|NCT05424380|455492193|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
126598900|NCT05424380|455492188|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126598901|NCT05424380|455492189|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126598902|NCT05424380|455492190|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126598903|NCT05424380|455492191|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
126598904|NCT05424380|455492192|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126598905|NCT05424380|455492193|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126598906|NCT05424380|455492188|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
126598907|NCT05424380|455492189|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
126598908|NCT05424380|455492190|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
126598909|NCT05424380|455492191|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
126598910|NCT05424380|455492192|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
126598911|NCT05424380|455492193|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
126598912|NCT05424380|455492188|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
126598913|NCT05424380|455492189|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
126779757|NCT00686920|456149592|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
126779758|NCT00686920|456149593|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
126779759|NCT00686920|456149592|FG000|Overall Study|Withdrawal by Subject|23|||
126598914|NCT05424380|455492190|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
126598915|NCT05424380|455492191|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
126598916|NCT05424380|455492192|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
126598917|NCT05424380|455492193|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
126598918|NCT05424380|455492188|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
126598919|NCT05424380|455492189|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
126598920|NCT05424380|455492190|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
126598921|NCT05424380|455492191|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
126598922|NCT05424380|455492192|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
126598923|NCT05424380|455492193|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
126598924|NCT05424380|455492188|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126598925|NCT05424380|455492189|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126598926|NCT05424380|455492190|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126598927|NCT05424380|455492191|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126598928|NCT05424380|455492192|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
126598929|NCT05424380|455492193|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
126598930|NCT05424380|455492188|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
126598931|NCT05424380|455492189|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
126598932|NCT05424380|455492190|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
126598933|NCT05424380|455492191|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
126598934|NCT05424380|455492192|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
126598935|NCT05424380|455492193|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
126598936|NCT02909686|455492194|FG000|Overall Study|Physician Decision|3|||
126598937|NCT02909686|455492194|FG000|Overall Study|Withdrawal by Subject|2|||
126598938|NCT03858517|455492195|FG000|Overall Study|Adverse Event|1|||
126598939|NCT03858517|455492195|FG000|Overall Study|Lost to Follow-up|1|||
126598940|NCT03858517|455492195|FG000|Overall Study|removed for being incarcerated|1|||
126598941|NCT03858517|455492195|FG000|Overall Study|Sponsor Closure|48|||
126598942|NCT06037668|455492196|FG000|Overall Study|Lost to Follow-up|1|||
126598943|NCT06037668|455492197|FG001|Overall Study|Lost to Follow-up|1|||
126598944|NCT06037668|455492196|FG000|Overall Study|Protocol Violation|1|||
126598945|NCT06037668|455492197|FG001|Overall Study|Protocol Violation|0|||
126598946|NCT06037668|455492196|FG000|Overall Study|Withdrawal by Subject|1|||
126598947|NCT06037668|455492197|FG001|Overall Study|Withdrawal by Subject|0|||
126598948|NCT06037668|455492196|FG000|Overall Study|Other Study Discontinuation Reason|1|||
126598949|NCT06037668|455492197|FG001|Overall Study|Other Study Discontinuation Reason|0|||
126598950|NCT05285137|455492199|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
126598951|NCT05285137|455492200|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
126598952|NCT05285137|455492201|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
126598953|NCT05285137|455492202|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
126598954|NCT05285137|455492203|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
126598955|NCT05285137|455492204|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
126598956|NCT05285137|455492205|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
126598957|NCT05285137|455492206|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
126598958|NCT05285137|455492207|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
126598959|NCT05285137|455492199|FG000|Overall Study|Lost to Follow-up|0|||
126598960|NCT05285137|455492200|FG001|Overall Study|Lost to Follow-up|0|||
126598961|NCT05285137|455492201|FG002|Overall Study|Lost to Follow-up|1|||
126598962|NCT05285137|455492202|FG003|Overall Study|Lost to Follow-up|3|||
126598963|NCT05285137|455492203|FG004|Overall Study|Lost to Follow-up|0|||
126598964|NCT05285137|455492204|FG005|Overall Study|Lost to Follow-up|0|||
126598965|NCT05285137|455492205|FG006|Overall Study|Lost to Follow-up|1|||
126598966|NCT05285137|455492206|FG007|Overall Study|Lost to Follow-up|0|||
126598967|NCT05285137|455492207|FG008|Overall Study|Lost to Follow-up|0|||
126598968|NCT05285137|455492199|FG000|Overall Study|Physician Decision|0|||
126598969|NCT05285137|455492200|FG001|Overall Study|Physician Decision|1|||
126598970|NCT05285137|455492201|FG002|Overall Study|Physician Decision|0|||
126598971|NCT05285137|455492202|FG003|Overall Study|Physician Decision|0|||
126598972|NCT05285137|455492203|FG004|Overall Study|Physician Decision|0|||
126598973|NCT05285137|455492204|FG005|Overall Study|Physician Decision|0|||
126598974|NCT05285137|455492205|FG006|Overall Study|Physician Decision|0|||
126598975|NCT05285137|455492206|FG007|Overall Study|Physician Decision|0|||
126598976|NCT05285137|455492207|FG008|Overall Study|Physician Decision|0|||
126598977|NCT05285137|455492199|FG000|Overall Study|Pregnancy|0|||
126598978|NCT05285137|455492200|FG001|Overall Study|Pregnancy|0|||
126598979|NCT05285137|455492201|FG002|Overall Study|Pregnancy|0|||
126598980|NCT05285137|455492202|FG003|Overall Study|Pregnancy|0|||
126598981|NCT05285137|455492203|FG004|Overall Study|Pregnancy|0|||
126598982|NCT05285137|455492204|FG005|Overall Study|Pregnancy|0|||
126598983|NCT05285137|455492205|FG006|Overall Study|Pregnancy|1|||
126598984|NCT05285137|455492206|FG007|Overall Study|Pregnancy|0|||
126598985|NCT05285137|455492207|FG008|Overall Study|Pregnancy|0|||
126598986|NCT05285137|455492199|FG000|Overall Study|Withdrawal by Subject|0|||
126598987|NCT05285137|455492200|FG001|Overall Study|Withdrawal by Subject|1|||
126598988|NCT05285137|455492201|FG002|Overall Study|Withdrawal by Subject|2|||
126598989|NCT05285137|455492202|FG003|Overall Study|Withdrawal by Subject|1|||
126598990|NCT05285137|455492203|FG004|Overall Study|Withdrawal by Subject|0|||
126598991|NCT05285137|455492204|FG005|Overall Study|Withdrawal by Subject|0|||
126598992|NCT05285137|455492205|FG006|Overall Study|Withdrawal by Subject|0|||
126598993|NCT05285137|455492206|FG007|Overall Study|Withdrawal by Subject|0|||
126598994|NCT05285137|455492207|FG008|Overall Study|Withdrawal by Subject|1|||
126598995|NCT03717935|455492208|FG000|Overall Study|Withdrawal by Subject|0|||
126598996|NCT03717935|455492209|FG001|Overall Study|Withdrawal by Subject|2|||
126598997|NCT03484819|455492214|FG000|Overall Study|Death|2|||
126598998|NCT03484819|455492214|FG000|Overall Study|Adverse Event|2|||
126598999|NCT03484819|455492214|FG000|Overall Study|Physician Decision|1|||
126599000|NCT03484819|455492214|FG000|Overall Study|Withdrawal by Subject|2|||
126599001|NCT03484819|455492214|FG000|Overall Study|Disease Progression|4|||
126599002|NCT03484819|455492214|FG000|Overall Study|Complicating Condition|1|||
126599003|NCT04479761|455492216|FG000|Overall Study|could not perform the balance tasks|1|||
126599004|NCT04479761|455492217|FG001|Overall Study|could not perform the balance tasks|0|||
126599005|NCT04479761|455492218|FG002|Overall Study|could not perform the balance tasks|0|||
126599006|NCT04479761|455492216|FG000|Overall Study|Adverse Event|1|||
126599007|NCT04479761|455492217|FG001|Overall Study|Adverse Event|0|||
126599008|NCT04479761|455492218|FG002|Overall Study|Adverse Event|0|||
126599009|NCT04479761|455492216|FG000|Overall Study|one control did not meet screening criteria|0|||
126599010|NCT04479761|455492217|FG001|Overall Study|one control did not meet screening criteria|0|||
126599011|NCT04479761|455492218|FG002|Overall Study|one control did not meet screening criteria|1|||
126599012|NCT04479761|455492216|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
126599013|NCT04479761|455492217|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
126599014|NCT04479761|455492218|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
126599015|NCT04186819|455492219|FG000|Overall Study|Adverse Event|1|||
126599016|NCT04186819|455492219|FG000|Overall Study|Lost to Follow-up|1|||
126599017|NCT04186819|455492219|FG000|Overall Study|Opted for EBRT|1|||
126599018|NCT04186819|455492219|FG000|Overall Study|Opted SBRT|1|||
126599019|NCT04186819|455492219|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
126599020|NCT04186819|455492219|FG000|Overall Study|Physician Decision|1|||
126599021|NCT04186819|455492219|FG000|Overall Study|RP Delayed|1|||
126599022|NCT04186819|455492219|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
126599023|NCT04186819|455492219|FG000|Overall Study|Subject declined for financial reasons|1|||
126599024|NCT04186819|455492219|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
126599025|NCT04186819|455492219|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
126599026|NCT04186819|455492219|FG000|Overall Study|The subject opted for other treatment option|2|||
126599027|NCT04186819|455492219|FG000|Overall Study|The subject opted for other treatment options|1|||
126599028|NCT04186819|455492219|FG000|Overall Study|Withdrawal by Subject|3|||
126599029|NCT04186819|455492219|FG000|Overall Study|Reason not specified|1|||
126599030|NCT04129554|455492233|FG000|Overall Study|Withdrawal by Subject|4|||
126599031|NCT04129554|455492234|FG001|Overall Study|Withdrawal by Subject|3|||
126599032|NCT04129554|455492233|FG000|Overall Study|Other|0|||
126599033|NCT04129554|455492234|FG001|Overall Study|Other|2|||
126599034|NCT02846545|455492235|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
126599035|NCT02846545|455492236|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
126599036|NCT02846545|455492235|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
126599037|NCT02846545|455492236|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
126599038|NCT02846545|455492235|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
126599039|NCT02846545|455492236|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
126599040|NCT02846545|455492235|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
126599041|NCT02846545|455492236|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
126599042|NCT02846545|455492235|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
126599043|NCT02846545|455492236|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
126599044|NCT03691298|455492239|FG000|Overall Study|Lost to Follow-up|8|||
126599045|NCT03691298|455492239|FG000|Overall Study|Sponsor terminated study|2|||
126599046|NCT02492711|455492243|FG000|Overall Study|Adverse Event|9|||
126599047|NCT02492711|455492244|FG001|Overall Study|Adverse Event|9|||
126599048|NCT02492711|455492245|FG002|Overall Study|Adverse Event|2|||
126599049|NCT02492711|455492243|FG000|Overall Study|Death|3|||
126599050|NCT02492711|455492244|FG001|Overall Study|Death|3|||
126599051|NCT02492711|455492245|FG002|Overall Study|Death|0|||
126733175|NCT00168064|455972325|FG000|Overall Study|Lost to Follow-up|4|||
126599052|NCT02492711|455492243|FG000|Overall Study|Withdrawal by Subject|10|||
126599053|NCT02492711|455492244|FG001|Overall Study|Withdrawal by Subject|16|||
126599054|NCT02492711|455492245|FG002|Overall Study|Withdrawal by Subject|5|||
126599055|NCT02492711|455492243|FG000|Overall Study|Physician Decision|10|||
126599056|NCT02492711|455492244|FG001|Overall Study|Physician Decision|6|||
126599057|NCT02492711|455492245|FG002|Overall Study|Physician Decision|4|||
126733176|NCT00168064|455972326|FG001|Overall Study|Lost to Follow-up|3|||
126599058|NCT02492711|455492243|FG000|Overall Study|Lost to Follow-up|0|||
126599059|NCT02492711|455492244|FG001|Overall Study|Lost to Follow-up|0|||
126599060|NCT02492711|455492245|FG002|Overall Study|Lost to Follow-up|1|||
126599061|NCT02492711|455492243|FG000|Overall Study|study treatment delay|2|||
126599062|NCT02492711|455492244|FG001|Overall Study|study treatment delay|1|||
126599063|NCT02492711|455492245|FG002|Overall Study|study treatment delay|0|||
126599064|NCT02492711|455492243|FG000|Overall Study|change in chemotherapy|0|||
126599065|NCT02492711|455492244|FG001|Overall Study|change in chemotherapy|1|||
126599066|NCT02492711|455492245|FG002|Overall Study|change in chemotherapy|0|||
126599067|NCT02492711|455492243|FG000|Overall Study|never treated|2|||
126599068|NCT02492711|455492244|FG001|Overall Study|never treated|4|||
126599069|NCT02492711|455492245|FG002|Overall Study|never treated|0|||
126599070|NCT02492711|455492243|FG000|Overall Study|Other|0|||
126599071|NCT02492711|455492244|FG001|Overall Study|Other|0|||
126599072|NCT02492711|455492245|FG002|Overall Study|Other|1|||
126599073|NCT03993392|455492250|FG000|Overall Study|Withdrawal by Subject|3|||
126599074|NCT03993392|455492250|FG000|Overall Study|Lost to Follow-up|2|||
126599075|NCT03993392|455492250|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
126599076|NCT02437136|455493339|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
126599077|NCT02437136|455493340|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
126599078|NCT02437136|455493341|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
126599079|NCT02437136|455493342|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
126599080|NCT02437136|455493343|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
126599081|NCT02437136|455493344|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
126599082|NCT02437136|455493345|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
126599083|NCT02437136|455493339|FG000|Expansion (Phase 2)|Death|0|||
126599084|NCT02437136|455493340|FG001|Expansion (Phase 2)|Death|0|||
126599085|NCT02437136|455493341|FG002|Expansion (Phase 2)|Death|0|||
126599086|NCT02437136|455493342|FG003|Expansion (Phase 2)|Death|6|||
126599087|NCT02437136|455493343|FG004|Expansion (Phase 2)|Death|37|||
126599088|NCT02437136|455493344|FG005|Expansion (Phase 2)|Death|29|||
126599089|NCT02437136|455493345|FG006|Expansion (Phase 2)|Death|24|||
126599090|NCT02437136|455493339|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
126599091|NCT02437136|455493340|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
126599092|NCT02437136|455493341|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
126599093|NCT02437136|455493342|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
126599094|NCT02437136|455493343|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
126599095|NCT02437136|455493344|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
126599096|NCT02437136|455493345|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
126599097|NCT02437136|455493339|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
126599098|NCT02437136|455493340|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
126599099|NCT02437136|455493341|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
126599100|NCT02437136|455493342|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
126599101|NCT02437136|455493343|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
126599102|NCT02437136|455493344|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
126599103|NCT02437136|455493345|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
126599104|NCT03640286|455493351|FG000|Overall Study|Adverse Event|6|||
126599105|NCT03640286|455493352|FG001|Overall Study|Adverse Event|6|||
126599106|NCT03640286|455493351|FG000|Overall Study|Lost to Follow-up|3|||
126599107|NCT03640286|455493352|FG001|Overall Study|Lost to Follow-up|6|||
126599108|NCT03640286|455493351|FG000|Overall Study|Pregnancy|1|||
126599109|NCT03640286|455493352|FG001|Overall Study|Pregnancy|0|||
126599110|NCT03640286|455493351|FG000|Overall Study|Withdrawal by Subject|10|||
126599111|NCT03640286|455493352|FG001|Overall Study|Withdrawal by Subject|10|||
126599112|NCT03640286|455493351|FG000|Overall Study|Non-compliance|4|||
126599113|NCT03640286|455493352|FG001|Overall Study|Non-compliance|10|||
126599114|NCT03640286|455493351|FG000|Overall Study|Medication change|1|||
126599115|NCT03640286|455493352|FG001|Overall Study|Medication change|0|||
126599116|NCT03640286|455493351|FG000|Overall Study|Other|1|||
126599117|NCT03640286|455493352|FG001|Overall Study|Other|2|||
126599118|NCT03640286|455493351|FG000|Overall Study|Joined another lifestyle program|0|||
126599119|NCT03640286|455493352|FG001|Overall Study|Joined another lifestyle program|1|||
126599120|NCT05524116|455493353|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
126599121|NCT05524116|455493354|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
126599122|NCT05524116|455493353|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
126599123|NCT05524116|455493354|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
126599124|NCT05524116|455493353|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
126599125|NCT05524116|455493354|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
126599126|NCT05524116|455493353|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
126599127|NCT05524116|455493354|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
126599128|NCT05524116|455493353|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
126599129|NCT05524116|455493354|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
126599130|NCT03181516|455493355|FG000|Overall Study|Withdrawal by Subject|14|||
126599131|NCT03181516|455493356|FG001|Overall Study|Withdrawal by Subject|7|||
126599132|NCT03181516|455493355|FG000|Overall Study|Lost to Follow-up|2|||
126599133|NCT03181516|455493356|FG001|Overall Study|Lost to Follow-up|2|||
126779760|NCT00686920|456149593|FG001|Overall Study|Withdrawal by Subject|5|||
126779761|NCT00686920|456149592|FG000|Overall Study|Protocol Violation|2|||
126779762|NCT00686920|456149593|FG001|Overall Study|Protocol Violation|1|||
126779763|NCT00686920|456149592|FG000|Overall Study|Adverse Event|10|||
126779764|NCT00686920|456149593|FG001|Overall Study|Adverse Event|2|||
126779765|NCT00686920|456149592|FG000|Overall Study|Personal Reason|0|||
126779766|NCT00686920|456149593|FG001|Overall Study|Personal Reason|1|||
126779767|NCT00686920|456149592|FG000|Overall Study|Lost to Follow-up|15|||
126779768|NCT00686920|456149593|FG001|Overall Study|Lost to Follow-up|3|||
126779769|NCT00686920|456149592|FG000|Overall Study|Moved to Another State|1|||
126779770|NCT00686920|456149593|FG001|Overall Study|Moved to Another State|0|||
126779771|NCT00686920|456149592|FG000|Overall Study|Transferred to Nursing Home|1|||
126599134|NCT05405985|455493357|FG000|Overall Study|Withdrawal by Subject|1|||
126599135|NCT05405985|455493358|FG001|Overall Study|Withdrawal by Subject|0|||
126599136|NCT05533190|455493359|FG000|Overall Study|Lost to Follow-up|19|||
126779772|NCT00686920|456149593|FG001|Overall Study|Transferred to Nursing Home|0|||
126779773|NCT00686920|456149592|FG000|Overall Study|Noncompliance|9|||
126779774|NCT00686920|456149593|FG001|Overall Study|Noncompliance|0|||
126779775|NCT00686920|456149592|FG000|Overall Study|Principal Investigator Decision|2|||
126779776|NCT00686920|456149593|FG001|Overall Study|Principal Investigator Decision|0|||
126779777|NCT01620983|456149598|FG000|Overall Study|Lost to Follow-up|8|||
126779778|NCT01620983|456149599|FG001|Overall Study|Lost to Follow-up|4|||
126779779|NCT01620983|456149600|FG002|Overall Study|Lost to Follow-up|9|||
126779780|NCT01620983|456149598|FG000|Overall Study|Withdrawal by Subject|6|||
126779781|NCT01620983|456149599|FG001|Overall Study|Withdrawal by Subject|8|||
126779782|NCT01620983|456149600|FG002|Overall Study|Withdrawal by Subject|1|||
126779783|NCT01620983|456149598|FG000|Overall Study|Death|2|||
126779784|NCT01620983|456149599|FG001|Overall Study|Death|0|||
126599137|NCT05533190|455493360|FG001|Overall Study|Lost to Follow-up|7|||
126599138|NCT05533190|455493359|FG000|Overall Study|Failed to download app|1|||
126599139|NCT05533190|455493360|FG001|Overall Study|Failed to download app|0|||
126599140|NCT05533190|455493359|FG000|Overall Study|Thought app was a scam|1|||
126599141|NCT05533190|455493360|FG001|Overall Study|Thought app was a scam|0|||
126599142|NCT05533190|455493359|FG000|Overall Study|Withdrawal by Subject|2|||
126599143|NCT05533190|455493360|FG001|Overall Study|Withdrawal by Subject|0|||
126599144|NCT05552508|455493361|FG000|Overall Study|Adverse Event|3|||
126599145|NCT01917084|455493362|FG000|Overall Study|Withdrawal by Subject|1|||
126599146|NCT04451772|455493370|FG000|Overall Study|Adverse Event|1|||
126599147|NCT04451772|455493371|FG001|Overall Study|Adverse Event|0|||
126599148|NCT04451772|455493372|FG002|Overall Study|Adverse Event|1|||
126599149|NCT04451772|455493373|FG003|Overall Study|Adverse Event|1|||
126599150|NCT04451772|455493374|FG004|Overall Study|Adverse Event|0|||
126599151|NCT04451772|455493375|FG005|Overall Study|Adverse Event|3|||
126599152|NCT04451772|455493370|FG000|Overall Study|Withdrawal by Subject|2|||
126599153|NCT04451772|455493371|FG001|Overall Study|Withdrawal by Subject|7|||
126599154|NCT04451772|455493372|FG002|Overall Study|Withdrawal by Subject|2|||
126599155|NCT04451772|455493373|FG003|Overall Study|Withdrawal by Subject|1|||
126599156|NCT04451772|455493374|FG004|Overall Study|Withdrawal by Subject|1|||
126599157|NCT04451772|455493375|FG005|Overall Study|Withdrawal by Subject|0|||
126599158|NCT04451772|455493370|FG000|Overall Study|Other, not specified|1|||
126599159|NCT04451772|455493371|FG001|Overall Study|Other, not specified|2|||
126779785|NCT01620983|456149600|FG002|Overall Study|Death|0|||
126779786|NCT01620983|456149598|FG000|Overall Study|Physician Decision|3|||
126779787|NCT01620983|456149599|FG001|Overall Study|Physician Decision|10|||
126779788|NCT01620983|456149600|FG002|Overall Study|Physician Decision|5|||
126779789|NCT00545233|456149602|FG000|Overall Study|Adverse Event|10|||
126779790|NCT00545233|456149603|FG001|Overall Study|Adverse Event|5|||
126779791|NCT00545233|456149602|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
126779792|NCT00545233|456149603|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
126779793|NCT00545233|456149602|FG000|Overall Study|Protocol Violation|2|||
126599160|NCT04451772|455493372|FG002|Overall Study|Other, not specified|1|||
126599161|NCT04451772|455493373|FG003|Overall Study|Other, not specified|0|||
126599162|NCT04451772|455493374|FG004|Overall Study|Other, not specified|0|||
126599163|NCT04451772|455493375|FG005|Overall Study|Other, not specified|1|||
126599164|NCT04451772|455493370|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
126599165|NCT04451772|455493371|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
126599166|NCT04451772|455493372|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
126599167|NCT04451772|455493373|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
126599168|NCT04451772|455493374|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
126599169|NCT04451772|455493375|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
126599170|NCT04167553|455493376|FG000|Overall Study|Withdrawal by Subject|1|||
126599171|NCT04167553|455493377|FG001|Overall Study|Withdrawal by Subject|0|||
126779794|NCT00545233|456149603|FG001|Overall Study|Protocol Violation|0|||
126779795|NCT00545233|456149602|FG000|Overall Study|Refused Treatment|9|||
126779796|NCT00545233|456149603|FG001|Overall Study|Refused Treatment|7|||
126599172|NCT04167553|455493378|FG002|Overall Study|Withdrawal by Subject|1|||
126779797|NCT00545233|456149602|FG000|Overall Study|Failure to Return|4|||
126779798|NCT00545233|456149603|FG001|Overall Study|Failure to Return|6|||
126779799|NCT00545233|456149602|FG000|Overall Study|Insufficient response|14|||
126779800|NCT00545233|456149603|FG001|Overall Study|Insufficient response|15|||
126779801|NCT00545233|456149602|FG000|Overall Study|Physician Decision|2|||
126779802|NCT00545233|456149603|FG001|Overall Study|Physician Decision|1|||
126779803|NCT01208402|456149604|FG000|Overall Study|Withdrawal by Subject|1|||
126779804|NCT01208402|456149605|FG001|Overall Study|Withdrawal by Subject|0|||
126779805|NCT03811249|456149606|FG000|Overall Study|Withdrawal by Subject|44|||
126779806|NCT03811249|456149606|FG000|Overall Study|Missed Visit|24|||
126779807|NCT01504867|456149610|FG000|Overall Study|Inclusion criteria not met|2|||
126779808|NCT01504867|456149611|FG001|Overall Study|Inclusion criteria not met|2|||
126779809|NCT01504867|456149610|FG000|Overall Study|Consent revoked|5|||
126779810|NCT01504867|456149611|FG001|Overall Study|Consent revoked|1|||
126779811|NCT02175966|456149612|FG000|Follow-up Period|Lack of Efficacy|10|||
126599173|NCT04167553|455493379|FG003|Overall Study|Withdrawal by Subject|2|||
126599174|NCT04167553|455493380|FG004|Overall Study|Withdrawal by Subject|1|||
126599175|NCT04167553|455493381|FG005|Overall Study|Withdrawal by Subject|0|||
126599176|NCT04167553|455493382|FG006|Overall Study|Withdrawal by Subject|0|||
126599177|NCT04167553|455493376|FG000|Overall Study|Physician Decision|0|||
126779812|NCT02175966|456149613|FG001|Follow-up Period|Lack of Efficacy|6|||
126779813|NCT01154153|456149614|FG000|Overall Study|Poor compliance to protocol|2|||
126779814|NCT01154153|456149615|FG001|Overall Study|Poor compliance to protocol|0|||
126779815|NCT01154153|456149614|FG000|Overall Study|Unable to use labs|2|||
126779816|NCT01154153|456149615|FG001|Overall Study|Unable to use labs|3|||
126779817|NCT01154153|456149614|FG000|Overall Study|Withdrew consent|1|||
126779818|NCT01154153|456149615|FG001|Overall Study|Withdrew consent|0|||
126779819|NCT00210626|456149616|FG000|Overall Study|Adverse Event|1|||
126779820|NCT00210626|456149617|FG001|Overall Study|Adverse Event|2|||
126779821|NCT00210626|456149616|FG000|Overall Study|Protocol Violation|1|||
126779822|NCT00210626|456149617|FG001|Overall Study|Protocol Violation|5|||
126779823|NCT00210626|456149616|FG000|Overall Study|Lost to Follow-up|11|||
126779824|NCT00210626|456149617|FG001|Overall Study|Lost to Follow-up|11|||
126779825|NCT00210626|456149616|FG000|Overall Study|Death|1|||
126779826|NCT00210626|456149617|FG001|Overall Study|Death|0|||
126779827|NCT00210626|456149616|FG000|Overall Study|Withdrawal by Subject|29|||
126779828|NCT00210626|456149617|FG001|Overall Study|Withdrawal by Subject|20|||
126779829|NCT00210626|456149616|FG000|Overall Study|Physician Decision|0|||
126779830|NCT00210626|456149617|FG001|Overall Study|Physician Decision|2|||
126779831|NCT00210626|456149616|FG000|Overall Study|Sponser Request|1|||
126779832|NCT00210626|456149617|FG001|Overall Study|Sponser Request|0|||
126779833|NCT00210626|456149616|FG000|Overall Study|Other|4|||
126779834|NCT00210626|456149617|FG001|Overall Study|Other|5|||
126779835|NCT02473510|456149618|FG000|Overall Study|Lost to Follow-up|1|||
126779836|NCT02473510|456149619|FG001|Overall Study|Lost to Follow-up|2|||
126779837|NCT01306253|456149620|FG000|Overall Study|Lost to Follow-up|1|||
126779838|NCT01306253|456149621|FG001|Overall Study|Lost to Follow-up|1|||
126779839|NCT02280356|456149625|FG000|Overall Study|Not Treated|2|||
126779840|NCT02280356|456149625|FG000|Overall Study|Withdrawal by Subject|1|||
126779841|NCT02280356|456149625|FG000|Overall Study|Not evaluable|2|||
126779842|NCT01086215|456149626|FG000|Overall Study|Death|14|||
126779843|NCT01086215|456149627|FG001|Overall Study|Death|8|||
126779844|NCT01086215|456149628|FG002|Overall Study|Death|8|||
126779845|NCT01086215|456149629|FG003|Overall Study|Death|1|||
126779846|NCT01086215|456149626|FG000|Overall Study|Lost to Follow-up|22|||
126779847|NCT01086215|456149627|FG001|Overall Study|Lost to Follow-up|39|||
126779848|NCT01086215|456149628|FG002|Overall Study|Lost to Follow-up|18|||
126779849|NCT01086215|456149629|FG003|Overall Study|Lost to Follow-up|2|||
126599178|NCT04167553|455493377|FG001|Overall Study|Physician Decision|0|||
126779850|NCT00408876|456149630|FG000|Overall Study|Adverse Event|9|||
126779851|NCT00408876|456149631|FG001|Overall Study|Adverse Event|17|||
126779852|NCT00408876|456149632|FG002|Overall Study|Adverse Event|27|||
126779853|NCT00408876|456149633|FG003|Overall Study|Adverse Event|10|||
126779854|NCT00408876|456149630|FG000|Overall Study|Withdrawal by Subject|3|||
126779855|NCT00408876|456149631|FG001|Overall Study|Withdrawal by Subject|6|||
126599179|NCT04167553|455493378|FG002|Overall Study|Physician Decision|0|||
126599180|NCT04167553|455493379|FG003|Overall Study|Physician Decision|0|||
126779856|NCT00408876|456149632|FG002|Overall Study|Withdrawal by Subject|6|||
126779857|NCT00408876|456149633|FG003|Overall Study|Withdrawal by Subject|14|||
126599181|NCT04167553|455493380|FG004|Overall Study|Physician Decision|2|||
126599182|NCT04167553|455493381|FG005|Overall Study|Physician Decision|2|||
126779858|NCT00408876|456149630|FG000|Overall Study|Lack of Efficacy|2|||
126779859|NCT00408876|456149631|FG001|Overall Study|Lack of Efficacy|4|||
126779860|NCT00408876|456149632|FG002|Overall Study|Lack of Efficacy|5|||
126779861|NCT00408876|456149633|FG003|Overall Study|Lack of Efficacy|6|||
126599183|NCT04167553|455493382|FG006|Overall Study|Physician Decision|0|||
126779862|NCT00408876|456149630|FG000|Overall Study|Lost to Follow-up|1|||
126779863|NCT00408876|456149631|FG001|Overall Study|Lost to Follow-up|6|||
126779864|NCT00408876|456149632|FG002|Overall Study|Lost to Follow-up|5|||
126779865|NCT00408876|456149633|FG003|Overall Study|Lost to Follow-up|2|||
126779866|NCT00408876|456149630|FG000|Overall Study|Protocol Violation|0|||
126779867|NCT00408876|456149631|FG001|Overall Study|Protocol Violation|3|||
126779868|NCT00408876|456149632|FG002|Overall Study|Protocol Violation|4|||
126779869|NCT00408876|456149633|FG003|Overall Study|Protocol Violation|3|||
126779870|NCT00408876|456149630|FG000|Overall Study|Physician Decision|1|||
126779871|NCT00408876|456149631|FG001|Overall Study|Physician Decision|0|||
126779872|NCT00408876|456149632|FG002|Overall Study|Physician Decision|3|||
126779873|NCT00408876|456149633|FG003|Overall Study|Physician Decision|0|||
126779874|NCT02006147|456149634|FG000|Overall Study|Protocol Violation|1|||
126779875|NCT02006147|456149635|FG001|Overall Study|Protocol Violation|1|||
126779876|NCT02006147|456149636|FG002|Overall Study|Protocol Violation|0|||
126779877|NCT02006147|456149637|FG003|Overall Study|Protocol Violation|0|||
126779878|NCT02006147|456149634|FG000|Overall Study|Withdrawal by Subject|0|||
126779879|NCT02006147|456149635|FG001|Overall Study|Withdrawal by Subject|1|||
126779880|NCT02006147|456149636|FG002|Overall Study|Withdrawal by Subject|0|||
126779881|NCT02006147|456149637|FG003|Overall Study|Withdrawal by Subject|0|||
126779882|NCT02006147|456149634|FG000|Overall Study|Withdrawal by Sponsor|1|||
126779883|NCT02006147|456149635|FG001|Overall Study|Withdrawal by Sponsor|0|||
126779884|NCT02006147|456149636|FG002|Overall Study|Withdrawal by Sponsor|0|||
126779885|NCT02006147|456149637|FG003|Overall Study|Withdrawal by Sponsor|0|||
126779886|NCT03361956|456149638|FG000|Overall Study|Adverse Event|1|||
126779887|NCT03361956|456149639|FG001|Overall Study|Adverse Event|0|||
126779888|NCT03361956|456149640|FG002|Overall Study|Adverse Event|1|||
126779889|NCT03361956|456149641|FG003|Overall Study|Adverse Event|1|||
126779890|NCT03361956|456149642|FG004|Overall Study|Adverse Event|0|||
126779891|NCT03361956|456149638|FG000|Overall Study|Other|0|||
126779892|NCT03361956|456149639|FG001|Overall Study|Other|0|||
126779893|NCT03361956|456149640|FG002|Overall Study|Other|0|||
126779894|NCT03361956|456149641|FG003|Overall Study|Other|1|||
126779895|NCT03361956|456149642|FG004|Overall Study|Other|0|||
126779896|NCT03361956|456149638|FG000|Overall Study|Withdrawal by Subject|2|||
126779897|NCT03361956|456149639|FG001|Overall Study|Withdrawal by Subject|2|||
126779898|NCT03361956|456149640|FG002|Overall Study|Withdrawal by Subject|2|||
126779899|NCT03361956|456149641|FG003|Overall Study|Withdrawal by Subject|0|||
126779900|NCT03361956|456149642|FG004|Overall Study|Withdrawal by Subject|3|||
126779901|NCT03361956|456149638|FG000|Overall Study|Disease Relapse|0|||
126779902|NCT03361956|456149639|FG001|Overall Study|Disease Relapse|0|||
126779903|NCT03361956|456149640|FG002|Overall Study|Disease Relapse|1|||
126779904|NCT03361956|456149641|FG003|Overall Study|Disease Relapse|0|||
126779905|NCT03361956|456149642|FG004|Overall Study|Disease Relapse|0|||
126779906|NCT03361956|456149638|FG000|Overall Study|Physician Decision|0|||
126779907|NCT03361956|456149639|FG001|Overall Study|Physician Decision|2|||
126779908|NCT03361956|456149640|FG002|Overall Study|Physician Decision|0|||
126779909|NCT03361956|456149641|FG003|Overall Study|Physician Decision|1|||
126779910|NCT03361956|456149642|FG004|Overall Study|Physician Decision|0|||
126779911|NCT03361956|456149638|FG000|Overall Study|Lost to Follow-up|0|||
126779912|NCT03361956|456149639|FG001|Overall Study|Lost to Follow-up|0|||
126779913|NCT03361956|456149640|FG002|Overall Study|Lost to Follow-up|1|||
126779914|NCT03361956|456149641|FG003|Overall Study|Lost to Follow-up|1|||
126779915|NCT03361956|456149642|FG004|Overall Study|Lost to Follow-up|2|||
126779916|NCT00871728|456149648|FG000|Overall Study|Adverse Event|1|||
126779917|NCT00871728|456149648|FG000|Overall Study|Protocol Violation|7|||
126779918|NCT00871728|456149648|FG000|Overall Study|Lost to Follow-up|2|||
126779919|NCT00871728|456149648|FG000|Overall Study|Failed to Visit Hospital|4|||
126779920|NCT00871728|456149648|FG000|Overall Study|Participant Non-compliance|1|||
126779921|NCT00871728|456149648|FG000|Overall Study|Withdrawal of Informed Consent|5|||
126599184|NCT04167553|455493376|FG000|Overall Study|Lost to Follow-up|0|||
126599185|NCT04167553|455493377|FG001|Overall Study|Lost to Follow-up|0|||
126599186|NCT04167553|455493378|FG002|Overall Study|Lost to Follow-up|2|||
126599187|NCT04167553|455493379|FG003|Overall Study|Lost to Follow-up|0|||
126599188|NCT04167553|455493380|FG004|Overall Study|Lost to Follow-up|0|||
126779922|NCT04147715|456149649|FG000|Overall Study|Adverse Event|0|||
126779923|NCT04147715|456149650|FG001|Overall Study|Adverse Event|0|||
126779924|NCT04147715|456149651|FG002|Overall Study|Adverse Event|0|||
126779925|NCT04147715|456149652|FG003|Overall Study|Adverse Event|0|||
126779926|NCT04147715|456149653|FG004|Overall Study|Adverse Event|0|||
126779927|NCT04147715|456149654|FG005|Overall Study|Adverse Event|0|||
126779928|NCT04147715|456149655|FG006|Overall Study|Adverse Event|0|||
126779929|NCT04147715|456149656|FG007|Overall Study|Adverse Event|2|||
126779930|NCT04147715|456149657|FG008|Overall Study|Adverse Event|1|||
126779931|NCT04147715|456149658|FG009|Overall Study|Adverse Event|0|||
126599189|NCT04167553|455493381|FG005|Overall Study|Lost to Follow-up|0|||
126599190|NCT04167553|455493382|FG006|Overall Study|Lost to Follow-up|0|||
126779932|NCT04147715|456149659|FG010|Overall Study|Adverse Event|0|||
126779933|NCT04147715|456149660|FG011|Overall Study|Adverse Event|0|||
126779934|NCT03404206|456149661|FG000|Overall Study|Withdrawal by Subject|1|||
126779935|NCT03404206|456149662|FG001|Overall Study|Withdrawal by Subject|1|||
126779936|NCT03404206|456149663|FG002|Overall Study|Withdrawal by Subject|0|||
126779937|NCT03404206|456149661|FG000|Overall Study|Lost to Follow-up|3|||
126779938|NCT03404206|456149662|FG001|Overall Study|Lost to Follow-up|1|||
126599191|NCT02828358|455493388|FG000|Overall Study|Physician Decision|7|||
126599192|NCT02828358|455493389|FG001|Overall Study|Physician Decision|1|||
126599193|NCT02828358|455493388|FG000|Overall Study|Treatment Failure|6|||
126599194|NCT02828358|455493389|FG001|Overall Study|Treatment Failure|0|||
126599195|NCT02828358|455493388|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
126599196|NCT02828358|455493389|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
126599197|NCT02828358|455493388|FG000|Overall Study|Refusal of further protocol therapy|2|||
126599198|NCT02828358|455493389|FG001|Overall Study|Refusal of further protocol therapy|0|||
126599199|NCT02828358|455493388|FG000|Overall Study|Relapse|25|||
126599200|NCT02828358|455493389|FG001|Overall Study|Relapse|0|||
126599201|NCT02828358|455493388|FG000|Overall Study|Still on therapy|5|||
126599202|NCT02828358|455493389|FG001|Overall Study|Still on therapy|0|||
126599203|NCT04804540|455493392|FG000|Overall Study|Adverse Event|26|||
126599204|NCT04804540|455493393|FG001|Overall Study|Adverse Event|13|||
126599205|NCT05172232|455493394|FG000|Overall Study|Lost to Follow-up|3|||
126599206|NCT01828021|455493395|FG000|Overall Study|Adverse Event|5|||
126599207|NCT01828021|455493395|FG000|Overall Study|Lack of Efficacy|17|||
126599208|NCT01828021|455493395|FG000|Overall Study|Withdrawal by Subject|2|||
126599209|NCT01828021|455493395|FG000|Overall Study|Ileal obstruction, unrelated|1|||
126599210|NCT01199133|455493396|FG000|Year 1|Adverse Event|16|||
126599211|NCT01199133|455493397|FG001|Year 1|Adverse Event|4|||
126599212|NCT01199133|455493396|FG000|Year 1|Withdrawal by Subject|8|||
126599213|NCT01199133|455493397|FG001|Year 1|Withdrawal by Subject|4|||
126599214|NCT01199133|455493396|FG000|Year 1|Any other reason not above-mentioned|6|||
126599215|NCT01199133|455493397|FG001|Year 1|Any other reason not above-mentioned|7|||
126599216|NCT01199133|455493396|FG000|Year 2|Adverse Event|1|||
126599217|NCT01199133|455493397|FG001|Year 2|Adverse Event|0|||
126599218|NCT01199133|455493396|FG000|Year 2|Withdrawal by Subject|1|||
126599219|NCT01199133|455493397|FG001|Year 2|Withdrawal by Subject|1|||
126599220|NCT01199133|455493396|FG000|Year 2|Any other reason not above-mentioned|1|||
126599221|NCT01199133|455493397|FG001|Year 2|Any other reason not above-mentioned|2|||
126599222|NCT03988621|455493398|FG000|Overall Study|Lost to Follow-up|16|||
126599223|NCT03988621|455493399|FG001|Overall Study|Lost to Follow-up|17|||
126599224|NCT03988621|455493398|FG000|Overall Study|Withdrawal by Subject|14|||
126599225|NCT03988621|455493399|FG001|Overall Study|Withdrawal by Subject|7|||
126599226|NCT03988621|455493398|FG000|Overall Study|Patient Lost to Follow Up|15|||
126599227|NCT03988621|455493399|FG001|Overall Study|Patient Lost to Follow Up|15|||
126599228|NCT03988621|455493398|FG000|Overall Study|Patient death|1|||
126599229|NCT03988621|455493399|FG001|Overall Study|Patient death|5|||
126599230|NCT05013385|455493400|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
126599231|NCT04629339|455493401|FG000|Overall Study|Death|1|||
126599232|NCT04629339|455493402|FG001|Overall Study|Death|0|||
126599233|NCT04629339|455493403|FG002|Overall Study|Death|2|||
126599234|NCT04629339|455493404|FG003|Overall Study|Death|2|||
126599235|NCT04629339|455493405|FG004|Overall Study|Death|0|||
126599236|NCT04629339|455493401|FG000|Overall Study|Disease Progression|0|||
126599237|NCT04629339|455493402|FG001|Overall Study|Disease Progression|0|||
126599238|NCT04629339|455493403|FG002|Overall Study|Disease Progression|1|||
126599239|NCT04629339|455493404|FG003|Overall Study|Disease Progression|1|||
126599240|NCT04629339|455493405|FG004|Overall Study|Disease Progression|0|||
126599241|NCT04629339|455493401|FG000|Overall Study|Lost to Follow-up|0|||
126599242|NCT04629339|455493402|FG001|Overall Study|Lost to Follow-up|0|||
126599243|NCT04629339|455493403|FG002|Overall Study|Lost to Follow-up|0|||
126599244|NCT04629339|455493404|FG003|Overall Study|Lost to Follow-up|1|||
126599245|NCT04629339|455493405|FG004|Overall Study|Lost to Follow-up|0|||
126599246|NCT04629339|455493401|FG000|Overall Study|Physician Decision|0|||
126599247|NCT04629339|455493402|FG001|Overall Study|Physician Decision|1|||
126599248|NCT04629339|455493403|FG002|Overall Study|Physician Decision|0|||
126599249|NCT04629339|455493404|FG003|Overall Study|Physician Decision|0|||
126599250|NCT04629339|455493405|FG004|Overall Study|Physician Decision|0|||
126599251|NCT04629339|455493401|FG000|Overall Study|Study Terminated by Sponsor|0|||
126599252|NCT04629339|455493402|FG001|Overall Study|Study Terminated by Sponsor|0|||
126599253|NCT04629339|455493403|FG002|Overall Study|Study Terminated by Sponsor|0|||
126599254|NCT04629339|455493404|FG003|Overall Study|Study Terminated by Sponsor|1|||
126599255|NCT04629339|455493405|FG004|Overall Study|Study Terminated by Sponsor|0|||
126599256|NCT04629339|455493401|FG000|Overall Study|Withdrawal by Subject|0|||
126599257|NCT04629339|455493402|FG001|Overall Study|Withdrawal by Subject|0|||
126599258|NCT04629339|455493403|FG002|Overall Study|Withdrawal by Subject|2|||
126599259|NCT04629339|455493404|FG003|Overall Study|Withdrawal by Subject|2|||
126599260|NCT04629339|455493405|FG004|Overall Study|Withdrawal by Subject|0|||
126599261|NCT01447719|455493408|FG000|Overall Study|Image acquisition failure|2|||
126599262|NCT01447719|455493408|FG000|Overall Study|Invalid image or not imaged|3|||
126599263|NCT01447719|455493408|FG000|Overall Study|Subject still living at end of study|79|||
126599264|NCT01447719|455493408|FG000|Overall Study|Withdrawal by Subject|2|||
126599265|NCT01447719|455493408|FG000|Overall Study|Family withdrew autopsy consent|7|||
126599266|NCT05100628|455493409|FG000|Overall Study|Progressive Disease|1|||
126599267|NCT05100628|455493410|FG001|Overall Study|Progressive Disease|0|||
126599268|NCT05100628|455493411|FG002|Overall Study|Progressive Disease|0|||
126599269|NCT05100628|455493412|FG003|Overall Study|Progressive Disease|0|||
126599270|NCT05100628|455493409|FG000|Overall Study|Study Terminated by Sponsor|0|||
126599271|NCT05100628|455493410|FG001|Overall Study|Study Terminated by Sponsor|0|||
126599272|NCT05100628|455493411|FG002|Overall Study|Study Terminated by Sponsor|3|||
126599273|NCT05100628|455493412|FG003|Overall Study|Study Terminated by Sponsor|0|||
126599274|NCT05100628|455493409|FG000|Overall Study|unkown|0|||
126599275|NCT05100628|455493410|FG001|Overall Study|unkown|1|||
126599276|NCT05100628|455493411|FG002|Overall Study|unkown|0|||
126599277|NCT05100628|455493412|FG003|Overall Study|unkown|0|||
126599278|NCT03252288|455493415|FG000|Overall Study|Death|1|||
126599279|NCT03252288|455493416|FG001|Overall Study|Death|0|||
126599280|NCT03252288|455493417|FG002|Overall Study|Death|0|||
126599281|NCT03252288|455493415|FG000|Overall Study|Death|11|||
126599282|NCT03252288|455493416|FG001|Overall Study|Death|0|||
126599283|NCT03252288|455493417|FG002|Overall Study|Death|0|||
126599284|NCT03252288|455493415|FG000|Overall Study|Withdrawal by Subject|2|||
126599285|NCT03252288|455493416|FG001|Overall Study|Withdrawal by Subject|0|||
126599286|NCT03252288|455493417|FG002|Overall Study|Withdrawal by Subject|0|||
126599287|NCT03252288|455493415|FG000|Overall Study|Lost to Follow-up|79|||
126599288|NCT03252288|455493416|FG001|Overall Study|Lost to Follow-up|0|||
126599289|NCT03252288|455493417|FG002|Overall Study|Lost to Follow-up|0|||
126599290|NCT03252288|455493415|FG000|Overall Study|Loss of baseline data on tablets|6|||
126599291|NCT03252288|455493416|FG001|Overall Study|Loss of baseline data on tablets|0|||
126599292|NCT03252288|455493417|FG002|Overall Study|Loss of baseline data on tablets|0|||
126599293|NCT01121588|455493422|FG000|Overall Study|Death|5|||
126599294|NCT01121588|455493423|FG001|Overall Study|Death|3|||
126599295|NCT01121588|455493424|FG002|Overall Study|Death|13|||
126599296|NCT01121588|455493422|FG000|Overall Study|Study Terminated by Sponsor|1|||
126599297|NCT01121588|455493423|FG001|Overall Study|Study Terminated by Sponsor|1|||
126599298|NCT01121588|455493424|FG002|Overall Study|Study Terminated by Sponsor|0|||
126599299|NCT01121588|455493422|FG000|Overall Study|Participant Refused Further Followup|2|||
126599300|NCT01121588|455493423|FG001|Overall Study|Participant Refused Further Followup|0|||
126599301|NCT01121588|455493424|FG002|Overall Study|Participant Refused Further Followup|2|||
126599302|NCT01121588|455493422|FG000|Overall Study|Lost to Follow-up|0|||
126599303|NCT01121588|455493423|FG001|Overall Study|Lost to Follow-up|1|||
126599304|NCT01121588|455493424|FG002|Overall Study|Lost to Follow-up|1|||
126599305|NCT01121588|455493422|FG000|Overall Study|Non-Specified Reasons|9|||
126599306|NCT01121588|455493423|FG001|Overall Study|Non-Specified Reasons|4|||
126599307|NCT01121588|455493424|FG002|Overall Study|Non-Specified Reasons|2|||
126599308|NCT02938923|455493433|FG000|Overall Study|Death|1|||
126599309|NCT02938923|455493434|FG001|Overall Study|Death|0|||
126599310|NCT02938923|455493435|FG002|Overall Study|Death|0|||
126599311|NCT02938923|455493433|FG000|Overall Study|Physician Decision|0|||
126599312|NCT02938923|455493434|FG001|Overall Study|Physician Decision|2|||
126599313|NCT02938923|455493435|FG002|Overall Study|Physician Decision|0|||
126599314|NCT02938923|455493433|FG000|Overall Study|Withdrawal by Subject|0|||
126599315|NCT02938923|455493434|FG001|Overall Study|Withdrawal by Subject|1|||
126599316|NCT02938923|455493435|FG002|Overall Study|Withdrawal by Subject|1|||
126599317|NCT00721149|455493436|FG000|Overall Study|Physician Decision|1|||
126599318|NCT02518048|455493447|FG000|Overall Study|Withdrawal by Subject|1|||
126599319|NCT04505410|455493448|FG000|Overall Study|Adverse Event|2|||
126599320|NCT04505410|455493449|FG001|Overall Study|Adverse Event|0|||
126599321|NCT04505410|455493448|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
126599322|NCT04505410|455493449|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
126599323|NCT04505410|455493448|FG000|Overall Study|did not want to follow diet|1|||
126599324|NCT04505410|455493449|FG001|Overall Study|did not want to follow diet|0|||
126599325|NCT04505410|455493448|FG000|Overall Study|flare up of ulcerative colitis|0|||
126599326|NCT04505410|455493449|FG001|Overall Study|flare up of ulcerative colitis|1|||
126599327|NCT04505410|455493448|FG000|Overall Study|Lost to Follow-up|0|||
126599328|NCT04505410|455493449|FG001|Overall Study|Lost to Follow-up|2|||
126599329|NCT04505410|455493448|FG000|Overall Study|Lost to Follow-up|1|||
126599330|NCT04505410|455493449|FG001|Overall Study|Lost to Follow-up|0|||
126599331|NCT04505410|455493448|FG000|Overall Study|initiated another diet on their own|0|||
126599332|NCT04505410|455493449|FG001|Overall Study|initiated another diet on their own|2|||
126599333|NCT01586910|455494261|FG000|Overall Study|Death|4|||
126599334|NCT01586910|455494262|FG001|Overall Study|Death|4|||
126599335|NCT01586910|455494261|FG000|Overall Study|Withdrawal by Subject|6|||
126599336|NCT01586910|455494262|FG001|Overall Study|Withdrawal by Subject|43|||
126599337|NCT01586910|455494261|FG000|Overall Study|Physician withdrew Subject|5|||
126733177|NCT00168064|455972325|FG000|Overall Study|Non-compliance|2|||
126733178|NCT00168064|455972326|FG001|Overall Study|Non-compliance|3|||
126599338|NCT01586910|455494262|FG001|Overall Study|Physician withdrew Subject|24|||
126599339|NCT03635424|455494265|FG000|Overall Study|Adverse Event|1|||
126599340|NCT03635424|455494265|FG000|Overall Study|Death|1|||
126599341|NCT03635424|455494265|FG000|Overall Study|Device not implanted|1|||
126599342|NCT02278211|455494266|FG000|Overall Study|Unable to analyse PET scan|2|||
126599343|NCT05224544|455494267|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
126599344|NCT05224544|455494268|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
126779939|NCT03404206|456149663|FG002|Overall Study|Lost to Follow-up|0|||
126779940|NCT01626859|456149674|FG000|Overall Study|Adverse Event|1|||
126779941|NCT01626859|456149675|FG001|Overall Study|Adverse Event|3|||
126779942|NCT01626859|456149676|FG002|Overall Study|Adverse Event|2|||
126779943|NCT01626859|456149674|FG000|Overall Study|Physician Decision|0|||
126779944|NCT01626859|456149675|FG001|Overall Study|Physician Decision|1|||
126779945|NCT01626859|456149676|FG002|Overall Study|Physician Decision|0|||
126779946|NCT01626859|456149674|FG000|Overall Study|Withdrawal by Subject|1|||
126779947|NCT01626859|456149675|FG001|Overall Study|Withdrawal by Subject|4|||
126779948|NCT01626859|456149676|FG002|Overall Study|Withdrawal by Subject|2|||
126779949|NCT02629965|456149677|FG000|Period 1|Adverse Event|1|||
126779950|NCT02629965|456149678|FG001|Period 1|Adverse Event|0|||
126779951|NCT02629965|456149677|FG000|Period 1|Unexpected worsening of disease|2|||
126779952|NCT02629965|456149678|FG001|Period 1|Unexpected worsening of disease|0|||
126779953|NCT02629965|456149677|FG000|Period 1|Other than listed above|1|||
126779954|NCT02629965|456149678|FG001|Period 1|Other than listed above|2|||
126779955|NCT02629965|456149677|FG000|Period 2|Adverse Event|1|||
126779956|NCT02629965|456149678|FG001|Period 2|Adverse Event|0|||
126779957|NCT02330081|456149679|FG000|Overall Study|Adverse Event|1|||
126779958|NCT02330081|456149679|FG000|Overall Study|Donation did not meet criteria|1|||
126779959|NCT02330081|456149679|FG000|Overall Study|Protocol Violation|6|||
126779960|NCT00905489|456149684|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
126779961|NCT00905489|456149684|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
126779962|NCT00905489|456149684|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
126779963|NCT00895583|456149692|FG000|Overall Study|Adverse Event|28|||
126779964|NCT00895583|456149693|FG001|Overall Study|Adverse Event|4|||
126779965|NCT00895583|456149692|FG000|Overall Study|Death|2|||
126779966|NCT00895583|456149693|FG001|Overall Study|Death|1|||
126779967|NCT00895583|456149692|FG000|Overall Study|Physician Decision|3|||
126779968|NCT00895583|456149693|FG001|Overall Study|Physician Decision|1|||
126779969|NCT00895583|456149692|FG000|Overall Study|Lost to Follow-up|1|||
126779970|NCT00895583|456149693|FG001|Overall Study|Lost to Follow-up|3|||
126779971|NCT00895583|456149692|FG000|Overall Study|Protocol Violation|1|||
126779972|NCT00895583|456149693|FG001|Overall Study|Protocol Violation|0|||
126779973|NCT00895583|456149692|FG000|Overall Study|Withdrawal by Subject|4|||
126779974|NCT00895583|456149693|FG001|Overall Study|Withdrawal by Subject|2|||
126779975|NCT00895583|456149692|FG000|Overall Study|Lack of Efficacy|5|||
126779976|NCT00895583|456149693|FG001|Overall Study|Lack of Efficacy|0|||
126779977|NCT00895583|456149692|FG000|Overall Study|Other|0|||
126779978|NCT00895583|456149693|FG001|Overall Study|Other|1|||
126779979|NCT00616928|456149694|FG000|Overall Study|Adverse Event|6|||
126779980|NCT00616928|456149695|FG001|Overall Study|Adverse Event|3|||
126779981|NCT00616928|456149696|FG002|Overall Study|Adverse Event|2|||
126779982|NCT00616928|456149697|FG003|Overall Study|Adverse Event|2|||
126779983|NCT00616928|456149694|FG000|Overall Study|Other|51|||
126779984|NCT00616928|456149695|FG001|Overall Study|Other|8|||
126779985|NCT00616928|456149696|FG002|Overall Study|Other|15|||
126599345|NCT00844415|455494269|FG000|Overall Study|Withdrawal by Subject|1|||
126599346|NCT02473445|455494270|FG000|Overall Study|Withdrawal by Subject|2|||
126599347|NCT02473445|455494270|FG000|Overall Study|Sponsor Decision|20|||
126599348|NCT03015532|455494271|FG000|Overall Study|Adverse Event|0|||
126599349|NCT03015532|455494272|FG001|Overall Study|Adverse Event|0|||
126599350|NCT03015532|455494273|FG002|Overall Study|Adverse Event|0|||
126599351|NCT03015532|455494274|FG003|Overall Study|Adverse Event|0|||
126599352|NCT03015532|455494275|FG004|Overall Study|Adverse Event|0|||
126599353|NCT03015532|455494276|FG005|Overall Study|Adverse Event|2|||
126599354|NCT03015532|455494277|FG006|Overall Study|Adverse Event|1|||
126599355|NCT03015532|455494278|FG007|Overall Study|Adverse Event|0|||
126599356|NCT03015532|455494271|FG000|Overall Study|Withdrawal by Subject|0|||
126599357|NCT03015532|455494272|FG001|Overall Study|Withdrawal by Subject|0|||
126599358|NCT03015532|455494273|FG002|Overall Study|Withdrawal by Subject|0|||
126599359|NCT03015532|455494274|FG003|Overall Study|Withdrawal by Subject|0|||
126599360|NCT03015532|455494275|FG004|Overall Study|Withdrawal by Subject|0|||
126779986|NCT00616928|456149697|FG003|Overall Study|Other|5|||
126779987|NCT00616928|456149694|FG000|Overall Study|Lost to Follow-up|5|||
126779988|NCT00616928|456149695|FG001|Overall Study|Lost to Follow-up|7|||
126779989|NCT00616928|456149696|FG002|Overall Study|Lost to Follow-up|0|||
126779990|NCT00616928|456149697|FG003|Overall Study|Lost to Follow-up|0|||
126779991|NCT04535583|456149698|FG000|Overall Study|Lost to Follow-up|1|||
126779992|NCT04535583|456149698|FG000|Overall Study|Physician Decision|1|||
126779993|NCT04535583|456149698|FG000|Overall Study|Withdrawal by Subject|1|||
126779994|NCT04049552|456149700|FG000|Overall Study|Lost to Follow-up|1|||
126779995|NCT02123459|456149703|FG000|Washout Period (1 Day)|Adverse Event|1|||
126779996|NCT02123459|456149704|FG001|Washout Period (1 Day)|Adverse Event|0|||
126599361|NCT03015532|455494276|FG005|Overall Study|Withdrawal by Subject|0|||
126599362|NCT03015532|455494277|FG006|Overall Study|Withdrawal by Subject|1|||
126599363|NCT03015532|455494278|FG007|Overall Study|Withdrawal by Subject|0|||
126779997|NCT02196506|456149709|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
126779998|NCT02196506|456149710|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
126599364|NCT05970861|455494279|FG000|Overall Study|Physician Decision|4|||
126599365|NCT05970861|455494280|FG001|Overall Study|Physician Decision|4|||
126599366|NCT05970861|455494279|FG000|Overall Study|Lost to Follow-up|4|||
126599367|NCT05970861|455494280|FG001|Overall Study|Lost to Follow-up|3|||
126599368|NCT04158739|455494281|FG000|Overall Study|Adverse Event|1|||
126599369|NCT04158739|455494282|FG001|Overall Study|Adverse Event|0|||
126599370|NCT04158739|455494281|FG000|Overall Study|Death|0|||
126599371|NCT04158739|455494282|FG001|Overall Study|Death|1|||
126599372|NCT04158739|455494281|FG000|Overall Study|Lack of Efficacy|3|||
126599373|NCT04158739|455494282|FG001|Overall Study|Lack of Efficacy|7|||
126599374|NCT04158739|455494281|FG000|Overall Study|Physician Decision|0|||
126599375|NCT04158739|455494282|FG001|Overall Study|Physician Decision|1|||
126599376|NCT04158739|455494281|FG000|Overall Study|Withdrawal by Subject|3|||
126599377|NCT04158739|455494282|FG001|Overall Study|Withdrawal by Subject|0|||
126599378|NCT03914469|455494283|FG000|Overall Study|Lost to Follow-up|1|||
126599379|NCT03914469|455494284|FG001|Overall Study|Lost to Follow-up|4|||
126599380|NCT04778410|455494285|FG000|Safety Run-in Period|Death|5|||
126599381|NCT04778410|455494286|FG001|Safety Run-in Period|Death|6|||
126599382|NCT04778410|455494287|FG002|Safety Run-in Period|Death|0|||
126599383|NCT04778410|455494288|FG003|Safety Run-in Period|Death|0|||
126599384|NCT04778410|455494289|FG004|Safety Run-in Period|Death|0|||
126599385|NCT04778410|455494290|FG005|Safety Run-in Period|Death|0|||
126599386|NCT04778410|455494285|FG000|Phase 2 Period|Death|0|||
126599387|NCT04778410|455494286|FG001|Phase 2 Period|Death|0|||
126599388|NCT04778410|455494287|FG002|Phase 2 Period|Death|0|||
126599389|NCT04778410|455494288|FG003|Phase 2 Period|Death|5|||
126599390|NCT04778410|455494289|FG004|Phase 2 Period|Death|18|||
126599391|NCT04778410|455494290|FG005|Phase 2 Period|Death|0|||
126599392|NCT04778410|455494285|FG000|Phase 2 Period|Lost to Follow-up|0|||
126599393|NCT04778410|455494286|FG001|Phase 2 Period|Lost to Follow-up|0|||
126599394|NCT04778410|455494287|FG002|Phase 2 Period|Lost to Follow-up|0|||
126599395|NCT04778410|455494288|FG003|Phase 2 Period|Lost to Follow-up|1|||
126599396|NCT04778410|455494289|FG004|Phase 2 Period|Lost to Follow-up|1|||
126599397|NCT04778410|455494290|FG005|Phase 2 Period|Lost to Follow-up|0|||
126599398|NCT04778410|455494285|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
126599399|NCT04778410|455494286|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
126599400|NCT04778410|455494287|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
126599401|NCT04778410|455494288|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
126599402|NCT04778410|455494289|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
126599403|NCT04778410|455494290|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
126599404|NCT04778410|455494285|FG000|Phase 2 Period|Withdrew Consent|0|||
126599405|NCT04778410|455494286|FG001|Phase 2 Period|Withdrew Consent|0|||
126599406|NCT04778410|455494287|FG002|Phase 2 Period|Withdrew Consent|0|||
126599407|NCT04778410|455494288|FG003|Phase 2 Period|Withdrew Consent|0|||
126599408|NCT04778410|455494289|FG004|Phase 2 Period|Withdrew Consent|2|||
126599409|NCT04778410|455494290|FG005|Phase 2 Period|Withdrew Consent|0|||
126599410|NCT00677365|455494297|FG000|Overall Study|Adverse Event|2|||
126599411|NCT00677365|455494298|FG001|Overall Study|Adverse Event|1|||
126599412|NCT00677365|455494299|FG002|Overall Study|Adverse Event|1|||
126599413|NCT00677365|455494300|FG003|Overall Study|Adverse Event|2|||
126599414|NCT00677365|455494297|FG000|Overall Study|Withdrawal by Subject|0|||
126599415|NCT00677365|455494298|FG001|Overall Study|Withdrawal by Subject|0|||
126599416|NCT00677365|455494299|FG002|Overall Study|Withdrawal by Subject|1|||
126599417|NCT00677365|455494300|FG003|Overall Study|Withdrawal by Subject|0|||
126599418|NCT00677365|455494297|FG000|Overall Study|Other reason|0|||
126599419|NCT00677365|455494298|FG001|Overall Study|Other reason|0|||
126599420|NCT00677365|455494299|FG002|Overall Study|Other reason|0|||
126599421|NCT00677365|455494300|FG003|Overall Study|Other reason|1|||
126599422|NCT02944968|455494301|FG000|Overall Study|Subject excluded before study procedure|1|||
126599423|NCT02944968|455494301|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
126599424|NCT02542631|455494302|FG000|Overall Study|Adverse Event|1|||
126599425|NCT02542631|455494303|FG001|Overall Study|Adverse Event|1|||
126599426|NCT02542631|455494302|FG000|Overall Study|Sponsor Termination|1|||
126733179|NCT00168064|455972325|FG000|Overall Study|Concurrent Illness|4|||
126599427|NCT02542631|455494303|FG001|Overall Study|Sponsor Termination|0|||
126599428|NCT02542631|455494302|FG000|Overall Study|Withdrawal by Subject|11|||
126599429|NCT02542631|455494303|FG001|Overall Study|Withdrawal by Subject|16|||
126599430|NCT02542631|455494302|FG000|Overall Study|Protocol Violation|1|||
126599431|NCT02542631|455494303|FG001|Overall Study|Protocol Violation|1|||
126599432|NCT02542631|455494302|FG000|Overall Study|Physician Decision|6|||
126733180|NCT00168064|455972326|FG001|Overall Study|Concurrent Illness|3|||
126599433|NCT02542631|455494303|FG001|Overall Study|Physician Decision|4|||
126599434|NCT02542631|455494302|FG000|Overall Study|Lost to Follow-up|6|||
126599435|NCT02542631|455494303|FG001|Overall Study|Lost to Follow-up|5|||
126599436|NCT02542631|455494302|FG000|Overall Study|Death|1|||
126599437|NCT02542631|455494303|FG001|Overall Study|Death|2|||
126599438|NCT02542631|455494302|FG000|Overall Study|Other|2|||
126599439|NCT02542631|455494303|FG001|Overall Study|Other|1|||
126599440|NCT02542631|455494302|FG000|Overall Study|Used Prohibited Medication|2|||
126599441|NCT02542631|455494303|FG001|Overall Study|Used Prohibited Medication|1|||
126779999|NCT02196506|456149711|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
126780000|NCT02196506|456149712|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
126780001|NCT02196506|456149709|FG000|Phase A|Withdrawal by Subject|34|||
126599442|NCT04583280|455494305|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
126599443|NCT04583280|455494306|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
126599444|NCT00631475|455494309|FG000|Overall Study|Death|18|||
126599445|NCT00631475|455494309|FG000|Overall Study|Adverse Event|14|||
126599446|NCT00631475|455494309|FG000|Overall Study|Withdrew consent|5|||
126599447|NCT00631475|455494309|FG000|Overall Study|Preparation for lung transplant|8|||
126599448|NCT05158504|455494310|FG000|Overall Study|Lost to Follow-up|2|||
126599449|NCT05158504|455494311|FG001|Overall Study|Lost to Follow-up|3|||
126599450|NCT03606512|455494312|FG000|Overall Study|Lost to Follow-up|0|||
126780002|NCT02196506|456149710|FG001|Phase A|Withdrawal by Subject|0|||
126780003|NCT02196506|456149711|FG002|Phase A|Withdrawal by Subject|0|||
126780004|NCT02196506|456149712|FG003|Phase A|Withdrawal by Subject|0|||
126599451|NCT03606512|455494313|FG001|Overall Study|Lost to Follow-up|1|||
126599452|NCT03606512|455494312|FG000|Overall Study|'moved from study area|0|||
126599453|NCT03606512|455494313|FG001|Overall Study|'moved from study area|1|||
126599454|NCT05513937|455494314|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
126599455|NCT05513937|455494315|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
126599456|NCT05513937|455494316|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
126599457|NCT05513937|455494317|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
126599458|NCT05513937|455494314|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
126599459|NCT05513937|455494315|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
126599460|NCT05513937|455494316|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
126780005|NCT02196506|456149709|FG000|Phase A|Adverse Event|22|||
126780006|NCT02196506|456149710|FG001|Phase A|Adverse Event|0|||
126780007|NCT02196506|456149711|FG002|Phase A|Adverse Event|0|||
126780008|NCT02196506|456149712|FG003|Phase A|Adverse Event|0|||
126780009|NCT02196506|456149709|FG000|Phase A|Lost to Follow-up|9|||
126780010|NCT02196506|456149710|FG001|Phase A|Lost to Follow-up|0|||
126780011|NCT02196506|456149711|FG002|Phase A|Lost to Follow-up|0|||
126780012|NCT02196506|456149712|FG003|Phase A|Lost to Follow-up|0|||
126780013|NCT02196506|456149709|FG000|Phase A|Protocol deviation|12|||
126780014|NCT02196506|456149710|FG001|Phase A|Protocol deviation|0|||
126780015|NCT02196506|456149711|FG002|Phase A|Protocol deviation|0|||
126780016|NCT02196506|456149712|FG003|Phase A|Protocol deviation|0|||
126780017|NCT02196506|456149709|FG000|Phase A|Participant withdrawn by investigator|10|||
126780018|NCT02196506|456149710|FG001|Phase A|Participant withdrawn by investigator|0|||
126780019|NCT02196506|456149711|FG002|Phase A|Participant withdrawn by investigator|0|||
126780020|NCT02196506|456149712|FG003|Phase A|Participant withdrawn by investigator|0|||
126780021|NCT02196506|456149709|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
126780022|NCT02196506|456149710|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
126780023|NCT02196506|456149711|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
126780024|NCT02196506|456149712|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
126780025|NCT02196506|456149709|FG000|Phase B|Lack of Efficacy|0|||
126780026|NCT02196506|456149710|FG001|Phase B|Lack of Efficacy|1|||
126780027|NCT02196506|456149711|FG002|Phase B|Lack of Efficacy|2|||
126780028|NCT02196506|456149712|FG003|Phase B|Lack of Efficacy|0|||
126780029|NCT02196506|456149709|FG000|Phase B|Withdrawal by Participant|0|||
126780030|NCT02196506|456149710|FG001|Phase B|Withdrawal by Participant|8|||
126780031|NCT02196506|456149711|FG002|Phase B|Withdrawal by Participant|1|||
126780032|NCT02196506|456149712|FG003|Phase B|Withdrawal by Participant|0|||
126780033|NCT02196506|456149709|FG000|Phase B|Adverse Event|0|||
126780034|NCT02196506|456149710|FG001|Phase B|Adverse Event|4|||
126780035|NCT02196506|456149711|FG002|Phase B|Adverse Event|1|||
126599461|NCT05513937|455494317|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
126599462|NCT05513937|455494314|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
126599463|NCT05513937|455494315|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
126599464|NCT05513937|455494316|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
126599465|NCT05513937|455494317|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
126599466|NCT05513937|455494314|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
126599467|NCT05513937|455494315|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
126780036|NCT02196506|456149712|FG003|Phase B|Adverse Event|0|||
126780037|NCT02196506|456149709|FG000|Phase B|Lost to Follow-up|0|||
126780038|NCT02196506|456149710|FG001|Phase B|Lost to Follow-up|2|||
126780039|NCT02196506|456149711|FG002|Phase B|Lost to Follow-up|1|||
126780040|NCT02196506|456149712|FG003|Phase B|Lost to Follow-up|0|||
126780041|NCT02196506|456149709|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
126780042|NCT02196506|456149710|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
126780043|NCT02196506|456149711|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
126780044|NCT02196506|456149712|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
126780045|NCT02196506|456149709|FG000|Phase A+|Withdrawal by Participant|0|||
126780046|NCT02196506|456149710|FG001|Phase A+|Withdrawal by Participant|0|||
126599468|NCT05513937|455494316|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
126599469|NCT05513937|455494317|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
126599470|NCT05513937|455494314|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
126599471|NCT05513937|455494315|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
126599472|NCT05513937|455494316|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
126599473|NCT05513937|455494317|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
126599474|NCT05513937|455494314|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
126599475|NCT05513937|455494315|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
126599476|NCT05513937|455494316|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
126599477|NCT05513937|455494317|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
126599478|NCT03663205|455494318|FG000|Overall Study|Death|144|||
126599479|NCT03663205|455494319|FG001|Overall Study|Death|69|||
126599480|NCT03663205|455494318|FG000|Overall Study|Sponsor decision|53|||
126599481|NCT03663205|455494319|FG001|Overall Study|Sponsor decision|19|||
126599482|NCT03663205|455494318|FG000|Overall Study|Withdrawal by Subject|8|||
126599483|NCT03663205|455494319|FG001|Overall Study|Withdrawal by Subject|11|||
126599484|NCT03663205|455494318|FG000|Overall Study|Lost to Follow-up|7|||
126599485|NCT03663205|455494319|FG001|Overall Study|Lost to Follow-up|9|||
126599486|NCT03663205|455494318|FG000|Overall Study|Transferred to long term extension study|11|||
126599487|NCT03663205|455494319|FG001|Overall Study|Transferred to long term extension study|3|||
126599488|NCT02577354|455494320|FG000|Overall Study|Lack of Efficacy|4|||
126599489|NCT02577354|455494321|FG001|Overall Study|Lack of Efficacy|4|||
126599490|NCT02577354|455494320|FG000|Overall Study|Lost to Follow-up|3|||
126599491|NCT02577354|455494321|FG001|Overall Study|Lost to Follow-up|1|||
126599492|NCT02577354|455494320|FG000|Overall Study|Missed Visit|4|||
126599493|NCT02577354|455494321|FG001|Overall Study|Missed Visit|3|||
126599494|NCT02577354|455494320|FG000|Overall Study|Adverse Event|4|||
126599495|NCT02577354|455494321|FG001|Overall Study|Adverse Event|5|||
126599496|NCT03245840|455494322|FG000|Overall Study|Adverse Event|6|||
126599497|NCT03245840|455494323|FG001|Overall Study|Adverse Event|0|||
126599498|NCT03245840|455494322|FG000|Overall Study|Death|2|||
126599499|NCT03245840|455494323|FG001|Overall Study|Death|0|||
126599500|NCT03245840|455494322|FG000|Overall Study|Withdrawal by Subject|31|||
126599501|NCT03245840|455494323|FG001|Overall Study|Withdrawal by Subject|1|||
126599502|NCT03245840|455494322|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
126599503|NCT03245840|455494323|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126599504|NCT03245840|455494322|FG000|Overall Study|Physician Decision|4|||
126599505|NCT03245840|455494323|FG001|Overall Study|Physician Decision|1|||
126599506|NCT03245840|455494322|FG000|Overall Study|Study Terminated by Sponsor|56|||
126599507|NCT03245840|455494323|FG001|Overall Study|Study Terminated by Sponsor|6|||
126599508|NCT03245840|455494322|FG000|Overall Study|Site Terminated by Sponsor|4|||
126599509|NCT03245840|455494323|FG001|Overall Study|Site Terminated by Sponsor|0|||
126599510|NCT03245840|455494322|FG000|Overall Study|Lost to Follow-up|12|||
126599511|NCT03245840|455494323|FG001|Overall Study|Lost to Follow-up|2|||
126599512|NCT03245840|455494322|FG000|Overall Study|Pregnancy|2|||
126599513|NCT03245840|455494323|FG001|Overall Study|Pregnancy|0|||
126599514|NCT03245840|455494322|FG000|Overall Study|Non-Compliance with Study Drug|2|||
126599515|NCT03245840|455494323|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126599516|NCT03245840|455494322|FG000|Overall Study|Not treated|1|||
126599517|NCT03245840|455494323|FG001|Overall Study|Not treated|1|||
126599518|NCT04109066|455494326|FG000|Pre-treatment|Participant withdrew consent|2|||
126599519|NCT04109066|455494327|FG001|Pre-treatment|Participant withdrew consent|0|||
126599520|NCT04109066|455494326|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
126599521|NCT04109066|455494327|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
126733181|NCT00168064|455972325|FG000|Overall Study|Subject's Best interest|2|||
126733182|NCT00168064|455972326|FG001|Overall Study|Subject's Best interest|2|||
126733183|NCT00168064|455972325|FG000|Overall Study|Various|4|||
126733184|NCT00168064|455972326|FG001|Overall Study|Various|3|||
126733185|NCT00290589|455972328|FG000|Overall Study|Lost to Follow-up|2|||
126733186|NCT00290589|455972329|FG001|Overall Study|Lost to Follow-up|2|||
126599522|NCT04109066|455494326|FG000|Treatment|Lack of Efficacy|2|||
126599523|NCT04109066|455494327|FG001|Treatment|Lack of Efficacy|4|||
126599524|NCT04109066|455494326|FG000|Treatment|Adverse Event|23|||
126733187|NCT01376245|455972331|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
126599525|NCT04109066|455494327|FG001|Treatment|Adverse Event|7|||
126599526|NCT04109066|455494326|FG000|Treatment|Participant request to discontinue Study treatment|15|||
126599527|NCT04109066|455494327|FG001|Treatment|Participant request to discontinue Study treatment|14|||
126599528|NCT04109066|455494326|FG000|Treatment|Withdrawal by Subject|8|||
126599529|NCT04109066|455494327|FG001|Treatment|Withdrawal by Subject|8|||
126599530|NCT04109066|455494326|FG000|Treatment|Death|3|||
126599531|NCT04109066|455494327|FG001|Treatment|Death|0|||
126599532|NCT04109066|455494326|FG000|Treatment|Participant no longer meets study criteria|2|||
126599533|NCT04109066|455494327|FG001|Treatment|Participant no longer meets study criteria|2|||
126599534|NCT04109066|455494326|FG000|Treatment|Administrative reasons by sponsor|2|||
126599535|NCT04109066|455494327|FG001|Treatment|Administrative reasons by sponsor|3|||
126780047|NCT02196506|456149711|FG002|Phase A+|Withdrawal by Participant|0|||
126780048|NCT02196506|456149712|FG003|Phase A+|Withdrawal by Participant|5|||
126780049|NCT02196506|456149709|FG000|Phase A+|Adverse Event|0|||
126780050|NCT02196506|456149710|FG001|Phase A+|Adverse Event|0|||
126780051|NCT02196506|456149711|FG002|Phase A+|Adverse Event|0|||
126780052|NCT02196506|456149712|FG003|Phase A+|Adverse Event|1|||
126780053|NCT02196506|456149709|FG000|Phase A+|Lost to Follow-up|0|||
126780054|NCT02196506|456149710|FG001|Phase A+|Lost to Follow-up|0|||
126780055|NCT02196506|456149711|FG002|Phase A+|Lost to Follow-up|0|||
126780056|NCT02196506|456149712|FG003|Phase A+|Lost to Follow-up|6|||
126780057|NCT02196506|456149709|FG000|Phase A+|Participant withdrawn by investigator|0|||
126780058|NCT02196506|456149710|FG001|Phase A+|Participant withdrawn by investigator|0|||
126780059|NCT02196506|456149711|FG002|Phase A+|Participant withdrawn by investigator|0|||
126780060|NCT02196506|456149712|FG003|Phase A+|Participant withdrawn by investigator|1|||
126780061|NCT00254397|456149713|FG000|Overall Study|Disease Progression|4|||
126780062|NCT00254397|456149714|FG001|Overall Study|Disease Progression|1|||
126780063|NCT00254397|456149715|FG002|Overall Study|Disease Progression|16|||
126780064|NCT00254397|456149716|FG003|Overall Study|Disease Progression|23|||
126780065|NCT00254397|456149713|FG000|Overall Study|Non-Compliant|0|||
126780066|NCT00254397|456149714|FG001|Overall Study|Non-Compliant|0|||
126780067|NCT00254397|456149715|FG002|Overall Study|Non-Compliant|0|||
126780068|NCT00254397|456149716|FG003|Overall Study|Non-Compliant|1|||
126780069|NCT00254397|456149713|FG000|Overall Study|Adverse Event|2|||
126780070|NCT00254397|456149714|FG001|Overall Study|Adverse Event|0|||
126780071|NCT00254397|456149715|FG002|Overall Study|Adverse Event|3|||
126780072|NCT00254397|456149716|FG003|Overall Study|Adverse Event|1|||
126780073|NCT01715415|456149728|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
126780074|NCT01715415|456149729|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
126780075|NCT01715415|456149728|FG000|Double-blind Treatment|Adverse Event|3|||
126780076|NCT01715415|456149729|FG001|Double-blind Treatment|Adverse Event|0|||
126780077|NCT01715415|456149728|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
126780078|NCT01715415|456149729|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
126780079|NCT01715415|456149728|FG000|Double-blind Treatment|Other|1|||
126780080|NCT01715415|456149729|FG001|Double-blind Treatment|Other|0|||
126780081|NCT01715415|456149728|FG000|Open-label Treatment|Adverse Event|0|||
126780082|NCT01715415|456149729|FG001|Open-label Treatment|Adverse Event|1|||
126780083|NCT01715415|456149728|FG000|Open-label Treatment|Subject Noncompliant|0|||
126780084|NCT01715415|456149729|FG001|Open-label Treatment|Subject Noncompliant|1|||
126780085|NCT05028751|456149730|FG000|Overall Study|Study Terminated by Sponsor|3|||
126780086|NCT05028751|456149731|FG001|Overall Study|Study Terminated by Sponsor|0|||
126780087|NCT05028751|456149732|FG002|Overall Study|Study Terminated by Sponsor|0|||
126780088|NCT05028751|456149733|FG003|Overall Study|Study Terminated by Sponsor|0|||
126780089|NCT05028751|456149730|FG000|Overall Study|Death|9|||
126780090|NCT05028751|456149731|FG001|Overall Study|Death|3|||
126780091|NCT05028751|456149732|FG002|Overall Study|Death|2|||
126780092|NCT05028751|456149733|FG003|Overall Study|Death|4|||
126780093|NCT05028751|456149730|FG000|Overall Study|Withdrawal by Subject|0|||
126780094|NCT05028751|456149731|FG001|Overall Study|Withdrawal by Subject|0|||
126780095|NCT05028751|456149732|FG002|Overall Study|Withdrawal by Subject|1|||
126780096|NCT05028751|456149733|FG003|Overall Study|Withdrawal by Subject|0|||
126780097|NCT05028751|456149730|FG000|Overall Study|Miscellaneous|2|||
126780098|NCT05028751|456149731|FG001|Overall Study|Miscellaneous|0|||
126780099|NCT05028751|456149732|FG002|Overall Study|Miscellaneous|0|||
126780100|NCT05028751|456149733|FG003|Overall Study|Miscellaneous|0|||
126780101|NCT03586830|456149735|FG000|Overall Study|Site terminated by Sponsor|1|||
126780102|NCT03586830|456149736|FG001|Overall Study|Site terminated by Sponsor|4|||
126780103|NCT03586830|456149737|FG002|Overall Study|Site terminated by Sponsor|3|||
126780104|NCT03586830|456149738|FG003|Overall Study|Site terminated by Sponsor|3|||
126780105|NCT03586830|456149735|FG000|Overall Study|Lost to Follow-up|0|||
126780106|NCT03586830|456149736|FG001|Overall Study|Lost to Follow-up|2|||
126780107|NCT03586830|456149737|FG002|Overall Study|Lost to Follow-up|2|||
126780108|NCT03586830|456149738|FG003|Overall Study|Lost to Follow-up|1|||
126780109|NCT03586830|456149735|FG000|Overall Study|Withdrawal by Subject|1|||
126780110|NCT03586830|456149736|FG001|Overall Study|Withdrawal by Subject|0|||
126780111|NCT03586830|456149737|FG002|Overall Study|Withdrawal by Subject|3|||
126780112|NCT03586830|456149738|FG003|Overall Study|Withdrawal by Subject|1|||
126780113|NCT04578548|456149739|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
126780114|NCT04578548|456149740|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
126780115|NCT04578548|456149739|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
126780116|NCT04578548|456149740|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
126780117|NCT04578548|456149739|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
126780118|NCT04578548|456149740|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
126780119|NCT04578548|456149739|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
126780120|NCT04578548|456149740|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
126780121|NCT04578548|456149739|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
126733188|NCT01376245|455972332|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
126733189|NCT01376245|455972333|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
126733190|NCT01376245|455972334|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
126733191|NCT01376245|455972335|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
126733192|NCT01376245|455972331|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
126733193|NCT01376245|455972332|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
126733194|NCT01376245|455972333|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
126733195|NCT01376245|455972334|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
126733196|NCT01376245|455972335|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
126733197|NCT01376245|455972331|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
126733198|NCT01376245|455972332|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
126733199|NCT01376245|455972333|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
126733200|NCT01376245|455972334|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
126733201|NCT01376245|455972335|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
126733202|NCT01376245|455972331|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
126733203|NCT01376245|455972332|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
126733204|NCT01376245|455972333|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
126733205|NCT01376245|455972334|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
126733206|NCT01376245|455972335|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
126733207|NCT01376245|455972331|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
126733208|NCT01376245|455972332|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
126733209|NCT01376245|455972333|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
126733210|NCT01376245|455972334|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
126733211|NCT01376245|455972335|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
126733212|NCT01376245|455972331|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
126733213|NCT01376245|455972332|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
126733214|NCT01376245|455972333|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
126733215|NCT01376245|455972334|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
126733216|NCT01376245|455972335|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
126733217|NCT01376245|455972331|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
126733218|NCT01376245|455972332|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
126733219|NCT01376245|455972333|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
126733220|NCT01376245|455972334|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
126733221|NCT01376245|455972335|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
126733222|NCT01376245|455972331|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
126733223|NCT01376245|455972332|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
126733224|NCT01376245|455972333|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
126733225|NCT01376245|455972334|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
126733226|NCT01376245|455972335|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
126733227|NCT01376245|455972331|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
126733228|NCT01376245|455972332|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
126733229|NCT01376245|455972333|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
126733230|NCT01376245|455972334|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
126733231|NCT01376245|455972335|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
126733232|NCT01376245|455972331|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126733233|NCT01376245|455972332|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
126733234|NCT01376245|455972333|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
126733235|NCT01376245|455972334|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
126733236|NCT01376245|455972335|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
126733237|NCT01376245|455972331|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
126733238|NCT01376245|455972332|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
126733239|NCT01376245|455972333|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
126733240|NCT01376245|455972334|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
126733241|NCT01376245|455972335|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
126733242|NCT01376245|455972331|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
126733243|NCT01376245|455972332|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
126733244|NCT01376245|455972333|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
126733245|NCT01376245|455972334|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
126733246|NCT01376245|455972335|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
126733247|NCT05159362|455972336|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
126733248|NCT05159362|455972337|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
126733249|NCT05159362|455972338|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
126733250|NCT01335698|455972339|FG000|Treatment Stage 1|Lack of Efficacy|3|||
126780122|NCT04578548|456149740|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
126780123|NCT04578548|456149739|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
126780124|NCT04578548|456149740|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
126780125|NCT00395083|456149743|FG000|Overall Study|Withdrawal by Subject|6|||
126780126|NCT00395083|456149744|FG001|Overall Study|Withdrawal by Subject|5|||
126599536|NCT04109066|455494326|FG000|Treatment|Other reasons|17|||
126599537|NCT04109066|455494327|FG001|Treatment|Other reasons|23|||
126599538|NCT04109066|455494326|FG000|Treatment|Disease Progression|4|||
126599539|NCT04109066|455494327|FG001|Treatment|Disease Progression|7|||
126599540|NCT04109066|455494326|FG000|Treatment|Study drug toxicity|12|||
126599541|NCT04109066|455494327|FG001|Treatment|Study drug toxicity|5|||
126599542|NCT04109066|455494326|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
126599543|NCT04109066|455494327|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
126599544|NCT04109066|455494326|FG000|Treatment|Disease Recurrence|0|||
126599545|NCT04109066|455494327|FG001|Treatment|Disease Recurrence|2|||
126599546|NCT04109066|455494326|FG000|Treatment|Not reported|4|||
126599547|NCT04109066|455494327|FG001|Treatment|Not reported|8|||
126599548|NCT05652010|455494328|FG000|First Intervention|Withdrawal by Subject|0|||
126599549|NCT05652010|455494329|FG001|First Intervention|Withdrawal by Subject|1|||
126599550|NCT05652010|455494328|FG000|Second Intervention|Withdrawal by Subject|1|||
126599551|NCT05652010|455494329|FG001|Second Intervention|Withdrawal by Subject|0|||
126599552|NCT05741294|455494331|FG000|Overall Study|Lost to Follow-up|3|||
126599553|NCT05741294|455494331|FG000|Overall Study|Protocol deviation|3|||
126599554|NCT05741294|455494331|FG000|Overall Study|Withdrawal by Subject|1|||
126599555|NCT04707768|455494332|FG000|Overall Study|Adverse Event|9|||
126599556|NCT04707768|455494333|FG001|Overall Study|Adverse Event|18|||
126599557|NCT04707768|455494334|FG002|Overall Study|Adverse Event|3|||
126599558|NCT04707768|455494332|FG000|Overall Study|Investigator's Discretion|8|||
126599559|NCT04707768|455494333|FG001|Overall Study|Investigator's Discretion|4|||
126599560|NCT04707768|455494334|FG002|Overall Study|Investigator's Discretion|3|||
126599561|NCT04707768|455494332|FG000|Overall Study|Withdrawal by Subject|6|||
126599562|NCT04707768|455494333|FG001|Overall Study|Withdrawal by Subject|8|||
126599563|NCT04707768|455494334|FG002|Overall Study|Withdrawal by Subject|2|||
126599564|NCT04707768|455494332|FG000|Overall Study|Lack of Efficacy|1|||
126599565|NCT04707768|455494333|FG001|Overall Study|Lack of Efficacy|3|||
126599566|NCT04707768|455494334|FG002|Overall Study|Lack of Efficacy|0|||
126599567|NCT04707768|455494332|FG000|Overall Study|Lost to Follow-up|0|||
126599568|NCT04707768|455494333|FG001|Overall Study|Lost to Follow-up|0|||
126599569|NCT04707768|455494334|FG002|Overall Study|Lost to Follow-up|3|||
126599570|NCT04707768|455494332|FG000|Overall Study|Death|13|||
126599571|NCT04707768|455494333|FG001|Overall Study|Death|11|||
126599572|NCT04707768|455494334|FG002|Overall Study|Death|13|||
126599573|NCT04707768|455494332|FG000|Overall Study|Protocol Violation|2|||
126599574|NCT04707768|455494333|FG001|Overall Study|Protocol Violation|1|||
126599575|NCT04707768|455494334|FG002|Overall Study|Protocol Violation|0|||
126599576|NCT04707768|455494332|FG000|Overall Study|Non Compliance with Study Drug|1|||
126599577|NCT04707768|455494333|FG001|Overall Study|Non Compliance with Study Drug|0|||
126599578|NCT04707768|455494334|FG002|Overall Study|Non Compliance with Study Drug|0|||
126599579|NCT04707768|455494332|FG000|Overall Study|Transplant|4|||
126599580|NCT04707768|455494333|FG001|Overall Study|Transplant|4|||
126599581|NCT04707768|455494334|FG002|Overall Study|Transplant|8|||
126780127|NCT00395083|456149743|FG000|Overall Study|Developed another disease|4|||
126780128|NCT00395083|456149744|FG001|Overall Study|Developed another disease|3|||
126780129|NCT00972153|456149745|FG000|Overall Study|Equipment malfunction during case|0|||
126780130|NCT00972153|456149746|FG001|Overall Study|Equipment malfunction during case|1|||
126780131|NCT00972153|456149747|FG002|Overall Study|Equipment malfunction during case|0|||
126599582|NCT04707768|455494332|FG000|Overall Study|Other|9|||
126599583|NCT04707768|455494333|FG001|Overall Study|Other|5|||
126599584|NCT04707768|455494334|FG002|Overall Study|Other|2|||
126599585|NCT04078152|455494335|FG000|Overall Study|Other|83|||
126599586|NCT04078152|455494336|FG001|Overall Study|Other|22|||
126599587|NCT04078152|455494337|FG002|Overall Study|Other|25|||
126599588|NCT04078152|455494335|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
126599589|NCT04078152|455494336|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
126599590|NCT04078152|455494337|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
126599591|NCT04078152|455494335|FG000|Overall Study|Withdrawal by Subject|5|||
126599592|NCT04078152|455494336|FG001|Overall Study|Withdrawal by Subject|0|||
126599593|NCT04078152|455494337|FG002|Overall Study|Withdrawal by Subject|1|||
126599594|NCT04078152|455494335|FG000|Overall Study|Death|10|||
126780132|NCT04136626|456149748|FG000|Treatment Phase|Withdrawal by Subject|1|||
126780133|NCT04136626|456149749|FG001|Treatment Phase|Withdrawal by Subject|9|||
126599595|NCT04078152|455494336|FG001|Overall Study|Death|2|||
126599596|NCT04078152|455494337|FG002|Overall Study|Death|12|||
126599597|NCT04078152|455494335|FG000|Overall Study|Adverse Event|1|||
126599598|NCT04078152|455494336|FG001|Overall Study|Adverse Event|0|||
126599599|NCT04078152|455494337|FG002|Overall Study|Adverse Event|0|||
126599600|NCT02510235|455494338|FG000|Overall Study|Withdrawal by Subject|1|||
126599601|NCT02510235|455494339|FG001|Overall Study|Withdrawal by Subject|0|||
126599602|NCT03367156|455495636|FG000|Overall Study|Lack of interest|3|||
126599603|NCT03367156|455495637|FG001|Overall Study|Lack of interest|1|||
126599604|NCT03367156|455495636|FG000|Overall Study|Death|2|||
126599605|NCT03367156|455495637|FG001|Overall Study|Death|0|||
126599606|NCT03367156|455495636|FG000|Overall Study|Lost to Follow-up|2|||
126599607|NCT03367156|455495637|FG001|Overall Study|Lost to Follow-up|1|||
126733251|NCT01335698|455972340|FG001|Treatment Stage 1|Lack of Efficacy|1|||
126733252|NCT01335698|455972341|FG002|Treatment Stage 1|Lack of Efficacy|3|||
126733253|NCT01335698|455972342|FG003|Treatment Stage 1|Lack of Efficacy|3|||
126733254|NCT01335698|455972343|FG004|Treatment Stage 1|Lack of Efficacy|1|||
126733255|NCT01335698|455972339|FG000|Treatment Stage 1|Adverse Event|1|||
126733256|NCT01335698|455972340|FG001|Treatment Stage 1|Adverse Event|2|||
126733257|NCT01335698|455972341|FG002|Treatment Stage 1|Adverse Event|2|||
126733258|NCT01335698|455972342|FG003|Treatment Stage 1|Adverse Event|1|||
126733259|NCT01335698|455972343|FG004|Treatment Stage 1|Adverse Event|1|||
126733260|NCT01335698|455972339|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
126733261|NCT01335698|455972340|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
126733262|NCT01335698|455972341|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
126733263|NCT01335698|455972342|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
126733264|NCT01335698|455972343|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
126733265|NCT01335698|455972339|FG000|Treatment Stage 1|Lost to Follow-up|1|||
126733266|NCT01335698|455972340|FG001|Treatment Stage 1|Lost to Follow-up|1|||
126733267|NCT01335698|455972341|FG002|Treatment Stage 1|Lost to Follow-up|0|||
126733268|NCT01335698|455972342|FG003|Treatment Stage 1|Lost to Follow-up|0|||
126733269|NCT01335698|455972343|FG004|Treatment Stage 1|Lost to Follow-up|0|||
126733270|NCT01335698|455972339|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
126733271|NCT01335698|455972340|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
126733272|NCT01335698|455972341|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
126733273|NCT01335698|455972342|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
126733274|NCT01335698|455972343|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
126733275|NCT01335698|455972339|FG000|Treatment Stage 1|No longer meets study criteria|1|||
126733276|NCT01335698|455972340|FG001|Treatment Stage 1|No longer meets study criteria|1|||
126733277|NCT01335698|455972341|FG002|Treatment Stage 1|No longer meets study criteria|0|||
126733278|NCT01335698|455972342|FG003|Treatment Stage 1|No longer meets study criteria|1|||
126733279|NCT01335698|455972343|FG004|Treatment Stage 1|No longer meets study criteria|0|||
126733280|NCT01335698|455972339|FG000|Treatment Stage 1|Other|1|||
126733281|NCT01335698|455972340|FG001|Treatment Stage 1|Other|0|||
126733282|NCT01335698|455972341|FG002|Treatment Stage 1|Other|0|||
126733283|NCT01335698|455972342|FG003|Treatment Stage 1|Other|1|||
126733284|NCT01335698|455972343|FG004|Treatment Stage 1|Other|0|||
126733285|NCT01335698|455972339|FG000|Treatment Stage 2|Lack of Efficacy|2|||
126733286|NCT01335698|455972340|FG001|Treatment Stage 2|Lack of Efficacy|1|||
126733287|NCT01335698|455972341|FG002|Treatment Stage 2|Lack of Efficacy|3|||
126733288|NCT01335698|455972342|FG003|Treatment Stage 2|Lack of Efficacy|1|||
126733289|NCT01335698|455972343|FG004|Treatment Stage 2|Lack of Efficacy|0|||
126733290|NCT01335698|455972339|FG000|Treatment Stage 2|Adverse Event|2|||
126733291|NCT01335698|455972340|FG001|Treatment Stage 2|Adverse Event|0|||
126733292|NCT01335698|455972341|FG002|Treatment Stage 2|Adverse Event|0|||
126733293|NCT01335698|455972342|FG003|Treatment Stage 2|Adverse Event|3|||
126733294|NCT01335698|455972343|FG004|Treatment Stage 2|Adverse Event|0|||
126733295|NCT01335698|455972339|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
126733296|NCT01335698|455972340|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
126733297|NCT01335698|455972341|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
126733298|NCT01335698|455972342|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
126733299|NCT01335698|455972343|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
126733300|NCT01335698|455972339|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
126733301|NCT01335698|455972340|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
126733302|NCT01335698|455972341|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
126733303|NCT01335698|455972342|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
126733304|NCT01335698|455972343|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
126733305|NCT01335698|455972339|FG000|Treatment Stage 2|Lost to Follow-up|1|||
126733306|NCT01335698|455972340|FG001|Treatment Stage 2|Lost to Follow-up|0|||
126733307|NCT01335698|455972341|FG002|Treatment Stage 2|Lost to Follow-up|0|||
126599608|NCT03367156|455495636|FG000|Overall Study|Became ineligible|1|||
126733308|NCT01335698|455972342|FG003|Treatment Stage 2|Lost to Follow-up|0|||
126733309|NCT01335698|455972343|FG004|Treatment Stage 2|Lost to Follow-up|0|||
126733310|NCT01335698|455972339|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
126733311|NCT01335698|455972340|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
126733312|NCT01335698|455972341|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
126733313|NCT01335698|455972342|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
126733314|NCT01335698|455972343|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
126733315|NCT01335698|455972339|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
126733316|NCT01335698|455972340|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
126599609|NCT03367156|455495637|FG001|Overall Study|Became ineligible|2|||
126733317|NCT01335698|455972341|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
126599610|NCT03367156|455495636|FG000|Overall Study|Hospitalization|1|||
126599611|NCT03367156|455495637|FG001|Overall Study|Hospitalization|0|||
126599612|NCT03367156|455495636|FG000|Overall Study|Concerned about Treatment|11|||
126599613|NCT03367156|455495637|FG001|Overall Study|Concerned about Treatment|3|||
126599614|NCT03367156|455495636|FG000|Overall Study|Started new treatment|4|||
126599615|NCT03367156|455495637|FG001|Overall Study|Started new treatment|1|||
126599616|NCT05507437|455495638|FG000|Overall Study|Withdrawal by Subject|1|||
126599617|NCT05507437|455495639|FG001|Overall Study|Withdrawal by Subject|1|||
126599618|NCT05507437|455495638|FG000|Overall Study|Death|3|||
126599619|NCT05507437|455495639|FG001|Overall Study|Death|0|||
126599620|NCT04282980|455495641|FG000|Overall Study|Remained on treatment|6|||
126599621|NCT04282980|455495641|FG000|Overall Study|Survival follow-up|11|||
126599622|NCT04282980|455495641|FG000|Overall Study|Withdrawal of informed consent|1|||
126599623|NCT04282980|455495641|FG000|Overall Study|Lost to Follow-up|1|||
126599624|NCT03571386|455495643|FG000|Overall Study|scheduling conflict|4|||
126599625|NCT03571386|455495644|FG001|Overall Study|scheduling conflict|0|||
126599626|NCT03571386|455495643|FG000|Overall Study|Withdrawal by Subject|15|||
126599627|NCT03571386|455495644|FG001|Overall Study|Withdrawal by Subject|5|||
126599628|NCT04311632|455495645|FG000|Overall Study|Withdrawal by Subject|0|||
126599629|NCT04311632|455495646|FG001|Overall Study|Withdrawal by Subject|0|||
126599630|NCT04311632|455495647|FG002|Overall Study|Withdrawal by Subject|1|||
126599631|NCT04605159|455495648|FG000|Overall Study|Adverse Event|6|||
126599632|NCT04605159|455495649|FG001|Overall Study|Adverse Event|3|||
126599633|NCT04605159|455495650|FG002|Overall Study|Adverse Event|21|||
126599634|NCT04605159|455495651|FG003|Overall Study|Adverse Event|4|||
126599635|NCT04605159|455495648|FG000|Overall Study|Lost to Follow-up|74|||
126599636|NCT04605159|455495649|FG001|Overall Study|Lost to Follow-up|45|||
126599637|NCT04605159|455495650|FG002|Overall Study|Lost to Follow-up|119|||
126599638|NCT04605159|455495651|FG003|Overall Study|Lost to Follow-up|80|||
126599639|NCT04605159|455495648|FG000|Overall Study|Protocol Violation|4|||
126599640|NCT04605159|455495649|FG001|Overall Study|Protocol Violation|5|||
126599641|NCT04605159|455495650|FG002|Overall Study|Protocol Violation|2|||
126599642|NCT04605159|455495651|FG003|Overall Study|Protocol Violation|0|||
126599643|NCT04605159|455495648|FG000|Overall Study|Withdrawal by Subject|66|||
126599644|NCT04605159|455495649|FG001|Overall Study|Withdrawal by Subject|37|||
126599645|NCT04605159|455495650|FG002|Overall Study|Withdrawal by Subject|68|||
126599646|NCT04605159|455495651|FG003|Overall Study|Withdrawal by Subject|50|||
126599647|NCT04605159|455495648|FG000|Overall Study|Migrated / moved from the study area|32|||
126599648|NCT04605159|455495649|FG001|Overall Study|Migrated / moved from the study area|22|||
126599649|NCT04605159|455495650|FG002|Overall Study|Migrated / moved from the study area|41|||
126599650|NCT04605159|455495651|FG003|Overall Study|Migrated / moved from the study area|21|||
126599651|NCT04605159|455495648|FG000|Overall Study|Other|1|||
126599652|NCT04605159|455495649|FG001|Overall Study|Other|2|||
126599653|NCT04605159|455495650|FG002|Overall Study|Other|7|||
126599654|NCT04605159|455495651|FG003|Overall Study|Other|3|||
126599655|NCT04881461|455495652|FG000|Overall Study|Adverse Event|2|||
126599656|NCT04881461|455495653|FG001|Overall Study|Adverse Event|4|||
126599657|NCT04881461|455495652|FG000|Overall Study|Withdrawal by Subject|19|||
126599658|NCT04881461|455495653|FG001|Overall Study|Withdrawal by Subject|19|||
126599659|NCT04881461|455495652|FG000|Overall Study|Lost to Follow-up|4|||
126599660|NCT04881461|455495653|FG001|Overall Study|Lost to Follow-up|4|||
126599661|NCT04881461|455495652|FG000|Overall Study|Lack of Efficacy|1|||
126599662|NCT04881461|455495653|FG001|Overall Study|Lack of Efficacy|0|||
126599663|NCT04881461|455495652|FG000|Overall Study|"Reason stated as other in CRF"|1|||
126599664|NCT04881461|455495653|FG001|Overall Study|"Reason stated as other in CRF"|2|||
126599665|NCT05422885|455495658|FG000|Overall Study|Lost to Follow-up|1|||
126599666|NCT05422885|455495658|FG000|Overall Study|Withdrawal by Subject|2|||
126599667|NCT04084574|455495659|FG000|Overall Study|Lost to Follow-up|1|||
126599668|NCT04084574|455495660|FG001|Overall Study|Lost to Follow-up|0|||
126599669|NCT04084574|455495659|FG000|Overall Study|Physician Decision|1|||
126599670|NCT04084574|455495660|FG001|Overall Study|Physician Decision|0|||
126599671|NCT04084574|455495659|FG000|Overall Study|Relocated out of state|1|||
126599672|NCT04084574|455495660|FG001|Overall Study|Relocated out of state|0|||
126599673|NCT02905331|455495661|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
126599674|NCT02905331|455495662|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
126599675|NCT02905331|455495663|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
126599676|NCT02905331|455495661|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
126599677|NCT02905331|455495662|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
126599678|NCT02905331|455495663|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
126599679|NCT02905331|455495661|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
126599680|NCT02905331|455495662|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
126599681|NCT02905331|455495663|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
126599682|NCT02905331|455495661|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
126599683|NCT02905331|455495662|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
126599684|NCT02905331|455495663|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
126780134|NCT04136626|456149748|FG000|Treatment Phase|Adverse Event|1|||
126599685|NCT02905331|455495661|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
126599686|NCT02905331|455495662|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
126599687|NCT02905331|455495663|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
126599688|NCT04102111|455495665|FG000|Overall Study|Withdrawal by Subject|2|||
126599689|NCT04102111|455495666|FG001|Overall Study|Withdrawal by Subject|3|||
126599690|NCT04102111|455495665|FG000|Overall Study|Adverse Event|1|||
126599691|NCT04102111|455495666|FG001|Overall Study|Adverse Event|1|||
126599692|NCT04102111|455495665|FG000|Overall Study|Study terminated by sponsor|1|||
126599693|NCT04102111|455495666|FG001|Overall Study|Study terminated by sponsor|3|||
126599694|NCT02641730|455495667|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
126599695|NCT02641730|455495668|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126599696|NCT02641730|455495669|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
126599697|NCT02641730|455495670|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
126599698|NCT02641730|455495671|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
126599699|NCT02641730|455495667|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
126599700|NCT02641730|455495668|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
126599701|NCT02641730|455495669|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
126599702|NCT02641730|455495670|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
126599703|NCT02641730|455495671|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
126599704|NCT02641730|455495667|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
126599705|NCT02641730|455495668|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
126599706|NCT02641730|455495669|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
126599707|NCT02641730|455495670|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
126599708|NCT02641730|455495671|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
126599709|NCT02641730|455495667|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126599710|NCT02641730|455495668|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126599711|NCT02641730|455495669|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
126599712|NCT02641730|455495670|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
126599713|NCT02641730|455495671|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
126599714|NCT02641730|455495667|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
126599715|NCT02641730|455495668|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
126599716|NCT02641730|455495669|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
126599717|NCT02641730|455495670|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
126599718|NCT02641730|455495671|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
126599719|NCT02641730|455495667|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
126599720|NCT02641730|455495668|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
126599721|NCT02641730|455495669|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
126599722|NCT02641730|455495670|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
126599723|NCT02641730|455495671|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
126599724|NCT00319046|455495672|FG000|Overall Study|withdrawal of subject's consent|7|||
126599725|NCT00319046|455495672|FG000|Overall Study|administrative reason|1|||
126599726|NCT04614948|455495676|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
126599727|NCT04614948|455495677|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
126599728|NCT04614948|455495678|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
126599729|NCT04614948|455495676|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
126599730|NCT04614948|455495677|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
126599731|NCT04614948|455495678|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
126599732|NCT04614948|455495676|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
126599733|NCT04614948|455495677|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
126599734|NCT04614948|455495678|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
126599735|NCT04614948|455495676|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
126599736|NCT04614948|455495677|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
126599737|NCT04614948|455495678|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
126599738|NCT04614948|455495676|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
126599739|NCT04614948|455495677|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
126599740|NCT04614948|455495678|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
126599741|NCT04614948|455495676|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
126599742|NCT04614948|455495677|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
126599743|NCT04614948|455495678|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
126599744|NCT04614948|455495676|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
126599745|NCT04614948|455495677|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
126599746|NCT04614948|455495678|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
126599747|NCT04614948|455495676|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
126599748|NCT04614948|455495677|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
126599749|NCT04614948|455495678|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
126599750|NCT04614948|455495676|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
126599751|NCT04614948|455495677|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
126780135|NCT04136626|456149749|FG001|Treatment Phase|Adverse Event|0|||
126780136|NCT04136626|456149748|FG000|Treatment Phase|Lost to Follow-up|1|||
126780137|NCT04136626|456149749|FG001|Treatment Phase|Lost to Follow-up|5|||
126780138|NCT04136626|456149748|FG000|12-month Follow-up|Lost to Follow-up|8|||
126780139|NCT04136626|456149749|FG001|12-month Follow-up|Lost to Follow-up|7|||
126780140|NCT00628745|456149750|FG000|Overall Study|Withdrawal by Subject|63|||
126780141|NCT00628745|456149751|FG001|Overall Study|Withdrawal by Subject|3|||
126780142|NCT00628745|456149752|FG002|Overall Study|Withdrawal by Subject|9|||
126780143|NCT00628745|456149753|FG003|Overall Study|Withdrawal by Subject|2|||
126780144|NCT00628745|456149754|FG004|Overall Study|Withdrawal by Subject|69|||
126780145|NCT00628745|456149750|FG000|Overall Study|Does not meet inclusion criteria|0|||
126780146|NCT00628745|456149751|FG001|Overall Study|Does not meet inclusion criteria|12|||
126780147|NCT00628745|456149752|FG002|Overall Study|Does not meet inclusion criteria|0|||
126780148|NCT00628745|456149753|FG003|Overall Study|Does not meet inclusion criteria|0|||
126780149|NCT00628745|456149754|FG004|Overall Study|Does not meet inclusion criteria|18|||
126780150|NCT00628745|456149750|FG000|Overall Study|Participation in an interventional clinical trial|81|||
126780151|NCT00628745|456149751|FG001|Overall Study|Participation in an interventional clinical trial|4|||
126780152|NCT00628745|456149752|FG002|Overall Study|Participation in an interventional clinical trial|7|||
126780153|NCT00628745|456149753|FG003|Overall Study|Participation in an interventional clinical trial|0|||
126780154|NCT00628745|456149754|FG004|Overall Study|Participation in an interventional clinical trial|63|||
126780155|NCT00628745|456149750|FG000|Overall Study|Physician Decision|8|||
126780156|NCT00628745|456149751|FG001|Overall Study|Physician Decision|4|||
126780157|NCT00628745|456149752|FG002|Overall Study|Physician Decision|3|||
126780158|NCT00628745|456149753|FG003|Overall Study|Physician Decision|0|||
126780159|NCT00628745|456149754|FG004|Overall Study|Physician Decision|30|||
126780160|NCT00628745|456149750|FG000|Overall Study|Lost to Follow-up|109|||
126780161|NCT00628745|456149751|FG001|Overall Study|Lost to Follow-up|7|||
126780162|NCT00628745|456149752|FG002|Overall Study|Lost to Follow-up|7|||
126780163|NCT00628745|456149753|FG003|Overall Study|Lost to Follow-up|0|||
126780164|NCT00628745|456149754|FG004|Overall Study|Lost to Follow-up|498|||
126780165|NCT00628745|456149750|FG000|Overall Study|Death|197|||
126780166|NCT00628745|456149751|FG001|Overall Study|Death|81|||
126780167|NCT00628745|456149752|FG002|Overall Study|Death|12|||
126780168|NCT00628745|456149753|FG003|Overall Study|Death|4|||
126780169|NCT00628745|456149754|FG004|Overall Study|Death|939|||
126780170|NCT00628745|456149750|FG000|Overall Study|Participant transferred to another THAOS site|6|||
126780171|NCT00628745|456149751|FG001|Overall Study|Participant transferred to another THAOS site|0|||
126780172|NCT00628745|456149752|FG002|Overall Study|Participant transferred to another THAOS site|0|||
126780173|NCT00628745|456149753|FG003|Overall Study|Participant transferred to another THAOS site|0|||
126780174|NCT00628745|456149754|FG004|Overall Study|Participant transferred to another THAOS site|7|||
126780175|NCT00628745|456149750|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
126780176|NCT00628745|456149751|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
126780177|NCT00628745|456149752|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
126780178|NCT00628745|456149753|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
126780179|NCT00628745|456149754|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
126780180|NCT00628745|456149750|FG000|Overall Study|Site closure|152|||
126780181|NCT00628745|456149751|FG001|Overall Study|Site closure|146|||
126780182|NCT00628745|456149752|FG002|Overall Study|Site closure|6|||
126780183|NCT00628745|456149753|FG003|Overall Study|Site closure|8|||
126780184|NCT00628745|456149754|FG004|Overall Study|Site closure|691|||
126780185|NCT00628745|456149750|FG000|Overall Study|Duplicate participant|0|||
126780186|NCT00628745|456149751|FG001|Overall Study|Duplicate participant|0|||
126780187|NCT00628745|456149752|FG002|Overall Study|Duplicate participant|0|||
126780188|NCT00628745|456149753|FG003|Overall Study|Duplicate participant|0|||
126780189|NCT00628745|456149754|FG004|Overall Study|Duplicate participant|1|||
126780190|NCT00628745|456149750|FG000|Overall Study|Missing|4|||
126780191|NCT00628745|456149751|FG001|Overall Study|Missing|3|||
126780192|NCT00628745|456149752|FG002|Overall Study|Missing|0|||
126780193|NCT00628745|456149753|FG003|Overall Study|Missing|0|||
126780194|NCT00628745|456149754|FG004|Overall Study|Missing|10|||
126599752|NCT04614948|455495678|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
126599753|NCT04614948|455495676|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
126599754|NCT04614948|455495677|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
126599755|NCT04614948|455495678|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
126780195|NCT00628745|456149750|FG000|Overall Study|Othe reasons|987|||
126780196|NCT00628745|456149751|FG001|Overall Study|Othe reasons|373|||
126780197|NCT00628745|456149752|FG002|Overall Study|Othe reasons|105|||
126780198|NCT00628745|456149753|FG003|Overall Study|Othe reasons|1|||
126780199|NCT00628745|456149754|FG004|Overall Study|Othe reasons|1772|||
126780200|NCT03322462|456151174|FG000|Overall Study|Technical difficulties|2|||
126780201|NCT03322462|456151174|FG000|Overall Study|Other|1|||
126780202|NCT00598559|456151175|FG000|Overall Study|Adverse Event|11|||
126780203|NCT00598559|456151176|FG001|Overall Study|Adverse Event|7|||
126780204|NCT00598559|456151177|FG002|Overall Study|Adverse Event|0|||
126599756|NCT04614948|455495676|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
126599757|NCT04614948|455495677|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
126599758|NCT04614948|455495678|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
126599759|NCT04614948|455495676|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
126599760|NCT04614948|455495677|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
126599761|NCT04614948|455495678|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
126733318|NCT01335698|455972342|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
126599762|NCT04614948|455495676|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
126599763|NCT04614948|455495677|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
126599764|NCT04614948|455495678|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
126599765|NCT04614948|455495676|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
126599766|NCT04614948|455495677|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
126599767|NCT04614948|455495678|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
126599768|NCT04614948|455495676|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
126599769|NCT04614948|455495677|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
126599770|NCT04614948|455495678|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
126599771|NCT04614948|455495676|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
126599772|NCT04614948|455495677|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
126599773|NCT04614948|455495678|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
126599774|NCT04614948|455495676|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
126599775|NCT04614948|455495677|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
126599776|NCT04614948|455495678|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
126599777|NCT04614948|455495676|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
126599778|NCT04614948|455495677|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
126599779|NCT04614948|455495678|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
126599780|NCT04614948|455495676|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
126599781|NCT04614948|455495677|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
126599782|NCT04614948|455495678|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
126599783|NCT04614948|455495676|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
126599784|NCT04614948|455495677|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
126599785|NCT04614948|455495678|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
126599786|NCT04614948|455495676|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
126599787|NCT04614948|455495677|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
126599788|NCT04614948|455495678|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
126599789|NCT04614948|455495676|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
126599790|NCT04614948|455495677|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
126599791|NCT04614948|455495678|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
126599792|NCT04614948|455495676|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
126599793|NCT04614948|455495677|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
126599794|NCT04614948|455495678|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
126599795|NCT04055012|455495679|FG000|Overall Study|Withdrawal by Subject|1|||
126599796|NCT04055012|455495680|FG001|Overall Study|Withdrawal by Subject|3|||
126599797|NCT04055012|455495681|FG002|Overall Study|Withdrawal by Subject|1|||
126733319|NCT01335698|455972343|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
126733320|NCT01335698|455972339|FG000|Treatment Stage 2|Switched to another formulation|1|||
126599798|NCT04055012|455495682|FG003|Overall Study|Withdrawal by Subject|0|||
126599799|NCT04055012|455495679|FG000|Overall Study|Metformin Recall|1|||
126599800|NCT04055012|455495680|FG001|Overall Study|Metformin Recall|1|||
126599801|NCT04055012|455495681|FG002|Overall Study|Metformin Recall|1|||
126599802|NCT04055012|455495682|FG003|Overall Study|Metformin Recall|0|||
126599803|NCT02326974|455495685|FG000|Overall Study|Withdrawal by Subject|2|||
126599804|NCT02326974|455495685|FG000|Overall Study|failed heterogenity evaluation|5|||
126599805|NCT04924400|455495693|FG000|Overall Study|Lost to Follow-up|3|||
126599806|NCT04924400|455495694|FG001|Overall Study|Lost to Follow-up|0|||
126599807|NCT04424316|455495695|FG000|Overall Study|Adverse Event|0|||
126599808|NCT04424316|455495696|FG001|Overall Study|Adverse Event|1|||
126599809|NCT04424316|455495697|FG002|Overall Study|Adverse Event|0|||
126599810|NCT04424316|455495698|FG003|Overall Study|Adverse Event|0|||
126599811|NCT04424316|455495695|FG000|Overall Study|Death|1|||
126599812|NCT04424316|455495696|FG001|Overall Study|Death|0|||
126599813|NCT04424316|455495697|FG002|Overall Study|Death|8|||
126599814|NCT04424316|455495698|FG003|Overall Study|Death|14|||
126599815|NCT04424316|455495695|FG000|Overall Study|Lost to Follow-up|93|||
126599816|NCT04424316|455495696|FG001|Overall Study|Lost to Follow-up|88|||
126599817|NCT04424316|455495697|FG002|Overall Study|Lost to Follow-up|224|||
126599818|NCT04424316|455495698|FG003|Overall Study|Lost to Follow-up|211|||
126599819|NCT04424316|455495695|FG000|Overall Study|No longer met eligibility criteria|1|||
126733321|NCT01335698|455972340|FG001|Treatment Stage 2|Switched to another formulation|1|||
126733322|NCT01335698|455972341|FG002|Treatment Stage 2|Switched to another formulation|0|||
126780205|NCT00598559|456151175|FG000|Overall Study|Withdrawal by Subject|2|||
126780206|NCT00598559|456151176|FG001|Overall Study|Withdrawal by Subject|2|||
126780207|NCT00598559|456151177|FG002|Overall Study|Withdrawal by Subject|0|||
126780208|NCT00598559|456151175|FG000|Overall Study|Protocol Non-compliance|1|||
126780209|NCT00598559|456151176|FG001|Overall Study|Protocol Non-compliance|0|||
126780210|NCT00598559|456151177|FG002|Overall Study|Protocol Non-compliance|0|||
126780211|NCT00598559|456151175|FG000|Overall Study|Early discharge from hospital|9|||
126780212|NCT00598559|456151176|FG001|Overall Study|Early discharge from hospital|12|||
126780213|NCT00598559|456151177|FG002|Overall Study|Early discharge from hospital|3|||
126780214|NCT00598559|456151175|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
126780215|NCT00598559|456151176|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
126780216|NCT00598559|456151177|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
126780217|NCT03381248|456151178|FG000|0-6 Months|Withdrawal by Subject|4|||
126780218|NCT03381248|456151179|FG001|0-6 Months|Withdrawal by Subject|1|||
126780219|NCT03381248|456151178|FG000|0-6 Months|Lost to Follow-up|3|||
126780220|NCT03381248|456151179|FG001|0-6 Months|Lost to Follow-up|2|||
126780221|NCT03381248|456151178|FG000|0-6 Months|Lack of Efficacy|1|||
126780222|NCT03381248|456151179|FG001|0-6 Months|Lack of Efficacy|0|||
126780223|NCT03381248|456151178|FG000|0-6 Months|Adverse Event|1|||
126780224|NCT03381248|456151179|FG001|0-6 Months|Adverse Event|0|||
126780225|NCT03381248|456151178|FG000|0-6 Months|Protocol Violation|2|||
126780226|NCT03381248|456151179|FG001|0-6 Months|Protocol Violation|1|||
126780227|NCT03381248|456151178|FG000|0-6 Months|Physician Decision|1|||
126780228|NCT03381248|456151179|FG001|0-6 Months|Physician Decision|0|||
126780229|NCT03381248|456151178|FG000|0-6 Months|Planning another procedure|1|||
126780230|NCT03381248|456151179|FG001|0-6 Months|Planning another procedure|2|||
126780231|NCT03381248|456151178|FG000|6-12 Months|Withdrawal by Subject|1|||
126780232|NCT03381248|456151179|FG001|6-12 Months|Withdrawal by Subject|3|||
126780233|NCT03381248|456151178|FG000|6-12 Months|Lost to Follow-up|0|||
126780234|NCT03381248|456151179|FG001|6-12 Months|Lost to Follow-up|2|||
126780235|NCT03381248|456151178|FG000|6-12 Months|Protocol Violation|3|||
126780236|NCT03381248|456151179|FG001|6-12 Months|Protocol Violation|2|||
126780237|NCT03381248|456151178|FG000|6-12 Months|Planning another procedure|6|||
126780238|NCT03381248|456151179|FG001|6-12 Months|Planning another procedure|2|||
126780239|NCT03381248|456151178|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
126780240|NCT03381248|456151179|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
126780241|NCT03381248|456151178|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
126780242|NCT03381248|456151179|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
126780243|NCT03381248|456151178|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
126780244|NCT03381248|456151179|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
126780245|NCT01405950|456151188|FG000|Overall Study|Withdrawal by Subject|1|||
126780246|NCT01405950|456151189|FG001|Overall Study|Withdrawal by Subject|0|||
126780247|NCT01405950|456151190|FG002|Overall Study|Withdrawal by Subject|0|||
126780248|NCT01405950|456151191|FG003|Overall Study|Withdrawal by Subject|0|||
126780249|NCT00112489|456151219|FG000|Overall Study|Refused further treatment|8|||
126780250|NCT00112489|456151219|FG000|Overall Study|Adverse Event|12|||
126780251|NCT00112489|456151219|FG000|Overall Study|Death|2|||
126780252|NCT00112489|456151219|FG000|Overall Study|Other, Not Specified|9|||
126780253|NCT00112489|456151219|FG000|Overall Study|Patient never treated|2|||
126780254|NCT00112489|456151219|FG000|Overall Study|Ineligible|7|||
126780255|NCT05751629|456151220|FG000|Overall Study|Withdrawal by Subject|6|||
126780256|NCT05751629|456151220|FG000|Overall Study|Death|25|||
126780257|NCT05751629|456151220|FG000|Overall Study|Study Site Closed|9|||
126780258|NCT05751629|456151220|FG000|Overall Study|Physician Decision|1|||
126780259|NCT00295854|456151223|FG000|Overall Study|Adverse Event|7|||
126780260|NCT00295854|456151224|FG001|Overall Study|Adverse Event|7|||
126780261|NCT00295854|456151225|FG002|Overall Study|Adverse Event|6|||
126780262|NCT00295854|456151223|FG000|Overall Study|Protocol Violation|1|||
126780263|NCT00295854|456151224|FG001|Overall Study|Protocol Violation|1|||
126780264|NCT00295854|456151225|FG002|Overall Study|Protocol Violation|1|||
126780265|NCT00295854|456151223|FG000|Overall Study|Lost to Follow-up|2|||
126780266|NCT00295854|456151224|FG001|Overall Study|Lost to Follow-up|0|||
126780267|NCT00295854|456151225|FG002|Overall Study|Lost to Follow-up|1|||
126780268|NCT00295854|456151223|FG000|Overall Study|Withdrawal by Subject|3|||
126780269|NCT00295854|456151224|FG001|Overall Study|Withdrawal by Subject|7|||
126780270|NCT00295854|456151225|FG002|Overall Study|Withdrawal by Subject|4|||
126780271|NCT00295854|456151223|FG000|Overall Study|did not continue to meet criteria|1|||
126780272|NCT00295854|456151224|FG001|Overall Study|did not continue to meet criteria|1|||
126780273|NCT00295854|456151225|FG002|Overall Study|did not continue to meet criteria|2|||
126780274|NCT00295854|456151223|FG000|Overall Study|required a prohibited medication|1|||
126780275|NCT00295854|456151224|FG001|Overall Study|required a prohibited medication|0|||
126780276|NCT00295854|456151225|FG002|Overall Study|required a prohibited medication|0|||
126780277|NCT00295854|456151223|FG000|Overall Study|Other|3|||
126780278|NCT00295854|456151224|FG001|Overall Study|Other|5|||
126780279|NCT00295854|456151225|FG002|Overall Study|Other|1|||
126780280|NCT00772577|456151226|FG000|Overall Study|Adverse Event|6|||
126599820|NCT04424316|455495696|FG001|Overall Study|No longer met eligibility criteria|0|||
126599821|NCT04424316|455495697|FG002|Overall Study|No longer met eligibility criteria|0|||
126599822|NCT04424316|455495698|FG003|Overall Study|No longer met eligibility criteria|0|||
126599823|NCT04424316|455495695|FG000|Overall Study|Other|15|||
126599824|NCT04424316|455495696|FG001|Overall Study|Other|11|||
126599825|NCT04424316|455495697|FG002|Overall Study|Other|34|||
126599826|NCT04424316|455495698|FG003|Overall Study|Other|45|||
126599827|NCT04424316|455495695|FG000|Overall Study|Physician Decision|1|||
126599828|NCT04424316|455495696|FG001|Overall Study|Physician Decision|0|||
126599829|NCT04424316|455495697|FG002|Overall Study|Physician Decision|1|||
126599830|NCT04424316|455495698|FG003|Overall Study|Physician Decision|1|||
126599831|NCT04424316|455495695|FG000|Overall Study|Protocol Violation|0|||
126599832|NCT04424316|455495696|FG001|Overall Study|Protocol Violation|1|||
126599833|NCT04424316|455495697|FG002|Overall Study|Protocol Violation|0|||
126599834|NCT04424316|455495698|FG003|Overall Study|Protocol Violation|0|||
126599835|NCT04424316|455495695|FG000|Overall Study|Withdrawal by Subject|71|||
126599836|NCT04424316|455495696|FG001|Overall Study|Withdrawal by Subject|77|||
126599837|NCT04424316|455495697|FG002|Overall Study|Withdrawal by Subject|0|||
126599838|NCT04424316|455495698|FG003|Overall Study|Withdrawal by Subject|0|||
126599839|NCT04424316|455495695|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126599840|NCT04424316|455495696|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126599841|NCT04424316|455495697|FG002|Overall Study|Withdrawal by parent/guardian|74|||
126599842|NCT04424316|455495698|FG003|Overall Study|Withdrawal by parent/guardian|81|||
126599843|NCT04424316|455495695|FG000|Overall Study|Randomized but not vaccinated|13|||
126599844|NCT04424316|455495696|FG001|Overall Study|Randomized but not vaccinated|21|||
126599845|NCT04424316|455495697|FG002|Overall Study|Randomized but not vaccinated|0|||
126599846|NCT04424316|455495698|FG003|Overall Study|Randomized but not vaccinated|0|||
126599847|NCT04424316|455495695|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
126599848|NCT04424316|455495696|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
126599849|NCT04424316|455495697|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
126599850|NCT04424316|455495698|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
126599851|NCT00412607|455495701|FG000|Overall Study|Withdrawal by Subject|9|||
126599852|NCT00412607|455495701|FG000|Overall Study|Lost to Follow-up|19|||
126599853|NCT00412607|455495701|FG000|Overall Study|Death|61|||
126599854|NCT00412607|455495701|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
126599855|NCT05890105|455495702|FG000|Overall Study|Adverse Event|1|||
126599856|NCT05890105|455495703|FG001|Overall Study|Adverse Event|0|||
126733323|NCT01335698|455972342|FG003|Treatment Stage 2|Switched to another formulation|0|||
126599857|NCT05890105|455495704|FG002|Overall Study|Adverse Event|0|||
126599858|NCT05890105|455495702|FG000|Overall Study|Other|1|||
126599859|NCT05890105|455495703|FG001|Overall Study|Other|2|||
126599860|NCT05890105|455495704|FG002|Overall Study|Other|0|||
126599861|NCT00450216|455495705|FG000|Overall Study|Adverse Event|38|||
126599862|NCT00450216|455495706|FG001|Overall Study|Adverse Event|23|||
126599863|NCT00450216|455495705|FG000|Overall Study|Withdrawal by Subject|48|||
126599864|NCT00450216|455495706|FG001|Overall Study|Withdrawal by Subject|26|||
126599865|NCT00450216|455495705|FG000|Overall Study|Lost to Follow-up|16|||
126599866|NCT00450216|455495706|FG001|Overall Study|Lost to Follow-up|9|||
126599867|NCT00450216|455495705|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
126599868|NCT00450216|455495706|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
126599869|NCT00450216|455495705|FG000|Overall Study|misc|21|||
126599870|NCT00450216|455495706|FG001|Overall Study|misc|20|||
126599871|NCT04206787|455495707|FG000|Overall Study|Other than listed|2|||
126599872|NCT04206787|455495707|FG000|Overall Study|Investigator decision|1|||
126599873|NCT04206787|455495707|FG000|Overall Study|Death|25|||
126599874|NCT04206787|455495707|FG000|Overall Study|Lost to Follow-up|9|||
126599875|NCT04206787|455495707|FG000|Overall Study|Withdrawal of consent|9|||
126599876|NCT03011034|455495709|FG000|Overall Study|Adverse Event|1|||
126599877|NCT03011034|455495710|FG001|Overall Study|Adverse Event|0|||
126599878|NCT03735979|455495715|FG000|Overall Study|Lost to Follow-up|1|||
126599879|NCT03735979|455495716|FG001|Overall Study|Lost to Follow-up|12|||
126599880|NCT03735979|455495717|FG002|Overall Study|Lost to Follow-up|14|||
126599881|NCT03735979|455495715|FG000|Overall Study|Withdrawal by Subject|1|||
126599882|NCT03735979|455495716|FG001|Overall Study|Withdrawal by Subject|5|||
126599883|NCT03735979|455495717|FG002|Overall Study|Withdrawal by Subject|2|||
126599884|NCT03735979|455495715|FG000|Overall Study|Not due to the above reasons|1|||
126733324|NCT01335698|455972343|FG004|Treatment Stage 2|Switched to another formulation|0|||
126599885|NCT03735979|455495716|FG001|Overall Study|Not due to the above reasons|0|||
126599886|NCT03735979|455495717|FG002|Overall Study|Not due to the above reasons|0|||
126599887|NCT04743973|455495721|FG000|Overall Study|Withdrawal by Subject|5|||
126599888|NCT05654662|455495722|FG000|Overall Study|Withdrawal by Subject|1|||
126599889|NCT05654662|455495723|FG001|Overall Study|Withdrawal by Subject|0|||
126599890|NCT05654662|455495722|FG000|Overall Study|A death in the family|1|||
126599891|NCT05654662|455495723|FG001|Overall Study|A death in the family|0|||
126599892|NCT03165955|455495724|FG000|Treatment|Withdrawal by Subject|3|||
126599893|NCT03165955|455495724|FG000|Treatment|Death|1|||
126599894|NCT03165955|455495724|FG000|Treatment|Adverse Event|1|||
126780281|NCT00772577|456151227|FG001|Overall Study|Adverse Event|3|||
126780282|NCT00772577|456151226|FG000|Overall Study|Abnormal laboratory values|0|||
126780283|NCT00772577|456151227|FG001|Overall Study|Abnormal laboratory values|1|||
126780284|NCT00772577|456151226|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126780285|NCT00772577|456151227|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
126780286|NCT00772577|456151226|FG000|Overall Study|Patient withdrew consent|8|||
126780287|NCT00772577|456151227|FG001|Overall Study|Patient withdrew consent|5|||
126780288|NCT00772577|456151226|FG000|Overall Study|Lost to Follow-up|4|||
126780289|NCT00772577|456151227|FG001|Overall Study|Lost to Follow-up|3|||
126780290|NCT00772577|456151226|FG000|Overall Study|Administrative problems|2|||
126780291|NCT00772577|456151227|FG001|Overall Study|Administrative problems|1|||
126780292|NCT00772577|456151226|FG000|Overall Study|Protocol Deviation|3|||
126780293|NCT00772577|456151227|FG001|Overall Study|Protocol Deviation|2|||
126780294|NCT00672620|456151228|FG000|Overall Study|Adverse Event|7|||
126780295|NCT00672620|456151229|FG001|Overall Study|Adverse Event|7|||
126780296|NCT00672620|456151230|FG002|Overall Study|Adverse Event|12|||
126780297|NCT00672620|456151231|FG003|Overall Study|Adverse Event|17|||
126780298|NCT00672620|456151228|FG000|Overall Study|Lack of Efficacy|1|||
126780299|NCT00672620|456151229|FG001|Overall Study|Lack of Efficacy|2|||
126780300|NCT00672620|456151230|FG002|Overall Study|Lack of Efficacy|2|||
126780301|NCT00672620|456151231|FG003|Overall Study|Lack of Efficacy|0|||
126780302|NCT00672620|456151228|FG000|Overall Study|Noncompliance with Study Drug|3|||
126780303|NCT00672620|456151229|FG001|Overall Study|Noncompliance with Study Drug|4|||
126780304|NCT00672620|456151230|FG002|Overall Study|Noncompliance with Study Drug|0|||
126780305|NCT00672620|456151231|FG003|Overall Study|Noncompliance with Study Drug|2|||
126780306|NCT00672620|456151228|FG000|Overall Study|Protocol Deviations|5|||
126780307|NCT00672620|456151229|FG001|Overall Study|Protocol Deviations|7|||
126780308|NCT00672620|456151230|FG002|Overall Study|Protocol Deviations|2|||
126780309|NCT00672620|456151231|FG003|Overall Study|Protocol Deviations|5|||
126780310|NCT00672620|456151228|FG000|Overall Study|Withdrawal of Consent|6|||
126780311|NCT00672620|456151229|FG001|Overall Study|Withdrawal of Consent|12|||
126780312|NCT00672620|456151230|FG002|Overall Study|Withdrawal of Consent|5|||
126780313|NCT00672620|456151231|FG003|Overall Study|Withdrawal of Consent|6|||
126780314|NCT00672620|456151228|FG000|Overall Study|Lost to Follow-up|8|||
126780315|NCT00672620|456151229|FG001|Overall Study|Lost to Follow-up|19|||
126780316|NCT00672620|456151230|FG002|Overall Study|Lost to Follow-up|8|||
126780317|NCT00672620|456151231|FG003|Overall Study|Lost to Follow-up|11|||
126780318|NCT00672620|456151228|FG000|Overall Study|Reason not Specified|3|||
126780319|NCT00672620|456151229|FG001|Overall Study|Reason not Specified|3|||
126780320|NCT00672620|456151230|FG002|Overall Study|Reason not Specified|2|||
126780321|NCT00672620|456151231|FG003|Overall Study|Reason not Specified|1|||
126780322|NCT03211156|456151232|FG000|Overall Study|Withdrawal by Subject|0|||
126780323|NCT03211156|456151233|FG001|Overall Study|Withdrawal by Subject|2|||
126780324|NCT03211156|456151232|FG000|Overall Study|Lost to Follow-up|1|||
126780325|NCT03211156|456151233|FG001|Overall Study|Lost to Follow-up|1|||
126599895|NCT03165955|455495724|FG000|Treatment|Progressive disease|3|||
126599896|NCT04499521|455495727|FG000|Overall Study|Disease Progression|1|||
126599897|NCT04499521|455495728|FG001|Overall Study|Disease Progression|0|||
126599898|NCT04678856|455495729|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
126599899|NCT04678856|455495730|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
126599900|NCT04678856|455495729|FG000|Overall Study|Withdrawal by Subject|5|||
126599901|NCT04678856|455495730|FG001|Overall Study|Withdrawal by Subject|1|||
126599902|NCT00942877|455497032|FG000|Overall Study|Refused further treatment|1|||
126599903|NCT00942877|455497033|FG001|Overall Study|Refused further treatment|1|||
126599904|NCT00942877|455497032|FG000|Overall Study|Patient was not treated|1|||
126599905|NCT00942877|455497033|FG001|Overall Study|Patient was not treated|0|||
126599906|NCT00942877|455497032|FG000|Overall Study|Adverse Event|1|||
126599907|NCT00942877|455497033|FG001|Overall Study|Adverse Event|0|||
126599908|NCT00942877|455497032|FG000|Overall Study|Progressive disease|42|||
126599909|NCT00942877|455497033|FG001|Overall Study|Progressive disease|3|||
126599910|NCT01385202|455497036|FG000|Overall Study|Lost to Follow-up|6|||
126599911|NCT01385202|455497036|FG000|Overall Study|Not Eligible|11|||
126599912|NCT01385202|455497036|FG000|Overall Study|Withdrawn|1|||
126599913|NCT03681262|455497037|FG000|Overall Study|Continuing on study|3|||
126599914|NCT03681262|455497038|FG001|Overall Study|Continuing on study|3|||
126599915|NCT03681262|455497037|FG000|Overall Study|Lost to Follow-up|1|||
126599916|NCT03681262|455497038|FG001|Overall Study|Lost to Follow-up|0|||
126599917|NCT00887198|455497039|FG000|Randomized Period|Ongoing|42|||
126599918|NCT00887198|455497040|FG001|Randomized Period|Ongoing|0|||
126780326|NCT03211156|456151232|FG000|Overall Study|Adverse Event|1|||
126780327|NCT03211156|456151233|FG001|Overall Study|Adverse Event|0|||
126780328|NCT00829413|456151234|FG000|Overall Study|No study drug admimnistered|13|||
126780329|NCT00829413|456151234|FG000|Overall Study|Training Patients|67|||
126780330|NCT00829413|456151234|FG000|Overall Study|No truth standard procedure available|9|||
126780331|NCT00829413|456151234|FG000|Overall Study|Technically inadequate truth standard|2|||
126780332|NCT00829413|456151234|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
126780333|NCT03487796|456151236|FG000|Overall Study|Lost to Follow-up|18|||
126599919|NCT00887198|455497041|FG002|Randomized Period|Ongoing|0|||
126599920|NCT00887198|455497039|FG000|Randomized Period|Adverse Event|50|||
126599921|NCT00887198|455497040|FG001|Randomized Period|Adverse Event|33|||
126599922|NCT00887198|455497041|FG002|Randomized Period|Adverse Event|0|||
126599923|NCT00887198|455497039|FG000|Randomized Period|Lost to Follow-up|1|||
126599924|NCT00887198|455497040|FG001|Randomized Period|Lost to Follow-up|0|||
126599925|NCT00887198|455497041|FG002|Randomized Period|Lost to Follow-up|0|||
126599926|NCT00887198|455497039|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
126599927|NCT00887198|455497040|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
126599928|NCT00887198|455497041|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
126599929|NCT00887198|455497039|FG000|Randomized Period|Withdrawal by Subject|41|||
126599930|NCT00887198|455497040|FG001|Randomized Period|Withdrawal by Subject|56|||
126599931|NCT00887198|455497041|FG002|Randomized Period|Withdrawal by Subject|0|||
126599932|NCT00887198|455497039|FG000|Randomized Period|Progressive disease|366|||
126599933|NCT00887198|455497040|FG001|Randomized Period|Progressive disease|370|||
126599934|NCT00887198|455497041|FG002|Randomized Period|Progressive disease|0|||
126599935|NCT00887198|455497039|FG000|Randomized Period|Other|42|||
126599936|NCT00887198|455497040|FG001|Randomized Period|Other|30|||
126599937|NCT00887198|455497041|FG002|Randomized Period|Other|0|||
126599938|NCT00887198|455497039|FG000|Randomized Period|Randomized, Not treated|4|||
126599939|NCT00887198|455497040|FG001|Randomized Period|Randomized, Not treated|2|||
126599940|NCT00887198|455497041|FG002|Randomized Period|Randomized, Not treated|0|||
126599941|NCT00887198|455497039|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
126599942|NCT00887198|455497040|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
126599943|NCT00887198|455497041|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
126599944|NCT00887198|455497039|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
126599945|NCT00887198|455497040|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
126599946|NCT00887198|455497041|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
126599947|NCT00887198|455497039|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
126599948|NCT00887198|455497040|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
126599949|NCT00887198|455497041|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
126599950|NCT00887198|455497039|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
126599951|NCT00887198|455497040|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
126599952|NCT00887198|455497041|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
126599953|NCT00887198|455497039|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
126599954|NCT00887198|455497040|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
126599955|NCT00887198|455497041|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
126599956|NCT00887198|455497039|FG000|Cross Over (Placebo to AA)|Other|0|||
126599957|NCT00887198|455497040|FG001|Cross Over (Placebo to AA)|Other|0|||
126599958|NCT00887198|455497041|FG002|Cross Over (Placebo to AA)|Other|19|||
126599959|NCT02782676|455497042|FG000|Overall Study|Lost to Follow-up|0|||
126599960|NCT02782676|455497043|FG001|Overall Study|Lost to Follow-up|1|||
126599961|NCT03334695|455497044|FG000|Overall Study|Lost to Follow-up|3|||
126599962|NCT03334695|455497045|FG001|Overall Study|Lost to Follow-up|3|||
126599963|NCT03334695|455497044|FG000|Overall Study|Physician Decision|1|||
126599964|NCT03334695|455497045|FG001|Overall Study|Physician Decision|2|||
126599965|NCT03334695|455497044|FG000|Overall Study|Protocol Violation|0|||
126599966|NCT03334695|455497045|FG001|Overall Study|Protocol Violation|1|||
126599967|NCT05007080|455497046|FG000|Overall Study|Lost to Follow-up|0|||
126599968|NCT05007080|455497047|FG001|Overall Study|Lost to Follow-up|1|||
126599969|NCT05007080|455497048|FG002|Overall Study|Lost to Follow-up|0|||
126599970|NCT05007080|455497049|FG003|Overall Study|Lost to Follow-up|1|||
126599971|NCT05007080|455497050|FG004|Overall Study|Lost to Follow-up|1|||
126599972|NCT05007080|455497051|FG005|Overall Study|Lost to Follow-up|1|||
126599973|NCT05007080|455497046|FG000|Overall Study|Death|0|||
126599974|NCT05007080|455497047|FG001|Overall Study|Death|1|||
126599975|NCT05007080|455497048|FG002|Overall Study|Death|0|||
126599976|NCT05007080|455497049|FG003|Overall Study|Death|0|||
126599977|NCT05007080|455497050|FG004|Overall Study|Death|0|||
126599978|NCT05007080|455497051|FG005|Overall Study|Death|0|||
126599979|NCT05007080|455497046|FG000|Overall Study|Withdrawal by Subject|1|||
126599980|NCT05007080|455497047|FG001|Overall Study|Withdrawal by Subject|2|||
126599981|NCT05007080|455497048|FG002|Overall Study|Withdrawal by Subject|0|||
126599982|NCT05007080|455497049|FG003|Overall Study|Withdrawal by Subject|2|||
126599983|NCT05007080|455497050|FG004|Overall Study|Withdrawal by Subject|1|||
126599984|NCT05007080|455497051|FG005|Overall Study|Withdrawal by Subject|1|||
126599985|NCT05007080|455497046|FG000|Overall Study|Other|1|||
126599986|NCT05007080|455497047|FG001|Overall Study|Other|0|||
126599987|NCT05007080|455497048|FG002|Overall Study|Other|1|||
126599988|NCT05007080|455497049|FG003|Overall Study|Other|1|||
126599989|NCT05007080|455497050|FG004|Overall Study|Other|0|||
126599990|NCT05007080|455497051|FG005|Overall Study|Other|2|||
126599991|NCT05007080|455497046|FG000|Overall Study|Randomized not vaccinated|0|||
126599992|NCT05007080|455497047|FG001|Overall Study|Randomized not vaccinated|0|||
126599993|NCT05007080|455497048|FG002|Overall Study|Randomized not vaccinated|0|||
126599994|NCT05007080|455497049|FG003|Overall Study|Randomized not vaccinated|0|||
126599995|NCT05007080|455497050|FG004|Overall Study|Randomized not vaccinated|0|||
126599996|NCT05007080|455497051|FG005|Overall Study|Randomized not vaccinated|1|||
126599997|NCT02874742|455497052|FG000|Overall Study|Death|0|||
126599998|NCT02874742|455497053|FG001|Overall Study|Death|1|||
126599999|NCT02874742|455497054|FG002|Overall Study|Death|0|||
126600000|NCT02874742|455497052|FG000|Overall Study|Lost to Follow-up|5|||
126600001|NCT02874742|455497053|FG001|Overall Study|Lost to Follow-up|4|||
126600002|NCT02874742|455497054|FG002|Overall Study|Lost to Follow-up|1|||
126600003|NCT02874742|455497052|FG000|Overall Study|Withdrawal by Subject|17|||
126600004|NCT02874742|455497053|FG001|Overall Study|Withdrawal by Subject|8|||
126600005|NCT02874742|455497054|FG002|Overall Study|Withdrawal by Subject|0|||
126600006|NCT02874742|455497052|FG000|Overall Study|Other|4|||
126600007|NCT02874742|455497053|FG001|Overall Study|Other|1|||
126600008|NCT02874742|455497054|FG002|Overall Study|Other|0|||
126600009|NCT02874742|455497052|FG000|Overall Study|Progressive Disease|1|||
126600010|NCT02874742|455497053|FG001|Overall Study|Progressive Disease|0|||
126600011|NCT02874742|455497054|FG002|Overall Study|Progressive Disease|0|||
126600012|NCT02874742|455497052|FG000|Overall Study|Screen Failure|0|||
126600013|NCT02874742|455497053|FG001|Overall Study|Screen Failure|2|||
126600014|NCT02874742|455497054|FG002|Overall Study|Screen Failure|0|||
126600015|NCT00964392|455497055|FG000|Overall Study|Withdrawal by Subject|4|||
126600016|NCT00964392|455497056|FG001|Overall Study|Withdrawal by Subject|6|||
126600017|NCT00964392|455497055|FG000|Overall Study|Lost to Follow-up|4|||
126600018|NCT00964392|455497056|FG001|Overall Study|Lost to Follow-up|10|||
126600019|NCT00964392|455497055|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
126600020|NCT00964392|455497056|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
126600021|NCT00964392|455497055|FG000|Overall Study|Not completed|44|||
126600022|NCT00964392|455497056|FG001|Overall Study|Not completed|168|||
126600023|NCT03652272|455497063|FG000|3 Month|Withdrawal by Subject|1|||
126600024|NCT03652272|455497064|FG001|3 Month|Withdrawal by Subject|1|||
126600025|NCT03652272|455497063|FG000|3 Month|Lost to Follow-up|16|||
126600026|NCT03652272|455497064|FG001|3 Month|Lost to Follow-up|14|||
126600027|NCT04173247|455497065|FG000|Overall Study|Withdrawal by Subject|0|||
126600028|NCT04173247|455497066|FG001|Overall Study|Withdrawal by Subject|2|||
126600029|NCT04173247|455497065|FG000|Overall Study|Death|1|||
126600030|NCT04173247|455497066|FG001|Overall Study|Death|0|||
126600031|NCT04173247|455497065|FG000|Overall Study|Physician Decision|1|||
126600032|NCT04173247|455497066|FG001|Overall Study|Physician Decision|0|||
126600033|NCT03884101|455497071|FG000|Overall Study|Participant Ongoing in Study|202|||
126600034|NCT03884101|455497072|FG001|Overall Study|Participant Ongoing in Study|186|||
126600035|NCT03884101|455497071|FG000|Overall Study|Death|212|||
126600036|NCT03884101|455497072|FG001|Overall Study|Death|224|||
126600037|NCT03884101|455497071|FG000|Overall Study|Lost to Follow-up|0|||
126600038|NCT03884101|455497072|FG001|Overall Study|Lost to Follow-up|1|||
126600039|NCT03884101|455497071|FG000|Overall Study|Withdrawal by Subject|6|||
126600040|NCT03884101|455497072|FG001|Overall Study|Withdrawal by Subject|11|||
126600041|NCT05070741|455497077|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
126600042|NCT03582033|455497078|FG000|Part A|Other|0|||
126600043|NCT03582033|455497079|FG001|Part A|Other|0|||
126600044|NCT03582033|455497080|FG002|Part A|Other|0|||
126600045|NCT03582033|455497081|FG003|Part A|Other|0|||
126600046|NCT03582033|455497082|FG004|Part A|Other|2|||
126600047|NCT03582033|455497083|FG005|Part A|Other|0|||
126600048|NCT03582033|455497084|FG006|Part A|Other|0|||
126600049|NCT03582033|455497085|FG007|Part A|Other|0|||
126600050|NCT03582033|455497086|FG008|Part A|Other|0|||
126600051|NCT03582033|455497087|FG009|Part A|Other|0|||
126600052|NCT03582033|455497078|FG000|Part A|Death|1|||
126600053|NCT03582033|455497079|FG001|Part A|Death|1|||
126600054|NCT03582033|455497080|FG002|Part A|Death|2|||
126600055|NCT03582033|455497081|FG003|Part A|Death|4|||
126600056|NCT03582033|455497082|FG004|Part A|Death|11|||
126600057|NCT03582033|455497083|FG005|Part A|Death|0|||
126600058|NCT03582033|455497084|FG006|Part A|Death|0|||
126600059|NCT03582033|455497085|FG007|Part A|Death|0|||
126600060|NCT03582033|455497086|FG008|Part A|Death|0|||
126600061|NCT03582033|455497087|FG009|Part A|Death|0|||
126600062|NCT03582033|455497078|FG000|Part A|Lost to Follow-up|0|||
126600063|NCT03582033|455497079|FG001|Part A|Lost to Follow-up|0|||
126600064|NCT03582033|455497080|FG002|Part A|Lost to Follow-up|0|||
126600065|NCT03582033|455497081|FG003|Part A|Lost to Follow-up|0|||
126600066|NCT03582033|455497082|FG004|Part A|Lost to Follow-up|1|||
126600067|NCT03582033|455497083|FG005|Part A|Lost to Follow-up|0|||
126600068|NCT03582033|455497084|FG006|Part A|Lost to Follow-up|0|||
126600069|NCT03582033|455497085|FG007|Part A|Lost to Follow-up|0|||
126600070|NCT03582033|455497086|FG008|Part A|Lost to Follow-up|0|||
126600071|NCT03582033|455497087|FG009|Part A|Lost to Follow-up|0|||
126600072|NCT03582033|455497078|FG000|Part A|Study terminated by sponsor|0|||
126600073|NCT03582033|455497079|FG001|Part A|Study terminated by sponsor|0|||
126600074|NCT03582033|455497080|FG002|Part A|Study terminated by sponsor|0|||
126600075|NCT03582033|455497081|FG003|Part A|Study terminated by sponsor|2|||
126600076|NCT03582033|455497082|FG004|Part A|Study terminated by sponsor|1|||
126600077|NCT03582033|455497083|FG005|Part A|Study terminated by sponsor|0|||
126600078|NCT03582033|455497084|FG006|Part A|Study terminated by sponsor|0|||
126600079|NCT03582033|455497085|FG007|Part A|Study terminated by sponsor|0|||
126600080|NCT03582033|455497086|FG008|Part A|Study terminated by sponsor|0|||
126600081|NCT03582033|455497087|FG009|Part A|Study terminated by sponsor|0|||
126600082|NCT03582033|455497078|FG000|Part A|Withdrawal by Subject|1|||
126600083|NCT03582033|455497079|FG001|Part A|Withdrawal by Subject|1|||
126600084|NCT03582033|455497080|FG002|Part A|Withdrawal by Subject|0|||
126600085|NCT03582033|455497081|FG003|Part A|Withdrawal by Subject|1|||
126600086|NCT03582033|455497082|FG004|Part A|Withdrawal by Subject|7|||
126600087|NCT03582033|455497083|FG005|Part A|Withdrawal by Subject|0|||
126600088|NCT03582033|455497084|FG006|Part A|Withdrawal by Subject|0|||
126600089|NCT03582033|455497085|FG007|Part A|Withdrawal by Subject|0|||
126600090|NCT03582033|455497086|FG008|Part A|Withdrawal by Subject|0|||
126600091|NCT03582033|455497087|FG009|Part A|Withdrawal by Subject|0|||
126600092|NCT03582033|455497078|FG000|Part B|Death|0|||
126600093|NCT03582033|455497079|FG001|Part B|Death|0|||
126600094|NCT03582033|455497080|FG002|Part B|Death|0|||
126600095|NCT03582033|455497081|FG003|Part B|Death|0|||
126600096|NCT03582033|455497082|FG004|Part B|Death|0|||
126600097|NCT03582033|455497083|FG005|Part B|Death|2|||
126600098|NCT03582033|455497084|FG006|Part B|Death|0|||
126600099|NCT03582033|455497085|FG007|Part B|Death|0|||
126600100|NCT03582033|455497086|FG008|Part B|Death|0|||
126600101|NCT03582033|455497087|FG009|Part B|Death|0|||
126600102|NCT03582033|455497078|FG000|Part B|Study terminated by sponsor|0|||
126600103|NCT03582033|455497079|FG001|Part B|Study terminated by sponsor|0|||
126600104|NCT03582033|455497080|FG002|Part B|Study terminated by sponsor|0|||
126600105|NCT03582033|455497081|FG003|Part B|Study terminated by sponsor|0|||
126600106|NCT03582033|455497082|FG004|Part B|Study terminated by sponsor|0|||
126600107|NCT03582033|455497083|FG005|Part B|Study terminated by sponsor|12|||
126600108|NCT03582033|455497084|FG006|Part B|Study terminated by sponsor|0|||
126600109|NCT03582033|455497085|FG007|Part B|Study terminated by sponsor|0|||
126600110|NCT03582033|455497086|FG008|Part B|Study terminated by sponsor|0|||
126600111|NCT03582033|455497087|FG009|Part B|Study terminated by sponsor|0|||
126600112|NCT03582033|455497078|FG000|Part B|Withdrawal by Subject|0|||
126600113|NCT03582033|455497079|FG001|Part B|Withdrawal by Subject|0|||
126600114|NCT03582033|455497080|FG002|Part B|Withdrawal by Subject|0|||
126600115|NCT03582033|455497081|FG003|Part B|Withdrawal by Subject|0|||
126600116|NCT03582033|455497082|FG004|Part B|Withdrawal by Subject|0|||
126600117|NCT03582033|455497083|FG005|Part B|Withdrawal by Subject|6|||
126600118|NCT03582033|455497084|FG006|Part B|Withdrawal by Subject|0|||
126600119|NCT03582033|455497085|FG007|Part B|Withdrawal by Subject|0|||
126600120|NCT03582033|455497086|FG008|Part B|Withdrawal by Subject|0|||
126600121|NCT03582033|455497087|FG009|Part B|Withdrawal by Subject|0|||
126600122|NCT03582033|455497078|FG000|Part C|Other|0|||
126600123|NCT03582033|455497079|FG001|Part C|Other|0|||
126600124|NCT03582033|455497080|FG002|Part C|Other|0|||
126600125|NCT03582033|455497081|FG003|Part C|Other|0|||
126600126|NCT03582033|455497082|FG004|Part C|Other|0|||
126600127|NCT03582033|455497083|FG005|Part C|Other|0|||
126600128|NCT03582033|455497084|FG006|Part C|Other|2|||
126600129|NCT03582033|455497085|FG007|Part C|Other|0|||
126600130|NCT03582033|455497086|FG008|Part C|Other|0|||
126600131|NCT03582033|455497087|FG009|Part C|Other|0|||
126600132|NCT03582033|455497078|FG000|Part C|Death|0|||
126600133|NCT03582033|455497079|FG001|Part C|Death|0|||
126600134|NCT03582033|455497080|FG002|Part C|Death|0|||
126600135|NCT03582033|455497081|FG003|Part C|Death|0|||
126600136|NCT03582033|455497082|FG004|Part C|Death|0|||
126780334|NCT03487796|456151237|FG001|Overall Study|Lost to Follow-up|6|||
126780335|NCT04272775|456151238|FG000|Overall Study|Study Terminated by Sponsor|1|||
126780336|NCT04272775|456151239|FG001|Overall Study|Study Terminated by Sponsor|0|||
126780337|NCT04272775|456151238|FG000|Overall Study|Protocol Violation|0|||
126780338|NCT04272775|456151239|FG001|Overall Study|Protocol Violation|1|||
126780339|NCT04272775|456151238|FG000|Overall Study|Symptomatic Deterioration|1|||
126780340|NCT04272775|456151239|FG001|Overall Study|Symptomatic Deterioration|1|||
126780341|NCT04272775|456151238|FG000|Overall Study|Withdrawal by Subject|1|||
126600137|NCT03582033|455497083|FG005|Part C|Death|0|||
126600138|NCT03582033|455497084|FG006|Part C|Death|6|||
126600139|NCT03582033|455497085|FG007|Part C|Death|1|||
126600140|NCT03582033|455497086|FG008|Part C|Death|2|||
126600141|NCT03582033|455497087|FG009|Part C|Death|0|||
126600142|NCT03582033|455497078|FG000|Part C|Study terminated by sponsor|0|||
126600143|NCT03582033|455497079|FG001|Part C|Study terminated by sponsor|0|||
126600144|NCT03582033|455497080|FG002|Part C|Study terminated by sponsor|0|||
126600145|NCT03582033|455497081|FG003|Part C|Study terminated by sponsor|0|||
126600146|NCT03582033|455497082|FG004|Part C|Study terminated by sponsor|0|||
126600147|NCT03582033|455497083|FG005|Part C|Study terminated by sponsor|0|||
126600148|NCT03582033|455497084|FG006|Part C|Study terminated by sponsor|3|||
126600149|NCT03582033|455497085|FG007|Part C|Study terminated by sponsor|3|||
126600150|NCT03582033|455497086|FG008|Part C|Study terminated by sponsor|2|||
126600151|NCT03582033|455497087|FG009|Part C|Study terminated by sponsor|0|||
126600152|NCT03582033|455497078|FG000|Part C|Withdrawal by Subject|0|||
126780342|NCT04272775|456151239|FG001|Overall Study|Withdrawal by Subject|2|||
126780343|NCT04272775|456151238|FG000|Overall Study|Adverse Event|1|||
126600153|NCT03582033|455497079|FG001|Part C|Withdrawal by Subject|0|||
126780344|NCT04272775|456151239|FG001|Overall Study|Adverse Event|2|||
126780345|NCT04272775|456151238|FG000|Overall Study|Progressive Disease|3|||
126780346|NCT04272775|456151239|FG001|Overall Study|Progressive Disease|1|||
126780347|NCT00124020|456151240|FG000|Overall Study|Death|67|||
126780348|NCT00124020|456151241|FG001|Overall Study|Death|71|||
126780349|NCT00124020|456151240|FG000|Overall Study|Withdrawal by Subject|13|||
126780350|NCT00124020|456151241|FG001|Overall Study|Withdrawal by Subject|11|||
126780351|NCT00124020|456151240|FG000|Overall Study|Lost to Follow-up|5|||
126780352|NCT00124020|456151241|FG001|Overall Study|Lost to Follow-up|8|||
126780353|NCT00124020|456151240|FG000|Overall Study|Other|1|||
126780354|NCT00124020|456151241|FG001|Overall Study|Other|1|||
126780355|NCT00124020|456151240|FG000|Overall Study|Transfer to another hospital|2|||
126780356|NCT00124020|456151241|FG001|Overall Study|Transfer to another hospital|0|||
126780357|NCT02043366|456151242|FG000|Overall Study|Lost to Follow-up|2|||
126780358|NCT02043366|456151243|FG001|Overall Study|Lost to Follow-up|2|||
126780359|NCT02043366|456151244|FG002|Overall Study|Lost to Follow-up|2|||
126780360|NCT02043366|456151245|FG003|Overall Study|Lost to Follow-up|2|||
126780361|NCT02043366|456151246|FG004|Overall Study|Lost to Follow-up|2|||
126780362|NCT02043366|456151247|FG005|Overall Study|Lost to Follow-up|2|||
126780363|NCT01489956|456151250|FG000|Overall Study|Lost to Follow-up|1|||
126780364|NCT01489956|456151251|FG001|Overall Study|Lost to Follow-up|0|||
126780365|NCT01489956|456151252|FG002|Overall Study|Lost to Follow-up|0|||
126780366|NCT01489956|456151250|FG000|Overall Study|Withdrawal by Subject|0|||
126780367|NCT01489956|456151251|FG001|Overall Study|Withdrawal by Subject|0|||
126780368|NCT01489956|456151252|FG002|Overall Study|Withdrawal by Subject|1|||
126780369|NCT00891774|456151253|FG000|Overall Study|Lost to Follow-up|5|||
126780370|NCT00891774|456151253|FG000|Overall Study|Illness (Self/Mother)|3|||
126780371|NCT00891774|456151253|FG000|Overall Study|Withdrawal by Subject|2|||
126780372|NCT00891774|456151253|FG000|Overall Study|Protocol Violation|4|||
126780373|NCT01977092|456151255|FG000|Overall Study|Death|3|||
126780374|NCT01977092|456151256|FG001|Overall Study|Death|4|||
126780375|NCT01977092|456151255|FG000|Overall Study|Lost to Follow-up|23|||
126780376|NCT01977092|456151256|FG001|Overall Study|Lost to Follow-up|14|||
126780377|NCT01977092|456151255|FG000|Overall Study|Withdrawal by Subject|2|||
126780378|NCT01977092|456151256|FG001|Overall Study|Withdrawal by Subject|1|||
126780379|NCT01977092|456151255|FG000|Overall Study|In prison|3|||
126780380|NCT01977092|456151256|FG001|Overall Study|In prison|11|||
126780381|NCT02927847|456151257|FG000|Overall Study|Lost to Follow-up|1|||
126780382|NCT02927847|456151258|FG001|Overall Study|Lost to Follow-up|0|||
126780383|NCT02927847|456151257|FG000|Overall Study|Withdrawal by Subject|4|||
126780384|NCT02927847|456151258|FG001|Overall Study|Withdrawal by Subject|2|||
126780385|NCT02927847|456151257|FG000|Overall Study|PI withdrawn due to missed visits|1|||
126780386|NCT02927847|456151258|FG001|Overall Study|PI withdrawn due to missed visits|1|||
126780387|NCT00723554|456151259|FG000|Overall Study|Adverse Event|12|||
126780388|NCT00723554|456151259|FG000|Overall Study|Investigator's judgement|5|||
126780389|NCT00723554|456151259|FG000|Overall Study|Inhaled medication other than iloprost|4|||
126780390|NCT00723554|456151259|FG000|Overall Study|Withdrawal of consent|3|||
126780391|NCT00723554|456151259|FG000|Overall Study|Other|3|||
126780392|NCT00723554|456151259|FG000|Overall Study|Lost to Follow-up|1|||
126780393|NCT00723554|456151259|FG000|Overall Study|Non-compliance|1|||
126780394|NCT01405820|456151260|FG000|Randomized Treatment Period|Adverse Event|3|||
126780395|NCT01405820|456151261|FG001|Randomized Treatment Period|Adverse Event|3|||
126780396|NCT01405820|456151262|FG002|Randomized Treatment Period|Adverse Event|3|||
126780397|NCT01405820|456151263|FG003|Randomized Treatment Period|Adverse Event|0|||
126780398|NCT01405820|456151264|FG004|Randomized Treatment Period|Adverse Event|2|||
126780399|NCT01405820|456151265|FG005|Randomized Treatment Period|Adverse Event|1|||
126600154|NCT03582033|455497080|FG002|Part C|Withdrawal by Subject|0|||
126600155|NCT03582033|455497081|FG003|Part C|Withdrawal by Subject|0|||
126600156|NCT03582033|455497082|FG004|Part C|Withdrawal by Subject|0|||
126600157|NCT03582033|455497083|FG005|Part C|Withdrawal by Subject|0|||
126600158|NCT03582033|455497084|FG006|Part C|Withdrawal by Subject|1|||
126780400|NCT01405820|456151260|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
126780401|NCT01405820|456151261|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
126780402|NCT01405820|456151262|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
126780403|NCT01405820|456151263|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
126780404|NCT01405820|456151264|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
126780405|NCT01405820|456151265|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
126600159|NCT03582033|455497085|FG007|Part C|Withdrawal by Subject|2|||
126780406|NCT01405820|456151260|FG000|Randomized Treatment Period|Other|2|||
126600160|NCT03582033|455497086|FG008|Part C|Withdrawal by Subject|1|||
126600161|NCT03582033|455497087|FG009|Part C|Withdrawal by Subject|0|||
126600162|NCT03582033|455497078|FG000|Part D|Death|0|||
126780407|NCT01405820|456151261|FG001|Randomized Treatment Period|Other|2|||
126780408|NCT01405820|456151262|FG002|Randomized Treatment Period|Other|1|||
126780409|NCT01405820|456151263|FG003|Randomized Treatment Period|Other|1|||
126780410|NCT01405820|456151264|FG004|Randomized Treatment Period|Other|0|||
126780411|NCT01405820|456151265|FG005|Randomized Treatment Period|Other|0|||
126780412|NCT01405820|456151260|FG000|Randomized Treatment Period|Physician Decision|0|||
126600163|NCT03582033|455497079|FG001|Part D|Death|0|||
126600164|NCT03582033|455497080|FG002|Part D|Death|0|||
126600165|NCT03582033|455497081|FG003|Part D|Death|0|||
126600166|NCT03582033|455497082|FG004|Part D|Death|0|||
126600167|NCT03582033|455497083|FG005|Part D|Death|0|||
126600168|NCT03582033|455497084|FG006|Part D|Death|0|||
126600169|NCT03582033|455497085|FG007|Part D|Death|0|||
126600170|NCT03582033|455497086|FG008|Part D|Death|0|||
126600171|NCT03582033|455497087|FG009|Part D|Death|1|||
126600172|NCT03582033|455497078|FG000|Part D|Study terminated by sponsor|0|||
126600173|NCT03582033|455497079|FG001|Part D|Study terminated by sponsor|0|||
126600174|NCT03582033|455497080|FG002|Part D|Study terminated by sponsor|0|||
126600175|NCT03582033|455497081|FG003|Part D|Study terminated by sponsor|0|||
126600176|NCT03582033|455497082|FG004|Part D|Study terminated by sponsor|0|||
126600177|NCT03582033|455497083|FG005|Part D|Study terminated by sponsor|0|||
126600178|NCT03582033|455497084|FG006|Part D|Study terminated by sponsor|0|||
126600179|NCT03582033|455497085|FG007|Part D|Study terminated by sponsor|0|||
126600180|NCT03582033|455497086|FG008|Part D|Study terminated by sponsor|0|||
126600181|NCT03582033|455497087|FG009|Part D|Study terminated by sponsor|4|||
126600182|NCT03812614|455497090|FG000|Intervention|Withdrawal by Subject|7|||
126600183|NCT03812614|455497091|FG001|Intervention|Withdrawal by Subject|2|||
126600184|NCT03812614|455497092|FG002|Intervention|Withdrawal by Subject|7|||
126600185|NCT03812614|455497093|FG003|Intervention|Withdrawal by Subject|2|||
126600186|NCT03812614|455497090|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
126600187|NCT03812614|455497091|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
126600188|NCT03812614|455497092|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
126600189|NCT03812614|455497093|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
126600190|NCT03812614|455497090|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
126600191|NCT03812614|455497091|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
126600192|NCT03812614|455497092|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
126600193|NCT03812614|455497093|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
126600194|NCT03812614|455497090|FG000|6-month Follow-up|Lost to Follow-up|0|||
126600195|NCT03812614|455497091|FG001|6-month Follow-up|Lost to Follow-up|0|||
126600196|NCT03812614|455497092|FG002|6-month Follow-up|Lost to Follow-up|12|||
126600197|NCT03812614|455497093|FG003|6-month Follow-up|Lost to Follow-up|8|||
126600198|NCT03812614|455497090|FG000|12-month Follow-up|Lost to Follow-up|18|||
126600199|NCT03812614|455497091|FG001|12-month Follow-up|Lost to Follow-up|17|||
126600200|NCT03812614|455497092|FG002|12-month Follow-up|Lost to Follow-up|5|||
126600201|NCT03812614|455497093|FG003|12-month Follow-up|Lost to Follow-up|2|||
126600202|NCT05205161|455497094|FG000|Overall Study|Study terminated by sponsor|3|||
126600203|NCT05205161|455497095|FG001|Overall Study|Study terminated by sponsor|3|||
126600204|NCT05205161|455497096|FG002|Overall Study|Study terminated by sponsor|1|||
126600205|NCT04675034|455497103|FG000|Overall Study|Lost to Follow-up|1|||
126600206|NCT04675034|455497104|FG001|Overall Study|Lost to Follow-up|1|||
126600207|NCT04675034|455497105|FG002|Overall Study|Lost to Follow-up|0|||
126600208|NCT04675034|455497106|FG003|Overall Study|Lost to Follow-up|2|||
126600209|NCT04675034|455497107|FG004|Overall Study|Lost to Follow-up|0|||
126600210|NCT04675034|455497103|FG000|Overall Study|Protocol Violation|1|||
126600211|NCT04675034|455497104|FG001|Overall Study|Protocol Violation|0|||
126600212|NCT04675034|455497105|FG002|Overall Study|Protocol Violation|0|||
126600213|NCT04675034|455497106|FG003|Overall Study|Protocol Violation|1|||
126600214|NCT04675034|455497107|FG004|Overall Study|Protocol Violation|3|||
126600215|NCT04675034|455497103|FG000|Overall Study|Withdrawal by Subject|9|||
126600216|NCT04675034|455497104|FG001|Overall Study|Withdrawal by Subject|3|||
126600217|NCT04675034|455497105|FG002|Overall Study|Withdrawal by Subject|4|||
126600218|NCT04675034|455497106|FG003|Overall Study|Withdrawal by Subject|8|||
126600219|NCT04675034|455497107|FG004|Overall Study|Withdrawal by Subject|6|||
126600220|NCT04163991|455497108|FG000|Overall Study|Adverse Event|0|||
126600221|NCT04163991|455497109|FG001|Overall Study|Adverse Event|0|||
126733325|NCT01357889|455972344|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
126733326|NCT01357889|455972345|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
126600222|NCT04163991|455497110|FG002|Overall Study|Adverse Event|0|||
126600223|NCT04163991|455497111|FG003|Overall Study|Adverse Event|1|||
126600224|NCT04163991|455497112|FG004|Overall Study|Adverse Event|0|||
126600225|NCT04163991|455497108|FG000|Overall Study|Death|0|||
126600226|NCT04163991|455497109|FG001|Overall Study|Death|0|||
126600227|NCT04163991|455497110|FG002|Overall Study|Death|1|||
126600228|NCT04163991|455497111|FG003|Overall Study|Death|0|||
126600229|NCT04163991|455497112|FG004|Overall Study|Death|0|||
126600230|NCT04163991|455497108|FG000|Overall Study|Lost to Follow-up|0|||
126600231|NCT04163991|455497109|FG001|Overall Study|Lost to Follow-up|1|||
126600232|NCT04163991|455497110|FG002|Overall Study|Lost to Follow-up|0|||
126600233|NCT04163991|455497111|FG003|Overall Study|Lost to Follow-up|0|||
126600234|NCT04163991|455497112|FG004|Overall Study|Lost to Follow-up|0|||
126780413|NCT01405820|456151261|FG001|Randomized Treatment Period|Physician Decision|2|||
126600235|NCT04163991|455497108|FG000|Overall Study|Withdrawal by Subject|1|||
126600236|NCT04163991|455497109|FG001|Overall Study|Withdrawal by Subject|1|||
126600237|NCT04163991|455497110|FG002|Overall Study|Withdrawal by Subject|3|||
126600238|NCT04163991|455497111|FG003|Overall Study|Withdrawal by Subject|1|||
126600239|NCT04163991|455497112|FG004|Overall Study|Withdrawal by Subject|1|||
126600240|NCT04163991|455497108|FG000|Overall Study|Other, Not Specified|0|||
126600241|NCT04163991|455497109|FG001|Overall Study|Other, Not Specified|1|||
126600242|NCT04163991|455497110|FG002|Overall Study|Other, Not Specified|1|||
126600243|NCT04163991|455497111|FG003|Overall Study|Other, Not Specified|1|||
126600244|NCT04163991|455497112|FG004|Overall Study|Other, Not Specified|0|||
126600245|NCT04214418|455497113|FG000|Overall Study|Withdrawal by Subject|1|||
126600246|NCT04214418|455497114|FG001|Overall Study|Withdrawal by Subject|0|||
126600247|NCT04214418|455497115|FG002|Overall Study|Withdrawal by Subject|0|||
126600248|NCT04214418|455497116|FG003|Overall Study|Withdrawal by Subject|0|||
126600249|NCT04214418|455497117|FG004|Overall Study|Withdrawal by Subject|0|||
126600250|NCT04214418|455497118|FG005|Overall Study|Withdrawal by Subject|0|||
126600251|NCT04214418|455497113|FG000|Overall Study|Adverse Event|0|||
126600252|NCT04214418|455497114|FG001|Overall Study|Adverse Event|2|||
126600253|NCT04214418|455497115|FG002|Overall Study|Adverse Event|0|||
126600254|NCT04214418|455497116|FG003|Overall Study|Adverse Event|0|||
126600255|NCT04214418|455497117|FG004|Overall Study|Adverse Event|0|||
126600256|NCT04214418|455497118|FG005|Overall Study|Adverse Event|0|||
126600257|NCT04214418|455497113|FG000|Overall Study|Death|1|||
126600258|NCT04214418|455497114|FG001|Overall Study|Death|0|||
126600259|NCT04214418|455497115|FG002|Overall Study|Death|0|||
126600260|NCT04214418|455497116|FG003|Overall Study|Death|0|||
126600261|NCT04214418|455497117|FG004|Overall Study|Death|0|||
126600262|NCT04214418|455497118|FG005|Overall Study|Death|0|||
126600263|NCT05008055|455497122|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
126600264|NCT05008055|455497123|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
126600265|NCT05008055|455497124|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
126600266|NCT04635059|455497125|FG000|Overall Study|Study terminated early.|4|||
126600267|NCT03248479|455497129|FG000|Overall Study|Death|12|||
126600268|NCT03248479|455497130|FG001|Overall Study|Death|44|||
126600269|NCT03248479|455497131|FG002|Overall Study|Death|1|||
126600270|NCT03248479|455497132|FG003|Overall Study|Death|72|||
126600271|NCT03248479|455497133|FG004|Overall Study|Death|17|||
126600272|NCT03248479|455497134|FG005|Overall Study|Death|6|||
126600273|NCT03248479|455497135|FG006|Overall Study|Death|1|||
126600274|NCT03248479|455497136|FG007|Overall Study|Death|14|||
126600275|NCT03248479|455497137|FG008|Overall Study|Death|3|||
126600276|NCT03248479|455497138|FG009|Overall Study|Death|7|||
126600277|NCT03248479|455497139|FG010|Overall Study|Death|3|||
126600278|NCT03248479|455497140|FG011|Overall Study|Death|1|||
126600279|NCT03248479|455497141|FG012|Overall Study|Death|1|||
126600280|NCT03248479|455497129|FG000|Overall Study|Study terminated by sponsor|12|||
126600281|NCT03248479|455497130|FG001|Overall Study|Study terminated by sponsor|15|||
126600282|NCT03248479|455497131|FG002|Overall Study|Study terminated by sponsor|0|||
126600283|NCT03248479|455497132|FG003|Overall Study|Study terminated by sponsor|5|||
126600284|NCT03248479|455497133|FG004|Overall Study|Study terminated by sponsor|0|||
126600285|NCT03248479|455497134|FG005|Overall Study|Study terminated by sponsor|0|||
126600286|NCT03248479|455497135|FG006|Overall Study|Study terminated by sponsor|0|||
126600287|NCT03248479|455497136|FG007|Overall Study|Study terminated by sponsor|1|||
126600288|NCT03248479|455497137|FG008|Overall Study|Study terminated by sponsor|1|||
126600289|NCT03248479|455497138|FG009|Overall Study|Study terminated by sponsor|0|||
126600290|NCT03248479|455497139|FG010|Overall Study|Study terminated by sponsor|5|||
126600291|NCT03248479|455497140|FG011|Overall Study|Study terminated by sponsor|4|||
126600292|NCT03248479|455497141|FG012|Overall Study|Study terminated by sponsor|0|||
126600293|NCT03248479|455497129|FG000|Overall Study|Consent withdrawn|6|||
126600294|NCT03248479|455497130|FG001|Overall Study|Consent withdrawn|3|||
126600295|NCT03248479|455497131|FG002|Overall Study|Consent withdrawn|0|||
126600296|NCT03248479|455497132|FG003|Overall Study|Consent withdrawn|9|||
126600297|NCT03248479|455497133|FG004|Overall Study|Consent withdrawn|1|||
126600298|NCT03248479|455497134|FG005|Overall Study|Consent withdrawn|0|||
126600299|NCT03248479|455497135|FG006|Overall Study|Consent withdrawn|0|||
126600300|NCT03248479|455497136|FG007|Overall Study|Consent withdrawn|1|||
126600301|NCT03248479|455497137|FG008|Overall Study|Consent withdrawn|0|||
126600302|NCT03248479|455497138|FG009|Overall Study|Consent withdrawn|3|||
126600303|NCT03248479|455497139|FG010|Overall Study|Consent withdrawn|1|||
126600304|NCT03248479|455497140|FG011|Overall Study|Consent withdrawn|0|||
126600305|NCT03248479|455497141|FG012|Overall Study|Consent withdrawn|1|||
126600306|NCT03248479|455497129|FG000|Overall Study|Lost to Follow-up|2|||
126600307|NCT03248479|455497130|FG001|Overall Study|Lost to Follow-up|1|||
126600308|NCT03248479|455497131|FG002|Overall Study|Lost to Follow-up|0|||
126600309|NCT03248479|455497132|FG003|Overall Study|Lost to Follow-up|0|||
126600310|NCT03248479|455497133|FG004|Overall Study|Lost to Follow-up|0|||
126600311|NCT03248479|455497134|FG005|Overall Study|Lost to Follow-up|0|||
126600312|NCT03248479|455497135|FG006|Overall Study|Lost to Follow-up|0|||
126780414|NCT01405820|456151262|FG002|Randomized Treatment Period|Physician Decision|1|||
126780415|NCT01405820|456151263|FG003|Randomized Treatment Period|Physician Decision|0|||
126780416|NCT01405820|456151264|FG004|Randomized Treatment Period|Physician Decision|0|||
126780417|NCT01405820|456151265|FG005|Randomized Treatment Period|Physician Decision|0|||
126780418|NCT01405820|456151260|FG000|Randomized Treatment Period|Rescue|0|||
126780419|NCT01405820|456151261|FG001|Randomized Treatment Period|Rescue|1|||
126780420|NCT01405820|456151262|FG002|Randomized Treatment Period|Rescue|13|||
126733327|NCT01357889|455972344|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
126733328|NCT01357889|455972345|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
126733329|NCT01357889|455972344|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
126733330|NCT01357889|455972345|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
126733331|NCT01357889|455972344|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
126733332|NCT01357889|455972345|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
126733333|NCT01357889|455972344|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
126733334|NCT01357889|455972345|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
126733335|NCT01357889|455972344|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
126733336|NCT01357889|455972345|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
126733337|NCT01357889|455972344|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
126733338|NCT01357889|455972345|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
126733339|NCT01357889|455972344|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
126733340|NCT01357889|455972345|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
126733341|NCT01357889|455972344|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
126733342|NCT01357889|455972345|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
126733343|NCT01357889|455972344|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
126733344|NCT01357889|455972345|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
126733345|NCT01357889|455972344|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
126733346|NCT01357889|455972345|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
126733347|NCT01357889|455972344|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
126733348|NCT01357889|455972345|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
126733349|NCT01357889|455972344|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
126733350|NCT01357889|455972345|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
126733351|NCT03970824|455972346|FG000|Overall Study|Withdrawal by Subject|1|||
126733352|NCT03970824|455972347|FG001|Overall Study|Withdrawal by Subject|1|||
126733353|NCT03970824|455972348|FG002|Overall Study|Withdrawal by Subject|3|||
126733354|NCT03970824|455972346|FG000|Overall Study|Lost to Follow-up|0|||
126733355|NCT03970824|455972347|FG001|Overall Study|Lost to Follow-up|2|||
126733356|NCT03970824|455972348|FG002|Overall Study|Lost to Follow-up|1|||
126733357|NCT03970824|455972346|FG000|Overall Study|Adverse Event|1|||
126733358|NCT03970824|455972347|FG001|Overall Study|Adverse Event|0|||
126733359|NCT03970824|455972348|FG002|Overall Study|Adverse Event|0|||
126733360|NCT00416312|455972349|FG000|Overall Study|tumors not visible on imaging|2|||
126733361|NCT00105560|455972350|FG000|Overall Study|Lost to Follow-up|1|||
126733362|NCT00305604|455972351|FG000|Overall Study|Adverse Event|6|||
126733363|NCT00305604|455972352|FG001|Overall Study|Adverse Event|3|||
126733364|NCT00305604|455972351|FG000|Overall Study|Lack of Efficacy|11|||
126733365|NCT00305604|455972352|FG001|Overall Study|Lack of Efficacy|18|||
126733366|NCT00305604|455972351|FG000|Overall Study|Lost to Follow-up|0|||
126733367|NCT00305604|455972352|FG001|Overall Study|Lost to Follow-up|4|||
126733368|NCT00305604|455972351|FG000|Overall Study|Protocol Violation|2|||
126733369|NCT00305604|455972352|FG001|Overall Study|Protocol Violation|1|||
126733370|NCT00305604|455972351|FG000|Overall Study|Withdrawal by Subject|12|||
126733371|NCT00305604|455972352|FG001|Overall Study|Withdrawal by Subject|21|||
126733372|NCT00305604|455972351|FG000|Overall Study|Patient moved|1|||
126733373|NCT00305604|455972352|FG001|Overall Study|Patient moved|0|||
126733374|NCT01248364|455972353|FG000|Overall Study|Adverse Event|0|||
126733375|NCT01248364|455972354|FG001|Overall Study|Adverse Event|1|||
126733376|NCT01248364|455972355|FG002|Overall Study|Adverse Event|0|||
126733377|NCT01248364|455972356|FG003|Overall Study|Adverse Event|0|||
126733378|NCT02431468|455972361|FG000|Overall Study|Adverse Event|2|||
126733379|NCT02431468|455972362|FG001|Overall Study|Adverse Event|4|||
126733380|NCT02431468|455972363|FG002|Overall Study|Adverse Event|5|||
126733381|NCT02431468|455972361|FG000|Overall Study|Withdrawal by Subject|4|||
126733382|NCT02431468|455972362|FG001|Overall Study|Withdrawal by Subject|12|||
126733383|NCT02431468|455972363|FG002|Overall Study|Withdrawal by Subject|2|||
126733384|NCT02431468|455972361|FG000|Overall Study|noncompliance, investigator termination,|2|||
126733385|NCT02431468|455972362|FG001|Overall Study|noncompliance, investigator termination,|2|||
126733386|NCT02431468|455972363|FG002|Overall Study|noncompliance, investigator termination,|2|||
126733387|NCT01361919|455972364|FG000|Overall Study|technical issues|10|||
126733388|NCT01361919|455972365|FG001|Overall Study|technical issues|12|||
126733389|NCT01361919|455972366|FG002|Overall Study|technical issues|10|||
126733390|NCT01767519|455972370|FG000|Overall Study|Other Reasons|4|||
126733391|NCT01767519|455972371|FG001|Overall Study|Other Reasons|4|||
126780421|NCT01405820|456151263|FG003|Randomized Treatment Period|Rescue|10|||
126600313|NCT03248479|455497136|FG007|Overall Study|Lost to Follow-up|0|||
126600314|NCT03248479|455497137|FG008|Overall Study|Lost to Follow-up|0|||
126600315|NCT03248479|455497138|FG009|Overall Study|Lost to Follow-up|0|||
126600316|NCT03248479|455497139|FG010|Overall Study|Lost to Follow-up|0|||
126600317|NCT03248479|455497140|FG011|Overall Study|Lost to Follow-up|0|||
126600318|NCT03248479|455497141|FG012|Overall Study|Lost to Follow-up|1|||
126600319|NCT03248479|455497129|FG000|Overall Study|Not reported|0|||
126600320|NCT03248479|455497130|FG001|Overall Study|Not reported|0|||
126600321|NCT03248479|455497131|FG002|Overall Study|Not reported|0|||
126733392|NCT01767519|455972372|FG002|Overall Study|Other Reasons|2|||
126733393|NCT01767519|455972370|FG000|Overall Study|Protocol Violation|0|||
126733394|NCT01767519|455972371|FG001|Overall Study|Protocol Violation|3|||
126733395|NCT01767519|455972372|FG002|Overall Study|Protocol Violation|0|||
126733396|NCT01767519|455972370|FG000|Overall Study|Personal Reasons|1|||
126733397|NCT01767519|455972371|FG001|Overall Study|Personal Reasons|0|||
126733398|NCT01767519|455972372|FG002|Overall Study|Personal Reasons|0|||
126733399|NCT01767519|455972370|FG000|Overall Study|Lost to Follow-up|3|||
126733400|NCT01767519|455972371|FG001|Overall Study|Lost to Follow-up|1|||
126733401|NCT01767519|455972372|FG002|Overall Study|Lost to Follow-up|2|||
126733402|NCT01767519|455972370|FG000|Overall Study|Lack of Efficacy|1|||
126733403|NCT01767519|455972371|FG001|Overall Study|Lack of Efficacy|0|||
126733404|NCT01767519|455972372|FG002|Overall Study|Lack of Efficacy|0|||
126733405|NCT01767519|455972370|FG000|Overall Study|Adverse Event|5|||
126733406|NCT01767519|455972371|FG001|Overall Study|Adverse Event|5|||
126733407|NCT01767519|455972372|FG002|Overall Study|Adverse Event|1|||
126733408|NCT00039741|455972373|FG000|Overall Study|Death|0|||
126733409|NCT00039741|455972374|FG001|Overall Study|Death|1|||
126733410|NCT00039741|455972375|FG002|Overall Study|Death|0|||
126733411|NCT00039741|455972376|FG003|Overall Study|Death|0|||
126733412|NCT00039741|455972373|FG000|Overall Study|Lost to Follow-up|3|||
126733413|NCT00039741|455972374|FG001|Overall Study|Lost to Follow-up|1|||
126733414|NCT00039741|455972375|FG002|Overall Study|Lost to Follow-up|5|||
126733415|NCT00039741|455972376|FG003|Overall Study|Lost to Follow-up|2|||
126733416|NCT00039741|455972373|FG000|Overall Study|Confounding medical condition|1|||
126733417|NCT00039741|455972374|FG001|Overall Study|Confounding medical condition|0|||
126733418|NCT00039741|455972375|FG002|Overall Study|Confounding medical condition|0|||
126733419|NCT00039741|455972376|FG003|Overall Study|Confounding medical condition|0|||
126733420|NCT00039741|455972373|FG000|Overall Study|Not able to get to clinic|5|||
126733421|NCT00039741|455972374|FG001|Overall Study|Not able to get to clinic|2|||
126733422|NCT00039741|455972375|FG002|Overall Study|Not able to get to clinic|0|||
126733423|NCT00039741|455972376|FG003|Overall Study|Not able to get to clinic|3|||
126733424|NCT00039741|455972373|FG000|Overall Study|Moved|3|||
126733425|NCT00039741|455972374|FG001|Overall Study|Moved|2|||
126733426|NCT00039741|455972375|FG002|Overall Study|Moved|3|||
126733427|NCT00039741|455972376|FG003|Overall Study|Moved|6|||
126733428|NCT00039741|455972373|FG000|Overall Study|Non-compliance with protocol|1|||
126733429|NCT00039741|455972374|FG001|Overall Study|Non-compliance with protocol|0|||
126733430|NCT00039741|455972375|FG002|Overall Study|Non-compliance with protocol|1|||
126733431|NCT00039741|455972376|FG003|Overall Study|Non-compliance with protocol|0|||
126733432|NCT00039741|455972373|FG000|Overall Study|Withdrew consent|0|||
126733433|NCT00039741|455972374|FG001|Overall Study|Withdrew consent|5|||
126733434|NCT00039741|455972375|FG002|Overall Study|Withdrew consent|0|||
126733435|NCT00039741|455972376|FG003|Overall Study|Withdrew consent|1|||
126733436|NCT00039741|455972373|FG000|Overall Study|Missed final visit|2|||
126733437|NCT00039741|455972374|FG001|Overall Study|Missed final visit|1|||
126733438|NCT00039741|455972375|FG002|Overall Study|Missed final visit|2|||
126733439|NCT00039741|455972376|FG003|Overall Study|Missed final visit|2|||
126733440|NCT00946881|455972377|FG000|First Treatment|Withdrawal by Subject|1|||
126733441|NCT00946881|455972377|FG000|First Treatment|Patient relocated to another state|1|||
126733442|NCT00946881|455972377|FG000|Retreatment|Withdrawal by Subject|1|||
126733443|NCT00293423|455972378|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
126733444|NCT00293423|455972379|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
126733445|NCT00293423|455972378|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
126733446|NCT00293423|455972379|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
126733447|NCT00293423|455972378|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
126733448|NCT00293423|455972379|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
126733449|NCT00293423|455972378|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
126733450|NCT00293423|455972379|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
126733451|NCT00293423|455972378|FG000|Surgical Resection|processing error during surgical resection|1|||
126733452|NCT00293423|455972379|FG001|Surgical Resection|processing error during surgical resection|0|||
126733453|NCT00293423|455972378|FG000|Surgical Resection|Withdrawal by Subject|4|||
126733454|NCT00293423|455972379|FG001|Surgical Resection|Withdrawal by Subject|0|||
126733455|NCT00293423|455972378|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
126733456|NCT00293423|455972379|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
126733457|NCT00805545|455972380|FG000|Overall Study|Protocol Violation|3|||
126600322|NCT03248479|455497132|FG003|Overall Study|Not reported|1|||
126600323|NCT03248479|455497133|FG004|Overall Study|Not reported|1|||
126600324|NCT03248479|455497134|FG005|Overall Study|Not reported|0|||
126600325|NCT03248479|455497135|FG006|Overall Study|Not reported|0|||
126600326|NCT03248479|455497136|FG007|Overall Study|Not reported|1|||
126600327|NCT03248479|455497137|FG008|Overall Study|Not reported|1|||
126600328|NCT03248479|455497138|FG009|Overall Study|Not reported|0|||
126600329|NCT03248479|455497139|FG010|Overall Study|Not reported|0|||
126600330|NCT03248479|455497140|FG011|Overall Study|Not reported|0|||
126600331|NCT03248479|455497141|FG012|Overall Study|Not reported|0|||
126600332|NCT00319111|455497142|FG000|Overall Study|Adverse Event|20|||
126600333|NCT00319111|455497142|FG000|Overall Study|Withdrawal of consent|11|||
126600334|NCT00319111|455497142|FG000|Overall Study|Death|9|||
126600335|NCT00319111|455497142|FG000|Overall Study|Lack of clinical improvement|4|||
126600336|NCT00319111|455497142|FG000|Overall Study|Administrative|2|||
126600337|NCT00319111|455497142|FG000|Overall Study|Treatment failure|1|||
126600338|NCT05525104|455497143|FG000|Overall Study|Failed caudal analgesia|1|||
126600339|NCT05525104|455497144|FG001|Overall Study|Failed caudal analgesia|3|||
126600340|NCT05525104|455497143|FG000|Overall Study|Premedication needed|0|||
126600341|NCT05525104|455497144|FG001|Overall Study|Premedication needed|1|||
126600342|NCT05525104|455497143|FG000|Overall Study|Protocol Violation|10|||
126600343|NCT05525104|455497144|FG001|Overall Study|Protocol Violation|0|||
126600344|NCT05525104|455497143|FG000|Overall Study|Cancelled operation|1|||
126600345|NCT05525104|455497144|FG001|Overall Study|Cancelled operation|0|||
126600346|NCT03990883|455497145|FG000|Blinded Treatment Phase|Adverse Event|1|||
126600347|NCT03990883|455497146|FG001|Blinded Treatment Phase|Adverse Event|1|||
126600348|NCT03990883|455497147|FG002|Blinded Treatment Phase|Adverse Event|0|||
126600349|NCT03990883|455497145|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
126600350|NCT03990883|455497146|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
126600351|NCT03990883|455497147|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
126600352|NCT03990883|455497145|FG000|Blinded Treatment Phase|Physician Decision|1|||
126600353|NCT03990883|455497146|FG001|Blinded Treatment Phase|Physician Decision|0|||
126600354|NCT03990883|455497147|FG002|Blinded Treatment Phase|Physician Decision|0|||
126600355|NCT03990883|455497145|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
126600356|NCT03990883|455497146|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
126600357|NCT03990883|455497147|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
126600358|NCT03990883|455497145|FG000|Blinded Treatment Phase|COVID-19|3|||
126600359|NCT03990883|455497146|FG001|Blinded Treatment Phase|COVID-19|2|||
126600360|NCT03990883|455497147|FG002|Blinded Treatment Phase|COVID-19|0|||
126600361|NCT03990883|455497145|FG000|Blinded Treatment Phase|Personal Reasons|6|||
126600362|NCT03990883|455497146|FG001|Blinded Treatment Phase|Personal Reasons|3|||
126600363|NCT03990883|455497147|FG002|Blinded Treatment Phase|Personal Reasons|0|||
126600364|NCT03990883|455497145|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
126600365|NCT03990883|455497146|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
126600366|NCT03990883|455497147|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
126600367|NCT03990883|455497145|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
126600368|NCT03990883|455497146|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
126600369|NCT03990883|455497147|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
126600370|NCT03990883|455497145|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
126600371|NCT03990883|455497146|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
126600372|NCT03990883|455497147|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
126600373|NCT04427007|455498607|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
126600374|NCT04427007|455498608|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
126600375|NCT04633278|455498609|FG000|Overall Study|Adverse Event|1|||
126600376|NCT04633278|455498610|FG001|Overall Study|Adverse Event|0|||
126600377|NCT04633278|455498609|FG000|Overall Study|Withdrawal by Subject|1|||
126600378|NCT04633278|455498610|FG001|Overall Study|Withdrawal by Subject|0|||
126600379|NCT04633278|455498609|FG000|Overall Study|Death|11|||
126600380|NCT04633278|455498610|FG001|Overall Study|Death|7|||
126600381|NCT04633278|455498609|FG000|Overall Study|Sponsor Decision|3|||
126600382|NCT04633278|455498610|FG001|Overall Study|Sponsor Decision|0|||
126600383|NCT04633278|455498609|FG000|Overall Study|Not Listed|1|||
126600384|NCT04633278|455498610|FG001|Overall Study|Not Listed|0|||
126600385|NCT03636490|455498611|FG000|Overall Study|Dropped out or incomplete data|141|||
126600386|NCT05247034|455498612|FG000|Overall Study|Lost to Follow-up|3|||
126600387|NCT05247034|455498613|FG001|Overall Study|Lost to Follow-up|2|||
126600388|NCT05247034|455498612|FG000|Overall Study|Organizational problems when attending appointments|1|||
126600389|NCT05247034|455498613|FG001|Overall Study|Organizational problems when attending appointments|0|||
126600390|NCT04464564|455498616|FG000|Period A (Placebo lead-in)|Other|5|||
126600391|NCT04464564|455498617|FG001|Period A (Placebo lead-in)|Other|0|||
126600392|NCT04464564|455498618|FG002|Period A (Placebo lead-in)|Other|0|||
126600393|NCT04464564|455498619|FG003|Period A (Placebo lead-in)|Other|0|||
126600394|NCT04464564|455498616|FG000|Period B (Randomization Period)|Adverse Event|0|||
126600395|NCT04464564|455498617|FG001|Period B (Randomization Period)|Adverse Event|1|||
126600396|NCT04464564|455498618|FG002|Period B (Randomization Period)|Adverse Event|2|||
126733458|NCT00805545|455972381|FG001|Overall Study|Protocol Violation|2|||
126600397|NCT04464564|455498619|FG003|Period B (Randomization Period)|Adverse Event|8|||
126600398|NCT04464564|455498616|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
126600399|NCT04464564|455498617|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
126600400|NCT04464564|455498618|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
126600401|NCT04464564|455498619|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
126600402|NCT04464564|455498616|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
126600403|NCT04464564|455498617|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
126600404|NCT04464564|455498618|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
126600405|NCT04464564|455498619|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
126600406|NCT04464564|455498616|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
126600407|NCT04464564|455498617|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
126600408|NCT04464564|455498618|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
126600409|NCT04464564|455498619|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
126600410|NCT04464564|455498616|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
126600411|NCT04464564|455498617|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
126600412|NCT04464564|455498618|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
126600413|NCT04464564|455498619|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
126600414|NCT04464564|455498616|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
126600415|NCT04464564|455498617|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
126600416|NCT04464564|455498618|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
126600417|NCT04464564|455498619|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
126600418|NCT04464564|455498616|FG000|Period B (Randomization Period)|Reason not Specified|0|||
126600419|NCT04464564|455498617|FG001|Period B (Randomization Period)|Reason not Specified|3|||
126600420|NCT04464564|455498618|FG002|Period B (Randomization Period)|Reason not Specified|3|||
126600421|NCT04464564|455498619|FG003|Period B (Randomization Period)|Reason not Specified|3|||
126600422|NCT03505710|455498620|FG000|Overall Study|Progressive Disease|24|||
126600423|NCT03505710|455498621|FG001|Overall Study|Progressive Disease|17|||
126600424|NCT03505710|455498622|FG002|Overall Study|Progressive Disease|43|||
126600425|NCT03505710|455498620|FG000|Overall Study|Clinical Progression|6|||
126600426|NCT03505710|455498621|FG001|Overall Study|Clinical Progression|8|||
126600427|NCT03505710|455498622|FG002|Overall Study|Clinical Progression|3|||
126600428|NCT03505710|455498620|FG000|Overall Study|Adverse Event|12|||
126600429|NCT03505710|455498621|FG001|Overall Study|Adverse Event|6|||
126600430|NCT03505710|455498622|FG002|Overall Study|Adverse Event|28|||
126600431|NCT03505710|455498620|FG000|Overall Study|Withdrawal by Subject|1|||
126600432|NCT03505710|455498621|FG001|Overall Study|Withdrawal by Subject|3|||
126600433|NCT03505710|455498622|FG002|Overall Study|Withdrawal by Subject|7|||
126600434|NCT03505710|455498620|FG000|Overall Study|Physician Decision|1|||
126600435|NCT03505710|455498621|FG001|Overall Study|Physician Decision|1|||
126600436|NCT03505710|455498622|FG002|Overall Study|Physician Decision|2|||
126600437|NCT03505710|455498620|FG000|Overall Study|Death|4|||
126600438|NCT03505710|455498621|FG001|Overall Study|Death|5|||
126600439|NCT03505710|455498622|FG002|Overall Study|Death|6|||
126600440|NCT03505710|455498620|FG000|Overall Study|Other Reasons|1|||
126600441|NCT03505710|455498621|FG001|Overall Study|Other Reasons|1|||
126600442|NCT03505710|455498622|FG002|Overall Study|Other Reasons|1|||
126600443|NCT03505710|455498620|FG000|Overall Study|Study Terminated by Sponsor|0|||
126600444|NCT03505710|455498621|FG001|Overall Study|Study Terminated by Sponsor|0|||
126600445|NCT03505710|455498622|FG002|Overall Study|Study Terminated by Sponsor|1|||
126600446|NCT04389957|455498626|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
126600447|NCT04389957|455498627|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
126600448|NCT04389957|455498628|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
126600449|NCT04389957|455498629|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
126600450|NCT04389957|455498630|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
126600451|NCT06655818|455498644|FG000|Overall Study|Withdrawal by Subject|1|||
126600452|NCT02095691|455498645|FG000|Overall Study|Physician Decision|1|||
126600453|NCT04623775|455498646|FG000|Randomization|No Longer Meets Study Criteria|2|||
126600454|NCT04623775|455498647|FG001|Randomization|No Longer Meets Study Criteria|1|||
126600455|NCT04623775|455498648|FG002|Randomization|No Longer Meets Study Criteria|0|||
126600456|NCT04623775|455498649|FG003|Randomization|No Longer Meets Study Criteria|0|||
126600457|NCT04623775|455498646|FG000|Randomization|Withdrew Consent|0|||
126600458|NCT04623775|455498647|FG001|Randomization|Withdrew Consent|0|||
126600459|NCT04623775|455498648|FG002|Randomization|Withdrew Consent|0|||
126600460|NCT04623775|455498649|FG003|Randomization|Withdrew Consent|1|||
126600461|NCT04623775|455498646|FG000|Randomization|Other Reasons|0|||
126600462|NCT04623775|455498647|FG001|Randomization|Other Reasons|0|||
126600463|NCT04623775|455498648|FG002|Randomization|Other Reasons|0|||
126600464|NCT04623775|455498649|FG003|Randomization|Other Reasons|1|||
126600465|NCT04623775|455498646|FG000|Treatment Period|participant withdrew consent|4|||
126600466|NCT04623775|455498647|FG001|Treatment Period|participant withdrew consent|0|||
126600467|NCT04623775|455498648|FG002|Treatment Period|participant withdrew consent|1|||
126780422|NCT01405820|456151264|FG004|Randomized Treatment Period|Rescue|8|||
126780423|NCT01405820|456151265|FG005|Randomized Treatment Period|Rescue|8|||
126780424|NCT01405820|456151260|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
126780425|NCT01405820|456151261|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
126780426|NCT01405820|456151262|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
126780427|NCT01405820|456151263|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
126780428|NCT01405820|456151264|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
126780429|NCT01405820|456151265|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
126780430|NCT01405820|456151260|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
126780431|NCT01405820|456151261|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
126780432|NCT01405820|456151262|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
126780433|NCT01405820|456151263|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
126780434|NCT01405820|456151264|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
126780435|NCT01405820|456151265|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
126780436|NCT01405820|456151260|FG000|Randomized Treatment Period|Death|0|||
126780437|NCT01405820|456151261|FG001|Randomized Treatment Period|Death|0|||
126780438|NCT01405820|456151262|FG002|Randomized Treatment Period|Death|0|||
126780439|NCT01405820|456151263|FG003|Randomized Treatment Period|Death|1|||
126780440|NCT01405820|456151264|FG004|Randomized Treatment Period|Death|0|||
126780441|NCT01405820|456151265|FG005|Randomized Treatment Period|Death|0|||
126780442|NCT01405820|456151260|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
126780443|NCT01405820|456151261|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
126780444|NCT01405820|456151262|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
126780445|NCT01405820|456151263|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
126780446|NCT01405820|456151264|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
126780447|NCT01405820|456151265|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
126780448|NCT01405820|456151260|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
126780449|NCT01405820|456151261|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
126780450|NCT01405820|456151262|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
126780451|NCT01405820|456151263|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
126780452|NCT01405820|456151264|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
126780453|NCT01405820|456151265|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
126780454|NCT01405820|456151260|FG000|Open-Label Treatment Period|Other|1|||
126780455|NCT01405820|456151261|FG001|Open-Label Treatment Period|Other|1|||
126780456|NCT01405820|456151262|FG002|Open-Label Treatment Period|Other|1|||
126780457|NCT01405820|456151263|FG003|Open-Label Treatment Period|Other|1|||
126780458|NCT01405820|456151264|FG004|Open-Label Treatment Period|Other|1|||
126780459|NCT01405820|456151265|FG005|Open-Label Treatment Period|Other|1|||
126780460|NCT01405820|456151260|FG000|Open-Label Treatment Period|Physician Decision|0|||
126780461|NCT01405820|456151261|FG001|Open-Label Treatment Period|Physician Decision|0|||
126780462|NCT01405820|456151262|FG002|Open-Label Treatment Period|Physician Decision|1|||
126780463|NCT01405820|456151263|FG003|Open-Label Treatment Period|Physician Decision|2|||
126780464|NCT01405820|456151264|FG004|Open-Label Treatment Period|Physician Decision|1|||
126780465|NCT01405820|456151265|FG005|Open-Label Treatment Period|Physician Decision|0|||
126780466|NCT01405820|456151260|FG000|Open-Label Treatment Period|Adverse Event|0|||
126780467|NCT01405820|456151261|FG001|Open-Label Treatment Period|Adverse Event|0|||
126780468|NCT01405820|456151262|FG002|Open-Label Treatment Period|Adverse Event|0|||
126780469|NCT01405820|456151263|FG003|Open-Label Treatment Period|Adverse Event|1|||
126780470|NCT01405820|456151264|FG004|Open-Label Treatment Period|Adverse Event|0|||
126780471|NCT01405820|456151265|FG005|Open-Label Treatment Period|Adverse Event|0|||
126780472|NCT03255031|456151272|FG000|Overall Study|Adverse Event|5|||
126780473|NCT03255031|456151273|FG001|Overall Study|Adverse Event|3|||
126780474|NCT03255031|456151272|FG000|Overall Study|Physician Decision|2|||
126780475|NCT03255031|456151273|FG001|Overall Study|Physician Decision|1|||
126780476|NCT03255031|456151272|FG000|Overall Study|Withdrawal by Subject|9|||
126780477|NCT03255031|456151273|FG001|Overall Study|Withdrawal by Subject|3|||
126780478|NCT01689974|456151275|FG000|Overall Study|Termination of Study|5|||
126780479|NCT01689974|456151276|FG001|Overall Study|Termination of Study|5|||
126780480|NCT00415532|456151280|FG000|Treatment Period|Adverse Event|2|||
126780481|NCT00415532|456151281|FG001|Treatment Period|Adverse Event|3|||
126780482|NCT00415532|456151280|FG000|Treatment Period|Death|2|||
126780483|NCT00415532|456151281|FG001|Treatment Period|Death|1|||
126780484|NCT00415532|456151280|FG000|Treatment Period|Lost to Follow-up|1|||
126780485|NCT00415532|456151281|FG001|Treatment Period|Lost to Follow-up|1|||
126780486|NCT00415532|456151280|FG000|Treatment Period|Protocol Violation|1|||
126780487|NCT00415532|456151281|FG001|Treatment Period|Protocol Violation|0|||
126780488|NCT00415532|456151280|FG000|Treatment Period|Withdrawal by Subject|6|||
126780489|NCT00415532|456151281|FG001|Treatment Period|Withdrawal by Subject|6|||
126780490|NCT00415532|456151280|FG000|Treatment Period|Other|2|||
126780491|NCT00415532|456151281|FG001|Treatment Period|Other|2|||
126780492|NCT00415532|456151280|FG000|Treatment Period|Ineligibility determined|1|||
126780493|NCT00415532|456151281|FG001|Treatment Period|Ineligibility determined|1|||
126780494|NCT00415532|456151280|FG000|Treatment Period|Noncompliance|1|||
126780495|NCT00415532|456151281|FG001|Treatment Period|Noncompliance|1|||
126600468|NCT04623775|455498649|FG003|Treatment Period|participant withdrew consent|2|||
126600469|NCT04623775|455498646|FG000|Treatment Period|Death|3|||
126600470|NCT04623775|455498647|FG001|Treatment Period|Death|1|||
126600471|NCT04623775|455498648|FG002|Treatment Period|Death|4|||
126600472|NCT04623775|455498649|FG003|Treatment Period|Death|2|||
126600473|NCT04623775|455498646|FG000|Treatment Period|Lost to Follow-up|0|||
126600474|NCT04623775|455498647|FG001|Treatment Period|Lost to Follow-up|2|||
126600475|NCT04623775|455498648|FG002|Treatment Period|Lost to Follow-up|0|||
126600476|NCT04623775|455498649|FG003|Treatment Period|Lost to Follow-up|0|||
126600477|NCT04623775|455498646|FG000|Treatment Period|poor/non compliance|0|||
126600478|NCT04623775|455498647|FG001|Treatment Period|poor/non compliance|0|||
126600479|NCT04623775|455498648|FG002|Treatment Period|poor/non compliance|1|||
126600480|NCT04623775|455498649|FG003|Treatment Period|poor/non compliance|0|||
126600481|NCT04623775|455498646|FG000|Treatment Period|participant no longer meets study criteria|0|||
126600482|NCT04623775|455498647|FG001|Treatment Period|participant no longer meets study criteria|1|||
126600483|NCT04623775|455498648|FG002|Treatment Period|participant no longer meets study criteria|0|||
126600484|NCT04623775|455498649|FG003|Treatment Period|participant no longer meets study criteria|0|||
126600485|NCT04623775|455498646|FG000|Treatment Period|administrative reasons by sponsor|3|||
126600486|NCT04623775|455498647|FG001|Treatment Period|administrative reasons by sponsor|2|||
126600487|NCT04623775|455498648|FG002|Treatment Period|administrative reasons by sponsor|0|||
126600488|NCT04623775|455498649|FG003|Treatment Period|administrative reasons by sponsor|0|||
126600489|NCT04623775|455498646|FG000|Treatment Period|other reasons|2|||
126600490|NCT04623775|455498647|FG001|Treatment Period|other reasons|0|||
126600491|NCT04623775|455498648|FG002|Treatment Period|other reasons|1|||
126600492|NCT04623775|455498649|FG003|Treatment Period|other reasons|1|||
126600493|NCT04623775|455498646|FG000|Treatment Period|disease progression|40|||
126600494|NCT04623775|455498647|FG001|Treatment Period|disease progression|35|||
126600495|NCT04623775|455498648|FG002|Treatment Period|disease progression|63|||
126600496|NCT04623775|455498649|FG003|Treatment Period|disease progression|63|||
126600497|NCT04623775|455498646|FG000|Treatment Period|study drug toxicity|12|||
126600498|NCT04623775|455498647|FG001|Treatment Period|study drug toxicity|15|||
126600499|NCT04623775|455498648|FG002|Treatment Period|study drug toxicity|13|||
126600500|NCT04623775|455498649|FG003|Treatment Period|study drug toxicity|12|||
126600501|NCT04623775|455498646|FG000|Treatment Period|AE unrelated to study drug|4|||
126600502|NCT04623775|455498647|FG001|Treatment Period|AE unrelated to study drug|9|||
126600503|NCT04623775|455498648|FG002|Treatment Period|AE unrelated to study drug|12|||
126600504|NCT04623775|455498649|FG003|Treatment Period|AE unrelated to study drug|9|||
126600505|NCT04623775|455498646|FG000|Treatment Period|participant request to discontinue treatment|0|||
126600506|NCT04623775|455498647|FG001|Treatment Period|participant request to discontinue treatment|2|||
126600507|NCT04623775|455498648|FG002|Treatment Period|participant request to discontinue treatment|2|||
126600508|NCT04623775|455498649|FG003|Treatment Period|participant request to discontinue treatment|0|||
126600509|NCT04633538|455498654|FG000|Overall Study|Death|1|||
126600510|NCT04633538|455498654|FG000|Overall Study|Lost to Follow-up|3|||
126600511|NCT04633538|455498654|FG000|Overall Study|Withdrawal by Subject|1|||
126600512|NCT02938520|455498657|FG000|Overall Study|On-going at the time of analysis|258|||
126600513|NCT02938520|455498658|FG001|Overall Study|On-going at the time of analysis|261|||
126600514|NCT02938520|455498657|FG000|Overall Study|Physician Decision|2|||
126600515|NCT02938520|455498658|FG001|Overall Study|Physician Decision|5|||
126600516|NCT02938520|455498657|FG000|Overall Study|Lost to Follow-up|2|||
126600517|NCT02938520|455498658|FG001|Overall Study|Lost to Follow-up|2|||
126600518|NCT02938520|455498657|FG000|Overall Study|Withdrawal by Subject|7|||
126600519|NCT02938520|455498658|FG001|Overall Study|Withdrawal by Subject|7|||
126600520|NCT02938520|455498657|FG000|Overall Study|Protocol Violation|0|||
126600521|NCT02938520|455498658|FG001|Overall Study|Protocol Violation|1|||
126600522|NCT02938520|455498657|FG000|Overall Study|Lack of Efficacy|5|||
126600523|NCT02938520|455498658|FG001|Overall Study|Lack of Efficacy|3|||
126600524|NCT02938520|455498657|FG000|Overall Study|Adverse Event|9|||
126600525|NCT02938520|455498658|FG001|Overall Study|Adverse Event|4|||
126600526|NCT03372057|455498663|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
126600527|NCT03372057|455498664|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
126600528|NCT03372057|455498665|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
126600529|NCT03372057|455498663|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
126600530|NCT03372057|455498664|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
126600531|NCT03372057|455498665|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
126600532|NCT03372057|455498663|FG000|Dose Optimization Phase|Death|16|||
126600533|NCT03372057|455498664|FG001|Dose Optimization Phase|Death|11|||
126600534|NCT03372057|455498665|FG002|Dose Optimization Phase|Death|0|||
126600535|NCT03372057|455498663|FG000|Expansion Phase|Withdrawal by Subject|0|||
126600536|NCT03372057|455498664|FG001|Expansion Phase|Withdrawal by Subject|0|||
126600537|NCT03372057|455498665|FG002|Expansion Phase|Withdrawal by Subject|4|||
126600538|NCT03372057|455498663|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
126600539|NCT03372057|455498664|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
126600540|NCT03372057|455498665|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
126600541|NCT03372057|455498663|FG000|Expansion Phase|Death|0|||
126600542|NCT03372057|455498664|FG001|Expansion Phase|Death|0|||
126600543|NCT03372057|455498665|FG002|Expansion Phase|Death|78|||
126600544|NCT03372057|455498663|FG000|Expansion Phase|Progressive Disease|0|||
126600545|NCT03372057|455498664|FG001|Expansion Phase|Progressive Disease|0|||
126600546|NCT03372057|455498665|FG002|Expansion Phase|Progressive Disease|1|||
126600547|NCT03372057|455498663|FG000|Expansion Phase|Adverse Event|0|||
126600548|NCT03372057|455498664|FG001|Expansion Phase|Adverse Event|0|||
126600549|NCT03372057|455498665|FG002|Expansion Phase|Adverse Event|1|||
126600550|NCT05953740|455498666|FG000|Period 1|Physician Decision|0|||
126600551|NCT05953740|455498667|FG001|Period 1|Physician Decision|1|||
126600552|NCT05953740|455498668|FG002|Period 1|Physician Decision|0|||
126600553|NCT05953740|455498669|FG003|Period 1|Physician Decision|0|||
126600554|NCT05953740|455498670|FG004|Period 1|Physician Decision|0|||
126600555|NCT05953740|455498671|FG005|Period 1|Physician Decision|0|||
126600556|NCT05953740|455498672|FG006|Period 1|Physician Decision|0|||
126600557|NCT05953740|455498673|FG007|Period 1|Physician Decision|0|||
126600558|NCT05953740|455498666|FG000|Period 2|Withdrawal by Subject|0|||
126600559|NCT05953740|455498667|FG001|Period 2|Withdrawal by Subject|1|||
126600560|NCT05953740|455498668|FG002|Period 2|Withdrawal by Subject|1|||
126600561|NCT05953740|455498669|FG003|Period 2|Withdrawal by Subject|0|||
126600562|NCT05953740|455498670|FG004|Period 2|Withdrawal by Subject|0|||
126600563|NCT05953740|455498671|FG005|Period 2|Withdrawal by Subject|0|||
126600564|NCT05953740|455498672|FG006|Period 2|Withdrawal by Subject|0|||
126600565|NCT05953740|455498673|FG007|Period 2|Withdrawal by Subject|0|||
126600566|NCT03880955|455498674|FG000|Overall Study|Adverse Event|1|||
126600567|NCT03880955|455498674|FG000|Overall Study|Death|1|||
126600568|NCT03880955|455498674|FG000|Overall Study|Lost to Follow-up|12|||
126600569|NCT03880955|455498674|FG000|Overall Study|Withdrawal by Subject|4|||
126600570|NCT03880955|455498674|FG000|Overall Study|Missing- Study Site Closed|27|||
126600571|NCT04679389|455498683|FG000|Overall Study|Adverse Event|1|||
126600572|NCT04679389|455498684|FG001|Overall Study|Adverse Event|0|||
126600573|NCT04679389|455498683|FG000|Overall Study|Protocol Violation|2|||
126600574|NCT04679389|455498684|FG001|Overall Study|Protocol Violation|0|||
126600575|NCT04679389|455498683|FG000|Overall Study|Physician Decision|3|||
126600576|NCT04679389|455498684|FG001|Overall Study|Physician Decision|5|||
126600577|NCT04679389|455498683|FG000|Overall Study|Withdrawal by Subject|5|||
126600578|NCT04679389|455498684|FG001|Overall Study|Withdrawal by Subject|7|||
126600579|NCT05123027|455498689|FG000|Overall Study|Lost to Follow-up|17|||
126600580|NCT05123027|455498690|FG001|Overall Study|Lost to Follow-up|22|||
126600581|NCT05123027|455498689|FG000|Overall Study|Incarceration|3|||
126600582|NCT05123027|455498690|FG001|Overall Study|Incarceration|4|||
126600583|NCT05123027|455498689|FG000|Overall Study|Death|2|||
126600584|NCT05123027|455498690|FG001|Overall Study|Death|2|||
126600585|NCT05123027|455498689|FG000|Overall Study|Other|2|||
126600586|NCT05123027|455498690|FG001|Overall Study|Other|0|||
126600587|NCT05112900|455498691|FG000|Overall Study|Withdrawal by Subject|960|||
126600588|NCT05112900|455498692|FG001|Overall Study|Withdrawal by Subject|921|||
126600589|NCT05112900|455498693|FG002|Overall Study|Withdrawal by Subject|968|||
126600590|NCT01438853|455498694|FG000|Overall Study|Death|0|||
126600591|NCT01438853|455498695|FG001|Overall Study|Death|0|||
126600592|NCT01438853|455498696|FG002|Overall Study|Death|0|||
126600593|NCT01438853|455498697|FG003|Overall Study|Death|1|||
126600594|NCT01438853|455498694|FG000|Overall Study|Withdrawal by Subject|0|||
126600595|NCT01438853|455498695|FG001|Overall Study|Withdrawal by Subject|0|||
126600596|NCT01438853|455498696|FG002|Overall Study|Withdrawal by Subject|1|||
126600597|NCT01438853|455498697|FG003|Overall Study|Withdrawal by Subject|0|||
126600598|NCT02624050|455498698|FG000|Overall Study|Physician Decision|4|||
126600599|NCT02624050|455498699|FG001|Overall Study|Physician Decision|0|||
126600600|NCT02624050|455498698|FG000|Overall Study|Protocol Violation|2|||
126600601|NCT02624050|455498699|FG001|Overall Study|Protocol Violation|0|||
126600602|NCT05215054|455498700|FG000|Overall Study|Lost to Follow-up|1|||
126600603|NCT05215054|455498701|FG001|Overall Study|Lost to Follow-up|1|||
126600604|NCT05215054|455498700|FG000|Overall Study|Protocol Violation|1|||
126600605|NCT05215054|455498701|FG001|Overall Study|Protocol Violation|1|||
126600606|NCT05215054|455498700|FG000|Overall Study|Withdrawal by Subject|4|||
126600607|NCT05215054|455498701|FG001|Overall Study|Withdrawal by Subject|4|||
126600608|NCT03279978|455498702|FG000|Overall Study|Withdrawal by Subject|0|||
126600609|NCT03279978|455498703|FG001|Overall Study|Withdrawal by Subject|1|||
126600610|NCT03279978|455498704|FG002|Overall Study|Withdrawal by Subject|0|||
126600611|NCT03279978|455498705|FG003|Overall Study|Withdrawal by Subject|0|||
126600612|NCT03279978|455498706|FG004|Overall Study|Withdrawal by Subject|0|||
126733459|NCT00805545|455972380|FG000|Overall Study|Protocol Violation|3|||
126600613|NCT03279978|455498707|FG005|Overall Study|Withdrawal by Subject|0|||
126600614|NCT03279978|455498708|FG006|Overall Study|Withdrawal by Subject|0|||
126600615|NCT03279978|455498709|FG007|Overall Study|Withdrawal by Subject|0|||
126600616|NCT03279978|455498710|FG008|Overall Study|Withdrawal by Subject|0|||
126600617|NCT03279978|455498711|FG009|Overall Study|Withdrawal by Subject|1|||
126600618|NCT03279978|455498702|FG000|Overall Study|Lost to Follow-up|1|||
126600619|NCT03279978|455498703|FG001|Overall Study|Lost to Follow-up|0|||
126600620|NCT03279978|455498704|FG002|Overall Study|Lost to Follow-up|1|||
126600621|NCT03279978|455498705|FG003|Overall Study|Lost to Follow-up|0|||
126600622|NCT03279978|455498706|FG004|Overall Study|Lost to Follow-up|0|||
126600623|NCT03279978|455498707|FG005|Overall Study|Lost to Follow-up|0|||
126600624|NCT03279978|455498708|FG006|Overall Study|Lost to Follow-up|0|||
126600625|NCT03279978|455498709|FG007|Overall Study|Lost to Follow-up|0|||
126600626|NCT03279978|455498710|FG008|Overall Study|Lost to Follow-up|0|||
126600627|NCT03279978|455498711|FG009|Overall Study|Lost to Follow-up|0|||
126600628|NCT03279978|455498702|FG000|Overall Study|Other than stated above|0|||
126600629|NCT03279978|455498703|FG001|Overall Study|Other than stated above|0|||
126600630|NCT03279978|455498704|FG002|Overall Study|Other than stated above|0|||
126600631|NCT03279978|455498705|FG003|Overall Study|Other than stated above|0|||
126600632|NCT03279978|455498706|FG004|Overall Study|Other than stated above|0|||
126600633|NCT03279978|455498707|FG005|Overall Study|Other than stated above|0|||
126600634|NCT03279978|455498708|FG006|Overall Study|Other than stated above|1|||
126600635|NCT03279978|455498709|FG007|Overall Study|Other than stated above|0|||
126600636|NCT03279978|455498710|FG008|Overall Study|Other than stated above|0|||
126600637|NCT03279978|455498711|FG009|Overall Study|Other than stated above|0|||
126600638|NCT04330040|455498712|FG000|Overall Study|Other: Adverse event|5|||
126600639|NCT04330040|455498713|FG001|Overall Study|Other: Adverse event|0|||
126600640|NCT04330040|455498714|FG002|Overall Study|Other: Adverse event|0|||
126600641|NCT04330040|455498712|FG000|Overall Study|Disease progression|38|||
126600642|NCT04330040|455498713|FG001|Overall Study|Disease progression|10|||
126600643|NCT04330040|455498714|FG002|Overall Study|Disease progression|0|||
126600644|NCT04330040|455498712|FG000|Overall Study|Physician Decision|5|||
126600645|NCT04330040|455498713|FG001|Overall Study|Physician Decision|3|||
126600646|NCT04330040|455498714|FG002|Overall Study|Physician Decision|0|||
126600647|NCT04330040|455498712|FG000|Overall Study|Lost to Follow-up|1|||
126600648|NCT04330040|455498713|FG001|Overall Study|Lost to Follow-up|1|||
126600649|NCT04330040|455498714|FG002|Overall Study|Lost to Follow-up|0|||
126600650|NCT04330040|455498712|FG000|Overall Study|Death|2|||
126600651|NCT04330040|455498713|FG001|Overall Study|Death|1|||
126600652|NCT04330040|455498714|FG002|Overall Study|Death|0|||
126600653|NCT04330040|455498712|FG000|Overall Study|Withdrawal by Subject|3|||
126600654|NCT04330040|455498713|FG001|Overall Study|Withdrawal by Subject|3|||
126600655|NCT04330040|455498714|FG002|Overall Study|Withdrawal by Subject|0|||
126600656|NCT04330040|455498712|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
126600657|NCT04330040|455498713|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
126600658|NCT04330040|455498714|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
126600659|NCT04330040|455498712|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
126600660|NCT04330040|455498713|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
126600661|NCT04330040|455498714|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
126600662|NCT04330040|455498712|FG000|Overall Study|Other: Disease progression|1|||
126600663|NCT04330040|455498713|FG001|Overall Study|Other: Disease progression|0|||
126600664|NCT04330040|455498714|FG002|Overall Study|Other: Disease progression|0|||
126600665|NCT04330040|455498712|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
126600666|NCT04330040|455498713|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
126600667|NCT04330040|455498714|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
126600668|NCT04330040|455498712|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
126600669|NCT04330040|455498713|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
126600670|NCT04330040|455498714|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
126600671|NCT04330040|455498712|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
126600672|NCT04330040|455498713|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
126600673|NCT04330040|455498714|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
126600674|NCT00626795|455498717|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
126600675|NCT00626795|455498718|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
126600676|NCT00626795|455498719|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
126600677|NCT00626795|455498717|FG000|Blinded Treatment|Lack of Efficacy|2|||
126600678|NCT00626795|455498718|FG001|Blinded Treatment|Lack of Efficacy|0|||
126600679|NCT00626795|455498719|FG002|Blinded Treatment|Lack of Efficacy|0|||
126600680|NCT00626795|455498717|FG000|Blinded Treatment|Unacceptable adverse event|0|||
126600681|NCT00626795|455498718|FG001|Blinded Treatment|Unacceptable adverse event|0|||
126600682|NCT00626795|455498719|FG002|Blinded Treatment|Unacceptable adverse event|1|||
126600683|NCT00626795|455498717|FG000|Blinded Treatment|Protocol Violation|0|||
126600684|NCT00626795|455498718|FG001|Blinded Treatment|Protocol Violation|1|||
126600685|NCT00626795|455498719|FG002|Blinded Treatment|Protocol Violation|1|||
126600686|NCT00626795|455498717|FG000|Blinded Treatment|Withdrawal by Subject|1|||
126600687|NCT00626795|455498718|FG001|Blinded Treatment|Withdrawal by Subject|1|||
126600688|NCT00626795|455498719|FG002|Blinded Treatment|Withdrawal by Subject|0|||
126600689|NCT00626795|455498717|FG000|Blinded Treatment|Other reasons|2|||
126600690|NCT00626795|455498718|FG001|Blinded Treatment|Other reasons|0|||
126780496|NCT00415532|456151280|FG000|Treatment Period|Requirement for alternative therapy|1|||
126780497|NCT00415532|456151281|FG001|Treatment Period|Requirement for alternative therapy|0|||
126780498|NCT00415532|456151280|FG000|Safety Follow Up Period|Adverse Event|1|||
126780499|NCT00415532|456151281|FG001|Safety Follow Up Period|Adverse Event|3|||
126780500|NCT00415532|456151280|FG000|Safety Follow Up Period|Death|3|||
126780501|NCT00415532|456151281|FG001|Safety Follow Up Period|Death|0|||
126780502|NCT00415532|456151280|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
126780503|NCT00415532|456151281|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
126780504|NCT00415532|456151280|FG000|Safety Follow Up Period|Other|1|||
126780505|NCT00415532|456151281|FG001|Safety Follow Up Period|Other|4|||
126780506|NCT00415532|456151280|FG000|Safety Follow Up Period|Ineligibility determined|1|||
126780507|NCT00415532|456151281|FG001|Safety Follow Up Period|Ineligibility determined|1|||
126780508|NCT00415532|456151280|FG000|Safety Follow Up Period|Noncompliance|1|||
126780509|NCT00415532|456151281|FG001|Safety Follow Up Period|Noncompliance|0|||
126780510|NCT00415532|456151280|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
126780511|NCT00415532|456151281|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
126780512|NCT01698320|456151282|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
126780513|NCT01698320|456151283|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
126780514|NCT01698320|456151284|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
126780515|NCT01698320|456151282|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
126780516|NCT01698320|456151283|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
126780517|NCT01698320|456151284|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
126780518|NCT01698320|456151282|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
126780519|NCT01698320|456151283|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
126780520|NCT01698320|456151284|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
126780521|NCT01698320|456151282|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
126780522|NCT01698320|456151283|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
126780523|NCT01698320|456151284|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
126780524|NCT01698320|456151282|FG000|12-Week Double-Blind Period|Adverse Event|0|||
126780525|NCT01698320|456151283|FG001|12-Week Double-Blind Period|Adverse Event|1|||
126780526|NCT01698320|456151284|FG002|12-Week Double-Blind Period|Adverse Event|1|||
126780527|NCT01698320|456151282|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
126780528|NCT01698320|456151283|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
126780529|NCT01698320|456151284|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
126780530|NCT01698320|456151282|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
126780531|NCT01698320|456151283|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
126780532|NCT01698320|456151284|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
126780533|NCT01698320|456151282|FG000|12-Week Double-Blind Period|Pregnancy|0|||
126780534|NCT01698320|456151283|FG001|12-Week Double-Blind Period|Pregnancy|1|||
126780535|NCT01698320|456151284|FG002|12-Week Double-Blind Period|Pregnancy|1|||
126780536|NCT01698320|456151282|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
126780537|NCT01698320|456151283|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
126780538|NCT01698320|456151284|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
126780539|NCT01698320|456151282|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
126780540|NCT01698320|456151283|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
126780541|NCT01698320|456151284|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
126780542|NCT01698320|456151282|FG000|40-Week Open-Label Period|Adverse Event|0|||
126780543|NCT01698320|456151283|FG001|40-Week Open-Label Period|Adverse Event|3|||
126780544|NCT01698320|456151284|FG002|40-Week Open-Label Period|Adverse Event|2|||
126780545|NCT01698320|456151282|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
126600691|NCT00626795|455498719|FG002|Blinded Treatment|Other reasons|2|||
126600692|NCT00626795|455498717|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
126600693|NCT00626795|455498718|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
126600694|NCT00626795|455498719|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
126600695|NCT04159519|455498720|FG000|Overall Study|Adverse Event|1|||
126600696|NCT04159519|455498721|FG001|Overall Study|Adverse Event|1|||
126600697|NCT04159519|455498720|FG000|Overall Study|Lack of Efficacy|1|||
126600698|NCT04159519|455498721|FG001|Overall Study|Lack of Efficacy|0|||
126600699|NCT04159519|455498720|FG000|Overall Study|Discontinued from study|1|||
126600700|NCT04159519|455498721|FG001|Overall Study|Discontinued from study|0|||
126600701|NCT04159519|455498720|FG000|Overall Study|Protocol Violation|1|||
126600702|NCT04159519|455498721|FG001|Overall Study|Protocol Violation|1|||
126600703|NCT04159519|455498720|FG000|Overall Study|Withdrawal by Subject|4|||
126600704|NCT04159519|455498721|FG001|Overall Study|Withdrawal by Subject|4|||
126600705|NCT02246127|455499438|FG000|First Course Treatment|Adverse Event|9|||
126600706|NCT02246127|455499439|FG001|First Course Treatment|Adverse Event|7|||
126780546|NCT01698320|456151283|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
126780547|NCT01698320|456151284|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
126600707|NCT02246127|455499438|FG000|First Course Treatment|Withdrawal by Subject|6|||
126600708|NCT02246127|455499439|FG001|First Course Treatment|Withdrawal by Subject|7|||
126600709|NCT02246127|455499438|FG000|First Course Treatment|Physician Decision|9|||
126600710|NCT02246127|455499439|FG001|First Course Treatment|Physician Decision|9|||
126600711|NCT02246127|455499438|FG000|First Course Treatment|Death|3|||
126600712|NCT02246127|455499439|FG001|First Course Treatment|Death|3|||
126600713|NCT02246127|455499438|FG000|First Course Treatment|Not reported reasons|6|||
126600714|NCT02246127|455499439|FG001|First Course Treatment|Not reported reasons|7|||
126600715|NCT02246127|455499438|FG000|First Course Treatment|Not treated|3|||
126600716|NCT02246127|455499439|FG001|First Course Treatment|Not treated|3|||
126600717|NCT05147584|455499442|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
126600718|NCT05460871|455499443|FG000|Overall Study|Withdrawal by Subject|1|||
126600719|NCT05460871|455499444|FG001|Overall Study|Withdrawal by Subject|2|||
126600720|NCT03498521|455499455|FG000|Overall Study|Death|191|||
126600721|NCT03498521|455499456|FG001|Overall Study|Death|64|||
126600722|NCT03498521|455499457|FG002|Overall Study|Death|72|||
126600723|NCT03498521|455499455|FG000|Overall Study|Exclusion criteria|1|||
126600724|NCT03498521|455499456|FG001|Overall Study|Exclusion criteria|0|||
126600725|NCT03498521|455499457|FG002|Overall Study|Exclusion criteria|0|||
126600726|NCT03498521|455499455|FG000|Overall Study|Lost to Follow-up|3|||
126600727|NCT03498521|455499456|FG001|Overall Study|Lost to Follow-up|3|||
126600728|NCT03498521|455499457|FG002|Overall Study|Lost to Follow-up|3|||
126600729|NCT03498521|455499455|FG000|Overall Study|No profile due to technical failure|1|||
126600730|NCT03498521|455499456|FG001|Overall Study|No profile due to technical failure|0|||
126600731|NCT03498521|455499457|FG002|Overall Study|No profile due to technical failure|0|||
126600732|NCT03498521|455499455|FG000|Overall Study|Physician Decision|0|||
126600733|NCT03498521|455499456|FG001|Overall Study|Physician Decision|1|||
126600734|NCT03498521|455499457|FG002|Overall Study|Physician Decision|0|||
126600735|NCT03498521|455499455|FG000|Overall Study|Withdrawal by Subject|9|||
126600736|NCT03498521|455499456|FG001|Overall Study|Withdrawal by Subject|6|||
126600737|NCT03498521|455499457|FG002|Overall Study|Withdrawal by Subject|2|||
126600738|NCT03498521|455499455|FG000|Overall Study|Study ongoing|121|||
126600739|NCT03498521|455499456|FG001|Overall Study|Study ongoing|36|||
126600740|NCT03498521|455499457|FG002|Overall Study|Study ongoing|15|||
126600741|NCT05830799|455499459|FG000|Overall Study|Withdrawal by Subject|1|||
126600742|NCT04214834|455499460|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
126600743|NCT04214834|455499461|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
126600744|NCT03370913|455499462|FG000|Overall Study|Death|1|||
126600745|NCT03370913|455499462|FG000|Overall Study|Lost to Follow-up|1|||
126600746|NCT04631016|455499465|FG000|Overall Study|Adverse Event|3|||
126600747|NCT04631016|455499466|FG001|Overall Study|Adverse Event|0|||
126600748|NCT04631016|455499465|FG000|Overall Study|Withdrawal by Subject|5|||
126600749|NCT04631016|455499466|FG001|Overall Study|Withdrawal by Subject|4|||
126600750|NCT04631016|455499465|FG000|Overall Study|Reason unspecified|1|||
126600751|NCT04631016|455499466|FG001|Overall Study|Reason unspecified|0|||
126600752|NCT04631016|455499465|FG000|Overall Study|Failure to meet randomization criteria|2|||
126600753|NCT04631016|455499466|FG001|Overall Study|Failure to meet randomization criteria|1|||
126600754|NCT06010836|455499467|FG000|Overall Study|Lost to Follow-up|2|||
126600755|NCT06010836|455499468|FG001|Overall Study|Lost to Follow-up|2|||
126600756|NCT06010836|455499467|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
126600757|NCT06010836|455499468|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
126600758|NCT06010836|455499467|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
126600759|NCT06010836|455499468|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
126600760|NCT06010836|455499467|FG000|Overall Study|Did not receive intervention discussion|0|||
126600761|NCT06010836|455499468|FG001|Overall Study|Did not receive intervention discussion|4|||
126600762|NCT04496752|455499469|FG000|Second Assessment|Lost to Follow-up|3|||
126600763|NCT04496752|455499470|FG001|Second Assessment|Lost to Follow-up|3|||
126600764|NCT04496752|455499469|FG000|Second Assessment|Adverse Event|2|||
126600765|NCT04496752|455499470|FG001|Second Assessment|Adverse Event|0|||
126600766|NCT04524689|455499473|FG000|Overall Study|Withdrawal by Subject|1|||
126600767|NCT04524689|455499474|FG001|Overall Study|Withdrawal by Subject|1|||
126600768|NCT04524689|455499475|FG002|Overall Study|Withdrawal by Subject|0|||
126600769|NCT04524689|455499476|FG003|Overall Study|Withdrawal by Subject|0|||
126600770|NCT04524689|455499477|FG004|Overall Study|Withdrawal by Subject|1|||
126600771|NCT04524689|455499478|FG005|Overall Study|Withdrawal by Subject|0|||
126600772|NCT04524689|455499473|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
126733460|NCT00805545|455972381|FG001|Overall Study|Protocol Violation|1|||
126600773|NCT04524689|455499474|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
126600774|NCT04524689|455499475|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
126600775|NCT04524689|455499476|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
126600776|NCT04524689|455499477|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
126600777|NCT04524689|455499478|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
126600778|NCT04524689|455499473|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
126600779|NCT04524689|455499474|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
126733461|NCT00507416|455972382|FG000|Overall Study|Adverse Event|58|||
126733462|NCT00507416|455972383|FG001|Overall Study|Adverse Event|67|||
126600780|NCT04524689|455499475|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
126600781|NCT04524689|455499476|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
126600782|NCT04524689|455499477|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
126600783|NCT04524689|455499478|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
126600784|NCT04967599|455499479|FG000|Overall Study|Lost to Follow-up|35|||
126600785|NCT04967599|455499480|FG001|Overall Study|Lost to Follow-up|19|||
126600786|NCT04967599|455499481|FG002|Overall Study|Lost to Follow-up|23|||
126600787|NCT04369911|455499482|FG000|Overall Study|Lost to Follow-up|3|||
126600788|NCT04369911|455499483|FG001|Overall Study|Lost to Follow-up|3|||
126600789|NCT04369911|455499482|FG000|Overall Study|Withdrawal by Subject|1|||
126600790|NCT04369911|455499483|FG001|Overall Study|Withdrawal by Subject|2|||
126600791|NCT05451693|455499484|FG000|Overall Study|Withdrawal by Subject|1|||
126600792|NCT05451693|455499485|FG001|Overall Study|Withdrawal by Subject|1|||
126600793|NCT05541484|455499498|FG000|Overall Study|Withdrawal by Subject|1|||
126600794|NCT05541484|455499499|FG001|Overall Study|Withdrawal by Subject|0|||
126600795|NCT03884439|455499504|FG000|Overall Study|No informed consent for publication of study results|38|||
126600796|NCT03884439|455499504|FG000|Overall Study|Contract violation/deficiency|7|||
126600797|NCT03904576|455499505|FG000|Washout Period|Protocol Violation|1|||
126600798|NCT03904576|455499506|FG001|Washout Period|Protocol Violation|1|||
126600799|NCT01756300|455499507|FG000|Overall Study|Death|1|||
126600800|NCT01756300|455499507|FG000|Overall Study|Withdrawal by Subject|1|||
126600801|NCT05311176|455499964|FG000|Overall Study|Death|6|||
126600802|NCT05311176|455499964|FG000|Overall Study|Sponsor discontinued the study|1|||
126600803|NCT06262347|455499968|FG000|Overall Study|Lost to Follow-up|4|||
126600804|NCT06262347|455499969|FG001|Overall Study|Lost to Follow-up|3|||
126600805|NCT06262347|455499968|FG000|Overall Study|Withdrawal by Subject|0|||
126600806|NCT06262347|455499969|FG001|Overall Study|Withdrawal by Subject|1|||
126600807|NCT02163694|455499972|FG000|Overall Study|Adverse event- related to progression|4|||
126600808|NCT02163694|455499973|FG001|Overall Study|Adverse event- related to progression|10|||
126600809|NCT02163694|455499972|FG000|Overall Study|Adverse event- not related to progression|7|||
126600810|NCT02163694|455499973|FG001|Overall Study|Adverse event- not related to progression|22|||
126600811|NCT02163694|455499972|FG000|Overall Study|Withdrew consent|13|||
126600812|NCT02163694|455499973|FG001|Overall Study|Withdrew consent|28|||
126600813|NCT02163694|455499972|FG000|Overall Study|Lost to Follow-up|2|||
126600814|NCT02163694|455499973|FG001|Overall Study|Lost to Follow-up|2|||
126600815|NCT02163694|455499972|FG000|Overall Study|Sponsor discontinued study|3|||
126600816|NCT02163694|455499973|FG001|Overall Study|Sponsor discontinued study|29|||
126600817|NCT02163694|455499972|FG000|Overall Study|Progressive disease per protocol|125|||
126600818|NCT02163694|455499973|FG001|Overall Study|Progressive disease per protocol|224|||
126600819|NCT02163694|455499972|FG000|Overall Study|Other, not specified|17|||
126600820|NCT02163694|455499973|FG001|Overall Study|Other, not specified|22|||
126600821|NCT02163694|455499972|FG000|Overall Study|Randomized but Not Treated|1|||
126600822|NCT02163694|455499973|FG001|Overall Study|Randomized but Not Treated|0|||
126600823|NCT02163694|455499972|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
126600824|NCT02163694|455499973|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
126600825|NCT04560179|455499976|FG000|Overall Study|Physician Decision|1|||
126600826|NCT04560179|455499977|FG001|Overall Study|Physician Decision|0|||
126600827|NCT04560179|455499978|FG002|Overall Study|Physician Decision|0|||
126600828|NCT04560179|455499979|FG003|Overall Study|Physician Decision|0|||
126600829|NCT04560179|455499980|FG004|Overall Study|Physician Decision|0|||
126600830|NCT04560179|455499976|FG000|Overall Study|Adverse Event|0|||
126600831|NCT04560179|455499977|FG001|Overall Study|Adverse Event|0|||
126600832|NCT04560179|455499978|FG002|Overall Study|Adverse Event|0|||
126600833|NCT04560179|455499979|FG003|Overall Study|Adverse Event|1|||
126600834|NCT04560179|455499980|FG004|Overall Study|Adverse Event|0|||
126600835|NCT03662022|455499981|FG000|Year 1 2019|prevalent case|83|||
126600836|NCT03662022|455499982|FG001|Year 1 2019|prevalent case|116|||
126600837|NCT03662022|455499983|FG002|Year 1 2019|prevalent case|158|||
126600838|NCT03662022|455499984|FG003|Year 1 2019|prevalent case|99|||
126600839|NCT03662022|455499981|FG000|Year 2 2020|incident case|18|||
126600840|NCT03662022|455499982|FG001|Year 2 2020|incident case|18|||
126600841|NCT03662022|455499983|FG002|Year 2 2020|incident case|16|||
126600842|NCT03662022|455499984|FG003|Year 2 2020|incident case|26|||
126600843|NCT03662022|455499981|FG000|Year 2 2020|other case|18|||
126600844|NCT03662022|455499982|FG001|Year 2 2020|other case|16|||
126600845|NCT03662022|455499983|FG002|Year 2 2020|other case|16|||
126600846|NCT03662022|455499984|FG003|Year 2 2020|other case|24|||
126600847|NCT03662022|455499981|FG000|Year 2 2020|Lost to Follow-up|1633|||
126600848|NCT03662022|455499982|FG001|Year 2 2020|Lost to Follow-up|1183|||
126600849|NCT03662022|455499983|FG002|Year 2 2020|Lost to Follow-up|1381|||
126600850|NCT03662022|455499984|FG003|Year 2 2020|Lost to Follow-up|2858|||
126600851|NCT03662022|455499981|FG000|Year 3 2021|incident case|24|||
126600852|NCT03662022|455499982|FG001|Year 3 2021|incident case|27|||
126600853|NCT03662022|455499983|FG002|Year 3 2021|incident case|24|||
126600854|NCT03662022|455499984|FG003|Year 3 2021|incident case|11|||
126600855|NCT03662022|455499981|FG000|Year 3 2021|other case|4|||
126600856|NCT03662022|455499982|FG001|Year 3 2021|other case|15|||
126600857|NCT03662022|455499983|FG002|Year 3 2021|other case|10|||
126600858|NCT03662022|455499984|FG003|Year 3 2021|other case|14|||
126600859|NCT03662022|455499981|FG000|Year 3 2021|Lost to Follow-up|179|||
126600860|NCT03662022|455499982|FG001|Year 3 2021|Lost to Follow-up|244|||
126600861|NCT03662022|455499983|FG002|Year 3 2021|Lost to Follow-up|480|||
126600862|NCT03662022|455499984|FG003|Year 3 2021|Lost to Follow-up|477|||
126600863|NCT03662022|455499981|FG000|Year 4 2022|incident case|25|||
126600864|NCT03662022|455499982|FG001|Year 4 2022|incident case|41|||
126600865|NCT03662022|455499983|FG002|Year 4 2022|incident case|28|||
126600866|NCT03662022|455499984|FG003|Year 4 2022|incident case|7|||
126600867|NCT03662022|455499981|FG000|Year 4 2022|other case|8|||
126600868|NCT03662022|455499982|FG001|Year 4 2022|other case|19|||
126600869|NCT03662022|455499983|FG002|Year 4 2022|other case|13|||
126600870|NCT03662022|455499984|FG003|Year 4 2022|other case|7|||
126600871|NCT03662022|455499981|FG000|Year 4 2022|Lost to Follow-up|986|||
126600872|NCT03662022|455499982|FG001|Year 4 2022|Lost to Follow-up|1079|||
126600873|NCT03662022|455499983|FG002|Year 4 2022|Lost to Follow-up|1236|||
126600874|NCT03662022|455499984|FG003|Year 4 2022|Lost to Follow-up|1826|||
126600875|NCT04490109|455499995|FG000|Overall Study|Lost to Follow-up|3|||
126600876|NCT04490109|455499996|FG001|Overall Study|Lost to Follow-up|10|||
126600877|NCT04490109|455499997|FG002|Overall Study|Lost to Follow-up|4|||
126600878|NCT04490109|455499995|FG000|Overall Study|Withdrawal by Subject|8|||
126600879|NCT04490109|455499996|FG001|Overall Study|Withdrawal by Subject|6|||
126600880|NCT04490109|455499997|FG002|Overall Study|Withdrawal by Subject|9|||
126600881|NCT04490109|455499995|FG000|Overall Study|Physician Decision|0|||
126600882|NCT04490109|455499996|FG001|Overall Study|Physician Decision|2|||
126600883|NCT04490109|455499997|FG002|Overall Study|Physician Decision|3|||
126600884|NCT04490109|455499995|FG000|Overall Study|Adverse Event|2|||
126600885|NCT04490109|455499996|FG001|Overall Study|Adverse Event|1|||
126600886|NCT04490109|455499997|FG002|Overall Study|Adverse Event|0|||
126600887|NCT04490109|455499995|FG000|Overall Study|Significant Non-Compliance|2|||
126600888|NCT04490109|455499996|FG001|Overall Study|Significant Non-Compliance|4|||
126600889|NCT04490109|455499997|FG002|Overall Study|Significant Non-Compliance|4|||
126600890|NCT04490109|455499995|FG000|Overall Study|Significant Clinical Event|0|||
126600891|NCT04490109|455499996|FG001|Overall Study|Significant Clinical Event|1|||
126600892|NCT04490109|455499997|FG002|Overall Study|Significant Clinical Event|0|||
126600893|NCT04490109|455499995|FG000|Overall Study|Other Reason|4|||
126600894|NCT04490109|455499996|FG001|Overall Study|Other Reason|1|||
126600895|NCT04490109|455499997|FG002|Overall Study|Other Reason|1|||
126600896|NCT03817983|455499998|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
126600897|NCT03817983|455499999|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
126600898|NCT03817983|455500000|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
126600899|NCT03744676|455500001|FG000|Pre-Treatment Phase|Disease related complications|2|||
126600900|NCT03744676|455500001|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
126600901|NCT03744676|455500001|FG000|Pre-Treatment Phase|Death|7|||
126600902|NCT03744676|455500001|FG000|Pre-Treatment Phase|Other Reasons|7|||
126600903|NCT03744676|455500001|FG000|Treatment Phase|Participant withdrew consent|8|||
126600904|NCT03744676|455500001|FG000|Treatment Phase|Death|33|||
126600905|NCT03744676|455500001|FG000|Treatment Phase|other reasons|6|||
126600906|NCT03533257|455500011|FG000|Overall Study|Adverse Event|4|||
126600907|NCT03533257|455500012|FG001|Overall Study|Adverse Event|2|||
126600908|NCT03533257|455500011|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
126600909|NCT03533257|455500012|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
126600910|NCT04780581|455500013|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
126600911|NCT04780581|455500014|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
126600912|NCT04780581|455500013|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
126600913|NCT04780581|455500014|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
126600914|NCT04626427|455500015|FG000|Overall Study|Death|1|||
126600915|NCT04626427|455500015|FG000|Overall Study|Withdrawal by Subject|1|||
126600916|NCT04626427|455500015|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
126600917|NCT04626427|455500015|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
126600918|NCT01651000|455500016|FG000|Overall Study|Adverse Event|2|||
126600919|NCT01651000|455500017|FG001|Overall Study|Adverse Event|8|||
126600920|NCT01651000|455500016|FG000|Overall Study|Lost to Follow-up|3|||
126600921|NCT01651000|455500017|FG001|Overall Study|Lost to Follow-up|2|||
126600922|NCT01651000|455500016|FG000|Overall Study|Protocol Violation|0|||
126600923|NCT01651000|455500017|FG001|Overall Study|Protocol Violation|3|||
126600924|NCT01651000|455500016|FG000|Overall Study|Withdrawal by Subject|2|||
126600925|NCT01651000|455500017|FG001|Overall Study|Withdrawal by Subject|10|||
126600926|NCT01651000|455500016|FG000|Overall Study|Subject noncompliance|0|||
126600927|NCT01651000|455500017|FG001|Overall Study|Subject noncompliance|3|||
126600928|NCT01651000|455500016|FG000|Overall Study|Lack of Efficacy|1|||
126600929|NCT01651000|455500017|FG001|Overall Study|Lack of Efficacy|1|||
126600930|NCT01651000|455500016|FG000|Overall Study|Physician Decision|1|||
126600931|NCT01651000|455500017|FG001|Overall Study|Physician Decision|0|||
126600932|NCT01651000|455500016|FG000|Overall Study|Administrative reason|1|||
126733463|NCT00507416|455972384|FG002|Overall Study|Adverse Event|65|||
126600933|NCT01651000|455500017|FG001|Overall Study|Administrative reason|0|||
126600934|NCT01651000|455500016|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
126600935|NCT01651000|455500017|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
126600936|NCT02765412|455500018|FG000|Overall Study|Death|482|||
126600937|NCT02765412|455500019|FG001|Overall Study|Death|855|||
126600938|NCT04244175|455501321|FG000|Overall Study|Adverse Event|3|||
126600939|NCT04244175|455501322|FG001|Overall Study|Adverse Event|2|||
126600940|NCT04244175|455501323|FG002|Overall Study|Adverse Event|5|||
126600941|NCT04244175|455501321|FG000|Overall Study|Lack of Efficacy|1|||
126600942|NCT04244175|455501322|FG001|Overall Study|Lack of Efficacy|0|||
126600943|NCT04244175|455501323|FG002|Overall Study|Lack of Efficacy|1|||
126600944|NCT04244175|455501321|FG000|Overall Study|Lost to Follow-up|1|||
126600945|NCT04244175|455501322|FG001|Overall Study|Lost to Follow-up|0|||
126600946|NCT04244175|455501323|FG002|Overall Study|Lost to Follow-up|0|||
126600947|NCT04244175|455501321|FG000|Overall Study|Non-compliance with study drug|1|||
126600948|NCT04244175|455501322|FG001|Overall Study|Non-compliance with study drug|0|||
126600949|NCT04244175|455501323|FG002|Overall Study|Non-compliance with study drug|1|||
126600950|NCT04244175|455501321|FG000|Overall Study|Protocol deviation|0|||
126600951|NCT04244175|455501322|FG001|Overall Study|Protocol deviation|1|||
126600952|NCT04244175|455501323|FG002|Overall Study|Protocol deviation|0|||
126600953|NCT04244175|455501321|FG000|Overall Study|Withdrawal by Subject|1|||
126600954|NCT04244175|455501322|FG001|Overall Study|Withdrawal by Subject|3|||
126600955|NCT04244175|455501323|FG002|Overall Study|Withdrawal by Subject|1|||
126600956|NCT04244175|455501321|FG000|Overall Study|Other, not specified|0|||
126600957|NCT04244175|455501322|FG001|Overall Study|Other, not specified|1|||
126600958|NCT04244175|455501323|FG002|Overall Study|Other, not specified|2|||
126600959|NCT04595331|455501324|FG000|Overall Study|Withdrawal by Subject|0|||
126600960|NCT04595331|455501325|FG001|Overall Study|Withdrawal by Subject|1|||
126600961|NCT04595331|455501324|FG000|Overall Study|Lost to Follow-up|0|||
126600962|NCT04595331|455501325|FG001|Overall Study|Lost to Follow-up|5|||
126600963|NCT04595331|455501324|FG000|Overall Study|Medical reason|0|||
126600964|NCT04595331|455501325|FG001|Overall Study|Medical reason|1|||
126600965|NCT03781089|455501326|FG000|Overall Study|Constipation|1|||
126600966|NCT03781089|455501327|FG001|Overall Study|Constipation|0|||
126600967|NCT03781089|455501326|FG000|Overall Study|Positive pregnancy test|0|||
126600968|NCT03781089|455501327|FG001|Overall Study|Positive pregnancy test|1|||
126600969|NCT05020353|455501328|FG000|Overall Study|Protocol Violation|7|||
126600970|NCT05020353|455501328|FG000|Overall Study|Withdrawal by Subject|33|||
126600971|NCT01880515|455501330|FG000|Overall Study|Lost to Follow-up|3|||
126600972|NCT01880515|455501331|FG001|Overall Study|Lost to Follow-up|2|||
126600973|NCT01880515|455501330|FG000|Overall Study|Disease Progression|5|||
126600974|NCT01880515|455501331|FG001|Overall Study|Disease Progression|7|||
126600975|NCT05836012|455501359|FG000|Overall Study|Lost to Follow-up|1|||
126600976|NCT05836012|455501360|FG001|Overall Study|Lost to Follow-up|0|||
126600977|NCT05836012|455501359|FG000|Overall Study|Withdrawal by Subject|1|||
126600978|NCT05836012|455501360|FG001|Overall Study|Withdrawal by Subject|3|||
126600979|NCT05836012|455501359|FG000|Overall Study|Reason not included in pre-specified categories|2|||
126600980|NCT05836012|455501360|FG001|Overall Study|Reason not included in pre-specified categories|1|||
126600981|NCT05454514|455501364|FG000|Overall Study|Withdrawal by Subject|4|||
126600982|NCT03547271|455501365|FG000|Overall Study|Adverse Event|1|||
126600983|NCT03547271|455501366|FG001|Overall Study|Adverse Event|1|||
126600984|NCT03547271|455501367|FG002|Overall Study|Adverse Event|0|||
126600985|NCT03547271|455501368|FG003|Overall Study|Adverse Event|0|||
126600986|NCT03547271|455501365|FG000|Overall Study|Protocol deviation|5|||
126600987|NCT03547271|455501366|FG001|Overall Study|Protocol deviation|7|||
126600988|NCT03547271|455501367|FG002|Overall Study|Protocol deviation|3|||
126600989|NCT03547271|455501368|FG003|Overall Study|Protocol deviation|0|||
126600990|NCT03547271|455501365|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
126600991|NCT03547271|455501366|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
126600992|NCT03547271|455501367|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
126600993|NCT03547271|455501368|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
126600994|NCT03547271|455501365|FG000|Overall Study|Lost to Follow-up|3|||
126600995|NCT03547271|455501366|FG001|Overall Study|Lost to Follow-up|3|||
126600996|NCT03547271|455501367|FG002|Overall Study|Lost to Follow-up|1|||
126600997|NCT03547271|455501368|FG003|Overall Study|Lost to Follow-up|0|||
126600998|NCT06065735|455501373|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
126600999|NCT06065735|455501374|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
126601000|NCT06065735|455501375|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
126601001|NCT06065735|455501373|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
126601002|NCT06065735|455501374|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
126780548|NCT01698320|456151282|FG000|40-Week Open-Label Period|Pregnancy|0|||
126601003|NCT06065735|455501375|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
126601004|NCT06065735|455501373|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
126601005|NCT06065735|455501374|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
126780549|NCT01698320|456151283|FG001|40-Week Open-Label Period|Pregnancy|2|||
126601006|NCT06065735|455501375|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
126601007|NCT06065735|455501373|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
126601008|NCT06065735|455501374|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
126601009|NCT06065735|455501375|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
126601010|NCT06065735|455501373|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
126601011|NCT06065735|455501374|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
126601012|NCT06065735|455501375|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
126601013|NCT02532621|455501376|FG000|Overall Study|Death|3|||
126601014|NCT02532621|455501376|FG000|Overall Study|Lost to Follow-up|3|||
126601015|NCT02532621|455501376|FG000|Overall Study|Withdrawal by Subject|6|||
126601016|NCT02532621|455501376|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
126601017|NCT02532621|455501376|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
126601018|NCT02919917|455501379|FG000|Overall Study|Withdrawal by Subject|4|||
126601019|NCT02919917|455501380|FG001|Overall Study|Withdrawal by Subject|8|||
126601020|NCT03418740|455501381|FG000|Overall Study|Lost to Follow-up|13|||
126601021|NCT03418740|455501381|FG000|Overall Study|Scheduling Issues|7|||
126601022|NCT03418740|455501381|FG000|Overall Study|Withdrawal by Subject|2|||
126601023|NCT03418740|455501381|FG000|Overall Study|Unable to Continue Consent|1|||
126601024|NCT04157517|455501386|FG000|Overall Study|Death|1|||
126601025|NCT04157517|455501387|FG001|Overall Study|Death|2|||
126601026|NCT04157517|455501388|FG002|Overall Study|Death|2|||
126601027|NCT04157517|455501389|FG003|Overall Study|Death|3|||
126601028|NCT04157517|455501390|FG004|Overall Study|Death|3|||
126601029|NCT04157517|455501391|FG005|Overall Study|Death|4|||
126601030|NCT04157517|455501392|FG006|Overall Study|Death|1|||
126601031|NCT04157517|455501393|FG007|Overall Study|Death|2|||
126601032|NCT04157517|455501394|FG008|Overall Study|Death|4|||
126601033|NCT04157517|455501395|FG009|Overall Study|Death|0|||
126601034|NCT04157517|455501386|FG000|Overall Study|Withdrawal by Subject|1|||
126601035|NCT04157517|455501387|FG001|Overall Study|Withdrawal by Subject|1|||
126601036|NCT04157517|455501388|FG002|Overall Study|Withdrawal by Subject|1|||
126601037|NCT04157517|455501389|FG003|Overall Study|Withdrawal by Subject|0|||
126601038|NCT04157517|455501390|FG004|Overall Study|Withdrawal by Subject|0|||
126601039|NCT04157517|455501391|FG005|Overall Study|Withdrawal by Subject|1|||
126601040|NCT04157517|455501392|FG006|Overall Study|Withdrawal by Subject|0|||
126601041|NCT04157517|455501393|FG007|Overall Study|Withdrawal by Subject|0|||
126601042|NCT04157517|455501394|FG008|Overall Study|Withdrawal by Subject|1|||
126601043|NCT04157517|455501395|FG009|Overall Study|Withdrawal by Subject|0|||
126601044|NCT04157517|455501386|FG000|Overall Study|Other|1|||
126601045|NCT04157517|455501387|FG001|Overall Study|Other|0|||
126601046|NCT04157517|455501388|FG002|Overall Study|Other|0|||
126601047|NCT04157517|455501389|FG003|Overall Study|Other|0|||
126601048|NCT04157517|455501390|FG004|Overall Study|Other|0|||
126601049|NCT04157517|455501391|FG005|Overall Study|Other|1|||
126601050|NCT04157517|455501392|FG006|Overall Study|Other|2|||
126601051|NCT04157517|455501393|FG007|Overall Study|Other|7|||
126601052|NCT04157517|455501394|FG008|Overall Study|Other|7|||
126601053|NCT04157517|455501395|FG009|Overall Study|Other|0|||
126601054|NCT02933489|455501396|FG000|Overall Study|Ineligible|3|||
126601055|NCT02933489|455501397|FG001|Overall Study|Ineligible|3|||
126601056|NCT02933489|455501396|FG000|Overall Study|Withdrawal by Subject|27|||
126601057|NCT02933489|455501397|FG001|Overall Study|Withdrawal by Subject|18|||
126601058|NCT02933489|455501396|FG000|Overall Study|Unable to complete exams (other)|14|||
126601059|NCT02933489|455501397|FG001|Overall Study|Unable to complete exams (other)|7|||
126601060|NCT02461134|455501398|FG000|Overall Study|Adverse Event|1|||
126601061|NCT04761198|455501399|FG000|Overall Study|Progressive Disease|1|||
126601062|NCT04761198|455501400|FG001|Overall Study|Progressive Disease|0|||
126601063|NCT04761198|455501401|FG002|Overall Study|Progressive Disease|0|||
126601064|NCT04761198|455501402|FG003|Overall Study|Progressive Disease|1|||
126601065|NCT04761198|455501403|FG004|Overall Study|Progressive Disease|4|||
126601066|NCT04761198|455501404|FG005|Overall Study|Progressive Disease|1|||
126733464|NCT00507416|455972382|FG000|Overall Study|Protocol Violation|1|||
126733465|NCT00507416|455972383|FG001|Overall Study|Protocol Violation|2|||
126601067|NCT04761198|455501405|FG006|Overall Study|Progressive Disease|2|||
126601068|NCT04761198|455501399|FG000|Overall Study|Protocol Violation|0|||
126601069|NCT04761198|455501400|FG001|Overall Study|Protocol Violation|0|||
126601070|NCT04761198|455501401|FG002|Overall Study|Protocol Violation|0|||
126601071|NCT04761198|455501402|FG003|Overall Study|Protocol Violation|0|||
126601072|NCT04761198|455501403|FG004|Overall Study|Protocol Violation|1|||
126601073|NCT04761198|455501404|FG005|Overall Study|Protocol Violation|0|||
126601074|NCT04761198|455501405|FG006|Overall Study|Protocol Violation|0|||
126601075|NCT04761198|455501399|FG000|Overall Study|Death|2|||
126733466|NCT00507416|455972384|FG002|Overall Study|Protocol Violation|0|||
126601076|NCT04761198|455501400|FG001|Overall Study|Death|1|||
126601077|NCT04761198|455501401|FG002|Overall Study|Death|2|||
126601078|NCT04761198|455501402|FG003|Overall Study|Death|5|||
126601079|NCT04761198|455501403|FG004|Overall Study|Death|14|||
126601080|NCT04761198|455501404|FG005|Overall Study|Death|2|||
126601081|NCT04761198|455501405|FG006|Overall Study|Death|5|||
126601082|NCT04761198|455501399|FG000|Overall Study|Lost to Follow-up|0|||
126601083|NCT04761198|455501400|FG001|Overall Study|Lost to Follow-up|0|||
126780550|NCT01698320|456151284|FG002|40-Week Open-Label Period|Pregnancy|1|||
126780551|NCT01698320|456151282|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
126780552|NCT01698320|456151283|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
126780553|NCT01698320|456151284|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
126780554|NCT01698320|456151282|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
126780555|NCT01698320|456151283|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
126780556|NCT01698320|456151284|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
126780557|NCT01952574|456151285|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
126780558|NCT01952574|456151286|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
126780559|NCT01952574|456151287|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
126780560|NCT01952574|456151288|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
126780561|NCT01952574|456151289|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126780562|NCT01952574|456151290|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126780563|NCT01952574|456151291|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
126780564|NCT01952574|456151285|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
126780565|NCT01952574|456151286|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
126780566|NCT01952574|456151287|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
126780567|NCT01952574|456151288|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
126780568|NCT01952574|456151289|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
126780569|NCT01952574|456151290|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
126780570|NCT01952574|456151291|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
126780571|NCT01952574|456151285|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
126780572|NCT01952574|456151286|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
126780573|NCT01952574|456151287|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
126780574|NCT01952574|456151288|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
126780575|NCT01952574|456151289|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
126780576|NCT01952574|456151290|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
126780577|NCT01952574|456151291|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
126780578|NCT01952574|456151285|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
126780579|NCT01952574|456151286|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
126780580|NCT01952574|456151287|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
126780581|NCT01952574|456151288|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
126780582|NCT01952574|456151289|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
126780583|NCT01952574|456151290|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
126780584|NCT01952574|456151291|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
126780585|NCT01952574|456151285|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
126780586|NCT01952574|456151286|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
126780587|NCT01952574|456151287|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
126780588|NCT01952574|456151288|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
126780589|NCT01952574|456151289|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
126780590|NCT01952574|456151290|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
126780591|NCT01952574|456151291|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
126780592|NCT01952574|456151285|FG000|Open-label Treatment Phase|Missing|0|||
126780593|NCT01952574|456151286|FG001|Open-label Treatment Phase|Missing|0|||
126780594|NCT01952574|456151287|FG002|Open-label Treatment Phase|Missing|0|||
126780595|NCT01952574|456151288|FG003|Open-label Treatment Phase|Missing|0|||
126780596|NCT01952574|456151289|FG004|Open-label Treatment Phase|Missing|4|||
126780597|NCT01952574|456151290|FG005|Open-label Treatment Phase|Missing|0|||
126780598|NCT01952574|456151291|FG006|Open-label Treatment Phase|Missing|0|||
126780599|NCT01952574|456151285|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
126601084|NCT04761198|455501401|FG002|Overall Study|Lost to Follow-up|0|||
126601085|NCT04761198|455501402|FG003|Overall Study|Lost to Follow-up|0|||
126601086|NCT04761198|455501403|FG004|Overall Study|Lost to Follow-up|1|||
126601087|NCT04761198|455501404|FG005|Overall Study|Lost to Follow-up|0|||
126601088|NCT04761198|455501405|FG006|Overall Study|Lost to Follow-up|0|||
126601089|NCT04761198|455501399|FG000|Overall Study|Withdrawal by Subject|2|||
126780600|NCT01952574|456151286|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
126780601|NCT01952574|456151287|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
126780602|NCT01952574|456151288|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
126780603|NCT01952574|456151289|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
126780604|NCT01952574|456151290|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
126780605|NCT01952574|456151291|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
126780606|NCT01952574|456151285|FG000|Open-label Treatment Phase|Death|0|||
126601090|NCT04761198|455501400|FG001|Overall Study|Withdrawal by Subject|0|||
126601091|NCT04761198|455501401|FG002|Overall Study|Withdrawal by Subject|1|||
126780607|NCT01952574|456151286|FG001|Open-label Treatment Phase|Death|0|||
126780608|NCT01952574|456151287|FG002|Open-label Treatment Phase|Death|0|||
126780609|NCT01952574|456151288|FG003|Open-label Treatment Phase|Death|0|||
126780610|NCT01952574|456151289|FG004|Open-label Treatment Phase|Death|1|||
126601092|NCT04761198|455501402|FG003|Overall Study|Withdrawal by Subject|0|||
126601093|NCT04761198|455501403|FG004|Overall Study|Withdrawal by Subject|2|||
126601094|NCT04761198|455501404|FG005|Overall Study|Withdrawal by Subject|0|||
126601095|NCT04761198|455501405|FG006|Overall Study|Withdrawal by Subject|1|||
126601096|NCT04761198|455501399|FG000|Overall Study|Study Terminated by Sponsor|6|||
126601097|NCT04761198|455501400|FG001|Overall Study|Study Terminated by Sponsor|0|||
126601098|NCT04761198|455501401|FG002|Overall Study|Study Terminated by Sponsor|5|||
126601099|NCT04761198|455501402|FG003|Overall Study|Study Terminated by Sponsor|3|||
126601100|NCT04761198|455501403|FG004|Overall Study|Study Terminated by Sponsor|10|||
126601101|NCT04761198|455501404|FG005|Overall Study|Study Terminated by Sponsor|1|||
126601102|NCT04761198|455501405|FG006|Overall Study|Study Terminated by Sponsor|2|||
126601103|NCT02994927|455501406|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126601104|NCT02994927|455501407|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126601105|NCT02994927|455501406|FG000|Overall Study|Did not meet eligibility criteria|0|||
126601106|NCT02994927|455501407|FG001|Overall Study|Did not meet eligibility criteria|1|||
126601107|NCT02994927|455501406|FG000|Overall Study|Physician Decision|4|||
126601108|NCT02994927|455501407|FG001|Overall Study|Physician Decision|3|||
126601109|NCT02994927|455501406|FG000|Overall Study|Death|4|||
126601110|NCT02994927|455501407|FG001|Overall Study|Death|2|||
126601111|NCT02994927|455501406|FG000|Overall Study|Adverse Event|2|||
126601112|NCT02994927|455501407|FG001|Overall Study|Adverse Event|1|||
126601113|NCT02994927|455501406|FG000|Overall Study|Withdrawal by Subject|3|||
126601114|NCT02994927|455501407|FG001|Overall Study|Withdrawal by Subject|6|||
126601115|NCT02994927|455501406|FG000|Overall Study|Lost to Follow-up|2|||
126601116|NCT02994927|455501407|FG001|Overall Study|Lost to Follow-up|1|||
126601117|NCT03250676|455501408|FG000|Overall Study|Adverse Event|0|||
126601118|NCT03250676|455501409|FG001|Overall Study|Adverse Event|0|||
126601119|NCT03250676|455501410|FG002|Overall Study|Adverse Event|0|||
126601120|NCT03250676|455501411|FG003|Overall Study|Adverse Event|1|||
126601121|NCT03250676|455501412|FG004|Overall Study|Adverse Event|2|||
126601122|NCT03250676|455501413|FG005|Overall Study|Adverse Event|9|||
126601123|NCT03250676|455501408|FG000|Overall Study|Withdrawal by Subject|1|||
126601124|NCT03250676|455501409|FG001|Overall Study|Withdrawal by Subject|0|||
126601125|NCT03250676|455501410|FG002|Overall Study|Withdrawal by Subject|0|||
126601126|NCT03250676|455501411|FG003|Overall Study|Withdrawal by Subject|1|||
126601127|NCT03250676|455501412|FG004|Overall Study|Withdrawal by Subject|1|||
126601128|NCT03250676|455501413|FG005|Overall Study|Withdrawal by Subject|2|||
126601129|NCT03250676|455501408|FG000|Overall Study|Physician Decision|0|||
126601130|NCT03250676|455501409|FG001|Overall Study|Physician Decision|0|||
126601131|NCT03250676|455501410|FG002|Overall Study|Physician Decision|0|||
126733467|NCT00507416|455972382|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
126733468|NCT00507416|455972383|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
126733469|NCT00507416|455972384|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
126733470|NCT00507416|455972382|FG000|Overall Study|Progressive Disease|20|||
126733471|NCT00507416|455972383|FG001|Overall Study|Progressive Disease|10|||
126733472|NCT00507416|455972384|FG002|Overall Study|Progressive Disease|13|||
126733473|NCT00507416|455972382|FG000|Overall Study|Patient declined further treatment|18|||
126733474|NCT00507416|455972383|FG001|Overall Study|Patient declined further treatment|14|||
126733475|NCT00507416|455972384|FG002|Overall Study|Patient declined further treatment|11|||
126733476|NCT00507416|455972382|FG000|Overall Study|Other|11|||
126733477|NCT00507416|455972383|FG001|Overall Study|Other|16|||
126733478|NCT00507416|455972384|FG002|Overall Study|Other|13|||
126733479|NCT00507416|455972382|FG000|Overall Study|Did not Receive Study Treatment|3|||
126733480|NCT00507416|455972383|FG001|Overall Study|Did not Receive Study Treatment|9|||
126733481|NCT00507416|455972384|FG002|Overall Study|Did not Receive Study Treatment|4|||
126733482|NCT02157506|455972387|FG000|Overall Study|Adverse Event|0|||
126733483|NCT02157506|455972388|FG001|Overall Study|Adverse Event|1|||
126733484|NCT02157506|455972389|FG002|Overall Study|Adverse Event|0|||
126733485|NCT02157506|455972390|FG003|Overall Study|Adverse Event|0|||
126733486|NCT02157506|455972391|FG004|Overall Study|Adverse Event|0|||
126733487|NCT02157506|455972387|FG000|Overall Study|Lost to Follow-up|0|||
126733488|NCT02157506|455972388|FG001|Overall Study|Lost to Follow-up|0|||
126733489|NCT02157506|455972389|FG002|Overall Study|Lost to Follow-up|1|||
126733490|NCT02157506|455972390|FG003|Overall Study|Lost to Follow-up|0|||
126733491|NCT02157506|455972391|FG004|Overall Study|Lost to Follow-up|0|||
126601132|NCT03250676|455501411|FG003|Overall Study|Physician Decision|2|||
126601133|NCT03250676|455501412|FG004|Overall Study|Physician Decision|0|||
126601134|NCT03250676|455501413|FG005|Overall Study|Physician Decision|3|||
126601135|NCT03250676|455501408|FG000|Overall Study|Withdrawal of consent|0|||
126601136|NCT03250676|455501409|FG001|Overall Study|Withdrawal of consent|0|||
126601137|NCT03250676|455501410|FG002|Overall Study|Withdrawal of consent|2|||
126601138|NCT03250676|455501411|FG003|Overall Study|Withdrawal of consent|0|||
126733492|NCT03101514|455972392|FG000|Overall Study|Withdrawal by Subject|4|||
126601139|NCT03250676|455501412|FG004|Overall Study|Withdrawal of consent|0|||
126601140|NCT03250676|455501413|FG005|Overall Study|Withdrawal of consent|2|||
126601141|NCT03250676|455501408|FG000|Overall Study|Other|1|||
126601142|NCT03250676|455501409|FG001|Overall Study|Other|0|||
126733493|NCT03101514|455972392|FG000|Overall Study|Protocol Violation|2|||
126733494|NCT03101514|455972392|FG000|Overall Study|patient's information was incomplete|1|||
126601143|NCT03250676|455501410|FG002|Overall Study|Other|0|||
126601144|NCT03250676|455501411|FG003|Overall Study|Other|0|||
126601145|NCT03250676|455501412|FG004|Overall Study|Other|0|||
126601146|NCT03250676|455501413|FG005|Overall Study|Other|0|||
126601147|NCT03250676|455501408|FG000|Overall Study|Disease progression|4|||
126601148|NCT03250676|455501409|FG001|Overall Study|Disease progression|12|||
126601149|NCT03250676|455501410|FG002|Overall Study|Disease progression|9|||
126601150|NCT03250676|455501411|FG003|Overall Study|Disease progression|7|||
126601151|NCT03250676|455501412|FG004|Overall Study|Disease progression|4|||
126601152|NCT03250676|455501413|FG005|Overall Study|Disease progression|88|||
126601153|NCT03587805|455501414|FG000|Overall Study|Adverse Event|72|||
126601154|NCT03587805|455501414|FG000|Overall Study|Death|1|||
126601155|NCT03587805|455501414|FG000|Overall Study|Lost to Follow-up|78|||
126601156|NCT03587805|455501414|FG000|Overall Study|Withdrawal by Subject|105|||
126601157|NCT03587805|455501414|FG000|Overall Study|Lack of Efficacy|119|||
126601158|NCT03587805|455501414|FG000|Overall Study|Reason unknown|26|||
126601159|NCT03587805|455501414|FG000|Overall Study|COVID_19 pandemic|4|||
126601160|NCT03587805|455501414|FG000|Overall Study|Various reasons|121|||
126601161|NCT03587805|455501414|FG000|Overall Study|Withdrawal by parent/guardian|3|||
126601162|NCT03982186|455501415|FG000|Overall Study|Lost to Follow-up|0|||
126601163|NCT03982186|455501416|FG001|Overall Study|Lost to Follow-up|1|||
126601164|NCT03982186|455501417|FG002|Overall Study|Lost to Follow-up|2|||
126601165|NCT03982186|455501418|FG003|Overall Study|Lost to Follow-up|1|||
126601166|NCT03982186|455501419|FG004|Overall Study|Lost to Follow-up|1|||
126601167|NCT03982186|455501420|FG005|Overall Study|Lost to Follow-up|0|||
126601168|NCT03982186|455501415|FG000|Overall Study|Physician Decision|0|||
126601169|NCT03982186|455501416|FG001|Overall Study|Physician Decision|1|||
126601170|NCT03982186|455501417|FG002|Overall Study|Physician Decision|0|||
126601171|NCT03982186|455501418|FG003|Overall Study|Physician Decision|0|||
126601172|NCT03982186|455501419|FG004|Overall Study|Physician Decision|0|||
126601173|NCT03982186|455501420|FG005|Overall Study|Physician Decision|0|||
126601174|NCT03982186|455501415|FG000|Overall Study|Withdrawal by Subject|3|||
126601175|NCT03982186|455501416|FG001|Overall Study|Withdrawal by Subject|4|||
126601176|NCT03982186|455501417|FG002|Overall Study|Withdrawal by Subject|1|||
126601177|NCT03982186|455501418|FG003|Overall Study|Withdrawal by Subject|7|||
126601178|NCT03982186|455501419|FG004|Overall Study|Withdrawal by Subject|2|||
126601179|NCT03982186|455501420|FG005|Overall Study|Withdrawal by Subject|0|||
126601180|NCT03982186|455501415|FG000|Overall Study|Randomized and not treated|0|||
126601181|NCT03982186|455501416|FG001|Overall Study|Randomized and not treated|0|||
126601182|NCT03982186|455501417|FG002|Overall Study|Randomized and not treated|0|||
126601183|NCT03982186|455501418|FG003|Overall Study|Randomized and not treated|1|||
126601184|NCT03982186|455501419|FG004|Overall Study|Randomized and not treated|0|||
126601185|NCT03982186|455501420|FG005|Overall Study|Randomized and not treated|0|||
126601186|NCT03417284|455501958|FG000|Overall Study|Inadequate supply on study drug|1|||
126601187|NCT03417284|455501959|FG001|Overall Study|Inadequate supply on study drug|0|||
126601188|NCT03417284|455501960|FG002|Overall Study|Inadequate supply on study drug|0|||
126601189|NCT03417284|455501961|FG003|Overall Study|Inadequate supply on study drug|0|||
126601190|NCT03417284|455501958|FG000|Overall Study|Disease Progression|0|||
126601191|NCT03417284|455501959|FG001|Overall Study|Disease Progression|0|||
126601192|NCT03417284|455501960|FG002|Overall Study|Disease Progression|1|||
126601193|NCT03417284|455501961|FG003|Overall Study|Disease Progression|0|||
126601194|NCT05132400|455501962|FG000|Overall Study|Withdrawal by Subject|14|||
126601195|NCT05132400|455501963|FG001|Overall Study|Withdrawal by Subject|8|||
126601196|NCT05132400|455501962|FG000|Overall Study|Lost to Follow-up|132|||
126601197|NCT05132400|455501963|FG001|Overall Study|Lost to Follow-up|121|||
126601198|NCT03333915|455501968|FG000|Overall Study|Lost to Follow-up|0|||
126601199|NCT03333915|455501969|FG001|Overall Study|Lost to Follow-up|0|||
126601200|NCT03333915|455501970|FG002|Overall Study|Lost to Follow-up|1|||
126601201|NCT03333915|455501971|FG003|Overall Study|Lost to Follow-up|0|||
126601202|NCT03333915|455501972|FG004|Overall Study|Lost to Follow-up|0|||
126601203|NCT03333915|455501968|FG000|Overall Study|Disease Progression|0|||
126601204|NCT03333915|455501969|FG001|Overall Study|Disease Progression|1|||
126780611|NCT01952574|456151290|FG005|Open-label Treatment Phase|Death|0|||
126780612|NCT01952574|456151291|FG006|Open-label Treatment Phase|Death|0|||
126780613|NCT01952574|456151285|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
126780614|NCT01952574|456151286|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
126601205|NCT03333915|455501970|FG002|Overall Study|Disease Progression|0|||
126601206|NCT03333915|455501971|FG003|Overall Study|Disease Progression|0|||
126601207|NCT03333915|455501972|FG004|Overall Study|Disease Progression|0|||
126601208|NCT03333915|455501968|FG000|Overall Study|Death|0|||
126601209|NCT03333915|455501969|FG001|Overall Study|Death|0|||
126601210|NCT03333915|455501970|FG002|Overall Study|Death|0|||
126601211|NCT03333915|455501971|FG003|Overall Study|Death|37|||
126601212|NCT03333915|455501972|FG004|Overall Study|Death|18|||
126601213|NCT03333915|455501968|FG000|Overall Study|Sponsor's Decision|0|||
126601214|NCT03333915|455501969|FG001|Overall Study|Sponsor's Decision|0|||
126601215|NCT03333915|455501970|FG002|Overall Study|Sponsor's Decision|0|||
126601216|NCT03333915|455501971|FG003|Overall Study|Sponsor's Decision|48|||
126601217|NCT03333915|455501972|FG004|Overall Study|Sponsor's Decision|4|||
126601218|NCT03333915|455501968|FG000|Overall Study|Withdrawal by Subject|0|||
126601219|NCT03333915|455501969|FG001|Overall Study|Withdrawal by Subject|0|||
126601220|NCT03333915|455501970|FG002|Overall Study|Withdrawal by Subject|0|||
126601221|NCT03333915|455501971|FG003|Overall Study|Withdrawal by Subject|5|||
126601222|NCT03333915|455501972|FG004|Overall Study|Withdrawal by Subject|1|||
126601223|NCT02777593|455501984|FG000|Overall Study|Still in study|1|||
126601224|NCT02777593|455501985|FG001|Overall Study|Still in study|32|||
126601225|NCT02777593|455501986|FG002|Overall Study|Still in study|3|||
126601226|NCT02777593|455501987|FG003|Overall Study|Still in study|6|||
126601227|NCT02777593|455501988|FG004|Overall Study|Still in study|5|||
126601228|NCT02777593|455501984|FG000|Overall Study|Death|21|||
126601229|NCT02777593|455501985|FG001|Overall Study|Death|28|||
126601230|NCT02777593|455501986|FG002|Overall Study|Death|0|||
126601231|NCT02777593|455501987|FG003|Overall Study|Death|5|||
126601232|NCT02777593|455501988|FG004|Overall Study|Death|0|||
126601233|NCT02777593|455501984|FG000|Overall Study|Withdrawal by Subject|8|||
126601234|NCT02777593|455501985|FG001|Overall Study|Withdrawal by Subject|4|||
126601235|NCT02777593|455501986|FG002|Overall Study|Withdrawal by Subject|1|||
126601236|NCT02777593|455501987|FG003|Overall Study|Withdrawal by Subject|1|||
126601237|NCT02777593|455501988|FG004|Overall Study|Withdrawal by Subject|0|||
126601238|NCT02777593|455501984|FG000|Overall Study|Lost to Follow-up|8|||
126601239|NCT02777593|455501985|FG001|Overall Study|Lost to Follow-up|16|||
126601240|NCT02777593|455501986|FG002|Overall Study|Lost to Follow-up|5|||
126601241|NCT02777593|455501987|FG003|Overall Study|Lost to Follow-up|0|||
126601242|NCT02777593|455501988|FG004|Overall Study|Lost to Follow-up|1|||
126601243|NCT02777593|455501984|FG000|Overall Study|Physician Decision|2|||
126601244|NCT02777593|455501985|FG001|Overall Study|Physician Decision|2|||
126601245|NCT02777593|455501986|FG002|Overall Study|Physician Decision|0|||
126601246|NCT02777593|455501987|FG003|Overall Study|Physician Decision|0|||
126601247|NCT02777593|455501988|FG004|Overall Study|Physician Decision|0|||
126601248|NCT02777593|455501984|FG000|Overall Study|Discontinued due to Other|1|||
126601249|NCT02777593|455501985|FG001|Overall Study|Discontinued due to Other|0|||
126601250|NCT02777593|455501986|FG002|Overall Study|Discontinued due to Other|0|||
126601251|NCT02777593|455501987|FG003|Overall Study|Discontinued due to Other|0|||
126601252|NCT02777593|455501988|FG004|Overall Study|Discontinued due to Other|0|||
126601253|NCT05785130|455501990|FG000|Overall Study|Withdrawal by Subject|1|||
126601254|NCT05785130|455501991|FG001|Overall Study|Withdrawal by Subject|0|||
126601255|NCT05785130|455501990|FG000|Overall Study|Lack of Efficacy|0|||
126601256|NCT05785130|455501991|FG001|Overall Study|Lack of Efficacy|1|||
126601257|NCT03522298|455501997|FG000|Overall Study|Adverse Event|1|||
126601258|NCT03522298|455501998|FG001|Overall Study|Adverse Event|0|||
126601259|NCT03522298|455501999|FG002|Overall Study|Adverse Event|0|||
126601260|NCT03522298|455502000|FG003|Overall Study|Adverse Event|1|||
126601261|NCT03522298|455501997|FG000|Overall Study|Death|2|||
126601262|NCT03522298|455501998|FG001|Overall Study|Death|4|||
126601263|NCT03522298|455501999|FG002|Overall Study|Death|8|||
126601264|NCT03522298|455502000|FG003|Overall Study|Death|8|||
126601265|NCT03522298|455501997|FG000|Overall Study|Patient decision|0|||
126601266|NCT03522298|455501998|FG001|Overall Study|Patient decision|2|||
126601267|NCT03522298|455501999|FG002|Overall Study|Patient decision|2|||
126601268|NCT03522298|455502000|FG003|Overall Study|Patient decision|2|||
126601269|NCT04795245|455502001|FG000|Overall Study|Unkown reason|7|||
126601270|NCT04795245|455502001|FG000|Overall Study|Death|17|||
126601271|NCT04795245|455502001|FG000|Overall Study|Other than listed|19|||
126601272|NCT04795245|455502001|FG000|Overall Study|Adverse Event|143|||
126601273|NCT04795245|455502001|FG000|Overall Study|Progressive disease|512|||
126601274|NCT04795245|455502001|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
126601275|NCT01897441|455502002|FG000|Overall Study|Lost to Follow-up|0|||
126601276|NCT01897441|455502003|FG001|Overall Study|Lost to Follow-up|0|||
126601277|NCT01897441|455502004|FG002|Overall Study|Lost to Follow-up|1|||
126601278|NCT01897441|455502005|FG003|Overall Study|Lost to Follow-up|0|||
126601279|NCT01897441|455502006|FG004|Overall Study|Lost to Follow-up|0|||
126601280|NCT01897441|455502007|FG005|Overall Study|Lost to Follow-up|0|||
126601281|NCT01897441|455502002|FG000|Overall Study|Withdrawal by Subject|0|||
126601282|NCT01897441|455502003|FG001|Overall Study|Withdrawal by Subject|0|||
126601283|NCT01897441|455502004|FG002|Overall Study|Withdrawal by Subject|0|||
126601284|NCT01897441|455502005|FG003|Overall Study|Withdrawal by Subject|0|||
126601285|NCT01897441|455502006|FG004|Overall Study|Withdrawal by Subject|1|||
126601286|NCT01897441|455502007|FG005|Overall Study|Withdrawal by Subject|0|||
126601287|NCT01897441|455502002|FG000|Overall Study|Withdrawn by Provider|0|||
126601288|NCT01897441|455502003|FG001|Overall Study|Withdrawn by Provider|2|||
126601289|NCT01897441|455502004|FG002|Overall Study|Withdrawn by Provider|0|||
126601290|NCT01897441|455502005|FG003|Overall Study|Withdrawn by Provider|0|||
126601291|NCT01897441|455502006|FG004|Overall Study|Withdrawn by Provider|0|||
126601292|NCT01897441|455502007|FG005|Overall Study|Withdrawn by Provider|0|||
126601293|NCT04093869|455502018|FG000|Overall Study|Death|0|||
126601294|NCT04093869|455502019|FG001|Overall Study|Death|1|||
126601295|NCT04093869|455502018|FG000|Overall Study|Withdrawal by Subject|1|||
126601296|NCT04093869|455502019|FG001|Overall Study|Withdrawal by Subject|0|||
126601297|NCT02806726|455502024|FG000|Overall Study|Lost to Follow-up|1|||
126780615|NCT01952574|456151287|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
126780616|NCT01952574|456151288|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
126780617|NCT01952574|456151289|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
126780618|NCT01952574|456151290|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
126780619|NCT01952574|456151291|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
126780620|NCT01952574|456151285|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
126780621|NCT01952574|456151286|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
126780622|NCT01952574|456151287|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
126780623|NCT01952574|456151288|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
126780624|NCT01952574|456151289|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
126780625|NCT01952574|456151290|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
126780626|NCT01952574|456151291|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
126780627|NCT02974114|456151297|FG000|Overall Study|Other (Not specified)|0|||
126780628|NCT02974114|456151298|FG001|Overall Study|Other (Not specified)|1|||
126780629|NCT02974114|456151299|FG002|Overall Study|Other (Not specified)|2|||
126780630|NCT01580020|456151300|FG000|Overall Study|Lack of Efficacy|0|||
126780631|NCT01580020|456151301|FG001|Overall Study|Lack of Efficacy|5|||
126780632|NCT01580020|456151302|FG002|Overall Study|Lack of Efficacy|0|||
126780633|NCT01580020|456151303|FG003|Overall Study|Lack of Efficacy|1|||
126780634|NCT01580020|456151300|FG000|Overall Study|Withdrawal by Subject|0|||
126780635|NCT01580020|456151301|FG001|Overall Study|Withdrawal by Subject|1|||
126780636|NCT01580020|456151302|FG002|Overall Study|Withdrawal by Subject|1|||
126780637|NCT01580020|456151303|FG003|Overall Study|Withdrawal by Subject|0|||
126780638|NCT01580020|456151300|FG000|Overall Study|Adverse Event|1|||
126780639|NCT01580020|456151301|FG001|Overall Study|Adverse Event|1|||
126780640|NCT01580020|456151302|FG002|Overall Study|Adverse Event|1|||
126780641|NCT01580020|456151303|FG003|Overall Study|Adverse Event|1|||
126780642|NCT01580020|456151300|FG000|Overall Study|Administrative Problems|0|||
126780643|NCT01580020|456151301|FG001|Overall Study|Administrative Problems|0|||
126780644|NCT01580020|456151302|FG002|Overall Study|Administrative Problems|1|||
126780645|NCT01580020|456151303|FG003|Overall Study|Administrative Problems|0|||
126780646|NCT01580020|456151300|FG000|Overall Study|Lost to Follow-up|0|||
126780647|NCT01580020|456151301|FG001|Overall Study|Lost to Follow-up|0|||
126780648|NCT01580020|456151302|FG002|Overall Study|Lost to Follow-up|1|||
126780649|NCT01580020|456151303|FG003|Overall Study|Lost to Follow-up|0|||
126780650|NCT01724359|456151304|FG000|Overall Study|Adverse Event|10|||
126780651|NCT01724359|456151304|FG000|Overall Study|Death|1|||
126780652|NCT01724359|456151304|FG000|Overall Study|Other|20|||
126780653|NCT01335464|456151311|FG000|Overall Study|Adverse Event|15|||
126780654|NCT01335464|456151312|FG001|Overall Study|Adverse Event|25|||
126780655|NCT01335464|456151311|FG000|Overall Study|Non compliant with protocol|2|||
126780656|NCT01335464|456151312|FG001|Overall Study|Non compliant with protocol|0|||
126780657|NCT01335464|456151311|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
126780658|NCT01335464|456151312|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
126780659|NCT01335464|456151311|FG000|Overall Study|Not treated|2|||
126780660|NCT01335464|456151312|FG001|Overall Study|Not treated|0|||
126780661|NCT01335464|456151311|FG000|Overall Study|Reason other than those stated above|1|||
126780662|NCT01335464|456151312|FG001|Overall Study|Reason other than those stated above|1|||
126780663|NCT00446654|456151313|FG000|Overall Study|Withdrawal by Subject|1|||
126601298|NCT05129501|455502025|FG000|Overall Study|Lost to Follow-up|54|||
126601299|NCT05129501|455502026|FG001|Overall Study|Lost to Follow-up|41|||
126601300|NCT04281498|455502027|FG000|Overall Study|Progression of disease|1|||
126601301|NCT04281498|455502027|FG000|Overall Study|Planned SCT|1|||
126601302|NCT04281498|455502027|FG000|Overall Study|Alternative Treatment|1|||
126601303|NCT05866926|455502028|FG000|Overall Study|Death|16|||
126601304|NCT05866926|455502029|FG001|Overall Study|Death|9|||
126601305|NCT05866926|455502028|FG000|Overall Study|Lost to Follow-up|0|||
126601306|NCT05866926|455502029|FG001|Overall Study|Lost to Follow-up|1|||
126601307|NCT05866926|455502028|FG000|Overall Study|Adverse Event|1|||
126601308|NCT05866926|455502029|FG001|Overall Study|Adverse Event|0|||
126601309|NCT05866926|455502028|FG000|Overall Study|Withdrawal by Subject|5|||
126601310|NCT05866926|455502029|FG001|Overall Study|Withdrawal by Subject|1|||
126780664|NCT00446654|456151314|FG001|Overall Study|Withdrawal by Subject|0|||
126780665|NCT00446654|456151313|FG000|Overall Study|Adverse Event|1|||
126780666|NCT00446654|456151314|FG001|Overall Study|Adverse Event|0|||
126780667|NCT00593333|456151319|FG000|Overall Study|Lost to Follow-up|10|||
126780668|NCT00593333|456151320|FG001|Overall Study|Lost to Follow-up|11|||
126780669|NCT01752920|456151321|FG000|Overall Study|Adverse Event|1|||
126780670|NCT01752920|456151322|FG001|Overall Study|Adverse Event|0|||
126780671|NCT01752920|456151323|FG002|Overall Study|Adverse Event|5|||
126601311|NCT05866926|455502028|FG000|Overall Study|Disease progression|1|||
126601312|NCT05866926|455502029|FG001|Overall Study|Disease progression|0|||
126601313|NCT05866926|455502028|FG000|Overall Study|other causes|2|||
126601314|NCT05866926|455502029|FG001|Overall Study|other causes|1|||
126601315|NCT05267639|455502293|FG000|Overall Study|Withdrawal by Subject|1|||
126780672|NCT01752920|456151324|FG003|Overall Study|Adverse Event|10|||
126780673|NCT01752920|456151321|FG000|Overall Study|Clinical Disease Progression|6|||
126601316|NCT05267639|455502294|FG001|Overall Study|Withdrawal by Subject|0|||
126601317|NCT02076009|455502297|FG000|Overall Study|Death|172|||
126601318|NCT02076009|455502298|FG001|Overall Study|Death|153|||
126601319|NCT02076009|455502297|FG000|Overall Study|Withdrawal by Subject|16|||
126601320|NCT02076009|455502298|FG001|Overall Study|Withdrawal by Subject|12|||
126601321|NCT02076009|455502297|FG000|Overall Study|Lost to Follow-up|4|||
126601322|NCT02076009|455502298|FG001|Overall Study|Lost to Follow-up|2|||
126601323|NCT02076009|455502297|FG000|Overall Study|Progressive Disease|1|||
126601324|NCT02076009|455502298|FG001|Overall Study|Progressive Disease|0|||
126601325|NCT02076009|455502297|FG000|Overall Study|Physician Decision|0|||
126601326|NCT02076009|455502298|FG001|Overall Study|Physician Decision|1|||
126601327|NCT02076009|455502297|FG000|Overall Study|End of data collection|90|||
126601328|NCT02076009|455502298|FG001|Overall Study|End of data collection|118|||
126601329|NCT03816397|455502303|FG000|Overall Study|Censored at interim analysis date.|13|||
126601330|NCT03816397|455502304|FG001|Overall Study|Censored at interim analysis date.|6|||
126601331|NCT03816397|455502303|FG000|Overall Study|Withdrawal by Subject|1|||
126601332|NCT03816397|455502304|FG001|Overall Study|Withdrawal by Subject|1|||
126601333|NCT05985395|455502305|FG000|Overall Study|Physician Decision|2|||
126601334|NCT05985395|455502306|FG001|Overall Study|Physician Decision|1|||
126601335|NCT05985395|455502305|FG000|Overall Study|Withdrawal by Subject|1|||
126601336|NCT05985395|455502306|FG001|Overall Study|Withdrawal by Subject|0|||
126601337|NCT03493542|455502307|FG000|Base Study|Withdrawal by Subject|0|||
126601338|NCT03493542|455502308|FG001|Base Study|Withdrawal by Subject|4|||
126601339|NCT03493542|455502309|FG002|Base Study|Withdrawal by Subject|0|||
126601340|NCT03493542|455502307|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
126601341|NCT03493542|455502308|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
126601342|NCT03493542|455502309|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
126601343|NCT03493542|455502307|FG000|Extension Study|Withdrawal by Subject|0|||
126601344|NCT03493542|455502308|FG001|Extension Study|Withdrawal by Subject|0|||
126601345|NCT03493542|455502309|FG002|Extension Study|Withdrawal by Subject|25|||
126601346|NCT05485935|455502310|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
126601347|NCT05485935|455502311|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
126601348|NCT05485935|455502310|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
126601349|NCT05485935|455502311|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
126601350|NCT05485935|455502310|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
126601351|NCT05485935|455502311|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
126601352|NCT05485935|455502310|FG000|Period 2 (T2 and V3)|loss of contact|0|||
126601353|NCT05485935|455502311|FG001|Period 2 (T2 and V3)|loss of contact|1|||
126601354|NCT01265537|455502317|FG000|Overall Study|Adverse Event|2|||
126601355|NCT01265537|455502318|FG001|Overall Study|Adverse Event|1|||
126601356|NCT01265537|455502317|FG000|Overall Study|Physician Decision|0|||
126601357|NCT01265537|455502318|FG001|Overall Study|Physician Decision|1|||
126601358|NCT03782116|455502319|FG000|Completed Intervetion|Lost to Follow-up|11|||
126601359|NCT03782116|455502320|FG001|Completed Intervetion|Lost to Follow-up|7|||
126601360|NCT03782116|455502319|FG000|Completed Intervetion|Withdrawal by Subject|6|||
126601361|NCT03782116|455502320|FG001|Completed Intervetion|Withdrawal by Subject|5|||
126601362|NCT03782116|455502319|FG000|Included in Analysis|Protocol Violation|5|||
126601363|NCT03782116|455502320|FG001|Included in Analysis|Protocol Violation|5|||
126601364|NCT00447980|455502809|FG000|Overall Study|Withdrawal by Subject|1|||
126601365|NCT00447980|455502810|FG001|Overall Study|Withdrawal by Subject|1|||
126601366|NCT00447980|455502811|FG002|Overall Study|Withdrawal by Subject|4|||
126601367|NCT00447980|455502812|FG003|Overall Study|Withdrawal by Subject|4|||
126601368|NCT00447980|455502809|FG000|Overall Study|Lost to Follow-up|1|||
126601369|NCT00447980|455502810|FG001|Overall Study|Lost to Follow-up|1|||
126601370|NCT00447980|455502811|FG002|Overall Study|Lost to Follow-up|0|||
126601371|NCT00447980|455502812|FG003|Overall Study|Lost to Follow-up|0|||
126601372|NCT00447980|455502809|FG000|Overall Study|Did not proceed with surgery|3|||
126601373|NCT00447980|455502810|FG001|Overall Study|Did not proceed with surgery|3|||
126601374|NCT00447980|455502811|FG002|Overall Study|Did not proceed with surgery|2|||
126601375|NCT00447980|455502812|FG003|Overall Study|Did not proceed with surgery|2|||
126601376|NCT03635567|455502815|FG000|Overall Study|Lost to Follow-up|4|||
126601377|NCT03635567|455502816|FG001|Overall Study|Lost to Follow-up|1|||
126601378|NCT03635567|455502815|FG000|Overall Study|Withdrawal by Subject|11|||
126601379|NCT03635567|455502816|FG001|Overall Study|Withdrawal by Subject|16|||
126601380|NCT03635567|455502815|FG000|Overall Study|Sponsor Decision|99|||
126601381|NCT03635567|455502816|FG001|Overall Study|Sponsor Decision|57|||
126601382|NCT03635567|455502815|FG000|Overall Study|Death|194|||
126601383|NCT03635567|455502816|FG001|Overall Study|Death|235|||
126601384|NCT05157841|455502817|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
126601385|NCT05157841|455502818|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
126601386|NCT05157841|455502819|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
126601387|NCT05157841|455502817|FG000|Part A (14 Days)|Adverse Event|1|||
126601388|NCT05157841|455502818|FG001|Part A (14 Days)|Adverse Event|0|||
126601389|NCT05157841|455502819|FG002|Part A (14 Days)|Adverse Event|0|||
126601390|NCT05157841|455502817|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
126601391|NCT05157841|455502818|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
126601392|NCT05157841|455502819|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
126601393|NCT04933474|455502822|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
126601394|NCT04933474|455502823|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
126601395|NCT04933474|455502822|FG000|Overall Study|Lost to Follow-up|19|||
126601396|NCT04933474|455502823|FG001|Overall Study|Lost to Follow-up|9|||
126601397|NCT04933474|455502822|FG000|Overall Study|Life Burden - unable to participate|6|||
126601398|NCT04933474|455502823|FG001|Overall Study|Life Burden - unable to participate|2|||
126601399|NCT04933474|455502822|FG000|Overall Study|Disease Burden - unable to participate|4|||
126601400|NCT04933474|455502823|FG001|Overall Study|Disease Burden - unable to participate|1|||
126601401|NCT04933474|455502822|FG000|Overall Study|Surgery/Hospitalization|1|||
126601402|NCT04933474|455502823|FG001|Overall Study|Surgery/Hospitalization|2|||
126601403|NCT04933474|455502822|FG000|Overall Study|Dissatisfied with Intervention|1|||
126601404|NCT04933474|455502823|FG001|Overall Study|Dissatisfied with Intervention|1|||
126601405|NCT04933474|455502822|FG000|Overall Study|Withdrew interest in participation|1|||
126601406|NCT04933474|455502823|FG001|Overall Study|Withdrew interest in participation|0|||
126601407|NCT04933474|455502822|FG000|Overall Study|Had previously enrolled in the study|0|||
126601408|NCT04933474|455502823|FG001|Overall Study|Had previously enrolled in the study|1|||
126601409|NCT00942734|455502833|FG000|Overall Study|Adverse Event|2|||
126601410|NCT00942734|455502833|FG000|Overall Study|Protocol Violation|3|||
126601411|NCT00942734|455502833|FG000|Overall Study|Disease Progression|2|||
126601412|NCT00942734|455502833|FG000|Overall Study|Physician Decision|1|||
126601413|NCT05718687|455502839|FG000|Overall Study|Withdrawal by Subject|3|||
126601414|NCT01527188|455502840|FG000|Overall Study|Adverse Event|5|||
126601415|NCT01527188|455502841|FG001|Overall Study|Adverse Event|5|||
126601416|NCT01527188|455502842|FG002|Overall Study|Adverse Event|11|||
126601417|NCT01527188|455502843|FG003|Overall Study|Adverse Event|0|||
126601418|NCT01527188|455502840|FG000|Overall Study|Withdrawal by Subject|3|||
126601419|NCT01527188|455502841|FG001|Overall Study|Withdrawal by Subject|6|||
126601420|NCT01527188|455502842|FG002|Overall Study|Withdrawal by Subject|4|||
126601421|NCT01527188|455502843|FG003|Overall Study|Withdrawal by Subject|4|||
126601422|NCT01527188|455502840|FG000|Overall Study|Any other reason not above-mentioned|6|||
126601423|NCT01527188|455502841|FG001|Overall Study|Any other reason not above-mentioned|7|||
126601424|NCT01527188|455502842|FG002|Overall Study|Any other reason not above-mentioned|8|||
126601425|NCT01527188|455502843|FG003|Overall Study|Any other reason not above-mentioned|8|||
126601426|NCT01220531|455502847|FG000|Overall Study|Death|7|||
126601427|NCT01220531|455502847|FG000|Overall Study|Lost to Follow-up|1|||
126601428|NCT04873232|455502848|FG000|Overall Study|Lost to Follow-up|1|||
126601429|NCT04873232|455502849|FG001|Overall Study|Lost to Follow-up|4|||
126601430|NCT04873232|455502848|FG000|Overall Study|Withdrawal by Subject|1|||
126601431|NCT04873232|455502849|FG001|Overall Study|Withdrawal by Subject|0|||
126601432|NCT02325154|455502850|FG000|Overall Study|Physician Decision|1|||
126601433|NCT03512301|455503467|FG000|Overall Study|Protocol Violation|2|||
126601434|NCT03512301|455503467|FG000|Overall Study|Did Not Qualify|3|||
126601435|NCT03512301|455503467|FG000|Overall Study|Age-ineligible|1|||
126601436|NCT03512301|455503467|FG000|Overall Study|Inadequate fluency with the English language|3|||
126601437|NCT02611687|455503472|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
126601438|NCT02611687|455503473|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
126601439|NCT03983382|455503474|FG000|Overall Study|Death|1|||
126601440|NCT03983382|455503474|FG000|Overall Study|Lost to Follow-up|3|||
126601441|NCT03983382|455503474|FG000|Overall Study|Physician Decision|2|||
126601442|NCT03983382|455503474|FG000|Overall Study|Withdrawal by Subject|10|||
126601443|NCT03983382|455503474|FG000|Overall Study|Change in cancer treatment|2|||
126601444|NCT04165213|455503475|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
126601445|NCT04165213|455503476|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
126601446|NCT04165213|455503475|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
126601447|NCT04165213|455503476|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
126601448|NCT04165213|455503475|FG000|Clinician Enrollment|Termination from site|0|||
126601449|NCT04165213|455503476|FG001|Clinician Enrollment|Termination from site|1|||
126601450|NCT04165213|455503475|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
126601451|NCT04165213|455503476|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
126601452|NCT04165213|455503475|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
126601453|NCT04165213|455503476|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
126601454|NCT04165213|455503475|FG000|Caregiver Enrollment|Physician Decision|1|||
126601455|NCT04165213|455503476|FG001|Caregiver Enrollment|Physician Decision|0|||
126601456|NCT04165213|455503475|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
126601457|NCT04165213|455503476|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
126601458|NCT04165213|455503475|FG000|Caregiver Enrollment|PLWD death|2|||
126601459|NCT04165213|455503476|FG001|Caregiver Enrollment|PLWD death|0|||
126601460|NCT04165213|455503475|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
126601461|NCT04165213|455503476|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
126601462|NCT04165213|455503475|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
126601463|NCT04165213|455503476|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
126601464|NCT04165213|455503475|FG000|PLWD Enrollment|Lost to Follow-up|1|||
126601465|NCT04165213|455503476|FG001|PLWD Enrollment|Lost to Follow-up|1|||
126601466|NCT04165213|455503475|FG000|PLWD Enrollment|Physician Decision|1|||
126601467|NCT04165213|455503476|FG001|PLWD Enrollment|Physician Decision|0|||
126601468|NCT04165213|455503475|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
126601469|NCT04165213|455503476|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
126601470|NCT04165213|455503475|FG000|PLWD Enrollment|Death|2|||
126601471|NCT04165213|455503476|FG001|PLWD Enrollment|Death|0|||
126601472|NCT04165213|455503475|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
126601473|NCT04165213|455503476|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
126601474|NCT04174170|455503477|FG000|Placebo Run-in Period|Not Randomized|38|||
126601475|NCT04174170|455503478|FG001|Placebo Run-in Period|Not Randomized|0|||
126601476|NCT04174170|455503479|FG002|Placebo Run-in Period|Not Randomized|0|||
126601477|NCT04174170|455503480|FG003|Placebo Run-in Period|Not Randomized|0|||
126601478|NCT04174170|455503477|FG000|Double Blind Treatment Period|Adverse Event|0|||
126601479|NCT04174170|455503478|FG001|Double Blind Treatment Period|Adverse Event|9|||
126601480|NCT04174170|455503479|FG002|Double Blind Treatment Period|Adverse Event|9|||
126601481|NCT04174170|455503480|FG003|Double Blind Treatment Period|Adverse Event|8|||
126601482|NCT04174170|455503477|FG000|Double Blind Treatment Period|Death|0|||
126601483|NCT04174170|455503478|FG001|Double Blind Treatment Period|Death|1|||
126601484|NCT04174170|455503479|FG002|Double Blind Treatment Period|Death|0|||
126601485|NCT04174170|455503480|FG003|Double Blind Treatment Period|Death|0|||
126601486|NCT04174170|455503477|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
126601487|NCT04174170|455503478|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
126601488|NCT04174170|455503479|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
126601489|NCT04174170|455503480|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
126601490|NCT04174170|455503477|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
126601491|NCT04174170|455503478|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
126601492|NCT04174170|455503479|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
126601493|NCT04174170|455503480|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
126601494|NCT04174170|455503477|FG000|Double Blind Treatment Period|Physician Decision|0|||
126601495|NCT04174170|455503478|FG001|Double Blind Treatment Period|Physician Decision|1|||
126601496|NCT04174170|455503479|FG002|Double Blind Treatment Period|Physician Decision|0|||
126601497|NCT04174170|455503480|FG003|Double Blind Treatment Period|Physician Decision|1|||
126601498|NCT04174170|455503477|FG000|Double Blind Treatment Period|Pregnancy|0|||
126601499|NCT04174170|455503478|FG001|Double Blind Treatment Period|Pregnancy|1|||
126601500|NCT04174170|455503479|FG002|Double Blind Treatment Period|Pregnancy|0|||
126601501|NCT04174170|455503480|FG003|Double Blind Treatment Period|Pregnancy|1|||
126601502|NCT04174170|455503477|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
126601503|NCT04174170|455503478|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
126601504|NCT04174170|455503479|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
126601505|NCT04174170|455503480|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
126601506|NCT04174170|455503477|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
126601507|NCT04174170|455503478|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
126601508|NCT04174170|455503479|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
126601509|NCT04174170|455503480|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
126601510|NCT04174170|455503477|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
126601511|NCT04174170|455503478|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
126601512|NCT04174170|455503479|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
126601513|NCT04174170|455503480|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
126601514|NCT04772534|455503488|FG000|Overall Study|Physician Decision|1|||
126601515|NCT04772534|455503489|FG001|Overall Study|Physician Decision|0|||
126601516|NCT04772534|455503490|FG002|Overall Study|Physician Decision|0|||
126601517|NCT04772534|455503488|FG000|Overall Study|Withdrawal by Subject|3|||
126733495|NCT01021813|455972393|FG000|DB Treatment Phase|Adverse Event|60|||
126733496|NCT01021813|455972394|FG001|DB Treatment Phase|Adverse Event|22|||
126733497|NCT01021813|455972395|FG002|DB Treatment Phase|Adverse Event|0|||
126733498|NCT01021813|455972396|FG003|DB Treatment Phase|Adverse Event|0|||
126733499|NCT01021813|455972397|FG004|DB Treatment Phase|Adverse Event|0|||
126733500|NCT01021813|455972393|FG000|DB Treatment Phase|Lack of Efficacy|44|||
126733501|NCT01021813|455972394|FG001|DB Treatment Phase|Lack of Efficacy|28|||
126733502|NCT01021813|455972395|FG002|DB Treatment Phase|Lack of Efficacy|0|||
126601518|NCT04772534|455503489|FG001|Overall Study|Withdrawal by Subject|0|||
126601519|NCT04772534|455503490|FG002|Overall Study|Withdrawal by Subject|1|||
126601520|NCT03242915|455503507|FG000|Overall Study|Adverse Event|5|||
126733503|NCT01021813|455972396|FG003|DB Treatment Phase|Lack of Efficacy|0|||
126601521|NCT03242915|455503508|FG001|Overall Study|Adverse Event|1|||
126601522|NCT03242915|455503507|FG000|Overall Study|Withdrawal by Subject|0|||
126601523|NCT03242915|455503508|FG001|Overall Study|Withdrawal by Subject|2|||
126601524|NCT03242915|455503507|FG000|Overall Study|Physician Decision|4|||
126601525|NCT03242915|455503508|FG001|Overall Study|Physician Decision|1|||
126601526|NCT05988398|455503509|FG000|Overall Study|Lack of time|21|||
126733504|NCT01021813|455972397|FG004|DB Treatment Phase|Lack of Efficacy|0|||
126601527|NCT05988398|455503510|FG001|Overall Study|Lack of time|0|||
126601528|NCT05988398|455503509|FG000|Overall Study|Absent from school|0|||
126601529|NCT05988398|455503510|FG001|Overall Study|Absent from school|38|||
126601530|NCT05988398|455503509|FG000|Overall Study|Chose not to participate|0|||
126601531|NCT05988398|455503510|FG001|Overall Study|Chose not to participate|42|||
126601532|NCT05988398|455503509|FG000|Overall Study|Other commitments (e.g., sports)|0|||
126601533|NCT05988398|455503510|FG001|Overall Study|Other commitments (e.g., sports)|25|||
126601534|NCT04908930|455503521|FG000|Overall Study|Lost to Follow-up|1|||
126601535|NCT04908930|455503522|FG001|Overall Study|Lost to Follow-up|1|||
126601536|NCT04908930|455503523|FG002|Overall Study|Lost to Follow-up|0|||
126601537|NCT04908930|455503524|FG003|Overall Study|Lost to Follow-up|0|||
126601538|NCT04908930|455503525|FG004|Overall Study|Lost to Follow-up|0|||
126601539|NCT04908930|455503521|FG000|Overall Study|hardware in mouth|1|||
126601540|NCT04908930|455503522|FG001|Overall Study|hardware in mouth|1|||
126601541|NCT04908930|455503523|FG002|Overall Study|hardware in mouth|0|||
126601542|NCT04908930|455503524|FG003|Overall Study|hardware in mouth|0|||
126601543|NCT04908930|455503525|FG004|Overall Study|hardware in mouth|0|||
126601544|NCT04908930|455503521|FG000|Overall Study|wrong team|1|||
126601545|NCT04908930|455503522|FG001|Overall Study|wrong team|0|||
126601546|NCT04908930|455503523|FG002|Overall Study|wrong team|0|||
126601547|NCT04908930|455503524|FG003|Overall Study|wrong team|0|||
126601548|NCT04908930|455503525|FG004|Overall Study|wrong team|0|||
126601549|NCT04908930|455503521|FG000|Overall Study|quit team|2|||
126601550|NCT04908930|455503522|FG001|Overall Study|quit team|4|||
126601551|NCT04908930|455503523|FG002|Overall Study|quit team|0|||
126601552|NCT04908930|455503524|FG003|Overall Study|quit team|0|||
126601553|NCT04908930|455503525|FG004|Overall Study|quit team|0|||
126601554|NCT04908930|455503521|FG000|Overall Study|Withdrawal by Subject|1|||
126601555|NCT04908930|455503522|FG001|Overall Study|Withdrawal by Subject|2|||
126601556|NCT04908930|455503523|FG002|Overall Study|Withdrawal by Subject|0|||
126601557|NCT04908930|455503524|FG003|Overall Study|Withdrawal by Subject|0|||
126601558|NCT04908930|455503525|FG004|Overall Study|Withdrawal by Subject|0|||
126601559|NCT04908930|455503521|FG000|Overall Study|parent not liking program|0|||
126601560|NCT04908930|455503522|FG001|Overall Study|parent not liking program|1|||
126601561|NCT04908930|455503523|FG002|Overall Study|parent not liking program|0|||
126601562|NCT04908930|455503524|FG003|Overall Study|parent not liking program|0|||
126601563|NCT04908930|455503525|FG004|Overall Study|parent not liking program|0|||
126601564|NCT04586244|455503526|FG000|Overall Study|Lost to Follow-up|1|||
126601565|NCT04586244|455503527|FG001|Overall Study|Lost to Follow-up|0|||
126601566|NCT04586244|455503528|FG002|Overall Study|Lost to Follow-up|0|||
126601567|NCT04586244|455503529|FG003|Overall Study|Lost to Follow-up|1|||
126601568|NCT04586244|455503530|FG004|Overall Study|Lost to Follow-up|0|||
126601569|NCT04586244|455503526|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
126601570|NCT04586244|455503527|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
126601571|NCT04586244|455503528|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
126601572|NCT04586244|455503529|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
126601573|NCT04586244|455503530|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
126601574|NCT03872466|455503533|FG000|Overall Study|Withdrawal by Subject|1|||
126601575|NCT03872466|455503534|FG001|Overall Study|Withdrawal by Subject|0|||
126601576|NCT03872466|455503533|FG000|Overall Study|Physician Decision|2|||
126601577|NCT03872466|455503534|FG001|Overall Study|Physician Decision|0|||
126601578|NCT05771467|455503535|FG000|Overall Study|Lost to Follow-up|6|||
126601579|NCT05771467|455503536|FG001|Overall Study|Lost to Follow-up|3|||
126601580|NCT00709956|455503539|FG000|Overall Study|Withdrawal by Subject|1|||
126601581|NCT00709956|455503540|FG001|Overall Study|Withdrawal by Subject|1|||
126601582|NCT00709956|455503539|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
126601583|NCT00709956|455503540|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
126601584|NCT04194450|455504059|FG000|Overall Study|not eligible|1|||
126601585|NCT04194450|455504060|FG001|Overall Study|not eligible|0|||
126601586|NCT00328783|455504063|FG000|Overall Study|Could not tolerate ABC|21|||
126601587|NCT00328783|455504063|FG000|Overall Study|No heart in RT field|4|||
126601588|NCT00328783|455504063|FG000|Overall Study|Withdrawal by Subject|1|||
126601589|NCT04408755|455504065|FG000|Period A (Placebo lead-in)|Other|11|||
126601590|NCT04408755|455504066|FG001|Period A (Placebo lead-in)|Other|0|||
126601591|NCT04408755|455504067|FG002|Period A (Placebo lead-in)|Other|0|||
126601592|NCT04408755|455504068|FG003|Period A (Placebo lead-in)|Other|0|||
126601593|NCT04408755|455504065|FG000|Period B (Randomization Period)|Adverse Event|0|||
126780674|NCT01752920|456151322|FG001|Overall Study|Clinical Disease Progression|4|||
126601594|NCT04408755|455504066|FG001|Period B (Randomization Period)|Adverse Event|3|||
126601595|NCT04408755|455504067|FG002|Period B (Randomization Period)|Adverse Event|0|||
126601596|NCT04408755|455504068|FG003|Period B (Randomization Period)|Adverse Event|1|||
126601597|NCT04408755|455504065|FG000|Period B (Randomization Period)|Death|0|||
126601598|NCT04408755|455504066|FG001|Period B (Randomization Period)|Death|0|||
126601599|NCT04408755|455504067|FG002|Period B (Randomization Period)|Death|1|||
126601600|NCT04408755|455504068|FG003|Period B (Randomization Period)|Death|0|||
126601601|NCT04408755|455504065|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
126601602|NCT04408755|455504066|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
126601603|NCT04408755|455504067|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
126601604|NCT04408755|455504068|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
126601605|NCT04408755|455504065|FG000|Period B (Randomization Period)|Physician Decision|0|||
126601606|NCT04408755|455504066|FG001|Period B (Randomization Period)|Physician Decision|0|||
126601607|NCT04408755|455504067|FG002|Period B (Randomization Period)|Physician Decision|1|||
126601608|NCT04408755|455504068|FG003|Period B (Randomization Period)|Physician Decision|0|||
126601609|NCT04408755|455504065|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
126601610|NCT04408755|455504066|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
126601611|NCT04408755|455504067|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
126601612|NCT04408755|455504068|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
126601613|NCT04408755|455504065|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
126601614|NCT04408755|455504066|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
126601615|NCT04408755|455504067|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
126601616|NCT04408755|455504068|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
126601617|NCT04408755|455504065|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
126601618|NCT04408755|455504066|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
126601619|NCT04408755|455504067|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
126601620|NCT04408755|455504068|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
126601621|NCT04408755|455504065|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
126601622|NCT04408755|455504066|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
126601623|NCT04408755|455504067|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
126601624|NCT04408755|455504068|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
126601625|NCT04408755|455504065|FG000|Period B (Randomization Period)|Reason not Specified|0|||
126601626|NCT04408755|455504066|FG001|Period B (Randomization Period)|Reason not Specified|1|||
126601627|NCT04408755|455504067|FG002|Period B (Randomization Period)|Reason not Specified|0|||
126601628|NCT04408755|455504068|FG003|Period B (Randomization Period)|Reason not Specified|2|||
126601629|NCT00308997|455504069|FG000|Overall Study|Subject feigned clinical data|0|||
126601630|NCT00308997|455504070|FG001|Overall Study|Subject feigned clinical data|1|||
126601631|NCT00308997|455504069|FG000|Overall Study|Unable to tolerate intervention|1|||
126601632|NCT00308997|455504070|FG001|Overall Study|Unable to tolerate intervention|0|||
126601633|NCT04490356|455504071|FG000|Overall Study|Lost to Follow-up|1|||
126601634|NCT03733626|455504072|FG000|Overall Study|Physician Decision|4|||
126601635|NCT03733626|455504073|FG001|Overall Study|Physician Decision|4|||
126601636|NCT03142009|455504084|FG000|Overall Study|Lost to Follow-up|45|||
126601637|NCT03142009|455504085|FG001|Overall Study|Lost to Follow-up|30|||
126601638|NCT01778686|455504086|FG000|Overall Study|Adverse Event|0|||
126601639|NCT01778686|455504087|FG001|Overall Study|Adverse Event|0|||
126601640|NCT01778686|455504088|FG002|Overall Study|Adverse Event|1|||
126601641|NCT01499368|455504089|FG000|Overall Study|Did not meet I/E criteria|8|||
126601642|NCT01499368|455504090|FG001|Overall Study|Did not meet I/E criteria|4|||
126601643|NCT01499368|455504091|FG002|Overall Study|Did not meet I/E criteria|4|||
126601644|NCT01499368|455504089|FG000|Overall Study|Prohibited Concomitant medication|1|||
126601645|NCT01499368|455504090|FG001|Overall Study|Prohibited Concomitant medication|1|||
126733505|NCT01021813|455972393|FG000|DB Treatment Phase|Lost to Follow-up|14|||
126733506|NCT01021813|455972394|FG001|DB Treatment Phase|Lost to Follow-up|12|||
126733507|NCT01021813|455972395|FG002|DB Treatment Phase|Lost to Follow-up|0|||
126601646|NCT01499368|455504091|FG002|Overall Study|Prohibited Concomitant medication|0|||
126601647|NCT01499368|455504089|FG000|Overall Study|Withdrawal by Subject|11|||
126601648|NCT01499368|455504090|FG001|Overall Study|Withdrawal by Subject|10|||
126601649|NCT01499368|455504091|FG002|Overall Study|Withdrawal by Subject|8|||
126601650|NCT01499368|455504089|FG000|Overall Study|Lost to Follow-up|3|||
126601651|NCT01499368|455504090|FG001|Overall Study|Lost to Follow-up|2|||
126601652|NCT01499368|455504091|FG002|Overall Study|Lost to Follow-up|5|||
126601653|NCT01499368|455504089|FG000|Overall Study|Adverse Event|4|||
126601654|NCT01499368|455504090|FG001|Overall Study|Adverse Event|0|||
126601655|NCT01499368|455504091|FG002|Overall Study|Adverse Event|2|||
126601656|NCT01499368|455504089|FG000|Overall Study|Physician Decision|0|||
126601657|NCT01499368|455504090|FG001|Overall Study|Physician Decision|1|||
126601658|NCT01499368|455504091|FG002|Overall Study|Physician Decision|0|||
126601659|NCT01499368|455504089|FG000|Overall Study|Deviation from visit window|0|||
126601660|NCT01499368|455504090|FG001|Overall Study|Deviation from visit window|0|||
126601661|NCT01499368|455504091|FG002|Overall Study|Deviation from visit window|1|||
126601662|NCT01499368|455504089|FG000|Overall Study|Error of Prescriptions|0|||
126601663|NCT01499368|455504090|FG001|Overall Study|Error of Prescriptions|0|||
126601664|NCT01499368|455504091|FG002|Overall Study|Error of Prescriptions|1|||
126601665|NCT06059443|455504092|FG000|Overall Study|Withdrawal by Subject|2|||
126601666|NCT06059443|455504093|FG001|Overall Study|Withdrawal by Subject|0|||
126601667|NCT06059443|455504092|FG000|Overall Study|Lost to Follow-up|2|||
126601668|NCT06059443|455504093|FG001|Overall Study|Lost to Follow-up|2|||
126601669|NCT03092674|455504094|FG000|Overall Study|Adverse Event or Side Effects|1|||
126601670|NCT03092674|455504095|FG001|Overall Study|Adverse Event or Side Effects|4|||
126601671|NCT03092674|455504096|FG002|Overall Study|Adverse Event or Side Effects|4|||
126601672|NCT03092674|455504094|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
126601673|NCT03092674|455504095|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
126601674|NCT03092674|455504096|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
126601675|NCT03092674|455504094|FG000|Overall Study|Progression/Relapse|5|||
126601676|NCT03092674|455504095|FG001|Overall Study|Progression/Relapse|4|||
126601677|NCT03092674|455504096|FG002|Overall Study|Progression/Relapse|8|||
126601678|NCT03092674|455504094|FG000|Overall Study|Death|4|||
126601679|NCT03092674|455504095|FG001|Overall Study|Death|8|||
126601680|NCT03092674|455504096|FG002|Overall Study|Death|2|||
126601681|NCT03092674|455504094|FG000|Overall Study|Other - Not Protocol Specified|11|||
126601682|NCT03092674|455504095|FG001|Overall Study|Other - Not Protocol Specified|8|||
126601683|NCT03092674|455504096|FG002|Overall Study|Other - Not Protocol Specified|8|||
126601684|NCT01105091|455504098|FG000|Overall Study|Death|2|||
126601685|NCT01105091|455504099|FG001|Overall Study|Death|0|||
126601686|NCT03008382|455504100|FG000|Overall Study|Withdrawal by Subject|2|||
126601687|NCT03008382|455504101|FG001|Overall Study|Withdrawal by Subject|5|||
126601688|NCT03008382|455504102|FG002|Overall Study|Withdrawal by Subject|2|||
126601689|NCT03008382|455504103|FG003|Overall Study|Withdrawal by Subject|0|||
126601690|NCT03008382|455504100|FG000|Overall Study|Protocol Violation|1|||
126601691|NCT03008382|455504101|FG001|Overall Study|Protocol Violation|0|||
126601692|NCT03008382|455504102|FG002|Overall Study|Protocol Violation|0|||
126601693|NCT03008382|455504103|FG003|Overall Study|Protocol Violation|0|||
126601694|NCT03008382|455504100|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
126601695|NCT03008382|455504101|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
126601696|NCT03008382|455504102|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
126601697|NCT03008382|455504103|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
126601698|NCT03008382|455504100|FG000|Overall Study|Lost to Follow-up|0|||
126601699|NCT03008382|455504101|FG001|Overall Study|Lost to Follow-up|0|||
126601700|NCT03008382|455504102|FG002|Overall Study|Lost to Follow-up|1|||
126601701|NCT03008382|455504103|FG003|Overall Study|Lost to Follow-up|0|||
126601702|NCT03008382|455504100|FG000|Overall Study|Screenfail|0|||
126601703|NCT03008382|455504101|FG001|Overall Study|Screenfail|0|||
126601704|NCT03008382|455504102|FG002|Overall Study|Screenfail|2|||
126601705|NCT03008382|455504103|FG003|Overall Study|Screenfail|0|||
126601706|NCT00994643|455504796|FG000|Overall Study|Withdrawal by Subject|1|||
126601707|NCT02720068|455504797|FG000|Overall Study|Adverse Event|0|||
126601708|NCT02720068|455504798|FG001|Overall Study|Adverse Event|0|||
126601709|NCT02720068|455504799|FG002|Overall Study|Adverse Event|0|||
126601710|NCT02720068|455504800|FG003|Overall Study|Adverse Event|0|||
126601711|NCT02720068|455504801|FG004|Overall Study|Adverse Event|0|||
126601712|NCT02720068|455504802|FG005|Overall Study|Adverse Event|0|||
126601713|NCT02720068|455504803|FG006|Overall Study|Adverse Event|0|||
126601714|NCT02720068|455504804|FG007|Overall Study|Adverse Event|0|||
126601715|NCT02720068|455504805|FG008|Overall Study|Adverse Event|0|||
126601716|NCT02720068|455504806|FG009|Overall Study|Adverse Event|0|||
126601717|NCT02720068|455504807|FG010|Overall Study|Adverse Event|0|||
126601718|NCT02720068|455504808|FG011|Overall Study|Adverse Event|1|||
126601719|NCT02720068|455504809|FG012|Overall Study|Adverse Event|0|||
126601720|NCT02720068|455504810|FG013|Overall Study|Adverse Event|0|||
126601721|NCT02720068|455504811|FG014|Overall Study|Adverse Event|0|||
126601722|NCT02720068|455504812|FG015|Overall Study|Adverse Event|0|||
126601723|NCT02720068|455504813|FG016|Overall Study|Adverse Event|0|||
126601724|NCT02720068|455504814|FG017|Overall Study|Adverse Event|0|||
126601725|NCT02720068|455504797|FG000|Overall Study|Death|1|||
126601726|NCT02720068|455504798|FG001|Overall Study|Death|3|||
126601727|NCT02720068|455504799|FG002|Overall Study|Death|2|||
126601728|NCT02720068|455504800|FG003|Overall Study|Death|1|||
126601729|NCT02720068|455504801|FG004|Overall Study|Death|2|||
126601730|NCT02720068|455504802|FG005|Overall Study|Death|1|||
126601731|NCT02720068|455504803|FG006|Overall Study|Death|2|||
126601732|NCT02720068|455504804|FG007|Overall Study|Death|2|||
126601733|NCT02720068|455504805|FG008|Overall Study|Death|3|||
126601734|NCT02720068|455504806|FG009|Overall Study|Death|1|||
126601735|NCT02720068|455504807|FG010|Overall Study|Death|20|||
126601736|NCT02720068|455504808|FG011|Overall Study|Death|166|||
126601737|NCT02720068|455504809|FG012|Overall Study|Death|34|||
126601738|NCT02720068|455504810|FG013|Overall Study|Death|30|||
126601739|NCT02720068|455504811|FG014|Overall Study|Death|45|||
126601740|NCT02720068|455504812|FG015|Overall Study|Death|16|||
126601741|NCT02720068|455504813|FG016|Overall Study|Death|20|||
126601742|NCT02720068|455504814|FG017|Overall Study|Death|28|||
126601743|NCT02720068|455504797|FG000|Overall Study|Lost to Follow-up|0|||
126601744|NCT02720068|455504798|FG001|Overall Study|Lost to Follow-up|0|||
126601745|NCT02720068|455504799|FG002|Overall Study|Lost to Follow-up|0|||
126601746|NCT02720068|455504800|FG003|Overall Study|Lost to Follow-up|0|||
126601747|NCT02720068|455504801|FG004|Overall Study|Lost to Follow-up|0|||
126601748|NCT02720068|455504802|FG005|Overall Study|Lost to Follow-up|0|||
126780675|NCT01752920|456151323|FG002|Overall Study|Clinical Disease Progression|1|||
126780676|NCT01752920|456151324|FG003|Overall Study|Clinical Disease Progression|13|||
126601749|NCT02720068|455504803|FG006|Overall Study|Lost to Follow-up|0|||
126601750|NCT02720068|455504804|FG007|Overall Study|Lost to Follow-up|0|||
126601751|NCT02720068|455504805|FG008|Overall Study|Lost to Follow-up|0|||
126601752|NCT02720068|455504806|FG009|Overall Study|Lost to Follow-up|0|||
126601753|NCT02720068|455504807|FG010|Overall Study|Lost to Follow-up|0|||
126601754|NCT02720068|455504808|FG011|Overall Study|Lost to Follow-up|1|||
126601755|NCT02720068|455504809|FG012|Overall Study|Lost to Follow-up|0|||
126601756|NCT02720068|455504810|FG013|Overall Study|Lost to Follow-up|1|||
126601757|NCT02720068|455504811|FG014|Overall Study|Lost to Follow-up|2|||
126601758|NCT02720068|455504812|FG015|Overall Study|Lost to Follow-up|0|||
126601759|NCT02720068|455504813|FG016|Overall Study|Lost to Follow-up|0|||
126601760|NCT02720068|455504814|FG017|Overall Study|Lost to Follow-up|1|||
126601761|NCT02720068|455504797|FG000|Overall Study|Physician Decision|0|||
126601762|NCT02720068|455504798|FG001|Overall Study|Physician Decision|0|||
126601763|NCT02720068|455504799|FG002|Overall Study|Physician Decision|0|||
126601764|NCT02720068|455504800|FG003|Overall Study|Physician Decision|1|||
126601765|NCT02720068|455504801|FG004|Overall Study|Physician Decision|0|||
126601766|NCT02720068|455504802|FG005|Overall Study|Physician Decision|0|||
126601767|NCT02720068|455504803|FG006|Overall Study|Physician Decision|0|||
126601768|NCT02720068|455504804|FG007|Overall Study|Physician Decision|0|||
126601769|NCT02720068|455504805|FG008|Overall Study|Physician Decision|0|||
126601770|NCT02720068|455504806|FG009|Overall Study|Physician Decision|0|||
126601771|NCT02720068|455504807|FG010|Overall Study|Physician Decision|0|||
126601772|NCT02720068|455504808|FG011|Overall Study|Physician Decision|1|||
126601773|NCT02720068|455504809|FG012|Overall Study|Physician Decision|0|||
126601774|NCT02720068|455504810|FG013|Overall Study|Physician Decision|0|||
126601775|NCT02720068|455504811|FG014|Overall Study|Physician Decision|0|||
126601776|NCT02720068|455504812|FG015|Overall Study|Physician Decision|0|||
126601777|NCT02720068|455504813|FG016|Overall Study|Physician Decision|0|||
126601778|NCT02720068|455504814|FG017|Overall Study|Physician Decision|1|||
126601779|NCT02720068|455504797|FG000|Overall Study|Progressive Disease|2|||
126601780|NCT02720068|455504798|FG001|Overall Study|Progressive Disease|3|||
126601781|NCT02720068|455504799|FG002|Overall Study|Progressive Disease|1|||
126601782|NCT02720068|455504800|FG003|Overall Study|Progressive Disease|1|||
126601783|NCT02720068|455504801|FG004|Overall Study|Progressive Disease|1|||
126601784|NCT02720068|455504802|FG005|Overall Study|Progressive Disease|2|||
126601785|NCT02720068|455504803|FG006|Overall Study|Progressive Disease|1|||
126601786|NCT02720068|455504804|FG007|Overall Study|Progressive Disease|1|||
126601787|NCT02720068|455504805|FG008|Overall Study|Progressive Disease|0|||
126601788|NCT02720068|455504806|FG009|Overall Study|Progressive Disease|1|||
126601789|NCT02720068|455504807|FG010|Overall Study|Progressive Disease|0|||
126601790|NCT02720068|455504808|FG011|Overall Study|Progressive Disease|4|||
126601791|NCT02720068|455504809|FG012|Overall Study|Progressive Disease|1|||
126601792|NCT02720068|455504810|FG013|Overall Study|Progressive Disease|0|||
126601793|NCT02720068|455504811|FG014|Overall Study|Progressive Disease|0|||
126601794|NCT02720068|455504812|FG015|Overall Study|Progressive Disease|0|||
126601795|NCT02720068|455504813|FG016|Overall Study|Progressive Disease|0|||
126601796|NCT02720068|455504814|FG017|Overall Study|Progressive Disease|0|||
126601797|NCT02720068|455504797|FG000|Overall Study|Sponsor Decision|0|||
126601798|NCT02720068|455504798|FG001|Overall Study|Sponsor Decision|0|||
126601799|NCT02720068|455504799|FG002|Overall Study|Sponsor Decision|0|||
126601800|NCT02720068|455504800|FG003|Overall Study|Sponsor Decision|0|||
126601801|NCT02720068|455504801|FG004|Overall Study|Sponsor Decision|0|||
126601802|NCT02720068|455504802|FG005|Overall Study|Sponsor Decision|0|||
126601803|NCT02720068|455504803|FG006|Overall Study|Sponsor Decision|0|||
126601804|NCT02720068|455504804|FG007|Overall Study|Sponsor Decision|0|||
126601805|NCT02720068|455504805|FG008|Overall Study|Sponsor Decision|0|||
126601806|NCT02720068|455504806|FG009|Overall Study|Sponsor Decision|0|||
126601807|NCT02720068|455504807|FG010|Overall Study|Sponsor Decision|0|||
126601808|NCT02720068|455504808|FG011|Overall Study|Sponsor Decision|6|||
126601809|NCT02720068|455504809|FG012|Overall Study|Sponsor Decision|3|||
126601810|NCT02720068|455504810|FG013|Overall Study|Sponsor Decision|2|||
126601811|NCT02720068|455504811|FG014|Overall Study|Sponsor Decision|4|||
126601812|NCT02720068|455504812|FG015|Overall Study|Sponsor Decision|4|||
126601813|NCT02720068|455504813|FG016|Overall Study|Sponsor Decision|0|||
126601814|NCT02720068|455504814|FG017|Overall Study|Sponsor Decision|8|||
126601815|NCT02720068|455504797|FG000|Overall Study|Withdrawal by Subject|0|||
126601816|NCT02720068|455504798|FG001|Overall Study|Withdrawal by Subject|0|||
126601817|NCT02720068|455504799|FG002|Overall Study|Withdrawal by Subject|0|||
126601818|NCT02720068|455504800|FG003|Overall Study|Withdrawal by Subject|0|||
126601819|NCT02720068|455504801|FG004|Overall Study|Withdrawal by Subject|0|||
126601820|NCT02720068|455504802|FG005|Overall Study|Withdrawal by Subject|0|||
126601821|NCT02720068|455504803|FG006|Overall Study|Withdrawal by Subject|0|||
126601822|NCT02720068|455504804|FG007|Overall Study|Withdrawal by Subject|0|||
126601823|NCT02720068|455504805|FG008|Overall Study|Withdrawal by Subject|0|||
126601824|NCT02720068|455504806|FG009|Overall Study|Withdrawal by Subject|1|||
126601825|NCT02720068|455504807|FG010|Overall Study|Withdrawal by Subject|0|||
126601826|NCT02720068|455504808|FG011|Overall Study|Withdrawal by Subject|27|||
126601827|NCT02720068|455504809|FG012|Overall Study|Withdrawal by Subject|2|||
126601828|NCT02720068|455504810|FG013|Overall Study|Withdrawal by Subject|8|||
126601829|NCT02720068|455504811|FG014|Overall Study|Withdrawal by Subject|7|||
126601830|NCT02720068|455504812|FG015|Overall Study|Withdrawal by Subject|0|||
126601831|NCT02720068|455504813|FG016|Overall Study|Withdrawal by Subject|0|||
126601832|NCT02720068|455504814|FG017|Overall Study|Withdrawal by Subject|2|||
126601833|NCT02720068|455504797|FG000|Overall Study|Protocol Violation|0|||
126601834|NCT02720068|455504798|FG001|Overall Study|Protocol Violation|0|||
126601835|NCT02720068|455504799|FG002|Overall Study|Protocol Violation|0|||
126601836|NCT02720068|455504800|FG003|Overall Study|Protocol Violation|0|||
126601837|NCT02720068|455504801|FG004|Overall Study|Protocol Violation|0|||
126601838|NCT02720068|455504802|FG005|Overall Study|Protocol Violation|0|||
126780677|NCT01752920|456151321|FG000|Overall Study|Physician Decision|1|||
126601839|NCT02720068|455504803|FG006|Overall Study|Protocol Violation|0|||
126601840|NCT02720068|455504804|FG007|Overall Study|Protocol Violation|0|||
126601841|NCT02720068|455504805|FG008|Overall Study|Protocol Violation|0|||
126601842|NCT02720068|455504806|FG009|Overall Study|Protocol Violation|0|||
126601843|NCT02720068|455504807|FG010|Overall Study|Protocol Violation|1|||
126601844|NCT02720068|455504808|FG011|Overall Study|Protocol Violation|0|||
126601845|NCT02720068|455504809|FG012|Overall Study|Protocol Violation|0|||
126601846|NCT02720068|455504810|FG013|Overall Study|Protocol Violation|0|||
126601847|NCT02720068|455504811|FG014|Overall Study|Protocol Violation|1|||
126601848|NCT02720068|455504812|FG015|Overall Study|Protocol Violation|0|||
126601849|NCT02720068|455504813|FG016|Overall Study|Protocol Violation|1|||
126601850|NCT02720068|455504814|FG017|Overall Study|Protocol Violation|0|||
126601851|NCT02231749|455504817|FG000|Overall Study|Disease progression|229|||
126601852|NCT02231749|455504818|FG001|Overall Study|Disease progression|297|||
126601853|NCT02231749|455504817|FG000|Overall Study|Study Drug Toxicity|134|||
126601854|NCT02231749|455504818|FG001|Overall Study|Study Drug Toxicity|63|||
126601855|NCT02231749|455504817|FG000|Overall Study|Death|1|||
126601856|NCT02231749|455504818|FG001|Overall Study|Death|1|||
126601857|NCT02231749|455504817|FG000|Overall Study|AE unrelated to Study drug|32|||
126601858|NCT02231749|455504818|FG001|Overall Study|AE unrelated to Study drug|31|||
126601859|NCT02231749|455504817|FG000|Overall Study|Participant's request to discontinue|10|||
126601860|NCT02231749|455504818|FG001|Overall Study|Participant's request to discontinue|21|||
126601861|NCT02231749|455504817|FG000|Overall Study|Participant withdrew Consent|8|||
126601862|NCT02231749|455504818|FG001|Overall Study|Participant withdrew Consent|15|||
126601863|NCT02231749|455504817|FG000|Overall Study|Lost to Follow-up|1|||
126601864|NCT02231749|455504818|FG001|Overall Study|Lost to Follow-up|2|||
126601865|NCT02231749|455504817|FG000|Overall Study|Maximum Clinical Benefit|5|||
126601866|NCT02231749|455504818|FG001|Overall Study|Maximum Clinical Benefit|8|||
126601867|NCT02231749|455504817|FG000|Overall Study|Poor/Non-Compliance|0|||
126601868|NCT02231749|455504818|FG001|Overall Study|Poor/Non-Compliance|3|||
126601869|NCT02231749|455504817|FG000|Overall Study|Pregnancy|1|||
126601870|NCT02231749|455504818|FG001|Overall Study|Pregnancy|0|||
126601871|NCT02231749|455504817|FG000|Overall Study|other|0|||
126601872|NCT02231749|455504818|FG001|Overall Study|other|8|||
126601873|NCT02231749|455504817|FG000|Overall Study|No longer meets Study Criteria|1|||
126601874|NCT02231749|455504818|FG001|Overall Study|No longer meets Study Criteria|0|||
126601875|NCT03786926|455504823|FG000|Overall Study|Adverse Event|0|||
126601876|NCT03786926|455504824|FG001|Overall Study|Adverse Event|0|||
126601877|NCT03786926|455504825|FG002|Overall Study|Adverse Event|0|||
126601878|NCT03786926|455504826|FG003|Overall Study|Adverse Event|0|||
126601879|NCT03786926|455504827|FG004|Overall Study|Adverse Event|0|||
126601880|NCT03786926|455504828|FG005|Overall Study|Adverse Event|0|||
126601881|NCT03786926|455504829|FG006|Overall Study|Adverse Event|0|||
126601882|NCT03786926|455504830|FG007|Overall Study|Adverse Event|1|||
126601883|NCT03786926|455504831|FG008|Overall Study|Adverse Event|1|||
126601884|NCT03786926|455504832|FG009|Overall Study|Adverse Event|0|||
126601885|NCT03786926|455504833|FG010|Overall Study|Adverse Event|1|||
126601886|NCT03786926|455504823|FG000|Overall Study|Progressive disease|3|||
126601887|NCT03786926|455504824|FG001|Overall Study|Progressive disease|0|||
126601888|NCT03786926|455504825|FG002|Overall Study|Progressive disease|3|||
126601889|NCT03786926|455504826|FG003|Overall Study|Progressive disease|1|||
126601890|NCT03786926|455504827|FG004|Overall Study|Progressive disease|2|||
126601891|NCT03786926|455504828|FG005|Overall Study|Progressive disease|2|||
126601892|NCT03786926|455504829|FG006|Overall Study|Progressive disease|1|||
126601893|NCT03786926|455504830|FG007|Overall Study|Progressive disease|6|||
126601894|NCT03786926|455504831|FG008|Overall Study|Progressive disease|1|||
126601895|NCT03786926|455504832|FG009|Overall Study|Progressive disease|1|||
126601896|NCT03786926|455504833|FG010|Overall Study|Progressive disease|1|||
126601897|NCT03786926|455504823|FG000|Overall Study|Death|0|||
126601898|NCT03786926|455504824|FG001|Overall Study|Death|1|||
126601899|NCT03786926|455504825|FG002|Overall Study|Death|1|||
126601900|NCT03786926|455504826|FG003|Overall Study|Death|0|||
126601901|NCT03786926|455504827|FG004|Overall Study|Death|0|||
126601902|NCT03786926|455504828|FG005|Overall Study|Death|0|||
126601903|NCT03786926|455504829|FG006|Overall Study|Death|0|||
126601904|NCT03786926|455504830|FG007|Overall Study|Death|0|||
126601905|NCT03786926|455504831|FG008|Overall Study|Death|0|||
126601906|NCT03786926|455504832|FG009|Overall Study|Death|1|||
126601907|NCT03786926|455504833|FG010|Overall Study|Death|2|||
126601908|NCT03786926|455504823|FG000|Overall Study|Physician Decision|0|||
126601909|NCT03786926|455504824|FG001|Overall Study|Physician Decision|1|||
126601910|NCT03786926|455504825|FG002|Overall Study|Physician Decision|0|||
126601911|NCT03786926|455504826|FG003|Overall Study|Physician Decision|1|||
126601912|NCT03786926|455504827|FG004|Overall Study|Physician Decision|2|||
126601913|NCT03786926|455504828|FG005|Overall Study|Physician Decision|0|||
126601914|NCT03786926|455504829|FG006|Overall Study|Physician Decision|0|||
126601915|NCT03786926|455504830|FG007|Overall Study|Physician Decision|2|||
126601916|NCT03786926|455504831|FG008|Overall Study|Physician Decision|1|||
126601917|NCT03786926|455504832|FG009|Overall Study|Physician Decision|1|||
126601918|NCT03786926|455504833|FG010|Overall Study|Physician Decision|0|||
126601919|NCT03786926|455504823|FG000|Overall Study|Withdrawal by Subject|0|||
126601920|NCT03786926|455504824|FG001|Overall Study|Withdrawal by Subject|1|||
126601921|NCT03786926|455504825|FG002|Overall Study|Withdrawal by Subject|1|||
126601922|NCT03786926|455504826|FG003|Overall Study|Withdrawal by Subject|0|||
126601923|NCT03786926|455504827|FG004|Overall Study|Withdrawal by Subject|0|||
126601924|NCT03786926|455504828|FG005|Overall Study|Withdrawal by Subject|0|||
126601925|NCT03786926|455504829|FG006|Overall Study|Withdrawal by Subject|1|||
126601926|NCT03786926|455504830|FG007|Overall Study|Withdrawal by Subject|0|||
126601927|NCT03786926|455504831|FG008|Overall Study|Withdrawal by Subject|1|||
126601928|NCT03786926|455504832|FG009|Overall Study|Withdrawal by Subject|0|||
126601929|NCT03786926|455504833|FG010|Overall Study|Withdrawal by Subject|1|||
126601930|NCT03786926|455504823|FG000|Overall Study|Study terminated by Sponsor|0|||
126601931|NCT03786926|455504824|FG001|Overall Study|Study terminated by Sponsor|0|||
126601932|NCT03786926|455504825|FG002|Overall Study|Study terminated by Sponsor|0|||
126601933|NCT03786926|455504826|FG003|Overall Study|Study terminated by Sponsor|0|||
126601934|NCT03786926|455504827|FG004|Overall Study|Study terminated by Sponsor|1|||
126601935|NCT03786926|455504828|FG005|Overall Study|Study terminated by Sponsor|0|||
126601936|NCT03786926|455504829|FG006|Overall Study|Study terminated by Sponsor|0|||
126601937|NCT03786926|455504830|FG007|Overall Study|Study terminated by Sponsor|4|||
126601938|NCT03786926|455504831|FG008|Overall Study|Study terminated by Sponsor|0|||
126601939|NCT03786926|455504832|FG009|Overall Study|Study terminated by Sponsor|0|||
126601940|NCT03786926|455504833|FG010|Overall Study|Study terminated by Sponsor|0|||
126601941|NCT03786926|455504823|FG000|Overall Study|Anti-neoplasm treatment|0|||
126601942|NCT03786926|455504824|FG001|Overall Study|Anti-neoplasm treatment|0|||
126601943|NCT03786926|455504825|FG002|Overall Study|Anti-neoplasm treatment|0|||
126601944|NCT03786926|455504826|FG003|Overall Study|Anti-neoplasm treatment|0|||
126601945|NCT03786926|455504827|FG004|Overall Study|Anti-neoplasm treatment|1|||
126601946|NCT03786926|455504828|FG005|Overall Study|Anti-neoplasm treatment|0|||
126601947|NCT03786926|455504829|FG006|Overall Study|Anti-neoplasm treatment|1|||
126601948|NCT03786926|455504830|FG007|Overall Study|Anti-neoplasm treatment|0|||
126601949|NCT03786926|455504831|FG008|Overall Study|Anti-neoplasm treatment|0|||
126601950|NCT03786926|455504832|FG009|Overall Study|Anti-neoplasm treatment|0|||
126601951|NCT03786926|455504833|FG010|Overall Study|Anti-neoplasm treatment|0|||
126601952|NCT03786926|455504823|FG000|Overall Study|Other|0|||
126601953|NCT03786926|455504824|FG001|Overall Study|Other|0|||
126601954|NCT03786926|455504825|FG002|Overall Study|Other|0|||
126601955|NCT03786926|455504826|FG003|Overall Study|Other|1|||
126601956|NCT03786926|455504827|FG004|Overall Study|Other|0|||
126601957|NCT03786926|455504828|FG005|Overall Study|Other|1|||
126601958|NCT03786926|455504829|FG006|Overall Study|Other|0|||
126601959|NCT03786926|455504830|FG007|Overall Study|Other|0|||
126601960|NCT03786926|455504831|FG008|Overall Study|Other|2|||
126601961|NCT03786926|455504832|FG009|Overall Study|Other|0|||
126601962|NCT03786926|455504833|FG010|Overall Study|Other|0|||
126601963|NCT05875701|455504837|FG000|Overall Study|Lost to Follow-up|2|||
126601964|NCT05875701|455504838|FG001|Overall Study|Lost to Follow-up|0|||
126601965|NCT05875701|455504837|FG000|Overall Study|Withdrawal by Subject|1|||
126601966|NCT05875701|455504838|FG001|Overall Study|Withdrawal by Subject|1|||
126601967|NCT02989662|455504839|FG000|Overall Study|Lost to Follow-up|0|||
126601968|NCT02989662|455504840|FG001|Overall Study|Lost to Follow-up|0|||
126601969|NCT02989662|455504841|FG002|Overall Study|Lost to Follow-up|0|||
126601970|NCT02989662|455504842|FG003|Overall Study|Lost to Follow-up|2|||
126601971|NCT02989662|455504839|FG000|Overall Study|Physician Decision|3|||
126601972|NCT02989662|455504840|FG001|Overall Study|Physician Decision|0|||
126601973|NCT02989662|455504841|FG002|Overall Study|Physician Decision|0|||
126601974|NCT02989662|455504842|FG003|Overall Study|Physician Decision|0|||
126601975|NCT02989662|455504839|FG000|Overall Study|Withdrawal by Subject|1|||
126601976|NCT02989662|455504840|FG001|Overall Study|Withdrawal by Subject|0|||
126601977|NCT02989662|455504841|FG002|Overall Study|Withdrawal by Subject|0|||
126601978|NCT02989662|455504842|FG003|Overall Study|Withdrawal by Subject|0|||
126601979|NCT00357682|455504843|FG000|Overall Study|Did not receive allocated Treatment|10|||
126601980|NCT00357682|455504844|FG001|Overall Study|Did not receive allocated Treatment|9|||
126601981|NCT00357682|455504845|FG002|Overall Study|Did not receive allocated Treatment|9|||
126601982|NCT00357682|455504846|FG003|Overall Study|Did not receive allocated Treatment|10|||
126601983|NCT00357682|455504843|FG000|Overall Study|Withdrew consent|6|||
126780678|NCT01752920|456151322|FG001|Overall Study|Physician Decision|0|||
126780679|NCT01752920|456151323|FG002|Overall Study|Physician Decision|0|||
126780680|NCT01752920|456151324|FG003|Overall Study|Physician Decision|3|||
126780681|NCT01752920|456151321|FG000|Overall Study|Radiographic Disease Progression|20|||
126780682|NCT01752920|456151322|FG001|Overall Study|Radiographic Disease Progression|7|||
126780683|NCT01752920|456151323|FG002|Overall Study|Radiographic Disease Progression|12|||
126780684|NCT01752920|456151324|FG003|Overall Study|Radiographic Disease Progression|29|||
126780685|NCT01752920|456151321|FG000|Overall Study|Study Terminated by Sponsor|0|||
126780686|NCT01752920|456151322|FG001|Overall Study|Study Terminated by Sponsor|0|||
126780687|NCT01752920|456151323|FG002|Overall Study|Study Terminated by Sponsor|0|||
126780688|NCT01752920|456151324|FG003|Overall Study|Study Terminated by Sponsor|1|||
126780689|NCT01752920|456151321|FG000|Overall Study|Withdrawal by Subject|0|||
126780690|NCT01752920|456151322|FG001|Overall Study|Withdrawal by Subject|1|||
126780691|NCT01752920|456151323|FG002|Overall Study|Withdrawal by Subject|0|||
126780692|NCT01752920|456151324|FG003|Overall Study|Withdrawal by Subject|1|||
126780693|NCT01752920|456151321|FG000|Overall Study|Lack of clinical benefit|1|||
126780694|NCT01752920|456151322|FG001|Overall Study|Lack of clinical benefit|1|||
126780695|NCT01752920|456151323|FG002|Overall Study|Lack of clinical benefit|1|||
126780696|NCT01752920|456151324|FG003|Overall Study|Lack of clinical benefit|1|||
126780697|NCT01738581|456151325|FG000|Overall Study|Lost to Follow-up|1|||
126780698|NCT01738581|456151326|FG001|Overall Study|Lost to Follow-up|0|||
126780699|NCT01186978|456151327|FG000|Overall Study|Withdrawal by Subject|1|||
126780700|NCT01227668|456151328|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
126780701|NCT01227668|456151329|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
126780702|NCT01227668|456151328|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
126780703|NCT01227668|456151329|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
126780704|NCT01227668|456151328|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
126780705|NCT01227668|456151329|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
126780706|NCT01227668|456151328|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
126780707|NCT01227668|456151329|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
126780708|NCT01227668|456151328|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
126780709|NCT01227668|456151329|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
126780710|NCT01227668|456151328|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
126780711|NCT01227668|456151329|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
126780712|NCT01227668|456151328|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
126780713|NCT01227668|456151329|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
126780714|NCT01227668|456151328|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
126780715|NCT01227668|456151329|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
126780716|NCT01227668|456151328|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
126780717|NCT01227668|456151329|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
126780718|NCT01227668|456151328|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
126780719|NCT01227668|456151329|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
126780720|NCT01227668|456151328|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
126780721|NCT01227668|456151329|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
126780722|NCT01227668|456151328|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
126780723|NCT01227668|456151329|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
126780724|NCT01709383|456151332|FG000|Overall Study|Lost to Follow-up|1|||
126780725|NCT01709383|456151333|FG001|Overall Study|Lost to Follow-up|0|||
126780726|NCT03264066|456151334|FG000|Overall Study|Adverse Event|1|||
126780727|NCT03264066|456151335|FG001|Overall Study|Adverse Event|1|||
126780728|NCT03264066|456151336|FG002|Overall Study|Adverse Event|0|||
126780729|NCT03264066|456151337|FG003|Overall Study|Adverse Event|0|||
126780730|NCT03264066|456151338|FG004|Overall Study|Adverse Event|0|||
126780731|NCT03264066|456151339|FG005|Overall Study|Adverse Event|0|||
126780732|NCT03264066|456151334|FG000|Overall Study|Death|12|||
126780733|NCT03264066|456151335|FG001|Overall Study|Death|12|||
126780734|NCT03264066|456151336|FG002|Overall Study|Death|8|||
126780735|NCT03264066|456151337|FG003|Overall Study|Death|10|||
126780736|NCT03264066|456151338|FG004|Overall Study|Death|6|||
126780737|NCT03264066|456151339|FG005|Overall Study|Death|1|||
126780738|NCT03264066|456151334|FG000|Overall Study|Lost to Follow-up|1|||
126780739|NCT03264066|456151335|FG001|Overall Study|Lost to Follow-up|0|||
126780740|NCT03264066|456151336|FG002|Overall Study|Lost to Follow-up|0|||
126780741|NCT03264066|456151337|FG003|Overall Study|Lost to Follow-up|0|||
126780742|NCT03264066|456151338|FG004|Overall Study|Lost to Follow-up|0|||
126780743|NCT03264066|456151339|FG005|Overall Study|Lost to Follow-up|0|||
126780744|NCT03264066|456151334|FG000|Overall Study|Progressive Disease|0|||
126780745|NCT03264066|456151335|FG001|Overall Study|Progressive Disease|2|||
126780746|NCT03264066|456151336|FG002|Overall Study|Progressive Disease|1|||
126780747|NCT03264066|456151337|FG003|Overall Study|Progressive Disease|0|||
126780748|NCT03264066|456151338|FG004|Overall Study|Progressive Disease|0|||
126780749|NCT03264066|456151339|FG005|Overall Study|Progressive Disease|0|||
126780750|NCT03264066|456151334|FG000|Overall Study|Study Terminated by Sponsor|5|||
126780751|NCT03264066|456151335|FG001|Overall Study|Study Terminated by Sponsor|5|||
126601984|NCT00357682|455504844|FG001|Overall Study|Withdrew consent|6|||
126601985|NCT00357682|455504845|FG002|Overall Study|Withdrew consent|5|||
126601986|NCT00357682|455504846|FG003|Overall Study|Withdrew consent|5|||
126601987|NCT00357682|455504843|FG000|Overall Study|Lost to Follow-up|39|||
126601988|NCT00357682|455504844|FG001|Overall Study|Lost to Follow-up|33|||
126601989|NCT00357682|455504845|FG002|Overall Study|Lost to Follow-up|26|||
126601990|NCT00357682|455504846|FG003|Overall Study|Lost to Follow-up|35|||
126601991|NCT00357682|455504843|FG000|Overall Study|Adverse Event|24|||
126601992|NCT00357682|455504844|FG001|Overall Study|Adverse Event|32|||
126601993|NCT00357682|455504845|FG002|Overall Study|Adverse Event|22|||
126601994|NCT00357682|455504846|FG003|Overall Study|Adverse Event|27|||
126601995|NCT00357682|455504843|FG000|Overall Study|Physician Decision|32|||
126601996|NCT00357682|455504844|FG001|Overall Study|Physician Decision|20|||
126601997|NCT00357682|455504845|FG002|Overall Study|Physician Decision|24|||
126601998|NCT00357682|455504846|FG003|Overall Study|Physician Decision|30|||
126601999|NCT00357682|455504843|FG000|Overall Study|Patient decision|73|||
126602000|NCT00357682|455504844|FG001|Overall Study|Patient decision|80|||
126602001|NCT00357682|455504845|FG002|Overall Study|Patient decision|51|||
126602002|NCT00357682|455504846|FG003|Overall Study|Patient decision|59|||
126602003|NCT00357682|455504843|FG000|Overall Study|Other reason|157|||
126602004|NCT00357682|455504844|FG001|Overall Study|Other reason|130|||
126602005|NCT00357682|455504845|FG002|Overall Study|Other reason|114|||
126602006|NCT00357682|455504846|FG003|Overall Study|Other reason|99|||
126602007|NCT04174560|455504847|FG000|Overall Study|Lost to Follow-up|1|||
126602008|NCT04174560|455504848|FG001|Overall Study|Lost to Follow-up|0|||
126602009|NCT04174560|455504849|FG002|Overall Study|Lost to Follow-up|0|||
126602010|NCT04174560|455504850|FG003|Overall Study|Lost to Follow-up|0|||
126602011|NCT04174560|455504847|FG000|Overall Study|Withdrawal by Subject|0|||
126602012|NCT04174560|455504848|FG001|Overall Study|Withdrawal by Subject|0|||
126602013|NCT04174560|455504849|FG002|Overall Study|Withdrawal by Subject|2|||
126602014|NCT04174560|455504850|FG003|Overall Study|Withdrawal by Subject|0|||
126602015|NCT05424718|455504852|FG000|Overall Study|Lost to Follow-up|5|||
126602016|NCT05424718|455504853|FG001|Overall Study|Lost to Follow-up|4|||
126602017|NCT04046549|455504855|FG000|Overall Study|Adverse Event|1|||
126602018|NCT04046549|455504855|FG000|Overall Study|Physician Decision|1|||
126602019|NCT04046549|455504855|FG000|Overall Study|Withdrawal by Subject|3|||
126602020|NCT04046549|455504855|FG000|Overall Study|Other, Not Specified|5|||
126602021|NCT01553149|455504858|FG000|Overall Study|Adverse Event|0|||
126602022|NCT01553149|455504859|FG001|Overall Study|Adverse Event|9|||
126602023|NCT01553149|455504858|FG000|Overall Study|Physician Decision|5|||
126602024|NCT01553149|455504859|FG001|Overall Study|Physician Decision|10|||
126602025|NCT01553149|455504858|FG000|Overall Study|Ineligible|0|||
126602026|NCT01553149|455504859|FG001|Overall Study|Ineligible|1|||
126602027|NCT03215706|455504870|FG000|Randomization|Adverse Event unrelated to study drug|1|||
126602028|NCT03215706|455504871|FG001|Randomization|Adverse Event unrelated to study drug|0|||
126602029|NCT03215706|455504870|FG000|Randomization|participant withdrew consent|1|||
126602030|NCT03215706|455504871|FG001|Randomization|participant withdrew consent|3|||
126602031|NCT03215706|455504870|FG000|Randomization|no longer meets study criteria|1|||
126602032|NCT03215706|455504871|FG001|Randomization|no longer meets study criteria|4|||
126602033|NCT03215706|455504870|FG000|Randomization|other reasons|0|||
126602034|NCT03215706|455504871|FG001|Randomization|other reasons|2|||
126602035|NCT03215706|455504870|FG000|Treatment Period|Disease Progression|150|||
126602036|NCT03215706|455504871|FG001|Treatment Period|Disease Progression|142|||
126602037|NCT03215706|455504870|FG000|Treatment Period|Study Drug Toxicity|53|||
126602038|NCT03215706|455504871|FG001|Treatment Period|Study Drug Toxicity|21|||
126602039|NCT03215706|455504870|FG000|Treatment Period|Death|2|||
126602040|NCT03215706|455504871|FG001|Treatment Period|Death|1|||
126602041|NCT03215706|455504870|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
126780752|NCT03264066|456151336|FG002|Overall Study|Study Terminated by Sponsor|8|||
126602042|NCT03215706|455504871|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
126602043|NCT03215706|455504870|FG000|Treatment Period|Request to D/C treatment|1|||
126602044|NCT03215706|455504871|FG001|Treatment Period|Request to D/C treatment|6|||
126602045|NCT03215706|455504870|FG000|Treatment Period|Participant withdrew consent|3|||
126602046|NCT03215706|455504871|FG001|Treatment Period|Participant withdrew consent|4|||
126602047|NCT03215706|455504870|FG000|Treatment Period|Lost to Follow-up|0|||
126602048|NCT03215706|455504871|FG001|Treatment Period|Lost to Follow-up|1|||
126602049|NCT03215706|455504870|FG000|Treatment Period|Other Reasons|4|||
126602050|NCT03215706|455504871|FG001|Treatment Period|Other Reasons|5|||
126602051|NCT03215706|455504870|FG000|Treatment Period|Ongoing in the treatment period|105|||
126602052|NCT03215706|455504871|FG001|Treatment Period|Ongoing in the treatment period|43|||
126602053|NCT00945724|455504872|FG000|Overall Study|Withdrawal by Subject|2|||
126602054|NCT00945724|455504872|FG000|Overall Study|Physician Decision|1|||
126602055|NCT00945724|455504872|FG000|Overall Study|Adverse Event|5|||
126602056|NCT00945724|455504872|FG000|Overall Study|Second malignancy|1|||
126602057|NCT05412004|455505577|FG000|Overall Study|Adverse Event|0|||
126602058|NCT05412004|455505578|FG001|Overall Study|Adverse Event|2|||
126602059|NCT05412004|455505579|FG002|Overall Study|Adverse Event|1|||
126602060|NCT05412004|455505580|FG003|Overall Study|Adverse Event|5|||
126602061|NCT05412004|455505577|FG000|Overall Study|Assigned Treatment by Mistake|5|||
126602062|NCT05412004|455505578|FG001|Overall Study|Assigned Treatment by Mistake|10|||
126602063|NCT05412004|455505579|FG002|Overall Study|Assigned Treatment by Mistake|2|||
126602064|NCT05412004|455505580|FG003|Overall Study|Assigned Treatment by Mistake|5|||
126602065|NCT05412004|455505577|FG000|Overall Study|Lost to Follow-up|3|||
126602066|NCT05412004|455505578|FG001|Overall Study|Lost to Follow-up|0|||
126602067|NCT05412004|455505579|FG002|Overall Study|Lost to Follow-up|0|||
126602068|NCT05412004|455505580|FG003|Overall Study|Lost to Follow-up|0|||
126602069|NCT05412004|455505577|FG000|Overall Study|Patient could not travel to site|0|||
126602070|NCT05412004|455505578|FG001|Overall Study|Patient could not travel to site|1|||
126602071|NCT05412004|455505579|FG002|Overall Study|Patient could not travel to site|0|||
126602072|NCT05412004|455505580|FG003|Overall Study|Patient could not travel to site|0|||
126602073|NCT05412004|455505577|FG000|Overall Study|Physician Decision|0|||
126602074|NCT05412004|455505578|FG001|Overall Study|Physician Decision|1|||
126602075|NCT05412004|455505579|FG002|Overall Study|Physician Decision|0|||
126602076|NCT05412004|455505580|FG003|Overall Study|Physician Decision|0|||
126602077|NCT05412004|455505577|FG000|Overall Study|Pregnancy|0|||
126602078|NCT05412004|455505578|FG001|Overall Study|Pregnancy|1|||
126602079|NCT05412004|455505579|FG002|Overall Study|Pregnancy|0|||
126602080|NCT05412004|455505580|FG003|Overall Study|Pregnancy|0|||
126602081|NCT05412004|455505577|FG000|Overall Study|Protocol Violation|1|||
126602082|NCT05412004|455505578|FG001|Overall Study|Protocol Violation|0|||
126602083|NCT05412004|455505579|FG002|Overall Study|Protocol Violation|0|||
126602084|NCT05412004|455505580|FG003|Overall Study|Protocol Violation|0|||
126602085|NCT05412004|455505577|FG000|Overall Study|Withdrawal by Subject|4|||
126602086|NCT05412004|455505578|FG001|Overall Study|Withdrawal by Subject|19|||
126602087|NCT05412004|455505579|FG002|Overall Study|Withdrawal by Subject|4|||
126602088|NCT05412004|455505580|FG003|Overall Study|Withdrawal by Subject|14|||
126602089|NCT05412004|455505577|FG000|Overall Study|Screen Failure|0|||
126602090|NCT05412004|455505578|FG001|Overall Study|Screen Failure|0|||
126602091|NCT05412004|455505579|FG002|Overall Study|Screen Failure|0|||
126602092|NCT05412004|455505580|FG003|Overall Study|Screen Failure|1|||
126602093|NCT05412004|455505577|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
126602094|NCT05412004|455505578|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
126602095|NCT05412004|455505579|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
126733508|NCT01021813|455972396|FG003|DB Treatment Phase|Lost to Follow-up|0|||
126733509|NCT01021813|455972397|FG004|DB Treatment Phase|Lost to Follow-up|0|||
126733510|NCT01021813|455972393|FG000|DB Treatment Phase|Physician Decision|17|||
126733511|NCT01021813|455972394|FG001|DB Treatment Phase|Physician Decision|8|||
126733512|NCT01021813|455972395|FG002|DB Treatment Phase|Physician Decision|0|||
126733513|NCT01021813|455972396|FG003|DB Treatment Phase|Physician Decision|0|||
126602096|NCT05412004|455505580|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
126602097|NCT00968149|455505581|FG000|Overall Study|Adverse Event|5|||
126602098|NCT00968149|455505582|FG001|Overall Study|Adverse Event|1|||
126602099|NCT00968149|455505581|FG000|Overall Study|Lack of Efficacy|0|||
126602100|NCT00968149|455505582|FG001|Overall Study|Lack of Efficacy|4|||
126602101|NCT00968149|455505581|FG000|Overall Study|Lost to Follow-up|0|||
126602102|NCT00968149|455505582|FG001|Overall Study|Lost to Follow-up|1|||
126602103|NCT00968149|455505581|FG000|Overall Study|Protocol Violation|4|||
126602104|NCT00968149|455505582|FG001|Overall Study|Protocol Violation|0|||
126602105|NCT00968149|455505581|FG000|Overall Study|Withdrawal by Subject|2|||
126602106|NCT00968149|455505582|FG001|Overall Study|Withdrawal by Subject|0|||
126602107|NCT03934931|455505583|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
126602108|NCT03934931|455505584|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
126602109|NCT03934931|455505585|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
126602110|NCT02467270|455505588|FG000|Overall Study|Participants Never Treated|0|||
126602111|NCT02467270|455505589|FG001|Overall Study|Participants Never Treated|1|||
126602112|NCT02467270|455505590|FG002|Overall Study|Participants Never Treated|0|||
126602113|NCT02467270|455505588|FG000|Overall Study|Ongoing|50|||
126602114|NCT02467270|455505589|FG001|Overall Study|Ongoing|41|||
126602115|NCT02467270|455505590|FG002|Overall Study|Ongoing|43|||
126602116|NCT02467270|455505588|FG000|Overall Study|Adverse Event|16|||
126602117|NCT02467270|455505589|FG001|Overall Study|Adverse Event|15|||
126602118|NCT02467270|455505590|FG002|Overall Study|Adverse Event|14|||
126602119|NCT02467270|455505588|FG000|Overall Study|Progressive Disease|7|||
126602120|NCT02467270|455505589|FG001|Overall Study|Progressive Disease|7|||
126602121|NCT02467270|455505590|FG002|Overall Study|Progressive Disease|4|||
126602122|NCT02467270|455505588|FG000|Overall Study|Death|2|||
126733514|NCT01021813|455972397|FG004|DB Treatment Phase|Physician Decision|0|||
126733515|NCT01021813|455972393|FG000|DB Treatment Phase|Pregnancy|1|||
126733516|NCT01021813|455972394|FG001|DB Treatment Phase|Pregnancy|0|||
126602123|NCT02467270|455505589|FG001|Overall Study|Death|0|||
126602124|NCT02467270|455505590|FG002|Overall Study|Death|2|||
126602125|NCT02467270|455505588|FG000|Overall Study|Lack of Efficacy|12|||
126602126|NCT02467270|455505589|FG001|Overall Study|Lack of Efficacy|18|||
126602127|NCT02467270|455505590|FG002|Overall Study|Lack of Efficacy|23|||
126780753|NCT03264066|456151337|FG003|Overall Study|Study Terminated by Sponsor|5|||
126780754|NCT03264066|456151338|FG004|Overall Study|Study Terminated by Sponsor|1|||
126780755|NCT03264066|456151339|FG005|Overall Study|Study Terminated by Sponsor|2|||
126602128|NCT02467270|455505588|FG000|Overall Study|Non-compliance With Study Drug|0|||
126602129|NCT02467270|455505589|FG001|Overall Study|Non-compliance With Study Drug|2|||
126602130|NCT02467270|455505590|FG002|Overall Study|Non-compliance With Study Drug|1|||
126602131|NCT02467270|455505588|FG000|Overall Study|Lost to Follow-up|2|||
126602132|NCT02467270|455505589|FG001|Overall Study|Lost to Follow-up|1|||
126602133|NCT02467270|455505590|FG002|Overall Study|Lost to Follow-up|0|||
126602134|NCT02467270|455505588|FG000|Overall Study|Pregnancy|0|||
126602135|NCT02467270|455505589|FG001|Overall Study|Pregnancy|1|||
126602136|NCT02467270|455505590|FG002|Overall Study|Pregnancy|0|||
126602137|NCT02467270|455505588|FG000|Overall Study|Physician Decision|0|||
126602138|NCT02467270|455505589|FG001|Overall Study|Physician Decision|4|||
126602139|NCT02467270|455505590|FG002|Overall Study|Physician Decision|1|||
126602140|NCT02467270|455505588|FG000|Overall Study|Withdrawal by Subject|4|||
126602141|NCT02467270|455505589|FG001|Overall Study|Withdrawal by Subject|3|||
126602142|NCT02467270|455505590|FG002|Overall Study|Withdrawal by Subject|5|||
126602143|NCT02467270|455505588|FG000|Overall Study|Reason not Specified|1|||
126602144|NCT02467270|455505589|FG001|Overall Study|Reason not Specified|2|||
126602145|NCT02467270|455505590|FG002|Overall Study|Reason not Specified|1|||
126602146|NCT00495677|455505592|FG000|Stage 1 (25 Days)|Adverse Event|0|||
126602147|NCT00495677|455505593|FG001|Stage 1 (25 Days)|Adverse Event|0|||
126602148|NCT00495677|455505594|FG002|Stage 1 (25 Days)|Adverse Event|1|||
126602149|NCT00495677|455505595|FG003|Stage 1 (25 Days)|Adverse Event|0|||
126602150|NCT00495677|455505596|FG004|Stage 1 (25 Days)|Adverse Event|0|||
126602151|NCT00495677|455505597|FG005|Stage 1 (25 Days)|Adverse Event|0|||
126602152|NCT00495677|455505598|FG006|Stage 1 (25 Days)|Adverse Event|0|||
126602153|NCT04129164|455505605|FG000|Overall Study|Non-compliance with procedures|0|||
126602154|NCT04129164|455505606|FG001|Overall Study|Non-compliance with procedures|0|||
126602155|NCT04129164|455505607|FG002|Overall Study|Non-compliance with procedures|2|||
126602156|NCT04129164|455505608|FG003|Overall Study|Non-compliance with procedures|0|||
126602157|NCT04129164|455505605|FG000|Overall Study|Adverse Event|0|||
126602158|NCT04129164|455505606|FG001|Overall Study|Adverse Event|0|||
126602159|NCT04129164|455505607|FG002|Overall Study|Adverse Event|2|||
126602160|NCT04129164|455505608|FG003|Overall Study|Adverse Event|0|||
126602161|NCT04129164|455505605|FG000|Overall Study|Pregnancy|0|||
126602162|NCT04129164|455505606|FG001|Overall Study|Pregnancy|0|||
126602163|NCT04129164|455505607|FG002|Overall Study|Pregnancy|0|||
126602164|NCT04129164|455505608|FG003|Overall Study|Pregnancy|1|||
126602165|NCT04129164|455505605|FG000|Overall Study|Withdrawal by Subject|3|||
126602166|NCT04129164|455505606|FG001|Overall Study|Withdrawal by Subject|2|||
126602167|NCT04129164|455505607|FG002|Overall Study|Withdrawal by Subject|4|||
126602168|NCT04129164|455505608|FG003|Overall Study|Withdrawal by Subject|6|||
126602169|NCT04129164|455505605|FG000|Overall Study|Death|0|||
126602170|NCT04129164|455505606|FG001|Overall Study|Death|1|||
126602171|NCT04129164|455505607|FG002|Overall Study|Death|0|||
126602172|NCT04129164|455505608|FG003|Overall Study|Death|0|||
126602173|NCT04129164|455505605|FG000|Overall Study|Lost to Follow-up|0|||
126602174|NCT04129164|455505606|FG001|Overall Study|Lost to Follow-up|1|||
126602175|NCT04129164|455505607|FG002|Overall Study|Lost to Follow-up|0|||
126602176|NCT04129164|455505608|FG003|Overall Study|Lost to Follow-up|0|||
126602177|NCT03868930|455505609|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
126602178|NCT03868930|455505610|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
126602179|NCT03868930|455505609|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
126602180|NCT03868930|455505610|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
126602181|NCT03868930|455505609|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
126602182|NCT03868930|455505610|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
126602183|NCT03868930|455505609|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
126602184|NCT03868930|455505610|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
126602185|NCT03868930|455505609|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
126602186|NCT03868930|455505610|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
126602187|NCT04227899|455505613|FG000|Overall Study|Withdrawal by Subject|6|||
126602188|NCT04227899|455505614|FG001|Overall Study|Withdrawal by Subject|3|||
126602189|NCT04227899|455505613|FG000|Overall Study|Death|12|||
126602190|NCT04227899|455505614|FG001|Overall Study|Death|6|||
126602191|NCT04227899|455505613|FG000|Overall Study|Lost to Follow-up|2|||
126602192|NCT04227899|455505614|FG001|Overall Study|Lost to Follow-up|1|||
126602193|NCT01773993|455505616|FG000|Overall Study|No Visit After Treatment|35|||
126602194|NCT04664881|455505617|FG000|Overall Study|Withdrawal by Subject|1|||
126602195|NCT04664881|455505618|FG001|Overall Study|Withdrawal by Subject|8|||
126602196|NCT04664881|455505617|FG000|Overall Study|Physician Decision|0|||
126602197|NCT04664881|455505618|FG001|Overall Study|Physician Decision|5|||
126602198|NCT04664881|455505617|FG000|Overall Study|Lost to Follow-up|1|||
126602199|NCT04664881|455505618|FG001|Overall Study|Lost to Follow-up|0|||
126602200|NCT02656706|455505624|FG000|Overall Study|Insurance Denial|1|||
126602201|NCT02726386|455505625|FG000|Overall Study|Adverse Event|17|||
126780756|NCT03264066|456151334|FG000|Overall Study|Withdrawal by Subject|1|||
126780757|NCT03264066|456151335|FG001|Overall Study|Withdrawal by Subject|0|||
126780758|NCT03264066|456151336|FG002|Overall Study|Withdrawal by Subject|0|||
126780759|NCT03264066|456151337|FG003|Overall Study|Withdrawal by Subject|5|||
126780760|NCT03264066|456151338|FG004|Overall Study|Withdrawal by Subject|0|||
126780761|NCT03264066|456151339|FG005|Overall Study|Withdrawal by Subject|0|||
126780762|NCT02668302|456151343|FG000|Overall Study|Withdrawal by Subject|1|||
126780763|NCT02668302|456151344|FG001|Overall Study|Withdrawal by Subject|0|||
126780764|NCT01078090|456151345|FG000|Overall Study|Lost to Follow-up|2363|||
126780765|NCT01078090|456151345|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
126780766|NCT01078090|456151345|FG000|Overall Study|Lack of Efficacy|1193|||
126780767|NCT01078090|456151345|FG000|Overall Study|ADR and lack of efficacy|61|||
126780768|NCT01078090|456151345|FG000|Overall Study|Other|523|||
126780769|NCT01015612|456151346|FG000|Overall Study|Death|113|||
126780770|NCT01015612|456151346|FG000|Overall Study|Withdrawal by Subject|40|||
126780771|NCT00066807|456151347|FG000|Overall Study|Study was terminated early|14|||
126780772|NCT00066807|456151348|FG001|Overall Study|Study was terminated early|15|||
126780773|NCT02468557|456152792|FG000|Overall Study|Adverse Event|1|||
126780774|NCT02468557|456152792|FG000|Overall Study|Death|1|||
126780775|NCT02468557|456152792|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
126780776|NCT02468557|456152792|FG000|Overall Study|All Enrolled but Never Dosed|4|||
126780777|NCT00982410|456152793|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
126780778|NCT00982410|456152794|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
126780779|NCT00982410|456152793|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
126780780|NCT00982410|456152794|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
126780781|NCT00982410|456152793|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
126780782|NCT00982410|456152794|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
126780783|NCT00982410|456152793|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
126780784|NCT00982410|456152794|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
126780785|NCT00982410|456152793|FG000|6-month Follow-up Assessment|participant no transportation|1|||
126780786|NCT00982410|456152794|FG001|6-month Follow-up Assessment|participant no transportation|0|||
126780787|NCT00982410|456152793|FG000|6-month Follow-up Assessment|incarceration|0|||
126602202|NCT02726386|455505626|FG001|Overall Study|Adverse Event|20|||
126602203|NCT02726386|455505625|FG000|Overall Study|Withdrawal by Subject|14|||
126602204|NCT02726386|455505626|FG001|Overall Study|Withdrawal by Subject|28|||
126602205|NCT02726386|455505625|FG000|Overall Study|Other reasons|7|||
126602206|NCT02726386|455505626|FG001|Overall Study|Other reasons|8|||
126602207|NCT04012567|455505635|FG000|Overall Study|Lost to Follow-up|0|||
126602208|NCT04012567|455505636|FG001|Overall Study|Lost to Follow-up|1|||
126602209|NCT04012567|455505635|FG000|Overall Study|Withdrawal by Subject|1|||
126602210|NCT04012567|455505636|FG001|Overall Study|Withdrawal by Subject|0|||
126602211|NCT02951052|455505638|FG000|Overall Study|Adverse Event|13|||
126602212|NCT02951052|455505639|FG001|Overall Study|Adverse Event|5|||
126602213|NCT02951052|455505638|FG000|Overall Study|Withdrawal by Subject|1|||
126602214|NCT02951052|455505639|FG001|Overall Study|Withdrawal by Subject|5|||
126602215|NCT02951052|455505638|FG000|Overall Study|Physician Decision|2|||
126602216|NCT02951052|455505639|FG001|Overall Study|Physician Decision|0|||
126602217|NCT02951052|455505638|FG000|Overall Study|Lost to Follow-up|1|||
126602218|NCT02951052|455505639|FG001|Overall Study|Lost to Follow-up|1|||
126602219|NCT02951052|455505638|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
126602220|NCT02951052|455505639|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
126602221|NCT02951052|455505638|FG000|Overall Study|Protocol Violation|5|||
126602222|NCT02951052|455505639|FG001|Overall Study|Protocol Violation|3|||
126602223|NCT02951052|455505638|FG000|Overall Study|Lack of Efficacy|3|||
126733517|NCT01021813|455972395|FG002|DB Treatment Phase|Pregnancy|0|||
126733518|NCT01021813|455972396|FG003|DB Treatment Phase|Pregnancy|0|||
126733519|NCT01021813|455972397|FG004|DB Treatment Phase|Pregnancy|0|||
126733520|NCT01021813|455972393|FG000|DB Treatment Phase|Protocol Violation|4|||
126733521|NCT01021813|455972394|FG001|DB Treatment Phase|Protocol Violation|3|||
126733522|NCT01021813|455972395|FG002|DB Treatment Phase|Protocol Violation|0|||
126733523|NCT01021813|455972396|FG003|DB Treatment Phase|Protocol Violation|0|||
126733524|NCT01021813|455972397|FG004|DB Treatment Phase|Protocol Violation|0|||
126733525|NCT01021813|455972393|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
126733526|NCT01021813|455972394|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
126733527|NCT01021813|455972395|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
126733528|NCT01021813|455972396|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
126733529|NCT01021813|455972397|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
126733530|NCT01021813|455972393|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
126733531|NCT01021813|455972394|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
126602224|NCT02951052|455505639|FG001|Overall Study|Lack of Efficacy|4|||
126602225|NCT02951052|455505638|FG000|Overall Study|Ongoing|1|||
126733532|NCT01021813|455972395|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
126733533|NCT01021813|455972396|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
126602226|NCT02951052|455505639|FG001|Overall Study|Ongoing|0|||
126602227|NCT04644029|455506547|FG000|Overall Study|Death|1|||
126602228|NCT04644029|455506548|FG001|Overall Study|Death|0|||
126602229|NCT04644029|455506547|FG000|Overall Study|Physician Decision|1|||
126602230|NCT04644029|455506548|FG001|Overall Study|Physician Decision|2|||
126602231|NCT04644029|455506547|FG000|Overall Study|Withdrawal by Subject|21|||
126602232|NCT04644029|455506548|FG001|Overall Study|Withdrawal by Subject|19|||
126602233|NCT04644029|455506547|FG000|Overall Study|Lost to Follow-up|31|||
126602234|NCT04644029|455506548|FG001|Overall Study|Lost to Follow-up|34|||
126602235|NCT04644029|455506547|FG000|Overall Study|Study Terminated by Sponsor|308|||
126602236|NCT04644029|455506548|FG001|Overall Study|Study Terminated by Sponsor|309|||
126602237|NCT04644029|455506547|FG000|Overall Study|Randomized in Error|2|||
126602238|NCT04644029|455506548|FG001|Overall Study|Randomized in Error|1|||
126602239|NCT04644029|455506547|FG000|Overall Study|Other|0|||
126602240|NCT04644029|455506548|FG001|Overall Study|Other|1|||
126602241|NCT03705793|455506549|FG000|Overall Study|Lost to Follow-up|3|||
126602242|NCT03705793|455506550|FG001|Overall Study|Lost to Follow-up|4|||
126602243|NCT03705793|455506549|FG000|Overall Study|Withdrawal by Subject|2|||
126602244|NCT03705793|455506550|FG001|Overall Study|Withdrawal by Subject|1|||
126602245|NCT02719574|455506551|FG000|Phase 1 (Dose Escalation)|Other|0|||
126602246|NCT02719574|455506552|FG001|Phase 1 (Dose Escalation)|Other|2|||
126602247|NCT02719574|455506553|FG002|Phase 1 (Dose Escalation)|Other|1|||
126602248|NCT02719574|455506554|FG003|Phase 1 (Dose Escalation)|Other|2|||
126602249|NCT02719574|455506555|FG004|Phase 1 (Dose Escalation)|Other|2|||
126602250|NCT02719574|455506556|FG005|Phase 1 (Dose Escalation)|Other|0|||
126602251|NCT02719574|455506557|FG006|Phase 1 (Dose Escalation)|Other|0|||
126602252|NCT02719574|455506558|FG007|Phase 1 (Dose Escalation)|Other|0|||
126602253|NCT02719574|455506559|FG008|Phase 1 (Dose Escalation)|Other|0|||
126602254|NCT02719574|455506560|FG009|Phase 1 (Dose Escalation)|Other|0|||
126602255|NCT02719574|455506561|FG010|Phase 1 (Dose Escalation)|Other|0|||
126602256|NCT02719574|455506562|FG011|Phase 1 (Dose Escalation)|Other|0|||
126602257|NCT02719574|455506563|FG012|Phase 1 (Dose Escalation)|Other|0|||
126602258|NCT02719574|455506564|FG013|Phase 1 (Dose Escalation)|Other|0|||
126602259|NCT02719574|455506565|FG014|Phase 1 (Dose Escalation)|Other|0|||
126602260|NCT02719574|455506566|FG015|Phase 1 (Dose Escalation)|Other|0|||
126602261|NCT02719574|455506567|FG016|Phase 1 (Dose Escalation)|Other|0|||
126602262|NCT02719574|455506551|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
126602263|NCT02719574|455506552|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
126602264|NCT02719574|455506553|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
126602265|NCT02719574|455506554|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
126602266|NCT02719574|455506555|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
126602267|NCT02719574|455506556|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
126602268|NCT02719574|455506557|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126602269|NCT02719574|455506558|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126602270|NCT02719574|455506559|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126602271|NCT02719574|455506560|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126602272|NCT02719574|455506561|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126602273|NCT02719574|455506562|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126602274|NCT02719574|455506563|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126602275|NCT02719574|455506564|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126602276|NCT02719574|455506565|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126602277|NCT02719574|455506566|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126602278|NCT02719574|455506567|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
126602279|NCT02719574|455506551|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602280|NCT02719574|455506552|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
126602281|NCT02719574|455506553|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
126602282|NCT02719574|455506554|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602283|NCT02719574|455506555|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
126602284|NCT02719574|455506556|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
126602285|NCT02719574|455506557|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602286|NCT02719574|455506558|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602287|NCT02719574|455506559|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602288|NCT02719574|455506560|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602289|NCT02719574|455506561|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602290|NCT02719574|455506562|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602291|NCT02719574|455506563|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602292|NCT02719574|455506564|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602293|NCT02719574|455506565|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602294|NCT02719574|455506566|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602295|NCT02719574|455506567|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
126602296|NCT02719574|455506551|FG000|Phase 1 (Dose Escalation)|Death|2|||
126602297|NCT02719574|455506552|FG001|Phase 1 (Dose Escalation)|Death|1|||
126602298|NCT02719574|455506553|FG002|Phase 1 (Dose Escalation)|Death|1|||
126602299|NCT02719574|455506554|FG003|Phase 1 (Dose Escalation)|Death|0|||
126602300|NCT02719574|455506555|FG004|Phase 1 (Dose Escalation)|Death|0|||
126602301|NCT02719574|455506556|FG005|Phase 1 (Dose Escalation)|Death|0|||
126602302|NCT02719574|455506557|FG006|Phase 1 (Dose Escalation)|Death|0|||
126602303|NCT02719574|455506558|FG007|Phase 1 (Dose Escalation)|Death|0|||
126602304|NCT02719574|455506559|FG008|Phase 1 (Dose Escalation)|Death|0|||
126602305|NCT02719574|455506560|FG009|Phase 1 (Dose Escalation)|Death|0|||
126602306|NCT02719574|455506561|FG010|Phase 1 (Dose Escalation)|Death|0|||
126602307|NCT02719574|455506562|FG011|Phase 1 (Dose Escalation)|Death|0|||
126602308|NCT02719574|455506563|FG012|Phase 1 (Dose Escalation)|Death|0|||
126602309|NCT02719574|455506564|FG013|Phase 1 (Dose Escalation)|Death|0|||
126602310|NCT02719574|455506565|FG014|Phase 1 (Dose Escalation)|Death|0|||
126602311|NCT02719574|455506566|FG015|Phase 1 (Dose Escalation)|Death|0|||
126602312|NCT02719574|455506567|FG016|Phase 1 (Dose Escalation)|Death|0|||
126602313|NCT02719574|455506551|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602314|NCT02719574|455506552|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
126602315|NCT02719574|455506553|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602316|NCT02719574|455506554|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602317|NCT02719574|455506555|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
126602318|NCT02719574|455506556|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
126602319|NCT02719574|455506557|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602320|NCT02719574|455506558|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602321|NCT02719574|455506559|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602322|NCT02719574|455506560|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602323|NCT02719574|455506561|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602324|NCT02719574|455506562|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602325|NCT02719574|455506563|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602326|NCT02719574|455506564|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602327|NCT02719574|455506565|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602328|NCT02719574|455506566|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602329|NCT02719574|455506567|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
126602330|NCT02719574|455506551|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602331|NCT02719574|455506552|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602332|NCT02719574|455506553|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602333|NCT02719574|455506554|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602334|NCT02719574|455506555|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
126602335|NCT02719574|455506556|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
126602336|NCT02719574|455506557|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602337|NCT02719574|455506558|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602338|NCT02719574|455506559|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602339|NCT02719574|455506560|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602340|NCT02719574|455506561|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602341|NCT02719574|455506562|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602342|NCT02719574|455506563|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602343|NCT02719574|455506564|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602344|NCT02719574|455506565|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602345|NCT02719574|455506566|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602346|NCT02719574|455506567|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
126602347|NCT02719574|455506551|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602348|NCT02719574|455506552|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602349|NCT02719574|455506553|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
126602350|NCT02719574|455506554|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602351|NCT02719574|455506555|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602352|NCT02719574|455506556|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602353|NCT02719574|455506557|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602354|NCT02719574|455506558|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602355|NCT02719574|455506559|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602356|NCT02719574|455506560|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602357|NCT02719574|455506561|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602358|NCT02719574|455506562|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602359|NCT02719574|455506563|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602360|NCT02719574|455506564|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602361|NCT02719574|455506565|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602362|NCT02719574|455506566|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602363|NCT02719574|455506567|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126602364|NCT02719574|455506551|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602365|NCT02719574|455506552|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602366|NCT02719574|455506553|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602367|NCT02719574|455506554|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602368|NCT02719574|455506555|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602369|NCT02719574|455506556|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602370|NCT02719574|455506557|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
126602371|NCT02719574|455506558|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
126602372|NCT02719574|455506559|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
126602373|NCT02719574|455506560|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602374|NCT02719574|455506561|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602375|NCT02719574|455506562|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602376|NCT02719574|455506563|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602377|NCT02719574|455506564|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602378|NCT02719574|455506565|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602379|NCT02719574|455506566|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602380|NCT02719574|455506567|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
126602381|NCT02719574|455506551|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602382|NCT02719574|455506552|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602383|NCT02719574|455506553|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602384|NCT02719574|455506554|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602385|NCT02719574|455506555|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602386|NCT02719574|455506556|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602387|NCT02719574|455506557|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
126602388|NCT02719574|455506558|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
126602389|NCT02719574|455506559|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602390|NCT02719574|455506560|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602391|NCT02719574|455506561|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602392|NCT02719574|455506562|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602393|NCT02719574|455506563|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602394|NCT02719574|455506564|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602395|NCT02719574|455506565|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602396|NCT02719574|455506566|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602397|NCT02719574|455506567|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
126602398|NCT02719574|455506551|FG000|Phase 1 (Dose Expansion)|Death|0|||
126602399|NCT02719574|455506552|FG001|Phase 1 (Dose Expansion)|Death|0|||
126602400|NCT02719574|455506553|FG002|Phase 1 (Dose Expansion)|Death|0|||
126602401|NCT02719574|455506554|FG003|Phase 1 (Dose Expansion)|Death|0|||
126602402|NCT02719574|455506555|FG004|Phase 1 (Dose Expansion)|Death|0|||
126602403|NCT02719574|455506556|FG005|Phase 1 (Dose Expansion)|Death|0|||
126602404|NCT02719574|455506557|FG006|Phase 1 (Dose Expansion)|Death|1|||
126602405|NCT02719574|455506558|FG007|Phase 1 (Dose Expansion)|Death|6|||
126602406|NCT02719574|455506559|FG008|Phase 1 (Dose Expansion)|Death|0|||
126602407|NCT02719574|455506560|FG009|Phase 1 (Dose Expansion)|Death|0|||
126602408|NCT02719574|455506561|FG010|Phase 1 (Dose Expansion)|Death|0|||
126602409|NCT02719574|455506562|FG011|Phase 1 (Dose Expansion)|Death|0|||
126602410|NCT02719574|455506563|FG012|Phase 1 (Dose Expansion)|Death|0|||
126602411|NCT02719574|455506564|FG013|Phase 1 (Dose Expansion)|Death|0|||
126602412|NCT02719574|455506565|FG014|Phase 1 (Dose Expansion)|Death|0|||
126602413|NCT02719574|455506566|FG015|Phase 1 (Dose Expansion)|Death|0|||
126602414|NCT02719574|455506567|FG016|Phase 1 (Dose Expansion)|Death|0|||
126602415|NCT02719574|455506551|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602416|NCT02719574|455506552|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602417|NCT02719574|455506553|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602418|NCT02719574|455506554|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602419|NCT02719574|455506555|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602420|NCT02719574|455506556|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602421|NCT02719574|455506557|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
126602422|NCT02719574|455506558|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
126602423|NCT02719574|455506559|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602424|NCT02719574|455506560|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602425|NCT02719574|455506561|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602426|NCT02719574|455506562|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602427|NCT02719574|455506563|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602428|NCT02719574|455506564|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602429|NCT02719574|455506565|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602430|NCT02719574|455506566|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602431|NCT02719574|455506567|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
126602432|NCT02719574|455506551|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602433|NCT02719574|455506552|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602434|NCT02719574|455506553|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602435|NCT02719574|455506554|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602436|NCT02719574|455506555|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602437|NCT02719574|455506556|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602438|NCT02719574|455506557|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
126602439|NCT02719574|455506558|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
126780788|NCT00982410|456152794|FG001|6-month Follow-up Assessment|incarceration|2|||
126780789|NCT00982410|456152793|FG000|6-month Follow-up Assessment|patent surgery|0|||
126602440|NCT02719574|455506559|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602441|NCT02719574|455506560|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602442|NCT02719574|455506561|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602443|NCT02719574|455506562|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602444|NCT02719574|455506563|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602445|NCT02719574|455506564|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602446|NCT02719574|455506565|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602447|NCT02719574|455506566|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602448|NCT02719574|455506567|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
126602449|NCT02719574|455506551|FG000|Phase 1 (Dose Expansion)|Other|0|||
126780790|NCT00982410|456152794|FG001|6-month Follow-up Assessment|patent surgery|1|||
126780791|NCT00982410|456152793|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
126780792|NCT00982410|456152794|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
126780793|NCT00982410|456152793|FG000|12-month Follow-up Assessment|Death|0|||
126780794|NCT00982410|456152794|FG001|12-month Follow-up Assessment|Death|2|||
126780795|NCT00982410|456152793|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
126780796|NCT00982410|456152794|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
126780797|NCT00982410|456152793|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
126780798|NCT00982410|456152794|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
126780799|NCT00982410|456152793|FG000|12-month Follow-up Assessment|incarceration|2|||
126780800|NCT00982410|456152794|FG001|12-month Follow-up Assessment|incarceration|1|||
126780801|NCT00982410|456152793|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
126780802|NCT00982410|456152794|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
126780803|NCT04014959|456152798|FG000|Baseline MRI and Assessments|Physician Decision|2|||
126780804|NCT04014959|456152798|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
126780805|NCT04014959|456152798|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
126780806|NCT02034799|456152802|FG000|Overall Study|Withdrawal by Subject|0|||
126780807|NCT02034799|456152803|FG001|Overall Study|Withdrawal by Subject|2|||
126780808|NCT02034799|456152802|FG000|Overall Study|Lost to Follow-up|0|||
126780809|NCT02034799|456152803|FG001|Overall Study|Lost to Follow-up|1|||
126780810|NCT02034799|456152802|FG000|Overall Study|Death|2|||
126780811|NCT02034799|456152803|FG001|Overall Study|Death|1|||
126602450|NCT02719574|455506552|FG001|Phase 1 (Dose Expansion)|Other|0|||
126602451|NCT02719574|455506553|FG002|Phase 1 (Dose Expansion)|Other|0|||
126602452|NCT02719574|455506554|FG003|Phase 1 (Dose Expansion)|Other|0|||
126602453|NCT02719574|455506555|FG004|Phase 1 (Dose Expansion)|Other|0|||
126602454|NCT02719574|455506556|FG005|Phase 1 (Dose Expansion)|Other|0|||
126602455|NCT02719574|455506557|FG006|Phase 1 (Dose Expansion)|Other|1|||
126602456|NCT02719574|455506558|FG007|Phase 1 (Dose Expansion)|Other|7|||
126602457|NCT02719574|455506559|FG008|Phase 1 (Dose Expansion)|Other|0|||
126602458|NCT02719574|455506560|FG009|Phase 1 (Dose Expansion)|Other|0|||
126602459|NCT02719574|455506561|FG010|Phase 1 (Dose Expansion)|Other|0|||
126602460|NCT02719574|455506562|FG011|Phase 1 (Dose Expansion)|Other|0|||
126602461|NCT02719574|455506563|FG012|Phase 1 (Dose Expansion)|Other|0|||
126602462|NCT02719574|455506564|FG013|Phase 1 (Dose Expansion)|Other|0|||
126602463|NCT02719574|455506565|FG014|Phase 1 (Dose Expansion)|Other|0|||
126602464|NCT02719574|455506566|FG015|Phase 1 (Dose Expansion)|Other|0|||
126602465|NCT02719574|455506567|FG016|Phase 1 (Dose Expansion)|Other|0|||
126602466|NCT02719574|455506551|FG000|Phase 2|Protocol Defined Disease Progression|0|||
126602467|NCT02719574|455506552|FG001|Phase 2|Protocol Defined Disease Progression|0|||
126602468|NCT02719574|455506553|FG002|Phase 2|Protocol Defined Disease Progression|0|||
126602469|NCT02719574|455506554|FG003|Phase 2|Protocol Defined Disease Progression|0|||
126602470|NCT02719574|455506555|FG004|Phase 2|Protocol Defined Disease Progression|0|||
126602471|NCT02719574|455506556|FG005|Phase 2|Protocol Defined Disease Progression|0|||
126602472|NCT02719574|455506557|FG006|Phase 2|Protocol Defined Disease Progression|0|||
126602473|NCT02719574|455506558|FG007|Phase 2|Protocol Defined Disease Progression|0|||
126602474|NCT02719574|455506559|FG008|Phase 2|Protocol Defined Disease Progression|0|||
126602475|NCT02719574|455506560|FG009|Phase 2|Protocol Defined Disease Progression|65|||
126602476|NCT02719574|455506561|FG010|Phase 2|Protocol Defined Disease Progression|8|||
126602477|NCT02719574|455506562|FG011|Phase 2|Protocol Defined Disease Progression|2|||
126602478|NCT02719574|455506563|FG012|Phase 2|Protocol Defined Disease Progression|4|||
126602479|NCT02719574|455506564|FG013|Phase 2|Protocol Defined Disease Progression|9|||
126602480|NCT02719574|455506565|FG014|Phase 2|Protocol Defined Disease Progression|11|||
126602481|NCT02719574|455506566|FG015|Phase 2|Protocol Defined Disease Progression|3|||
126602482|NCT02719574|455506567|FG016|Phase 2|Protocol Defined Disease Progression|4|||
126602483|NCT02719574|455506551|FG000|Phase 2|Adverse Event|0|||
126602484|NCT02719574|455506552|FG001|Phase 2|Adverse Event|0|||
126602485|NCT02719574|455506553|FG002|Phase 2|Adverse Event|0|||
126602486|NCT02719574|455506554|FG003|Phase 2|Adverse Event|0|||
126602487|NCT02719574|455506555|FG004|Phase 2|Adverse Event|0|||
126602488|NCT02719574|455506556|FG005|Phase 2|Adverse Event|0|||
126602489|NCT02719574|455506557|FG006|Phase 2|Adverse Event|0|||
126602490|NCT02719574|455506558|FG007|Phase 2|Adverse Event|0|||
126780812|NCT01133821|456152808|FG000|Overall Study|Lost to Follow-up|8|||
126780813|NCT01133821|456152809|FG001|Overall Study|Lost to Follow-up|11|||
126602491|NCT02719574|455506559|FG008|Phase 2|Adverse Event|0|||
126602492|NCT02719574|455506560|FG009|Phase 2|Adverse Event|27|||
126602493|NCT02719574|455506561|FG010|Phase 2|Adverse Event|0|||
126602494|NCT02719574|455506562|FG011|Phase 2|Adverse Event|1|||
126602495|NCT02719574|455506563|FG012|Phase 2|Adverse Event|1|||
126602496|NCT02719574|455506564|FG013|Phase 2|Adverse Event|1|||
126602497|NCT02719574|455506565|FG014|Phase 2|Adverse Event|2|||
126602498|NCT02719574|455506566|FG015|Phase 2|Adverse Event|2|||
126602499|NCT02719574|455506567|FG016|Phase 2|Adverse Event|3|||
126602500|NCT02719574|455506551|FG000|Phase 2|Other|0|||
126602501|NCT02719574|455506552|FG001|Phase 2|Other|0|||
126602502|NCT02719574|455506553|FG002|Phase 2|Other|0|||
126602503|NCT02719574|455506554|FG003|Phase 2|Other|0|||
126602504|NCT02719574|455506555|FG004|Phase 2|Other|0|||
126602505|NCT02719574|455506556|FG005|Phase 2|Other|0|||
126602506|NCT02719574|455506557|FG006|Phase 2|Other|0|||
126602507|NCT02719574|455506558|FG007|Phase 2|Other|0|||
126602508|NCT02719574|455506559|FG008|Phase 2|Other|0|||
126602509|NCT02719574|455506560|FG009|Phase 2|Other|20|||
126602510|NCT02719574|455506561|FG010|Phase 2|Other|7|||
126602511|NCT02719574|455506562|FG011|Phase 2|Other|0|||
126602512|NCT02719574|455506563|FG012|Phase 2|Other|5|||
126602513|NCT02719574|455506564|FG013|Phase 2|Other|7|||
126602514|NCT02719574|455506565|FG014|Phase 2|Other|0|||
126602515|NCT02719574|455506566|FG015|Phase 2|Other|1|||
126602516|NCT02719574|455506567|FG016|Phase 2|Other|4|||
126602517|NCT02719574|455506551|FG000|Phase 2|Transplant|0|||
126602518|NCT02719574|455506552|FG001|Phase 2|Transplant|0|||
126602519|NCT02719574|455506553|FG002|Phase 2|Transplant|0|||
126602520|NCT02719574|455506554|FG003|Phase 2|Transplant|0|||
126602521|NCT02719574|455506555|FG004|Phase 2|Transplant|0|||
126602522|NCT02719574|455506556|FG005|Phase 2|Transplant|0|||
126602523|NCT02719574|455506557|FG006|Phase 2|Transplant|0|||
126602524|NCT02719574|455506558|FG007|Phase 2|Transplant|0|||
126602525|NCT02719574|455506559|FG008|Phase 2|Transplant|0|||
126602526|NCT02719574|455506560|FG009|Phase 2|Transplant|15|||
126602527|NCT02719574|455506561|FG010|Phase 2|Transplant|2|||
126602528|NCT02719574|455506562|FG011|Phase 2|Transplant|0|||
126602529|NCT02719574|455506563|FG012|Phase 2|Transplant|6|||
126602530|NCT02719574|455506564|FG013|Phase 2|Transplant|1|||
126602531|NCT02719574|455506565|FG014|Phase 2|Transplant|1|||
126602532|NCT02719574|455506566|FG015|Phase 2|Transplant|0|||
126602533|NCT02719574|455506567|FG016|Phase 2|Transplant|0|||
126602534|NCT02719574|455506551|FG000|Phase 2|Death|0|||
126602535|NCT02719574|455506552|FG001|Phase 2|Death|0|||
126602536|NCT02719574|455506553|FG002|Phase 2|Death|0|||
126602537|NCT02719574|455506554|FG003|Phase 2|Death|0|||
126602538|NCT02719574|455506555|FG004|Phase 2|Death|0|||
126602539|NCT02719574|455506556|FG005|Phase 2|Death|0|||
126602540|NCT02719574|455506557|FG006|Phase 2|Death|0|||
126602541|NCT02719574|455506558|FG007|Phase 2|Death|0|||
126602542|NCT02719574|455506559|FG008|Phase 2|Death|0|||
126602543|NCT02719574|455506560|FG009|Phase 2|Death|14|||
126602544|NCT02719574|455506561|FG010|Phase 2|Death|0|||
126602545|NCT02719574|455506562|FG011|Phase 2|Death|0|||
126602546|NCT02719574|455506563|FG012|Phase 2|Death|1|||
126602547|NCT02719574|455506564|FG013|Phase 2|Death|1|||
126602548|NCT02719574|455506565|FG014|Phase 2|Death|2|||
126602549|NCT02719574|455506566|FG015|Phase 2|Death|0|||
126602550|NCT02719574|455506567|FG016|Phase 2|Death|0|||
126602551|NCT02719574|455506551|FG000|Phase 2|Investigator Decision|0|||
126602552|NCT02719574|455506552|FG001|Phase 2|Investigator Decision|0|||
126602553|NCT02719574|455506553|FG002|Phase 2|Investigator Decision|0|||
126602554|NCT02719574|455506554|FG003|Phase 2|Investigator Decision|0|||
126602555|NCT02719574|455506555|FG004|Phase 2|Investigator Decision|0|||
126602556|NCT02719574|455506556|FG005|Phase 2|Investigator Decision|0|||
126602557|NCT02719574|455506557|FG006|Phase 2|Investigator Decision|0|||
126602558|NCT02719574|455506558|FG007|Phase 2|Investigator Decision|0|||
126602559|NCT02719574|455506559|FG008|Phase 2|Investigator Decision|0|||
126602560|NCT02719574|455506560|FG009|Phase 2|Investigator Decision|6|||
126602561|NCT02719574|455506561|FG010|Phase 2|Investigator Decision|1|||
126602562|NCT02719574|455506562|FG011|Phase 2|Investigator Decision|2|||
126602563|NCT02719574|455506563|FG012|Phase 2|Investigator Decision|3|||
126602564|NCT02719574|455506564|FG013|Phase 2|Investigator Decision|1|||
126602565|NCT02719574|455506565|FG014|Phase 2|Investigator Decision|3|||
126602566|NCT02719574|455506566|FG015|Phase 2|Investigator Decision|2|||
126602567|NCT02719574|455506567|FG016|Phase 2|Investigator Decision|0|||
126602568|NCT02719574|455506551|FG000|Phase 2|Withdrawal by Subject|0|||
126602569|NCT02719574|455506552|FG001|Phase 2|Withdrawal by Subject|0|||
126602570|NCT02719574|455506553|FG002|Phase 2|Withdrawal by Subject|0|||
126733534|NCT01021813|455972397|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
126602571|NCT02719574|455506554|FG003|Phase 2|Withdrawal by Subject|0|||
126602572|NCT02719574|455506555|FG004|Phase 2|Withdrawal by Subject|0|||
126602573|NCT02719574|455506556|FG005|Phase 2|Withdrawal by Subject|0|||
126602574|NCT02719574|455506557|FG006|Phase 2|Withdrawal by Subject|0|||
126602575|NCT02719574|455506558|FG007|Phase 2|Withdrawal by Subject|0|||
126602576|NCT02719574|455506559|FG008|Phase 2|Withdrawal by Subject|0|||
126602577|NCT02719574|455506560|FG009|Phase 2|Withdrawal by Subject|5|||
126602578|NCT02719574|455506561|FG010|Phase 2|Withdrawal by Subject|0|||
126602579|NCT02719574|455506562|FG011|Phase 2|Withdrawal by Subject|0|||
126602580|NCT02719574|455506563|FG012|Phase 2|Withdrawal by Subject|0|||
126602581|NCT02719574|455506564|FG013|Phase 2|Withdrawal by Subject|1|||
126602582|NCT02719574|455506565|FG014|Phase 2|Withdrawal by Subject|1|||
126602583|NCT02719574|455506566|FG015|Phase 2|Withdrawal by Subject|2|||
126602584|NCT02719574|455506567|FG016|Phase 2|Withdrawal by Subject|0|||
126602585|NCT02719574|455506551|FG000|Phase 2|Protocol Violation|0|||
126602586|NCT02719574|455506552|FG001|Phase 2|Protocol Violation|0|||
126602587|NCT02719574|455506553|FG002|Phase 2|Protocol Violation|0|||
126602588|NCT02719574|455506554|FG003|Phase 2|Protocol Violation|0|||
126602589|NCT02719574|455506555|FG004|Phase 2|Protocol Violation|0|||
126602590|NCT02719574|455506556|FG005|Phase 2|Protocol Violation|0|||
126602591|NCT02719574|455506557|FG006|Phase 2|Protocol Violation|0|||
126602592|NCT02719574|455506558|FG007|Phase 2|Protocol Violation|0|||
126602593|NCT02719574|455506559|FG008|Phase 2|Protocol Violation|0|||
126602594|NCT02719574|455506560|FG009|Phase 2|Protocol Violation|1|||
126602595|NCT02719574|455506561|FG010|Phase 2|Protocol Violation|0|||
126602596|NCT02719574|455506562|FG011|Phase 2|Protocol Violation|0|||
126602597|NCT02719574|455506563|FG012|Phase 2|Protocol Violation|0|||
126602598|NCT02719574|455506564|FG013|Phase 2|Protocol Violation|0|||
126602599|NCT02719574|455506565|FG014|Phase 2|Protocol Violation|0|||
126602600|NCT02719574|455506566|FG015|Phase 2|Protocol Violation|0|||
126602601|NCT02719574|455506567|FG016|Phase 2|Protocol Violation|0|||
126602602|NCT00113360|455506574|FG000|Overall Study|Adverse Event|3|||
126602603|NCT00113360|455506574|FG000|Overall Study|Subject required surgery|1|||
126602604|NCT00113360|455506574|FG000|Overall Study|Did not meet eligibility criteria|3|||
126602605|NCT00739908|455506575|FG000|Overall Study|Adverse Event|5|||
126602606|NCT00739908|455506576|FG001|Overall Study|Adverse Event|6|||
126602607|NCT00739908|455506575|FG000|Overall Study|Withdrawal by Subject|4|||
126602608|NCT00739908|455506576|FG001|Overall Study|Withdrawal by Subject|2|||
126602609|NCT00739908|455506575|FG000|Overall Study|Lost to Follow-up|14|||
126602610|NCT00739908|455506576|FG001|Overall Study|Lost to Follow-up|9|||
126602611|NCT00739908|455506575|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
126602612|NCT00739908|455506576|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
126602613|NCT00739908|455506575|FG000|Overall Study|Non-Compliance With Study Medication|0|||
126602614|NCT00739908|455506576|FG001|Overall Study|Non-Compliance With Study Medication|3|||
126602615|NCT00739908|455506575|FG000|Overall Study|Lack of Efficacy|0|||
126602616|NCT00739908|455506576|FG001|Overall Study|Lack of Efficacy|1|||
126602617|NCT00739908|455506575|FG000|Overall Study|Relocation|0|||
126602618|NCT00739908|455506576|FG001|Overall Study|Relocation|1|||
126602619|NCT03875313|455506577|FG000|Overall Study|Withdrawal by Subject|1|||
126602620|NCT03875313|455506578|FG001|Overall Study|Withdrawal by Subject|3|||
126602621|NCT03875313|455506579|FG002|Overall Study|Withdrawal by Subject|0|||
126602622|NCT03875313|455506580|FG003|Overall Study|Withdrawal by Subject|0|||
126602623|NCT03875313|455506581|FG004|Overall Study|Withdrawal by Subject|0|||
126733535|NCT01021813|455972393|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
126733536|NCT01021813|455972394|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
126733537|NCT01021813|455972395|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
126733538|NCT01021813|455972396|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
126733539|NCT01021813|455972397|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
126733540|NCT01021813|455972393|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
126733541|NCT01021813|455972394|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
126733542|NCT01021813|455972395|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
126733543|NCT01021813|455972396|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
126733544|NCT01021813|455972397|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
126733545|NCT01021813|455972393|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
126733546|NCT01021813|455972394|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
126733547|NCT01021813|455972395|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
126733548|NCT01021813|455972396|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
126733549|NCT01021813|455972397|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
126733550|NCT01021813|455972393|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
126733551|NCT01021813|455972394|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
126733552|NCT01021813|455972395|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
126733553|NCT01021813|455972396|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
126733554|NCT01021813|455972397|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
126733555|NCT00764478|455972398|FG000|Overall Study|Adverse Event|1|||
126733556|NCT00764478|455972399|FG001|Overall Study|Adverse Event|1|||
126733557|NCT00764478|455972400|FG002|Overall Study|Adverse Event|1|||
126733558|NCT00764478|455972398|FG000|Overall Study|Withdrawal by Subject|7|||
126733559|NCT00764478|455972399|FG001|Overall Study|Withdrawal by Subject|12|||
126733560|NCT00764478|455972400|FG002|Overall Study|Withdrawal by Subject|1|||
126733561|NCT00764478|455972398|FG000|Overall Study|Lost to Follow-up|7|||
126733562|NCT00764478|455972399|FG001|Overall Study|Lost to Follow-up|8|||
126733563|NCT00764478|455972400|FG002|Overall Study|Lost to Follow-up|5|||
126733564|NCT00764478|455972398|FG000|Overall Study|Protocol Violation|0|||
126602624|NCT03875313|455506577|FG000|Overall Study|Death|0|||
126733565|NCT00764478|455972399|FG001|Overall Study|Protocol Violation|1|||
126733566|NCT00764478|455972400|FG002|Overall Study|Protocol Violation|1|||
126733567|NCT02270684|455972401|FG000|Overall Study|Lost to Follow-up|0|||
126733568|NCT02270684|455972402|FG001|Overall Study|Lost to Follow-up|3|||
126733569|NCT02270684|455972401|FG000|Overall Study|Study terminated|1|||
126602625|NCT03875313|455506578|FG001|Overall Study|Death|0|||
126602626|NCT03875313|455506579|FG002|Overall Study|Death|0|||
126602627|NCT03875313|455506580|FG003|Overall Study|Death|0|||
126602628|NCT03875313|455506581|FG004|Overall Study|Death|1|||
126602629|NCT03875313|455506577|FG000|Overall Study|Lost to Follow-up|0|||
126602630|NCT03875313|455506578|FG001|Overall Study|Lost to Follow-up|0|||
126602631|NCT03875313|455506579|FG002|Overall Study|Lost to Follow-up|0|||
126602632|NCT03875313|455506580|FG003|Overall Study|Lost to Follow-up|0|||
126602633|NCT03875313|455506581|FG004|Overall Study|Lost to Follow-up|1|||
126602634|NCT03875313|455506577|FG000|Overall Study|Study Termination by Sponsor|0|||
126602635|NCT03875313|455506578|FG001|Overall Study|Study Termination by Sponsor|1|||
126602636|NCT03875313|455506579|FG002|Overall Study|Study Termination by Sponsor|1|||
126602637|NCT03875313|455506580|FG003|Overall Study|Study Termination by Sponsor|0|||
126602638|NCT03875313|455506581|FG004|Overall Study|Study Termination by Sponsor|1|||
126602639|NCT03875313|455506577|FG000|Overall Study|New Anticancer Treatment|0|||
126602640|NCT03875313|455506578|FG001|Overall Study|New Anticancer Treatment|1|||
126602641|NCT03875313|455506579|FG002|Overall Study|New Anticancer Treatment|2|||
126602642|NCT03875313|455506580|FG003|Overall Study|New Anticancer Treatment|1|||
126602643|NCT03875313|455506581|FG004|Overall Study|New Anticancer Treatment|0|||
126602644|NCT03875313|455506577|FG000|Overall Study|Other, Not Specified|2|||
126602645|NCT03875313|455506578|FG001|Overall Study|Other, Not Specified|11|||
126602646|NCT03875313|455506579|FG002|Overall Study|Other, Not Specified|3|||
126602647|NCT03875313|455506580|FG003|Overall Study|Other, Not Specified|3|||
126602648|NCT03875313|455506581|FG004|Overall Study|Other, Not Specified|1|||
126602649|NCT04121546|455506582|FG000|Overall Study|Lost to Follow-up|1|||
126602650|NCT04121546|455506583|FG001|Overall Study|Lost to Follow-up|3|||
126602651|NCT03286114|455506588|FG000|Overall Study|Adverse Event|6|||
126602652|NCT03286114|455506588|FG000|Overall Study|Death|3|||
126602653|NCT01046825|455506589|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
126602654|NCT01046825|455506590|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
126602655|NCT01046825|455506591|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
126733570|NCT02270684|455972402|FG001|Overall Study|Study terminated|0|||
126733571|NCT03498287|455972409|FG000|Overall Study|Withdrawal by Subject|3|||
126733572|NCT03498287|455972410|FG001|Overall Study|Withdrawal by Subject|0|||
126733573|NCT03498287|455972409|FG000|Overall Study|Protocol Violation|0|||
126733574|NCT03498287|455972410|FG001|Overall Study|Protocol Violation|4|||
126733575|NCT03498287|455972409|FG000|Overall Study|Adverse Event|0|||
126733576|NCT03498287|455972410|FG001|Overall Study|Adverse Event|1|||
126733577|NCT01374217|455972411|FG000|Overall Study|Lack of Efficacy|13|||
126733578|NCT01641991|455972412|FG000|Overall Study|Physician Decision|0|||
126733579|NCT01641991|455972413|FG001|Overall Study|Physician Decision|1|||
126733580|NCT01641991|455972414|FG002|Overall Study|Physician Decision|7|||
126733581|NCT01641991|455972415|FG003|Overall Study|Physician Decision|5|||
126733582|NCT01641991|455972412|FG000|Overall Study|Withdrawal by Subject|4|||
126733583|NCT01641991|455972413|FG001|Overall Study|Withdrawal by Subject|2|||
126733584|NCT01641991|455972414|FG002|Overall Study|Withdrawal by Subject|1|||
126733585|NCT01641991|455972415|FG003|Overall Study|Withdrawal by Subject|5|||
126733586|NCT01641991|455972412|FG000|Overall Study|Adverse Event|2|||
126733587|NCT01641991|455972413|FG001|Overall Study|Adverse Event|1|||
126733588|NCT01641991|455972414|FG002|Overall Study|Adverse Event|2|||
126733589|NCT01641991|455972415|FG003|Overall Study|Adverse Event|1|||
126733590|NCT01641991|455972412|FG000|Overall Study|Lost to Follow-up|0|||
126733591|NCT01641991|455972413|FG001|Overall Study|Lost to Follow-up|2|||
126733592|NCT01641991|455972414|FG002|Overall Study|Lost to Follow-up|3|||
126733593|NCT01641991|455972415|FG003|Overall Study|Lost to Follow-up|1|||
126733594|NCT01641991|455972412|FG000|Overall Study|Protocol Violation|1|||
126733595|NCT01641991|455972413|FG001|Overall Study|Protocol Violation|1|||
126733596|NCT01641991|455972414|FG002|Overall Study|Protocol Violation|3|||
126733597|NCT01641991|455972415|FG003|Overall Study|Protocol Violation|0|||
126733598|NCT01641991|455972412|FG000|Overall Study|Pregnancy|0|||
126733599|NCT01641991|455972413|FG001|Overall Study|Pregnancy|0|||
126733600|NCT01641991|455972414|FG002|Overall Study|Pregnancy|1|||
126733601|NCT01641991|455972415|FG003|Overall Study|Pregnancy|0|||
126733602|NCT01641991|455972412|FG000|Overall Study|no longer eligible|2|||
126733603|NCT01641991|455972413|FG001|Overall Study|no longer eligible|1|||
126733604|NCT01641991|455972414|FG002|Overall Study|no longer eligible|0|||
126733605|NCT01641991|455972415|FG003|Overall Study|no longer eligible|4|||
126733606|NCT01578785|455972416|FG000|Overall Study|Withdrawal by Subject|0|||
126733607|NCT01578785|455972417|FG001|Overall Study|Withdrawal by Subject|1|||
126733608|NCT01578785|455972416|FG000|Overall Study|Study terminated by sponsor|59|||
126733609|NCT01578785|455972417|FG001|Overall Study|Study terminated by sponsor|118|||
126733610|NCT03371732|455972418|FG000|Overall Study|Withdrawal by Subject|9|||
126733611|NCT03371732|455972419|FG001|Overall Study|Withdrawal by Subject|3|||
126733612|NCT03371732|455972418|FG000|Overall Study|Refusal to continue|3|||
126602656|NCT01046825|455506592|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
126602657|NCT01046825|455506593|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
126733613|NCT03371732|455972419|FG001|Overall Study|Refusal to continue|4|||
126733614|NCT02581982|455972420|FG000|Overall Study|Lack of Efficacy|12|||
126733615|NCT02581982|455972420|FG000|Overall Study|Adverse Event|3|||
126733616|NCT02581982|455972420|FG000|Overall Study|Physician Decision|1|||
126733617|NCT03479216|455972422|FG000|Overall Study|Withdrawal by Subject|3|||
126733618|NCT03479216|455972423|FG001|Overall Study|Withdrawal by Subject|2|||
126733619|NCT03479216|455972422|FG000|Overall Study|Physician Decision|2|||
126602658|NCT01046825|455506589|FG000|Overall Study|Physician Decision|0|||
126602659|NCT01046825|455506590|FG001|Overall Study|Physician Decision|1|||
126602660|NCT01046825|455506591|FG002|Overall Study|Physician Decision|2|||
126602661|NCT01046825|455506592|FG003|Overall Study|Physician Decision|0|||
126602662|NCT01046825|455506593|FG004|Overall Study|Physician Decision|0|||
126602663|NCT01046825|455506589|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
126602664|NCT01046825|455506590|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
126602665|NCT01046825|455506591|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
126602666|NCT01046825|455506592|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
126602667|NCT01046825|455506593|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
126602668|NCT01046825|455506589|FG000|Overall Study|Found to be ineligible|0|||
126602669|NCT01046825|455506590|FG001|Overall Study|Found to be ineligible|1|||
126602670|NCT01046825|455506591|FG002|Overall Study|Found to be ineligible|0|||
126602671|NCT01046825|455506592|FG003|Overall Study|Found to be ineligible|0|||
126602672|NCT01046825|455506593|FG004|Overall Study|Found to be ineligible|0|||
126602673|NCT01046825|455506589|FG000|Overall Study|Death|0|||
126602674|NCT01046825|455506590|FG001|Overall Study|Death|0|||
126602675|NCT01046825|455506591|FG002|Overall Study|Death|0|||
126602676|NCT01046825|455506592|FG003|Overall Study|Death|1|||
126602677|NCT01046825|455506593|FG004|Overall Study|Death|0|||
126602678|NCT01046825|455506589|FG000|Overall Study|Did not submit biology samples|0|||
126602679|NCT01046825|455506590|FG001|Overall Study|Did not submit biology samples|0|||
126602680|NCT01046825|455506591|FG002|Overall Study|Did not submit biology samples|0|||
126602681|NCT01046825|455506592|FG003|Overall Study|Did not submit biology samples|0|||
126602682|NCT01046825|455506593|FG004|Overall Study|Did not submit biology samples|13|||
126602683|NCT04993677|455506601|FG000|Overall Study|Lost to Follow-up|1|||
126602684|NCT04993677|455506602|FG001|Overall Study|Lost to Follow-up|0|||
126602685|NCT04993677|455506603|FG002|Overall Study|Lost to Follow-up|0|||
126602686|NCT04993677|455506604|FG003|Overall Study|Lost to Follow-up|0|||
126602687|NCT04993677|455506601|FG000|Overall Study|Death|11|||
126602688|NCT04993677|455506602|FG001|Overall Study|Death|8|||
126602689|NCT04993677|455506603|FG002|Overall Study|Death|3|||
126602690|NCT04993677|455506604|FG003|Overall Study|Death|1|||
126602691|NCT04993677|455506601|FG000|Overall Study|Subject withdrawal of consent|4|||
126602692|NCT04993677|455506602|FG001|Overall Study|Subject withdrawal of consent|3|||
126602693|NCT04993677|455506603|FG002|Overall Study|Subject withdrawal of consent|0|||
126602694|NCT04993677|455506604|FG003|Overall Study|Subject withdrawal of consent|2|||
126602695|NCT04993677|455506601|FG000|Overall Study|Study termination by sponsor|3|||
126602696|NCT04993677|455506602|FG001|Overall Study|Study termination by sponsor|25|||
126602697|NCT04993677|455506603|FG002|Overall Study|Study termination by sponsor|3|||
126602698|NCT04993677|455506604|FG003|Overall Study|Study termination by sponsor|3|||
126602699|NCT04993677|455506601|FG000|Overall Study|Other|2|||
126602700|NCT04993677|455506602|FG001|Overall Study|Other|3|||
126602701|NCT04993677|455506603|FG002|Overall Study|Other|3|||
126602702|NCT04993677|455506604|FG003|Overall Study|Other|2|||
126602703|NCT00003222|455506607|FG000|Overall Study|Physician Decision|0|||
126602704|NCT00003222|455506608|FG001|Overall Study|Physician Decision|1|||
126602705|NCT04757753|455506609|FG000|Overall Study|Lost to Follow-up|7|||
126602706|NCT04757753|455506610|FG001|Overall Study|Lost to Follow-up|7|||
126602707|NCT04757753|455506609|FG000|Overall Study|Withdrawal by Subject|0|||
126602708|NCT04757753|455506610|FG001|Overall Study|Withdrawal by Subject|3|||
126602709|NCT04757753|455506609|FG000|Overall Study|Endodontic treatment failure|1|||
126602710|NCT04757753|455506610|FG001|Overall Study|Endodontic treatment failure|2|||
126602711|NCT04757753|455506609|FG000|Overall Study|Tooth fracture/extraction|3|||
126602712|NCT04757753|455506610|FG001|Overall Study|Tooth fracture/extraction|0|||
126602713|NCT01313559|455506611|FG000|Overall Study|Withdrawal by Subject|1|||
126602714|NCT01313559|455506612|FG001|Overall Study|Withdrawal by Subject|2|||
126602715|NCT01313559|455506611|FG000|Overall Study|Disease progression|1|||
126602716|NCT01313559|455506612|FG001|Overall Study|Disease progression|0|||
126602717|NCT01313559|455506611|FG000|Overall Study|Rising PSA|2|||
126602718|NCT01313559|455506612|FG001|Overall Study|Rising PSA|0|||
126602719|NCT03725332|455506614|FG000|Overall Study|Adverse Event|5|||
126602720|NCT03725332|455506615|FG001|Overall Study|Adverse Event|10|||
126733620|NCT03479216|455972423|FG001|Overall Study|Physician Decision|3|||
126733621|NCT05406440|455973892|FG000|Overall Study|Lost to Follow-up|0|||
126602721|NCT03725332|455506614|FG000|Overall Study|Death|1|||
126602722|NCT03725332|455506615|FG001|Overall Study|Death|3|||
126602723|NCT03725332|455506614|FG000|Overall Study|Lost to Follow-up|43|||
126602724|NCT03725332|455506615|FG001|Overall Study|Lost to Follow-up|122|||
126602725|NCT03725332|455506614|FG000|Overall Study|Withdrawal by Subject|0|||
126602726|NCT03725332|455506615|FG001|Overall Study|Withdrawal by Subject|1|||
126602727|NCT03725332|455506614|FG000|Overall Study|Duplicate enrollment|0|||
126602728|NCT03725332|455506615|FG001|Overall Study|Duplicate enrollment|1|||
126602729|NCT03725332|455506614|FG000|Overall Study|Did not consent|0|||
126602730|NCT03725332|455506615|FG001|Overall Study|Did not consent|1|||
126602731|NCT03201939|455506621|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
126602732|NCT03201939|455506622|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
126602733|NCT05707351|455506623|FG000|Overall Study|Withdrawal by Subject|2|||
126602734|NCT05707351|455506623|FG000|Overall Study|Reason Not Specified|1|||
126602735|NCT05795153|455507326|FG000|Overall Study|Adverse Event|2|||
126602736|NCT05795153|455507326|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126602737|NCT05795153|455507326|FG000|Overall Study|Lost to Follow-up|1|||
126602738|NCT05795153|455507326|FG000|Overall Study|Subject decision|2|||
126602739|NCT05180539|455507327|FG000|Overall Study|Lost to Follow-up|27|||
126602740|NCT05180539|455507328|FG001|Overall Study|Lost to Follow-up|30|||
126602741|NCT02566889|455507331|FG000|Overall Study|Withdrawal by Subject|3|||
126602742|NCT02566889|455507332|FG001|Overall Study|Withdrawal by Subject|1|||
126602743|NCT02566889|455507331|FG000|Overall Study|Adverse Event|4|||
126602744|NCT02566889|455507332|FG001|Overall Study|Adverse Event|2|||
126602745|NCT02566889|455507331|FG000|Overall Study|Other|6|||
126602746|NCT02566889|455507332|FG001|Overall Study|Other|2|||
126602747|NCT04518943|455507333|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
126602748|NCT04518943|455507334|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
126602749|NCT04518943|455507335|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
126602750|NCT04518943|455507336|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
126602751|NCT04518943|455507337|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
126602752|NCT04518943|455507338|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
126602753|NCT04518943|455507339|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
126602754|NCT04518943|455507340|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
126602755|NCT04518943|455507341|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
126602756|NCT04518943|455507342|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
126602757|NCT04518943|455507343|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
126602758|NCT04518943|455507344|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
126602759|NCT04518943|455507345|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
126602760|NCT04518943|455507346|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
126602761|NCT04518943|455507347|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
126602762|NCT04518943|455507348|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
126602763|NCT03699163|455507349|FG000|Overall Study|Physician Decision|12|||
126602764|NCT03699163|455507350|FG001|Overall Study|Physician Decision|0|||
126602765|NCT03699163|455507349|FG000|Overall Study|failed QC measures|205|||
126602766|NCT03699163|455507350|FG001|Overall Study|failed QC measures|206|||
126602767|NCT02075554|455507363|FG000|Overall Study|Lost to Follow-up|7|||
126602768|NCT02075554|455507363|FG000|Overall Study|Withdrawal by Subject|5|||
126602769|NCT02075554|455507363|FG000|Overall Study|Physician Decision|3|||
126602770|NCT03248492|455507370|FG000|Overall Study|Progressive Disease|24|||
126602771|NCT03248492|455507371|FG001|Overall Study|Progressive Disease|23|||
126602772|NCT03248492|455507372|FG002|Overall Study|Progressive Disease|11|||
126602773|NCT03248492|455507373|FG003|Overall Study|Progressive Disease|66|||
126602774|NCT03248492|455507374|FG004|Overall Study|Progressive Disease|1|||
126602775|NCT03248492|455507370|FG000|Overall Study|Adverse Event|14|||
126602776|NCT03248492|455507371|FG001|Overall Study|Adverse Event|13|||
126602777|NCT03248492|455507372|FG002|Overall Study|Adverse Event|9|||
126602778|NCT03248492|455507373|FG003|Overall Study|Adverse Event|22|||
126602779|NCT03248492|455507374|FG004|Overall Study|Adverse Event|2|||
126602780|NCT03248492|455507370|FG000|Overall Study|Withdrawal by Subject|5|||
126602781|NCT03248492|455507371|FG001|Overall Study|Withdrawal by Subject|4|||
126602782|NCT03248492|455507372|FG002|Overall Study|Withdrawal by Subject|0|||
126602783|NCT03248492|455507373|FG003|Overall Study|Withdrawal by Subject|8|||
126602784|NCT03248492|455507374|FG004|Overall Study|Withdrawal by Subject|1|||
126602785|NCT03248492|455507370|FG000|Overall Study|Physician Decision|1|||
126602786|NCT03248492|455507371|FG001|Overall Study|Physician Decision|1|||
126602787|NCT03248492|455507372|FG002|Overall Study|Physician Decision|1|||
126602788|NCT03248492|455507373|FG003|Overall Study|Physician Decision|7|||
126602789|NCT03248492|455507374|FG004|Overall Study|Physician Decision|0|||
126602790|NCT03248492|455507370|FG000|Overall Study|Death|1|||
126602791|NCT03248492|455507371|FG001|Overall Study|Death|1|||
126602792|NCT03248492|455507372|FG002|Overall Study|Death|0|||
126602793|NCT03248492|455507373|FG003|Overall Study|Death|6|||
126780814|NCT01133821|456152808|FG000|Overall Study|Withdrawal by Subject|8|||
126780815|NCT01133821|456152809|FG001|Overall Study|Withdrawal by Subject|3|||
126602794|NCT03248492|455507374|FG004|Overall Study|Death|0|||
126780816|NCT01133821|456152808|FG000|Overall Study|preferred other treatment|1|||
126780817|NCT01133821|456152809|FG001|Overall Study|preferred other treatment|1|||
126602795|NCT03248492|455507370|FG000|Overall Study|Study Terminated by Sponsor|3|||
126602796|NCT03248492|455507371|FG001|Overall Study|Study Terminated by Sponsor|1|||
126602797|NCT03248492|455507372|FG002|Overall Study|Study Terminated by Sponsor|0|||
126602798|NCT03248492|455507373|FG003|Overall Study|Study Terminated by Sponsor|7|||
126602799|NCT03248492|455507374|FG004|Overall Study|Study Terminated by Sponsor|0|||
126602800|NCT03248492|455507370|FG000|Overall Study|Other|2|||
126602801|NCT03248492|455507371|FG001|Overall Study|Other|5|||
126602802|NCT03248492|455507372|FG002|Overall Study|Other|0|||
126602803|NCT03248492|455507373|FG003|Overall Study|Other|14|||
126602804|NCT03248492|455507374|FG004|Overall Study|Other|0|||
126602805|NCT03767335|455507375|FG000|Overall Study|Physician Decision|1|||
126602806|NCT03767335|455507376|FG001|Overall Study|Physician Decision|1|||
126602807|NCT03767335|455507377|FG002|Overall Study|Physician Decision|0|||
126602808|NCT03767335|455507375|FG000|Overall Study|Withdrawal by Subject|0|||
126602809|NCT03767335|455507376|FG001|Overall Study|Withdrawal by Subject|0|||
126602810|NCT03767335|455507377|FG002|Overall Study|Withdrawal by Subject|6|||
126602811|NCT03767335|455507375|FG000|Overall Study|Participant excluded from efficacy population|0|||
126602812|NCT03767335|455507376|FG001|Overall Study|Participant excluded from efficacy population|0|||
126602813|NCT03767335|455507377|FG002|Overall Study|Participant excluded from efficacy population|1|||
126602814|NCT03767335|455507375|FG000|Overall Study|Death|0|||
126602815|NCT03767335|455507376|FG001|Overall Study|Death|0|||
126602816|NCT03767335|455507377|FG002|Overall Study|Death|2|||
126602817|NCT03767335|455507375|FG000|Overall Study|Progressive Disease|2|||
126602818|NCT03767335|455507376|FG001|Overall Study|Progressive Disease|2|||
126602819|NCT03767335|455507377|FG002|Overall Study|Progressive Disease|2|||
126602820|NCT03767335|455507375|FG000|Overall Study|Disease progression needing additional medication|0|||
126602821|NCT03767335|455507376|FG001|Overall Study|Disease progression needing additional medication|0|||
126602822|NCT03767335|455507377|FG002|Overall Study|Disease progression needing additional medication|17|||
126602823|NCT03767335|455507375|FG000|Overall Study|Sponsor decision|0|||
126602824|NCT03767335|455507376|FG001|Overall Study|Sponsor decision|0|||
126602825|NCT03767335|455507377|FG002|Overall Study|Sponsor decision|2|||
126602826|NCT03767335|455507375|FG000|Overall Study|Other Medical Reasons|0|||
126602827|NCT03767335|455507376|FG001|Overall Study|Other Medical Reasons|0|||
126602828|NCT03767335|455507377|FG002|Overall Study|Other Medical Reasons|3|||
126602829|NCT03705390|455507378|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
126602830|NCT03705390|455507378|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
126602831|NCT04495621|455507380|FG000|Overall Study|Withdrawal by Subject|0|||
126602832|NCT04495621|455507381|FG001|Overall Study|Withdrawal by Subject|3|||
126602833|NCT04495621|455507380|FG000|Overall Study|Death|7|||
126602834|NCT04495621|455507381|FG001|Overall Study|Death|11|||
126602835|NCT04495621|455507380|FG000|Overall Study|Investigator Decision|0|||
126602836|NCT04495621|455507381|FG001|Overall Study|Investigator Decision|7|||
126602837|NCT04495621|455507380|FG000|Overall Study|Lost to Follow-up|0|||
126602838|NCT04495621|455507381|FG001|Overall Study|Lost to Follow-up|1|||
126602839|NCT02701283|455507392|FG000|Overall Study|Death|25|||
126602840|NCT02701283|455507393|FG001|Overall Study|Death|29|||
126602841|NCT02701283|455507394|FG002|Overall Study|Death|19|||
126602842|NCT02701283|455507392|FG000|Overall Study|Lost to Follow-up|3|||
126602843|NCT02701283|455507393|FG001|Overall Study|Lost to Follow-up|8|||
126602844|NCT02701283|455507394|FG002|Overall Study|Lost to Follow-up|1|||
126602845|NCT02701283|455507392|FG000|Overall Study|Withdrawal by Subject|12|||
126602846|NCT02701283|455507393|FG001|Overall Study|Withdrawal by Subject|41|||
126602847|NCT02701283|455507394|FG002|Overall Study|Withdrawal by Subject|1|||
126602848|NCT02701283|455507392|FG000|Overall Study|Missed 2-year visit|22|||
126602849|NCT02701283|455507393|FG001|Overall Study|Missed 2-year visit|27|||
126602850|NCT02701283|455507394|FG002|Overall Study|Missed 2-year visit|0|||
126602851|NCT02701283|455507392|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
126602852|NCT02701283|455507393|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
126602853|NCT02701283|455507394|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
126602854|NCT01830595|455507397|FG000|First Period|Withdrawal by Subject|1|||
126602855|NCT01830595|455507398|FG001|First Period|Withdrawal by Subject|3|||
126602856|NCT01830595|455507397|FG000|Washout|Withdrawal by Subject|2|||
126602857|NCT01830595|455507398|FG001|Washout|Withdrawal by Subject|2|||
126602858|NCT04908514|455507401|FG000|Overall Study|Lost to Follow-up|2|||
126602859|NCT04908514|455507401|FG000|Overall Study|Withdrawal by Subject|1|||
126602860|NCT03891758|455507403|FG000|Overall Study|Adverse Event|2|||
126602861|NCT03891758|455507404|FG001|Overall Study|Adverse Event|0|||
126602862|NCT03891758|455507403|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126602863|NCT03891758|455507404|FG001|Overall Study|Withdrawal by parent/guardian|2|||
126602864|NCT03213457|455508055|FG000|Screening Period|Withdrawal by Subject|0|||
126602865|NCT03213457|455508056|FG001|Screening Period|Withdrawal by Subject|1|||
126733622|NCT05406440|455973893|FG001|Overall Study|Lost to Follow-up|0|||
126602866|NCT03213457|455508057|FG002|Screening Period|Withdrawal by Subject|0|||
126602867|NCT03213457|455508055|FG000|Screening Period|Other|1|||
126602868|NCT03213457|455508056|FG001|Screening Period|Other|0|||
126602869|NCT03213457|455508057|FG002|Screening Period|Other|0|||
126602870|NCT03213457|455508055|FG000|Double-Blind Period|Adverse Event|3|||
126602871|NCT03213457|455508056|FG001|Double-Blind Period|Adverse Event|2|||
126602872|NCT03213457|455508057|FG002|Double-Blind Period|Adverse Event|7|||
126602873|NCT03213457|455508055|FG000|Double-Blind Period|Withdrawal by Subject|14|||
126602874|NCT03213457|455508056|FG001|Double-Blind Period|Withdrawal by Subject|2|||
126602875|NCT03213457|455508057|FG002|Double-Blind Period|Withdrawal by Subject|14|||
126602876|NCT03213457|455508055|FG000|Double-Blind Period|Lost to Follow-up|2|||
126602877|NCT03213457|455508056|FG001|Double-Blind Period|Lost to Follow-up|3|||
126602878|NCT03213457|455508057|FG002|Double-Blind Period|Lost to Follow-up|9|||
126602879|NCT03213457|455508055|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
126602880|NCT03213457|455508056|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
126602881|NCT03213457|455508057|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
126602882|NCT03213457|455508055|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
126602883|NCT03213457|455508056|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
126602884|NCT03213457|455508057|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
126602885|NCT03213457|455508055|FG000|Double-Blind Period|Pregnancy|5|||
126602886|NCT03213457|455508056|FG001|Double-Blind Period|Pregnancy|0|||
126602887|NCT03213457|455508057|FG002|Double-Blind Period|Pregnancy|0|||
126602888|NCT03213457|455508055|FG000|Double-Blind Period|Other|10|||
126602889|NCT03213457|455508056|FG001|Double-Blind Period|Other|3|||
126602890|NCT03213457|455508057|FG002|Double-Blind Period|Other|17|||
126602891|NCT03213457|455508055|FG000|Open-Label Period|Adverse Event|1|||
126602892|NCT03213457|455508056|FG001|Open-Label Period|Adverse Event|2|||
126602893|NCT03213457|455508057|FG002|Open-Label Period|Adverse Event|2|||
126602894|NCT03213457|455508055|FG000|Open-Label Period|Withdrawal by Subject|12|||
126602895|NCT03213457|455508056|FG001|Open-Label Period|Withdrawal by Subject|5|||
126602896|NCT03213457|455508057|FG002|Open-Label Period|Withdrawal by Subject|24|||
126602897|NCT03213457|455508055|FG000|Open-Label Period|Lost to Follow-up|1|||
126602898|NCT03213457|455508056|FG001|Open-Label Period|Lost to Follow-up|2|||
126602899|NCT03213457|455508057|FG002|Open-Label Period|Lost to Follow-up|8|||
126602900|NCT03213457|455508055|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
126602901|NCT03213457|455508056|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
126602902|NCT03213457|455508057|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
126602903|NCT03213457|455508055|FG000|Open-Label Period|Non-compliance with study procedures|1|||
126602904|NCT03213457|455508056|FG001|Open-Label Period|Non-compliance with study procedures|1|||
126602905|NCT03213457|455508057|FG002|Open-Label Period|Non-compliance with study procedures|2|||
126602906|NCT03213457|455508055|FG000|Open-Label Period|Exclusionary medications|0|||
126602907|NCT03213457|455508056|FG001|Open-Label Period|Exclusionary medications|0|||
126602908|NCT03213457|455508057|FG002|Open-Label Period|Exclusionary medications|1|||
126602909|NCT03213457|455508055|FG000|Open-Label Period|Other|1|||
126602910|NCT03213457|455508056|FG001|Open-Label Period|Other|1|||
126602911|NCT03213457|455508057|FG002|Open-Label Period|Other|6|||
126602912|NCT03213457|455508055|FG000|Follow-Up Period|Adverse Event|16|||
126602913|NCT03213457|455508056|FG001|Follow-Up Period|Adverse Event|8|||
126602914|NCT03213457|455508057|FG002|Follow-Up Period|Adverse Event|37|||
126602915|NCT03213457|455508055|FG000|Follow-Up Period|Withdrawal by Subject|18|||
126602916|NCT03213457|455508056|FG001|Follow-Up Period|Withdrawal by Subject|11|||
126602917|NCT03213457|455508057|FG002|Follow-Up Period|Withdrawal by Subject|55|||
126602918|NCT03213457|455508055|FG000|Follow-Up Period|Lost to Follow-up|28|||
126602919|NCT03213457|455508056|FG001|Follow-Up Period|Lost to Follow-up|15|||
126602920|NCT03213457|455508057|FG002|Follow-Up Period|Lost to Follow-up|50|||
126602921|NCT03213457|455508055|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
126602922|NCT03213457|455508056|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
126602923|NCT03213457|455508057|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
126602924|NCT03213457|455508055|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
126602925|NCT03213457|455508056|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
126602926|NCT03213457|455508057|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
126602927|NCT03213457|455508055|FG000|Follow-Up Period|Pregnancy|7|||
126602928|NCT03213457|455508056|FG001|Follow-Up Period|Pregnancy|0|||
126602929|NCT03213457|455508057|FG002|Follow-Up Period|Pregnancy|18|||
126602930|NCT03213457|455508055|FG000|Follow-Up Period|Exclusionary medications|1|||
126602931|NCT03213457|455508056|FG001|Follow-Up Period|Exclusionary medications|1|||
126602932|NCT03213457|455508057|FG002|Follow-Up Period|Exclusionary medications|5|||
126602933|NCT03213457|455508055|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
126602934|NCT03213457|455508056|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
126602935|NCT03213457|455508057|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
126602936|NCT03213457|455508055|FG000|Follow-Up Period|Other|14|||
126602937|NCT03213457|455508056|FG001|Follow-Up Period|Other|10|||
126602938|NCT03213457|455508057|FG002|Follow-Up Period|Other|31|||
126602939|NCT04940624|455508058|FG000|Overall Study|Adverse Event|4|||
126602940|NCT04940624|455508059|FG001|Overall Study|Adverse Event|11|||
126602941|NCT04940624|455508058|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126602942|NCT04940624|455508059|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
126602943|NCT04940624|455508058|FG000|Overall Study|Physician Decision|1|||
126602944|NCT04940624|455508059|FG001|Overall Study|Physician Decision|0|||
126602945|NCT04940624|455508058|FG000|Overall Study|Lost to Follow-up|1|||
126602946|NCT04940624|455508059|FG001|Overall Study|Lost to Follow-up|0|||
126733623|NCT05406440|455973894|FG002|Overall Study|Lost to Follow-up|0|||
126733624|NCT05406440|455973895|FG003|Overall Study|Lost to Follow-up|0|||
126733625|NCT05406440|455973896|FG004|Overall Study|Lost to Follow-up|2|||
126602947|NCT04940624|455508058|FG000|Overall Study|Reason Not Specified|1|||
126602948|NCT04940624|455508059|FG001|Overall Study|Reason Not Specified|0|||
126602949|NCT05934292|455508067|FG000|Overall Study|Lost to Follow-up|0|||
126602950|NCT05934292|455508068|FG001|Overall Study|Lost to Follow-up|0|||
126602951|NCT05934292|455508069|FG002|Overall Study|Lost to Follow-up|1|||
126602952|NCT05934292|455508070|FG003|Overall Study|Lost to Follow-up|0|||
126602953|NCT04479787|455508071|FG000|Through 6 Months|Withdrawal by Subject|16|||
126602954|NCT04479787|455508072|FG001|Through 6 Months|Withdrawal by Subject|14|||
126602955|NCT04479787|455508071|FG000|Through 6 Months|Unsuccessful Trial|17|||
126602956|NCT04479787|455508072|FG001|Through 6 Months|Unsuccessful Trial|0|||
126602957|NCT04479787|455508071|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
126602958|NCT04479787|455508072|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
126602959|NCT04479787|455508071|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
126602960|NCT04479787|455508072|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
126602961|NCT04479787|455508071|FG000|Through 6 Months|Lost to Follow-up|3|||
126602962|NCT04479787|455508072|FG001|Through 6 Months|Lost to Follow-up|2|||
126602963|NCT04479787|455508071|FG000|Through 6 Months|Death|3|||
126602964|NCT04479787|455508072|FG001|Through 6 Months|Death|0|||
126602965|NCT04479787|455508071|FG000|Through 6 Months|Inclusion/Exclusion|2|||
126602966|NCT04479787|455508072|FG001|Through 6 Months|Inclusion/Exclusion|1|||
126602967|NCT04479787|455508071|FG000|Through 6 Months|Subject Became Pregnant|1|||
126602968|NCT04479787|455508072|FG001|Through 6 Months|Subject Became Pregnant|1|||
126602969|NCT04479787|455508071|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
126602970|NCT04479787|455508072|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
126602971|NCT04479787|455508071|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
126602972|NCT04479787|455508072|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
126602973|NCT04479787|455508071|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
126602974|NCT04479787|455508072|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
126602975|NCT04479787|455508071|FG000|After 6 Months|Withdrawal by Subject|3|||
126602976|NCT04479787|455508072|FG001|After 6 Months|Withdrawal by Subject|13|||
126602977|NCT04479787|455508071|FG000|After 6 Months|Unsuccessful Trial|0|||
126602978|NCT04479787|455508072|FG001|After 6 Months|Unsuccessful Trial|7|||
126602979|NCT04479787|455508071|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
126602980|NCT04479787|455508072|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
126602981|NCT04479787|455508071|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
126602982|NCT04479787|455508072|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
126602983|NCT04479787|455508071|FG000|After 6 Months|Death|2|||
126602984|NCT04479787|455508072|FG001|After 6 Months|Death|0|||
126602985|NCT04479787|455508071|FG000|After 6 Months|Lost to Follow-up|1|||
126602986|NCT04479787|455508072|FG001|After 6 Months|Lost to Follow-up|1|||
126602987|NCT04479787|455508071|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
126602988|NCT04479787|455508072|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
126602989|NCT04479787|455508071|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
126602990|NCT04479787|455508072|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
126602991|NCT04479787|455508071|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
126602992|NCT04479787|455508072|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
126602993|NCT04479787|455508071|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
126602994|NCT04479787|455508072|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
126602995|NCT05714059|455508075|FG000|Overall Study|Withdrawal by Subject|2|||
126602996|NCT05714059|455508076|FG001|Overall Study|Withdrawal by Subject|2|||
126602997|NCT05714059|455508075|FG000|Overall Study|Adverse Event|0|||
126602998|NCT05714059|455508076|FG001|Overall Study|Adverse Event|1|||
126602999|NCT05714059|455508075|FG000|Overall Study|Lost to Follow-up|0|||
126603000|NCT05714059|455508076|FG001|Overall Study|Lost to Follow-up|1|||
126603001|NCT05714059|455508075|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
126603002|NCT05714059|455508076|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
126603003|NCT05714059|455508075|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
126603004|NCT05714059|455508076|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
126603005|NCT05116774|455508077|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
126603006|NCT05116774|455508078|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
126603007|NCT05116774|455508077|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
126603008|NCT05116774|455508078|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
126603009|NCT05116774|455508077|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
126603010|NCT05116774|455508078|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
126780818|NCT01133821|456152808|FG000|Overall Study|Protocol Violation|0|||
126603011|NCT05116774|455508077|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
126603012|NCT05116774|455508078|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
126603013|NCT03150862|455508080|FG000|Overall Study|Death|2|||
126603014|NCT03150862|455508081|FG001|Overall Study|Death|7|||
126603015|NCT03150862|455508082|FG002|Overall Study|Death|8|||
126603016|NCT03150862|455508083|FG003|Overall Study|Death|27|||
126603017|NCT03150862|455508084|FG004|Overall Study|Death|4|||
126603018|NCT03150862|455508085|FG005|Overall Study|Death|8|||
126603019|NCT03150862|455508086|FG006|Overall Study|Death|6|||
126603020|NCT03150862|455508087|FG007|Overall Study|Death|21|||
126603021|NCT03150862|455508080|FG000|Overall Study|Withdrawal by Subject|1|||
126603022|NCT03150862|455508081|FG001|Overall Study|Withdrawal by Subject|1|||
126603023|NCT03150862|455508082|FG002|Overall Study|Withdrawal by Subject|0|||
126603024|NCT03150862|455508083|FG003|Overall Study|Withdrawal by Subject|3|||
126603025|NCT03150862|455508084|FG004|Overall Study|Withdrawal by Subject|1|||
126603026|NCT03150862|455508085|FG005|Overall Study|Withdrawal by Subject|1|||
126603027|NCT03150862|455508086|FG006|Overall Study|Withdrawal by Subject|1|||
126603028|NCT03150862|455508087|FG007|Overall Study|Withdrawal by Subject|3|||
126603029|NCT03150862|455508080|FG000|Overall Study|Lost to Follow-up|0|||
126603030|NCT03150862|455508081|FG001|Overall Study|Lost to Follow-up|0|||
126603031|NCT03150862|455508082|FG002|Overall Study|Lost to Follow-up|1|||
126603032|NCT03150862|455508083|FG003|Overall Study|Lost to Follow-up|0|||
126603033|NCT03150862|455508084|FG004|Overall Study|Lost to Follow-up|0|||
126603034|NCT03150862|455508085|FG005|Overall Study|Lost to Follow-up|0|||
126603035|NCT03150862|455508086|FG006|Overall Study|Lost to Follow-up|0|||
126603036|NCT03150862|455508087|FG007|Overall Study|Lost to Follow-up|2|||
126603037|NCT03150862|455508080|FG000|Overall Study|Sponsor's decision|0|||
126603038|NCT03150862|455508081|FG001|Overall Study|Sponsor's decision|0|||
126603039|NCT03150862|455508082|FG002|Overall Study|Sponsor's decision|0|||
126603040|NCT03150862|455508083|FG003|Overall Study|Sponsor's decision|10|||
126603041|NCT03150862|455508084|FG004|Overall Study|Sponsor's decision|3|||
126603042|NCT03150862|455508085|FG005|Overall Study|Sponsor's decision|0|||
126603043|NCT03150862|455508086|FG006|Overall Study|Sponsor's decision|1|||
126603044|NCT03150862|455508087|FG007|Overall Study|Sponsor's decision|1|||
126603045|NCT03150862|455508080|FG000|Overall Study|Change in Methylation status|0|||
126603046|NCT03150862|455508081|FG001|Overall Study|Change in Methylation status|0|||
126603047|NCT03150862|455508082|FG002|Overall Study|Change in Methylation status|0|||
126603048|NCT03150862|455508083|FG003|Overall Study|Change in Methylation status|0|||
126603049|NCT03150862|455508084|FG004|Overall Study|Change in Methylation status|1|||
126603050|NCT03150862|455508085|FG005|Overall Study|Change in Methylation status|0|||
126603051|NCT03150862|455508086|FG006|Overall Study|Change in Methylation status|0|||
126603052|NCT03150862|455508087|FG007|Overall Study|Change in Methylation status|0|||
126603053|NCT03150862|455508080|FG000|Overall Study|Roll over in to Long Term Extension|0|||
126603054|NCT03150862|455508081|FG001|Overall Study|Roll over in to Long Term Extension|0|||
126603055|NCT03150862|455508082|FG002|Overall Study|Roll over in to Long Term Extension|0|||
126603056|NCT03150862|455508083|FG003|Overall Study|Roll over in to Long Term Extension|0|||
126603057|NCT03150862|455508084|FG004|Overall Study|Roll over in to Long Term Extension|0|||
126603058|NCT03150862|455508085|FG005|Overall Study|Roll over in to Long Term Extension|0|||
126603059|NCT03150862|455508086|FG006|Overall Study|Roll over in to Long Term Extension|0|||
126603060|NCT03150862|455508087|FG007|Overall Study|Roll over in to Long Term Extension|1|||
126603061|NCT03150862|455508080|FG000|Overall Study|Progressive Disease|0|||
126603062|NCT03150862|455508081|FG001|Overall Study|Progressive Disease|0|||
126603063|NCT03150862|455508082|FG002|Overall Study|Progressive Disease|0|||
126603064|NCT03150862|455508083|FG003|Overall Study|Progressive Disease|0|||
126603065|NCT03150862|455508084|FG004|Overall Study|Progressive Disease|0|||
126603066|NCT03150862|455508085|FG005|Overall Study|Progressive Disease|0|||
126603067|NCT03150862|455508086|FG006|Overall Study|Progressive Disease|0|||
126603068|NCT03150862|455508087|FG007|Overall Study|Progressive Disease|2|||
126603069|NCT04505722|455508091|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
126603070|NCT04505722|455508092|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
126603071|NCT04505722|455508093|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
126603072|NCT04505722|455508091|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
126603073|NCT04505722|455508092|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
126603074|NCT04505722|455508093|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
126603075|NCT04505722|455508091|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
126603076|NCT04505722|455508092|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
126603077|NCT04505722|455508093|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
126603078|NCT04505722|455508091|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
126603079|NCT04505722|455508092|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
126603080|NCT04505722|455508093|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
126603081|NCT04505722|455508091|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
126603082|NCT04505722|455508092|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
126603083|NCT04505722|455508093|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
126733626|NCT05406440|455973897|FG005|Overall Study|Lost to Follow-up|0|||
126733627|NCT05406440|455973898|FG006|Overall Study|Lost to Follow-up|0|||
126733628|NCT05406440|455973892|FG000|Overall Study|Physician Decision|0|||
126603084|NCT04505722|455508091|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
126603085|NCT04505722|455508092|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
126603086|NCT04505722|455508093|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
126603087|NCT04505722|455508091|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
126603088|NCT04505722|455508092|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
126733629|NCT05406440|455973893|FG001|Overall Study|Physician Decision|0|||
126733630|NCT05406440|455973894|FG002|Overall Study|Physician Decision|0|||
126603089|NCT04505722|455508093|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
126603090|NCT04505722|455508091|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
126603091|NCT04505722|455508092|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
126603092|NCT04505722|455508093|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
126603093|NCT04505722|455508091|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
126603094|NCT04505722|455508092|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
126603095|NCT04505722|455508093|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
126603096|NCT04505722|455508091|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
126603097|NCT04505722|455508092|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
126603098|NCT04505722|455508093|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
126603099|NCT04505722|455508091|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
126603100|NCT04505722|455508092|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
126603101|NCT04505722|455508093|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
126603102|NCT04505722|455508091|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
126603103|NCT04505722|455508092|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
126603104|NCT04505722|455508093|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
126603105|NCT04505722|455508091|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
126603106|NCT04505722|455508092|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
126603107|NCT04505722|455508093|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
126603108|NCT04505722|455508091|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
126603109|NCT04505722|455508092|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
126603110|NCT04505722|455508093|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
126603111|NCT04505722|455508091|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
126603112|NCT04505722|455508092|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
126603113|NCT04505722|455508093|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
126603114|NCT04755595|455508094|FG000|Overall Study|Lost to Follow-up|1|||
126603115|NCT02206828|455508095|FG000|Overall Study|Lost to Follow-up|7|||
126603116|NCT05039021|455508431|FG000|Overall Study|Death|1|||
126603117|NCT05039021|455508431|FG000|Overall Study|Lost to Follow-up|3|||
126603118|NCT02422615|455508432|FG000|Treatment Period|Progressive disease|314|||
126603119|NCT02422615|455508433|FG001|Treatment Period|Progressive disease|200|||
126603120|NCT02422615|455508432|FG000|Treatment Period|Adverse Event|51|||
126603121|NCT02422615|455508433|FG001|Treatment Period|Adverse Event|9|||
126603122|NCT02422615|455508432|FG000|Treatment Period|Physician Decision|32|||
126603123|NCT02422615|455508433|FG001|Treatment Period|Physician Decision|8|||
126603124|NCT02422615|455508432|FG000|Treatment Period|Subject/guardian decision|38|||
126603125|NCT02422615|455508433|FG001|Treatment Period|Subject/guardian decision|8|||
126603126|NCT02422615|455508432|FG000|Treatment Period|Death|2|||
126603127|NCT02422615|455508433|FG001|Treatment Period|Death|1|||
126603128|NCT02422615|455508432|FG000|Treatment Period|Technical problems|0|||
126603129|NCT02422615|455508433|FG001|Treatment Period|Technical problems|1|||
126603130|NCT02422615|455508432|FG000|Treatment Period|Protocol deviation|1|||
126603131|NCT02422615|455508433|FG001|Treatment Period|Protocol deviation|1|||
126603132|NCT02422615|455508432|FG000|Treatment Period|Study terminated as per protocol|46|||
126603133|NCT02422615|455508433|FG001|Treatment Period|Study terminated as per protocol|14|||
126603134|NCT02422615|455508432|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
126603135|NCT02422615|455508433|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126603136|NCT02422615|455508432|FG000|Post-treatment Efficacy Follow-up|Death|2|||
126603137|NCT02422615|455508433|FG001|Post-treatment Efficacy Follow-up|Death|1|||
126603138|NCT02422615|455508432|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
126603139|NCT02422615|455508433|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126603140|NCT02422615|455508432|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
126603141|NCT02422615|455508433|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
126603142|NCT02422615|455508432|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
126603143|NCT02422615|455508433|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
126603144|NCT02422615|455508432|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
126603145|NCT02422615|455508433|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
126603146|NCT01639131|455508434|FG000|Overall Study|Disease Progression|6|||
126603147|NCT03653364|455508436|FG000|Overall Study|Withdrawal by Subject|1|||
126603148|NCT03653364|455508436|FG000|Overall Study|Enrolled in Error|1|||
126603149|NCT03653364|455508436|FG000|Overall Study|Death|1|||
126603150|NCT00087685|455508437|FG000|Overall Study|Adverse Event|5|||
126603151|NCT00087685|455508437|FG000|Overall Study|Non-Compliance|1|||
126603152|NCT00087685|455508437|FG000|Overall Study|Progressive Disease|5|||
126603153|NCT00087685|455508437|FG000|Overall Study|Withdrawal by Subject|3|||
126603154|NCT06688357|455508438|FG000|Overall Study|Adverse Event|0|||
126603155|NCT06688357|455508439|FG001|Overall Study|Adverse Event|1|||
126603156|NCT04899674|455508440|FG000|Test|Adverse Event|1|||
126603157|NCT03774472|455508441|FG000|Overall Study|Physician Decision|1|||
126603158|NCT03774472|455508442|FG001|Overall Study|Physician Decision|0|||
126603159|NCT03774472|455508443|FG002|Overall Study|Physician Decision|0|||
126733631|NCT05406440|455973895|FG003|Overall Study|Physician Decision|0|||
126733632|NCT05406440|455973896|FG004|Overall Study|Physician Decision|1|||
126603160|NCT03774472|455508441|FG000|Overall Study|Progression prior to 4 weeks|0|||
126603161|NCT03774472|455508442|FG001|Overall Study|Progression prior to 4 weeks|1|||
126603162|NCT03774472|455508443|FG002|Overall Study|Progression prior to 4 weeks|0|||
126603163|NCT03774472|455508441|FG000|Overall Study|Withdrawal by Subject|0|||
126603164|NCT03774472|455508442|FG001|Overall Study|Withdrawal by Subject|1|||
126603165|NCT03774472|455508443|FG002|Overall Study|Withdrawal by Subject|0|||
126603166|NCT04059406|455508444|FG000|Overall Study|Early Treatment Termination|5|||
126603167|NCT04059406|455508445|FG001|Overall Study|Early Treatment Termination|5|||
126603168|NCT04059406|455508446|FG002|Overall Study|Early Treatment Termination|15|||
126603169|NCT05155306|455508447|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
126603170|NCT05155306|455508448|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
126603171|NCT05155306|455508449|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
126603172|NCT05155306|455508450|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
126603173|NCT05155306|455508447|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
126603174|NCT05155306|455508448|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
126603175|NCT05155306|455508449|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
126603176|NCT05155306|455508450|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
126603177|NCT05601882|455508451|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
126603178|NCT05601882|455508452|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
126603179|NCT05601882|455508453|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
126603180|NCT05601882|455508454|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
126603181|NCT05601882|455508451|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
126603182|NCT05601882|455508452|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
126603183|NCT05601882|455508453|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
126603184|NCT05601882|455508454|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
126603185|NCT05601882|455508451|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
126603186|NCT05601882|455508452|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
126603187|NCT05601882|455508453|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
126603188|NCT05601882|455508454|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
126603189|NCT05601882|455508451|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
126603190|NCT05601882|455508452|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
126603191|NCT05601882|455508453|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
126603192|NCT05601882|455508454|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
126603193|NCT05601882|455508451|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
126603194|NCT05601882|455508452|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
126603195|NCT05601882|455508453|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
126603196|NCT05601882|455508454|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
126603197|NCT05601882|455508451|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
126603198|NCT05601882|455508452|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
126603199|NCT05601882|455508453|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
126603200|NCT05601882|455508454|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
126603201|NCT04158141|455508455|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
126603202|NCT04158141|455508456|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
126603203|NCT04158141|455508457|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
126603204|NCT04158141|455508455|FG000|Step 1: Registration|Adverse Event|1|||
126603205|NCT04158141|455508456|FG001|Step 1: Registration|Adverse Event|0|||
126603206|NCT04158141|455508457|FG002|Step 1: Registration|Adverse Event|0|||
126603207|NCT04158141|455508455|FG000|Step 1: Registration|Withdrawal by Subject|1|||
126603208|NCT04158141|455508456|FG001|Step 1: Registration|Withdrawal by Subject|0|||
126603209|NCT04158141|455508457|FG002|Step 1: Registration|Withdrawal by Subject|0|||
126603210|NCT04158141|455508455|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
126603211|NCT04158141|455508456|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
126603212|NCT04158141|455508457|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
126603213|NCT00319696|455508461|FG000|Overall Study|Adverse Event|36|||
126603214|NCT00319696|455508461|FG000|Overall Study|withdrawal of consent|14|||
126603215|NCT00319696|455508461|FG000|Overall Study|administrative|7|||
126603216|NCT00319696|455508461|FG000|Overall Study|Lost to Follow-up|3|||
126603217|NCT03834740|455508462|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
126603218|NCT03834740|455508463|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
126603219|NCT03834740|455508464|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
126603220|NCT00115934|455508465|FG000|Overall Study|Lost to Follow-up|1|||
126603221|NCT00115934|455508466|FG001|Overall Study|Lost to Follow-up|0|||
126603222|NCT00115934|455508465|FG000|Overall Study|Did not receive intervention|3|||
126603223|NCT00115934|455508466|FG001|Overall Study|Did not receive intervention|2|||
126603224|NCT04977583|455509374|FG000|Overall Study|Lost to Follow-up|8|||
126603225|NCT04977583|455509375|FG001|Overall Study|Lost to Follow-up|4|||
126603226|NCT04977583|455509376|FG002|Overall Study|Lost to Follow-up|13|||
126603227|NCT04977583|455509374|FG000|Overall Study|Withdrawal by Subject|3|||
126733633|NCT05406440|455973897|FG005|Overall Study|Physician Decision|0|||
126733634|NCT05406440|455973898|FG006|Overall Study|Physician Decision|0|||
126733635|NCT05406440|455973892|FG000|Overall Study|Withdrawal by Subject|0|||
126603228|NCT04977583|455509375|FG001|Overall Study|Withdrawal by Subject|2|||
126603229|NCT04977583|455509376|FG002|Overall Study|Withdrawal by Subject|1|||
126603230|NCT02325466|455509377|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
126603231|NCT02325466|455509378|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
126603232|NCT02325466|455509379|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
126603233|NCT02325466|455509377|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
126603234|NCT02325466|455509378|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
126603235|NCT02325466|455509379|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
126603236|NCT02325466|455509377|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
126603237|NCT02325466|455509378|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
126603238|NCT02325466|455509379|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
126603239|NCT02325466|455509377|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
126603240|NCT02325466|455509378|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
126603241|NCT02325466|455509379|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
126603242|NCT02325466|455509377|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
126603243|NCT02325466|455509378|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
126603244|NCT02325466|455509379|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
126603245|NCT02325466|455509377|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
126603246|NCT02325466|455509378|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
126603247|NCT02325466|455509379|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
126603248|NCT02325466|455509377|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
126603249|NCT02325466|455509378|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
126603250|NCT02325466|455509379|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
126603251|NCT02325466|455509377|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
126603252|NCT02325466|455509378|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
126603253|NCT02325466|455509379|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
126603254|NCT02325466|455509377|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
126603255|NCT02325466|455509378|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
126603256|NCT02325466|455509379|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
126603257|NCT01105975|455509387|FG000|Overall Study|Adverse Event|2|||
126603258|NCT01105975|455509388|FG001|Overall Study|Adverse Event|1|||
126603259|NCT01105975|455509389|FG002|Overall Study|Adverse Event|5|||
126603260|NCT01105975|455509390|FG003|Overall Study|Adverse Event|1|||
126603261|NCT01105975|455509391|FG004|Overall Study|Adverse Event|0|||
126603262|NCT01105975|455509392|FG005|Overall Study|Adverse Event|1|||
126603263|NCT01105975|455509393|FG006|Overall Study|Adverse Event|2|||
126603264|NCT01105975|455509394|FG007|Overall Study|Adverse Event|4|||
126603265|NCT01105975|455509395|FG008|Overall Study|Adverse Event|1|||
126603266|NCT01105975|455509396|FG009|Overall Study|Adverse Event|4|||
126603267|NCT01105975|455509387|FG000|Overall Study|Withdrawal by Subject|2|||
126603268|NCT01105975|455509388|FG001|Overall Study|Withdrawal by Subject|2|||
126603269|NCT01105975|455509389|FG002|Overall Study|Withdrawal by Subject|2|||
126603270|NCT01105975|455509390|FG003|Overall Study|Withdrawal by Subject|0|||
126603271|NCT01105975|455509391|FG004|Overall Study|Withdrawal by Subject|4|||
126603272|NCT01105975|455509392|FG005|Overall Study|Withdrawal by Subject|1|||
126603273|NCT01105975|455509393|FG006|Overall Study|Withdrawal by Subject|2|||
126603274|NCT01105975|455509394|FG007|Overall Study|Withdrawal by Subject|1|||
126603275|NCT01105975|455509395|FG008|Overall Study|Withdrawal by Subject|0|||
126603276|NCT01105975|455509396|FG009|Overall Study|Withdrawal by Subject|3|||
126603277|NCT01105975|455509387|FG000|Overall Study|Lost to Follow-up|1|||
126603278|NCT01105975|455509388|FG001|Overall Study|Lost to Follow-up|0|||
126603279|NCT01105975|455509389|FG002|Overall Study|Lost to Follow-up|0|||
126603280|NCT01105975|455509390|FG003|Overall Study|Lost to Follow-up|1|||
126603281|NCT01105975|455509391|FG004|Overall Study|Lost to Follow-up|1|||
126603282|NCT01105975|455509392|FG005|Overall Study|Lost to Follow-up|0|||
126603283|NCT01105975|455509393|FG006|Overall Study|Lost to Follow-up|0|||
126603284|NCT01105975|455509394|FG007|Overall Study|Lost to Follow-up|0|||
126603285|NCT01105975|455509395|FG008|Overall Study|Lost to Follow-up|1|||
126603286|NCT01105975|455509396|FG009|Overall Study|Lost to Follow-up|0|||
126603287|NCT01105975|455509387|FG000|Overall Study|Physician Decision|0|||
126603288|NCT01105975|455509388|FG001|Overall Study|Physician Decision|0|||
126603289|NCT01105975|455509389|FG002|Overall Study|Physician Decision|0|||
126603290|NCT01105975|455509390|FG003|Overall Study|Physician Decision|0|||
126603291|NCT01105975|455509391|FG004|Overall Study|Physician Decision|0|||
126603292|NCT01105975|455509392|FG005|Overall Study|Physician Decision|0|||
126603293|NCT01105975|455509393|FG006|Overall Study|Physician Decision|2|||
126603294|NCT01105975|455509394|FG007|Overall Study|Physician Decision|0|||
126780819|NCT01133821|456152809|FG001|Overall Study|Protocol Violation|1|||
126780820|NCT01133821|456152808|FG000|Overall Study|Refused participation|1|||
126603295|NCT01105975|455509395|FG008|Overall Study|Physician Decision|0|||
126603296|NCT01105975|455509396|FG009|Overall Study|Physician Decision|0|||
126603297|NCT01105975|455509387|FG000|Overall Study|Protocol Violation|0|||
126603298|NCT01105975|455509388|FG001|Overall Study|Protocol Violation|2|||
126603299|NCT01105975|455509389|FG002|Overall Study|Protocol Violation|2|||
126603300|NCT01105975|455509390|FG003|Overall Study|Protocol Violation|0|||
126603301|NCT01105975|455509391|FG004|Overall Study|Protocol Violation|1|||
126603302|NCT01105975|455509392|FG005|Overall Study|Protocol Violation|1|||
126603303|NCT01105975|455509393|FG006|Overall Study|Protocol Violation|1|||
126603304|NCT01105975|455509394|FG007|Overall Study|Protocol Violation|1|||
126603305|NCT01105975|455509395|FG008|Overall Study|Protocol Violation|2|||
126603306|NCT01105975|455509396|FG009|Overall Study|Protocol Violation|2|||
126603307|NCT01105975|455509387|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126603308|NCT01105975|455509388|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126603309|NCT01105975|455509389|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
126603310|NCT01105975|455509390|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126603311|NCT01105975|455509391|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126603312|NCT01105975|455509392|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
126603313|NCT01105975|455509393|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
126603314|NCT01105975|455509394|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
126603315|NCT01105975|455509395|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
126603316|NCT01105975|455509396|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
126603317|NCT00686595|455509397|FG000|Overall Study|Adverse Event|3|||
126603318|NCT00686595|455509397|FG000|Overall Study|Protocol Violation|1|||
126603319|NCT00686595|455509397|FG000|Overall Study|Lost to Follow-up|1|||
126603320|NCT00686595|455509397|FG000|Overall Study|Lack of Efficacy|1|||
126603321|NCT00686595|455509397|FG000|Overall Study|Poor Compliance|1|||
126603322|NCT03776812|455509405|FG000|Overall Study|Death|27|||
126603323|NCT03776812|455509406|FG001|Overall Study|Death|19|||
126603324|NCT03776812|455509407|FG002|Overall Study|Death|29|||
126603325|NCT03776812|455509405|FG000|Overall Study|Withdrawal by Subject|1|||
126603326|NCT03776812|455509406|FG001|Overall Study|Withdrawal by Subject|7|||
126603327|NCT03776812|455509407|FG002|Overall Study|Withdrawal by Subject|1|||
126603328|NCT03776812|455509405|FG000|Overall Study|Lost to Follow-up|0|||
126603329|NCT03776812|455509406|FG001|Overall Study|Lost to Follow-up|1|||
126603330|NCT03776812|455509407|FG002|Overall Study|Lost to Follow-up|0|||
126603331|NCT03776812|455509405|FG000|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
126603332|NCT03776812|455509406|FG001|Overall Study|Still on study as of March 22, 2021 data cutoff date|33|||
126603333|NCT03776812|455509407|FG002|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
126603334|NCT05018143|455509413|FG000|Overall Study|Lost to Follow-up|5|||
126603335|NCT05018143|455509414|FG001|Overall Study|Lost to Follow-up|4|||
126603336|NCT05018143|455509413|FG000|Overall Study|Withdrawal by Subject|0|||
126603337|NCT05018143|455509414|FG001|Overall Study|Withdrawal by Subject|1|||
126603338|NCT04018495|455509415|FG000|Overall Study|Physician Decision|1|||
126603339|NCT04121741|455509418|FG000|Overall Study|Protocol Violation|1|||
126603340|NCT04121741|455509419|FG001|Overall Study|Protocol Violation|0|||
126603341|NCT04121741|455509420|FG002|Overall Study|Protocol Violation|0|||
126603342|NCT04121741|455509421|FG003|Overall Study|Protocol Violation|0|||
126603343|NCT04121741|455509422|FG004|Overall Study|Protocol Violation|0|||
126603344|NCT04121741|455509423|FG005|Overall Study|Protocol Violation|0|||
126603345|NCT01084863|455509424|FG000|Main Study Treatment Period|Disease progression|11|||
126603346|NCT01084863|455509425|FG001|Main Study Treatment Period|Disease progression|7|||
126603347|NCT01084863|455509424|FG000|Main Study Treatment Period|Adverse Event|5|||
126603348|NCT01084863|455509425|FG001|Main Study Treatment Period|Adverse Event|3|||
126603349|NCT01084863|455509424|FG000|Main Study Treatment Period|Other Reason|0|||
126603350|NCT01084863|455509425|FG001|Main Study Treatment Period|Other Reason|1|||
126603351|NCT01084863|455509424|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
126603352|NCT01084863|455509425|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
126603353|NCT01084863|455509424|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
126603354|NCT01084863|455509425|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
126603355|NCT01084863|455509424|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
126603356|NCT01084863|455509425|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
126603357|NCT01084863|455509424|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
126603358|NCT01084863|455509425|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
126603359|NCT01084863|455509424|FG000|Treatment Period Beyond Cycle 8|Other|0|||
126603360|NCT01084863|455509425|FG001|Treatment Period Beyond Cycle 8|Other|1|||
126603361|NCT01084863|455509424|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
126603362|NCT01084863|455509425|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
126603363|NCT03473223|455509426|FG000|Overall Study|Lost to Follow-up|1|||
126603364|NCT03473223|455509427|FG001|Overall Study|Lost to Follow-up|1|||
126603365|NCT03473223|455509426|FG000|Overall Study|Withdrawal by Subject|47|||
126603366|NCT03473223|455509427|FG001|Overall Study|Withdrawal by Subject|42|||
126603367|NCT03473223|455509426|FG000|Overall Study|Indirect contact|32|||
126603368|NCT03473223|455509427|FG001|Overall Study|Indirect contact|29|||
126603369|NCT03473223|455509426|FG000|Overall Study|Other (Not specified)|32|||
126603370|NCT03473223|455509427|FG001|Overall Study|Other (Not specified)|20|||
126603371|NCT03524092|455509428|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
126603372|NCT03524092|455509429|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
126603373|NCT03524092|455509430|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
126603374|NCT03524092|455509431|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
126603375|NCT03524092|455509432|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
126603376|NCT03524092|455509433|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
126603377|NCT03524092|455509428|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
126603378|NCT03524092|455509429|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
126603379|NCT03524092|455509430|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
126603380|NCT03524092|455509431|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
126603381|NCT03524092|455509432|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
126603382|NCT03524092|455509433|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
126603383|NCT03524092|455509428|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
126603384|NCT03524092|455509429|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
126603385|NCT03524092|455509430|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
126603386|NCT03524092|455509431|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
126603387|NCT03524092|455509432|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
126603388|NCT03524092|455509433|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
126603389|NCT03524092|455509428|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
126603390|NCT03524092|455509429|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
126603391|NCT03524092|455509430|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
126603392|NCT03524092|455509431|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
126603393|NCT03524092|455509432|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
126603394|NCT03524092|455509433|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
126603395|NCT03524092|455509428|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
126603396|NCT03524092|455509429|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
126603397|NCT03524092|455509430|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
126603398|NCT03524092|455509431|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
126603399|NCT03524092|455509432|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
126603400|NCT03524092|455509433|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
126603401|NCT03524092|455509428|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
126603402|NCT03524092|455509429|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
126603403|NCT03524092|455509430|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
126603404|NCT03524092|455509431|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
126603405|NCT03524092|455509432|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
126603406|NCT03524092|455509433|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
126603407|NCT03524092|455509428|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
126603408|NCT03524092|455509429|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
126603409|NCT03524092|455509430|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
126603410|NCT03524092|455509431|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
126603411|NCT03524092|455509432|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
126603412|NCT03524092|455509433|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
126603413|NCT03524092|455509428|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
126603414|NCT03524092|455509429|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
126603415|NCT03524092|455509430|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
126603416|NCT03524092|455509431|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
126603417|NCT03524092|455509432|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
126603418|NCT03524092|455509433|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
126603419|NCT03524092|455509428|FG000|Loss of Response Rescue Period|Adverse Event|0|||
126603420|NCT03524092|455509429|FG001|Loss of Response Rescue Period|Adverse Event|0|||
126603421|NCT03524092|455509430|FG002|Loss of Response Rescue Period|Adverse Event|0|||
126603422|NCT03524092|455509431|FG003|Loss of Response Rescue Period|Adverse Event|2|||
126603423|NCT03524092|455509432|FG004|Loss of Response Rescue Period|Adverse Event|0|||
126603424|NCT03524092|455509433|FG005|Loss of Response Rescue Period|Adverse Event|0|||
126603425|NCT03524092|455509428|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
126603426|NCT03524092|455509429|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
126603427|NCT03524092|455509430|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
126603428|NCT03524092|455509431|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
126603429|NCT03524092|455509432|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
126603430|NCT03524092|455509433|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
126603431|NCT03524092|455509428|FG000|Loss of Response Rescue Period|Pregnancy|0|||
126603432|NCT03524092|455509429|FG001|Loss of Response Rescue Period|Pregnancy|0|||
126603433|NCT03524092|455509430|FG002|Loss of Response Rescue Period|Pregnancy|0|||
126603434|NCT03524092|455509431|FG003|Loss of Response Rescue Period|Pregnancy|1|||
126603435|NCT03524092|455509432|FG004|Loss of Response Rescue Period|Pregnancy|0|||
126603436|NCT03524092|455509433|FG005|Loss of Response Rescue Period|Pregnancy|0|||
126603437|NCT03524092|455509428|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
126780821|NCT01133821|456152809|FG001|Overall Study|Refused participation|3|||
126603438|NCT03524092|455509429|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
126603439|NCT03524092|455509430|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
126603440|NCT03524092|455509431|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
126603441|NCT03524092|455509432|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
126603442|NCT03524092|455509433|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
126603443|NCT03524092|455509428|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
126603444|NCT03524092|455509429|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
126603445|NCT03524092|455509430|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
126603446|NCT03524092|455509431|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
126603447|NCT03524092|455509432|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
126603448|NCT03524092|455509433|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
126603449|NCT03524092|455509428|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
126603450|NCT03524092|455509429|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
126603451|NCT03524092|455509430|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
126603452|NCT03524092|455509431|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
126603453|NCT03524092|455509432|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
126603454|NCT03524092|455509433|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
126603455|NCT03524092|455509428|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
126603456|NCT03524092|455509429|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
126603457|NCT03524092|455509430|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
126603458|NCT03524092|455509431|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
126603459|NCT03524092|455509432|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
126603460|NCT03524092|455509433|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
126603461|NCT03524092|455509428|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
126603462|NCT03524092|455509429|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
126603463|NCT03524092|455509430|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
126603464|NCT03524092|455509431|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
126603465|NCT03524092|455509432|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
126603466|NCT03524092|455509433|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
126603467|NCT03524092|455509428|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
126603468|NCT03524092|455509429|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
126603469|NCT03524092|455509430|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
126603470|NCT03524092|455509431|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
126603471|NCT03524092|455509432|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
126603472|NCT03524092|455509433|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
126603473|NCT03524092|455509428|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
126603474|NCT03524092|455509429|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
126603475|NCT03524092|455509430|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
126603476|NCT03524092|455509431|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
126603477|NCT03524092|455509432|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
126603478|NCT03524092|455509433|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
126603479|NCT03524092|455509428|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
126603480|NCT03524092|455509429|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
126603481|NCT03524092|455509430|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
126603482|NCT03524092|455509431|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
126603483|NCT03524092|455509432|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
126603484|NCT03524092|455509433|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
126603485|NCT03524092|455509428|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
126603486|NCT03524092|455509429|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
126603487|NCT03524092|455509430|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
126603488|NCT03524092|455509431|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
126603489|NCT03524092|455509432|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
126603490|NCT03524092|455509433|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
126603491|NCT03524092|455509428|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
126603492|NCT03524092|455509429|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
126603493|NCT03524092|455509430|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
126603494|NCT03524092|455509431|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
126603495|NCT03524092|455509432|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
126603496|NCT03524092|455509433|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
126603497|NCT03524092|455509428|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
126733636|NCT05406440|455973893|FG001|Overall Study|Withdrawal by Subject|0|||
126603498|NCT03524092|455509429|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
126603499|NCT03524092|455509430|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
126603500|NCT03524092|455509431|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
126603501|NCT03524092|455509432|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
126603502|NCT03524092|455509433|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
126603503|NCT03524092|455509428|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
126603504|NCT03524092|455509429|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
126603505|NCT03524092|455509430|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
126603506|NCT03524092|455509431|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
126603507|NCT03524092|455509432|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
126603508|NCT03524092|455509433|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
126603509|NCT03275285|455509436|FG000|Overall Study|Ongoing|45|||
126603510|NCT03275285|455509437|FG001|Overall Study|Ongoing|69|||
126603511|NCT06191679|455509438|FG000|Baseline|Lost to Follow-up|1|||
126603512|NCT06191679|455509439|FG001|Baseline|Lost to Follow-up|0|||
126603513|NCT06191679|455509440|FG002|Baseline|Lost to Follow-up|1|||
126603514|NCT06191679|455509441|FG003|Baseline|Lost to Follow-up|0|||
126603515|NCT06191679|455509438|FG000|Allocation to Group|Withdrawal by Subject|0|||
126603516|NCT06191679|455509439|FG001|Allocation to Group|Withdrawal by Subject|1|||
126603517|NCT06191679|455509440|FG002|Allocation to Group|Withdrawal by Subject|2|||
126603518|NCT06191679|455509441|FG003|Allocation to Group|Withdrawal by Subject|0|||
126603519|NCT06191679|455509438|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
126603520|NCT06191679|455509439|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
126603521|NCT06191679|455509440|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
126603522|NCT06191679|455509441|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
126603523|NCT06191679|455509438|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
126603524|NCT06191679|455509439|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
126603525|NCT06191679|455509440|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
126603526|NCT06191679|455509441|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
126603527|NCT06191679|455509438|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
126603528|NCT06191679|455509439|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
126603529|NCT06191679|455509440|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
126603530|NCT06191679|455509441|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
126603531|NCT05827068|455509443|FG000|Overall Study|Lost to Follow-up|1|||
126603532|NCT05827068|455509444|FG001|Overall Study|Lost to Follow-up|4|||
126603533|NCT05827068|455509445|FG002|Overall Study|Lost to Follow-up|1|||
126603534|NCT05827068|455509446|FG003|Overall Study|Lost to Follow-up|1|||
126603535|NCT05827068|455509447|FG004|Overall Study|Lost to Follow-up|2|||
126603536|NCT05827068|455509448|FG005|Overall Study|Lost to Follow-up|4|||
126603537|NCT05827068|455509449|FG006|Overall Study|Lost to Follow-up|1|||
126603538|NCT05827068|455509443|FG000|Overall Study|Withdrawal by Subject|4|||
126603539|NCT05827068|455509444|FG001|Overall Study|Withdrawal by Subject|0|||
126603540|NCT05827068|455509445|FG002|Overall Study|Withdrawal by Subject|1|||
126603541|NCT05827068|455509446|FG003|Overall Study|Withdrawal by Subject|2|||
126603542|NCT05827068|455509447|FG004|Overall Study|Withdrawal by Subject|3|||
126603543|NCT05827068|455509448|FG005|Overall Study|Withdrawal by Subject|0|||
126603544|NCT05827068|455509449|FG006|Overall Study|Withdrawal by Subject|1|||
126603545|NCT05827068|455509443|FG000|Overall Study|Physician Decision|0|||
126603546|NCT05827068|455509444|FG001|Overall Study|Physician Decision|0|||
126603547|NCT05827068|455509445|FG002|Overall Study|Physician Decision|0|||
126603548|NCT05827068|455509446|FG003|Overall Study|Physician Decision|0|||
126603549|NCT05827068|455509447|FG004|Overall Study|Physician Decision|1|||
126603550|NCT05827068|455509448|FG005|Overall Study|Physician Decision|0|||
126603551|NCT05827068|455509449|FG006|Overall Study|Physician Decision|1|||
126603552|NCT05827068|455509443|FG000|Overall Study|Other Than Specified|0|||
126603553|NCT05827068|455509444|FG001|Overall Study|Other Than Specified|1|||
126603554|NCT05827068|455509445|FG002|Overall Study|Other Than Specified|0|||
126603555|NCT05827068|455509446|FG003|Overall Study|Other Than Specified|0|||
126780822|NCT03572933|456152811|FG000|Overall Study|Adverse Event|4|||
126780823|NCT03572933|456152812|FG001|Overall Study|Adverse Event|1|||
126780824|NCT03572933|456152811|FG000|Overall Study|Withdrawal by Subject|0|||
126780825|NCT03572933|456152812|FG001|Overall Study|Withdrawal by Subject|1|||
126603556|NCT05827068|455509447|FG004|Overall Study|Other Than Specified|0|||
126603557|NCT05827068|455509448|FG005|Overall Study|Other Than Specified|0|||
126603558|NCT05827068|455509449|FG006|Overall Study|Other Than Specified|0|||
126603559|NCT04039113|455509450|FG000|Overall Study|Withdrawal by Subject|8|||
126603560|NCT04039113|455509451|FG001|Overall Study|Withdrawal by Subject|11|||
126603561|NCT04039113|455509450|FG000|Overall Study|Lost to Follow-up|1|||
126603562|NCT04039113|455509451|FG001|Overall Study|Lost to Follow-up|1|||
126603563|NCT04039113|455509450|FG000|Overall Study|Adverse Event|2|||
126780826|NCT01466686|456152817|FG000|Overall Study|Withdrawal by Subject|1|||
126603564|NCT04039113|455509451|FG001|Overall Study|Adverse Event|2|||
126603565|NCT04039113|455509450|FG000|Overall Study|Death|2|||
126603566|NCT04039113|455509451|FG001|Overall Study|Death|4|||
126603567|NCT04039113|455509450|FG000|Overall Study|Site Closure|6|||
126603568|NCT04039113|455509451|FG001|Overall Study|Site Closure|0|||
126603569|NCT04039113|455509450|FG000|Overall Study|Failure to meet randomisation criteria|4|||
126603570|NCT04039113|455509451|FG001|Overall Study|Failure to meet randomisation criteria|0|||
126603571|NCT00353496|455509452|FG000|Overall Study|Adverse Event|1|||
126603572|NCT00353496|455509453|FG001|Overall Study|Adverse Event|0|||
126603573|NCT00353496|455509452|FG000|Overall Study|Protocol Violation|2|||
126603574|NCT00353496|455509453|FG001|Overall Study|Protocol Violation|2|||
126603575|NCT00353496|455509452|FG000|Overall Study|Withdrawal by Subject|3|||
126603576|NCT00353496|455509453|FG001|Overall Study|Withdrawal by Subject|4|||
126603577|NCT00353496|455509452|FG000|Overall Study|Physician Decision|6|||
126603578|NCT00353496|455509453|FG001|Overall Study|Physician Decision|9|||
126603579|NCT00353496|455509452|FG000|Overall Study|Not otherwise specified|4|||
126603580|NCT00353496|455509453|FG001|Overall Study|Not otherwise specified|2|||
126603581|NCT03997474|455509454|FG000|Overall Study|Death|6|||
126603582|NCT03997474|455509455|FG001|Overall Study|Death|2|||
126603583|NCT03997474|455509456|FG002|Overall Study|Death|1|||
126603584|NCT03997474|455509454|FG000|Overall Study|Physician Decision|2|||
126603585|NCT03997474|455509455|FG001|Overall Study|Physician Decision|0|||
126603586|NCT03997474|455509456|FG002|Overall Study|Physician Decision|0|||
126603587|NCT03997474|455509454|FG000|Overall Study|study terminated by sponsor|1|||
126603588|NCT03997474|455509455|FG001|Overall Study|study terminated by sponsor|0|||
126603589|NCT03997474|455509456|FG002|Overall Study|study terminated by sponsor|1|||
126603590|NCT04980300|455509458|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
126603591|NCT04980300|455509459|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
126603592|NCT04980300|455509458|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
126603593|NCT04980300|455509459|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
126603594|NCT04980300|455509458|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
126603595|NCT04980300|455509459|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
126603596|NCT04980300|455509458|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
126603597|NCT04980300|455509459|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
126603598|NCT01470144|455509460|FG000|Overall Study|Adverse Event|2|||
126603599|NCT01470144|455509460|FG000|Overall Study|Death|1|||
126603600|NCT01470144|455509460|FG000|Overall Study|Lung transplant|6|||
126603601|NCT01470144|455509460|FG000|Overall Study|Patient's and investigator's decision|1|||
126603602|NCT02284113|455510144|FG000|Overall Study|Adverse Event|1|||
126603603|NCT02284113|455510145|FG001|Overall Study|Adverse Event|0|||
126603604|NCT02284113|455510144|FG000|Overall Study|non-compliance|0|||
126603605|NCT02284113|455510145|FG001|Overall Study|non-compliance|1|||
126603606|NCT02284113|455510144|FG000|Overall Study|Withdrawal by Subject|0|||
126603607|NCT02284113|455510145|FG001|Overall Study|Withdrawal by Subject|1|||
126603608|NCT02284113|455510144|FG000|Overall Study|not provided|0|||
126603609|NCT02284113|455510145|FG001|Overall Study|not provided|1|||
126603610|NCT02284113|455510144|FG000|Overall Study|surgery cancelled|2|||
126603611|NCT02284113|455510145|FG001|Overall Study|surgery cancelled|0|||
126603612|NCT03885232|455510146|FG000|Overall Study|Lost to Follow-up|74|||
126603613|NCT03885232|455510147|FG001|Overall Study|Lost to Follow-up|32|||
126603614|NCT03885232|455510146|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
126603615|NCT03885232|455510147|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
126603616|NCT01315132|455510148|FG000|Overall Study|not treated due to disease progression|1|||
126603617|NCT03840902|455510151|FG000|Overall Study|Randomized but not treated|1|||
126603618|NCT03840902|455510152|FG001|Overall Study|Randomized but not treated|1|||
126603619|NCT03660930|455510153|FG000|Overall Study|Adverse Event|0|||
126603620|NCT03660930|455510154|FG001|Overall Study|Adverse Event|0|||
126603621|NCT03660930|455510155|FG002|Overall Study|Adverse Event|0|||
126603622|NCT03660930|455510156|FG003|Overall Study|Adverse Event|2|||
126603623|NCT03660930|455510157|FG004|Overall Study|Adverse Event|0|||
126603624|NCT03660930|455510158|FG005|Overall Study|Adverse Event|1|||
126603625|NCT03660930|455510159|FG006|Overall Study|Adverse Event|0|||
126603626|NCT03660930|455510160|FG007|Overall Study|Adverse Event|0|||
126603627|NCT03660930|455510153|FG000|Overall Study|Withdrawal by Subject|0|||
126603628|NCT03660930|455510154|FG001|Overall Study|Withdrawal by Subject|0|||
126603629|NCT03660930|455510155|FG002|Overall Study|Withdrawal by Subject|0|||
126603630|NCT03660930|455510156|FG003|Overall Study|Withdrawal by Subject|0|||
126603631|NCT03660930|455510157|FG004|Overall Study|Withdrawal by Subject|0|||
126603632|NCT03660930|455510158|FG005|Overall Study|Withdrawal by Subject|1|||
126603633|NCT03660930|455510159|FG006|Overall Study|Withdrawal by Subject|0|||
126603634|NCT03660930|455510160|FG007|Overall Study|Withdrawal by Subject|0|||
126603635|NCT03280030|455510164|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
126603636|NCT03280030|455510165|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
126603637|NCT03280030|455510166|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
126603638|NCT03280030|455510164|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
126603639|NCT03280030|455510165|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
126603640|NCT03280030|455510166|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
126603641|NCT03280030|455510164|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
126603642|NCT03280030|455510165|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
126603643|NCT03280030|455510166|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
126603644|NCT03280030|455510164|FG000|Part 2 - Efficacy|Adverse Event|0|||
126603645|NCT03280030|455510165|FG001|Part 2 - Efficacy|Adverse Event|4|||
126603646|NCT03280030|455510166|FG002|Part 2 - Efficacy|Adverse Event|6|||
126603647|NCT03280030|455510164|FG000|Part 2 - Efficacy|Death|0|||
126603648|NCT03280030|455510165|FG001|Part 2 - Efficacy|Death|3|||
126603649|NCT03280030|455510166|FG002|Part 2 - Efficacy|Death|0|||
126603650|NCT03280030|455510164|FG000|Part 2 - Efficacy|Physician Decision|0|||
126603651|NCT03280030|455510165|FG001|Part 2 - Efficacy|Physician Decision|10|||
126603652|NCT03280030|455510166|FG002|Part 2 - Efficacy|Physician Decision|16|||
126603653|NCT03280030|455510164|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
126603654|NCT03280030|455510165|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
126603655|NCT03280030|455510166|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
126603656|NCT03280030|455510164|FG000|Part 2 - Efficacy|Progressive disease|0|||
126603657|NCT03280030|455510165|FG001|Part 2 - Efficacy|Progressive disease|7|||
126603658|NCT03280030|455510166|FG002|Part 2 - Efficacy|Progressive disease|5|||
126603659|NCT03222609|455510167|FG000|Overall Study|Withdrew consent|2|||
126603660|NCT03222609|455510168|FG001|Overall Study|Withdrew consent|3|||
126603661|NCT03222609|455510169|FG002|Overall Study|Withdrew consent|4|||
126603662|NCT03222609|455510170|FG003|Overall Study|Withdrew consent|2|||
126603663|NCT03222609|455510167|FG000|Overall Study|Lost to Follow-up|1|||
126603664|NCT03222609|455510168|FG001|Overall Study|Lost to Follow-up|0|||
126603665|NCT03222609|455510169|FG002|Overall Study|Lost to Follow-up|0|||
126603666|NCT03222609|455510170|FG003|Overall Study|Lost to Follow-up|0|||
126603667|NCT03222609|455510167|FG000|Overall Study|Death|16|||
126603668|NCT03222609|455510168|FG001|Overall Study|Death|13|||
126603669|NCT03222609|455510169|FG002|Overall Study|Death|9|||
126603670|NCT03222609|455510170|FG003|Overall Study|Death|6|||
126603671|NCT03222609|455510167|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
126603672|NCT03222609|455510168|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
126603673|NCT03222609|455510169|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
126603674|NCT03222609|455510170|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
126603675|NCT04305327|455510171|FG000|Overall Study|Study early termination|2|||
126603676|NCT04305327|455510172|FG001|Overall Study|Study early termination|5|||
126603677|NCT04305327|455510173|FG002|Overall Study|Study early termination|2|||
126603678|NCT04305327|455510174|FG003|Overall Study|Study early termination|2|||
126603679|NCT04305327|455510171|FG000|Overall Study|Withdrawal by Subject|0|||
126603680|NCT04305327|455510172|FG001|Overall Study|Withdrawal by Subject|1|||
126603681|NCT04305327|455510173|FG002|Overall Study|Withdrawal by Subject|0|||
126603682|NCT04305327|455510174|FG003|Overall Study|Withdrawal by Subject|0|||
126603683|NCT03656718|455510175|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
126603684|NCT03656718|455510176|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
126603685|NCT03656718|455510177|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
126603686|NCT03656718|455510178|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
126603687|NCT03656718|455510179|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
126603688|NCT03656718|455510180|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
126603689|NCT03656718|455510181|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
126603690|NCT03656718|455510175|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
126603691|NCT03656718|455510176|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
126603692|NCT03656718|455510177|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
126603693|NCT03656718|455510178|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
126603694|NCT03656718|455510179|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
126603695|NCT03656718|455510180|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
126603696|NCT03656718|455510181|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
126603697|NCT03656718|455510175|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
126603698|NCT03656718|455510176|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
126603699|NCT03656718|455510177|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
126603700|NCT03656718|455510178|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
126603701|NCT03656718|455510179|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
126603702|NCT03656718|455510180|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
126603703|NCT03656718|455510181|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
126603704|NCT03656718|455510175|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
126603705|NCT03656718|455510176|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
126603706|NCT03656718|455510177|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
126603707|NCT03656718|455510178|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
126603708|NCT03656718|455510179|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
126603709|NCT03656718|455510180|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
126603710|NCT03656718|455510181|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
126603711|NCT03656718|455510175|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
126780827|NCT00633152|456152820|FG000|Overall Study|Adverse Event|1|||
126603712|NCT03656718|455510176|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
126603713|NCT03656718|455510177|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
126603714|NCT03656718|455510178|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
126603715|NCT03656718|455510179|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
126603716|NCT03656718|455510180|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
126603717|NCT03656718|455510181|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
126603718|NCT03656718|455510175|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
126603719|NCT03656718|455510176|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
126603720|NCT03656718|455510177|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
126603721|NCT03656718|455510178|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
126603722|NCT03656718|455510179|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
126603723|NCT03656718|455510180|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
126603724|NCT03656718|455510181|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
126603725|NCT03656718|455510175|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
126603726|NCT03656718|455510176|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
126603727|NCT03656718|455510177|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
126603728|NCT03656718|455510178|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
126603729|NCT03656718|455510179|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
126603730|NCT03656718|455510180|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
126603731|NCT03656718|455510181|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
126603732|NCT03656718|455510175|FG000|Treatment Period Part C|Disease progression|0|||
126603733|NCT03656718|455510176|FG001|Treatment Period Part C|Disease progression|0|||
126603734|NCT03656718|455510177|FG002|Treatment Period Part C|Disease progression|0|||
126603735|NCT03656718|455510178|FG003|Treatment Period Part C|Disease progression|0|||
126603736|NCT03656718|455510179|FG004|Treatment Period Part C|Disease progression|12|||
126603737|NCT03656718|455510180|FG005|Treatment Period Part C|Disease progression|0|||
126603738|NCT03656718|455510181|FG006|Treatment Period Part C|Disease progression|0|||
126603739|NCT03656718|455510175|FG000|Treatment Period Part C|Death|0|||
126603740|NCT03656718|455510176|FG001|Treatment Period Part C|Death|0|||
126603741|NCT03656718|455510177|FG002|Treatment Period Part C|Death|0|||
126603742|NCT03656718|455510178|FG003|Treatment Period Part C|Death|0|||
126603743|NCT03656718|455510179|FG004|Treatment Period Part C|Death|1|||
126603744|NCT03656718|455510180|FG005|Treatment Period Part C|Death|0|||
126603745|NCT03656718|455510181|FG006|Treatment Period Part C|Death|0|||
126603746|NCT03656718|455510175|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
126603747|NCT03656718|455510176|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
126603748|NCT03656718|455510177|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
126603749|NCT03656718|455510178|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
126603750|NCT03656718|455510179|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
126603751|NCT03656718|455510180|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
126603752|NCT03656718|455510181|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
126603753|NCT03656718|455510175|FG000|Treatment Period Part C|Other reasons|0|||
126603754|NCT03656718|455510176|FG001|Treatment Period Part C|Other reasons|0|||
126603755|NCT03656718|455510177|FG002|Treatment Period Part C|Other reasons|0|||
126603756|NCT03656718|455510178|FG003|Treatment Period Part C|Other reasons|0|||
126603757|NCT03656718|455510179|FG004|Treatment Period Part C|Other reasons|1|||
126603758|NCT03656718|455510180|FG005|Treatment Period Part C|Other reasons|0|||
126603759|NCT03656718|455510181|FG006|Treatment Period Part C|Other reasons|0|||
126603760|NCT03656718|455510175|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
126603761|NCT03656718|455510176|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
126603762|NCT03656718|455510177|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
126603763|NCT03656718|455510178|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
126603764|NCT03656718|455510179|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
126603765|NCT03656718|455510180|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
126603766|NCT03656718|455510181|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
126603767|NCT03211247|455510182|FG000|Overall Study|Adverse Event|8|||
126603768|NCT03211247|455510183|FG001|Overall Study|Adverse Event|0|||
126603769|NCT03211247|455510184|FG002|Overall Study|Adverse Event|1|||
126603770|NCT03211247|455510185|FG003|Overall Study|Adverse Event|0|||
126603771|NCT03211247|455510186|FG004|Overall Study|Adverse Event|0|||
126603772|NCT03211247|455510182|FG000|Overall Study|Lost to Follow-up|2|||
126603773|NCT03211247|455510183|FG001|Overall Study|Lost to Follow-up|1|||
126603774|NCT03211247|455510184|FG002|Overall Study|Lost to Follow-up|0|||
126603775|NCT03211247|455510185|FG003|Overall Study|Lost to Follow-up|0|||
126603776|NCT03211247|455510186|FG004|Overall Study|Lost to Follow-up|0|||
126603777|NCT03211247|455510182|FG000|Overall Study|Physician Decision|1|||
126603778|NCT03211247|455510183|FG001|Overall Study|Physician Decision|2|||
126603779|NCT03211247|455510184|FG002|Overall Study|Physician Decision|0|||
126603780|NCT03211247|455510185|FG003|Overall Study|Physician Decision|0|||
126603781|NCT03211247|455510186|FG004|Overall Study|Physician Decision|0|||
126603782|NCT03211247|455510182|FG000|Overall Study|Non-compliance with study drug|2|||
126603783|NCT03211247|455510183|FG001|Overall Study|Non-compliance with study drug|0|||
126603784|NCT03211247|455510184|FG002|Overall Study|Non-compliance with study drug|0|||
126603785|NCT03211247|455510185|FG003|Overall Study|Non-compliance with study drug|0|||
126603786|NCT03211247|455510186|FG004|Overall Study|Non-compliance with study drug|0|||
126603787|NCT03211247|455510182|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
126603788|NCT03211247|455510183|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
126603789|NCT03211247|455510184|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
126603790|NCT03211247|455510185|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
126603791|NCT03211247|455510186|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
126603792|NCT03211247|455510182|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
126603793|NCT03211247|455510183|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
126603794|NCT03211247|455510184|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
126603795|NCT03211247|455510185|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
126603796|NCT03211247|455510186|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
126603797|NCT03211247|455510182|FG000|Overall Study|Protocol Violation|0|||
126603798|NCT03211247|455510183|FG001|Overall Study|Protocol Violation|1|||
126603799|NCT03211247|455510184|FG002|Overall Study|Protocol Violation|0|||
126603800|NCT03211247|455510185|FG003|Overall Study|Protocol Violation|0|||
126603801|NCT03211247|455510186|FG004|Overall Study|Protocol Violation|0|||
126603802|NCT02039401|455510187|FG000|Overall Study|Adverse Event|0|||
126603803|NCT02039401|455510188|FG001|Overall Study|Adverse Event|1|||
126603804|NCT02500576|455510191|FG000|Overall Study|Adverse Event|0|||
126603805|NCT02500576|455510192|FG001|Overall Study|Adverse Event|1|||
126603806|NCT02500576|455510191|FG000|Overall Study|Death|2|||
126603807|NCT02500576|455510192|FG001|Overall Study|Death|1|||
126603808|NCT02500576|455510191|FG000|Overall Study|Lack of Efficacy|5|||
126603809|NCT02500576|455510192|FG001|Overall Study|Lack of Efficacy|5|||
126603810|NCT02500576|455510191|FG000|Overall Study|Withdrawal by Subject|1|||
126603811|NCT02500576|455510192|FG001|Overall Study|Withdrawal by Subject|1|||
126603812|NCT03691493|455510198|FG000|Overall Study|Withdrawal by Subject|1|||
126603813|NCT03867201|455510199|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
126603814|NCT03867201|455510200|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
126603815|NCT03867201|455510199|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
126603816|NCT03867201|455510200|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
126603817|NCT03867201|455510199|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
126603818|NCT03867201|455510200|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
126603819|NCT03867201|455510199|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
126603820|NCT03867201|455510200|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
126603821|NCT03867201|455510199|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
126603822|NCT03867201|455510200|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
126603823|NCT03867201|455510199|FG000|Open-Label Period From Week 12|Adverse Event|5|||
126603824|NCT03867201|455510200|FG001|Open-Label Period From Week 12|Adverse Event|11|||
126603825|NCT03867201|455510199|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
126603826|NCT03867201|455510200|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
126603827|NCT03867201|455510199|FG000|Open-Label Period From Week 12|Physician Decision|6|||
126603828|NCT03867201|455510200|FG001|Open-Label Period From Week 12|Physician Decision|3|||
126603829|NCT03867201|455510199|FG000|Open-Label Period From Week 12|Pregnancy|2|||
126603830|NCT03867201|455510200|FG001|Open-Label Period From Week 12|Pregnancy|2|||
126603831|NCT03867201|455510199|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
126603832|NCT03867201|455510200|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
126603833|NCT03867201|455510199|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
126603834|NCT03867201|455510200|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
126603835|NCT03867201|455510199|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
126603836|NCT03867201|455510200|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
126603837|NCT03867201|455510199|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
126603838|NCT03867201|455510200|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
126603839|NCT01983683|455510201|FG000|Overall Study|Withdrawal by Subject|14|||
126603840|NCT01983683|455510202|FG001|Overall Study|Withdrawal by Subject|18|||
126603841|NCT01983683|455510201|FG000|Overall Study|Death|11|||
126603842|NCT01983683|455510202|FG001|Overall Study|Death|15|||
126603843|NCT01983683|455510201|FG000|Overall Study|Physician Decision|8|||
126603844|NCT01983683|455510202|FG001|Overall Study|Physician Decision|9|||
126603845|NCT01983683|455510201|FG000|Overall Study|Lost to Follow-up|4|||
126603846|NCT01983683|455510202|FG001|Overall Study|Lost to Follow-up|8|||
126603847|NCT01983683|455510201|FG000|Overall Study|Sponsor Decision|1|||
126603848|NCT01983683|455510202|FG001|Overall Study|Sponsor Decision|1|||
126603849|NCT03459196|455511381|FG000|Overall Study|Subject didn't receive study catheter|2|||
126603850|NCT03140670|455511388|FG000|Overall Study|Withdrawal by Subject|2|||
126603851|NCT03140670|455511388|FG000|Overall Study|Lost to Follow-up|1|||
126603852|NCT03140670|455511388|FG000|Overall Study|Physician Decision|1|||
126603853|NCT00220805|455511389|FG000|Overall Study|Adverse Event|1|||
126603854|NCT00220805|455511390|FG001|Overall Study|Adverse Event|3|||
126603855|NCT00220805|455511389|FG000|Overall Study|Withdrawal by Subject|3|||
126603856|NCT00220805|455511390|FG001|Overall Study|Withdrawal by Subject|0|||
126603857|NCT00220805|455511389|FG000|Overall Study|Lack of Efficacy|1|||
126603858|NCT00220805|455511390|FG001|Overall Study|Lack of Efficacy|0|||
126603859|NCT00220805|455511389|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
126603860|NCT00220805|455511390|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
126603861|NCT01288443|455511391|FG000|Overall Study|Adverse Event|0|||
126603862|NCT01288443|455511392|FG001|Overall Study|Adverse Event|0|||
126603863|NCT01288443|455511393|FG002|Overall Study|Adverse Event|1|||
126603864|NCT01288443|455511394|FG003|Overall Study|Adverse Event|1|||
126603865|NCT01288443|455511395|FG004|Overall Study|Adverse Event|3|||
126603866|NCT01288443|455511396|FG005|Overall Study|Adverse Event|1|||
126603867|NCT01288443|455511391|FG000|Overall Study|Poor compliance to protocol|0|||
126603868|NCT01288443|455511392|FG001|Overall Study|Poor compliance to protocol|0|||
126603869|NCT01288443|455511393|FG002|Overall Study|Poor compliance to protocol|0|||
126603870|NCT01288443|455511394|FG003|Overall Study|Poor compliance to protocol|0|||
126603871|NCT01288443|455511395|FG004|Overall Study|Poor compliance to protocol|0|||
126603872|NCT01288443|455511396|FG005|Overall Study|Poor compliance to protocol|1|||
126603873|NCT01288443|455511391|FG000|Overall Study|Participant Moved|0|||
126603874|NCT01288443|455511392|FG001|Overall Study|Participant Moved|0|||
126603875|NCT01288443|455511393|FG002|Overall Study|Participant Moved|0|||
126603876|NCT01288443|455511394|FG003|Overall Study|Participant Moved|1|||
126603877|NCT01288443|455511395|FG004|Overall Study|Participant Moved|2|||
126603878|NCT01288443|455511396|FG005|Overall Study|Participant Moved|1|||
126603879|NCT01288443|455511391|FG000|Overall Study|Consent withdrawn by Participant|0|||
126603880|NCT01288443|455511392|FG001|Overall Study|Consent withdrawn by Participant|0|||
126603881|NCT01288443|455511393|FG002|Overall Study|Consent withdrawn by Participant|0|||
126603882|NCT01288443|455511394|FG003|Overall Study|Consent withdrawn by Participant|0|||
126603883|NCT01288443|455511395|FG004|Overall Study|Consent withdrawn by Participant|0|||
126603884|NCT01288443|455511396|FG005|Overall Study|Consent withdrawn by Participant|1|||
126603885|NCT01288443|455511391|FG000|Overall Study|Lost to Follow-up|0|||
126603886|NCT01288443|455511392|FG001|Overall Study|Lost to Follow-up|1|||
126603887|NCT01288443|455511393|FG002|Overall Study|Lost to Follow-up|0|||
126603888|NCT01288443|455511394|FG003|Overall Study|Lost to Follow-up|0|||
126603889|NCT01288443|455511395|FG004|Overall Study|Lost to Follow-up|0|||
126603890|NCT01288443|455511396|FG005|Overall Study|Lost to Follow-up|0|||
126603891|NCT01288443|455511391|FG000|Overall Study|Study drug auto-injector administration|0|||
126603892|NCT01288443|455511392|FG001|Overall Study|Study drug auto-injector administration|0|||
126603893|NCT01288443|455511393|FG002|Overall Study|Study drug auto-injector administration|0|||
126603894|NCT01288443|455511394|FG003|Overall Study|Study drug auto-injector administration|0|||
126603895|NCT01288443|455511395|FG004|Overall Study|Study drug auto-injector administration|1|||
126603896|NCT01288443|455511396|FG005|Overall Study|Study drug auto-injector administration|1|||
126603897|NCT01288443|455511391|FG000|Overall Study|Other than above|0|||
126603898|NCT01288443|455511392|FG001|Overall Study|Other than above|0|||
126603899|NCT01288443|455511393|FG002|Overall Study|Other than above|0|||
126603900|NCT01288443|455511394|FG003|Overall Study|Other than above|2|||
126603901|NCT01288443|455511395|FG004|Overall Study|Other than above|1|||
126603902|NCT01288443|455511396|FG005|Overall Study|Other than above|0|||
126603903|NCT01596972|455511397|FG000|Overall Study|Physician Decision|1|||
126603904|NCT01596972|455511398|FG001|Overall Study|Physician Decision|9|||
126603905|NCT01596972|455511397|FG000|Overall Study|Lost to Follow-up|0|||
126603906|NCT01596972|455511398|FG001|Overall Study|Lost to Follow-up|4|||
126603907|NCT01596972|455511397|FG000|Overall Study|Withdrawal by Subject|0|||
126603908|NCT01596972|455511398|FG001|Overall Study|Withdrawal by Subject|1|||
126603909|NCT01964300|455511401|FG000|Overall Study|Ineligible after enrollment|0|||
126733637|NCT05406440|455973894|FG002|Overall Study|Withdrawal by Subject|0|||
126733638|NCT05406440|455973895|FG003|Overall Study|Withdrawal by Subject|0|||
126733639|NCT05406440|455973896|FG004|Overall Study|Withdrawal by Subject|0|||
126733640|NCT05406440|455973897|FG005|Overall Study|Withdrawal by Subject|2|||
126603910|NCT01964300|455511402|FG001|Overall Study|Ineligible after enrollment|1|||
126603911|NCT01964300|455511401|FG000|Overall Study|Adverse Event|1|||
126603912|NCT01964300|455511402|FG001|Overall Study|Adverse Event|1|||
126603913|NCT01964300|455511401|FG000|Overall Study|Lack of Efficacy|3|||
126733641|NCT05406440|455973898|FG006|Overall Study|Withdrawal by Subject|0|||
126603914|NCT01964300|455511402|FG001|Overall Study|Lack of Efficacy|5|||
126603915|NCT01964300|455511401|FG000|Overall Study|Withdrawal by Subject|0|||
126603916|NCT01964300|455511402|FG001|Overall Study|Withdrawal by Subject|1|||
126603917|NCT01964300|455511401|FG000|Overall Study|To receive alternative therapy|1|||
126603918|NCT01964300|455511402|FG001|Overall Study|To receive alternative therapy|2|||
126603919|NCT01964300|455511401|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
126733642|NCT02455388|455973899|FG000|Overall Study|Protocol Violation|1|||
126780828|NCT00633152|456152821|FG001|Overall Study|Adverse Event|0|||
126780829|NCT00633152|456152820|FG000|Overall Study|Randomized, did not receive study drug|5|||
126780830|NCT00633152|456152821|FG001|Overall Study|Randomized, did not receive study drug|2|||
126780831|NCT00633152|456152820|FG000|Overall Study|Withdrawal by Subject|1|||
126780832|NCT00633152|456152821|FG001|Overall Study|Withdrawal by Subject|1|||
126780833|NCT00633152|456152820|FG000|Overall Study|Lost to Follow-up|4|||
126780834|NCT00633152|456152821|FG001|Overall Study|Lost to Follow-up|1|||
126780835|NCT00633152|456152820|FG000|Overall Study|Miscellaneous Other|3|||
126780836|NCT00633152|456152821|FG001|Overall Study|Miscellaneous Other|2|||
126780837|NCT02049359|456152822|FG000|Overall Study|Lost to Follow-up|26|||
126780838|NCT02049359|456152823|FG001|Overall Study|Lost to Follow-up|19|||
126780839|NCT03273387|456152824|FG000|Overall Study|Death|2|||
126780840|NCT03273387|456152825|FG001|Overall Study|Death|2|||
126780841|NCT03273387|456152824|FG000|Overall Study|Withdrawal by Subject|1|||
126603920|NCT01964300|455511402|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
126603921|NCT01964300|455511401|FG000|Overall Study|Weight criteria not met|0|||
126603922|NCT01964300|455511402|FG001|Overall Study|Weight criteria not met|1|||
126603923|NCT03183050|455511403|FG000|Overall Study|Lost to Follow-up|23|||
126603924|NCT00754065|455511404|FG000|Overall Study|Never received treatment|12|||
126603925|NCT00754065|455511405|FG001|Overall Study|Never received treatment|2|||
126603926|NCT00754065|455511404|FG000|Overall Study|Adverse Event|19|||
126603927|NCT00754065|455511405|FG001|Overall Study|Adverse Event|25|||
126603928|NCT00754065|455511404|FG000|Overall Study|Lost to Follow-up|7|||
126603929|NCT00754065|455511405|FG001|Overall Study|Lost to Follow-up|11|||
126603930|NCT00754065|455511404|FG000|Overall Study|Protocol Violation|12|||
126603931|NCT00754065|455511405|FG001|Overall Study|Protocol Violation|10|||
126603932|NCT00754065|455511404|FG000|Overall Study|Withdrawal by Subject|4|||
126603933|NCT00754065|455511405|FG001|Overall Study|Withdrawal by Subject|5|||
126603934|NCT00754065|455511404|FG000|Overall Study|Pregnancy|6|||
126733643|NCT02455388|455973900|FG001|Overall Study|Protocol Violation|0|||
126733644|NCT02455388|455973901|FG002|Overall Study|Protocol Violation|4|||
126733645|NCT02455388|455973899|FG000|Overall Study|Withdrawal by Subject|0|||
126733646|NCT02455388|455973900|FG001|Overall Study|Withdrawal by Subject|0|||
126733647|NCT02455388|455973901|FG002|Overall Study|Withdrawal by Subject|7|||
126733648|NCT00525785|455973902|FG000|Overall Study|Withdrawal by Subject|1|||
126733649|NCT00525785|455973902|FG000|Overall Study|Lack of Efficacy|1|||
126733650|NCT00525785|455973902|FG000|Overall Study|Physician Decision|1|||
126733651|NCT01316939|455973903|FG000|Overall Study|Study closed/terminated|26|||
126733652|NCT01316939|455973904|FG001|Overall Study|Study closed/terminated|25|||
126733653|NCT01316939|455973905|FG002|Overall Study|Study closed/terminated|23|||
126733654|NCT01316939|455973903|FG000|Overall Study|Lack of Efficacy|24|||
126733655|NCT01316939|455973904|FG001|Overall Study|Lack of Efficacy|25|||
126733656|NCT01316939|455973905|FG002|Overall Study|Lack of Efficacy|25|||
126733657|NCT01316939|455973903|FG000|Overall Study|Adverse Event|9|||
126733658|NCT01316939|455973904|FG001|Overall Study|Adverse Event|12|||
126733659|NCT01316939|455973905|FG002|Overall Study|Adverse Event|11|||
126733660|NCT01316939|455973903|FG000|Overall Study|Withdrawal by Subject|1|||
126733661|NCT01316939|455973904|FG001|Overall Study|Withdrawal by Subject|3|||
126733662|NCT01316939|455973905|FG002|Overall Study|Withdrawal by Subject|6|||
126733663|NCT01316939|455973903|FG000|Overall Study|Physician Decision|2|||
126733664|NCT01316939|455973904|FG001|Overall Study|Physician Decision|2|||
126733665|NCT01316939|455973905|FG002|Overall Study|Physician Decision|1|||
126733666|NCT01316939|455973903|FG000|Overall Study|Lost to Follow-up|0|||
126733667|NCT01316939|455973904|FG001|Overall Study|Lost to Follow-up|0|||
126733668|NCT01316939|455973905|FG002|Overall Study|Lost to Follow-up|2|||
126733669|NCT01316939|455973903|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
126733670|NCT01316939|455973904|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
126733671|NCT01316939|455973905|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
126733672|NCT01316939|455973903|FG000|Overall Study|Protocol Violation|0|||
126733673|NCT01316939|455973904|FG001|Overall Study|Protocol Violation|1|||
126733674|NCT01316939|455973905|FG002|Overall Study|Protocol Violation|0|||
126733675|NCT00801892|455973906|FG000|Main Study Period|Withdrawal by Subject|0|||
126733676|NCT00801892|455973907|FG001|Main Study Period|Withdrawal by Subject|1|||
126733677|NCT00801892|455973906|FG000|Sham Crossover Period|Lost to Follow-up|0|||
126733678|NCT00801892|455973907|FG001|Sham Crossover Period|Lost to Follow-up|2|||
126733679|NCT01711541|455973916|FG000|Overall Study|Cancel prior to treatment|0|||
126733680|NCT01711541|455973917|FG001|Overall Study|Cancel prior to treatment|0|||
126733681|NCT01711541|455973918|FG002|Overall Study|Cancel prior to treatment|0|||
126733682|NCT01711541|455973919|FG003|Overall Study|Cancel prior to treatment|1|||
126780842|NCT03273387|456152825|FG001|Overall Study|Withdrawal by Subject|1|||
126780843|NCT01907087|456152826|FG000|Overall Study|Withdrawal by Subject|1|||
126603935|NCT00754065|455511405|FG001|Overall Study|Pregnancy|0|||
126733683|NCT01711541|455973920|FG004|Overall Study|Cancel prior to treatment|0|||
126733684|NCT01711541|455973916|FG000|Overall Study|Ineligible|0|||
126733685|NCT01711541|455973917|FG001|Overall Study|Ineligible|1|||
126603936|NCT00754065|455511404|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
126603937|NCT00754065|455511405|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
126603938|NCT01074294|455511406|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
126603939|NCT01074294|455511407|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
126603940|NCT01074294|455511408|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
126603941|NCT01074294|455511409|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
126603942|NCT01074294|455511406|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
126603943|NCT01074294|455511407|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
126603944|NCT01074294|455511408|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
126603945|NCT01074294|455511409|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
126603946|NCT01074294|455511406|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
126603947|NCT01074294|455511407|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
126603948|NCT01074294|455511408|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
126603949|NCT01074294|455511409|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
126603950|NCT01074294|455511406|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
126603951|NCT01074294|455511407|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
126603952|NCT01074294|455511408|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
126603953|NCT01074294|455511409|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
126603954|NCT01074294|455511406|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
126603955|NCT01074294|455511407|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
126603956|NCT01074294|455511408|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
126603957|NCT01074294|455511409|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
126603958|NCT01074294|455511406|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
126603959|NCT01074294|455511407|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
126603960|NCT01074294|455511408|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
126603961|NCT01074294|455511409|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
126603962|NCT01074294|455511406|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
126603963|NCT01074294|455511407|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
126603964|NCT01074294|455511408|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
126603965|NCT01074294|455511409|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
126603966|NCT01074294|455511406|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
126603967|NCT01074294|455511407|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
126603968|NCT01074294|455511408|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
126603969|NCT01074294|455511409|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
126603970|NCT01074294|455511406|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
126603971|NCT01074294|455511407|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
126603972|NCT01074294|455511408|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
126603973|NCT01074294|455511409|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
126603974|NCT01074294|455511406|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
126603975|NCT01074294|455511407|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
126603976|NCT01074294|455511408|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
126603977|NCT01074294|455511409|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
126603978|NCT01074294|455511406|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
126603979|NCT01074294|455511407|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
126603980|NCT01074294|455511408|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
126603981|NCT01074294|455511409|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
126603982|NCT01074294|455511406|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
126603983|NCT01074294|455511407|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
126603984|NCT01074294|455511408|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
126603985|NCT01074294|455511409|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
126603986|NCT01074294|455511406|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
126603987|NCT01074294|455511407|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
126603988|NCT01074294|455511408|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
126603989|NCT01074294|455511409|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
126603990|NCT00623194|455511410|FG000|Overall Study|Lack of Efficacy|1|||
126603991|NCT00623194|455511410|FG000|Overall Study|Protocol Violation|3|||
126603992|NCT00623194|455511410|FG000|Overall Study|Unclassified|1|||
126603993|NCT01260896|455511411|FG000|First Intervention|Withdrawn Due to Emesis|2|||
126603994|NCT01260896|455511412|FG001|First Intervention|Withdrawn Due to Emesis|0|||
126603995|NCT00312208|455511414|FG000|Overall Study|Adverse Event|97|||
126603996|NCT00312208|455511415|FG001|Overall Study|Adverse Event|61|||
126603997|NCT00312208|455511414|FG000|Overall Study|Protocol Violation|5|||
126603998|NCT00312208|455511415|FG001|Overall Study|Protocol Violation|3|||
126603999|NCT00312208|455511414|FG000|Overall Study|Death|2|||
126604000|NCT00312208|455511415|FG001|Overall Study|Death|1|||
126604001|NCT00312208|455511414|FG000|Overall Study|Lack of Efficacy|7|||
126604002|NCT00312208|455511415|FG001|Overall Study|Lack of Efficacy|4|||
126733686|NCT01711541|455973918|FG002|Overall Study|Ineligible|0|||
126733687|NCT01711541|455973919|FG003|Overall Study|Ineligible|0|||
126733688|NCT01711541|455973920|FG004|Overall Study|Ineligible|0|||
126604003|NCT00312208|455511414|FG000|Overall Study|Lost to Follow-up|3|||
126604004|NCT00312208|455511415|FG001|Overall Study|Lost to Follow-up|5|||
126604005|NCT00312208|455511414|FG000|Overall Study|Withdrawal by Subject|53|||
126604006|NCT00312208|455511415|FG001|Overall Study|Withdrawal by Subject|42|||
126604007|NCT00312208|455511414|FG000|Overall Study|Other|5|||
126604008|NCT00312208|455511415|FG001|Overall Study|Other|7|||
126604009|NCT00982644|455511418|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
126604010|NCT00982644|455511419|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
126604011|NCT00982644|455511418|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
126604012|NCT00982644|455511419|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
126604013|NCT00982644|455511418|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
126604014|NCT00982644|455511419|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
126604015|NCT00982644|455511418|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
126604016|NCT00982644|455511419|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
126604017|NCT00982644|455511418|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
126604018|NCT00982644|455511419|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
126604019|NCT00982644|455511418|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
126604020|NCT00982644|455511419|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
126604021|NCT00982644|455511418|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
126604022|NCT00982644|455511419|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
126604023|NCT00982644|455511418|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
126604024|NCT00982644|455511419|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
126733689|NCT00728936|455973921|FG000|Overall Study|Withdrawal by Subject|0|||
126733690|NCT00728936|455973922|FG001|Overall Study|Withdrawal by Subject|0|||
126733691|NCT00728936|455973923|FG002|Overall Study|Withdrawal by Subject|0|||
126733692|NCT00728936|455973924|FG003|Overall Study|Withdrawal by Subject|0|||
126733693|NCT00728936|455973925|FG004|Overall Study|Withdrawal by Subject|0|||
126733694|NCT00728936|455973926|FG005|Overall Study|Withdrawal by Subject|1|||
126733695|NCT00728936|455973927|FG006|Overall Study|Withdrawal by Subject|0|||
126733696|NCT02966353|455973936|FG000|Overall Study|Withdrawal by Subject|7|||
126733697|NCT02966353|455973936|FG000|Overall Study|Adverse Event|4|||
126733698|NCT02966353|455973936|FG000|Overall Study|Death|4|||
126780844|NCT05216978|456152827|FG000|Overall Study|Withdrawal by Subject|3|||
126780845|NCT05216978|456152827|FG000|Overall Study|Lost to Follow-up|5|||
126780846|NCT02180061|456152828|FG000|Overall Study|Adverse Event|4|||
126780847|NCT02180061|456152829|FG001|Overall Study|Adverse Event|2|||
126780848|NCT02180061|456152828|FG000|Overall Study|Clinical Progression|5|||
126780849|NCT02180061|456152829|FG001|Overall Study|Clinical Progression|1|||
126780850|NCT02180061|456152828|FG000|Overall Study|Progressive Disease|15|||
126780851|NCT02180061|456152829|FG001|Overall Study|Progressive Disease|5|||
126780852|NCT02180061|456152828|FG000|Overall Study|Physician Decision|1|||
126780853|NCT02180061|456152829|FG001|Overall Study|Physician Decision|0|||
126780854|NCT00658320|456152833|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
126780855|NCT00658320|456152834|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
126780856|NCT00658320|456152833|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
126780857|NCT00658320|456152834|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
126733699|NCT02966353|455973936|FG000|Overall Study|Physician Decision|3|||
126780858|NCT00658320|456152833|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
126780859|NCT00658320|456152834|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
126604025|NCT00982644|455511418|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
126604026|NCT00982644|455511419|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
126604027|NCT00982644|455511418|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
126604028|NCT00982644|455511419|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
126604029|NCT00943917|455511422|FG000|Stage I|Adverse Event|1|||
126604030|NCT00943917|455511423|FG001|Stage I|Adverse Event|2|||
126604031|NCT00943917|455511424|FG002|Stage I|Adverse Event|2|||
126604032|NCT00943917|455511425|FG003|Stage I|Adverse Event|0|||
126604033|NCT00943917|455511426|FG004|Stage I|Adverse Event|0|||
126604034|NCT00943917|455511427|FG005|Stage I|Adverse Event|0|||
126604035|NCT00943917|455511428|FG006|Stage I|Adverse Event|0|||
126604036|NCT00943917|455511429|FG007|Stage I|Adverse Event|0|||
126604037|NCT00943917|455511430|FG008|Stage I|Adverse Event|0|||
126604038|NCT00943917|455511431|FG009|Stage I|Adverse Event|0|||
126604039|NCT00943917|455511432|FG010|Stage I|Adverse Event|0|||
126604040|NCT00943917|455511433|FG011|Stage I|Adverse Event|0|||
126604041|NCT00943917|455511434|FG012|Stage I|Adverse Event|0|||
126604042|NCT00943917|455511435|FG013|Stage I|Adverse Event|0|||
126604043|NCT00943917|455511436|FG014|Stage I|Adverse Event|0|||
126604044|NCT00943917|455511422|FG000|Stage I|Lost to Follow-up|0|||
126604045|NCT00943917|455511423|FG001|Stage I|Lost to Follow-up|0|||
126604046|NCT00943917|455511424|FG002|Stage I|Lost to Follow-up|1|||
126604047|NCT00943917|455511425|FG003|Stage I|Lost to Follow-up|0|||
126604048|NCT00943917|455511426|FG004|Stage I|Lost to Follow-up|0|||
126604049|NCT00943917|455511427|FG005|Stage I|Lost to Follow-up|0|||
126604050|NCT00943917|455511428|FG006|Stage I|Lost to Follow-up|0|||
126733700|NCT02966353|455973936|FG000|Overall Study|Progressive disease|2|||
126780860|NCT00658320|456152833|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
126780861|NCT00658320|456152834|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
126780862|NCT02410252|456152839|FG000|Overall Study|Withdrawal by Subject|4|||
126780863|NCT02410252|456152839|FG000|Overall Study|Physician Decision|2|||
126780864|NCT00387712|456152854|FG000|Overall Study|Physician Decision|6|||
126780865|NCT00387712|456152855|FG001|Overall Study|Physician Decision|4|||
126780866|NCT00387712|456152854|FG000|Overall Study|Lost to Follow-up|17|||
126780867|NCT00387712|456152855|FG001|Overall Study|Lost to Follow-up|20|||
126780868|NCT00387712|456152854|FG000|Overall Study|Withdrawal by Subject|6|||
126780869|NCT00387712|456152855|FG001|Overall Study|Withdrawal by Subject|12|||
126780870|NCT01907737|456152860|FG000|Overall Study|Withdrawal by Subject|1|||
126780871|NCT01772368|456152862|FG000|Overall Study|Adverse Event|1|||
126780872|NCT01772368|456152862|FG000|Overall Study|Withdrawal by Subject|3|||
126780873|NCT01772368|456152862|FG000|Overall Study|Protocol Violation|2|||
126780874|NCT01772368|456152862|FG000|Overall Study|Other|1|||
126780875|NCT01452529|456152863|FG000|Run-in Period|Adverse Event|96|||
126780876|NCT01452529|456152864|FG001|Run-in Period|Adverse Event|0|||
126780877|NCT01452529|456152865|FG002|Run-in Period|Adverse Event|0|||
126780878|NCT01452529|456152863|FG000|Run-in Period|Withdrawal by Subject|49|||
126780879|NCT01452529|456152864|FG001|Run-in Period|Withdrawal by Subject|0|||
126780880|NCT01452529|456152865|FG002|Run-in Period|Withdrawal by Subject|0|||
126780881|NCT01452529|456152863|FG000|Run-in Period|Lost to Follow-up|19|||
126780882|NCT01452529|456152864|FG001|Run-in Period|Lost to Follow-up|0|||
126780883|NCT01452529|456152865|FG002|Run-in Period|Lost to Follow-up|0|||
126780884|NCT01452529|456152863|FG000|Run-in Period|Lack of Efficacy|46|||
126780885|NCT01452529|456152864|FG001|Run-in Period|Lack of Efficacy|0|||
126780886|NCT01452529|456152865|FG002|Run-in Period|Lack of Efficacy|0|||
126780887|NCT01452529|456152863|FG000|Run-in Period|Confirmed or suspected diversion|23|||
126780888|NCT01452529|456152864|FG001|Run-in Period|Confirmed or suspected diversion|0|||
126780889|NCT01452529|456152865|FG002|Run-in Period|Confirmed or suspected diversion|0|||
126780890|NCT01452529|456152863|FG000|Run-in Period|Administrative|21|||
126780891|NCT01452529|456152864|FG001|Run-in Period|Administrative|0|||
126780892|NCT01452529|456152865|FG002|Run-in Period|Administrative|0|||
126780893|NCT01452529|456152863|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
126780894|NCT01452529|456152864|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
126780895|NCT01452529|456152865|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
126780896|NCT01452529|456152863|FG000|Double-blind (DB) Period|Adverse Event|0|||
126780897|NCT01452529|456152864|FG001|Double-blind (DB) Period|Adverse Event|18|||
126780898|NCT01452529|456152865|FG002|Double-blind (DB) Period|Adverse Event|11|||
126780899|NCT01452529|456152863|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
126780900|NCT01452529|456152864|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
126780901|NCT01452529|456152865|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
126780902|NCT01452529|456152863|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
126780903|NCT01452529|456152864|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
126780904|NCT01452529|456152865|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
126780905|NCT01452529|456152863|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
126780906|NCT01452529|456152864|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
126780907|NCT01452529|456152865|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
126780908|NCT01452529|456152863|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
126780909|NCT01452529|456152864|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
126780910|NCT01452529|456152865|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
126780911|NCT01452529|456152863|FG000|Double-blind (DB) Period|Administrative|0|||
126780912|NCT01452529|456152864|FG001|Double-blind (DB) Period|Administrative|11|||
126780913|NCT01452529|456152865|FG002|Double-blind (DB) Period|Administrative|7|||
126780914|NCT03551730|456152869|FG000|Overall Study|Adverse Event|1|||
126780915|NCT03551730|456152870|FG001|Overall Study|Adverse Event|0|||
126780916|NCT03551730|456152871|FG002|Overall Study|Adverse Event|0|||
126780917|NCT03551730|456152872|FG003|Overall Study|Adverse Event|0|||
126604051|NCT00943917|455511429|FG007|Stage I|Lost to Follow-up|0|||
126604052|NCT00943917|455511430|FG008|Stage I|Lost to Follow-up|0|||
126604053|NCT00943917|455511431|FG009|Stage I|Lost to Follow-up|0|||
126604054|NCT00943917|455511432|FG010|Stage I|Lost to Follow-up|0|||
126604055|NCT00943917|455511433|FG011|Stage I|Lost to Follow-up|0|||
126604056|NCT00943917|455511434|FG012|Stage I|Lost to Follow-up|0|||
126780918|NCT03347695|456152873|FG000|Overall Study|Death|0|||
126780919|NCT03347695|456152874|FG001|Overall Study|Death|4|||
126604057|NCT00943917|455511435|FG013|Stage I|Lost to Follow-up|0|||
126780920|NCT03347695|456152873|FG000|Overall Study|Lost to Follow-up|0|||
126780921|NCT03347695|456152874|FG001|Overall Study|Lost to Follow-up|1|||
126780922|NCT02668783|456152875|FG000|Overall Study|Pregnancy|0|||
126604058|NCT00943917|455511436|FG014|Stage I|Lost to Follow-up|0|||
126780923|NCT02668783|456152876|FG001|Overall Study|Pregnancy|1|||
126780924|NCT02668783|456152875|FG000|Overall Study|Protocol Violation|2|||
126780925|NCT02668783|456152876|FG001|Overall Study|Protocol Violation|1|||
126780926|NCT02668783|456152875|FG000|Overall Study|Study terminated by sponsor|9|||
126604059|NCT00943917|455511422|FG000|Stage I|hyperglycemia|0|||
126604060|NCT00943917|455511423|FG001|Stage I|hyperglycemia|0|||
126780927|NCT02668783|456152876|FG001|Overall Study|Study terminated by sponsor|10|||
126780928|NCT02668783|456152875|FG000|Overall Study|Subject moved|1|||
126780929|NCT02668783|456152876|FG001|Overall Study|Subject moved|0|||
126780930|NCT02668783|456152875|FG000|Overall Study|Withdrawal by Subject|1|||
126780931|NCT02668783|456152876|FG001|Overall Study|Withdrawal by Subject|0|||
126780932|NCT01003886|456152879|FG000|Overall Study|Lack of Efficacy|5|||
126780933|NCT01003886|456152879|FG000|Overall Study|Lost to Follow-up|169|||
126780934|NCT01003886|456152879|FG000|Overall Study|Withdrawal by Subject|39|||
126780935|NCT01003886|456152879|FG000|Overall Study|Other|14|||
126780936|NCT01003886|456152879|FG000|Overall Study|Adverse Event|3|||
126780937|NCT04467697|456152880|FG000|Overall Study|Adverse Event|2|||
126780938|NCT04467697|456152880|FG000|Overall Study|Lost to Follow-up|6|||
126780939|NCT04467697|456152880|FG000|Overall Study|Withdrawal by Subject|9|||
126780940|NCT04467697|456152880|FG000|Overall Study|Protocol Violation|3|||
126780941|NCT03907280|456152881|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
126780942|NCT03907280|456152882|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
126780943|NCT03907280|456152883|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
126780944|NCT00909727|456152886|FG000|Overall Study|Adverse Event|1|||
126780945|NCT00909727|456152887|FG001|Overall Study|Adverse Event|0|||
126780946|NCT00909727|456152886|FG000|Overall Study|Wrong Genotype|1|||
126780947|NCT00909727|456152887|FG001|Overall Study|Wrong Genotype|0|||
126780948|NCT00909727|456152886|FG000|Overall Study|Withdrawal of Consent|1|||
126780949|NCT00909727|456152887|FG001|Overall Study|Withdrawal of Consent|0|||
126780950|NCT00909727|456152886|FG000|Overall Study|Prohibited Medication|1|||
126780951|NCT00909727|456152887|FG001|Overall Study|Prohibited Medication|0|||
126780952|NCT02231710|456152888|FG000|Overall Study|Physician Decision|1|||
126780953|NCT04081337|456152889|FG000|Overall Study|Adverse Event|0|||
126780954|NCT04081337|456152890|FG001|Overall Study|Adverse Event|1|||
126780955|NCT04081337|456152889|FG000|Overall Study|Withdrawal by Subject|2|||
126780956|NCT04081337|456152890|FG001|Overall Study|Withdrawal by Subject|0|||
126780957|NCT04081337|456152889|FG000|Overall Study|Physician Decision|1|||
126780958|NCT04081337|456152890|FG001|Overall Study|Physician Decision|2|||
126780959|NCT04081337|456152889|FG000|Overall Study|Lost to Follow-up|1|||
126780960|NCT04081337|456152890|FG001|Overall Study|Lost to Follow-up|0|||
126780961|NCT00673361|456152895|FG000|Overall Study|Screen Failure|2|||
126780962|NCT01799590|456152898|FG000|Overall Study|Adverse Event|13|||
126780963|NCT01799590|456152899|FG001|Overall Study|Adverse Event|7|||
126780964|NCT01799590|456152900|FG002|Overall Study|Adverse Event|5|||
126780965|NCT01799590|456152898|FG000|Overall Study|Pregnancy|2|||
126780966|NCT01799590|456152899|FG001|Overall Study|Pregnancy|0|||
126780967|NCT01799590|456152900|FG002|Overall Study|Pregnancy|0|||
126780968|NCT01799590|456152898|FG000|Overall Study|Lack of Efficacy|3|||
126780969|NCT01799590|456152899|FG001|Overall Study|Lack of Efficacy|1|||
126780970|NCT01799590|456152900|FG002|Overall Study|Lack of Efficacy|3|||
126780971|NCT01799590|456152898|FG000|Overall Study|Participants convenience|4|||
126780972|NCT01799590|456152899|FG001|Overall Study|Participants convenience|4|||
126780973|NCT01799590|456152900|FG002|Overall Study|Participants convenience|2|||
126780974|NCT01799590|456152898|FG000|Overall Study|Aggravation of complications|0|||
126780975|NCT01799590|456152899|FG001|Overall Study|Aggravation of complications|1|||
126780976|NCT01799590|456152900|FG002|Overall Study|Aggravation of complications|1|||
126780977|NCT01799590|456152898|FG000|Overall Study|Using drugs with restricted days of use|0|||
126780978|NCT01799590|456152899|FG001|Overall Study|Using drugs with restricted days of use|3|||
126780979|NCT01799590|456152900|FG002|Overall Study|Using drugs with restricted days of use|2|||
126780980|NCT01799590|456152898|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
126780981|NCT01799590|456152899|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
126780982|NCT01799590|456152900|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
126780983|NCT01799590|456152898|FG000|Overall Study|Other|3|||
126780984|NCT01799590|456152899|FG001|Overall Study|Other|0|||
126780985|NCT01799590|456152900|FG002|Overall Study|Other|1|||
126780986|NCT03175120|456152903|FG000|Overall Study|Adverse Event|2|||
126780987|NCT03175120|456152904|FG001|Overall Study|Adverse Event|2|||
126780988|NCT03175120|456152903|FG000|Overall Study|Protocol Violation|5|||
126780989|NCT03175120|456152904|FG001|Overall Study|Protocol Violation|2|||
126780990|NCT03175120|456152903|FG000|Overall Study|Lost to Follow-up|1|||
126780991|NCT03175120|456152904|FG001|Overall Study|Lost to Follow-up|0|||
126780992|NCT03175120|456152903|FG000|Overall Study|Withdrawal by Subject|2|||
126780993|NCT03175120|456152904|FG001|Overall Study|Withdrawal by Subject|5|||
126780994|NCT03175120|456152903|FG000|Overall Study|Other|2|||
126780995|NCT03175120|456152904|FG001|Overall Study|Other|3|||
126780996|NCT00678392|456152905|FG000|Overall Study|Adverse Event|0|||
126780997|NCT00678392|456152906|FG001|Overall Study|Adverse Event|6|||
126780998|NCT00678392|456152905|FG000|Overall Study|Death|280|||
126780999|NCT00678392|456152906|FG001|Overall Study|Death|269|||
126781000|NCT00678392|456152905|FG000|Overall Study|Lost to Follow-up|15|||
126781001|NCT00678392|456152906|FG001|Overall Study|Lost to Follow-up|13|||
126781002|NCT00678392|456152905|FG000|Overall Study|Objective Progression or Relapse|3|||
126604061|NCT00943917|455511424|FG002|Stage I|hyperglycemia|1|||
126604062|NCT00943917|455511425|FG003|Stage I|hyperglycemia|0|||
126604063|NCT00943917|455511426|FG004|Stage I|hyperglycemia|0|||
126604064|NCT00943917|455511427|FG005|Stage I|hyperglycemia|0|||
126604065|NCT00943917|455511428|FG006|Stage I|hyperglycemia|0|||
126604066|NCT00943917|455511429|FG007|Stage I|hyperglycemia|0|||
126604067|NCT00943917|455511430|FG008|Stage I|hyperglycemia|0|||
126604068|NCT00943917|455511431|FG009|Stage I|hyperglycemia|0|||
126604069|NCT00943917|455511432|FG010|Stage I|hyperglycemia|0|||
126604070|NCT00943917|455511433|FG011|Stage I|hyperglycemia|0|||
126604071|NCT00943917|455511434|FG012|Stage I|hyperglycemia|0|||
126604072|NCT00943917|455511435|FG013|Stage I|hyperglycemia|0|||
126604073|NCT00943917|455511436|FG014|Stage I|hyperglycemia|0|||
126604074|NCT00943917|455511422|FG000|Stage I|A1C elevation|1|||
126604075|NCT00943917|455511423|FG001|Stage I|A1C elevation|0|||
126604076|NCT00943917|455511424|FG002|Stage I|A1C elevation|0|||
126604077|NCT00943917|455511425|FG003|Stage I|A1C elevation|0|||
126604078|NCT00943917|455511426|FG004|Stage I|A1C elevation|0|||
126604079|NCT00943917|455511427|FG005|Stage I|A1C elevation|0|||
126604080|NCT00943917|455511428|FG006|Stage I|A1C elevation|0|||
126604081|NCT00943917|455511429|FG007|Stage I|A1C elevation|0|||
126604082|NCT00943917|455511430|FG008|Stage I|A1C elevation|0|||
126604083|NCT00943917|455511431|FG009|Stage I|A1C elevation|0|||
126604084|NCT00943917|455511432|FG010|Stage I|A1C elevation|0|||
126604085|NCT00943917|455511433|FG011|Stage I|A1C elevation|0|||
126604086|NCT00943917|455511434|FG012|Stage I|A1C elevation|0|||
126604087|NCT00943917|455511435|FG013|Stage I|A1C elevation|0|||
126604088|NCT00943917|455511436|FG014|Stage I|A1C elevation|0|||
126604089|NCT00943917|455511422|FG000|Stage I|Withdrawal by Subject|2|||
126604090|NCT00943917|455511423|FG001|Stage I|Withdrawal by Subject|1|||
126604091|NCT00943917|455511424|FG002|Stage I|Withdrawal by Subject|2|||
126604092|NCT00943917|455511425|FG003|Stage I|Withdrawal by Subject|0|||
126604093|NCT00943917|455511426|FG004|Stage I|Withdrawal by Subject|0|||
126604094|NCT00943917|455511427|FG005|Stage I|Withdrawal by Subject|0|||
126604095|NCT00943917|455511428|FG006|Stage I|Withdrawal by Subject|0|||
126604096|NCT00943917|455511429|FG007|Stage I|Withdrawal by Subject|0|||
126604097|NCT00943917|455511430|FG008|Stage I|Withdrawal by Subject|0|||
126604098|NCT00943917|455511431|FG009|Stage I|Withdrawal by Subject|0|||
126604099|NCT00943917|455511432|FG010|Stage I|Withdrawal by Subject|0|||
126604100|NCT00943917|455511433|FG011|Stage I|Withdrawal by Subject|0|||
126604101|NCT00943917|455511434|FG012|Stage I|Withdrawal by Subject|0|||
126604102|NCT00943917|455511435|FG013|Stage I|Withdrawal by Subject|0|||
126604103|NCT00943917|455511436|FG014|Stage I|Withdrawal by Subject|0|||
126604104|NCT00943917|455511422|FG000|Stage II|Adverse Event|0|||
126604105|NCT00943917|455511423|FG001|Stage II|Adverse Event|0|||
126604106|NCT00943917|455511424|FG002|Stage II|Adverse Event|0|||
126604107|NCT00943917|455511425|FG003|Stage II|Adverse Event|0|||
126604108|NCT00943917|455511426|FG004|Stage II|Adverse Event|0|||
126604109|NCT00943917|455511427|FG005|Stage II|Adverse Event|1|||
126604110|NCT00943917|455511428|FG006|Stage II|Adverse Event|3|||
126604111|NCT00943917|455511429|FG007|Stage II|Adverse Event|0|||
126604112|NCT00943917|455511430|FG008|Stage II|Adverse Event|1|||
126604113|NCT00943917|455511431|FG009|Stage II|Adverse Event|0|||
126604114|NCT00943917|455511432|FG010|Stage II|Adverse Event|0|||
126604115|NCT00943917|455511433|FG011|Stage II|Adverse Event|0|||
126604116|NCT00943917|455511434|FG012|Stage II|Adverse Event|0|||
126604117|NCT00943917|455511435|FG013|Stage II|Adverse Event|0|||
126604118|NCT00943917|455511436|FG014|Stage II|Adverse Event|0|||
126604119|NCT00943917|455511422|FG000|Stage II|Withdrawal by Subject|0|||
126604120|NCT00943917|455511423|FG001|Stage II|Withdrawal by Subject|0|||
126604121|NCT00943917|455511424|FG002|Stage II|Withdrawal by Subject|0|||
126604122|NCT00943917|455511425|FG003|Stage II|Withdrawal by Subject|0|||
126604123|NCT00943917|455511426|FG004|Stage II|Withdrawal by Subject|0|||
126604124|NCT00943917|455511427|FG005|Stage II|Withdrawal by Subject|1|||
126604125|NCT00943917|455511428|FG006|Stage II|Withdrawal by Subject|0|||
126604126|NCT00943917|455511429|FG007|Stage II|Withdrawal by Subject|0|||
126604127|NCT00943917|455511430|FG008|Stage II|Withdrawal by Subject|0|||
126604128|NCT00943917|455511431|FG009|Stage II|Withdrawal by Subject|0|||
126604129|NCT00943917|455511432|FG010|Stage II|Withdrawal by Subject|0|||
126604130|NCT00943917|455511433|FG011|Stage II|Withdrawal by Subject|0|||
126604131|NCT00943917|455511434|FG012|Stage II|Withdrawal by Subject|0|||
126604132|NCT00943917|455511435|FG013|Stage II|Withdrawal by Subject|0|||
126604133|NCT00943917|455511436|FG014|Stage II|Withdrawal by Subject|0|||
126604134|NCT00943917|455511422|FG000|Stage II|Pregnancy|0|||
126604135|NCT00943917|455511423|FG001|Stage II|Pregnancy|0|||
126604136|NCT00943917|455511424|FG002|Stage II|Pregnancy|0|||
126604137|NCT00943917|455511425|FG003|Stage II|Pregnancy|0|||
126604138|NCT00943917|455511426|FG004|Stage II|Pregnancy|0|||
126604139|NCT00943917|455511427|FG005|Stage II|Pregnancy|1|||
126604140|NCT00943917|455511428|FG006|Stage II|Pregnancy|0|||
126604141|NCT00943917|455511429|FG007|Stage II|Pregnancy|0|||
126604142|NCT00943917|455511430|FG008|Stage II|Pregnancy|0|||
126604143|NCT00943917|455511431|FG009|Stage II|Pregnancy|0|||
126604144|NCT00943917|455511432|FG010|Stage II|Pregnancy|0|||
126604145|NCT00943917|455511433|FG011|Stage II|Pregnancy|0|||
126604146|NCT00943917|455511434|FG012|Stage II|Pregnancy|0|||
126604147|NCT00943917|455511435|FG013|Stage II|Pregnancy|0|||
126604148|NCT00943917|455511436|FG014|Stage II|Pregnancy|0|||
126604149|NCT00943917|455511422|FG000|Stage II Continuation|Adverse Event|0|||
126604150|NCT00943917|455511423|FG001|Stage II Continuation|Adverse Event|0|||
126604151|NCT00943917|455511424|FG002|Stage II Continuation|Adverse Event|0|||
126604152|NCT00943917|455511425|FG003|Stage II Continuation|Adverse Event|0|||
126604153|NCT00943917|455511426|FG004|Stage II Continuation|Adverse Event|0|||
126604154|NCT00943917|455511427|FG005|Stage II Continuation|Adverse Event|0|||
126604155|NCT00943917|455511428|FG006|Stage II Continuation|Adverse Event|0|||
126604156|NCT00943917|455511429|FG007|Stage II Continuation|Adverse Event|0|||
126604157|NCT00943917|455511430|FG008|Stage II Continuation|Adverse Event|0|||
126604158|NCT00943917|455511431|FG009|Stage II Continuation|Adverse Event|0|||
126604159|NCT00943917|455511432|FG010|Stage II Continuation|Adverse Event|0|||
126604160|NCT00943917|455511433|FG011|Stage II Continuation|Adverse Event|1|||
126604161|NCT00943917|455511434|FG012|Stage II Continuation|Adverse Event|2|||
126604162|NCT00943917|455511435|FG013|Stage II Continuation|Adverse Event|1|||
126604163|NCT00943917|455511436|FG014|Stage II Continuation|Adverse Event|1|||
126604164|NCT00943917|455511422|FG000|Stage II Continuation|Withdrawal by Subject|0|||
126604165|NCT00943917|455511423|FG001|Stage II Continuation|Withdrawal by Subject|0|||
126604166|NCT00943917|455511424|FG002|Stage II Continuation|Withdrawal by Subject|0|||
126604167|NCT00943917|455511425|FG003|Stage II Continuation|Withdrawal by Subject|0|||
126604168|NCT00943917|455511426|FG004|Stage II Continuation|Withdrawal by Subject|0|||
126604169|NCT00943917|455511427|FG005|Stage II Continuation|Withdrawal by Subject|0|||
126604170|NCT00943917|455511428|FG006|Stage II Continuation|Withdrawal by Subject|0|||
126604171|NCT00943917|455511429|FG007|Stage II Continuation|Withdrawal by Subject|0|||
126604172|NCT00943917|455511430|FG008|Stage II Continuation|Withdrawal by Subject|0|||
126604173|NCT00943917|455511431|FG009|Stage II Continuation|Withdrawal by Subject|0|||
126604174|NCT00943917|455511432|FG010|Stage II Continuation|Withdrawal by Subject|0|||
126604175|NCT00943917|455511433|FG011|Stage II Continuation|Withdrawal by Subject|0|||
126604176|NCT00943917|455511434|FG012|Stage II Continuation|Withdrawal by Subject|0|||
126604177|NCT00943917|455511435|FG013|Stage II Continuation|Withdrawal by Subject|1|||
126604178|NCT00943917|455511436|FG014|Stage II Continuation|Withdrawal by Subject|3|||
126604179|NCT00943917|455511422|FG000|Stage II Continuation|Protocol Violation|0|||
126604180|NCT00943917|455511423|FG001|Stage II Continuation|Protocol Violation|0|||
126604181|NCT00943917|455511424|FG002|Stage II Continuation|Protocol Violation|0|||
126604182|NCT00943917|455511425|FG003|Stage II Continuation|Protocol Violation|0|||
126604183|NCT00943917|455511426|FG004|Stage II Continuation|Protocol Violation|0|||
126604184|NCT00943917|455511427|FG005|Stage II Continuation|Protocol Violation|0|||
126604185|NCT00943917|455511428|FG006|Stage II Continuation|Protocol Violation|0|||
126604186|NCT00943917|455511429|FG007|Stage II Continuation|Protocol Violation|0|||
126604187|NCT00943917|455511430|FG008|Stage II Continuation|Protocol Violation|0|||
126604188|NCT00943917|455511431|FG009|Stage II Continuation|Protocol Violation|1|||
126604189|NCT00943917|455511432|FG010|Stage II Continuation|Protocol Violation|0|||
126604190|NCT00943917|455511433|FG011|Stage II Continuation|Protocol Violation|1|||
126604191|NCT00943917|455511434|FG012|Stage II Continuation|Protocol Violation|0|||
126604192|NCT00943917|455511435|FG013|Stage II Continuation|Protocol Violation|0|||
126604193|NCT00943917|455511436|FG014|Stage II Continuation|Protocol Violation|0|||
126604194|NCT00943917|455511422|FG000|Stage II Continuation|hypoglycemia|0|||
126604195|NCT00943917|455511423|FG001|Stage II Continuation|hypoglycemia|0|||
126604196|NCT00943917|455511424|FG002|Stage II Continuation|hypoglycemia|0|||
126604197|NCT00943917|455511425|FG003|Stage II Continuation|hypoglycemia|0|||
126604198|NCT00943917|455511426|FG004|Stage II Continuation|hypoglycemia|0|||
126604199|NCT00943917|455511427|FG005|Stage II Continuation|hypoglycemia|0|||
126604200|NCT00943917|455511428|FG006|Stage II Continuation|hypoglycemia|0|||
126604201|NCT00943917|455511429|FG007|Stage II Continuation|hypoglycemia|0|||
126604202|NCT00943917|455511430|FG008|Stage II Continuation|hypoglycemia|0|||
126604203|NCT00943917|455511431|FG009|Stage II Continuation|hypoglycemia|0|||
126604204|NCT00943917|455511432|FG010|Stage II Continuation|hypoglycemia|0|||
126604205|NCT00943917|455511433|FG011|Stage II Continuation|hypoglycemia|0|||
126604206|NCT00943917|455511434|FG012|Stage II Continuation|hypoglycemia|1|||
126604207|NCT00943917|455511435|FG013|Stage II Continuation|hypoglycemia|0|||
126604208|NCT00943917|455511436|FG014|Stage II Continuation|hypoglycemia|0|||
126604209|NCT00943917|455511422|FG000|Stage II Continuation|A1C elevation|0|||
126604210|NCT00943917|455511423|FG001|Stage II Continuation|A1C elevation|0|||
126604211|NCT00943917|455511424|FG002|Stage II Continuation|A1C elevation|0|||
126604212|NCT00943917|455511425|FG003|Stage II Continuation|A1C elevation|0|||
126604213|NCT00943917|455511426|FG004|Stage II Continuation|A1C elevation|0|||
126604214|NCT00943917|455511427|FG005|Stage II Continuation|A1C elevation|0|||
126604215|NCT00943917|455511428|FG006|Stage II Continuation|A1C elevation|0|||
126604216|NCT00943917|455511429|FG007|Stage II Continuation|A1C elevation|0|||
126604217|NCT00943917|455511430|FG008|Stage II Continuation|A1C elevation|0|||
126604218|NCT00943917|455511431|FG009|Stage II Continuation|A1C elevation|0|||
126604219|NCT00943917|455511432|FG010|Stage II Continuation|A1C elevation|0|||
126604220|NCT00943917|455511433|FG011|Stage II Continuation|A1C elevation|0|||
126604221|NCT00943917|455511434|FG012|Stage II Continuation|A1C elevation|0|||
126604222|NCT00943917|455511435|FG013|Stage II Continuation|A1C elevation|1|||
126604223|NCT00943917|455511436|FG014|Stage II Continuation|A1C elevation|0|||
126604224|NCT01171976|455511437|FG000|Overall Study|Protocol Violation|0|||
126604225|NCT01171976|455511438|FG001|Overall Study|Protocol Violation|0|||
126604226|NCT01171976|455511439|FG002|Overall Study|Protocol Violation|1|||
126604227|NCT01171976|455511437|FG000|Overall Study|Death|2|||
126604228|NCT01171976|455511438|FG001|Overall Study|Death|4|||
126604229|NCT01171976|455511439|FG002|Overall Study|Death|1|||
126604230|NCT01171976|455511437|FG000|Overall Study|Lost to Follow-up|4|||
126604231|NCT01171976|455511438|FG001|Overall Study|Lost to Follow-up|0|||
126604232|NCT01171976|455511439|FG002|Overall Study|Lost to Follow-up|2|||
126604233|NCT01171976|455511437|FG000|Overall Study|Withdrawal by Subject|1|||
126604234|NCT01171976|455511438|FG001|Overall Study|Withdrawal by Subject|5|||
126604235|NCT01171976|455511439|FG002|Overall Study|Withdrawal by Subject|6|||
126604236|NCT01171976|455511437|FG000|Overall Study|Abnormal test result|1|||
126604237|NCT01171976|455511438|FG001|Overall Study|Abnormal test result|0|||
126604238|NCT01171976|455511439|FG002|Overall Study|Abnormal test result|0|||
126604239|NCT01171976|455511437|FG000|Overall Study|Adverse Event|6|||
126604240|NCT01171976|455511438|FG001|Overall Study|Adverse Event|2|||
126604241|NCT01171976|455511439|FG002|Overall Study|Adverse Event|5|||
126604242|NCT02844439|455511440|FG000|Overall Study|Withdrawal by Subject|1|||
126604243|NCT02844439|455511440|FG000|Overall Study|Lost to Follow-up|2|||
126604244|NCT02844439|455511440|FG000|Overall Study|Termination by Sponsor|4|||
126604245|NCT02844439|455511440|FG000|Overall Study|Death|28|||
126604246|NCT02844439|455511440|FG000|Overall Study|Other|5|||
126604247|NCT03170648|455511445|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
126604248|NCT03170648|455511445|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
126604249|NCT03509909|455511446|FG000|Overall Study|Withdrawal by Subject|16|||
126604250|NCT03509909|455511447|FG001|Overall Study|Withdrawal by Subject|9|||
126604251|NCT03509909|455511446|FG000|Overall Study|Lost to Follow-up|3|||
126604252|NCT03509909|455511447|FG001|Overall Study|Lost to Follow-up|4|||
126604253|NCT03509909|455511446|FG000|Overall Study|Adverse Event|2|||
126604254|NCT03509909|455511447|FG001|Overall Study|Adverse Event|0|||
126604255|NCT03500549|455511448|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
126604256|NCT03500549|455511449|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
126604257|NCT03500549|455511448|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
126604258|NCT03500549|455511449|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
126604259|NCT02107261|455511450|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
126604260|NCT02107261|455511451|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
126604261|NCT02107261|455511450|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
126604262|NCT02107261|455511451|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
126604263|NCT04337931|455511452|FG000|Overall Study|Death|4|||
126604264|NCT04337931|455511453|FG001|Overall Study|Death|1|||
126604265|NCT04337931|455511454|FG002|Overall Study|Death|7|||
126604266|NCT04337931|455511452|FG000|Overall Study|Withdrawal by Subject|0|||
126604267|NCT04337931|455511453|FG001|Overall Study|Withdrawal by Subject|1|||
126604268|NCT04337931|455511454|FG002|Overall Study|Withdrawal by Subject|0|||
126604269|NCT04337931|455511452|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
126604270|NCT04337931|455511453|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
126604271|NCT04337931|455511454|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
126604272|NCT04337931|455511452|FG000|Overall Study|Study terminated by sponsor|3|||
126604273|NCT04337931|455511453|FG001|Overall Study|Study terminated by sponsor|6|||
126604274|NCT04337931|455511454|FG002|Overall Study|Study terminated by sponsor|2|||
126604275|NCT04337931|455511452|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
126604276|NCT04337931|455511453|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
126604277|NCT04337931|455511454|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
126604278|NCT04337931|455511452|FG000|Overall Study|Colorectal cancer treatment|1|||
126604279|NCT04337931|455511453|FG001|Overall Study|Colorectal cancer treatment|0|||
126604280|NCT04337931|455511454|FG002|Overall Study|Colorectal cancer treatment|0|||
126604281|NCT04337931|455511452|FG000|Overall Study|Participant decision|0|||
126604282|NCT04337931|455511453|FG001|Overall Study|Participant decision|1|||
126604283|NCT04337931|455511454|FG002|Overall Study|Participant decision|0|||
126604284|NCT04436289|455511456|FG000|Overall Study|Death prior to hospital discharge|8|||
126604285|NCT04436289|455511457|FG001|Overall Study|Death prior to hospital discharge|5|||
126604286|NCT04436289|455511458|FG002|Overall Study|Death prior to hospital discharge|0|||
126604287|NCT04436289|455511459|FG003|Overall Study|Death prior to hospital discharge|1|||
126604288|NCT04436289|455511456|FG000|Overall Study|Withdrawal by Subject|0|||
126604289|NCT04436289|455511457|FG001|Overall Study|Withdrawal by Subject|1|||
126604290|NCT04436289|455511458|FG002|Overall Study|Withdrawal by Subject|4|||
126604291|NCT04436289|455511459|FG003|Overall Study|Withdrawal by Subject|0|||
126604292|NCT04436289|455511456|FG000|Overall Study|Extended hospital stay|0|||
126604293|NCT04436289|455511457|FG001|Overall Study|Extended hospital stay|1|||
126604294|NCT04436289|455511458|FG002|Overall Study|Extended hospital stay|0|||
126604295|NCT04436289|455511459|FG003|Overall Study|Extended hospital stay|0|||
126604296|NCT04436289|455511456|FG000|Overall Study|Lost to Follow-up|0|||
126604297|NCT04436289|455511457|FG001|Overall Study|Lost to Follow-up|4|||
126604298|NCT04436289|455511458|FG002|Overall Study|Lost to Follow-up|1|||
126604299|NCT04436289|455511459|FG003|Overall Study|Lost to Follow-up|3|||
126604300|NCT03357952|455511462|FG000|Overall Study|Withdrawal by Subject|0|||
126604301|NCT03357952|455511463|FG001|Overall Study|Withdrawal by Subject|1|||
126604302|NCT03357952|455511462|FG000|Overall Study|Sponsor Decision|9|||
126604303|NCT03357952|455511463|FG001|Overall Study|Sponsor Decision|0|||
126604304|NCT01371994|455511464|FG000|Overall Study|Adverse Event|3|||
126604305|NCT01371994|455511465|FG001|Overall Study|Adverse Event|6|||
126604306|NCT01371994|455511464|FG000|Overall Study|Lack of Efficacy|3|||
126604307|NCT01371994|455511465|FG001|Overall Study|Lack of Efficacy|0|||
126604308|NCT01371994|455511464|FG000|Overall Study|Withdrawal by Subject|13|||
126604309|NCT01371994|455511465|FG001|Overall Study|Withdrawal by Subject|7|||
126604310|NCT01371994|455511464|FG000|Overall Study|Lost to Follow-up|1|||
126604311|NCT01371994|455511465|FG001|Overall Study|Lost to Follow-up|1|||
126604312|NCT01371994|455511464|FG000|Overall Study|Protocol Violation|24|||
126733701|NCT02966353|455973936|FG000|Overall Study|Protocol deviation|2|||
126733702|NCT00093470|455973939|FG000|Overall Study|Disease progression|39|||
126733703|NCT00093470|455973940|FG001|Overall Study|Disease progression|0|||
126604313|NCT01371994|455511465|FG001|Overall Study|Protocol Violation|17|||
126604314|NCT01371994|455511464|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
126604315|NCT01371994|455511465|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
126604316|NCT01371994|455511464|FG000|Overall Study|Physician Decision|1|||
126604317|NCT01371994|455511465|FG001|Overall Study|Physician Decision|1|||
126604318|NCT01371994|455511464|FG000|Overall Study|Miscellaneous Reasons|6|||
126604319|NCT01371994|455511465|FG001|Overall Study|Miscellaneous Reasons|4|||
126604320|NCT05139992|455511468|FG000|Overall Study|Withdrawal by Subject|12|||
126604321|NCT05139992|455511468|FG000|Overall Study|Lost to Follow-up|6|||
126604322|NCT01208974|455511469|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
126604323|NCT01208974|455511470|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
126604324|NCT01208974|455511471|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
126604325|NCT01208974|455511472|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
126604326|NCT01208974|455511469|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
126604327|NCT01208974|455511470|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
126604328|NCT01208974|455511471|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
126604329|NCT01208974|455511472|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
126604330|NCT01208974|455511469|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
126604331|NCT01208974|455511470|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
126604332|NCT01208974|455511471|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
126604333|NCT01208974|455511472|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
126604334|NCT05521516|455511473|FG000|Overall Study|Withdrawal by Subject|1|||
126604335|NCT05521516|455511474|FG001|Overall Study|Withdrawal by Subject|1|||
126604336|NCT03777657|455511475|FG000|Overall Study|Death|397|||
126604337|NCT03777657|455511476|FG001|Overall Study|Death|431|||
126604338|NCT03777657|455511475|FG000|Overall Study|Study Closed by Sponsor|77|||
126604339|NCT03777657|455511476|FG001|Overall Study|Study Closed by Sponsor|38|||
126604340|NCT03777657|455511475|FG000|Overall Study|Withdrawal by Subject|20|||
126604341|NCT03777657|455511476|FG001|Overall Study|Withdrawal by Subject|17|||
126604342|NCT03777657|455511475|FG000|Overall Study|Lost to Follow-up|6|||
126604343|NCT03777657|455511476|FG001|Overall Study|Lost to Follow-up|10|||
126604344|NCT05464732|455511477|FG000|Overall Study|Lost to Follow-up|0|||
126604345|NCT05464732|455511478|FG001|Overall Study|Lost to Follow-up|1|||
126604346|NCT05464732|455511477|FG000|Overall Study|Adverse Event|1|||
126604347|NCT05464732|455511478|FG001|Overall Study|Adverse Event|0|||
126604348|NCT04153890|455511479|FG000|Overall Study|Lost to Follow-up|9|||
126604349|NCT04153890|455511480|FG001|Overall Study|Lost to Follow-up|0|||
126604350|NCT04153890|455511481|FG002|Overall Study|Lost to Follow-up|9|||
126604351|NCT04153890|455511482|FG003|Overall Study|Lost to Follow-up|0|||
126604352|NCT04153890|455511479|FG000|Overall Study|Death|0|||
126604353|NCT04153890|455511480|FG001|Overall Study|Death|2|||
126604354|NCT04153890|455511481|FG002|Overall Study|Death|0|||
126604355|NCT04153890|455511482|FG003|Overall Study|Death|0|||
126604356|NCT04153890|455511479|FG000|Overall Study|Withdrawal by Subject|0|||
126604357|NCT04153890|455511480|FG001|Overall Study|Withdrawal by Subject|0|||
126604358|NCT04153890|455511481|FG002|Overall Study|Withdrawal by Subject|0|||
126604359|NCT04153890|455511482|FG003|Overall Study|Withdrawal by Subject|2|||
126604360|NCT05786612|455511483|FG000|Overall Study|Adverse Event|1|||
126604361|NCT05786612|455511484|FG001|Overall Study|Adverse Event|2|||
126604362|NCT05786612|455511483|FG000|Overall Study|one screening failure|0|||
126604363|NCT05786612|455511484|FG001|Overall Study|one screening failure|2|||
126604364|NCT04926740|455511485|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
126604365|NCT04926740|455511486|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
126604366|NCT04926740|455511485|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
126604367|NCT04926740|455511486|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
126781003|NCT00678392|456152906|FG001|Overall Study|Objective Progression or Relapse|8|||
126781004|NCT00678392|456152905|FG000|Overall Study|Sponsor's Decision|1|||
126781005|NCT00678392|456152906|FG001|Overall Study|Sponsor's Decision|2|||
126781006|NCT00678392|456152905|FG000|Overall Study|Withdrawal by Subject|4|||
126781007|NCT00678392|456152906|FG001|Overall Study|Withdrawal by Subject|4|||
126781008|NCT00678392|456152905|FG000|Overall Study|Randomized But Not Treated|2|||
126781009|NCT00678392|456152906|FG001|Overall Study|Randomized But Not Treated|7|||
126781010|NCT00678392|456152905|FG000|Overall Study|Other|56|||
126781011|NCT00678392|456152906|FG001|Overall Study|Other|53|||
126781012|NCT03341507|456152908|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
126604368|NCT00655499|455512386|FG000|Overall Study|not eligible|4|||
126604369|NCT00146172|455512387|FG000|Overall Study|Adverse Event|0|||
126604370|NCT00146172|455512388|FG001|Overall Study|Adverse Event|0|||
126604371|NCT00146172|455512389|FG002|Overall Study|Adverse Event|1|||
126604372|NCT00146172|455512390|FG003|Overall Study|Adverse Event|1|||
126604373|NCT00146172|455512391|FG004|Overall Study|Adverse Event|0|||
126604374|NCT00146172|455512392|FG005|Overall Study|Adverse Event|2|||
126604375|NCT00146172|455512393|FG006|Overall Study|Adverse Event|3|||
126604376|NCT00146172|455512394|FG007|Overall Study|Adverse Event|10|||
126604377|NCT00146172|455512387|FG000|Overall Study|Lost to Follow-up|0|||
126604378|NCT00146172|455512388|FG001|Overall Study|Lost to Follow-up|0|||
126604379|NCT00146172|455512389|FG002|Overall Study|Lost to Follow-up|0|||
126604380|NCT00146172|455512390|FG003|Overall Study|Lost to Follow-up|0|||
126604381|NCT00146172|455512391|FG004|Overall Study|Lost to Follow-up|0|||
126604382|NCT00146172|455512392|FG005|Overall Study|Lost to Follow-up|0|||
126604383|NCT00146172|455512393|FG006|Overall Study|Lost to Follow-up|0|||
126604384|NCT00146172|455512394|FG007|Overall Study|Lost to Follow-up|1|||
126604385|NCT00146172|455512387|FG000|Overall Study|Disease Progression|2|||
126604386|NCT00146172|455512388|FG001|Overall Study|Disease Progression|4|||
126604387|NCT00146172|455512389|FG002|Overall Study|Disease Progression|2|||
126604388|NCT00146172|455512390|FG003|Overall Study|Disease Progression|5|||
126604389|NCT00146172|455512391|FG004|Overall Study|Disease Progression|2|||
126604390|NCT00146172|455512392|FG005|Overall Study|Disease Progression|2|||
126604391|NCT00146172|455512393|FG006|Overall Study|Disease Progression|1|||
126604392|NCT00146172|455512394|FG007|Overall Study|Disease Progression|22|||
126604393|NCT00146172|455512387|FG000|Overall Study|Death|0|||
126604394|NCT00146172|455512388|FG001|Overall Study|Death|0|||
126604395|NCT00146172|455512389|FG002|Overall Study|Death|0|||
126604396|NCT00146172|455512390|FG003|Overall Study|Death|0|||
126604397|NCT00146172|455512391|FG004|Overall Study|Death|0|||
126604398|NCT00146172|455512392|FG005|Overall Study|Death|0|||
126604399|NCT00146172|455512393|FG006|Overall Study|Death|1|||
126604400|NCT00146172|455512394|FG007|Overall Study|Death|0|||
126604401|NCT00146172|455512387|FG000|Overall Study|Physician Decision|0|||
126604402|NCT00146172|455512388|FG001|Overall Study|Physician Decision|0|||
126604403|NCT00146172|455512389|FG002|Overall Study|Physician Decision|0|||
126604404|NCT00146172|455512390|FG003|Overall Study|Physician Decision|0|||
126604405|NCT00146172|455512391|FG004|Overall Study|Physician Decision|0|||
126604406|NCT00146172|455512392|FG005|Overall Study|Physician Decision|0|||
126604407|NCT00146172|455512393|FG006|Overall Study|Physician Decision|0|||
126604408|NCT00146172|455512394|FG007|Overall Study|Physician Decision|1|||
126604409|NCT00146172|455512387|FG000|Overall Study|Withdrawal by Subject|0|||
126604410|NCT00146172|455512388|FG001|Overall Study|Withdrawal by Subject|0|||
126604411|NCT00146172|455512389|FG002|Overall Study|Withdrawal by Subject|0|||
126604412|NCT00146172|455512390|FG003|Overall Study|Withdrawal by Subject|0|||
126604413|NCT00146172|455512391|FG004|Overall Study|Withdrawal by Subject|0|||
126604414|NCT00146172|455512392|FG005|Overall Study|Withdrawal by Subject|1|||
126604415|NCT00146172|455512393|FG006|Overall Study|Withdrawal by Subject|1|||
126604416|NCT00146172|455512394|FG007|Overall Study|Withdrawal by Subject|4|||
126604417|NCT00146172|455512387|FG000|Overall Study|Symptomatic Deterioration|1|||
126604418|NCT00146172|455512388|FG001|Overall Study|Symptomatic Deterioration|0|||
126604419|NCT00146172|455512389|FG002|Overall Study|Symptomatic Deterioration|1|||
126604420|NCT00146172|455512390|FG003|Overall Study|Symptomatic Deterioration|0|||
126604421|NCT00146172|455512391|FG004|Overall Study|Symptomatic Deterioration|1|||
126604422|NCT00146172|455512392|FG005|Overall Study|Symptomatic Deterioration|2|||
126604423|NCT00146172|455512393|FG006|Overall Study|Symptomatic Deterioration|0|||
126604424|NCT00146172|455512394|FG007|Overall Study|Symptomatic Deterioration|2|||
126604425|NCT03876457|455512397|FG000|Overall Study|Lost to Follow-up|1|||
126604426|NCT03876457|455512398|FG001|Overall Study|Lost to Follow-up|3|||
126604427|NCT01184326|455512399|FG000|Overall Study|Adverse Event|1|||
126604428|NCT01184326|455512400|FG001|Overall Study|Adverse Event|2|||
126604429|NCT01184326|455512401|FG002|Overall Study|Adverse Event|0|||
126604430|NCT01184326|455512399|FG000|Overall Study|Death|0|||
126604431|NCT01184326|455512400|FG001|Overall Study|Death|0|||
126604432|NCT01184326|455512401|FG002|Overall Study|Death|1|||
126781013|NCT00770991|456152911|FG000|Overall Study|Physician Decision|2|||
126604433|NCT01184326|455512399|FG000|Overall Study|Withdrawal by Subject|0|||
126604434|NCT01184326|455512400|FG001|Overall Study|Withdrawal by Subject|0|||
126604435|NCT01184326|455512401|FG002|Overall Study|Withdrawal by Subject|1|||
126604436|NCT01184326|455512399|FG000|Overall Study|Physician Decision|1|||
126604437|NCT01184326|455512400|FG001|Overall Study|Physician Decision|1|||
126604438|NCT01184326|455512401|FG002|Overall Study|Physician Decision|0|||
126604439|NCT01184326|455512399|FG000|Overall Study|Disease Progression|1|||
126604440|NCT01184326|455512400|FG001|Overall Study|Disease Progression|3|||
126604441|NCT01184326|455512401|FG002|Overall Study|Disease Progression|12|||
126604442|NCT01036724|455512402|FG000|Overall Study|Adverse Event|1|||
126604443|NCT01036724|455512403|FG001|Overall Study|Adverse Event|2|||
126604444|NCT01036724|455512402|FG000|Overall Study|Lack of Efficacy|1|||
126604445|NCT01036724|455512403|FG001|Overall Study|Lack of Efficacy|1|||
126604446|NCT01036724|455512402|FG000|Overall Study|Protocol Violation|4|||
126781014|NCT00770991|456152912|FG001|Overall Study|Physician Decision|0|||
126781015|NCT00770991|456152911|FG000|Overall Study|Withdrawal by Subject|1|||
126781016|NCT00770991|456152912|FG001|Overall Study|Withdrawal by Subject|0|||
126781017|NCT00770991|456152911|FG000|Overall Study|Adverse Event|1|||
126781018|NCT00770991|456152912|FG001|Overall Study|Adverse Event|5|||
126781019|NCT00770991|456152911|FG000|Overall Study|Pregnancy|1|||
126781020|NCT00770991|456152912|FG001|Overall Study|Pregnancy|0|||
126781021|NCT03465891|456152913|FG000|Overall Study|Withdrawal by Subject|0|||
126604447|NCT01036724|455512403|FG001|Overall Study|Protocol Violation|5|||
126604448|NCT00557492|455512411|FG000|Overall Study|Change in health insurance|1|||
126604449|NCT04213807|455512412|FG000|Overall Study|Physician Decision|0|||
126604450|NCT04213807|455512413|FG001|Overall Study|Physician Decision|0|||
126604451|NCT04213807|455512414|FG002|Overall Study|Physician Decision|1|||
126604452|NCT01574716|455512415|FG000|Part 1|Death|3|||
126604453|NCT01574716|455512416|FG001|Part 1|Death|1|||
126604454|NCT01574716|455512417|FG002|Part 1|Death|8|||
126604455|NCT01574716|455512418|FG003|Part 1|Death|0|||
126604456|NCT01574716|455512419|FG004|Part 1|Death|0|||
126604457|NCT01574716|455512415|FG000|Part 1|Discontinuation of study by sponsor|0|||
126604458|NCT01574716|455512416|FG001|Part 1|Discontinuation of study by sponsor|0|||
126604459|NCT01574716|455512417|FG002|Part 1|Discontinuation of study by sponsor|1|||
126604460|NCT01574716|455512418|FG003|Part 1|Discontinuation of study by sponsor|0|||
126604461|NCT01574716|455512419|FG004|Part 1|Discontinuation of study by sponsor|0|||
126604462|NCT01574716|455512415|FG000|Part 1|Withdrawal by Subject|0|||
126604463|NCT01574716|455512416|FG001|Part 1|Withdrawal by Subject|2|||
126604464|NCT01574716|455512417|FG002|Part 1|Withdrawal by Subject|0|||
126604465|NCT01574716|455512418|FG003|Part 1|Withdrawal by Subject|0|||
126604466|NCT01574716|455512419|FG004|Part 1|Withdrawal by Subject|0|||
126604467|NCT01574716|455512415|FG000|Part 1|Lost to Follow-up|0|||
126604468|NCT01574716|455512416|FG001|Part 1|Lost to Follow-up|1|||
126604469|NCT01574716|455512417|FG002|Part 1|Lost to Follow-up|0|||
126604470|NCT01574716|455512418|FG003|Part 1|Lost to Follow-up|0|||
126604471|NCT01574716|455512419|FG004|Part 1|Lost to Follow-up|0|||
126604472|NCT01574716|455512415|FG000|Part 2|Progressive disease|0|||
126604473|NCT01574716|455512416|FG001|Part 2|Progressive disease|0|||
126604474|NCT01574716|455512417|FG002|Part 2|Progressive disease|0|||
126604475|NCT01574716|455512418|FG003|Part 2|Progressive disease|1|||
126604476|NCT01574716|455512419|FG004|Part 2|Progressive disease|0|||
126604477|NCT01574716|455512415|FG000|Part 2|Death|0|||
126604478|NCT01574716|455512416|FG001|Part 2|Death|0|||
126604479|NCT01574716|455512417|FG002|Part 2|Death|0|||
126604480|NCT01574716|455512418|FG003|Part 2|Death|76|||
126604481|NCT01574716|455512419|FG004|Part 2|Death|35|||
126604482|NCT01574716|455512415|FG000|Part 2|Discontinuation of study by sponsor|0|||
126604483|NCT01574716|455512416|FG001|Part 2|Discontinuation of study by sponsor|0|||
126604484|NCT01574716|455512417|FG002|Part 2|Discontinuation of study by sponsor|0|||
126604485|NCT01574716|455512418|FG003|Part 2|Discontinuation of study by sponsor|51|||
126604486|NCT01574716|455512419|FG004|Part 2|Discontinuation of study by sponsor|31|||
126604487|NCT01574716|455512415|FG000|Part 2|Withdrawal by Subject|0|||
126604488|NCT01574716|455512416|FG001|Part 2|Withdrawal by Subject|0|||
126604489|NCT01574716|455512417|FG002|Part 2|Withdrawal by Subject|0|||
126604490|NCT01574716|455512418|FG003|Part 2|Withdrawal by Subject|5|||
126604491|NCT01574716|455512419|FG004|Part 2|Withdrawal by Subject|4|||
126604492|NCT01574716|455512415|FG000|Part 2|Brain metastases|0|||
126604493|NCT01574716|455512416|FG001|Part 2|Brain metastases|0|||
126604494|NCT01574716|455512417|FG002|Part 2|Brain metastases|0|||
126604495|NCT01574716|455512418|FG003|Part 2|Brain metastases|1|||
126604496|NCT01574716|455512419|FG004|Part 2|Brain metastases|0|||
126604497|NCT01574716|455512415|FG000|Part 2|Lost to Follow-up|0|||
126604498|NCT01574716|455512416|FG001|Part 2|Lost to Follow-up|0|||
126604499|NCT01574716|455512417|FG002|Part 2|Lost to Follow-up|0|||
126604500|NCT01574716|455512418|FG003|Part 2|Lost to Follow-up|3|||
126604501|NCT01574716|455512419|FG004|Part 2|Lost to Follow-up|0|||
126604502|NCT02438137|455512420|FG000|Overall Study|Lost to Follow-up|3|||
126781022|NCT03465891|456152914|FG001|Overall Study|Withdrawal by Subject|1|||
126604503|NCT02438137|455512421|FG001|Overall Study|Lost to Follow-up|2|||
126604504|NCT02438137|455512420|FG000|Overall Study|Adverse Event|1|||
126604505|NCT02438137|455512421|FG001|Overall Study|Adverse Event|0|||
126604506|NCT02438137|455512420|FG000|Overall Study|Withdrawal by Subject|4|||
126604507|NCT02438137|455512421|FG001|Overall Study|Withdrawal by Subject|3|||
126604508|NCT02438137|455512420|FG000|Overall Study|Physician Decision|0|||
126604509|NCT02438137|455512421|FG001|Overall Study|Physician Decision|1|||
126604510|NCT01637402|455512423|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
126604511|NCT01637402|455512424|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
126604512|NCT01637402|455512423|FG000|Standard Dose Regimen|Adverse Event|1|||
126604513|NCT01637402|455512424|FG001|Standard Dose Regimen|Adverse Event|0|||
126604514|NCT01637402|455512423|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
126604515|NCT01637402|455512424|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
126604516|NCT01637402|455512423|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
126604517|NCT01637402|455512424|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
126604518|NCT01637402|455512423|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
126604519|NCT01637402|455512424|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
126604520|NCT01637402|455512423|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
126604521|NCT01637402|455512424|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
126604522|NCT02285270|455512425|FG000|Overall Study|Lost to Follow-up|1|||
126604523|NCT02285270|455512425|FG000|Overall Study|Physician Decision|3|||
126604524|NCT02285270|455512425|FG000|Overall Study|Determined to be ineligible|1|||
126604525|NCT02111096|455512426|FG000|Overall Study|Adverse Event|4|||
126604526|NCT02111096|455512427|FG001|Overall Study|Adverse Event|1|||
126604527|NCT02111096|455512428|FG002|Overall Study|Adverse Event|2|||
126604528|NCT02111096|455512426|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126604529|NCT02111096|455512427|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126604530|NCT02111096|455512428|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126604531|NCT02111096|455512426|FG000|Overall Study|Lost to Follow Up|1|||
126604532|NCT02111096|455512427|FG001|Overall Study|Lost to Follow Up|1|||
126604533|NCT02111096|455512428|FG002|Overall Study|Lost to Follow Up|1|||
126604534|NCT02111096|455512426|FG000|Overall Study|Physician Decision|0|||
126604535|NCT02111096|455512427|FG001|Overall Study|Physician Decision|1|||
126604536|NCT02111096|455512428|FG002|Overall Study|Physician Decision|0|||
126604537|NCT02111096|455512426|FG000|Overall Study|Protocol Violation|1|||
126604538|NCT02111096|455512427|FG001|Overall Study|Protocol Violation|0|||
126604539|NCT02111096|455512428|FG002|Overall Study|Protocol Violation|1|||
126604540|NCT02111096|455512426|FG000|Overall Study|Terminated by Sponsor|53|||
126604541|NCT02111096|455512427|FG001|Overall Study|Terminated by Sponsor|35|||
126604542|NCT02111096|455512428|FG002|Overall Study|Terminated by Sponsor|54|||
126604543|NCT02111096|455512426|FG000|Overall Study|Withdrawal by Subject|4|||
126604544|NCT02111096|455512427|FG001|Overall Study|Withdrawal by Subject|2|||
126604545|NCT02111096|455512428|FG002|Overall Study|Withdrawal by Subject|8|||
126604546|NCT03709706|455512429|FG000|Overall Study|Adverse Event|0|||
126604547|NCT03709706|455512430|FG001|Overall Study|Adverse Event|1|||
126604548|NCT03709706|455512429|FG000|Overall Study|Physician Decision|14|||
126604549|NCT03709706|455512430|FG001|Overall Study|Physician Decision|8|||
126604550|NCT03709706|455512429|FG000|Overall Study|Withdrawal by Subject|2|||
126604551|NCT03709706|455512430|FG001|Overall Study|Withdrawal by Subject|1|||
126604552|NCT03709706|455512429|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
126604553|NCT03709706|455512430|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
126604554|NCT04868617|455512431|FG000|Overall Study|Death|1|||
126604555|NCT04868617|455512432|FG001|Overall Study|Death|0|||
126604556|NCT04868617|455512431|FG000|Overall Study|Adverse Event|1|||
126604557|NCT04868617|455512432|FG001|Overall Study|Adverse Event|0|||
126604558|NCT04868617|455512431|FG000|Overall Study|Withdrawal by Subject|1|||
126604559|NCT04868617|455512432|FG001|Overall Study|Withdrawal by Subject|0|||
126604560|NCT04868617|455512431|FG000|Overall Study|Device deficiency|1|||
126604561|NCT04868617|455512432|FG001|Overall Study|Device deficiency|0|||
126604562|NCT01627561|455512433|FG000|Overall Study|Lost to Follow-up|1|||
126604563|NCT01627561|455512434|FG001|Overall Study|Lost to Follow-up|0|||
126604564|NCT01627561|455512433|FG000|Overall Study|Withdrawal by Subject|0|||
126604565|NCT01627561|455512434|FG001|Overall Study|Withdrawal by Subject|1|||
126604566|NCT01627561|455512433|FG000|Overall Study|Migrated/moved from study area|0|||
126604567|NCT01627561|455512434|FG001|Overall Study|Migrated/moved from study area|2|||
126604568|NCT01579318|455512437|FG000|Overall Study|Disease Progression|1|||
126604569|NCT02797132|455512438|FG000|Part A (15 Days)|Adverse Event|1|||
126604570|NCT02797132|455512438|FG000|Part B (24 Weeks)|Adverse Event|3|||
126604571|NCT02347332|455512439|FG000|Overall Study|Not treated|5|||
126604572|NCT02347332|455512440|FG001|Overall Study|Not treated|2|||
126604573|NCT02347332|455512439|FG000|Overall Study|Progressive disease|141|||
126604574|NCT02347332|455512440|FG001|Overall Study|Progressive disease|159|||
126604575|NCT02347332|455512439|FG000|Overall Study|Adverse Event|50|||
126604576|NCT02347332|455512440|FG001|Overall Study|Adverse Event|41|||
126604577|NCT02347332|455512439|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
126604578|NCT02347332|455512440|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
126604579|NCT02347332|455512439|FG000|Overall Study|Protocol Violation|1|||
126604580|NCT02347332|455512440|FG001|Overall Study|Protocol Violation|1|||
126604581|NCT02347332|455512439|FG000|Overall Study|Lost to Follow-up|2|||
126604582|NCT02347332|455512440|FG001|Overall Study|Lost to Follow-up|1|||
126604583|NCT02347332|455512439|FG000|Overall Study|Physician Decision|4|||
126604584|NCT02347332|455512440|FG001|Overall Study|Physician Decision|3|||
126604585|NCT02347332|455512439|FG000|Overall Study|Withdrawal by Subject|20|||
126604586|NCT02347332|455512440|FG001|Overall Study|Withdrawal by Subject|14|||
126604587|NCT02347332|455512439|FG000|Overall Study|Protocol requirement|1|||
126604588|NCT02347332|455512440|FG001|Overall Study|Protocol requirement|1|||
126604589|NCT02347332|455512439|FG000|Overall Study|Switch Post-Trial program|0|||
126604590|NCT02347332|455512440|FG001|Overall Study|Switch Post-Trial program|1|||
126604591|NCT01970007|455512441|FG000|Overall Study|Death|5|||
126604592|NCT01970007|455512441|FG000|Overall Study|Withdrawal by Subject|23|||
126604593|NCT01970007|455512441|FG000|Overall Study|Lost to Follow-up|24|||
126604594|NCT01970007|455512441|FG000|Overall Study|"Other endpoint"|3|||
126604595|NCT02787005|455512448|FG000|Overall Study|Adverse Event|24|||
126604596|NCT02787005|455512449|FG001|Overall Study|Adverse Event|9|||
126604597|NCT02787005|455512450|FG002|Overall Study|Adverse Event|9|||
126604598|NCT02787005|455512451|FG003|Overall Study|Adverse Event|7|||
126604599|NCT02787005|455512452|FG004|Overall Study|Adverse Event|2|||
126604600|NCT02787005|455512448|FG000|Overall Study|Death|100|||
126604601|NCT02787005|455512449|FG001|Overall Study|Death|53|||
126604602|NCT02787005|455512450|FG002|Overall Study|Death|48|||
126604603|NCT02787005|455512451|FG003|Overall Study|Death|69|||
126604604|NCT02787005|455512452|FG004|Overall Study|Death|38|||
126604605|NCT02787005|455512448|FG000|Overall Study|Sponsor Decision|7|||
126604606|NCT02787005|455512449|FG001|Overall Study|Sponsor Decision|4|||
126604607|NCT02787005|455512450|FG002|Overall Study|Sponsor Decision|0|||
126604608|NCT02787005|455512451|FG003|Overall Study|Sponsor Decision|4|||
126604609|NCT02787005|455512452|FG004|Overall Study|Sponsor Decision|5|||
126604610|NCT02787005|455512448|FG000|Overall Study|Withdrawal by Subject|2|||
126604611|NCT02787005|455512449|FG001|Overall Study|Withdrawal by Subject|1|||
126604612|NCT02787005|455512450|FG002|Overall Study|Withdrawal by Subject|1|||
126604613|NCT02787005|455512451|FG003|Overall Study|Withdrawal by Subject|0|||
126604614|NCT02787005|455512452|FG004|Overall Study|Withdrawal by Subject|1|||
126604615|NCT02787005|455512448|FG000|Overall Study|Screen Failure|0|||
126604616|NCT02787005|455512449|FG001|Overall Study|Screen Failure|2|||
126604617|NCT02787005|455512450|FG002|Overall Study|Screen Failure|0|||
126604618|NCT02787005|455512451|FG003|Overall Study|Screen Failure|0|||
126604619|NCT02787005|455512452|FG004|Overall Study|Screen Failure|1|||
126604620|NCT02787005|455512448|FG000|Overall Study|Lost to Follow-up|0|||
126604621|NCT02787005|455512449|FG001|Overall Study|Lost to Follow-up|0|||
126604622|NCT02787005|455512450|FG002|Overall Study|Lost to Follow-up|0|||
126604623|NCT02787005|455512451|FG003|Overall Study|Lost to Follow-up|1|||
126604624|NCT02787005|455512452|FG004|Overall Study|Lost to Follow-up|0|||
126604625|NCT02754596|455512453|FG000|Overall Study|Withdrawal by Subject|3|||
126604626|NCT02754596|455512454|FG001|Overall Study|Withdrawal by Subject|4|||
126604627|NCT02754596|455512455|FG002|Overall Study|Withdrawal by Subject|0|||
126604628|NCT02754596|455512453|FG000|Overall Study|Physician Decision|1|||
126604629|NCT02754596|455512454|FG001|Overall Study|Physician Decision|1|||
126604630|NCT02754596|455512455|FG002|Overall Study|Physician Decision|1|||
126604631|NCT02754596|455512453|FG000|Overall Study|Lost to Follow-up|1|||
126604632|NCT02754596|455512454|FG001|Overall Study|Lost to Follow-up|1|||
126604633|NCT02754596|455512455|FG002|Overall Study|Lost to Follow-up|2|||
126604634|NCT02754596|455512453|FG000|Overall Study|Death|0|||
126604635|NCT02754596|455512454|FG001|Overall Study|Death|2|||
126604636|NCT02754596|455512455|FG002|Overall Study|Death|0|||
126604637|NCT02754596|455512453|FG000|Overall Study|Adverse Event|1|||
126604638|NCT02754596|455512454|FG001|Overall Study|Adverse Event|0|||
126604639|NCT02754596|455512455|FG002|Overall Study|Adverse Event|1|||
126604640|NCT02754596|455512453|FG000|Overall Study|Other|1|||
126604641|NCT02754596|455512454|FG001|Overall Study|Other|0|||
126604642|NCT02754596|455512455|FG002|Overall Study|Other|0|||
126604643|NCT00747565|455512456|FG000|Overall Study|Withdrawal by Subject|10|||
126604644|NCT00747565|455512457|FG001|Overall Study|Withdrawal by Subject|6|||
126604645|NCT00747565|455512456|FG000|Overall Study|Lost to Follow-up|4|||
126604646|NCT00747565|455512457|FG001|Overall Study|Lost to Follow-up|1|||
126604647|NCT00545545|455512458|FG000|Overall Study|Progressive Neoplastic Disease|1|||
126604648|NCT00545545|455512459|FG001|Overall Study|Progressive Neoplastic Disease|5|||
126604649|NCT00545545|455512460|FG002|Overall Study|Progressive Neoplastic Disease|0|||
126604650|NCT00545545|455512461|FG003|Overall Study|Progressive Neoplastic Disease|4|||
126604651|NCT00545545|455512462|FG004|Overall Study|Progressive Neoplastic Disease|8|||
126604652|NCT00545545|455512463|FG005|Overall Study|Progressive Neoplastic Disease|7|||
126604653|NCT00545545|455512458|FG000|Overall Study|Withdrawal by Subject|0|||
126604654|NCT00545545|455512459|FG001|Overall Study|Withdrawal by Subject|1|||
126604655|NCT00545545|455512460|FG002|Overall Study|Withdrawal by Subject|0|||
126604656|NCT00545545|455512461|FG003|Overall Study|Withdrawal by Subject|0|||
126604657|NCT00545545|455512462|FG004|Overall Study|Withdrawal by Subject|0|||
126604658|NCT00545545|455512463|FG005|Overall Study|Withdrawal by Subject|0|||
126604659|NCT00545545|455512458|FG000|Overall Study|Physician Decision|1|||
126604660|NCT00545545|455512459|FG001|Overall Study|Physician Decision|0|||
126604661|NCT00545545|455512460|FG002|Overall Study|Physician Decision|0|||
126604662|NCT00545545|455512461|FG003|Overall Study|Physician Decision|0|||
126604663|NCT00545545|455512462|FG004|Overall Study|Physician Decision|0|||
126604664|NCT00545545|455512463|FG005|Overall Study|Physician Decision|1|||
126604665|NCT00545545|455512458|FG000|Overall Study|Irinotecan intolerance|1|||
126604666|NCT00545545|455512459|FG001|Overall Study|Irinotecan intolerance|1|||
126604667|NCT00545545|455512460|FG002|Overall Study|Irinotecan intolerance|0|||
126604668|NCT00545545|455512461|FG003|Overall Study|Irinotecan intolerance|0|||
126604669|NCT00545545|455512462|FG004|Overall Study|Irinotecan intolerance|0|||
126604670|NCT00545545|455512463|FG005|Overall Study|Irinotecan intolerance|0|||
126604671|NCT00545545|455512458|FG000|Overall Study|No target lesions to track post surgery|0|||
126604672|NCT00545545|455512459|FG001|Overall Study|No target lesions to track post surgery|0|||
126604673|NCT00545545|455512460|FG002|Overall Study|No target lesions to track post surgery|0|||
126604674|NCT00545545|455512461|FG003|Overall Study|No target lesions to track post surgery|0|||
126604675|NCT00545545|455512462|FG004|Overall Study|No target lesions to track post surgery|1|||
126604676|NCT00545545|455512463|FG005|Overall Study|No target lesions to track post surgery|1|||
126604677|NCT00319020|455512466|FG000|Overall Study|Death|2|||
126604678|NCT00319020|455512467|FG001|Overall Study|Death|2|||
126604679|NCT00319020|455512466|FG000|Overall Study|Withdrawal by Subject|4|||
126604680|NCT00319020|455512467|FG001|Overall Study|Withdrawal by Subject|1|||
126604681|NCT00319020|455512466|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
126604682|NCT00319020|455512467|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
126604683|NCT00319020|455512466|FG000|Overall Study|Administrative reason|0|||
126604684|NCT00319020|455512467|FG001|Overall Study|Administrative reason|5|||
126604685|NCT00319020|455512466|FG000|Overall Study|Disease progression|0|||
126604686|NCT00319020|455512467|FG001|Overall Study|Disease progression|2|||
126604687|NCT00319020|455512466|FG000|Overall Study|Transplant|0|||
126604688|NCT00319020|455512467|FG001|Overall Study|Transplant|1|||
126604689|NCT00319020|455512466|FG000|Overall Study|Treatment failure|0|||
126604690|NCT00319020|455512467|FG001|Overall Study|Treatment failure|1|||
126604691|NCT00319020|455512466|FG000|Overall Study|Adverse Event|0|||
126604692|NCT00319020|455512467|FG001|Overall Study|Adverse Event|1|||
126604693|NCT03959423|455512468|FG000|Overall Study|Withdrawal by Subject|2|||
126604694|NCT03959423|455512469|FG001|Overall Study|Withdrawal by Subject|3|||
126604695|NCT03959423|455512468|FG000|Overall Study|Physician Decision|0|||
126604696|NCT03959423|455512469|FG001|Overall Study|Physician Decision|1|||
126604697|NCT03959423|455512468|FG000|Overall Study|Lost to Follow-up|1|||
126604698|NCT03959423|455512469|FG001|Overall Study|Lost to Follow-up|0|||
126604699|NCT03959423|455512468|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
126604700|NCT03959423|455512469|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126604701|NCT02549352|455512470|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
126604702|NCT02549352|455512471|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
126604703|NCT02549352|455512470|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
126604704|NCT02549352|455512471|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
126604705|NCT02549352|455512470|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
126604706|NCT02549352|455512471|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
126604707|NCT02549352|455512470|FG000|12-month Follow-up|Withdrawal by Subject|4|||
126604708|NCT02549352|455512471|FG001|12-month Follow-up|Withdrawal by Subject|5|||
126604709|NCT02549352|455512470|FG000|12-month Follow-up|Lost to Follow-up|3|||
126604710|NCT02549352|455512471|FG001|12-month Follow-up|Lost to Follow-up|2|||
126604711|NCT02549352|455512470|FG000|12-month Follow-up|Death|0|||
126604712|NCT02549352|455512471|FG001|12-month Follow-up|Death|1|||
126604713|NCT02549352|455512470|FG000|12-month Follow-up|Protocol Violation|0|||
126604714|NCT02549352|455512471|FG001|12-month Follow-up|Protocol Violation|1|||
126604715|NCT02549352|455512470|FG000|12-month Follow-up|Other|1|||
126604716|NCT02549352|455512471|FG001|12-month Follow-up|Other|3|||
126604717|NCT00593840|455512474|FG000|Overall Study|Withdrawal by Subject|1|||
126604718|NCT04530487|455513925|FG000|Overall Study|Death|1|||
126604719|NCT01128595|455513928|FG000|Treatment Period 3|Withdrawal by Subject|0|||
126604720|NCT01128595|455513929|FG001|Treatment Period 3|Withdrawal by Subject|1|||
126604721|NCT01128595|455513930|FG002|Treatment Period 3|Withdrawal by Subject|0|||
126604722|NCT01128595|455513931|FG003|Treatment Period 3|Withdrawal by Subject|0|||
126604723|NCT00605306|455513932|FG000|Overall Study|Adverse Event|0|||
126604724|NCT00605306|455513933|FG001|Overall Study|Adverse Event|1|||
126604725|NCT00372775|455513934|FG000|Overall Study|Adverse Event|8|||
126604726|NCT00372775|455513934|FG000|Overall Study|Death|15|||
126604727|NCT00372775|455513934|FG000|Overall Study|Objective progression or relapse|30|||
126604728|NCT00372775|455513934|FG000|Overall Study|Global deterioration of health status|6|||
126604729|NCT00372775|455513934|FG000|Overall Study|Withdrawal by Subject|1|||
126604730|NCT00372775|455513934|FG000|Overall Study|Other|1|||
126604731|NCT00372775|455513934|FG000|Overall Study|Not Treated|2|||
126604732|NCT00890591|455513941|FG000|Overall Study|Lack of Efficacy|20|||
126604733|NCT00724126|455513944|FG000|Overall Study|Adverse Event|2|||
126604734|NCT00724126|455513945|FG001|Overall Study|Adverse Event|0|||
126604735|NCT00724126|455513944|FG000|Overall Study|Withdrawal by Subject|8|||
126604736|NCT00724126|455513945|FG001|Overall Study|Withdrawal by Subject|6|||
126604737|NCT00724126|455513944|FG000|Overall Study|Lost to Follow-up|6|||
126604738|NCT00724126|455513945|FG001|Overall Study|Lost to Follow-up|6|||
126604739|NCT00724126|455513944|FG000|Overall Study|Noncompliance|2|||
126604740|NCT00724126|455513945|FG001|Overall Study|Noncompliance|1|||
126604741|NCT00724126|455513944|FG000|Overall Study|Subject randomized although ineligible|1|||
126604742|NCT00724126|455513945|FG001|Overall Study|Subject randomized although ineligible|1|||
126604743|NCT00724126|455513944|FG000|Overall Study|Subject had to leave vicinity of site|0|||
126604744|NCT00724126|455513945|FG001|Overall Study|Subject had to leave vicinity of site|1|||
126604745|NCT02502526|455513947|FG000|Overall Study|Lost to Follow-up|2|||
126604746|NCT02502526|455513948|FG001|Overall Study|Lost to Follow-up|2|||
126604747|NCT02502526|455513949|FG002|Overall Study|Lost to Follow-up|3|||
126604748|NCT02502526|455513947|FG000|Overall Study|Withdrawal by Subject|0|||
126604749|NCT02502526|455513948|FG001|Overall Study|Withdrawal by Subject|1|||
126604750|NCT02502526|455513949|FG002|Overall Study|Withdrawal by Subject|1|||
126604751|NCT02502526|455513947|FG000|Overall Study|Disqualified due to cataract grading|0|||
126604752|NCT02502526|455513948|FG001|Overall Study|Disqualified due to cataract grading|0|||
126604753|NCT02502526|455513949|FG002|Overall Study|Disqualified due to cataract grading|1|||
126604754|NCT02502526|455513947|FG000|Overall Study|Enrollment suspension|4|||
126604755|NCT02502526|455513948|FG001|Overall Study|Enrollment suspension|1|||
126604756|NCT02502526|455513949|FG002|Overall Study|Enrollment suspension|1|||
126604757|NCT00112359|455513950|FG000|Overall Study|Unrelated adverse event|16|||
126604758|NCT00112359|455513951|FG001|Overall Study|Unrelated adverse event|8|||
126604759|NCT00112359|455513950|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
126604760|NCT00112359|455513951|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
126604761|NCT00112359|455513950|FG000|Overall Study|Related adverse event|5|||
126604762|NCT00112359|455513951|FG001|Overall Study|Related adverse event|3|||
126604763|NCT00112359|455513950|FG000|Overall Study|Lost to Follow-up|0|||
126604764|NCT00112359|455513951|FG001|Overall Study|Lost to Follow-up|1|||
126604765|NCT00112359|455513950|FG000|Overall Study|Personal/administrative|1|||
126604766|NCT00112359|455513951|FG001|Overall Study|Personal/administrative|1|||
126604767|NCT00112359|455513950|FG000|Overall Study|Other|3|||
126604768|NCT00112359|455513951|FG001|Overall Study|Other|0|||
126604769|NCT01961609|455513952|FG000|Initiation|Missing|3|||
126604770|NCT01961609|455513953|FG001|Initiation|Missing|2|||
126604771|NCT01961609|455513954|FG002|Initiation|Missing|0|||
126604772|NCT01961609|455513955|FG003|Initiation|Missing|0|||
126604773|NCT01961609|455513952|FG000|Initiation|Protocol deviation|1|||
126604774|NCT01961609|455513953|FG001|Initiation|Protocol deviation|0|||
126604775|NCT01961609|455513954|FG002|Initiation|Protocol deviation|0|||
126604776|NCT01961609|455513955|FG003|Initiation|Protocol deviation|0|||
126604777|NCT01961609|455513952|FG000|Initiation|Death|0|||
126604778|NCT01961609|455513953|FG001|Initiation|Death|1|||
126604779|NCT01961609|455513954|FG002|Initiation|Death|0|||
126604780|NCT01961609|455513955|FG003|Initiation|Death|0|||
126604781|NCT01961609|455513952|FG000|Initiation|Administrative problems|1|||
126604782|NCT01961609|455513953|FG001|Initiation|Administrative problems|0|||
126604783|NCT01961609|455513954|FG002|Initiation|Administrative problems|0|||
126604784|NCT01961609|455513955|FG003|Initiation|Administrative problems|0|||
126604785|NCT01961609|455513952|FG000|Initiation|Withdrawal by Subject|1|||
126604786|NCT01961609|455513953|FG001|Initiation|Withdrawal by Subject|2|||
126604787|NCT01961609|455513954|FG002|Initiation|Withdrawal by Subject|0|||
126604788|NCT01961609|455513955|FG003|Initiation|Withdrawal by Subject|0|||
126604789|NCT01961609|455513952|FG000|Initiation|Lack of Efficacy|2|||
126604790|NCT01961609|455513953|FG001|Initiation|Lack of Efficacy|1|||
126604791|NCT01961609|455513954|FG002|Initiation|Lack of Efficacy|0|||
126604792|NCT01961609|455513955|FG003|Initiation|Lack of Efficacy|0|||
126604793|NCT01961609|455513952|FG000|Initiation|Abnormal lab values|0|||
126604794|NCT01961609|455513953|FG001|Initiation|Abnormal lab values|1|||
126604795|NCT01961609|455513954|FG002|Initiation|Abnormal lab values|0|||
126604796|NCT01961609|455513955|FG003|Initiation|Abnormal lab values|0|||
126604797|NCT01961609|455513952|FG000|Initiation|Adverse Event|3|||
126604798|NCT01961609|455513953|FG001|Initiation|Adverse Event|5|||
126604799|NCT01961609|455513954|FG002|Initiation|Adverse Event|0|||
126604800|NCT01961609|455513955|FG003|Initiation|Adverse Event|0|||
126604801|NCT01961609|455513952|FG000|Initiation|Randomized but not treated|1|||
126604802|NCT01961609|455513953|FG001|Initiation|Randomized but not treated|1|||
126733704|NCT00093470|455973939|FG000|Overall Study|Adverse Event|15|||
126733705|NCT00093470|455973940|FG001|Overall Study|Adverse Event|0|||
126733706|NCT00093470|455973939|FG000|Overall Study|Death|2|||
126733707|NCT00093470|455973940|FG001|Overall Study|Death|0|||
126733708|NCT00093470|455973939|FG000|Overall Study|Withdrawal by Subject|8|||
126604803|NCT01961609|455513954|FG002|Initiation|Randomized but not treated|0|||
126604804|NCT01961609|455513955|FG003|Initiation|Randomized but not treated|0|||
126604805|NCT01961609|455513952|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
126604806|NCT01961609|455513953|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
126604807|NCT01961609|455513954|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
126604808|NCT01961609|455513955|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
126604809|NCT01961609|455513952|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
126604810|NCT01961609|455513953|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
126604811|NCT01961609|455513954|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
126733709|NCT00093470|455973940|FG001|Overall Study|Withdrawal by Subject|0|||
126604812|NCT01961609|455513955|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
126604813|NCT01961609|455513952|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
126604814|NCT01961609|455513953|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
126604815|NCT01961609|455513954|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
126604816|NCT01961609|455513955|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
126604817|NCT01961609|455513952|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
126604818|NCT01961609|455513953|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
126604819|NCT01961609|455513954|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
126604820|NCT01961609|455513955|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
126604821|NCT01961609|455513952|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
126604822|NCT01961609|455513953|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
126604823|NCT01961609|455513954|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
126604824|NCT01961609|455513955|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
126604825|NCT01961609|455513952|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
126604826|NCT01961609|455513953|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
126604827|NCT01961609|455513954|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
126604828|NCT01961609|455513955|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
126604829|NCT01961609|455513952|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
126604830|NCT01961609|455513953|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
126604831|NCT01961609|455513954|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
126604832|NCT01961609|455513955|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
126604833|NCT01961609|455513952|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
126604834|NCT01961609|455513953|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
126604835|NCT01961609|455513954|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
126604836|NCT01961609|455513955|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
126604837|NCT01961609|455513952|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
126604838|NCT01961609|455513953|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
126604839|NCT01961609|455513954|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
126604840|NCT01961609|455513955|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
126604841|NCT01961609|455513952|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
126604842|NCT01961609|455513953|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
126604843|NCT01961609|455513954|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
126604844|NCT01961609|455513955|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
126604845|NCT01961609|455513952|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
126604846|NCT01961609|455513953|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
126604847|NCT01961609|455513954|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
126604848|NCT01961609|455513955|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
126604849|NCT01961609|455513952|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
126604850|NCT01961609|455513953|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
126604851|NCT01961609|455513954|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
126604852|NCT01961609|455513955|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
126604853|NCT01988402|455513956|FG000|Overall Study|Adverse Event|1|||
126604854|NCT01988402|455513957|FG001|Overall Study|Adverse Event|2|||
126604855|NCT01988402|455513956|FG000|Overall Study|Withdrawal by Subject|1|||
126604856|NCT01988402|455513957|FG001|Overall Study|Withdrawal by Subject|0|||
126604857|NCT00571649|455513959|FG000|Treatment Period|Adverse Event|438|||
126604858|NCT00571649|455513960|FG001|Treatment Period|Adverse Event|385|||
126604859|NCT00571649|455513959|FG000|Treatment Period|Clinical endpoint reached|50|||
126604860|NCT00571649|455513960|FG001|Treatment Period|Clinical endpoint reached|56|||
126604861|NCT00571649|455513959|FG000|Treatment Period|Withdrawal by Subject|285|||
126604862|NCT00571649|455513960|FG001|Treatment Period|Withdrawal by Subject|255|||
126604863|NCT00571649|455513959|FG000|Treatment Period|Death|76|||
126604864|NCT00571649|455513960|FG001|Treatment Period|Death|59|||
126604865|NCT00571649|455513959|FG000|Treatment Period|Physician Decision|8|||
126604866|NCT00571649|455513960|FG001|Treatment Period|Physician Decision|9|||
126604867|NCT00571649|455513959|FG000|Treatment Period|Lost to Follow-up|43|||
126604868|NCT00571649|455513960|FG001|Treatment Period|Lost to Follow-up|41|||
126604869|NCT00571649|455513959|FG000|Treatment Period|Non-compliant with study medication|88|||
126604870|NCT00571649|455513960|FG001|Treatment Period|Non-compliant with study medication|89|||
126604871|NCT00571649|455513959|FG000|Treatment Period|Patient convenience|11|||
126604872|NCT00571649|455513960|FG001|Treatment Period|Patient convenience|13|||
126604873|NCT00571649|455513959|FG000|Treatment Period|Protocol Violation|90|||
126604874|NCT00571649|455513960|FG001|Treatment Period|Protocol Violation|92|||
126604875|NCT00571649|455513959|FG000|Treatment Period|Technical problems|3|||
126604876|NCT00571649|455513960|FG001|Treatment Period|Technical problems|5|||
126604877|NCT00571649|455513959|FG000|Follow-up Period|Adverse Event|46|||
126604878|NCT00571649|455513960|FG001|Follow-up Period|Adverse Event|40|||
126604879|NCT00571649|455513959|FG000|Follow-up Period|Clinical endpoint reached|5|||
126604880|NCT00571649|455513960|FG001|Follow-up Period|Clinical endpoint reached|2|||
126604881|NCT00571649|455513959|FG000|Follow-up Period|Withdrawal by Subject|119|||
126733710|NCT00093470|455973939|FG000|Overall Study|Alternative therapy|2|||
126604882|NCT00571649|455513960|FG001|Follow-up Period|Withdrawal by Subject|115|||
126604883|NCT00571649|455513959|FG000|Follow-up Period|Death|132|||
126604884|NCT00571649|455513960|FG001|Follow-up Period|Death|133|||
126604885|NCT00571649|455513959|FG000|Follow-up Period|Physician Decision|7|||
126604886|NCT00571649|455513960|FG001|Follow-up Period|Physician Decision|13|||
126604887|NCT00571649|455513959|FG000|Follow-up Period|Lost to Follow-up|95|||
126604888|NCT00571649|455513960|FG001|Follow-up Period|Lost to Follow-up|92|||
126604889|NCT00571649|455513959|FG000|Follow-up Period|Patient convenience|136|||
126604890|NCT00571649|455513960|FG001|Follow-up Period|Patient convenience|121|||
126604891|NCT00571649|455513959|FG000|Follow-up Period|Protocol Violation|5|||
126604892|NCT00571649|455513960|FG001|Follow-up Period|Protocol Violation|12|||
126604893|NCT00582972|455513961|FG000|Overall Study|Protocol Violation|2|||
126604894|NCT01566890|455513964|FG000|Overall Study|Adverse Event|1|||
126604895|NCT01566890|455513965|FG001|Overall Study|Adverse Event|0|||
126604896|NCT01566890|455513966|FG002|Overall Study|Adverse Event|0|||
126604897|NCT01566890|455513967|FG003|Overall Study|Adverse Event|0|||
126604898|NCT01566890|455513968|FG004|Overall Study|Adverse Event|0|||
126604899|NCT01566890|455513964|FG000|Overall Study|Withdrawal by Subject|3|||
126604900|NCT01566890|455513965|FG001|Overall Study|Withdrawal by Subject|1|||
126604901|NCT01566890|455513966|FG002|Overall Study|Withdrawal by Subject|1|||
126604902|NCT01566890|455513967|FG003|Overall Study|Withdrawal by Subject|1|||
126604903|NCT01566890|455513968|FG004|Overall Study|Withdrawal by Subject|0|||
126604904|NCT01566890|455513964|FG000|Overall Study|Screen failure|6|||
126604905|NCT01566890|455513965|FG001|Overall Study|Screen failure|0|||
126604906|NCT01566890|455513966|FG002|Overall Study|Screen failure|1|||
126604907|NCT01566890|455513967|FG003|Overall Study|Screen failure|1|||
126604908|NCT01566890|455513968|FG004|Overall Study|Screen failure|0|||
126604909|NCT01566890|455513964|FG000|Overall Study|Incomplete CEU data|1|||
126604910|NCT01566890|455513965|FG001|Overall Study|Incomplete CEU data|3|||
126604911|NCT01566890|455513966|FG002|Overall Study|Incomplete CEU data|5|||
126604912|NCT01566890|455513967|FG003|Overall Study|Incomplete CEU data|8|||
126604913|NCT01566890|455513968|FG004|Overall Study|Incomplete CEU data|0|||
126604914|NCT01566890|455513964|FG000|Overall Study|Lost to Follow-up|0|||
126604915|NCT01566890|455513965|FG001|Overall Study|Lost to Follow-up|0|||
126604916|NCT01566890|455513966|FG002|Overall Study|Lost to Follow-up|4|||
126604917|NCT01566890|455513967|FG003|Overall Study|Lost to Follow-up|4|||
126604918|NCT01566890|455513968|FG004|Overall Study|Lost to Follow-up|0|||
126604919|NCT01566890|455513964|FG000|Overall Study|Other|0|||
126604920|NCT01566890|455513965|FG001|Overall Study|Other|0|||
126604921|NCT01566890|455513966|FG002|Overall Study|Other|0|||
126604922|NCT01566890|455513967|FG003|Overall Study|Other|0|||
126604923|NCT01566890|455513968|FG004|Overall Study|Other|7|||
126604924|NCT01211184|455513976|FG000|Overall Study|Withdrawal by Subject|0|||
126604925|NCT01211184|455513977|FG001|Overall Study|Withdrawal by Subject|2|||
126604926|NCT01211184|455513978|FG002|Overall Study|Withdrawal by Subject|1|||
126604927|NCT01421667|455513979|FG000|Overall Study|Withdrawal by Subject|0|||
126604928|NCT01421667|455513980|FG001|Overall Study|Withdrawal by Subject|1|||
126604929|NCT01421667|455513981|FG002|Overall Study|Withdrawal by Subject|2|||
126604930|NCT01421667|455513982|FG003|Overall Study|Withdrawal by Subject|1|||
126604931|NCT01421667|455513979|FG000|Overall Study|Lost to Follow-up|0|||
126604932|NCT01421667|455513980|FG001|Overall Study|Lost to Follow-up|1|||
126604933|NCT01421667|455513981|FG002|Overall Study|Lost to Follow-up|0|||
126604934|NCT01421667|455513982|FG003|Overall Study|Lost to Follow-up|0|||
126604935|NCT00822120|455513983|FG000|Initial Registration|Adverse Event|1|||
126604936|NCT00822120|455513984|FG001|Initial Registration|Adverse Event|0|||
126604937|NCT00822120|455513985|FG002|Initial Registration|Adverse Event|0|||
126733711|NCT00093470|455973940|FG001|Overall Study|Alternative therapy|0|||
126733712|NCT00093470|455973939|FG000|Overall Study|Other complicating disease|3|||
126733713|NCT00093470|455973940|FG001|Overall Study|Other complicating disease|0|||
126733714|NCT00093470|455973939|FG000|Overall Study|Physician Decision|2|||
126733715|NCT00093470|455973940|FG001|Overall Study|Physician Decision|0|||
126733716|NCT00093470|455973939|FG000|Overall Study|Never started treatment|1|||
126604938|NCT00822120|455513986|FG003|Initial Registration|Adverse Event|0|||
126604939|NCT00822120|455513987|FG004|Initial Registration|Adverse Event|0|||
126604940|NCT00822120|455513988|FG005|Initial Registration|Adverse Event|0|||
126733717|NCT00093470|455973940|FG001|Overall Study|Never started treatment|0|||
126733718|NCT00093470|455973939|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
126781023|NCT03465891|456152913|FG000|Overall Study|Disease progression|1|||
126604941|NCT00822120|455513983|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
126604942|NCT00822120|455513984|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
126604943|NCT00822120|455513985|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
126604944|NCT00822120|455513986|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
126604945|NCT00822120|455513987|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
126604946|NCT00822120|455513988|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
126604947|NCT00822120|455513983|FG000|Initial Registration|Reasons not Protocol Specified|2|||
126604948|NCT00822120|455513984|FG001|Initial Registration|Reasons not Protocol Specified|0|||
126733719|NCT00093470|455973940|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
126781024|NCT03465891|456152914|FG001|Overall Study|Disease progression|0|||
126781025|NCT01001169|456152915|FG000|Overall Study|Withdrawal by Subject|2|||
126781026|NCT01001169|456152916|FG001|Overall Study|Withdrawal by Subject|1|||
126781027|NCT02040766|456152919|FG000|Overall Study|Adverse Event|1|||
126604949|NCT00822120|455513985|FG002|Initial Registration|Reasons not Protocol Specified|0|||
126604950|NCT00822120|455513986|FG003|Initial Registration|Reasons not Protocol Specified|0|||
126604951|NCT00822120|455513987|FG004|Initial Registration|Reasons not Protocol Specified|0|||
126604952|NCT00822120|455513988|FG005|Initial Registration|Reasons not Protocol Specified|0|||
126781028|NCT02040766|456152920|FG001|Overall Study|Adverse Event|1|||
126781029|NCT02040766|456152921|FG002|Overall Study|Adverse Event|1|||
126781030|NCT02040766|456152922|FG003|Overall Study|Adverse Event|0|||
126781031|NCT02040766|456152923|FG004|Overall Study|Adverse Event|2|||
126781032|NCT02040766|456152919|FG000|Overall Study|Withdrawal by Subject|4|||
126781033|NCT02040766|456152920|FG001|Overall Study|Withdrawal by Subject|3|||
126781034|NCT02040766|456152921|FG002|Overall Study|Withdrawal by Subject|2|||
126781035|NCT02040766|456152922|FG003|Overall Study|Withdrawal by Subject|3|||
126781036|NCT02040766|456152923|FG004|Overall Study|Withdrawal by Subject|2|||
126781037|NCT02040766|456152919|FG000|Overall Study|Non-compliance|0|||
126604953|NCT00822120|455513983|FG000|Initial Registration|Ineligible|22|||
126604954|NCT00822120|455513984|FG001|Initial Registration|Ineligible|1|||
126604955|NCT00822120|455513985|FG002|Initial Registration|Ineligible|0|||
126604956|NCT00822120|455513986|FG003|Initial Registration|Ineligible|0|||
126604957|NCT00822120|455513987|FG004|Initial Registration|Ineligible|0|||
126604958|NCT00822120|455513988|FG005|Initial Registration|Ineligible|0|||
126604959|NCT00822120|455513983|FG000|PET-directed Therapy|Adverse Event|0|||
126604960|NCT00822120|455513984|FG001|PET-directed Therapy|Adverse Event|0|||
126604961|NCT00822120|455513985|FG002|PET-directed Therapy|Adverse Event|0|||
126604962|NCT00822120|455513986|FG003|PET-directed Therapy|Adverse Event|1|||
126604963|NCT00822120|455513987|FG004|PET-directed Therapy|Adverse Event|0|||
126604964|NCT00822120|455513988|FG005|PET-directed Therapy|Adverse Event|0|||
126604965|NCT00822120|455513983|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
126604966|NCT00822120|455513984|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
126604967|NCT00822120|455513985|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
126604968|NCT00822120|455513986|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
126604969|NCT00822120|455513987|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
126604970|NCT00822120|455513988|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
126604971|NCT00822120|455513983|FG000|PET-directed Therapy|Death|0|||
126604972|NCT00822120|455513984|FG001|PET-directed Therapy|Death|0|||
126604973|NCT00822120|455513985|FG002|PET-directed Therapy|Death|0|||
126604974|NCT00822120|455513986|FG003|PET-directed Therapy|Death|2|||
126604975|NCT00822120|455513987|FG004|PET-directed Therapy|Death|0|||
126604976|NCT00822120|455513988|FG005|PET-directed Therapy|Death|0|||
126604977|NCT00822120|455513983|FG000|PET-directed Therapy|Protocol Violation|0|||
126604978|NCT00822120|455513984|FG001|PET-directed Therapy|Protocol Violation|0|||
126604979|NCT00822120|455513985|FG002|PET-directed Therapy|Protocol Violation|0|||
126604980|NCT00822120|455513986|FG003|PET-directed Therapy|Protocol Violation|6|||
126604981|NCT00822120|455513987|FG004|PET-directed Therapy|Protocol Violation|0|||
126604982|NCT00822120|455513988|FG005|PET-directed Therapy|Protocol Violation|0|||
126604983|NCT01324310|455513989|FG000|Overall Study|Adverse Event|1|||
126604984|NCT01324310|455513989|FG000|Overall Study|Disease Progression|1|||
126604985|NCT04060212|455513991|FG000|Overall Study|Withdrawal by Subject|7|||
126604986|NCT01387516|455514009|FG000|Overall Study|Lost to Follow-up|4|||
126604987|NCT01387516|455514010|FG001|Overall Study|Lost to Follow-up|4|||
126604988|NCT01387516|455514011|FG002|Overall Study|Lost to Follow-up|2|||
126604989|NCT01387516|455514012|FG003|Overall Study|Lost to Follow-up|3|||
126604990|NCT01387516|455514009|FG000|Overall Study|Withdrawal by Subject|1|||
126604991|NCT01387516|455514010|FG001|Overall Study|Withdrawal by Subject|1|||
126604992|NCT01387516|455514011|FG002|Overall Study|Withdrawal by Subject|2|||
126604993|NCT01387516|455514012|FG003|Overall Study|Withdrawal by Subject|0|||
126604994|NCT01387516|455514009|FG000|Overall Study|Death|0|||
126604995|NCT01387516|455514010|FG001|Overall Study|Death|0|||
126604996|NCT01387516|455514011|FG002|Overall Study|Death|0|||
126604997|NCT01387516|455514012|FG003|Overall Study|Death|1|||
126604998|NCT02928172|455514016|FG000|Overall Study|Device did not record data|1|||
126781038|NCT02040766|456152920|FG001|Overall Study|Non-compliance|1|||
126604999|NCT02016872|455514021|FG000|Overall Study|Withdrawal by Subject|10|||
126605000|NCT02016872|455514021|FG000|Overall Study|Death Progression|2|||
126605001|NCT02016872|455514021|FG000|Overall Study|No FMISO scan|1|||
126605002|NCT02016872|455514021|FG000|Overall Study|Ineligible|2|||
126781039|NCT02040766|456152921|FG002|Overall Study|Non-compliance|0|||
126781040|NCT02040766|456152922|FG003|Overall Study|Non-compliance|0|||
126781041|NCT02040766|456152923|FG004|Overall Study|Non-compliance|0|||
126605003|NCT03593226|455514040|FG000|Overall Study|Disease progression|6|||
126605004|NCT03593226|455514041|FG001|Overall Study|Disease progression|13|||
126605005|NCT03593226|455514042|FG002|Overall Study|Disease progression|5|||
126781042|NCT02040766|456152919|FG000|Overall Study|Protocol Violation|2|||
126605006|NCT03593226|455514043|FG003|Overall Study|Disease progression|6|||
126605007|NCT03593226|455514040|FG000|Overall Study|Adverse Event|0|||
126605008|NCT03593226|455514041|FG001|Overall Study|Adverse Event|1|||
126605009|NCT03593226|455514042|FG002|Overall Study|Adverse Event|0|||
126605010|NCT03593226|455514043|FG003|Overall Study|Adverse Event|0|||
126605011|NCT03593226|455514040|FG000|Overall Study|Withdrawal by Subject|0|||
126605012|NCT03593226|455514041|FG001|Overall Study|Withdrawal by Subject|4|||
126605013|NCT03593226|455514042|FG002|Overall Study|Withdrawal by Subject|1|||
126605014|NCT03593226|455514043|FG003|Overall Study|Withdrawal by Subject|0|||
126605015|NCT03593226|455514040|FG000|Overall Study|Physician Decision|0|||
126605016|NCT03593226|455514041|FG001|Overall Study|Physician Decision|1|||
126605017|NCT03593226|455514042|FG002|Overall Study|Physician Decision|0|||
126605018|NCT03593226|455514043|FG003|Overall Study|Physician Decision|0|||
126605019|NCT03593226|455514040|FG000|Overall Study|Clinical disease progression|0|||
126605020|NCT03593226|455514041|FG001|Overall Study|Clinical disease progression|0|||
126605021|NCT03593226|455514042|FG002|Overall Study|Clinical disease progression|1|||
126605022|NCT03593226|455514043|FG003|Overall Study|Clinical disease progression|0|||
126605023|NCT04517435|455514044|FG000|Overall Study|Withdrawal by Subject|0|||
126605024|NCT04517435|455514045|FG001|Overall Study|Withdrawal by Subject|0|||
126605025|NCT04517435|455514046|FG002|Overall Study|Withdrawal by Subject|1|||
126605026|NCT04517435|455514044|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
126605027|NCT04517435|455514045|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
126605028|NCT04517435|455514046|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
126605029|NCT04882917|455514059|FG000|Overall Study|Adverse Event|0|||
126605030|NCT04882917|455514060|FG001|Overall Study|Adverse Event|1|||
126605031|NCT04882917|455514061|FG002|Overall Study|Adverse Event|2|||
126605032|NCT04882917|455514062|FG003|Overall Study|Adverse Event|2|||
126605033|NCT04882917|455514059|FG000|Overall Study|Withdrawal by Subject|1|||
126605034|NCT04882917|455514060|FG001|Overall Study|Withdrawal by Subject|0|||
126605035|NCT04882917|455514061|FG002|Overall Study|Withdrawal by Subject|2|||
126605036|NCT04882917|455514062|FG003|Overall Study|Withdrawal by Subject|1|||
126605037|NCT04882917|455514059|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
126605038|NCT04882917|455514060|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
126605039|NCT04882917|455514061|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
126605040|NCT04882917|455514062|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
126605041|NCT00227266|455514063|FG000|Overall Study|Withdrawal by Subject|0|||
126605042|NCT00227266|455514064|FG001|Overall Study|Withdrawal by Subject|0|||
126605043|NCT00227266|455514065|FG002|Overall Study|Withdrawal by Subject|1|||
126605044|NCT00227266|455514063|FG000|Overall Study|Protocol Violation|1|||
126605045|NCT00227266|455514064|FG001|Overall Study|Protocol Violation|0|||
126605046|NCT00227266|455514065|FG002|Overall Study|Protocol Violation|1|||
126605047|NCT00227266|455514063|FG000|Overall Study|Excessive weight gain|0|||
126605048|NCT00227266|455514064|FG001|Overall Study|Excessive weight gain|0|||
126605049|NCT00227266|455514065|FG002|Overall Study|Excessive weight gain|2|||
126605050|NCT02678689|455514066|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
126605051|NCT02678689|455514067|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
126605052|NCT02761187|455514071|FG000|Overall Study|Too ill to Participate|13|||
126605053|NCT02761187|455514072|FG001|Overall Study|Too ill to Participate|8|||
126605054|NCT02761187|455514071|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
126605055|NCT02761187|455514072|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
126605056|NCT02761187|455514071|FG000|Overall Study|Patient withdrew consent|64|||
126605057|NCT02761187|455514072|FG001|Overall Study|Patient withdrew consent|58|||
126605058|NCT02761187|455514071|FG000|Overall Study|Physician discretion|4|||
126605059|NCT02761187|455514072|FG001|Overall Study|Physician discretion|8|||
126605060|NCT02761187|455514071|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
126605061|NCT02761187|455514072|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
126605062|NCT02761187|455514071|FG000|Overall Study|On Hospice|20|||
126605063|NCT02761187|455514072|FG001|Overall Study|On Hospice|26|||
126605064|NCT02761187|455514071|FG000|Overall Study|Deceased|474|||
126605065|NCT02761187|455514072|FG001|Overall Study|Deceased|642|||
126605066|NCT02761187|455514071|FG000|Overall Study|Lost to Follow-up|73|||
126781043|NCT02040766|456152920|FG001|Overall Study|Protocol Violation|1|||
126781044|NCT02040766|456152921|FG002|Overall Study|Protocol Violation|2|||
126605067|NCT02761187|455514072|FG001|Overall Study|Lost to Follow-up|63|||
126605068|NCT02761187|455514071|FG000|Overall Study|Due to study discontinued at site|100|||
126781045|NCT02040766|456152922|FG003|Overall Study|Protocol Violation|3|||
126781046|NCT02040766|456152923|FG004|Overall Study|Protocol Violation|0|||
126781047|NCT02040766|456152919|FG000|Overall Study|Lost to Follow-up|4|||
126605069|NCT02761187|455514072|FG001|Overall Study|Due to study discontinued at site|85|||
126605070|NCT02761187|455514071|FG000|Overall Study|Reason not Specified|1484|||
126605071|NCT02761187|455514072|FG001|Overall Study|Reason not Specified|937|||
126781048|NCT02040766|456152920|FG001|Overall Study|Lost to Follow-up|1|||
126605072|NCT03978637|455514073|FG000|Overall Study|Death|0|||
126605073|NCT03978637|455514074|FG001|Overall Study|Death|2|||
126605074|NCT03978637|455514075|FG002|Overall Study|Death|2|||
126605075|NCT03978637|455514076|FG003|Overall Study|Death|0|||
126605076|NCT03978637|455514073|FG000|Overall Study|Withdrawal by Subject|0|||
126605077|NCT03978637|455514074|FG001|Overall Study|Withdrawal by Subject|0|||
126605078|NCT03978637|455514075|FG002|Overall Study|Withdrawal by Subject|1|||
126605079|NCT03978637|455514076|FG003|Overall Study|Withdrawal by Subject|0|||
126605080|NCT03978637|455514073|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
126605081|NCT03978637|455514074|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
126605082|NCT03978637|455514075|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
126605083|NCT03978637|455514076|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
126605084|NCT02307682|455514077|FG000|Overall Study|Adverse Event|9|||
126605085|NCT02307682|455514078|FG001|Overall Study|Adverse Event|8|||
126605086|NCT02307682|455514079|FG002|Overall Study|Adverse Event|12|||
126605087|NCT02307682|455514077|FG000|Overall Study|Lack of Efficacy|1|||
126605088|NCT02307682|455514078|FG001|Overall Study|Lack of Efficacy|0|||
126605089|NCT02307682|455514079|FG002|Overall Study|Lack of Efficacy|1|||
126605090|NCT02307682|455514077|FG000|Overall Study|Physician Decision|2|||
126605091|NCT02307682|455514078|FG001|Overall Study|Physician Decision|2|||
126605092|NCT02307682|455514079|FG002|Overall Study|Physician Decision|8|||
126605093|NCT02307682|455514077|FG000|Overall Study|Progressive Disease|1|||
126605094|NCT02307682|455514078|FG001|Overall Study|Progressive Disease|0|||
126605095|NCT02307682|455514079|FG002|Overall Study|Progressive Disease|0|||
126605096|NCT02307682|455514077|FG000|Overall Study|Withdrawal by Subject|26|||
126605097|NCT02307682|455514078|FG001|Overall Study|Withdrawal by Subject|34|||
126605098|NCT02307682|455514079|FG002|Overall Study|Withdrawal by Subject|23|||
126605099|NCT02307682|455514077|FG000|Overall Study|Death|9|||
126605100|NCT02307682|455514078|FG001|Overall Study|Death|7|||
126605101|NCT02307682|455514079|FG002|Overall Study|Death|12|||
126605102|NCT02307682|455514077|FG000|Overall Study|Lost to Follow-up|1|||
126605103|NCT02307682|455514078|FG001|Overall Study|Lost to Follow-up|5|||
126605104|NCT02307682|455514079|FG002|Overall Study|Lost to Follow-up|6|||
126605105|NCT02307682|455514077|FG000|Overall Study|Protocol Deviation|0|||
126605106|NCT02307682|455514078|FG001|Overall Study|Protocol Deviation|0|||
126605107|NCT02307682|455514079|FG002|Overall Study|Protocol Deviation|2|||
126605108|NCT02307682|455514077|FG000|Overall Study|Other|1|||
126605109|NCT02307682|455514078|FG001|Overall Study|Other|1|||
126605110|NCT02307682|455514079|FG002|Overall Study|Other|0|||
126605111|NCT05630833|455514080|FG000|Overall Study|Adverse Event|3|||
126605112|NCT05630833|455514081|FG001|Overall Study|Adverse Event|0|||
126605113|NCT05630833|455514080|FG000|Overall Study|Lack of Efficacy|0|||
126605114|NCT05630833|455514081|FG001|Overall Study|Lack of Efficacy|1|||
126605115|NCT05630833|455514080|FG000|Overall Study|Lost to Follow-up|1|||
126605116|NCT05630833|455514081|FG001|Overall Study|Lost to Follow-up|0|||
126605117|NCT05630833|455514080|FG000|Overall Study|Withdrawal by Subject|3|||
126605118|NCT05630833|455514081|FG001|Overall Study|Withdrawal by Subject|1|||
126605119|NCT01084694|455514941|FG000|Overall Study|Withdrawal by Subject|2|||
126605120|NCT01084694|455514942|FG001|Overall Study|Withdrawal by Subject|1|||
126605121|NCT01084694|455514941|FG000|Overall Study|Death|2|||
126605122|NCT01084694|455514942|FG001|Overall Study|Death|12|||
126605123|NCT01084694|455514941|FG000|Overall Study|eligibility not maintained|2|||
126605124|NCT01084694|455514942|FG001|Overall Study|eligibility not maintained|7|||
126605125|NCT00945321|455514943|FG000|Period 1|Adverse Event|0|||
126605126|NCT00945321|455514944|FG001|Period 1|Adverse Event|0|||
126605127|NCT00945321|455514945|FG002|Period 1|Adverse Event|0|||
126605128|NCT00945321|455514946|FG003|Period 1|Adverse Event|0|||
126605129|NCT00945321|455514947|FG004|Period 1|Adverse Event|1|||
126605130|NCT00945321|455514948|FG005|Period 1|Adverse Event|0|||
126605131|NCT00945321|455514943|FG000|Period 4|Lost to Follow-up|0|||
126605132|NCT00945321|455514944|FG001|Period 4|Lost to Follow-up|0|||
126605133|NCT00945321|455514945|FG002|Period 4|Lost to Follow-up|0|||
126605134|NCT00945321|455514946|FG003|Period 4|Lost to Follow-up|0|||
126605135|NCT00945321|455514947|FG004|Period 4|Lost to Follow-up|0|||
126605136|NCT00945321|455514948|FG005|Period 4|Lost to Follow-up|1|||
126605137|NCT02633215|455514949|FG000|Overall Study|Lost to Follow-up|2|||
126605138|NCT02633215|455514950|FG001|Overall Study|Lost to Follow-up|3|||
126605139|NCT04017611|455514951|FG000|Overall Study|Withdrawn prior to completion|1|||
126605140|NCT00692913|455514952|FG000|Overall Study|Adverse Event|8|||
126605141|NCT00692913|455514953|FG001|Overall Study|Adverse Event|4|||
126605142|NCT00692913|455514952|FG000|Overall Study|Lost to Follow-up|3|||
126605143|NCT00692913|455514953|FG001|Overall Study|Lost to Follow-up|5|||
126605144|NCT00692913|455514952|FG000|Overall Study|Physician Decision|2|||
126605145|NCT00692913|455514953|FG001|Overall Study|Physician Decision|0|||
126605146|NCT00692913|455514952|FG000|Overall Study|Protocol Violation|1|||
126605147|NCT00692913|455514953|FG001|Overall Study|Protocol Violation|1|||
126605148|NCT00692913|455514952|FG000|Overall Study|Withdrawal by Subject|15|||
126605149|NCT00692913|455514953|FG001|Overall Study|Withdrawal by Subject|20|||
126605150|NCT02291913|455514954|FG000|Overall Study|Progressive Disease|32|||
126605151|NCT02291913|455514954|FG000|Overall Study|Adverse Event|11|||
126605152|NCT02291913|455514954|FG000|Overall Study|Death|2|||
126605153|NCT02291913|455514954|FG000|Overall Study|Physician Decision|1|||
126605154|NCT02291913|455514954|FG000|Overall Study|Withdrawal by Subject|1|||
126605155|NCT02291913|455514954|FG000|Overall Study|Protocol Violation|1|||
126605156|NCT02866942|455514963|FG000|Overall Study|Invalid consent|1|||
126605157|NCT01268306|455514964|FG000|Overall Study|Lost to Follow-up|1|||
126605158|NCT04334317|455514965|FG000|Overall Study|Adverse Event|1|||
126605159|NCT04334317|455514966|FG001|Overall Study|Adverse Event|2|||
126605160|NCT04334317|455514967|FG002|Overall Study|Adverse Event|0|||
126605161|NCT04334317|455514968|FG003|Overall Study|Adverse Event|0|||
126605162|NCT04334317|455514965|FG000|Overall Study|Protocol Deviation|0|||
126605163|NCT04334317|455514966|FG001|Overall Study|Protocol Deviation|1|||
126605164|NCT04334317|455514967|FG002|Overall Study|Protocol Deviation|0|||
126605165|NCT04334317|455514968|FG003|Overall Study|Protocol Deviation|0|||
126605166|NCT04334317|455514965|FG000|Overall Study|Withdrawal by Subject|2|||
126605167|NCT04334317|455514966|FG001|Overall Study|Withdrawal by Subject|2|||
126605168|NCT04334317|455514967|FG002|Overall Study|Withdrawal by Subject|0|||
126605169|NCT04334317|455514968|FG003|Overall Study|Withdrawal by Subject|0|||
126605170|NCT03621735|455514969|FG000|Overall Study|Withdrawal by Subject|13|||
126605171|NCT03621735|455514970|FG001|Overall Study|Withdrawal by Subject|13|||
126605172|NCT02568215|455514972|FG000|Overall Study|Death|1|||
126605173|NCT02568215|455514973|FG001|Overall Study|Death|2|||
126605174|NCT02568215|455514974|FG002|Overall Study|Death|0|||
126605175|NCT02568215|455514972|FG000|Overall Study|Physician Decision|2|||
126605176|NCT02568215|455514973|FG001|Overall Study|Physician Decision|2|||
126605177|NCT02568215|455514974|FG002|Overall Study|Physician Decision|2|||
126605178|NCT02568215|455514972|FG000|Overall Study|Lost to Follow-up|29|||
126605179|NCT02568215|455514973|FG001|Overall Study|Lost to Follow-up|32|||
126605180|NCT02568215|455514974|FG002|Overall Study|Lost to Follow-up|41|||
126605181|NCT02568215|455514972|FG000|Overall Study|Withdrawal by Subject|21|||
126605182|NCT02568215|455514973|FG001|Overall Study|Withdrawal by Subject|19|||
126605183|NCT02568215|455514974|FG002|Overall Study|Withdrawal by Subject|22|||
126605184|NCT02568215|455514972|FG000|Overall Study|Protocol Violation|1|||
126605185|NCT02568215|455514973|FG001|Overall Study|Protocol Violation|1|||
126605186|NCT02568215|455514974|FG002|Overall Study|Protocol Violation|0|||
126605187|NCT02568215|455514972|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
126605188|NCT02568215|455514973|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
126605189|NCT02568215|455514974|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
126605190|NCT02568215|455514972|FG000|Overall Study|Other|0|||
126605191|NCT02568215|455514973|FG001|Overall Study|Other|1|||
126605192|NCT02568215|455514974|FG002|Overall Study|Other|4|||
126605193|NCT00336505|455514975|FG000|Overall Study|Adverse Event|10|||
126605194|NCT00336505|455514976|FG001|Overall Study|Adverse Event|9|||
126605195|NCT00336505|455514975|FG000|Overall Study|Lack of Efficacy|8|||
126605196|NCT00336505|455514976|FG001|Overall Study|Lack of Efficacy|4|||
126605197|NCT00336505|455514975|FG000|Overall Study|Lost to Follow-up|7|||
126605198|NCT00336505|455514976|FG001|Overall Study|Lost to Follow-up|4|||
126605199|NCT00336505|455514975|FG000|Overall Study|Withdrawal by Subject|5|||
126605200|NCT00336505|455514976|FG001|Overall Study|Withdrawal by Subject|3|||
126605201|NCT00336505|455514975|FG000|Overall Study|Other|7|||
126605202|NCT00336505|455514976|FG001|Overall Study|Other|7|||
126605203|NCT01561300|455514977|FG000|Run in on Placebo|Adverse Event|1|||
126605204|NCT01561300|455514978|FG001|Run in on Placebo|Adverse Event|0|||
126605205|NCT00246805|455514979|FG000|Phase 1|Lost to Follow-up|1|||
126605206|NCT00246805|455514980|FG001|Phase 1|Lost to Follow-up|0|||
126605207|NCT00609869|455514981|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
126605208|NCT00609869|455514981|FG000|Overall Study|Severe hematologic toxicity|1|||
126605209|NCT00609869|455514981|FG000|Overall Study|Withdrawal by Subject|1|||
126605210|NCT00609869|455514981|FG000|Overall Study|Seizures|1|||
126605211|NCT00609869|455514981|FG000|Overall Study|Severe tumor flare reaction|1|||
126733720|NCT00877006|455973941|FG000|Treatment Period|Death|2|||
126733721|NCT00877006|455973942|FG001|Treatment Period|Death|1|||
126733722|NCT00877006|455973941|FG000|Treatment Period|Adverse Event|10|||
126733723|NCT00877006|455973942|FG001|Treatment Period|Adverse Event|3|||
126733724|NCT00877006|455973941|FG000|Treatment Period|Withdrawal by Subject|2|||
126733725|NCT00877006|455973942|FG001|Treatment Period|Withdrawal by Subject|3|||
126733726|NCT00877006|455973941|FG000|Treatment Period|Protocol Violation|1|||
126733727|NCT00877006|455973942|FG001|Treatment Period|Protocol Violation|0|||
126733728|NCT00877006|455973941|FG000|Treatment Period|Lost to Follow-up|0|||
126733729|NCT00877006|455973942|FG001|Treatment Period|Lost to Follow-up|1|||
126733730|NCT00877006|455973941|FG000|Treatment Period|Disease Progression|1|||
126733731|NCT00877006|455973942|FG001|Treatment Period|Disease Progression|2|||
126733732|NCT00877006|455973941|FG000|Treatment Period|Started New Treatment Regimen|2|||
126733733|NCT00877006|455973942|FG001|Treatment Period|Started New Treatment Regimen|5|||
126605212|NCT00609869|455514981|FG000|Overall Study|Hepatitis B infection|1|||
126605213|NCT00609869|455514981|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
126733734|NCT00877006|455973941|FG000|Treatment Period|Other|4|||
126733735|NCT00877006|455973942|FG001|Treatment Period|Other|4|||
126605214|NCT00609869|455514981|FG000|Overall Study|Mantle cell: not evaluable|4|||
126605215|NCT01952366|455514982|FG000|Overall Study|Death|22|||
126605216|NCT01952366|455514982|FG000|Overall Study|Withdrawal by Subject|9|||
126733736|NCT00877006|455973941|FG000|Treatment Period|Randomized but Not Treated|3|||
126605217|NCT00293397|455514985|FG000|Overall Study|Death|2|||
126605218|NCT00503906|455514986|FG000|Overall Study|Withdrawal by Subject|1|||
126605219|NCT02029235|455514989|FG000|Overall Study|Non-compliance with study meds or diary|4|||
126605220|NCT02029235|455514990|FG001|Overall Study|Non-compliance with study meds or diary|1|||
126605221|NCT01738438|455514992|FG000|Overall Study|Disease Progression|32|||
126605222|NCT01738438|455514992|FG000|Overall Study|Adverse Event|3|||
126605223|NCT04066075|455514993|FG000|Overall Study|Lost to Follow-up|3|||
126605224|NCT04066075|455514994|FG001|Overall Study|Lost to Follow-up|3|||
126605225|NCT04066075|455514993|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
126605226|NCT04066075|455514994|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
126605227|NCT04066075|455514993|FG000|Overall Study|Withdrawal by Subject|2|||
126605228|NCT04066075|455514994|FG001|Overall Study|Withdrawal by Subject|2|||
126605229|NCT00309166|455514995|FG000|Overall Study|Adverse event, non-fatal|1|||
126605230|NCT00309166|455514996|FG001|Overall Study|Adverse event, non-fatal|0|||
126605231|NCT00309166|455514995|FG000|Overall Study|Withdrawal by Subject|4|||
126605232|NCT00309166|455514996|FG001|Overall Study|Withdrawal by Subject|3|||
126605233|NCT03477175|455514997|FG000|Overall Study|Unable to travel due to COVID-19|0|||
126605234|NCT03477175|455514998|FG001|Overall Study|Unable to travel due to COVID-19|1|||
126605235|NCT03477175|455514997|FG000|Overall Study|Physician Decision|1|||
126605236|NCT03477175|455514998|FG001|Overall Study|Physician Decision|0|||
126605237|NCT03477175|455514997|FG000|Overall Study|Transitioned to commercial drug|6|||
126605238|NCT03477175|455514998|FG001|Overall Study|Transitioned to commercial drug|6|||
126605239|NCT03477175|455514997|FG000|Overall Study|Lost to Follow-up|1|||
126605240|NCT03477175|455514998|FG001|Overall Study|Lost to Follow-up|1|||
126605241|NCT03477175|455514997|FG000|Overall Study|Withdrawal by Subject|3|||
126605242|NCT03477175|455514998|FG001|Overall Study|Withdrawal by Subject|1|||
126605243|NCT03477175|455514997|FG000|Overall Study|Adverse Event|1|||
126605244|NCT03477175|455514998|FG001|Overall Study|Adverse Event|5|||
126605245|NCT03477175|455514997|FG000|Overall Study|Disease Progression|7|||
126605246|NCT03477175|455514998|FG001|Overall Study|Disease Progression|7|||
126605247|NCT03789110|455514999|FG000|Overall Study|Adverse Event|2|||
126605248|NCT03789110|455514999|FG000|Overall Study|Physician Decision|1|||
126605249|NCT03789110|455514999|FG000|Overall Study|Withdrawal by Subject|2|||
126605250|NCT03789110|455514999|FG000|Overall Study|Lack of Efficacy|22|||
126605251|NCT03789110|455514999|FG000|Overall Study|still on treatment|3|||
126605252|NCT03160885|455515000|FG000|Initial Treatment Period|Not dosed|2|||
126605253|NCT03160885|455515001|FG001|Initial Treatment Period|Not dosed|0|||
126605254|NCT03160885|455515002|FG002|Initial Treatment Period|Not dosed|0|||
126605255|NCT03160885|455515003|FG003|Initial Treatment Period|Not dosed|0|||
126605256|NCT03160885|455515004|FG004|Initial Treatment Period|Not dosed|0|||
126605257|NCT03160885|455515005|FG005|Initial Treatment Period|Not dosed|0|||
126605258|NCT03160885|455515006|FG006|Initial Treatment Period|Not dosed|0|||
126605259|NCT03160885|455515000|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
126605260|NCT03160885|455515001|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
126605261|NCT03160885|455515002|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126605262|NCT03160885|455515003|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126605263|NCT03160885|455515004|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126605264|NCT03160885|455515005|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126605265|NCT03160885|455515006|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
126605266|NCT03160885|455515000|FG000|Open-label Treatment|Not dosed|0|||
126605267|NCT03160885|455515001|FG001|Open-label Treatment|Not dosed|0|||
126605268|NCT03160885|455515002|FG002|Open-label Treatment|Not dosed|0|||
126605269|NCT03160885|455515003|FG003|Open-label Treatment|Not dosed|0|||
126605270|NCT03160885|455515004|FG004|Open-label Treatment|Not dosed|0|||
126605271|NCT03160885|455515005|FG005|Open-label Treatment|Not dosed|0|||
126605272|NCT03160885|455515006|FG006|Open-label Treatment|Not dosed|2|||
126605273|NCT03160885|455515000|FG000|Open-label Treatment|Discontinued IMP|0|||
126605274|NCT03160885|455515001|FG001|Open-label Treatment|Discontinued IMP|0|||
126605275|NCT03160885|455515002|FG002|Open-label Treatment|Discontinued IMP|0|||
126605276|NCT03160885|455515003|FG003|Open-label Treatment|Discontinued IMP|0|||
126605277|NCT03160885|455515004|FG004|Open-label Treatment|Discontinued IMP|0|||
126605278|NCT03160885|455515005|FG005|Open-label Treatment|Discontinued IMP|0|||
126605279|NCT03160885|455515006|FG006|Open-label Treatment|Discontinued IMP|131|||
126605280|NCT03160885|455515000|FG000|Open-label Treatment|Completed Week 50|0|||
126605281|NCT03160885|455515001|FG001|Open-label Treatment|Completed Week 50|0|||
126605282|NCT03160885|455515002|FG002|Open-label Treatment|Completed Week 50|0|||
126605283|NCT03160885|455515003|FG003|Open-label Treatment|Completed Week 50|0|||
126605284|NCT03160885|455515004|FG004|Open-label Treatment|Completed Week 50|0|||
126605285|NCT03160885|455515005|FG005|Open-label Treatment|Completed Week 50|0|||
126605286|NCT03160885|455515006|FG006|Open-label Treatment|Completed Week 50|4|||
126605287|NCT03160885|455515000|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
126605288|NCT03160885|455515001|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
126605289|NCT03160885|455515002|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
126605290|NCT03160885|455515003|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
126605291|NCT03160885|455515004|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
126605292|NCT03160885|455515005|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
126605293|NCT03160885|455515006|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
126605294|NCT03160885|455515000|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
126605295|NCT03160885|455515001|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
126605296|NCT03160885|455515002|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
126605297|NCT03160885|455515003|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
126605298|NCT03160885|455515004|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
126605299|NCT03160885|455515005|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
126605300|NCT03160885|455515006|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
126605301|NCT03160885|455515000|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126605302|NCT03160885|455515001|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126605303|NCT03160885|455515002|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
126605304|NCT03160885|455515003|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
126605305|NCT03160885|455515004|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
126605306|NCT03160885|455515005|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
126781049|NCT02040766|456152921|FG002|Overall Study|Lost to Follow-up|3|||
126781050|NCT02040766|456152922|FG003|Overall Study|Lost to Follow-up|1|||
126781051|NCT02040766|456152923|FG004|Overall Study|Lost to Follow-up|4|||
126781052|NCT02040766|456152919|FG000|Overall Study|Not reported|1|||
126781053|NCT02040766|456152920|FG001|Overall Study|Not reported|0|||
126781054|NCT02040766|456152921|FG002|Overall Study|Not reported|0|||
126605307|NCT03160885|455515006|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
126605308|NCT03160885|455515000|FG000|Maintenance Treatment Period|Completed Week 50|0|||
126605309|NCT03160885|455515001|FG001|Maintenance Treatment Period|Completed Week 50|0|||
126605310|NCT03160885|455515002|FG002|Maintenance Treatment Period|Completed Week 50|1|||
126605311|NCT03160885|455515003|FG003|Maintenance Treatment Period|Completed Week 50|0|||
126605312|NCT03160885|455515004|FG004|Maintenance Treatment Period|Completed Week 50|0|||
126605313|NCT03160885|455515005|FG005|Maintenance Treatment Period|Completed Week 50|0|||
126605314|NCT03160885|455515006|FG006|Maintenance Treatment Period|Completed Week 50|0|||
126605315|NCT03277989|455515010|FG000|Overall Study|Lost to Follow-up|6|||
126605316|NCT03277989|455515010|FG000|Overall Study|Adverse Event|6|||
126605317|NCT03277989|455515010|FG000|Overall Study|Withdrawal by Subject|3|||
126605318|NCT03277989|455515010|FG000|Overall Study|Didn't Receive Study Device|7|||
126605319|NCT03277989|455515010|FG000|Overall Study|Site Closure|26|||
126605320|NCT03277989|455515010|FG000|Overall Study|Sponsor Closure|107|||
126733737|NCT00877006|455973942|FG001|Treatment Period|Randomized but Not Treated|8|||
126733738|NCT00877006|455973941|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
126733739|NCT00877006|455973942|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
126733740|NCT00877006|455973941|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
126733741|NCT00877006|455973942|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
126733742|NCT00877006|455973941|FG000|Long-Term Follow-up Period|Death|26|||
126733743|NCT00877006|455973942|FG001|Long-Term Follow-up Period|Death|18|||
126733744|NCT00877006|455973941|FG000|Long-Term Follow-up Period|Other|7|||
126733745|NCT00877006|455973942|FG001|Long-Term Follow-up Period|Other|9|||
126733746|NCT01415908|455973943|FG000|Overall Study|Withdrawal by Subject|1|||
126733747|NCT01415908|455973944|FG001|Overall Study|Withdrawal by Subject|0|||
126733748|NCT02034552|455973945|FG000|Overall Study|Never treated|3|||
126733749|NCT02034552|455973946|FG001|Overall Study|Never treated|2|||
126733750|NCT02034552|455973947|FG002|Overall Study|Never treated|0|||
126733751|NCT02034552|455973945|FG000|Overall Study|Radiological progression|3|||
126733752|NCT02034552|455973946|FG001|Overall Study|Radiological progression|5|||
126733753|NCT02034552|455973947|FG002|Overall Study|Radiological progression|4|||
126733754|NCT02034552|455973945|FG000|Overall Study|AE not assoc. with disease progression|1|||
126733755|NCT02034552|455973946|FG001|Overall Study|AE not assoc. with disease progression|4|||
126733756|NCT02034552|455973947|FG002|Overall Study|AE not assoc. with disease progression|2|||
126733757|NCT02034552|455973945|FG000|Overall Study|AE associated with disease progression|0|||
126733758|NCT02034552|455973946|FG001|Overall Study|AE associated with disease progression|1|||
126733759|NCT02034552|455973947|FG002|Overall Study|AE associated with disease progression|0|||
126733760|NCT02034552|455973945|FG000|Overall Study|Withdrawal by Subject|2|||
126733761|NCT02034552|455973946|FG001|Overall Study|Withdrawal by Subject|1|||
126733762|NCT02034552|455973947|FG002|Overall Study|Withdrawal by Subject|1|||
126781055|NCT02040766|456152922|FG003|Overall Study|Not reported|0|||
126781056|NCT02040766|456152923|FG004|Overall Study|Not reported|0|||
126733763|NCT02034552|455973945|FG000|Overall Study|Non-compliance with study drug|0|||
126733764|NCT02034552|455973946|FG001|Overall Study|Non-compliance with study drug|0|||
126733765|NCT02034552|455973947|FG002|Overall Study|Non-compliance with study drug|1|||
126733766|NCT02034552|455973945|FG000|Overall Study|Clinical progression|5|||
126733767|NCT02034552|455973946|FG001|Overall Study|Clinical progression|7|||
126733768|NCT02034552|455973947|FG002|Overall Study|Clinical progression|9|||
126781057|NCT02040766|456152919|FG000|Overall Study|Lack of Efficacy|6|||
126781058|NCT02040766|456152920|FG001|Overall Study|Lack of Efficacy|3|||
126605321|NCT03170349|455515011|FG000|From Implant to the 30-Day Visit|Death|1|||
126605322|NCT03170349|455515011|FG000|From 30-Day to 6-Month Visit|Death|3|||
126605323|NCT03170349|455515011|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
126605324|NCT03170349|455515011|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
126605325|NCT03170349|455515011|FG000|From 6-Month to 1-Year Visit|Death|6|||
126605326|NCT03170349|455515011|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
126605327|NCT03170349|455515011|FG000|From 1-Year to 2-Year Visit|Death|13|||
126605328|NCT03170349|455515011|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
126605329|NCT03170349|455515011|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
126605330|NCT03170349|455515011|FG000|From 2-Year to 3-Year Visit|Death|10|||
126605331|NCT03170349|455515011|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
126605332|NCT03170349|455515011|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
126605333|NCT03170349|455515011|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
126605334|NCT03516942|455515012|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
126605335|NCT03516942|455515012|FG000|Registration Through Baseline Survey Com|Death|8|||
126605336|NCT03516942|455515012|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
126605337|NCT03516942|455515012|FG000|T0: Baseline|LOST|13|||
126605338|NCT03516942|455515012|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
126605339|NCT03516942|455515012|FG000|T1: 3 Months Survey|Death|10|||
126605340|NCT03516942|455515012|FG000|T1: 3 Months Survey|Lost|163|||
126605341|NCT03516942|455515012|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
126605342|NCT03516942|455515012|FG000|T2: 6 Month Survey|Death|14|||
126605343|NCT03516942|455515012|FG000|T2: 6 Month Survey|Lost|180|||
126605344|NCT03516942|455515012|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
126605345|NCT03516942|455515012|FG000|T3: 12 Month Survey|Death|19|||
126605346|NCT03516942|455515012|FG000|T3: 12 Month Survey|Lost|209|||
126605347|NCT04551066|455515013|FG000|Overall Study|Death|5|||
126605348|NCT04551066|455515014|FG001|Overall Study|Death|3|||
126605349|NCT04551066|455515013|FG000|Overall Study|Lost to Follow-up|1|||
126605350|NCT04551066|455515014|FG001|Overall Study|Lost to Follow-up|0|||
126605351|NCT04551066|455515013|FG000|Overall Study|Sponsor Decision|103|||
126605352|NCT04551066|455515014|FG001|Overall Study|Sponsor Decision|117|||
126605353|NCT04551066|455515013|FG000|Overall Study|Withdrawal by Subject|8|||
126605354|NCT04551066|455515014|FG001|Overall Study|Withdrawal by Subject|2|||
126605355|NCT04551066|455515013|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
126605356|NCT04551066|455515014|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
126605357|NCT04551066|455515013|FG000|Overall Study|Adverse Event|2|||
126605358|NCT04551066|455515014|FG001|Overall Study|Adverse Event|0|||
126605359|NCT04551066|455515013|FG000|Overall Study|Physician Decision|2|||
126605360|NCT04551066|455515014|FG001|Overall Study|Physician Decision|0|||
126605361|NCT04551066|455515013|FG000|Overall Study|Protocol Violation|1|||
126605362|NCT04551066|455515014|FG001|Overall Study|Protocol Violation|0|||
126605363|NCT04551066|455515013|FG000|Overall Study|Lack of Efficacy|0|||
126605364|NCT04551066|455515014|FG001|Overall Study|Lack of Efficacy|1|||
126605365|NCT04551066|455515013|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
126605366|NCT04551066|455515014|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
126605367|NCT05529992|455515015|FG000|Overall Study|Withdrawal by Subject|1|||
126605368|NCT02798471|455515018|FG000|Overall Study|Adverse Event|7|||
126605369|NCT02798471|455515019|FG001|Overall Study|Adverse Event|2|||
126605370|NCT02798471|455515018|FG000|Overall Study|Physician Decision|3|||
126605371|NCT02798471|455515019|FG001|Overall Study|Physician Decision|7|||
126605372|NCT02798471|455515018|FG000|Overall Study|Death|2|||
126605373|NCT02798471|455515019|FG001|Overall Study|Death|3|||
126605374|NCT02798471|455515018|FG000|Overall Study|Lost to Follow-up|0|||
126605375|NCT02798471|455515019|FG001|Overall Study|Lost to Follow-up|1|||
126605376|NCT02798471|455515018|FG000|Overall Study|Other|5|||
126605377|NCT02798471|455515019|FG001|Overall Study|Other|3|||
126605378|NCT02798471|455515018|FG000|Overall Study|Subject withdrew consent|0|||
126605379|NCT02798471|455515019|FG001|Overall Study|Subject withdrew consent|6|||
126605380|NCT02798471|455515018|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
126605381|NCT02798471|455515019|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
126605382|NCT02798471|455515018|FG000|Overall Study|Randomized, but not treated|0|||
126605383|NCT02798471|455515019|FG001|Overall Study|Randomized, but not treated|2|||
126605384|NCT05293717|455515020|FG000|Overall Study|Physician Decision|1|||
126605385|NCT00065182|455516356|FG000|Overall Study|Adverse Event|24|||
126605386|NCT00065182|455516357|FG001|Overall Study|Adverse Event|17|||
126605387|NCT00065182|455516356|FG000|Overall Study|Lost to Follow-up|0|||
126605388|NCT00065182|455516357|FG001|Overall Study|Lost to Follow-up|4|||
126605389|NCT00065182|455516356|FG000|Overall Study|Protocol Violation|3|||
126733769|NCT01188096|455973949|FG000|Overall Study|progression of disease|4|||
126733770|NCT01188096|455973949|FG000|Overall Study|Withdrawal by Subject|2|||
126733771|NCT00851253|455973953|FG000|Overall Study|Disease Progression|1|||
126733772|NCT00851253|455973954|FG001|Overall Study|Disease Progression|0|||
126733773|NCT02062398|455973955|FG000|Overall Study|Implant removal|1|||
126733774|NCT01779648|455973956|FG000|Overall Study|Protocol Violation|1|||
126733775|NCT01779648|455973957|FG001|Overall Study|Protocol Violation|0|||
126733776|NCT00415519|455973958|FG000|Overall Study|Adverse Event|1|||
126733777|NCT00415519|455973959|FG001|Overall Study|Adverse Event|0|||
126733778|NCT00415519|455973958|FG000|Overall Study|Withdrawal by Subject|2|||
126733779|NCT00415519|455973959|FG001|Overall Study|Withdrawal by Subject|0|||
126733780|NCT00415519|455973958|FG000|Overall Study|Patient's convenience|1|||
126733781|NCT00415519|455973959|FG001|Overall Study|Patient's convenience|0|||
126733782|NCT03485222|455973966|FG000|Overall Study|Death|0|||
126733783|NCT03485222|455973967|FG001|Overall Study|Death|1|||
126733784|NCT03485222|455973966|FG000|Overall Study|Lost to Follow-up|2|||
126733785|NCT03485222|455973967|FG001|Overall Study|Lost to Follow-up|1|||
126733786|NCT01705587|455973969|FG000|Overall Study|Withdrawal by Subject|0|||
126733787|NCT01705587|455973970|FG001|Overall Study|Withdrawal by Subject|1|||
126733788|NCT01373918|455973973|FG000|Overall Study|Physician Decision|0|||
126733789|NCT01373918|455973974|FG001|Overall Study|Physician Decision|1|||
126733790|NCT03004976|455973976|FG000|Overall Study|Lost to Follow-up|7|||
126733791|NCT03004976|455973977|FG001|Overall Study|Lost to Follow-up|5|||
126733792|NCT03004976|455973976|FG000|Overall Study|Physician Decision|1|||
126733793|NCT03004976|455973977|FG001|Overall Study|Physician Decision|0|||
126733794|NCT03004976|455973976|FG000|Overall Study|Withdrawal by Subject|1|||
126733795|NCT03004976|455973977|FG001|Overall Study|Withdrawal by Subject|0|||
126733796|NCT03004976|455973976|FG000|Overall Study|Death|4|||
126733797|NCT03004976|455973977|FG001|Overall Study|Death|1|||
126733798|NCT00291499|455973981|FG000|Overall Study|Adverse Event|3|||
126733799|NCT00291499|455973982|FG001|Overall Study|Adverse Event|8|||
126733800|NCT00291499|455973981|FG000|Overall Study|Change to other therapy|2|||
126781059|NCT02040766|456152921|FG002|Overall Study|Lack of Efficacy|4|||
126781060|NCT02040766|456152922|FG003|Overall Study|Lack of Efficacy|6|||
126605390|NCT00065182|455516357|FG001|Overall Study|Protocol Violation|4|||
126605391|NCT00065182|455516356|FG000|Overall Study|Serious adverse events (SAE)|1|||
126605392|NCT00065182|455516357|FG001|Overall Study|Serious adverse events (SAE)|0|||
126605393|NCT00065182|455516356|FG000|Overall Study|Sponsor Decision|11|||
126605394|NCT00065182|455516357|FG001|Overall Study|Sponsor Decision|7|||
126605395|NCT00065182|455516356|FG000|Overall Study|Withdrawal by Subject|8|||
126605396|NCT00065182|455516357|FG001|Overall Study|Withdrawal by Subject|3|||
126605397|NCT00065182|455516356|FG000|Overall Study|No clinical benefit|1|||
126605398|NCT00065182|455516357|FG001|Overall Study|No clinical benefit|0|||
126605399|NCT00065182|455516356|FG000|Overall Study|Death|0|||
126605400|NCT00065182|455516357|FG001|Overall Study|Death|1|||
126605401|NCT00065182|455516356|FG000|Overall Study|Decline in Status|0|||
126605402|NCT00065182|455516357|FG001|Overall Study|Decline in Status|1|||
126605403|NCT00754325|455516358|FG000|Initial Treatment|Continuing Active Treatment|4|||
126605404|NCT00754325|455516359|FG001|Initial Treatment|Continuing Active Treatment|5|||
126605405|NCT00754325|455516358|FG000|Initial Treatment|Adverse Event|7|||
126605406|NCT00754325|455516359|FG001|Initial Treatment|Adverse Event|6|||
126605407|NCT00754325|455516358|FG000|Initial Treatment|Withdrawal by Subject|2|||
126605408|NCT00754325|455516359|FG001|Initial Treatment|Withdrawal by Subject|2|||
126605409|NCT00754325|455516358|FG000|Initial Treatment|Physician Decision|2|||
126605410|NCT00754325|455516359|FG001|Initial Treatment|Physician Decision|0|||
126605411|NCT00754325|455516358|FG000|Initial Treatment|Sponsor Request|0|||
126605412|NCT00754325|455516359|FG001|Initial Treatment|Sponsor Request|1|||
126605413|NCT00754325|455516358|FG000|Initial Treatment|Disease Progression|35|||
126605414|NCT00754325|455516359|FG001|Initial Treatment|Disease Progression|35|||
126605415|NCT04876417|455516362|FG000|Overall Study|Lost to Follow-up|5|||
126605416|NCT04876417|455516363|FG001|Overall Study|Lost to Follow-up|8|||
126605417|NCT04876417|455516364|FG002|Overall Study|Lost to Follow-up|0|||
126605418|NCT04876417|455516365|FG003|Overall Study|Lost to Follow-up|0|||
126605419|NCT03801148|455516366|FG000|Period 1 (2 Days)|Adverse Event|1|||
126605420|NCT03801148|455516367|FG001|Period 1 (2 Days)|Adverse Event|1|||
126605421|NCT03801148|455516368|FG002|Period 1 (2 Days)|Adverse Event|0|||
126605422|NCT03801148|455516369|FG003|Period 1 (2 Days)|Adverse Event|0|||
126605423|NCT03801148|455516366|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
126605424|NCT03801148|455516367|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
126605425|NCT03801148|455516368|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
126605426|NCT03801148|455516369|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
126605427|NCT03801148|455516366|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126605428|NCT03801148|455516367|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126605429|NCT03801148|455516368|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
126605430|NCT03801148|455516369|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
126605431|NCT03801148|455516366|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
126733801|NCT00291499|455973982|FG001|Overall Study|Change to other therapy|1|||
126733802|NCT00291499|455973981|FG000|Overall Study|Intercurrent illness|1|||
126733803|NCT00291499|455973982|FG001|Overall Study|Intercurrent illness|0|||
126733804|NCT00291499|455973981|FG000|Overall Study|Protocol Violation|2|||
126733805|NCT00291499|455973982|FG001|Overall Study|Protocol Violation|2|||
126733806|NCT00291499|455973981|FG000|Overall Study|Other reasons|1|||
126781061|NCT02040766|456152923|FG004|Overall Study|Lack of Efficacy|5|||
126733807|NCT00291499|455973982|FG001|Overall Study|Other reasons|4|||
126605432|NCT03801148|455516367|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
126605433|NCT03801148|455516368|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
126605434|NCT03801148|455516369|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
126605435|NCT00439270|455516372|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
126605436|NCT00439270|455516373|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
126605437|NCT00439270|455516374|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
126605438|NCT00439270|455516375|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
126605439|NCT00439270|455516376|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
126605440|NCT00439270|455516372|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
126605441|NCT00439270|455516373|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
126605442|NCT00439270|455516374|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
126605443|NCT00439270|455516375|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
126605444|NCT00439270|455516376|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
126605445|NCT00439270|455516372|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
126605446|NCT00439270|455516373|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
126605447|NCT00439270|455516374|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
126605448|NCT00439270|455516375|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
126605449|NCT00439270|455516376|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
126605450|NCT00439270|455516372|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
126605451|NCT00439270|455516373|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
126605452|NCT00439270|455516374|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
126605453|NCT00439270|455516375|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
126605454|NCT00439270|455516376|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
126605455|NCT00439270|455516372|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
126605456|NCT00439270|455516373|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
126605457|NCT00439270|455516374|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
126605458|NCT00439270|455516375|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
126605459|NCT00439270|455516376|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
126605460|NCT00439270|455516372|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
126605461|NCT00439270|455516373|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
126605462|NCT00439270|455516374|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
126605463|NCT00439270|455516375|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
126605464|NCT00439270|455516376|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
126605465|NCT00439270|455516372|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
126605466|NCT00439270|455516373|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
126605467|NCT00439270|455516374|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
126605468|NCT00439270|455516375|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
126605469|NCT00439270|455516376|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
126605470|NCT00439270|455516372|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
126605471|NCT00439270|455516373|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
126605472|NCT00439270|455516374|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
126605473|NCT00439270|455516375|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
126605474|NCT00439270|455516376|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
126605475|NCT00439270|455516372|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
126605476|NCT00439270|455516373|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
126605477|NCT00439270|455516374|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
126605478|NCT00439270|455516375|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
126605479|NCT00439270|455516376|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
126605480|NCT00439270|455516372|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
126605481|NCT00439270|455516373|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
126605482|NCT00439270|455516374|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
126605483|NCT00439270|455516375|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
126605484|NCT00439270|455516376|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
126605485|NCT01750684|455516379|FG000|Overall Study|Death|1|||
126605486|NCT01750684|455516380|FG001|Overall Study|Death|0|||
126605487|NCT01750684|455516379|FG000|Overall Study|Non-compliance with Study Drug|0|||
126605488|NCT01750684|455516380|FG001|Overall Study|Non-compliance with Study Drug|1|||
126605489|NCT01750684|455516379|FG000|Overall Study|Withdrawn by Sponsor|0|||
126605490|NCT01750684|455516380|FG001|Overall Study|Withdrawn by Sponsor|1|||
126605491|NCT01750684|455516379|FG000|Overall Study|Protocol Violation|1|||
126605492|NCT01750684|455516380|FG001|Overall Study|Protocol Violation|0|||
126605493|NCT02185794|455516382|FG000|Overall Study|Enrolled but Never Dosed|1|||
126605494|NCT02185794|455516383|FG001|Overall Study|Enrolled but Never Dosed|6|||
126605495|NCT02185794|455516384|FG002|Overall Study|Enrolled but Never Dosed|3|||
126605496|NCT02185794|455516385|FG003|Overall Study|Enrolled but Never Dosed|1|||
126605497|NCT02185794|455516386|FG004|Overall Study|Enrolled but Never Dosed|1|||
126605498|NCT02185794|455516387|FG005|Overall Study|Enrolled but Never Dosed|0|||
126605499|NCT02185794|455516382|FG000|Overall Study|Investigator's Discretion|1|||
126605500|NCT02185794|455516383|FG001|Overall Study|Investigator's Discretion|0|||
126781062|NCT00696709|456152926|FG000|Overall Study|Withdrawal by Subject|1|||
126781063|NCT00696709|456152927|FG001|Overall Study|Withdrawal by Subject|2|||
126605501|NCT02185794|455516384|FG002|Overall Study|Investigator's Discretion|1|||
126605502|NCT02185794|455516385|FG003|Overall Study|Investigator's Discretion|2|||
126605503|NCT02185794|455516386|FG004|Overall Study|Investigator's Discretion|2|||
126605504|NCT02185794|455516387|FG005|Overall Study|Investigator's Discretion|15|||
126605505|NCT02185794|455516382|FG000|Overall Study|Withdrew Consent|2|||
126605506|NCT02185794|455516383|FG001|Overall Study|Withdrew Consent|5|||
126605507|NCT02185794|455516384|FG002|Overall Study|Withdrew Consent|10|||
126605508|NCT02185794|455516385|FG003|Overall Study|Withdrew Consent|2|||
126605509|NCT02185794|455516386|FG004|Overall Study|Withdrew Consent|0|||
126605510|NCT02185794|455516387|FG005|Overall Study|Withdrew Consent|0|||
126605511|NCT02185794|455516382|FG000|Overall Study|Lost to Follow-up|1|||
126605512|NCT02185794|455516383|FG001|Overall Study|Lost to Follow-up|2|||
126605513|NCT02185794|455516384|FG002|Overall Study|Lost to Follow-up|2|||
126605514|NCT02185794|455516385|FG003|Overall Study|Lost to Follow-up|3|||
126605515|NCT02185794|455516386|FG004|Overall Study|Lost to Follow-up|0|||
126605516|NCT02185794|455516387|FG005|Overall Study|Lost to Follow-up|1|||
126605517|NCT01092416|455516388|FG000|Enrollment|Atherectomy device not inserted|3|||
126605518|NCT01092416|455516388|FG000|30-Day Follow-up|Death|2|||
126605519|NCT01092416|455516388|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
126605520|NCT01092416|455516388|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
126605521|NCT01092416|455516388|FG000|12-Month Follow-up|Death|16|||
126605522|NCT01092416|455516388|FG000|12-Month Follow-up|Lost to Follow-up|4|||
126605523|NCT01092416|455516388|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
126605524|NCT01092416|455516388|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
126733808|NCT01532570|455973983|FG000|Overall Study|Lack of Efficacy|1|||
126733809|NCT01532570|455973984|FG001|Overall Study|Lack of Efficacy|0|||
126605525|NCT01092416|455516388|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
126605526|NCT00366249|455516389|FG000|Overall Study|Adverse Event|53|||
126605527|NCT00366249|455516390|FG001|Overall Study|Adverse Event|28|||
126605528|NCT00366249|455516389|FG000|Overall Study|Death|0|||
126605529|NCT00366249|455516390|FG001|Overall Study|Death|1|||
126605530|NCT00366249|455516389|FG000|Overall Study|Physician Decision|5|||
126605531|NCT00366249|455516390|FG001|Overall Study|Physician Decision|2|||
126605532|NCT00366249|455516389|FG000|Overall Study|Lost to Follow-up|2|||
126605533|NCT00366249|455516390|FG001|Overall Study|Lost to Follow-up|0|||
126605534|NCT00366249|455516389|FG000|Overall Study|Protocol Violation|1|||
126605535|NCT00366249|455516390|FG001|Overall Study|Protocol Violation|2|||
126605536|NCT00366249|455516389|FG000|Overall Study|Withdrawal by Subject|18|||
126605537|NCT00366249|455516390|FG001|Overall Study|Withdrawal by Subject|4|||
126605538|NCT00366249|455516389|FG000|Overall Study|Lack of Efficacy|21|||
126605539|NCT00366249|455516390|FG001|Overall Study|Lack of Efficacy|21|||
126605540|NCT00366249|455516389|FG000|Overall Study|Most due to osteomylitis status|31|||
126605541|NCT00366249|455516390|FG001|Overall Study|Most due to osteomylitis status|20|||
126605542|NCT00777049|455516391|FG000|Overall Study|Withdrawal by Subject|1|||
126605543|NCT00777049|455516392|FG001|Overall Study|Withdrawal by Subject|0|||
126605544|NCT00777049|455516391|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
126605545|NCT00777049|455516392|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
126605546|NCT03478969|455516393|FG000|Overall Study|Withdrawal by Subject|4|||
126605547|NCT03478969|455516394|FG001|Overall Study|Withdrawal by Subject|7|||
126605548|NCT03478969|455516395|FG002|Overall Study|Withdrawal by Subject|6|||
126605549|NCT03478969|455516393|FG000|Overall Study|Adverse Event|2|||
126733810|NCT01532570|455973985|FG002|Overall Study|Lack of Efficacy|0|||
126733811|NCT01532570|455973986|FG003|Overall Study|Lack of Efficacy|0|||
126605550|NCT03478969|455516394|FG001|Overall Study|Adverse Event|0|||
126605551|NCT03478969|455516395|FG002|Overall Study|Adverse Event|1|||
126605552|NCT03478969|455516393|FG000|Overall Study|Pregnancy|1|||
126605553|NCT03478969|455516394|FG001|Overall Study|Pregnancy|0|||
126733812|NCT01532570|455973983|FG000|Overall Study|Withdrawal by Subject|0|||
126733813|NCT01532570|455973984|FG001|Overall Study|Withdrawal by Subject|1|||
126733814|NCT01532570|455973985|FG002|Overall Study|Withdrawal by Subject|0|||
126733815|NCT01532570|455973986|FG003|Overall Study|Withdrawal by Subject|0|||
126733816|NCT01807949|455973988|FG000|Overall Study|Adverse Event|1|||
126605554|NCT03478969|455516395|FG002|Overall Study|Pregnancy|0|||
126605555|NCT03478969|455516393|FG000|Overall Study|Personal Reasons|1|||
126605556|NCT03478969|455516394|FG001|Overall Study|Personal Reasons|0|||
126605557|NCT03478969|455516395|FG002|Overall Study|Personal Reasons|1|||
126605558|NCT03478969|455516393|FG000|Overall Study|Covid-19|1|||
126605559|NCT03478969|455516394|FG001|Overall Study|Covid-19|4|||
126605560|NCT03478969|455516395|FG002|Overall Study|Covid-19|3|||
126605561|NCT03478969|455516393|FG000|Overall Study|Multiple Reasons|0|||
126605562|NCT03478969|455516394|FG001|Overall Study|Multiple Reasons|1|||
126605563|NCT03478969|455516395|FG002|Overall Study|Multiple Reasons|1|||
126605564|NCT03478969|455516393|FG000|Overall Study|Eligibility Criteria|0|||
126605565|NCT03478969|455516394|FG001|Overall Study|Eligibility Criteria|0|||
126733817|NCT01807949|455973989|FG001|Overall Study|Adverse Event|2|||
126605566|NCT03478969|455516395|FG002|Overall Study|Eligibility Criteria|5|||
126605567|NCT03478969|455516393|FG000|Overall Study|Lost to Follow-up|0|||
126605568|NCT03478969|455516394|FG001|Overall Study|Lost to Follow-up|0|||
126733818|NCT01807949|455973990|FG002|Overall Study|Adverse Event|2|||
126605569|NCT03478969|455516395|FG002|Overall Study|Lost to Follow-up|1|||
126605570|NCT01185600|455516396|FG000|Overall Study|Adverse Event|1|||
126605571|NCT01185600|455516397|FG001|Overall Study|Adverse Event|1|||
126605572|NCT01185600|455516396|FG000|Overall Study|Death|0|||
126605573|NCT01185600|455516397|FG001|Overall Study|Death|1|||
126605574|NCT01185600|455516396|FG000|Overall Study|Lost to Follow-up|0|||
126605575|NCT01185600|455516397|FG001|Overall Study|Lost to Follow-up|5|||
126605576|NCT01185600|455516396|FG000|Overall Study|Physician Decision|29|||
126605577|NCT01185600|455516397|FG001|Overall Study|Physician Decision|35|||
126605578|NCT01185600|455516396|FG000|Overall Study|Withdrawal by Subject|1|||
126605579|NCT01185600|455516397|FG001|Overall Study|Withdrawal by Subject|1|||
126605580|NCT01185600|455516396|FG000|Overall Study|Hold by DSMB|1|||
126605581|NCT01185600|455516397|FG001|Overall Study|Hold by DSMB|2|||
126605582|NCT02941549|455516398|FG000|Overall Study|Adverse Event|1|||
126605583|NCT02941549|455516399|FG001|Overall Study|Adverse Event|0|||
126605584|NCT02941549|455516400|FG002|Overall Study|Adverse Event|0|||
126605585|NCT02941549|455516398|FG000|Overall Study|Withdrawal by Subject|2|||
126605586|NCT02941549|455516399|FG001|Overall Study|Withdrawal by Subject|1|||
126605587|NCT02941549|455516400|FG002|Overall Study|Withdrawal by Subject|2|||
126605588|NCT01436175|455516401|FG000|Overall Study|Adverse Event|111|||
126605589|NCT01436175|455516401|FG000|Overall Study|Protocol Violation|49|||
126605590|NCT01436175|455516401|FG000|Overall Study|Withdrawal by Subject|108|||
126605591|NCT01436175|455516401|FG000|Overall Study|Lost to Follow-up|89|||
126605592|NCT01436175|455516401|FG000|Overall Study|Lack of Efficacy|24|||
126605593|NCT01436175|455516401|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
126605594|NCT01436175|455516401|FG000|Overall Study|Other|826|||
126605595|NCT05405244|455516403|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
126605596|NCT05405244|455516404|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
126605597|NCT05405244|455516403|FG000|Washout (2 Weeks)|Adverse Event|2|||
126605598|NCT05405244|455516404|FG001|Washout (2 Weeks)|Adverse Event|0|||
126605599|NCT05405244|455516403|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
126605600|NCT05405244|455516404|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
126605601|NCT00739934|455516407|FG000|Voriconazole IV|Adverse Event|6|||
126605602|NCT00739934|455516407|FG000|Voriconazole Oral|Other|3|||
126605603|NCT03418922|455516408|FG000|Overall Study|Withdrawal by Subject|0|||
126605604|NCT03418922|455516409|FG001|Overall Study|Withdrawal by Subject|2|||
126605605|NCT03418922|455516408|FG000|Overall Study|Adverse Event|2|||
126605606|NCT03418922|455516409|FG001|Overall Study|Adverse Event|2|||
126605607|NCT03418922|455516408|FG000|Overall Study|Death|0|||
126605608|NCT03418922|455516409|FG001|Overall Study|Death|1|||
126605609|NCT03418922|455516408|FG000|Overall Study|Physician Decision|0|||
126605610|NCT03418922|455516409|FG001|Overall Study|Physician Decision|1|||
126605611|NCT03577106|455516410|FG000|Overall Study|Withdrawal by Subject|3|||
126605612|NCT03451422|455516411|FG000|Overall Study|Lost to Follow-up|0|||
126605613|NCT03451422|455516412|FG001|Overall Study|Lost to Follow-up|0|||
126605614|NCT03451422|455516413|FG002|Overall Study|Lost to Follow-up|0|||
126605615|NCT03451422|455516414|FG003|Overall Study|Lost to Follow-up|0|||
126605616|NCT03451422|455516415|FG004|Overall Study|Lost to Follow-up|0|||
126605617|NCT03451422|455516416|FG005|Overall Study|Lost to Follow-up|1|||
126605618|NCT03451422|455516411|FG000|Overall Study|Decision by sponsor|1|||
126605619|NCT03451422|455516412|FG001|Overall Study|Decision by sponsor|0|||
126605620|NCT03451422|455516413|FG002|Overall Study|Decision by sponsor|1|||
126605621|NCT03451422|455516414|FG003|Overall Study|Decision by sponsor|0|||
126605622|NCT03451422|455516415|FG004|Overall Study|Decision by sponsor|0|||
126605623|NCT03451422|455516416|FG005|Overall Study|Decision by sponsor|0|||
126605624|NCT03451422|455516411|FG000|Overall Study|Withdrawal by Subject|0|||
126605625|NCT03451422|455516412|FG001|Overall Study|Withdrawal by Subject|0|||
126605626|NCT03451422|455516413|FG002|Overall Study|Withdrawal by Subject|2|||
126605627|NCT03451422|455516414|FG003|Overall Study|Withdrawal by Subject|3|||
126605628|NCT03451422|455516415|FG004|Overall Study|Withdrawal by Subject|2|||
126605629|NCT03451422|455516416|FG005|Overall Study|Withdrawal by Subject|1|||
126605630|NCT01342367|455516419|FG000|Overall Study|Death|1|||
126605631|NCT01342367|455516420|FG001|Overall Study|Death|0|||
126605632|NCT01342367|455516419|FG000|Overall Study|Withdrawal by Subject|1|||
126605633|NCT01342367|455516420|FG001|Overall Study|Withdrawal by Subject|2|||
126605634|NCT02964741|455516421|FG000|Overall Study|Protocol Violation|1|||
126605635|NCT02964741|455516422|FG001|Overall Study|Protocol Violation|0|||
126605636|NCT02964741|455516423|FG002|Overall Study|Protocol Violation|0|||
126605637|NCT02964741|455516421|FG000|Overall Study|Withdrawal by Subject|0|||
126605638|NCT02964741|455516422|FG001|Overall Study|Withdrawal by Subject|1|||
126605639|NCT02964741|455516423|FG002|Overall Study|Withdrawal by Subject|0|||
126605640|NCT02964741|455516421|FG000|Overall Study|claustrophobia|1|||
126605641|NCT02964741|455516422|FG001|Overall Study|claustrophobia|0|||
126605642|NCT02964741|455516423|FG002|Overall Study|claustrophobia|0|||
126605643|NCT00640159|455516424|FG000|Overall Study|Lost to Follow-up|2|||
126605644|NCT01500200|455516425|FG000|Stage 1|Adverse Event|1|||
126605645|NCT01500200|455516426|FG001|Stage 1|Adverse Event|4|||
126605646|NCT01500200|455516427|FG002|Stage 1|Adverse Event|5|||
126605647|NCT01500200|455516428|FG003|Stage 1|Adverse Event|0|||
126605648|NCT01500200|455516429|FG004|Stage 1|Adverse Event|0|||
126605649|NCT01500200|455516430|FG005|Stage 1|Adverse Event|0|||
126605650|NCT01500200|455516425|FG000|Stage 1|Lost to Follow-up|2|||
126605651|NCT01500200|455516426|FG001|Stage 1|Lost to Follow-up|2|||
126605652|NCT01500200|455516427|FG002|Stage 1|Lost to Follow-up|1|||
126605653|NCT01500200|455516428|FG003|Stage 1|Lost to Follow-up|0|||
126605654|NCT01500200|455516429|FG004|Stage 1|Lost to Follow-up|0|||
126605655|NCT01500200|455516430|FG005|Stage 1|Lost to Follow-up|0|||
126605656|NCT01500200|455516425|FG000|Stage 1|Withdrawal by Subject|3|||
126605657|NCT01500200|455516426|FG001|Stage 1|Withdrawal by Subject|0|||
126605658|NCT01500200|455516427|FG002|Stage 1|Withdrawal by Subject|0|||
126605659|NCT01500200|455516428|FG003|Stage 1|Withdrawal by Subject|0|||
126605660|NCT01500200|455516429|FG004|Stage 1|Withdrawal by Subject|0|||
126605661|NCT01500200|455516430|FG005|Stage 1|Withdrawal by Subject|0|||
126605662|NCT01500200|455516425|FG000|Stage 1|Noncompliance with Study Drug|1|||
126605663|NCT01500200|455516426|FG001|Stage 1|Noncompliance with Study Drug|0|||
126605664|NCT01500200|455516427|FG002|Stage 1|Noncompliance with Study Drug|0|||
126605665|NCT01500200|455516428|FG003|Stage 1|Noncompliance with Study Drug|0|||
126605666|NCT01500200|455516429|FG004|Stage 1|Noncompliance with Study Drug|0|||
126605667|NCT01500200|455516430|FG005|Stage 1|Noncompliance with Study Drug|0|||
126605668|NCT01500200|455516425|FG000|Stage 1|Physician Decision|1|||
126605669|NCT01500200|455516426|FG001|Stage 1|Physician Decision|0|||
126605670|NCT01500200|455516427|FG002|Stage 1|Physician Decision|0|||
126605671|NCT01500200|455516428|FG003|Stage 1|Physician Decision|0|||
126605672|NCT01500200|455516429|FG004|Stage 1|Physician Decision|0|||
126605673|NCT01500200|455516430|FG005|Stage 1|Physician Decision|0|||
126605674|NCT01500200|455516425|FG000|Stage 2|Adverse Event|0|||
126605675|NCT01500200|455516426|FG001|Stage 2|Adverse Event|0|||
126605676|NCT01500200|455516427|FG002|Stage 2|Adverse Event|0|||
126605677|NCT01500200|455516428|FG003|Stage 2|Adverse Event|0|||
126605678|NCT01500200|455516429|FG004|Stage 2|Adverse Event|5|||
126605679|NCT01500200|455516430|FG005|Stage 2|Adverse Event|4|||
126605680|NCT04860505|455516437|FG000|Overall Study|Lost to Follow-up|2|||
126605681|NCT01212744|455516446|FG000|Overall Study|Withdrawal by Subject|1|||
126605682|NCT02167451|455516447|FG000|Overall Study|Withdrawal by Subject|1|||
126605683|NCT01218659|455516448|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
126605684|NCT01218659|455516449|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
126605685|NCT01218659|455516450|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
126605686|NCT01218659|455516448|FG000|18-Month Randomized Period|Did not receive study drug|0|||
126605687|NCT01218659|455516449|FG001|18-Month Randomized Period|Did not receive study drug|3|||
126605688|NCT01218659|455516450|FG002|18-Month Randomized Period|Did not receive study drug|0|||
126605689|NCT01218659|455516448|FG000|12-Month OLE|Withdrawal by Subject|0|||
126605690|NCT01218659|455516449|FG001|12-Month OLE|Withdrawal by Subject|0|||
126605691|NCT01218659|455516450|FG002|12-Month OLE|Withdrawal by Subject|2|||
126605692|NCT01218659|455516448|FG000|12-Month OLE|Physician Decision|0|||
126605693|NCT01218659|455516449|FG001|12-Month OLE|Physician Decision|0|||
126605694|NCT01218659|455516450|FG002|12-Month OLE|Physician Decision|1|||
126605695|NCT01218659|455516448|FG000|12-Month OLE|Lost to Follow-up|0|||
126605696|NCT01218659|455516449|FG001|12-Month OLE|Lost to Follow-up|0|||
126605697|NCT01218659|455516450|FG002|12-Month OLE|Lost to Follow-up|1|||
126605698|NCT01218659|455516448|FG000|12-Month OLE|Pregnancy|0|||
126605699|NCT01218659|455516449|FG001|12-Month OLE|Pregnancy|0|||
126605700|NCT01218659|455516450|FG002|12-Month OLE|Pregnancy|1|||
126605701|NCT01218659|455516448|FG000|12-Month OLE|Lack of Efficacy|0|||
126605702|NCT01218659|455516449|FG001|12-Month OLE|Lack of Efficacy|0|||
126605703|NCT01218659|455516450|FG002|12-Month OLE|Lack of Efficacy|1|||
126605704|NCT01218659|455516448|FG000|12-Month OLE|Declined to participate in the OLE|0|||
126605705|NCT01218659|455516449|FG001|12-Month OLE|Declined to participate in the OLE|0|||
126605706|NCT01218659|455516450|FG002|12-Month OLE|Declined to participate in the OLE|4|||
126605707|NCT03066609|455516455|FG000|INDUCTION|Pregnancy|0|||
126605708|NCT03066609|455516456|FG001|INDUCTION|Pregnancy|0|||
126605709|NCT03066609|455516457|FG002|INDUCTION|Pregnancy|1|||
126781064|NCT00696709|456152928|FG002|Overall Study|Withdrawal by Subject|1|||
126605710|NCT03066609|455516458|FG003|INDUCTION|Pregnancy|0|||
126605711|NCT03066609|455516455|FG000|INDUCTION|Lack of Efficacy|0|||
126605712|NCT03066609|455516456|FG001|INDUCTION|Lack of Efficacy|0|||
126605713|NCT03066609|455516457|FG002|INDUCTION|Lack of Efficacy|1|||
126605714|NCT03066609|455516458|FG003|INDUCTION|Lack of Efficacy|0|||
126605715|NCT03066609|455516455|FG000|INDUCTION|Adverse Event|2|||
126605716|NCT03066609|455516456|FG001|INDUCTION|Adverse Event|2|||
126605717|NCT03066609|455516457|FG002|INDUCTION|Adverse Event|0|||
126605718|NCT03066609|455516458|FG003|INDUCTION|Adverse Event|0|||
126605719|NCT03066609|455516455|FG000|MAINTENANCE|Adverse Event|0|||
126605720|NCT03066609|455516456|FG001|MAINTENANCE|Adverse Event|0|||
126605721|NCT03066609|455516457|FG002|MAINTENANCE|Adverse Event|0|||
126605722|NCT03066609|455516458|FG003|MAINTENANCE|Adverse Event|1|||
126605723|NCT03066609|455516455|FG000|MAINTENANCE|Withdrawal by Subject|4|||
126605724|NCT03066609|455516456|FG001|MAINTENANCE|Withdrawal by Subject|2|||
126605725|NCT03066609|455516457|FG002|MAINTENANCE|Withdrawal by Subject|1|||
126605726|NCT03066609|455516458|FG003|MAINTENANCE|Withdrawal by Subject|1|||
126605727|NCT03066609|455516455|FG000|MAINTENANCE|Lost to Follow-up|0|||
126605728|NCT03066609|455516456|FG001|MAINTENANCE|Lost to Follow-up|1|||
126605729|NCT03066609|455516457|FG002|MAINTENANCE|Lost to Follow-up|1|||
126605730|NCT03066609|455516458|FG003|MAINTENANCE|Lost to Follow-up|0|||
126605731|NCT03066609|455516455|FG000|MAINTENANCE|Pregnancy|1|||
126605732|NCT03066609|455516456|FG001|MAINTENANCE|Pregnancy|0|||
126605733|NCT03066609|455516457|FG002|MAINTENANCE|Pregnancy|0|||
126605734|NCT03066609|455516458|FG003|MAINTENANCE|Pregnancy|0|||
126605735|NCT03066609|455516455|FG000|MAINTENANCE|Lack of Efficacy|2|||
126605736|NCT03066609|455516456|FG001|MAINTENANCE|Lack of Efficacy|1|||
126605737|NCT03066609|455516457|FG002|MAINTENANCE|Lack of Efficacy|0|||
126605738|NCT03066609|455516458|FG003|MAINTENANCE|Lack of Efficacy|1|||
126605739|NCT03066609|455516455|FG000|OVERALL STUDY|Adverse Event|2|||
126605740|NCT03066609|455516456|FG001|OVERALL STUDY|Adverse Event|2|||
126605741|NCT03066609|455516457|FG002|OVERALL STUDY|Adverse Event|0|||
126605742|NCT03066609|455516458|FG003|OVERALL STUDY|Adverse Event|1|||
126605743|NCT03066609|455516455|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
126605744|NCT03066609|455516456|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
126605745|NCT03066609|455516457|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
126605746|NCT03066609|455516458|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
126605747|NCT03066609|455516455|FG000|OVERALL STUDY|Lost to Follow-up|1|||
126605748|NCT03066609|455516456|FG001|OVERALL STUDY|Lost to Follow-up|1|||
126605749|NCT03066609|455516457|FG002|OVERALL STUDY|Lost to Follow-up|1|||
126605750|NCT03066609|455516458|FG003|OVERALL STUDY|Lost to Follow-up|1|||
126605751|NCT03066609|455516455|FG000|OVERALL STUDY|Pregnancy|1|||
126605752|NCT03066609|455516456|FG001|OVERALL STUDY|Pregnancy|0|||
126605753|NCT03066609|455516457|FG002|OVERALL STUDY|Pregnancy|1|||
126605754|NCT03066609|455516458|FG003|OVERALL STUDY|Pregnancy|0|||
126605755|NCT03066609|455516455|FG000|OVERALL STUDY|Lack of Efficacy|2|||
126605756|NCT03066609|455516456|FG001|OVERALL STUDY|Lack of Efficacy|1|||
126605757|NCT03066609|455516457|FG002|OVERALL STUDY|Lack of Efficacy|1|||
126605758|NCT03066609|455516458|FG003|OVERALL STUDY|Lack of Efficacy|1|||
126605759|NCT03066609|455516455|FG000|OVERALL STUDY|discontinued follow up|0|||
126605760|NCT03066609|455516456|FG001|OVERALL STUDY|discontinued follow up|2|||
126605761|NCT03066609|455516457|FG002|OVERALL STUDY|discontinued follow up|0|||
126605762|NCT03066609|455516458|FG003|OVERALL STUDY|discontinued follow up|0|||
126605763|NCT00523419|455516461|FG000|Overall Study|Adverse Event|1|||
126605764|NCT00523419|455516461|FG000|Overall Study|Withdrawal by Subject|1|||
126605765|NCT00523419|455516461|FG000|Overall Study|Physician Decision|2|||
126605766|NCT00523419|455516461|FG000|Overall Study|Progressive Disease|22|||
126605767|NCT00523419|455516461|FG000|Overall Study|Death due to Study Disease|4|||
126605768|NCT00523419|455516461|FG000|Overall Study|Death due to Adverse Event|2|||
126605769|NCT01218009|455516462|FG000|Overall Study|Protocol Violation|2|||
126605770|NCT01218009|455516463|FG001|Overall Study|Protocol Violation|1|||
126605771|NCT01218009|455516462|FG000|Overall Study|Withdrawal by Subject|3|||
126605772|NCT01218009|455516463|FG001|Overall Study|Withdrawal by Subject|1|||
126605773|NCT01218009|455516462|FG000|Overall Study|Sponsor terminated study|161|||
126605774|NCT01218009|455516463|FG001|Overall Study|Sponsor terminated study|163|||
126605775|NCT01437319|455516466|FG000|Phase I|Lost to Follow-up|2|||
126605776|NCT01437319|455516467|FG001|Phase I|Lost to Follow-up|0|||
126605777|NCT01437319|455516468|FG002|Phase I|Lost to Follow-up|0|||
126605778|NCT01437319|455516466|FG000|Phase I|Protocol Violation|1|||
126605779|NCT01437319|455516467|FG001|Phase I|Protocol Violation|0|||
126605780|NCT01437319|455516468|FG002|Phase I|Protocol Violation|0|||
126605781|NCT01437319|455516466|FG000|Phase I|Study related symptoms/complaints|27|||
126605782|NCT01437319|455516467|FG001|Phase I|Study related symptoms/complaints|0|||
126605783|NCT01437319|455516468|FG002|Phase I|Study related symptoms/complaints|0|||
126605784|NCT01437319|455516466|FG000|Phase I|Withdrawal by Subject|25|||
126605785|NCT01437319|455516467|FG001|Phase I|Withdrawal by Subject|0|||
126605786|NCT01437319|455516468|FG002|Phase I|Withdrawal by Subject|0|||
126605787|NCT01437319|455516466|FG000|Phase II|Withdrawal by Subject|0|||
126605788|NCT01437319|455516467|FG001|Phase II|Withdrawal by Subject|8|||
126605789|NCT01437319|455516468|FG002|Phase II|Withdrawal by Subject|16|||
126605790|NCT01437319|455516466|FG000|Phase II|Lost to Follow-up|0|||
126605791|NCT01437319|455516467|FG001|Phase II|Lost to Follow-up|7|||
126605792|NCT01437319|455516468|FG002|Phase II|Lost to Follow-up|2|||
126605793|NCT01437319|455516466|FG000|Phase II|Study related symptoms/complaints|0|||
126605794|NCT01437319|455516467|FG001|Phase II|Study related symptoms/complaints|28|||
126605795|NCT01437319|455516468|FG002|Phase II|Study related symptoms/complaints|19|||
126605796|NCT01437319|455516466|FG000|Phase II|Protocol Violation|0|||
126605797|NCT01437319|455516467|FG001|Phase II|Protocol Violation|1|||
126605798|NCT01437319|455516468|FG002|Phase II|Protocol Violation|0|||
126605799|NCT01499849|455516469|FG000|Overall Study|Adverse Event|28|||
126605800|NCT01499849|455516470|FG001|Overall Study|Adverse Event|32|||
126605801|NCT01499849|455516469|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
126605802|NCT01499849|455516470|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
126605803|NCT01499849|455516469|FG000|Overall Study|Withdrawal by Subject|43|||
126605804|NCT01499849|455516470|FG001|Overall Study|Withdrawal by Subject|43|||
126605805|NCT01499849|455516469|FG000|Overall Study|Death|5|||
126605806|NCT01499849|455516470|FG001|Overall Study|Death|7|||
126605807|NCT01499849|455516469|FG000|Overall Study|Disease Progression|11|||
126605808|NCT01499849|455516470|FG001|Overall Study|Disease Progression|10|||
126605809|NCT01499849|455516469|FG000|Overall Study|Protocol Violation|11|||
126605810|NCT01499849|455516470|FG001|Overall Study|Protocol Violation|11|||
126605811|NCT01499849|455516469|FG000|Overall Study|Physician Decision|20|||
126605812|NCT01499849|455516470|FG001|Overall Study|Physician Decision|19|||
126605813|NCT01499849|455516469|FG000|Overall Study|Lack of Efficacy|3|||
126605814|NCT01499849|455516470|FG001|Overall Study|Lack of Efficacy|4|||
126605815|NCT01499849|455516469|FG000|Overall Study|Lost to Follow-up|6|||
126605816|NCT01499849|455516470|FG001|Overall Study|Lost to Follow-up|3|||
126605817|NCT01499849|455516469|FG000|Overall Study|Other Reasons|27|||
126605818|NCT01499849|455516470|FG001|Overall Study|Other Reasons|30|||
126605819|NCT00174252|455516471|FG000|Overall Study|Protocol Violation|2|||
126605820|NCT03170882|455516472|FG000|Overall Study|Death|17|||
126605821|NCT03170882|455516473|FG001|Overall Study|Death|29|||
126605822|NCT03170882|455516472|FG000|Overall Study|Lost to Follow-up|0|||
126605823|NCT03170882|455516473|FG001|Overall Study|Lost to Follow-up|1|||
126605824|NCT03170882|455516472|FG000|Overall Study|Withdrawal by Subject|4|||
126605825|NCT03170882|455516473|FG001|Overall Study|Withdrawal by Subject|7|||
126605826|NCT03170882|455516472|FG000|Overall Study|Reason not Specified|28|||
126605827|NCT03170882|455516473|FG001|Overall Study|Reason not Specified|36|||
126605828|NCT00811941|455516474|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
126605829|NCT00811941|455516475|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
126605830|NCT00811941|455516474|FG000|All Treated Patients|Adverse Event|2|||
126605831|NCT00811941|455516475|FG001|All Treated Patients|Adverse Event|43|||
126605832|NCT00811941|455516474|FG000|All Treated Patients|Lack of Efficacy|2|||
126605833|NCT00811941|455516475|FG001|All Treated Patients|Lack of Efficacy|3|||
126605834|NCT00811941|455516474|FG000|All Treated Patients|Non-compliance|1|||
126605835|NCT00811941|455516475|FG001|All Treated Patients|Non-compliance|8|||
126605836|NCT00811941|455516474|FG000|All Treated Patients|Protocol Violation|5|||
126605837|NCT00811941|455516475|FG001|All Treated Patients|Protocol Violation|17|||
126605838|NCT00811941|455516474|FG000|All Treated Patients|Withdrawal by Subject|35|||
126605839|NCT00811941|455516475|FG001|All Treated Patients|Withdrawal by Subject|94|||
126605840|NCT00811941|455516474|FG000|All Treated Patients|Lost to Follow-up|3|||
126605841|NCT00811941|455516475|FG001|All Treated Patients|Lost to Follow-up|12|||
126605842|NCT00811941|455516474|FG000|All Treated Patients|Other Reason|4|||
126605843|NCT00811941|455516475|FG001|All Treated Patients|Other Reason|14|||
126605844|NCT03802994|455516476|FG000|Overall Study|Lost to Follow-up|0|||
126605845|NCT03802994|455516477|FG001|Overall Study|Lost to Follow-up|2|||
126605846|NCT03802994|455516478|FG002|Overall Study|Lost to Follow-up|3|||
126605847|NCT03802994|455516479|FG003|Overall Study|Lost to Follow-up|2|||
126605848|NCT03802994|455516480|FG004|Overall Study|Lost to Follow-up|2|||
126605849|NCT00622700|455516483|FG000|Core Treatment Period|Randomized but Not Treated|0|||
126605850|NCT00622700|455516484|FG001|Core Treatment Period|Randomized but Not Treated|2|||
126605851|NCT00622700|455516485|FG002|Core Treatment Period|Randomized but Not Treated|2|||
126605852|NCT00622700|455516486|FG003|Core Treatment Period|Randomized but Not Treated|0|||
126605853|NCT00622700|455516487|FG004|Core Treatment Period|Randomized but Not Treated|0|||
126605854|NCT00622700|455516488|FG005|Core Treatment Period|Randomized but Not Treated|0|||
126605855|NCT00622700|455516489|FG006|Core Treatment Period|Randomized but Not Treated|0|||
126605856|NCT00622700|455516483|FG000|Core Treatment Period|Adverse Event|18|||
126605857|NCT00622700|455516484|FG001|Core Treatment Period|Adverse Event|25|||
126605858|NCT00622700|455516485|FG002|Core Treatment Period|Adverse Event|18|||
126605859|NCT00622700|455516486|FG003|Core Treatment Period|Adverse Event|0|||
126605860|NCT00622700|455516487|FG004|Core Treatment Period|Adverse Event|0|||
126605861|NCT00622700|455516488|FG005|Core Treatment Period|Adverse Event|0|||
126605862|NCT00622700|455516489|FG006|Core Treatment Period|Adverse Event|0|||
126605863|NCT00622700|455516483|FG000|Core Treatment Period|Lack of Efficacy|19|||
126605864|NCT00622700|455516484|FG001|Core Treatment Period|Lack of Efficacy|6|||
126605865|NCT00622700|455516485|FG002|Core Treatment Period|Lack of Efficacy|12|||
126605866|NCT00622700|455516486|FG003|Core Treatment Period|Lack of Efficacy|0|||
126605867|NCT00622700|455516487|FG004|Core Treatment Period|Lack of Efficacy|0|||
126605868|NCT00622700|455516488|FG005|Core Treatment Period|Lack of Efficacy|0|||
126605869|NCT00622700|455516489|FG006|Core Treatment Period|Lack of Efficacy|0|||
126605870|NCT00622700|455516483|FG000|Core Treatment Period|Lost to Follow-up|1|||
126605871|NCT00622700|455516484|FG001|Core Treatment Period|Lost to Follow-up|1|||
126605872|NCT00622700|455516485|FG002|Core Treatment Period|Lost to Follow-up|1|||
126605873|NCT00622700|455516486|FG003|Core Treatment Period|Lost to Follow-up|0|||
126605874|NCT00622700|455516487|FG004|Core Treatment Period|Lost to Follow-up|0|||
126605875|NCT00622700|455516488|FG005|Core Treatment Period|Lost to Follow-up|0|||
126605876|NCT00622700|455516489|FG006|Core Treatment Period|Lost to Follow-up|0|||
126605877|NCT00622700|455516483|FG000|Core Treatment Period|Death|1|||
126605878|NCT00622700|455516484|FG001|Core Treatment Period|Death|0|||
126605879|NCT00622700|455516485|FG002|Core Treatment Period|Death|0|||
126605880|NCT00622700|455516486|FG003|Core Treatment Period|Death|0|||
126605881|NCT00622700|455516487|FG004|Core Treatment Period|Death|0|||
126605882|NCT00622700|455516488|FG005|Core Treatment Period|Death|0|||
126605883|NCT00622700|455516489|FG006|Core Treatment Period|Death|0|||
126605884|NCT00622700|455516483|FG000|Core Treatment Period|Progressive Disease|3|||
126605885|NCT00622700|455516484|FG001|Core Treatment Period|Progressive Disease|1|||
126605886|NCT00622700|455516485|FG002|Core Treatment Period|Progressive Disease|0|||
126605887|NCT00622700|455516486|FG003|Core Treatment Period|Progressive Disease|0|||
126605888|NCT00622700|455516487|FG004|Core Treatment Period|Progressive Disease|0|||
126605889|NCT00622700|455516488|FG005|Core Treatment Period|Progressive Disease|0|||
126605890|NCT00622700|455516489|FG006|Core Treatment Period|Progressive Disease|0|||
126605891|NCT00622700|455516483|FG000|Core Treatment Period|Withdrawal by Subject|12|||
126605892|NCT00622700|455516484|FG001|Core Treatment Period|Withdrawal by Subject|18|||
126605893|NCT00622700|455516485|FG002|Core Treatment Period|Withdrawal by Subject|15|||
126605894|NCT00622700|455516486|FG003|Core Treatment Period|Withdrawal by Subject|0|||
126605895|NCT00622700|455516487|FG004|Core Treatment Period|Withdrawal by Subject|0|||
126605896|NCT00622700|455516488|FG005|Core Treatment Period|Withdrawal by Subject|0|||
126605897|NCT00622700|455516489|FG006|Core Treatment Period|Withdrawal by Subject|0|||
126605898|NCT00622700|455516483|FG000|Core Treatment Period|Other than specified above|2|||
126605899|NCT00622700|455516484|FG001|Core Treatment Period|Other than specified above|2|||
126605900|NCT00622700|455516485|FG002|Core Treatment Period|Other than specified above|5|||
126605901|NCT00622700|455516486|FG003|Core Treatment Period|Other than specified above|0|||
126605902|NCT00622700|455516487|FG004|Core Treatment Period|Other than specified above|0|||
126605903|NCT00622700|455516488|FG005|Core Treatment Period|Other than specified above|0|||
126605904|NCT00622700|455516489|FG006|Core Treatment Period|Other than specified above|0|||
126605905|NCT00622700|455516483|FG000|Extension Treatment Period|Adverse Event|0|||
126605906|NCT00622700|455516484|FG001|Extension Treatment Period|Adverse Event|0|||
126605907|NCT00622700|455516485|FG002|Extension Treatment Period|Adverse Event|0|||
126605908|NCT00622700|455516486|FG003|Extension Treatment Period|Adverse Event|5|||
126605909|NCT00622700|455516487|FG004|Extension Treatment Period|Adverse Event|9|||
126605910|NCT00622700|455516488|FG005|Extension Treatment Period|Adverse Event|6|||
126605911|NCT00622700|455516489|FG006|Extension Treatment Period|Adverse Event|8|||
126605912|NCT00622700|455516483|FG000|Extension Treatment Period|Lack of Efficacy|0|||
126605913|NCT00622700|455516484|FG001|Extension Treatment Period|Lack of Efficacy|0|||
126605914|NCT00622700|455516485|FG002|Extension Treatment Period|Lack of Efficacy|0|||
126605915|NCT00622700|455516486|FG003|Extension Treatment Period|Lack of Efficacy|2|||
126605916|NCT00622700|455516487|FG004|Extension Treatment Period|Lack of Efficacy|8|||
126605917|NCT00622700|455516488|FG005|Extension Treatment Period|Lack of Efficacy|1|||
126605918|NCT00622700|455516489|FG006|Extension Treatment Period|Lack of Efficacy|9|||
126605919|NCT00622700|455516483|FG000|Extension Treatment Period|Protocol Violation|0|||
126605920|NCT00622700|455516484|FG001|Extension Treatment Period|Protocol Violation|0|||
126605921|NCT00622700|455516485|FG002|Extension Treatment Period|Protocol Violation|0|||
126605922|NCT00622700|455516486|FG003|Extension Treatment Period|Protocol Violation|0|||
126605923|NCT00622700|455516487|FG004|Extension Treatment Period|Protocol Violation|0|||
126605924|NCT00622700|455516488|FG005|Extension Treatment Period|Protocol Violation|2|||
126605925|NCT00622700|455516489|FG006|Extension Treatment Period|Protocol Violation|0|||
126605926|NCT00622700|455516483|FG000|Extension Treatment Period|Lost to Follow-up|0|||
126605927|NCT00622700|455516484|FG001|Extension Treatment Period|Lost to Follow-up|0|||
126605928|NCT00622700|455516485|FG002|Extension Treatment Period|Lost to Follow-up|0|||
126605929|NCT00622700|455516486|FG003|Extension Treatment Period|Lost to Follow-up|0|||
126605930|NCT00622700|455516487|FG004|Extension Treatment Period|Lost to Follow-up|1|||
126605931|NCT00622700|455516488|FG005|Extension Treatment Period|Lost to Follow-up|0|||
126605932|NCT00622700|455516489|FG006|Extension Treatment Period|Lost to Follow-up|0|||
126605933|NCT00622700|455516483|FG000|Extension Treatment Period|Progressive Disease|0|||
126605934|NCT00622700|455516484|FG001|Extension Treatment Period|Progressive Disease|0|||
126605935|NCT00622700|455516485|FG002|Extension Treatment Period|Progressive Disease|0|||
126605936|NCT00622700|455516486|FG003|Extension Treatment Period|Progressive Disease|1|||
126605937|NCT00622700|455516487|FG004|Extension Treatment Period|Progressive Disease|2|||
126605938|NCT00622700|455516488|FG005|Extension Treatment Period|Progressive Disease|0|||
126605939|NCT00622700|455516489|FG006|Extension Treatment Period|Progressive Disease|2|||
126605940|NCT00622700|455516483|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
126605941|NCT00622700|455516484|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
126605942|NCT00622700|455516485|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
126605943|NCT00622700|455516486|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
126605944|NCT00622700|455516487|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
126605945|NCT00622700|455516488|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
126605946|NCT00622700|455516489|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
126605947|NCT00622700|455516483|FG000|Extension Treatment Period|Missing|0|||
126605948|NCT00622700|455516484|FG001|Extension Treatment Period|Missing|0|||
126605949|NCT00622700|455516485|FG002|Extension Treatment Period|Missing|0|||
126605950|NCT00622700|455516486|FG003|Extension Treatment Period|Missing|2|||
126605951|NCT00622700|455516487|FG004|Extension Treatment Period|Missing|3|||
126605952|NCT00622700|455516488|FG005|Extension Treatment Period|Missing|1|||
126605953|NCT00622700|455516489|FG006|Extension Treatment Period|Missing|0|||
126605954|NCT00622700|455516483|FG000|Extension Treatment Period|Other than specified above|0|||
126605955|NCT00622700|455516484|FG001|Extension Treatment Period|Other than specified above|0|||
126605956|NCT00622700|455516485|FG002|Extension Treatment Period|Other than specified above|0|||
126605957|NCT00622700|455516486|FG003|Extension Treatment Period|Other than specified above|0|||
126605958|NCT00622700|455516487|FG004|Extension Treatment Period|Other than specified above|0|||
126605959|NCT00622700|455516488|FG005|Extension Treatment Period|Other than specified above|1|||
126605960|NCT00622700|455516489|FG006|Extension Treatment Period|Other than specified above|1|||
126605961|NCT01753999|455516490|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
126605962|NCT01753999|455516491|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
126605963|NCT01753999|455516490|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
126605964|NCT01753999|455516491|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
126605965|NCT01753999|455516490|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
126605966|NCT01753999|455516491|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
126605967|NCT01753999|455516490|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
126605968|NCT01753999|455516491|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
126605969|NCT01753999|455516490|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
126605970|NCT01753999|455516491|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
126605971|NCT01753999|455516490|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
126605972|NCT01753999|455516491|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
126605973|NCT02392234|455516492|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
126605974|NCT02392234|455516493|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
126605975|NCT02392234|455516494|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
126605976|NCT02392234|455516495|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
126605977|NCT02392234|455516496|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
126605978|NCT02392234|455516497|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
126605979|NCT02392234|455516492|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
126605980|NCT02392234|455516493|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
126605981|NCT02392234|455516494|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
126605982|NCT02392234|455516495|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
126605983|NCT02392234|455516496|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
126605984|NCT02392234|455516497|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
126605985|NCT02392234|455516492|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126605986|NCT02392234|455516493|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126605987|NCT02392234|455516494|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126605988|NCT02392234|455516495|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126605989|NCT02392234|455516496|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
126605990|NCT02392234|455516497|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
126605991|NCT02392234|455516492|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
126605992|NCT02392234|455516493|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
126605993|NCT02392234|455516494|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
126605994|NCT02392234|455516495|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
126605995|NCT02392234|455516496|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
126605996|NCT02392234|455516497|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
126605997|NCT02392234|455516492|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
126605998|NCT02392234|455516493|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
126605999|NCT02392234|455516494|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
126606000|NCT02392234|455516495|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
126606001|NCT02392234|455516496|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
126606002|NCT02392234|455516497|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
126606003|NCT02392234|455516492|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
126606004|NCT02392234|455516493|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
126606005|NCT02392234|455516494|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
126606006|NCT02392234|455516495|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
126606007|NCT02392234|455516496|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
126606008|NCT02392234|455516497|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
126606009|NCT02392234|455516492|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
126606010|NCT02392234|455516493|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
126606011|NCT02392234|455516494|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
126606012|NCT02392234|455516495|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
126606013|NCT02392234|455516496|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
126606014|NCT02392234|455516497|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
126606015|NCT02392234|455516492|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
126606016|NCT02392234|455516493|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
126606017|NCT02392234|455516494|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
126606018|NCT02392234|455516495|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
126606019|NCT02392234|455516496|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
126606020|NCT02392234|455516497|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
126606021|NCT04088227|455516502|FG000|Overall Study|Withdrawal by Subject|1|||
126606022|NCT04088227|455516503|FG001|Overall Study|Withdrawal by Subject|0|||
126606023|NCT04088227|455516502|FG000|Overall Study|Surgery postponed >5weeks|1|||
126606024|NCT04088227|455516503|FG001|Overall Study|Surgery postponed >5weeks|0|||
126606025|NCT02415127|455516504|FG000|Overall Study|Adverse Event|1|||
126606026|NCT02415127|455516505|FG001|Overall Study|Adverse Event|0|||
126606027|NCT01855750|455516506|FG000|Overall Study|Death|78|||
126606028|NCT01855750|455516507|FG001|Overall Study|Death|78|||
126606029|NCT01855750|455516506|FG000|Overall Study|Lost to Follow-up|9|||
126606030|NCT01855750|455516507|FG001|Overall Study|Lost to Follow-up|23|||
126606031|NCT01855750|455516506|FG000|Overall Study|Withdrawal by Subject|35|||
126606032|NCT01855750|455516507|FG001|Overall Study|Withdrawal by Subject|28|||
126606033|NCT01855750|455516506|FG000|Overall Study|Sponsor ends the study|297|||
126606034|NCT01855750|455516507|FG001|Overall Study|Sponsor ends the study|290|||
126606035|NCT04300023|455516508|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
126606036|NCT04300023|455516509|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
126606037|NCT05525572|455516510|FG000|Overall Study|Lost to Follow-up|2|||
126606038|NCT04057131|455516511|FG000|Overall Study|Protocol Violation|24|||
126606039|NCT03425682|455516512|FG000|Overall Study|Lost to Follow-up|2|||
126606040|NCT03425682|455516513|FG001|Overall Study|Lost to Follow-up|4|||
126606041|NCT03425682|455516512|FG000|Overall Study|Withdrawal by Subject|0|||
126606042|NCT03425682|455516513|FG001|Overall Study|Withdrawal by Subject|3|||
126606043|NCT03425682|455516512|FG000|Overall Study|Subject did not meet I/E|4|||
126606044|NCT03425682|455516513|FG001|Overall Study|Subject did not meet I/E|10|||
126606045|NCT05704725|455516516|FG000|Overall Study|Lost to Follow-up|0|||
126606046|NCT05704725|455516517|FG001|Overall Study|Lost to Follow-up|1|||
126606047|NCT05704725|455516516|FG000|Overall Study|Withdrawal by Subject|1|||
126606048|NCT05704725|455516517|FG001|Overall Study|Withdrawal by Subject|0|||
126606049|NCT03227861|455516518|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
126606050|NCT03227861|455516518|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
126606051|NCT03227861|455516518|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
126606052|NCT03227861|455516518|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
126606053|NCT03227861|455516518|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
126606054|NCT03227861|455516518|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
126606055|NCT03227861|455516518|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
126606056|NCT03227861|455516518|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
126606057|NCT03227861|455516518|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
126606058|NCT03227861|455516518|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
126606059|NCT03762850|455518274|FG000|Overall Study|Death|0|||
126606060|NCT03762850|455518275|FG001|Overall Study|Death|1|||
126606061|NCT03762850|455518274|FG000|Overall Study|Lost to Follow-up|0|||
126606062|NCT03762850|455518275|FG001|Overall Study|Lost to Follow-up|1|||
126606063|NCT03762850|455518274|FG000|Overall Study|Physician Decision|0|||
126606064|NCT03762850|455518275|FG001|Overall Study|Physician Decision|1|||
126606065|NCT03762850|455518274|FG000|Overall Study|Withdrawal by Subject|4|||
126606066|NCT03762850|455518275|FG001|Overall Study|Withdrawal by Subject|9|||
126606067|NCT03083366|455518276|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
126606068|NCT03083366|455518277|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
126606069|NCT03083366|455518276|FG000|Enrollment Period|Lack of Efficacy|1|||
126606070|NCT03083366|455518277|FG001|Enrollment Period|Lack of Efficacy|0|||
126606071|NCT04503681|455518285|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
126606072|NCT04503681|455518286|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
126606073|NCT03352713|455518287|FG000|Overall Study|Lost to Follow-up|8|||
126606074|NCT03352713|455518287|FG000|Overall Study|Withdrawn by investigator|5|||
126606075|NCT03352713|455518287|FG000|Overall Study|Completed 0 EMAs|8|||
126606076|NCT03352713|455518287|FG000|Overall Study|Device incompatible/stolen|5|||
126733819|NCT01807949|455973988|FG000|Overall Study|Withdrawal by Subject|1|||
126733820|NCT01807949|455973989|FG001|Overall Study|Withdrawal by Subject|2|||
126606077|NCT01812759|455518288|FG000|Overall Study|Physician Decision|0|||
126606078|NCT01812759|455518289|FG001|Overall Study|Physician Decision|0|||
126606079|NCT01812759|455518290|FG002|Overall Study|Physician Decision|1|||
126606080|NCT00536120|455518291|FG000|Overall Study|Lost to Follow-up|1|||
126606081|NCT00536120|455518292|FG001|Overall Study|Lost to Follow-up|0|||
126733821|NCT01807949|455973990|FG002|Overall Study|Withdrawal by Subject|2|||
126733822|NCT01807949|455973988|FG000|Overall Study|Non-Compliance|0|||
126733823|NCT01807949|455973989|FG001|Overall Study|Non-Compliance|0|||
126733824|NCT01807949|455973990|FG002|Overall Study|Non-Compliance|1|||
126733825|NCT01807949|455973988|FG000|Overall Study|Undefined|0|||
126733826|NCT01807949|455973989|FG001|Overall Study|Undefined|1|||
126606082|NCT00536120|455518291|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
126606083|NCT00536120|455518292|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
126606084|NCT00536120|455518291|FG000|Overall Study|Non-compliance|1|||
126606085|NCT00536120|455518292|FG001|Overall Study|Non-compliance|0|||
126606086|NCT00536120|455518291|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
126606087|NCT00536120|455518292|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
126606088|NCT00536120|455518291|FG000|Overall Study|Steroid Use|0|||
126606089|NCT00536120|455518292|FG001|Overall Study|Steroid Use|2|||
126606090|NCT00536120|455518291|FG000|Overall Study|Missed Study Visit|0|||
126606091|NCT00536120|455518292|FG001|Overall Study|Missed Study Visit|1|||
126606092|NCT00360269|455518293|FG000|Overall Study|Lost to Follow-up|7|||
126606093|NCT00360269|455518294|FG001|Overall Study|Lost to Follow-up|9|||
126606094|NCT00360269|455518293|FG000|Overall Study|Physician Decision|1|||
126606095|NCT00360269|455518294|FG001|Overall Study|Physician Decision|2|||
126606096|NCT00360269|455518293|FG000|Overall Study|Adverse Event|1|||
126606097|NCT00360269|455518294|FG001|Overall Study|Adverse Event|0|||
126606098|NCT00360269|455518293|FG000|Overall Study|Withdrawal by Subject|1|||
126606099|NCT00360269|455518294|FG001|Overall Study|Withdrawal by Subject|1|||
126606100|NCT04989816|455518300|FG000|Overall Study|Death|77|||
126606101|NCT04989816|455518300|FG000|Overall Study|Lost to Follow-up|3|||
126606102|NCT03437733|455518301|FG000|Overall Study|Eligibility criteria not met|0|||
126606103|NCT03437733|455518302|FG001|Overall Study|Eligibility criteria not met|3|||
126606104|NCT01982682|455518303|FG000|Overall Study|Physician Decision|1|||
126606105|NCT02760654|455518304|FG000|Overall Study|Lost to Follow-up|3|||
126606106|NCT02760654|455518305|FG001|Overall Study|Lost to Follow-up|3|||
126606107|NCT02760654|455518304|FG000|Overall Study|Withdrawal by Subject|4|||
126606108|NCT02760654|455518305|FG001|Overall Study|Withdrawal by Subject|3|||
126606109|NCT00210106|455518306|FG000|Overall Study|Death|1|||
126606110|NCT00210106|455518306|FG000|Overall Study|Protocol Violation|13|||
126606111|NCT03601715|455518309|FG000|Second Intervention|Lost to Follow-up|1|||
126606112|NCT03601715|455518310|FG001|Second Intervention|Lost to Follow-up|1|||
126606113|NCT03601715|455518311|FG002|Second Intervention|Lost to Follow-up|0|||
126606114|NCT00918333|455518314|FG000|Overall Study|Drug not taken per protocol|1|||
126606115|NCT00918333|455518315|FG001|Overall Study|Drug not taken per protocol|0|||
126606116|NCT00918333|455518314|FG000|Overall Study|Inadequate amount of drugs provided|1|||
126606117|NCT00918333|455518315|FG001|Overall Study|Inadequate amount of drugs provided|4|||
126606118|NCT00918333|455518314|FG000|Overall Study|Ineligible|1|||
126606119|NCT00918333|455518315|FG001|Overall Study|Ineligible|0|||
126606120|NCT00918333|455518314|FG000|Overall Study|Withdrawal by Subject|0|||
126606121|NCT00918333|455518315|FG001|Overall Study|Withdrawal by Subject|1|||
126606122|NCT01313884|455518317|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
126606123|NCT00263757|455518318|FG000|Overall Study|Withdrawal by Subject|5|||
126606124|NCT00263757|455518319|FG001|Overall Study|Withdrawal by Subject|4|||
126606125|NCT00263757|455518318|FG000|Overall Study|Screen failure|0|||
126606126|NCT00263757|455518319|FG001|Overall Study|Screen failure|1|||
126606127|NCT00263757|455518318|FG000|Overall Study|Adverse Event|3|||
126606128|NCT00263757|455518319|FG001|Overall Study|Adverse Event|3|||
126606129|NCT04191824|455518322|FG000|Overall Study|Death|13|||
126606130|NCT04191824|455518323|FG001|Overall Study|Death|12|||
126606131|NCT04191824|455518322|FG000|Overall Study|Lost to Follow-up|456|||
126606132|NCT04191824|455518323|FG001|Overall Study|Lost to Follow-up|435|||
126606133|NCT04191824|455518322|FG000|Overall Study|Physician Decision|2|||
126606134|NCT04191824|455518323|FG001|Overall Study|Physician Decision|1|||
126606135|NCT04191824|455518322|FG000|Overall Study|Protocol Violation|0|||
126606136|NCT04191824|455518323|FG001|Overall Study|Protocol Violation|2|||
126606137|NCT04191824|455518322|FG000|Overall Study|Withdrawal by Subject|16|||
126606138|NCT04191824|455518323|FG001|Overall Study|Withdrawal by Subject|18|||
126606139|NCT04191824|455518322|FG000|Overall Study|Early site closure|24|||
126606140|NCT04191824|455518323|FG001|Overall Study|Early site closure|22|||
126606141|NCT03611556|455518330|FG000|Overall Study|Death|7|||
126606142|NCT03611556|455518331|FG001|Overall Study|Death|7|||
126606143|NCT03611556|455518332|FG002|Overall Study|Death|3|||
126606144|NCT03611556|455518333|FG003|Overall Study|Death|8|||
126606145|NCT03611556|455518334|FG004|Overall Study|Death|47|||
126606146|NCT03611556|455518335|FG005|Overall Study|Death|32|||
126606147|NCT03611556|455518336|FG006|Overall Study|Death|53|||
126606148|NCT03611556|455518330|FG000|Overall Study|Withdrawal by Subject|0|||
126606149|NCT03611556|455518331|FG001|Overall Study|Withdrawal by Subject|0|||
126606150|NCT03611556|455518332|FG002|Overall Study|Withdrawal by Subject|0|||
126606151|NCT03611556|455518333|FG003|Overall Study|Withdrawal by Subject|0|||
126781065|NCT00696709|456152929|FG003|Overall Study|Withdrawal by Subject|4|||
126781066|NCT00696709|456152930|FG004|Overall Study|Withdrawal by Subject|3|||
126606152|NCT03611556|455518334|FG004|Overall Study|Withdrawal by Subject|4|||
126606153|NCT03611556|455518335|FG005|Overall Study|Withdrawal by Subject|2|||
126606154|NCT03611556|455518336|FG006|Overall Study|Withdrawal by Subject|4|||
126606155|NCT03611556|455518330|FG000|Overall Study|Sponsor decision|0|||
126606156|NCT03611556|455518331|FG001|Overall Study|Sponsor decision|0|||
126606157|NCT03611556|455518332|FG002|Overall Study|Sponsor decision|0|||
126606158|NCT03611556|455518333|FG003|Overall Study|Sponsor decision|0|||
126606159|NCT03611556|455518334|FG004|Overall Study|Sponsor decision|9|||
126606160|NCT03611556|455518335|FG005|Overall Study|Sponsor decision|4|||
126606161|NCT03611556|455518336|FG006|Overall Study|Sponsor decision|12|||
126606162|NCT03611556|455518330|FG000|Overall Study|Reasons|0|||
126606163|NCT03611556|455518331|FG001|Overall Study|Reasons|0|||
126606164|NCT03611556|455518332|FG002|Overall Study|Reasons|0|||
126606165|NCT03611556|455518333|FG003|Overall Study|Reasons|0|||
126606166|NCT03611556|455518334|FG004|Overall Study|Reasons|2|||
126606167|NCT03611556|455518335|FG005|Overall Study|Reasons|0|||
126606168|NCT03611556|455518336|FG006|Overall Study|Reasons|1|||
126606169|NCT02646618|455518337|FG000|Overall Study|Lost to Follow-up|10|||
126606170|NCT02646618|455518338|FG001|Overall Study|Lost to Follow-up|14|||
126606171|NCT00390884|455518339|FG000|Overall Study|Withdrawal by Subject|2|||
126606172|NCT00390884|455518340|FG001|Overall Study|Withdrawal by Subject|2|||
126606173|NCT04035447|455518341|FG000|Treatment Period|Lost to Follow-up|6|||
126606174|NCT04035447|455518342|FG001|Treatment Period|Lost to Follow-up|5|||
126606175|NCT04035447|455518341|FG000|Treatment Period|Physician Decision|0|||
126606176|NCT04035447|455518342|FG001|Treatment Period|Physician Decision|2|||
126606177|NCT03304587|455518343|FG000|Overall Study|Headache after intervention|0|||
126606178|NCT03304587|455518344|FG001|Overall Study|Headache after intervention|1|||
126606179|NCT03304587|455518343|FG000|Overall Study|Withdrawal by Subject|1|||
126606180|NCT03304587|455518344|FG001|Overall Study|Withdrawal by Subject|0|||
126606181|NCT01458366|455518346|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
126606182|NCT01458366|455518347|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
126606183|NCT01458366|455518348|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
126606184|NCT01458366|455518349|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
126606185|NCT01458366|455518350|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
126606186|NCT01458366|455518346|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
126606187|NCT01458366|455518347|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
126606188|NCT01458366|455518348|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
126606189|NCT01458366|455518349|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
126606190|NCT01458366|455518350|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
126606191|NCT02397096|455518351|FG000|Day 1 to Week 24|Adverse Event|7|||
126606192|NCT02397096|455518352|FG001|Day 1 to Week 24|Adverse Event|1|||
126606193|NCT02397096|455518351|FG000|Day 1 to Week 24|Death|1|||
126606194|NCT02397096|455518352|FG001|Day 1 to Week 24|Death|0|||
126606195|NCT02397096|455518351|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
126606196|NCT02397096|455518352|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
126606197|NCT02397096|455518351|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
126606198|NCT02397096|455518352|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
126606199|NCT02397096|455518351|FG000|Day 1 to Week 24|Physician Decision|2|||
126606200|NCT02397096|455518352|FG001|Day 1 to Week 24|Physician Decision|3|||
126606201|NCT02397096|455518351|FG000|Day 1 to Week 24|Protocol Violation|1|||
126606202|NCT02397096|455518352|FG001|Day 1 to Week 24|Protocol Violation|4|||
126606203|NCT02397096|455518351|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
126606204|NCT02397096|455518352|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
126606205|NCT02397096|455518351|FG000|Day 1 to Week 24|Randomized, not treated|3|||
126606206|NCT02397096|455518352|FG001|Day 1 to Week 24|Randomized, not treated|0|||
126606207|NCT02397096|455518351|FG000|Week 24 to Week 48|Adverse Event|6|||
126606208|NCT02397096|455518352|FG001|Week 24 to Week 48|Adverse Event|2|||
126606209|NCT02397096|455518351|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
126606210|NCT02397096|455518352|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
126606211|NCT02397096|455518351|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
126606212|NCT02397096|455518352|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
126606213|NCT02397096|455518351|FG000|Week 24 to Week 48|Physician Decision|2|||
126606214|NCT02397096|455518352|FG001|Week 24 to Week 48|Physician Decision|1|||
126606215|NCT02397096|455518351|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
126606216|NCT02397096|455518352|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
126606217|NCT02397096|455518351|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
126606218|NCT02397096|455518352|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
126606219|NCT02397096|455518351|FG000|Study Extension 1|Adverse Event|7|||
126606220|NCT02397096|455518352|FG001|Study Extension 1|Adverse Event|5|||
126606221|NCT02397096|455518351|FG000|Study Extension 1|Death|1|||
126606222|NCT02397096|455518352|FG001|Study Extension 1|Death|0|||
126606223|NCT02397096|455518351|FG000|Study Extension 1|Lack of Efficacy|2|||
126606224|NCT02397096|455518352|FG001|Study Extension 1|Lack of Efficacy|5|||
126606225|NCT02397096|455518351|FG000|Study Extension 1|Lost to Follow-up|2|||
126606226|NCT02397096|455518352|FG001|Study Extension 1|Lost to Follow-up|3|||
126606227|NCT02397096|455518351|FG000|Study Extension 1|Non-compliance with study drug|3|||
126606228|NCT02397096|455518352|FG001|Study Extension 1|Non-compliance with study drug|0|||
126606229|NCT02397096|455518351|FG000|Study Extension 1|Physician Decision|4|||
126606230|NCT02397096|455518352|FG001|Study Extension 1|Physician Decision|2|||
126606231|NCT02397096|455518351|FG000|Study Extension 1|Pregnancy|1|||
126606232|NCT02397096|455518352|FG001|Study Extension 1|Pregnancy|0|||
126606233|NCT02397096|455518351|FG000|Study Extension 1|Protocol Violation|0|||
126606234|NCT02397096|455518352|FG001|Study Extension 1|Protocol Violation|1|||
126606235|NCT02397096|455518351|FG000|Study Extension 1|Withdrawal by Subject|21|||
126606236|NCT02397096|455518352|FG001|Study Extension 1|Withdrawal by Subject|7|||
126606237|NCT02397096|455518351|FG000|Study Extension 2|Adverse Event|3|||
126606238|NCT02397096|455518352|FG001|Study Extension 2|Adverse Event|3|||
126606239|NCT02397096|455518351|FG000|Study Extension 2|Availability of study medication locally|152|||
126733827|NCT01807949|455973990|FG002|Overall Study|Undefined|2|||
126733828|NCT01807949|455973988|FG000|Overall Study|Randomized But Not Treated|0|||
126606240|NCT02397096|455518352|FG001|Study Extension 2|Availability of study medication locally|64|||
126606241|NCT02397096|455518351|FG000|Study Extension 2|Death|2|||
126606242|NCT02397096|455518352|FG001|Study Extension 2|Death|0|||
126606243|NCT02397096|455518351|FG000|Study Extension 2|Lack of Efficacy|1|||
126606244|NCT02397096|455518352|FG001|Study Extension 2|Lack of Efficacy|0|||
126606245|NCT02397096|455518351|FG000|Study Extension 2|Lost to Follow-up|2|||
126606246|NCT02397096|455518352|FG001|Study Extension 2|Lost to Follow-up|1|||
126606247|NCT02397096|455518351|FG000|Study Extension 2|Non-compliance with study drug|1|||
126606248|NCT02397096|455518352|FG001|Study Extension 2|Non-compliance with study drug|0|||
126606249|NCT02397096|455518351|FG000|Study Extension 2|Physician Decision|2|||
126606250|NCT02397096|455518352|FG001|Study Extension 2|Physician Decision|5|||
126606251|NCT02397096|455518351|FG000|Study Extension 2|Pregnancy|1|||
126606252|NCT02397096|455518352|FG001|Study Extension 2|Pregnancy|0|||
126606253|NCT02397096|455518351|FG000|Study Extension 2|Withdrawal by Subject|10|||
126606254|NCT02397096|455518352|FG001|Study Extension 2|Withdrawal by Subject|3|||
126606255|NCT02397096|455518351|FG000|Study Extension 3|Adverse Event|1|||
126606256|NCT02397096|455518352|FG001|Study Extension 3|Adverse Event|0|||
126606257|NCT02397096|455518351|FG000|Study Extension 3|Availability of study medication locally|11|||
126606258|NCT02397096|455518352|FG001|Study Extension 3|Availability of study medication locally|3|||
126606259|NCT02397096|455518351|FG000|Study Extension 3|Lost to Follow-up|1|||
126606260|NCT02397096|455518352|FG001|Study Extension 3|Lost to Follow-up|0|||
126606261|NCT02397096|455518351|FG000|Study Extension 3|Withdrawal by Subject|2|||
126606262|NCT02397096|455518352|FG001|Study Extension 3|Withdrawal by Subject|1|||
126606263|NCT05580003|455518353|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606264|NCT05580003|455518354|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606265|NCT05580003|455518355|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606266|NCT05580003|455518356|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606267|NCT05580003|455518357|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606268|NCT05580003|455518358|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606269|NCT05580003|455518359|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
126606270|NCT05580003|455518360|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606271|NCT05580003|455518361|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606272|NCT05580003|455518362|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606273|NCT05580003|455518363|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606274|NCT05580003|455518364|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606275|NCT05580003|455518365|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606276|NCT05580003|455518366|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606277|NCT05580003|455518367|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606278|NCT05580003|455518368|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606279|NCT05580003|455518369|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606280|NCT05580003|455518370|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606281|NCT05580003|455518371|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606282|NCT05580003|455518372|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606283|NCT05580003|455518373|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606284|NCT05580003|455518374|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606285|NCT05580003|455518375|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606286|NCT05580003|455518376|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606287|NCT05580003|455518377|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606288|NCT05580003|455518378|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606289|NCT05580003|455518379|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606290|NCT05580003|455518380|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126606291|NCT05580003|455518353|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606292|NCT05580003|455518354|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606293|NCT05580003|455518355|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606294|NCT05580003|455518356|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606295|NCT05580003|455518357|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606296|NCT05580003|455518358|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
126606297|NCT05580003|455518359|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606298|NCT05580003|455518360|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606299|NCT05580003|455518361|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606300|NCT05580003|455518362|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606301|NCT05580003|455518363|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606302|NCT05580003|455518364|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606303|NCT05580003|455518365|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606304|NCT05580003|455518366|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606305|NCT05580003|455518367|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606306|NCT05580003|455518368|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126733829|NCT01807949|455973989|FG001|Overall Study|Randomized But Not Treated|2|||
126733830|NCT01807949|455973990|FG002|Overall Study|Randomized But Not Treated|2|||
126606307|NCT05580003|455518369|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606308|NCT05580003|455518370|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606309|NCT05580003|455518371|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606310|NCT05580003|455518372|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606311|NCT05580003|455518373|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606312|NCT05580003|455518374|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606313|NCT05580003|455518375|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606314|NCT05580003|455518376|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606315|NCT05580003|455518377|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606316|NCT05580003|455518378|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606317|NCT05580003|455518379|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606318|NCT05580003|455518380|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
126606319|NCT05580003|455518353|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606320|NCT05580003|455518354|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606321|NCT05580003|455518355|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606322|NCT05580003|455518356|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
126606323|NCT05580003|455518357|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606324|NCT05580003|455518358|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606325|NCT05580003|455518359|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606326|NCT05580003|455518360|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606327|NCT05580003|455518361|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606328|NCT05580003|455518362|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606329|NCT05580003|455518363|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606330|NCT05580003|455518364|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606331|NCT05580003|455518365|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606332|NCT05580003|455518366|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606333|NCT05580003|455518367|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606334|NCT05580003|455518368|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606335|NCT05580003|455518369|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606336|NCT05580003|455518370|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606337|NCT05580003|455518371|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606338|NCT05580003|455518372|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606339|NCT05580003|455518373|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606340|NCT05580003|455518374|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606341|NCT05580003|455518375|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606342|NCT05580003|455518376|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606343|NCT05580003|455518377|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606344|NCT05580003|455518378|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606345|NCT05580003|455518379|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606346|NCT05580003|455518380|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
126606347|NCT05580003|455518353|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606348|NCT05580003|455518354|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
126606349|NCT05580003|455518355|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606350|NCT05580003|455518356|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606351|NCT05580003|455518357|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606352|NCT05580003|455518358|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606353|NCT05580003|455518359|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606354|NCT05580003|455518360|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606355|NCT05580003|455518361|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126733831|NCT04325906|455973991|FG000|Overall Study|Withdrawal by Subject|2|||
126733832|NCT04325906|455973992|FG001|Overall Study|Withdrawal by Subject|0|||
126606356|NCT05580003|455518362|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606357|NCT05580003|455518363|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606358|NCT05580003|455518364|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606359|NCT05580003|455518365|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606360|NCT05580003|455518366|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606361|NCT05580003|455518367|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606362|NCT05580003|455518368|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606363|NCT05580003|455518369|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606364|NCT05580003|455518370|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606365|NCT05580003|455518371|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606366|NCT05580003|455518372|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606367|NCT05580003|455518373|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606368|NCT05580003|455518374|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606369|NCT05580003|455518375|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606370|NCT05580003|455518376|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606371|NCT05580003|455518377|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606372|NCT05580003|455518378|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126733833|NCT05014542|455973993|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
126606373|NCT05580003|455518379|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606374|NCT05580003|455518380|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
126606375|NCT05580003|455518353|FG000|Part 2 (up to 10 Days)|Other|0|||
126606376|NCT05580003|455518354|FG001|Part 2 (up to 10 Days)|Other|0|||
126606377|NCT05580003|455518355|FG002|Part 2 (up to 10 Days)|Other|0|||
126606378|NCT05580003|455518356|FG003|Part 2 (up to 10 Days)|Other|0|||
126606379|NCT05580003|455518357|FG004|Part 2 (up to 10 Days)|Other|0|||
126606380|NCT05580003|455518358|FG005|Part 2 (up to 10 Days)|Other|0|||
126606381|NCT05580003|455518359|FG006|Part 2 (up to 10 Days)|Other|0|||
126606382|NCT05580003|455518360|FG007|Part 2 (up to 10 Days)|Other|0|||
126606383|NCT05580003|455518361|FG008|Part 2 (up to 10 Days)|Other|0|||
126606384|NCT05580003|455518362|FG009|Part 2 (up to 10 Days)|Other|1|||
126606385|NCT05580003|455518363|FG010|Part 2 (up to 10 Days)|Other|0|||
126606386|NCT05580003|455518364|FG011|Part 2 (up to 10 Days)|Other|0|||
126606387|NCT05580003|455518365|FG012|Part 2 (up to 10 Days)|Other|0|||
126606388|NCT05580003|455518366|FG013|Part 2 (up to 10 Days)|Other|0|||
126606389|NCT05580003|455518367|FG014|Part 2 (up to 10 Days)|Other|0|||
126606390|NCT05580003|455518368|FG015|Part 2 (up to 10 Days)|Other|0|||
126606391|NCT05580003|455518369|FG016|Part 2 (up to 10 Days)|Other|0|||
126606392|NCT05580003|455518370|FG017|Part 2 (up to 10 Days)|Other|0|||
126606393|NCT05580003|455518371|FG018|Part 2 (up to 10 Days)|Other|0|||
126606394|NCT05580003|455518372|FG019|Part 2 (up to 10 Days)|Other|0|||
126606395|NCT05580003|455518373|FG020|Part 2 (up to 10 Days)|Other|0|||
126606396|NCT05580003|455518374|FG021|Part 2 (up to 10 Days)|Other|0|||
126606397|NCT05580003|455518375|FG022|Part 2 (up to 10 Days)|Other|0|||
126606398|NCT05580003|455518376|FG023|Part 2 (up to 10 Days)|Other|0|||
126606399|NCT05580003|455518377|FG024|Part 2 (up to 10 Days)|Other|0|||
126606400|NCT05580003|455518378|FG025|Part 2 (up to 10 Days)|Other|0|||
126606401|NCT05580003|455518379|FG026|Part 2 (up to 10 Days)|Other|0|||
126606402|NCT05580003|455518380|FG027|Part 2 (up to 10 Days)|Other|0|||
126606403|NCT05580003|455518353|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606404|NCT05580003|455518354|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606405|NCT05580003|455518355|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606406|NCT05580003|455518356|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606407|NCT05580003|455518357|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606408|NCT05580003|455518358|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606409|NCT05580003|455518359|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606410|NCT05580003|455518360|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606411|NCT05580003|455518361|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606412|NCT05580003|455518362|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606413|NCT05580003|455518363|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606414|NCT05580003|455518364|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606415|NCT05580003|455518365|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606416|NCT05580003|455518366|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606417|NCT05580003|455518367|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606418|NCT05580003|455518368|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606419|NCT05580003|455518369|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606420|NCT05580003|455518370|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606421|NCT05580003|455518371|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606422|NCT05580003|455518372|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
126606423|NCT05580003|455518373|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606424|NCT05580003|455518374|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606425|NCT05580003|455518375|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606426|NCT05580003|455518376|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606427|NCT05580003|455518377|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606428|NCT05580003|455518378|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606429|NCT05580003|455518379|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606430|NCT05580003|455518380|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
126606431|NCT05580003|455518353|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606432|NCT05580003|455518354|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606433|NCT05580003|455518355|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606434|NCT05580003|455518356|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606435|NCT05580003|455518357|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606436|NCT05580003|455518358|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606437|NCT05580003|455518359|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606438|NCT05580003|455518360|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606439|NCT05580003|455518361|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606440|NCT05580003|455518362|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606441|NCT05580003|455518363|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606442|NCT05580003|455518364|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606443|NCT05580003|455518365|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606444|NCT05580003|455518366|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606445|NCT05580003|455518367|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606446|NCT05580003|455518368|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126781067|NCT00696709|456152926|FG000|Overall Study|Protocol Violation|1|||
126606447|NCT05580003|455518369|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606448|NCT05580003|455518370|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606449|NCT05580003|455518371|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606450|NCT05580003|455518372|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606451|NCT05580003|455518373|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
126606452|NCT05580003|455518374|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606453|NCT05580003|455518375|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606454|NCT05580003|455518376|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606455|NCT05580003|455518377|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606456|NCT05580003|455518378|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606457|NCT05580003|455518379|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606458|NCT05580003|455518380|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
126606459|NCT05580003|455518353|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606460|NCT05580003|455518354|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606461|NCT05580003|455518355|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606462|NCT05580003|455518356|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606463|NCT05580003|455518357|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606464|NCT05580003|455518358|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606465|NCT05580003|455518359|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606466|NCT05580003|455518360|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606467|NCT05580003|455518361|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606468|NCT05580003|455518362|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606469|NCT05580003|455518363|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606470|NCT05580003|455518364|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606471|NCT05580003|455518365|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606472|NCT05580003|455518366|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606473|NCT05580003|455518367|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606474|NCT05580003|455518368|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606475|NCT05580003|455518369|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606476|NCT05580003|455518370|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606477|NCT05580003|455518371|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606478|NCT05580003|455518372|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606479|NCT05580003|455518373|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606480|NCT05580003|455518374|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
126606481|NCT05580003|455518375|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606482|NCT05580003|455518376|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606483|NCT05580003|455518377|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606484|NCT05580003|455518378|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606485|NCT05580003|455518379|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606486|NCT05580003|455518380|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
126606487|NCT05580003|455518353|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606488|NCT05580003|455518354|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606489|NCT05580003|455518355|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606490|NCT05580003|455518356|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606491|NCT05580003|455518357|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606492|NCT05580003|455518358|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126733834|NCT05014542|455973994|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
126733835|NCT05014542|455973993|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
126733836|NCT05014542|455973994|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
126733837|NCT05014542|455973993|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
126733838|NCT05014542|455973994|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
126733839|NCT05014542|455973993|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
126733840|NCT05014542|455973994|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
126733841|NCT06000501|455973995|FG000|Overall Study|Screen failure|3|||
126733842|NCT06000501|455973995|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
126781068|NCT00696709|456152927|FG001|Overall Study|Protocol Violation|0|||
126781069|NCT00696709|456152928|FG002|Overall Study|Protocol Violation|0|||
126781070|NCT00696709|456152929|FG003|Overall Study|Protocol Violation|0|||
126781071|NCT00696709|456152930|FG004|Overall Study|Protocol Violation|0|||
126733843|NCT06000501|455973995|FG000|Overall Study|Physician Decision|4|||
126733844|NCT06000501|455973995|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
126733845|NCT06000501|455973995|FG000|Overall Study|Scheduling issues|2|||
126733846|NCT00318565|455973996|FG000|Overall Study|Excluded per protocol|24|||
126733847|NCT01896856|455973998|FG000|Overall Study|Transportation issues / Non-compliance|0|||
126733848|NCT01896856|455973999|FG001|Overall Study|Transportation issues / Non-compliance|0|||
126781072|NCT00696709|456152926|FG000|Overall Study|Lost to Follow-up|1|||
126606493|NCT05580003|455518359|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606494|NCT05580003|455518360|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606495|NCT05580003|455518361|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606496|NCT05580003|455518362|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606497|NCT05580003|455518363|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606498|NCT05580003|455518364|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606499|NCT05580003|455518365|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606500|NCT05580003|455518366|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606501|NCT05580003|455518367|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606502|NCT05580003|455518368|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606503|NCT05580003|455518369|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606504|NCT05580003|455518370|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606505|NCT05580003|455518371|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606506|NCT05580003|455518372|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606507|NCT05580003|455518373|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606508|NCT05580003|455518374|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606509|NCT05580003|455518375|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606510|NCT05580003|455518376|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606511|NCT05580003|455518377|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606512|NCT05580003|455518378|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606513|NCT05580003|455518379|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
126606514|NCT05580003|455518380|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
126606515|NCT05580003|455518353|FG000|Part 6 Period 2 (Day 1)|Other|0|||
126606516|NCT05580003|455518354|FG001|Part 6 Period 2 (Day 1)|Other|0|||
126606517|NCT05580003|455518355|FG002|Part 6 Period 2 (Day 1)|Other|0|||
126606518|NCT05580003|455518356|FG003|Part 6 Period 2 (Day 1)|Other|0|||
126606519|NCT05580003|455518357|FG004|Part 6 Period 2 (Day 1)|Other|0|||
126606520|NCT05580003|455518358|FG005|Part 6 Period 2 (Day 1)|Other|0|||
126606521|NCT05580003|455518359|FG006|Part 6 Period 2 (Day 1)|Other|0|||
126606522|NCT05580003|455518360|FG007|Part 6 Period 2 (Day 1)|Other|0|||
126606523|NCT05580003|455518361|FG008|Part 6 Period 2 (Day 1)|Other|0|||
126606524|NCT05580003|455518362|FG009|Part 6 Period 2 (Day 1)|Other|0|||
126606525|NCT05580003|455518363|FG010|Part 6 Period 2 (Day 1)|Other|0|||
126606526|NCT05580003|455518364|FG011|Part 6 Period 2 (Day 1)|Other|0|||
126606527|NCT05580003|455518365|FG012|Part 6 Period 2 (Day 1)|Other|0|||
126606528|NCT05580003|455518366|FG013|Part 6 Period 2 (Day 1)|Other|0|||
126606529|NCT05580003|455518367|FG014|Part 6 Period 2 (Day 1)|Other|0|||
126606530|NCT05580003|455518368|FG015|Part 6 Period 2 (Day 1)|Other|0|||
126606531|NCT05580003|455518369|FG016|Part 6 Period 2 (Day 1)|Other|0|||
126606532|NCT05580003|455518370|FG017|Part 6 Period 2 (Day 1)|Other|0|||
126606533|NCT05580003|455518371|FG018|Part 6 Period 2 (Day 1)|Other|0|||
126606534|NCT05580003|455518372|FG019|Part 6 Period 2 (Day 1)|Other|0|||
126606535|NCT05580003|455518373|FG020|Part 6 Period 2 (Day 1)|Other|0|||
126606536|NCT05580003|455518374|FG021|Part 6 Period 2 (Day 1)|Other|0|||
126606537|NCT05580003|455518375|FG022|Part 6 Period 2 (Day 1)|Other|0|||
126606538|NCT05580003|455518376|FG023|Part 6 Period 2 (Day 1)|Other|0|||
126606539|NCT05580003|455518377|FG024|Part 6 Period 2 (Day 1)|Other|1|||
126606540|NCT05580003|455518378|FG025|Part 6 Period 2 (Day 1)|Other|0|||
126606541|NCT05580003|455518379|FG026|Part 6 Period 2 (Day 1)|Other|0|||
126606542|NCT05580003|455518380|FG027|Part 6 Period 2 (Day 1)|Other|0|||
126606543|NCT02052440|455518381|FG000|Overall Study|Withdrawal by Subject|0|||
126606544|NCT02052440|455518382|FG001|Overall Study|Withdrawal by Subject|1|||
126606545|NCT02130557|455518383|FG000|Overall Study|Withdrawal by Subject|12|||
126606546|NCT02130557|455518384|FG001|Overall Study|Withdrawal by Subject|12|||
126606547|NCT02130557|455518383|FG000|Overall Study|Investigator Request|0|||
126606548|NCT02130557|455518384|FG001|Overall Study|Investigator Request|2|||
126606549|NCT02130557|455518383|FG000|Overall Study|Deceased|14|||
126606550|NCT02130557|455518384|FG001|Overall Study|Deceased|14|||
126606551|NCT02130557|455518383|FG000|Overall Study|Lost to Follow-up|6|||
126606552|NCT02130557|455518384|FG001|Overall Study|Lost to Follow-up|7|||
126606553|NCT02130557|455518383|FG000|Overall Study|Other|2|||
126606554|NCT02130557|455518384|FG001|Overall Study|Other|1|||
126606555|NCT02130557|455518383|FG000|Overall Study|Missing|2|||
126606556|NCT02130557|455518384|FG001|Overall Study|Missing|1|||
126606557|NCT02408887|455518385|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
126606558|NCT02408887|455518386|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
126606559|NCT02408887|455518385|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
126606560|NCT02408887|455518386|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
126606561|NCT03333109|455518387|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
126606562|NCT03333109|455518388|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
126606563|NCT03333109|455518389|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
126606564|NCT03333109|455518387|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
126606565|NCT03333109|455518388|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
126606566|NCT03333109|455518389|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
126606567|NCT03333109|455518387|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
126606568|NCT03333109|455518388|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
126606569|NCT03333109|455518389|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
126606570|NCT03333109|455518387|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
126781073|NCT00696709|456152927|FG001|Overall Study|Lost to Follow-up|1|||
126781074|NCT00696709|456152928|FG002|Overall Study|Lost to Follow-up|0|||
126781075|NCT00696709|456152929|FG003|Overall Study|Lost to Follow-up|0|||
126781076|NCT00696709|456152930|FG004|Overall Study|Lost to Follow-up|0|||
126781077|NCT00696709|456152926|FG000|Overall Study|Adverse Event|0|||
126781078|NCT00696709|456152927|FG001|Overall Study|Adverse Event|0|||
126781079|NCT00696709|456152928|FG002|Overall Study|Adverse Event|0|||
126781080|NCT00696709|456152929|FG003|Overall Study|Adverse Event|1|||
126781081|NCT00696709|456152930|FG004|Overall Study|Adverse Event|0|||
126781082|NCT00526890|456152940|FG000|Overall Study|Adverse Event|2|||
126781083|NCT03529955|456152941|FG000|Overall Study|Adverse Event|1|||
126781084|NCT03529955|456152941|FG000|Overall Study|Lack of Efficacy|1|||
126781085|NCT00580983|456152942|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
126781086|NCT03740100|456152943|FG000|Overall Study|Adverse Event|1|||
126781087|NCT03740100|456152943|FG000|Overall Study|Death|1|||
126781088|NCT03387059|456152945|FG000|Overall Study|Study termination|5|||
126781089|NCT03387059|456152946|FG001|Overall Study|Study termination|4|||
126781090|NCT01859702|456152947|FG000|Overall Study|Protocol deviation|3|||
126781091|NCT01859702|456152947|FG000|Overall Study|Adverse Event|2|||
126781092|NCT02004847|456154437|FG000|Overall Study|Protocol Violation|1|||
126781093|NCT02004847|456154438|FG001|Overall Study|Protocol Violation|1|||
126781094|NCT00759148|456154445|FG000|Overall Study|Adverse Event|1|||
126781095|NCT00759148|456154446|FG001|Overall Study|Adverse Event|6|||
126781096|NCT00759148|456154445|FG000|Overall Study|Withdrawal by Subject|3|||
126781097|NCT00759148|456154446|FG001|Overall Study|Withdrawal by Subject|7|||
126781098|NCT00759148|456154445|FG000|Overall Study|Lost to Follow-up|3|||
126781099|NCT00759148|456154446|FG001|Overall Study|Lost to Follow-up|9|||
126781100|NCT00759148|456154445|FG000|Overall Study|Treatment Failure|6|||
126781101|NCT00759148|456154446|FG001|Overall Study|Treatment Failure|10|||
126781102|NCT00759148|456154445|FG000|Overall Study|Reason not given|1|||
126781103|NCT00759148|456154446|FG001|Overall Study|Reason not given|0|||
126781104|NCT00434161|456154449|FG000|Overall Study|Adverse Event|5|||
126781105|NCT00434161|456154450|FG001|Overall Study|Adverse Event|1|||
126781106|NCT00434161|456154451|FG002|Overall Study|Adverse Event|4|||
126781107|NCT00434161|456154449|FG000|Overall Study|Lost to Follow-up|0|||
126781108|NCT00434161|456154450|FG001|Overall Study|Lost to Follow-up|1|||
126781109|NCT00434161|456154451|FG002|Overall Study|Lost to Follow-up|0|||
126781110|NCT00434161|456154449|FG000|Overall Study|Death|1|||
126781111|NCT00434161|456154450|FG001|Overall Study|Death|0|||
126781112|NCT00434161|456154451|FG002|Overall Study|Death|1|||
126781113|NCT00434161|456154449|FG000|Overall Study|Non-Compliance|1|||
126781114|NCT00434161|456154450|FG001|Overall Study|Non-Compliance|1|||
126781115|NCT00434161|456154451|FG002|Overall Study|Non-Compliance|0|||
126781116|NCT00434161|456154449|FG000|Overall Study|Withdrawal by Subject|2|||
126781117|NCT00434161|456154450|FG001|Overall Study|Withdrawal by Subject|0|||
126781118|NCT00434161|456154451|FG002|Overall Study|Withdrawal by Subject|3|||
126781119|NCT00434161|456154449|FG000|Overall Study|Logistical error study assessments|1|||
126781120|NCT00434161|456154450|FG001|Overall Study|Logistical error study assessments|0|||
126781121|NCT00434161|456154451|FG002|Overall Study|Logistical error study assessments|3|||
126781122|NCT03342898|456154452|FG000|Overall Study|Adverse Event|3|||
126781123|NCT03342898|456154453|FG001|Overall Study|Adverse Event|1|||
126781124|NCT03342898|456154454|FG002|Overall Study|Adverse Event|0|||
126781125|NCT03342898|456154452|FG000|Overall Study|Lost to Follow-up|44|||
126606571|NCT03333109|455518388|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
126606572|NCT03333109|455518389|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
126606573|NCT03333109|455518387|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
126606574|NCT03333109|455518388|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
126606575|NCT03333109|455518389|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
126606576|NCT03333109|455518387|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
126606577|NCT03333109|455518388|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
126606578|NCT03333109|455518389|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
126606579|NCT03333109|455518387|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
126606580|NCT03333109|455518388|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
126606581|NCT03333109|455518389|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
126781126|NCT03342898|456154453|FG001|Overall Study|Lost to Follow-up|40|||
126781127|NCT03342898|456154454|FG002|Overall Study|Lost to Follow-up|42|||
126781128|NCT03342898|456154452|FG000|Overall Study|Withdrawal of Consent|5|||
126781129|NCT03342898|456154453|FG001|Overall Study|Withdrawal of Consent|9|||
126606582|NCT03333109|455518387|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
126606583|NCT03333109|455518388|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
126781130|NCT03342898|456154454|FG002|Overall Study|Withdrawal of Consent|11|||
126781131|NCT03342898|456154452|FG000|Overall Study|Death|0|||
126606584|NCT03333109|455518389|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
126781132|NCT03342898|456154453|FG001|Overall Study|Death|1|||
126781133|NCT03342898|456154454|FG002|Overall Study|Death|1|||
126781134|NCT03342898|456154452|FG000|Overall Study|Reason not Specified|2|||
126781135|NCT03342898|456154453|FG001|Overall Study|Reason not Specified|2|||
126781136|NCT03342898|456154454|FG002|Overall Study|Reason not Specified|0|||
126781137|NCT01387282|456154455|FG000|Overall Study|Death|47|||
126781138|NCT01387282|456154456|FG001|Overall Study|Death|16|||
126781139|NCT01387282|456154455|FG000|Overall Study|Other|5|||
126781140|NCT01387282|456154456|FG001|Overall Study|Other|1|||
126781141|NCT01387282|456154455|FG000|Overall Study|Unrelated AE|6|||
126606585|NCT00918203|455518393|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
126606586|NCT00918203|455518394|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
126606587|NCT00918203|455518395|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
126606588|NCT00918203|455518393|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
126606589|NCT00918203|455518394|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
126606590|NCT00918203|455518395|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
126606591|NCT00918203|455518393|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
126606592|NCT00918203|455518394|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
126606593|NCT00918203|455518395|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
126606594|NCT00918203|455518393|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
126606595|NCT00918203|455518394|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
126606596|NCT00918203|455518395|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
126606597|NCT00701701|455518398|FG000|Overall Study|Withdrawal by Subject|0|||
126606598|NCT00701701|455518399|FG001|Overall Study|Withdrawal by Subject|1|||
126606599|NCT00701701|455518398|FG000|Overall Study|Adverse Event|0|||
126606600|NCT00701701|455518399|FG001|Overall Study|Adverse Event|1|||
126606601|NCT00589875|455518400|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
126606602|NCT00589875|455518400|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
126606603|NCT03488719|455518403|FG000|Overall Study|Adverse Event|0|||
126606604|NCT03488719|455518404|FG001|Overall Study|Adverse Event|4|||
126606605|NCT03488719|455518405|FG002|Overall Study|Adverse Event|2|||
126606606|NCT03488719|455518403|FG000|Overall Study|Other|0|||
126606607|NCT03488719|455518404|FG001|Overall Study|Other|0|||
126606608|NCT03488719|455518405|FG002|Overall Study|Other|5|||
126606609|NCT02078648|455518406|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
126606610|NCT02078648|455518407|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
126606611|NCT02078648|455518406|FG000|Overall Study|Adverse Event|0|||
126606612|NCT02078648|455518407|FG001|Overall Study|Adverse Event|1|||
126606613|NCT02078648|455518406|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
126606614|NCT02078648|455518407|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
126606615|NCT02078648|455518406|FG000|Overall Study|Withdrawal by Subject|3|||
126606616|NCT02078648|455518407|FG001|Overall Study|Withdrawal by Subject|1|||
126606617|NCT02078648|455518406|FG000|Overall Study|Investigator Decision|5|||
126606618|NCT02078648|455518407|FG001|Overall Study|Investigator Decision|7|||
126606619|NCT02078648|455518406|FG000|Overall Study|Death|1|||
126606620|NCT02078648|455518407|FG001|Overall Study|Death|1|||
126606621|NCT02078648|455518406|FG000|Overall Study|Undefined|0|||
126606622|NCT02078648|455518407|FG001|Overall Study|Undefined|1|||
126606623|NCT01675492|455518408|FG000|Overall Study|study completed early - product approval|42|||
126606624|NCT00490139|455518413|FG000|Overall Study|Lost to Follow-up|249|||
126606625|NCT00490139|455518414|FG001|Overall Study|Lost to Follow-up|216|||
126606626|NCT00490139|455518415|FG002|Overall Study|Lost to Follow-up|205|||
126606627|NCT00490139|455518416|FG003|Overall Study|Lost to Follow-up|229|||
126606628|NCT00490139|455518413|FG000|Overall Study|Withdrawal by Subject|333|||
126606629|NCT00490139|455518414|FG001|Overall Study|Withdrawal by Subject|322|||
126606630|NCT00490139|455518415|FG002|Overall Study|Withdrawal by Subject|396|||
126606631|NCT00490139|455518416|FG003|Overall Study|Withdrawal by Subject|295|||
126606632|NCT00490139|455518413|FG000|Overall Study|Patient did not sign ICF 12|169|||
126606633|NCT00490139|455518414|FG001|Overall Study|Patient did not sign ICF 12|176|||
126606634|NCT00490139|455518415|FG002|Overall Study|Patient did not sign ICF 12|139|||
126606635|NCT00490139|455518416|FG003|Overall Study|Patient did not sign ICF 12|167|||
126733849|NCT01896856|455974000|FG002|Overall Study|Transportation issues / Non-compliance|1|||
126733850|NCT01896856|455974001|FG003|Overall Study|Transportation issues / Non-compliance|0|||
126733851|NCT01896856|455974002|FG004|Overall Study|Transportation issues / Non-compliance|0|||
126733852|NCT01896856|455974003|FG005|Overall Study|Transportation issues / Non-compliance|0|||
126733853|NCT00282867|455974004|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
126733854|NCT00282867|455974005|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
126733855|NCT00282867|455974006|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
126733856|NCT02727660|455974009|FG000|Overall Study|Lack of Efficacy|40|||
126781142|NCT01387282|456154456|FG001|Overall Study|Unrelated AE|4|||
126781143|NCT01387282|456154455|FG000|Overall Study|Withdrawal by patient|33|||
126781144|NCT01387282|456154456|FG001|Overall Study|Withdrawal by patient|23|||
126606636|NCT00490139|455518413|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
126606637|NCT00490139|455518414|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
126606638|NCT00490139|455518415|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
126733857|NCT02727660|455974010|FG001|Overall Study|Lack of Efficacy|40|||
126606639|NCT00490139|455518416|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
126606640|NCT00490139|455518413|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
126606641|NCT00490139|455518414|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
126606642|NCT00490139|455518415|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
126606643|NCT00490139|455518416|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
126606644|NCT00490139|455518413|FG000|Overall Study|Other reasons as defined per protocol|98|||
126606645|NCT00490139|455518414|FG001|Overall Study|Other reasons as defined per protocol|84|||
126606646|NCT00490139|455518415|FG002|Overall Study|Other reasons as defined per protocol|82|||
126606647|NCT00490139|455518416|FG003|Overall Study|Other reasons as defined per protocol|105|||
126606648|NCT04484623|455518417|FG000|Overall Study|Lost to Follow-up|0|||
126606649|NCT04484623|455518418|FG001|Overall Study|Lost to Follow-up|1|||
126606650|NCT04484623|455518417|FG000|Overall Study|Protocol Deviation|1|||
126606651|NCT04484623|455518418|FG001|Overall Study|Protocol Deviation|0|||
126606652|NCT04484623|455518417|FG000|Overall Study|Physician Decision|1|||
126606653|NCT04484623|455518418|FG001|Overall Study|Physician Decision|0|||
126606654|NCT04484623|455518417|FG000|Overall Study|Withdrawal by Subject|11|||
126606655|NCT04484623|455518418|FG001|Overall Study|Withdrawal by Subject|8|||
126606656|NCT04484623|455518417|FG000|Overall Study|Ongoing|94|||
126606657|NCT04484623|455518418|FG001|Overall Study|Ongoing|84|||
126606658|NCT02488408|455518419|FG000|Part A|Adverse Event|2|||
126606659|NCT02488408|455518420|FG001|Part A|Adverse Event|0|||
126606660|NCT02488408|455518421|FG002|Part A|Adverse Event|0|||
126606661|NCT02488408|455518422|FG003|Part A|Adverse Event|0|||
126606662|NCT02488408|455518423|FG004|Part A|Adverse Event|0|||
126606663|NCT02488408|455518424|FG005|Part A|Adverse Event|0|||
126606664|NCT02488408|455518425|FG006|Part A|Adverse Event|0|||
126606665|NCT02488408|455518426|FG007|Part A|Adverse Event|0|||
126606666|NCT02488408|455518427|FG008|Part A|Adverse Event|0|||
126606667|NCT02488408|455518428|FG009|Part A|Adverse Event|0|||
126606668|NCT02488408|455518419|FG000|Part A|Death|1|||
126606669|NCT02488408|455518420|FG001|Part A|Death|5|||
126606670|NCT02488408|455518421|FG002|Part A|Death|0|||
126606671|NCT02488408|455518422|FG003|Part A|Death|0|||
126606672|NCT02488408|455518423|FG004|Part A|Death|3|||
126606673|NCT02488408|455518424|FG005|Part A|Death|0|||
126606674|NCT02488408|455518425|FG006|Part A|Death|0|||
126606675|NCT02488408|455518426|FG007|Part A|Death|0|||
126606676|NCT02488408|455518427|FG008|Part A|Death|0|||
126606677|NCT02488408|455518428|FG009|Part A|Death|0|||
126606678|NCT02488408|455518419|FG000|Part A|Disease Progression|2|||
126606679|NCT02488408|455518420|FG001|Part A|Disease Progression|8|||
126606680|NCT02488408|455518421|FG002|Part A|Disease Progression|2|||
126606681|NCT02488408|455518422|FG003|Part A|Disease Progression|3|||
126606682|NCT02488408|455518423|FG004|Part A|Disease Progression|4|||
126606683|NCT02488408|455518424|FG005|Part A|Disease Progression|0|||
126606684|NCT02488408|455518425|FG006|Part A|Disease Progression|0|||
126606685|NCT02488408|455518426|FG007|Part A|Disease Progression|0|||
126606686|NCT02488408|455518427|FG008|Part A|Disease Progression|0|||
126606687|NCT02488408|455518428|FG009|Part A|Disease Progression|0|||
126606688|NCT02488408|455518419|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
126606689|NCT02488408|455518420|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
126606690|NCT02488408|455518421|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
126606691|NCT02488408|455518422|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
126606692|NCT02488408|455518423|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
126606693|NCT02488408|455518424|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
126606694|NCT02488408|455518425|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
126606695|NCT02488408|455518426|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
126606696|NCT02488408|455518427|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
126606697|NCT02488408|455518428|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
126606698|NCT02488408|455518419|FG000|Part A|Investigator Decision|0|||
126606699|NCT02488408|455518420|FG001|Part A|Investigator Decision|1|||
126606700|NCT02488408|455518421|FG002|Part A|Investigator Decision|1|||
126606701|NCT02488408|455518422|FG003|Part A|Investigator Decision|0|||
126606702|NCT02488408|455518423|FG004|Part A|Investigator Decision|0|||
126606703|NCT02488408|455518424|FG005|Part A|Investigator Decision|0|||
126606704|NCT02488408|455518425|FG006|Part A|Investigator Decision|0|||
126606705|NCT02488408|455518426|FG007|Part A|Investigator Decision|0|||
126606706|NCT02488408|455518427|FG008|Part A|Investigator Decision|0|||
126606707|NCT02488408|455518428|FG009|Part A|Investigator Decision|0|||
126606708|NCT02488408|455518419|FG000|Part A|Withdrawal by Subject|0|||
126606709|NCT02488408|455518420|FG001|Part A|Withdrawal by Subject|0|||
126606710|NCT02488408|455518421|FG002|Part A|Withdrawal by Subject|2|||
126733858|NCT02727660|455974011|FG002|Overall Study|Lack of Efficacy|70|||
126606711|NCT02488408|455518422|FG003|Part A|Withdrawal by Subject|0|||
126606712|NCT02488408|455518423|FG004|Part A|Withdrawal by Subject|0|||
126606713|NCT02488408|455518424|FG005|Part A|Withdrawal by Subject|0|||
126606714|NCT02488408|455518425|FG006|Part A|Withdrawal by Subject|0|||
126606715|NCT02488408|455518426|FG007|Part A|Withdrawal by Subject|0|||
126606716|NCT02488408|455518427|FG008|Part A|Withdrawal by Subject|0|||
126733859|NCT02727660|455974009|FG000|Overall Study|Adverse Event|28|||
126606717|NCT02488408|455518428|FG009|Part A|Withdrawal by Subject|0|||
126606718|NCT02488408|455518419|FG000|Part A|Other|1|||
126606719|NCT02488408|455518420|FG001|Part A|Other|0|||
126606720|NCT02488408|455518421|FG002|Part A|Other|0|||
126606721|NCT02488408|455518422|FG003|Part A|Other|0|||
126606722|NCT02488408|455518423|FG004|Part A|Other|0|||
126606723|NCT02488408|455518424|FG005|Part A|Other|0|||
126606724|NCT02488408|455518425|FG006|Part A|Other|0|||
126606725|NCT02488408|455518426|FG007|Part A|Other|0|||
126606726|NCT02488408|455518427|FG008|Part A|Other|0|||
126606727|NCT02488408|455518428|FG009|Part A|Other|0|||
126606728|NCT02488408|455518419|FG000|Part B|Adverse Event|0|||
126606729|NCT02488408|455518420|FG001|Part B|Adverse Event|0|||
126606730|NCT02488408|455518421|FG002|Part B|Adverse Event|0|||
126606731|NCT02488408|455518422|FG003|Part B|Adverse Event|0|||
126606732|NCT02488408|455518423|FG004|Part B|Adverse Event|0|||
126606733|NCT02488408|455518424|FG005|Part B|Adverse Event|2|||
126606734|NCT02488408|455518425|FG006|Part B|Adverse Event|2|||
126606735|NCT02488408|455518426|FG007|Part B|Adverse Event|7|||
126606736|NCT02488408|455518427|FG008|Part B|Adverse Event|2|||
126606737|NCT02488408|455518428|FG009|Part B|Adverse Event|2|||
126606738|NCT02488408|455518419|FG000|Part B|Death|0|||
126606739|NCT02488408|455518420|FG001|Part B|Death|0|||
126606740|NCT02488408|455518421|FG002|Part B|Death|0|||
126606741|NCT02488408|455518422|FG003|Part B|Death|0|||
126606742|NCT02488408|455518423|FG004|Part B|Death|0|||
126606743|NCT02488408|455518424|FG005|Part B|Death|3|||
126606744|NCT02488408|455518425|FG006|Part B|Death|1|||
126606745|NCT02488408|455518426|FG007|Part B|Death|2|||
126606746|NCT02488408|455518427|FG008|Part B|Death|2|||
126606747|NCT02488408|455518428|FG009|Part B|Death|2|||
126606748|NCT02488408|455518419|FG000|Part B|Death due to Disease Progression|0|||
126606749|NCT02488408|455518420|FG001|Part B|Death due to Disease Progression|0|||
126606750|NCT02488408|455518421|FG002|Part B|Death due to Disease Progression|0|||
126606751|NCT02488408|455518422|FG003|Part B|Death due to Disease Progression|0|||
126606752|NCT02488408|455518423|FG004|Part B|Death due to Disease Progression|0|||
126606753|NCT02488408|455518424|FG005|Part B|Death due to Disease Progression|2|||
126606754|NCT02488408|455518425|FG006|Part B|Death due to Disease Progression|2|||
126606755|NCT02488408|455518426|FG007|Part B|Death due to Disease Progression|1|||
126606756|NCT02488408|455518427|FG008|Part B|Death due to Disease Progression|1|||
126606757|NCT02488408|455518428|FG009|Part B|Death due to Disease Progression|1|||
126606758|NCT02488408|455518419|FG000|Part B|Disease Progression|0|||
126606759|NCT02488408|455518420|FG001|Part B|Disease Progression|0|||
126606760|NCT02488408|455518421|FG002|Part B|Disease Progression|0|||
126606761|NCT02488408|455518422|FG003|Part B|Disease Progression|0|||
126606762|NCT02488408|455518423|FG004|Part B|Disease Progression|0|||
126606763|NCT02488408|455518424|FG005|Part B|Disease Progression|6|||
126606764|NCT02488408|455518425|FG006|Part B|Disease Progression|9|||
126606765|NCT02488408|455518426|FG007|Part B|Disease Progression|7|||
126606766|NCT02488408|455518427|FG008|Part B|Disease Progression|9|||
126606767|NCT02488408|455518428|FG009|Part B|Disease Progression|11|||
126606768|NCT02488408|455518419|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
126606769|NCT02488408|455518420|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
126606770|NCT02488408|455518421|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
126606771|NCT02488408|455518422|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
126606772|NCT02488408|455518423|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
126606773|NCT02488408|455518424|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
126606774|NCT02488408|455518425|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
126606775|NCT02488408|455518426|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
126606776|NCT02488408|455518427|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
126606777|NCT02488408|455518428|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
126606778|NCT02488408|455518419|FG000|Part B|Investigator Decision|0|||
126606779|NCT02488408|455518420|FG001|Part B|Investigator Decision|0|||
126606780|NCT02488408|455518421|FG002|Part B|Investigator Decision|0|||
126606781|NCT02488408|455518422|FG003|Part B|Investigator Decision|0|||
126733860|NCT02727660|455974010|FG001|Overall Study|Adverse Event|21|||
126733861|NCT02727660|455974011|FG002|Overall Study|Adverse Event|32|||
126733862|NCT02727660|455974009|FG000|Overall Study|Withdrawal by Subject|26|||
126733863|NCT02727660|455974010|FG001|Overall Study|Withdrawal by Subject|25|||
126606782|NCT02488408|455518423|FG004|Part B|Investigator Decision|0|||
126606783|NCT02488408|455518424|FG005|Part B|Investigator Decision|0|||
126606784|NCT02488408|455518425|FG006|Part B|Investigator Decision|1|||
126606785|NCT02488408|455518426|FG007|Part B|Investigator Decision|0|||
126606786|NCT02488408|455518427|FG008|Part B|Investigator Decision|2|||
126606787|NCT02488408|455518428|FG009|Part B|Investigator Decision|1|||
126606788|NCT03664804|455518432|FG000|Overall Study|Withdrawal by Subject|7|||
126606789|NCT04701203|455518433|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
126606790|NCT04701203|455518434|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
126606791|NCT04701203|455518435|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
126606792|NCT04701203|455518433|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
126733864|NCT02727660|455974011|FG002|Overall Study|Withdrawal by Subject|30|||
126733865|NCT02727660|455974009|FG000|Overall Study|Physician Decision|3|||
126733866|NCT02727660|455974010|FG001|Overall Study|Physician Decision|8|||
126733867|NCT02727660|455974011|FG002|Overall Study|Physician Decision|14|||
126733868|NCT02727660|455974009|FG000|Overall Study|Lost to Follow-up|5|||
126733869|NCT02727660|455974010|FG001|Overall Study|Lost to Follow-up|9|||
126733870|NCT02727660|455974011|FG002|Overall Study|Lost to Follow-up|8|||
126733871|NCT02727660|455974009|FG000|Overall Study|Protocol Violation|7|||
126733872|NCT02727660|455974010|FG001|Overall Study|Protocol Violation|5|||
126733873|NCT02727660|455974011|FG002|Overall Study|Protocol Violation|5|||
126733874|NCT02727660|455974009|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
126733875|NCT02727660|455974010|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
126733876|NCT02727660|455974011|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
126733877|NCT02727660|455974009|FG000|Overall Study|Administrative Reasons|2|||
126733878|NCT02727660|455974010|FG001|Overall Study|Administrative Reasons|3|||
126733879|NCT02727660|455974011|FG002|Overall Study|Administrative Reasons|4|||
126733880|NCT00764946|455974015|FG000|Overall Study|Lack of Efficacy|1|||
126733881|NCT00764946|455974016|FG001|Overall Study|Lack of Efficacy|0|||
126733882|NCT00764946|455974017|FG002|Overall Study|Lack of Efficacy|0|||
126781145|NCT01387282|456154455|FG000|Overall Study|Study drug-related AE|2|||
126781146|NCT01387282|456154456|FG001|Overall Study|Study drug-related AE|2|||
126606793|NCT04701203|455518434|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
126606794|NCT04701203|455518435|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
126606795|NCT04701203|455518433|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
126606796|NCT04701203|455518434|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
126781147|NCT01387282|456154455|FG000|Overall Study|Lost to Follow-up|4|||
126781148|NCT01387282|456154456|FG001|Overall Study|Lost to Follow-up|1|||
126781149|NCT03997448|456154457|FG000|Study Treatment|Disease Progression|1|||
126781150|NCT03997448|456154457|FG000|Study Treatment|Symptomatic Deterioration|1|||
126781151|NCT03997448|456154457|FG000|Follow up|Death|2|||
126781152|NCT03997448|456154457|FG000|Follow up|study terminated|1|||
126781153|NCT01267266|456154460|FG000|Enrollment Phase|Withdrawal by Subject|2|||
126781154|NCT01267266|456154461|FG001|Enrollment Phase|Withdrawal by Subject|0|||
126781155|NCT01267266|456154460|FG000|Lead-in Phase|Lack of Efficacy|20|||
126781156|NCT01267266|456154461|FG001|Lead-in Phase|Lack of Efficacy|0|||
126781157|NCT01267266|456154460|FG000|Lead-in Phase|Adverse Event|2|||
126781158|NCT01267266|456154461|FG001|Lead-in Phase|Adverse Event|0|||
126781159|NCT01267266|456154460|FG000|Lead-in Phase|Withdrawal by Subject|1|||
126781160|NCT01267266|456154461|FG001|Lead-in Phase|Withdrawal by Subject|0|||
126781161|NCT01464827|456154477|FG000|Overall Study|Adverse Event|0|||
126606797|NCT04701203|455518435|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
126606798|NCT04701203|455518433|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
126606799|NCT04701203|455518434|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
126606800|NCT04701203|455518435|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
126606801|NCT06140290|455518437|FG000|Period 1|Adverse Event|1|||
126606802|NCT06140290|455518438|FG001|Period 1|Adverse Event|0|||
126606803|NCT06140290|455518437|FG000|Period 2|Assigned but not treated|0|||
126606804|NCT06140290|455518438|FG001|Period 2|Assigned but not treated|1|||
126606805|NCT06140290|455518437|FG000|Period 2|Withdrawal by Subject|0|||
126606806|NCT06140290|455518438|FG001|Period 2|Withdrawal by Subject|1|||
126606807|NCT02036970|455519750|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
126606808|NCT02036970|455519751|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
126606809|NCT02036970|455519752|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
126606810|NCT02036970|455519753|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
126606811|NCT02036970|455519754|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
126606812|NCT02036970|455519755|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
126606813|NCT02036970|455519756|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
126606814|NCT02036970|455519757|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
126606815|NCT02036970|455519758|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
126606816|NCT02036970|455519759|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
126606817|NCT02036970|455519750|FG000|Part 1: Day 1 Through Week 16|Death|0|||
126606818|NCT02036970|455519751|FG001|Part 1: Day 1 Through Week 16|Death|0|||
126606819|NCT02036970|455519752|FG002|Part 1: Day 1 Through Week 16|Death|0|||
126606820|NCT02036970|455519753|FG003|Part 1: Day 1 Through Week 16|Death|0|||
126606821|NCT02036970|455519754|FG004|Part 1: Day 1 Through Week 16|Death|0|||
126606822|NCT02036970|455519755|FG005|Part 1: Day 1 Through Week 16|Death|0|||
126606823|NCT02036970|455519756|FG006|Part 1: Day 1 Through Week 16|Death|0|||
126606824|NCT02036970|455519757|FG007|Part 1: Day 1 Through Week 16|Death|0|||
126606825|NCT02036970|455519758|FG008|Part 1: Day 1 Through Week 16|Death|1|||
126606826|NCT02036970|455519759|FG009|Part 1: Day 1 Through Week 16|Death|0|||
126606827|NCT02036970|455519750|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
126781162|NCT01464827|456154478|FG001|Overall Study|Adverse Event|0|||
126781163|NCT01464827|456154479|FG002|Overall Study|Adverse Event|0|||
126733883|NCT00764946|455974015|FG000|Overall Study|Lost to Follow-up|3|||
126733884|NCT00764946|455974016|FG001|Overall Study|Lost to Follow-up|4|||
126733885|NCT00764946|455974017|FG002|Overall Study|Lost to Follow-up|0|||
126781164|NCT01464827|456154480|FG003|Overall Study|Adverse Event|0|||
126781165|NCT01464827|456154481|FG004|Overall Study|Adverse Event|0|||
126606828|NCT02036970|455519751|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126606829|NCT02036970|455519752|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
126606830|NCT02036970|455519753|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126606831|NCT02036970|455519754|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126606832|NCT02036970|455519755|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126606833|NCT02036970|455519756|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126606834|NCT02036970|455519757|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126606835|NCT02036970|455519758|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
126606836|NCT02036970|455519759|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
126606837|NCT02036970|455519750|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126606838|NCT02036970|455519751|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126606839|NCT02036970|455519752|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126606840|NCT02036970|455519753|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126606841|NCT02036970|455519754|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
126606842|NCT02036970|455519755|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126606843|NCT02036970|455519756|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126606844|NCT02036970|455519757|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
126606845|NCT02036970|455519758|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
126606846|NCT02036970|455519759|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
126606847|NCT02036970|455519750|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126606848|NCT02036970|455519751|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126606849|NCT02036970|455519752|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126606850|NCT02036970|455519753|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
126606851|NCT02036970|455519754|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126606852|NCT02036970|455519755|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126606853|NCT02036970|455519756|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126606854|NCT02036970|455519757|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126606855|NCT02036970|455519758|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126606856|NCT02036970|455519759|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
126606857|NCT02036970|455519750|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
126606858|NCT02036970|455519751|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
126606859|NCT02036970|455519752|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
126606860|NCT02036970|455519753|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
126606861|NCT02036970|455519754|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
126606862|NCT02036970|455519755|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
126606863|NCT02036970|455519756|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
126606864|NCT02036970|455519757|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
126606865|NCT02036970|455519758|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
126606866|NCT02036970|455519759|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
126606867|NCT02036970|455519750|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
126606868|NCT02036970|455519751|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
126606869|NCT02036970|455519752|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
126606870|NCT02036970|455519753|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
126606871|NCT02036970|455519754|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
126606872|NCT02036970|455519755|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
126606873|NCT02036970|455519756|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
126606874|NCT02036970|455519757|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
126606875|NCT02036970|455519758|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
126606876|NCT02036970|455519759|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
126606877|NCT02036970|455519750|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126606878|NCT02036970|455519751|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
126606879|NCT02036970|455519752|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
126606880|NCT02036970|455519753|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126606881|NCT02036970|455519754|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126606882|NCT02036970|455519755|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126606883|NCT02036970|455519756|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126606884|NCT02036970|455519757|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126606885|NCT02036970|455519758|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
126606886|NCT02036970|455519759|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
126606887|NCT02036970|455519750|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
126606888|NCT02036970|455519751|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
126606889|NCT02036970|455519752|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
126606890|NCT02036970|455519753|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
126606891|NCT02036970|455519754|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
126606892|NCT02036970|455519755|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
126606893|NCT02036970|455519756|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
126606894|NCT02036970|455519757|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
126606895|NCT02036970|455519758|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
126606896|NCT02036970|455519759|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
126606897|NCT02386098|455519760|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
126606898|NCT02386098|455519761|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
126606899|NCT02386098|455519762|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
126606900|NCT02386098|455519763|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
126606901|NCT02386098|455519764|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
126606902|NCT02386098|455519760|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
126606903|NCT02386098|455519761|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
126606904|NCT02386098|455519762|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
126606905|NCT02386098|455519763|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
126606906|NCT02386098|455519764|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
126606907|NCT02386098|455519760|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
126606908|NCT02386098|455519761|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
126606909|NCT02386098|455519762|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
126733886|NCT00764946|455974015|FG000|Overall Study|Physician Decision|2|||
126733887|NCT00764946|455974016|FG001|Overall Study|Physician Decision|4|||
126733888|NCT00764946|455974017|FG002|Overall Study|Physician Decision|0|||
126733889|NCT00764946|455974015|FG000|Overall Study|Adverse Event|3|||
126733890|NCT00764946|455974016|FG001|Overall Study|Adverse Event|2|||
126733891|NCT00764946|455974017|FG002|Overall Study|Adverse Event|1|||
126733892|NCT00764946|455974015|FG000|Overall Study|Withdrawal by Subject|3|||
126733893|NCT00764946|455974016|FG001|Overall Study|Withdrawal by Subject|6|||
126733894|NCT00764946|455974017|FG002|Overall Study|Withdrawal by Subject|2|||
126733895|NCT00764946|455974015|FG000|Overall Study|Never Treated|1|||
126733896|NCT00764946|455974016|FG001|Overall Study|Never Treated|1|||
126606910|NCT02386098|455519763|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
126606911|NCT02386098|455519764|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
126606912|NCT02386098|455519760|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
126606913|NCT02386098|455519761|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
126606914|NCT02386098|455519762|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
126606915|NCT02386098|455519763|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
126606916|NCT02386098|455519764|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
126606917|NCT02386098|455519760|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
126606918|NCT02386098|455519761|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
126606919|NCT02386098|455519762|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
126606920|NCT02386098|455519763|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
126606921|NCT02386098|455519764|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
126606922|NCT02386098|455519760|FG000|Stage 1 (96 Weeks)|Other|1|||
126606923|NCT02386098|455519761|FG001|Stage 1 (96 Weeks)|Other|0|||
126606924|NCT02386098|455519762|FG002|Stage 1 (96 Weeks)|Other|0|||
126606925|NCT02386098|455519763|FG003|Stage 1 (96 Weeks)|Other|0|||
126606926|NCT02386098|455519764|FG004|Stage 1 (96 Weeks)|Other|0|||
126606927|NCT02386098|455519760|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
126606928|NCT02386098|455519761|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
126606929|NCT02386098|455519762|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
126606930|NCT02386098|455519763|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
126606931|NCT02386098|455519764|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
126606932|NCT03752684|455519768|FG000|Overall Study|Lost to Follow-up|4|||
126606933|NCT02722434|455519771|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
126606934|NCT02722434|455519772|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
126606935|NCT02722434|455519771|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
126606936|NCT02722434|455519772|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
126606937|NCT02200705|455519773|FG000|Overall Study|Excluded|12|||
126606938|NCT02200705|455519773|FG000|Overall Study|Death|21|||
126606939|NCT02200705|455519773|FG000|Overall Study|Withdrawal by Subject|22|||
126606940|NCT02200705|455519773|FG000|Overall Study|Lost to Follow-up|13|||
126606941|NCT02200705|455519773|FG000|Overall Study|Physician Decision|5|||
126606942|NCT02200705|455519773|FG000|Overall Study|Adverse Event|2|||
126606943|NCT00442104|455519774|FG000|Overall Study|Adverse Event|5|||
126606944|NCT00442104|455519774|FG000|Overall Study|Death|2|||
126606945|NCT00442104|455519774|FG000|Overall Study|Lost to Follow-up|3|||
126606946|NCT00442104|455519774|FG000|Overall Study|Withdrawal by Subject|5|||
126606947|NCT00442104|455519774|FG000|Overall Study|Insufficient Clinical Response|10|||
126606948|NCT00442104|455519774|FG000|Overall Study|Other|21|||
126733897|NCT00764946|455974017|FG002|Overall Study|Never Treated|1|||
126606949|NCT00442104|455519774|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
126606950|NCT01767467|455519777|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
126606951|NCT01767467|455519778|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
126606952|NCT01767467|455519777|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
126606953|NCT01767467|455519778|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
126606954|NCT01767467|455519777|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
126606955|NCT01767467|455519778|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
126606956|NCT01767467|455519777|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
126733898|NCT00493974|455974024|FG000|Overall Study|Death|1|||
126733899|NCT00493974|455974025|FG001|Overall Study|Death|2|||
126733900|NCT00493974|455974024|FG000|Overall Study|Withdrawal by Subject|8|||
126733901|NCT00493974|455974025|FG001|Overall Study|Withdrawal by Subject|6|||
126733902|NCT00493974|455974024|FG000|Overall Study|Lost to Follow-up|4|||
126733903|NCT00493974|455974025|FG001|Overall Study|Lost to Follow-up|6|||
126733904|NCT02555657|455974026|FG000|Overall Study|Death|274|||
126733905|NCT02555657|455974027|FG001|Overall Study|Death|262|||
126733906|NCT02555657|455974026|FG000|Overall Study|Physician Decision|0|||
126733907|NCT02555657|455974027|FG001|Overall Study|Physician Decision|1|||
126733908|NCT02555657|455974026|FG000|Overall Study|Sponsor Decision|27|||
126733909|NCT02555657|455974027|FG001|Overall Study|Sponsor Decision|15|||
126733910|NCT02555657|455974026|FG000|Overall Study|Withdrawal by Subject|11|||
126733911|NCT02555657|455974027|FG001|Overall Study|Withdrawal by Subject|32|||
126733912|NCT02188719|455974028|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
126733913|NCT02188719|455974029|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
126781166|NCT01464827|456154482|FG005|Overall Study|Adverse Event|0|||
126781167|NCT01464827|456154483|FG006|Overall Study|Adverse Event|0|||
126606957|NCT01767467|455519778|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
126606958|NCT01767467|455519777|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
126606959|NCT01767467|455519778|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
126606960|NCT01767467|455519777|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
126606961|NCT01767467|455519778|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
126606962|NCT01767467|455519777|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
126606963|NCT01767467|455519778|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
126606964|NCT01767467|455519777|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
126606965|NCT01767467|455519778|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
126606966|NCT01767467|455519777|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
126606967|NCT01767467|455519778|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
126606968|NCT01767467|455519777|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
126606969|NCT01767467|455519778|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
126606970|NCT01767467|455519777|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
126606971|NCT01767467|455519778|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
126606972|NCT01767467|455519777|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
126606973|NCT01767467|455519778|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
126606974|NCT01767467|455519777|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
126606975|NCT01767467|455519778|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
126606976|NCT01767467|455519777|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
126606977|NCT01767467|455519778|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
126606978|NCT01640951|455519779|FG000|Overall Study|Adverse Event|8|||
126606979|NCT01640951|455519780|FG001|Overall Study|Adverse Event|3|||
126606980|NCT01640951|455519781|FG002|Overall Study|Adverse Event|10|||
126606981|NCT01640951|455519782|FG003|Overall Study|Adverse Event|6|||
126606982|NCT01640951|455519783|FG004|Overall Study|Adverse Event|1|||
126606983|NCT01640951|455519784|FG005|Overall Study|Adverse Event|11|||
126606984|NCT01640951|455519785|FG006|Overall Study|Adverse Event|1|||
126606985|NCT01640951|455519786|FG007|Overall Study|Adverse Event|3|||
126606986|NCT01640951|455519779|FG000|Overall Study|Lack of Efficacy|20|||
126606987|NCT01640951|455519780|FG001|Overall Study|Lack of Efficacy|1|||
126606988|NCT01640951|455519781|FG002|Overall Study|Lack of Efficacy|7|||
126606989|NCT01640951|455519782|FG003|Overall Study|Lack of Efficacy|14|||
126606990|NCT01640951|455519783|FG004|Overall Study|Lack of Efficacy|0|||
126606991|NCT01640951|455519784|FG005|Overall Study|Lack of Efficacy|6|||
126606992|NCT01640951|455519785|FG006|Overall Study|Lack of Efficacy|5|||
126606993|NCT01640951|455519786|FG007|Overall Study|Lack of Efficacy|6|||
126606994|NCT01640951|455519779|FG000|Overall Study|Lost to Follow-up|1|||
126606995|NCT01640951|455519780|FG001|Overall Study|Lost to Follow-up|0|||
126606996|NCT01640951|455519781|FG002|Overall Study|Lost to Follow-up|6|||
126606997|NCT01640951|455519782|FG003|Overall Study|Lost to Follow-up|2|||
126606998|NCT01640951|455519783|FG004|Overall Study|Lost to Follow-up|2|||
126606999|NCT01640951|455519784|FG005|Overall Study|Lost to Follow-up|3|||
126607000|NCT01640951|455519785|FG006|Overall Study|Lost to Follow-up|1|||
126607001|NCT01640951|455519786|FG007|Overall Study|Lost to Follow-up|1|||
126607002|NCT01640951|455519779|FG000|Overall Study|Non-compliance with study treatment|0|||
126607003|NCT01640951|455519780|FG001|Overall Study|Non-compliance with study treatment|0|||
126733914|NCT02188719|455974030|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
126733915|NCT02188719|455974031|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
126607004|NCT01640951|455519781|FG002|Overall Study|Non-compliance with study treatment|1|||
126607005|NCT01640951|455519782|FG003|Overall Study|Non-compliance with study treatment|1|||
126607006|NCT01640951|455519783|FG004|Overall Study|Non-compliance with study treatment|1|||
126607007|NCT01640951|455519784|FG005|Overall Study|Non-compliance with study treatment|4|||
126607008|NCT01640951|455519785|FG006|Overall Study|Non-compliance with study treatment|1|||
126607009|NCT01640951|455519786|FG007|Overall Study|Non-compliance with study treatment|0|||
126733916|NCT00966693|455974032|FG000|Overall Study|Adverse Event|0|||
126733917|NCT00966693|455974033|FG001|Overall Study|Adverse Event|0|||
126607010|NCT01640951|455519779|FG000|Overall Study|Physician Decision|2|||
126607011|NCT01640951|455519780|FG001|Overall Study|Physician Decision|5|||
126607012|NCT01640951|455519781|FG002|Overall Study|Physician Decision|2|||
126607013|NCT01640951|455519782|FG003|Overall Study|Physician Decision|2|||
126607014|NCT01640951|455519783|FG004|Overall Study|Physician Decision|2|||
126607015|NCT01640951|455519784|FG005|Overall Study|Physician Decision|3|||
126607016|NCT01640951|455519785|FG006|Overall Study|Physician Decision|3|||
126607017|NCT01640951|455519786|FG007|Overall Study|Physician Decision|0|||
126607018|NCT01640951|455519779|FG000|Overall Study|Pregnancy|3|||
126607019|NCT01640951|455519780|FG001|Overall Study|Pregnancy|0|||
126607020|NCT01640951|455519781|FG002|Overall Study|Pregnancy|0|||
126607021|NCT01640951|455519782|FG003|Overall Study|Pregnancy|4|||
126607022|NCT01640951|455519783|FG004|Overall Study|Pregnancy|0|||
126607023|NCT01640951|455519784|FG005|Overall Study|Pregnancy|0|||
126607024|NCT01640951|455519785|FG006|Overall Study|Pregnancy|2|||
126607025|NCT01640951|455519786|FG007|Overall Study|Pregnancy|0|||
126607026|NCT01640951|455519779|FG000|Overall Study|Protocol Deviation|0|||
126607027|NCT01640951|455519780|FG001|Overall Study|Protocol Deviation|1|||
126607028|NCT01640951|455519781|FG002|Overall Study|Protocol Deviation|2|||
126607029|NCT01640951|455519782|FG003|Overall Study|Protocol Deviation|1|||
126607030|NCT01640951|455519783|FG004|Overall Study|Protocol Deviation|0|||
126607031|NCT01640951|455519784|FG005|Overall Study|Protocol Deviation|1|||
126607032|NCT01640951|455519785|FG006|Overall Study|Protocol Deviation|0|||
126607033|NCT01640951|455519786|FG007|Overall Study|Protocol Deviation|0|||
126607034|NCT01640951|455519779|FG000|Overall Study|Subject/Guardian decision|12|||
126607035|NCT01640951|455519780|FG001|Overall Study|Subject/Guardian decision|4|||
126607036|NCT01640951|455519781|FG002|Overall Study|Subject/Guardian decision|13|||
126607037|NCT01640951|455519782|FG003|Overall Study|Subject/Guardian decision|15|||
126607038|NCT01640951|455519783|FG004|Overall Study|Subject/Guardian decision|7|||
126607039|NCT01640951|455519784|FG005|Overall Study|Subject/Guardian decision|19|||
126607040|NCT01640951|455519785|FG006|Overall Study|Subject/Guardian decision|5|||
126607041|NCT01640951|455519786|FG007|Overall Study|Subject/Guardian decision|4|||
126607042|NCT01640951|455519779|FG000|Overall Study|Death|0|||
126607043|NCT01640951|455519780|FG001|Overall Study|Death|1|||
126607044|NCT01640951|455519781|FG002|Overall Study|Death|1|||
126607045|NCT01640951|455519782|FG003|Overall Study|Death|0|||
126607046|NCT01640951|455519783|FG004|Overall Study|Death|0|||
126607047|NCT01640951|455519784|FG005|Overall Study|Death|0|||
126607048|NCT01640951|455519785|FG006|Overall Study|Death|0|||
126607049|NCT01640951|455519786|FG007|Overall Study|Death|2|||
126607050|NCT03355573|455519787|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
126607051|NCT03355573|455519787|FG000|Overall Study|Sponsor's decision|1|||
126607052|NCT03355573|455519787|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
126607053|NCT03355573|455519787|FG000|Overall Study|PI's decision|2|||
126607054|NCT03355573|455519787|FG000|Overall Study|Withdrawal by Subject|23|||
126607055|NCT03355573|455519787|FG000|Overall Study|Lost to Follow-up|4|||
126607056|NCT03355573|455519787|FG000|Overall Study|Lack of Efficacy|2|||
126607057|NCT03355573|455519787|FG000|Overall Study|Adverse Event, non-fatal|17|||
126607058|NCT03355573|455519787|FG000|Overall Study|Adverse Event, serious fatal|2|||
126607059|NCT00942266|455519790|FG000|Overall Study|Withdrawal by Subject|1|||
126607060|NCT00942266|455519791|FG001|Overall Study|Withdrawal by Subject|0|||
126607061|NCT00942266|455519790|FG000|Overall Study|Adverse Event|2|||
126607062|NCT00942266|455519791|FG001|Overall Study|Adverse Event|1|||
126607063|NCT00942266|455519790|FG000|Overall Study|Disease Progression|38|||
126607064|NCT00942266|455519791|FG001|Overall Study|Disease Progression|11|||
126607065|NCT00942266|455519790|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
126607066|NCT00942266|455519791|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
126607067|NCT00942266|455519790|FG000|Overall Study|Intercurrent illness|0|||
126607068|NCT00942266|455519791|FG001|Overall Study|Intercurrent illness|1|||
126607069|NCT00942266|455519790|FG000|Overall Study|Physician Decision|2|||
126607070|NCT00942266|455519791|FG001|Overall Study|Physician Decision|0|||
126733918|NCT00966693|455974034|FG002|Overall Study|Adverse Event|1|||
126733919|NCT00966693|455974035|FG003|Overall Study|Adverse Event|2|||
126733920|NCT00966693|455974032|FG000|Overall Study|Death|0|||
126733921|NCT00966693|455974033|FG001|Overall Study|Death|0|||
126607071|NCT00942266|455519790|FG000|Overall Study|medical deterioration (pneumonia)|0|||
126607072|NCT00942266|455519791|FG001|Overall Study|medical deterioration (pneumonia)|1|||
126607073|NCT00756574|455519797|FG000|Overall Study|Withdrawal by Subject|9|||
126607074|NCT00756574|455519798|FG001|Overall Study|Withdrawal by Subject|7|||
126607075|NCT00756574|455519797|FG000|Overall Study|Lost to Follow-up|4|||
126607076|NCT00756574|455519798|FG001|Overall Study|Lost to Follow-up|4|||
126607077|NCT04795167|455519799|FG000|Overall Study|Death|1|||
126607078|NCT04795167|455519800|FG001|Overall Study|Death|18|||
126607079|NCT04795167|455519801|FG002|Overall Study|Death|1|||
126607080|NCT04795167|455519799|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
126607081|NCT04795167|455519800|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
126607082|NCT04795167|455519801|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
126607083|NCT01588951|455519803|FG000|Overall Study|Ineligible in retrospect|0|||
126607084|NCT01588951|455519804|FG001|Overall Study|Ineligible in retrospect|0|||
126607085|NCT01588951|455519805|FG002|Overall Study|Ineligible in retrospect|1|||
126607086|NCT05025384|455519819|FG000|Overall Study|Physician Decision|5|||
126607087|NCT05025384|455519820|FG001|Overall Study|Physician Decision|6|||
126607088|NCT03610581|455519821|FG000|Overall Study|Study terminated by sponsor|2|||
126607089|NCT03610581|455519822|FG001|Overall Study|Study terminated by sponsor|0|||
126607090|NCT03610581|455519821|FG000|Overall Study|Other|0|||
126607091|NCT03610581|455519822|FG001|Overall Study|Other|1|||
126607092|NCT03610581|455519821|FG000|Overall Study|Withdrawal by Subject|1|||
126607093|NCT03610581|455519822|FG001|Overall Study|Withdrawal by Subject|0|||
126607094|NCT05613907|455519830|FG000|Overall Study|Lost to Follow-up|5|||
126607095|NCT05613907|455519830|FG000|Overall Study|Death|3|||
126607096|NCT05613907|455519830|FG000|Overall Study|Withdrawal by Subject|2|||
126607097|NCT00748709|455519833|FG000|Overall Study|Progressive disease|15|||
126607098|NCT00748709|455519833|FG000|Overall Study|Drug reducing Toxity|2|||
126607099|NCT00748709|455519833|FG000|Overall Study|Other Adverse Event|1|||
126607100|NCT00748709|455519833|FG000|Overall Study|Withdrawal by Subject|1|||
126607101|NCT00748709|455519833|FG000|Overall Study|Other Reasons|1|||
126607102|NCT02751528|455519838|FG000|Overall Study|Withdrawal by Subject|1|||
126607103|NCT02751528|455519838|FG000|Overall Study|Adverse Event|1|||
126607104|NCT05485805|455519839|FG000|Overall Study|Withdrawal by Subject|1|||
126607105|NCT05485805|455519840|FG001|Overall Study|Withdrawal by Subject|2|||
126607106|NCT05485805|455519841|FG002|Overall Study|Withdrawal by Subject|2|||
126607107|NCT05485805|455519842|FG003|Overall Study|Withdrawal by Subject|0|||
126607108|NCT05485805|455519843|FG004|Overall Study|Withdrawal by Subject|2|||
126607109|NCT05485805|455519839|FG000|Overall Study|Adverse Event|0|||
126607110|NCT05485805|455519840|FG001|Overall Study|Adverse Event|1|||
126607111|NCT05485805|455519841|FG002|Overall Study|Adverse Event|0|||
126607112|NCT05485805|455519842|FG003|Overall Study|Adverse Event|0|||
126607113|NCT05485805|455519843|FG004|Overall Study|Adverse Event|0|||
126607114|NCT05485805|455519839|FG000|Overall Study|Lost to Follow-up|1|||
126607115|NCT05485805|455519840|FG001|Overall Study|Lost to Follow-up|1|||
126607116|NCT05485805|455519841|FG002|Overall Study|Lost to Follow-up|3|||
126607117|NCT05485805|455519842|FG003|Overall Study|Lost to Follow-up|1|||
126607118|NCT05485805|455519843|FG004|Overall Study|Lost to Follow-up|0|||
126607119|NCT04218357|455519845|FG000|1st Allocation|Withdrawal by Subject|1|||
126607120|NCT04218357|455519846|FG001|1st Allocation|Withdrawal by Subject|0|||
126607121|NCT05349838|455519847|FG000|Overall Study|Virological Failure|1|||
126607122|NCT05349838|455519848|FG001|Overall Study|Virological Failure|2|||
126607123|NCT05349838|455519847|FG000|Overall Study|Withdrawal by Subject|2|||
126607124|NCT05349838|455519848|FG001|Overall Study|Withdrawal by Subject|3|||
126607125|NCT05349838|455519847|FG000|Overall Study|Adverse Event|3|||
126607126|NCT05349838|455519848|FG001|Overall Study|Adverse Event|1|||
126607127|NCT05349838|455519847|FG000|Overall Study|Lost to Follow-up|1|||
126607128|NCT05349838|455519848|FG001|Overall Study|Lost to Follow-up|2|||
126607129|NCT05349838|455519847|FG000|Overall Study|Other reasons|5|||
126607130|NCT05349838|455519848|FG001|Overall Study|Other reasons|1|||
126607131|NCT05071430|455519850|FG000|Overall Study|Adverse Event|1|||
126607132|NCT05071430|455519851|FG001|Overall Study|Adverse Event|2|||
126607133|NCT05071430|455519850|FG000|Overall Study|Lost to Follow-up|4|||
126607134|NCT05071430|455519851|FG001|Overall Study|Lost to Follow-up|4|||
126607135|NCT05071430|455519850|FG000|Overall Study|Protocol Violation|1|||
126607136|NCT05071430|455519851|FG001|Overall Study|Protocol Violation|0|||
126607137|NCT05071430|455519850|FG000|Overall Study|Withdrawal by Subject|3|||
126607138|NCT05071430|455519851|FG001|Overall Study|Withdrawal by Subject|2|||
126607139|NCT05071430|455519850|FG000|Overall Study|Other|1|||
126607140|NCT05071430|455519851|FG001|Overall Study|Other|1|||
126607141|NCT01958021|455519852|FG000|Treatment|Progressive disease|206|||
126607142|NCT01958021|455519853|FG001|Treatment|Progressive disease|265|||
126733922|NCT00966693|455974034|FG002|Overall Study|Death|1|||
126733923|NCT00966693|455974035|FG003|Overall Study|Death|0|||
126733924|NCT00966693|455974032|FG000|Overall Study|Withdrawal by Subject|1|||
126733925|NCT00966693|455974033|FG001|Overall Study|Withdrawal by Subject|0|||
126733926|NCT00966693|455974034|FG002|Overall Study|Withdrawal by Subject|0|||
126607143|NCT01958021|455519852|FG000|Treatment|Adverse Event|38|||
126607144|NCT01958021|455519853|FG001|Treatment|Adverse Event|10|||
126607145|NCT01958021|455519852|FG000|Treatment|Subject/guardian decision|29|||
126607146|NCT01958021|455519853|FG001|Treatment|Subject/guardian decision|25|||
126607147|NCT01958021|455519852|FG000|Treatment|Physician Decision|28|||
126607148|NCT01958021|455519853|FG001|Treatment|Physician Decision|21|||
126607149|NCT01958021|455519852|FG000|Treatment|Death|6|||
126607150|NCT01958021|455519853|FG001|Treatment|Death|1|||
126607151|NCT01958021|455519852|FG000|Treatment|Protocol deviation|3|||
126607152|NCT01958021|455519853|FG001|Treatment|Protocol deviation|1|||
126607153|NCT01958021|455519852|FG000|Treatment|Sponsor decision|24|||
126607154|NCT01958021|455519853|FG001|Treatment|Sponsor decision|11|||
126607155|NCT01958021|455519852|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
126607156|NCT01958021|455519853|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
126607157|NCT01958021|455519852|FG000|Post-treatment Efficacy Follow-up|Death|1|||
126607158|NCT01958021|455519853|FG001|Post-treatment Efficacy Follow-up|Death|0|||
126733927|NCT00966693|455974035|FG003|Overall Study|Withdrawal by Subject|5|||
126607159|NCT01958021|455519852|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
126607160|NCT01958021|455519853|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
126607161|NCT01958021|455519852|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
126607162|NCT01958021|455519853|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
126607163|NCT01958021|455519852|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
126607164|NCT01958021|455519853|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
126607165|NCT01958021|455519852|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
126607166|NCT01958021|455519853|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
126607167|NCT01958021|455519852|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
126607168|NCT01958021|455519853|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
126607169|NCT05886777|455519855|FG000|Overall Study|Lost to Follow-up|1|||
126607170|NCT05886777|455519856|FG001|Overall Study|Lost to Follow-up|0|||
126607171|NCT05886777|455519857|FG002|Overall Study|Lost to Follow-up|2|||
126607172|NCT05886777|455519858|FG003|Overall Study|Lost to Follow-up|1|||
126607173|NCT05886777|455519859|FG004|Overall Study|Lost to Follow-up|0|||
126607174|NCT05886777|455519860|FG005|Overall Study|Lost to Follow-up|2|||
126607175|NCT05886777|455519861|FG006|Overall Study|Lost to Follow-up|0|||
126607176|NCT05886777|455519855|FG000|Overall Study|Other|0|||
126607177|NCT05886777|455519856|FG001|Overall Study|Other|2|||
126607178|NCT05886777|455519857|FG002|Overall Study|Other|1|||
126607179|NCT05886777|455519858|FG003|Overall Study|Other|0|||
126607180|NCT05886777|455519859|FG004|Overall Study|Other|0|||
126607181|NCT05886777|455519860|FG005|Overall Study|Other|0|||
126607182|NCT05886777|455519861|FG006|Overall Study|Other|0|||
126607183|NCT05886777|455519855|FG000|Overall Study|Withdrawal by Subject|1|||
126607184|NCT05886777|455519856|FG001|Overall Study|Withdrawal by Subject|0|||
126607185|NCT05886777|455519857|FG002|Overall Study|Withdrawal by Subject|1|||
126607186|NCT05886777|455519858|FG003|Overall Study|Withdrawal by Subject|4|||
126607187|NCT05886777|455519859|FG004|Overall Study|Withdrawal by Subject|3|||
126607188|NCT05886777|455519860|FG005|Overall Study|Withdrawal by Subject|1|||
126607189|NCT05886777|455519861|FG006|Overall Study|Withdrawal by Subject|1|||
126607190|NCT05886777|455519855|FG000|Overall Study|Protocol Violation|0|||
126607191|NCT05886777|455519856|FG001|Overall Study|Protocol Violation|0|||
126607192|NCT05886777|455519857|FG002|Overall Study|Protocol Violation|1|||
126607193|NCT05886777|455519858|FG003|Overall Study|Protocol Violation|0|||
126607194|NCT05886777|455519859|FG004|Overall Study|Protocol Violation|0|||
126607195|NCT05886777|455519860|FG005|Overall Study|Protocol Violation|0|||
126607196|NCT05886777|455519861|FG006|Overall Study|Protocol Violation|0|||
126607197|NCT05886777|455519855|FG000|Overall Study|No longer met eligibility criteria|0|||
126607198|NCT05886777|455519856|FG001|Overall Study|No longer met eligibility criteria|1|||
126607199|NCT05886777|455519857|FG002|Overall Study|No longer met eligibility criteria|0|||
126607200|NCT05886777|455519858|FG003|Overall Study|No longer met eligibility criteria|0|||
126607201|NCT05886777|455519859|FG004|Overall Study|No longer met eligibility criteria|0|||
126607202|NCT05886777|455519860|FG005|Overall Study|No longer met eligibility criteria|0|||
126607203|NCT05886777|455519861|FG006|Overall Study|No longer met eligibility criteria|0|||
126607204|NCT00048932|455521215|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
126607205|NCT00048932|455521216|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
126607206|NCT00048932|455521217|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
126607207|NCT00048932|455521215|FG000|Double Blind Period (DB)|Adverse Event|51|||
126607208|NCT00048932|455521216|FG001|Double Blind Period (DB)|Adverse Event|19|||
126607209|NCT00048932|455521217|FG002|Double Blind Period (DB)|Adverse Event|0|||
126607210|NCT00048932|455521215|FG000|Double Blind Period (DB)|Death|5|||
126607211|NCT00048932|455521216|FG001|Double Blind Period (DB)|Death|3|||
126607212|NCT00048932|455521217|FG002|Double Blind Period (DB)|Death|0|||
126607213|NCT00048932|455521215|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
126607214|NCT00048932|455521216|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
126607215|NCT00048932|455521217|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
126607216|NCT00048932|455521215|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
126607217|NCT00048932|455521216|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
126607218|NCT00048932|455521217|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
126607219|NCT00048932|455521215|FG000|Double Blind Period (DB)|Relocation|1|||
126607220|NCT00048932|455521216|FG001|Double Blind Period (DB)|Relocation|0|||
126607221|NCT00048932|455521217|FG002|Double Blind Period (DB)|Relocation|0|||
126607222|NCT00048932|455521215|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
126607223|NCT00048932|455521216|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
126607224|NCT00048932|455521217|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
126607225|NCT00048932|455521215|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
126607226|NCT00048932|455521216|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
126607227|NCT00048932|455521217|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
126607228|NCT00048932|455521215|FG000|Double Blind Period (DB)|Pregnancy|1|||
126607229|NCT00048932|455521216|FG001|Double Blind Period (DB)|Pregnancy|0|||
126607230|NCT00048932|455521217|FG002|Double Blind Period (DB)|Pregnancy|0|||
126607231|NCT00048932|455521215|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
126607232|NCT00048932|455521216|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
126607233|NCT00048932|455521217|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
126607234|NCT00048932|455521215|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
126607235|NCT00048932|455521216|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
126607236|NCT00048932|455521217|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
126607237|NCT00048932|455521215|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
126607238|NCT00048932|455521216|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
126607239|NCT00048932|455521217|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
126607240|NCT00048932|455521215|FG000|Open Label Period (OL)|Death|0|||
126607241|NCT00048932|455521216|FG001|Open Label Period (OL)|Death|0|||
126607242|NCT00048932|455521217|FG002|Open Label Period (OL)|Death|25|||
126607243|NCT00048932|455521215|FG000|Open Label Period (OL)|Adverse Event|0|||
126607244|NCT00048932|455521216|FG001|Open Label Period (OL)|Adverse Event|0|||
126607245|NCT00048932|455521217|FG002|Open Label Period (OL)|Adverse Event|103|||
126607246|NCT00048932|455521215|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
126607247|NCT00048932|455521216|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
126607248|NCT00048932|455521217|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
126607249|NCT00048932|455521215|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
126607250|NCT00048932|455521216|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
126607251|NCT00048932|455521217|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
126607252|NCT00048932|455521215|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
126607253|NCT00048932|455521216|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
126607254|NCT00048932|455521217|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
126607255|NCT00048932|455521215|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
126607256|NCT00048932|455521216|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
126607257|NCT00048932|455521217|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
126607258|NCT00048932|455521215|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
126607259|NCT00048932|455521216|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
126607260|NCT00048932|455521217|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
126607261|NCT00048932|455521215|FG000|Open Label Period (OL)|Pregnancy|0|||
126607262|NCT00048932|455521216|FG001|Open Label Period (OL)|Pregnancy|0|||
126607263|NCT00048932|455521217|FG002|Open Label Period (OL)|Pregnancy|6|||
126607264|NCT00048932|455521215|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
126607265|NCT00048932|455521216|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
126607266|NCT00048932|455521217|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
126607267|NCT00048932|455521215|FG000|Open Label Period (OL)|Investigator Retiring|0|||
126607268|NCT00048932|455521216|FG001|Open Label Period (OL)|Investigator Retiring|0|||
126607269|NCT00048932|455521217|FG002|Open Label Period (OL)|Investigator Retiring|2|||
126607270|NCT00048932|455521215|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
126607271|NCT00048932|455521216|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
126607272|NCT00048932|455521217|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
126607273|NCT00048932|455521215|FG000|Open Label Period (OL)|Participant Relocated|0|||
126607274|NCT00048932|455521216|FG001|Open Label Period (OL)|Participant Relocated|0|||
126607275|NCT00048932|455521217|FG002|Open Label Period (OL)|Participant Relocated|6|||
126607276|NCT00048932|455521215|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
126607277|NCT00048932|455521216|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
126607278|NCT00048932|455521217|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
126607279|NCT00048932|455521215|FG000|Open Label Period (OL)|Site Closure|0|||
126607280|NCT00048932|455521216|FG001|Open Label Period (OL)|Site Closure|0|||
126607281|NCT00048932|455521217|FG002|Open Label Period (OL)|Site Closure|3|||
126607282|NCT00048932|455521215|FG000|Open Label Period (OL)|Trial Terminated|0|||
126607283|NCT00048932|455521216|FG001|Open Label Period (OL)|Trial Terminated|0|||
126607284|NCT00048932|455521217|FG002|Open Label Period (OL)|Trial Terminated|1|||
126607285|NCT00048932|455521215|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
126607286|NCT00048932|455521216|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
126607287|NCT00048932|455521217|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
126607288|NCT00048932|455521215|FG000|Open Label Period (OL)|Patient Decision|0|||
126607289|NCT00048932|455521216|FG001|Open Label Period (OL)|Patient Decision|0|||
126607290|NCT00048932|455521217|FG002|Open Label Period (OL)|Patient Decision|4|||
126733928|NCT00966693|455974032|FG000|Overall Study|Disease Progression|0|||
126607291|NCT00048932|455521215|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
126607292|NCT00048932|455521216|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
126607293|NCT00048932|455521217|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
126607294|NCT00048932|455521215|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
126607295|NCT00048932|455521216|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
126607296|NCT00048932|455521217|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
126607297|NCT00048932|455521215|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
126607298|NCT00048932|455521216|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
126607299|NCT00048932|455521217|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
126607300|NCT00048932|455521215|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
126607301|NCT00048932|455521216|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
126607302|NCT00048932|455521217|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
126607303|NCT00048932|455521215|FG000|Open Label Period (OL)|Investigator Decision|0|||
126607304|NCT00048932|455521216|FG001|Open Label Period (OL)|Investigator Decision|0|||
126607305|NCT00048932|455521217|FG002|Open Label Period (OL)|Investigator Decision|4|||
126607306|NCT00048932|455521215|FG000|Open Label Period (OL)|Site Staff Issues|0|||
126607307|NCT00048932|455521216|FG001|Open Label Period (OL)|Site Staff Issues|0|||
126607308|NCT00048932|455521217|FG002|Open Label Period (OL)|Site Staff Issues|2|||
126733929|NCT00966693|455974033|FG001|Overall Study|Disease Progression|0|||
126733930|NCT00966693|455974034|FG002|Overall Study|Disease Progression|1|||
126607309|NCT00048932|455521215|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
126607310|NCT00048932|455521216|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
126607311|NCT00048932|455521217|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
126607312|NCT00048932|455521215|FG000|Open Label Period (OL)|Participant Surgery|0|||
126607313|NCT00048932|455521216|FG001|Open Label Period (OL)|Participant Surgery|0|||
126607314|NCT00048932|455521217|FG002|Open Label Period (OL)|Participant Surgery|1|||
126607315|NCT02232737|455521218|FG000|Overall Study|Lost to Follow-up|18|||
126607316|NCT02232737|455521219|FG001|Overall Study|Lost to Follow-up|28|||
126607317|NCT02232737|455521220|FG002|Overall Study|Lost to Follow-up|33|||
126607318|NCT02232737|455521218|FG000|Overall Study|Personal reasons|7|||
126607319|NCT02232737|455521219|FG001|Overall Study|Personal reasons|8|||
126607320|NCT02232737|455521220|FG002|Overall Study|Personal reasons|14|||
126607321|NCT02232737|455521218|FG000|Overall Study|Adverse Event|6|||
126607322|NCT02232737|455521219|FG001|Overall Study|Adverse Event|3|||
126607323|NCT02232737|455521220|FG002|Overall Study|Adverse Event|8|||
126607324|NCT02232737|455521218|FG000|Overall Study|Incarcerated|2|||
126607325|NCT02232737|455521219|FG001|Overall Study|Incarcerated|1|||
126607326|NCT02232737|455521220|FG002|Overall Study|Incarcerated|2|||
126607327|NCT02232737|455521218|FG000|Overall Study|Withdrawal by Subject|0|||
126607328|NCT02232737|455521219|FG001|Overall Study|Withdrawal by Subject|1|||
126607329|NCT02232737|455521220|FG002|Overall Study|Withdrawal by Subject|2|||
126607330|NCT02232737|455521218|FG000|Overall Study|Death|0|||
126607331|NCT02232737|455521219|FG001|Overall Study|Death|1|||
126607332|NCT02232737|455521220|FG002|Overall Study|Death|1|||
126607333|NCT02232737|455521218|FG000|Overall Study|Physician Decision|1|||
126607334|NCT02232737|455521219|FG001|Overall Study|Physician Decision|3|||
126607335|NCT02232737|455521220|FG002|Overall Study|Physician Decision|1|||
126607336|NCT02232737|455521218|FG000|Overall Study|Protocol Violation|1|||
126607337|NCT02232737|455521219|FG001|Overall Study|Protocol Violation|0|||
126607338|NCT02232737|455521220|FG002|Overall Study|Protocol Violation|1|||
126607339|NCT02232737|455521218|FG000|Overall Study|Reason unknown|1|||
126607340|NCT02232737|455521219|FG001|Overall Study|Reason unknown|0|||
126607341|NCT02232737|455521220|FG002|Overall Study|Reason unknown|0|||
126607342|NCT04559698|455521221|FG000|Overall Study|Lost to Follow-up|14|||
126607343|NCT04559698|455521222|FG001|Overall Study|Lost to Follow-up|15|||
126607344|NCT04559698|455521221|FG000|Overall Study|Withdrawal by Subject|0|||
126607345|NCT04559698|455521222|FG001|Overall Study|Withdrawal by Subject|1|||
126607346|NCT00786864|455521232|FG000|Overall Study|Lost to Follow-up|0|||
126607347|NCT00786864|455521233|FG001|Overall Study|Lost to Follow-up|1|||
126607348|NCT00786864|455521232|FG000|Overall Study|Sustained serious back injury|1|||
126607349|NCT00786864|455521233|FG001|Overall Study|Sustained serious back injury|0|||
126607350|NCT03442777|455521241|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
126607351|NCT03442777|455521242|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
126607352|NCT03442777|455521243|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
126733931|NCT00966693|455974035|FG003|Overall Study|Disease Progression|16|||
126607353|NCT01641900|455521244|FG000|Overall Study|Withdrawal by Subject|2|||
126607354|NCT01641900|455521245|FG001|Overall Study|Withdrawal by Subject|2|||
126607355|NCT03220724|455521251|FG000|Overall Study|Lost to Follow-up|2|||
126607356|NCT03220724|455521252|FG001|Overall Study|Lost to Follow-up|2|||
126607357|NCT03220724|455521253|FG002|Overall Study|Lost to Follow-up|0|||
126607358|NCT03220724|455521254|FG003|Overall Study|Lost to Follow-up|3|||
126607359|NCT03220724|455521255|FG004|Overall Study|Lost to Follow-up|1|||
126607360|NCT03220724|455521256|FG005|Overall Study|Lost to Follow-up|0|||
126607361|NCT03220724|455521257|FG006|Overall Study|Lost to Follow-up|2|||
126607362|NCT03220724|455521258|FG007|Overall Study|Lost to Follow-up|1|||
126607363|NCT03220724|455521259|FG008|Overall Study|Lost to Follow-up|0|||
126733932|NCT00599027|455974036|FG000|Overall Study|Withdrawal by Subject|1|||
126607364|NCT03220724|455521251|FG000|Overall Study|Withdrawal by Subject|1|||
126607365|NCT03220724|455521252|FG001|Overall Study|Withdrawal by Subject|0|||
126733933|NCT00599027|455974037|FG001|Overall Study|Withdrawal by Subject|1|||
126607366|NCT03220724|455521253|FG002|Overall Study|Withdrawal by Subject|1|||
126607367|NCT03220724|455521254|FG003|Overall Study|Withdrawal by Subject|0|||
126607368|NCT03220724|455521255|FG004|Overall Study|Withdrawal by Subject|0|||
126607369|NCT03220724|455521256|FG005|Overall Study|Withdrawal by Subject|0|||
126733934|NCT00599027|455974036|FG000|Overall Study|Adverse Event|0|||
126607370|NCT03220724|455521257|FG006|Overall Study|Withdrawal by Subject|0|||
126607371|NCT03220724|455521258|FG007|Overall Study|Withdrawal by Subject|0|||
126607372|NCT03220724|455521259|FG008|Overall Study|Withdrawal by Subject|0|||
126607373|NCT02463448|455521265|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
126607374|NCT02463448|455521265|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
126607375|NCT02463448|455521265|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
126607376|NCT02463448|455521265|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
126607377|NCT00463229|455521269|FG000|Overall Study|Lost to Follow-up|5|||
126607378|NCT00463229|455521270|FG001|Overall Study|Lost to Follow-up|7|||
126607379|NCT00463229|455521269|FG000|Overall Study|Death|4|||
126607380|NCT00463229|455521270|FG001|Overall Study|Death|3|||
126607381|NCT01932970|455521271|FG000|Overall Study|Withdrawal by Subject|5|||
126607382|NCT01932970|455521271|FG000|Overall Study|Death|1|||
126607383|NCT01932970|455521271|FG000|Overall Study|Lost to Follow-up|2|||
126607384|NCT01932970|455521271|FG000|Overall Study|Protocol Specified Criteria|10|||
126607385|NCT01359150|455521272|FG000|Overall Study|Lack of Efficacy|1|||
126607386|NCT01359150|455521273|FG001|Overall Study|Lack of Efficacy|1|||
126607387|NCT01359150|455521272|FG000|Overall Study|Withdrawal by Subject|1|||
126607388|NCT01359150|455521273|FG001|Overall Study|Withdrawal by Subject|1|||
126607389|NCT01359150|455521272|FG000|Overall Study|Adverse Event|4|||
126607390|NCT01359150|455521273|FG001|Overall Study|Adverse Event|3|||
126607391|NCT01359150|455521272|FG000|Overall Study|Other|1|||
126607392|NCT01359150|455521273|FG001|Overall Study|Other|0|||
126607393|NCT00857766|455521274|FG000|Overall Study|Adverse Event|13|||
126607394|NCT00857766|455521275|FG001|Overall Study|Adverse Event|12|||
126607395|NCT00857766|455521274|FG000|Overall Study|Protocol Violation|11|||
126607396|NCT00857766|455521275|FG001|Overall Study|Protocol Violation|11|||
126607397|NCT00857766|455521274|FG000|Overall Study|Lost to Follow-up|1|||
126607398|NCT00857766|455521275|FG001|Overall Study|Lost to Follow-up|0|||
126607399|NCT00857766|455521274|FG000|Overall Study|Investigator Discretion|2|||
126607400|NCT00857766|455521275|FG001|Overall Study|Investigator Discretion|3|||
126607401|NCT00857766|455521274|FG000|Overall Study|Participant Withdrew Consent|4|||
126607402|NCT00857766|455521275|FG001|Overall Study|Participant Withdrew Consent|4|||
126607403|NCT03113409|455521276|FG000|Overall Study|Withdrawal by Subject|5|||
126607404|NCT03113409|455521277|FG001|Overall Study|Withdrawal by Subject|0|||
126607405|NCT03113409|455521278|FG002|Overall Study|Withdrawal by Subject|0|||
126607406|NCT01787032|455521285|FG000|Overall Study|Protocol Violation|0|||
126607407|NCT01787032|455521286|FG001|Overall Study|Protocol Violation|0|||
126607408|NCT01787032|455521287|FG002|Overall Study|Protocol Violation|0|||
126607409|NCT01787032|455521288|FG003|Overall Study|Protocol Violation|0|||
126607410|NCT01787032|455521289|FG004|Overall Study|Protocol Violation|1|||
126607411|NCT01787032|455521290|FG005|Overall Study|Protocol Violation|1|||
126607412|NCT00776009|455521291|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
126607413|NCT00776009|455521292|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
126607414|NCT00776009|455521293|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
126607415|NCT00776009|455521294|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
126607416|NCT00776009|455521295|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
126607417|NCT00776009|455521296|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
126607418|NCT00776009|455521291|FG000|Period 1: First Intervention|Protocol Violation|0|||
126607419|NCT00776009|455521292|FG001|Period 1: First Intervention|Protocol Violation|1|||
126607420|NCT00776009|455521293|FG002|Period 1: First Intervention|Protocol Violation|0|||
126607421|NCT00776009|455521294|FG003|Period 1: First Intervention|Protocol Violation|0|||
126607422|NCT00776009|455521295|FG004|Period 1: First Intervention|Protocol Violation|1|||
126607423|NCT00776009|455521296|FG005|Period 1: First Intervention|Protocol Violation|0|||
126781168|NCT01464827|456154484|FG007|Overall Study|Adverse Event|0|||
126781169|NCT01464827|456154485|FG008|Overall Study|Adverse Event|0|||
126781170|NCT01464827|456154486|FG009|Overall Study|Adverse Event|0|||
126781171|NCT01464827|456154487|FG010|Overall Study|Adverse Event|0|||
126781172|NCT01464827|456154488|FG011|Overall Study|Adverse Event|0|||
126607424|NCT00776009|455521291|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
126607425|NCT00776009|455521292|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
126607426|NCT00776009|455521293|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
126607427|NCT00776009|455521294|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
126607428|NCT00776009|455521295|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
126607429|NCT00776009|455521296|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
126607430|NCT00776009|455521291|FG000|Period 2: Second Intervention|Protocol Violation|1|||
126607431|NCT00776009|455521292|FG001|Period 2: Second Intervention|Protocol Violation|0|||
126607432|NCT00776009|455521293|FG002|Period 2: Second Intervention|Protocol Violation|1|||
126607433|NCT00776009|455521294|FG003|Period 2: Second Intervention|Protocol Violation|0|||
126607434|NCT00776009|455521295|FG004|Period 2: Second Intervention|Protocol Violation|0|||
126607435|NCT00776009|455521296|FG005|Period 2: Second Intervention|Protocol Violation|0|||
126607436|NCT00776009|455521291|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
126607437|NCT00776009|455521292|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
126781173|NCT01464827|456154489|FG012|Overall Study|Adverse Event|1|||
126607438|NCT00776009|455521293|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
126607439|NCT00776009|455521294|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
126607440|NCT00776009|455521295|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
126607441|NCT00776009|455521296|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
126607442|NCT02040870|455521297|FG000|Overall Study|Completed treatment phase|6|||
126607443|NCT02040870|455521297|FG000|Overall Study|Adverse Event|7|||
126607444|NCT02040870|455521297|FG000|Overall Study|Progressive disease|58|||
126607445|NCT02040870|455521297|FG000|Overall Study|Physician Decision|6|||
126607446|NCT02040870|455521297|FG000|Overall Study|Subject/guardian decision|10|||
126607447|NCT02040870|455521297|FG000|Overall Study|Lost to Follow-up|3|||
126607448|NCT02040870|455521297|FG000|Overall Study|Death|13|||
126607449|NCT01536093|455521298|FG000|Overall Study|Death|1|||
126607450|NCT01536093|455521299|FG001|Overall Study|Death|2|||
126607451|NCT01536093|455521298|FG000|Overall Study|absence of maternal colostrum|2|||
126607452|NCT01536093|455521299|FG001|Overall Study|absence of maternal colostrum|0|||
126607453|NCT01536093|455521298|FG000|Overall Study|Withdrawal by Subject|0|||
126607454|NCT01536093|455521299|FG001|Overall Study|Withdrawal by Subject|1|||
126607455|NCT04971733|455521300|FG000|Overall Study|Adverse Event|1|||
126607456|NCT04971733|455521301|FG001|Overall Study|Adverse Event|1|||
126607457|NCT04971733|455521300|FG000|Overall Study|Subject choice|2|||
126607458|NCT04971733|455521301|FG001|Overall Study|Subject choice|0|||
126607459|NCT04971733|455521300|FG000|Overall Study|Withdrawal by Subject|1|||
126607460|NCT04971733|455521301|FG001|Overall Study|Withdrawal by Subject|0|||
126607461|NCT04971733|455521300|FG000|Overall Study|Other|1|||
126607462|NCT04971733|455521301|FG001|Overall Study|Other|0|||
126607463|NCT02275611|455521304|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
126607464|NCT02275611|455521305|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
126607465|NCT02275611|455521306|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
126607466|NCT02275611|455521307|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
126607467|NCT02406092|455521311|FG000|Overall Study|Screen failure|10|||
126607468|NCT02406092|455521312|FG001|Overall Study|Screen failure|7|||
126607469|NCT02406092|455521311|FG000|Overall Study|Death|22|||
126607470|NCT02406092|455521312|FG001|Overall Study|Death|5|||
126607471|NCT02406092|455521311|FG000|Overall Study|Lost to Follow-up|4|||
126607472|NCT02406092|455521312|FG001|Overall Study|Lost to Follow-up|1|||
126607473|NCT02406092|455521311|FG000|Overall Study|Adverse Event|1|||
126607474|NCT02406092|455521312|FG001|Overall Study|Adverse Event|0|||
126607475|NCT02406092|455521311|FG000|Overall Study|Withdrawal by Subject|1|||
126607476|NCT02406092|455521312|FG001|Overall Study|Withdrawal by Subject|0|||
126607477|NCT01759862|455521313|FG000|Overall Study|Physician Decision|3|||
126607478|NCT01759862|455521314|FG001|Overall Study|Physician Decision|1|||
126607479|NCT01759862|455521313|FG000|Overall Study|Adverse Event|0|||
126607480|NCT01759862|455521314|FG001|Overall Study|Adverse Event|1|||
126607481|NCT03631407|455521315|FG000|Overall Study|Withdrawal by Subject|3|||
126607482|NCT03631407|455521316|FG001|Overall Study|Withdrawal by Subject|2|||
126607483|NCT03631407|455521315|FG000|Overall Study|Sponsor Decision|0|||
126607484|NCT03631407|455521316|FG001|Overall Study|Sponsor Decision|2|||
126607485|NCT03631407|455521315|FG000|Overall Study|Death|16|||
126607486|NCT03631407|455521316|FG001|Overall Study|Death|16|||
126607487|NCT03631407|455521315|FG000|Overall Study|Randomized by mistake without study treatment|1|||
126607488|NCT03631407|455521316|FG001|Overall Study|Randomized by mistake without study treatment|0|||
126607489|NCT02628626|455521317|FG000|Overall Study|Withdrawal by Subject|2|||
126607490|NCT02628626|455521318|FG001|Overall Study|Withdrawal by Subject|2|||
126607491|NCT01593020|455521319|FG000|Overall Study|Adverse Event|1|||
126607492|NCT01593020|455521320|FG001|Overall Study|Adverse Event|1|||
126607493|NCT01593020|455521319|FG000|Overall Study|Death|0|||
126607494|NCT01593020|455521320|FG001|Overall Study|Death|1|||
126607495|NCT01593020|455521319|FG000|Overall Study|Ineligible|1|||
126607496|NCT01593020|455521320|FG001|Overall Study|Ineligible|0|||
126607497|NCT03598907|455521325|FG000|Overall Study|Physician Decision|14|||
126607498|NCT03598907|455521326|FG001|Overall Study|Physician Decision|19|||
126607499|NCT05251363|455521327|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
126607500|NCT05251363|455521327|FG000|Overall Study After Implant Period|Death|9|||
126607501|NCT05251363|455521327|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
126607502|NCT05251363|455521327|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
126607503|NCT05251363|455521327|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
126607504|NCT05251363|455521327|FG000|Overall Study After Implant Period|Physician Decision|1|||
126607505|NCT05251363|455521327|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
126607506|NCT03835754|455521330|FG000|Overall Study|Death|4|||
126607507|NCT02517268|455521334|FG000|Overall Study|Withdrawal by Subject|1|||
126607508|NCT02517268|455521335|FG001|Overall Study|Withdrawal by Subject|0|||
126607509|NCT04686266|455521336|FG000|Overall Study|Withdrawal by Subject|0|||
126607510|NCT04686266|455521337|FG001|Overall Study|Withdrawal by Subject|1|||
126607511|NCT04306367|455521342|FG000|Overall Study|Progression of Disease|9|||
126607512|NCT04306367|455521342|FG000|Overall Study|Adverse Event|3|||
126607513|NCT04306367|455521342|FG000|Overall Study|Withdrawal by Subject|1|||
126607514|NCT02401815|455521345|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126607515|NCT02401815|455521346|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126607516|NCT02401815|455521347|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126607517|NCT02401815|455521348|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
126607518|NCT02401815|455521349|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126607519|NCT02401815|455521350|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126607520|NCT02401815|455521351|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126607521|NCT02401815|455521352|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126607522|NCT02401815|455521353|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126607523|NCT02401815|455521354|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
126607524|NCT02401815|455521345|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
126607525|NCT02401815|455521346|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126607526|NCT02401815|455521347|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126607527|NCT02401815|455521348|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
126607528|NCT02401815|455521349|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126607529|NCT02401815|455521350|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126607530|NCT02401815|455521351|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126607531|NCT02401815|455521352|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126607532|NCT02401815|455521353|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126607533|NCT02401815|455521354|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
126607534|NCT02401815|455521345|FG000|Dose Escalation (up to 670 Days)|Death|1|||
126733935|NCT00599027|455974037|FG001|Overall Study|Adverse Event|1|||
126733936|NCT00599027|455974036|FG000|Overall Study|Treatment Failure|0|||
126733937|NCT00599027|455974037|FG001|Overall Study|Treatment Failure|1|||
126733938|NCT00476996|455974038|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
126733939|NCT00476996|455974039|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
126733940|NCT00476996|455974040|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
126733941|NCT00476996|455974041|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
126733942|NCT00476996|455974038|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
126733943|NCT00476996|455974039|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
126733944|NCT00476996|455974040|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
126733945|NCT00476996|455974041|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
126733946|NCT00476996|455974038|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
126733947|NCT00476996|455974039|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
126733948|NCT00476996|455974040|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
126733949|NCT00476996|455974041|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
126733950|NCT00476996|455974038|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
126733951|NCT00476996|455974039|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
126733952|NCT00476996|455974040|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
126733953|NCT00476996|455974041|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
126733954|NCT00476996|455974038|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
126733955|NCT00476996|455974039|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
126733956|NCT00476996|455974040|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
126733957|NCT00476996|455974041|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
126733958|NCT00476996|455974038|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
126733959|NCT00476996|455974039|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
126733960|NCT00476996|455974040|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
126733961|NCT00476996|455974041|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
126733962|NCT00476996|455974038|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
126733963|NCT00476996|455974039|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
126733964|NCT00476996|455974040|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
126733965|NCT00476996|455974041|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
126733966|NCT00476996|455974038|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
126733967|NCT00476996|455974039|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
126733968|NCT00476996|455974040|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
126733969|NCT00476996|455974041|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
126733970|NCT00476996|455974038|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
126733971|NCT00476996|455974039|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
126733972|NCT00476996|455974040|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
126733973|NCT00476996|455974041|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
126733974|NCT00476996|455974038|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
126733975|NCT00476996|455974039|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
126733976|NCT00476996|455974040|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
126733977|NCT00476996|455974041|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
126607535|NCT02401815|455521346|FG001|Dose Escalation (up to 670 Days)|Death|2|||
126607536|NCT02401815|455521347|FG002|Dose Escalation (up to 670 Days)|Death|3|||
126607537|NCT02401815|455521348|FG003|Dose Escalation (up to 670 Days)|Death|5|||
126607538|NCT02401815|455521349|FG004|Dose Escalation (up to 670 Days)|Death|4|||
126607539|NCT02401815|455521350|FG005|Dose Escalation (up to 670 Days)|Death|0|||
126607540|NCT02401815|455521351|FG006|Dose Escalation (up to 670 Days)|Death|0|||
126607541|NCT02401815|455521352|FG007|Dose Escalation (up to 670 Days)|Death|0|||
126607542|NCT02401815|455521353|FG008|Dose Escalation (up to 670 Days)|Death|0|||
126607543|NCT02401815|455521354|FG009|Dose Escalation (up to 670 Days)|Death|0|||
126607544|NCT02401815|455521345|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126607545|NCT02401815|455521346|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
126607546|NCT02401815|455521347|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126607547|NCT02401815|455521348|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126607548|NCT02401815|455521349|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
126607549|NCT02401815|455521350|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126607550|NCT02401815|455521351|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126607551|NCT02401815|455521352|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126607552|NCT02401815|455521353|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126607553|NCT02401815|455521354|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
126607554|NCT02401815|455521345|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
126607555|NCT02401815|455521346|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126607556|NCT02401815|455521347|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126607557|NCT02401815|455521348|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126607558|NCT02401815|455521349|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
126607559|NCT02401815|455521350|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126607560|NCT02401815|455521351|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126607561|NCT02401815|455521352|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126607562|NCT02401815|455521353|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126607563|NCT02401815|455521354|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
126607564|NCT02401815|455521345|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126607565|NCT02401815|455521346|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126607566|NCT02401815|455521347|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126607567|NCT02401815|455521348|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126607568|NCT02401815|455521349|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126607569|NCT02401815|455521350|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
126607570|NCT02401815|455521351|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126607571|NCT02401815|455521352|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126607572|NCT02401815|455521353|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126607573|NCT02401815|455521354|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
126607574|NCT02401815|455521345|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607575|NCT02401815|455521346|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607576|NCT02401815|455521347|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607577|NCT02401815|455521348|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607578|NCT02401815|455521349|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607579|NCT02401815|455521350|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607580|NCT02401815|455521351|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
126607581|NCT02401815|455521352|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607582|NCT02401815|455521353|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607583|NCT02401815|455521354|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607584|NCT02401815|455521345|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126607585|NCT02401815|455521346|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126607586|NCT02401815|455521347|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126607587|NCT02401815|455521348|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126607588|NCT02401815|455521349|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126607589|NCT02401815|455521350|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
126607590|NCT02401815|455521351|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
126607591|NCT02401815|455521352|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126607592|NCT02401815|455521353|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126607593|NCT02401815|455521354|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
126607594|NCT02401815|455521345|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126607595|NCT02401815|455521346|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126607596|NCT02401815|455521347|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126607597|NCT02401815|455521348|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126607598|NCT02401815|455521349|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126607599|NCT02401815|455521350|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
126607600|NCT02401815|455521351|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126607601|NCT02401815|455521352|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126607602|NCT02401815|455521353|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126607603|NCT02401815|455521354|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
126607604|NCT02401815|455521345|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126607605|NCT02401815|455521346|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126607606|NCT02401815|455521347|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126607607|NCT02401815|455521348|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126607608|NCT02401815|455521349|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126607609|NCT02401815|455521350|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126607610|NCT02401815|455521351|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
126607611|NCT02401815|455521352|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
126607612|NCT02401815|455521353|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
126607613|NCT02401815|455521354|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
126607614|NCT02401815|455521345|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607615|NCT02401815|455521346|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607616|NCT02401815|455521347|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607617|NCT02401815|455521348|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607618|NCT02401815|455521349|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607619|NCT02401815|455521350|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607620|NCT02401815|455521351|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607621|NCT02401815|455521352|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
126607622|NCT02401815|455521353|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
126607623|NCT02401815|455521354|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
126607624|NCT02401815|455521345|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126607625|NCT02401815|455521346|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126607626|NCT02401815|455521347|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126607627|NCT02401815|455521348|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126607628|NCT02401815|455521349|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126607629|NCT02401815|455521350|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126607630|NCT02401815|455521351|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126607631|NCT02401815|455521352|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126607632|NCT02401815|455521353|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
126607633|NCT02401815|455521354|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
126607634|NCT02401815|455521345|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126607635|NCT02401815|455521346|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126607636|NCT02401815|455521347|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126607637|NCT02401815|455521348|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126607638|NCT02401815|455521349|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126607639|NCT02401815|455521350|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126607640|NCT02401815|455521351|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126607641|NCT02401815|455521352|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126607642|NCT02401815|455521353|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
126607643|NCT02401815|455521354|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
126607644|NCT02401815|455521345|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126607645|NCT02401815|455521346|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126607646|NCT02401815|455521347|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126607647|NCT02401815|455521348|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126607648|NCT02401815|455521349|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126607649|NCT02401815|455521350|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126607650|NCT02401815|455521351|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126607651|NCT02401815|455521352|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
126607652|NCT02401815|455521353|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
126607653|NCT02401815|455521354|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
126607654|NCT04912856|455521355|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
126607655|NCT04912856|455521356|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
126607656|NCT04912856|455521355|FG000|Overall Study|Not reported in synoptic CSR.|0|||
126607657|NCT04912856|455521356|FG001|Overall Study|Not reported in synoptic CSR.|1|||
126607658|NCT04649047|455521370|FG000|Overall Study|Withdrawal by Subject|3|||
126607659|NCT00719888|455521371|FG000|Overall Study|Death|24|||
126607660|NCT00719888|455521372|FG001|Overall Study|Death|9|||
126607661|NCT00719888|455521371|FG000|Overall Study|Relapse|8|||
126607662|NCT00719888|455521372|FG001|Overall Study|Relapse|3|||
126607663|NCT00719888|455521371|FG000|Overall Study|Physician Decision|1|||
126607664|NCT00719888|455521372|FG001|Overall Study|Physician Decision|0|||
126733978|NCT00476996|455974038|FG000|OLE Phase (From Week 48)|Death|0|||
126733979|NCT00476996|455974039|FG001|OLE Phase (From Week 48)|Death|0|||
126607665|NCT00719888|455521371|FG000|Overall Study|Withdrawal by Subject|1|||
126607666|NCT00719888|455521372|FG001|Overall Study|Withdrawal by Subject|0|||
126607667|NCT05037513|455521373|FG000|Intervention Period|Lost to Follow-up|1|||
126607668|NCT05037513|455521374|FG001|Intervention Period|Lost to Follow-up|2|||
126607669|NCT05037513|455521373|FG000|Follow Up Period|Lost to Follow-up|16|||
126607670|NCT05037513|455521374|FG001|Follow Up Period|Lost to Follow-up|21|||
126607671|NCT05037513|455521373|FG000|Follow Up Period|Death|0|||
126607672|NCT05037513|455521374|FG001|Follow Up Period|Death|1|||
126607673|NCT05037513|455521373|FG000|Follow Up Period|Incarcerated|4|||
126607674|NCT05037513|455521374|FG001|Follow Up Period|Incarcerated|2|||
126607675|NCT05864209|455523179|FG000|Overall Study|Lost to Follow-up|2|||
126607676|NCT05864209|455523180|FG001|Overall Study|Lost to Follow-up|3|||
126607677|NCT00092534|455523183|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
126607678|NCT00092534|455523184|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
126607679|NCT00092534|455523185|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126607680|NCT00092534|455523186|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126607681|NCT00092534|455523187|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
126607682|NCT00092534|455523183|FG000|Base Study Vaccination Period|Adverse Event|3|||
126607683|NCT00092534|455523184|FG001|Base Study Vaccination Period|Adverse Event|1|||
126607684|NCT00092534|455523185|FG002|Base Study Vaccination Period|Adverse Event|0|||
126607685|NCT00092534|455523186|FG003|Base Study Vaccination Period|Adverse Event|0|||
126607686|NCT00092534|455523187|FG004|Base Study Vaccination Period|Adverse Event|0|||
126607687|NCT00092534|455523183|FG000|Base Study Vaccination Period|Death|5|||
126607688|NCT00092534|455523184|FG001|Base Study Vaccination Period|Death|4|||
126607689|NCT00092534|455523185|FG002|Base Study Vaccination Period|Death|0|||
126607690|NCT00092534|455523186|FG003|Base Study Vaccination Period|Death|0|||
126607691|NCT00092534|455523187|FG004|Base Study Vaccination Period|Death|0|||
126607692|NCT00092534|455523183|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
126607693|NCT00092534|455523184|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
126607694|NCT00092534|455523185|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
126607695|NCT00092534|455523186|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
126607696|NCT00092534|455523187|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
126607697|NCT00092534|455523183|FG000|Base Study Vaccination Period|Physician Decision|1|||
126607698|NCT00092534|455523184|FG001|Base Study Vaccination Period|Physician Decision|0|||
126607699|NCT00092534|455523185|FG002|Base Study Vaccination Period|Physician Decision|0|||
126607700|NCT00092534|455523186|FG003|Base Study Vaccination Period|Physician Decision|0|||
126607701|NCT00092534|455523187|FG004|Base Study Vaccination Period|Physician Decision|0|||
126607702|NCT00092534|455523183|FG000|Base Study Vaccination Period|Pregnancy|9|||
126607703|NCT00092534|455523184|FG001|Base Study Vaccination Period|Pregnancy|7|||
126607704|NCT00092534|455523185|FG002|Base Study Vaccination Period|Pregnancy|0|||
126607705|NCT00092534|455523186|FG003|Base Study Vaccination Period|Pregnancy|0|||
126607706|NCT00092534|455523187|FG004|Base Study Vaccination Period|Pregnancy|0|||
126607707|NCT00092534|455523183|FG000|Base Study Vaccination Period|Protocol Violation|2|||
126607708|NCT00092534|455523184|FG001|Base Study Vaccination Period|Protocol Violation|1|||
126607709|NCT00092534|455523185|FG002|Base Study Vaccination Period|Protocol Violation|0|||
126607710|NCT00092534|455523186|FG003|Base Study Vaccination Period|Protocol Violation|0|||
126607711|NCT00092534|455523187|FG004|Base Study Vaccination Period|Protocol Violation|0|||
126607712|NCT00092534|455523183|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
126607713|NCT00092534|455523184|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
126607714|NCT00092534|455523185|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
126607715|NCT00092534|455523186|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
126607716|NCT00092534|455523187|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
126607717|NCT00092534|455523183|FG000|Base Study Vaccination Period|Moved|14|||
126607718|NCT00092534|455523184|FG001|Base Study Vaccination Period|Moved|12|||
126607719|NCT00092534|455523185|FG002|Base Study Vaccination Period|Moved|0|||
126607720|NCT00092534|455523186|FG003|Base Study Vaccination Period|Moved|0|||
126607721|NCT00092534|455523187|FG004|Base Study Vaccination Period|Moved|0|||
126607722|NCT00092534|455523183|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
126607723|NCT00092534|455523184|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
126607724|NCT00092534|455523185|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
126607725|NCT00092534|455523186|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
126607726|NCT00092534|455523187|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
126607727|NCT00092534|455523183|FG000|Base Study Vaccination Period|Travel|1|||
126607728|NCT00092534|455523184|FG001|Base Study Vaccination Period|Travel|0|||
126607729|NCT00092534|455523185|FG002|Base Study Vaccination Period|Travel|0|||
126607730|NCT00092534|455523186|FG003|Base Study Vaccination Period|Travel|0|||
126607731|NCT00092534|455523187|FG004|Base Study Vaccination Period|Travel|0|||
126607732|NCT00092534|455523183|FG000|Base Study Vaccination Period|Site Closed|0|||
126607733|NCT00092534|455523184|FG001|Base Study Vaccination Period|Site Closed|1|||
126607734|NCT00092534|455523185|FG002|Base Study Vaccination Period|Site Closed|0|||
126607735|NCT00092534|455523186|FG003|Base Study Vaccination Period|Site Closed|0|||
126733980|NCT00476996|455974040|FG002|OLE Phase (From Week 48)|Death|0|||
126607736|NCT00092534|455523187|FG004|Base Study Vaccination Period|Site Closed|0|||
126607737|NCT00092534|455523183|FG000|Base Study Follow-Up Period|Adverse Event|2|||
126607738|NCT00092534|455523184|FG001|Base Study Follow-Up Period|Adverse Event|4|||
126607739|NCT00092534|455523185|FG002|Base Study Follow-Up Period|Adverse Event|0|||
126607740|NCT00092534|455523186|FG003|Base Study Follow-Up Period|Adverse Event|0|||
126607741|NCT00092534|455523187|FG004|Base Study Follow-Up Period|Adverse Event|0|||
126607742|NCT00092534|455523183|FG000|Base Study Follow-Up Period|Death|2|||
126607743|NCT00092534|455523184|FG001|Base Study Follow-Up Period|Death|1|||
126607744|NCT00092534|455523185|FG002|Base Study Follow-Up Period|Death|0|||
126607745|NCT00092534|455523186|FG003|Base Study Follow-Up Period|Death|0|||
126607746|NCT00092534|455523187|FG004|Base Study Follow-Up Period|Death|0|||
126607747|NCT00092534|455523183|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
126607748|NCT00092534|455523184|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
126607749|NCT00092534|455523185|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
126607750|NCT00092534|455523186|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
126607751|NCT00092534|455523187|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
126607752|NCT00092534|455523183|FG000|Base Study Follow-Up Period|Pregnancy|6|||
126607753|NCT00092534|455523184|FG001|Base Study Follow-Up Period|Pregnancy|10|||
126607754|NCT00092534|455523185|FG002|Base Study Follow-Up Period|Pregnancy|0|||
126607755|NCT00092534|455523186|FG003|Base Study Follow-Up Period|Pregnancy|0|||
126607756|NCT00092534|455523187|FG004|Base Study Follow-Up Period|Pregnancy|0|||
126607757|NCT00092534|455523183|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
126607758|NCT00092534|455523184|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
126607759|NCT00092534|455523185|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
126607760|NCT00092534|455523186|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
126607761|NCT00092534|455523187|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
126607762|NCT00092534|455523183|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
126607763|NCT00092534|455523184|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
126607764|NCT00092534|455523185|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
126607765|NCT00092534|455523186|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
126607766|NCT00092534|455523187|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
126607767|NCT00092534|455523183|FG000|Base Study Follow-Up Period|Moved|62|||
126607768|NCT00092534|455523184|FG001|Base Study Follow-Up Period|Moved|58|||
126607769|NCT00092534|455523185|FG002|Base Study Follow-Up Period|Moved|0|||
126607770|NCT00092534|455523186|FG003|Base Study Follow-Up Period|Moved|0|||
126607771|NCT00092534|455523187|FG004|Base Study Follow-Up Period|Moved|0|||
126607772|NCT00092534|455523183|FG000|Base Study Follow-Up Period|Travel|10|||
126607773|NCT00092534|455523184|FG001|Base Study Follow-Up Period|Travel|7|||
126607774|NCT00092534|455523185|FG002|Base Study Follow-Up Period|Travel|0|||
126607775|NCT00092534|455523186|FG003|Base Study Follow-Up Period|Travel|0|||
126607776|NCT00092534|455523187|FG004|Base Study Follow-Up Period|Travel|0|||
126607777|NCT00092534|455523183|FG000|Base Study Follow-Up Period|Site Closed|0|||
126607778|NCT00092534|455523184|FG001|Base Study Follow-Up Period|Site Closed|2|||
126607779|NCT00092534|455523185|FG002|Base Study Follow-Up Period|Site Closed|0|||
126607780|NCT00092534|455523186|FG003|Base Study Follow-Up Period|Site Closed|0|||
126607781|NCT00092534|455523187|FG004|Base Study Follow-Up Period|Site Closed|0|||
126607782|NCT00092534|455523183|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
126607783|NCT00092534|455523184|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
126607784|NCT00092534|455523185|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
126607785|NCT00092534|455523186|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
126607786|NCT00092534|455523187|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
126607787|NCT00092534|455523183|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
126607788|NCT00092534|455523184|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
126607789|NCT00092534|455523185|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
126607790|NCT00092534|455523186|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
126607791|NCT00092534|455523187|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
126607792|NCT00092534|455523183|FG000|Base Study EXT|Lost to Follow-up|0|||
126607793|NCT00092534|455523184|FG001|Base Study EXT|Lost to Follow-up|0|||
126607794|NCT00092534|455523185|FG002|Base Study EXT|Lost to Follow-up|41|||
126607795|NCT00092534|455523186|FG003|Base Study EXT|Lost to Follow-up|0|||
126607796|NCT00092534|455523187|FG004|Base Study EXT|Lost to Follow-up|0|||
126607797|NCT00092534|455523183|FG000|Base Study EXT|Physician Decision|0|||
126607798|NCT00092534|455523184|FG001|Base Study EXT|Physician Decision|0|||
126607799|NCT00092534|455523185|FG002|Base Study EXT|Physician Decision|1|||
126607800|NCT00092534|455523186|FG003|Base Study EXT|Physician Decision|0|||
126607801|NCT00092534|455523187|FG004|Base Study EXT|Physician Decision|0|||
126607802|NCT00092534|455523183|FG000|Base Study EXT|Pregnancy|0|||
126607803|NCT00092534|455523184|FG001|Base Study EXT|Pregnancy|0|||
126607804|NCT00092534|455523185|FG002|Base Study EXT|Pregnancy|12|||
126607805|NCT00092534|455523186|FG003|Base Study EXT|Pregnancy|0|||
126607806|NCT00092534|455523187|FG004|Base Study EXT|Pregnancy|0|||
126607807|NCT00092534|455523183|FG000|Base Study EXT|Withdrawal by Subject|0|||
126607808|NCT00092534|455523184|FG001|Base Study EXT|Withdrawal by Subject|0|||
126607809|NCT00092534|455523185|FG002|Base Study EXT|Withdrawal by Subject|18|||
126607810|NCT00092534|455523186|FG003|Base Study EXT|Withdrawal by Subject|0|||
126607811|NCT00092534|455523187|FG004|Base Study EXT|Withdrawal by Subject|0|||
126607812|NCT00092534|455523183|FG000|Base Study EXT|Participant moved|0|||
126607813|NCT00092534|455523184|FG001|Base Study EXT|Participant moved|0|||
126607814|NCT00092534|455523185|FG002|Base Study EXT|Participant moved|6|||
126607815|NCT00092534|455523186|FG003|Base Study EXT|Participant moved|0|||
126607816|NCT00092534|455523187|FG004|Base Study EXT|Participant moved|0|||
126607817|NCT00092534|455523183|FG000|Base Study EXT|Travel|0|||
126607818|NCT00092534|455523184|FG001|Base Study EXT|Travel|0|||
126607819|NCT00092534|455523185|FG002|Base Study EXT|Travel|2|||
126607820|NCT00092534|455523186|FG003|Base Study EXT|Travel|0|||
126607821|NCT00092534|455523187|FG004|Base Study EXT|Travel|0|||
126607822|NCT00092534|455523183|FG000|Base Study EXT|Site closed|0|||
126607823|NCT00092534|455523184|FG001|Base Study EXT|Site closed|0|||
126607824|NCT00092534|455523185|FG002|Base Study EXT|Site closed|21|||
126607825|NCT00092534|455523186|FG003|Base Study EXT|Site closed|0|||
126607826|NCT00092534|455523187|FG004|Base Study EXT|Site closed|0|||
126607827|NCT00092534|455523183|FG000|Base Study EXT|Study ended|0|||
126607828|NCT00092534|455523184|FG001|Base Study EXT|Study ended|0|||
126607829|NCT00092534|455523185|FG002|Base Study EXT|Study ended|29|||
126607830|NCT00092534|455523186|FG003|Base Study EXT|Study ended|0|||
126607831|NCT00092534|455523187|FG004|Base Study EXT|Study ended|0|||
126607832|NCT00092534|455523183|FG000|Base Study EXT|Protocol Violation|0|||
126607833|NCT00092534|455523184|FG001|Base Study EXT|Protocol Violation|0|||
126607834|NCT00092534|455523185|FG002|Base Study EXT|Protocol Violation|15|||
126607835|NCT00092534|455523186|FG003|Base Study EXT|Protocol Violation|0|||
126607836|NCT00092534|455523187|FG004|Base Study EXT|Protocol Violation|0|||
126607837|NCT00092534|455523183|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
126607838|NCT00092534|455523184|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
126607839|NCT00092534|455523185|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
126607840|NCT00092534|455523186|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
126607841|NCT00092534|455523187|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
126607842|NCT05029284|455523188|FG000|Overall Study|Lost to Follow-up|1|||
126607843|NCT04001829|455523189|FG000|Overall Study|Never start protocol therapy|5|||
126607844|NCT04001829|455523190|FG001|Overall Study|Never start protocol therapy|5|||
126607845|NCT04001829|455523189|FG000|Overall Study|Adverse Event|11|||
126607846|NCT04001829|455523190|FG001|Overall Study|Adverse Event|7|||
126607847|NCT04001829|455523189|FG000|Overall Study|Alternative therapy|1|||
126607848|NCT04001829|455523190|FG001|Overall Study|Alternative therapy|2|||
126607849|NCT04001829|455523189|FG000|Overall Study|Disease progression/relapse|2|||
126607850|NCT04001829|455523190|FG001|Overall Study|Disease progression/relapse|1|||
126607851|NCT04001829|455523189|FG000|Overall Study|Other complicating disease|1|||
126607852|NCT04001829|455523190|FG001|Overall Study|Other complicating disease|0|||
126607853|NCT04001829|455523189|FG000|Overall Study|Withdrawal by Subject|1|||
126607854|NCT04001829|455523190|FG001|Overall Study|Withdrawal by Subject|4|||
126607855|NCT04001829|455523189|FG000|Overall Study|Ineligible|2|||
126607856|NCT04001829|455523190|FG001|Overall Study|Ineligible|2|||
126607857|NCT04001829|455523189|FG000|Overall Study|Reason missing due to delinquent data|1|||
126607858|NCT04001829|455523190|FG001|Overall Study|Reason missing due to delinquent data|0|||
126607859|NCT03678688|455523191|FG000|Overall Study|Reason not Specified|0|||
126607860|NCT03678688|455523192|FG001|Overall Study|Reason not Specified|0|||
126607861|NCT03678688|455523193|FG002|Overall Study|Reason not Specified|3|||
126607862|NCT03678688|455523194|FG003|Overall Study|Reason not Specified|0|||
126607863|NCT03678688|455523195|FG004|Overall Study|Reason not Specified|1|||
126607864|NCT03678688|455523196|FG005|Overall Study|Reason not Specified|0|||
126607865|NCT03678688|455523197|FG006|Overall Study|Reason not Specified|0|||
126607866|NCT03678688|455523198|FG007|Overall Study|Reason not Specified|0|||
126607867|NCT03678688|455523199|FG008|Overall Study|Reason not Specified|0|||
126607868|NCT03678688|455523191|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
126607869|NCT03678688|455523192|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
126607870|NCT03678688|455523193|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
126607871|NCT03678688|455523194|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
126607872|NCT03678688|455523195|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
126607873|NCT03678688|455523196|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
126607874|NCT03678688|455523197|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
126607875|NCT03678688|455523198|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
126607876|NCT03678688|455523199|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
126607877|NCT03678688|455523191|FG000|Overall Study|Covid Related Adverse Event|0|||
126607878|NCT03678688|455523192|FG001|Overall Study|Covid Related Adverse Event|0|||
126607879|NCT03678688|455523193|FG002|Overall Study|Covid Related Adverse Event|0|||
126607880|NCT03678688|455523194|FG003|Overall Study|Covid Related Adverse Event|0|||
126607881|NCT03678688|455523195|FG004|Overall Study|Covid Related Adverse Event|0|||
126607882|NCT03678688|455523196|FG005|Overall Study|Covid Related Adverse Event|3|||
126607883|NCT03678688|455523197|FG006|Overall Study|Covid Related Adverse Event|1|||
126607884|NCT03678688|455523198|FG007|Overall Study|Covid Related Adverse Event|1|||
126607885|NCT03678688|455523199|FG008|Overall Study|Covid Related Adverse Event|0|||
126607886|NCT03678688|455523191|FG000|Overall Study|Physician Decision|0|||
126607887|NCT03678688|455523192|FG001|Overall Study|Physician Decision|0|||
126607888|NCT03678688|455523193|FG002|Overall Study|Physician Decision|0|||
126607889|NCT03678688|455523194|FG003|Overall Study|Physician Decision|0|||
126607890|NCT03678688|455523195|FG004|Overall Study|Physician Decision|0|||
126607891|NCT03678688|455523196|FG005|Overall Study|Physician Decision|1|||
126607892|NCT03678688|455523197|FG006|Overall Study|Physician Decision|0|||
126607893|NCT03678688|455523198|FG007|Overall Study|Physician Decision|0|||
126607894|NCT03678688|455523199|FG008|Overall Study|Physician Decision|0|||
126607895|NCT03678688|455523191|FG000|Overall Study|Withdrawal by Subject|0|||
126607896|NCT03678688|455523192|FG001|Overall Study|Withdrawal by Subject|0|||
126607897|NCT03678688|455523193|FG002|Overall Study|Withdrawal by Subject|0|||
126607898|NCT03678688|455523194|FG003|Overall Study|Withdrawal by Subject|0|||
126607899|NCT03678688|455523195|FG004|Overall Study|Withdrawal by Subject|0|||
126607900|NCT03678688|455523196|FG005|Overall Study|Withdrawal by Subject|0|||
126607901|NCT03678688|455523197|FG006|Overall Study|Withdrawal by Subject|2|||
126607902|NCT03678688|455523198|FG007|Overall Study|Withdrawal by Subject|1|||
126607903|NCT03678688|455523199|FG008|Overall Study|Withdrawal by Subject|0|||
126607904|NCT03002194|455523200|FG000|Overall Study|Lost to Follow-up|6|||
126607905|NCT03002194|455523200|FG000|Overall Study|Adverse Event|1|||
126607906|NCT03002194|455523200|FG000|Overall Study|Lack of Efficacy|1|||
126607907|NCT03002194|455523200|FG000|Overall Study|Withdrawal by Subject|2|||
126607908|NCT00985088|455523201|FG000|Overall Study|Serious Adverse Event|1|||
126607909|NCT00985088|455523202|FG001|Overall Study|Serious Adverse Event|1|||
126607910|NCT00985088|455523203|FG002|Overall Study|Serious Adverse Event|0|||
126607911|NCT00985088|455523204|FG003|Overall Study|Serious Adverse Event|0|||
126607912|NCT00985088|455523205|FG004|Overall Study|Serious Adverse Event|0|||
126607913|NCT00985088|455523206|FG005|Overall Study|Serious Adverse Event|0|||
126607914|NCT00985088|455523207|FG006|Overall Study|Serious Adverse Event|0|||
126607915|NCT00985088|455523208|FG007|Overall Study|Serious Adverse Event|1|||
126607916|NCT00985088|455523201|FG000|Overall Study|Adverse Event|0|||
126607917|NCT00985088|455523202|FG001|Overall Study|Adverse Event|0|||
126607918|NCT00985088|455523203|FG002|Overall Study|Adverse Event|1|||
126607919|NCT00985088|455523204|FG003|Overall Study|Adverse Event|0|||
126607920|NCT00985088|455523205|FG004|Overall Study|Adverse Event|0|||
126607921|NCT00985088|455523206|FG005|Overall Study|Adverse Event|0|||
126607922|NCT00985088|455523207|FG006|Overall Study|Adverse Event|0|||
126607923|NCT00985088|455523208|FG007|Overall Study|Adverse Event|0|||
126607924|NCT00985088|455523201|FG000|Overall Study|Withdrawal by Subject|4|||
126607925|NCT00985088|455523202|FG001|Overall Study|Withdrawal by Subject|0|||
126607926|NCT00985088|455523203|FG002|Overall Study|Withdrawal by Subject|0|||
126607927|NCT00985088|455523204|FG003|Overall Study|Withdrawal by Subject|1|||
126607928|NCT00985088|455523205|FG004|Overall Study|Withdrawal by Subject|3|||
126607929|NCT00985088|455523206|FG005|Overall Study|Withdrawal by Subject|2|||
126607930|NCT00985088|455523207|FG006|Overall Study|Withdrawal by Subject|1|||
126607931|NCT00985088|455523208|FG007|Overall Study|Withdrawal by Subject|2|||
126607932|NCT00985088|455523201|FG000|Overall Study|Migrated/moved from study area|0|||
126607933|NCT00985088|455523202|FG001|Overall Study|Migrated/moved from study area|0|||
126607934|NCT00985088|455523203|FG002|Overall Study|Migrated/moved from study area|1|||
126607935|NCT00985088|455523204|FG003|Overall Study|Migrated/moved from study area|0|||
126607936|NCT00985088|455523205|FG004|Overall Study|Migrated/moved from study area|0|||
126607937|NCT00985088|455523206|FG005|Overall Study|Migrated/moved from study area|0|||
126607938|NCT00985088|455523207|FG006|Overall Study|Migrated/moved from study area|0|||
126607939|NCT00985088|455523208|FG007|Overall Study|Migrated/moved from study area|1|||
126607940|NCT00985088|455523201|FG000|Overall Study|Lost to Follow-up|6|||
126607941|NCT00985088|455523202|FG001|Overall Study|Lost to Follow-up|1|||
126607942|NCT00985088|455523203|FG002|Overall Study|Lost to Follow-up|2|||
126607943|NCT00985088|455523204|FG003|Overall Study|Lost to Follow-up|6|||
126607944|NCT00985088|455523205|FG004|Overall Study|Lost to Follow-up|6|||
126607945|NCT00985088|455523206|FG005|Overall Study|Lost to Follow-up|5|||
126607946|NCT00985088|455523207|FG006|Overall Study|Lost to Follow-up|3|||
126607947|NCT00985088|455523208|FG007|Overall Study|Lost to Follow-up|2|||
126607948|NCT04162210|455523213|FG000|Overall Study|Lost to Follow-up|4|||
126607949|NCT04162210|455523214|FG001|Overall Study|Lost to Follow-up|1|||
126607950|NCT04162210|455523213|FG000|Overall Study|Withdrawal by Subject|17|||
126607951|NCT04162210|455523214|FG001|Overall Study|Withdrawal by Subject|9|||
126607952|NCT04162210|455523213|FG000|Overall Study|Ongoing|113|||
126607953|NCT04162210|455523214|FG001|Overall Study|Ongoing|59|||
126607954|NCT00371345|455523217|FG000|Overall Study|Disease Progression|21|||
126607955|NCT00371345|455523218|FG001|Overall Study|Disease Progression|35|||
126607956|NCT00371345|455523217|FG000|Overall Study|Study Drug Toxicity|1|||
126607957|NCT00371345|455523218|FG001|Overall Study|Study Drug Toxicity|7|||
126607958|NCT00371345|455523217|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
126607959|NCT00371345|455523218|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
126607960|NCT00371345|455523217|FG000|Overall Study|Participant Request|1|||
126607961|NCT00371345|455523218|FG001|Overall Study|Participant Request|1|||
126607962|NCT00371345|455523217|FG000|Overall Study|Participant Withdrew Consent|0|||
126607963|NCT00371345|455523218|FG001|Overall Study|Participant Withdrew Consent|1|||
126607964|NCT01478594|455523219|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
126607965|NCT01478594|455523220|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
126733981|NCT00476996|455974041|FG003|OLE Phase (From Week 48)|Death|7|||
126733982|NCT00476996|455974038|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
126733983|NCT00476996|455974039|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
126733984|NCT00476996|455974040|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
126733985|NCT00476996|455974041|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
126733986|NCT00476996|455974038|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
126733987|NCT00476996|455974039|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
126733988|NCT00476996|455974040|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
126733989|NCT00476996|455974041|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
126733990|NCT00476996|455974038|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
126733991|NCT00476996|455974039|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
126733992|NCT00476996|455974040|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
126733993|NCT00476996|455974041|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
126733994|NCT00476996|455974038|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
126733995|NCT00476996|455974039|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
126733996|NCT00476996|455974040|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
126733997|NCT00476996|455974041|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
126733998|NCT01181778|455974048|FG000|Overall Study|Physician Decision|48|||
126733999|NCT01265420|455974049|FG000|Overall Study|Lost to Follow-up|1|||
126734000|NCT02332798|455975792|FG000|Overall Study|Unwilling to Participate in Study|0|||
126734001|NCT02332798|455975793|FG001|Overall Study|Unwilling to Participate in Study|1|||
126734002|NCT02332798|455975794|FG002|Overall Study|Unwilling to Participate in Study|1|||
126734003|NCT02332798|455975792|FG000|Overall Study|Positive Urine Drug Test|0|||
126734004|NCT02332798|455975793|FG001|Overall Study|Positive Urine Drug Test|1|||
126734005|NCT02332798|455975794|FG002|Overall Study|Positive Urine Drug Test|0|||
126734006|NCT02332798|455975792|FG000|Overall Study|Abnormal Laboratory Findings|1|||
126734007|NCT02332798|455975793|FG001|Overall Study|Abnormal Laboratory Findings|0|||
126734008|NCT02332798|455975794|FG002|Overall Study|Abnormal Laboratory Findings|0|||
126734009|NCT01175590|455975801|FG000|Overall Study|Lost to Follow-up|1|||
126607966|NCT01478594|455523219|FG000|Overall Study|Death|45|||
126607967|NCT01478594|455523220|FG001|Overall Study|Death|18|||
126607968|NCT01478594|455523219|FG000|Overall Study|Lost to Follow-up|3|||
126607969|NCT01478594|455523220|FG001|Overall Study|Lost to Follow-up|1|||
126607970|NCT01478594|455523219|FG000|Overall Study|Withdrawal by Subject|9|||
126607971|NCT01478594|455523220|FG001|Overall Study|Withdrawal by Subject|3|||
126607972|NCT01478594|455523219|FG000|Overall Study|Study Closed by Sponsor|8|||
126607973|NCT01478594|455523220|FG001|Overall Study|Study Closed by Sponsor|5|||
126607974|NCT00713596|455523221|FG000|Overall Study|Study was terminated|2|||
126607975|NCT00713596|455523222|FG001|Overall Study|Study was terminated|3|||
126607976|NCT00713596|455523223|FG002|Overall Study|Study was terminated|2|||
126607977|NCT04545619|455523224|FG000|Overall Study|due to equipment challenges|1|||
126607978|NCT03041233|455523237|FG000|Overall Study|Death|5|||
126607979|NCT03041233|455523237|FG000|Overall Study|Physician Decision|1|||
126607980|NCT03041233|455523237|FG000|Overall Study|Lost to Follow-up|16|||
126607981|NCT03041233|455523237|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
126607982|NCT03041233|455523237|FG000|Overall Study|Sponsor Request|1|||
126607983|NCT03041233|455523237|FG000|Overall Study|Duplicate subject|1|||
126607984|NCT03041233|455523237|FG000|Overall Study|Re-ablation|1|||
126607985|NCT03229408|455523238|FG000|Overall Study|Withdrawal by Subject|4|||
126607986|NCT03229408|455523239|FG001|Overall Study|Withdrawal by Subject|1|||
126607987|NCT03229408|455523238|FG000|Overall Study|Adverse Event|2|||
126607988|NCT03229408|455523239|FG001|Overall Study|Adverse Event|0|||
126607989|NCT03229408|455523238|FG000|Overall Study|Pregnancy|0|||
126607990|NCT03229408|455523239|FG001|Overall Study|Pregnancy|1|||
126607991|NCT03229408|455523238|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
126607992|NCT03229408|455523239|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
126607993|NCT04541589|455523240|FG000|Treatment Period|Adverse Event|8|||
126607994|NCT04541589|455523241|FG001|Treatment Period|Adverse Event|2|||
126607995|NCT04541589|455523240|FG000|Treatment Period|Physician Decision|3|||
126607996|NCT04541589|455523241|FG001|Treatment Period|Physician Decision|1|||
126607997|NCT04541589|455523240|FG000|Treatment Period|Subject decision|7|||
126607998|NCT04541589|455523241|FG001|Treatment Period|Subject decision|4|||
126607999|NCT04541589|455523240|FG000|Treatment Period|Withdrawal by Subject|1|||
126608000|NCT04541589|455523241|FG001|Treatment Period|Withdrawal by Subject|0|||
126608001|NCT04541589|455523240|FG000|Safety Follow-up Period|Adverse Event|2|||
126734010|NCT01175590|455975802|FG001|Overall Study|Lost to Follow-up|0|||
126734011|NCT01175590|455975801|FG000|Overall Study|Withdrawal by Subject|0|||
126734012|NCT01175590|455975802|FG001|Overall Study|Withdrawal by Subject|2|||
126608002|NCT04541589|455523241|FG001|Safety Follow-up Period|Adverse Event|1|||
126608003|NCT04541589|455523240|FG000|Safety Follow-up Period|Physician Decision|1|||
126608004|NCT04541589|455523241|FG001|Safety Follow-up Period|Physician Decision|0|||
126608005|NCT04541589|455523240|FG000|Safety Follow-up Period|Subject decision|5|||
126608006|NCT04541589|455523241|FG001|Safety Follow-up Period|Subject decision|3|||
126734013|NCT01175590|455975801|FG000|Overall Study|Adverse Event|4|||
126734014|NCT01175590|455975802|FG001|Overall Study|Adverse Event|0|||
126734015|NCT01175590|455975801|FG000|Overall Study|Physician Decision|1|||
126734016|NCT01175590|455975802|FG001|Overall Study|Physician Decision|4|||
126734017|NCT01175590|455975801|FG000|Overall Study|Lack of Efficacy|1|||
126608007|NCT04541589|455523240|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
126608008|NCT04541589|455523241|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
126608009|NCT03890289|455523242|FG000|Overall Study|Adverse Event|1|||
126608010|NCT03890289|455523242|FG000|Overall Study|Physician Decision|1|||
126608011|NCT03890289|455523242|FG000|Overall Study|Lack of Efficacy|2|||
126608012|NCT02426138|455523245|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
126608013|NCT02426138|455523246|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
126608014|NCT00274261|455523247|FG000|Overall Study|Adverse Event|19|||
126608015|NCT00274261|455523248|FG001|Overall Study|Adverse Event|11|||
126608016|NCT00274261|455523247|FG000|Overall Study|Pregnancy|114|||
126608017|NCT00274261|455523248|FG001|Overall Study|Pregnancy|83|||
126608018|NCT00274261|455523247|FG000|Overall Study|Withdrawal by Subject|179|||
126608019|NCT00274261|455523248|FG001|Overall Study|Withdrawal by Subject|126|||
126608020|NCT00274261|455523247|FG000|Overall Study|Protocol Violation|71|||
126734018|NCT01175590|455975802|FG001|Overall Study|Lack of Efficacy|1|||
126608021|NCT00274261|455523248|FG001|Overall Study|Protocol Violation|42|||
126608022|NCT00274261|455523247|FG000|Overall Study|Lost to Follow-up|106|||
126608023|NCT00274261|455523248|FG001|Overall Study|Lost to Follow-up|75|||
126608024|NCT02816398|455523256|FG000|Overall Study|Death|5|||
126608025|NCT02816398|455523256|FG000|Overall Study|Lack of Efficacy|8|||
126608026|NCT02816398|455523256|FG000|Overall Study|Lost to Follow-up|1|||
126608027|NCT03362190|455523262|FG000|Overall Study|Adverse Event|0|||
126608028|NCT03362190|455523263|FG001|Overall Study|Adverse Event|0|||
126608029|NCT03362190|455523264|FG002|Overall Study|Adverse Event|0|||
126608030|NCT03362190|455523265|FG003|Overall Study|Adverse Event|1|||
126608031|NCT03362190|455523262|FG000|Overall Study|Withdrawal by Subject|0|||
126608032|NCT03362190|455523263|FG001|Overall Study|Withdrawal by Subject|0|||
126608033|NCT03362190|455523264|FG002|Overall Study|Withdrawal by Subject|0|||
126608034|NCT03362190|455523265|FG003|Overall Study|Withdrawal by Subject|1|||
126608035|NCT00687219|455523266|FG000|Overall Study|Adverse Event|8|||
126608036|NCT00687219|455523266|FG000|Overall Study|Discontinuance criteria met|7|||
126608037|NCT00687219|455523266|FG000|Overall Study|HCV-RNA positive conversion|34|||
126608038|NCT00687219|455523266|FG000|Overall Study|Withdrawal by Subject|1|||
126608039|NCT00687219|455523266|FG000|Overall Study|Lack of Efficacy|1|||
126608040|NCT01367236|455523270|FG000|Overall Study|Withdrawal by Subject|3|||
126608041|NCT01367236|455523271|FG001|Overall Study|Withdrawal by Subject|1|||
126608042|NCT02350634|455523274|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
126608043|NCT01400958|455523283|FG000|Overall Study|Physician Decision|0|||
126608044|NCT01400958|455523284|FG001|Overall Study|Physician Decision|1|||
126608045|NCT01400958|455523283|FG000|Overall Study|Withdrawal by Subject|0|||
126608046|NCT01400958|455523284|FG001|Overall Study|Withdrawal by Subject|1|||
126608047|NCT01400958|455523283|FG000|Overall Study|Adverse Event|1|||
126608048|NCT01400958|455523284|FG001|Overall Study|Adverse Event|0|||
126608049|NCT02063659|455523288|FG000|Double-Blind Treatment Period|Adverse Event|1|||
126608050|NCT02063659|455523289|FG001|Double-Blind Treatment Period|Adverse Event|2|||
126608051|NCT02063659|455523290|FG002|Double-Blind Treatment Period|Adverse Event|0|||
126608052|NCT02063659|455523291|FG003|Double-Blind Treatment Period|Adverse Event|0|||
126608053|NCT02063659|455523288|FG000|Double-Blind Treatment Period|Physician Decision|1|||
126608054|NCT02063659|455523289|FG001|Double-Blind Treatment Period|Physician Decision|0|||
126608055|NCT02063659|455523290|FG002|Double-Blind Treatment Period|Physician Decision|0|||
126608056|NCT02063659|455523291|FG003|Double-Blind Treatment Period|Physician Decision|0|||
126608057|NCT02063659|455523288|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
126608058|NCT02063659|455523289|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
126608059|NCT02063659|455523290|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
126608060|NCT02063659|455523291|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
126608061|NCT02063659|455523288|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
126608062|NCT02063659|455523289|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
126608063|NCT02063659|455523290|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
126608064|NCT02063659|455523291|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
126608065|NCT02063659|455523288|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
126608066|NCT02063659|455523289|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
126608067|NCT02063659|455523290|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
126608068|NCT02063659|455523291|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
126608069|NCT02063659|455523288|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
126608070|NCT02063659|455523289|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
126608071|NCT02063659|455523290|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
126608072|NCT02063659|455523291|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
126734019|NCT01175590|455975801|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
126734020|NCT01175590|455975802|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
126608073|NCT02063659|455523288|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
126608074|NCT02063659|455523289|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
126608075|NCT02063659|455523290|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
126608076|NCT02063659|455523291|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
126608077|NCT02063659|455523288|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
126608078|NCT02063659|455523289|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
126608079|NCT02063659|455523290|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
126608080|NCT02063659|455523291|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
126608081|NCT02972359|455523292|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
126608082|NCT02972359|455523292|FG000|Overall Study|Lack of Efficacy|1|||
126608083|NCT02972359|455523292|FG000|Overall Study|Adverse Event|4|||
126608084|NCT02972359|455523292|FG000|Overall Study|Death|1|||
126608085|NCT02972359|455523292|FG000|Overall Study|Withdrawal by Subject|30|||
126734021|NCT01175590|455975801|FG000|Overall Study|Treated not as randomized|3|||
126734022|NCT01175590|455975802|FG001|Overall Study|Treated not as randomized|2|||
126734023|NCT01175590|455975801|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
126734024|NCT01175590|455975802|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
126734025|NCT01175590|455975801|FG000|Overall Study|Protocol Violation|0|||
126734026|NCT01175590|455975802|FG001|Overall Study|Protocol Violation|1|||
126734027|NCT00688545|455975805|FG000|Overall Study|Lost to Follow-up|1|||
126734028|NCT00688545|455975806|FG001|Overall Study|Lost to Follow-up|4|||
126781174|NCT01464827|456154490|FG013|Overall Study|Adverse Event|0|||
126781175|NCT01464827|456154477|FG000|Overall Study|Withdrawal by Subject|1|||
126781176|NCT01464827|456154478|FG001|Overall Study|Withdrawal by Subject|0|||
126608086|NCT02972359|455523292|FG000|Overall Study|Protocol Violation|1|||
126608087|NCT02972359|455523292|FG000|Overall Study|Lost to Follow-up|26|||
126608088|NCT02972359|455523292|FG000|Overall Study|Other reasons|5|||
126608089|NCT02972359|455523292|FG000|Overall Study|Missing|1|||
126608090|NCT01532999|455523293|FG000|Overall Study|Lost to Follow-up|14|||
126608091|NCT01532999|455523294|FG001|Overall Study|Lost to Follow-up|8|||
126608092|NCT01532999|455523293|FG000|Overall Study|Physician Decision|1|||
126608093|NCT01532999|455523294|FG001|Overall Study|Physician Decision|2|||
126608094|NCT01532999|455523293|FG000|Overall Study|Withdrawal by Subject|5|||
126608095|NCT01532999|455523294|FG001|Overall Study|Withdrawal by Subject|0|||
126608096|NCT01532999|455523293|FG000|Overall Study|Relocated|2|||
126608097|NCT01532999|455523294|FG001|Overall Study|Relocated|0|||
126608098|NCT01532999|455523293|FG000|Overall Study|should not have been randomized|1|||
126608099|NCT01532999|455523294|FG001|Overall Study|should not have been randomized|0|||
126608100|NCT01532999|455523293|FG000|Overall Study|substantial noncompliance|2|||
126608101|NCT01532999|455523294|FG001|Overall Study|substantial noncompliance|0|||
126608102|NCT01532999|455523293|FG000|Overall Study|no show for week 9 assessments|6|||
126608103|NCT01532999|455523294|FG001|Overall Study|no show for week 9 assessments|4|||
126608104|NCT01532999|455523293|FG000|Overall Study|Adverse Event|0|||
126608105|NCT01532999|455523294|FG001|Overall Study|Adverse Event|1|||
126608106|NCT01532999|455523293|FG000|Overall Study|incarcerated|0|||
126608107|NCT01532999|455523294|FG001|Overall Study|incarcerated|1|||
126608108|NCT01532999|455523293|FG000|Overall Study|New job|0|||
126608109|NCT01532999|455523294|FG001|Overall Study|New job|2|||
126608110|NCT00914966|455523295|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
126608111|NCT00914966|455523295|FG000|Step 1: 1500 Units|Physician Decision|1|||
126608112|NCT00914966|455523295|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
126608113|NCT04021862|455523298|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
126608114|NCT04021862|455523299|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
126608115|NCT04021862|455523300|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
126608116|NCT04021862|455523301|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
126608117|NCT04021862|455523302|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
126608118|NCT04021862|455523303|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
126608119|NCT04021862|455523298|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
126608120|NCT04021862|455523299|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
126608121|NCT04021862|455523300|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
126608122|NCT04021862|455523301|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
126608123|NCT04021862|455523302|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
126608124|NCT04021862|455523303|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
126608125|NCT04021862|455523298|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
126608126|NCT04021862|455523299|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
126734029|NCT00688545|455975805|FG000|Overall Study|Insurance/cost of drug|0|||
126734030|NCT00688545|455975806|FG001|Overall Study|Insurance/cost of drug|1|||
126734031|NCT00688545|455975805|FG000|Overall Study|Withdrawal by Subject|2|||
126608127|NCT04021862|455523300|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
126608128|NCT04021862|455523301|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
126608129|NCT04021862|455523302|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
126734032|NCT00688545|455975806|FG001|Overall Study|Withdrawal by Subject|3|||
126734033|NCT00688545|455975805|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
126608130|NCT04021862|455523303|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
126608131|NCT04021862|455523298|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
126608132|NCT04021862|455523299|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
126608133|NCT04021862|455523300|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
126608134|NCT04021862|455523301|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
126608135|NCT04021862|455523302|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
126608136|NCT04021862|455523303|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
126608137|NCT04021862|455523298|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
126608138|NCT04021862|455523299|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
126608139|NCT04021862|455523300|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
126608140|NCT04021862|455523301|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
126608141|NCT04021862|455523302|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
126608142|NCT04021862|455523303|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
126608143|NCT02830204|455523304|FG000|Overall Study|Death|9|||
126608144|NCT02830204|455523304|FG000|Overall Study|Withdrawal by Subject|1|||
126608145|NCT01690624|455523305|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
126608146|NCT01690624|455523306|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
126608147|NCT01690624|455523307|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
126608148|NCT01690624|455523308|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
126608149|NCT01690624|455523305|FG000|Overall Study|Adverse event (other than DLT)|3|||
126608150|NCT01690624|455523306|FG001|Overall Study|Adverse event (other than DLT)|1|||
126608151|NCT01690624|455523307|FG002|Overall Study|Adverse event (other than DLT)|1|||
126608152|NCT01690624|455523308|FG003|Overall Study|Adverse event (other than DLT)|1|||
126608153|NCT01690624|455523305|FG000|Overall Study|Withdrawal by Subject|0|||
126608154|NCT01690624|455523306|FG001|Overall Study|Withdrawal by Subject|0|||
126608155|NCT01690624|455523307|FG002|Overall Study|Withdrawal by Subject|1|||
126608156|NCT01690624|455523308|FG003|Overall Study|Withdrawal by Subject|0|||
126608157|NCT01690624|455523305|FG000|Overall Study|Sponsor is ending trial|0|||
126608158|NCT01690624|455523306|FG001|Overall Study|Sponsor is ending trial|0|||
126608159|NCT01690624|455523307|FG002|Overall Study|Sponsor is ending trial|0|||
126608160|NCT01690624|455523308|FG003|Overall Study|Sponsor is ending trial|1|||
126608161|NCT01690624|455523305|FG000|Overall Study|Physician Decision|0|||
126608162|NCT01690624|455523306|FG001|Overall Study|Physician Decision|0|||
126608163|NCT01690624|455523307|FG002|Overall Study|Physician Decision|0|||
126608164|NCT01690624|455523308|FG003|Overall Study|Physician Decision|1|||
126608165|NCT01690624|455523305|FG000|Overall Study|Withdrawal by Subject|0|||
126608166|NCT01690624|455523306|FG001|Overall Study|Withdrawal by Subject|1|||
126608167|NCT01690624|455523307|FG002|Overall Study|Withdrawal by Subject|0|||
126608168|NCT01690624|455523308|FG003|Overall Study|Withdrawal by Subject|0|||
126608169|NCT01690624|455523305|FG000|Overall Study|Lack of Efficacy|1|||
126608170|NCT01690624|455523306|FG001|Overall Study|Lack of Efficacy|1|||
126608171|NCT01690624|455523307|FG002|Overall Study|Lack of Efficacy|3|||
126608172|NCT01690624|455523308|FG003|Overall Study|Lack of Efficacy|0|||
126608173|NCT04445831|455523309|FG000|Overall Study|Withdrawal by Subject|2|||
126608174|NCT04445831|455523310|FG001|Overall Study|Withdrawal by Subject|1|||
126608175|NCT04445831|455523311|FG002|Overall Study|Withdrawal by Subject|1|||
126608176|NCT04445831|455523312|FG003|Overall Study|Withdrawal by Subject|0|||
126608177|NCT04445831|455523313|FG004|Overall Study|Withdrawal by Subject|0|||
126608178|NCT04445831|455523314|FG005|Overall Study|Withdrawal by Subject|0|||
126608179|NCT04445831|455523315|FG006|Overall Study|Withdrawal by Subject|0|||
126608180|NCT04445831|455523309|FG000|Overall Study|Subject withdrawal by caregiver|0|||
126608181|NCT04445831|455523310|FG001|Overall Study|Subject withdrawal by caregiver|1|||
126608182|NCT04445831|455523311|FG002|Overall Study|Subject withdrawal by caregiver|0|||
126608183|NCT04445831|455523312|FG003|Overall Study|Subject withdrawal by caregiver|0|||
126608184|NCT04445831|455523313|FG004|Overall Study|Subject withdrawal by caregiver|0|||
126608185|NCT04445831|455523314|FG005|Overall Study|Subject withdrawal by caregiver|0|||
126608186|NCT04445831|455523315|FG006|Overall Study|Subject withdrawal by caregiver|0|||
126608187|NCT03773107|455523316|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
126608188|NCT03773107|455523317|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
126734034|NCT00688545|455975806|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
126608189|NCT03773107|455523318|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
126608190|NCT03773107|455523319|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
126608191|NCT01563185|455523323|FG000|Overall Study|Withdrawal by Subject|1|||
126608192|NCT01563185|455523323|FG000|Overall Study|Non-Compliance with study drug|1|||
126608193|NCT02328014|455524335|FG000|Overall Study|Adverse Event|1|||
126608194|NCT02328014|455524336|FG001|Overall Study|Adverse Event|0|||
126608195|NCT02328014|455524337|FG002|Overall Study|Adverse Event|0|||
126608196|NCT02328014|455524338|FG003|Overall Study|Adverse Event|1|||
126608197|NCT02328014|455524335|FG000|Overall Study|Death|0|||
126608198|NCT02328014|455524336|FG001|Overall Study|Death|0|||
126608199|NCT02328014|455524337|FG002|Overall Study|Death|0|||
126608200|NCT02328014|455524338|FG003|Overall Study|Death|4|||
126608201|NCT02328014|455524335|FG000|Overall Study|Physician Decision|0|||
126608202|NCT02328014|455524336|FG001|Overall Study|Physician Decision|0|||
126608203|NCT02328014|455524337|FG002|Overall Study|Physician Decision|0|||
126608204|NCT02328014|455524338|FG003|Overall Study|Physician Decision|1|||
126608205|NCT02328014|455524335|FG000|Overall Study|Disease Progression|1|||
126608206|NCT02328014|455524336|FG001|Overall Study|Disease Progression|0|||
126608207|NCT02328014|455524337|FG002|Overall Study|Disease Progression|1|||
126608208|NCT02328014|455524338|FG003|Overall Study|Disease Progression|3|||
126608209|NCT02328014|455524335|FG000|Overall Study|Study Terminated by Sponsor|4|||
126608210|NCT02328014|455524336|FG001|Overall Study|Study Terminated by Sponsor|1|||
126608211|NCT02328014|455524337|FG002|Overall Study|Study Terminated by Sponsor|1|||
126608212|NCT02328014|455524338|FG003|Overall Study|Study Terminated by Sponsor|0|||
126608213|NCT02328014|455524335|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
126608214|NCT02328014|455524336|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
126608215|NCT02328014|455524337|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
126608216|NCT02328014|455524338|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
126608217|NCT02328014|455524335|FG000|Overall Study|Withdrawal by Subject|0|||
126608218|NCT02328014|455524336|FG001|Overall Study|Withdrawal by Subject|0|||
126608219|NCT02328014|455524337|FG002|Overall Study|Withdrawal by Subject|0|||
126608220|NCT02328014|455524338|FG003|Overall Study|Withdrawal by Subject|1|||
126608221|NCT01274338|455524339|FG000|Overall Study|Lack of Efficacy|72|||
126608222|NCT01274338|455524340|FG001|Overall Study|Lack of Efficacy|108|||
126608223|NCT01274338|455524341|FG002|Overall Study|Lack of Efficacy|116|||
126608224|NCT01274338|455524342|FG003|Overall Study|Lack of Efficacy|0|||
126608225|NCT01274338|455524343|FG004|Overall Study|Lack of Efficacy|0|||
126608226|NCT01274338|455524344|FG005|Overall Study|Lack of Efficacy|0|||
126608227|NCT01274338|455524339|FG000|Overall Study|Adverse Event|272|||
126608228|NCT01274338|455524340|FG001|Overall Study|Adverse Event|105|||
126608229|NCT01274338|455524341|FG002|Overall Study|Adverse Event|180|||
126608230|NCT01274338|455524342|FG003|Overall Study|Adverse Event|1|||
126608231|NCT01274338|455524343|FG004|Overall Study|Adverse Event|0|||
126608232|NCT01274338|455524344|FG005|Overall Study|Adverse Event|0|||
126608233|NCT01274338|455524339|FG000|Overall Study|Death|8|||
126608234|NCT01274338|455524340|FG001|Overall Study|Death|1|||
126608235|NCT01274338|455524341|FG002|Overall Study|Death|0|||
126608236|NCT01274338|455524342|FG003|Overall Study|Death|0|||
126608237|NCT01274338|455524343|FG004|Overall Study|Death|0|||
126608238|NCT01274338|455524344|FG005|Overall Study|Death|0|||
126608239|NCT01274338|455524339|FG000|Overall Study|Withdrawal by Subject|27|||
126608240|NCT01274338|455524340|FG001|Overall Study|Withdrawal by Subject|99|||
126608241|NCT01274338|455524341|FG002|Overall Study|Withdrawal by Subject|17|||
126608242|NCT01274338|455524342|FG003|Overall Study|Withdrawal by Subject|0|||
126608243|NCT01274338|455524343|FG004|Overall Study|Withdrawal by Subject|0|||
126608244|NCT01274338|455524344|FG005|Overall Study|Withdrawal by Subject|0|||
126608245|NCT01274338|455524339|FG000|Overall Study|Did not start treatment|8|||
126608246|NCT01274338|455524340|FG001|Overall Study|Did not start treatment|116|||
126608247|NCT01274338|455524341|FG002|Overall Study|Did not start treatment|7|||
126608248|NCT01274338|455524342|FG003|Overall Study|Did not start treatment|0|||
126608249|NCT01274338|455524343|FG004|Overall Study|Did not start treatment|0|||
126608250|NCT01274338|455524344|FG005|Overall Study|Did not start treatment|0|||
126608251|NCT01274338|455524339|FG000|Overall Study|Alternative therapy|0|||
126608252|NCT01274338|455524340|FG001|Overall Study|Alternative therapy|1|||
126608253|NCT01274338|455524341|FG002|Overall Study|Alternative therapy|0|||
126608254|NCT01274338|455524342|FG003|Overall Study|Alternative therapy|0|||
126608255|NCT01274338|455524343|FG004|Overall Study|Alternative therapy|0|||
126608256|NCT01274338|455524344|FG005|Overall Study|Alternative therapy|0|||
126608257|NCT01274338|455524339|FG000|Overall Study|Other complicating diseases|0|||
126608258|NCT01274338|455524340|FG001|Overall Study|Other complicating diseases|3|||
126608259|NCT01274338|455524341|FG002|Overall Study|Other complicating diseases|1|||
126608260|NCT01274338|455524342|FG003|Overall Study|Other complicating diseases|0|||
126608261|NCT01274338|455524343|FG004|Overall Study|Other complicating diseases|0|||
126608262|NCT01274338|455524344|FG005|Overall Study|Other complicating diseases|0|||
126608263|NCT01274338|455524339|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
126608264|NCT01274338|455524340|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
126608265|NCT01274338|455524341|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
126608266|NCT01274338|455524342|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
126608267|NCT01274338|455524343|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
126608268|NCT01274338|455524344|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
126608269|NCT01274338|455524339|FG000|Overall Study|Pregnancy|0|||
126608270|NCT01274338|455524340|FG001|Overall Study|Pregnancy|0|||
126608271|NCT01274338|455524341|FG002|Overall Study|Pregnancy|1|||
126608272|NCT01274338|455524342|FG003|Overall Study|Pregnancy|0|||
126608273|NCT01274338|455524343|FG004|Overall Study|Pregnancy|0|||
126608274|NCT01274338|455524344|FG005|Overall Study|Pregnancy|0|||
126608275|NCT01274338|455524339|FG000|Overall Study|Reason not reported|12|||
126608276|NCT01274338|455524340|FG001|Overall Study|Reason not reported|21|||
126608277|NCT01274338|455524341|FG002|Overall Study|Reason not reported|3|||
126608278|NCT01274338|455524342|FG003|Overall Study|Reason not reported|0|||
126608279|NCT01274338|455524343|FG004|Overall Study|Reason not reported|1|||
126608280|NCT01274338|455524344|FG005|Overall Study|Reason not reported|0|||
126608281|NCT05422339|455524345|FG000|Overall Study|Withdrawal by Subject|17|||
126608282|NCT05422339|455524346|FG001|Overall Study|Withdrawal by Subject|15|||
126608283|NCT06056310|455524347|FG000|Overall Study|Other Reasons|2|||
126608284|NCT06056310|455524347|FG000|Overall Study|Sponsor Request|16|||
126608285|NCT01278030|455524366|FG000|Overall Study|Withdrawal by Subject|8|||
126608286|NCT01278030|455524367|FG001|Overall Study|Withdrawal by Subject|4|||
126608287|NCT00458783|455524369|FG000|Overall Study|Protocol Violation|1228|||
126608288|NCT00458783|455524370|FG001|Overall Study|Protocol Violation|1220|||
126608289|NCT01737398|455524371|FG000|Overall Study|Adverse event or SAE|16|||
126608290|NCT01737398|455524372|FG001|Overall Study|Adverse event or SAE|1|||
126608291|NCT01737398|455524371|FG000|Overall Study|Stopping rule met|2|||
126608292|NCT01737398|455524372|FG001|Overall Study|Stopping rule met|1|||
126608293|NCT01737398|455524371|FG000|Overall Study|Voluntary withdrawal|2|||
126608294|NCT01737398|455524372|FG001|Overall Study|Voluntary withdrawal|3|||
126608295|NCT01737398|455524371|FG000|Overall Study|Ineligibility|1|||
126608296|NCT01737398|455524372|FG001|Overall Study|Ineligibility|0|||
126608297|NCT01737398|455524371|FG000|Overall Study|Liver transplant|1|||
126608298|NCT01737398|455524372|FG001|Overall Study|Liver transplant|0|||
126608299|NCT01737398|455524371|FG000|Overall Study|Disease progression|2|||
126608300|NCT01737398|455524372|FG001|Overall Study|Disease progression|3|||
126608301|NCT01737398|455524371|FG000|Overall Study|Sponsor's decision|2|||
126608302|NCT01737398|455524372|FG001|Overall Study|Sponsor's decision|0|||
126608303|NCT05250115|455524373|FG000|Overall Study|Premature study end|40|||
126608304|NCT05250115|455524373|FG000|Overall Study|Adverse Event|8|||
126608305|NCT05250115|455524373|FG000|Overall Study|Lost to Follow-up|7|||
126781177|NCT01464827|456154479|FG002|Overall Study|Withdrawal by Subject|0|||
126781178|NCT01464827|456154480|FG003|Overall Study|Withdrawal by Subject|0|||
126781179|NCT01464827|456154481|FG004|Overall Study|Withdrawal by Subject|1|||
126781180|NCT01464827|456154482|FG005|Overall Study|Withdrawal by Subject|0|||
126781181|NCT01464827|456154483|FG006|Overall Study|Withdrawal by Subject|0|||
126781182|NCT01464827|456154484|FG007|Overall Study|Withdrawal by Subject|1|||
126781183|NCT01464827|456154485|FG008|Overall Study|Withdrawal by Subject|0|||
126781184|NCT01464827|456154486|FG009|Overall Study|Withdrawal by Subject|0|||
126781185|NCT01464827|456154487|FG010|Overall Study|Withdrawal by Subject|0|||
126781186|NCT01464827|456154488|FG011|Overall Study|Withdrawal by Subject|0|||
126781187|NCT01464827|456154489|FG012|Overall Study|Withdrawal by Subject|0|||
126781188|NCT01464827|456154490|FG013|Overall Study|Withdrawal by Subject|0|||
126781189|NCT01464827|456154477|FG000|Overall Study|Lost to Follow-up|0|||
126781190|NCT01464827|456154478|FG001|Overall Study|Lost to Follow-up|2|||
126781191|NCT01464827|456154479|FG002|Overall Study|Lost to Follow-up|0|||
126781192|NCT01464827|456154480|FG003|Overall Study|Lost to Follow-up|2|||
126608306|NCT05250115|455524373|FG000|Overall Study|Withdrawal by Subject|6|||
126608307|NCT05250115|455524373|FG000|Overall Study|Withdrawal of informed consent|1|||
126608308|NCT05250115|455524373|FG000|Overall Study|Other|7|||
126608309|NCT04401267|455524375|FG000|Overall Study|Death|0|||
126608310|NCT04401267|455524376|FG001|Overall Study|Death|1|||
126608311|NCT04401267|455524375|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
126608312|NCT04401267|455524376|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
126608313|NCT04401267|455524375|FG000|Overall Study|Found to be Ineligible|1|||
126608314|NCT04401267|455524376|FG001|Overall Study|Found to be Ineligible|0|||
126608315|NCT02962284|455524377|FG000|Overall Study|Death|2|||
126608316|NCT02962284|455524378|FG001|Overall Study|Death|0|||
126608317|NCT02962284|455524377|FG000|Overall Study|Progressive disease|2|||
126608318|NCT02962284|455524378|FG001|Overall Study|Progressive disease|3|||
126608319|NCT02962284|455524377|FG000|Overall Study|Withdrawal by Subject|1|||
126608320|NCT02962284|455524378|FG001|Overall Study|Withdrawal by Subject|0|||
126608321|NCT05815342|455524379|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
126608322|NCT05815342|455524379|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
126781193|NCT01464827|456154481|FG004|Overall Study|Lost to Follow-up|3|||
126781194|NCT01464827|456154482|FG005|Overall Study|Lost to Follow-up|1|||
126608323|NCT05815342|455524379|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
126608324|NCT05815342|455524379|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
126608325|NCT05815342|455524379|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
126608326|NCT00357994|455524382|FG000|Overall Study|Adverse Event|1|||
126608327|NCT00357994|455524383|FG001|Overall Study|Adverse Event|2|||
126608328|NCT00357994|455524382|FG000|Overall Study|Lack of Efficacy|0|||
126608329|NCT00357994|455524383|FG001|Overall Study|Lack of Efficacy|1|||
126781195|NCT01464827|456154483|FG006|Overall Study|Lost to Follow-up|2|||
126781196|NCT01464827|456154484|FG007|Overall Study|Lost to Follow-up|2|||
126781197|NCT01464827|456154485|FG008|Overall Study|Lost to Follow-up|0|||
126781198|NCT01464827|456154486|FG009|Overall Study|Lost to Follow-up|0|||
126608330|NCT00357994|455524382|FG000|Overall Study|Protocol Violation|1|||
126608331|NCT00357994|455524383|FG001|Overall Study|Protocol Violation|0|||
126608332|NCT03244800|455524384|FG000|Overall Study|Adverse Event|0|||
126608333|NCT03244800|455524385|FG001|Overall Study|Adverse Event|1|||
126608334|NCT03244800|455524386|FG002|Overall Study|Adverse Event|0|||
126608335|NCT03244800|455524387|FG003|Overall Study|Adverse Event|1|||
126608336|NCT03244800|455524384|FG000|Overall Study|Withdrew treatment|0|||
126608337|NCT03244800|455524385|FG001|Overall Study|Withdrew treatment|0|||
126608338|NCT03244800|455524386|FG002|Overall Study|Withdrew treatment|0|||
126608339|NCT03244800|455524387|FG003|Overall Study|Withdrew treatment|1|||
126608340|NCT04885998|455524388|FG000|Overall Study|Withdrawal by Subject|0|||
126608341|NCT04885998|455524389|FG001|Overall Study|Withdrawal by Subject|2|||
126608342|NCT04885998|455524390|FG002|Overall Study|Withdrawal by Subject|0|||
126608343|NCT04885998|455524391|FG003|Overall Study|Withdrawal by Subject|3|||
126608344|NCT04885998|455524388|FG000|Overall Study|Lost to Follow-up|1|||
126608345|NCT04885998|455524389|FG001|Overall Study|Lost to Follow-up|1|||
126608346|NCT04885998|455524390|FG002|Overall Study|Lost to Follow-up|0|||
126608347|NCT04885998|455524391|FG003|Overall Study|Lost to Follow-up|0|||
126608348|NCT04885998|455524388|FG000|Overall Study|Death|2|||
126608349|NCT04885998|455524389|FG001|Overall Study|Death|1|||
126608350|NCT04885998|455524390|FG002|Overall Study|Death|2|||
126608351|NCT04885998|455524391|FG003|Overall Study|Death|2|||
126608352|NCT04885998|455524388|FG000|Overall Study|Decision by sponsor|1|||
126608353|NCT04885998|455524389|FG001|Overall Study|Decision by sponsor|1|||
126608354|NCT04885998|455524390|FG002|Overall Study|Decision by sponsor|0|||
126608355|NCT04885998|455524391|FG003|Overall Study|Decision by sponsor|0|||
126608356|NCT03712371|455524395|FG000|Overall Study|Lack of Efficacy|0|||
126608357|NCT03712371|455524396|FG001|Overall Study|Lack of Efficacy|0|||
126608358|NCT03712371|455524397|FG002|Overall Study|Lack of Efficacy|0|||
126608359|NCT03712371|455524398|FG003|Overall Study|Lack of Efficacy|1|||
126608360|NCT02362035|455524403|FG000|Overall Study|Death|67|||
126608361|NCT02362035|455524403|FG000|Overall Study|Lost to Follow-up|3|||
126608362|NCT02362035|455524403|FG000|Overall Study|Adverse Event|1|||
126608363|NCT02362035|455524403|FG000|Overall Study|Physician Decision|1|||
126608364|NCT02362035|455524403|FG000|Overall Study|Subject started another cancer therapy|10|||
126608365|NCT02362035|455524403|FG000|Overall Study|Study terminated by sponsor|45|||
126608366|NCT02362035|455524403|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
126608367|NCT02362035|455524403|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
126608368|NCT02362035|455524403|FG000|Overall Study|Disease progression|11|||
126608369|NCT02362035|455524403|FG000|Overall Study|Withdrawal by Subject|20|||
126608370|NCT02788981|455524404|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
126608371|NCT02788981|455524405|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
126608372|NCT04250194|455524408|FG000|Overall Study|Declined to schedule biopsy|6|||
126608373|NCT04250194|455524409|FG001|Overall Study|Declined to schedule biopsy|10|||
126608374|NCT04250194|455524408|FG000|Overall Study|Medically Unfit for Biopsy|2|||
126608375|NCT04250194|455524409|FG001|Overall Study|Medically Unfit for Biopsy|1|||
126608376|NCT04250194|455524408|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
126734035|NCT03911869|455975807|FG000|Safety Lead-in Phase|Death|7|||
126734036|NCT03911869|455975808|FG001|Safety Lead-in Phase|Death|0|||
126734037|NCT03911869|455975809|FG002|Safety Lead-in Phase|Death|0|||
126734038|NCT03911869|455975807|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
126734039|NCT03911869|455975808|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
126734040|NCT03911869|455975809|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
126734041|NCT03911869|455975807|FG000|Safety Lead-in Phase|Other|1|||
126734042|NCT03911869|455975808|FG001|Safety Lead-in Phase|Other|0|||
126734043|NCT03911869|455975809|FG002|Safety Lead-in Phase|Other|0|||
126734044|NCT03911869|455975807|FG000|Phase 2|Death|0|||
126734045|NCT03911869|455975808|FG001|Phase 2|Death|3|||
126734046|NCT03911869|455975809|FG002|Phase 2|Death|0|||
126734047|NCT01878097|455975810|FG000|Baseline|Surveys not fully completed|2497|||
126734048|NCT01878097|455975811|FG001|Baseline|Surveys not fully completed|1800|||
126734049|NCT01878097|455975810|FG000|Implementation Year 1|Surveys not fully completed|3202|||
126734050|NCT01878097|455975811|FG001|Implementation Year 1|Surveys not fully completed|2549|||
126608377|NCT04250194|455524409|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
126608378|NCT04250194|455524408|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
126608379|NCT04250194|455524409|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
126608380|NCT04250194|455524408|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
126608381|NCT04250194|455524409|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
126734051|NCT01878097|455975810|FG000|Implementation Year 2|Surveys not fully completed|3281|||
126734052|NCT01878097|455975811|FG001|Implementation Year 2|Surveys not fully completed|2841|||
126734053|NCT01878097|455975810|FG000|Implementation Year 3|Surveys not fully completed|3494|||
126734054|NCT01878097|455975811|FG001|Implementation Year 3|Surveys not fully completed|2980|||
126734055|NCT01878097|455975810|FG000|Implementation Year 4|Surveys not fully completed|3604|||
126734056|NCT01878097|455975811|FG001|Implementation Year 4|Surveys not fully completed|3007|||
126608382|NCT00229658|455524410|FG000|Overall Study|Administrative|2|||
126608383|NCT00229658|455524411|FG001|Overall Study|Administrative|1|||
126608384|NCT00229658|455524410|FG000|Overall Study|Investigator decision|13|||
126734057|NCT00367341|455975812|FG000|Overall Study|Physician Decision|1|||
126734058|NCT00367341|455975813|FG001|Overall Study|Physician Decision|0|||
126608385|NCT00229658|455524411|FG001|Overall Study|Investigator decision|10|||
126608386|NCT00229658|455524410|FG000|Overall Study|Other|80|||
126608387|NCT00229658|455524411|FG001|Overall Study|Other|60|||
126608388|NCT00229658|455524410|FG000|Overall Study|Lost to Follow-up|82|||
126608389|NCT00229658|455524411|FG001|Overall Study|Lost to Follow-up|55|||
126608390|NCT00229658|455524410|FG000|Overall Study|Serious Adverse Event|2|||
126608391|NCT00229658|455524411|FG001|Overall Study|Serious Adverse Event|2|||
126608392|NCT00229658|455524410|FG000|Overall Study|Withdrawal of consent|46|||
126608393|NCT00229658|455524411|FG001|Overall Study|Withdrawal of consent|39|||
126608394|NCT00249769|455524412|FG000|Overall Study|Withdrawal by Subject|1|||
126608395|NCT00249769|455524413|FG001|Overall Study|Withdrawal by Subject|10|||
126608396|NCT00249769|455524414|FG002|Overall Study|Withdrawal by Subject|6|||
126608397|NCT00249769|455524412|FG000|Overall Study|Migration from Study Area|1|||
126608398|NCT00249769|455524413|FG001|Overall Study|Migration from Study Area|3|||
126608399|NCT00249769|455524414|FG002|Overall Study|Migration from Study Area|14|||
126608400|NCT00249769|455524412|FG000|Overall Study|Miscellaneous|0|||
126608401|NCT00249769|455524413|FG001|Overall Study|Miscellaneous|2|||
126608402|NCT00249769|455524414|FG002|Overall Study|Miscellaneous|2|||
126608403|NCT00249769|455524412|FG000|Overall Study|Adverse Event|0|||
126608404|NCT00249769|455524413|FG001|Overall Study|Adverse Event|0|||
126608405|NCT00249769|455524414|FG002|Overall Study|Adverse Event|1|||
126608406|NCT00249769|455524412|FG000|Overall Study|Physician Decision|0|||
126608407|NCT00249769|455524413|FG001|Overall Study|Physician Decision|0|||
126608408|NCT00249769|455524414|FG002|Overall Study|Physician Decision|2|||
126608409|NCT00249769|455524412|FG000|Overall Study|Lost to Follow-up|0|||
126608410|NCT00249769|455524413|FG001|Overall Study|Lost to Follow-up|0|||
126608411|NCT00249769|455524414|FG002|Overall Study|Lost to Follow-up|3|||
126608412|NCT01953224|455524415|FG000|Overall Study|Lost to Follow-up|1|||
126608413|NCT01953224|455524416|FG001|Overall Study|Lost to Follow-up|1|||
126608414|NCT01953224|455524415|FG000|Overall Study|Withdrawal by Subject|1|||
126608415|NCT01953224|455524416|FG001|Overall Study|Withdrawal by Subject|2|||
126608416|NCT05014412|455524419|FG000|Overall Study|Death|11|||
126608417|NCT05014412|455524420|FG001|Overall Study|Death|7|||
126608418|NCT05014412|455524421|FG002|Overall Study|Death|4|||
126608419|NCT05014412|455524422|FG003|Overall Study|Death|7|||
126608420|NCT05014412|455524419|FG000|Overall Study|Withdrawal by Subject|1|||
126608421|NCT05014412|455524420|FG001|Overall Study|Withdrawal by Subject|1|||
126608422|NCT05014412|455524421|FG002|Overall Study|Withdrawal by Subject|1|||
126608423|NCT05014412|455524422|FG003|Overall Study|Withdrawal by Subject|2|||
126608424|NCT05014412|455524419|FG000|Overall Study|Ongoing|21|||
126608425|NCT05014412|455524420|FG001|Overall Study|Ongoing|4|||
126608426|NCT05014412|455524421|FG002|Overall Study|Ongoing|6|||
126608427|NCT05014412|455524422|FG003|Overall Study|Ongoing|20|||
126608428|NCT03745313|455524425|FG000|At 30 Days Follow-up|Death|2|||
126608429|NCT03745313|455524425|FG000|At 6 Months Follow-up|Death|1|||
126608430|NCT03745313|455524425|FG000|At 6 Months Follow-up|Missed Visit|1|||
126608431|NCT03745313|455524425|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
126608432|NCT03745313|455524425|FG000|At 1 Year Follow-up|Death|2|||
126608433|NCT03745313|455524425|FG000|At 1 Year Follow-up|Missed Visit|2|||
126608434|NCT03745313|455524425|FG000|At 2 Year Follow-up|Missed Visit|1|||
126608435|NCT03516812|455524426|FG000|Overall Study|Adverse Event|4|||
126608436|NCT03516812|455524426|FG000|Overall Study|Lack of Efficacy|2|||
126608437|NCT05470114|455524427|FG000|Overall Study|Withdrawal by Subject|1|||
126608438|NCT05470114|455524428|FG001|Overall Study|Withdrawal by Subject|0|||
126608439|NCT05470114|455524427|FG000|Overall Study|Lost to Follow-up|1|||
126608440|NCT05470114|455524428|FG001|Overall Study|Lost to Follow-up|0|||
126608441|NCT02101775|455525014|FG000|Overall Study|Adverse Event|4|||
126608442|NCT02101775|455525015|FG001|Overall Study|Adverse Event|0|||
126608443|NCT02101775|455525016|FG002|Overall Study|Adverse Event|0|||
126608444|NCT02101775|455525014|FG000|Overall Study|Admission to Hospital|0|||
126608445|NCT02101775|455525015|FG001|Overall Study|Admission to Hospital|1|||
126608446|NCT02101775|455525016|FG002|Overall Study|Admission to Hospital|0|||
126608447|NCT01886872|455525019|FG000|Overall Study|Ineligible|7|||
126608448|NCT01886872|455525020|FG001|Overall Study|Ineligible|4|||
126608449|NCT01886872|455525021|FG002|Overall Study|Ineligible|12|||
126608450|NCT04941482|455525022|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
126608451|NCT04941482|455525023|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
126608452|NCT03389802|455525024|FG000|Overall Study|Lack of Efficacy|3|||
126608453|NCT03389802|455525025|FG001|Overall Study|Lack of Efficacy|3|||
126608454|NCT03389802|455525026|FG002|Overall Study|Lack of Efficacy|13|||
126608455|NCT03389802|455525027|FG003|Overall Study|Lack of Efficacy|6|||
126608456|NCT03389802|455525028|FG004|Overall Study|Lack of Efficacy|1|||
126608457|NCT03389802|455525024|FG000|Overall Study|Adverse Event|0|||
126608458|NCT03389802|455525025|FG001|Overall Study|Adverse Event|0|||
126608459|NCT03389802|455525026|FG002|Overall Study|Adverse Event|1|||
126608460|NCT03389802|455525027|FG003|Overall Study|Adverse Event|0|||
126608461|NCT03389802|455525028|FG004|Overall Study|Adverse Event|4|||
126608462|NCT03389802|455525024|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
126608463|NCT03389802|455525025|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
126608464|NCT03389802|455525026|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
126608465|NCT03389802|455525027|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
126608466|NCT03389802|455525028|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
126608467|NCT04745676|455525030|FG000|Overall Study|Death|1|||
126608468|NCT04745676|455525031|FG001|Overall Study|Death|0|||
126608469|NCT04745676|455525032|FG002|Overall Study|Death|0|||
126608470|NCT04827732|455525036|FG000|Overall Study|Did not start treatment|0|||
126608471|NCT04827732|455525037|FG001|Overall Study|Did not start treatment|1|||
126608472|NCT04827732|455525038|FG002|Overall Study|Did not start treatment|0|||
126608473|NCT04827732|455525039|FG003|Overall Study|Did not start treatment|1|||
126608474|NCT03414684|455525043|FG000|First-course Treatment|Complete response|0|||
126608475|NCT03414684|455525044|FG001|First-course Treatment|Complete response|1|||
126608476|NCT03414684|455525043|FG000|First-course Treatment|Intercurrent illness|1|||
126608477|NCT03414684|455525044|FG001|First-course Treatment|Intercurrent illness|0|||
126608478|NCT03414684|455525043|FG000|First-course Treatment|Progressive Disease|31|||
126608479|NCT03414684|455525044|FG001|First-course Treatment|Progressive Disease|32|||
126608480|NCT03414684|455525043|FG000|First-course Treatment|Adverse Event|1|||
126608481|NCT03414684|455525044|FG001|First-course Treatment|Adverse Event|2|||
126608482|NCT03414684|455525043|FG000|First-course Treatment|Physician Decision|0|||
126608483|NCT03414684|455525044|FG001|First-course Treatment|Physician Decision|1|||
126608484|NCT03414684|455525043|FG000|First-course Treatment|Withdrawal by Subject|0|||
126608485|NCT03414684|455525044|FG001|First-course Treatment|Withdrawal by Subject|1|||
126608486|NCT03414684|455525043|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
126608487|NCT03414684|455525044|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
126608488|NCT03414684|455525043|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
126608489|NCT03414684|455525044|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
126608490|NCT03414684|455525043|FG000|First-course Treatment|Still on treatment|3|||
126608491|NCT03414684|455525044|FG001|First-course Treatment|Still on treatment|0|||
126608492|NCT03414684|455525043|FG000|First-course Treatment|Never started protocol therapy|2|||
126608493|NCT03414684|455525044|FG001|First-course Treatment|Never started protocol therapy|1|||
126608494|NCT03414684|455525043|FG000|Crossover Treatment|Progressive disease|0|||
126608495|NCT03414684|455525044|FG001|Crossover Treatment|Progressive disease|12|||
126608496|NCT03414684|455525043|FG000|Crossover Treatment|Adverse Event|0|||
126608497|NCT03414684|455525044|FG001|Crossover Treatment|Adverse Event|3|||
126608498|NCT03414684|455525043|FG000|Crossover Treatment|Physician Decision|0|||
126608499|NCT03414684|455525044|FG001|Crossover Treatment|Physician Decision|1|||
126608500|NCT03414684|455525043|FG000|Crossover Treatment|Still on treatment|0|||
126608501|NCT03414684|455525044|FG001|Crossover Treatment|Still on treatment|2|||
126608502|NCT04038580|455525045|FG000|Washout 1|Death|0|||
126608503|NCT04038580|455525046|FG001|Washout 1|Death|0|||
126608504|NCT04038580|455525047|FG002|Washout 1|Death|0|||
126608505|NCT04038580|455525048|FG003|Washout 1|Death|1|||
126608506|NCT04038580|455525049|FG004|Washout 1|Death|0|||
126608507|NCT04038580|455525050|FG005|Washout 1|Death|0|||
126608508|NCT04038580|455525045|FG000|Washout 1|Withdrawal by Subject|0|||
126608509|NCT04038580|455525046|FG001|Washout 1|Withdrawal by Subject|0|||
126608510|NCT04038580|455525047|FG002|Washout 1|Withdrawal by Subject|0|||
126608511|NCT04038580|455525048|FG003|Washout 1|Withdrawal by Subject|0|||
126608512|NCT04038580|455525049|FG004|Washout 1|Withdrawal by Subject|1|||
126608513|NCT04038580|455525050|FG005|Washout 1|Withdrawal by Subject|0|||
126608514|NCT04038580|455525045|FG000|Wash-out 2|Withdrawal by Subject|1|||
126608515|NCT04038580|455525046|FG001|Wash-out 2|Withdrawal by Subject|0|||
126608516|NCT04038580|455525047|FG002|Wash-out 2|Withdrawal by Subject|0|||
126608517|NCT04038580|455525048|FG003|Wash-out 2|Withdrawal by Subject|2|||
126608518|NCT04038580|455525049|FG004|Wash-out 2|Withdrawal by Subject|0|||
126608519|NCT04038580|455525050|FG005|Wash-out 2|Withdrawal by Subject|1|||
126608520|NCT04038580|455525045|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
126608521|NCT04038580|455525046|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
126608522|NCT04038580|455525047|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
126608523|NCT04038580|455525048|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
126608524|NCT04038580|455525049|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
126608525|NCT04038580|455525050|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
126608526|NCT04038580|455525045|FG000|Wash-out 3|Withdrawal by Subject|1|||
126608527|NCT04038580|455525046|FG001|Wash-out 3|Withdrawal by Subject|0|||
126608528|NCT04038580|455525047|FG002|Wash-out 3|Withdrawal by Subject|2|||
126608529|NCT04038580|455525048|FG003|Wash-out 3|Withdrawal by Subject|0|||
126608530|NCT04038580|455525049|FG004|Wash-out 3|Withdrawal by Subject|0|||
126608531|NCT04038580|455525050|FG005|Wash-out 3|Withdrawal by Subject|0|||
126608532|NCT03147287|455525057|FG000|Overall Study|Randomized Not Treated|2|||
126608533|NCT03147287|455525058|FG001|Overall Study|Randomized Not Treated|1|||
126608534|NCT03147287|455525059|FG002|Overall Study|Randomized Not Treated|1|||
126608535|NCT03147287|455525057|FG000|Overall Study|Progressive Disease RECIST|31|||
126608536|NCT03147287|455525058|FG001|Overall Study|Progressive Disease RECIST|72|||
126608537|NCT03147287|455525059|FG002|Overall Study|Progressive Disease RECIST|32|||
126608538|NCT03147287|455525057|FG000|Overall Study|Progressive Disease not RECIST|13|||
126608539|NCT03147287|455525058|FG001|Overall Study|Progressive Disease not RECIST|21|||
126608540|NCT03147287|455525059|FG002|Overall Study|Progressive Disease not RECIST|13|||
126608541|NCT03147287|455525057|FG000|Overall Study|Physician Decision|1|||
126608542|NCT03147287|455525058|FG001|Overall Study|Physician Decision|2|||
126608543|NCT03147287|455525059|FG002|Overall Study|Physician Decision|1|||
126608544|NCT03147287|455525057|FG000|Overall Study|Intercurrent illness|0|||
126608545|NCT03147287|455525058|FG001|Overall Study|Intercurrent illness|1|||
126608546|NCT03147287|455525059|FG002|Overall Study|Intercurrent illness|0|||
126608547|NCT03147287|455525057|FG000|Overall Study|Withdrawal by Subject|2|||
126608548|NCT03147287|455525058|FG001|Overall Study|Withdrawal by Subject|3|||
126608549|NCT03147287|455525059|FG002|Overall Study|Withdrawal by Subject|2|||
126608550|NCT03147287|455525057|FG000|Overall Study|Patient Non-Compliance|0|||
126608551|NCT03147287|455525058|FG001|Overall Study|Patient Non-Compliance|2|||
126608552|NCT03147287|455525059|FG002|Overall Study|Patient Non-Compliance|0|||
126608553|NCT03147287|455525057|FG000|Overall Study|Patient moved|0|||
126608554|NCT03147287|455525058|FG001|Overall Study|Patient moved|1|||
126608555|NCT03147287|455525059|FG002|Overall Study|Patient moved|0|||
126608556|NCT03147287|455525057|FG000|Overall Study|Arm A crossover without PD|1|||
126608557|NCT03147287|455525058|FG001|Overall Study|Arm A crossover without PD|0|||
126608558|NCT03147287|455525059|FG002|Overall Study|Arm A crossover without PD|0|||
126608559|NCT03147287|455525057|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
126608560|NCT03147287|455525058|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
126608561|NCT03147287|455525059|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
126608562|NCT03214081|455525717|FG000|Overall Study|Case Report Forms Uncollected|9|||
126608563|NCT03214081|455525717|FG000|Overall Study|Protocol Deviation|54|||
126608564|NCT01372085|455525720|FG000|Washout Period 2|Physician Decision|0|||
126608565|NCT01372085|455525721|FG001|Washout Period 2|Physician Decision|0|||
126608566|NCT01372085|455525722|FG002|Washout Period 2|Physician Decision|0|||
126608567|NCT01372085|455525723|FG003|Washout Period 2|Physician Decision|0|||
126608568|NCT01372085|455525724|FG004|Washout Period 2|Physician Decision|1|||
126608569|NCT01372085|455525725|FG005|Washout Period 2|Physician Decision|0|||
126608570|NCT01372085|455525726|FG006|Washout Period 2|Physician Decision|0|||
126608571|NCT01372085|455525727|FG007|Washout Period 2|Physician Decision|0|||
126608572|NCT01372085|455525728|FG008|Washout Period 2|Physician Decision|0|||
126608573|NCT01372085|455525729|FG009|Washout Period 2|Physician Decision|0|||
126608574|NCT01372085|455525720|FG000|Washout Period 3|Withdrawal by Subject|0|||
126608575|NCT01372085|455525721|FG001|Washout Period 3|Withdrawal by Subject|0|||
126608576|NCT01372085|455525722|FG002|Washout Period 3|Withdrawal by Subject|0|||
126608577|NCT01372085|455525723|FG003|Washout Period 3|Withdrawal by Subject|0|||
126608578|NCT01372085|455525724|FG004|Washout Period 3|Withdrawal by Subject|0|||
126608579|NCT01372085|455525725|FG005|Washout Period 3|Withdrawal by Subject|2|||
126608580|NCT01372085|455525726|FG006|Washout Period 3|Withdrawal by Subject|0|||
126608581|NCT01372085|455525727|FG007|Washout Period 3|Withdrawal by Subject|0|||
126608582|NCT01372085|455525728|FG008|Washout Period 3|Withdrawal by Subject|0|||
126608583|NCT01372085|455525729|FG009|Washout Period 3|Withdrawal by Subject|0|||
126608584|NCT00790569|455525730|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
126608585|NCT00790569|455525731|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
126608586|NCT00790569|455525732|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
126608587|NCT00790569|455525730|FG000|End of Treatment (6 Month Interview)|Death|0|||
126608588|NCT00790569|455525731|FG001|End of Treatment (6 Month Interview)|Death|2|||
126608589|NCT00790569|455525732|FG002|End of Treatment (6 Month Interview)|Death|1|||
126608590|NCT00790569|455525730|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
126608591|NCT00790569|455525731|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
126608592|NCT00790569|455525732|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
126608593|NCT00790569|455525730|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
126608594|NCT00790569|455525731|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
126608595|NCT00790569|455525732|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
126608596|NCT00790569|455525730|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
126608597|NCT00790569|455525731|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
126608598|NCT00790569|455525732|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
126608599|NCT00790569|455525730|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
126608600|NCT00790569|455525731|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
126608601|NCT00790569|455525732|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
126608602|NCT00705406|455525736|FG000|Overall Study|Lost to Follow-up|3|||
126608603|NCT00705406|455525737|FG001|Overall Study|Lost to Follow-up|3|||
126608604|NCT00705406|455525736|FG000|Overall Study|Did not receive study drug|1|||
126608605|NCT00705406|455525737|FG001|Overall Study|Did not receive study drug|2|||
126608606|NCT02357966|455525738|FG000|Overall Study|Death|0|||
126608607|NCT02357966|455525739|FG001|Overall Study|Death|0|||
126608608|NCT02357966|455525740|FG002|Overall Study|Death|1|||
126608609|NCT02357966|455525741|FG003|Overall Study|Death|0|||
126608610|NCT02357966|455525742|FG004|Overall Study|Death|2|||
126608611|NCT02357966|455525743|FG005|Overall Study|Death|0|||
126608612|NCT02357966|455525738|FG000|Overall Study|Physician Decision|1|||
126608613|NCT02357966|455525739|FG001|Overall Study|Physician Decision|0|||
126608614|NCT02357966|455525740|FG002|Overall Study|Physician Decision|0|||
126608615|NCT02357966|455525741|FG003|Overall Study|Physician Decision|0|||
126608616|NCT02357966|455525742|FG004|Overall Study|Physician Decision|1|||
126608617|NCT02357966|455525743|FG005|Overall Study|Physician Decision|0|||
126608618|NCT03732807|455525744|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
126608619|NCT03732807|455525745|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
126608620|NCT03732807|455525746|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
126608621|NCT03732807|455525747|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
126608622|NCT03732807|455525748|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
126608623|NCT03732807|455525749|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
126608624|NCT03732807|455525750|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
126608625|NCT03732807|455525744|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
126608626|NCT03732807|455525745|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
126608627|NCT03732807|455525746|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
126608628|NCT03732807|455525747|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
126608629|NCT03732807|455525748|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
126608630|NCT03732807|455525749|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
126608631|NCT03732807|455525750|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
126608632|NCT03732807|455525744|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
126608633|NCT03732807|455525745|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
126608634|NCT03732807|455525746|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
126608635|NCT03732807|455525747|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
126608636|NCT03732807|455525748|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
126608637|NCT03732807|455525749|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
126608638|NCT03732807|455525750|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
126608639|NCT03732807|455525744|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
126608640|NCT03732807|455525745|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
126608641|NCT03732807|455525746|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
126608642|NCT03732807|455525747|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
126608643|NCT03732807|455525748|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
126608644|NCT03732807|455525749|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
126608645|NCT03732807|455525750|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
126608646|NCT03732807|455525744|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
126608647|NCT03732807|455525745|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
126608648|NCT03732807|455525746|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
126608649|NCT03732807|455525747|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
126608650|NCT03732807|455525748|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
126608651|NCT03732807|455525749|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
126608652|NCT03732807|455525750|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
126608653|NCT03732807|455525744|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
126608654|NCT03732807|455525745|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
126608655|NCT03732807|455525746|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
126608656|NCT03732807|455525747|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
126608657|NCT03732807|455525748|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
126608658|NCT03732807|455525749|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
126608659|NCT03732807|455525750|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
126608660|NCT03732807|455525744|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126608661|NCT03732807|455525745|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126608662|NCT03732807|455525746|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126608663|NCT03732807|455525747|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126608664|NCT03732807|455525748|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126608665|NCT03732807|455525749|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
126608666|NCT03732807|455525750|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
126608667|NCT03732807|455525744|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
126608668|NCT03732807|455525745|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
126608669|NCT03732807|455525746|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
126608670|NCT03732807|455525747|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
126608671|NCT03732807|455525748|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
126608672|NCT03732807|455525749|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
126608673|NCT03732807|455525750|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
126608674|NCT03732807|455525744|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
126608675|NCT03732807|455525745|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
126608676|NCT03732807|455525746|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
126608677|NCT03732807|455525747|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
126608678|NCT03732807|455525748|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
126734059|NCT00367341|455975812|FG000|Overall Study|Protocol Violation|1|||
126608679|NCT03732807|455525749|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
126608680|NCT03732807|455525750|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
126608681|NCT03732807|455525744|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
126608682|NCT03732807|455525745|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
126608683|NCT03732807|455525746|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
126608684|NCT03732807|455525747|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
126608685|NCT03732807|455525748|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
126608686|NCT03732807|455525749|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
126608687|NCT03732807|455525750|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
126608688|NCT03732807|455525744|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
126608689|NCT03732807|455525745|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
126608690|NCT03732807|455525746|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
126608691|NCT03732807|455525747|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
126608692|NCT03732807|455525748|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
126608693|NCT03732807|455525749|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
126608694|NCT03732807|455525750|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
126608695|NCT03732807|455525744|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
126608696|NCT03732807|455525745|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
126608697|NCT03732807|455525746|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
126608698|NCT03732807|455525747|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
126608699|NCT03732807|455525748|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
126608700|NCT03732807|455525749|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
126608701|NCT03732807|455525750|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
126608702|NCT03732807|455525744|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
126608703|NCT03732807|455525745|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
126608704|NCT03732807|455525746|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
126608705|NCT03732807|455525747|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
126608706|NCT03732807|455525748|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
126608707|NCT03732807|455525749|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
126608708|NCT03732807|455525750|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
126608709|NCT03732807|455525744|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
126608710|NCT03732807|455525745|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
126608711|NCT03732807|455525746|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
126608712|NCT03732807|455525747|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
126608713|NCT03732807|455525748|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
126608714|NCT03732807|455525749|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
126608715|NCT03732807|455525750|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
126608716|NCT00586313|455525752|FG000|Overall Study|Lack of Efficacy|2|||
126608717|NCT04200664|455525753|FG000|Overall Study|Withdrawal by Subject|1|||
126608718|NCT04200664|455525754|FG001|Overall Study|Withdrawal by Subject|0|||
126608719|NCT04200664|455525755|FG002|Overall Study|Withdrawal by Subject|0|||
126608720|NCT03582475|455525761|FG000|Treatment Period|Withdrawal by Subject|0|||
126608721|NCT03582475|455525762|FG001|Treatment Period|Withdrawal by Subject|1|||
126608722|NCT03582475|455525761|FG000|Follow-up Period|Withdrawal by Subject|0|||
126608723|NCT03582475|455525762|FG001|Follow-up Period|Withdrawal by Subject|1|||
126608724|NCT03775486|455525767|FG000|Initial Therapy Phase|Other reason provided|0|||
126608725|NCT03775486|455525768|FG001|Initial Therapy Phase|Other reason provided|15|||
126608726|NCT03775486|455525767|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
126608727|NCT03775486|455525768|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
126608728|NCT03775486|455525767|FG000|Initial Therapy Phase|Protocol Violation|0|||
126608729|NCT03775486|455525768|FG001|Initial Therapy Phase|Protocol Violation|2|||
126608730|NCT03775486|455525767|FG000|Initial Therapy Phase|Adverse Event|0|||
126608731|NCT03775486|455525768|FG001|Initial Therapy Phase|Adverse Event|34|||
126608732|NCT03775486|455525767|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
126608733|NCT03775486|455525768|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
126608734|NCT03775486|455525767|FG000|Maintenance Phase|Withdrawal by Subject|13|||
126608735|NCT03775486|455525768|FG001|Maintenance Phase|Withdrawal by Subject|12|||
126608736|NCT03775486|455525767|FG000|Maintenance Phase|Death|44|||
126608737|NCT03775486|455525768|FG001|Maintenance Phase|Death|45|||
126608738|NCT02744066|455525773|FG000|Overall Study|Withdrawal by parent|0|||
126608739|NCT02744066|455525774|FG001|Overall Study|Withdrawal by parent|1|||
126608740|NCT02744066|455525773|FG000|Overall Study|Discharged from NICU prior to completion|0|||
126608741|NCT02744066|455525774|FG001|Overall Study|Discharged from NICU prior to completion|4|||
126608742|NCT02454959|455525775|FG000|Overall Study|Protocol-Specified Criteria|3|||
126608743|NCT02454959|455525775|FG000|Overall Study|Physician Decision|1|||
126608744|NCT02454959|455525775|FG000|Overall Study|Withdrawal by Subject|3|||
126608745|NCT02454959|455525775|FG000|Overall Study|Adverse Event|2|||
126608746|NCT05810285|455525782|FG000|Overall Study|Death|4|||
126608747|NCT05810285|455525783|FG001|Overall Study|Death|21|||
126608748|NCT05810285|455525782|FG000|Overall Study|Adverse Event|18|||
126608749|NCT05810285|455525783|FG001|Overall Study|Adverse Event|16|||
126608750|NCT05325294|455525784|FG000|Overall Study|Adverse Event|3|||
126608751|NCT05325294|455525785|FG001|Overall Study|Adverse Event|3|||
126608752|NCT05325294|455525784|FG000|Overall Study|Physician Decision|0|||
126608753|NCT05325294|455525785|FG001|Overall Study|Physician Decision|1|||
126608754|NCT05325294|455525784|FG000|Overall Study|Withdrawal by Subject|0|||
126608755|NCT05325294|455525785|FG001|Overall Study|Withdrawal by Subject|3|||
126608756|NCT05325294|455525784|FG000|Overall Study|Lost to Follow-up|1|||
126608757|NCT05325294|455525785|FG001|Overall Study|Lost to Follow-up|0|||
126608758|NCT05325294|455525784|FG000|Overall Study|Sponsor Request|0|||
126608759|NCT05325294|455525785|FG001|Overall Study|Sponsor Request|2|||
126608760|NCT04577651|455525786|FG000|Overall Study|Screen Failure|7|||
126608761|NCT04577651|455525786|FG000|Overall Study|Adverse Event|1|||
126608762|NCT04577651|455525786|FG000|Overall Study|Death|1|||
126608763|NCT04577651|455525786|FG000|Overall Study|Physician Decision|1|||
126608764|NCT04577651|455525786|FG000|Overall Study|Withdrawal by Subject|3|||
126608765|NCT00647387|455525787|FG000|Overall Study|Lost to Follow-up|6|||
126608766|NCT00647387|455525787|FG000|Overall Study|Unsuccessful implant|5|||
126608767|NCT00647387|455525787|FG000|Overall Study|Device explanted|3|||
126608768|NCT00647387|455525787|FG000|Overall Study|Other Reason|3|||
126608769|NCT00647387|455525787|FG000|Overall Study|Death|2|||
126608770|NCT04172675|455527295|FG000|Overall Study|Withdrawal by Subject|7|||
126608771|NCT04172675|455527296|FG001|Overall Study|Withdrawal by Subject|5|||
126608772|NCT04172675|455527297|FG002|Overall Study|Withdrawal by Subject|1|||
126608773|NCT04172675|455527298|FG003|Overall Study|Withdrawal by Subject|4|||
126608774|NCT03945773|455527299|FG000|Overall Study|Consent Withdrawn|1|||
126608775|NCT03945773|455527300|FG001|Overall Study|Consent Withdrawn|1|||
126608776|NCT03945773|455527299|FG000|Overall Study|Lost to Follow-up|1|||
126608777|NCT03945773|455527300|FG001|Overall Study|Lost to Follow-up|0|||
126608778|NCT03945773|455527299|FG000|Overall Study|Death|46|||
126608779|NCT03945773|455527300|FG001|Overall Study|Death|22|||
126608780|NCT03945773|455527299|FG000|Overall Study|Physician Decision|1|||
126608781|NCT03945773|455527300|FG001|Overall Study|Physician Decision|0|||
126608782|NCT03945773|455527299|FG000|Overall Study|Other|1|||
126608783|NCT03945773|455527300|FG001|Overall Study|Other|0|||
126608784|NCT03945773|455527299|FG000|Overall Study|Ongoing at the time of DCO|4|||
126608785|NCT03945773|455527300|FG001|Overall Study|Ongoing at the time of DCO|3|||
126608786|NCT02972034|455527301|FG000|Overall Study|Death|11|||
126608787|NCT02972034|455527302|FG001|Overall Study|Death|1|||
126608788|NCT02972034|455527303|FG002|Overall Study|Death|3|||
126608789|NCT02972034|455527304|FG003|Overall Study|Death|3|||
126608790|NCT02972034|455527305|FG004|Overall Study|Death|2|||
126608791|NCT02972034|455527306|FG005|Overall Study|Death|2|||
126608792|NCT02972034|455527307|FG006|Overall Study|Death|3|||
126608793|NCT02972034|455527308|FG007|Overall Study|Death|4|||
126608794|NCT02972034|455527309|FG008|Overall Study|Death|8|||
126608795|NCT02972034|455527310|FG009|Overall Study|Death|11|||
126608796|NCT02972034|455527311|FG010|Overall Study|Death|3|||
126608797|NCT02972034|455527312|FG011|Overall Study|Death|2|||
126608798|NCT02972034|455527313|FG012|Overall Study|Death|11|||
126608799|NCT02972034|455527314|FG013|Overall Study|Death|10|||
126608800|NCT02972034|455527315|FG014|Overall Study|Death|9|||
126608801|NCT02972034|455527301|FG000|Overall Study|Lost to Follow-up|0|||
126608802|NCT02972034|455527302|FG001|Overall Study|Lost to Follow-up|0|||
126608803|NCT02972034|455527303|FG002|Overall Study|Lost to Follow-up|0|||
126608804|NCT02972034|455527304|FG003|Overall Study|Lost to Follow-up|0|||
126608805|NCT02972034|455527305|FG004|Overall Study|Lost to Follow-up|1|||
126608806|NCT02972034|455527306|FG005|Overall Study|Lost to Follow-up|0|||
126608807|NCT02972034|455527307|FG006|Overall Study|Lost to Follow-up|0|||
126608808|NCT02972034|455527308|FG007|Overall Study|Lost to Follow-up|1|||
126734060|NCT00367341|455975813|FG001|Overall Study|Protocol Violation|0|||
126608809|NCT02972034|455527309|FG008|Overall Study|Lost to Follow-up|0|||
126608810|NCT02972034|455527310|FG009|Overall Study|Lost to Follow-up|0|||
126608811|NCT02972034|455527311|FG010|Overall Study|Lost to Follow-up|0|||
126608812|NCT02972034|455527312|FG011|Overall Study|Lost to Follow-up|0|||
126608813|NCT02972034|455527313|FG012|Overall Study|Lost to Follow-up|0|||
126608814|NCT02972034|455527314|FG013|Overall Study|Lost to Follow-up|0|||
126608815|NCT02972034|455527315|FG014|Overall Study|Lost to Follow-up|1|||
126608816|NCT02972034|455527301|FG000|Overall Study|Physician Decision|0|||
126608817|NCT02972034|455527302|FG001|Overall Study|Physician Decision|0|||
126608818|NCT02972034|455527303|FG002|Overall Study|Physician Decision|0|||
126608819|NCT02972034|455527304|FG003|Overall Study|Physician Decision|0|||
126734061|NCT03325556|455975814|FG000|Open-label Period|Lack of Response in OL period|70|||
126608820|NCT02972034|455527305|FG004|Overall Study|Physician Decision|0|||
126608821|NCT02972034|455527306|FG005|Overall Study|Physician Decision|0|||
126608822|NCT02972034|455527307|FG006|Overall Study|Physician Decision|0|||
126608823|NCT02972034|455527308|FG007|Overall Study|Physician Decision|1|||
126608824|NCT02972034|455527309|FG008|Overall Study|Physician Decision|0|||
126608825|NCT02972034|455527310|FG009|Overall Study|Physician Decision|0|||
126608826|NCT02972034|455527311|FG010|Overall Study|Physician Decision|1|||
126608827|NCT02972034|455527312|FG011|Overall Study|Physician Decision|0|||
126608828|NCT02972034|455527313|FG012|Overall Study|Physician Decision|0|||
126608829|NCT02972034|455527314|FG013|Overall Study|Physician Decision|0|||
126608830|NCT02972034|455527315|FG014|Overall Study|Physician Decision|0|||
126608831|NCT02972034|455527301|FG000|Overall Study|Sponsor Decision|0|||
126608832|NCT02972034|455527302|FG001|Overall Study|Sponsor Decision|0|||
126608833|NCT02972034|455527303|FG002|Overall Study|Sponsor Decision|0|||
126608834|NCT02972034|455527304|FG003|Overall Study|Sponsor Decision|1|||
126608835|NCT02972034|455527305|FG004|Overall Study|Sponsor Decision|0|||
126608836|NCT02972034|455527306|FG005|Overall Study|Sponsor Decision|0|||
126608837|NCT02972034|455527307|FG006|Overall Study|Sponsor Decision|1|||
126608838|NCT02972034|455527308|FG007|Overall Study|Sponsor Decision|1|||
126608839|NCT02972034|455527309|FG008|Overall Study|Sponsor Decision|1|||
126608840|NCT02972034|455527310|FG009|Overall Study|Sponsor Decision|2|||
126608841|NCT02972034|455527311|FG010|Overall Study|Sponsor Decision|2|||
126608842|NCT02972034|455527312|FG011|Overall Study|Sponsor Decision|0|||
126608843|NCT02972034|455527313|FG012|Overall Study|Sponsor Decision|1|||
126608844|NCT02972034|455527314|FG013|Overall Study|Sponsor Decision|0|||
126608845|NCT02972034|455527315|FG014|Overall Study|Sponsor Decision|1|||
126608846|NCT02972034|455527301|FG000|Overall Study|Withdrawal by Subject|3|||
126608847|NCT02972034|455527302|FG001|Overall Study|Withdrawal by Subject|0|||
126608848|NCT02972034|455527303|FG002|Overall Study|Withdrawal by Subject|0|||
126608849|NCT02972034|455527304|FG003|Overall Study|Withdrawal by Subject|0|||
126608850|NCT02972034|455527305|FG004|Overall Study|Withdrawal by Subject|1|||
126608851|NCT02972034|455527306|FG005|Overall Study|Withdrawal by Subject|1|||
126608852|NCT02972034|455527307|FG006|Overall Study|Withdrawal by Subject|0|||
126608853|NCT02972034|455527308|FG007|Overall Study|Withdrawal by Subject|0|||
126608854|NCT02972034|455527309|FG008|Overall Study|Withdrawal by Subject|1|||
126608855|NCT02972034|455527310|FG009|Overall Study|Withdrawal by Subject|1|||
126608856|NCT02972034|455527311|FG010|Overall Study|Withdrawal by Subject|2|||
126608857|NCT02972034|455527312|FG011|Overall Study|Withdrawal by Subject|1|||
126608858|NCT02972034|455527313|FG012|Overall Study|Withdrawal by Subject|1|||
126608859|NCT02972034|455527314|FG013|Overall Study|Withdrawal by Subject|1|||
126608860|NCT02972034|455527315|FG014|Overall Study|Withdrawal by Subject|0|||
126608861|NCT02972034|455527301|FG000|Overall Study|Screen Failure|0|||
126608862|NCT02972034|455527302|FG001|Overall Study|Screen Failure|0|||
126608863|NCT02972034|455527303|FG002|Overall Study|Screen Failure|0|||
126608864|NCT02972034|455527304|FG003|Overall Study|Screen Failure|0|||
126608865|NCT02972034|455527305|FG004|Overall Study|Screen Failure|0|||
126608866|NCT02972034|455527306|FG005|Overall Study|Screen Failure|0|||
126608867|NCT02972034|455527307|FG006|Overall Study|Screen Failure|0|||
126608868|NCT02972034|455527308|FG007|Overall Study|Screen Failure|0|||
126608869|NCT02972034|455527309|FG008|Overall Study|Screen Failure|0|||
126608870|NCT02972034|455527310|FG009|Overall Study|Screen Failure|0|||
126608871|NCT02972034|455527311|FG010|Overall Study|Screen Failure|0|||
126608872|NCT02972034|455527312|FG011|Overall Study|Screen Failure|0|||
126608873|NCT02972034|455527313|FG012|Overall Study|Screen Failure|1|||
126608874|NCT02972034|455527314|FG013|Overall Study|Screen Failure|0|||
126608875|NCT02972034|455527315|FG014|Overall Study|Screen Failure|0|||
126608876|NCT03861052|455527316|FG000|Overall Study|Adverse Event|1|||
126608877|NCT03861052|455527317|FG001|Overall Study|Adverse Event|1|||
126608878|NCT03861052|455527318|FG002|Overall Study|Adverse Event|2|||
126608879|NCT03861052|455527319|FG003|Overall Study|Adverse Event|4|||
126608880|NCT03861052|455527316|FG000|Overall Study|Lost to Follow-up|0|||
126608881|NCT03861052|455527317|FG001|Overall Study|Lost to Follow-up|0|||
126608882|NCT03861052|455527318|FG002|Overall Study|Lost to Follow-up|0|||
126608883|NCT03861052|455527319|FG003|Overall Study|Lost to Follow-up|1|||
126608884|NCT03861052|455527316|FG000|Overall Study|Physician Decision|0|||
126608885|NCT03861052|455527317|FG001|Overall Study|Physician Decision|1|||
126608886|NCT03861052|455527318|FG002|Overall Study|Physician Decision|0|||
126781199|NCT01464827|456154487|FG010|Overall Study|Lost to Follow-up|0|||
126608887|NCT03861052|455527319|FG003|Overall Study|Physician Decision|0|||
126608888|NCT03861052|455527316|FG000|Overall Study|Withdrawal by Subject|2|||
126608889|NCT03861052|455527317|FG001|Overall Study|Withdrawal by Subject|5|||
126608890|NCT03861052|455527318|FG002|Overall Study|Withdrawal by Subject|3|||
126608891|NCT03861052|455527319|FG003|Overall Study|Withdrawal by Subject|0|||
126608892|NCT03861052|455527316|FG000|Overall Study|Relocation to other city|1|||
126608893|NCT03861052|455527317|FG001|Overall Study|Relocation to other city|0|||
126608894|NCT03861052|455527318|FG002|Overall Study|Relocation to other city|0|||
126608895|NCT03861052|455527319|FG003|Overall Study|Relocation to other city|0|||
126608896|NCT01970878|455527321|FG000|Overall Study|Withdrawal by Subject|11|||
126608897|NCT01970878|455527322|FG001|Overall Study|Withdrawal by Subject|10|||
126608898|NCT01970878|455527323|FG002|Overall Study|Withdrawal by Subject|14|||
126608899|NCT01970878|455527324|FG003|Overall Study|Withdrawal by Subject|7|||
126608900|NCT01970878|455527321|FG000|Overall Study|Lost to Follow-up|1|||
126608901|NCT01970878|455527322|FG001|Overall Study|Lost to Follow-up|3|||
126608902|NCT01970878|455527323|FG002|Overall Study|Lost to Follow-up|2|||
126608903|NCT01970878|455527324|FG003|Overall Study|Lost to Follow-up|4|||
126608904|NCT01970878|455527321|FG000|Overall Study|Administrative Reasons|1|||
126608905|NCT01970878|455527322|FG001|Overall Study|Administrative Reasons|0|||
126608906|NCT01970878|455527323|FG002|Overall Study|Administrative Reasons|0|||
126608907|NCT01970878|455527324|FG003|Overall Study|Administrative Reasons|4|||
126608908|NCT01970878|455527321|FG000|Overall Study|Lack of Efficacy|2|||
126608909|NCT01970878|455527322|FG001|Overall Study|Lack of Efficacy|1|||
126608910|NCT01970878|455527323|FG002|Overall Study|Lack of Efficacy|2|||
126608911|NCT01970878|455527324|FG003|Overall Study|Lack of Efficacy|0|||
126608912|NCT01970878|455527321|FG000|Overall Study|Adverse Event|12|||
126608913|NCT01970878|455527322|FG001|Overall Study|Adverse Event|7|||
126608914|NCT01970878|455527323|FG002|Overall Study|Adverse Event|4|||
126608915|NCT01970878|455527324|FG003|Overall Study|Adverse Event|3|||
126608916|NCT01970878|455527321|FG000|Overall Study|Protocol Specified Criteria|10|||
126608917|NCT01970878|455527322|FG001|Overall Study|Protocol Specified Criteria|4|||
126608918|NCT01970878|455527323|FG002|Overall Study|Protocol Specified Criteria|3|||
126608919|NCT01970878|455527324|FG003|Overall Study|Protocol Specified Criteria|6|||
126608920|NCT01970878|455527321|FG000|Overall Study|Physician Decision|0|||
126608921|NCT01970878|455527322|FG001|Overall Study|Physician Decision|1|||
126608922|NCT01970878|455527323|FG002|Overall Study|Physician Decision|1|||
126608923|NCT01970878|455527324|FG003|Overall Study|Physician Decision|0|||
126608924|NCT01970878|455527321|FG000|Overall Study|No Completion Status|0|||
126608925|NCT01970878|455527322|FG001|Overall Study|No Completion Status|1|||
126608926|NCT01970878|455527323|FG002|Overall Study|No Completion Status|0|||
126608927|NCT01970878|455527324|FG003|Overall Study|No Completion Status|0|||
126608928|NCT02278796|455527325|FG000|Overall Study|Death|2|||
126608929|NCT02278796|455527326|FG001|Overall Study|Death|3|||
126608930|NCT00345046|455527331|FG000|Overall Study|Protocol Violation|1|||
126608931|NCT00345046|455527332|FG001|Overall Study|Protocol Violation|1|||
126608932|NCT00345046|455527333|FG002|Overall Study|Protocol Violation|2|||
126608933|NCT02824198|455527334|FG000|Overall Study|Non-compliance with the protocol|5|||
126608934|NCT02824198|455527335|FG001|Overall Study|Non-compliance with the protocol|1|||
126608935|NCT02824198|455527334|FG000|Overall Study|Lost to Follow-up|5|||
126608936|NCT02824198|455527335|FG001|Overall Study|Lost to Follow-up|2|||
126608937|NCT02824198|455527334|FG000|Overall Study|Withdrawal by Subject|5|||
126608938|NCT02824198|455527335|FG001|Overall Study|Withdrawal by Subject|0|||
126608939|NCT01613417|455527336|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
126608940|NCT01613417|455527337|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
126608941|NCT00512252|455527338|FG000|Overall Study|Lost to Follow-up|0|||
126608942|NCT00512252|455527339|FG001|Overall Study|Lost to Follow-up|0|||
126608943|NCT00512252|455527340|FG002|Overall Study|Lost to Follow-up|1|||
126608944|NCT00512252|455527338|FG000|Overall Study|Protocol Violation|0|||
126608945|NCT00512252|455527339|FG001|Overall Study|Protocol Violation|0|||
126608946|NCT00512252|455527340|FG002|Overall Study|Protocol Violation|1|||
126608947|NCT00512252|455527338|FG000|Overall Study|Death|0|||
126608948|NCT00512252|455527339|FG001|Overall Study|Death|0|||
126608949|NCT00512252|455527340|FG002|Overall Study|Death|1|||
126608950|NCT01079806|455527343|FG000|Day 1 to Week 96|Adverse Event|0|||
126608951|NCT01079806|455527344|FG001|Day 1 to Week 96|Adverse Event|3|||
126608952|NCT01079806|455527343|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
126608953|NCT01079806|455527344|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
126608954|NCT01079806|455527343|FG000|Day 1 to Week 96|Pregnancy|0|||
126608955|NCT01079806|455527344|FG001|Day 1 to Week 96|Pregnancy|1|||
126608956|NCT01079806|455527343|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
126608957|NCT01079806|455527344|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
126608958|NCT01079806|455527343|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
126608959|NCT01079806|455527344|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
126608960|NCT01079806|455527343|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
126608961|NCT01079806|455527344|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
126608962|NCT01079806|455527343|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
126608963|NCT01079806|455527344|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
126608964|NCT01079806|455527343|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
126608965|NCT01079806|455527344|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
126608966|NCT01079806|455527343|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
126608967|NCT01079806|455527344|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
126608968|NCT01079806|455527343|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
126608969|NCT01079806|455527344|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
126608970|NCT01779700|455527345|FG000|Overall Study|Adverse Event|4|||
126608971|NCT01779700|455527346|FG001|Overall Study|Adverse Event|3|||
126608972|NCT01779700|455527345|FG000|Overall Study|Withdrawal by Subject|0|||
126608973|NCT01779700|455527346|FG001|Overall Study|Withdrawal by Subject|2|||
126608974|NCT00019604|455527347|FG000|Overall Study|Death|1|||
126608975|NCT00019604|455527347|FG000|Overall Study|Progressive disease|23|||
126608976|NCT00019604|455527347|FG000|Overall Study|Refused treatment|1|||
126608977|NCT00019604|455527347|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
126608978|NCT00019604|455527347|FG000|Overall Study|Going to have liver transplant|1|||
126608979|NCT00019604|455527347|FG000|Overall Study|Move to a different study|1|||
126608980|NCT00019604|455527347|FG000|Overall Study|Non compliant on systemic CH|1|||
126608981|NCT00019604|455527347|FG000|Overall Study|Non compliant|1|||
126608982|NCT00019604|455527347|FG000|Overall Study|Resectable disease|1|||
126608983|NCT00019604|455527347|FG000|Overall Study|Started new chemo regimen|1|||
126608984|NCT00019604|455527347|FG000|Overall Study|Pt going to immunotherapy study|1|||
126608985|NCT00019604|455527347|FG000|Overall Study|Too much disease|1|||
126608986|NCT00019604|455527347|FG000|Overall Study|Unable to evaluate|1|||
126608987|NCT00019604|455527347|FG000|Overall Study|Details for other not available|4|||
126608988|NCT04608409|455527348|FG000|Overall Study|Physician Decision|1|||
126608989|NCT04608409|455527349|FG001|Overall Study|Physician Decision|1|||
126608990|NCT04608409|455527350|FG002|Overall Study|Physician Decision|2|||
126608991|NCT00599196|455527351|FG000|Overall Study|Lack of Efficacy|22|||
126608992|NCT00599196|455527351|FG000|Overall Study|Adverse Event|93|||
126608993|NCT00599196|455527351|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
126608994|NCT00599196|455527351|FG000|Overall Study|Subject withdrew consent|43|||
126608995|NCT00599196|455527351|FG000|Overall Study|Study ended per sponsor|197|||
126608996|NCT00599196|455527351|FG000|Overall Study|Lost to Follow-up|17|||
126608997|NCT00599196|455527351|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
126608998|NCT00599196|455527351|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
126608999|NCT00599196|455527351|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
126609000|NCT00599196|455527351|FG000|Overall Study|Other: Pt Moved To Australia|1|||
126609001|NCT00599196|455527351|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
126609002|NCT00599196|455527351|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
126609003|NCT04497415|455527369|FG000|Overall Study|Lost to Follow-up|43|||
126609004|NCT04497415|455527370|FG001|Overall Study|Lost to Follow-up|27|||
126609005|NCT00734578|455527373|FG000|Overall Study|Adverse Event|4|||
126609006|NCT00734578|455527374|FG001|Overall Study|Adverse Event|6|||
126609007|NCT00734578|455527375|FG002|Overall Study|Adverse Event|1|||
126609008|NCT00734578|455527373|FG000|Overall Study|Protocol Violation|8|||
126609009|NCT00734578|455527374|FG001|Overall Study|Protocol Violation|6|||
126609010|NCT00734578|455527375|FG002|Overall Study|Protocol Violation|3|||
126609011|NCT00734578|455527373|FG000|Overall Study|Withdrawal by Subject|7|||
126609012|NCT00734578|455527374|FG001|Overall Study|Withdrawal by Subject|8|||
126609013|NCT00734578|455527375|FG002|Overall Study|Withdrawal by Subject|11|||
126609014|NCT00734578|455527373|FG000|Overall Study|Lost to Follow-up|9|||
126609015|NCT00734578|455527374|FG001|Overall Study|Lost to Follow-up|3|||
126609016|NCT00734578|455527375|FG002|Overall Study|Lost to Follow-up|5|||
126609017|NCT00734578|455527373|FG000|Overall Study|Lack of Efficacy|3|||
126609018|NCT00734578|455527374|FG001|Overall Study|Lack of Efficacy|2|||
126609019|NCT00734578|455527375|FG002|Overall Study|Lack of Efficacy|5|||
126609020|NCT00734578|455527373|FG000|Overall Study|Randomized in error|1|||
126609021|NCT00734578|455527374|FG001|Overall Study|Randomized in error|0|||
126609022|NCT00734578|455527375|FG002|Overall Study|Randomized in error|0|||
126609023|NCT00734578|455527373|FG000|Overall Study|Exclusion criteria|1|||
126609024|NCT00734578|455527374|FG001|Overall Study|Exclusion criteria|0|||
126609025|NCT00734578|455527375|FG002|Overall Study|Exclusion criteria|0|||
126609026|NCT02085941|455527379|FG000|Overall Study|Lack of Efficacy|1|||
126609027|NCT02085941|455527380|FG001|Overall Study|Lack of Efficacy|0|||
126609028|NCT02085941|455527379|FG000|Overall Study|Death|6|||
126609029|NCT02085941|455527380|FG001|Overall Study|Death|1|||
126609030|NCT02085941|455527379|FG000|Overall Study|Lost to Follow-up|1|||
126609031|NCT02085941|455527380|FG001|Overall Study|Lost to Follow-up|0|||
126609032|NCT02085941|455527379|FG000|Overall Study|Physician Decision|0|||
126609033|NCT02085941|455527380|FG001|Overall Study|Physician Decision|2|||
126609034|NCT04652726|455527386|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
126609035|NCT04652726|455527387|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
126609036|NCT04652726|455527388|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
126609037|NCT04652726|455527386|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
126609038|NCT04652726|455527387|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
126609039|NCT04652726|455527388|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
126609040|NCT02157116|455527389|FG000|Overall Study|Withdrawal by Subject|4|||
126609041|NCT02157116|455527389|FG000|Overall Study|Physician Decision|3|||
126609042|NCT02157116|455527389|FG000|Overall Study|Failed Screening|2|||
126609043|NCT00093496|455527390|FG000|Overall Study|Protocol Violation|1|||
126609044|NCT00093496|455527391|FG001|Overall Study|Protocol Violation|3|||
126609045|NCT03274076|455527393|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
126609046|NCT03274076|455527394|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
126609047|NCT03274076|455527395|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
126609048|NCT03274076|455527396|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
126609049|NCT03274076|455527393|FG000|24 Weeks Open Label|Adverse Event|0|||
126609050|NCT03274076|455527394|FG001|24 Weeks Open Label|Adverse Event|0|||
126609051|NCT03274076|455527395|FG002|24 Weeks Open Label|Adverse Event|2|||
126609052|NCT03274076|455527396|FG003|24 Weeks Open Label|Adverse Event|0|||
126781200|NCT01464827|456154488|FG011|Overall Study|Lost to Follow-up|1|||
126781201|NCT01464827|456154489|FG012|Overall Study|Lost to Follow-up|0|||
126609053|NCT03274076|455527393|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
126609054|NCT03274076|455527394|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
126781202|NCT01464827|456154490|FG013|Overall Study|Lost to Follow-up|1|||
126609055|NCT03274076|455527395|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
126609056|NCT03274076|455527396|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
126609057|NCT00975585|455527397|FG000|Overall Study|Adverse Event|0|||
126609058|NCT00975585|455527398|FG001|Overall Study|Adverse Event|4|||
126609059|NCT00975585|455527397|FG000|Overall Study|Lost to Follow-up|3|||
126609060|NCT00975585|455527398|FG001|Overall Study|Lost to Follow-up|5|||
126609061|NCT00975585|455527397|FG000|Overall Study|Withdrawal by Subject|2|||
126609062|NCT00975585|455527398|FG001|Overall Study|Withdrawal by Subject|1|||
126609063|NCT00975585|455527397|FG000|Overall Study|Lens issue|2|||
126609064|NCT00975585|455527398|FG001|Overall Study|Lens issue|2|||
126609065|NCT00795184|455527399|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
126609066|NCT00795184|455527400|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
126609067|NCT00683800|455527401|FG000|Overall Study|Adverse Event|195|||
126609068|NCT00683800|455527402|FG001|Overall Study|Adverse Event|102|||
126609069|NCT00683800|455527401|FG000|Overall Study|Death|0|||
126609070|NCT00683800|455527402|FG001|Overall Study|Death|1|||
126609071|NCT00683800|455527401|FG000|Overall Study|Lost to Follow-up|57|||
126609072|NCT00683800|455527402|FG001|Overall Study|Lost to Follow-up|44|||
126609073|NCT00683800|455527401|FG000|Overall Study|Other|5|||
126609074|NCT00683800|455527402|FG001|Overall Study|Other|2|||
126609075|NCT00683800|455527401|FG000|Overall Study|Protocol Violation|13|||
126609076|NCT00683800|455527402|FG001|Overall Study|Protocol Violation|16|||
126609077|NCT00683800|455527401|FG000|Overall Study|Withdrawal by Subject|66|||
126609078|NCT00683800|455527402|FG001|Overall Study|Withdrawal by Subject|64|||
126609079|NCT00683800|455527401|FG000|Overall Study|Lack of Efficacy|61|||
126609080|NCT00683800|455527402|FG001|Overall Study|Lack of Efficacy|104|||
126609081|NCT00683800|455527401|FG000|Overall Study|Randomized, not treated|35|||
126609082|NCT00683800|455527402|FG001|Overall Study|Randomized, not treated|33|||
126609083|NCT00205179|455527405|FG000|Overall Study|Death|0|||
126609084|NCT00205179|455527406|FG001|Overall Study|Death|2|||
126609085|NCT00205179|455527405|FG000|Overall Study|Physician Decision|1|||
126609086|NCT00205179|455527406|FG001|Overall Study|Physician Decision|1|||
126609087|NCT00205179|455527405|FG000|Overall Study|Adverse Event|1|||
126609088|NCT00205179|455527406|FG001|Overall Study|Adverse Event|1|||
126609089|NCT02079649|455527409|FG000|Overall Study|Lost to Follow-up|0|||
126609090|NCT02079649|455527410|FG001|Overall Study|Lost to Follow-up|0|||
126609091|NCT02079649|455527411|FG002|Overall Study|Lost to Follow-up|0|||
126609092|NCT02079649|455527412|FG003|Overall Study|Lost to Follow-up|1|||
126609093|NCT02079649|455527409|FG000|Overall Study|Withdrawal by Subject|0|||
126609094|NCT02079649|455527410|FG001|Overall Study|Withdrawal by Subject|0|||
126609095|NCT02079649|455527411|FG002|Overall Study|Withdrawal by Subject|0|||
126609096|NCT02079649|455527412|FG003|Overall Study|Withdrawal by Subject|1|||
126609097|NCT02079649|455527409|FG000|Overall Study|Randomization error (prior to treatment)|1|||
126609098|NCT02079649|455527410|FG001|Overall Study|Randomization error (prior to treatment)|0|||
126609099|NCT02079649|455527411|FG002|Overall Study|Randomization error (prior to treatment)|1|||
126609100|NCT02079649|455527412|FG003|Overall Study|Randomization error (prior to treatment)|0|||
126609101|NCT01700205|455527416|FG000|Overall Study|Withdrawal by Subject|13|||
126609102|NCT01700205|455527417|FG001|Overall Study|Withdrawal by Subject|13|||
126609103|NCT01700205|455527416|FG000|Overall Study|Protocol Violation|2|||
126609104|NCT01700205|455527417|FG001|Overall Study|Protocol Violation|2|||
126609105|NCT01170208|455527418|FG000|Overall Study|Withdrawal by Subject|5|||
126609106|NCT01170208|455527419|FG001|Overall Study|Withdrawal by Subject|0|||
126609107|NCT01170208|455527420|FG002|Overall Study|Withdrawal by Subject|1|||
126609108|NCT01170208|455527418|FG000|Overall Study|Protocol Violation|1|||
126609109|NCT01170208|455527419|FG001|Overall Study|Protocol Violation|0|||
126609110|NCT01170208|455527420|FG002|Overall Study|Protocol Violation|1|||
126609111|NCT02251652|455527428|FG000|Overall Study|Withdrawal by Subject|1|||
126781203|NCT01464827|456154477|FG000|Overall Study|Other|2|||
126609112|NCT01160354|455527436|FG000|Overall Study|Death|0|||
126609113|NCT01160354|455527437|FG001|Overall Study|Death|1|||
126609114|NCT01160354|455527438|FG002|Overall Study|Death|1|||
126609115|NCT00983294|455527443|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
126609116|NCT00983294|455527443|FG000|Colchicine With Azithromycin|Adverse Event|1|||
126609117|NCT00853593|455527444|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
126781204|NCT01464827|456154478|FG001|Overall Study|Other|3|||
126781205|NCT01464827|456154479|FG002|Overall Study|Other|0|||
126609118|NCT00853593|455527444|FG000|Overall Study|Model 4396 lead not attempted|29|||
126609119|NCT00853593|455527444|FG000|Overall Study|Implant not attempted|4|||
126609120|NCT00600353|455527450|FG000|Overall Study|history of malignancy within 5 years|1|||
126609121|NCT00600353|455527451|FG001|Overall Study|history of malignancy within 5 years|0|||
126609122|NCT00600353|455527450|FG000|Overall Study|History of prepartive regimen|0|||
126609123|NCT00600353|455527451|FG001|Overall Study|History of prepartive regimen|1|||
126609124|NCT05966155|455527453|FG000|Overall Study|Death|1|||
126609125|NCT05966155|455527454|FG001|Overall Study|Death|2|||
126609126|NCT05966155|455527453|FG000|Overall Study|Lost to Follow-up|63|||
126609127|NCT05966155|455527454|FG001|Overall Study|Lost to Follow-up|67|||
126609128|NCT05966155|455527453|FG000|Overall Study|Protocol Violation|1|||
126609129|NCT05966155|455527454|FG001|Overall Study|Protocol Violation|0|||
126609130|NCT05966155|455527453|FG000|Overall Study|Withdrawal by Subject|8|||
126609131|NCT05966155|455527454|FG001|Overall Study|Withdrawal by Subject|9|||
126609132|NCT05966155|455527453|FG000|Overall Study|Enrolled Erroneously|0|||
126609133|NCT05966155|455527454|FG001|Overall Study|Enrolled Erroneously|1|||
126609134|NCT05966155|455527453|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
126609135|NCT05966155|455527454|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
126609136|NCT02743819|455527455|FG000|Overall Study|Lack of Efficacy|5|||
126609137|NCT02743819|455527455|FG000|Overall Study|Death|2|||
126781206|NCT01464827|456154480|FG003|Overall Study|Other|2|||
126781207|NCT01464827|456154481|FG004|Overall Study|Other|3|||
126781208|NCT01464827|456154482|FG005|Overall Study|Other|0|||
126781209|NCT01464827|456154483|FG006|Overall Study|Other|1|||
126781210|NCT01464827|456154484|FG007|Overall Study|Other|0|||
126781211|NCT01464827|456154485|FG008|Overall Study|Other|3|||
126781212|NCT01464827|456154486|FG009|Overall Study|Other|1|||
126781213|NCT01464827|456154487|FG010|Overall Study|Other|2|||
126781214|NCT01464827|456154488|FG011|Overall Study|Other|0|||
126781215|NCT01464827|456154489|FG012|Overall Study|Other|1|||
126781216|NCT01464827|456154490|FG013|Overall Study|Other|0|||
126781217|NCT01464827|456154477|FG000|Overall Study|Not Treated|0|||
126781218|NCT01464827|456154478|FG001|Overall Study|Not Treated|2|||
126781219|NCT01464827|456154479|FG002|Overall Study|Not Treated|0|||
126781220|NCT01464827|456154480|FG003|Overall Study|Not Treated|0|||
126781221|NCT01464827|456154481|FG004|Overall Study|Not Treated|1|||
126781222|NCT01464827|456154482|FG005|Overall Study|Not Treated|0|||
126781223|NCT01464827|456154483|FG006|Overall Study|Not Treated|1|||
126609138|NCT02743819|455527455|FG000|Overall Study|Adverse Event|1|||
126609139|NCT01706159|455527456|FG000|Overall Study|Withdrawal Criteria|2|||
126609140|NCT01706159|455527457|FG001|Overall Study|Withdrawal Criteria|1|||
126609141|NCT01706159|455527456|FG000|Overall Study|Unclassified|6|||
126609142|NCT01706159|455527457|FG001|Overall Study|Unclassified|1|||
126609143|NCT00553332|455527458|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
126781224|NCT01464827|456154484|FG007|Overall Study|Not Treated|0|||
126781225|NCT01464827|456154485|FG008|Overall Study|Not Treated|0|||
126781226|NCT01464827|456154486|FG009|Overall Study|Not Treated|2|||
126781227|NCT01464827|456154487|FG010|Overall Study|Not Treated|0|||
126781228|NCT01464827|456154488|FG011|Overall Study|Not Treated|1|||
126609144|NCT02235298|455527460|FG000|Overall Study|Lost to Follow-up|6|||
126609145|NCT02235298|455527461|FG001|Overall Study|Lost to Follow-up|5|||
126734062|NCT03325556|455975815|FG001|Open-label Period|Lack of Response in OL period|0|||
126734063|NCT03325556|455975816|FG002|Open-label Period|Lack of Response in OL period|0|||
126734064|NCT03325556|455975814|FG000|Open-label Period|Adverse Event|27|||
126609146|NCT02235298|455527460|FG000|Overall Study|Adverse Event|2|||
126609147|NCT02235298|455527461|FG001|Overall Study|Adverse Event|2|||
126609148|NCT02235298|455527460|FG000|Overall Study|Withdrawal by Subject|0|||
126609149|NCT02235298|455527461|FG001|Overall Study|Withdrawal by Subject|1|||
126609150|NCT03683576|455527465|FG000|Overall Study|Withdrawal by Subject|2|||
126609151|NCT03683576|455527466|FG001|Overall Study|Withdrawal by Subject|0|||
126609152|NCT03683576|455527467|FG002|Overall Study|Withdrawal by Subject|8|||
126609153|NCT03683576|455527468|FG003|Overall Study|Withdrawal by Subject|3|||
126609154|NCT03683576|455527465|FG000|Overall Study|Adverse Event|3|||
126734065|NCT03325556|455975815|FG001|Open-label Period|Adverse Event|0|||
126734066|NCT03325556|455975816|FG002|Open-label Period|Adverse Event|0|||
126734067|NCT03325556|455975814|FG000|Open-label Period|Death|1|||
126734068|NCT03325556|455975815|FG001|Open-label Period|Death|0|||
126609155|NCT03683576|455527466|FG001|Overall Study|Adverse Event|0|||
126609156|NCT03683576|455527467|FG002|Overall Study|Adverse Event|0|||
126609157|NCT03683576|455527468|FG003|Overall Study|Adverse Event|4|||
126609158|NCT03683576|455527465|FG000|Overall Study|Lack of Efficacy|1|||
126734069|NCT03325556|455975816|FG002|Open-label Period|Death|0|||
126781229|NCT01464827|456154489|FG012|Overall Study|Not Treated|0|||
126609159|NCT03683576|455527466|FG001|Overall Study|Lack of Efficacy|0|||
126609160|NCT03683576|455527467|FG002|Overall Study|Lack of Efficacy|1|||
126609161|NCT03683576|455527468|FG003|Overall Study|Lack of Efficacy|1|||
126609162|NCT03683576|455527465|FG000|Overall Study|Lost to Follow-up|0|||
126609163|NCT03683576|455527466|FG001|Overall Study|Lost to Follow-up|1|||
126781230|NCT01464827|456154490|FG013|Overall Study|Not Treated|2|||
126781231|NCT00268346|456154491|FG000|Overall Study|Adverse Event|0|||
126781232|NCT00268346|456154492|FG001|Overall Study|Adverse Event|1|||
126781233|NCT00268346|456154491|FG000|Overall Study|Death|0|||
126781234|NCT00268346|456154492|FG001|Overall Study|Death|1|||
126609164|NCT03683576|455527467|FG002|Overall Study|Lost to Follow-up|2|||
126609165|NCT03683576|455527468|FG003|Overall Study|Lost to Follow-up|0|||
126609166|NCT03683576|455527465|FG000|Overall Study|Other, Not Specified|0|||
126734070|NCT03325556|455975814|FG000|Open-label Period|Lost to Follow-up|1|||
126734071|NCT03325556|455975815|FG001|Open-label Period|Lost to Follow-up|0|||
126734072|NCT03325556|455975816|FG002|Open-label Period|Lost to Follow-up|0|||
126781235|NCT00268346|456154491|FG000|Overall Study|Withdrawal by Subject|0|||
126781236|NCT00268346|456154492|FG001|Overall Study|Withdrawal by Subject|1|||
126781237|NCT05487456|456154493|FG000|Overall Study|Withdrawal by Subject|0|||
126781238|NCT05487456|456154494|FG001|Overall Study|Withdrawal by Subject|0|||
126609167|NCT03683576|455527466|FG001|Overall Study|Other, Not Specified|2|||
126609168|NCT03683576|455527467|FG002|Overall Study|Other, Not Specified|0|||
126609169|NCT03683576|455527468|FG003|Overall Study|Other, Not Specified|0|||
126609170|NCT03683576|455527465|FG000|Overall Study|Protocol Violation|0|||
126609171|NCT03683576|455527466|FG001|Overall Study|Protocol Violation|1|||
126609172|NCT03683576|455527467|FG002|Overall Study|Protocol Violation|1|||
126609173|NCT03683576|455527468|FG003|Overall Study|Protocol Violation|0|||
126609174|NCT01827839|455527469|FG000|Overall Study|Adverse Event|1|||
126609175|NCT01827839|455527469|FG000|Overall Study|Consent Withdrawal|2|||
126609176|NCT00491894|455527473|FG000|Overall Study|Adverse Event|14|||
126609177|NCT00491894|455527473|FG000|Overall Study|Withdrawal by Subject|5|||
126609178|NCT00491894|455527473|FG000|Overall Study|Death|3|||
126609179|NCT00491894|455527473|FG000|Overall Study|Lost to Follow-up|3|||
126609180|NCT00491894|455527473|FG000|Overall Study|Lack of Efficacy|2|||
126609181|NCT00491894|455527473|FG000|Overall Study|Other-Failed to meet any criteria|2|||
126609182|NCT00491894|455527473|FG000|Overall Study|Physician Decision|2|||
126609183|NCT00491894|455527473|FG000|Overall Study|Protocol Violation|2|||
126609184|NCT00491894|455527473|FG000|Overall Study|Other-Intake of prohibited medication|1|||
126609185|NCT02969356|455527477|FG000|Overall Study|Adverse Event|7|||
126609186|NCT02969356|455527477|FG000|Overall Study|Consent withdrawn|2|||
126609187|NCT02969356|455527477|FG000|Overall Study|Lost to Follow-up|3|||
126609188|NCT02969356|455527477|FG000|Overall Study|Did not need to be reinjected|6|||
126609189|NCT02969356|455527477|FG000|Overall Study|Personal reasons|5|||
126609190|NCT05349721|455529518|FG000|Part A (24 Weeks)|Adverse Event|9|||
126609191|NCT05349721|455529519|FG001|Part A (24 Weeks)|Adverse Event|2|||
126609192|NCT05349721|455529518|FG000|Part A (24 Weeks)|Death|8|||
126609193|NCT05349721|455529519|FG001|Part A (24 Weeks)|Death|3|||
126609194|NCT05349721|455529518|FG000|Part A (24 Weeks)|Disease Progression|1|||
126609195|NCT05349721|455529519|FG001|Part A (24 Weeks)|Disease Progression|1|||
126609196|NCT05349721|455529518|FG000|Part A (24 Weeks)|Screen Failure|2|||
126609197|NCT05349721|455529519|FG001|Part A (24 Weeks)|Screen Failure|0|||
126609198|NCT05349721|455529518|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
126609199|NCT05349721|455529519|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
126609200|NCT05349721|455529518|FG000|Part A (24 Weeks)|Other Than Specified|5|||
126609201|NCT05349721|455529519|FG001|Part A (24 Weeks)|Other Than Specified|1|||
126609202|NCT05349721|455529518|FG000|Part B (28 Weeks)|Adverse Event|3|||
126609203|NCT05349721|455529519|FG001|Part B (28 Weeks)|Adverse Event|0|||
126609204|NCT05349721|455529518|FG000|Part B (28 Weeks)|Death|21|||
126609205|NCT05349721|455529519|FG001|Part B (28 Weeks)|Death|11|||
126609206|NCT05349721|455529518|FG000|Part B (28 Weeks)|Disease Progression|2|||
126609207|NCT05349721|455529519|FG001|Part B (28 Weeks)|Disease Progression|1|||
126609208|NCT05349721|455529518|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
126609209|NCT05349721|455529519|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
126609210|NCT05349721|455529518|FG000|Part B (28 Weeks)|Physician Decision|1|||
126609211|NCT05349721|455529519|FG001|Part B (28 Weeks)|Physician Decision|0|||
126609212|NCT05349721|455529518|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
126609213|NCT05349721|455529519|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
126609214|NCT05349721|455529518|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
126609215|NCT05349721|455529519|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
126609216|NCT05349721|455529518|FG000|Part B (28 Weeks)|Other Than Specified|4|||
126609217|NCT05349721|455529519|FG001|Part B (28 Weeks)|Other Than Specified|2|||
126609218|NCT05349721|455529518|FG000|Part C (108 Weeks)|Death|0|||
126609219|NCT05349721|455529519|FG001|Part C (108 Weeks)|Death|1|||
126609220|NCT05349721|455529518|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
126609221|NCT05349721|455529519|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
126609222|NCT05349721|455529518|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
126609223|NCT05349721|455529519|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
126609224|NCT05349721|455529518|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
126609225|NCT05349721|455529519|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
126609226|NCT03070392|455529520|FG000|Overall Study|Not Treated|7|||
126609227|NCT03070392|455529521|FG001|Overall Study|Not Treated|0|||
126609228|NCT03070392|455529522|FG002|Overall Study|Not Treated|3|||
126609229|NCT03070392|455529523|FG003|Overall Study|Not Treated|12|||
126609230|NCT03070392|455529520|FG000|Overall Study|Death|3|||
126609231|NCT03070392|455529521|FG001|Overall Study|Death|0|||
126609232|NCT03070392|455529522|FG002|Overall Study|Death|0|||
126609233|NCT03070392|455529523|FG003|Overall Study|Death|1|||
126609234|NCT03070392|455529520|FG000|Overall Study|Withdrawal by Subject|7|||
126609235|NCT03070392|455529521|FG001|Overall Study|Withdrawal by Subject|0|||
126609236|NCT03070392|455529522|FG002|Overall Study|Withdrawal by Subject|0|||
126609237|NCT03070392|455529523|FG003|Overall Study|Withdrawal by Subject|3|||
126609238|NCT03070392|455529520|FG000|Overall Study|Physician Decision|1|||
126609239|NCT03070392|455529521|FG001|Overall Study|Physician Decision|0|||
126609240|NCT03070392|455529522|FG002|Overall Study|Physician Decision|0|||
126609241|NCT03070392|455529523|FG003|Overall Study|Physician Decision|2|||
126609242|NCT03070392|455529520|FG000|Overall Study|Progressive Disease|154|||
126609243|NCT03070392|455529521|FG001|Overall Study|Progressive Disease|6|||
126609244|NCT03070392|455529522|FG002|Overall Study|Progressive Disease|2|||
126609245|NCT03070392|455529523|FG003|Overall Study|Progressive Disease|70|||
126609246|NCT03070392|455529520|FG000|Overall Study|Adverse Event|6|||
126609247|NCT03070392|455529521|FG001|Overall Study|Adverse Event|1|||
126609248|NCT03070392|455529522|FG002|Overall Study|Adverse Event|1|||
126609249|NCT03070392|455529523|FG003|Overall Study|Adverse Event|3|||
126609250|NCT03070392|455529520|FG000|Overall Study|Alternate anticancer treatment|1|||
126609251|NCT03070392|455529521|FG001|Overall Study|Alternate anticancer treatment|0|||
126609252|NCT03070392|455529522|FG002|Overall Study|Alternate anticancer treatment|0|||
126609253|NCT03070392|455529523|FG003|Overall Study|Alternate anticancer treatment|1|||
126609254|NCT03070392|455529520|FG000|Overall Study|Ongoing|73|||
126609255|NCT03070392|455529521|FG001|Overall Study|Ongoing|0|||
126609256|NCT03070392|455529522|FG002|Overall Study|Ongoing|0|||
126609257|NCT03070392|455529523|FG003|Overall Study|Ongoing|11|||
126609258|NCT03823703|455529524|FG000|Overall Study|Sponsor request|0|||
126609259|NCT03823703|455529525|FG001|Overall Study|Sponsor request|3|||
126609260|NCT03823703|455529526|FG002|Overall Study|Sponsor request|4|||
126609261|NCT03823703|455529524|FG000|Overall Study|Adverse Event|3|||
126609262|NCT03823703|455529525|FG001|Overall Study|Adverse Event|1|||
126609263|NCT03823703|455529526|FG002|Overall Study|Adverse Event|0|||
126609264|NCT03823703|455529524|FG000|Overall Study|Withdrawal by Subject|0|||
126609265|NCT03823703|455529525|FG001|Overall Study|Withdrawal by Subject|1|||
126609266|NCT03823703|455529526|FG002|Overall Study|Withdrawal by Subject|0|||
126609267|NCT03137459|455529527|FG000|2-month Assessment|Withdrawal by Subject|13|||
126609268|NCT03137459|455529528|FG001|2-month Assessment|Withdrawal by Subject|3|||
126609269|NCT03137459|455529527|FG000|2-month Assessment|Unable to reach|42|||
126609270|NCT03137459|455529528|FG001|2-month Assessment|Unable to reach|32|||
126609271|NCT03137459|455529527|FG000|2-month Assessment|Refused assessment|7|||
126609272|NCT03137459|455529528|FG001|2-month Assessment|Refused assessment|5|||
126609273|NCT03137459|455529527|FG000|2-month Assessment|Acutely ill|6|||
126609274|NCT03137459|455529528|FG001|2-month Assessment|Acutely ill|2|||
126609275|NCT03137459|455529527|FG000|4-month Assessment|Death|4|||
126609276|NCT03137459|455529528|FG001|4-month Assessment|Death|2|||
126609277|NCT03137459|455529527|FG000|4-month Assessment|Withdrawal by Subject|4|||
126609278|NCT03137459|455529528|FG001|4-month Assessment|Withdrawal by Subject|2|||
126609279|NCT03137459|455529527|FG000|4-month Assessment|Unable to reach|44|||
126609280|NCT03137459|455529528|FG001|4-month Assessment|Unable to reach|29|||
126609281|NCT03137459|455529527|FG000|4-month Assessment|Refused assessment|24|||
126734073|NCT03325556|455975814|FG000|Open-label Period|Non-compliance with study drug|5|||
126609282|NCT03137459|455529528|FG001|4-month Assessment|Refused assessment|10|||
126609283|NCT03137459|455529527|FG000|4-month Assessment|Acutely ill|2|||
126609284|NCT03137459|455529528|FG001|4-month Assessment|Acutely ill|3|||
126609285|NCT03137459|455529527|FG000|6-months|Lost to Follow-up|14|||
126609286|NCT03137459|455529528|FG001|6-months|Lost to Follow-up|11|||
126734074|NCT03325556|455975815|FG001|Open-label Period|Non-compliance with study drug|0|||
126734075|NCT03325556|455975816|FG002|Open-label Period|Non-compliance with study drug|0|||
126734076|NCT03325556|455975814|FG000|Open-label Period|Use of prohibited medication|1|||
126734077|NCT03325556|455975815|FG001|Open-label Period|Use of prohibited medication|0|||
126734078|NCT03325556|455975816|FG002|Open-label Period|Use of prohibited medication|0|||
126734079|NCT03325556|455975814|FG000|Open-label Period|Protocol Violation|4|||
126734080|NCT03325556|455975815|FG001|Open-label Period|Protocol Violation|0|||
126734081|NCT03325556|455975816|FG002|Open-label Period|Protocol Violation|0|||
126734082|NCT03325556|455975814|FG000|Open-label Period|Withdrawal by Subject|17|||
126734083|NCT03325556|455975815|FG001|Open-label Period|Withdrawal by Subject|0|||
126734084|NCT03325556|455975816|FG002|Open-label Period|Withdrawal by Subject|0|||
126734085|NCT03325556|455975814|FG000|Open-label Period|Not otherwise specified|8|||
126734086|NCT03325556|455975815|FG001|Open-label Period|Not otherwise specified|0|||
126734087|NCT03325556|455975816|FG002|Open-label Period|Not otherwise specified|0|||
126734088|NCT03325556|455975814|FG000|Open-label Period|Administrative discont. at study termination|41|||
126734089|NCT03325556|455975815|FG001|Open-label Period|Administrative discont. at study termination|0|||
126734090|NCT03325556|455975816|FG002|Open-label Period|Administrative discont. at study termination|0|||
126734091|NCT03325556|455975814|FG000|Double-blind Period|Relapse|0|||
126734092|NCT03325556|455975815|FG001|Double-blind Period|Relapse|15|||
126734093|NCT03325556|455975816|FG002|Double-blind Period|Relapse|34|||
126734094|NCT03325556|455975814|FG000|Double-blind Period|Adverse Event|0|||
126734095|NCT03325556|455975815|FG001|Double-blind Period|Adverse Event|3|||
126734096|NCT03325556|455975816|FG002|Double-blind Period|Adverse Event|1|||
126734097|NCT03325556|455975814|FG000|Double-blind Period|Noncompliance with study drug|0|||
126734098|NCT03325556|455975815|FG001|Double-blind Period|Noncompliance with study drug|0|||
126734099|NCT03325556|455975816|FG002|Double-blind Period|Noncompliance with study drug|1|||
126609287|NCT03137459|455529527|FG000|6-months|Death|0|||
126609288|NCT03137459|455529528|FG001|6-months|Death|2|||
126609289|NCT03137459|455529527|FG000|6-months|Refused assessment|6|||
126609290|NCT03137459|455529528|FG001|6-months|Refused assessment|3|||
126609291|NCT03137459|455529527|FG000|6-months|Acutely ill|1|||
126609292|NCT03137459|455529528|FG001|6-months|Acutely ill|1|||
126609293|NCT00925548|455529529|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
126609294|NCT00925548|455529530|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
126609295|NCT04921358|455529531|FG000|Overall Study|Withdrawal by Subject|6|||
126609296|NCT04921358|455529532|FG001|Overall Study|Withdrawal by Subject|13|||
126609297|NCT04921358|455529531|FG000|Overall Study|Lost to Follow-up|3|||
126609298|NCT04921358|455529532|FG001|Overall Study|Lost to Follow-up|6|||
126609299|NCT04921358|455529531|FG000|Overall Study|Study Terminated by Sponsor|86|||
126609300|NCT04921358|455529532|FG001|Overall Study|Study Terminated by Sponsor|89|||
126609301|NCT04921358|455529531|FG000|Overall Study|Death|92|||
126609302|NCT04921358|455529532|FG001|Overall Study|Death|82|||
126609303|NCT04926857|455529533|FG000|Overall Study|Withdrawal by Subject|40|||
126609304|NCT04926857|455529533|FG000|Overall Study|Death|9|||
126609305|NCT04926857|455529533|FG000|Overall Study|Study product no longer in use|44|||
126609306|NCT04926857|455529533|FG000|Overall Study|Inadequate data to address primary objective|16|||
126609307|NCT02372799|455529538|FG000|Treatment Period|Adverse Event|3|||
126609308|NCT02372799|455529539|FG001|Treatment Period|Adverse Event|10|||
126609309|NCT02372799|455529540|FG002|Treatment Period|Adverse Event|6|||
126609310|NCT02372799|455529538|FG000|Treatment Period|Insufficient therapeutic response|2|||
126609311|NCT02372799|455529539|FG001|Treatment Period|Insufficient therapeutic response|2|||
126609312|NCT02372799|455529540|FG002|Treatment Period|Insufficient therapeutic response|0|||
126609313|NCT02372799|455529538|FG000|Treatment Period|Withdrawal by Subject|10|||
126609314|NCT02372799|455529539|FG001|Treatment Period|Withdrawal by Subject|10|||
126609315|NCT02372799|455529540|FG002|Treatment Period|Withdrawal by Subject|2|||
126609316|NCT02372799|455529538|FG000|Treatment Period|Lost to Follow-up|11|||
126609317|NCT02372799|455529539|FG001|Treatment Period|Lost to Follow-up|5|||
126609318|NCT02372799|455529540|FG002|Treatment Period|Lost to Follow-up|3|||
126609319|NCT02372799|455529538|FG000|Treatment Period|Protocol Violation|3|||
126609320|NCT02372799|455529539|FG001|Treatment Period|Protocol Violation|0|||
126609321|NCT02372799|455529540|FG002|Treatment Period|Protocol Violation|0|||
126609322|NCT02372799|455529538|FG000|Treatment Period|Non-compliance with study drug|4|||
126609323|NCT02372799|455529539|FG001|Treatment Period|Non-compliance with study drug|4|||
126609324|NCT02372799|455529540|FG002|Treatment Period|Non-compliance with study drug|4|||
126609325|NCT02372799|455529538|FG000|Treatment Period|Miscellaneous Reasons|1|||
126609326|NCT02372799|455529539|FG001|Treatment Period|Miscellaneous Reasons|1|||
126609327|NCT02372799|455529540|FG002|Treatment Period|Miscellaneous Reasons|0|||
126609328|NCT02372799|455529538|FG000|Down-taper Period|Lost to Follow-up|1|||
126609329|NCT02372799|455529539|FG001|Down-taper Period|Lost to Follow-up|2|||
126609330|NCT02372799|455529540|FG002|Down-taper Period|Lost to Follow-up|2|||
126609331|NCT02637063|455529542|FG000|Overall Study|Lost to Follow-up|3|||
126609332|NCT02637063|455529543|FG001|Overall Study|Lost to Follow-up|2|||
126609333|NCT02637063|455529544|FG002|Overall Study|Lost to Follow-up|3|||
126609334|NCT02637063|455529542|FG000|Overall Study|Withdrawal by Subject|2|||
126609335|NCT02637063|455529543|FG001|Overall Study|Withdrawal by Subject|2|||
126609336|NCT02637063|455529544|FG002|Overall Study|Withdrawal by Subject|3|||
126609337|NCT00491400|455529545|FG000|Overall Study|Withdrawal by Subject|5|||
126609338|NCT00491400|455529546|FG001|Overall Study|Withdrawal by Subject|4|||
126609339|NCT00747006|455529547|FG000|Overall Study|Adverse Event|1|||
126609340|NCT00747006|455529548|FG001|Overall Study|Adverse Event|0|||
126609341|NCT00747006|455529549|FG002|Overall Study|Adverse Event|0|||
126609342|NCT00747006|455529547|FG000|Overall Study|Lost to Follow-up|0|||
126609343|NCT00747006|455529548|FG001|Overall Study|Lost to Follow-up|1|||
126609344|NCT00747006|455529549|FG002|Overall Study|Lost to Follow-up|0|||
126609345|NCT00747006|455529547|FG000|Overall Study|Physician Decision|2|||
126609346|NCT00747006|455529548|FG001|Overall Study|Physician Decision|0|||
126609347|NCT00747006|455529549|FG002|Overall Study|Physician Decision|1|||
126609348|NCT00562094|455529550|FG000|Overall Study|Lost to Follow-up|62|||
126609349|NCT03689946|455529553|FG000|Overall Study|Withdrawal by Subject|3|||
126609350|NCT03689946|455529553|FG000|Overall Study|Lost to Follow-up|3|||
126609351|NCT03689946|455529553|FG000|Overall Study|Data corruption|2|||
126609352|NCT01555138|455529554|FG000|Overall Study|Death|0|||
126609353|NCT01555138|455529555|FG001|Overall Study|Death|1|||
126609354|NCT01555138|455529554|FG000|Overall Study|Lost to Follow-up|1|||
126609355|NCT01555138|455529555|FG001|Overall Study|Lost to Follow-up|0|||
126609356|NCT01555138|455529554|FG000|Overall Study|Abnormal Lab reults|1|||
126609357|NCT01555138|455529555|FG001|Overall Study|Abnormal Lab reults|3|||
126609358|NCT01555138|455529554|FG000|Overall Study|Lack of Efficacy|2|||
126609359|NCT01555138|455529555|FG001|Overall Study|Lack of Efficacy|2|||
126609360|NCT01555138|455529554|FG000|Overall Study|Protocol Violation|5|||
126609361|NCT01555138|455529555|FG001|Overall Study|Protocol Violation|3|||
126609362|NCT01555138|455529554|FG000|Overall Study|Administrative problems|8|||
126609363|NCT01555138|455529555|FG001|Overall Study|Administrative problems|0|||
126609364|NCT01555138|455529554|FG000|Overall Study|Withdrawal by Subject|16|||
126609365|NCT01555138|455529555|FG001|Overall Study|Withdrawal by Subject|15|||
126609366|NCT01555138|455529554|FG000|Overall Study|Adverse Event|14|||
126609367|NCT01555138|455529555|FG001|Overall Study|Adverse Event|14|||
126609368|NCT03499964|455529556|FG000|Overall Study|Lack of Efficacy|6|||
126609369|NCT03499964|455529557|FG001|Overall Study|Lack of Efficacy|26|||
126609370|NCT03499964|455529556|FG000|Overall Study|Adverse Event|1|||
126609371|NCT03499964|455529557|FG001|Overall Study|Adverse Event|0|||
126609372|NCT03499964|455529556|FG000|Overall Study|Death|1|||
126609373|NCT03499964|455529557|FG001|Overall Study|Death|0|||
126609374|NCT03499964|455529556|FG000|Overall Study|Withdrawal by Subject|2|||
126609375|NCT03499964|455529557|FG001|Overall Study|Withdrawal by Subject|1|||
126609376|NCT03499964|455529556|FG000|Overall Study|Lost to Follow-up|1|||
126609377|NCT03499964|455529557|FG001|Overall Study|Lost to Follow-up|0|||
126609378|NCT03739866|455529580|FG000|Overall Study|Lost to Follow-up|0|||
126609379|NCT03739866|455529581|FG001|Overall Study|Lost to Follow-up|0|||
126609380|NCT03739866|455529582|FG002|Overall Study|Lost to Follow-up|0|||
126609381|NCT03739866|455529583|FG003|Overall Study|Lost to Follow-up|1|||
126609382|NCT03739866|455529584|FG004|Overall Study|Lost to Follow-up|0|||
126609383|NCT03739866|455529585|FG005|Overall Study|Lost to Follow-up|0|||
126609384|NCT03739866|455529586|FG006|Overall Study|Lost to Follow-up|0|||
126609385|NCT03739866|455529587|FG007|Overall Study|Lost to Follow-up|0|||
126609386|NCT03739866|455529580|FG000|Overall Study|Enrolled but not treated|0|||
126609387|NCT03739866|455529581|FG001|Overall Study|Enrolled but not treated|0|||
126609388|NCT03739866|455529582|FG002|Overall Study|Enrolled but not treated|1|||
126609389|NCT03739866|455529583|FG003|Overall Study|Enrolled but not treated|0|||
126609390|NCT03739866|455529584|FG004|Overall Study|Enrolled but not treated|1|||
126609391|NCT03739866|455529585|FG005|Overall Study|Enrolled but not treated|0|||
126609392|NCT03739866|455529586|FG006|Overall Study|Enrolled but not treated|0|||
126609393|NCT03739866|455529587|FG007|Overall Study|Enrolled but not treated|0|||
126609394|NCT00853580|455529588|FG000|Overall Study|Lost to Follow-up|3|||
126609395|NCT00853580|455529589|FG001|Overall Study|Lost to Follow-up|5|||
126609396|NCT00853580|455529588|FG000|Overall Study|Protocol Violation|2|||
126609397|NCT00853580|455529589|FG001|Overall Study|Protocol Violation|1|||
126609398|NCT00853580|455529588|FG000|Overall Study|Withdrawal by Subject|2|||
126609399|NCT00853580|455529589|FG001|Overall Study|Withdrawal by Subject|8|||
126609400|NCT00853580|455529588|FG000|Overall Study|Commenced contraindicated therapy|0|||
126609401|NCT00853580|455529589|FG001|Overall Study|Commenced contraindicated therapy|2|||
126609402|NCT01728324|455529590|FG000|Termination of DBV|Adverse Event|14|||
126609403|NCT01728324|455529591|FG001|Termination of DBV|Adverse Event|13|||
126609404|NCT01728324|455529592|FG002|Termination of DBV|Adverse Event|4|||
126609405|NCT01728324|455529590|FG000|Termination of DBV|Lack of Efficacy|14|||
126609406|NCT01728324|455529591|FG001|Termination of DBV|Lack of Efficacy|12|||
126609407|NCT01728324|455529592|FG002|Termination of DBV|Lack of Efficacy|8|||
126609408|NCT01728324|455529590|FG000|Termination of DBV|Withdrawal by Subject|9|||
126609409|NCT01728324|455529591|FG001|Termination of DBV|Withdrawal by Subject|6|||
126609410|NCT01728324|455529592|FG002|Termination of DBV|Withdrawal by Subject|2|||
126609411|NCT01728324|455529590|FG000|Termination of DBV|Other than stated|1|||
126609412|NCT01728324|455529591|FG001|Termination of DBV|Other than stated|3|||
126609413|NCT01728324|455529592|FG002|Termination of DBV|Other than stated|0|||
126609414|NCT01728324|455529590|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
126609415|NCT01728324|455529591|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
126609416|NCT01728324|455529592|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
126609417|NCT01728324|455529590|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
126609418|NCT01728324|455529591|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
126609419|NCT01728324|455529592|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
126609420|NCT01728324|455529590|FG000|Termination of FDV|Adverse Event|14|||
126609421|NCT01728324|455529591|FG001|Termination of FDV|Adverse Event|13|||
126609422|NCT01728324|455529592|FG002|Termination of FDV|Adverse Event|4|||
126609423|NCT01728324|455529590|FG000|Termination of FDV|Lack of Efficacy|14|||
126609424|NCT01728324|455529591|FG001|Termination of FDV|Lack of Efficacy|12|||
126609425|NCT01728324|455529592|FG002|Termination of FDV|Lack of Efficacy|8|||
126609426|NCT01728324|455529590|FG000|Termination of FDV|Withdrawal by Subject|9|||
126609427|NCT01728324|455529591|FG001|Termination of FDV|Withdrawal by Subject|6|||
126609428|NCT01728324|455529592|FG002|Termination of FDV|Withdrawal by Subject|2|||
126609429|NCT01728324|455529590|FG000|Termination of FDV|Other than stated|1|||
126609430|NCT01728324|455529591|FG001|Termination of FDV|Other than stated|3|||
126609431|NCT01728324|455529592|FG002|Termination of FDV|Other than stated|0|||
126609432|NCT01728324|455529590|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
126609433|NCT01728324|455529591|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
126609434|NCT01728324|455529592|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
126609435|NCT01728324|455529590|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
126609436|NCT01728324|455529591|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
126609437|NCT01728324|455529592|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
126609438|NCT01728324|455529590|FG000|Termination of RBV|Adverse Event|15|||
126609439|NCT01728324|455529591|FG001|Termination of RBV|Adverse Event|16|||
126609440|NCT01728324|455529592|FG002|Termination of RBV|Adverse Event|5|||
126781239|NCT05487456|456154495|FG002|Overall Study|Withdrawal by Subject|1|||
126609441|NCT01728324|455529590|FG000|Termination of RBV|Lack of Efficacy|14|||
126609442|NCT01728324|455529591|FG001|Termination of RBV|Lack of Efficacy|11|||
126609443|NCT01728324|455529592|FG002|Termination of RBV|Lack of Efficacy|7|||
126609444|NCT01728324|455529590|FG000|Termination of RBV|Withdrawal by Subject|9|||
126609445|NCT01728324|455529591|FG001|Termination of RBV|Withdrawal by Subject|5|||
126609446|NCT01728324|455529592|FG002|Termination of RBV|Withdrawal by Subject|2|||
126609447|NCT01728324|455529590|FG000|Termination of RBV|Other than stated|1|||
126609448|NCT01728324|455529591|FG001|Termination of RBV|Other than stated|3|||
126609449|NCT01728324|455529592|FG002|Termination of RBV|Other than stated|1|||
126609450|NCT01728324|455529590|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
126609451|NCT01728324|455529591|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
126609452|NCT01728324|455529592|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
126609453|NCT01728324|455529590|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
126609454|NCT01728324|455529591|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
126609455|NCT01728324|455529592|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
126609456|NCT03057600|455529595|FG000|Overall Study|Adverse Event|0|||
126609457|NCT03057600|455529596|FG001|Overall Study|Adverse Event|0|||
126609458|NCT03057600|455529597|FG002|Overall Study|Adverse Event|4|||
126609459|NCT03057600|455529598|FG003|Overall Study|Adverse Event|0|||
126609460|NCT03057600|455529595|FG000|Overall Study|Radiologic Disease Progression|8|||
126609461|NCT03057600|455529596|FG001|Overall Study|Radiologic Disease Progression|7|||
126609462|NCT03057600|455529597|FG002|Overall Study|Radiologic Disease Progression|13|||
126609463|NCT03057600|455529598|FG003|Overall Study|Radiologic Disease Progression|10|||
126609464|NCT03057600|455529595|FG000|Overall Study|Symptomatic Deterioration|0|||
126609465|NCT03057600|455529596|FG001|Overall Study|Symptomatic Deterioration|1|||
126609466|NCT03057600|455529597|FG002|Overall Study|Symptomatic Deterioration|1|||
126609467|NCT03057600|455529598|FG003|Overall Study|Symptomatic Deterioration|0|||
126609468|NCT03057600|455529595|FG000|Overall Study|Investigator Decision|0|||
126609469|NCT03057600|455529596|FG001|Overall Study|Investigator Decision|0|||
126609470|NCT03057600|455529597|FG002|Overall Study|Investigator Decision|1|||
126609471|NCT03057600|455529598|FG003|Overall Study|Investigator Decision|0|||
126609472|NCT03057600|455529595|FG000|Overall Study|Study Termination by Sponsor|0|||
126609473|NCT03057600|455529596|FG001|Overall Study|Study Termination by Sponsor|0|||
126609474|NCT03057600|455529597|FG002|Overall Study|Study Termination by Sponsor|0|||
126609475|NCT03057600|455529598|FG003|Overall Study|Study Termination by Sponsor|2|||
126609476|NCT03057600|455529595|FG000|Overall Study|Withdrawal by Subject|0|||
126609477|NCT03057600|455529596|FG001|Overall Study|Withdrawal by Subject|1|||
126609478|NCT03057600|455529597|FG002|Overall Study|Withdrawal by Subject|0|||
126609479|NCT03057600|455529598|FG003|Overall Study|Withdrawal by Subject|0|||
126609480|NCT03057600|455529595|FG000|Overall Study|Other, Not Specified|1|||
126609481|NCT03057600|455529596|FG001|Overall Study|Other, Not Specified|1|||
126609482|NCT03057600|455529597|FG002|Overall Study|Other, Not Specified|1|||
126609483|NCT03057600|455529598|FG003|Overall Study|Other, Not Specified|1|||
126609484|NCT01968967|455529599|FG000|Treatment Period|Other|22|||
126609485|NCT01968967|455529600|FG001|Treatment Period|Other|22|||
126609486|NCT01968967|455529601|FG002|Treatment Period|Other|0|||
126609487|NCT01968967|455529602|FG003|Treatment Period|Other|0|||
126609488|NCT01968967|455529603|FG004|Treatment Period|Other|0|||
126609489|NCT01968967|455529599|FG000|Treatment Period|Withdrawal by Subject|71|||
126609490|NCT01968967|455529600|FG001|Treatment Period|Withdrawal by Subject|61|||
126609491|NCT01968967|455529601|FG002|Treatment Period|Withdrawal by Subject|0|||
126609492|NCT01968967|455529602|FG003|Treatment Period|Withdrawal by Subject|0|||
126609493|NCT01968967|455529603|FG004|Treatment Period|Withdrawal by Subject|0|||
126609494|NCT01968967|455529599|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
126609495|NCT01968967|455529600|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
126609496|NCT01968967|455529601|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
126609497|NCT01968967|455529602|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
126609498|NCT01968967|455529603|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
126609499|NCT01968967|455529599|FG000|Treatment Period|Lost to Follow-up|26|||
126609500|NCT01968967|455529600|FG001|Treatment Period|Lost to Follow-up|31|||
126609501|NCT01968967|455529601|FG002|Treatment Period|Lost to Follow-up|0|||
126609502|NCT01968967|455529602|FG003|Treatment Period|Lost to Follow-up|0|||
126609503|NCT01968967|455529603|FG004|Treatment Period|Lost to Follow-up|0|||
126609504|NCT01968967|455529599|FG000|Treatment Period|Protocol Violation|1|||
126609505|NCT01968967|455529600|FG001|Treatment Period|Protocol Violation|2|||
126609506|NCT01968967|455529601|FG002|Treatment Period|Protocol Violation|0|||
126609507|NCT01968967|455529602|FG003|Treatment Period|Protocol Violation|0|||
126609508|NCT01968967|455529603|FG004|Treatment Period|Protocol Violation|0|||
126609509|NCT01968967|455529599|FG000|Treatment Period|Adverse Event|9|||
126609510|NCT01968967|455529600|FG001|Treatment Period|Adverse Event|8|||
126609511|NCT01968967|455529601|FG002|Treatment Period|Adverse Event|0|||
126609512|NCT01968967|455529602|FG003|Treatment Period|Adverse Event|0|||
126609513|NCT01968967|455529603|FG004|Treatment Period|Adverse Event|0|||
126609514|NCT01968967|455529599|FG000|Treatment Period|Death|9|||
126609515|NCT01968967|455529600|FG001|Treatment Period|Death|2|||
126609516|NCT01968967|455529601|FG002|Treatment Period|Death|0|||
126609517|NCT01968967|455529602|FG003|Treatment Period|Death|0|||
126609518|NCT01968967|455529603|FG004|Treatment Period|Death|0|||
126609519|NCT01968967|455529599|FG000|Treatment Period|Randomized Not Treated|6|||
126609520|NCT01968967|455529600|FG001|Treatment Period|Randomized Not Treated|5|||
126609521|NCT01968967|455529601|FG002|Treatment Period|Randomized Not Treated|0|||
126609522|NCT01968967|455529602|FG003|Treatment Period|Randomized Not Treated|0|||
126609523|NCT01968967|455529603|FG004|Treatment Period|Randomized Not Treated|0|||
126609524|NCT01968967|455529599|FG000|Extension Period|Withdrew Consent|0|||
126609525|NCT01968967|455529600|FG001|Extension Period|Withdrew Consent|0|||
126609526|NCT01968967|455529601|FG002|Extension Period|Withdrew Consent|2|||
126609527|NCT01968967|455529602|FG003|Extension Period|Withdrew Consent|0|||
126609528|NCT01968967|455529603|FG004|Extension Period|Withdrew Consent|5|||
126609529|NCT03335488|455529604|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
126609530|NCT03335488|455529605|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
126609531|NCT03335488|455529604|FG000|Safety Extension Period|Adverse Event|1|||
126609532|NCT03335488|455529605|FG001|Safety Extension Period|Adverse Event|0|||
126609533|NCT03335488|455529604|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
126609534|NCT03335488|455529605|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
126609535|NCT00388726|455529606|FG000|Overall Study|Adverse Event|50|||
126609536|NCT00388726|455529607|FG001|Overall Study|Adverse Event|24|||
126609537|NCT00388726|455529606|FG000|Overall Study|Progressive Disease|336|||
126609538|NCT00388726|455529607|FG001|Overall Study|Progressive Disease|153|||
126609539|NCT00388726|455529606|FG000|Overall Study|Clinical Progression|61|||
126609540|NCT00388726|455529607|FG001|Overall Study|Clinical Progression|36|||
126609541|NCT00388726|455529606|FG000|Overall Study|Withdrawal by Subject|10|||
126609542|NCT00388726|455529607|FG001|Overall Study|Withdrawal by Subject|7|||
126609543|NCT00388726|455529606|FG000|Overall Study|Administrative|6|||
126609544|NCT00388726|455529607|FG001|Overall Study|Administrative|9|||
126609545|NCT00388726|455529606|FG000|Overall Study|Physician Decision|18|||
126609546|NCT00388726|455529607|FG001|Overall Study|Physician Decision|13|||
126609547|NCT00388726|455529606|FG000|Overall Study|Death|3|||
126609548|NCT00388726|455529607|FG001|Overall Study|Death|2|||
126609549|NCT01953692|455529608|FG000|Overall Study|Adverse Event|5|||
126609550|NCT01953692|455529609|FG001|Overall Study|Adverse Event|2|||
126609551|NCT01953692|455529610|FG002|Overall Study|Adverse Event|4|||
126609552|NCT01953692|455529611|FG003|Overall Study|Adverse Event|2|||
126609553|NCT01953692|455529612|FG004|Overall Study|Adverse Event|1|||
126609554|NCT01953692|455529613|FG005|Overall Study|Adverse Event|2|||
126609555|NCT01953692|455529614|FG006|Overall Study|Adverse Event|0|||
126609556|NCT01953692|455529615|FG007|Overall Study|Adverse Event|0|||
126609557|NCT01953692|455529616|FG008|Overall Study|Adverse Event|0|||
126609558|NCT01953692|455529608|FG000|Overall Study|Clinical Progression|0|||
126609559|NCT01953692|455529609|FG001|Overall Study|Clinical Progression|15|||
126609560|NCT01953692|455529610|FG002|Overall Study|Clinical Progression|7|||
126609561|NCT01953692|455529611|FG003|Overall Study|Clinical Progression|5|||
126609562|NCT01953692|455529612|FG004|Overall Study|Clinical Progression|0|||
126609563|NCT01953692|455529613|FG005|Overall Study|Clinical Progression|7|||
126609564|NCT01953692|455529614|FG006|Overall Study|Clinical Progression|20|||
126609565|NCT01953692|455529615|FG007|Overall Study|Clinical Progression|3|||
126609566|NCT01953692|455529616|FG008|Overall Study|Clinical Progression|3|||
126609567|NCT01953692|455529608|FG000|Overall Study|Death|5|||
126609568|NCT01953692|455529609|FG001|Overall Study|Death|0|||
126609569|NCT01953692|455529610|FG002|Overall Study|Death|2|||
126609570|NCT01953692|455529611|FG003|Overall Study|Death|2|||
126609571|NCT01953692|455529612|FG004|Overall Study|Death|1|||
126609572|NCT01953692|455529613|FG005|Overall Study|Death|3|||
126609573|NCT01953692|455529614|FG006|Overall Study|Death|6|||
126609574|NCT01953692|455529615|FG007|Overall Study|Death|2|||
126609575|NCT01953692|455529616|FG008|Overall Study|Death|1|||
126609576|NCT01953692|455529608|FG000|Overall Study|Excluded Medication|1|||
126609577|NCT01953692|455529609|FG001|Overall Study|Excluded Medication|0|||
126609578|NCT01953692|455529610|FG002|Overall Study|Excluded Medication|0|||
126609579|NCT01953692|455529611|FG003|Overall Study|Excluded Medication|0|||
126609580|NCT01953692|455529612|FG004|Overall Study|Excluded Medication|0|||
126609581|NCT01953692|455529613|FG005|Overall Study|Excluded Medication|0|||
126609582|NCT01953692|455529614|FG006|Overall Study|Excluded Medication|0|||
126609583|NCT01953692|455529615|FG007|Overall Study|Excluded Medication|0|||
126609584|NCT01953692|455529616|FG008|Overall Study|Excluded Medication|0|||
126609585|NCT01953692|455529608|FG000|Overall Study|Lost to Follow-up|1|||
126609586|NCT01953692|455529609|FG001|Overall Study|Lost to Follow-up|0|||
126609587|NCT01953692|455529610|FG002|Overall Study|Lost to Follow-up|3|||
126609588|NCT01953692|455529611|FG003|Overall Study|Lost to Follow-up|1|||
126609589|NCT01953692|455529612|FG004|Overall Study|Lost to Follow-up|0|||
126609590|NCT01953692|455529613|FG005|Overall Study|Lost to Follow-up|1|||
126609591|NCT01953692|455529614|FG006|Overall Study|Lost to Follow-up|0|||
126609592|NCT01953692|455529615|FG007|Overall Study|Lost to Follow-up|0|||
126609593|NCT01953692|455529616|FG008|Overall Study|Lost to Follow-up|0|||
126609594|NCT01953692|455529608|FG000|Overall Study|Physician Decision|11|||
126609595|NCT01953692|455529609|FG001|Overall Study|Physician Decision|4|||
126609596|NCT01953692|455529610|FG002|Overall Study|Physician Decision|2|||
126609597|NCT01953692|455529611|FG003|Overall Study|Physician Decision|2|||
126609598|NCT01953692|455529612|FG004|Overall Study|Physician Decision|1|||
126609599|NCT01953692|455529613|FG005|Overall Study|Physician Decision|2|||
126609600|NCT01953692|455529614|FG006|Overall Study|Physician Decision|4|||
126609601|NCT01953692|455529615|FG007|Overall Study|Physician Decision|1|||
126609602|NCT01953692|455529616|FG008|Overall Study|Physician Decision|0|||
126609603|NCT01953692|455529608|FG000|Overall Study|Protocol Violation|0|||
126609604|NCT01953692|455529609|FG001|Overall Study|Protocol Violation|2|||
126609605|NCT01953692|455529610|FG002|Overall Study|Protocol Violation|1|||
126609606|NCT01953692|455529611|FG003|Overall Study|Protocol Violation|0|||
126609607|NCT01953692|455529612|FG004|Overall Study|Protocol Violation|0|||
126609608|NCT01953692|455529613|FG005|Overall Study|Protocol Violation|0|||
126609609|NCT01953692|455529614|FG006|Overall Study|Protocol Violation|0|||
126609610|NCT01953692|455529615|FG007|Overall Study|Protocol Violation|1|||
126609611|NCT01953692|455529616|FG008|Overall Study|Protocol Violation|0|||
126609612|NCT01953692|455529608|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126609613|NCT01953692|455529609|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126609614|NCT01953692|455529610|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126609615|NCT01953692|455529611|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126609616|NCT01953692|455529612|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126609617|NCT01953692|455529613|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126609618|NCT01953692|455529614|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126609619|NCT01953692|455529615|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
126609620|NCT01953692|455529616|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
126609621|NCT01953692|455529608|FG000|Overall Study|Withdrawal by Subject|4|||
126609622|NCT01953692|455529609|FG001|Overall Study|Withdrawal by Subject|2|||
126609623|NCT01953692|455529610|FG002|Overall Study|Withdrawal by Subject|1|||
126609624|NCT01953692|455529611|FG003|Overall Study|Withdrawal by Subject|2|||
126609625|NCT01953692|455529612|FG004|Overall Study|Withdrawal by Subject|0|||
126609626|NCT01953692|455529613|FG005|Overall Study|Withdrawal by Subject|3|||
126609627|NCT01953692|455529614|FG006|Overall Study|Withdrawal by Subject|2|||
126609628|NCT01953692|455529615|FG007|Overall Study|Withdrawal by Subject|1|||
126609629|NCT01953692|455529616|FG008|Overall Study|Withdrawal by Subject|1|||
126609630|NCT04638816|455529617|FG000|Overall Study|Withdrawal by Subject|0|||
126609631|NCT04638816|455529618|FG001|Overall Study|Withdrawal by Subject|1|||
126609632|NCT04638816|455529617|FG000|Overall Study|Lost to Follow-up|0|||
126609633|NCT04638816|455529618|FG001|Overall Study|Lost to Follow-up|1|||
126609634|NCT01822756|455529619|FG000|Overall Study|Adverse Event|0|||
126609635|NCT01822756|455529620|FG001|Overall Study|Adverse Event|0|||
126609636|NCT01822756|455529621|FG002|Overall Study|Adverse Event|0|||
126609637|NCT01822756|455529622|FG003|Overall Study|Adverse Event|2|||
126609638|NCT01822756|455529623|FG004|Overall Study|Adverse Event|0|||
126609639|NCT01822756|455529619|FG000|Overall Study|Disease progression|11|||
126609640|NCT01822756|455529620|FG001|Overall Study|Disease progression|1|||
126609641|NCT01822756|455529621|FG002|Overall Study|Disease progression|7|||
126609642|NCT01822756|455529622|FG003|Overall Study|Disease progression|2|||
126609643|NCT01822756|455529623|FG004|Overall Study|Disease progression|6|||
126609644|NCT01822756|455529619|FG000|Overall Study|Death|2|||
126609645|NCT01822756|455529620|FG001|Overall Study|Death|2|||
126609646|NCT01822756|455529621|FG002|Overall Study|Death|1|||
126609647|NCT01822756|455529622|FG003|Overall Study|Death|0|||
126609648|NCT01822756|455529623|FG004|Overall Study|Death|0|||
126609649|NCT01822756|455529619|FG000|Overall Study|Lost to Follow-up|1|||
126609650|NCT01822756|455529620|FG001|Overall Study|Lost to Follow-up|0|||
126609651|NCT01822756|455529621|FG002|Overall Study|Lost to Follow-up|1|||
126609652|NCT01822756|455529622|FG003|Overall Study|Lost to Follow-up|0|||
126609653|NCT01822756|455529623|FG004|Overall Study|Lost to Follow-up|1|||
126609654|NCT01822756|455529619|FG000|Overall Study|Physician Decision|0|||
126609655|NCT01822756|455529620|FG001|Overall Study|Physician Decision|1|||
126609656|NCT01822756|455529621|FG002|Overall Study|Physician Decision|0|||
126609657|NCT01822756|455529622|FG003|Overall Study|Physician Decision|0|||
126609658|NCT01822756|455529623|FG004|Overall Study|Physician Decision|0|||
126734100|NCT03325556|455975814|FG000|Double-blind Period|Use of prohibited medication|0|||
126734101|NCT03325556|455975815|FG001|Double-blind Period|Use of prohibited medication|1|||
126734102|NCT03325556|455975816|FG002|Double-blind Period|Use of prohibited medication|0|||
126734103|NCT03325556|455975814|FG000|Double-blind Period|Physician Decision|0|||
126734104|NCT03325556|455975815|FG001|Double-blind Period|Physician Decision|0|||
126734105|NCT03325556|455975816|FG002|Double-blind Period|Physician Decision|1|||
126609659|NCT01822756|455529619|FG000|Overall Study|disease progression & patient preference|2|||
126609660|NCT01822756|455529620|FG001|Overall Study|disease progression & patient preference|0|||
126609661|NCT01822756|455529621|FG002|Overall Study|disease progression & patient preference|1|||
126609662|NCT01822756|455529622|FG003|Overall Study|disease progression & patient preference|0|||
126609663|NCT01822756|455529623|FG004|Overall Study|disease progression & patient preference|0|||
126609664|NCT01328496|455529624|FG000|Overall Study|Significant Change in Health Status|1|||
126609665|NCT01328496|455529625|FG001|Overall Study|Significant Change in Health Status|0|||
126609666|NCT03102034|455529637|FG000|Overall Study|Withdrawal by Subject|1|||
126609667|NCT03102034|455529638|FG001|Overall Study|Withdrawal by Subject|0|||
126609668|NCT03611075|455529641|FG000|Overall Study|Physician Decision|0|||
126609669|NCT03611075|455529642|FG001|Overall Study|Physician Decision|1|||
126609670|NCT03611075|455529643|FG002|Overall Study|Physician Decision|1|||
126609671|NCT03611075|455529644|FG003|Overall Study|Physician Decision|0|||
126609672|NCT03611075|455529645|FG004|Overall Study|Physician Decision|0|||
126609673|NCT03611075|455529646|FG005|Overall Study|Physician Decision|0|||
126609674|NCT03611075|455529647|FG006|Overall Study|Physician Decision|0|||
126609675|NCT03611075|455529648|FG007|Overall Study|Physician Decision|0|||
126609676|NCT03611075|455529649|FG008|Overall Study|Physician Decision|0|||
126609677|NCT03611075|455529641|FG000|Overall Study|Lost to Follow-up|1|||
126609678|NCT03611075|455529642|FG001|Overall Study|Lost to Follow-up|0|||
126609679|NCT03611075|455529643|FG002|Overall Study|Lost to Follow-up|0|||
126609680|NCT03611075|455529644|FG003|Overall Study|Lost to Follow-up|2|||
126609681|NCT03611075|455529645|FG004|Overall Study|Lost to Follow-up|0|||
126609682|NCT03611075|455529646|FG005|Overall Study|Lost to Follow-up|0|||
126609683|NCT03611075|455529647|FG006|Overall Study|Lost to Follow-up|0|||
126609684|NCT03611075|455529648|FG007|Overall Study|Lost to Follow-up|0|||
126609685|NCT03611075|455529649|FG008|Overall Study|Lost to Follow-up|0|||
126609686|NCT03611075|455529641|FG000|Overall Study|Withdrawal by Subject|0|||
126609687|NCT03611075|455529642|FG001|Overall Study|Withdrawal by Subject|1|||
126609688|NCT03611075|455529643|FG002|Overall Study|Withdrawal by Subject|1|||
126609689|NCT03611075|455529644|FG003|Overall Study|Withdrawal by Subject|1|||
126609690|NCT03611075|455529645|FG004|Overall Study|Withdrawal by Subject|0|||
126609691|NCT03611075|455529646|FG005|Overall Study|Withdrawal by Subject|0|||
126609692|NCT03611075|455529647|FG006|Overall Study|Withdrawal by Subject|1|||
126609693|NCT03611075|455529648|FG007|Overall Study|Withdrawal by Subject|0|||
126609694|NCT03611075|455529649|FG008|Overall Study|Withdrawal by Subject|0|||
126609695|NCT03611075|455529641|FG000|Overall Study|Reason unknown|0|||
126609696|NCT03611075|455529642|FG001|Overall Study|Reason unknown|0|||
126609697|NCT03611075|455529643|FG002|Overall Study|Reason unknown|0|||
126609698|NCT03611075|455529644|FG003|Overall Study|Reason unknown|1|||
126609699|NCT03611075|455529645|FG004|Overall Study|Reason unknown|0|||
126609700|NCT03611075|455529646|FG005|Overall Study|Reason unknown|0|||
126609701|NCT03611075|455529647|FG006|Overall Study|Reason unknown|1|||
126609702|NCT03611075|455529648|FG007|Overall Study|Reason unknown|0|||
126609703|NCT03611075|455529649|FG008|Overall Study|Reason unknown|0|||
126609704|NCT00676091|455529650|FG000|Infant Series|Parent or legal guardian request|10|||
126609705|NCT00676091|455529651|FG001|Infant Series|Parent or legal guardian request|8|||
126609706|NCT00676091|455529650|FG000|Infant Series|Protocol Violation|6|||
126609707|NCT00676091|455529651|FG001|Infant Series|Protocol Violation|3|||
126609708|NCT00676091|455529650|FG000|Infant Series|Adverse Event|2|||
126609709|NCT00676091|455529651|FG001|Infant Series|Adverse Event|3|||
126609710|NCT00676091|455529650|FG000|Infant Series|Failed to return|1|||
126609711|NCT00676091|455529651|FG001|Infant Series|Failed to return|3|||
126609712|NCT00676091|455529650|FG000|Infant Series|Lost to Follow-up|1|||
126609713|NCT00676091|455529651|FG001|Infant Series|Lost to Follow-up|0|||
126609714|NCT00676091|455529650|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
126609715|NCT00676091|455529651|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
126609716|NCT00676091|455529650|FG000|After Infant Series|Adverse Event|0|||
126609717|NCT00676091|455529651|FG001|After Infant Series|Adverse Event|1|||
126609718|NCT00676091|455529650|FG000|After Infant Series|Protocol Violation|0|||
126609719|NCT00676091|455529651|FG001|After Infant Series|Protocol Violation|1|||
126609720|NCT00676091|455529650|FG000|After Infant Series|Failed to return|1|||
126609721|NCT00676091|455529651|FG001|After Infant Series|Failed to return|1|||
126609722|NCT00676091|455529650|FG000|Toddler Dose|Failed to return|2|||
126609723|NCT00676091|455529651|FG001|Toddler Dose|Failed to return|0|||
126609724|NCT00676091|455529650|FG000|Toddler Dose|Parent or legal guardian request|1|||
126609725|NCT00676091|455529651|FG001|Toddler Dose|Parent or legal guardian request|0|||
126609726|NCT01701401|455529655|FG000|Overall Study|Randomized But Not Treated|3|||
126609727|NCT01701401|455529656|FG001|Overall Study|Randomized But Not Treated|1|||
126609728|NCT01701401|455529657|FG002|Overall Study|Randomized But Not Treated|0|||
126609729|NCT01701401|455529658|FG003|Overall Study|Randomized But Not Treated|1|||
126609730|NCT01701401|455529655|FG000|Overall Study|Lost to Follow-up|5|||
126609731|NCT01701401|455529656|FG001|Overall Study|Lost to Follow-up|5|||
126609732|NCT01701401|455529657|FG002|Overall Study|Lost to Follow-up|1|||
126609733|NCT01701401|455529658|FG003|Overall Study|Lost to Follow-up|3|||
126609734|NCT01701401|455529655|FG000|Overall Study|Withdrew Consent|0|||
126609735|NCT01701401|455529656|FG001|Overall Study|Withdrew Consent|3|||
126609736|NCT01701401|455529657|FG002|Overall Study|Withdrew Consent|1|||
126609737|NCT01701401|455529658|FG003|Overall Study|Withdrew Consent|2|||
126609738|NCT01701401|455529655|FG000|Overall Study|Lack of Efficacy|1|||
126609739|NCT01701401|455529656|FG001|Overall Study|Lack of Efficacy|0|||
126734106|NCT03325556|455975814|FG000|Double-blind Period|Withdrawal by Subject|0|||
126734107|NCT03325556|455975815|FG001|Double-blind Period|Withdrawal by Subject|6|||
126609740|NCT01701401|455529657|FG002|Overall Study|Lack of Efficacy|2|||
126734108|NCT03325556|455975816|FG002|Double-blind Period|Withdrawal by Subject|4|||
126609741|NCT01701401|455529658|FG003|Overall Study|Lack of Efficacy|0|||
126609742|NCT01701401|455529655|FG000|Overall Study|Adverse Event|1|||
126609743|NCT01701401|455529656|FG001|Overall Study|Adverse Event|0|||
126609744|NCT01701401|455529657|FG002|Overall Study|Adverse Event|0|||
126609745|NCT01701401|455529658|FG003|Overall Study|Adverse Event|0|||
126609746|NCT01701401|455529655|FG000|Overall Study|Protocol Violation|0|||
126609747|NCT01701401|455529656|FG001|Overall Study|Protocol Violation|0|||
126609748|NCT01701401|455529657|FG002|Overall Study|Protocol Violation|1|||
126609749|NCT01701401|455529658|FG003|Overall Study|Protocol Violation|0|||
126609750|NCT00933270|455529659|FG000|Overall Study|Withdrawal by Subject|26|||
126734109|NCT03325556|455975814|FG000|Double-blind Period|Not otherwise specified|0|||
126734110|NCT03325556|455975815|FG001|Double-blind Period|Not otherwise specified|1|||
126734111|NCT03325556|455975816|FG002|Double-blind Period|Not otherwise specified|5|||
126734112|NCT03325556|455975814|FG000|Double-blind Period|Administrative discont. at study termination|0|||
126734113|NCT03325556|455975815|FG001|Double-blind Period|Administrative discont. at study termination|35|||
126734114|NCT03325556|455975816|FG002|Double-blind Period|Administrative discont. at study termination|31|||
126734115|NCT02119026|455975817|FG000|1st-line Treatment|Adverse Event|9|||
126734116|NCT02119026|455975818|FG001|1st-line Treatment|Adverse Event|14|||
126734117|NCT02119026|455975817|FG000|1st-line Treatment|Physician Decision|3|||
126734118|NCT02119026|455975818|FG001|1st-line Treatment|Physician Decision|8|||
126734119|NCT02119026|455975817|FG000|1st-line Treatment|Withdrawal by Subject|4|||
126609751|NCT00933270|455529659|FG000|Overall Study|Insufficient Follow-up|10|||
126609752|NCT00933270|455529659|FG000|Overall Study|Lost to Follow-up|14|||
126609753|NCT00933270|455529659|FG000|Overall Study|Adverse Event|1|||
126609754|NCT00933270|455529659|FG000|Overall Study|Missed Visit|2|||
126609755|NCT00933270|455529659|FG000|Overall Study|Death|24|||
126609756|NCT00933270|455529659|FG000|Overall Study|Moved or would not return|10|||
126609757|NCT00989196|455529660|FG000|Treatment Period|Lost to Follow-up|1|||
126609758|NCT00989196|455529661|FG001|Treatment Period|Lost to Follow-up|0|||
126609759|NCT01000805|455529662|FG000|Overall Study|Adverse Event|21|||
126609760|NCT01000805|455529663|FG001|Overall Study|Adverse Event|9|||
126609761|NCT01000805|455529662|FG000|Overall Study|Lack of Efficacy|5|||
126609762|NCT01000805|455529663|FG001|Overall Study|Lack of Efficacy|16|||
126609763|NCT01000805|455529662|FG000|Overall Study|Lost to Follow-up|16|||
126609764|NCT01000805|455529663|FG001|Overall Study|Lost to Follow-up|21|||
126609765|NCT01000805|455529662|FG000|Overall Study|Physician Decision|0|||
126609766|NCT01000805|455529663|FG001|Overall Study|Physician Decision|1|||
126609767|NCT01000805|455529662|FG000|Overall Study|Protocol Violation|12|||
126609768|NCT01000805|455529663|FG001|Overall Study|Protocol Violation|8|||
126609769|NCT01000805|455529662|FG000|Overall Study|Withdrawal by Subject|16|||
126609770|NCT01000805|455529663|FG001|Overall Study|Withdrawal by Subject|6|||
126609771|NCT01000805|455529662|FG000|Overall Study|Sponsor Decision|0|||
126609772|NCT01000805|455529663|FG001|Overall Study|Sponsor Decision|1|||
126609773|NCT03476798|455529666|FG000|Overall Study|Death|1|||
126609774|NCT03476798|455529666|FG000|Overall Study|Withdrawal by Subject|2|||
126609775|NCT03476798|455529666|FG000|Overall Study|Protocol Violation|2|||
126609776|NCT02409680|455529671|FG000|Overall Study|Lost to Follow-up|15|||
126609777|NCT02409680|455529672|FG001|Overall Study|Lost to Follow-up|30|||
126609778|NCT03343704|455529676|FG000|Overall Study|Refused to complete follow up|0|||
126609779|NCT03343704|455529677|FG001|Overall Study|Refused to complete follow up|1|||
126609780|NCT03343704|455529676|FG000|Overall Study|Death|0|||
126609781|NCT03343704|455529677|FG001|Overall Study|Death|1|||
126609782|NCT03343704|455529676|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
126609783|NCT03343704|455529677|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
126609784|NCT03789656|455529682|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
126609785|NCT03789656|455529683|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
126609786|NCT03789656|455529684|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
126609787|NCT03789656|455529685|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
126609788|NCT03789656|455529686|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
126609789|NCT03789656|455529682|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
126609790|NCT03789656|455529683|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
126609791|NCT03789656|455529684|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
126609792|NCT03789656|455529685|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
126609793|NCT03789656|455529686|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
126609794|NCT03789656|455529682|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
126609795|NCT03789656|455529683|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
126609796|NCT03789656|455529684|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
126609797|NCT03789656|455529685|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
126609798|NCT03789656|455529686|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
126609799|NCT03789656|455529682|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
126609800|NCT03789656|455529683|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
126609801|NCT03789656|455529684|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
126609802|NCT03789656|455529685|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
126609803|NCT03789656|455529686|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
126609804|NCT02434328|455529694|FG000|Overall Study|Adverse Event|9|||
126609805|NCT02434328|455529695|FG001|Overall Study|Adverse Event|4|||
126609806|NCT02434328|455529694|FG000|Overall Study|Lack of Efficacy|0|||
126609807|NCT02434328|455529695|FG001|Overall Study|Lack of Efficacy|2|||
126609808|NCT02434328|455529694|FG000|Overall Study|Physician Decision|0|||
126609809|NCT02434328|455529695|FG001|Overall Study|Physician Decision|1|||
126609810|NCT02434328|455529694|FG000|Overall Study|Withdrawal by Subject|12|||
126609811|NCT02434328|455529695|FG001|Overall Study|Withdrawal by Subject|21|||
126609812|NCT02434328|455529694|FG000|Overall Study|Death|4|||
126609813|NCT02434328|455529695|FG001|Overall Study|Death|7|||
126609814|NCT02434328|455529694|FG000|Overall Study|Lost to Follow-up|1|||
126609815|NCT02434328|455529695|FG001|Overall Study|Lost to Follow-up|6|||
126609816|NCT02434328|455529694|FG000|Overall Study|Other|4|||
126609817|NCT02434328|455529695|FG001|Overall Study|Other|1|||
126609818|NCT02294461|455529698|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
126609819|NCT02294461|455529699|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
126609820|NCT02294461|455529700|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
126609821|NCT02294461|455529698|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
126609822|NCT02294461|455529699|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
126609823|NCT02294461|455529700|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
126609824|NCT02294461|455529698|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
126609825|NCT02294461|455529699|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
126609826|NCT02294461|455529700|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
126609827|NCT02294461|455529698|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
126609828|NCT02294461|455529699|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
126609829|NCT02294461|455529700|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
126609830|NCT02294461|455529698|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
126609831|NCT02294461|455529699|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
126609832|NCT02294461|455529700|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
126609833|NCT02294461|455529698|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
126609834|NCT02294461|455529699|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
126609835|NCT02294461|455529700|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
126609836|NCT02294461|455529698|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
126609837|NCT02294461|455529699|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
126609838|NCT02294461|455529700|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
126609839|NCT02294461|455529698|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
126609840|NCT02294461|455529699|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
126609841|NCT02294461|455529700|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
126609842|NCT02294461|455529698|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
126609843|NCT02294461|455529699|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
126609844|NCT02294461|455529700|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
126609845|NCT02294461|455529698|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
126609846|NCT02294461|455529699|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
126609847|NCT02294461|455529700|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
126609848|NCT02294461|455529698|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
126609849|NCT02294461|455529699|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
126609850|NCT02294461|455529700|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
126609851|NCT02294461|455529698|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
126609852|NCT02294461|455529699|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
126609853|NCT02294461|455529700|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
126609854|NCT02294461|455529698|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
126609855|NCT02294461|455529699|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
126609856|NCT02294461|455529700|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
126609857|NCT02294461|455529698|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
126609858|NCT02294461|455529699|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
126609859|NCT02294461|455529700|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
126609860|NCT05432986|455529701|FG000|Overall Study|Withdrawal by Subject|2|||
126609861|NCT05432986|455529701|FG000|Overall Study|incomplete measurement|7|||
126609862|NCT03009344|455530814|FG000|Overall Study|Lack of Efficacy|5|||
126609863|NCT03009344|455530814|FG000|Overall Study|Withdrawal by Subject|1|||
126609864|NCT03009344|455530814|FG000|Overall Study|Adverse Event|1|||
126609865|NCT00378898|455530815|FG000|Overall Study|Withdrawal by Subject|10|||
126609866|NCT00378898|455530816|FG001|Overall Study|Withdrawal by Subject|5|||
126609867|NCT00378898|455530815|FG000|Overall Study|Protocol Violation|1|||
126609868|NCT00378898|455530816|FG001|Overall Study|Protocol Violation|1|||
126609869|NCT02534233|455530819|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
126609870|NCT03136159|455530820|FG000|Overall Study|chorioamnionitis|2|||
126609871|NCT03136159|455530821|FG001|Overall Study|chorioamnionitis|0|||
126609872|NCT03136159|455530820|FG000|Overall Study|vertical skin incision|1|||
126609873|NCT03136159|455530821|FG001|Overall Study|vertical skin incision|0|||
126609874|NCT03136159|455530820|FG000|Overall Study|additional dressing|1|||
126609875|NCT03136159|455530821|FG001|Overall Study|additional dressing|0|||
126609876|NCT03136159|455530820|FG000|Overall Study|never got dressing placed|1|||
126609877|NCT03136159|455530821|FG001|Overall Study|never got dressing placed|0|||
126609878|NCT01732757|455530822|FG000|Overall Study|Lost to Follow-up|1|||
126609879|NCT01732757|455530823|FG001|Overall Study|Lost to Follow-up|0|||
126609880|NCT01732757|455530824|FG002|Overall Study|Lost to Follow-up|0|||
126609881|NCT00089609|455530827|FG000|Overall Study|Withdrawal by Subject|3|||
126609882|NCT00089609|455530828|FG001|Overall Study|Withdrawal by Subject|1|||
126609883|NCT03116464|455530829|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
126609884|NCT00597376|455530830|FG000|Overall Study|Withdrawal by Subject|4|||
126609885|NCT00597376|455530831|FG001|Overall Study|Withdrawal by Subject|3|||
126609886|NCT00597376|455530830|FG000|Overall Study|Adverse Event|4|||
126609887|NCT00597376|455530831|FG001|Overall Study|Adverse Event|1|||
126609888|NCT04237792|455530836|FG000|Treatment (Day 1)|Adverse Event|1|||
126609889|NCT04237792|455530837|FG001|Treatment (Day 1)|Adverse Event|0|||
126609890|NCT04237792|455530838|FG002|Treatment (Day 1)|Adverse Event|0|||
126609891|NCT04237792|455530839|FG003|Treatment (Day 1)|Adverse Event|0|||
126609892|NCT04237792|455530840|FG004|Treatment (Day 1)|Adverse Event|1|||
126609893|NCT04237792|455530841|FG005|Treatment (Day 1)|Adverse Event|1|||
126609894|NCT04237792|455530836|FG000|Treatment (Day 1)|Other|0|||
126609895|NCT04237792|455530837|FG001|Treatment (Day 1)|Other|0|||
126609896|NCT04237792|455530838|FG002|Treatment (Day 1)|Other|1|||
126609897|NCT04237792|455530839|FG003|Treatment (Day 1)|Other|0|||
126609898|NCT04237792|455530840|FG004|Treatment (Day 1)|Other|0|||
126609899|NCT04237792|455530841|FG005|Treatment (Day 1)|Other|1|||
126609900|NCT04237792|455530836|FG000|Treatment (Day 1)|Not treated|1|||
126609901|NCT04237792|455530837|FG001|Treatment (Day 1)|Not treated|1|||
126609902|NCT04237792|455530838|FG002|Treatment (Day 1)|Not treated|2|||
126609903|NCT04237792|455530839|FG003|Treatment (Day 1)|Not treated|1|||
126609904|NCT04237792|455530840|FG004|Treatment (Day 1)|Not treated|0|||
126609905|NCT04237792|455530841|FG005|Treatment (Day 1)|Not treated|1|||
126609906|NCT04693637|455530842|FG000|Overall Study|Death|4|||
126609907|NCT04693637|455530842|FG000|Overall Study|Withdrawal by Subject|3|||
126609908|NCT04693637|455530842|FG000|Overall Study|Physician Decision|2|||
126609909|NCT04693637|455530842|FG000|Overall Study|Lost to Follow-up|1|||
126609910|NCT03205566|455530845|FG000|Phase 1|Protocol Violation|1|||
126609911|NCT03205566|455530846|FG001|Phase 1|Protocol Violation|1|||
126609912|NCT03489369|455530849|FG000|Overall Study|Documented Progressive Disease|3|||
126609913|NCT03489369|455530850|FG001|Overall Study|Documented Progressive Disease|2|||
126609914|NCT03489369|455530851|FG002|Overall Study|Documented Progressive Disease|3|||
126609915|NCT03489369|455530852|FG003|Overall Study|Documented Progressive Disease|6|||
126609916|NCT03489369|455530849|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
126609917|NCT03489369|455530850|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
126609918|NCT03489369|455530851|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
126609919|NCT03489369|455530852|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
126609920|NCT02022670|455530853|FG000|Overall Study|Adverse Event|1|||
126609921|NCT02022670|455530854|FG001|Overall Study|Adverse Event|0|||
126609922|NCT02022670|455530855|FG002|Overall Study|Adverse Event|1|||
126609923|NCT02113449|455530856|FG000|Overall Study|Adverse Event|4|||
126609924|NCT01074242|455530861|FG000|Overall Study|Case report before date of contract|40|||
126609925|NCT01074242|455530861|FG000|Overall Study|Lost to Follow-up|1|||
126609926|NCT01074242|455530861|FG000|Overall Study|Case report unclear|6|||
126609927|NCT01074242|455530861|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
126609928|NCT01074242|455530861|FG000|Overall Study|Duplicate Case Report Form|5|||
126609929|NCT00109031|455530862|FG000|Overall Study|Adverse Event|0|||
126609930|NCT00109031|455530863|FG001|Overall Study|Adverse Event|0|||
126609931|NCT00109031|455530864|FG002|Overall Study|Adverse Event|1|||
126609932|NCT00109031|455530865|FG003|Overall Study|Adverse Event|0|||
126609933|NCT00109031|455530862|FG000|Overall Study|Withdrawal by Subject|0|||
126609934|NCT00109031|455530863|FG001|Overall Study|Withdrawal by Subject|1|||
126609935|NCT00109031|455530864|FG002|Overall Study|Withdrawal by Subject|0|||
126609936|NCT00109031|455530865|FG003|Overall Study|Withdrawal by Subject|0|||
126609937|NCT00109031|455530862|FG000|Overall Study|Physician Decision|0|||
126609938|NCT00109031|455530863|FG001|Overall Study|Physician Decision|1|||
126609939|NCT00109031|455530864|FG002|Overall Study|Physician Decision|0|||
126609940|NCT00109031|455530865|FG003|Overall Study|Physician Decision|0|||
126609941|NCT00109031|455530862|FG000|Overall Study|Protocol Violation|0|||
126609942|NCT00109031|455530863|FG001|Overall Study|Protocol Violation|0|||
126609943|NCT00109031|455530864|FG002|Overall Study|Protocol Violation|1|||
126609944|NCT00109031|455530865|FG003|Overall Study|Protocol Violation|0|||
126609945|NCT01957163|455530871|FG000|Overall Study|Adverse Event|5|||
126609946|NCT01957163|455530872|FG001|Overall Study|Adverse Event|2|||
126609947|NCT01957163|455530873|FG002|Overall Study|Adverse Event|4|||
126609948|NCT01957163|455530871|FG000|Overall Study|Lack of Efficacy|5|||
126609949|NCT01957163|455530872|FG001|Overall Study|Lack of Efficacy|4|||
126609950|NCT01957163|455530873|FG002|Overall Study|Lack of Efficacy|9|||
126609951|NCT01957163|455530871|FG000|Overall Study|Protocol Violation|1|||
126609952|NCT01957163|455530872|FG001|Overall Study|Protocol Violation|2|||
126609953|NCT01957163|455530873|FG002|Overall Study|Protocol Violation|0|||
126609954|NCT01957163|455530871|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
126609955|NCT01957163|455530872|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
126609956|NCT01957163|455530873|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
126609957|NCT01957163|455530871|FG000|Overall Study|Lost to Follow-up|0|||
126609958|NCT01957163|455530872|FG001|Overall Study|Lost to Follow-up|1|||
126609959|NCT01957163|455530873|FG002|Overall Study|Lost to Follow-up|0|||
126609960|NCT01957163|455530871|FG000|Overall Study|Withdrawal by Subject|4|||
126609961|NCT01957163|455530872|FG001|Overall Study|Withdrawal by Subject|2|||
126609962|NCT01957163|455530873|FG002|Overall Study|Withdrawal by Subject|4|||
126609963|NCT03697603|455530875|FG000|Overall Study|Adverse Event|3|||
126609964|NCT03697603|455530876|FG001|Overall Study|Adverse Event|18|||
126609965|NCT03697603|455530877|FG002|Overall Study|Adverse Event|3|||
126609966|NCT03697603|455530875|FG000|Overall Study|Physician Decision|1|||
126609967|NCT03697603|455530876|FG001|Overall Study|Physician Decision|0|||
126609968|NCT03697603|455530877|FG002|Overall Study|Physician Decision|2|||
126609969|NCT03697603|455530875|FG000|Overall Study|Protocol Violation|3|||
126609970|NCT03697603|455530876|FG001|Overall Study|Protocol Violation|8|||
126609971|NCT03697603|455530877|FG002|Overall Study|Protocol Violation|5|||
126609972|NCT03697603|455530875|FG000|Overall Study|Withdrawal by Subject|5|||
126609973|NCT03697603|455530876|FG001|Overall Study|Withdrawal by Subject|1|||
126609974|NCT03697603|455530877|FG002|Overall Study|Withdrawal by Subject|1|||
126609975|NCT03697603|455530875|FG000|Overall Study|Protocol Violation|0|||
126609976|NCT03697603|455530876|FG001|Overall Study|Protocol Violation|0|||
126609977|NCT03697603|455530877|FG002|Overall Study|Protocol Violation|1|||
126609978|NCT02686658|455530878|FG000|Overall Study|Adverse Event|0|||
126609979|NCT02686658|455530879|FG001|Overall Study|Adverse Event|0|||
126609980|NCT02686658|455530880|FG002|Overall Study|Adverse Event|1|||
126609981|NCT02686658|455530881|FG003|Overall Study|Adverse Event|1|||
126609982|NCT02686658|455530882|FG004|Overall Study|Adverse Event|2|||
126609983|NCT02686658|455530883|FG005|Overall Study|Adverse Event|1|||
126609984|NCT02686658|455530878|FG000|Overall Study|Investigator decision|0|||
126609985|NCT02686658|455530879|FG001|Overall Study|Investigator decision|0|||
126609986|NCT02686658|455530880|FG002|Overall Study|Investigator decision|0|||
126609987|NCT02686658|455530881|FG003|Overall Study|Investigator decision|1|||
126609988|NCT02686658|455530882|FG004|Overall Study|Investigator decision|2|||
126609989|NCT02686658|455530883|FG005|Overall Study|Investigator decision|1|||
126609990|NCT02686658|455530878|FG000|Overall Study|Sponsor decision|1|||
126609991|NCT02686658|455530879|FG001|Overall Study|Sponsor decision|2|||
126609992|NCT02686658|455530880|FG002|Overall Study|Sponsor decision|1|||
126609993|NCT02686658|455530881|FG003|Overall Study|Sponsor decision|5|||
126609994|NCT02686658|455530882|FG004|Overall Study|Sponsor decision|13|||
126609995|NCT02686658|455530883|FG005|Overall Study|Sponsor decision|2|||
126609996|NCT02686658|455530878|FG000|Overall Study|Lost to Follow-up|0|||
126609997|NCT02686658|455530879|FG001|Overall Study|Lost to Follow-up|0|||
126609998|NCT02686658|455530880|FG002|Overall Study|Lost to Follow-up|2|||
126609999|NCT02686658|455530881|FG003|Overall Study|Lost to Follow-up|0|||
126610000|NCT02686658|455530882|FG004|Overall Study|Lost to Follow-up|0|||
126610001|NCT02686658|455530883|FG005|Overall Study|Lost to Follow-up|1|||
126610002|NCT02686658|455530878|FG000|Overall Study|Death|1|||
126610003|NCT02686658|455530879|FG001|Overall Study|Death|0|||
126610004|NCT02686658|455530880|FG002|Overall Study|Death|0|||
126610005|NCT02686658|455530881|FG003|Overall Study|Death|1|||
126610006|NCT02686658|455530882|FG004|Overall Study|Death|1|||
126610007|NCT02686658|455530883|FG005|Overall Study|Death|1|||
126610008|NCT02686658|455530878|FG000|Overall Study|Withdrawal by Subject|2|||
126610009|NCT02686658|455530879|FG001|Overall Study|Withdrawal by Subject|5|||
126610010|NCT02686658|455530880|FG002|Overall Study|Withdrawal by Subject|4|||
126610011|NCT02686658|455530881|FG003|Overall Study|Withdrawal by Subject|4|||
126610012|NCT02686658|455530882|FG004|Overall Study|Withdrawal by Subject|17|||
126610013|NCT02686658|455530883|FG005|Overall Study|Withdrawal by Subject|8|||
126610014|NCT02686658|455530878|FG000|Overall Study|Placed in hospice care|0|||
126610015|NCT02686658|455530879|FG001|Overall Study|Placed in hospice care|0|||
126610016|NCT02686658|455530880|FG002|Overall Study|Placed in hospice care|1|||
126610017|NCT02686658|455530881|FG003|Overall Study|Placed in hospice care|0|||
126610018|NCT02686658|455530882|FG004|Overall Study|Placed in hospice care|0|||
126610019|NCT02686658|455530883|FG005|Overall Study|Placed in hospice care|0|||
126610020|NCT02686658|455530878|FG000|Overall Study|Participant non-compliance|0|||
126610021|NCT02686658|455530879|FG001|Overall Study|Participant non-compliance|0|||
126610022|NCT02686658|455530880|FG002|Overall Study|Participant non-compliance|0|||
126610023|NCT02686658|455530881|FG003|Overall Study|Participant non-compliance|0|||
126610024|NCT02686658|455530882|FG004|Overall Study|Participant non-compliance|0|||
126610025|NCT02686658|455530883|FG005|Overall Study|Participant non-compliance|1|||
126610026|NCT02686658|455530878|FG000|Overall Study|Concern over coronavirus disease care|0|||
126610027|NCT02686658|455530879|FG001|Overall Study|Concern over coronavirus disease care|0|||
126610028|NCT02686658|455530880|FG002|Overall Study|Concern over coronavirus disease care|0|||
126610029|NCT02686658|455530881|FG003|Overall Study|Concern over coronavirus disease care|0|||
126610030|NCT02686658|455530882|FG004|Overall Study|Concern over coronavirus disease care|2|||
126610031|NCT02686658|455530883|FG005|Overall Study|Concern over coronavirus disease care|1|||
126610032|NCT02309294|455530886|FG000|Overall Study|Withdrawal by Subject|2|||
126610033|NCT03520036|455530887|FG000|Overall Study|Adverse Event|1|||
126610034|NCT03520036|455530888|FG001|Overall Study|Adverse Event|2|||
126610035|NCT03520036|455530889|FG002|Overall Study|Adverse Event|0|||
126610036|NCT03520036|455530887|FG000|Overall Study|Protocol Violation|1|||
126610037|NCT03520036|455530888|FG001|Overall Study|Protocol Violation|0|||
126781240|NCT05487456|456154496|FG003|Overall Study|Withdrawal by Subject|0|||
126610038|NCT03520036|455530889|FG002|Overall Study|Protocol Violation|0|||
126610039|NCT03520036|455530887|FG000|Overall Study|Withdrawal by Subject|0|||
126610040|NCT03520036|455530888|FG001|Overall Study|Withdrawal by Subject|1|||
126610041|NCT03520036|455530889|FG002|Overall Study|Withdrawal by Subject|4|||
126610042|NCT03520036|455530887|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
126610043|NCT03520036|455530888|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
126610044|NCT03520036|455530889|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
126610045|NCT00467272|455530892|FG000|Overall Study|Pneumonia|2|||
126610046|NCT00467272|455530892|FG000|Overall Study|Thrombophlebitis|1|||
126610047|NCT05426109|455530895|FG000|Overall Study|Withdrawal by Subject|0|||
126610048|NCT05426109|455530896|FG001|Overall Study|Withdrawal by Subject|1|||
126610049|NCT02222493|455530897|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
126610050|NCT02222493|455530898|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
126610051|NCT02222493|455530897|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
126610052|NCT02222493|455530898|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
126610053|NCT02222493|455530897|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
126610054|NCT02222493|455530898|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
126610055|NCT02222493|455530897|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
126610056|NCT02222493|455530898|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
126610057|NCT02222493|455530897|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
126610058|NCT02222493|455530898|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
126610059|NCT02222493|455530897|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
126610060|NCT02222493|455530898|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
126610061|NCT02222493|455530897|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
126610062|NCT02222493|455530898|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
126610063|NCT02222493|455530897|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
126610064|NCT02222493|455530898|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
126610065|NCT02222493|455530897|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
126610066|NCT02222493|455530898|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
126610067|NCT02222493|455530897|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
126610068|NCT02222493|455530898|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
126610069|NCT02222493|455530897|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
126610070|NCT02222493|455530898|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
126610071|NCT02222493|455530897|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
126610072|NCT02222493|455530898|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
126610073|NCT02222493|455530897|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
126610074|NCT02222493|455530898|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
126610075|NCT02222493|455530897|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
126610076|NCT02222493|455530898|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
126610077|NCT02222493|455530897|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
126610078|NCT02222493|455530898|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
126610079|NCT02222493|455530897|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
126610080|NCT02222493|455530898|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
126610081|NCT02222493|455530897|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
126610082|NCT02222493|455530898|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
126610083|NCT02222493|455530897|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
126610084|NCT02222493|455530898|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
126610085|NCT02222493|455530897|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
126610086|NCT02222493|455530898|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
126610087|NCT02222493|455530897|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
126610088|NCT02222493|455530898|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
126610089|NCT02222493|455530897|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
126610090|NCT02222493|455530898|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
126610091|NCT02222493|455530897|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
126610092|NCT02222493|455530898|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
126610093|NCT03924869|455530902|FG000|Overall Study|Death|66|||
126610094|NCT03924869|455530903|FG001|Overall Study|Death|53|||
126610095|NCT03924869|455530902|FG000|Overall Study|Lost to Follow-up|2|||
126610096|NCT03924869|455530903|FG001|Overall Study|Lost to Follow-up|0|||
126610097|NCT03924869|455530902|FG000|Overall Study|Physician Decision|0|||
126610098|NCT03924869|455530903|FG001|Overall Study|Physician Decision|3|||
126610099|NCT03924869|455530902|FG000|Overall Study|Withdrawal by Subject|5|||
126610100|NCT03924869|455530903|FG001|Overall Study|Withdrawal by Subject|1|||
126610101|NCT03924869|455530902|FG000|Overall Study|Participants Ongoing|154|||
126781241|NCT03882047|456154499|FG000|Overall Study|Adverse Event|0|||
126610102|NCT03924869|455530903|FG001|Overall Study|Participants Ongoing|164|||
126610103|NCT02542943|455530904|FG000|Overall Study|Lost to Follow-up|1|||
126610104|NCT02542943|455530905|FG001|Overall Study|Lost to Follow-up|0|||
126610105|NCT02542943|455530906|FG002|Overall Study|Lost to Follow-up|0|||
126610106|NCT02542943|455530904|FG000|Overall Study|Withdrawal by Subject|0|||
126610107|NCT02542943|455530905|FG001|Overall Study|Withdrawal by Subject|1|||
126610108|NCT02542943|455530906|FG002|Overall Study|Withdrawal by Subject|0|||
126610109|NCT05865392|455530910|FG000|Overall Study|Withdrawal by Subject|4|||
126610110|NCT05865392|455530911|FG001|Overall Study|Withdrawal by Subject|0|||
126610111|NCT05865392|455530910|FG000|Overall Study|Didn't meet inclusion criteria|4|||
126610112|NCT05865392|455530911|FG001|Overall Study|Didn't meet inclusion criteria|0|||
126610113|NCT05366751|455530912|FG000|Overall Study|Adverse Event|25|||
126610114|NCT05366751|455530912|FG000|Overall Study|Physician Decision|3|||
126610115|NCT05366751|455530912|FG000|Overall Study|Lost to Follow-up|2|||
126610116|NCT05366751|455530912|FG000|Overall Study|Withdrawal by Subject|14|||
126610117|NCT05366751|455530912|FG000|Overall Study|Study Terminated by Sponsor|50|||
126610118|NCT05366751|455530912|FG000|Overall Study|Site Terminated by Sponsor|3|||
126610119|NCT00302211|455530918|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
126610120|NCT00302211|455530919|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
126610121|NCT00302211|455530920|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
126610122|NCT00302211|455530921|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
126610123|NCT00302211|455530922|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
126610124|NCT00302211|455530918|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
126610125|NCT00302211|455530919|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
126610126|NCT00302211|455530920|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
126610127|NCT00302211|455530921|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
126610128|NCT00302211|455530922|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
126610129|NCT00302211|455530918|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
126610130|NCT00302211|455530919|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
126610131|NCT00302211|455530920|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
126610132|NCT00302211|455530921|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
126610133|NCT00302211|455530922|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
126610134|NCT00302211|455530918|FG000|Double Blind Period (New Patients)|Disease progression|0|||
126610135|NCT00302211|455530919|FG001|Double Blind Period (New Patients)|Disease progression|1|||
126610136|NCT00302211|455530920|FG002|Double Blind Period (New Patients)|Disease progression|1|||
126610137|NCT00302211|455530921|FG003|Double Blind Period (New Patients)|Disease progression|0|||
126610138|NCT00302211|455530922|FG004|Double Blind Period (New Patients)|Disease progression|0|||
126610139|NCT00302211|455530918|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
126610140|NCT00302211|455530919|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
126610141|NCT00302211|455530920|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
126610142|NCT00302211|455530921|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
126610143|NCT00302211|455530922|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
126610144|NCT00302211|455530918|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
126610145|NCT00302211|455530919|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
126610146|NCT00302211|455530920|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
126610147|NCT00302211|455530921|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
126610148|NCT00302211|455530922|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
126610149|NCT00302211|455530918|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
126610150|NCT00302211|455530919|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
126610151|NCT00302211|455530920|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
126610152|NCT00302211|455530921|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
126610153|NCT00302211|455530922|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
126610154|NCT00302211|455530918|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
126610155|NCT00302211|455530919|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
126610156|NCT00302211|455530920|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
126610157|NCT00302211|455530921|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
126610158|NCT00302211|455530922|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
126610159|NCT00302211|455530918|FG000|Open Label-Patients From Double-Blind|Death|0|||
126610160|NCT00302211|455530919|FG001|Open Label-Patients From Double-Blind|Death|0|||
126610161|NCT00302211|455530920|FG002|Open Label-Patients From Double-Blind|Death|0|||
126610162|NCT00302211|455530921|FG003|Open Label-Patients From Double-Blind|Death|1|||
126610163|NCT00302211|455530922|FG004|Open Label-Patients From Double-Blind|Death|1|||
126610164|NCT00302211|455530918|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
126610165|NCT00302211|455530919|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
126610166|NCT00302211|455530920|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
126610167|NCT00302211|455530921|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
126610168|NCT00302211|455530922|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
126781242|NCT03882047|456154500|FG001|Overall Study|Adverse Event|2|||
126610169|NCT00302211|455530918|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
126610170|NCT00302211|455530919|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
126610171|NCT00302211|455530920|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
126610172|NCT00302211|455530921|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
126610173|NCT00302211|455530922|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
126610174|NCT00302211|455530918|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
126610175|NCT00302211|455530919|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
126610176|NCT00302211|455530920|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
126610177|NCT00302211|455530921|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
126610178|NCT00302211|455530922|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
126610179|NCT00551421|455532324|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
126610180|NCT02634307|455532334|FG000|Overall Study|Adverse Event|50|||
126610181|NCT02634307|455532335|FG001|Overall Study|Adverse Event|24|||
126610182|NCT02634307|455532336|FG002|Overall Study|Adverse Event|14|||
126610183|NCT02634307|455532334|FG000|Overall Study|Lost to Follow-up|21|||
126610184|NCT02634307|455532335|FG001|Overall Study|Lost to Follow-up|5|||
126610185|NCT02634307|455532336|FG002|Overall Study|Lost to Follow-up|6|||
126610186|NCT02634307|455532334|FG000|Overall Study|Pregnancy|5|||
126610187|NCT02634307|455532335|FG001|Overall Study|Pregnancy|1|||
126610188|NCT02634307|455532336|FG002|Overall Study|Pregnancy|3|||
126610189|NCT02634307|455532334|FG000|Overall Study|Withdrawal by Subject|38|||
126610190|NCT02634307|455532335|FG001|Overall Study|Withdrawal by Subject|24|||
126610191|NCT02634307|455532336|FG002|Overall Study|Withdrawal by Subject|18|||
126610192|NCT02634307|455532334|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126610193|NCT02634307|455532335|FG001|Overall Study|Non-Compliance with Study Drug|2|||
126610194|NCT02634307|455532336|FG002|Overall Study|Non-Compliance with Study Drug|2|||
126610195|NCT02634307|455532334|FG000|Overall Study|Lack of Efficacy|1|||
126610196|NCT02634307|455532335|FG001|Overall Study|Lack of Efficacy|5|||
126610197|NCT02634307|455532336|FG002|Overall Study|Lack of Efficacy|3|||
126610198|NCT02634307|455532334|FG000|Overall Study|Physician Decision|7|||
126610199|NCT02634307|455532335|FG001|Overall Study|Physician Decision|5|||
126610200|NCT02634307|455532336|FG002|Overall Study|Physician Decision|5|||
126610201|NCT02634307|455532334|FG000|Overall Study|Reason not Specified|3|||
126610202|NCT02634307|455532335|FG001|Overall Study|Reason not Specified|5|||
126610203|NCT02634307|455532336|FG002|Overall Study|Reason not Specified|10|||
126610204|NCT02698475|455532337|FG000|Main Study Period|Lack of Efficacy|1|||
126610205|NCT02698475|455532337|FG000|Main Study Period|Protocol Violation|2|||
126610206|NCT02698475|455532337|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
126610207|NCT02698475|455532337|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
126610208|NCT02698475|455532337|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
126610209|NCT02698475|455532337|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
126610210|NCT02698475|455532337|FG000|Long-Term Extension Period|Other|1|||
126610211|NCT02132949|455532338|FG000|Overall Study|Death|7|||
126610212|NCT02132949|455532339|FG001|Overall Study|Death|13|||
126610213|NCT02132949|455532338|FG000|Overall Study|Lost to Follow-up|14|||
126610214|NCT02132949|455532339|FG001|Overall Study|Lost to Follow-up|4|||
126610215|NCT02132949|455532338|FG000|Overall Study|Withdrawal by Subject|6|||
126610216|NCT02132949|455532339|FG001|Overall Study|Withdrawal by Subject|5|||
126610217|NCT02132949|455532338|FG000|Overall Study|Noncompliance|5|||
126610218|NCT02132949|455532339|FG001|Overall Study|Noncompliance|1|||
126610219|NCT02132949|455532338|FG000|Overall Study|Physician Decision|3|||
126610220|NCT02132949|455532339|FG001|Overall Study|Physician Decision|1|||
126610221|NCT02132949|455532338|FG000|Overall Study|Disease Progression|3|||
126610222|NCT02132949|455532339|FG001|Overall Study|Disease Progression|0|||
126610223|NCT02132949|455532338|FG000|Overall Study|Adverse Event|2|||
126610224|NCT02132949|455532339|FG001|Overall Study|Adverse Event|1|||
126610225|NCT02132949|455532338|FG000|Overall Study|Withdrew Prior to Treatment|1|||
126734120|NCT02119026|455975818|FG001|1st-line Treatment|Withdrawal by Subject|10|||
126734121|NCT02119026|455975817|FG000|1st-line Treatment|Patient condition or compliance|6|||
126610226|NCT02132949|455532339|FG001|Overall Study|Withdrew Prior to Treatment|2|||
126610227|NCT02132949|455532338|FG000|Overall Study|Reason Unspecified|0|||
126610228|NCT02132949|455532339|FG001|Overall Study|Reason Unspecified|1|||
126610229|NCT00745875|455532342|FG000|Overall Study|Continuing study treatment|4|||
126610230|NCT00745875|455532343|FG001|Overall Study|Continuing study treatment|4|||
126610231|NCT01532648|455532344|FG000|Overall Study|Lost to Follow-up|3|||
126610232|NCT01532648|455532345|FG001|Overall Study|Lost to Follow-up|4|||
126610233|NCT01532648|455532344|FG000|Overall Study|Lack of Efficacy|4|||
126610234|NCT01532648|455532345|FG001|Overall Study|Lack of Efficacy|1|||
126610235|NCT01532648|455532344|FG000|Overall Study|Protocol Violation|1|||
126610236|NCT01532648|455532345|FG001|Overall Study|Protocol Violation|1|||
126610237|NCT01532648|455532344|FG000|Overall Study|Adverse Event|12|||
126781243|NCT03882047|456154501|FG002|Overall Study|Adverse Event|2|||
126610238|NCT01532648|455532345|FG001|Overall Study|Adverse Event|9|||
126610239|NCT01532648|455532344|FG000|Overall Study|Withdrawal by Subject|16|||
126610240|NCT01532648|455532345|FG001|Overall Study|Withdrawal by Subject|2|||
126610241|NCT01833455|455532346|FG000|Overall Study|Withdrawal by Subject|1|||
126610242|NCT01833455|455532347|FG001|Overall Study|Withdrawal by Subject|0|||
126610243|NCT01256359|455532348|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
126610244|NCT01256359|455532349|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
126610245|NCT01256359|455532348|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
126610246|NCT01256359|455532349|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
126610247|NCT02000752|455532350|FG000|Overall Study|Dystocic delivery|19|||
126610248|NCT02000752|455532351|FG001|Overall Study|Dystocic delivery|8|||
126610249|NCT02000752|455532350|FG000|Overall Study|Shift Changes|12|||
126610250|NCT02000752|455532351|FG001|Overall Study|Shift Changes|5|||
126610251|NCT04658784|455532357|FG000|6-month Follow-up|Lost to Follow-up|2|||
126610252|NCT04658784|455532358|FG001|6-month Follow-up|Lost to Follow-up|5|||
126610253|NCT02095145|455532360|FG000|Overall Study|Withdrawal by Subject|1|||
126610254|NCT02095145|455532361|FG001|Overall Study|Withdrawal by Subject|0|||
126610255|NCT02630186|455532362|FG000|Overall Study|Withdrawal by Subject|1|||
126610256|NCT00670488|455532364|FG000|Overall Study|Adverse Event|0|||
126610257|NCT00670488|455532365|FG001|Overall Study|Adverse Event|7|||
126610258|NCT00670488|455532366|FG002|Overall Study|Adverse Event|0|||
126610259|NCT00670488|455532367|FG003|Overall Study|Adverse Event|3|||
126610260|NCT00670488|455532368|FG004|Overall Study|Adverse Event|1|||
126610261|NCT00670488|455532369|FG005|Overall Study|Adverse Event|1|||
126610262|NCT00670488|455532370|FG006|Overall Study|Adverse Event|5|||
126610263|NCT00670488|455532371|FG007|Overall Study|Adverse Event|1|||
126610264|NCT00670488|455532372|FG008|Overall Study|Adverse Event|0|||
126610265|NCT00670488|455532373|FG009|Overall Study|Adverse Event|1|||
126610266|NCT00670488|455532364|FG000|Overall Study|Physician Decision|1|||
126610267|NCT00670488|455532365|FG001|Overall Study|Physician Decision|9|||
126610268|NCT00670488|455532366|FG002|Overall Study|Physician Decision|0|||
126610269|NCT00670488|455532367|FG003|Overall Study|Physician Decision|1|||
126610270|NCT00670488|455532368|FG004|Overall Study|Physician Decision|0|||
126610271|NCT00670488|455532369|FG005|Overall Study|Physician Decision|0|||
126610272|NCT00670488|455532370|FG006|Overall Study|Physician Decision|0|||
126610273|NCT00670488|455532371|FG007|Overall Study|Physician Decision|0|||
126610274|NCT00670488|455532372|FG008|Overall Study|Physician Decision|0|||
126610275|NCT00670488|455532373|FG009|Overall Study|Physician Decision|0|||
126610276|NCT00670488|455532364|FG000|Overall Study|Progressive Disease|2|||
126610277|NCT00670488|455532365|FG001|Overall Study|Progressive Disease|41|||
126610278|NCT00670488|455532366|FG002|Overall Study|Progressive Disease|3|||
126610279|NCT00670488|455532367|FG003|Overall Study|Progressive Disease|2|||
126610280|NCT00670488|455532368|FG004|Overall Study|Progressive Disease|2|||
126610281|NCT00670488|455532369|FG005|Overall Study|Progressive Disease|4|||
126610282|NCT00670488|455532370|FG006|Overall Study|Progressive Disease|11|||
126610283|NCT00670488|455532371|FG007|Overall Study|Progressive Disease|2|||
126610284|NCT00670488|455532372|FG008|Overall Study|Progressive Disease|2|||
126610285|NCT00670488|455532373|FG009|Overall Study|Progressive Disease|1|||
126610286|NCT00670488|455532364|FG000|Overall Study|Withdrawal by Subject|0|||
126610287|NCT00670488|455532365|FG001|Overall Study|Withdrawal by Subject|1|||
126610288|NCT00670488|455532366|FG002|Overall Study|Withdrawal by Subject|0|||
126610289|NCT00670488|455532367|FG003|Overall Study|Withdrawal by Subject|1|||
126610290|NCT00670488|455532368|FG004|Overall Study|Withdrawal by Subject|0|||
126610291|NCT00670488|455532369|FG005|Overall Study|Withdrawal by Subject|0|||
126610292|NCT00670488|455532370|FG006|Overall Study|Withdrawal by Subject|1|||
126610293|NCT00670488|455532371|FG007|Overall Study|Withdrawal by Subject|0|||
126610294|NCT00670488|455532372|FG008|Overall Study|Withdrawal by Subject|1|||
126610295|NCT00670488|455532373|FG009|Overall Study|Withdrawal by Subject|0|||
126610296|NCT01034306|455532381|FG000|Overall Study|Adverse Event|1|||
126610297|NCT01034306|455532382|FG001|Overall Study|Adverse Event|0|||
126610298|NCT01034306|455532381|FG000|Overall Study|Lost to Follow-up|0|||
126610299|NCT01034306|455532382|FG001|Overall Study|Lost to Follow-up|1|||
126610300|NCT01034306|455532381|FG000|Overall Study|Withdrawal by Subject|2|||
126610301|NCT01034306|455532382|FG001|Overall Study|Withdrawal by Subject|2|||
126610302|NCT01034306|455532381|FG000|Overall Study|hospitalized and decided to stop|1|||
126610303|NCT01034306|455532382|FG001|Overall Study|hospitalized and decided to stop|0|||
126610304|NCT01034306|455532381|FG000|Overall Study|Noncomplience|1|||
126610305|NCT01034306|455532382|FG001|Overall Study|Noncomplience|0|||
126610306|NCT00836498|455532383|FG000|Overall Study|Adverse Event|1|||
126610307|NCT00836498|455532384|FG001|Overall Study|Adverse Event|0|||
126610308|NCT00836498|455532383|FG000|Overall Study|Lost to Follow-up|1|||
126610309|NCT00836498|455532384|FG001|Overall Study|Lost to Follow-up|0|||
126610310|NCT00836498|455532383|FG000|Overall Study|Withdrawal by Subject|2|||
126610311|NCT00836498|455532384|FG001|Overall Study|Withdrawal by Subject|1|||
126610312|NCT01619059|455532385|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
126610313|NCT01619059|455532386|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
126610314|NCT01619059|455532385|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
126610315|NCT01619059|455532386|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
126610316|NCT01619059|455532385|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
126610317|NCT01619059|455532386|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
126610318|NCT01619059|455532385|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
126610319|NCT01619059|455532386|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
126610320|NCT01619059|455532385|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
126610321|NCT01619059|455532386|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
126610322|NCT01619059|455532385|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
126610323|NCT01619059|455532386|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
126610324|NCT01619059|455532385|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
126610325|NCT01619059|455532386|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
126610326|NCT01619059|455532385|FG000|Long-Term (LT) Treatment Period|Death|1|||
126610327|NCT01619059|455532386|FG001|Long-Term (LT) Treatment Period|Death|0|||
126610328|NCT01619059|455532385|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
126610329|NCT01619059|455532386|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
126610330|NCT01619059|455532385|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
126610331|NCT01619059|455532386|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
126610332|NCT03418545|455532387|FG000|Overall Study|Withdrawal by Participant|2|||
126610333|NCT03418545|455532388|FG001|Overall Study|Withdrawal by Participant|4|||
126610334|NCT03418545|455532387|FG000|Overall Study|Lost to Follow-up|3|||
126610335|NCT03418545|455532388|FG001|Overall Study|Lost to Follow-up|5|||
126610336|NCT03418545|455532387|FG000|Overall Study|Reason Not Specified|0|||
126610337|NCT03418545|455532388|FG001|Overall Study|Reason Not Specified|1|||
126610338|NCT03418545|455532387|FG000|Overall Study|Missing Completion Status|0|||
126610339|NCT03418545|455532388|FG001|Overall Study|Missing Completion Status|1|||
126610340|NCT02384382|455532396|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
126610341|NCT02384382|455532396|FG000|Overall Study|Death|1|||
126610342|NCT02384382|455532396|FG000|Overall Study|Adverse Event|1|||
126610343|NCT02384382|455532396|FG000|Overall Study|Disease progression|16|||
126610344|NCT03567616|455532405|FG000|Overall Study|Disease progression|4|||
126610345|NCT03567616|455532405|FG000|Overall Study|Withdrawal by Subject|1|||
126610346|NCT03567616|455532405|FG000|Overall Study|Physician Decision|1|||
126610347|NCT03567616|455532405|FG000|Overall Study|Death|1|||
126610348|NCT03567616|455532405|FG000|Overall Study|Adverse Event|1|||
126610349|NCT00570505|455532416|FG000|Overall Study|Adverse Event|7|||
126610350|NCT00570505|455532416|FG000|Overall Study|Withdrawal by Subject|7|||
126610351|NCT00570505|455532416|FG000|Overall Study|Lost to Follow-up|23|||
126610352|NCT00570505|455532416|FG000|Overall Study|Other loss to follow-up|4|||
126610353|NCT00614614|455532419|FG000|Primary Vaccination Phase|Adverse Event|6|||
126610354|NCT00614614|455532420|FG001|Primary Vaccination Phase|Adverse Event|0|||
126610355|NCT00614614|455532421|FG002|Primary Vaccination Phase|Adverse Event|0|||
126610356|NCT00614614|455532422|FG003|Primary Vaccination Phase|Adverse Event|0|||
126610357|NCT00614614|455532423|FG004|Primary Vaccination Phase|Adverse Event|0|||
126610358|NCT00614614|455532419|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
126610359|NCT00614614|455532420|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
126610360|NCT00614614|455532421|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
126610361|NCT00614614|455532422|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
126610362|NCT00614614|455532423|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
126610363|NCT00614614|455532419|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
126610364|NCT00614614|455532420|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
126610365|NCT00614614|455532421|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
126610366|NCT00614614|455532422|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
126610367|NCT00614614|455532423|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
126610368|NCT00614614|455532419|FG000|Primary Vaccination Phase|Protocol Violation|9|||
126610369|NCT00614614|455532420|FG001|Primary Vaccination Phase|Protocol Violation|3|||
126610370|NCT00614614|455532421|FG002|Primary Vaccination Phase|Protocol Violation|0|||
126610371|NCT00614614|455532422|FG003|Primary Vaccination Phase|Protocol Violation|0|||
126610372|NCT00614614|455532423|FG004|Primary Vaccination Phase|Protocol Violation|0|||
126610373|NCT00614614|455532419|FG000|Primary Vaccination Phase|Other|4|||
126610374|NCT00614614|455532420|FG001|Primary Vaccination Phase|Other|0|||
126610375|NCT00614614|455532421|FG002|Primary Vaccination Phase|Other|0|||
126610376|NCT00614614|455532422|FG003|Primary Vaccination Phase|Other|0|||
126610377|NCT00614614|455532423|FG004|Primary Vaccination Phase|Other|0|||
126610378|NCT00614614|455532419|FG000|Booster Vaccination Phase|Adverse Event|0|||
126610379|NCT00614614|455532420|FG001|Booster Vaccination Phase|Adverse Event|0|||
126610380|NCT00614614|455532421|FG002|Booster Vaccination Phase|Adverse Event|1|||
126610381|NCT00614614|455532422|FG003|Booster Vaccination Phase|Adverse Event|1|||
126610382|NCT00614614|455532423|FG004|Booster Vaccination Phase|Adverse Event|0|||
126610383|NCT00614614|455532419|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
126610384|NCT00614614|455532420|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
126610385|NCT00614614|455532421|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
126610386|NCT00614614|455532422|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
126610387|NCT00614614|455532423|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
126610388|NCT00614614|455532419|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
126781244|NCT03882047|456154499|FG000|Overall Study|Treatment Failure|3|||
126781245|NCT03882047|456154500|FG001|Overall Study|Treatment Failure|3|||
126610389|NCT00614614|455532420|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
126610390|NCT00614614|455532421|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
126610391|NCT00614614|455532422|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
126610392|NCT00614614|455532423|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
126610393|NCT00614614|455532419|FG000|Booster Vaccination Phase|Protocol Violation|0|||
126734122|NCT02119026|455975818|FG001|1st-line Treatment|Patient condition or compliance|4|||
126734123|NCT02119026|455975817|FG000|1st-line Treatment|Surgery of metastases|2|||
126734124|NCT02119026|455975818|FG001|1st-line Treatment|Surgery of metastases|1|||
126734125|NCT02119026|455975817|FG000|1st-line Treatment|Death|2|||
126734126|NCT02119026|455975818|FG001|1st-line Treatment|Death|1|||
126734127|NCT02119026|455975817|FG000|2nd-line Treatment|Lost to Follow-up|2|||
126734128|NCT02119026|455975818|FG001|2nd-line Treatment|Lost to Follow-up|0|||
126734129|NCT02119026|455975817|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
126734130|NCT02119026|455975818|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
126734131|NCT02119026|455975817|FG000|2nd-line Treatment|Adverse Event|4|||
126734132|NCT02119026|455975818|FG001|2nd-line Treatment|Adverse Event|1|||
126734133|NCT00340834|455975819|FG000|Core Phase of Study|Adverse Event|26|||
126734134|NCT00340834|455975820|FG001|Core Phase of Study|Adverse Event|9|||
126610394|NCT00614614|455532420|FG001|Booster Vaccination Phase|Protocol Violation|0|||
126610395|NCT00614614|455532421|FG002|Booster Vaccination Phase|Protocol Violation|2|||
126610396|NCT00614614|455532422|FG003|Booster Vaccination Phase|Protocol Violation|3|||
126610397|NCT00614614|455532423|FG004|Booster Vaccination Phase|Protocol Violation|0|||
126610398|NCT00614614|455532419|FG000|Booster Vaccination Phase|Other|0|||
126610399|NCT00614614|455532420|FG001|Booster Vaccination Phase|Other|1|||
126610400|NCT00614614|455532421|FG002|Booster Vaccination Phase|Other|3|||
126610401|NCT00614614|455532422|FG003|Booster Vaccination Phase|Other|2|||
126610402|NCT00614614|455532423|FG004|Booster Vaccination Phase|Other|1|||
126610403|NCT05212285|455532424|FG000|Overall Study|Lack of Efficacy|12|||
126610404|NCT05212285|455532425|FG001|Overall Study|Lack of Efficacy|8|||
126610405|NCT05212285|455532424|FG000|Overall Study|Withdrawal by Subject|8|||
126610406|NCT05212285|455532425|FG001|Overall Study|Withdrawal by Subject|1|||
126610407|NCT05212285|455532424|FG000|Overall Study|Lost to Follow-up|13|||
126610408|NCT05212285|455532425|FG001|Overall Study|Lost to Follow-up|1|||
126610409|NCT05212285|455532424|FG000|Overall Study|miss data|21|||
126610410|NCT05212285|455532425|FG001|Overall Study|miss data|2|||
126610411|NCT05824559|455532426|FG000|Overall Study|Adverse Event|2|||
126610412|NCT05824559|455532426|FG000|Overall Study|Physician Decision|2|||
126610413|NCT05824559|455532426|FG000|Overall Study|Progressive Disease|16|||
126610414|NCT05824559|455532426|FG000|Overall Study|Study Terminated by Sponsor|1|||
126610415|NCT05824559|455532426|FG000|Overall Study|Withdrawal by Subject|2|||
126610416|NCT04602728|455532432|FG000|Overall Study|Lost to Follow-up|4|||
126610417|NCT04602728|455532433|FG001|Overall Study|Lost to Follow-up|4|||
126610418|NCT02831049|455532440|FG000|Overall Study|Lost to Follow-up|0|||
126610419|NCT02831049|455532441|FG001|Overall Study|Lost to Follow-up|0|||
126610420|NCT02831049|455532442|FG002|Overall Study|Lost to Follow-up|1|||
126610421|NCT02831049|455532440|FG000|Overall Study|Withdrawal by Subject|0|||
126610422|NCT02831049|455532441|FG001|Overall Study|Withdrawal by Subject|1|||
126610423|NCT02831049|455532442|FG002|Overall Study|Withdrawal by Subject|1|||
126610424|NCT02831049|455532440|FG000|Overall Study|Pandemic shutdown|1|||
126610425|NCT02831049|455532441|FG001|Overall Study|Pandemic shutdown|0|||
126610426|NCT02831049|455532442|FG002|Overall Study|Pandemic shutdown|0|||
126610427|NCT04224272|455532443|FG000|Part 1 - Dose Finding|Death|4|||
126610428|NCT04224272|455532443|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
126610429|NCT04224272|455532443|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
126610430|NCT04224272|455532443|FG000|Part 2 - Dose Expansion|Death|10|||
126610431|NCT04224272|455532443|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
126610432|NCT02609048|455532444|FG000|Overall Study|Adverse Event|3|||
126610433|NCT02609048|455532445|FG001|Overall Study|Adverse Event|0|||
126610434|NCT02609048|455532446|FG002|Overall Study|Adverse Event|0|||
126610435|NCT02609048|455532444|FG000|Overall Study|Randomized but never treated|1|||
126734135|NCT00340834|455975821|FG002|Core Phase of Study|Adverse Event|9|||
126734136|NCT00340834|455975822|FG003|Core Phase of Study|Adverse Event|0|||
126734137|NCT00340834|455975823|FG004|Core Phase of Study|Adverse Event|0|||
126610436|NCT02609048|455532445|FG001|Overall Study|Randomized but never treated|1|||
126610437|NCT02609048|455532446|FG002|Overall Study|Randomized but never treated|1|||
126610438|NCT02609048|455532444|FG000|Overall Study|Withdrawal of informed consent|1|||
126610439|NCT02609048|455532445|FG001|Overall Study|Withdrawal of informed consent|0|||
126610440|NCT02609048|455532446|FG002|Overall Study|Withdrawal of informed consent|0|||
126610441|NCT02609048|455532444|FG000|Overall Study|Reason not specified|6|||
126610442|NCT02609048|455532445|FG001|Overall Study|Reason not specified|9|||
126610443|NCT02609048|455532446|FG002|Overall Study|Reason not specified|9|||
126610444|NCT02485925|455532447|FG000|Overall Study|Withdrawal by Subject|3|||
126610445|NCT02485925|455532447|FG000|Overall Study|Death|1|||
126734138|NCT00340834|455975819|FG000|Core Phase of Study|Withdrawal by Subject|11|||
126734139|NCT00340834|455975820|FG001|Core Phase of Study|Withdrawal by Subject|9|||
126610446|NCT02485925|455532447|FG000|Overall Study|Lost to Follow-up|11|||
126610447|NCT05995977|455532448|FG000|Overall Study|Withdrawal by Subject|1|||
126610448|NCT05995977|455532449|FG001|Overall Study|Withdrawal by Subject|4|||
126610449|NCT05995977|455532448|FG000|Overall Study|Lost to Follow-up|2|||
126610450|NCT05995977|455532449|FG001|Overall Study|Lost to Follow-up|0|||
126610451|NCT04181788|455532450|FG000|TREATMENT|Adverse Event|0|||
126610452|NCT04181788|455532451|FG001|TREATMENT|Adverse Event|2|||
126610453|NCT04181788|455532452|FG002|TREATMENT|Adverse Event|1|||
126610454|NCT04181788|455532453|FG003|TREATMENT|Adverse Event|0|||
126610455|NCT04181788|455532454|FG004|TREATMENT|Adverse Event|1|||
126610456|NCT04181788|455532455|FG005|TREATMENT|Adverse Event|3|||
126610457|NCT04181788|455532450|FG000|TREATMENT|Death|0|||
126610458|NCT04181788|455532451|FG001|TREATMENT|Death|0|||
126610459|NCT04181788|455532452|FG002|TREATMENT|Death|0|||
126610460|NCT04181788|455532453|FG003|TREATMENT|Death|0|||
126610461|NCT04181788|455532454|FG004|TREATMENT|Death|8|||
126610462|NCT04181788|455532455|FG005|TREATMENT|Death|8|||
126610463|NCT04181788|455532450|FG000|TREATMENT|Physician Decision|0|||
126610464|NCT04181788|455532451|FG001|TREATMENT|Physician Decision|0|||
126610465|NCT04181788|455532452|FG002|TREATMENT|Physician Decision|0|||
126610466|NCT04181788|455532453|FG003|TREATMENT|Physician Decision|0|||
126610467|NCT04181788|455532454|FG004|TREATMENT|Physician Decision|0|||
126610468|NCT04181788|455532455|FG005|TREATMENT|Physician Decision|1|||
126610469|NCT04181788|455532450|FG000|TREATMENT|Progressive disease|3|||
126610470|NCT04181788|455532451|FG001|TREATMENT|Progressive disease|3|||
126610471|NCT04181788|455532452|FG002|TREATMENT|Progressive disease|5|||
126610472|NCT04181788|455532453|FG003|TREATMENT|Progressive disease|7|||
126610473|NCT04181788|455532454|FG004|TREATMENT|Progressive disease|20|||
126610474|NCT04181788|455532455|FG005|TREATMENT|Progressive disease|38|||
126610475|NCT04181788|455532450|FG000|TREATMENT|Global deterioration of health status|0|||
126610476|NCT04181788|455532451|FG001|TREATMENT|Global deterioration of health status|2|||
126610477|NCT04181788|455532452|FG002|TREATMENT|Global deterioration of health status|0|||
126610478|NCT04181788|455532453|FG003|TREATMENT|Global deterioration of health status|0|||
126610479|NCT04181788|455532454|FG004|TREATMENT|Global deterioration of health status|2|||
126610480|NCT04181788|455532455|FG005|TREATMENT|Global deterioration of health status|8|||
126610481|NCT04181788|455532450|FG000|TREATMENT|Withdrawal by Subject|1|||
126610482|NCT04181788|455532451|FG001|TREATMENT|Withdrawal by Subject|2|||
126610483|NCT04181788|455532452|FG002|TREATMENT|Withdrawal by Subject|0|||
126610484|NCT04181788|455532453|FG003|TREATMENT|Withdrawal by Subject|0|||
126610485|NCT04181788|455532454|FG004|TREATMENT|Withdrawal by Subject|3|||
126610486|NCT04181788|455532455|FG005|TREATMENT|Withdrawal by Subject|5|||
126610487|NCT04181788|455532450|FG000|TREATMENT|Other unspecified|0|||
126610488|NCT04181788|455532451|FG001|TREATMENT|Other unspecified|0|||
126610489|NCT04181788|455532452|FG002|TREATMENT|Other unspecified|0|||
126610490|NCT04181788|455532453|FG003|TREATMENT|Other unspecified|0|||
126610491|NCT04181788|455532454|FG004|TREATMENT|Other unspecified|0|||
126610492|NCT04181788|455532455|FG005|TREATMENT|Other unspecified|2|||
126610493|NCT04181788|455532450|FG000|TREATMENT|Ongoing|0|||
126610494|NCT04181788|455532451|FG001|TREATMENT|Ongoing|3|||
126610495|NCT04181788|455532452|FG002|TREATMENT|Ongoing|0|||
126610496|NCT04181788|455532453|FG003|TREATMENT|Ongoing|5|||
126610497|NCT04181788|455532454|FG004|TREATMENT|Ongoing|7|||
126610498|NCT04181788|455532455|FG005|TREATMENT|Ongoing|15|||
126610499|NCT04181788|455532450|FG000|FOLLOW-UP|Death|0|||
126610500|NCT04181788|455532451|FG001|FOLLOW-UP|Death|0|||
126610501|NCT04181788|455532452|FG002|FOLLOW-UP|Death|1|||
126610502|NCT04181788|455532453|FG003|FOLLOW-UP|Death|2|||
126610503|NCT04181788|455532454|FG004|FOLLOW-UP|Death|8|||
126610504|NCT04181788|455532455|FG005|FOLLOW-UP|Death|20|||
126610505|NCT04181788|455532450|FG000|FOLLOW-UP|Lost to Follow-up|0|||
126610506|NCT04181788|455532451|FG001|FOLLOW-UP|Lost to Follow-up|0|||
126734140|NCT00340834|455975821|FG002|Core Phase of Study|Withdrawal by Subject|16|||
126610507|NCT04181788|455532452|FG002|FOLLOW-UP|Lost to Follow-up|0|||
126734141|NCT00340834|455975822|FG003|Core Phase of Study|Withdrawal by Subject|0|||
126734142|NCT00340834|455975823|FG004|Core Phase of Study|Withdrawal by Subject|0|||
126734143|NCT00340834|455975819|FG000|Core Phase of Study|Administrative Problems|6|||
126610508|NCT04181788|455532453|FG003|FOLLOW-UP|Lost to Follow-up|0|||
126610509|NCT04181788|455532454|FG004|FOLLOW-UP|Lost to Follow-up|0|||
126610510|NCT04181788|455532455|FG005|FOLLOW-UP|Lost to Follow-up|2|||
126610511|NCT04181788|455532450|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
126610512|NCT04181788|455532451|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
126734144|NCT00340834|455975820|FG001|Core Phase of Study|Administrative Problems|2|||
126610513|NCT04181788|455532452|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
126610514|NCT04181788|455532453|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
126610515|NCT04181788|455532454|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
126610516|NCT04181788|455532455|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
126610517|NCT04181788|455532450|FG000|FOLLOW-UP|Other unspecified|0|||
126610518|NCT04181788|455532451|FG001|FOLLOW-UP|Other unspecified|1|||
126610519|NCT04181788|455532452|FG002|FOLLOW-UP|Other unspecified|0|||
126610520|NCT04181788|455532453|FG003|FOLLOW-UP|Other unspecified|0|||
126610521|NCT04181788|455532454|FG004|FOLLOW-UP|Other unspecified|0|||
126610522|NCT04181788|455532455|FG005|FOLLOW-UP|Other unspecified|3|||
126610523|NCT04181788|455532450|FG000|FOLLOW-UP|Ongoing|0|||
126610524|NCT04181788|455532451|FG001|FOLLOW-UP|Ongoing|0|||
126610525|NCT04181788|455532452|FG002|FOLLOW-UP|Ongoing|1|||
126610526|NCT04181788|455532453|FG003|FOLLOW-UP|Ongoing|3|||
126610527|NCT04181788|455532454|FG004|FOLLOW-UP|Ongoing|2|||
126610528|NCT04181788|455532455|FG005|FOLLOW-UP|Ongoing|2|||
126610529|NCT02556918|455534427|FG000|Overall Study|Protocol Violation|5|||
126610530|NCT02556918|455534428|FG001|Overall Study|Protocol Violation|6|||
126610531|NCT02556918|455534427|FG000|Overall Study|Withdrawal by Subject|4|||
126610532|NCT02556918|455534428|FG001|Overall Study|Withdrawal by Subject|4|||
126610533|NCT01823224|455534439|FG000|Overall Study|Lost to Follow-up|5|||
126610534|NCT01823224|455534440|FG001|Overall Study|Lost to Follow-up|6|||
126610535|NCT01823224|455534439|FG000|Overall Study|didn't qualify|1|||
126610536|NCT01823224|455534440|FG001|Overall Study|didn't qualify|2|||
126610537|NCT01823224|455534439|FG000|Overall Study|pharmacy error|0|||
126610538|NCT01823224|455534440|FG001|Overall Study|pharmacy error|1|||
126610539|NCT01823224|455534439|FG000|Overall Study|missed med dose|0|||
126610540|NCT01823224|455534440|FG001|Overall Study|missed med dose|1|||
126610541|NCT01823224|455534439|FG000|Overall Study|Withdrawal by Subject|0|||
126610542|NCT01823224|455534440|FG001|Overall Study|Withdrawal by Subject|1|||
126610543|NCT02148705|455534448|FG000|Overall Study|Death|2|||
126610544|NCT02148705|455534449|FG001|Overall Study|Death|0|||
126610545|NCT02148705|455534450|FG002|Overall Study|Death|0|||
126610546|NCT02148705|455534448|FG000|Overall Study|Lost to Follow-up|13|||
126610547|NCT02148705|455534449|FG001|Overall Study|Lost to Follow-up|4|||
126610548|NCT02148705|455534450|FG002|Overall Study|Lost to Follow-up|10|||
126610549|NCT02148705|455534448|FG000|Overall Study|Withdrawal by Subject|3|||
126610550|NCT02148705|455534449|FG001|Overall Study|Withdrawal by Subject|0|||
126610551|NCT02148705|455534450|FG002|Overall Study|Withdrawal by Subject|2|||
126610552|NCT02148705|455534448|FG000|Overall Study|Not Treated|0|||
126610553|NCT02148705|455534449|FG001|Overall Study|Not Treated|1|||
126610554|NCT02148705|455534450|FG002|Overall Study|Not Treated|5|||
126610555|NCT01583166|455534451|FG000|Overall Study|Withdrawal by Subject|4|||
126610556|NCT01583166|455534452|FG001|Overall Study|Withdrawal by Subject|6|||
126610557|NCT01737021|455534455|FG000|Overall Study|Lost to Follow-up|5|||
126610558|NCT01737021|455534456|FG001|Overall Study|Lost to Follow-up|3|||
126610559|NCT02310581|455534457|FG000|Overall Study|Adverse Event|1|||
126610560|NCT02310581|455534458|FG001|Overall Study|Adverse Event|1|||
126610561|NCT02310581|455534459|FG002|Overall Study|Adverse Event|1|||
126610562|NCT02310581|455534460|FG003|Overall Study|Adverse Event|0|||
126610563|NCT02310581|455534457|FG000|Overall Study|Withdrawal by Subject|2|||
126610564|NCT02310581|455534458|FG001|Overall Study|Withdrawal by Subject|1|||
126610565|NCT02310581|455534459|FG002|Overall Study|Withdrawal by Subject|0|||
126610566|NCT02310581|455534460|FG003|Overall Study|Withdrawal by Subject|1|||
126610567|NCT01673594|455534461|FG000|Overall Study|Adverse Event|3|||
126610568|NCT01673594|455534462|FG001|Overall Study|Adverse Event|1|||
126610569|NCT01673594|455534461|FG000|Overall Study|Lost to Follow-up|1|||
126610570|NCT01673594|455534462|FG001|Overall Study|Lost to Follow-up|0|||
126610571|NCT01673594|455534461|FG000|Overall Study|Physician Decision|2|||
126610572|NCT01673594|455534462|FG001|Overall Study|Physician Decision|4|||
126610573|NCT01673594|455534461|FG000|Overall Study|Withdrawal by Subject|0|||
126610574|NCT01673594|455534462|FG001|Overall Study|Withdrawal by Subject|1|||
126610575|NCT04652869|455534465|FG000|Overall Study|Withdrawal by Subject|0|||
126610576|NCT04652869|455534466|FG001|Overall Study|Withdrawal by Subject|2|||
126610577|NCT04652869|455534467|FG002|Overall Study|Withdrawal by Subject|0|||
126610578|NCT00887224|455534468|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
126610579|NCT00887224|455534469|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
126610580|NCT00887224|455534470|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
126610581|NCT00887224|455534468|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
126610582|NCT00887224|455534469|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
126610583|NCT00887224|455534470|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
126610584|NCT00887224|455534468|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
126610585|NCT00887224|455534469|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
126610586|NCT00887224|455534470|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
126610587|NCT00887224|455534468|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
126610588|NCT00887224|455534469|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
126610589|NCT00887224|455534470|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
126610590|NCT00887224|455534468|FG000|Open-label Response (OLR) Phase|Other|1|||
126610591|NCT00887224|455534469|FG001|Open-label Response (OLR) Phase|Other|0|||
126610592|NCT00887224|455534470|FG002|Open-label Response (OLR) Phase|Other|0|||
126610593|NCT00887224|455534468|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
126610594|NCT00887224|455534469|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
126610595|NCT00887224|455534470|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
126610596|NCT00887224|455534468|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
126610597|NCT00887224|455534469|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
126610598|NCT00887224|455534470|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
126610599|NCT00887224|455534468|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
126610600|NCT00887224|455534469|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
126610601|NCT00887224|455534470|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
126610602|NCT00887224|455534468|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
126610603|NCT00887224|455534469|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
126610604|NCT00887224|455534470|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
126610605|NCT00887224|455534468|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
126610606|NCT00887224|455534469|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
126610607|NCT00887224|455534470|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
126610608|NCT00887224|455534468|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
126610609|NCT00887224|455534469|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
126610610|NCT00887224|455534470|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
126610611|NCT00887224|455534468|FG000|Open-label Stability (OLS) Phase|Other|1|||
126610612|NCT00887224|455534469|FG001|Open-label Stability (OLS) Phase|Other|0|||
126610613|NCT00887224|455534470|FG002|Open-label Stability (OLS) Phase|Other|0|||
126610614|NCT00887224|455534468|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
126610615|NCT00887224|455534469|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
126610616|NCT00887224|455534470|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
126610617|NCT00887224|455534468|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
126610618|NCT00887224|455534469|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
126610619|NCT00887224|455534470|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
126610620|NCT00887224|455534468|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
126610621|NCT00887224|455534469|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
126610622|NCT00887224|455534470|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
126610623|NCT00887224|455534468|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
126610624|NCT00887224|455534469|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
126610625|NCT00887224|455534470|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
126610626|NCT00887224|455534468|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
126610627|NCT00887224|455534469|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
126610628|NCT00887224|455534470|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
126610629|NCT00887224|455534468|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
126610630|NCT00887224|455534469|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
126610631|NCT00887224|455534470|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
126610632|NCT00887224|455534468|FG000|OL Taper Phase / OL Follow Up|Other|30|||
126610633|NCT00887224|455534469|FG001|OL Taper Phase / OL Follow Up|Other|0|||
126610634|NCT00887224|455534470|FG002|OL Taper Phase / OL Follow Up|Other|0|||
126610635|NCT00887224|455534468|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
126610636|NCT00887224|455534469|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
126610637|NCT00887224|455534470|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
126610638|NCT00887224|455534468|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
126610639|NCT00887224|455534469|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
126610640|NCT00887224|455534470|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
126610641|NCT00887224|455534468|FG000|Double-blind (DB) Phase|Adverse Event|0|||
126610642|NCT00887224|455534469|FG001|Double-blind (DB) Phase|Adverse Event|7|||
126610643|NCT00887224|455534470|FG002|Double-blind (DB) Phase|Adverse Event|2|||
126610644|NCT00887224|455534468|FG000|Double-blind (DB) Phase|Failed to return|0|||
126610645|NCT00887224|455534469|FG001|Double-blind (DB) Phase|Failed to return|2|||
126610646|NCT00887224|455534470|FG002|Double-blind (DB) Phase|Failed to return|2|||
126610647|NCT00887224|455534468|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
126610648|NCT00887224|455534469|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
126610649|NCT00887224|455534470|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
126610650|NCT00887224|455534468|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
126610651|NCT00887224|455534469|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
126610652|NCT00887224|455534470|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
126610653|NCT00887224|455534468|FG000|Double-blind (DB) Phase|Other|0|||
126610654|NCT00887224|455534469|FG001|Double-blind (DB) Phase|Other|2|||
126610655|NCT00887224|455534470|FG002|Double-blind (DB) Phase|Other|0|||
126610656|NCT00887224|455534468|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
126610657|NCT00887224|455534469|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
126610658|NCT00887224|455534470|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
126610659|NCT00887224|455534468|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
126610660|NCT00887224|455534469|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
126610661|NCT00887224|455534470|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
126610662|NCT00887224|455534468|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
126781246|NCT03882047|456154501|FG002|Overall Study|Treatment Failure|12|||
126610663|NCT00887224|455534469|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
126610664|NCT00887224|455534470|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
126610665|NCT00887224|455534468|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
126610666|NCT00887224|455534469|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
126610667|NCT00887224|455534470|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
126610668|NCT00887224|455534468|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
126610669|NCT00887224|455534469|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
126610670|NCT00887224|455534470|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
126610671|NCT00887224|455534468|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
126610672|NCT00887224|455534469|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
126610673|NCT00887224|455534470|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
126610674|NCT00887224|455534468|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
126610675|NCT00887224|455534469|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
126610676|NCT00887224|455534470|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
126610677|NCT00887224|455534468|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
126610678|NCT00887224|455534469|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
126610679|NCT00887224|455534470|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
126610680|NCT00887224|455534468|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
126610681|NCT00887224|455534469|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
126610682|NCT00887224|455534470|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
126610683|NCT03883828|455534471|FG000|Overall Study|Did not start radiotherapy|1|||
126610684|NCT03883828|455534472|FG001|Overall Study|Did not start radiotherapy|2|||
126610685|NCT04938453|455534477|FG000|Washout Period 1|Adverse Event|1|||
126610686|NCT04938453|455534478|FG001|Washout Period 1|Adverse Event|0|||
126610687|NCT04938453|455534477|FG000|Washout Period 1|Physician Decision|0|||
126610688|NCT04938453|455534478|FG001|Washout Period 1|Physician Decision|1|||
126610689|NCT00454194|455534483|FG000|Overall Study|Adverse Event|7|||
126610690|NCT00454194|455534484|FG001|Overall Study|Adverse Event|2|||
126610691|NCT00454194|455534483|FG000|Overall Study|Withdrawal by Subject|12|||
126610692|NCT00454194|455534484|FG001|Overall Study|Withdrawal by Subject|8|||
126610693|NCT00454194|455534483|FG000|Overall Study|Other Medical Problems|1|||
126610694|NCT00454194|455534484|FG001|Overall Study|Other Medical Problems|2|||
126610695|NCT00454194|455534483|FG000|Overall Study|Other Unspecified Reason|2|||
126610696|NCT00454194|455534484|FG001|Overall Study|Other Unspecified Reason|2|||
126610697|NCT02827201|455534485|FG000|Overall Study|Death|1|||
126610698|NCT02827201|455534486|FG001|Overall Study|Death|2|||
126610699|NCT02827201|455534485|FG000|Overall Study|Patients not treated|1|||
126610700|NCT02827201|455534486|FG001|Overall Study|Patients not treated|1|||
126610701|NCT03345979|455534487|FG000|Overall Study|Withdrawal by Subject|20|||
126610702|NCT03345979|455534488|FG001|Overall Study|Withdrawal by Subject|31|||
126610703|NCT03345979|455534487|FG000|Overall Study|Adverse Event|10|||
126610704|NCT03345979|455534488|FG001|Overall Study|Adverse Event|11|||
126610705|NCT03345979|455534487|FG000|Overall Study|Lost to Follow-up|8|||
126610706|NCT03345979|455534488|FG001|Overall Study|Lost to Follow-up|9|||
126610707|NCT03345979|455534487|FG000|Overall Study|Lack of Efficacy|4|||
126610708|NCT03345979|455534488|FG001|Overall Study|Lack of Efficacy|2|||
126610709|NCT03345979|455534487|FG000|Overall Study|Protocol Violation|1|||
126610710|NCT03345979|455534488|FG001|Overall Study|Protocol Violation|3|||
126610711|NCT03345979|455534487|FG000|Overall Study|Physician Decision|0|||
126610712|NCT03345979|455534488|FG001|Overall Study|Physician Decision|2|||
126610713|NCT03176407|455534491|FG000|Overall Study|Protocol Violation|1|||
126610714|NCT03176407|455534491|FG000|Overall Study|human failure|1|||
126610715|NCT03176407|455534491|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
126610716|NCT01428583|455534493|FG000|Overall Study|Adverse Event|75|||
126610717|NCT01428583|455534493|FG000|Overall Study|Withdrawal by Subject|51|||
126610718|NCT01428583|455534493|FG000|Overall Study|Lack of Efficacy|37|||
126610719|NCT01428583|455534493|FG000|Overall Study|Lost to Follow-up|17|||
126610720|NCT01428583|455534493|FG000|Overall Study|Death|1|||
126610721|NCT01428583|455534493|FG000|Overall Study|Pregnancy|1|||
126610722|NCT01428583|455534493|FG000|Overall Study|Protocol Violation|1|||
126610723|NCT01428583|455534493|FG000|Overall Study|Physician Decision|12|||
126610724|NCT01428583|455534493|FG000|Overall Study|Non-compliant|25|||
126610725|NCT01428583|455534493|FG000|Overall Study|Confirmed positive urine drug test|8|||
126610726|NCT01428583|455534493|FG000|Overall Study|Sponsor's request|3|||
126610727|NCT01428583|455534493|FG000|Overall Study|Other|6|||
126610728|NCT01124045|455534495|FG000|Overall Study|Lost to Follow-up|0|||
126610729|NCT01124045|455534496|FG001|Overall Study|Lost to Follow-up|1|||
126610730|NCT01124045|455534495|FG000|Overall Study|Physician Decision|0|||
126734145|NCT00340834|455975821|FG002|Core Phase of Study|Administrative Problems|7|||
126734146|NCT00340834|455975822|FG003|Core Phase of Study|Administrative Problems|0|||
126610731|NCT01124045|455534496|FG001|Overall Study|Physician Decision|2|||
126610732|NCT05553366|455534497|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
126610733|NCT05553366|455534498|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
126610734|NCT05553366|455534499|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
126610735|NCT05553366|455534497|FG000|Overall Study|Lost to Follow-up|3|||
126610736|NCT05553366|455534498|FG001|Overall Study|Lost to Follow-up|3|||
126610737|NCT05553366|455534499|FG002|Overall Study|Lost to Follow-up|3|||
126610738|NCT05553366|455534497|FG000|Overall Study|Other non-compliance|1|||
126610739|NCT05553366|455534498|FG001|Overall Study|Other non-compliance|1|||
126610740|NCT05553366|455534499|FG002|Overall Study|Other non-compliance|0|||
126610741|NCT05553366|455534497|FG000|Overall Study|Randomized but not dosed|0|||
126610742|NCT05553366|455534498|FG001|Overall Study|Randomized but not dosed|0|||
126610743|NCT05553366|455534499|FG002|Overall Study|Randomized but not dosed|2|||
126610744|NCT02022657|455534500|FG000|Overall Study|Withdrawal by Subject|2|||
126610745|NCT02022657|455534501|FG001|Overall Study|Withdrawal by Subject|0|||
126610746|NCT02022657|455534502|FG002|Overall Study|Withdrawal by Subject|1|||
126610747|NCT02022657|455534503|FG003|Overall Study|Withdrawal by Subject|0|||
126610748|NCT02022657|455534504|FG004|Overall Study|Withdrawal by Subject|0|||
126610749|NCT02022657|455534505|FG005|Overall Study|Withdrawal by Subject|0|||
126610750|NCT02022657|455534500|FG000|Overall Study|Physician Decision|0|||
126610751|NCT02022657|455534501|FG001|Overall Study|Physician Decision|0|||
126610752|NCT02022657|455534502|FG002|Overall Study|Physician Decision|0|||
126610753|NCT02022657|455534503|FG003|Overall Study|Physician Decision|0|||
126610754|NCT02022657|455534504|FG004|Overall Study|Physician Decision|0|||
126610755|NCT02022657|455534505|FG005|Overall Study|Physician Decision|1|||
126610756|NCT00659373|455534510|FG000|Overall Study|Withdrawal by Subject|3|||
126610757|NCT00659373|455534511|FG001|Overall Study|Withdrawal by Subject|5|||
126610758|NCT00659373|455534510|FG000|Overall Study|Assessment Missed|2|||
126610759|NCT00659373|455534511|FG001|Overall Study|Assessment Missed|2|||
126610760|NCT02382640|455534512|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
126610761|NCT02382640|455534513|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
126610762|NCT02382640|455534514|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
126610763|NCT02382640|455534515|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
126610764|NCT03162614|455534518|FG000|Overall Study|Lost to Follow-up|2|||
126610765|NCT03162614|455534519|FG001|Overall Study|Lost to Follow-up|1|||
126610766|NCT03162614|455534520|FG002|Overall Study|Lost to Follow-up|1|||
126610767|NCT03162614|455534521|FG003|Overall Study|Lost to Follow-up|1|||
126610768|NCT03162614|455534522|FG004|Overall Study|Lost to Follow-up|2|||
126610769|NCT03162614|455534523|FG005|Overall Study|Lost to Follow-up|0|||
126610770|NCT03162614|455534518|FG000|Overall Study|Protocol Violation|0|||
126610771|NCT03162614|455534519|FG001|Overall Study|Protocol Violation|1|||
126610772|NCT03162614|455534520|FG002|Overall Study|Protocol Violation|0|||
126610773|NCT03162614|455534521|FG003|Overall Study|Protocol Violation|1|||
126610774|NCT03162614|455534522|FG004|Overall Study|Protocol Violation|0|||
126610775|NCT03162614|455534523|FG005|Overall Study|Protocol Violation|0|||
126610776|NCT03162614|455534518|FG000|Overall Study|Withdrawal by Subject|2|||
126610777|NCT03162614|455534519|FG001|Overall Study|Withdrawal by Subject|1|||
126610778|NCT03162614|455534520|FG002|Overall Study|Withdrawal by Subject|1|||
126610779|NCT03162614|455534521|FG003|Overall Study|Withdrawal by Subject|1|||
126610780|NCT03162614|455534522|FG004|Overall Study|Withdrawal by Subject|0|||
126610781|NCT03162614|455534523|FG005|Overall Study|Withdrawal by Subject|0|||
126610782|NCT03162614|455534518|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
126610783|NCT03162614|455534519|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
126610784|NCT03162614|455534520|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
126610785|NCT03162614|455534521|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
126610786|NCT03162614|455534522|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
126610787|NCT03162614|455534523|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
126610788|NCT00380250|455534524|FG000|Overall Study|Withdrawal by Subject|39|||
126610789|NCT00380250|455534525|FG001|Overall Study|Withdrawal by Subject|28|||
126610790|NCT00380250|455534524|FG000|Overall Study|Adverse Event|20|||
126610791|NCT00380250|455534525|FG001|Overall Study|Adverse Event|9|||
126610792|NCT00380250|455534524|FG000|Overall Study|Lack of Efficacy|10|||
126610793|NCT00380250|455534525|FG001|Overall Study|Lack of Efficacy|8|||
126610794|NCT00380250|455534524|FG000|Overall Study|Protocol Violation|15|||
126610795|NCT00380250|455534525|FG001|Overall Study|Protocol Violation|5|||
126610796|NCT00380250|455534524|FG000|Overall Study|Lost to Follow-up|14|||
126610797|NCT00380250|455534525|FG001|Overall Study|Lost to Follow-up|5|||
126610798|NCT00380250|455534524|FG000|Overall Study|Physician Decision|1|||
126610799|NCT00380250|455534525|FG001|Overall Study|Physician Decision|0|||
126610800|NCT02630966|455534526|FG000|Overall Study|Adverse Event|1|||
126610801|NCT02630966|455534527|FG001|Overall Study|Adverse Event|3|||
126610802|NCT02630966|455534526|FG000|Overall Study|Significant Protocol Deviation|0|||
126610803|NCT02630966|455534527|FG001|Overall Study|Significant Protocol Deviation|2|||
126610804|NCT02630966|455534526|FG000|Overall Study|Voluntary Withdrawal|1|||
126610805|NCT02630966|455534527|FG001|Overall Study|Voluntary Withdrawal|1|||
126610806|NCT02630966|455534526|FG000|Overall Study|Lack of Efficacy|0|||
126610807|NCT02630966|455534527|FG001|Overall Study|Lack of Efficacy|2|||
126610808|NCT00641537|455534528|FG000|96-week Period|Adverse Event|0|||
126610809|NCT00641537|455534529|FG001|96-week Period|Adverse Event|1|||
126610810|NCT00641537|455534530|FG002|96-week Period|Adverse Event|3|||
126610811|NCT00641537|455534531|FG003|96-week Period|Adverse Event|0|||
126610812|NCT00641537|455534532|FG004|96-week Period|Adverse Event|2|||
126610813|NCT00641537|455534533|FG005|96-week Period|Adverse Event|0|||
126734147|NCT00340834|455975823|FG004|Core Phase of Study|Administrative Problems|0|||
126610814|NCT00641537|455534534|FG006|96-week Period|Adverse Event|0|||
126610815|NCT00641537|455534535|FG007|96-week Period|Adverse Event|0|||
126610816|NCT00641537|455534528|FG000|96-week Period|Lost to Follow-up|3|||
126610817|NCT00641537|455534529|FG001|96-week Period|Lost to Follow-up|1|||
126610818|NCT00641537|455534530|FG002|96-week Period|Lost to Follow-up|2|||
126610819|NCT00641537|455534531|FG003|96-week Period|Lost to Follow-up|2|||
126610820|NCT00641537|455534532|FG004|96-week Period|Lost to Follow-up|4|||
126610821|NCT00641537|455534533|FG005|96-week Period|Lost to Follow-up|0|||
126610822|NCT00641537|455534534|FG006|96-week Period|Lost to Follow-up|1|||
126610823|NCT00641537|455534535|FG007|96-week Period|Lost to Follow-up|0|||
126610824|NCT00641537|455534528|FG000|96-week Period|Protocol Violation|0|||
126610825|NCT00641537|455534529|FG001|96-week Period|Protocol Violation|1|||
126610826|NCT00641537|455534530|FG002|96-week Period|Protocol Violation|0|||
126610827|NCT00641537|455534531|FG003|96-week Period|Protocol Violation|1|||
126610828|NCT00641537|455534532|FG004|96-week Period|Protocol Violation|0|||
126610829|NCT00641537|455534533|FG005|96-week Period|Protocol Violation|1|||
126610830|NCT00641537|455534534|FG006|96-week Period|Protocol Violation|0|||
126610831|NCT00641537|455534535|FG007|96-week Period|Protocol Violation|0|||
126610832|NCT00641537|455534528|FG000|96-week Period|Death|2|||
126610833|NCT00641537|455534529|FG001|96-week Period|Death|0|||
126610834|NCT00641537|455534530|FG002|96-week Period|Death|1|||
126610835|NCT00641537|455534531|FG003|96-week Period|Death|0|||
126610836|NCT00641537|455534532|FG004|96-week Period|Death|0|||
126610837|NCT00641537|455534533|FG005|96-week Period|Death|0|||
126610838|NCT00641537|455534534|FG006|96-week Period|Death|0|||
126610839|NCT00641537|455534535|FG007|96-week Period|Death|0|||
126610840|NCT00641537|455534528|FG000|96-week Period|Other|4|||
126610841|NCT00641537|455534529|FG001|96-week Period|Other|7|||
126610842|NCT00641537|455534530|FG002|96-week Period|Other|14|||
126610843|NCT00641537|455534531|FG003|96-week Period|Other|9|||
126610844|NCT00641537|455534532|FG004|96-week Period|Other|11|||
126610845|NCT00641537|455534533|FG005|96-week Period|Other|6|||
126610846|NCT00641537|455534534|FG006|96-week Period|Other|4|||
126610847|NCT00641537|455534535|FG007|96-week Period|Other|6|||
126610848|NCT00641537|455534528|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
126610849|NCT00641537|455534529|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
126610850|NCT00641537|455534530|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
126610851|NCT00641537|455534531|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
126610852|NCT00641537|455534532|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
126610853|NCT00641537|455534533|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
126610854|NCT00641537|455534534|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
126610855|NCT00641537|455534535|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
126610856|NCT00641537|455534528|FG000|24-Week Supplemental Follow-up Period|Other|0|||
126610857|NCT00641537|455534529|FG001|24-Week Supplemental Follow-up Period|Other|2|||
126610858|NCT00641537|455534530|FG002|24-Week Supplemental Follow-up Period|Other|2|||
126610859|NCT00641537|455534531|FG003|24-Week Supplemental Follow-up Period|Other|1|||
126610860|NCT00641537|455534532|FG004|24-Week Supplemental Follow-up Period|Other|3|||
126610861|NCT00641537|455534533|FG005|24-Week Supplemental Follow-up Period|Other|0|||
126610862|NCT00641537|455534534|FG006|24-Week Supplemental Follow-up Period|Other|1|||
126610863|NCT00641537|455534535|FG007|24-Week Supplemental Follow-up Period|Other|1|||
126610864|NCT01801007|455534536|FG000|Overall Study|Adverse Event|2|||
126610865|NCT01801007|455534536|FG000|Overall Study|Lost to Follow-up|4|||
126610866|NCT01801007|455534536|FG000|Overall Study|Withdrawal by Subject|5|||
126610867|NCT00665392|455534537|FG000|Overall Study|not treated|1|||
126610868|NCT00243867|455534538|FG000|Overall Study|Adverse Event|24|||
126610869|NCT00243867|455534539|FG001|Overall Study|Adverse Event|34|||
126610870|NCT00243867|455534538|FG000|Overall Study|Lack of Efficacy|115|||
126610871|NCT00243867|455534539|FG001|Overall Study|Lack of Efficacy|78|||
126610872|NCT00243867|455534538|FG000|Overall Study|Withdrawal by Subject|11|||
126610873|NCT00243867|455534539|FG001|Overall Study|Withdrawal by Subject|23|||
126610874|NCT00243867|455534538|FG000|Overall Study|Lost to Follow-up|2|||
126610875|NCT00243867|455534539|FG001|Overall Study|Lost to Follow-up|1|||
126610876|NCT00243867|455534538|FG000|Overall Study|Physician Decision|2|||
126610877|NCT00243867|455534539|FG001|Overall Study|Physician Decision|7|||
126610878|NCT00243867|455534538|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
126610879|NCT00243867|455534539|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
126610880|NCT01321073|455534544|FG000|Overall Study|Did not attempt implant|4|||
126734148|NCT00340834|455975819|FG000|Core Phase of Study|Lack of Efficacy|3|||
126610881|NCT01321073|455534544|FG000|Overall Study|Death|3|||
126734149|NCT00340834|455975820|FG001|Core Phase of Study|Lack of Efficacy|3|||
126734150|NCT00340834|455975821|FG002|Core Phase of Study|Lack of Efficacy|7|||
126610882|NCT01638000|455534551|FG000|Overall Study|Randomized but Never Received Drug|7|||
126610883|NCT01638000|455534552|FG001|Overall Study|Randomized but Never Received Drug|10|||
126610884|NCT01638000|455534551|FG000|Overall Study|Adverse Event|14|||
126610885|NCT01638000|455534552|FG001|Overall Study|Adverse Event|16|||
126610886|NCT01638000|455534551|FG000|Overall Study|Lack of Efficacy|5|||
126610887|NCT01638000|455534552|FG001|Overall Study|Lack of Efficacy|6|||
126610888|NCT01638000|455534551|FG000|Overall Study|Protocol Violation|11|||
126610889|NCT01638000|455534552|FG001|Overall Study|Protocol Violation|13|||
126610890|NCT01638000|455534551|FG000|Overall Study|Withdrawal by Subject|21|||
126610891|NCT01638000|455534552|FG001|Overall Study|Withdrawal by Subject|24|||
126610892|NCT01638000|455534551|FG000|Overall Study|Miscellaneous|2|||
126610893|NCT01638000|455534552|FG001|Overall Study|Miscellaneous|2|||
126610894|NCT05352230|455534553|FG000|First Intervention (3 Months)|study terminated|2|||
126610895|NCT05352230|455534554|FG001|First Intervention (3 Months)|study terminated|2|||
126610896|NCT01683409|455534555|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
126610897|NCT01683409|455534556|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
126610898|NCT01683409|455534557|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
126610899|NCT01683409|455534558|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
126610900|NCT01683409|455534559|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
126610901|NCT01683409|455534555|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
126610902|NCT01683409|455534556|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
126610903|NCT01683409|455534557|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
126610904|NCT01683409|455534558|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
126610905|NCT01683409|455534559|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
126610906|NCT01683409|455534555|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
126610907|NCT01683409|455534556|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
126610908|NCT01683409|455534557|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
126610909|NCT01683409|455534558|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
126610910|NCT01683409|455534559|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
126610911|NCT01683409|455534555|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
126610912|NCT01683409|455534556|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
126610913|NCT01683409|455534557|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
126610914|NCT01683409|455534558|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
126610915|NCT01683409|455534559|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
126610916|NCT01683409|455534555|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
126610917|NCT01683409|455534556|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
126610918|NCT01683409|455534557|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
126610919|NCT01683409|455534558|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
126610920|NCT01683409|455534559|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
126610921|NCT01683409|455534555|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
126610922|NCT01683409|455534556|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
126610923|NCT01683409|455534557|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
126610924|NCT01683409|455534558|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
126610925|NCT01683409|455534559|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
126610926|NCT01683409|455534555|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
126610927|NCT01683409|455534556|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
126610928|NCT01683409|455534557|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
126610929|NCT01683409|455534558|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
126610930|NCT01683409|455534559|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
126610931|NCT01683409|455534555|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
126610932|NCT01683409|455534556|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
126610933|NCT01683409|455534557|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
126610934|NCT01683409|455534558|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
126610935|NCT01683409|455534559|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
126610936|NCT01683409|455534555|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
126610937|NCT01683409|455534556|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
126610938|NCT01683409|455534557|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
126610939|NCT01683409|455534558|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
126610940|NCT01683409|455534559|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
126610941|NCT01683409|455534555|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
126610942|NCT01683409|455534556|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
126610943|NCT01683409|455534557|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
126610944|NCT01683409|455534558|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
126610945|NCT01683409|455534559|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
126610946|NCT01683409|455534555|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
126610947|NCT01683409|455534556|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
126610948|NCT01683409|455534557|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
126610949|NCT01683409|455534558|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
126610950|NCT01683409|455534559|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
126610951|NCT04218864|455534560|FG000|Overall Study|Lost to Follow-up|8|||
126610952|NCT04218864|455534561|FG001|Overall Study|Lost to Follow-up|4|||
126610953|NCT04218864|455534560|FG000|Overall Study|Withdrawal by Subject|1|||
126610954|NCT04218864|455534561|FG001|Overall Study|Withdrawal by Subject|3|||
126610955|NCT01227421|455534562|FG000|Overall Study|Lost to Follow-up|6|||
126610956|NCT01227421|455534563|FG001|Overall Study|Lost to Follow-up|7|||
126610957|NCT01227421|455534564|FG002|Overall Study|Lost to Follow-up|5|||
126610958|NCT01227421|455534562|FG000|Overall Study|Adverse Event|2|||
126610959|NCT01227421|455534563|FG001|Overall Study|Adverse Event|7|||
126610960|NCT01227421|455534564|FG002|Overall Study|Adverse Event|2|||
126610961|NCT01227421|455534562|FG000|Overall Study|Withdrawal by Subject|1|||
126610962|NCT01227421|455534563|FG001|Overall Study|Withdrawal by Subject|2|||
126781247|NCT03882047|456154499|FG000|Overall Study|Lost to Follow-up|0|||
126734151|NCT00340834|455975822|FG003|Core Phase of Study|Lack of Efficacy|0|||
126734152|NCT00340834|455975823|FG004|Core Phase of Study|Lack of Efficacy|0|||
126734153|NCT00340834|455975819|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
126734154|NCT00340834|455975820|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
126734155|NCT00340834|455975821|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
126734156|NCT00340834|455975822|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
126734157|NCT00340834|455975823|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
126734158|NCT00340834|455975819|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
126734159|NCT00340834|455975820|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
126734160|NCT00340834|455975821|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
126734161|NCT00340834|455975822|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
126734162|NCT00340834|455975823|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
126734163|NCT00340834|455975819|FG000|Core Phase of Study|Lost to Follow-up|1|||
126734164|NCT00340834|455975820|FG001|Core Phase of Study|Lost to Follow-up|1|||
126734165|NCT00340834|455975821|FG002|Core Phase of Study|Lost to Follow-up|4|||
126734166|NCT00340834|455975822|FG003|Core Phase of Study|Lost to Follow-up|0|||
126734167|NCT00340834|455975823|FG004|Core Phase of Study|Lost to Follow-up|0|||
126734168|NCT00340834|455975819|FG000|Core Phase of Study|Death|2|||
126734169|NCT00340834|455975820|FG001|Core Phase of Study|Death|0|||
126734170|NCT00340834|455975821|FG002|Core Phase of Study|Death|0|||
126734171|NCT00340834|455975822|FG003|Core Phase of Study|Death|0|||
126734172|NCT00340834|455975823|FG004|Core Phase of Study|Death|0|||
126610963|NCT01227421|455534564|FG002|Overall Study|Withdrawal by Subject|1|||
126610964|NCT01227421|455534562|FG000|Overall Study|Protocol Violation|1|||
126610965|NCT01227421|455534563|FG001|Overall Study|Protocol Violation|1|||
126610966|NCT01227421|455534564|FG002|Overall Study|Protocol Violation|2|||
126610967|NCT01227421|455534562|FG000|Overall Study|Randomized in error|1|||
126610968|NCT01227421|455534563|FG001|Overall Study|Randomized in error|1|||
126610969|NCT01227421|455534564|FG002|Overall Study|Randomized in error|0|||
126610970|NCT02499328|455534565|FG000|Overall Study|Withdrawal by Subject|1|||
126610971|NCT02499328|455534566|FG001|Overall Study|Withdrawal by Subject|1|||
126610972|NCT02499328|455534567|FG002|Overall Study|Withdrawal by Subject|5|||
126610973|NCT02499328|455534568|FG003|Overall Study|Withdrawal by Subject|3|||
126610974|NCT02499328|455534569|FG004|Overall Study|Withdrawal by Subject|5|||
126610975|NCT02499328|455534570|FG005|Overall Study|Withdrawal by Subject|0|||
126610976|NCT02499328|455534571|FG006|Overall Study|Withdrawal by Subject|0|||
126610977|NCT02499328|455534572|FG007|Overall Study|Withdrawal by Subject|0|||
126610978|NCT02499328|455534573|FG008|Overall Study|Withdrawal by Subject|2|||
126610979|NCT02499328|455534574|FG009|Overall Study|Withdrawal by Subject|2|||
126610980|NCT02499328|455534575|FG010|Overall Study|Withdrawal by Subject|0|||
126610981|NCT02499328|455534576|FG011|Overall Study|Withdrawal by Subject|3|||
126610982|NCT02499328|455534577|FG012|Overall Study|Withdrawal by Subject|7|||
126610983|NCT02499328|455534578|FG013|Overall Study|Withdrawal by Subject|3|||
126610984|NCT02499328|455534579|FG014|Overall Study|Withdrawal by Subject|1|||
126610985|NCT02499328|455534580|FG015|Overall Study|Withdrawal by Subject|0|||
126610986|NCT02499328|455534581|FG016|Overall Study|Withdrawal by Subject|0|||
126610987|NCT02499328|455534582|FG017|Overall Study|Withdrawal by Subject|3|||
126610988|NCT02499328|455534583|FG018|Overall Study|Withdrawal by Subject|0|||
126610989|NCT02499328|455534565|FG000|Overall Study|Lost to Follow-up|0|||
126610990|NCT02499328|455534566|FG001|Overall Study|Lost to Follow-up|1|||
126610991|NCT02499328|455534567|FG002|Overall Study|Lost to Follow-up|1|||
126610992|NCT02499328|455534568|FG003|Overall Study|Lost to Follow-up|2|||
126610993|NCT02499328|455534569|FG004|Overall Study|Lost to Follow-up|0|||
126610994|NCT02499328|455534570|FG005|Overall Study|Lost to Follow-up|0|||
126610995|NCT02499328|455534571|FG006|Overall Study|Lost to Follow-up|0|||
126610996|NCT02499328|455534572|FG007|Overall Study|Lost to Follow-up|2|||
126610997|NCT02499328|455534573|FG008|Overall Study|Lost to Follow-up|3|||
126610998|NCT02499328|455534574|FG009|Overall Study|Lost to Follow-up|0|||
126610999|NCT02499328|455534575|FG010|Overall Study|Lost to Follow-up|0|||
126611000|NCT02499328|455534576|FG011|Overall Study|Lost to Follow-up|0|||
126611001|NCT02499328|455534577|FG012|Overall Study|Lost to Follow-up|0|||
126611002|NCT02499328|455534578|FG013|Overall Study|Lost to Follow-up|0|||
126611003|NCT02499328|455534579|FG014|Overall Study|Lost to Follow-up|0|||
126611004|NCT02499328|455534580|FG015|Overall Study|Lost to Follow-up|0|||
126611005|NCT02499328|455534581|FG016|Overall Study|Lost to Follow-up|0|||
126611006|NCT02499328|455534582|FG017|Overall Study|Lost to Follow-up|0|||
126611007|NCT02499328|455534583|FG018|Overall Study|Lost to Follow-up|1|||
126611008|NCT02499328|455534565|FG000|Overall Study|Death|0|||
126611009|NCT02499328|455534566|FG001|Overall Study|Death|3|||
126611010|NCT02499328|455534567|FG002|Overall Study|Death|3|||
126611011|NCT02499328|455534568|FG003|Overall Study|Death|2|||
126611012|NCT02499328|455534569|FG004|Overall Study|Death|4|||
126611013|NCT02499328|455534570|FG005|Overall Study|Death|7|||
126734173|NCT00340834|455975819|FG000|Core Phase of Study|Protocol Violation|0|||
126611014|NCT02499328|455534571|FG006|Overall Study|Death|3|||
126611015|NCT02499328|455534572|FG007|Overall Study|Death|0|||
126611016|NCT02499328|455534573|FG008|Overall Study|Death|2|||
126611017|NCT02499328|455534574|FG009|Overall Study|Death|6|||
126781248|NCT03882047|456154500|FG001|Overall Study|Lost to Follow-up|1|||
126611018|NCT02499328|455534575|FG010|Overall Study|Death|6|||
126611019|NCT02499328|455534576|FG011|Overall Study|Death|20|||
126611020|NCT02499328|455534577|FG012|Overall Study|Death|9|||
126611021|NCT02499328|455534578|FG013|Overall Study|Death|7|||
126611022|NCT02499328|455534579|FG014|Overall Study|Death|3|||
126611023|NCT02499328|455534580|FG015|Overall Study|Death|1|||
126611024|NCT02499328|455534581|FG016|Overall Study|Death|1|||
126611025|NCT02499328|455534582|FG017|Overall Study|Death|16|||
126611026|NCT02499328|455534583|FG018|Overall Study|Death|5|||
126611027|NCT02499328|455534565|FG000|Overall Study|"Other"|2|||
126611028|NCT02499328|455534566|FG001|Overall Study|"Other"|2|||
126611029|NCT02499328|455534567|FG002|Overall Study|"Other"|1|||
126611030|NCT02499328|455534568|FG003|Overall Study|"Other"|3|||
126611031|NCT02499328|455534569|FG004|Overall Study|"Other"|6|||
126611032|NCT02499328|455534570|FG005|Overall Study|"Other"|2|||
126611033|NCT02499328|455534571|FG006|Overall Study|"Other"|3|||
126611034|NCT02499328|455534572|FG007|Overall Study|"Other"|4|||
126611035|NCT02499328|455534573|FG008|Overall Study|"Other"|6|||
126611036|NCT02499328|455534574|FG009|Overall Study|"Other"|16|||
126611037|NCT02499328|455534575|FG010|Overall Study|"Other"|13|||
126611038|NCT02499328|455534576|FG011|Overall Study|"Other"|31|||
126611039|NCT02499328|455534577|FG012|Overall Study|"Other"|8|||
126611040|NCT02499328|455534578|FG013|Overall Study|"Other"|7|||
126611041|NCT02499328|455534579|FG014|Overall Study|"Other"|6|||
126611042|NCT02499328|455534580|FG015|Overall Study|"Other"|0|||
126611043|NCT02499328|455534581|FG016|Overall Study|"Other"|0|||
126611044|NCT02499328|455534582|FG017|Overall Study|"Other"|34|||
126611045|NCT02499328|455534583|FG018|Overall Study|"Other"|43|||
126611046|NCT02499328|455534565|FG000|Overall Study|Disease Progression|0|||
126611047|NCT02499328|455534566|FG001|Overall Study|Disease Progression|0|||
126611048|NCT02499328|455534567|FG002|Overall Study|Disease Progression|0|||
126611049|NCT02499328|455534568|FG003|Overall Study|Disease Progression|0|||
126611050|NCT02499328|455534569|FG004|Overall Study|Disease Progression|0|||
126611051|NCT02499328|455534570|FG005|Overall Study|Disease Progression|0|||
126611052|NCT02499328|455534571|FG006|Overall Study|Disease Progression|1|||
126611053|NCT02499328|455534572|FG007|Overall Study|Disease Progression|0|||
126611054|NCT02499328|455534573|FG008|Overall Study|Disease Progression|1|||
126611055|NCT02499328|455534574|FG009|Overall Study|Disease Progression|0|||
126611056|NCT02499328|455534575|FG010|Overall Study|Disease Progression|1|||
126611057|NCT02499328|455534576|FG011|Overall Study|Disease Progression|0|||
126611058|NCT02499328|455534577|FG012|Overall Study|Disease Progression|0|||
126611059|NCT02499328|455534578|FG013|Overall Study|Disease Progression|0|||
126611060|NCT02499328|455534579|FG014|Overall Study|Disease Progression|0|||
126611061|NCT02499328|455534580|FG015|Overall Study|Disease Progression|0|||
126611062|NCT02499328|455534581|FG016|Overall Study|Disease Progression|0|||
126611063|NCT02499328|455534582|FG017|Overall Study|Disease Progression|2|||
126611064|NCT02499328|455534583|FG018|Overall Study|Disease Progression|0|||
126611065|NCT02499328|455534565|FG000|Overall Study|Adverse Event|1|||
126611066|NCT02499328|455534566|FG001|Overall Study|Adverse Event|0|||
126611067|NCT02499328|455534567|FG002|Overall Study|Adverse Event|0|||
126611068|NCT02499328|455534568|FG003|Overall Study|Adverse Event|1|||
126611069|NCT02499328|455534569|FG004|Overall Study|Adverse Event|0|||
126611070|NCT02499328|455534570|FG005|Overall Study|Adverse Event|0|||
126611071|NCT02499328|455534571|FG006|Overall Study|Adverse Event|0|||
126611072|NCT02499328|455534572|FG007|Overall Study|Adverse Event|0|||
126611073|NCT02499328|455534573|FG008|Overall Study|Adverse Event|0|||
126611074|NCT02499328|455534574|FG009|Overall Study|Adverse Event|0|||
126611075|NCT02499328|455534575|FG010|Overall Study|Adverse Event|0|||
126611076|NCT02499328|455534576|FG011|Overall Study|Adverse Event|0|||
126611077|NCT02499328|455534577|FG012|Overall Study|Adverse Event|1|||
126611078|NCT02499328|455534578|FG013|Overall Study|Adverse Event|0|||
126611079|NCT02499328|455534579|FG014|Overall Study|Adverse Event|0|||
126611080|NCT02499328|455534580|FG015|Overall Study|Adverse Event|0|||
126611081|NCT02499328|455534581|FG016|Overall Study|Adverse Event|0|||
126781249|NCT03882047|456154501|FG002|Overall Study|Lost to Follow-up|0|||
126611082|NCT02499328|455534582|FG017|Overall Study|Adverse Event|0|||
126611083|NCT02499328|455534583|FG018|Overall Study|Adverse Event|0|||
126611084|NCT00145470|455534584|FG000|Overall Study|Adverse Event|19|||
126611085|NCT00145470|455534585|FG001|Overall Study|Adverse Event|25|||
126611086|NCT00145470|455534584|FG000|Overall Study|Lack of Efficacy|27|||
126611087|NCT00145470|455534585|FG001|Overall Study|Lack of Efficacy|13|||
126611088|NCT00145470|455534584|FG000|Overall Study|Withdrawal by Subject|36|||
126611089|NCT00145470|455534585|FG001|Overall Study|Withdrawal by Subject|34|||
126611090|NCT00145470|455534584|FG000|Overall Study|Lost to Follow-up|21|||
126611091|NCT00145470|455534585|FG001|Overall Study|Lost to Follow-up|17|||
126611092|NCT00145470|455534584|FG000|Overall Study|Reason Not Reported|9|||
126611093|NCT00145470|455534585|FG001|Overall Study|Reason Not Reported|9|||
126611094|NCT06269003|455534587|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
126611095|NCT06269003|455534588|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
126611096|NCT06269003|455534589|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
126781250|NCT03882047|456154499|FG000|Overall Study|Did Not Wish to Continue|1|||
126611097|NCT06269003|455534590|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
126611098|NCT04447027|455534591|FG000|Dose Escalation|Withdrawal by Subject|1|||
126611099|NCT04447027|455534592|FG001|Dose Escalation|Withdrawal by Subject|4|||
126611100|NCT04447027|455534593|FG002|Dose Escalation|Withdrawal by Subject|3|||
126611101|NCT04447027|455534594|FG003|Dose Escalation|Withdrawal by Subject|3|||
126611102|NCT04447027|455534595|FG004|Dose Escalation|Withdrawal by Subject|1|||
126611103|NCT04447027|455534596|FG005|Dose Escalation|Withdrawal by Subject|0|||
126611104|NCT04447027|455534597|FG006|Dose Escalation|Withdrawal by Subject|0|||
126611105|NCT04447027|455534598|FG007|Dose Escalation|Withdrawal by Subject|0|||
126611106|NCT04447027|455534599|FG008|Dose Escalation|Withdrawal by Subject|0|||
126611107|NCT04447027|455534591|FG000|Dose Escalation|Refused further treatment|0|||
126611108|NCT04447027|455534592|FG001|Dose Escalation|Refused further treatment|1|||
126611109|NCT04447027|455534593|FG002|Dose Escalation|Refused further treatment|1|||
126611110|NCT04447027|455534594|FG003|Dose Escalation|Refused further treatment|0|||
126611111|NCT04447027|455534595|FG004|Dose Escalation|Refused further treatment|0|||
126611112|NCT04447027|455534596|FG005|Dose Escalation|Refused further treatment|0|||
126611113|NCT04447027|455534597|FG006|Dose Escalation|Refused further treatment|0|||
126611114|NCT04447027|455534598|FG007|Dose Escalation|Refused further treatment|0|||
126611115|NCT04447027|455534599|FG008|Dose Escalation|Refused further treatment|0|||
126611116|NCT04447027|455534591|FG000|Dose Expansion|Withdrawal by Subject|0|||
126611117|NCT04447027|455534592|FG001|Dose Expansion|Withdrawal by Subject|0|||
126611118|NCT04447027|455534593|FG002|Dose Expansion|Withdrawal by Subject|0|||
126611119|NCT04447027|455534594|FG003|Dose Expansion|Withdrawal by Subject|0|||
126611120|NCT04447027|455534595|FG004|Dose Expansion|Withdrawal by Subject|0|||
126611121|NCT04447027|455534596|FG005|Dose Expansion|Withdrawal by Subject|2|||
126611122|NCT04447027|455534597|FG006|Dose Expansion|Withdrawal by Subject|0|||
126611123|NCT04447027|455534598|FG007|Dose Expansion|Withdrawal by Subject|2|||
126611124|NCT04447027|455534599|FG008|Dose Expansion|Withdrawal by Subject|0|||
126611125|NCT04937504|455534600|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
126611126|NCT04937504|455534601|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
126611127|NCT04937504|455534600|FG000|9 Months Assessment|Lost to Follow-up|3|||
126611128|NCT04937504|455534601|FG001|9 Months Assessment|Lost to Follow-up|2|||
126611129|NCT04535414|455534602|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
126611130|NCT04535414|455534603|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
126611131|NCT04535414|455534602|FG000|Overall Study|Cancelled appointment|1|||
126611132|NCT04535414|455534603|FG001|Overall Study|Cancelled appointment|0|||
126611133|NCT04535414|455534602|FG000|Overall Study|cancelled - food in stomach|2|||
126611134|NCT04535414|455534603|FG001|Overall Study|cancelled - food in stomach|0|||
126611135|NCT04535414|455534602|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
126611136|NCT04535414|455534603|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
126611137|NCT04535414|455534602|FG000|Overall Study|Withdrawal by Subject|0|||
126611138|NCT04535414|455534603|FG001|Overall Study|Withdrawal by Subject|1|||
126611139|NCT04186247|455534604|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
126611140|NCT04186247|455534605|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
126611141|NCT04186247|455534606|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
126611142|NCT04186247|455534607|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
126611143|NCT04186247|455534608|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
126611144|NCT03662659|455534609|FG000|Pre-treatment|Participant no longer met study criteria|1|||
126611145|NCT03662659|455534610|FG001|Pre-treatment|Participant no longer met study criteria|1|||
126611146|NCT03662659|455534609|FG000|Pre-treatment|Other reasons|1|||
126611147|NCT03662659|455534610|FG001|Pre-treatment|Other reasons|0|||
126611148|NCT03662659|455534609|FG000|Treatment|Completed Treatment|0|||
126611149|NCT03662659|455534610|FG001|Treatment|Completed Treatment|2|||
126611150|NCT03662659|455534609|FG000|Treatment|Disease Progression|85|||
126611151|NCT03662659|455534610|FG001|Treatment|Disease Progression|97|||
126611152|NCT03662659|455534609|FG000|Treatment|Study Drug Toxicity|19|||
126611153|NCT03662659|455534610|FG001|Treatment|Study Drug Toxicity|9|||
126611154|NCT03662659|455534609|FG000|Treatment|Death|11|||
126611155|NCT03662659|455534610|FG001|Treatment|Death|9|||
126611156|NCT03662659|455534609|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
126611157|NCT03662659|455534610|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
126611158|NCT03662659|455534609|FG000|Treatment|Withdrawal by Subject|1|||
126611159|NCT03662659|455534610|FG001|Treatment|Withdrawal by Subject|1|||
126611160|NCT03662659|455534609|FG000|Treatment|Poor/Non-compliance|1|||
126611161|NCT03662659|455534610|FG001|Treatment|Poor/Non-compliance|0|||
126611162|NCT03662659|455534609|FG000|Treatment|Participant no longer meets study criteria|1|||
126611163|NCT03662659|455534610|FG001|Treatment|Participant no longer meets study criteria|0|||
126611164|NCT03662659|455534609|FG000|Treatment|Other reasons|10|||
126611165|NCT03662659|455534610|FG001|Treatment|Other reasons|8|||
126611166|NCT03662659|455534609|FG000|Treatment|Administrative reasons by sponsor|1|||
126611167|NCT03662659|455534610|FG001|Treatment|Administrative reasons by sponsor|0|||
126611168|NCT03662659|455534609|FG000|Treatment|maximum clinical benefit|0|||
126611169|NCT03662659|455534610|FG001|Treatment|maximum clinical benefit|2|||
126611170|NCT04118894|455534612|FG000|Overall Study|Lost to Follow-up|21|||
126611171|NCT04118894|455534612|FG000|Overall Study|Withdrawal by Subject|10|||
126611172|NCT04118894|455534612|FG000|Overall Study|Adverse Event|4|||
126611173|NCT04323800|455536186|FG000|Overall Study|Withdrawal by Subject|4|||
126611174|NCT04323800|455536187|FG001|Overall Study|Withdrawal by Subject|4|||
126611175|NCT04323800|455536186|FG000|Overall Study|Incomplete transfusion|1|||
126734174|NCT00340834|455975820|FG001|Core Phase of Study|Protocol Violation|0|||
126734175|NCT00340834|455975821|FG002|Core Phase of Study|Protocol Violation|2|||
126734176|NCT00340834|455975822|FG003|Core Phase of Study|Protocol Violation|0|||
126734177|NCT00340834|455975823|FG004|Core Phase of Study|Protocol Violation|0|||
126734178|NCT00340834|455975819|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
126734179|NCT00340834|455975820|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
126734180|NCT00340834|455975821|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
126734181|NCT00340834|455975822|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
126734182|NCT00340834|455975823|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
126734183|NCT00340834|455975819|FG000|Extension Phase of Study|Subject withdrew consent|26|||
126734184|NCT00340834|455975820|FG001|Extension Phase of Study|Subject withdrew consent|31|||
126734185|NCT00340834|455975821|FG002|Extension Phase of Study|Subject withdrew consent|0|||
126734186|NCT00340834|455975822|FG003|Extension Phase of Study|Subject withdrew consent|12|||
126734187|NCT00340834|455975823|FG004|Extension Phase of Study|Subject withdrew consent|15|||
126734188|NCT00340834|455975819|FG000|Extension Phase of Study|Adverse Event|21|||
126734189|NCT00340834|455975820|FG001|Extension Phase of Study|Adverse Event|22|||
126734190|NCT00340834|455975821|FG002|Extension Phase of Study|Adverse Event|0|||
126734191|NCT00340834|455975822|FG003|Extension Phase of Study|Adverse Event|19|||
126734192|NCT00340834|455975823|FG004|Extension Phase of Study|Adverse Event|7|||
126734193|NCT00340834|455975819|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
126734194|NCT00340834|455975820|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
126734195|NCT00340834|455975821|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
126734196|NCT00340834|455975822|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
126734197|NCT00340834|455975823|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
126734198|NCT00340834|455975819|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
126734199|NCT00340834|455975820|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
126734200|NCT00340834|455975821|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
126734201|NCT00340834|455975822|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
126734202|NCT00340834|455975823|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
126734203|NCT00340834|455975819|FG000|Extension Phase of Study|Lost to Follow-up|1|||
126734204|NCT00340834|455975820|FG001|Extension Phase of Study|Lost to Follow-up|1|||
126734205|NCT00340834|455975821|FG002|Extension Phase of Study|Lost to Follow-up|0|||
126734206|NCT00340834|455975822|FG003|Extension Phase of Study|Lost to Follow-up|2|||
126734207|NCT00340834|455975823|FG004|Extension Phase of Study|Lost to Follow-up|3|||
126734208|NCT00340834|455975819|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
126734209|NCT00340834|455975820|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
126734210|NCT00340834|455975821|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
126734211|NCT00340834|455975822|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
126781251|NCT03882047|456154500|FG001|Overall Study|Did Not Wish to Continue|4|||
126781252|NCT03882047|456154501|FG002|Overall Study|Did Not Wish to Continue|1|||
126781253|NCT03882047|456154499|FG000|Overall Study|Noncompliance With Protocol|2|||
126611176|NCT04323800|455536187|FG001|Overall Study|Incomplete transfusion|0|||
126611177|NCT04323800|455536186|FG000|Overall Study|Other|0|||
126611178|NCT04323800|455536187|FG001|Overall Study|Other|1|||
126611179|NCT04323800|455536186|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
126611180|NCT04323800|455536187|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
126611181|NCT00489554|455536188|FG000|Overall Study|Adverse Event|2|||
126611182|NCT00489554|455536188|FG000|Overall Study|Withdrawal by Subject|1|||
126611183|NCT00489554|455536188|FG000|Overall Study|Lost to Follow-up|1|||
126611184|NCT06571695|455536189|FG000|Overall Study|Lost to Follow-up|1|||
126611185|NCT06571695|455536190|FG001|Overall Study|Lost to Follow-up|6|||
126611186|NCT01380145|455536191|FG000|Overall Study|Progressive disease|4|||
126611187|NCT02038049|455536196|FG000|Overall Study|Lost to Follow-up|1|||
126611188|NCT02038049|455536197|FG001|Overall Study|Lost to Follow-up|0|||
126611189|NCT01808534|455536198|FG000|Overall Study|Disease progression|3|||
126611190|NCT01808534|455536198|FG000|Overall Study|Physician Decision|1|||
126611191|NCT02660086|455536199|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
126611192|NCT02660086|455536200|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
126611193|NCT02660086|455536199|FG000|Overall Study- 12-month|Left full-time employment|12|||
126611194|NCT02660086|455536200|FG001|Overall Study- 12-month|Left full-time employment|20|||
126611195|NCT02660086|455536199|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
126611196|NCT02660086|455536200|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
126611197|NCT02660086|455536199|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
126611198|NCT02660086|455536200|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
126611199|NCT02660086|455536199|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
126611200|NCT02660086|455536200|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
126611201|NCT02660086|455536199|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
126611202|NCT02660086|455536200|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
126611203|NCT00667017|455536203|FG000|Overall Study|Withdrawal by Subject|1|||
126611204|NCT02605174|455536210|FG000|Overall Study|Adverse Event|0|||
126611205|NCT02605174|455536211|FG001|Overall Study|Adverse Event|0|||
126611206|NCT02605174|455536212|FG002|Overall Study|Adverse Event|1|||
126611207|NCT02605174|455536213|FG003|Overall Study|Adverse Event|0|||
126611208|NCT02605174|455536214|FG004|Overall Study|Adverse Event|4|||
126611209|NCT02605174|455536215|FG005|Overall Study|Adverse Event|0|||
126611210|NCT02605174|455536216|FG006|Overall Study|Adverse Event|0|||
126611211|NCT02605174|455536210|FG000|Overall Study|Lost to Follow-up|20|||
126611212|NCT02605174|455536211|FG001|Overall Study|Lost to Follow-up|7|||
126611213|NCT02605174|455536212|FG002|Overall Study|Lost to Follow-up|27|||
126611214|NCT02605174|455536213|FG003|Overall Study|Lost to Follow-up|10|||
126611215|NCT02605174|455536214|FG004|Overall Study|Lost to Follow-up|20|||
126611216|NCT02605174|455536215|FG005|Overall Study|Lost to Follow-up|10|||
126611217|NCT02605174|455536216|FG006|Overall Study|Lost to Follow-up|29|||
126611218|NCT02605174|455536210|FG000|Overall Study|Protocol Violation|10|||
126611219|NCT02605174|455536211|FG001|Overall Study|Protocol Violation|4|||
126611220|NCT02605174|455536212|FG002|Overall Study|Protocol Violation|14|||
126611221|NCT02605174|455536213|FG003|Overall Study|Protocol Violation|6|||
126611222|NCT02605174|455536214|FG004|Overall Study|Protocol Violation|7|||
126611223|NCT02605174|455536215|FG005|Overall Study|Protocol Violation|7|||
126611224|NCT02605174|455536216|FG006|Overall Study|Protocol Violation|12|||
126611225|NCT02605174|455536210|FG000|Overall Study|Pregnancy|1|||
126611226|NCT02605174|455536211|FG001|Overall Study|Pregnancy|0|||
126611227|NCT02605174|455536212|FG002|Overall Study|Pregnancy|0|||
126611228|NCT02605174|455536213|FG003|Overall Study|Pregnancy|2|||
126611229|NCT02605174|455536214|FG004|Overall Study|Pregnancy|0|||
126611230|NCT02605174|455536215|FG005|Overall Study|Pregnancy|0|||
126611231|NCT02605174|455536216|FG006|Overall Study|Pregnancy|0|||
126611232|NCT02605174|455536210|FG000|Overall Study|Withdrawal by Subject|9|||
126611233|NCT02605174|455536211|FG001|Overall Study|Withdrawal by Subject|6|||
126611234|NCT02605174|455536212|FG002|Overall Study|Withdrawal by Subject|14|||
126611235|NCT02605174|455536213|FG003|Overall Study|Withdrawal by Subject|11|||
126611236|NCT02605174|455536214|FG004|Overall Study|Withdrawal by Subject|6|||
126611237|NCT02605174|455536215|FG005|Overall Study|Withdrawal by Subject|4|||
126611238|NCT02605174|455536216|FG006|Overall Study|Withdrawal by Subject|15|||
126611239|NCT02605174|455536210|FG000|Overall Study|Physician Decision|2|||
126611240|NCT02605174|455536211|FG001|Overall Study|Physician Decision|0|||
126611241|NCT02605174|455536212|FG002|Overall Study|Physician Decision|0|||
126611242|NCT02605174|455536213|FG003|Overall Study|Physician Decision|0|||
126611243|NCT02605174|455536214|FG004|Overall Study|Physician Decision|0|||
126611244|NCT02605174|455536215|FG005|Overall Study|Physician Decision|0|||
126611245|NCT02605174|455536216|FG006|Overall Study|Physician Decision|3|||
126611246|NCT02605174|455536210|FG000|Overall Study|Randomization Failure|22|||
126611247|NCT02605174|455536211|FG001|Overall Study|Randomization Failure|6|||
126611248|NCT02605174|455536212|FG002|Overall Study|Randomization Failure|20|||
126611249|NCT02605174|455536213|FG003|Overall Study|Randomization Failure|7|||
126611250|NCT02605174|455536214|FG004|Overall Study|Randomization Failure|16|||
126611251|NCT02605174|455536215|FG005|Overall Study|Randomization Failure|11|||
126611252|NCT02605174|455536216|FG006|Overall Study|Randomization Failure|30|||
126611253|NCT03737110|455536217|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
126611254|NCT03737110|455536218|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
126611255|NCT03737110|455536219|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
126611256|NCT03737110|455536220|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
126611257|NCT03737110|455536221|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
126611258|NCT03737110|455536222|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
126611259|NCT03737110|455536217|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
126734212|NCT00340834|455975823|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
126734213|NCT00340834|455975819|FG000|Extension Phase of Study|Administrative problems|3|||
126734214|NCT00340834|455975820|FG001|Extension Phase of Study|Administrative problems|0|||
126611260|NCT03737110|455536218|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
126611261|NCT03737110|455536219|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
126611262|NCT03737110|455536220|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
126611263|NCT03737110|455536221|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
126611264|NCT03737110|455536222|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
126611265|NCT03737110|455536217|FG000|Run-in (RI) Period|Adverse Event|4|||
126611266|NCT03737110|455536218|FG001|Run-in (RI) Period|Adverse Event|0|||
126611267|NCT03737110|455536219|FG002|Run-in (RI) Period|Adverse Event|0|||
126611268|NCT03737110|455536220|FG003|Run-in (RI) Period|Adverse Event|0|||
126611269|NCT03737110|455536221|FG004|Run-in (RI) Period|Adverse Event|0|||
126611270|NCT03737110|455536222|FG005|Run-in (RI) Period|Adverse Event|0|||
126734215|NCT00340834|455975821|FG002|Extension Phase of Study|Administrative problems|0|||
126611271|NCT03737110|455536217|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
126611272|NCT03737110|455536218|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
126611273|NCT03737110|455536219|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
126611274|NCT03737110|455536220|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
126611275|NCT03737110|455536221|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
126611276|NCT03737110|455536222|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
126611277|NCT03737110|455536217|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
126611278|NCT03737110|455536218|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
126611279|NCT03737110|455536219|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
126611280|NCT03737110|455536220|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
126611281|NCT03737110|455536221|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
126611282|NCT03737110|455536222|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
126611283|NCT03737110|455536217|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
126611284|NCT03737110|455536218|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
126611285|NCT03737110|455536219|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
126611286|NCT03737110|455536220|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
126611287|NCT03737110|455536221|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
126611288|NCT03737110|455536222|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
126611289|NCT03737110|455536217|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
126611290|NCT03737110|455536218|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
126611291|NCT03737110|455536219|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
126611292|NCT03737110|455536220|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
126611293|NCT03737110|455536221|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
126611294|NCT03737110|455536222|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
126611295|NCT03737110|455536217|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
126611296|NCT03737110|455536218|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
126611297|NCT03737110|455536219|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
126611298|NCT03737110|455536220|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
126611299|NCT03737110|455536221|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
126611300|NCT03737110|455536222|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
126611301|NCT02575365|455536227|FG000|Overall Study|Lost to Follow-up|4|||
126611302|NCT03865732|455536228|FG000|Overall Study|Adverse Event|0|||
126611303|NCT03865732|455536229|FG001|Overall Study|Adverse Event|1|||
126611304|NCT03392194|455536230|FG000|Overall Study|Withdrawal by Subject|1|||
126611305|NCT03392194|455536231|FG001|Overall Study|Withdrawal by Subject|2|||
126611306|NCT03392194|455536230|FG000|Overall Study|Conflicts with personal schedule|1|||
126611307|NCT03392194|455536231|FG001|Overall Study|Conflicts with personal schedule|0|||
126611308|NCT00273052|455536242|FG000|Overall Study|Withdrawal by Subject|16|||
126611309|NCT00273052|455536243|FG001|Overall Study|Withdrawal by Subject|19|||
126611310|NCT00273052|455536242|FG000|Overall Study|Adverse Event|21|||
126611311|NCT00273052|455536243|FG001|Overall Study|Adverse Event|19|||
126611312|NCT00273052|455536242|FG000|Overall Study|Protocol Violation|14|||
126611313|NCT00273052|455536243|FG001|Overall Study|Protocol Violation|18|||
126611314|NCT00273052|455536242|FG000|Overall Study|Lost to Follow-up|7|||
126611315|NCT00273052|455536243|FG001|Overall Study|Lost to Follow-up|25|||
126611316|NCT00273052|455536242|FG000|Overall Study|Lack of Efficacy|6|||
126611317|NCT00273052|455536243|FG001|Overall Study|Lack of Efficacy|4|||
126611318|NCT00273052|455536242|FG000|Overall Study|Non-Compliance|3|||
126611319|NCT00273052|455536243|FG001|Overall Study|Non-Compliance|1|||
126611320|NCT00273052|455536242|FG000|Overall Study|Other|2|||
126611321|NCT00273052|455536243|FG001|Overall Study|Other|0|||
126611322|NCT00273052|455536242|FG000|Overall Study|Worsening serum lipid levels|0|||
126611323|NCT00273052|455536243|FG001|Overall Study|Worsening serum lipid levels|2|||
126611324|NCT01951703|455536244|FG000|First Intervention|Withdrawal by Subject|1|||
126611325|NCT01951703|455536245|FG001|First Intervention|Withdrawal by Subject|0|||
126611326|NCT01951703|455536244|FG000|First Intervention|Subject was not compliant|1|||
126611327|NCT01951703|455536245|FG001|First Intervention|Subject was not compliant|1|||
126611328|NCT01951703|455536244|FG000|First Intervention|Physician Decision|1|||
126611329|NCT01951703|455536245|FG001|First Intervention|Physician Decision|0|||
126611330|NCT01951703|455536244|FG000|Second Intervention|Protocol Violation|0|||
126611331|NCT01951703|455536245|FG001|Second Intervention|Protocol Violation|1|||
126611332|NCT01951703|455536244|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
126611333|NCT01951703|455536245|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
126611334|NCT01009645|455536246|FG000|Overall Study|Lost to Follow-up|2|||
126611335|NCT01009645|455536247|FG001|Overall Study|Lost to Follow-up|8|||
126611336|NCT01009645|455536248|FG002|Overall Study|Lost to Follow-up|4|||
126611337|NCT01009645|455536249|FG003|Overall Study|Lost to Follow-up|5|||
126611338|NCT00620854|455536250|FG000|Washout 1|Withdrawal by Subject|0|||
126611339|NCT00620854|455536251|FG001|Washout 1|Withdrawal by Subject|0|||
126611340|NCT00620854|455536252|FG002|Washout 1|Withdrawal by Subject|1|||
126611341|NCT00620854|455536253|FG003|Washout 1|Withdrawal by Subject|1|||
126611342|NCT00620854|455536254|FG004|Washout 1|Withdrawal by Subject|0|||
126611343|NCT00620854|455536255|FG005|Washout 1|Withdrawal by Subject|0|||
126611344|NCT00487240|455536258|FG000|Overall Study|Withdrawal by Subject|12|||
126611345|NCT00487240|455536259|FG001|Overall Study|Withdrawal by Subject|6|||
126611346|NCT00487240|455536258|FG000|Overall Study|Lost to Follow-up|7|||
126611347|NCT00487240|455536259|FG001|Overall Study|Lost to Follow-up|6|||
126611348|NCT00487240|455536258|FG000|Overall Study|Adverse Event|0|||
126611349|NCT00487240|455536259|FG001|Overall Study|Adverse Event|4|||
126611350|NCT00487240|455536258|FG000|Overall Study|Protocol Violation|5|||
126611351|NCT00487240|455536259|FG001|Overall Study|Protocol Violation|5|||
126611352|NCT00487240|455536258|FG000|Overall Study|Entry Criteria Not Met|3|||
126611353|NCT00487240|455536259|FG001|Overall Study|Entry Criteria Not Met|4|||
126611354|NCT00487240|455536258|FG000|Overall Study|Sponsor Decision|2|||
126611355|NCT00487240|455536259|FG001|Overall Study|Sponsor Decision|1|||
126611356|NCT00487240|455536258|FG000|Overall Study|Physician Decision|2|||
126611357|NCT00487240|455536259|FG001|Overall Study|Physician Decision|0|||
126611358|NCT00999596|455536260|FG000|Overall Study|Statistical population not required|101|||
126611359|NCT01019135|455536261|FG000|Overall Study|Did not receive allocated intervention|12|||
126611360|NCT01019135|455536262|FG001|Overall Study|Did not receive allocated intervention|6|||
126611361|NCT01019135|455536263|FG002|Overall Study|Did not receive allocated intervention|25|||
126611362|NCT01019135|455536261|FG000|Overall Study|Did not attend CR|8|||
126611363|NCT01019135|455536262|FG001|Overall Study|Did not attend CR|13|||
126611364|NCT01019135|455536263|FG002|Overall Study|Did not attend CR|6|||
126611365|NCT00439218|455536264|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
126611366|NCT05124210|455536265|FG000|Overall Study|Lost to Follow-up|1|||
126611367|NCT05124210|455536266|FG001|Overall Study|Lost to Follow-up|0|||
126611368|NCT05124210|455536265|FG000|Overall Study|Withdrawal by Subject|1|||
126611369|NCT05124210|455536266|FG001|Overall Study|Withdrawal by Subject|0|||
126611370|NCT00768755|455536269|FG000|Phase 1|Death|6|||
126611371|NCT00768755|455536270|FG001|Phase 1|Death|0|||
126611372|NCT00768755|455536271|FG002|Phase 1|Death|0|||
126611373|NCT00768755|455536272|FG003|Phase 1|Death|0|||
126611374|NCT00768755|455536269|FG000|Phase 1|Other|4|||
126611375|NCT00768755|455536270|FG001|Phase 1|Other|0|||
126611376|NCT00768755|455536271|FG002|Phase 1|Other|0|||
126611377|NCT00768755|455536272|FG003|Phase 1|Other|0|||
126611378|NCT00768755|455536269|FG000|Phase 2|Death|0|||
126611379|NCT00768755|455536270|FG001|Phase 2|Death|37|||
126611380|NCT00768755|455536271|FG002|Phase 2|Death|48|||
126611381|NCT00768755|455536272|FG003|Phase 2|Death|31|||
126611382|NCT00768755|455536269|FG000|Phase 2|Protocol Violation|0|||
126611383|NCT00768755|455536270|FG001|Phase 2|Protocol Violation|2|||
126611384|NCT00768755|455536271|FG002|Phase 2|Protocol Violation|0|||
126611385|NCT00768755|455536272|FG003|Phase 2|Protocol Violation|1|||
126611386|NCT00768755|455536269|FG000|Phase 2|Lost to Follow-up|0|||
126611387|NCT00768755|455536270|FG001|Phase 2|Lost to Follow-up|1|||
126611388|NCT00768755|455536271|FG002|Phase 2|Lost to Follow-up|1|||
126611389|NCT00768755|455536272|FG003|Phase 2|Lost to Follow-up|4|||
126611390|NCT00768755|455536269|FG000|Phase 2|Withdrawal by Subject|0|||
126611391|NCT00768755|455536270|FG001|Phase 2|Withdrawal by Subject|1|||
126611392|NCT00768755|455536271|FG002|Phase 2|Withdrawal by Subject|0|||
126611393|NCT00768755|455536272|FG003|Phase 2|Withdrawal by Subject|1|||
126611394|NCT00768755|455536269|FG000|Phase 2|Other|0|||
126611395|NCT00768755|455536270|FG001|Phase 2|Other|1|||
126611396|NCT00768755|455536271|FG002|Phase 2|Other|2|||
126611397|NCT00768755|455536272|FG003|Phase 2|Other|4|||
126611398|NCT00768755|455536269|FG000|Phase 2|Study Terminated by Sponsor|0|||
126611399|NCT00768755|455536270|FG001|Phase 2|Study Terminated by Sponsor|13|||
126611400|NCT00768755|455536271|FG002|Phase 2|Study Terminated by Sponsor|7|||
126611401|NCT00768755|455536272|FG003|Phase 2|Study Terminated by Sponsor|14|||
126611402|NCT00768755|455536269|FG000|Phase 2|Randomized but not treated|0|||
126611403|NCT00768755|455536270|FG001|Phase 2|Randomized but not treated|0|||
126611404|NCT00768755|455536271|FG002|Phase 2|Randomized but not treated|0|||
126611405|NCT00768755|455536272|FG003|Phase 2|Randomized but not treated|2|||
126611406|NCT03298087|455536275|FG000|Overall Study|Withdrawal by Subject|4|||
126611407|NCT01530334|455536279|FG000|Overall Study|Adverse Event|3|||
126611408|NCT01530334|455536279|FG000|Overall Study|unknown reason|1|||
126611409|NCT01530334|455536279|FG000|Overall Study|Progressive disease|47|||
126611410|NCT01485887|455536280|FG000|Overall Study|Withdrawal by Subject|2|||
126611411|NCT01485887|455536280|FG000|Overall Study|Adverse Event|8|||
126611412|NCT01485887|455536280|FG000|Overall Study|Deterioration of primary disease|1|||
126611413|NCT01485887|455536280|FG000|Overall Study|Primary disease markedly improved|1|||
126611414|NCT03184987|455536284|FG000|Overall Study|Withdrawal by Subject|0|||
126734216|NCT00340834|455975822|FG003|Extension Phase of Study|Administrative problems|1|||
126611415|NCT03184987|455536285|FG001|Overall Study|Withdrawal by Subject|1|||
126611416|NCT03184987|455536286|FG002|Overall Study|Withdrawal by Subject|2|||
126611417|NCT03184987|455536284|FG000|Overall Study|Physician Decision|0|||
126611418|NCT03184987|455536285|FG001|Overall Study|Physician Decision|0|||
126611419|NCT03184987|455536286|FG002|Overall Study|Physician Decision|1|||
126734217|NCT00340834|455975823|FG004|Extension Phase of Study|Administrative problems|1|||
126611420|NCT03184987|455536284|FG000|Overall Study|Adverse Event|1|||
126611421|NCT03184987|455536285|FG001|Overall Study|Adverse Event|0|||
126611422|NCT03184987|455536286|FG002|Overall Study|Adverse Event|1|||
126611423|NCT02203799|455536287|FG000|Overall Study|Withdrawal by Subject|3|||
126611424|NCT00681109|455536288|FG000|Overall Study|Lost to Follow-up|2|||
126611425|NCT00681109|455536289|FG001|Overall Study|Lost to Follow-up|6|||
126611426|NCT00681109|455536290|FG002|Overall Study|Lost to Follow-up|0|||
126611427|NCT04660799|455536291|FG000|Overall Study|Progressive Disease|1|||
126611428|NCT04660799|455536292|FG001|Overall Study|Progressive Disease|1|||
126611429|NCT04660799|455536291|FG000|Overall Study|Death|2|||
126611430|NCT04660799|455536292|FG001|Overall Study|Death|1|||
126611431|NCT04660799|455536291|FG000|Overall Study|Adverse Event|2|||
126611432|NCT04660799|455536292|FG001|Overall Study|Adverse Event|1|||
126611433|NCT04660799|455536291|FG000|Overall Study|Withdrawal by Subject|2|||
126611434|NCT04660799|455536292|FG001|Overall Study|Withdrawal by Subject|5|||
126611435|NCT00391170|455536303|FG000|Overall Study|Withdrawal by Subject|1|||
126611436|NCT00391170|455536304|FG001|Overall Study|Withdrawal by Subject|0|||
126611437|NCT00391170|455536303|FG000|Overall Study|Adverse Event|3|||
126611438|NCT00391170|455536304|FG001|Overall Study|Adverse Event|2|||
126611439|NCT00391170|455536303|FG000|Overall Study|Physician Decision|2|||
126611440|NCT00391170|455536304|FG001|Overall Study|Physician Decision|2|||
126611441|NCT03035942|455536307|FG000|Overall Study|Adverse Event|8|||
126611442|NCT03035942|455536308|FG001|Overall Study|Adverse Event|4|||
126611443|NCT03035942|455536309|FG002|Overall Study|Adverse Event|5|||
126611444|NCT05270460|455536310|FG000|Overall Study|Adverse Event|0|||
126611445|NCT05270460|455536311|FG001|Overall Study|Adverse Event|1|||
126611446|NCT05270460|455536312|FG002|Overall Study|Adverse Event|0|||
126611447|NCT05270460|455536310|FG000|Overall Study|Early Termination|0|||
126611448|NCT05270460|455536311|FG001|Overall Study|Early Termination|1|||
126611449|NCT05270460|455536312|FG002|Overall Study|Early Termination|0|||
126611450|NCT01989104|455536313|FG000|Overall Study|Withdrawal by Subject|3|||
126611451|NCT01989104|455536314|FG001|Overall Study|Withdrawal by Subject|0|||
126611452|NCT01989104|455536315|FG002|Overall Study|Withdrawal by Subject|0|||
126611453|NCT01989104|455536316|FG003|Overall Study|Withdrawal by Subject|0|||
126611454|NCT01989104|455536317|FG004|Overall Study|Withdrawal by Subject|0|||
126611455|NCT04029090|455536319|FG000|Overall Study|Protocol Violation|1|||
126611456|NCT04029090|455536320|FG001|Overall Study|Protocol Violation|0|||
126611457|NCT04029090|455536321|FG002|Overall Study|Protocol Violation|0|||
126611458|NCT04029090|455536319|FG000|Overall Study|Withdrawal by Subject|0|||
126611459|NCT04029090|455536320|FG001|Overall Study|Withdrawal by Subject|1|||
126611460|NCT04029090|455536321|FG002|Overall Study|Withdrawal by Subject|0|||
126611461|NCT01065779|455536322|FG000|Overall Study|Duplicate Investigation|1|||
126611462|NCT01065779|455536322|FG000|Overall Study|Investigation Before Contract Date|37|||
126611463|NCT01065779|455536322|FG000|Overall Study|Non-enrollment Period Administration|10|||
126611464|NCT01065779|455536322|FG000|Overall Study|Not Administered With Study Drug|17|||
126611465|NCT01065779|455536322|FG000|Overall Study|Failed to Follow-up|10|||
126611466|NCT01065779|455536322|FG000|Overall Study|Inclusion Criteria Violation|7|||
126611467|NCT02157948|455536326|FG000|Overall Study|Withdrawal by Subject|4|||
126611468|NCT02157948|455536327|FG001|Overall Study|Withdrawal by Subject|5|||
126611469|NCT02157948|455536326|FG000|Overall Study|Lost to Follow-up|3|||
126611470|NCT02157948|455536327|FG001|Overall Study|Lost to Follow-up|2|||
126611471|NCT02157948|455536326|FG000|Overall Study|Protocol Specified Criteria|2|||
126611472|NCT02157948|455536327|FG001|Overall Study|Protocol Specified Criteria|1|||
126611473|NCT02157948|455536326|FG000|Overall Study|Decision by Sponsor|0|||
126611474|NCT02157948|455536327|FG001|Overall Study|Decision by Sponsor|1|||
126611475|NCT04821271|455536334|FG000|Period 1|Withdrawal by Subject|2|||
126734218|NCT00340834|455975819|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
126734219|NCT00340834|455975820|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
126734220|NCT00340834|455975821|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
126611476|NCT04821271|455536335|FG001|Period 1|Withdrawal by Subject|0|||
126611477|NCT01567852|455537135|FG000|Overall Study|Withdrawal by Subject|3|||
126611478|NCT01567852|455537136|FG001|Overall Study|Withdrawal by Subject|6|||
126611479|NCT01567852|455537135|FG000|Overall Study|ECT discontinued|1|||
126734221|NCT00340834|455975822|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
126734222|NCT00340834|455975823|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
126734223|NCT00340834|455975819|FG000|Extension Phase of Study|Protocol Violation|3|||
126611480|NCT01567852|455537136|FG001|Overall Study|ECT discontinued|1|||
126611481|NCT04809623|455537137|FG000|Overall Study|Study Terminated by Sponsor|1|||
126611482|NCT04809623|455537138|FG001|Overall Study|Study Terminated by Sponsor|0|||
126611483|NCT00822900|455537150|FG000|Overall Study|Withdrawal by Subject|14|||
126734224|NCT00340834|455975820|FG001|Extension Phase of Study|Protocol Violation|0|||
126734225|NCT00340834|455975821|FG002|Extension Phase of Study|Protocol Violation|0|||
126611484|NCT00822900|455537151|FG001|Overall Study|Withdrawal by Subject|14|||
126611485|NCT00822900|455537150|FG000|Overall Study|Lost to Follow-up|9|||
126611486|NCT00822900|455537151|FG001|Overall Study|Lost to Follow-up|9|||
126734226|NCT00340834|455975822|FG003|Extension Phase of Study|Protocol Violation|0|||
126734227|NCT00340834|455975823|FG004|Extension Phase of Study|Protocol Violation|0|||
126734228|NCT00340834|455975819|FG000|Extension Phase of Study|Death|0|||
126734229|NCT00340834|455975820|FG001|Extension Phase of Study|Death|0|||
126734230|NCT00340834|455975821|FG002|Extension Phase of Study|Death|0|||
126734231|NCT00340834|455975822|FG003|Extension Phase of Study|Death|0|||
126734232|NCT00340834|455975823|FG004|Extension Phase of Study|Death|1|||
126734233|NCT02786836|455975826|FG000|Overall Study|Death|1|||
126734234|NCT02786836|455975826|FG000|Overall Study|Lack of Efficacy|2|||
126734235|NCT02786836|455975826|FG000|Overall Study|Protocol Violation|3|||
126734236|NCT02786836|455975826|FG000|Overall Study|Withdrawal by Subject|3|||
126734237|NCT02786836|455975826|FG000|Overall Study|Liver Transplantation|2|||
126734238|NCT02786836|455975826|FG000|Overall Study|Device or Pharmacy Issues|3|||
126734239|NCT01143714|455975828|FG000|Overall Study|Adverse Event|4|||
126734240|NCT01143714|455975829|FG001|Overall Study|Adverse Event|2|||
126734241|NCT01143714|455975828|FG000|Overall Study|Withdrawal by Subject|1|||
126734242|NCT01143714|455975829|FG001|Overall Study|Withdrawal by Subject|0|||
126734243|NCT01143714|455975828|FG000|Overall Study|Subject non-compliance|0|||
126734244|NCT01143714|455975829|FG001|Overall Study|Subject non-compliance|1|||
126734245|NCT01143714|455975828|FG000|Overall Study|wound closed = deemed healed|1|||
126734246|NCT01143714|455975829|FG001|Overall Study|wound closed = deemed healed|0|||
126734247|NCT01143714|455975828|FG000|Overall Study|wound size increased|1|||
126734248|NCT01143714|455975829|FG001|Overall Study|wound size increased|0|||
126734249|NCT01387074|455975830|FG000|Overall Study|Lost to Follow-up|7|||
126734250|NCT01387074|455975830|FG000|Overall Study|Lack of Efficacy|1|||
126734251|NCT03892707|455975836|FG000|Overall Study|Screen failure|6|||
126734252|NCT03892707|455975837|FG001|Overall Study|Screen failure|0|||
126734253|NCT03892707|455975836|FG000|Overall Study|Pain resolution|0|||
126734254|NCT03892707|455975837|FG001|Overall Study|Pain resolution|4|||
126734255|NCT03892707|455975836|FG000|Overall Study|Withdrawal by Subject|0|||
126734256|NCT03892707|455975837|FG001|Overall Study|Withdrawal by Subject|1|||
126734257|NCT03892707|455975836|FG000|Overall Study|Other (long business trip)|0|||
126734258|NCT03892707|455975837|FG001|Overall Study|Other (long business trip)|1|||
126734259|NCT02137837|455975840|FG000|Overall Study|Adverse Event|0|||
126734260|NCT02137837|455975841|FG001|Overall Study|Adverse Event|2|||
126734261|NCT02137837|455975842|FG002|Overall Study|Adverse Event|1|||
126734262|NCT02137837|455975840|FG000|Overall Study|Refusal unrelated to adverse event|2|||
126734263|NCT02137837|455975841|FG001|Overall Study|Refusal unrelated to adverse event|2|||
126734264|NCT02137837|455975842|FG002|Overall Study|Refusal unrelated to adverse event|1|||
126734265|NCT02137837|455975840|FG000|Overall Study|Progression/relapse|9|||
126734266|NCT02137837|455975841|FG001|Overall Study|Progression/relapse|7|||
126734267|NCT02137837|455975842|FG002|Overall Study|Progression/relapse|7|||
126734268|NCT02137837|455975840|FG000|Overall Study|Not protocol specified|2|||
126734269|NCT02137837|455975841|FG001|Overall Study|Not protocol specified|1|||
126734270|NCT02137837|455975842|FG002|Overall Study|Not protocol specified|3|||
126734271|NCT02141217|455975843|FG000|Overall Study|Adverse Event|1|||
126734272|NCT02141217|455975844|FG001|Overall Study|Adverse Event|2|||
126734273|NCT02141217|455975843|FG000|Overall Study|Protocol Violation|1|||
126781254|NCT03882047|456154500|FG001|Overall Study|Noncompliance With Protocol|0|||
126781255|NCT03882047|456154501|FG002|Overall Study|Noncompliance With Protocol|0|||
126611487|NCT00822900|455537150|FG000|Overall Study|Death|83|||
126611488|NCT00822900|455537151|FG001|Overall Study|Death|69|||
126611489|NCT00822900|455537150|FG000|Overall Study|Became a ward of the state|2|||
126611490|NCT00822900|455537151|FG001|Overall Study|Became a ward of the state|1|||
126611491|NCT02095678|455537152|FG000|Overall Study|Withdrawal by Subject|0|||
126611492|NCT02095678|455537153|FG001|Overall Study|Withdrawal by Subject|1|||
126611493|NCT02095678|455537152|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
126611494|NCT02095678|455537153|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
126611495|NCT02095678|455537152|FG000|Overall Study|lesion impacted by previous treatment|1|||
126611496|NCT02095678|455537153|FG001|Overall Study|lesion impacted by previous treatment|1|||
126611497|NCT02095678|455537152|FG000|Overall Study|No Confirmed Diagnosis|0|||
126611498|NCT02095678|455537153|FG001|Overall Study|No Confirmed Diagnosis|3|||
126611499|NCT02095678|455537152|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
126611500|NCT02095678|455537153|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
126781256|NCT03882047|456154499|FG000|Overall Study|Did Not Meet Eligibility|0|||
126734274|NCT02141217|455975844|FG001|Overall Study|Protocol Violation|4|||
126734275|NCT02141217|455975843|FG000|Overall Study|Withdrawal by Subject|6|||
126734276|NCT02141217|455975844|FG001|Overall Study|Withdrawal by Subject|0|||
126734277|NCT02141217|455975843|FG000|Overall Study|Lost to Follow-up|1|||
126734278|NCT02141217|455975844|FG001|Overall Study|Lost to Follow-up|1|||
126734279|NCT02141217|455975843|FG000|Overall Study|Physician Decision|1|||
126734280|NCT02141217|455975844|FG001|Overall Study|Physician Decision|0|||
126734281|NCT02141217|455975843|FG000|Overall Study|Surgical Intervention|1|||
126734282|NCT02141217|455975844|FG001|Overall Study|Surgical Intervention|1|||
126734283|NCT01181141|455975849|FG000|Overall Study|Adverse Event|2|||
126734284|NCT01181141|455975850|FG001|Overall Study|Adverse Event|1|||
126611501|NCT02095678|455537152|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
126611502|NCT02095678|455537153|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
126611503|NCT00701415|455537154|FG000|Overall Study|Adverse Event|0|||
126611504|NCT00701415|455537155|FG001|Overall Study|Adverse Event|1|||
126611505|NCT00701415|455537154|FG000|Overall Study|Social/family issues and needle phobia|1|||
126611506|NCT00701415|455537155|FG001|Overall Study|Social/family issues and needle phobia|0|||
126611507|NCT02106884|455537160|FG000|Overall Study|Change of diagnosis/exclusion|0|||
126611508|NCT02106884|455537161|FG001|Overall Study|Change of diagnosis/exclusion|1|||
126611509|NCT02161458|455537164|FG000|Overall Study|Withdrawal by Subject|0|||
126611510|NCT02161458|455537165|FG001|Overall Study|Withdrawal by Subject|4|||
126611511|NCT02161458|455537166|FG002|Overall Study|Withdrawal by Subject|4|||
126611512|NCT02161458|455537167|FG003|Overall Study|Withdrawal by Subject|0|||
126611513|NCT02161458|455537164|FG000|Overall Study|Lost to Follow-up|0|||
126611514|NCT02161458|455537165|FG001|Overall Study|Lost to Follow-up|2|||
126611515|NCT02161458|455537166|FG002|Overall Study|Lost to Follow-up|1|||
126611516|NCT02161458|455537167|FG003|Overall Study|Lost to Follow-up|0|||
126611517|NCT01220999|455537170|FG000|Overall Study|Progressive disease|0|||
126611518|NCT01220999|455537171|FG001|Overall Study|Progressive disease|0|||
126611519|NCT01220999|455537172|FG002|Overall Study|Progressive disease|1|||
126611520|NCT01220999|455537173|FG003|Overall Study|Progressive disease|0|||
126611521|NCT01220999|455537174|FG004|Overall Study|Progressive disease|0|||
126611522|NCT01560429|455537175|FG000|Overall Study|Protocol Violation|3|||
126611523|NCT01560429|455537176|FG001|Overall Study|Protocol Violation|6|||
126611524|NCT00705159|455537180|FG000|Overall Study|Withdrawal by Subject|0|||
126611525|NCT00705159|455537181|FG001|Overall Study|Withdrawal by Subject|1|||
126611526|NCT00705159|455537182|FG002|Overall Study|Withdrawal by Subject|1|||
126611527|NCT00705159|455537183|FG003|Overall Study|Withdrawal by Subject|1|||
126611528|NCT00705159|455537180|FG000|Overall Study|Protocol Violation|0|||
126611529|NCT00705159|455537181|FG001|Overall Study|Protocol Violation|1|||
126611530|NCT00705159|455537182|FG002|Overall Study|Protocol Violation|0|||
126611531|NCT00705159|455537183|FG003|Overall Study|Protocol Violation|0|||
126611532|NCT00705159|455537180|FG000|Overall Study|Adverse Event|0|||
126611533|NCT00705159|455537181|FG001|Overall Study|Adverse Event|0|||
126611534|NCT00705159|455537182|FG002|Overall Study|Adverse Event|1|||
126611535|NCT00705159|455537183|FG003|Overall Study|Adverse Event|0|||
126611536|NCT00705159|455537180|FG000|Overall Study|Lost to Follow-up|0|||
126611537|NCT00705159|455537181|FG001|Overall Study|Lost to Follow-up|0|||
126611538|NCT00705159|455537182|FG002|Overall Study|Lost to Follow-up|3|||
126611539|NCT00705159|455537183|FG003|Overall Study|Lost to Follow-up|2|||
126611540|NCT00705159|455537180|FG000|Overall Study|Screen Failure|0|||
126611541|NCT00705159|455537181|FG001|Overall Study|Screen Failure|0|||
126611542|NCT00705159|455537182|FG002|Overall Study|Screen Failure|0|||
126611543|NCT00705159|455537183|FG003|Overall Study|Screen Failure|1|||
126611544|NCT03026166|455537186|FG000|Overall Study|Death|22|||
126611545|NCT03026166|455537187|FG001|Overall Study|Death|7|||
126611546|NCT03026166|455537186|FG000|Overall Study|Physician Decision|2|||
126611547|NCT03026166|455537187|FG001|Overall Study|Physician Decision|0|||
126611548|NCT03026166|455537186|FG000|Overall Study|Withdrawal by Subject|1|||
126611549|NCT03026166|455537187|FG001|Overall Study|Withdrawal by Subject|2|||
126611550|NCT03026166|455537186|FG000|Overall Study|Lost to Follow-up|1|||
126611551|NCT03026166|455537187|FG001|Overall Study|Lost to Follow-up|0|||
126611552|NCT03026166|455537186|FG000|Overall Study|Study Terminated by Sponsor|3|||
126611553|NCT03026166|455537187|FG001|Overall Study|Study Terminated by Sponsor|3|||
126611554|NCT03026166|455537186|FG000|Overall Study|Other|1|||
126611555|NCT03026166|455537187|FG001|Overall Study|Other|0|||
126611556|NCT02091752|455537188|FG000|Overall Study|Study terminated by Sponsor|2|||
126611557|NCT02091752|455537188|FG000|Overall Study|Adverse Event|1|||
126611558|NCT01604824|455537189|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
126611559|NCT01604824|455537190|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
126611560|NCT01604824|455537191|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
126611561|NCT01604824|455537192|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
126611562|NCT01604824|455537193|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
126611563|NCT01604824|455537194|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
126611564|NCT01604824|455537189|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
126611565|NCT01604824|455537190|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
126611566|NCT01604824|455537191|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
126611567|NCT01604824|455537192|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
126611568|NCT01604824|455537193|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
126611569|NCT01604824|455537194|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
126611570|NCT03775213|455537197|FG000|Overall Study|Withdrawal by Subject|51|||
126611571|NCT03775213|455537198|FG001|Overall Study|Withdrawal by Subject|53|||
126611572|NCT03775213|455537197|FG000|Overall Study|Incomplete Survey|7|||
126611573|NCT03775213|455537198|FG001|Overall Study|Incomplete Survey|7|||
126611574|NCT04076059|455537199|FG000|Double Blind Phase|Progressive disease|22|||
126611575|NCT04076059|455537200|FG001|Double Blind Phase|Progressive disease|26|||
126734285|NCT01181141|455975849|FG000|Overall Study|Lack of Efficacy|1|||
126734286|NCT01181141|455975850|FG001|Overall Study|Lack of Efficacy|0|||
126734287|NCT01181141|455975849|FG000|Overall Study|Lost to Follow-up|1|||
126734288|NCT01181141|455975850|FG001|Overall Study|Lost to Follow-up|1|||
126734289|NCT01181141|455975849|FG000|Overall Study|Physician Decision|2|||
126734290|NCT01181141|455975850|FG001|Overall Study|Physician Decision|0|||
126734291|NCT01181141|455975849|FG000|Overall Study|Protocol Violation|3|||
126781257|NCT03882047|456154500|FG001|Overall Study|Did Not Meet Eligibility|0|||
126781258|NCT03882047|456154501|FG002|Overall Study|Did Not Meet Eligibility|1|||
126781259|NCT00441584|456154504|FG000|Overall Study|Lack of Efficacy|79|||
126781260|NCT00441584|456154504|FG000|Overall Study|Withdrawal by Subject|8|||
126781261|NCT00441584|456154504|FG000|Overall Study|Adverse Event|6|||
126781262|NCT00441584|456154504|FG000|Overall Study|Protocol Violation|5|||
126781263|NCT00441584|456154504|FG000|Overall Study|Lost to Follow-up|4|||
126781264|NCT00441584|456154504|FG000|Overall Study|Failure to meet eligibility criteria|3|||
126781265|NCT00798889|456154507|FG000|Overall Study|Adverse Event|53|||
126781266|NCT00798889|456154507|FG000|Overall Study|Protocol Violation|2|||
126781267|NCT00798889|456154507|FG000|Overall Study|Withdrawal by Subject|31|||
126781268|NCT00798889|456154507|FG000|Overall Study|Lost to Follow-up|1|||
126781269|NCT00798889|456154507|FG000|Overall Study|Lack of Efficacy|213|||
126611576|NCT04076059|455537201|FG002|Double Blind Phase|Progressive disease|0|||
126611577|NCT04076059|455537199|FG000|Double Blind Phase|Withdrawal by Subject|4|||
126611578|NCT04076059|455537200|FG001|Double Blind Phase|Withdrawal by Subject|11|||
126611579|NCT04076059|455537201|FG002|Double Blind Phase|Withdrawal by Subject|0|||
126611580|NCT04076059|455537199|FG000|Double Blind Phase|Death|1|||
126611581|NCT04076059|455537200|FG001|Double Blind Phase|Death|1|||
126611582|NCT04076059|455537201|FG002|Double Blind Phase|Death|0|||
126611583|NCT04076059|455537199|FG000|Double Blind Phase|Lost to Follow-up|1|||
126611584|NCT04076059|455537200|FG001|Double Blind Phase|Lost to Follow-up|0|||
126611585|NCT04076059|455537201|FG002|Double Blind Phase|Lost to Follow-up|0|||
126611586|NCT04076059|455537199|FG000|Double Blind Phase|Adverse Event|5|||
126611587|NCT04076059|455537200|FG001|Double Blind Phase|Adverse Event|1|||
126611588|NCT04076059|455537201|FG002|Double Blind Phase|Adverse Event|0|||
126611589|NCT04076059|455537199|FG000|Double Blind Phase|Ongoing Participants|82|||
126611590|NCT04076059|455537200|FG001|Double Blind Phase|Ongoing Participants|18|||
126611591|NCT04076059|455537201|FG002|Double Blind Phase|Ongoing Participants|0|||
126611592|NCT04076059|455537199|FG000|Double Blind Phase|Miscellaneous|3|||
126611593|NCT04076059|455537200|FG001|Double Blind Phase|Miscellaneous|1|||
126611594|NCT04076059|455537201|FG002|Double Blind Phase|Miscellaneous|0|||
126611595|NCT04076059|455537199|FG000|Double Blind Phase|Protocol Deviation|1|||
126611596|NCT04076059|455537200|FG001|Double Blind Phase|Protocol Deviation|1|||
126611597|NCT04076059|455537201|FG002|Double Blind Phase|Protocol Deviation|0|||
126611598|NCT04076059|455537199|FG000|Double Blind Phase|Did not take study drug|1|||
126611599|NCT04076059|455537200|FG001|Double Blind Phase|Did not take study drug|1|||
126611600|NCT04076059|455537201|FG002|Double Blind Phase|Did not take study drug|0|||
126611601|NCT04076059|455537199|FG000|Open Label Phase|Progressive disease|0|||
126611602|NCT04076059|455537200|FG001|Open Label Phase|Progressive disease|0|||
126611603|NCT04076059|455537201|FG002|Open Label Phase|Progressive disease|7|||
126611604|NCT04076059|455537199|FG000|Open Label Phase|Withdrawal by Subject|0|||
126611605|NCT04076059|455537200|FG001|Open Label Phase|Withdrawal by Subject|0|||
126611606|NCT04076059|455537201|FG002|Open Label Phase|Withdrawal by Subject|3|||
126611607|NCT04076059|455537199|FG000|Open Label Phase|Death|0|||
126611608|NCT04076059|455537200|FG001|Open Label Phase|Death|0|||
126611609|NCT04076059|455537201|FG002|Open Label Phase|Death|2|||
126611610|NCT04076059|455537199|FG000|Open Label Phase|Ongoing Participants|0|||
126611611|NCT04076059|455537200|FG001|Open Label Phase|Ongoing Participants|0|||
126611612|NCT04076059|455537201|FG002|Open Label Phase|Ongoing Participants|11|||
126611613|NCT00452114|455537204|FG000|Overall Study|Physician Decision|3|||
126611614|NCT00452114|455537205|FG001|Overall Study|Physician Decision|3|||
126781270|NCT00798889|456154507|FG000|Overall Study|Decision of Sponsor|11|||
126781271|NCT00798889|456154507|FG000|Overall Study|Enrolled, Not treated|3|||
126611615|NCT00949117|455538692|FG000|Overall Study|Lack of Efficacy|2|||
126781272|NCT00358826|456154508|FG000|Core Study|Adverse Event|1|||
126734292|NCT01181141|455975850|FG001|Overall Study|Protocol Violation|1|||
126734293|NCT01181141|455975849|FG000|Overall Study|Withdrawal by Subject|3|||
126781273|NCT00358826|456154509|FG001|Core Study|Adverse Event|3|||
126781274|NCT00358826|456154510|FG002|Core Study|Adverse Event|1|||
126781275|NCT00358826|456154511|FG003|Core Study|Adverse Event|1|||
126781276|NCT00358826|456154512|FG004|Core Study|Adverse Event|0|||
126611616|NCT00949117|455538693|FG001|Overall Study|Lack of Efficacy|3|||
126611617|NCT00949117|455538692|FG000|Overall Study|Protocol Violation|1|||
126611618|NCT00949117|455538693|FG001|Overall Study|Protocol Violation|1|||
126611619|NCT00949117|455538692|FG000|Overall Study|Adverse Event|0|||
126611620|NCT00949117|455538693|FG001|Overall Study|Adverse Event|1|||
126611621|NCT03964974|455538694|FG000|Overall Study|Lost to Follow-up|3|||
126734294|NCT01181141|455975850|FG001|Overall Study|Withdrawal by Subject|1|||
126734295|NCT00448760|455975851|FG000|Overall Study|Death|3|||
126734296|NCT01213264|455975857|FG000|Overall Study|Adverse Event|1|||
126781277|NCT00358826|456154513|FG005|Core Study|Adverse Event|0|||
126611622|NCT03964974|455538695|FG001|Overall Study|Lost to Follow-up|2|||
126611623|NCT03964974|455538694|FG000|Overall Study|Withdrawal by Subject|0|||
126611624|NCT03964974|455538695|FG001|Overall Study|Withdrawal by Subject|3|||
126611625|NCT01214200|455538696|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
126611626|NCT01214200|455538696|FG000|Overall Study|Withdrawal by Subject|2|||
126611627|NCT01719172|455538697|FG000|Overall Study|Lost to Follow-up|1|||
126611628|NCT01719172|455538697|FG000|Overall Study|Death|1|||
126611629|NCT04250636|455538700|FG000|Overall Study|Lost to Follow-up|2|||
126611630|NCT03041090|455538701|FG000|Overall Study|technical error|0|||
126611631|NCT03041090|455538702|FG001|Overall Study|technical error|3|||
126611632|NCT02202317|455538704|FG000|Overall Study|Lost to Follow-up|1|||
126611633|NCT01353274|455538705|FG000|Overall Study|No case report form (CRF) collected|28|||
126611634|NCT01409837|455538706|FG000|Overall Study|Withdrawal by Subject|2|||
126611635|NCT01409837|455538707|FG001|Overall Study|Withdrawal by Subject|1|||
126611636|NCT01409837|455538706|FG000|Overall Study|Lost to Follow-up|1|||
126611637|NCT01409837|455538707|FG001|Overall Study|Lost to Follow-up|0|||
126611638|NCT01409837|455538706|FG000|Overall Study|Physician Decision|0|||
126611639|NCT01409837|455538707|FG001|Overall Study|Physician Decision|1|||
126611640|NCT03960645|455538708|FG000|Overall Study|Protocol Violation|1|||
126611641|NCT03960645|455538709|FG001|Overall Study|Protocol Violation|0|||
126611642|NCT03292406|455538711|FG000|Overall Study|Progressive Disease|6|||
126611643|NCT03292406|455538712|FG001|Overall Study|Progressive Disease|3|||
126611644|NCT03292406|455538713|FG002|Overall Study|Progressive Disease|4|||
126611645|NCT03292406|455538711|FG000|Overall Study|Adverse Event|7|||
126611646|NCT03292406|455538712|FG001|Overall Study|Adverse Event|1|||
126611647|NCT03292406|455538713|FG002|Overall Study|Adverse Event|4|||
126611648|NCT03292406|455538711|FG000|Overall Study|Withdrawal by Subject|0|||
126611649|NCT03292406|455538712|FG001|Overall Study|Withdrawal by Subject|7|||
126611650|NCT03292406|455538713|FG002|Overall Study|Withdrawal by Subject|2|||
126611651|NCT03292406|455538711|FG000|Overall Study|Protocol Violation|0|||
126611652|NCT03292406|455538712|FG001|Overall Study|Protocol Violation|1|||
126611653|NCT03292406|455538713|FG002|Overall Study|Protocol Violation|1|||
126611654|NCT03292406|455538711|FG000|Overall Study|Other|0|||
126611655|NCT03292406|455538712|FG001|Overall Study|Other|1|||
126611656|NCT03292406|455538713|FG002|Overall Study|Other|2|||
126611657|NCT00022672|455538715|FG000|Main Phase: 24 Months|Adverse Event|6|||
126611658|NCT00022672|455538716|FG001|Main Phase: 24 Months|Adverse Event|0|||
126611659|NCT00022672|455538715|FG000|Main Phase: 24 Months|Death|0|||
126611660|NCT00022672|455538716|FG001|Main Phase: 24 Months|Death|3|||
126611661|NCT00022672|455538715|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
126611662|NCT00022672|455538716|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
126611663|NCT00022672|455538715|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
126611664|NCT00022672|455538716|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
126611665|NCT00022672|455538715|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
126611666|NCT00022672|455538716|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
126611667|NCT00022672|455538715|FG000|Main Phase: 24 Months|Refused Treatment|3|||
126611668|NCT00022672|455538716|FG001|Main Phase: 24 Months|Refused Treatment|4|||
126611669|NCT00022672|455538715|FG000|Main Phase: 24 Months|Failure to Return|1|||
126611670|NCT00022672|455538716|FG001|Main Phase: 24 Months|Failure to Return|1|||
126611671|NCT00022672|455538715|FG000|Main Phase: 24 Months|Other|1|||
126611672|NCT00022672|455538716|FG001|Main Phase: 24 Months|Other|0|||
126611673|NCT00022672|455538715|FG000|Extension Phase|Adverse Event|1|||
126611674|NCT00022672|455538716|FG001|Extension Phase|Adverse Event|3|||
126611675|NCT00022672|455538715|FG000|Extension Phase|Death|0|||
126611676|NCT00022672|455538716|FG001|Extension Phase|Death|1|||
126611677|NCT00022672|455538715|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
126611678|NCT00022672|455538716|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
126611679|NCT00022672|455538715|FG000|Extension Phase|Refused Treatment|0|||
126611680|NCT00022672|455538716|FG001|Extension Phase|Refused Treatment|2|||
126611681|NCT00022672|455538715|FG000|Extension Phase|Other|1|||
126611682|NCT00022672|455538716|FG001|Extension Phase|Other|1|||
126611683|NCT00403494|455538717|FG000|Overall Study|Adverse Event|10|||
126611684|NCT00403494|455538718|FG001|Overall Study|Adverse Event|8|||
126734297|NCT01213264|455975858|FG001|Overall Study|Adverse Event|0|||
126734298|NCT01213264|455975859|FG002|Overall Study|Adverse Event|0|||
126734299|NCT01213264|455975857|FG000|Overall Study|Lost to Follow-up|1|||
126611685|NCT00403494|455538717|FG000|Overall Study|Withdrew Consent|3|||
126611686|NCT00403494|455538718|FG001|Overall Study|Withdrew Consent|2|||
126611687|NCT00403494|455538717|FG000|Overall Study|Inappropriately enrolled|0|||
126611688|NCT00403494|455538718|FG001|Overall Study|Inappropriately enrolled|1|||
126611689|NCT00403494|455538717|FG000|Overall Study|Lost to Follow-up|0|||
126611690|NCT00403494|455538718|FG001|Overall Study|Lost to Follow-up|2|||
126611691|NCT00403494|455538717|FG000|Overall Study|Protocol noncompliance|0|||
126611692|NCT00403494|455538718|FG001|Overall Study|Protocol noncompliance|1|||
126611693|NCT00403494|455538717|FG000|Overall Study|Death|1|||
126734300|NCT01213264|455975858|FG001|Overall Study|Lost to Follow-up|2|||
126734301|NCT01213264|455975859|FG002|Overall Study|Lost to Follow-up|6|||
126611694|NCT00403494|455538718|FG001|Overall Study|Death|0|||
126611695|NCT00403494|455538717|FG000|Overall Study|Sponsor Request|1|||
126611696|NCT00403494|455538718|FG001|Overall Study|Sponsor Request|0|||
126611697|NCT01450007|455538719|FG000|Overall Study|Late exclusion before treatment|2|||
126611698|NCT01450007|455538720|FG001|Overall Study|Late exclusion before treatment|3|||
126611699|NCT01450007|455538721|FG002|Overall Study|Late exclusion before treatment|2|||
126611700|NCT01450007|455538719|FG000|Overall Study|Protocol Violation|0|||
126611701|NCT01450007|455538720|FG001|Overall Study|Protocol Violation|1|||
126611702|NCT01450007|455538721|FG002|Overall Study|Protocol Violation|1|||
126611703|NCT01450007|455538719|FG000|Overall Study|Adverse Event|0|||
126611704|NCT01450007|455538720|FG001|Overall Study|Adverse Event|1|||
126611705|NCT01450007|455538721|FG002|Overall Study|Adverse Event|0|||
126611706|NCT03851094|455538723|FG000|Overall Study|Withdrawal by Subject|0|||
126611707|NCT03851094|455538724|FG001|Overall Study|Withdrawal by Subject|1|||
126611708|NCT03851094|455538723|FG000|Overall Study|Participant lost device|0|||
126611709|NCT03851094|455538724|FG001|Overall Study|Participant lost device|1|||
126611710|NCT03851094|455538723|FG000|Overall Study|Participant returned device|0|||
126611711|NCT03851094|455538724|FG001|Overall Study|Participant returned device|2|||
126611712|NCT01332266|455538725|FG000|Phase 1b|Death|3|||
126611713|NCT01332266|455538726|FG001|Phase 1b|Death|3|||
126611714|NCT01332266|455538727|FG002|Phase 1b|Death|2|||
126611715|NCT01332266|455538728|FG003|Phase 1b|Death|0|||
126611716|NCT01332266|455538729|FG004|Phase 1b|Death|0|||
126611717|NCT01332266|455538725|FG000|Phase 1b|Lost to Follow-up|0|||
126611718|NCT01332266|455538726|FG001|Phase 1b|Lost to Follow-up|1|||
126611719|NCT01332266|455538727|FG002|Phase 1b|Lost to Follow-up|0|||
126611720|NCT01332266|455538728|FG003|Phase 1b|Lost to Follow-up|0|||
126611721|NCT01332266|455538729|FG004|Phase 1b|Lost to Follow-up|0|||
126611722|NCT01332266|455538725|FG000|Phase 1b|Withdrawal by Subject|1|||
126611723|NCT01332266|455538726|FG001|Phase 1b|Withdrawal by Subject|1|||
126611724|NCT01332266|455538727|FG002|Phase 1b|Withdrawal by Subject|1|||
126611725|NCT01332266|455538728|FG003|Phase 1b|Withdrawal by Subject|0|||
126611726|NCT01332266|455538729|FG004|Phase 1b|Withdrawal by Subject|0|||
126611727|NCT01332266|455538725|FG000|Phase 2|Death|0|||
126611728|NCT01332266|455538726|FG001|Phase 2|Death|0|||
126611729|NCT01332266|455538727|FG002|Phase 2|Death|0|||
126611730|NCT01332266|455538728|FG003|Phase 2|Death|33|||
126611731|NCT01332266|455538729|FG004|Phase 2|Death|36|||
126611732|NCT01332266|455538725|FG000|Phase 2|Lost to Follow-up|0|||
126611733|NCT01332266|455538726|FG001|Phase 2|Lost to Follow-up|0|||
126611734|NCT01332266|455538727|FG002|Phase 2|Lost to Follow-up|0|||
126611735|NCT01332266|455538728|FG003|Phase 2|Lost to Follow-up|2|||
126611736|NCT01332266|455538729|FG004|Phase 2|Lost to Follow-up|0|||
126611737|NCT01332266|455538725|FG000|Phase 2|Physician Decision|0|||
126611738|NCT01332266|455538726|FG001|Phase 2|Physician Decision|0|||
126611739|NCT01332266|455538727|FG002|Phase 2|Physician Decision|0|||
126611740|NCT01332266|455538728|FG003|Phase 2|Physician Decision|3|||
126611741|NCT01332266|455538729|FG004|Phase 2|Physician Decision|1|||
126611742|NCT01332266|455538725|FG000|Phase 2|Symptomatic deterioration|0|||
126611743|NCT01332266|455538726|FG001|Phase 2|Symptomatic deterioration|0|||
126611744|NCT01332266|455538727|FG002|Phase 2|Symptomatic deterioration|0|||
126611745|NCT01332266|455538728|FG003|Phase 2|Symptomatic deterioration|0|||
126611746|NCT01332266|455538729|FG004|Phase 2|Symptomatic deterioration|1|||
126611747|NCT01332266|455538725|FG000|Phase 2|Progression Disease|0|||
126611748|NCT01332266|455538726|FG001|Phase 2|Progression Disease|0|||
126611749|NCT01332266|455538727|FG002|Phase 2|Progression Disease|0|||
126611750|NCT01332266|455538728|FG003|Phase 2|Progression Disease|2|||
126611751|NCT01332266|455538729|FG004|Phase 2|Progression Disease|1|||
126611752|NCT01332266|455538725|FG000|Phase 2|Withdrawal by Subject|0|||
126611753|NCT01332266|455538726|FG001|Phase 2|Withdrawal by Subject|0|||
126611754|NCT01332266|455538727|FG002|Phase 2|Withdrawal by Subject|0|||
126611755|NCT01332266|455538728|FG003|Phase 2|Withdrawal by Subject|2|||
126611756|NCT01332266|455538729|FG004|Phase 2|Withdrawal by Subject|2|||
126611757|NCT01536704|455538732|FG000|Washout Period 1|Withdrawal by Subject|1|||
126734302|NCT00118911|455975860|FG000|Overall Study|Withdrawal by Subject|2|||
126611758|NCT01536704|455538733|FG001|Washout Period 1|Withdrawal by Subject|2|||
126611759|NCT01536704|455538734|FG002|Washout Period 1|Withdrawal by Subject|0|||
126611760|NCT01536704|455538735|FG003|Washout Period 1|Withdrawal by Subject|0|||
126611761|NCT01536704|455538732|FG000|Washout Period 2|Adverse Event|1|||
126611762|NCT01536704|455538733|FG001|Washout Period 2|Adverse Event|0|||
126611763|NCT01536704|455538734|FG002|Washout Period 2|Adverse Event|0|||
126611764|NCT01536704|455538735|FG003|Washout Period 2|Adverse Event|0|||
126611765|NCT01536704|455538732|FG000|Washout Period 2|Withdrawal by Subject|0|||
126611766|NCT01536704|455538733|FG001|Washout Period 2|Withdrawal by Subject|0|||
126611767|NCT01536704|455538734|FG002|Washout Period 2|Withdrawal by Subject|0|||
126611768|NCT01536704|455538735|FG003|Washout Period 2|Withdrawal by Subject|1|||
126611769|NCT01536704|455538732|FG000|Period 3|Adverse Event|0|||
126734303|NCT00118911|455975861|FG001|Overall Study|Withdrawal by Subject|5|||
126611770|NCT01536704|455538733|FG001|Period 3|Adverse Event|0|||
126611771|NCT01536704|455538734|FG002|Period 3|Adverse Event|0|||
126611772|NCT01536704|455538735|FG003|Period 3|Adverse Event|1|||
126611773|NCT01536704|455538732|FG000|Washout Period 3|Adverse Event|0|||
126611774|NCT01536704|455538733|FG001|Washout Period 3|Adverse Event|0|||
126611775|NCT01536704|455538734|FG002|Washout Period 3|Adverse Event|1|||
126611776|NCT01536704|455538735|FG003|Washout Period 3|Adverse Event|0|||
126611777|NCT00047385|455538736|FG000|Overall Study|Death before any screening|2|||
126611778|NCT00047385|455538737|FG001|Overall Study|Death before any screening|5|||
126611779|NCT00047385|455538736|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
126611780|NCT00047385|455538737|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
126611781|NCT00047385|455538736|FG000|Overall Study|Eligible for screening but had no screen|260|||
126611782|NCT00047385|455538737|FG001|Overall Study|Eligible for screening but had no screen|492|||
126611783|NCT03490032|455538738|FG000|Overall Study|family issue (child custody)|1|||
126611784|NCT03490032|455538739|FG001|Overall Study|family issue (child custody)|0|||
126611785|NCT03490032|455538740|FG002|Overall Study|family issue (child custody)|0|||
126611786|NCT01852045|455538741|FG000|Overall Study|Adverse Event|1|||
126611787|NCT01852045|455538742|FG001|Overall Study|Adverse Event|0|||
126611788|NCT01852045|455538743|FG002|Overall Study|Adverse Event|0|||
126611789|NCT01852045|455538741|FG000|Overall Study|Lack of Efficacy|3|||
126611790|NCT01852045|455538742|FG001|Overall Study|Lack of Efficacy|0|||
126611791|NCT01852045|455538743|FG002|Overall Study|Lack of Efficacy|0|||
126611792|NCT01852045|455538741|FG000|Overall Study|Lost to Follow-up|0|||
126611793|NCT01852045|455538742|FG001|Overall Study|Lost to Follow-up|1|||
126611794|NCT01852045|455538743|FG002|Overall Study|Lost to Follow-up|1|||
126611795|NCT01852045|455538741|FG000|Overall Study|Withdrawal by Subject|1|||
126611796|NCT01852045|455538742|FG001|Overall Study|Withdrawal by Subject|0|||
126611797|NCT01852045|455538743|FG002|Overall Study|Withdrawal by Subject|1|||
126611798|NCT01852045|455538741|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126611799|NCT01852045|455538742|FG001|Overall Study|Other Miscellaneous Reasons|3|||
126611800|NCT01852045|455538743|FG002|Overall Study|Other Miscellaneous Reasons|2|||
126611801|NCT01698918|455538745|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
126611802|NCT01698918|455538745|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
126611803|NCT01698918|455538745|FG000|First Line Treatment (Core+Extension)|Death|2|||
126611804|NCT01698918|455538745|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
126611805|NCT01698918|455538745|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
126611806|NCT01698918|455538745|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
126611807|NCT01698918|455538745|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
126611808|NCT01698918|455538745|FG000|Second Line Treatment (Core+Extension)|Death|1|||
126611809|NCT01698918|455538745|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
126611810|NCT01698918|455538745|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
126611811|NCT00310037|455538747|FG000|Overall Study|Adverse Event|7|||
126611812|NCT00310037|455538748|FG001|Overall Study|Adverse Event|14|||
126611813|NCT00310037|455538747|FG000|Overall Study|Withdrawal by Subject|4|||
126611814|NCT00310037|455538748|FG001|Overall Study|Withdrawal by Subject|3|||
126611815|NCT00310037|455538747|FG000|Overall Study|Progression|6|||
126611816|NCT00310037|455538748|FG001|Overall Study|Progression|0|||
126611817|NCT00310037|455538747|FG000|Overall Study|Non-protocol treatment|1|||
126611818|NCT00310037|455538748|FG001|Overall Study|Non-protocol treatment|0|||
126611819|NCT02128269|455538751|FG000|Treatment Period|Adverse Event|1|||
126611820|NCT02128269|455538751|FG000|Treatment Period|Physician Decision|1|||
126611821|NCT00878189|455538752|FG000|Overall Study|Death|0|||
126611822|NCT00878189|455538753|FG001|Overall Study|Death|1|||
126611823|NCT00878189|455538754|FG002|Overall Study|Death|0|||
126611824|NCT00878189|455538755|FG003|Overall Study|Death|1|||
126611825|NCT00878189|455538756|FG004|Overall Study|Death|0|||
126611826|NCT00878189|455538757|FG005|Overall Study|Death|0|||
126611827|NCT00878189|455538758|FG006|Overall Study|Death|0|||
126611828|NCT00878189|455538759|FG007|Overall Study|Death|0|||
126611829|NCT00878189|455538760|FG008|Overall Study|Death|1|||
126611830|NCT00878189|455538752|FG000|Overall Study|Participant Refused to Follow-up|0|||
126611831|NCT00878189|455538753|FG001|Overall Study|Participant Refused to Follow-up|0|||
126611832|NCT00878189|455538754|FG002|Overall Study|Participant Refused to Follow-up|0|||
126611833|NCT00878189|455538755|FG003|Overall Study|Participant Refused to Follow-up|0|||
126611834|NCT00878189|455538756|FG004|Overall Study|Participant Refused to Follow-up|0|||
126611835|NCT00878189|455538757|FG005|Overall Study|Participant Refused to Follow-up|4|||
126611836|NCT00878189|455538758|FG006|Overall Study|Participant Refused to Follow-up|0|||
126611837|NCT00878189|455538759|FG007|Overall Study|Participant Refused to Follow-up|0|||
126611838|NCT00878189|455538760|FG008|Overall Study|Participant Refused to Follow-up|0|||
126611839|NCT00878189|455538752|FG000|Overall Study|Other|3|||
126611840|NCT00878189|455538753|FG001|Overall Study|Other|2|||
126611841|NCT00878189|455538754|FG002|Overall Study|Other|4|||
126611842|NCT00878189|455538755|FG003|Overall Study|Other|7|||
126611843|NCT00878189|455538756|FG004|Overall Study|Other|4|||
126611844|NCT00878189|455538757|FG005|Overall Study|Other|18|||
126611845|NCT00878189|455538758|FG006|Overall Study|Other|15|||
126611846|NCT00878189|455538759|FG007|Overall Study|Other|3|||
126611847|NCT00878189|455538760|FG008|Overall Study|Other|4|||
126611848|NCT00878189|455538752|FG000|Overall Study|Lost to Follow-up|0|||
126611849|NCT00878189|455538753|FG001|Overall Study|Lost to Follow-up|0|||
126611850|NCT00878189|455538754|FG002|Overall Study|Lost to Follow-up|0|||
126611851|NCT00878189|455538755|FG003|Overall Study|Lost to Follow-up|0|||
126611852|NCT00878189|455538756|FG004|Overall Study|Lost to Follow-up|0|||
126611853|NCT00878189|455538757|FG005|Overall Study|Lost to Follow-up|1|||
126611854|NCT00878189|455538758|FG006|Overall Study|Lost to Follow-up|1|||
126611855|NCT00878189|455538759|FG007|Overall Study|Lost to Follow-up|0|||
126611856|NCT00878189|455538760|FG008|Overall Study|Lost to Follow-up|0|||
126611857|NCT00878189|455538752|FG000|Overall Study|Objection Progression or Relapse|0|||
126611858|NCT00878189|455538753|FG001|Overall Study|Objection Progression or Relapse|0|||
126611859|NCT00878189|455538754|FG002|Overall Study|Objection Progression or Relapse|0|||
126611860|NCT00878189|455538755|FG003|Overall Study|Objection Progression or Relapse|0|||
126611861|NCT00878189|455538756|FG004|Overall Study|Objection Progression or Relapse|0|||
126611862|NCT00878189|455538757|FG005|Overall Study|Objection Progression or Relapse|0|||
126611863|NCT00878189|455538758|FG006|Overall Study|Objection Progression or Relapse|0|||
126611864|NCT00878189|455538759|FG007|Overall Study|Objection Progression or Relapse|0|||
126611865|NCT00878189|455538760|FG008|Overall Study|Objection Progression or Relapse|3|||
126611866|NCT02007070|455538761|FG000|Overall Study|Adverse Event|4|||
126611867|NCT02007070|455538761|FG000|Overall Study|Clinical Progression|4|||
126611868|NCT02007070|455538761|FG000|Overall Study|Death|1|||
126611869|NCT02007070|455538761|FG000|Overall Study|Protocol Violation|2|||
126611870|NCT02007070|455538761|FG000|Overall Study|Physician Decision|1|||
126611871|NCT02007070|455538761|FG000|Overall Study|Progressive Disease|21|||
126611872|NCT02708498|455538762|FG000|Overall Study|Death|20|||
126611873|NCT02708498|455538763|FG001|Overall Study|Death|19|||
126611874|NCT02708498|455538764|FG002|Overall Study|Death|0|||
126611875|NCT02708498|455538765|FG003|Overall Study|Death|0|||
126611876|NCT02708498|455538766|FG004|Overall Study|Death|1|||
126611877|NCT02708498|455538767|FG005|Overall Study|Death|0|||
126611878|NCT02708498|455538768|FG006|Overall Study|Death|0|||
126611879|NCT02708498|455538769|FG007|Overall Study|Death|0|||
126611880|NCT02708498|455538762|FG000|Overall Study|Unknown reason, missing data|0|||
126611881|NCT02708498|455538763|FG001|Overall Study|Unknown reason, missing data|0|||
126611882|NCT02708498|455538764|FG002|Overall Study|Unknown reason, missing data|62|||
126611883|NCT02708498|455538765|FG003|Overall Study|Unknown reason, missing data|51|||
126611884|NCT02708498|455538766|FG004|Overall Study|Unknown reason, missing data|195|||
126611885|NCT02708498|455538767|FG005|Overall Study|Unknown reason, missing data|132|||
126734304|NCT05507580|455975862|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
126734305|NCT05507580|455975863|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
126734306|NCT05507580|455975864|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
126734307|NCT05507580|455975865|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
126734308|NCT05507580|455975866|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
126734309|NCT05507580|455975867|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
126734310|NCT05507580|455975862|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
126734311|NCT05507580|455975863|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
126734312|NCT05507580|455975864|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126734313|NCT05507580|455975865|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126734314|NCT05507580|455975866|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126734315|NCT05507580|455975867|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
126734316|NCT05507580|455975862|FG000|Double-Blind Treatment Period|Other, not specified|5|||
126734317|NCT05507580|455975863|FG001|Double-Blind Treatment Period|Other, not specified|4|||
126734318|NCT05507580|455975864|FG002|Double-Blind Treatment Period|Other, not specified|0|||
126734319|NCT05507580|455975865|FG003|Double-Blind Treatment Period|Other, not specified|0|||
126734320|NCT05507580|455975866|FG004|Double-Blind Treatment Period|Other, not specified|0|||
126734321|NCT05507580|455975867|FG005|Double-Blind Treatment Period|Other, not specified|0|||
126734322|NCT05507580|455975862|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
126734323|NCT05507580|455975863|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
126734324|NCT05507580|455975864|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
126734325|NCT05507580|455975865|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
126734326|NCT05507580|455975866|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
126781278|NCT00358826|456154514|FG006|Core Study|Adverse Event|0|||
126611886|NCT02708498|455538768|FG006|Overall Study|Unknown reason, missing data|0|||
126611887|NCT02708498|455538769|FG007|Overall Study|Unknown reason, missing data|0|||
126611888|NCT03052517|455538773|FG000|Overall Study|Study Terminated By Sponsor|928|||
126611889|NCT03052517|455538774|FG001|Overall Study|Study Terminated By Sponsor|938|||
126611890|NCT03052517|455538775|FG002|Overall Study|Study Terminated By Sponsor|296|||
126611891|NCT03052517|455538773|FG000|Overall Study|Subject/Guardian Decision|50|||
126611892|NCT03052517|455538774|FG001|Overall Study|Subject/Guardian Decision|45|||
126611893|NCT03052517|455538775|FG002|Overall Study|Subject/Guardian Decision|22|||
126734327|NCT05507580|455975867|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
126734328|NCT05507580|455975862|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
126734329|NCT05507580|455975863|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
126611894|NCT03052517|455538773|FG000|Overall Study|Lack of Efficacy|23|||
126611895|NCT03052517|455538774|FG001|Overall Study|Lack of Efficacy|14|||
126611896|NCT03052517|455538775|FG002|Overall Study|Lack of Efficacy|7|||
126611897|NCT03052517|455538773|FG000|Overall Study|Adverse Event|6|||
126611898|NCT03052517|455538774|FG001|Overall Study|Adverse Event|5|||
126611899|NCT03052517|455538775|FG002|Overall Study|Adverse Event|0|||
126611900|NCT03052517|455538773|FG000|Overall Study|Physician Decision|4|||
126611901|NCT03052517|455538774|FG001|Overall Study|Physician Decision|5|||
126611902|NCT03052517|455538775|FG002|Overall Study|Physician Decision|1|||
126611903|NCT03052517|455538773|FG000|Overall Study|Death|3|||
126611904|NCT03052517|455538774|FG001|Overall Study|Death|0|||
126611905|NCT03052517|455538775|FG002|Overall Study|Death|1|||
126611906|NCT03052517|455538773|FG000|Overall Study|Lost to Follow-up|2|||
126611907|NCT03052517|455538774|FG001|Overall Study|Lost to Follow-up|4|||
126611908|NCT03052517|455538775|FG002|Overall Study|Lost to Follow-up|0|||
126611909|NCT03052517|455538773|FG000|Overall Study|Pregnancy|1|||
126611910|NCT03052517|455538774|FG001|Overall Study|Pregnancy|0|||
126611911|NCT03052517|455538775|FG002|Overall Study|Pregnancy|1|||
126611912|NCT03052517|455538773|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
126611913|NCT03052517|455538774|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
126611914|NCT03052517|455538775|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
126611915|NCT03052517|455538773|FG000|Overall Study|Technical Problems|0|||
126611916|NCT03052517|455538774|FG001|Overall Study|Technical Problems|1|||
126611917|NCT03052517|455538775|FG002|Overall Study|Technical Problems|0|||
126611918|NCT01640288|455538776|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
126611919|NCT01640288|455538777|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
126611920|NCT01640288|455538776|FG000|Overall Study|Screen Failure|20|||
126611921|NCT01640288|455538777|FG001|Overall Study|Screen Failure|18|||
126611922|NCT01640288|455538776|FG000|Overall Study|Withdrawn by PI|5|||
126611923|NCT01640288|455538777|FG001|Overall Study|Withdrawn by PI|0|||
126611924|NCT01640288|455538776|FG000|Overall Study|Withdrawal by Subject|1|||
126611925|NCT01640288|455538777|FG001|Overall Study|Withdrawal by Subject|0|||
126611926|NCT04803734|455538778|FG000|Overall Study|Withdrawal by Subject|0|||
126611927|NCT04803734|455538779|FG001|Overall Study|Withdrawal by Subject|1|||
126611928|NCT04803734|455538778|FG000|Overall Study|Protocol Violation|0|||
126611929|NCT04803734|455538779|FG001|Overall Study|Protocol Violation|1|||
126611930|NCT00195819|455538785|FG000|Double-Blind|Withdrawal by Subject|1|||
126611931|NCT00195819|455538786|FG001|Double-Blind|Withdrawal by Subject|0|||
126611932|NCT00195819|455538785|FG000|Double-Blind|Moved|1|||
126611933|NCT00195819|455538786|FG001|Double-Blind|Moved|0|||
126611934|NCT00195819|455538785|FG000|Open-label|Adverse Event|0|||
126611935|NCT00195819|455538786|FG001|Open-label|Adverse Event|9|||
126611936|NCT00195819|455538785|FG000|Open-label|Lack of Efficacy|0|||
126611937|NCT00195819|455538786|FG001|Open-label|Lack of Efficacy|2|||
126611938|NCT00195819|455538785|FG000|Open-label|Pregnancy|0|||
126611939|NCT00195819|455538786|FG001|Open-label|Pregnancy|1|||
126611940|NCT00195819|455538785|FG000|Open-label|Protocol Violation|0|||
126611941|NCT00195819|455538786|FG001|Open-label|Protocol Violation|2|||
126611942|NCT00195819|455538785|FG000|Open-label|Moved|0|||
126611943|NCT00195819|455538786|FG001|Open-label|Moved|1|||
126611944|NCT00195819|455538785|FG000|Open-label|Withdrawal by Subject|0|||
126611945|NCT00195819|455538786|FG001|Open-label|Withdrawal by Subject|5|||
126611946|NCT01629589|455538789|FG000|Overall Study|Protocol Violation|4|||
126611947|NCT01629589|455538790|FG001|Overall Study|Protocol Violation|2|||
126611948|NCT01629589|455538789|FG000|Overall Study|Lost to Follow-up|2|||
126611949|NCT01629589|455538790|FG001|Overall Study|Lost to Follow-up|1|||
126611950|NCT01629589|455538789|FG000|Overall Study|Withdrawal by Subject|2|||
126611951|NCT01629589|455538790|FG001|Overall Study|Withdrawal by Subject|3|||
126611952|NCT01629589|455538789|FG000|Overall Study|Did not receive study vaccine|0|||
126611953|NCT01629589|455538790|FG001|Overall Study|Did not receive study vaccine|1|||
126611954|NCT03781375|455538791|FG000|Double-blind Phase|Adverse Event|0|||
126611955|NCT03781375|455538792|FG001|Double-blind Phase|Adverse Event|1|||
126611956|NCT03781375|455538791|FG000|Double-blind Phase|Lack of Response|6|||
126611957|NCT03781375|455538792|FG001|Double-blind Phase|Lack of Response|2|||
126611958|NCT03781375|455538791|FG000|Double-blind Phase|Other|1|||
126611959|NCT03781375|455538792|FG001|Double-blind Phase|Other|3|||
126611960|NCT03781375|455538791|FG000|Open-label Phase|Protocol Issues|0|||
126611961|NCT03781375|455538792|FG001|Open-label Phase|Protocol Issues|1|||
126611962|NCT03781375|455538791|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
126611963|NCT03781375|455538792|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
126611964|NCT03781375|455538791|FG000|Open-label Phase|Other|2|||
126611965|NCT03781375|455538792|FG001|Open-label Phase|Other|2|||
126611966|NCT01303510|455538793|FG000|Overall Study|Lost to Follow-up|1|||
126611967|NCT01303510|455538794|FG001|Overall Study|Lost to Follow-up|0|||
126611968|NCT02404441|455538795|FG000|Phase 1 Part|Adverse Event|1|||
126611969|NCT02404441|455538796|FG001|Phase 1 Part|Adverse Event|0|||
126611970|NCT02404441|455538797|FG002|Phase 1 Part|Adverse Event|0|||
126734330|NCT05507580|455975864|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
126611971|NCT02404441|455538798|FG003|Phase 1 Part|Adverse Event|0|||
126611972|NCT02404441|455538799|FG004|Phase 1 Part|Adverse Event|0|||
126611973|NCT02404441|455538800|FG005|Phase 1 Part|Adverse Event|0|||
126611974|NCT02404441|455538801|FG006|Phase 1 Part|Adverse Event|0|||
126611975|NCT02404441|455538802|FG007|Phase 1 Part|Adverse Event|0|||
126611976|NCT02404441|455538803|FG008|Phase 1 Part|Adverse Event|0|||
126611977|NCT02404441|455538804|FG009|Phase 1 Part|Adverse Event|0|||
126611978|NCT02404441|455538795|FG000|Phase 1 Part|Physician Decision|0|||
126611979|NCT02404441|455538796|FG001|Phase 1 Part|Physician Decision|1|||
126611980|NCT02404441|455538797|FG002|Phase 1 Part|Physician Decision|0|||
126611981|NCT02404441|455538798|FG003|Phase 1 Part|Physician Decision|0|||
126611982|NCT02404441|455538799|FG004|Phase 1 Part|Physician Decision|0|||
126611983|NCT02404441|455538800|FG005|Phase 1 Part|Physician Decision|0|||
126611984|NCT02404441|455538801|FG006|Phase 1 Part|Physician Decision|0|||
126611985|NCT02404441|455538802|FG007|Phase 1 Part|Physician Decision|0|||
126611986|NCT02404441|455538803|FG008|Phase 1 Part|Physician Decision|0|||
126611987|NCT02404441|455538804|FG009|Phase 1 Part|Physician Decision|0|||
126611988|NCT02404441|455538795|FG000|Phase 1 Part|Progressive Disease|14|||
126611989|NCT02404441|455538796|FG001|Phase 1 Part|Progressive Disease|11|||
126611990|NCT02404441|455538797|FG002|Phase 1 Part|Progressive Disease|7|||
126611991|NCT02404441|455538798|FG003|Phase 1 Part|Progressive Disease|6|||
126611992|NCT02404441|455538799|FG004|Phase 1 Part|Progressive Disease|9|||
126611993|NCT02404441|455538800|FG005|Phase 1 Part|Progressive Disease|0|||
126611994|NCT02404441|455538801|FG006|Phase 1 Part|Progressive Disease|0|||
126611995|NCT02404441|455538802|FG007|Phase 1 Part|Progressive Disease|0|||
126611996|NCT02404441|455538803|FG008|Phase 1 Part|Progressive Disease|0|||
126611997|NCT02404441|455538804|FG009|Phase 1 Part|Progressive Disease|0|||
126611998|NCT02404441|455538795|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
126611999|NCT02404441|455538796|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
126612000|NCT02404441|455538797|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
126612001|NCT02404441|455538798|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
126612002|NCT02404441|455538799|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
126612003|NCT02404441|455538800|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
126612004|NCT02404441|455538801|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
126612005|NCT02404441|455538802|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
126612006|NCT02404441|455538803|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
126612007|NCT02404441|455538804|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
126612008|NCT02404441|455538795|FG000|Phase 1 Part|Death|1|||
126612009|NCT02404441|455538796|FG001|Phase 1 Part|Death|1|||
126612010|NCT02404441|455538797|FG002|Phase 1 Part|Death|1|||
126612011|NCT02404441|455538798|FG003|Phase 1 Part|Death|0|||
126612012|NCT02404441|455538799|FG004|Phase 1 Part|Death|1|||
126612013|NCT02404441|455538800|FG005|Phase 1 Part|Death|0|||
126612014|NCT02404441|455538801|FG006|Phase 1 Part|Death|0|||
126612015|NCT02404441|455538802|FG007|Phase 1 Part|Death|0|||
126612016|NCT02404441|455538803|FG008|Phase 1 Part|Death|0|||
126612017|NCT02404441|455538804|FG009|Phase 1 Part|Death|0|||
126612018|NCT02404441|455538795|FG000|Phase 2 Part|Adverse Event|0|||
126612019|NCT02404441|455538796|FG001|Phase 2 Part|Adverse Event|0|||
126612020|NCT02404441|455538797|FG002|Phase 2 Part|Adverse Event|0|||
126612021|NCT02404441|455538798|FG003|Phase 2 Part|Adverse Event|0|||
126612022|NCT02404441|455538799|FG004|Phase 2 Part|Adverse Event|0|||
126612023|NCT02404441|455538800|FG005|Phase 2 Part|Adverse Event|2|||
126612024|NCT02404441|455538801|FG006|Phase 2 Part|Adverse Event|3|||
126612025|NCT02404441|455538802|FG007|Phase 2 Part|Adverse Event|3|||
126612026|NCT02404441|455538803|FG008|Phase 2 Part|Adverse Event|6|||
126612027|NCT02404441|455538804|FG009|Phase 2 Part|Adverse Event|1|||
126612028|NCT02404441|455538795|FG000|Phase 2 Part|Physician Decision|0|||
126612029|NCT02404441|455538796|FG001|Phase 2 Part|Physician Decision|0|||
126612030|NCT02404441|455538797|FG002|Phase 2 Part|Physician Decision|0|||
126612031|NCT02404441|455538798|FG003|Phase 2 Part|Physician Decision|0|||
126612032|NCT02404441|455538799|FG004|Phase 2 Part|Physician Decision|0|||
126612033|NCT02404441|455538800|FG005|Phase 2 Part|Physician Decision|7|||
126612034|NCT02404441|455538801|FG006|Phase 2 Part|Physician Decision|9|||
126612035|NCT02404441|455538802|FG007|Phase 2 Part|Physician Decision|2|||
126612036|NCT02404441|455538803|FG008|Phase 2 Part|Physician Decision|1|||
126612037|NCT02404441|455538804|FG009|Phase 2 Part|Physician Decision|3|||
126612038|NCT02404441|455538795|FG000|Phase 2 Part|Progressive disease|0|||
126612039|NCT02404441|455538796|FG001|Phase 2 Part|Progressive disease|0|||
126612040|NCT02404441|455538797|FG002|Phase 2 Part|Progressive disease|0|||
126612041|NCT02404441|455538798|FG003|Phase 2 Part|Progressive disease|0|||
126734331|NCT05507580|455975865|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
126734332|NCT05507580|455975866|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
126612042|NCT02404441|455538799|FG004|Phase 2 Part|Progressive disease|0|||
126612043|NCT02404441|455538800|FG005|Phase 2 Part|Progressive disease|43|||
126612044|NCT02404441|455538801|FG006|Phase 2 Part|Progressive disease|32|||
126612045|NCT02404441|455538802|FG007|Phase 2 Part|Progressive disease|31|||
126612046|NCT02404441|455538803|FG008|Phase 2 Part|Progressive disease|39|||
126612047|NCT02404441|455538804|FG009|Phase 2 Part|Progressive disease|27|||
126612048|NCT02404441|455538795|FG000|Phase 2 Part|Subject/guardian decision|0|||
126612049|NCT02404441|455538796|FG001|Phase 2 Part|Subject/guardian decision|0|||
126612050|NCT02404441|455538797|FG002|Phase 2 Part|Subject/guardian decision|0|||
126612051|NCT02404441|455538798|FG003|Phase 2 Part|Subject/guardian decision|0|||
126612052|NCT02404441|455538799|FG004|Phase 2 Part|Subject/guardian decision|0|||
126612053|NCT02404441|455538800|FG005|Phase 2 Part|Subject/guardian decision|3|||
126612054|NCT02404441|455538801|FG006|Phase 2 Part|Subject/guardian decision|9|||
126612055|NCT02404441|455538802|FG007|Phase 2 Part|Subject/guardian decision|0|||
126612056|NCT02404441|455538803|FG008|Phase 2 Part|Subject/guardian decision|3|||
126612057|NCT02404441|455538804|FG009|Phase 2 Part|Subject/guardian decision|2|||
126612058|NCT02404441|455538795|FG000|Phase 2 Part|Death|0|||
126612059|NCT02404441|455538796|FG001|Phase 2 Part|Death|0|||
126612060|NCT02404441|455538797|FG002|Phase 2 Part|Death|0|||
126612061|NCT02404441|455538798|FG003|Phase 2 Part|Death|0|||
126612062|NCT02404441|455538799|FG004|Phase 2 Part|Death|0|||
126612063|NCT02404441|455538800|FG005|Phase 2 Part|Death|4|||
126612064|NCT02404441|455538801|FG006|Phase 2 Part|Death|8|||
126612065|NCT02404441|455538802|FG007|Phase 2 Part|Death|4|||
126612066|NCT02404441|455538803|FG008|Phase 2 Part|Death|10|||
126612067|NCT02404441|455538804|FG009|Phase 2 Part|Death|9|||
126612068|NCT03042767|455538805|FG000|Overall Study|Lost to Follow-up|1|||
126612069|NCT03042767|455538806|FG001|Overall Study|Lost to Follow-up|2|||
126612070|NCT02037568|455538807|FG000|Overall Study|Withdrawal by Subject|17|||
126612071|NCT02037568|455538808|FG001|Overall Study|Withdrawal by Subject|24|||
126612072|NCT02037568|455538807|FG000|Overall Study|Lost to Follow-up|16|||
126612073|NCT02037568|455538808|FG001|Overall Study|Lost to Follow-up|13|||
126612074|NCT02037568|455538807|FG000|Overall Study|Screen Failure|3|||
126612075|NCT02037568|455538808|FG001|Overall Study|Screen Failure|1|||
126612076|NCT02037568|455538807|FG000|Overall Study|Patient did not receive transplant|0|||
126612077|NCT02037568|455538808|FG001|Overall Study|Patient did not receive transplant|1|||
126612078|NCT03861234|455538809|FG000|Overall Study|Not treated|0|||
126612079|NCT03861234|455538810|FG001|Overall Study|Not treated|0|||
126612080|NCT03861234|455538811|FG002|Overall Study|Not treated|0|||
126612081|NCT03861234|455538812|FG003|Overall Study|Not treated|0|||
126612082|NCT03861234|455538813|FG004|Overall Study|Not treated|0|||
126612083|NCT03861234|455538814|FG005|Overall Study|Not treated|1|||
126612084|NCT03861234|455538815|FG006|Overall Study|Not treated|0|||
126612085|NCT03861234|455538816|FG007|Overall Study|Not treated|0|||
126612086|NCT03861234|455538809|FG000|Overall Study|Adverse Event|0|||
126612087|NCT03861234|455538810|FG001|Overall Study|Adverse Event|0|||
126612088|NCT03861234|455538811|FG002|Overall Study|Adverse Event|0|||
126612089|NCT03861234|455538812|FG003|Overall Study|Adverse Event|0|||
126612090|NCT03861234|455538813|FG004|Overall Study|Adverse Event|0|||
126612091|NCT03861234|455538814|FG005|Overall Study|Adverse Event|1|||
126612092|NCT03861234|455538815|FG006|Overall Study|Adverse Event|0|||
126612093|NCT03861234|455538816|FG007|Overall Study|Adverse Event|0|||
126612094|NCT03861234|455538809|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
126612095|NCT03861234|455538810|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
126612096|NCT03861234|455538811|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
126612097|NCT03861234|455538812|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
126612098|NCT03861234|455538813|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
126612099|NCT03861234|455538814|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
126612100|NCT03861234|455538815|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
126612101|NCT03861234|455538816|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
126612102|NCT03861234|455538809|FG000|Overall Study|As per sponsor decision|0|||
126612103|NCT03861234|455538810|FG001|Overall Study|As per sponsor decision|0|||
126612104|NCT03861234|455538811|FG002|Overall Study|As per sponsor decision|0|||
126612105|NCT03861234|455538812|FG003|Overall Study|As per sponsor decision|0|||
126612106|NCT03861234|455538813|FG004|Overall Study|As per sponsor decision|0|||
126612107|NCT03861234|455538814|FG005|Overall Study|As per sponsor decision|0|||
126612108|NCT03861234|455538815|FG006|Overall Study|As per sponsor decision|1|||
126612109|NCT03861234|455538816|FG007|Overall Study|As per sponsor decision|0|||
126612110|NCT03861234|455538809|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
126612111|NCT03861234|455538810|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
126612112|NCT03861234|455538811|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
126612113|NCT03861234|455538812|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
126612114|NCT03861234|455538813|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
126612115|NCT03861234|455538814|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
126612116|NCT03861234|455538815|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
126612117|NCT03861234|455538816|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
126612118|NCT02066636|455538817|FG000|Overall Study|Disease progression|51|||
126612119|NCT02066636|455538818|FG001|Overall Study|Disease progression|60|||
126612120|NCT02066636|455538819|FG002|Overall Study|Disease progression|700|||
126612121|NCT02066636|455538817|FG000|Overall Study|Study drug toxicity|13|||
126612122|NCT02066636|455538818|FG001|Overall Study|Study drug toxicity|2|||
126612123|NCT02066636|455538819|FG002|Overall Study|Study drug toxicity|58|||
126612124|NCT02066636|455538817|FG000|Overall Study|Death|4|||
126612125|NCT02066636|455538818|FG001|Overall Study|Death|2|||
126612126|NCT02066636|455538819|FG002|Overall Study|Death|158|||
126612127|NCT02066636|455538817|FG000|Overall Study|Adverse event unrelated to study drug|6|||
126612128|NCT02066636|455538818|FG001|Overall Study|Adverse event unrelated to study drug|4|||
126612129|NCT02066636|455538819|FG002|Overall Study|Adverse event unrelated to study drug|45|||
126612130|NCT02066636|455538817|FG000|Overall Study|Participant request to discontinue treatment|12|||
126612131|NCT02066636|455538818|FG001|Overall Study|Participant request to discontinue treatment|12|||
126612132|NCT02066636|455538819|FG002|Overall Study|Participant request to discontinue treatment|70|||
126612133|NCT02066636|455538817|FG000|Overall Study|Participant withdrew consent|10|||
126612134|NCT02066636|455538818|FG001|Overall Study|Participant withdrew consent|18|||
126612135|NCT02066636|455538819|FG002|Overall Study|Participant withdrew consent|61|||
126612136|NCT02066636|455538817|FG000|Overall Study|Lost to Follow-up|0|||
126612137|NCT02066636|455538818|FG001|Overall Study|Lost to Follow-up|2|||
126612138|NCT02066636|455538819|FG002|Overall Study|Lost to Follow-up|2|||
126612139|NCT02066636|455538817|FG000|Overall Study|Maximum clinical benefit|2|||
126612140|NCT02066636|455538818|FG001|Overall Study|Maximum clinical benefit|2|||
126612141|NCT02066636|455538819|FG002|Overall Study|Maximum clinical benefit|3|||
126612142|NCT02066636|455538817|FG000|Overall Study|Poor/non-compliance|2|||
126612143|NCT02066636|455538818|FG001|Overall Study|Poor/non-compliance|1|||
126612144|NCT02066636|455538819|FG002|Overall Study|Poor/non-compliance|1|||
126612145|NCT02066636|455538817|FG000|Overall Study|Participant no loner meets study criteria|3|||
126612146|NCT02066636|455538818|FG001|Overall Study|Participant no loner meets study criteria|2|||
126612147|NCT02066636|455538819|FG002|Overall Study|Participant no loner meets study criteria|28|||
126612148|NCT02066636|455538817|FG000|Overall Study|Administrative reasons by sponsor|8|||
126612149|NCT02066636|455538818|FG001|Overall Study|Administrative reasons by sponsor|5|||
126612150|NCT02066636|455538819|FG002|Overall Study|Administrative reasons by sponsor|0|||
126612151|NCT02066636|455538817|FG000|Overall Study|Other reasons|16|||
126612152|NCT02066636|455538818|FG001|Overall Study|Other reasons|15|||
126612153|NCT02066636|455538819|FG002|Overall Study|Other reasons|50|||
126612154|NCT02833948|455538821|FG000|Overall Study|Death|2|||
126612155|NCT02833948|455538822|FG001|Overall Study|Death|3|||
126612156|NCT02833948|455538821|FG000|Overall Study|were not scanned|8|||
126612157|NCT02833948|455538822|FG001|Overall Study|were not scanned|13|||
126612158|NCT02833948|455538821|FG000|Overall Study|scans could not be evaluated|5|||
126612159|NCT02833948|455538822|FG001|Overall Study|scans could not be evaluated|2|||
126612160|NCT02852824|455538825|FG000|Overall Study|Withdrawal by Subject|1|||
126612161|NCT02852824|455538826|FG001|Overall Study|Withdrawal by Subject|0|||
126612162|NCT02852824|455538827|FG002|Overall Study|Withdrawal by Subject|0|||
126612163|NCT02852824|455538828|FG003|Overall Study|Withdrawal by Subject|0|||
126612164|NCT02852824|455538829|FG004|Overall Study|Withdrawal by Subject|0|||
126612165|NCT02852824|455538830|FG005|Overall Study|Withdrawal by Subject|0|||
126612166|NCT02852824|455538831|FG006|Overall Study|Withdrawal by Subject|0|||
126612167|NCT02852824|455538825|FG000|Overall Study|Adverse Event|0|||
126612168|NCT02852824|455538826|FG001|Overall Study|Adverse Event|0|||
126612169|NCT02852824|455538827|FG002|Overall Study|Adverse Event|0|||
126612170|NCT02852824|455538828|FG003|Overall Study|Adverse Event|0|||
126612171|NCT02852824|455538829|FG004|Overall Study|Adverse Event|2|||
126612172|NCT02852824|455538830|FG005|Overall Study|Adverse Event|0|||
126612173|NCT02852824|455538831|FG006|Overall Study|Adverse Event|0|||
126612174|NCT00680771|455538832|FG000|Overall Study|Withdrawal by Subject|1|||
126612175|NCT00680771|455538833|FG001|Overall Study|Withdrawal by Subject|0|||
126612176|NCT00680771|455538832|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
126612177|NCT00680771|455538833|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
126612178|NCT00680771|455538832|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
126612179|NCT00680771|455538833|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
126612180|NCT02521493|455538837|FG000|Overall Study|Death|3|||
126612181|NCT02521493|455538838|FG001|Overall Study|Death|4|||
126612182|NCT02521493|455538839|FG002|Overall Study|Death|1|||
126612183|NCT02521493|455538837|FG000|Overall Study|Physician Decision|19|||
126612184|NCT02521493|455538838|FG001|Overall Study|Physician Decision|1|||
126612185|NCT02521493|455538839|FG002|Overall Study|Physician Decision|2|||
126612186|NCT02521493|455538837|FG000|Overall Study|Withdrawal by Subject|3|||
126612187|NCT02521493|455538838|FG001|Overall Study|Withdrawal by Subject|0|||
126612188|NCT02521493|455538839|FG002|Overall Study|Withdrawal by Subject|0|||
126612189|NCT02521493|455538837|FG000|Overall Study|Ineligible|0|||
126612190|NCT02521493|455538838|FG001|Overall Study|Ineligible|1|||
126612191|NCT02521493|455538839|FG002|Overall Study|Ineligible|0|||
126612192|NCT02521493|455538837|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
126612193|NCT02521493|455538838|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
126612194|NCT02521493|455538839|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
126612195|NCT02521493|455538837|FG000|Overall Study|No MRD result|0|||
126612196|NCT02521493|455538838|FG001|Overall Study|No MRD result|0|||
126612197|NCT02521493|455538839|FG002|Overall Study|No MRD result|4|||
126612198|NCT01218594|455538840|FG000|Overall Study|Death|1|||
126612199|NCT01218594|455538840|FG000|Overall Study|Withdrawal by Subject|3|||
126612200|NCT01218594|455538840|FG000|Overall Study|Adverse Event|2|||
126612201|NCT01218594|455538840|FG000|Overall Study|Physician Decision|6|||
126612202|NCT04748341|455538841|FG000|Overall Study|Lost to Follow-up|1|||
126612203|NCT04748341|455538842|FG001|Overall Study|Lost to Follow-up|1|||
126612204|NCT03769090|455540438|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
126612205|NCT03769090|455540439|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
126612206|NCT03769090|455540440|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
126612207|NCT03769090|455540438|FG000|Overall Study|Withdrawal by Subject|52|||
126612208|NCT03769090|455540439|FG001|Overall Study|Withdrawal by Subject|62|||
126612209|NCT03769090|455540440|FG002|Overall Study|Withdrawal by Subject|74|||
126734333|NCT05507580|455975867|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
126734334|NCT05507580|455975862|FG000|Single-Blind Treatment Period|Other, not specified|0|||
126734335|NCT05507580|455975863|FG001|Single-Blind Treatment Period|Other, not specified|0|||
126734336|NCT05507580|455975864|FG002|Single-Blind Treatment Period|Other, not specified|2|||
126734337|NCT05507580|455975865|FG003|Single-Blind Treatment Period|Other, not specified|7|||
126734338|NCT05507580|455975866|FG004|Single-Blind Treatment Period|Other, not specified|3|||
126734339|NCT05507580|455975867|FG005|Single-Blind Treatment Period|Other, not specified|5|||
126734340|NCT04702984|455975868|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
126734341|NCT03496662|455975869|FG000|Overall Study|Adverse Event|0|||
126734342|NCT03496662|455975870|FG001|Overall Study|Adverse Event|0|||
126734343|NCT03496662|455975871|FG002|Overall Study|Adverse Event|4|||
126734344|NCT03496662|455975869|FG000|Overall Study|Withdrawal by Subject|1|||
126734345|NCT03496662|455975870|FG001|Overall Study|Withdrawal by Subject|0|||
126734346|NCT03496662|455975871|FG002|Overall Study|Withdrawal by Subject|2|||
126734347|NCT03496662|455975869|FG000|Overall Study|Death|0|||
126734348|NCT03496662|455975870|FG001|Overall Study|Death|0|||
126734349|NCT03496662|455975871|FG002|Overall Study|Death|2|||
126734350|NCT03496662|455975869|FG000|Overall Study|Noncompliance|0|||
126734351|NCT03496662|455975870|FG001|Overall Study|Noncompliance|0|||
126734352|NCT03496662|455975871|FG002|Overall Study|Noncompliance|1|||
126734353|NCT03037307|455975872|FG000|Period 1|Did Not Meet Study Criteria|0|||
126734354|NCT03037307|455975873|FG001|Period 1|Did Not Meet Study Criteria|0|||
126734355|NCT03037307|455975874|FG002|Period 1|Did Not Meet Study Criteria|0|||
126734356|NCT03037307|455975875|FG003|Period 1|Did Not Meet Study Criteria|1|||
126734357|NCT03037307|455975876|FG004|Period 1|Did Not Meet Study Criteria|0|||
126734358|NCT03037307|455975877|FG005|Period 1|Did Not Meet Study Criteria|0|||
126734359|NCT00691093|455975878|FG000|Overall Study|Adverse Event|1|||
126734360|NCT00691093|455975878|FG000|Overall Study|Lost to Follow-up|1|||
126734361|NCT00691093|455975878|FG000|Overall Study|Lack of Efficacy|1|||
126734362|NCT00691093|455975878|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
126734363|NCT01588353|455975879|FG000|Step2|Withdrawal by Subject|0|||
126734364|NCT01588353|455975880|FG001|Step2|Withdrawal by Subject|1|||
126612210|NCT03769090|455540438|FG000|Overall Study|Death|4|||
126612211|NCT03769090|455540439|FG001|Overall Study|Death|2|||
126612212|NCT03769090|455540440|FG002|Overall Study|Death|2|||
126612213|NCT03769090|455540438|FG000|Overall Study|Adverse Event|7|||
126612214|NCT03769090|455540439|FG001|Overall Study|Adverse Event|7|||
126612215|NCT03769090|455540440|FG002|Overall Study|Adverse Event|8|||
126612216|NCT03769090|455540438|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
126612217|NCT03769090|455540439|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
126612218|NCT03769090|455540440|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
126612219|NCT03769090|455540438|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
126612220|NCT03769090|455540439|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
126612221|NCT03769090|455540440|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
126612222|NCT03769090|455540438|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
126612223|NCT03769090|455540439|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
126612224|NCT03769090|455540440|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
126612225|NCT03769090|455540438|FG000|Overall Study|Protocol Violation|5|||
126612226|NCT03769090|455540439|FG001|Overall Study|Protocol Violation|6|||
126612227|NCT03769090|455540440|FG002|Overall Study|Protocol Violation|8|||
126612228|NCT03769090|455540438|FG000|Overall Study|Pregnancy|1|||
126612229|NCT03769090|455540439|FG001|Overall Study|Pregnancy|0|||
126612230|NCT03769090|455540440|FG002|Overall Study|Pregnancy|3|||
126612231|NCT03769090|455540438|FG000|Overall Study|Lost to Follow-up|19|||
126612232|NCT03769090|455540439|FG001|Overall Study|Lost to Follow-up|25|||
126612233|NCT03769090|455540440|FG002|Overall Study|Lost to Follow-up|21|||
126612234|NCT03769090|455540438|FG000|Overall Study|Condition under investigation worsened|2|||
126612235|NCT03769090|455540439|FG001|Overall Study|Condition under investigation worsened|0|||
126612236|NCT03769090|455540440|FG002|Overall Study|Condition under investigation worsened|1|||
126612237|NCT03769090|455540438|FG000|Overall Study|Lack of Efficacy|1|||
126612238|NCT03769090|455540439|FG001|Overall Study|Lack of Efficacy|2|||
126612239|NCT03769090|455540440|FG002|Overall Study|Lack of Efficacy|2|||
126734365|NCT01588353|455975881|FG002|Step2|Withdrawal by Subject|0|||
126734366|NCT01588353|455975879|FG000|Step3|Adverse Event|0|||
126734367|NCT01588353|455975880|FG001|Step3|Adverse Event|0|||
126734368|NCT01588353|455975881|FG002|Step3|Adverse Event|2|||
126734369|NCT05489081|455975883|FG000|Overall Study|student left classroom|0|||
126734370|NCT05489081|455975884|FG001|Overall Study|student left classroom|1|||
126734371|NCT05489081|455975883|FG000|Overall Study|teacher left school|0|||
126734372|NCT05489081|455975884|FG001|Overall Study|teacher left school|2|||
126612240|NCT03769090|455540438|FG000|Overall Study|Other reasons|8|||
126612241|NCT03769090|455540439|FG001|Overall Study|Other reasons|12|||
126612242|NCT03769090|455540440|FG002|Overall Study|Other reasons|15|||
126612243|NCT00799409|455540441|FG000|Overall Study|Withdrawal by Subject|1|||
126612244|NCT00799409|455540442|FG001|Overall Study|Withdrawal by Subject|0|||
126612245|NCT00799409|455540443|FG002|Overall Study|Withdrawal by Subject|0|||
126612246|NCT00799409|455540441|FG000|Overall Study|Lost to Follow-up|1|||
126612247|NCT00799409|455540442|FG001|Overall Study|Lost to Follow-up|0|||
126612248|NCT00799409|455540443|FG002|Overall Study|Lost to Follow-up|0|||
126612249|NCT00799409|455540441|FG000|Overall Study|Optimal Dose Not Achieved|2|||
126612250|NCT00799409|455540442|FG001|Overall Study|Optimal Dose Not Achieved|0|||
126612251|NCT00799409|455540443|FG002|Overall Study|Optimal Dose Not Achieved|0|||
126612252|NCT00799409|455540441|FG000|Overall Study|Failure to follow study protocol)|1|||
126612253|NCT00799409|455540442|FG001|Overall Study|Failure to follow study protocol)|0|||
126612254|NCT00799409|455540443|FG002|Overall Study|Failure to follow study protocol)|0|||
126612255|NCT00799409|455540441|FG000|Overall Study|Did not attend lab school day 1|1|||
126612256|NCT00799409|455540442|FG001|Overall Study|Did not attend lab school day 1|0|||
126612257|NCT00799409|455540443|FG002|Overall Study|Did not attend lab school day 1|0|||
126612258|NCT00799409|455540441|FG000|Overall Study|medication compliance|1|||
126612259|NCT00799409|455540442|FG001|Overall Study|medication compliance|0|||
126612260|NCT00799409|455540443|FG002|Overall Study|medication compliance|0|||
126612261|NCT00443820|455540444|FG000|Overall Study|Adverse Event|1|||
126612262|NCT00443820|455540445|FG001|Overall Study|Adverse Event|1|||
126612263|NCT00443820|455540446|FG002|Overall Study|Adverse Event|0|||
126612264|NCT00443820|455540447|FG003|Overall Study|Adverse Event|0|||
126612265|NCT00443820|455540444|FG000|Overall Study|Lack of Efficacy|3|||
126612266|NCT00443820|455540445|FG001|Overall Study|Lack of Efficacy|2|||
126612267|NCT00443820|455540446|FG002|Overall Study|Lack of Efficacy|1|||
126612268|NCT00443820|455540447|FG003|Overall Study|Lack of Efficacy|1|||
126612269|NCT00443820|455540444|FG000|Overall Study|Protocol Violation|2|||
126612270|NCT00443820|455540445|FG001|Overall Study|Protocol Violation|1|||
126612271|NCT00443820|455540446|FG002|Overall Study|Protocol Violation|2|||
126612272|NCT00443820|455540447|FG003|Overall Study|Protocol Violation|1|||
126612273|NCT00443820|455540444|FG000|Overall Study|Withdrawal by Subject|6|||
126612274|NCT00443820|455540445|FG001|Overall Study|Withdrawal by Subject|7|||
126612275|NCT00443820|455540446|FG002|Overall Study|Withdrawal by Subject|8|||
126612276|NCT00443820|455540447|FG003|Overall Study|Withdrawal by Subject|9|||
126612277|NCT00443820|455540444|FG000|Overall Study|Lost to Follow-up|9|||
126734373|NCT00810810|455975885|FG000|Overall Study|Withdrawal by Subject|0|||
126734374|NCT00810810|455975886|FG001|Overall Study|Withdrawal by Subject|8|||
126734375|NCT00810810|455975887|FG002|Overall Study|Withdrawal by Subject|10|||
126734376|NCT00810810|455975888|FG003|Overall Study|Withdrawal by Subject|8|||
126734377|NCT00810810|455975885|FG000|Overall Study|Physician Decision|0|||
126734378|NCT00810810|455975886|FG001|Overall Study|Physician Decision|3|||
126734379|NCT00810810|455975887|FG002|Overall Study|Physician Decision|1|||
126734380|NCT00810810|455975888|FG003|Overall Study|Physician Decision|5|||
126734381|NCT01409993|455975889|FG000|Overall Study|Adverse Event|4|||
126734382|NCT01409993|455975890|FG001|Overall Study|Adverse Event|4|||
126734383|NCT01409993|455975891|FG002|Overall Study|Adverse Event|3|||
126734384|NCT01409993|455975892|FG003|Overall Study|Adverse Event|1|||
126734385|NCT01409993|455975889|FG000|Overall Study|Withdrawal by Subject|0|||
126734386|NCT01409993|455975890|FG001|Overall Study|Withdrawal by Subject|0|||
126734387|NCT01409993|455975891|FG002|Overall Study|Withdrawal by Subject|0|||
126734388|NCT01409993|455975892|FG003|Overall Study|Withdrawal by Subject|4|||
126734389|NCT01409993|455975889|FG000|Overall Study|Lost to Follow-up|0|||
126734390|NCT01409993|455975890|FG001|Overall Study|Lost to Follow-up|1|||
126734391|NCT01409993|455975891|FG002|Overall Study|Lost to Follow-up|0|||
126734392|NCT01409993|455975892|FG003|Overall Study|Lost to Follow-up|0|||
126734393|NCT01700985|455975893|FG000|Overall Study|Incarcerated|0|||
126612278|NCT00443820|455540445|FG001|Overall Study|Lost to Follow-up|8|||
126612279|NCT00443820|455540446|FG002|Overall Study|Lost to Follow-up|6|||
126612280|NCT00443820|455540447|FG003|Overall Study|Lost to Follow-up|5|||
126612281|NCT00443820|455540444|FG000|Overall Study|Administrative problems|0|||
126612282|NCT00443820|455540445|FG001|Overall Study|Administrative problems|0|||
126612283|NCT00443820|455540446|FG002|Overall Study|Administrative problems|0|||
126612284|NCT00443820|455540447|FG003|Overall Study|Administrative problems|1|||
126612285|NCT00443820|455540444|FG000|Overall Study|Death|0|||
126612286|NCT00443820|455540445|FG001|Overall Study|Death|0|||
126612287|NCT00443820|455540446|FG002|Overall Study|Death|1|||
126612288|NCT00443820|455540447|FG003|Overall Study|Death|0|||
126612289|NCT02713594|455540448|FG000|Overall Study|Withdrawal by Subject|32|||
126612290|NCT02713594|455540449|FG001|Overall Study|Withdrawal by Subject|22|||
126612291|NCT02713594|455540448|FG000|Overall Study|Lost to Follow-up|358|||
126734394|NCT01700985|455975894|FG001|Overall Study|Incarcerated|1|||
126734395|NCT05067452|455975895|FG000|Overall Study|Lost to Follow-up|0|||
126734396|NCT05067452|455975896|FG001|Overall Study|Lost to Follow-up|4|||
126734397|NCT00067470|455975899|FG000|Overall Study|Withdrawal by Subject|0|||
126734398|NCT00067470|455975900|FG001|Overall Study|Withdrawal by Subject|1|||
126612292|NCT02713594|455540449|FG001|Overall Study|Lost to Follow-up|374|||
126612293|NCT00670449|455540450|FG000|Overall Study|Adverse Event|6|||
126612294|NCT00670449|455540451|FG001|Overall Study|Adverse Event|2|||
126612295|NCT00670449|455540452|FG002|Overall Study|Adverse Event|8|||
126612296|NCT00670449|455540453|FG003|Overall Study|Adverse Event|5|||
126612297|NCT00670449|455540450|FG000|Overall Study|Protocol Deviation|1|||
126612298|NCT00670449|455540451|FG001|Overall Study|Protocol Deviation|2|||
126612299|NCT00670449|455540452|FG002|Overall Study|Protocol Deviation|0|||
126612300|NCT00670449|455540453|FG003|Overall Study|Protocol Deviation|1|||
126612301|NCT00670449|455540450|FG000|Overall Study|Administrative Problems|0|||
126612302|NCT00670449|455540451|FG001|Overall Study|Administrative Problems|2|||
126612303|NCT00670449|455540452|FG002|Overall Study|Administrative Problems|0|||
126612304|NCT00670449|455540453|FG003|Overall Study|Administrative Problems|1|||
126612305|NCT00670449|455540450|FG000|Overall Study|Subject Withdrew Consent|0|||
126612306|NCT00670449|455540451|FG001|Overall Study|Subject Withdrew Consent|2|||
126612307|NCT00670449|455540452|FG002|Overall Study|Subject Withdrew Consent|0|||
126612308|NCT00670449|455540453|FG003|Overall Study|Subject Withdrew Consent|1|||
126612309|NCT00670449|455540450|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
126612310|NCT00670449|455540451|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126612311|NCT00670449|455540452|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
126612312|NCT00670449|455540453|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
126612313|NCT00670449|455540450|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
126612314|NCT00670449|455540451|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
126612315|NCT00670449|455540452|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
126612316|NCT00670449|455540453|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
126612317|NCT02771366|455540454|FG000|Period 1|Withdrawal by Subject|0|||
126612318|NCT02771366|455540455|FG001|Period 1|Withdrawal by Subject|2|||
126612319|NCT02771366|455540454|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
126612320|NCT02771366|455540455|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
126612321|NCT00671853|455540458|FG000|Overall Study|Lack of Efficacy|3|||
126612322|NCT00671853|455540459|FG001|Overall Study|Lack of Efficacy|7|||
126612323|NCT00671853|455540458|FG000|Overall Study|Adverse Event|7|||
126612324|NCT00671853|455540459|FG001|Overall Study|Adverse Event|1|||
126612325|NCT00671853|455540458|FG000|Overall Study|Withdrawal by Subject|1|||
126612326|NCT00671853|455540459|FG001|Overall Study|Withdrawal by Subject|5|||
126612327|NCT00671853|455540458|FG000|Overall Study|Lost to Follow-up|8|||
126612328|NCT00671853|455540459|FG001|Overall Study|Lost to Follow-up|8|||
126612329|NCT00671853|455540458|FG000|Overall Study|Physician Decision|0|||
126612330|NCT00671853|455540459|FG001|Overall Study|Physician Decision|2|||
126612331|NCT00671853|455540458|FG000|Overall Study|Non-adherence with study procedures|1|||
126612332|NCT00671853|455540459|FG001|Overall Study|Non-adherence with study procedures|4|||
126612333|NCT00587171|455540461|FG000|Overall Study|Lost to Follow-up|1|||
126612334|NCT00587171|455540462|FG001|Overall Study|Lost to Follow-up|1|||
126612335|NCT01848483|455540463|FG000|Overall Study|Death|2|||
126612336|NCT01848483|455540464|FG001|Overall Study|Death|1|||
126612337|NCT01848483|455540463|FG000|Overall Study|Lost to Follow-up|6|||
126612338|NCT01848483|455540464|FG001|Overall Study|Lost to Follow-up|8|||
126612339|NCT01848483|455540463|FG000|Overall Study|Withdrawal by Subject|1|||
126612340|NCT01848483|455540464|FG001|Overall Study|Withdrawal by Subject|0|||
126612341|NCT01848483|455540463|FG000|Overall Study|Incarceration|2|||
126612342|NCT01848483|455540464|FG001|Overall Study|Incarceration|2|||
126612343|NCT01148017|455540465|FG000|Overall Study|Withdrawal by Subject|31|||
126612344|NCT01148017|455540466|FG001|Overall Study|Withdrawal by Subject|14|||
126734399|NCT03074149|455975901|FG000|Overall Study|Reason unknown|22|||
126612345|NCT01148017|455540467|FG002|Overall Study|Withdrawal by Subject|0|||
126612346|NCT01148017|455540468|FG003|Overall Study|Withdrawal by Subject|0|||
126612347|NCT01148017|455540465|FG000|Overall Study|Lost to Follow-up|23|||
126612348|NCT01148017|455540466|FG001|Overall Study|Lost to Follow-up|10|||
126612349|NCT01148017|455540467|FG002|Overall Study|Lost to Follow-up|0|||
126612350|NCT01148017|455540468|FG003|Overall Study|Lost to Follow-up|0|||
126612351|NCT01148017|455540465|FG000|Overall Study|Inappropriate enrollment|1|||
126612352|NCT01148017|455540466|FG001|Overall Study|Inappropriate enrollment|0|||
126612353|NCT01148017|455540467|FG002|Overall Study|Inappropriate enrollment|0|||
126612354|NCT01148017|455540468|FG003|Overall Study|Inappropriate enrollment|0|||
126612355|NCT01148017|455540465|FG000|Overall Study|Administrative reason|22|||
126612356|NCT01148017|455540466|FG001|Overall Study|Administrative reason|9|||
126612357|NCT01148017|455540467|FG002|Overall Study|Administrative reason|0|||
126612358|NCT01148017|455540468|FG003|Overall Study|Administrative reason|0|||
126612359|NCT01148017|455540465|FG000|Overall Study|Unable to classify|3|||
126612360|NCT01148017|455540466|FG001|Overall Study|Unable to classify|1|||
126612361|NCT01148017|455540467|FG002|Overall Study|Unable to classify|0|||
126612362|NCT01148017|455540468|FG003|Overall Study|Unable to classify|0|||
126612363|NCT03928743|455540469|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
126612364|NCT03928743|455540470|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
126612365|NCT03928743|455540471|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
126734400|NCT03074149|455975902|FG001|Overall Study|Reason unknown|35|||
126734401|NCT03074149|455975901|FG000|Overall Study|Death|10|||
126612366|NCT03928743|455540469|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
126612367|NCT03928743|455540470|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
126612368|NCT03928743|455540471|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
126612369|NCT03928743|455540469|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
126612370|NCT03928743|455540470|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
126612371|NCT03928743|455540471|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
126612372|NCT03928743|455540469|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
126612373|NCT03928743|455540470|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
126612374|NCT03928743|455540471|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
126612375|NCT03928743|455540469|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
126612376|NCT03928743|455540470|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
126612377|NCT03928743|455540471|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
126612378|NCT03928743|455540469|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
126612379|NCT03928743|455540470|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
126612380|NCT03928743|455540471|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
126612381|NCT03928743|455540469|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
126612382|NCT03928743|455540470|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
126612383|NCT03928743|455540471|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
126612384|NCT03928743|455540469|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
126612385|NCT03928743|455540470|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
126612386|NCT03928743|455540471|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
126612387|NCT03928743|455540469|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
126612388|NCT03928743|455540470|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
126612389|NCT03928743|455540471|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
126612390|NCT03928743|455540469|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
126612391|NCT03928743|455540470|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
126612392|NCT03928743|455540471|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
126612393|NCT03928743|455540469|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
126612394|NCT03928743|455540470|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
126612395|NCT03928743|455540471|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
126612396|NCT01779050|455540472|FG000|Overall Study|Withdrawal by Subject|1|||
126612397|NCT01779050|455540473|FG001|Overall Study|Withdrawal by Subject|0|||
126612398|NCT02392507|455540474|FG000|Induction Regimen|Death|3|||
126612399|NCT02392507|455540474|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
126612400|NCT02392507|455540474|FG000|Induction Regimen|Physician Decision|1|||
126612401|NCT02392507|455540474|FG000|Induction Regimen|Withdrawal by Subject|2|||
126612402|NCT02392507|455540474|FG000|Maintenance Regimen|Death|1|||
126612403|NCT02392507|455540474|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
126612404|NCT02224755|455540475|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
126612405|NCT02224755|455540476|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
126612406|NCT02224755|455540475|FG000|Two Year Follow up Post-implant|Death|103|||
126612407|NCT02224755|455540476|FG001|Two Year Follow up Post-implant|Death|98|||
126612408|NCT02224755|455540475|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
126612409|NCT02224755|455540476|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
126612410|NCT02224755|455540475|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
126612411|NCT02224755|455540476|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
126612412|NCT02224755|455540475|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
126612413|NCT02224755|455540476|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
126612414|NCT00703092|455540479|FG000|Overall Study|Withdrawal by Subject|2|||
126612415|NCT01021748|455540480|FG000|Overall Study|Adverse Event|2|||
126612416|NCT01021748|455540481|FG001|Overall Study|Adverse Event|1|||
126612417|NCT01021748|455540482|FG002|Overall Study|Adverse Event|2|||
126612418|NCT01021748|455540483|FG003|Overall Study|Adverse Event|0|||
126612419|NCT01021748|455540484|FG004|Overall Study|Adverse Event|2|||
126612420|NCT01021748|455540485|FG005|Overall Study|Adverse Event|0|||
126612421|NCT01021748|455540486|FG006|Overall Study|Adverse Event|1|||
126612422|NCT01021748|455540487|FG007|Overall Study|Adverse Event|0|||
126612423|NCT01021748|455540488|FG008|Overall Study|Adverse Event|7|||
126612424|NCT01021748|455540480|FG000|Overall Study|Physician Decision|1|||
126612425|NCT01021748|455540481|FG001|Overall Study|Physician Decision|0|||
126612426|NCT01021748|455540482|FG002|Overall Study|Physician Decision|1|||
126612427|NCT01021748|455540483|FG003|Overall Study|Physician Decision|1|||
126612428|NCT01021748|455540484|FG004|Overall Study|Physician Decision|0|||
126612429|NCT01021748|455540485|FG005|Overall Study|Physician Decision|0|||
126612430|NCT01021748|455540486|FG006|Overall Study|Physician Decision|1|||
126612431|NCT01021748|455540487|FG007|Overall Study|Physician Decision|1|||
126612432|NCT01021748|455540488|FG008|Overall Study|Physician Decision|2|||
126612433|NCT01021748|455540480|FG000|Overall Study|Progressive Disease|3|||
126612434|NCT01021748|455540481|FG001|Overall Study|Progressive Disease|3|||
126612435|NCT01021748|455540482|FG002|Overall Study|Progressive Disease|4|||
126612436|NCT01021748|455540483|FG003|Overall Study|Progressive Disease|6|||
126612437|NCT01021748|455540484|FG004|Overall Study|Progressive Disease|7|||
126612438|NCT01021748|455540485|FG005|Overall Study|Progressive Disease|3|||
126612439|NCT01021748|455540486|FG006|Overall Study|Progressive Disease|0|||
126612440|NCT01021748|455540487|FG007|Overall Study|Progressive Disease|5|||
126612441|NCT01021748|455540488|FG008|Overall Study|Progressive Disease|6|||
126612442|NCT01021748|455540480|FG000|Overall Study|Withdrawal by Subject|0|||
126612443|NCT01021748|455540481|FG001|Overall Study|Withdrawal by Subject|0|||
126612444|NCT01021748|455540482|FG002|Overall Study|Withdrawal by Subject|0|||
126612445|NCT01021748|455540483|FG003|Overall Study|Withdrawal by Subject|0|||
126612446|NCT01021748|455540484|FG004|Overall Study|Withdrawal by Subject|0|||
126612447|NCT01021748|455540485|FG005|Overall Study|Withdrawal by Subject|0|||
126612448|NCT01021748|455540486|FG006|Overall Study|Withdrawal by Subject|1|||
126612449|NCT01021748|455540487|FG007|Overall Study|Withdrawal by Subject|0|||
126612450|NCT01021748|455540488|FG008|Overall Study|Withdrawal by Subject|1|||
126612451|NCT01021748|455540480|FG000|Overall Study|Not Treated|0|||
126612452|NCT01021748|455540481|FG001|Overall Study|Not Treated|1|||
126612453|NCT01021748|455540482|FG002|Overall Study|Not Treated|0|||
126612454|NCT01021748|455540483|FG003|Overall Study|Not Treated|0|||
126612455|NCT01021748|455540484|FG004|Overall Study|Not Treated|0|||
126612456|NCT01021748|455540485|FG005|Overall Study|Not Treated|0|||
126612457|NCT01021748|455540486|FG006|Overall Study|Not Treated|0|||
126612458|NCT01021748|455540487|FG007|Overall Study|Not Treated|0|||
126612459|NCT01021748|455540488|FG008|Overall Study|Not Treated|0|||
126612460|NCT01829711|455540493|FG000|Overall Study|Lost to Follow-up|2|||
126612461|NCT01829711|455540493|FG000|Overall Study|Withdrawal by Subject|3|||
126612462|NCT01829711|455540493|FG000|Overall Study|Death|4|||
126612463|NCT01829711|455540493|FG000|Overall Study|Started new therapies|17|||
126612464|NCT01829711|455540493|FG000|Overall Study|Adverse Event|3|||
126612465|NCT01829711|455540493|FG000|Overall Study|Due to progression of disease|13|||
126612466|NCT01829711|455540493|FG000|Overall Study|Due to lack of response|1|||
126612467|NCT01480258|455540494|FG000|Infant Series|Protocol Violation|2|||
126612468|NCT01480258|455540495|FG001|Infant Series|Protocol Violation|0|||
126612469|NCT01480258|455540494|FG000|Infant Series|Physician Decision|0|||
126612470|NCT01480258|455540495|FG001|Infant Series|Physician Decision|1|||
126612471|NCT01480258|455540494|FG000|Infant Series|Not Vaccinated|3|||
126612472|NCT01480258|455540495|FG001|Infant Series|Not Vaccinated|0|||
126612473|NCT01480258|455540494|FG000|Infant Series|Adverse Event|1|||
126612474|NCT01480258|455540495|FG001|Infant Series|Adverse Event|1|||
126612475|NCT01480258|455540494|FG000|Infant Series|Withdrawal by Subject|1|||
126612476|NCT01480258|455540495|FG001|Infant Series|Withdrawal by Subject|6|||
126612477|NCT01480258|455540494|FG000|Interim Period|Lost to Follow-up|0|||
126612478|NCT01480258|455540495|FG001|Interim Period|Lost to Follow-up|2|||
126612479|NCT01480258|455540494|FG000|Interim Period|Physician Decision|1|||
126612480|NCT01480258|455540495|FG001|Interim Period|Physician Decision|0|||
126612481|NCT01480258|455540494|FG000|Interim Period|Protocol Violation|0|||
126612482|NCT01480258|455540495|FG001|Interim Period|Protocol Violation|1|||
126612483|NCT01480258|455540494|FG000|Interim Period|Withdrawal by Subject|9|||
126612484|NCT01480258|455540495|FG001|Interim Period|Withdrawal by Subject|6|||
126612485|NCT03316170|455540498|FG000|Overall Study|Death|1|||
126612486|NCT03316170|455540499|FG001|Overall Study|Death|0|||
126612487|NCT03316170|455540498|FG000|Overall Study|Lost to Follow-up|6|||
126612488|NCT03316170|455540499|FG001|Overall Study|Lost to Follow-up|7|||
126612489|NCT02169414|455540500|FG000|Overall Study|Withdrawal by Subject|1|||
126612490|NCT02169414|455540501|FG001|Overall Study|Withdrawal by Subject|0|||
126612491|NCT02169414|455540502|FG002|Overall Study|Withdrawal by Subject|0|||
126612492|NCT02169414|455540503|FG003|Overall Study|Withdrawal by Subject|0|||
126612493|NCT02169414|455540500|FG000|Overall Study|Adverse Event|0|||
126612494|NCT02169414|455540501|FG001|Overall Study|Adverse Event|1|||
126612495|NCT02169414|455540502|FG002|Overall Study|Adverse Event|0|||
126612496|NCT02169414|455540503|FG003|Overall Study|Adverse Event|0|||
126612497|NCT03374254|455540504|FG000|Overall Study|Death|5|||
126612498|NCT03374254|455540505|FG001|Overall Study|Death|16|||
126612499|NCT03374254|455540506|FG002|Overall Study|Death|13|||
126612500|NCT03374254|455540507|FG003|Overall Study|Death|11|||
126612501|NCT03374254|455540508|FG004|Overall Study|Death|9|||
126612502|NCT03374254|455540509|FG005|Overall Study|Death|12|||
126612503|NCT03374254|455540510|FG006|Overall Study|Death|11|||
126612504|NCT03374254|455540511|FG007|Overall Study|Death|6|||
126612505|NCT03374254|455540512|FG008|Overall Study|Death|7|||
126612506|NCT03374254|455540504|FG000|Overall Study|Lost to Follow-up|0|||
126612507|NCT03374254|455540505|FG001|Overall Study|Lost to Follow-up|0|||
126612508|NCT03374254|455540506|FG002|Overall Study|Lost to Follow-up|0|||
126612509|NCT03374254|455540507|FG003|Overall Study|Lost to Follow-up|0|||
126612510|NCT03374254|455540508|FG004|Overall Study|Lost to Follow-up|0|||
126612511|NCT03374254|455540509|FG005|Overall Study|Lost to Follow-up|0|||
126612512|NCT03374254|455540510|FG006|Overall Study|Lost to Follow-up|2|||
126612513|NCT03374254|455540511|FG007|Overall Study|Lost to Follow-up|0|||
126612514|NCT03374254|455540512|FG008|Overall Study|Lost to Follow-up|0|||
126612515|NCT03374254|455540504|FG000|Overall Study|Sponsor Decision|1|||
126612516|NCT03374254|455540505|FG001|Overall Study|Sponsor Decision|0|||
126612517|NCT03374254|455540506|FG002|Overall Study|Sponsor Decision|2|||
126612518|NCT03374254|455540507|FG003|Overall Study|Sponsor Decision|3|||
126612519|NCT03374254|455540508|FG004|Overall Study|Sponsor Decision|2|||
126612520|NCT03374254|455540509|FG005|Overall Study|Sponsor Decision|3|||
126612521|NCT03374254|455540510|FG006|Overall Study|Sponsor Decision|3|||
126612522|NCT03374254|455540511|FG007|Overall Study|Sponsor Decision|3|||
126612523|NCT03374254|455540512|FG008|Overall Study|Sponsor Decision|4|||
126612524|NCT03374254|455540504|FG000|Overall Study|Withdrawal by Subject|0|||
126612525|NCT03374254|455540505|FG001|Overall Study|Withdrawal by Subject|0|||
126612526|NCT03374254|455540506|FG002|Overall Study|Withdrawal by Subject|0|||
126612527|NCT03374254|455540507|FG003|Overall Study|Withdrawal by Subject|2|||
126612528|NCT03374254|455540508|FG004|Overall Study|Withdrawal by Subject|0|||
126612529|NCT03374254|455540509|FG005|Overall Study|Withdrawal by Subject|1|||
126612530|NCT03374254|455540510|FG006|Overall Study|Withdrawal by Subject|0|||
126612531|NCT03374254|455540511|FG007|Overall Study|Withdrawal by Subject|0|||
126612532|NCT03374254|455540512|FG008|Overall Study|Withdrawal by Subject|0|||
126612533|NCT02309515|455540513|FG000|Overall Study|Withdrawal by Subject|0|||
126612534|NCT02309515|455540514|FG001|Overall Study|Withdrawal by Subject|1|||
126612535|NCT00624377|455540520|FG000|Overall Study|Lost to Follow-up|355|||
126612536|NCT00624377|455540520|FG000|Overall Study|Withdrawal by Subject|100|||
126612537|NCT00624377|455540520|FG000|Overall Study|Adverse Event|14|||
126612538|NCT00624377|455540520|FG000|Overall Study|Other|91|||
126612539|NCT00624377|455540520|FG000|Overall Study|Non-evaluable population|84|||
126612540|NCT05260437|455540521|FG000|Overall Study|Lost to Follow-up|5|||
126612541|NCT05260437|455540522|FG001|Overall Study|Lost to Follow-up|2|||
126612542|NCT05260437|455540523|FG002|Overall Study|Lost to Follow-up|1|||
126612543|NCT05260437|455540524|FG003|Overall Study|Lost to Follow-up|2|||
126612544|NCT05260437|455540525|FG004|Overall Study|Lost to Follow-up|2|||
126612545|NCT05260437|455540521|FG000|Overall Study|Withdrawal by Subject|3|||
126612546|NCT05260437|455540522|FG001|Overall Study|Withdrawal by Subject|0|||
126612547|NCT05260437|455540523|FG002|Overall Study|Withdrawal by Subject|4|||
126612548|NCT05260437|455540524|FG003|Overall Study|Withdrawal by Subject|5|||
126612549|NCT05260437|455540525|FG004|Overall Study|Withdrawal by Subject|0|||
126612550|NCT05260437|455540521|FG000|Overall Study|Vaccine Not Administered|0|||
126612551|NCT05260437|455540522|FG001|Overall Study|Vaccine Not Administered|1|||
126612552|NCT05260437|455540523|FG002|Overall Study|Vaccine Not Administered|0|||
126612553|NCT05260437|455540524|FG003|Overall Study|Vaccine Not Administered|0|||
126612554|NCT05260437|455540525|FG004|Overall Study|Vaccine Not Administered|0|||
126612555|NCT00910962|455540526|FG000|Overall Study|Adverse Event|5|||
126612556|NCT00910962|455540527|FG001|Overall Study|Adverse Event|20|||
126612557|NCT00910962|455540528|FG002|Overall Study|Adverse Event|17|||
126612558|NCT00910962|455540526|FG000|Overall Study|Protocol Violation|1|||
126612559|NCT00910962|455540527|FG001|Overall Study|Protocol Violation|3|||
126612560|NCT00910962|455540528|FG002|Overall Study|Protocol Violation|3|||
126612561|NCT00910962|455540526|FG000|Overall Study|Lost to Follow-up|0|||
126612562|NCT00910962|455540527|FG001|Overall Study|Lost to Follow-up|3|||
126612563|NCT00910962|455540528|FG002|Overall Study|Lost to Follow-up|1|||
126612564|NCT00910962|455540526|FG000|Overall Study|Physician Decision|0|||
126612565|NCT00910962|455540527|FG001|Overall Study|Physician Decision|6|||
126612566|NCT00910962|455540528|FG002|Overall Study|Physician Decision|6|||
126612567|NCT00910962|455540526|FG000|Overall Study|Withdrawal by Subject|25|||
126612568|NCT00910962|455540527|FG001|Overall Study|Withdrawal by Subject|32|||
126734402|NCT03074149|455975902|FG001|Overall Study|Death|45|||
126734403|NCT00050622|455975903|FG000|Overall Study|Adverse Event|1|||
126734404|NCT01192204|455975904|FG000|Overall Study|could not keep recall appointments|1|||
126734405|NCT01192204|455975905|FG001|Overall Study|could not keep recall appointments|0|||
126734406|NCT02146248|455975906|FG000|Overall Study|Withdrawal by Subject|2|||
126734407|NCT01315847|455975907|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
126734408|NCT01315847|455975908|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
126781279|NCT00358826|456154515|FG007|Core Study|Adverse Event|0|||
126612569|NCT00910962|455540528|FG002|Overall Study|Withdrawal by Subject|32|||
126612570|NCT00910962|455540526|FG000|Overall Study|Reached defined stopping criteria|12|||
126612571|NCT00910962|455540527|FG001|Overall Study|Reached defined stopping criteria|14|||
126612572|NCT00910962|455540528|FG002|Overall Study|Reached defined stopping criteria|17|||
126612573|NCT01858688|455540529|FG000|Overall Study|Withdrawal by Subject|8|||
126612574|NCT01858688|455540529|FG000|Overall Study|Participant began another therapy|3|||
126612575|NCT01858688|455540529|FG000|Overall Study|Physician Decision|2|||
126612576|NCT01858688|455540529|FG000|Overall Study|Progressive Disease|2|||
126612577|NCT01858688|455540529|FG000|Overall Study|Reason not reproted|5|||
126612578|NCT01999335|455540530|FG000|Overall Study|Discontinued before receiving treatment|0|||
126612579|NCT01999335|455540531|FG001|Overall Study|Discontinued before receiving treatment|0|||
126612580|NCT01999335|455540532|FG002|Overall Study|Discontinued before receiving treatment|0|||
126734409|NCT01315847|455975907|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
126734410|NCT01315847|455975908|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
126612581|NCT01999335|455540533|FG003|Overall Study|Discontinued before receiving treatment|0|||
126612582|NCT01999335|455540534|FG004|Overall Study|Discontinued before receiving treatment|2|||
126612583|NCT00787176|455540535|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
126612584|NCT00787176|455540536|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
126612585|NCT00787176|455540537|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
126612586|NCT00787176|455540538|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
126612587|NCT04679675|455540545|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
126612588|NCT04679675|455540546|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
126612589|NCT04679675|455540547|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
126612590|NCT04679675|455540548|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
126612591|NCT04679675|455540545|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
126612592|NCT04679675|455540546|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
126612593|NCT04679675|455540547|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
126612594|NCT04679675|455540548|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
126612595|NCT02234141|455540549|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
126612596|NCT02234141|455540550|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
126612597|NCT02234141|455540551|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
126612598|NCT02234141|455540552|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
126612599|NCT02234141|455540553|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
126612600|NCT02234141|455540554|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
126612601|NCT02234141|455540555|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
126612602|NCT02234141|455540549|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
126612603|NCT02234141|455540550|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
126612604|NCT02234141|455540551|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
126612605|NCT02234141|455540552|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
126612606|NCT02234141|455540553|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
126612607|NCT02234141|455540554|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
126612608|NCT02234141|455540555|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
126612609|NCT02234141|455540549|FG000|Treatment Period (24 Weeks)|Death|1|||
126612610|NCT02234141|455540550|FG001|Treatment Period (24 Weeks)|Death|2|||
126612611|NCT02234141|455540551|FG002|Treatment Period (24 Weeks)|Death|0|||
126612612|NCT02234141|455540552|FG003|Treatment Period (24 Weeks)|Death|1|||
126612613|NCT02234141|455540553|FG004|Treatment Period (24 Weeks)|Death|0|||
126612614|NCT02234141|455540554|FG005|Treatment Period (24 Weeks)|Death|0|||
126612615|NCT02234141|455540555|FG006|Treatment Period (24 Weeks)|Death|0|||
126612616|NCT02234141|455540549|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
126612617|NCT02234141|455540550|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
126612618|NCT02234141|455540551|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
126612619|NCT02234141|455540552|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
126612620|NCT02234141|455540553|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
126612621|NCT02234141|455540554|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
126612622|NCT02234141|455540555|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
126612623|NCT02234141|455540549|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
126612624|NCT02234141|455540550|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
126612625|NCT02234141|455540551|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
126612626|NCT02234141|455540552|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
126612627|NCT02234141|455540553|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
126612628|NCT02234141|455540554|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
126612629|NCT02234141|455540555|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
126612630|NCT02234141|455540549|FG000|Long-Term Treatment Period|Death|0|||
126612631|NCT02234141|455540550|FG001|Long-Term Treatment Period|Death|0|||
126612632|NCT02234141|455540551|FG002|Long-Term Treatment Period|Death|0|||
126612633|NCT02234141|455540552|FG003|Long-Term Treatment Period|Death|0|||
126612634|NCT02234141|455540553|FG004|Long-Term Treatment Period|Death|0|||
126612635|NCT02234141|455540554|FG005|Long-Term Treatment Period|Death|1|||
126612636|NCT02234141|455540555|FG006|Long-Term Treatment Period|Death|0|||
126612637|NCT02234141|455540549|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
126612638|NCT02234141|455540550|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
126612639|NCT02234141|455540551|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
126612640|NCT02234141|455540552|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
126612641|NCT02234141|455540553|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
126612642|NCT02234141|455540554|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
126612643|NCT02234141|455540555|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
126612644|NCT02234141|455540549|FG000|Long-Term Treatment Period|Adverse Event|4|||
126612645|NCT02234141|455540550|FG001|Long-Term Treatment Period|Adverse Event|0|||
126612646|NCT02234141|455540551|FG002|Long-Term Treatment Period|Adverse Event|5|||
126734411|NCT03589885|455975909|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
126734412|NCT03589885|455975910|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
126734413|NCT03589885|455975911|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
126734414|NCT03589885|455975912|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
126612647|NCT02234141|455540552|FG003|Long-Term Treatment Period|Adverse Event|0|||
126612648|NCT02234141|455540553|FG004|Long-Term Treatment Period|Adverse Event|1|||
126612649|NCT02234141|455540554|FG005|Long-Term Treatment Period|Adverse Event|1|||
126612650|NCT02234141|455540555|FG006|Long-Term Treatment Period|Adverse Event|1|||
126612651|NCT02234141|455540549|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
126612652|NCT02234141|455540550|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
126612653|NCT02234141|455540551|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
126612654|NCT02234141|455540552|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
126612655|NCT02234141|455540553|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
126612656|NCT02234141|455540554|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
126612657|NCT02234141|455540555|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
126612658|NCT02234141|455540549|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
126612659|NCT02234141|455540550|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
126612660|NCT02234141|455540551|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
126612661|NCT02234141|455540552|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
126612662|NCT02234141|455540553|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
126612663|NCT02234141|455540554|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
126612664|NCT02234141|455540555|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
126612665|NCT03326856|455540556|FG000|Overall Study|Lost to Follow-up|1|||
126612666|NCT03326856|455540557|FG001|Overall Study|Lost to Follow-up|1|||
126612667|NCT03326856|455540558|FG002|Overall Study|Lost to Follow-up|0|||
126612668|NCT03326856|455540559|FG003|Overall Study|Lost to Follow-up|0|||
126612669|NCT03326856|455540560|FG004|Overall Study|Lost to Follow-up|0|||
126612670|NCT00621842|455540561|FG000|Overall Study|Adverse Event|6|||
126612671|NCT00621842|455540561|FG000|Overall Study|Withdrawal by Subject|7|||
126612672|NCT00621842|455540561|FG000|Overall Study|Protocol Violation|4|||
126612673|NCT00621842|455540561|FG000|Overall Study|Lack of Efficacy|2|||
126612674|NCT00526994|455540562|FG000|Overall Study|Lost to Follow-up|98|||
126612675|NCT00526994|455540563|FG001|Overall Study|Lost to Follow-up|108|||
126612676|NCT00526994|455540564|FG002|Overall Study|Lost to Follow-up|96|||
126612677|NCT00526994|455540562|FG000|Overall Study|Death|4|||
126612678|NCT00526994|455540563|FG001|Overall Study|Death|3|||
126612679|NCT00526994|455540564|FG002|Overall Study|Death|3|||
126612680|NCT00526994|455540562|FG000|Overall Study|Withdrawal by Subject|2|||
126612681|NCT00526994|455540563|FG001|Overall Study|Withdrawal by Subject|7|||
126612682|NCT00526994|455540564|FG002|Overall Study|Withdrawal by Subject|5|||
126612683|NCT00526994|455540562|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
126612684|NCT00526994|455540563|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
126612685|NCT00526994|455540564|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
126612686|NCT03692871|455540568|FG000|Overall Study|Death|1|||
126612687|NCT03692871|455540569|FG001|Overall Study|Death|1|||
126612688|NCT03692871|455540568|FG000|Overall Study|Lost to Follow-up|24|||
126612689|NCT03692871|455540569|FG001|Overall Study|Lost to Follow-up|9|||
126612690|NCT03692871|455540568|FG000|Overall Study|Physician Decision|22|||
126612691|NCT03692871|455540569|FG001|Overall Study|Physician Decision|7|||
126612692|NCT03692871|455540568|FG000|Overall Study|Protocol Deviation|1|||
126612693|NCT03692871|455540569|FG001|Overall Study|Protocol Deviation|0|||
126612694|NCT03692871|455540568|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
126612695|NCT03692871|455540569|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
126612696|NCT02644122|455540573|FG000|Overall Study|Withdrawal by Subject|1|||
126612697|NCT03182244|455540574|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
126612698|NCT03182244|455540575|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
126612699|NCT03182244|455540574|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
126612700|NCT03182244|455540575|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
126612701|NCT03182244|455540574|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
126612702|NCT03182244|455540575|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
126612703|NCT03182244|455540574|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
126612704|NCT03182244|455540575|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
126612705|NCT03182244|455540574|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
126612706|NCT03182244|455540575|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
126734415|NCT03589885|455975913|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
126612707|NCT03182244|455540574|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
126612708|NCT03182244|455540575|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
126612709|NCT03182244|455540574|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
126612710|NCT03182244|455540575|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
126612711|NCT03182244|455540574|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
126612712|NCT03182244|455540575|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
126734416|NCT03589885|455975909|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
126734417|NCT03589885|455975910|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
126612713|NCT03182244|455540574|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
126612714|NCT03182244|455540575|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
126612715|NCT03182244|455540574|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
126612716|NCT03182244|455540575|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
126734418|NCT03589885|455975911|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
126734419|NCT03589885|455975912|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
126734420|NCT03589885|455975913|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
126734421|NCT03589885|455975909|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
126734422|NCT03589885|455975910|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
126734423|NCT03589885|455975911|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
126734424|NCT03589885|455975912|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
126734425|NCT03589885|455975913|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
126734426|NCT03589885|455975909|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
126734427|NCT03589885|455975910|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
126734428|NCT03589885|455975911|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
126734429|NCT03589885|455975912|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
126734430|NCT03589885|455975913|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
126734431|NCT03589885|455975909|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
126734432|NCT03589885|455975910|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
126734433|NCT03589885|455975911|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
126734434|NCT03589885|455975912|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
126734435|NCT03589885|455975913|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
126734436|NCT03589885|455975909|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
126734437|NCT03589885|455975910|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
126734438|NCT03589885|455975911|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
126734439|NCT03589885|455975912|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
126734440|NCT03589885|455975913|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
126734441|NCT03589885|455975909|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
126734442|NCT03589885|455975910|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
126734443|NCT03589885|455975911|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
126734444|NCT03589885|455975912|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
126734445|NCT03589885|455975913|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
126734446|NCT03589885|455975909|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
126734447|NCT03589885|455975910|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
126734448|NCT03589885|455975911|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
126734449|NCT03589885|455975912|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
126734450|NCT03589885|455975913|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
126734451|NCT01117012|455975915|FG000|Overall Study|Adverse Event|0|||
126734452|NCT01117012|455975916|FG001|Overall Study|Adverse Event|1|||
126734453|NCT01117012|455975915|FG000|Overall Study|Death|1|||
126734454|NCT01117012|455975916|FG001|Overall Study|Death|1|||
126734455|NCT01117012|455975915|FG000|Overall Study|Withdrawal by Subject|3|||
126734456|NCT01117012|455975916|FG001|Overall Study|Withdrawal by Subject|0|||
126734457|NCT01117012|455975915|FG000|Overall Study|Undefined|4|||
126734458|NCT01117012|455975916|FG001|Overall Study|Undefined|3|||
126734459|NCT03695393|455975917|FG000|Overall Study|Death|3|||
126734460|NCT03695393|455975918|FG001|Overall Study|Death|1|||
126734461|NCT03695393|455975917|FG000|Overall Study|Lost to Follow-up|0|||
126734462|NCT03695393|455975918|FG001|Overall Study|Lost to Follow-up|1|||
126734463|NCT00673894|455975919|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
126734464|NCT00673894|455975920|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
126734465|NCT00673894|455975919|FG000|First Intervention 4 Weeks|Adverse Event|1|||
126734466|NCT00673894|455975920|FG001|First Intervention 4 Weeks|Adverse Event|0|||
126734467|NCT02807363|455975921|FG000|Dosing Period|Adverse Event|0|||
126734468|NCT02807363|455975922|FG001|Dosing Period|Adverse Event|1|||
126734469|NCT02807363|455975923|FG002|Dosing Period|Adverse Event|0|||
126734470|NCT02807363|455975924|FG003|Dosing Period|Adverse Event|0|||
126734471|NCT01164865|455975925|FG000|Overall Study|Lost to Follow-up|2|||
126734472|NCT01164865|455975926|FG001|Overall Study|Lost to Follow-up|1|||
126734473|NCT00405821|455975929|FG000|Overall Study|Death|5|||
126734474|NCT00405821|455975930|FG001|Overall Study|Death|7|||
126734475|NCT00405821|455975929|FG000|Overall Study|Lost to Follow-up|7|||
126734476|NCT00405821|455975930|FG001|Overall Study|Lost to Follow-up|7|||
126734477|NCT00405821|455975929|FG000|Overall Study|Protocol Violation|1|||
126734478|NCT00405821|455975930|FG001|Overall Study|Protocol Violation|0|||
126734479|NCT00405821|455975929|FG000|Overall Study|initiated ART|9|||
126734480|NCT00405821|455975930|FG001|Overall Study|initiated ART|8|||
126734481|NCT01769469|455975933|FG000|Overall Study|Consent Withdrawn|5|||
126781280|NCT00358826|456154508|FG000|Core Study|Withdrawal by Subject|2|||
126734482|NCT01769469|455975933|FG000|Overall Study|Moved Out Of Area|3|||
126734483|NCT01769469|455975933|FG000|Overall Study|Lost to Follow-up|17|||
126734484|NCT01769469|455975933|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
126734485|NCT01769469|455975933|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
126734486|NCT02031432|455975938|FG000|Overall Study|Protocol Violation|1|||
126734487|NCT02031432|455975938|FG000|Overall Study|Lack of Efficacy|5|||
126734488|NCT02031432|455975938|FG000|Overall Study|Cancer Progression|2|||
126734489|NCT02031432|455975938|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
126734490|NCT02031432|455975938|FG000|Overall Study|Adverse Event|8|||
126734491|NCT02031432|455975938|FG000|Overall Study|Withdrawal by Subject|5|||
126734492|NCT02031432|455975938|FG000|Overall Study|Lost to Follow-up|1|||
126734493|NCT02031432|455975938|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
126734494|NCT02031432|455975938|FG000|Overall Study|Death|10|||
126734495|NCT01617187|455975939|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
126734496|NCT01617187|455975940|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
126734497|NCT01617187|455975941|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
126734498|NCT01617187|455975942|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
126734499|NCT01617187|455975939|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
126734500|NCT01617187|455975940|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
126734501|NCT01617187|455975941|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
126734502|NCT01617187|455975942|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
126734503|NCT01617187|455975939|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
126734504|NCT01617187|455975940|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
126734505|NCT01617187|455975941|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
126734506|NCT01617187|455975942|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
126734507|NCT01617187|455975939|FG000|Treatment Through Study Completion|Adverse Event|1|||
126734508|NCT01617187|455975940|FG001|Treatment Through Study Completion|Adverse Event|1|||
126734509|NCT01617187|455975941|FG002|Treatment Through Study Completion|Adverse Event|0|||
126734510|NCT01617187|455975942|FG003|Treatment Through Study Completion|Adverse Event|1|||
126734511|NCT01617187|455975939|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
126734512|NCT01617187|455975940|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
126734513|NCT01617187|455975941|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
126734514|NCT01617187|455975942|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
126734515|NCT01617187|455975939|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
126734516|NCT01617187|455975940|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
126734517|NCT01617187|455975941|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
126734518|NCT01617187|455975942|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
126734519|NCT01617187|455975939|FG000|Treatment Through Study Completion|Protocol Violation|1|||
126734520|NCT01617187|455975940|FG001|Treatment Through Study Completion|Protocol Violation|0|||
126734521|NCT01617187|455975941|FG002|Treatment Through Study Completion|Protocol Violation|0|||
126734522|NCT01617187|455975942|FG003|Treatment Through Study Completion|Protocol Violation|1|||
126734523|NCT03862131|455975946|FG000|Overall Study|Lost to Follow-up|1|||
126734524|NCT03862131|455975947|FG001|Overall Study|Lost to Follow-up|0|||
126734525|NCT03862131|455975948|FG002|Overall Study|Lost to Follow-up|1|||
126734526|NCT03862131|455975946|FG000|Overall Study|Determined to be ineligible|0|||
126734527|NCT03862131|455975947|FG001|Overall Study|Determined to be ineligible|0|||
126734528|NCT03862131|455975948|FG002|Overall Study|Determined to be ineligible|5|||
126734529|NCT03862131|455975946|FG000|Overall Study|Death|4|||
126734530|NCT03862131|455975947|FG001|Overall Study|Death|4|||
126734531|NCT03862131|455975948|FG002|Overall Study|Death|0|||
126734532|NCT03862131|455975946|FG000|Overall Study|Withdrawal by Subject|5|||
126734533|NCT03862131|455975947|FG001|Overall Study|Withdrawal by Subject|3|||
126734534|NCT03862131|455975948|FG002|Overall Study|Withdrawal by Subject|0|||
126734535|NCT03862131|455975946|FG000|Overall Study|Physician Decision|0|||
126734536|NCT03862131|455975947|FG001|Overall Study|Physician Decision|1|||
126734537|NCT03862131|455975948|FG002|Overall Study|Physician Decision|0|||
126734538|NCT01770145|455977545|FG000|Baseline|Adverse Event|20|||
126734539|NCT01770145|455977545|FG000|Baseline|Withdrawal by Subject|1|||
126734540|NCT01770145|455977545|FG000|Baseline|Lost to Follow-up|1|||
126734541|NCT01770145|455977545|FG000|Baseline|Unable to define optimal dose|4|||
126734542|NCT01770145|455977545|FG000|Treatment|Adverse Event|3|||
126734543|NCT01770145|455977545|FG000|Treatment|Withdrawal by Subject|1|||
126734544|NCT00595868|455977546|FG000|Overall Study|Lost to Follow-up|45|||
126734545|NCT00595868|455977547|FG001|Overall Study|Lost to Follow-up|50|||
126734546|NCT04268303|455977549|FG000|Overall Study|Lost to Follow-up|1|||
126734547|NCT04268303|455977550|FG001|Overall Study|Lost to Follow-up|1|||
126734548|NCT04268303|455977551|FG002|Overall Study|Lost to Follow-up|2|||
126734549|NCT04268303|455977549|FG000|Overall Study|Withdrawal by Subject|0|||
126734550|NCT04268303|455977550|FG001|Overall Study|Withdrawal by Subject|1|||
126781281|NCT00358826|456154509|FG001|Core Study|Withdrawal by Subject|2|||
126781282|NCT00358826|456154510|FG002|Core Study|Withdrawal by Subject|0|||
126781283|NCT00358826|456154511|FG003|Core Study|Withdrawal by Subject|0|||
126734551|NCT04268303|455977551|FG002|Overall Study|Withdrawal by Subject|1|||
126781284|NCT00358826|456154512|FG004|Core Study|Withdrawal by Subject|0|||
126781285|NCT00358826|456154513|FG005|Core Study|Withdrawal by Subject|0|||
126734552|NCT04268303|455977549|FG000|Overall Study|Adverse Event|2|||
126734553|NCT04268303|455977550|FG001|Overall Study|Adverse Event|0|||
126734554|NCT04268303|455977551|FG002|Overall Study|Adverse Event|0|||
126781286|NCT00358826|456154514|FG006|Core Study|Withdrawal by Subject|0|||
126781287|NCT00358826|456154515|FG007|Core Study|Withdrawal by Subject|0|||
126734555|NCT05742841|455977555|FG000|Overall Study|Withdrawal by Subject|1|||
126734556|NCT05742841|455977555|FG000|Overall Study|Lost to Follow-up|1|||
126734557|NCT00510484|455977556|FG000|Wash-out Period|Adverse Event|0|||
126734558|NCT00510484|455977557|FG001|Wash-out Period|Adverse Event|1|||
126734559|NCT02533401|455977560|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
126734560|NCT02533401|455977560|FG000|Overall Study|Death|5|||
126734561|NCT02533401|455977560|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
126734562|NCT02533401|455977560|FG000|Overall Study|Lost to Follow-up|1|||
126734563|NCT02533401|455977560|FG000|Overall Study|Violation of Selection Criteria|1|||
126734564|NCT00973622|455977565|FG000|Overall Study|did not attend MRI|14|||
126734565|NCT00973622|455977566|FG001|Overall Study|did not attend MRI|3|||
126734566|NCT00973622|455977565|FG000|Overall Study|did not pass MRI screen|6|||
126734567|NCT00973622|455977566|FG001|Overall Study|did not pass MRI screen|0|||
126734568|NCT00973622|455977565|FG000|Overall Study|did not complete rTMS sessions|11|||
126734569|NCT00973622|455977566|FG001|Overall Study|did not complete rTMS sessions|2|||
126734570|NCT00555568|455977567|FG000|Overall Study|Lost to Follow-up|26|||
126734571|NCT00555568|455977568|FG001|Overall Study|Lost to Follow-up|16|||
126734572|NCT00555568|455977569|FG002|Overall Study|Lost to Follow-up|16|||
126734573|NCT02378883|455977572|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
126734574|NCT02378883|455977572|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
126734575|NCT02378883|455977572|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
126734576|NCT02378883|455977572|FG000|30 Day Follow-Up|Physician Decision|2|||
126734577|NCT02378883|455977572|FG000|30 Day Follow-Up|Missed Visit|2|||
126734578|NCT02378883|455977572|FG000|30 Day Follow-Up|Death|1|||
126734579|NCT02378883|455977572|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
126734580|NCT02378883|455977572|FG000|12 Months Follow-Up|Death|2|||
126734581|NCT00493467|455977575|FG000|Overall Study|Death|1|||
126734582|NCT03814005|455977578|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
126734583|NCT03814005|455977579|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
126734584|NCT03814005|455977580|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
126734585|NCT03814005|455977578|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
126734586|NCT03814005|455977579|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
126734587|NCT03814005|455977580|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
126734588|NCT03814005|455977578|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
126734589|NCT03814005|455977579|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
126734590|NCT03814005|455977580|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
126734591|NCT03814005|455977578|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
126734592|NCT03814005|455977579|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
126734593|NCT03814005|455977580|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
126734594|NCT03814005|455977578|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
126734595|NCT03814005|455977579|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
126734596|NCT03814005|455977580|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
126734597|NCT03814005|455977578|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
126734598|NCT03814005|455977579|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
126734599|NCT03814005|455977580|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
126734600|NCT01855945|455977581|FG000|Overall Study|Adverse Event|0|||
126734601|NCT01855945|455977582|FG001|Overall Study|Adverse Event|0|||
126734602|NCT01855945|455977583|FG002|Overall Study|Adverse Event|0|||
126734603|NCT01855945|455977584|FG003|Overall Study|Adverse Event|0|||
126734604|NCT01855945|455977585|FG004|Overall Study|Adverse Event|0|||
126734605|NCT01855945|455977586|FG005|Overall Study|Adverse Event|0|||
126734606|NCT01855945|455977587|FG006|Overall Study|Adverse Event|1|||
126734607|NCT01855945|455977588|FG007|Overall Study|Adverse Event|0|||
126734608|NCT01855945|455977589|FG008|Overall Study|Adverse Event|0|||
126734609|NCT01855945|455977590|FG009|Overall Study|Adverse Event|0|||
126781288|NCT00358826|456154508|FG000|Core Study|Lost to Follow-up|0|||
126612717|NCT03182244|455540574|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
126612718|NCT03182244|455540575|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
126612719|NCT03182244|455540574|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
126612720|NCT03182244|455540575|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
126612721|NCT03182244|455540574|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
126612722|NCT03182244|455540575|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
126612723|NCT05169684|455540576|FG000|Overall Study|Adverse Event|1|||
126612724|NCT05169684|455540577|FG001|Overall Study|Adverse Event|3|||
126612725|NCT05169684|455540576|FG000|Overall Study|Physician Decision|0|||
126612726|NCT05169684|455540577|FG001|Overall Study|Physician Decision|1|||
126612727|NCT05169684|455540576|FG000|Overall Study|Progressive Disease|1|||
126612728|NCT05169684|455540577|FG001|Overall Study|Progressive Disease|1|||
126612729|NCT05169684|455540576|FG000|Overall Study|Participant request to discontinue treatment|0|||
126612730|NCT05169684|455540577|FG001|Overall Study|Participant request to discontinue treatment|1|||
126734610|NCT01855945|455977591|FG010|Overall Study|Adverse Event|0|||
126734611|NCT01855945|455977592|FG011|Overall Study|Adverse Event|0|||
126734612|NCT01855945|455977581|FG000|Overall Study|Death|0|||
126734613|NCT01855945|455977582|FG001|Overall Study|Death|0|||
126734614|NCT01855945|455977583|FG002|Overall Study|Death|0|||
126734615|NCT01855945|455977584|FG003|Overall Study|Death|0|||
126734616|NCT01855945|455977585|FG004|Overall Study|Death|0|||
126734617|NCT01855945|455977586|FG005|Overall Study|Death|0|||
126734618|NCT01855945|455977587|FG006|Overall Study|Death|2|||
126734619|NCT01855945|455977588|FG007|Overall Study|Death|0|||
126734620|NCT01855945|455977589|FG008|Overall Study|Death|0|||
126734621|NCT01855945|455977590|FG009|Overall Study|Death|0|||
126734622|NCT01855945|455977591|FG010|Overall Study|Death|0|||
126734623|NCT01855945|455977592|FG011|Overall Study|Death|0|||
126734624|NCT01855945|455977581|FG000|Overall Study|Lost to Follow-up|11|||
126734625|NCT01855945|455977582|FG001|Overall Study|Lost to Follow-up|10|||
126734626|NCT01855945|455977583|FG002|Overall Study|Lost to Follow-up|7|||
126734627|NCT01855945|455977584|FG003|Overall Study|Lost to Follow-up|3|||
126734628|NCT01855945|455977585|FG004|Overall Study|Lost to Follow-up|0|||
126734629|NCT01855945|455977586|FG005|Overall Study|Lost to Follow-up|3|||
126734630|NCT01855945|455977587|FG006|Overall Study|Lost to Follow-up|4|||
126734631|NCT01855945|455977588|FG007|Overall Study|Lost to Follow-up|7|||
126734632|NCT01855945|455977589|FG008|Overall Study|Lost to Follow-up|2|||
126734633|NCT01855945|455977590|FG009|Overall Study|Lost to Follow-up|0|||
126734634|NCT01855945|455977591|FG010|Overall Study|Lost to Follow-up|0|||
126734635|NCT01855945|455977592|FG011|Overall Study|Lost to Follow-up|2|||
126734636|NCT01855945|455977581|FG000|Overall Study|Other - Unclassified|1|||
126734637|NCT01855945|455977582|FG001|Overall Study|Other - Unclassified|1|||
126734638|NCT01855945|455977583|FG002|Overall Study|Other - Unclassified|1|||
126734639|NCT01855945|455977584|FG003|Overall Study|Other - Unclassified|0|||
126734640|NCT01855945|455977585|FG004|Overall Study|Other - Unclassified|0|||
126734641|NCT01855945|455977586|FG005|Overall Study|Other - Unclassified|0|||
126734642|NCT01855945|455977587|FG006|Overall Study|Other - Unclassified|2|||
126734643|NCT01855945|455977588|FG007|Overall Study|Other - Unclassified|1|||
126734644|NCT01855945|455977589|FG008|Overall Study|Other - Unclassified|0|||
126734645|NCT01855945|455977590|FG009|Overall Study|Other - Unclassified|0|||
126734646|NCT01855945|455977591|FG010|Overall Study|Other - Unclassified|1|||
126734647|NCT01855945|455977592|FG011|Overall Study|Other - Unclassified|0|||
126734648|NCT01855945|455977581|FG000|Overall Study|Withdrawal by Subject|4|||
126734649|NCT01855945|455977582|FG001|Overall Study|Withdrawal by Subject|0|||
126734650|NCT01855945|455977583|FG002|Overall Study|Withdrawal by Subject|4|||
126734651|NCT01855945|455977584|FG003|Overall Study|Withdrawal by Subject|1|||
126734652|NCT01855945|455977585|FG004|Overall Study|Withdrawal by Subject|1|||
126734653|NCT01855945|455977586|FG005|Overall Study|Withdrawal by Subject|0|||
126734654|NCT01855945|455977587|FG006|Overall Study|Withdrawal by Subject|1|||
126734655|NCT01855945|455977588|FG007|Overall Study|Withdrawal by Subject|0|||
126734656|NCT01855945|455977589|FG008|Overall Study|Withdrawal by Subject|0|||
126734657|NCT01855945|455977590|FG009|Overall Study|Withdrawal by Subject|2|||
126734658|NCT01855945|455977591|FG010|Overall Study|Withdrawal by Subject|4|||
126734659|NCT01855945|455977592|FG011|Overall Study|Withdrawal by Subject|1|||
126734660|NCT01170221|455977598|FG000|Overall Study|Lost to Follow-up|22|||
126734661|NCT01170221|455977599|FG001|Overall Study|Lost to Follow-up|21|||
126734662|NCT01170221|455977598|FG000|Overall Study|Withdrawal by Subject|9|||
126734663|NCT01170221|455977599|FG001|Overall Study|Withdrawal by Subject|7|||
126734664|NCT01170221|455977598|FG000|Overall Study|Subject completed only screening and LFU|1|||
126734665|NCT01170221|455977599|FG001|Overall Study|Subject completed only screening and LFU|0|||
126734666|NCT01170221|455977598|FG000|Overall Study|Randomized but not treated|1|||
126734667|NCT01170221|455977599|FG001|Overall Study|Randomized but not treated|0|||
126734668|NCT02247401|455977602|FG000|Overall Study|Adverse Event|1|||
126734669|NCT02247401|455977603|FG001|Overall Study|Adverse Event|0|||
126734670|NCT02247401|455977604|FG002|Overall Study|Adverse Event|0|||
126734671|NCT02247401|455977602|FG000|Overall Study|Withdrawal by Subject|4|||
126734672|NCT02247401|455977603|FG001|Overall Study|Withdrawal by Subject|1|||
126734673|NCT02247401|455977604|FG002|Overall Study|Withdrawal by Subject|1|||
126734674|NCT02247401|455977602|FG000|Overall Study|Lost to Follow-up|1|||
126734675|NCT02247401|455977603|FG001|Overall Study|Lost to Follow-up|1|||
126734676|NCT02247401|455977604|FG002|Overall Study|Lost to Follow-up|1|||
126734677|NCT00192036|455977608|FG000|Overall Study|Protocol Violation|3|||
126734678|NCT00192036|455977608|FG000|Overall Study|Adverse Event|6|||
126734679|NCT00192036|455977608|FG000|Overall Study|Patient/Physician Perception|1|||
126734680|NCT00192036|455977608|FG000|Overall Study|Objective Tumor Progression|4|||
126734681|NCT00192036|455977608|FG000|Overall Study|Clinical Disease Progression|1|||
126734682|NCT00192036|455977608|FG000|Overall Study|Death|1|||
126612731|NCT05169684|455540576|FG000|Overall Study|Other Reason|0|||
126734683|NCT00192036|455977608|FG000|Overall Study|Unknown or Not Specified|5|||
126612732|NCT05169684|455540577|FG001|Overall Study|Other Reason|1|||
126734684|NCT05425719|455977611|FG000|Overall Study|Lost to Follow-up|4|||
126734685|NCT05425719|455977612|FG001|Overall Study|Lost to Follow-up|0|||
126734686|NCT05425719|455977611|FG000|Overall Study|Withdrew consent|1|||
126734687|NCT05425719|455977612|FG001|Overall Study|Withdrew consent|1|||
126734688|NCT04682353|455977613|FG000|Overall Study|Lost to Follow-up|0|||
126734689|NCT04682353|455977614|FG001|Overall Study|Lost to Follow-up|1|||
126734690|NCT04682353|455977615|FG002|Overall Study|Lost to Follow-up|0|||
126734691|NCT04682353|455977616|FG003|Overall Study|Lost to Follow-up|1|||
126734692|NCT04682353|455977613|FG000|Overall Study|Personal reasons|0|||
126734693|NCT04682353|455977614|FG001|Overall Study|Personal reasons|1|||
126734694|NCT04682353|455977615|FG002|Overall Study|Personal reasons|0|||
126734695|NCT04682353|455977616|FG003|Overall Study|Personal reasons|0|||
126734696|NCT01586806|455977617|FG000|Overall Study|Protocol Violation|0|||
126734697|NCT01586806|455977618|FG001|Overall Study|Protocol Violation|1|||
126734698|NCT01586806|455977619|FG002|Overall Study|Protocol Violation|0|||
126734699|NCT01586806|455977617|FG000|Overall Study|Withdrawal by Subject|1|||
126734700|NCT01586806|455977618|FG001|Overall Study|Withdrawal by Subject|0|||
126734701|NCT01586806|455977619|FG002|Overall Study|Withdrawal by Subject|0|||
126734702|NCT01586806|455977617|FG000|Overall Study|Lost to Follow-up|2|||
126734703|NCT01586806|455977618|FG001|Overall Study|Lost to Follow-up|3|||
126734704|NCT01586806|455977619|FG002|Overall Study|Lost to Follow-up|2|||
126734705|NCT00862654|455977620|FG000|Overall Study|Lack of Efficacy|1|||
126734706|NCT00862654|455977621|FG001|Overall Study|Lack of Efficacy|0|||
126734707|NCT00862654|455977622|FG002|Overall Study|Lack of Efficacy|1|||
126734708|NCT00862654|455977623|FG003|Overall Study|Lack of Efficacy|0|||
126734709|NCT00862654|455977620|FG000|Overall Study|Lost to Follow-up|1|||
126734710|NCT00862654|455977621|FG001|Overall Study|Lost to Follow-up|2|||
126734711|NCT00862654|455977622|FG002|Overall Study|Lost to Follow-up|1|||
126734712|NCT00862654|455977623|FG003|Overall Study|Lost to Follow-up|3|||
126734713|NCT00862654|455977620|FG000|Overall Study|Adverse Event|0|||
126734714|NCT00862654|455977621|FG001|Overall Study|Adverse Event|1|||
126734715|NCT00862654|455977622|FG002|Overall Study|Adverse Event|1|||
126734716|NCT00862654|455977623|FG003|Overall Study|Adverse Event|0|||
126734717|NCT00862654|455977620|FG000|Overall Study|Pregnancy|1|||
126734718|NCT00862654|455977621|FG001|Overall Study|Pregnancy|1|||
126734719|NCT00862654|455977622|FG002|Overall Study|Pregnancy|0|||
126734720|NCT00862654|455977623|FG003|Overall Study|Pregnancy|0|||
126734721|NCT00862654|455977620|FG000|Overall Study|Withdrawal by Subject|2|||
126734722|NCT00862654|455977621|FG001|Overall Study|Withdrawal by Subject|2|||
126734723|NCT00862654|455977622|FG002|Overall Study|Withdrawal by Subject|2|||
126734724|NCT00862654|455977623|FG003|Overall Study|Withdrawal by Subject|3|||
126734725|NCT00862654|455977620|FG000|Overall Study|Subject mistake|0|||
126734726|NCT00862654|455977621|FG001|Overall Study|Subject mistake|1|||
126734727|NCT00862654|455977622|FG002|Overall Study|Subject mistake|0|||
126734728|NCT00862654|455977623|FG003|Overall Study|Subject mistake|0|||
126734729|NCT00862654|455977620|FG000|Overall Study|Familly constraint|0|||
126734730|NCT00862654|455977621|FG001|Overall Study|Familly constraint|1|||
126734731|NCT00862654|455977622|FG002|Overall Study|Familly constraint|0|||
126734732|NCT00862654|455977623|FG003|Overall Study|Familly constraint|0|||
126734733|NCT00862654|455977620|FG000|Overall Study|Never used study drugs|1|||
126734734|NCT00862654|455977621|FG001|Overall Study|Never used study drugs|0|||
126734735|NCT00862654|455977622|FG002|Overall Study|Never used study drugs|0|||
126734736|NCT00862654|455977623|FG003|Overall Study|Never used study drugs|0|||
126734737|NCT00862654|455977620|FG000|Overall Study|Included after end of inclusions|0|||
126734738|NCT00862654|455977621|FG001|Overall Study|Included after end of inclusions|0|||
126734739|NCT00862654|455977622|FG002|Overall Study|Included after end of inclusions|1|||
126734740|NCT00862654|455977623|FG003|Overall Study|Included after end of inclusions|0|||
126734741|NCT03219567|455977629|FG000|Overall Study|Withdrawal by Subject|0|||
126734742|NCT03219567|455977630|FG001|Overall Study|Withdrawal by Subject|1|||
126734743|NCT02394795|455977631|FG000|Overall Study|Adverse Event|92|||
126734744|NCT02394795|455977632|FG001|Overall Study|Adverse Event|70|||
126734745|NCT02394795|455977631|FG000|Overall Study|Lost to Follow-up|0|||
126734746|NCT02394795|455977632|FG001|Overall Study|Lost to Follow-up|1|||
126734747|NCT02394795|455977631|FG000|Overall Study|Withdrawal by Subject|17|||
126734748|NCT02394795|455977632|FG001|Overall Study|Withdrawal by Subject|26|||
126734749|NCT02394795|455977631|FG000|Overall Study|Lack of Efficacy|181|||
126734750|NCT02394795|455977632|FG001|Overall Study|Lack of Efficacy|211|||
126781289|NCT00358826|456154509|FG001|Core Study|Lost to Follow-up|0|||
126781290|NCT00358826|456154510|FG002|Core Study|Lost to Follow-up|0|||
126781291|NCT00358826|456154511|FG003|Core Study|Lost to Follow-up|1|||
126781292|NCT00358826|456154512|FG004|Core Study|Lost to Follow-up|0|||
126781293|NCT00358826|456154513|FG005|Core Study|Lost to Follow-up|0|||
126781294|NCT00358826|456154514|FG006|Core Study|Lost to Follow-up|0|||
126612733|NCT03539055|455540578|FG000|Overall Study|Death|4|||
126612734|NCT03539055|455540578|FG000|Overall Study|Lost to Follow-up|1|||
126734751|NCT02394795|455977631|FG000|Overall Study|Death|4|||
126781295|NCT00358826|456154515|FG007|Core Study|Lost to Follow-up|0|||
126781296|NCT00358826|456154508|FG000|Core Study|Physician Decision|0|||
126781297|NCT00358826|456154509|FG001|Core Study|Physician Decision|0|||
126734752|NCT02394795|455977632|FG001|Overall Study|Death|5|||
126734753|NCT02394795|455977631|FG000|Overall Study|Physician Decision|109|||
126734754|NCT02394795|455977632|FG001|Overall Study|Physician Decision|93|||
126734755|NCT04377672|455977639|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
126781298|NCT00358826|456154510|FG002|Core Study|Physician Decision|1|||
126734756|NCT03954444|455977640|FG000|Overall Study|Withdrawal by Subject|5|||
126734757|NCT03954444|455977641|FG001|Overall Study|Withdrawal by Subject|5|||
126734758|NCT03954444|455977642|FG002|Overall Study|Withdrawal by Subject|5|||
126734759|NCT03954444|455977640|FG000|Overall Study|Adverse Event|1|||
126734760|NCT03954444|455977641|FG001|Overall Study|Adverse Event|3|||
126734761|NCT03954444|455977642|FG002|Overall Study|Adverse Event|2|||
126734762|NCT03954444|455977640|FG000|Overall Study|Protocol Violation|0|||
126734763|NCT03954444|455977641|FG001|Overall Study|Protocol Violation|3|||
126734764|NCT03954444|455977642|FG002|Overall Study|Protocol Violation|5|||
126734765|NCT03954444|455977640|FG000|Overall Study|Use of prohibited therapy|1|||
126734766|NCT03954444|455977641|FG001|Overall Study|Use of prohibited therapy|1|||
126734767|NCT03954444|455977642|FG002|Overall Study|Use of prohibited therapy|2|||
126734768|NCT03954444|455977640|FG000|Overall Study|Lost to Follow-up|1|||
126734769|NCT03954444|455977641|FG001|Overall Study|Lost to Follow-up|0|||
126734770|NCT03954444|455977642|FG002|Overall Study|Lost to Follow-up|1|||
126734771|NCT03954444|455977640|FG000|Overall Study|Non-compliant with study drug application|2|||
126734772|NCT03954444|455977641|FG001|Overall Study|Non-compliant with study drug application|2|||
126734773|NCT03954444|455977642|FG002|Overall Study|Non-compliant with study drug application|0|||
126734774|NCT03954444|455977640|FG000|Overall Study|Administrative reasons|0|||
126734775|NCT03954444|455977641|FG001|Overall Study|Administrative reasons|0|||
126734776|NCT03954444|455977642|FG002|Overall Study|Administrative reasons|1|||
126734777|NCT03954444|455977640|FG000|Overall Study|Miscellaneous|3|||
126734778|NCT03954444|455977641|FG001|Overall Study|Miscellaneous|2|||
126734779|NCT03954444|455977642|FG002|Overall Study|Miscellaneous|1|||
126734780|NCT02447458|455977645|FG000|Overall Study|Other|0|||
126734781|NCT02447458|455977646|FG001|Overall Study|Other|0|||
126734782|NCT02447458|455977647|FG002|Overall Study|Other|1|||
126734783|NCT02447458|455977648|FG003|Overall Study|Other|0|||
126734784|NCT02447458|455977649|FG004|Overall Study|Other|0|||
126734785|NCT02447458|455977650|FG005|Overall Study|Other|0|||
126734786|NCT02133742|455977651|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
126734787|NCT02133742|455977651|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
126734788|NCT02133742|455977651|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
126734789|NCT02133742|455977651|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
126734790|NCT02133742|455977651|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
126734791|NCT03505749|455977652|FG000|Overall Study|Lost to Follow-up|7|||
126734792|NCT03505749|455977653|FG001|Overall Study|Lost to Follow-up|11|||
126734793|NCT03505749|455977652|FG000|Overall Study|Withdrawal by Subject|6|||
126734794|NCT03505749|455977653|FG001|Overall Study|Withdrawal by Subject|0|||
126734795|NCT03505749|455977652|FG000|Overall Study|Discharged from treatment|3|||
126734796|NCT03505749|455977653|FG001|Overall Study|Discharged from treatment|6|||
126734797|NCT03846219|455977655|FG000|Overall Study|Withdrawal by Subject|3|||
126734798|NCT03846219|455977656|FG001|Overall Study|Withdrawal by Subject|2|||
126734799|NCT03846219|455977657|FG002|Overall Study|Withdrawal by Subject|2|||
126734800|NCT03846219|455977655|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
126734801|NCT03846219|455977656|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
126734802|NCT03846219|455977657|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
126734803|NCT03846219|455977655|FG000|Overall Study|Physician Decision|0|||
126734804|NCT03846219|455977656|FG001|Overall Study|Physician Decision|0|||
126734805|NCT03846219|455977657|FG002|Overall Study|Physician Decision|2|||
126734806|NCT01688635|455977658|FG000|Washout 1|Withdrawal by Subject|1|||
126734807|NCT01688635|455977659|FG001|Washout 1|Withdrawal by Subject|0|||
126734808|NCT01688635|455977658|FG000|Washout 1|Adverse Event|0|||
126734809|NCT01688635|455977659|FG001|Washout 1|Adverse Event|1|||
126734810|NCT01688635|455977658|FG000|Washout 1|Physician Decision|0|||
126734811|NCT01688635|455977659|FG001|Washout 1|Physician Decision|1|||
126734812|NCT01688635|455977658|FG000|Washout 2|Physician Decision|1|||
126734813|NCT01688635|455977659|FG001|Washout 2|Physician Decision|0|||
126734814|NCT01688635|455977658|FG000|Washout 2|Withdrawal by Subject|1|||
126781299|NCT00358826|456154511|FG003|Core Study|Physician Decision|0|||
126612735|NCT03539055|455540578|FG000|Overall Study|Withdrawal by Subject|2|||
126612736|NCT03539055|455540578|FG000|Overall Study|Screen Fail|7|||
126612737|NCT03539055|455540578|FG000|Overall Study|Drug Intolerance|2|||
126612738|NCT02060487|455540579|FG000|Overall Study|Other|1|||
126612739|NCT02060487|455540580|FG001|Overall Study|Other|2|||
126612740|NCT02060487|455540581|FG002|Overall Study|Other|1|||
126612741|NCT02060487|455540579|FG000|Overall Study|Lack of Efficacy|0|||
126612742|NCT02060487|455540580|FG001|Overall Study|Lack of Efficacy|1|||
126612743|NCT02060487|455540581|FG002|Overall Study|Lack of Efficacy|0|||
126734815|NCT01688635|455977659|FG001|Washout 2|Withdrawal by Subject|0|||
126734816|NCT01688635|455977658|FG000|Washout 2|Sponsor Decision|1|||
126781300|NCT00358826|456154512|FG004|Core Study|Physician Decision|0|||
126734817|NCT01688635|455977659|FG001|Washout 2|Sponsor Decision|2|||
126734818|NCT01688635|455977658|FG000|Washout 3|Withdrawal by Subject|1|||
126734819|NCT01688635|455977659|FG001|Washout 3|Withdrawal by Subject|0|||
126734820|NCT03549117|455977663|FG000|Overall Study|Withdrawal by Subject|1|||
126734821|NCT03549117|455977664|FG001|Overall Study|Withdrawal by Subject|0|||
126734822|NCT01924299|455977665|FG000|Period 2|Withdrawal by Subject|1|||
126612744|NCT02060487|455540579|FG000|Overall Study|Withdrawal by Subject|3|||
126612745|NCT02060487|455540580|FG001|Overall Study|Withdrawal by Subject|10|||
126612746|NCT02060487|455540581|FG002|Overall Study|Withdrawal by Subject|4|||
126612747|NCT02060487|455540579|FG000|Overall Study|Study Terminated By Sponsor|87|||
126612748|NCT02060487|455540580|FG001|Overall Study|Study Terminated By Sponsor|89|||
126612749|NCT02060487|455540581|FG002|Overall Study|Study Terminated By Sponsor|100|||
126612750|NCT02060487|455540579|FG000|Overall Study|Randomized in error|1|||
126612751|NCT02060487|455540580|FG001|Overall Study|Randomized in error|0|||
126612752|NCT02060487|455540581|FG002|Overall Study|Randomized in error|0|||
126612753|NCT02060487|455540579|FG000|Overall Study|Protocol Violation|0|||
126612754|NCT02060487|455540580|FG001|Overall Study|Protocol Violation|1|||
126612755|NCT02060487|455540581|FG002|Overall Study|Protocol Violation|1|||
126612756|NCT02060487|455540579|FG000|Overall Study|Lost to Follow-up|3|||
126612757|NCT02060487|455540580|FG001|Overall Study|Lost to Follow-up|0|||
126612758|NCT02060487|455540581|FG002|Overall Study|Lost to Follow-up|2|||
126612759|NCT02060487|455540579|FG000|Overall Study|Death|34|||
126612760|NCT02060487|455540580|FG001|Overall Study|Death|25|||
126612761|NCT02060487|455540581|FG002|Overall Study|Death|19|||
126612762|NCT02060487|455540579|FG000|Overall Study|Adverse Event|0|||
126612763|NCT02060487|455540580|FG001|Overall Study|Adverse Event|0|||
126612764|NCT02060487|455540581|FG002|Overall Study|Adverse Event|1|||
126612765|NCT05484661|455540582|FG000|Overall Study|Withdrawal by Subject|1|||
126612766|NCT05484661|455540583|FG001|Overall Study|Withdrawal by Subject|0|||
126612767|NCT02950961|455540585|FG000|Overall Study|Study had to stop due to COVID.|7|||
126612768|NCT02241785|455540586|FG000|Overall Study|Sponsor Termination|43|||
126612769|NCT02241785|455540586|FG000|Overall Study|Withdrawal by Subject|1|||
126612770|NCT02241785|455540586|FG000|Overall Study|Lost to Follow-up|2|||
126612771|NCT02241785|455540586|FG000|Overall Study|Adverse Event|1|||
126612772|NCT03055988|455540589|FG000|Period 1|Adverse Event|0|||
126612773|NCT03055988|455540590|FG001|Period 1|Adverse Event|1|||
126612774|NCT03055988|455540589|FG000|Period 1|Lost to Follow-up|1|||
126612775|NCT03055988|455540590|FG001|Period 1|Lost to Follow-up|0|||
126612776|NCT03055988|455540589|FG000|Period 1|Withdrawal by Subject|0|||
126612777|NCT03055988|455540590|FG001|Period 1|Withdrawal by Subject|4|||
126612778|NCT03055988|455540589|FG000|Period 2|Adverse Event|0|||
126612779|NCT03055988|455540590|FG001|Period 2|Adverse Event|1|||
126612780|NCT03055988|455540589|FG000|Period 2|Other than listed|1|||
126612781|NCT03055988|455540590|FG001|Period 2|Other than listed|1|||
126612782|NCT00845520|455540591|FG000|Overall Study|Death|1|||
126612783|NCT00845520|455540592|FG001|Overall Study|Death|2|||
126612784|NCT00845520|455540593|FG002|Overall Study|Death|0|||
126612785|NCT00845520|455540591|FG000|Overall Study|Lost to Follow-up|1|||
126612786|NCT00845520|455540592|FG001|Overall Study|Lost to Follow-up|0|||
126612787|NCT00845520|455540593|FG002|Overall Study|Lost to Follow-up|0|||
126612788|NCT00845520|455540591|FG000|Overall Study|Adverse Event|0|||
126612789|NCT00845520|455540592|FG001|Overall Study|Adverse Event|0|||
126612790|NCT00845520|455540593|FG002|Overall Study|Adverse Event|1|||
126612791|NCT01736475|455540594|FG000|Overall Study|Adverse Event|4|||
126612792|NCT01736475|455540595|FG001|Overall Study|Adverse Event|0|||
126612793|NCT01736475|455540594|FG000|Overall Study|Withdrawal by Subject|2|||
126612794|NCT01736475|455540595|FG001|Overall Study|Withdrawal by Subject|0|||
126612795|NCT01736475|455540594|FG000|Overall Study|Protocol Violation|4|||
126612796|NCT01736475|455540595|FG001|Overall Study|Protocol Violation|0|||
126612797|NCT01736475|455540594|FG000|Overall Study|Other - Screen failure|1|||
126612798|NCT01736475|455540595|FG001|Overall Study|Other - Screen failure|0|||
126612799|NCT01736475|455540594|FG000|Overall Study|Other - Surgical procedure|1|||
126612800|NCT01736475|455540595|FG001|Overall Study|Other - Surgical procedure|0|||
126612801|NCT02807857|455540596|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
126612802|NCT02807857|455540596|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
126612803|NCT02807857|455540596|FG000|Follow-Up Set|Withdrawal by Subject|8|||
126612804|NCT02807857|455540596|FG000|Follow-Up Set|Lost to Follow-up|7|||
126612805|NCT02807857|455540596|FG000|Follow-Up Set|Physician Decision|6|||
126612806|NCT02807857|455540596|FG000|Follow-Up Set|Adverse Event|3|||
126612807|NCT02807857|455540596|FG000|Follow-Up Set|Death|27|||
126612808|NCT02807857|455540596|FG000|Follow-Up Set|Relocation|2|||
126612809|NCT03905642|455540598|FG000|Overall Study|Withdrawal by Subject|3|||
126612810|NCT03905642|455540598|FG000|Overall Study|Pregnancy|1|||
126612811|NCT03905642|455540598|FG000|Overall Study|Adverse Event|1|||
126612812|NCT03905642|455540598|FG000|Overall Study|Lack of Efficacy|1|||
126612813|NCT03905642|455540598|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
126612814|NCT02014402|455542253|FG000|Overall Study|Adverse Event|1|||
126612815|NCT02014402|455542254|FG001|Overall Study|Adverse Event|0|||
126612816|NCT02014402|455542255|FG002|Overall Study|Adverse Event|0|||
126612817|NCT02014402|455542256|FG003|Overall Study|Adverse Event|0|||
126612818|NCT02014402|455542253|FG000|Overall Study|Withdrawal by Subject|1|||
126612819|NCT02014402|455542254|FG001|Overall Study|Withdrawal by Subject|2|||
126612820|NCT02014402|455542255|FG002|Overall Study|Withdrawal by Subject|2|||
126612821|NCT02014402|455542256|FG003|Overall Study|Withdrawal by Subject|1|||
126612822|NCT02014402|455542253|FG000|Overall Study|Subject did not have transportation|0|||
126612823|NCT02014402|455542254|FG001|Overall Study|Subject did not have transportation|1|||
126612824|NCT02014402|455542255|FG002|Overall Study|Subject did not have transportation|0|||
126734823|NCT01924299|455977666|FG001|Period 2|Withdrawal by Subject|0|||
126734824|NCT01924299|455977665|FG000|Period 2|Adverse Event|0|||
126734825|NCT01924299|455977666|FG001|Period 2|Adverse Event|1|||
126734826|NCT00888615|455977671|FG000|Overall Study|No treatment|2|||
126734827|NCT02293902|455977674|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
126734828|NCT02293902|455977675|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
126734829|NCT02293902|455977676|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
126734830|NCT02293902|455977677|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
126734831|NCT02293902|455977678|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
126734832|NCT02293902|455977674|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
126734833|NCT02293902|455977675|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
126734834|NCT02293902|455977676|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
126734835|NCT02293902|455977677|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
126734836|NCT02293902|455977678|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
126734837|NCT02293902|455977674|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
126734838|NCT02293902|455977675|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
126734839|NCT02293902|455977676|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
126734840|NCT02293902|455977677|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
126734841|NCT02293902|455977678|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
126734842|NCT02293902|455977674|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
126734843|NCT02293902|455977675|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
126734844|NCT02293902|455977676|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
126734845|NCT02293902|455977677|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
126734846|NCT02293902|455977678|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
126734847|NCT02293902|455977674|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
126734848|NCT02293902|455977675|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
126734849|NCT02293902|455977676|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
126734850|NCT02293902|455977677|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
126734851|NCT02293902|455977678|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
126734852|NCT02947022|455977679|FG000|Overall Study|Study Stopped|1|||
126734853|NCT02905825|455979341|FG000|Overall Study|Protocol Violation|11|||
126734854|NCT02905825|455979341|FG000|Overall Study|Device Malfunction|1|||
126734855|NCT01281189|455979342|FG000|Overall Study|Adverse Event|7|||
126734856|NCT01281189|455979343|FG001|Overall Study|Adverse Event|9|||
126734857|NCT01281189|455979342|FG000|Overall Study|Lost to Follow-up|6|||
126734858|NCT01281189|455979343|FG001|Overall Study|Lost to Follow-up|4|||
126734859|NCT01281189|455979342|FG000|Overall Study|Withdrawal by Subject|21|||
126734860|NCT01281189|455979343|FG001|Overall Study|Withdrawal by Subject|24|||
126734861|NCT01281189|455979342|FG000|Overall Study|Physician Decision|2|||
126734862|NCT01281189|455979343|FG001|Overall Study|Physician Decision|3|||
126734863|NCT01281189|455979342|FG000|Overall Study|Death|103|||
126734864|NCT01281189|455979343|FG001|Overall Study|Death|91|||
126734865|NCT01281189|455979342|FG000|Overall Study|Other|8|||
126734866|NCT01281189|455979343|FG001|Overall Study|Other|12|||
126734867|NCT05355818|455979344|FG000|Overall Study|Adverse Event|1|||
126734868|NCT05355818|455979345|FG001|Overall Study|Adverse Event|1|||
126734869|NCT05355818|455979344|FG000|Overall Study|Lack of Efficacy|2|||
126734870|NCT05355818|455979345|FG001|Overall Study|Lack of Efficacy|1|||
126734871|NCT05355818|455979344|FG000|Overall Study|Lost to Follow-up|0|||
126734872|NCT05355818|455979345|FG001|Overall Study|Lost to Follow-up|1|||
126734873|NCT00092677|455979350|FG000|Overall Study|Lost to Follow-up|0|||
126734874|NCT00092677|455979351|FG001|Overall Study|Lost to Follow-up|2|||
126734875|NCT00092677|455979350|FG000|Overall Study|Adminstrative|5|||
126734876|NCT00092677|455979351|FG001|Overall Study|Adminstrative|9|||
126734877|NCT00010803|455979355|FG000|Overall Study|Withdrawal by Subject|97|||
126734878|NCT00010803|455979356|FG001|Overall Study|Withdrawal by Subject|98|||
126781301|NCT00358826|456154513|FG005|Core Study|Physician Decision|0|||
126781302|NCT00358826|456154514|FG006|Core Study|Physician Decision|0|||
126781303|NCT00358826|456154515|FG007|Core Study|Physician Decision|0|||
126781304|NCT00358826|456154508|FG000|MDCT Substudy|Adverse Event|0|||
126781305|NCT00358826|456154509|FG001|MDCT Substudy|Adverse Event|0|||
126781306|NCT00358826|456154510|FG002|MDCT Substudy|Adverse Event|0|||
126781307|NCT00358826|456154511|FG003|MDCT Substudy|Adverse Event|0|||
126781308|NCT00358826|456154512|FG004|MDCT Substudy|Adverse Event|1|||
126612825|NCT02014402|455542256|FG003|Overall Study|Subject did not have transportation|0|||
126612826|NCT02014402|455542253|FG000|Overall Study|Lost to Follow-up|0|||
126612827|NCT02014402|455542254|FG001|Overall Study|Lost to Follow-up|0|||
126734879|NCT01019252|455979357|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
126734880|NCT01019252|455979358|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
126734881|NCT01019252|455979357|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
126734882|NCT01019252|455979358|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
126734883|NCT01019252|455979357|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
126734884|NCT01019252|455979358|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
126781309|NCT00358826|456154513|FG005|MDCT Substudy|Adverse Event|0|||
126734885|NCT01019252|455979357|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
126734886|NCT01019252|455979358|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
126734887|NCT04671342|455979359|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
126734888|NCT04671342|455979359|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
126734889|NCT04671342|455979359|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
126734890|NCT04671342|455979359|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
126734891|NCT04671342|455979359|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
126734892|NCT04671342|455979359|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
126734893|NCT02273037|455979360|FG000|Overall Study|Lost to Follow-up|1|||
126734894|NCT02273037|455979361|FG001|Overall Study|Lost to Follow-up|0|||
126734895|NCT02273037|455979360|FG000|Overall Study|Delivered before monitoring initiated|1|||
126734896|NCT02273037|455979361|FG001|Overall Study|Delivered before monitoring initiated|3|||
126734897|NCT02273037|455979360|FG000|Overall Study|Breech delivery|2|||
126734898|NCT02273037|455979361|FG001|Overall Study|Breech delivery|3|||
126734899|NCT02273037|455979360|FG000|Overall Study|Multiple delivery|2|||
126734900|NCT02273037|455979361|FG001|Overall Study|Multiple delivery|2|||
126734901|NCT02273037|455979360|FG000|Overall Study|Other complication|2|||
126734902|NCT02273037|455979361|FG001|Overall Study|Other complication|0|||
126734903|NCT03351478|455979364|FG000|Overall Study|At the subject's own request|11|||
126734904|NCT03351478|455979365|FG001|Overall Study|At the subject's own request|12|||
126734905|NCT03351478|455979366|FG002|Overall Study|At the subject's own request|5|||
126734906|NCT03351478|455979364|FG000|Overall Study|Adverse Event|1|||
126734907|NCT03351478|455979365|FG001|Overall Study|Adverse Event|2|||
126734908|NCT03351478|455979366|FG002|Overall Study|Adverse Event|1|||
126734909|NCT03351478|455979364|FG000|Overall Study|Poor compliance to protocol|1|||
126734910|NCT03351478|455979365|FG001|Overall Study|Poor compliance to protocol|0|||
126734911|NCT03351478|455979366|FG002|Overall Study|Poor compliance to protocol|0|||
126734912|NCT03351478|455979364|FG000|Overall Study|Reason not Specified|1|||
126734913|NCT03351478|455979365|FG001|Overall Study|Reason not Specified|3|||
126734914|NCT03351478|455979366|FG002|Overall Study|Reason not Specified|0|||
126734915|NCT03351478|455979364|FG000|Overall Study|Lost to Follow-up|0|||
126734916|NCT03351478|455979365|FG001|Overall Study|Lost to Follow-up|0|||
126734917|NCT03351478|455979366|FG002|Overall Study|Lost to Follow-up|1|||
126734918|NCT00762268|455979370|FG000|Overall Study|Withdrawal by Subject|3|||
126734919|NCT00762268|455979371|FG001|Overall Study|Withdrawal by Subject|3|||
126734920|NCT01438307|455979376|FG000|Overall Study|Death|1|||
126734921|NCT01438307|455979377|FG001|Overall Study|Death|1|||
126734922|NCT03395223|455979380|FG000|Overall Study|Lost to Follow-up|3|||
126734923|NCT03395223|455979380|FG000|Overall Study|Other|1|||
126734924|NCT01135017|455979386|FG000|Overall Study|Adverse Event|3|||
126734925|NCT01135017|455979387|FG001|Overall Study|Adverse Event|8|||
126734926|NCT01135017|455979386|FG000|Overall Study|Other than above|3|||
126734927|NCT01135017|455979387|FG001|Overall Study|Other than above|4|||
126734928|NCT01148693|455979388|FG000|Overall Study|Attempts for cannulation were failed|13|||
126734929|NCT01148693|455979389|FG001|Overall Study|Attempts for cannulation were failed|10|||
126734930|NCT01074658|455979390|FG000|Overall Study|No implant attempted|19|||
126734931|NCT01342952|455979391|FG000|Overall Study|Adverse Event|0|||
126734932|NCT01342952|455979392|FG001|Overall Study|Adverse Event|5|||
126734933|NCT01342952|455979393|FG002|Overall Study|Adverse Event|1|||
126734934|NCT01342952|455979394|FG003|Overall Study|Adverse Event|0|||
126734935|NCT01342952|455979391|FG000|Overall Study|Lost to Follow-up|0|||
126734936|NCT01342952|455979392|FG001|Overall Study|Lost to Follow-up|2|||
126734937|NCT01342952|455979393|FG002|Overall Study|Lost to Follow-up|0|||
126734938|NCT01342952|455979394|FG003|Overall Study|Lost to Follow-up|0|||
126734939|NCT01342952|455979391|FG000|Overall Study|Withdrawal by Subject|1|||
126734940|NCT01342952|455979392|FG001|Overall Study|Withdrawal by Subject|1|||
126734941|NCT01342952|455979393|FG002|Overall Study|Withdrawal by Subject|0|||
126734942|NCT01342952|455979394|FG003|Overall Study|Withdrawal by Subject|0|||
126734943|NCT01342952|455979391|FG000|Overall Study|Physician Decision|3|||
126734944|NCT01342952|455979392|FG001|Overall Study|Physician Decision|3|||
126734945|NCT01342952|455979393|FG002|Overall Study|Physician Decision|1|||
126781310|NCT00358826|456154514|FG006|MDCT Substudy|Adverse Event|0|||
126612828|NCT02014402|455542255|FG002|Overall Study|Lost to Follow-up|1|||
126612829|NCT02014402|455542256|FG003|Overall Study|Lost to Follow-up|2|||
126734946|NCT01342952|455979394|FG003|Overall Study|Physician Decision|0|||
126734947|NCT02156804|455979395|FG000|Overall Study|Withdrawal by Subject|1|||
126734948|NCT03228394|455979396|FG000|Overall Study|Lost to Follow-up|0|||
126734949|NCT03228394|455979397|FG001|Overall Study|Lost to Follow-up|0|||
126734950|NCT03228394|455979398|FG002|Overall Study|Lost to Follow-up|1|||
126734951|NCT03228394|455979399|FG003|Overall Study|Lost to Follow-up|1|||
126734952|NCT03228394|455979400|FG004|Overall Study|Lost to Follow-up|0|||
126734953|NCT03228394|455979401|FG005|Overall Study|Lost to Follow-up|0|||
126734954|NCT03228394|455979402|FG006|Overall Study|Lost to Follow-up|2|||
126734955|NCT03228394|455979403|FG007|Overall Study|Lost to Follow-up|0|||
126734956|NCT03228394|455979396|FG000|Overall Study|Withdrawal by Subject|0|||
126734957|NCT03228394|455979397|FG001|Overall Study|Withdrawal by Subject|0|||
126734958|NCT03228394|455979398|FG002|Overall Study|Withdrawal by Subject|1|||
126734959|NCT03228394|455979399|FG003|Overall Study|Withdrawal by Subject|0|||
126734960|NCT03228394|455979400|FG004|Overall Study|Withdrawal by Subject|0|||
126734961|NCT03228394|455979401|FG005|Overall Study|Withdrawal by Subject|0|||
126734962|NCT03228394|455979402|FG006|Overall Study|Withdrawal by Subject|1|||
126734963|NCT03228394|455979403|FG007|Overall Study|Withdrawal by Subject|3|||
126734964|NCT03228394|455979396|FG000|Overall Study|Protocol Violation|0|||
126734965|NCT03228394|455979397|FG001|Overall Study|Protocol Violation|0|||
126734966|NCT03228394|455979398|FG002|Overall Study|Protocol Violation|0|||
126734967|NCT03228394|455979399|FG003|Overall Study|Protocol Violation|1|||
126734968|NCT03228394|455979400|FG004|Overall Study|Protocol Violation|0|||
126734969|NCT03228394|455979401|FG005|Overall Study|Protocol Violation|0|||
126734970|NCT03228394|455979402|FG006|Overall Study|Protocol Violation|0|||
126734971|NCT03228394|455979403|FG007|Overall Study|Protocol Violation|0|||
126734972|NCT03228394|455979396|FG000|Overall Study|Physician Decision|0|||
126734973|NCT03228394|455979397|FG001|Overall Study|Physician Decision|0|||
126734974|NCT03228394|455979398|FG002|Overall Study|Physician Decision|0|||
126734975|NCT03228394|455979399|FG003|Overall Study|Physician Decision|0|||
126734976|NCT03228394|455979400|FG004|Overall Study|Physician Decision|0|||
126734977|NCT03228394|455979401|FG005|Overall Study|Physician Decision|0|||
126734978|NCT03228394|455979402|FG006|Overall Study|Physician Decision|1|||
126734979|NCT03228394|455979403|FG007|Overall Study|Physician Decision|0|||
126734980|NCT03228394|455979396|FG000|Overall Study|Noncompliance|0|||
126734981|NCT03228394|455979397|FG001|Overall Study|Noncompliance|0|||
126734982|NCT03228394|455979398|FG002|Overall Study|Noncompliance|0|||
126734983|NCT03228394|455979399|FG003|Overall Study|Noncompliance|0|||
126734984|NCT03228394|455979400|FG004|Overall Study|Noncompliance|0|||
126734985|NCT03228394|455979401|FG005|Overall Study|Noncompliance|0|||
126734986|NCT03228394|455979402|FG006|Overall Study|Noncompliance|1|||
126734987|NCT03228394|455979403|FG007|Overall Study|Noncompliance|0|||
126734988|NCT04581863|455979404|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
126734989|NCT04581863|455979405|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
126734990|NCT01803711|455979406|FG000|Overall Study|Adverse Event|1|||
126734991|NCT01803711|455979407|FG001|Overall Study|Adverse Event|1|||
126734992|NCT00432562|455979411|FG000|Overall Study|Death|3|||
126734993|NCT00432562|455979412|FG001|Overall Study|Death|0|||
126734994|NCT02693691|455979413|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
126734995|NCT02693691|455979413|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
126734996|NCT02693691|455979413|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
126734997|NCT02693691|455979413|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
126734998|NCT02693691|455979413|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
126734999|NCT02693691|455979413|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
126735000|NCT02693691|455979413|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
126735001|NCT00636441|455979415|FG000|Overall Study|Adverse Event|0|||
126735002|NCT00636441|455979416|FG001|Overall Study|Adverse Event|1|||
126735003|NCT00636441|455979417|FG002|Overall Study|Adverse Event|1|||
126735004|NCT00636441|455979418|FG003|Overall Study|Adverse Event|0|||
126735005|NCT00636441|455979419|FG004|Overall Study|Adverse Event|0|||
126735006|NCT00636441|455979420|FG005|Overall Study|Adverse Event|1|||
126735007|NCT00636441|455979421|FG006|Overall Study|Adverse Event|0|||
126735008|NCT00636441|455979415|FG000|Overall Study|Late, ineligible|0|||
126735009|NCT00636441|455979416|FG001|Overall Study|Late, ineligible|0|||
126735010|NCT00636441|455979417|FG002|Overall Study|Late, ineligible|0|||
126735011|NCT00636441|455979418|FG003|Overall Study|Late, ineligible|0|||
126735012|NCT00636441|455979419|FG004|Overall Study|Late, ineligible|0|||
126735013|NCT00636441|455979420|FG005|Overall Study|Late, ineligible|0|||
126735014|NCT00636441|455979421|FG006|Overall Study|Late, ineligible|1|||
126735015|NCT00636441|455979415|FG000|Overall Study|Screen Failure|0|||
126735016|NCT00636441|455979416|FG001|Overall Study|Screen Failure|0|||
126735017|NCT00636441|455979417|FG002|Overall Study|Screen Failure|0|||
126735018|NCT00636441|455979418|FG003|Overall Study|Screen Failure|0|||
126735019|NCT00636441|455979419|FG004|Overall Study|Screen Failure|0|||
126612830|NCT04633200|455542257|FG000|Overall Study|Lost to Follow-up|3|||
126612831|NCT04633200|455542258|FG001|Overall Study|Lost to Follow-up|5|||
126612832|NCT01190124|455542259|FG000|Overall Study|Death|3|||
126735020|NCT00636441|455979420|FG005|Overall Study|Screen Failure|0|||
126735021|NCT00636441|455979421|FG006|Overall Study|Screen Failure|17|||
126735022|NCT01162304|455979422|FG000|Overall Study|Beck scale to high|11|||
126735023|NCT04169061|455979424|FG000|Overall Study|Adverse Event|2|||
126735024|NCT04169061|455979424|FG000|Overall Study|Death|1|||
126735025|NCT04169061|455979424|FG000|Overall Study|Withdrawal by Subject|1|||
126735026|NCT04169061|455979424|FG000|Overall Study|Protocol Violation|1|||
126735027|NCT00844285|455979425|FG000|Overall Study|Other|0|||
126735028|NCT00844285|455979426|FG001|Overall Study|Other|1|||
126735029|NCT00844285|455979427|FG002|Overall Study|Other|0|||
126735030|NCT00844285|455979425|FG000|Overall Study|Other than specified|95|||
126735031|NCT00844285|455979426|FG001|Overall Study|Other than specified|129|||
126735032|NCT00844285|455979427|FG002|Overall Study|Other than specified|12|||
126735033|NCT00844285|455979425|FG000|Overall Study|Site closure|256|||
126735034|NCT00844285|455979426|FG001|Overall Study|Site closure|450|||
126735035|NCT00844285|455979427|FG002|Overall Study|Site closure|50|||
126735036|NCT00844285|455979425|FG000|Overall Study|Follow-up < 8 years|16|||
126735037|NCT00844285|455979426|FG001|Overall Study|Follow-up < 8 years|23|||
126735038|NCT00844285|455979427|FG002|Overall Study|Follow-up < 8 years|4|||
126735039|NCT00844285|455979425|FG000|Overall Study|Protocol Violation|26|||
126735040|NCT00844285|455979426|FG001|Overall Study|Protocol Violation|28|||
126735041|NCT00844285|455979427|FG002|Overall Study|Protocol Violation|54|||
126735042|NCT00844285|455979425|FG000|Overall Study|Death|22|||
126735043|NCT00844285|455979426|FG001|Overall Study|Death|21|||
126735044|NCT00844285|455979427|FG002|Overall Study|Death|8|||
126735045|NCT00844285|455979425|FG000|Overall Study|Withdrew Consent|344|||
126735046|NCT00844285|455979426|FG001|Overall Study|Withdrew Consent|466|||
126735047|NCT00844285|455979427|FG002|Overall Study|Withdrew Consent|70|||
126735048|NCT00844285|455979425|FG000|Overall Study|Lost to Follow-up|330|||
126735049|NCT00844285|455979426|FG001|Overall Study|Lost to Follow-up|486|||
126735050|NCT00844285|455979427|FG002|Overall Study|Lost to Follow-up|74|||
126735051|NCT02849626|455979430|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
126735052|NCT02849626|455979431|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
126735053|NCT02849626|455979432|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
126735054|NCT02849626|455979433|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
126735055|NCT02849626|455979430|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
126735056|NCT02849626|455979431|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
126735057|NCT02849626|455979432|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
126735058|NCT02849626|455979433|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
126735059|NCT02849626|455979430|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
126735060|NCT02849626|455979431|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
126735061|NCT02849626|455979432|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
126735062|NCT02849626|455979433|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
126735063|NCT02849626|455979430|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
126735064|NCT02849626|455979431|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
126735065|NCT02849626|455979432|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
126735066|NCT02849626|455979433|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
126735067|NCT02849626|455979430|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
126735068|NCT02849626|455979431|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
126735069|NCT02849626|455979432|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
126735070|NCT02849626|455979433|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
126735071|NCT02849626|455979430|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
126735072|NCT02849626|455979431|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
126735073|NCT02849626|455979432|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
126735074|NCT02849626|455979433|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
126735075|NCT02849626|455979430|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
126735076|NCT02849626|455979431|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
126735077|NCT02849626|455979432|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
126735078|NCT02849626|455979433|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
126735079|NCT02849626|455979430|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
126735080|NCT02849626|455979431|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
126735081|NCT02849626|455979432|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
126735082|NCT02849626|455979433|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
126735083|NCT02849626|455979430|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
126735084|NCT02849626|455979431|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
126735085|NCT02849626|455979432|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
126735086|NCT02849626|455979433|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
126735087|NCT02849626|455979430|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
126735088|NCT02849626|455979431|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
126735089|NCT02849626|455979432|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
126735090|NCT02849626|455979433|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
126735091|NCT02849626|455979430|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
126735092|NCT02849626|455979431|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
126735093|NCT02849626|455979432|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
126735094|NCT02849626|455979433|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
126735095|NCT01654523|455979434|FG000|Overall Study|Withdrawal by Subject|1|||
126735096|NCT04176445|455979435|FG000|Overall Study|Adverse Event|0|||
126735097|NCT04176445|455979436|FG001|Overall Study|Adverse Event|1|||
126735098|NCT04176445|455979435|FG000|Overall Study|change plans weaning after first intervention|0|||
126735099|NCT04176445|455979436|FG001|Overall Study|change plans weaning after first intervention|1|||
126735100|NCT00405652|455979439|FG000|Overall Study|Adverse Event|4|||
126735101|NCT00435994|455979440|FG000|Overall Study|Lost to Follow-up|7|||
126735102|NCT00435994|455979441|FG001|Overall Study|Lost to Follow-up|0|||
126735103|NCT00435994|455979442|FG002|Overall Study|Lost to Follow-up|0|||
126735104|NCT05109702|455979445|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
126735105|NCT05109702|455979446|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
126735106|NCT05109702|455979447|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
126735107|NCT05109702|455979445|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
126735108|NCT05109702|455979446|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
126735109|NCT05109702|455979447|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
126735110|NCT05109702|455979445|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
126735111|NCT05109702|455979446|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
126735112|NCT05109702|455979447|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
126735113|NCT05109702|455979445|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
126735114|NCT05109702|455979446|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
126735115|NCT05109702|455979447|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
126735116|NCT05109702|455979445|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
126735117|NCT05109702|455979446|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
126735118|NCT05109702|455979447|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
126735119|NCT01392378|455979454|FG000|Infant Series|Adverse Event|0|||
126735120|NCT01392378|455979455|FG001|Infant Series|Adverse Event|0|||
126735121|NCT01392378|455979456|FG002|Infant Series|Adverse Event|0|||
126735122|NCT01392378|455979457|FG003|Infant Series|Adverse Event|1|||
126735123|NCT01392378|455979458|FG004|Infant Series|Adverse Event|0|||
126735124|NCT01392378|455979454|FG000|Infant Series|Lost to Follow-up|0|||
126735125|NCT01392378|455979455|FG001|Infant Series|Lost to Follow-up|0|||
126735126|NCT01392378|455979456|FG002|Infant Series|Lost to Follow-up|0|||
126735127|NCT01392378|455979457|FG003|Infant Series|Lost to Follow-up|1|||
126735128|NCT01392378|455979458|FG004|Infant Series|Lost to Follow-up|0|||
126735129|NCT01392378|455979454|FG000|Infant Series|Protocol Violation|0|||
126735130|NCT01392378|455979455|FG001|Infant Series|Protocol Violation|1|||
126735131|NCT01392378|455979456|FG002|Infant Series|Protocol Violation|0|||
126735132|NCT01392378|455979457|FG003|Infant Series|Protocol Violation|0|||
126735133|NCT01392378|455979458|FG004|Infant Series|Protocol Violation|0|||
126735134|NCT01392378|455979454|FG000|Infant Series|Withdrawal by Parent|4|||
126735135|NCT01392378|455979455|FG001|Infant Series|Withdrawal by Parent|1|||
126735136|NCT01392378|455979456|FG002|Infant Series|Withdrawal by Parent|0|||
126735137|NCT01392378|455979457|FG003|Infant Series|Withdrawal by Parent|0|||
126735138|NCT01392378|455979458|FG004|Infant Series|Withdrawal by Parent|0|||
126735139|NCT01392378|455979454|FG000|After Infant Series|Lost to Follow-up|0|||
126735140|NCT01392378|455979455|FG001|After Infant Series|Lost to Follow-up|0|||
126735141|NCT01392378|455979456|FG002|After Infant Series|Lost to Follow-up|1|||
126735142|NCT01392378|455979457|FG003|After Infant Series|Lost to Follow-up|0|||
126735143|NCT01392378|455979458|FG004|After Infant Series|Lost to Follow-up|0|||
126735144|NCT01392378|455979454|FG000|After Infant Series|Withdrawal by Parent|0|||
126735145|NCT01392378|455979455|FG001|After Infant Series|Withdrawal by Parent|1|||
126735146|NCT01392378|455979456|FG002|After Infant Series|Withdrawal by Parent|1|||
126735147|NCT01392378|455979457|FG003|After Infant Series|Withdrawal by Parent|0|||
126735148|NCT01392378|455979458|FG004|After Infant Series|Withdrawal by Parent|1|||
126735149|NCT01392378|455979454|FG000|Toddler Dose|Lost to Follow-up|0|||
126735150|NCT01392378|455979455|FG001|Toddler Dose|Lost to Follow-up|0|||
126735151|NCT01392378|455979456|FG002|Toddler Dose|Lost to Follow-up|0|||
126735152|NCT01392378|455979457|FG003|Toddler Dose|Lost to Follow-up|1|||
126735153|NCT01392378|455979458|FG004|Toddler Dose|Lost to Follow-up|0|||
126735154|NCT01392378|455979454|FG000|Toddler Dose|Withdrawal by Parent|0|||
126735155|NCT01392378|455979455|FG001|Toddler Dose|Withdrawal by Parent|1|||
126735156|NCT01392378|455979456|FG002|Toddler Dose|Withdrawal by Parent|0|||
126735157|NCT01392378|455979457|FG003|Toddler Dose|Withdrawal by Parent|1|||
126735158|NCT01392378|455979458|FG004|Toddler Dose|Withdrawal by Parent|1|||
126735159|NCT02322411|455979461|FG000|Overall Study|Lost to Follow-up|4|||
126735160|NCT02322411|455979462|FG001|Overall Study|Lost to Follow-up|7|||
126735161|NCT02322411|455979461|FG000|Overall Study|Withdrawal by Subject|1|||
126735162|NCT02322411|455979462|FG001|Overall Study|Withdrawal by Subject|0|||
126735163|NCT02713789|455979463|FG000|Overall Study|Lost to Follow-up|0|||
126735164|NCT02713789|455979464|FG001|Overall Study|Lost to Follow-up|1|||
126735165|NCT02713789|455979465|FG002|Overall Study|Lost to Follow-up|1|||
126735166|NCT00367432|455979466|FG000|First Period (16 Weeks)|Adverse Event|6|||
126735167|NCT00367432|455979467|FG001|First Period (16 Weeks)|Adverse Event|0|||
126735168|NCT00367432|455979466|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
126735169|NCT00367432|455979467|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
126735170|NCT00367432|455979466|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
126735171|NCT00367432|455979467|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
126735172|NCT00367432|455979466|FG000|First Period (16 Weeks)|Other Reason|2|||
126735173|NCT00367432|455979467|FG001|First Period (16 Weeks)|Other Reason|0|||
126735174|NCT00367432|455979466|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
126735175|NCT00367432|455979467|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
126735176|NCT00367432|455979466|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
126735177|NCT00367432|455979467|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
126735178|NCT00367432|455979466|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
126735179|NCT00367432|455979467|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
126735180|NCT00367432|455979466|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
126735181|NCT00367432|455979467|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
126735182|NCT00367432|455979466|FG000|Second Period (up to 54 Months)|Other Reason|6|||
126735183|NCT00367432|455979467|FG001|Second Period (up to 54 Months)|Other Reason|2|||
126735184|NCT00903370|455979468|FG000|Overall Study|Death|13|||
126735185|NCT00903370|455979469|FG001|Overall Study|Death|10|||
126735186|NCT00903370|455979468|FG000|Overall Study|Withdrawal by Subject|9|||
126735187|NCT00903370|455979469|FG001|Overall Study|Withdrawal by Subject|6|||
126735188|NCT00903370|455979468|FG000|Overall Study|Lost to Follow-up|6|||
126735189|NCT00903370|455979469|FG001|Overall Study|Lost to Follow-up|8|||
126735190|NCT00014911|455979470|FG000|Overall Study|Adverse Event|1|||
126735191|NCT00014911|455979470|FG000|Overall Study|Lost to Follow-up|1|||
126735192|NCT00014911|455979470|FG000|Overall Study|Withdrawal by Subject|6|||
126735193|NCT00014911|455979470|FG000|Overall Study|Unknown Reasons|2|||
126735194|NCT00014911|455979470|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
126735195|NCT01999946|455979471|FG000|Overall Study|Participant not released from jail|2|||
126735196|NCT01999946|455979472|FG001|Overall Study|Participant not released from jail|2|||
126735197|NCT01999946|455979473|FG002|Overall Study|Participant not released from jail|0|||
126735198|NCT01999946|455979471|FG000|Overall Study|Not included in primary outcome analysis|0|||
126735199|NCT01999946|455979472|FG001|Overall Study|Not included in primary outcome analysis|0|||
126735200|NCT01999946|455979473|FG002|Overall Study|Not included in primary outcome analysis|79|||
126735201|NCT02091921|455979474|FG000|Overall Study|Adverse Event|3|||
126735202|NCT03307629|455979475|FG000|Overall Study|Withdrawal by Subject|0|||
126735203|NCT03307629|455979476|FG001|Overall Study|Withdrawal by Subject|0|||
126735204|NCT03307629|455979477|FG002|Overall Study|Withdrawal by Subject|0|||
126735205|NCT03307629|455979478|FG003|Overall Study|Withdrawal by Subject|2|||
126735206|NCT03307629|455979475|FG000|Overall Study|Disease Progression|0|||
126735207|NCT03307629|455979476|FG001|Overall Study|Disease Progression|0|||
126735208|NCT03307629|455979477|FG002|Overall Study|Disease Progression|0|||
126735209|NCT03307629|455979478|FG003|Overall Study|Disease Progression|3|||
126735210|NCT03307629|455979475|FG000|Overall Study|Death|0|||
126735211|NCT03307629|455979476|FG001|Overall Study|Death|3|||
126735212|NCT03307629|455979477|FG002|Overall Study|Death|0|||
126735213|NCT03307629|455979478|FG003|Overall Study|Death|1|||
126735214|NCT00719953|455979483|FG000|Overall Study|Adverse Event|4|||
126735215|NCT01626989|455979484|FG000|Screening Period|Screen Failure|15|||
126735216|NCT01626989|455979485|FG001|Screening Period|Screen Failure|0|||
126735217|NCT01626989|455979486|FG002|Screening Period|Screen Failure|0|||
126735218|NCT01626989|455979484|FG000|Screening Period|Withdrawal by Subject|2|||
126735219|NCT01626989|455979485|FG001|Screening Period|Withdrawal by Subject|0|||
126735220|NCT01626989|455979486|FG002|Screening Period|Withdrawal by Subject|0|||
126735221|NCT01230749|455979492|FG000|Overall Study|Adverse Event|0|||
126735222|NCT01230749|455979493|FG001|Overall Study|Adverse Event|0|||
126735223|NCT01230749|455979494|FG002|Overall Study|Adverse Event|0|||
126735224|NCT01230749|455979495|FG003|Overall Study|Adverse Event|1|||
126735225|NCT01230749|455979492|FG000|Overall Study|Physician Decision|0|||
126735226|NCT01230749|455979493|FG001|Overall Study|Physician Decision|0|||
126735227|NCT01230749|455979494|FG002|Overall Study|Physician Decision|1|||
126735228|NCT01230749|455979495|FG003|Overall Study|Physician Decision|0|||
126735229|NCT01230749|455979492|FG000|Overall Study|Withdrawal by Subject|0|||
126735230|NCT01230749|455979493|FG001|Overall Study|Withdrawal by Subject|1|||
126735231|NCT01230749|455979494|FG002|Overall Study|Withdrawal by Subject|0|||
126735232|NCT01230749|455979495|FG003|Overall Study|Withdrawal by Subject|0|||
126735233|NCT01230749|455979492|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
126735234|NCT01230749|455979493|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
126735235|NCT01230749|455979494|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
126735236|NCT01230749|455979495|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
126735237|NCT04021706|455981362|FG000|Overall Study|Adverse Event|2|||
126612833|NCT01190124|455542260|FG001|Overall Study|Death|0|||
126735238|NCT04021706|455981363|FG001|Overall Study|Adverse Event|0|||
126735239|NCT04021706|455981362|FG000|Overall Study|Withdrawal by Subject|1|||
126735240|NCT04021706|455981363|FG001|Overall Study|Withdrawal by Subject|2|||
126735241|NCT04021706|455981362|FG000|Overall Study|Physician Decision|1|||
126735242|NCT04021706|455981363|FG001|Overall Study|Physician Decision|0|||
126735243|NCT00355134|455981366|FG000|Core Phase|Withdrawal by Subject|35|||
126735244|NCT00355134|455981367|FG001|Core Phase|Withdrawal by Subject|24|||
126735245|NCT00355134|455981368|FG002|Core Phase|Withdrawal by Subject|35|||
126735246|NCT00355134|455981369|FG003|Core Phase|Withdrawal by Subject|0|||
126735247|NCT00355134|455981370|FG004|Core Phase|Withdrawal by Subject|0|||
126735248|NCT00355134|455981366|FG000|Core Phase|Adverse Event|28|||
126735249|NCT00355134|455981367|FG001|Core Phase|Adverse Event|22|||
126735250|NCT00355134|455981368|FG002|Core Phase|Adverse Event|16|||
126735251|NCT00355134|455981369|FG003|Core Phase|Adverse Event|0|||
126735252|NCT00355134|455981370|FG004|Core Phase|Adverse Event|0|||
126735253|NCT00355134|455981366|FG000|Core Phase|Lost to Follow-up|17|||
126735254|NCT00355134|455981367|FG001|Core Phase|Lost to Follow-up|13|||
126735255|NCT00355134|455981368|FG002|Core Phase|Lost to Follow-up|21|||
126735256|NCT00355134|455981369|FG003|Core Phase|Lost to Follow-up|0|||
126735257|NCT00355134|455981370|FG004|Core Phase|Lost to Follow-up|0|||
126735258|NCT00355134|455981366|FG000|Core Phase|Abnormal laboratory value(s)|19|||
126735259|NCT00355134|455981367|FG001|Core Phase|Abnormal laboratory value(s)|14|||
126735260|NCT00355134|455981368|FG002|Core Phase|Abnormal laboratory value(s)|2|||
126735261|NCT00355134|455981369|FG003|Core Phase|Abnormal laboratory value(s)|0|||
126735262|NCT00355134|455981370|FG004|Core Phase|Abnormal laboratory value(s)|0|||
126735263|NCT00355134|455981366|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
126735264|NCT00355134|455981367|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
126735265|NCT00355134|455981368|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
126735266|NCT00355134|455981369|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
126735267|NCT00355134|455981370|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
126735268|NCT00355134|455981366|FG000|Core Phase|Administrative problems|5|||
126735269|NCT00355134|455981367|FG001|Core Phase|Administrative problems|3|||
126735270|NCT00355134|455981368|FG002|Core Phase|Administrative problems|5|||
126735271|NCT00355134|455981369|FG003|Core Phase|Administrative problems|0|||
126735272|NCT00355134|455981370|FG004|Core Phase|Administrative problems|0|||
126735273|NCT00355134|455981366|FG000|Core Phase|Protocol Violation|3|||
126735274|NCT00355134|455981367|FG001|Core Phase|Protocol Violation|2|||
126735275|NCT00355134|455981368|FG002|Core Phase|Protocol Violation|2|||
126735276|NCT00355134|455981369|FG003|Core Phase|Protocol Violation|0|||
126735277|NCT00355134|455981370|FG004|Core Phase|Protocol Violation|0|||
126735278|NCT00355134|455981366|FG000|Core Phase|Abnormal test procedure result(s)|1|||
126735279|NCT00355134|455981367|FG001|Core Phase|Abnormal test procedure result(s)|2|||
126735280|NCT00355134|455981368|FG002|Core Phase|Abnormal test procedure result(s)|1|||
126735281|NCT00355134|455981369|FG003|Core Phase|Abnormal test procedure result(s)|0|||
126735282|NCT00355134|455981370|FG004|Core Phase|Abnormal test procedure result(s)|0|||
126735283|NCT00355134|455981366|FG000|Core Phase|Condition no longer requires study drug|1|||
126735284|NCT00355134|455981367|FG001|Core Phase|Condition no longer requires study drug|0|||
126735285|NCT00355134|455981368|FG002|Core Phase|Condition no longer requires study drug|1|||
126735286|NCT00355134|455981369|FG003|Core Phase|Condition no longer requires study drug|0|||
126735287|NCT00355134|455981370|FG004|Core Phase|Condition no longer requires study drug|0|||
126735288|NCT00355134|455981366|FG000|Extension Phase|Withdrawal by Subject|7|||
126735289|NCT00355134|455981367|FG001|Extension Phase|Withdrawal by Subject|11|||
126735290|NCT00355134|455981368|FG002|Extension Phase|Withdrawal by Subject|0|||
126735291|NCT00355134|455981369|FG003|Extension Phase|Withdrawal by Subject|7|||
126735292|NCT00355134|455981370|FG004|Extension Phase|Withdrawal by Subject|5|||
126735293|NCT00355134|455981366|FG000|Extension Phase|Adverse Event|13|||
126735294|NCT00355134|455981367|FG001|Extension Phase|Adverse Event|9|||
126735295|NCT00355134|455981368|FG002|Extension Phase|Adverse Event|0|||
126735296|NCT00355134|455981369|FG003|Extension Phase|Adverse Event|3|||
126735297|NCT00355134|455981370|FG004|Extension Phase|Adverse Event|5|||
126735298|NCT00355134|455981366|FG000|Extension Phase|Lost to Follow-up|2|||
126735299|NCT00355134|455981367|FG001|Extension Phase|Lost to Follow-up|6|||
126735300|NCT00355134|455981368|FG002|Extension Phase|Lost to Follow-up|0|||
126735301|NCT00355134|455981369|FG003|Extension Phase|Lost to Follow-up|2|||
126735302|NCT00355134|455981370|FG004|Extension Phase|Lost to Follow-up|4|||
126735303|NCT00355134|455981366|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
126735304|NCT00355134|455981367|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
126735305|NCT00355134|455981368|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
126735306|NCT00355134|455981369|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
126735307|NCT00355134|455981370|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
126735308|NCT00355134|455981366|FG000|Extension Phase|Administrative problems|2|||
126735309|NCT00355134|455981367|FG001|Extension Phase|Administrative problems|4|||
126735310|NCT00355134|455981368|FG002|Extension Phase|Administrative problems|0|||
126735311|NCT00355134|455981369|FG003|Extension Phase|Administrative problems|1|||
126735312|NCT00355134|455981370|FG004|Extension Phase|Administrative problems|1|||
126612834|NCT01190124|455542261|FG002|Overall Study|Death|0|||
126612835|NCT01190124|455542259|FG000|Overall Study|Therapeutic Failure|12|||
126612836|NCT01190124|455542260|FG001|Overall Study|Therapeutic Failure|0|||
126612837|NCT01190124|455542261|FG002|Overall Study|Therapeutic Failure|1|||
126735313|NCT00355134|455981366|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
126735314|NCT00355134|455981367|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
126735315|NCT00355134|455981368|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
126735316|NCT00355134|455981369|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
126735317|NCT00355134|455981370|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
126735318|NCT00355134|455981366|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
126735319|NCT00355134|455981367|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
126735320|NCT00355134|455981368|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
126735321|NCT00355134|455981369|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
126735322|NCT00355134|455981370|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
126735323|NCT00355134|455981366|FG000|Extension Phase|Protocol Violation|0|||
126735324|NCT00355134|455981367|FG001|Extension Phase|Protocol Violation|0|||
126735325|NCT00355134|455981368|FG002|Extension Phase|Protocol Violation|0|||
126735326|NCT00355134|455981369|FG003|Extension Phase|Protocol Violation|1|||
126781311|NCT00358826|456154515|FG007|MDCT Substudy|Adverse Event|0|||
126735327|NCT00355134|455981370|FG004|Extension Phase|Protocol Violation|0|||
126735328|NCT01412151|455981371|FG000|Week 0 - 306 - Treatment Period|Death|1|||
126735329|NCT01412151|455981371|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
126735330|NCT01412151|455981371|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
126735331|NCT01412151|455981371|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
126735332|NCT03127852|455981373|FG000|Overall Study|Withdrawal by Subject|4|||
126735333|NCT03127852|455981374|FG001|Overall Study|Withdrawal by Subject|1|||
126735334|NCT03127852|455981373|FG000|Overall Study|Death|1|||
126735335|NCT03127852|455981374|FG001|Overall Study|Death|1|||
126735336|NCT00859573|455981376|FG000|Overall Study|Withdrawal by Subject|4|||
126735337|NCT00859573|455981377|FG001|Overall Study|Withdrawal by Subject|1|||
126735338|NCT00859573|455981376|FG000|Overall Study|Physician Decision|1|||
126735339|NCT00859573|455981377|FG001|Overall Study|Physician Decision|1|||
126735340|NCT03077243|455981378|FG000|Overall Study|Death|1|||
126735341|NCT03077243|455981379|FG001|Overall Study|Death|2|||
126735342|NCT03077243|455981380|FG002|Overall Study|Death|0|||
126735343|NCT03077243|455981381|FG003|Overall Study|Death|0|||
126735344|NCT03077243|455981378|FG000|Overall Study|Withdrawal by Subject|1|||
126735345|NCT03077243|455981379|FG001|Overall Study|Withdrawal by Subject|3|||
126735346|NCT03077243|455981380|FG002|Overall Study|Withdrawal by Subject|0|||
126735347|NCT03077243|455981381|FG003|Overall Study|Withdrawal by Subject|0|||
126735348|NCT03077243|455981378|FG000|Overall Study|Physician Decision|1|||
126735349|NCT03077243|455981379|FG001|Overall Study|Physician Decision|0|||
126735350|NCT03077243|455981380|FG002|Overall Study|Physician Decision|0|||
126735351|NCT03077243|455981381|FG003|Overall Study|Physician Decision|0|||
126735352|NCT03077243|455981378|FG000|Overall Study|Research at two study sites terminated early|0|||
126735353|NCT03077243|455981379|FG001|Overall Study|Research at two study sites terminated early|0|||
126735354|NCT03077243|455981380|FG002|Overall Study|Research at two study sites terminated early|0|||
126735355|NCT03077243|455981381|FG003|Overall Study|Research at two study sites terminated early|69|||
126735356|NCT01432457|455981382|FG000|Overall Study|Adverse Event|7|||
126735357|NCT01432457|455981383|FG001|Overall Study|Adverse Event|10|||
126735358|NCT01432457|455981384|FG002|Overall Study|Adverse Event|16|||
126735359|NCT01432457|455981382|FG000|Overall Study|Lack of Efficacy|2|||
126735360|NCT01432457|455981383|FG001|Overall Study|Lack of Efficacy|1|||
126735361|NCT01432457|455981384|FG002|Overall Study|Lack of Efficacy|1|||
126735362|NCT01432457|455981382|FG000|Overall Study|Lost to Follow-up|11|||
126735363|NCT01432457|455981383|FG001|Overall Study|Lost to Follow-up|15|||
126735364|NCT01432457|455981384|FG002|Overall Study|Lost to Follow-up|20|||
126735365|NCT01432457|455981382|FG000|Overall Study|Protocol Violation|3|||
126735366|NCT01432457|455981383|FG001|Overall Study|Protocol Violation|2|||
126735367|NCT01432457|455981384|FG002|Overall Study|Protocol Violation|6|||
126735368|NCT01432457|455981382|FG000|Overall Study|Withdrawal by Subject|6|||
126735369|NCT01432457|455981383|FG001|Overall Study|Withdrawal by Subject|11|||
126735370|NCT01432457|455981384|FG002|Overall Study|Withdrawal by Subject|9|||
126735371|NCT01432457|455981382|FG000|Overall Study|Reasons not defined|2|||
126735372|NCT01432457|455981383|FG001|Overall Study|Reasons not defined|3|||
126735373|NCT01432457|455981384|FG002|Overall Study|Reasons not defined|4|||
126735374|NCT01432457|455981382|FG000|Overall Study|Did not take study drug|6|||
126735375|NCT01432457|455981383|FG001|Overall Study|Did not take study drug|6|||
126735376|NCT01432457|455981384|FG002|Overall Study|Did not take study drug|3|||
126735377|NCT02848313|455981385|FG000|Overall Study|Adverse Event|1|||
126735378|NCT02848313|455981386|FG001|Overall Study|Adverse Event|2|||
126735379|NCT02848313|455981385|FG000|Overall Study|Lack of Efficacy|0|||
126735380|NCT02848313|455981386|FG001|Overall Study|Lack of Efficacy|1|||
126735381|NCT02848313|455981385|FG000|Overall Study|Withdrawal by Subject|1|||
126735382|NCT02848313|455981386|FG001|Overall Study|Withdrawal by Subject|1|||
126735383|NCT02848313|455981385|FG000|Overall Study|Lost to follow up|1|||
126735384|NCT02848313|455981386|FG001|Overall Study|Lost to follow up|0|||
126735385|NCT01544478|455981387|FG000|Overall Study|Adverse Event|1|||
126735386|NCT01544478|455981387|FG000|Overall Study|Death|1|||
126735387|NCT01544478|455981387|FG000|Overall Study|Lost to Follow-up|48|||
126735388|NCT01544478|455981387|FG000|Overall Study|Physician Decision|15|||
126735389|NCT01544478|455981387|FG000|Overall Study|Pregnancy|1|||
126735390|NCT01544478|455981387|FG000|Overall Study|Withdrawal by Subject|52|||
126735391|NCT02574481|455981388|FG000|Overall Study|Withdrawal by Subject|29|||
126735392|NCT02574481|455981389|FG001|Overall Study|Withdrawal by Subject|15|||
126735393|NCT02574481|455981390|FG002|Overall Study|Withdrawal by Subject|4|||
126735394|NCT02574481|455981391|FG003|Overall Study|Withdrawal by Subject|1|||
126735395|NCT02574481|455981388|FG000|Overall Study|Adverse Event|5|||
126735396|NCT02574481|455981389|FG001|Overall Study|Adverse Event|1|||
126735397|NCT02574481|455981390|FG002|Overall Study|Adverse Event|1|||
126735398|NCT02574481|455981391|FG003|Overall Study|Adverse Event|0|||
126735399|NCT02574481|455981388|FG000|Overall Study|Visit Missed|15|||
126735400|NCT02574481|455981389|FG001|Overall Study|Visit Missed|7|||
126735401|NCT02574481|455981390|FG002|Overall Study|Visit Missed|5|||
126735402|NCT02574481|455981391|FG003|Overall Study|Visit Missed|0|||
126735403|NCT02574481|455981388|FG000|Overall Study|Other|7|||
126735404|NCT02574481|455981389|FG001|Overall Study|Other|2|||
126735405|NCT02574481|455981390|FG002|Overall Study|Other|0|||
126735406|NCT02574481|455981391|FG003|Overall Study|Other|0|||
126735407|NCT02574481|455981388|FG000|Overall Study|Death|48|||
126735408|NCT02574481|455981389|FG001|Overall Study|Death|26|||
126735409|NCT02574481|455981390|FG002|Overall Study|Death|12|||
126735410|NCT02574481|455981391|FG003|Overall Study|Death|4|||
126735411|NCT02574481|455981388|FG000|Overall Study|Physician Decision|5|||
126735412|NCT02574481|455981389|FG001|Overall Study|Physician Decision|2|||
126735413|NCT02574481|455981390|FG002|Overall Study|Physician Decision|0|||
126735414|NCT02574481|455981391|FG003|Overall Study|Physician Decision|0|||
126735415|NCT02574481|455981388|FG000|Overall Study|Lost to Follow-up|5|||
126735416|NCT02574481|455981389|FG001|Overall Study|Lost to Follow-up|1|||
126735417|NCT02574481|455981390|FG002|Overall Study|Lost to Follow-up|3|||
126735418|NCT02574481|455981391|FG003|Overall Study|Lost to Follow-up|0|||
126735419|NCT04134728|455981395|FG000|Overall Study|Adverse Event|3|||
126735420|NCT04134728|455981396|FG001|Overall Study|Adverse Event|2|||
126735421|NCT04134728|455981397|FG002|Overall Study|Adverse Event|9|||
126735422|NCT04134728|455981398|FG003|Overall Study|Adverse Event|0|||
126735423|NCT04134728|455981399|FG004|Overall Study|Adverse Event|0|||
126735424|NCT04134728|455981400|FG005|Overall Study|Adverse Event|0|||
126735425|NCT04134728|455981395|FG000|Overall Study|Lack of Efficacy|3|||
126735426|NCT04134728|455981396|FG001|Overall Study|Lack of Efficacy|3|||
126735427|NCT04134728|455981397|FG002|Overall Study|Lack of Efficacy|1|||
126735428|NCT04134728|455981398|FG003|Overall Study|Lack of Efficacy|2|||
126735429|NCT04134728|455981399|FG004|Overall Study|Lack of Efficacy|0|||
126735430|NCT04134728|455981400|FG005|Overall Study|Lack of Efficacy|0|||
126735431|NCT04134728|455981395|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
126735432|NCT04134728|455981396|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126735433|NCT04134728|455981397|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
126735434|NCT04134728|455981398|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126735435|NCT04134728|455981399|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126735436|NCT04134728|455981400|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126735437|NCT04134728|455981395|FG000|Overall Study|Protocol Deviation|0|||
126735438|NCT04134728|455981396|FG001|Overall Study|Protocol Deviation|0|||
126735439|NCT04134728|455981397|FG002|Overall Study|Protocol Deviation|1|||
126735440|NCT04134728|455981398|FG003|Overall Study|Protocol Deviation|0|||
126735441|NCT04134728|455981399|FG004|Overall Study|Protocol Deviation|0|||
126735442|NCT04134728|455981400|FG005|Overall Study|Protocol Deviation|0|||
126735443|NCT04134728|455981395|FG000|Overall Study|Informed Consent Withdrawn|3|||
126735444|NCT04134728|455981396|FG001|Overall Study|Informed Consent Withdrawn|6|||
126735445|NCT04134728|455981397|FG002|Overall Study|Informed Consent Withdrawn|8|||
126735446|NCT04134728|455981398|FG003|Overall Study|Informed Consent Withdrawn|1|||
126735447|NCT04134728|455981399|FG004|Overall Study|Informed Consent Withdrawn|1|||
126735448|NCT04134728|455981400|FG005|Overall Study|Informed Consent Withdrawn|0|||
126735449|NCT04134728|455981395|FG000|Overall Study|Physician Decision|2|||
126735450|NCT04134728|455981396|FG001|Overall Study|Physician Decision|0|||
126735451|NCT04134728|455981397|FG002|Overall Study|Physician Decision|0|||
126735452|NCT04134728|455981398|FG003|Overall Study|Physician Decision|0|||
126735453|NCT04134728|455981399|FG004|Overall Study|Physician Decision|0|||
126735454|NCT04134728|455981400|FG005|Overall Study|Physician Decision|0|||
126735455|NCT04134728|455981395|FG000|Overall Study|Lost to Follow-up|1|||
126735456|NCT04134728|455981396|FG001|Overall Study|Lost to Follow-up|2|||
126735457|NCT04134728|455981397|FG002|Overall Study|Lost to Follow-up|1|||
126735458|NCT04134728|455981398|FG003|Overall Study|Lost to Follow-up|0|||
126735459|NCT04134728|455981399|FG004|Overall Study|Lost to Follow-up|0|||
126735460|NCT04134728|455981400|FG005|Overall Study|Lost to Follow-up|1|||
126735461|NCT04134728|455981395|FG000|Overall Study|Investigator Site Closed|0|||
126735462|NCT04134728|455981396|FG001|Overall Study|Investigator Site Closed|1|||
126735463|NCT04134728|455981397|FG002|Overall Study|Investigator Site Closed|1|||
126735464|NCT04134728|455981398|FG003|Overall Study|Investigator Site Closed|0|||
126735465|NCT04134728|455981399|FG004|Overall Study|Investigator Site Closed|0|||
126735466|NCT04134728|455981400|FG005|Overall Study|Investigator Site Closed|0|||
126735467|NCT03382262|455981401|FG000|Overall Study|Physician Decision|0|||
126735468|NCT03382262|455981402|FG001|Overall Study|Physician Decision|0|||
126735469|NCT03382262|455981403|FG002|Overall Study|Physician Decision|1|||
126735470|NCT03382262|455981404|FG003|Overall Study|Physician Decision|0|||
126735471|NCT03382262|455981401|FG000|Overall Study|Withdrawal by Subject|0|||
126735472|NCT03382262|455981402|FG001|Overall Study|Withdrawal by Subject|0|||
126735473|NCT03382262|455981403|FG002|Overall Study|Withdrawal by Subject|0|||
126735474|NCT03382262|455981404|FG003|Overall Study|Withdrawal by Subject|1|||
126735475|NCT02038790|455981406|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
126735476|NCT02038790|455981407|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
126735477|NCT00438464|455981415|FG000|Overall Study|Terminated Early|14|||
126735478|NCT00438464|455981416|FG001|Overall Study|Terminated Early|5|||
126735479|NCT00438464|455981415|FG000|Overall Study|Incomplete data submission|0|||
126735480|NCT00438464|455981416|FG001|Overall Study|Incomplete data submission|2|||
126735481|NCT03943446|455981418|FG000|Overall Study|Lost to Follow-up|0|||
126735482|NCT03943446|455981419|FG001|Overall Study|Lost to Follow-up|0|||
126612838|NCT01190124|455542259|FG000|Overall Study|Lost to Follow-up|2|||
126612839|NCT01190124|455542260|FG001|Overall Study|Lost to Follow-up|0|||
126612840|NCT01190124|455542261|FG002|Overall Study|Lost to Follow-up|0|||
126612841|NCT03493282|455542262|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
126612842|NCT03493282|455542263|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
126612843|NCT03493282|455542264|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
126612844|NCT03493282|455542262|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
126612845|NCT03493282|455542263|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
126612846|NCT03493282|455542264|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
126612847|NCT00070707|455542265|FG000|Overall Study|Adverse Event|1|||
126612848|NCT00070707|455542266|FG001|Overall Study|Adverse Event|2|||
126612849|NCT00070707|455542265|FG000|Overall Study|Lack of Efficacy|4|||
126612850|NCT00070707|455542266|FG001|Overall Study|Lack of Efficacy|1|||
126612851|NCT00070707|455542265|FG000|Overall Study|Protocol Violation|8|||
126612852|NCT00070707|455542266|FG001|Overall Study|Protocol Violation|4|||
126612853|NCT00070707|455542265|FG000|Overall Study|Unrelated to Study Medication|1|||
126612854|NCT00070707|455542266|FG001|Overall Study|Unrelated to Study Medication|0|||
126612855|NCT01128959|455542267|FG000|Lead in Period|Adverse Event|3|||
126612856|NCT01128959|455542267|FG000|Treatment Period|Adverse Event|3|||
126612857|NCT01128959|455542267|FG000|Treatment Period|Withdrawal by Subject|1|||
126612858|NCT02338999|455542268|FG000|First Intervention|Withdrawal by Subject|3|||
126612859|NCT02338999|455542269|FG001|First Intervention|Withdrawal by Subject|1|||
126612860|NCT02338999|455542268|FG000|Washout Period|Withdrawal by Subject|0|||
126612861|NCT02338999|455542269|FG001|Washout Period|Withdrawal by Subject|2|||
126612862|NCT02338999|455542268|FG000|Second Intervention|Withdrawal by Subject|0|||
126612863|NCT02338999|455542269|FG001|Second Intervention|Withdrawal by Subject|2|||
126612864|NCT00308308|455542270|FG000|Overall Study|Adverse Event|17|||
126612865|NCT00308308|455542271|FG001|Overall Study|Adverse Event|2|||
126612866|NCT00308308|455542270|FG000|Overall Study|Lost to Follow-up|5|||
126612867|NCT00308308|455542271|FG001|Overall Study|Lost to Follow-up|5|||
126612868|NCT00308308|455542270|FG000|Overall Study|Physician Decision|15|||
126612869|NCT00308308|455542271|FG001|Overall Study|Physician Decision|7|||
126612870|NCT00308308|455542270|FG000|Overall Study|Protocol Violation|3|||
126612871|NCT00308308|455542271|FG001|Overall Study|Protocol Violation|14|||
126612872|NCT00308308|455542270|FG000|Overall Study|Withdrawal by Subject|47|||
126612873|NCT00308308|455542271|FG001|Overall Study|Withdrawal by Subject|19|||
126612874|NCT00308308|455542270|FG000|Overall Study|Various|7|||
126612875|NCT00308308|455542271|FG001|Overall Study|Various|5|||
126612876|NCT00308308|455542270|FG000|Overall Study|Randomized but not dosed|8|||
126612877|NCT00308308|455542271|FG001|Overall Study|Randomized but not dosed|16|||
126612878|NCT00308308|455542270|FG000|Overall Study|Other|1|||
126612879|NCT00308308|455542271|FG001|Overall Study|Other|0|||
126612880|NCT01802333|455542272|FG000|Overall Study|Ineligible|2|||
126612881|NCT01802333|455542273|FG001|Overall Study|Ineligible|6|||
126612882|NCT01802333|455542274|FG002|Overall Study|Ineligible|8|||
126612883|NCT01802333|455542272|FG000|Overall Study|Adverse Event|1|||
126612884|NCT01802333|455542273|FG001|Overall Study|Adverse Event|8|||
126612885|NCT01802333|455542274|FG002|Overall Study|Adverse Event|8|||
126612886|NCT01802333|455542272|FG000|Overall Study|Withdrawal by Subject|6|||
126612887|NCT01802333|455542273|FG001|Overall Study|Withdrawal by Subject|6|||
126612888|NCT01802333|455542274|FG002|Overall Study|Withdrawal by Subject|5|||
126612889|NCT01802333|455542272|FG000|Overall Study|Progression/relapse|1|||
126612890|NCT01802333|455542273|FG001|Overall Study|Progression/relapse|3|||
126612891|NCT01802333|455542274|FG002|Overall Study|Progression/relapse|0|||
126612892|NCT01802333|455542272|FG000|Overall Study|Death|7|||
126612893|NCT01802333|455542273|FG001|Overall Study|Death|14|||
126612894|NCT01802333|455542274|FG002|Overall Study|Death|13|||
126612895|NCT01802333|455542272|FG000|Overall Study|Other - not protocol specified|32|||
126612896|NCT01802333|455542273|FG001|Overall Study|Other - not protocol specified|22|||
126612897|NCT01802333|455542274|FG002|Overall Study|Other - not protocol specified|24|||
126612898|NCT01802333|455542272|FG000|Overall Study|Did not start treatment|0|||
126612899|NCT01802333|455542273|FG001|Overall Study|Did not start treatment|2|||
126612900|NCT01802333|455542274|FG002|Overall Study|Did not start treatment|5|||
126612901|NCT01947491|455542275|FG000|Overall Study|Lost to Follow-up|5|||
126612902|NCT01947491|455542276|FG001|Overall Study|Lost to Follow-up|3|||
126612903|NCT01947491|455542277|FG002|Overall Study|Lost to Follow-up|1|||
126612904|NCT01947491|455542278|FG003|Overall Study|Lost to Follow-up|2|||
126735483|NCT03943446|455981420|FG002|Overall Study|Lost to Follow-up|1|||
126735484|NCT03943446|455981418|FG000|Overall Study|Withdrawal by Subject|1|||
126735485|NCT03943446|455981419|FG001|Overall Study|Withdrawal by Subject|1|||
126612905|NCT01947491|455542275|FG000|Overall Study|Lack of Efficacy|1|||
126612906|NCT01947491|455542276|FG001|Overall Study|Lack of Efficacy|0|||
126612907|NCT01947491|455542277|FG002|Overall Study|Lack of Efficacy|0|||
126612908|NCT01947491|455542278|FG003|Overall Study|Lack of Efficacy|1|||
126612909|NCT01947491|455542275|FG000|Overall Study|Protocol Violation|1|||
126612910|NCT01947491|455542276|FG001|Overall Study|Protocol Violation|0|||
126612911|NCT01947491|455542277|FG002|Overall Study|Protocol Violation|0|||
126612912|NCT01947491|455542278|FG003|Overall Study|Protocol Violation|0|||
126735486|NCT03943446|455981420|FG002|Overall Study|Withdrawal by Subject|2|||
126735487|NCT03943446|455981418|FG000|Overall Study|Study Terminated by Sponsor|1|||
126735488|NCT03943446|455981419|FG001|Overall Study|Study Terminated by Sponsor|2|||
126735489|NCT03943446|455981420|FG002|Overall Study|Study Terminated by Sponsor|1|||
126735490|NCT03943446|455981418|FG000|Overall Study|Reason not Specified|5|||
126735491|NCT03943446|455981419|FG001|Overall Study|Reason not Specified|1|||
126735492|NCT03943446|455981420|FG002|Overall Study|Reason not Specified|3|||
126735493|NCT01136746|455981423|FG000|Overall Study|Lost to Follow-up|0|||
126735494|NCT01136746|455981424|FG001|Overall Study|Lost to Follow-up|2|||
126735495|NCT01136746|455981423|FG000|Overall Study|Protocol Violation|2|||
126735496|NCT01136746|455981424|FG001|Overall Study|Protocol Violation|1|||
126735497|NCT01136746|455981423|FG000|Overall Study|Death|1|||
126735498|NCT01136746|455981424|FG001|Overall Study|Death|0|||
126735499|NCT01090102|455981434|FG000|First 12 Weeks|Withdrawal by Subject|1|||
126735500|NCT01090102|455981435|FG001|First 12 Weeks|Withdrawal by Subject|1|||
126735501|NCT01090102|455981434|FG000|First 12 Weeks|Adverse Event|2|||
126735502|NCT01090102|455981435|FG001|First 12 Weeks|Adverse Event|0|||
126735503|NCT01090102|455981434|FG000|First 12 Weeks|Death|1|||
126735504|NCT01090102|455981435|FG001|First 12 Weeks|Death|1|||
126735505|NCT01090102|455981434|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
126735506|NCT01090102|455981435|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
126735507|NCT01601704|455981436|FG000|Overall Study|Randomized but not dispensed study med|1|||
126735508|NCT01601704|455981437|FG001|Overall Study|Randomized but not dispensed study med|4|||
126735509|NCT03518034|455981438|FG000|Overall Study|Not Treated|5|||
126735510|NCT03518034|455981439|FG001|Overall Study|Not Treated|1|||
126735511|NCT03518034|455981438|FG000|Overall Study|Withdrawal by Subject|309|||
126735512|NCT03518034|455981439|FG001|Overall Study|Withdrawal by Subject|351|||
126735513|NCT03518034|455981438|FG000|Overall Study|Lost to Follow-up|446|||
126735514|NCT03518034|455981439|FG001|Overall Study|Lost to Follow-up|458|||
126735515|NCT03518034|455981438|FG000|Overall Study|Adverse Event|138|||
126735516|NCT03518034|455981439|FG001|Overall Study|Adverse Event|130|||
126735517|NCT03518034|455981438|FG000|Overall Study|Lack of Efficacy|11|||
126735518|NCT03518034|455981439|FG001|Overall Study|Lack of Efficacy|23|||
126735519|NCT03518034|455981438|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
126735520|NCT03518034|455981439|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
126735521|NCT03518034|455981438|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
126735522|NCT03518034|455981439|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
126735523|NCT03518034|455981438|FG000|Overall Study|Other, Not Specified|84|||
126735524|NCT03518034|455981439|FG001|Overall Study|Other, Not Specified|53|||
126735525|NCT03518034|455981438|FG000|Overall Study|Reason Missing|2|||
126735526|NCT03518034|455981439|FG001|Overall Study|Reason Missing|3|||
126735527|NCT00985738|455981447|FG000|Overall Study|Study closed prematurely|8|||
126735528|NCT00985738|455981448|FG001|Overall Study|Study closed prematurely|8|||
126735529|NCT02227849|455981450|FG000|Overall Study|Adverse Event|4|||
126735530|NCT02227849|455981450|FG000|Overall Study|Physician Decision|1|||
126735531|NCT02227849|455981450|FG000|Overall Study|Withdrawal by Subject|3|||
126735532|NCT01590212|455981453|FG000|Overall Study|Withdrawal by Subject|2|||
126735533|NCT01590212|455981454|FG001|Overall Study|Withdrawal by Subject|2|||
126735534|NCT01590212|455981455|FG002|Overall Study|Withdrawal by Subject|2|||
126735535|NCT01590212|455981453|FG000|Overall Study|Lost to Follow-up|1|||
126735536|NCT01590212|455981454|FG001|Overall Study|Lost to Follow-up|2|||
126735537|NCT01590212|455981455|FG002|Overall Study|Lost to Follow-up|3|||
126735538|NCT04897594|455981457|FG000|Overall Study|Lost to Follow-up|0|||
126735539|NCT04897594|455981458|FG001|Overall Study|Lost to Follow-up|1|||
126735540|NCT04897594|455981459|FG002|Overall Study|Lost to Follow-up|1|||
126735541|NCT04897594|455981457|FG000|Overall Study|Sponsor Decision|0|||
126735542|NCT04897594|455981458|FG001|Overall Study|Sponsor Decision|0|||
126781312|NCT00358826|456154508|FG000|MDCT Substudy|Lost to Follow-up|0|||
126781313|NCT00358826|456154509|FG001|MDCT Substudy|Lost to Follow-up|0|||
126781314|NCT00358826|456154510|FG002|MDCT Substudy|Lost to Follow-up|0|||
126612913|NCT01947491|455542275|FG000|Overall Study|Withdrawal by Subject|1|||
126735543|NCT04897594|455981459|FG002|Overall Study|Sponsor Decision|1|||
126735544|NCT04897594|455981457|FG000|Overall Study|Withdrawal by Subject|1|||
126735545|NCT04897594|455981458|FG001|Overall Study|Withdrawal by Subject|0|||
126735546|NCT04897594|455981459|FG002|Overall Study|Withdrawal by Subject|1|||
126735547|NCT00150345|455981462|FG000|Overall Study|Death|5|||
126735548|NCT00150345|455981463|FG001|Overall Study|Death|2|||
126735549|NCT00150345|455981462|FG000|Overall Study|Adverse Event|8|||
126735550|NCT00150345|455981463|FG001|Overall Study|Adverse Event|6|||
126735551|NCT00150345|455981462|FG000|Overall Study|Lack of Efficacy|5|||
126735552|NCT00150345|455981463|FG001|Overall Study|Lack of Efficacy|4|||
126735553|NCT00150345|455981462|FG000|Overall Study|Withdrawal by Subject|3|||
126735554|NCT00150345|455981463|FG001|Overall Study|Withdrawal by Subject|4|||
126735555|NCT00150345|455981462|FG000|Overall Study|Laboratory abnormality|1|||
126735556|NCT00150345|455981463|FG001|Overall Study|Laboratory abnormality|2|||
126735557|NCT00150345|455981462|FG000|Overall Study|Other|12|||
126735558|NCT00150345|455981463|FG001|Overall Study|Other|14|||
126735559|NCT01457924|455981466|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
126735560|NCT01457924|455981467|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
126735561|NCT01457924|455981468|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
126735562|NCT01457924|455981469|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
126735563|NCT01457924|455981470|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
126735564|NCT01457924|455981466|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
126735565|NCT01457924|455981467|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
126735566|NCT01457924|455981468|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
126735567|NCT01457924|455981469|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
126735568|NCT01457924|455981470|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
126735569|NCT01457924|455981466|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
126735570|NCT01457924|455981467|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
126735571|NCT01457924|455981468|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
126735572|NCT01457924|455981469|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
126735573|NCT01457924|455981470|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
126735574|NCT01457924|455981466|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
126735575|NCT01457924|455981467|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
126735576|NCT01457924|455981468|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
126735577|NCT01457924|455981469|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
126735578|NCT01457924|455981470|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
126735579|NCT01457924|455981466|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
126735580|NCT01457924|455981467|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
126735581|NCT01457924|455981468|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
126735582|NCT01457924|455981469|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
126735583|NCT01457924|455981470|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
126735584|NCT01457924|455981466|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
126735585|NCT01457924|455981467|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
126735586|NCT01457924|455981468|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
126735587|NCT01457924|455981469|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
126735588|NCT01457924|455981470|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
126735589|NCT01457924|455981466|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
126735590|NCT01457924|455981467|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
126735591|NCT01457924|455981468|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
126735592|NCT01457924|455981469|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
126735593|NCT01457924|455981470|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
126735594|NCT01457924|455981466|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
126735595|NCT01457924|455981467|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
126735596|NCT01457924|455981468|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
126735597|NCT01457924|455981469|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
126735598|NCT01457924|455981470|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
126735599|NCT01457924|455981466|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
126735600|NCT01457924|455981467|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
126735601|NCT01457924|455981468|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
126735602|NCT01457924|455981469|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
126735603|NCT01457924|455981470|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
126735604|NCT01457924|455981466|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
126735605|NCT01457924|455981467|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
126735606|NCT01457924|455981468|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
126735607|NCT01457924|455981469|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
126735608|NCT01457924|455981470|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
126735609|NCT01457924|455981466|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
126735610|NCT01457924|455981467|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
126735611|NCT01457924|455981468|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
126735612|NCT01457924|455981469|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
126735613|NCT01457924|455981470|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
126735614|NCT01457924|455981466|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
126735615|NCT01457924|455981467|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
126735616|NCT01457924|455981468|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
126735617|NCT01457924|455981469|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
126735618|NCT01457924|455981470|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
126735619|NCT01457924|455981466|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
126735620|NCT01457924|455981467|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
126735621|NCT01457924|455981468|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
126735622|NCT01457924|455981469|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
126735623|NCT01457924|455981470|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
126735624|NCT03862495|455981471|FG000|Overall Study|Lost to Follow-up|37|||
126781315|NCT00358826|456154511|FG003|MDCT Substudy|Lost to Follow-up|0|||
126781316|NCT00358826|456154512|FG004|MDCT Substudy|Lost to Follow-up|0|||
126735625|NCT03862495|455981472|FG001|Overall Study|Lost to Follow-up|35|||
126781317|NCT00358826|456154513|FG005|MDCT Substudy|Lost to Follow-up|1|||
126781318|NCT00358826|456154514|FG006|MDCT Substudy|Lost to Follow-up|0|||
126735626|NCT00615914|455981473|FG000|Overall Study|Adverse Event|274|||
126735627|NCT00615914|455981473|FG000|Overall Study|Death|20|||
126735628|NCT00615914|455981473|FG000|Overall Study|Lack of Efficacy|59|||
126735629|NCT00615914|455981473|FG000|Overall Study|Lost to Follow-up|187|||
126735630|NCT00615914|455981473|FG000|Overall Study|Withdrawal by Subject|16|||
126735631|NCT00615914|455981473|FG000|Overall Study|Physician Decision|4|||
126735632|NCT00615914|455981473|FG000|Overall Study|No data was collected.|65|||
126735633|NCT00615914|455981473|FG000|Overall Study|No treatment|2|||
126735634|NCT00615914|455981473|FG000|Overall Study|Irregularly enrolled patients|10|||
126735635|NCT03673956|455981474|FG000|Overall Study|Lost to Follow-up|1|||
126735636|NCT03673956|455981475|FG001|Overall Study|Lost to Follow-up|0|||
126735637|NCT03673956|455981476|FG002|Overall Study|Lost to Follow-up|0|||
126735638|NCT03673956|455981477|FG003|Overall Study|Lost to Follow-up|0|||
126735639|NCT03673956|455981474|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
126735640|NCT03673956|455981475|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
126735641|NCT03673956|455981476|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
126735642|NCT03673956|455981477|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
126735643|NCT00270998|455981478|FG000|3 Month Follow-up|Adverse Event|1|||
126735644|NCT00270998|455981479|FG001|3 Month Follow-up|Adverse Event|0|||
126735645|NCT00270998|455981480|FG002|3 Month Follow-up|Adverse Event|0|||
126735646|NCT00270998|455981478|FG000|3 Month Follow-up|Lack of Efficacy|1|||
126735647|NCT00270998|455981479|FG001|3 Month Follow-up|Lack of Efficacy|2|||
126735648|NCT00270998|455981480|FG002|3 Month Follow-up|Lack of Efficacy|1|||
126735649|NCT00270998|455981478|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
126735650|NCT00270998|455981479|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
126735651|NCT00270998|455981480|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
126735652|NCT00270998|455981478|FG000|3 Month Follow-up|Pessary did not fit|12|||
126735653|NCT00270998|455981479|FG001|3 Month Follow-up|Pessary did not fit|0|||
126735654|NCT00270998|455981480|FG002|3 Month Follow-up|Pessary did not fit|0|||
126735655|NCT00270998|455981478|FG000|3 Month Follow-up|Personal/family health|1|||
126735656|NCT00270998|455981479|FG001|3 Month Follow-up|Personal/family health|1|||
126735657|NCT00270998|455981480|FG002|3 Month Follow-up|Personal/family health|0|||
126735658|NCT00270998|455981478|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
126735659|NCT00270998|455981479|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
126735660|NCT00270998|455981480|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
126735661|NCT00270998|455981478|FG000|12 Month Follow-up|Lack of Efficacy|5|||
126735662|NCT00270998|455981479|FG001|12 Month Follow-up|Lack of Efficacy|4|||
126735663|NCT00270998|455981480|FG002|12 Month Follow-up|Lack of Efficacy|3|||
126735664|NCT00270998|455981478|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
126735665|NCT00270998|455981479|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
126735666|NCT00270998|455981480|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
126735667|NCT00270998|455981478|FG000|12 Month Follow-up|Pessary did not fit|1|||
126735668|NCT00270998|455981479|FG001|12 Month Follow-up|Pessary did not fit|0|||
126735669|NCT00270998|455981480|FG002|12 Month Follow-up|Pessary did not fit|0|||
126735670|NCT00270998|455981478|FG000|12 Month Follow-up|Personal/family health|0|||
126735671|NCT00270998|455981479|FG001|12 Month Follow-up|Personal/family health|5|||
126735672|NCT00270998|455981480|FG002|12 Month Follow-up|Personal/family health|1|||
126735673|NCT00270998|455981478|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
126735674|NCT00270998|455981479|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
126735675|NCT00270998|455981480|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
126735676|NCT00425113|455981481|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
126735677|NCT00425113|455981482|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
126735678|NCT00425113|455981481|FG000|Overall Study|diagnosis of abdominal TB|0|||
126735679|NCT00425113|455981482|FG001|Overall Study|diagnosis of abdominal TB|1|||
126735680|NCT00425113|455981481|FG000|Overall Study|missing study drug more than 14 days|0|||
126735681|NCT00425113|455981482|FG001|Overall Study|missing study drug more than 14 days|1|||
126735682|NCT00425113|455981481|FG000|Overall Study|Withdrawal by Subject|1|||
126735683|NCT00425113|455981482|FG001|Overall Study|Withdrawal by Subject|0|||
126735684|NCT03495817|455981489|FG000|26 Week Open Label|Adverse Event|3|||
126735685|NCT03495817|455981489|FG000|26 Week Open Label|Withdrawal by Subject|4|||
126735686|NCT03495817|455981489|FG000|26 Week Open Label|Lost to Follow-up|1|||
126735687|NCT03495817|455981489|FG000|26 Week Extension|Lost to Follow-up|2|||
126735688|NCT04585451|455981494|FG000|Overall Study|Withdrawal by Subject|26|||
126735689|NCT04585451|455981495|FG001|Overall Study|Withdrawal by Subject|0|||
126735690|NCT00326417|455981496|FG000|Overall Study|Withdrawal by Subject|0|||
126735691|NCT00326417|455981497|FG001|Overall Study|Withdrawal by Subject|0|||
126735692|NCT00326417|455981498|FG002|Overall Study|Withdrawal by Subject|1|||
126735693|NCT00326417|455981499|FG003|Overall Study|Withdrawal by Subject|0|||
126735694|NCT00326417|455981496|FG000|Overall Study|Arm Closed|7|||
126735695|NCT00326417|455981497|FG001|Overall Study|Arm Closed|0|||
126735696|NCT00326417|455981498|FG002|Overall Study|Arm Closed|0|||
126735697|NCT00326417|455981499|FG003|Overall Study|Arm Closed|3|||
126735698|NCT00326417|455981496|FG000|Overall Study|Death|7|||
126735699|NCT00326417|455981497|FG001|Overall Study|Death|0|||
126735700|NCT00326417|455981498|FG002|Overall Study|Death|0|||
126735701|NCT00326417|455981499|FG003|Overall Study|Death|0|||
126735702|NCT01313208|455981506|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
126735703|NCT01313208|455981507|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
126735704|NCT01313208|455981506|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
126735705|NCT01313208|455981507|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
126735706|NCT01313208|455981506|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
126735707|NCT01313208|455981507|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
126735708|NCT01313208|455981506|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
126735709|NCT01313208|455981507|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
126735710|NCT01313208|455981506|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
126735711|NCT01313208|455981507|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
126735712|NCT01313208|455981506|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
126735713|NCT01313208|455981507|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
126735714|NCT01313208|455981506|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
126735715|NCT01313208|455981507|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
126735716|NCT01313208|455981506|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
126735717|NCT01313208|455981507|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
126735718|NCT01313208|455981506|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
126735719|NCT01313208|455981507|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
126735720|NCT01957787|455981508|FG000|Overall Study|Death|18|||
126735721|NCT01957787|455981508|FG000|Overall Study|Lost to Follow-up|3|||
126735722|NCT01957787|455981508|FG000|Overall Study|Withdrawal by Subject|3|||
126735723|NCT01957787|455981508|FG000|Overall Study|Entered Hospice or Similar Program|2|||
126735724|NCT01957787|455981508|FG000|Overall Study|Index Tumor(s) Resected|2|||
126735725|NCT01957787|455981508|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
126735726|NCT01957787|455981508|FG000|Overall Study|Local therapy, not cryoablation|6|||
126735727|NCT04046341|455981511|FG000|Overall Study|Lost to Follow-up|2|||
126735728|NCT04046341|455981511|FG000|Overall Study|Withdrawal by Subject|1|||
126735729|NCT02248857|455981514|FG000|3 Month|Withdrawal by Subject|9|||
126735730|NCT02248857|455981515|FG001|3 Month|Withdrawal by Subject|3|||
126735731|NCT02248857|455981516|FG002|3 Month|Withdrawal by Subject|4|||
126735732|NCT02248857|455981514|FG000|3 Month|Unable to reach for 3 month|35|||
126735733|NCT02248857|455981515|FG001|3 Month|Unable to reach for 3 month|29|||
126735734|NCT02248857|455981516|FG002|3 Month|Unable to reach for 3 month|26|||
126735735|NCT02248857|455981514|FG000|3 Month|Partially completed, unable to finish|2|||
126735736|NCT02248857|455981515|FG001|3 Month|Partially completed, unable to finish|2|||
126735737|NCT02248857|455981516|FG002|3 Month|Partially completed, unable to finish|1|||
126735738|NCT02248857|455981514|FG000|6 Month|Lost to Follow-up|27|||
126735739|NCT02248857|455981515|FG001|6 Month|Lost to Follow-up|26|||
126735740|NCT02248857|455981516|FG002|6 Month|Lost to Follow-up|15|||
126735741|NCT02248857|455981514|FG000|6 Month|Partially completed, unable to finish|0|||
126735742|NCT02248857|455981515|FG001|6 Month|Partially completed, unable to finish|1|||
126735743|NCT02248857|455981516|FG002|6 Month|Partially completed, unable to finish|0|||
126735744|NCT02248857|455981514|FG000|6 Month|Withdrawal by Subject|0|||
126735745|NCT02248857|455981515|FG001|6 Month|Withdrawal by Subject|2|||
126735746|NCT02248857|455981516|FG002|6 Month|Withdrawal by Subject|2|||
126735747|NCT02248857|455981514|FG000|6 Month|Death|1|||
126735748|NCT02248857|455981515|FG001|6 Month|Death|0|||
126735749|NCT02248857|455981516|FG002|6 Month|Death|0|||
126735750|NCT02261883|455981517|FG000|Overall Study|Death|3|||
126735751|NCT02261883|455981518|FG001|Overall Study|Death|2|||
126735752|NCT02261883|455981517|FG000|Overall Study|Physician Decision|1|||
126735753|NCT02261883|455981518|FG001|Overall Study|Physician Decision|0|||
126735754|NCT02261883|455981517|FG000|Overall Study|Protocol Violation|1|||
126735755|NCT02261883|455981518|FG001|Overall Study|Protocol Violation|0|||
126735756|NCT02261883|455981517|FG000|Overall Study|Withdrawal by Subject|0|||
126735757|NCT02261883|455981518|FG001|Overall Study|Withdrawal by Subject|1|||
126735758|NCT02261883|455981517|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
126735759|NCT02261883|455981518|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
126735760|NCT00004732|455981520|FG000|Overall Study|Withdrawal by Subject|36|||
126735761|NCT00004732|455981521|FG001|Overall Study|Withdrawal by Subject|64|||
126735762|NCT00004732|455981520|FG000|Overall Study|Lost to Follow-up|33|||
126735763|NCT00004732|455981521|FG001|Overall Study|Lost to Follow-up|47|||
126735764|NCT02674685|455981525|FG000|Overall Study|Withdrawal by Subject|4|||
126735765|NCT04199793|455981526|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
126735766|NCT04199793|455981527|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
126735767|NCT04199793|455981526|FG000|Overall Study|Withdrawal by Subject|1|||
126735768|NCT04199793|455981527|FG001|Overall Study|Withdrawal by Subject|1|||
126735769|NCT00642018|455981534|FG000|Overall Study|Adverse Event|11|||
126735770|NCT00642018|455981535|FG001|Overall Study|Adverse Event|36|||
126735771|NCT00642018|455981534|FG000|Overall Study|Withdrawal by Subject|4|||
126735772|NCT00642018|455981535|FG001|Overall Study|Withdrawal by Subject|10|||
126735773|NCT00642018|455981534|FG000|Overall Study|Progressive Disease|13|||
126735774|NCT00642018|455981535|FG001|Overall Study|Progressive Disease|18|||
126735775|NCT00642018|455981534|FG000|Overall Study|Physician Decision|0|||
126735776|NCT00642018|455981535|FG001|Overall Study|Physician Decision|10|||
126735777|NCT00642018|455981534|FG000|Overall Study|Protocol Violation|0|||
126735778|NCT00642018|455981535|FG001|Overall Study|Protocol Violation|1|||
126735779|NCT00642018|455981534|FG000|Overall Study|Death|0|||
126735780|NCT00642018|455981535|FG001|Overall Study|Death|3|||
126735781|NCT00642018|455981534|FG000|Overall Study|Entry Criteria Not Met|0|||
126735782|NCT00642018|455981535|FG001|Overall Study|Entry Criteria Not Met|1|||
126735783|NCT02687711|455983338|FG000|Overall Study|Adverse Event|89|||
126735784|NCT02687711|455983338|FG000|Overall Study|Lack of Efficacy|70|||
126735785|NCT02687711|455983338|FG000|Overall Study|Lost to Follow-up|20|||
126735786|NCT02687711|455983338|FG000|Overall Study|Consent withdrawn|15|||
126735787|NCT02687711|455983338|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
126735788|NCT02687711|455983338|FG000|Overall Study|Too expensive|4|||
126735789|NCT02687711|455983338|FG000|Overall Study|Participant moved abroad|1|||
126735790|NCT02687711|455983338|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
126735791|NCT02687711|455983338|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
126735792|NCT02687711|455983338|FG000|Overall Study|Disliked taste|1|||
126735793|NCT02687711|455983338|FG000|Overall Study|Low mood|1|||
126735794|NCT02687711|455983338|FG000|Overall Study|Side effects|1|||
126735795|NCT02687711|455983338|FG000|Overall Study|Change of Hospital|1|||
126735796|NCT02687711|455983338|FG000|Overall Study|Liver Encephalopathy|1|||
126735797|NCT02687711|455983338|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
126735798|NCT02687711|455983338|FG000|Overall Study|Withdrawn due to intake interruption|1|||
126735799|NCT02687711|455983338|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
126735800|NCT02687711|455983338|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
126735801|NCT02687711|455983338|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
126735802|NCT03621189|455983339|FG000|Overall Study|Withdrawal by Subject|0|||
126735803|NCT03621189|455983340|FG001|Overall Study|Withdrawal by Subject|3|||
126735804|NCT03621189|455983339|FG000|Overall Study|Physician Decision|0|||
126735805|NCT03621189|455983340|FG001|Overall Study|Physician Decision|2|||
126735806|NCT00247273|455983341|FG000|Overall Study|Adverse Event|85|||
126735807|NCT00247273|455983342|FG001|Overall Study|Adverse Event|80|||
126735808|NCT00247273|455983341|FG000|Overall Study|Physician Decision|6|||
126735809|NCT00247273|455983342|FG001|Overall Study|Physician Decision|3|||
126735810|NCT00247273|455983341|FG000|Overall Study|Lost to Follow-up|7|||
126735811|NCT00247273|455983342|FG001|Overall Study|Lost to Follow-up|7|||
126735812|NCT00247273|455983341|FG000|Overall Study|Withdrawal by Subject|46|||
126735813|NCT00247273|455983342|FG001|Overall Study|Withdrawal by Subject|47|||
126735814|NCT00247273|455983341|FG000|Overall Study|Did not take any study drug|2|||
126735815|NCT00247273|455983342|FG001|Overall Study|Did not take any study drug|0|||
126735816|NCT01419015|455983343|FG000|Overall Study|Death|2|||
126735817|NCT04209530|455983344|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
126735818|NCT04209530|455983345|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
126735819|NCT04209530|455983344|FG000|Overall Study|Withdrawal by Subject|0|||
126735820|NCT04209530|455983345|FG001|Overall Study|Withdrawal by Subject|1|||
126735821|NCT02580240|455983346|FG000|Overall Study|Physician Decision|2|||
126735822|NCT02580240|455983347|FG001|Overall Study|Physician Decision|0|||
126735823|NCT00607919|455983348|FG000|Acute Phase|Adverse Event|9|||
126735824|NCT00607919|455983349|FG001|Acute Phase|Adverse Event|2|||
126735825|NCT00607919|455983348|FG000|Acute Phase|Entry Criteria Not Met|1|||
126735826|NCT00607919|455983349|FG001|Acute Phase|Entry Criteria Not Met|1|||
126735827|NCT00607919|455983348|FG000|Acute Phase|Lack of Efficacy|1|||
126735828|NCT00607919|455983349|FG001|Acute Phase|Lack of Efficacy|2|||
126735829|NCT00607919|455983348|FG000|Acute Phase|Lost to Follow-up|9|||
126735830|NCT00607919|455983349|FG001|Acute Phase|Lost to Follow-up|3|||
126735831|NCT00607919|455983348|FG000|Acute Phase|Parent/Caregiver Decision|6|||
126735832|NCT00607919|455983349|FG001|Acute Phase|Parent/Caregiver Decision|4|||
126735833|NCT00607919|455983348|FG000|Acute Phase|Protocol Violation|5|||
126735834|NCT00607919|455983349|FG001|Acute Phase|Protocol Violation|1|||
126735835|NCT00607919|455983348|FG000|Acute Phase|Withdrawal by Subject|3|||
126735836|NCT00607919|455983349|FG001|Acute Phase|Withdrawal by Subject|3|||
126735837|NCT00607919|455983348|FG000|Open-Label Phase|Adverse Event|1|||
126735838|NCT00607919|455983349|FG001|Open-Label Phase|Adverse Event|5|||
126735839|NCT00607919|455983348|FG000|Open-Label Phase|Lost to Follow-up|4|||
126735840|NCT00607919|455983349|FG001|Open-Label Phase|Lost to Follow-up|1|||
126735841|NCT00607919|455983348|FG000|Open-Label Phase|Protocol Violation|2|||
126735842|NCT00607919|455983349|FG001|Open-Label Phase|Protocol Violation|2|||
126735843|NCT00607919|455983348|FG000|Open-Label Phase|Withdrawal by Subject|2|||
126781319|NCT00358826|456154515|FG007|MDCT Substudy|Lost to Follow-up|0|||
126735844|NCT00607919|455983349|FG001|Open-Label Phase|Withdrawal by Subject|2|||
126735845|NCT00607919|455983348|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
126781320|NCT00358826|456154508|FG000|MDCT Substudy|Withdrawal by Subject|0|||
126612914|NCT01947491|455542276|FG001|Overall Study|Withdrawal by Subject|1|||
126781321|NCT00358826|456154509|FG001|MDCT Substudy|Withdrawal by Subject|0|||
126612915|NCT01947491|455542277|FG002|Overall Study|Withdrawal by Subject|1|||
126612916|NCT01947491|455542278|FG003|Overall Study|Withdrawal by Subject|0|||
126612917|NCT01947491|455542275|FG000|Overall Study|Worsening of condition|0|||
126612918|NCT01947491|455542276|FG001|Overall Study|Worsening of condition|1|||
126612919|NCT01947491|455542277|FG002|Overall Study|Worsening of condition|0|||
126612920|NCT01947491|455542278|FG003|Overall Study|Worsening of condition|0|||
126612921|NCT01947491|455542275|FG000|Overall Study|Adverse Event|0|||
126612922|NCT01947491|455542276|FG001|Overall Study|Adverse Event|1|||
126612923|NCT01947491|455542277|FG002|Overall Study|Adverse Event|0|||
126612924|NCT01947491|455542278|FG003|Overall Study|Adverse Event|2|||
126612925|NCT02067663|455542279|FG000|Overall Study|Lost to Follow-up|13|||
126612926|NCT02067663|455542280|FG001|Overall Study|Lost to Follow-up|14|||
126612927|NCT03137784|455542281|FG000|Overall Study|Adverse Event|1|||
126612928|NCT03137784|455542282|FG001|Overall Study|Adverse Event|1|||
126612929|NCT03137784|455542283|FG002|Overall Study|Adverse Event|0|||
126612930|NCT03137784|455542284|FG003|Overall Study|Adverse Event|0|||
126612931|NCT03137784|455542285|FG004|Overall Study|Adverse Event|0|||
126612932|NCT03137784|455542286|FG005|Overall Study|Adverse Event|0|||
126612933|NCT03137784|455542281|FG000|Overall Study|Subject/guardian decision|1|||
126612934|NCT03137784|455542282|FG001|Overall Study|Subject/guardian decision|0|||
126612935|NCT03137784|455542283|FG002|Overall Study|Subject/guardian decision|0|||
126612936|NCT03137784|455542284|FG003|Overall Study|Subject/guardian decision|0|||
126612937|NCT03137784|455542285|FG004|Overall Study|Subject/guardian decision|0|||
126612938|NCT03137784|455542286|FG005|Overall Study|Subject/guardian decision|0|||
126612939|NCT03137784|455542281|FG000|Overall Study|Non-compliance with study treatment|0|||
126612940|NCT03137784|455542282|FG001|Overall Study|Non-compliance with study treatment|0|||
126612941|NCT03137784|455542283|FG002|Overall Study|Non-compliance with study treatment|0|||
126612942|NCT03137784|455542284|FG003|Overall Study|Non-compliance with study treatment|0|||
126612943|NCT03137784|455542285|FG004|Overall Study|Non-compliance with study treatment|1|||
126612944|NCT03137784|455542286|FG005|Overall Study|Non-compliance with study treatment|0|||
126612945|NCT02736188|455542287|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
126612946|NCT02736188|455542287|FG000|Overall Study|Adverse Event|1|||
126612947|NCT02736188|455542287|FG000|Overall Study|Withdrawal by Subject|1|||
126612948|NCT02736188|455542287|FG000|Overall Study|Other|6|||
126612949|NCT00240994|455542288|FG000|Overall Study|Lost to Follow-up|1|||
126612950|NCT00240994|455542288|FG000|Overall Study|Protocol Violation|1|||
126612951|NCT00240994|455542288|FG000|Overall Study|Graft failure|1|||
126612952|NCT03142932|455542289|FG000|Overall Study|Lost to Follow-up|2|||
126612953|NCT03142932|455542290|FG001|Overall Study|Lost to Follow-up|11|||
126612954|NCT04070105|455542291|FG000|Overall Study|Lost to Follow-up|0|||
126612955|NCT04070105|455542292|FG001|Overall Study|Lost to Follow-up|0|||
126612956|NCT04070105|455542293|FG002|Overall Study|Lost to Follow-up|0|||
126612957|NCT04070105|455542294|FG003|Overall Study|Lost to Follow-up|0|||
126612958|NCT04070105|455542295|FG004|Overall Study|Lost to Follow-up|0|||
126612959|NCT04070105|455542296|FG005|Overall Study|Lost to Follow-up|1|||
126612960|NCT00749944|455542301|FG000|Overall Study|Lost to Follow-up|2|||
126612961|NCT00749944|455542302|FG001|Overall Study|Lost to Follow-up|1|||
126612962|NCT00749944|455542301|FG000|Overall Study|Other|1|||
126612963|NCT00749944|455542302|FG001|Overall Study|Other|0|||
126612964|NCT00749944|455542301|FG000|Overall Study|Withdrawal by Subject|2|||
126612965|NCT00749944|455542302|FG001|Overall Study|Withdrawal by Subject|0|||
126612966|NCT00923078|455542306|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
126612967|NCT00923078|455542307|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
126612968|NCT00923078|455542308|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
126612969|NCT00923078|455542306|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
126612970|NCT00923078|455542307|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
126612971|NCT00923078|455542308|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
126612972|NCT03547154|455542319|FG000|Overall Study|Disease Progression/Recurrence|6|||
126612973|NCT03547154|455542320|FG001|Overall Study|Disease Progression/Recurrence|14|||
126612974|NCT03547154|455542319|FG000|Overall Study|Adverse Event|26|||
126612975|NCT03547154|455542320|FG001|Overall Study|Adverse Event|31|||
126612976|NCT03547154|455542319|FG000|Overall Study|Protocol Violation|6|||
126612977|NCT03547154|455542320|FG001|Overall Study|Protocol Violation|1|||
126612978|NCT03547154|455542319|FG000|Overall Study|Physician Decision|4|||
126735846|NCT00607919|455983349|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
126735847|NCT01527110|455983362|FG000|Overall Study|Adverse Event|1|||
126735848|NCT02007252|455983365|FG000|Overall Study|Administrative problems|3|||
126735849|NCT02007252|455983366|FG001|Overall Study|Administrative problems|7|||
126735850|NCT02007252|455983365|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126735851|NCT02007252|455983366|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126612979|NCT03547154|455542320|FG001|Overall Study|Physician Decision|3|||
126612980|NCT03547154|455542319|FG000|Overall Study|Insufficient Therapeutic Response|13|||
126612981|NCT03547154|455542320|FG001|Overall Study|Insufficient Therapeutic Response|10|||
126612982|NCT03547154|455542319|FG000|Overall Study|Withdrawal by Subject|10|||
126612983|NCT03547154|455542320|FG001|Overall Study|Withdrawal by Subject|6|||
126612984|NCT03547154|455542319|FG000|Overall Study|Not Selected|0|||
126735852|NCT02007252|455983365|FG000|Overall Study|Adverse Event|7|||
126735853|NCT02007252|455983366|FG001|Overall Study|Adverse Event|4|||
126735854|NCT01628393|455983367|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
126735855|NCT01628393|455983368|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126735856|NCT01628393|455983369|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126735857|NCT01628393|455983370|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126735858|NCT01628393|455983371|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
126735859|NCT01628393|455983367|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
126735860|NCT01628393|455983368|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
126735861|NCT01628393|455983369|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
126735862|NCT01628393|455983370|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
126735863|NCT01628393|455983371|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
126735864|NCT01628393|455983367|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
126735865|NCT01628393|455983368|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
126735866|NCT01628393|455983369|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
126735867|NCT01628393|455983370|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
126735868|NCT01628393|455983371|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
126735869|NCT01628393|455983367|FG000|Blinded Active Extension Period|Adverse Event|0|||
126735870|NCT01628393|455983368|FG001|Blinded Active Extension Period|Adverse Event|1|||
126735871|NCT01628393|455983369|FG002|Blinded Active Extension Period|Adverse Event|0|||
126735872|NCT01628393|455983370|FG003|Blinded Active Extension Period|Adverse Event|2|||
126735873|NCT01628393|455983371|FG004|Blinded Active Extension Period|Adverse Event|2|||
126735874|NCT01628393|455983367|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
126735875|NCT01628393|455983368|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
126735876|NCT01628393|455983369|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
126735877|NCT01628393|455983370|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
126735878|NCT01628393|455983371|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
126735879|NCT01628393|455983367|FG000|Blinded Active Extension Period|Physician Decision|0|||
126735880|NCT01628393|455983368|FG001|Blinded Active Extension Period|Physician Decision|3|||
126735881|NCT01628393|455983369|FG002|Blinded Active Extension Period|Physician Decision|0|||
126735882|NCT01628393|455983370|FG003|Blinded Active Extension Period|Physician Decision|1|||
126735883|NCT01628393|455983371|FG004|Blinded Active Extension Period|Physician Decision|0|||
126735884|NCT01628393|455983367|FG000|Blinded Active Extension Period|Protocol Violation|0|||
126735885|NCT01628393|455983368|FG001|Blinded Active Extension Period|Protocol Violation|0|||
126735886|NCT01628393|455983369|FG002|Blinded Active Extension Period|Protocol Violation|2|||
126735887|NCT01628393|455983370|FG003|Blinded Active Extension Period|Protocol Violation|1|||
126735888|NCT01628393|455983371|FG004|Blinded Active Extension Period|Protocol Violation|0|||
126781322|NCT00358826|456154510|FG002|MDCT Substudy|Withdrawal by Subject|0|||
126735889|NCT01628393|455983367|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
126735890|NCT01628393|455983368|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
126735891|NCT01628393|455983369|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
126735892|NCT01628393|455983370|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
126735893|NCT01628393|455983371|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
126735894|NCT02001688|455983372|FG000|Overall Study|Withdrawal by Subject|0|||
126735895|NCT02001688|455983373|FG001|Overall Study|Withdrawal by Subject|0|||
126735896|NCT02001688|455983374|FG002|Overall Study|Withdrawal by Subject|1|||
126735897|NCT02001688|455983372|FG000|Overall Study|Adverse Event|0|||
126735898|NCT02001688|455983373|FG001|Overall Study|Adverse Event|1|||
126735899|NCT02001688|455983374|FG002|Overall Study|Adverse Event|0|||
126735900|NCT05441540|455983378|FG000|Overall Study|Withdrawal by Subject|2|||
126735901|NCT00813917|455983379|FG000|Overall Study|Adverse Event|0|||
126735902|NCT00813917|455983380|FG001|Overall Study|Adverse Event|1|||
126735903|NCT00813917|455983379|FG000|Overall Study|Withdrawal by Subject|3|||
126735904|NCT00813917|455983380|FG001|Overall Study|Withdrawal by Subject|4|||
126735905|NCT00813917|455983379|FG000|Overall Study|Lost to Follow-up|3|||
126735906|NCT00813917|455983380|FG001|Overall Study|Lost to Follow-up|1|||
126735907|NCT00792701|455983385|FG000|Overall Study|Adverse Event|0|||
126735908|NCT00792701|455983386|FG001|Overall Study|Adverse Event|22|||
126735909|NCT00792701|455983385|FG000|Overall Study|Ineligible|1|||
126735910|NCT00792701|455983386|FG001|Overall Study|Ineligible|3|||
126735911|NCT00792701|455983385|FG000|Overall Study|Withdrawal by Subject|1|||
126735912|NCT00792701|455983386|FG001|Overall Study|Withdrawal by Subject|19|||
126735913|NCT00792701|455983385|FG000|Overall Study|Not protocol specified|17|||
126735914|NCT00792701|455983386|FG001|Overall Study|Not protocol specified|0|||
126735915|NCT02143141|455983395|FG000|Overall Study|pain scores at 24 hours not collected|1|||
126735916|NCT02143141|455983396|FG001|Overall Study|pain scores at 24 hours not collected|0|||
126735917|NCT01467661|455983397|FG000|Overall Study|Adverse Event|16|||
126612985|NCT03547154|455542320|FG001|Overall Study|Not Selected|1|||
126612986|NCT03547154|455542319|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
126735918|NCT01467661|455983397|FG000|Overall Study|Withdrawal by Subject|1|||
126735919|NCT01467661|455983397|FG000|Overall Study|Lack of Efficacy|3|||
126735920|NCT01467661|455983397|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
126735921|NCT00563368|455983398|FG000|Overall Study|Lost to Follow-up|14|||
126735922|NCT00563368|455983399|FG001|Overall Study|Lost to Follow-up|14|||
126735923|NCT00563368|455983400|FG002|Overall Study|Lost to Follow-up|12|||
126735924|NCT00563368|455983401|FG003|Overall Study|Lost to Follow-up|6|||
126735925|NCT00563368|455983402|FG004|Overall Study|Lost to Follow-up|9|||
126735926|NCT00563368|455983403|FG005|Overall Study|Lost to Follow-up|8|||
126735927|NCT00563368|455983404|FG006|Overall Study|Lost to Follow-up|9|||
126735928|NCT00563368|455983398|FG000|Overall Study|Adverse Event|3|||
126735929|NCT00563368|455983399|FG001|Overall Study|Adverse Event|4|||
126735930|NCT00563368|455983400|FG002|Overall Study|Adverse Event|5|||
126735931|NCT00563368|455983401|FG003|Overall Study|Adverse Event|9|||
126735932|NCT00563368|455983402|FG004|Overall Study|Adverse Event|6|||
126735933|NCT00563368|455983403|FG005|Overall Study|Adverse Event|10|||
126735934|NCT00563368|455983404|FG006|Overall Study|Adverse Event|17|||
126735935|NCT00563368|455983398|FG000|Overall Study|Withdrawal by Subject|11|||
126735936|NCT00563368|455983399|FG001|Overall Study|Withdrawal by Subject|6|||
126735937|NCT00563368|455983400|FG002|Overall Study|Withdrawal by Subject|5|||
126735938|NCT00563368|455983401|FG003|Overall Study|Withdrawal by Subject|7|||
126735939|NCT00563368|455983402|FG004|Overall Study|Withdrawal by Subject|8|||
126735940|NCT00563368|455983403|FG005|Overall Study|Withdrawal by Subject|5|||
126735941|NCT00563368|455983404|FG006|Overall Study|Withdrawal by Subject|4|||
126735942|NCT00563368|455983398|FG000|Overall Study|protocol non-compliance|1|||
126735943|NCT00563368|455983399|FG001|Overall Study|protocol non-compliance|1|||
126735944|NCT00563368|455983400|FG002|Overall Study|protocol non-compliance|2|||
126735945|NCT00563368|455983401|FG003|Overall Study|protocol non-compliance|1|||
126735946|NCT00563368|455983402|FG004|Overall Study|protocol non-compliance|0|||
126735947|NCT00563368|455983403|FG005|Overall Study|protocol non-compliance|1|||
126735948|NCT00563368|455983404|FG006|Overall Study|protocol non-compliance|3|||
126735949|NCT00563368|455983398|FG000|Overall Study|Pregnancy|1|||
126735950|NCT00563368|455983399|FG001|Overall Study|Pregnancy|0|||
126735951|NCT00563368|455983400|FG002|Overall Study|Pregnancy|1|||
126735952|NCT00563368|455983401|FG003|Overall Study|Pregnancy|2|||
126735953|NCT00563368|455983402|FG004|Overall Study|Pregnancy|1|||
126735954|NCT00563368|455983403|FG005|Overall Study|Pregnancy|2|||
126735955|NCT00563368|455983404|FG006|Overall Study|Pregnancy|0|||
126735956|NCT00563368|455983398|FG000|Overall Study|requirement for restricted medication|0|||
126735957|NCT00563368|455983399|FG001|Overall Study|requirement for restricted medication|0|||
126735958|NCT00563368|455983400|FG002|Overall Study|requirement for restricted medication|2|||
126735959|NCT00563368|455983401|FG003|Overall Study|requirement for restricted medication|0|||
126735960|NCT00563368|455983402|FG004|Overall Study|requirement for restricted medication|0|||
126735961|NCT00563368|455983403|FG005|Overall Study|requirement for restricted medication|0|||
126735962|NCT00563368|455983404|FG006|Overall Study|requirement for restricted medication|0|||
126735963|NCT00563368|455983398|FG000|Overall Study|Other|5|||
126735964|NCT00563368|455983399|FG001|Overall Study|Other|5|||
126735965|NCT00563368|455983400|FG002|Overall Study|Other|3|||
126735966|NCT00563368|455983401|FG003|Overall Study|Other|4|||
126735967|NCT00563368|455983402|FG004|Overall Study|Other|4|||
126735968|NCT00563368|455983403|FG005|Overall Study|Other|4|||
126735969|NCT00563368|455983404|FG006|Overall Study|Other|0|||
126735970|NCT00879437|455983405|FG000|Overall Study|Protocol Violation|0|||
126735971|NCT00879437|455983406|FG001|Overall Study|Protocol Violation|1|||
126735972|NCT00879437|455983405|FG000|Overall Study|Death|1|||
126735973|NCT00879437|455983406|FG001|Overall Study|Death|0|||
126735974|NCT01112982|455983407|FG000|Overall Study|Withdrawal by Subject|1|||
126735975|NCT01112982|455983407|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
126735976|NCT01001234|455983415|FG000|Overall Study|Withdrawal by Subject|2|||
126735977|NCT01001234|455983416|FG001|Overall Study|Withdrawal by Subject|0|||
126735978|NCT01001234|455983417|FG002|Overall Study|Withdrawal by Subject|3|||
126735979|NCT01001234|455983418|FG003|Overall Study|Withdrawal by Subject|0|||
126735980|NCT01001234|455983419|FG004|Overall Study|Withdrawal by Subject|0|||
126735981|NCT01001234|455983415|FG000|Overall Study|Protocol Violation|34|||
126735982|NCT01001234|455983416|FG001|Overall Study|Protocol Violation|3|||
126735983|NCT01001234|455983417|FG002|Overall Study|Protocol Violation|19|||
126735984|NCT01001234|455983418|FG003|Overall Study|Protocol Violation|18|||
126735985|NCT01001234|455983419|FG004|Overall Study|Protocol Violation|0|||
126735986|NCT01001234|455983415|FG000|Overall Study|Lost to Follow-up|0|||
126735987|NCT01001234|455983416|FG001|Overall Study|Lost to Follow-up|0|||
126735988|NCT01001234|455983417|FG002|Overall Study|Lost to Follow-up|1|||
126735989|NCT01001234|455983418|FG003|Overall Study|Lost to Follow-up|2|||
126735990|NCT01001234|455983419|FG004|Overall Study|Lost to Follow-up|0|||
126735991|NCT01001234|455983415|FG000|Overall Study|Physician Decision|1|||
126735992|NCT01001234|455983416|FG001|Overall Study|Physician Decision|0|||
126735993|NCT01001234|455983417|FG002|Overall Study|Physician Decision|0|||
126735994|NCT01001234|455983418|FG003|Overall Study|Physician Decision|0|||
126735995|NCT01001234|455983419|FG004|Overall Study|Physician Decision|0|||
126735996|NCT01001234|455983415|FG000|Overall Study|Not Treated: Adverse Event|1|||
126735997|NCT01001234|455983416|FG001|Overall Study|Not Treated: Adverse Event|0|||
126612987|NCT03547154|455542320|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
126612988|NCT00895245|455542321|FG000|Overall Study|Lack of Efficacy|6|||
126612989|NCT02706483|455542322|FG000|Overall Study|Adverse Event|97|||
126612990|NCT02706483|455542322|FG000|Overall Study|Death|1|||
126612991|NCT02706483|455542322|FG000|Overall Study|Lack of Efficacy|39|||
126612992|NCT02706483|455542322|FG000|Overall Study|Lost to Follow-up|101|||
126612993|NCT02706483|455542322|FG000|Overall Study|Non-compliance with study drug|15|||
126612994|NCT02706483|455542322|FG000|Overall Study|Physician Decision|6|||
126612995|NCT02706483|455542322|FG000|Overall Study|Pregnancy|6|||
126612996|NCT02706483|455542322|FG000|Overall Study|Protocol Violation|18|||
126612997|NCT02706483|455542322|FG000|Overall Study|Withdrawal by Subject|136|||
126612998|NCT02706483|455542322|FG000|Overall Study|Non-compliance with visits|6|||
126612999|NCT02706483|455542322|FG000|Overall Study|Site closure|4|||
126613000|NCT02706483|455542322|FG000|Overall Study|Subject moved|1|||
126613001|NCT01972776|455542323|FG000|Part 1|Withdrawal by Subject|0|||
126613002|NCT01972776|455542324|FG001|Part 1|Withdrawal by Subject|0|||
126613003|NCT01972776|455542325|FG002|Part 1|Withdrawal by Subject|1|||
126613004|NCT01972776|455542326|FG003|Part 1|Withdrawal by Subject|0|||
126613005|NCT01972776|455542327|FG004|Part 1|Withdrawal by Subject|0|||
126613006|NCT01972776|455542328|FG005|Part 1|Withdrawal by Subject|0|||
126613007|NCT01972776|455542323|FG000|Part 1|Adverse Event|0|||
126613008|NCT01972776|455542324|FG001|Part 1|Adverse Event|0|||
126613009|NCT01972776|455542325|FG002|Part 1|Adverse Event|1|||
126613010|NCT01972776|455542326|FG003|Part 1|Adverse Event|1|||
126613011|NCT01972776|455542327|FG004|Part 1|Adverse Event|0|||
126613012|NCT01972776|455542328|FG005|Part 1|Adverse Event|0|||
126613013|NCT01972776|455542323|FG000|Part 2|Adverse Event|0|||
126613014|NCT01972776|455542324|FG001|Part 2|Adverse Event|0|||
126613015|NCT01972776|455542325|FG002|Part 2|Adverse Event|0|||
126613016|NCT01972776|455542326|FG003|Part 2|Adverse Event|0|||
126613017|NCT01972776|455542327|FG004|Part 2|Adverse Event|3|||
126613018|NCT01972776|455542328|FG005|Part 2|Adverse Event|0|||
126613019|NCT01972776|455542323|FG000|Part 2|Administrative problems|0|||
126613020|NCT01972776|455542324|FG001|Part 2|Administrative problems|0|||
126613021|NCT01972776|455542325|FG002|Part 2|Administrative problems|0|||
126613022|NCT01972776|455542326|FG003|Part 2|Administrative problems|0|||
126613023|NCT01972776|455542327|FG004|Part 2|Administrative problems|10|||
126613024|NCT01972776|455542328|FG005|Part 2|Administrative problems|7|||
126613025|NCT01543204|455542329|FG000|Overall Study|Non-compliance|1|||
126613026|NCT01543204|455542329|FG000|Overall Study|Adverse Event|1|||
126613027|NCT01543204|455542329|FG000|Overall Study|Withdrawal by Subject|4|||
126613028|NCT01543204|455542329|FG000|Overall Study|Requirement for Alternative Therapy|1|||
126613029|NCT01543204|455542329|FG000|Overall Study|Lost to Follow-up|1|||
126613030|NCT02449902|455542333|FG000|Overall Study|Adverse Event|0|||
126613031|NCT02449902|455542334|FG001|Overall Study|Adverse Event|1|||
126613032|NCT02449902|455542333|FG000|Overall Study|Withdrawal by Subject|0|||
126613033|NCT02449902|455542334|FG001|Overall Study|Withdrawal by Subject|1|||
126613034|NCT02362789|455542335|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
126613035|NCT02362789|455542336|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
126613036|NCT02362789|455542337|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
126613037|NCT02362789|455542335|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
126613038|NCT02362789|455542336|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
126613039|NCT02362789|455542337|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
126613040|NCT02362789|455542335|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
126613041|NCT02362789|455542336|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
126613042|NCT02362789|455542337|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
126613043|NCT02362789|455542335|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
126613044|NCT02362789|455542336|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
126613045|NCT02362789|455542337|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
126613046|NCT02362789|455542335|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
126613047|NCT02362789|455542336|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
126613048|NCT02362789|455542337|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
126613049|NCT00068107|455542344|FG000|Overall Study|end-stage renal disease|6|||
126613050|NCT00068107|455542344|FG000|Overall Study|Death|2|||
126613051|NCT00068107|455542344|FG000|Overall Study|Withdrawal by Subject|1|||
126613052|NCT03288506|455542345|FG000|Overall Study|Withdrawal by Subject|52|||
126613053|NCT01419184|455542348|FG000|Overall Study|Site data not available|3|||
126613054|NCT01419184|455542349|FG001|Overall Study|Site data not available|2|||
126613055|NCT01419184|455542348|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
126613056|NCT01419184|455542349|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
126613057|NCT01419184|455542348|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
126735998|NCT01001234|455983417|FG002|Overall Study|Not Treated: Adverse Event|0|||
126613058|NCT01419184|455542349|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
126735999|NCT01001234|455983418|FG003|Overall Study|Not Treated: Adverse Event|0|||
126613059|NCT01419184|455542348|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
126613060|NCT01419184|455542349|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
126613061|NCT01419184|455542348|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
126613062|NCT01419184|455542349|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
126613063|NCT01419184|455542348|FG000|Overall Study|Participant randomized, not treated|1|||
126613064|NCT01419184|455542349|FG001|Overall Study|Participant randomized, not treated|0|||
126613065|NCT01316913|455542350|FG000|Overall Study|Adverse Event|17|||
126613066|NCT01316913|455542351|FG001|Overall Study|Adverse Event|20|||
126613067|NCT01316913|455542352|FG002|Overall Study|Adverse Event|15|||
126613068|NCT01316913|455542353|FG003|Overall Study|Adverse Event|11|||
126613069|NCT01316913|455542350|FG000|Overall Study|Lack of Efficacy|22|||
126613070|NCT01316913|455542351|FG001|Overall Study|Lack of Efficacy|12|||
126613071|NCT01316913|455542352|FG002|Overall Study|Lack of Efficacy|9|||
126613072|NCT01316913|455542353|FG003|Overall Study|Lack of Efficacy|13|||
126613073|NCT01316913|455542350|FG000|Overall Study|Protocol Violation|1|||
126613074|NCT01316913|455542351|FG001|Overall Study|Protocol Violation|4|||
126613075|NCT01316913|455542352|FG002|Overall Study|Protocol Violation|4|||
126613076|NCT01316913|455542353|FG003|Overall Study|Protocol Violation|1|||
126613077|NCT01316913|455542350|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
126613078|NCT01316913|455542351|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
126613079|NCT01316913|455542352|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
126613080|NCT01316913|455542353|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
126613081|NCT01316913|455542350|FG000|Overall Study|Lost to Follow-up|0|||
126613082|NCT01316913|455542351|FG001|Overall Study|Lost to Follow-up|1|||
126613083|NCT01316913|455542352|FG002|Overall Study|Lost to Follow-up|0|||
126613084|NCT01316913|455542353|FG003|Overall Study|Lost to Follow-up|2|||
126613085|NCT01316913|455542350|FG000|Overall Study|Withdrawal by Subject|10|||
126613086|NCT01316913|455542351|FG001|Overall Study|Withdrawal by Subject|9|||
126613087|NCT01316913|455542352|FG002|Overall Study|Withdrawal by Subject|10|||
126613088|NCT01316913|455542353|FG003|Overall Study|Withdrawal by Subject|6|||
126613089|NCT02691702|455542354|FG000|Overall Study|Adverse Event|1|||
126613090|NCT02691702|455542355|FG001|Overall Study|Adverse Event|0|||
126613091|NCT02691702|455542356|FG002|Overall Study|Adverse Event|0|||
126613092|NCT02691702|455542357|FG003|Overall Study|Adverse Event|0|||
126613093|NCT02691702|455542358|FG004|Overall Study|Adverse Event|0|||
126613094|NCT02691702|455542359|FG005|Overall Study|Adverse Event|0|||
126613095|NCT02691702|455542360|FG006|Overall Study|Adverse Event|0|||
126613096|NCT02691702|455542361|FG007|Overall Study|Adverse Event|0|||
126613097|NCT02691702|455542362|FG008|Overall Study|Adverse Event|1|||
126613098|NCT02691702|455542363|FG009|Overall Study|Adverse Event|0|||
126613099|NCT02691702|455542364|FG010|Overall Study|Adverse Event|1|||
126613100|NCT02691702|455542354|FG000|Overall Study|Lost to Follow-up|0|||
126613101|NCT02691702|455542355|FG001|Overall Study|Lost to Follow-up|0|||
126613102|NCT02691702|455542356|FG002|Overall Study|Lost to Follow-up|1|||
126613103|NCT02691702|455542357|FG003|Overall Study|Lost to Follow-up|0|||
126613104|NCT02691702|455542358|FG004|Overall Study|Lost to Follow-up|0|||
126613105|NCT02691702|455542359|FG005|Overall Study|Lost to Follow-up|2|||
126613106|NCT02691702|455542360|FG006|Overall Study|Lost to Follow-up|0|||
126613107|NCT02691702|455542361|FG007|Overall Study|Lost to Follow-up|0|||
126613108|NCT02691702|455542362|FG008|Overall Study|Lost to Follow-up|0|||
126613109|NCT02691702|455542363|FG009|Overall Study|Lost to Follow-up|0|||
126613110|NCT02691702|455542364|FG010|Overall Study|Lost to Follow-up|1|||
126613111|NCT02691702|455542354|FG000|Overall Study|Withdrawal by Subject|1|||
126613112|NCT02691702|455542355|FG001|Overall Study|Withdrawal by Subject|1|||
126613113|NCT02691702|455542356|FG002|Overall Study|Withdrawal by Subject|0|||
126613114|NCT02691702|455542357|FG003|Overall Study|Withdrawal by Subject|0|||
126613115|NCT02691702|455542358|FG004|Overall Study|Withdrawal by Subject|0|||
126613116|NCT02691702|455542359|FG005|Overall Study|Withdrawal by Subject|1|||
126613117|NCT02691702|455542360|FG006|Overall Study|Withdrawal by Subject|2|||
126613118|NCT02691702|455542361|FG007|Overall Study|Withdrawal by Subject|0|||
126613119|NCT02691702|455542362|FG008|Overall Study|Withdrawal by Subject|0|||
126613120|NCT02691702|455542363|FG009|Overall Study|Withdrawal by Subject|0|||
126613121|NCT02691702|455542364|FG010|Overall Study|Withdrawal by Subject|0|||
126613122|NCT02691702|455542354|FG000|Overall Study|Other|0|||
126613123|NCT02691702|455542355|FG001|Overall Study|Other|0|||
126613124|NCT02691702|455542356|FG002|Overall Study|Other|0|||
126613125|NCT02691702|455542357|FG003|Overall Study|Other|0|||
126613126|NCT02691702|455542358|FG004|Overall Study|Other|0|||
126613127|NCT02691702|455542359|FG005|Overall Study|Other|0|||
126613128|NCT02691702|455542360|FG006|Overall Study|Other|1|||
126613129|NCT02691702|455542361|FG007|Overall Study|Other|0|||
126613130|NCT02691702|455542362|FG008|Overall Study|Other|1|||
126613131|NCT02691702|455542363|FG009|Overall Study|Other|0|||
126613132|NCT02691702|455542364|FG010|Overall Study|Other|0|||
126613133|NCT02691702|455542354|FG000|Overall Study|Protocol Violation|0|||
126613134|NCT02691702|455542355|FG001|Overall Study|Protocol Violation|0|||
126613135|NCT02691702|455542356|FG002|Overall Study|Protocol Violation|0|||
126613136|NCT02691702|455542357|FG003|Overall Study|Protocol Violation|0|||
126613137|NCT02691702|455542358|FG004|Overall Study|Protocol Violation|0|||
126613138|NCT02691702|455542359|FG005|Overall Study|Protocol Violation|0|||
126736000|NCT01001234|455983419|FG004|Overall Study|Not Treated: Adverse Event|0|||
126736001|NCT01001234|455983415|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
126736002|NCT01001234|455983416|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
126736003|NCT01001234|455983417|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
126736004|NCT01001234|455983418|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
126736005|NCT01001234|455983419|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
126736006|NCT01001234|455983415|FG000|Overall Study|Not Treated: Protocol Violation|3|||
126736007|NCT01001234|455983416|FG001|Overall Study|Not Treated: Protocol Violation|0|||
126736008|NCT01001234|455983417|FG002|Overall Study|Not Treated: Protocol Violation|0|||
126736009|NCT01001234|455983418|FG003|Overall Study|Not Treated: Protocol Violation|0|||
126736010|NCT01001234|455983419|FG004|Overall Study|Not Treated: Protocol Violation|0|||
126736011|NCT01001234|455983415|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
126736012|NCT01001234|455983416|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
126736013|NCT01001234|455983417|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
126736014|NCT01001234|455983418|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
126736015|NCT01001234|455983419|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
126736016|NCT01001234|455983415|FG000|Overall Study|Not Treated: Pregnancy|3|||
126736017|NCT01001234|455983416|FG001|Overall Study|Not Treated: Pregnancy|0|||
126736018|NCT01001234|455983417|FG002|Overall Study|Not Treated: Pregnancy|0|||
126736019|NCT01001234|455983418|FG003|Overall Study|Not Treated: Pregnancy|0|||
126736020|NCT01001234|455983419|FG004|Overall Study|Not Treated: Pregnancy|0|||
126736021|NCT01001234|455983415|FG000|Overall Study|Not Treated: Physician Decision|37|||
126736022|NCT01001234|455983416|FG001|Overall Study|Not Treated: Physician Decision|4|||
126736023|NCT01001234|455983417|FG002|Overall Study|Not Treated: Physician Decision|0|||
126736024|NCT01001234|455983418|FG003|Overall Study|Not Treated: Physician Decision|0|||
126736025|NCT01001234|455983419|FG004|Overall Study|Not Treated: Physician Decision|0|||
126736026|NCT01001234|455983415|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
126736027|NCT01001234|455983416|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
126736028|NCT01001234|455983417|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
126736029|NCT01001234|455983418|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
126736030|NCT01001234|455983419|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
126736031|NCT01611298|455983420|FG000|Overall Study|Relapsed|2|||
126736032|NCT00753623|455983421|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
126736033|NCT00753623|455983422|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
126736034|NCT00753623|455983421|FG000|Phase I (14 Days)|Physician Decision|1|||
126736035|NCT00753623|455983422|FG001|Phase I (14 Days)|Physician Decision|2|||
126736036|NCT00753623|455983421|FG000|Phase I (14 Days)|Adverse Event|0|||
126736037|NCT00753623|455983422|FG001|Phase I (14 Days)|Adverse Event|1|||
126736038|NCT00753623|455983421|FG000|Washout (7 Days)|Physician Decision|1|||
126736039|NCT00753623|455983422|FG001|Washout (7 Days)|Physician Decision|0|||
126736040|NCT00753623|455983421|FG000|Phase II (14 Days)|Physician Decision|0|||
126736041|NCT00753623|455983422|FG001|Phase II (14 Days)|Physician Decision|1|||
126736042|NCT03332303|455983423|FG000|Overall Study|Participant did not dose|1|||
126736043|NCT03332303|455983424|FG001|Overall Study|Participant did not dose|2|||
126736044|NCT03332303|455983425|FG002|Overall Study|Participant did not dose|0|||
126736045|NCT03332303|455983423|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
126736046|NCT03332303|455983424|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
126736047|NCT03332303|455983425|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
126736048|NCT03332303|455983423|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
126736049|NCT03332303|455983424|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
126736050|NCT03332303|455983425|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
126736051|NCT03332303|455983423|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
126736052|NCT03332303|455983424|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
126736053|NCT03332303|455983425|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
126736054|NCT03332303|455983423|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
126736055|NCT03332303|455983424|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
126736056|NCT03332303|455983425|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
126736057|NCT03332303|455983423|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
126736058|NCT03332303|455983424|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
126736059|NCT03332303|455983425|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
126736060|NCT03332303|455983423|FG000|Overall Study|Participant had a significant protocol deviation|0|||
126736061|NCT03332303|455983424|FG001|Overall Study|Participant had a significant protocol deviation|1|||
126736062|NCT03332303|455983425|FG002|Overall Study|Participant had a significant protocol deviation|0|||
126736063|NCT03639987|455983426|FG000|Overall Study|Study terminated by sponsor|26|||
126736064|NCT03639987|455983427|FG001|Overall Study|Study terminated by sponsor|25|||
126736065|NCT03639987|455983426|FG000|Overall Study|Lost to Follow-up|0|||
126736066|NCT03639987|455983427|FG001|Overall Study|Lost to Follow-up|1|||
126736067|NCT00425100|455983428|FG000|Overall Study|Adverse Event|36|||
126736068|NCT00425100|455983428|FG000|Overall Study|Lack of Efficacy|4|||
126613139|NCT02691702|455542360|FG006|Overall Study|Protocol Violation|0|||
126613140|NCT02691702|455542361|FG007|Overall Study|Protocol Violation|0|||
126613141|NCT02691702|455542362|FG008|Overall Study|Protocol Violation|0|||
126613142|NCT02691702|455542363|FG009|Overall Study|Protocol Violation|2|||
126613143|NCT02691702|455542364|FG010|Overall Study|Protocol Violation|0|||
126613144|NCT01668719|455542365|FG000|Phase I|On treatment|1|||
126613145|NCT01668719|455542366|FG001|Phase I|On treatment|0|||
126613146|NCT01668719|455542367|FG002|Phase I|On treatment|0|||
126613147|NCT01668719|455542365|FG000|Phase I|Adverse Event|2|||
126613148|NCT01668719|455542366|FG001|Phase I|Adverse Event|0|||
126613149|NCT01668719|455542367|FG002|Phase I|Adverse Event|0|||
126613150|NCT01668719|455542365|FG000|Phase I|Progression/relapse|1|||
126613151|NCT01668719|455542366|FG001|Phase I|Progression/relapse|0|||
126613152|NCT01668719|455542367|FG002|Phase I|Progression/relapse|0|||
126613153|NCT01668719|455542365|FG000|Phase I|not protocol specified|2|||
126613154|NCT01668719|455542366|FG001|Phase I|not protocol specified|0|||
126613155|NCT01668719|455542367|FG002|Phase I|not protocol specified|0|||
126613156|NCT01668719|455542365|FG000|Phase II|On treatment|0|||
126613157|NCT01668719|455542366|FG001|Phase II|On treatment|4|||
126613158|NCT01668719|455542367|FG002|Phase II|On treatment|3|||
126613159|NCT01668719|455542365|FG000|Phase II|Adverse Event|0|||
126613160|NCT01668719|455542366|FG001|Phase II|Adverse Event|18|||
126613161|NCT01668719|455542367|FG002|Phase II|Adverse Event|18|||
126613162|NCT01668719|455542365|FG000|Phase II|Refusal unrelated to adverse event|0|||
126613163|NCT01668719|455542366|FG001|Phase II|Refusal unrelated to adverse event|4|||
126613164|NCT01668719|455542367|FG002|Phase II|Refusal unrelated to adverse event|1|||
126613165|NCT01668719|455542365|FG000|Phase II|Progression/relapse|0|||
126613166|NCT01668719|455542366|FG001|Phase II|Progression/relapse|13|||
126613167|NCT01668719|455542367|FG002|Phase II|Progression/relapse|17|||
126613168|NCT01668719|455542365|FG000|Phase II|Death|0|||
126613169|NCT01668719|455542366|FG001|Phase II|Death|0|||
126613170|NCT01668719|455542367|FG002|Phase II|Death|2|||
126613171|NCT01668719|455542365|FG000|Phase II|not protocol specified|0|||
126613172|NCT01668719|455542366|FG001|Phase II|not protocol specified|13|||
126613173|NCT01668719|455542367|FG002|Phase II|not protocol specified|7|||
126613174|NCT00875706|455542368|FG000|Overall Study|Withdrawal by Subject|1|||
126613175|NCT00875706|455542369|FG001|Overall Study|Withdrawal by Subject|0|||
126613176|NCT00875706|455542370|FG002|Overall Study|Withdrawal by Subject|0|||
126613177|NCT01856569|455542371|FG000|Overall Study|Other|1|||
126613178|NCT01856569|455542371|FG000|Overall Study|Changed Site/Structure|1|||
126613179|NCT01856569|455542371|FG000|Overall Study|Lost to Follow-up|3|||
126613180|NCT01856569|455542371|FG000|Overall Study|Did not met inclusion criteria|8|||
126613181|NCT01860079|455542372|FG000|Overall Study|Physician Decision|14|||
126613182|NCT01860079|455542373|FG001|Overall Study|Physician Decision|22|||
126613183|NCT00786188|455542374|FG000|Overall Study|Adverse Event|3|||
126613184|NCT00786188|455542375|FG001|Overall Study|Adverse Event|1|||
126613185|NCT00786188|455542374|FG000|Overall Study|Withdrawal by Subject|2|||
126613186|NCT00786188|455542375|FG001|Overall Study|Withdrawal by Subject|0|||
126613187|NCT02279732|455542377|FG000|Overall Study|Death|23|||
126613188|NCT02279732|455542378|FG001|Overall Study|Death|20|||
126613189|NCT02279732|455542377|FG000|Overall Study|Disease Progression|13|||
126613190|NCT02279732|455542378|FG001|Overall Study|Disease Progression|3|||
126613191|NCT02279732|455542377|FG000|Overall Study|Withdrawal by Subject|2|||
126613192|NCT02279732|455542378|FG001|Overall Study|Withdrawal by Subject|7|||
126613193|NCT02279732|455542377|FG000|Overall Study|Adverse Event|1|||
126613194|NCT02279732|455542378|FG001|Overall Study|Adverse Event|2|||
126613195|NCT02279732|455542377|FG000|Overall Study|Administrative Reason By Sponsor|0|||
126613196|NCT02279732|455542378|FG001|Overall Study|Administrative Reason By Sponsor|2|||
126613197|NCT02279732|455542377|FG000|Overall Study|Study Drug Toxicity|2|||
126613198|NCT02279732|455542378|FG001|Overall Study|Study Drug Toxicity|0|||
126613199|NCT02279732|455542377|FG000|Overall Study|Lost to Follow-up|0|||
126613200|NCT02279732|455542378|FG001|Overall Study|Lost to Follow-up|1|||
126613201|NCT02279732|455542377|FG000|Overall Study|Maximum Clinical Benefit|1|||
126781323|NCT00358826|456154511|FG003|MDCT Substudy|Withdrawal by Subject|0|||
126781324|NCT00358826|456154512|FG004|MDCT Substudy|Withdrawal by Subject|0|||
126781325|NCT00358826|456154513|FG005|MDCT Substudy|Withdrawal by Subject|1|||
126613202|NCT02279732|455542378|FG001|Overall Study|Maximum Clinical Benefit|0|||
126613203|NCT02279732|455542377|FG000|Overall Study|Subject Requested to Discontinue|0|||
126613204|NCT02279732|455542378|FG001|Overall Study|Subject Requested to Discontinue|1|||
126781326|NCT00358826|456154514|FG006|MDCT Substudy|Withdrawal by Subject|0|||
126781327|NCT00358826|456154515|FG007|MDCT Substudy|Withdrawal by Subject|0|||
126781328|NCT00903383|456154519|FG000|Overall Study|Adverse Event|1|||
126781329|NCT00903383|456154520|FG001|Overall Study|Adverse Event|2|||
126781330|NCT00903383|456154521|FG002|Overall Study|Adverse Event|3|||
126613205|NCT02279732|455542377|FG000|Overall Study|Other|53|||
126613206|NCT02279732|455542378|FG001|Overall Study|Other|67|||
126613207|NCT02279732|455542377|FG000|Overall Study|Other|3|||
126613208|NCT02279732|455542378|FG001|Overall Study|Other|3|||
126613209|NCT02970318|455542379|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
126613210|NCT02970318|455542380|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
126736069|NCT00425100|455983428|FG000|Overall Study|Lost to Follow-up|2|||
126736070|NCT00425100|455983428|FG000|Overall Study|Protocol Violation|4|||
126736071|NCT00425100|455983428|FG000|Overall Study|Withdrawal by Subject|7|||
126736072|NCT00555906|455983429|FG000|Phase 1|Objective Progression or Relapse|3|||
126736073|NCT00555906|455983430|FG001|Phase 1|Objective Progression or Relapse|5|||
126736074|NCT00555906|455983431|FG002|Phase 1|Objective Progression or Relapse|3|||
126736075|NCT00555906|455983432|FG003|Phase 1|Objective Progression or Relapse|1|||
126736076|NCT00555906|455983433|FG004|Phase 1|Objective Progression or Relapse|0|||
126736077|NCT00555906|455983429|FG000|Phase 1|Global Deterioration of Health Status|0|||
126736078|NCT00555906|455983430|FG001|Phase 1|Global Deterioration of Health Status|1|||
126736079|NCT00555906|455983431|FG002|Phase 1|Global Deterioration of Health Status|1|||
126736080|NCT00555906|455983432|FG003|Phase 1|Global Deterioration of Health Status|1|||
126736081|NCT00555906|455983433|FG004|Phase 1|Global Deterioration of Health Status|0|||
126736082|NCT00555906|455983429|FG000|Phase 1|Adverse Event|0|||
126736083|NCT00555906|455983430|FG001|Phase 1|Adverse Event|0|||
126736084|NCT00555906|455983431|FG002|Phase 1|Adverse Event|3|||
126736085|NCT00555906|455983432|FG003|Phase 1|Adverse Event|2|||
126736086|NCT00555906|455983433|FG004|Phase 1|Adverse Event|0|||
126736087|NCT00555906|455983429|FG000|Phase 1|Withdrawal by Subject|0|||
126736088|NCT00555906|455983430|FG001|Phase 1|Withdrawal by Subject|0|||
126736089|NCT00555906|455983431|FG002|Phase 1|Withdrawal by Subject|0|||
126736090|NCT00555906|455983432|FG003|Phase 1|Withdrawal by Subject|1|||
126736091|NCT00555906|455983433|FG004|Phase 1|Withdrawal by Subject|0|||
126736092|NCT00555906|455983429|FG000|Phase 2|Adverse Event|0|||
126736093|NCT00555906|455983430|FG001|Phase 2|Adverse Event|0|||
126736094|NCT00555906|455983431|FG002|Phase 2|Adverse Event|0|||
126736095|NCT00555906|455983432|FG003|Phase 2|Adverse Event|0|||
126736096|NCT00555906|455983433|FG004|Phase 2|Adverse Event|4|||
126736097|NCT00555906|455983429|FG000|Phase 2|Global Deterioration of Health Status|0|||
126736098|NCT00555906|455983430|FG001|Phase 2|Global Deterioration of Health Status|0|||
126736099|NCT00555906|455983431|FG002|Phase 2|Global Deterioration of Health Status|0|||
126736100|NCT00555906|455983432|FG003|Phase 2|Global Deterioration of Health Status|0|||
126736101|NCT00555906|455983433|FG004|Phase 2|Global Deterioration of Health Status|2|||
126736102|NCT00555906|455983429|FG000|Phase 2|Objective Progression or Relapse|0|||
126736103|NCT00555906|455983430|FG001|Phase 2|Objective Progression or Relapse|0|||
126736104|NCT00555906|455983431|FG002|Phase 2|Objective Progression or Relapse|0|||
126736105|NCT00555906|455983432|FG003|Phase 2|Objective Progression or Relapse|0|||
126736106|NCT00555906|455983433|FG004|Phase 2|Objective Progression or Relapse|16|||
126736107|NCT00555906|455983429|FG000|Phase 2|Withdrawal by Subject|0|||
126736108|NCT00555906|455983430|FG001|Phase 2|Withdrawal by Subject|0|||
126736109|NCT00555906|455983431|FG002|Phase 2|Withdrawal by Subject|0|||
126736110|NCT00555906|455983432|FG003|Phase 2|Withdrawal by Subject|0|||
126736111|NCT00555906|455983433|FG004|Phase 2|Withdrawal by Subject|2|||
126736112|NCT00555906|455983429|FG000|Phase 2|Other|0|||
126736113|NCT00555906|455983430|FG001|Phase 2|Other|0|||
126736114|NCT00555906|455983431|FG002|Phase 2|Other|0|||
126736115|NCT00555906|455983432|FG003|Phase 2|Other|0|||
126736116|NCT00555906|455983433|FG004|Phase 2|Other|6|||
126736117|NCT00555906|455983429|FG000|Phase 2|Randomized but not Treated|0|||
126736118|NCT00555906|455983430|FG001|Phase 2|Randomized but not Treated|0|||
126736119|NCT00555906|455983431|FG002|Phase 2|Randomized but not Treated|0|||
126736120|NCT00555906|455983432|FG003|Phase 2|Randomized but not Treated|0|||
126736121|NCT00555906|455983433|FG004|Phase 2|Randomized but not Treated|2|||
126736122|NCT00889681|455983434|FG000|Overall Study|Not meeting qualification Criteria|2|||
126736123|NCT00889681|455983434|FG000|Overall Study|Insurance disapproval|1|||
126736124|NCT00788697|455983440|FG000|Overall Study|No study drug administered|12|||
126736125|NCT00788697|455983440|FG000|Overall Study|Training Patients|74|||
126736126|NCT00788697|455983440|FG000|Overall Study|no truth standard procedure available|5|||
126736127|NCT00788697|455983440|FG000|Overall Study|Technically inadequate truth standard|1|||
126736128|NCT00788697|455983440|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
126736129|NCT02671461|455983441|FG000|Treatment|Adverse Event|0|||
126736130|NCT02671461|455983442|FG001|Treatment|Adverse Event|0|||
126736131|NCT02671461|455983443|FG002|Treatment|Adverse Event|1|||
126736132|NCT02671461|455983441|FG000|Treatment|Administrative Reason by Sponsor|1|||
126736133|NCT02671461|455983442|FG001|Treatment|Administrative Reason by Sponsor|3|||
126736134|NCT02671461|455983443|FG002|Treatment|Administrative Reason by Sponsor|4|||
126736135|NCT02671461|455983441|FG000|Treatment|Randomized, not treated|1|||
126736136|NCT02671461|455983442|FG001|Treatment|Randomized, not treated|0|||
126736137|NCT02671461|455983443|FG002|Treatment|Randomized, not treated|0|||
126736138|NCT02671461|455983441|FG000|Follow-up|Withdrawal by Subject|1|||
126736139|NCT02671461|455983442|FG001|Follow-up|Withdrawal by Subject|0|||
126736140|NCT02671461|455983443|FG002|Follow-up|Withdrawal by Subject|0|||
126736141|NCT02671461|455983441|FG000|Follow-up|Lost to Follow-up|0|||
126736142|NCT02671461|455983442|FG001|Follow-up|Lost to Follow-up|0|||
126781331|NCT00903383|456154522|FG003|Overall Study|Adverse Event|1|||
126736143|NCT02671461|455983443|FG002|Follow-up|Lost to Follow-up|1|||
126736144|NCT02671461|455983441|FG000|Follow-up|Administrative Reason by Sponsor|0|||
126736145|NCT02671461|455983442|FG001|Follow-up|Administrative Reason by Sponsor|1|||
126613211|NCT02970318|455542381|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
126613212|NCT02970318|455542382|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
126613213|NCT02970318|455542379|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
126613214|NCT02970318|455542380|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
126613215|NCT02970318|455542381|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
126613216|NCT02970318|455542382|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
126613217|NCT02970318|455542379|FG000|Overall for Arm A & Main for Arm B|Death|41|||
126613218|NCT02970318|455542380|FG001|Overall for Arm A & Main for Arm B|Death|33|||
126613219|NCT02970318|455542381|FG002|Overall for Arm A & Main for Arm B|Death|0|||
126613220|NCT02970318|455542382|FG003|Overall for Arm A & Main for Arm B|Death|0|||
126613221|NCT02970318|455542379|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
126613222|NCT02970318|455542380|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
126613223|NCT02970318|455542381|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
126613224|NCT02970318|455542382|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
126613225|NCT02970318|455542379|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
126613226|NCT02970318|455542380|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
126613227|NCT02970318|455542381|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
126613228|NCT02970318|455542382|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
126613229|NCT02970318|455542379|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
126613230|NCT02970318|455542380|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
126613231|NCT02970318|455542381|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
126613232|NCT02970318|455542382|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
126613233|NCT02970318|455542379|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
126613234|NCT02970318|455542380|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
126613235|NCT02970318|455542381|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
126613236|NCT02970318|455542382|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
126613237|NCT00824408|455542383|FG000|Run-in Phase|Progressive disease|4|||
126613238|NCT00824408|455542384|FG001|Run-in Phase|Progressive disease|4|||
126613239|NCT00824408|455542385|FG002|Run-in Phase|Progressive disease|0|||
126613240|NCT00824408|455542386|FG003|Run-in Phase|Progressive disease|0|||
126613241|NCT00824408|455542387|FG004|Run-in Phase|Progressive disease|0|||
126613242|NCT00824408|455542383|FG000|Run-in Phase|Adverse Event|1|||
126613243|NCT00824408|455542384|FG001|Run-in Phase|Adverse Event|1|||
126613244|NCT00824408|455542385|FG002|Run-in Phase|Adverse Event|0|||
126613245|NCT00824408|455542386|FG003|Run-in Phase|Adverse Event|0|||
126613246|NCT00824408|455542387|FG004|Run-in Phase|Adverse Event|0|||
126613247|NCT00824408|455542383|FG000|Run-in Phase|Refused to continue medication|1|||
126613248|NCT00824408|455542384|FG001|Run-in Phase|Refused to continue medication|0|||
126613249|NCT00824408|455542385|FG002|Run-in Phase|Refused to continue medication|0|||
126613250|NCT00824408|455542386|FG003|Run-in Phase|Refused to continue medication|0|||
126613251|NCT00824408|455542387|FG004|Run-in Phase|Refused to continue medication|0|||
126613252|NCT00824408|455542383|FG000|Run-in Phase|Other reason not defined above|0|||
126613253|NCT00824408|455542384|FG001|Run-in Phase|Other reason not defined above|1|||
126613254|NCT00824408|455542385|FG002|Run-in Phase|Other reason not defined above|0|||
126613255|NCT00824408|455542386|FG003|Run-in Phase|Other reason not defined above|0|||
126613256|NCT00824408|455542387|FG004|Run-in Phase|Other reason not defined above|0|||
126613257|NCT00824408|455542383|FG000|Randomized Phase|Not treated|0|||
126613258|NCT00824408|455542384|FG001|Randomized Phase|Not treated|0|||
126613259|NCT00824408|455542385|FG002|Randomized Phase|Not treated|1|||
126613260|NCT00824408|455542386|FG003|Randomized Phase|Not treated|1|||
126613261|NCT00824408|455542387|FG004|Randomized Phase|Not treated|1|||
126613262|NCT00824408|455542383|FG000|Randomized Phase|Progressive disease|0|||
126613263|NCT00824408|455542384|FG001|Randomized Phase|Progressive disease|0|||
126613264|NCT00824408|455542385|FG002|Randomized Phase|Progressive disease|25|||
126613265|NCT00824408|455542386|FG003|Randomized Phase|Progressive disease|36|||
126613266|NCT00824408|455542387|FG004|Randomized Phase|Progressive disease|34|||
126613267|NCT00824408|455542383|FG000|Randomized Phase|Adverse Event|0|||
126613268|NCT00824408|455542384|FG001|Randomized Phase|Adverse Event|0|||
126613269|NCT00824408|455542385|FG002|Randomized Phase|Adverse Event|4|||
126613270|NCT00824408|455542386|FG003|Randomized Phase|Adverse Event|5|||
126613271|NCT00824408|455542387|FG004|Randomized Phase|Adverse Event|5|||
126613272|NCT00824408|455542383|FG000|Randomized Phase|Refused to continue medication|0|||
126613273|NCT00824408|455542384|FG001|Randomized Phase|Refused to continue medication|0|||
126613274|NCT00824408|455542385|FG002|Randomized Phase|Refused to continue medication|2|||
126613275|NCT00824408|455542386|FG003|Randomized Phase|Refused to continue medication|2|||
126613276|NCT00824408|455542387|FG004|Randomized Phase|Refused to continue medication|2|||
126613277|NCT00824408|455542383|FG000|Randomized Phase|Other reason not defined above|0|||
126613278|NCT00824408|455542384|FG001|Randomized Phase|Other reason not defined above|0|||
126736146|NCT02671461|455983443|FG002|Follow-up|Administrative Reason by Sponsor|0|||
126736147|NCT01412060|455983444|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
126736148|NCT01412060|455983445|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
126613279|NCT00824408|455542385|FG002|Randomized Phase|Other reason not defined above|4|||
126613280|NCT00824408|455542386|FG003|Randomized Phase|Other reason not defined above|2|||
126613281|NCT00824408|455542387|FG004|Randomized Phase|Other reason not defined above|4|||
126613282|NCT02915783|455542394|FG000|Overall Study|Death|21|||
126613283|NCT02915783|455542394|FG000|Overall Study|Lost to Follow-up|1|||
126613284|NCT02915783|455542394|FG000|Overall Study|Withdrawal by Subject|2|||
126613285|NCT01075152|455542397|FG000|Overall Study|Withdrawal by Subject|1|||
126613286|NCT01075152|455542398|FG001|Overall Study|Withdrawal by Subject|0|||
126613287|NCT02334215|455542399|FG000|Overall Study|Death|1|||
126613288|NCT02334215|455542400|FG001|Overall Study|Death|1|||
126613289|NCT02334215|455542401|FG002|Overall Study|Death|0|||
126613290|NCT02334215|455542399|FG000|Overall Study|Lost to Follow-up|1|||
126613291|NCT02334215|455542400|FG001|Overall Study|Lost to Follow-up|0|||
126613292|NCT02334215|455542401|FG002|Overall Study|Lost to Follow-up|4|||
126613293|NCT02334215|455542399|FG000|Overall Study|Withdrawal by Subject|2|||
126613294|NCT02334215|455542400|FG001|Overall Study|Withdrawal by Subject|2|||
126613295|NCT02334215|455542401|FG002|Overall Study|Withdrawal by Subject|1|||
126613296|NCT02334215|455542399|FG000|Overall Study|Not released from incarceration on time|3|||
126613297|NCT02334215|455542400|FG001|Overall Study|Not released from incarceration on time|3|||
126613298|NCT02334215|455542401|FG002|Overall Study|Not released from incarceration on time|3|||
126613299|NCT02334215|455542399|FG000|Overall Study|Incarcerated|0|||
126613300|NCT02334215|455542400|FG001|Overall Study|Incarcerated|0|||
126613301|NCT02334215|455542401|FG002|Overall Study|Incarcerated|7|||
126613302|NCT01523392|455544153|FG000|Treatment Period 1|Withdrawal by Subject|2|||
126613303|NCT01523392|455544154|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126613304|NCT01523392|455544153|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
126613305|NCT01523392|455544154|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
126613306|NCT01523392|455544153|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
126613307|NCT01523392|455544154|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
126613308|NCT01377844|455544156|FG000|Overall Study|Withdrawal by Subject|25|||
126613309|NCT01377844|455544157|FG001|Overall Study|Withdrawal by Subject|28|||
126613310|NCT01377844|455544156|FG000|Overall Study|Protocol Violation|2|||
126613311|NCT01377844|455544157|FG001|Overall Study|Protocol Violation|3|||
126613312|NCT01377844|455544156|FG000|Overall Study|Adverse Event|3|||
126613313|NCT01377844|455544157|FG001|Overall Study|Adverse Event|0|||
126613314|NCT01377844|455544156|FG000|Overall Study|Physician Decision|6|||
126613315|NCT01377844|455544157|FG001|Overall Study|Physician Decision|3|||
126613316|NCT01377844|455544156|FG000|Overall Study|Study terminated by Sponsor|0|||
126613317|NCT01377844|455544157|FG001|Overall Study|Study terminated by Sponsor|1|||
126613318|NCT02236611|455544159|FG000|Overall Study|Adverse Event|10|||
126613319|NCT02236611|455544160|FG001|Overall Study|Adverse Event|16|||
126613320|NCT02236611|455544159|FG000|Overall Study|Lack of Efficacy|4|||
126613321|NCT02236611|455544160|FG001|Overall Study|Lack of Efficacy|7|||
126613322|NCT02236611|455544159|FG000|Overall Study|Lost to Follow-up|0|||
126613323|NCT02236611|455544160|FG001|Overall Study|Lost to Follow-up|2|||
126613324|NCT02236611|455544159|FG000|Overall Study|Protocol deviation|3|||
126613325|NCT02236611|455544160|FG001|Overall Study|Protocol deviation|5|||
126613326|NCT02236611|455544159|FG000|Overall Study|Withdrew consent|9|||
126613327|NCT02236611|455544160|FG001|Overall Study|Withdrew consent|4|||
126613328|NCT03403036|455544164|FG000|Overall Study|Lack of Efficacy|5|||
126613329|NCT02701296|455544167|FG000|Overall Study|Incomplete Data|0|||
126613330|NCT02701296|455544168|FG001|Overall Study|Incomplete Data|2|||
126613331|NCT02958553|455544169|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
126613332|NCT02958553|455544169|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
126613333|NCT01686152|455544170|FG000|Overall Study|Withdrawal by Subject|11|||
126613334|NCT01686152|455544171|FG001|Overall Study|Withdrawal by Subject|11|||
126613335|NCT01686152|455544172|FG002|Overall Study|Withdrawal by Subject|3|||
126613336|NCT01686152|455544170|FG000|Overall Study|Drug Code Unblinded|0|||
126613337|NCT01686152|455544171|FG001|Overall Study|Drug Code Unblinded|1|||
126613338|NCT01686152|455544172|FG002|Overall Study|Drug Code Unblinded|0|||
126613339|NCT01686152|455544170|FG000|Overall Study|Protocol Violation|6|||
126613340|NCT01686152|455544171|FG001|Overall Study|Protocol Violation|1|||
126613341|NCT01686152|455544172|FG002|Overall Study|Protocol Violation|0|||
126613342|NCT01686152|455544170|FG000|Overall Study|Adverse Event|12|||
126613343|NCT01686152|455544171|FG001|Overall Study|Adverse Event|11|||
126613344|NCT01686152|455544172|FG002|Overall Study|Adverse Event|0|||
126613345|NCT01686152|455544170|FG000|Overall Study|Lack of Efficacy|0|||
126613346|NCT01686152|455544171|FG001|Overall Study|Lack of Efficacy|0|||
126613347|NCT01686152|455544172|FG002|Overall Study|Lack of Efficacy|1|||
126613348|NCT01686152|455544170|FG000|Overall Study|IP Non-compliance|5|||
126613349|NCT01686152|455544171|FG001|Overall Study|IP Non-compliance|5|||
126613350|NCT01686152|455544172|FG002|Overall Study|IP Non-compliance|0|||
126613351|NCT01686152|455544170|FG000|Overall Study|Lost to Follow-up|7|||
126613352|NCT01686152|455544171|FG001|Overall Study|Lost to Follow-up|6|||
126613353|NCT01686152|455544172|FG002|Overall Study|Lost to Follow-up|5|||
126613354|NCT00704340|455544174|FG000|Overall Study|Lost to Follow-up|2|||
126613355|NCT00704340|455544175|FG001|Overall Study|Lost to Follow-up|1|||
126613356|NCT00704340|455544174|FG000|Overall Study|Death|0|||
126736149|NCT01412060|455983446|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
126736150|NCT01412060|455983444|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
126736151|NCT01412060|455983445|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
126736152|NCT01412060|455983446|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
126736153|NCT01412060|455983444|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
126736154|NCT01412060|455983445|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
126736155|NCT01412060|455983446|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
126736156|NCT01412060|455983444|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
126736157|NCT01412060|455983445|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
126736158|NCT01412060|455983446|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
126736159|NCT01412060|455983444|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
126736160|NCT01412060|455983445|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
126736161|NCT01412060|455983446|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
126736162|NCT01412060|455983444|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
126736163|NCT01412060|455983445|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
126736164|NCT01412060|455983446|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
126736165|NCT01412060|455983444|FG000|Period Between RIP and SP|Adverse Event|4|||
126736166|NCT01412060|455983445|FG001|Period Between RIP and SP|Adverse Event|0|||
126736167|NCT01412060|455983446|FG002|Period Between RIP and SP|Adverse Event|0|||
126736168|NCT01412060|455983444|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
126736169|NCT01412060|455983445|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
126736170|NCT01412060|455983446|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
126736171|NCT01412060|455983444|FG000|Period Between RIP and SP|Protocol Violation|2|||
126736172|NCT01412060|455983445|FG001|Period Between RIP and SP|Protocol Violation|0|||
126736173|NCT01412060|455983446|FG002|Period Between RIP and SP|Protocol Violation|0|||
126736174|NCT01412060|455983444|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
126736175|NCT01412060|455983445|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
126736176|NCT01412060|455983446|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
126736177|NCT01412060|455983444|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
126736178|NCT01412060|455983445|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
126736179|NCT01412060|455983446|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
126736180|NCT01412060|455983444|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
126736181|NCT01412060|455983445|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
126736182|NCT01412060|455983446|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
126736183|NCT01412060|455983444|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
126736184|NCT01412060|455983445|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
126736185|NCT01412060|455983446|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
126736186|NCT01412060|455983444|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
126736187|NCT01412060|455983445|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
126736188|NCT01412060|455983446|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
126736189|NCT01412060|455983444|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
126736190|NCT01412060|455983445|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
126736191|NCT01412060|455983446|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
126736192|NCT01412060|455983444|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
126736193|NCT01412060|455983445|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
126736194|NCT01412060|455983446|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
126736195|NCT01412060|455983444|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
126736196|NCT01412060|455983445|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
126736197|NCT01412060|455983446|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
126736198|NCT01412060|455983444|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
126736199|NCT01412060|455983445|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
126736200|NCT01412060|455983446|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
126736201|NCT01412060|455983444|FG000|Period Between SP and DBP|Protocol Violation|2|||
126736202|NCT01412060|455983445|FG001|Period Between SP and DBP|Protocol Violation|0|||
126736203|NCT01412060|455983446|FG002|Period Between SP and DBP|Protocol Violation|0|||
126736204|NCT01412060|455983444|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
126736205|NCT01412060|455983445|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
126736206|NCT01412060|455983446|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
126736207|NCT01412060|455983444|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
126736208|NCT01412060|455983445|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
126736209|NCT01412060|455983446|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
126736210|NCT01412060|455983444|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
126736211|NCT01412060|455983445|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
126736212|NCT01412060|455983446|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
126736213|NCT01412060|455983444|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
126736214|NCT01412060|455983445|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
126736215|NCT01412060|455983446|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
126736216|NCT01412060|455983444|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
126736217|NCT01412060|455983445|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
126736218|NCT01412060|455983446|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
126736219|NCT01412060|455983444|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
126736220|NCT01412060|455983445|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
126736221|NCT01412060|455983446|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
126736222|NCT01412060|455983444|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
126736223|NCT01412060|455983445|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
126736224|NCT01412060|455983446|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
126736225|NCT01412060|455983444|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
126736226|NCT01412060|455983445|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
126736227|NCT01412060|455983446|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
126736228|NCT01412060|455983444|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
126736229|NCT01412060|455983445|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
126736230|NCT01412060|455983446|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
126736231|NCT01412060|455983444|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
126736232|NCT01412060|455983445|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
126736233|NCT01412060|455983446|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
126736234|NCT05567393|455983451|FG000|Overall Study|Voluntary Withdrawal|0|||
126736235|NCT05567393|455983452|FG001|Overall Study|Voluntary Withdrawal|0|||
126736236|NCT05567393|455983453|FG002|Overall Study|Voluntary Withdrawal|0|||
126736237|NCT05567393|455983454|FG003|Overall Study|Voluntary Withdrawal|0|||
126736238|NCT05567393|455983455|FG004|Overall Study|Voluntary Withdrawal|0|||
126736239|NCT05567393|455983456|FG005|Overall Study|Voluntary Withdrawal|0|||
126736240|NCT05567393|455983457|FG006|Overall Study|Voluntary Withdrawal|0|||
126736241|NCT05567393|455983458|FG007|Overall Study|Voluntary Withdrawal|0|||
126736242|NCT05567393|455983459|FG008|Overall Study|Voluntary Withdrawal|0|||
126736243|NCT05567393|455983460|FG009|Overall Study|Voluntary Withdrawal|0|||
126736244|NCT05567393|455983461|FG010|Overall Study|Voluntary Withdrawal|0|||
126736245|NCT05567393|455983462|FG011|Overall Study|Voluntary Withdrawal|0|||
126736246|NCT05567393|455983463|FG012|Overall Study|Voluntary Withdrawal|0|||
126736247|NCT05567393|455983464|FG013|Overall Study|Voluntary Withdrawal|1|||
126736248|NCT05567393|455983465|FG014|Overall Study|Voluntary Withdrawal|0|||
126736249|NCT05567393|455983466|FG015|Overall Study|Voluntary Withdrawal|0|||
126736250|NCT05567393|455983467|FG016|Overall Study|Voluntary Withdrawal|0|||
126736251|NCT05567393|455983468|FG017|Overall Study|Voluntary Withdrawal|0|||
126736252|NCT04179786|455983469|FG000|Overall Study|Withdrawal by Subject|8|||
126736253|NCT03310580|455983470|FG000|Overall Study|Adverse Event|0|||
126736254|NCT03310580|455983471|FG001|Overall Study|Adverse Event|1|||
126736255|NCT03310580|455983472|FG002|Overall Study|Adverse Event|0|||
126736256|NCT02762708|455983475|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
126736257|NCT02762708|455983476|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
126736258|NCT02762708|455983477|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
126736259|NCT02762708|455983478|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
126736260|NCT01468701|455983485|FG000|Overall Study|Not eligible|91|||
126736261|NCT01468701|455983486|FG001|Overall Study|Not eligible|140|||
126736262|NCT01468701|455983487|FG002|Overall Study|Not eligible|29|||
126736263|NCT01468701|455983488|FG003|Overall Study|Not eligible|12|||
126736264|NCT01468701|455983489|FG004|Overall Study|Not eligible|22|||
126736265|NCT01468701|455983490|FG005|Overall Study|Not eligible|2|||
126736266|NCT01468701|455983491|FG006|Overall Study|Not eligible|39|||
126736267|NCT01468701|455983492|FG007|Overall Study|Not eligible|1|||
126736268|NCT01468701|455983493|FG008|Overall Study|Not eligible|40|||
126736269|NCT01468701|455983494|FG009|Overall Study|Not eligible|126|||
126736270|NCT01468701|455983495|FG010|Overall Study|Not eligible|39|||
126736271|NCT01468701|455983496|FG011|Overall Study|Not eligible|33|||
126736272|NCT01468701|455983497|FG012|Overall Study|Not eligible|1|||
126736273|NCT01468701|455983498|FG013|Overall Study|Not eligible|19|||
126736274|NCT01468701|455983499|FG014|Overall Study|Not eligible|1|||
126736275|NCT01468701|455983500|FG015|Overall Study|Not eligible|32|||
126736276|NCT01468701|455983501|FG016|Overall Study|Not eligible|0|||
126736277|NCT01468701|455983485|FG000|Overall Study|Lost to Follow-up|306|||
126736278|NCT01468701|455983486|FG001|Overall Study|Lost to Follow-up|0|||
126736279|NCT01468701|455983487|FG002|Overall Study|Lost to Follow-up|0|||
126736280|NCT01468701|455983488|FG003|Overall Study|Lost to Follow-up|0|||
126736281|NCT01468701|455983489|FG004|Overall Study|Lost to Follow-up|0|||
126736282|NCT01468701|455983490|FG005|Overall Study|Lost to Follow-up|0|||
126736283|NCT01468701|455983491|FG006|Overall Study|Lost to Follow-up|0|||
126736284|NCT01468701|455983492|FG007|Overall Study|Lost to Follow-up|0|||
126736285|NCT01468701|455983493|FG008|Overall Study|Lost to Follow-up|215|||
126736286|NCT01468701|455983494|FG009|Overall Study|Lost to Follow-up|309|||
126736287|NCT01468701|455983495|FG010|Overall Study|Lost to Follow-up|224|||
126736288|NCT01468701|455983496|FG011|Overall Study|Lost to Follow-up|212|||
126736289|NCT01468701|455983497|FG012|Overall Study|Lost to Follow-up|11|||
126736290|NCT01468701|455983498|FG013|Overall Study|Lost to Follow-up|164|||
126736291|NCT01468701|455983499|FG014|Overall Study|Lost to Follow-up|17|||
126736292|NCT01468701|455983500|FG015|Overall Study|Lost to Follow-up|127|||
126736293|NCT01468701|455983501|FG016|Overall Study|Lost to Follow-up|1|||
126736294|NCT01468701|455983485|FG000|Overall Study|Withdrawal by Subject|165|||
126736295|NCT01468701|455983486|FG001|Overall Study|Withdrawal by Subject|0|||
126736296|NCT01468701|455983487|FG002|Overall Study|Withdrawal by Subject|0|||
126736297|NCT01468701|455983488|FG003|Overall Study|Withdrawal by Subject|0|||
126736298|NCT01468701|455983489|FG004|Overall Study|Withdrawal by Subject|0|||
126736299|NCT01468701|455983490|FG005|Overall Study|Withdrawal by Subject|0|||
126736300|NCT01468701|455983491|FG006|Overall Study|Withdrawal by Subject|0|||
126736301|NCT01468701|455983492|FG007|Overall Study|Withdrawal by Subject|0|||
126736302|NCT01468701|455983493|FG008|Overall Study|Withdrawal by Subject|83|||
126736303|NCT01468701|455983494|FG009|Overall Study|Withdrawal by Subject|88|||
126736304|NCT01468701|455983495|FG010|Overall Study|Withdrawal by Subject|100|||
126781332|NCT00903383|456154519|FG000|Overall Study|Physician Decision|1|||
126781333|NCT00903383|456154520|FG001|Overall Study|Physician Decision|2|||
126781334|NCT00903383|456154521|FG002|Overall Study|Physician Decision|0|||
126781335|NCT00903383|456154522|FG003|Overall Study|Physician Decision|0|||
126781336|NCT00903383|456154519|FG000|Overall Study|Lost to Follow-up|0|||
126781337|NCT00903383|456154520|FG001|Overall Study|Lost to Follow-up|0|||
126781338|NCT00903383|456154521|FG002|Overall Study|Lost to Follow-up|0|||
126781339|NCT00903383|456154522|FG003|Overall Study|Lost to Follow-up|1|||
126781340|NCT00903383|456154519|FG000|Overall Study|Decision of Sponsor|1|||
126781341|NCT00903383|456154520|FG001|Overall Study|Decision of Sponsor|0|||
126781342|NCT00903383|456154521|FG002|Overall Study|Decision of Sponsor|0|||
126781343|NCT00903383|456154522|FG003|Overall Study|Decision of Sponsor|0|||
126781344|NCT00903383|456154519|FG000|Overall Study|Withdrawal by Subject|4|||
126781345|NCT00903383|456154520|FG001|Overall Study|Withdrawal by Subject|1|||
126781346|NCT00903383|456154521|FG002|Overall Study|Withdrawal by Subject|0|||
126781347|NCT00903383|456154522|FG003|Overall Study|Withdrawal by Subject|2|||
126781348|NCT00903383|456154519|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
126781349|NCT00903383|456154520|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
126781350|NCT00903383|456154521|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
126781351|NCT00903383|456154522|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
126781352|NCT00903383|456154519|FG000|Overall Study|Patient Decision|0|||
126781353|NCT00903383|456154520|FG001|Overall Study|Patient Decision|0|||
126781354|NCT00903383|456154521|FG002|Overall Study|Patient Decision|0|||
126781355|NCT00903383|456154522|FG003|Overall Study|Patient Decision|1|||
126613357|NCT00704340|455544175|FG001|Overall Study|Death|1|||
126613358|NCT01437540|455544176|FG000|Overall Study|Not listed below|7|||
126613359|NCT01437540|455544177|FG001|Overall Study|Not listed below|6|||
126613360|NCT01437540|455544176|FG000|Overall Study|COPD exacerbation|13|||
126613361|NCT01437540|455544177|FG001|Overall Study|COPD exacerbation|3|||
126613362|NCT01437540|455544176|FG000|Overall Study|Lost to Follow-up|3|||
126613363|NCT01437540|455544177|FG001|Overall Study|Lost to Follow-up|5|||
126613364|NCT01437540|455544176|FG000|Overall Study|Lack of Efficacy|23|||
126613365|NCT01437540|455544177|FG001|Overall Study|Lack of Efficacy|11|||
126613366|NCT01437540|455544176|FG000|Overall Study|Protocol Violation|24|||
126613367|NCT01437540|455544177|FG001|Overall Study|Protocol Violation|12|||
126613368|NCT01437540|455544176|FG000|Overall Study|Adverse Event|26|||
126781356|NCT01821625|456154525|FG000|Overall Study|Withdrawal by Subject|2|||
126781357|NCT01821625|456154525|FG000|Overall Study|Lack of Efficacy|2|||
126781358|NCT01821625|456154525|FG000|Overall Study|Adverse Event|1|||
126781359|NCT01821625|456154525|FG000|Overall Study|Medical contraindication|1|||
126781360|NCT00320593|456154528|FG000|Overall Study|Lost to Follow-up|3|||
126781361|NCT00320593|456154529|FG001|Overall Study|Lost to Follow-up|0|||
126781362|NCT00320593|456154528|FG000|Overall Study|Moved to another state|1|||
126781363|NCT00320593|456154529|FG001|Overall Study|Moved to another state|0|||
126781364|NCT00320593|456154528|FG000|Overall Study|Withdrawal by Subject|2|||
126781365|NCT00320593|456154529|FG001|Overall Study|Withdrawal by Subject|1|||
126781366|NCT00320593|456154528|FG000|Overall Study|Withdrawal by clinical center|1|||
126781367|NCT00320593|456154529|FG001|Overall Study|Withdrawal by clinical center|0|||
126781368|NCT00481247|456154534|FG000|Overall Study|Death|0|||
126781369|NCT00481247|456154535|FG001|Overall Study|Death|1|||
126781370|NCT00481247|456154534|FG000|Overall Study|Disease progression|18|||
126781371|NCT00481247|456154535|FG001|Overall Study|Disease progression|22|||
126781372|NCT00481247|456154534|FG000|Overall Study|Intolerance|42|||
126781373|NCT00481247|456154535|FG001|Overall Study|Intolerance|17|||
126781374|NCT00481247|456154534|FG000|Overall Study|Treatment failure|10|||
126781375|NCT00481247|456154535|FG001|Overall Study|Treatment failure|14|||
126613369|NCT01437540|455544177|FG001|Overall Study|Adverse Event|13|||
126613370|NCT01437540|455544176|FG000|Overall Study|Withdrawal by Subject|31|||
126613371|NCT01437540|455544177|FG001|Overall Study|Withdrawal by Subject|15|||
126736305|NCT01468701|455983496|FG011|Overall Study|Withdrawal by Subject|114|||
126736306|NCT01468701|455983497|FG012|Overall Study|Withdrawal by Subject|9|||
126781376|NCT00481247|456154534|FG000|Overall Study|AE unrelated to study drug|13|||
126613372|NCT02547974|455544178|FG000|Overall Study|Withdrawal by Subject|1|||
126613373|NCT02547974|455544179|FG001|Overall Study|Withdrawal by Subject|0|||
126613374|NCT02547974|455544180|FG002|Overall Study|Withdrawal by Subject|0|||
126613375|NCT02547974|455544181|FG003|Overall Study|Withdrawal by Subject|0|||
126613376|NCT01393600|455544185|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
126613377|NCT01393600|455544186|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
126613378|NCT01393600|455544187|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
126613379|NCT01393600|455544188|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
126613380|NCT01393600|455544185|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
126613381|NCT01393600|455544186|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
126613382|NCT01393600|455544187|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
126613383|NCT01393600|455544188|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
126613384|NCT01393600|455544185|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
126613385|NCT01393600|455544186|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
126613386|NCT01393600|455544187|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
126613387|NCT01393600|455544188|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
126613388|NCT01393600|455544185|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
126613389|NCT01393600|455544186|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
126613390|NCT01393600|455544187|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
126613391|NCT01393600|455544188|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
126613392|NCT01393600|455544185|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
126613393|NCT01393600|455544186|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
126613394|NCT01393600|455544187|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
126613395|NCT01393600|455544188|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
126613396|NCT01393600|455544185|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
126613397|NCT01393600|455544186|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
126613398|NCT01393600|455544187|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
126613399|NCT01393600|455544188|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
126613400|NCT01393600|455544185|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
126613401|NCT01393600|455544186|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
126613402|NCT01393600|455544187|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
126613403|NCT01393600|455544188|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
126613404|NCT00603798|455544189|FG000|Overall Study|Adverse Event|4|||
126613405|NCT00603798|455544190|FG001|Overall Study|Adverse Event|2|||
126613406|NCT00603798|455544191|FG002|Overall Study|Adverse Event|1|||
126613407|NCT00603798|455544189|FG000|Overall Study|Withdrawal by Subject|4|||
126613408|NCT00603798|455544190|FG001|Overall Study|Withdrawal by Subject|3|||
126613409|NCT00603798|455544191|FG002|Overall Study|Withdrawal by Subject|4|||
126613410|NCT00603798|455544189|FG000|Overall Study|Lost to Follow-up|1|||
126613411|NCT00603798|455544190|FG001|Overall Study|Lost to Follow-up|0|||
126613412|NCT00603798|455544191|FG002|Overall Study|Lost to Follow-up|1|||
126613413|NCT00603798|455544189|FG000|Overall Study|Non-compliance with study procedures|0|||
126613414|NCT00603798|455544190|FG001|Overall Study|Non-compliance with study procedures|1|||
126613415|NCT00603798|455544191|FG002|Overall Study|Non-compliance with study procedures|0|||
126613416|NCT00603798|455544189|FG000|Overall Study|Not due to AE|1|||
126613417|NCT00603798|455544190|FG001|Overall Study|Not due to AE|1|||
126613418|NCT00603798|455544191|FG002|Overall Study|Not due to AE|4|||
126613419|NCT04766996|455544192|FG000|Overall Study|Withdrawal by Subject|1|||
126613420|NCT04766996|455544193|FG001|Overall Study|Withdrawal by Subject|0|||
126613421|NCT04766996|455544194|FG002|Overall Study|Withdrawal by Subject|13|||
126613422|NCT02988713|455544197|FG000|Overall Study|Withdrawal by Subject|1|||
126613423|NCT02988713|455544197|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
126613424|NCT04248868|455544201|FG000|Overall Study|Death|1|||
126613425|NCT04248868|455544201|FG000|Overall Study|Lost to Follow-up|3|||
126613426|NCT04248868|455544201|FG000|Overall Study|Protocol Violation|2|||
126613427|NCT03131713|455544204|FG000|Overall Study|Lost to Follow-up|5|||
126613428|NCT03131713|455544205|FG001|Overall Study|Lost to Follow-up|0|||
126613429|NCT02208843|455544206|FG000|Overall Study|Clinical symptoms of progression|2|||
126613430|NCT02208843|455544206|FG000|Overall Study|Progression disease according to RECIST|24|||
126613431|NCT02208843|455544206|FG000|Overall Study|Adverse Event|12|||
126613432|NCT02208843|455544206|FG000|Overall Study|Protocol Violation|1|||
126613433|NCT02208843|455544206|FG000|Overall Study|Withdrawal by Subject|1|||
126613434|NCT02208843|455544206|FG000|Overall Study|Switched to commercial afatinib|20|||
126613435|NCT01976507|455544207|FG000|Overall Study|Adverse Event|6|||
126613436|NCT01976507|455544207|FG000|Overall Study|ablation not done, drug not given|1|||
126613437|NCT01794299|455544217|FG000|Overall Study|ATIR manufacturing not possible|1|||
126613438|NCT01794299|455544217|FG000|Overall Study|Death|14|||
126613439|NCT01794299|455544217|FG000|Overall Study|Graft failure|1|||
126613440|NCT01794299|455544217|FG000|Overall Study|ATIR batch rejected|2|||
126613441|NCT01794299|455544217|FG000|Overall Study|Relapse|2|||
126613442|NCT01794299|455544217|FG000|Overall Study|Discontinued from active follow-up|1|||
126613443|NCT01794299|455544217|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
126736307|NCT01468701|455983498|FG013|Overall Study|Withdrawal by Subject|47|||
126736308|NCT01468701|455983499|FG014|Overall Study|Withdrawal by Subject|6|||
126736309|NCT01468701|455983500|FG015|Overall Study|Withdrawal by Subject|31|||
126736310|NCT01468701|455983501|FG016|Overall Study|Withdrawal by Subject|0|||
126736311|NCT01468701|455983485|FG000|Overall Study|Other reasons than listed|437|||
126736312|NCT01468701|455983486|FG001|Overall Study|Other reasons than listed|0|||
126736313|NCT01468701|455983487|FG002|Overall Study|Other reasons than listed|0|||
126736314|NCT01468701|455983488|FG003|Overall Study|Other reasons than listed|0|||
126736315|NCT01468701|455983489|FG004|Overall Study|Other reasons than listed|0|||
126736316|NCT01468701|455983490|FG005|Overall Study|Other reasons than listed|0|||
126736317|NCT01468701|455983491|FG006|Overall Study|Other reasons than listed|0|||
126736318|NCT01468701|455983492|FG007|Overall Study|Other reasons than listed|0|||
126736319|NCT01468701|455983493|FG008|Overall Study|Other reasons than listed|318|||
126736320|NCT01468701|455983494|FG009|Overall Study|Other reasons than listed|658|||
126736321|NCT01468701|455983495|FG010|Overall Study|Other reasons than listed|433|||
126736322|NCT01468701|455983496|FG011|Overall Study|Other reasons than listed|504|||
126736323|NCT01468701|455983497|FG012|Overall Study|Other reasons than listed|28|||
126736324|NCT01468701|455983498|FG013|Overall Study|Other reasons than listed|239|||
126736325|NCT01468701|455983499|FG014|Overall Study|Other reasons than listed|39|||
126736326|NCT01468701|455983500|FG015|Overall Study|Other reasons than listed|172|||
126736327|NCT01468701|455983501|FG016|Overall Study|Other reasons than listed|0|||
126736328|NCT01468701|455983485|FG000|Overall Study|No end of study case report form|0|||
126736329|NCT01468701|455983486|FG001|Overall Study|No end of study case report form|0|||
126736330|NCT01468701|455983487|FG002|Overall Study|No end of study case report form|0|||
126736331|NCT01468701|455983488|FG003|Overall Study|No end of study case report form|0|||
126736332|NCT01468701|455983489|FG004|Overall Study|No end of study case report form|0|||
126736333|NCT01468701|455983490|FG005|Overall Study|No end of study case report form|0|||
126736334|NCT01468701|455983491|FG006|Overall Study|No end of study case report form|0|||
126736335|NCT01468701|455983492|FG007|Overall Study|No end of study case report form|0|||
126736336|NCT01468701|455983493|FG008|Overall Study|No end of study case report form|4|||
126736337|NCT01468701|455983494|FG009|Overall Study|No end of study case report form|1|||
126736338|NCT01468701|455983495|FG010|Overall Study|No end of study case report form|2|||
126736339|NCT01468701|455983496|FG011|Overall Study|No end of study case report form|3|||
126736340|NCT01468701|455983497|FG012|Overall Study|No end of study case report form|0|||
126736341|NCT01468701|455983498|FG013|Overall Study|No end of study case report form|1|||
126736342|NCT01468701|455983499|FG014|Overall Study|No end of study case report form|0|||
126736343|NCT01468701|455983500|FG015|Overall Study|No end of study case report form|0|||
126736344|NCT01468701|455983501|FG016|Overall Study|No end of study case report form|0|||
126736345|NCT01468701|455983485|FG000|Overall Study|Not being followed up|0|||
126736346|NCT01468701|455983486|FG001|Overall Study|Not being followed up|4963|||
126613444|NCT01029704|455544221|FG000|Overall Study|Adverse Event|0|||
126613445|NCT01029704|455544222|FG001|Overall Study|Adverse Event|0|||
126613446|NCT01029704|455544223|FG002|Overall Study|Adverse Event|0|||
126613447|NCT01029704|455544224|FG003|Overall Study|Adverse Event|0|||
126613448|NCT01029704|455544225|FG004|Overall Study|Adverse Event|0|||
126613449|NCT01029704|455544226|FG005|Overall Study|Adverse Event|0|||
126613450|NCT01029704|455544227|FG006|Overall Study|Adverse Event|1|||
126613451|NCT01029704|455544228|FG007|Overall Study|Adverse Event|1|||
126613452|NCT01029704|455544229|FG008|Overall Study|Adverse Event|0|||
126613453|NCT01029704|455544221|FG000|Overall Study|Withdrawal by Subject|0|||
126613454|NCT01029704|455544222|FG001|Overall Study|Withdrawal by Subject|0|||
126613455|NCT01029704|455544223|FG002|Overall Study|Withdrawal by Subject|0|||
126613456|NCT01029704|455544224|FG003|Overall Study|Withdrawal by Subject|0|||
126613457|NCT01029704|455544225|FG004|Overall Study|Withdrawal by Subject|2|||
126613458|NCT01029704|455544226|FG005|Overall Study|Withdrawal by Subject|1|||
126613459|NCT01029704|455544227|FG006|Overall Study|Withdrawal by Subject|1|||
126613460|NCT01029704|455544228|FG007|Overall Study|Withdrawal by Subject|1|||
126613461|NCT01029704|455544229|FG008|Overall Study|Withdrawal by Subject|0|||
126613462|NCT01029704|455544221|FG000|Overall Study|Lost to Follow-up|0|||
126613463|NCT01029704|455544222|FG001|Overall Study|Lost to Follow-up|0|||
126613464|NCT01029704|455544223|FG002|Overall Study|Lost to Follow-up|0|||
126613465|NCT01029704|455544224|FG003|Overall Study|Lost to Follow-up|0|||
126613466|NCT01029704|455544225|FG004|Overall Study|Lost to Follow-up|0|||
126613467|NCT01029704|455544226|FG005|Overall Study|Lost to Follow-up|0|||
126613468|NCT01029704|455544227|FG006|Overall Study|Lost to Follow-up|1|||
126736347|NCT01468701|455983487|FG002|Overall Study|Not being followed up|1755|||
126613469|NCT01029704|455544228|FG007|Overall Study|Lost to Follow-up|1|||
126736348|NCT01468701|455983488|FG003|Overall Study|Not being followed up|703|||
126613470|NCT01029704|455544229|FG008|Overall Study|Lost to Follow-up|1|||
126613471|NCT01029704|455544221|FG000|Overall Study|Lack of Efficacy|0|||
126613472|NCT01029704|455544222|FG001|Overall Study|Lack of Efficacy|0|||
126613473|NCT01029704|455544223|FG002|Overall Study|Lack of Efficacy|0|||
126613474|NCT01029704|455544224|FG003|Overall Study|Lack of Efficacy|0|||
126736349|NCT01468701|455983489|FG004|Overall Study|Not being followed up|1714|||
126736350|NCT01468701|455983490|FG005|Overall Study|Not being followed up|126|||
126736351|NCT01468701|455983491|FG006|Overall Study|Not being followed up|1170|||
126781377|NCT00481247|456154535|FG001|Overall Study|AE unrelated to study drug|4|||
126781378|NCT00481247|456154534|FG000|Overall Study|Withdrawal by Subject|8|||
126781379|NCT00481247|456154535|FG001|Overall Study|Withdrawal by Subject|13|||
126781380|NCT00481247|456154534|FG000|Overall Study|Pregnancy|2|||
126781381|NCT00481247|456154535|FG001|Overall Study|Pregnancy|1|||
126781382|NCT00481247|456154534|FG000|Overall Study|Lost to Follow-up|1|||
126781383|NCT00481247|456154535|FG001|Overall Study|Lost to Follow-up|2|||
126781384|NCT00481247|456154534|FG000|Overall Study|Poor compliance/noncompliance|1|||
126736352|NCT01468701|455983492|FG007|Overall Study|Not being followed up|4|||
126736353|NCT01468701|455983493|FG008|Overall Study|Not being followed up|0|||
126736354|NCT01468701|455983494|FG009|Overall Study|Not being followed up|0|||
126736355|NCT01468701|455983495|FG010|Overall Study|Not being followed up|0|||
126736356|NCT01468701|455983496|FG011|Overall Study|Not being followed up|0|||
126736357|NCT01468701|455983497|FG012|Overall Study|Not being followed up|0|||
126736358|NCT01468701|455983498|FG013|Overall Study|Not being followed up|0|||
126736359|NCT01468701|455983499|FG014|Overall Study|Not being followed up|0|||
126736360|NCT01468701|455983500|FG015|Overall Study|Not being followed up|0|||
126736361|NCT01468701|455983501|FG016|Overall Study|Not being followed up|0|||
126736362|NCT01068717|455983502|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
126736363|NCT01068717|455983503|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
126736364|NCT01068717|455983504|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
126736365|NCT01068717|455983505|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
126736366|NCT04186663|455983508|FG000|Overall Study|Lost to Follow-up|1|||
126736367|NCT04186663|455983508|FG000|Overall Study|Unable to complete blood draw|3|||
126736368|NCT01602549|455983512|FG000|Overall Study|Protocol Violation|0|||
126736369|NCT01602549|455983513|FG001|Overall Study|Protocol Violation|1|||
126736370|NCT01602549|455983512|FG000|Overall Study|Withdrawal by Subject|1|||
126736371|NCT01602549|455983513|FG001|Overall Study|Withdrawal by Subject|0|||
126736372|NCT05200455|455983514|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
126736373|NCT00719862|455983517|FG000|Overall Study|Adverse Event|1|||
126736374|NCT00719862|455983518|FG001|Overall Study|Adverse Event|2|||
126736375|NCT00719862|455983517|FG000|Overall Study|Lack of Efficacy|3|||
126736376|NCT00719862|455983518|FG001|Overall Study|Lack of Efficacy|0|||
126736377|NCT00719862|455983517|FG000|Overall Study|Non-Compliance|1|||
126736378|NCT00719862|455983518|FG001|Overall Study|Non-Compliance|0|||
126736379|NCT00719862|455983517|FG000|Overall Study|Withdrawal by Subject|1|||
126736380|NCT00719862|455983518|FG001|Overall Study|Withdrawal by Subject|0|||
126736381|NCT00719862|455983517|FG000|Overall Study|Lost to Follow-up|0|||
126736382|NCT00719862|455983518|FG001|Overall Study|Lost to Follow-up|1|||
126736383|NCT00719862|455983517|FG000|Overall Study|Other|2|||
126736384|NCT00719862|455983518|FG001|Overall Study|Other|3|||
126736385|NCT01184846|455983520|FG000|Overall Study|Adverse Event|2|||
126736386|NCT01184846|455983520|FG000|Overall Study|Insufficient response|1|||
126736387|NCT00892957|455983521|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
126736388|NCT00892957|455983522|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
126736389|NCT00892957|455983521|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
126736390|NCT00892957|455983522|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
126736391|NCT02853032|455983523|FG000|Overall Study|Adverse Event|4|||
126736392|NCT02853032|455983524|FG001|Overall Study|Adverse Event|0|||
126736393|NCT02853032|455983523|FG000|Overall Study|Withdrawal by Subject|3|||
126736394|NCT02853032|455983524|FG001|Overall Study|Withdrawal by Subject|1|||
126736395|NCT02853032|455983523|FG000|Overall Study|Requested to withdraw from all treatment|2|||
126736396|NCT02853032|455983524|FG001|Overall Study|Requested to withdraw from all treatment|2|||
126736397|NCT03700736|455983527|FG000|Overall Study|Pregnancy|1|||
126736398|NCT03700736|455983528|FG001|Overall Study|Pregnancy|1|||
126781385|NCT00481247|456154535|FG001|Overall Study|Poor compliance/noncompliance|7|||
126781386|NCT00481247|456154534|FG000|Overall Study|Administrative reason by sponsor|157|||
126781387|NCT00481247|456154535|FG001|Overall Study|Administrative reason by sponsor|162|||
126736399|NCT03700736|455983527|FG000|Overall Study|Withdrawal by Subject|2|||
126736400|NCT03700736|455983528|FG001|Overall Study|Withdrawal by Subject|6|||
126736401|NCT00107172|455986481|FG000|Overall Study|Withdrawal by Subject|1|||
126736402|NCT00107172|455986482|FG001|Overall Study|Withdrawal by Subject|0|||
126736403|NCT00107172|455986481|FG000|Overall Study|Death|0|||
126736404|NCT00107172|455986482|FG001|Overall Study|Death|2|||
126736405|NCT00107172|455986481|FG000|Overall Study|Other Reason|4|||
126736406|NCT00107172|455986482|FG001|Overall Study|Other Reason|3|||
126736407|NCT01102140|455986483|FG000|Overall Study|Lost to Follow-up|1|||
126736408|NCT01102140|455986484|FG001|Overall Study|Lost to Follow-up|0|||
126736409|NCT01102140|455986483|FG000|Overall Study|Investigator terminated study|2|||
126736410|NCT01102140|455986484|FG001|Overall Study|Investigator terminated study|2|||
126736411|NCT01742091|455986489|FG000|Overall Study|Adverse Event|0|||
126736412|NCT01742091|455986490|FG001|Overall Study|Adverse Event|0|||
126736413|NCT01742091|455986491|FG002|Overall Study|Adverse Event|0|||
126736414|NCT01742091|455986492|FG003|Overall Study|Adverse Event|0|||
126781388|NCT00481247|456154534|FG000|Overall Study|Varied|6|||
126736415|NCT01742091|455986493|FG004|Overall Study|Adverse Event|1|||
126736416|NCT01742091|455986494|FG005|Overall Study|Adverse Event|0|||
126736417|NCT01742091|455986489|FG000|Overall Study|Physician Decision|0|||
126736418|NCT01742091|455986490|FG001|Overall Study|Physician Decision|0|||
126736419|NCT01742091|455986491|FG002|Overall Study|Physician Decision|0|||
126736420|NCT01742091|455986492|FG003|Overall Study|Physician Decision|0|||
126736421|NCT01742091|455986493|FG004|Overall Study|Physician Decision|0|||
126736422|NCT01742091|455986494|FG005|Overall Study|Physician Decision|1|||
126736423|NCT01742091|455986489|FG000|Overall Study|Withdrawal by Subject|0|||
126736424|NCT01742091|455986490|FG001|Overall Study|Withdrawal by Subject|0|||
126736425|NCT01742091|455986491|FG002|Overall Study|Withdrawal by Subject|0|||
126736426|NCT01742091|455986492|FG003|Overall Study|Withdrawal by Subject|1|||
126736427|NCT01742091|455986493|FG004|Overall Study|Withdrawal by Subject|0|||
126736428|NCT01742091|455986494|FG005|Overall Study|Withdrawal by Subject|0|||
126736429|NCT01742091|455986489|FG000|Overall Study|Lost to Follow-up|0|||
126736430|NCT01742091|455986490|FG001|Overall Study|Lost to Follow-up|0|||
126736431|NCT01742091|455986491|FG002|Overall Study|Lost to Follow-up|0|||
126736432|NCT01742091|455986492|FG003|Overall Study|Lost to Follow-up|0|||
126736433|NCT01742091|455986493|FG004|Overall Study|Lost to Follow-up|0|||
126736434|NCT01742091|455986494|FG005|Overall Study|Lost to Follow-up|1|||
126736435|NCT03706040|455986495|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
126736436|NCT03706040|455986496|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
126736437|NCT03706040|455986497|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
126736438|NCT03706040|455986498|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
126736439|NCT03706040|455986499|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
126736440|NCT03706040|455986500|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
126736441|NCT03706040|455986501|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
126736442|NCT03706040|455986495|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
126736443|NCT03706040|455986496|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
126736444|NCT03706040|455986497|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
126736445|NCT03706040|455986498|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
126736446|NCT03706040|455986499|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
126736447|NCT03706040|455986500|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
126736448|NCT03706040|455986501|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
126736449|NCT03706040|455986495|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
126736450|NCT03706040|455986496|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
126736451|NCT03706040|455986497|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
126736452|NCT03706040|455986498|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
126736453|NCT03706040|455986499|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
126736454|NCT03706040|455986500|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
126736455|NCT03706040|455986501|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
126736456|NCT03706040|455986495|FG000|Period A (Week 0 to Week 16)|Other|2|||
126736457|NCT03706040|455986496|FG001|Period A (Week 0 to Week 16)|Other|0|||
126736458|NCT03706040|455986497|FG002|Period A (Week 0 to Week 16)|Other|2|||
126736459|NCT03706040|455986498|FG003|Period A (Week 0 to Week 16)|Other|0|||
126736460|NCT03706040|455986499|FG004|Period A (Week 0 to Week 16)|Other|0|||
126736461|NCT03706040|455986500|FG005|Period A (Week 0 to Week 16)|Other|0|||
126736462|NCT03706040|455986501|FG006|Period A (Week 0 to Week 16)|Other|0|||
126736463|NCT03706040|455986495|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
126736464|NCT03706040|455986496|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
126736465|NCT03706040|455986497|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
126736466|NCT03706040|455986498|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
126613475|NCT01029704|455544225|FG004|Overall Study|Lack of Efficacy|2|||
126613476|NCT01029704|455544226|FG005|Overall Study|Lack of Efficacy|3|||
126736467|NCT03706040|455986499|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
126736468|NCT03706040|455986500|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
126736469|NCT03706040|455986501|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
126736470|NCT03706040|455986495|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
126736471|NCT03706040|455986496|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
126736472|NCT03706040|455986497|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
126736473|NCT03706040|455986498|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
126736474|NCT03706040|455986499|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
126736475|NCT03706040|455986500|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
126736476|NCT03706040|455986501|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
126736477|NCT03706040|455986495|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126736478|NCT03706040|455986496|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126736479|NCT03706040|455986497|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126736480|NCT03706040|455986498|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126736481|NCT03706040|455986499|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
126736482|NCT03706040|455986500|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
126736483|NCT03706040|455986501|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
126736484|NCT03706040|455986495|FG000|Period B (Week 16 to Week 52)|Other|0|||
126736485|NCT03706040|455986496|FG001|Period B (Week 16 to Week 52)|Other|0|||
126613477|NCT01029704|455544227|FG006|Overall Study|Lack of Efficacy|1|||
126613478|NCT01029704|455544228|FG007|Overall Study|Lack of Efficacy|2|||
126613479|NCT01029704|455544229|FG008|Overall Study|Lack of Efficacy|0|||
126613480|NCT01029704|455544221|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
126613481|NCT01029704|455544222|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
126613482|NCT01029704|455544223|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
126613483|NCT01029704|455544224|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
126613484|NCT01029704|455544225|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
126613485|NCT01029704|455544226|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
126613486|NCT01029704|455544227|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
126613487|NCT01029704|455544228|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
126613488|NCT01029704|455544229|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
126613489|NCT00089791|455544230|FG000|Overall Study|Physician Decision|6|||
126613490|NCT00089791|455544231|FG001|Overall Study|Physician Decision|3|||
126613491|NCT00089791|455544230|FG000|Overall Study|Adverse Event|81|||
126613492|NCT00089791|455544231|FG001|Overall Study|Adverse Event|93|||
126613493|NCT00089791|455544230|FG000|Overall Study|Withdrawal by Subject|403|||
126613494|NCT00089791|455544231|FG001|Overall Study|Withdrawal by Subject|344|||
126613495|NCT00089791|455544230|FG000|Overall Study|Death|78|||
126613496|NCT00089791|455544231|FG001|Overall Study|Death|62|||
126613497|NCT00089791|455544230|FG000|Overall Study|Disease progression|7|||
126613498|NCT00089791|455544231|FG001|Overall Study|Disease progression|3|||
126613499|NCT00089791|455544230|FG000|Overall Study|Ineligibility determined|12|||
126613500|NCT00089791|455544231|FG001|Overall Study|Ineligibility determined|9|||
126613501|NCT00089791|455544230|FG000|Overall Study|Lost to Follow-up|57|||
126613502|NCT00089791|455544231|FG001|Overall Study|Lost to Follow-up|57|||
126613503|NCT00089791|455544230|FG000|Overall Study|Noncompliance|17|||
126613504|NCT00089791|455544231|FG001|Overall Study|Noncompliance|13|||
126613505|NCT00089791|455544230|FG000|Overall Study|Other|20|||
126613506|NCT00089791|455544231|FG001|Overall Study|Other|32|||
126613507|NCT00089791|455544230|FG000|Overall Study|Protocol deviation|12|||
126613508|NCT00089791|455544231|FG001|Overall Study|Protocol deviation|10|||
126613509|NCT00089791|455544230|FG000|Overall Study|Requirement for alternative therapy|7|||
126613510|NCT00089791|455544231|FG001|Overall Study|Requirement for alternative therapy|4|||
126613511|NCT00148122|455544232|FG000|Overall Study|Withdrawal by Subject|2|||
126613512|NCT01365546|455544233|FG000|Overall Study|Withdrawal by Subject|1|||
126613513|NCT01365546|455544233|FG000|Overall Study|Screen failure|9|||
126613514|NCT01365546|455544233|FG000|Overall Study|Study termination|1|||
126613515|NCT00721734|455544234|FG000|Overall Study|Progressive Disease|3|||
126613516|NCT00721734|455544235|FG001|Overall Study|Progressive Disease|10|||
126613517|NCT00721734|455544236|FG002|Overall Study|Progressive Disease|4|||
126613518|NCT00721734|455544237|FG003|Overall Study|Progressive Disease|5|||
126613519|NCT00721734|455544238|FG004|Overall Study|Progressive Disease|2|||
126613520|NCT00721734|455544234|FG000|Overall Study|Adverse Event|3|||
126613521|NCT00721734|455544235|FG001|Overall Study|Adverse Event|1|||
126613522|NCT00721734|455544236|FG002|Overall Study|Adverse Event|4|||
126613523|NCT00721734|455544237|FG003|Overall Study|Adverse Event|0|||
126613524|NCT00721734|455544238|FG004|Overall Study|Adverse Event|3|||
126613525|NCT00721734|455544234|FG000|Overall Study|Withdrawal by Subject|2|||
126613526|NCT00721734|455544235|FG001|Overall Study|Withdrawal by Subject|1|||
126613527|NCT00721734|455544236|FG002|Overall Study|Withdrawal by Subject|0|||
126613528|NCT00721734|455544237|FG003|Overall Study|Withdrawal by Subject|0|||
126613529|NCT00721734|455544238|FG004|Overall Study|Withdrawal by Subject|1|||
126613530|NCT00721734|455544234|FG000|Overall Study|Other|0|||
126613531|NCT00721734|455544235|FG001|Overall Study|Other|0|||
126613532|NCT00721734|455544236|FG002|Overall Study|Other|0|||
126613533|NCT00721734|455544237|FG003|Overall Study|Other|1|||
126613534|NCT00721734|455544238|FG004|Overall Study|Other|0|||
126613535|NCT01989689|455544239|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
126613536|NCT01989689|455544240|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
126736486|NCT03706040|455986497|FG002|Period B (Week 16 to Week 52)|Other|0|||
126736487|NCT03706040|455986498|FG003|Period B (Week 16 to Week 52)|Other|4|||
126736488|NCT03706040|455986499|FG004|Period B (Week 16 to Week 52)|Other|5|||
126736489|NCT03706040|455986500|FG005|Period B (Week 16 to Week 52)|Other|23|||
126736490|NCT03706040|455986501|FG006|Period B (Week 16 to Week 52)|Other|17|||
126613537|NCT01989689|455544239|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
126613538|NCT01989689|455544240|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
126613539|NCT03938272|455544241|FG000|Overall Study|Withdrawal by Subject|1|||
126613540|NCT03938272|455544242|FG001|Overall Study|Withdrawal by Subject|0|||
126613541|NCT03938272|455544241|FG000|Overall Study|Physician Decision|0|||
126736491|NCT00212758|455986505|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
126613542|NCT03938272|455544242|FG001|Overall Study|Physician Decision|2|||
126613543|NCT03938272|455544241|FG000|Overall Study|Study termination by sponsor|10|||
126613544|NCT03938272|455544242|FG001|Overall Study|Study termination by sponsor|8|||
126613545|NCT03989232|455544243|FG000|Overall Study|Lost to Follow-up|3|||
126736492|NCT00212758|455986506|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
126781389|NCT00481247|456154535|FG001|Overall Study|Varied|15|||
126736493|NCT00212758|455986505|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
126736494|NCT00212758|455986506|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
126736495|NCT01709708|455986513|FG000|Overall Study|Protocol Violation|1|||
126736496|NCT01709708|455986514|FG001|Overall Study|Protocol Violation|2|||
126736497|NCT00527072|455986515|FG000|Overall Study|Adverse Event|13|||
126736498|NCT00527072|455986515|FG000|Overall Study|Lack of Efficacy|11|||
126736499|NCT00527072|455986515|FG000|Overall Study|Lost to Follow-up|3|||
126736500|NCT00527072|455986515|FG000|Overall Study|Protocol Violation|2|||
126736501|NCT00527072|455986515|FG000|Overall Study|Withdrawal by Subject|7|||
126736502|NCT01369225|455986518|FG000|Overall Study|Withdrawal by Subject|1|||
126736503|NCT01369225|455986519|FG001|Overall Study|Withdrawal by Subject|0|||
126736504|NCT01369225|455986520|FG002|Overall Study|Withdrawal by Subject|2|||
126736505|NCT01369225|455986521|FG003|Overall Study|Withdrawal by Subject|1|||
126736506|NCT01369225|455986522|FG004|Overall Study|Withdrawal by Subject|0|||
126736507|NCT01369225|455986523|FG005|Overall Study|Withdrawal by Subject|0|||
126736508|NCT01369225|455986518|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
126736509|NCT01369225|455986519|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
126736510|NCT01369225|455986520|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
126736511|NCT01369225|455986521|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
126736512|NCT01369225|455986522|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
126736513|NCT01369225|455986523|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
126736514|NCT01369225|455986518|FG000|Overall Study|Other|1|||
126736515|NCT01369225|455986519|FG001|Overall Study|Other|0|||
126736516|NCT01369225|455986520|FG002|Overall Study|Other|0|||
126736517|NCT01369225|455986521|FG003|Overall Study|Other|0|||
126736518|NCT01369225|455986522|FG004|Overall Study|Other|1|||
126736519|NCT01369225|455986523|FG005|Overall Study|Other|0|||
126736520|NCT01369225|455986518|FG000|Overall Study|Adverse Event|0|||
126736521|NCT01369225|455986519|FG001|Overall Study|Adverse Event|0|||
126736522|NCT01369225|455986520|FG002|Overall Study|Adverse Event|0|||
126736523|NCT01369225|455986521|FG003|Overall Study|Adverse Event|1|||
126736524|NCT01369225|455986522|FG004|Overall Study|Adverse Event|1|||
126736525|NCT01369225|455986523|FG005|Overall Study|Adverse Event|0|||
126736526|NCT02980692|455986524|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
126736527|NCT02980692|455986525|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
126736528|NCT02980692|455986526|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
126736529|NCT02980692|455986527|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
126736530|NCT02980692|455986528|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
126736531|NCT02980692|455986524|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
126736532|NCT02980692|455986525|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
126736533|NCT02980692|455986526|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
126736534|NCT02980692|455986527|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
126736535|NCT02980692|455986528|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
126736536|NCT02980692|455986524|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
126736537|NCT02980692|455986525|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
126736538|NCT02980692|455986526|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
126736539|NCT02980692|455986527|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
126736540|NCT02980692|455986528|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
126736541|NCT02980692|455986524|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
126736542|NCT02980692|455986525|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
126736543|NCT02980692|455986526|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
126736544|NCT02980692|455986527|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
126736545|NCT02980692|455986528|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
126736546|NCT02980692|455986524|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
126736547|NCT02980692|455986525|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
126736548|NCT02980692|455986526|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
126736549|NCT02980692|455986527|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
126736550|NCT02980692|455986528|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
126736551|NCT02980692|455986524|FG000|Double Blind Placebo Controlled Period|Other|1|||
126736552|NCT02980692|455986525|FG001|Double Blind Placebo Controlled Period|Other|0|||
126736553|NCT02980692|455986526|FG002|Double Blind Placebo Controlled Period|Other|0|||
126736554|NCT02980692|455986527|FG003|Double Blind Placebo Controlled Period|Other|0|||
126736555|NCT02980692|455986528|FG004|Double Blind Placebo Controlled Period|Other|1|||
126736556|NCT02980692|455986524|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
126736557|NCT02980692|455986525|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
126736558|NCT02980692|455986526|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
126736559|NCT02980692|455986527|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
126756577|NCT00883896|456059484|FG002|Overall Study|Withdrawal by Subject|1|||
126756578|NCT00883896|456059485|FG003|Overall Study|Withdrawal by Subject|3|||
126613546|NCT03989232|455544244|FG001|Overall Study|Lost to Follow-up|10|||
126613547|NCT03989232|455544243|FG000|Overall Study|Withdrawal by Subject|6|||
126613548|NCT03989232|455544244|FG001|Overall Study|Withdrawal by Subject|6|||
126613549|NCT03989232|455544243|FG000|Overall Study|Death|1|||
126613550|NCT03989232|455544244|FG001|Overall Study|Death|2|||
126613551|NCT03652610|455544247|FG000|Overall Study|Lost to Follow-up|1|||
126613552|NCT03652610|455544248|FG001|Overall Study|Lost to Follow-up|0|||
126613553|NCT03652610|455544247|FG000|Overall Study|Withdrawal by Subject|3|||
126613554|NCT03652610|455544248|FG001|Overall Study|Withdrawal by Subject|5|||
126613555|NCT01323790|455544251|FG000|Overall Study|Other|3|||
126613556|NCT01323790|455544252|FG001|Overall Study|Other|2|||
126613557|NCT01323790|455544253|FG002|Overall Study|Other|1|||
126613558|NCT01323790|455544251|FG000|Overall Study|Lost to Follow-up|11|||
126613559|NCT01323790|455544252|FG001|Overall Study|Lost to Follow-up|9|||
126613560|NCT01323790|455544253|FG002|Overall Study|Lost to Follow-up|9|||
126613561|NCT01323790|455544251|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
126613562|NCT01323790|455544252|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
126613563|NCT01323790|455544253|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
126613564|NCT01323790|455544251|FG000|Overall Study|Lack of Efficacy|3|||
126613565|NCT01323790|455544252|FG001|Overall Study|Lack of Efficacy|0|||
126613566|NCT01323790|455544253|FG002|Overall Study|Lack of Efficacy|3|||
126613567|NCT01323790|455544251|FG000|Overall Study|Adverse Event|11|||
126613568|NCT01323790|455544252|FG001|Overall Study|Adverse Event|24|||
126613569|NCT01323790|455544253|FG002|Overall Study|Adverse Event|12|||
126613570|NCT01323790|455544251|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
126613571|NCT01323790|455544252|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
126613572|NCT01323790|455544253|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
126613573|NCT01323790|455544251|FG000|Overall Study|Withdrawal by Subject|23|||
126613574|NCT01323790|455544252|FG001|Overall Study|Withdrawal by Subject|20|||
126613575|NCT01323790|455544253|FG002|Overall Study|Withdrawal by Subject|13|||
126613576|NCT01323790|455544251|FG000|Overall Study|Did Not Receive Treatment|2|||
126613577|NCT01323790|455544252|FG001|Overall Study|Did Not Receive Treatment|0|||
126613578|NCT01323790|455544253|FG002|Overall Study|Did Not Receive Treatment|1|||
126613579|NCT01323790|455544251|FG000|Overall Study|Severe non-compliance with protocol|2|||
126613580|NCT01323790|455544252|FG001|Overall Study|Severe non-compliance with protocol|2|||
126613581|NCT01323790|455544253|FG002|Overall Study|Severe non-compliance with protocol|2|||
126613582|NCT01880736|455544254|FG000|Overall Study|Adverse Event|0|||
126613583|NCT01880736|455544255|FG001|Overall Study|Adverse Event|0|||
126613584|NCT01880736|455544256|FG002|Overall Study|Adverse Event|0|||
126613585|NCT01880736|455544257|FG003|Overall Study|Adverse Event|1|||
126613586|NCT01880736|455544254|FG000|Overall Study|Withdrawal Criteria|1|||
126613587|NCT01880736|455544255|FG001|Overall Study|Withdrawal Criteria|2|||
126613588|NCT01880736|455544256|FG002|Overall Study|Withdrawal Criteria|1|||
126613589|NCT01880736|455544257|FG003|Overall Study|Withdrawal Criteria|5|||
126613590|NCT01263496|455544258|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
126613591|NCT01263496|455544259|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126613592|NCT01263496|455544260|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126613593|NCT01263496|455544261|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126613594|NCT01263496|455544262|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126613595|NCT01263496|455544263|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126613596|NCT01263496|455544264|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126613597|NCT01263496|455544265|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126613598|NCT01263496|455544266|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
126613599|NCT01263496|455544258|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126613600|NCT01263496|455544259|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126613601|NCT01263496|455544260|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126613602|NCT01263496|455544261|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
126613603|NCT01263496|455544262|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
126613604|NCT01263496|455544263|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126613605|NCT01263496|455544264|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126613606|NCT01263496|455544265|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126613607|NCT01263496|455544266|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
126613608|NCT01263496|455544258|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
126613609|NCT01263496|455544259|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
126613610|NCT01263496|455544260|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
126613611|NCT01263496|455544261|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
126613612|NCT01263496|455544262|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
126613613|NCT01263496|455544263|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
126613614|NCT01263496|455544264|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
126613615|NCT01263496|455544265|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
126613616|NCT01263496|455544266|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
126756579|NCT00883896|456059482|FG000|Overall Study|Lack of Efficacy|0|||
126756580|NCT00883896|456059483|FG001|Overall Study|Lack of Efficacy|0|||
126756581|NCT00883896|456059484|FG002|Overall Study|Lack of Efficacy|0|||
126736560|NCT02980692|455986528|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
126736561|NCT02980692|455986524|FG000|Double-blind Follow-up Period|Adverse Event|0|||
126736562|NCT02980692|455986525|FG001|Double-blind Follow-up Period|Adverse Event|0|||
126736563|NCT02980692|455986526|FG002|Double-blind Follow-up Period|Adverse Event|0|||
126736564|NCT02980692|455986527|FG003|Double-blind Follow-up Period|Adverse Event|1|||
126736565|NCT02980692|455986528|FG004|Double-blind Follow-up Period|Adverse Event|1|||
126736566|NCT02980692|455986524|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
126736567|NCT02980692|455986525|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
126736568|NCT02980692|455986526|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
126736569|NCT02980692|455986527|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
126736570|NCT02980692|455986528|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
126736571|NCT02980692|455986524|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
126736572|NCT02980692|455986525|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
126736573|NCT02980692|455986526|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
126736574|NCT02980692|455986527|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
126736575|NCT02980692|455986528|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
126736576|NCT02980692|455986524|FG000|Double-blind Follow-up Period|Pregnancy|0|||
126736577|NCT02980692|455986525|FG001|Double-blind Follow-up Period|Pregnancy|0|||
126736578|NCT02980692|455986526|FG002|Double-blind Follow-up Period|Pregnancy|1|||
126736579|NCT02980692|455986527|FG003|Double-blind Follow-up Period|Pregnancy|1|||
126736580|NCT02980692|455986528|FG004|Double-blind Follow-up Period|Pregnancy|0|||
126736581|NCT02980692|455986524|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
126736582|NCT02980692|455986525|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
126736583|NCT02980692|455986526|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
126736584|NCT02980692|455986527|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
126736585|NCT02980692|455986528|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
126736586|NCT02980692|455986524|FG000|Double-blind Follow-up Period|Other|0|||
126736587|NCT02980692|455986525|FG001|Double-blind Follow-up Period|Other|0|||
126736588|NCT02980692|455986526|FG002|Double-blind Follow-up Period|Other|1|||
126736589|NCT02980692|455986527|FG003|Double-blind Follow-up Period|Other|1|||
126736590|NCT02980692|455986528|FG004|Double-blind Follow-up Period|Other|3|||
126736591|NCT00064077|455986531|FG000|Overall Study|Improper prior treatment|1|||
126736592|NCT00064077|455986532|FG001|Overall Study|Improper prior treatment|0|||
126736593|NCT00064077|455986533|FG002|Overall Study|Improper prior treatment|0|||
126736594|NCT00064077|455986534|FG003|Overall Study|Improper prior treatment|0|||
126736595|NCT00064077|455986531|FG000|Overall Study|Poor risk|2|||
126736596|NCT00064077|455986532|FG001|Overall Study|Poor risk|0|||
126736597|NCT00064077|455986533|FG002|Overall Study|Poor risk|1|||
126736598|NCT00064077|455986534|FG003|Overall Study|Poor risk|1|||
126736599|NCT00064077|455986531|FG000|Overall Study|Pathology|10|||
126736600|NCT00064077|455986532|FG001|Overall Study|Pathology|7|||
126736601|NCT00064077|455986533|FG002|Overall Study|Pathology|3|||
126736602|NCT00064077|455986534|FG003|Overall Study|Pathology|4|||
126736603|NCT00064077|455986531|FG000|Overall Study|No surgery|0|||
126736604|NCT00064077|455986532|FG001|Overall Study|No surgery|0|||
126736605|NCT00064077|455986533|FG002|Overall Study|No surgery|1|||
126736606|NCT00064077|455986534|FG003|Overall Study|No surgery|0|||
126736607|NCT00064077|455986531|FG000|Overall Study|No tumor|0|||
126736608|NCT00064077|455986532|FG001|Overall Study|No tumor|0|||
126736609|NCT00064077|455986533|FG002|Overall Study|No tumor|1|||
126736610|NCT00064077|455986534|FG003|Overall Study|No tumor|0|||
126781390|NCT00481247|456154534|FG000|Overall Study|Did not receive treatment|1|||
126781391|NCT00481247|456154535|FG001|Overall Study|Did not receive treatment|2|||
126781392|NCT01716754|456154536|FG000|Overall Study|Death|0|||
126781393|NCT01716754|456154537|FG001|Overall Study|Death|0|||
126781394|NCT01716754|456154538|FG002|Overall Study|Death|0|||
126781395|NCT01716754|456154539|FG003|Overall Study|Death|1|||
126781396|NCT01716754|456154536|FG000|Overall Study|Protocol deviation|0|||
126781397|NCT01716754|456154537|FG001|Overall Study|Protocol deviation|2|||
126736611|NCT00064077|455986531|FG000|Overall Study|Other reasons|2|||
126736612|NCT00064077|455986532|FG001|Overall Study|Other reasons|2|||
126736613|NCT00064077|455986533|FG002|Overall Study|Other reasons|1|||
126736614|NCT00064077|455986534|FG003|Overall Study|Other reasons|2|||
126736615|NCT01819506|455986535|FG000|Overall Study|Physician Decision|5|||
126736616|NCT01819506|455986536|FG001|Overall Study|Physician Decision|2|||
126736617|NCT01819506|455986535|FG000|Overall Study|Withdrawal by Subject|3|||
126736618|NCT01819506|455986536|FG001|Overall Study|Withdrawal by Subject|3|||
126736619|NCT03000686|455986537|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
126736620|NCT03000686|455986538|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
126736621|NCT03000686|455986539|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
126736622|NCT03000686|455986540|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
126736623|NCT03379376|455986544|FG000|Overall Study|Lost to Follow-up|2|||
126736624|NCT03379376|455986544|FG000|Overall Study|Did not wish to complete follow up|1|||
126736625|NCT03379376|455986544|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
126736626|NCT03379376|455986544|FG000|Overall Study|Death|1|||
126736627|NCT00928512|455986545|FG000|Overall Study|Adverse Event|4|||
126736628|NCT00928512|455986546|FG001|Overall Study|Adverse Event|3|||
126736629|NCT00928512|455986547|FG002|Overall Study|Adverse Event|2|||
126736630|NCT00928512|455986548|FG003|Overall Study|Adverse Event|8|||
126736631|NCT00928512|455986549|FG004|Overall Study|Adverse Event|6|||
126736632|NCT00928512|455986545|FG000|Overall Study|Lack of Efficacy|2|||
126736633|NCT00928512|455986546|FG001|Overall Study|Lack of Efficacy|0|||
126736634|NCT00928512|455986547|FG002|Overall Study|Lack of Efficacy|4|||
126736635|NCT00928512|455986548|FG003|Overall Study|Lack of Efficacy|7|||
126736636|NCT00928512|455986549|FG004|Overall Study|Lack of Efficacy|3|||
126736637|NCT00928512|455986545|FG000|Overall Study|Protocol Violation|0|||
126736638|NCT00928512|455986546|FG001|Overall Study|Protocol Violation|1|||
126736639|NCT00928512|455986547|FG002|Overall Study|Protocol Violation|0|||
126736640|NCT00928512|455986548|FG003|Overall Study|Protocol Violation|1|||
126736641|NCT00928512|455986549|FG004|Overall Study|Protocol Violation|3|||
126736642|NCT00928512|455986545|FG000|Overall Study|Withdrawal by Subject|3|||
126736643|NCT00928512|455986546|FG001|Overall Study|Withdrawal by Subject|0|||
126736644|NCT00928512|455986547|FG002|Overall Study|Withdrawal by Subject|3|||
126736645|NCT00928512|455986548|FG003|Overall Study|Withdrawal by Subject|4|||
126736646|NCT00928512|455986549|FG004|Overall Study|Withdrawal by Subject|0|||
126736647|NCT00928512|455986545|FG000|Overall Study|Lost to Follow-up|1|||
126736648|NCT00928512|455986546|FG001|Overall Study|Lost to Follow-up|1|||
126736649|NCT00928512|455986547|FG002|Overall Study|Lost to Follow-up|2|||
126736650|NCT00928512|455986548|FG003|Overall Study|Lost to Follow-up|1|||
126736651|NCT00928512|455986549|FG004|Overall Study|Lost to Follow-up|3|||
126736652|NCT00928512|455986545|FG000|Overall Study|Administrative Problems|0|||
126736653|NCT00928512|455986546|FG001|Overall Study|Administrative Problems|1|||
126736654|NCT00928512|455986547|FG002|Overall Study|Administrative Problems|0|||
126736655|NCT00928512|455986548|FG003|Overall Study|Administrative Problems|0|||
126736656|NCT00928512|455986549|FG004|Overall Study|Administrative Problems|0|||
126736657|NCT04153929|455986550|FG000|Overall Study|Other than listed|2|||
126736658|NCT04153929|455986551|FG001|Overall Study|Other than listed|2|||
126736659|NCT04153929|455986552|FG002|Overall Study|Other than listed|0|||
126736660|NCT04153929|455986553|FG003|Overall Study|Other than listed|1|||
126736661|NCT04153929|455986554|FG004|Overall Study|Other than listed|0|||
126736662|NCT04153929|455986555|FG005|Overall Study|Other than listed|2|||
126736663|NCT04153929|455986556|FG006|Overall Study|Other than listed|2|||
126736664|NCT04153929|455986557|FG007|Overall Study|Other than listed|1|||
126736665|NCT04153929|455986550|FG000|Overall Study|Lost to Follow-up|2|||
126736666|NCT04153929|455986551|FG001|Overall Study|Lost to Follow-up|1|||
126736667|NCT04153929|455986552|FG002|Overall Study|Lost to Follow-up|0|||
126736668|NCT04153929|455986553|FG003|Overall Study|Lost to Follow-up|1|||
126736669|NCT04153929|455986554|FG004|Overall Study|Lost to Follow-up|1|||
126736670|NCT04153929|455986555|FG005|Overall Study|Lost to Follow-up|0|||
126736671|NCT04153929|455986556|FG006|Overall Study|Lost to Follow-up|0|||
126736672|NCT04153929|455986557|FG007|Overall Study|Lost to Follow-up|0|||
126736673|NCT04153929|455986550|FG000|Overall Study|Withdrawal by Subject|3|||
126736674|NCT04153929|455986551|FG001|Overall Study|Withdrawal by Subject|1|||
126736675|NCT04153929|455986552|FG002|Overall Study|Withdrawal by Subject|0|||
126736676|NCT04153929|455986553|FG003|Overall Study|Withdrawal by Subject|3|||
126736677|NCT04153929|455986554|FG004|Overall Study|Withdrawal by Subject|1|||
126781398|NCT01716754|456154538|FG002|Overall Study|Protocol deviation|7|||
126781399|NCT01716754|456154539|FG003|Overall Study|Protocol deviation|2|||
126781400|NCT01716754|456154536|FG000|Overall Study|Non-compliance with study treatment|0|||
126736678|NCT04153929|455986555|FG005|Overall Study|Withdrawal by Subject|0|||
126736679|NCT04153929|455986556|FG006|Overall Study|Withdrawal by Subject|1|||
126736680|NCT04153929|455986557|FG007|Overall Study|Withdrawal by Subject|0|||
126736681|NCT04153929|455986550|FG000|Overall Study|Protocol Violation|0|||
126736682|NCT04153929|455986551|FG001|Overall Study|Protocol Violation|0|||
126736683|NCT04153929|455986552|FG002|Overall Study|Protocol Violation|0|||
126736684|NCT04153929|455986553|FG003|Overall Study|Protocol Violation|0|||
126736685|NCT04153929|455986554|FG004|Overall Study|Protocol Violation|0|||
126736686|NCT04153929|455986555|FG005|Overall Study|Protocol Violation|0|||
126736687|NCT04153929|455986556|FG006|Overall Study|Protocol Violation|1|||
126736688|NCT04153929|455986557|FG007|Overall Study|Protocol Violation|2|||
126736689|NCT04153929|455986550|FG000|Overall Study|Adverse Event|3|||
126736690|NCT04153929|455986551|FG001|Overall Study|Adverse Event|5|||
126736691|NCT04153929|455986552|FG002|Overall Study|Adverse Event|5|||
126736692|NCT04153929|455986553|FG003|Overall Study|Adverse Event|11|||
126736693|NCT04153929|455986554|FG004|Overall Study|Adverse Event|15|||
126736694|NCT04153929|455986555|FG005|Overall Study|Adverse Event|4|||
126736695|NCT04153929|455986556|FG006|Overall Study|Adverse Event|8|||
126736696|NCT04153929|455986557|FG007|Overall Study|Adverse Event|2|||
126736697|NCT04153929|455986550|FG000|Overall Study|Not treated|1|||
126736698|NCT04153929|455986551|FG001|Overall Study|Not treated|0|||
126736699|NCT04153929|455986552|FG002|Overall Study|Not treated|0|||
126736700|NCT04153929|455986553|FG003|Overall Study|Not treated|0|||
126736701|NCT04153929|455986554|FG004|Overall Study|Not treated|0|||
126736702|NCT04153929|455986555|FG005|Overall Study|Not treated|0|||
126613617|NCT01263496|455544258|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126613618|NCT01263496|455544259|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
126613619|NCT01263496|455544260|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126613620|NCT01263496|455544261|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126613621|NCT01263496|455544262|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126613622|NCT01263496|455544263|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126613623|NCT01263496|455544264|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126613624|NCT01263496|455544265|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126613625|NCT01263496|455544266|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
126613626|NCT01263496|455544258|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126613627|NCT01263496|455544259|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126613628|NCT01263496|455544260|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126613629|NCT01263496|455544261|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126613630|NCT01263496|455544262|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
126613631|NCT01263496|455544263|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126613632|NCT01263496|455544264|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126613633|NCT01263496|455544265|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126613634|NCT01263496|455544266|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126613635|NCT01263496|455544258|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
126613636|NCT01263496|455544259|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
126613637|NCT01263496|455544260|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
126613638|NCT01263496|455544261|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
126613639|NCT01263496|455544262|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
126613640|NCT01263496|455544263|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
126613641|NCT01263496|455544264|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
126613642|NCT01263496|455544265|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
126613643|NCT01263496|455544266|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
126613644|NCT01263496|455544258|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126613645|NCT01263496|455544259|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126613646|NCT01263496|455544260|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126613647|NCT01263496|455544261|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126613648|NCT01263496|455544262|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126613649|NCT01263496|455544263|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126613650|NCT01263496|455544264|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126613651|NCT01263496|455544265|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
126613652|NCT01263496|455544266|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126613653|NCT00266656|455544270|FG000|Overall Study|Death|1|||
126613654|NCT00266656|455544271|FG001|Overall Study|Death|0|||
126613655|NCT00266656|455544270|FG000|Overall Study|Lost to Follow-up|4|||
126613656|NCT00266656|455544271|FG001|Overall Study|Lost to Follow-up|1|||
126613657|NCT00266656|455544270|FG000|Overall Study|Withdrawal by Subject|4|||
126613658|NCT00266656|455544271|FG001|Overall Study|Withdrawal by Subject|2|||
126613659|NCT00266656|455544270|FG000|Overall Study|Did Not Reach Final Height|4|||
126613660|NCT00266656|455544271|FG001|Overall Study|Did Not Reach Final Height|8|||
126613661|NCT00266656|455544270|FG000|Overall Study|Parent/Caregiver Decision|1|||
126613662|NCT00266656|455544271|FG001|Overall Study|Parent/Caregiver Decision|2|||
126613663|NCT02203032|455544272|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
126613664|NCT02203032|455544273|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
126613665|NCT02203032|455544274|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
126613666|NCT02203032|455544275|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
126613667|NCT02203032|455544272|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
126613668|NCT02203032|455544273|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
126613669|NCT02203032|455544274|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
126613670|NCT02203032|455544275|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
126613671|NCT02203032|455544272|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
126613672|NCT02203032|455544273|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
126613673|NCT02203032|455544274|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
126613674|NCT02203032|455544275|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
126736703|NCT04153929|455986556|FG006|Overall Study|Not treated|1|||
126613675|NCT02203032|455544272|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
126613676|NCT02203032|455544273|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
126613677|NCT02203032|455544274|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
126613678|NCT02203032|455544275|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
126613679|NCT02203032|455544272|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
126613680|NCT02203032|455544273|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
126736704|NCT04153929|455986557|FG007|Overall Study|Not treated|0|||
126736705|NCT01963780|455986558|FG000|Overall Study|Death|7|||
126613681|NCT02203032|455544274|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
126613682|NCT02203032|455544275|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
126613683|NCT02203032|455544272|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
126613684|NCT02203032|455544273|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
126613685|NCT02203032|455544274|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
126613686|NCT02203032|455544275|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
126613687|NCT02203032|455544272|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
126613688|NCT02203032|455544273|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
126613689|NCT02203032|455544274|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
126613690|NCT02203032|455544275|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
126613691|NCT02203032|455544272|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
126613692|NCT02203032|455544273|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
126613693|NCT02203032|455544274|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
126613694|NCT02203032|455544275|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
126613695|NCT02203032|455544272|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
126613696|NCT02203032|455544273|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
126613697|NCT02203032|455544274|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
126613698|NCT02203032|455544275|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
126613699|NCT02203032|455544272|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
126613700|NCT02203032|455544273|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
126613701|NCT02203032|455544274|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
126613702|NCT02203032|455544275|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
126613703|NCT02203032|455544272|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
126613704|NCT02203032|455544273|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
126613705|NCT02203032|455544274|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
126613706|NCT02203032|455544275|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
126613707|NCT02203032|455544272|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
126613708|NCT02203032|455544273|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
126613709|NCT02203032|455544274|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
126613710|NCT02203032|455544275|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
126613711|NCT01915914|455544276|FG000|Acute Phase|Withdrawal by Subject|4|||
126613712|NCT01915914|455544277|FG001|Acute Phase|Withdrawal by Subject|0|||
126613713|NCT01915914|455544278|FG002|Acute Phase|Withdrawal by Subject|0|||
126613714|NCT01915914|455544279|FG003|Acute Phase|Withdrawal by Subject|0|||
126613715|NCT01915914|455544276|FG000|Acute Phase|Lost to Follow-up|4|||
126613716|NCT01915914|455544277|FG001|Acute Phase|Lost to Follow-up|0|||
126613717|NCT01915914|455544278|FG002|Acute Phase|Lost to Follow-up|0|||
126613718|NCT01915914|455544279|FG003|Acute Phase|Lost to Follow-up|0|||
126613719|NCT01915914|455544276|FG000|Acute Phase|Physician Decision|1|||
126613720|NCT01915914|455544277|FG001|Acute Phase|Physician Decision|0|||
126613721|NCT01915914|455544278|FG002|Acute Phase|Physician Decision|0|||
126613722|NCT01915914|455544279|FG003|Acute Phase|Physician Decision|0|||
126613723|NCT01915914|455544276|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
126613724|NCT01915914|455544277|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
126613725|NCT01915914|455544278|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
126613726|NCT01915914|455544279|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
126613727|NCT01915914|455544276|FG000|Acute Phase|"Not Achieved treatment success"|1|||
126613728|NCT01915914|455544277|FG001|Acute Phase|"Not Achieved treatment success"|0|||
126613729|NCT01915914|455544278|FG002|Acute Phase|"Not Achieved treatment success"|0|||
126613730|NCT01915914|455544279|FG003|Acute Phase|"Not Achieved treatment success"|0|||
126613731|NCT01915914|455544276|FG000|Acute Phase|Missing|1|||
126613732|NCT01915914|455544277|FG001|Acute Phase|Missing|0|||
126613733|NCT01915914|455544278|FG002|Acute Phase|Missing|0|||
126613734|NCT01915914|455544279|FG003|Acute Phase|Missing|0|||
126613735|NCT01915914|455544276|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126613736|NCT01915914|455544277|FG001|Maintenance Phase|Withdrawal by Subject|1|||
126613737|NCT01915914|455544278|FG002|Maintenance Phase|Withdrawal by Subject|1|||
126613738|NCT01915914|455544279|FG003|Maintenance Phase|Withdrawal by Subject|0|||
126613739|NCT01915914|455544276|FG000|Maintenance Phase|Lost to Follow-up|0|||
126613740|NCT01915914|455544277|FG001|Maintenance Phase|Lost to Follow-up|4|||
126613741|NCT01915914|455544278|FG002|Maintenance Phase|Lost to Follow-up|1|||
126613742|NCT01915914|455544279|FG003|Maintenance Phase|Lost to Follow-up|0|||
126613743|NCT01915914|455544276|FG000|Maintenance Phase|Missing|0|||
126613744|NCT01915914|455544277|FG001|Maintenance Phase|Missing|1|||
126613745|NCT01915914|455544278|FG002|Maintenance Phase|Missing|0|||
126613746|NCT01915914|455544279|FG003|Maintenance Phase|Missing|0|||
126613747|NCT01915914|455544276|FG000|Follow-up Phase|Withdrawal by Subject|0|||
126613748|NCT01915914|455544277|FG001|Follow-up Phase|Withdrawal by Subject|0|||
126613749|NCT01915914|455544278|FG002|Follow-up Phase|Withdrawal by Subject|0|||
126613750|NCT01915914|455544279|FG003|Follow-up Phase|Withdrawal by Subject|1|||
126613751|NCT01915914|455544276|FG000|Follow-up Phase|Physician Decision|0|||
126613752|NCT01915914|455544277|FG001|Follow-up Phase|Physician Decision|0|||
126613753|NCT01915914|455544278|FG002|Follow-up Phase|Physician Decision|0|||
126613754|NCT01915914|455544279|FG003|Follow-up Phase|Physician Decision|1|||
126613755|NCT02432274|455544280|FG000|Overall Study|Death|2|||
126613756|NCT02432274|455544281|FG001|Overall Study|Death|6|||
126613757|NCT02432274|455544282|FG002|Overall Study|Death|7|||
126613758|NCT02432274|455544283|FG003|Overall Study|Death|0|||
126613759|NCT02432274|455544284|FG004|Overall Study|Death|27|||
126613760|NCT02432274|455544285|FG005|Overall Study|Death|7|||
126613761|NCT02432274|455544286|FG006|Overall Study|Death|9|||
126613762|NCT02432274|455544287|FG007|Overall Study|Death|14|||
126613763|NCT02432274|455544280|FG000|Overall Study|Withdrawal of Consent|0|||
126613764|NCT02432274|455544281|FG001|Overall Study|Withdrawal of Consent|0|||
126613765|NCT02432274|455544282|FG002|Overall Study|Withdrawal of Consent|0|||
126613766|NCT02432274|455544283|FG003|Overall Study|Withdrawal of Consent|0|||
126613767|NCT02432274|455544284|FG004|Overall Study|Withdrawal of Consent|2|||
126613768|NCT02432274|455544285|FG005|Overall Study|Withdrawal of Consent|0|||
126613769|NCT02432274|455544286|FG006|Overall Study|Withdrawal of Consent|1|||
126613770|NCT02432274|455544287|FG007|Overall Study|Withdrawal of Consent|2|||
126613771|NCT00116649|455544288|FG000|Overall Study|Adverse Event|20|||
126613772|NCT00116649|455544288|FG000|Overall Study|Lack of Efficacy|1|||
126613773|NCT00116649|455544288|FG000|Overall Study|Lost to Follow-up|32|||
126613774|NCT00116649|455544288|FG000|Overall Study|Withdrawal by Subject|68|||
126613775|NCT00116649|455544288|FG000|Overall Study|Local Skin Reaction|9|||
126613776|NCT00116649|455544288|FG000|Overall Study|Various Reasons|18|||
126613777|NCT00116649|455544288|FG000|Overall Study|Protocol Specified|7|||
126613778|NCT00513071|455544291|FG000|Overall Study|Adverse Event|1|||
126613779|NCT00513071|455544291|FG000|Overall Study|Withdrawal by Subject|1|||
126613780|NCT00513071|455544291|FG000|Overall Study|Physician Decision|3|||
126613781|NCT02114515|455544294|FG000|Overall Study|Lost to Follow-up|52|||
126613782|NCT02114515|455544295|FG001|Overall Study|Lost to Follow-up|55|||
126613783|NCT02114515|455544294|FG000|Overall Study|Death|12|||
126613784|NCT02114515|455544295|FG001|Overall Study|Death|12|||
126613785|NCT02114515|455544294|FG000|Overall Study|Withdrawal by Subject|4|||
126613786|NCT02114515|455544295|FG001|Overall Study|Withdrawal by Subject|22|||
126613787|NCT02114515|455544294|FG000|Overall Study|Other|65|||
126613788|NCT02114515|455544295|FG001|Overall Study|Other|61|||
126613789|NCT00667732|455544296|FG000|Run -In (8 Weeks)|Adverse Event|4|||
126613790|NCT00667732|455544297|FG001|Run -In (8 Weeks)|Adverse Event|0|||
126613791|NCT00667732|455544298|FG002|Run -In (8 Weeks)|Adverse Event|0|||
126613792|NCT00667732|455544296|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
126613793|NCT00667732|455544297|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
126613794|NCT00667732|455544298|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
126613795|NCT00667732|455544296|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
126613796|NCT00667732|455544297|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
126613797|NCT00667732|455544298|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
126613798|NCT01240590|455544299|FG000|Phase I|Refused further treatment|0|||
126613799|NCT01240590|455544300|FG001|Phase I|Refused further treatment|0|||
126613800|NCT01240590|455544301|FG002|Phase I|Refused further treatment|3|||
126613801|NCT01240590|455544302|FG003|Phase I|Refused further treatment|0|||
126613802|NCT01240590|455544303|FG004|Phase I|Refused further treatment|0|||
126613803|NCT01240590|455544299|FG000|Phase II|Refused further treatment|0|||
126613804|NCT01240590|455544300|FG001|Phase II|Refused further treatment|0|||
126613805|NCT01240590|455544301|FG002|Phase II|Refused further treatment|0|||
126613806|NCT01240590|455544302|FG003|Phase II|Refused further treatment|2|||
126613807|NCT01240590|455544303|FG004|Phase II|Refused further treatment|1|||
126613808|NCT02659540|455544308|FG000|Overall Study|Adverse Event|3|||
126613809|NCT02659540|455544309|FG001|Overall Study|Adverse Event|2|||
126613810|NCT02659540|455544308|FG000|Overall Study|Death|1|||
126613811|NCT02659540|455544309|FG001|Overall Study|Death|0|||
126613812|NCT02659540|455544308|FG000|Overall Study|Progressive disease|2|||
126613813|NCT02659540|455544309|FG001|Overall Study|Progressive disease|6|||
126613814|NCT03890484|455544310|FG000|Overall Study|Lost to Follow-up|1|||
126613815|NCT03890484|455544311|FG001|Overall Study|Lost to Follow-up|1|||
126613816|NCT02106325|455544312|FG000|Phase 1|Lost to Follow-up|2|||
126613817|NCT02106325|455544313|FG001|Phase 1|Lost to Follow-up|2|||
126613818|NCT02106325|455544312|FG000|Phase 2|Lost to Follow-up|2|||
126613819|NCT02106325|455544313|FG001|Phase 2|Lost to Follow-up|3|||
126613820|NCT02106325|455544312|FG000|Phase 3|Lost to Follow-up|2|||
126613821|NCT02106325|455544313|FG001|Phase 3|Lost to Follow-up|1|||
126613822|NCT00824850|455544315|FG000|Overall Study|Withdrawal by Subject|0|||
126613823|NCT00824850|455544316|FG001|Overall Study|Withdrawal by Subject|1|||
126613824|NCT04820491|455544317|FG000|Overall Study|Withdrawal by Subject|1|||
126613825|NCT04820491|455544318|FG001|Overall Study|Withdrawal by Subject|0|||
126613826|NCT05184062|455544319|FG000|Overall Study|Lost to Follow-up|5|||
126613827|NCT05184062|455544320|FG001|Overall Study|Lost to Follow-up|1|||
126613828|NCT05184062|455544319|FG000|Overall Study|Withdrawal by Subject|1|||
126613829|NCT05184062|455544320|FG001|Overall Study|Withdrawal by Subject|0|||
126613830|NCT03976323|455544321|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
126613831|NCT03976323|455544322|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
126613832|NCT03976323|455544323|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
126736706|NCT03383614|455986559|FG000|Overall Study|Withdrawal by Subject|0|||
126736707|NCT03383614|455986560|FG001|Overall Study|Withdrawal by Subject|1|||
126736708|NCT03383614|455986561|FG002|Overall Study|Withdrawal by Subject|0|||
126736709|NCT03383614|455986562|FG003|Overall Study|Withdrawal by Subject|0|||
126736710|NCT00729326|455986569|FG000|Overall Study|Lost to Follow-up|2|||
126736711|NCT00729326|455986570|FG001|Overall Study|Lost to Follow-up|0|||
126736712|NCT00729326|455986569|FG000|Overall Study|Physician Decision|0|||
126736713|NCT00729326|455986570|FG001|Overall Study|Physician Decision|1|||
126736714|NCT00729326|455986569|FG000|Overall Study|Protocol Violation|3|||
126736715|NCT00729326|455986570|FG001|Overall Study|Protocol Violation|2|||
126736716|NCT00729326|455986569|FG000|Overall Study|Subject Decision|4|||
126736717|NCT00729326|455986570|FG001|Overall Study|Subject Decision|4|||
126736718|NCT00729326|455986569|FG000|Overall Study|Sponsor Decision|1|||
126736719|NCT00729326|455986570|FG001|Overall Study|Sponsor Decision|2|||
126736720|NCT01235728|455986571|FG000|Overall Study|Protocol Violation|0|||
126736721|NCT01235728|455986572|FG001|Overall Study|Protocol Violation|0|||
126736722|NCT01235728|455986573|FG002|Overall Study|Protocol Violation|0|||
126736723|NCT01235728|455986574|FG003|Overall Study|Protocol Violation|1|||
126736724|NCT01235728|455986575|FG004|Overall Study|Protocol Violation|0|||
126736725|NCT01235728|455986576|FG005|Overall Study|Protocol Violation|0|||
126736726|NCT01235728|455986577|FG006|Overall Study|Protocol Violation|0|||
126736727|NCT01235728|455986578|FG007|Overall Study|Protocol Violation|0|||
126736728|NCT02559713|455986579|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
126736729|NCT02193828|455986583|FG000|Overall Study|Withdrawal by Subject|0|||
126736730|NCT02193828|455986584|FG001|Overall Study|Withdrawal by Subject|0|||
126736731|NCT02193828|455986585|FG002|Overall Study|Withdrawal by Subject|1|||
126736732|NCT02193828|455986586|FG003|Overall Study|Withdrawal by Subject|1|||
126736733|NCT01185704|455986587|FG000|Overall Study|Randomized but not treated|3|||
126736734|NCT01185704|455986588|FG001|Overall Study|Randomized but not treated|3|||
126736735|NCT01185704|455986587|FG000|Overall Study|Lack of ovarian response|5|||
126736736|NCT01185704|455986588|FG001|Overall Study|Lack of ovarian response|1|||
126736737|NCT01185704|455986587|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
126736738|NCT01185704|455986588|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
126736739|NCT01185704|455986587|FG000|Overall Study|Ectopic pregnancy|0|||
126736740|NCT01185704|455986588|FG001|Overall Study|Ectopic pregnancy|1|||
126736741|NCT01686958|455986591|FG000|Overall Study|Withdrawal by Subject|1|||
126736742|NCT00187889|455986592|FG000|Overall Study|Withdrawal by Subject|6|||
126736743|NCT00187889|455986593|FG001|Overall Study|Withdrawal by Subject|4|||
126736744|NCT01151540|455986594|FG000|Overall Study|Other|2|||
126736745|NCT01151540|455986594|FG000|Overall Study|Adverse event, non-fatal|4|||
126736746|NCT01151540|455986594|FG000|Overall Study|Withdrawal by Subject|7|||
126736747|NCT03094832|455986597|FG000|Overall Study|Lost to Follow-up|0|||
126736748|NCT03094832|455986598|FG001|Overall Study|Lost to Follow-up|0|||
126736749|NCT03094832|455986599|FG002|Overall Study|Lost to Follow-up|0|||
126736750|NCT03094832|455986600|FG003|Overall Study|Lost to Follow-up|1|||
126736751|NCT03094832|455986601|FG004|Overall Study|Lost to Follow-up|1|||
126736752|NCT03094832|455986597|FG000|Overall Study|Death|1|||
126736753|NCT03094832|455986598|FG001|Overall Study|Death|0|||
126736754|NCT03094832|455986599|FG002|Overall Study|Death|0|||
126736755|NCT03094832|455986600|FG003|Overall Study|Death|0|||
126736756|NCT03094832|455986601|FG004|Overall Study|Death|0|||
126736757|NCT03094832|455986597|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
126736758|NCT03094832|455986598|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
126736759|NCT03094832|455986599|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126736760|NCT03094832|455986600|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126736761|NCT03094832|455986601|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126736762|NCT03094832|455986597|FG000|Overall Study|Other|13|||
126736763|NCT03094832|455986598|FG001|Overall Study|Other|20|||
126736764|NCT03094832|455986599|FG002|Overall Study|Other|1|||
126736765|NCT03094832|455986600|FG003|Overall Study|Other|7|||
126736766|NCT03094832|455986601|FG004|Overall Study|Other|1|||
126736767|NCT01419080|455986602|FG000|Overall Study|Withdrawal by Subject|75|||
126736768|NCT01419080|455986602|FG000|Overall Study|Death|30|||
126736769|NCT01419080|455986602|FG000|Overall Study|Lost to Follow-up|23|||
126736770|NCT01419080|455986602|FG000|Overall Study|Too Ill|3|||
126736771|NCT01998880|455986603|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
126736772|NCT01998880|455986604|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
126736773|NCT01998880|455986603|FG000|Overall Study|Disease Progression|1|||
126736774|NCT01998880|455986604|FG001|Overall Study|Disease Progression|8|||
126736775|NCT01998880|455986603|FG000|Overall Study|Withdrew Consent|2|||
126736776|NCT01998880|455986604|FG001|Overall Study|Withdrew Consent|1|||
126736777|NCT01998880|455986603|FG000|Overall Study|Death|3|||
126736778|NCT01998880|455986604|FG001|Overall Study|Death|6|||
126736779|NCT01998880|455986603|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126736780|NCT01998880|455986604|FG001|Overall Study|Insufficient Therapeutic Response|5|||
126736781|NCT01998880|455986603|FG000|Overall Study|Administrative/Other|1|||
126736782|NCT01998880|455986604|FG001|Overall Study|Administrative/Other|1|||
126736783|NCT01998880|455986603|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
126613833|NCT03976323|455544321|FG000|Induction Phase|Death|80|||
126613834|NCT03976323|455544322|FG001|Induction Phase|Death|0|||
126613835|NCT03976323|455544323|FG002|Induction Phase|Death|0|||
126613836|NCT03976323|455544321|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
126613837|NCT03976323|455544322|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
126613838|NCT03976323|455544323|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
126613839|NCT03976323|455544321|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126613840|NCT03976323|455544322|FG001|Maintenance Phase|Withdrawal by Subject|9|||
126613841|NCT03976323|455544323|FG002|Maintenance Phase|Withdrawal by Subject|3|||
126613842|NCT03976323|455544321|FG000|Maintenance Phase|Physician Decision|0|||
126613843|NCT03976323|455544322|FG001|Maintenance Phase|Physician Decision|0|||
126613844|NCT03976323|455544323|FG002|Maintenance Phase|Physician Decision|1|||
126613845|NCT03976323|455544321|FG000|Maintenance Phase|Death|0|||
126613846|NCT03976323|455544322|FG001|Maintenance Phase|Death|228|||
126613847|NCT03976323|455544323|FG002|Maintenance Phase|Death|234|||
126613848|NCT00535626|455546052|FG000|Overall Study|Death|15|||
126613849|NCT00535626|455546052|FG000|Overall Study|Lost to Follow-up|29|||
126613850|NCT00535626|455546052|FG000|Overall Study|Withdrawal by Subject|20|||
126613851|NCT00535626|455546052|FG000|Overall Study|Removal/revision of study component|8|||
126613852|NCT00535626|455546052|FG000|Overall Study|Subject terminated|31|||
126613853|NCT00535626|455546052|FG000|Overall Study|Unable to return|2|||
126613854|NCT02830893|455546053|FG000|Overall Study|Relocation to out of the country|1|||
126613855|NCT02830893|455546054|FG001|Overall Study|Relocation to out of the country|0|||
126613856|NCT02830893|455546053|FG000|Overall Study|Lost to Follow-up|0|||
126613857|NCT02830893|455546054|FG001|Overall Study|Lost to Follow-up|2|||
126613858|NCT02830893|455546053|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
126613859|NCT02830893|455546054|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
126613860|NCT01277302|455546055|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
126613861|NCT01277302|455546056|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
126613862|NCT01277302|455546057|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
126613863|NCT01277302|455546055|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
126613864|NCT01277302|455546056|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
126613865|NCT01277302|455546057|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
126613866|NCT01277302|455546055|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
126613867|NCT01277302|455546056|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
126613868|NCT01277302|455546057|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
126613869|NCT01277302|455546055|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
126613870|NCT01277302|455546056|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
126613871|NCT01277302|455546057|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
126613872|NCT01277302|455546055|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
126613873|NCT01277302|455546056|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
126613874|NCT01277302|455546057|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
126613875|NCT01277302|455546055|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
126613876|NCT01277302|455546056|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
126613877|NCT01277302|455546057|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
126613878|NCT01277302|455546055|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
126613879|NCT01277302|455546056|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
126613880|NCT01277302|455546057|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
126613881|NCT01277302|455546055|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
126613882|NCT01277302|455546056|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
126613883|NCT01277302|455546057|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
126613884|NCT01277302|455546055|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
126613885|NCT01277302|455546056|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
126613886|NCT01277302|455546057|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
126613887|NCT02710669|455546058|FG000|Overall Study|Physician Decision|2|||
126613888|NCT02710669|455546059|FG001|Overall Study|Physician Decision|1|||
126613889|NCT02710669|455546060|FG002|Overall Study|Physician Decision|0|||
126613890|NCT02710669|455546058|FG000|Overall Study|Institutional delays (including COVID)|2|||
126613891|NCT02710669|455546059|FG001|Overall Study|Institutional delays (including COVID)|2|||
126613892|NCT02710669|455546060|FG002|Overall Study|Institutional delays (including COVID)|0|||
126613893|NCT02710669|455546058|FG000|Overall Study|arrived in afib/aflutter|10|||
126613894|NCT02710669|455546059|FG001|Overall Study|arrived in afib/aflutter|8|||
126613895|NCT02710669|455546060|FG002|Overall Study|arrived in afib/aflutter|2|||
126613896|NCT00731692|455546061|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
126613897|NCT00731692|455546062|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
126613898|NCT00731692|455546063|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
126613899|NCT00731692|455546061|FG000|Core Study (36 Months)|Physician Decision|1|||
126613900|NCT00731692|455546062|FG001|Core Study (36 Months)|Physician Decision|0|||
126613901|NCT00731692|455546063|FG002|Core Study (36 Months)|Physician Decision|2|||
126613902|NCT00731692|455546061|FG000|Core Study (36 Months)|Death|2|||
126613903|NCT00731692|455546062|FG001|Core Study (36 Months)|Death|1|||
126736784|NCT01998880|455986604|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
126736785|NCT01998880|455986603|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
126736786|NCT01998880|455986604|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
126736787|NCT01998880|455986603|FG000|Overall Study|Did Not Receive Treatment|3|||
126736788|NCT01998880|455986604|FG001|Overall Study|Did Not Receive Treatment|2|||
126736789|NCT03199638|455986608|FG000|Overall Study|inability to drink glutamine during regularly|0|||
126736790|NCT03199638|455986609|FG001|Overall Study|inability to drink glutamine during regularly|2|||
126736791|NCT01575899|455986610|FG000|Overall Study|Lost to Follow-up|3|||
126736792|NCT01575899|455986611|FG001|Overall Study|Lost to Follow-up|4|||
126736793|NCT01575899|455986612|FG002|Overall Study|Lost to Follow-up|2|||
126736794|NCT01575899|455986610|FG000|Overall Study|Protocol Violation|2|||
126736795|NCT01575899|455986611|FG001|Overall Study|Protocol Violation|1|||
126736796|NCT01575899|455986612|FG002|Overall Study|Protocol Violation|0|||
126736797|NCT02807844|455986613|FG000|Overall Study|Physician Decision|0|||
126736798|NCT02807844|455986614|FG001|Overall Study|Physician Decision|0|||
126736799|NCT02807844|455986615|FG002|Overall Study|Physician Decision|0|||
126736800|NCT02807844|455986616|FG003|Overall Study|Physician Decision|0|||
126736801|NCT02807844|455986617|FG004|Overall Study|Physician Decision|0|||
126736802|NCT02807844|455986618|FG005|Overall Study|Physician Decision|0|||
126736803|NCT02807844|455986619|FG006|Overall Study|Physician Decision|3|||
126736804|NCT02807844|455986620|FG007|Overall Study|Physician Decision|0|||
126736805|NCT02807844|455986621|FG008|Overall Study|Physician Decision|1|||
126736806|NCT02807844|455986622|FG009|Overall Study|Physician Decision|2|||
126736807|NCT02807844|455986613|FG000|Overall Study|Death|0|||
126736808|NCT02807844|455986614|FG001|Overall Study|Death|0|||
126736809|NCT02807844|455986615|FG002|Overall Study|Death|2|||
126736810|NCT02807844|455986616|FG003|Overall Study|Death|4|||
126736811|NCT02807844|455986617|FG004|Overall Study|Death|1|||
126736812|NCT02807844|455986618|FG005|Overall Study|Death|2|||
126736813|NCT02807844|455986619|FG006|Overall Study|Death|1|||
126736814|NCT02807844|455986620|FG007|Overall Study|Death|2|||
126736815|NCT02807844|455986621|FG008|Overall Study|Death|0|||
126736816|NCT02807844|455986622|FG009|Overall Study|Death|1|||
126736817|NCT02807844|455986613|FG000|Overall Study|Withdrawal by Subject|0|||
126736818|NCT02807844|455986614|FG001|Overall Study|Withdrawal by Subject|0|||
126736819|NCT02807844|455986615|FG002|Overall Study|Withdrawal by Subject|2|||
126736820|NCT02807844|455986616|FG003|Overall Study|Withdrawal by Subject|1|||
126613904|NCT00731692|455546063|FG002|Core Study (36 Months)|Death|2|||
126613905|NCT00731692|455546061|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
126613906|NCT00731692|455546062|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
126613907|NCT00731692|455546063|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
126613908|NCT00731692|455546061|FG000|Core Study (36 Months)|Administrative|2|||
126613909|NCT00731692|455546062|FG001|Core Study (36 Months)|Administrative|2|||
126613910|NCT00731692|455546063|FG002|Core Study (36 Months)|Administrative|6|||
126613911|NCT00731692|455546061|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
126613912|NCT00731692|455546062|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
126613913|NCT00731692|455546063|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
126613914|NCT00731692|455546061|FG000|Core Study (36 Months)|Protocol Violation|4|||
126613915|NCT00731692|455546062|FG001|Core Study (36 Months)|Protocol Violation|5|||
126613916|NCT00731692|455546063|FG002|Core Study (36 Months)|Protocol Violation|8|||
126613917|NCT00731692|455546061|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
126613918|NCT00731692|455546062|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
126613919|NCT00731692|455546063|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
126613920|NCT00731692|455546061|FG000|Core Study (36 Months)|Adverse Event|25|||
126613921|NCT00731692|455546062|FG001|Core Study (36 Months)|Adverse Event|28|||
126613922|NCT00731692|455546063|FG002|Core Study (36 Months)|Adverse Event|29|||
126613923|NCT00731692|455546061|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
126613924|NCT00731692|455546062|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
126613925|NCT00731692|455546063|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
126613926|NCT00731692|455546061|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
126613927|NCT00731692|455546062|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
126613928|NCT00731692|455546063|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
126613929|NCT00731692|455546061|FG000|Extension Phase|Abnormal test procedure|0|||
126736821|NCT02807844|455986617|FG004|Overall Study|Withdrawal by Subject|1|||
126736822|NCT02807844|455986618|FG005|Overall Study|Withdrawal by Subject|0|||
126736823|NCT02807844|455986619|FG006|Overall Study|Withdrawal by Subject|1|||
126736824|NCT02807844|455986620|FG007|Overall Study|Withdrawal by Subject|0|||
126736825|NCT02807844|455986621|FG008|Overall Study|Withdrawal by Subject|0|||
126736826|NCT02807844|455986622|FG009|Overall Study|Withdrawal by Subject|0|||
126613930|NCT00731692|455546062|FG001|Extension Phase|Abnormal test procedure|0|||
126613931|NCT00731692|455546063|FG002|Extension Phase|Abnormal test procedure|1|||
126736827|NCT02807844|455986613|FG000|Overall Study|Progressive disease|5|||
126736828|NCT02807844|455986614|FG001|Overall Study|Progressive disease|12|||
126736829|NCT02807844|455986615|FG002|Overall Study|Progressive disease|8|||
126736830|NCT02807844|455986616|FG003|Overall Study|Progressive disease|8|||
126736831|NCT02807844|455986617|FG004|Overall Study|Progressive disease|3|||
126736832|NCT02807844|455986618|FG005|Overall Study|Progressive disease|8|||
126736833|NCT02807844|455986619|FG006|Overall Study|Progressive disease|14|||
126736834|NCT02807844|455986620|FG007|Overall Study|Progressive disease|17|||
126736835|NCT02807844|455986621|FG008|Overall Study|Progressive disease|19|||
126736836|NCT02807844|455986622|FG009|Overall Study|Progressive disease|15|||
126736837|NCT02807844|455986613|FG000|Overall Study|Adverse Event|1|||
126736838|NCT02807844|455986614|FG001|Overall Study|Adverse Event|0|||
126736839|NCT02807844|455986615|FG002|Overall Study|Adverse Event|0|||
126736840|NCT02807844|455986616|FG003|Overall Study|Adverse Event|0|||
126736841|NCT02807844|455986617|FG004|Overall Study|Adverse Event|1|||
126736842|NCT02807844|455986618|FG005|Overall Study|Adverse Event|1|||
126736843|NCT02807844|455986619|FG006|Overall Study|Adverse Event|1|||
126736844|NCT02807844|455986620|FG007|Overall Study|Adverse Event|1|||
126736845|NCT02807844|455986621|FG008|Overall Study|Adverse Event|1|||
126736846|NCT02807844|455986622|FG009|Overall Study|Adverse Event|2|||
126736847|NCT00709124|455986623|FG000|Overall Study|Death|3|||
126736848|NCT00709124|455986624|FG001|Overall Study|Death|1|||
126736849|NCT00709124|455986623|FG000|Overall Study|encephalopathy; can't do assessment|1|||
126736850|NCT00709124|455986624|FG001|Overall Study|encephalopathy; can't do assessment|0|||
126736851|NCT00373490|455986625|FG000|Overall Study|Adverse Event|0|||
126736852|NCT00373490|455986626|FG001|Overall Study|Adverse Event|1|||
126736853|NCT00373490|455986625|FG000|Overall Study|Lack of Efficacy|9|||
126736854|NCT00373490|455986626|FG001|Overall Study|Lack of Efficacy|4|||
126736855|NCT00373490|455986625|FG000|Overall Study|Withdrawal by Subject|0|||
126736856|NCT00373490|455986626|FG001|Overall Study|Withdrawal by Subject|1|||
126736857|NCT04294095|455986627|FG000|Overall Study|Adverse Event|1|||
126736858|NCT04294095|455986628|FG001|Overall Study|Adverse Event|0|||
126736859|NCT02661464|455986630|FG000|Overall Study|Lost to Follow-up|28|||
126736860|NCT02661464|455986631|FG001|Overall Study|Lost to Follow-up|0|||
126736861|NCT02661464|455986632|FG002|Overall Study|Lost to Follow-up|0|||
126736862|NCT02661464|455986633|FG003|Overall Study|Lost to Follow-up|0|||
126736863|NCT02661464|455986630|FG000|Overall Study|Withdrawal by Subject|3|||
126736864|NCT02661464|455986631|FG001|Overall Study|Withdrawal by Subject|1|||
126736865|NCT02661464|455986632|FG002|Overall Study|Withdrawal by Subject|0|||
126736866|NCT02661464|455986633|FG003|Overall Study|Withdrawal by Subject|0|||
126736867|NCT02661464|455986630|FG000|Overall Study|Participants terminated prematurely|288|||
126736868|NCT02661464|455986631|FG001|Overall Study|Participants terminated prematurely|52|||
126736869|NCT02661464|455986632|FG002|Overall Study|Participants terminated prematurely|1|||
126736870|NCT02661464|455986633|FG003|Overall Study|Participants terminated prematurely|1|||
126736871|NCT02661464|455986630|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
126736872|NCT02661464|455986631|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
126736873|NCT02661464|455986632|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
126736874|NCT02661464|455986633|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
126736875|NCT03148756|455986634|FG000|Overall Study|Study Terminated|0|||
126736876|NCT03148756|455986635|FG001|Overall Study|Study Terminated|1|||
126736877|NCT02177175|455986638|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
126736878|NCT02177175|455986639|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
126736879|NCT03820726|455986644|FG000|Overall Study|Other than listed|23|||
126736880|NCT03820726|455986644|FG000|Overall Study|Withdrawal by Subject|37|||
126736881|NCT03820726|455986644|FG000|Overall Study|Lost to Follow-up|3|||
126736882|NCT03820726|455986644|FG000|Overall Study|Protocol deviation|1|||
126736883|NCT03820726|455986644|FG000|Overall Study|Adverse Event|146|||
126736884|NCT03820726|455986644|FG000|Overall Study|Not treated|1|||
126736885|NCT00345540|455986645|FG000|Overall Study|Withdrawal by Subject|1|||
126736886|NCT01406652|455986646|FG000|Overall Study|Lost-to-follow-up|3|||
126736887|NCT01406652|455986647|FG001|Overall Study|Lost-to-follow-up|4|||
126736888|NCT01406652|455986646|FG000|Overall Study|Withdrawal by Subject|2|||
126736889|NCT01406652|455986647|FG001|Overall Study|Withdrawal by Subject|2|||
126736890|NCT01406652|455986646|FG000|Overall Study|Insufficient follow-up|5|||
126736891|NCT01406652|455986647|FG001|Overall Study|Insufficient follow-up|4|||
126736892|NCT01406652|455986646|FG000|Overall Study|Infection not sure|10|||
126736893|NCT01406652|455986647|FG001|Overall Study|Infection not sure|10|||
126736894|NCT00141037|455986648|FG000|Overall Study|Physician Decision|1|||
126736895|NCT00141037|455986649|FG001|Overall Study|Physician Decision|2|||
126736896|NCT00141037|455986648|FG000|Overall Study|Lost to Follow-up|3|||
126736897|NCT00141037|455986649|FG001|Overall Study|Lost to Follow-up|1|||
126736898|NCT00141037|455986648|FG000|Overall Study|Protocol Violation|0|||
126736899|NCT00141037|455986649|FG001|Overall Study|Protocol Violation|2|||
126736900|NCT00141037|455986648|FG000|Overall Study|Withdrawal by Subject|2|||
126736901|NCT00141037|455986649|FG001|Overall Study|Withdrawal by Subject|1|||
126736902|NCT00141037|455986648|FG000|Overall Study|Other|0|||
126736903|NCT00141037|455986649|FG001|Overall Study|Other|1|||
126736904|NCT00141037|455986648|FG000|Overall Study|Moved from area|1|||
126736905|NCT00141037|455986649|FG001|Overall Study|Moved from area|7|||
126736906|NCT00141037|455986648|FG000|Overall Study|Graft Failure|3|||
126736907|NCT00141037|455986649|FG001|Overall Study|Graft Failure|4|||
126736908|NCT00260429|455986650|FG000|Overall Study|failure to follow appointments|1|||
126756582|NCT00883896|456059485|FG003|Overall Study|Lack of Efficacy|2|||
126736909|NCT00260429|455986651|FG001|Overall Study|failure to follow appointments|0|||
126736910|NCT00260429|455986650|FG000|Overall Study|scheduled hand surgery|1|||
126736911|NCT00260429|455986651|FG001|Overall Study|scheduled hand surgery|0|||
126736912|NCT00861380|455986652|FG000|Overall Study|Withdrawal Information not recorded|8427|||
126736913|NCT00861380|455986653|FG001|Overall Study|Withdrawal Information not recorded|9112|||
126736914|NCT00861380|455986654|FG002|Overall Study|Withdrawal Information not recorded|8872|||
126736915|NCT00861380|455986655|FG003|Overall Study|Withdrawal Information not recorded|3689|||
126736916|NCT00861380|455986656|FG004|Overall Study|Withdrawal Information not recorded|1812|||
126736917|NCT00861380|455986657|FG005|Overall Study|Withdrawal Information not recorded|6249|||
126736918|NCT00861380|455986658|FG006|Overall Study|Withdrawal Information not recorded|3020|||
126736919|NCT00628758|455986659|FG000|Overall Study|Adverse Event|2|||
126736920|NCT00628758|455986660|FG001|Overall Study|Adverse Event|3|||
126736921|NCT00628758|455986659|FG000|Overall Study|Withdrawal by Subject|6|||
126736922|NCT00628758|455986660|FG001|Overall Study|Withdrawal by Subject|3|||
126736923|NCT00628758|455986659|FG000|Overall Study|Death|1|||
126736924|NCT00628758|455986660|FG001|Overall Study|Death|0|||
126736925|NCT00628758|455986659|FG000|Overall Study|Protocol Violation|5|||
126736926|NCT00628758|455986660|FG001|Overall Study|Protocol Violation|1|||
126736927|NCT00628758|455986659|FG000|Overall Study|Lost to Follow-up|25|||
126736928|NCT00628758|455986660|FG001|Overall Study|Lost to Follow-up|31|||
126736929|NCT00628758|455986659|FG000|Overall Study|Pregnancy|2|||
126736930|NCT00628758|455986660|FG001|Overall Study|Pregnancy|2|||
126736931|NCT00628758|455986659|FG000|Overall Study|Investigator Moved|3|||
126736932|NCT00628758|455986660|FG001|Overall Study|Investigator Moved|0|||
126736933|NCT00628758|455986659|FG000|Overall Study|Treatment Failure|0|||
126736934|NCT00628758|455986660|FG001|Overall Study|Treatment Failure|2|||
126736935|NCT00637377|455986661|FG000|Overall Study|Adverse Event|2|||
126736936|NCT00637377|455986662|FG001|Overall Study|Adverse Event|6|||
126736937|NCT00637377|455986663|FG002|Overall Study|Adverse Event|8|||
126736938|NCT00637377|455986664|FG003|Overall Study|Adverse Event|9|||
126736939|NCT00637377|455986661|FG000|Overall Study|Death|1|||
126736940|NCT00637377|455986662|FG001|Overall Study|Death|3|||
126736941|NCT00637377|455986663|FG002|Overall Study|Death|2|||
126736942|NCT00637377|455986664|FG003|Overall Study|Death|1|||
126736943|NCT00637377|455986661|FG000|Overall Study|Lack of Efficacy|0|||
126736944|NCT00637377|455986662|FG001|Overall Study|Lack of Efficacy|0|||
126736945|NCT00637377|455986663|FG002|Overall Study|Lack of Efficacy|1|||
126736946|NCT00637377|455986664|FG003|Overall Study|Lack of Efficacy|1|||
126736947|NCT00637377|455986661|FG000|Overall Study|Lost to Follow-up|4|||
126736948|NCT00637377|455986662|FG001|Overall Study|Lost to Follow-up|1|||
126736949|NCT00637377|455986663|FG002|Overall Study|Lost to Follow-up|2|||
126736950|NCT00637377|455986664|FG003|Overall Study|Lost to Follow-up|2|||
126736951|NCT00637377|455986661|FG000|Overall Study|Protocol Violation|2|||
126736952|NCT00637377|455986662|FG001|Overall Study|Protocol Violation|1|||
126736953|NCT00637377|455986663|FG002|Overall Study|Protocol Violation|1|||
126736954|NCT00637377|455986664|FG003|Overall Study|Protocol Violation|0|||
126736955|NCT00637377|455986661|FG000|Overall Study|Withdrawal by Subject|11|||
126736956|NCT00637377|455986662|FG001|Overall Study|Withdrawal by Subject|15|||
126736957|NCT00637377|455986663|FG002|Overall Study|Withdrawal by Subject|13|||
126736958|NCT00637377|455986664|FG003|Overall Study|Withdrawal by Subject|11|||
126736959|NCT00637377|455986661|FG000|Overall Study|Other (no further information available)|7|||
126736960|NCT00637377|455986662|FG001|Overall Study|Other (no further information available)|6|||
126736961|NCT00637377|455986663|FG002|Overall Study|Other (no further information available)|10|||
126736962|NCT00637377|455986664|FG003|Overall Study|Other (no further information available)|5|||
126736963|NCT01938001|455986665|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
126736964|NCT01938001|455986666|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
126736965|NCT01938001|455986665|FG000|Pre-Treatment|Death|1|||
126736966|NCT01938001|455986666|FG001|Pre-Treatment|Death|0|||
126736967|NCT01938001|455986665|FG000|Treatment|Death|2|||
126736968|NCT01938001|455986666|FG001|Treatment|Death|0|||
126736969|NCT01938001|455986665|FG000|Treatment|Adverse Event|14|||
126736970|NCT01938001|455986666|FG001|Treatment|Adverse Event|8|||
126736971|NCT01938001|455986665|FG000|Treatment|Progressive Disease|21|||
126736972|NCT01938001|455986666|FG001|Treatment|Progressive Disease|54|||
126736973|NCT01938001|455986665|FG000|Treatment|Withdrawal by Subject|13|||
126736974|NCT01938001|455986666|FG001|Treatment|Withdrawal by Subject|7|||
126736975|NCT01938001|455986665|FG000|Treatment|Other reasons|2|||
126736976|NCT01938001|455986666|FG001|Treatment|Other reasons|1|||
126736977|NCT01822223|455986667|FG000|Overall Study|Death|0|||
126736978|NCT01822223|455986668|FG001|Overall Study|Death|1|||
126736979|NCT02483078|455986675|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
126736980|NCT02483078|455986676|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
126736981|NCT02483078|455986675|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
126736982|NCT02483078|455986676|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
126736983|NCT02483078|455986675|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
126736984|NCT02483078|455986676|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
126736985|NCT02483078|455986675|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
126736986|NCT02483078|455986676|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
126736987|NCT02483078|455986675|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
126736988|NCT02483078|455986676|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
126736989|NCT02483078|455986675|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
126736990|NCT02483078|455986676|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
126736991|NCT04876599|455986677|FG000|Overall Study|Missed|2|||
126736992|NCT04876599|455986678|FG001|Overall Study|Missed|0|||
126736993|NCT04876599|455986677|FG000|Overall Study|Declined|2|||
126736994|NCT04876599|455986678|FG001|Overall Study|Declined|3|||
126736995|NCT03175562|455986679|FG000|Overall Study|Adverse Event|1|||
126736996|NCT03175562|455986679|FG000|Overall Study|Lost to Follow-up|3|||
126613932|NCT00731692|455546061|FG000|Extension Phase|Abnormal lab values|0|||
126613933|NCT00731692|455546062|FG001|Extension Phase|Abnormal lab values|0|||
126613934|NCT00731692|455546063|FG002|Extension Phase|Abnormal lab values|1|||
126613935|NCT00731692|455546061|FG000|Extension Phase|Lost to Follow-up|0|||
126613936|NCT00731692|455546062|FG001|Extension Phase|Lost to Follow-up|1|||
126613937|NCT00731692|455546063|FG002|Extension Phase|Lost to Follow-up|4|||
126613938|NCT00731692|455546061|FG000|Extension Phase|Withdrawal by Subject|4|||
126613939|NCT00731692|455546062|FG001|Extension Phase|Withdrawal by Subject|5|||
126613940|NCT00731692|455546063|FG002|Extension Phase|Withdrawal by Subject|3|||
126613941|NCT00731692|455546061|FG000|Extension Phase|Adverse Event|1|||
126613942|NCT00731692|455546062|FG001|Extension Phase|Adverse Event|1|||
126613943|NCT00731692|455546063|FG002|Extension Phase|Adverse Event|15|||
126613944|NCT03332589|455546064|FG000|Overall Study|Lack of Efficacy|2|||
126613945|NCT03332589|455546065|FG001|Overall Study|Lack of Efficacy|0|||
126613946|NCT03332589|455546066|FG002|Overall Study|Lack of Efficacy|0|||
126613947|NCT03332589|455546064|FG000|Overall Study|Adverse Event|1|||
126613948|NCT03332589|455546065|FG001|Overall Study|Adverse Event|0|||
126613949|NCT03332589|455546066|FG002|Overall Study|Adverse Event|0|||
126613950|NCT03332589|455546064|FG000|Overall Study|Death|1|||
126613951|NCT03332589|455546065|FG001|Overall Study|Death|0|||
126613952|NCT03332589|455546066|FG002|Overall Study|Death|0|||
126613953|NCT00108355|455546070|FG000|Overall Study|Peritonitis at index paracentesis|1|||
126613954|NCT00108355|455546071|FG001|Overall Study|Peritonitis at index paracentesis|1|||
126613955|NCT00108355|455546070|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
126613956|NCT00108355|455546071|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
126613957|NCT02002689|455546076|FG000|Overall Study|Disease Progression|7|||
126613958|NCT02002689|455546076|FG000|Overall Study|Adverse Event|3|||
126613959|NCT01185340|455546079|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
126613960|NCT01185340|455546080|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126613961|NCT01185340|455546081|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126613962|NCT01185340|455546082|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126613963|NCT01185340|455546079|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
126613964|NCT01185340|455546080|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126613965|NCT01185340|455546081|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126613966|NCT01185340|455546082|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126613967|NCT01185340|455546079|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
126613968|NCT01185340|455546080|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126613969|NCT01185340|455546081|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126613970|NCT01185340|455546082|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126613971|NCT01185340|455546079|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
126613972|NCT01185340|455546080|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126613973|NCT01185340|455546081|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126613974|NCT01185340|455546082|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126613975|NCT01185340|455546079|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
126613976|NCT01185340|455546080|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126613977|NCT01185340|455546081|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126613978|NCT01185340|455546082|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126613979|NCT01185340|455546079|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
126613980|NCT01185340|455546080|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126613981|NCT01185340|455546081|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126613982|NCT01185340|455546082|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126613983|NCT01185340|455546079|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
126613984|NCT01185340|455546080|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126736997|NCT03175562|455986679|FG000|Overall Study|Withdrawal by Subject|7|||
126736998|NCT03175562|455986679|FG000|Overall Study|Other (Not Specified)|5|||
126613985|NCT01185340|455546081|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126613986|NCT01185340|455546082|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126613987|NCT01185340|455546079|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
126613988|NCT01185340|455546080|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
126613989|NCT01185340|455546081|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
126613990|NCT01185340|455546082|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
126736999|NCT02146833|455986680|FG000|Overall Study|Death|10|||
126737000|NCT02146833|455986680|FG000|Overall Study|No longer consented to study treatment|1|||
126737001|NCT01410799|455986682|FG000|Overall Study|PI decision|13|||
126737002|NCT04126031|455986684|FG000|Part A|Withdrawal by Subject|0|||
126737003|NCT04126031|455986685|FG001|Part A|Withdrawal by Subject|0|||
126737004|NCT04126031|455986686|FG002|Part A|Withdrawal by Subject|1|||
126737005|NCT04126031|455986687|FG003|Part A|Withdrawal by Subject|0|||
126737006|NCT04126031|455986688|FG004|Part A|Withdrawal by Subject|0|||
126737007|NCT04126031|455986689|FG005|Part A|Withdrawal by Subject|0|||
126737008|NCT04126031|455986684|FG000|Part A|Other|1|||
126737009|NCT04126031|455986685|FG001|Part A|Other|0|||
126737010|NCT04126031|455986686|FG002|Part A|Other|0|||
126737011|NCT04126031|455986687|FG003|Part A|Other|0|||
126737012|NCT04126031|455986688|FG004|Part A|Other|0|||
126737013|NCT04126031|455986689|FG005|Part A|Other|0|||
126737014|NCT04126031|455986684|FG000|Part B|Adverse Event|0|||
126737015|NCT04126031|455986685|FG001|Part B|Adverse Event|0|||
126737016|NCT04126031|455986686|FG002|Part B|Adverse Event|0|||
126737017|NCT04126031|455986687|FG003|Part B|Adverse Event|0|||
126737018|NCT04126031|455986688|FG004|Part B|Adverse Event|0|||
126737019|NCT04126031|455986689|FG005|Part B|Adverse Event|2|||
126737020|NCT04126031|455986684|FG000|Part B|Pre-existing hypertransaminasemia|0|||
126737021|NCT04126031|455986685|FG001|Part B|Pre-existing hypertransaminasemia|0|||
126737022|NCT04126031|455986686|FG002|Part B|Pre-existing hypertransaminasemia|0|||
126737023|NCT04126031|455986687|FG003|Part B|Pre-existing hypertransaminasemia|0|||
126737024|NCT04126031|455986688|FG004|Part B|Pre-existing hypertransaminasemia|1|||
126737025|NCT04126031|455986689|FG005|Part B|Pre-existing hypertransaminasemia|0|||
126737026|NCT00131664|455986690|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
126737027|NCT00131664|455986691|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
126737028|NCT00131664|455986692|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
126737029|NCT00131664|455986693|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
126737030|NCT00131664|455986694|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
126737031|NCT00131664|455986695|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
126737032|NCT00131664|455986690|FG000|First Period (First 6 Months)|Death|0|||
126737033|NCT00131664|455986691|FG001|First Period (First 6 Months)|Death|1|||
126737034|NCT00131664|455986692|FG002|First Period (First 6 Months)|Death|0|||
126737035|NCT00131664|455986693|FG003|First Period (First 6 Months)|Death|0|||
126737036|NCT00131664|455986694|FG004|First Period (First 6 Months)|Death|0|||
126737037|NCT00131664|455986695|FG005|First Period (First 6 Months)|Death|0|||
126737038|NCT00131664|455986690|FG000|First Period (First 6 Months)|Protocol Violation|2|||
126737039|NCT00131664|455986691|FG001|First Period (First 6 Months)|Protocol Violation|2|||
126737040|NCT00131664|455986692|FG002|First Period (First 6 Months)|Protocol Violation|1|||
126737041|NCT00131664|455986693|FG003|First Period (First 6 Months)|Protocol Violation|0|||
126737042|NCT00131664|455986694|FG004|First Period (First 6 Months)|Protocol Violation|0|||
126737043|NCT00131664|455986695|FG005|First Period (First 6 Months)|Protocol Violation|0|||
126737044|NCT00131664|455986690|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
126737045|NCT00131664|455986691|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
126737046|NCT00131664|455986692|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
126737047|NCT00131664|455986693|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
126737048|NCT00131664|455986694|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
126737049|NCT00131664|455986695|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
126737050|NCT00131664|455986690|FG000|First Period (First 6 Months)|Adverse Event|9|||
126737051|NCT00131664|455986691|FG001|First Period (First 6 Months)|Adverse Event|4|||
126737052|NCT00131664|455986692|FG002|First Period (First 6 Months)|Adverse Event|5|||
126737053|NCT00131664|455986693|FG003|First Period (First 6 Months)|Adverse Event|0|||
126737054|NCT00131664|455986694|FG004|First Period (First 6 Months)|Adverse Event|0|||
126737055|NCT00131664|455986695|FG005|First Period (First 6 Months)|Adverse Event|0|||
126737056|NCT00131664|455986690|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
126737057|NCT00131664|455986691|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
126737058|NCT00131664|455986692|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
126737059|NCT00131664|455986693|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
126737060|NCT00131664|455986694|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
126737061|NCT00131664|455986695|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
126737062|NCT00131664|455986690|FG000|First Period (First 6 Months)|Administrative reasons|2|||
126737063|NCT00131664|455986691|FG001|First Period (First 6 Months)|Administrative reasons|0|||
126737064|NCT00131664|455986692|FG002|First Period (First 6 Months)|Administrative reasons|5|||
126737065|NCT00131664|455986693|FG003|First Period (First 6 Months)|Administrative reasons|0|||
126737066|NCT00131664|455986694|FG004|First Period (First 6 Months)|Administrative reasons|0|||
126737067|NCT00131664|455986695|FG005|First Period (First 6 Months)|Administrative reasons|0|||
126737068|NCT00131664|455986690|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
126737069|NCT00131664|455986691|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
126737070|NCT00131664|455986692|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
126737071|NCT00131664|455986693|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
126737072|NCT00131664|455986694|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
126737073|NCT00131664|455986695|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
126737074|NCT00131664|455986690|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
126737075|NCT00131664|455986691|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
126737076|NCT00131664|455986692|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
126737077|NCT00131664|455986693|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
126737078|NCT00131664|455986694|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
126737079|NCT00131664|455986695|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
126737080|NCT00131664|455986690|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
126737081|NCT00131664|455986691|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
126737082|NCT00131664|455986692|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
126737083|NCT00131664|455986693|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
126737084|NCT00131664|455986694|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
126737085|NCT00131664|455986695|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
126737086|NCT00131664|455986690|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
126737087|NCT00131664|455986691|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
126737088|NCT00131664|455986692|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
126737089|NCT00131664|455986693|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
126737090|NCT00131664|455986694|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
126737091|NCT00131664|455986695|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
126613991|NCT01185340|455546079|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
126613992|NCT01185340|455546080|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
126613993|NCT01185340|455546081|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
126613994|NCT01185340|455546082|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
126613995|NCT01185340|455546079|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
126613996|NCT01185340|455546080|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
126613997|NCT01185340|455546081|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
126613998|NCT01185340|455546082|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
126613999|NCT01185340|455546079|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126614000|NCT01185340|455546080|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
126614001|NCT01185340|455546081|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126614002|NCT01185340|455546082|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
126614003|NCT01185340|455546079|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
126614004|NCT01185340|455546080|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
126614005|NCT01185340|455546081|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
126614006|NCT01185340|455546082|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
126614007|NCT01185340|455546079|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
126614008|NCT01185340|455546080|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
126614009|NCT01185340|455546081|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
126614010|NCT01185340|455546082|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
126614011|NCT01185340|455546079|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
126614012|NCT01185340|455546080|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
126614013|NCT01185340|455546081|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
126614014|NCT01185340|455546082|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
126614015|NCT00087516|455546083|FG000|Overall Study|Adverse Event|10|||
126614016|NCT00087516|455546084|FG001|Overall Study|Adverse Event|10|||
126614017|NCT00087516|455546085|FG002|Overall Study|Adverse Event|3|||
126614018|NCT00087516|455546086|FG003|Overall Study|Adverse Event|6|||
126614019|NCT00087516|455546083|FG000|Overall Study|Lack of Efficacy|82|||
126614020|NCT00087516|455546084|FG001|Overall Study|Lack of Efficacy|80|||
126614021|NCT00087516|455546085|FG002|Overall Study|Lack of Efficacy|39|||
126614022|NCT00087516|455546086|FG003|Overall Study|Lack of Efficacy|29|||
126614023|NCT00087516|455546083|FG000|Overall Study|Lost to Follow-up|8|||
126614024|NCT00087516|455546084|FG001|Overall Study|Lost to Follow-up|6|||
126614025|NCT00087516|455546085|FG002|Overall Study|Lost to Follow-up|5|||
126614026|NCT00087516|455546086|FG003|Overall Study|Lost to Follow-up|5|||
126614027|NCT00087516|455546083|FG000|Overall Study|Protocol Violation|4|||
126614028|NCT00087516|455546084|FG001|Overall Study|Protocol Violation|8|||
126614029|NCT00087516|455546085|FG002|Overall Study|Protocol Violation|3|||
126737092|NCT00131664|455986690|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
126737093|NCT00131664|455986691|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
126737094|NCT00131664|455986692|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
126737095|NCT00131664|455986693|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
126614030|NCT00087516|455546086|FG003|Overall Study|Protocol Violation|6|||
126614031|NCT00087516|455546083|FG000|Overall Study|Withdrawal by Subject|16|||
126614032|NCT00087516|455546084|FG001|Overall Study|Withdrawal by Subject|27|||
126614033|NCT00087516|455546085|FG002|Overall Study|Withdrawal by Subject|11|||
126756583|NCT00883896|456059482|FG000|Overall Study|Other|1|||
126737096|NCT00131664|455986694|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
126737097|NCT00131664|455986695|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
126737098|NCT00131664|455986690|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
126737099|NCT00131664|455986691|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
126737100|NCT00131664|455986692|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
126737101|NCT00131664|455986693|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
126737102|NCT00131664|455986694|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
126737103|NCT00131664|455986695|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
126737104|NCT00617656|455986696|FG000|Overall Study|Inclusion error|4|||
126737105|NCT00617656|455986697|FG001|Overall Study|Inclusion error|4|||
126737106|NCT00617656|455986698|FG002|Overall Study|Inclusion error|0|||
126737107|NCT00617656|455986699|FG003|Overall Study|Inclusion error|0|||
126737108|NCT00617656|455986696|FG000|Overall Study|Missing data|44|||
126737109|NCT00617656|455986697|FG001|Overall Study|Missing data|30|||
126737110|NCT00617656|455986698|FG002|Overall Study|Missing data|13|||
126737111|NCT00617656|455986699|FG003|Overall Study|Missing data|6|||
126737112|NCT00617656|455986696|FG000|Overall Study|Withdrawal by Subject|0|||
126737113|NCT00617656|455986697|FG001|Overall Study|Withdrawal by Subject|2|||
126737114|NCT00617656|455986698|FG002|Overall Study|Withdrawal by Subject|0|||
126737115|NCT00617656|455986699|FG003|Overall Study|Withdrawal by Subject|0|||
126737116|NCT03366844|455988389|FG000|Overall Study|Physician Decision|1|||
126737117|NCT03366844|455988389|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
126737118|NCT02688153|455988392|FG000|Overall Study|Death|7|||
126737119|NCT02688153|455988393|FG001|Overall Study|Death|5|||
126737120|NCT02688153|455988392|FG000|Overall Study|Withdrawal by Subject|4|||
126737121|NCT02688153|455988393|FG001|Overall Study|Withdrawal by Subject|2|||
126737122|NCT02688153|455988392|FG000|Overall Study|Valve Explant|1|||
126737123|NCT02688153|455988393|FG001|Overall Study|Valve Explant|0|||
126737124|NCT02688153|455988392|FG000|Overall Study|Conversion to Commercial Valve|3|||
126737125|NCT02688153|455988393|FG001|Overall Study|Conversion to Commercial Valve|0|||
126737126|NCT03682055|455988394|FG000|Overall Study|Lack of Efficacy|1|||
126737127|NCT03682055|455988395|FG001|Overall Study|Lack of Efficacy|2|||
126737128|NCT03682055|455988396|FG002|Overall Study|Lack of Efficacy|1|||
126737129|NCT03682055|455988397|FG003|Overall Study|Lack of Efficacy|2|||
126737130|NCT03682055|455988398|FG004|Overall Study|Lack of Efficacy|1|||
126737131|NCT03682055|455988399|FG005|Overall Study|Lack of Efficacy|3|||
126737132|NCT03682055|455988394|FG000|Overall Study|Withdrawal by Subject|0|||
126737133|NCT03682055|455988395|FG001|Overall Study|Withdrawal by Subject|0|||
126737134|NCT03682055|455988396|FG002|Overall Study|Withdrawal by Subject|0|||
126737135|NCT03682055|455988397|FG003|Overall Study|Withdrawal by Subject|0|||
126737136|NCT03682055|455988398|FG004|Overall Study|Withdrawal by Subject|0|||
126737137|NCT03682055|455988399|FG005|Overall Study|Withdrawal by Subject|1|||
126737138|NCT03682055|455988394|FG000|Overall Study|Termination of Study by Sponsor|0|||
126737139|NCT03682055|455988395|FG001|Overall Study|Termination of Study by Sponsor|0|||
126737140|NCT03682055|455988396|FG002|Overall Study|Termination of Study by Sponsor|0|||
126737141|NCT03682055|455988397|FG003|Overall Study|Termination of Study by Sponsor|0|||
126737142|NCT03682055|455988398|FG004|Overall Study|Termination of Study by Sponsor|0|||
126737143|NCT03682055|455988399|FG005|Overall Study|Termination of Study by Sponsor|3|||
126737144|NCT01135394|455988400|FG000|Screening|Lost to Follow-up|2|||
126737145|NCT01135394|455988400|FG000|Screening|Withdrawal by Subject|10|||
126737146|NCT01135394|455988400|FG000|Screening|Screening failure|16|||
126737147|NCT01135394|455988400|FG000|Screening|Physician Decision|5|||
126737148|NCT01135394|455988400|FG000|Baseline Assessment|Withdrawal by Subject|9|||
126737149|NCT01135394|455988400|FG000|Baseline Assessment|Physician Decision|3|||
126737150|NCT01135394|455988400|FG000|Baseline Assessment|Lost to Follow-up|2|||
126737151|NCT01135394|455988400|FG000|Baseline Assessment|Adverse Event|1|||
126737152|NCT01135394|455988400|FG000|Study Treatment|Withdrawal by Subject|1|||
126737153|NCT01135394|455988400|FG000|Study Treatment|Physician Decision|1|||
126737154|NCT01135394|455988400|FG000|Study Treatment|Adverse Event|2|||
126737155|NCT00191386|455988401|FG000|Overall Study|Adverse Event|16|||
126737156|NCT00191386|455988401|FG000|Overall Study|Lost to Follow-up|1|||
126737157|NCT00191386|455988401|FG000|Overall Study|Entry Criteria Exclusion|3|||
126737158|NCT00191386|455988401|FG000|Overall Study|Protocol Violation|18|||
126737159|NCT00191386|455988401|FG000|Overall Study|Withdrawal by Subject|96|||
126781401|NCT01716754|456154537|FG001|Overall Study|Non-compliance with study treatment|0|||
126737160|NCT00191386|455988401|FG000|Overall Study|Physician Decision|11|||
126737161|NCT00191386|455988401|FG000|Overall Study|Lack of Efficacy|15|||
126737162|NCT00462488|455988402|FG000|Overall Study|Protocol Violation|1|||
126781402|NCT01716754|456154538|FG002|Overall Study|Non-compliance with study treatment|1|||
126737163|NCT00462488|455988403|FG001|Overall Study|Protocol Violation|0|||
126737164|NCT00462488|455988402|FG000|Overall Study|Lack of Efficacy|19|||
126737165|NCT00462488|455988403|FG001|Overall Study|Lack of Efficacy|17|||
126737166|NCT03750240|455988404|FG000|Overall Study|Technical Difficulties|2|||
126737167|NCT00927758|455988405|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
126737168|NCT00927758|455988406|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
126737169|NCT00927758|455988407|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
126737170|NCT00927758|455988408|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
126737171|NCT00927758|455988409|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
126737172|NCT00927758|455988410|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
126737173|NCT00927758|455988405|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
126737174|NCT00927758|455988406|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
126737175|NCT00927758|455988407|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
126737176|NCT00927758|455988408|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
126737177|NCT00927758|455988409|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
126737178|NCT00927758|455988410|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
126737179|NCT00439725|455988412|FG000|Treatment Period|Withdrawal by Subject|22|||
126737180|NCT00439725|455988413|FG001|Treatment Period|Withdrawal by Subject|19|||
126737181|NCT00439725|455988412|FG000|Treatment Period|Study terminated by sponsor|156|||
126737182|NCT00439725|455988413|FG001|Treatment Period|Study terminated by sponsor|148|||
126737183|NCT00439725|455988412|FG000|Treatment Period|Site closed by investigator|1|||
126737184|NCT00439725|455988413|FG001|Treatment Period|Site closed by investigator|2|||
126737185|NCT00439725|455988412|FG000|Treatment Period|Adverse Event|39|||
126737186|NCT00439725|455988413|FG001|Treatment Period|Adverse Event|18|||
126737187|NCT00439725|455988412|FG000|Treatment Period|Physician Decision|1|||
126737188|NCT00439725|455988413|FG001|Treatment Period|Physician Decision|1|||
126737189|NCT00439725|455988412|FG000|Treatment Period|Protocol Violation|2|||
126737190|NCT00439725|455988413|FG001|Treatment Period|Protocol Violation|1|||
126737191|NCT00439725|455988412|FG000|Treatment Period|Clinical endpoint reached|6|||
126737192|NCT00439725|455988413|FG001|Treatment Period|Clinical endpoint reached|50|||
126737193|NCT00439725|455988412|FG000|Treatment Period|Technical problems|1|||
126737194|NCT00439725|455988413|FG001|Treatment Period|Technical problems|0|||
126737195|NCT00439725|455988412|FG000|Treatment Period|Lost to Follow-up|1|||
126737196|NCT00439725|455988413|FG001|Treatment Period|Lost to Follow-up|1|||
126737197|NCT00439725|455988412|FG000|Treatment Period|Participant convenience|1|||
126614034|NCT00087516|455546086|FG003|Overall Study|Withdrawal by Subject|12|||
126614035|NCT00087516|455546083|FG000|Overall Study|Site terminated|0|||
126614036|NCT00087516|455546084|FG001|Overall Study|Site terminated|2|||
126614037|NCT00087516|455546085|FG002|Overall Study|Site terminated|1|||
126614038|NCT00087516|455546086|FG003|Overall Study|Site terminated|0|||
126614039|NCT00087516|455546083|FG000|Overall Study|Protocol specified discontinuation|35|||
126614040|NCT00087516|455546084|FG001|Overall Study|Protocol specified discontinuation|33|||
126614041|NCT00087516|455546085|FG002|Overall Study|Protocol specified discontinuation|33|||
126614042|NCT00087516|455546086|FG003|Overall Study|Protocol specified discontinuation|26|||
126614043|NCT00087516|455546083|FG000|Overall Study|Patient moved|3|||
126614044|NCT00087516|455546084|FG001|Overall Study|Patient moved|2|||
126614045|NCT00087516|455546085|FG002|Overall Study|Patient moved|1|||
126614046|NCT00087516|455546086|FG003|Overall Study|Patient moved|0|||
126614047|NCT00087516|455546083|FG000|Overall Study|Patient was non-compliant|3|||
126614048|NCT00087516|455546084|FG001|Overall Study|Patient was non-compliant|1|||
126614049|NCT00087516|455546085|FG002|Overall Study|Patient was non-compliant|0|||
126614050|NCT00087516|455546086|FG003|Overall Study|Patient was non-compliant|0|||
126614051|NCT00087516|455546083|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
126614052|NCT00087516|455546084|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
126614053|NCT00087516|455546085|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
126614054|NCT00087516|455546086|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
126614055|NCT00087516|455546083|FG000|Overall Study|Other|0|||
126614056|NCT00087516|455546084|FG001|Overall Study|Other|0|||
126614057|NCT00087516|455546085|FG002|Overall Study|Other|1|||
126614058|NCT00087516|455546086|FG003|Overall Study|Other|0|||
126614059|NCT02065895|455546087|FG000|Overall Study|Protocol Violation|1|||
126614060|NCT02065895|455546088|FG001|Overall Study|Protocol Violation|0|||
126614061|NCT02065895|455546089|FG002|Overall Study|Protocol Violation|0|||
126614062|NCT02065895|455546090|FG003|Overall Study|Protocol Violation|1|||
126614063|NCT02065895|455546091|FG004|Overall Study|Protocol Violation|0|||
126614064|NCT02065895|455546092|FG005|Overall Study|Protocol Violation|0|||
126614065|NCT02065895|455546087|FG000|Overall Study|Scheduling conflicts|0|||
126614066|NCT02065895|455546088|FG001|Overall Study|Scheduling conflicts|1|||
126614067|NCT02065895|455546089|FG002|Overall Study|Scheduling conflicts|0|||
126614068|NCT02065895|455546090|FG003|Overall Study|Scheduling conflicts|0|||
126614069|NCT02065895|455546091|FG004|Overall Study|Scheduling conflicts|0|||
126614070|NCT02065895|455546092|FG005|Overall Study|Scheduling conflicts|0|||
126614071|NCT00569166|455546097|FG000|Overall Study|Withdrawal by Subject|7|||
126614072|NCT00569166|455546098|FG001|Overall Study|Withdrawal by Subject|5|||
126614073|NCT00569166|455546099|FG002|Overall Study|Withdrawal by Subject|3|||
126614074|NCT00569166|455546097|FG000|Overall Study|Lost to Follow-up|2|||
126614075|NCT00569166|455546098|FG001|Overall Study|Lost to Follow-up|1|||
126737198|NCT00439725|455988413|FG001|Treatment Period|Participant convenience|0|||
126737199|NCT00439725|455988412|FG000|Treatment Period|Protocol driven decision point|1|||
126737200|NCT00439725|455988413|FG001|Treatment Period|Protocol driven decision point|1|||
126737201|NCT00439725|455988412|FG000|Treatment Period|Death|1|||
126737202|NCT00439725|455988413|FG001|Treatment Period|Death|1|||
126737203|NCT00439725|455988412|FG000|Treatment Period|Participant did not receive treatment|4|||
126737204|NCT00439725|455988413|FG001|Treatment Period|Participant did not receive treatment|4|||
126737205|NCT00439725|455988412|FG000|Observational Period|Withdrawal by Subject|2|||
126737206|NCT00439725|455988413|FG001|Observational Period|Withdrawal by Subject|2|||
126737207|NCT00439725|455988412|FG000|Observational Period|Lost to Follow-up|0|||
126737208|NCT00439725|455988413|FG001|Observational Period|Lost to Follow-up|1|||
126737209|NCT00439725|455988412|FG000|Observational Period|Death|0|||
126737210|NCT00439725|455988413|FG001|Observational Period|Death|2|||
126614076|NCT00569166|455546099|FG002|Overall Study|Lost to Follow-up|1|||
126614077|NCT05005247|455546100|FG000|Overall Study|Withdrawal by Subject|0|||
126614078|NCT05005247|455546101|FG001|Overall Study|Withdrawal by Subject|1|||
126614079|NCT05005247|455546102|FG002|Overall Study|Withdrawal by Subject|0|||
126614080|NCT00484198|455546103|FG000|Overall Study|Participant Withdrew Consent|12|||
126614081|NCT00484198|455546104|FG001|Overall Study|Participant Withdrew Consent|21|||
126614082|NCT00484198|455546105|FG002|Overall Study|Participant Withdrew Consent|47|||
126614083|NCT00484198|455546106|FG003|Overall Study|Participant Withdrew Consent|59|||
126614084|NCT00484198|455546103|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
126614085|NCT00484198|455546104|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
126614086|NCT00484198|455546105|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
126614087|NCT00484198|455546106|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
126614088|NCT00484198|455546103|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
126614089|NCT00484198|455546104|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
126614090|NCT00484198|455546105|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
126614091|NCT00484198|455546106|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
126614092|NCT00484198|455546103|FG000|Overall Study|Adverse Event|3|||
126614093|NCT00484198|455546104|FG001|Overall Study|Adverse Event|11|||
126614094|NCT00484198|455546105|FG002|Overall Study|Adverse Event|32|||
126614095|NCT00484198|455546106|FG003|Overall Study|Adverse Event|31|||
126614096|NCT00484198|455546103|FG000|Overall Study|Protocol Violation|0|||
126614097|NCT00484198|455546104|FG001|Overall Study|Protocol Violation|5|||
126614098|NCT00484198|455546105|FG002|Overall Study|Protocol Violation|6|||
126614099|NCT00484198|455546106|FG003|Overall Study|Protocol Violation|8|||
126614100|NCT00484198|455546103|FG000|Overall Study|Other|7|||
126614101|NCT00484198|455546104|FG001|Overall Study|Other|10|||
126614102|NCT00484198|455546105|FG002|Overall Study|Other|31|||
126614103|NCT00484198|455546106|FG003|Overall Study|Other|28|||
126614104|NCT00486954|455546108|FG000|Pilot Part|Adverse Event|4|||
126614105|NCT00486954|455546109|FG001|Pilot Part|Adverse Event|0|||
126614106|NCT00486954|455546110|FG002|Pilot Part|Adverse Event|5|||
126614107|NCT00486954|455546111|FG003|Pilot Part|Adverse Event|0|||
126614108|NCT00486954|455546112|FG004|Pilot Part|Adverse Event|0|||
126614109|NCT00486954|455546108|FG000|Pilot Part|Disease Progression|2|||
126614110|NCT00486954|455546109|FG001|Pilot Part|Disease Progression|0|||
126614111|NCT00486954|455546110|FG002|Pilot Part|Disease Progression|1|||
126614112|NCT00486954|455546111|FG003|Pilot Part|Disease Progression|0|||
126614113|NCT00486954|455546112|FG004|Pilot Part|Disease Progression|0|||
126614114|NCT00486954|455546108|FG000|Randomized Part|Lost to Follow-up|0|||
126614115|NCT00486954|455546109|FG001|Randomized Part|Lost to Follow-up|0|||
126614116|NCT00486954|455546110|FG002|Randomized Part|Lost to Follow-up|0|||
126614117|NCT00486954|455546111|FG003|Randomized Part|Lost to Follow-up|0|||
126614118|NCT00486954|455546112|FG004|Randomized Part|Lost to Follow-up|1|||
126614119|NCT00486954|455546108|FG000|Randomized Part|Withdrawal by Subject|0|||
126614120|NCT00486954|455546109|FG001|Randomized Part|Withdrawal by Subject|0|||
126614121|NCT00486954|455546110|FG002|Randomized Part|Withdrawal by Subject|0|||
126614122|NCT00486954|455546111|FG003|Randomized Part|Withdrawal by Subject|1|||
126614123|NCT00486954|455546112|FG004|Randomized Part|Withdrawal by Subject|0|||
126614124|NCT00486954|455546108|FG000|Randomized Part|Sponsor Terminated Study|0|||
126614125|NCT00486954|455546109|FG001|Randomized Part|Sponsor Terminated Study|0|||
126614126|NCT00486954|455546110|FG002|Randomized Part|Sponsor Terminated Study|0|||
126614127|NCT00486954|455546111|FG003|Randomized Part|Sponsor Terminated Study|19|||
126614128|NCT00486954|455546112|FG004|Randomized Part|Sponsor Terminated Study|13|||
126614129|NCT00929526|455546113|FG000|Overall Study|Withdrawal by Subject|1|||
126614130|NCT00929526|455546114|FG001|Overall Study|Withdrawal by Subject|11|||
126614131|NCT00929526|455546113|FG000|Overall Study|Lost to Follow-up|8|||
126614132|NCT00929526|455546114|FG001|Overall Study|Lost to Follow-up|12|||
126614133|NCT00929526|455546113|FG000|Overall Study|Other|8|||
126614134|NCT00929526|455546114|FG001|Overall Study|Other|6|||
126614135|NCT00889863|455546117|FG000|Part I: Open Label|Death|1|||
126614136|NCT00889863|455546118|FG001|Part I: Open Label|Death|0|||
126614137|NCT00889863|455546117|FG000|Part I: Open Label|Adverse Event|4|||
126614138|NCT00889863|455546118|FG001|Part I: Open Label|Adverse Event|0|||
126614139|NCT00889863|455546117|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
126737211|NCT00439725|455988412|FG000|Observational Period|Study termination by sponsor|1|||
126737212|NCT00439725|455988413|FG001|Observational Period|Study termination by sponsor|1|||
126737213|NCT00439725|455988412|FG000|Observational Period|Clinical endpoint reached|3|||
126737214|NCT00439725|455988413|FG001|Observational Period|Clinical endpoint reached|1|||
126737215|NCT00439725|455988412|FG000|Observational Period|Technical problems|1|||
126737216|NCT00439725|455988413|FG001|Observational Period|Technical problems|0|||
126737217|NCT00439725|455988412|FG000|Observational Period|Participant convenience|1|||
126737218|NCT00439725|455988413|FG001|Observational Period|Participant convenience|0|||
126737219|NCT03510910|455988414|FG000|Overall Study|Incomplete Survey|2|||
126737220|NCT03510910|455988415|FG001|Overall Study|Incomplete Survey|3|||
126737221|NCT01673490|455988416|FG000|Overall Study|Lost to Follow-up|1|||
126737222|NCT01673490|455988416|FG000|Overall Study|Adverse Event|3|||
126737223|NCT01673490|455988416|FG000|Overall Study|Withdrawal by Subject|3|||
126737224|NCT00379236|455988417|FG000|Double-blind|Adverse Event|11|||
126737225|NCT00379236|455988418|FG001|Double-blind|Adverse Event|6|||
126737226|NCT00379236|455988419|FG002|Double-blind|Adverse Event|0|||
126737227|NCT00379236|455988417|FG000|Double-blind|Protocol Violation|3|||
126737228|NCT00379236|455988418|FG001|Double-blind|Protocol Violation|3|||
126737229|NCT00379236|455988419|FG002|Double-blind|Protocol Violation|0|||
126737230|NCT00379236|455988417|FG000|Double-blind|Withdrawal by Subject|12|||
126737231|NCT00379236|455988418|FG001|Double-blind|Withdrawal by Subject|13|||
126737232|NCT00379236|455988419|FG002|Double-blind|Withdrawal by Subject|0|||
126737233|NCT00379236|455988417|FG000|Double-blind|Lost to Follow-up|4|||
126737234|NCT00379236|455988418|FG001|Double-blind|Lost to Follow-up|3|||
126737235|NCT00379236|455988419|FG002|Double-blind|Lost to Follow-up|0|||
126737236|NCT00379236|455988417|FG000|Double-blind|Use of exclusionary medication|1|||
126737237|NCT00379236|455988418|FG001|Double-blind|Use of exclusionary medication|2|||
126737238|NCT00379236|455988419|FG002|Double-blind|Use of exclusionary medication|0|||
126737239|NCT00379236|455988417|FG000|Double-blind|Other|3|||
126737240|NCT00379236|455988418|FG001|Double-blind|Other|7|||
126737241|NCT00379236|455988419|FG002|Double-blind|Other|0|||
126737242|NCT00379236|455988417|FG000|Double-blind|Data could not be retrieved|2|||
126737243|NCT00379236|455988418|FG001|Double-blind|Data could not be retrieved|2|||
126737244|NCT00379236|455988419|FG002|Double-blind|Data could not be retrieved|0|||
126737245|NCT00379236|455988417|FG000|Open-label Extension|Adverse Event|0|||
126737246|NCT00379236|455988418|FG001|Open-label Extension|Adverse Event|0|||
126737247|NCT00379236|455988419|FG002|Open-label Extension|Adverse Event|13|||
126737248|NCT00379236|455988417|FG000|Open-label Extension|Protocol Violation|0|||
126737249|NCT00379236|455988418|FG001|Open-label Extension|Protocol Violation|0|||
126737250|NCT00379236|455988419|FG002|Open-label Extension|Protocol Violation|7|||
126737251|NCT00379236|455988417|FG000|Open-label Extension|Withdrawal by Subject|0|||
126737252|NCT00379236|455988418|FG001|Open-label Extension|Withdrawal by Subject|0|||
126737253|NCT00379236|455988419|FG002|Open-label Extension|Withdrawal by Subject|13|||
126737254|NCT00379236|455988417|FG000|Open-label Extension|Lost to Follow-up|0|||
126737255|NCT00379236|455988418|FG001|Open-label Extension|Lost to Follow-up|0|||
126737256|NCT00379236|455988419|FG002|Open-label Extension|Lost to Follow-up|12|||
126737257|NCT00379236|455988417|FG000|Open-label Extension|Use of exclusionary medication|0|||
126737258|NCT00379236|455988418|FG001|Open-label Extension|Use of exclusionary medication|0|||
126737259|NCT00379236|455988419|FG002|Open-label Extension|Use of exclusionary medication|3|||
126737260|NCT00379236|455988417|FG000|Open-label Extension|Other|0|||
126737261|NCT00379236|455988418|FG001|Open-label Extension|Other|0|||
126737262|NCT00379236|455988419|FG002|Open-label Extension|Other|7|||
126737263|NCT02940860|455988420|FG000|Overall Study|Non-serious AE|1|||
126737264|NCT02940860|455988421|FG001|Overall Study|Non-serious AE|2|||
126737265|NCT02940860|455988420|FG000|Overall Study|Serious AE|7|||
126737266|NCT02940860|455988421|FG001|Overall Study|Serious AE|3|||
126737267|NCT02940860|455988420|FG000|Overall Study|Withdrawal by Subject|19|||
126737268|NCT02940860|455988421|FG001|Overall Study|Withdrawal by Subject|9|||
126737269|NCT02940860|455988420|FG000|Overall Study|Lost to Follow-up|13|||
126737270|NCT02940860|455988421|FG001|Overall Study|Lost to Follow-up|7|||
126737271|NCT02940860|455988420|FG000|Overall Study|Physician Decision|5|||
126737272|NCT02940860|455988421|FG001|Overall Study|Physician Decision|3|||
126737273|NCT02940860|455988420|FG000|Overall Study|Sponsor Decision|0|||
126737274|NCT02940860|455988421|FG001|Overall Study|Sponsor Decision|1|||
126737275|NCT02940860|455988420|FG000|Overall Study|Protocol Violation|0|||
126781403|NCT01716754|456154539|FG003|Overall Study|Non-compliance with study treatment|0|||
126781404|NCT01716754|456154536|FG000|Overall Study|Physician Decision|1|||
126737276|NCT02940860|455988421|FG001|Overall Study|Protocol Violation|2|||
126737277|NCT02940860|455988420|FG000|Overall Study|Death|3|||
126737278|NCT02940860|455988421|FG001|Overall Study|Death|2|||
126737279|NCT02940860|455988420|FG000|Overall Study|Moved, poor venous access, transport|6|||
126781405|NCT01716754|456154537|FG001|Overall Study|Physician Decision|0|||
126737280|NCT02940860|455988421|FG001|Overall Study|Moved, poor venous access, transport|4|||
126737281|NCT02940860|455988420|FG000|Overall Study|Not treated|2|||
126737282|NCT02940860|455988421|FG001|Overall Study|Not treated|2|||
126737283|NCT04914819|455988422|FG000|Overall Study|Pregnancy|3|||
126737284|NCT04914819|455988423|FG001|Overall Study|Pregnancy|1|||
126737285|NCT04914819|455988422|FG000|Overall Study|Discontinued study|4|||
126737286|NCT04914819|455988423|FG001|Overall Study|Discontinued study|1|||
126737287|NCT04914819|455988422|FG000|Overall Study|Lost to Follow-up|7|||
126737288|NCT04914819|455988423|FG001|Overall Study|Lost to Follow-up|0|||
126737289|NCT02715804|455988424|FG000|Overall Study|Death|222|||
126737290|NCT02715804|455988425|FG001|Overall Study|Death|106|||
126737291|NCT02715804|455988424|FG000|Overall Study|Withdrawal by Subject|5|||
126737292|NCT02715804|455988425|FG001|Overall Study|Withdrawal by Subject|4|||
126737293|NCT02715804|455988424|FG000|Overall Study|Other than specified|2|||
126737294|NCT02715804|455988425|FG001|Overall Study|Other than specified|3|||
126737295|NCT04038385|455988426|FG000|Overall Study|Completed baseline assessment only|7|||
126737296|NCT04038385|455988427|FG001|Overall Study|Completed baseline assessment only|4|||
126737297|NCT04038385|455988426|FG000|Overall Study|Moved out of area|4|||
126614140|NCT00889863|455546118|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
126614141|NCT00889863|455546117|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
126614142|NCT00889863|455546118|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
126614143|NCT00889863|455546117|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
126614144|NCT00889863|455546118|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
126614145|NCT00889863|455546117|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
126614146|NCT00889863|455546118|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
126614147|NCT00889863|455546117|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
126614148|NCT00889863|455546118|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
126614149|NCT01918033|455546120|FG000|Overall Study|Adverse Event|1|||
126614150|NCT01918033|455546121|FG001|Overall Study|Adverse Event|0|||
126614151|NCT01918033|455546122|FG002|Overall Study|Adverse Event|2|||
126614152|NCT01918033|455546120|FG000|Overall Study|Lost to Follow-up|0|||
126614153|NCT01918033|455546121|FG001|Overall Study|Lost to Follow-up|1|||
126614154|NCT01918033|455546122|FG002|Overall Study|Lost to Follow-up|0|||
126614155|NCT01918033|455546120|FG000|Overall Study|Protocol Violation|2|||
126614156|NCT01918033|455546121|FG001|Overall Study|Protocol Violation|0|||
126614157|NCT01918033|455546122|FG002|Overall Study|Protocol Violation|1|||
126614158|NCT01918033|455546120|FG000|Overall Study|Withdrawal by Subject|2|||
126614159|NCT01918033|455546121|FG001|Overall Study|Withdrawal by Subject|1|||
126614160|NCT01918033|455546122|FG002|Overall Study|Withdrawal by Subject|0|||
126614161|NCT03259568|455546126|FG000|Overall Study|Participant performance was low|3|||
126614162|NCT03006393|455546127|FG000|Overall Study|Withdrawal by Subject|1|||
126614163|NCT03006393|455546128|FG001|Overall Study|Withdrawal by Subject|1|||
126614164|NCT03006393|455546127|FG000|Overall Study|Pregnancy|0|||
126614165|NCT03006393|455546128|FG001|Overall Study|Pregnancy|1|||
126614166|NCT03006393|455546127|FG000|Overall Study|Lost to Follow-up|0|||
126614167|NCT03006393|455546128|FG001|Overall Study|Lost to Follow-up|1|||
126614168|NCT03136861|455546129|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
126614169|NCT03136861|455546130|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
126614170|NCT03136861|455546131|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
126614171|NCT03136861|455546132|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
126614172|NCT03136861|455546133|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
126614173|NCT03136861|455546134|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
126614174|NCT03136861|455546135|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
126614175|NCT03136861|455546129|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
126614176|NCT03136861|455546130|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
126614177|NCT03136861|455546131|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
126614178|NCT03136861|455546132|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
126614179|NCT03136861|455546133|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
126614180|NCT03136861|455546134|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
126614181|NCT03136861|455546135|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
126614182|NCT03136861|455546129|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
126614183|NCT03136861|455546130|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
126614184|NCT03136861|455546131|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
126614185|NCT03136861|455546132|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
126614186|NCT03136861|455546133|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
126614187|NCT03136861|455546134|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
126614188|NCT03136861|455546135|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
126614189|NCT03136861|455546129|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
126614190|NCT03136861|455546130|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
126737298|NCT04038385|455988427|FG001|Overall Study|Moved out of area|2|||
126781406|NCT01716754|456154538|FG002|Overall Study|Physician Decision|0|||
126614191|NCT03136861|455546131|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
126614192|NCT03136861|455546132|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
126614193|NCT03136861|455546133|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
126737299|NCT04038385|455988426|FG000|Overall Study|Discontinued study involvement|6|||
126737300|NCT04038385|455988427|FG001|Overall Study|Discontinued study involvement|1|||
126737301|NCT00948194|455988430|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
126614194|NCT03136861|455546134|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
126614195|NCT03136861|455546135|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
126614196|NCT03136861|455546129|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
126614197|NCT03136861|455546130|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
126614198|NCT03136861|455546131|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
126614199|NCT03136861|455546132|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
126614200|NCT03136861|455546133|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
126614201|NCT03136861|455546134|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
126614202|NCT03136861|455546135|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
126614203|NCT03136861|455546129|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
126614204|NCT03136861|455546130|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
126614205|NCT03136861|455546131|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
126614206|NCT03136861|455546132|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
126614207|NCT03136861|455546133|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
126614208|NCT03136861|455546134|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
126614209|NCT03136861|455546135|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
126614210|NCT03136861|455546129|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
126614211|NCT03136861|455546130|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
126614212|NCT03136861|455546131|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
126614213|NCT03136861|455546132|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
126614214|NCT03136861|455546133|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
126614215|NCT03136861|455546134|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
126614216|NCT03136861|455546135|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
126614217|NCT03136861|455546129|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
126614218|NCT03136861|455546130|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
126614219|NCT03136861|455546131|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
126614220|NCT03136861|455546132|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
126614221|NCT03136861|455546133|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
126614222|NCT03136861|455546134|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
126614223|NCT03136861|455546135|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
126614224|NCT01584648|455546136|FG000|Overall Study|Death|136|||
126614225|NCT01584648|455546137|FG001|Overall Study|Death|146|||
126614226|NCT01584648|455546136|FG000|Overall Study|Lost to Follow-up|9|||
126614227|NCT01584648|455546137|FG001|Overall Study|Lost to Follow-up|9|||
126614228|NCT01584648|455546136|FG000|Overall Study|Investigator discretion|3|||
126614229|NCT01584648|455546137|FG001|Overall Study|Investigator discretion|2|||
126614230|NCT01584648|455546136|FG000|Overall Study|Withdrew consent|13|||
126614231|NCT01584648|455546137|FG001|Overall Study|Withdrew consent|4|||
126614232|NCT01584648|455546136|FG000|Overall Study|Study closed/terminated|50|||
126614233|NCT01584648|455546137|FG001|Overall Study|Study closed/terminated|23|||
126614234|NCT01584648|455546136|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
126614235|NCT01584648|455546137|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
126614236|NCT05376397|455546140|FG000|Overall Study|Lost to Follow-up|1|||
126614237|NCT01328756|455546141|FG000|Overall Study|Protocol Violation|4|||
126614238|NCT01328756|455546141|FG000|Overall Study|Adverse Event|39|||
126614239|NCT01328756|455546141|FG000|Overall Study|Lack of Efficacy|5|||
126614240|NCT01328756|455546141|FG000|Overall Study|Withdrawal by Subject|41|||
126614241|NCT01328756|455546141|FG000|Overall Study|Lost to Follow-up|5|||
126614242|NCT01328756|455546141|FG000|Overall Study|Other|29|||
126614243|NCT01137682|455546142|FG000|Overall Study|Adverse Event-CORE|2|||
126614244|NCT01137682|455546143|FG001|Overall Study|Adverse Event-CORE|4|||
126614245|NCT01137682|455546144|FG002|Overall Study|Adverse Event-CORE|0|||
126614246|NCT01137682|455546142|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
126614247|NCT01137682|455546143|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
126614248|NCT01137682|455546144|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
126614249|NCT01137682|455546142|FG000|Overall Study|Administrative problems-CORE|2|||
126614250|NCT01137682|455546143|FG001|Overall Study|Administrative problems-CORE|1|||
126614251|NCT01137682|455546144|FG002|Overall Study|Administrative problems-CORE|0|||
126614252|NCT01137682|455546142|FG000|Overall Study|Protocol Violation-CORE|0|||
126614253|NCT01137682|455546143|FG001|Overall Study|Protocol Violation-CORE|1|||
126614254|NCT01137682|455546144|FG002|Overall Study|Protocol Violation-CORE|1|||
126614255|NCT01137682|455546142|FG000|Overall Study|Adverse Event-Extension|4|||
126614256|NCT01137682|455546143|FG001|Overall Study|Adverse Event-Extension|8|||
126614257|NCT01137682|455546144|FG002|Overall Study|Adverse Event-Extension|7|||
126614258|NCT01137682|455546142|FG000|Overall Study|Lack of Efficacy-Extension|15|||
126614259|NCT01137682|455546143|FG001|Overall Study|Lack of Efficacy-Extension|9|||
126614260|NCT01137682|455546144|FG002|Overall Study|Lack of Efficacy-Extension|13|||
126614261|NCT01137682|455546142|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
126614262|NCT01137682|455546143|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
126614263|NCT01137682|455546144|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
126614264|NCT01137682|455546142|FG000|Overall Study|Lost to Follow Up-Extension|0|||
126614265|NCT01137682|455546143|FG001|Overall Study|Lost to Follow Up-Extension|1|||
126614266|NCT01137682|455546144|FG002|Overall Study|Lost to Follow Up-Extension|0|||
126614267|NCT01137682|455546142|FG000|Overall Study|Administrative problems-Extension|0|||
126614268|NCT01137682|455546143|FG001|Overall Study|Administrative problems-Extension|2|||
126614269|NCT01137682|455546144|FG002|Overall Study|Administrative problems-Extension|0|||
126614270|NCT01137682|455546142|FG000|Overall Study|Death-Extension|2|||
126614271|NCT01137682|455546143|FG001|Overall Study|Death-Extension|0|||
126614272|NCT01137682|455546144|FG002|Overall Study|Death-Extension|0|||
126614273|NCT01137682|455546142|FG000|Overall Study|Protocol Violation-Extension|2|||
126614274|NCT01137682|455546143|FG001|Overall Study|Protocol Violation-Extension|1|||
126614275|NCT01137682|455546144|FG002|Overall Study|Protocol Violation-Extension|0|||
126614276|NCT01137682|455546142|FG000|Overall Study|Did not enter extension|2|||
126614277|NCT01137682|455546143|FG001|Overall Study|Did not enter extension|3|||
126614278|NCT01137682|455546144|FG002|Overall Study|Did not enter extension|2|||
126614279|NCT01137682|455546142|FG000|Overall Study|Did not receive treatment in extension|0|||
126614280|NCT01137682|455546143|FG001|Overall Study|Did not receive treatment in extension|0|||
126614281|NCT01137682|455546144|FG002|Overall Study|Did not receive treatment in extension|1|||
126614282|NCT00472082|455546145|FG000|Overall Study|Study prematurely terminated|5|||
126614283|NCT04617847|455546146|FG000|Overall Study|Withdrawal by Subject|1|||
126737302|NCT00948194|455988431|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
126737303|NCT00233324|455988432|FG000|Main Study|Death|68|||
126737304|NCT00233324|455988433|FG001|Main Study|Death|60|||
126737305|NCT00233324|455988434|FG002|Main Study|Death|62|||
126737306|NCT00233324|455988435|FG003|Main Study|Death|47|||
126737307|NCT00233324|455988432|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
126737308|NCT00233324|455988433|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
126737309|NCT00233324|455988434|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
126737310|NCT00233324|455988435|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
126737311|NCT00233324|455988432|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
126737312|NCT00233324|455988433|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
126737313|NCT00233324|455988434|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
126737314|NCT00233324|455988435|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
126737315|NCT03276572|455988438|FG000|Overall Study|In follow-up|0|||
126737316|NCT03276572|455988439|FG001|Overall Study|In follow-up|0|||
126737317|NCT03276572|455988440|FG002|Overall Study|In follow-up|0|||
126737318|NCT03276572|455988441|FG003|Overall Study|In follow-up|0|||
126737319|NCT03276572|455988442|FG004|Overall Study|In follow-up|0|||
126737320|NCT03276572|455988443|FG005|Overall Study|In follow-up|1|||
126737321|NCT03276572|455988444|FG006|Overall Study|In follow-up|1|||
126737322|NCT03276572|455988438|FG000|Overall Study|Lost to Follow-up|0|||
126737323|NCT03276572|455988439|FG001|Overall Study|Lost to Follow-up|0|||
126737324|NCT03276572|455988440|FG002|Overall Study|Lost to Follow-up|0|||
126737325|NCT03276572|455988441|FG003|Overall Study|Lost to Follow-up|0|||
126737326|NCT03276572|455988442|FG004|Overall Study|Lost to Follow-up|0|||
126737327|NCT03276572|455988443|FG005|Overall Study|Lost to Follow-up|0|||
126737328|NCT03276572|455988444|FG006|Overall Study|Lost to Follow-up|1|||
126737329|NCT02657434|455988449|FG000|Overall Study|Study Terminated By Sponsor|64|||
126737330|NCT02657434|455988450|FG001|Overall Study|Study Terminated By Sponsor|82|||
126737331|NCT02657434|455988449|FG000|Overall Study|Death|189|||
126737332|NCT02657434|455988450|FG001|Overall Study|Death|190|||
126737333|NCT02657434|455988449|FG000|Overall Study|Lost to Follow-up|2|||
126737334|NCT02657434|455988450|FG001|Overall Study|Lost to Follow-up|2|||
126737335|NCT02657434|455988449|FG000|Overall Study|Randomization by Error|2|||
126737336|NCT02657434|455988450|FG001|Overall Study|Randomization by Error|0|||
126737337|NCT02657434|455988449|FG000|Overall Study|Withdrawal by Subject|28|||
126737338|NCT02657434|455988450|FG001|Overall Study|Withdrawal by Subject|17|||
126737339|NCT02657434|455988449|FG000|Overall Study|Protocol Violation|1|||
126737340|NCT02657434|455988450|FG001|Overall Study|Protocol Violation|0|||
126737341|NCT02657434|455988449|FG000|Overall Study|Physician Decision|0|||
126737342|NCT02657434|455988450|FG001|Overall Study|Physician Decision|1|||
126737343|NCT00608881|455988451|FG000|Overall Study|Death|22|||
126737344|NCT00608881|455988452|FG001|Overall Study|Death|13|||
126614284|NCT04617847|455546147|FG001|Overall Study|Withdrawal by Subject|0|||
126614285|NCT04617847|455546146|FG000|Overall Study|Adverse Event|0|||
126614286|NCT04617847|455546147|FG001|Overall Study|Adverse Event|2|||
126737345|NCT00608881|455988451|FG000|Overall Study|Adverse Event|5|||
126737346|NCT00608881|455988452|FG001|Overall Study|Adverse Event|3|||
126737347|NCT00608881|455988451|FG000|Overall Study|Lost to Follow-up|28|||
126737348|NCT00608881|455988452|FG001|Overall Study|Lost to Follow-up|14|||
126737349|NCT00608881|455988451|FG000|Overall Study|Withdrawal by Subject|18|||
126614287|NCT04617847|455546146|FG000|Overall Study|Death|0|||
126614288|NCT04617847|455546147|FG001|Overall Study|Death|1|||
126737350|NCT00608881|455988452|FG001|Overall Study|Withdrawal by Subject|29|||
126737351|NCT00608881|455988451|FG000|Overall Study|Physician Decision|5|||
126737352|NCT00608881|455988452|FG001|Overall Study|Physician Decision|5|||
126737353|NCT00608881|455988451|FG000|Overall Study|Institutionalized|1|||
126737354|NCT00608881|455988452|FG001|Overall Study|Institutionalized|2|||
126737355|NCT01998958|455988455|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737356|NCT01998958|455988456|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
126737357|NCT01998958|455988457|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737358|NCT01998958|455988458|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737359|NCT01998958|455988459|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737360|NCT01998958|455988460|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737361|NCT01998958|455988461|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737362|NCT01998958|455988462|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737363|NCT01998958|455988463|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737364|NCT01998958|455988464|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737365|NCT01998958|455988465|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737366|NCT01998958|455988466|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737367|NCT01998958|455988467|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737368|NCT01998958|455988468|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737369|NCT01998958|455988469|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737370|NCT01998958|455988470|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737371|NCT01998958|455988471|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737372|NCT01998958|455988472|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737373|NCT01998958|455988473|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737374|NCT01998958|455988474|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737375|NCT01998958|455988475|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737376|NCT01998958|455988476|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737377|NCT01998958|455988477|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737378|NCT01998958|455988478|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737379|NCT01998958|455988479|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737380|NCT01998958|455988480|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737381|NCT01998958|455988481|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737382|NCT01998958|455988482|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737383|NCT01998958|455988483|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737384|NCT01998958|455988484|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737385|NCT01998958|455988485|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737386|NCT01998958|455988486|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
126737387|NCT01998958|455988455|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737388|NCT01998958|455988456|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
126737389|NCT01998958|455988457|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737390|NCT01998958|455988458|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737391|NCT01998958|455988459|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737392|NCT01998958|455988460|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737393|NCT01998958|455988461|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737394|NCT01998958|455988462|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737395|NCT01998958|455988463|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737396|NCT01998958|455988464|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737397|NCT01998958|455988465|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737398|NCT01998958|455988466|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737399|NCT01998958|455988467|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737400|NCT01998958|455988468|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737401|NCT01998958|455988469|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737402|NCT01998958|455988470|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737403|NCT01998958|455988471|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737404|NCT01998958|455988472|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737405|NCT01998958|455988473|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737406|NCT01998958|455988474|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737407|NCT01998958|455988475|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737408|NCT01998958|455988476|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737409|NCT01998958|455988477|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737410|NCT01998958|455988478|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737411|NCT01998958|455988479|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737412|NCT01998958|455988480|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737413|NCT01998958|455988481|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126614289|NCT04617847|455546146|FG000|Overall Study|Termination of Study by Sponsor|2|||
126781407|NCT01716754|456154539|FG003|Overall Study|Physician Decision|0|||
126781408|NCT01716754|456154536|FG000|Overall Study|Lost to Follow-up|1|||
126737414|NCT01998958|455988482|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737415|NCT01998958|455988483|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737416|NCT01998958|455988484|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737417|NCT01998958|455988485|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737418|NCT01998958|455988486|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
126737419|NCT01998958|455988455|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
126737420|NCT01998958|455988456|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
126737421|NCT01998958|455988457|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
126737422|NCT01998958|455988458|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
126737423|NCT01998958|455988459|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
126737424|NCT01998958|455988460|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
126737425|NCT01998958|455988461|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
126737426|NCT01998958|455988462|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
126737427|NCT01998958|455988463|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
126737428|NCT01998958|455988464|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
126737429|NCT01998958|455988465|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
126737430|NCT01998958|455988466|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
126737431|NCT01998958|455988467|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
126737432|NCT01998958|455988468|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
126737433|NCT01998958|455988469|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
126737434|NCT01998958|455988470|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
126737435|NCT01998958|455988471|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
126737436|NCT01998958|455988472|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
126737437|NCT01998958|455988473|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
126737438|NCT01998958|455988474|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
126737439|NCT01998958|455988475|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
126737440|NCT01998958|455988476|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
126737441|NCT01998958|455988477|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
126737442|NCT01998958|455988478|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
126737443|NCT01998958|455988479|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
126737444|NCT01998958|455988480|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
126737445|NCT01998958|455988481|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
126737446|NCT01998958|455988482|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
126737447|NCT01998958|455988483|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
126737448|NCT01998958|455988484|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
126737449|NCT01998958|455988485|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
126737450|NCT01998958|455988486|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
126737451|NCT01998958|455988455|FG000|Period 1 (Panel A and B)|Other|1|||
126737452|NCT01998958|455988456|FG001|Period 1 (Panel A and B)|Other|0|||
126737453|NCT01998958|455988457|FG002|Period 1 (Panel A and B)|Other|0|||
126737454|NCT01998958|455988458|FG003|Period 1 (Panel A and B)|Other|0|||
126737455|NCT01998958|455988459|FG004|Period 1 (Panel A and B)|Other|0|||
126737456|NCT01998958|455988460|FG005|Period 1 (Panel A and B)|Other|0|||
126737457|NCT01998958|455988461|FG006|Period 1 (Panel A and B)|Other|0|||
126737458|NCT01998958|455988462|FG007|Period 1 (Panel A and B)|Other|0|||
126737459|NCT01998958|455988463|FG008|Period 1 (Panel A and B)|Other|0|||
126737460|NCT01998958|455988464|FG009|Period 1 (Panel A and B)|Other|0|||
126737461|NCT01998958|455988465|FG010|Period 1 (Panel A and B)|Other|0|||
126737462|NCT01998958|455988466|FG011|Period 1 (Panel A and B)|Other|0|||
126737463|NCT01998958|455988467|FG012|Period 1 (Panel A and B)|Other|0|||
126737464|NCT01998958|455988468|FG013|Period 1 (Panel A and B)|Other|0|||
126737465|NCT01998958|455988469|FG014|Period 1 (Panel A and B)|Other|0|||
126737466|NCT01998958|455988470|FG015|Period 1 (Panel A and B)|Other|0|||
126737467|NCT01998958|455988471|FG016|Period 1 (Panel A and B)|Other|0|||
126737468|NCT01998958|455988472|FG017|Period 1 (Panel A and B)|Other|0|||
126737469|NCT01998958|455988473|FG018|Period 1 (Panel A and B)|Other|0|||
126737470|NCT01998958|455988474|FG019|Period 1 (Panel A and B)|Other|0|||
126737471|NCT01998958|455988475|FG020|Period 1 (Panel A and B)|Other|0|||
126737472|NCT01998958|455988476|FG021|Period 1 (Panel A and B)|Other|0|||
126737473|NCT01998958|455988477|FG022|Period 1 (Panel A and B)|Other|0|||
126737474|NCT01998958|455988478|FG023|Period 1 (Panel A and B)|Other|0|||
126737475|NCT01998958|455988479|FG024|Period 1 (Panel A and B)|Other|0|||
126737476|NCT01998958|455988480|FG025|Period 1 (Panel A and B)|Other|0|||
126737477|NCT01998958|455988481|FG026|Period 1 (Panel A and B)|Other|0|||
126737478|NCT01998958|455988482|FG027|Period 1 (Panel A and B)|Other|0|||
126737479|NCT01998958|455988483|FG028|Period 1 (Panel A and B)|Other|0|||
126737480|NCT01998958|455988484|FG029|Period 1 (Panel A and B)|Other|0|||
126737481|NCT01998958|455988485|FG030|Period 1 (Panel A and B)|Other|0|||
126737482|NCT01998958|455988486|FG031|Period 1 (Panel A and B)|Other|0|||
126737483|NCT01998958|455988455|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
126737484|NCT01998958|455988456|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
126737485|NCT01998958|455988457|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
126737486|NCT01998958|455988458|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
126737487|NCT01998958|455988459|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
126737488|NCT01998958|455988460|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
126737489|NCT01998958|455988461|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
126737490|NCT01998958|455988462|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
126737491|NCT01998958|455988463|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
126737492|NCT01998958|455988464|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
126737493|NCT01998958|455988465|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
126737494|NCT01998958|455988466|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
126614290|NCT04617847|455546147|FG001|Overall Study|Termination of Study by Sponsor|21|||
126737495|NCT01998958|455988467|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
126737496|NCT01998958|455988468|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
126737497|NCT01998958|455988469|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
126756584|NCT00883896|456059483|FG001|Overall Study|Other|0|||
126737498|NCT01998958|455988470|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
126737499|NCT01998958|455988471|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
126737500|NCT01998958|455988472|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
126737501|NCT01998958|455988473|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
126737502|NCT01998958|455988474|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
126737503|NCT01998958|455988475|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
126737504|NCT01998958|455988476|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
126737505|NCT01998958|455988477|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
126737506|NCT01998958|455988478|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
126737507|NCT01998958|455988479|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
126737508|NCT01998958|455988480|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
126737509|NCT01998958|455988481|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
126737510|NCT01998958|455988482|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
126737511|NCT01998958|455988483|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
126737512|NCT01998958|455988484|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
126737513|NCT01998958|455988485|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
126737514|NCT01998958|455988486|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
126737515|NCT01998958|455988455|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737516|NCT01998958|455988456|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737517|NCT01998958|455988457|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737518|NCT01998958|455988458|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737519|NCT01998958|455988459|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737520|NCT01998958|455988460|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737521|NCT01998958|455988461|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737522|NCT01998958|455988462|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737523|NCT01998958|455988463|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737524|NCT01998958|455988464|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737525|NCT01998958|455988465|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737526|NCT01998958|455988466|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737527|NCT01998958|455988467|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737528|NCT01998958|455988468|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737529|NCT01998958|455988469|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
126737530|NCT01998958|455988470|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737531|NCT01998958|455988471|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737532|NCT01998958|455988472|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737533|NCT01998958|455988473|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
126737534|NCT01998958|455988474|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737535|NCT01998958|455988475|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737536|NCT01998958|455988476|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737537|NCT01998958|455988477|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737538|NCT01998958|455988478|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737539|NCT01998958|455988479|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737540|NCT01998958|455988480|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737541|NCT01998958|455988481|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737542|NCT01998958|455988482|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737543|NCT01998958|455988483|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737544|NCT01998958|455988484|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737545|NCT01998958|455988485|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737546|NCT01998958|455988486|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
126737547|NCT01998958|455988455|FG000|Open Label Phase (Optional)|Adverse Event|0|||
126737548|NCT01998958|455988456|FG001|Open Label Phase (Optional)|Adverse Event|0|||
126737549|NCT01998958|455988457|FG002|Open Label Phase (Optional)|Adverse Event|0|||
126737550|NCT01998958|455988458|FG003|Open Label Phase (Optional)|Adverse Event|0|||
126737551|NCT01998958|455988459|FG004|Open Label Phase (Optional)|Adverse Event|0|||
126737552|NCT01998958|455988460|FG005|Open Label Phase (Optional)|Adverse Event|0|||
126737553|NCT01998958|455988461|FG006|Open Label Phase (Optional)|Adverse Event|0|||
126737554|NCT01998958|455988462|FG007|Open Label Phase (Optional)|Adverse Event|0|||
126737555|NCT01998958|455988463|FG008|Open Label Phase (Optional)|Adverse Event|0|||
126737556|NCT01998958|455988464|FG009|Open Label Phase (Optional)|Adverse Event|0|||
126737557|NCT01998958|455988465|FG010|Open Label Phase (Optional)|Adverse Event|0|||
126737558|NCT01998958|455988466|FG011|Open Label Phase (Optional)|Adverse Event|0|||
126737559|NCT01998958|455988467|FG012|Open Label Phase (Optional)|Adverse Event|0|||
126737560|NCT01998958|455988468|FG013|Open Label Phase (Optional)|Adverse Event|0|||
126737561|NCT01998958|455988469|FG014|Open Label Phase (Optional)|Adverse Event|0|||
126737562|NCT01998958|455988470|FG015|Open Label Phase (Optional)|Adverse Event|0|||
126737563|NCT01998958|455988471|FG016|Open Label Phase (Optional)|Adverse Event|0|||
126737564|NCT01998958|455988472|FG017|Open Label Phase (Optional)|Adverse Event|0|||
126737565|NCT01998958|455988473|FG018|Open Label Phase (Optional)|Adverse Event|0|||
126737566|NCT01998958|455988474|FG019|Open Label Phase (Optional)|Adverse Event|0|||
126737567|NCT01998958|455988475|FG020|Open Label Phase (Optional)|Adverse Event|0|||
126737568|NCT01998958|455988476|FG021|Open Label Phase (Optional)|Adverse Event|0|||
126737569|NCT01998958|455988477|FG022|Open Label Phase (Optional)|Adverse Event|0|||
126737570|NCT01998958|455988478|FG023|Open Label Phase (Optional)|Adverse Event|1|||
126737571|NCT01998958|455988479|FG024|Open Label Phase (Optional)|Adverse Event|0|||
126737572|NCT01998958|455988480|FG025|Open Label Phase (Optional)|Adverse Event|0|||
126737573|NCT01998958|455988481|FG026|Open Label Phase (Optional)|Adverse Event|0|||
126737574|NCT01998958|455988482|FG027|Open Label Phase (Optional)|Adverse Event|0|||
126737575|NCT01998958|455988483|FG028|Open Label Phase (Optional)|Adverse Event|0|||
126737576|NCT01998958|455988484|FG029|Open Label Phase (Optional)|Adverse Event|0|||
126737577|NCT01998958|455988485|FG030|Open Label Phase (Optional)|Adverse Event|0|||
126737578|NCT01998958|455988486|FG031|Open Label Phase (Optional)|Adverse Event|0|||
126737579|NCT01998958|455988455|FG000|Open Label Phase (Optional)|Other|0|||
126737580|NCT01998958|455988456|FG001|Open Label Phase (Optional)|Other|0|||
126737581|NCT01998958|455988457|FG002|Open Label Phase (Optional)|Other|0|||
126737582|NCT01998958|455988458|FG003|Open Label Phase (Optional)|Other|0|||
126737583|NCT01998958|455988459|FG004|Open Label Phase (Optional)|Other|0|||
126737584|NCT01998958|455988460|FG005|Open Label Phase (Optional)|Other|0|||
126737585|NCT01998958|455988461|FG006|Open Label Phase (Optional)|Other|0|||
126737586|NCT01998958|455988462|FG007|Open Label Phase (Optional)|Other|0|||
126737587|NCT01998958|455988463|FG008|Open Label Phase (Optional)|Other|0|||
126737588|NCT01998958|455988464|FG009|Open Label Phase (Optional)|Other|0|||
126737589|NCT01998958|455988465|FG010|Open Label Phase (Optional)|Other|0|||
126737590|NCT01998958|455988466|FG011|Open Label Phase (Optional)|Other|0|||
126737591|NCT01998958|455988467|FG012|Open Label Phase (Optional)|Other|0|||
126737592|NCT01998958|455988468|FG013|Open Label Phase (Optional)|Other|0|||
126737593|NCT01998958|455988469|FG014|Open Label Phase (Optional)|Other|0|||
126737594|NCT01998958|455988470|FG015|Open Label Phase (Optional)|Other|0|||
126737595|NCT01998958|455988471|FG016|Open Label Phase (Optional)|Other|0|||
126737596|NCT01998958|455988472|FG017|Open Label Phase (Optional)|Other|0|||
126737597|NCT01998958|455988473|FG018|Open Label Phase (Optional)|Other|0|||
126737598|NCT01998958|455988474|FG019|Open Label Phase (Optional)|Other|0|||
126737599|NCT01998958|455988475|FG020|Open Label Phase (Optional)|Other|0|||
126737600|NCT01998958|455988476|FG021|Open Label Phase (Optional)|Other|0|||
126737601|NCT01998958|455988477|FG022|Open Label Phase (Optional)|Other|5|||
126737602|NCT01998958|455988478|FG023|Open Label Phase (Optional)|Other|1|||
126737603|NCT01998958|455988479|FG024|Open Label Phase (Optional)|Other|0|||
126737604|NCT01998958|455988480|FG025|Open Label Phase (Optional)|Other|0|||
126737605|NCT01998958|455988481|FG026|Open Label Phase (Optional)|Other|0|||
126737606|NCT01998958|455988482|FG027|Open Label Phase (Optional)|Other|0|||
126737607|NCT01998958|455988483|FG028|Open Label Phase (Optional)|Other|0|||
126737608|NCT01998958|455988484|FG029|Open Label Phase (Optional)|Other|0|||
126737609|NCT01998958|455988485|FG030|Open Label Phase (Optional)|Other|0|||
126737610|NCT01998958|455988486|FG031|Open Label Phase (Optional)|Other|0|||
126737611|NCT01998958|455988455|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737612|NCT01998958|455988456|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737613|NCT01998958|455988457|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737614|NCT01998958|455988458|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737615|NCT01998958|455988459|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737616|NCT01998958|455988460|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737617|NCT01998958|455988461|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737618|NCT01998958|455988462|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737619|NCT01998958|455988463|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737620|NCT01998958|455988464|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737621|NCT01998958|455988465|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737622|NCT01998958|455988466|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737623|NCT01998958|455988467|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737624|NCT01998958|455988468|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737625|NCT01998958|455988469|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
126781409|NCT01716754|456154537|FG001|Overall Study|Lost to Follow-up|0|||
126781410|NCT01716754|456154538|FG002|Overall Study|Lost to Follow-up|0|||
126781411|NCT01716754|456154539|FG003|Overall Study|Lost to Follow-up|1|||
126781412|NCT01716754|456154536|FG000|Overall Study|Adverse Event|4|||
126781413|NCT01716754|456154537|FG001|Overall Study|Adverse Event|2|||
126781414|NCT01716754|456154538|FG002|Overall Study|Adverse Event|2|||
126737626|NCT01998958|455988470|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737627|NCT01998958|455988471|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737628|NCT01998958|455988472|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737629|NCT01998958|455988473|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737630|NCT01998958|455988474|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737631|NCT01998958|455988475|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737632|NCT01998958|455988476|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737633|NCT01998958|455988477|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
126737634|NCT01998958|455988478|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737635|NCT01998958|455988479|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
126781415|NCT01716754|456154539|FG003|Overall Study|Adverse Event|1|||
126737636|NCT01998958|455988480|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737637|NCT01998958|455988481|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737638|NCT01998958|455988482|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
126781416|NCT01716754|456154536|FG000|Overall Study|Withdrawal by Subject|5|||
126737639|NCT01998958|455988483|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737640|NCT01998958|455988484|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737641|NCT01998958|455988485|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737642|NCT01998958|455988486|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
126737643|NCT01998958|455988455|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737644|NCT01998958|455988456|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737645|NCT01998958|455988457|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737646|NCT01998958|455988458|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737647|NCT01998958|455988459|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737648|NCT01998958|455988460|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737649|NCT01998958|455988461|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737650|NCT01998958|455988462|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737651|NCT01998958|455988463|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737652|NCT01998958|455988464|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737653|NCT01998958|455988465|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737654|NCT01998958|455988466|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737655|NCT01998958|455988467|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737656|NCT01998958|455988468|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737657|NCT01998958|455988469|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737658|NCT01998958|455988470|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737659|NCT01998958|455988471|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737660|NCT01998958|455988472|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737661|NCT01998958|455988473|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737662|NCT01998958|455988474|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737663|NCT01998958|455988475|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737664|NCT01998958|455988476|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
126737665|NCT01998958|455988477|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
126737666|NCT01998958|455988478|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737667|NCT01998958|455988479|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737668|NCT01998958|455988480|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737669|NCT01998958|455988481|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737670|NCT01998958|455988482|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737671|NCT01998958|455988483|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737672|NCT01998958|455988484|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737673|NCT01998958|455988485|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737674|NCT01998958|455988486|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
126737675|NCT01998958|455988455|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737676|NCT01998958|455988456|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737677|NCT01998958|455988457|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737678|NCT01998958|455988458|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737679|NCT01998958|455988459|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737680|NCT01998958|455988460|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737681|NCT01998958|455988461|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737682|NCT01998958|455988462|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737683|NCT01998958|455988463|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737684|NCT01998958|455988464|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737685|NCT01998958|455988465|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737686|NCT01998958|455988466|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737687|NCT01998958|455988467|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737688|NCT01998958|455988468|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737689|NCT01998958|455988469|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737690|NCT01998958|455988470|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737691|NCT01998958|455988471|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737692|NCT01998958|455988472|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737693|NCT01998958|455988473|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737694|NCT01998958|455988474|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737695|NCT01998958|455988475|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737696|NCT01998958|455988476|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
126737697|NCT01998958|455988477|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
126737698|NCT01998958|455988478|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
126737699|NCT01998958|455988479|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737700|NCT01998958|455988480|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737701|NCT01998958|455988481|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737702|NCT01998958|455988482|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737703|NCT01998958|455988483|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737704|NCT01998958|455988484|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737705|NCT01998958|455988485|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126781417|NCT01716754|456154537|FG001|Overall Study|Withdrawal by Subject|0|||
126781418|NCT01716754|456154538|FG002|Overall Study|Withdrawal by Subject|4|||
126781419|NCT01716754|456154539|FG003|Overall Study|Withdrawal by Subject|3|||
126737706|NCT01998958|455988486|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
126737707|NCT00724815|455988487|FG000|Overall Study|Randomized, not treated|31|||
126737708|NCT00724815|455988488|FG001|Overall Study|Randomized, not treated|30|||
126737709|NCT00724815|455988487|FG000|Overall Study|Adverse Event|5|||
126737710|NCT00724815|455988488|FG001|Overall Study|Adverse Event|3|||
126737711|NCT00724815|455988487|FG000|Overall Study|Lost to Follow-up|4|||
126737712|NCT00724815|455988488|FG001|Overall Study|Lost to Follow-up|1|||
126737713|NCT00724815|455988487|FG000|Overall Study|Other Various|3|||
126737714|NCT00724815|455988488|FG001|Overall Study|Other Various|5|||
126737715|NCT00810043|455988489|FG000|Overall Study|Withdrawal by Subject|1|||
126737716|NCT00810043|455988490|FG001|Overall Study|Withdrawal by Subject|0|||
126737717|NCT00810043|455988491|FG002|Overall Study|Withdrawal by Subject|2|||
126737718|NCT00810043|455988489|FG000|Overall Study|Lost to Follow-up|1|||
126737719|NCT00810043|455988490|FG001|Overall Study|Lost to Follow-up|0|||
126737720|NCT00810043|455988491|FG002|Overall Study|Lost to Follow-up|0|||
126737721|NCT00810043|455988489|FG000|Overall Study|Physician Decision|0|||
126737722|NCT00810043|455988490|FG001|Overall Study|Physician Decision|0|||
126737723|NCT00810043|455988491|FG002|Overall Study|Physician Decision|2|||
126737724|NCT00810043|455988489|FG000|Overall Study|Death|2|||
126737725|NCT00810043|455988490|FG001|Overall Study|Death|0|||
126737726|NCT00810043|455988491|FG002|Overall Study|Death|0|||
126737727|NCT00810043|455988489|FG000|Overall Study|Unrelated medical problem|0|||
126737728|NCT00810043|455988490|FG001|Overall Study|Unrelated medical problem|1|||
126737729|NCT00810043|455988491|FG002|Overall Study|Unrelated medical problem|0|||
126737730|NCT00810043|455988489|FG000|Overall Study|Non-medical problem|0|||
126737731|NCT00810043|455988490|FG001|Overall Study|Non-medical problem|0|||
126737732|NCT00810043|455988491|FG002|Overall Study|Non-medical problem|1|||
126737733|NCT00810043|455988489|FG000|Overall Study|No longer met enrollment criteria|0|||
126737734|NCT00810043|455988490|FG001|Overall Study|No longer met enrollment criteria|0|||
126737735|NCT00810043|455988491|FG002|Overall Study|No longer met enrollment criteria|3|||
126737736|NCT01989754|455988492|FG000|Overall Study|Withdrawal by Subject|10|||
126737737|NCT01989754|455988493|FG001|Overall Study|Withdrawal by Subject|14|||
126737738|NCT01989754|455988492|FG000|Overall Study|Lost to Follow-up|28|||
126737739|NCT01989754|455988493|FG001|Overall Study|Lost to Follow-up|20|||
126737740|NCT01989754|455988492|FG000|Overall Study|Closed Site|1|||
126737741|NCT01989754|455988493|FG001|Overall Study|Closed Site|1|||
126737742|NCT00105183|455988501|FG000|Overall Study|Death|19|||
126737743|NCT00105183|455988502|FG001|Overall Study|Death|13|||
126737744|NCT00105183|455988503|FG002|Overall Study|Death|15|||
126737745|NCT00105183|455988501|FG000|Overall Study|Withdrawal by Subject|1|||
126737746|NCT00105183|455988502|FG001|Overall Study|Withdrawal by Subject|1|||
126737747|NCT00105183|455988503|FG002|Overall Study|Withdrawal by Subject|4|||
126737748|NCT00105183|455988501|FG000|Overall Study|Physician Decision|1|||
126737749|NCT00105183|455988502|FG001|Overall Study|Physician Decision|2|||
126737750|NCT00105183|455988503|FG002|Overall Study|Physician Decision|3|||
126737751|NCT00105183|455988501|FG000|Overall Study|Lost to Follow-up|0|||
126737752|NCT00105183|455988502|FG001|Overall Study|Lost to Follow-up|1|||
126737753|NCT00105183|455988503|FG002|Overall Study|Lost to Follow-up|1|||
126737754|NCT00105183|455988501|FG000|Overall Study|Other reason|1|||
126737755|NCT00105183|455988502|FG001|Overall Study|Other reason|2|||
126737756|NCT00105183|455988503|FG002|Overall Study|Other reason|0|||
126737757|NCT00294684|455988504|FG000|Overall Study|Lost to Follow-up|5|||
126737758|NCT00294684|455988505|FG001|Overall Study|Lost to Follow-up|8|||
126737759|NCT00389441|455988506|FG000|Overall Study|Adverse Event|7|||
126737760|NCT00389441|455988506|FG000|Overall Study|Death|4|||
126737761|NCT00389441|455988506|FG000|Overall Study|Lost to Follow-up|2|||
126737762|NCT00389441|455988506|FG000|Overall Study|Withdrawal by Subject|4|||
126737763|NCT00389441|455988506|FG000|Overall Study|Physician Decision|1|||
126737764|NCT00389441|455988506|FG000|Overall Study|Protocol Violation|1|||
126737765|NCT00389441|455988506|FG000|Overall Study|Global deterioration of health status|4|||
126737766|NCT00389441|455988506|FG000|Overall Study|Objective progression or relapse|26|||
126737767|NCT00389441|455988506|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
126737768|NCT00389441|455988506|FG000|Overall Study|Clinical progression|1|||
126737769|NCT01981109|455988507|FG000|Overall Study|Death|36|||
126737770|NCT01981109|455988507|FG000|Overall Study|Withdrawal by Subject|40|||
126737771|NCT01981109|455988507|FG000|Overall Study|Lost to Follow-up|9|||
126737772|NCT01981109|455988507|FG000|Overall Study|No Discontinuation Documentation|37|||
126737773|NCT01981109|455988507|FG000|Overall Study|Study Termination|100|||
126737774|NCT01981109|455988507|FG000|Overall Study|No data available|2|||
126737775|NCT03407170|455988508|FG000|Overall Study|Adverse Event|1|||
126737776|NCT00126672|455988511|FG000|Overall Study|Adverse Event|4|||
126737777|NCT00126672|455988511|FG000|Overall Study|Lost to Follow-up|4|||
126737778|NCT00615459|455988512|FG000|Period I|Adverse Event|2|||
126737779|NCT00615459|455988513|FG001|Period I|Adverse Event|0|||
126737780|NCT00615459|455988514|FG002|Period I|Adverse Event|1|||
126737781|NCT00615459|455988515|FG003|Period I|Adverse Event|0|||
126737782|NCT00615459|455988512|FG000|Period I|Subject withdrew consent|1|||
126737783|NCT00615459|455988513|FG001|Period I|Subject withdrew consent|0|||
126737784|NCT00615459|455988514|FG002|Period I|Subject withdrew consent|0|||
126737785|NCT00615459|455988515|FG003|Period I|Subject withdrew consent|1|||
126737786|NCT00615459|455988512|FG000|Period I|Abnormal test procedure results|1|||
126737787|NCT00615459|455988513|FG001|Period I|Abnormal test procedure results|1|||
126737788|NCT00615459|455988514|FG002|Period I|Abnormal test procedure results|1|||
126737789|NCT00615459|455988515|FG003|Period I|Abnormal test procedure results|0|||
126737790|NCT00615459|455988512|FG000|Period II|Adverse Event|1|||
126737791|NCT00615459|455988513|FG001|Period II|Adverse Event|0|||
126737792|NCT00615459|455988514|FG002|Period II|Adverse Event|0|||
126737793|NCT00615459|455988515|FG003|Period II|Adverse Event|0|||
126737794|NCT00615459|455988512|FG000|Period II|Lost to Follow-up|0|||
126737795|NCT00615459|455988513|FG001|Period II|Lost to Follow-up|0|||
126737796|NCT00615459|455988514|FG002|Period II|Lost to Follow-up|0|||
126737797|NCT00615459|455988515|FG003|Period II|Lost to Follow-up|1|||
126737798|NCT00615459|455988512|FG000|Period III|Adverse Event|0|||
126737799|NCT00615459|455988513|FG001|Period III|Adverse Event|1|||
126737800|NCT00615459|455988514|FG002|Period III|Adverse Event|0|||
126737801|NCT00615459|455988515|FG003|Period III|Adverse Event|0|||
126737802|NCT00615459|455988512|FG000|Period III|Administrative problems|0|||
126737803|NCT00615459|455988513|FG001|Period III|Administrative problems|1|||
126737804|NCT00615459|455988514|FG002|Period III|Administrative problems|1|||
126737805|NCT00615459|455988515|FG003|Period III|Administrative problems|0|||
126737806|NCT00615459|455988512|FG000|Period III|Unsatisfactory therapeutic effect|0|||
126737807|NCT00615459|455988513|FG001|Period III|Unsatisfactory therapeutic effect|1|||
126737808|NCT00615459|455988514|FG002|Period III|Unsatisfactory therapeutic effect|0|||
126737809|NCT00615459|455988515|FG003|Period III|Unsatisfactory therapeutic effect|0|||
126737810|NCT01851863|455988518|FG000|Overall Study|Did not receive study medication|2|||
126737811|NCT01851863|455988519|FG001|Overall Study|Did not receive study medication|5|||
126737812|NCT01851863|455988520|FG002|Overall Study|Did not receive study medication|3|||
126737813|NCT01851863|455988521|FG003|Overall Study|Did not receive study medication|0|||
126737814|NCT01851863|455988518|FG000|Overall Study|Lost to Follow-up|3|||
126737815|NCT01851863|455988519|FG001|Overall Study|Lost to Follow-up|4|||
126737816|NCT01851863|455988520|FG002|Overall Study|Lost to Follow-up|2|||
126737817|NCT01851863|455988521|FG003|Overall Study|Lost to Follow-up|3|||
126737818|NCT02076334|455988522|FG000|Overall Study|Protocol Violation|1|||
126737819|NCT02076334|455988523|FG001|Overall Study|Protocol Violation|0|||
126737820|NCT02076334|455988524|FG002|Overall Study|Protocol Violation|0|||
126737821|NCT02076334|455988525|FG003|Overall Study|Protocol Violation|0|||
126737822|NCT02076334|455988522|FG000|Overall Study|Lost to Follow-up|0|||
126737823|NCT02076334|455988523|FG001|Overall Study|Lost to Follow-up|1|||
126737824|NCT02076334|455988524|FG002|Overall Study|Lost to Follow-up|1|||
126737825|NCT02076334|455988525|FG003|Overall Study|Lost to Follow-up|0|||
126737826|NCT02076334|455988522|FG000|Overall Study|muscle soreness|0|||
126737827|NCT02076334|455988523|FG001|Overall Study|muscle soreness|0|||
126737828|NCT02076334|455988524|FG002|Overall Study|muscle soreness|0|||
126737829|NCT02076334|455988525|FG003|Overall Study|muscle soreness|1|||
126737830|NCT03238352|455988526|FG000|Overall Study|Lost to Follow-up|0|||
126737831|NCT03238352|455988527|FG001|Overall Study|Lost to Follow-up|2|||
126737832|NCT03238352|455988528|FG002|Overall Study|Lost to Follow-up|1|||
126737833|NCT03238352|455988526|FG000|Overall Study|Withdrawal by Subject|0|||
126737834|NCT03238352|455988527|FG001|Overall Study|Withdrawal by Subject|1|||
126737835|NCT03238352|455988528|FG002|Overall Study|Withdrawal by Subject|0|||
126737836|NCT04083794|455988529|FG000|Overall Study|Lost to Follow-up|9|||
126737837|NCT01296698|455988530|FG000|Overall Study|Adverse Event|1|||
126737838|NCT01296698|455988531|FG001|Overall Study|Adverse Event|0|||
126737839|NCT01296698|455988530|FG000|Overall Study|Death|1|||
126737840|NCT01296698|455988531|FG001|Overall Study|Death|0|||
126737841|NCT01296698|455988530|FG000|Overall Study|Lost to Follow-up|19|||
126737842|NCT01296698|455988531|FG001|Overall Study|Lost to Follow-up|1|||
126737843|NCT01296698|455988530|FG000|Overall Study|Withdrawal by Subject|12|||
126737844|NCT01296698|455988531|FG001|Overall Study|Withdrawal by Subject|0|||
126737845|NCT01296698|455988530|FG000|Overall Study|Difficulty Contacting Subject|2|||
126737846|NCT01296698|455988531|FG001|Overall Study|Difficulty Contacting Subject|0|||
126737847|NCT01296698|455988530|FG000|Overall Study|Study Terminated by Sponsor|209|||
126737848|NCT01296698|455988531|FG001|Overall Study|Study Terminated by Sponsor|12|||
126737849|NCT03097029|455988534|FG000|Overall Study|Withdrawal by Subject|1|||
126737850|NCT00108953|455988542|FG000|Follow-up|Death|18|||
126737851|NCT00108953|455988543|FG001|Follow-up|Death|26|||
126737852|NCT00108953|455988542|FG000|Follow-up|Lost to Follow-up|1|||
126737853|NCT00108953|455988543|FG001|Follow-up|Lost to Follow-up|1|||
126737854|NCT00108953|455988542|FG000|Follow-up|Study terminated by sponsor|10|||
126781420|NCT02535000|456154540|FG000|Overall Study|Cancellation of surgery.|1|||
126781421|NCT02535000|456154541|FG001|Overall Study|Cancellation of surgery.|2|||
126781422|NCT04317781|456154543|FG000|Overall Study|Adverse Event|1|||
126737855|NCT00108953|455988543|FG001|Follow-up|Study terminated by sponsor|6|||
126737856|NCT01125293|455988546|FG000|Overall Study|Disease Progression|1|||
126737857|NCT01125293|455988547|FG001|Overall Study|Disease Progression|3|||
126737858|NCT01125293|455988548|FG002|Overall Study|Disease Progression|4|||
126737859|NCT01125293|455988549|FG003|Overall Study|Disease Progression|3|||
126737860|NCT01125293|455988550|FG004|Overall Study|Disease Progression|5|||
126614291|NCT00761267|455546148|FG000|Overall Study|Death|1|||
126614292|NCT00761267|455546149|FG001|Overall Study|Death|2|||
126614293|NCT00761267|455546150|FG002|Overall Study|Death|5|||
126614294|NCT00761267|455546148|FG000|Overall Study|Lost to Follow-up|0|||
126614295|NCT00761267|455546149|FG001|Overall Study|Lost to Follow-up|0|||
126614296|NCT00761267|455546150|FG002|Overall Study|Lost to Follow-up|1|||
126614297|NCT00761267|455546148|FG000|Overall Study|Randomized but not treated|1|||
126614298|NCT00761267|455546149|FG001|Overall Study|Randomized but not treated|1|||
126614299|NCT00761267|455546150|FG002|Overall Study|Randomized but not treated|0|||
126614300|NCT00761267|455546148|FG000|Overall Study|Withdrawal by Subject|0|||
126614301|NCT00761267|455546149|FG001|Overall Study|Withdrawal by Subject|1|||
126614302|NCT00761267|455546150|FG002|Overall Study|Withdrawal by Subject|0|||
126614303|NCT04492475|455546151|FG000|Overall Study|Enrolled but not treated|8|||
126614304|NCT04492475|455546152|FG001|Overall Study|Enrolled but not treated|8|||
126614305|NCT04492475|455546151|FG000|Overall Study|Withdrawal by Subject|4|||
126614306|NCT04492475|455546152|FG001|Overall Study|Withdrawal by Subject|0|||
126614307|NCT04492475|455546151|FG000|Overall Study|Became ineligible after enrollment|2|||
126614308|NCT04492475|455546152|FG001|Overall Study|Became ineligible after enrollment|0|||
126614309|NCT03200574|455546168|FG000|Overall Study|Death|4|||
126614310|NCT03200574|455546168|FG000|Overall Study|Withdrawal by Subject|8|||
126614311|NCT03200574|455546168|FG000|Overall Study|Long-Term need for anticoagulation|1|||
126614312|NCT03200574|455546168|FG000|Overall Study|Relocation|2|||
126614313|NCT03200574|455546168|FG000|Overall Study|Lost to Follow-up|2|||
126614314|NCT04183491|455546169|FG000|Overall Study|Withdrawal by Subject|0|||
126614315|NCT04183491|455546170|FG001|Overall Study|Withdrawal by Subject|0|||
126614316|NCT04183491|455546171|FG002|Overall Study|Withdrawal by Subject|1|||
126614317|NCT04183491|455546172|FG003|Overall Study|Withdrawal by Subject|0|||
126614318|NCT04183491|455546173|FG004|Overall Study|Withdrawal by Subject|0|||
126614319|NCT04183491|455546174|FG005|Overall Study|Withdrawal by Subject|1|||
126614320|NCT04183491|455546175|FG006|Overall Study|Withdrawal by Subject|0|||
126614321|NCT02538094|455546176|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
126614322|NCT02538094|455546177|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
126614323|NCT02538094|455546176|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
126614324|NCT02538094|455546177|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
126614325|NCT00326183|455546190|FG000|Overall Study|Lost to Follow-up|104|||
126614326|NCT00326183|455546191|FG001|Overall Study|Lost to Follow-up|56|||
126614327|NCT00326183|455546190|FG000|Overall Study|Protocol Violation|6|||
126614328|NCT00326183|455546191|FG001|Overall Study|Protocol Violation|3|||
126614329|NCT00326183|455546190|FG000|Overall Study|Withdrawal by Subject|35|||
126614330|NCT00326183|455546191|FG001|Overall Study|Withdrawal by Subject|7|||
126614331|NCT00326183|455546190|FG000|Overall Study|Subject Moved|7|||
126614332|NCT00326183|455546191|FG001|Overall Study|Subject Moved|4|||
126614333|NCT00326183|455546190|FG000|Overall Study|Other|47|||
126614334|NCT00326183|455546191|FG001|Overall Study|Other|13|||
126614335|NCT00326183|455546190|FG000|Overall Study|Adverse Event|1|||
126614336|NCT00326183|455546191|FG001|Overall Study|Adverse Event|0|||
126614337|NCT01528605|455546198|FG000|Overall Study|Lost to Follow-up|1|||
126614338|NCT01528605|455546199|FG001|Overall Study|Lost to Follow-up|0|||
126614339|NCT01528605|455546200|FG002|Overall Study|Lost to Follow-up|1|||
126614340|NCT01528605|455546201|FG003|Overall Study|Lost to Follow-up|1|||
126614341|NCT01528605|455546202|FG004|Overall Study|Lost to Follow-up|0|||
126614342|NCT01528605|455546203|FG005|Overall Study|Lost to Follow-up|0|||
126614343|NCT01528605|455546198|FG000|Overall Study|Death|1|||
126614344|NCT01528605|455546199|FG001|Overall Study|Death|0|||
126614345|NCT01528605|455546200|FG002|Overall Study|Death|0|||
126614346|NCT01528605|455546201|FG003|Overall Study|Death|0|||
126614347|NCT01528605|455546202|FG004|Overall Study|Death|0|||
126614348|NCT01528605|455546203|FG005|Overall Study|Death|0|||
126614349|NCT01156675|455546204|FG000|Overall Study|Death|5|||
126614350|NCT01156675|455546205|FG001|Overall Study|Death|3|||
126614351|NCT01156675|455546206|FG002|Overall Study|Death|0|||
126614352|NCT01156675|455546204|FG000|Overall Study|No data|29|||
126614353|NCT01156675|455546205|FG001|Overall Study|No data|22|||
126614354|NCT01156675|455546206|FG002|Overall Study|No data|2|||
126614355|NCT02326220|455546207|FG000|Double-blind Treatment Period|Adverse Event|1|||
126614356|NCT02326220|455546208|FG001|Double-blind Treatment Period|Adverse Event|2|||
126614357|NCT02326220|455546209|FG002|Double-blind Treatment Period|Adverse Event|0|||
126614358|NCT02326220|455546207|FG000|Double-blind Treatment Period|Protocol Violation|0|||
126614359|NCT02326220|455546208|FG001|Double-blind Treatment Period|Protocol Violation|1|||
126614360|NCT02326220|455546209|FG002|Double-blind Treatment Period|Protocol Violation|0|||
126614361|NCT02326220|455546207|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
126614362|NCT02326220|455546208|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
126614363|NCT02326220|455546209|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126737861|NCT01125293|455988551|FG005|Overall Study|Disease Progression|12|||
126737862|NCT01125293|455988546|FG000|Overall Study|Adverse Event|1|||
126614364|NCT02326220|455546207|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
126614365|NCT02326220|455546208|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
126614366|NCT02326220|455546209|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
126737863|NCT01125293|455988547|FG001|Overall Study|Adverse Event|0|||
126737864|NCT01125293|455988548|FG002|Overall Study|Adverse Event|0|||
126737865|NCT01125293|455988549|FG003|Overall Study|Adverse Event|0|||
126737866|NCT01125293|455988550|FG004|Overall Study|Adverse Event|2|||
126737867|NCT01125293|455988551|FG005|Overall Study|Adverse Event|8|||
126737868|NCT01125293|455988546|FG000|Overall Study|Symptomatic Deterioration|1|||
126737869|NCT01125293|455988547|FG001|Overall Study|Symptomatic Deterioration|0|||
126737870|NCT01125293|455988548|FG002|Overall Study|Symptomatic Deterioration|0|||
126737871|NCT01125293|455988549|FG003|Overall Study|Symptomatic Deterioration|0|||
126737872|NCT01125293|455988550|FG004|Overall Study|Symptomatic Deterioration|0|||
126737873|NCT01125293|455988551|FG005|Overall Study|Symptomatic Deterioration|0|||
126737874|NCT01125293|455988546|FG000|Overall Study|Death|0|||
126737875|NCT01125293|455988547|FG001|Overall Study|Death|0|||
126737876|NCT01125293|455988548|FG002|Overall Study|Death|0|||
126737877|NCT01125293|455988549|FG003|Overall Study|Death|0|||
126737878|NCT01125293|455988550|FG004|Overall Study|Death|1|||
126737879|NCT01125293|455988551|FG005|Overall Study|Death|0|||
126737880|NCT01125293|455988546|FG000|Overall Study|Withdrawal by Subject|0|||
126737881|NCT01125293|455988547|FG001|Overall Study|Withdrawal by Subject|0|||
126737882|NCT01125293|455988548|FG002|Overall Study|Withdrawal by Subject|0|||
126737883|NCT01125293|455988549|FG003|Overall Study|Withdrawal by Subject|0|||
126737884|NCT01125293|455988550|FG004|Overall Study|Withdrawal by Subject|2|||
126737885|NCT01125293|455988551|FG005|Overall Study|Withdrawal by Subject|1|||
126737886|NCT01125293|455988546|FG000|Overall Study|Physician Decision|0|||
126737887|NCT01125293|455988547|FG001|Overall Study|Physician Decision|0|||
126737888|NCT01125293|455988548|FG002|Overall Study|Physician Decision|0|||
126737889|NCT01125293|455988549|FG003|Overall Study|Physician Decision|0|||
126737890|NCT01125293|455988550|FG004|Overall Study|Physician Decision|0|||
126737891|NCT01125293|455988551|FG005|Overall Study|Physician Decision|2|||
126737892|NCT03205982|455988561|FG000|Overall Study|Lost to Follow-up|20|||
126737893|NCT03205982|455988562|FG001|Overall Study|Lost to Follow-up|19|||
126737894|NCT03205982|455988561|FG000|Overall Study|Withdrawal by Subject|4|||
126737895|NCT03205982|455988562|FG001|Overall Study|Withdrawal by Subject|3|||
126737896|NCT03205982|455988561|FG000|Overall Study|Withdrawal by PI|0|||
126737897|NCT03205982|455988562|FG001|Overall Study|Withdrawal by PI|1|||
126737898|NCT00994162|455988563|FG000|Overall Study|Withdrawal by Subject|1|||
126737899|NCT00994162|455988563|FG000|Overall Study|Lost to Follow-up|2|||
126737900|NCT00994162|455988563|FG000|Overall Study|Product Complaint|1|||
126737901|NCT00994162|455988563|FG000|Overall Study|Poor Compliance|5|||
126737902|NCT00994162|455988563|FG000|Overall Study|Lack of Response|3|||
126737903|NCT00994162|455988563|FG000|Overall Study|Discharged from Hospital|4|||
126737904|NCT00994162|455988563|FG000|Overall Study|Death|2|||
126737905|NCT00994162|455988563|FG000|Overall Study|Care Transferred to Another Physician|2|||
126737906|NCT00994162|455988563|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
126737907|NCT00994162|455988563|FG000|Overall Study|Physician Decision|2|||
126737908|NCT00994162|455988563|FG000|Overall Study|Surrounding Wound Erythematous|1|||
126737909|NCT00994162|455988563|FG000|Overall Study|Machine Losing Vaccum|1|||
126737910|NCT00994162|455988563|FG000|Overall Study|Patient Lived Too Far Away|1|||
126737911|NCT00994162|455988563|FG000|Overall Study|Above Knee Amputation|1|||
126737912|NCT00994162|455988563|FG000|Overall Study|Reason Not Reported By Site|1|||
126737913|NCT00631540|455988568|FG000|Overall Study|Withdrawal by Subject|5|||
126737914|NCT00631540|455988568|FG000|Overall Study|Death|4|||
126737915|NCT00631540|455988568|FG000|Overall Study|Lost to Follow-up|2|||
126737916|NCT00631540|455988568|FG000|Overall Study|Core Lab Data Unavailable|3|||
126737917|NCT03136367|455988570|FG000|T1 Consultation|discontinued mistakenly included|2|||
126737918|NCT03136367|455988571|FG001|T1 Consultation|discontinued mistakenly included|6|||
126737919|NCT03136367|455988572|FG002|T1 Consultation|discontinued mistakenly included|1|||
126737920|NCT03136367|455988570|FG000|T1 Consultation|Discontinued other|0|||
126737921|NCT03136367|455988571|FG001|T1 Consultation|Discontinued other|1|||
126737922|NCT03136367|455988572|FG002|T1 Consultation|Discontinued other|0|||
126737923|NCT03136367|455988570|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
126737924|NCT03136367|455988571|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
126737925|NCT03136367|455988572|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
126737926|NCT03136367|455988570|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
126781423|NCT04317781|456154543|FG000|Overall Study|Disease relapse|1|||
126781424|NCT04317781|456154543|FG000|Overall Study|Withdrawal by Subject|1|||
126737927|NCT03136367|455988571|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
126737928|NCT03136367|455988572|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
126737929|NCT03136367|455988570|FG000|T2 Post-consultation|Discontinued other|0|||
126737930|NCT03136367|455988571|FG001|T2 Post-consultation|Discontinued other|2|||
126737931|NCT03136367|455988572|FG002|T2 Post-consultation|Discontinued other|6|||
126781425|NCT01620489|456154544|FG000|Overall Study|Adverse Event|17|||
126737932|NCT03136367|455988570|FG000|T2 Post-consultation|Discontinued transferred care|0|||
126737933|NCT03136367|455988571|FG001|T2 Post-consultation|Discontinued transferred care|0|||
126737934|NCT03136367|455988572|FG002|T2 Post-consultation|Discontinued transferred care|3|||
126737935|NCT03136367|455988570|FG000|T2 Post-consultation|Discontinued lost contact|0|||
126737936|NCT03136367|455988571|FG001|T2 Post-consultation|Discontinued lost contact|1|||
126737937|NCT03136367|455988572|FG002|T2 Post-consultation|Discontinued lost contact|0|||
126737938|NCT03136367|455988570|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
126737939|NCT03136367|455988571|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
126737940|NCT03136367|455988572|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
126737941|NCT03136367|455988570|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
126737942|NCT03136367|455988571|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
126737943|NCT03136367|455988572|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
126737944|NCT03136367|455988570|FG000|T3 1 Week After Surgery|other discontinued|2|||
126737945|NCT03136367|455988571|FG001|T3 1 Week After Surgery|other discontinued|4|||
126737946|NCT03136367|455988572|FG002|T3 1 Week After Surgery|other discontinued|3|||
126737947|NCT03136367|455988570|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
126737948|NCT03136367|455988571|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
126737949|NCT03136367|455988572|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
126737950|NCT03136367|455988570|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
126737951|NCT03136367|455988571|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
126737952|NCT03136367|455988572|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
126737953|NCT03136367|455988570|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
126737954|NCT03136367|455988571|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
126737955|NCT03136367|455988572|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
126737956|NCT03136367|455988570|FG000|T4 12 Weeks After Surgery|Death|0|||
126737957|NCT03136367|455988571|FG001|T4 12 Weeks After Surgery|Death|1|||
126737958|NCT03136367|455988572|FG002|T4 12 Weeks After Surgery|Death|3|||
126737959|NCT03136367|455988570|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
126737960|NCT03136367|455988571|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
126737961|NCT03136367|455988572|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
126737962|NCT03136367|455988570|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
126737963|NCT03136367|455988571|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
126737964|NCT03136367|455988572|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
126737965|NCT03136367|455988570|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
126737966|NCT03136367|455988571|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
126737967|NCT03136367|455988572|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
126737968|NCT03136367|455988570|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
126737969|NCT03136367|455988571|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
126737970|NCT03136367|455988572|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
126737971|NCT03136367|455988570|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
126737972|NCT03136367|455988571|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
126737973|NCT03136367|455988572|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
126737974|NCT03136367|455988570|FG000|T5 1 Year After Surgery|Death|0|||
126737975|NCT03136367|455988571|FG001|T5 1 Year After Surgery|Death|0|||
126737976|NCT03136367|455988572|FG002|T5 1 Year After Surgery|Death|1|||
126737977|NCT03136367|455988570|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
126737978|NCT03136367|455988571|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
126737979|NCT03136367|455988572|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
126737980|NCT03136367|455988570|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
126737981|NCT03136367|455988571|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
126737982|NCT03136367|455988572|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
126737983|NCT03136367|455988570|FG000|T5 1 Year After Surgery|study ended before due|31|||
126737984|NCT03136367|455988571|FG001|T5 1 Year After Surgery|study ended before due|103|||
126737985|NCT03136367|455988572|FG002|T5 1 Year After Surgery|study ended before due|110|||
126737986|NCT03136367|455988570|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
126737987|NCT03136367|455988571|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
126737988|NCT03136367|455988572|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
126737989|NCT00676208|455988574|FG000|Overall Study|Lost to Follow-up|0|||
126737990|NCT00676208|455988575|FG001|Overall Study|Lost to Follow-up|2|||
126737991|NCT00676208|455988574|FG000|Overall Study|Incomplete data|2|||
126737992|NCT00676208|455988575|FG001|Overall Study|Incomplete data|4|||
126737993|NCT03726333|455988576|FG000|Overall Study|Progressive Disease|0|||
126737994|NCT03726333|455988577|FG001|Overall Study|Progressive Disease|0|||
126737995|NCT03726333|455988578|FG002|Overall Study|Progressive Disease|1|||
126737996|NCT03726333|455988579|FG003|Overall Study|Progressive Disease|0|||
126737997|NCT03726333|455988580|FG004|Overall Study|Progressive Disease|0|||
126737998|NCT01946412|455988581|FG000|Overall Study|Adverse Event|1|||
126737999|NCT01946412|455988581|FG000|Overall Study|Non-Compliance|1|||
126738000|NCT01946412|455988581|FG000|Overall Study|Continued with commercial Kalydeco|2|||
126738001|NCT01946412|455988581|FG000|Overall Study|Difficulty in swallowing|1|||
126738002|NCT02088541|455990686|FG000|Overall Study|Adverse Event|3|||
126738003|NCT02088541|455990687|FG001|Overall Study|Adverse Event|0|||
126738004|NCT02088541|455990688|FG002|Overall Study|Adverse Event|3|||
126738005|NCT02088541|455990689|FG003|Overall Study|Adverse Event|3|||
126738006|NCT02088541|455990690|FG004|Overall Study|Adverse Event|0|||
126738007|NCT02088541|455990686|FG000|Overall Study|Death|51|||
126738008|NCT02088541|455990687|FG001|Overall Study|Death|21|||
126738009|NCT02088541|455990688|FG002|Overall Study|Death|85|||
126738010|NCT02088541|455990689|FG003|Overall Study|Death|28|||
126738011|NCT02088541|455990690|FG004|Overall Study|Death|38|||
126738012|NCT02088541|455990686|FG000|Overall Study|Lost to Follow-up|2|||
126738013|NCT02088541|455990687|FG001|Overall Study|Lost to Follow-up|0|||
126738014|NCT02088541|455990688|FG002|Overall Study|Lost to Follow-up|1|||
126738015|NCT02088541|455990689|FG003|Overall Study|Lost to Follow-up|0|||
126738016|NCT02088541|455990690|FG004|Overall Study|Lost to Follow-up|0|||
126738017|NCT02088541|455990686|FG000|Overall Study|Physician Decision|2|||
126738018|NCT02088541|455990687|FG001|Overall Study|Physician Decision|1|||
126738019|NCT02088541|455990688|FG002|Overall Study|Physician Decision|2|||
126738020|NCT02088541|455990689|FG003|Overall Study|Physician Decision|0|||
126738021|NCT02088541|455990690|FG004|Overall Study|Physician Decision|2|||
126738022|NCT02088541|455990686|FG000|Overall Study|Disease progression|7|||
126738023|NCT02088541|455990687|FG001|Overall Study|Disease progression|1|||
126738024|NCT02088541|455990688|FG002|Overall Study|Disease progression|2|||
126738025|NCT02088541|455990689|FG003|Overall Study|Disease progression|3|||
126738026|NCT02088541|455990690|FG004|Overall Study|Disease progression|1|||
126738027|NCT02088541|455990686|FG000|Overall Study|Study terminated by sponsor|1|||
126738028|NCT02088541|455990687|FG001|Overall Study|Study terminated by sponsor|1|||
126738029|NCT02088541|455990688|FG002|Overall Study|Study terminated by sponsor|12|||
126738030|NCT02088541|455990689|FG003|Overall Study|Study terminated by sponsor|2|||
126738031|NCT02088541|455990690|FG004|Overall Study|Study terminated by sponsor|6|||
126738032|NCT02088541|455990686|FG000|Overall Study|Withdrawal by Subject|3|||
126738033|NCT02088541|455990687|FG001|Overall Study|Withdrawal by Subject|2|||
126738034|NCT02088541|455990688|FG002|Overall Study|Withdrawal by Subject|9|||
126738035|NCT02088541|455990689|FG003|Overall Study|Withdrawal by Subject|7|||
126738036|NCT02088541|455990690|FG004|Overall Study|Withdrawal by Subject|10|||
126738037|NCT02088541|455990686|FG000|Overall Study|Other|2|||
126738038|NCT02088541|455990687|FG001|Overall Study|Other|1|||
126738039|NCT02088541|455990688|FG002|Overall Study|Other|3|||
126738040|NCT02088541|455990689|FG003|Overall Study|Other|1|||
126738041|NCT02088541|455990690|FG004|Overall Study|Other|1|||
126738042|NCT01105936|455990692|FG000|Period 1|Adverse Event|0|||
126738043|NCT01105936|455990693|FG001|Period 1|Adverse Event|0|||
126738044|NCT01105936|455990694|FG002|Period 1|Adverse Event|0|||
126738045|NCT01105936|455990695|FG003|Period 1|Adverse Event|1|||
126738046|NCT01105936|455990692|FG000|Period 2|Adverse Event|1|||
126738047|NCT01105936|455990693|FG001|Period 2|Adverse Event|0|||
126738048|NCT01105936|455990694|FG002|Period 2|Adverse Event|0|||
126738049|NCT01105936|455990695|FG003|Period 2|Adverse Event|0|||
126738050|NCT01105936|455990692|FG000|Period 3|Protocol Violation|0|||
126738051|NCT01105936|455990693|FG001|Period 3|Protocol Violation|2|||
126738052|NCT01105936|455990694|FG002|Period 3|Protocol Violation|0|||
126738053|NCT01105936|455990695|FG003|Period 3|Protocol Violation|0|||
126738054|NCT01625611|455990703|FG000|Overall Study|No adlib drinks Lab 1|3|||
126738055|NCT01625611|455990704|FG001|Overall Study|No adlib drinks Lab 1|0|||
126738056|NCT01625611|455990703|FG000|Overall Study|Technical issues with PET|1|||
126738057|NCT01625611|455990704|FG001|Overall Study|Technical issues with PET|0|||
126738058|NCT01625611|455990703|FG000|Overall Study|Unable to complete study procedures|1|||
126738059|NCT01625611|455990704|FG001|Overall Study|Unable to complete study procedures|0|||
126738060|NCT01625611|455990703|FG000|Overall Study|Withdrawal by Subject|3|||
126738061|NCT01625611|455990704|FG001|Overall Study|Withdrawal by Subject|0|||
126738062|NCT02431793|455990705|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
126738063|NCT02431793|455990706|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
126738064|NCT02431793|455990707|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
126738065|NCT02431793|455990705|FG000|Overall Study|Withdrawal by Subject|7|||
126738066|NCT02431793|455990706|FG001|Overall Study|Withdrawal by Subject|5|||
126738067|NCT02431793|455990707|FG002|Overall Study|Withdrawal by Subject|5|||
126738068|NCT02431793|455990705|FG000|Overall Study|Lost to Follow-up|101|||
126738069|NCT02431793|455990706|FG001|Overall Study|Lost to Follow-up|122|||
126738070|NCT02431793|455990707|FG002|Overall Study|Lost to Follow-up|104|||
126738071|NCT03170258|455990711|FG000|Overall Study|Physician Decision|4|||
126738072|NCT03170258|455990712|FG001|Overall Study|Physician Decision|0|||
126738073|NCT03170258|455990711|FG000|Overall Study|Equipment issues|1|||
126738074|NCT03170258|455990712|FG001|Overall Study|Equipment issues|0|||
126738075|NCT03170258|455990711|FG000|Overall Study|Medication|1|||
126738076|NCT03170258|455990712|FG001|Overall Study|Medication|0|||
126738077|NCT03170258|455990711|FG000|Overall Study|Sleep issues|1|||
126738078|NCT03170258|455990712|FG001|Overall Study|Sleep issues|0|||
126738079|NCT01563107|455990713|FG000|Overall Study|Physician Decision|0|||
126738080|NCT01563107|455990714|FG001|Overall Study|Physician Decision|1|||
126738081|NCT01563107|455990715|FG002|Overall Study|Physician Decision|1|||
126738082|NCT01563107|455990716|FG003|Overall Study|Physician Decision|3|||
126738083|NCT01563107|455990713|FG000|Overall Study|Withdrawal by Subject|1|||
126738084|NCT01563107|455990714|FG001|Overall Study|Withdrawal by Subject|2|||
126738085|NCT01563107|455990715|FG002|Overall Study|Withdrawal by Subject|1|||
126738086|NCT01563107|455990716|FG003|Overall Study|Withdrawal by Subject|2|||
126738087|NCT03907969|455990717|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
126738088|NCT03907969|455990718|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
126738089|NCT03907969|455990719|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
126738090|NCT03907969|455990720|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
126738091|NCT03907969|455990721|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
126738092|NCT03907969|455990722|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
126738093|NCT03907969|455990723|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
126738094|NCT03907969|455990724|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
126738095|NCT03907969|455990725|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
126738096|NCT03907969|455990726|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
126738097|NCT03907969|455990727|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
126738098|NCT03907969|455990717|FG000|Monotherapy Part A|Progressive Disease|0|||
126738099|NCT03907969|455990718|FG001|Monotherapy Part A|Progressive Disease|1|||
126738100|NCT03907969|455990719|FG002|Monotherapy Part A|Progressive Disease|0|||
126738101|NCT03907969|455990720|FG003|Monotherapy Part A|Progressive Disease|0|||
126738102|NCT03907969|455990721|FG004|Monotherapy Part A|Progressive Disease|0|||
126738103|NCT03907969|455990722|FG005|Monotherapy Part A|Progressive Disease|1|||
126738104|NCT03907969|455990723|FG006|Monotherapy Part A|Progressive Disease|2|||
126738105|NCT03907969|455990724|FG007|Monotherapy Part A|Progressive Disease|0|||
126738106|NCT03907969|455990725|FG008|Monotherapy Part A|Progressive Disease|0|||
126738107|NCT03907969|455990726|FG009|Monotherapy Part A|Progressive Disease|0|||
126738108|NCT03907969|455990727|FG010|Monotherapy Part A|Progressive Disease|0|||
126738109|NCT03907969|455990717|FG000|Monotherapy Part A|Death|0|||
126738110|NCT03907969|455990718|FG001|Monotherapy Part A|Death|0|||
126738111|NCT03907969|455990719|FG002|Monotherapy Part A|Death|1|||
126738112|NCT03907969|455990720|FG003|Monotherapy Part A|Death|1|||
126738113|NCT03907969|455990721|FG004|Monotherapy Part A|Death|0|||
126738114|NCT03907969|455990722|FG005|Monotherapy Part A|Death|1|||
126738115|NCT03907969|455990723|FG006|Monotherapy Part A|Death|0|||
126738116|NCT03907969|455990724|FG007|Monotherapy Part A|Death|0|||
126738117|NCT03907969|455990725|FG008|Monotherapy Part A|Death|0|||
126738118|NCT03907969|455990726|FG009|Monotherapy Part A|Death|0|||
126738119|NCT03907969|455990727|FG010|Monotherapy Part A|Death|0|||
126738120|NCT03907969|455990717|FG000|Combination Therapy Part A|Adverse Event|0|||
126738121|NCT03907969|455990718|FG001|Combination Therapy Part A|Adverse Event|0|||
126738122|NCT03907969|455990719|FG002|Combination Therapy Part A|Adverse Event|0|||
126738123|NCT03907969|455990720|FG003|Combination Therapy Part A|Adverse Event|0|||
126738124|NCT03907969|455990721|FG004|Combination Therapy Part A|Adverse Event|0|||
126738125|NCT03907969|455990722|FG005|Combination Therapy Part A|Adverse Event|0|||
126738126|NCT03907969|455990723|FG006|Combination Therapy Part A|Adverse Event|0|||
126738127|NCT03907969|455990724|FG007|Combination Therapy Part A|Adverse Event|0|||
126738128|NCT03907969|455990725|FG008|Combination Therapy Part A|Adverse Event|0|||
126738129|NCT03907969|455990726|FG009|Combination Therapy Part A|Adverse Event|1|||
126738130|NCT03907969|455990727|FG010|Combination Therapy Part A|Adverse Event|1|||
126738131|NCT03907969|455990717|FG000|Combination Therapy Part A|Progressive disease|0|||
126738132|NCT03907969|455990718|FG001|Combination Therapy Part A|Progressive disease|0|||
126738133|NCT03907969|455990719|FG002|Combination Therapy Part A|Progressive disease|0|||
126738134|NCT03907969|455990720|FG003|Combination Therapy Part A|Progressive disease|0|||
126738135|NCT03907969|455990721|FG004|Combination Therapy Part A|Progressive disease|0|||
126738136|NCT03907969|455990722|FG005|Combination Therapy Part A|Progressive disease|0|||
126738137|NCT03907969|455990723|FG006|Combination Therapy Part A|Progressive disease|0|||
126738138|NCT03907969|455990724|FG007|Combination Therapy Part A|Progressive disease|1|||
126738139|NCT03907969|455990725|FG008|Combination Therapy Part A|Progressive disease|0|||
126738140|NCT03907969|455990726|FG009|Combination Therapy Part A|Progressive disease|2|||
126738141|NCT03907969|455990727|FG010|Combination Therapy Part A|Progressive disease|3|||
126738142|NCT03907969|455990717|FG000|Combination Therapy Part A|Death|0|||
126738143|NCT03907969|455990718|FG001|Combination Therapy Part A|Death|0|||
126738144|NCT03907969|455990719|FG002|Combination Therapy Part A|Death|0|||
126738145|NCT03907969|455990720|FG003|Combination Therapy Part A|Death|0|||
126738146|NCT03907969|455990721|FG004|Combination Therapy Part A|Death|0|||
126738147|NCT03907969|455990722|FG005|Combination Therapy Part A|Death|0|||
126738148|NCT03907969|455990723|FG006|Combination Therapy Part A|Death|0|||
126738149|NCT03907969|455990724|FG007|Combination Therapy Part A|Death|0|||
126738150|NCT03907969|455990725|FG008|Combination Therapy Part A|Death|1|||
126738151|NCT03907969|455990726|FG009|Combination Therapy Part A|Death|0|||
126738152|NCT03907969|455990727|FG010|Combination Therapy Part A|Death|1|||
126738153|NCT03907969|455990717|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
126738154|NCT03907969|455990718|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
126738155|NCT03907969|455990719|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
126738156|NCT03907969|455990720|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
126738157|NCT03907969|455990721|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
126738158|NCT03907969|455990722|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
126738159|NCT03907969|455990723|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
126738160|NCT03907969|455990724|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
126738161|NCT03907969|455990725|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
126738162|NCT03907969|455990726|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
126738163|NCT03907969|455990727|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
126614367|NCT02326220|455546207|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
126614368|NCT02326220|455546208|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
126614369|NCT02326220|455546209|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
126614370|NCT02699099|455546210|FG000|Overall Study|Adverse Event|1|||
126614371|NCT02699099|455546211|FG001|Overall Study|Adverse Event|0|||
126614372|NCT02699099|455546212|FG002|Overall Study|Adverse Event|2|||
126614373|NCT02699099|455546210|FG000|Overall Study|Lost to Follow-up|0|||
126614374|NCT02699099|455546211|FG001|Overall Study|Lost to Follow-up|1|||
126614375|NCT02699099|455546212|FG002|Overall Study|Lost to Follow-up|0|||
126614376|NCT02699099|455546210|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
126614377|NCT02699099|455546211|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
126614378|NCT02699099|455546212|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
126614379|NCT03659136|455546218|FG000|Overall Study|Not treated|2|||
126614380|NCT03659136|455546219|FG001|Overall Study|Not treated|0|||
126614381|NCT03659136|455546218|FG000|Overall Study|Covid-19 related|1|||
126614382|NCT03659136|455546219|FG001|Overall Study|Covid-19 related|1|||
126614383|NCT03659136|455546218|FG000|Overall Study|Withdrawal by Subject|1|||
126614384|NCT03659136|455546219|FG001|Overall Study|Withdrawal by Subject|6|||
126614385|NCT03659136|455546218|FG000|Overall Study|Adverse Event|4|||
126614386|NCT03659136|455546219|FG001|Overall Study|Adverse Event|6|||
126614387|NCT03659136|455546218|FG000|Overall Study|Progressive disease|37|||
126614388|NCT03659136|455546219|FG001|Overall Study|Progressive disease|31|||
126614389|NCT03659136|455546218|FG000|Overall Study|Study closure|2|||
126614390|NCT03659136|455546219|FG001|Overall Study|Study closure|2|||
126614391|NCT03659136|455546218|FG000|Overall Study|Sponsor decision/recommendation|3|||
126614392|NCT03659136|455546219|FG001|Overall Study|Sponsor decision/recommendation|2|||
126614393|NCT03659136|455546218|FG000|Overall Study|Switched to other drug/therapy|2|||
126614394|NCT03659136|455546219|FG001|Overall Study|Switched to other drug/therapy|2|||
126614395|NCT03659136|455546218|FG000|Overall Study|Lack of clinical benefit|0|||
126614396|NCT03659136|455546219|FG001|Overall Study|Lack of clinical benefit|1|||
126614397|NCT00647699|455547457|FG000|Overall Study|Lost to Follow-up|5|||
126614398|NCT00647699|455547458|FG001|Overall Study|Lost to Follow-up|4|||
126614399|NCT00647699|455547457|FG000|Overall Study|Withdrawal by Subject|3|||
126614400|NCT00647699|455547458|FG001|Overall Study|Withdrawal by Subject|8|||
126614401|NCT00413283|455547459|FG000|Overall Study|Withdrawal by Subject|1|||
126614402|NCT00413283|455547460|FG001|Overall Study|Withdrawal by Subject|0|||
126614403|NCT00413283|455547461|FG002|Overall Study|Withdrawal by Subject|0|||
126614404|NCT00413283|455547462|FG003|Overall Study|Withdrawal by Subject|1|||
126614405|NCT00413283|455547459|FG000|Overall Study|Death|0|||
126614406|NCT00413283|455547460|FG001|Overall Study|Death|0|||
126614407|NCT00413283|455547461|FG002|Overall Study|Death|1|||
126614408|NCT00413283|455547462|FG003|Overall Study|Death|1|||
126614409|NCT00413283|455547459|FG000|Overall Study|Adverse Event|0|||
126614410|NCT00413283|455547460|FG001|Overall Study|Adverse Event|0|||
126614411|NCT00413283|455547461|FG002|Overall Study|Adverse Event|0|||
126614412|NCT00413283|455547462|FG003|Overall Study|Adverse Event|1|||
126614413|NCT00413283|455547459|FG000|Overall Study|Ineligibility determined|0|||
126614414|NCT00413283|455547460|FG001|Overall Study|Ineligibility determined|0|||
126614415|NCT00413283|455547461|FG002|Overall Study|Ineligibility determined|0|||
126614416|NCT00413283|455547462|FG003|Overall Study|Ineligibility determined|1|||
126614417|NCT00413283|455547459|FG000|Overall Study|Protocol deviation|0|||
126614418|NCT00413283|455547460|FG001|Overall Study|Protocol deviation|1|||
126614419|NCT00413283|455547461|FG002|Overall Study|Protocol deviation|0|||
126614420|NCT00413283|455547462|FG003|Overall Study|Protocol deviation|0|||
126614421|NCT00413283|455547459|FG000|Overall Study|Requirement for alternative therapy|0|||
126614422|NCT00413283|455547460|FG001|Overall Study|Requirement for alternative therapy|2|||
126614423|NCT00413283|455547461|FG002|Overall Study|Requirement for alternative therapy|0|||
126614424|NCT00413283|455547462|FG003|Overall Study|Requirement for alternative therapy|0|||
126614425|NCT00413283|455547459|FG000|Overall Study|Other|0|||
126614426|NCT00413283|455547460|FG001|Overall Study|Other|0|||
126614427|NCT00413283|455547461|FG002|Overall Study|Other|1|||
126614428|NCT00413283|455547462|FG003|Overall Study|Other|0|||
126614429|NCT02354417|455547463|FG000|Overall Study|Physician Decision|1|||
126614430|NCT00246129|455547464|FG000|Overall Study|Lost to Follow-up|1|||
126614431|NCT00246129|455547465|FG001|Overall Study|Lost to Follow-up|0|||
126614432|NCT00246129|455547464|FG000|Overall Study|Death|2|||
126614433|NCT00246129|455547465|FG001|Overall Study|Death|1|||
126614434|NCT00246129|455547464|FG000|Overall Study|suffered primary non-function|1|||
126614435|NCT00246129|455547465|FG001|Overall Study|suffered primary non-function|0|||
126614436|NCT00246129|455547464|FG000|Overall Study|grafts failed|3|||
126614437|NCT00246129|455547465|FG001|Overall Study|grafts failed|1|||
126614438|NCT03469258|455547466|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
126614439|NCT03340961|455547470|FG000|Overall Study|Adverse Event|1|||
126614440|NCT03340961|455547471|FG001|Overall Study|Adverse Event|3|||
126614441|NCT03340961|455547472|FG002|Overall Study|Adverse Event|2|||
126614442|NCT03340961|455547473|FG003|Overall Study|Adverse Event|4|||
126614443|NCT03340961|455547470|FG000|Overall Study|Lost to Follow-up|0|||
126614444|NCT03340961|455547471|FG001|Overall Study|Lost to Follow-up|1|||
126738164|NCT03907969|455990717|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
126738165|NCT03907969|455990718|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
126738166|NCT03907969|455990719|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
126738167|NCT03907969|455990720|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
126738168|NCT03907969|455990721|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
126738169|NCT03907969|455990722|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
126738170|NCT03907969|455990723|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
126738171|NCT03907969|455990724|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
126738172|NCT03907969|455990725|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
126738173|NCT03907969|455990726|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
126738174|NCT03907969|455990727|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
126738175|NCT03907969|455990717|FG000|Combination Therapy Part A|Physician Decision|0|||
126738176|NCT03907969|455990718|FG001|Combination Therapy Part A|Physician Decision|0|||
126738177|NCT03907969|455990719|FG002|Combination Therapy Part A|Physician Decision|0|||
126738178|NCT03907969|455990720|FG003|Combination Therapy Part A|Physician Decision|0|||
126738179|NCT03907969|455990721|FG004|Combination Therapy Part A|Physician Decision|0|||
126738180|NCT03907969|455990722|FG005|Combination Therapy Part A|Physician Decision|0|||
126738181|NCT03907969|455990723|FG006|Combination Therapy Part A|Physician Decision|0|||
126738182|NCT03907969|455990724|FG007|Combination Therapy Part A|Physician Decision|1|||
126738183|NCT03907969|455990725|FG008|Combination Therapy Part A|Physician Decision|0|||
126738184|NCT03907969|455990726|FG009|Combination Therapy Part A|Physician Decision|0|||
126738185|NCT03907969|455990727|FG010|Combination Therapy Part A|Physician Decision|1|||
126738186|NCT00666536|455990728|FG000|Overall Study|Adverse Event|9|||
126738187|NCT00666536|455990729|FG001|Overall Study|Adverse Event|19|||
126738188|NCT00666536|455990728|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126738189|NCT00666536|455990729|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
126738190|NCT00666536|455990728|FG000|Overall Study|Protocol deviation(s)|8|||
126738191|NCT00666536|455990729|FG001|Overall Study|Protocol deviation(s)|6|||
126738192|NCT00666536|455990728|FG000|Overall Study|Withdrawal by Subject|10|||
126738193|NCT00666536|455990729|FG001|Overall Study|Withdrawal by Subject|9|||
126738194|NCT00666536|455990728|FG000|Overall Study|Lost to Follow-up|4|||
126738195|NCT00666536|455990729|FG001|Overall Study|Lost to Follow-up|3|||
126738196|NCT00511108|455990733|FG000|Overall Study|Adverse Event|2|||
126738197|NCT00511108|455990734|FG001|Overall Study|Adverse Event|0|||
126738198|NCT00511108|455990735|FG002|Overall Study|Adverse Event|1|||
126738199|NCT00511108|455990736|FG003|Overall Study|Adverse Event|2|||
126738200|NCT00511108|455990733|FG000|Overall Study|Lost to Follow-up|0|||
126738201|NCT00511108|455990734|FG001|Overall Study|Lost to Follow-up|2|||
126738202|NCT00511108|455990735|FG002|Overall Study|Lost to Follow-up|1|||
126738203|NCT00511108|455990736|FG003|Overall Study|Lost to Follow-up|0|||
126738204|NCT00511108|455990733|FG000|Overall Study|Physician Decision|0|||
126738205|NCT00511108|455990734|FG001|Overall Study|Physician Decision|0|||
126738206|NCT00511108|455990735|FG002|Overall Study|Physician Decision|0|||
126738207|NCT00511108|455990736|FG003|Overall Study|Physician Decision|1|||
126738208|NCT00511108|455990733|FG000|Overall Study|Withdrawal by Subject|4|||
126738209|NCT00511108|455990734|FG001|Overall Study|Withdrawal by Subject|0|||
126738210|NCT00511108|455990735|FG002|Overall Study|Withdrawal by Subject|3|||
126738211|NCT00511108|455990736|FG003|Overall Study|Withdrawal by Subject|2|||
126738212|NCT01831804|455990743|FG000|Overall Study|Adverse Event|0|||
126738213|NCT01831804|455990744|FG001|Overall Study|Adverse Event|0|||
126738214|NCT01831804|455990745|FG002|Overall Study|Adverse Event|0|||
126738215|NCT01831804|455990746|FG003|Overall Study|Adverse Event|0|||
126738216|NCT01831804|455990747|FG004|Overall Study|Adverse Event|0|||
126738217|NCT01831804|455990748|FG005|Overall Study|Adverse Event|0|||
126738218|NCT01831804|455990749|FG006|Overall Study|Adverse Event|1|||
126738219|NCT01831804|455990750|FG007|Overall Study|Adverse Event|0|||
126738220|NCT01831804|455990751|FG008|Overall Study|Adverse Event|1|||
126738221|NCT01831804|455990743|FG000|Overall Study|Protocol Violation|0|||
126738222|NCT01831804|455990744|FG001|Overall Study|Protocol Violation|0|||
126738223|NCT01831804|455990745|FG002|Overall Study|Protocol Violation|2|||
126738224|NCT01831804|455990746|FG003|Overall Study|Protocol Violation|0|||
126738225|NCT01831804|455990747|FG004|Overall Study|Protocol Violation|0|||
126738226|NCT01831804|455990748|FG005|Overall Study|Protocol Violation|0|||
126738227|NCT01831804|455990749|FG006|Overall Study|Protocol Violation|0|||
126781426|NCT01620489|456154545|FG001|Overall Study|Adverse Event|4|||
126781427|NCT01620489|456154544|FG000|Overall Study|Protocol Violation|0|||
126781428|NCT01620489|456154545|FG001|Overall Study|Protocol Violation|3|||
126781429|NCT01620489|456154544|FG000|Overall Study|Withdrawal Criteria|17|||
126781430|NCT01620489|456154545|FG001|Overall Study|Withdrawal Criteria|25|||
126781431|NCT01620489|456154544|FG000|Overall Study|Unclassified|1|||
126781432|NCT01620489|456154545|FG001|Overall Study|Unclassified|2|||
126738228|NCT01831804|455990750|FG007|Overall Study|Protocol Violation|0|||
126738229|NCT01831804|455990751|FG008|Overall Study|Protocol Violation|0|||
126738230|NCT01831804|455990743|FG000|Overall Study|Protocol defined stopping criteria|1|||
126738231|NCT01831804|455990744|FG001|Overall Study|Protocol defined stopping criteria|1|||
126738232|NCT01831804|455990745|FG002|Overall Study|Protocol defined stopping criteria|3|||
126738233|NCT01831804|455990746|FG003|Overall Study|Protocol defined stopping criteria|0|||
126738234|NCT01831804|455990747|FG004|Overall Study|Protocol defined stopping criteria|1|||
126738235|NCT01831804|455990748|FG005|Overall Study|Protocol defined stopping criteria|0|||
126738236|NCT01831804|455990749|FG006|Overall Study|Protocol defined stopping criteria|0|||
126738237|NCT01831804|455990750|FG007|Overall Study|Protocol defined stopping criteria|0|||
126738238|NCT01831804|455990751|FG008|Overall Study|Protocol defined stopping criteria|0|||
126738239|NCT01831804|455990743|FG000|Overall Study|Lost to Follow-up|0|||
126738240|NCT01831804|455990744|FG001|Overall Study|Lost to Follow-up|0|||
126738241|NCT01831804|455990745|FG002|Overall Study|Lost to Follow-up|1|||
126738242|NCT01831804|455990746|FG003|Overall Study|Lost to Follow-up|0|||
126738243|NCT01831804|455990747|FG004|Overall Study|Lost to Follow-up|0|||
126738244|NCT01831804|455990748|FG005|Overall Study|Lost to Follow-up|0|||
126738245|NCT01831804|455990749|FG006|Overall Study|Lost to Follow-up|0|||
126738246|NCT01831804|455990750|FG007|Overall Study|Lost to Follow-up|0|||
126738247|NCT01831804|455990751|FG008|Overall Study|Lost to Follow-up|1|||
126738248|NCT01831804|455990743|FG000|Overall Study|Investigator discretion|0|||
126738249|NCT01831804|455990744|FG001|Overall Study|Investigator discretion|0|||
126738250|NCT01831804|455990745|FG002|Overall Study|Investigator discretion|0|||
126738251|NCT01831804|455990746|FG003|Overall Study|Investigator discretion|0|||
126738252|NCT01831804|455990747|FG004|Overall Study|Investigator discretion|1|||
126738253|NCT01831804|455990748|FG005|Overall Study|Investigator discretion|0|||
126738254|NCT01831804|455990749|FG006|Overall Study|Investigator discretion|0|||
126738255|NCT01831804|455990750|FG007|Overall Study|Investigator discretion|1|||
126738256|NCT01831804|455990751|FG008|Overall Study|Investigator discretion|0|||
126738257|NCT01831804|455990743|FG000|Overall Study|Withdrew Consent|0|||
126738258|NCT01831804|455990744|FG001|Overall Study|Withdrew Consent|1|||
126738259|NCT01831804|455990745|FG002|Overall Study|Withdrew Consent|0|||
126738260|NCT01831804|455990746|FG003|Overall Study|Withdrew Consent|0|||
126738261|NCT01831804|455990747|FG004|Overall Study|Withdrew Consent|0|||
126738262|NCT01831804|455990748|FG005|Overall Study|Withdrew Consent|0|||
126738263|NCT01831804|455990749|FG006|Overall Study|Withdrew Consent|0|||
126738264|NCT01831804|455990750|FG007|Overall Study|Withdrew Consent|2|||
126738265|NCT01831804|455990751|FG008|Overall Study|Withdrew Consent|0|||
126738266|NCT00268463|455990754|FG000|Overall Study|study terminated due to low accrual|10|||
126738267|NCT00268463|455990755|FG001|Overall Study|study terminated due to low accrual|12|||
126738268|NCT02920450|455990756|FG000|Overall Study|Death|1|||
126738269|NCT02920450|455990757|FG001|Overall Study|Death|0|||
126738270|NCT02920450|455990758|FG002|Overall Study|Death|0|||
126738271|NCT02920450|455990759|FG003|Overall Study|Death|0|||
126738272|NCT02920450|455990756|FG000|Overall Study|Withdrawal by Subject|1|||
126614445|NCT03340961|455547472|FG002|Overall Study|Lost to Follow-up|0|||
126614446|NCT03340961|455547473|FG003|Overall Study|Lost to Follow-up|1|||
126614447|NCT03340961|455547470|FG000|Overall Study|Withdrawal by Subject|3|||
126614448|NCT03340961|455547471|FG001|Overall Study|Withdrawal by Subject|2|||
126614449|NCT03340961|455547472|FG002|Overall Study|Withdrawal by Subject|4|||
126614450|NCT03340961|455547473|FG003|Overall Study|Withdrawal by Subject|7|||
126614451|NCT03340961|455547470|FG000|Overall Study|Use of prohibited treatment|0|||
126614452|NCT03340961|455547471|FG001|Overall Study|Use of prohibited treatment|3|||
126614453|NCT03340961|455547472|FG002|Overall Study|Use of prohibited treatment|2|||
126614454|NCT03340961|455547473|FG003|Overall Study|Use of prohibited treatment|4|||
126614455|NCT03340961|455547470|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
126614456|NCT03340961|455547471|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
126614457|NCT03340961|455547472|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
126614458|NCT03340961|455547473|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
126614459|NCT03340961|455547470|FG000|Overall Study|Subject developed an exclusion criterion|0|||
126614460|NCT03340961|455547471|FG001|Overall Study|Subject developed an exclusion criterion|1|||
126614461|NCT03340961|455547472|FG002|Overall Study|Subject developed an exclusion criterion|0|||
126614462|NCT03340961|455547473|FG003|Overall Study|Subject developed an exclusion criterion|0|||
126614463|NCT03340961|455547470|FG000|Overall Study|Protocol Violation|1|||
126614464|NCT03340961|455547471|FG001|Overall Study|Protocol Violation|0|||
126738273|NCT02920450|455990757|FG001|Overall Study|Withdrawal by Subject|0|||
126738274|NCT02920450|455990758|FG002|Overall Study|Withdrawal by Subject|0|||
126738275|NCT02920450|455990759|FG003|Overall Study|Withdrawal by Subject|0|||
126738276|NCT00968708|455990762|FG000|Overall Study|Adverse Event|169|||
126614465|NCT03340961|455547472|FG002|Overall Study|Protocol Violation|1|||
126614466|NCT03340961|455547473|FG003|Overall Study|Protocol Violation|0|||
126614467|NCT03340961|455547470|FG000|Overall Study|Adverse Event|1|||
126614468|NCT03340961|455547471|FG001|Overall Study|Adverse Event|1|||
126614469|NCT03340961|455547472|FG002|Overall Study|Adverse Event|0|||
126614470|NCT03340961|455547473|FG003|Overall Study|Adverse Event|0|||
126738277|NCT00968708|455990763|FG001|Overall Study|Adverse Event|150|||
126738278|NCT00968708|455990762|FG000|Overall Study|Major Protocol Deviation|0|||
126738279|NCT00968708|455990763|FG001|Overall Study|Major Protocol Deviation|1|||
126614471|NCT03340961|455547470|FG000|Overall Study|Lack of Efficacy|0|||
126738280|NCT00968708|455990762|FG000|Overall Study|Lost to Follow-up|19|||
126738281|NCT00968708|455990763|FG001|Overall Study|Lost to Follow-up|11|||
126738282|NCT00968708|455990762|FG000|Overall Study|Voluntary Withdrawal|104|||
126738283|NCT00968708|455990763|FG001|Overall Study|Voluntary Withdrawal|101|||
126738284|NCT00968708|455990762|FG000|Overall Study|Investigator Discretion|0|||
126738285|NCT00968708|455990763|FG001|Overall Study|Investigator Discretion|1|||
126738286|NCT00968708|455990762|FG000|Overall Study|Other|26|||
126738287|NCT00968708|455990763|FG001|Overall Study|Other|34|||
126738288|NCT01732107|455990764|FG000|Overall Study|Adverse Event|2|||
126738289|NCT01732107|455990764|FG000|Overall Study|Disease Progression|8|||
126738290|NCT01732107|455990764|FG000|Overall Study|Physician Decision|1|||
126738291|NCT01732107|455990764|FG000|Overall Study|Withdrawal by Subject|2|||
126738292|NCT01975675|455990767|FG000|Overall Study|Death|0|||
126738293|NCT01975675|455990768|FG001|Overall Study|Death|1|||
126738294|NCT01975675|455990769|FG002|Overall Study|Death|0|||
126738295|NCT01975675|455990770|FG003|Overall Study|Death|0|||
126738296|NCT00224003|455990771|FG000|Overall Study|Adverse Event|1|||
126738297|NCT00224003|455990771|FG000|Overall Study|Protocol Violation|2|||
126738298|NCT00224003|455990771|FG000|Overall Study|Withdrawal by Subject|1|||
126738299|NCT00224003|455990771|FG000|Overall Study|unk|3|||
126738300|NCT01202760|455990772|FG000|Overall Study|Entry Criteria Not Met|0|||
126738301|NCT01202760|455990773|FG001|Overall Study|Entry Criteria Not Met|3|||
126738302|NCT01202760|455990774|FG002|Overall Study|Entry Criteria Not Met|1|||
126738303|NCT01202760|455990772|FG000|Overall Study|Adverse Event|11|||
126738304|NCT01202760|455990773|FG001|Overall Study|Adverse Event|9|||
126738305|NCT01202760|455990774|FG002|Overall Study|Adverse Event|10|||
126738306|NCT01202760|455990772|FG000|Overall Study|Death|2|||
126738307|NCT01202760|455990773|FG001|Overall Study|Death|1|||
126738308|NCT01202760|455990774|FG002|Overall Study|Death|0|||
126738309|NCT01202760|455990772|FG000|Overall Study|Lack of Efficacy|6|||
126738310|NCT01202760|455990773|FG001|Overall Study|Lack of Efficacy|8|||
126738311|NCT01202760|455990774|FG002|Overall Study|Lack of Efficacy|7|||
126738312|NCT01202760|455990772|FG000|Overall Study|Lost to Follow-up|0|||
126738313|NCT01202760|455990773|FG001|Overall Study|Lost to Follow-up|2|||
126738314|NCT01202760|455990774|FG002|Overall Study|Lost to Follow-up|1|||
126738315|NCT01202760|455990772|FG000|Overall Study|Parent / Caregiver Decision|0|||
126738316|NCT01202760|455990773|FG001|Overall Study|Parent / Caregiver Decision|1|||
126738317|NCT01202760|455990774|FG002|Overall Study|Parent / Caregiver Decision|0|||
126738318|NCT01202760|455990772|FG000|Overall Study|Withdrawal by Subject|17|||
126738319|NCT01202760|455990773|FG001|Overall Study|Withdrawal by Subject|18|||
126738320|NCT01202760|455990774|FG002|Overall Study|Withdrawal by Subject|14|||
126738321|NCT01202760|455990772|FG000|Overall Study|Physician Decision|0|||
126738322|NCT01202760|455990773|FG001|Overall Study|Physician Decision|1|||
126738323|NCT01202760|455990774|FG002|Overall Study|Physician Decision|0|||
126738324|NCT01202760|455990772|FG000|Overall Study|Protocol Violation|7|||
126738325|NCT01202760|455990773|FG001|Overall Study|Protocol Violation|5|||
126738326|NCT01202760|455990774|FG002|Overall Study|Protocol Violation|2|||
126738327|NCT01202760|455990772|FG000|Overall Study|Sponsor Decision|4|||
126738328|NCT01202760|455990773|FG001|Overall Study|Sponsor Decision|4|||
126738329|NCT01202760|455990774|FG002|Overall Study|Sponsor Decision|0|||
126738330|NCT00871572|455990775|FG000|Overall Study|Adverse Event|0|||
126738331|NCT00871572|455990776|FG001|Overall Study|Adverse Event|2|||
126738332|NCT00871572|455990777|FG002|Overall Study|Adverse Event|0|||
126738333|NCT00871572|455990778|FG003|Overall Study|Adverse Event|3|||
126738334|NCT00871572|455990775|FG000|Overall Study|Investigator Decision|0|||
126738335|NCT00871572|455990776|FG001|Overall Study|Investigator Decision|1|||
126738336|NCT00871572|455990777|FG002|Overall Study|Investigator Decision|0|||
126738337|NCT00871572|455990778|FG003|Overall Study|Investigator Decision|1|||
126738338|NCT00871572|455990775|FG000|Overall Study|Lost to Follow-up|0|||
126738339|NCT00871572|455990776|FG001|Overall Study|Lost to Follow-up|1|||
126738340|NCT00871572|455990777|FG002|Overall Study|Lost to Follow-up|0|||
126738341|NCT00871572|455990778|FG003|Overall Study|Lost to Follow-up|1|||
126738342|NCT00871572|455990775|FG000|Overall Study|Protocol Violation|0|||
126738343|NCT00871572|455990776|FG001|Overall Study|Protocol Violation|0|||
126738344|NCT00871572|455990777|FG002|Overall Study|Protocol Violation|1|||
126738345|NCT00871572|455990778|FG003|Overall Study|Protocol Violation|1|||
126738346|NCT00871572|455990775|FG000|Overall Study|Sponsor Decision|1|||
126738347|NCT00871572|455990776|FG001|Overall Study|Sponsor Decision|0|||
126738348|NCT00871572|455990777|FG002|Overall Study|Sponsor Decision|0|||
126781433|NCT02611752|456154550|FG000|Overall Study|Adverse Event|0|||
126781434|NCT02611752|456154551|FG001|Overall Study|Adverse Event|1|||
126738349|NCT00871572|455990778|FG003|Overall Study|Sponsor Decision|0|||
126738350|NCT00871572|455990775|FG000|Overall Study|Withdrawal by Subject|1|||
126738351|NCT00871572|455990776|FG001|Overall Study|Withdrawal by Subject|2|||
126738352|NCT00871572|455990777|FG002|Overall Study|Withdrawal by Subject|3|||
126738353|NCT00871572|455990778|FG003|Overall Study|Withdrawal by Subject|1|||
126738354|NCT04354155|455990781|FG000|Overall Study|Withdrawal by Subject|1|||
126738355|NCT04354155|455990781|FG000|Overall Study|Did not meet criteria for study intervention|1|||
126738356|NCT02565615|455990784|FG000|Overall Study|Death|0|||
126738357|NCT02565615|455990785|FG001|Overall Study|Death|1|||
126738358|NCT02565615|455990786|FG002|Overall Study|Death|0|||
126738359|NCT02565615|455990787|FG003|Overall Study|Death|0|||
126738360|NCT02565615|455990788|FG004|Overall Study|Death|4|||
126738361|NCT02565615|455990784|FG000|Overall Study|Not willing to participate in study|2|||
126738362|NCT02565615|455990785|FG001|Overall Study|Not willing to participate in study|21|||
126738363|NCT02565615|455990786|FG002|Overall Study|Not willing to participate in study|0|||
126738364|NCT02565615|455990787|FG003|Overall Study|Not willing to participate in study|1|||
126738365|NCT02565615|455990788|FG004|Overall Study|Not willing to participate in study|169|||
126738366|NCT02565615|455990784|FG000|Overall Study|Lost to Follow-up|0|||
126738367|NCT02565615|455990785|FG001|Overall Study|Lost to Follow-up|4|||
126738368|NCT02565615|455990786|FG002|Overall Study|Lost to Follow-up|0|||
126738369|NCT02565615|455990787|FG003|Overall Study|Lost to Follow-up|1|||
126738370|NCT02565615|455990788|FG004|Overall Study|Lost to Follow-up|765|||
126738371|NCT02565615|455990784|FG000|Overall Study|Not meeting eligibility criteria|0|||
126738372|NCT02565615|455990785|FG001|Overall Study|Not meeting eligibility criteria|7|||
126738373|NCT02565615|455990786|FG002|Overall Study|Not meeting eligibility criteria|0|||
126738374|NCT02565615|455990787|FG003|Overall Study|Not meeting eligibility criteria|0|||
126738375|NCT02565615|455990788|FG004|Overall Study|Not meeting eligibility criteria|25|||
126738376|NCT02565615|455990784|FG000|Overall Study|Reason not defined|0|||
126738377|NCT02565615|455990785|FG001|Overall Study|Reason not defined|2|||
126738378|NCT02565615|455990786|FG002|Overall Study|Reason not defined|0|||
126738379|NCT02565615|455990787|FG003|Overall Study|Reason not defined|1|||
126738380|NCT02565615|455990788|FG004|Overall Study|Reason not defined|62|||
126738381|NCT02565615|455990784|FG000|Overall Study|Adverse Event|1|||
126738382|NCT02565615|455990785|FG001|Overall Study|Adverse Event|1|||
126738383|NCT02565615|455990786|FG002|Overall Study|Adverse Event|0|||
126738384|NCT02565615|455990787|FG003|Overall Study|Adverse Event|0|||
126738385|NCT02565615|455990788|FG004|Overall Study|Adverse Event|9|||
126738386|NCT02565615|455990784|FG000|Overall Study|Untreated|0|||
126738387|NCT02565615|455990785|FG001|Overall Study|Untreated|0|||
126738388|NCT02565615|455990786|FG002|Overall Study|Untreated|0|||
126738389|NCT02565615|455990787|FG003|Overall Study|Untreated|0|||
126738390|NCT02565615|455990788|FG004|Overall Study|Untreated|567|||
126738391|NCT00753688|455990794|FG000|Overall Study|Death|102|||
126738392|NCT00753688|455990795|FG001|Overall Study|Death|203|||
126738393|NCT00753688|455990794|FG000|Overall Study|Missing|4|||
126738394|NCT00753688|455990795|FG001|Overall Study|Missing|9|||
126738395|NCT00753688|455990794|FG000|Overall Study|Participant Withdrew Consent|2|||
126738396|NCT00753688|455990795|FG001|Overall Study|Participant Withdrew Consent|2|||
126738397|NCT00753688|455990794|FG000|Overall Study|Ongoing - in Follow-up|15|||
126738398|NCT00753688|455990795|FG001|Overall Study|Ongoing - in Follow-up|31|||
126738399|NCT00753688|455990794|FG000|Overall Study|Adverse Event|0|||
126738400|NCT00753688|455990795|FG001|Overall Study|Adverse Event|1|||
126738401|NCT02999100|455990799|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
126738402|NCT02999100|455990800|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
126738403|NCT02999100|455990801|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
126738404|NCT02999100|455990802|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
126738405|NCT02999100|455990803|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
126738406|NCT02999100|455990804|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
126738407|NCT02999100|455990799|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
126738408|NCT02999100|455990800|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
126738409|NCT02999100|455990801|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
126738410|NCT02999100|455990802|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
126738411|NCT02999100|455990803|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
126738412|NCT02999100|455990804|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
126738413|NCT02999100|455990799|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
126738414|NCT02999100|455990800|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
126738415|NCT02999100|455990801|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
126738416|NCT02999100|455990802|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
126738417|NCT02999100|455990803|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
126738418|NCT02999100|455990804|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
126738419|NCT03803202|455990808|FG000|Overall Study|Other|0|||
126738420|NCT03803202|455990809|FG001|Overall Study|Other|1|||
126738421|NCT03803202|455990810|FG002|Overall Study|Other|0|||
126738422|NCT03803202|455990811|FG003|Overall Study|Other|0|||
126738423|NCT03803202|455990812|FG004|Overall Study|Other|0|||
126738424|NCT03803202|455990813|FG005|Overall Study|Other|0|||
126738425|NCT03803202|455990814|FG006|Overall Study|Other|0|||
126738426|NCT03803202|455990815|FG007|Overall Study|Other|0|||
126738427|NCT03803202|455990816|FG008|Overall Study|Other|0|||
126738428|NCT03803202|455990808|FG000|Overall Study|Death|0|||
126738429|NCT03803202|455990809|FG001|Overall Study|Death|0|||
126738430|NCT03803202|455990810|FG002|Overall Study|Death|0|||
126738431|NCT03803202|455990811|FG003|Overall Study|Death|0|||
126738432|NCT03803202|455990812|FG004|Overall Study|Death|0|||
126738433|NCT03803202|455990813|FG005|Overall Study|Death|1|||
126738434|NCT03803202|455990814|FG006|Overall Study|Death|0|||
126738435|NCT03803202|455990815|FG007|Overall Study|Death|0|||
126738436|NCT03803202|455990816|FG008|Overall Study|Death|0|||
126738437|NCT03803202|455990808|FG000|Overall Study|Withdrawal by Subject|0|||
126738438|NCT03803202|455990809|FG001|Overall Study|Withdrawal by Subject|0|||
126738439|NCT03803202|455990810|FG002|Overall Study|Withdrawal by Subject|1|||
126738440|NCT03803202|455990811|FG003|Overall Study|Withdrawal by Subject|0|||
126738441|NCT03803202|455990812|FG004|Overall Study|Withdrawal by Subject|0|||
126738442|NCT03803202|455990813|FG005|Overall Study|Withdrawal by Subject|0|||
126738443|NCT03803202|455990814|FG006|Overall Study|Withdrawal by Subject|0|||
126738444|NCT03803202|455990815|FG007|Overall Study|Withdrawal by Subject|1|||
126738445|NCT03803202|455990816|FG008|Overall Study|Withdrawal by Subject|0|||
126738446|NCT03803202|455990808|FG000|Overall Study|Lost to Follow-up|0|||
126738447|NCT03803202|455990809|FG001|Overall Study|Lost to Follow-up|0|||
126738448|NCT03803202|455990810|FG002|Overall Study|Lost to Follow-up|0|||
126738449|NCT03803202|455990811|FG003|Overall Study|Lost to Follow-up|1|||
126738450|NCT03803202|455990812|FG004|Overall Study|Lost to Follow-up|1|||
126738451|NCT03803202|455990813|FG005|Overall Study|Lost to Follow-up|0|||
126738452|NCT03803202|455990814|FG006|Overall Study|Lost to Follow-up|1|||
126738453|NCT03803202|455990815|FG007|Overall Study|Lost to Follow-up|0|||
126738454|NCT03803202|455990816|FG008|Overall Study|Lost to Follow-up|0|||
126738455|NCT03595384|455990817|FG000|Overall Study|Other time commitments|8|||
126738456|NCT03595384|455990817|FG000|Overall Study|Changes to session time|7|||
126738457|NCT03595384|455990817|FG000|Overall Study|Relocation out of country|1|||
126738458|NCT00293241|455990818|FG000|Overall Study|Lost to Follow-up|9|||
126738459|NCT00293241|455990819|FG001|Overall Study|Lost to Follow-up|16|||
126738460|NCT00293241|455990818|FG000|Overall Study|Physician Decision|23|||
126738461|NCT00293241|455990819|FG001|Overall Study|Physician Decision|17|||
126738462|NCT00293241|455990818|FG000|Overall Study|Withdrawal by Subject|4|||
126738463|NCT00293241|455990819|FG001|Overall Study|Withdrawal by Subject|8|||
126738464|NCT02224638|455990820|FG000|Overall Study|Adverse Event|1|||
126738465|NCT02224638|455990821|FG001|Overall Study|Adverse Event|1|||
126738466|NCT01270958|455990824|FG000|Overall Study|Lost to Follow-up|2|||
126738467|NCT01270958|455990824|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
126738468|NCT00659126|455990831|FG000|Overall Study|Adverse Event|2|||
126738469|NCT00659126|455990832|FG001|Overall Study|Adverse Event|2|||
126738470|NCT00659126|455990831|FG000|Overall Study|Screen failure|1|||
126738471|NCT00659126|455990832|FG001|Overall Study|Screen failure|1|||
126738472|NCT00659126|455990831|FG000|Overall Study|Technical problems with MRI|0|||
126738473|NCT00659126|455990832|FG001|Overall Study|Technical problems with MRI|1|||
126738474|NCT02633046|455990835|FG000|Overall Study|Adverse Event|8|||
126738475|NCT02633046|455990835|FG000|Overall Study|Physician Decision|7|||
126738476|NCT02633046|455990835|FG000|Overall Study|Withdrawal by Subject|8|||
126738477|NCT02633046|455990835|FG000|Overall Study|Increased proteinuria|2|||
126738478|NCT02633046|455990835|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
126738479|NCT02633046|455990835|FG000|Overall Study|Mutual decision patient and physician|1|||
126738480|NCT02925312|455990836|FG000|Overall Study|Lost to Follow-up|25|||
126738481|NCT02925312|455990837|FG001|Overall Study|Lost to Follow-up|0|||
126738482|NCT02925312|455990836|FG000|Overall Study|Adverse Event|2|||
126738483|NCT02925312|455990837|FG001|Overall Study|Adverse Event|0|||
126738484|NCT01455415|455990848|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
126738485|NCT01455415|455990849|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
126738486|NCT01455415|455990848|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
126738487|NCT01455415|455990849|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
126738488|NCT01455415|455990848|FG000|Period 1|Drug Error not Associated to AE|0|||
126738489|NCT01455415|455990849|FG001|Period 1|Drug Error not Associated to AE|1|||
126738490|NCT01455415|455990848|FG000|Period 1|AE Not Related to Study Drug|2|||
126738491|NCT01455415|455990849|FG001|Period 1|AE Not Related to Study Drug|6|||
126738492|NCT01455415|455990848|FG000|Period 1|Withdrawal by Subject|4|||
126738493|NCT01455415|455990849|FG001|Period 1|Withdrawal by Subject|5|||
126738494|NCT01455415|455990848|FG000|Period 1|Unspecified Reason|1|||
126738495|NCT01455415|455990849|FG001|Period 1|Unspecified Reason|1|||
126738496|NCT01455415|455990848|FG000|Period 1|Protocol Violation|0|||
126738497|NCT01455415|455990849|FG001|Period 1|Protocol Violation|2|||
126738498|NCT01455415|455990848|FG000|Washout|AE Related to Study Drug|2|||
126614472|NCT03340961|455547471|FG001|Overall Study|Lack of Efficacy|0|||
126738499|NCT01455415|455990849|FG001|Washout|AE Related to Study Drug|0|||
126738500|NCT01455415|455990848|FG000|Washout|Lost to Follow-up|1|||
126781435|NCT00321711|456154552|FG000|Part A|Adverse Event|3|||
126781436|NCT00321711|456154553|FG001|Part A|Adverse Event|3|||
126781437|NCT00321711|456154554|FG002|Part A|Adverse Event|2|||
126738501|NCT01455415|455990849|FG001|Washout|Lost to Follow-up|0|||
126738502|NCT01455415|455990848|FG000|Washout|Drug Error not Associated to AE|2|||
126738503|NCT01455415|455990849|FG001|Washout|Drug Error not Associated to AE|1|||
126738504|NCT01455415|455990848|FG000|Washout|AE Not Related to Study Drug|2|||
126738505|NCT01455415|455990849|FG001|Washout|AE Not Related to Study Drug|3|||
126738506|NCT01455415|455990848|FG000|Washout|Unspecified Reason|1|||
126738507|NCT01455415|455990849|FG001|Washout|Unspecified Reason|2|||
126738508|NCT01455415|455990848|FG000|Washout|Protocol Violation|0|||
126738509|NCT01455415|455990849|FG001|Washout|Protocol Violation|1|||
126781438|NCT00321711|456154555|FG003|Part A|Adverse Event|0|||
126738510|NCT01455415|455990848|FG000|Period 2|AE Related to Study Drug|1|||
126738511|NCT01455415|455990849|FG001|Period 2|AE Related to Study Drug|2|||
126738512|NCT01455415|455990848|FG000|Period 2|Lost to Follow-up|2|||
126738513|NCT01455415|455990849|FG001|Period 2|Lost to Follow-up|1|||
126738514|NCT01455415|455990848|FG000|Period 2|AE Not Related to Study Drug|2|||
126738515|NCT01455415|455990849|FG001|Period 2|AE Not Related to Study Drug|1|||
126738516|NCT01455415|455990848|FG000|Period 2|Lack of Efficacy|2|||
126738517|NCT01455415|455990849|FG001|Period 2|Lack of Efficacy|0|||
126738518|NCT01455415|455990848|FG000|Period 2|Withdrawal by Subject|2|||
126738519|NCT01455415|455990849|FG001|Period 2|Withdrawal by Subject|3|||
126738520|NCT01455415|455990848|FG000|Period 2|Unspecified Reason|2|||
126738521|NCT01455415|455990849|FG001|Period 2|Unspecified Reason|3|||
126738522|NCT01455415|455990848|FG000|Period 2|Protocol Violation|2|||
126738523|NCT01455415|455990849|FG001|Period 2|Protocol Violation|0|||
126738524|NCT01455415|455990848|FG000|Follow-up|AE Related to Study Drug|0|||
126738525|NCT01455415|455990849|FG001|Follow-up|AE Related to Study Drug|1|||
126738526|NCT01455415|455990848|FG000|Follow-up|Lack of Efficacy|0|||
126738527|NCT01455415|455990849|FG001|Follow-up|Lack of Efficacy|1|||
126738528|NCT01455415|455990848|FG000|Follow-up|Withdrawal by Subject|2|||
126738529|NCT01455415|455990849|FG001|Follow-up|Withdrawal by Subject|0|||
126738530|NCT01455415|455990848|FG000|Follow-up|Unspecified Reason|1|||
126738531|NCT01455415|455990849|FG001|Follow-up|Unspecified Reason|0|||
126738532|NCT00587301|455990850|FG000|Overall Study|Screen Failure|9|||
126738533|NCT00587301|455990850|FG000|Overall Study|Lost to Follow-up|22|||
126738534|NCT00587301|455990850|FG000|Overall Study|Withdrawal by Subject|7|||
126738535|NCT00587301|455990850|FG000|Overall Study|Protocol Violation|7|||
126738536|NCT02758613|455990851|FG000|Treatment|Physician and Sponsor Decision|1|||
126738537|NCT02758613|455990852|FG001|Treatment|Physician and Sponsor Decision|0|||
126738538|NCT02758613|455990853|FG002|Treatment|Physician and Sponsor Decision|0|||
126738539|NCT02758613|455990854|FG003|Treatment|Physician and Sponsor Decision|0|||
126738540|NCT02758613|455990851|FG000|Treatment|Withdrawal by Subject|1|||
126738541|NCT02758613|455990852|FG001|Treatment|Withdrawal by Subject|0|||
126738542|NCT02758613|455990853|FG002|Treatment|Withdrawal by Subject|1|||
126738543|NCT02758613|455990854|FG003|Treatment|Withdrawal by Subject|0|||
126738544|NCT01496274|455990856|FG000|Overall Study|Protocol Violation|0|||
126738545|NCT01496274|455990857|FG001|Overall Study|Protocol Violation|1|||
126738546|NCT01496274|455990856|FG000|Overall Study|Adverse Event|1|||
126738547|NCT01496274|455990857|FG001|Overall Study|Adverse Event|1|||
126738548|NCT01496274|455990856|FG000|Overall Study|Withdrawal by Subject|2|||
126738549|NCT01496274|455990857|FG001|Overall Study|Withdrawal by Subject|0|||
126738550|NCT01496274|455990856|FG000|Overall Study|Lost to Follow-up|0|||
126738551|NCT01496274|455990857|FG001|Overall Study|Lost to Follow-up|3|||
126738552|NCT00351819|455990858|FG000|Overall Study|Lost to Follow-up|4|||
126738553|NCT00351819|455990859|FG001|Overall Study|Lost to Follow-up|4|||
126738554|NCT00351819|455990858|FG000|Overall Study|Withdrawal by Subject|0|||
126738555|NCT00351819|455990859|FG001|Overall Study|Withdrawal by Subject|4|||
126738556|NCT00351819|455990858|FG000|Overall Study|Elevated PSA|1|||
126738557|NCT00351819|455990859|FG001|Overall Study|Elevated PSA|1|||
126738558|NCT00351819|455990858|FG000|Overall Study|Traumatic ankle fracture|1|||
126738559|NCT00351819|455990859|FG001|Overall Study|Traumatic ankle fracture|0|||
126738560|NCT00351819|455990858|FG000|Overall Study|Unprofessional behavior|1|||
126738561|NCT00351819|455990859|FG001|Overall Study|Unprofessional behavior|0|||
126738562|NCT00351819|455990858|FG000|Overall Study|Non-compliance|0|||
126738563|NCT00351819|455990859|FG001|Overall Study|Non-compliance|1|||
126738564|NCT00351819|455990858|FG000|Overall Study|Incarcerated|0|||
126738565|NCT00351819|455990859|FG001|Overall Study|Incarcerated|1|||
126738566|NCT00351819|455990858|FG000|Overall Study|Enrolled in another trial|0|||
126738567|NCT00351819|455990859|FG001|Overall Study|Enrolled in another trial|1|||
126738568|NCT01425749|455990860|FG000|Overall Study|progression of melanoma|0|||
126738569|NCT01425749|455990861|FG001|Overall Study|progression of melanoma|1|||
126738570|NCT01293084|455990862|FG000|Overall Study|Physician Decision|3|||
126738571|NCT01293084|455990862|FG000|Overall Study|Withdrawal by Subject|2|||
126738572|NCT02096042|455990863|FG000|Overall Study|Disease Progression|1|||
126738573|NCT02096042|455990864|FG001|Overall Study|Disease Progression|0|||
126738574|NCT02096042|455990865|FG002|Overall Study|Disease Progression|0|||
126738575|NCT02983799|455990866|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
126738576|NCT02983799|455990867|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
126738577|NCT02983799|455990868|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
126738578|NCT02983799|455990869|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
126738579|NCT02983799|455990870|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
126738580|NCT02983799|455990866|FG000|Overall Study|Death|20|||
126738581|NCT02983799|455990867|FG001|Overall Study|Death|5|||
126738582|NCT02983799|455990868|FG002|Overall Study|Death|23|||
126738583|NCT02983799|455990869|FG003|Overall Study|Death|47|||
126738584|NCT02983799|455990870|FG004|Overall Study|Death|7|||
126738585|NCT02983799|455990866|FG000|Overall Study|Withdrawal by Subject|1|||
126738586|NCT02983799|455990867|FG001|Overall Study|Withdrawal by Subject|0|||
126738587|NCT02983799|455990868|FG002|Overall Study|Withdrawal by Subject|3|||
126756585|NCT00883896|456059484|FG002|Overall Study|Other|0|||
126738588|NCT02983799|455990869|FG003|Overall Study|Withdrawal by Subject|4|||
126738589|NCT02983799|455990870|FG004|Overall Study|Withdrawal by Subject|1|||
126738590|NCT02983799|455990866|FG000|Overall Study|Protocol Violation|0|||
126738591|NCT02983799|455990867|FG001|Overall Study|Protocol Violation|1|||
126738592|NCT02983799|455990868|FG002|Overall Study|Protocol Violation|0|||
126738593|NCT02983799|455990869|FG003|Overall Study|Protocol Violation|0|||
126738594|NCT02983799|455990870|FG004|Overall Study|Protocol Violation|1|||
126738595|NCT02983799|455990866|FG000|Overall Study|Lost to Follow-up|1|||
126738596|NCT02983799|455990867|FG001|Overall Study|Lost to Follow-up|0|||
126738597|NCT02983799|455990868|FG002|Overall Study|Lost to Follow-up|1|||
126738598|NCT02983799|455990869|FG003|Overall Study|Lost to Follow-up|0|||
126738599|NCT02983799|455990870|FG004|Overall Study|Lost to Follow-up|0|||
126738600|NCT01313078|455990877|FG000|Overall Study|Death|1|||
126738601|NCT01313078|455990877|FG000|Overall Study|Discontinued study drug|1|||
126738602|NCT01313078|455990877|FG000|Overall Study|Withdrawal by Subject|1|||
126738603|NCT01225172|455990881|FG000|Overall Study|Subject decision to stop|1|||
126738604|NCT01225172|455990882|FG001|Overall Study|Subject decision to stop|0|||
126738605|NCT01225172|455990881|FG000|Overall Study|Subject request to discontinue treatment|3|||
126738606|NCT01225172|455990882|FG001|Overall Study|Subject request to discontinue treatment|1|||
126738607|NCT01225172|455990881|FG000|Overall Study|Subject no longer meets study criteria|1|||
126738608|NCT01225172|455990882|FG001|Overall Study|Subject no longer meets study criteria|0|||
126738609|NCT01225172|455990881|FG000|Overall Study|Withdrawal by Subject|1|||
126738610|NCT01225172|455990882|FG001|Overall Study|Withdrawal by Subject|0|||
126738611|NCT01375647|455992704|FG000|Overall Study|Lost to Follow-up|3|||
126738612|NCT01375647|455992705|FG001|Overall Study|Lost to Follow-up|3|||
126738613|NCT01375647|455992706|FG002|Overall Study|Lost to Follow-up|7|||
126738614|NCT01375647|455992707|FG003|Overall Study|Lost to Follow-up|10|||
126738615|NCT01375647|455992704|FG000|Overall Study|Death|1|||
126738616|NCT01375647|455992705|FG001|Overall Study|Death|2|||
126738617|NCT01375647|455992706|FG002|Overall Study|Death|1|||
126738618|NCT01375647|455992707|FG003|Overall Study|Death|0|||
126738619|NCT01375647|455992704|FG000|Overall Study|Withdrawal by Subject|17|||
126738620|NCT01375647|455992705|FG001|Overall Study|Withdrawal by Subject|20|||
126738621|NCT01375647|455992706|FG002|Overall Study|Withdrawal by Subject|26|||
126738622|NCT01375647|455992707|FG003|Overall Study|Withdrawal by Subject|14|||
126738623|NCT01375647|455992704|FG000|Overall Study|Physician Decision|1|||
126738624|NCT01375647|455992705|FG001|Overall Study|Physician Decision|0|||
126738625|NCT01375647|455992706|FG002|Overall Study|Physician Decision|0|||
126738626|NCT01375647|455992707|FG003|Overall Study|Physician Decision|0|||
126738627|NCT02147691|455992708|FG000|Overall Study|Withdrawal by Subject|2|||
126738628|NCT02147691|455992709|FG001|Overall Study|Withdrawal by Subject|0|||
126738629|NCT02147691|455992708|FG000|Overall Study|Adverse Event|2|||
126738630|NCT02147691|455992709|FG001|Overall Study|Adverse Event|0|||
126738631|NCT02147691|455992708|FG000|Overall Study|Lost to Follow-up|0|||
126738632|NCT02147691|455992709|FG001|Overall Study|Lost to Follow-up|1|||
126738633|NCT02954952|455992710|FG000|Overall Study|Withdrawal by Subject|1|||
126738634|NCT02954952|455992711|FG001|Overall Study|Withdrawal by Subject|0|||
126738635|NCT02954952|455992712|FG002|Overall Study|Withdrawal by Subject|0|||
126738636|NCT02954952|455992710|FG000|Overall Study|No data collected|0|||
126738637|NCT02954952|455992711|FG001|Overall Study|No data collected|1|||
126738638|NCT02954952|455992712|FG002|Overall Study|No data collected|0|||
126738639|NCT01392742|455992715|FG000|Overall Study|Premature study termination|42|||
126738640|NCT01392742|455992715|FG000|Overall Study|Failure to return|35|||
126738641|NCT01392742|455992715|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
126738642|NCT01392742|455992715|FG000|Overall Study|Lost to Follow-up|34|||
126738643|NCT01392742|455992715|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
126738644|NCT01392742|455992715|FG000|Overall Study|ITR and Protocol deviation|1|||
126738645|NCT01392742|455992715|FG000|Overall Study|Adverse event/intercurrent illness|17|||
126738646|NCT01392742|455992715|FG000|Overall Study|Protocol Violation|14|||
126738647|NCT01392742|455992715|FG000|Overall Study|Other|3|||
126738648|NCT01392742|455992715|FG000|Overall Study|Missing information|13|||
126738649|NCT04179032|455992716|FG000|Part B (Up to Week 52)|Adverse Event|1|||
126738650|NCT04179032|455992716|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
126738651|NCT04179032|455992716|FG000|Access Extension Phase|Ongoing|11|||
126738652|NCT02432703|455992717|FG000|Overall Study|Adverse Event|1|||
126738653|NCT02432703|455992718|FG001|Overall Study|Adverse Event|4|||
126738654|NCT02432703|455992717|FG000|Overall Study|Lack of Efficacy|1|||
126738655|NCT02432703|455992718|FG001|Overall Study|Lack of Efficacy|0|||
126738656|NCT02432703|455992717|FG000|Overall Study|Lost to Follow-up|5|||
126738657|NCT02432703|455992718|FG001|Overall Study|Lost to Follow-up|3|||
126738658|NCT02432703|455992717|FG000|Overall Study|Withdrawal by Subject|9|||
126738659|NCT02432703|455992718|FG001|Overall Study|Withdrawal by Subject|6|||
126738660|NCT02432703|455992717|FG000|Overall Study|Other|6|||
126738661|NCT02432703|455992718|FG001|Overall Study|Other|5|||
126738662|NCT03210220|455992719|FG000|Overall Study|Physician Decision|1|||
126738663|NCT03210220|455992720|FG001|Overall Study|Physician Decision|0|||
126738664|NCT00653328|455992721|FG000|Overall Study|Withdrawal by Subject|1|||
126738665|NCT00653328|455992721|FG000|Overall Study|Adverse Event|2|||
126738666|NCT00653328|455992721|FG000|Overall Study|Disease progression|10|||
126738667|NCT00653328|455992721|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
126738668|NCT02911519|455992722|FG000|Overall Study|Lost to Follow-up|2|||
126738669|NCT02911519|455992723|FG001|Overall Study|Lost to Follow-up|2|||
126738670|NCT02911519|455992722|FG000|Overall Study|Death|0|||
126738671|NCT02911519|455992723|FG001|Overall Study|Death|2|||
126738672|NCT00839436|455992726|FG000|Overall Study|Developed exclusionary condition|1|||
126738673|NCT00839436|455992727|FG001|Overall Study|Developed exclusionary condition|0|||
126738674|NCT00839436|455992728|FG002|Overall Study|Developed exclusionary condition|0|||
126738675|NCT00839436|455992726|FG000|Overall Study|Withdrawal by Subject|0|||
126738676|NCT00839436|455992727|FG001|Overall Study|Withdrawal by Subject|1|||
126738677|NCT00839436|455992728|FG002|Overall Study|Withdrawal by Subject|0|||
126738678|NCT00839436|455992726|FG000|Overall Study|Study drug no longer available|0|||
126738679|NCT00839436|455992727|FG001|Overall Study|Study drug no longer available|0|||
126738680|NCT00839436|455992728|FG002|Overall Study|Study drug no longer available|1|||
126738681|NCT01444898|455992730|FG000|Overall Study|Withdrawal by Subject|1|||
126738682|NCT02580591|455992732|FG000|Overall Study|Adverse Event|0|||
126738683|NCT02580591|455992733|FG001|Overall Study|Adverse Event|1|||
126738684|NCT02580591|455992734|FG002|Overall Study|Adverse Event|2|||
126738685|NCT02580591|455992735|FG003|Overall Study|Adverse Event|5|||
126738686|NCT02580591|455992732|FG000|Overall Study|Protocol Violation|3|||
126738687|NCT02580591|455992733|FG001|Overall Study|Protocol Violation|2|||
126738688|NCT02580591|455992734|FG002|Overall Study|Protocol Violation|1|||
126738689|NCT02580591|455992735|FG003|Overall Study|Protocol Violation|1|||
126738690|NCT02580591|455992732|FG000|Overall Study|Lost to Follow-up|5|||
126738691|NCT02580591|455992733|FG001|Overall Study|Lost to Follow-up|3|||
126738692|NCT02580591|455992734|FG002|Overall Study|Lost to Follow-up|3|||
126738693|NCT02580591|455992735|FG003|Overall Study|Lost to Follow-up|1|||
126738694|NCT02580591|455992732|FG000|Overall Study|Withdrawal by Subject|6|||
126738695|NCT02580591|455992733|FG001|Overall Study|Withdrawal by Subject|1|||
126738696|NCT02580591|455992734|FG002|Overall Study|Withdrawal by Subject|2|||
126738697|NCT02580591|455992735|FG003|Overall Study|Withdrawal by Subject|3|||
126738698|NCT02580591|455992732|FG000|Overall Study|Not treated|1|||
126738699|NCT02580591|455992733|FG001|Overall Study|Not treated|1|||
126738700|NCT02580591|455992734|FG002|Overall Study|Not treated|0|||
126738701|NCT02580591|455992735|FG003|Overall Study|Not treated|0|||
126738702|NCT02580591|455992732|FG000|Overall Study|Other than specified|3|||
126738703|NCT02580591|455992733|FG001|Overall Study|Other than specified|2|||
126738704|NCT02580591|455992734|FG002|Overall Study|Other than specified|5|||
126738705|NCT02580591|455992735|FG003|Overall Study|Other than specified|2|||
126738706|NCT00561340|455992739|FG000|Overall Study|refused to drink pediasure|6|||
126738707|NCT00561340|455992740|FG001|Overall Study|refused to drink pediasure|0|||
126738708|NCT00445341|455992741|FG000|Overall Study|refused further treatment|1|||
126738709|NCT00445341|455992741|FG000|Overall Study|taken off treatment too early|1|||
126738710|NCT03051217|455992742|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
126738711|NCT03051217|455992743|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126738712|NCT03051217|455992744|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
126738713|NCT03051217|455992745|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126738714|NCT03051217|455992746|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126738715|NCT03051217|455992747|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126738716|NCT03051217|455992748|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
126738717|NCT03051217|455992742|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
126738718|NCT03051217|455992743|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
126738719|NCT03051217|455992744|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
126738720|NCT03051217|455992745|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
126738721|NCT03051217|455992746|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
126738722|NCT03051217|455992747|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
126738723|NCT03051217|455992748|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
126738724|NCT03051217|455992742|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
126738725|NCT03051217|455992743|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
126781439|NCT00321711|456154556|FG004|Part A|Adverse Event|0|||
126738726|NCT03051217|455992744|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
126738727|NCT03051217|455992745|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126738728|NCT03051217|455992746|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126738729|NCT03051217|455992747|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126738730|NCT03051217|455992748|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
126738731|NCT03051217|455992742|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
126738732|NCT03051217|455992743|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
126738733|NCT03051217|455992744|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
126738734|NCT03051217|455992745|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
126738735|NCT03051217|455992746|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
126738736|NCT03051217|455992747|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
126738737|NCT03051217|455992748|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
126614473|NCT03340961|455547472|FG002|Overall Study|Lack of Efficacy|0|||
126614474|NCT03340961|455547473|FG003|Overall Study|Lack of Efficacy|1|||
126614475|NCT01853384|455547474|FG000|Randomized|Adverse Event|5|||
126614476|NCT01853384|455547475|FG001|Randomized|Adverse Event|3|||
126614477|NCT01853384|455547474|FG000|Randomized|Death|1|||
126614478|NCT01853384|455547475|FG001|Randomized|Death|2|||
126614479|NCT01853384|455547474|FG000|Randomized|Lost to Follow-up|1|||
126614480|NCT01853384|455547475|FG001|Randomized|Lost to Follow-up|1|||
126614481|NCT01853384|455547474|FG000|Randomized|Withdrawal by Subject|5|||
126614482|NCT01853384|455547475|FG001|Randomized|Withdrawal by Subject|3|||
126614483|NCT01853384|455547474|FG000|Randomized|Sponsor Decision|47|||
126614484|NCT01853384|455547475|FG001|Randomized|Sponsor Decision|34|||
126614485|NCT01853384|455547474|FG000|Randomized|Other|3|||
126614486|NCT01853384|455547475|FG001|Randomized|Other|3|||
126614487|NCT01853384|455547474|FG000|Completed Follow up Visit 1|Early Termination|13|||
126614488|NCT01853384|455547475|FG001|Completed Follow up Visit 1|Early Termination|9|||
126614489|NCT01853384|455547474|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
126614490|NCT01853384|455547475|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
126614491|NCT01853384|455547474|FG000|Completed Follow up Visit 2|Adverse Event|1|||
126614492|NCT01853384|455547475|FG001|Completed Follow up Visit 2|Adverse Event|0|||
126614493|NCT01853384|455547474|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
126614494|NCT01853384|455547475|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
126614495|NCT01853384|455547474|FG000|Completed Follow up Visit 2|Death|1|||
126614496|NCT01853384|455547475|FG001|Completed Follow up Visit 2|Death|0|||
126614497|NCT01853384|455547474|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
126614498|NCT01853384|455547475|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
126614499|NCT01205126|455547476|FG000|Titration Phase|Adverse Event|5|||
126614500|NCT01205126|455547477|FG001|Titration Phase|Adverse Event|3|||
126614501|NCT01205126|455547476|FG000|Titration Phase|Withdrawal by Subject|5|||
126614502|NCT01205126|455547477|FG001|Titration Phase|Withdrawal by Subject|5|||
126614503|NCT01205126|455547476|FG000|Titration Phase|Lost to Follow-up|2|||
126614504|NCT01205126|455547477|FG001|Titration Phase|Lost to Follow-up|2|||
126614505|NCT01205126|455547476|FG000|Titration Phase|No stable titration dose|1|||
126614506|NCT01205126|455547477|FG001|Titration Phase|No stable titration dose|0|||
126614507|NCT01205126|455547476|FG000|Titration Phase|More than maximum dosage required|2|||
126614508|NCT01205126|455547477|FG001|Titration Phase|More than maximum dosage required|3|||
126614509|NCT01205126|455547476|FG000|Titration Phase|Other|8|||
126614510|NCT01205126|455547477|FG001|Titration Phase|Other|6|||
126614511|NCT01205126|455547476|FG000|Between Titration & Maintenance Phase|Other|0|||
126614512|NCT01205126|455547477|FG001|Between Titration & Maintenance Phase|Other|4|||
126614513|NCT01205126|455547476|FG000|Maintenance Phase|Adverse Event|3|||
126614514|NCT01205126|455547477|FG001|Maintenance Phase|Adverse Event|7|||
126614515|NCT01205126|455547476|FG000|Maintenance Phase|Death|4|||
126614516|NCT01205126|455547477|FG001|Maintenance Phase|Death|4|||
126614517|NCT01205126|455547476|FG000|Maintenance Phase|More than the maximum dosage required|5|||
126614518|NCT01205126|455547477|FG001|Maintenance Phase|More than the maximum dosage required|5|||
126614519|NCT01205126|455547476|FG000|Maintenance Phase|Prohibited drugs used|1|||
126614520|NCT01205126|455547477|FG001|Maintenance Phase|Prohibited drugs used|0|||
126614521|NCT01205126|455547476|FG000|Maintenance Phase|Other|11|||
126614522|NCT01205126|455547477|FG001|Maintenance Phase|Other|8|||
126614523|NCT01205126|455547476|FG000|Maintenance Phase|Lost to Follow-up|5|||
126614524|NCT01205126|455547477|FG001|Maintenance Phase|Lost to Follow-up|5|||
126614525|NCT01205126|455547476|FG000|Maintenance Phase|Withdrawal by Subject|8|||
126614526|NCT01205126|455547477|FG001|Maintenance Phase|Withdrawal by Subject|11|||
126614527|NCT00638456|455547480|FG000|Overall Study|Withdrawal by Subject|6|||
126614528|NCT00638456|455547481|FG001|Overall Study|Withdrawal by Subject|2|||
126614529|NCT03236779|455547482|FG000|Overall Study|Lost to Follow-up|13|||
126614530|NCT03236779|455547483|FG001|Overall Study|Lost to Follow-up|21|||
126614531|NCT00805792|455547484|FG000|Overall Study|Death|3|||
126614532|NCT00805792|455547484|FG000|Overall Study|Lost to Follow-up|2|||
126614533|NCT01836523|455547485|FG000|Overall Study|Adverse Event|15|||
126614534|NCT01836523|455547486|FG001|Overall Study|Adverse Event|41|||
126614535|NCT01836523|455547487|FG002|Overall Study|Adverse Event|49|||
126614536|NCT01836523|455547488|FG003|Overall Study|Adverse Event|14|||
126614537|NCT01836523|455547485|FG000|Overall Study|Protocol Violation|6|||
126614538|NCT01836523|455547486|FG001|Overall Study|Protocol Violation|3|||
126614539|NCT01836523|455547487|FG002|Overall Study|Protocol Violation|2|||
126614540|NCT01836523|455547488|FG003|Overall Study|Protocol Violation|4|||
126614541|NCT01836523|455547485|FG000|Overall Study|Met Withdrawal Criteria|13|||
126614542|NCT01836523|455547486|FG001|Overall Study|Met Withdrawal Criteria|13|||
126614543|NCT01836523|455547487|FG002|Overall Study|Met Withdrawal Criteria|21|||
126614544|NCT01836523|455547488|FG003|Overall Study|Met Withdrawal Criteria|27|||
126614545|NCT01836523|455547485|FG000|Overall Study|Unclassified|17|||
126614546|NCT01836523|455547486|FG001|Overall Study|Unclassified|28|||
126614547|NCT01836523|455547487|FG002|Overall Study|Unclassified|19|||
126614548|NCT01836523|455547488|FG003|Overall Study|Unclassified|29|||
126614549|NCT00813709|455547490|FG000|Double Blind Period|Adverse Event|4|||
126614550|NCT00813709|455547491|FG001|Double Blind Period|Adverse Event|1|||
126614551|NCT00813709|455547492|FG002|Double Blind Period|Adverse Event|4|||
126738738|NCT03051217|455992742|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
126738739|NCT03051217|455992743|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
126738740|NCT03051217|455992744|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
126738741|NCT03051217|455992745|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
126738742|NCT03051217|455992746|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
126738743|NCT03051217|455992747|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
126738744|NCT03051217|455992748|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
126738745|NCT03051217|455992742|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
126738746|NCT03051217|455992743|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
126738747|NCT03051217|455992744|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
126738748|NCT03051217|455992745|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
126738749|NCT03051217|455992746|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
126738750|NCT03051217|455992747|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
126738751|NCT03051217|455992748|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
126738752|NCT03051217|455992742|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
126738753|NCT03051217|455992743|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
126738754|NCT03051217|455992744|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
126738755|NCT03051217|455992745|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
126738756|NCT03051217|455992746|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
126738757|NCT03051217|455992747|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
126738758|NCT03051217|455992748|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
126738759|NCT03051217|455992742|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
126738760|NCT03051217|455992743|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
126738761|NCT03051217|455992744|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
126738762|NCT03051217|455992745|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
126738763|NCT03051217|455992746|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
126738764|NCT03051217|455992747|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
126738765|NCT03051217|455992748|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
126738766|NCT00109772|455992749|FG000|Double-blind Treatment|Adverse Event|14|||
126738767|NCT00109772|455992750|FG001|Double-blind Treatment|Adverse Event|5|||
126738768|NCT00109772|455992749|FG000|Double-blind Treatment|Lack of Efficacy|1|||
126738769|NCT00109772|455992750|FG001|Double-blind Treatment|Lack of Efficacy|0|||
126738770|NCT00109772|455992749|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
126738771|NCT00109772|455992750|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
126738772|NCT00109772|455992749|FG000|Double-blind Treatment|Lost to Follow-up|2|||
126738773|NCT00109772|455992750|FG001|Double-blind Treatment|Lost to Follow-up|3|||
126738774|NCT00109772|455992749|FG000|Double-blind Treatment|Protocol Violation|0|||
126738775|NCT00109772|455992750|FG001|Double-blind Treatment|Protocol Violation|1|||
126738776|NCT00109772|455992749|FG000|Double-blind Treatment|Other|0|||
126738777|NCT00109772|455992750|FG001|Double-blind Treatment|Other|4|||
126738778|NCT00109772|455992749|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
126738779|NCT00109772|455992750|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
126738780|NCT00109772|455992749|FG000|Open-label Extension|Adverse Event|10|||
126738781|NCT00109772|455992750|FG001|Open-label Extension|Adverse Event|19|||
126738782|NCT00109772|455992749|FG000|Open-label Extension|Lack of Efficacy|19|||
126738783|NCT00109772|455992750|FG001|Open-label Extension|Lack of Efficacy|11|||
126738784|NCT00109772|455992749|FG000|Open-label Extension|Withdrawal by Subject|9|||
126738785|NCT00109772|455992750|FG001|Open-label Extension|Withdrawal by Subject|6|||
126738786|NCT00109772|455992749|FG000|Open-label Extension|Lost to Follow-up|1|||
126738787|NCT00109772|455992750|FG001|Open-label Extension|Lost to Follow-up|0|||
126738788|NCT00109772|455992749|FG000|Open-label Extension|Death|0|||
126738789|NCT00109772|455992750|FG001|Open-label Extension|Death|1|||
126738790|NCT00109772|455992749|FG000|Open-label Extension|Protocol Violation|2|||
126738791|NCT00109772|455992750|FG001|Open-label Extension|Protocol Violation|2|||
126738792|NCT00109772|455992749|FG000|Open-label Extension|Other|4|||
126738793|NCT00109772|455992750|FG001|Open-label Extension|Other|10|||
126738794|NCT01359046|455992753|FG000|Overall Study|Did not receive allocated intervention|6|||
126738795|NCT01359046|455992754|FG001|Overall Study|Did not receive allocated intervention|6|||
126738796|NCT01359046|455992753|FG000|Overall Study|Physician Decision|1|||
126738797|NCT01359046|455992754|FG001|Overall Study|Physician Decision|11|||
126738798|NCT04539262|455992755|FG000|Overall Study|Adverse Event|0|||
126738799|NCT04539262|455992756|FG001|Overall Study|Adverse Event|0|||
126738800|NCT04539262|455992757|FG002|Overall Study|Adverse Event|1|||
126738801|NCT04539262|455992758|FG003|Overall Study|Adverse Event|0|||
126738802|NCT04539262|455992759|FG004|Overall Study|Adverse Event|0|||
126738803|NCT04539262|455992760|FG005|Overall Study|Adverse Event|0|||
126738804|NCT04539262|455992761|FG006|Overall Study|Adverse Event|0|||
126738805|NCT04539262|455992762|FG007|Overall Study|Adverse Event|0|||
126738806|NCT04539262|455992755|FG000|Overall Study|Withdrew Consent|0|||
126738807|NCT04539262|455992756|FG001|Overall Study|Withdrew Consent|0|||
126738808|NCT04539262|455992757|FG002|Overall Study|Withdrew Consent|0|||
126738809|NCT04539262|455992758|FG003|Overall Study|Withdrew Consent|1|||
126738810|NCT04539262|455992759|FG004|Overall Study|Withdrew Consent|0|||
126738811|NCT04539262|455992760|FG005|Overall Study|Withdrew Consent|0|||
126738812|NCT04539262|455992761|FG006|Overall Study|Withdrew Consent|0|||
126738813|NCT04539262|455992762|FG007|Overall Study|Withdrew Consent|0|||
126738814|NCT04539262|455992755|FG000|Overall Study|Randomized, Not treated|0|||
126738815|NCT04539262|455992756|FG001|Overall Study|Randomized, Not treated|1|||
126738816|NCT04539262|455992757|FG002|Overall Study|Randomized, Not treated|0|||
126738817|NCT04539262|455992758|FG003|Overall Study|Randomized, Not treated|0|||
126738818|NCT04539262|455992759|FG004|Overall Study|Randomized, Not treated|0|||
126738819|NCT04539262|455992760|FG005|Overall Study|Randomized, Not treated|0|||
126738820|NCT04539262|455992761|FG006|Overall Study|Randomized, Not treated|1|||
126738821|NCT04539262|455992762|FG007|Overall Study|Randomized, Not treated|0|||
126738822|NCT01061567|455992767|FG000|Overall Study|Adverse Event|32|||
126738823|NCT01061567|455992767|FG000|Overall Study|Death|2|||
126738824|NCT01061567|455992767|FG000|Overall Study|Lack of Efficacy|3|||
126738825|NCT01061567|455992767|FG000|Overall Study|Lost to Follow-up|24|||
126738826|NCT01061567|455992767|FG000|Overall Study|Protocol Violation|1|||
126738827|NCT01061567|455992767|FG000|Overall Study|Withdrawal by Subject|11|||
126738828|NCT01061567|455992767|FG000|Overall Study|Other reason than stated above|3|||
126738829|NCT01156532|455992768|FG000|Overall Study|Family Reasons|1|||
126738830|NCT01156532|455992768|FG000|Overall Study|Lost to Follow-up|1|||
126738831|NCT02443805|455992771|FG000|Overall Study|Adverse Event|100|||
126738832|NCT02443805|455992772|FG001|Overall Study|Adverse Event|18|||
126738833|NCT02443805|455992771|FG000|Overall Study|Withdrawal by Subject|73|||
126738834|NCT02443805|455992772|FG001|Overall Study|Withdrawal by Subject|74|||
126738835|NCT02443805|455992771|FG000|Overall Study|Lost to Follow-up|19|||
126738836|NCT02443805|455992772|FG001|Overall Study|Lost to Follow-up|14|||
126738837|NCT02443805|455992771|FG000|Overall Study|Pregnancy|6|||
126738838|NCT02443805|455992772|FG001|Overall Study|Pregnancy|5|||
126738839|NCT02443805|455992771|FG000|Overall Study|Protocol Violation|2|||
126738840|NCT02443805|455992772|FG001|Overall Study|Protocol Violation|4|||
126738841|NCT02443805|455992771|FG000|Overall Study|Lack of Efficacy|1|||
126738842|NCT02443805|455992772|FG001|Overall Study|Lack of Efficacy|1|||
126738843|NCT02443805|455992771|FG000|Overall Study|Non-compliance with study drug|6|||
126738844|NCT02443805|455992772|FG001|Overall Study|Non-compliance with study drug|4|||
126738845|NCT02443805|455992771|FG000|Overall Study|Withdrawal by parent/guardian|3|||
126738846|NCT02443805|455992772|FG001|Overall Study|Withdrawal by parent/guardian|5|||
126738847|NCT02443805|455992771|FG000|Overall Study|Any other reason not above-mentioned|3|||
126738848|NCT02443805|455992772|FG001|Overall Study|Any other reason not above-mentioned|2|||
126738849|NCT04362813|455992773|FG000|Overall Study|Death|12|||
126738850|NCT04362813|455992774|FG001|Overall Study|Death|16|||
126738851|NCT04362813|455992773|FG000|Overall Study|Withdrawal by Subject|3|||
126738852|NCT04362813|455992774|FG001|Overall Study|Withdrawal by Subject|1|||
126738853|NCT04362813|455992773|FG000|Overall Study|Protocol Violation|0|||
126738854|NCT04362813|455992774|FG001|Overall Study|Protocol Violation|3|||
126738855|NCT04362813|455992773|FG000|Overall Study|Lost to Follow-up|1|||
126738856|NCT04362813|455992774|FG001|Overall Study|Lost to Follow-up|1|||
126738857|NCT04362813|455992773|FG000|Overall Study|Enrolled but did not receive treatment|2|||
126738858|NCT04362813|455992774|FG001|Overall Study|Enrolled but did not receive treatment|4|||
126738859|NCT00961116|455992775|FG000|Washout Period of 7 Days|Adverse Event|1|||
126738860|NCT00961116|455992776|FG001|Washout Period of 7 Days|Adverse Event|1|||
126738861|NCT00961116|455992775|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
126738862|NCT00961116|455992776|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
126738863|NCT00961116|455992775|FG000|Washout Period of 7 Days|Protocol Violation|0|||
126738864|NCT00961116|455992776|FG001|Washout Period of 7 Days|Protocol Violation|1|||
126738865|NCT00719537|455992783|FG000|Overall Study|Withdrawal by Subject|1|||
126738866|NCT00719537|455992784|FG001|Overall Study|Withdrawal by Subject|0|||
126738867|NCT00719537|455992783|FG000|Overall Study|Lost to Follow-up|0|||
126738868|NCT00719537|455992784|FG001|Overall Study|Lost to Follow-up|1|||
126738869|NCT01142193|455992785|FG000|Overall Study|Adverse Event|12|||
126738870|NCT01142193|455992786|FG001|Overall Study|Adverse Event|4|||
126738871|NCT01142193|455992785|FG000|Overall Study|Lack of Efficacy|2|||
126738872|NCT01142193|455992786|FG001|Overall Study|Lack of Efficacy|1|||
126738873|NCT01142193|455992785|FG000|Overall Study|Physician Decision|1|||
126738874|NCT01142193|455992786|FG001|Overall Study|Physician Decision|1|||
126738875|NCT01142193|455992785|FG000|Overall Study|Withdrawal by Subject|4|||
126738876|NCT01142193|455992786|FG001|Overall Study|Withdrawal by Subject|3|||
126738877|NCT01142193|455992785|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
126738878|NCT01142193|455992786|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
126738879|NCT01142193|455992785|FG000|Overall Study|Other|1|||
126738880|NCT01142193|455992786|FG001|Overall Study|Other|2|||
126614552|NCT00813709|455547493|FG003|Double Blind Period|Adverse Event|0|||
126738881|NCT01459068|455992787|FG000|Overall Study|Withdrawal by Subject|8|||
126738882|NCT01459068|455992788|FG001|Overall Study|Withdrawal by Subject|18|||
126614553|NCT00813709|455547494|FG004|Double Blind Period|Adverse Event|0|||
126614554|NCT00813709|455547495|FG005|Double Blind Period|Adverse Event|0|||
126614555|NCT00813709|455547490|FG000|Double Blind Period|Lost to Follow-up|3|||
126614556|NCT00813709|455547491|FG001|Double Blind Period|Lost to Follow-up|2|||
126614557|NCT00813709|455547492|FG002|Double Blind Period|Lost to Follow-up|2|||
126738883|NCT01459068|455992787|FG000|Overall Study|Lost to Follow-up|31|||
126738884|NCT01459068|455992788|FG001|Overall Study|Lost to Follow-up|15|||
126738885|NCT01459068|455992787|FG000|Overall Study|Death|0|||
126738886|NCT01459068|455992788|FG001|Overall Study|Death|1|||
126738887|NCT00196196|455992791|FG000|Overall Study|Withdrawal by Subject|2|||
126738888|NCT00196196|455992791|FG000|Overall Study|Did not have required condition (hydroce|5|||
126738889|NCT02910219|455992792|FG000|Overall Study|Withdrawal by Subject|1|||
126738890|NCT02910219|455992793|FG001|Overall Study|Withdrawal by Subject|1|||
126738891|NCT01015820|455992794|FG000|Overall Study|Suboptimal measurements|1|||
126738892|NCT01015820|455992795|FG001|Overall Study|Suboptimal measurements|0|||
126738893|NCT00701441|455992796|FG000|Overall Study|failure in cpap compliance|0|||
126738894|NCT00701441|455992797|FG001|Overall Study|failure in cpap compliance|4|||
126738895|NCT02679781|455992801|FG000|Overall Study|Lost to Follow-up|1|||
126738896|NCT02679781|455992802|FG001|Overall Study|Lost to Follow-up|2|||
126738897|NCT02679781|455992801|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
126738898|NCT02679781|455992802|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
126738899|NCT04209400|455992803|FG000|Overall Study|Withdrawal by Subject|0|||
126738900|NCT04209400|455992804|FG001|Overall Study|Withdrawal by Subject|1|||
126738901|NCT00795509|455992810|FG000|Overall Study|Protocol Violation|31|||
126738902|NCT00970268|455992811|FG000|Overall Study|Withdrawal by Subject|12|||
126738903|NCT00970268|455992812|FG001|Overall Study|Withdrawal by Subject|19|||
126738904|NCT00970268|455992811|FG000|Overall Study|Adverse Event|15|||
126738905|NCT00970268|455992812|FG001|Overall Study|Adverse Event|12|||
126738906|NCT00970268|455992811|FG000|Overall Study|Lack of Efficacy|3|||
126738907|NCT00970268|455992812|FG001|Overall Study|Lack of Efficacy|6|||
126738908|NCT00970268|455992811|FG000|Overall Study|Protocol Violation|4|||
126738909|NCT00970268|455992812|FG001|Overall Study|Protocol Violation|7|||
126738910|NCT00970268|455992811|FG000|Overall Study|Other Reason|3|||
126738911|NCT00970268|455992812|FG001|Overall Study|Other Reason|1|||
126738912|NCT00970268|455992811|FG000|Overall Study|COPD Exacerbation|4|||
126738913|NCT00970268|455992812|FG001|Overall Study|COPD Exacerbation|2|||
126738914|NCT00970268|455992811|FG000|Overall Study|Lost to Follow-up|1|||
126738915|NCT00970268|455992812|FG001|Overall Study|Lost to Follow-up|2|||
126738916|NCT00970268|455992811|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
126738917|NCT00970268|455992812|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
126738918|NCT01601470|455992813|FG000|Period 2 - LCZ696|Physician Decision|1|||
126738919|NCT01203787|455992814|FG000|Overall Study|Death|12|||
126738920|NCT01203787|455992815|FG001|Overall Study|Death|10|||
126738921|NCT01203787|455992814|FG000|Overall Study|Withdrawal by Subject|6|||
126738922|NCT01203787|455992815|FG001|Overall Study|Withdrawal by Subject|2|||
126738923|NCT01203787|455992814|FG000|Overall Study|Lost to Follow-up|2|||
126738924|NCT01203787|455992815|FG001|Overall Study|Lost to Follow-up|0|||
126738925|NCT01203787|455992814|FG000|Overall Study|Adverse Event|11|||
126738926|NCT01203787|455992815|FG001|Overall Study|Adverse Event|15|||
126738927|NCT03404518|455992816|FG000|Overall Study|Lost to Follow-up|28|||
126738928|NCT03404518|455992817|FG001|Overall Study|Lost to Follow-up|30|||
126738929|NCT03404518|455992816|FG000|Overall Study|Protocol Violation|13|||
126738930|NCT03404518|455992817|FG001|Overall Study|Protocol Violation|6|||
126738931|NCT01079195|455992818|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
126738932|NCT01079195|455992818|FG000|Overall Study|No Documentation Available|437|||
126738933|NCT01079195|455992818|FG000|Overall Study|Adverse Event|157|||
126738934|NCT01079195|455992818|FG000|Overall Study|Reason Unknown|39|||
126738935|NCT01079195|455992818|FG000|Overall Study|Withdrawal by Subject|18|||
126738936|NCT01079195|455992818|FG000|Overall Study|Financial Reasons|15|||
126738937|NCT01079195|455992818|FG000|Overall Study|Lack of Effectiveness|12|||
126738938|NCT01079195|455992818|FG000|Overall Study|Physician Decision|4|||
126738939|NCT01079195|455992818|FG000|Overall Study|Improved Status of Participant|4|||
126738940|NCT01079195|455992818|FG000|Overall Study|No Follow-up Documentation Available|4|||
126738941|NCT01079195|455992818|FG000|Overall Study|Non-compliance|2|||
126738942|NCT03693404|455992823|FG000|Overall Study|Withdrawal by Subject|1|||
126738943|NCT03693404|455992824|FG001|Overall Study|Withdrawal by Subject|0|||
126738944|NCT03693404|455992823|FG000|Overall Study|Lost to Follow-up|0|||
126738945|NCT03693404|455992824|FG001|Overall Study|Lost to Follow-up|5|||
126738946|NCT03693404|455992823|FG000|Overall Study|Excluded from Analysis|0|||
126738947|NCT03693404|455992824|FG001|Overall Study|Excluded from Analysis|1|||
126738948|NCT02079519|455992825|FG000|Overall Study|Disease Progression|9|||
126614558|NCT00813709|455547493|FG003|Double Blind Period|Lost to Follow-up|0|||
126738949|NCT02079519|455992825|FG000|Overall Study|Adverse Event|1|||
126738950|NCT01041404|455992829|FG000|Overall Study|Adverse Event|45|||
126738951|NCT01041404|455992830|FG001|Overall Study|Adverse Event|35|||
126738952|NCT01041404|455992829|FG000|Overall Study|Lack of Efficacy|200|||
126738953|NCT01041404|455992830|FG001|Overall Study|Lack of Efficacy|210|||
126781440|NCT00321711|456154552|FG000|Part A|Withdrawal by Subject|1|||
126781441|NCT00321711|456154553|FG001|Part A|Withdrawal by Subject|1|||
126781442|NCT00321711|456154554|FG002|Part A|Withdrawal by Subject|1|||
126781443|NCT00321711|456154555|FG003|Part A|Withdrawal by Subject|0|||
126781444|NCT00321711|456154556|FG004|Part A|Withdrawal by Subject|0|||
126781445|NCT00321711|456154552|FG000|Part A|Disease progression|0|||
126781446|NCT00321711|456154553|FG001|Part A|Disease progression|1|||
126781447|NCT00321711|456154554|FG002|Part A|Disease progression|0|||
126781448|NCT00321711|456154555|FG003|Part A|Disease progression|0|||
126781449|NCT00321711|456154556|FG004|Part A|Disease progression|0|||
126781450|NCT00321711|456154552|FG000|Part A|Requirement for alternative therapy|0|||
126781451|NCT00321711|456154553|FG001|Part A|Requirement for alternative therapy|2|||
126781452|NCT00321711|456154554|FG002|Part A|Requirement for alternative therapy|1|||
126781453|NCT00321711|456154555|FG003|Part A|Requirement for alternative therapy|0|||
126781454|NCT00321711|456154556|FG004|Part A|Requirement for alternative therapy|0|||
126781455|NCT00321711|456154552|FG000|Part A|Physician Decision|0|||
126738954|NCT01041404|455992829|FG000|Overall Study|Violation of Selection Criteria|0|||
126738955|NCT01041404|455992830|FG001|Overall Study|Violation of Selection Criteria|1|||
126738956|NCT01041404|455992829|FG000|Overall Study|Protocol Violation|4|||
126738957|NCT01041404|455992830|FG001|Overall Study|Protocol Violation|0|||
126738958|NCT01041404|455992829|FG000|Overall Study|Withdrawal by Subject|29|||
126738959|NCT01041404|455992830|FG001|Overall Study|Withdrawal by Subject|23|||
126738960|NCT01041404|455992829|FG000|Overall Study|Failure to Return|1|||
126738961|NCT01041404|455992830|FG001|Overall Study|Failure to Return|2|||
126738962|NCT01041404|455992829|FG000|Overall Study|Other|11|||
126738963|NCT01041404|455992830|FG001|Overall Study|Other|23|||
126738964|NCT01685203|455992832|FG000|Overall Study|Lost to Follow-up|3|||
126738965|NCT01685203|455992833|FG001|Overall Study|Lost to Follow-up|3|||
126738966|NCT01685203|455992834|FG002|Overall Study|Lost to Follow-up|0|||
126738967|NCT01685203|455992835|FG003|Overall Study|Lost to Follow-up|1|||
126738968|NCT01685203|455992836|FG004|Overall Study|Lost to Follow-up|0|||
126738969|NCT01685203|455992837|FG005|Overall Study|Lost to Follow-up|0|||
126738970|NCT01685203|455992838|FG006|Overall Study|Lost to Follow-up|0|||
126738971|NCT01685203|455992832|FG000|Overall Study|Adverse Event|0|||
126738972|NCT01685203|455992833|FG001|Overall Study|Adverse Event|0|||
126738973|NCT01685203|455992834|FG002|Overall Study|Adverse Event|0|||
126738974|NCT01685203|455992835|FG003|Overall Study|Adverse Event|0|||
126738975|NCT01685203|455992836|FG004|Overall Study|Adverse Event|0|||
126738976|NCT01685203|455992837|FG005|Overall Study|Adverse Event|2|||
126738977|NCT01685203|455992838|FG006|Overall Study|Adverse Event|0|||
126738978|NCT01685203|455992832|FG000|Overall Study|Adverse event and withdrew consent|1|||
126738979|NCT01685203|455992833|FG001|Overall Study|Adverse event and withdrew consent|0|||
126738980|NCT01685203|455992834|FG002|Overall Study|Adverse event and withdrew consent|0|||
126738981|NCT01685203|455992835|FG003|Overall Study|Adverse event and withdrew consent|0|||
126738982|NCT01685203|455992836|FG004|Overall Study|Adverse event and withdrew consent|0|||
126738983|NCT01685203|455992837|FG005|Overall Study|Adverse event and withdrew consent|0|||
126738984|NCT01685203|455992838|FG006|Overall Study|Adverse event and withdrew consent|0|||
126738985|NCT01685203|455992832|FG000|Overall Study|Patient's decision|0|||
126738986|NCT01685203|455992833|FG001|Overall Study|Patient's decision|0|||
126738987|NCT01685203|455992834|FG002|Overall Study|Patient's decision|0|||
126738988|NCT01685203|455992835|FG003|Overall Study|Patient's decision|0|||
126738989|NCT01685203|455992836|FG004|Overall Study|Patient's decision|0|||
126738990|NCT01685203|455992837|FG005|Overall Study|Patient's decision|1|||
126738991|NCT01685203|455992838|FG006|Overall Study|Patient's decision|0|||
126738992|NCT00383708|455992839|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
126738993|NCT00383708|455992839|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
126738994|NCT00383708|455992839|FG000|Run-in Period|Protocol Violation|4|||
126781456|NCT00321711|456154553|FG001|Part A|Physician Decision|1|||
126781457|NCT00321711|456154554|FG002|Part A|Physician Decision|3|||
126781458|NCT00321711|456154555|FG003|Part A|Physician Decision|0|||
126781459|NCT00321711|456154556|FG004|Part A|Physician Decision|0|||
126781460|NCT00321711|456154552|FG000|Part A|Other|1|||
126781461|NCT00321711|456154553|FG001|Part A|Other|2|||
126738995|NCT00383708|455992839|FG000|Run-in Period|Adverse Event|2|||
126738996|NCT00383708|455992839|FG000|Run-in Period|Claustrophobia|1|||
126738997|NCT00383708|455992839|FG000|Co-administration Period|Adverse Event|5|||
126738998|NCT00318370|455992840|FG000|Period 1|Lack of Efficacy|5|||
126738999|NCT00318370|455992841|FG001|Period 1|Lack of Efficacy|0|||
126739000|NCT00318370|455992842|FG002|Period 1|Lack of Efficacy|0|||
126739001|NCT00318370|455992840|FG000|Period 1|Physician Decision|1|||
126781462|NCT00321711|456154554|FG002|Part A|Other|3|||
126739002|NCT00318370|455992841|FG001|Period 1|Physician Decision|0|||
126739003|NCT00318370|455992842|FG002|Period 1|Physician Decision|0|||
126739004|NCT00318370|455992840|FG000|Period 1|Withdrawal by Subject|1|||
126739005|NCT00318370|455992841|FG001|Period 1|Withdrawal by Subject|0|||
126739006|NCT00318370|455992842|FG002|Period 1|Withdrawal by Subject|0|||
126781463|NCT00321711|456154555|FG003|Part A|Other|0|||
126781464|NCT00321711|456154556|FG004|Part A|Other|0|||
126781465|NCT00321711|456154552|FG000|Part A|Protocol deviation|0|||
126781466|NCT00321711|456154553|FG001|Part A|Protocol deviation|0|||
126739007|NCT00318370|455992840|FG000|Period 2|Adverse Event|0|||
126739008|NCT00318370|455992841|FG001|Period 2|Adverse Event|3|||
126739009|NCT00318370|455992842|FG002|Period 2|Adverse Event|0|||
126739010|NCT00318370|455992840|FG000|Period 2|Lack of Efficacy|0|||
126739011|NCT00318370|455992841|FG001|Period 2|Lack of Efficacy|5|||
126739012|NCT00318370|455992842|FG002|Period 2|Lack of Efficacy|0|||
126739013|NCT00318370|455992840|FG000|Period 2|Physician Decision|0|||
126739014|NCT00318370|455992841|FG001|Period 2|Physician Decision|1|||
126739015|NCT00318370|455992842|FG002|Period 2|Physician Decision|0|||
126739016|NCT00318370|455992840|FG000|Period 2|Withdrawal by Subject|0|||
126739017|NCT00318370|455992841|FG001|Period 2|Withdrawal by Subject|1|||
126739018|NCT00318370|455992842|FG002|Period 2|Withdrawal by Subject|0|||
126739019|NCT00318370|455992840|FG000|Period 2|Other|0|||
126739020|NCT00318370|455992841|FG001|Period 2|Other|1|||
126739021|NCT00318370|455992842|FG002|Period 2|Other|0|||
126739022|NCT00318370|455992840|FG000|Period 3|Adverse Event|0|||
126739023|NCT00318370|455992841|FG001|Period 3|Adverse Event|0|||
126739024|NCT00318370|455992842|FG002|Period 3|Adverse Event|1|||
126739025|NCT00318370|455992840|FG000|Period 3|Lack of Efficacy|0|||
126739026|NCT00318370|455992841|FG001|Period 3|Lack of Efficacy|0|||
126739027|NCT00318370|455992842|FG002|Period 3|Lack of Efficacy|24|||
126739028|NCT00318370|455992840|FG000|Period 3|Death|0|||
126739029|NCT00318370|455992841|FG001|Period 3|Death|0|||
126739030|NCT00318370|455992842|FG002|Period 3|Death|1|||
126739031|NCT00318370|455992840|FG000|Period 3|Physician Decision|0|||
126739032|NCT00318370|455992841|FG001|Period 3|Physician Decision|0|||
126739033|NCT00318370|455992842|FG002|Period 3|Physician Decision|1|||
126739034|NCT00318370|455992840|FG000|Period 3|Withdrawal by Subject|0|||
126739035|NCT00318370|455992841|FG001|Period 3|Withdrawal by Subject|0|||
126739036|NCT00318370|455992842|FG002|Period 3|Withdrawal by Subject|3|||
126739037|NCT00318370|455992840|FG000|Period 3|Other|0|||
126739038|NCT00318370|455992841|FG001|Period 3|Other|0|||
126739039|NCT00318370|455992842|FG002|Period 3|Other|3|||
126739040|NCT01750840|455992843|FG000|Overall Study|Lost to Follow-up|4|||
126739041|NCT01576406|455992845|FG000|Overall Study|Lost to Follow-up|1|||
126739042|NCT01576406|455992846|FG001|Overall Study|Lost to Follow-up|2|||
126739043|NCT01576406|455992847|FG002|Overall Study|Lost to Follow-up|0|||
126739044|NCT01576406|455992848|FG003|Overall Study|Lost to Follow-up|0|||
126739045|NCT01576406|455992849|FG004|Overall Study|Lost to Follow-up|0|||
126739046|NCT01576406|455992850|FG005|Overall Study|Lost to Follow-up|0|||
126739047|NCT01576406|455992845|FG000|Overall Study|Death|3|||
126739048|NCT01576406|455992846|FG001|Overall Study|Death|4|||
126739049|NCT01576406|455992847|FG002|Overall Study|Death|8|||
126739050|NCT01576406|455992848|FG003|Overall Study|Death|5|||
126739051|NCT01576406|455992849|FG004|Overall Study|Death|7|||
126739052|NCT01576406|455992850|FG005|Overall Study|Death|9|||
126739053|NCT01576406|455992845|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
126739054|NCT01576406|455992846|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
126739055|NCT01576406|455992847|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
126739056|NCT01576406|455992848|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
126739057|NCT01576406|455992849|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
126739058|NCT01576406|455992850|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
126739059|NCT01576406|455992845|FG000|Overall Study|Withdrawal the consent|2|||
126739060|NCT01576406|455992846|FG001|Overall Study|Withdrawal the consent|2|||
126739061|NCT01576406|455992847|FG002|Overall Study|Withdrawal the consent|5|||
126739062|NCT01576406|455992848|FG003|Overall Study|Withdrawal the consent|1|||
126739063|NCT01576406|455992849|FG004|Overall Study|Withdrawal the consent|1|||
126739064|NCT01576406|455992850|FG005|Overall Study|Withdrawal the consent|3|||
126739065|NCT01576406|455992845|FG000|Overall Study|Other|0|||
126739066|NCT01576406|455992846|FG001|Overall Study|Other|0|||
126739067|NCT01576406|455992847|FG002|Overall Study|Other|2|||
126739068|NCT01576406|455992848|FG003|Overall Study|Other|2|||
126739069|NCT01576406|455992849|FG004|Overall Study|Other|0|||
126739070|NCT01576406|455992850|FG005|Overall Study|Other|0|||
126739071|NCT00669032|455992855|FG000|Overall Study|Lost to Follow-up|6|||
126739072|NCT00669032|455992856|FG001|Overall Study|Lost to Follow-up|5|||
126739073|NCT00669032|455992855|FG000|Overall Study|Lack of Efficacy|8|||
126739074|NCT00669032|455992856|FG001|Overall Study|Lack of Efficacy|19|||
126739075|NCT00669032|455992855|FG000|Overall Study|Withdrawal by Subject|12|||
126739076|NCT00669032|455992856|FG001|Overall Study|Withdrawal by Subject|13|||
126739077|NCT00669032|455992855|FG000|Overall Study|Adverse Event|12|||
126739078|NCT00669032|455992856|FG001|Overall Study|Adverse Event|16|||
126739079|NCT00669032|455992855|FG000|Overall Study|Physician Decision|1|||
126739080|NCT00669032|455992856|FG001|Overall Study|Physician Decision|1|||
126739081|NCT00669032|455992855|FG000|Overall Study|No fulfilment of the selection criteria|5|||
126739082|NCT00669032|455992856|FG001|Overall Study|No fulfilment of the selection criteria|5|||
126739083|NCT01607073|455992857|FG000|Overall Study|Adverse Event|1|||
126739084|NCT03627494|455992858|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
126739085|NCT03627494|455992859|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
126739086|NCT03627494|455992860|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
126739087|NCT03627494|455992861|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
126739088|NCT03627494|455992862|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
126781467|NCT00321711|456154554|FG002|Part A|Protocol deviation|1|||
126781468|NCT00321711|456154555|FG003|Part A|Protocol deviation|0|||
126781469|NCT00321711|456154556|FG004|Part A|Protocol deviation|0|||
126781470|NCT00321711|456154552|FG000|Part B|Noncompliance|0|||
126781471|NCT00321711|456154553|FG001|Part B|Noncompliance|0|||
126781472|NCT00321711|456154554|FG002|Part B|Noncompliance|0|||
126781473|NCT00321711|456154555|FG003|Part B|Noncompliance|0|||
126781474|NCT00321711|456154556|FG004|Part B|Noncompliance|1|||
126781475|NCT00321711|456154552|FG000|Part B|Adverse Event|0|||
126781476|NCT00321711|456154553|FG001|Part B|Adverse Event|0|||
126781477|NCT00321711|456154554|FG002|Part B|Adverse Event|0|||
126781478|NCT00321711|456154555|FG003|Part B|Adverse Event|2|||
126781479|NCT00321711|456154556|FG004|Part B|Adverse Event|1|||
126781480|NCT00321711|456154552|FG000|Part B|Disease progression|0|||
126781481|NCT00321711|456154553|FG001|Part B|Disease progression|0|||
126781482|NCT00321711|456154554|FG002|Part B|Disease progression|0|||
126781483|NCT00321711|456154555|FG003|Part B|Disease progression|1|||
126781484|NCT00321711|456154556|FG004|Part B|Disease progression|0|||
126781485|NCT00321711|456154552|FG000|Part B|Physician Decision|0|||
126781486|NCT00321711|456154553|FG001|Part B|Physician Decision|0|||
126781487|NCT00321711|456154554|FG002|Part B|Physician Decision|0|||
126781488|NCT00321711|456154555|FG003|Part B|Physician Decision|1|||
126781489|NCT00321711|456154556|FG004|Part B|Physician Decision|2|||
126781490|NCT00321711|456154552|FG000|Part B|Death|0|||
126781491|NCT00321711|456154553|FG001|Part B|Death|0|||
126781492|NCT00321711|456154554|FG002|Part B|Death|0|||
126781493|NCT00321711|456154555|FG003|Part B|Death|2|||
126781494|NCT00321711|456154556|FG004|Part B|Death|1|||
126781495|NCT00947856|456154559|FG000|Treatment Period|Progressive Disease|33|||
126781496|NCT00947856|456154560|FG001|Treatment Period|Progressive Disease|12|||
126781497|NCT00947856|456154559|FG000|Treatment Period|Adverse Event|15|||
126781498|NCT00947856|456154560|FG001|Treatment Period|Adverse Event|9|||
126781499|NCT00947856|456154559|FG000|Treatment Period|Physician Decision|14|||
126781500|NCT00947856|456154560|FG001|Treatment Period|Physician Decision|6|||
126781501|NCT00947856|456154559|FG000|Treatment Period|Study Stopped by Sponsor|4|||
126781502|NCT00947856|456154560|FG001|Treatment Period|Study Stopped by Sponsor|4|||
126781503|NCT00947856|456154559|FG000|Treatment Period|Withdrawal by Subject|12|||
126781504|NCT00947856|456154560|FG001|Treatment Period|Withdrawal by Subject|1|||
126781505|NCT00947856|456154559|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
126781506|NCT00947856|456154560|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
126781507|NCT00947856|456154559|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
126781508|NCT00947856|456154560|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
126781509|NCT00947856|456154559|FG000|Follow-up Period|Lost to Follow-up|7|||
126781510|NCT00947856|456154560|FG001|Follow-up Period|Lost to Follow-up|0|||
126614559|NCT00813709|455547494|FG004|Double Blind Period|Lost to Follow-up|0|||
126614560|NCT00813709|455547495|FG005|Double Blind Period|Lost to Follow-up|0|||
126614561|NCT00813709|455547490|FG000|Double Blind Period|Switched to open label phase|9|||
126614562|NCT00813709|455547491|FG001|Double Blind Period|Switched to open label phase|26|||
126614563|NCT00813709|455547492|FG002|Double Blind Period|Switched to open label phase|18|||
126614564|NCT00813709|455547493|FG003|Double Blind Period|Switched to open label phase|0|||
126614565|NCT00813709|455547494|FG004|Double Blind Period|Switched to open label phase|0|||
126614566|NCT00813709|455547495|FG005|Double Blind Period|Switched to open label phase|0|||
126614567|NCT00813709|455547490|FG000|Double Blind Period|Randomized but not treated|1|||
126614568|NCT00813709|455547491|FG001|Double Blind Period|Randomized but not treated|3|||
126614569|NCT00813709|455547492|FG002|Double Blind Period|Randomized but not treated|1|||
126614570|NCT00813709|455547493|FG003|Double Blind Period|Randomized but not treated|0|||
126614571|NCT00813709|455547494|FG004|Double Blind Period|Randomized but not treated|0|||
126614572|NCT00813709|455547495|FG005|Double Blind Period|Randomized but not treated|0|||
126614573|NCT00813709|455547490|FG000|Double Blind Period|Other|14|||
126614574|NCT00813709|455547491|FG001|Double Blind Period|Other|9|||
126614575|NCT00813709|455547492|FG002|Double Blind Period|Other|6|||
126614576|NCT00813709|455547493|FG003|Double Blind Period|Other|0|||
126781511|NCT00947856|456154559|FG000|Follow-up Period|Patient unavailable for site visits|1|||
126781512|NCT00947856|456154560|FG001|Follow-up Period|Patient unavailable for site visits|0|||
126781513|NCT00947856|456154559|FG000|Follow-up Period|Withdrawal by Subject|1|||
126614577|NCT00813709|455547494|FG004|Double Blind Period|Other|0|||
126614578|NCT00813709|455547495|FG005|Double Blind Period|Other|0|||
126614579|NCT00813709|455547490|FG000|Open Label Period|Adverse Event|0|||
126614580|NCT00813709|455547491|FG001|Open Label Period|Adverse Event|0|||
126614581|NCT00813709|455547492|FG002|Open Label Period|Adverse Event|0|||
126614582|NCT00813709|455547493|FG003|Open Label Period|Adverse Event|5|||
126781514|NCT00947856|456154560|FG001|Follow-up Period|Withdrawal by Subject|0|||
126781515|NCT01211769|456154561|FG000|Overall Study|Lost to Follow-up|7|||
126781516|NCT01211769|456154562|FG001|Overall Study|Lost to Follow-up|9|||
126781517|NCT01211769|456154563|FG002|Overall Study|Lost to Follow-up|5|||
126781518|NCT01211769|456154564|FG003|Overall Study|Lost to Follow-up|9|||
126781519|NCT01211769|456154561|FG000|Overall Study|Physician Decision|2|||
126781520|NCT01211769|456154562|FG001|Overall Study|Physician Decision|0|||
126781521|NCT01211769|456154563|FG002|Overall Study|Physician Decision|2|||
126781522|NCT01211769|456154564|FG003|Overall Study|Physician Decision|1|||
126614583|NCT00813709|455547494|FG004|Open Label Period|Adverse Event|4|||
126614584|NCT00813709|455547495|FG005|Open Label Period|Adverse Event|3|||
126614585|NCT00813709|455547490|FG000|Open Label Period|Lack of Efficacy|0|||
126614586|NCT00813709|455547491|FG001|Open Label Period|Lack of Efficacy|0|||
126614587|NCT00813709|455547492|FG002|Open Label Period|Lack of Efficacy|0|||
126614588|NCT00813709|455547493|FG003|Open Label Period|Lack of Efficacy|3|||
126614589|NCT00813709|455547494|FG004|Open Label Period|Lack of Efficacy|1|||
126614590|NCT00813709|455547495|FG005|Open Label Period|Lack of Efficacy|1|||
126614591|NCT00813709|455547490|FG000|Open Label Period|Randomized but not treated|0|||
126614592|NCT00813709|455547491|FG001|Open Label Period|Randomized but not treated|0|||
126614593|NCT00813709|455547492|FG002|Open Label Period|Randomized but not treated|0|||
126614594|NCT00813709|455547493|FG003|Open Label Period|Randomized but not treated|1|||
126614595|NCT00813709|455547494|FG004|Open Label Period|Randomized but not treated|0|||
126614596|NCT00813709|455547495|FG005|Open Label Period|Randomized but not treated|1|||
126614597|NCT00813709|455547490|FG000|Open Label Period|Other|0|||
126739089|NCT03627494|455992863|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
126739090|NCT03627494|455992864|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
126739091|NCT03627494|455992865|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
126739092|NCT03627494|455992866|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
126739093|NCT03627494|455992867|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
126739094|NCT03627494|455992868|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
126739095|NCT03627494|455992869|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
126739096|NCT03627494|455992858|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
126739097|NCT03627494|455992859|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
126739098|NCT03627494|455992860|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
126739099|NCT03627494|455992861|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
126739100|NCT03627494|455992862|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
126739101|NCT03627494|455992863|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
126739102|NCT03627494|455992864|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
126739103|NCT03627494|455992865|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
126739104|NCT03627494|455992866|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
126739105|NCT03627494|455992867|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
126739106|NCT03627494|455992868|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
126739107|NCT03627494|455992869|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
126739108|NCT03627494|455992858|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
126739109|NCT03627494|455992859|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
126739110|NCT03627494|455992860|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
126739111|NCT03627494|455992861|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
126739112|NCT03627494|455992862|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
126739113|NCT03627494|455992863|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
126739114|NCT03627494|455992864|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
126739115|NCT03627494|455992865|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
126739116|NCT03627494|455992866|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
126739117|NCT03627494|455992867|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
126739118|NCT03627494|455992868|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
126739119|NCT03627494|455992869|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
126739120|NCT03906136|455995091|FG000|Overall Study|Adverse Event|1|||
126739121|NCT03906136|455995092|FG001|Overall Study|Adverse Event|0|||
126739122|NCT03906136|455995091|FG000|Overall Study|Lost to Follow-up|7|||
126739123|NCT03906136|455995092|FG001|Overall Study|Lost to Follow-up|4|||
126739124|NCT03906136|455995091|FG000|Overall Study|Physician Decision|1|||
126739125|NCT03906136|455995092|FG001|Overall Study|Physician Decision|0|||
126739126|NCT03906136|455995091|FG000|Overall Study|Withdrawal by Subject|3|||
126739127|NCT03906136|455995092|FG001|Overall Study|Withdrawal by Subject|7|||
126739128|NCT00323310|455995095|FG000|Overall Study|Withdrawal by Subject|1|||
126739129|NCT00323310|455995095|FG000|Overall Study|a parent refused blood draw|1|||
126739130|NCT00323310|455995095|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
126739131|NCT03984812|455995096|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126739132|NCT03984812|455995097|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126739133|NCT03984812|455995098|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
126739134|NCT03984812|455995099|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126739135|NCT03984812|455995100|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126739136|NCT03984812|455995101|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126739137|NCT03984812|455995102|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126739138|NCT03984812|455995103|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126739139|NCT03984812|455995104|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126739140|NCT03984812|455995105|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126739141|NCT03984812|455995106|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
126739142|NCT00446641|455995107|FG000|Overall Study|Withdrawal by Subject|8|||
126614598|NCT00813709|455547491|FG001|Open Label Period|Other|0|||
126614599|NCT00813709|455547492|FG002|Open Label Period|Other|0|||
126614600|NCT00813709|455547493|FG003|Open Label Period|Other|11|||
126739143|NCT00446641|455995108|FG001|Overall Study|Withdrawal by Subject|3|||
126739144|NCT00446641|455995107|FG000|Overall Study|poor compliance|8|||
126739145|NCT00446641|455995108|FG001|Overall Study|poor compliance|6|||
126781523|NCT01211769|456154561|FG000|Overall Study|Adverse Event|0|||
126614601|NCT00813709|455547494|FG004|Open Label Period|Other|5|||
126614602|NCT00813709|455547495|FG005|Open Label Period|Other|6|||
126614603|NCT02753075|455547496|FG000|Overall Study|Adverse Event|2|||
126614604|NCT02753075|455547497|FG001|Overall Study|Adverse Event|1|||
126614605|NCT02753075|455547498|FG002|Overall Study|Adverse Event|0|||
126614606|NCT02753075|455547496|FG000|Overall Study|Lost to Follow-up|2|||
126614607|NCT02753075|455547497|FG001|Overall Study|Lost to Follow-up|0|||
126614608|NCT02753075|455547498|FG002|Overall Study|Lost to Follow-up|0|||
126614609|NCT02753075|455547496|FG000|Overall Study|Withdrawal of Consent|1|||
126614610|NCT02753075|455547497|FG001|Overall Study|Withdrawal of Consent|1|||
126614611|NCT02753075|455547498|FG002|Overall Study|Withdrawal of Consent|3|||
126614612|NCT02753075|455547496|FG000|Overall Study|Physician Decision|3|||
126614613|NCT02753075|455547497|FG001|Overall Study|Physician Decision|1|||
126614614|NCT02753075|455547498|FG002|Overall Study|Physician Decision|0|||
126614615|NCT02245620|455547500|FG000|Overall Study|Physician Decision|1|||
126614616|NCT02245620|455547501|FG001|Overall Study|Physician Decision|1|||
126614617|NCT01102426|455547504|FG000|Overall Study|Randomized but not treated|4|||
126614618|NCT01102426|455547505|FG001|Overall Study|Randomized but not treated|1|||
126614619|NCT01102426|455547504|FG000|Overall Study|Adverse Events (treatment-related)|15|||
126614620|NCT01102426|455547505|FG001|Overall Study|Adverse Events (treatment-related)|8|||
126614621|NCT01102426|455547504|FG000|Overall Study|Physician Decision|9|||
126614622|NCT01102426|455547505|FG001|Overall Study|Physician Decision|6|||
126614623|NCT01102426|455547504|FG000|Overall Study|Progressive Disease|85|||
126614624|NCT01102426|455547505|FG001|Overall Study|Progressive Disease|44|||
126614625|NCT01102426|455547504|FG000|Overall Study|Adverse Events (unrelated to|9|||
126614626|NCT01102426|455547505|FG001|Overall Study|Adverse Events (unrelated to|1|||
126614627|NCT01102426|455547504|FG000|Overall Study|Patient Refusal|24|||
126614628|NCT01102426|455547505|FG001|Overall Study|Patient Refusal|12|||
126614629|NCT01102426|455547504|FG000|Overall Study|Death (due to adverse events|0|||
126614630|NCT01102426|455547505|FG001|Overall Study|Death (due to adverse events|1|||
126614631|NCT01102426|455547504|FG000|Overall Study|Death (non-related to the study|19|||
126614632|NCT01102426|455547505|FG001|Overall Study|Death (non-related to the study|8|||
126614633|NCT04361617|455547506|FG000|Overall Study|Withdrawal by Subject|0|||
126614634|NCT04361617|455547507|FG001|Overall Study|Withdrawal by Subject|1|||
126614635|NCT00930644|455547508|FG000|Overall Study|Withdrawal by Subject|4|||
126614636|NCT00930644|455547508|FG000|Overall Study|Physician Decision|2|||
126614637|NCT00930644|455547508|FG000|Overall Study|Death|1|||
126614638|NCT00930644|455547508|FG000|Overall Study|Adverse Event|16|||
126614639|NCT01393964|455547509|FG000|Overall Study|Disease Progression|4|||
126614640|NCT01393964|455547510|FG001|Overall Study|Disease Progression|3|||
126614641|NCT01393964|455547511|FG002|Overall Study|Disease Progression|5|||
126614642|NCT01393964|455547509|FG000|Overall Study|Study drug toxicity|1|||
126614643|NCT01393964|455547510|FG001|Overall Study|Study drug toxicity|0|||
126614644|NCT01393964|455547511|FG002|Overall Study|Study drug toxicity|0|||
126614645|NCT01393964|455547509|FG000|Overall Study|Withdrawal by Subject|0|||
126614646|NCT01393964|455547510|FG001|Overall Study|Withdrawal by Subject|0|||
126614647|NCT01393964|455547511|FG002|Overall Study|Withdrawal by Subject|1|||
126614648|NCT01393964|455547509|FG000|Overall Study|Adverse event unrelated to study drug|0|||
126614649|NCT01393964|455547510|FG001|Overall Study|Adverse event unrelated to study drug|3|||
126614650|NCT01393964|455547511|FG002|Overall Study|Adverse event unrelated to study drug|0|||
126614651|NCT01393964|455547509|FG000|Overall Study|Subject request stop study treatment|0|||
126614652|NCT01393964|455547510|FG001|Overall Study|Subject request stop study treatment|1|||
126614653|NCT01393964|455547511|FG002|Overall Study|Subject request stop study treatment|0|||
126614654|NCT01393964|455547509|FG000|Overall Study|Subject decided to move to transplant|1|||
126614655|NCT01393964|455547510|FG001|Overall Study|Subject decided to move to transplant|0|||
126614656|NCT01393964|455547511|FG002|Overall Study|Subject decided to move to transplant|0|||
126614657|NCT01393964|455547509|FG000|Overall Study|Subject switched to commercial supply|1|||
126614658|NCT01393964|455547510|FG001|Overall Study|Subject switched to commercial supply|0|||
126614659|NCT01393964|455547511|FG002|Overall Study|Subject switched to commercial supply|2|||
126614660|NCT01393964|455547509|FG000|Overall Study|Subject plateaued in terms of effect|1|||
126614661|NCT01393964|455547510|FG001|Overall Study|Subject plateaued in terms of effect|0|||
126614662|NCT01393964|455547511|FG002|Overall Study|Subject plateaued in terms of effect|0|||
126614663|NCT01393964|455547509|FG000|Overall Study|Investigator removed subject from study|0|||
126614664|NCT01393964|455547510|FG001|Overall Study|Investigator removed subject from study|1|||
126614665|NCT01393964|455547511|FG002|Overall Study|Investigator removed subject from study|0|||
126614666|NCT01393964|455547509|FG000|Overall Study|Subject converted to roll-over study|0|||
126614667|NCT01393964|455547510|FG001|Overall Study|Subject converted to roll-over study|1|||
126614668|NCT01393964|455547511|FG002|Overall Study|Subject converted to roll-over study|0|||
126614669|NCT01393964|455547509|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
126614670|NCT01393964|455547510|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
126614671|NCT01393964|455547511|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
126614672|NCT03265132|455547520|FG000|Overall Study|Adverse Event|0|||
126781524|NCT01211769|456154562|FG001|Overall Study|Adverse Event|1|||
126614673|NCT03265132|455547521|FG001|Overall Study|Adverse Event|1|||
126614674|NCT03265132|455547520|FG000|Overall Study|Lack of Efficacy|0|||
126614675|NCT03265132|455547521|FG001|Overall Study|Lack of Efficacy|2|||
126614676|NCT03265132|455547520|FG000|Overall Study|Progressive disease|0|||
126614677|NCT03265132|455547521|FG001|Overall Study|Progressive disease|2|||
126614678|NCT03265132|455547520|FG000|Overall Study|Withdrawal by Subject|0|||
126614679|NCT03265132|455547521|FG001|Overall Study|Withdrawal by Subject|1|||
126614680|NCT00687297|455547524|FG000|Randomization|Withdrawal by Subject|2|||
126614681|NCT00687297|455547525|FG001|Randomization|Withdrawal by Subject|0|||
126614682|NCT00687297|455547524|FG000|Randomization|Withdrew before treatment, ineligible|1|||
126614683|NCT00687297|455547525|FG001|Randomization|Withdrew before treatment, ineligible|1|||
126614684|NCT00687297|455547524|FG000|Induction|Withdrawal by Subject|4|||
126614685|NCT00687297|455547525|FG001|Induction|Withdrawal by Subject|4|||
126614686|NCT00687297|455547524|FG000|Induction|Adverse Event|16|||
126614687|NCT00687297|455547525|FG001|Induction|Adverse Event|15|||
126614688|NCT00687297|455547524|FG000|Induction|Death|7|||
126614689|NCT00687297|455547525|FG001|Induction|Death|11|||
126614690|NCT00687297|455547524|FG000|Induction|Lack of Efficacy|17|||
126614691|NCT00687297|455547525|FG001|Induction|Lack of Efficacy|21|||
126614692|NCT00687297|455547524|FG000|Induction|Ineligible|0|||
126614693|NCT00687297|455547525|FG001|Induction|Ineligible|1|||
126614694|NCT00687297|455547524|FG000|Induction|Patient Noncompliance|1|||
126614695|NCT00687297|455547525|FG001|Induction|Patient Noncompliance|0|||
126614696|NCT00687297|455547524|FG000|Induction|Physician Decision|0|||
126614697|NCT00687297|455547525|FG001|Induction|Physician Decision|2|||
126614698|NCT00687297|455547524|FG000|Induction|Other|0|||
126614699|NCT00687297|455547525|FG001|Induction|Other|1|||
126614700|NCT00244751|455547530|FG000|Overall Study|Adverse Event|7|||
126614701|NCT00244751|455547531|FG001|Overall Study|Adverse Event|7|||
126614702|NCT00244751|455547532|FG002|Overall Study|Adverse Event|5|||
126614703|NCT00244751|455547530|FG000|Overall Study|Lost to Follow-up|0|||
126614704|NCT00244751|455547531|FG001|Overall Study|Lost to Follow-up|1|||
126614705|NCT00244751|455547532|FG002|Overall Study|Lost to Follow-up|0|||
126614706|NCT00244751|455547530|FG000|Overall Study|Protocol Violation|1|||
126614707|NCT00244751|455547531|FG001|Overall Study|Protocol Violation|0|||
126614708|NCT00244751|455547532|FG002|Overall Study|Protocol Violation|1|||
126614709|NCT00244751|455547530|FG000|Overall Study|Withdrawal by Subject|7|||
126614710|NCT00244751|455547531|FG001|Overall Study|Withdrawal by Subject|5|||
126614711|NCT00244751|455547532|FG002|Overall Study|Withdrawal by Subject|3|||
126614712|NCT00244751|455547530|FG000|Overall Study|Elevated liver enzymes|1|||
126614713|NCT00244751|455547531|FG001|Overall Study|Elevated liver enzymes|0|||
126614714|NCT00244751|455547532|FG002|Overall Study|Elevated liver enzymes|0|||
126614715|NCT00244751|455547530|FG000|Overall Study|Lack of compliance with protocol|0|||
126614716|NCT00244751|455547531|FG001|Overall Study|Lack of compliance with protocol|1|||
126614717|NCT00244751|455547532|FG002|Overall Study|Lack of compliance with protocol|0|||
126614718|NCT00244751|455547530|FG000|Overall Study|Safety reasons|0|||
126614719|NCT00244751|455547531|FG001|Overall Study|Safety reasons|1|||
126614720|NCT00244751|455547532|FG002|Overall Study|Safety reasons|0|||
126614721|NCT00244751|455547530|FG000|Overall Study|Participant randomized by mistake|0|||
126614722|NCT00244751|455547531|FG001|Overall Study|Participant randomized by mistake|0|||
126614723|NCT00244751|455547532|FG002|Overall Study|Participant randomized by mistake|1|||
126614724|NCT02206607|455547533|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
126614725|NCT02206607|455547534|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
126614726|NCT02206607|455547535|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
126614727|NCT02206607|455547536|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
126614728|NCT02206607|455547537|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
126614729|NCT02206607|455547533|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
126614730|NCT02206607|455547534|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
126614731|NCT02206607|455547535|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
126614732|NCT02206607|455547536|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
126614733|NCT02206607|455547537|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
126614734|NCT00879710|455547538|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
126614735|NCT00879710|455547539|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
126614736|NCT00879710|455547540|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
126614737|NCT00879710|455547541|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
126614738|NCT00879710|455547538|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
126614739|NCT00879710|455547539|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
126614740|NCT00879710|455547540|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
126614741|NCT00879710|455547541|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
126614742|NCT01262456|455547542|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
126614743|NCT01262456|455547543|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
126614744|NCT01262456|455547544|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
126614745|NCT01262456|455547542|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
126614746|NCT01262456|455547543|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
126614747|NCT01262456|455547544|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
126614748|NCT01262456|455547542|FG000|3-Month Double-Blind Period|Adverse Event|6|||
126614749|NCT01262456|455547543|FG001|3-Month Double-Blind Period|Adverse Event|4|||
126614750|NCT01262456|455547544|FG002|3-Month Double-Blind Period|Adverse Event|8|||
126614751|NCT01262456|455547542|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
126614752|NCT01262456|455547543|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
126614753|NCT01262456|455547544|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
126614754|NCT01262456|455547542|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
126614755|NCT01262456|455547543|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
126614756|NCT01262456|455547544|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
126614757|NCT01262456|455547542|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
126614758|NCT01262456|455547543|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
126614759|NCT01262456|455547544|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
126614760|NCT01262456|455547542|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
126614761|NCT01262456|455547543|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
126614762|NCT01262456|455547544|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
126614763|NCT01262456|455547542|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
126614764|NCT01262456|455547543|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
126614765|NCT01262456|455547544|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
126614766|NCT01262456|455547542|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
126614767|NCT01262456|455547543|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
126614768|NCT01262456|455547544|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
126614769|NCT04085614|455547545|FG000|Overall Study|Protocol Violation|9|||
126614770|NCT04085614|455547546|FG001|Overall Study|Protocol Violation|6|||
126614771|NCT02399449|455547547|FG000|Overall Study|Withdrawal by Subject|3|||
126614772|NCT02399449|455547548|FG001|Overall Study|Withdrawal by Subject|9|||
126614773|NCT02399449|455547547|FG000|Overall Study|Physician Decision|0|||
126614774|NCT02399449|455547548|FG001|Overall Study|Physician Decision|1|||
126614775|NCT02516202|455547549|FG000|Overall Study|Withdrawal by Subject|1|||
126614776|NCT02516202|455547550|FG001|Overall Study|Withdrawal by Subject|0|||
126614777|NCT02516202|455547551|FG002|Overall Study|Withdrawal by Subject|1|||
126614778|NCT02516202|455547549|FG000|Overall Study|Lost to Follow-up|1|||
126614779|NCT02516202|455547550|FG001|Overall Study|Lost to Follow-up|1|||
126614780|NCT02516202|455547551|FG002|Overall Study|Lost to Follow-up|1|||
126614781|NCT02516202|455547549|FG000|Overall Study|Stopped Follow-up|0|||
126614782|NCT02516202|455547550|FG001|Overall Study|Stopped Follow-up|0|||
126614783|NCT02516202|455547551|FG002|Overall Study|Stopped Follow-up|1|||
126614784|NCT00337610|455547552|FG000|Overall Study|Adverse Event|2|||
126614785|NCT00337610|455547553|FG001|Overall Study|Adverse Event|2|||
126614786|NCT00337610|455547552|FG000|Overall Study|Death|0|||
126614787|NCT00337610|455547553|FG001|Overall Study|Death|1|||
126614788|NCT00337610|455547552|FG000|Overall Study|Lack of Efficacy|6|||
126614789|NCT00337610|455547553|FG001|Overall Study|Lack of Efficacy|3|||
126614790|NCT00337610|455547552|FG000|Overall Study|Lost to Follow-up|3|||
126614791|NCT00337610|455547553|FG001|Overall Study|Lost to Follow-up|3|||
126614792|NCT00337610|455547552|FG000|Overall Study|Withdrawal by Subject|6|||
126614793|NCT00337610|455547553|FG001|Overall Study|Withdrawal by Subject|5|||
126614794|NCT03205488|455547556|FG000|Overall Study|Adverse Event|1|||
126614795|NCT03205488|455547557|FG001|Overall Study|Adverse Event|2|||
126614796|NCT03205488|455547558|FG002|Overall Study|Adverse Event|4|||
126614797|NCT03205488|455547556|FG000|Overall Study|Protocol Violation|0|||
126614798|NCT03205488|455547557|FG001|Overall Study|Protocol Violation|0|||
126614799|NCT03205488|455547558|FG002|Overall Study|Protocol Violation|1|||
126614800|NCT04867382|455547559|FG000|Overall Study|Did not complete the survey|2|||
126614801|NCT04867382|455547560|FG001|Overall Study|Did not complete the survey|1|||
126614802|NCT05445557|455547564|FG000|Double Blind Part|Lost to Follow-up|1|||
126614803|NCT02008916|455547565|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
126614804|NCT02008916|455547566|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
126614805|NCT02008916|455547567|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
126614806|NCT02008916|455547565|FG000|Week 16 - 156|Adverse Event|4|||
126614807|NCT02008916|455547566|FG001|Week 16 - 156|Adverse Event|2|||
126614808|NCT02008916|455547567|FG002|Week 16 - 156|Adverse Event|3|||
126614809|NCT02008916|455547565|FG000|Week 16 - 156|Withdrawal by Subject|7|||
126614810|NCT02008916|455547566|FG001|Week 16 - 156|Withdrawal by Subject|3|||
126614811|NCT02008916|455547567|FG002|Week 16 - 156|Withdrawal by Subject|5|||
126614812|NCT02008916|455547565|FG000|Week 16 - 156|No longer requires treatment|0|||
126781525|NCT01211769|456154563|FG002|Overall Study|Adverse Event|1|||
126614813|NCT02008916|455547566|FG001|Week 16 - 156|No longer requires treatment|1|||
126614814|NCT02008916|455547567|FG002|Week 16 - 156|No longer requires treatment|0|||
126614815|NCT02008916|455547565|FG000|Week 16 - 156|Lost to Follow-up|5|||
126614816|NCT02008916|455547566|FG001|Week 16 - 156|Lost to Follow-up|0|||
126614817|NCT02008916|455547567|FG002|Week 16 - 156|Lost to Follow-up|0|||
126614818|NCT02008916|455547565|FG000|Week 16 - 156|Lack of Efficacy|3|||
126614819|NCT02008916|455547566|FG001|Week 16 - 156|Lack of Efficacy|5|||
126781526|NCT01211769|456154564|FG003|Overall Study|Adverse Event|1|||
126614820|NCT02008916|455547567|FG002|Week 16 - 156|Lack of Efficacy|2|||
126614821|NCT02008916|455547565|FG000|Week 16 - 156|Pregnancy|0|||
126614822|NCT02008916|455547566|FG001|Week 16 - 156|Pregnancy|1|||
126781527|NCT01348542|456154565|FG000|Overall Study|Withdrawal by Subject|3|||
126614823|NCT02008916|455547567|FG002|Week 16 - 156|Pregnancy|0|||
126614824|NCT02008916|455547565|FG000|Week 16 - 156|Physician Decision|0|||
126614825|NCT02008916|455547566|FG001|Week 16 - 156|Physician Decision|1|||
126614826|NCT02008916|455547567|FG002|Week 16 - 156|Physician Decision|0|||
126614827|NCT03803475|455547568|FG000|Overall Study|Physician Decision|1|||
126614828|NCT00392197|455547571|FG000|Overall Study|Adverse Event|4|||
126614829|NCT00392197|455547572|FG001|Overall Study|Adverse Event|12|||
126614830|NCT00392197|455547571|FG000|Overall Study|Lack of Efficacy|3|||
126614831|NCT00392197|455547572|FG001|Overall Study|Lack of Efficacy|4|||
126614832|NCT00392197|455547571|FG000|Overall Study|Lost to Follow-up|0|||
126614833|NCT00392197|455547572|FG001|Overall Study|Lost to Follow-up|1|||
126614834|NCT00392197|455547571|FG000|Overall Study|Physician Decision|3|||
126614835|NCT00392197|455547572|FG001|Overall Study|Physician Decision|2|||
126614836|NCT00392197|455547571|FG000|Overall Study|Protocol Violation|7|||
126614837|NCT00392197|455547572|FG001|Overall Study|Protocol Violation|5|||
126614838|NCT00392197|455547571|FG000|Overall Study|Withdrawal by Subject|4|||
126614839|NCT00392197|455547572|FG001|Overall Study|Withdrawal by Subject|6|||
126614840|NCT00428714|455547574|FG000|Overall Study|Progressive Disease|28|||
126614841|NCT00428714|455547575|FG001|Overall Study|Progressive Disease|36|||
126614842|NCT00428714|455547574|FG000|Overall Study|Withdrawal by Subject|0|||
126614843|NCT00428714|455547575|FG001|Overall Study|Withdrawal by Subject|3|||
126614844|NCT00428714|455547574|FG000|Overall Study|Adverse Event|0|||
126781528|NCT01348542|456154566|FG001|Overall Study|Withdrawal by Subject|0|||
126781529|NCT03402893|456154567|FG000|Overall Study|Withdrawal by Subject|1|||
126781530|NCT01484028|456154568|FG000|Period 1|Lost to Follow-up|0|||
126781531|NCT01484028|456154569|FG001|Period 1|Lost to Follow-up|1|||
126781532|NCT01484028|456154570|FG002|Period 1|Lost to Follow-up|0|||
126781533|NCT01484028|456154571|FG003|Period 1|Lost to Follow-up|0|||
126781534|NCT01484028|456154568|FG000|Period 1|Non-Compliance to Protocol|0|||
126781535|NCT01484028|456154569|FG001|Period 1|Non-Compliance to Protocol|1|||
126781536|NCT01484028|456154570|FG002|Period 1|Non-Compliance to Protocol|0|||
126781537|NCT01484028|456154571|FG003|Period 1|Non-Compliance to Protocol|1|||
126781538|NCT01484028|456154568|FG000|Period 1|Lens Discomfort|0|||
126781539|NCT01484028|456154569|FG001|Period 1|Lens Discomfort|1|||
126781540|NCT01484028|456154570|FG002|Period 1|Lens Discomfort|0|||
126781541|NCT01484028|456154571|FG003|Period 1|Lens Discomfort|0|||
126781542|NCT00926289|456154574|FG000|Overall Study|Adverse Event|9|||
126781543|NCT00926289|456154575|FG001|Overall Study|Adverse Event|11|||
126614845|NCT00428714|455547575|FG001|Overall Study|Adverse Event|2|||
126614846|NCT00428714|455547574|FG000|Overall Study|Physician Decision|1|||
126614847|NCT00428714|455547575|FG001|Overall Study|Physician Decision|1|||
126614848|NCT00428714|455547574|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
126614849|NCT00428714|455547575|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
126614850|NCT00428714|455547574|FG000|Overall Study|Death due to other then PD|1|||
126739146|NCT00446641|455995107|FG000|Overall Study|Lost to Follow-up|1|||
126739147|NCT00446641|455995108|FG001|Overall Study|Lost to Follow-up|1|||
126739148|NCT03565991|455995110|FG000|Overall Study|Other|11|||
126739149|NCT03565991|455995111|FG001|Overall Study|Other|0|||
126739150|NCT03565991|455995110|FG000|Overall Study|Global deterioration of health status|14|||
126739151|NCT03565991|455995111|FG001|Overall Study|Global deterioration of health status|4|||
126739152|NCT03565991|455995110|FG000|Overall Study|Withdrawal by Subject|2|||
126739153|NCT03565991|455995111|FG001|Overall Study|Withdrawal by Subject|6|||
126739154|NCT03565991|455995110|FG000|Overall Study|Progressive disease|121|||
126739155|NCT03565991|455995111|FG001|Overall Study|Progressive disease|29|||
126739156|NCT03565991|455995110|FG000|Overall Study|Death|3|||
126739157|NCT03565991|455995111|FG001|Overall Study|Death|0|||
126739158|NCT03565991|455995110|FG000|Overall Study|Adverse Event|7|||
126739159|NCT03565991|455995111|FG001|Overall Study|Adverse Event|2|||
126739160|NCT03424044|455995113|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126739161|NCT03424044|455995114|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126739162|NCT03424044|455995115|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
126739163|NCT03424044|455995116|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126781544|NCT00926289|456154574|FG000|Overall Study|Protocol Violation|8|||
126781545|NCT00926289|456154575|FG001|Overall Study|Protocol Violation|12|||
126781546|NCT00926289|456154574|FG000|Overall Study|Lost to Follow-up|3|||
126781547|NCT00926289|456154575|FG001|Overall Study|Lost to Follow-up|6|||
126781548|NCT00926289|456154574|FG000|Overall Study|Withdrawal by Subject|4|||
126781549|NCT00926289|456154575|FG001|Overall Study|Withdrawal by Subject|4|||
126781550|NCT00926289|456154574|FG000|Overall Study|Other|1|||
126781551|NCT00926289|456154575|FG001|Overall Study|Other|3|||
126614851|NCT00428714|455547575|FG001|Overall Study|Death due to other then PD|0|||
126614852|NCT01681511|455547576|FG000|Overall Study|No Treatment Received|1|||
126614853|NCT01681511|455547577|FG001|Overall Study|No Treatment Received|3|||
126614854|NCT01681511|455547576|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
126614855|NCT01681511|455547577|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
126614856|NCT01681511|455547576|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
126614857|NCT01681511|455547577|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
126781552|NCT01193517|456154576|FG000|Overall Study|Early Progression|1|||
126739164|NCT03424044|455995117|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126739165|NCT03424044|455995118|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126739166|NCT03424044|455995119|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126739167|NCT03424044|455995120|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126739168|NCT03424044|455995121|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
126739169|NCT03424044|455995113|FG000|First Intervention (76 Hours)|Adverse Event|0|||
126739170|NCT03424044|455995114|FG001|First Intervention (76 Hours)|Adverse Event|0|||
126739171|NCT03424044|455995115|FG002|First Intervention (76 Hours)|Adverse Event|0|||
126739172|NCT03424044|455995116|FG003|First Intervention (76 Hours)|Adverse Event|0|||
126739173|NCT03424044|455995117|FG004|First Intervention (76 Hours)|Adverse Event|1|||
126739174|NCT03424044|455995118|FG005|First Intervention (76 Hours)|Adverse Event|0|||
126739175|NCT03424044|455995119|FG006|First Intervention (76 Hours)|Adverse Event|0|||
126739176|NCT03424044|455995120|FG007|First Intervention (76 Hours)|Adverse Event|0|||
126739177|NCT03424044|455995121|FG008|First Intervention (76 Hours)|Adverse Event|0|||
126739178|NCT03424044|455995113|FG000|First Intervention (76 Hours)|device issues|0|||
126739179|NCT03424044|455995114|FG001|First Intervention (76 Hours)|device issues|0|||
126739180|NCT03424044|455995115|FG002|First Intervention (76 Hours)|device issues|0|||
126739181|NCT03424044|455995116|FG003|First Intervention (76 Hours)|device issues|0|||
126739182|NCT03424044|455995117|FG004|First Intervention (76 Hours)|device issues|0|||
126739183|NCT03424044|455995118|FG005|First Intervention (76 Hours)|device issues|0|||
126739184|NCT03424044|455995119|FG006|First Intervention (76 Hours)|device issues|1|||
126739185|NCT03424044|455995120|FG007|First Intervention (76 Hours)|device issues|1|||
126739186|NCT03424044|455995121|FG008|First Intervention (76 Hours)|device issues|1|||
126739187|NCT03424044|455995113|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
126739188|NCT03424044|455995114|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
126739189|NCT03424044|455995115|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
126739190|NCT03424044|455995116|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
126781553|NCT01193517|456154577|FG001|Overall Study|Early Progression|0|||
126781554|NCT01193517|456154578|FG002|Overall Study|Early Progression|0|||
126781555|NCT02115256|456154579|FG000|Overall Study|Withdrawal by Subject|0|||
126781556|NCT02115256|456154580|FG001|Overall Study|Withdrawal by Subject|1|||
126781557|NCT00146770|456154582|FG000|Overall Study|Adverse Event|2|||
126781558|NCT00146770|456154583|FG001|Overall Study|Adverse Event|0|||
126781559|NCT00146770|456154582|FG000|Overall Study|Pregnancy|1|||
126781560|NCT00146770|456154583|FG001|Overall Study|Pregnancy|0|||
126781561|NCT00146770|456154582|FG000|Overall Study|Withdrawal by Subject|2|||
126781562|NCT00146770|456154583|FG001|Overall Study|Withdrawal by Subject|0|||
126781563|NCT03775681|456154588|FG000|Overall Study|Physician Decision|3|||
126781564|NCT01855126|456154589|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
126781565|NCT01855126|456154590|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
126781566|NCT01855126|456154589|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
126781567|NCT01855126|456154590|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
126781568|NCT01512979|456154599|FG000|Overall Study|Adverse Event|2|||
126781569|NCT01512979|456154600|FG001|Overall Study|Adverse Event|2|||
126781570|NCT01512979|456154599|FG000|Overall Study|Protocol Violation|1|||
126781571|NCT01512979|456154600|FG001|Overall Study|Protocol Violation|4|||
126781572|NCT01512979|456154599|FG000|Overall Study|Lost to Follow-up|2|||
126781573|NCT01512979|456154600|FG001|Overall Study|Lost to Follow-up|5|||
126781574|NCT01512979|456154599|FG000|Overall Study|Withdrawal by Subject|1|||
126781575|NCT01512979|456154600|FG001|Overall Study|Withdrawal by Subject|2|||
126781576|NCT01512979|456154599|FG000|Overall Study|Reason other than stated above|13|||
126781577|NCT01512979|456154600|FG001|Overall Study|Reason other than stated above|9|||
126781578|NCT01748890|456154610|FG000|Overall Study|Insufficient recruitment for analysis|4|||
126781579|NCT00874757|456154615|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
126781580|NCT02806232|456156180|FG000|Overall Study|Lost to Follow-up|1|||
126781581|NCT02806232|456156181|FG001|Overall Study|Lost to Follow-up|2|||
126781582|NCT02806232|456156182|FG002|Overall Study|Lost to Follow-up|1|||
126781583|NCT02806232|456156183|FG003|Overall Study|Lost to Follow-up|0|||
126781584|NCT02806232|456156184|FG004|Overall Study|Lost to Follow-up|0|||
126781585|NCT02806232|456156185|FG005|Overall Study|Lost to Follow-up|1|||
126781586|NCT02806232|456156186|FG006|Overall Study|Lost to Follow-up|0|||
126781587|NCT02806232|456156187|FG007|Overall Study|Lost to Follow-up|0|||
126781588|NCT02806232|456156188|FG008|Overall Study|Lost to Follow-up|0|||
126739191|NCT03424044|455995117|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
126781589|NCT02806232|456156180|FG000|Overall Study|Withdrawal by Subject|0|||
126781590|NCT02806232|456156181|FG001|Overall Study|Withdrawal by Subject|2|||
126739192|NCT03424044|455995118|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
126739193|NCT03424044|455995119|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
126739194|NCT03424044|455995120|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
126781591|NCT02806232|456156182|FG002|Overall Study|Withdrawal by Subject|0|||
126781592|NCT02806232|456156183|FG003|Overall Study|Withdrawal by Subject|0|||
126781593|NCT02806232|456156184|FG004|Overall Study|Withdrawal by Subject|2|||
126781594|NCT02806232|456156185|FG005|Overall Study|Withdrawal by Subject|1|||
126739195|NCT03424044|455995121|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
126739196|NCT03424044|455995113|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126739197|NCT03424044|455995114|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126739198|NCT03424044|455995115|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126739199|NCT03424044|455995116|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
126739200|NCT03424044|455995117|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126739201|NCT03424044|455995118|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126739202|NCT03424044|455995119|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126739203|NCT03424044|455995120|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126739204|NCT03424044|455995121|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
126739205|NCT02971007|455995122|FG000|Overall Study|Adverse Event|1|||
126739206|NCT02971007|455995123|FG001|Overall Study|Adverse Event|0|||
126739207|NCT02971007|455995124|FG002|Overall Study|Adverse Event|0|||
126739208|NCT02971007|455995122|FG000|Overall Study|Lost to Follow-up|0|||
126739209|NCT02971007|455995123|FG001|Overall Study|Lost to Follow-up|1|||
126739210|NCT02971007|455995124|FG002|Overall Study|Lost to Follow-up|1|||
126739211|NCT02971007|455995122|FG000|Overall Study|Withdrawal by Subject|0|||
126739212|NCT02971007|455995123|FG001|Overall Study|Withdrawal by Subject|1|||
126739213|NCT02971007|455995124|FG002|Overall Study|Withdrawal by Subject|0|||
126739214|NCT02971007|455995122|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
126739215|NCT02971007|455995123|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
126739216|NCT02971007|455995124|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
126739217|NCT02971007|455995122|FG000|Overall Study|Patient discontinued study drug|0|||
126739218|NCT02971007|455995123|FG001|Overall Study|Patient discontinued study drug|1|||
126739219|NCT02971007|455995124|FG002|Overall Study|Patient discontinued study drug|0|||
126739220|NCT00402285|455995127|FG000|Overall Study|insufficient RNA quality|7|||
126739221|NCT00402285|455995128|FG001|Overall Study|insufficient RNA quality|6|||
126739222|NCT00402285|455995129|FG002|Overall Study|insufficient RNA quality|2|||
126739223|NCT00784459|455995130|FG000|Overall Study|Adverse Event|0|||
126739224|NCT00784459|455995131|FG001|Overall Study|Adverse Event|2|||
126739225|NCT02707601|455995132|FG000|Overall Study|Death|0|||
126739226|NCT02707601|455995133|FG001|Overall Study|Death|1|||
126739227|NCT02707601|455995132|FG000|Overall Study|Lack of Efficacy|0|||
126739228|NCT02707601|455995133|FG001|Overall Study|Lack of Efficacy|1|||
126739229|NCT02707601|455995132|FG000|Overall Study|Investigator's Discretion|1|||
126739230|NCT02707601|455995133|FG001|Overall Study|Investigator's Discretion|0|||
126739231|NCT02707601|455995132|FG000|Overall Study|Withdrew Consent|0|||
126739232|NCT02707601|455995133|FG001|Overall Study|Withdrew Consent|1|||
126739233|NCT02707601|455995132|FG000|Overall Study|Lost to Follow-up|1|||
126739234|NCT02707601|455995133|FG001|Overall Study|Lost to Follow-up|1|||
126739235|NCT02707601|455995132|FG000|Overall Study|Participants Randomized but Not Treated|2|||
126739236|NCT02707601|455995133|FG001|Overall Study|Participants Randomized but Not Treated|0|||
126739237|NCT02009930|455995134|FG000|Overall Study|withdrawn|5|||
126739238|NCT02959970|455995136|FG000|Overall Study|Adverse Event|1|||
126739239|NCT02959970|455995137|FG001|Overall Study|Adverse Event|0|||
126739240|NCT02959970|455995136|FG000|Overall Study|Withdrawal by Subject|0|||
126739241|NCT02959970|455995137|FG001|Overall Study|Withdrawal by Subject|2|||
126739242|NCT02959970|455995136|FG000|Overall Study|Lost to Follow-up|1|||
126739243|NCT02959970|455995137|FG001|Overall Study|Lost to Follow-up|5|||
126739244|NCT00693420|455995138|FG000|Overall Study|Adverse Event|4|||
126739245|NCT00693420|455995139|FG001|Overall Study|Adverse Event|4|||
126739246|NCT00693420|455995138|FG000|Overall Study|Lost to Follow-up|0|||
126739247|NCT00693420|455995139|FG001|Overall Study|Lost to Follow-up|3|||
126739248|NCT00693420|455995138|FG000|Overall Study|Withdrawal by Subject|1|||
126739249|NCT00693420|455995139|FG001|Overall Study|Withdrawal by Subject|0|||
126739250|NCT00693420|455995138|FG000|Overall Study|Protocol Violation|0|||
126739251|NCT00693420|455995139|FG001|Overall Study|Protocol Violation|2|||
126739252|NCT00693420|455995138|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
126739253|NCT00693420|455995139|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
126739254|NCT00693420|455995138|FG000|Overall Study|Personal Reasons|1|||
126739255|NCT00693420|455995139|FG001|Overall Study|Personal Reasons|4|||
126739256|NCT00063986|455995143|FG000|Overall Study|Withdrawal by Subject|1|||
126739257|NCT00063986|455995143|FG000|Overall Study|Ineligible|1|||
126739258|NCT00063986|455995143|FG000|Overall Study|Intra-operatively ineligible|4|||
126739259|NCT00633893|455995149|FG000|Overall Study|Death|1|||
126739260|NCT00633893|455995150|FG001|Overall Study|Death|3|||
126739261|NCT00633893|455995151|FG002|Overall Study|Death|9|||
126739262|NCT00633893|455995149|FG000|Overall Study|Adverse Event|65|||
126739263|NCT00633893|455995150|FG001|Overall Study|Adverse Event|58|||
126739264|NCT00633893|455995151|FG002|Overall Study|Adverse Event|126|||
126739265|NCT00633893|455995149|FG000|Overall Study|Withdrawal by Subject|7|||
126739266|NCT00633893|455995150|FG001|Overall Study|Withdrawal by Subject|12|||
126739267|NCT00633893|455995151|FG002|Overall Study|Withdrawal by Subject|6|||
126739268|NCT00633893|455995149|FG000|Overall Study|Lost to Follow-up|2|||
126739269|NCT00633893|455995150|FG001|Overall Study|Lost to Follow-up|4|||
126739270|NCT00633893|455995151|FG002|Overall Study|Lost to Follow-up|8|||
126739271|NCT00633893|455995149|FG000|Overall Study|Poor/non-compliance|5|||
126739272|NCT00633893|455995150|FG001|Overall Study|Poor/non-compliance|12|||
126739273|NCT00633893|455995151|FG002|Overall Study|Poor/non-compliance|3|||
126739274|NCT00633893|455995149|FG000|Overall Study|Pregnancy|2|||
126739275|NCT00633893|455995150|FG001|Overall Study|Pregnancy|1|||
126739276|NCT00633893|455995151|FG002|Overall Study|Pregnancy|1|||
126739277|NCT00633893|455995149|FG000|Overall Study|Not meet/no longer meets criteria|4|||
126739278|NCT00633893|455995150|FG001|Overall Study|Not meet/no longer meets criteria|6|||
126739279|NCT00633893|455995151|FG002|Overall Study|Not meet/no longer meets criteria|4|||
126739280|NCT00633893|455995149|FG000|Overall Study|Other|28|||
126739281|NCT00633893|455995150|FG001|Overall Study|Other|33|||
126739282|NCT00633893|455995151|FG002|Overall Study|Other|31|||
126739283|NCT02741310|455995152|FG000|Overall Study|Sponsor Decision|2|||
126739284|NCT02741310|455995153|FG001|Overall Study|Sponsor Decision|2|||
126739285|NCT05091918|455995154|FG000|Overall Study|Adverse Event|1|||
126739286|NCT05091918|455995154|FG000|Overall Study|Withdrawal by Subject|81|||
126739287|NCT00239356|455995155|FG000|Overall Study|Lack of Efficacy|1|||
126739288|NCT00239356|455995156|FG001|Overall Study|Lack of Efficacy|0|||
126739289|NCT00239356|455995155|FG000|Overall Study|Adverse Event|6|||
126739290|NCT00239356|455995156|FG001|Overall Study|Adverse Event|0|||
126739291|NCT00239356|455995155|FG000|Overall Study|Withdrawal by Subject|15|||
126739292|NCT00239356|455995156|FG001|Overall Study|Withdrawal by Subject|6|||
126739293|NCT00239356|455995155|FG000|Overall Study|Lost to Follow-up|3|||
126739294|NCT00239356|455995156|FG001|Overall Study|Lost to Follow-up|0|||
126739295|NCT00239356|455995155|FG000|Overall Study|poor/non-compliance|2|||
126739296|NCT00239356|455995156|FG001|Overall Study|poor/non-compliance|0|||
126739297|NCT00239356|455995155|FG000|Overall Study|Pregnancy|1|||
126739298|NCT00239356|455995156|FG001|Overall Study|Pregnancy|0|||
126739299|NCT00239356|455995155|FG000|Overall Study|Administrative reason|0|||
126739300|NCT00239356|455995156|FG001|Overall Study|Administrative reason|1|||
126739301|NCT00239356|455995155|FG000|Overall Study|Drug available on market|11|||
126739302|NCT00239356|455995156|FG001|Overall Study|Drug available on market|2|||
126739303|NCT02044822|455995157|FG000|Overall Study|Study Terminated by Sponsor|77|||
126739304|NCT02044822|455995157|FG000|Overall Study|Investigator's Discretion|10|||
126739305|NCT02044822|455995157|FG000|Overall Study|Withdrew Consent|3|||
126739306|NCT02044822|455995157|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
126739307|NCT02044822|455995157|FG000|Overall Study|Lost to Follow-up|1|||
126739308|NCT03417505|455995160|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
126739309|NCT03417505|455995161|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
126739310|NCT03006926|455995164|FG000|Overall Study|Adverse Event|0|||
126739311|NCT03006926|455995165|FG001|Overall Study|Adverse Event|27|||
126739312|NCT03006926|455995164|FG000|Overall Study|Withdrawal by Subject|0|||
126739313|NCT03006926|455995165|FG001|Overall Study|Withdrawal by Subject|1|||
126739314|NCT03006926|455995164|FG000|Overall Study|Radiological Disease Progression|0|||
126739315|NCT03006926|455995165|FG001|Overall Study|Radiological Disease Progression|52|||
126739316|NCT03006926|455995164|FG000|Overall Study|Clinical Disease Progression|0|||
126739317|NCT03006926|455995165|FG001|Overall Study|Clinical Disease Progression|10|||
126739318|NCT03006926|455995164|FG000|Overall Study|Other|0|||
126739319|NCT03006926|455995165|FG001|Overall Study|Other|8|||
126739320|NCT03689972|455995166|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
126739321|NCT03689972|455995167|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
126739322|NCT03689972|455995168|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
126739323|NCT03689972|455995169|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
126739324|NCT03689972|455995170|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
126739325|NCT03689972|455995166|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
126739326|NCT03689972|455995167|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
126739327|NCT03689972|455995168|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
126739328|NCT03689972|455995169|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
126739329|NCT03689972|455995170|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
126739330|NCT03689972|455995166|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
126739331|NCT03689972|455995167|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
126739332|NCT03689972|455995168|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
126739333|NCT03689972|455995169|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
126739334|NCT03689972|455995170|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
126739335|NCT03689972|455995166|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
126739336|NCT03689972|455995167|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
126739337|NCT03689972|455995168|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
126739338|NCT03689972|455995169|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
126739339|NCT03689972|455995170|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
126739340|NCT03689972|455995166|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
126739341|NCT03689972|455995167|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
126739342|NCT03689972|455995168|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
126739343|NCT03689972|455995169|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
126614858|NCT01681511|455547576|FG000|Overall Study|No Daily Urine Sample Collected|0|||
126614859|NCT01681511|455547577|FG001|Overall Study|No Daily Urine Sample Collected|1|||
126614860|NCT01681511|455547576|FG000|Overall Study|No post-catheter sample collected|11|||
126614861|NCT01681511|455547577|FG001|Overall Study|No post-catheter sample collected|4|||
126614862|NCT01276509|455549648|FG000|Overall Study|Adverse Event|9|||
126614863|NCT01276509|455549649|FG001|Overall Study|Adverse Event|8|||
126614864|NCT01276509|455549650|FG002|Overall Study|Adverse Event|4|||
126614865|NCT01276509|455549651|FG003|Overall Study|Adverse Event|3|||
126614866|NCT01276509|455549648|FG000|Overall Study|Lack of Efficacy|2|||
126614867|NCT01276509|455549649|FG001|Overall Study|Lack of Efficacy|1|||
126614868|NCT01276509|455549650|FG002|Overall Study|Lack of Efficacy|1|||
126614869|NCT01276509|455549651|FG003|Overall Study|Lack of Efficacy|2|||
126614870|NCT01276509|455549648|FG000|Overall Study|Pregnancy|1|||
126614871|NCT01276509|455549649|FG001|Overall Study|Pregnancy|0|||
126614872|NCT01276509|455549650|FG002|Overall Study|Pregnancy|0|||
126614873|NCT01276509|455549651|FG003|Overall Study|Pregnancy|0|||
126614874|NCT01276509|455549648|FG000|Overall Study|Withdrawal by Subject|1|||
126614875|NCT01276509|455549649|FG001|Overall Study|Withdrawal by Subject|2|||
126614876|NCT01276509|455549650|FG002|Overall Study|Withdrawal by Subject|0|||
126614877|NCT01276509|455549651|FG003|Overall Study|Withdrawal by Subject|0|||
126614878|NCT01276509|455549648|FG000|Overall Study|Other|0|||
126614879|NCT01276509|455549649|FG001|Overall Study|Other|1|||
126614880|NCT01276509|455549650|FG002|Overall Study|Other|0|||
126614881|NCT01276509|455549651|FG003|Overall Study|Other|0|||
126614882|NCT02196259|455549657|FG000|Overall Study|Researcher choice|0|||
126614883|NCT02196259|455549658|FG001|Overall Study|Researcher choice|0|||
126614884|NCT02196259|455549659|FG002|Overall Study|Researcher choice|1|||
126614885|NCT02196259|455549657|FG000|Overall Study|Partial data analysis|0|||
126614886|NCT02196259|455549658|FG001|Overall Study|Partial data analysis|3|||
126614887|NCT02196259|455549659|FG002|Overall Study|Partial data analysis|0|||
126614888|NCT01668355|455549660|FG000|Overall Study|Death|3|||
126614889|NCT01668355|455549661|FG001|Overall Study|Death|1|||
126614890|NCT01668355|455549660|FG000|Overall Study|Withdrawal by Subject|6|||
126614891|NCT01668355|455549661|FG001|Overall Study|Withdrawal by Subject|1|||
126614892|NCT00215943|455549662|FG000|Overall Study|Disease Progression|3|||
126614893|NCT00215943|455549663|FG001|Overall Study|Disease Progression|5|||
126614894|NCT00215943|455549662|FG000|Overall Study|Alternate therapy|0|||
126614895|NCT00215943|455549663|FG001|Overall Study|Alternate therapy|1|||
126614896|NCT00215943|455549662|FG000|Overall Study|Adverse Event|3|||
126614897|NCT00215943|455549663|FG001|Overall Study|Adverse Event|6|||
126614898|NCT00215943|455549662|FG000|Overall Study|Other disease|0|||
126614899|NCT00215943|455549663|FG001|Overall Study|Other disease|1|||
126614900|NCT00215943|455549662|FG000|Overall Study|Other complications|3|||
126614901|NCT00215943|455549663|FG001|Overall Study|Other complications|1|||
126614902|NCT04311983|455549664|FG000|Overall Study|Lost to Follow-up|421|||
126614903|NCT04311983|455549665|FG001|Overall Study|Lost to Follow-up|456|||
126614904|NCT04311983|455549664|FG000|Overall Study|Incomplete survey|7|||
126614905|NCT04311983|455549665|FG001|Overall Study|Incomplete survey|9|||
126614906|NCT04311983|455549664|FG000|Overall Study|Death|1|||
126614907|NCT04311983|455549665|FG001|Overall Study|Death|0|||
126614908|NCT00403845|455549675|FG000|Treatment Period 1|Subject withdrew consent|1|||
126614909|NCT00403845|455549676|FG001|Treatment Period 1|Subject withdrew consent|0|||
126614910|NCT00403845|455549677|FG002|Treatment Period 1|Subject withdrew consent|0|||
126614911|NCT00403845|455549678|FG003|Treatment Period 1|Subject withdrew consent|0|||
126614912|NCT00403845|455549675|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
126614913|NCT00403845|455549676|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
126614914|NCT00403845|455549677|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
126614915|NCT00403845|455549678|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
126614916|NCT00403845|455549675|FG000|Treatment Period 2|Subject withdrew consent|1|||
126614917|NCT00403845|455549676|FG001|Treatment Period 2|Subject withdrew consent|0|||
126614918|NCT00403845|455549677|FG002|Treatment Period 2|Subject withdrew consent|0|||
126614919|NCT00403845|455549678|FG003|Treatment Period 2|Subject withdrew consent|0|||
126614920|NCT00403845|455549675|FG000|Treatment Period 3|Subject withdrew consent|0|||
126614921|NCT00403845|455549676|FG001|Treatment Period 3|Subject withdrew consent|0|||
126614922|NCT00403845|455549677|FG002|Treatment Period 3|Subject withdrew consent|0|||
126739344|NCT03689972|455995170|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
126614923|NCT00403845|455549678|FG003|Treatment Period 3|Subject withdrew consent|1|||
126614924|NCT00403845|455549675|FG000|Treatment Period 3|Adverse Event|0|||
126614925|NCT00403845|455549676|FG001|Treatment Period 3|Adverse Event|0|||
126614926|NCT00403845|455549677|FG002|Treatment Period 3|Adverse Event|0|||
126614927|NCT00403845|455549678|FG003|Treatment Period 3|Adverse Event|1|||
126614928|NCT02152384|455549679|FG000|Period 1|Withdrawal by Subject|0|||
126614929|NCT02152384|455549680|FG001|Period 1|Withdrawal by Subject|1|||
126614930|NCT02152384|455549679|FG000|Period 1|Adverse Event|1|||
126614931|NCT02152384|455549680|FG001|Period 1|Adverse Event|1|||
126614932|NCT00088166|455549682|FG000|Overall Study|Adverse Event|11|||
126614933|NCT00088166|455549683|FG001|Overall Study|Adverse Event|9|||
126614934|NCT00088166|455549682|FG000|Overall Study|Death|3|||
126739345|NCT03689972|455995166|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
126739346|NCT03689972|455995167|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
126739347|NCT03689972|455995168|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
126739348|NCT03689972|455995169|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
126739349|NCT03689972|455995170|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
126739350|NCT03689972|455995166|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
126739351|NCT03689972|455995167|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
126739352|NCT03689972|455995168|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
126739353|NCT03689972|455995169|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
126739354|NCT03689972|455995170|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
126739355|NCT03689972|455995166|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
126739356|NCT03689972|455995167|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
126739357|NCT03689972|455995168|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
126739358|NCT03689972|455995169|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
126739359|NCT03689972|455995170|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
126739360|NCT03689972|455995166|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
126739361|NCT03689972|455995167|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
126739362|NCT03689972|455995168|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
126739363|NCT03689972|455995169|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
126739364|NCT03689972|455995170|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
126739365|NCT03689972|455995166|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
126739366|NCT03689972|455995167|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
126739367|NCT03689972|455995168|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
126739368|NCT03689972|455995169|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
126739369|NCT03689972|455995170|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
126739370|NCT03689972|455995166|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
126739371|NCT03689972|455995167|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
126739372|NCT03689972|455995168|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
126739373|NCT03689972|455995169|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
126739374|NCT03689972|455995170|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
126739375|NCT03689972|455995166|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
126739376|NCT03689972|455995167|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
126739377|NCT03689972|455995168|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
126739378|NCT03689972|455995169|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
126739379|NCT03689972|455995170|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
126739380|NCT03689972|455995166|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
126739381|NCT03689972|455995167|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
126739382|NCT03689972|455995168|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
126739383|NCT03689972|455995169|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
126739384|NCT03689972|455995170|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
126739385|NCT03689972|455995166|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
126739386|NCT03689972|455995167|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
126739387|NCT03689972|455995168|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
126739388|NCT03689972|455995169|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
126739389|NCT03689972|455995170|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
126739390|NCT03689972|455995166|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
126739391|NCT03689972|455995167|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
126739392|NCT03689972|455995168|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
126739393|NCT03689972|455995169|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
126739394|NCT03689972|455995170|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
126739395|NCT03689972|455995166|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
126739396|NCT03689972|455995167|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
126739397|NCT03689972|455995168|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
126739398|NCT03689972|455995169|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
126739399|NCT03689972|455995170|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
126739400|NCT03689972|455995166|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
126739401|NCT03689972|455995167|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
126739402|NCT03689972|455995168|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
126739403|NCT03689972|455995169|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
126739404|NCT03689972|455995170|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
126739405|NCT03689972|455995166|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
126739406|NCT03689972|455995167|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
126756586|NCT00883896|456059485|FG003|Overall Study|Other|0|||
126756587|NCT01856920|456059495|FG000|Overall Study|Disease Progression On Study|3|||
126756588|NCT01856920|456059496|FG001|Overall Study|Disease Progression On Study|4|||
126614935|NCT00088166|455549683|FG001|Overall Study|Death|1|||
126614936|NCT00088166|455549682|FG000|Overall Study|Lost to Follow-up|0|||
126614937|NCT00088166|455549683|FG001|Overall Study|Lost to Follow-up|1|||
126614938|NCT00088166|455549682|FG000|Overall Study|Physician Decision|4|||
126614939|NCT00088166|455549683|FG001|Overall Study|Physician Decision|1|||
126614940|NCT00088166|455549682|FG000|Overall Study|Protocol Violation|1|||
126614941|NCT00088166|455549683|FG001|Overall Study|Protocol Violation|5|||
126614942|NCT00088166|455549682|FG000|Overall Study|Patient deterioration|29|||
126614943|NCT00088166|455549683|FG001|Overall Study|Patient deterioration|39|||
126614944|NCT00088166|455549682|FG000|Overall Study|Withdrawal by Subject|5|||
126614945|NCT00088166|455549683|FG001|Overall Study|Withdrawal by Subject|5|||
126614946|NCT02671266|455549684|FG000|Overall Study|Withdrawal by Subject|1|||
126614947|NCT02671266|455549685|FG001|Overall Study|Withdrawal by Subject|1|||
126614948|NCT00666705|455549686|FG000|Overall Study|Withdrawal by Subject|1|||
126614949|NCT01109979|455549687|FG000|Overall Study|Physician Decision|2|||
126614950|NCT01109979|455549688|FG001|Overall Study|Physician Decision|0|||
126614951|NCT01109979|455549687|FG000|Overall Study|Withdrawal by Subject|0|||
126614952|NCT01109979|455549688|FG001|Overall Study|Withdrawal by Subject|1|||
126614953|NCT01228734|455549689|FG000|Overall Study|Randomized, but not treated|0|||
126614954|NCT01228734|455549690|FG001|Overall Study|Randomized, but not treated|4|||
126614955|NCT03128099|455549692|FG000|Overall Study|High dose task was too long|0|||
126614956|NCT03128099|455549693|FG001|Overall Study|High dose task was too long|4|||
126614957|NCT03128099|455549694|FG002|Overall Study|High dose task was too long|0|||
126614958|NCT03128099|455549692|FG000|Overall Study|Participant got a full time job.|1|||
126614959|NCT03128099|455549693|FG001|Overall Study|Participant got a full time job.|0|||
126614960|NCT03128099|455549694|FG002|Overall Study|Participant got a full time job.|0|||
126614961|NCT03128099|455549692|FG000|Overall Study|Became homeless and lost contact|1|||
126614962|NCT03128099|455549693|FG001|Overall Study|Became homeless and lost contact|0|||
126614963|NCT03128099|455549694|FG002|Overall Study|Became homeless and lost contact|0|||
126614964|NCT03128099|455549692|FG000|Overall Study|Did not complete all the assessments|0|||
126614965|NCT03128099|455549693|FG001|Overall Study|Did not complete all the assessments|0|||
126614966|NCT03128099|455549694|FG002|Overall Study|Did not complete all the assessments|1|||
126614967|NCT03456856|455549697|FG000|Overall Study|Lost to Follow-up|2|||
126614968|NCT03456856|455549697|FG000|Overall Study|Withdrawal by Subject|1|||
126614969|NCT02542696|455549700|FG000|Overall Study|Adverse Event|167|||
126614970|NCT02542696|455549700|FG000|Overall Study|Lack of Efficacy|26|||
126614971|NCT02542696|455549700|FG000|Overall Study|Lost to Follow-up|6|||
126614972|NCT02542696|455549700|FG000|Overall Study|Withdrawal by Subject|104|||
126614973|NCT02542696|455549700|FG000|Overall Study|Protocol Violation|5|||
126614974|NCT02542696|455549700|FG000|Overall Study|Death|8|||
126614975|NCT02542696|455549700|FG000|Overall Study|DECREASED OFF TIME|1|||
126614976|NCT02542696|455549700|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
126614977|NCT02542696|455549700|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
126614978|NCT02542696|455549700|FG000|Overall Study|MEDICAL HISTORY|1|||
126614979|NCT02542696|455549700|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
126614980|NCT02542696|455549700|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
126614981|NCT02542696|455549700|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
126614982|NCT02542696|455549700|FG000|Overall Study|SPONSOR DECISION|3|||
126614983|NCT02542696|455549700|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
126614984|NCT02542696|455549700|FG000|Overall Study|SUBJECT DECISION|2|||
126614985|NCT02137785|455549704|FG000|Overall Study|Lost to Follow-up|1|||
126614986|NCT02137785|455549705|FG001|Overall Study|Lost to Follow-up|0|||
126614987|NCT02137785|455549704|FG000|Overall Study|Withdrawal by Subject|1|||
126614988|NCT02137785|455549705|FG001|Overall Study|Withdrawal by Subject|4|||
126614989|NCT02137785|455549704|FG000|Overall Study|subject moved out of state|1|||
126614990|NCT02137785|455549705|FG001|Overall Study|subject moved out of state|0|||
126614991|NCT03390166|455549706|FG000|Overall Study|Death|0|||
126614992|NCT03390166|455549707|FG001|Overall Study|Death|1|||
126614993|NCT03390166|455549706|FG000|Overall Study|Lost to Follow-up|6|||
126614994|NCT03390166|455549707|FG001|Overall Study|Lost to Follow-up|4|||
126614995|NCT03390166|455549706|FG000|Overall Study|Physician Decision|2|||
126614996|NCT03390166|455549707|FG001|Overall Study|Physician Decision|1|||
126614997|NCT03390166|455549706|FG000|Overall Study|Move from study area|3|||
126614998|NCT03390166|455549707|FG001|Overall Study|Move from study area|2|||
126614999|NCT03390166|455549706|FG000|Overall Study|To militarycamp for conscript|1|||
126615000|NCT03390166|455549707|FG001|Overall Study|To militarycamp for conscript|0|||
126615001|NCT03390166|455549706|FG000|Overall Study|To drug therapy course|0|||
126615002|NCT03390166|455549707|FG001|Overall Study|To drug therapy course|1|||
126615003|NCT03390166|455549706|FG000|Overall Study|Move to work oversea|0|||
126615004|NCT03390166|455549707|FG001|Overall Study|Move to work oversea|1|||
126615005|NCT03150589|455549712|FG000|Overall Study|Withdrawal by Subject|16|||
126615006|NCT03150589|455549713|FG001|Overall Study|Withdrawal by Subject|9|||
126615007|NCT03150589|455549712|FG000|Overall Study|Adverse Event|7|||
126615008|NCT03150589|455549713|FG001|Overall Study|Adverse Event|6|||
126615009|NCT03150589|455549712|FG000|Overall Study|Protocol Violation|4|||
126781595|NCT02806232|456156186|FG006|Overall Study|Withdrawal by Subject|0|||
126781596|NCT02806232|456156187|FG007|Overall Study|Withdrawal by Subject|0|||
126781597|NCT02806232|456156188|FG008|Overall Study|Withdrawal by Subject|0|||
126781598|NCT02482805|456156195|FG000|Overall Study|Lost to Follow-up|4|||
126781599|NCT02482805|456156196|FG001|Overall Study|Lost to Follow-up|4|||
126781600|NCT02482805|456156197|FG002|Overall Study|Lost to Follow-up|0|||
126781601|NCT02497391|456156199|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
126781602|NCT02497391|456156200|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
126781603|NCT02497391|456156201|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
126781604|NCT02497391|456156202|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
126781605|NCT02497391|456156203|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
126781606|NCT02497391|456156204|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
126781607|NCT02497391|456156199|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
126781608|NCT02497391|456156200|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
126781609|NCT02497391|456156201|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
126781610|NCT02497391|456156202|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
126781611|NCT02497391|456156203|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
126781612|NCT02497391|456156204|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
126781613|NCT02497391|456156199|FG000|Period 3 (14 Days)|Adverse Event|0|||
126781614|NCT02497391|456156200|FG001|Period 3 (14 Days)|Adverse Event|1|||
126781615|NCT02497391|456156201|FG002|Period 3 (14 Days)|Adverse Event|0|||
126781616|NCT02497391|456156202|FG003|Period 3 (14 Days)|Adverse Event|0|||
126781617|NCT02497391|456156203|FG004|Period 3 (14 Days)|Adverse Event|0|||
126781618|NCT02497391|456156204|FG005|Period 3 (14 Days)|Adverse Event|0|||
126615010|NCT03150589|455549713|FG001|Overall Study|Protocol Violation|3|||
126615011|NCT03150589|455549712|FG000|Overall Study|Lost to Follow-up|3|||
126739407|NCT03689972|455995168|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
126739408|NCT03689972|455995169|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
126739409|NCT03689972|455995170|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
126739410|NCT03689972|455995166|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
126739411|NCT03689972|455995167|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
126739412|NCT03689972|455995168|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
126739413|NCT03689972|455995169|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
126739414|NCT03689972|455995170|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
126739415|NCT01838213|455995171|FG000|Overall Study|Ineligible|166|||
126739416|NCT01838213|455995172|FG001|Overall Study|Ineligible|191|||
126739417|NCT02417064|455995177|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
126739418|NCT02417064|455995178|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
126739419|NCT02417064|455995179|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
126739420|NCT02417064|455995177|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
126739421|NCT02417064|455995178|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
126781619|NCT02497391|456156199|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
126615012|NCT03150589|455549713|FG001|Overall Study|Lost to Follow-up|3|||
126615013|NCT03150589|455549712|FG000|Overall Study|Death|2|||
126615014|NCT03150589|455549713|FG001|Overall Study|Death|3|||
126615015|NCT03150589|455549712|FG000|Overall Study|IP non-compliance and other reasons|12|||
126615016|NCT03150589|455549713|FG001|Overall Study|IP non-compliance and other reasons|3|||
126615017|NCT01000649|455549716|FG000|Overall Study|Adverse Event|5|||
126615018|NCT01000649|455549717|FG001|Overall Study|Adverse Event|1|||
126615019|NCT01000649|455549718|FG002|Overall Study|Adverse Event|2|||
126615020|NCT01000649|455549719|FG003|Overall Study|Adverse Event|4|||
126615021|NCT01000649|455549716|FG000|Overall Study|Lost to Follow-up|0|||
126615022|NCT01000649|455549717|FG001|Overall Study|Lost to Follow-up|2|||
126615023|NCT01000649|455549718|FG002|Overall Study|Lost to Follow-up|0|||
126615024|NCT01000649|455549719|FG003|Overall Study|Lost to Follow-up|2|||
126615025|NCT00346398|455549720|FG000|Overall Study|Lost to Follow-up|3|||
126615026|NCT00346398|455549721|FG001|Overall Study|Lost to Follow-up|0|||
126615027|NCT00346398|455549720|FG000|Overall Study|Withdrawal by Subject|0|||
126615028|NCT00346398|455549721|FG001|Overall Study|Withdrawal by Subject|2|||
126615029|NCT03979040|455549722|FG000|Overall Study|Withdrawal by Subject|24|||
126615030|NCT03979040|455549723|FG001|Overall Study|Withdrawal by Subject|32|||
126615031|NCT03979040|455549722|FG000|Overall Study|randomized but never started treatment|32|||
126615032|NCT03979040|455549723|FG001|Overall Study|randomized but never started treatment|39|||
126615033|NCT03979040|455549722|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
126739422|NCT02417064|455995179|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
126739423|NCT02417064|455995177|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
126781620|NCT02497391|456156200|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
126781621|NCT02497391|456156201|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
126781622|NCT02497391|456156202|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
126615034|NCT03979040|455549723|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
126615035|NCT02607956|455549724|FG000|Double-Blinded Phase|Withdrew Consent|17|||
126615036|NCT02607956|455549725|FG001|Double-Blinded Phase|Withdrew Consent|19|||
126615037|NCT02607956|455549726|FG002|Double-Blinded Phase|Withdrew Consent|0|||
126739424|NCT02417064|455995178|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
126739425|NCT02417064|455995179|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
126739426|NCT02417064|455995177|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
126739427|NCT02417064|455995178|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
126739428|NCT02417064|455995179|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
126739429|NCT02417064|455995177|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
126739430|NCT02417064|455995178|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
126739431|NCT02417064|455995179|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
126739432|NCT02417064|455995177|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
126739433|NCT02417064|455995178|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
126739434|NCT02417064|455995179|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
126739435|NCT02417064|455995177|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
126739436|NCT02417064|455995178|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
126739437|NCT02417064|455995179|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
126739438|NCT02417064|455995177|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
126739439|NCT02417064|455995178|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
126739440|NCT02417064|455995179|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
126739441|NCT02417064|455995177|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
126739442|NCT02417064|455995178|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
126739443|NCT02417064|455995179|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
126739444|NCT02417064|455995177|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
126739445|NCT02417064|455995178|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
126739446|NCT02417064|455995179|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
126739447|NCT02417064|455995177|FG000|Follow-up Phase (24 Weeks)|Other|2|||
126739448|NCT02417064|455995178|FG001|Follow-up Phase (24 Weeks)|Other|2|||
126739449|NCT02417064|455995179|FG002|Follow-up Phase (24 Weeks)|Other|3|||
126739450|NCT00990249|455995182|FG000|Overall Study|Disease Progression|8|||
126739451|NCT00990249|455995182|FG000|Overall Study|Non-Compliance|1|||
126739452|NCT00990249|455995182|FG000|Overall Study|Death|2|||
126739453|NCT00990249|455995182|FG000|Overall Study|Not treated|2|||
126739454|NCT01548417|455995183|FG000|Overall Study|Withdrawal by Subject|0|||
126739455|NCT01548417|455995184|FG001|Overall Study|Withdrawal by Subject|2|||
126739456|NCT03725293|455995185|FG000|Overall Study|Physician Decision|9|||
126739457|NCT03725293|455995186|FG001|Overall Study|Physician Decision|6|||
126739458|NCT03725293|455995185|FG000|Overall Study|alternative vascular access needs|1|||
126739459|NCT03725293|455995186|FG001|Overall Study|alternative vascular access needs|2|||
126739460|NCT03725293|455995185|FG000|Overall Study|venous anatomy screen failures|2|||
126739461|NCT03725293|455995186|FG001|Overall Study|venous anatomy screen failures|1|||
126739462|NCT04583969|455995189|FG000|Overall Study|Death|31|||
126739463|NCT04583969|455995190|FG001|Overall Study|Death|38|||
126739464|NCT04583969|455995189|FG000|Overall Study|Lost to Follow-up|16|||
126739465|NCT04583969|455995190|FG001|Overall Study|Lost to Follow-up|13|||
126739466|NCT04583969|455995189|FG000|Overall Study|Protocol Violation|1|||
126739467|NCT04583969|455995190|FG001|Overall Study|Protocol Violation|0|||
126739468|NCT04583969|455995189|FG000|Overall Study|Withdrawal by Subject|3|||
126739469|NCT04583969|455995190|FG001|Overall Study|Withdrawal by Subject|3|||
126739470|NCT04583969|455995189|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
126739471|NCT04583969|455995190|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
126739472|NCT04583969|455995189|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
126739473|NCT04583969|455995190|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
126739474|NCT04583969|455995189|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
126739475|NCT04583969|455995190|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
126739476|NCT04583969|455995189|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
126739477|NCT04583969|455995190|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
126739478|NCT04583969|455995189|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
126739479|NCT04583969|455995190|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
126739480|NCT04397796|455995191|FG000|Overall Study|Death|3|||
126739481|NCT04397796|455995192|FG001|Overall Study|Death|1|||
126739482|NCT01057862|455995193|FG000|Overall Study|Withdrawal by Subject|1|||
126739483|NCT01057862|455995194|FG001|Overall Study|Withdrawal by Subject|2|||
126739484|NCT00415584|455995195|FG000|Overall Study|Withdrawal by Subject|1|||
126739485|NCT00802867|455995196|FG000|Overall Study|Lost to Follow-up|6|||
126739486|NCT00802867|455995196|FG000|Overall Study|Protocol Violation|6|||
126739487|NCT00802867|455995196|FG000|Overall Study|Withdrawal by Subject|1|||
126739488|NCT02640755|455995197|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
126739489|NCT02640755|455995198|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
126739490|NCT02640755|455995197|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
126739491|NCT02640755|455995198|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
126739492|NCT02640755|455995197|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
126739493|NCT02640755|455995198|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
126739494|NCT04075396|455995199|FG000|Overall Study|Death|11|||
126739495|NCT04075396|455995200|FG001|Overall Study|Death|9|||
126739496|NCT04075396|455995199|FG000|Overall Study|Withdrawal by Subject|1|||
126739497|NCT04075396|455995200|FG001|Overall Study|Withdrawal by Subject|2|||
126739498|NCT04075396|455995199|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
126739499|NCT04075396|455995200|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
126739500|NCT04075396|455995199|FG000|Overall Study|Enrolled but not-treated|0|||
126739501|NCT04075396|455995200|FG001|Overall Study|Enrolled but not-treated|1|||
126739502|NCT03434041|455995201|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
126739503|NCT03434041|455995202|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
126739504|NCT03434041|455995201|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
126739505|NCT03434041|455995202|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
126739506|NCT03434041|455995201|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
126739507|NCT03434041|455995202|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
126739508|NCT03434041|455995201|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
126739509|NCT03434041|455995202|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
126739510|NCT03434041|455995201|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
126739511|NCT03434041|455995202|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
126739512|NCT03434041|455995201|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
126739513|NCT03434041|455995202|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
126739514|NCT03434041|455995201|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
126739515|NCT03434041|455995202|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
126739516|NCT03434041|455995201|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
126739517|NCT03434041|455995202|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
126739518|NCT03434041|455995201|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
126739519|NCT03434041|455995202|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
126739520|NCT03434041|455995201|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
126739521|NCT03434041|455995202|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
126739522|NCT03434041|455995201|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
126739523|NCT03434041|455995202|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
126739524|NCT03363165|455995209|FG000|3-month Follow-up|Death|0|||
126739525|NCT03363165|455995210|FG001|3-month Follow-up|Death|1|||
126739526|NCT03363165|455995209|FG000|6-month Follow-up|Death|0|||
126739527|NCT03363165|455995210|FG001|6-month Follow-up|Death|1|||
126739528|NCT03363165|455995209|FG000|6-month Follow-up|Withdrawal by Subject|1|||
126739529|NCT03363165|455995210|FG001|6-month Follow-up|Withdrawal by Subject|1|||
126739530|NCT03363165|455995209|FG000|12-month Follow-up|Death|1|||
126739531|NCT03363165|455995210|FG001|12-month Follow-up|Death|1|||
126739532|NCT03363165|455995209|FG000|12-month Follow-up|Withdrawal by Subject|1|||
126739533|NCT03363165|455995210|FG001|12-month Follow-up|Withdrawal by Subject|1|||
126739534|NCT02255760|455995211|FG000|Overall Study|Lost to Follow-up|0|||
126739535|NCT02255760|455995212|FG001|Overall Study|Lost to Follow-up|1|||
126739536|NCT02255760|455995213|FG002|Overall Study|Lost to Follow-up|0|||
126739537|NCT02255760|455995214|FG003|Overall Study|Lost to Follow-up|0|||
126739538|NCT02255760|455995215|FG004|Overall Study|Lost to Follow-up|0|||
126739539|NCT00618813|455995216|FG000|Overall Study|Lack of Efficacy|1|||
126739540|NCT00618813|455995216|FG000|Overall Study|Physician Decision|2|||
126739541|NCT00618813|455995216|FG000|Overall Study|Withdrawal by Subject|1|||
126739542|NCT00003838|455995217|FG000|Overall Study|Death|0|||
126739543|NCT00003838|455995218|FG001|Overall Study|Death|12|||
126739544|NCT00003838|455995219|FG002|Overall Study|Death|7|||
126739545|NCT00003838|455995217|FG000|Overall Study|Lost to Follow-up|0|||
126739546|NCT00003838|455995218|FG001|Overall Study|Lost to Follow-up|1|||
126739547|NCT00003838|455995219|FG002|Overall Study|Lost to Follow-up|1|||
126739548|NCT00003838|455995217|FG000|Overall Study|Disease Progression|0|||
126739549|NCT00003838|455995218|FG001|Overall Study|Disease Progression|12|||
126739550|NCT00003838|455995219|FG002|Overall Study|Disease Progression|0|||
126739551|NCT01809197|455995220|FG000|Overall Study|Lost to Follow-up|4|||
126739552|NCT01809197|455995221|FG001|Overall Study|Lost to Follow-up|2|||
126739553|NCT01809197|455995220|FG000|Overall Study|Adverse Event|2|||
126739554|NCT01809197|455995221|FG001|Overall Study|Adverse Event|3|||
126739555|NCT01809197|455995220|FG000|Overall Study|Failed slit lamp exam|1|||
126739556|NCT01809197|455995221|FG001|Overall Study|Failed slit lamp exam|0|||
126739557|NCT01809197|455995220|FG000|Overall Study|Non-Compliance|1|||
126739558|NCT01809197|455995221|FG001|Overall Study|Non-Compliance|1|||
126739559|NCT01809197|455995220|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
126739560|NCT01809197|455995221|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
126739561|NCT01809197|455995220|FG000|Overall Study|Withdrawal by Subject|1|||
126739562|NCT01809197|455995221|FG001|Overall Study|Withdrawal by Subject|1|||
126739563|NCT01809197|455995220|FG000|Overall Study|Product not available|0|||
126739564|NCT01809197|455995221|FG001|Overall Study|Product not available|1|||
126739565|NCT01484561|455995226|FG000|Overall Study|Lack of Efficacy|3|||
126739566|NCT01484561|455995227|FG001|Overall Study|Lack of Efficacy|1|||
126739567|NCT01484561|455995226|FG000|Overall Study|Lost to Follow-up|1|||
126739568|NCT01484561|455995227|FG001|Overall Study|Lost to Follow-up|0|||
126739569|NCT01484561|455995226|FG000|Overall Study|Withdrawal by Subject|3|||
126739570|NCT01484561|455995227|FG001|Overall Study|Withdrawal by Subject|0|||
126739571|NCT01484561|455995226|FG000|Overall Study|Other|1|||
126739572|NCT01484561|455995227|FG001|Overall Study|Other|1|||
126739573|NCT01484561|455995226|FG000|Overall Study|Adverse Event|1|||
126739574|NCT01484561|455995227|FG001|Overall Study|Adverse Event|4|||
126739575|NCT03371251|455995228|FG000|Overall Study|Withdrawal by Subject|1|||
126739576|NCT03371251|455995229|FG001|Overall Study|Withdrawal by Subject|0|||
126739577|NCT03371251|455995230|FG002|Overall Study|Withdrawal by Subject|1|||
126739578|NCT03371251|455995231|FG003|Overall Study|Withdrawal by Subject|0|||
126739579|NCT03371251|455995232|FG004|Overall Study|Withdrawal by Subject|2|||
126739580|NCT03371251|455995233|FG005|Overall Study|Withdrawal by Subject|2|||
126739581|NCT03371251|455995228|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
126739582|NCT03371251|455995229|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
126739583|NCT03371251|455995230|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
126739584|NCT03371251|455995231|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
126739585|NCT03371251|455995232|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
126739586|NCT03371251|455995233|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
126739587|NCT03371251|455995228|FG000|Overall Study|Adverse Event|0|||
126739588|NCT03371251|455995229|FG001|Overall Study|Adverse Event|0|||
126739589|NCT03371251|455995230|FG002|Overall Study|Adverse Event|0|||
126739590|NCT03371251|455995231|FG003|Overall Study|Adverse Event|0|||
126739591|NCT03371251|455995232|FG004|Overall Study|Adverse Event|1|||
126739592|NCT03371251|455995233|FG005|Overall Study|Adverse Event|0|||
126739593|NCT03371251|455995228|FG000|Overall Study|Decision by Sponsor|0|||
126739594|NCT03371251|455995229|FG001|Overall Study|Decision by Sponsor|0|||
126739595|NCT03371251|455995230|FG002|Overall Study|Decision by Sponsor|0|||
126739596|NCT03371251|455995231|FG003|Overall Study|Decision by Sponsor|0|||
126739597|NCT03371251|455995232|FG004|Overall Study|Decision by Sponsor|2|||
126739598|NCT03371251|455995233|FG005|Overall Study|Decision by Sponsor|0|||
126739599|NCT00291187|455995234|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
126739600|NCT00291187|455995235|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
126739601|NCT00291187|455995236|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
126739602|NCT00291187|455995237|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
126739603|NCT00114218|455995238|FG000|Overall Study|Wrong Cell Type|2|||
126739604|NCT00114218|455995238|FG000|Overall Study|Wrong Primary|1|||
126781623|NCT02497391|456156203|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
126615038|NCT02607956|455549727|FG003|Double-Blinded Phase|Withdrew Consent|0|||
126615039|NCT02607956|455549724|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
126615040|NCT02607956|455549725|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
126615041|NCT02607956|455549726|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
126615042|NCT02607956|455549727|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
126615043|NCT02607956|455549724|FG000|Double-Blinded Phase|Randomized but never treated|7|||
126615044|NCT02607956|455549725|FG001|Double-Blinded Phase|Randomized but never treated|5|||
126615045|NCT02607956|455549726|FG002|Double-Blinded Phase|Randomized but never treated|0|||
126615046|NCT02607956|455549727|FG003|Double-Blinded Phase|Randomized but never treated|0|||
126615047|NCT02607956|455549724|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
126615048|NCT02607956|455549725|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
126615049|NCT02607956|455549726|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
126615050|NCT02607956|455549727|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
126615051|NCT02607956|455549724|FG000|Double-Blinded Phase|Death|4|||
126615052|NCT02607956|455549725|FG001|Double-Blinded Phase|Death|4|||
126615053|NCT02607956|455549726|FG002|Double-Blinded Phase|Death|0|||
126615054|NCT02607956|455549727|FG003|Double-Blinded Phase|Death|0|||
126615055|NCT02607956|455549724|FG000|Double-Blinded Phase|Adverse Event|4|||
126615056|NCT02607956|455549725|FG001|Double-Blinded Phase|Adverse Event|3|||
126615057|NCT02607956|455549726|FG002|Double-Blinded Phase|Adverse Event|0|||
126615058|NCT02607956|455549727|FG003|Double-Blinded Phase|Adverse Event|0|||
126615059|NCT02607956|455549724|FG000|Double-Blinded Phase|Protocol Violation|3|||
126615060|NCT02607956|455549725|FG001|Double-Blinded Phase|Protocol Violation|1|||
126615061|NCT02607956|455549726|FG002|Double-Blinded Phase|Protocol Violation|0|||
126615062|NCT02607956|455549727|FG003|Double-Blinded Phase|Protocol Violation|0|||
126739605|NCT00114218|455995238|FG000|Overall Study|Never Treated|1|||
126739606|NCT03168555|455995240|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
126739607|NCT03168555|455995240|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
126781624|NCT02497391|456156204|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
126781625|NCT02497391|456156199|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
126781626|NCT02497391|456156200|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
126781627|NCT02497391|456156201|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
126615063|NCT02607956|455549724|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
126615064|NCT02607956|455549725|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
126615065|NCT02607956|455549726|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
126615066|NCT02607956|455549727|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
126615067|NCT02607956|455549724|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
126615068|NCT02607956|455549725|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
126615069|NCT02607956|455549726|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
126615070|NCT02607956|455549727|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
126615071|NCT02607956|455549724|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
126615072|NCT02607956|455549725|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
126615073|NCT02607956|455549726|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
126615074|NCT02607956|455549727|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
126615075|NCT02607956|455549724|FG000|Open-Label Extension Phase|Death|0|||
126615076|NCT02607956|455549725|FG001|Open-Label Extension Phase|Death|0|||
126615077|NCT02607956|455549726|FG002|Open-Label Extension Phase|Death|1|||
126615078|NCT02607956|455549727|FG003|Open-Label Extension Phase|Death|3|||
126615079|NCT02607956|455549724|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
126615080|NCT02607956|455549725|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
126615081|NCT02607956|455549726|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
126615082|NCT02607956|455549727|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
126615083|NCT02607956|455549724|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
126615084|NCT02607956|455549725|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
126615085|NCT02607956|455549726|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
126615086|NCT02607956|455549727|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
126615087|NCT02607956|455549724|FG000|Open-Label Extension Phase|Protocol Violation|0|||
126615088|NCT02607956|455549725|FG001|Open-Label Extension Phase|Protocol Violation|0|||
126615089|NCT02607956|455549726|FG002|Open-Label Extension Phase|Protocol Violation|0|||
126615090|NCT02607956|455549727|FG003|Open-Label Extension Phase|Protocol Violation|2|||
126615091|NCT02607956|455549724|FG000|Open-Label Extension Phase|Pregnancy|0|||
126615092|NCT02607956|455549725|FG001|Open-Label Extension Phase|Pregnancy|0|||
126615093|NCT02607956|455549726|FG002|Open-Label Extension Phase|Pregnancy|0|||
126615094|NCT02607956|455549727|FG003|Open-Label Extension Phase|Pregnancy|1|||
126615095|NCT03541369|455549728|FG000|Overall Study|Death|0|||
126615096|NCT03541369|455549729|FG001|Overall Study|Death|0|||
126615097|NCT03541369|455549730|FG002|Overall Study|Death|0|||
126615098|NCT03541369|455549731|FG003|Overall Study|Death|0|||
126615099|NCT03541369|455549732|FG004|Overall Study|Death|1|||
126615100|NCT03541369|455549733|FG005|Overall Study|Death|1|||
126615101|NCT03541369|455549734|FG006|Overall Study|Death|0|||
126615102|NCT03541369|455549735|FG007|Overall Study|Death|2|||
126615103|NCT03541369|455549736|FG008|Overall Study|Death|1|||
126615104|NCT03541369|455549737|FG009|Overall Study|Death|2|||
126615105|NCT03541369|455549738|FG010|Overall Study|Death|1|||
126615106|NCT03541369|455549739|FG011|Overall Study|Death|0|||
126739608|NCT03168555|455995240|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
126739609|NCT03168555|455995240|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
126739610|NCT01040845|455995241|FG000|Overall Study|Withdrawal by Subject|1|||
126739611|NCT01040845|455995242|FG001|Overall Study|Withdrawal by Subject|1|||
126739612|NCT01040845|455995241|FG000|Overall Study|Physician Decision|1|||
126739613|NCT01040845|455995242|FG001|Overall Study|Physician Decision|0|||
126739614|NCT02708966|455995246|FG000|Overall Study|Lost to Follow-up|2|||
126615107|NCT03541369|455549740|FG012|Overall Study|Death|2|||
126615108|NCT03541369|455549741|FG013|Overall Study|Death|1|||
126615109|NCT03541369|455549742|FG014|Overall Study|Death|1|||
126615110|NCT03541369|455549743|FG015|Overall Study|Death|1|||
126615111|NCT03541369|455549744|FG016|Overall Study|Death|0|||
126615112|NCT03541369|455549745|FG017|Overall Study|Death|1|||
126615113|NCT03541369|455549728|FG000|Overall Study|Decision by sponsor|0|||
126615114|NCT03541369|455549729|FG001|Overall Study|Decision by sponsor|0|||
126615115|NCT03541369|455549730|FG002|Overall Study|Decision by sponsor|0|||
126615116|NCT03541369|455549731|FG003|Overall Study|Decision by sponsor|1|||
126615117|NCT03541369|455549732|FG004|Overall Study|Decision by sponsor|0|||
126739615|NCT02708966|455995247|FG001|Overall Study|Lost to Follow-up|2|||
126615118|NCT03541369|455549733|FG005|Overall Study|Decision by sponsor|2|||
126615119|NCT03541369|455549734|FG006|Overall Study|Decision by sponsor|0|||
126615120|NCT03541369|455549735|FG007|Overall Study|Decision by sponsor|1|||
126615121|NCT03541369|455549736|FG008|Overall Study|Decision by sponsor|2|||
126615122|NCT03541369|455549737|FG009|Overall Study|Decision by sponsor|0|||
126739616|NCT02959190|455995251|FG000|Open Label|Adverse Event|5|||
126739617|NCT02959190|455995252|FG001|Open Label|Adverse Event|7|||
126739618|NCT02959190|455995253|FG002|Open Label|Adverse Event|3|||
126615123|NCT03541369|455549738|FG010|Overall Study|Decision by sponsor|0|||
126615124|NCT03541369|455549739|FG011|Overall Study|Decision by sponsor|0|||
126615125|NCT03541369|455549740|FG012|Overall Study|Decision by sponsor|2|||
126615126|NCT03541369|455549741|FG013|Overall Study|Decision by sponsor|2|||
126615127|NCT03541369|455549742|FG014|Overall Study|Decision by sponsor|0|||
126615128|NCT03541369|455549743|FG015|Overall Study|Decision by sponsor|1|||
126615129|NCT03541369|455549744|FG016|Overall Study|Decision by sponsor|1|||
126615130|NCT03541369|455549745|FG017|Overall Study|Decision by sponsor|1|||
126615131|NCT03541369|455549728|FG000|Overall Study|Withdrawal by Subject|0|||
126781628|NCT02497391|456156202|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
126781629|NCT02497391|456156203|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
126781630|NCT02497391|456156204|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
126781631|NCT01007916|456156205|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
126781632|NCT01007916|456156206|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
126781633|NCT01007916|456156205|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
126615132|NCT03541369|455549729|FG001|Overall Study|Withdrawal by Subject|0|||
126615133|NCT03541369|455549730|FG002|Overall Study|Withdrawal by Subject|0|||
126615134|NCT03541369|455549731|FG003|Overall Study|Withdrawal by Subject|0|||
126615135|NCT03541369|455549732|FG004|Overall Study|Withdrawal by Subject|0|||
126615136|NCT03541369|455549733|FG005|Overall Study|Withdrawal by Subject|0|||
126615137|NCT03541369|455549734|FG006|Overall Study|Withdrawal by Subject|1|||
126615138|NCT03541369|455549735|FG007|Overall Study|Withdrawal by Subject|0|||
126615139|NCT03541369|455549736|FG008|Overall Study|Withdrawal by Subject|0|||
126615140|NCT03541369|455549737|FG009|Overall Study|Withdrawal by Subject|0|||
126615141|NCT03541369|455549738|FG010|Overall Study|Withdrawal by Subject|0|||
126615142|NCT03541369|455549739|FG011|Overall Study|Withdrawal by Subject|1|||
126615143|NCT03541369|455549740|FG012|Overall Study|Withdrawal by Subject|0|||
126615144|NCT03541369|455549741|FG013|Overall Study|Withdrawal by Subject|0|||
126615145|NCT03541369|455549742|FG014|Overall Study|Withdrawal by Subject|3|||
126615146|NCT03541369|455549743|FG015|Overall Study|Withdrawal by Subject|0|||
126615147|NCT03541369|455549744|FG016|Overall Study|Withdrawal by Subject|4|||
126615148|NCT03541369|455549745|FG017|Overall Study|Withdrawal by Subject|2|||
126615149|NCT03541369|455549728|FG000|Overall Study|Lost to Follow-up|0|||
126615150|NCT03541369|455549729|FG001|Overall Study|Lost to Follow-up|0|||
126615151|NCT03541369|455549730|FG002|Overall Study|Lost to Follow-up|0|||
126615152|NCT03541369|455549731|FG003|Overall Study|Lost to Follow-up|0|||
126615153|NCT03541369|455549732|FG004|Overall Study|Lost to Follow-up|1|||
126615154|NCT03541369|455549733|FG005|Overall Study|Lost to Follow-up|0|||
126615155|NCT03541369|455549734|FG006|Overall Study|Lost to Follow-up|0|||
126615156|NCT03541369|455549735|FG007|Overall Study|Lost to Follow-up|0|||
126615157|NCT03541369|455549736|FG008|Overall Study|Lost to Follow-up|1|||
126615158|NCT03541369|455549737|FG009|Overall Study|Lost to Follow-up|0|||
126615159|NCT03541369|455549738|FG010|Overall Study|Lost to Follow-up|0|||
126615160|NCT03541369|455549739|FG011|Overall Study|Lost to Follow-up|0|||
126615161|NCT03541369|455549740|FG012|Overall Study|Lost to Follow-up|1|||
126615162|NCT03541369|455549741|FG013|Overall Study|Lost to Follow-up|0|||
126615163|NCT03541369|455549742|FG014|Overall Study|Lost to Follow-up|0|||
126615164|NCT03541369|455549743|FG015|Overall Study|Lost to Follow-up|0|||
126615165|NCT03541369|455549744|FG016|Overall Study|Lost to Follow-up|0|||
126615166|NCT03541369|455549745|FG017|Overall Study|Lost to Follow-up|0|||
126615167|NCT01005914|455549746|FG000|Overall Study|Adverse Event|4|||
126615168|NCT01005914|455549746|FG000|Overall Study|Death|4|||
126615169|NCT01005914|455549746|FG000|Overall Study|Lack of Efficacy|1|||
126615170|NCT01005914|455549746|FG000|Overall Study|Withdrawal by Subject|1|||
126615171|NCT01240785|455549748|FG000|Overall Study|Lost to Follow-up|1|||
126615172|NCT01240785|455549749|FG001|Overall Study|Lost to Follow-up|0|||
126615173|NCT01240785|455549748|FG000|Overall Study|Protocol Violation|0|||
126615174|NCT01240785|455549749|FG001|Overall Study|Protocol Violation|3|||
126615175|NCT00696241|455549750|FG000|Overall Study|Adverse Event|11|||
126615176|NCT00696241|455549751|FG001|Overall Study|Adverse Event|3|||
126615177|NCT00696241|455549752|FG002|Overall Study|Adverse Event|6|||
126615178|NCT00696241|455549753|FG003|Overall Study|Adverse Event|4|||
126615179|NCT00696241|455549754|FG004|Overall Study|Adverse Event|5|||
126615180|NCT00696241|455549750|FG000|Overall Study|Protocol Violation|1|||
126615181|NCT00696241|455549751|FG001|Overall Study|Protocol Violation|1|||
126615182|NCT00696241|455549752|FG002|Overall Study|Protocol Violation|2|||
126615183|NCT00696241|455549753|FG003|Overall Study|Protocol Violation|0|||
126615184|NCT00696241|455549754|FG004|Overall Study|Protocol Violation|3|||
126615185|NCT00696241|455549750|FG000|Overall Study|Lost to Follow-up|1|||
126615186|NCT00696241|455549751|FG001|Overall Study|Lost to Follow-up|4|||
126615187|NCT00696241|455549752|FG002|Overall Study|Lost to Follow-up|1|||
126615188|NCT00696241|455549753|FG003|Overall Study|Lost to Follow-up|2|||
126615189|NCT00696241|455549754|FG004|Overall Study|Lost to Follow-up|0|||
126615190|NCT00696241|455549750|FG000|Overall Study|Withdrawal by Subject|4|||
126615191|NCT00696241|455549751|FG001|Overall Study|Withdrawal by Subject|8|||
126615192|NCT00696241|455549752|FG002|Overall Study|Withdrawal by Subject|6|||
126615193|NCT00696241|455549753|FG003|Overall Study|Withdrawal by Subject|1|||
126615194|NCT00696241|455549754|FG004|Overall Study|Withdrawal by Subject|0|||
126615195|NCT00696241|455549750|FG000|Overall Study|Lack of Efficacy|1|||
126615196|NCT00696241|455549751|FG001|Overall Study|Lack of Efficacy|5|||
126615197|NCT00696241|455549752|FG002|Overall Study|Lack of Efficacy|4|||
126615198|NCT00696241|455549753|FG003|Overall Study|Lack of Efficacy|5|||
126615199|NCT00696241|455549754|FG004|Overall Study|Lack of Efficacy|3|||
126615200|NCT00696241|455549750|FG000|Overall Study|Other|6|||
126781634|NCT01007916|456156206|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
126615201|NCT00696241|455549751|FG001|Overall Study|Other|1|||
126615202|NCT00696241|455549752|FG002|Overall Study|Other|5|||
126615203|NCT00696241|455549753|FG003|Overall Study|Other|2|||
126615204|NCT00696241|455549754|FG004|Overall Study|Other|1|||
126615205|NCT03347396|455549761|FG000|Part A (26 Weeks)|Adverse Event|1|||
126615206|NCT03347396|455549762|FG001|Part A (26 Weeks)|Adverse Event|0|||
126615207|NCT03347396|455549761|FG000|Part A (26 Weeks)|Death|0|||
126615208|NCT03347396|455549762|FG001|Part A (26 Weeks)|Death|1|||
126615209|NCT03347396|455549761|FG000|Part B (149 Weeks)|Adverse Event|1|||
126615210|NCT03347396|455549762|FG001|Part B (149 Weeks)|Adverse Event|1|||
126615211|NCT03347396|455549761|FG000|Part B (149 Weeks)|Death|1|||
126615212|NCT03347396|455549762|FG001|Part B (149 Weeks)|Death|0|||
126615213|NCT03060525|455549763|FG000|Overall Study|moved out of state|1|||
126615214|NCT03060525|455549764|FG001|Overall Study|moved out of state|1|||
126615215|NCT03060525|455549765|FG002|Overall Study|moved out of state|1|||
126615216|NCT03060525|455549766|FG003|Overall Study|moved out of state|1|||
126615217|NCT03060525|455549763|FG000|Overall Study|unable to meet time commitment required of study|2|||
126615218|NCT03060525|455549764|FG001|Overall Study|unable to meet time commitment required of study|3|||
126615219|NCT03060525|455549765|FG002|Overall Study|unable to meet time commitment required of study|3|||
126615220|NCT03060525|455549766|FG003|Overall Study|unable to meet time commitment required of study|1|||
126615221|NCT03060525|455549763|FG000|Overall Study|no longer interested in doing intervention|0|||
126615222|NCT03060525|455549764|FG001|Overall Study|no longer interested in doing intervention|0|||
126615223|NCT03060525|455549765|FG002|Overall Study|no longer interested in doing intervention|0|||
126615224|NCT03060525|455549766|FG003|Overall Study|no longer interested in doing intervention|1|||
126615225|NCT00090519|455549767|FG000|Overall Study|Adverse Event|5|||
126615226|NCT00090519|455549768|FG001|Overall Study|Adverse Event|4|||
126615227|NCT00090519|455549767|FG000|Overall Study|Death|9|||
126615228|NCT00090519|455549768|FG001|Overall Study|Death|9|||
126615229|NCT00090519|455549767|FG000|Overall Study|Lost to Follow-up|26|||
126615230|NCT00090519|455549768|FG001|Overall Study|Lost to Follow-up|29|||
126615231|NCT00090519|455549767|FG000|Overall Study|Withdrawal by Subject|28|||
126615232|NCT00090519|455549768|FG001|Overall Study|Withdrawal by Subject|29|||
126615233|NCT00090519|455549767|FG000|Overall Study|Physician Decision|2|||
126615234|NCT00090519|455549768|FG001|Overall Study|Physician Decision|3|||
126615235|NCT00090519|455549767|FG000|Overall Study|Sponsor Decision|3|||
126615236|NCT00090519|455549768|FG001|Overall Study|Sponsor Decision|1|||
126615237|NCT02161146|455549771|FG000|Overall Study|Adverse Event|1|||
126615238|NCT02161146|455549772|FG001|Overall Study|Adverse Event|1|||
126615239|NCT02161146|455549773|FG002|Overall Study|Adverse Event|0|||
126615240|NCT02161146|455549774|FG003|Overall Study|Adverse Event|1|||
126615241|NCT02161146|455549775|FG004|Overall Study|Adverse Event|0|||
126615242|NCT02161146|455549771|FG000|Overall Study|Lost to Follow-up|0|||
126615243|NCT02161146|455549772|FG001|Overall Study|Lost to Follow-up|1|||
126615244|NCT02161146|455549773|FG002|Overall Study|Lost to Follow-up|0|||
126615245|NCT02161146|455549774|FG003|Overall Study|Lost to Follow-up|0|||
126615246|NCT02161146|455549775|FG004|Overall Study|Lost to Follow-up|0|||
126615247|NCT02161146|455549771|FG000|Overall Study|Personal Reasons|0|||
126615248|NCT02161146|455549772|FG001|Overall Study|Personal Reasons|1|||
126615249|NCT02161146|455549773|FG002|Overall Study|Personal Reasons|0|||
126615250|NCT02161146|455549774|FG003|Overall Study|Personal Reasons|2|||
126615251|NCT02161146|455549775|FG004|Overall Study|Personal Reasons|1|||
126615252|NCT02161146|455549771|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126615253|NCT02161146|455549772|FG001|Overall Study|Other Miscellaneous Reasons|1|||
126615254|NCT02161146|455549773|FG002|Overall Study|Other Miscellaneous Reasons|0|||
126615255|NCT02161146|455549774|FG003|Overall Study|Other Miscellaneous Reasons|0|||
126615256|NCT02161146|455549775|FG004|Overall Study|Other Miscellaneous Reasons|0|||
126615257|NCT02613403|455549778|FG000|Overall Study|Lost to Follow-up|0|||
126615258|NCT02613403|455549779|FG001|Overall Study|Lost to Follow-up|1|||
126615259|NCT02613403|455549780|FG002|Overall Study|Lost to Follow-up|0|||
126615260|NCT02613403|455549781|FG003|Overall Study|Lost to Follow-up|0|||
126615261|NCT02613403|455549782|FG004|Overall Study|Lost to Follow-up|0|||
126615262|NCT02613403|455549778|FG000|Overall Study|Withdrawal by Subject|2|||
126615263|NCT02613403|455549779|FG001|Overall Study|Withdrawal by Subject|0|||
126615264|NCT02613403|455549780|FG002|Overall Study|Withdrawal by Subject|0|||
126615265|NCT02613403|455549781|FG003|Overall Study|Withdrawal by Subject|0|||
126615266|NCT02613403|455549782|FG004|Overall Study|Withdrawal by Subject|0|||
126615267|NCT02189759|455549783|FG000|Overall Study|Lost to Follow-up|0|||
126615268|NCT02189759|455549784|FG001|Overall Study|Lost to Follow-up|0|||
126615269|NCT02189759|455549785|FG002|Overall Study|Lost to Follow-up|2|||
126615270|NCT02189759|455549786|FG003|Overall Study|Lost to Follow-up|5|||
126615271|NCT00800176|455549789|FG000|Overall Study|Adverse Event|2|||
126615272|NCT00800176|455549790|FG001|Overall Study|Adverse Event|1|||
126615273|NCT00800176|455549791|FG002|Overall Study|Adverse Event|0|||
126615274|NCT00800176|455549792|FG003|Overall Study|Adverse Event|2|||
126615275|NCT00800176|455549793|FG004|Overall Study|Adverse Event|1|||
126615276|NCT00800176|455549794|FG005|Overall Study|Adverse Event|1|||
126615277|NCT00800176|455549789|FG000|Overall Study|Refused treatment|3|||
126615278|NCT00800176|455549790|FG001|Overall Study|Refused treatment|2|||
126615279|NCT00800176|455549791|FG002|Overall Study|Refused treatment|0|||
126615280|NCT00800176|455549792|FG003|Overall Study|Refused treatment|0|||
126615281|NCT00800176|455549793|FG004|Overall Study|Refused treatment|1|||
126615282|NCT00800176|455549794|FG005|Overall Study|Refused treatment|4|||
126615283|NCT00800176|455549789|FG000|Overall Study|Failure to return|3|||
126615284|NCT00800176|455549790|FG001|Overall Study|Failure to return|3|||
126615285|NCT00800176|455549791|FG002|Overall Study|Failure to return|0|||
126615286|NCT00800176|455549792|FG003|Overall Study|Failure to return|2|||
126615287|NCT00800176|455549793|FG004|Overall Study|Failure to return|0|||
126615288|NCT00800176|455549794|FG005|Overall Study|Failure to return|0|||
126615289|NCT00800176|455549789|FG000|Overall Study|Other|1|||
126739619|NCT02959190|455995254|FG003|Open Label|Adverse Event|4|||
126739620|NCT02959190|455995251|FG000|Open Label|Pregnancy|0|||
126739621|NCT02959190|455995252|FG001|Open Label|Pregnancy|1|||
126739622|NCT02959190|455995253|FG002|Open Label|Pregnancy|0|||
126739623|NCT02959190|455995254|FG003|Open Label|Pregnancy|0|||
126739624|NCT02959190|455995251|FG000|Open Label|Withdrawal by Subject|2|||
126739625|NCT02959190|455995252|FG001|Open Label|Withdrawal by Subject|8|||
126739626|NCT02959190|455995253|FG002|Open Label|Withdrawal by Subject|0|||
126739627|NCT02959190|455995254|FG003|Open Label|Withdrawal by Subject|0|||
126739628|NCT02959190|455995251|FG000|Open Label|Physician Decision|0|||
126739629|NCT02959190|455995252|FG001|Open Label|Physician Decision|0|||
126739630|NCT02959190|455995253|FG002|Open Label|Physician Decision|1|||
126739631|NCT02959190|455995254|FG003|Open Label|Physician Decision|0|||
126739632|NCT02959190|455995251|FG000|Open Label|Protocol Violation|0|||
126739633|NCT02959190|455995252|FG001|Open Label|Protocol Violation|0|||
126739634|NCT02959190|455995253|FG002|Open Label|Protocol Violation|0|||
126739635|NCT02959190|455995254|FG003|Open Label|Protocol Violation|2|||
126739636|NCT02959190|455995251|FG000|Post Treatment Follow Up|Adverse Event|1|||
126739637|NCT02959190|455995252|FG001|Post Treatment Follow Up|Adverse Event|1|||
126739638|NCT02959190|455995253|FG002|Post Treatment Follow Up|Adverse Event|0|||
126739639|NCT02959190|455995254|FG003|Post Treatment Follow Up|Adverse Event|0|||
126739640|NCT02959190|455995251|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
126739641|NCT02959190|455995252|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
126739642|NCT02959190|455995253|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
126739643|NCT02959190|455995254|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
126739644|NCT02023268|455995255|FG000|Overall Study|Lack of Efficacy|0|||
126739645|NCT02023268|455995256|FG001|Overall Study|Lack of Efficacy|1|||
126739646|NCT02023268|455995255|FG000|Overall Study|Adverse Event|0|||
126739647|NCT02023268|455995256|FG001|Overall Study|Adverse Event|2|||
126739648|NCT02023268|455995255|FG000|Overall Study|Withdrawal by Subject|0|||
126739649|NCT02023268|455995256|FG001|Overall Study|Withdrawal by Subject|1|||
126739650|NCT04445688|455995257|FG000|Washout (One Week)|Adverse Event|2|||
126739651|NCT04445688|455995257|FG000|Washout (One Week)|Withdrawal by Subject|1|||
126739652|NCT01998399|455995261|FG000|Overall Study|Lost to Follow-up|1|||
126739653|NCT01998399|455995262|FG001|Overall Study|Lost to Follow-up|3|||
126739654|NCT01998399|455995261|FG000|Overall Study|Death|4|||
126739655|NCT01998399|455995262|FG001|Overall Study|Death|2|||
126739656|NCT01998399|455995261|FG000|Overall Study|Study stopped before dosing completed|3|||
126739657|NCT01998399|455995262|FG001|Overall Study|Study stopped before dosing completed|3|||
126739658|NCT01998399|455995261|FG000|Overall Study|Withdrawal by Subject|0|||
126739659|NCT01998399|455995262|FG001|Overall Study|Withdrawal by Subject|1|||
126739660|NCT04114539|455995266|FG000|Overall Study|Adverse Event|14|||
126739661|NCT04114539|455995266|FG000|Overall Study|Lost to Follow-up|2|||
126739662|NCT04114539|455995266|FG000|Overall Study|Non-compliance with Protocol|2|||
126739663|NCT04114539|455995266|FG000|Overall Study|Non-compliance with Study Drug|1|||
126739664|NCT04114539|455995266|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
126739665|NCT04114539|455995266|FG000|Overall Study|Withdrew consent|10|||
126739666|NCT04114539|455995266|FG000|Overall Study|Others not specified|5|||
126739667|NCT04114539|455995266|FG000|Overall Study|Investigator Decision|2|||
126739668|NCT01826448|455997216|FG000|Overall Study|Adverse Event|1|||
126739669|NCT01826448|455997217|FG001|Overall Study|Adverse Event|3|||
126739670|NCT01826448|455997216|FG000|Overall Study|Disease progression|2|||
126739671|NCT01826448|455997217|FG001|Overall Study|Disease progression|4|||
126739672|NCT01826448|455997216|FG000|Overall Study|Withdrawal by Subject|1|||
126739673|NCT01826448|455997217|FG001|Overall Study|Withdrawal by Subject|0|||
126739674|NCT01826448|455997216|FG000|Overall Study|Physician Decision|0|||
126739675|NCT01826448|455997217|FG001|Overall Study|Physician Decision|1|||
126739676|NCT01826448|455997216|FG000|Overall Study|2 active cancers|0|||
126739677|NCT01826448|455997217|FG001|Overall Study|2 active cancers|1|||
126739678|NCT02431702|455997222|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
126739679|NCT02431702|455997223|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
126739680|NCT02431702|455997224|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
126615290|NCT00800176|455549790|FG001|Overall Study|Other|0|||
126615291|NCT00800176|455549791|FG002|Overall Study|Other|0|||
126739681|NCT02431702|455997225|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
126739682|NCT02431702|455997226|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
126739683|NCT02431702|455997227|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
126739684|NCT02431702|455997228|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
126781635|NCT01165996|456156223|FG000|Overall Study|Death|1|||
126615292|NCT00800176|455549792|FG003|Overall Study|Other|0|||
126615293|NCT00800176|455549793|FG004|Overall Study|Other|2|||
126739685|NCT02431702|455997222|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
126739686|NCT02431702|455997223|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
126739687|NCT02431702|455997224|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
126739688|NCT02431702|455997225|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
126739689|NCT02431702|455997226|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
126739690|NCT02431702|455997227|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
126739691|NCT02431702|455997228|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
126739692|NCT02431702|455997222|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
126739693|NCT02431702|455997223|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
126739694|NCT02431702|455997224|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
126739695|NCT02431702|455997225|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
126739696|NCT02431702|455997226|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
126739697|NCT02431702|455997227|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
126739698|NCT02431702|455997228|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
126739699|NCT02431702|455997222|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
126739700|NCT02431702|455997223|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
126739701|NCT02431702|455997224|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
126739702|NCT02431702|455997225|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
126739703|NCT02431702|455997226|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
126739704|NCT02431702|455997227|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
126739705|NCT02431702|455997228|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
126739706|NCT02431702|455997222|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
126739707|NCT02431702|455997223|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
126739708|NCT02431702|455997224|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
126739709|NCT02431702|455997225|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
126739710|NCT02431702|455997226|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
126739711|NCT02431702|455997227|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
126739712|NCT02431702|455997228|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
126739713|NCT02431702|455997222|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
126739714|NCT02431702|455997223|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
126739715|NCT02431702|455997224|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
126739716|NCT02431702|455997225|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
126739717|NCT02431702|455997226|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
126739718|NCT02431702|455997227|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
126739719|NCT02431702|455997228|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
126739720|NCT02431702|455997222|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
126739721|NCT02431702|455997223|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
126739722|NCT02431702|455997224|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
126739723|NCT02431702|455997225|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
126739724|NCT02431702|455997226|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
126739725|NCT02431702|455997227|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
126739726|NCT02431702|455997228|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
126739727|NCT02431702|455997222|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
126739728|NCT02431702|455997223|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
126739729|NCT02431702|455997224|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
126739730|NCT02431702|455997225|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
126739731|NCT02431702|455997226|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
126739732|NCT02431702|455997227|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
126739733|NCT02431702|455997228|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
126739734|NCT02431702|455997222|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
126739735|NCT02431702|455997223|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
126739736|NCT02431702|455997224|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
126739737|NCT02431702|455997225|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
126739738|NCT02431702|455997226|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
126739739|NCT02431702|455997227|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
126739740|NCT02431702|455997228|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
126739741|NCT02431702|455997222|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
126739742|NCT02431702|455997223|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
126739743|NCT02431702|455997224|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
126739744|NCT02431702|455997225|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
126739745|NCT02431702|455997226|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
126739746|NCT02431702|455997227|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
126615294|NCT00800176|455549794|FG005|Overall Study|Other|0|||
126739747|NCT02431702|455997228|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
126739748|NCT02431702|455997222|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
126739749|NCT02431702|455997223|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
126739750|NCT02431702|455997224|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
126739751|NCT02431702|455997225|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
126739752|NCT02431702|455997226|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
126739753|NCT02431702|455997227|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
126739754|NCT02431702|455997228|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
126739755|NCT02431702|455997222|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
126739756|NCT02431702|455997223|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
126739757|NCT02431702|455997224|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
126739758|NCT02431702|455997225|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
126739759|NCT02431702|455997226|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
126739760|NCT02431702|455997227|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
126739761|NCT02431702|455997228|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
126739762|NCT02431702|455997222|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
126739763|NCT02431702|455997223|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
126739764|NCT02431702|455997224|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
126739765|NCT02431702|455997225|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
126739766|NCT02431702|455997226|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
126739767|NCT02431702|455997227|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
126739768|NCT02431702|455997228|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
126739769|NCT02431702|455997222|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
126739770|NCT02431702|455997223|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
126739771|NCT02431702|455997224|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
126739772|NCT02431702|455997225|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
126739773|NCT02431702|455997226|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
126739774|NCT02431702|455997227|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
126739775|NCT02431702|455997228|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
126739776|NCT02431702|455997222|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
126739777|NCT02431702|455997223|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
126739778|NCT02431702|455997224|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
126739779|NCT02431702|455997225|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
126739780|NCT02431702|455997226|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
126781636|NCT01165996|456156223|FG000|Overall Study|Physician Decision|1|||
126781637|NCT01927757|456156224|FG000|Overall Study|Withdrawal by Subject|14|||
126781638|NCT01927757|456156224|FG000|Overall Study|Lost to Follow-up|2|||
126781639|NCT01927757|456156224|FG000|Overall Study|Decision by Sponsor|2|||
126781640|NCT01927757|456156224|FG000|Overall Study|Other|1|||
126781641|NCT01927757|456156224|FG000|Overall Study|Ethical Reasons|4|||
126781642|NCT01399723|456156225|FG000|Overall Study|Lost to Follow-up|0|||
126781643|NCT01399723|456156226|FG001|Overall Study|Lost to Follow-up|1|||
126781644|NCT00294723|456156230|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
126781645|NCT00294723|456156231|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
126781646|NCT00294723|456156232|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
126781647|NCT00294723|456156230|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
126781648|NCT00294723|456156231|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
126781649|NCT00294723|456156232|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
126781650|NCT00294723|456156230|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
126781651|NCT00294723|456156231|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
126781652|NCT00294723|456156232|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
126781653|NCT00294723|456156230|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
126781654|NCT00294723|456156231|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
126781655|NCT00294723|456156232|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
126781656|NCT00294723|456156230|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
126781657|NCT00294723|456156231|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
126781658|NCT00294723|456156232|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
126781659|NCT00294723|456156230|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
126781660|NCT00294723|456156231|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
126781661|NCT00294723|456156232|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
126781662|NCT00294723|456156230|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
126781663|NCT00294723|456156231|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
126781664|NCT00294723|456156232|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
126781665|NCT00294723|456156230|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
126781666|NCT00294723|456156231|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
126781667|NCT00294723|456156232|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
126781668|NCT00294723|456156230|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
126781669|NCT00294723|456156231|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
126739781|NCT02431702|455997227|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
126739782|NCT02431702|455997228|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
126739783|NCT03250624|455997237|FG000|Overall Study|Lack of Efficacy|1|||
126739784|NCT03250624|455997238|FG001|Overall Study|Lack of Efficacy|4|||
126739785|NCT03250624|455997237|FG000|Overall Study|Adverse Event|0|||
126739786|NCT03250624|455997238|FG001|Overall Study|Adverse Event|1|||
126739787|NCT03250624|455997237|FG000|Overall Study|Other|1|||
126739788|NCT03250624|455997238|FG001|Overall Study|Other|2|||
126739789|NCT01235338|455997243|FG000|Overall Study|Adverse Event|3|||
126739790|NCT01235338|455997244|FG001|Overall Study|Adverse Event|2|||
126739791|NCT01235338|455997243|FG000|Overall Study|Protocol Violation|1|||
126739792|NCT01235338|455997244|FG001|Overall Study|Protocol Violation|1|||
126739793|NCT01235338|455997243|FG000|Overall Study|Withdrawal by Subject|5|||
126739794|NCT01235338|455997244|FG001|Overall Study|Withdrawal by Subject|0|||
126739795|NCT01235338|455997243|FG000|Overall Study|Exclusion criteria violations|1|||
126739796|NCT01235338|455997244|FG001|Overall Study|Exclusion criteria violations|1|||
126739797|NCT01235338|455997243|FG000|Overall Study|Positive drug screen|0|||
126739798|NCT01235338|455997244|FG001|Overall Study|Positive drug screen|1|||
126739799|NCT01235338|455997243|FG000|Overall Study|Prohibited meds|1|||
126739800|NCT01235338|455997244|FG001|Overall Study|Prohibited meds|0|||
126739801|NCT00509028|455997245|FG000|Overall Study|Adverse Event|2|||
126739802|NCT00509028|455997246|FG001|Overall Study|Adverse Event|0|||
126739803|NCT00509028|455997245|FG000|Overall Study|Withdrawal by Subject|4|||
126739804|NCT00509028|455997246|FG001|Overall Study|Withdrawal by Subject|3|||
126739805|NCT00509028|455997245|FG000|Overall Study|Lost to Follow-up|0|||
126739806|NCT00509028|455997246|FG001|Overall Study|Lost to Follow-up|1|||
126739807|NCT00509028|455997245|FG000|Overall Study|Protocol Violation|4|||
126739808|NCT00509028|455997246|FG001|Overall Study|Protocol Violation|2|||
126739809|NCT00509028|455997245|FG000|Overall Study|Non-compliance|2|||
126739810|NCT00509028|455997246|FG001|Overall Study|Non-compliance|1|||
126739811|NCT00948428|455997247|FG000|Overall Study|Withdrawal by Subject|6|||
126739812|NCT00948428|455997248|FG001|Overall Study|Withdrawal by Subject|12|||
126739813|NCT00948428|455997249|FG002|Overall Study|Withdrawal by Subject|7|||
126739814|NCT00948428|455997247|FG000|Overall Study|Adverse Event|6|||
126739815|NCT00948428|455997248|FG001|Overall Study|Adverse Event|3|||
126739816|NCT00948428|455997249|FG002|Overall Study|Adverse Event|0|||
126739817|NCT00948428|455997247|FG000|Overall Study|Lost to Follow-up|2|||
126739818|NCT00948428|455997248|FG001|Overall Study|Lost to Follow-up|1|||
126739819|NCT00948428|455997249|FG002|Overall Study|Lost to Follow-up|1|||
126739820|NCT00948428|455997247|FG000|Overall Study|Death|2|||
126739821|NCT00948428|455997248|FG001|Overall Study|Death|0|||
126739822|NCT00948428|455997249|FG002|Overall Study|Death|0|||
126739823|NCT00948428|455997247|FG000|Overall Study|Intercurrent Illness|1|||
126739824|NCT00948428|455997248|FG001|Overall Study|Intercurrent Illness|0|||
126739825|NCT00948428|455997249|FG002|Overall Study|Intercurrent Illness|0|||
126739826|NCT00948428|455997247|FG000|Overall Study|Non-compliance|1|||
126739827|NCT00948428|455997248|FG001|Overall Study|Non-compliance|2|||
126615295|NCT01294644|455549800|FG000|Overall Study|Adverse Event|2|||
126615296|NCT01294644|455549801|FG001|Overall Study|Adverse Event|0|||
126615297|NCT01294644|455549802|FG002|Overall Study|Adverse Event|1|||
126615298|NCT01294644|455549800|FG000|Overall Study|Withdrawal by Subject|3|||
126615299|NCT01294644|455549801|FG001|Overall Study|Withdrawal by Subject|7|||
126615300|NCT01294644|455549802|FG002|Overall Study|Withdrawal by Subject|4|||
126615301|NCT01294644|455549800|FG000|Overall Study|Lost to Follow-up|3|||
126615302|NCT01294644|455549801|FG001|Overall Study|Lost to Follow-up|2|||
126615303|NCT01294644|455549802|FG002|Overall Study|Lost to Follow-up|5|||
126615304|NCT01294644|455549800|FG000|Overall Study|Miscellaneous Reason|2|||
126615305|NCT01294644|455549801|FG001|Overall Study|Miscellaneous Reason|1|||
126615306|NCT01294644|455549802|FG002|Overall Study|Miscellaneous Reason|4|||
126615307|NCT02188459|455549803|FG000|Overall Study|Lost to Follow-up|3|||
126615308|NCT02188459|455549804|FG001|Overall Study|Lost to Follow-up|4|||
126615309|NCT02188459|455549803|FG000|Overall Study|Early Termination|0|||
126615310|NCT02188459|455549804|FG001|Overall Study|Early Termination|3|||
126615311|NCT02548585|455549805|FG000|Overall Study|Withdrawal by Subject|0|||
126615312|NCT02548585|455549806|FG001|Overall Study|Withdrawal by Subject|0|||
126615313|NCT02548585|455549807|FG002|Overall Study|Withdrawal by Subject|0|||
126739828|NCT00948428|455997249|FG002|Overall Study|Non-compliance|0|||
126739829|NCT02408484|455997251|FG000|Overall Study|Withdrawal by Subject|3|||
126739830|NCT02408484|455997251|FG000|Overall Study|Not treated during study period|1|||
126739831|NCT04839393|455997263|FG000|Overall Study|Adverse Event|0|||
126615314|NCT02548585|455549808|FG003|Overall Study|Withdrawal by Subject|0|||
126615315|NCT02548585|455549809|FG004|Overall Study|Withdrawal by Subject|0|||
126739832|NCT04839393|455997264|FG001|Overall Study|Adverse Event|0|||
126739833|NCT04839393|455997265|FG002|Overall Study|Adverse Event|2|||
126739834|NCT04839393|455997263|FG000|Overall Study|Withdrawal by participant|0|||
126739835|NCT04839393|455997264|FG001|Overall Study|Withdrawal by participant|0|||
126615316|NCT02548585|455549810|FG005|Overall Study|Withdrawal by Subject|1|||
126615317|NCT02548585|455549811|FG006|Overall Study|Withdrawal by Subject|0|||
126739836|NCT04839393|455997265|FG002|Overall Study|Withdrawal by participant|1|||
126739837|NCT00517413|455997268|FG000|Overall Study|Adverse Event|7|||
126739838|NCT00517413|455997268|FG000|Overall Study|Death|13|||
126739839|NCT00517413|455997268|FG000|Overall Study|Protocol Violation|15|||
126739840|NCT00517413|455997268|FG000|Overall Study|Withdrawal by Subject|2|||
126739841|NCT00517413|455997268|FG000|Overall Study|Failure to return|1|||
126739842|NCT00517413|455997268|FG000|Overall Study|Other-Reasons|23|||
126739843|NCT00441727|455997273|FG000|Overall Study|Protocol Violation|19|||
126739844|NCT00441727|455997274|FG001|Overall Study|Protocol Violation|28|||
126739845|NCT00441727|455997275|FG002|Overall Study|Protocol Violation|32|||
126739846|NCT00441727|455997273|FG000|Overall Study|Adverse Event|26|||
126739847|NCT00441727|455997274|FG001|Overall Study|Adverse Event|33|||
126739848|NCT00441727|455997275|FG002|Overall Study|Adverse Event|28|||
126739849|NCT00441727|455997273|FG000|Overall Study|Lack of Efficacy|7|||
126739850|NCT00441727|455997274|FG001|Overall Study|Lack of Efficacy|8|||
126739851|NCT00441727|455997275|FG002|Overall Study|Lack of Efficacy|48|||
126739852|NCT00441727|455997273|FG000|Overall Study|Withdrawal by Subject|40|||
126739853|NCT00441727|455997274|FG001|Overall Study|Withdrawal by Subject|34|||
126739854|NCT00441727|455997275|FG002|Overall Study|Withdrawal by Subject|47|||
126739855|NCT00441727|455997273|FG000|Overall Study|Lost to Follow-up|5|||
126739856|NCT00441727|455997274|FG001|Overall Study|Lost to Follow-up|6|||
126739857|NCT00441727|455997275|FG002|Overall Study|Lost to Follow-up|5|||
126739858|NCT00441727|455997273|FG000|Overall Study|Safety Reasons|3|||
126739859|NCT00441727|455997274|FG001|Overall Study|Safety Reasons|1|||
126739860|NCT00441727|455997275|FG002|Overall Study|Safety Reasons|3|||
126739861|NCT00441727|455997273|FG000|Overall Study|Various reason specified|6|||
126739862|NCT00441727|455997274|FG001|Overall Study|Various reason specified|8|||
126739863|NCT00441727|455997275|FG002|Overall Study|Various reason specified|5|||
126739864|NCT01237223|455997282|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
126739865|NCT01237223|455997283|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
126739866|NCT01237223|455997284|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
126739867|NCT01237223|455997285|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
126739868|NCT01237223|455997286|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
126739869|NCT01237223|455997287|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
126739870|NCT01237223|455997282|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
126739871|NCT01237223|455997283|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
126739872|NCT01237223|455997284|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
126739873|NCT01237223|455997285|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
126739874|NCT01237223|455997286|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
126739875|NCT01237223|455997287|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
126739876|NCT01237223|455997282|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
126739877|NCT01237223|455997283|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
126739878|NCT01237223|455997284|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
126739879|NCT01237223|455997285|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
126739880|NCT01237223|455997286|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
126739881|NCT01237223|455997287|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
126739882|NCT01237223|455997282|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
126739883|NCT01237223|455997283|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
126739884|NCT01237223|455997284|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
126739885|NCT01237223|455997285|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
126739886|NCT01237223|455997286|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
126739887|NCT01237223|455997287|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
126739888|NCT01237223|455997282|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
126739889|NCT01237223|455997283|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
126739890|NCT01237223|455997284|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
126739891|NCT01237223|455997285|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
126739892|NCT01237223|455997286|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
126739893|NCT01237223|455997287|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
126739894|NCT01237223|455997282|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
126739895|NCT01237223|455997283|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
126739896|NCT01237223|455997284|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
126739897|NCT01237223|455997285|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
126739898|NCT01237223|455997286|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
126739899|NCT01237223|455997287|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
126739900|NCT01237223|455997282|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
126739901|NCT01237223|455997283|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
126739902|NCT01237223|455997284|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
126739903|NCT01237223|455997285|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
126739904|NCT01237223|455997286|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
126739905|NCT01237223|455997287|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
126739906|NCT01237223|455997282|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
126739907|NCT01237223|455997283|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
126739908|NCT01237223|455997284|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
126739909|NCT01237223|455997285|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
126739910|NCT01237223|455997286|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
126739911|NCT01237223|455997287|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
126739912|NCT01237223|455997282|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
126739913|NCT01237223|455997283|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
126739914|NCT01237223|455997284|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
126739915|NCT01237223|455997285|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
126739916|NCT01237223|455997286|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
126739917|NCT01237223|455997287|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
126739918|NCT01237223|455997282|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
126739919|NCT01237223|455997283|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
126739920|NCT01237223|455997284|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
126739921|NCT01237223|455997285|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
126739922|NCT01237223|455997286|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
126739923|NCT01237223|455997287|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
126739924|NCT00407550|455997292|FG000|Overall Study|Adverse Event|0|||
126739925|NCT00407550|455997293|FG001|Overall Study|Adverse Event|1|||
126739926|NCT00407550|455997292|FG000|Overall Study|Withdrawal by Subject|0|||
126739927|NCT00407550|455997293|FG001|Overall Study|Withdrawal by Subject|2|||
126739928|NCT00407550|455997292|FG000|Overall Study|Death|1|||
126739929|NCT00407550|455997293|FG001|Overall Study|Death|0|||
126739930|NCT00407550|455997292|FG000|Overall Study|Insurance or Other medical condition|2|||
126739931|NCT00407550|455997293|FG001|Overall Study|Insurance or Other medical condition|1|||
126739932|NCT03235726|455997294|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126739933|NCT03235726|455997295|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126739934|NCT03235726|455997296|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126739935|NCT03235726|455997297|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126739936|NCT03235726|455997298|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
126739937|NCT03235726|455997299|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126739938|NCT03235726|455997300|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126739939|NCT03235726|455997301|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126739940|NCT03235726|455997302|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126739941|NCT03235726|455997303|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
126739942|NCT03235726|455997294|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126739943|NCT03235726|455997295|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126739944|NCT03235726|455997296|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126739945|NCT03235726|455997297|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126739946|NCT03235726|455997298|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
126739947|NCT03235726|455997299|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126739948|NCT03235726|455997300|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126739949|NCT03235726|455997301|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126739950|NCT03235726|455997302|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126739951|NCT03235726|455997303|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
126739952|NCT00443846|455997304|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
126739953|NCT00443846|455997305|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
126739954|NCT00443846|455997304|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
126739955|NCT00443846|455997305|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
126739956|NCT00443846|455997304|FG000|Overall Study|Adverse Event|0|||
126739957|NCT00443846|455997305|FG001|Overall Study|Adverse Event|1|||
126739958|NCT00443846|455997304|FG000|Overall Study|Personal reason|8|||
126739959|NCT00443846|455997305|FG001|Overall Study|Personal reason|3|||
126739960|NCT00443846|455997304|FG000|Overall Study|Lost to Follow-up|1|||
126739961|NCT00443846|455997305|FG001|Overall Study|Lost to Follow-up|2|||
126739962|NCT00641706|455997307|FG000|Overall Study|Adverse Event|2|||
126739963|NCT00641706|455997308|FG001|Overall Study|Adverse Event|1|||
126739964|NCT00641706|455997307|FG000|Overall Study|Withdrawal by Subject|6|||
126781670|NCT00294723|456156232|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
126739965|NCT00641706|455997308|FG001|Overall Study|Withdrawal by Subject|1|||
126781671|NCT00294723|456156230|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
126781672|NCT00294723|456156231|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
126739966|NCT00641706|455997307|FG000|Overall Study|Clinical Decline|1|||
126739967|NCT00641706|455997308|FG001|Overall Study|Clinical Decline|0|||
126739968|NCT00641706|455997307|FG000|Overall Study|Lead Investigator Decision|0|||
126739969|NCT00641706|455997308|FG001|Overall Study|Lead Investigator Decision|1|||
126739970|NCT01599806|455997311|FG000|Overall Study|Lost to Follow-up|20|||
126739971|NCT01599806|455997312|FG001|Overall Study|Lost to Follow-up|20|||
126739972|NCT01599806|455997311|FG000|Overall Study|Withdrawal by Subject|12|||
126739973|NCT01599806|455997312|FG001|Overall Study|Withdrawal by Subject|12|||
126739974|NCT01599806|455997311|FG000|Overall Study|Other Eligibility criteria|11|||
126739975|NCT01599806|455997312|FG001|Overall Study|Other Eligibility criteria|9|||
126739976|NCT00391807|455997314|FG000|Overall Study|Did not receive study medication|23|||
126739977|NCT00391807|455997314|FG000|Overall Study|Adverse Event|177|||
126739978|NCT00391807|455997314|FG000|Overall Study|Pregnancy|25|||
126739979|NCT00391807|455997314|FG000|Overall Study|Lost to Follow-up|227|||
126739980|NCT00391807|455997314|FG000|Overall Study|Withdrawal by Subject|147|||
126739981|NCT00391807|455997314|FG000|Overall Study|Protocol Violation|20|||
126739982|NCT00391807|455997314|FG000|Overall Study|Various|96|||
126739983|NCT00282568|455997324|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
126739984|NCT00282568|455997324|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
126739985|NCT00282568|455997324|FG000|Extended Treatment Period|Adverse Event|17|||
126739986|NCT00282568|455997324|FG000|Extended Treatment Period|Non-compliance|4|||
126739987|NCT00282568|455997324|FG000|Extended Treatment Period|Physician Decision|1|||
126739988|NCT00282568|455997324|FG000|Extended Treatment Period|Lost to Follow-up|2|||
126739989|NCT01266070|455997325|FG000|Overall Study|Adverse Event|3|||
126739990|NCT01266070|455997325|FG000|Overall Study|Protocol Violation|1|||
126739991|NCT01585168|455997326|FG000|Overall Study|Lost to Follow-up|3|||
126739992|NCT01585168|455997327|FG001|Overall Study|Lost to Follow-up|1|||
126739993|NCT01585168|455997328|FG002|Overall Study|Lost to Follow-up|1|||
126739994|NCT01585168|455997329|FG003|Overall Study|Lost to Follow-up|1|||
126739995|NCT01194414|455997330|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
126739996|NCT01194414|455997331|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
126739997|NCT01194414|455997332|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
126739998|NCT01194414|455997333|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
126739999|NCT01194414|455997330|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
126740000|NCT01194414|455997331|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
126740001|NCT01194414|455997332|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
126740002|NCT01194414|455997333|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
126740003|NCT01194414|455997330|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
126740004|NCT01194414|455997331|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
126740005|NCT01194414|455997332|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
126740006|NCT01194414|455997333|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
126740007|NCT01194414|455997330|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
126740008|NCT01194414|455997331|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
126740009|NCT01194414|455997332|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
126740010|NCT01194414|455997333|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
126740011|NCT01194414|455997330|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
126740012|NCT01194414|455997331|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
126740013|NCT01194414|455997332|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
126740014|NCT01194414|455997333|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
126740015|NCT01194414|455997330|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
126740016|NCT01194414|455997331|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
126740017|NCT01194414|455997332|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
126740018|NCT01194414|455997333|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
126740019|NCT01194414|455997330|FG000|24 Weeks Double Blind Period|Other|0|||
126740020|NCT01194414|455997331|FG001|24 Weeks Double Blind Period|Other|1|||
126740021|NCT01194414|455997332|FG002|24 Weeks Double Blind Period|Other|0|||
126740022|NCT01194414|455997333|FG003|24 Weeks Double Blind Period|Other|0|||
126740023|NCT01194414|455997330|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
126740024|NCT01194414|455997331|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
126740025|NCT01194414|455997332|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
126740026|NCT01194414|455997333|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
126740027|NCT01194414|455997330|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
126740028|NCT01194414|455997331|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
126740029|NCT01194414|455997332|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
126740030|NCT01194414|455997333|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
126740031|NCT01194414|455997330|FG000|24 Weeks Double Blind Period|Death|0|||
126740032|NCT01194414|455997331|FG001|24 Weeks Double Blind Period|Death|1|||
126740033|NCT01194414|455997332|FG002|24 Weeks Double Blind Period|Death|0|||
126740034|NCT01194414|455997333|FG003|24 Weeks Double Blind Period|Death|0|||
126740035|NCT01194414|455997330|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
126740036|NCT01194414|455997331|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
126740037|NCT01194414|455997332|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
126740038|NCT01194414|455997333|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
126740039|NCT01194414|455997330|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
126740040|NCT01194414|455997331|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
126740041|NCT01194414|455997332|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
126740042|NCT01194414|455997333|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
126740043|NCT01194414|455997330|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
126740044|NCT01194414|455997331|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
126740045|NCT01194414|455997332|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
126740046|NCT01194414|455997333|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
126740047|NCT01194414|455997330|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
126740048|NCT01194414|455997331|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
126740049|NCT01194414|455997332|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
126740050|NCT01194414|455997333|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
126740051|NCT01194414|455997330|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
126740052|NCT01194414|455997331|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
126740053|NCT01194414|455997332|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
126740054|NCT01194414|455997333|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
126740055|NCT01194414|455997330|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
126740056|NCT01194414|455997331|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
126740057|NCT01194414|455997332|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
126740058|NCT01194414|455997333|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
126740059|NCT01194414|455997330|FG000|72 Weeks Open Label Extension|Other|2|||
126740060|NCT01194414|455997331|FG001|72 Weeks Open Label Extension|Other|1|||
126740061|NCT01194414|455997332|FG002|72 Weeks Open Label Extension|Other|0|||
126740062|NCT01194414|455997333|FG003|72 Weeks Open Label Extension|Other|0|||
126740063|NCT01194414|455997330|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
126740064|NCT01194414|455997331|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
126740065|NCT01194414|455997332|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
126740066|NCT01194414|455997333|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
126740067|NCT01194414|455997330|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
126740068|NCT01194414|455997331|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
126740069|NCT01194414|455997332|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
126740070|NCT01194414|455997333|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
126740071|NCT01194414|455997330|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
126740072|NCT01194414|455997331|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
126740073|NCT01194414|455997332|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
126740074|NCT01194414|455997333|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
126740075|NCT01194414|455997330|FG000|72 Weeks Open Label Extension|Death|1|||
126740076|NCT01194414|455997331|FG001|72 Weeks Open Label Extension|Death|2|||
126740077|NCT01194414|455997332|FG002|72 Weeks Open Label Extension|Death|0|||
126740078|NCT01194414|455997333|FG003|72 Weeks Open Label Extension|Death|2|||
126740079|NCT04685538|455997340|FG000|Overall Study|Adverse Event|0|||
126740080|NCT04685538|455997341|FG001|Overall Study|Adverse Event|1|||
126740081|NCT04685538|455997340|FG000|Overall Study|Lost to Follow-up|0|||
126740082|NCT04685538|455997341|FG001|Overall Study|Lost to Follow-up|2|||
126740083|NCT00770224|455997346|FG000|Step 1: Induction|Adverse Event|3|||
126740084|NCT00770224|455997347|FG001|Step 1: Induction|Adverse Event|0|||
126740085|NCT00770224|455997346|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
126740086|NCT00770224|455997347|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
126740087|NCT00770224|455997346|FG000|Step 1: Induction|Other reason not protocol specified|2|||
126740088|NCT00770224|455997347|FG001|Step 1: Induction|Other reason not protocol specified|0|||
126740089|NCT00770224|455997346|FG000|Step 1: Induction|Ineligible|2|||
126740090|NCT00770224|455997347|FG001|Step 1: Induction|Ineligible|0|||
126740091|NCT00770224|455997346|FG000|Step 1: Induction|No protocol treatment given|1|||
126740092|NCT00770224|455997347|FG001|Step 1: Induction|No protocol treatment given|0|||
126740093|NCT00770224|455997346|FG000|Step 2: Maintenance|Adverse Event|0|||
126740094|NCT00770224|455997347|FG001|Step 2: Maintenance|Adverse Event|10|||
126740095|NCT00770224|455997346|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
126740096|NCT00770224|455997347|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
126740097|NCT00770224|455997346|FG000|Step 2: Maintenance|Progression/relapse|0|||
126740098|NCT00770224|455997347|FG001|Step 2: Maintenance|Progression/relapse|1|||
126740099|NCT00770224|455997346|FG000|Step 2: Maintenance|Death|0|||
126740100|NCT00770224|455997347|FG001|Step 2: Maintenance|Death|2|||
126740101|NCT00770224|455997346|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
126740102|NCT00770224|455997347|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
126740103|NCT00770224|455997346|FG000|Step 2: Maintenance|Ineligible|0|||
126740104|NCT00770224|455997347|FG001|Step 2: Maintenance|Ineligible|2|||
126740105|NCT01505114|455997356|FG000|Overall Study|Withdrawal by Subject|5|||
126740106|NCT01505114|455997357|FG001|Overall Study|Withdrawal by Subject|4|||
126740107|NCT01505114|455997358|FG002|Overall Study|Withdrawal by Subject|4|||
126740108|NCT01505114|455997359|FG003|Overall Study|Withdrawal by Subject|7|||
126740109|NCT01505114|455997356|FG000|Overall Study|Death|1|||
126740110|NCT01505114|455997357|FG001|Overall Study|Death|0|||
126740111|NCT01505114|455997358|FG002|Overall Study|Death|0|||
126740112|NCT01505114|455997359|FG003|Overall Study|Death|1|||
126740113|NCT01505114|455997356|FG000|Overall Study|unable to adhere to visit schedule|3|||
126740114|NCT01505114|455997357|FG001|Overall Study|unable to adhere to visit schedule|2|||
126740115|NCT01505114|455997358|FG002|Overall Study|unable to adhere to visit schedule|3|||
126740116|NCT01505114|455997359|FG003|Overall Study|unable to adhere to visit schedule|3|||
126740117|NCT01505114|455997356|FG000|Overall Study|Lost to Follow-up|11|||
126740118|NCT01505114|455997357|FG001|Overall Study|Lost to Follow-up|5|||
126740119|NCT01505114|455997358|FG002|Overall Study|Lost to Follow-up|8|||
126740120|NCT01505114|455997359|FG003|Overall Study|Lost to Follow-up|7|||
126740121|NCT01505114|455997356|FG000|Overall Study|relocated|4|||
126740122|NCT01505114|455997357|FG001|Overall Study|relocated|2|||
126740123|NCT01505114|455997358|FG002|Overall Study|relocated|2|||
126740124|NCT01505114|455997359|FG003|Overall Study|relocated|3|||
126740125|NCT01505114|455997356|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
126740126|NCT01505114|455997357|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
126740127|NCT01505114|455997358|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
126740128|NCT01505114|455997359|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
126740129|NCT01505114|455997356|FG000|Overall Study|staff safety concerns|0|||
126740130|NCT01505114|455997357|FG001|Overall Study|staff safety concerns|0|||
126740131|NCT01505114|455997358|FG002|Overall Study|staff safety concerns|0|||
126740132|NCT01505114|455997359|FG003|Overall Study|staff safety concerns|1|||
126740133|NCT01505114|455997356|FG000|Overall Study|investigator decision|1|||
126740134|NCT01505114|455997357|FG001|Overall Study|investigator decision|0|||
126740135|NCT01505114|455997358|FG002|Overall Study|investigator decision|1|||
126740136|NCT01505114|455997359|FG003|Overall Study|investigator decision|0|||
126740137|NCT01235507|455997360|FG000|Overall Study|Adverse Event|1|||
126740138|NCT01235507|455997360|FG000|Overall Study|Withdrawal by Subject|1|||
126740139|NCT01587274|455997364|FG000|Overall Study|Lost to Follow-up|4|||
126740140|NCT01587274|455997365|FG001|Overall Study|Lost to Follow-up|5|||
126740141|NCT01587274|455997366|FG002|Overall Study|Lost to Follow-up|3|||
126740142|NCT02475629|455997367|FG000|Overall Study|Adverse Event|1|||
126740143|NCT02475629|455997367|FG000|Overall Study|Death|4|||
126740144|NCT02475629|455997367|FG000|Overall Study|Physician Decision|1|||
126740145|NCT02475629|455997367|FG000|Overall Study|Withdrawal by Subject|1|||
126740146|NCT02475629|455997367|FG000|Overall Study|Lost to Follow-up|1|||
126740147|NCT02475629|455997367|FG000|Overall Study|Subject non-compliance|1|||
126740148|NCT04423757|455997378|FG000|Overall Study|Adverse Event|2|||
126740149|NCT04423757|455997379|FG001|Overall Study|Adverse Event|0|||
126740150|NCT04423757|455997378|FG000|Overall Study|Not treated|1|||
126740151|NCT04423757|455997379|FG001|Overall Study|Not treated|1|||
126740152|NCT02709109|455997380|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
126740153|NCT02709109|455997381|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
126740154|NCT02709109|455997382|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
126740155|NCT02709109|455997383|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
126740156|NCT02709109|455997380|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
126740157|NCT02709109|455997381|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
126740158|NCT02709109|455997382|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
126740159|NCT02709109|455997383|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
126740160|NCT02709109|455997380|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
126740161|NCT02709109|455997381|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
126740162|NCT02709109|455997382|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
126740163|NCT02709109|455997383|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
126740164|NCT02709109|455997380|FG000|Washout Period (28 Days)|Other|2|||
126740165|NCT02709109|455997381|FG001|Washout Period (28 Days)|Other|2|||
126740166|NCT02709109|455997382|FG002|Washout Period (28 Days)|Other|3|||
126740167|NCT02709109|455997383|FG003|Washout Period (28 Days)|Other|0|||
126740168|NCT02709109|455997380|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
126740169|NCT02709109|455997381|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
126740170|NCT02709109|455997382|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
126615318|NCT02548585|455549805|FG000|Overall Study|Lost to Follow-up|1|||
126615319|NCT02548585|455549806|FG001|Overall Study|Lost to Follow-up|0|||
126615320|NCT02548585|455549807|FG002|Overall Study|Lost to Follow-up|0|||
126740171|NCT02709109|455997383|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
126740172|NCT02709109|455997380|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
126740173|NCT02709109|455997381|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
126740174|NCT02709109|455997382|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
126740175|NCT02709109|455997383|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
126740176|NCT02709109|455997380|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
126740177|NCT02709109|455997381|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
126740178|NCT02709109|455997382|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
126740179|NCT02709109|455997383|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
126740180|NCT02709109|455997380|FG000|Treatment Period 2 (28 Days)|Other|0|||
126740181|NCT02709109|455997381|FG001|Treatment Period 2 (28 Days)|Other|0|||
126740182|NCT02709109|455997382|FG002|Treatment Period 2 (28 Days)|Other|1|||
126740183|NCT02709109|455997383|FG003|Treatment Period 2 (28 Days)|Other|0|||
126740184|NCT05563714|455997384|FG000|Overall Study|Death|2|||
126740185|NCT05563714|455997385|FG001|Overall Study|Death|2|||
126740186|NCT05563714|455997386|FG002|Overall Study|Death|0|||
126740187|NCT05563714|455997387|FG003|Overall Study|Death|0|||
126740188|NCT05563714|455997384|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
126740189|NCT05563714|455997385|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
126740190|NCT05563714|455997386|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
126740191|NCT05563714|455997387|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
126740192|NCT05563714|455997384|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
126740193|NCT05563714|455997385|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
126740194|NCT05563714|455997386|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
126740195|NCT05563714|455997387|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
126740196|NCT05563714|455997384|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
126740197|NCT05563714|455997385|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
126740198|NCT05563714|455997386|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
126740199|NCT05563714|455997387|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
126740200|NCT05563714|455997384|FG000|Overall Study|Lost to Follow-up|22|||
126740201|NCT05563714|455997385|FG001|Overall Study|Lost to Follow-up|19|||
126740202|NCT05563714|455997386|FG002|Overall Study|Lost to Follow-up|0|||
126740203|NCT05563714|455997387|FG003|Overall Study|Lost to Follow-up|0|||
126740204|NCT01815580|455997388|FG000|Overall Study|Lost to Follow-up|4|||
126740205|NCT01815580|455997389|FG001|Overall Study|Lost to Follow-up|7|||
126740206|NCT01815580|455997388|FG000|Overall Study|Withdrawal by Subject|3|||
126740207|NCT01815580|455997389|FG001|Overall Study|Withdrawal by Subject|4|||
126740208|NCT01815580|455997388|FG000|Overall Study|Excluded from analysis|5|||
126740209|NCT01815580|455997389|FG001|Overall Study|Excluded from analysis|4|||
126740210|NCT02228564|455997390|FG000|Overall Study|Withdrawal by Subject|10|||
126740211|NCT02228564|455997390|FG000|Overall Study|Death|11|||
126740212|NCT02228564|455997390|FG000|Overall Study|Physician Decision|5|||
126740213|NCT02228564|455997390|FG000|Overall Study|Lost to Follow-up|17|||
126740214|NCT02228564|455997390|FG000|Overall Study|Other|6|||
126740215|NCT00617591|455997391|FG000|Overall Study|Withdrew consent during Induction|4|||
126740216|NCT00617591|455997391|FG000|Overall Study|Withdrew consent during Maintenance|6|||
126740217|NCT00376246|455997392|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
126740218|NCT00376246|455997393|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
126740219|NCT00376246|455997392|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126740220|NCT00376246|455997393|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
126740221|NCT00376246|455997392|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
126740222|NCT00376246|455997393|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126781673|NCT00294723|456156232|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
126781674|NCT00294723|456156230|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
126615321|NCT02548585|455549808|FG003|Overall Study|Lost to Follow-up|0|||
126615322|NCT02548585|455549809|FG004|Overall Study|Lost to Follow-up|0|||
126615323|NCT02548585|455549810|FG005|Overall Study|Lost to Follow-up|0|||
126615324|NCT02548585|455549811|FG006|Overall Study|Lost to Follow-up|0|||
126740223|NCT01072448|455997402|FG000|Overall Study|Adverse Event|9|||
126740224|NCT01072448|455997403|FG001|Overall Study|Adverse Event|10|||
126740225|NCT01072448|455997402|FG000|Overall Study|Subject withdrew consent|4|||
126740226|NCT01072448|455997403|FG001|Overall Study|Subject withdrew consent|9|||
126740227|NCT01072448|455997402|FG000|Overall Study|Protocol deviation|3|||
126740228|NCT01072448|455997403|FG001|Overall Study|Protocol deviation|4|||
126740229|NCT01072448|455997402|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126740230|NCT01072448|455997403|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126740231|NCT01072448|455997402|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126740232|NCT01072448|455997403|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
126740233|NCT01072448|455997402|FG000|Overall Study|Lost to Follow-up|1|||
126740234|NCT01072448|455997403|FG001|Overall Study|Lost to Follow-up|1|||
126740235|NCT01072448|455997402|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126740236|NCT01072448|455997403|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126781675|NCT00294723|456156231|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
126615325|NCT02548585|455549805|FG000|Overall Study|Other|1|||
126615326|NCT02548585|455549806|FG001|Overall Study|Other|0|||
126615327|NCT02548585|455549807|FG002|Overall Study|Other|0|||
126615328|NCT02548585|455549808|FG003|Overall Study|Other|2|||
126615329|NCT02548585|455549809|FG004|Overall Study|Other|3|||
126615330|NCT02548585|455549810|FG005|Overall Study|Other|0|||
126781676|NCT00294723|456156232|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
126781677|NCT00294723|456156230|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
126781678|NCT00294723|456156231|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
126615331|NCT02548585|455549811|FG006|Overall Study|Other|1|||
126615332|NCT02548585|455549805|FG000|Overall Study|Randomized but not treated|0|||
126615333|NCT02548585|455549806|FG001|Overall Study|Randomized but not treated|0|||
126615334|NCT02548585|455549807|FG002|Overall Study|Randomized but not treated|0|||
126615335|NCT02548585|455549808|FG003|Overall Study|Randomized but not treated|0|||
126615336|NCT02548585|455549809|FG004|Overall Study|Randomized but not treated|0|||
126615337|NCT02548585|455549810|FG005|Overall Study|Randomized but not treated|1|||
126615338|NCT02548585|455549811|FG006|Overall Study|Randomized but not treated|0|||
126615339|NCT01986348|455549812|FG000|Overall Study|Death|8|||
126615340|NCT01986348|455549813|FG001|Overall Study|Death|22|||
126615341|NCT01986348|455549814|FG002|Overall Study|Death|10|||
126615342|NCT01986348|455549815|FG003|Overall Study|Death|21|||
126615343|NCT01986348|455549812|FG000|Overall Study|Lost to Follow-up|0|||
126615344|NCT01986348|455549813|FG001|Overall Study|Lost to Follow-up|0|||
126615345|NCT01986348|455549814|FG002|Overall Study|Lost to Follow-up|0|||
126615346|NCT01986348|455549815|FG003|Overall Study|Lost to Follow-up|2|||
126615347|NCT01986348|455549812|FG000|Overall Study|Physician Decision|0|||
126615348|NCT01986348|455549813|FG001|Overall Study|Physician Decision|0|||
126615349|NCT01986348|455549814|FG002|Overall Study|Physician Decision|0|||
126615350|NCT01986348|455549815|FG003|Overall Study|Physician Decision|1|||
126615351|NCT01986348|455549812|FG000|Overall Study|Progressive Disease|0|||
126615352|NCT01986348|455549813|FG001|Overall Study|Progressive Disease|0|||
126615353|NCT01986348|455549814|FG002|Overall Study|Progressive Disease|2|||
126615354|NCT01986348|455549815|FG003|Overall Study|Progressive Disease|0|||
126615355|NCT01986348|455549812|FG000|Overall Study|Withdrawal by Participant|0|||
126615356|NCT01986348|455549813|FG001|Overall Study|Withdrawal by Participant|1|||
126615357|NCT01986348|455549814|FG002|Overall Study|Withdrawal by Participant|2|||
126615358|NCT01986348|455549815|FG003|Overall Study|Withdrawal by Participant|1|||
126615359|NCT01986348|455549812|FG000|Overall Study|Study Terminated by Sponsor|0|||
126615360|NCT01986348|455549813|FG001|Overall Study|Study Terminated by Sponsor|0|||
126615361|NCT01986348|455549814|FG002|Overall Study|Study Terminated by Sponsor|0|||
126615362|NCT01986348|455549815|FG003|Overall Study|Study Terminated by Sponsor|3|||
126615363|NCT01986348|455549812|FG000|Overall Study|Other-unspecified|0|||
126615364|NCT01986348|455549813|FG001|Overall Study|Other-unspecified|1|||
126615365|NCT01986348|455549814|FG002|Overall Study|Other-unspecified|0|||
126615366|NCT01986348|455549815|FG003|Overall Study|Other-unspecified|2|||
126615367|NCT02935894|455549817|FG000|Overall Study|Subject dismissed|1|||
126615368|NCT03242863|455549820|FG000|Study Week 1|Withdrawal by Subject|0|||
126615369|NCT03242863|455549821|FG001|Study Week 1|Withdrawal by Subject|1|||
126615370|NCT03242863|455549822|FG002|Study Week 1|Withdrawal by Subject|0|||
126615371|NCT03242863|455549823|FG003|Study Week 1|Withdrawal by Subject|0|||
126615372|NCT03242863|455549824|FG004|Study Week 1|Withdrawal by Subject|3|||
126615373|NCT03242863|455549825|FG005|Study Week 1|Withdrawal by Subject|0|||
126615374|NCT01079949|455549829|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
126615375|NCT01079949|455549830|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
126615376|NCT01079949|455549829|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
126615377|NCT01079949|455549830|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
126615378|NCT01079949|455549829|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
126615379|NCT01079949|455549830|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
126615380|NCT01079949|455549829|FG000|Overall Study|Randomized but not treated|1|||
126615381|NCT01079949|455549830|FG001|Overall Study|Randomized but not treated|0|||
126615382|NCT02144285|455549831|FG000|Overall Study|Withdrawal by Subject|0|||
126615383|NCT02144285|455549832|FG001|Overall Study|Withdrawal by Subject|0|||
126615384|NCT02144285|455549833|FG002|Overall Study|Withdrawal by Subject|0|||
126615385|NCT02144285|455549834|FG003|Overall Study|Withdrawal by Subject|0|||
126615386|NCT02144285|455549835|FG004|Overall Study|Withdrawal by Subject|1|||
126615387|NCT02144285|455549836|FG005|Overall Study|Withdrawal by Subject|0|||
126615388|NCT02144285|455549837|FG006|Overall Study|Withdrawal by Subject|0|||
126615389|NCT02144285|455549838|FG007|Overall Study|Withdrawal by Subject|0|||
126615390|NCT02144285|455549839|FG008|Overall Study|Withdrawal by Subject|0|||
126615391|NCT02144285|455549840|FG009|Overall Study|Withdrawal by Subject|0|||
126615392|NCT01529632|455549841|FG000|Overall Study|Administrative problem|2|||
126615393|NCT01529632|455549842|FG001|Overall Study|Administrative problem|1|||
126615394|NCT01529632|455549841|FG000|Overall Study|Protocol Violation|0|||
126615395|NCT01529632|455549842|FG001|Overall Study|Protocol Violation|1|||
126615396|NCT01529632|455549841|FG000|Overall Study|Adverse Event|1|||
126615397|NCT01529632|455549842|FG001|Overall Study|Adverse Event|1|||
126615398|NCT04919499|455549843|FG000|Overall Study|Adverse Event|0|||
126615399|NCT04919499|455549844|FG001|Overall Study|Adverse Event|0|||
126615400|NCT04919499|455549845|FG002|Overall Study|Adverse Event|0|||
126615401|NCT04919499|455549846|FG003|Overall Study|Adverse Event|0|||
126615402|NCT04919499|455549847|FG004|Overall Study|Adverse Event|2|||
126615403|NCT04919499|455549843|FG000|Overall Study|Not treated|0|||
126615404|NCT04919499|455549844|FG001|Overall Study|Not treated|0|||
126615405|NCT04919499|455549845|FG002|Overall Study|Not treated|0|||
126615406|NCT04919499|455549846|FG003|Overall Study|Not treated|1|||
126615407|NCT04919499|455549847|FG004|Overall Study|Not treated|0|||
126615408|NCT03786471|455549848|FG000|Overall Study|Death|254|||
126615409|NCT03786471|455549849|FG001|Overall Study|Death|223|||
126615410|NCT03786471|455549850|FG002|Overall Study|Death|37|||
126615411|NCT03786471|455549848|FG000|Overall Study|Lost to Follow-up|63|||
126615412|NCT03786471|455549849|FG001|Overall Study|Lost to Follow-up|50|||
126615413|NCT03786471|455549850|FG002|Overall Study|Lost to Follow-up|15|||
126615414|NCT03786471|455549848|FG000|Overall Study|Withdrawal by Subject|99|||
126615415|NCT03786471|455549849|FG001|Overall Study|Withdrawal by Subject|81|||
126615416|NCT03786471|455549850|FG002|Overall Study|Withdrawal by Subject|11|||
126615417|NCT00747149|455551545|FG000|Overall Study|Adverse Event|0|||
126615418|NCT00747149|455551546|FG001|Overall Study|Adverse Event|15|||
126615419|NCT00747149|455551545|FG000|Overall Study|Lost to Follow-up|0|||
126615420|NCT00747149|455551546|FG001|Overall Study|Lost to Follow-up|10|||
126615421|NCT00747149|455551545|FG000|Overall Study|Withdrawal by Subject|0|||
126615422|NCT00747149|455551546|FG001|Overall Study|Withdrawal by Subject|6|||
126615423|NCT00747149|455551545|FG000|Overall Study|Did not receive treatment|0|||
126615424|NCT00747149|455551546|FG001|Overall Study|Did not receive treatment|1|||
126615425|NCT00747149|455551545|FG000|Overall Study|Incorrect enrollment|0|||
126615426|NCT00747149|455551546|FG001|Overall Study|Incorrect enrollment|6|||
126615427|NCT00747149|455551545|FG000|Overall Study|Severe non-compliance to protocol|0|||
126615428|NCT00747149|455551546|FG001|Overall Study|Severe non-compliance to protocol|1|||
126615429|NCT00747149|455551545|FG000|Overall Study|Not reported|1|||
126615430|NCT00747149|455551546|FG001|Overall Study|Not reported|4|||
126615431|NCT05522777|455551547|FG000|Overall Study|Lack of Efficacy|1|||
126615432|NCT05522777|455551547|FG000|Overall Study|Withdrawal by Subject|1|||
126615433|NCT01381549|455551548|FG000|Overall Study|Ineligible: No organisms isolated|0|||
126615434|NCT01381549|455551549|FG001|Overall Study|Ineligible: No organisms isolated|0|||
126615435|NCT01381549|455551550|FG002|Overall Study|Ineligible: No organisms isolated|1|||
126615436|NCT01416285|455551551|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
126615437|NCT01416285|455551552|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
126615438|NCT00578344|455551553|FG000|Overall Study|Insurance problems|1|||
126615439|NCT00578344|455551553|FG000|Overall Study|Graft failure|1|||
126615440|NCT02935673|455551554|FG000|Overall Study|Adverse Event|0|||
126615441|NCT02935673|455551555|FG001|Overall Study|Adverse Event|1|||
126615442|NCT02935673|455551556|FG002|Overall Study|Adverse Event|0|||
126615443|NCT02935673|455551554|FG000|Overall Study|Withdrawal by Subject|1|||
126615444|NCT02935673|455551555|FG001|Overall Study|Withdrawal by Subject|2|||
126615445|NCT02935673|455551556|FG002|Overall Study|Withdrawal by Subject|0|||
126615446|NCT04328467|455551557|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
126615447|NCT04328467|455551558|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
126615448|NCT04328467|455551559|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
126615449|NCT00990184|455551560|FG000|Overall Study|Physician Decision|1|||
126615450|NCT01090739|455551563|FG000|Enrollment|Withdrawal by Subject|24|||
126615451|NCT01090739|455551563|FG000|Enrollment|Protocol Violation|14|||
126615452|NCT01090739|455551563|FG000|Enrollment|Lost to Follow-up|5|||
126615453|NCT01090739|455551563|FG000|Enrollment|Physician Decision|5|||
126615454|NCT01090739|455551563|FG000|Enrollment|Sponsor termination of site|4|||
126615455|NCT01090739|455551563|FG000|Enrollment|Study implant limit reached|2|||
126615456|NCT01090739|455551563|FG000|Enrollment|Adverse Event|1|||
126615457|NCT01090739|455551563|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
126615458|NCT01090739|455551563|FG000|12 Month Follow-up|Lost to Follow-up|1|||
126615459|NCT01090739|455551563|FG000|12 Month Follow-up|Physician Decision|1|||
126615460|NCT01090739|455551563|FG000|12 Month Follow-up|Death|1|||
126615461|NCT01090739|455551563|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
126615462|NCT01090739|455551563|FG000|24 Month Follow-up|Lost to Follow-up|1|||
126615463|NCT01090739|455551563|FG000|24 Month Follow-up|Death|1|||
126615464|NCT01090739|455551563|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
126615465|NCT01090739|455551563|FG000|36 Month Follow-up|Visit still pending|17|||
126615466|NCT00441168|455551564|FG000|Treatment Period|Death|3|||
126615467|NCT00441168|455551565|FG001|Treatment Period|Death|0|||
126615468|NCT00441168|455551564|FG000|Treatment Period|Adverse Event|1|||
126615469|NCT00441168|455551565|FG001|Treatment Period|Adverse Event|2|||
126615470|NCT00441168|455551564|FG000|Treatment Period|Progressive Disease|0|||
126615471|NCT00441168|455551565|FG001|Treatment Period|Progressive Disease|2|||
126615472|NCT00441168|455551564|FG000|Treatment Period|Protocol Violation|0|||
126615473|NCT00441168|455551565|FG001|Treatment Period|Protocol Violation|1|||
126615474|NCT00441168|455551564|FG000|Treatment Period|Lost to Follow-up|0|||
126615475|NCT00441168|455551565|FG001|Treatment Period|Lost to Follow-up|1|||
126740237|NCT01072448|455997402|FG000|Overall Study|Death|0|||
126740238|NCT01072448|455997403|FG001|Overall Study|Death|2|||
126740239|NCT00418717|455997406|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
126740240|NCT00418717|455997406|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
126740241|NCT01400139|455997407|FG000|HYD Core Study|Adverse Event|210|||
126740242|NCT01400139|455997407|FG000|HYD Core Study|Lack of Efficacy|59|||
126740243|NCT01400139|455997407|FG000|HYD Core Study|Withdrawal by Subject|114|||
126740244|NCT01400139|455997407|FG000|HYD Core Study|Lost to Follow-up|39|||
126740245|NCT01400139|455997407|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
126740246|NCT01400139|455997407|FG000|HYD Core Study|Administrative|56|||
126740247|NCT01400139|455997407|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
126740248|NCT01400139|455997407|FG000|HYD Extension Period|Adverse Event|8|||
126740249|NCT01400139|455997407|FG000|HYD Extension Period|Withdrawal by Subject|5|||
126740250|NCT01400139|455997407|FG000|HYD Extension Period|Administrative|10|||
126740251|NCT00249795|455997408|FG000|Overall Study|Not treated|16|||
126740252|NCT00249795|455997409|FG001|Overall Study|Not treated|14|||
126740253|NCT00249795|455997408|FG000|Overall Study|Symptomatic hypotension|127|||
126740254|NCT00249795|455997409|FG001|Overall Study|Symptomatic hypotension|64|||
126740255|NCT00249795|455997408|FG000|Overall Study|Other Serious Adverse Event|84|||
126740256|NCT00249795|455997409|FG001|Overall Study|Other Serious Adverse Event|93|||
126740257|NCT00249795|455997408|FG000|Overall Study|Qualifying condition not present|26|||
126740258|NCT00249795|455997409|FG001|Overall Study|Qualifying condition not present|29|||
126740259|NCT00249795|455997408|FG000|Overall Study|Withdrawal by Subject|678|||
126740260|NCT00249795|455997409|FG001|Overall Study|Withdrawal by Subject|742|||
126740261|NCT00249795|455997408|FG000|Overall Study|Thromboembolic / outcome event|39|||
126740262|NCT00249795|455997409|FG001|Overall Study|Thromboembolic / outcome event|45|||
126740263|NCT00249795|455997408|FG000|Overall Study|Oral anticoagulant required|2|||
126740264|NCT00249795|455997409|FG001|Overall Study|Oral anticoagulant required|0|||
126740265|NCT00249795|455997408|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
126740266|NCT00249795|455997409|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
126740267|NCT00249795|455997408|FG000|Overall Study|Non-compliance|71|||
126740268|NCT00249795|455997409|FG001|Overall Study|Non-compliance|69|||
126740269|NCT00249795|455997408|FG000|Overall Study|Study drug intolerance|3|||
126740270|NCT00249795|455997409|FG001|Overall Study|Study drug intolerance|3|||
126740271|NCT00249795|455997408|FG000|Overall Study|Other adverse events (non-serious)|188|||
126740272|NCT00249795|455997409|FG001|Overall Study|Other adverse events (non-serious)|159|||
126740273|NCT00249795|455997408|FG000|Overall Study|Physician withdrew consent|71|||
126740274|NCT00249795|455997409|FG001|Overall Study|Physician withdrew consent|63|||
126740275|NCT00249795|455997408|FG000|Overall Study|Surgery / procedure|4|||
126740276|NCT00249795|455997409|FG001|Overall Study|Surgery / procedure|5|||
126740277|NCT00249795|455997408|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
126740278|NCT00249795|455997409|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
126740279|NCT00249795|455997408|FG000|Overall Study|Lightheadedness / dizziness|15|||
126740280|NCT00249795|455997409|FG001|Overall Study|Lightheadedness / dizziness|11|||
126740281|NCT00249795|455997408|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
126615476|NCT00441168|455551564|FG000|Treatment Period|Withdrawal by Subject|3|||
126615477|NCT00441168|455551565|FG001|Treatment Period|Withdrawal by Subject|0|||
126615478|NCT00441168|455551564|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
126615479|NCT00441168|455551565|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
126615480|NCT00441168|455551564|FG000|Treatment Period|refractory disease|1|||
126615481|NCT00441168|455551565|FG001|Treatment Period|refractory disease|0|||
126615482|NCT00441168|455551564|FG000|Follow-up Period|Death|3|||
126615483|NCT00441168|455551565|FG001|Follow-up Period|Death|0|||
126615484|NCT00441168|455551564|FG000|Follow-up Period|Lost to Follow-up|5|||
126615485|NCT00441168|455551565|FG001|Follow-up Period|Lost to Follow-up|6|||
126615486|NCT00441168|455551564|FG000|Follow-up Period|Withdrawal by Subject|3|||
126615487|NCT00441168|455551565|FG001|Follow-up Period|Withdrawal by Subject|0|||
126740282|NCT00249795|455997409|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
126740283|NCT00249795|455997408|FG000|Overall Study|Other contraindicated medication|1|||
126740284|NCT00249795|455997409|FG001|Overall Study|Other contraindicated medication|1|||
126740285|NCT00249795|455997408|FG000|Overall Study|Event related to cardiac condition|17|||
126740286|NCT00249795|455997409|FG001|Overall Study|Event related to cardiac condition|16|||
126740287|NCT00249795|455997408|FG000|Overall Study|Patient not wish to continue after May08|4|||
126740288|NCT00249795|455997409|FG001|Overall Study|Patient not wish to continue after May08|6|||
126740289|NCT00249795|455997408|FG000|Overall Study|Site not agree to continue after May08|1|||
126740290|NCT00249795|455997409|FG001|Overall Study|Site not agree to continue after May08|1|||
126740291|NCT00249795|455997408|FG000|Overall Study|Lost to Follow-up|0|||
126740292|NCT00249795|455997409|FG001|Overall Study|Lost to Follow-up|2|||
126740293|NCT00249795|455997408|FG000|Overall Study|Missing|0|||
126740294|NCT00249795|455997409|FG001|Overall Study|Missing|1|||
126615488|NCT00441168|455551564|FG000|Follow-up Period|Other|1|||
126615489|NCT00441168|455551565|FG001|Follow-up Period|Other|3|||
126740295|NCT02460978|455997411|FG000|Overall Study|Adverse Event|17|||
126740296|NCT02460978|455997412|FG001|Overall Study|Adverse Event|11|||
126740297|NCT02460978|455997413|FG002|Overall Study|Adverse Event|11|||
126615490|NCT03909100|455551566|FG000|Overall Study|Protocol Deviation|2|||
126615491|NCT03909100|455551566|FG000|Overall Study|Technical Problems|4|||
126615492|NCT03909100|455551566|FG000|Overall Study|Withdrawal by Subject|4|||
126615493|NCT03909100|455551566|FG000|Overall Study|Lost to Follow-up|1|||
126615494|NCT03909100|455551566|FG000|Overall Study|Reason not Specified|4|||
126615495|NCT00807599|455551569|FG000|Overall Study|Not treated on protocol study|0|||
126615496|NCT00807599|455551570|FG001|Overall Study|Not treated on protocol study|0|||
126615497|NCT00807599|455551571|FG002|Overall Study|Not treated on protocol study|2|||
126615498|NCT00807599|455551569|FG000|Overall Study|Adverse Event|0|||
126615499|NCT00807599|455551570|FG001|Overall Study|Adverse Event|0|||
126615500|NCT00807599|455551571|FG002|Overall Study|Adverse Event|5|||
126615501|NCT00807599|455551569|FG000|Overall Study|Inadequate response to induction|0|||
126615502|NCT00807599|455551570|FG001|Overall Study|Inadequate response to induction|0|||
126615503|NCT00807599|455551571|FG002|Overall Study|Inadequate response to induction|9|||
126615504|NCT00807599|455551569|FG000|Overall Study|Withdrawal by Subject|0|||
126615505|NCT00807599|455551570|FG001|Overall Study|Withdrawal by Subject|0|||
126615506|NCT00807599|455551571|FG002|Overall Study|Withdrawal by Subject|1|||
126615507|NCT02410278|455551572|FG000|Run-in Period|Adverse Event|5|||
126615508|NCT02410278|455551573|FG001|Run-in Period|Adverse Event|0|||
126615509|NCT02410278|455551574|FG002|Run-in Period|Adverse Event|0|||
126740298|NCT02460978|455997411|FG000|Overall Study|Withdrawal by Subject|5|||
126740299|NCT02460978|455997412|FG001|Overall Study|Withdrawal by Subject|5|||
126740300|NCT02460978|455997413|FG002|Overall Study|Withdrawal by Subject|14|||
126740301|NCT02460978|455997411|FG000|Overall Study|Lost to Follow-up|2|||
126740302|NCT02460978|455997412|FG001|Overall Study|Lost to Follow-up|3|||
126740303|NCT02460978|455997413|FG002|Overall Study|Lost to Follow-up|1|||
126740304|NCT02460978|455997411|FG000|Overall Study|Protocol Violation|1|||
126740305|NCT02460978|455997412|FG001|Overall Study|Protocol Violation|1|||
126740306|NCT02460978|455997413|FG002|Overall Study|Protocol Violation|1|||
126740307|NCT02460978|455997411|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
126740308|NCT02460978|455997412|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
126740309|NCT02460978|455997413|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
126740310|NCT02460978|455997411|FG000|Overall Study|Pregnancy|0|||
126740311|NCT02460978|455997412|FG001|Overall Study|Pregnancy|0|||
126740312|NCT02460978|455997413|FG002|Overall Study|Pregnancy|2|||
126740313|NCT03549429|455997416|FG000|Overall Study|Protocol Violation|5|||
126740314|NCT03549429|455997417|FG001|Overall Study|Protocol Violation|3|||
126740315|NCT00588523|455997421|FG000|Overall Study|Not treated|3|||
126740316|NCT03032510|455997422|FG000|Overall Study|Adverse Event|5|||
126740317|NCT03032510|455997423|FG001|Overall Study|Adverse Event|2|||
126740318|NCT03032510|455997422|FG000|Overall Study|Lost to Follow-up|8|||
126740319|NCT03032510|455997423|FG001|Overall Study|Lost to Follow-up|7|||
126740320|NCT03032510|455997422|FG000|Overall Study|Withdrawal by Subject|8|||
126740321|NCT03032510|455997423|FG001|Overall Study|Withdrawal by Subject|7|||
126740322|NCT03032510|455997422|FG000|Overall Study|Subject noncompliance|4|||
126740323|NCT03032510|455997423|FG001|Overall Study|Subject noncompliance|2|||
126740324|NCT03032510|455997422|FG000|Overall Study|Physician Decision|2|||
126740325|NCT03032510|455997423|FG001|Overall Study|Physician Decision|0|||
126740326|NCT02371980|455998758|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
126740327|NCT02371980|455998759|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
126740328|NCT02371980|455998760|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
126740329|NCT02371980|455998761|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
126740330|NCT02371980|455998762|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
126740331|NCT02371980|455998758|FG000|Open-label Period|Significant Protocol Deviation|19|||
126740332|NCT02371980|455998759|FG001|Open-label Period|Significant Protocol Deviation|0|||
126740333|NCT02371980|455998760|FG002|Open-label Period|Significant Protocol Deviation|0|||
126740334|NCT02371980|455998761|FG003|Open-label Period|Significant Protocol Deviation|0|||
126740335|NCT02371980|455998762|FG004|Open-label Period|Significant Protocol Deviation|0|||
126740336|NCT02371980|455998758|FG000|Open-label Period|Noncompliance with Study Drug|10|||
126740337|NCT02371980|455998759|FG001|Open-label Period|Noncompliance with Study Drug|0|||
126740338|NCT02371980|455998760|FG002|Open-label Period|Noncompliance with Study Drug|0|||
126740339|NCT02371980|455998761|FG003|Open-label Period|Noncompliance with Study Drug|0|||
126781679|NCT00294723|456156232|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
126781680|NCT00752791|456156233|FG000|Overall Study|Adverse Event|7|||
126615510|NCT02410278|455551572|FG000|Run-in Period|GSRS Threshold Not Met|30|||
126615511|NCT02410278|455551573|FG001|Run-in Period|GSRS Threshold Not Met|0|||
126615512|NCT02410278|455551574|FG002|Run-in Period|GSRS Threshold Not Met|0|||
126740340|NCT02371980|455998762|FG004|Open-label Period|Noncompliance with Study Drug|0|||
126740341|NCT02371980|455998758|FG000|Open-label Period|Lost to Follow-up|55|||
126740342|NCT02371980|455998759|FG001|Open-label Period|Lost to Follow-up|0|||
126740343|NCT02371980|455998760|FG002|Open-label Period|Lost to Follow-up|0|||
126615513|NCT02410278|455551572|FG000|Run-in Period|Lost to Follow-up|1|||
126615514|NCT02410278|455551573|FG001|Run-in Period|Lost to Follow-up|0|||
126615515|NCT02410278|455551574|FG002|Run-in Period|Lost to Follow-up|0|||
126615516|NCT02410278|455551572|FG000|Run-in Period|Withdrawal by Subject|1|||
126740344|NCT02371980|455998761|FG003|Open-label Period|Lost to Follow-up|0|||
126740345|NCT02371980|455998762|FG004|Open-label Period|Lost to Follow-up|0|||
126740346|NCT02371980|455998758|FG000|Open-label Period|Voluntary Withdrawal|91|||
126740347|NCT02371980|455998759|FG001|Open-label Period|Voluntary Withdrawal|0|||
126740348|NCT02371980|455998760|FG002|Open-label Period|Voluntary Withdrawal|0|||
126740349|NCT02371980|455998761|FG003|Open-label Period|Voluntary Withdrawal|0|||
126740350|NCT02371980|455998762|FG004|Open-label Period|Voluntary Withdrawal|0|||
126740351|NCT02371980|455998758|FG000|Open-label Period|Pregnancy|1|||
126740352|NCT02371980|455998759|FG001|Open-label Period|Pregnancy|0|||
126740353|NCT02371980|455998760|FG002|Open-label Period|Pregnancy|0|||
126740354|NCT02371980|455998761|FG003|Open-label Period|Pregnancy|0|||
126740355|NCT02371980|455998762|FG004|Open-label Period|Pregnancy|0|||
126740356|NCT02371980|455998758|FG000|Open-label Period|Lack of Efficacy|116|||
126740357|NCT02371980|455998759|FG001|Open-label Period|Lack of Efficacy|0|||
126740358|NCT02371980|455998760|FG002|Open-label Period|Lack of Efficacy|0|||
126740359|NCT02371980|455998761|FG003|Open-label Period|Lack of Efficacy|0|||
126740360|NCT02371980|455998762|FG004|Open-label Period|Lack of Efficacy|0|||
126740361|NCT02371980|455998758|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
126740362|NCT02371980|455998759|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
126740363|NCT02371980|455998760|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
126615517|NCT02410278|455551573|FG001|Run-in Period|Withdrawal by Subject|0|||
126615518|NCT02410278|455551574|FG002|Run-in Period|Withdrawal by Subject|0|||
126615519|NCT02410278|455551572|FG000|Run-in Period|Pregnancy|1|||
126615520|NCT02410278|455551573|FG001|Run-in Period|Pregnancy|0|||
126615521|NCT02410278|455551574|FG002|Run-in Period|Pregnancy|0|||
126615522|NCT02410278|455551572|FG000|Study Treatment Period|Adverse Event|0|||
126615523|NCT02410278|455551573|FG001|Study Treatment Period|Adverse Event|6|||
126615524|NCT02410278|455551574|FG002|Study Treatment Period|Adverse Event|3|||
126615525|NCT02410278|455551572|FG000|Study Treatment Period|Physician Decision|0|||
126615526|NCT02410278|455551573|FG001|Study Treatment Period|Physician Decision|0|||
126615527|NCT02410278|455551574|FG002|Study Treatment Period|Physician Decision|1|||
126615528|NCT02410278|455551572|FG000|Study Treatment Period|Withdrawal by Subject|0|||
126615529|NCT02410278|455551573|FG001|Study Treatment Period|Withdrawal by Subject|1|||
126615530|NCT02410278|455551574|FG002|Study Treatment Period|Withdrawal by Subject|0|||
126615531|NCT02410278|455551572|FG000|Study Treatment Period|Other|0|||
126615532|NCT02410278|455551573|FG001|Study Treatment Period|Other|3|||
126615533|NCT02410278|455551574|FG002|Study Treatment Period|Other|0|||
126615534|NCT02410278|455551572|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
126615535|NCT02410278|455551573|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
126615536|NCT02410278|455551574|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
126615537|NCT03695185|455551575|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
126615538|NCT03695185|455551575|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
126615539|NCT03695185|455551575|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
126615540|NCT03695185|455551575|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
126615541|NCT03695185|455551575|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
126615542|NCT03695185|455551575|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
126615543|NCT02584257|455551576|FG000|Period 1|Withdrawal by Subject|0|||
126615544|NCT02584257|455551577|FG001|Period 1|Withdrawal by Subject|0|||
126615545|NCT02584257|455551578|FG002|Period 1|Withdrawal by Subject|0|||
126615546|NCT02584257|455551579|FG003|Period 1|Withdrawal by Subject|0|||
126615547|NCT02584257|455551580|FG004|Period 1|Withdrawal by Subject|0|||
126615548|NCT02584257|455551581|FG005|Period 1|Withdrawal by Subject|0|||
126615549|NCT02584257|455551582|FG006|Period 1|Withdrawal by Subject|1|||
126615550|NCT02584257|455551583|FG007|Period 1|Withdrawal by Subject|0|||
126615551|NCT02584257|455551584|FG008|Period 1|Withdrawal by Subject|0|||
126615552|NCT02584257|455551576|FG000|Period 2|Physician Decision|1|||
126615553|NCT02584257|455551577|FG001|Period 2|Physician Decision|0|||
126615554|NCT02584257|455551578|FG002|Period 2|Physician Decision|0|||
126615555|NCT02584257|455551579|FG003|Period 2|Physician Decision|0|||
126615556|NCT02584257|455551580|FG004|Period 2|Physician Decision|0|||
126615557|NCT02584257|455551581|FG005|Period 2|Physician Decision|0|||
126615558|NCT02584257|455551582|FG006|Period 2|Physician Decision|0|||
126615559|NCT02584257|455551583|FG007|Period 2|Physician Decision|0|||
126615560|NCT02584257|455551584|FG008|Period 2|Physician Decision|0|||
126615561|NCT02584257|455551576|FG000|Period 2|Adverse Event|0|||
126615562|NCT02584257|455551577|FG001|Period 2|Adverse Event|1|||
126615563|NCT02584257|455551578|FG002|Period 2|Adverse Event|0|||
126615564|NCT02584257|455551579|FG003|Period 2|Adverse Event|0|||
126615565|NCT02584257|455551580|FG004|Period 2|Adverse Event|0|||
126615566|NCT02584257|455551581|FG005|Period 2|Adverse Event|0|||
126615567|NCT02584257|455551582|FG006|Period 2|Adverse Event|0|||
126615568|NCT02584257|455551583|FG007|Period 2|Adverse Event|0|||
126615569|NCT02584257|455551584|FG008|Period 2|Adverse Event|0|||
126615570|NCT01670877|455551585|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
126615571|NCT01670877|455551586|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
126615572|NCT01670877|455551587|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
126740364|NCT02371980|455998761|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
126740365|NCT02371980|455998762|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
126740366|NCT02371980|455998758|FG000|Open-label Period|Reason not Specified|9|||
126740367|NCT02371980|455998759|FG001|Open-label Period|Reason not Specified|0|||
126740368|NCT02371980|455998760|FG002|Open-label Period|Reason not Specified|0|||
126740369|NCT02371980|455998761|FG003|Open-label Period|Reason not Specified|0|||
126740370|NCT02371980|455998762|FG004|Open-label Period|Reason not Specified|0|||
126740371|NCT02371980|455998758|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
126740372|NCT02371980|455998759|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
126740373|NCT02371980|455998760|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
126740374|NCT02371980|455998761|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
126740375|NCT02371980|455998762|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
126740376|NCT02371980|455998758|FG000|Double-blind Period|Significant Protocol Deviation|0|||
126740377|NCT02371980|455998759|FG001|Double-blind Period|Significant Protocol Deviation|2|||
126740378|NCT02371980|455998760|FG002|Double-blind Period|Significant Protocol Deviation|7|||
126740379|NCT02371980|455998761|FG003|Double-blind Period|Significant Protocol Deviation|3|||
126740380|NCT02371980|455998762|FG004|Double-blind Period|Significant Protocol Deviation|3|||
126740381|NCT02371980|455998758|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
126740382|NCT02371980|455998759|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
126740383|NCT02371980|455998760|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
126740384|NCT02371980|455998761|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
126740385|NCT02371980|455998762|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
126740386|NCT02371980|455998758|FG000|Double-blind Period|Lost to Follow-up|0|||
126740387|NCT02371980|455998759|FG001|Double-blind Period|Lost to Follow-up|8|||
126740388|NCT02371980|455998760|FG002|Double-blind Period|Lost to Follow-up|8|||
126740389|NCT02371980|455998761|FG003|Double-blind Period|Lost to Follow-up|6|||
126740390|NCT02371980|455998762|FG004|Double-blind Period|Lost to Follow-up|5|||
126740391|NCT02371980|455998758|FG000|Double-blind Period|Voluntary Withdrawal|0|||
126740392|NCT02371980|455998759|FG001|Double-blind Period|Voluntary Withdrawal|12|||
126740393|NCT02371980|455998760|FG002|Double-blind Period|Voluntary Withdrawal|8|||
126740394|NCT02371980|455998761|FG003|Double-blind Period|Voluntary Withdrawal|9|||
126740395|NCT02371980|455998762|FG004|Double-blind Period|Voluntary Withdrawal|11|||
126740396|NCT02371980|455998758|FG000|Double-blind Period|Relapse|0|||
126740397|NCT02371980|455998759|FG001|Double-blind Period|Relapse|50|||
126740398|NCT02371980|455998760|FG002|Double-blind Period|Relapse|25|||
126740399|NCT02371980|455998761|FG003|Double-blind Period|Relapse|25|||
126740400|NCT02371980|455998762|FG004|Double-blind Period|Relapse|26|||
126740401|NCT02371980|455998758|FG000|Double-blind Period|Reason not Specified|0|||
126740402|NCT02371980|455998759|FG001|Double-blind Period|Reason not Specified|3|||
126740403|NCT02371980|455998760|FG002|Double-blind Period|Reason not Specified|3|||
126740404|NCT02371980|455998761|FG003|Double-blind Period|Reason not Specified|2|||
126740405|NCT02371980|455998762|FG004|Double-blind Period|Reason not Specified|1|||
126740406|NCT02371980|455998758|FG000|Double-blind Period|Missing|0|||
126740407|NCT02371980|455998759|FG001|Double-blind Period|Missing|1|||
126740408|NCT02371980|455998760|FG002|Double-blind Period|Missing|0|||
126740409|NCT02371980|455998761|FG003|Double-blind Period|Missing|0|||
126740410|NCT02371980|455998762|FG004|Double-blind Period|Missing|0|||
126740411|NCT01731990|455998763|FG000|Overall Study|Adverse Event|1|||
126740412|NCT01731990|455998764|FG001|Overall Study|Adverse Event|5|||
126740413|NCT01731990|455998763|FG000|Overall Study|Withdrawal by Subject|1|||
126740414|NCT01731990|455998764|FG001|Overall Study|Withdrawal by Subject|1|||
126740415|NCT01731990|455998763|FG000|Overall Study|Protocol deviation|1|||
126740416|NCT01731990|455998764|FG001|Overall Study|Protocol deviation|2|||
126615573|NCT01670877|455551588|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
126740417|NCT01731990|455998763|FG000|Overall Study|Death|1|||
126740418|NCT01731990|455998764|FG001|Overall Study|Death|0|||
126740419|NCT01280812|455998765|FG000|Overall Study|Withdrawal by Subject|2|||
126740420|NCT01280812|455998766|FG001|Overall Study|Withdrawal by Subject|1|||
126740421|NCT01280812|455998767|FG002|Overall Study|Withdrawal by Subject|0|||
126740422|NCT01280812|455998765|FG000|Overall Study|Lost to Follow-up|1|||
126740423|NCT01280812|455998766|FG001|Overall Study|Lost to Follow-up|1|||
126740424|NCT01280812|455998767|FG002|Overall Study|Lost to Follow-up|1|||
126740425|NCT04483544|455998768|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
126740426|NCT04483544|455998768|FG000|Post-Treatment|Admitted to hospice|2|||
126740427|NCT04483544|455998768|FG000|Post-Treatment|Study terminated|3|||
126740428|NCT01131078|455998771|FG000|Overall Study|Adverse Event|22|||
126740429|NCT01131078|455998772|FG001|Overall Study|Adverse Event|12|||
126740430|NCT01131078|455998773|FG002|Overall Study|Adverse Event|17|||
126740431|NCT01131078|455998771|FG000|Overall Study|Progressive Disease|58|||
126740432|NCT01131078|455998772|FG001|Overall Study|Progressive Disease|77|||
126740433|NCT01131078|455998773|FG002|Overall Study|Progressive Disease|71|||
126740434|NCT01131078|455998771|FG000|Overall Study|Protocol Violation|1|||
126740435|NCT01131078|455998772|FG001|Overall Study|Protocol Violation|0|||
126740436|NCT01131078|455998773|FG002|Overall Study|Protocol Violation|0|||
126740437|NCT01131078|455998771|FG000|Overall Study|Lost to Follow-up|1|||
126740438|NCT01131078|455998772|FG001|Overall Study|Lost to Follow-up|1|||
126740439|NCT01131078|455998773|FG002|Overall Study|Lost to Follow-up|1|||
126740440|NCT01131078|455998771|FG000|Overall Study|Withdrawal by Subject|2|||
126740441|NCT01131078|455998772|FG001|Overall Study|Withdrawal by Subject|4|||
126740442|NCT01131078|455998773|FG002|Overall Study|Withdrawal by Subject|3|||
126740443|NCT01131078|455998771|FG000|Overall Study|Non-compliance|3|||
126740444|NCT01131078|455998772|FG001|Overall Study|Non-compliance|0|||
126740445|NCT01131078|455998773|FG002|Overall Study|Non-compliance|0|||
126740446|NCT01131078|455998771|FG000|Overall Study|Physician Decision|10|||
126740447|NCT01131078|455998772|FG001|Overall Study|Physician Decision|6|||
126740448|NCT01131078|455998773|FG002|Overall Study|Physician Decision|8|||
126740449|NCT01131078|455998771|FG000|Overall Study|Death|4|||
126740450|NCT01131078|455998772|FG001|Overall Study|Death|0|||
126740451|NCT01131078|455998773|FG002|Overall Study|Death|2|||
126740452|NCT01131078|455998771|FG000|Overall Study|Other|0|||
126740453|NCT01131078|455998772|FG001|Overall Study|Other|1|||
126740454|NCT01131078|455998773|FG002|Overall Study|Other|0|||
126740455|NCT00790218|455998775|FG000|Overall Study|Death|1|||
126740456|NCT00790218|455998776|FG001|Overall Study|Death|0|||
126740457|NCT00790218|455998777|FG002|Overall Study|Death|0|||
126740458|NCT02809118|455998780|FG000|Overall Study|Withdrawal by Subject|0|||
126740459|NCT02809118|455998781|FG001|Overall Study|Withdrawal by Subject|1|||
126740460|NCT02809118|455998782|FG002|Overall Study|Withdrawal by Subject|1|||
126740461|NCT03805971|455998786|FG000|Overall Study|Withdrawal by Subject|1|||
126740462|NCT03805971|455998786|FG000|Overall Study|Protocol Violation|2|||
126740463|NCT01510028|455998790|FG000|Overall Study|Lack of Efficacy|1|||
126740464|NCT01510028|455998791|FG001|Overall Study|Lack of Efficacy|0|||
126740465|NCT01510028|455998792|FG002|Overall Study|Lack of Efficacy|0|||
126740466|NCT01510028|455998793|FG003|Overall Study|Lack of Efficacy|0|||
126740467|NCT01355497|455998794|FG000|Overall Study|Death|19|||
126740468|NCT01355497|455998795|FG001|Overall Study|Death|18|||
126740469|NCT01355497|455998794|FG000|Overall Study|Lost to Follow-up|3|||
126740470|NCT01355497|455998795|FG001|Overall Study|Lost to Follow-up|0|||
126740471|NCT01355497|455998794|FG000|Overall Study|Protocol Violation|0|||
126740472|NCT01355497|455998795|FG001|Overall Study|Protocol Violation|1|||
126740473|NCT01355497|455998794|FG000|Overall Study|other-not provided|9|||
126740474|NCT01355497|455998795|FG001|Overall Study|other-not provided|4|||
126740475|NCT01355497|455998794|FG000|Overall Study|Withdrawal by Subject|12|||
126740476|NCT01355497|455998795|FG001|Overall Study|Withdrawal by Subject|20|||
126740477|NCT01355497|455998794|FG000|Overall Study|noncompliance|1|||
126740478|NCT01355497|455998795|FG001|Overall Study|noncompliance|2|||
126740479|NCT01355497|455998794|FG000|Overall Study|progressive disease|11|||
126740480|NCT01355497|455998795|FG001|Overall Study|progressive disease|8|||
126740481|NCT01355497|455998794|FG000|Overall Study|Adverse Event|11|||
126740482|NCT01355497|455998795|FG001|Overall Study|Adverse Event|10|||
126740483|NCT03135262|455998802|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
126740484|NCT03135262|455998803|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
126740485|NCT03135262|455998804|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
126740486|NCT03135262|455998805|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
126740487|NCT03135262|455998806|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
126740488|NCT03135262|455998802|FG000|Overall Study|Progression of disease|0|||
126740489|NCT03135262|455998803|FG001|Overall Study|Progression of disease|0|||
126740490|NCT03135262|455998804|FG002|Overall Study|Progression of disease|0|||
126740491|NCT03135262|455998805|FG003|Overall Study|Progression of disease|1|||
126740492|NCT03135262|455998806|FG004|Overall Study|Progression of disease|0|||
126740493|NCT03135262|455998802|FG000|Overall Study|Death|6|||
126740494|NCT03135262|455998803|FG001|Overall Study|Death|2|||
126740495|NCT03135262|455998804|FG002|Overall Study|Death|2|||
126740496|NCT03135262|455998805|FG003|Overall Study|Death|2|||
126740497|NCT03135262|455998806|FG004|Overall Study|Death|0|||
126740498|NCT03135262|455998802|FG000|Overall Study|Withdrawal by Subject|0|||
126740499|NCT03135262|455998803|FG001|Overall Study|Withdrawal by Subject|0|||
126740500|NCT03135262|455998804|FG002|Overall Study|Withdrawal by Subject|1|||
126740501|NCT03135262|455998805|FG003|Overall Study|Withdrawal by Subject|0|||
126740502|NCT03135262|455998806|FG004|Overall Study|Withdrawal by Subject|1|||
126740503|NCT03135262|455998802|FG000|Overall Study|Study terminated by sponsor|2|||
126740504|NCT03135262|455998803|FG001|Overall Study|Study terminated by sponsor|4|||
126740505|NCT03135262|455998804|FG002|Overall Study|Study terminated by sponsor|4|||
126740506|NCT03135262|455998805|FG003|Overall Study|Study terminated by sponsor|3|||
126740507|NCT03135262|455998806|FG004|Overall Study|Study terminated by sponsor|0|||
126740508|NCT01675141|455998807|FG000|Overall Study|Lenalidomide outside NIH|3|||
126740509|NCT01675141|455998807|FG000|Overall Study|Withdrawal by Subject|3|||
126740510|NCT01675141|455998807|FG000|Overall Study|Physician Decision|4|||
126740511|NCT01675141|455998807|FG000|Overall Study|No treatment, per protocol|1|||
126740512|NCT03097133|455998810|FG000|Overall Study|Lost to Follow-up|3|||
126740513|NCT03097133|455998811|FG001|Overall Study|Lost to Follow-up|2|||
126740514|NCT03097133|455998810|FG000|Overall Study|Withdrawal by Subject|2|||
126740515|NCT03097133|455998811|FG001|Overall Study|Withdrawal by Subject|5|||
126740516|NCT03097133|455998810|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
126740517|NCT03097133|455998811|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
126740518|NCT03097133|455998810|FG000|Overall Study|Other|3|||
126740519|NCT03097133|455998811|FG001|Overall Study|Other|2|||
126740520|NCT03097133|455998810|FG000|Overall Study|Adverse Event|1|||
126615574|NCT01670877|455551589|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
126615575|NCT01670877|455551590|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
126615576|NCT01670877|455551585|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
126615577|NCT01670877|455551586|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
126615578|NCT01670877|455551587|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
126615579|NCT01670877|455551588|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
126615580|NCT01670877|455551589|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
126615581|NCT01670877|455551590|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
126615582|NCT01670877|455551585|FG000|Part I and Part 2|Grade 2 vomiting|0|||
126615583|NCT01670877|455551586|FG001|Part I and Part 2|Grade 2 vomiting|0|||
126615584|NCT01670877|455551587|FG002|Part I and Part 2|Grade 2 vomiting|0|||
126615585|NCT01670877|455551588|FG003|Part I and Part 2|Grade 2 vomiting|1|||
126615586|NCT01670877|455551589|FG004|Part I and Part 2|Grade 2 vomiting|0|||
126615587|NCT01670877|455551590|FG005|Part I and Part 2|Grade 2 vomiting|0|||
126615588|NCT01670877|455551585|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
126615589|NCT01670877|455551586|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
126615590|NCT01670877|455551587|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
126615591|NCT01670877|455551588|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
126615592|NCT01670877|455551589|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
126615593|NCT01670877|455551590|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
126615594|NCT01670877|455551585|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
126615595|NCT01670877|455551586|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
126615596|NCT01670877|455551587|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
126615597|NCT01670877|455551588|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
126615598|NCT01670877|455551589|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
126615599|NCT01670877|455551590|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
126615600|NCT03693989|455551591|FG000|Overall Study|Protocol Violation|3|||
126615601|NCT03693989|455551592|FG001|Overall Study|Protocol Violation|4|||
126615602|NCT00113529|455551593|FG000|Overall Study|Adverse Event|4|||
126615603|NCT00113529|455551593|FG000|Overall Study|Lack of Efficacy|20|||
126615604|NCT00113529|455551593|FG000|Overall Study|Decision of sponsor|6|||
126615605|NCT00113529|455551593|FG000|Overall Study|Withdrawal by Subject|4|||
126615606|NCT02825550|455551595|FG000|Overall Study|Physician Decision|1|||
126615607|NCT00042939|455551599|FG000|Overall Study|Adverse Event|6|||
126615608|NCT00042939|455551600|FG001|Overall Study|Adverse Event|7|||
126615609|NCT00042939|455551599|FG000|Overall Study|Death|3|||
126615610|NCT00042939|455551600|FG001|Overall Study|Death|2|||
126615611|NCT00042939|455551599|FG000|Overall Study|Withdrawal by Subject|3|||
126615612|NCT00042939|455551600|FG001|Overall Study|Withdrawal by Subject|4|||
126615613|NCT00042939|455551599|FG000|Overall Study|Other disease|1|||
126615614|NCT00042939|455551600|FG001|Overall Study|Other disease|0|||
126615615|NCT00042939|455551599|FG000|Overall Study|Ineligible|2|||
126615616|NCT00042939|455551600|FG001|Overall Study|Ineligible|2|||
126615617|NCT00042939|455551599|FG000|Overall Study|Deterioration of health|3|||
126615618|NCT00042939|455551600|FG001|Overall Study|Deterioration of health|4|||
126615619|NCT00042939|455551599|FG000|Overall Study|QOL diminished|1|||
126615620|NCT00042939|455551600|FG001|Overall Study|QOL diminished|0|||
126615621|NCT00042939|455551599|FG000|Overall Study|Rising ca 19-9|1|||
126615622|NCT00042939|455551600|FG001|Overall Study|Rising ca 19-9|0|||
126615623|NCT00042939|455551599|FG000|Overall Study|Patient non-compliance|1|||
126615624|NCT00042939|455551600|FG001|Overall Study|Patient non-compliance|0|||
126615625|NCT00042939|455551599|FG000|Overall Study|Still on treatment|1|||
126615626|NCT00042939|455551600|FG001|Overall Study|Still on treatment|0|||
126615627|NCT00042939|455551599|FG000|Overall Study|Treatment break > 4 weeks|0|||
126615628|NCT00042939|455551600|FG001|Overall Study|Treatment break > 4 weeks|1|||
126615629|NCT00042939|455551599|FG000|Overall Study|Did not start treatment|2|||
126615630|NCT00042939|455551600|FG001|Overall Study|Did not start treatment|1|||
126615631|NCT00795639|455551601|FG000|Overall Study|Death|1|||
126615632|NCT00795639|455551602|FG001|Overall Study|Death|6|||
126615633|NCT00795639|455551601|FG000|Overall Study|Withdrawal by Subject|1|||
126615634|NCT00795639|455551602|FG001|Overall Study|Withdrawal by Subject|3|||
126615635|NCT00795639|455551601|FG000|Overall Study|Pregnancy|1|||
126615636|NCT00795639|455551602|FG001|Overall Study|Pregnancy|0|||
126615637|NCT00795639|455551601|FG000|Overall Study|Adverse Event|5|||
126615638|NCT00795639|455551602|FG001|Overall Study|Adverse Event|2|||
126615639|NCT00795639|455551601|FG000|Overall Study|Other|0|||
126615640|NCT00795639|455551602|FG001|Overall Study|Other|2|||
126615641|NCT00795639|455551601|FG000|Overall Study|Terminated by sponsor|13|||
126615642|NCT00795639|455551602|FG001|Overall Study|Terminated by sponsor|12|||
126740521|NCT03097133|455998811|FG001|Overall Study|Adverse Event|0|||
126740522|NCT02873208|455998812|FG000|Overall Study|Withdrawal by Subject|36|||
126740523|NCT02873208|455998812|FG000|Overall Study|Lost to Follow-up|22|||
126740524|NCT02873208|455998812|FG000|Overall Study|Adverse Event|15|||
126740525|NCT02873208|455998812|FG000|Overall Study|Non-compliance with study drug|12|||
126740526|NCT02873208|455998812|FG000|Overall Study|Protocol Violation|8|||
126740527|NCT02873208|455998812|FG000|Overall Study|Pregnancy|2|||
126740528|NCT02873208|455998812|FG000|Overall Study|Incarceration|1|||
126740529|NCT02873208|455998812|FG000|Overall Study|Lack of Efficacy|1|||
126740530|NCT02873208|455998812|FG000|Overall Study|Physician Decision|1|||
126740531|NCT04080752|455998813|FG000|Overall Study|Adverse Event|2|||
126740532|NCT04080752|455998814|FG001|Overall Study|Adverse Event|3|||
126740533|NCT04080752|455998813|FG000|Overall Study|Lack of Efficacy|1|||
126740534|NCT04080752|455998814|FG001|Overall Study|Lack of Efficacy|0|||
126740535|NCT04080752|455998813|FG000|Overall Study|Lost to Follow-up|1|||
126740536|NCT04080752|455998814|FG001|Overall Study|Lost to Follow-up|0|||
126740537|NCT04080752|455998813|FG000|Overall Study|Pregnancy|0|||
126740538|NCT04080752|455998814|FG001|Overall Study|Pregnancy|1|||
126740539|NCT04080752|455998813|FG000|Overall Study|Withdrawal by Subject|7|||
126740540|NCT04080752|455998814|FG001|Overall Study|Withdrawal by Subject|0|||
126740541|NCT04080752|455998813|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126740542|NCT04080752|455998814|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126740543|NCT04080752|455998813|FG000|Overall Study|Other|2|||
126740544|NCT04080752|455998814|FG001|Overall Study|Other|1|||
126740545|NCT01192100|455998815|FG000|Overall Study|Withdrawal by Subject|0|||
126740546|NCT01192100|455998816|FG001|Overall Study|Withdrawal by Subject|0|||
126740547|NCT01192100|455998817|FG002|Overall Study|Withdrawal by Subject|0|||
126740548|NCT01192100|455998818|FG003|Overall Study|Withdrawal by Subject|0|||
126740549|NCT01192100|455998819|FG004|Overall Study|Withdrawal by Subject|1|||
126740550|NCT01192100|455998820|FG005|Overall Study|Withdrawal by Subject|0|||
126740551|NCT01192100|455998815|FG000|Overall Study|Protocol Violation|0|||
126740552|NCT01192100|455998816|FG001|Overall Study|Protocol Violation|0|||
126740553|NCT01192100|455998817|FG002|Overall Study|Protocol Violation|0|||
126740554|NCT01192100|455998818|FG003|Overall Study|Protocol Violation|1|||
126740555|NCT01192100|455998819|FG004|Overall Study|Protocol Violation|0|||
126740556|NCT01192100|455998820|FG005|Overall Study|Protocol Violation|0|||
126740557|NCT04737759|455998821|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
126740558|NCT04737759|455998822|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
126740559|NCT04737759|455998821|FG000|Overall Study|Death|2|||
126740560|NCT04737759|455998822|FG001|Overall Study|Death|0|||
126740561|NCT04737759|455998821|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
126740562|NCT04737759|455998822|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
126740563|NCT04737759|455998821|FG000|Overall Study|Lost to Follow-up|4|||
126740564|NCT04737759|455998822|FG001|Overall Study|Lost to Follow-up|12|||
126740565|NCT02260388|455998823|FG000|Overall Study|Lost to Follow-up|2|||
126740566|NCT02260388|455998824|FG001|Overall Study|Lost to Follow-up|8|||
126740567|NCT02260388|455998825|FG002|Overall Study|Lost to Follow-up|3|||
126740568|NCT02260388|455998826|FG003|Overall Study|Lost to Follow-up|4|||
126740569|NCT02017704|455998829|FG000|Overall Study|Withdrawal by Subject|2|||
126740570|NCT02017704|455998830|FG001|Overall Study|Withdrawal by Subject|0|||
126740571|NCT00918346|455998831|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
126740572|NCT00918346|455998832|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
126740573|NCT01421069|455998833|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
126740574|NCT01421069|455998833|FG000|Parent Study|Failed to return|3|||
126740575|NCT01421069|455998833|FG000|Parent Study|Withdrawal by Subject|1|||
126740576|NCT01421069|455998833|FG000|Parent Study|Lost to Follow-up|2|||
126740577|NCT01421069|455998833|FG000|Parent Study|Lack of Efficacy|1|||
126740578|NCT01421069|455998833|FG000|Overall Period for Extension Study|Other|2|||
126740579|NCT01421069|455998833|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
126740580|NCT01421069|455998833|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
126740581|NCT01421069|455998833|FG000|Overall Period for Extension Study|Pregnancy|1|||
126740582|NCT01421069|455998833|FG000|Overall Period for Extension Study|Adverse Event|1|||
126740583|NCT01421069|455998833|FG000|Overall Period for Extension Study|Protocol Violation|1|||
126740584|NCT01421069|455998833|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
126740585|NCT01421069|455998833|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
126781681|NCT00752791|456156233|FG000|Overall Study|Withdrawal by Subject|1|||
126740586|NCT01421069|455998833|FG000|Active Treatment Period|Other|1|||
126740587|NCT01421069|455998833|FG000|Active Treatment Period|No longer willing to participate in study|8|||
126740588|NCT01421069|455998833|FG000|Active Treatment Period|Insufficient clinical response|1|||
126740589|NCT01421069|455998833|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
126740590|NCT01421069|455998833|FG000|Active Treatment Period|Pregnancy|1|||
126781682|NCT00752791|456156233|FG000|Overall Study|Physician Decision|1|||
126740591|NCT01421069|455998833|FG000|Active Treatment Period|Adverse Event|1|||
126740592|NCT01421069|455998833|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
126740593|NCT01421069|455998833|FG000|Active Treatment Period|Enrolled in observational period|29|||
126740594|NCT01421069|455998833|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
126740595|NCT01421069|455998833|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
126740596|NCT01421069|455998833|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
126740597|NCT01421069|455998833|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
126740598|NCT01421069|455998833|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
126740599|NCT01421069|455998833|FG000|2b. Retreatment Period|Protocol Violation|1|||
126740600|NCT01421069|455998833|FG000|Observational Period|Other|1|||
126740601|NCT01421069|455998833|FG000|Observational Period|No longer willing to participate in study|4|||
126740602|NCT01421069|455998833|FG000|Observational Period|Lost to Follow-up|3|||
126740603|NCT01641081|455998834|FG000|Period 1|Sponsor request (potential unblinding)|0|||
126740604|NCT01641081|455998835|FG001|Period 1|Sponsor request (potential unblinding)|0|||
126740605|NCT01641081|455998836|FG002|Period 1|Sponsor request (potential unblinding)|0|||
126740606|NCT01641081|455998837|FG003|Period 1|Sponsor request (potential unblinding)|0|||
126740607|NCT01641081|455998838|FG004|Period 1|Sponsor request (potential unblinding)|0|||
126740608|NCT01641081|455998839|FG005|Period 1|Sponsor request (potential unblinding)|0|||
126740609|NCT01641081|455998840|FG006|Period 1|Sponsor request (potential unblinding)|1|||
126740610|NCT01641081|455998841|FG007|Period 1|Sponsor request (potential unblinding)|0|||
126740611|NCT01641081|455998842|FG008|Period 1|Sponsor request (potential unblinding)|0|||
126740612|NCT01641081|455998843|FG009|Period 1|Sponsor request (potential unblinding)|0|||
126740613|NCT01641081|455998834|FG000|Period 1|Protocol Violation|0|||
126740614|NCT01641081|455998835|FG001|Period 1|Protocol Violation|0|||
126740615|NCT01641081|455998836|FG002|Period 1|Protocol Violation|0|||
126740616|NCT01641081|455998837|FG003|Period 1|Protocol Violation|0|||
126740617|NCT01641081|455998838|FG004|Period 1|Protocol Violation|1|||
126740618|NCT01641081|455998839|FG005|Period 1|Protocol Violation|0|||
126740619|NCT01641081|455998840|FG006|Period 1|Protocol Violation|0|||
126740620|NCT01641081|455998841|FG007|Period 1|Protocol Violation|1|||
126740621|NCT01641081|455998842|FG008|Period 1|Protocol Violation|0|||
126740622|NCT01641081|455998843|FG009|Period 1|Protocol Violation|0|||
126740623|NCT01641081|455998834|FG000|Period 1|Adverse Event|1|||
126740624|NCT01641081|455998835|FG001|Period 1|Adverse Event|0|||
126740625|NCT01641081|455998836|FG002|Period 1|Adverse Event|0|||
126740626|NCT01641081|455998837|FG003|Period 1|Adverse Event|0|||
126740627|NCT01641081|455998838|FG004|Period 1|Adverse Event|0|||
126740628|NCT01641081|455998839|FG005|Period 1|Adverse Event|0|||
126740629|NCT01641081|455998840|FG006|Period 1|Adverse Event|0|||
126740630|NCT01641081|455998841|FG007|Period 1|Adverse Event|2|||
126740631|NCT01641081|455998842|FG008|Period 1|Adverse Event|0|||
126740632|NCT01641081|455998843|FG009|Period 1|Adverse Event|0|||
126740633|NCT01641081|455998834|FG000|Period 2|Adverse Event|0|||
126740634|NCT01641081|455998835|FG001|Period 2|Adverse Event|0|||
126740635|NCT01641081|455998836|FG002|Period 2|Adverse Event|0|||
126740636|NCT01641081|455998837|FG003|Period 2|Adverse Event|0|||
126740637|NCT01641081|455998838|FG004|Period 2|Adverse Event|0|||
126740638|NCT01641081|455998839|FG005|Period 2|Adverse Event|1|||
126740639|NCT01641081|455998840|FG006|Period 2|Adverse Event|0|||
126740640|NCT01641081|455998841|FG007|Period 2|Adverse Event|0|||
126740641|NCT01641081|455998842|FG008|Period 2|Adverse Event|0|||
126740642|NCT01641081|455998843|FG009|Period 2|Adverse Event|0|||
126740643|NCT01641081|455998834|FG000|Period 2|Withdrawal by Subject|0|||
126740644|NCT01641081|455998835|FG001|Period 2|Withdrawal by Subject|0|||
126740645|NCT01641081|455998836|FG002|Period 2|Withdrawal by Subject|0|||
126740646|NCT01641081|455998837|FG003|Period 2|Withdrawal by Subject|1|||
126740647|NCT01641081|455998838|FG004|Period 2|Withdrawal by Subject|0|||
126740648|NCT01641081|455998839|FG005|Period 2|Withdrawal by Subject|0|||
126740649|NCT01641081|455998840|FG006|Period 2|Withdrawal by Subject|2|||
126740650|NCT01641081|455998841|FG007|Period 2|Withdrawal by Subject|0|||
126740651|NCT01641081|455998842|FG008|Period 2|Withdrawal by Subject|0|||
126740652|NCT01641081|455998843|FG009|Period 2|Withdrawal by Subject|0|||
126740653|NCT01641081|455998834|FG000|Period 2|Protocol Violation|1|||
126740654|NCT01641081|455998835|FG001|Period 2|Protocol Violation|0|||
126740655|NCT01641081|455998836|FG002|Period 2|Protocol Violation|0|||
126740656|NCT01641081|455998837|FG003|Period 2|Protocol Violation|0|||
126740657|NCT01641081|455998838|FG004|Period 2|Protocol Violation|0|||
126740658|NCT01641081|455998839|FG005|Period 2|Protocol Violation|0|||
126740659|NCT01641081|455998840|FG006|Period 2|Protocol Violation|0|||
126740660|NCT01641081|455998841|FG007|Period 2|Protocol Violation|0|||
126740661|NCT01641081|455998842|FG008|Period 2|Protocol Violation|0|||
126740662|NCT01641081|455998843|FG009|Period 2|Protocol Violation|0|||
126740663|NCT01641081|455998834|FG000|Period 3|Adverse Event|0|||
126740664|NCT01641081|455998835|FG001|Period 3|Adverse Event|0|||
126740665|NCT01641081|455998836|FG002|Period 3|Adverse Event|1|||
126740666|NCT01641081|455998837|FG003|Period 3|Adverse Event|0|||
126740667|NCT01641081|455998838|FG004|Period 3|Adverse Event|0|||
126740668|NCT01641081|455998839|FG005|Period 3|Adverse Event|0|||
126740669|NCT01641081|455998840|FG006|Period 3|Adverse Event|0|||
126740670|NCT01641081|455998841|FG007|Period 3|Adverse Event|0|||
126740671|NCT01641081|455998842|FG008|Period 3|Adverse Event|0|||
126740672|NCT01641081|455998843|FG009|Period 3|Adverse Event|0|||
126740673|NCT01641081|455998834|FG000|Period 3|Withdrawal by Subject|0|||
126740674|NCT01641081|455998835|FG001|Period 3|Withdrawal by Subject|0|||
126740675|NCT01641081|455998836|FG002|Period 3|Withdrawal by Subject|0|||
126740676|NCT01641081|455998837|FG003|Period 3|Withdrawal by Subject|0|||
126740677|NCT01641081|455998838|FG004|Period 3|Withdrawal by Subject|0|||
126740678|NCT01641081|455998839|FG005|Period 3|Withdrawal by Subject|0|||
126740679|NCT01641081|455998840|FG006|Period 3|Withdrawal by Subject|0|||
126740680|NCT01641081|455998841|FG007|Period 3|Withdrawal by Subject|0|||
126740681|NCT01641081|455998842|FG008|Period 3|Withdrawal by Subject|1|||
126740682|NCT01641081|455998843|FG009|Period 3|Withdrawal by Subject|0|||
126740683|NCT01641081|455998834|FG000|Period 4|Adverse Event|0|||
126740684|NCT01641081|455998835|FG001|Period 4|Adverse Event|1|||
126740685|NCT01641081|455998836|FG002|Period 4|Adverse Event|0|||
126740686|NCT01641081|455998837|FG003|Period 4|Adverse Event|1|||
126740687|NCT01641081|455998838|FG004|Period 4|Adverse Event|0|||
126740688|NCT01641081|455998839|FG005|Period 4|Adverse Event|0|||
126740689|NCT01641081|455998840|FG006|Period 4|Adverse Event|0|||
126740690|NCT01641081|455998841|FG007|Period 4|Adverse Event|0|||
126740691|NCT01641081|455998842|FG008|Period 4|Adverse Event|0|||
126740692|NCT01641081|455998843|FG009|Period 4|Adverse Event|0|||
126740693|NCT01641081|455998834|FG000|Period 5|Adverse Event|0|||
126740694|NCT01641081|455998835|FG001|Period 5|Adverse Event|0|||
126740695|NCT01641081|455998836|FG002|Period 5|Adverse Event|2|||
126740696|NCT01641081|455998837|FG003|Period 5|Adverse Event|0|||
126740697|NCT01641081|455998838|FG004|Period 5|Adverse Event|0|||
126740698|NCT01641081|455998839|FG005|Period 5|Adverse Event|0|||
126740699|NCT01641081|455998840|FG006|Period 5|Adverse Event|0|||
126740700|NCT01641081|455998841|FG007|Period 5|Adverse Event|0|||
126740701|NCT01641081|455998842|FG008|Period 5|Adverse Event|0|||
126740702|NCT01641081|455998843|FG009|Period 5|Adverse Event|0|||
126740703|NCT01095666|455998844|FG000|Overall Study|Lack of Efficacy|0|||
126740704|NCT01095666|455998845|FG001|Overall Study|Lack of Efficacy|0|||
126740705|NCT01095666|455998846|FG002|Overall Study|Lack of Efficacy|1|||
126740706|NCT01095666|455998844|FG000|Overall Study|Adverse Event|2|||
126740707|NCT01095666|455998845|FG001|Overall Study|Adverse Event|1|||
126740708|NCT01095666|455998846|FG002|Overall Study|Adverse Event|3|||
126740709|NCT01095666|455998844|FG000|Overall Study|Lost to Follow-up|2|||
126740710|NCT01095666|455998845|FG001|Overall Study|Lost to Follow-up|2|||
126740711|NCT01095666|455998846|FG002|Overall Study|Lost to Follow-up|0|||
126740712|NCT01095666|455998844|FG000|Overall Study|Withdrawal by Subject|6|||
126740713|NCT01095666|455998845|FG001|Overall Study|Withdrawal by Subject|6|||
126740714|NCT01095666|455998846|FG002|Overall Study|Withdrawal by Subject|1|||
126740715|NCT01095666|455998844|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
126740716|NCT01095666|455998845|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
126740717|NCT01095666|455998846|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
126740718|NCT01749800|455998850|FG000|Overall Study|not meeting inclusion criteria|3|||
126740719|NCT01749800|455998851|FG001|Overall Study|not meeting inclusion criteria|0|||
126740720|NCT01749800|455998852|FG002|Overall Study|not meeting inclusion criteria|0|||
126740721|NCT01749800|455998850|FG000|Overall Study|Withdrawal by Subject|0|||
126740722|NCT01749800|455998851|FG001|Overall Study|Withdrawal by Subject|1|||
126740723|NCT01749800|455998852|FG002|Overall Study|Withdrawal by Subject|0|||
126740724|NCT01000025|455998855|FG000|Overall Study|Adverse Event|43|||
126740725|NCT01000025|455998856|FG001|Overall Study|Adverse Event|2|||
126740726|NCT01000025|455998855|FG000|Overall Study|Withdrawal by Subject|13|||
126740727|NCT01000025|455998856|FG001|Overall Study|Withdrawal by Subject|8|||
126740728|NCT01000025|455998855|FG000|Overall Study|Death|23|||
126740729|NCT01000025|455998856|FG001|Overall Study|Death|13|||
126740730|NCT01000025|455998855|FG000|Overall Study|Lack of Efficacy|363|||
126740731|NCT01000025|455998856|FG001|Overall Study|Lack of Efficacy|208|||
126740732|NCT01000025|455998855|FG000|Overall Study|Intercurrent Illness|26|||
126740733|NCT01000025|455998856|FG001|Overall Study|Intercurrent Illness|7|||
126740734|NCT00422669|455998857|FG000|Overall Study|The study was terminated early.|98|||
126740735|NCT00422669|455998858|FG001|Overall Study|The study was terminated early.|100|||
126740736|NCT00422669|455998859|FG002|Overall Study|The study was terminated early.|7|||
126740737|NCT02738580|455998860|FG000|Overall Study|Adverse Event|1|||
126615643|NCT00795639|455551601|FG000|Overall Study|Randomized and not treated|0|||
126740738|NCT02738580|455998861|FG001|Overall Study|Adverse Event|0|||
126740739|NCT02738580|455998860|FG000|Overall Study|Lack of Efficacy|3|||
126740740|NCT02738580|455998861|FG001|Overall Study|Lack of Efficacy|2|||
126740741|NCT02738580|455998860|FG000|Overall Study|Withdrawal by Subject|0|||
126740742|NCT02738580|455998861|FG001|Overall Study|Withdrawal by Subject|1|||
126740743|NCT02738580|455998860|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
126740744|NCT02738580|455998861|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
126740745|NCT00996593|455998863|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
126740746|NCT00996593|455998863|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
126615644|NCT00795639|455551602|FG001|Overall Study|Randomized and not treated|1|||
126740747|NCT00996593|455998863|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
126740748|NCT00996593|455998863|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
126740749|NCT00996593|455998863|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
126615645|NCT03349476|455551603|FG000|Overall Study|Physician Decision|3|||
126615646|NCT02525744|455551604|FG000|Period 1|Physician Decision|0|||
126740750|NCT00996593|455998863|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
126740751|NCT00996593|455998863|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
126740752|NCT00996593|455998863|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
126740753|NCT00996593|455998863|FG000|Long-Term Follow-Up|Site Closed|1|||
126740754|NCT00741260|455998864|FG000|Overall Study|Disease Progression|3|||
126740755|NCT00741260|455998865|FG001|Overall Study|Disease Progression|5|||
126740756|NCT00741260|455998866|FG002|Overall Study|Disease Progression|3|||
126740757|NCT00741260|455998867|FG003|Overall Study|Disease Progression|3|||
126740758|NCT00741260|455998868|FG004|Overall Study|Disease Progression|5|||
126740759|NCT00741260|455998869|FG005|Overall Study|Disease Progression|37|||
126740760|NCT00741260|455998870|FG006|Overall Study|Disease Progression|4|||
126740761|NCT00741260|455998864|FG000|Overall Study|Death|0|||
126740762|NCT00741260|455998865|FG001|Overall Study|Death|1|||
126740763|NCT00741260|455998866|FG002|Overall Study|Death|0|||
126740764|NCT00741260|455998867|FG003|Overall Study|Death|1|||
126740765|NCT00741260|455998868|FG004|Overall Study|Death|2|||
126740766|NCT00741260|455998869|FG005|Overall Study|Death|2|||
126740767|NCT00741260|455998870|FG006|Overall Study|Death|1|||
126740768|NCT00741260|455998864|FG000|Overall Study|Withdrawal by Subject|0|||
126740769|NCT00741260|455998865|FG001|Overall Study|Withdrawal by Subject|0|||
126740770|NCT00741260|455998866|FG002|Overall Study|Withdrawal by Subject|0|||
126740771|NCT00741260|455998867|FG003|Overall Study|Withdrawal by Subject|0|||
126740772|NCT00741260|455998868|FG004|Overall Study|Withdrawal by Subject|1|||
126740773|NCT00741260|455998869|FG005|Overall Study|Withdrawal by Subject|3|||
126740774|NCT00741260|455998870|FG006|Overall Study|Withdrawal by Subject|1|||
126740775|NCT00741260|455998864|FG000|Overall Study|Physician Decision|1|||
126740776|NCT00741260|455998865|FG001|Overall Study|Physician Decision|1|||
126740777|NCT00741260|455998866|FG002|Overall Study|Physician Decision|0|||
126740778|NCT00741260|455998867|FG003|Overall Study|Physician Decision|0|||
126740779|NCT00741260|455998868|FG004|Overall Study|Physician Decision|0|||
126740780|NCT00741260|455998869|FG005|Overall Study|Physician Decision|0|||
126740781|NCT00741260|455998870|FG006|Overall Study|Physician Decision|0|||
126615647|NCT02525744|455551605|FG001|Period 1|Physician Decision|0|||
126615648|NCT02525744|455551606|FG002|Period 1|Physician Decision|1|||
126740782|NCT00741260|455998864|FG000|Overall Study|Other|2|||
126740783|NCT00741260|455998865|FG001|Overall Study|Other|1|||
126740784|NCT00741260|455998866|FG002|Overall Study|Other|1|||
126740785|NCT00741260|455998867|FG003|Overall Study|Other|2|||
126740786|NCT00741260|455998868|FG004|Overall Study|Other|1|||
126740787|NCT00741260|455998869|FG005|Overall Study|Other|3|||
126740788|NCT00741260|455998870|FG006|Overall Study|Other|1|||
126740789|NCT02810951|455998871|FG000|Overall Study|Adverse Event|1|||
126740790|NCT01250756|455998872|FG000|Infant Series|Withdrawal by Subject|4|||
126740791|NCT01250756|455998873|FG001|Infant Series|Withdrawal by Subject|5|||
126740792|NCT01250756|455998872|FG000|Infant Series|Randomized, Not Vaccinated|2|||
126740793|NCT01250756|455998873|FG001|Infant Series|Randomized, Not Vaccinated|2|||
126740794|NCT01250756|455998872|FG000|Infant Series|Other|22|||
126740795|NCT01250756|455998873|FG001|Infant Series|Other|0|||
126740796|NCT01250756|455998872|FG000|After Infant Series|Adverse Event|5|||
126740797|NCT01250756|455998873|FG001|After Infant Series|Adverse Event|2|||
126740798|NCT01250756|455998872|FG000|After Infant Series|Withdrawal by Subject|4|||
126740799|NCT01250756|455998873|FG001|After Infant Series|Withdrawal by Subject|1|||
126740800|NCT01250756|455998872|FG000|After Infant Series|Other|2|||
126740801|NCT01250756|455998873|FG001|After Infant Series|Other|1|||
126740802|NCT01250756|455998872|FG000|Toddler Dose|Adverse Event|0|||
126740803|NCT01250756|455998873|FG001|Toddler Dose|Adverse Event|1|||
126740804|NCT01250756|455998872|FG000|After Toddler Dose|Adverse Event|0|||
126740805|NCT01250756|455998873|FG001|After Toddler Dose|Adverse Event|1|||
126740806|NCT01928082|455998874|FG000|Overall Study|Study terminated.|1|||
126740807|NCT01610206|455998882|FG000|Overall Study|Adverse Event|10|||
126615649|NCT02525744|455551607|FG003|Period 1|Physician Decision|0|||
126740808|NCT01610206|455998883|FG001|Overall Study|Adverse Event|30|||
126740809|NCT00166517|455998884|FG000|Overall Study|Lost to Follow-up|1|||
126740810|NCT00166517|455998885|FG001|Overall Study|Lost to Follow-up|0|||
126740811|NCT00166517|455998884|FG000|Overall Study|Protocol Violation|4|||
126781683|NCT00752791|456156233|FG000|Overall Study|Death|1|||
126615650|NCT02525744|455551604|FG000|Period 3|Adverse Event|0|||
126615651|NCT02525744|455551605|FG001|Period 3|Adverse Event|1|||
126740812|NCT00166517|455998885|FG001|Overall Study|Protocol Violation|1|||
126740813|NCT00166517|455998884|FG000|Overall Study|Withdrawal by Subject|0|||
126615652|NCT02525744|455551606|FG002|Period 3|Adverse Event|0|||
126615653|NCT02525744|455551607|FG003|Period 3|Adverse Event|0|||
126740814|NCT00166517|455998885|FG001|Overall Study|Withdrawal by Subject|1|||
126740815|NCT02186561|455998886|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
126740816|NCT02186561|455998886|FG000|Enrollment|Enrollment Cap Reached|5|||
126740817|NCT02186561|455998886|FG000|Enrollment|Insurance Denial|2|||
126740818|NCT02186561|455998886|FG000|Enrollment|Withdrawal by Subject|2|||
126740819|NCT02186561|455998886|FG000|Enrollment|Investigator Withdrew Consent|1|||
126740820|NCT02186561|455998886|FG000|30-Day Post Index Procedure Visit|Death|1|||
126740821|NCT02186561|455998886|FG000|1- Year Post Index Procedure Visit|Death|1|||
126740822|NCT02186561|455998886|FG000|1- Year Post Index Procedure Visit|Missed|1|||
126740823|NCT04285853|455998887|FG000|Overall Study|Withdrawal by Subject|1|||
126740824|NCT04285853|455998888|FG001|Overall Study|Withdrawal by Subject|0|||
126740825|NCT04285853|455998887|FG000|Overall Study|Lost to Follow-up|9|||
126740826|NCT04285853|455998888|FG001|Overall Study|Lost to Follow-up|5|||
126740827|NCT00653068|456001298|FG000|Overall Study|Death|9|||
126740828|NCT00653068|456001298|FG000|Overall Study|Lack of Efficacy|34|||
126740829|NCT00653068|456001298|FG000|Overall Study|Physician Decision|4|||
126740830|NCT00653068|456001298|FG000|Overall Study|Withdrawal by Subject|1|||
126740831|NCT00653068|456001298|FG000|Overall Study|Ineligible|2|||
126740832|NCT01685060|456001303|FG000|Overall Study|Rollover patients|16|||
126740833|NCT01685060|456001303|FG000|Overall Study|Adverse Event|12|||
126740834|NCT01685060|456001303|FG000|Overall Study|Progressive disease|69|||
126740835|NCT01685060|456001303|FG000|Overall Study|Physician Decision|14|||
126740836|NCT01685060|456001303|FG000|Overall Study|Subject/guardian decision|20|||
126740837|NCT01685060|456001303|FG000|Overall Study|Lost to Follow-up|1|||
126740838|NCT01685060|456001303|FG000|Overall Study|Death|8|||
126740839|NCT03597503|456001304|FG000|Overall Study|Withdrawal by Subject|0|||
126740840|NCT03597503|456001305|FG001|Overall Study|Withdrawal by Subject|2|||
126740841|NCT03597503|456001304|FG000|Overall Study|Lost to Follow-up|1|||
126740842|NCT03597503|456001305|FG001|Overall Study|Lost to Follow-up|2|||
126740843|NCT03597503|456001304|FG000|Overall Study|Protocol Violation|1|||
126740844|NCT03597503|456001305|FG001|Overall Study|Protocol Violation|0|||
126740845|NCT02944513|456001306|FG000|Overall Study|Withdrawal by Subject|4|||
126740846|NCT02944513|456001307|FG001|Overall Study|Withdrawal by Subject|1|||
126740847|NCT00937326|456001311|FG000|Overall Study|Adverse Event|0|||
126740848|NCT00937326|456001312|FG001|Overall Study|Adverse Event|3|||
126740849|NCT00937326|456001313|FG002|Overall Study|Adverse Event|1|||
126740850|NCT00937326|456001314|FG003|Overall Study|Adverse Event|1|||
126740851|NCT00937326|456001315|FG004|Overall Study|Adverse Event|2|||
126740852|NCT00937326|456001311|FG000|Overall Study|Death|0|||
126740853|NCT00937326|456001312|FG001|Overall Study|Death|0|||
126740854|NCT00937326|456001313|FG002|Overall Study|Death|1|||
126740855|NCT00937326|456001314|FG003|Overall Study|Death|0|||
126740856|NCT00937326|456001315|FG004|Overall Study|Death|0|||
126740857|NCT00937326|456001311|FG000|Overall Study|Withdrawal by Subject|3|||
126740858|NCT00937326|456001312|FG001|Overall Study|Withdrawal by Subject|4|||
126740859|NCT00937326|456001313|FG002|Overall Study|Withdrawal by Subject|1|||
126740860|NCT00937326|456001314|FG003|Overall Study|Withdrawal by Subject|4|||
126740861|NCT00937326|456001315|FG004|Overall Study|Withdrawal by Subject|3|||
126740862|NCT00937326|456001311|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
126740863|NCT00937326|456001312|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
126740864|NCT00937326|456001313|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
126740865|NCT00937326|456001314|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
126740866|NCT00937326|456001315|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
126740867|NCT02578992|456001316|FG000|Overall Study|equipment not available or malfunction|3|||
126740868|NCT02578992|456001317|FG001|Overall Study|equipment not available or malfunction|3|||
126740869|NCT00086385|456001320|FG000|Overall Study|Death|2|||
126740870|NCT00086385|456001321|FG001|Overall Study|Death|2|||
126740871|NCT00086385|456001322|FG002|Overall Study|Death|1|||
126740872|NCT00086385|456001323|FG003|Overall Study|Death|1|||
126740873|NCT00880100|456001326|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
126740874|NCT00880100|456001326|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
126740875|NCT00880100|456001326|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
126740876|NCT00405275|456001328|FG000|Overall Study|Death|1|||
126740877|NCT00405275|456001329|FG001|Overall Study|Death|0|||
126740878|NCT00405275|456001328|FG000|Overall Study|Lost to Follow-up|5|||
126740879|NCT00405275|456001329|FG001|Overall Study|Lost to Follow-up|1|||
126740880|NCT00405275|456001328|FG000|Overall Study|Withdrawal by Subject|7|||
126740881|NCT00405275|456001329|FG001|Overall Study|Withdrawal by Subject|9|||
126740882|NCT00405275|456001328|FG000|Overall Study|Unwilling to continue|10|||
126740883|NCT00405275|456001329|FG001|Overall Study|Unwilling to continue|9|||
126740884|NCT00731666|456001330|FG000|Overall Study|Adverse Event|2|||
126740885|NCT00731666|456001330|FG000|Overall Study|Lost to Follow-up|8|||
126740886|NCT00731666|456001330|FG000|Overall Study|Withdrawal by Subject|2|||
126740887|NCT02853123|456001333|FG000|Treatment Period 1|Adverse Event|0|||
126740888|NCT02853123|456001334|FG001|Treatment Period 1|Adverse Event|3|||
126740889|NCT02853123|456001333|FG000|Washout Period|Worsening of COPD|0|||
126740890|NCT02853123|456001334|FG001|Washout Period|Worsening of COPD|3|||
126740891|NCT02853123|456001333|FG000|Washout Period|Adverse Event|1|||
126740892|NCT02853123|456001334|FG001|Washout Period|Adverse Event|0|||
126740893|NCT05283499|456001335|FG000|Overall Study|Did not receive intervention|1|||
126740894|NCT05283499|456001336|FG001|Overall Study|Did not receive intervention|2|||
126740895|NCT02471586|456001337|FG000|Overall Study|Lost to Follow-up|3|||
126740896|NCT02471586|456001338|FG001|Overall Study|Lost to Follow-up|8|||
126740897|NCT02471586|456001339|FG002|Overall Study|Lost to Follow-up|4|||
126740898|NCT02471586|456001337|FG000|Overall Study|Death|2|||
126740899|NCT02471586|456001338|FG001|Overall Study|Death|2|||
126740900|NCT02471586|456001339|FG002|Overall Study|Death|0|||
126740901|NCT05516134|456001340|FG000|Overall Study|Lost to Follow-up|1|||
126740902|NCT05516134|456001341|FG001|Overall Study|Lost to Follow-up|0|||
126740903|NCT05516134|456001342|FG002|Overall Study|Lost to Follow-up|0|||
126740904|NCT01094808|456001344|FG000|Overall Study|Withdrawal by Subject|1|||
126740905|NCT01094808|456001345|FG001|Overall Study|Withdrawal by Subject|1|||
126740906|NCT01094808|456001346|FG002|Overall Study|Withdrawal by Subject|0|||
126740907|NCT00369278|456001347|FG000|Overall Study|Adverse Event|14|||
126740908|NCT00369278|456001348|FG001|Overall Study|Adverse Event|11|||
126740909|NCT00369278|456001347|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126740910|NCT00369278|456001348|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
126740911|NCT00369278|456001347|FG000|Overall Study|Protocol Violation|2|||
126740912|NCT00369278|456001348|FG001|Overall Study|Protocol Violation|1|||
126740913|NCT00369278|456001347|FG000|Overall Study|Withdrawal by Subject|2|||
126740914|NCT00369278|456001348|FG001|Overall Study|Withdrawal by Subject|2|||
126740915|NCT00369278|456001347|FG000|Overall Study|Lost to Follow-up|1|||
126740916|NCT00369278|456001348|FG001|Overall Study|Lost to Follow-up|0|||
126740917|NCT00369278|456001347|FG000|Overall Study|Graft loss|1|||
126740918|NCT00369278|456001348|FG001|Overall Study|Graft loss|2|||
126740919|NCT01224106|456001349|FG000|Double-Blind Treatment Phase|Death|3|||
126740920|NCT01224106|456001350|FG001|Double-Blind Treatment Phase|Death|0|||
126740921|NCT01224106|456001351|FG002|Double-Blind Treatment Phase|Death|0|||
126740922|NCT01224106|456001352|FG003|Double-Blind Treatment Phase|Death|0|||
126740923|NCT01224106|456001353|FG004|Double-Blind Treatment Phase|Death|0|||
126740924|NCT01224106|456001349|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
126740925|NCT01224106|456001350|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
126740926|NCT01224106|456001351|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
126740927|NCT01224106|456001352|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
126740928|NCT01224106|456001353|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
126740929|NCT01224106|456001349|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
126740930|NCT01224106|456001350|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
126740931|NCT01224106|456001351|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
126740932|NCT01224106|456001352|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
126740933|NCT01224106|456001353|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
126740934|NCT01224106|456001349|FG000|Double-Blind Treatment Phase|Other|0|||
126740935|NCT01224106|456001350|FG001|Double-Blind Treatment Phase|Other|0|||
126740936|NCT01224106|456001351|FG002|Double-Blind Treatment Phase|Other|1|||
126740937|NCT01224106|456001352|FG003|Double-Blind Treatment Phase|Other|0|||
126740938|NCT01224106|456001353|FG004|Double-Blind Treatment Phase|Other|0|||
126740939|NCT01224106|456001349|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
126740940|NCT01224106|456001350|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
126740941|NCT01224106|456001351|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
126740942|NCT01224106|456001352|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
126740943|NCT01224106|456001353|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
126740944|NCT01224106|456001349|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
126740945|NCT01224106|456001350|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
126740946|NCT01224106|456001351|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
126740947|NCT01224106|456001352|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
126740948|NCT01224106|456001353|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
126740949|NCT01224106|456001349|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
126740950|NCT01224106|456001350|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126740951|NCT01224106|456001351|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
126740952|NCT01224106|456001352|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126740953|NCT01224106|456001353|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126740954|NCT01224106|456001349|FG000|Open-Label Extension (OLE) Phase|Death|0|||
126740955|NCT01224106|456001350|FG001|Open-Label Extension (OLE) Phase|Death|0|||
126740956|NCT01224106|456001351|FG002|Open-Label Extension (OLE) Phase|Death|0|||
126740957|NCT01224106|456001352|FG003|Open-Label Extension (OLE) Phase|Death|1|||
126740958|NCT01224106|456001353|FG004|Open-Label Extension (OLE) Phase|Death|3|||
126740959|NCT01224106|456001349|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
126615654|NCT02525744|455551604|FG000|Period 4|Withdrawal by Subject|1|||
126740960|NCT01224106|456001350|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
126740961|NCT01224106|456001351|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
126740962|NCT01224106|456001352|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
126740963|NCT01224106|456001353|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
126740964|NCT01224106|456001349|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
126740965|NCT01224106|456001350|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
126740966|NCT01224106|456001351|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
126740967|NCT01224106|456001352|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
126740968|NCT01224106|456001353|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
126740969|NCT01224106|456001349|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
126740970|NCT01224106|456001350|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
126740971|NCT01224106|456001351|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
126740972|NCT01224106|456001352|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
126740973|NCT01224106|456001353|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
126740974|NCT01224106|456001349|FG000|Open-Label Extension (OLE) Phase|Other|0|||
126740975|NCT01224106|456001350|FG001|Open-Label Extension (OLE) Phase|Other|0|||
126740976|NCT01224106|456001351|FG002|Open-Label Extension (OLE) Phase|Other|0|||
126740977|NCT01224106|456001352|FG003|Open-Label Extension (OLE) Phase|Other|5|||
126740978|NCT01224106|456001353|FG004|Open-Label Extension (OLE) Phase|Other|3|||
126740979|NCT00446797|456001354|FG000|Overall Study|Lack of Efficacy|0|||
126740980|NCT00446797|456001355|FG001|Overall Study|Lack of Efficacy|2|||
126740981|NCT00446797|456001354|FG000|Overall Study|Lost to Follow-up|5|||
126740982|NCT00446797|456001355|FG001|Overall Study|Lost to Follow-up|3|||
126740983|NCT00446797|456001354|FG000|Overall Study|Withdrawal by Subject|2|||
126740984|NCT00446797|456001355|FG001|Overall Study|Withdrawal by Subject|2|||
126740985|NCT00446797|456001354|FG000|Overall Study|Protocol Violation|1|||
126740986|NCT00446797|456001355|FG001|Overall Study|Protocol Violation|3|||
126740987|NCT00446797|456001354|FG000|Overall Study|subject entered at another site|0|||
126740988|NCT00446797|456001355|FG001|Overall Study|subject entered at another site|1|||
126740989|NCT00446797|456001354|FG000|Overall Study|did not meet entrance criteria|0|||
126740990|NCT00446797|456001355|FG001|Overall Study|did not meet entrance criteria|1|||
126740991|NCT02133001|456001356|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
126740992|NCT02133001|456001357|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
126740993|NCT02133001|456001356|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
126740994|NCT02133001|456001357|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
126740995|NCT02133001|456001356|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
126740996|NCT02133001|456001357|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
126740997|NCT02133001|456001356|FG000|Double Blind (Day 1-25)|Other|2|||
126740998|NCT02133001|456001357|FG001|Double Blind (Day 1-25)|Other|2|||
126740999|NCT02133001|456001356|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
126741000|NCT02133001|456001357|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
126741001|NCT02133001|456001356|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
126741002|NCT02133001|456001357|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
126741003|NCT02133001|456001356|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
126741004|NCT02133001|456001357|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
126741005|NCT02133001|456001356|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
126741006|NCT02133001|456001357|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
126741007|NCT02498392|456001362|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
126741008|NCT02498392|456001363|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
126741009|NCT02498392|456001362|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
126741010|NCT02498392|456001363|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
126741011|NCT02498392|456001362|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
126741012|NCT02498392|456001363|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
126741013|NCT02498392|456001362|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
126741014|NCT02498392|456001363|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
126741015|NCT02498392|456001362|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
126741016|NCT02498392|456001363|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
126741017|NCT02498392|456001362|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
126741018|NCT02498392|456001363|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
126741019|NCT00841672|456001373|FG000|Overall Study|Adverse Event|7|||
126741020|NCT00841672|456001374|FG001|Overall Study|Adverse Event|16|||
126741021|NCT00841672|456001373|FG000|Overall Study|Abnormal test procedure result(s)|0|||
126741022|NCT00841672|456001374|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126741023|NCT00841672|456001373|FG000|Overall Study|Subject withdrew consent|2|||
126741024|NCT00841672|456001374|FG001|Overall Study|Subject withdrew consent|4|||
126741025|NCT00841672|456001373|FG000|Overall Study|Lost to Follow-up|1|||
126741026|NCT00841672|456001374|FG001|Overall Study|Lost to Follow-up|1|||
126741027|NCT00841672|456001373|FG000|Overall Study|Administrative problems|9|||
126741028|NCT00841672|456001374|FG001|Overall Study|Administrative problems|9|||
126741029|NCT00841672|456001373|FG000|Overall Study|Misrandomized|1|||
126741030|NCT00841672|456001374|FG001|Overall Study|Misrandomized|0|||
126741031|NCT00841672|456001373|FG000|Overall Study|Protocol Deviation|0|||
126741032|NCT00841672|456001374|FG001|Overall Study|Protocol Deviation|1|||
126741033|NCT01451398|456001378|FG000|Overall Study|Adverse Event|7|||
126741034|NCT01451398|456001379|FG001|Overall Study|Adverse Event|9|||
126741035|NCT01451398|456001378|FG000|Overall Study|Protocol Violation|1|||
126741036|NCT01451398|456001379|FG001|Overall Study|Protocol Violation|2|||
126741037|NCT01451398|456001378|FG000|Overall Study|Physician Decision|1|||
126741038|NCT01451398|456001379|FG001|Overall Study|Physician Decision|1|||
126741039|NCT01451398|456001378|FG000|Overall Study|Withdrawal by Subject|10|||
126781684|NCT00752791|456156233|FG000|Overall Study|Renal transplant|3|||
126781685|NCT00752791|456156233|FG000|Overall Study|Switched to hemodialysis|2|||
126781686|NCT00752791|456156233|FG000|Overall Study|Protocol deviation|1|||
126741040|NCT01451398|456001379|FG001|Overall Study|Withdrawal by Subject|14|||
126741041|NCT01451398|456001378|FG000|Overall Study|Lost to Follow-up|6|||
126741042|NCT01451398|456001379|FG001|Overall Study|Lost to Follow-up|4|||
126741043|NCT01451398|456001378|FG000|Overall Study|Non-compliance with study drug|1|||
126741044|NCT01451398|456001379|FG001|Overall Study|Non-compliance with study drug|3|||
126741045|NCT01451398|456001378|FG000|Overall Study|Non-compliance with protocol|1|||
126741046|NCT01451398|456001379|FG001|Overall Study|Non-compliance with protocol|1|||
126741047|NCT01451398|456001378|FG000|Overall Study|Moved out of country|0|||
126741048|NCT01451398|456001379|FG001|Overall Study|Moved out of country|1|||
126741049|NCT01451398|456001378|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
126741050|NCT01451398|456001379|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
126741051|NCT01451398|456001378|FG000|Overall Study|Lack of Efficacy|0|||
126741052|NCT01451398|456001379|FG001|Overall Study|Lack of Efficacy|1|||
126741053|NCT02142504|456001383|FG000|Overall Study|Protocol Violation|2|||
126741054|NCT02142504|456001384|FG001|Overall Study|Protocol Violation|1|||
126741055|NCT02142504|456001385|FG002|Overall Study|Protocol Violation|2|||
126741056|NCT02142504|456001383|FG000|Overall Study|Adverse Event|2|||
126741057|NCT02142504|456001384|FG001|Overall Study|Adverse Event|3|||
126741058|NCT02142504|456001385|FG002|Overall Study|Adverse Event|4|||
126741059|NCT02142504|456001383|FG000|Overall Study|Lost to Follow-up|12|||
126741060|NCT02142504|456001384|FG001|Overall Study|Lost to Follow-up|19|||
126741061|NCT02142504|456001385|FG002|Overall Study|Lost to Follow-up|17|||
126741062|NCT02142504|456001383|FG000|Overall Study|Withdrawal by Subject|7|||
126741063|NCT02142504|456001384|FG001|Overall Study|Withdrawal by Subject|9|||
126741064|NCT02142504|456001385|FG002|Overall Study|Withdrawal by Subject|11|||
126741065|NCT02142504|456001383|FG000|Overall Study|Pregnancy|4|||
126741066|NCT02142504|456001384|FG001|Overall Study|Pregnancy|4|||
126741067|NCT02142504|456001385|FG002|Overall Study|Pregnancy|2|||
126741068|NCT02142504|456001383|FG000|Overall Study|Physician Decision|0|||
126741069|NCT02142504|456001384|FG001|Overall Study|Physician Decision|1|||
126741070|NCT02142504|456001385|FG002|Overall Study|Physician Decision|3|||
126741071|NCT02142504|456001383|FG000|Overall Study|Reason Not Specified|4|||
126741072|NCT02142504|456001384|FG001|Overall Study|Reason Not Specified|5|||
126741073|NCT02142504|456001385|FG002|Overall Study|Reason Not Specified|4|||
126741074|NCT02120352|456001386|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
126741075|NCT02120352|456001387|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
126741076|NCT02120352|456001388|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
126741077|NCT02120352|456001389|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
126741078|NCT02120352|456001390|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
126741079|NCT02120352|456001391|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
126741080|NCT02120352|456001392|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
126741081|NCT02120352|456001386|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
126741082|NCT02120352|456001387|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
126741083|NCT02120352|456001388|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
126741084|NCT02120352|456001389|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
126741085|NCT02120352|456001390|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
126741086|NCT02120352|456001391|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
126741087|NCT02120352|456001392|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
126741088|NCT02120352|456001386|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
126741089|NCT02120352|456001387|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
126741090|NCT02120352|456001388|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
126741091|NCT02120352|456001389|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
126741092|NCT02120352|456001390|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
126741093|NCT02120352|456001391|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
126741094|NCT02120352|456001392|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
126741095|NCT02120352|456001386|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
126741096|NCT02120352|456001387|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
126741097|NCT02120352|456001388|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
126741098|NCT02120352|456001389|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
126741099|NCT02120352|456001390|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
126741100|NCT02120352|456001391|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
126741101|NCT02120352|456001392|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
126741102|NCT02120352|456001386|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
126781687|NCT01958281|456156234|FG000|Overall Study|Lack of Efficacy|5|||
126781688|NCT01958281|456156235|FG001|Overall Study|Lack of Efficacy|2|||
126615655|NCT02525744|455551605|FG001|Period 4|Withdrawal by Subject|0|||
126615656|NCT02525744|455551606|FG002|Period 4|Withdrawal by Subject|0|||
126741103|NCT02120352|456001387|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
126741104|NCT02120352|456001388|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
126741105|NCT02120352|456001389|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
126741106|NCT02120352|456001390|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
126741107|NCT02120352|456001391|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
126741108|NCT02120352|456001392|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
126781689|NCT01958281|456156236|FG002|Overall Study|Lack of Efficacy|0|||
126781690|NCT01958281|456156234|FG000|Overall Study|Adverse Event|0|||
126781691|NCT01958281|456156235|FG001|Overall Study|Adverse Event|2|||
126781692|NCT01958281|456156236|FG002|Overall Study|Adverse Event|0|||
126781693|NCT01958281|456156234|FG000|Overall Study|Withdrew Consent|1|||
126781694|NCT01958281|456156235|FG001|Overall Study|Withdrew Consent|0|||
126781695|NCT01958281|456156236|FG002|Overall Study|Withdrew Consent|0|||
126781696|NCT02784106|456156237|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
126781697|NCT02784106|456156238|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
126781698|NCT02784106|456156239|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
126781699|NCT02784106|456156240|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
126781700|NCT02784106|456156237|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
126781701|NCT02784106|456156238|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
126781702|NCT02784106|456156239|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
126781703|NCT02784106|456156240|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
126781704|NCT02784106|456156237|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
126781705|NCT02784106|456156238|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
126781706|NCT02784106|456156239|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
126781707|NCT02784106|456156240|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
126615657|NCT02525744|455551607|FG003|Period 4|Withdrawal by Subject|0|||
126615658|NCT02525744|455551604|FG000|Period 5|Physician Decision|1|||
126615659|NCT02525744|455551605|FG001|Period 5|Physician Decision|0|||
126615660|NCT02525744|455551606|FG002|Period 5|Physician Decision|0|||
126615661|NCT02525744|455551607|FG003|Period 5|Physician Decision|0|||
126615662|NCT04421456|455551614|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
126615663|NCT04421456|455551615|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
126615664|NCT04421456|455551616|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
126615665|NCT04421456|455551614|FG000|Randomized Treatment Period|Adverse Event|0|||
126615666|NCT04421456|455551615|FG001|Randomized Treatment Period|Adverse Event|1|||
126615667|NCT04421456|455551616|FG002|Randomized Treatment Period|Adverse Event|0|||
126615668|NCT04421456|455551614|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
126615669|NCT04421456|455551615|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
126615670|NCT04421456|455551616|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
126615671|NCT04421456|455551614|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
126615672|NCT04421456|455551615|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
126615673|NCT04421456|455551616|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
126615674|NCT04421456|455551614|FG000|Randomized Treatment Period|Participant non-compliance|1|||
126615675|NCT04421456|455551615|FG001|Randomized Treatment Period|Participant non-compliance|1|||
126615676|NCT04421456|455551616|FG002|Randomized Treatment Period|Participant non-compliance|2|||
126615677|NCT04421456|455551614|FG000|Randomized Treatment Period|Other|0|||
126615678|NCT04421456|455551615|FG001|Randomized Treatment Period|Other|1|||
126615679|NCT04421456|455551616|FG002|Randomized Treatment Period|Other|3|||
126615680|NCT00274287|455551617|FG000|Overall Study|Withdrawal by Subject|1|||
126615681|NCT00274287|455551617|FG000|Overall Study|subject non-compliance|1|||
126615682|NCT01777932|455551620|FG000|Overall Study|Disease progression|136|||
126615683|NCT01777932|455551620|FG000|Overall Study|Death|3|||
126615684|NCT01777932|455551620|FG000|Overall Study|Adverse Event|34|||
126615685|NCT01777932|455551620|FG000|Overall Study|Lost to Follow-up|3|||
126615686|NCT01777932|455551620|FG000|Overall Study|Investigator decision|10|||
126615687|NCT01777932|455551620|FG000|Overall Study|Reimbursement limit|9|||
126615688|NCT01777932|455551620|FG000|Overall Study|Patient refused further treatment|10|||
126615689|NCT03031782|455551628|FG000|Treatment Period 1|Lack of Efficacy|3|||
126615690|NCT03031782|455551629|FG001|Treatment Period 1|Lack of Efficacy|0|||
126615691|NCT03031782|455551630|FG002|Treatment Period 1|Lack of Efficacy|0|||
126615692|NCT03031782|455551631|FG003|Treatment Period 1|Lack of Efficacy|0|||
126615693|NCT03031782|455551632|FG004|Treatment Period 1|Lack of Efficacy|0|||
126615694|NCT03031782|455551628|FG000|Treatment Period 2|Physician Decision|0|||
126615695|NCT03031782|455551629|FG001|Treatment Period 2|Physician Decision|1|||
126615696|NCT03031782|455551630|FG002|Treatment Period 2|Physician Decision|0|||
126615697|NCT03031782|455551631|FG003|Treatment Period 2|Physician Decision|0|||
126615698|NCT03031782|455551632|FG004|Treatment Period 2|Physician Decision|3|||
126615699|NCT03031782|455551628|FG000|Treatment Period 2|Lack of Efficacy|0|||
126615700|NCT03031782|455551629|FG001|Treatment Period 2|Lack of Efficacy|1|||
126615701|NCT03031782|455551630|FG002|Treatment Period 2|Lack of Efficacy|0|||
126781708|NCT02784106|456156237|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
126615702|NCT03031782|455551631|FG003|Treatment Period 2|Lack of Efficacy|0|||
126615703|NCT03031782|455551632|FG004|Treatment Period 2|Lack of Efficacy|1|||
126615704|NCT03031782|455551628|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126615705|NCT03031782|455551629|FG001|Treatment Period 2|Withdrawal by Subject|3|||
126615706|NCT03031782|455551630|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126615707|NCT03031782|455551631|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126615708|NCT03031782|455551632|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126741109|NCT02120352|456001386|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
126741110|NCT02120352|456001387|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
126741111|NCT02120352|456001388|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
126741112|NCT02120352|456001389|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
126741113|NCT02120352|456001390|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
126741114|NCT02120352|456001391|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
126741115|NCT02120352|456001392|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
126741116|NCT02120352|456001386|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
126741117|NCT02120352|456001387|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
126741118|NCT02120352|456001388|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
126741119|NCT02120352|456001389|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
126741120|NCT02120352|456001390|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
126741121|NCT02120352|456001391|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
126741122|NCT02120352|456001392|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
126741123|NCT02120352|456001386|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
126741124|NCT02120352|456001387|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
126741125|NCT02120352|456001388|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
126741126|NCT02120352|456001389|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
126741127|NCT02120352|456001390|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
126741128|NCT02120352|456001391|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
126741129|NCT02120352|456001392|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
126741130|NCT02120352|456001386|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
126741131|NCT02120352|456001387|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
126741132|NCT02120352|456001388|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
126741133|NCT02120352|456001389|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
126741134|NCT02120352|456001390|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
126741135|NCT02120352|456001391|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
126741136|NCT02120352|456001392|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
126741137|NCT02120352|456001386|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
126741138|NCT02120352|456001387|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
126741139|NCT02120352|456001388|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
126741140|NCT02120352|456001389|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
126741141|NCT02120352|456001390|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
126741142|NCT02120352|456001391|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
126741143|NCT02120352|456001392|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
126741144|NCT02120352|456001386|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
126741145|NCT02120352|456001387|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
126741146|NCT02120352|456001388|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
126741147|NCT02120352|456001389|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
126741148|NCT02120352|456001390|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
126741149|NCT02120352|456001391|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
126741150|NCT02120352|456001392|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
126741151|NCT02120352|456001386|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
126741152|NCT02120352|456001387|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
126741153|NCT02120352|456001388|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
126741154|NCT02120352|456001389|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
126741155|NCT02120352|456001390|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
126741156|NCT02120352|456001391|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
126741157|NCT02120352|456001392|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
126741158|NCT02120352|456001386|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
126741159|NCT02120352|456001387|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
126741160|NCT02120352|456001388|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
126741161|NCT02120352|456001389|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
126741162|NCT02120352|456001390|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
126741163|NCT02120352|456001391|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
126741164|NCT02120352|456001392|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
126741165|NCT02120352|456001386|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
126741166|NCT02120352|456001387|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
126741167|NCT02120352|456001388|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
126741168|NCT02120352|456001389|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
126781709|NCT02784106|456156238|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
126615709|NCT03031782|455551628|FG000|Treatment Period 2|Adverse Event|0|||
126615710|NCT03031782|455551629|FG001|Treatment Period 2|Adverse Event|1|||
126741169|NCT02120352|456001390|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
126741170|NCT02120352|456001391|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
126741171|NCT02120352|456001392|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
126615711|NCT03031782|455551630|FG002|Treatment Period 2|Adverse Event|2|||
126615712|NCT03031782|455551631|FG003|Treatment Period 2|Adverse Event|0|||
126615713|NCT03031782|455551632|FG004|Treatment Period 2|Adverse Event|0|||
126615714|NCT03031782|455551628|FG000|Treatment Period 3|Withdrawal by Subject|0|||
126615715|NCT03031782|455551629|FG001|Treatment Period 3|Withdrawal by Subject|0|||
126615716|NCT03031782|455551630|FG002|Treatment Period 3|Withdrawal by Subject|0|||
126615717|NCT03031782|455551631|FG003|Treatment Period 3|Withdrawal by Subject|1|||
126615718|NCT03031782|455551632|FG004|Treatment Period 3|Withdrawal by Subject|0|||
126615719|NCT01930188|455551633|FG000|Overall Study|unclassified|4|||
126615720|NCT01930188|455551634|FG001|Overall Study|unclassified|5|||
126615721|NCT01930188|455551635|FG002|Overall Study|unclassified|3|||
126615722|NCT01930188|455551633|FG000|Overall Study|Missing follow-up information|2|||
126615723|NCT01930188|455551634|FG001|Overall Study|Missing follow-up information|2|||
126615724|NCT01930188|455551635|FG002|Overall Study|Missing follow-up information|3|||
126615725|NCT01930188|455551633|FG000|Overall Study|Lost to Follow-up|5|||
126615726|NCT01930188|455551634|FG001|Overall Study|Lost to Follow-up|2|||
126615727|NCT01930188|455551635|FG002|Overall Study|Lost to Follow-up|2|||
126615728|NCT01930188|455551633|FG000|Overall Study|Death|2|||
126615729|NCT01930188|455551634|FG001|Overall Study|Death|1|||
126615730|NCT01930188|455551635|FG002|Overall Study|Death|3|||
126615731|NCT01930188|455551633|FG000|Overall Study|Withdrawal by Subject|9|||
126615732|NCT01930188|455551634|FG001|Overall Study|Withdrawal by Subject|11|||
126615733|NCT01930188|455551635|FG002|Overall Study|Withdrawal by Subject|8|||
126615734|NCT02514824|455551636|FG000|Overall Study|Withdrawal by Subject|1|||
126615735|NCT02514824|455551637|FG001|Overall Study|Withdrawal by Subject|0|||
126615736|NCT02514824|455551638|FG002|Overall Study|Withdrawal by Subject|0|||
126615737|NCT02514824|455551639|FG003|Overall Study|Withdrawal by Subject|0|||
126615738|NCT02514824|455551636|FG000|Overall Study|Dose-Limiting Toxicity|0|||
126615739|NCT02514824|455551637|FG001|Overall Study|Dose-Limiting Toxicity|1|||
126615740|NCT02514824|455551638|FG002|Overall Study|Dose-Limiting Toxicity|0|||
126615741|NCT02514824|455551639|FG003|Overall Study|Dose-Limiting Toxicity|0|||
126615742|NCT02170207|455551642|FG000|Overall Study|Case report forms unavailable|5|||
126615743|NCT00886834|455551643|FG000|Overall Study|Protocol Violation|0|||
126615744|NCT00886834|455551644|FG001|Overall Study|Protocol Violation|3|||
126615745|NCT03122860|455551645|FG000|Overall Study|Discontinued Before Treatment|1|||
126615746|NCT03122860|455551646|FG001|Overall Study|Discontinued Before Treatment|1|||
126615747|NCT03122860|455551647|FG002|Overall Study|Discontinued Before Treatment|2|||
126615748|NCT03122860|455551648|FG003|Overall Study|Discontinued Before Treatment|0|||
126615749|NCT03122860|455551649|FG004|Overall Study|Discontinued Before Treatment|1|||
126615750|NCT03122860|455551650|FG005|Overall Study|Discontinued Before Treatment|0|||
126615751|NCT03122860|455551645|FG000|Overall Study|Adverse Event|1|||
126615752|NCT03122860|455551646|FG001|Overall Study|Adverse Event|0|||
126615753|NCT03122860|455551647|FG002|Overall Study|Adverse Event|1|||
126615754|NCT03122860|455551648|FG003|Overall Study|Adverse Event|1|||
126615755|NCT03122860|455551649|FG004|Overall Study|Adverse Event|0|||
126615756|NCT03122860|455551650|FG005|Overall Study|Adverse Event|0|||
126615757|NCT03122860|455551645|FG000|Overall Study|Lost to Follow-up|5|||
126615758|NCT03122860|455551646|FG001|Overall Study|Lost to Follow-up|2|||
126615759|NCT03122860|455551647|FG002|Overall Study|Lost to Follow-up|3|||
126615760|NCT03122860|455551648|FG003|Overall Study|Lost to Follow-up|3|||
126615761|NCT03122860|455551649|FG004|Overall Study|Lost to Follow-up|5|||
126615762|NCT03122860|455551650|FG005|Overall Study|Lost to Follow-up|4|||
126615763|NCT03122860|455551645|FG000|Overall Study|Subject Non-Compliance|0|||
126615764|NCT03122860|455551646|FG001|Overall Study|Subject Non-Compliance|0|||
126615765|NCT03122860|455551647|FG002|Overall Study|Subject Non-Compliance|1|||
126615766|NCT03122860|455551648|FG003|Overall Study|Subject Non-Compliance|0|||
126615767|NCT03122860|455551649|FG004|Overall Study|Subject Non-Compliance|0|||
126615768|NCT03122860|455551650|FG005|Overall Study|Subject Non-Compliance|0|||
126615769|NCT03122860|455551645|FG000|Overall Study|Withdrawal by Subject|3|||
126615770|NCT03122860|455551646|FG001|Overall Study|Withdrawal by Subject|2|||
126615771|NCT03122860|455551647|FG002|Overall Study|Withdrawal by Subject|5|||
126615772|NCT03122860|455551648|FG003|Overall Study|Withdrawal by Subject|7|||
126615773|NCT03122860|455551649|FG004|Overall Study|Withdrawal by Subject|9|||
126615774|NCT03122860|455551650|FG005|Overall Study|Withdrawal by Subject|8|||
126615775|NCT01138657|455551651|FG000|Overall Study|Adverse Event|3|||
126615776|NCT01138657|455551652|FG001|Overall Study|Adverse Event|10|||
126615777|NCT01138657|455551651|FG000|Overall Study|Lack of Efficacy|2|||
126615778|NCT01138657|455551652|FG001|Overall Study|Lack of Efficacy|1|||
126615779|NCT01138657|455551651|FG000|Overall Study|Lost to Follow-up|0|||
126615780|NCT01138657|455551652|FG001|Overall Study|Lost to Follow-up|3|||
126615781|NCT01138657|455551651|FG000|Overall Study|Miscellaneous Reasons|3|||
126615782|NCT01138657|455551652|FG001|Overall Study|Miscellaneous Reasons|4|||
126615783|NCT00529529|455551653|FG000|Overall Study|Adverse Event|12|||
126615784|NCT00529529|455551654|FG001|Overall Study|Adverse Event|17|||
126615785|NCT00529529|455551655|FG002|Overall Study|Adverse Event|8|||
126615786|NCT00529529|455551653|FG000|Overall Study|Subject withdrew consent|12|||
126615787|NCT00529529|455551654|FG001|Overall Study|Subject withdrew consent|9|||
126741172|NCT02120352|456001386|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
126741173|NCT02120352|456001387|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
126741174|NCT02120352|456001388|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
126741175|NCT02120352|456001389|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
126741176|NCT02120352|456001390|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
126741177|NCT02120352|456001391|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
126741178|NCT02120352|456001392|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
126741179|NCT02120352|456001386|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
126741180|NCT02120352|456001387|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
126741181|NCT02120352|456001388|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
126741182|NCT02120352|456001389|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
126741183|NCT02120352|456001390|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
126741184|NCT02120352|456001391|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
126741185|NCT02120352|456001392|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
126741186|NCT02120352|456001386|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
126741187|NCT02120352|456001387|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
126741188|NCT02120352|456001388|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
126741189|NCT02120352|456001389|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
126741190|NCT02120352|456001390|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
126741191|NCT02120352|456001391|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
126741192|NCT02120352|456001392|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
126741193|NCT02120352|456001386|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
126781710|NCT02784106|456156239|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
126781711|NCT02784106|456156240|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
126781712|NCT02784106|456156237|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
126781713|NCT02784106|456156238|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
126781714|NCT02784106|456156239|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
126781715|NCT02784106|456156240|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
126781716|NCT02784106|456156237|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
126781717|NCT02784106|456156238|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
126781718|NCT02784106|456156239|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
126615788|NCT00529529|455551655|FG002|Overall Study|Subject withdrew consent|12|||
126615789|NCT00529529|455551653|FG000|Overall Study|Protocol deviation|8|||
126781719|NCT02784106|456156240|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
126781720|NCT03222141|456156241|FG000|Overall Study|Death|15|||
126781721|NCT03222141|456156241|FG000|Overall Study|Lost to Follow-up|3|||
126781722|NCT02022007|456156242|FG000|Overall Study|Withdrawal by Subject|1|||
126781723|NCT02022007|456156243|FG001|Overall Study|Withdrawal by Subject|1|||
126781724|NCT02022007|456156244|FG002|Overall Study|Withdrawal by Subject|1|||
126781725|NCT02022007|456156242|FG000|Overall Study|Noncompliant|0|||
126781726|NCT02022007|456156243|FG001|Overall Study|Noncompliant|0|||
126781727|NCT02022007|456156244|FG002|Overall Study|Noncompliant|1|||
126781728|NCT01107535|456156245|FG000|Overall Study|Death|5|||
126781729|NCT00192296|456156250|FG000|Overall Study|Withdrawal by Subject|0|||
126781730|NCT00192296|456156251|FG001|Overall Study|Withdrawal by Subject|1|||
126781731|NCT00192296|456156252|FG002|Overall Study|Withdrawal by Subject|0|||
126615790|NCT00529529|455551654|FG001|Overall Study|Protocol deviation|12|||
126615791|NCT00529529|455551655|FG002|Overall Study|Protocol deviation|5|||
126615792|NCT00529529|455551653|FG000|Overall Study|Lost to Follow-up|5|||
126615793|NCT00529529|455551654|FG001|Overall Study|Lost to Follow-up|3|||
126615794|NCT00529529|455551655|FG002|Overall Study|Lost to Follow-up|1|||
126615795|NCT00529529|455551653|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
126615796|NCT00529529|455551654|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126615797|NCT00529529|455551655|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
126615798|NCT00529529|455551653|FG000|Overall Study|Death|2|||
126615799|NCT00529529|455551654|FG001|Overall Study|Death|0|||
126615800|NCT00529529|455551655|FG002|Overall Study|Death|0|||
126615801|NCT00529529|455551653|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126615802|NCT00529529|455551654|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126615803|NCT00529529|455551655|FG002|Overall Study|Abnormal test procedure result(s)|0|||
126615804|NCT00529529|455551653|FG000|Overall Study|Administrative problems|1|||
126615805|NCT00529529|455551654|FG001|Overall Study|Administrative problems|0|||
126741194|NCT02120352|456001387|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
126741195|NCT02120352|456001388|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
126781732|NCT00192296|456156253|FG003|Overall Study|Withdrawal by Subject|0|||
126781733|NCT02536378|456156254|FG000|Overall Study|Physician Decision|0|||
126781734|NCT02536378|456156255|FG001|Overall Study|Physician Decision|2|||
126615806|NCT00529529|455551655|FG002|Overall Study|Administrative problems|3|||
126615807|NCT01020435|455551656|FG000|Overall Study|Lost to Follow-up|0|||
126615808|NCT01020435|455551657|FG001|Overall Study|Lost to Follow-up|1|||
126615809|NCT00103857|455551658|FG000|54-Week Base Study|Adverse Event|12|||
126615810|NCT00103857|455551659|FG001|54-Week Base Study|Adverse Event|9|||
126615811|NCT00103857|455551660|FG002|54-Week Base Study|Adverse Event|11|||
126615812|NCT00103857|455551661|FG003|54-Week Base Study|Adverse Event|6|||
126615813|NCT00103857|455551662|FG004|54-Week Base Study|Adverse Event|5|||
126615814|NCT00103857|455551663|FG005|54-Week Base Study|Adverse Event|11|||
126615815|NCT00103857|455551664|FG006|54-Week Base Study|Adverse Event|3|||
126615816|NCT00103857|455551658|FG000|54-Week Base Study|Death|0|||
126615817|NCT00103857|455551659|FG001|54-Week Base Study|Death|0|||
126781735|NCT02536378|456156254|FG000|Overall Study|Withdrawal by Subject|0|||
126781736|NCT02536378|456156255|FG001|Overall Study|Withdrawal by Subject|1|||
126781737|NCT02536378|456156254|FG000|Overall Study|Death|1|||
126781738|NCT02536378|456156255|FG001|Overall Study|Death|2|||
126781739|NCT02536378|456156254|FG000|Overall Study|Patient refused further follow up|6|||
126781740|NCT02536378|456156255|FG001|Overall Study|Patient refused further follow up|2|||
126781741|NCT00617461|456156256|FG000|First Treatment Intervention Period|Adverse Event|2|||
126781742|NCT00617461|456156257|FG001|First Treatment Intervention Period|Adverse Event|0|||
126781743|NCT00617461|456156256|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
126615818|NCT00103857|455551660|FG002|54-Week Base Study|Death|0|||
126615819|NCT00103857|455551661|FG003|54-Week Base Study|Death|0|||
126615820|NCT00103857|455551662|FG004|54-Week Base Study|Death|1|||
126615821|NCT00103857|455551663|FG005|54-Week Base Study|Death|1|||
126615822|NCT00103857|455551664|FG006|54-Week Base Study|Death|0|||
126615823|NCT00103857|455551658|FG000|54-Week Base Study|Lack of Efficacy|11|||
126615824|NCT00103857|455551659|FG001|54-Week Base Study|Lack of Efficacy|14|||
126615825|NCT00103857|455551660|FG002|54-Week Base Study|Lack of Efficacy|8|||
126615826|NCT00103857|455551661|FG003|54-Week Base Study|Lack of Efficacy|4|||
126615827|NCT00103857|455551662|FG004|54-Week Base Study|Lack of Efficacy|3|||
126615828|NCT00103857|455551663|FG005|54-Week Base Study|Lack of Efficacy|14|||
126615829|NCT00103857|455551664|FG006|54-Week Base Study|Lack of Efficacy|19|||
126615830|NCT00103857|455551658|FG000|54-Week Base Study|Lost to Follow-up|5|||
126615831|NCT00103857|455551659|FG001|54-Week Base Study|Lost to Follow-up|4|||
126615832|NCT00103857|455551660|FG002|54-Week Base Study|Lost to Follow-up|7|||
126615833|NCT00103857|455551661|FG003|54-Week Base Study|Lost to Follow-up|5|||
126615834|NCT00103857|455551662|FG004|54-Week Base Study|Lost to Follow-up|10|||
126615835|NCT00103857|455551663|FG005|54-Week Base Study|Lost to Follow-up|9|||
126615836|NCT00103857|455551664|FG006|54-Week Base Study|Lost to Follow-up|3|||
126615837|NCT00103857|455551658|FG000|54-Week Base Study|Physician Decision|1|||
126615838|NCT00103857|455551659|FG001|54-Week Base Study|Physician Decision|1|||
126615839|NCT00103857|455551660|FG002|54-Week Base Study|Physician Decision|0|||
126615840|NCT00103857|455551661|FG003|54-Week Base Study|Physician Decision|0|||
126615841|NCT00103857|455551662|FG004|54-Week Base Study|Physician Decision|1|||
126615842|NCT00103857|455551663|FG005|54-Week Base Study|Physician Decision|0|||
126615843|NCT00103857|455551664|FG006|54-Week Base Study|Physician Decision|0|||
126615844|NCT00103857|455551658|FG000|54-Week Base Study|Pregnancy|1|||
126741196|NCT02120352|456001389|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
126741197|NCT02120352|456001390|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
126741198|NCT02120352|456001391|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
126741199|NCT02120352|456001392|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
126741200|NCT02120352|456001386|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
126741201|NCT02120352|456001387|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
126741202|NCT02120352|456001388|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
126615845|NCT00103857|455551659|FG001|54-Week Base Study|Pregnancy|0|||
126615846|NCT00103857|455551660|FG002|54-Week Base Study|Pregnancy|0|||
126615847|NCT00103857|455551661|FG003|54-Week Base Study|Pregnancy|0|||
126615848|NCT00103857|455551662|FG004|54-Week Base Study|Pregnancy|1|||
126615849|NCT00103857|455551663|FG005|54-Week Base Study|Pregnancy|0|||
126615850|NCT00103857|455551664|FG006|54-Week Base Study|Pregnancy|1|||
126741203|NCT02120352|456001389|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
126781744|NCT00617461|456156257|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
126615851|NCT00103857|455551658|FG000|54-Week Base Study|Protocol Violation|6|||
126615852|NCT00103857|455551659|FG001|54-Week Base Study|Protocol Violation|4|||
126615853|NCT00103857|455551660|FG002|54-Week Base Study|Protocol Violation|2|||
126615854|NCT00103857|455551661|FG003|54-Week Base Study|Protocol Violation|4|||
126615855|NCT00103857|455551662|FG004|54-Week Base Study|Protocol Violation|0|||
126615856|NCT00103857|455551663|FG005|54-Week Base Study|Protocol Violation|3|||
126615857|NCT00103857|455551664|FG006|54-Week Base Study|Protocol Violation|3|||
126615858|NCT00103857|455551658|FG000|54-Week Base Study|Withdrawal by Subject|17|||
126615859|NCT00103857|455551659|FG001|54-Week Base Study|Withdrawal by Subject|16|||
126781745|NCT00617461|456156256|FG000|First Treatment Intervention Period|Protocol Violation|2|||
126781746|NCT00617461|456156257|FG001|First Treatment Intervention Period|Protocol Violation|1|||
126615860|NCT00103857|455551660|FG002|54-Week Base Study|Withdrawal by Subject|16|||
126615861|NCT00103857|455551661|FG003|54-Week Base Study|Withdrawal by Subject|15|||
126615862|NCT00103857|455551662|FG004|54-Week Base Study|Withdrawal by Subject|10|||
126615863|NCT00103857|455551663|FG005|54-Week Base Study|Withdrawal by Subject|15|||
126615864|NCT00103857|455551664|FG006|54-Week Base Study|Withdrawal by Subject|4|||
126741204|NCT02120352|456001390|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
126741205|NCT02120352|456001391|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
126741206|NCT02120352|456001392|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
126741207|NCT02120352|456001386|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
126741208|NCT02120352|456001387|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
126741209|NCT02120352|456001388|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
126741210|NCT02120352|456001389|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
126741211|NCT02120352|456001390|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
126741212|NCT02120352|456001391|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
126741213|NCT02120352|456001392|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
126741214|NCT02120352|456001386|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
126741215|NCT02120352|456001387|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
126741216|NCT02120352|456001388|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
126741217|NCT02120352|456001389|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
126741218|NCT02120352|456001390|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
126741219|NCT02120352|456001391|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
126741220|NCT02120352|456001392|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
126741221|NCT02120352|456001386|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
126741222|NCT02120352|456001387|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
126741223|NCT02120352|456001388|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
126741224|NCT02120352|456001389|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
126741225|NCT02120352|456001390|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
126741226|NCT02120352|456001391|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
126741227|NCT02120352|456001392|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
126741228|NCT02427100|456001393|FG000|Overall Study|Lost to Follow-up|0|||
126741229|NCT02427100|456001394|FG001|Overall Study|Lost to Follow-up|2|||
126741230|NCT03094611|456001396|FG000|Overall Study|Lack of Efficacy|1|||
126741231|NCT03094611|456001396|FG000|Overall Study|Stem Cell Transplant|1|||
126741232|NCT00842361|456001397|FG000|Overall Study|Protocol Violation|1|||
126741233|NCT00842361|456001398|FG001|Overall Study|Protocol Violation|0|||
126741234|NCT00842361|456001397|FG000|Overall Study|Unclassified|0|||
126741235|NCT00842361|456001398|FG001|Overall Study|Unclassified|2|||
126741236|NCT00924729|456001406|FG000|Overall Study|insufficient volume for analysis|1|||
126741237|NCT00924729|456001407|FG001|Overall Study|insufficient volume for analysis|0|||
126741238|NCT00924729|456001406|FG000|Overall Study|Protocol Violation|1|||
126741239|NCT00924729|456001407|FG001|Overall Study|Protocol Violation|0|||
126741240|NCT00981747|456001410|FG000|Losartan|Withdrawal by Subject|1|||
126741241|NCT00981747|456001410|FG000|Losartan|Death|1|||
126741242|NCT00981747|456001410|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
126741243|NCT01814826|456001411|FG000|Overall Study|Other|3|||
126741244|NCT01814826|456001412|FG001|Overall Study|Other|5|||
126741245|NCT01814826|456001413|FG002|Overall Study|Other|0|||
126741246|NCT01814826|456001411|FG000|Overall Study|Death|29|||
126741247|NCT01814826|456001412|FG001|Overall Study|Death|24|||
126741248|NCT01814826|456001413|FG002|Overall Study|Death|3|||
126741249|NCT02917629|456001414|FG000|Overall Study|Withdrawal by Subject|0|||
126741250|NCT02917629|456001415|FG001|Overall Study|Withdrawal by Subject|1|||
126741251|NCT03339401|456001416|FG000|Overall Study|Death|2|||
126741252|NCT03339401|456001417|FG001|Overall Study|Death|1|||
126741253|NCT03339401|456001416|FG000|Overall Study|Withdrawal by Subject|2|||
126741254|NCT03339401|456001417|FG001|Overall Study|Withdrawal by Subject|0|||
126741255|NCT03339401|456001416|FG000|Overall Study|Study terminated|4|||
126741256|NCT03339401|456001417|FG001|Overall Study|Study terminated|3|||
126741257|NCT03339401|456001416|FG000|Overall Study|Investigator Decision|1|||
126741258|NCT03339401|456001417|FG001|Overall Study|Investigator Decision|0|||
126741259|NCT00718523|456001418|FG000|Overall Study|Withdrawal by Subject|5|||
126741260|NCT00718523|456001419|FG001|Overall Study|Withdrawal by Subject|7|||
126741261|NCT00718523|456001418|FG000|Overall Study|Death|13|||
126741262|NCT00718523|456001419|FG001|Overall Study|Death|17|||
126741263|NCT03271307|456001420|FG000|Overall Study|Lost to Follow-up|0|||
126741264|NCT03271307|456001421|FG001|Overall Study|Lost to Follow-up|0|||
126741265|NCT03271307|456001422|FG002|Overall Study|Lost to Follow-up|0|||
126741266|NCT03271307|456001423|FG003|Overall Study|Lost to Follow-up|28|||
126741267|NCT03271307|456001424|FG004|Overall Study|Lost to Follow-up|91|||
126741268|NCT03365947|456001425|FG000|Overall Study|Lost to Follow-up|0|||
126741269|NCT03365947|456001426|FG001|Overall Study|Lost to Follow-up|0|||
126741270|NCT03365947|456001427|FG002|Overall Study|Lost to Follow-up|0|||
126741271|NCT03365947|456001428|FG003|Overall Study|Lost to Follow-up|0|||
126741272|NCT03365947|456001429|FG004|Overall Study|Lost to Follow-up|0|||
126741273|NCT03365947|456001430|FG005|Overall Study|Lost to Follow-up|1|||
126741274|NCT03365947|456001431|FG006|Overall Study|Lost to Follow-up|0|||
126741275|NCT03365947|456001432|FG007|Overall Study|Lost to Follow-up|0|||
126741276|NCT03365947|456001433|FG008|Overall Study|Lost to Follow-up|0|||
126741277|NCT03365947|456001434|FG009|Overall Study|Lost to Follow-up|0|||
126741278|NCT03365947|456001435|FG010|Overall Study|Lost to Follow-up|0|||
126615865|NCT00103857|455551658|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
126615866|NCT00103857|455551659|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
126615867|NCT00103857|455551660|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
126615868|NCT00103857|455551661|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
126615869|NCT00103857|455551662|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
126615870|NCT00103857|455551663|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
126615871|NCT00103857|455551664|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
126615872|NCT00103857|455551658|FG000|54-Week Base Study|patient moved|0|||
126615873|NCT00103857|455551659|FG001|54-Week Base Study|patient moved|1|||
126615874|NCT00103857|455551660|FG002|54-Week Base Study|patient moved|1|||
126615875|NCT00103857|455551661|FG003|54-Week Base Study|patient moved|2|||
126615876|NCT00103857|455551662|FG004|54-Week Base Study|patient moved|3|||
126615877|NCT00103857|455551663|FG005|54-Week Base Study|patient moved|1|||
126615878|NCT00103857|455551664|FG006|54-Week Base Study|patient moved|0|||
126615879|NCT00103857|455551658|FG000|54-Week Base Study|non-compliance with study procedures|1|||
126615880|NCT00103857|455551659|FG001|54-Week Base Study|non-compliance with study procedures|2|||
126615881|NCT00103857|455551660|FG002|54-Week Base Study|non-compliance with study procedures|0|||
126615882|NCT00103857|455551661|FG003|54-Week Base Study|non-compliance with study procedures|0|||
126615883|NCT00103857|455551662|FG004|54-Week Base Study|non-compliance with study procedures|0|||
126615884|NCT00103857|455551663|FG005|54-Week Base Study|non-compliance with study procedures|2|||
126615885|NCT00103857|455551664|FG006|54-Week Base Study|non-compliance with study procedures|0|||
126615886|NCT00103857|455551658|FG000|54-Week Base Study|patient incarcerated|0|||
126615887|NCT00103857|455551659|FG001|54-Week Base Study|patient incarcerated|0|||
126615888|NCT00103857|455551660|FG002|54-Week Base Study|patient incarcerated|0|||
126615889|NCT00103857|455551661|FG003|54-Week Base Study|patient incarcerated|0|||
126615890|NCT00103857|455551662|FG004|54-Week Base Study|patient incarcerated|1|||
126615891|NCT00103857|455551663|FG005|54-Week Base Study|patient incarcerated|1|||
126615892|NCT00103857|455551664|FG006|54-Week Base Study|patient incarcerated|0|||
126615893|NCT00103857|455551658|FG000|54-Week Base Study|laboratory reporting error|0|||
126615894|NCT00103857|455551659|FG001|54-Week Base Study|laboratory reporting error|0|||
126615895|NCT00103857|455551660|FG002|54-Week Base Study|laboratory reporting error|0|||
126615896|NCT00103857|455551661|FG003|54-Week Base Study|laboratory reporting error|0|||
126615897|NCT00103857|455551662|FG004|54-Week Base Study|laboratory reporting error|1|||
126615898|NCT00103857|455551663|FG005|54-Week Base Study|laboratory reporting error|0|||
126615899|NCT00103857|455551664|FG006|54-Week Base Study|laboratory reporting error|0|||
126615900|NCT00103857|455551658|FG000|54-Week Base Study|site error|0|||
126615901|NCT00103857|455551659|FG001|54-Week Base Study|site error|0|||
126615902|NCT00103857|455551660|FG002|54-Week Base Study|site error|0|||
126615903|NCT00103857|455551661|FG003|54-Week Base Study|site error|0|||
126615904|NCT00103857|455551662|FG004|54-Week Base Study|site error|0|||
126615905|NCT00103857|455551663|FG005|54-Week Base Study|site error|1|||
126615906|NCT00103857|455551664|FG006|54-Week Base Study|site error|0|||
126615907|NCT00103857|455551658|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
126615908|NCT00103857|455551659|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
126615909|NCT00103857|455551660|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
126615910|NCT00103857|455551661|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
126615911|NCT00103857|455551662|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
126615912|NCT00103857|455551663|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
126615913|NCT00103857|455551664|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
126615914|NCT00103857|455551658|FG000|50-Week Extension Study|Adverse Event|2|||
126615915|NCT00103857|455551659|FG001|50-Week Extension Study|Adverse Event|3|||
126615916|NCT00103857|455551660|FG002|50-Week Extension Study|Adverse Event|2|||
126615917|NCT00103857|455551661|FG003|50-Week Extension Study|Adverse Event|0|||
126615918|NCT00103857|455551662|FG004|50-Week Extension Study|Adverse Event|1|||
126615919|NCT00103857|455551663|FG005|50-Week Extension Study|Adverse Event|1|||
126615920|NCT00103857|455551664|FG006|50-Week Extension Study|Adverse Event|0|||
126615921|NCT00103857|455551658|FG000|50-Week Extension Study|Death|0|||
126741279|NCT03365947|456001436|FG011|Overall Study|Lost to Follow-up|0|||
126741280|NCT03365947|456001437|FG012|Overall Study|Lost to Follow-up|0|||
126741281|NCT03365947|456001438|FG013|Overall Study|Lost to Follow-up|0|||
126741282|NCT03365947|456001439|FG014|Overall Study|Lost to Follow-up|0|||
126741283|NCT03365947|456001440|FG015|Overall Study|Lost to Follow-up|0|||
126741284|NCT03365947|456001441|FG016|Overall Study|Lost to Follow-up|0|||
126741285|NCT03365947|456001442|FG017|Overall Study|Lost to Follow-up|0|||
126741286|NCT03365947|456001443|FG018|Overall Study|Lost to Follow-up|0|||
126741287|NCT01042938|456001444|FG000|Overall Study|Withdrawal by Subject|1|||
126741288|NCT01042938|456001445|FG001|Overall Study|Withdrawal by Subject|1|||
126615922|NCT00103857|455551659|FG001|50-Week Extension Study|Death|0|||
126615923|NCT00103857|455551660|FG002|50-Week Extension Study|Death|0|||
126615924|NCT00103857|455551661|FG003|50-Week Extension Study|Death|1|||
126615925|NCT00103857|455551662|FG004|50-Week Extension Study|Death|0|||
126615926|NCT00103857|455551663|FG005|50-Week Extension Study|Death|1|||
126615927|NCT00103857|455551664|FG006|50-Week Extension Study|Death|0|||
126741289|NCT01042938|456001444|FG000|Overall Study|Protocol Violation|1|||
126741290|NCT01042938|456001445|FG001|Overall Study|Protocol Violation|1|||
126741291|NCT01042938|456001444|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
126741292|NCT01042938|456001445|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
126741293|NCT03136484|456001446|FG000|Overall Study|Withdrawal by Subject|19|||
126741294|NCT03136484|456001447|FG001|Overall Study|Withdrawal by Subject|14|||
126741295|NCT03136484|456001446|FG000|Overall Study|Lost to Follow-up|7|||
126741296|NCT03136484|456001447|FG001|Overall Study|Lost to Follow-up|8|||
126741297|NCT03136484|456001446|FG000|Overall Study|Death|1|||
126741298|NCT03136484|456001447|FG001|Overall Study|Death|0|||
126741299|NCT03997760|456001452|FG000|Overall Study|Protocol Deviation|0|||
126741300|NCT03997760|456001453|FG001|Overall Study|Protocol Deviation|1|||
126741301|NCT03997760|456001454|FG002|Overall Study|Protocol Deviation|0|||
126741302|NCT03997760|456001455|FG003|Overall Study|Protocol Deviation|0|||
126741303|NCT00856986|456001456|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
126741304|NCT00856986|456001457|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
126741305|NCT00856986|456001458|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
126741306|NCT00856986|456001459|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
126741307|NCT00856986|456001460|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
126741308|NCT00856986|456001456|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
126615928|NCT00103857|455551658|FG000|50-Week Extension Study|Lack of Efficacy|26|||
126741309|NCT00856986|456001457|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
126741310|NCT00856986|456001458|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
126741311|NCT00856986|456001459|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
126741312|NCT00856986|456001460|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
126741313|NCT00856986|456001456|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
126741314|NCT00856986|456001457|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
126741315|NCT00856986|456001458|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
126741316|NCT00856986|456001459|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
126741317|NCT00856986|456001460|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
126741318|NCT00856986|456001456|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
126741319|NCT00856986|456001457|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
126741320|NCT00856986|456001458|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
126741321|NCT00856986|456001459|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
126741322|NCT00856986|456001460|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
126741323|NCT00856986|456001456|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
126741324|NCT00856986|456001457|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
126741325|NCT00856986|456001458|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
126741326|NCT00856986|456001459|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
126741327|NCT00856986|456001460|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
126741328|NCT00856986|456001456|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
126741329|NCT00856986|456001457|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
126741330|NCT00856986|456001458|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
126741331|NCT00856986|456001459|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
126741332|NCT00856986|456001460|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
126741333|NCT00856986|456001456|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
126741334|NCT00856986|456001457|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
126741335|NCT00856986|456001458|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
126741336|NCT00856986|456001459|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
126741337|NCT00856986|456001460|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
126741338|NCT00856986|456001456|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
126741339|NCT00856986|456001457|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
126741340|NCT00856986|456001458|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
126741341|NCT00856986|456001459|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
126741342|NCT00856986|456001460|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
126741343|NCT00856986|456001456|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
126741344|NCT00856986|456001457|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
126741345|NCT00856986|456001458|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
126741346|NCT00856986|456001459|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
126741347|NCT00856986|456001460|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
126741348|NCT00856986|456001456|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
126741349|NCT00856986|456001457|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
126741350|NCT00856986|456001458|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
126741351|NCT00856986|456001459|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
126741352|NCT00856986|456001460|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
126741353|NCT00856986|456001456|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
126741354|NCT00856986|456001457|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
126741355|NCT00856986|456001458|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
126741356|NCT00856986|456001459|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
126741357|NCT00856986|456001460|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
126741358|NCT00856986|456001456|FG000|Main Period, Weeks 0-26|Unclassified|7|||
126741359|NCT00856986|456001457|FG001|Main Period, Weeks 0-26|Unclassified|6|||
126781747|NCT00617461|456156256|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
126781748|NCT00617461|456156257|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
126615929|NCT00103857|455551659|FG001|50-Week Extension Study|Lack of Efficacy|15|||
126615930|NCT00103857|455551660|FG002|50-Week Extension Study|Lack of Efficacy|13|||
126615931|NCT00103857|455551661|FG003|50-Week Extension Study|Lack of Efficacy|16|||
126615932|NCT00103857|455551662|FG004|50-Week Extension Study|Lack of Efficacy|8|||
126615933|NCT00103857|455551663|FG005|50-Week Extension Study|Lack of Efficacy|8|||
126615934|NCT00103857|455551664|FG006|50-Week Extension Study|Lack of Efficacy|0|||
126615935|NCT00103857|455551658|FG000|50-Week Extension Study|Lost to Follow-up|4|||
126615936|NCT00103857|455551659|FG001|50-Week Extension Study|Lost to Follow-up|0|||
126615937|NCT00103857|455551660|FG002|50-Week Extension Study|Lost to Follow-up|1|||
126615938|NCT00103857|455551661|FG003|50-Week Extension Study|Lost to Follow-up|4|||
126615939|NCT00103857|455551662|FG004|50-Week Extension Study|Lost to Follow-up|3|||
126615940|NCT00103857|455551663|FG005|50-Week Extension Study|Lost to Follow-up|3|||
126615941|NCT00103857|455551664|FG006|50-Week Extension Study|Lost to Follow-up|0|||
126615942|NCT00103857|455551658|FG000|50-Week Extension Study|Physician Decision|0|||
126615943|NCT00103857|455551659|FG001|50-Week Extension Study|Physician Decision|1|||
126615944|NCT00103857|455551660|FG002|50-Week Extension Study|Physician Decision|1|||
126615945|NCT00103857|455551661|FG003|50-Week Extension Study|Physician Decision|0|||
126615946|NCT00103857|455551662|FG004|50-Week Extension Study|Physician Decision|0|||
126615947|NCT00103857|455551663|FG005|50-Week Extension Study|Physician Decision|0|||
126615948|NCT00103857|455551664|FG006|50-Week Extension Study|Physician Decision|0|||
126615949|NCT00103857|455551658|FG000|50-Week Extension Study|Pregnancy|0|||
126615950|NCT00103857|455551659|FG001|50-Week Extension Study|Pregnancy|0|||
126615951|NCT00103857|455551660|FG002|50-Week Extension Study|Pregnancy|1|||
126615952|NCT00103857|455551661|FG003|50-Week Extension Study|Pregnancy|0|||
126615953|NCT00103857|455551662|FG004|50-Week Extension Study|Pregnancy|1|||
126615954|NCT00103857|455551663|FG005|50-Week Extension Study|Pregnancy|0|||
126615955|NCT00103857|455551664|FG006|50-Week Extension Study|Pregnancy|0|||
126615956|NCT00103857|455551658|FG000|50-Week Extension Study|Protocol Violation|1|||
126615957|NCT00103857|455551659|FG001|50-Week Extension Study|Protocol Violation|1|||
126615958|NCT00103857|455551660|FG002|50-Week Extension Study|Protocol Violation|1|||
126615959|NCT00103857|455551661|FG003|50-Week Extension Study|Protocol Violation|2|||
126615960|NCT00103857|455551662|FG004|50-Week Extension Study|Protocol Violation|0|||
126615961|NCT00103857|455551663|FG005|50-Week Extension Study|Protocol Violation|1|||
126615962|NCT00103857|455551664|FG006|50-Week Extension Study|Protocol Violation|0|||
126615963|NCT00103857|455551658|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
126615964|NCT00103857|455551659|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
126615965|NCT00103857|455551660|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
126615966|NCT00103857|455551661|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
126615967|NCT00103857|455551662|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
126615968|NCT00103857|455551663|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
126615969|NCT00103857|455551664|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
126615970|NCT00103857|455551658|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
126615971|NCT00103857|455551659|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
126615972|NCT00103857|455551660|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
126615973|NCT00103857|455551661|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
126615974|NCT00103857|455551662|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
126615975|NCT00103857|455551663|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
126615976|NCT00103857|455551664|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
126615977|NCT00103857|455551658|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
126615978|NCT00103857|455551659|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
126615979|NCT00103857|455551660|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
126615980|NCT00103857|455551661|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
126615981|NCT00103857|455551662|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
126615982|NCT00103857|455551663|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
126615983|NCT00103857|455551664|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
126615984|NCT00103857|455551658|FG000|50-Week Extension Study|patient moved|0|||
126615985|NCT00103857|455551659|FG001|50-Week Extension Study|patient moved|0|||
126615986|NCT00103857|455551660|FG002|50-Week Extension Study|patient moved|1|||
126615987|NCT00103857|455551661|FG003|50-Week Extension Study|patient moved|2|||
126615988|NCT00103857|455551662|FG004|50-Week Extension Study|patient moved|0|||
126615989|NCT00103857|455551663|FG005|50-Week Extension Study|patient moved|0|||
126615990|NCT00103857|455551664|FG006|50-Week Extension Study|patient moved|0|||
126615991|NCT00103857|455551658|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
126615992|NCT00103857|455551659|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
126615993|NCT00103857|455551660|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
126615994|NCT00103857|455551661|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
126615995|NCT00103857|455551662|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
126781749|NCT00617461|456156256|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
126615996|NCT00103857|455551663|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
126781750|NCT00617461|456156257|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
126741360|NCT00856986|456001458|FG002|Main Period, Weeks 0-26|Unclassified|7|||
126741361|NCT00856986|456001459|FG003|Main Period, Weeks 0-26|Unclassified|0|||
126741362|NCT00856986|456001460|FG004|Main Period, Weeks 0-26|Unclassified|0|||
126741363|NCT00856986|456001456|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
126741364|NCT00856986|456001457|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
126741365|NCT00856986|456001458|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
126741366|NCT00856986|456001459|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
126741367|NCT00856986|456001460|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
126741368|NCT00856986|456001456|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
126741369|NCT00856986|456001457|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
126741370|NCT00856986|456001458|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
126741371|NCT00856986|456001459|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
126741372|NCT00856986|456001460|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
126741373|NCT00856986|456001456|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
126741374|NCT00856986|456001457|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
126741375|NCT00856986|456001458|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
126741376|NCT00856986|456001459|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
126741377|NCT00856986|456001460|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
126741378|NCT00856986|456001456|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
126741379|NCT00856986|456001457|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
126741380|NCT00856986|456001458|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
126741381|NCT00856986|456001459|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
126741382|NCT00856986|456001460|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
126741383|NCT00856986|456001456|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
126741384|NCT00856986|456001457|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
126741385|NCT00856986|456001458|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
126741386|NCT00856986|456001459|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
126741387|NCT00856986|456001460|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
126741388|NCT00856986|456001456|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
126741389|NCT00856986|456001457|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
126741390|NCT00856986|456001458|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
126741391|NCT00856986|456001459|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
126741392|NCT00856986|456001460|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
126741393|NCT05041062|456001461|FG000|Overall Study|Adverse Event|2|||
126741394|NCT04018612|456001462|FG000|Overall Study|Withdrawal by Subject|1|||
126741395|NCT04018612|456001463|FG001|Overall Study|Withdrawal by Subject|0|||
126741396|NCT04018612|456001464|FG002|Overall Study|Withdrawal by Subject|1|||
126741397|NCT01915095|456001465|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
126741398|NCT01915095|456001466|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
126741399|NCT01915095|456001467|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
126741400|NCT01915095|456001468|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
126741401|NCT01915095|456001469|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
126741402|NCT02671760|456001473|FG000|Overall Study|Lost to Follow-up|0|||
126741403|NCT02671760|456001474|FG001|Overall Study|Lost to Follow-up|1|||
126741404|NCT02671760|456001475|FG002|Overall Study|Lost to Follow-up|0|||
126741405|NCT02999191|456001476|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
126741406|NCT02999191|456001477|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
126741407|NCT02999191|456001478|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
126741408|NCT01802515|456001485|FG000|Overall Study|Withdrawal by Subject|3|||
126741409|NCT01802515|456001486|FG001|Overall Study|Withdrawal by Subject|0|||
126741410|NCT01802515|456001487|FG002|Overall Study|Withdrawal by Subject|0|||
126741411|NCT01176240|456001490|FG000|Study 306A|Lack of Efficacy|2|||
126741412|NCT01176240|456001491|FG001|Study 306A|Lack of Efficacy|1|||
126741413|NCT01176240|456001490|FG000|Study 306A|Protocol Violation|0|||
126741414|NCT01176240|456001491|FG001|Study 306A|Protocol Violation|1|||
126741415|NCT01176240|456001490|FG000|Study 306A|Withdrawal by Subject|0|||
126741416|NCT01176240|456001491|FG001|Study 306A|Withdrawal by Subject|1|||
126741417|NCT01176240|456001490|FG000|Study 306A|Stop due to diverse problems|1|||
126741418|NCT01176240|456001491|FG001|Study 306A|Stop due to diverse problems|0|||
126741419|NCT01176240|456001490|FG000|Study 306B|Lack of Efficacy|5|||
126741420|NCT01176240|456001491|FG001|Study 306B|Lack of Efficacy|3|||
126741421|NCT01176240|456001490|FG000|Study 306B|Adverse Event|10|||
126741422|NCT01176240|456001491|FG001|Study 306B|Adverse Event|5|||
126741423|NCT01176240|456001490|FG000|Study 306B|Protocol Violation|2|||
126741424|NCT01176240|456001491|FG001|Study 306B|Protocol Violation|3|||
126741425|NCT01176240|456001490|FG000|Study 306B|Withdrawal by Subject|4|||
126741426|NCT01176240|456001491|FG001|Study 306B|Withdrawal by Subject|1|||
126741427|NCT01176240|456001490|FG000|Study 306B|Physician Decision|2|||
126741428|NCT01176240|456001491|FG001|Study 306B|Physician Decision|1|||
126741429|NCT01176240|456001490|FG000|Study 306B|Supine Hypertension|1|||
126741430|NCT01176240|456001491|FG001|Study 306B|Supine Hypertension|2|||
126741431|NCT01176240|456001490|FG000|Study 306B|Lost to Follow-up|0|||
126615997|NCT00103857|455551664|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
126741432|NCT01176240|456001491|FG001|Study 306B|Lost to Follow-up|1|||
126741433|NCT01176240|456001490|FG000|Study 306B|withdrew prior to dosing|2|||
126741434|NCT01176240|456001491|FG001|Study 306B|withdrew prior to dosing|1|||
126741435|NCT03038672|456003002|FG000|Initial Treatment|Unacceptable chemistry|0|||
126741436|NCT03038672|456003003|FG001|Initial Treatment|Unacceptable chemistry|1|||
126741437|NCT03038672|456003002|FG000|Initial Treatment|Progression prior to treatment|1|||
126741438|NCT03038672|456003003|FG001|Initial Treatment|Progression prior to treatment|0|||
126741439|NCT03038672|456003002|FG000|Initial Treatment|No treatment per protocol|1|||
126741440|NCT03038672|456003003|FG001|Initial Treatment|No treatment per protocol|0|||
126741441|NCT00959894|456003004|FG000|Overall Study|Lost to Follow-up|10|||
126741442|NCT00959894|456003004|FG000|Overall Study|Adverse Event|3|||
126741443|NCT00959894|456003004|FG000|Overall Study|Withdrawal by Subject|1|||
126741444|NCT00959894|456003004|FG000|Overall Study|Need for contraindicated medication|1|||
126741445|NCT00959894|456003004|FG000|Overall Study|Subject moved out of town|1|||
126741446|NCT01305941|456003005|FG000|Overall Study|Adverse Event|6|||
126741447|NCT01305941|456003005|FG000|Overall Study|Clinical decline|2|||
126741448|NCT01305941|456003005|FG000|Overall Study|Withdrawal by Subject|1|||
126741449|NCT01305941|456003005|FG000|Overall Study|Death|1|||
126741450|NCT02892734|456003006|FG000|Treatment on Study|Progressive Disease|2|||
126741451|NCT02892734|456003006|FG000|Follow up for 2 Years|Death|2|||
126741452|NCT02892734|456003006|FG000|Follow up for 2 Years|Study closed early|1|||
126741453|NCT02043509|456003007|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
126741454|NCT02043509|456003008|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
126741455|NCT02043509|456003007|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
126741456|NCT02043509|456003008|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
126741457|NCT02043509|456003007|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
126741458|NCT02043509|456003008|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
126741459|NCT02043509|456003007|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
126741460|NCT02043509|456003008|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
126741461|NCT00608244|456003013|FG000|Overall Study|Adverse Event|1|||
126741462|NCT00608244|456003013|FG000|Overall Study|Low trough levels|1|||
126741463|NCT01495689|456003021|FG000|Overall Study|Death|0|||
126741464|NCT01495689|456003022|FG001|Overall Study|Death|1|||
126741465|NCT01495689|456003021|FG000|Overall Study|Withdrawal by Subject|3|||
126741466|NCT01495689|456003022|FG001|Overall Study|Withdrawal by Subject|0|||
126741467|NCT01495689|456003021|FG000|Overall Study|Lost to Follow-up|7|||
126741468|NCT01495689|456003022|FG001|Overall Study|Lost to Follow-up|6|||
126741469|NCT00254163|456003023|FG000|Overall Study|Adverse Event|29|||
126741470|NCT00254163|456003024|FG001|Overall Study|Adverse Event|26|||
126741471|NCT00254163|456003023|FG000|Overall Study|Patient request/withdrew consent|6|||
126741472|NCT00254163|456003024|FG001|Overall Study|Patient request/withdrew consent|4|||
126741473|NCT00254163|456003023|FG000|Overall Study|Investigator request|1|||
126741474|NCT00254163|456003024|FG001|Overall Study|Investigator request|3|||
126741475|NCT00254163|456003023|FG000|Overall Study|Failed entry|1|||
126741476|NCT00254163|456003024|FG001|Overall Study|Failed entry|3|||
126741477|NCT00254163|456003023|FG000|Overall Study|Progressive disease|0|||
126741478|NCT00254163|456003024|FG001|Overall Study|Progressive disease|1|||
126741479|NCT00254163|456003023|FG000|Overall Study|Death|0|||
126741480|NCT00254163|456003024|FG001|Overall Study|Death|1|||
126741481|NCT00254163|456003023|FG000|Overall Study|Other|8|||
126741482|NCT00254163|456003024|FG001|Overall Study|Other|8|||
126741483|NCT00606177|456003027|FG000|Overall Study|Adverse Event|9|||
126741484|NCT00606177|456003028|FG001|Overall Study|Adverse Event|5|||
126741485|NCT00606177|456003027|FG000|Overall Study|Lack of Efficacy|3|||
126741486|NCT00606177|456003028|FG001|Overall Study|Lack of Efficacy|7|||
126741487|NCT00606177|456003027|FG000|Overall Study|Physician Decision|1|||
126741488|NCT00606177|456003028|FG001|Overall Study|Physician Decision|0|||
126741489|NCT00606177|456003027|FG000|Overall Study|Protocol Violation|1|||
126741490|NCT00606177|456003028|FG001|Overall Study|Protocol Violation|4|||
126615998|NCT00103857|455551658|FG000|50-Week Extension Study|reason unspecified|0|||
126615999|NCT00103857|455551659|FG001|50-Week Extension Study|reason unspecified|0|||
126616000|NCT00103857|455551660|FG002|50-Week Extension Study|reason unspecified|0|||
126616001|NCT00103857|455551661|FG003|50-Week Extension Study|reason unspecified|0|||
126616002|NCT00103857|455551662|FG004|50-Week Extension Study|reason unspecified|1|||
126616003|NCT00103857|455551663|FG005|50-Week Extension Study|reason unspecified|0|||
126741491|NCT00606177|456003027|FG000|Overall Study|Withdrawal by Subject|5|||
126741492|NCT00606177|456003028|FG001|Overall Study|Withdrawal by Subject|6|||
126741493|NCT00606177|456003027|FG000|Overall Study|Progression to depressive phase|6|||
126741494|NCT00606177|456003028|FG001|Overall Study|Progression to depressive phase|1|||
126741495|NCT00606177|456003027|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
126781751|NCT00617461|456156256|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
126741496|NCT00606177|456003028|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
126781752|NCT00617461|456156257|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
126616004|NCT00103857|455551664|FG006|50-Week Extension Study|reason unspecified|0|||
126781753|NCT00617461|456156256|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
126741497|NCT00606177|456003027|FG000|Overall Study|Change of residence or other commitments|1|||
126741498|NCT00606177|456003028|FG001|Overall Study|Change of residence or other commitments|1|||
126741499|NCT00136357|456003029|FG000|Overall Study|Withdrawal by Subject|3|||
126741500|NCT00136357|456003030|FG001|Overall Study|Withdrawal by Subject|2|||
126741501|NCT00216086|456003038|FG000|Overall Study|Protocol Violation|1|||
126741502|NCT00216086|456003038|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
126741503|NCT00216086|456003038|FG000|Overall Study|Social Reasons|2|||
126741504|NCT01784211|456003039|FG000|Part A (Days 1-15)|Adverse Event|1|||
126741505|NCT01784211|456003040|FG001|Part A (Days 1-15)|Adverse Event|1|||
126741506|NCT01784211|456003041|FG002|Part A (Days 1-15)|Adverse Event|0|||
126741507|NCT01784211|456003042|FG003|Part A (Days 1-15)|Adverse Event|0|||
126741508|NCT01784211|456003043|FG004|Part A (Days 1-15)|Adverse Event|0|||
126741509|NCT01784211|456003044|FG005|Part A (Days 1-15)|Adverse Event|0|||
126741510|NCT01784211|456003039|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
126741511|NCT01784211|456003040|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
126741512|NCT01784211|456003041|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
126741513|NCT01784211|456003042|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
126741514|NCT01784211|456003043|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
126741515|NCT01784211|456003044|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
126741516|NCT01001572|456003045|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
126741517|NCT01001572|456003046|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
126741518|NCT01001572|456003047|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
126741519|NCT01001572|456003045|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
126741520|NCT01001572|456003046|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
126741521|NCT01001572|456003047|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
126741522|NCT01001572|456003045|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
126741523|NCT01001572|456003046|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
126741524|NCT01001572|456003047|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
126741525|NCT01001572|456003045|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
126741526|NCT01001572|456003046|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
126741527|NCT01001572|456003047|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
126741528|NCT01001572|456003045|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
126741529|NCT01001572|456003046|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
126741530|NCT01001572|456003047|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
126741531|NCT01001572|456003045|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
126741532|NCT01001572|456003046|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
126741533|NCT01001572|456003047|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
126741534|NCT01001572|456003045|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
126741535|NCT01001572|456003046|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
126741536|NCT01001572|456003047|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
126741537|NCT01001572|456003045|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
126741538|NCT01001572|456003046|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
126741539|NCT01001572|456003047|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
126741540|NCT01001572|456003045|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
126741541|NCT01001572|456003046|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
126741542|NCT01001572|456003047|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
126741543|NCT01001572|456003045|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126741544|NCT01001572|456003046|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
126741545|NCT01001572|456003047|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
126741546|NCT01001572|456003045|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
126741547|NCT01001572|456003046|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
126741548|NCT01001572|456003047|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
126741549|NCT01001572|456003045|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
126741550|NCT01001572|456003046|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
126741551|NCT01001572|456003047|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
126741552|NCT01001572|456003045|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
126741553|NCT01001572|456003046|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
126741554|NCT01001572|456003047|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
126741555|NCT01001572|456003045|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126741556|NCT01001572|456003046|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126741557|NCT01001572|456003047|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
126616005|NCT02132195|455551667|FG000|Initial Assignment|Relapsed|14|||
126616006|NCT02132195|455551668|FG001|Initial Assignment|Relapsed|0|||
126741558|NCT02025530|456003050|FG000|Overall Study|No longer met elligibility criteria|5|||
126741559|NCT02025530|456003051|FG001|Overall Study|No longer met elligibility criteria|1|||
126741560|NCT03551626|456003058|FG000|Overall Study|Adverse Event|88|||
126741561|NCT03551626|456003058|FG000|Overall Study|Disease relapse|18|||
126741562|NCT03551626|456003058|FG000|Overall Study|Withdrawal of informed consent|6|||
126616007|NCT02132195|455551669|FG002|Initial Assignment|Relapsed|0|||
126616008|NCT02132195|455551667|FG000|Rescue Therapy|Relapsed|0|||
126616009|NCT02132195|455551668|FG001|Rescue Therapy|Relapsed|0|||
126616010|NCT02132195|455551669|FG002|Rescue Therapy|Relapsed|7|||
126741563|NCT03551626|456003058|FG000|Overall Study|Patient decision|5|||
126741564|NCT03551626|456003058|FG000|Overall Study|Physician Decision|4|||
126741565|NCT03551626|456003058|FG000|Overall Study|Lost to Follow-up|3|||
126741566|NCT03551626|456003058|FG000|Overall Study|Pregnancy|1|||
126741567|NCT03551626|456003058|FG000|Overall Study|Protocol deviation|1|||
126741568|NCT03551626|456003058|FG000|Overall Study|Technical problems|1|||
126741569|NCT04211961|456003059|FG000|Overall Study|Death|0|||
126741570|NCT04211961|456003060|FG001|Overall Study|Death|1|||
126741571|NCT04211961|456003059|FG000|Overall Study|Lost to Follow-up|0|||
126741572|NCT04211961|456003060|FG001|Overall Study|Lost to Follow-up|1|||
126741573|NCT04211961|456003059|FG000|Overall Study|Withdrawal by Subject|0|||
126741574|NCT04211961|456003060|FG001|Overall Study|Withdrawal by Subject|1|||
126741575|NCT05784129|456003061|FG000|Overall Study|Study terminated by sponsor|2|||
126741576|NCT05784129|456003062|FG001|Overall Study|Study terminated by sponsor|2|||
126741577|NCT01156363|456003063|FG000|Overall Study|Adverse Event|6|||
126741578|NCT01156363|456003063|FG000|Overall Study|Insufficient Therapeutic Response|5|||
126741579|NCT01156363|456003063|FG000|Overall Study|Failure to Return|1|||
126741580|NCT01156363|456003063|FG000|Overall Study|Refused Treatment|4|||
126741581|NCT01156363|456003063|FG000|Overall Study|Other|6|||
126741582|NCT04882072|456003070|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
126741583|NCT04882072|456003071|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
126741584|NCT04882072|456003070|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
126741585|NCT04882072|456003071|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
126741586|NCT04882072|456003070|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
126741587|NCT04882072|456003071|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
126741588|NCT02918318|456003072|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
126741589|NCT02918318|456003073|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
126741590|NCT02918318|456003074|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
126741591|NCT02918318|456003075|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
126741592|NCT02918318|456003076|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
126741593|NCT02918318|456003072|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
126741594|NCT02918318|456003073|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
126741595|NCT02918318|456003074|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
126741596|NCT02918318|456003075|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
126741597|NCT02918318|456003076|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
126741598|NCT02918318|456003072|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
126741599|NCT02918318|456003073|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
126741600|NCT02918318|456003074|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
126741601|NCT02918318|456003075|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
126741602|NCT02918318|456003076|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
126741603|NCT02918318|456003072|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
126741604|NCT02918318|456003073|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
126741605|NCT02918318|456003074|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
126741606|NCT02918318|456003075|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
126741607|NCT02918318|456003076|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
126741608|NCT02918318|456003072|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
126741609|NCT02918318|456003073|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
126741610|NCT02918318|456003074|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
126741611|NCT02918318|456003075|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
126741612|NCT02918318|456003076|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
126741613|NCT02918318|456003072|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
126741614|NCT02918318|456003073|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
126741615|NCT02918318|456003074|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
126781754|NCT00617461|456156257|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
126616011|NCT02132195|455551667|FG000|Rescue Therapy|Physician Decision|0|||
126616012|NCT02132195|455551668|FG001|Rescue Therapy|Physician Decision|0|||
126616013|NCT02132195|455551669|FG002|Rescue Therapy|Physician Decision|1|||
126741616|NCT02918318|456003075|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
126741617|NCT02918318|456003076|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
126741618|NCT02918318|456003072|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
126741619|NCT02918318|456003073|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
126741620|NCT02918318|456003074|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
126741621|NCT02918318|456003075|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
126741622|NCT02918318|456003076|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
126741623|NCT02918318|456003072|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
126741624|NCT02918318|456003073|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
126616014|NCT02132195|455551667|FG000|Rescue Therapy|Withdrawal by Subject|0|||
126781755|NCT00617461|456156256|FG000|Second Treatment Intervention Period|Adverse Event|0|||
126781756|NCT00617461|456156257|FG001|Second Treatment Intervention Period|Adverse Event|1|||
126781757|NCT00617461|456156256|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
126781758|NCT00617461|456156257|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
126781759|NCT00617461|456156256|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
126781760|NCT00617461|456156257|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
126781761|NCT00617461|456156256|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
126781762|NCT00617461|456156257|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
126616015|NCT02132195|455551668|FG001|Rescue Therapy|Withdrawal by Subject|0|||
126616016|NCT02132195|455551669|FG002|Rescue Therapy|Withdrawal by Subject|1|||
126616017|NCT02132195|455551667|FG000|Rescue Therapy|Adverse Event|0|||
126616018|NCT02132195|455551668|FG001|Rescue Therapy|Adverse Event|0|||
126616019|NCT02132195|455551669|FG002|Rescue Therapy|Adverse Event|2|||
126616020|NCT03065400|455551672|FG000|Overall Study|Adverse Event|1|||
126616021|NCT03065400|455551672|FG000|Overall Study|Physician Decision|3|||
126616022|NCT03065400|455551672|FG000|Overall Study|Withdrawal by Subject|1|||
126616023|NCT03065400|455551672|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
126616024|NCT02102724|455551673|FG000|Overall Study|Lost to Follow-up|1|||
126616025|NCT02102724|455551674|FG001|Overall Study|Lost to Follow-up|0|||
126616026|NCT02102724|455551673|FG000|Overall Study|surgery for brain aneurysm|1|||
126616027|NCT02102724|455551674|FG001|Overall Study|surgery for brain aneurysm|1|||
126616028|NCT03072862|455551675|FG000|Overall Study|Withdrawal by Subject|4|||
126616029|NCT03072862|455551675|FG000|Overall Study|Lost to Follow-up|6|||
126616030|NCT03072862|455551675|FG000|Overall Study|Protocol Violation|4|||
126616031|NCT03072862|455551675|FG000|Overall Study|Physician Decision|2|||
126616032|NCT03072862|455551675|FG000|Overall Study|Death|1|||
126616033|NCT03072862|455551675|FG000|Overall Study|Adverse Event|1|||
126616034|NCT02203513|455551676|FG000|Overall Study|Refused further treatment|2|||
126616035|NCT02203513|455551677|FG001|Overall Study|Refused further treatment|0|||
126616036|NCT02203513|455551678|FG002|Overall Study|Refused further treatment|1|||
126616037|NCT02203513|455551679|FG003|Overall Study|Refused further treatment|0|||
126616038|NCT02203513|455551680|FG004|Overall Study|Refused further treatment|0|||
126616039|NCT02203513|455551676|FG000|Overall Study|Switched to alternative treatment|3|||
126616040|NCT02203513|455551677|FG001|Overall Study|Switched to alternative treatment|4|||
126616041|NCT02203513|455551678|FG002|Overall Study|Switched to alternative treatment|0|||
126616042|NCT02203513|455551679|FG003|Overall Study|Switched to alternative treatment|0|||
126616043|NCT02203513|455551680|FG004|Overall Study|Switched to alternative treatment|4|||
126616044|NCT02203513|455551676|FG000|Overall Study|Did not receive investigational product (IP)|0|||
126616045|NCT02203513|455551677|FG001|Overall Study|Did not receive investigational product (IP)|1|||
126616046|NCT02203513|455551678|FG002|Overall Study|Did not receive investigational product (IP)|0|||
126616047|NCT02203513|455551679|FG003|Overall Study|Did not receive investigational product (IP)|0|||
126616048|NCT02203513|455551680|FG004|Overall Study|Did not receive investigational product (IP)|0|||
126616049|NCT02203513|455551676|FG000|Overall Study|Death (unrelated to study therapy)|1|||
126616050|NCT02203513|455551677|FG001|Overall Study|Death (unrelated to study therapy)|3|||
126616051|NCT02203513|455551678|FG002|Overall Study|Death (unrelated to study therapy)|1|||
126616052|NCT02203513|455551679|FG003|Overall Study|Death (unrelated to study therapy)|0|||
126616053|NCT02203513|455551680|FG004|Overall Study|Death (unrelated to study therapy)|2|||
126616054|NCT02203513|455551676|FG000|Overall Study|Lost to Follow-up|0|||
126616055|NCT02203513|455551677|FG001|Overall Study|Lost to Follow-up|0|||
126616056|NCT02203513|455551678|FG002|Overall Study|Lost to Follow-up|1|||
126616057|NCT02203513|455551679|FG003|Overall Study|Lost to Follow-up|1|||
126616058|NCT02203513|455551680|FG004|Overall Study|Lost to Follow-up|0|||
126616059|NCT02513667|455551681|FG000|Overall Study|Withdrawal by Subject|0|||
126616060|NCT02513667|455551682|FG001|Overall Study|Withdrawal by Subject|1|||
126616061|NCT00912964|455551691|FG000|Overall Study|Eligibility criterion not met|1|||
126616062|NCT00912964|455551692|FG001|Overall Study|Eligibility criterion not met|1|||
126616063|NCT00912964|455551693|FG002|Overall Study|Eligibility criterion not met|0|||
126616064|NCT00912964|455551691|FG000|Overall Study|Adverse Event|15|||
126616065|NCT00912964|455551692|FG001|Overall Study|Adverse Event|18|||
126616066|NCT00912964|455551693|FG002|Overall Study|Adverse Event|12|||
126616067|NCT00912964|455551691|FG000|Overall Study|Lack of Efficacy|11|||
126616068|NCT00912964|455551692|FG001|Overall Study|Lack of Efficacy|4|||
126616069|NCT00912964|455551693|FG002|Overall Study|Lack of Efficacy|3|||
126616070|NCT00912964|455551691|FG000|Overall Study|Withdrawal by Subject|20|||
126616071|NCT00912964|455551692|FG001|Overall Study|Withdrawal by Subject|12|||
126781763|NCT00457665|456156258|FG000|12 Months|Drug allergy|1|||
126616072|NCT00912964|455551693|FG002|Overall Study|Withdrawal by Subject|18|||
126616073|NCT00912964|455551691|FG000|Overall Study|Lost to Follow-up|4|||
126616074|NCT00912964|455551692|FG001|Overall Study|Lost to Follow-up|3|||
126616075|NCT00912964|455551693|FG002|Overall Study|Lost to Follow-up|3|||
126616076|NCT00912964|455551691|FG000|Overall Study|Protocol Violation|5|||
126616077|NCT00912964|455551692|FG001|Overall Study|Protocol Violation|3|||
126616078|NCT00912964|455551693|FG002|Overall Study|Protocol Violation|8|||
126616079|NCT00912964|455551691|FG000|Overall Study|Taking exclusionary medications|7|||
126741625|NCT02918318|456003074|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
126741626|NCT02918318|456003075|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
126741627|NCT02918318|456003076|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
126741628|NCT02918318|456003072|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
126741629|NCT02918318|456003073|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
126741630|NCT02918318|456003074|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
126741631|NCT02918318|456003075|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
126741632|NCT02918318|456003076|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
126741633|NCT02918318|456003072|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
126741634|NCT02918318|456003073|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
126741635|NCT02918318|456003074|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
126741636|NCT02918318|456003075|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
126741637|NCT02918318|456003076|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
126741638|NCT02918318|456003072|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
126741639|NCT02918318|456003073|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
126741640|NCT02918318|456003074|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
126741641|NCT02918318|456003075|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
126741642|NCT02918318|456003076|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
126741643|NCT02918318|456003072|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
126741644|NCT02918318|456003073|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
126741645|NCT02918318|456003074|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
126741646|NCT02918318|456003075|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
126741647|NCT02918318|456003076|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
126741648|NCT00045630|456003078|FG000|Overall Study|Adverse Event|1|||
126741649|NCT00045630|456003078|FG000|Overall Study|Refusal unrelated to adverse event|1|||
126741650|NCT00045630|456003078|FG000|Overall Study|Progression/relapse|1|||
126741651|NCT00045630|456003078|FG000|Overall Study|Death|1|||
126741652|NCT00045630|456003078|FG000|Overall Study|Ineligible|2|||
126741653|NCT02023112|456003083|FG000|Overall Study|Withdrawal by Subject|2|||
126741654|NCT02023112|456003084|FG001|Overall Study|Withdrawal by Subject|1|||
126741655|NCT02067533|456003088|FG000|Overall Study|Lost to Follow-up|4|||
126741656|NCT02067533|456003089|FG001|Overall Study|Lost to Follow-up|2|||
126741657|NCT02566109|456003090|FG000|Overall Study|Withdrawal by Subject|1|||
126741658|NCT01906476|456003091|FG000|Overall Study|Lost to Follow-up|17|||
126741659|NCT01906476|456003092|FG001|Overall Study|Lost to Follow-up|16|||
126741660|NCT01993667|456003093|FG000|Overall Study|Insufficient data to analyze|16|||
126741661|NCT01993667|456003094|FG001|Overall Study|Insufficient data to analyze|16|||
126741662|NCT01993667|456003093|FG000|Overall Study|Insufficient altitude reached|3|||
126741663|NCT01993667|456003094|FG001|Overall Study|Insufficient altitude reached|1|||
126741664|NCT01993667|456003093|FG000|Overall Study|Lost to Follow-up|2|||
126741665|NCT01993667|456003094|FG001|Overall Study|Lost to Follow-up|2|||
126741666|NCT01931150|456003095|FG000|Overall Study|Withdrawal by Subject|1|||
126741667|NCT01931150|456003096|FG001|Overall Study|Withdrawal by Subject|2|||
126741668|NCT02896192|456003100|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
126741669|NCT02896192|456003100|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
126741670|NCT02896192|456003100|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
126741671|NCT00479167|456003107|FG000|Overall Study|Withdrawal by Subject|1|||
126741672|NCT01997281|456003112|FG000|Overall Study|Withdrawal by Subject|1|||
126741673|NCT01997281|456003113|FG001|Overall Study|Withdrawal by Subject|0|||
126741674|NCT00560794|456003114|FG000|Overall Study|Adverse Event|2|||
126741675|NCT00560794|456003114|FG000|Overall Study|Patient was not Compliant|1|||
126616080|NCT00912964|455551692|FG001|Overall Study|Taking exclusionary medications|4|||
126741676|NCT00560794|456003114|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
126741677|NCT00560794|456003114|FG000|Overall Study|Hematological Relapse|1|||
126741678|NCT00560794|456003114|FG000|Overall Study|Received Bone Marrow Transplant|6|||
126741679|NCT04857892|456003115|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
126741680|NCT04857892|456003116|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
126741681|NCT04857892|456003117|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
126741682|NCT04857892|456003118|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
126741683|NCT04857892|456003119|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
126741684|NCT04857892|456003115|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
126741685|NCT04857892|456003116|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
126741686|NCT04857892|456003117|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
126741687|NCT04857892|456003118|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
126741688|NCT04857892|456003119|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
126741689|NCT04857892|456003115|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
126741690|NCT04857892|456003116|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
126741691|NCT04857892|456003117|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
126741692|NCT04857892|456003118|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
126741693|NCT04857892|456003119|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
126741694|NCT01390038|456003120|FG000|Overall Study|Death|1|||
126741695|NCT01390038|456003120|FG000|Overall Study|Lost to Follow-up|1|||
126741696|NCT01390038|456003120|FG000|Overall Study|Withdrawal by Subject|4|||
126741697|NCT01390038|456003120|FG000|Overall Study|Simpliciti System Removal|2|||
126741698|NCT00368472|456003127|FG000|Overall Study|Adverse Event|22|||
126741699|NCT00368472|456003127|FG000|Overall Study|Medication non-compliance|4|||
126741700|NCT00368472|456003127|FG000|Overall Study|Protocol Violation|2|||
126741701|NCT00368472|456003127|FG000|Overall Study|Request of Investigator or Sponsor|3|||
126741702|NCT00368472|456003127|FG000|Overall Study|Withdrawal by Subject|40|||
126741703|NCT00368472|456003127|FG000|Overall Study|Diary non-compliance|1|||
126741704|NCT00368472|456003127|FG000|Overall Study|Other|32|||
126741705|NCT00368472|456003127|FG000|Overall Study|Missing Final Disposition Date|1|||
126741706|NCT04095793|456003131|FG000|Overall Study|Adverse Event|3|||
126741707|NCT04095793|456003131|FG000|Overall Study|Study Terminated by Sponsor|103|||
126741708|NCT04095793|456003131|FG000|Overall Study|Withdrawal by Subject|4|||
126741709|NCT03619837|456003132|FG000|Screening|received organs from HCV-negative donors|47|||
126741710|NCT03619837|456003132|FG000|Screening|died on the wait-list|2|||
126741711|NCT03619837|456003132|FG000|Screening|remained on the wait list|40|||
126741712|NCT03619837|456003132|FG000|Screening|didn't meet eligibility criteria|3|||
126741713|NCT03619837|456003132|FG000|Screening|withdrew consent|2|||
126741714|NCT03619837|456003132|FG000|Screening|never listed for HCV-viremic donor|1|||
126741715|NCT03619837|456003132|FG000|Screening|developed exclusion criteria|2|||
126741716|NCT03619837|456003132|FG000|Screening|excluded by the investigator due to non-compliance|1|||
126741717|NCT02384993|456003133|FG000|Overall Study|Adverse Event|0|||
126741718|NCT02384993|456003134|FG001|Overall Study|Adverse Event|1|||
126741719|NCT00807014|456003138|FG000|Overall Study|Participant Considered Disease Cured|13|||
126741720|NCT00807014|456003139|FG001|Overall Study|Participant Considered Disease Cured|2|||
126741721|NCT00807014|456003138|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
126741722|NCT00807014|456003139|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
126741723|NCT00807014|456003138|FG000|Overall Study|Protocol Violation|2|||
126741724|NCT00807014|456003139|FG001|Overall Study|Protocol Violation|8|||
126741725|NCT00807014|456003138|FG000|Overall Study|Adverse Event|0|||
126741726|NCT00807014|456003139|FG001|Overall Study|Adverse Event|2|||
126741727|NCT00807014|456003138|FG000|Overall Study|Lost to Follow-up|9|||
126741728|NCT00807014|456003139|FG001|Overall Study|Lost to Follow-up|7|||
126741729|NCT00807014|456003138|FG000|Overall Study|Recovery|1|||
126741730|NCT00807014|456003139|FG001|Overall Study|Recovery|0|||
126741731|NCT00807014|456003138|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
126741732|NCT00807014|456003139|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
126741733|NCT00651313|456003140|FG000|Overall Study|Adverse Event|0|||
126741734|NCT00651313|456003141|FG001|Overall Study|Adverse Event|1|||
126741735|NCT00651313|456003140|FG000|Overall Study|Withdrawal by Subject|3|||
126741736|NCT00651313|456003141|FG001|Overall Study|Withdrawal by Subject|1|||
126741737|NCT00651313|456003140|FG000|Overall Study|Lost to Follow-up|1|||
126741738|NCT00651313|456003141|FG001|Overall Study|Lost to Follow-up|1|||
126741739|NCT00651313|456003140|FG000|Overall Study|Adminstrative Discontinuation|2|||
126741740|NCT00651313|456003141|FG001|Overall Study|Adminstrative Discontinuation|3|||
126741741|NCT02650895|456003142|FG000|Overall Study|Withdrawal by Subject|0|||
126741742|NCT02650895|456003143|FG001|Overall Study|Withdrawal by Subject|1|||
126741743|NCT02650895|456003144|FG002|Overall Study|Withdrawal by Subject|0|||
126741744|NCT02650895|456003145|FG003|Overall Study|Withdrawal by Subject|0|||
126741745|NCT02650895|456003146|FG004|Overall Study|Withdrawal by Subject|0|||
126741746|NCT02650895|456003147|FG005|Overall Study|Withdrawal by Subject|0|||
126741747|NCT00981682|456003155|FG000|Overall Study|Adverse Event|48|||
126741748|NCT00981682|456003155|FG000|Overall Study|Withdrawal by Subject|52|||
126741749|NCT00981682|456003155|FG000|Overall Study|Lost to Follow-up|14|||
126741750|NCT00981682|456003155|FG000|Overall Study|Lack of Efficacy|13|||
126741751|NCT00981682|456003155|FG000|Overall Study|Protocol Violation|6|||
126741752|NCT00981682|456003155|FG000|Overall Study|administrative|9|||
126741753|NCT01696396|456005481|FG000|Overall Study|Withdrawal by Subject|19|||
126741754|NCT01696396|456005482|FG001|Overall Study|Withdrawal by Subject|5|||
126741755|NCT01696396|456005483|FG002|Overall Study|Withdrawal by Subject|19|||
126741756|NCT01696396|456005484|FG003|Overall Study|Withdrawal by Subject|11|||
126741757|NCT01696396|456005481|FG000|Overall Study|Decision by Sponsor|3|||
126741758|NCT01696396|456005482|FG001|Overall Study|Decision by Sponsor|1|||
126741759|NCT01696396|456005483|FG002|Overall Study|Decision by Sponsor|2|||
126741760|NCT01696396|456005484|FG003|Overall Study|Decision by Sponsor|2|||
126741761|NCT01696396|456005481|FG000|Overall Study|Lost to Follow-up|9|||
126741762|NCT01696396|456005482|FG001|Overall Study|Lost to Follow-up|1|||
126741763|NCT01696396|456005483|FG002|Overall Study|Lost to Follow-up|4|||
126741764|NCT01696396|456005484|FG003|Overall Study|Lost to Follow-up|1|||
126741765|NCT01696396|456005481|FG000|Overall Study|Death|0|||
126741766|NCT01696396|456005482|FG001|Overall Study|Death|0|||
126741767|NCT01696396|456005483|FG002|Overall Study|Death|1|||
126741768|NCT01696396|456005484|FG003|Overall Study|Death|0|||
126741769|NCT02712008|456005491|FG000|Baseline (Day 1) up to Week 12|Death|3|||
126741770|NCT02712008|456005492|FG001|Baseline (Day 1) up to Week 12|Death|0|||
126741771|NCT02712008|456005493|FG002|Baseline (Day 1) up to Week 12|Death|0|||
126616081|NCT00912964|455551693|FG002|Overall Study|Taking exclusionary medications|8|||
126616082|NCT00912964|455551691|FG000|Overall Study|Medical History|1|||
126616083|NCT00912964|455551692|FG001|Overall Study|Medical History|0|||
126616084|NCT00912964|455551693|FG002|Overall Study|Medical History|0|||
126616085|NCT00912964|455551691|FG000|Overall Study|Non-compliance with study procedures|2|||
126616086|NCT00912964|455551692|FG001|Overall Study|Non-compliance with study procedures|0|||
126616087|NCT00912964|455551693|FG002|Overall Study|Non-compliance with study procedures|0|||
126616088|NCT00912964|455551691|FG000|Overall Study|Violation of exclusion criterion|0|||
126616089|NCT00912964|455551692|FG001|Overall Study|Violation of exclusion criterion|0|||
126616090|NCT00912964|455551693|FG002|Overall Study|Violation of exclusion criterion|2|||
126616091|NCT00912964|455551691|FG000|Overall Study|Randomized but never received study drug|0|||
126616092|NCT00912964|455551692|FG001|Overall Study|Randomized but never received study drug|1|||
126616093|NCT00912964|455551693|FG002|Overall Study|Randomized but never received study drug|0|||
126781764|NCT00457665|456156259|FG001|12 Months|Drug allergy|1|||
126781765|NCT00457665|456156258|FG000|12 Months|High HIV viral load|5|||
126616094|NCT02978716|455551694|FG000|Overall Study|Death|25|||
126616095|NCT02978716|455551695|FG001|Overall Study|Death|13|||
126616096|NCT02978716|455551696|FG002|Overall Study|Death|20|||
126616097|NCT02978716|455551694|FG000|Overall Study|Lost to Follow-up|0|||
126616098|NCT02978716|455551695|FG001|Overall Study|Lost to Follow-up|0|||
126616099|NCT02978716|455551696|FG002|Overall Study|Lost to Follow-up|1|||
126616100|NCT02978716|455551694|FG000|Overall Study|Withdrawal by Subject|6|||
126616101|NCT02978716|455551695|FG001|Overall Study|Withdrawal by Subject|4|||
126616102|NCT02978716|455551696|FG002|Overall Study|Withdrawal by Subject|5|||
126616103|NCT02978716|455551694|FG000|Overall Study|Sponsor terminated|2|||
126616104|NCT02978716|455551695|FG001|Overall Study|Sponsor terminated|13|||
126616105|NCT02978716|455551696|FG002|Overall Study|Sponsor terminated|9|||
126616106|NCT02978716|455551694|FG000|Overall Study|Other|1|||
126616107|NCT02978716|455551695|FG001|Overall Study|Other|3|||
126616108|NCT02978716|455551696|FG002|Overall Study|Other|0|||
126616109|NCT02470806|455551697|FG000|Overall Study|Lost to Follow-up|1|||
126616110|NCT02470806|455551698|FG001|Overall Study|Lost to Follow-up|1|||
126616111|NCT02470806|455551697|FG000|Overall Study|Adverse Event|5|||
126616112|NCT02470806|455551698|FG001|Overall Study|Adverse Event|2|||
126616113|NCT02470806|455551697|FG000|Overall Study|Protocol Violation|4|||
126781766|NCT00457665|456156259|FG001|12 Months|High HIV viral load|1|||
126781767|NCT00457665|456156258|FG000|12 Months|Lipodystrophy|2|||
126781768|NCT00457665|456156259|FG001|12 Months|Lipodystrophy|0|||
126781769|NCT00457665|456156258|FG000|12 Months|Withdrawal by Subject|0|||
126781770|NCT00457665|456156259|FG001|12 Months|Withdrawal by Subject|2|||
126781771|NCT00457665|456156258|FG000|12 Months|Abnormal Liver function tests|0|||
126781772|NCT00457665|456156259|FG001|12 Months|Abnormal Liver function tests|5|||
126781773|NCT00457665|456156258|FG000|24 Months|Withdrawal by Subject|3|||
126781774|NCT00457665|456156259|FG001|24 Months|Withdrawal by Subject|2|||
126781775|NCT00457665|456156258|FG000|24 Months|Lipodystrophy|1|||
126781776|NCT00457665|456156259|FG001|24 Months|Lipodystrophy|1|||
126781777|NCT00457665|456156258|FG000|24 Months|Abnormal liver function tests|1|||
126781778|NCT00457665|456156259|FG001|24 Months|Abnormal liver function tests|5|||
126616114|NCT02470806|455551698|FG001|Overall Study|Protocol Violation|11|||
126616115|NCT02470806|455551697|FG000|Overall Study|Physician Decision|0|||
126616116|NCT02470806|455551698|FG001|Overall Study|Physician Decision|3|||
126616117|NCT02470806|455551697|FG000|Overall Study|Withdrawal by Subject|3|||
126616118|NCT02470806|455551698|FG001|Overall Study|Withdrawal by Subject|10|||
126616119|NCT02470806|455551697|FG000|Overall Study|Lack of Efficacy|5|||
126616120|NCT02470806|455551698|FG001|Overall Study|Lack of Efficacy|15|||
126616121|NCT01147471|455551699|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
126616122|NCT01147471|455551700|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
126616123|NCT01147471|455551699|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
126616124|NCT01147471|455551700|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
126616125|NCT01147471|455551699|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
126616126|NCT01147471|455551700|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
126616127|NCT01147471|455551699|FG000|3 Month Follow Up|Lost to Follow-up|1|||
126616128|NCT01147471|455551700|FG001|3 Month Follow Up|Lost to Follow-up|1|||
126616129|NCT01147471|455551699|FG000|3 Month Follow Up|Physician Decision|0|||
126616130|NCT01147471|455551700|FG001|3 Month Follow Up|Physician Decision|1|||
126616131|NCT01147471|455551699|FG000|6 Month Follow Up|Lost to Follow-up|4|||
126616132|NCT01147471|455551700|FG001|6 Month Follow Up|Lost to Follow-up|2|||
126616133|NCT04369664|455553351|FG000|Overall Study|Physician Decision|1|||
126616134|NCT04369664|455553352|FG001|Overall Study|Physician Decision|0|||
126616135|NCT03840200|455553355|FG000|Overall Study|Death|6|||
126616136|NCT03840200|455553356|FG001|Overall Study|Death|3|||
126616137|NCT03840200|455553357|FG002|Overall Study|Death|6|||
126616138|NCT03840200|455553358|FG003|Overall Study|Death|10|||
126616139|NCT03840200|455553355|FG000|Overall Study|Reason Not Specified|2|||
126616140|NCT03840200|455553356|FG001|Overall Study|Reason Not Specified|2|||
126616141|NCT03840200|455553357|FG002|Overall Study|Reason Not Specified|1|||
126781779|NCT01851590|456156263|FG000|Overall Study|Withdrawal by Subject|0|||
126741772|NCT02712008|456005494|FG003|Baseline (Day 1) up to Week 12|Death|0|||
126741773|NCT02712008|456005495|FG004|Baseline (Day 1) up to Week 12|Death|0|||
126741774|NCT02712008|456005496|FG005|Baseline (Day 1) up to Week 12|Death|0|||
126741775|NCT02712008|456005497|FG006|Baseline (Day 1) up to Week 12|Death|0|||
126741776|NCT02712008|456005498|FG007|Baseline (Day 1) up to Week 12|Death|0|||
126741777|NCT02712008|456005491|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126741778|NCT02712008|456005492|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
126741779|NCT02712008|456005493|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
126741780|NCT02712008|456005494|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126741781|NCT02712008|456005495|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126741782|NCT02712008|456005496|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126741783|NCT02712008|456005497|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126741784|NCT02712008|456005498|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
126741785|NCT02712008|456005491|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
126741786|NCT02712008|456005492|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126741787|NCT02712008|456005493|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
126741788|NCT02712008|456005494|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126741789|NCT02712008|456005495|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126741790|NCT02712008|456005496|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126741791|NCT02712008|456005497|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126741792|NCT02712008|456005498|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
126741793|NCT02712008|456005491|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126741794|NCT02712008|456005492|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126741795|NCT02712008|456005493|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
126741796|NCT02712008|456005494|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126741797|NCT02712008|456005495|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126741798|NCT02712008|456005496|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126741799|NCT02712008|456005497|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126741800|NCT02712008|456005498|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
126741801|NCT02712008|456005491|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126741802|NCT02712008|456005492|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
126741803|NCT02712008|456005493|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126741804|NCT02712008|456005494|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126781780|NCT01851590|456156264|FG001|Overall Study|Withdrawal by Subject|0|||
126781781|NCT01851590|456156265|FG002|Overall Study|Withdrawal by Subject|1|||
126616142|NCT03840200|455553358|FG003|Overall Study|Reason Not Specified|15|||
126616143|NCT03840200|455553355|FG000|Overall Study|Physician Decision|0|||
126616144|NCT03840200|455553356|FG001|Overall Study|Physician Decision|0|||
126616145|NCT03840200|455553357|FG002|Overall Study|Physician Decision|0|||
126616146|NCT03840200|455553358|FG003|Overall Study|Physician Decision|2|||
126616147|NCT03840200|455553355|FG000|Overall Study|Progressive Disease|0|||
126616148|NCT03840200|455553356|FG001|Overall Study|Progressive Disease|0|||
126616149|NCT03840200|455553357|FG002|Overall Study|Progressive Disease|0|||
126616150|NCT03840200|455553358|FG003|Overall Study|Progressive Disease|1|||
126616151|NCT03840200|455553355|FG000|Overall Study|Withdrawal by Subject|0|||
126616152|NCT03840200|455553356|FG001|Overall Study|Withdrawal by Subject|1|||
126616153|NCT03840200|455553357|FG002|Overall Study|Withdrawal by Subject|0|||
126616154|NCT03840200|455553358|FG003|Overall Study|Withdrawal by Subject|2|||
126616155|NCT05487300|455553361|FG000|Overall Study|Withdrawal by Subject|1|||
126616156|NCT05487300|455553362|FG001|Overall Study|Withdrawal by Subject|0|||
126616157|NCT05006703|455553363|FG000|Overall Study|Withdrawal by Subject|1|||
126616158|NCT05006703|455553364|FG001|Overall Study|Withdrawal by Subject|0|||
126616159|NCT05006703|455553363|FG000|Overall Study|Lost to Follow-up|13|||
126616160|NCT05006703|455553364|FG001|Overall Study|Lost to Follow-up|5|||
126616161|NCT04820023|455553366|FG000|Overall Study|Death|0|||
126616162|NCT04820023|455553367|FG001|Overall Study|Death|0|||
126616163|NCT04820023|455553368|FG002|Overall Study|Death|0|||
126616164|NCT04820023|455553369|FG003|Overall Study|Death|0|||
126616165|NCT04820023|455553370|FG004|Overall Study|Death|0|||
126616166|NCT04820023|455553371|FG005|Overall Study|Death|0|||
126616167|NCT04820023|455553372|FG006|Overall Study|Death|1|||
126741805|NCT02712008|456005495|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126741806|NCT02712008|456005496|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126741807|NCT02712008|456005497|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126741808|NCT02712008|456005498|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
126781782|NCT01851590|456156263|FG000|Overall Study|Adverse Event|0|||
126616168|NCT04820023|455553373|FG007|Overall Study|Death|0|||
126616169|NCT04820023|455553374|FG008|Overall Study|Death|1|||
126616170|NCT04820023|455553366|FG000|Overall Study|Withdrawal by Subject|1|||
126616171|NCT04820023|455553367|FG001|Overall Study|Withdrawal by Subject|2|||
126616172|NCT04820023|455553368|FG002|Overall Study|Withdrawal by Subject|2|||
126616173|NCT04820023|455553369|FG003|Overall Study|Withdrawal by Subject|1|||
126616174|NCT04820023|455553370|FG004|Overall Study|Withdrawal by Subject|4|||
126616175|NCT04820023|455553371|FG005|Overall Study|Withdrawal by Subject|3|||
126616176|NCT04820023|455553372|FG006|Overall Study|Withdrawal by Subject|3|||
126616177|NCT04820023|455553373|FG007|Overall Study|Withdrawal by Subject|6|||
126616178|NCT04820023|455553374|FG008|Overall Study|Withdrawal by Subject|5|||
126616179|NCT04820023|455553366|FG000|Overall Study|Progressive Disease|3|||
126616180|NCT04820023|455553367|FG001|Overall Study|Progressive Disease|0|||
126616181|NCT04820023|455553368|FG002|Overall Study|Progressive Disease|2|||
126616182|NCT04820023|455553369|FG003|Overall Study|Progressive Disease|2|||
126616183|NCT04820023|455553370|FG004|Overall Study|Progressive Disease|2|||
126616184|NCT04820023|455553371|FG005|Overall Study|Progressive Disease|0|||
126616185|NCT04820023|455553372|FG006|Overall Study|Progressive Disease|1|||
126616186|NCT04820023|455553373|FG007|Overall Study|Progressive Disease|1|||
126616187|NCT04820023|455553374|FG008|Overall Study|Progressive Disease|0|||
126616188|NCT04820023|455553366|FG000|Overall Study|New anti-cancer therapy|0|||
126616189|NCT04820023|455553367|FG001|Overall Study|New anti-cancer therapy|0|||
126616190|NCT04820023|455553368|FG002|Overall Study|New anti-cancer therapy|0|||
126616191|NCT04820023|455553369|FG003|Overall Study|New anti-cancer therapy|0|||
126741809|NCT02712008|456005491|FG000|From Week 12 up to Week 36|Adverse Event|0|||
126741810|NCT02712008|456005492|FG001|From Week 12 up to Week 36|Adverse Event|0|||
126741811|NCT02712008|456005493|FG002|From Week 12 up to Week 36|Adverse Event|0|||
126741812|NCT02712008|456005494|FG003|From Week 12 up to Week 36|Adverse Event|0|||
126741813|NCT02712008|456005495|FG004|From Week 12 up to Week 36|Adverse Event|1|||
126741814|NCT02712008|456005496|FG005|From Week 12 up to Week 36|Adverse Event|0|||
126741815|NCT02712008|456005497|FG006|From Week 12 up to Week 36|Adverse Event|0|||
126741816|NCT02712008|456005498|FG007|From Week 12 up to Week 36|Adverse Event|2|||
126741817|NCT02712008|456005491|FG000|From Week 12 up to Week 36|Death|1|||
126741818|NCT02712008|456005492|FG001|From Week 12 up to Week 36|Death|0|||
126741819|NCT02712008|456005493|FG002|From Week 12 up to Week 36|Death|0|||
126741820|NCT02712008|456005494|FG003|From Week 12 up to Week 36|Death|0|||
126741821|NCT02712008|456005495|FG004|From Week 12 up to Week 36|Death|0|||
126741822|NCT02712008|456005496|FG005|From Week 12 up to Week 36|Death|0|||
126741823|NCT02712008|456005497|FG006|From Week 12 up to Week 36|Death|1|||
126741824|NCT02712008|456005498|FG007|From Week 12 up to Week 36|Death|0|||
126741825|NCT02712008|456005491|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
126741826|NCT02712008|456005492|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
126741827|NCT02712008|456005493|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
126741828|NCT02712008|456005494|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
126741829|NCT02712008|456005495|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
126741830|NCT02712008|456005496|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
126741831|NCT02712008|456005497|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
126741832|NCT02712008|456005498|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
126741833|NCT02712008|456005491|FG000|From Week 12 up to Week 36|Physician Decision|0|||
126741834|NCT02712008|456005492|FG001|From Week 12 up to Week 36|Physician Decision|0|||
126741835|NCT02712008|456005493|FG002|From Week 12 up to Week 36|Physician Decision|0|||
126741836|NCT02712008|456005494|FG003|From Week 12 up to Week 36|Physician Decision|1|||
126741837|NCT02712008|456005495|FG004|From Week 12 up to Week 36|Physician Decision|1|||
126741838|NCT02712008|456005496|FG005|From Week 12 up to Week 36|Physician Decision|0|||
126741839|NCT02712008|456005497|FG006|From Week 12 up to Week 36|Physician Decision|0|||
126741840|NCT02712008|456005498|FG007|From Week 12 up to Week 36|Physician Decision|0|||
126741841|NCT02712008|456005491|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
126741842|NCT02712008|456005492|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
126741843|NCT02712008|456005493|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
126741844|NCT02712008|456005494|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
126741845|NCT02712008|456005495|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
126741846|NCT02712008|456005496|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
126741847|NCT02712008|456005497|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
126741848|NCT02712008|456005498|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
126741849|NCT01199198|456005499|FG000|Overall Study|Adverse Event|3|||
126741850|NCT01199198|456005500|FG001|Overall Study|Adverse Event|0|||
126741851|NCT01199198|456005499|FG000|Overall Study|Lost to Follow-up|1|||
126741852|NCT01199198|456005500|FG001|Overall Study|Lost to Follow-up|5|||
126741853|NCT01199198|456005499|FG000|Overall Study|Withdrawal by Subject|1|||
126741854|NCT01199198|456005500|FG001|Overall Study|Withdrawal by Subject|2|||
126741855|NCT01199198|456005499|FG000|Overall Study|ICU Transfer|1|||
126741856|NCT01199198|456005500|FG001|Overall Study|ICU Transfer|2|||
126741857|NCT01199198|456005499|FG000|Overall Study|Hospice-care transfer|1|||
126741858|NCT01199198|456005500|FG001|Overall Study|Hospice-care transfer|2|||
126741859|NCT00922974|456005501|FG000|Phase II Component|Protocol Violation|2|||
126781783|NCT01851590|456156264|FG001|Overall Study|Adverse Event|0|||
126781784|NCT01851590|456156265|FG002|Overall Study|Adverse Event|2|||
126616192|NCT04820023|455553370|FG004|Overall Study|New anti-cancer therapy|2|||
126616193|NCT04820023|455553371|FG005|Overall Study|New anti-cancer therapy|0|||
126616194|NCT04820023|455553372|FG006|Overall Study|New anti-cancer therapy|0|||
126741860|NCT00922974|456005502|FG001|Phase II Component|Protocol Violation|0|||
126741861|NCT00922974|456005501|FG000|Phase II Component|Not evaluable for treatment review|5|||
126741862|NCT00922974|456005502|FG001|Phase II Component|Not evaluable for treatment review|0|||
126741863|NCT00922974|456005501|FG000|Phase III Component|Protocol Violation|8|||
126741864|NCT00922974|456005502|FG001|Phase III Component|Protocol Violation|6|||
126741865|NCT03950440|456005503|FG000|Overall Study|Death|8|||
126741866|NCT03950440|456005504|FG001|Overall Study|Death|2|||
126741867|NCT03950440|456005505|FG002|Overall Study|Death|1|||
126741868|NCT00430027|456005506|FG000|Overall Study|Study terminated|8|||
126741869|NCT01957215|456005507|FG000|Overall Study|Adverse Event|2|||
126741870|NCT01957215|456005508|FG001|Overall Study|Adverse Event|2|||
126741871|NCT01957215|456005507|FG000|Overall Study|Lost to Follow-up|3|||
126741872|NCT01957215|456005508|FG001|Overall Study|Lost to Follow-up|3|||
126741873|NCT01957215|456005507|FG000|Overall Study|Protocol Violation|1|||
126741874|NCT01957215|456005508|FG001|Overall Study|Protocol Violation|2|||
126741875|NCT01957215|456005507|FG000|Overall Study|Withdrawal by Subject|7|||
126741876|NCT01957215|456005508|FG001|Overall Study|Withdrawal by Subject|5|||
126741877|NCT02443155|456005511|FG000|Overall Study|Adverse Event|3|||
126741878|NCT02443155|456005512|FG001|Overall Study|Adverse Event|4|||
126741879|NCT02443155|456005513|FG002|Overall Study|Adverse Event|1|||
126741880|NCT02443155|456005514|FG003|Overall Study|Adverse Event|2|||
126741881|NCT02443155|456005511|FG000|Overall Study|Unclassified|0|||
126741882|NCT02443155|456005512|FG001|Overall Study|Unclassified|0|||
126741883|NCT02443155|456005513|FG002|Overall Study|Unclassified|2|||
126741884|NCT02443155|456005514|FG003|Overall Study|Unclassified|1|||
126741885|NCT02443155|456005511|FG000|Overall Study|Withdrawal by Subject|4|||
126741886|NCT02443155|456005512|FG001|Overall Study|Withdrawal by Subject|7|||
126741887|NCT02443155|456005513|FG002|Overall Study|Withdrawal by Subject|3|||
126741888|NCT02443155|456005514|FG003|Overall Study|Withdrawal by Subject|9|||
126741889|NCT02443155|456005511|FG000|Overall Study|Pregnancy|3|||
126741890|NCT02443155|456005512|FG001|Overall Study|Pregnancy|1|||
126741891|NCT02443155|456005513|FG002|Overall Study|Pregnancy|1|||
126741892|NCT02443155|456005514|FG003|Overall Study|Pregnancy|2|||
126741893|NCT02443155|456005511|FG000|Overall Study|Lost to Follow-up|1|||
126741894|NCT02443155|456005512|FG001|Overall Study|Lost to Follow-up|2|||
126741895|NCT02443155|456005513|FG002|Overall Study|Lost to Follow-up|0|||
126741896|NCT02443155|456005514|FG003|Overall Study|Lost to Follow-up|1|||
126741897|NCT02443155|456005511|FG000|Overall Study|Protocol Violation|1|||
126741898|NCT02443155|456005512|FG001|Overall Study|Protocol Violation|0|||
126741899|NCT02443155|456005513|FG002|Overall Study|Protocol Violation|1|||
126741900|NCT02443155|456005514|FG003|Overall Study|Protocol Violation|1|||
126741901|NCT02443155|456005511|FG000|Overall Study|Death|0|||
126741902|NCT02443155|456005512|FG001|Overall Study|Death|0|||
126741903|NCT02443155|456005513|FG002|Overall Study|Death|1|||
126741904|NCT02443155|456005514|FG003|Overall Study|Death|0|||
126741905|NCT02000219|456005515|FG000|14-Week Study Period|Physician Decision|1|||
126741906|NCT02000219|456005515|FG000|14-Week Study Period|Adverse Event|1|||
126741907|NCT02000219|456005515|FG000|14-Week Study Period|Underwent transplantation|1|||
126741908|NCT02000219|456005515|FG000|Continuation Period|Withdrawal by Subject|1|||
126741909|NCT02000219|456005515|FG000|Continuation Period|Had liver transplant|2|||
126741910|NCT02000219|456005515|FG000|Continuation Period|Non-compliance with study drug|2|||
126741911|NCT00088595|456005519|FG000|Overall Study|Adverse Event|11|||
126741912|NCT00088595|456005519|FG000|Overall Study|Withdrawal by Subject|8|||
126741913|NCT00088595|456005519|FG000|Overall Study|Ongoing (After Core)|7|||
126741914|NCT00088595|456005519|FG000|Overall Study|New Cancer Therapy|2|||
126741915|NCT00608894|456005520|FG000|Overall Study|Withdrawal by Subject|0|||
126741916|NCT00608894|456005521|FG001|Overall Study|Withdrawal by Subject|2|||
126741917|NCT01376388|456005526|FG000|Overall Study|Adverse Event|13|||
126741918|NCT01376388|456005526|FG000|Overall Study|Lack of Efficacy|2|||
126741919|NCT01376388|456005526|FG000|Overall Study|Withdrawal by Subject|3|||
126741920|NCT00106249|456005535|FG000|Overall Study|Lost to Follow-up|3|||
126741921|NCT00106249|456005536|FG001|Overall Study|Lost to Follow-up|2|||
126741922|NCT00524043|456005544|FG000|Overall Study|Lack of Efficacy|15|||
126741923|NCT00524043|456005545|FG001|Overall Study|Lack of Efficacy|13|||
126741924|NCT00524043|456005546|FG002|Overall Study|Lack of Efficacy|14|||
126741925|NCT00524043|456005544|FG000|Overall Study|Withdrawal by Subject|5|||
126741926|NCT00524043|456005545|FG001|Overall Study|Withdrawal by Subject|7|||
126741927|NCT00524043|456005546|FG002|Overall Study|Withdrawal by Subject|7|||
126741928|NCT00524043|456005544|FG000|Overall Study|Adverse Event|5|||
126741929|NCT00524043|456005545|FG001|Overall Study|Adverse Event|2|||
126741930|NCT00524043|456005546|FG002|Overall Study|Adverse Event|7|||
126741931|NCT00524043|456005544|FG000|Overall Study|Lost to Follow-up|3|||
126741932|NCT00524043|456005545|FG001|Overall Study|Lost to Follow-up|5|||
126741933|NCT00524043|456005546|FG002|Overall Study|Lost to Follow-up|3|||
126741934|NCT00524043|456005544|FG000|Overall Study|Various (eg, incarceration)|2|||
126741935|NCT00524043|456005545|FG001|Overall Study|Various (eg, incarceration)|1|||
126741936|NCT00524043|456005546|FG002|Overall Study|Various (eg, incarceration)|0|||
126741937|NCT01843205|456005551|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
126741938|NCT01843205|456005552|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
126741939|NCT03938636|456005553|FG000|Overall Study|Protocol Violation|0|||
126741940|NCT03938636|456005554|FG001|Overall Study|Protocol Violation|1|||
126741941|NCT03938636|456005555|FG002|Overall Study|Protocol Violation|1|||
126781785|NCT01851590|456156263|FG000|Overall Study|Lack of Efficacy|0|||
126741942|NCT03938636|456005553|FG000|Overall Study|Subject withdrew due to death in family|0|||
126741943|NCT03938636|456005554|FG001|Overall Study|Subject withdrew due to death in family|1|||
126741944|NCT03938636|456005555|FG002|Overall Study|Subject withdrew due to death in family|0|||
126741945|NCT03938636|456005553|FG000|Overall Study|Missed visit|0|||
126741946|NCT03938636|456005554|FG001|Overall Study|Missed visit|1|||
126741947|NCT03938636|456005555|FG002|Overall Study|Missed visit|0|||
126741948|NCT03938636|456005553|FG000|Overall Study|Adverse Event|0|||
126741949|NCT03938636|456005554|FG001|Overall Study|Adverse Event|0|||
126741950|NCT03938636|456005555|FG002|Overall Study|Adverse Event|1|||
126741951|NCT03938636|456005553|FG000|Overall Study|Lost to Follow-up|0|||
126741952|NCT03938636|456005554|FG001|Overall Study|Lost to Follow-up|0|||
126741953|NCT03938636|456005555|FG002|Overall Study|Lost to Follow-up|1|||
126741954|NCT02728206|456005556|FG000|Overall Study|Death|1|||
126741955|NCT00429572|456005557|FG000|Overall Study|Disease progression|1|||
126741956|NCT02773368|456005560|FG000|Overall Study|Lost to Follow-up|4|||
126741957|NCT02773368|456005561|FG001|Overall Study|Lost to Follow-up|1|||
126741958|NCT02773368|456005560|FG000|Overall Study|Withdrawal by Subject|5|||
126741959|NCT02773368|456005561|FG001|Overall Study|Withdrawal by Subject|1|||
126741960|NCT02773368|456005560|FG000|Overall Study|Unclassified|1|||
126741961|NCT02773368|456005561|FG001|Overall Study|Unclassified|1|||
126741962|NCT02773368|456005560|FG000|Overall Study|Missing|0|||
126741963|NCT02773368|456005561|FG001|Overall Study|Missing|1|||
126741964|NCT01929018|456005562|FG000|Overall Study|Lost to Follow-up|1|||
126741965|NCT01929018|456005563|FG001|Overall Study|Lost to Follow-up|0|||
126741966|NCT01929018|456005562|FG000|Overall Study|Hospitalization|0|||
126741967|NCT01929018|456005563|FG001|Overall Study|Hospitalization|1|||
126741968|NCT01366534|456005564|FG000|Overall Study|Lost to Follow-up|1|||
126741969|NCT01366534|456005565|FG001|Overall Study|Lost to Follow-up|0|||
126741970|NCT01366534|456005566|FG002|Overall Study|Lost to Follow-up|0|||
126741971|NCT01366534|456005564|FG000|Overall Study|Migrated|1|||
126741972|NCT01366534|456005565|FG001|Overall Study|Migrated|1|||
126741973|NCT01366534|456005566|FG002|Overall Study|Migrated|0|||
126741974|NCT01366534|456005564|FG000|Overall Study|Declined challenged|0|||
126741975|NCT01366534|456005565|FG001|Overall Study|Declined challenged|1|||
126741976|NCT01366534|456005566|FG002|Overall Study|Declined challenged|0|||
126741977|NCT02635867|456005569|FG000|Overall Study|Lost to Follow-up|4|||
126741978|NCT02635867|456005570|FG001|Overall Study|Lost to Follow-up|3|||
126741979|NCT02635867|456005571|FG002|Overall Study|Lost to Follow-up|3|||
126741980|NCT02635867|456005572|FG003|Overall Study|Lost to Follow-up|4|||
126741981|NCT02635867|456005573|FG004|Overall Study|Lost to Follow-up|1|||
126741982|NCT02565576|456005574|FG000|Overall Study|abnormal lab value|2|||
126741983|NCT02565576|456005575|FG001|Overall Study|abnormal lab value|0|||
126741984|NCT02565576|456005574|FG000|Overall Study|subject / guardian decision|1|||
126741985|NCT02565576|456005575|FG001|Overall Study|subject / guardian decision|3|||
126741986|NCT02565576|456005574|FG000|Overall Study|Lost to Follow-up|1|||
126741987|NCT02565576|456005575|FG001|Overall Study|Lost to Follow-up|0|||
126741988|NCT02565576|456005574|FG000|Overall Study|Death|0|||
126741989|NCT02565576|456005575|FG001|Overall Study|Death|2|||
126741990|NCT02565576|456005574|FG000|Overall Study|Adverse Event|1|||
126741991|NCT02565576|456005575|FG001|Overall Study|Adverse Event|0|||
126741992|NCT03345342|456005576|FG000|Open-Label Phase|Adverse Event|30|||
126741993|NCT03345342|456005577|FG001|Open-Label Phase|Adverse Event|0|||
126741994|NCT03345342|456005578|FG002|Open-Label Phase|Adverse Event|0|||
126741995|NCT03345342|456005579|FG003|Open-Label Phase|Adverse Event|0|||
126741996|NCT03345342|456005580|FG004|Open-Label Phase|Adverse Event|0|||
126741997|NCT03345342|456005576|FG000|Open-Label Phase|Death|1|||
126741998|NCT03345342|456005577|FG001|Open-Label Phase|Death|0|||
126741999|NCT03345342|456005578|FG002|Open-Label Phase|Death|0|||
126742000|NCT03345342|456005579|FG003|Open-Label Phase|Death|0|||
126742001|NCT03345342|456005580|FG004|Open-Label Phase|Death|0|||
126742002|NCT03345342|456005576|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
126742003|NCT03345342|456005577|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
126742004|NCT03345342|456005578|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
126742005|NCT03345342|456005579|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
126742006|NCT03345342|456005580|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
126742007|NCT03345342|456005576|FG000|Open-Label Phase|Lack of Efficacy|6|||
126742008|NCT03345342|456005577|FG001|Open-Label Phase|Lack of Efficacy|0|||
126742009|NCT03345342|456005578|FG002|Open-Label Phase|Lack of Efficacy|0|||
126742010|NCT03345342|456005579|FG003|Open-Label Phase|Lack of Efficacy|0|||
126742011|NCT03345342|456005580|FG004|Open-Label Phase|Lack of Efficacy|0|||
126742012|NCT03345342|456005576|FG000|Open-Label Phase|Lost to Follow-up|9|||
126742013|NCT03345342|456005577|FG001|Open-Label Phase|Lost to Follow-up|0|||
126742014|NCT03345342|456005578|FG002|Open-Label Phase|Lost to Follow-up|0|||
126742015|NCT03345342|456005579|FG003|Open-Label Phase|Lost to Follow-up|0|||
126742016|NCT03345342|456005580|FG004|Open-Label Phase|Lost to Follow-up|0|||
126742017|NCT03345342|456005576|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
126742018|NCT03345342|456005577|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
126742019|NCT03345342|456005578|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
126742020|NCT03345342|456005579|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
126742021|NCT03345342|456005580|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
126742022|NCT03345342|456005576|FG000|Open-Label Phase|Physician Decision|4|||
126742023|NCT03345342|456005577|FG001|Open-Label Phase|Physician Decision|0|||
126742024|NCT03345342|456005578|FG002|Open-Label Phase|Physician Decision|0|||
126742025|NCT03345342|456005579|FG003|Open-Label Phase|Physician Decision|0|||
126742026|NCT03345342|456005580|FG004|Open-Label Phase|Physician Decision|0|||
126742027|NCT03345342|456005576|FG000|Open-Label Phase|Protocol Violation|8|||
126742028|NCT03345342|456005577|FG001|Open-Label Phase|Protocol Violation|0|||
126742029|NCT03345342|456005578|FG002|Open-Label Phase|Protocol Violation|0|||
126742030|NCT03345342|456005579|FG003|Open-Label Phase|Protocol Violation|0|||
126742031|NCT03345342|456005580|FG004|Open-Label Phase|Protocol Violation|0|||
126742032|NCT03345342|456005576|FG000|Open-Label Phase|Withdrawal by Subject|57|||
126742033|NCT03345342|456005577|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126742034|NCT03345342|456005578|FG002|Open-Label Phase|Withdrawal by Subject|0|||
126742035|NCT03345342|456005579|FG003|Open-Label Phase|Withdrawal by Subject|0|||
126742036|NCT03345342|456005580|FG004|Open-Label Phase|Withdrawal by Subject|0|||
126742037|NCT03345342|456005576|FG000|Open-Label Phase|Other|15|||
126742038|NCT03345342|456005577|FG001|Open-Label Phase|Other|0|||
126742039|NCT03345342|456005578|FG002|Open-Label Phase|Other|0|||
126742040|NCT03345342|456005579|FG003|Open-Label Phase|Other|0|||
126742041|NCT03345342|456005580|FG004|Open-Label Phase|Other|0|||
126742042|NCT03345342|456005576|FG000|Double-Blind Phase|Adverse Event|0|||
126742043|NCT03345342|456005577|FG001|Double-Blind Phase|Adverse Event|1|||
126742044|NCT03345342|456005578|FG002|Double-Blind Phase|Adverse Event|6|||
126742045|NCT03345342|456005579|FG003|Double-Blind Phase|Adverse Event|0|||
126742046|NCT03345342|456005580|FG004|Double-Blind Phase|Adverse Event|0|||
126742047|NCT03345342|456005576|FG000|Double-Blind Phase|Death|0|||
126742048|NCT03345342|456005577|FG001|Double-Blind Phase|Death|2|||
126742049|NCT03345342|456005578|FG002|Double-Blind Phase|Death|1|||
126742050|NCT03345342|456005579|FG003|Double-Blind Phase|Death|0|||
126742051|NCT03345342|456005580|FG004|Double-Blind Phase|Death|0|||
126742052|NCT03345342|456005576|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
126742053|NCT03345342|456005577|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
126742054|NCT03345342|456005578|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
126742055|NCT03345342|456005579|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
126742056|NCT03345342|456005580|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
126616195|NCT04820023|455553373|FG007|Overall Study|New anti-cancer therapy|0|||
126616196|NCT04820023|455553374|FG008|Overall Study|New anti-cancer therapy|0|||
126616197|NCT04820023|455553366|FG000|Overall Study|Other|0|||
126616198|NCT04820023|455553367|FG001|Overall Study|Other|1|||
126616199|NCT04820023|455553368|FG002|Overall Study|Other|0|||
126616200|NCT04820023|455553369|FG003|Overall Study|Other|0|||
126616201|NCT04820023|455553370|FG004|Overall Study|Other|0|||
126616202|NCT04820023|455553371|FG005|Overall Study|Other|0|||
126616203|NCT04820023|455553372|FG006|Overall Study|Other|0|||
126616204|NCT04820023|455553373|FG007|Overall Study|Other|2|||
126616205|NCT04820023|455553374|FG008|Overall Study|Other|0|||
126616206|NCT05066230|455553375|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
126616207|NCT05066230|455553376|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
126616208|NCT05066230|455553375|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
126616209|NCT05066230|455553376|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
126616210|NCT05066230|455553375|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
126616211|NCT05066230|455553376|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
126616212|NCT05066230|455553375|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
126616213|NCT05066230|455553376|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
126742057|NCT03345342|456005576|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126742058|NCT03345342|456005577|FG001|Double-Blind Phase|Lost to Follow-up|1|||
126742059|NCT03345342|456005578|FG002|Double-Blind Phase|Lost to Follow-up|7|||
126742060|NCT03345342|456005579|FG003|Double-Blind Phase|Lost to Follow-up|0|||
126616214|NCT05066230|455553375|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
126616215|NCT05066230|455553376|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
126616216|NCT05066230|455553375|FG000|After Week 48|Adverse Event|1|||
126616217|NCT05066230|455553376|FG001|After Week 48|Adverse Event|0|||
126616218|NCT05066230|455553375|FG000|After Week 48|Non-compliance with study schedule|1|||
126616219|NCT05066230|455553376|FG001|After Week 48|Non-compliance with study schedule|0|||
126616220|NCT05066230|455553375|FG000|After Week 48|Withdrawal by Subject|0|||
126616221|NCT05066230|455553376|FG001|After Week 48|Withdrawal by Subject|1|||
126616222|NCT05066230|455553375|FG000|After Week 48|Lost to Follow-up|3|||
126616223|NCT05066230|455553376|FG001|After Week 48|Lost to Follow-up|3|||
126742061|NCT03345342|456005580|FG004|Double-Blind Phase|Lost to Follow-up|0|||
126742062|NCT03345342|456005576|FG000|Double-Blind Phase|Physician Decision|0|||
126742063|NCT03345342|456005577|FG001|Double-Blind Phase|Physician Decision|1|||
126742064|NCT03345342|456005578|FG002|Double-Blind Phase|Physician Decision|4|||
126742065|NCT03345342|456005579|FG003|Double-Blind Phase|Physician Decision|0|||
126742066|NCT03345342|456005580|FG004|Double-Blind Phase|Physician Decision|0|||
126742067|NCT03345342|456005576|FG000|Double-Blind Phase|Protocol Violation|0|||
126616224|NCT05066230|455553375|FG000|After Week 48|Sponsor Request|115|||
126742068|NCT03345342|456005577|FG001|Double-Blind Phase|Protocol Violation|0|||
126742069|NCT03345342|456005578|FG002|Double-Blind Phase|Protocol Violation|1|||
126742070|NCT03345342|456005579|FG003|Double-Blind Phase|Protocol Violation|0|||
126742071|NCT03345342|456005580|FG004|Double-Blind Phase|Protocol Violation|0|||
126742072|NCT03345342|456005576|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
126742073|NCT03345342|456005577|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
126742074|NCT03345342|456005578|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
126742075|NCT03345342|456005579|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
126742076|NCT03345342|456005580|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
126742077|NCT03345342|456005576|FG000|Double-Blind Phase|Other|0|||
126742078|NCT03345342|456005577|FG001|Double-Blind Phase|Other|1|||
126742079|NCT03345342|456005578|FG002|Double-Blind Phase|Other|3|||
126742080|NCT03345342|456005579|FG003|Double-Blind Phase|Other|0|||
126742081|NCT03345342|456005580|FG004|Double-Blind Phase|Other|0|||
126742082|NCT03345342|456005576|FG000|Follow-Up Phase|Adverse Event|0|||
126742083|NCT03345342|456005577|FG001|Follow-Up Phase|Adverse Event|0|||
126742084|NCT03345342|456005578|FG002|Follow-Up Phase|Adverse Event|0|||
126742085|NCT03345342|456005579|FG003|Follow-Up Phase|Adverse Event|0|||
126742086|NCT03345342|456005580|FG004|Follow-Up Phase|Adverse Event|4|||
126742087|NCT03345342|456005576|FG000|Follow-Up Phase|Lost to Follow-up|0|||
126742088|NCT03345342|456005577|FG001|Follow-Up Phase|Lost to Follow-up|0|||
126742089|NCT03345342|456005578|FG002|Follow-Up Phase|Lost to Follow-up|0|||
126742090|NCT03345342|456005579|FG003|Follow-Up Phase|Lost to Follow-up|0|||
126742091|NCT03345342|456005580|FG004|Follow-Up Phase|Lost to Follow-up|6|||
126742092|NCT03345342|456005576|FG000|Follow-Up Phase|Physician Decision|0|||
126742093|NCT03345342|456005577|FG001|Follow-Up Phase|Physician Decision|0|||
126742094|NCT03345342|456005578|FG002|Follow-Up Phase|Physician Decision|0|||
126742095|NCT03345342|456005579|FG003|Follow-Up Phase|Physician Decision|0|||
126742096|NCT03345342|456005580|FG004|Follow-Up Phase|Physician Decision|5|||
126742097|NCT03345342|456005576|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
126742098|NCT03345342|456005577|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
126742099|NCT03345342|456005578|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
126742100|NCT03345342|456005579|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
126742101|NCT03345342|456005580|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
126742102|NCT03345342|456005576|FG000|Follow-Up Phase|Other|0|||
126742103|NCT03345342|456005577|FG001|Follow-Up Phase|Other|0|||
126742104|NCT03345342|456005578|FG002|Follow-Up Phase|Other|0|||
126742105|NCT03345342|456005579|FG003|Follow-Up Phase|Other|3|||
126742106|NCT03345342|456005580|FG004|Follow-Up Phase|Other|1|||
126742107|NCT02782104|456005585|FG000|Overall Study|Other|215|||
126742108|NCT02782104|456005585|FG000|Overall Study|Induction Day 28 Non Responder|9|||
126742109|NCT02782104|456005585|FG000|Overall Study|Non-Compliance with Study Drug|2|||
126742110|NCT02782104|456005585|FG000|Overall Study|Death|8|||
126742111|NCT02782104|456005585|FG000|Overall Study|Pregnancy|6|||
126742112|NCT02782104|456005585|FG000|Overall Study|Withdrawal by Subject|63|||
126742113|NCT02782104|456005585|FG000|Overall Study|Protocol Violation|7|||
126742114|NCT02782104|456005585|FG000|Overall Study|Lack of Efficacy|61|||
126742115|NCT02782104|456005585|FG000|Overall Study|Lost to Follow-up|23|||
126742116|NCT02782104|456005585|FG000|Overall Study|Adverse Event|74|||
126742117|NCT03185819|456005586|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
126742118|NCT03185819|456005587|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
126742119|NCT03185819|456005588|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
126742120|NCT03185819|456005589|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
126742121|NCT03185819|456005586|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
126742122|NCT03185819|456005587|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
126742123|NCT03185819|456005588|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
126742124|NCT03185819|456005589|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
126742125|NCT03185819|456005586|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
126742126|NCT03185819|456005587|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
126742127|NCT03185819|456005588|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
126742128|NCT03185819|456005589|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
126742129|NCT03185819|456005586|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
126781786|NCT01851590|456156264|FG001|Overall Study|Lack of Efficacy|1|||
126616225|NCT05066230|455553376|FG001|After Week 48|Sponsor Request|111|||
126616226|NCT02164578|455553377|FG000|Treatment Period|Withdrawal by Subject|3|||
126616227|NCT02164578|455553378|FG001|Treatment Period|Withdrawal by Subject|3|||
126616228|NCT02164578|455553377|FG000|Treatment Period|Adverse Event|13|||
126742130|NCT03185819|456005587|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
126742131|NCT03185819|456005588|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
126742132|NCT03185819|456005589|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
126742133|NCT03185819|456005586|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
126742134|NCT03185819|456005587|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
126742135|NCT03185819|456005588|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
126742136|NCT03185819|456005589|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
126781787|NCT01851590|456156265|FG002|Overall Study|Lack of Efficacy|0|||
126781788|NCT00310856|456156266|FG000|Overall Study|Withdrawal by Subject|2|||
126781789|NCT00310856|456156267|FG001|Overall Study|Withdrawal by Subject|2|||
126781790|NCT00310856|456156268|FG002|Overall Study|Withdrawal by Subject|2|||
126781791|NCT00310856|456156266|FG000|Overall Study|Lost to Follow-up|1|||
126781792|NCT00310856|456156267|FG001|Overall Study|Lost to Follow-up|2|||
126781793|NCT00310856|456156268|FG002|Overall Study|Lost to Follow-up|6|||
126781794|NCT00310856|456156266|FG000|Overall Study|Inappropriate enrollment|1|||
126781795|NCT00310856|456156267|FG001|Overall Study|Inappropriate enrollment|1|||
126781796|NCT00310856|456156268|FG002|Overall Study|Inappropriate enrollment|0|||
126781797|NCT00310856|456156266|FG000|Overall Study|Unable to classify|1|||
126781798|NCT00310856|456156267|FG001|Overall Study|Unable to classify|0|||
126781799|NCT00310856|456156268|FG002|Overall Study|Unable to classify|0|||
126781800|NCT02843074|456156272|FG000|Overall Study|Withdrawal by Subject|5|||
126781801|NCT02843074|456156272|FG000|Overall Study|Progressive disease|1|||
126781802|NCT02843074|456156272|FG000|Overall Study|Physician Decision|1|||
126781803|NCT02843074|456156272|FG000|Overall Study|Lost to Follow-up|1|||
126781804|NCT02843074|456156272|FG000|Overall Study|Death|9|||
126781805|NCT01214330|456156273|FG000|Overall Study|Withdrawal by Subject|2|||
126781806|NCT01214330|456156273|FG000|Overall Study|Withdrawal by Subject|2|||
126781807|NCT00686036|456156275|FG000|Overall Study|Adverse Event|3|||
126781808|NCT00686036|456156276|FG001|Overall Study|Adverse Event|0|||
126781809|NCT00686036|456156275|FG000|Overall Study|Withdrawal by Subject|3|||
126781810|NCT00686036|456156276|FG001|Overall Study|Withdrawal by Subject|1|||
126781811|NCT00686036|456156275|FG000|Overall Study|Study terminated by AstraZeneca|2|||
126781812|NCT00686036|456156276|FG001|Overall Study|Study terminated by AstraZeneca|1|||
126616229|NCT02164578|455553378|FG001|Treatment Period|Adverse Event|6|||
126616230|NCT02164578|455553377|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
126616231|NCT02164578|455553378|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
126616232|NCT02164578|455553377|FG000|Treatment Period|Protocol Violation|0|||
126742137|NCT03185819|456005586|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
126742138|NCT03185819|456005587|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
126742139|NCT03185819|456005588|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
126742140|NCT03185819|456005589|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
126742141|NCT03185819|456005586|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
126742142|NCT03185819|456005587|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
126742143|NCT03185819|456005588|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
126742144|NCT03185819|456005589|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
126742145|NCT03185819|456005586|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
126742146|NCT03185819|456005587|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
126742147|NCT03185819|456005588|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
126742148|NCT03185819|456005589|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
126742149|NCT03185819|456005586|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
126742150|NCT03185819|456005587|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
126742151|NCT03185819|456005588|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
126742152|NCT03185819|456005589|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
126742153|NCT03185819|456005586|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
126742154|NCT03185819|456005587|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
126742155|NCT03185819|456005588|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
126742156|NCT03185819|456005589|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
126742157|NCT03185819|456005586|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
126742158|NCT03185819|456005587|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
126742159|NCT03185819|456005588|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
126742160|NCT03185819|456005589|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
126742161|NCT03185819|456005586|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
126742162|NCT03185819|456005587|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
126742163|NCT03185819|456005588|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
126742164|NCT03185819|456005589|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
126781813|NCT00686036|456156275|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
126781814|NCT00686036|456156276|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
126616233|NCT02164578|455553378|FG001|Treatment Period|Protocol Violation|2|||
126781815|NCT00686036|456156275|FG000|Overall Study|Other reasons not identified|0|||
126781816|NCT00686036|456156276|FG001|Overall Study|Other reasons not identified|4|||
126781817|NCT01199601|456156280|FG000|Overall Study|Lost to Follow-up|47|||
126616234|NCT02164578|455553377|FG000|Extension Period|Withdrawal by Subject|2|||
126616235|NCT02164578|455553378|FG001|Extension Period|Withdrawal by Subject|0|||
126616236|NCT02164578|455553377|FG000|Extension Period|Adverse Event|4|||
126742165|NCT03185819|456005586|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
126742166|NCT03185819|456005587|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
126742167|NCT03185819|456005588|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
126742168|NCT03185819|456005589|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
126742169|NCT02438787|456005590|FG000|Overall Study|Adverse Event|1|||
126742170|NCT02438787|456005591|FG001|Overall Study|Adverse Event|0|||
126742171|NCT02438787|456005592|FG002|Overall Study|Adverse Event|2|||
126742172|NCT02438787|456005590|FG000|Overall Study|Lack of Efficacy|1|||
126742173|NCT02438787|456005591|FG001|Overall Study|Lack of Efficacy|2|||
126742174|NCT02438787|456005592|FG002|Overall Study|Lack of Efficacy|0|||
126742175|NCT02438787|456005590|FG000|Overall Study|Lost to Follow-up|0|||
126742176|NCT02438787|456005591|FG001|Overall Study|Lost to Follow-up|1|||
126742177|NCT02438787|456005592|FG002|Overall Study|Lost to Follow-up|0|||
126742178|NCT02438787|456005590|FG000|Overall Study|Protocol Violation|0|||
126742179|NCT02438787|456005591|FG001|Overall Study|Protocol Violation|0|||
126742180|NCT02438787|456005592|FG002|Overall Study|Protocol Violation|1|||
126742181|NCT02438787|456005590|FG000|Overall Study|Withdrawal by Subject|15|||
126742182|NCT02438787|456005591|FG001|Overall Study|Withdrawal by Subject|7|||
126742183|NCT02438787|456005592|FG002|Overall Study|Withdrawal by Subject|10|||
126742184|NCT02438787|456005590|FG000|Overall Study|Study discontinued by sponsor|64|||
126742185|NCT02438787|456005591|FG001|Overall Study|Study discontinued by sponsor|72|||
126742186|NCT02438787|456005592|FG002|Overall Study|Study discontinued by sponsor|69|||
126742187|NCT02438787|456005590|FG000|Overall Study|Other|0|||
126742188|NCT02438787|456005591|FG001|Overall Study|Other|1|||
126742189|NCT02438787|456005592|FG002|Overall Study|Other|0|||
126742190|NCT02438787|456005590|FG000|Overall Study|Site terminated by sponsor|0|||
126742191|NCT02438787|456005591|FG001|Overall Study|Site terminated by sponsor|0|||
126742192|NCT02438787|456005592|FG002|Overall Study|Site terminated by sponsor|1|||
126742193|NCT03375203|456005593|FG000|Overall Study|Protocol Violation|0|||
126742194|NCT03375203|456005594|FG001|Overall Study|Protocol Violation|0|||
126742195|NCT03375203|456005595|FG002|Overall Study|Protocol Violation|1|||
126742196|NCT03375203|456005596|FG003|Overall Study|Protocol Violation|0|||
126742197|NCT03375203|456005597|FG004|Overall Study|Protocol Violation|0|||
126742198|NCT03375203|456005593|FG000|Overall Study|Adverse Event|2|||
126742199|NCT03375203|456005594|FG001|Overall Study|Adverse Event|3|||
126742200|NCT03375203|456005595|FG002|Overall Study|Adverse Event|0|||
126742201|NCT03375203|456005596|FG003|Overall Study|Adverse Event|2|||
126742202|NCT03375203|456005597|FG004|Overall Study|Adverse Event|2|||
126742203|NCT03375203|456005593|FG000|Overall Study|Withdrawal by Subject|3|||
126742204|NCT03375203|456005594|FG001|Overall Study|Withdrawal by Subject|0|||
126742205|NCT03375203|456005595|FG002|Overall Study|Withdrawal by Subject|1|||
126742206|NCT03375203|456005596|FG003|Overall Study|Withdrawal by Subject|0|||
126742207|NCT03375203|456005597|FG004|Overall Study|Withdrawal by Subject|2|||
126742208|NCT03375203|456005593|FG000|Overall Study|Non-compliance with study drug|1|||
126742209|NCT03375203|456005594|FG001|Overall Study|Non-compliance with study drug|0|||
126742210|NCT03375203|456005595|FG002|Overall Study|Non-compliance with study drug|0|||
126742211|NCT03375203|456005596|FG003|Overall Study|Non-compliance with study drug|0|||
126742212|NCT03375203|456005597|FG004|Overall Study|Non-compliance with study drug|0|||
126742213|NCT03375203|456005593|FG000|Overall Study|Randomized, not treated.|0|||
126742214|NCT03375203|456005594|FG001|Overall Study|Randomized, not treated.|1|||
126742215|NCT03375203|456005595|FG002|Overall Study|Randomized, not treated.|0|||
126742216|NCT03375203|456005596|FG003|Overall Study|Randomized, not treated.|0|||
126742217|NCT03375203|456005597|FG004|Overall Study|Randomized, not treated.|0|||
126742218|NCT03321526|456005598|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
126742219|NCT03321526|456005599|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
126742220|NCT03321526|456005598|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
126742221|NCT03321526|456005599|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
126742222|NCT03321526|456005598|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
126742223|NCT03321526|456005599|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
126742224|NCT03321526|456005598|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
126742225|NCT03321526|456005599|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
126742226|NCT03321526|456005598|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
126742227|NCT03321526|456005599|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
126742228|NCT03321526|456005598|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
126742229|NCT03321526|456005599|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
126742230|NCT03321526|456005598|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
126742231|NCT03321526|456005599|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
126742232|NCT03321526|456005598|FG000|Follow-up Phase (2 Weeks)|Other|24|||
126616237|NCT02164578|455553378|FG001|Extension Period|Adverse Event|0|||
126616238|NCT02164578|455553377|FG000|Extension Period|Expiry of study medication|1|||
126742233|NCT03321526|456005599|FG001|Follow-up Phase (2 Weeks)|Other|24|||
126742234|NCT00732641|456005600|FG000|Overall Study|Relapse or Progressive Disease|65|||
126742235|NCT00732641|456005601|FG001|Overall Study|Relapse or Progressive Disease|101|||
126742236|NCT00732641|456005600|FG000|Overall Study|Serious Adverse Events|12|||
126742237|NCT00732641|456005601|FG001|Overall Study|Serious Adverse Events|3|||
126742238|NCT00732641|456005600|FG000|Overall Study|Physician Decision|6|||
126742239|NCT00732641|456005601|FG001|Overall Study|Physician Decision|0|||
126742240|NCT00732641|456005600|FG000|Overall Study|Withdrawal by Subject|4|||
126742241|NCT00732641|456005601|FG001|Overall Study|Withdrawal by Subject|2|||
126742242|NCT00732641|456005600|FG000|Overall Study|Unable to Complete|1|||
126742243|NCT00732641|456005601|FG001|Overall Study|Unable to Complete|1|||
126742244|NCT00732641|456005600|FG000|Overall Study|Other|18|||
126742245|NCT00732641|456005601|FG001|Overall Study|Other|5|||
126742246|NCT03447821|456005604|FG000|Overall Study|Withdrawal by Subject|1|||
126742247|NCT03447821|456005605|FG001|Overall Study|Withdrawal by Subject|1|||
126742248|NCT03447821|456005606|FG002|Overall Study|Withdrawal by Subject|0|||
126742249|NCT03447821|456005604|FG000|Overall Study|Lost to Follow-up|0|||
126742250|NCT03447821|456005605|FG001|Overall Study|Lost to Follow-up|0|||
126742251|NCT03447821|456005606|FG002|Overall Study|Lost to Follow-up|1|||
126742252|NCT00329784|456005609|FG000|Overall Study|Lost to Follow-up|0|||
126742253|NCT00329784|456005610|FG001|Overall Study|Lost to Follow-up|1|||
126742254|NCT00329784|456005611|FG002|Overall Study|Lost to Follow-up|0|||
126742255|NCT00329784|456005612|FG003|Overall Study|Lost to Follow-up|0|||
126742256|NCT00329784|456005609|FG000|Overall Study|Withdrawal by Subject|4|||
126742257|NCT00329784|456005610|FG001|Overall Study|Withdrawal by Subject|2|||
126742258|NCT00329784|456005611|FG002|Overall Study|Withdrawal by Subject|0|||
126742259|NCT00329784|456005612|FG003|Overall Study|Withdrawal by Subject|0|||
126742260|NCT00329784|456005609|FG000|Overall Study|Other|1|||
126742261|NCT00329784|456005610|FG001|Overall Study|Other|2|||
126742262|NCT00329784|456005611|FG002|Overall Study|Other|0|||
126742263|NCT00329784|456005612|FG003|Overall Study|Other|0|||
126742264|NCT00654420|456005613|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
126742265|NCT00654420|456005614|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
126742266|NCT00654420|456005615|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
126742267|NCT00654420|456005616|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
126742268|NCT00654420|456005613|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
126742269|NCT00654420|456005614|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
126742270|NCT00654420|456005615|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
126742271|NCT00654420|456005616|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
126742272|NCT00654420|456005613|FG000|Phase II|Adverse Event|0|||
126742273|NCT00654420|456005614|FG001|Phase II|Adverse Event|0|||
126742274|NCT00654420|456005615|FG002|Phase II|Adverse Event|3|||
126742275|NCT00654420|456005616|FG003|Phase II|Adverse Event|3|||
126742276|NCT00654420|456005613|FG000|Phase II|Lost to Follow-up|0|||
126742277|NCT00654420|456005614|FG001|Phase II|Lost to Follow-up|0|||
126742278|NCT00654420|456005615|FG002|Phase II|Lost to Follow-up|0|||
126742279|NCT00654420|456005616|FG003|Phase II|Lost to Follow-up|1|||
126742280|NCT00654420|456005613|FG000|Phase II|Physician Decision|0|||
126742281|NCT00654420|456005614|FG001|Phase II|Physician Decision|0|||
126742282|NCT00654420|456005615|FG002|Phase II|Physician Decision|0|||
126742283|NCT00654420|456005616|FG003|Phase II|Physician Decision|4|||
126742284|NCT00654420|456005613|FG000|Phase II|Progressive Disease|0|||
126742285|NCT00654420|456005614|FG001|Phase II|Progressive Disease|0|||
126742286|NCT00654420|456005615|FG002|Phase II|Progressive Disease|29|||
126742287|NCT00654420|456005616|FG003|Phase II|Progressive Disease|29|||
126742288|NCT00654420|456005613|FG000|Phase II|Withdrawal by Subject|0|||
126742289|NCT00654420|456005614|FG001|Phase II|Withdrawal by Subject|0|||
126742290|NCT00654420|456005615|FG002|Phase II|Withdrawal by Subject|4|||
126742291|NCT00654420|456005616|FG003|Phase II|Withdrawal by Subject|1|||
126742292|NCT00654420|456005613|FG000|Phase II|Missing Disposition Record|0|||
126742293|NCT00654420|456005614|FG001|Phase II|Missing Disposition Record|0|||
126742294|NCT00654420|456005615|FG002|Phase II|Missing Disposition Record|1|||
126742295|NCT00654420|456005616|FG003|Phase II|Missing Disposition Record|0|||
126742296|NCT03034057|456005622|FG000|Overall Study|Withdrawal by Subject|10|||
126742297|NCT03034057|456005622|FG000|Overall Study|Protocol Violation|1|||
126742298|NCT03034057|456005622|FG000|Overall Study|Not defined|2|||
126742299|NCT03034057|456005622|FG000|Overall Study|Lost to Follow-up|19|||
126781818|NCT01199601|456156281|FG001|Overall Study|Lost to Follow-up|66|||
126781819|NCT01199601|456156280|FG000|Overall Study|Withdrawal by Subject|15|||
126616239|NCT02164578|455553378|FG001|Extension Period|Expiry of study medication|0|||
126742300|NCT03034057|456005622|FG000|Overall Study|Adverse Event|22|||
126742301|NCT03034057|456005622|FG000|Overall Study|Medication error without associated AE|1|||
126742302|NCT00701103|456005623|FG000|Overall Study|Adverse Event|0|||
126742303|NCT00701103|456005624|FG001|Overall Study|Adverse Event|0|||
126742304|NCT00701103|456005625|FG002|Overall Study|Adverse Event|1|||
126742305|NCT00701103|456005626|FG003|Overall Study|Adverse Event|1|||
126742306|NCT00701103|456005627|FG004|Overall Study|Adverse Event|0|||
126742307|NCT00701103|456005628|FG005|Overall Study|Adverse Event|1|||
126742308|NCT00701103|456005629|FG006|Overall Study|Adverse Event|1|||
126742309|NCT00701103|456005630|FG007|Overall Study|Adverse Event|0|||
126742310|NCT00701103|456005631|FG008|Overall Study|Adverse Event|0|||
126742311|NCT00701103|456005632|FG009|Overall Study|Adverse Event|2|||
126742312|NCT00701103|456005633|FG010|Overall Study|Adverse Event|0|||
126742313|NCT00701103|456005623|FG000|Overall Study|Progressive Disease|5|||
126742314|NCT00701103|456005624|FG001|Overall Study|Progressive Disease|2|||
126742315|NCT00701103|456005625|FG002|Overall Study|Progressive Disease|6|||
126742316|NCT00701103|456005626|FG003|Overall Study|Progressive Disease|5|||
126742317|NCT00701103|456005627|FG004|Overall Study|Progressive Disease|6|||
126742318|NCT00701103|456005628|FG005|Overall Study|Progressive Disease|5|||
126742319|NCT00701103|456005629|FG006|Overall Study|Progressive Disease|7|||
126742320|NCT00701103|456005630|FG007|Overall Study|Progressive Disease|7|||
126742321|NCT00701103|456005631|FG008|Overall Study|Progressive Disease|8|||
126742322|NCT00701103|456005632|FG009|Overall Study|Progressive Disease|8|||
126742323|NCT00701103|456005633|FG010|Overall Study|Progressive Disease|11|||
126742324|NCT00701103|456005623|FG000|Overall Study|Withdrawal by Subject|0|||
126742325|NCT00701103|456005624|FG001|Overall Study|Withdrawal by Subject|1|||
126742326|NCT00701103|456005625|FG002|Overall Study|Withdrawal by Subject|1|||
126742327|NCT00701103|456005626|FG003|Overall Study|Withdrawal by Subject|0|||
126742328|NCT00701103|456005627|FG004|Overall Study|Withdrawal by Subject|0|||
126742329|NCT00701103|456005628|FG005|Overall Study|Withdrawal by Subject|0|||
126742330|NCT00701103|456005629|FG006|Overall Study|Withdrawal by Subject|0|||
126742331|NCT00701103|456005630|FG007|Overall Study|Withdrawal by Subject|0|||
126742332|NCT00701103|456005631|FG008|Overall Study|Withdrawal by Subject|0|||
126742333|NCT00701103|456005632|FG009|Overall Study|Withdrawal by Subject|0|||
126742334|NCT00701103|456005633|FG010|Overall Study|Withdrawal by Subject|0|||
126742335|NCT00701103|456005623|FG000|Overall Study|Other|0|||
126742336|NCT00701103|456005624|FG001|Overall Study|Other|0|||
126742337|NCT00701103|456005625|FG002|Overall Study|Other|0|||
126742338|NCT00701103|456005626|FG003|Overall Study|Other|0|||
126742339|NCT00701103|456005627|FG004|Overall Study|Other|0|||
126742340|NCT00701103|456005628|FG005|Overall Study|Other|0|||
126742341|NCT00701103|456005629|FG006|Overall Study|Other|0|||
126742342|NCT00701103|456005630|FG007|Overall Study|Other|0|||
126742343|NCT00701103|456005631|FG008|Overall Study|Other|1|||
126742344|NCT00701103|456005632|FG009|Overall Study|Other|1|||
126742345|NCT00701103|456005633|FG010|Overall Study|Other|0|||
126742346|NCT01929707|456005634|FG000|Intervention Period 1|Lost to Follow-up|0|||
126742347|NCT01929707|456005635|FG001|Intervention Period 1|Lost to Follow-up|0|||
126742348|NCT01929707|456005636|FG002|Intervention Period 1|Lost to Follow-up|0|||
126742349|NCT01929707|456005637|FG003|Intervention Period 1|Lost to Follow-up|1|||
126742350|NCT01929707|456005638|FG004|Intervention Period 1|Lost to Follow-up|0|||
126742351|NCT01929707|456005639|FG005|Intervention Period 1|Lost to Follow-up|0|||
126742352|NCT01929707|456005640|FG006|Intervention Period 1|Lost to Follow-up|0|||
126742353|NCT01929707|456005641|FG007|Intervention Period 1|Lost to Follow-up|0|||
126742354|NCT01929707|456005634|FG000|Intervention Period 1|Withdrawal by Subject|0|||
126742355|NCT01929707|456005635|FG001|Intervention Period 1|Withdrawal by Subject|0|||
126742356|NCT01929707|456005636|FG002|Intervention Period 1|Withdrawal by Subject|0|||
126742357|NCT01929707|456005637|FG003|Intervention Period 1|Withdrawal by Subject|2|||
126742358|NCT01929707|456005638|FG004|Intervention Period 1|Withdrawal by Subject|0|||
126742359|NCT01929707|456005639|FG005|Intervention Period 1|Withdrawal by Subject|0|||
126742360|NCT01929707|456005640|FG006|Intervention Period 1|Withdrawal by Subject|0|||
126742361|NCT01929707|456005641|FG007|Intervention Period 1|Withdrawal by Subject|0|||
126742362|NCT01929707|456005634|FG000|Intervention Period 2|Withdrawal by Subject|0|||
126742363|NCT01929707|456005635|FG001|Intervention Period 2|Withdrawal by Subject|0|||
126742364|NCT01929707|456005636|FG002|Intervention Period 2|Withdrawal by Subject|0|||
126742365|NCT01929707|456005637|FG003|Intervention Period 2|Withdrawal by Subject|0|||
126742366|NCT01929707|456005638|FG004|Intervention Period 2|Withdrawal by Subject|0|||
126742367|NCT01929707|456005639|FG005|Intervention Period 2|Withdrawal by Subject|2|||
126742368|NCT01929707|456005640|FG006|Intervention Period 2|Withdrawal by Subject|0|||
126742369|NCT01929707|456005641|FG007|Intervention Period 2|Withdrawal by Subject|0|||
126742370|NCT00179517|456005642|FG000|Overall Study|Withdrawal by Subject|2|||
126742371|NCT00179517|456005643|FG001|Overall Study|Withdrawal by Subject|1|||
126742372|NCT00437203|456005644|FG000|Overall Study|Death|0|||
126742373|NCT00437203|456005645|FG001|Overall Study|Death|0|||
126742374|NCT00437203|456005646|FG002|Overall Study|Death|1|||
126742375|NCT00437203|456005647|FG003|Overall Study|Death|0|||
126742376|NCT00437203|456005648|FG004|Overall Study|Death|0|||
126616240|NCT02164578|455553377|FG000|Extension Period|Protocol Violation|0|||
126742377|NCT00437203|456005649|FG005|Overall Study|Death|0|||
126742378|NCT00437203|456005650|FG006|Overall Study|Death|0|||
126616241|NCT02164578|455553378|FG001|Extension Period|Protocol Violation|1|||
126616242|NCT02507297|455553379|FG000|Overall Study|Withdrawal by Subject|1|||
126742379|NCT00437203|456005651|FG007|Overall Study|Death|1|||
126742380|NCT00437203|456005652|FG008|Overall Study|Death|0|||
126742381|NCT00437203|456005653|FG009|Overall Study|Death|1|||
126742382|NCT00437203|456005644|FG000|Overall Study|Adverse Event|1|||
126742383|NCT00437203|456005645|FG001|Overall Study|Adverse Event|1|||
126742384|NCT00437203|456005646|FG002|Overall Study|Adverse Event|0|||
126742385|NCT00437203|456005647|FG003|Overall Study|Adverse Event|0|||
126742386|NCT00437203|456005648|FG004|Overall Study|Adverse Event|0|||
126742387|NCT00437203|456005649|FG005|Overall Study|Adverse Event|0|||
126742388|NCT00437203|456005650|FG006|Overall Study|Adverse Event|0|||
126742389|NCT00437203|456005651|FG007|Overall Study|Adverse Event|1|||
126742390|NCT00437203|456005652|FG008|Overall Study|Adverse Event|0|||
126742391|NCT00437203|456005653|FG009|Overall Study|Adverse Event|1|||
126742392|NCT00437203|456005644|FG000|Overall Study|Study terminated by sponsor|0|||
126742393|NCT00437203|456005645|FG001|Overall Study|Study terminated by sponsor|0|||
126742394|NCT00437203|456005646|FG002|Overall Study|Study terminated by sponsor|0|||
126742395|NCT00437203|456005647|FG003|Overall Study|Study terminated by sponsor|0|||
126742396|NCT00437203|456005648|FG004|Overall Study|Study terminated by sponsor|0|||
126742397|NCT00437203|456005649|FG005|Overall Study|Study terminated by sponsor|0|||
126742398|NCT00437203|456005650|FG006|Overall Study|Study terminated by sponsor|0|||
126742399|NCT00437203|456005651|FG007|Overall Study|Study terminated by sponsor|0|||
126742400|NCT00437203|456005652|FG008|Overall Study|Study terminated by sponsor|1|||
126742401|NCT00437203|456005653|FG009|Overall Study|Study terminated by sponsor|0|||
126742402|NCT00437203|456005644|FG000|Overall Study|Objective progression or relapse|5|||
126742403|NCT00437203|456005645|FG001|Overall Study|Objective progression or relapse|6|||
126742404|NCT00437203|456005646|FG002|Overall Study|Objective progression or relapse|2|||
126742405|NCT00437203|456005647|FG003|Overall Study|Objective progression or relapse|3|||
126742406|NCT00437203|456005648|FG004|Overall Study|Objective progression or relapse|3|||
126742407|NCT00437203|456005649|FG005|Overall Study|Objective progression or relapse|3|||
126742408|NCT00437203|456005650|FG006|Overall Study|Objective progression or relapse|6|||
126742409|NCT00437203|456005651|FG007|Overall Study|Objective progression or relapse|1|||
126742410|NCT00437203|456005652|FG008|Overall Study|Objective progression or relapse|2|||
126742411|NCT00437203|456005653|FG009|Overall Study|Objective progression or relapse|2|||
126742412|NCT00437203|456005644|FG000|Overall Study|Other|0|||
126742413|NCT00437203|456005645|FG001|Overall Study|Other|1|||
126742414|NCT00437203|456005646|FG002|Overall Study|Other|0|||
126742415|NCT00437203|456005647|FG003|Overall Study|Other|0|||
126742416|NCT00437203|456005648|FG004|Overall Study|Other|0|||
126742417|NCT00437203|456005649|FG005|Overall Study|Other|0|||
126742418|NCT00437203|456005650|FG006|Overall Study|Other|1|||
126742419|NCT00437203|456005651|FG007|Overall Study|Other|0|||
126742420|NCT00437203|456005652|FG008|Overall Study|Other|0|||
126742421|NCT00437203|456005653|FG009|Overall Study|Other|0|||
126742422|NCT01449955|456005654|FG000|Overall Study|Withdrawal by Subject|1|||
126742423|NCT01449955|456005655|FG001|Overall Study|Withdrawal by Subject|2|||
126742424|NCT00431496|456005662|FG000|Overall Study|Adverse Event|3|||
126742425|NCT00431496|456005662|FG000|Overall Study|Lost to Follow-up|1|||
126742426|NCT00431496|456005662|FG000|Overall Study|Withdrawal by Subject|2|||
126742427|NCT00431496|456005662|FG000|Overall Study|Protocol-specified criteria|5|||
126742428|NCT00361218|456005663|FG000|Overall Study|Lost to Follow-up|11|||
126742429|NCT00361218|456005663|FG000|Overall Study|Personal Reasons|7|||
126742430|NCT00361218|456005663|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
126742431|NCT01570309|456005666|FG000|Overall Study|Withdrawal by Subject|3|||
126742432|NCT01570309|456005667|FG001|Overall Study|Withdrawal by Subject|3|||
126742433|NCT01119963|456007560|FG000|Overall Study|Lost to Follow-up|1|||
126742434|NCT01119963|456007561|FG001|Overall Study|Lost to Follow-up|1|||
126742435|NCT02603172|456007562|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126742436|NCT02603172|456007563|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126742437|NCT02603172|456007564|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
126742438|NCT02603172|456007565|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126742439|NCT02603172|456007566|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126742440|NCT02603172|456007567|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126742441|NCT02603172|456007568|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126742442|NCT02603172|456007569|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
126742443|NCT01100658|456007570|FG000|Overall Study|Withdrawal by Subject|1|||
126742444|NCT00711412|456007571|FG000|Induction Treatment|Death|2|||
126742445|NCT00711412|456007571|FG000|Induction Treatment|Adverse Event|1|||
126742446|NCT00711412|456007571|FG000|Induction Treatment|Other|1|||
126742447|NCT00711412|456007571|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
126742448|NCT00711412|456007571|FG000|Evaluated for Combination Treatment|Death|1|||
126742449|NCT00711412|456007571|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
126742450|NCT00711412|456007571|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
126742451|NCT00711412|456007571|FG000|Combination Treatment|Progressive Disease|1|||
126742452|NCT00711412|456007571|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
126742453|NCT00711412|456007571|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
126742454|NCT00711412|456007571|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
126616243|NCT02507297|455553380|FG001|Overall Study|Withdrawal by Subject|0|||
126616244|NCT02507297|455553379|FG000|Overall Study|Lost to Follow-up|0|||
126616245|NCT02507297|455553380|FG001|Overall Study|Lost to Follow-up|1|||
126616246|NCT01018992|455553381|FG000|Overall Study|Adverse Event|8|||
126742455|NCT00711412|456007571|FG000|Evaluation for Response and Surgery|Death|1|||
126742456|NCT00711412|456007571|FG000|Survival Follow up Until Death|Other|12|||
126742457|NCT00420342|456007575|FG000|Overall Study|Lost to Follow-up|1|||
126742458|NCT00420342|456007576|FG001|Overall Study|Lost to Follow-up|0|||
126616247|NCT01018992|455553382|FG001|Overall Study|Adverse Event|3|||
126742459|NCT00420342|456007577|FG002|Overall Study|Lost to Follow-up|1|||
126742460|NCT00420342|456007575|FG000|Overall Study|Withdrawal by Subject|0|||
126742461|NCT00420342|456007576|FG001|Overall Study|Withdrawal by Subject|2|||
126742462|NCT00420342|456007577|FG002|Overall Study|Withdrawal by Subject|0|||
126742463|NCT01017549|456007578|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
126742464|NCT01017549|456007578|FG000|One-year Follow-up|Lost to Follow-up|2|||
126742465|NCT01017549|456007578|FG000|One-year Follow-up|Withdrawal by Subject|5|||
126742466|NCT01017549|456007578|FG000|5 Year Follow-up|Lost to Follow-up|9|||
126742467|NCT01017549|456007578|FG000|5 Year Follow-up|Mastectomy|3|||
126742468|NCT04072575|456007579|FG000|Overall Study|Physician Decision|1|||
126742469|NCT04072575|456007579|FG000|Overall Study|Adverse Event|7|||
126742470|NCT04072575|456007579|FG000|Overall Study|Withdrawal by Subject|14|||
126742471|NCT04072575|456007579|FG000|Overall Study|Other|2|||
126742472|NCT02473289|456007580|FG000|Overall Study|Adverse Event|2|||
126742473|NCT02473289|456007581|FG001|Overall Study|Adverse Event|3|||
126742474|NCT02473289|456007580|FG000|Overall Study|Lost to Follow-up|1|||
126742475|NCT02473289|456007581|FG001|Overall Study|Lost to Follow-up|1|||
126742476|NCT02473289|456007580|FG000|Overall Study|Protocol Violation|0|||
126742477|NCT02473289|456007581|FG001|Overall Study|Protocol Violation|1|||
126742478|NCT02473289|456007580|FG000|Overall Study|Withdrawal of consent|6|||
126742479|NCT02473289|456007581|FG001|Overall Study|Withdrawal of consent|7|||
126742480|NCT02473289|456007580|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
126742481|NCT02473289|456007581|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
126742482|NCT02473289|456007580|FG000|Overall Study|Other|2|||
126742483|NCT02473289|456007581|FG001|Overall Study|Other|0|||
126742484|NCT02244619|456007582|FG000|Overall Study|Did not receive study intervention|8|||
126742485|NCT02244619|456007583|FG001|Overall Study|Did not receive study intervention|21|||
126742486|NCT03285490|456007585|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
126742487|NCT03285490|456007586|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
126742488|NCT03285490|456007585|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
126742489|NCT03285490|456007586|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
126742490|NCT03745989|456007587|FG000|Overall Study|Death|3|||
126742491|NCT03745989|456007588|FG001|Overall Study|Death|7|||
126742492|NCT03745989|456007589|FG002|Overall Study|Death|4|||
126742493|NCT03745989|456007587|FG000|Overall Study|Lost to Follow-up|0|||
126742494|NCT03745989|456007588|FG001|Overall Study|Lost to Follow-up|2|||
126742495|NCT03745989|456007589|FG002|Overall Study|Lost to Follow-up|0|||
126742496|NCT03745989|456007587|FG000|Overall Study|Sponsor Decision|0|||
126742497|NCT03745989|456007588|FG001|Overall Study|Sponsor Decision|2|||
126742498|NCT03745989|456007589|FG002|Overall Study|Sponsor Decision|8|||
126742499|NCT03745989|456007587|FG000|Overall Study|Withdrawal by Subject|0|||
126742500|NCT03745989|456007588|FG001|Overall Study|Withdrawal by Subject|1|||
126742501|NCT03745989|456007589|FG002|Overall Study|Withdrawal by Subject|3|||
126742502|NCT01291511|456007590|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
126742503|NCT01291511|456007591|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
126742504|NCT01291511|456007590|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
126742505|NCT01291511|456007591|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
126742506|NCT01291511|456007590|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
126742507|NCT01291511|456007591|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
126742508|NCT01291511|456007590|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
126742509|NCT01291511|456007591|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
126742510|NCT01291511|456007590|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
126742511|NCT01291511|456007591|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
126742512|NCT01291511|456007590|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
126742513|NCT01291511|456007591|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
126742514|NCT01291511|456007590|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
126742515|NCT01291511|456007591|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
126616248|NCT01018992|455553381|FG000|Overall Study|Withdrawal by Subject|3|||
126616249|NCT01018992|455553382|FG001|Overall Study|Withdrawal by Subject|8|||
126742516|NCT01291511|456007590|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
126742517|NCT01291511|456007591|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
126742518|NCT01291511|456007590|FG000|Cross-Titration and Stabilization Phase|Death|1|||
126742519|NCT01291511|456007591|FG001|Cross-Titration and Stabilization Phase|Death|0|||
126616250|NCT01018992|455553381|FG000|Overall Study|Protocol Violation|0|||
126616251|NCT01018992|455553382|FG001|Overall Study|Protocol Violation|4|||
126742520|NCT01291511|456007590|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
126742521|NCT01291511|456007591|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
126742522|NCT01291511|456007590|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
126742523|NCT01291511|456007591|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
126742524|NCT01291511|456007590|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
126742525|NCT01291511|456007591|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
126742526|NCT01291511|456007590|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
126742527|NCT01291511|456007591|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
126742528|NCT01291511|456007590|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
126742529|NCT01291511|456007591|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
126742530|NCT01291511|456007590|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
126742531|NCT01291511|456007591|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
126742532|NCT01291511|456007590|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
126742533|NCT01291511|456007591|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
126742534|NCT01291511|456007590|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
126742535|NCT01291511|456007591|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
126742536|NCT01291511|456007590|FG000|Double-blind Relapse Prevention Phase|Death|1|||
126742537|NCT01291511|456007591|FG001|Double-blind Relapse Prevention Phase|Death|0|||
126742538|NCT00047008|456007593|FG000|Overall Study|Withdrawn consent|2|||
126742539|NCT00047008|456007594|FG001|Overall Study|Withdrawn consent|3|||
126742540|NCT00047008|456007593|FG000|Overall Study|Ineligible|9|||
126742541|NCT00047008|456007594|FG001|Overall Study|Ineligible|8|||
126742542|NCT01047436|456007599|FG000|Overall Study|Protocol Violation|1|||
126742543|NCT01047436|456007600|FG001|Overall Study|Protocol Violation|0|||
126742544|NCT00939341|456007603|FG000|Overall Study|Adverse Event|15|||
126742545|NCT00939341|456007603|FG000|Overall Study|Pregnancy|1|||
126742546|NCT00939341|456007603|FG000|Overall Study|Lost to Follow-up|23|||
126742547|NCT00939341|456007603|FG000|Overall Study|Withdrawal by Subject|13|||
126742548|NCT00939341|456007603|FG000|Overall Study|Protocol Violation|6|||
126742549|NCT00939341|456007603|FG000|Overall Study|Incorrect enrolment|8|||
126742550|NCT00424099|456007604|FG000|Overall Study|Adverse Event|0|||
126742551|NCT00424099|456007605|FG001|Overall Study|Adverse Event|1|||
126616252|NCT01018992|455553381|FG000|Overall Study|Lost to Follow-up|5|||
126616253|NCT01018992|455553382|FG001|Overall Study|Lost to Follow-up|1|||
126616254|NCT03029585|455553383|FG000|Overall Study|Death|1|||
126616255|NCT03029585|455553384|FG001|Overall Study|Death|1|||
126616256|NCT03029585|455553383|FG000|Overall Study|Withdrawal by Subject|1|||
126616257|NCT03029585|455553384|FG001|Overall Study|Withdrawal by Subject|0|||
126616258|NCT02092285|455553385|FG000|Induction Phase|Adverse Event|7|||
126616259|NCT02092285|455553385|FG000|Induction Phase|Physician Decision|4|||
126616260|NCT02092285|455553385|FG000|Induction Phase|Pregnancy|1|||
126616261|NCT02092285|455553385|FG000|Induction Phase|Relapse/Recurrence|7|||
126616262|NCT02092285|455553385|FG000|Induction Phase|Withdrawal by Subject|2|||
126616263|NCT02092285|455553385|FG000|Induction Phase|Lack of Efficacy|14|||
126616264|NCT02092285|455553385|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
126616265|NCT02092285|455553385|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
126616266|NCT02092285|455553385|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
126616267|NCT02092285|455553385|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
126616268|NCT02092285|455553385|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
126616269|NCT02092285|455553385|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
126616270|NCT02092285|455553385|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
126616271|NCT02092285|455553385|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
126616272|NCT02092285|455553385|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
126616273|NCT01825785|455553386|FG000|Overall Study|Adverse Event|0|||
126616274|NCT01825785|455553387|FG001|Overall Study|Adverse Event|0|||
126616275|NCT01825785|455553388|FG002|Overall Study|Adverse Event|0|||
126616276|NCT01825785|455553389|FG003|Overall Study|Adverse Event|0|||
126616277|NCT01825785|455553390|FG004|Overall Study|Adverse Event|1|||
126616278|NCT01825785|455553391|FG005|Overall Study|Adverse Event|0|||
126616279|NCT01825785|455553392|FG006|Overall Study|Adverse Event|0|||
126616280|NCT01825785|455553386|FG000|Overall Study|Withdrawal by Subject|0|||
126616281|NCT01825785|455553387|FG001|Overall Study|Withdrawal by Subject|0|||
126616282|NCT01825785|455553388|FG002|Overall Study|Withdrawal by Subject|0|||
126616283|NCT01825785|455553389|FG003|Overall Study|Withdrawal by Subject|0|||
126616284|NCT01825785|455553390|FG004|Overall Study|Withdrawal by Subject|1|||
126616285|NCT01825785|455553391|FG005|Overall Study|Withdrawal by Subject|1|||
126616286|NCT01825785|455553392|FG006|Overall Study|Withdrawal by Subject|0|||
126616287|NCT01304940|455553394|FG000|Overall Study|not meet symptom severity requirement|3|||
126616288|NCT01304940|455553395|FG001|Overall Study|not meet symptom severity requirement|0|||
126616289|NCT00278395|455553398|FG000|Overall Study|Adverse Event|2|||
126616290|NCT00278395|455553398|FG000|Overall Study|Nonevaluable|1|||
126616291|NCT03740737|455553399|FG000|Overall Study|Protocol deviation|13|||
126616292|NCT03740737|455553400|FG001|Overall Study|Protocol deviation|0|||
126616293|NCT03740737|455553399|FG000|Overall Study|Adverse Event|2|||
126616294|NCT03740737|455553400|FG001|Overall Study|Adverse Event|0|||
126616295|NCT03740737|455553399|FG000|Overall Study|Lost to Follow-up|1|||
126742552|NCT00424099|456007606|FG002|Overall Study|Adverse Event|1|||
126742553|NCT00424099|456007607|FG003|Overall Study|Adverse Event|0|||
126742554|NCT00424099|456007604|FG000|Overall Study|Death|0|||
126742555|NCT00424099|456007605|FG001|Overall Study|Death|1|||
126742556|NCT00424099|456007606|FG002|Overall Study|Death|0|||
126742557|NCT00424099|456007607|FG003|Overall Study|Death|0|||
126616296|NCT03740737|455553400|FG001|Overall Study|Lost to Follow-up|0|||
126742558|NCT00424099|456007604|FG000|Overall Study|Illness|2|||
126742559|NCT00424099|456007605|FG001|Overall Study|Illness|0|||
126742560|NCT00424099|456007606|FG002|Overall Study|Illness|1|||
126742561|NCT00424099|456007607|FG003|Overall Study|Illness|4|||
126742562|NCT00424099|456007604|FG000|Overall Study|Lost to Follow-up|0|||
126742563|NCT00424099|456007605|FG001|Overall Study|Lost to Follow-up|0|||
126742564|NCT00424099|456007606|FG002|Overall Study|Lost to Follow-up|3|||
126742565|NCT00424099|456007607|FG003|Overall Study|Lost to Follow-up|0|||
126742566|NCT00424099|456007604|FG000|Overall Study|Hospitalized|1|||
126742567|NCT00424099|456007605|FG001|Overall Study|Hospitalized|2|||
126742568|NCT00424099|456007606|FG002|Overall Study|Hospitalized|1|||
126742569|NCT00424099|456007607|FG003|Overall Study|Hospitalized|3|||
126742570|NCT00424099|456007604|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
126742571|NCT00424099|456007605|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
126742572|NCT00424099|456007606|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
126742573|NCT00424099|456007607|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
126742574|NCT00424099|456007604|FG000|Overall Study|Withdrawal by Subject|1|||
126742575|NCT00424099|456007605|FG001|Overall Study|Withdrawal by Subject|9|||
126742576|NCT00424099|456007606|FG002|Overall Study|Withdrawal by Subject|4|||
126742577|NCT00424099|456007607|FG003|Overall Study|Withdrawal by Subject|6|||
126742578|NCT00424099|456007604|FG000|Overall Study|Physician Decision|0|||
126742579|NCT00424099|456007605|FG001|Overall Study|Physician Decision|0|||
126742580|NCT00424099|456007606|FG002|Overall Study|Physician Decision|1|||
126742581|NCT00424099|456007607|FG003|Overall Study|Physician Decision|0|||
126742582|NCT00424099|456007604|FG000|Overall Study|Missing|0|||
126742583|NCT00424099|456007605|FG001|Overall Study|Missing|0|||
126742584|NCT00424099|456007606|FG002|Overall Study|Missing|1|||
126742585|NCT00424099|456007607|FG003|Overall Study|Missing|0|||
126742586|NCT01408732|456007608|FG000|Overall Study|Withdrawal by Subject|2|||
126742587|NCT01408732|456007609|FG001|Overall Study|Withdrawal by Subject|2|||
126742588|NCT03377452|456007610|FG000|Overall Study|Refused assessment|0|||
126742589|NCT03377452|456007611|FG001|Overall Study|Refused assessment|2|||
126742590|NCT03377452|456007610|FG000|Overall Study|Lost to Follow-up|5|||
126742591|NCT03377452|456007611|FG001|Overall Study|Lost to Follow-up|4|||
126742592|NCT00796003|456007613|FG000|Overall Study|Disease Progression|2|||
126742593|NCT00796003|456007614|FG001|Overall Study|Disease Progression|13|||
126742594|NCT00796003|456007613|FG000|Overall Study|Adverse Event|1|||
126742595|NCT00796003|456007614|FG001|Overall Study|Adverse Event|7|||
126742596|NCT00796003|456007613|FG000|Overall Study|Specified organ function not met|0|||
126742597|NCT00796003|456007614|FG001|Overall Study|Specified organ function not met|1|||
126742598|NCT00796003|456007613|FG000|Overall Study|Physician Decision|0|||
126742599|NCT00796003|456007614|FG001|Overall Study|Physician Decision|4|||
126742600|NCT00796003|456007613|FG000|Overall Study|Withdrawal by Subject|0|||
126742601|NCT00796003|456007614|FG001|Overall Study|Withdrawal by Subject|1|||
126742602|NCT00796003|456007613|FG000|Overall Study|Other|0|||
126742603|NCT00796003|456007614|FG001|Overall Study|Other|1|||
126742604|NCT00796003|456007613|FG000|Overall Study|Participants Not treated|0|||
126742605|NCT00796003|456007614|FG001|Overall Study|Participants Not treated|2|||
126742606|NCT05179057|456007615|FG000|Overall Study|Adverse Event|3|||
126742607|NCT05179057|456007616|FG001|Overall Study|Adverse Event|2|||
126742608|NCT05179057|456007615|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
126742609|NCT05179057|456007616|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
126742610|NCT05179057|456007615|FG000|Overall Study|Study terminated|13|||
126742611|NCT05179057|456007616|FG001|Overall Study|Study terminated|7|||
126742612|NCT05179057|456007615|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
126742613|NCT05179057|456007616|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
126742614|NCT05179057|456007615|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
126742615|NCT05179057|456007616|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
126742616|NCT02437162|456007617|FG000|Overall Study|Protocol Violation|0|||
126742617|NCT02437162|456007618|FG001|Overall Study|Protocol Violation|1|||
126742618|NCT02437162|456007619|FG002|Overall Study|Protocol Violation|0|||
126742619|NCT02437162|456007617|FG000|Overall Study|Randomized but not treated|0|||
126742620|NCT02437162|456007618|FG001|Overall Study|Randomized but not treated|0|||
126742621|NCT02437162|456007619|FG002|Overall Study|Randomized but not treated|1|||
126742622|NCT02437162|456007617|FG000|Overall Study|Study discontinued by Sponsor|93|||
126742623|NCT02437162|456007618|FG001|Overall Study|Study discontinued by Sponsor|98|||
126742624|NCT02437162|456007619|FG002|Overall Study|Study discontinued by Sponsor|97|||
126742625|NCT02437162|456007617|FG000|Overall Study|Withdrawal by Subject|13|||
126742626|NCT02437162|456007618|FG001|Overall Study|Withdrawal by Subject|7|||
126742627|NCT02437162|456007619|FG002|Overall Study|Withdrawal by Subject|9|||
126742628|NCT02437162|456007617|FG000|Overall Study|Adverse Event|0|||
126742629|NCT02437162|456007618|FG001|Overall Study|Adverse Event|1|||
126742630|NCT02437162|456007619|FG002|Overall Study|Adverse Event|0|||
126742631|NCT02437162|456007617|FG000|Overall Study|Lost to Follow-up|1|||
126742632|NCT02437162|456007618|FG001|Overall Study|Lost to Follow-up|0|||
126742633|NCT02437162|456007619|FG002|Overall Study|Lost to Follow-up|1|||
126742634|NCT02437162|456007617|FG000|Overall Study|Death|0|||
126742635|NCT02437162|456007618|FG001|Overall Study|Death|1|||
126742636|NCT02437162|456007619|FG002|Overall Study|Death|0|||
126742637|NCT02437162|456007617|FG000|Overall Study|Other|0|||
126742638|NCT02437162|456007618|FG001|Overall Study|Other|0|||
126742639|NCT02437162|456007619|FG002|Overall Study|Other|1|||
126742640|NCT04338321|456007620|FG000|Overall Study|Adverse Event|4|||
126742641|NCT04338321|456007621|FG001|Overall Study|Adverse Event|10|||
126742642|NCT04338321|456007620|FG000|Overall Study|Death|1|||
126742643|NCT04338321|456007621|FG001|Overall Study|Death|1|||
126742644|NCT04338321|456007620|FG000|Overall Study|Lost to Follow-up|4|||
126742645|NCT04338321|456007621|FG001|Overall Study|Lost to Follow-up|9|||
126742646|NCT04338321|456007620|FG000|Overall Study|Withdrawal by Subject|45|||
126742647|NCT04338321|456007621|FG001|Overall Study|Withdrawal by Subject|69|||
126742648|NCT04338321|456007620|FG000|Overall Study|Physician Decision|5|||
126742649|NCT04338321|456007621|FG001|Overall Study|Physician Decision|9|||
126742650|NCT04338321|456007620|FG000|Overall Study|Other|3|||
126742651|NCT04338321|456007621|FG001|Overall Study|Other|10|||
126742652|NCT03107793|456007622|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
126742653|NCT03107793|456007623|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
126742654|NCT03107793|456007624|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
126742655|NCT03107793|456007625|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
126742656|NCT03107793|456007626|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
126742657|NCT03107793|456007622|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
126742658|NCT03107793|456007623|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
126742659|NCT03107793|456007624|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
126742660|NCT03107793|456007625|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
126742661|NCT03107793|456007626|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
126742662|NCT03107793|456007622|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
126742663|NCT03107793|456007623|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
126742664|NCT03107793|456007624|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
126742665|NCT03107793|456007625|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
126742666|NCT03107793|456007626|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
126742667|NCT03107793|456007622|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
126742668|NCT03107793|456007623|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126742669|NCT03107793|456007624|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126742670|NCT03107793|456007625|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126742671|NCT03107793|456007626|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
126742672|NCT03107793|456007622|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126742673|NCT03107793|456007623|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
126742674|NCT03107793|456007624|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
126742675|NCT03107793|456007625|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126742676|NCT03107793|456007626|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
126742677|NCT03107793|456007622|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
126742678|NCT03107793|456007623|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
126742679|NCT03107793|456007624|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
126742680|NCT03107793|456007625|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
126742681|NCT03107793|456007626|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
126742682|NCT03107793|456007622|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
126742683|NCT03107793|456007623|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
126742684|NCT03107793|456007624|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
126742685|NCT03107793|456007625|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
126742686|NCT03107793|456007626|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
126742687|NCT03107793|456007622|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126742688|NCT03107793|456007623|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
126742689|NCT03107793|456007624|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
126742690|NCT03107793|456007625|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126742691|NCT03107793|456007626|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
126742692|NCT03107793|456007622|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
126742693|NCT03107793|456007623|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
126742694|NCT03107793|456007624|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
126742695|NCT03107793|456007625|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
126742696|NCT03107793|456007626|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
126742697|NCT03107793|456007622|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
126742698|NCT03107793|456007623|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
126781820|NCT01199601|456156281|FG001|Overall Study|Withdrawal by Subject|3|||
126742699|NCT03107793|456007624|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
126742700|NCT03107793|456007625|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
126742701|NCT03107793|456007626|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
126742702|NCT03107793|456007622|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126742703|NCT03107793|456007623|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
126616297|NCT03740737|455553399|FG000|Overall Study|Randomization failure|1|||
126616298|NCT03740737|455553400|FG001|Overall Study|Randomization failure|0|||
126616299|NCT03740737|455553399|FG000|Overall Study|Participant withdrew consent|1|||
126616300|NCT03740737|455553400|FG001|Overall Study|Participant withdrew consent|0|||
126616301|NCT03740737|455553399|FG000|Overall Study|Participant withdrew from trial|2|||
126616302|NCT03740737|455553400|FG001|Overall Study|Participant withdrew from trial|1|||
126616303|NCT01286311|455553402|FG000|Overall Study|Physician did not want outreach sent|14|||
126616304|NCT01286311|455553403|FG001|Overall Study|Physician did not want outreach sent|0|||
126616305|NCT02981953|455553409|FG000|Overall Study|Death|9|||
126616306|NCT02981953|455553409|FG000|Overall Study|Withdrawal by Subject|1|||
126616307|NCT02981953|455553409|FG000|Overall Study|Withdrawal to non-compliance|1|||
126742704|NCT03107793|456007624|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126742705|NCT03107793|456007625|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126742706|NCT03107793|456007626|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
126616308|NCT02889900|455553410|FG000|Overall Study|Adverse Event|11|||
126616309|NCT02889900|455553410|FG000|Overall Study|Condition under investigation worsened|32|||
126616310|NCT02889900|455553410|FG000|Overall Study|Other|5|||
126616311|NCT02889900|455553410|FG000|Overall Study|Withdrawal by Subject|7|||
126616312|NCT02889900|455553410|FG000|Overall Study|Not treated|2|||
126616313|NCT03146845|455553415|FG000|Overall Study|Reference ulcer healed|1|||
126616314|NCT03146845|455553416|FG001|Overall Study|Reference ulcer healed|0|||
126616315|NCT03146845|455553415|FG000|Overall Study|Physician Decision|1|||
126616316|NCT03146845|455553416|FG001|Overall Study|Physician Decision|0|||
126616317|NCT03146845|455553415|FG000|Overall Study|Adverse Event|1|||
126616318|NCT03146845|455553416|FG001|Overall Study|Adverse Event|0|||
126616319|NCT03146845|455553415|FG000|Overall Study|Withdrawal by Subject|2|||
126616320|NCT03146845|455553416|FG001|Overall Study|Withdrawal by Subject|0|||
126616321|NCT03146845|455553415|FG000|Overall Study|Noncompliance|0|||
126616322|NCT03146845|455553416|FG001|Overall Study|Noncompliance|1|||
126616323|NCT03146845|455553415|FG000|Overall Study|Protocol Violation|0|||
126742707|NCT03107793|456007622|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
126742708|NCT03107793|456007623|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
126742709|NCT03107793|456007624|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
126742710|NCT03107793|456007625|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
126742711|NCT03107793|456007626|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
126742712|NCT03107793|456007622|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
126742713|NCT03107793|456007623|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
126742714|NCT03107793|456007624|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
126742715|NCT03107793|456007625|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
126742716|NCT03107793|456007626|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
126742717|NCT03107793|456007622|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
126742718|NCT03107793|456007623|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
126742719|NCT03107793|456007624|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
126742720|NCT03107793|456007625|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
126742721|NCT03107793|456007626|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
126742722|NCT03107793|456007622|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
126742723|NCT03107793|456007623|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
126742724|NCT03107793|456007624|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
126742725|NCT03107793|456007625|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
126742726|NCT03107793|456007626|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
126742727|NCT03107793|456007622|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
126742728|NCT03107793|456007623|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
126742729|NCT03107793|456007624|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
126742730|NCT03107793|456007625|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
126742731|NCT03107793|456007626|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
126742732|NCT03107793|456007622|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
126742733|NCT03107793|456007623|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
126742734|NCT03107793|456007624|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
126742735|NCT03107793|456007625|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
126742736|NCT03107793|456007626|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
126742737|NCT03107793|456007622|FG000|Extension Period (Week 48- Week 104)|Death|0|||
126742738|NCT03107793|456007623|FG001|Extension Period (Week 48- Week 104)|Death|0|||
126616324|NCT03146845|455553416|FG001|Overall Study|Protocol Violation|2|||
126616325|NCT03146845|455553415|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
126616326|NCT03146845|455553416|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
126616327|NCT01535261|455553423|FG000|Overall Study|Physician Decision|8|||
126616328|NCT01535261|455553423|FG000|Overall Study|Protocol Violation|3|||
126616329|NCT01535261|455553423|FG000|Overall Study|Death|5|||
126742739|NCT03107793|456007624|FG002|Extension Period (Week 48- Week 104)|Death|0|||
126742740|NCT03107793|456007625|FG003|Extension Period (Week 48- Week 104)|Death|0|||
126742741|NCT03107793|456007626|FG004|Extension Period (Week 48- Week 104)|Death|1|||
126742742|NCT03107793|456007622|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
126742743|NCT03107793|456007623|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
126742744|NCT03107793|456007624|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
126742745|NCT03107793|456007625|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
126742746|NCT03107793|456007626|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
126742747|NCT03107793|456007622|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
126742748|NCT03107793|456007623|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
126742749|NCT03107793|456007624|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
126742750|NCT03107793|456007625|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
126742751|NCT03107793|456007626|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
126742752|NCT03107793|456007622|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
126742753|NCT03107793|456007623|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
126742754|NCT03107793|456007624|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
126742755|NCT03107793|456007625|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
126742756|NCT03107793|456007626|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
126742757|NCT03107793|456007622|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
126742758|NCT03107793|456007623|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
126742759|NCT03107793|456007624|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
126742760|NCT03107793|456007625|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
126742761|NCT03107793|456007626|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
126742762|NCT03107793|456007622|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
126742763|NCT03107793|456007623|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
126742764|NCT03107793|456007624|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
126742765|NCT03107793|456007625|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
126742766|NCT03107793|456007626|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
126742767|NCT03107793|456007622|FG000|Extension Period (Week 48- Week 104)|Other|0|||
126742768|NCT03107793|456007623|FG001|Extension Period (Week 48- Week 104)|Other|0|||
126742769|NCT03107793|456007624|FG002|Extension Period (Week 48- Week 104)|Other|0|||
126742770|NCT03107793|456007625|FG003|Extension Period (Week 48- Week 104)|Other|1|||
126742771|NCT03107793|456007626|FG004|Extension Period (Week 48- Week 104)|Other|3|||
126742772|NCT03107793|456007622|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
126742773|NCT03107793|456007623|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
126742774|NCT03107793|456007624|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
126742775|NCT03107793|456007625|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
126742776|NCT03107793|456007626|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
126742777|NCT01989572|456007630|FG000|Overall Study|Lack of Efficacy|35|||
126742778|NCT01989572|456007631|FG001|Overall Study|Lack of Efficacy|48|||
126742779|NCT01989572|456007632|FG002|Overall Study|Lack of Efficacy|48|||
126742780|NCT01989572|456007633|FG003|Overall Study|Lack of Efficacy|43|||
126742781|NCT01989572|456007634|FG004|Overall Study|Lack of Efficacy|71|||
126742782|NCT01989572|456007635|FG005|Overall Study|Lack of Efficacy|79|||
126742783|NCT01989572|456007630|FG000|Overall Study|Adverse Event|2|||
126742784|NCT01989572|456007631|FG001|Overall Study|Adverse Event|1|||
126742785|NCT01989572|456007632|FG002|Overall Study|Adverse Event|3|||
126742786|NCT01989572|456007633|FG003|Overall Study|Adverse Event|0|||
126742787|NCT01989572|456007634|FG004|Overall Study|Adverse Event|3|||
126742788|NCT01989572|456007635|FG005|Overall Study|Adverse Event|0|||
126742789|NCT01989572|456007630|FG000|Overall Study|Death|0|||
126742790|NCT01989572|456007631|FG001|Overall Study|Death|0|||
126742791|NCT01989572|456007632|FG002|Overall Study|Death|0|||
126742792|NCT01989572|456007633|FG003|Overall Study|Death|0|||
126742793|NCT01989572|456007634|FG004|Overall Study|Death|1|||
126742794|NCT01989572|456007635|FG005|Overall Study|Death|0|||
126742795|NCT01989572|456007630|FG000|Overall Study|Withdrawal by Subject|4|||
126742796|NCT01989572|456007631|FG001|Overall Study|Withdrawal by Subject|1|||
126742797|NCT01989572|456007632|FG002|Overall Study|Withdrawal by Subject|5|||
126742798|NCT01989572|456007633|FG003|Overall Study|Withdrawal by Subject|1|||
126742799|NCT01989572|456007634|FG004|Overall Study|Withdrawal by Subject|12|||
126742800|NCT01989572|456007635|FG005|Overall Study|Withdrawal by Subject|4|||
126742801|NCT01989572|456007630|FG000|Overall Study|complicating disease|1|||
126742802|NCT01989572|456007631|FG001|Overall Study|complicating disease|1|||
126742803|NCT01989572|456007632|FG002|Overall Study|complicating disease|2|||
126742804|NCT01989572|456007633|FG003|Overall Study|complicating disease|0|||
126742805|NCT01989572|456007634|FG004|Overall Study|complicating disease|1|||
126742806|NCT01989572|456007635|FG005|Overall Study|complicating disease|0|||
126742807|NCT01989572|456007630|FG000|Overall Study|error|2|||
126742808|NCT01989572|456007631|FG001|Overall Study|error|1|||
126616330|NCT01535261|455553423|FG000|Overall Study|Lost to Follow-up|8|||
126616331|NCT01535261|455553423|FG000|Overall Study|Withdrawal by Subject|14|||
126616332|NCT01535261|455553423|FG000|Overall Study|Adverse Event|12|||
126616333|NCT01757288|455553427|FG000|Overall Study|Consent withdrawal|0|||
126616334|NCT01757288|455553428|FG001|Overall Study|Consent withdrawal|4|||
126616335|NCT01757288|455553429|FG002|Overall Study|Consent withdrawal|4|||
126616336|NCT01757288|455553427|FG000|Overall Study|Patient off study, IRB hold.|0|||
126616337|NCT01757288|455553428|FG001|Overall Study|Patient off study, IRB hold.|0|||
126616338|NCT01757288|455553429|FG002|Overall Study|Patient off study, IRB hold.|1|||
126616339|NCT01757288|455553427|FG000|Overall Study|Patient death prior to starting treatment|0|||
126616340|NCT01757288|455553428|FG001|Overall Study|Patient death prior to starting treatment|0|||
126616341|NCT01757288|455553429|FG002|Overall Study|Patient death prior to starting treatment|1|||
126616342|NCT01757288|455553427|FG000|Overall Study|Wrong medication administered|0|||
126616343|NCT01757288|455553428|FG001|Overall Study|Wrong medication administered|1|||
126616344|NCT01757288|455553429|FG002|Overall Study|Wrong medication administered|0|||
126616345|NCT01757288|455553427|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
126616346|NCT01757288|455553428|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
126616347|NCT01757288|455553429|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
126616348|NCT01757288|455553427|FG000|Overall Study|Not meeting protocol constraints|0|||
126616349|NCT01757288|455553428|FG001|Overall Study|Not meeting protocol constraints|1|||
126616350|NCT01757288|455553429|FG002|Overall Study|Not meeting protocol constraints|1|||
126616351|NCT01757288|455553427|FG000|Overall Study|Multiple missed appointments|0|||
126616352|NCT01757288|455553428|FG001|Overall Study|Multiple missed appointments|1|||
126616353|NCT01757288|455553429|FG002|Overall Study|Multiple missed appointments|0|||
126616354|NCT01757288|455553427|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
126616355|NCT01757288|455553428|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
126616356|NCT01757288|455553429|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
126616357|NCT01757288|455553427|FG000|Overall Study|>2 weeks treatment break|0|||
126616358|NCT01757288|455553428|FG001|Overall Study|>2 weeks treatment break|0|||
126616359|NCT01757288|455553429|FG002|Overall Study|>2 weeks treatment break|1|||
126616360|NCT03875729|455553432|FG000|Overall Study|Adverse Event|0|||
126616361|NCT03875729|455553433|FG001|Overall Study|Adverse Event|5|||
126616362|NCT03875729|455553432|FG000|Overall Study|Withdrawal by Subject|8|||
126616363|NCT03875729|455553433|FG001|Overall Study|Withdrawal by Subject|11|||
126616364|NCT03875729|455553432|FG000|Overall Study|Pregnancy|0|||
126616365|NCT03875729|455553433|FG001|Overall Study|Pregnancy|1|||
126616366|NCT03875729|455553432|FG000|Overall Study|Lost to Follow-up|0|||
126616367|NCT03875729|455553433|FG001|Overall Study|Lost to Follow-up|5|||
126616368|NCT03875729|455553432|FG000|Overall Study|Personal reasons|2|||
126616369|NCT03875729|455553433|FG001|Overall Study|Personal reasons|0|||
126616370|NCT02764320|455553434|FG000|Overall Study|Withdrawal by Subject|35|||
126616371|NCT02764320|455553435|FG001|Overall Study|Withdrawal by Subject|38|||
126616372|NCT02764320|455553434|FG000|Overall Study|Protocol Violation|11|||
126616373|NCT02764320|455553435|FG001|Overall Study|Protocol Violation|6|||
126616374|NCT02764320|455553434|FG000|Overall Study|Adverse Event|2|||
126616375|NCT02764320|455553435|FG001|Overall Study|Adverse Event|0|||
126616376|NCT02764320|455553434|FG000|Overall Study|Health Issues unable to continue|2|||
126616377|NCT02764320|455553435|FG001|Overall Study|Health Issues unable to continue|0|||
126616378|NCT02764320|455553434|FG000|Overall Study|Did not meet inclusion criteria|1|||
126616379|NCT02764320|455553435|FG001|Overall Study|Did not meet inclusion criteria|0|||
126616380|NCT02764320|455553434|FG000|Overall Study|Subject moved|0|||
126616381|NCT02764320|455553435|FG001|Overall Study|Subject moved|2|||
126616382|NCT02764320|455553434|FG000|Overall Study|Overused medication unavailable|0|||
126616383|NCT02764320|455553435|FG001|Overall Study|Overused medication unavailable|1|||
126616384|NCT02764320|455553434|FG000|Overall Study|Seeking care outside site|0|||
126616385|NCT02764320|455553435|FG001|Overall Study|Seeking care outside site|1|||
126616386|NCT02764320|455553434|FG000|Overall Study|Technology barriers|0|||
126616387|NCT02764320|455553435|FG001|Overall Study|Technology barriers|1|||
126616388|NCT01405508|455553438|FG000|Overall Study|AE, non-serious non-fatal|1|||
126616389|NCT01405508|455553439|FG001|Overall Study|AE, non-serious non-fatal|1|||
126616390|NCT01405508|455553440|FG002|Overall Study|AE, non-serious non-fatal|0|||
126616391|NCT01405508|455553441|FG003|Overall Study|AE, non-serious non-fatal|0|||
126616392|NCT00476957|455553446|FG000|Overall Study|Lost to Follow-up|176|||
126616393|NCT00476957|455553447|FG001|Overall Study|Lost to Follow-up|193|||
126616394|NCT02159352|455553448|FG000|Overall Study|Adverse Event|3|||
126616395|NCT02159352|455553449|FG001|Overall Study|Adverse Event|1|||
126616396|NCT02159352|455553448|FG000|Overall Study|Withdrawal by Subject|0|||
126616397|NCT02159352|455553449|FG001|Overall Study|Withdrawal by Subject|1|||
126616398|NCT01964547|455553456|FG000|Overall Study|Adverse Event|8|||
126616399|NCT01964547|455553457|FG001|Overall Study|Adverse Event|2|||
126616400|NCT01964547|455553456|FG000|Overall Study|Withdrawal by Subject|4|||
126616401|NCT01964547|455553457|FG001|Overall Study|Withdrawal by Subject|7|||
126616402|NCT01964547|455553456|FG000|Overall Study|Lost to Follow-up|0|||
126616403|NCT01964547|455553457|FG001|Overall Study|Lost to Follow-up|1|||
126742809|NCT01989572|456007632|FG002|Overall Study|error|1|||
126742810|NCT01989572|456007633|FG003|Overall Study|error|1|||
126742811|NCT01989572|456007634|FG004|Overall Study|error|1|||
126742812|NCT01989572|456007635|FG005|Overall Study|error|1|||
126742813|NCT01989572|456007630|FG000|Overall Study|maximum dose reached|0|||
126742814|NCT01989572|456007631|FG001|Overall Study|maximum dose reached|1|||
126742815|NCT01989572|456007632|FG002|Overall Study|maximum dose reached|0|||
126742816|NCT01989572|456007633|FG003|Overall Study|maximum dose reached|0|||
126742817|NCT01989572|456007634|FG004|Overall Study|maximum dose reached|1|||
126742818|NCT01989572|456007635|FG005|Overall Study|maximum dose reached|0|||
126742819|NCT01989572|456007630|FG000|Overall Study|unknown/not specify|3|||
126742820|NCT01989572|456007631|FG001|Overall Study|unknown/not specify|4|||
126742821|NCT01989572|456007632|FG002|Overall Study|unknown/not specify|1|||
126742822|NCT01989572|456007633|FG003|Overall Study|unknown/not specify|3|||
126742823|NCT01989572|456007634|FG004|Overall Study|unknown/not specify|3|||
126742824|NCT01989572|456007635|FG005|Overall Study|unknown/not specify|5|||
126742825|NCT01989572|456007630|FG000|Overall Study|not start protocol therapy|5|||
126742826|NCT01989572|456007631|FG001|Overall Study|not start protocol therapy|1|||
126742827|NCT01989572|456007632|FG002|Overall Study|not start protocol therapy|2|||
126742828|NCT01989572|456007633|FG003|Overall Study|not start protocol therapy|3|||
126742829|NCT01989572|456007634|FG004|Overall Study|not start protocol therapy|4|||
126742830|NCT01989572|456007635|FG005|Overall Study|not start protocol therapy|18|||
126742831|NCT01989572|456007630|FG000|Overall Study|alternative therapy|3|||
126742832|NCT01989572|456007631|FG001|Overall Study|alternative therapy|0|||
126742833|NCT01989572|456007632|FG002|Overall Study|alternative therapy|0|||
126742834|NCT01989572|456007633|FG003|Overall Study|alternative therapy|0|||
126742835|NCT01989572|456007634|FG004|Overall Study|alternative therapy|1|||
126742836|NCT01989572|456007635|FG005|Overall Study|alternative therapy|3|||
126742837|NCT02910089|456007636|FG000|Overall Study|Lost insurance eligibility|22|||
126742838|NCT02910089|456007637|FG001|Overall Study|Lost insurance eligibility|16|||
126742839|NCT02280096|456007638|FG000|Overall Study|Pregnancy|1|||
126742840|NCT02280096|456007639|FG001|Overall Study|Pregnancy|0|||
126742841|NCT02280096|456007638|FG000|Overall Study|Functional neurological disorder|1|||
126742842|NCT02280096|456007639|FG001|Overall Study|Functional neurological disorder|0|||
126742843|NCT02280096|456007638|FG000|Overall Study|Lack of attachment|0|||
126742844|NCT02280096|456007639|FG001|Overall Study|Lack of attachment|1|||
126742845|NCT02939976|456007640|FG000|Overall Study|Lost to Follow-up|7|||
126742846|NCT02939976|456007641|FG001|Overall Study|Lost to Follow-up|1|||
126742847|NCT02939976|456007642|FG002|Overall Study|Lost to Follow-up|1|||
126742848|NCT02939976|456007643|FG003|Overall Study|Lost to Follow-up|2|||
126742849|NCT02939976|456007640|FG000|Overall Study|Withdrawal by Subject|4|||
126742850|NCT02939976|456007641|FG001|Overall Study|Withdrawal by Subject|0|||
126742851|NCT02939976|456007642|FG002|Overall Study|Withdrawal by Subject|2|||
126742852|NCT02939976|456007643|FG003|Overall Study|Withdrawal by Subject|4|||
126742853|NCT02939976|456007640|FG000|Overall Study|Due to early study closure|4|||
126742854|NCT02939976|456007641|FG001|Overall Study|Due to early study closure|3|||
126742855|NCT02939976|456007642|FG002|Overall Study|Due to early study closure|2|||
126742856|NCT02939976|456007643|FG003|Overall Study|Due to early study closure|3|||
126742857|NCT01872897|456007644|FG000|Overall Study|Withdrawal by Subject|1|||
126742858|NCT01872897|456007645|FG001|Overall Study|Withdrawal by Subject|0|||
126742859|NCT02418585|456007646|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
126742860|NCT02418585|456007647|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
126742861|NCT02418585|456007646|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
126742862|NCT02418585|456007647|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
126742863|NCT02418585|456007646|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
126742864|NCT02418585|456007647|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
126742865|NCT02418585|456007646|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
126742866|NCT02418585|456007647|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
126742867|NCT02418585|456007646|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
126742868|NCT02418585|456007647|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
126742869|NCT02418585|456007646|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
126742870|NCT02418585|456007647|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
126742871|NCT02418585|456007646|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
126742872|NCT02418585|456007647|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
126742873|NCT02418585|456007646|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
126742874|NCT02418585|456007647|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
126616404|NCT01964547|455553456|FG000|Overall Study|Withdrawal by Investigator|0|||
126616405|NCT01964547|455553457|FG001|Overall Study|Withdrawal by Investigator|1|||
126742875|NCT02418585|456007646|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
126742876|NCT02418585|456007647|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
126742877|NCT02418585|456007646|FG000|Follow-up Phase (24 Weeks)|Other|3|||
126742878|NCT02418585|456007647|FG001|Follow-up Phase (24 Weeks)|Other|2|||
126742879|NCT02040857|456007648|FG000|Overall Study|Adverse Event|14|||
126742880|NCT02040857|456007648|FG000|Overall Study|Physician Decision|5|||
126742881|NCT02040857|456007648|FG000|Overall Study|Withdrawal by Subject|31|||
126742882|NCT02040857|456007648|FG000|Overall Study|patient non-compliance|3|||
126742883|NCT02040857|456007648|FG000|Overall Study|Lost to Follow-up|2|||
126742884|NCT02040857|456007648|FG000|Overall Study|recurrence|4|||
126742885|NCT02040857|456007648|FG000|Overall Study|ineligible|1|||
126742886|NCT04159701|456007649|FG000|Period 1: Treatment Period|Pregnancy|1|||
126742887|NCT04159701|456007650|FG001|Period 1: Treatment Period|Pregnancy|0|||
126742888|NCT04159701|456007649|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
126742889|NCT04159701|456007650|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
126742890|NCT04159701|456007649|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
126742891|NCT04159701|456007650|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
126742892|NCT04159701|456007649|FG000|Washout Period|site terminated by sponsor|0|||
126742893|NCT04159701|456007650|FG001|Washout Period|site terminated by sponsor|1|||
126742894|NCT04159701|456007649|FG000|Washout Period|study terminated by sponsor|10|||
126742895|NCT04159701|456007650|FG001|Washout Period|study terminated by sponsor|3|||
126742896|NCT04159701|456007649|FG000|Washout Period|Withdrawal by Subject|1|||
126742897|NCT04159701|456007650|FG001|Washout Period|Withdrawal by Subject|0|||
126616406|NCT03246724|455553458|FG000|Overall Study|Withdrawal by Subject|5|||
126616407|NCT03246724|455553459|FG001|Overall Study|Withdrawal by Subject|2|||
126616408|NCT03246724|455553460|FG002|Overall Study|Withdrawal by Subject|4|||
126616409|NCT03246724|455553461|FG003|Overall Study|Withdrawal by Subject|2|||
126616410|NCT03246724|455553458|FG000|Overall Study|Ineligible on day of surgery|7|||
126616411|NCT03246724|455553459|FG001|Overall Study|Ineligible on day of surgery|2|||
126616412|NCT03246724|455553460|FG002|Overall Study|Ineligible on day of surgery|0|||
126616413|NCT03246724|455553461|FG003|Overall Study|Ineligible on day of surgery|3|||
126616414|NCT03246724|455553458|FG000|Overall Study|Study completed before surgical date|2|||
126616415|NCT03246724|455553459|FG001|Overall Study|Study completed before surgical date|1|||
126616416|NCT03246724|455553460|FG002|Overall Study|Study completed before surgical date|8|||
126616417|NCT03246724|455553461|FG003|Overall Study|Study completed before surgical date|1|||
126616418|NCT03246724|455553458|FG000|Overall Study|Transferred to other arm|0|||
126616419|NCT03246724|455553459|FG001|Overall Study|Transferred to other arm|0|||
126616420|NCT03246724|455553460|FG002|Overall Study|Transferred to other arm|1|||
126616421|NCT03246724|455553461|FG003|Overall Study|Transferred to other arm|0|||
126616422|NCT03246724|455553458|FG000|Overall Study|Unable to obtain medication timely|0|||
126616423|NCT03246724|455553459|FG001|Overall Study|Unable to obtain medication timely|2|||
126616424|NCT03246724|455553460|FG002|Overall Study|Unable to obtain medication timely|2|||
126616425|NCT03246724|455553461|FG003|Overall Study|Unable to obtain medication timely|1|||
126616426|NCT03246724|455553458|FG000|Overall Study|Re-consented to participate|0|||
126616427|NCT03246724|455553459|FG001|Overall Study|Re-consented to participate|0|||
126616428|NCT03246724|455553460|FG002|Overall Study|Re-consented to participate|0|||
126616429|NCT03246724|455553461|FG003|Overall Study|Re-consented to participate|1|||
126616430|NCT00960206|455553462|FG000|Overall Study|Death|7|||
126616431|NCT00960206|455553463|FG001|Overall Study|Death|4|||
126616432|NCT00960206|455553464|FG002|Overall Study|Death|1|||
126616433|NCT00960206|455553462|FG000|Overall Study|Unwilling/Unable to return|1|||
126616434|NCT00960206|455553463|FG001|Overall Study|Unwilling/Unable to return|2|||
126616435|NCT00960206|455553464|FG002|Overall Study|Unwilling/Unable to return|0|||
126616436|NCT00960206|455553462|FG000|Overall Study|Lost to Follow-up|8|||
126616437|NCT00960206|455553463|FG001|Overall Study|Lost to Follow-up|14|||
126616438|NCT00960206|455553464|FG002|Overall Study|Lost to Follow-up|8|||
126616439|NCT00960206|455553462|FG000|Overall Study|Withdrawal by Subject|2|||
126616440|NCT00960206|455553463|FG001|Overall Study|Withdrawal by Subject|4|||
126616441|NCT00960206|455553464|FG002|Overall Study|Withdrawal by Subject|0|||
126616442|NCT00960206|455553462|FG000|Overall Study|Revision of study component|2|||
126616443|NCT00960206|455553463|FG001|Overall Study|Revision of study component|2|||
126616444|NCT00960206|455553464|FG002|Overall Study|Revision of study component|2|||
126616445|NCT00960206|455553462|FG000|Overall Study|Missing 10 year data|20|||
126616446|NCT00960206|455553463|FG001|Overall Study|Missing 10 year data|1|||
126616447|NCT00960206|455553464|FG002|Overall Study|Missing 10 year data|1|||
126616448|NCT02255474|455553466|FG000|Overall Study|Lost to Follow-up|1|||
126616449|NCT02255474|455553467|FG001|Overall Study|Lost to Follow-up|1|||
126616450|NCT02255474|455553468|FG002|Overall Study|Lost to Follow-up|3|||
126616451|NCT02255474|455553466|FG000|Overall Study|Withdrawal by Subject|1|||
126616452|NCT02255474|455553467|FG001|Overall Study|Withdrawal by Subject|1|||
126616453|NCT02255474|455553468|FG002|Overall Study|Withdrawal by Subject|0|||
126616454|NCT03075878|455553472|FG000|Overall Study|Physician Decision|1|||
126616455|NCT02612285|455553473|FG000|Overall Study|Withdrawal by Subject|1|||
126616456|NCT00805441|455553474|FG000|Overall Study|Adverse Event|5|||
126616457|NCT00805441|455553475|FG001|Overall Study|Adverse Event|2|||
126616458|NCT00805441|455553474|FG000|Overall Study|Lack of Efficacy|0|||
126742898|NCT04159701|456007649|FG000|Washout Period|Inadvertent Enrollment|1|||
126742899|NCT04159701|456007650|FG001|Washout Period|Inadvertent Enrollment|0|||
126742900|NCT04159701|456007649|FG000|Washout Period|Miscellaneous|1|||
126616459|NCT00805441|455553475|FG001|Overall Study|Lack of Efficacy|2|||
126616460|NCT00805441|455553474|FG000|Overall Study|Protocol Violation|4|||
126616461|NCT00805441|455553475|FG001|Overall Study|Protocol Violation|8|||
126616462|NCT00805441|455553474|FG000|Overall Study|Lost to Follow-up|10|||
126742901|NCT04159701|456007650|FG001|Washout Period|Miscellaneous|0|||
126742902|NCT04159701|456007649|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
126742903|NCT04159701|456007650|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
126742904|NCT04159701|456007649|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
126742905|NCT04159701|456007650|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
126742906|NCT04159701|456007649|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
126742907|NCT04159701|456007650|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
126742908|NCT04159701|456007649|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
126742909|NCT04159701|456007650|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
126742910|NCT04159701|456007649|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
126742911|NCT04159701|456007650|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
126742912|NCT03605836|456007651|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
126742913|NCT03605836|456007652|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
126742914|NCT03605836|456007653|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
126742915|NCT03605836|456007654|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
126742916|NCT03605836|456007651|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
126742917|NCT03605836|456007652|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
126742918|NCT03605836|456007653|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
126742919|NCT03605836|456007654|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
126742920|NCT03605836|456007651|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
126742921|NCT03605836|456007652|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
126742922|NCT03605836|456007653|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
126742923|NCT03605836|456007654|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
126742924|NCT03605836|456007651|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
126742925|NCT03605836|456007652|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
126742926|NCT03605836|456007653|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
126742927|NCT03605836|456007654|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
126742928|NCT03605836|456007651|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
126742929|NCT03605836|456007652|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
126742930|NCT03605836|456007653|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
126742931|NCT03605836|456007654|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
126742932|NCT03605836|456007651|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
126742933|NCT03605836|456007652|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
126742934|NCT03605836|456007653|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
126742935|NCT03605836|456007654|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
126742936|NCT03605836|456007651|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
126742937|NCT03605836|456007652|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
126742938|NCT03605836|456007653|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
126742939|NCT03605836|456007654|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
126742940|NCT03605836|456007651|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
126742941|NCT03605836|456007652|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
126742942|NCT03605836|456007653|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
126742943|NCT03605836|456007654|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
126742944|NCT03605836|456007651|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
126742945|NCT03605836|456007652|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
126742946|NCT03605836|456007653|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
126742947|NCT03605836|456007654|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
126742948|NCT03605836|456007651|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
126742949|NCT03605836|456007652|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
126742950|NCT03605836|456007653|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
126742951|NCT03605836|456007654|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
126742952|NCT03605836|456007651|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
126742953|NCT03605836|456007652|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
126742954|NCT03605836|456007653|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
126742955|NCT03605836|456007654|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
126742956|NCT03605836|456007651|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
126742957|NCT03605836|456007652|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
126742958|NCT03605836|456007653|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
126742959|NCT03605836|456007654|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
126742960|NCT03605836|456007651|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
126742961|NCT03605836|456007652|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
126742962|NCT03605836|456007653|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
126616463|NCT00805441|455553475|FG001|Overall Study|Lost to Follow-up|13|||
126742963|NCT03605836|456007654|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
126742964|NCT03605836|456007651|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
126742965|NCT03605836|456007652|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
126742966|NCT03605836|456007653|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
126742967|NCT03605836|456007654|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
126742968|NCT03605836|456007651|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
126742969|NCT03605836|456007652|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
126742970|NCT03605836|456007653|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
126742971|NCT03605836|456007654|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
126742972|NCT03605836|456007651|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
126742973|NCT03605836|456007652|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
126742974|NCT03605836|456007653|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
126742975|NCT03605836|456007654|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
126742976|NCT03605836|456007651|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
126742977|NCT03605836|456007652|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
126742978|NCT03605836|456007653|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
126742979|NCT03605836|456007654|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
126742980|NCT03605836|456007651|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
126742981|NCT03605836|456007652|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
126742982|NCT03605836|456007653|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
126742983|NCT03605836|456007654|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
126742984|NCT03605836|456007651|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
126742985|NCT03605836|456007652|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
126742986|NCT03605836|456007653|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
126742987|NCT03605836|456007654|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
126742988|NCT03605836|456007651|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
126742989|NCT03605836|456007652|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
126742990|NCT03605836|456007653|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
126742991|NCT03605836|456007654|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
126742992|NCT03605836|456007651|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
126742993|NCT03605836|456007652|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
126742994|NCT03605836|456007653|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
126742995|NCT03605836|456007654|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
126742996|NCT03605836|456007651|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
126742997|NCT03605836|456007652|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
126742998|NCT03605836|456007653|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
126742999|NCT03605836|456007654|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
126743000|NCT02057068|456007661|FG000|Overall Study|Withdrawal by Subject|2|||
126743001|NCT02057068|456007662|FG001|Overall Study|Withdrawal by Subject|2|||
126743002|NCT02057068|456007661|FG000|Overall Study|Caregiver (CG) Health|0|||
126743003|NCT02057068|456007662|FG001|Overall Study|Caregiver (CG) Health|2|||
126743004|NCT02057068|456007661|FG000|Overall Study|Carepartner (CP) Health|4|||
126743005|NCT02057068|456007662|FG001|Overall Study|Carepartner (CP) Health|2|||
126743006|NCT02057068|456007661|FG000|Overall Study|Lost to Follow-up|2|||
126743007|NCT02057068|456007662|FG001|Overall Study|Lost to Follow-up|2|||
126743008|NCT00865046|456007663|FG000|Overall Study|Lost to Follow-up|1|||
126743009|NCT00865046|456007664|FG001|Overall Study|Lost to Follow-up|4|||
126743010|NCT00865046|456007665|FG002|Overall Study|Lost to Follow-up|0|||
126743011|NCT00865046|456007663|FG000|Overall Study|Death|0|||
126743012|NCT00865046|456007664|FG001|Overall Study|Death|1|||
126743013|NCT00865046|456007665|FG002|Overall Study|Death|1|||
126743014|NCT00865046|456007663|FG000|Overall Study|Withdrawal by Subject|5|||
126743015|NCT00865046|456007664|FG001|Overall Study|Withdrawal by Subject|0|||
126743016|NCT00865046|456007665|FG002|Overall Study|Withdrawal by Subject|0|||
126743017|NCT01782885|456007667|FG000|Overall Study|Lost to Follow-up|4|||
126743018|NCT01782885|456007668|FG001|Overall Study|Lost to Follow-up|6|||
126743019|NCT01024920|456007670|FG000|Overall Study|Progressive disease|47|||
126743020|NCT01024920|456007671|FG001|Overall Study|Progressive disease|25|||
126743021|NCT01024920|456007670|FG000|Overall Study|Adverse Event|8|||
126743022|NCT01024920|456007671|FG001|Overall Study|Adverse Event|4|||
126743023|NCT01024920|456007670|FG000|Overall Study|Lost to Follow-up|0|||
126743024|NCT01024920|456007671|FG001|Overall Study|Lost to Follow-up|1|||
126743025|NCT01024920|456007670|FG000|Overall Study|Patient refusal to continue|4|||
126743026|NCT01024920|456007671|FG001|Overall Study|Patient refusal to continue|0|||
126743027|NCT01024920|456007670|FG000|Overall Study|Other than listed|5|||
126743028|NCT01024920|456007671|FG001|Overall Study|Other than listed|1|||
126743029|NCT01024920|456007670|FG000|Overall Study|Not treated|3|||
126743030|NCT01024920|456007671|FG001|Overall Study|Not treated|0|||
126743031|NCT01024920|456007670|FG000|Overall Study|Protocol Violation|0|||
126743032|NCT01024920|456007671|FG001|Overall Study|Protocol Violation|1|||
126743033|NCT02977507|456007672|FG000|Overall Study|Protocol Deviation|1|||
126743034|NCT02977507|456007673|FG001|Overall Study|Protocol Deviation|0|||
126743035|NCT02977507|456007672|FG000|Overall Study|Lost to Follow-up|1|||
126743036|NCT02977507|456007673|FG001|Overall Study|Lost to Follow-up|0|||
126743037|NCT00633360|456007674|FG000|Overall Study|Lost to Follow-up|1|||
126743038|NCT00633360|456007675|FG001|Overall Study|Lost to Follow-up|1|||
126743039|NCT00633360|456007674|FG000|Overall Study|Adverse Event|3|||
126743040|NCT00633360|456007675|FG001|Overall Study|Adverse Event|1|||
126743041|NCT00633360|456007674|FG000|Overall Study|Protocol Violation|0|||
126743042|NCT00633360|456007675|FG001|Overall Study|Protocol Violation|1|||
126743043|NCT01098032|456007678|FG000|Overall Study|Withdrawal by Subject|1|||
126743044|NCT01098032|456007679|FG001|Overall Study|Withdrawal by Subject|1|||
126743045|NCT00481988|456007680|FG000|Overall Study|Withdrawal by Subject|1|||
126743046|NCT00481988|456007681|FG001|Overall Study|Withdrawal by Subject|1|||
126743047|NCT00471276|456007683|FG000|Overall Study|Death|2|||
126743048|NCT00471276|456007683|FG000|Overall Study|Adverse Event|16|||
126743049|NCT00471276|456007683|FG000|Overall Study|Protocol Violation|1|||
126743050|NCT00471276|456007683|FG000|Overall Study|Objective progression or relapse|54|||
126743051|NCT00471276|456007683|FG000|Overall Study|Global deterioration of health status|1|||
126743052|NCT00471276|456007683|FG000|Overall Study|Other|3|||
126743053|NCT00471276|456007683|FG000|Overall Study|Refused treatment|6|||
126743054|NCT01594411|456007684|FG000|Overall Study|Lost to Follow-up|2|||
126743055|NCT00910728|456007690|FG000|Overall Study|Lack of Efficacy|2|||
126743056|NCT00910728|456007691|FG001|Overall Study|Lack of Efficacy|3|||
126743057|NCT00910728|456007692|FG002|Overall Study|Lack of Efficacy|1|||
126743058|NCT00910728|456007693|FG003|Overall Study|Lack of Efficacy|2|||
126743059|NCT00910728|456007694|FG004|Overall Study|Lack of Efficacy|1|||
126743060|NCT00910728|456007695|FG005|Overall Study|Lack of Efficacy|0|||
126743061|NCT00910728|456007696|FG006|Overall Study|Lack of Efficacy|2|||
126743062|NCT00910728|456007697|FG007|Overall Study|Lack of Efficacy|2|||
126743063|NCT00910728|456007698|FG008|Overall Study|Lack of Efficacy|2|||
126743064|NCT00910728|456007690|FG000|Overall Study|Withdrawal by Subject|0|||
126743065|NCT00910728|456007691|FG001|Overall Study|Withdrawal by Subject|0|||
126743066|NCT00910728|456007692|FG002|Overall Study|Withdrawal by Subject|0|||
126743067|NCT00910728|456007693|FG003|Overall Study|Withdrawal by Subject|0|||
126743068|NCT00910728|456007694|FG004|Overall Study|Withdrawal by Subject|3|||
126743069|NCT00910728|456007695|FG005|Overall Study|Withdrawal by Subject|1|||
126743070|NCT00910728|456007696|FG006|Overall Study|Withdrawal by Subject|2|||
126743071|NCT00910728|456007697|FG007|Overall Study|Withdrawal by Subject|0|||
126743072|NCT00910728|456007698|FG008|Overall Study|Withdrawal by Subject|0|||
126743073|NCT00910728|456007690|FG000|Overall Study|(not specified)|2|||
126743074|NCT00910728|456007691|FG001|Overall Study|(not specified)|0|||
126743075|NCT00910728|456007692|FG002|Overall Study|(not specified)|1|||
126743076|NCT00910728|456007693|FG003|Overall Study|(not specified)|0|||
126743077|NCT00910728|456007694|FG004|Overall Study|(not specified)|1|||
126743078|NCT00910728|456007695|FG005|Overall Study|(not specified)|0|||
126743079|NCT00910728|456007696|FG006|Overall Study|(not specified)|0|||
126616464|NCT00805441|455553474|FG000|Overall Study|Withdrawal by Subject|15|||
126616465|NCT00805441|455553475|FG001|Overall Study|Withdrawal by Subject|9|||
126743080|NCT00910728|456007697|FG007|Overall Study|(not specified)|0|||
126743081|NCT00910728|456007698|FG008|Overall Study|(not specified)|0|||
126743082|NCT00910728|456007690|FG000|Overall Study|Adverse Event|2|||
126743083|NCT00910728|456007691|FG001|Overall Study|Adverse Event|0|||
126743084|NCT00910728|456007692|FG002|Overall Study|Adverse Event|1|||
126743085|NCT00910728|456007693|FG003|Overall Study|Adverse Event|1|||
126743086|NCT00910728|456007694|FG004|Overall Study|Adverse Event|0|||
126743087|NCT00910728|456007695|FG005|Overall Study|Adverse Event|0|||
126743088|NCT00910728|456007696|FG006|Overall Study|Adverse Event|2|||
126743089|NCT00910728|456007697|FG007|Overall Study|Adverse Event|1|||
126743090|NCT00910728|456007698|FG008|Overall Study|Adverse Event|1|||
126743091|NCT00044213|456007699|FG000|Overall Study|Withdrawal by Subject|50|||
126743092|NCT00044213|456007700|FG001|Overall Study|Withdrawal by Subject|65|||
126743093|NCT00044213|456007701|FG002|Overall Study|Withdrawal by Subject|91|||
126743094|NCT00044213|456007702|FG003|Overall Study|Withdrawal by Subject|83|||
126743095|NCT00044213|456007699|FG000|Overall Study|Death|42|||
126743096|NCT00044213|456007700|FG001|Overall Study|Death|42|||
126743097|NCT00044213|456007701|FG002|Overall Study|Death|42|||
126743098|NCT00044213|456007702|FG003|Overall Study|Death|49|||
126743099|NCT00044213|456007699|FG000|Overall Study|Lost to Follow-up|8|||
126743100|NCT00044213|456007700|FG001|Overall Study|Lost to Follow-up|5|||
126743101|NCT00044213|456007701|FG002|Overall Study|Lost to Follow-up|5|||
126743102|NCT00044213|456007702|FG003|Overall Study|Lost to Follow-up|4|||
126743103|NCT01927068|456007704|FG000|Overall Study|Death|37|||
126743104|NCT01927068|456007705|FG001|Overall Study|Death|3|||
126616466|NCT00805441|455553474|FG000|Overall Study|Physician Decision|0|||
126743105|NCT01927068|456007704|FG000|Overall Study|Withdrawal by Subject|50|||
126743106|NCT01927068|456007705|FG001|Overall Study|Withdrawal by Subject|3|||
126743107|NCT01927068|456007704|FG000|Overall Study|Lost to Follow-up|10|||
126743108|NCT01927068|456007705|FG001|Overall Study|Lost to Follow-up|2|||
126743109|NCT01927068|456007704|FG000|Overall Study|Physician Decision|9|||
126616467|NCT00805441|455553475|FG001|Overall Study|Physician Decision|1|||
126616468|NCT00805441|455553474|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
126616469|NCT00805441|455553475|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
126616470|NCT00853957|455553480|FG000|Overall Study|Adverse Event|9|||
126616471|NCT00853957|455553481|FG001|Overall Study|Adverse Event|3|||
126616472|NCT00853957|455553480|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126616473|NCT00853957|455553481|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126616474|NCT00853957|455553480|FG000|Overall Study|Subject withdrew consent|4|||
126616475|NCT00853957|455553481|FG001|Overall Study|Subject withdrew consent|5|||
126616476|NCT00853957|455553480|FG000|Overall Study|Lost to Follow-up|1|||
126616477|NCT00853957|455553481|FG001|Overall Study|Lost to Follow-up|6|||
126616478|NCT00853957|455553480|FG000|Overall Study|Protocol deviation|0|||
126616479|NCT00853957|455553481|FG001|Overall Study|Protocol deviation|3|||
126616480|NCT02158806|455553482|FG000|Overall Study|Death|2|||
126616481|NCT02158806|455553483|FG001|Overall Study|Death|0|||
126616482|NCT02158806|455553482|FG000|Overall Study|Withdrawal by Subject|2|||
126616483|NCT02158806|455553483|FG001|Overall Study|Withdrawal by Subject|0|||
126616484|NCT02158806|455553482|FG000|Overall Study|Lost to Follow-up|0|||
126616485|NCT02158806|455553483|FG001|Overall Study|Lost to Follow-up|3|||
126616486|NCT02158806|455553482|FG000|Overall Study|Moved out of area|0|||
126616487|NCT02158806|455553483|FG001|Overall Study|Moved out of area|1|||
126616488|NCT02158806|455553482|FG000|Overall Study|Transferred to palliative care|0|||
126616489|NCT02158806|455553483|FG001|Overall Study|Transferred to palliative care|1|||
126616490|NCT01898299|455553484|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
126616491|NCT01898299|455553485|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
126616492|NCT02340806|455553486|FG000|Overall Study|Protocol Violation|2|||
126616493|NCT02340806|455553487|FG001|Overall Study|Protocol Violation|0|||
126616494|NCT02340806|455553486|FG000|Overall Study|epidural catheter replaced|2|||
126616495|NCT02340806|455553487|FG001|Overall Study|epidural catheter replaced|1|||
126616496|NCT02340806|455553486|FG000|Overall Study|history of chronic pain medication|1|||
126616497|NCT02340806|455553487|FG001|Overall Study|history of chronic pain medication|0|||
126616498|NCT02340806|455553486|FG000|Overall Study|re-dose < 90 min of CSE|1|||
126616499|NCT02340806|455553487|FG001|Overall Study|re-dose < 90 min of CSE|3|||
126616500|NCT00452452|455553488|FG000|Overall Study|Protocol Violation|0|||
126616501|NCT00452452|455553489|FG001|Overall Study|Protocol Violation|0|||
126616502|NCT00452452|455553490|FG002|Overall Study|Protocol Violation|1|||
126616503|NCT00452452|455553488|FG000|Overall Study|Withdrawal by Subject|1|||
126616504|NCT00452452|455553489|FG001|Overall Study|Withdrawal by Subject|0|||
126616505|NCT00452452|455553490|FG002|Overall Study|Withdrawal by Subject|0|||
126616506|NCT00452452|455553488|FG000|Overall Study|Lost to Follow-up|1|||
126616507|NCT00452452|455553489|FG001|Overall Study|Lost to Follow-up|0|||
126616508|NCT00452452|455553490|FG002|Overall Study|Lost to Follow-up|0|||
126616509|NCT03070301|455553495|FG000|Overall Study|Progression of disease|16|||
126616510|NCT03070301|455553495|FG000|Overall Study|Physician Decision|3|||
126616511|NCT03070301|455553495|FG000|Overall Study|Withdrawal by Subject|1|||
126616512|NCT04520256|455553499|FG000|Overall Study|Lost to Follow-up|6|||
126616513|NCT04520256|455553500|FG001|Overall Study|Lost to Follow-up|4|||
126616514|NCT04520256|455553501|FG002|Overall Study|Lost to Follow-up|2|||
126616515|NCT04520256|455553502|FG003|Overall Study|Lost to Follow-up|3|||
126616516|NCT04520256|455553503|FG004|Overall Study|Lost to Follow-up|6|||
126616517|NCT04520256|455553504|FG005|Overall Study|Lost to Follow-up|6|||
126616518|NCT04520256|455553505|FG006|Overall Study|Lost to Follow-up|4|||
126616519|NCT04520256|455553506|FG007|Overall Study|Lost to Follow-up|6|||
126616520|NCT04520256|455553507|FG008|Overall Study|Lost to Follow-up|1|||
126616521|NCT04520256|455553508|FG009|Overall Study|Lost to Follow-up|3|||
126616522|NCT04520256|455553509|FG010|Overall Study|Lost to Follow-up|3|||
126616523|NCT04520256|455553510|FG011|Overall Study|Lost to Follow-up|2|||
126616524|NCT04520256|455553511|FG012|Overall Study|Lost to Follow-up|5|||
126616525|NCT04520256|455553512|FG013|Overall Study|Lost to Follow-up|3|||
126616526|NCT04520256|455553513|FG014|Overall Study|Lost to Follow-up|3|||
126616527|NCT04520256|455553514|FG015|Overall Study|Lost to Follow-up|6|||
126616528|NCT04520256|455553515|FG016|Overall Study|Lost to Follow-up|6|||
126616529|NCT04520256|455553516|FG017|Overall Study|Lost to Follow-up|4|||
126616530|NCT04520256|455553517|FG018|Overall Study|Lost to Follow-up|3|||
126616531|NCT04520256|455553518|FG019|Overall Study|Lost to Follow-up|3|||
126616532|NCT04520256|455553519|FG020|Overall Study|Lost to Follow-up|7|||
126616533|NCT04520256|455553520|FG021|Overall Study|Lost to Follow-up|3|||
126616534|NCT04520256|455553521|FG022|Overall Study|Lost to Follow-up|3|||
126616535|NCT04520256|455553522|FG023|Overall Study|Lost to Follow-up|8|||
126616536|NCT04520256|455553523|FG024|Overall Study|Lost to Follow-up|5|||
126616537|NCT04520256|455553524|FG025|Overall Study|Lost to Follow-up|4|||
126616538|NCT04520256|455553525|FG026|Overall Study|Lost to Follow-up|3|||
126616539|NCT04520256|455553526|FG027|Overall Study|Lost to Follow-up|4|||
126616540|NCT04520256|455553527|FG028|Overall Study|Lost to Follow-up|3|||
126743110|NCT01927068|456007705|FG001|Overall Study|Physician Decision|0|||
126616541|NCT04520256|455553528|FG029|Overall Study|Lost to Follow-up|4|||
126616542|NCT04520256|455553529|FG030|Overall Study|Lost to Follow-up|4|||
126616543|NCT04520256|455553530|FG031|Overall Study|Lost to Follow-up|4|||
126616544|NCT02880293|455555341|FG000|Overall Study|Inevaluable|5|||
126743111|NCT01927068|456007704|FG000|Overall Study|Missed last follow-up visit|2|||
126743112|NCT01927068|456007705|FG001|Overall Study|Missed last follow-up visit|0|||
126743113|NCT00880607|456007706|FG000|Overall Study|Physician Decision|2|||
126743114|NCT00880607|456007707|FG001|Overall Study|Physician Decision|2|||
126743115|NCT00880607|456007706|FG000|Overall Study|Protocol Violation|2|||
126743116|NCT00880607|456007707|FG001|Overall Study|Protocol Violation|1|||
126743117|NCT00880607|456007706|FG000|Overall Study|surgery did not extend past L1 level|3|||
126743118|NCT00880607|456007707|FG001|Overall Study|surgery did not extend past L1 level|0|||
126743119|NCT02963766|456007709|FG000|Double-Blind Period|Adverse Event|1|||
126743120|NCT02963766|456007710|FG001|Double-Blind Period|Adverse Event|0|||
126743121|NCT02963766|456007711|FG002|Double-Blind Period|Adverse Event|1|||
126743122|NCT02963766|456007709|FG000|Double-Blind Period|Physician Decision|1|||
126743123|NCT02963766|456007710|FG001|Double-Blind Period|Physician Decision|0|||
126743124|NCT02963766|456007711|FG002|Double-Blind Period|Physician Decision|0|||
126743125|NCT02963766|456007709|FG000|Double-Blind Period|Withdrawal by Subject|1|||
126743126|NCT02963766|456007710|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126743127|NCT02963766|456007711|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126743128|NCT02963766|456007709|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
126743129|NCT02963766|456007710|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
126743130|NCT02963766|456007711|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
126743131|NCT02963766|456007709|FG000|Double-Blind Period|Protocol Violation|1|||
126743132|NCT02963766|456007710|FG001|Double-Blind Period|Protocol Violation|0|||
126743133|NCT02963766|456007711|FG002|Double-Blind Period|Protocol Violation|0|||
126743134|NCT02963766|456007709|FG000|Double-Blind Period|Lost to Follow-up|0|||
126743135|NCT02963766|456007710|FG001|Double-Blind Period|Lost to Follow-up|1|||
126743136|NCT02963766|456007711|FG002|Double-Blind Period|Lost to Follow-up|0|||
126743137|NCT02963766|456007709|FG000|Open Label Extension (OLE)|Physician Decision|1|||
126743138|NCT02963766|456007710|FG001|Open Label Extension (OLE)|Physician Decision|2|||
126743139|NCT02963766|456007711|FG002|Open Label Extension (OLE)|Physician Decision|2|||
126743140|NCT02963766|456007709|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
126743141|NCT02963766|456007710|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
126743142|NCT02963766|456007711|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
126743143|NCT00499460|456007712|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
126743144|NCT00499460|456007713|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
126743145|NCT00499460|456007712|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
126743146|NCT00499460|456007713|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
126743147|NCT00499460|456007712|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
126743148|NCT00499460|456007713|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
126743149|NCT00814307|456007714|FG000|Overall Study|Randomized but not treated|1|||
126743150|NCT00814307|456007715|FG001|Overall Study|Randomized but not treated|0|||
126743151|NCT00814307|456007716|FG002|Overall Study|Randomized but not treated|0|||
126743152|NCT00814307|456007717|FG003|Overall Study|Randomized but not treated|0|||
126743153|NCT00814307|456007714|FG000|Overall Study|Adverse Event|3|||
126743154|NCT00814307|456007715|FG001|Overall Study|Adverse Event|9|||
126743155|NCT00814307|456007716|FG002|Overall Study|Adverse Event|3|||
126743156|NCT00814307|456007717|FG003|Overall Study|Adverse Event|2|||
126743157|NCT00814307|456007714|FG000|Overall Study|Lack of Efficacy|1|||
126743158|NCT00814307|456007715|FG001|Overall Study|Lack of Efficacy|1|||
126743159|NCT00814307|456007716|FG002|Overall Study|Lack of Efficacy|3|||
126743160|NCT00814307|456007717|FG003|Overall Study|Lack of Efficacy|4|||
126743161|NCT00814307|456007714|FG000|Overall Study|Other|1|||
126743162|NCT00814307|456007715|FG001|Overall Study|Other|2|||
126743163|NCT00814307|456007716|FG002|Overall Study|Other|0|||
126743164|NCT00814307|456007717|FG003|Overall Study|Other|1|||
126743165|NCT00814307|456007714|FG000|Overall Study|Protocol Violation|2|||
126743166|NCT00814307|456007715|FG001|Overall Study|Protocol Violation|8|||
126743167|NCT00814307|456007716|FG002|Overall Study|Protocol Violation|1|||
126743168|NCT00814307|456007717|FG003|Overall Study|Protocol Violation|1|||
126743169|NCT00814307|456007714|FG000|Overall Study|Withdrawal by Subject|4|||
126743170|NCT00814307|456007715|FG001|Overall Study|Withdrawal by Subject|6|||
126743171|NCT00814307|456007716|FG002|Overall Study|Withdrawal by Subject|0|||
126743172|NCT00814307|456007717|FG003|Overall Study|Withdrawal by Subject|2|||
126743173|NCT00814307|456007714|FG000|Overall Study|Death|0|||
126743174|NCT00814307|456007715|FG001|Overall Study|Death|1|||
126743175|NCT00814307|456007716|FG002|Overall Study|Death|0|||
126743176|NCT00814307|456007717|FG003|Overall Study|Death|0|||
126743177|NCT02290340|456007719|FG000|Overall Study|Lost to Follow-up|0|||
126743178|NCT02290340|456007720|FG001|Overall Study|Lost to Follow-up|0|||
126743179|NCT02290340|456007721|FG002|Overall Study|Lost to Follow-up|0|||
126743180|NCT02290340|456007722|FG003|Overall Study|Lost to Follow-up|1|||
126743181|NCT02290340|456007719|FG000|Overall Study|Withdrawal by Subject|1|||
126743182|NCT02290340|456007720|FG001|Overall Study|Withdrawal by Subject|0|||
126743183|NCT02290340|456007721|FG002|Overall Study|Withdrawal by Subject|0|||
126743184|NCT02290340|456007722|FG003|Overall Study|Withdrawal by Subject|0|||
126743185|NCT02290340|456007719|FG000|Overall Study|Other|1|||
126743186|NCT02290340|456007720|FG001|Overall Study|Other|0|||
126743187|NCT02290340|456007721|FG002|Overall Study|Other|0|||
126743188|NCT02290340|456007722|FG003|Overall Study|Other|1|||
126743189|NCT01594749|456009692|FG000|Overall Study|Adverse Event|2|||
126743190|NCT01594749|456009693|FG001|Overall Study|Adverse Event|1|||
126743191|NCT01594749|456009692|FG000|Overall Study|Withdrawal by Subject|2|||
126743192|NCT01594749|456009693|FG001|Overall Study|Withdrawal by Subject|2|||
126743193|NCT01594749|456009692|FG000|Overall Study|Protocol Violation|2|||
126743194|NCT01594749|456009693|FG001|Overall Study|Protocol Violation|0|||
126743195|NCT01594749|456009692|FG000|Overall Study|Physician Decision|1|||
126743196|NCT01594749|456009693|FG001|Overall Study|Physician Decision|1|||
126743197|NCT01594749|456009692|FG000|Overall Study|Non-compliance with Protocol|0|||
126743198|NCT01594749|456009693|FG001|Overall Study|Non-compliance with Protocol|1|||
126743199|NCT01594749|456009692|FG000|Overall Study|Lost to Follow-up|1|||
126743200|NCT01594749|456009693|FG001|Overall Study|Lost to Follow-up|0|||
126743201|NCT01594749|456009692|FG000|Overall Study|Death|9|||
126743202|NCT01594749|456009693|FG001|Overall Study|Death|3|||
126743203|NCT01594749|456009692|FG000|Overall Study|Not Treated|4|||
126743204|NCT01594749|456009693|FG001|Overall Study|Not Treated|10|||
126743205|NCT01594749|456009692|FG000|Overall Study|Lost Source Documentation|1|||
126743206|NCT01594749|456009693|FG001|Overall Study|Lost Source Documentation|0|||
126743207|NCT02177786|456009694|FG000|Overall Study|Withdrew Consent|2|||
126743208|NCT02177786|456009695|FG001|Overall Study|Withdrew Consent|6|||
126743209|NCT02177786|456009696|FG002|Overall Study|Withdrew Consent|9|||
126743210|NCT02177786|456009697|FG003|Overall Study|Withdrew Consent|5|||
126743211|NCT02177786|456009694|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
126743212|NCT02177786|456009695|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
126743213|NCT02177786|456009696|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
126743214|NCT02177786|456009697|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
126743215|NCT02177786|456009694|FG000|Overall Study|Adverse Event|1|||
126743216|NCT02177786|456009695|FG001|Overall Study|Adverse Event|1|||
126743217|NCT02177786|456009696|FG002|Overall Study|Adverse Event|2|||
126743218|NCT02177786|456009697|FG003|Overall Study|Adverse Event|3|||
126743219|NCT02177786|456009694|FG000|Overall Study|Death|1|||
126743220|NCT02177786|456009695|FG001|Overall Study|Death|1|||
126743221|NCT02177786|456009696|FG002|Overall Study|Death|1|||
126743222|NCT02177786|456009697|FG003|Overall Study|Death|1|||
126743223|NCT02177786|456009694|FG000|Overall Study|Lost to Follow-up|0|||
126743224|NCT02177786|456009695|FG001|Overall Study|Lost to Follow-up|0|||
126743225|NCT02177786|456009696|FG002|Overall Study|Lost to Follow-up|2|||
126743226|NCT02177786|456009697|FG003|Overall Study|Lost to Follow-up|2|||
126743227|NCT02177786|456009694|FG000|Overall Study|Non-Compliance with Study Drug|0|||
126743228|NCT02177786|456009695|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126743229|NCT02177786|456009696|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126743230|NCT02177786|456009697|FG003|Overall Study|Non-Compliance with Study Drug|1|||
126743231|NCT02177786|456009694|FG000|Overall Study|Protocol Violation|0|||
126743232|NCT02177786|456009695|FG001|Overall Study|Protocol Violation|0|||
126743233|NCT02177786|456009696|FG002|Overall Study|Protocol Violation|2|||
126743234|NCT02177786|456009697|FG003|Overall Study|Protocol Violation|0|||
126743235|NCT02177786|456009694|FG000|Overall Study|Progressive Disease|0|||
126743236|NCT02177786|456009695|FG001|Overall Study|Progressive Disease|1|||
126743237|NCT02177786|456009696|FG002|Overall Study|Progressive Disease|0|||
126743238|NCT02177786|456009697|FG003|Overall Study|Progressive Disease|0|||
126743239|NCT02177786|456009694|FG000|Overall Study|Missing study completion status|0|||
126743240|NCT02177786|456009695|FG001|Overall Study|Missing study completion status|1|||
126743241|NCT02177786|456009696|FG002|Overall Study|Missing study completion status|0|||
126743242|NCT02177786|456009697|FG003|Overall Study|Missing study completion status|0|||
126743243|NCT00439309|456009698|FG000|Follow-Up|Death|1|||
126743244|NCT00439309|456009699|FG001|Follow-Up|Death|0|||
126743245|NCT00439309|456009698|FG000|Follow-Up|Lost to Follow-up|2|||
126743246|NCT00439309|456009699|FG001|Follow-Up|Lost to Follow-up|0|||
126743247|NCT00439309|456009698|FG000|Follow-Up|Withdrawal by Subject|0|||
126743248|NCT00439309|456009699|FG001|Follow-Up|Withdrawal by Subject|1|||
126743249|NCT00439309|456009698|FG000|Follow-Up|Late response by subject|0|||
126743250|NCT00439309|456009699|FG001|Follow-Up|Late response by subject|1|||
126743251|NCT01977040|456009700|FG000|Overall Study|Vasa previa not confirmed|2|||
126743252|NCT00634751|456009706|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
126743253|NCT00634751|456009707|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
126743254|NCT00634751|456009708|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
126743255|NCT00634751|456009709|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
126743256|NCT00634751|456009706|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
126743257|NCT00634751|456009707|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
126743258|NCT00634751|456009708|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
126743259|NCT00634751|456009709|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
126743260|NCT00634751|456009706|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
126743261|NCT00634751|456009707|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
126743262|NCT00634751|456009708|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
126743263|NCT00634751|456009709|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
126743264|NCT04402385|456009712|FG000|Overall Study|Withdrawal by Subject|4|||
126743265|NCT04402385|456009713|FG001|Overall Study|Withdrawal by Subject|4|||
126616545|NCT04620733|455555342|FG000|Overall Study|Adverse Event|4|||
126616546|NCT04620733|455555343|FG001|Overall Study|Adverse Event|3|||
126616547|NCT04620733|455555342|FG000|Overall Study|Withdrawal by Subject|2|||
126616548|NCT04620733|455555343|FG001|Overall Study|Withdrawal by Subject|5|||
126616549|NCT04620733|455555342|FG000|Overall Study|Lost to Follow-up|1|||
126616550|NCT04620733|455555343|FG001|Overall Study|Lost to Follow-up|1|||
126616551|NCT04620733|455555342|FG000|Overall Study|Protocol Deviation|1|||
126616552|NCT04620733|455555343|FG001|Overall Study|Protocol Deviation|1|||
126616553|NCT04620733|455555342|FG000|Overall Study|Reason Not Specified|0|||
126616554|NCT04620733|455555343|FG001|Overall Study|Reason Not Specified|1|||
126616555|NCT00264576|455555350|FG000|Overall Study|Lost to Follow-up|1|||
126616556|NCT00264576|455555351|FG001|Overall Study|Lost to Follow-up|1|||
126616557|NCT02659059|455555354|FG000|Overall Study|Other reasons|6|||
126616558|NCT02659059|455555355|FG001|Overall Study|Other reasons|1|||
126616559|NCT02659059|455555354|FG000|Overall Study|Disease Progression|143|||
126616560|NCT02659059|455555355|FG001|Overall Study|Disease Progression|16|||
126616561|NCT02659059|455555354|FG000|Overall Study|Study Drug toxicity|56|||
126616562|NCT02659059|455555355|FG001|Overall Study|Study Drug toxicity|9|||
126616563|NCT02659059|455555354|FG000|Overall Study|Death|3|||
126616564|NCT02659059|455555355|FG001|Overall Study|Death|1|||
126616565|NCT02659059|455555354|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
126616566|NCT02659059|455555355|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
126616567|NCT02659059|455555354|FG000|Overall Study|Participant request to discontinue study treatment|5|||
126781821|NCT01199601|456156280|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
126781822|NCT01199601|456156281|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
126781823|NCT02669264|456156282|FG000|Overall Study|Death|5|||
126781824|NCT02669264|456156283|FG001|Overall Study|Death|5|||
126781825|NCT02669264|456156284|FG002|Overall Study|Death|3|||
126743266|NCT04402385|456009712|FG000|Overall Study|Lost to Follow-up|1|||
126743267|NCT04402385|456009713|FG001|Overall Study|Lost to Follow-up|1|||
126743268|NCT04402385|456009712|FG000|Overall Study|Physician Decision|0|||
126743269|NCT04402385|456009713|FG001|Overall Study|Physician Decision|1|||
126743270|NCT01308853|456009719|FG000|Overall Study|Adverse Event|1|||
126743271|NCT01308853|456009719|FG000|Overall Study|Lost to Follow-up|2|||
126743272|NCT01308853|456009719|FG000|Overall Study|Insertion of permanent implants|1|||
126743273|NCT02204410|456009722|FG000|Overall Study|Lost to Follow-up|5|||
126743274|NCT02204410|456009722|FG000|Overall Study|Physician Decision|2|||
126743275|NCT02204410|456009722|FG000|Overall Study|Protocol Violation|1|||
126743276|NCT02204410|456009722|FG000|Overall Study|Withdrawal by Subject|3|||
126743277|NCT03654560|456009723|FG000|Overall Study|Death|3|||
126743278|NCT03654560|456009724|FG001|Overall Study|Death|1|||
126743279|NCT03654560|456009723|FG000|Overall Study|Lost to Follow-up|1|||
126743280|NCT03654560|456009724|FG001|Overall Study|Lost to Follow-up|0|||
126743281|NCT01473355|456009725|FG000|Overall Study|Protocol Violation|2|||
126743282|NCT01473355|456009725|FG000|Overall Study|Adverse Event|2|||
126743283|NCT01473355|456009725|FG000|Overall Study|Lost to Follow-up|2|||
126743284|NCT00863317|456009728|FG000|Overall Study|Lost to Follow-up|8|||
126743285|NCT00863317|456009729|FG001|Overall Study|Lost to Follow-up|9|||
126743286|NCT00735072|456009733|FG000|Overall Study|interrupted study med during ARV change|1|||
126743287|NCT00735072|456009734|FG001|Overall Study|interrupted study med during ARV change|0|||
126743288|NCT00735072|456009733|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
126743289|NCT00735072|456009734|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
126781826|NCT02669264|456156285|FG003|Overall Study|Death|3|||
126781827|NCT02669264|456156286|FG004|Overall Study|Death|3|||
126616568|NCT02659059|455555355|FG001|Overall Study|Participant request to discontinue study treatment|0|||
126616569|NCT02659059|455555354|FG000|Overall Study|Participant withdrew consent|6|||
126616570|NCT02659059|455555355|FG001|Overall Study|Participant withdrew consent|1|||
126616571|NCT03976102|455555358|FG000|Overall Study|Withdrawal by Subject|4|||
126743290|NCT00911144|456009735|FG000|Overall Study|Withdrawal by Subject|16|||
126743291|NCT00911144|456009736|FG001|Overall Study|Withdrawal by Subject|5|||
126743292|NCT03981744|456009737|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
126743293|NCT03981744|456009738|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
126743294|NCT03981744|456009739|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
126743295|NCT03981744|456009740|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
126743296|NCT03981744|456009737|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
126781828|NCT02669264|456156287|FG005|Overall Study|Death|6|||
126616572|NCT03976102|455555359|FG001|Overall Study|Withdrawal by Subject|4|||
126616573|NCT03976102|455555358|FG000|Overall Study|Adverse Event|2|||
126616574|NCT03976102|455555359|FG001|Overall Study|Adverse Event|4|||
126743297|NCT03981744|456009738|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
126743298|NCT03981744|456009739|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
126743299|NCT03981744|456009740|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
126743300|NCT03981744|456009737|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
126616575|NCT03976102|455555358|FG000|Overall Study|Not related to Covid-19|9|||
126781829|NCT02669264|456156288|FG006|Overall Study|Death|3|||
126781830|NCT02669264|456156282|FG000|Overall Study|Withdrawal by Subject|0|||
126743301|NCT03981744|456009738|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
126743302|NCT03981744|456009739|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
126743303|NCT03981744|456009740|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
126743304|NCT00732238|456009741|FG000|Overall Study|Bacteremia|4|||
126743305|NCT00732238|456009742|FG001|Overall Study|Bacteremia|1|||
126743306|NCT00732238|456009741|FG000|Overall Study|Asymptomatic bacteriuria|1|||
126743307|NCT00732238|456009742|FG001|Overall Study|Asymptomatic bacteriuria|0|||
126743308|NCT00246376|456009745|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
126743309|NCT00246376|456009746|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
126616576|NCT03976102|455555359|FG001|Overall Study|Not related to Covid-19|13|||
126616577|NCT03976102|455555358|FG000|Overall Study|Lost to Follow-up|0|||
126743310|NCT00246376|456009747|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
126743311|NCT00246376|456009748|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
126743312|NCT00246376|456009749|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
126743313|NCT00246376|456009745|FG000|Overall Study|Adverse Event|2|||
126743314|NCT00246376|456009746|FG001|Overall Study|Adverse Event|3|||
126743315|NCT00246376|456009747|FG002|Overall Study|Adverse Event|1|||
126743316|NCT00246376|456009748|FG003|Overall Study|Adverse Event|3|||
126743317|NCT00246376|456009749|FG004|Overall Study|Adverse Event|1|||
126743318|NCT00246376|456009745|FG000|Overall Study|Lost to Follow-up|2|||
126743319|NCT00246376|456009746|FG001|Overall Study|Lost to Follow-up|11|||
126616578|NCT03976102|455555359|FG001|Overall Study|Lost to Follow-up|2|||
126616579|NCT03976102|455555358|FG000|Overall Study|Death|3|||
126616580|NCT03976102|455555359|FG001|Overall Study|Death|2|||
126616581|NCT03976102|455555358|FG000|Overall Study|Physician Decision|1|||
126616582|NCT03976102|455555359|FG001|Overall Study|Physician Decision|1|||
126616583|NCT00092456|455555365|FG000|Overall Study|Adverse Event|0|||
126616584|NCT00092456|455555366|FG001|Overall Study|Adverse Event|0|||
126616585|NCT00092456|455555367|FG002|Overall Study|Adverse Event|1|||
126616586|NCT00092456|455555368|FG003|Overall Study|Adverse Event|1|||
126616587|NCT00092456|455555365|FG000|Overall Study|Lost to Follow-up|2|||
126616588|NCT00092456|455555366|FG001|Overall Study|Lost to Follow-up|2|||
126616589|NCT00092456|455555367|FG002|Overall Study|Lost to Follow-up|1|||
126616590|NCT00092456|455555368|FG003|Overall Study|Lost to Follow-up|2|||
126616591|NCT00092456|455555365|FG000|Overall Study|Protocol Violation|5|||
126616592|NCT00092456|455555366|FG001|Overall Study|Protocol Violation|7|||
126616593|NCT00092456|455555367|FG002|Overall Study|Protocol Violation|8|||
126616594|NCT00092456|455555368|FG003|Overall Study|Protocol Violation|6|||
126616595|NCT00092456|455555365|FG000|Overall Study|Withdrawal by Subject|13|||
126616596|NCT00092456|455555366|FG001|Overall Study|Withdrawal by Subject|5|||
126616597|NCT00092456|455555367|FG002|Overall Study|Withdrawal by Subject|16|||
126616598|NCT00092456|455555368|FG003|Overall Study|Withdrawal by Subject|6|||
126616599|NCT00092456|455555365|FG000|Overall Study|Moved|1|||
126616600|NCT00092456|455555366|FG001|Overall Study|Moved|1|||
126616601|NCT00092456|455555367|FG002|Overall Study|Moved|0|||
126616602|NCT00092456|455555368|FG003|Overall Study|Moved|1|||
126616603|NCT00092456|455555365|FG000|Overall Study|Other|4|||
126616604|NCT00092456|455555366|FG001|Overall Study|Other|2|||
126616605|NCT00092456|455555367|FG002|Overall Study|Other|3|||
126616606|NCT00092456|455555368|FG003|Overall Study|Other|0|||
126616607|NCT04783389|455555371|FG000|Overall Study|Withdrawal by Subject|2|||
126616608|NCT04783389|455555372|FG001|Overall Study|Withdrawal by Subject|0|||
126616609|NCT04783389|455555373|FG002|Overall Study|Withdrawal by Subject|0|||
126616610|NCT04783389|455555371|FG000|Overall Study|Termination of Study by Sponsor|10|||
126616611|NCT04783389|455555372|FG001|Overall Study|Termination of Study by Sponsor|12|||
126616612|NCT04783389|455555373|FG002|Overall Study|Termination of Study by Sponsor|14|||
126616613|NCT00451906|455555374|FG000|Overall Study|Adverse Event|515|||
126616614|NCT00451906|455555374|FG000|Overall Study|Lost to Follow-up|31|||
126616615|NCT00451906|455555374|FG000|Overall Study|Withdrawal by Subject|111|||
126616616|NCT00451906|455555374|FG000|Overall Study|Protocol Violation|21|||
126616617|NCT00451906|455555374|FG000|Overall Study|Progressive disease|1328|||
126616618|NCT00451906|455555374|FG000|Overall Study|Termination of the study|108|||
126616619|NCT00451906|455555374|FG000|Overall Study|Other Reasons|121|||
126616620|NCT00451906|455555374|FG000|Overall Study|Did not complete final visit|4|||
126616621|NCT02121808|455555379|FG000|Overall Study|Technical problem|3|||
126743320|NCT00246376|456009747|FG002|Overall Study|Lost to Follow-up|11|||
126743321|NCT00246376|456009748|FG003|Overall Study|Lost to Follow-up|16|||
126743322|NCT00246376|456009749|FG004|Overall Study|Lost to Follow-up|13|||
126743323|NCT00610207|456009753|FG000|Overall Study|Lost to Follow-up|3|||
126743324|NCT02465489|456009754|FG000|Overall Study|Adverse Event|5|||
126743325|NCT00693693|456009757|FG000|Overall Study|Lost to Follow-up|1|||
126743326|NCT00693693|456009758|FG001|Overall Study|Lost to Follow-up|1|||
126616622|NCT03072238|455555380|FG000|Overall Study|Withdrawal by Subject|44|||
126616623|NCT03072238|455555381|FG001|Overall Study|Withdrawal by Subject|64|||
126616624|NCT03072238|455555380|FG000|Overall Study|Lost to Follow-up|14|||
126743327|NCT00693693|456009759|FG002|Overall Study|Lost to Follow-up|2|||
126743328|NCT02972593|456009760|FG000|Overall Study|Lost to Follow-up|19|||
126743329|NCT02972593|456009761|FG001|Overall Study|Lost to Follow-up|15|||
126743330|NCT02972593|456009760|FG000|Overall Study|Protocol Violation|1|||
126743331|NCT02972593|456009761|FG001|Overall Study|Protocol Violation|0|||
126743332|NCT04599972|456009762|FG000|Overall Study|Withdrawal by Subject|6|||
126743333|NCT04599972|456009763|FG001|Overall Study|Withdrawal by Subject|1|||
126743334|NCT04599972|456009762|FG000|Overall Study|Adverse Event|1|||
126743335|NCT04599972|456009763|FG001|Overall Study|Adverse Event|1|||
126743336|NCT04599972|456009762|FG000|Overall Study|Lost to Follow-up|1|||
126743337|NCT04599972|456009763|FG001|Overall Study|Lost to Follow-up|6|||
126743338|NCT04599972|456009762|FG000|Overall Study|Protocol Violation|1|||
126743339|NCT04599972|456009763|FG001|Overall Study|Protocol Violation|0|||
126743340|NCT04599972|456009762|FG000|Overall Study|Other reason|1|||
126743341|NCT04599972|456009763|FG001|Overall Study|Other reason|0|||
126743342|NCT00621244|456009765|FG000|Overall Study|Withdrawal by Subject|7|||
126743343|NCT00621244|456009766|FG001|Overall Study|Withdrawal by Subject|3|||
126743344|NCT00621244|456009767|FG002|Overall Study|Withdrawal by Subject|3|||
126743345|NCT00621244|456009768|FG003|Overall Study|Withdrawal by Subject|3|||
126743346|NCT00621244|456009765|FG000|Overall Study|Disease progression|44|||
126743347|NCT00621244|456009766|FG001|Overall Study|Disease progression|20|||
126743348|NCT00621244|456009767|FG002|Overall Study|Disease progression|20|||
126743349|NCT00621244|456009768|FG003|Overall Study|Disease progression|15|||
126743350|NCT00621244|456009765|FG000|Overall Study|Death|3|||
126743351|NCT00621244|456009766|FG001|Overall Study|Death|3|||
126743352|NCT00621244|456009767|FG002|Overall Study|Death|1|||
126743353|NCT00621244|456009768|FG003|Overall Study|Death|1|||
126743354|NCT00621244|456009765|FG000|Overall Study|Adverse Event|27|||
126743355|NCT00621244|456009766|FG001|Overall Study|Adverse Event|7|||
126743356|NCT00621244|456009767|FG002|Overall Study|Adverse Event|9|||
126743357|NCT00621244|456009768|FG003|Overall Study|Adverse Event|2|||
126743358|NCT00621244|456009765|FG000|Overall Study|Administrative problems|5|||
126743359|NCT00621244|456009766|FG001|Overall Study|Administrative problems|1|||
126743360|NCT00621244|456009767|FG002|Overall Study|Administrative problems|0|||
126743361|NCT00621244|456009768|FG003|Overall Study|Administrative problems|2|||
126743362|NCT04449276|456009774|FG000|Overall Study|Adverse Event|1|||
126743363|NCT04449276|456009775|FG001|Overall Study|Adverse Event|2|||
126743364|NCT04449276|456009776|FG002|Overall Study|Adverse Event|0|||
126743365|NCT04449276|456009777|FG003|Overall Study|Adverse Event|0|||
126743366|NCT04449276|456009778|FG004|Overall Study|Adverse Event|2|||
126743367|NCT04449276|456009779|FG005|Overall Study|Adverse Event|0|||
126743368|NCT04449276|456009780|FG006|Overall Study|Adverse Event|0|||
126743369|NCT04449276|456009781|FG007|Overall Study|Adverse Event|1|||
126743370|NCT04449276|456009774|FG000|Overall Study|Withdrawal by Subject|2|||
126743371|NCT04449276|456009775|FG001|Overall Study|Withdrawal by Subject|0|||
126743372|NCT04449276|456009776|FG002|Overall Study|Withdrawal by Subject|0|||
126743373|NCT04449276|456009777|FG003|Overall Study|Withdrawal by Subject|1|||
126743374|NCT04449276|456009778|FG004|Overall Study|Withdrawal by Subject|0|||
126743375|NCT04449276|456009779|FG005|Overall Study|Withdrawal by Subject|0|||
126743376|NCT04449276|456009780|FG006|Overall Study|Withdrawal by Subject|0|||
126743377|NCT04449276|456009781|FG007|Overall Study|Withdrawal by Subject|0|||
126743378|NCT04449276|456009774|FG000|Overall Study|Other|0|||
126743379|NCT04449276|456009775|FG001|Overall Study|Other|2|||
126743380|NCT04449276|456009776|FG002|Overall Study|Other|3|||
126743381|NCT04449276|456009777|FG003|Overall Study|Other|2|||
126743382|NCT04449276|456009778|FG004|Overall Study|Other|0|||
126743383|NCT04449276|456009779|FG005|Overall Study|Other|0|||
126743384|NCT04449276|456009780|FG006|Overall Study|Other|0|||
126743385|NCT04449276|456009781|FG007|Overall Study|Other|1|||
126743386|NCT01614795|456009782|FG000|Overall Study|Adverse Event|0|||
126743387|NCT01614795|456009783|FG001|Overall Study|Adverse Event|0|||
126743388|NCT01614795|456009784|FG002|Overall Study|Adverse Event|1|||
126743389|NCT01614795|456009785|FG003|Overall Study|Adverse Event|1|||
126743390|NCT01614795|456009782|FG000|Overall Study|Lack of Efficacy|10|||
126743391|NCT01614795|456009783|FG001|Overall Study|Lack of Efficacy|10|||
126743392|NCT01614795|456009784|FG002|Overall Study|Lack of Efficacy|9|||
126743393|NCT01614795|456009785|FG003|Overall Study|Lack of Efficacy|8|||
126743394|NCT01614795|456009782|FG000|Overall Study|Physician Decision|1|||
126743395|NCT01614795|456009783|FG001|Overall Study|Physician Decision|0|||
126616625|NCT03072238|455555381|FG001|Overall Study|Lost to Follow-up|5|||
126616626|NCT03072238|455555380|FG000|Overall Study|Physician Decision|4|||
126743396|NCT01614795|456009784|FG002|Overall Study|Physician Decision|1|||
126743397|NCT01614795|456009785|FG003|Overall Study|Physician Decision|1|||
126743398|NCT01614795|456009782|FG000|Overall Study|Withdrawal by Subject|0|||
126743399|NCT01614795|456009783|FG001|Overall Study|Withdrawal by Subject|1|||
126743400|NCT01614795|456009784|FG002|Overall Study|Withdrawal by Subject|0|||
126743401|NCT01614795|456009785|FG003|Overall Study|Withdrawal by Subject|2|||
126743402|NCT01614795|456009782|FG000|Overall Study|Ineligible|0|||
126743403|NCT01614795|456009783|FG001|Overall Study|Ineligible|1|||
126743404|NCT01614795|456009784|FG002|Overall Study|Ineligible|0|||
126743405|NCT01614795|456009785|FG003|Overall Study|Ineligible|0|||
126743406|NCT00023712|456009786|FG000|Overall Study|Not platinum sensitive|1|||
126743407|NCT00023712|456009787|FG001|Overall Study|Not platinum sensitive|0|||
126743408|NCT00023712|456009786|FG000|Overall Study|Never treated|1|||
126743409|NCT00023712|456009787|FG001|Overall Study|Never treated|1|||
126743410|NCT00565812|456009790|FG000|Overall Study|Death|2|||
126743411|NCT00565812|456009791|FG001|Overall Study|Death|1|||
126743412|NCT00565812|456009792|FG002|Overall Study|Death|3|||
126743413|NCT00565812|456009790|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
126743414|NCT00565812|456009791|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
126743415|NCT00565812|456009792|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
126743416|NCT00565812|456009790|FG000|Overall Study|Lost to Follow-up|10|||
126743417|NCT00565812|456009791|FG001|Overall Study|Lost to Follow-up|8|||
126743418|NCT00565812|456009792|FG002|Overall Study|Lost to Follow-up|8|||
126743419|NCT00565812|456009790|FG000|Overall Study|Withdrawal by Subject|58|||
126743420|NCT00565812|456009791|FG001|Overall Study|Withdrawal by Subject|47|||
126743421|NCT00565812|456009792|FG002|Overall Study|Withdrawal by Subject|48|||
126743422|NCT00565812|456009790|FG000|Overall Study|Work Schedule|5|||
126743423|NCT00565812|456009791|FG001|Overall Study|Work Schedule|3|||
126743424|NCT00565812|456009792|FG002|Overall Study|Work Schedule|1|||
126743425|NCT00565812|456009790|FG000|Overall Study|Protocol Violation|2|||
126743426|NCT00565812|456009791|FG001|Overall Study|Protocol Violation|6|||
126743427|NCT00565812|456009792|FG002|Overall Study|Protocol Violation|4|||
126743428|NCT00565812|456009790|FG000|Overall Study|Adverse Event|41|||
126743429|NCT00565812|456009791|FG001|Overall Study|Adverse Event|54|||
126743430|NCT00565812|456009792|FG002|Overall Study|Adverse Event|40|||
126743431|NCT00565812|456009790|FG000|Overall Study|Jury Duty|1|||
126743432|NCT00565812|456009791|FG001|Overall Study|Jury Duty|0|||
126743433|NCT00565812|456009792|FG002|Overall Study|Jury Duty|0|||
126743434|NCT00565812|456009790|FG000|Overall Study|Relocated Out of Area|5|||
126743435|NCT00565812|456009791|FG001|Overall Study|Relocated Out of Area|8|||
126743436|NCT00565812|456009792|FG002|Overall Study|Relocated Out of Area|9|||
126743437|NCT00565812|456009790|FG000|Overall Study|Sponsor Decision|1|||
126743438|NCT00565812|456009791|FG001|Overall Study|Sponsor Decision|5|||
126743439|NCT00565812|456009792|FG002|Overall Study|Sponsor Decision|1|||
126743440|NCT00565812|456009790|FG000|Overall Study|Domestic Reasons|7|||
126743441|NCT00565812|456009791|FG001|Overall Study|Domestic Reasons|1|||
126743442|NCT00565812|456009792|FG002|Overall Study|Domestic Reasons|3|||
126743443|NCT00565812|456009790|FG000|Overall Study|Research Site Closure|6|||
126743444|NCT00565812|456009791|FG001|Overall Study|Research Site Closure|1|||
126743445|NCT00565812|456009792|FG002|Overall Study|Research Site Closure|8|||
126743446|NCT00565812|456009790|FG000|Overall Study|Surgical Intervention|0|||
126743447|NCT00565812|456009791|FG001|Overall Study|Surgical Intervention|1|||
126743448|NCT00565812|456009792|FG002|Overall Study|Surgical Intervention|2|||
126743449|NCT00565812|456009790|FG000|Overall Study|Low Compliance|1|||
126743450|NCT00565812|456009791|FG001|Overall Study|Low Compliance|0|||
126743451|NCT00565812|456009792|FG002|Overall Study|Low Compliance|1|||
126743452|NCT00565812|456009790|FG000|Overall Study|Follow-up Visit Not Completed|2|||
126743453|NCT00565812|456009791|FG001|Overall Study|Follow-up Visit Not Completed|0|||
126743454|NCT00565812|456009792|FG002|Overall Study|Follow-up Visit Not Completed|1|||
126743455|NCT00565812|456009790|FG000|Overall Study|Physician Decision|2|||
126743456|NCT00565812|456009791|FG001|Overall Study|Physician Decision|0|||
126743457|NCT00565812|456009792|FG002|Overall Study|Physician Decision|0|||
126743458|NCT04968353|456009793|FG000|Overall Study|Non-compliance|1|||
126743459|NCT04968353|456009794|FG001|Overall Study|Non-compliance|0|||
126743460|NCT04968353|456009795|FG002|Overall Study|Non-compliance|2|||
126743461|NCT04968353|456009796|FG003|Overall Study|Non-compliance|0|||
126743462|NCT00845845|456009797|FG000|Overall Study|Lost to Follow-up|0|||
126743463|NCT00845845|456009798|FG001|Overall Study|Lost to Follow-up|4|||
126743464|NCT02033850|456009804|FG000|Overall Study|Death|1|||
126743465|NCT02033850|456009805|FG001|Overall Study|Death|0|||
126743466|NCT02033850|456009804|FG000|Overall Study|unrelated medical reason|1|||
126743467|NCT02033850|456009805|FG001|Overall Study|unrelated medical reason|1|||
126743468|NCT02820038|456009806|FG000|Overall Study|Lost to Follow-up|7|||
126743469|NCT02820038|456009807|FG001|Overall Study|Lost to Follow-up|11|||
126743470|NCT02820038|456009808|FG002|Overall Study|Lost to Follow-up|2|||
126743471|NCT02820038|456009809|FG003|Overall Study|Lost to Follow-up|9|||
126743472|NCT02820038|456009806|FG000|Overall Study|Withdrawal by Subject|3|||
126743473|NCT02820038|456009807|FG001|Overall Study|Withdrawal by Subject|14|||
126743474|NCT02820038|456009808|FG002|Overall Study|Withdrawal by Subject|3|||
126743475|NCT02820038|456009809|FG003|Overall Study|Withdrawal by Subject|13|||
126743476|NCT03215667|456009810|FG000|Overall Study|Physician Decision|4|||
126743477|NCT01810380|456009813|FG000|Overall Study|Randomised not treated|2|||
126743478|NCT01810380|456009814|FG001|Overall Study|Randomised not treated|1|||
126743479|NCT01810380|456009815|FG002|Overall Study|Randomised not treated|1|||
126743480|NCT01810380|456009813|FG000|Overall Study|Adverse Event|11|||
126743481|NCT01810380|456009814|FG001|Overall Study|Adverse Event|14|||
126743482|NCT01810380|456009815|FG002|Overall Study|Adverse Event|4|||
126743483|NCT01810380|456009813|FG000|Overall Study|Lack of Efficacy|24|||
126743484|NCT01810380|456009814|FG001|Overall Study|Lack of Efficacy|10|||
126743485|NCT01810380|456009815|FG002|Overall Study|Lack of Efficacy|11|||
126743486|NCT01810380|456009813|FG000|Overall Study|Protocol Violation|1|||
126743487|NCT01810380|456009814|FG001|Overall Study|Protocol Violation|0|||
126743488|NCT01810380|456009815|FG002|Overall Study|Protocol Violation|1|||
126743489|NCT01810380|456009813|FG000|Overall Study|Withdrawal by Subject|6|||
126743490|NCT01810380|456009814|FG001|Overall Study|Withdrawal by Subject|0|||
126743491|NCT01810380|456009815|FG002|Overall Study|Withdrawal by Subject|6|||
126743492|NCT01810380|456009813|FG000|Overall Study|Administrative or other reasons|11|||
126743493|NCT01810380|456009814|FG001|Overall Study|Administrative or other reasons|13|||
126743494|NCT01810380|456009815|FG002|Overall Study|Administrative or other reasons|9|||
126743495|NCT00614991|456009816|FG000|Overall Study|Adverse Event|3|||
126743496|NCT00614991|456009817|FG001|Overall Study|Adverse Event|3|||
126743497|NCT00614991|456009818|FG002|Overall Study|Adverse Event|0|||
126743498|NCT00614991|456009819|FG003|Overall Study|Adverse Event|0|||
126743499|NCT00614991|456009820|FG004|Overall Study|Adverse Event|1|||
126743500|NCT00614991|456009821|FG005|Overall Study|Adverse Event|0|||
126743501|NCT03148795|456009822|FG000|Overall Study|Progressive Disease|1|||
126743502|NCT03209362|456009827|FG000|Overall Study|Adverse Event|0|||
126743503|NCT03209362|456009828|FG001|Overall Study|Adverse Event|1|||
126743504|NCT03209362|456009827|FG000|Overall Study|Lost to Follow-up|0|||
126743505|NCT03209362|456009828|FG001|Overall Study|Lost to Follow-up|1|||
126743506|NCT03209362|456009827|FG000|Overall Study|Withdrawal by Subject|2|||
126743507|NCT03209362|456009828|FG001|Overall Study|Withdrawal by Subject|0|||
126743508|NCT03209362|456009827|FG000|Overall Study|Other|0|||
126743509|NCT03209362|456009828|FG001|Overall Study|Other|1|||
126743510|NCT00251589|456009833|FG000|Overall Study|Adverse Event|5|||
126743511|NCT00251589|456009834|FG001|Overall Study|Adverse Event|1|||
126743512|NCT00251589|456009835|FG002|Overall Study|Adverse Event|2|||
126743513|NCT00251589|456009836|FG003|Overall Study|Adverse Event|1|||
126743514|NCT00251589|456009833|FG000|Overall Study|Withdrawal by Subject|1|||
126743515|NCT00251589|456009834|FG001|Overall Study|Withdrawal by Subject|1|||
126743516|NCT00251589|456009835|FG002|Overall Study|Withdrawal by Subject|0|||
126743517|NCT00251589|456009836|FG003|Overall Study|Withdrawal by Subject|0|||
126743518|NCT00251589|456009833|FG000|Overall Study|Discontinued due to progressive disease|9|||
126743519|NCT00251589|456009834|FG001|Overall Study|Discontinued due to progressive disease|1|||
126743520|NCT00251589|456009835|FG002|Overall Study|Discontinued due to progressive disease|0|||
126743521|NCT00251589|456009836|FG003|Overall Study|Discontinued due to progressive disease|1|||
126743522|NCT02571972|456009839|FG000|Overall Study|Protocol Violation|2|||
126743523|NCT02571972|456009839|FG000|Overall Study|Withdrawal by Subject|2|||
126743524|NCT03039192|456009840|FG000|Overall Study|Lost to Follow-up|4|||
126743525|NCT03039192|456009841|FG001|Overall Study|Lost to Follow-up|4|||
126743526|NCT03039192|456009840|FG000|Overall Study|Adverse event, serious fatal|0|||
126743527|NCT03039192|456009841|FG001|Overall Study|Adverse event, serious fatal|1|||
126743528|NCT03039192|456009840|FG000|Overall Study|Adverse event, non-fatal|0|||
126743529|NCT03039192|456009841|FG001|Overall Study|Adverse event, non-fatal|2|||
126743530|NCT03039192|456009840|FG000|Overall Study|Withdrawal by Subject|6|||
126743531|NCT03039192|456009841|FG001|Overall Study|Withdrawal by Subject|9|||
126743532|NCT03039192|456009840|FG000|Overall Study|Discontinued from treatment phase|19|||
126743533|NCT03039192|456009841|FG001|Overall Study|Discontinued from treatment phase|12|||
126743534|NCT03039192|456009840|FG000|Overall Study|Other|3|||
126743535|NCT03039192|456009841|FG001|Overall Study|Other|2|||
126743536|NCT02493868|456009842|FG000|Induction Phase: DE Participants|Adverse Event|22|||
126743537|NCT02493868|456009843|FG001|Induction Phase: DE Participants|Adverse Event|0|||
126743538|NCT02493868|456009842|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
126743539|NCT02493868|456009843|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
126743540|NCT02493868|456009842|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
126781831|NCT02669264|456156283|FG001|Overall Study|Withdrawal by Subject|1|||
126743541|NCT02493868|456009843|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
126743542|NCT02493868|456009842|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
126743543|NCT02493868|456009843|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
126743544|NCT02493868|456009842|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
126743545|NCT02493868|456009843|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
126743546|NCT02493868|456009842|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
126743547|NCT02493868|456009843|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
126781832|NCT02669264|456156284|FG002|Overall Study|Withdrawal by Subject|0|||
126743548|NCT02493868|456009842|FG000|Induction Phase: DE Participants|Other|8|||
126743549|NCT02493868|456009843|FG001|Induction Phase: DE Participants|Other|0|||
126743550|NCT02493868|456009842|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
126743551|NCT02493868|456009843|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
126743552|NCT02493868|456009842|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
126743553|NCT02493868|456009843|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
126743554|NCT02493868|456009842|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
126743555|NCT02493868|456009843|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
126743556|NCT02493868|456009842|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
126743557|NCT02493868|456009843|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
126743558|NCT02493868|456009842|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
126743559|NCT02493868|456009843|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
126743560|NCT02493868|456009842|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
126743561|NCT02493868|456009843|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
126743562|NCT02493868|456009842|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
126743563|NCT02493868|456009843|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
126743564|NCT02493868|456009842|FG000|Optimization Phase: DE+TE Participants|Other|10|||
126743565|NCT02493868|456009843|FG001|Optimization Phase: DE+TE Participants|Other|2|||
126743566|NCT02493868|456009842|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
126743567|NCT02493868|456009843|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
126743568|NCT02493868|456009842|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
126743569|NCT02493868|456009843|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
126743570|NCT02493868|456009842|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
126743571|NCT02493868|456009843|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
126743572|NCT02493868|456009842|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
126743573|NCT02493868|456009843|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
126743574|NCT02493868|456009842|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
126743575|NCT02493868|456009843|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
126743576|NCT02493868|456009842|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
126743577|NCT02493868|456009843|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
126743578|NCT02493868|456009842|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
126743579|NCT02493868|456009843|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
126743580|NCT02493868|456009842|FG000|Follow-up Phase|Lost to Follow-up|1|||
126743581|NCT02493868|456009843|FG001|Follow-up Phase|Lost to Follow-up|0|||
126743582|NCT02493868|456009842|FG000|Follow-up Phase|Withdrawal by Subject|3|||
126743583|NCT02493868|456009843|FG001|Follow-up Phase|Withdrawal by Subject|0|||
126743584|NCT02493868|456009842|FG000|Follow-up Phase|Investigator Decision|5|||
126743585|NCT02493868|456009843|FG001|Follow-up Phase|Investigator Decision|1|||
126743586|NCT02493868|456009842|FG000|Follow-up Phase|Other|2|||
126743587|NCT02493868|456009843|FG001|Follow-up Phase|Other|1|||
126743588|NCT02407236|456009844|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
126743589|NCT02407236|456009845|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
126743590|NCT02407236|456009846|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
126743591|NCT02407236|456009847|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
126743592|NCT02407236|456009848|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
126743593|NCT02407236|456009849|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
126743594|NCT02407236|456009850|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
126743595|NCT02407236|456009851|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
126743596|NCT02407236|456009852|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
126743597|NCT02407236|456009853|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
126743598|NCT02407236|456009854|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
126743599|NCT02407236|456009855|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
126743600|NCT02407236|456009856|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
126743601|NCT02407236|456009844|FG000|Induction Study (8 Weeks)|Death|0|||
126743602|NCT02407236|456009845|FG001|Induction Study (8 Weeks)|Death|0|||
126743603|NCT02407236|456009846|FG002|Induction Study (8 Weeks)|Death|1|||
126743604|NCT02407236|456009847|FG003|Induction Study (8 Weeks)|Death|0|||
126743605|NCT02407236|456009848|FG004|Induction Study (8 Weeks)|Death|0|||
126743606|NCT02407236|456009849|FG005|Induction Study (8 Weeks)|Death|0|||
126743607|NCT02407236|456009850|FG006|Induction Study (8 Weeks)|Death|0|||
126743608|NCT02407236|456009851|FG007|Induction Study (8 Weeks)|Death|0|||
126743609|NCT02407236|456009852|FG008|Induction Study (8 Weeks)|Death|0|||
126743610|NCT02407236|456009853|FG009|Induction Study (8 Weeks)|Death|0|||
126743611|NCT02407236|456009854|FG010|Induction Study (8 Weeks)|Death|0|||
126743612|NCT02407236|456009855|FG011|Induction Study (8 Weeks)|Death|0|||
126743613|NCT02407236|456009856|FG012|Induction Study (8 Weeks)|Death|0|||
126743614|NCT02407236|456009844|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
126743615|NCT02407236|456009845|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
126743616|NCT02407236|456009846|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
126743617|NCT02407236|456009847|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126743618|NCT02407236|456009848|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126616627|NCT03072238|455555381|FG001|Overall Study|Physician Decision|6|||
126616628|NCT03072238|455555380|FG000|Overall Study|Death|351|||
126743619|NCT02407236|456009849|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126743620|NCT02407236|456009850|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126743621|NCT02407236|456009851|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126743622|NCT02407236|456009852|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126743623|NCT02407236|456009853|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126743624|NCT02407236|456009854|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126743625|NCT02407236|456009855|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126743626|NCT02407236|456009856|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
126743627|NCT02407236|456009844|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126743628|NCT02407236|456009845|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126743629|NCT02407236|456009846|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
126743630|NCT02407236|456009847|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126743631|NCT02407236|456009848|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126743632|NCT02407236|456009849|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126743633|NCT02407236|456009850|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126743634|NCT02407236|456009851|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126743635|NCT02407236|456009852|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126743636|NCT02407236|456009853|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126743637|NCT02407236|456009854|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126743638|NCT02407236|456009855|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126743639|NCT02407236|456009856|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
126743640|NCT02407236|456009844|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
126743641|NCT02407236|456009845|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
126743642|NCT02407236|456009846|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
126743643|NCT02407236|456009847|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
126743644|NCT02407236|456009848|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
126743645|NCT02407236|456009849|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
126743646|NCT02407236|456009850|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
126743647|NCT02407236|456009851|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
126743648|NCT02407236|456009852|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
126743649|NCT02407236|456009853|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
126743650|NCT02407236|456009854|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
126743651|NCT02407236|456009855|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
126743652|NCT02407236|456009856|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
126743653|NCT02407236|456009844|FG000|Induction Study (8 Weeks)|Other|2|||
126743654|NCT02407236|456009845|FG001|Induction Study (8 Weeks)|Other|1|||
126616629|NCT03072238|455555381|FG001|Overall Study|Death|318|||
126616630|NCT03072238|455555380|FG000|Overall Study|Progressive Disease|3|||
126616631|NCT03072238|455555381|FG001|Overall Study|Progressive Disease|4|||
126616632|NCT03072238|455555380|FG000|Overall Study|Reason Not Specified|138|||
126616633|NCT03072238|455555381|FG001|Overall Study|Reason Not Specified|150|||
126616634|NCT03924193|455555387|FG000|Overall Study|Adverse Event|10|||
126616635|NCT03924193|455555388|FG001|Overall Study|Adverse Event|0|||
126616636|NCT03924193|455555389|FG002|Overall Study|Adverse Event|10|||
126616637|NCT03924193|455555387|FG000|Overall Study|Withdrawal by Subject|5|||
126616638|NCT03924193|455555388|FG001|Overall Study|Withdrawal by Subject|10|||
126616639|NCT03924193|455555389|FG002|Overall Study|Withdrawal by Subject|2|||
126616640|NCT02489799|455555390|FG000|Overall Study|Lost to Follow-up|4|||
126616641|NCT02489799|455555391|FG001|Overall Study|Lost to Follow-up|1|||
126616642|NCT02489799|455555390|FG000|Overall Study|Failure to Maintain Eligibility|4|||
126616643|NCT02489799|455555391|FG001|Overall Study|Failure to Maintain Eligibility|6|||
126616644|NCT02489799|455555390|FG000|Overall Study|Withdrawal by Subject|1|||
126616645|NCT02489799|455555391|FG001|Overall Study|Withdrawal by Subject|1|||
126616646|NCT02489799|455555390|FG000|Overall Study|Death|0|||
126616647|NCT02489799|455555391|FG001|Overall Study|Death|1|||
126616648|NCT04909593|455555392|FG000|Overall Study|Withdrawal by Subject|1|||
126616649|NCT01241448|455555393|FG000|Overall Study|Adverse Event|1|||
126616650|NCT01241448|455555394|FG001|Overall Study|Adverse Event|0|||
126616651|NCT01241448|455555395|FG002|Overall Study|Adverse Event|2|||
126616652|NCT01241448|455555396|FG003|Overall Study|Adverse Event|2|||
126616653|NCT01241448|455555393|FG000|Overall Study|Lost to Follow-up|2|||
126616654|NCT01241448|455555394|FG001|Overall Study|Lost to Follow-up|1|||
126616655|NCT01241448|455555395|FG002|Overall Study|Lost to Follow-up|1|||
126616656|NCT01241448|455555396|FG003|Overall Study|Lost to Follow-up|1|||
126616657|NCT01241448|455555393|FG000|Overall Study|Physician Decision|0|||
126616658|NCT01241448|455555394|FG001|Overall Study|Physician Decision|2|||
126616659|NCT01241448|455555395|FG002|Overall Study|Physician Decision|0|||
126616660|NCT01241448|455555396|FG003|Overall Study|Physician Decision|0|||
126616661|NCT01241448|455555393|FG000|Overall Study|Protocol Violation|10|||
126616662|NCT01241448|455555394|FG001|Overall Study|Protocol Violation|5|||
126616663|NCT01241448|455555395|FG002|Overall Study|Protocol Violation|3|||
126616664|NCT01241448|455555396|FG003|Overall Study|Protocol Violation|6|||
126616665|NCT01241448|455555393|FG000|Overall Study|Sponsor Decision|17|||
126616666|NCT01241448|455555394|FG001|Overall Study|Sponsor Decision|14|||
126616667|NCT01241448|455555395|FG002|Overall Study|Sponsor Decision|12|||
126616668|NCT01241448|455555396|FG003|Overall Study|Sponsor Decision|6|||
126616669|NCT01241448|455555393|FG000|Overall Study|Withdrawal by Subject|4|||
126616670|NCT01241448|455555394|FG001|Overall Study|Withdrawal by Subject|5|||
126616671|NCT01241448|455555395|FG002|Overall Study|Withdrawal by Subject|3|||
126616672|NCT01241448|455555396|FG003|Overall Study|Withdrawal by Subject|6|||
126743655|NCT02407236|456009846|FG002|Induction Study (8 Weeks)|Other|5|||
126616673|NCT01241448|455555393|FG000|Overall Study|Excluded due to data integrity issues|3|||
126616674|NCT01241448|455555394|FG001|Overall Study|Excluded due to data integrity issues|2|||
126616675|NCT01241448|455555395|FG002|Overall Study|Excluded due to data integrity issues|2|||
126743656|NCT02407236|456009847|FG003|Induction Study (8 Weeks)|Other|0|||
126743657|NCT02407236|456009848|FG004|Induction Study (8 Weeks)|Other|0|||
126743658|NCT02407236|456009849|FG005|Induction Study (8 Weeks)|Other|0|||
126743659|NCT02407236|456009850|FG006|Induction Study (8 Weeks)|Other|0|||
126743660|NCT02407236|456009851|FG007|Induction Study (8 Weeks)|Other|0|||
126743661|NCT02407236|456009852|FG008|Induction Study (8 Weeks)|Other|0|||
126743662|NCT02407236|456009853|FG009|Induction Study (8 Weeks)|Other|0|||
126743663|NCT02407236|456009854|FG010|Induction Study (8 Weeks)|Other|0|||
126743664|NCT02407236|456009855|FG011|Induction Study (8 Weeks)|Other|0|||
126743665|NCT02407236|456009856|FG012|Induction Study (8 Weeks)|Other|0|||
126743666|NCT02407236|456009844|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
126743667|NCT02407236|456009845|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
126743668|NCT02407236|456009846|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
126743669|NCT02407236|456009847|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
126743670|NCT02407236|456009848|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
126743671|NCT02407236|456009849|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
126743672|NCT02407236|456009850|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
126743673|NCT02407236|456009851|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
126743674|NCT02407236|456009852|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
126743675|NCT02407236|456009853|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
126743676|NCT02407236|456009854|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
126743677|NCT02407236|456009855|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
126743678|NCT02407236|456009856|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
126743679|NCT02407236|456009844|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126743680|NCT02407236|456009845|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126743681|NCT02407236|456009846|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126743682|NCT02407236|456009847|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
126743683|NCT02407236|456009848|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
126743684|NCT02407236|456009849|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
126743685|NCT02407236|456009850|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
126743686|NCT02407236|456009851|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
126743687|NCT02407236|456009852|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126743688|NCT02407236|456009853|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126743689|NCT02407236|456009854|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126743690|NCT02407236|456009855|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126743691|NCT02407236|456009856|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
126743692|NCT02407236|456009844|FG000|Maintenance Study (44 Weeks)|Other|0|||
126743693|NCT02407236|456009845|FG001|Maintenance Study (44 Weeks)|Other|0|||
126743694|NCT02407236|456009846|FG002|Maintenance Study (44 Weeks)|Other|0|||
126743695|NCT02407236|456009847|FG003|Maintenance Study (44 Weeks)|Other|5|||
126743696|NCT02407236|456009848|FG004|Maintenance Study (44 Weeks)|Other|7|||
126743697|NCT02407236|456009849|FG005|Maintenance Study (44 Weeks)|Other|8|||
126743698|NCT02407236|456009850|FG006|Maintenance Study (44 Weeks)|Other|4|||
126743699|NCT02407236|456009851|FG007|Maintenance Study (44 Weeks)|Other|6|||
126743700|NCT02407236|456009852|FG008|Maintenance Study (44 Weeks)|Other|0|||
126743701|NCT02407236|456009853|FG009|Maintenance Study (44 Weeks)|Other|0|||
126743702|NCT02407236|456009854|FG010|Maintenance Study (44 Weeks)|Other|0|||
126743703|NCT02407236|456009855|FG011|Maintenance Study (44 Weeks)|Other|0|||
126743704|NCT02407236|456009856|FG012|Maintenance Study (44 Weeks)|Other|0|||
126743705|NCT02407236|456009844|FG000|Maintenance Study (44 Weeks)|Death|0|||
126743706|NCT02407236|456009845|FG001|Maintenance Study (44 Weeks)|Death|0|||
126743707|NCT02407236|456009846|FG002|Maintenance Study (44 Weeks)|Death|0|||
126743708|NCT02407236|456009847|FG003|Maintenance Study (44 Weeks)|Death|0|||
126743709|NCT02407236|456009848|FG004|Maintenance Study (44 Weeks)|Death|0|||
126743710|NCT02407236|456009849|FG005|Maintenance Study (44 Weeks)|Death|0|||
126743711|NCT02407236|456009850|FG006|Maintenance Study (44 Weeks)|Death|0|||
126743712|NCT02407236|456009851|FG007|Maintenance Study (44 Weeks)|Death|1|||
126743713|NCT02407236|456009852|FG008|Maintenance Study (44 Weeks)|Death|0|||
126743714|NCT02407236|456009853|FG009|Maintenance Study (44 Weeks)|Death|0|||
126743715|NCT02407236|456009854|FG010|Maintenance Study (44 Weeks)|Death|0|||
126743716|NCT02407236|456009855|FG011|Maintenance Study (44 Weeks)|Death|0|||
126743717|NCT02407236|456009856|FG012|Maintenance Study (44 Weeks)|Death|0|||
126743718|NCT02407236|456009844|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126743719|NCT02407236|456009845|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126743720|NCT02407236|456009846|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126743721|NCT02407236|456009847|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126743722|NCT02407236|456009848|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126743723|NCT02407236|456009849|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126743724|NCT02407236|456009850|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126743725|NCT02407236|456009851|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
126743726|NCT02407236|456009852|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
126743727|NCT02407236|456009853|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
126743728|NCT02407236|456009854|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
126743729|NCT02407236|456009855|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
126743730|NCT02407236|456009856|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
126743731|NCT02407236|456009844|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126743732|NCT02407236|456009845|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126743733|NCT02407236|456009846|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126743734|NCT02407236|456009847|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126743735|NCT02407236|456009848|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126743736|NCT02407236|456009849|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126743737|NCT02407236|456009850|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126743738|NCT02407236|456009851|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126743739|NCT02407236|456009852|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126743740|NCT02407236|456009853|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126743741|NCT02407236|456009854|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
126743742|NCT02407236|456009855|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126743743|NCT02407236|456009856|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
126743744|NCT02407236|456009844|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126743745|NCT02407236|456009845|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126743746|NCT02407236|456009846|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126743747|NCT02407236|456009847|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126743748|NCT02407236|456009848|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126743749|NCT02407236|456009849|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126743750|NCT02407236|456009850|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126743751|NCT02407236|456009851|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
126743752|NCT02407236|456009852|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
126743753|NCT02407236|456009853|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
126743754|NCT02407236|456009854|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
126743755|NCT02407236|456009855|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
126743756|NCT02407236|456009856|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
126743757|NCT02407236|456009844|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
126743758|NCT02407236|456009845|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
126743759|NCT02407236|456009846|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
126743760|NCT02407236|456009847|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
126743761|NCT02407236|456009848|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
126743762|NCT02407236|456009849|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
126743763|NCT02407236|456009850|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
126743764|NCT02407236|456009851|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
126743765|NCT02407236|456009852|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
126743766|NCT02407236|456009853|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
126743767|NCT02407236|456009854|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
126743768|NCT02407236|456009855|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
126743769|NCT02407236|456009856|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
126743770|NCT00464620|456011481|FG000|Overall Study|Physician Decision|1|||
126743771|NCT00464620|456011482|FG001|Overall Study|Physician Decision|0|||
126743772|NCT00464620|456011483|FG002|Overall Study|Physician Decision|0|||
126743773|NCT00464620|456011481|FG000|Overall Study|Withdrawal by Subject|1|||
126743774|NCT00464620|456011482|FG001|Overall Study|Withdrawal by Subject|0|||
126743775|NCT00464620|456011483|FG002|Overall Study|Withdrawal by Subject|3|||
126743776|NCT00464620|456011481|FG000|Overall Study|Ineligible sarcoma subtype|0|||
126743777|NCT00464620|456011482|FG001|Overall Study|Ineligible sarcoma subtype|2|||
126743778|NCT00464620|456011483|FG002|Overall Study|Ineligible sarcoma subtype|2|||
126743779|NCT00464620|456011481|FG000|Overall Study|Use of prohibited concomitant medication|0|||
126743780|NCT00464620|456011482|FG001|Overall Study|Use of prohibited concomitant medication|0|||
126743781|NCT00464620|456011483|FG002|Overall Study|Use of prohibited concomitant medication|2|||
126743782|NCT04984876|456011484|FG000|Overall Study|Subject decision|2|||
126743783|NCT04984876|456011485|FG001|Overall Study|Subject decision|10|||
126743784|NCT04984876|456011486|FG002|Overall Study|Subject decision|3|||
126743785|NCT04984876|456011487|FG003|Overall Study|Subject decision|3|||
126743786|NCT04984876|456011488|FG004|Overall Study|Subject decision|3|||
126743787|NCT04984876|456011489|FG005|Overall Study|Subject decision|0|||
126743788|NCT04984876|456011484|FG000|Overall Study|Guardian decision|0|||
126743789|NCT04984876|456011485|FG001|Overall Study|Guardian decision|1|||
126743790|NCT04984876|456011486|FG002|Overall Study|Guardian decision|0|||
126743791|NCT04984876|456011487|FG003|Overall Study|Guardian decision|2|||
126781833|NCT02669264|456156285|FG003|Overall Study|Withdrawal by Subject|0|||
126616676|NCT01241448|455555396|FG003|Overall Study|Excluded due to data integrity issues|2|||
126616677|NCT02165202|455555398|FG000|Oral Phase|Refused further participation|5|||
126743792|NCT04984876|456011488|FG004|Overall Study|Guardian decision|0|||
126743793|NCT04984876|456011489|FG005|Overall Study|Guardian decision|1|||
126743794|NCT04984876|456011484|FG000|Overall Study|Lost to Follow-up|0|||
126616678|NCT02165202|455555399|FG001|Oral Phase|Refused further participation|1|||
126616679|NCT02165202|455555398|FG000|Oral Phase|Study product Related Toxicity|1|||
126616680|NCT02165202|455555399|FG001|Oral Phase|Study product Related Toxicity|0|||
126616681|NCT02165202|455555398|FG000|Oral Phase|Unable to contact Participant|1|||
126616682|NCT02165202|455555399|FG001|Oral Phase|Unable to contact Participant|1|||
126616683|NCT02165202|455555398|FG000|Oral Phase|Clinical reasons|1|||
126616684|NCT02165202|455555399|FG001|Oral Phase|Clinical reasons|0|||
126616685|NCT02165202|455555398|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
126616686|NCT02165202|455555399|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
126616687|NCT02165202|455555398|FG000|Oral Phase|CMC advised termination|1|||
126616688|NCT02165202|455555399|FG001|Oral Phase|CMC advised termination|0|||
126616689|NCT02165202|455555398|FG000|Oral Phase|Relocated, no follow-up planned|1|||
126616690|NCT02165202|455555399|FG001|Oral Phase|Relocated, no follow-up planned|0|||
126616691|NCT02165202|455555398|FG000|Oral Phase|Abnormal EKG|0|||
126616692|NCT02165202|455555399|FG001|Oral Phase|Abnormal EKG|1|||
126616693|NCT02165202|455555398|FG000|Injection Phase|Abnormal Lab Value|5|||
126616694|NCT02165202|455555399|FG001|Injection Phase|Abnormal Lab Value|1|||
126616695|NCT02165202|455555398|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
126616696|NCT02165202|455555399|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
126616697|NCT02165202|455555398|FG000|Injection Phase|Unable to attend within Visit Window|1|||
126616698|NCT02165202|455555399|FG001|Injection Phase|Unable to attend within Visit Window|0|||
126616699|NCT02165202|455555398|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
126616700|NCT02165202|455555399|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
126616701|NCT02165202|455555398|FG000|Injection Phase|End of Study|2|||
126616702|NCT02165202|455555399|FG001|Injection Phase|End of Study|1|||
126616703|NCT02165202|455555398|FG000|Injection Phase|Study Product related Toxicity|1|||
126616704|NCT02165202|455555399|FG001|Injection Phase|Study Product related Toxicity|0|||
126616705|NCT02165202|455555398|FG000|Injection Phase|No longer interested|0|||
126616706|NCT02165202|455555399|FG001|Injection Phase|No longer interested|1|||
126616707|NCT02165202|455555398|FG000|Injection Phase|Participant unwilling to comply|1|||
126616708|NCT02165202|455555399|FG001|Injection Phase|Participant unwilling to comply|0|||
126616709|NCT01655498|455555408|FG000|Overall Study|Unrelated health issue|2|||
126616710|NCT01655498|455555408|FG000|Overall Study|Protocol Violation|2|||
126616711|NCT01655498|455555408|FG000|Overall Study|Withdrawal by Subject|1|||
126616712|NCT01072149|455555411|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616713|NCT01072149|455555412|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616714|NCT01072149|455555413|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
126616715|NCT01072149|455555414|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616716|NCT01072149|455555415|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616717|NCT01072149|455555416|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616718|NCT01072149|455555417|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616719|NCT01072149|455555418|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616720|NCT01072149|455555419|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616721|NCT01072149|455555420|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616722|NCT01072149|455555421|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616723|NCT01072149|455555422|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616724|NCT01072149|455555423|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616725|NCT01072149|455555424|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616726|NCT01072149|455555425|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616727|NCT01072149|455555426|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616728|NCT01072149|455555427|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616729|NCT01072149|455555428|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
126616730|NCT01072149|455555411|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616731|NCT01072149|455555412|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616732|NCT01072149|455555413|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616733|NCT01072149|455555414|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616734|NCT01072149|455555415|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616735|NCT01072149|455555416|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616736|NCT01072149|455555417|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616737|NCT01072149|455555418|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616738|NCT01072149|455555419|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616739|NCT01072149|455555420|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616740|NCT01072149|455555421|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616741|NCT01072149|455555422|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616742|NCT01072149|455555423|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616743|NCT01072149|455555424|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616744|NCT01072149|455555425|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616745|NCT01072149|455555426|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616746|NCT01072149|455555427|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
126616747|NCT01072149|455555428|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
126616748|NCT01072149|455555411|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126743795|NCT04984876|456011485|FG001|Overall Study|Lost to Follow-up|0|||
126743796|NCT04984876|456011486|FG002|Overall Study|Lost to Follow-up|1|||
126743797|NCT04984876|456011487|FG003|Overall Study|Lost to Follow-up|1|||
126743798|NCT04984876|456011488|FG004|Overall Study|Lost to Follow-up|0|||
126743799|NCT04984876|456011489|FG005|Overall Study|Lost to Follow-up|0|||
126743800|NCT04984876|456011484|FG000|Overall Study|Physician Decision|1|||
126743801|NCT04984876|456011485|FG001|Overall Study|Physician Decision|0|||
126743802|NCT04984876|456011486|FG002|Overall Study|Physician Decision|0|||
126743803|NCT04984876|456011487|FG003|Overall Study|Physician Decision|1|||
126743804|NCT04984876|456011488|FG004|Overall Study|Physician Decision|0|||
126743805|NCT04984876|456011489|FG005|Overall Study|Physician Decision|0|||
126743806|NCT04984876|456011484|FG000|Overall Study|Adverse Event|0|||
126743807|NCT04984876|456011485|FG001|Overall Study|Adverse Event|0|||
126743808|NCT04984876|456011486|FG002|Overall Study|Adverse Event|1|||
126743809|NCT04984876|456011487|FG003|Overall Study|Adverse Event|0|||
126743810|NCT04984876|456011488|FG004|Overall Study|Adverse Event|0|||
126743811|NCT04984876|456011489|FG005|Overall Study|Adverse Event|0|||
126743812|NCT00209092|456011492|FG000|Overall Study|Progression of disease|7|||
126743813|NCT00209092|456011493|FG001|Overall Study|Progression of disease|1|||
126743814|NCT00209092|456011492|FG000|Overall Study|Adverse Event|0|||
126743815|NCT00209092|456011493|FG001|Overall Study|Adverse Event|1|||
126743816|NCT00209092|456011492|FG000|Overall Study|Withdrawal by Subject|1|||
126743817|NCT00209092|456011493|FG001|Overall Study|Withdrawal by Subject|0|||
126743818|NCT01462045|456011496|FG000|Overall Study|Family matter|0|||
126743819|NCT01462045|456011497|FG001|Overall Study|Family matter|1|||
126743820|NCT01462045|456011498|FG002|Overall Study|Family matter|0|||
126743821|NCT02828644|456011501|FG000|Overall Study|Lost to Follow-up|23|||
126743822|NCT02828644|456011502|FG001|Overall Study|Lost to Follow-up|22|||
126743823|NCT02436915|456011503|FG000|Overall Study|Withdrawal by Subject|0|||
126743824|NCT02436915|456011504|FG001|Overall Study|Withdrawal by Subject|1|||
126743825|NCT01117181|456011511|FG000|Overall Study|Lost to Follow-up|1|||
126743826|NCT01117181|456011512|FG001|Overall Study|Lost to Follow-up|0|||
126743827|NCT01117181|456011511|FG000|Overall Study|Withdrawal by Subject|0|||
126743828|NCT01117181|456011512|FG001|Overall Study|Withdrawal by Subject|2|||
126743829|NCT02158728|456011513|FG000|Overall Study|no procedure according to CIP done|3|||
126743830|NCT02158728|456011513|FG000|Overall Study|no qualified dataset|24|||
126743831|NCT01518309|456011514|FG000|Overall Study|Adverse Event|6|||
126743832|NCT01518309|456011514|FG000|Overall Study|Death|6|||
126743833|NCT01518309|456011514|FG000|Overall Study|Lack of Efficacy|7|||
126743834|NCT01518309|456011514|FG000|Overall Study|Withdrawal by Subject|6|||
126743835|NCT01518309|456011514|FG000|Overall Study|Physician Decision|3|||
126743836|NCT01518309|456011514|FG000|Overall Study|Sponsor Decision|2|||
126743837|NCT01518309|456011514|FG000|Overall Study|Not in Predefined Categories|9|||
126743838|NCT02579863|456011515|FG000|Overall Study|Final Disposition Unknown|2|||
126743839|NCT02579863|456011516|FG001|Overall Study|Final Disposition Unknown|1|||
126743840|NCT02579863|456011515|FG000|Overall Study|Adverse Event|18|||
126743841|NCT02579863|456011516|FG001|Overall Study|Adverse Event|11|||
126743842|NCT02579863|456011515|FG000|Overall Study|Death|31|||
126743843|NCT02579863|456011516|FG001|Overall Study|Death|29|||
126743844|NCT02579863|456011515|FG000|Overall Study|Lost to Follow-up|2|||
126743845|NCT02579863|456011516|FG001|Overall Study|Lost to Follow-up|1|||
126743846|NCT02579863|456011515|FG000|Overall Study|Physician Decision|1|||
126743847|NCT02579863|456011516|FG001|Overall Study|Physician Decision|2|||
126743848|NCT02579863|456011515|FG000|Overall Study|Screen Failure|0|||
126743849|NCT02579863|456011516|FG001|Overall Study|Screen Failure|2|||
126743850|NCT02579863|456011515|FG000|Overall Study|Study Terminated at Selected Sites|82|||
126743851|NCT02579863|456011516|FG001|Overall Study|Study Terminated at Selected Sites|88|||
126743852|NCT02579863|456011515|FG000|Overall Study|Withdrawal by Subject|20|||
126743853|NCT02579863|456011516|FG001|Overall Study|Withdrawal by Subject|20|||
126743854|NCT03878160|456011522|FG000|Overall Study|Lost to Follow-up|1|||
126743855|NCT03878160|456011523|FG001|Overall Study|Lost to Follow-up|1|||
126743856|NCT03878160|456011524|FG002|Overall Study|Lost to Follow-up|1|||
126743857|NCT03878160|456011522|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
126616749|NCT01072149|455555412|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126743858|NCT03878160|456011523|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
126743859|NCT03878160|456011524|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
126743860|NCT00038142|456011527|FG000|Overall Study|Ineligible|1|||
126743861|NCT00038142|456011528|FG001|Overall Study|Ineligible|0|||
126743862|NCT00038142|456011527|FG000|Overall Study|Progressive Disease|11|||
126743863|NCT00038142|456011528|FG001|Overall Study|Progressive Disease|7|||
126743864|NCT00038142|456011527|FG000|Overall Study|Death|1|||
126616750|NCT01072149|455555413|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126616751|NCT01072149|455555414|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126743865|NCT00038142|456011528|FG001|Overall Study|Death|0|||
126743866|NCT00038142|456011527|FG000|Overall Study|Adverse Event|1|||
126743867|NCT00038142|456011528|FG001|Overall Study|Adverse Event|0|||
126743868|NCT00038142|456011527|FG000|Overall Study|Unknown Reason|8|||
126743869|NCT00038142|456011528|FG001|Overall Study|Unknown Reason|0|||
126743870|NCT00809614|456011535|FG000|Overall Study|Lack of Efficacy|2|||
126743871|NCT00809614|456011536|FG001|Overall Study|Lack of Efficacy|3|||
126743872|NCT00809614|456011535|FG000|Overall Study|Withdrawal by Subject|1|||
126743873|NCT00809614|456011536|FG001|Overall Study|Withdrawal by Subject|1|||
126743874|NCT01080625|456011537|FG000|Overall Study|Physician Decision|0|||
126743875|NCT01080625|456011538|FG001|Overall Study|Physician Decision|2|||
126743876|NCT01080625|456011539|FG002|Overall Study|Physician Decision|1|||
126743877|NCT00364832|456011543|FG000|Core Period|Early Withdrawals|2|||
126743878|NCT00364832|456011544|FG001|Core Period|Early Withdrawals|2|||
126743879|NCT00364832|456011545|FG002|Core Period|Early Withdrawals|1|||
126743880|NCT00364832|456011546|FG003|Core Period|Early Withdrawals|1|||
126743881|NCT00364832|456011547|FG004|Core Period|Early Withdrawals|0|||
126743882|NCT00364832|456011548|FG005|Core Period|Early Withdrawals|0|||
126743883|NCT00364832|456011549|FG006|Core Period|Early Withdrawals|4|||
126743884|NCT00364832|456011550|FG007|Core Period|Early Withdrawals|1|||
126743885|NCT00364832|456011551|FG008|Core Period|Early Withdrawals|0|||
126743886|NCT00364832|456011552|FG009|Core Period|Early Withdrawals|0|||
126743887|NCT00364832|456011553|FG010|Core Period|Early Withdrawals|0|||
126743888|NCT00364832|456011554|FG011|Core Period|Early Withdrawals|0|||
126743889|NCT00364832|456011543|FG000|Extension Year 1|Early Withdrawals|0|||
126743890|NCT00364832|456011544|FG001|Extension Year 1|Early Withdrawals|0|||
126743891|NCT00364832|456011545|FG002|Extension Year 1|Early Withdrawals|0|||
126743892|NCT00364832|456011546|FG003|Extension Year 1|Early Withdrawals|0|||
126743893|NCT00364832|456011547|FG004|Extension Year 1|Early Withdrawals|0|||
126743894|NCT00364832|456011548|FG005|Extension Year 1|Early Withdrawals|0|||
126743895|NCT00364832|456011549|FG006|Extension Year 1|Early Withdrawals|0|||
126743896|NCT00364832|456011550|FG007|Extension Year 1|Early Withdrawals|0|||
126743897|NCT00364832|456011551|FG008|Extension Year 1|Early Withdrawals|0|||
126743898|NCT00364832|456011552|FG009|Extension Year 1|Early Withdrawals|4|||
126743899|NCT00364832|456011553|FG010|Extension Year 1|Early Withdrawals|2|||
126743900|NCT00364832|456011554|FG011|Extension Year 1|Early Withdrawals|10|||
126743901|NCT00364832|456011543|FG000|Extension Year 2|Early Withdrawals|0|||
126743902|NCT00364832|456011544|FG001|Extension Year 2|Early Withdrawals|0|||
126743903|NCT00364832|456011545|FG002|Extension Year 2|Early Withdrawals|0|||
126743904|NCT00364832|456011546|FG003|Extension Year 2|Early Withdrawals|0|||
126743905|NCT00364832|456011547|FG004|Extension Year 2|Early Withdrawals|0|||
126743906|NCT00364832|456011548|FG005|Extension Year 2|Early Withdrawals|0|||
126743907|NCT00364832|456011549|FG006|Extension Year 2|Early Withdrawals|0|||
126743908|NCT00364832|456011550|FG007|Extension Year 2|Early Withdrawals|0|||
126743909|NCT00364832|456011551|FG008|Extension Year 2|Early Withdrawals|0|||
126743910|NCT00364832|456011552|FG009|Extension Year 2|Early Withdrawals|5|||
126743911|NCT00364832|456011553|FG010|Extension Year 2|Early Withdrawals|5|||
126743912|NCT00364832|456011554|FG011|Extension Year 2|Early Withdrawals|3|||
126743913|NCT00589602|456011558|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
126743914|NCT02658149|456011560|FG000|Overall Study|Physician Decision|1|||
126743915|NCT02658149|456011561|FG001|Overall Study|Physician Decision|0|||
126743916|NCT01804842|456011569|FG000|Overall Study|Adverse Event|1|||
126743917|NCT01804842|456011570|FG001|Overall Study|Adverse Event|1|||
126743918|NCT01804842|456011571|FG002|Overall Study|Adverse Event|0|||
126743919|NCT01804842|456011569|FG000|Overall Study|Lost to Follow-up|1|||
126743920|NCT01804842|456011570|FG001|Overall Study|Lost to Follow-up|0|||
126743921|NCT01804842|456011571|FG002|Overall Study|Lost to Follow-up|0|||
126743922|NCT01804842|456011569|FG000|Overall Study|Non-Compliance|1|||
126743923|NCT01804842|456011570|FG001|Overall Study|Non-Compliance|1|||
126743924|NCT01804842|456011571|FG002|Overall Study|Non-Compliance|0|||
126743925|NCT01804842|456011569|FG000|Overall Study|Personal Reason|0|||
126743926|NCT01804842|456011570|FG001|Overall Study|Personal Reason|0|||
126743927|NCT01804842|456011571|FG002|Overall Study|Personal Reason|1|||
126743928|NCT01440972|456011572|FG000|Overall Study|Withdrawal by Subject|3|||
126743929|NCT01440972|456011573|FG001|Overall Study|Withdrawal by Subject|2|||
126743930|NCT03933215|456011574|FG000|Overall Study|Other|6|||
126743931|NCT03933215|456011574|FG000|Overall Study|Sponsor decision|5|||
126743932|NCT03933215|456011574|FG000|Overall Study|Protocol Violation|5|||
126743933|NCT03933215|456011574|FG000|Overall Study|Withdrawal by Subject|6|||
126743934|NCT03933215|456011574|FG000|Overall Study|Lost to Follow-up|6|||
126743935|NCT03933215|456011574|FG000|Overall Study|Enrolled but not treated|38|||
126743936|NCT04222673|456011575|FG000|Overall Study|Lost to Follow-up|5|||
126743937|NCT04097028|456011576|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
126743938|NCT04097028|456011576|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
126743939|NCT04097028|456011576|FG000|Overall Study|Disease Progression prior to Surgery|2|||
126743940|NCT04097028|456011576|FG000|Overall Study|Adverse Event prior to Surgery|1|||
126743941|NCT02352090|456011577|FG000|Overall Study|general malaise|1|||
126743942|NCT02352090|456011578|FG001|Overall Study|general malaise|0|||
126743943|NCT02352090|456011579|FG002|Overall Study|general malaise|0|||
126743944|NCT02352090|456011577|FG000|Overall Study|non-specified mild side-effects|0|||
126743945|NCT02352090|456011578|FG001|Overall Study|non-specified mild side-effects|0|||
126743946|NCT02352090|456011579|FG002|Overall Study|non-specified mild side-effects|2|||
126616752|NCT01072149|455555415|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126743947|NCT00068822|456011581|FG000|First Randomized Intervention|Lost to Follow-up|1|||
126743948|NCT00068822|456011582|FG001|First Randomized Intervention|Lost to Follow-up|2|||
126743949|NCT03146403|456011583|FG000|Overall Study|Withdrawal by Subject|0|||
126743950|NCT03146403|456011584|FG001|Overall Study|Withdrawal by Subject|3|||
126743951|NCT03146403|456011583|FG000|Overall Study|Lost to Follow-up|2|||
126743952|NCT03146403|456011584|FG001|Overall Study|Lost to Follow-up|0|||
126743953|NCT02266004|456011585|FG000|Overall Study|unrelated adverse event|1|||
126743954|NCT02266004|456011585|FG000|Overall Study|Physician Decision|1|||
126743955|NCT00638690|456011598|FG000|Overall Study|Death|655|||
126743956|NCT00638690|456011599|FG001|Overall Study|Death|335|||
126743957|NCT00638690|456011598|FG000|Overall Study|Withdrawal by Subject|22|||
126743958|NCT00638690|456011599|FG001|Overall Study|Withdrawal by Subject|5|||
126743959|NCT00638690|456011598|FG000|Overall Study|Lost to Follow-up|4|||
126743960|NCT00638690|456011599|FG001|Overall Study|Lost to Follow-up|2|||
126743961|NCT01347073|456011609|FG000|Overall Study|Adverse Event|1|||
126743962|NCT01347073|456011609|FG000|Overall Study|Liver Transplant|1|||
126743963|NCT00372489|456011616|FG000|Overall Study|Adverse Event|18|||
126743964|NCT00372489|456011616|FG000|Overall Study|Lack of Efficacy|1|||
126743965|NCT00372489|456011616|FG000|Overall Study|Lost to Follow-up|3|||
126743966|NCT00372489|456011616|FG000|Overall Study|Physician Decision|3|||
126743967|NCT00372489|456011616|FG000|Overall Study|Withdrawal by Subject|5|||
126743968|NCT00372489|456011616|FG000|Overall Study|Patient Relocation|2|||
126743969|NCT00372489|456011616|FG000|Overall Study|Renal transplant|6|||
126743970|NCT00372489|456011616|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
126743971|NCT00552344|456011621|FG000|Overall Study|Lack of Efficacy|55|||
126743972|NCT00552344|456011621|FG000|Overall Study|Loss of efficacy|75|||
126743973|NCT00552344|456011621|FG000|Overall Study|Lost to Follow-up|8|||
126743974|NCT00552344|456011621|FG000|Overall Study|Withdrawal by Subject|48|||
126743975|NCT00552344|456011621|FG000|Overall Study|SAE, non-fatal|6|||
126743976|NCT00552344|456011621|FG000|Overall Study|AE, non-serious non-fatal|38|||
126743977|NCT00552344|456011621|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
126743978|NCT00552344|456011621|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
126743979|NCT00552344|456011621|FG000|Overall Study|Other Reason|22|||
126743980|NCT02623699|456011622|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126743981|NCT02623699|456011623|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
126743982|NCT02623699|456011624|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126743983|NCT02623699|456011625|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126743984|NCT02623699|456011626|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126743985|NCT02623699|456011627|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126743986|NCT02623699|456011628|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126743987|NCT02623699|456011629|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126743988|NCT02623699|456011630|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126743989|NCT02623699|456011631|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126743990|NCT02623699|456011632|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126743991|NCT02623699|456011633|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
126743992|NCT02623699|456011622|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126743993|NCT02623699|456011623|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126743994|NCT02623699|456011624|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126743995|NCT02623699|456011625|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126743996|NCT02623699|456011626|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126743997|NCT02623699|456011627|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126743998|NCT02623699|456011628|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
126743999|NCT02623699|456011629|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126744000|NCT02623699|456011630|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126744001|NCT02623699|456011631|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126744002|NCT02623699|456011632|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126744003|NCT02623699|456011633|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
126744004|NCT02623699|456011622|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126744005|NCT02623699|456011623|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126744006|NCT02623699|456011624|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126744007|NCT02623699|456011625|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126744008|NCT02623699|456011626|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126616753|NCT01072149|455555416|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126744009|NCT02623699|456011627|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
126744010|NCT02623699|456011628|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126744011|NCT02623699|456011629|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126744012|NCT02623699|456011630|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126744013|NCT02623699|456011631|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126744014|NCT02623699|456011632|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126744015|NCT02623699|456011633|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
126744016|NCT02623699|456011622|FG000|Part B (Up to 289 Days)|Death|0|||
126744017|NCT02623699|456011623|FG001|Part B (Up to 289 Days)|Death|0|||
126744018|NCT02623699|456011624|FG002|Part B (Up to 289 Days)|Death|0|||
126744019|NCT02623699|456011625|FG003|Part B (Up to 289 Days)|Death|0|||
126744020|NCT02623699|456011626|FG004|Part B (Up to 289 Days)|Death|0|||
126744021|NCT02623699|456011627|FG005|Part B (Up to 289 Days)|Death|1|||
126744022|NCT02623699|456011628|FG006|Part B (Up to 289 Days)|Death|1|||
126744023|NCT02623699|456011629|FG007|Part B (Up to 289 Days)|Death|0|||
126744024|NCT02623699|456011630|FG008|Part B (Up to 289 Days)|Death|1|||
126744025|NCT02623699|456011631|FG009|Part B (Up to 289 Days)|Death|0|||
126744026|NCT02623699|456011632|FG010|Part B (Up to 289 Days)|Death|0|||
126744027|NCT02623699|456011633|FG011|Part B (Up to 289 Days)|Death|0|||
126744028|NCT02623699|456011622|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
126744029|NCT02623699|456011623|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
126744030|NCT02623699|456011624|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
126744031|NCT02623699|456011625|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
126744032|NCT02623699|456011626|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
126744033|NCT02623699|456011627|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
126744034|NCT02623699|456011628|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
126744035|NCT02623699|456011629|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
126744036|NCT02623699|456011630|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
126744037|NCT02623699|456011631|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
126744038|NCT02623699|456011632|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
126744039|NCT02623699|456011633|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
126744040|NCT02623699|456011622|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126744041|NCT02623699|456011623|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126744042|NCT02623699|456011624|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126744043|NCT02623699|456011625|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126744044|NCT02623699|456011626|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126744045|NCT02623699|456011627|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126744046|NCT02623699|456011628|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126744047|NCT02623699|456011629|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126744048|NCT02623699|456011630|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126744049|NCT02623699|456011631|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
126744050|NCT02623699|456011632|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
126744051|NCT02623699|456011633|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
126744052|NCT02623699|456011622|FG000|Part C (Up to 236 Days)|Death|0|||
126744053|NCT02623699|456011623|FG001|Part C (Up to 236 Days)|Death|0|||
126744054|NCT02623699|456011624|FG002|Part C (Up to 236 Days)|Death|0|||
126744055|NCT02623699|456011625|FG003|Part C (Up to 236 Days)|Death|0|||
126744056|NCT02623699|456011626|FG004|Part C (Up to 236 Days)|Death|0|||
126744057|NCT02623699|456011627|FG005|Part C (Up to 236 Days)|Death|0|||
126744058|NCT02623699|456011628|FG006|Part C (Up to 236 Days)|Death|0|||
126744059|NCT02623699|456011629|FG007|Part C (Up to 236 Days)|Death|0|||
126744060|NCT02623699|456011630|FG008|Part C (Up to 236 Days)|Death|0|||
126744061|NCT02623699|456011631|FG009|Part C (Up to 236 Days)|Death|0|||
126744062|NCT02623699|456011632|FG010|Part C (Up to 236 Days)|Death|0|||
126744063|NCT02623699|456011633|FG011|Part C (Up to 236 Days)|Death|1|||
126744064|NCT02623699|456011622|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
126744065|NCT02623699|456011623|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
126744066|NCT02623699|456011624|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
126744067|NCT02623699|456011625|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
126744068|NCT02623699|456011626|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
126744069|NCT02623699|456011627|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
126744070|NCT02623699|456011628|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
126744071|NCT02623699|456011629|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
126744072|NCT02623699|456011630|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
126744073|NCT02623699|456011631|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
126744074|NCT02623699|456011632|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
126744075|NCT02623699|456011633|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
126744076|NCT03074318|456011636|FG000|Overall Study|Adverse Event|0|||
126744077|NCT03074318|456011637|FG001|Overall Study|Adverse Event|1|||
126744078|NCT03074318|456011638|FG002|Overall Study|Adverse Event|1|||
126744079|NCT03074318|456011639|FG003|Overall Study|Adverse Event|1|||
126744080|NCT03074318|456011636|FG000|Overall Study|Death|1|||
126744081|NCT03074318|456011637|FG001|Overall Study|Death|0|||
126744082|NCT03074318|456011638|FG002|Overall Study|Death|0|||
126744083|NCT03074318|456011639|FG003|Overall Study|Death|0|||
126744084|NCT03074318|456011636|FG000|Overall Study|Withdrawal by Subject|1|||
126744085|NCT03074318|456011637|FG001|Overall Study|Withdrawal by Subject|2|||
126744086|NCT03074318|456011638|FG002|Overall Study|Withdrawal by Subject|2|||
126744087|NCT03074318|456011639|FG003|Overall Study|Withdrawal by Subject|4|||
126744088|NCT03074318|456011636|FG000|Overall Study|Trial Closure|2|||
126744089|NCT03074318|456011637|FG001|Overall Study|Trial Closure|2|||
126744090|NCT03074318|456011638|FG002|Overall Study|Trial Closure|3|||
126744091|NCT03074318|456011639|FG003|Overall Study|Trial Closure|11|||
126744092|NCT01627782|456011642|FG000|Overall Study|Adverse Event|1|||
126744093|NCT01627782|456011643|FG001|Overall Study|Adverse Event|2|||
126744094|NCT01627782|456011644|FG002|Overall Study|Adverse Event|0|||
126744095|NCT01627782|456011645|FG003|Overall Study|Adverse Event|1|||
126744096|NCT01627782|456011642|FG000|Overall Study|Lack of Efficacy|11|||
126744097|NCT01627782|456011643|FG001|Overall Study|Lack of Efficacy|1|||
126744098|NCT01627782|456011644|FG002|Overall Study|Lack of Efficacy|15|||
126744099|NCT01627782|456011645|FG003|Overall Study|Lack of Efficacy|2|||
126616754|NCT01072149|455555417|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126616755|NCT01072149|455555418|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126744100|NCT01627782|456011642|FG000|Overall Study|Protocol Violation|1|||
126744101|NCT01627782|456011643|FG001|Overall Study|Protocol Violation|0|||
126744102|NCT01627782|456011644|FG002|Overall Study|Protocol Violation|0|||
126744103|NCT01627782|456011645|FG003|Overall Study|Protocol Violation|0|||
126744104|NCT01627782|456011642|FG000|Overall Study|Withdrawal by Subject|2|||
126744105|NCT01627782|456011643|FG001|Overall Study|Withdrawal by Subject|1|||
126744106|NCT01627782|456011644|FG002|Overall Study|Withdrawal by Subject|0|||
126744107|NCT01627782|456011645|FG003|Overall Study|Withdrawal by Subject|0|||
126744108|NCT01627782|456011642|FG000|Overall Study|Other|0|||
126744109|NCT01627782|456011643|FG001|Overall Study|Other|2|||
126744110|NCT01627782|456011644|FG002|Overall Study|Other|0|||
126744111|NCT01627782|456011645|FG003|Overall Study|Other|3|||
126744112|NCT01627782|456011642|FG000|Overall Study|Randomized But Not Treated|1|||
126744113|NCT01627782|456011643|FG001|Overall Study|Randomized But Not Treated|0|||
126744114|NCT01627782|456011644|FG002|Overall Study|Randomized But Not Treated|0|||
126744115|NCT01627782|456011645|FG003|Overall Study|Randomized But Not Treated|0|||
126744116|NCT03573401|456011646|FG000|Overall Study|Withdrawal by Subject|2|||
126744117|NCT03573401|456011647|FG001|Overall Study|Withdrawal by Subject|0|||
126744118|NCT03573401|456011646|FG000|Overall Study|Subject non-compliance with study schedule|1|||
126744119|NCT03573401|456011647|FG001|Overall Study|Subject non-compliance with study schedule|0|||
126744120|NCT03573401|456011646|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
126744121|NCT03573401|456011647|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
126744122|NCT03573401|456011646|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
126744123|NCT03573401|456011647|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
126744124|NCT00643448|456011649|FG000|Overall Study|Lack of Efficacy|2|||
126744125|NCT00643448|456011650|FG001|Overall Study|Lack of Efficacy|0|||
126744126|NCT00643448|456011651|FG002|Overall Study|Lack of Efficacy|4|||
126744127|NCT00643448|456011649|FG000|Overall Study|Adverse Event|2|||
126744128|NCT00643448|456011650|FG001|Overall Study|Adverse Event|2|||
126744129|NCT00643448|456011651|FG002|Overall Study|Adverse Event|2|||
126744130|NCT00643448|456011649|FG000|Overall Study|QTcF>550 ms|0|||
126744131|NCT00643448|456011650|FG001|Overall Study|QTcF>550 ms|3|||
126744132|NCT00643448|456011651|FG002|Overall Study|QTcF>550 ms|0|||
126744133|NCT02177812|456011652|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
126744134|NCT02177812|456011653|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
126744135|NCT02177812|456011654|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
126744136|NCT02177812|456011655|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
126744137|NCT02177812|456011656|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
126744138|NCT02177812|456011657|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
126744139|NCT02177812|456011658|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
126616756|NCT01072149|455555419|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126616757|NCT01072149|455555420|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126616758|NCT01072149|455555421|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
126616759|NCT01072149|455555422|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126616760|NCT01072149|455555423|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126616761|NCT01072149|455555424|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126616762|NCT01072149|455555425|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126616763|NCT01072149|455555426|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126616764|NCT01072149|455555427|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126616765|NCT01072149|455555428|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
126744140|NCT02177812|456011659|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
126744141|NCT02177812|456011660|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
126744142|NCT02177812|456011652|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126744143|NCT02177812|456011653|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126744144|NCT02177812|456011654|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126616766|NCT01072149|455555411|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126616767|NCT01072149|455555412|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
126616768|NCT01072149|455555413|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126744145|NCT02177812|456011655|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126744146|NCT02177812|456011656|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126744147|NCT02177812|456011657|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
126616769|NCT01072149|455555414|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126616770|NCT01072149|455555415|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126744148|NCT02177812|456011658|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
126744149|NCT02177812|456011659|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126744150|NCT02177812|456011660|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
126781834|NCT02669264|456156286|FG004|Overall Study|Withdrawal by Subject|1|||
126744151|NCT02177812|456011652|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
126616771|NCT01072149|455555416|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126616772|NCT01072149|455555417|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126744152|NCT02177812|456011653|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
126744153|NCT02177812|456011654|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
126744154|NCT02177812|456011655|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
126744155|NCT02177812|456011656|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
126744156|NCT02177812|456011657|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
126744157|NCT02177812|456011658|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
126744158|NCT02177812|456011659|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
126744159|NCT02177812|456011660|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
126744160|NCT00089999|456011661|FG000|Overall Study|Adverse Event|4|||
126744161|NCT00089999|456011662|FG001|Overall Study|Adverse Event|7|||
126744162|NCT00089999|456011661|FG000|Overall Study|Withdrawal by Subject|0|||
126744163|NCT00089999|456011662|FG001|Overall Study|Withdrawal by Subject|4|||
126744164|NCT00089999|456011661|FG000|Overall Study|Lost to Follow-up|2|||
126744165|NCT00089999|456011662|FG001|Overall Study|Lost to Follow-up|1|||
126744166|NCT00089999|456011661|FG000|Overall Study|Radiological Progression of Cancer|52|||
126744167|NCT00089999|456011662|FG001|Overall Study|Radiological Progression of Cancer|44|||
126744168|NCT00089999|456011661|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
126744169|NCT00089999|456011662|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
126744170|NCT00089999|456011661|FG000|Overall Study|Death|3|||
126744171|NCT00089999|456011662|FG001|Overall Study|Death|3|||
126744172|NCT00089999|456011661|FG000|Overall Study|Poor General Condition|1|||
126744173|NCT00089999|456011662|FG001|Overall Study|Poor General Condition|0|||
126744174|NCT00089999|456011661|FG000|Overall Study|Clinical Progression|1|||
126744175|NCT00089999|456011662|FG001|Overall Study|Clinical Progression|2|||
126744176|NCT00089999|456011661|FG000|Overall Study|Physician Decision|2|||
126744177|NCT00089999|456011662|FG001|Overall Study|Physician Decision|2|||
126744178|NCT00089999|456011661|FG000|Overall Study|Patient Underwent Surgery|2|||
126744179|NCT00089999|456011662|FG001|Overall Study|Patient Underwent Surgery|0|||
126744180|NCT00089999|456011661|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
126744181|NCT00089999|456011662|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
126744182|NCT01167153|456011665|FG000|Overall Study|Non-effective therapy|1|||
126744183|NCT01167153|456011666|FG001|Overall Study|Non-effective therapy|4|||
126744184|NCT01167153|456011665|FG000|Overall Study|AE including clinical laboratory AE|2|||
126744185|NCT01167153|456011666|FG001|Overall Study|AE including clinical laboratory AE|8|||
126744186|NCT01167153|456011665|FG000|Overall Study|Hypotension|1|||
126744187|NCT01167153|456011666|FG001|Overall Study|Hypotension|0|||
126744188|NCT01167153|456011665|FG000|Overall Study|Lost to Follow-up|7|||
126744189|NCT01167153|456011666|FG001|Overall Study|Lost to Follow-up|9|||
126744190|NCT01167153|456011665|FG000|Overall Study|Non-compliance to concomitant medication|0|||
126744191|NCT01167153|456011666|FG001|Overall Study|Non-compliance to concomitant medication|2|||
126744192|NCT01167153|456011665|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
126744193|NCT01167153|456011666|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
126744194|NCT01167153|456011665|FG000|Overall Study|Withdrawal consent|1|||
126744195|NCT01167153|456011666|FG001|Overall Study|Withdrawal consent|1|||
126744196|NCT01167153|456011665|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
126744197|NCT01167153|456011666|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
126744198|NCT05166603|456011669|FG000|Overall Study|Withdrawal by Subject|68|||
126744199|NCT05166603|456011670|FG001|Overall Study|Withdrawal by Subject|0|||
126744200|NCT00777257|456013875|FG000|Overall Study|Adverse Event|3|||
126744201|NCT00777257|456013876|FG001|Overall Study|Adverse Event|1|||
126744202|NCT00777257|456013877|FG002|Overall Study|Adverse Event|0|||
126744203|NCT00777257|456013875|FG000|Overall Study|Lost to Follow-up|3|||
126744204|NCT00777257|456013876|FG001|Overall Study|Lost to Follow-up|3|||
126744205|NCT00777257|456013877|FG002|Overall Study|Lost to Follow-up|2|||
126744206|NCT00777257|456013875|FG000|Overall Study|Protocol Violation|2|||
126744207|NCT00777257|456013876|FG001|Overall Study|Protocol Violation|2|||
126744208|NCT00777257|456013877|FG002|Overall Study|Protocol Violation|2|||
126744209|NCT00777257|456013875|FG000|Overall Study|Withdrawal by Subject|3|||
126744210|NCT00777257|456013876|FG001|Overall Study|Withdrawal by Subject|6|||
126744211|NCT00777257|456013877|FG002|Overall Study|Withdrawal by Subject|5|||
126744212|NCT04315298|456013878|FG000|Overall Study|Withdrawal by Subject|0|||
126744213|NCT04315298|456013879|FG001|Overall Study|Withdrawal by Subject|0|||
126744214|NCT04315298|456013880|FG002|Overall Study|Withdrawal by Subject|0|||
126744215|NCT04315298|456013881|FG003|Overall Study|Withdrawal by Subject|2|||
126744216|NCT04315298|456013882|FG004|Overall Study|Withdrawal by Subject|2|||
126744217|NCT04315298|456013883|FG005|Overall Study|Withdrawal by Subject|2|||
126744218|NCT04315298|456013884|FG006|Overall Study|Withdrawal by Subject|0|||
126744219|NCT04315298|456013885|FG007|Overall Study|Withdrawal by Subject|1|||
126744220|NCT04315298|456013886|FG008|Overall Study|Withdrawal by Subject|1|||
126744221|NCT04315298|456013887|FG009|Overall Study|Withdrawal by Subject|1|||
126744222|NCT04315298|456013888|FG010|Overall Study|Withdrawal by Subject|0|||
126744223|NCT04315298|456013889|FG011|Overall Study|Withdrawal by Subject|0|||
126744224|NCT04315298|456013890|FG012|Overall Study|Withdrawal by Subject|0|||
126744225|NCT04315298|456013891|FG013|Overall Study|Withdrawal by Subject|0|||
126744226|NCT04315298|456013892|FG014|Overall Study|Withdrawal by Subject|0|||
126744227|NCT04315298|456013893|FG015|Overall Study|Withdrawal by Subject|0|||
126744228|NCT04315298|456013894|FG016|Overall Study|Withdrawal by Subject|0|||
126744229|NCT04315298|456013895|FG017|Overall Study|Withdrawal by Subject|0|||
126744230|NCT04315298|456013896|FG018|Overall Study|Withdrawal by Subject|0|||
126744231|NCT04315298|456013878|FG000|Overall Study|Physician Decision|0|||
126744232|NCT04315298|456013879|FG001|Overall Study|Physician Decision|0|||
126744233|NCT04315298|456013880|FG002|Overall Study|Physician Decision|0|||
126744234|NCT04315298|456013881|FG003|Overall Study|Physician Decision|0|||
126744235|NCT04315298|456013882|FG004|Overall Study|Physician Decision|1|||
126744236|NCT04315298|456013883|FG005|Overall Study|Physician Decision|0|||
126744237|NCT04315298|456013884|FG006|Overall Study|Physician Decision|0|||
126744238|NCT04315298|456013885|FG007|Overall Study|Physician Decision|0|||
126744239|NCT04315298|456013886|FG008|Overall Study|Physician Decision|0|||
126744240|NCT04315298|456013887|FG009|Overall Study|Physician Decision|0|||
126744241|NCT04315298|456013888|FG010|Overall Study|Physician Decision|0|||
126744242|NCT04315298|456013889|FG011|Overall Study|Physician Decision|0|||
126744243|NCT04315298|456013890|FG012|Overall Study|Physician Decision|0|||
126744244|NCT04315298|456013891|FG013|Overall Study|Physician Decision|0|||
126744245|NCT04315298|456013892|FG014|Overall Study|Physician Decision|0|||
126744246|NCT04315298|456013893|FG015|Overall Study|Physician Decision|0|||
126744247|NCT04315298|456013894|FG016|Overall Study|Physician Decision|0|||
126744248|NCT04315298|456013895|FG017|Overall Study|Physician Decision|0|||
126744249|NCT04315298|456013896|FG018|Overall Study|Physician Decision|0|||
126744250|NCT04315298|456013878|FG000|Overall Study|Lost to Follow-up|5|||
126744251|NCT04315298|456013879|FG001|Overall Study|Lost to Follow-up|10|||
126744252|NCT04315298|456013880|FG002|Overall Study|Lost to Follow-up|6|||
126744253|NCT04315298|456013881|FG003|Overall Study|Lost to Follow-up|8|||
126744254|NCT04315298|456013882|FG004|Overall Study|Lost to Follow-up|12|||
126744255|NCT04315298|456013883|FG005|Overall Study|Lost to Follow-up|13|||
126744256|NCT04315298|456013884|FG006|Overall Study|Lost to Follow-up|9|||
126744257|NCT04315298|456013885|FG007|Overall Study|Lost to Follow-up|16|||
126744258|NCT04315298|456013886|FG008|Overall Study|Lost to Follow-up|14|||
126744259|NCT04315298|456013887|FG009|Overall Study|Lost to Follow-up|0|||
126744260|NCT04315298|456013888|FG010|Overall Study|Lost to Follow-up|2|||
126744261|NCT04315298|456013889|FG011|Overall Study|Lost to Follow-up|1|||
126744262|NCT04315298|456013890|FG012|Overall Study|Lost to Follow-up|0|||
126744263|NCT04315298|456013891|FG013|Overall Study|Lost to Follow-up|0|||
126744264|NCT04315298|456013892|FG014|Overall Study|Lost to Follow-up|0|||
126744265|NCT04315298|456013893|FG015|Overall Study|Lost to Follow-up|2|||
126744266|NCT04315298|456013894|FG016|Overall Study|Lost to Follow-up|0|||
126744267|NCT04315298|456013895|FG017|Overall Study|Lost to Follow-up|0|||
126744268|NCT04315298|456013896|FG018|Overall Study|Lost to Follow-up|0|||
126616773|NCT01072149|455555418|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126616774|NCT01072149|455555419|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126616775|NCT01072149|455555420|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126616776|NCT01072149|455555421|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126744269|NCT04315298|456013878|FG000|Overall Study|Death|24|||
126744270|NCT04315298|456013879|FG001|Overall Study|Death|60|||
126744271|NCT04315298|456013880|FG002|Overall Study|Death|49|||
126744272|NCT04315298|456013881|FG003|Overall Study|Death|59|||
126744273|NCT04315298|456013882|FG004|Overall Study|Death|70|||
126744274|NCT04315298|456013883|FG005|Overall Study|Death|114|||
126744275|NCT04315298|456013884|FG006|Overall Study|Death|9|||
126744276|NCT04315298|456013885|FG007|Overall Study|Death|12|||
126744277|NCT04315298|456013886|FG008|Overall Study|Death|21|||
126744278|NCT04315298|456013887|FG009|Overall Study|Death|16|||
126744279|NCT04315298|456013888|FG010|Overall Study|Death|40|||
126744280|NCT04315298|456013889|FG011|Overall Study|Death|40|||
126744281|NCT04315298|456013890|FG012|Overall Study|Death|3|||
126744282|NCT04315298|456013891|FG013|Overall Study|Death|4|||
126744283|NCT04315298|456013892|FG014|Overall Study|Death|6|||
126744284|NCT04315298|456013893|FG015|Overall Study|Death|4|||
126744285|NCT04315298|456013894|FG016|Overall Study|Death|3|||
126781835|NCT02669264|456156287|FG005|Overall Study|Withdrawal by Subject|0|||
126781836|NCT02669264|456156288|FG006|Overall Study|Withdrawal by Subject|0|||
126744286|NCT04315298|456013895|FG017|Overall Study|Death|1|||
126744287|NCT04315298|456013896|FG018|Overall Study|Death|0|||
126744288|NCT00736385|456013897|FG000|Overall Study|Withdrawal by Subject|2|||
126744289|NCT00736385|456013898|FG001|Overall Study|Withdrawal by Subject|2|||
126744290|NCT00736385|456013897|FG000|Overall Study|Adverse Event|0|||
126744291|NCT00736385|456013898|FG001|Overall Study|Adverse Event|1|||
126744292|NCT00098865|456013899|FG000|Overall Study|Progressive Disease|6|||
126744293|NCT00098865|456013899|FG000|Overall Study|Adverse Event|2|||
126744294|NCT00098865|456013899|FG000|Overall Study|Alternative Therapy|1|||
126744295|NCT01183104|456013900|FG000|Overall Study|Adverse Event|8|||
126744296|NCT01183104|456013901|FG001|Overall Study|Adverse Event|6|||
126744297|NCT01183104|456013900|FG000|Overall Study|Death|0|||
126744298|NCT01183104|456013901|FG001|Overall Study|Death|1|||
126744299|NCT01183104|456013900|FG000|Overall Study|Lost to Follow-up|14|||
126744300|NCT01183104|456013901|FG001|Overall Study|Lost to Follow-up|7|||
126744301|NCT01183104|456013900|FG000|Overall Study|Physician Decision|5|||
126781837|NCT02669264|456156282|FG000|Overall Study|Lost to Follow-up|0|||
126744302|NCT01183104|456013901|FG001|Overall Study|Physician Decision|8|||
126744303|NCT01183104|456013900|FG000|Overall Study|Withdrawal by Subject|6|||
126744304|NCT01183104|456013901|FG001|Overall Study|Withdrawal by Subject|11|||
126744305|NCT01183104|456013900|FG000|Overall Study|Nonparticipation in Extension Study|39|||
126744306|NCT01183104|456013901|FG001|Overall Study|Nonparticipation in Extension Study|50|||
126744307|NCT01183104|456013900|FG000|Overall Study|Did not receive study drug|5|||
126744308|NCT01183104|456013901|FG001|Overall Study|Did not receive study drug|9|||
126744309|NCT03267511|456013902|FG000|Overall Study|Lost to Follow-up|0|||
126744310|NCT03267511|456013903|FG001|Overall Study|Lost to Follow-up|0|||
126744311|NCT03267511|456013904|FG002|Overall Study|Lost to Follow-up|0|||
126744312|NCT03267511|456013905|FG003|Overall Study|Lost to Follow-up|1|||
126744313|NCT00364351|456013906|FG000|Overall Study|Adverse Event|90|||
126744314|NCT00364351|456013907|FG001|Overall Study|Adverse Event|44|||
126744315|NCT00364351|456013906|FG000|Overall Study|Condition under investigation worsened|469|||
126744316|NCT00364351|456013907|FG001|Overall Study|Condition under investigation worsened|497|||
126744317|NCT00364351|456013906|FG000|Overall Study|Prohibited concomitant medication|0|||
126744318|NCT00364351|456013907|FG001|Overall Study|Prohibited concomitant medication|2|||
126744319|NCT00364351|456013906|FG000|Overall Study|Lost to Follow-up|1|||
126744320|NCT00364351|456013907|FG001|Overall Study|Lost to Follow-up|1|||
126744321|NCT00364351|456013906|FG000|Overall Study|Withdrawal by Subject|30|||
126744322|NCT00364351|456013907|FG001|Overall Study|Withdrawal by Subject|29|||
126744323|NCT00364351|456013906|FG000|Overall Study|Incorrect enrollment|1|||
126744324|NCT00364351|456013907|FG001|Overall Study|Incorrect enrollment|1|||
126744325|NCT00364351|456013906|FG000|Overall Study|Sponsor decision|1|||
126744326|NCT00364351|456013907|FG001|Overall Study|Sponsor decision|0|||
126744327|NCT00364351|456013906|FG000|Overall Study|Poor treatment compliance|0|||
126744328|NCT00364351|456013907|FG001|Overall Study|Poor treatment compliance|3|||
126744329|NCT00364351|456013906|FG000|Overall Study|Investigator error|0|||
126744330|NCT00364351|456013907|FG001|Overall Study|Investigator error|2|||
126744331|NCT00364351|456013906|FG000|Overall Study|Patient could not travel to site|0|||
126744332|NCT00364351|456013907|FG001|Overall Study|Patient could not travel to site|1|||
126744333|NCT00364351|456013906|FG000|Overall Study|Randomised treatment not started|0|||
126744334|NCT00364351|456013907|FG001|Overall Study|Randomised treatment not started|3|||
126744335|NCT00688623|456013909|FG000|Overall Study|Adverse Event|22|||
126616777|NCT01072149|455555422|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126616778|NCT01072149|455555423|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126781838|NCT02669264|456156283|FG001|Overall Study|Lost to Follow-up|0|||
126781839|NCT02669264|456156284|FG002|Overall Study|Lost to Follow-up|0|||
126781840|NCT02669264|456156285|FG003|Overall Study|Lost to Follow-up|0|||
126781841|NCT02669264|456156286|FG004|Overall Study|Lost to Follow-up|1|||
126781842|NCT02669264|456156287|FG005|Overall Study|Lost to Follow-up|0|||
126781843|NCT02669264|456156288|FG006|Overall Study|Lost to Follow-up|0|||
126781844|NCT02669264|456156282|FG000|Overall Study|Miscellaneous|0|||
126781845|NCT02669264|456156283|FG001|Overall Study|Miscellaneous|0|||
126781846|NCT02669264|456156284|FG002|Overall Study|Miscellaneous|0|||
126781847|NCT02669264|456156285|FG003|Overall Study|Miscellaneous|0|||
126781848|NCT02669264|456156286|FG004|Overall Study|Miscellaneous|0|||
126781849|NCT02669264|456156287|FG005|Overall Study|Miscellaneous|0|||
126616779|NCT01072149|455555424|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126616780|NCT01072149|455555425|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126616781|NCT01072149|455555426|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126616782|NCT01072149|455555427|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126616783|NCT01072149|455555428|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
126616784|NCT01072149|455555411|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616785|NCT01072149|455555412|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616786|NCT01072149|455555413|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
126616787|NCT01072149|455555414|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616788|NCT01072149|455555415|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616789|NCT01072149|455555416|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616790|NCT01072149|455555417|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616791|NCT01072149|455555418|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616792|NCT01072149|455555419|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616793|NCT01072149|455555420|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616794|NCT01072149|455555421|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126744336|NCT00688623|456013909|FG000|Overall Study|abnormal lab value|1|||
126781850|NCT02669264|456156288|FG006|Overall Study|Miscellaneous|2|||
126781851|NCT01688037|456156289|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
126744337|NCT00688623|456013909|FG000|Overall Study|Withdrawal by Subject|4|||
126744338|NCT00688623|456013909|FG000|Overall Study|Death|3|||
126744339|NCT00688623|456013909|FG000|Overall Study|disease progression|23|||
126744340|NCT00688623|456013909|FG000|Overall Study|Protocol Violation|2|||
126781852|NCT01688037|456156290|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
126744341|NCT02667236|456013910|FG000|Overall Study|Adverse Event|1|||
126744342|NCT02667236|456013911|FG001|Overall Study|Adverse Event|1|||
126744343|NCT02667236|456013910|FG000|Overall Study|Withdrawal by Subject|2|||
126744344|NCT02667236|456013911|FG001|Overall Study|Withdrawal by Subject|0|||
126744345|NCT03887052|456013917|FG000|Overall Study|Adverse Event|2|||
126744346|NCT03887052|456013917|FG000|Overall Study|Physician Decision|2|||
126744347|NCT03887052|456013917|FG000|Overall Study|Withdrawal by Subject|3|||
126744348|NCT03887052|456013917|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
126744349|NCT03887052|456013917|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
126744350|NCT01678313|456013919|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
126744351|NCT01678313|456013920|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
126744352|NCT01678313|456013919|FG000|Completed the 3-month Therapy|Physician Decision|3|||
126744353|NCT01678313|456013920|FG001|Completed the 3-month Therapy|Physician Decision|4|||
126744354|NCT01678313|456013919|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
126744355|NCT01678313|456013920|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
126744356|NCT01678313|456013919|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
126744357|NCT01678313|456013920|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
126744358|NCT00981292|456013923|FG000|Day 1|Protocol Violation|1|||
126744359|NCT00981292|456013924|FG001|Day 1|Protocol Violation|0|||
126744360|NCT00981292|456013925|FG002|Day 1|Protocol Violation|0|||
126744361|NCT00981292|456013926|FG003|Day 1|Protocol Violation|0|||
126744362|NCT00981292|456013927|FG004|Day 1|Protocol Violation|0|||
126744363|NCT00981292|456013928|FG005|Day 1|Protocol Violation|2|||
126744364|NCT00981292|456013923|FG000|Day 2|Protocol Violation|2|||
126744365|NCT00981292|456013924|FG001|Day 2|Protocol Violation|0|||
126744366|NCT00981292|456013925|FG002|Day 2|Protocol Violation|0|||
126744367|NCT00981292|456013926|FG003|Day 2|Protocol Violation|0|||
126744368|NCT00981292|456013927|FG004|Day 2|Protocol Violation|0|||
126744369|NCT00981292|456013928|FG005|Day 2|Protocol Violation|0|||
126744370|NCT00981292|456013923|FG000|Day 3|Protocol Violation|0|||
126744371|NCT00981292|456013924|FG001|Day 3|Protocol Violation|0|||
126744372|NCT00981292|456013925|FG002|Day 3|Protocol Violation|0|||
126744373|NCT00981292|456013926|FG003|Day 3|Protocol Violation|0|||
126744374|NCT00981292|456013927|FG004|Day 3|Protocol Violation|0|||
126744375|NCT00981292|456013928|FG005|Day 3|Protocol Violation|1|||
126744376|NCT01131130|456013929|FG000|Period 1 - Baseline|Pregnancy|1|||
126744377|NCT01131130|456013929|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
126616795|NCT01072149|455555422|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616796|NCT01072149|455555423|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616797|NCT01072149|455555424|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616798|NCT01072149|455555425|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616799|NCT01072149|455555426|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616800|NCT01072149|455555427|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616801|NCT01072149|455555428|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
126616802|NCT01072149|455555411|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
126744378|NCT03464136|456013930|FG000|Overall Study|Lost to Follow-up|5|||
126744379|NCT03464136|456013931|FG001|Overall Study|Lost to Follow-up|8|||
126744380|NCT03464136|456013930|FG000|Overall Study|Withdrawal by Subject|16|||
126744381|NCT03464136|456013931|FG001|Overall Study|Withdrawal by Subject|13|||
126744382|NCT03464136|456013930|FG000|Overall Study|Death|1|||
126744383|NCT03464136|456013931|FG001|Overall Study|Death|0|||
126744384|NCT03464136|456013930|FG000|Overall Study|Other|8|||
126744385|NCT03464136|456013931|FG001|Overall Study|Other|4|||
126744386|NCT03412565|456013932|FG000|Overall Study|Lost to Follow-up|0|||
126744387|NCT03412565|456013933|FG001|Overall Study|Lost to Follow-up|0|||
126744388|NCT03412565|456013934|FG002|Overall Study|Lost to Follow-up|1|||
126744389|NCT03412565|456013935|FG003|Overall Study|Lost to Follow-up|0|||
126744390|NCT03412565|456013932|FG000|Overall Study|Physician Decision|0|||
126744391|NCT03412565|456013933|FG001|Overall Study|Physician Decision|0|||
126744392|NCT03412565|456013934|FG002|Overall Study|Physician Decision|0|||
126744393|NCT03412565|456013935|FG003|Overall Study|Physician Decision|1|||
126744394|NCT03412565|456013932|FG000|Overall Study|Withdrawal by Subject|0|||
126744395|NCT03412565|456013933|FG001|Overall Study|Withdrawal by Subject|4|||
126744396|NCT03412565|456013934|FG002|Overall Study|Withdrawal by Subject|5|||
126616803|NCT01072149|455555412|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
126744397|NCT03412565|456013935|FG003|Overall Study|Withdrawal by Subject|5|||
126744398|NCT03412565|456013932|FG000|Overall Study|Death|1|||
126616804|NCT01072149|455555413|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
126744399|NCT03412565|456013933|FG001|Overall Study|Death|3|||
126744400|NCT03412565|456013934|FG002|Overall Study|Death|4|||
126744401|NCT03412565|456013935|FG003|Overall Study|Death|5|||
126744402|NCT03412565|456013932|FG000|Overall Study|Data collection ended|0|||
126744403|NCT03412565|456013933|FG001|Overall Study|Data collection ended|41|||
126744404|NCT03412565|456013934|FG002|Overall Study|Data collection ended|41|||
126744405|NCT03412565|456013935|FG003|Overall Study|Data collection ended|40|||
126744406|NCT03277105|456013936|FG000|Overall Study|Death|129|||
126744407|NCT03277105|456013937|FG001|Overall Study|Death|124|||
126744408|NCT03277105|456013936|FG000|Overall Study|Lost to Follow-up|2|||
126744409|NCT03277105|456013937|FG001|Overall Study|Lost to Follow-up|4|||
126744410|NCT03277105|456013936|FG000|Overall Study|Withdrawal by Subject|10|||
126744411|NCT03277105|456013937|FG001|Overall Study|Withdrawal by Subject|10|||
126744412|NCT03277105|456013936|FG000|Overall Study|Other|118|||
126744413|NCT03277105|456013937|FG001|Overall Study|Other|125|||
126744414|NCT01849562|456013944|FG000|Overall Study|Lost to Follow-up|1|||
126744415|NCT01849562|456013945|FG001|Overall Study|Lost to Follow-up|0|||
126744416|NCT01849562|456013946|FG002|Overall Study|Lost to Follow-up|0|||
126744417|NCT01849562|456013944|FG000|Overall Study|Non-compliance with Study Drug|1|||
126744418|NCT01849562|456013945|FG001|Overall Study|Non-compliance with Study Drug|0|||
126744419|NCT01849562|456013946|FG002|Overall Study|Non-compliance with Study Drug|0|||
126744420|NCT02182999|456013950|FG000|Overall Study|Adverse Event|4|||
126744421|NCT02182999|456013951|FG001|Overall Study|Adverse Event|3|||
126744422|NCT02182999|456013950|FG000|Overall Study|Physician Decision|1|||
126744423|NCT02182999|456013951|FG001|Overall Study|Physician Decision|0|||
126744424|NCT02252588|456013952|FG000|Overall Study|Withdrawal by Subject|4|||
126744425|NCT02252588|456013953|FG001|Overall Study|Withdrawal by Subject|0|||
126744426|NCT03039790|456013954|FG000|Overall Study|Lost to Follow-up|2|||
126744427|NCT03039790|456013955|FG001|Overall Study|Lost to Follow-up|0|||
126744428|NCT03039790|456013956|FG002|Overall Study|Lost to Follow-up|1|||
126744429|NCT03039790|456013957|FG003|Overall Study|Lost to Follow-up|1|||
126744430|NCT03039790|456013958|FG004|Overall Study|Lost to Follow-up|0|||
126744431|NCT03039790|456013959|FG005|Overall Study|Lost to Follow-up|1|||
126744432|NCT03039790|456013960|FG006|Overall Study|Lost to Follow-up|1|||
126744433|NCT03039790|456013961|FG007|Overall Study|Lost to Follow-up|1|||
126744434|NCT03039790|456013962|FG008|Overall Study|Lost to Follow-up|0|||
126744435|NCT03039790|456013963|FG009|Overall Study|Lost to Follow-up|1|||
126744436|NCT03039790|456013964|FG010|Overall Study|Lost to Follow-up|1|||
126744437|NCT03039790|456013965|FG011|Overall Study|Lost to Follow-up|0|||
126744438|NCT03039790|456013966|FG012|Overall Study|Lost to Follow-up|1|||
126744439|NCT03039790|456013967|FG013|Overall Study|Lost to Follow-up|0|||
126744440|NCT03039790|456013968|FG014|Overall Study|Lost to Follow-up|3|||
126744441|NCT03039790|456013969|FG015|Overall Study|Lost to Follow-up|1|||
126744442|NCT03039790|456013970|FG016|Overall Study|Lost to Follow-up|2|||
126744443|NCT03039790|456013971|FG017|Overall Study|Lost to Follow-up|2|||
126744444|NCT03039790|456013972|FG018|Overall Study|Lost to Follow-up|1|||
126744445|NCT03039790|456013973|FG019|Overall Study|Lost to Follow-up|3|||
126744446|NCT03039790|456013954|FG000|Overall Study|Withdrawal of Consent|1|||
126744447|NCT03039790|456013955|FG001|Overall Study|Withdrawal of Consent|0|||
126744448|NCT03039790|456013956|FG002|Overall Study|Withdrawal of Consent|0|||
126744449|NCT03039790|456013957|FG003|Overall Study|Withdrawal of Consent|1|||
126744450|NCT03039790|456013958|FG004|Overall Study|Withdrawal of Consent|0|||
126744451|NCT03039790|456013959|FG005|Overall Study|Withdrawal of Consent|0|||
126744452|NCT03039790|456013960|FG006|Overall Study|Withdrawal of Consent|0|||
126744453|NCT03039790|456013961|FG007|Overall Study|Withdrawal of Consent|0|||
126744454|NCT03039790|456013962|FG008|Overall Study|Withdrawal of Consent|0|||
126744455|NCT03039790|456013963|FG009|Overall Study|Withdrawal of Consent|1|||
126744456|NCT03039790|456013964|FG010|Overall Study|Withdrawal of Consent|0|||
126744457|NCT03039790|456013965|FG011|Overall Study|Withdrawal of Consent|0|||
126744458|NCT03039790|456013966|FG012|Overall Study|Withdrawal of Consent|2|||
126744459|NCT03039790|456013967|FG013|Overall Study|Withdrawal of Consent|0|||
126744460|NCT03039790|456013968|FG014|Overall Study|Withdrawal of Consent|1|||
126744461|NCT03039790|456013969|FG015|Overall Study|Withdrawal of Consent|5|||
126744462|NCT03039790|456013970|FG016|Overall Study|Withdrawal of Consent|3|||
126744463|NCT03039790|456013971|FG017|Overall Study|Withdrawal of Consent|0|||
126744464|NCT03039790|456013972|FG018|Overall Study|Withdrawal of Consent|2|||
126744465|NCT03039790|456013973|FG019|Overall Study|Withdrawal of Consent|5|||
126744466|NCT03039790|456013954|FG000|Overall Study|Death|0|||
126744467|NCT03039790|456013955|FG001|Overall Study|Death|0|||
126744468|NCT03039790|456013956|FG002|Overall Study|Death|0|||
126744469|NCT03039790|456013957|FG003|Overall Study|Death|0|||
126744470|NCT03039790|456013958|FG004|Overall Study|Death|0|||
126744471|NCT03039790|456013959|FG005|Overall Study|Death|0|||
126744472|NCT03039790|456013960|FG006|Overall Study|Death|0|||
126744473|NCT03039790|456013961|FG007|Overall Study|Death|0|||
126744474|NCT03039790|456013962|FG008|Overall Study|Death|0|||
126744475|NCT03039790|456013963|FG009|Overall Study|Death|0|||
126744476|NCT03039790|456013964|FG010|Overall Study|Death|0|||
126744477|NCT03039790|456013965|FG011|Overall Study|Death|0|||
126744478|NCT03039790|456013966|FG012|Overall Study|Death|0|||
126744479|NCT03039790|456013967|FG013|Overall Study|Death|0|||
126744480|NCT03039790|456013968|FG014|Overall Study|Death|0|||
126781853|NCT01688037|456156291|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
126744481|NCT03039790|456013969|FG015|Overall Study|Death|1|||
126744482|NCT03039790|456013970|FG016|Overall Study|Death|3|||
126744483|NCT03039790|456013971|FG017|Overall Study|Death|0|||
126744484|NCT03039790|456013972|FG018|Overall Study|Death|2|||
126744485|NCT03039790|456013973|FG019|Overall Study|Death|0|||
126744486|NCT03039790|456013954|FG000|Overall Study|Reason, not Specified|1|||
126744487|NCT03039790|456013955|FG001|Overall Study|Reason, not Specified|0|||
126744488|NCT03039790|456013956|FG002|Overall Study|Reason, not Specified|0|||
126744489|NCT03039790|456013957|FG003|Overall Study|Reason, not Specified|0|||
126616805|NCT01072149|455555414|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
126744490|NCT03039790|456013958|FG004|Overall Study|Reason, not Specified|0|||
126744491|NCT03039790|456013959|FG005|Overall Study|Reason, not Specified|0|||
126744492|NCT03039790|456013960|FG006|Overall Study|Reason, not Specified|0|||
126744493|NCT03039790|456013961|FG007|Overall Study|Reason, not Specified|0|||
126744494|NCT03039790|456013962|FG008|Overall Study|Reason, not Specified|0|||
126744495|NCT03039790|456013963|FG009|Overall Study|Reason, not Specified|0|||
126744496|NCT03039790|456013964|FG010|Overall Study|Reason, not Specified|0|||
126744497|NCT03039790|456013965|FG011|Overall Study|Reason, not Specified|0|||
126744498|NCT03039790|456013966|FG012|Overall Study|Reason, not Specified|0|||
126744499|NCT03039790|456013967|FG013|Overall Study|Reason, not Specified|0|||
126744500|NCT03039790|456013968|FG014|Overall Study|Reason, not Specified|0|||
126744501|NCT03039790|456013969|FG015|Overall Study|Reason, not Specified|0|||
126744502|NCT03039790|456013970|FG016|Overall Study|Reason, not Specified|2|||
126744503|NCT03039790|456013971|FG017|Overall Study|Reason, not Specified|0|||
126744504|NCT03039790|456013972|FG018|Overall Study|Reason, not Specified|1|||
126744505|NCT03039790|456013973|FG019|Overall Study|Reason, not Specified|0|||
126744506|NCT00498368|456013983|FG000|Overall Study|Withdrawal by Subject|3|||
126744507|NCT00498368|456013984|FG001|Overall Study|Withdrawal by Subject|2|||
126744508|NCT00537771|456013989|FG000|Overall Study|Withdrawal by Subject|6|||
126744509|NCT00537771|456013990|FG001|Overall Study|Withdrawal by Subject|23|||
126744510|NCT00537771|456013989|FG000|Overall Study|Adverse Event|8|||
126744511|NCT00537771|456013990|FG001|Overall Study|Adverse Event|15|||
126744512|NCT00537771|456013989|FG000|Overall Study|Lost to Follow-up|9|||
126744513|NCT00537771|456013990|FG001|Overall Study|Lost to Follow-up|15|||
126744514|NCT00537771|456013989|FG000|Overall Study|Protocol Violation|2|||
126744515|NCT00537771|456013990|FG001|Overall Study|Protocol Violation|6|||
126744516|NCT00537771|456013989|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
126744517|NCT00537771|456013990|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
126744518|NCT02736929|456013992|FG000|Main Study|Lost to Follow-up|7|||
126744519|NCT02736929|456013993|FG001|Main Study|Lost to Follow-up|1|||
126744520|NCT02736929|456013994|FG002|Main Study|Lost to Follow-up|0|||
126744521|NCT02736929|456013992|FG000|Main Study|Withdrawal by Subject|1|||
126744522|NCT02736929|456013993|FG001|Main Study|Withdrawal by Subject|1|||
126744523|NCT02736929|456013994|FG002|Main Study|Withdrawal by Subject|0|||
126744524|NCT02736929|456013992|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
126744525|NCT02736929|456013993|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
126744526|NCT02736929|456013994|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
126744527|NCT00285649|456013997|FG000|Overall Study|Lost to Follow-up|6|||
126744528|NCT00285649|456013998|FG001|Overall Study|Lost to Follow-up|4|||
126744529|NCT00285649|456013999|FG002|Overall Study|Lost to Follow-up|4|||
126744530|NCT00285649|456013997|FG000|Overall Study|Withdrawal by Subject|3|||
126744531|NCT00285649|456013998|FG001|Overall Study|Withdrawal by Subject|2|||
126744532|NCT00285649|456013999|FG002|Overall Study|Withdrawal by Subject|2|||
126744533|NCT03342404|456014000|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
126744534|NCT03342404|456014001|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
126744535|NCT03342404|456014000|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
126744536|NCT03342404|456014001|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
126744537|NCT03342404|456014000|FG000|Blinded Treatment Phase|Adverse Event|5|||
126744538|NCT03342404|456014001|FG001|Blinded Treatment Phase|Adverse Event|4|||
126744539|NCT03342404|456014000|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
126744540|NCT03342404|456014001|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
126744541|NCT03342404|456014000|FG000|Blinded Treatment Phase|Other reasons|1|||
126744542|NCT03342404|456014001|FG001|Blinded Treatment Phase|Other reasons|0|||
126744543|NCT03342404|456014000|FG000|Blinded Treatment Phase|Physician Decision|1|||
126744544|NCT03342404|456014001|FG001|Blinded Treatment Phase|Physician Decision|0|||
126744545|NCT03342404|456014000|FG000|Blinded Treatment Phase|Death|1|||
126744546|NCT03342404|456014001|FG001|Blinded Treatment Phase|Death|0|||
126744547|NCT03342404|456014000|FG000|Open-Label Phase|Lost to Follow-up|0|||
126744548|NCT03342404|456014001|FG001|Open-Label Phase|Lost to Follow-up|1|||
126744549|NCT03342404|456014000|FG000|Open-Label Phase|Other reasons|0|||
126744550|NCT03342404|456014001|FG001|Open-Label Phase|Other reasons|1|||
126744551|NCT03342404|456014000|FG000|Open-Label Phase|Adverse Event|0|||
126744552|NCT03342404|456014001|FG001|Open-Label Phase|Adverse Event|3|||
126616806|NCT01072149|455555415|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
126616807|NCT01072149|455555416|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
126616808|NCT01072149|455555417|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
126744553|NCT03342404|456014000|FG000|Open-Label Phase|Withdrawal by Subject|0|||
126744554|NCT03342404|456014001|FG001|Open-Label Phase|Withdrawal by Subject|6|||
126744555|NCT01855425|456014002|FG000|Overall Study|Physician Decision|20|||
126744556|NCT01690988|456014003|FG000|Overall Study|Withdrawal by Subject|2|||
126744557|NCT01690988|456014004|FG001|Overall Study|Withdrawal by Subject|2|||
126744558|NCT01690988|456014005|FG002|Overall Study|Withdrawal by Subject|3|||
126744559|NCT01690988|456014003|FG000|Overall Study|Physician Decision|0|||
126744560|NCT01690988|456014004|FG001|Overall Study|Physician Decision|0|||
126744561|NCT01690988|456014005|FG002|Overall Study|Physician Decision|1|||
126744562|NCT01690988|456014003|FG000|Overall Study|Operation Cancelled|1|||
126744563|NCT01690988|456014004|FG001|Overall Study|Operation Cancelled|1|||
126744564|NCT01690988|456014005|FG002|Overall Study|Operation Cancelled|0|||
126744565|NCT01690988|456014003|FG000|Overall Study|Determined ineligible|1|||
126744566|NCT01690988|456014004|FG001|Overall Study|Determined ineligible|0|||
126744567|NCT01690988|456014005|FG002|Overall Study|Determined ineligible|0|||
126744568|NCT01690988|456014003|FG000|Overall Study|Death|1|||
126744569|NCT01690988|456014004|FG001|Overall Study|Death|1|||
126744570|NCT01690988|456014005|FG002|Overall Study|Death|1|||
126744571|NCT01690988|456014003|FG000|Overall Study|Sedated|1|||
126744572|NCT01690988|456014004|FG001|Overall Study|Sedated|1|||
126744573|NCT01690988|456014005|FG002|Overall Study|Sedated|2|||
126744574|NCT01634100|456014008|FG000|Overall Study|Withdrawal by Subject|1|||
126744575|NCT01634100|456014009|FG001|Overall Study|Withdrawal by Subject|0|||
126744576|NCT01634100|456014010|FG002|Overall Study|Withdrawal by Subject|1|||
126744577|NCT01634100|456014011|FG003|Overall Study|Withdrawal by Subject|0|||
126744578|NCT01634100|456014012|FG004|Overall Study|Withdrawal by Subject|0|||
126744579|NCT01634100|456014013|FG005|Overall Study|Withdrawal by Subject|0|||
126744580|NCT01662986|456014014|FG000|Overall Study|Adverse Event|5|||
126744581|NCT01662986|456014015|FG001|Overall Study|Adverse Event|4|||
126744582|NCT01662986|456014014|FG000|Overall Study|Protocol Violation|2|||
126744583|NCT01662986|456014015|FG001|Overall Study|Protocol Violation|3|||
126744584|NCT01662986|456014014|FG000|Overall Study|Lost to Follow-up|5|||
126744585|NCT01662986|456014015|FG001|Overall Study|Lost to Follow-up|4|||
126744586|NCT01662986|456014014|FG000|Overall Study|Withdrawal by Subject|2|||
126744587|NCT01662986|456014015|FG001|Overall Study|Withdrawal by Subject|2|||
126744588|NCT01662986|456014014|FG000|Overall Study|Not Treated|1|||
126744589|NCT01662986|456014015|FG001|Overall Study|Not Treated|0|||
126744590|NCT01662986|456014014|FG000|Overall Study|Other than stated above|3|||
126744591|NCT01662986|456014015|FG001|Overall Study|Other than stated above|0|||
126744592|NCT01512693|456014021|FG000|Overall Study|Withdrawal by Subject|0|||
126744593|NCT01512693|456014022|FG001|Overall Study|Withdrawal by Subject|1|||
126744594|NCT01975376|456014023|FG000|Overall Study|Adverse Event|5|||
126744595|NCT01975376|456014024|FG001|Overall Study|Adverse Event|5|||
126744596|NCT01975376|456014023|FG000|Overall Study|Death|65|||
126744597|NCT01975376|456014024|FG001|Overall Study|Death|72|||
126744598|NCT01975376|456014023|FG000|Overall Study|Lost to Follow-up|70|||
126744599|NCT01975376|456014024|FG001|Overall Study|Lost to Follow-up|66|||
126744600|NCT01975376|456014023|FG000|Overall Study|Withdrew consent|68|||
126744601|NCT01975376|456014024|FG001|Overall Study|Withdrew consent|62|||
126744602|NCT01975376|456014023|FG000|Overall Study|Other|2|||
126744603|NCT01975376|456014024|FG001|Overall Study|Other|4|||
126744604|NCT01975376|456014023|FG000|Overall Study|Randomized, Not Treated|16|||
126744605|NCT01975376|456014024|FG001|Overall Study|Randomized, Not Treated|8|||
126744606|NCT04731922|456014025|FG000|Overall Study|Adverse Event|0|||
126744607|NCT04731922|456014026|FG001|Overall Study|Adverse Event|0|||
126744608|NCT04731922|456014027|FG002|Overall Study|Adverse Event|0|||
126744609|NCT04731922|456014028|FG003|Overall Study|Adverse Event|0|||
126744610|NCT04731922|456014029|FG004|Overall Study|Adverse Event|0|||
126744611|NCT04731922|456014030|FG005|Overall Study|Adverse Event|0|||
126744612|NCT04731922|456014031|FG006|Overall Study|Adverse Event|0|||
126744613|NCT04731922|456014032|FG007|Overall Study|Adverse Event|0|||
126744614|NCT04731922|456014033|FG008|Overall Study|Adverse Event|0|||
126744615|NCT04731922|456014034|FG009|Overall Study|Adverse Event|0|||
126744616|NCT04731922|456014035|FG010|Overall Study|Adverse Event|1|||
126744617|NCT04731922|456014036|FG011|Overall Study|Adverse Event|0|||
126744618|NCT04731922|456014037|FG012|Overall Study|Adverse Event|0|||
126744619|NCT04731922|456014038|FG013|Overall Study|Adverse Event|0|||
126744620|NCT04731922|456014039|FG014|Overall Study|Adverse Event|0|||
126744621|NCT04731922|456014040|FG015|Overall Study|Adverse Event|0|||
126744622|NCT04731922|456014041|FG016|Overall Study|Adverse Event|0|||
126744623|NCT04731922|456014025|FG000|Overall Study|Lost to Follow-up|0|||
126781854|NCT01688037|456156289|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
126744624|NCT04731922|456014026|FG001|Overall Study|Lost to Follow-up|0|||
126744625|NCT04731922|456014027|FG002|Overall Study|Lost to Follow-up|0|||
126744626|NCT04731922|456014028|FG003|Overall Study|Lost to Follow-up|1|||
126744627|NCT04731922|456014029|FG004|Overall Study|Lost to Follow-up|0|||
126744628|NCT04731922|456014030|FG005|Overall Study|Lost to Follow-up|1|||
126744629|NCT04731922|456014031|FG006|Overall Study|Lost to Follow-up|0|||
126744630|NCT04731922|456014032|FG007|Overall Study|Lost to Follow-up|0|||
126744631|NCT04731922|456014033|FG008|Overall Study|Lost to Follow-up|0|||
126744632|NCT04731922|456014034|FG009|Overall Study|Lost to Follow-up|0|||
126744633|NCT04731922|456014035|FG010|Overall Study|Lost to Follow-up|0|||
126744634|NCT04731922|456014036|FG011|Overall Study|Lost to Follow-up|0|||
126744635|NCT04731922|456014037|FG012|Overall Study|Lost to Follow-up|0|||
126744636|NCT04731922|456014038|FG013|Overall Study|Lost to Follow-up|0|||
126744637|NCT04731922|456014039|FG014|Overall Study|Lost to Follow-up|0|||
126744638|NCT04731922|456014040|FG015|Overall Study|Lost to Follow-up|0|||
126744639|NCT04731922|456014041|FG016|Overall Study|Lost to Follow-up|0|||
126744640|NCT04731922|456014025|FG000|Overall Study|Withdrawal by Subject|1|||
126744641|NCT04731922|456014026|FG001|Overall Study|Withdrawal by Subject|0|||
126744642|NCT04731922|456014027|FG002|Overall Study|Withdrawal by Subject|0|||
126744643|NCT04731922|456014028|FG003|Overall Study|Withdrawal by Subject|0|||
126744644|NCT04731922|456014029|FG004|Overall Study|Withdrawal by Subject|1|||
126744645|NCT04731922|456014030|FG005|Overall Study|Withdrawal by Subject|0|||
126744646|NCT04731922|456014031|FG006|Overall Study|Withdrawal by Subject|1|||
126744647|NCT04731922|456014032|FG007|Overall Study|Withdrawal by Subject|0|||
126744648|NCT04731922|456014033|FG008|Overall Study|Withdrawal by Subject|0|||
126744649|NCT04731922|456014034|FG009|Overall Study|Withdrawal by Subject|0|||
126744650|NCT04731922|456014035|FG010|Overall Study|Withdrawal by Subject|0|||
126744651|NCT04731922|456014036|FG011|Overall Study|Withdrawal by Subject|0|||
126744652|NCT04731922|456014037|FG012|Overall Study|Withdrawal by Subject|0|||
126616809|NCT01072149|455555418|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
126616810|NCT01072149|455555419|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
126616811|NCT01072149|455555420|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
126616812|NCT01072149|455555421|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
126616813|NCT01072149|455555422|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
126616814|NCT01072149|455555423|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
126616815|NCT01072149|455555424|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
126616816|NCT01072149|455555425|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
126616817|NCT01072149|455555426|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
126616818|NCT01072149|455555427|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
126616819|NCT01072149|455555428|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
126616820|NCT01072149|455555411|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
126616821|NCT01072149|455555412|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
126616822|NCT01072149|455555413|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
126616823|NCT01072149|455555414|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
126616824|NCT01072149|455555415|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
126616825|NCT01072149|455555416|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
126616826|NCT01072149|455555417|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
126616827|NCT01072149|455555418|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
126616828|NCT01072149|455555419|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
126616829|NCT01072149|455555420|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
126616830|NCT01072149|455555421|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
126616831|NCT01072149|455555422|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
126616832|NCT01072149|455555423|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
126616833|NCT01072149|455555424|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
126616834|NCT01072149|455555425|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
126616835|NCT01072149|455555426|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
126616836|NCT01072149|455555427|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
126616837|NCT01072149|455555428|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
126744653|NCT04731922|456014038|FG013|Overall Study|Withdrawal by Subject|1|||
126744654|NCT04731922|456014039|FG014|Overall Study|Withdrawal by Subject|0|||
126744655|NCT04731922|456014040|FG015|Overall Study|Withdrawal by Subject|0|||
126744656|NCT04731922|456014041|FG016|Overall Study|Withdrawal by Subject|0|||
126744657|NCT04731922|456014025|FG000|Overall Study|Other|0|||
126744658|NCT04731922|456014026|FG001|Overall Study|Other|0|||
126744659|NCT04731922|456014027|FG002|Overall Study|Other|0|||
126744660|NCT04731922|456014028|FG003|Overall Study|Other|0|||
126744661|NCT04731922|456014029|FG004|Overall Study|Other|0|||
126744662|NCT04731922|456014030|FG005|Overall Study|Other|0|||
126744663|NCT04731922|456014031|FG006|Overall Study|Other|1|||
126744664|NCT04731922|456014032|FG007|Overall Study|Other|0|||
126744665|NCT04731922|456014033|FG008|Overall Study|Other|0|||
126744666|NCT04731922|456014034|FG009|Overall Study|Other|0|||
126744667|NCT04731922|456014035|FG010|Overall Study|Other|0|||
126744668|NCT04731922|456014036|FG011|Overall Study|Other|0|||
126744669|NCT04731922|456014037|FG012|Overall Study|Other|0|||
126744670|NCT04731922|456014038|FG013|Overall Study|Other|0|||
126744671|NCT04731922|456014039|FG014|Overall Study|Other|0|||
126744672|NCT04731922|456014040|FG015|Overall Study|Other|0|||
126744673|NCT04731922|456014041|FG016|Overall Study|Other|0|||
126744674|NCT01819194|456014043|FG000|Overall Study|Loss of study articles|2|||
126744675|NCT02343952|456014046|FG000|Study Treatment|Disease Progression|23|||
126744676|NCT02343952|456014046|FG000|Study Treatment|Death|3|||
126744677|NCT02343952|456014046|FG000|Study Treatment|Adverse Event|19|||
126744678|NCT02343952|456014046|FG000|Study Treatment|Withdrawal by Subject|7|||
126744679|NCT02343952|456014046|FG000|Study Treatment|other complicating Diseases|1|||
126744680|NCT02343952|456014046|FG000|Follow up|Withdrawal by Subject|3|||
126744681|NCT02343952|456014046|FG000|Follow up|Death|33|||
126744682|NCT02343952|456014046|FG000|Follow up|Patient does not meet eligibility for study.|1|||
126744683|NCT02343952|456014046|FG000|Follow up|Research department closed by the practice.|5|||
126744684|NCT02343952|456014046|FG000|Follow up|Patient went home to Russia|1|||
126744685|NCT02343952|456014046|FG000|Follow up|Disease Progression|1|||
126744686|NCT02343952|456014046|FG000|Follow up|study terminated|1|||
126744687|NCT01448707|456014050|FG000|Overall Study|Adverse Event|3|||
126744688|NCT01448707|456014051|FG001|Overall Study|Adverse Event|1|||
126744689|NCT01448707|456014050|FG000|Overall Study|Lost to Follow-up|2|||
126744690|NCT01448707|456014051|FG001|Overall Study|Lost to Follow-up|6|||
126744691|NCT01448707|456014050|FG000|Overall Study|Withdrawal by Subject|6|||
126744692|NCT01448707|456014051|FG001|Overall Study|Withdrawal by Subject|7|||
126744693|NCT01448707|456014050|FG000|Overall Study|Other|7|||
126744694|NCT01448707|456014051|FG001|Overall Study|Other|4|||
126744695|NCT00899678|456014052|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
126744696|NCT00899678|456014053|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
126744697|NCT00899678|456014054|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
126744698|NCT00899678|456014052|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
126744699|NCT00899678|456014053|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
126744700|NCT00899678|456014054|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
126744701|NCT00899678|456014052|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
126744702|NCT00899678|456014053|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
126744703|NCT00899678|456014054|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
126744704|NCT00899678|456014052|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
126744705|NCT00899678|456014053|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
126744706|NCT00899678|456014054|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
126744707|NCT00899678|456014052|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
126744708|NCT00899678|456014053|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
126744709|NCT00899678|456014054|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
126744710|NCT00899678|456014052|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
126744711|NCT00899678|456014053|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
126744712|NCT00899678|456014054|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
126744713|NCT00899678|456014052|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
126744714|NCT00899678|456014053|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
126744715|NCT00899678|456014054|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
126744716|NCT00899678|456014052|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
126744717|NCT00899678|456014053|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
126744718|NCT00899678|456014054|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
126744719|NCT00899678|456014052|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
126744720|NCT00899678|456014053|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
126744721|NCT00899678|456014054|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
126744722|NCT00033371|456014055|FG000|Overall Study|Adverse Event|1|||
126744723|NCT00033371|456014056|FG001|Overall Study|Adverse Event|5|||
126744724|NCT00033371|456014055|FG000|Overall Study|Lost to Follow-up|2|||
126744725|NCT00033371|456014056|FG001|Overall Study|Lost to Follow-up|1|||
126744726|NCT00033371|456014055|FG000|Overall Study|Withdrawal by Subject|3|||
126744727|NCT00033371|456014056|FG001|Overall Study|Withdrawal by Subject|3|||
126744728|NCT00033371|456014055|FG000|Overall Study|Disease Progression|0|||
126744729|NCT00033371|456014056|FG001|Overall Study|Disease Progression|1|||
126744730|NCT03796195|456014059|FG000|Overall Study|Study closed early|1|||
126744731|NCT03799627|456014064|FG000|Overall Study|Adverse Event|1|||
126744732|NCT03799627|456014065|FG001|Overall Study|Adverse Event|2|||
126744733|NCT03799627|456014066|FG002|Overall Study|Adverse Event|0|||
126744734|NCT03799627|456014067|FG003|Overall Study|Adverse Event|0|||
126744735|NCT03799627|456014068|FG004|Overall Study|Adverse Event|2|||
126744736|NCT03799627|456014069|FG005|Overall Study|Adverse Event|5|||
126744737|NCT03799627|456014070|FG006|Overall Study|Adverse Event|0|||
126744738|NCT03799627|456014071|FG007|Overall Study|Adverse Event|2|||
126744739|NCT03799627|456014072|FG008|Overall Study|Adverse Event|0|||
126744740|NCT03799627|456014064|FG000|Overall Study|Physician Decision|2|||
126744741|NCT03799627|456014065|FG001|Overall Study|Physician Decision|2|||
126744742|NCT03799627|456014066|FG002|Overall Study|Physician Decision|0|||
126744743|NCT03799627|456014067|FG003|Overall Study|Physician Decision|0|||
126744744|NCT03799627|456014068|FG004|Overall Study|Physician Decision|2|||
126744745|NCT03799627|456014069|FG005|Overall Study|Physician Decision|2|||
126744746|NCT03799627|456014070|FG006|Overall Study|Physician Decision|0|||
126744747|NCT03799627|456014071|FG007|Overall Study|Physician Decision|0|||
126744748|NCT03799627|456014072|FG008|Overall Study|Physician Decision|0|||
126744749|NCT03799627|456014064|FG000|Overall Study|Withdrawal by Subject|1|||
126744750|NCT03799627|456014065|FG001|Overall Study|Withdrawal by Subject|1|||
126744751|NCT03799627|456014066|FG002|Overall Study|Withdrawal by Subject|0|||
126744752|NCT03799627|456014067|FG003|Overall Study|Withdrawal by Subject|2|||
126744753|NCT03799627|456014068|FG004|Overall Study|Withdrawal by Subject|0|||
126744754|NCT03799627|456014069|FG005|Overall Study|Withdrawal by Subject|3|||
126744755|NCT03799627|456014070|FG006|Overall Study|Withdrawal by Subject|0|||
126744756|NCT03799627|456014071|FG007|Overall Study|Withdrawal by Subject|0|||
126744757|NCT03799627|456014072|FG008|Overall Study|Withdrawal by Subject|0|||
126744758|NCT03799627|456014064|FG000|Overall Study|Lack of Efficacy|0|||
126744759|NCT03799627|456014065|FG001|Overall Study|Lack of Efficacy|0|||
126744760|NCT03799627|456014066|FG002|Overall Study|Lack of Efficacy|0|||
126744761|NCT03799627|456014067|FG003|Overall Study|Lack of Efficacy|1|||
126744762|NCT03799627|456014068|FG004|Overall Study|Lack of Efficacy|0|||
126744763|NCT03799627|456014069|FG005|Overall Study|Lack of Efficacy|0|||
126744764|NCT03799627|456014070|FG006|Overall Study|Lack of Efficacy|0|||
126744765|NCT03799627|456014071|FG007|Overall Study|Lack of Efficacy|0|||
126744766|NCT03799627|456014072|FG008|Overall Study|Lack of Efficacy|0|||
126744767|NCT03799627|456014064|FG000|Overall Study|Lost to Follow-up|0|||
126744768|NCT03799627|456014065|FG001|Overall Study|Lost to Follow-up|0|||
126744769|NCT03799627|456014066|FG002|Overall Study|Lost to Follow-up|0|||
126744770|NCT03799627|456014067|FG003|Overall Study|Lost to Follow-up|0|||
126744771|NCT03799627|456014068|FG004|Overall Study|Lost to Follow-up|0|||
126744772|NCT03799627|456014069|FG005|Overall Study|Lost to Follow-up|0|||
126744773|NCT03799627|456014070|FG006|Overall Study|Lost to Follow-up|1|||
126744774|NCT03799627|456014071|FG007|Overall Study|Lost to Follow-up|0|||
126744775|NCT03799627|456014072|FG008|Overall Study|Lost to Follow-up|1|||
126744776|NCT03799627|456014064|FG000|Overall Study|Death|0|||
126744777|NCT03799627|456014065|FG001|Overall Study|Death|0|||
126744778|NCT03799627|456014066|FG002|Overall Study|Death|0|||
126744779|NCT03799627|456014067|FG003|Overall Study|Death|1|||
126744780|NCT03799627|456014068|FG004|Overall Study|Death|0|||
126744781|NCT03799627|456014069|FG005|Overall Study|Death|0|||
126744782|NCT03799627|456014070|FG006|Overall Study|Death|0|||
126744783|NCT03799627|456014071|FG007|Overall Study|Death|0|||
126744784|NCT03799627|456014072|FG008|Overall Study|Death|0|||
126744785|NCT03799627|456014064|FG000|Overall Study|Study Drug Put on Hold|1|||
126744786|NCT03799627|456014065|FG001|Overall Study|Study Drug Put on Hold|0|||
126744787|NCT03799627|456014066|FG002|Overall Study|Study Drug Put on Hold|0|||
126744788|NCT03799627|456014067|FG003|Overall Study|Study Drug Put on Hold|0|||
126744789|NCT03799627|456014068|FG004|Overall Study|Study Drug Put on Hold|0|||
126744790|NCT03799627|456014069|FG005|Overall Study|Study Drug Put on Hold|0|||
126744791|NCT03799627|456014070|FG006|Overall Study|Study Drug Put on Hold|0|||
126744792|NCT03799627|456014071|FG007|Overall Study|Study Drug Put on Hold|0|||
126744793|NCT03799627|456014072|FG008|Overall Study|Study Drug Put on Hold|0|||
126744794|NCT03799627|456014064|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
126744795|NCT03799627|456014065|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
126744796|NCT03799627|456014066|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
126744797|NCT03799627|456014067|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
126744798|NCT03799627|456014068|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
126744799|NCT03799627|456014069|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
126744800|NCT03799627|456014070|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
126744801|NCT03799627|456014071|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
126744802|NCT03799627|456014072|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
126744803|NCT03799627|456014064|FG000|Overall Study|Kidney Transplantation|1|||
126744804|NCT03799627|456014065|FG001|Overall Study|Kidney Transplantation|0|||
126744805|NCT03799627|456014066|FG002|Overall Study|Kidney Transplantation|0|||
126744806|NCT03799627|456014067|FG003|Overall Study|Kidney Transplantation|1|||
126744807|NCT03799627|456014068|FG004|Overall Study|Kidney Transplantation|1|||
126744808|NCT03799627|456014069|FG005|Overall Study|Kidney Transplantation|0|||
126744809|NCT03799627|456014070|FG006|Overall Study|Kidney Transplantation|0|||
126744810|NCT03799627|456014071|FG007|Overall Study|Kidney Transplantation|0|||
126744811|NCT03799627|456014072|FG008|Overall Study|Kidney Transplantation|0|||
126744812|NCT03799627|456014064|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
126744813|NCT03799627|456014065|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
126744814|NCT03799627|456014066|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
126744815|NCT03799627|456014067|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
126744816|NCT03799627|456014068|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
126744817|NCT03799627|456014069|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
126744818|NCT03799627|456014070|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
126744819|NCT03799627|456014071|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
126744820|NCT03799627|456014072|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
126744821|NCT03799627|456014064|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126744822|NCT03799627|456014065|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
126744823|NCT03799627|456014066|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126744824|NCT03799627|456014067|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126744825|NCT03799627|456014068|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126744826|NCT03799627|456014069|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126744827|NCT03799627|456014070|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126744828|NCT03799627|456014071|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126744829|NCT03799627|456014072|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
126744830|NCT03799627|456014064|FG000|Overall Study|Met Exclusion Criteria|0|||
126744831|NCT03799627|456014065|FG001|Overall Study|Met Exclusion Criteria|0|||
126744832|NCT03799627|456014066|FG002|Overall Study|Met Exclusion Criteria|0|||
126744833|NCT03799627|456014067|FG003|Overall Study|Met Exclusion Criteria|1|||
126744834|NCT03799627|456014068|FG004|Overall Study|Met Exclusion Criteria|0|||
126744835|NCT03799627|456014069|FG005|Overall Study|Met Exclusion Criteria|0|||
126744836|NCT03799627|456014070|FG006|Overall Study|Met Exclusion Criteria|0|||
126744837|NCT03799627|456014071|FG007|Overall Study|Met Exclusion Criteria|0|||
126744838|NCT03799627|456014072|FG008|Overall Study|Met Exclusion Criteria|0|||
126744839|NCT03799627|456014064|FG000|Overall Study|Investigational Product Noncompliance|0|||
126744840|NCT03799627|456014065|FG001|Overall Study|Investigational Product Noncompliance|0|||
126744841|NCT03799627|456014066|FG002|Overall Study|Investigational Product Noncompliance|0|||
126744842|NCT03799627|456014067|FG003|Overall Study|Investigational Product Noncompliance|1|||
126744843|NCT03799627|456014068|FG004|Overall Study|Investigational Product Noncompliance|0|||
126744844|NCT03799627|456014069|FG005|Overall Study|Investigational Product Noncompliance|0|||
126744845|NCT03799627|456014070|FG006|Overall Study|Investigational Product Noncompliance|0|||
126744846|NCT03799627|456014071|FG007|Overall Study|Investigational Product Noncompliance|0|||
126744847|NCT03799627|456014072|FG008|Overall Study|Investigational Product Noncompliance|0|||
126744848|NCT03799627|456014064|FG000|Overall Study|Participant Relocation|0|||
126744849|NCT03799627|456014065|FG001|Overall Study|Participant Relocation|0|||
126744850|NCT03799627|456014066|FG002|Overall Study|Participant Relocation|0|||
126744851|NCT03799627|456014067|FG003|Overall Study|Participant Relocation|1|||
126744852|NCT03799627|456014068|FG004|Overall Study|Participant Relocation|0|||
126744853|NCT03799627|456014069|FG005|Overall Study|Participant Relocation|1|||
126744854|NCT03799627|456014070|FG006|Overall Study|Participant Relocation|0|||
126744855|NCT03799627|456014071|FG007|Overall Study|Participant Relocation|0|||
126744856|NCT03799627|456014072|FG008|Overall Study|Participant Relocation|0|||
126744857|NCT03799627|456014064|FG000|Overall Study|Eurofin Issue|0|||
126744858|NCT03799627|456014065|FG001|Overall Study|Eurofin Issue|0|||
126744859|NCT03799627|456014066|FG002|Overall Study|Eurofin Issue|0|||
126744860|NCT03799627|456014067|FG003|Overall Study|Eurofin Issue|0|||
126744861|NCT03799627|456014068|FG004|Overall Study|Eurofin Issue|1|||
126744862|NCT03799627|456014069|FG005|Overall Study|Eurofin Issue|0|||
126744863|NCT03799627|456014070|FG006|Overall Study|Eurofin Issue|0|||
126744864|NCT03799627|456014071|FG007|Overall Study|Eurofin Issue|0|||
126744865|NCT03799627|456014072|FG008|Overall Study|Eurofin Issue|0|||
126744866|NCT03799627|456014064|FG000|Overall Study|Noncompliance with Site Instructions|0|||
126744867|NCT03799627|456014065|FG001|Overall Study|Noncompliance with Site Instructions|0|||
126744868|NCT03799627|456014066|FG002|Overall Study|Noncompliance with Site Instructions|0|||
126744869|NCT03799627|456014067|FG003|Overall Study|Noncompliance with Site Instructions|0|||
126744870|NCT03799627|456014068|FG004|Overall Study|Noncompliance with Site Instructions|1|||
126744871|NCT03799627|456014069|FG005|Overall Study|Noncompliance with Site Instructions|0|||
126744872|NCT03799627|456014070|FG006|Overall Study|Noncompliance with Site Instructions|0|||
126744873|NCT03799627|456014071|FG007|Overall Study|Noncompliance with Site Instructions|0|||
126744874|NCT03799627|456014072|FG008|Overall Study|Noncompliance with Site Instructions|0|||
126744875|NCT03799627|456014064|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126744876|NCT03799627|456014065|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126744877|NCT03799627|456014066|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126744878|NCT03799627|456014067|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126744879|NCT03799627|456014068|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
126744880|NCT03799627|456014069|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126744881|NCT03799627|456014070|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126744882|NCT03799627|456014071|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126744883|NCT03799627|456014072|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
126744884|NCT03799627|456014064|FG000|Overall Study|Changes In Hemoglobin Values|1|||
126744885|NCT03799627|456014065|FG001|Overall Study|Changes In Hemoglobin Values|2|||
126744886|NCT03799627|456014066|FG002|Overall Study|Changes In Hemoglobin Values|1|||
126744887|NCT03799627|456014067|FG003|Overall Study|Changes In Hemoglobin Values|0|||
126744888|NCT03799627|456014068|FG004|Overall Study|Changes In Hemoglobin Values|0|||
126744889|NCT03799627|456014069|FG005|Overall Study|Changes In Hemoglobin Values|2|||
126744890|NCT03799627|456014070|FG006|Overall Study|Changes In Hemoglobin Values|1|||
126744891|NCT03799627|456014071|FG007|Overall Study|Changes In Hemoglobin Values|0|||
126744892|NCT03799627|456014072|FG008|Overall Study|Changes In Hemoglobin Values|1|||
126744893|NCT01922739|456014075|FG000|Titration/Adjustment Period|Adverse Event|3|||
126744894|NCT01922739|456014075|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
126744895|NCT01922739|456014075|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
126744896|NCT01922739|456014075|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
126744897|NCT01922739|456014075|FG000|Open-label Treatment Period|Adverse Event|6|||
126744898|NCT01922739|456014075|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
126744899|NCT01922739|456014075|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
126744900|NCT01922739|456014075|FG000|Open-label Treatment Period|Protocol Violation|5|||
126744901|NCT01922739|456014075|FG000|Open-label Treatment Period|Pregnancy|1|||
126744902|NCT01922739|456014075|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
126744903|NCT01922739|456014075|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
126744904|NCT01922739|456014075|FG000|Open-label Treatment Period|Physician Decision|1|||
126744905|NCT01922739|456014075|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
126616838|NCT01072149|455555411|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126616839|NCT01072149|455555412|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126616840|NCT01072149|455555413|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126744906|NCT04498468|456014078|FG000|Overall Study|Lost to Follow-up|3|||
126744907|NCT02725268|456014079|FG000|Overall Study|Death|58|||
126744908|NCT02725268|456014080|FG001|Overall Study|Death|59|||
126744909|NCT02725268|456014081|FG002|Overall Study|Death|30|||
126744910|NCT02725268|456014082|FG003|Overall Study|Death|16|||
126744911|NCT02725268|456014079|FG000|Overall Study|Lost to Follow-up|4|||
126744912|NCT02725268|456014080|FG001|Overall Study|Lost to Follow-up|3|||
126744913|NCT02725268|456014081|FG002|Overall Study|Lost to Follow-up|0|||
126744914|NCT02725268|456014082|FG003|Overall Study|Lost to Follow-up|1|||
126744915|NCT02725268|456014079|FG000|Overall Study|Site Terminated by Sponsor|0|||
126744916|NCT02725268|456014080|FG001|Overall Study|Site Terminated by Sponsor|1|||
126744917|NCT02725268|456014081|FG002|Overall Study|Site Terminated by Sponsor|0|||
126744918|NCT02725268|456014082|FG003|Overall Study|Site Terminated by Sponsor|0|||
126744919|NCT02725268|456014079|FG000|Overall Study|Withdrawal by Subject|8|||
126744920|NCT02725268|456014080|FG001|Overall Study|Withdrawal by Subject|6|||
126744921|NCT02725268|456014081|FG002|Overall Study|Withdrawal by Subject|8|||
126744922|NCT02725268|456014082|FG003|Overall Study|Withdrawal by Subject|1|||
126744923|NCT02725268|456014079|FG000|Overall Study|Reason not Specified|2|||
126744924|NCT02725268|456014080|FG001|Overall Study|Reason not Specified|1|||
126744925|NCT02725268|456014081|FG002|Overall Study|Reason not Specified|0|||
126744926|NCT02725268|456014082|FG003|Overall Study|Reason not Specified|0|||
126744927|NCT02224274|456014084|FG000|Overall Study|Death|1|||
126744928|NCT02224274|456014085|FG001|Overall Study|Death|0|||
126744929|NCT01976624|456014086|FG000|Overall Study|Participants contraindicated|2|||
126744930|NCT01976624|456014086|FG000|Overall Study|Participants age less than 19 years|12|||
126744931|NCT04350372|456014087|FG000|Overall Study|Death|1|||
126744932|NCT00412113|456014089|FG000|Overall Study|Adverse Event|11|||
126744933|NCT00412113|456014090|FG001|Overall Study|Adverse Event|15|||
126744934|NCT00412113|456014089|FG000|Overall Study|did not receive treatment|1|||
126744935|NCT00412113|456014090|FG001|Overall Study|did not receive treatment|0|||
126744936|NCT01190020|456014093|FG000|Overall Study|Adverse Event|2|||
126744937|NCT01190020|456014094|FG001|Overall Study|Adverse Event|0|||
126744938|NCT01190020|456014093|FG000|Overall Study|Lost to Follow-up|2|||
126744939|NCT01190020|456014094|FG001|Overall Study|Lost to Follow-up|0|||
126744940|NCT01190020|456014093|FG000|Overall Study|Withdrawal by Subject|3|||
126744941|NCT01190020|456014094|FG001|Overall Study|Withdrawal by Subject|0|||
126744942|NCT01998906|456015476|FG000|Overall Study|Participants ongoing in follow-up|77|||
126744943|NCT01998906|456015477|FG001|Overall Study|Participants ongoing in follow-up|60|||
126744944|NCT01998906|456015478|FG002|Overall Study|Participants ongoing in follow-up|58|||
126744945|NCT01998906|456015476|FG000|Overall Study|Death|21|||
126744946|NCT01998906|456015477|FG001|Overall Study|Death|30|||
126744947|NCT01998906|456015478|FG002|Overall Study|Death|17|||
126744948|NCT01998906|456015476|FG000|Overall Study|Lack of Efficacy|10|||
126744949|NCT01998906|456015477|FG001|Overall Study|Lack of Efficacy|9|||
126744950|NCT01998906|456015478|FG002|Overall Study|Lack of Efficacy|8|||
126744951|NCT01998906|456015476|FG000|Overall Study|Failure to return|0|||
126744952|NCT01998906|456015477|FG001|Overall Study|Failure to return|2|||
126744953|NCT01998906|456015478|FG002|Overall Study|Failure to return|4|||
126744954|NCT01998906|456015476|FG000|Overall Study|Violation of Selection Criteria|0|||
126744955|NCT01998906|456015477|FG001|Overall Study|Violation of Selection Criteria|0|||
126744956|NCT01998906|456015478|FG002|Overall Study|Violation of Selection Criteria|1|||
126744957|NCT01998906|456015476|FG000|Overall Study|Withdrawal by Subject|1|||
126744958|NCT01998906|456015477|FG001|Overall Study|Withdrawal by Subject|4|||
126744959|NCT01998906|456015478|FG002|Overall Study|Withdrawal by Subject|3|||
126744960|NCT01998906|456015476|FG000|Overall Study|Administrative/Other|2|||
126744961|NCT01998906|456015477|FG001|Overall Study|Administrative/Other|1|||
126616841|NCT01072149|455555414|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126781855|NCT01688037|456156290|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
126781856|NCT01688037|456156291|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
126781857|NCT01688037|456156289|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
126744962|NCT01998906|456015478|FG002|Overall Study|Administrative/Other|3|||
126744963|NCT01998906|456015476|FG000|Overall Study|Other|3|||
126744964|NCT01998906|456015477|FG001|Overall Study|Other|8|||
126744965|NCT01998906|456015478|FG002|Overall Study|Other|4|||
126744966|NCT02996110|456015479|FG000|Pre-Treatment|Other Reasons|0|||
126744967|NCT02996110|456015480|FG001|Pre-Treatment|Other Reasons|1|||
126744968|NCT02996110|456015481|FG002|Pre-Treatment|Other Reasons|0|||
126744969|NCT02996110|456015482|FG003|Pre-Treatment|Other Reasons|0|||
126744970|NCT02996110|456015483|FG004|Pre-Treatment|Other Reasons|1|||
126744971|NCT02996110|456015479|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
126744972|NCT02996110|456015480|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
126744973|NCT02996110|456015481|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
126744974|NCT02996110|456015482|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
126744975|NCT02996110|456015483|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
126744976|NCT02996110|456015479|FG000|Track 1|Disease Progression|15|||
126744977|NCT02996110|456015480|FG001|Track 1|Disease Progression|17|||
126744978|NCT02996110|456015481|FG002|Track 1|Disease Progression|0|||
126744979|NCT02996110|456015482|FG003|Track 1|Disease Progression|0|||
126744980|NCT02996110|456015483|FG004|Track 1|Disease Progression|0|||
126744981|NCT02996110|456015479|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
126744982|NCT02996110|456015480|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
126744983|NCT02996110|456015481|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
126744984|NCT02996110|456015482|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
126744985|NCT02996110|456015483|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
126744986|NCT02996110|456015479|FG000|Track 1|Study Drug Toxicity|5|||
126744987|NCT02996110|456015480|FG001|Track 1|Study Drug Toxicity|3|||
126744988|NCT02996110|456015481|FG002|Track 1|Study Drug Toxicity|0|||
126744989|NCT02996110|456015482|FG003|Track 1|Study Drug Toxicity|0|||
126744990|NCT02996110|456015483|FG004|Track 1|Study Drug Toxicity|0|||
126744991|NCT02996110|456015479|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
126744992|NCT02996110|456015480|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
126744993|NCT02996110|456015481|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
126744994|NCT02996110|456015482|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
126744995|NCT02996110|456015483|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
126744996|NCT02996110|456015479|FG000|Track 1|Administrative Reason by Sponsor|0|||
126744997|NCT02996110|456015480|FG001|Track 1|Administrative Reason by Sponsor|1|||
126744998|NCT02996110|456015481|FG002|Track 1|Administrative Reason by Sponsor|0|||
126744999|NCT02996110|456015482|FG003|Track 1|Administrative Reason by Sponsor|0|||
126745000|NCT02996110|456015483|FG004|Track 1|Administrative Reason by Sponsor|0|||
126745001|NCT02996110|456015479|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
126745002|NCT02996110|456015480|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
126745003|NCT02996110|456015481|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
126745004|NCT02996110|456015482|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
126745005|NCT02996110|456015483|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
126745006|NCT02996110|456015479|FG000|Track 2|Disease Progression|33|||
126745007|NCT02996110|456015480|FG001|Track 2|Disease Progression|26|||
126745008|NCT02996110|456015481|FG002|Track 2|Disease Progression|19|||
126745009|NCT02996110|456015482|FG003|Track 2|Disease Progression|16|||
126745010|NCT02996110|456015483|FG004|Track 2|Disease Progression|15|||
126745011|NCT02996110|456015479|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
126745012|NCT02996110|456015480|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
126745013|NCT02996110|456015481|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
126745014|NCT02996110|456015482|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
126745015|NCT02996110|456015483|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
126745016|NCT02996110|456015479|FG000|Track 2|Death|0|||
126745017|NCT02996110|456015480|FG001|Track 2|Death|0|||
126745018|NCT02996110|456015481|FG002|Track 2|Death|1|||
126745019|NCT02996110|456015482|FG003|Track 2|Death|0|||
126745020|NCT02996110|456015483|FG004|Track 2|Death|1|||
126745021|NCT02996110|456015479|FG000|Track 2|Study Drug Toxicity|4|||
126745022|NCT02996110|456015480|FG001|Track 2|Study Drug Toxicity|1|||
126745023|NCT02996110|456015481|FG002|Track 2|Study Drug Toxicity|4|||
126745024|NCT02996110|456015482|FG003|Track 2|Study Drug Toxicity|1|||
126745025|NCT02996110|456015483|FG004|Track 2|Study Drug Toxicity|0|||
126745026|NCT02996110|456015479|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
126745027|NCT02996110|456015480|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
126745028|NCT02996110|456015481|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
126745029|NCT02996110|456015482|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
126745030|NCT02996110|456015483|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
126745031|NCT02996110|456015479|FG000|Track 2|Participant Withdrew Consent|1|||
126745032|NCT02996110|456015480|FG001|Track 2|Participant Withdrew Consent|2|||
126745033|NCT02996110|456015481|FG002|Track 2|Participant Withdrew Consent|3|||
126616842|NCT01072149|455555415|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126745034|NCT02996110|456015482|FG003|Track 2|Participant Withdrew Consent|1|||
126745035|NCT02996110|456015483|FG004|Track 2|Participant Withdrew Consent|1|||
126745036|NCT02996110|456015479|FG000|Track 2|Other Reasons|0|||
126745037|NCT02996110|456015480|FG001|Track 2|Other Reasons|0|||
126745038|NCT02996110|456015481|FG002|Track 2|Other Reasons|1|||
126616843|NCT01072149|455555416|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126745039|NCT02996110|456015482|FG003|Track 2|Other Reasons|0|||
126745040|NCT02996110|456015483|FG004|Track 2|Other Reasons|1|||
126745041|NCT01077193|456015484|FG000|Overall Study|Lost to Follow-up|1|||
126745042|NCT01077193|456015484|FG000|Overall Study|Withdrawal by Subject|2|||
126616844|NCT01072149|455555417|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126745043|NCT01077193|456015484|FG000|Overall Study|Lack of Efficacy|1|||
126745044|NCT01077193|456015484|FG000|Overall Study|Study Terminated by Sponsor|40|||
126745045|NCT06048809|456015489|FG000|Overall Study|Adverse Event|2|||
126745046|NCT06048809|456015490|FG001|Overall Study|Adverse Event|0|||
126745047|NCT06048809|456015489|FG000|Overall Study|Withdrawal by Subject|1|||
126616845|NCT01072149|455555418|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126616846|NCT01072149|455555419|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126616847|NCT01072149|455555420|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126616848|NCT01072149|455555421|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126616849|NCT01072149|455555422|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126616850|NCT01072149|455555423|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126616851|NCT01072149|455555424|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126616852|NCT01072149|455555425|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126616853|NCT01072149|455555426|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
126616854|NCT01072149|455555427|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126616855|NCT01072149|455555428|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
126616856|NCT01072149|455555411|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
126616857|NCT01072149|455555412|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
126616858|NCT01072149|455555413|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
126616859|NCT01072149|455555414|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
126616860|NCT01072149|455555415|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
126616861|NCT01072149|455555416|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
126616862|NCT01072149|455555417|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
126616863|NCT01072149|455555418|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
126616864|NCT01072149|455555419|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
126616865|NCT01072149|455555420|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
126616866|NCT01072149|455555421|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
126616867|NCT01072149|455555422|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
126616868|NCT01072149|455555423|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
126616869|NCT01072149|455555424|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
126616870|NCT01072149|455555425|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
126616871|NCT01072149|455555426|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
126616872|NCT01072149|455555427|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
126616873|NCT01072149|455555428|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
126616874|NCT01072149|455555411|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616875|NCT01072149|455555412|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616876|NCT01072149|455555413|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616877|NCT01072149|455555414|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616878|NCT01072149|455555415|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616879|NCT01072149|455555416|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616880|NCT01072149|455555417|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616881|NCT01072149|455555418|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616882|NCT01072149|455555419|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616883|NCT01072149|455555420|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616884|NCT01072149|455555421|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616885|NCT01072149|455555422|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616886|NCT01072149|455555423|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
126616887|NCT01072149|455555424|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616888|NCT01072149|455555425|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616889|NCT01072149|455555426|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616890|NCT01072149|455555427|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616891|NCT01072149|455555428|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
126616892|NCT01072149|455555411|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616893|NCT01072149|455555412|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616894|NCT01072149|455555413|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
126616895|NCT01072149|455555414|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616896|NCT01072149|455555415|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616897|NCT01072149|455555416|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616898|NCT01072149|455555417|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616899|NCT01072149|455555418|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616900|NCT01072149|455555419|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616901|NCT01072149|455555420|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616902|NCT01072149|455555421|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616903|NCT01072149|455555422|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616904|NCT01072149|455555423|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616905|NCT01072149|455555424|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
126616906|NCT01072149|455555425|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616907|NCT01072149|455555426|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616908|NCT01072149|455555427|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616909|NCT01072149|455555428|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
126616910|NCT02784834|455555429|FG000|Overall Study|Lack of Efficacy|1|||
126616911|NCT00080119|455555430|FG000|Overall Study|Discontinued because of study closure|0|||
126616912|NCT00080119|455555431|FG001|Overall Study|Discontinued because of study closure|0|||
126616913|NCT00080119|455555432|FG002|Overall Study|Discontinued because of study closure|130|||
126616914|NCT00080119|455555433|FG003|Overall Study|Discontinued because of study closure|141|||
126745048|NCT06048809|456015490|FG001|Overall Study|Withdrawal by Subject|1|||
126745049|NCT03687827|456015496|FG000|Treatment Period 1|Death|0|||
126745050|NCT03687827|456015497|FG001|Treatment Period 1|Death|1|||
126745051|NCT03687827|456015496|FG000|Treatment Period 1|Lost to Follow-up|2|||
126745052|NCT03687827|456015497|FG001|Treatment Period 1|Lost to Follow-up|2|||
126745053|NCT03687827|456015496|FG000|Treatment Period 1|Physician Decision|5|||
126745054|NCT03687827|456015497|FG001|Treatment Period 1|Physician Decision|2|||
126745055|NCT03687827|456015496|FG000|Treatment Period 1|Withdrawal by Subject|7|||
126745056|NCT03687827|456015497|FG001|Treatment Period 1|Withdrawal by Subject|3|||
126745057|NCT03687827|456015496|FG000|Treatment Period 2|Physician Decision|4|||
126745058|NCT03687827|456015497|FG001|Treatment Period 2|Physician Decision|1|||
126745059|NCT03687827|456015496|FG000|Treatment Period 2|Withdrawal by Subject|1|||
126745060|NCT03687827|456015497|FG001|Treatment Period 2|Withdrawal by Subject|2|||
126745061|NCT00373880|456015499|FG000|Overall Study|Physician Decision|3|||
126745062|NCT00373880|456015499|FG000|Overall Study|Arrested|1|||
126745063|NCT00373880|456015499|FG000|Overall Study|Protocol Violation|14|||
126745064|NCT03748420|456015500|FG000|Overall Study|No 12 month medication adherence data available|0|||
126745065|NCT03748420|456015501|FG001|Overall Study|No 12 month medication adherence data available|1|||
126745066|NCT03748420|456015500|FG000|Overall Study|Death|24|||
126745067|NCT03748420|456015501|FG001|Overall Study|Death|28|||
126745068|NCT03748420|456015500|FG000|Overall Study|Lost to Follow-up|231|||
126745069|NCT03748420|456015501|FG001|Overall Study|Lost to Follow-up|230|||
126745070|NCT01925014|456015502|FG000|Overall Study|Inappropriate enrollment|4|||
126745071|NCT01925014|456015503|FG001|Overall Study|Inappropriate enrollment|6|||
126745072|NCT01925014|456015502|FG000|Overall Study|Withdrawal by Subject|5|||
126745073|NCT01925014|456015503|FG001|Overall Study|Withdrawal by Subject|13|||
126745074|NCT02139280|456015504|FG000|Overall Study|No longer eligible|2|||
126745075|NCT02139280|456015505|FG001|Overall Study|No longer eligible|0|||
126745076|NCT01302691|456015508|FG000|Overall Study|Adverse Event|2|||
126745077|NCT01302691|456015509|FG001|Overall Study|Adverse Event|0|||
126745078|NCT01302691|456015508|FG000|Overall Study|Death|0|||
126745079|NCT01302691|456015509|FG001|Overall Study|Death|1|||
126745080|NCT01302691|456015508|FG000|Overall Study|Lost to Follow-up|1|||
126745081|NCT01302691|456015509|FG001|Overall Study|Lost to Follow-up|0|||
126745082|NCT01302691|456015508|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
126745083|NCT01302691|456015509|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
126745084|NCT01302691|456015508|FG000|Overall Study|Physician Decision|0|||
126745085|NCT01302691|456015509|FG001|Overall Study|Physician Decision|1|||
126745086|NCT01302691|456015508|FG000|Overall Study|Protocol Violation|1|||
126745087|NCT01302691|456015509|FG001|Overall Study|Protocol Violation|0|||
126745088|NCT01437267|456015510|FG000|Overall Study|Withdrawal by Subject|0|||
126745089|NCT01437267|456015511|FG001|Overall Study|Withdrawal by Subject|0|||
126745090|NCT01437267|456015512|FG002|Overall Study|Withdrawal by Subject|0|||
126745091|NCT01437267|456015513|FG003|Overall Study|Withdrawal by Subject|1|||
126745092|NCT01437267|456015514|FG004|Overall Study|Withdrawal by Subject|0|||
126745093|NCT01437267|456015515|FG005|Overall Study|Withdrawal by Subject|0|||
126745094|NCT01437267|456015510|FG000|Overall Study|Protocol Violation|0|||
126745095|NCT01437267|456015511|FG001|Overall Study|Protocol Violation|1|||
126745096|NCT01437267|456015512|FG002|Overall Study|Protocol Violation|0|||
126745097|NCT01437267|456015513|FG003|Overall Study|Protocol Violation|0|||
126745098|NCT01437267|456015514|FG004|Overall Study|Protocol Violation|0|||
126745099|NCT01437267|456015515|FG005|Overall Study|Protocol Violation|0|||
126745100|NCT03934203|456015518|FG000|Overall Study|Adverse Event|0|||
126745101|NCT03934203|456015519|FG001|Overall Study|Adverse Event|0|||
126745102|NCT03934203|456015520|FG002|Overall Study|Adverse Event|1|||
126745103|NCT03934203|456015521|FG003|Overall Study|Adverse Event|0|||
126745104|NCT03934203|456015522|FG004|Overall Study|Adverse Event|1|||
126745105|NCT03934203|456015523|FG005|Overall Study|Adverse Event|0|||
126745106|NCT03934203|456015524|FG006|Overall Study|Adverse Event|2|||
126745107|NCT03934203|456015525|FG007|Overall Study|Adverse Event|0|||
126745108|NCT03934203|456015526|FG008|Overall Study|Adverse Event|0|||
126745109|NCT03934203|456015527|FG009|Overall Study|Adverse Event|0|||
126745110|NCT03934203|456015528|FG010|Overall Study|Adverse Event|0|||
126745111|NCT03934203|456015529|FG011|Overall Study|Adverse Event|0|||
126745112|NCT03934203|456015530|FG012|Overall Study|Adverse Event|0|||
126745113|NCT03934203|456015531|FG013|Overall Study|Adverse Event|1|||
126745114|NCT03934203|456015532|FG014|Overall Study|Adverse Event|0|||
126745115|NCT00441480|456015536|FG000|Overall Study|Protocol Violation|1|||
126745116|NCT00441480|456015537|FG001|Overall Study|Protocol Violation|1|||
126745117|NCT00441480|456015536|FG000|Overall Study|Withdrawal by Subject|2|||
126745118|NCT00441480|456015537|FG001|Overall Study|Withdrawal by Subject|3|||
126745119|NCT00608842|456015538|FG000|Overall Study|Participant's Request|0|||
126745120|NCT00608842|456015539|FG001|Overall Study|Participant's Request|1|||
126745121|NCT00608842|456015540|FG002|Overall Study|Participant's Request|2|||
126745122|NCT00608842|456015541|FG003|Overall Study|Participant's Request|1|||
126745123|NCT00608842|456015538|FG000|Overall Study|Lost to Follow-up|1|||
126745124|NCT00608842|456015539|FG001|Overall Study|Lost to Follow-up|0|||
126745125|NCT00608842|456015540|FG002|Overall Study|Lost to Follow-up|0|||
126745126|NCT00608842|456015541|FG003|Overall Study|Lost to Follow-up|0|||
126745127|NCT02699125|456015542|FG000|Placebo|Lost to Follow-up|2|||
126745128|NCT02699125|456015543|FG001|Placebo|Lost to Follow-up|0|||
126745129|NCT02699125|456015542|FG000|Placebo|Protocol Violation|1|||
126745130|NCT02699125|456015543|FG001|Placebo|Protocol Violation|0|||
126745131|NCT02699125|456015542|FG000|Placebo|Withdrawal by Subject|0|||
126745132|NCT02699125|456015543|FG001|Placebo|Withdrawal by Subject|4|||
126745133|NCT02699125|456015542|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
126745134|NCT02699125|456015543|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
126745135|NCT02092324|456015548|FG000|Overall Study|Adverse Event|1|||
126745136|NCT02092324|456015548|FG000|Overall Study|Lack of Efficacy|6|||
126745137|NCT02092324|456015548|FG000|Overall Study|Proceed to Transplant|3|||
126745138|NCT02092324|456015548|FG000|Overall Study|Physician Decision|7|||
126745139|NCT02092324|456015548|FG000|Overall Study|Misdiagnosis|2|||
126745140|NCT01039428|456015549|FG000|Overall Study|Protocol Violation|1|||
126745141|NCT01039428|456015550|FG001|Overall Study|Protocol Violation|0|||
126745142|NCT01039428|456015549|FG000|Overall Study|Withdrawal by Subject|1|||
126745143|NCT01039428|456015550|FG001|Overall Study|Withdrawal by Subject|0|||
126745144|NCT00422240|456015557|FG000|Overall Study|Lack of Efficacy|1|||
126745145|NCT00422240|456015558|FG001|Overall Study|Lack of Efficacy|2|||
126745146|NCT00422240|456015559|FG002|Overall Study|Lack of Efficacy|0|||
126745147|NCT00422240|456015560|FG003|Overall Study|Lack of Efficacy|1|||
126745148|NCT00422240|456015557|FG000|Overall Study|Adverse Event|11|||
126745149|NCT00422240|456015558|FG001|Overall Study|Adverse Event|4|||
126745150|NCT00422240|456015559|FG002|Overall Study|Adverse Event|5|||
126745151|NCT00422240|456015560|FG003|Overall Study|Adverse Event|2|||
126745152|NCT00422240|456015557|FG000|Overall Study|Subject request|21|||
126745153|NCT00422240|456015558|FG001|Overall Study|Subject request|17|||
126745154|NCT00422240|456015559|FG002|Overall Study|Subject request|18|||
126745155|NCT00422240|456015560|FG003|Overall Study|Subject request|30|||
126745156|NCT00422240|456015557|FG000|Overall Study|Protocol Violation|0|||
126745157|NCT00422240|456015558|FG001|Overall Study|Protocol Violation|1|||
126745158|NCT00422240|456015559|FG002|Overall Study|Protocol Violation|0|||
126745159|NCT00422240|456015560|FG003|Overall Study|Protocol Violation|1|||
126745160|NCT00422240|456015557|FG000|Overall Study|Lost to Follow-up|31|||
126745161|NCT00422240|456015558|FG001|Overall Study|Lost to Follow-up|32|||
126745162|NCT00422240|456015559|FG002|Overall Study|Lost to Follow-up|19|||
126745163|NCT00422240|456015560|FG003|Overall Study|Lost to Follow-up|34|||
126745164|NCT00422240|456015557|FG000|Overall Study|Other|1|||
126745165|NCT00422240|456015558|FG001|Overall Study|Other|0|||
126745166|NCT00422240|456015559|FG002|Overall Study|Other|0|||
126745167|NCT00422240|456015560|FG003|Overall Study|Other|1|||
126745168|NCT00422240|456015557|FG000|Overall Study|Pregnancy|3|||
126745169|NCT00422240|456015558|FG001|Overall Study|Pregnancy|1|||
126745170|NCT00422240|456015559|FG002|Overall Study|Pregnancy|1|||
126745171|NCT00422240|456015560|FG003|Overall Study|Pregnancy|2|||
126745172|NCT00441012|456015561|FG000|Overall Study|Adverse Event|0|||
126745173|NCT00441012|456015562|FG001|Overall Study|Adverse Event|1|||
126745174|NCT00441012|456015561|FG000|Overall Study|Lost to Follow-up|3|||
126745175|NCT00441012|456015562|FG001|Overall Study|Lost to Follow-up|3|||
126745176|NCT00441012|456015561|FG000|Overall Study|Protocol Violation|10|||
126745177|NCT00441012|456015562|FG001|Overall Study|Protocol Violation|9|||
126745178|NCT00441012|456015561|FG000|Overall Study|Withdrawal by Subject|4|||
126745179|NCT00441012|456015562|FG001|Overall Study|Withdrawal by Subject|0|||
126745180|NCT00441012|456015561|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
126745181|NCT00441012|456015562|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
126745182|NCT04489940|456015563|FG000|Overall Study|Other|2|||
126745183|NCT04489940|456015563|FG000|Overall Study|Withdrawal by Subject|2|||
126745184|NCT04489940|456015563|FG000|Overall Study|Death|5|||
126745185|NCT04489940|456015563|FG000|Overall Study|Lost to Follow-up|1|||
126745186|NCT01624467|456015564|FG000|Overall Study|Withdrawal by Subject|2|||
126745187|NCT01624467|456015564|FG000|Overall Study|Lost to Follow-up|1|||
126745188|NCT01624467|456015564|FG000|Overall Study|Adverse Event|7|||
126745189|NCT01624467|456015564|FG000|Overall Study|Progressive Disease|19|||
126745190|NCT01624467|456015564|FG000|Overall Study|Per Sponsor Requirement|1|||
126745191|NCT01624467|456015564|FG000|Overall Study|Subject Withdrew from Treatment|1|||
126745192|NCT02201472|456015567|FG000|Overall Study|Lack of Efficacy|2|||
126745193|NCT00262314|456015570|FG000|Overall Study|Changing physicians|38|||
126745194|NCT00262314|456015570|FG000|Overall Study|Death|12|||
126745195|NCT00262314|456015570|FG000|Overall Study|Patient's decision|92|||
126745196|NCT00262314|456015570|FG000|Overall Study|Other|95|||
126745197|NCT00262314|456015570|FG000|Overall Study|Lost to Follow-up|70|||
126745198|NCT00262314|456015570|FG000|Overall Study|Administrative withdrawal|30|||
126745199|NCT05104749|456015571|FG000|Overall Study|Lost to Follow-up|2|||
126745200|NCT05104749|456015572|FG001|Overall Study|Lost to Follow-up|3|||
126745201|NCT03964493|456015573|FG000|Overall Study|Withdrawal by Subject|4|||
126745202|NCT03964493|456015574|FG001|Overall Study|Withdrawal by Subject|1|||
126745203|NCT03964493|456015573|FG000|Overall Study|Lost to Follow-up|13|||
126745204|NCT03964493|456015574|FG001|Overall Study|Lost to Follow-up|4|||
126745205|NCT02470429|456015575|FG000|Overall Study|Adverse Event|1|||
126745206|NCT02470429|456015576|FG001|Overall Study|Adverse Event|0|||
126745207|NCT02470429|456015575|FG000|Overall Study|Withdrawal by Subject|1|||
126745208|NCT02470429|456015576|FG001|Overall Study|Withdrawal by Subject|0|||
126745209|NCT01300767|456015577|FG000|Overall Study|Discomfort|2|||
126745210|NCT01300767|456015577|FG000|Overall Study|Biomicroscopy|1|||
126745211|NCT01300767|456015577|FG000|Overall Study|Unacceptable fit|1|||
126745212|NCT00398138|456015578|FG000|Overall Study|Adverse Event|2|||
126745213|NCT00117572|456015581|FG000|Overall Study|Site withdrew before starting treatment|2|||
126745214|NCT00117572|456015582|FG001|Overall Study|Site withdrew before starting treatment|3|||
126745215|NCT00117572|456015581|FG000|Overall Study|Withdrawal by Subject|3|||
126745216|NCT00117572|456015582|FG001|Overall Study|Withdrawal by Subject|3|||
126745217|NCT00117572|456015581|FG000|Overall Study|Protocol Violation|1|||
126745218|NCT00117572|456015582|FG001|Overall Study|Protocol Violation|0|||
126745219|NCT04973085|456015587|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
126745220|NCT04973085|456015588|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
126745221|NCT00887068|456015589|FG000|Overall Study|Withdrawal by Subject|2|||
126745222|NCT00887068|456015590|FG001|Overall Study|Withdrawal by Subject|0|||
126745223|NCT00887068|456015589|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
126745224|NCT00887068|456015590|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
126745225|NCT01188811|456015596|FG000|Overall Study|Withdrawal by Subject|0|||
126745226|NCT01188811|456015597|FG001|Overall Study|Withdrawal by Subject|2|||
126745227|NCT01188811|456015596|FG000|Overall Study|Adverse Event|6|||
126745228|NCT01188811|456015597|FG001|Overall Study|Adverse Event|0|||
126745229|NCT01602744|456015598|FG000|Overall Study|Death|17|||
126745230|NCT01602744|456015599|FG001|Overall Study|Death|15|||
126745231|NCT01602744|456015598|FG000|Overall Study|Lost to Follow-up|13|||
126745232|NCT01602744|456015599|FG001|Overall Study|Lost to Follow-up|8|||
126745233|NCT03418376|456015600|FG000|Overall Study|Musculoskeletal injury|1|||
126745234|NCT03418376|456015601|FG001|Overall Study|Musculoskeletal injury|2|||
126745235|NCT03418376|456015602|FG002|Overall Study|Musculoskeletal injury|1|||
126745236|NCT03418376|456015603|FG003|Overall Study|Musculoskeletal injury|0|||
126745237|NCT03418376|456015600|FG000|Overall Study|Personal reasons|0|||
126745238|NCT03418376|456015601|FG001|Overall Study|Personal reasons|2|||
126745239|NCT03418376|456015602|FG002|Overall Study|Personal reasons|2|||
126745240|NCT03418376|456015603|FG003|Overall Study|Personal reasons|1|||
126745241|NCT03418376|456015600|FG000|Overall Study|Exacerbation|0|||
126745242|NCT03418376|456015601|FG001|Overall Study|Exacerbation|1|||
126745243|NCT03418376|456015602|FG002|Overall Study|Exacerbation|0|||
126745244|NCT03418376|456015603|FG003|Overall Study|Exacerbation|0|||
126745245|NCT01387594|456015608|FG000|Overall Study|Withdrawal by Subject|0|||
126745246|NCT01387594|456015609|FG001|Overall Study|Withdrawal by Subject|2|||
126745247|NCT01387594|456015608|FG000|Overall Study|Lost to Follow-up|0|||
126745248|NCT01387594|456015609|FG001|Overall Study|Lost to Follow-up|1|||
126745249|NCT03573804|456015621|FG000|Overall Study|claustrophobia or MRI table problems|10|||
126745250|NCT04507360|456017546|FG000|Week 1|Lost to Follow-up|0|||
126745251|NCT04507360|456017547|FG001|Week 1|Lost to Follow-up|0|||
126745252|NCT04507360|456017548|FG002|Week 1|Lost to Follow-up|0|||
126745253|NCT04507360|456017549|FG003|Week 1|Lost to Follow-up|0|||
126745254|NCT04507360|456017550|FG004|Week 1|Lost to Follow-up|0|||
126745255|NCT04507360|456017551|FG005|Week 1|Lost to Follow-up|0|||
126745256|NCT04507360|456017552|FG006|Week 1|Lost to Follow-up|0|||
126745257|NCT04507360|456017553|FG007|Week 1|Lost to Follow-up|0|||
126745258|NCT04507360|456017554|FG008|Week 1|Lost to Follow-up|72|||
126745259|NCT04507360|456017555|FG009|Week 1|Lost to Follow-up|22|||
126745260|NCT04507360|456017556|FG010|Week 1|Lost to Follow-up|10|||
126616915|NCT00080119|455555430|FG000|Overall Study|Unable to get to clinic|24|||
126616916|NCT00080119|455555431|FG001|Overall Study|Unable to get to clinic|24|||
126616917|NCT00080119|455555432|FG002|Overall Study|Unable to get to clinic|7|||
126616918|NCT00080119|455555433|FG003|Overall Study|Unable to get to clinic|1|||
126616919|NCT00080119|455555430|FG000|Overall Study|Consent withdrawn|13|||
126616920|NCT00080119|455555431|FG001|Overall Study|Consent withdrawn|17|||
126616921|NCT00080119|455555432|FG002|Overall Study|Consent withdrawn|4|||
126616922|NCT00080119|455555433|FG003|Overall Study|Consent withdrawn|6|||
126616923|NCT00080119|455555430|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
126745261|NCT04507360|456017546|FG000|Week 2|Lost to Follow-up|0|||
126745262|NCT04507360|456017547|FG001|Week 2|Lost to Follow-up|0|||
126745263|NCT04507360|456017548|FG002|Week 2|Lost to Follow-up|0|||
126745264|NCT04507360|456017549|FG003|Week 2|Lost to Follow-up|0|||
126745265|NCT04507360|456017550|FG004|Week 2|Lost to Follow-up|0|||
126745266|NCT04507360|456017551|FG005|Week 2|Lost to Follow-up|0|||
126745267|NCT04507360|456017552|FG006|Week 2|Lost to Follow-up|0|||
126745268|NCT04507360|456017553|FG007|Week 2|Lost to Follow-up|0|||
126745269|NCT04507360|456017554|FG008|Week 2|Lost to Follow-up|121|||
126616924|NCT00080119|455555431|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
126616925|NCT00080119|455555432|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
126745270|NCT04507360|456017555|FG009|Week 2|Lost to Follow-up|85|||
126745271|NCT04507360|456017556|FG010|Week 2|Lost to Follow-up|82|||
126745272|NCT04507360|456017546|FG000|Week 3|Lost to Follow-up|0|||
126745273|NCT04507360|456017547|FG001|Week 3|Lost to Follow-up|0|||
126745274|NCT04507360|456017548|FG002|Week 3|Lost to Follow-up|0|||
126745275|NCT04507360|456017549|FG003|Week 3|Lost to Follow-up|0|||
126745276|NCT04507360|456017550|FG004|Week 3|Lost to Follow-up|0|||
126745277|NCT04507360|456017551|FG005|Week 3|Lost to Follow-up|0|||
126745278|NCT04507360|456017552|FG006|Week 3|Lost to Follow-up|0|||
126745279|NCT04507360|456017553|FG007|Week 3|Lost to Follow-up|0|||
126745280|NCT04507360|456017554|FG008|Week 3|Lost to Follow-up|123|||
126745281|NCT04507360|456017555|FG009|Week 3|Lost to Follow-up|92|||
126745282|NCT04507360|456017556|FG010|Week 3|Lost to Follow-up|84|||
126745283|NCT04507360|456017546|FG000|Week 4|Lost to Follow-up|0|||
126745284|NCT04507360|456017547|FG001|Week 4|Lost to Follow-up|0|||
126745285|NCT04507360|456017548|FG002|Week 4|Lost to Follow-up|0|||
126745286|NCT04507360|456017549|FG003|Week 4|Lost to Follow-up|0|||
126745287|NCT04507360|456017550|FG004|Week 4|Lost to Follow-up|0|||
126745288|NCT04507360|456017551|FG005|Week 4|Lost to Follow-up|0|||
126745289|NCT04507360|456017552|FG006|Week 4|Lost to Follow-up|0|||
126745290|NCT04507360|456017553|FG007|Week 4|Lost to Follow-up|0|||
126745291|NCT04507360|456017554|FG008|Week 4|Lost to Follow-up|131|||
126745292|NCT04507360|456017555|FG009|Week 4|Lost to Follow-up|115|||
126745293|NCT04507360|456017556|FG010|Week 4|Lost to Follow-up|102|||
126745294|NCT04507360|456017546|FG000|Week 5|Lost to Follow-up|0|||
126745295|NCT04507360|456017547|FG001|Week 5|Lost to Follow-up|0|||
126745296|NCT04507360|456017548|FG002|Week 5|Lost to Follow-up|0|||
126745297|NCT04507360|456017549|FG003|Week 5|Lost to Follow-up|0|||
126745298|NCT04507360|456017550|FG004|Week 5|Lost to Follow-up|0|||
126745299|NCT04507360|456017551|FG005|Week 5|Lost to Follow-up|0|||
126745300|NCT04507360|456017552|FG006|Week 5|Lost to Follow-up|0|||
126745301|NCT04507360|456017553|FG007|Week 5|Lost to Follow-up|0|||
126745302|NCT04507360|456017554|FG008|Week 5|Lost to Follow-up|103|||
126745303|NCT04507360|456017555|FG009|Week 5|Lost to Follow-up|135|||
126745304|NCT04507360|456017556|FG010|Week 5|Lost to Follow-up|143|||
126745305|NCT04507360|456017546|FG000|Week 8|Lost to Follow-up|0|||
126745306|NCT04507360|456017547|FG001|Week 8|Lost to Follow-up|0|||
126745307|NCT04507360|456017548|FG002|Week 8|Lost to Follow-up|0|||
126745308|NCT04507360|456017549|FG003|Week 8|Lost to Follow-up|0|||
126745309|NCT04507360|456017550|FG004|Week 8|Lost to Follow-up|0|||
126745310|NCT04507360|456017551|FG005|Week 8|Lost to Follow-up|0|||
126745311|NCT04507360|456017552|FG006|Week 8|Lost to Follow-up|0|||
126745312|NCT04507360|456017553|FG007|Week 8|Lost to Follow-up|0|||
126745313|NCT04507360|456017554|FG008|Week 8|Lost to Follow-up|139|||
126745314|NCT04507360|456017555|FG009|Week 8|Lost to Follow-up|145|||
126745315|NCT04507360|456017556|FG010|Week 8|Lost to Follow-up|152|||
126745316|NCT00636155|456017557|FG000|Overall Study|Adverse Event|8|||
126745317|NCT00636155|456017557|FG000|Overall Study|Lack of Efficacy|1|||
126745318|NCT00636155|456017557|FG000|Overall Study|Withdrawal by Subject|3|||
126745319|NCT00636155|456017557|FG000|Overall Study|Stem cell transplant|1|||
126745320|NCT00636155|456017557|FG000|Overall Study|Physician Decision|5|||
126745321|NCT01432756|456017558|FG000|Overall Study|Lost to Follow-up|1|||
126745322|NCT01432756|456017559|FG001|Overall Study|Lost to Follow-up|0|||
126745323|NCT01432756|456017560|FG002|Overall Study|Lost to Follow-up|2|||
126745324|NCT01432756|456017561|FG003|Overall Study|Lost to Follow-up|1|||
126745325|NCT01004159|456017569|FG000|Overall Study|Adverse Event|2|||
126745326|NCT01004159|456017569|FG000|Overall Study|Disease Progression|18|||
126745327|NCT03050307|456017574|FG000|Overall Study|Adverse Event|4|||
126745328|NCT03050307|456017575|FG001|Overall Study|Adverse Event|2|||
126745329|NCT03050307|456017574|FG000|Overall Study|Significant Protocol Deviation|0|||
126745330|NCT03050307|456017575|FG001|Overall Study|Significant Protocol Deviation|1|||
126745331|NCT03050307|456017574|FG000|Overall Study|Lost to Follow-up|0|||
126745332|NCT03050307|456017575|FG001|Overall Study|Lost to Follow-up|1|||
126616926|NCT00080119|455555433|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
126616927|NCT00080119|455555430|FG000|Overall Study|Lost to Follow-up|16|||
126616928|NCT00080119|455555431|FG001|Overall Study|Lost to Follow-up|19|||
126616929|NCT00080119|455555432|FG002|Overall Study|Lost to Follow-up|19|||
126745333|NCT03050307|456017574|FG000|Overall Study|Voluntary Withdrawal|3|||
126745334|NCT03050307|456017575|FG001|Overall Study|Voluntary Withdrawal|4|||
126745335|NCT03050307|456017574|FG000|Overall Study|Reason not Specified|1|||
126745336|NCT03050307|456017575|FG001|Overall Study|Reason not Specified|1|||
126745337|NCT02973997|456017576|FG000|Overall Study|Withdrawal by Subject|4|||
126745338|NCT02973997|456017577|FG001|Overall Study|Withdrawal by Subject|0|||
126745339|NCT02973997|456017576|FG000|Overall Study|Adverse Event|4|||
126745340|NCT02973997|456017577|FG001|Overall Study|Adverse Event|1|||
126745341|NCT02973997|456017576|FG000|Overall Study|Disease Progression|11|||
126745342|NCT02973997|456017577|FG001|Overall Study|Disease Progression|20|||
126745343|NCT02973997|456017576|FG000|Overall Study|Alternative Therapy|3|||
126745344|NCT02973997|456017577|FG001|Overall Study|Alternative Therapy|0|||
126616930|NCT00080119|455555433|FG003|Overall Study|Lost to Follow-up|14|||
126745345|NCT02973997|456017576|FG000|Overall Study|Other complicating disease|0|||
126745346|NCT02973997|456017577|FG001|Overall Study|Other complicating disease|1|||
126745347|NCT02973997|456017576|FG000|Overall Study|Death|0|||
126745348|NCT02973997|456017577|FG001|Overall Study|Death|1|||
126745349|NCT00444951|456017578|FG000|Overall Study|Lost to Follow-up|1|||
126745350|NCT00444951|456017579|FG001|Overall Study|Lost to Follow-up|1|||
126745351|NCT00444951|456017580|FG002|Overall Study|Lost to Follow-up|0|||
126745352|NCT00444951|456017578|FG000|Overall Study|Withdrawal by Subject|4|||
126745353|NCT00444951|456017579|FG001|Overall Study|Withdrawal by Subject|5|||
126745354|NCT00444951|456017580|FG002|Overall Study|Withdrawal by Subject|3|||
126745355|NCT01938391|456017587|FG000|6 Month Follow up|Withdrawal by Subject|1|||
126745356|NCT01938391|456017587|FG000|12 Month Follow up|Physician Decision|1|||
126745357|NCT01938391|456017587|FG000|12 Month Follow up|Withdrawal by Subject|1|||
126745358|NCT01536418|456017598|FG000|Overall Study|Protocol Violation|2|||
126745359|NCT01536418|456017599|FG001|Overall Study|Protocol Violation|3|||
126745360|NCT01536418|456017598|FG000|Overall Study|Physician Decision|1|||
126745361|NCT01536418|456017599|FG001|Overall Study|Physician Decision|3|||
126745362|NCT01536418|456017598|FG000|Overall Study|Study closed/terminated|41|||
126745363|NCT01536418|456017599|FG001|Overall Study|Study closed/terminated|37|||
126745364|NCT01536418|456017598|FG000|Overall Study|Lack of Efficacy|10|||
126745365|NCT01536418|456017599|FG001|Overall Study|Lack of Efficacy|16|||
126745366|NCT01536418|456017598|FG000|Overall Study|Adverse Event|9|||
126745367|NCT01536418|456017599|FG001|Overall Study|Adverse Event|4|||
126745368|NCT01536418|456017598|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
126745369|NCT01536418|456017599|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
126745370|NCT01536418|456017598|FG000|Overall Study|Withdrawal by Subject|5|||
126745371|NCT01536418|456017599|FG001|Overall Study|Withdrawal by Subject|3|||
126745372|NCT01680991|456017600|FG000|Overall Study|Adverse Event|1|||
126745373|NCT01680991|456017601|FG001|Overall Study|Adverse Event|0|||
126745374|NCT01680991|456017602|FG002|Overall Study|Adverse Event|0|||
126745375|NCT01680991|456017600|FG000|Overall Study|Death|1|||
126745376|NCT01680991|456017601|FG001|Overall Study|Death|0|||
126745377|NCT01680991|456017602|FG002|Overall Study|Death|1|||
126745378|NCT01680991|456017600|FG000|Overall Study|Protocol Violation|0|||
126745379|NCT01680991|456017601|FG001|Overall Study|Protocol Violation|1|||
126745380|NCT01680991|456017602|FG002|Overall Study|Protocol Violation|0|||
126745381|NCT01680991|456017600|FG000|Overall Study|Withdrawal by Subject|5|||
126745382|NCT01680991|456017601|FG001|Overall Study|Withdrawal by Subject|1|||
126745383|NCT01680991|456017602|FG002|Overall Study|Withdrawal by Subject|0|||
126745384|NCT01680991|456017600|FG000|Overall Study|Progressive disease (PD)|0|||
126745385|NCT01680991|456017601|FG001|Overall Study|Progressive disease (PD)|10|||
126745386|NCT01680991|456017602|FG002|Overall Study|Progressive disease (PD)|0|||
126745387|NCT01680991|456017600|FG000|Overall Study|Physician Decision|0|||
126745388|NCT01680991|456017601|FG001|Overall Study|Physician Decision|7|||
126745389|NCT01680991|456017602|FG002|Overall Study|Physician Decision|2|||
126745390|NCT01680991|456017600|FG000|Overall Study|Bad physical condition|0|||
126745391|NCT01680991|456017601|FG001|Overall Study|Bad physical condition|0|||
126745392|NCT01680991|456017602|FG002|Overall Study|Bad physical condition|1|||
126745393|NCT01680991|456017600|FG000|Overall Study|PD confirmed in other hospital|1|||
126745394|NCT01680991|456017601|FG001|Overall Study|PD confirmed in other hospital|0|||
126745395|NCT01680991|456017602|FG002|Overall Study|PD confirmed in other hospital|0|||
126745396|NCT01600105|456017606|FG000|Total Participants|Withdrawal by Subject|1|||
126745397|NCT01600105|456017607|FG001|Total Participants|Withdrawal by Subject|0|||
126745398|NCT01600105|456017606|FG000|Total Participants|No images in PACS|10|||
126745399|NCT01600105|456017607|FG001|Total Participants|No images in PACS|0|||
126745400|NCT01600105|456017606|FG000|Total Participants|Insufficient image quality|30|||
126745401|NCT01600105|456017607|FG001|Total Participants|Insufficient image quality|10|||
126745402|NCT01600105|456017606|FG000|Sub Study I|Insufficient image quality|0|||
126745403|NCT01600105|456017607|FG001|Sub Study I|Insufficient image quality|10|||
126745404|NCT01600105|456017606|FG000|Sub Study II|Withdrawal by Subject|1|||
126745405|NCT01600105|456017607|FG001|Sub Study II|Withdrawal by Subject|0|||
126745406|NCT01600105|456017606|FG000|Sub Study II|No images in PACS|1|||
126745407|NCT01600105|456017607|FG001|Sub Study II|No images in PACS|0|||
126745408|NCT01600105|456017606|FG000|Sub Study II|Insufficient image quality|3|||
126745409|NCT01600105|456017607|FG001|Sub Study II|Insufficient image quality|0|||
126745410|NCT01600105|456017606|FG000|Sub Study III|Insufficient image quality|5|||
126745411|NCT01600105|456017607|FG001|Sub Study III|Insufficient image quality|0|||
126745412|NCT01600105|456017606|FG000|Sub Study V|Poor Image Quality|2|||
126745413|NCT01600105|456017607|FG001|Sub Study V|Poor Image Quality|0|||
126745414|NCT04007367|456017608|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
126745415|NCT04007367|456017609|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
126745416|NCT04007367|456017610|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
126745417|NCT04007367|456017608|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
126745418|NCT04007367|456017609|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
126745419|NCT04007367|456017610|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
126745420|NCT04007367|456017608|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
126745421|NCT04007367|456017609|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
126745422|NCT04007367|456017610|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
126745423|NCT04007367|456017608|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
126745424|NCT04007367|456017609|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
126745425|NCT04007367|456017610|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
126745426|NCT04007367|456017608|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
126745427|NCT04007367|456017609|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
126745428|NCT04007367|456017610|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
126745429|NCT01764022|456017611|FG000|Overall Study|Death|3|||
126745430|NCT01764022|456017612|FG001|Overall Study|Death|5|||
126745431|NCT01764022|456017611|FG000|Overall Study|Withdrawal by Subject|2|||
126745432|NCT01764022|456017612|FG001|Overall Study|Withdrawal by Subject|6|||
126745433|NCT01764022|456017611|FG000|Overall Study|Lack of Efficacy|0|||
126745434|NCT01764022|456017612|FG001|Overall Study|Lack of Efficacy|1|||
126745435|NCT01764022|456017611|FG000|Overall Study|Physician Decision|0|||
126745436|NCT01764022|456017612|FG001|Overall Study|Physician Decision|2|||
126745437|NCT01764022|456017611|FG000|Overall Study|Lost to Follow-up|2|||
126745438|NCT01764022|456017612|FG001|Overall Study|Lost to Follow-up|0|||
126745439|NCT01764022|456017611|FG000|Overall Study|Protocol Violation|1|||
126745440|NCT01764022|456017612|FG001|Overall Study|Protocol Violation|0|||
126745441|NCT01899768|456017613|FG000|Part A|Adverse Event|2|||
126745442|NCT01899768|456017613|FG000|Part A|Withdrawal by Subject|1|||
126745443|NCT01899768|456017613|FG000|Part B|Adverse Event|1|||
126745444|NCT01899768|456017613|FG000|Part B|Withdrawal by Subject|1|||
126745445|NCT00312728|456017632|FG000|Overall Study|Progressive disease|53|||
126745446|NCT00312728|456017632|FG000|Overall Study|Adverse Event|32|||
126745447|NCT00312728|456017632|FG000|Overall Study|Withdrawal by Subject|10|||
126745448|NCT00312728|456017632|FG000|Overall Study|Required non-protocol cancer treatment|2|||
126745449|NCT00312728|456017632|FG000|Overall Study|Protocol Violation|2|||
126745450|NCT00312728|456017632|FG000|Overall Study|Other|10|||
126745451|NCT00312728|456017632|FG000|Overall Study|Other|1|||
126745452|NCT00850135|456017633|FG000|Overall Study|Physician Decision|1|||
126745453|NCT00338806|456017635|FG000|Acute Phase|Withdrawal by Subject|0|||
126745454|NCT00338806|456017636|FG001|Acute Phase|Withdrawal by Subject|1|||
126745455|NCT00338806|456017635|FG000|Follow-up|Lost to Follow-up|1|||
126745456|NCT00338806|456017636|FG001|Follow-up|Lost to Follow-up|3|||
126745457|NCT00744991|456017639|FG000|Overall Study|Progressive Disease|11|||
126745458|NCT00744991|456017639|FG000|Overall Study|Withdrawal by Subject|8|||
126745459|NCT00744991|456017639|FG000|Overall Study|Physician Decision|3|||
126745460|NCT00744991|456017639|FG000|Overall Study|Adverse Event|2|||
126745461|NCT00744991|456017639|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
126745462|NCT01487863|456017647|FG000|Overall Study|Death|19|||
126745463|NCT01487863|456017648|FG001|Overall Study|Death|19|||
126745464|NCT04259346|456017649|FG000|Overall Study|Lost to Follow-up|1|||
126745465|NCT04259346|456017650|FG001|Overall Study|Lost to Follow-up|3|||
126745466|NCT04259346|456017649|FG000|Overall Study|Protocol Violation|1|||
126745467|NCT04259346|456017650|FG001|Overall Study|Protocol Violation|0|||
126745468|NCT04259346|456017649|FG000|Overall Study|Withdrawal by Subject|1|||
126745469|NCT04259346|456017650|FG001|Overall Study|Withdrawal by Subject|0|||
126745470|NCT04259346|456017649|FG000|Overall Study|Adverse Event|1|||
126745471|NCT04259346|456017650|FG001|Overall Study|Adverse Event|1|||
126745472|NCT00623766|456017654|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
126745473|NCT00623766|456017655|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
126745474|NCT00623766|456017654|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
126745475|NCT00623766|456017655|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
126745476|NCT00623766|456017654|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
126745477|NCT00623766|456017655|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
126745478|NCT00623766|456017654|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
126745479|NCT00623766|456017655|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
126745480|NCT00623766|456017654|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
126745481|NCT00623766|456017655|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
126616931|NCT01919489|455555435|FG000|Overall Study|Rejected the need of injections|4|||
126616932|NCT01919489|455555436|FG001|Overall Study|Rejected the need of injections|7|||
126616933|NCT01919489|455555435|FG000|Overall Study|Adverse Event|10|||
126616934|NCT01919489|455555436|FG001|Overall Study|Adverse Event|0|||
126616935|NCT01919489|455555435|FG000|Overall Study|Hospital readmission|2|||
126745482|NCT00486889|456017656|FG000|Overall Study|Death|3|||
126745483|NCT00486889|456017656|FG000|Overall Study|Non-compliant|2|||
126745484|NCT00486889|456017656|FG000|Overall Study|Withdrawal by Subject|6|||
126745485|NCT00893763|456017657|FG000|Overall Study|extubated|110|||
126745486|NCT00893763|456017658|FG001|Overall Study|extubated|110|||
126745487|NCT04157751|456017668|FG000|Overall Study|Withdrawal by Subject|12|||
126745488|NCT04157751|456017669|FG001|Overall Study|Withdrawal by Subject|17|||
126745489|NCT04157751|456017668|FG000|Overall Study|Lost to Follow-up|6|||
126745490|NCT04157751|456017669|FG001|Overall Study|Lost to Follow-up|2|||
126745491|NCT04157751|456017668|FG000|Overall Study|Adverse Event|34|||
126745492|NCT04157751|456017669|FG001|Overall Study|Adverse Event|23|||
126745493|NCT04157751|456017668|FG000|Overall Study|Not treated|1|||
126745494|NCT04157751|456017669|FG001|Overall Study|Not treated|5|||
126745495|NCT04157751|456017668|FG000|Overall Study|Other reason not stated above|10|||
126745496|NCT04157751|456017669|FG001|Overall Study|Other reason not stated above|10|||
126745497|NCT00422903|456017675|FG000|Overall Study|Disease Progression|3|||
126745498|NCT00422903|456017676|FG001|Overall Study|Disease Progression|1|||
126616936|NCT01919489|455555436|FG001|Overall Study|Hospital readmission|9|||
126616937|NCT01919489|455555435|FG000|Overall Study|Death|2|||
126616938|NCT01919489|455555436|FG001|Overall Study|Death|1|||
126616939|NCT01919489|455555435|FG000|Overall Study|Lost to Follow-up|38|||
126616940|NCT01919489|455555436|FG001|Overall Study|Lost to Follow-up|27|||
126616941|NCT01322386|455555437|FG000|Overall Study|Protocol Violation|0|||
126616942|NCT01322386|455555438|FG001|Overall Study|Protocol Violation|1|||
126616943|NCT01322386|455555437|FG000|Overall Study|Physician Decision|0|||
126616944|NCT01322386|455555438|FG001|Overall Study|Physician Decision|1|||
126616945|NCT00871494|455555442|FG000|Overall Study|Protocol Violation|5|||
126616946|NCT00871494|455555442|FG000|Overall Study|Lack of Efficacy|4|||
126616947|NCT00871494|455555442|FG000|Overall Study|Adverse Event|4|||
126616948|NCT00871494|455555442|FG000|Overall Study|Lost to Follow-up|1|||
126616949|NCT00963924|455555443|FG000|Overall Study|Adverse Event|1|||
126616950|NCT00963924|455555444|FG001|Overall Study|Adverse Event|0|||
126745499|NCT00422903|456017675|FG000|Overall Study|Adverse Event|0|||
126745500|NCT00422903|456017676|FG001|Overall Study|Adverse Event|2|||
126745501|NCT00422903|456017675|FG000|Overall Study|Informed Consent Withdrawn|1|||
126745502|NCT00422903|456017676|FG001|Overall Study|Informed Consent Withdrawn|2|||
126745503|NCT00423592|456017677|FG000|Overall Study|Adverse Event (through Week 12)|2|||
126745504|NCT00423592|456017677|FG000|Overall Study|Adverse Event (post Week 12)|5|||
126745505|NCT03446612|456017678|FG000|Overall Study|Protocol defined stopping criteria|0|||
126745506|NCT03446612|456017679|FG001|Overall Study|Protocol defined stopping criteria|1|||
126745507|NCT04445051|456017680|FG000|Overall Study|Adverse Event|0|||
126745508|NCT04445051|456017681|FG001|Overall Study|Adverse Event|0|||
126745509|NCT04445051|456017682|FG002|Overall Study|Adverse Event|1|||
126745510|NCT04445051|456017683|FG003|Overall Study|Adverse Event|0|||
126745511|NCT04445051|456017684|FG004|Overall Study|Adverse Event|0|||
126745512|NCT04445051|456017685|FG005|Overall Study|Adverse Event|0|||
126745513|NCT00901394|456017693|FG000|Overall Study|Physician Decision|1|||
126745514|NCT00901394|456017694|FG001|Overall Study|Physician Decision|1|||
126745515|NCT00901394|456017695|FG002|Overall Study|Physician Decision|2|||
126745516|NCT00796224|456017698|FG000|Overall Study|Adverse Event|1|||
126745517|NCT00796224|456017699|FG001|Overall Study|Adverse Event|0|||
126745518|NCT00796224|456017698|FG000|Overall Study|Protocol Violation|0|||
126745519|NCT00796224|456017699|FG001|Overall Study|Protocol Violation|1|||
126745520|NCT02569398|456017700|FG000|Overall Study|Adverse Event|0|||
126745521|NCT02569398|456017701|FG001|Overall Study|Adverse Event|1|||
126745522|NCT02569398|456017702|FG002|Overall Study|Adverse Event|6|||
126745523|NCT02569398|456017700|FG000|Overall Study|Withdrawal by Subject|43|||
126745524|NCT02569398|456017701|FG001|Overall Study|Withdrawal by Subject|43|||
126745525|NCT02569398|456017702|FG002|Overall Study|Withdrawal by Subject|30|||
126745526|NCT02569398|456017700|FG000|Overall Study|Study terminated by sponsor|130|||
126745527|NCT02569398|456017701|FG001|Overall Study|Study terminated by sponsor|131|||
126745528|NCT02569398|456017702|FG002|Overall Study|Study terminated by sponsor|134|||
126745529|NCT02569398|456017700|FG000|Overall Study|Other|12|||
126745530|NCT02569398|456017701|FG001|Overall Study|Other|14|||
126745531|NCT02569398|456017702|FG002|Overall Study|Other|13|||
126745532|NCT02116361|456017703|FG000|Overall Study|Pregnancy|0|||
126745533|NCT02116361|456017704|FG001|Overall Study|Pregnancy|0|||
126745534|NCT02116361|456017705|FG002|Overall Study|Pregnancy|0|||
126745535|NCT02116361|456017706|FG003|Overall Study|Pregnancy|1|||
126745536|NCT02116361|456017703|FG000|Overall Study|Protocol Violation|1|||
126616951|NCT00963924|455555443|FG000|Overall Study|Withdrawal by Subject|0|||
126616952|NCT00963924|455555444|FG001|Overall Study|Withdrawal by Subject|1|||
126616953|NCT00963924|455555443|FG000|Overall Study|Changed antipsychotic|0|||
126616954|NCT00963924|455555444|FG001|Overall Study|Changed antipsychotic|1|||
126616955|NCT00963924|455555443|FG000|Overall Study|Lost to Follow-up|0|||
126745537|NCT02116361|456017704|FG001|Overall Study|Protocol Violation|0|||
126745538|NCT02116361|456017705|FG002|Overall Study|Protocol Violation|0|||
126745539|NCT02116361|456017706|FG003|Overall Study|Protocol Violation|2|||
126745540|NCT02116361|456017703|FG000|Overall Study|Physician Decision|2|||
126745541|NCT02116361|456017704|FG001|Overall Study|Physician Decision|3|||
126745542|NCT02116361|456017705|FG002|Overall Study|Physician Decision|0|||
126745543|NCT02116361|456017706|FG003|Overall Study|Physician Decision|0|||
126745544|NCT02116361|456017703|FG000|Overall Study|Adverse Event|1|||
126745545|NCT02116361|456017704|FG001|Overall Study|Adverse Event|0|||
126745546|NCT02116361|456017705|FG002|Overall Study|Adverse Event|0|||
126745547|NCT02116361|456017706|FG003|Overall Study|Adverse Event|3|||
126745548|NCT02116361|456017703|FG000|Overall Study|Other Reasons|3|||
126745549|NCT02116361|456017704|FG001|Overall Study|Other Reasons|3|||
126745550|NCT02116361|456017705|FG002|Overall Study|Other Reasons|3|||
126745551|NCT02116361|456017706|FG003|Overall Study|Other Reasons|3|||
126745552|NCT02116361|456017703|FG000|Overall Study|Lack of Efficacy|5|||
126616956|NCT00963924|455555444|FG001|Overall Study|Lost to Follow-up|1|||
126616957|NCT00237809|455555445|FG000|Overall Study|Lost to Follow-up|11|||
126616958|NCT00237809|455555446|FG001|Overall Study|Lost to Follow-up|10|||
126616959|NCT00237809|455555447|FG002|Overall Study|Lost to Follow-up|9|||
126616960|NCT00237809|455555448|FG003|Overall Study|Lost to Follow-up|9|||
126745553|NCT02116361|456017704|FG001|Overall Study|Lack of Efficacy|7|||
126745554|NCT02116361|456017705|FG002|Overall Study|Lack of Efficacy|4|||
126616961|NCT00871715|455555451|FG000|Overall Study|Withdrawal by Subject|6|||
126616962|NCT00871715|455555452|FG001|Overall Study|Withdrawal by Subject|10|||
126616963|NCT00871715|455555453|FG002|Overall Study|Withdrawal by Subject|15|||
126616964|NCT00871715|455555451|FG000|Overall Study|Physician Decision|6|||
126616965|NCT00871715|455555452|FG001|Overall Study|Physician Decision|0|||
126616966|NCT00871715|455555453|FG002|Overall Study|Physician Decision|2|||
126616967|NCT00871715|455555451|FG000|Overall Study|Lost to Follow-up|3|||
126616968|NCT00871715|455555452|FG001|Overall Study|Lost to Follow-up|6|||
126616969|NCT00871715|455555453|FG002|Overall Study|Lost to Follow-up|9|||
126616970|NCT03015220|455555454|FG000|Overall Study|Withdrawal by Subject|3|||
126616971|NCT03015220|455555455|FG001|Overall Study|Withdrawal by Subject|2|||
126616972|NCT03015220|455555456|FG002|Overall Study|Withdrawal by Subject|2|||
126616973|NCT03015220|455555457|FG003|Overall Study|Withdrawal by Subject|2|||
126616974|NCT03015220|455555454|FG000|Overall Study|Lost to Follow-up|0|||
126616975|NCT03015220|455555455|FG001|Overall Study|Lost to Follow-up|0|||
126781858|NCT01688037|456156290|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
126781859|NCT01688037|456156291|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
126781860|NCT01688037|456156289|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
126781861|NCT01688037|456156290|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
126781862|NCT01688037|456156291|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
126616976|NCT03015220|455555456|FG002|Overall Study|Lost to Follow-up|1|||
126616977|NCT03015220|455555457|FG003|Overall Study|Lost to Follow-up|0|||
126616978|NCT01670526|455555458|FG000|Overall Study|Withdrawal by Subject|3|||
126616979|NCT01670526|455555459|FG001|Overall Study|Withdrawal by Subject|1|||
126616980|NCT01670526|455555458|FG000|Overall Study|Lost to Follow-up|9|||
126616981|NCT01670526|455555459|FG001|Overall Study|Lost to Follow-up|5|||
126616982|NCT02291549|455555460|FG000|Overall Study|Lost to Follow-up|1|||
126616983|NCT02291549|455555461|FG001|Overall Study|Lost to Follow-up|0|||
126616984|NCT02291549|455555460|FG000|Overall Study|Withdrawal by Subject|0|||
126616985|NCT02291549|455555461|FG001|Overall Study|Withdrawal by Subject|1|||
126616986|NCT01970527|455555463|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
126616987|NCT01970527|455555464|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
126616988|NCT01970527|455555463|FG000|Treatment|Disease progression|0|||
126616989|NCT01970527|455555464|FG001|Treatment|Disease progression|1|||
126616990|NCT01970527|455555463|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
126616991|NCT01970527|455555464|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
126616992|NCT01970527|455555463|FG000|Treatment|Death|0|||
126616993|NCT01970527|455555464|FG001|Treatment|Death|1|||
126616994|NCT01970527|455555463|FG000|Follow-up Clinic Visit|Disease progression|1|||
126616995|NCT01970527|455555464|FG001|Follow-up Clinic Visit|Disease progression|1|||
126616996|NCT01970527|455555463|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
126616997|NCT01970527|455555464|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
126616998|NCT01970527|455555463|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
126616999|NCT01970527|455555464|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
126617000|NCT01115309|455555465|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
126617001|NCT01115309|455555465|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
126617002|NCT01115309|455555465|FG000|Long-term Follow-up|Lost to Follow-up|6|||
126617003|NCT04447287|455555466|FG000|Period 1: Run-in Period|Adverse Event|3|||
126617004|NCT04447287|455555467|FG001|Period 1: Run-in Period|Adverse Event|0|||
126617005|NCT04447287|455555468|FG002|Period 1: Run-in Period|Adverse Event|0|||
126617006|NCT04447287|455555466|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
126617007|NCT04447287|455555467|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
126617008|NCT04447287|455555468|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
126617009|NCT04447287|455555466|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
126617010|NCT04447287|455555467|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
126617011|NCT04447287|455555468|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
126617012|NCT05700851|455555469|FG000|Overall Study|Received a kidney transplant|1|||
126617013|NCT05700851|455555469|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
126617014|NCT05700851|455555469|FG000|Overall Study|Withdrawal by Subject|1|||
126617015|NCT02147093|455555472|FG000|Period 1|Lost to Follow-up|0|||
126617016|NCT02147093|455555473|FG001|Period 1|Lost to Follow-up|1|||
126617017|NCT02147093|455555472|FG000|Period 2|Protocol Violation|2|||
126617018|NCT02147093|455555473|FG001|Period 2|Protocol Violation|0|||
126617019|NCT00655824|455555474|FG000|Overall Study|Adverse Event|3|||
126617020|NCT00655824|455555474|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
126617021|NCT00655824|455555474|FG000|Overall Study|Protocol Violation|1|||
126617022|NCT00655824|455555474|FG000|Overall Study|Withdrawal by Subject|4|||
126617023|NCT00655824|455555474|FG000|Overall Study|Deterioration of Trial Disease|2|||
126617024|NCT00589628|455555475|FG000|Overall Study|Lost to Follow-up|0|||
126617025|NCT00589628|455555476|FG001|Overall Study|Lost to Follow-up|1|||
126617026|NCT03032198|455555484|FG000|Overall Study|Screen Fail|1|||
126617027|NCT01307800|455555485|FG000|Overall Study|Adverse Event|9|||
126745555|NCT02116361|456017706|FG003|Overall Study|Lack of Efficacy|3|||
126745556|NCT02116361|456017703|FG000|Overall Study|Lost to Follow-up|4|||
126745557|NCT02116361|456017704|FG001|Overall Study|Lost to Follow-up|5|||
126745558|NCT02116361|456017705|FG002|Overall Study|Lost to Follow-up|7|||
126745559|NCT02116361|456017706|FG003|Overall Study|Lost to Follow-up|5|||
126745560|NCT02116361|456017703|FG000|Overall Study|Personal Reasons|6|||
126745561|NCT02116361|456017704|FG001|Overall Study|Personal Reasons|6|||
126745562|NCT02116361|456017705|FG002|Overall Study|Personal Reasons|4|||
126745563|NCT02116361|456017706|FG003|Overall Study|Personal Reasons|9|||
126745564|NCT02116361|456017703|FG000|Overall Study|Investigator Decision - Relapse|9|||
126745565|NCT02116361|456017704|FG001|Overall Study|Investigator Decision - Relapse|7|||
126745566|NCT02116361|456017705|FG002|Overall Study|Investigator Decision - Relapse|8|||
126745567|NCT02116361|456017706|FG003|Overall Study|Investigator Decision - Relapse|5|||
126745568|NCT03227224|456017707|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
126745569|NCT03227224|456017708|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
126745570|NCT03227224|456017709|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
126745571|NCT03227224|456017710|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
126745572|NCT03227224|456017707|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
126745573|NCT03227224|456017708|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
126745574|NCT03227224|456017709|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
126745575|NCT03227224|456017710|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
126745576|NCT03227224|456017707|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
126745577|NCT03227224|456017708|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
126745578|NCT03227224|456017709|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
126745579|NCT03227224|456017710|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
126745580|NCT03227224|456017707|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
126745581|NCT03227224|456017708|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126745582|NCT03227224|456017709|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126745583|NCT03227224|456017710|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
126745584|NCT03227224|456017707|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
126745585|NCT03227224|456017708|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
126745586|NCT03227224|456017709|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
126745587|NCT03227224|456017710|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
126745588|NCT03227224|456017707|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
126617028|NCT01307800|455555486|FG001|Overall Study|Adverse Event|8|||
126617029|NCT01307800|455555487|FG002|Overall Study|Adverse Event|10|||
126617030|NCT01307800|455555488|FG003|Overall Study|Adverse Event|14|||
126617031|NCT01307800|455555485|FG000|Overall Study|Entry Criteria Not Met|0|||
126617032|NCT01307800|455555486|FG001|Overall Study|Entry Criteria Not Met|0|||
126617033|NCT01307800|455555487|FG002|Overall Study|Entry Criteria Not Met|0|||
126617034|NCT01307800|455555488|FG003|Overall Study|Entry Criteria Not Met|2|||
126617035|NCT01307800|455555485|FG000|Overall Study|Lost to Follow-up|5|||
126617036|NCT01307800|455555486|FG001|Overall Study|Lost to Follow-up|6|||
126617037|NCT01307800|455555487|FG002|Overall Study|Lost to Follow-up|2|||
126617038|NCT01307800|455555488|FG003|Overall Study|Lost to Follow-up|8|||
126617039|NCT01307800|455555485|FG000|Overall Study|Perceived Lack of Efficacy|24|||
126617040|NCT01307800|455555486|FG001|Overall Study|Perceived Lack of Efficacy|23|||
126617041|NCT01307800|455555487|FG002|Overall Study|Perceived Lack of Efficacy|20|||
126617042|NCT01307800|455555488|FG003|Overall Study|Perceived Lack of Efficacy|33|||
126617043|NCT01307800|455555485|FG000|Overall Study|Protocol Violation|0|||
126617044|NCT01307800|455555486|FG001|Overall Study|Protocol Violation|3|||
126617045|NCT01307800|455555487|FG002|Overall Study|Protocol Violation|4|||
126617046|NCT01307800|455555488|FG003|Overall Study|Protocol Violation|5|||
126617047|NCT01307800|455555485|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
126617048|NCT01307800|455555486|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
126617049|NCT01307800|455555487|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
126617050|NCT01307800|455555488|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
126617051|NCT01307800|455555485|FG000|Overall Study|Sponsor Decision|6|||
126617052|NCT01307800|455555486|FG001|Overall Study|Sponsor Decision|9|||
126617053|NCT01307800|455555487|FG002|Overall Study|Sponsor Decision|12|||
126617054|NCT01307800|455555488|FG003|Overall Study|Sponsor Decision|28|||
126617055|NCT01307800|455555485|FG000|Overall Study|Withdrawal by Subject|10|||
126617056|NCT01307800|455555486|FG001|Overall Study|Withdrawal by Subject|11|||
126617057|NCT01307800|455555487|FG002|Overall Study|Withdrawal by Subject|8|||
126617058|NCT01307800|455555488|FG003|Overall Study|Withdrawal by Subject|15|||
126745589|NCT03227224|456017708|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
126617059|NCT01307800|455555485|FG000|Overall Study|Participant Moved|0|||
126617060|NCT01307800|455555486|FG001|Overall Study|Participant Moved|2|||
126617061|NCT01307800|455555487|FG002|Overall Study|Participant Moved|1|||
126617062|NCT01307800|455555488|FG003|Overall Study|Participant Moved|3|||
126617063|NCT00689351|455555489|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
126745590|NCT03227224|456017709|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
126745591|NCT03227224|456017710|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
126617064|NCT00689351|455555490|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
126617065|NCT00689351|455555489|FG000|Infant Series of Dosing|Adverse Event|1|||
126617066|NCT00689351|455555490|FG001|Infant Series of Dosing|Adverse Event|0|||
126617067|NCT00689351|455555489|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
126617068|NCT00689351|455555490|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
126617069|NCT00689351|455555489|FG000|After Infant Series|Parent/legal guardian request|1|||
126745592|NCT03227224|456017707|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
126745593|NCT03227224|456017708|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
126745594|NCT03227224|456017709|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
126745595|NCT03227224|456017710|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
126745596|NCT03227224|456017707|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
126745597|NCT03227224|456017708|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
126745598|NCT03227224|456017709|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
126745599|NCT03227224|456017710|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
126745600|NCT03227224|456017707|FG000|Follow-up Phase (2 Weeks)|Other|4|||
126745601|NCT03227224|456017708|FG001|Follow-up Phase (2 Weeks)|Other|4|||
126745602|NCT03227224|456017709|FG002|Follow-up Phase (2 Weeks)|Other|6|||
126745603|NCT03227224|456017710|FG003|Follow-up Phase (2 Weeks)|Other|3|||
126745604|NCT04195750|456017711|FG000|Overall Study|Death|245|||
126745605|NCT04195750|456017712|FG001|Overall Study|Death|253|||
126745606|NCT04195750|456017713|FG002|Overall Study|Death|5|||
126745607|NCT04195750|456017711|FG000|Overall Study|Physician Decision|0|||
126745608|NCT04195750|456017712|FG001|Overall Study|Physician Decision|1|||
126745609|NCT04195750|456017713|FG002|Overall Study|Physician Decision|0|||
126745610|NCT04195750|456017711|FG000|Overall Study|Withdrawal by Subject|9|||
126745611|NCT04195750|456017712|FG001|Overall Study|Withdrawal by Subject|8|||
126745612|NCT04195750|456017713|FG002|Overall Study|Withdrawal by Subject|0|||
126745613|NCT04195750|456017711|FG000|Overall Study|Ongoing|120|||
126745614|NCT04195750|456017712|FG001|Overall Study|Ongoing|110|||
126745615|NCT04195750|456017713|FG002|Overall Study|Ongoing|4|||
126745616|NCT02406027|456017714|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
126745617|NCT02406027|456017715|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
126745618|NCT02406027|456017716|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
126745619|NCT02406027|456017717|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
126745620|NCT02406027|456017718|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
126745621|NCT02406027|456017719|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
126745622|NCT02406027|456017720|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
126745623|NCT02406027|456017714|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
126745624|NCT02406027|456017715|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
126745625|NCT02406027|456017716|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
126745626|NCT02406027|456017717|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
126745627|NCT02406027|456017718|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
126745628|NCT02406027|456017719|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
126745629|NCT02406027|456017720|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
126745630|NCT02406027|456017714|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
126745631|NCT02406027|456017715|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
126745632|NCT02406027|456017716|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
126745633|NCT02406027|456017717|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
126745634|NCT02406027|456017718|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
126745635|NCT02406027|456017719|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
126745636|NCT02406027|456017720|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
126745637|NCT02406027|456017714|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
126745638|NCT02406027|456017715|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
126745639|NCT02406027|456017716|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
126745640|NCT02406027|456017717|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
126745641|NCT02406027|456017718|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
126745642|NCT02406027|456017719|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
126745643|NCT02406027|456017720|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
126745644|NCT02406027|456017714|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
126745645|NCT02406027|456017715|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
126745646|NCT02406027|456017716|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
126745647|NCT02406027|456017717|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
126617070|NCT00689351|455555490|FG001|After Infant Series|Parent/legal guardian request|0|||
126617071|NCT01662505|455555491|FG000|Overall Study|Progressive disease|6|||
126617072|NCT01662505|455555492|FG001|Overall Study|Progressive disease|1|||
126617073|NCT01662505|455555493|FG002|Overall Study|Progressive disease|5|||
126781863|NCT01688037|456156289|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
126781864|NCT01688037|456156290|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
126781865|NCT01688037|456156291|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
126781866|NCT01688037|456156289|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
126617074|NCT01662505|455555491|FG000|Overall Study|Refused cont. medication|0|||
126617075|NCT01662505|455555492|FG001|Overall Study|Refused cont. medication|0|||
126617076|NCT01662505|455555493|FG002|Overall Study|Refused cont. medication|1|||
126617077|NCT01662505|455555491|FG000|Overall Study|Not specified above|1|||
126617078|NCT01662505|455555492|FG001|Overall Study|Not specified above|3|||
126617079|NCT01662505|455555493|FG002|Overall Study|Not specified above|2|||
126617080|NCT01229176|455555494|FG000|Overall Study|Withdrawal by Subject|0|||
126617081|NCT01229176|455555495|FG001|Overall Study|Withdrawal by Subject|0|||
126617082|NCT01229176|455555496|FG002|Overall Study|Withdrawal by Subject|0|||
126617083|NCT01229176|455555497|FG003|Overall Study|Withdrawal by Subject|1|||
126617084|NCT01229176|455555498|FG004|Overall Study|Withdrawal by Subject|1|||
126617085|NCT01229176|455555499|FG005|Overall Study|Withdrawal by Subject|1|||
126617086|NCT01229176|455555500|FG006|Overall Study|Withdrawal by Subject|0|||
126617087|NCT01229176|455555501|FG007|Overall Study|Withdrawal by Subject|1|||
126617088|NCT01229176|455555494|FG000|Overall Study|Lost to Follow-up|0|||
126617089|NCT01229176|455555495|FG001|Overall Study|Lost to Follow-up|3|||
126617090|NCT01229176|455555496|FG002|Overall Study|Lost to Follow-up|0|||
126617091|NCT01229176|455555497|FG003|Overall Study|Lost to Follow-up|0|||
126617092|NCT01229176|455555498|FG004|Overall Study|Lost to Follow-up|1|||
126617093|NCT01229176|455555499|FG005|Overall Study|Lost to Follow-up|1|||
126617094|NCT01229176|455555500|FG006|Overall Study|Lost to Follow-up|0|||
126617095|NCT01229176|455555501|FG007|Overall Study|Lost to Follow-up|2|||
126617096|NCT00882050|455555509|FG000|Overall Study|Physician Decision|1|||
126617097|NCT00882050|455555510|FG001|Overall Study|Physician Decision|0|||
126617098|NCT00882050|455555511|FG002|Overall Study|Physician Decision|0|||
126617099|NCT02367794|455555512|FG000|Overall Study|Death|252|||
126617100|NCT02367794|455555513|FG001|Overall Study|Death|245|||
126617101|NCT02367794|455555514|FG002|Overall Study|Death|243|||
126617102|NCT02367794|455555512|FG000|Overall Study|Lost to Follow-up|1|||
126617103|NCT02367794|455555513|FG001|Overall Study|Lost to Follow-up|2|||
126617104|NCT02367794|455555514|FG002|Overall Study|Lost to Follow-up|2|||
126617105|NCT02367794|455555512|FG000|Overall Study|Physician Decision|0|||
126617106|NCT02367794|455555513|FG001|Overall Study|Physician Decision|5|||
126617107|NCT02367794|455555514|FG002|Overall Study|Physician Decision|3|||
126617108|NCT02367794|455555512|FG000|Overall Study|Protocol Violation|1|||
126617109|NCT02367794|455555513|FG001|Overall Study|Protocol Violation|0|||
126617110|NCT02367794|455555514|FG002|Overall Study|Protocol Violation|1|||
126617111|NCT02367794|455555512|FG000|Overall Study|Withdrawal by Subject|25|||
126617112|NCT02367794|455555513|FG001|Overall Study|Withdrawal by Subject|12|||
126617113|NCT02367794|455555514|FG002|Overall Study|Withdrawal by Subject|20|||
126617114|NCT02367794|455555512|FG000|Overall Study|Brain metastasis|1|||
126617115|NCT02367794|455555513|FG001|Overall Study|Brain metastasis|0|||
126617116|NCT02367794|455555514|FG002|Overall Study|Brain metastasis|0|||
126617117|NCT02367794|455555512|FG000|Overall Study|Randomized in error|0|||
126617118|NCT02367794|455555513|FG001|Overall Study|Randomized in error|0|||
126617119|NCT02367794|455555514|FG002|Overall Study|Randomized in error|1|||
126617120|NCT02367794|455555512|FG000|Overall Study|Patient unable to receive carboplatin|0|||
126617121|NCT02367794|455555513|FG001|Overall Study|Patient unable to receive carboplatin|0|||
126617122|NCT02367794|455555514|FG002|Overall Study|Patient unable to receive carboplatin|1|||
126617123|NCT02367794|455555512|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
126617124|NCT02367794|455555513|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
126617125|NCT02367794|455555514|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
126617126|NCT02367794|455555512|FG000|Overall Study|Adverse Event|0|||
126617127|NCT02367794|455555513|FG001|Overall Study|Adverse Event|0|||
126617128|NCT02367794|455555514|FG002|Overall Study|Adverse Event|2|||
126617129|NCT02367794|455555512|FG000|Overall Study|Study Terminated By Sponsor|0|||
126617130|NCT02367794|455555513|FG001|Overall Study|Study Terminated By Sponsor|1|||
126617131|NCT02367794|455555514|FG002|Overall Study|Study Terminated By Sponsor|1|||
126617132|NCT02367794|455555512|FG000|Overall Study|Moved to Roll-Over Study|0|||
126617133|NCT02367794|455555513|FG001|Overall Study|Moved to Roll-Over Study|15|||
126781867|NCT01688037|456156290|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
126781868|NCT01688037|456156291|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
126781869|NCT01688037|456156289|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
126617134|NCT02367794|455555514|FG002|Overall Study|Moved to Roll-Over Study|13|||
126617135|NCT02367794|455555512|FG000|Overall Study|Sponsor Request|60|||
126617136|NCT02367794|455555513|FG001|Overall Study|Sponsor Request|57|||
126617137|NCT02367794|455555514|FG002|Overall Study|Sponsor Request|45|||
126617138|NCT02367794|455555512|FG000|Overall Study|Moved into PTAP Study|0|||
126617139|NCT02367794|455555513|FG001|Overall Study|Moved into PTAP Study|2|||
126617140|NCT02367794|455555514|FG002|Overall Study|Moved into PTAP Study|3|||
126617141|NCT02367794|455555512|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
126617142|NCT02367794|455555513|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
126617143|NCT02367794|455555514|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
126745648|NCT02406027|456017718|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
126745649|NCT02406027|456017719|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
126745650|NCT02406027|456017720|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
126745651|NCT02406027|456017714|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
126745652|NCT02406027|456017715|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
126745653|NCT02406027|456017716|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
126745654|NCT02406027|456017717|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
126745655|NCT02406027|456017718|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
126745656|NCT02406027|456017719|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
126745657|NCT02406027|456017720|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
126745658|NCT02406027|456017714|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
126745659|NCT02406027|456017715|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
126745660|NCT02406027|456017716|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
126745661|NCT02406027|456017717|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
126745662|NCT02406027|456017718|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
126745663|NCT02406027|456017719|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
126745664|NCT02406027|456017720|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
126745665|NCT02406027|456017714|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
126745666|NCT02406027|456017715|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
126745667|NCT02406027|456017716|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
126745668|NCT02406027|456017717|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
126745669|NCT02406027|456017718|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
126745670|NCT02406027|456017719|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
126745671|NCT02406027|456017720|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
126745672|NCT02406027|456017714|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
126745673|NCT02406027|456017715|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
126745674|NCT02406027|456017716|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
126745675|NCT02406027|456017717|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
126745676|NCT02406027|456017718|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
126745677|NCT02406027|456017719|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
126745678|NCT02406027|456017720|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
126745679|NCT02406027|456017714|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
126745680|NCT02406027|456017715|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
126745681|NCT02406027|456017716|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
126745682|NCT02406027|456017717|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
126745683|NCT02406027|456017718|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
126745684|NCT02406027|456017719|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
126745685|NCT02406027|456017720|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
126745686|NCT02497287|456017721|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
126745687|NCT02497287|456017721|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
126745688|NCT02497287|456017721|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
126745689|NCT02497287|456017721|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
126745690|NCT02497287|456017721|FG000|Induction Phase (4 Weeks)|Other|13|||
126745691|NCT02497287|456017721|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
126745692|NCT02497287|456017721|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
126745693|NCT02497287|456017721|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
126745694|NCT02497287|456017721|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
126745695|NCT02497287|456017721|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
126745696|NCT02497287|456017721|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
126745697|NCT02497287|456017721|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
126745698|NCT02497287|456017721|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
126745699|NCT02497287|456017721|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
126745700|NCT02497287|456017721|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
126745701|NCT02497287|456017721|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
126745702|NCT02497287|456017721|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
126745703|NCT02497287|456017721|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
126745704|NCT02497287|456017721|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
126745705|NCT02497287|456017721|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
126745706|NCT02497287|456017721|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
126745707|NCT02497287|456017721|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
126745708|NCT02497287|456017721|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
126745709|NCT02497287|456017721|FG000|Follow-up Phase (4 Week)|Other|1|||
126745710|NCT03559192|456017722|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
126745711|NCT03559192|456017723|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
126745712|NCT03559192|456017724|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
126745713|NCT03559192|456017722|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
126745714|NCT03559192|456017723|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
126745715|NCT03559192|456017724|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
126745716|NCT03559192|456017722|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
126745717|NCT03559192|456017723|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
126745718|NCT03559192|456017724|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
126745719|NCT03559192|456017722|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
126745720|NCT03559192|456017723|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
126745721|NCT03559192|456017724|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
126745722|NCT03559192|456017722|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
126745723|NCT03559192|456017723|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
126745724|NCT03559192|456017724|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
126745725|NCT03559192|456017722|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
126745726|NCT03559192|456017723|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
126745727|NCT03559192|456017724|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
126745728|NCT03559192|456017722|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
126745729|NCT03559192|456017723|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
126745730|NCT03559192|456017724|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
126745731|NCT03559192|456017722|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
126745732|NCT03559192|456017723|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
126745733|NCT03559192|456017724|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
126745734|NCT03559192|456017722|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
126745735|NCT03559192|456017723|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
126745736|NCT03559192|456017724|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
126745737|NCT03517722|456017725|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
126745738|NCT03517722|456017726|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
126745739|NCT03517722|456017725|FG000|Double Blind Period: Week 0-52|Death|0|||
126745740|NCT03517722|456017726|FG001|Double Blind Period: Week 0-52|Death|4|||
126745741|NCT03517722|456017725|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
126745742|NCT03517722|456017726|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
126745743|NCT03517722|456017725|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
126745744|NCT03517722|456017726|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
126745745|NCT03517722|456017725|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
126745746|NCT03517722|456017726|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
126745747|NCT03517722|456017725|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
126745748|NCT03517722|456017726|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
126745749|NCT03517722|456017725|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
126745750|NCT03517722|456017726|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
126745751|NCT03517722|456017725|FG000|Double Blind Period: Week 0-52|Other|4|||
126745752|NCT03517722|456017726|FG001|Double Blind Period: Week 0-52|Other|3|||
126745753|NCT03517722|456017725|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
126745754|NCT03517722|456017726|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
126745755|NCT03517722|456017725|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
126745756|NCT03517722|456017726|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
126745757|NCT03517722|456017725|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
126745758|NCT03517722|456017726|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
126745759|NCT03517722|456017725|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
126745760|NCT03517722|456017726|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
126745761|NCT03517722|456017725|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
126745762|NCT03517722|456017726|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
126745763|NCT02422186|456017727|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
126745764|NCT02422186|456017728|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
126745765|NCT02422186|456017727|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
126745766|NCT02422186|456017728|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
126745767|NCT02422186|456017727|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
126745768|NCT02422186|456017728|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
126745769|NCT02422186|456017727|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
126745770|NCT02422186|456017728|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
126745771|NCT02422186|456017727|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
126745772|NCT02422186|456017728|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
126745773|NCT02422186|456017727|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
126745774|NCT02422186|456017728|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
126745775|NCT02422186|456017727|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
126745776|NCT02422186|456017728|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
126745777|NCT02422186|456017727|FG000|Follow-up Phase (2 Weeks)|Other|3|||
126745778|NCT02422186|456017728|FG001|Follow-up Phase (2 Weeks)|Other|0|||
126745779|NCT03277794|456017733|FG000|Overall Study|Lost to Follow-up|2|||
126745780|NCT03277794|456017734|FG001|Overall Study|Lost to Follow-up|4|||
126745781|NCT03277794|456017733|FG000|Overall Study|Withdrew due to high acuity|1|||
126745782|NCT03277794|456017734|FG001|Overall Study|Withdrew due to high acuity|0|||
126745783|NCT03039569|456017738|FG000|Overall Study|Lost to Follow-up|5|||
126745784|NCT03039569|456017739|FG001|Overall Study|Lost to Follow-up|4|||
126745785|NCT02254304|456017740|FG000|Overall Study|Adverse Event|2|||
126745786|NCT02254304|456017741|FG001|Overall Study|Adverse Event|1|||
126745787|NCT02254304|456017740|FG000|Overall Study|Lost to Follow-up|2|||
126745788|NCT02254304|456017741|FG001|Overall Study|Lost to Follow-up|2|||
126745789|NCT02254304|456017740|FG000|Overall Study|Protocol Violation|1|||
126745790|NCT02254304|456017741|FG001|Overall Study|Protocol Violation|0|||
126745791|NCT02254304|456017740|FG000|Overall Study|Withdrawal by Subject|3|||
126745792|NCT02254304|456017741|FG001|Overall Study|Withdrawal by Subject|0|||
126745793|NCT02254304|456017740|FG000|Overall Study|Injection site pain and Injection fear|1|||
126745794|NCT02254304|456017741|FG001|Overall Study|Injection site pain and Injection fear|0|||
126745795|NCT02254304|456017740|FG000|Overall Study|Personal causes|4|||
126745796|NCT02254304|456017741|FG001|Overall Study|Personal causes|1|||
126745797|NCT02254304|456017740|FG000|Overall Study|Personal decision|1|||
126745798|NCT02254304|456017741|FG001|Overall Study|Personal decision|0|||
126745799|NCT01226472|456017742|FG000|Overall Study|Progressive Disease|1|||
126745800|NCT00952419|456017743|FG000|Overall Study|Adverse Event|2|||
126745801|NCT00952419|456017744|FG001|Overall Study|Adverse Event|0|||
126745802|NCT00952419|456017745|FG002|Overall Study|Adverse Event|0|||
126745803|NCT00952419|456017743|FG000|Overall Study|Protocol Violation|3|||
126745804|NCT00952419|456017744|FG001|Overall Study|Protocol Violation|7|||
126745805|NCT00952419|456017745|FG002|Overall Study|Protocol Violation|0|||
126745806|NCT00952419|456017743|FG000|Overall Study|Withdrawal by Subject|1|||
126745807|NCT00952419|456017744|FG001|Overall Study|Withdrawal by Subject|3|||
126745808|NCT00952419|456017745|FG002|Overall Study|Withdrawal by Subject|0|||
126745809|NCT03399786|456017746|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
126745810|NCT03399786|456017747|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126745811|NCT03399786|456017748|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126745812|NCT03399786|456017749|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
126745813|NCT03399786|456017746|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
126745814|NCT03399786|456017747|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
126745815|NCT03399786|456017748|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
126745816|NCT03399786|456017749|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
126745817|NCT03399786|456017746|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
126745818|NCT03399786|456017747|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
126745819|NCT03399786|456017748|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
126745820|NCT03399786|456017749|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
126745821|NCT04888507|456019578|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
126745822|NCT00400946|456019579|FG000|Overall Study|Ineligible|0|||
126745823|NCT00400946|456019580|FG001|Overall Study|Ineligible|0|||
126745824|NCT00400946|456019581|FG002|Overall Study|Ineligible|0|||
126745825|NCT00400946|456019582|FG003|Overall Study|Ineligible|5|||
126745826|NCT00400946|456019583|FG004|Overall Study|Ineligible|1|||
126745827|NCT00400946|456019579|FG000|Overall Study|Induction Failure|0|||
126745828|NCT00400946|456019580|FG001|Overall Study|Induction Failure|0|||
126745829|NCT00400946|456019581|FG002|Overall Study|Induction Failure|0|||
126745830|NCT00400946|456019582|FG003|Overall Study|Induction Failure|11|||
126745831|NCT00400946|456019583|FG004|Overall Study|Induction Failure|8|||
126745832|NCT00400946|456019579|FG000|Overall Study|Induction Death|0|||
126745833|NCT00400946|456019580|FG001|Overall Study|Induction Death|0|||
126745834|NCT00400946|456019581|FG002|Overall Study|Induction Death|0|||
126745835|NCT00400946|456019582|FG003|Overall Study|Induction Death|13|||
126745836|NCT00400946|456019583|FG004|Overall Study|Induction Death|3|||
126745837|NCT00400946|456019579|FG000|Overall Study|Lost to Follow-up|1|||
126745838|NCT00400946|456019580|FG001|Overall Study|Lost to Follow-up|1|||
126745839|NCT00400946|456019581|FG002|Overall Study|Lost to Follow-up|0|||
126745840|NCT00400946|456019582|FG003|Overall Study|Lost to Follow-up|0|||
126745841|NCT00400946|456019583|FG004|Overall Study|Lost to Follow-up|1|||
126745842|NCT00400946|456019579|FG000|Overall Study|Remission Death|1|||
126745843|NCT00400946|456019580|FG001|Overall Study|Remission Death|1|||
126745844|NCT00400946|456019581|FG002|Overall Study|Remission Death|0|||
126745845|NCT00400946|456019582|FG003|Overall Study|Remission Death|0|||
126745846|NCT00400946|456019583|FG004|Overall Study|Remission Death|1|||
126745847|NCT00400946|456019579|FG000|Overall Study|Relapse|9|||
126745848|NCT00400946|456019580|FG001|Overall Study|Relapse|2|||
126745849|NCT00400946|456019581|FG002|Overall Study|Relapse|1|||
126745850|NCT00400946|456019582|FG003|Overall Study|Relapse|1|||
126745851|NCT00400946|456019583|FG004|Overall Study|Relapse|5|||
126745852|NCT00400946|456019579|FG000|Overall Study|Transplant in CR1|0|||
126745853|NCT00400946|456019580|FG001|Overall Study|Transplant in CR1|0|||
126745854|NCT00400946|456019581|FG002|Overall Study|Transplant in CR1|0|||
126745855|NCT00400946|456019582|FG003|Overall Study|Transplant in CR1|10|||
126745856|NCT00400946|456019583|FG004|Overall Study|Transplant in CR1|1|||
126745857|NCT00400946|456019579|FG000|Overall Study|Withdrawal by Subject|2|||
126745858|NCT00400946|456019580|FG001|Overall Study|Withdrawal by Subject|5|||
126745859|NCT00400946|456019581|FG002|Overall Study|Withdrawal by Subject|1|||
126745860|NCT00400946|456019582|FG003|Overall Study|Withdrawal by Subject|5|||
126745861|NCT00400946|456019583|FG004|Overall Study|Withdrawal by Subject|8|||
126745862|NCT00400946|456019579|FG000|Overall Study|Clinical|1|||
126745863|NCT00400946|456019580|FG001|Overall Study|Clinical|2|||
126745864|NCT00400946|456019581|FG002|Overall Study|Clinical|0|||
126745865|NCT00400946|456019582|FG003|Overall Study|Clinical|2|||
126745866|NCT00400946|456019583|FG004|Overall Study|Clinical|9|||
126745867|NCT00400946|456019579|FG000|Overall Study|Other|0|||
126745868|NCT00400946|456019580|FG001|Overall Study|Other|0|||
126745869|NCT00400946|456019581|FG002|Overall Study|Other|0|||
126745870|NCT00400946|456019582|FG003|Overall Study|Other|0|||
126745871|NCT00400946|456019583|FG004|Overall Study|Other|1|||
126745872|NCT05643170|456019584|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
126745873|NCT05643170|456019584|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
126745874|NCT01673373|456019586|FG000|Overall Study|Death|2|||
126745875|NCT05426460|456019591|FG000|Overall Study|Protocol Violation|1|||
126745876|NCT05426460|456019592|FG001|Overall Study|Protocol Violation|1|||
126745877|NCT05426460|456019593|FG002|Overall Study|Protocol Violation|1|||
126745878|NCT05426460|456019594|FG003|Overall Study|Protocol Violation|0|||
126745879|NCT01431521|456019598|FG000|Overall Study|Withdrawal by Subject|0|||
126745880|NCT01431521|456019599|FG001|Overall Study|Withdrawal by Subject|0|||
126745881|NCT01431521|456019600|FG002|Overall Study|Withdrawal by Subject|1|||
126745882|NCT01431521|456019601|FG003|Overall Study|Withdrawal by Subject|0|||
126745883|NCT01572844|456019602|FG000|Overall Study|Physician Decision|1|||
126745884|NCT01572844|456019603|FG001|Overall Study|Physician Decision|1|||
126745885|NCT00366444|456019605|FG000|Overall Study|Withdrawal by Subject|1|||
126745886|NCT00366444|456019606|FG001|Overall Study|Withdrawal by Subject|1|||
126745887|NCT00366444|456019605|FG000|Overall Study|Lack of Efficacy|0|||
126745888|NCT00366444|456019606|FG001|Overall Study|Lack of Efficacy|1|||
126745889|NCT05171816|456019607|FG000|Overall Study|Death|18|||
126745890|NCT05171816|456019608|FG001|Overall Study|Death|16|||
126745891|NCT04667949|456019609|FG000|Overall Study|Adverse Event|0|||
126745892|NCT04667949|456019610|FG001|Overall Study|Adverse Event|2|||
126745893|NCT04667949|456019609|FG000|Overall Study|Lost to Follow-up|0|||
126745894|NCT04667949|456019610|FG001|Overall Study|Lost to Follow-up|1|||
126745895|NCT04667949|456019609|FG000|Overall Study|Physician Decision|0|||
126745896|NCT04667949|456019610|FG001|Overall Study|Physician Decision|2|||
126745897|NCT04667949|456019609|FG000|Overall Study|Subject decision|1|||
126745898|NCT04667949|456019610|FG001|Overall Study|Subject decision|7|||
126745899|NCT02000622|456019613|FG000|Overall Study|Withdrawal by Subject|5|||
126745900|NCT02000622|456019614|FG001|Overall Study|Withdrawal by Subject|7|||
126745901|NCT02000622|456019613|FG000|Overall Study|Lost to Follow-up|4|||
126745902|NCT02000622|456019614|FG001|Overall Study|Lost to Follow-up|0|||
126745903|NCT02000622|456019613|FG000|Overall Study|Death|159|||
126745904|NCT02000622|456019614|FG001|Overall Study|Death|73|||
126745905|NCT02000622|456019613|FG000|Overall Study|Withdrawn due to site closure|1|||
126745906|NCT02000622|456019614|FG001|Overall Study|Withdrawn due to site closure|0|||
126745907|NCT01405027|456019615|FG000|Overall Study|Withdrawn consent|3|||
126745908|NCT01405027|456019616|FG001|Overall Study|Withdrawn consent|0|||
126745909|NCT01405027|456019615|FG000|Overall Study|Lost to Follow-up|16|||
126745910|NCT01405027|456019616|FG001|Overall Study|Lost to Follow-up|24|||
126745911|NCT01405027|456019615|FG000|Overall Study|Investigator judgement|0|||
126745912|NCT01405027|456019616|FG001|Overall Study|Investigator judgement|2|||
126745913|NCT01405027|456019615|FG000|Overall Study|Death|1|||
126745914|NCT01405027|456019616|FG001|Overall Study|Death|0|||
126745915|NCT01405027|456019615|FG000|Overall Study|Other or Unknown|12|||
126745916|NCT01405027|456019616|FG001|Overall Study|Other or Unknown|25|||
126745917|NCT01320033|456019621|FG000|Overall Study|Lack of Efficacy|0|||
126745918|NCT01320033|456019622|FG001|Overall Study|Lack of Efficacy|0|||
126745919|NCT01320033|456019623|FG002|Overall Study|Lack of Efficacy|1|||
126745920|NCT01320033|456019621|FG000|Overall Study|Adverse Event|9|||
126745921|NCT01320033|456019622|FG001|Overall Study|Adverse Event|7|||
126745922|NCT01320033|456019623|FG002|Overall Study|Adverse Event|8|||
126745923|NCT01320033|456019621|FG000|Overall Study|Withdrawal by Subject|22|||
126745924|NCT01320033|456019622|FG001|Overall Study|Withdrawal by Subject|23|||
126745925|NCT01320033|456019623|FG002|Overall Study|Withdrawal by Subject|23|||
126745926|NCT01320033|456019621|FG000|Overall Study|Protocol Violation|3|||
126745927|NCT01320033|456019622|FG001|Overall Study|Protocol Violation|5|||
126745928|NCT01320033|456019623|FG002|Overall Study|Protocol Violation|3|||
126745929|NCT01320033|456019621|FG000|Overall Study|Lost to Follow-up|22|||
126745930|NCT01320033|456019622|FG001|Overall Study|Lost to Follow-up|26|||
126745931|NCT01320033|456019623|FG002|Overall Study|Lost to Follow-up|17|||
126745932|NCT01320033|456019621|FG000|Overall Study|Other|2|||
126745933|NCT01320033|456019622|FG001|Overall Study|Other|3|||
126745934|NCT01320033|456019623|FG002|Overall Study|Other|1|||
126745935|NCT00963469|456019624|FG000|Overall Study|Adverse Event|15|||
126745936|NCT00963469|456019625|FG001|Overall Study|Adverse Event|11|||
126745937|NCT00963469|456019626|FG002|Overall Study|Adverse Event|1|||
126745938|NCT00963469|456019624|FG000|Overall Study|Lack of Efficacy|10|||
126781870|NCT01688037|456156290|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
126640573|NCT00732992|455642812|FG001|Overall Study|Global Deterioration of Health Status|0|||
126640574|NCT00732992|455642811|FG000|Overall Study|Withdrawal by Subject|1|||
126640575|NCT00732992|455642812|FG001|Overall Study|Withdrawal by Subject|0|||
126640576|NCT03933462|455642815|FG000|Overall Study|Adverse Event|2|||
126640577|NCT03933462|455642816|FG001|Overall Study|Adverse Event|0|||
126640578|NCT00422734|455642822|FG000|Overall Study|Physician Decision|1|||
126640579|NCT00422734|455642823|FG001|Overall Study|Physician Decision|1|||
126640580|NCT00422734|455642822|FG000|Overall Study|Protocol Violation|1|||
126640581|NCT00422734|455642823|FG001|Overall Study|Protocol Violation|6|||
126640582|NCT00422734|455642822|FG000|Overall Study|Withdrawal by Subject|12|||
126640583|NCT00422734|455642823|FG001|Overall Study|Withdrawal by Subject|8|||
126640584|NCT00422734|455642822|FG000|Overall Study|Adverse Event|0|||
126640585|NCT00422734|455642823|FG001|Overall Study|Adverse Event|3|||
126640586|NCT00422734|455642822|FG000|Overall Study|Partner Decision|0|||
126640587|NCT00422734|455642823|FG001|Overall Study|Partner Decision|3|||
126640588|NCT00368875|455642827|FG000|Overall Study|Adverse Event|0|||
126640589|NCT00368875|455642828|FG001|Overall Study|Adverse Event|12|||
126640590|NCT00368875|455642827|FG000|Overall Study|Progressive disease|3|||
126640591|NCT00368875|455642828|FG001|Overall Study|Progressive disease|27|||
126640592|NCT00368875|455642827|FG000|Overall Study|Withdrawal by Subject|2|||
126640593|NCT00368875|455642828|FG001|Overall Study|Withdrawal by Subject|6|||
126640594|NCT00368875|455642827|FG000|Overall Study|Other Reason|0|||
126640595|NCT00368875|455642828|FG001|Overall Study|Other Reason|2|||
126640596|NCT00368875|455642827|FG000|Overall Study|Alternative Therapy|1|||
126640597|NCT00368875|455642828|FG001|Overall Study|Alternative Therapy|1|||
126640598|NCT03041792|455642835|FG000|Overall Study|Adverse Event|4|||
126640599|NCT03041792|455642836|FG001|Overall Study|Adverse Event|0|||
126640600|NCT03041792|455642835|FG000|Overall Study|Death in the family|0|||
126640601|NCT03041792|455642836|FG001|Overall Study|Death in the family|2|||
126640602|NCT03041792|455642835|FG000|Overall Study|Randomized but not treated|0|||
126640603|NCT03041792|455642836|FG001|Overall Study|Randomized but not treated|1|||
126640604|NCT04978090|455642837|FG000|Overall Study|unable to adequately fit device|2|||
126640605|NCT00996606|455642840|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
126640606|NCT00996606|455642840|FG000|Overall Study|Insufficient Therapeutic Response|2|||
126640607|NCT00996606|455642840|FG000|Overall Study|Protocol Violation|1|||
126640608|NCT00996606|455642840|FG000|Overall Study|Withdrawal by Subject|3|||
126640609|NCT00632502|455642842|FG000|Overall Study|Adverse Event|0|||
126640610|NCT00632502|455642843|FG001|Overall Study|Adverse Event|1|||
126640611|NCT00632502|455642842|FG000|Overall Study|Randomized not treated|3|||
126640612|NCT00632502|455642843|FG001|Overall Study|Randomized not treated|0|||
126640613|NCT03075527|455642844|FG000|Overall Study|Death|1|||
126640614|NCT03075527|455642844|FG000|Overall Study|Withdrawal by Subject|1|||
126640615|NCT03075527|455642844|FG000|Overall Study|Physician Decision|3|||
126640616|NCT03075527|455642844|FG000|Overall Study|Progression/Relapse|14|||
126640617|NCT00681668|455642845|FG000|Overall Study|Protocol Violation|1|||
126640618|NCT00681668|455642845|FG000|Overall Study|Withdrawal by Subject|1|||
126640619|NCT02209181|455642846|FG000|Overall Study|Adverse Event|1|||
126640620|NCT02209181|455642847|FG001|Overall Study|Adverse Event|0|||
126640621|NCT02209181|455642848|FG002|Overall Study|Adverse Event|1|||
126640622|NCT02209181|455642849|FG003|Overall Study|Adverse Event|0|||
126640623|NCT02209181|455642846|FG000|Overall Study|Withdrawal by Subject|0|||
126640624|NCT02209181|455642847|FG001|Overall Study|Withdrawal by Subject|1|||
126640625|NCT02209181|455642848|FG002|Overall Study|Withdrawal by Subject|0|||
126640626|NCT02209181|455642849|FG003|Overall Study|Withdrawal by Subject|0|||
126640627|NCT04641962|455642855|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
126640628|NCT04641962|455642856|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
126640629|NCT04641962|455642857|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
126640630|NCT04641962|455642858|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
126640631|NCT04641962|455642859|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
126640632|NCT04641962|455642855|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
126640633|NCT04641962|455642856|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
126640634|NCT04641962|455642857|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
126640635|NCT04641962|455642858|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
126640636|NCT04641962|455642859|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
126640637|NCT04641962|455642855|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
126640638|NCT04641962|455642856|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
126640639|NCT04641962|455642857|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
126640640|NCT04641962|455642858|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
126640641|NCT04641962|455642859|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
126640642|NCT04641962|455642855|FG000|DBT Period: Up to 52 Weeks|Death|1|||
126640643|NCT04641962|455642856|FG001|DBT Period: Up to 52 Weeks|Death|0|||
126640644|NCT04641962|455642857|FG002|DBT Period: Up to 52 Weeks|Death|0|||
126640645|NCT04641962|455642858|FG003|DBT Period: Up to 52 Weeks|Death|0|||
126745939|NCT00963469|456019625|FG001|Overall Study|Lack of Efficacy|7|||
126745940|NCT00963469|456019626|FG002|Overall Study|Lack of Efficacy|2|||
126745941|NCT00963469|456019624|FG000|Overall Study|Lost to Follow-up|1|||
126745942|NCT00963469|456019625|FG001|Overall Study|Lost to Follow-up|1|||
126745943|NCT00963469|456019626|FG002|Overall Study|Lost to Follow-up|0|||
126745944|NCT00963469|456019624|FG000|Overall Study|Protocol Violation|5|||
126745945|NCT00963469|456019625|FG001|Overall Study|Protocol Violation|5|||
126745946|NCT00963469|456019626|FG002|Overall Study|Protocol Violation|3|||
126745947|NCT00963469|456019624|FG000|Overall Study|Withdrawal by Subject|4|||
126745948|NCT00963469|456019625|FG001|Overall Study|Withdrawal by Subject|1|||
126745949|NCT00963469|456019626|FG002|Overall Study|Withdrawal by Subject|1|||
126745950|NCT00963469|456019624|FG000|Overall Study|Pre-randomization Adverse Event|1|||
126745951|NCT00963469|456019625|FG001|Overall Study|Pre-randomization Adverse Event|2|||
126745952|NCT00963469|456019626|FG002|Overall Study|Pre-randomization Adverse Event|0|||
126745953|NCT00963469|456019624|FG000|Overall Study|Moved|1|||
126745954|NCT00963469|456019625|FG001|Overall Study|Moved|0|||
126745955|NCT00963469|456019626|FG002|Overall Study|Moved|0|||
126745956|NCT00963469|456019624|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
126745957|NCT00963469|456019625|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
126745958|NCT00963469|456019626|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
126745959|NCT00673816|456019638|FG000|Overall Study|Adverse Event|1|||
126745960|NCT00673816|456019638|FG000|Overall Study|Withdrawal by Subject|1|||
126745961|NCT02234050|456019640|FG000|Overall Study|Lack of Efficacy|38|||
126745962|NCT02234050|456019641|FG001|Overall Study|Lack of Efficacy|22|||
126745963|NCT02234050|456019640|FG000|Overall Study|Adverse Event|13|||
126745964|NCT02234050|456019641|FG001|Overall Study|Adverse Event|1|||
126745965|NCT02234050|456019640|FG000|Overall Study|Withdrawal by Subject|4|||
126745966|NCT02234050|456019641|FG001|Overall Study|Withdrawal by Subject|2|||
126745967|NCT02234050|456019640|FG000|Overall Study|Sponsor's decision|6|||
126745968|NCT02234050|456019641|FG001|Overall Study|Sponsor's decision|0|||
126745969|NCT02365506|456019642|FG000|Overall Study|Investigator's Discretion|0|||
126745970|NCT02365506|456019643|FG001|Overall Study|Investigator's Discretion|0|||
126745971|NCT02365506|456019644|FG002|Overall Study|Investigator's Discretion|1|||
126745972|NCT01852591|456019646|FG000|Overall Study|Withdrawal by Subject|2|||
126745973|NCT01852591|456019646|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
126745974|NCT03728881|456019647|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
126745975|NCT03728881|456019648|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
126745976|NCT03728881|456019647|FG000|Enrolled and Received 1st Vaccination|Death|1|||
126745977|NCT03728881|456019648|FG001|Enrolled and Received 1st Vaccination|Death|1|||
126745978|NCT03728881|456019647|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
126745979|NCT03728881|456019648|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
126745980|NCT03728881|456019647|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
126745981|NCT03728881|456019648|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
126745982|NCT03728881|456019647|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
126745983|NCT03728881|456019648|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
126745984|NCT03728881|456019647|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
126745985|NCT03728881|456019648|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
126745986|NCT03728881|456019647|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
126745987|NCT03728881|456019648|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
126745988|NCT03728881|456019647|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
126745989|NCT03728881|456019648|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
126745990|NCT03728881|456019647|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
126745991|NCT03728881|456019648|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
126745992|NCT03728881|456019647|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
126745993|NCT03728881|456019648|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
126745994|NCT03728881|456019647|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
126745995|NCT03728881|456019648|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
126745996|NCT06073054|456019649|FG000|Overall Study|Withdrawal by Subject|2|||
126745997|NCT00413777|456019654|FG000|Fixed-dose Period|Lost to Follow-up|1|||
126745998|NCT00413777|456019655|FG001|Fixed-dose Period|Lost to Follow-up|1|||
126745999|NCT00413777|456019654|FG000|Fixed-dose Period|Adverse Event|2|||
126746000|NCT00413777|456019655|FG001|Fixed-dose Period|Adverse Event|1|||
126746001|NCT00413777|456019654|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
126746002|NCT00413777|456019655|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
126746003|NCT00413777|456019654|FG000|Fixed-dose Period|Withdrew Consent|0|||
126617144|NCT02367794|455555512|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
126617145|NCT02367794|455555513|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
126617146|NCT02367794|455555514|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
126781871|NCT01688037|456156291|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
126746004|NCT00413777|456019655|FG001|Fixed-dose Period|Withdrew Consent|1|||
126746005|NCT04088331|456019656|FG000|Overall Study|Lost to Follow-up|3|||
126746006|NCT04088331|456019656|FG000|Overall Study|Withdrawal by Subject|7|||
126746007|NCT04088331|456019656|FG000|Overall Study|Adverse Event|4|||
126746008|NCT05505734|456019657|FG000|Overall Study|Withdrawal by Subject|51|||
126746009|NCT05505734|456019658|FG001|Overall Study|Withdrawal by Subject|64|||
126746010|NCT05505734|456019657|FG000|Overall Study|Adverse Event|6|||
126746011|NCT05505734|456019658|FG001|Overall Study|Adverse Event|20|||
126746012|NCT05505734|456019657|FG000|Overall Study|Protocol Violation|8|||
126746013|NCT05505734|456019658|FG001|Overall Study|Protocol Violation|15|||
126746014|NCT05505734|456019657|FG000|Overall Study|Lack of therapeutic response|0|||
126746015|NCT05505734|456019658|FG001|Overall Study|Lack of therapeutic response|1|||
126746016|NCT05505734|456019657|FG000|Overall Study|Lost to Follow-up|247|||
126746017|NCT05505734|456019658|FG001|Overall Study|Lost to Follow-up|237|||
126746018|NCT05505734|456019657|FG000|Overall Study|Physician Decision|22|||
126746019|NCT05505734|456019658|FG001|Overall Study|Physician Decision|13|||
126746020|NCT05505734|456019657|FG000|Overall Study|Death|2|||
126746021|NCT05505734|456019658|FG001|Overall Study|Death|1|||
126746022|NCT05505734|456019657|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126746023|NCT05505734|456019658|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126746024|NCT05505734|456019657|FG000|Overall Study|Pregnancy|1|||
126746025|NCT05505734|456019658|FG001|Overall Study|Pregnancy|0|||
126746026|NCT05505734|456019657|FG000|Overall Study|Other|17|||
126746027|NCT05505734|456019658|FG001|Overall Study|Other|13|||
126746028|NCT00764322|456019659|FG000|Overall Study|Withdrawal by Subject|11|||
126746029|NCT00764322|456019659|FG000|Overall Study|No CYP2D6 genotyping|9|||
126746030|NCT00976963|456019662|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
126746031|NCT00976963|456019663|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
126746032|NCT00976963|456019662|FG000|Overall Study|administrative error|1|||
126746033|NCT00976963|456019663|FG001|Overall Study|administrative error|0|||
126746034|NCT00976963|456019662|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
126746035|NCT00976963|456019663|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
126746036|NCT02768103|456019666|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
126746037|NCT03369704|456019672|FG000|Treatment Epoch|technical problems|1|||
126746038|NCT03369704|456019673|FG001|Treatment Epoch|technical problems|0|||
126746039|NCT03369704|456019672|FG000|Treatment Epoch|Protocol Violation|1|||
126746040|NCT03369704|456019673|FG001|Treatment Epoch|Protocol Violation|0|||
126746041|NCT03369704|456019672|FG000|Treatment Epoch|Lost to Follow-up|0|||
126746042|NCT03369704|456019673|FG001|Treatment Epoch|Lost to Follow-up|1|||
126746043|NCT03369704|456019672|FG000|Treatment Epoch|Lack of Efficacy|0|||
126746044|NCT03369704|456019673|FG001|Treatment Epoch|Lack of Efficacy|2|||
126746045|NCT03369704|456019672|FG000|Treatment Epoch|Adverse Event|2|||
126746046|NCT03369704|456019673|FG001|Treatment Epoch|Adverse Event|0|||
126746047|NCT03369704|456019672|FG000|Follow-up Epoch|Lost to Follow-up|1|||
126746048|NCT03369704|456019673|FG001|Follow-up Epoch|Lost to Follow-up|0|||
126746049|NCT02348840|456019674|FG000|Overall Study|Withdrawal by Subject|2|||
126746050|NCT02348840|456019675|FG001|Overall Study|Withdrawal by Subject|1|||
126746051|NCT02348840|456019676|FG002|Overall Study|Withdrawal by Subject|0|||
126746052|NCT02348840|456019677|FG003|Overall Study|Withdrawal by Subject|0|||
126746053|NCT02148952|456019678|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
126746054|NCT02148952|456019679|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
126746055|NCT02148952|456019678|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
126746056|NCT02148952|456019679|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
126746057|NCT02148952|456019678|FG000|Follow-Up|Lost to Follow-up|219|||
126746058|NCT02148952|456019679|FG001|Follow-Up|Lost to Follow-up|231|||
126746059|NCT02148952|456019678|FG000|Follow-Up|Withdrawal by Subject|46|||
126746060|NCT02148952|456019679|FG001|Follow-Up|Withdrawal by Subject|48|||
126746061|NCT01025232|456019680|FG000|Overall Study|Study drug no longer available|3|||
126746062|NCT01025232|456019681|FG001|Overall Study|Study drug no longer available|6|||
126746063|NCT01263444|456019682|FG000|Overall Study|Adverse Event|8|||
126746064|NCT01263444|456019682|FG000|Overall Study|Withdrawal by Subject|1|||
126746065|NCT01263444|456019682|FG000|Overall Study|Protocol Violation|1|||
126746066|NCT02203916|456019686|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
126746067|NCT02203916|456019687|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
126746068|NCT02203916|456019688|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
126746069|NCT02203916|456019686|FG000|Overall Study|Major Protocol Deviation|1|||
126746070|NCT02203916|456019687|FG001|Overall Study|Major Protocol Deviation|1|||
126746071|NCT02203916|456019688|FG002|Overall Study|Major Protocol Deviation|0|||
126746072|NCT02203916|456019686|FG000|Overall Study|Lost to Follow-up|0|||
126746073|NCT02203916|456019687|FG001|Overall Study|Lost to Follow-up|1|||
126746074|NCT02203916|456019688|FG002|Overall Study|Lost to Follow-up|0|||
126746075|NCT02203916|456019686|FG000|Overall Study|Voluntary Withdrawal|3|||
126746076|NCT02203916|456019687|FG001|Overall Study|Voluntary Withdrawal|3|||
126746077|NCT02203916|456019688|FG002|Overall Study|Voluntary Withdrawal|8|||
126746078|NCT02203916|456019686|FG000|Overall Study|Lack of Efficacy|3|||
126746079|NCT02203916|456019687|FG001|Overall Study|Lack of Efficacy|0|||
126617147|NCT02367794|455555512|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
126617148|NCT02367794|455555513|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
126617149|NCT02367794|455555514|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
126617150|NCT02367794|455555512|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
126617151|NCT02367794|455555513|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
126617152|NCT02367794|455555514|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
126617153|NCT02010684|455555515|FG000|Overall Study|Lost to Follow-up|8|||
126746080|NCT02203916|456019688|FG002|Overall Study|Lack of Efficacy|0|||
126746081|NCT02203916|456019686|FG000|Overall Study|Reason Not Specified|0|||
126746082|NCT02203916|456019687|FG001|Overall Study|Reason Not Specified|2|||
126746083|NCT02203916|456019688|FG002|Overall Study|Reason Not Specified|1|||
126746084|NCT04043416|456019689|FG000|Washout|Change in health condition|0|||
126746085|NCT04043416|456019690|FG001|Washout|Change in health condition|1|||
126746086|NCT00414973|456019691|FG000|Overall Study|Withdrawal by Subject|14|||
126746087|NCT00414973|456019692|FG001|Overall Study|Withdrawal by Subject|4|||
126746088|NCT00414973|456019693|FG002|Overall Study|Withdrawal by Subject|1|||
126746089|NCT00414973|456019694|FG003|Overall Study|Withdrawal by Subject|0|||
126746090|NCT00414973|456019691|FG000|Overall Study|Adverse Event|10|||
126746091|NCT00414973|456019692|FG001|Overall Study|Adverse Event|0|||
126746092|NCT00414973|456019693|FG002|Overall Study|Adverse Event|1|||
126746093|NCT00414973|456019694|FG003|Overall Study|Adverse Event|0|||
126746094|NCT00414973|456019691|FG000|Overall Study|Protocol Violation|3|||
126746095|NCT00414973|456019692|FG001|Overall Study|Protocol Violation|4|||
126746096|NCT00414973|456019693|FG002|Overall Study|Protocol Violation|0|||
126746097|NCT00414973|456019694|FG003|Overall Study|Protocol Violation|0|||
126746098|NCT00414973|456019691|FG000|Overall Study|Lost to Follow-up|0|||
126746099|NCT00414973|456019692|FG001|Overall Study|Lost to Follow-up|2|||
126746100|NCT00414973|456019693|FG002|Overall Study|Lost to Follow-up|0|||
126746101|NCT00414973|456019694|FG003|Overall Study|Lost to Follow-up|0|||
126746102|NCT00414973|456019691|FG000|Overall Study|Sponsor Decision|1|||
126746103|NCT00414973|456019692|FG001|Overall Study|Sponsor Decision|0|||
126746104|NCT00414973|456019693|FG002|Overall Study|Sponsor Decision|0|||
126746105|NCT00414973|456019694|FG003|Overall Study|Sponsor Decision|0|||
126746106|NCT00414973|456019691|FG000|Overall Study|Death|0|||
126746107|NCT00414973|456019692|FG001|Overall Study|Death|0|||
126746108|NCT00414973|456019693|FG002|Overall Study|Death|1|||
126746109|NCT00414973|456019694|FG003|Overall Study|Death|0|||
126746110|NCT03236506|456019695|FG000|Overall Study|Death|1|||
126746111|NCT03236506|456019696|FG001|Overall Study|Death|1|||
126746112|NCT03236506|456019697|FG002|Overall Study|Death|1|||
126746113|NCT03236506|456019695|FG000|Overall Study|Withdrawal by Subject|3|||
126617154|NCT02010684|455555516|FG001|Overall Study|Lost to Follow-up|18|||
126617155|NCT02010684|455555515|FG000|Overall Study|Withdrawal by Subject|4|||
126617156|NCT02010684|455555516|FG001|Overall Study|Withdrawal by Subject|5|||
126617157|NCT01884571|455555521|FG000|Overall Study|Adverse Event|1|||
126617158|NCT01884571|455555521|FG000|Overall Study|Death|2|||
126617159|NCT01884571|455555521|FG000|Overall Study|Withdrawal by Subject|2|||
126617160|NCT01884571|455555521|FG000|Overall Study|Disease progression|3|||
126617161|NCT00091572|455555522|FG000|Overall Study|Lost to Follow-up|1|||
126617162|NCT00091572|455555523|FG001|Overall Study|Lost to Follow-up|1|||
126617163|NCT00091572|455555522|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
126617164|NCT00091572|455555523|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
126617165|NCT00091572|455555522|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
126617166|NCT00091572|455555523|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
126617167|NCT00091572|455555522|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
126617168|NCT00091572|455555523|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
126617169|NCT00091572|455555522|FG000|Overall Study|Other Reason|6|||
126617170|NCT00091572|455555523|FG001|Overall Study|Other Reason|13|||
126617171|NCT00091572|455555522|FG000|Overall Study|Ongoing (still on treatment)|8|||
126617172|NCT00091572|455555523|FG001|Overall Study|Ongoing (still on treatment)|12|||
126617173|NCT00091572|455555522|FG000|Overall Study|Major Protocol Violation|2|||
126617174|NCT00091572|455555523|FG001|Overall Study|Major Protocol Violation|0|||
126617175|NCT00091572|455555522|FG000|Overall Study|Toxicity (Related AE)|53|||
126617176|NCT00091572|455555523|FG001|Overall Study|Toxicity (Related AE)|9|||
126617177|NCT02942771|455555525|FG000|Overall Study|Adverse Event|1|||
126617178|NCT02942771|455555526|FG001|Overall Study|Adverse Event|0|||
126617179|NCT02942771|455555527|FG002|Overall Study|Adverse Event|0|||
126617180|NCT02942771|455555528|FG003|Overall Study|Adverse Event|0|||
126746114|NCT03236506|456019696|FG001|Overall Study|Withdrawal by Subject|3|||
126746115|NCT03236506|456019697|FG002|Overall Study|Withdrawal by Subject|4|||
126746116|NCT03236506|456019695|FG000|Overall Study|Did not initiate treatment|2|||
126746117|NCT03236506|456019696|FG001|Overall Study|Did not initiate treatment|1|||
126746118|NCT03236506|456019697|FG002|Overall Study|Did not initiate treatment|2|||
126746119|NCT01466062|456019698|FG000|Overall Study|Adverse Event|1|||
126746120|NCT01466062|456019698|FG000|Overall Study|Withdrawal by Subject|1|||
126746121|NCT02865928|456019699|FG000|Overall Study|Withdrawal by Subject|1|||
126746122|NCT02865928|456019700|FG001|Overall Study|Withdrawal by Subject|0|||
126746123|NCT02865928|456019699|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
126746124|NCT02865928|456019700|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
126746125|NCT02865928|456019699|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
126746126|NCT02865928|456019700|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
126746127|NCT03152110|456019701|FG000|Overall Study|Withdrawal by Subject|3|||
126746128|NCT03696576|456019702|FG000|Overall Study|Soreness of throat after therapy|1|||
126746129|NCT03696576|456019703|FG001|Overall Study|Soreness of throat after therapy|1|||
126746130|NCT03696576|456019702|FG000|Overall Study|Lost to Follow-up|2|||
126746131|NCT03696576|456019703|FG001|Overall Study|Lost to Follow-up|4|||
126746132|NCT00085644|456019706|FG000|Double-Blind Period|Adverse Event|5|||
126746133|NCT00085644|456019707|FG001|Double-Blind Period|Adverse Event|2|||
126746134|NCT00085644|456019708|FG002|Double-Blind Period|Adverse Event|0|||
126746135|NCT00085644|456019706|FG000|Double-Blind Period|Withdrawal by Subject|3|||
126746136|NCT00085644|456019707|FG001|Double-Blind Period|Withdrawal by Subject|0|||
126746137|NCT00085644|456019708|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126746138|NCT00085644|456019706|FG000|Double-Blind Period|Lost to Follow-up|2|||
126746139|NCT00085644|456019707|FG001|Double-Blind Period|Lost to Follow-up|1|||
126746140|NCT00085644|456019708|FG002|Double-Blind Period|Lost to Follow-up|0|||
126746141|NCT00085644|456019706|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
126746142|NCT00085644|456019707|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
126746143|NCT00085644|456019708|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
126746144|NCT00085644|456019706|FG000|Double-Blind Period|Contemplating pregnancy|1|||
126746145|NCT00085644|456019707|FG001|Double-Blind Period|Contemplating pregnancy|0|||
126746146|NCT00085644|456019708|FG002|Double-Blind Period|Contemplating pregnancy|0|||
126746147|NCT00085644|456019706|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
126746148|NCT00085644|456019707|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
126746149|NCT00085644|456019708|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
126746150|NCT00085644|456019706|FG000|Open-Label Period|Adverse Event|0|||
126746151|NCT00085644|456019707|FG001|Open-Label Period|Adverse Event|0|||
126746152|NCT00085644|456019708|FG002|Open-Label Period|Adverse Event|38|||
126746153|NCT00085644|456019706|FG000|Open-Label Period|Withdrawal by Subject|0|||
126746154|NCT00085644|456019707|FG001|Open-Label Period|Withdrawal by Subject|0|||
126746155|NCT00085644|456019708|FG002|Open-Label Period|Withdrawal by Subject|29|||
126746156|NCT00085644|456019706|FG000|Open-Label Period|Lost to Follow-up|0|||
126746157|NCT00085644|456019707|FG001|Open-Label Period|Lost to Follow-up|0|||
126746158|NCT00085644|456019708|FG002|Open-Label Period|Lost to Follow-up|13|||
126746159|NCT00085644|456019706|FG000|Open-Label Period|Lack of Efficacy|0|||
126746160|NCT00085644|456019707|FG001|Open-Label Period|Lack of Efficacy|0|||
126746161|NCT00085644|456019708|FG002|Open-Label Period|Lack of Efficacy|15|||
126746162|NCT00085644|456019706|FG000|Open-Label Period|Pregnancy|0|||
126746163|NCT00085644|456019707|FG001|Open-Label Period|Pregnancy|0|||
126746164|NCT00085644|456019708|FG002|Open-Label Period|Pregnancy|3|||
126746165|NCT00085644|456019706|FG000|Open-Label Period|Contemplating pregnancy|0|||
126746166|NCT00085644|456019707|FG001|Open-Label Period|Contemplating pregnancy|0|||
126746167|NCT00085644|456019708|FG002|Open-Label Period|Contemplating pregnancy|3|||
126746168|NCT00085644|456019706|FG000|Open-Label Period|Protocol Violation|0|||
126746169|NCT00085644|456019707|FG001|Open-Label Period|Protocol Violation|0|||
126746170|NCT00085644|456019708|FG002|Open-Label Period|Protocol Violation|4|||
126746171|NCT00085644|456019706|FG000|Open-Label Period|Personal reason|0|||
126746172|NCT00085644|456019707|FG001|Open-Label Period|Personal reason|0|||
126746173|NCT00085644|456019708|FG002|Open-Label Period|Personal reason|4|||
126746174|NCT03330106|456019709|FG000|Part A|Withdrawal by Subject|1|||
126746175|NCT03330106|456019710|FG001|Part A|Withdrawal by Subject|1|||
126746176|NCT03330106|456019711|FG002|Part A|Withdrawal by Subject|0|||
126746177|NCT03330106|456019712|FG003|Part A|Withdrawal by Subject|0|||
126746178|NCT03330106|456019709|FG000|Part A|Death|2|||
126746179|NCT03330106|456019710|FG001|Part A|Death|1|||
126746180|NCT03330106|456019711|FG002|Part A|Death|0|||
126746181|NCT03330106|456019712|FG003|Part A|Death|0|||
126746182|NCT03330106|456019709|FG000|Part A|Adverse Event|0|||
126746183|NCT03330106|456019710|FG001|Part A|Adverse Event|1|||
126746184|NCT03330106|456019711|FG002|Part A|Adverse Event|0|||
126746185|NCT03330106|456019712|FG003|Part A|Adverse Event|0|||
126746186|NCT03330106|456019709|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
126746187|NCT03330106|456019710|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
126746188|NCT03330106|456019711|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
126746189|NCT03330106|456019712|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
126746190|NCT03330106|456019709|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
126746191|NCT03330106|456019710|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
126746192|NCT03330106|456019711|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
126746193|NCT03330106|456019712|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
126746194|NCT03330106|456019709|FG000|Part A|Progressive Disease|0|||
126746195|NCT03330106|456019710|FG001|Part A|Progressive Disease|1|||
126746196|NCT03330106|456019711|FG002|Part A|Progressive Disease|0|||
126746197|NCT03330106|456019712|FG003|Part A|Progressive Disease|0|||
126746198|NCT03330106|456019709|FG000|Part B|Lost to Follow-up|0|||
126746199|NCT03330106|456019710|FG001|Part B|Lost to Follow-up|0|||
126746200|NCT03330106|456019711|FG002|Part B|Lost to Follow-up|0|||
126746201|NCT03330106|456019712|FG003|Part B|Lost to Follow-up|1|||
126746202|NCT03330106|456019709|FG000|Part B|Withdrawal by Subject|0|||
126746203|NCT03330106|456019710|FG001|Part B|Withdrawal by Subject|0|||
126746204|NCT03330106|456019711|FG002|Part B|Withdrawal by Subject|4|||
126746205|NCT03330106|456019712|FG003|Part B|Withdrawal by Subject|0|||
126746206|NCT03330106|456019709|FG000|Part B|Death|0|||
126746207|NCT03330106|456019710|FG001|Part B|Death|0|||
126746208|NCT03330106|456019711|FG002|Part B|Death|2|||
126746209|NCT03330106|456019712|FG003|Part B|Death|0|||
126746210|NCT03330106|456019709|FG000|Part B|Clinical Progression|0|||
126746211|NCT03330106|456019710|FG001|Part B|Clinical Progression|0|||
126746212|NCT03330106|456019711|FG002|Part B|Clinical Progression|1|||
126746213|NCT03330106|456019712|FG003|Part B|Clinical Progression|1|||
126746214|NCT03330106|456019709|FG000|Part B|Symptomatic Deterioration|0|||
126746215|NCT03330106|456019710|FG001|Part B|Symptomatic Deterioration|0|||
126746216|NCT03330106|456019711|FG002|Part B|Symptomatic Deterioration|0|||
126746217|NCT03330106|456019712|FG003|Part B|Symptomatic Deterioration|1|||
126746218|NCT03330106|456019709|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
126746219|NCT03330106|456019710|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
126746220|NCT03330106|456019711|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
126746221|NCT03330106|456019712|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
126746222|NCT03330106|456019709|FG000|Part B|Progressive Disease|0|||
126746223|NCT03330106|456019710|FG001|Part B|Progressive Disease|0|||
126746224|NCT03330106|456019711|FG002|Part B|Progressive Disease|11|||
126746225|NCT03330106|456019712|FG003|Part B|Progressive Disease|4|||
126746226|NCT02324049|456019714|FG000|Part C|Study terminated|11|||
126746227|NCT02829775|456019723|FG000|Overall Study|Death|1|||
126746228|NCT02829775|456019723|FG000|Overall Study|Withdrawal by Subject|3|||
126746229|NCT02829775|456019723|FG000|Overall Study|Disease remission|1|||
126746230|NCT01313039|456019730|FG000|Overall Study|Physician Decision|1|||
126746231|NCT01313039|456019730|FG000|Overall Study|Adverse Event|1|||
126746232|NCT03864627|456019731|FG000|Overall Study|Adverse Event|0|||
126746233|NCT03864627|456019732|FG001|Overall Study|Adverse Event|1|||
126746234|NCT03864627|456019731|FG000|Overall Study|Lack of Efficacy|0|||
126746235|NCT03864627|456019732|FG001|Overall Study|Lack of Efficacy|1|||
126746236|NCT03864627|456019731|FG000|Overall Study|Lost to Follow-up|0|||
126746237|NCT03864627|456019732|FG001|Overall Study|Lost to Follow-up|1|||
126746238|NCT03864627|456019731|FG000|Overall Study|Withdrawal by Subject|4|||
126746239|NCT03864627|456019732|FG001|Overall Study|Withdrawal by Subject|8|||
126746240|NCT03864627|456019731|FG000|Overall Study|Study terminated by sponsor|0|||
126746241|NCT03864627|456019732|FG001|Overall Study|Study terminated by sponsor|1|||
126746242|NCT01388491|456019733|FG000|Overall Study|Adverse Event|10|||
126746243|NCT01388491|456019734|FG001|Overall Study|Adverse Event|9|||
126746244|NCT01388491|456019733|FG000|Overall Study|Sponsor Request|9|||
126746245|NCT01388491|456019734|FG001|Overall Study|Sponsor Request|7|||
126746246|NCT01388491|456019733|FG000|Overall Study|Withdrawal by Subject|6|||
126746247|NCT01388491|456019734|FG001|Overall Study|Withdrawal by Subject|10|||
126746248|NCT01388491|456019733|FG000|Overall Study|Lost to Follow-up|4|||
126746249|NCT01388491|456019734|FG001|Overall Study|Lost to Follow-up|3|||
126746250|NCT01388491|456019733|FG000|Overall Study|Protocol Violation|2|||
126746251|NCT01388491|456019734|FG001|Overall Study|Protocol Violation|0|||
126746252|NCT01388491|456019733|FG000|Overall Study|Noncompliance|2|||
126746253|NCT01388491|456019734|FG001|Overall Study|Noncompliance|0|||
126746254|NCT01388491|456019733|FG000|Overall Study|Pregnancy|1|||
126746255|NCT01388491|456019734|FG001|Overall Study|Pregnancy|0|||
126746256|NCT00397891|456019735|FG000|Overall Study|Withdrawal by Subject|1|||
126746257|NCT00397891|456019736|FG001|Overall Study|Withdrawal by Subject|0|||
126746258|NCT00397891|456019737|FG002|Overall Study|Withdrawal by Subject|0|||
126746259|NCT00397891|456019738|FG003|Overall Study|Withdrawal by Subject|0|||
126746260|NCT00397891|456019739|FG004|Overall Study|Withdrawal by Subject|1|||
126746261|NCT03782376|456019742|FG000|Overall Study|Lost to Follow-up|2|||
126746262|NCT03782376|456019743|FG001|Overall Study|Lost to Follow-up|2|||
126746263|NCT03782376|456019742|FG000|Overall Study|Withdrawal by Subject|7|||
126746264|NCT03782376|456019743|FG001|Overall Study|Withdrawal by Subject|11|||
126746265|NCT03782376|456019742|FG000|Overall Study|Death|1|||
126746266|NCT03782376|456019743|FG001|Overall Study|Death|0|||
126746267|NCT03782376|456019742|FG000|Overall Study|Other|16|||
126746268|NCT03782376|456019743|FG001|Overall Study|Other|17|||
126746269|NCT02531633|456021875|FG000|Part A (52 Weeks)|Sponsor request|24|||
126746270|NCT02531633|456021876|FG001|Part A (52 Weeks)|Sponsor request|24|||
126746271|NCT02531633|456021877|FG002|Part A (52 Weeks)|Sponsor request|18|||
126746272|NCT02531633|456021878|FG003|Part A (52 Weeks)|Sponsor request|18|||
126746273|NCT02531633|456021879|FG004|Part A (52 Weeks)|Sponsor request|19|||
126746274|NCT02531633|456021880|FG005|Part A (52 Weeks)|Sponsor request|0|||
126746275|NCT02531633|456021881|FG006|Part A (52 Weeks)|Sponsor request|0|||
126746276|NCT02531633|456021882|FG007|Part A (52 Weeks)|Sponsor request|0|||
126746277|NCT02531633|456021883|FG008|Part A (52 Weeks)|Sponsor request|0|||
126746278|NCT02531633|456021884|FG009|Part A (52 Weeks)|Sponsor request|0|||
126746279|NCT02531633|456021875|FG000|Part A (52 Weeks)|Protocol Violation|1|||
126746280|NCT02531633|456021876|FG001|Part A (52 Weeks)|Protocol Violation|0|||
126746281|NCT02531633|456021877|FG002|Part A (52 Weeks)|Protocol Violation|0|||
126746282|NCT02531633|456021878|FG003|Part A (52 Weeks)|Protocol Violation|0|||
126746283|NCT02531633|456021879|FG004|Part A (52 Weeks)|Protocol Violation|0|||
126746284|NCT02531633|456021880|FG005|Part A (52 Weeks)|Protocol Violation|0|||
126746285|NCT02531633|456021881|FG006|Part A (52 Weeks)|Protocol Violation|0|||
126746286|NCT02531633|456021882|FG007|Part A (52 Weeks)|Protocol Violation|0|||
126746287|NCT02531633|456021883|FG008|Part A (52 Weeks)|Protocol Violation|0|||
126746288|NCT02531633|456021884|FG009|Part A (52 Weeks)|Protocol Violation|0|||
126746289|NCT02531633|456021875|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
126746290|NCT02531633|456021876|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
126746291|NCT02531633|456021877|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
126746292|NCT02531633|456021878|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
126746293|NCT02531633|456021879|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
126746294|NCT02531633|456021880|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
126746295|NCT02531633|456021881|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
126746296|NCT02531633|456021882|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
126746297|NCT02531633|456021883|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
126746298|NCT02531633|456021884|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
126746299|NCT02531633|456021875|FG000|Part A (52 Weeks)|Physician Decision|1|||
126746300|NCT02531633|456021876|FG001|Part A (52 Weeks)|Physician Decision|4|||
126746301|NCT02531633|456021877|FG002|Part A (52 Weeks)|Physician Decision|3|||
126746302|NCT02531633|456021878|FG003|Part A (52 Weeks)|Physician Decision|1|||
126746303|NCT02531633|456021879|FG004|Part A (52 Weeks)|Physician Decision|0|||
126746304|NCT02531633|456021880|FG005|Part A (52 Weeks)|Physician Decision|0|||
126746305|NCT02531633|456021881|FG006|Part A (52 Weeks)|Physician Decision|0|||
126746306|NCT02531633|456021882|FG007|Part A (52 Weeks)|Physician Decision|0|||
126746307|NCT02531633|456021883|FG008|Part A (52 Weeks)|Physician Decision|0|||
126746308|NCT02531633|456021884|FG009|Part A (52 Weeks)|Physician Decision|0|||
126746309|NCT02531633|456021875|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
126746310|NCT02531633|456021876|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
126746311|NCT02531633|456021877|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
126746312|NCT02531633|456021878|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
126746313|NCT02531633|456021879|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
126746314|NCT02531633|456021880|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
126746315|NCT02531633|456021881|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
126746316|NCT02531633|456021882|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
126746317|NCT02531633|456021883|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
126746318|NCT02531633|456021884|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
126746319|NCT02531633|456021875|FG000|Part A (52 Weeks)|Other|2|||
126746320|NCT02531633|456021876|FG001|Part A (52 Weeks)|Other|0|||
126746321|NCT02531633|456021877|FG002|Part A (52 Weeks)|Other|0|||
126746322|NCT02531633|456021878|FG003|Part A (52 Weeks)|Other|0|||
126746323|NCT02531633|456021879|FG004|Part A (52 Weeks)|Other|0|||
126746324|NCT02531633|456021880|FG005|Part A (52 Weeks)|Other|0|||
126746325|NCT02531633|456021881|FG006|Part A (52 Weeks)|Other|0|||
126746326|NCT02531633|456021882|FG007|Part A (52 Weeks)|Other|0|||
126746327|NCT02531633|456021883|FG008|Part A (52 Weeks)|Other|0|||
126746328|NCT02531633|456021884|FG009|Part A (52 Weeks)|Other|0|||
126617181|NCT02942771|455555529|FG004|Overall Study|Adverse Event|2|||
126617182|NCT02942771|455555525|FG000|Overall Study|Lost to Follow-up|1|||
126781872|NCT01688037|456156289|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
126781873|NCT01688037|456156290|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
126746329|NCT02531633|456021875|FG000|Part B (104 Weeks)|Sponsor request|0|||
126746330|NCT02531633|456021876|FG001|Part B (104 Weeks)|Sponsor request|0|||
126746331|NCT02531633|456021877|FG002|Part B (104 Weeks)|Sponsor request|0|||
126617183|NCT02942771|455555526|FG001|Overall Study|Lost to Follow-up|0|||
126746332|NCT02531633|456021878|FG003|Part B (104 Weeks)|Sponsor request|0|||
126746333|NCT02531633|456021879|FG004|Part B (104 Weeks)|Sponsor request|0|||
126781874|NCT01688037|456156291|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
126617184|NCT02942771|455555527|FG002|Overall Study|Lost to Follow-up|0|||
126746334|NCT02531633|456021880|FG005|Part B (104 Weeks)|Sponsor request|8|||
126746335|NCT02531633|456021881|FG006|Part B (104 Weeks)|Sponsor request|5|||
126746336|NCT02531633|456021882|FG007|Part B (104 Weeks)|Sponsor request|3|||
126746337|NCT02531633|456021883|FG008|Part B (104 Weeks)|Sponsor request|5|||
126746338|NCT02531633|456021884|FG009|Part B (104 Weeks)|Sponsor request|4|||
126746339|NCT02531633|456021875|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
126746340|NCT02531633|456021876|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
126746341|NCT02531633|456021877|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
126746342|NCT02531633|456021878|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
126746343|NCT02531633|456021879|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
126746344|NCT02531633|456021880|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
126746345|NCT02531633|456021881|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
126746346|NCT02531633|456021882|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
126746347|NCT02531633|456021883|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
126746348|NCT02531633|456021884|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
126746349|NCT04960202|456021893|FG000|Overall Study|Other|5|||
126746350|NCT04960202|456021894|FG001|Overall Study|Other|0|||
126746351|NCT04960202|456021893|FG000|Overall Study|Withdrawal by Subject|37|||
126746352|NCT04960202|456021894|FG001|Overall Study|Withdrawal by Subject|43|||
126746353|NCT04960202|456021893|FG000|Overall Study|Lost to Follow-up|20|||
126746354|NCT04960202|456021894|FG001|Overall Study|Lost to Follow-up|16|||
126746355|NCT04960202|456021893|FG000|Overall Study|Death|0|||
126746356|NCT04960202|456021894|FG001|Overall Study|Death|15|||
126746357|NCT03558828|456021898|FG000|Overall Study|Lost to Follow-up|4|||
126746358|NCT03558828|456021899|FG001|Overall Study|Lost to Follow-up|3|||
126746359|NCT03558828|456021900|FG002|Overall Study|Lost to Follow-up|3|||
126746360|NCT03558828|456021901|FG003|Overall Study|Lost to Follow-up|5|||
126746361|NCT03558828|456021902|FG004|Overall Study|Lost to Follow-up|2|||
126746362|NCT03558828|456021903|FG005|Overall Study|Lost to Follow-up|3|||
126746363|NCT03558828|456021898|FG000|Overall Study|dropped before the intervention|1|||
126746364|NCT03558828|456021899|FG001|Overall Study|dropped before the intervention|1|||
126746365|NCT03558828|456021900|FG002|Overall Study|dropped before the intervention|0|||
126746366|NCT03558828|456021901|FG003|Overall Study|dropped before the intervention|0|||
126746367|NCT03558828|456021902|FG004|Overall Study|dropped before the intervention|0|||
126746368|NCT03558828|456021903|FG005|Overall Study|dropped before the intervention|0|||
126746369|NCT03671148|456021909|FG000|Overall Study|Adverse Event|3|||
126746370|NCT03671148|456021910|FG001|Overall Study|Adverse Event|2|||
126746371|NCT03671148|456021909|FG000|Overall Study|Withdrawal by Subject|8|||
126746372|NCT03671148|456021910|FG001|Overall Study|Withdrawal by Subject|2|||
126746373|NCT03671148|456021909|FG000|Overall Study|Lost to Follow-up|1|||
126746374|NCT03671148|456021910|FG001|Overall Study|Lost to Follow-up|2|||
126746375|NCT03671148|456021909|FG000|Overall Study|Lack of Efficacy|7|||
126746376|NCT03671148|456021910|FG001|Overall Study|Lack of Efficacy|2|||
126746377|NCT03671148|456021909|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
126746378|NCT03671148|456021910|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
126746379|NCT03671148|456021909|FG000|Overall Study|Other|1|||
126746380|NCT03671148|456021910|FG001|Overall Study|Other|0|||
126746381|NCT03671148|456021909|FG000|Overall Study|Incomplete Randomization Visit|1|||
126746382|NCT03671148|456021910|FG001|Overall Study|Incomplete Randomization Visit|0|||
126746383|NCT02155712|456021920|FG000|Overall Study|Death|12|||
126746384|NCT02155712|456021921|FG001|Overall Study|Death|0|||
126746385|NCT02155712|456021920|FG000|Overall Study|Lost to Follow-up|37|||
126746386|NCT02155712|456021921|FG001|Overall Study|Lost to Follow-up|22|||
126746387|NCT02155712|456021920|FG000|Overall Study|Revision of device|4|||
126746388|NCT02155712|456021921|FG001|Overall Study|Revision of device|3|||
126746389|NCT02155712|456021920|FG000|Overall Study|Withdrawal by Subject|39|||
126746390|NCT02155712|456021921|FG001|Overall Study|Withdrawal by Subject|21|||
126746391|NCT02155712|456021920|FG000|Overall Study|Site termination|77|||
126746392|NCT02155712|456021921|FG001|Overall Study|Site termination|19|||
126746393|NCT02155712|456021920|FG000|Overall Study|Sponsor terminated study early|150|||
126746394|NCT02155712|456021921|FG001|Overall Study|Sponsor terminated study early|0|||
126746395|NCT02155712|456021920|FG000|Overall Study|Missed final 5-year protocol visit|0|||
126746396|NCT02155712|456021921|FG001|Overall Study|Missed final 5-year protocol visit|32|||
126746397|NCT02155712|456021920|FG000|Overall Study|Censored because surgery cancelled|6|||
126746398|NCT02155712|456021921|FG001|Overall Study|Censored because surgery cancelled|10|||
126746399|NCT02155712|456021920|FG000|Overall Study|Censored because study device was not implanted|61|||
126746400|NCT02155712|456021921|FG001|Overall Study|Censored because study device was not implanted|66|||
126746401|NCT02155712|456021920|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
126746402|NCT02155712|456021921|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
126746403|NCT02756845|456021927|FG000|Overall Study|Death|12|||
126746404|NCT02756845|456021928|FG001|Overall Study|Death|2|||
126746405|NCT02756845|456021927|FG000|Overall Study|Withdrawal by Subject|1|||
126746406|NCT02756845|456021928|FG001|Overall Study|Withdrawal by Subject|0|||
126746407|NCT01688999|456021929|FG000|Overall Study|Withdrawal by Subject|5|||
126746408|NCT01688999|456021930|FG001|Overall Study|Withdrawal by Subject|1|||
126746409|NCT01688999|456021931|FG002|Overall Study|Withdrawal by Subject|1|||
126746410|NCT01688999|456021929|FG000|Overall Study|Adverse Event|2|||
126746411|NCT01688999|456021930|FG001|Overall Study|Adverse Event|0|||
126746412|NCT01688999|456021931|FG002|Overall Study|Adverse Event|2|||
126746413|NCT01688999|456021929|FG000|Overall Study|Ineligible/Not treated|1|||
126746414|NCT01688999|456021930|FG001|Overall Study|Ineligible/Not treated|0|||
126746415|NCT01688999|456021931|FG002|Overall Study|Ineligible/Not treated|0|||
126746416|NCT03198728|456021949|FG000|Overall Study|Adverse Event|10|||
126746417|NCT03198728|456021950|FG001|Overall Study|Adverse Event|5|||
126746418|NCT03198728|456021949|FG000|Overall Study|Lost to Follow-up|21|||
126746419|NCT03198728|456021950|FG001|Overall Study|Lost to Follow-up|7|||
126746420|NCT03198728|456021949|FG000|Overall Study|Physician Decision|7|||
126746421|NCT03198728|456021950|FG001|Overall Study|Physician Decision|2|||
126746422|NCT03198728|456021949|FG000|Overall Study|Withdrawal by Subject|14|||
126746423|NCT03198728|456021950|FG001|Overall Study|Withdrawal by Subject|10|||
126746424|NCT04051944|456021951|FG000|Overall Study|Study ending|1|||
126746425|NCT04051944|456021952|FG001|Overall Study|Study ending|1|||
126746426|NCT04051944|456021951|FG000|Overall Study|Early study termination by participant|1|||
126746427|NCT04051944|456021952|FG001|Overall Study|Early study termination by participant|0|||
126746428|NCT04051944|456021951|FG000|Overall Study|Withdrawal by Subject|2|||
126746429|NCT04051944|456021952|FG001|Overall Study|Withdrawal by Subject|2|||
126746430|NCT04051944|456021951|FG000|Overall Study|Lack of Efficacy|3|||
126746431|NCT04051944|456021952|FG001|Overall Study|Lack of Efficacy|0|||
126617185|NCT02942771|455555528|FG003|Overall Study|Lost to Follow-up|0|||
126617186|NCT02942771|455555529|FG004|Overall Study|Lost to Follow-up|0|||
126617187|NCT02942771|455555525|FG000|Overall Study|Withdrawal by Subject|1|||
126617188|NCT02942771|455555526|FG001|Overall Study|Withdrawal by Subject|0|||
126617189|NCT02942771|455555527|FG002|Overall Study|Withdrawal by Subject|0|||
126617190|NCT02942771|455555528|FG003|Overall Study|Withdrawal by Subject|0|||
126617191|NCT02942771|455555529|FG004|Overall Study|Withdrawal by Subject|2|||
126617192|NCT01186809|455555533|FG000|Overall Study|Death|30|||
126617193|NCT04895085|455555534|FG000|Overall Study|Death|1|||
126617194|NCT04895085|455555534|FG000|Overall Study|Withdrawal by Subject|1|||
126617195|NCT04895085|455555534|FG000|Overall Study|No longer eligible: Moved from area|1|||
126617196|NCT01159600|455555536|FG000|Overall Study|Not treated|0|||
126617197|NCT01159600|455555537|FG001|Overall Study|Not treated|0|||
126617198|NCT01159600|455555538|FG002|Overall Study|Not treated|1|||
126617199|NCT01159600|455555539|FG003|Overall Study|Not treated|0|||
126617200|NCT01159600|455555540|FG004|Overall Study|Not treated|0|||
126617201|NCT01159600|455555541|FG005|Overall Study|Not treated|1|||
126617202|NCT01159600|455555542|FG006|Overall Study|Not treated|2|||
126617203|NCT01159600|455555543|FG007|Overall Study|Not treated|2|||
126617204|NCT01159600|455555536|FG000|Overall Study|Adverse Event|7|||
126617205|NCT01159600|455555537|FG001|Overall Study|Adverse Event|2|||
126617206|NCT01159600|455555538|FG002|Overall Study|Adverse Event|5|||
126617207|NCT01159600|455555539|FG003|Overall Study|Adverse Event|1|||
126617208|NCT01159600|455555540|FG004|Overall Study|Adverse Event|8|||
126617209|NCT01159600|455555541|FG005|Overall Study|Adverse Event|6|||
126617210|NCT01159600|455555542|FG006|Overall Study|Adverse Event|7|||
126617211|NCT01159600|455555543|FG007|Overall Study|Adverse Event|5|||
126617212|NCT01159600|455555536|FG000|Overall Study|Lack of Efficacy|0|||
126617213|NCT01159600|455555537|FG001|Overall Study|Lack of Efficacy|0|||
126617214|NCT01159600|455555538|FG002|Overall Study|Lack of Efficacy|0|||
126617215|NCT01159600|455555539|FG003|Overall Study|Lack of Efficacy|0|||
126617216|NCT01159600|455555540|FG004|Overall Study|Lack of Efficacy|2|||
126617217|NCT01159600|455555541|FG005|Overall Study|Lack of Efficacy|0|||
126617218|NCT01159600|455555542|FG006|Overall Study|Lack of Efficacy|0|||
126617219|NCT01159600|455555543|FG007|Overall Study|Lack of Efficacy|1|||
126617220|NCT01159600|455555536|FG000|Overall Study|Non compliant with protocol|2|||
126617221|NCT01159600|455555537|FG001|Overall Study|Non compliant with protocol|1|||
126617222|NCT01159600|455555538|FG002|Overall Study|Non compliant with protocol|0|||
126617223|NCT01159600|455555539|FG003|Overall Study|Non compliant with protocol|0|||
126617224|NCT01159600|455555540|FG004|Overall Study|Non compliant with protocol|2|||
126617225|NCT01159600|455555541|FG005|Overall Study|Non compliant with protocol|0|||
126617226|NCT01159600|455555542|FG006|Overall Study|Non compliant with protocol|2|||
126617227|NCT01159600|455555543|FG007|Overall Study|Non compliant with protocol|0|||
126617228|NCT01159600|455555536|FG000|Overall Study|Lost to Follow-up|2|||
126617229|NCT01159600|455555537|FG001|Overall Study|Lost to Follow-up|3|||
126617230|NCT01159600|455555538|FG002|Overall Study|Lost to Follow-up|4|||
126617231|NCT01159600|455555539|FG003|Overall Study|Lost to Follow-up|3|||
126617232|NCT01159600|455555540|FG004|Overall Study|Lost to Follow-up|3|||
126617233|NCT01159600|455555541|FG005|Overall Study|Lost to Follow-up|0|||
126617234|NCT01159600|455555542|FG006|Overall Study|Lost to Follow-up|3|||
126617235|NCT01159600|455555543|FG007|Overall Study|Lost to Follow-up|2|||
126617236|NCT01159600|455555536|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
126617237|NCT01159600|455555537|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
126617238|NCT01159600|455555538|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
126617239|NCT01159600|455555539|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
126617240|NCT01159600|455555540|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
126617241|NCT01159600|455555541|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
126617242|NCT01159600|455555542|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
126746432|NCT04051944|456021951|FG000|Overall Study|Adverse event, non- fatal|1|||
126617243|NCT01159600|455555543|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
126617244|NCT01159600|455555536|FG000|Overall Study|Other reason not defined above|3|||
126617245|NCT01159600|455555537|FG001|Overall Study|Other reason not defined above|0|||
126746433|NCT04051944|456021952|FG001|Overall Study|Adverse event, non- fatal|1|||
126746434|NCT00736450|456021953|FG000|Overall Study|Not ABC gene eligible|19|||
126746435|NCT00736450|456021953|FG000|Overall Study|Withdrawal by Subject|5|||
126617246|NCT01159600|455555538|FG002|Overall Study|Other reason not defined above|4|||
126746436|NCT00736450|456021953|FG000|Overall Study|Physician Decision|1|||
126746437|NCT01947894|456021957|FG000|Overall Study|Other|3|||
126746438|NCT01947894|456021958|FG001|Overall Study|Other|4|||
126746439|NCT01947894|456021959|FG002|Overall Study|Other|3|||
126746440|NCT01947894|456021957|FG000|Overall Study|Withdrawal by Subject|12|||
126746441|NCT01947894|456021958|FG001|Overall Study|Withdrawal by Subject|4|||
126746442|NCT01947894|456021959|FG002|Overall Study|Withdrawal by Subject|1|||
126746443|NCT01947894|456021957|FG000|Overall Study|Death|12|||
126746444|NCT01947894|456021958|FG001|Overall Study|Death|1|||
126746445|NCT01947894|456021959|FG002|Overall Study|Death|0|||
126746446|NCT01947894|456021957|FG000|Overall Study|Physician Decision|2|||
126746447|NCT01947894|456021958|FG001|Overall Study|Physician Decision|0|||
126746448|NCT01947894|456021959|FG002|Overall Study|Physician Decision|0|||
126746449|NCT01947894|456021957|FG000|Overall Study|Adverse Event|5|||
126746450|NCT01947894|456021958|FG001|Overall Study|Adverse Event|1|||
126746451|NCT01947894|456021959|FG002|Overall Study|Adverse Event|0|||
126746452|NCT01947894|456021957|FG000|Overall Study|Switched to other growth hormone brand|53|||
126746453|NCT01947894|456021958|FG001|Overall Study|Switched to other growth hormone brand|8|||
126617247|NCT01159600|455555539|FG003|Overall Study|Other reason not defined above|2|||
126617248|NCT01159600|455555540|FG004|Overall Study|Other reason not defined above|5|||
126617249|NCT01159600|455555541|FG005|Overall Study|Other reason not defined above|7|||
126617250|NCT01159600|455555542|FG006|Overall Study|Other reason not defined above|3|||
126617251|NCT01159600|455555543|FG007|Overall Study|Other reason not defined above|3|||
126617252|NCT04433091|455555544|FG000|Overall Study|Lost to Follow-up|1|||
126617253|NCT04433091|455555545|FG001|Overall Study|Lost to Follow-up|0|||
126617254|NCT04433091|455555544|FG000|Overall Study|Withdrawn .|2|||
126617255|NCT04433091|455555545|FG001|Overall Study|Withdrawn .|4|||
126617256|NCT04097535|455555546|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
126617257|NCT01863368|455557041|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
126617258|NCT01863368|455557042|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
126617259|NCT01863368|455557041|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
126617260|NCT01863368|455557042|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
126617261|NCT01863368|455557041|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
126617262|NCT01863368|455557042|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
126617263|NCT01863368|455557041|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
126617264|NCT01863368|455557042|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
126617265|NCT01863368|455557041|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
126617266|NCT01863368|455557042|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
126617267|NCT01863368|455557041|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
126617268|NCT01863368|455557042|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
126617269|NCT01975701|455557051|FG000|Overall Study|Lost to Follow-up|1|||
126617270|NCT01975701|455557051|FG000|Overall Study|Death|23|||
126617271|NCT01975701|455557051|FG000|Overall Study|Physician Decision|1|||
126617272|NCT02143713|455557056|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
126617273|NCT02143713|455557057|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
126617274|NCT02143713|455557058|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
126617275|NCT02143713|455557059|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
126617276|NCT02143713|455557056|FG000|Treatment Period (6 Months)|Adverse Event|7|||
126617277|NCT02143713|455557057|FG001|Treatment Period (6 Months)|Adverse Event|8|||
126617278|NCT02143713|455557058|FG002|Treatment Period (6 Months)|Adverse Event|8|||
126617279|NCT02143713|455557059|FG003|Treatment Period (6 Months)|Adverse Event|9|||
126617280|NCT02143713|455557056|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
126617281|NCT02143713|455557057|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
126617282|NCT02143713|455557058|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
126617283|NCT02143713|455557059|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
126617284|NCT02143713|455557056|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
126617285|NCT02143713|455557057|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
126617286|NCT02143713|455557058|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
126617287|NCT02143713|455557059|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
126617288|NCT02143713|455557056|FG000|Treatment Period (6 Months)|Pregnancy|0|||
126617289|NCT02143713|455557057|FG001|Treatment Period (6 Months)|Pregnancy|2|||
126617290|NCT02143713|455557058|FG002|Treatment Period (6 Months)|Pregnancy|2|||
126617291|NCT02143713|455557059|FG003|Treatment Period (6 Months)|Pregnancy|0|||
126617292|NCT02143713|455557056|FG000|Treatment Period (6 Months)|Non-compliance|1|||
126746454|NCT01947894|456021959|FG002|Overall Study|Switched to other growth hormone brand|23|||
126746455|NCT00333970|456021960|FG000|Overall Study|Withdrawal by Subject|13|||
126746456|NCT00333970|456021961|FG001|Overall Study|Withdrawal by Subject|7|||
126746457|NCT01249157|456021962|FG000|Overall Study|Withdrawal by Subject|1|||
126617293|NCT02143713|455557057|FG001|Treatment Period (6 Months)|Non-compliance|0|||
126617294|NCT02143713|455557058|FG002|Treatment Period (6 Months)|Non-compliance|0|||
126617295|NCT02143713|455557059|FG003|Treatment Period (6 Months)|Non-compliance|3|||
126617296|NCT02143713|455557056|FG000|Treatment Period (6 Months)|Other|3|||
126617297|NCT02143713|455557057|FG001|Treatment Period (6 Months)|Other|0|||
126746458|NCT00062647|456021963|FG000|Overall Study|Death|2|||
126746459|NCT00062647|456021964|FG001|Overall Study|Death|2|||
126746460|NCT00062647|456021963|FG000|Overall Study|Adverse Event|1|||
126746461|NCT00062647|456021964|FG001|Overall Study|Adverse Event|1|||
126746462|NCT00062647|456021963|FG000|Overall Study|Withdrawal by Subject|2|||
126746463|NCT00062647|456021964|FG001|Overall Study|Withdrawal by Subject|1|||
126746464|NCT00062647|456021963|FG000|Overall Study|Protocol Violation|1|||
126746465|NCT00062647|456021964|FG001|Overall Study|Protocol Violation|0|||
126746466|NCT00062647|456021963|FG000|Overall Study|Lost to Follow-up|1|||
126746467|NCT00062647|456021964|FG001|Overall Study|Lost to Follow-up|2|||
126746468|NCT00062647|456021963|FG000|Overall Study|Failed continuation criteria|4|||
126746469|NCT00062647|456021964|FG001|Overall Study|Failed continuation criteria|2|||
126746470|NCT00062647|456021963|FG000|Overall Study|Other|4|||
126746471|NCT00062647|456021964|FG001|Overall Study|Other|4|||
126746472|NCT00062647|456021963|FG000|Overall Study|Never received study treatment|1|||
126746473|NCT00062647|456021964|FG001|Overall Study|Never received study treatment|1|||
126746474|NCT02392468|456021966|FG000|Overall Study|Adverse Event|0|||
126746475|NCT02392468|456021967|FG001|Overall Study|Adverse Event|1|||
126746476|NCT02392468|456021968|FG002|Overall Study|Adverse Event|0|||
126746477|NCT02392468|456021969|FG003|Overall Study|Adverse Event|0|||
126746478|NCT02392468|456021970|FG004|Overall Study|Adverse Event|0|||
126746479|NCT02392468|456021971|FG005|Overall Study|Adverse Event|1|||
126746480|NCT05083949|456021977|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
126746481|NCT05083949|456021978|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
126746482|NCT05083949|456021977|FG000|Period 1|Adverse Event|1|||
126746483|NCT05083949|456021978|FG001|Period 1|Adverse Event|1|||
126746484|NCT05083949|456021977|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
126746485|NCT05083949|456021978|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
126746486|NCT05083949|456021977|FG000|Period 2|Adverse Event|0|||
126746487|NCT05083949|456021978|FG001|Period 2|Adverse Event|2|||
126746488|NCT01678560|456021979|FG000|Overall Study|Physician Decision|4|||
126746489|NCT01678560|456021980|FG001|Overall Study|Physician Decision|4|||
126746490|NCT01678560|456021979|FG000|Overall Study|Death|0|||
126746491|NCT01678560|456021980|FG001|Overall Study|Death|1|||
126746492|NCT01678560|456021979|FG000|Overall Study|Withdrawal by Subject|0|||
126746493|NCT01678560|456021980|FG001|Overall Study|Withdrawal by Subject|1|||
126746494|NCT00322387|456021984|FG000|Treatment Period|Adverse Event|0|||
126746495|NCT00322387|456021985|FG001|Treatment Period|Adverse Event|1|||
126746496|NCT00322387|456021984|FG000|Follow-up Period|Final assessment not done|1|||
126746497|NCT00322387|456021985|FG001|Follow-up Period|Final assessment not done|3|||
126746498|NCT00322387|456021984|FG000|Follow-up Period|Death|1|||
126746499|NCT00322387|456021985|FG001|Follow-up Period|Death|0|||
126746500|NCT00090766|456021990|FG000|Overall Study|Nephrectomy Planned|0|||
126746501|NCT00090766|456021991|FG001|Overall Study|Nephrectomy Planned|0|||
126746502|NCT00090766|456021992|FG002|Overall Study|Nephrectomy Planned|1|||
126746503|NCT00090766|456021990|FG000|Overall Study|Death|1|||
126746504|NCT00090766|456021991|FG001|Overall Study|Death|0|||
126746505|NCT00090766|456021992|FG002|Overall Study|Death|0|||
126746506|NCT00090766|456021990|FG000|Overall Study|Admin|0|||
126746507|NCT00090766|456021991|FG001|Overall Study|Admin|2|||
126746508|NCT00090766|456021992|FG002|Overall Study|Admin|0|||
126746509|NCT00090766|456021990|FG000|Overall Study|Lost to Follow-up|2|||
126746510|NCT00090766|456021991|FG001|Overall Study|Lost to Follow-up|0|||
126746511|NCT00090766|456021992|FG002|Overall Study|Lost to Follow-up|2|||
126746512|NCT00654368|456021993|FG000|Overall Study|Ineligibility determined|6|||
126746513|NCT00654368|456021994|FG001|Overall Study|Ineligibility determined|0|||
126746514|NCT00654368|456021995|FG002|Overall Study|Ineligibility determined|0|||
126746515|NCT00654368|456021993|FG000|Overall Study|Protocol deviation|3|||
126746516|NCT00654368|456021994|FG001|Overall Study|Protocol deviation|2|||
126746517|NCT00654368|456021995|FG002|Overall Study|Protocol deviation|1|||
126746518|NCT00654368|456021993|FG000|Overall Study|Non-compliance|2|||
126746519|NCT00654368|456021994|FG001|Overall Study|Non-compliance|1|||
126746520|NCT00654368|456021995|FG002|Overall Study|Non-compliance|2|||
126746521|NCT00654368|456021993|FG000|Overall Study|Withdrawal by Subject|5|||
126746522|NCT00654368|456021994|FG001|Overall Study|Withdrawal by Subject|2|||
126746523|NCT00654368|456021995|FG002|Overall Study|Withdrawal by Subject|2|||
126746524|NCT00654368|456021993|FG000|Overall Study|Disease progression|21|||
126746525|NCT00654368|456021994|FG001|Overall Study|Disease progression|31|||
126746526|NCT00654368|456021995|FG002|Overall Study|Disease progression|13|||
126746527|NCT00654368|456021993|FG000|Overall Study|Requirement for alternative therapy|1|||
126746528|NCT00654368|456021994|FG001|Overall Study|Requirement for alternative therapy|1|||
126746529|NCT00654368|456021995|FG002|Overall Study|Requirement for alternative therapy|1|||
126746530|NCT00654368|456021993|FG000|Overall Study|Physician Decision|0|||
126746531|NCT00654368|456021994|FG001|Overall Study|Physician Decision|0|||
126746532|NCT00654368|456021995|FG002|Overall Study|Physician Decision|2|||
126746533|NCT00654368|456021993|FG000|Overall Study|Death|1|||
126746534|NCT00654368|456021994|FG001|Overall Study|Death|0|||
126746535|NCT00654368|456021995|FG002|Overall Study|Death|0|||
126746536|NCT00654368|456021993|FG000|Overall Study|Pregnancy|0|||
126746537|NCT00654368|456021994|FG001|Overall Study|Pregnancy|0|||
126746538|NCT00654368|456021995|FG002|Overall Study|Pregnancy|2|||
126746539|NCT00654368|456021993|FG000|Overall Study|Other|0|||
126746540|NCT00654368|456021994|FG001|Overall Study|Other|2|||
126746541|NCT00654368|456021995|FG002|Overall Study|Other|3|||
126746542|NCT00654368|456021993|FG000|Overall Study|Adverse Event|14|||
126746543|NCT00654368|456021994|FG001|Overall Study|Adverse Event|9|||
126746544|NCT00654368|456021995|FG002|Overall Study|Adverse Event|6|||
126746545|NCT00804986|456022002|FG000|Overall Study|Adverse Event|0|||
126746546|NCT00804986|456022003|FG001|Overall Study|Adverse Event|1|||
126617298|NCT02143713|455557058|FG002|Treatment Period (6 Months)|Other|3|||
126617299|NCT02143713|455557059|FG003|Treatment Period (6 Months)|Other|2|||
126617300|NCT02143713|455557056|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
126617301|NCT02143713|455557057|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
126617302|NCT02143713|455557058|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
126617303|NCT02143713|455557059|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
126617304|NCT02143713|455557056|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
126617305|NCT02143713|455557057|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
126617306|NCT02143713|455557058|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
126617307|NCT02143713|455557059|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
126617308|NCT02143713|455557056|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
126617309|NCT02143713|455557057|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
126617310|NCT02143713|455557058|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
126617311|NCT02143713|455557059|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
126617312|NCT02143713|455557056|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
126617313|NCT02143713|455557057|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
126617314|NCT02143713|455557058|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
126617315|NCT02143713|455557059|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
126617316|NCT02143713|455557056|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
126617317|NCT02143713|455557057|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
126617318|NCT02143713|455557058|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
126617319|NCT02143713|455557059|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
126617320|NCT02143713|455557056|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
126617321|NCT02143713|455557057|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
126617322|NCT02143713|455557058|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
126617323|NCT02143713|455557059|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
126617324|NCT02143713|455557056|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
126617325|NCT02143713|455557057|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
126617326|NCT02143713|455557058|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
126617327|NCT02143713|455557059|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
126617328|NCT02143713|455557056|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
126617329|NCT02143713|455557057|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
126617330|NCT02143713|455557058|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
126617331|NCT02143713|455557059|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
126617332|NCT02143713|455557056|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
126617333|NCT02143713|455557057|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
126617334|NCT02143713|455557058|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
126617335|NCT02143713|455557059|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
126617336|NCT01768572|455557060|FG000|Overall Study|Adverse Event|7|||
126617337|NCT01768572|455557061|FG001|Overall Study|Adverse Event|8|||
126617338|NCT01768572|455557062|FG002|Overall Study|Adverse Event|4|||
126617339|NCT01768572|455557060|FG000|Overall Study|Lack of Efficacy|1|||
126617340|NCT01768572|455557061|FG001|Overall Study|Lack of Efficacy|3|||
126617341|NCT01768572|455557062|FG002|Overall Study|Lack of Efficacy|1|||
126617342|NCT01768572|455557060|FG000|Overall Study|Other, Not due to an adverse event|1|||
126617343|NCT01768572|455557061|FG001|Overall Study|Other, Not due to an adverse event|1|||
126617344|NCT01768572|455557062|FG002|Overall Study|Other, Not due to an adverse event|1|||
126617345|NCT03761849|455557066|FG000|Overall Study|transferred to OpenLabelExtension|35|||
126617346|NCT03761849|455557067|FG001|Overall Study|transferred to OpenLabelExtension|34|||
126617347|NCT03761849|455557068|FG002|Overall Study|transferred to OpenLabelExtension|36|||
126746547|NCT00804986|456022004|FG002|Overall Study|Adverse Event|2|||
126781875|NCT01688037|456156289|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
126781876|NCT01688037|456156290|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
126617348|NCT03761849|455557069|FG003|Overall Study|transferred to OpenLabelExtension|0|||
126617349|NCT03761849|455557070|FG004|Overall Study|transferred to OpenLabelExtension|0|||
126617350|NCT03761849|455557071|FG005|Overall Study|transferred to OpenLabelExtension|0|||
126746548|NCT00804986|456022005|FG003|Overall Study|Adverse Event|1|||
126746549|NCT00804986|456022006|FG004|Overall Study|Adverse Event|3|||
126746550|NCT00804986|456022007|FG005|Overall Study|Adverse Event|0|||
126746551|NCT00804986|456022002|FG000|Overall Study|Lack of Efficacy|0|||
126781877|NCT01688037|456156291|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
126617351|NCT03761849|455557066|FG000|Overall Study|Adverse Event|1|||
126617352|NCT03761849|455557067|FG001|Overall Study|Adverse Event|0|||
126617353|NCT03761849|455557068|FG002|Overall Study|Adverse Event|0|||
126617354|NCT03761849|455557069|FG003|Overall Study|Adverse Event|0|||
126617355|NCT03761849|455557070|FG004|Overall Study|Adverse Event|2|||
126617356|NCT03761849|455557071|FG005|Overall Study|Adverse Event|3|||
126617357|NCT03761849|455557066|FG000|Overall Study|Withdrawal by Subject|0|||
126617358|NCT03761849|455557067|FG001|Overall Study|Withdrawal by Subject|0|||
126617359|NCT03761849|455557068|FG002|Overall Study|Withdrawal by Subject|0|||
126617360|NCT03761849|455557069|FG003|Overall Study|Withdrawal by Subject|41|||
126617361|NCT03761849|455557070|FG004|Overall Study|Withdrawal by Subject|43|||
126617362|NCT03761849|455557071|FG005|Overall Study|Withdrawal by Subject|35|||
126617363|NCT03761849|455557066|FG000|Overall Study|Lost to Follow-up|0|||
126617364|NCT03761849|455557067|FG001|Overall Study|Lost to Follow-up|1|||
126617365|NCT03761849|455557068|FG002|Overall Study|Lost to Follow-up|0|||
126617366|NCT03761849|455557069|FG003|Overall Study|Lost to Follow-up|2|||
126617367|NCT03761849|455557070|FG004|Overall Study|Lost to Follow-up|4|||
126617368|NCT03761849|455557071|FG005|Overall Study|Lost to Follow-up|5|||
126617369|NCT03761849|455557066|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
126617370|NCT03761849|455557067|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
126617371|NCT03761849|455557068|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
126617372|NCT03761849|455557069|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
126617373|NCT03761849|455557070|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
126617374|NCT03761849|455557071|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
126617375|NCT03761849|455557066|FG000|Overall Study|Physician Decision|0|||
126617376|NCT03761849|455557067|FG001|Overall Study|Physician Decision|0|||
126746552|NCT00804986|456022003|FG001|Overall Study|Lack of Efficacy|0|||
126746553|NCT00804986|456022004|FG002|Overall Study|Lack of Efficacy|0|||
126746554|NCT00804986|456022005|FG003|Overall Study|Lack of Efficacy|1|||
126746555|NCT00804986|456022006|FG004|Overall Study|Lack of Efficacy|0|||
126746556|NCT00804986|456022007|FG005|Overall Study|Lack of Efficacy|3|||
126746557|NCT00804986|456022002|FG000|Overall Study|Lost to Follow-up|0|||
126746558|NCT00804986|456022003|FG001|Overall Study|Lost to Follow-up|0|||
126746559|NCT00804986|456022004|FG002|Overall Study|Lost to Follow-up|0|||
126746560|NCT00804986|456022005|FG003|Overall Study|Lost to Follow-up|1|||
126746561|NCT00804986|456022006|FG004|Overall Study|Lost to Follow-up|1|||
126746562|NCT00804986|456022007|FG005|Overall Study|Lost to Follow-up|3|||
126746563|NCT00804986|456022002|FG000|Overall Study|Protocol Violation|0|||
126746564|NCT00804986|456022003|FG001|Overall Study|Protocol Violation|1|||
126746565|NCT00804986|456022004|FG002|Overall Study|Protocol Violation|0|||
126746566|NCT00804986|456022005|FG003|Overall Study|Protocol Violation|1|||
126746567|NCT00804986|456022006|FG004|Overall Study|Protocol Violation|0|||
126746568|NCT00804986|456022007|FG005|Overall Study|Protocol Violation|0|||
126746569|NCT00804986|456022002|FG000|Overall Study|Withdrawal by Subject|0|||
126746570|NCT00804986|456022003|FG001|Overall Study|Withdrawal by Subject|3|||
126746571|NCT00804986|456022004|FG002|Overall Study|Withdrawal by Subject|0|||
126746572|NCT00804986|456022005|FG003|Overall Study|Withdrawal by Subject|3|||
126746573|NCT00804986|456022006|FG004|Overall Study|Withdrawal by Subject|5|||
126746574|NCT00804986|456022007|FG005|Overall Study|Withdrawal by Subject|3|||
126746575|NCT00804986|456022002|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
126746576|NCT00804986|456022003|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
126746577|NCT00804986|456022004|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
126746578|NCT00804986|456022005|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
126746579|NCT00804986|456022006|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
126746580|NCT00804986|456022007|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
126746581|NCT00804986|456022002|FG000|Overall Study|Sponsor Decision|0|||
126746582|NCT00804986|456022003|FG001|Overall Study|Sponsor Decision|1|||
126746583|NCT00804986|456022004|FG002|Overall Study|Sponsor Decision|0|||
126746584|NCT00804986|456022005|FG003|Overall Study|Sponsor Decision|0|||
126746585|NCT00804986|456022006|FG004|Overall Study|Sponsor Decision|0|||
126746586|NCT00804986|456022007|FG005|Overall Study|Sponsor Decision|0|||
126617377|NCT03761849|455557068|FG002|Overall Study|Physician Decision|0|||
126617378|NCT03761849|455557069|FG003|Overall Study|Physician Decision|1|||
126617379|NCT03761849|455557070|FG004|Overall Study|Physician Decision|4|||
126617380|NCT03761849|455557071|FG005|Overall Study|Physician Decision|4|||
126617381|NCT03761849|455557066|FG000|Overall Study|Death|0|||
126617382|NCT03761849|455557067|FG001|Overall Study|Death|0|||
126746587|NCT00804986|456022002|FG000|Overall Study|Physician Decision|1|||
126746588|NCT00804986|456022003|FG001|Overall Study|Physician Decision|0|||
126746589|NCT00804986|456022004|FG002|Overall Study|Physician Decision|0|||
126746590|NCT00804986|456022005|FG003|Overall Study|Physician Decision|0|||
126746591|NCT00804986|456022006|FG004|Overall Study|Physician Decision|0|||
126746592|NCT00804986|456022007|FG005|Overall Study|Physician Decision|0|||
126746593|NCT04228445|456022012|FG000|Overall Study|Lost to Follow-up|1|||
126746594|NCT04228445|456022013|FG001|Overall Study|Lost to Follow-up|1|||
126746595|NCT04228445|456022012|FG000|Overall Study|Physician Decision|1|||
126746596|NCT04228445|456022013|FG001|Overall Study|Physician Decision|2|||
126746597|NCT04228445|456022012|FG000|Overall Study|Withdrawal by Subject|0|||
126617383|NCT03761849|455557068|FG002|Overall Study|Death|0|||
126617384|NCT03761849|455557069|FG003|Overall Study|Death|1|||
126617385|NCT03761849|455557070|FG004|Overall Study|Death|1|||
126617386|NCT03761849|455557071|FG005|Overall Study|Death|3|||
126617387|NCT03761849|455557066|FG000|Overall Study|Protocol Violation|0|||
126617388|NCT03761849|455557067|FG001|Overall Study|Protocol Violation|0|||
126617389|NCT03761849|455557068|FG002|Overall Study|Protocol Violation|0|||
126617390|NCT03761849|455557069|FG003|Overall Study|Protocol Violation|2|||
126617391|NCT03761849|455557070|FG004|Overall Study|Protocol Violation|2|||
126617392|NCT03761849|455557071|FG005|Overall Study|Protocol Violation|1|||
126617393|NCT03761849|455557066|FG000|Overall Study|Participant could not come to site|0|||
126617394|NCT03761849|455557067|FG001|Overall Study|Participant could not come to site|0|||
126617395|NCT03761849|455557068|FG002|Overall Study|Participant could not come to site|0|||
126617396|NCT03761849|455557069|FG003|Overall Study|Participant could not come to site|0|||
126617397|NCT03761849|455557070|FG004|Overall Study|Participant could not come to site|1|||
126617398|NCT03761849|455557071|FG005|Overall Study|Participant could not come to site|0|||
126617399|NCT03761849|455557066|FG000|Overall Study|SF- safety Finding|0|||
126617400|NCT03761849|455557067|FG001|Overall Study|SF- safety Finding|0|||
126617401|NCT03761849|455557068|FG002|Overall Study|SF- safety Finding|0|||
126617402|NCT03761849|455557069|FG003|Overall Study|SF- safety Finding|0|||
126617403|NCT03761849|455557070|FG004|Overall Study|SF- safety Finding|0|||
126617404|NCT03761849|455557071|FG005|Overall Study|SF- safety Finding|1|||
126617405|NCT03761849|455557066|FG000|Overall Study|Patient did not attend visit|0|||
126617406|NCT03761849|455557067|FG001|Overall Study|Patient did not attend visit|0|||
126617407|NCT03761849|455557068|FG002|Overall Study|Patient did not attend visit|0|||
126617408|NCT03761849|455557069|FG003|Overall Study|Patient did not attend visit|0|||
126617409|NCT03761849|455557070|FG004|Overall Study|Patient did not attend visit|0|||
126617410|NCT03761849|455557071|FG005|Overall Study|Patient did not attend visit|1|||
126617411|NCT03840993|455557075|FG000|Overall Study|Adverse Event|1|||
126617412|NCT03840993|455557076|FG001|Overall Study|Adverse Event|0|||
126617413|NCT03840993|455557075|FG000|Overall Study|Lost to Follow-up|4|||
126617414|NCT03840993|455557076|FG001|Overall Study|Lost to Follow-up|0|||
126617415|NCT03840993|455557075|FG000|Overall Study|Physician Decision|0|||
126617416|NCT03840993|455557076|FG001|Overall Study|Physician Decision|1|||
126617417|NCT03840993|455557075|FG000|Overall Study|Pregnancy|0|||
126617418|NCT03840993|455557076|FG001|Overall Study|Pregnancy|1|||
126617419|NCT03840993|455557075|FG000|Overall Study|Withdrawal by Subject|1|||
126617420|NCT03840993|455557076|FG001|Overall Study|Withdrawal by Subject|3|||
126617421|NCT03840993|455557075|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
126617422|NCT03840993|455557076|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
126617423|NCT00988429|455557077|FG000|Overall Study|Adverse Event|9|||
126617424|NCT00988429|455557078|FG001|Overall Study|Adverse Event|21|||
126617425|NCT00988429|455557079|FG002|Overall Study|Adverse Event|45|||
126617426|NCT00988429|455557077|FG000|Overall Study|Lack of Efficacy|0|||
126617427|NCT00988429|455557078|FG001|Overall Study|Lack of Efficacy|0|||
126617428|NCT00988429|455557079|FG002|Overall Study|Lack of Efficacy|1|||
126617429|NCT00988429|455557077|FG000|Overall Study|Non-Compliance with Study Drug|5|||
126617430|NCT00988429|455557078|FG001|Overall Study|Non-Compliance with Study Drug|1|||
126617431|NCT00988429|455557079|FG002|Overall Study|Non-Compliance with Study Drug|3|||
126617432|NCT00988429|455557077|FG000|Overall Study|Physician Decision|1|||
126617433|NCT00988429|455557078|FG001|Overall Study|Physician Decision|0|||
126617434|NCT00988429|455557079|FG002|Overall Study|Physician Decision|3|||
126617435|NCT00988429|455557077|FG000|Overall Study|Pregnancy|2|||
126617436|NCT00988429|455557078|FG001|Overall Study|Pregnancy|1|||
126617437|NCT00988429|455557079|FG002|Overall Study|Pregnancy|0|||
126617438|NCT00988429|455557077|FG000|Overall Study|Protocol Violation|4|||
126617439|NCT00988429|455557078|FG001|Overall Study|Protocol Violation|3|||
126617440|NCT00988429|455557079|FG002|Overall Study|Protocol Violation|3|||
126617441|NCT00988429|455557077|FG000|Overall Study|Withdrawal by Subject|7|||
126617442|NCT00988429|455557078|FG001|Overall Study|Withdrawal by Subject|7|||
126617443|NCT00988429|455557079|FG002|Overall Study|Withdrawal by Subject|12|||
126617444|NCT00988429|455557077|FG000|Overall Study|Administrative Reasons|1|||
126617445|NCT00988429|455557078|FG001|Overall Study|Administrative Reasons|2|||
126617446|NCT00988429|455557079|FG002|Overall Study|Administrative Reasons|1|||
126617447|NCT00988429|455557077|FG000|Overall Study|other reasons|8|||
126617448|NCT00988429|455557078|FG001|Overall Study|other reasons|8|||
126617449|NCT00988429|455557079|FG002|Overall Study|other reasons|1|||
126617450|NCT01074229|455557080|FG000|Overall Study|Lost to Follow-up|1|||
126617451|NCT01074229|455557081|FG001|Overall Study|Lost to Follow-up|0|||
126746598|NCT04228445|456022013|FG001|Overall Study|Withdrawal by Subject|1|||
126746599|NCT04228445|456022012|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
126617452|NCT01074229|455557082|FG002|Overall Study|Lost to Follow-up|0|||
126746600|NCT04228445|456022013|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
126617453|NCT01074229|455557080|FG000|Overall Study|Change to open surgical procedure|1|||
126617454|NCT01074229|455557081|FG001|Overall Study|Change to open surgical procedure|3|||
126617455|NCT01074229|455557082|FG002|Overall Study|Change to open surgical procedure|4|||
126617456|NCT02291861|455557083|FG000|Overall Study|Adverse Event|2|||
126617457|NCT02291861|455557084|FG001|Overall Study|Adverse Event|4|||
126617458|NCT02291861|455557085|FG002|Overall Study|Adverse Event|1|||
126617459|NCT02291861|455557086|FG003|Overall Study|Adverse Event|2|||
126617460|NCT02291861|455557083|FG000|Overall Study|Death|0|||
126617461|NCT02291861|455557084|FG001|Overall Study|Death|0|||
126617462|NCT02291861|455557085|FG002|Overall Study|Death|1|||
126617463|NCT02291861|455557086|FG003|Overall Study|Death|1|||
126617464|NCT02291861|455557083|FG000|Overall Study|Protocol Violation|1|||
126617465|NCT02291861|455557084|FG001|Overall Study|Protocol Violation|0|||
126617466|NCT02291861|455557085|FG002|Overall Study|Protocol Violation|0|||
126617467|NCT02291861|455557086|FG003|Overall Study|Protocol Violation|1|||
126617468|NCT02291861|455557083|FG000|Overall Study|Withdrawal by Subject|1|||
126617469|NCT02291861|455557084|FG001|Overall Study|Withdrawal by Subject|2|||
126617470|NCT02291861|455557085|FG002|Overall Study|Withdrawal by Subject|1|||
126617471|NCT02291861|455557086|FG003|Overall Study|Withdrawal by Subject|4|||
126617472|NCT02291861|455557083|FG000|Overall Study|Noncompliance|1|||
126617473|NCT02291861|455557084|FG001|Overall Study|Noncompliance|1|||
126617474|NCT02291861|455557085|FG002|Overall Study|Noncompliance|2|||
126617475|NCT02291861|455557086|FG003|Overall Study|Noncompliance|1|||
126617476|NCT02291861|455557083|FG000|Overall Study|Lost to Follow-up|2|||
126617477|NCT02291861|455557084|FG001|Overall Study|Lost to Follow-up|1|||
126617478|NCT02291861|455557085|FG002|Overall Study|Lost to Follow-up|4|||
126617479|NCT02291861|455557086|FG003|Overall Study|Lost to Follow-up|0|||
126617480|NCT02291861|455557083|FG000|Overall Study|Other|0|||
126617481|NCT02291861|455557084|FG001|Overall Study|Other|0|||
126617482|NCT02291861|455557085|FG002|Overall Study|Other|0|||
126617483|NCT02291861|455557086|FG003|Overall Study|Other|1|||
126617484|NCT00590759|455557090|FG000|Overall Study|Death|52|||
126617485|NCT00590759|455557090|FG000|Overall Study|Lost to Follow-up|28|||
126617486|NCT03845517|455557097|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
126617487|NCT03845517|455557098|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
126617488|NCT03845517|455557099|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
126617489|NCT03845517|455557100|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
126617490|NCT03845517|455557097|FG000|Treatment Period (52 Weeks)|Death|0|||
126617491|NCT03845517|455557098|FG001|Treatment Period (52 Weeks)|Death|0|||
126617492|NCT03845517|455557099|FG002|Treatment Period (52 Weeks)|Death|1|||
126617493|NCT03845517|455557100|FG003|Treatment Period (52 Weeks)|Death|0|||
126617494|NCT03845517|455557097|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
126617495|NCT03845517|455557098|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
126617496|NCT03845517|455557099|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
126617497|NCT03845517|455557100|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
126617498|NCT03845517|455557097|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
126617499|NCT03845517|455557098|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
126617500|NCT03845517|455557099|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
126617501|NCT03845517|455557100|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
126617502|NCT03845517|455557097|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
126617503|NCT03845517|455557098|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
126617504|NCT03845517|455557099|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
126617505|NCT03845517|455557100|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
126617506|NCT03845517|455557097|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
126617507|NCT03845517|455557098|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
126617508|NCT03845517|455557099|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
126617509|NCT03845517|455557100|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
126617510|NCT03845517|455557097|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
126617511|NCT03845517|455557098|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
126617512|NCT03845517|455557099|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
126617513|NCT03845517|455557100|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
126617514|NCT03845517|455557097|FG000|Treatment Period (52 Weeks)|Other|2|||
126617515|NCT03845517|455557098|FG001|Treatment Period (52 Weeks)|Other|0|||
126617516|NCT03845517|455557099|FG002|Treatment Period (52 Weeks)|Other|0|||
126617517|NCT03845517|455557100|FG003|Treatment Period (52 Weeks)|Other|0|||
126617518|NCT03845517|455557097|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
126617519|NCT03845517|455557098|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
126617520|NCT03845517|455557099|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
126617521|NCT03845517|455557100|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
126746601|NCT00606294|456022020|FG000|Overall Study|Withdrawal by Subject|36|||
126746602|NCT00606294|456022021|FG001|Overall Study|Withdrawal by Subject|0|||
126746603|NCT03924427|456022022|FG000|Overall Study|Adverse Event|4|||
126746604|NCT03924427|456022022|FG000|Overall Study|Lack of Efficacy|1|||
126746605|NCT03924427|456022022|FG000|Overall Study|Withdrawal by Subject|1|||
126617522|NCT03845517|455557097|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
126617523|NCT03845517|455557098|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
126617524|NCT03845517|455557099|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
126617525|NCT03845517|455557100|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
126617526|NCT03845517|455557097|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
126617527|NCT03845517|455557098|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
126617528|NCT03845517|455557099|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
126617529|NCT03845517|455557100|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
126617530|NCT03845517|455557097|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
126617531|NCT03845517|455557098|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
126617532|NCT03845517|455557099|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
126617533|NCT03845517|455557100|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
126617534|NCT03845517|455557097|FG000|Follow-up Period (4 Weeks)|Death|0|||
126617535|NCT03845517|455557098|FG001|Follow-up Period (4 Weeks)|Death|0|||
126617536|NCT03845517|455557099|FG002|Follow-up Period (4 Weeks)|Death|1|||
126617537|NCT03845517|455557100|FG003|Follow-up Period (4 Weeks)|Death|1|||
126617538|NCT03845517|455557097|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
126617539|NCT03845517|455557098|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
126617540|NCT03845517|455557099|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
126617541|NCT03845517|455557100|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
126617542|NCT03845517|455557097|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
126617543|NCT03845517|455557098|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
126617544|NCT03845517|455557099|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
126617545|NCT03845517|455557100|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
126617546|NCT03845517|455557097|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
126617547|NCT03845517|455557098|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
126617548|NCT03845517|455557099|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
126617549|NCT03845517|455557100|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
126617550|NCT03845517|455557097|FG000|Follow-up Period (4 Weeks)|Other|1|||
126617551|NCT03845517|455557098|FG001|Follow-up Period (4 Weeks)|Other|0|||
126617552|NCT03845517|455557099|FG002|Follow-up Period (4 Weeks)|Other|1|||
126617553|NCT03845517|455557100|FG003|Follow-up Period (4 Weeks)|Other|0|||
126617554|NCT03845517|455557097|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
126617555|NCT03845517|455557098|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
126617556|NCT03845517|455557099|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
126617557|NCT03845517|455557100|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
126617558|NCT03845517|455557097|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
126617559|NCT03845517|455557098|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
126617560|NCT03845517|455557099|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
126617561|NCT03845517|455557100|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
126617562|NCT03845517|455557097|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
126617563|NCT03845517|455557098|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
126617564|NCT03845517|455557099|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
126617565|NCT03845517|455557100|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
126617566|NCT01912599|455557103|FG000|Overall Study|Withdrawal by Subject|0|||
126617567|NCT01912599|455557104|FG001|Overall Study|Withdrawal by Subject|1|||
126617568|NCT03386344|455557105|FG000|Overall Study|Adverse Event|6|||
126617569|NCT03386344|455557106|FG001|Overall Study|Adverse Event|3|||
126617570|NCT03386344|455557107|FG002|Overall Study|Adverse Event|1|||
126617571|NCT03386344|455557105|FG000|Overall Study|Poor Compliance to Protocol|0|||
126617572|NCT03386344|455557106|FG001|Overall Study|Poor Compliance to Protocol|1|||
126617573|NCT03386344|455557107|FG002|Overall Study|Poor Compliance to Protocol|0|||
126617574|NCT03386344|455557105|FG000|Overall Study|Study Terminated by Sponsor|101|||
126617575|NCT03386344|455557106|FG001|Overall Study|Study Terminated by Sponsor|102|||
126617576|NCT03386344|455557107|FG002|Overall Study|Study Terminated by Sponsor|106|||
126617577|NCT03386344|455557105|FG000|Overall Study|Lost to Follow-up|3|||
126617578|NCT03386344|455557106|FG001|Overall Study|Lost to Follow-up|2|||
126617579|NCT03386344|455557107|FG002|Overall Study|Lost to Follow-up|1|||
126617580|NCT03386344|455557105|FG000|Overall Study|At the Participant's own Request|7|||
126617581|NCT03386344|455557106|FG001|Overall Study|At the Participant's own Request|7|||
126617582|NCT03386344|455557107|FG002|Overall Study|At the Participant's own Request|8|||
126617583|NCT03386344|455557105|FG000|Overall Study|Reason not Specified|0|||
126617584|NCT03386344|455557106|FG001|Overall Study|Reason not Specified|1|||
126617585|NCT03386344|455557107|FG002|Overall Study|Reason not Specified|0|||
126617586|NCT01280721|455557108|FG000|Overall Study|Adverse Event|4|||
126617587|NCT01280721|455557108|FG000|Overall Study|Physician Decision|3|||
126617588|NCT01280721|455557108|FG000|Overall Study|Withdrawal by Subject|6|||
126617589|NCT01280721|455557108|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
126617590|NCT01280721|455557108|FG000|Overall Study|No tolerability for the lowest dose|2|||
126617591|NCT03449979|455557109|FG000|Overall Study|Technical difficulty|0|||
126617592|NCT03449979|455557110|FG001|Overall Study|Technical difficulty|0|||
126617593|NCT03449979|455557111|FG002|Overall Study|Technical difficulty|0|||
126617594|NCT03449979|455557112|FG003|Overall Study|Technical difficulty|1|||
126617595|NCT02632747|455557113|FG000|Wash-out Period|Adverse Event|1|||
126617596|NCT02632747|455557114|FG001|Wash-out Period|Adverse Event|0|||
126617597|NCT02069379|455557115|FG000|Baseline Measurements|Lost to Follow-up|1|||
126617598|NCT02069379|455557116|FG001|Baseline Measurements|Lost to Follow-up|0|||
126617599|NCT02069379|455557117|FG002|Baseline Measurements|Lost to Follow-up|0|||
126617600|NCT02069379|455557118|FG003|Baseline Measurements|Lost to Follow-up|0|||
126617601|NCT02069379|455557115|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
126781878|NCT01688037|456156289|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
126617602|NCT02069379|455557116|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
126617603|NCT02069379|455557117|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
126617604|NCT02069379|455557118|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
126617605|NCT02069379|455557115|FG000|First Treatment Arm|Lost to Follow-up|0|||
126617606|NCT02069379|455557116|FG001|First Treatment Arm|Lost to Follow-up|1|||
126617607|NCT02069379|455557117|FG002|First Treatment Arm|Lost to Follow-up|1|||
126617608|NCT02069379|455557118|FG003|First Treatment Arm|Lost to Follow-up|0|||
126617609|NCT02069379|455557115|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
126617610|NCT02069379|455557116|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
126617611|NCT02069379|455557117|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
126617612|NCT02069379|455557118|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
126617613|NCT02069379|455557115|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
126617614|NCT02069379|455557116|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
126617615|NCT02069379|455557117|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
126617616|NCT02069379|455557118|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
126617617|NCT02069379|455557115|FG000|Second Treatment Arm|Lost to Follow-up|0|||
126617618|NCT02069379|455557116|FG001|Second Treatment Arm|Lost to Follow-up|0|||
126617619|NCT02069379|455557117|FG002|Second Treatment Arm|Lost to Follow-up|1|||
126617620|NCT02069379|455557118|FG003|Second Treatment Arm|Lost to Follow-up|0|||
126617621|NCT00700999|455557119|FG000|Overall Study|Lost to Follow-up|7|||
126617622|NCT00700999|455557120|FG001|Overall Study|Lost to Follow-up|7|||
126617623|NCT00700999|455557119|FG000|Overall Study|Excluded - did not meet study criteria|0|||
126617624|NCT00700999|455557120|FG001|Overall Study|Excluded - did not meet study criteria|1|||
126617625|NCT00700999|455557119|FG000|Overall Study|Withdrawal by Subject|8|||
126617626|NCT00700999|455557120|FG001|Overall Study|Withdrawal by Subject|1|||
126617627|NCT03481725|455557121|FG000|Overall Study|Withdrawal by Subject|1|||
126617628|NCT03481725|455557122|FG001|Overall Study|Withdrawal by Subject|0|||
126617629|NCT03651271|455557123|FG000|Overall Study|Death|4|||
126617630|NCT03651271|455557124|FG001|Overall Study|Death|37|||
126617631|NCT03651271|455557125|FG002|Overall Study|Death|0|||
126617632|NCT03651271|455557126|FG003|Overall Study|Death|2|||
126617633|NCT03651271|455557127|FG004|Overall Study|Death|6|||
126617634|NCT03651271|455557123|FG000|Overall Study|Lost to Follow-up|1|||
126617635|NCT03651271|455557124|FG001|Overall Study|Lost to Follow-up|5|||
126617636|NCT03651271|455557125|FG002|Overall Study|Lost to Follow-up|0|||
126617637|NCT03651271|455557126|FG003|Overall Study|Lost to Follow-up|1|||
126617638|NCT03651271|455557127|FG004|Overall Study|Lost to Follow-up|0|||
126617639|NCT03651271|455557123|FG000|Overall Study|Physician Decision|0|||
126617640|NCT03651271|455557124|FG001|Overall Study|Physician Decision|2|||
126617641|NCT03651271|455557125|FG002|Overall Study|Physician Decision|0|||
126617642|NCT03651271|455557126|FG003|Overall Study|Physician Decision|0|||
126617643|NCT03651271|455557127|FG004|Overall Study|Physician Decision|0|||
126617644|NCT03651271|455557123|FG000|Overall Study|Withdrawal by Subject|1|||
126617645|NCT03651271|455557124|FG001|Overall Study|Withdrawal by Subject|15|||
126617646|NCT03651271|455557125|FG002|Overall Study|Withdrawal by Subject|0|||
126617647|NCT03651271|455557126|FG003|Overall Study|Withdrawal by Subject|0|||
126617648|NCT03651271|455557127|FG004|Overall Study|Withdrawal by Subject|1|||
126617649|NCT03651271|455557123|FG000|Overall Study|Patient medically unable to continue|0|||
126617650|NCT03651271|455557124|FG001|Overall Study|Patient medically unable to continue|0|||
126617651|NCT03651271|455557125|FG002|Overall Study|Patient medically unable to continue|0|||
126617652|NCT03651271|455557126|FG003|Overall Study|Patient medically unable to continue|1|||
126617653|NCT03651271|455557127|FG004|Overall Study|Patient medically unable to continue|0|||
126617654|NCT01864200|455557134|FG000|Overall Study|Lost to Follow-up|1|||
126617655|NCT01864200|455557135|FG001|Overall Study|Lost to Follow-up|3|||
126617656|NCT01864200|455557134|FG000|Overall Study|Protocol Violation|1|||
126617657|NCT01864200|455557135|FG001|Overall Study|Protocol Violation|0|||
126617658|NCT02991118|455557136|FG000|Overall Study|Death|3|||
126617659|NCT02991118|455557137|FG001|Overall Study|Death|8|||
126617660|NCT02991118|455557136|FG000|Overall Study|Protocol Violation|0|||
126617661|NCT02991118|455557137|FG001|Overall Study|Protocol Violation|3|||
126617662|NCT02991118|455557136|FG000|Overall Study|Physician Decision|0|||
126781879|NCT01688037|456156290|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
126781880|NCT01688037|456156291|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
126617663|NCT02991118|455557137|FG001|Overall Study|Physician Decision|1|||
126617664|NCT02991118|455557136|FG000|Overall Study|Moved out of the country|0|||
126781881|NCT03035227|456156292|FG000|Overall Study|study stopped due to PI leaving institut|1|||
126781882|NCT03035227|456156293|FG001|Overall Study|study stopped due to PI leaving institut|1|||
126617665|NCT02991118|455557137|FG001|Overall Study|Moved out of the country|1|||
126617666|NCT02991118|455557136|FG000|Overall Study|Adverse Event|2|||
126617667|NCT02991118|455557137|FG001|Overall Study|Adverse Event|2|||
126617668|NCT02991118|455557136|FG000|Overall Study|Withdrawal by Subject|1|||
126617669|NCT02991118|455557137|FG001|Overall Study|Withdrawal by Subject|7|||
126617670|NCT02991118|455557136|FG000|Overall Study|Could not attend study visits|0|||
126617671|NCT02991118|455557137|FG001|Overall Study|Could not attend study visits|1|||
126617672|NCT02991118|455557136|FG000|Overall Study|Lost to Follow-up|1|||
126617673|NCT02991118|455557137|FG001|Overall Study|Lost to Follow-up|9|||
126617674|NCT00595959|455557138|FG000|Overall Study|Withdrawal by Subject|1|||
126617675|NCT00595959|455557138|FG000|Overall Study|Lost to Follow-up|1|||
126617676|NCT02077374|455557142|FG000|Overall Study|Withdrawal by Subject|0|||
126617677|NCT02077374|455557143|FG001|Overall Study|Withdrawal by Subject|1|||
126617678|NCT02077374|455557142|FG000|Overall Study|Protocol Violation|0|||
126617679|NCT02077374|455557143|FG001|Overall Study|Protocol Violation|1|||
126617680|NCT00446095|455557144|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
126617681|NCT00446095|455557145|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
126617682|NCT00446095|455557146|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
126617683|NCT00446095|455557147|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
126617684|NCT00446095|455557148|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
126617685|NCT00446095|455557144|FG000|Phase II (8 Weeks)|Adverse Event|0|||
126617686|NCT00446095|455557145|FG001|Phase II (8 Weeks)|Adverse Event|1|||
126617687|NCT00446095|455557146|FG002|Phase II (8 Weeks)|Adverse Event|1|||
126617688|NCT00446095|455557147|FG003|Phase II (8 Weeks)|Adverse Event|0|||
126617689|NCT00446095|455557148|FG004|Phase II (8 Weeks)|Adverse Event|0|||
126617690|NCT00446095|455557144|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
126617691|NCT00446095|455557145|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
126617692|NCT00446095|455557146|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
126617693|NCT00446095|455557147|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
126617694|NCT00446095|455557148|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
126617695|NCT00446095|455557144|FG000|Phase II (8 Weeks)|Physician Decision|1|||
126617696|NCT00446095|455557145|FG001|Phase II (8 Weeks)|Physician Decision|0|||
126617697|NCT00446095|455557146|FG002|Phase II (8 Weeks)|Physician Decision|0|||
126617698|NCT00446095|455557147|FG003|Phase II (8 Weeks)|Physician Decision|0|||
126617699|NCT00446095|455557148|FG004|Phase II (8 Weeks)|Physician Decision|0|||
126617700|NCT00446095|455557144|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
126617701|NCT00446095|455557145|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
126617702|NCT00446095|455557146|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
126617703|NCT00446095|455557147|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
126617704|NCT00446095|455557148|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
126617705|NCT00446095|455557144|FG000|Phase II (8 Weeks)|Ongoing|0|||
126617706|NCT00446095|455557145|FG001|Phase II (8 Weeks)|Ongoing|0|||
126617707|NCT00446095|455557146|FG002|Phase II (8 Weeks)|Ongoing|1|||
126617708|NCT00446095|455557147|FG003|Phase II (8 Weeks)|Ongoing|0|||
126746606|NCT02774291|456022026|FG000|Overall Study|Lost to Follow-up|1|||
126746607|NCT00126425|456022027|FG000|Overall Study|Withdrawal by Subject|17|||
126746608|NCT00126425|456022028|FG001|Overall Study|Withdrawal by Subject|1|||
126746609|NCT00126425|456022027|FG000|Overall Study|Lost to Follow-up|8|||
126746610|NCT00126425|456022028|FG001|Overall Study|Lost to Follow-up|4|||
126746611|NCT00126425|456022027|FG000|Overall Study|Protocol Violation|9|||
126746612|NCT00126425|456022028|FG001|Overall Study|Protocol Violation|6|||
126746613|NCT00126425|456022027|FG000|Overall Study|Adverse Event|1|||
126746614|NCT00126425|456022028|FG001|Overall Study|Adverse Event|0|||
126746615|NCT00126425|456022027|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
126746616|NCT00126425|456022028|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
126746617|NCT00126425|456022027|FG000|Overall Study|Other|5|||
126746618|NCT00126425|456022028|FG001|Overall Study|Other|0|||
126746619|NCT01316380|456022032|FG000|Overall Study|Adverse Event|0|||
126746620|NCT01316380|456022033|FG001|Overall Study|Adverse Event|2|||
126746621|NCT01316380|456022034|FG002|Overall Study|Adverse Event|1|||
126746622|NCT01316380|456022032|FG000|Overall Study|Protocol Violation|0|||
126746623|NCT01316380|456022033|FG001|Overall Study|Protocol Violation|0|||
126746624|NCT01316380|456022034|FG002|Overall Study|Protocol Violation|1|||
126746625|NCT01316380|456022032|FG000|Overall Study|Withdrawal by Subject|1|||
126746626|NCT01316380|456022033|FG001|Overall Study|Withdrawal by Subject|2|||
126746627|NCT01316380|456022034|FG002|Overall Study|Withdrawal by Subject|0|||
126746628|NCT01316380|456022032|FG000|Overall Study|Other|0|||
126746629|NCT01316380|456022033|FG001|Overall Study|Other|1|||
126746630|NCT01316380|456022034|FG002|Overall Study|Other|1|||
126746631|NCT01316380|456022032|FG000|Overall Study|Not treated|1|||
126746632|NCT01316380|456022033|FG001|Overall Study|Not treated|0|||
126746633|NCT01316380|456022034|FG002|Overall Study|Not treated|0|||
126746634|NCT00149890|456022035|FG000|Overall Study|Adverse Event|1|||
126746635|NCT00149890|456022036|FG001|Overall Study|Adverse Event|8|||
126746636|NCT00149890|456022035|FG000|Overall Study|Lack of Efficacy|8|||
126746637|NCT00149890|456022036|FG001|Overall Study|Lack of Efficacy|9|||
126781883|NCT02100956|456156294|FG000|At Least One Week Between Injections|Adverse Event|0|||
126617709|NCT00446095|455557148|FG004|Phase II (8 Weeks)|Ongoing|0|||
126617710|NCT00446095|455557144|FG000|Phase I (28 Days)|Adverse Event|0|||
126617711|NCT00446095|455557145|FG001|Phase I (28 Days)|Adverse Event|0|||
126617712|NCT00446095|455557146|FG002|Phase I (28 Days)|Adverse Event|0|||
126617713|NCT00446095|455557147|FG003|Phase I (28 Days)|Adverse Event|1|||
126617714|NCT00446095|455557148|FG004|Phase I (28 Days)|Adverse Event|0|||
126746638|NCT00149890|456022035|FG000|Overall Study|Protocol Violation|1|||
126746639|NCT00149890|456022036|FG001|Overall Study|Protocol Violation|0|||
126746640|NCT00149890|456022035|FG000|Overall Study|Lost to Follow-up|1|||
126617715|NCT00446095|455557144|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
126617716|NCT00446095|455557145|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
126617717|NCT00446095|455557146|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
126617718|NCT00446095|455557147|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
126617719|NCT00446095|455557148|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
126617720|NCT00409747|455557149|FG000|Overall Study|Withdrawal by Subject|1|||
126617721|NCT01916109|455557152|FG000|Overall Study|Withdrawal by Subject|1|||
126781884|NCT02100956|456156295|FG001|At Least One Week Between Injections|Adverse Event|1|||
126617722|NCT00636168|455557155|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
126617723|NCT00636168|455557156|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
126617724|NCT00636168|455557155|FG000|Randomized to Study Drug|Adverse Event|1|||
126617725|NCT00636168|455557156|FG001|Randomized to Study Drug|Adverse Event|0|||
126617726|NCT00636168|455557155|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
126617727|NCT00636168|455557156|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
126617728|NCT00636168|455557155|FG000|Treated With Study Drug|Recurrence of disease|135|||
126617729|NCT00636168|455557156|FG001|Treated With Study Drug|Recurrence of disease|282|||
126617730|NCT00636168|455557155|FG000|Treated With Study Drug|Adverse Event|250|||
126617731|NCT00636168|455557156|FG001|Treated With Study Drug|Adverse Event|22|||
126617732|NCT00636168|455557155|FG000|Treated With Study Drug|Participant withdrew consent|16|||
126617733|NCT00636168|455557156|FG001|Treated With Study Drug|Participant withdrew consent|21|||
126617734|NCT00636168|455557155|FG000|Treated With Study Drug|Poor/non-compliance|1|||
126617735|NCT00636168|455557156|FG001|Treated With Study Drug|Poor/non-compliance|3|||
126617736|NCT00636168|455557155|FG000|Treated With Study Drug|Death|3|||
126617737|NCT00636168|455557156|FG001|Treated With Study Drug|Death|0|||
126617738|NCT00636168|455557155|FG000|Treated With Study Drug|Pregnancy|1|||
126617739|NCT00636168|455557156|FG001|Treated With Study Drug|Pregnancy|0|||
126617740|NCT00636168|455557155|FG000|Treated With Study Drug|No longer meets study criteria|1|||
126617741|NCT00636168|455557156|FG001|Treated With Study Drug|No longer meets study criteria|0|||
126617742|NCT00636168|455557155|FG000|Treated With Study Drug|Other reason|1|||
126617743|NCT00636168|455557156|FG001|Treated With Study Drug|Other reason|3|||
126617744|NCT00636168|455557155|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
126617745|NCT00636168|455557156|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
126617746|NCT00636168|455557155|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
126617747|NCT00636168|455557156|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
126617748|NCT00636168|455557155|FG000|Long Term Follow-Up|Death|8|||
126781885|NCT00859469|456156297|FG000|Overall Study|Adverse Event|2|||
126781886|NCT00859469|456156297|FG000|Overall Study|Lack of Efficacy|9|||
126781887|NCT00859469|456156297|FG000|Overall Study|Withdrawal by Subject|1|||
126781888|NCT00859469|456156297|FG000|Overall Study|Death|16|||
126781889|NCT02220907|456156298|FG000|Overall Study|Adverse Event|7|||
126781890|NCT02220907|456156298|FG000|Overall Study|Physician Decision|1|||
126781891|NCT02220907|456156298|FG000|Overall Study|Withdrawal by Subject|2|||
126781892|NCT02220907|456156298|FG000|Overall Study|Conflict with the stopping criteria|1|||
126781893|NCT03111147|456156299|FG000|Overall Study|Lost to Follow-up|2|||
126617749|NCT00636168|455557156|FG001|Long Term Follow-Up|Death|9|||
126617750|NCT02707952|455557159|FG000|Overall Study|Adverse Event|1|||
126617751|NCT02707952|455557160|FG001|Overall Study|Adverse Event|0|||
126617752|NCT02707952|455557161|FG002|Overall Study|Adverse Event|0|||
126617753|NCT02707952|455557162|FG003|Overall Study|Adverse Event|0|||
126617754|NCT02707952|455557159|FG000|Overall Study|Lost to Follow-up|1|||
126617755|NCT02707952|455557160|FG001|Overall Study|Lost to Follow-up|0|||
126617756|NCT02707952|455557161|FG002|Overall Study|Lost to Follow-up|0|||
126617757|NCT02707952|455557162|FG003|Overall Study|Lost to Follow-up|0|||
126617758|NCT02707952|455557159|FG000|Overall Study|Withdrawal by Subject|0|||
126617759|NCT02707952|455557160|FG001|Overall Study|Withdrawal by Subject|1|||
126617760|NCT02707952|455557161|FG002|Overall Study|Withdrawal by Subject|2|||
126746641|NCT00149890|456022036|FG001|Overall Study|Lost to Follow-up|0|||
126746642|NCT00149890|456022035|FG000|Overall Study|Graft Loss|2|||
126746643|NCT00149890|456022036|FG001|Overall Study|Graft Loss|1|||
126746644|NCT01894776|456022037|FG000|Overall Study|Withdrawal by Subject|1|||
126746645|NCT02332876|456022038|FG000|Overall Study|Lost to Follow-up|1|||
126746646|NCT02332876|456022039|FG001|Overall Study|Lost to Follow-up|1|||
126746647|NCT02415595|456022041|FG000|Overall Study|Administrative reason by sponsor|39|||
126781894|NCT03111147|456156300|FG001|Overall Study|Lost to Follow-up|5|||
126617761|NCT02707952|455557162|FG003|Overall Study|Withdrawal by Subject|0|||
126781895|NCT03111147|456156299|FG000|Overall Study|Withdrawal by Subject|4|||
126617762|NCT02006641|455557163|FG000|Overall Study|Withdrawal before treatment|2|||
126617763|NCT02006641|455557164|FG001|Overall Study|Withdrawal before treatment|5|||
126617764|NCT02006641|455557165|FG002|Overall Study|Withdrawal before treatment|3|||
126617765|NCT02006641|455557163|FG000|Overall Study|Adverse Event|15|||
126746648|NCT02415595|456022042|FG001|Overall Study|Administrative reason by sponsor|40|||
126746649|NCT02415595|456022043|FG002|Overall Study|Administrative reason by sponsor|41|||
126746650|NCT02415595|456022044|FG003|Overall Study|Administrative reason by sponsor|39|||
126781896|NCT03111147|456156300|FG001|Overall Study|Withdrawal by Subject|3|||
126781897|NCT03111147|456156299|FG000|Overall Study|Protocol Violation|2|||
126617766|NCT02006641|455557164|FG001|Overall Study|Adverse Event|11|||
126617767|NCT02006641|455557165|FG002|Overall Study|Adverse Event|15|||
126617768|NCT02006641|455557163|FG000|Overall Study|Protocol Violation|0|||
126617769|NCT02006641|455557164|FG001|Overall Study|Protocol Violation|2|||
126617770|NCT02006641|455557165|FG002|Overall Study|Protocol Violation|2|||
126617771|NCT02006641|455557163|FG000|Overall Study|Lost to Follow-up|0|||
126617772|NCT02006641|455557164|FG001|Overall Study|Lost to Follow-up|1|||
126617773|NCT02006641|455557165|FG002|Overall Study|Lost to Follow-up|0|||
126617774|NCT02006641|455557163|FG000|Overall Study|Withdrawal by Subject|7|||
126617775|NCT02006641|455557164|FG001|Overall Study|Withdrawal by Subject|12|||
126617776|NCT02006641|455557165|FG002|Overall Study|Withdrawal by Subject|11|||
126617777|NCT02006641|455557163|FG000|Overall Study|Other reason: patient didn't show up|1|||
126617778|NCT02006641|455557164|FG001|Overall Study|Other reason: patient didn't show up|0|||
126617779|NCT02006641|455557165|FG002|Overall Study|Other reason: patient didn't show up|0|||
126617780|NCT02006641|455557163|FG000|Overall Study|Other reason:patient didn't want to come|0|||
126617781|NCT02006641|455557164|FG001|Overall Study|Other reason:patient didn't want to come|0|||
126617782|NCT02006641|455557165|FG002|Overall Study|Other reason:patient didn't want to come|1|||
126617783|NCT02006641|455557163|FG000|Overall Study|Other reason: patient has moved|1|||
126617784|NCT02006641|455557164|FG001|Overall Study|Other reason: patient has moved|0|||
126617785|NCT02006641|455557165|FG002|Overall Study|Other reason: patient has moved|1|||
126617786|NCT02006641|455557163|FG000|Overall Study|Other reason: caregiver in hospital|0|||
126617787|NCT02006641|455557164|FG001|Overall Study|Other reason: caregiver in hospital|1|||
126617788|NCT02006641|455557165|FG002|Overall Study|Other reason: caregiver in hospital|0|||
126617789|NCT02006641|455557163|FG000|Overall Study|Other reason: patient's wife has died|0|||
126617790|NCT02006641|455557164|FG001|Overall Study|Other reason: patient's wife has died|0|||
126617791|NCT02006641|455557165|FG002|Overall Study|Other reason: patient's wife has died|1|||
126617792|NCT02006641|455557163|FG000|Overall Study|Other reason: hospitalisation|0|||
126617793|NCT02006641|455557164|FG001|Overall Study|Other reason: hospitalisation|1|||
126617794|NCT02006641|455557165|FG002|Overall Study|Other reason: hospitalisation|0|||
126617795|NCT02006641|455557163|FG000|Overall Study|Other reason: caregiver impossibility|0|||
126617796|NCT02006641|455557164|FG001|Overall Study|Other reason: caregiver impossibility|0|||
126617797|NCT02006641|455557165|FG002|Overall Study|Other reason: caregiver impossibility|1|||
126617798|NCT02006641|455557163|FG000|Overall Study|Other reason: protocol non-compliance|0|||
126617799|NCT02006641|455557164|FG001|Overall Study|Other reason: protocol non-compliance|0|||
126617800|NCT02006641|455557165|FG002|Overall Study|Other reason: protocol non-compliance|1|||
126617801|NCT01287832|455557166|FG000|Overall Study|Adverse Event|1|||
126617802|NCT01287832|455557167|FG001|Overall Study|Adverse Event|0|||
126617803|NCT01287832|455557166|FG000|Overall Study|Death|0|||
126617804|NCT01287832|455557167|FG001|Overall Study|Death|1|||
126617805|NCT04749797|455557169|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
126617806|NCT04749797|455557170|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
126617807|NCT04749797|455557171|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
126617808|NCT00632736|455557172|FG000|Overall Study|Adverse Event|104|||
126617809|NCT00632736|455557172|FG000|Overall Study|Lost to Follow-up|15|||
126617810|NCT00632736|455557172|FG000|Overall Study|Protocol Violation|14|||
126617811|NCT00632736|455557172|FG000|Overall Study|Withdrawal by Subject|99|||
126617812|NCT00632736|455557172|FG000|Overall Study|Lack of Efficacy|5|||
126617813|NCT00632736|455557172|FG000|Overall Study|Sponsor terminated study|5|||
126617814|NCT00632736|455557172|FG000|Overall Study|Non-compliance|10|||
126617815|NCT00632736|455557172|FG000|Overall Study|Other|16|||
126617816|NCT01441596|455557173|FG000|Overall Study|Other reason not defined below|0|||
126617817|NCT01441596|455557174|FG001|Overall Study|Other reason not defined below|2|||
126617818|NCT01441596|455557175|FG002|Overall Study|Other reason not defined below|1|||
126617819|NCT01441596|455557173|FG000|Overall Study|Withdrawal by Subject|4|||
126617820|NCT01441596|455557174|FG001|Overall Study|Withdrawal by Subject|0|||
126617821|NCT01441596|455557175|FG002|Overall Study|Withdrawal by Subject|2|||
126617822|NCT01441596|455557173|FG000|Overall Study|Not treated|0|||
126617823|NCT01441596|455557174|FG001|Overall Study|Not treated|1|||
126617824|NCT01441596|455557175|FG002|Overall Study|Not treated|1|||
126617825|NCT01794689|455557179|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
126617826|NCT01794689|455557180|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
126617827|NCT01794689|455557181|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
126617828|NCT01794689|455557182|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
126617829|NCT01794689|455557179|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
126617830|NCT01794689|455557180|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
126617831|NCT01794689|455557181|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
126617832|NCT01794689|455557182|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
126617833|NCT01794689|455557179|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
126617834|NCT01794689|455557180|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
126617835|NCT01794689|455557181|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
126617836|NCT01794689|455557182|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
126617837|NCT01794689|455557179|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
126617838|NCT01794689|455557180|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
126617839|NCT01794689|455557181|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
126617840|NCT01794689|455557182|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
126617841|NCT01697956|455557183|FG000|Overall Study|Protocol Violation|1|||
126617842|NCT01697956|455557184|FG001|Overall Study|Protocol Violation|1|||
126617843|NCT03100370|455557195|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126617844|NCT03100370|455557196|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126617845|NCT03100370|455557197|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126617846|NCT03100370|455557198|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
126617847|NCT03100370|455557199|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126617848|NCT03100370|455557200|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
126617849|NCT02892019|455557201|FG000|Overall Study|randomized but not treated|0|||
126617850|NCT02892019|455557202|FG001|Overall Study|randomized but not treated|1|||
126617851|NCT02892019|455557201|FG000|Overall Study|Withdrawal by Subject|0|||
126617852|NCT02892019|455557202|FG001|Overall Study|Withdrawal by Subject|1|||
126617853|NCT02892019|455557201|FG000|Overall Study|Adverse Event|1|||
126617854|NCT02892019|455557202|FG001|Overall Study|Adverse Event|1|||
126617855|NCT01766206|455557203|FG000|Overall Study|Withdrawal by Subject|22|||
126617856|NCT01766206|455557203|FG000|Overall Study|Lost to Follow-up|10|||
126617857|NCT01766206|455557203|FG000|Overall Study|Inappropriate enrollment|18|||
126617858|NCT01766206|455557203|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
126617859|NCT01313663|455557204|FG000|Overall Study|Study Closed/Terminated|2|||
126617860|NCT01313663|455557205|FG001|Overall Study|Study Closed/Terminated|4|||
126617861|NCT01313663|455557204|FG000|Overall Study|Lost to Follow-up|0|||
126617862|NCT01313663|455557205|FG001|Overall Study|Lost to Follow-up|1|||
126617863|NCT01313663|455557204|FG000|Overall Study|Physician Decision|0|||
126617864|NCT01313663|455557205|FG001|Overall Study|Physician Decision|2|||
126617865|NCT01313663|455557204|FG000|Overall Study|Withdrawal by Subject|2|||
126617866|NCT01313663|455557205|FG001|Overall Study|Withdrawal by Subject|1|||
126640646|NCT04641962|455642859|FG004|DBT Period: Up to 52 Weeks|Death|0|||
126640647|NCT04641962|455642855|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
126640648|NCT04641962|455642856|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
126640649|NCT04641962|455642857|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
126640650|NCT04641962|455642858|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
126640651|NCT04641962|455642859|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
126640652|NCT04641962|455642855|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
126640653|NCT04641962|455642856|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
126640654|NCT04641962|455642857|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
126640655|NCT04641962|455642858|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
126640656|NCT04641962|455642859|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
126640657|NCT04641962|455642855|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
126640658|NCT04641962|455642856|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
126640659|NCT04641962|455642857|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
126640660|NCT04641962|455642858|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
126640661|NCT04641962|455642859|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
126640662|NCT06926673|455642860|FG000|Overall Study|Lost to Follow-up|0|||
126640663|NCT06926673|455642861|FG001|Overall Study|Lost to Follow-up|0|||
126640664|NCT06926673|455642862|FG002|Overall Study|Lost to Follow-up|0|||
126640665|NCT06926673|455642863|FG003|Overall Study|Lost to Follow-up|1|||
126640666|NCT06926673|455642864|FG004|Overall Study|Lost to Follow-up|0|||
126640667|NCT06926673|455642865|FG005|Overall Study|Lost to Follow-up|0|||
126640668|NCT06926673|455642866|FG006|Overall Study|Lost to Follow-up|0|||
126640669|NCT06926673|455642860|FG000|Overall Study|Physician Decision|0|||
126640670|NCT06926673|455642861|FG001|Overall Study|Physician Decision|0|||
126640671|NCT06926673|455642862|FG002|Overall Study|Physician Decision|0|||
126640672|NCT06926673|455642863|FG003|Overall Study|Physician Decision|0|||
126640673|NCT06926673|455642864|FG004|Overall Study|Physician Decision|0|||
126640674|NCT06926673|455642865|FG005|Overall Study|Physician Decision|0|||
126640675|NCT06926673|455642866|FG006|Overall Study|Physician Decision|1|||
126640676|NCT06926673|455642860|FG000|Overall Study|Withdrawal by Subject|0|||
126640677|NCT06926673|455642861|FG001|Overall Study|Withdrawal by Subject|3|||
126640678|NCT06926673|455642862|FG002|Overall Study|Withdrawal by Subject|2|||
126640679|NCT06926673|455642863|FG003|Overall Study|Withdrawal by Subject|1|||
126640680|NCT06926673|455642864|FG004|Overall Study|Withdrawal by Subject|0|||
126640681|NCT06926673|455642865|FG005|Overall Study|Withdrawal by Subject|2|||
126640682|NCT06926673|455642866|FG006|Overall Study|Withdrawal by Subject|0|||
126640683|NCT02271984|455644515|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126640684|NCT02271984|455644516|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126640685|NCT02271984|455644517|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126640686|NCT02271984|455644518|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126640687|NCT02271984|455644519|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126640688|NCT02271984|455644520|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
126640689|NCT02271984|455644521|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126640690|NCT02271984|455644522|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
126640691|NCT02271984|455644523|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126640692|NCT02271984|455644524|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126617867|NCT01562275|455558959|FG000|Stage 1|Adverse Event|0|||
126617868|NCT01562275|455558960|FG001|Stage 1|Adverse Event|0|||
126617869|NCT01562275|455558961|FG002|Stage 1|Adverse Event|0|||
126617870|NCT01562275|455558962|FG003|Stage 1|Adverse Event|1|||
126617871|NCT01562275|455558963|FG004|Stage 1|Adverse Event|1|||
126617872|NCT01562275|455558964|FG005|Stage 1|Adverse Event|0|||
126617873|NCT01562275|455558965|FG006|Stage 1|Adverse Event|0|||
126617874|NCT01562275|455558966|FG007|Stage 1|Adverse Event|0|||
126617875|NCT01562275|455558967|FG008|Stage 1|Adverse Event|0|||
126617876|NCT01562275|455558968|FG009|Stage 1|Adverse Event|1|||
126617877|NCT01562275|455558969|FG010|Stage 1|Adverse Event|0|||
126617878|NCT01562275|455558970|FG011|Stage 1|Adverse Event|0|||
126617879|NCT01562275|455558971|FG012|Stage 1|Adverse Event|0|||
126617880|NCT01562275|455558959|FG000|Stage 1|Death|1|||
126617881|NCT01562275|455558960|FG001|Stage 1|Death|0|||
126617882|NCT01562275|455558961|FG002|Stage 1|Death|0|||
126617883|NCT01562275|455558962|FG003|Stage 1|Death|0|||
126617884|NCT01562275|455558963|FG004|Stage 1|Death|0|||
126617885|NCT01562275|455558964|FG005|Stage 1|Death|0|||
126617886|NCT01562275|455558965|FG006|Stage 1|Death|0|||
126617887|NCT01562275|455558966|FG007|Stage 1|Death|0|||
126617888|NCT01562275|455558967|FG008|Stage 1|Death|0|||
126617889|NCT01562275|455558968|FG009|Stage 1|Death|0|||
126617890|NCT01562275|455558969|FG010|Stage 1|Death|0|||
126617891|NCT01562275|455558970|FG011|Stage 1|Death|0|||
126617892|NCT01562275|455558971|FG012|Stage 1|Death|0|||
126617893|NCT01562275|455558959|FG000|Stage 1|Non Compliance|0|||
126617894|NCT01562275|455558960|FG001|Stage 1|Non Compliance|0|||
126617895|NCT01562275|455558961|FG002|Stage 1|Non Compliance|1|||
126617896|NCT01562275|455558962|FG003|Stage 1|Non Compliance|0|||
126617897|NCT01562275|455558963|FG004|Stage 1|Non Compliance|0|||
126617898|NCT01562275|455558964|FG005|Stage 1|Non Compliance|0|||
126617899|NCT01562275|455558965|FG006|Stage 1|Non Compliance|0|||
126617900|NCT01562275|455558966|FG007|Stage 1|Non Compliance|0|||
126617901|NCT01562275|455558967|FG008|Stage 1|Non Compliance|0|||
126617902|NCT01562275|455558968|FG009|Stage 1|Non Compliance|0|||
126617903|NCT01562275|455558969|FG010|Stage 1|Non Compliance|0|||
126617904|NCT01562275|455558970|FG011|Stage 1|Non Compliance|0|||
126617905|NCT01562275|455558971|FG012|Stage 1|Non Compliance|0|||
126617906|NCT01562275|455558959|FG000|Stage 1|Physician Decision|0|||
126617907|NCT01562275|455558960|FG001|Stage 1|Physician Decision|0|||
126617908|NCT01562275|455558961|FG002|Stage 1|Physician Decision|0|||
126617909|NCT01562275|455558962|FG003|Stage 1|Physician Decision|0|||
126617910|NCT01562275|455558963|FG004|Stage 1|Physician Decision|1|||
126617911|NCT01562275|455558964|FG005|Stage 1|Physician Decision|0|||
126617912|NCT01562275|455558965|FG006|Stage 1|Physician Decision|1|||
126617913|NCT01562275|455558966|FG007|Stage 1|Physician Decision|0|||
126617914|NCT01562275|455558967|FG008|Stage 1|Physician Decision|1|||
126617915|NCT01562275|455558968|FG009|Stage 1|Physician Decision|0|||
126617916|NCT01562275|455558969|FG010|Stage 1|Physician Decision|0|||
126617917|NCT01562275|455558970|FG011|Stage 1|Physician Decision|0|||
126617918|NCT01562275|455558971|FG012|Stage 1|Physician Decision|0|||
126617919|NCT01562275|455558959|FG000|Stage 1|Progression of Disease|2|||
126617920|NCT01562275|455558960|FG001|Stage 1|Progression of Disease|6|||
126617921|NCT01562275|455558961|FG002|Stage 1|Progression of Disease|2|||
126617922|NCT01562275|455558962|FG003|Stage 1|Progression of Disease|1|||
126617923|NCT01562275|455558963|FG004|Stage 1|Progression of Disease|2|||
126617924|NCT01562275|455558964|FG005|Stage 1|Progression of Disease|4|||
126617925|NCT01562275|455558965|FG006|Stage 1|Progression of Disease|1|||
126617926|NCT01562275|455558966|FG007|Stage 1|Progression of Disease|7|||
126617927|NCT01562275|455558967|FG008|Stage 1|Progression of Disease|2|||
126617928|NCT01562275|455558968|FG009|Stage 1|Progression of Disease|5|||
126617929|NCT01562275|455558969|FG010|Stage 1|Progression of Disease|3|||
126617930|NCT01562275|455558970|FG011|Stage 1|Progression of Disease|0|||
126617931|NCT01562275|455558971|FG012|Stage 1|Progression of Disease|0|||
126617932|NCT01562275|455558959|FG000|Stage 1|Withdrawal by Subject|0|||
126617933|NCT01562275|455558960|FG001|Stage 1|Withdrawal by Subject|1|||
126617934|NCT01562275|455558961|FG002|Stage 1|Withdrawal by Subject|0|||
126617935|NCT01562275|455558962|FG003|Stage 1|Withdrawal by Subject|2|||
126617936|NCT01562275|455558963|FG004|Stage 1|Withdrawal by Subject|0|||
126617937|NCT01562275|455558964|FG005|Stage 1|Withdrawal by Subject|0|||
126617938|NCT01562275|455558965|FG006|Stage 1|Withdrawal by Subject|1|||
126617939|NCT01562275|455558966|FG007|Stage 1|Withdrawal by Subject|0|||
126617940|NCT01562275|455558967|FG008|Stage 1|Withdrawal by Subject|0|||
126617941|NCT01562275|455558968|FG009|Stage 1|Withdrawal by Subject|1|||
126617942|NCT01562275|455558969|FG010|Stage 1|Withdrawal by Subject|0|||
126617943|NCT01562275|455558970|FG011|Stage 1|Withdrawal by Subject|0|||
126617944|NCT01562275|455558971|FG012|Stage 1|Withdrawal by Subject|0|||
126617945|NCT01562275|455558959|FG000|Stage 2|Death|0|||
126617946|NCT01562275|455558960|FG001|Stage 2|Death|0|||
126617947|NCT01562275|455558961|FG002|Stage 2|Death|0|||
126617948|NCT01562275|455558962|FG003|Stage 2|Death|0|||
126617949|NCT01562275|455558963|FG004|Stage 2|Death|0|||
126617950|NCT01562275|455558964|FG005|Stage 2|Death|0|||
126617951|NCT01562275|455558965|FG006|Stage 2|Death|0|||
126617952|NCT01562275|455558966|FG007|Stage 2|Death|0|||
126617953|NCT01562275|455558967|FG008|Stage 2|Death|0|||
126617954|NCT01562275|455558968|FG009|Stage 2|Death|0|||
126617955|NCT01562275|455558969|FG010|Stage 2|Death|0|||
126617956|NCT01562275|455558970|FG011|Stage 2|Death|2|||
126617957|NCT01562275|455558971|FG012|Stage 2|Death|1|||
126617958|NCT01562275|455558959|FG000|Stage 2|Progression of Disease|0|||
126617959|NCT01562275|455558960|FG001|Stage 2|Progression of Disease|0|||
126617960|NCT01562275|455558961|FG002|Stage 2|Progression of Disease|0|||
126617961|NCT01562275|455558962|FG003|Stage 2|Progression of Disease|0|||
126746651|NCT02415595|456022041|FG000|Overall Study|Adverse Event|1|||
126746652|NCT02415595|456022042|FG001|Overall Study|Adverse Event|3|||
126746653|NCT02415595|456022043|FG002|Overall Study|Adverse Event|5|||
126746654|NCT02415595|456022044|FG003|Overall Study|Adverse Event|10|||
126746655|NCT02415595|456022041|FG000|Overall Study|Lack of Efficacy|4|||
126746656|NCT02415595|456022042|FG001|Overall Study|Lack of Efficacy|4|||
126746657|NCT02415595|456022043|FG002|Overall Study|Lack of Efficacy|0|||
126746658|NCT02415595|456022044|FG003|Overall Study|Lack of Efficacy|0|||
126746659|NCT02415595|456022041|FG000|Overall Study|Lost to Follow-up|1|||
126746660|NCT02415595|456022042|FG001|Overall Study|Lost to Follow-up|3|||
126746661|NCT02415595|456022043|FG002|Overall Study|Lost to Follow-up|1|||
126746662|NCT02415595|456022044|FG003|Overall Study|Lost to Follow-up|1|||
126746663|NCT02415595|456022041|FG000|Overall Study|Poor/Non-compliance|1|||
126746664|NCT02415595|456022042|FG001|Overall Study|Poor/Non-compliance|0|||
126746665|NCT02415595|456022043|FG002|Overall Study|Poor/Non-compliance|1|||
126746666|NCT02415595|456022044|FG003|Overall Study|Poor/Non-compliance|0|||
126746667|NCT02415595|456022041|FG000|Overall Study|Reached stopping criteria|0|||
126746668|NCT02415595|456022042|FG001|Overall Study|Reached stopping criteria|1|||
126746669|NCT02415595|456022043|FG002|Overall Study|Reached stopping criteria|1|||
126781898|NCT03111147|456156300|FG001|Overall Study|Protocol Violation|1|||
126781899|NCT03111147|456156299|FG000|Overall Study|Death|1|||
126617962|NCT01562275|455558963|FG004|Stage 2|Progression of Disease|0|||
126617963|NCT01562275|455558964|FG005|Stage 2|Progression of Disease|0|||
126617964|NCT01562275|455558965|FG006|Stage 2|Progression of Disease|0|||
126617965|NCT01562275|455558966|FG007|Stage 2|Progression of Disease|0|||
126617966|NCT01562275|455558967|FG008|Stage 2|Progression of Disease|0|||
126617967|NCT01562275|455558968|FG009|Stage 2|Progression of Disease|0|||
126617968|NCT01562275|455558969|FG010|Stage 2|Progression of Disease|0|||
126617969|NCT01562275|455558970|FG011|Stage 2|Progression of Disease|12|||
126617970|NCT01562275|455558971|FG012|Stage 2|Progression of Disease|4|||
126617971|NCT01020487|455558973|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
126617972|NCT01020487|455558974|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
126617973|NCT01020487|455558975|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
126617974|NCT01020487|455558973|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
126617975|NCT01020487|455558974|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
126617976|NCT01020487|455558975|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
126617977|NCT01020487|455558973|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
126617978|NCT01020487|455558974|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
126617979|NCT01020487|455558975|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
126617980|NCT01020487|455558973|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
126617981|NCT01020487|455558974|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
126617982|NCT01020487|455558975|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
126617983|NCT01020487|455558973|FG000|Part 2 Open-label Period|Adverse Event|0|||
126617984|NCT01020487|455558974|FG001|Part 2 Open-label Period|Adverse Event|4|||
126617985|NCT01020487|455558975|FG002|Part 2 Open-label Period|Adverse Event|1|||
126617986|NCT04049578|455558976|FG000|Overall Study|Physician Decision|1|||
126617987|NCT02400749|455558977|FG000|Week 0 -16|Withdrawal by Subject|5|||
126617988|NCT02400749|455558978|FG001|Week 0 -16|Withdrawal by Subject|5|||
126617989|NCT02400749|455558977|FG000|Week 0 -16|Adverse Event|3|||
126617990|NCT02400749|455558978|FG001|Week 0 -16|Adverse Event|1|||
126617991|NCT02400749|455558977|FG000|Week 0 -16|Lost to Follow-up|2|||
126617992|NCT02400749|455558978|FG001|Week 0 -16|Lost to Follow-up|0|||
126617993|NCT02400749|455558977|FG000|Week 0 -16|Protocol Violation|1|||
126746670|NCT02415595|456022044|FG003|Overall Study|Reached stopping criteria|0|||
126746671|NCT02415595|456022041|FG000|Overall Study|Withdrawal by Subject|4|||
126746672|NCT02415595|456022042|FG001|Overall Study|Withdrawal by Subject|0|||
126746673|NCT02415595|456022043|FG002|Overall Study|Withdrawal by Subject|1|||
126617994|NCT02400749|455558978|FG001|Week 0 -16|Protocol Violation|0|||
126617995|NCT02400749|455558977|FG000|Week 17 - 32|Withdrawal by Subject|3|||
126617996|NCT02400749|455558978|FG001|Week 17 - 32|Withdrawal by Subject|2|||
126617997|NCT02400749|455558977|FG000|Week 17 - 32|Adverse Event|2|||
126746674|NCT02415595|456022044|FG003|Overall Study|Withdrawal by Subject|3|||
126746675|NCT02415595|456022041|FG000|Overall Study|Other|0|||
126617998|NCT02400749|455558978|FG001|Week 17 - 32|Adverse Event|1|||
126617999|NCT00307489|455558981|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
126618000|NCT00307489|455558982|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
126618001|NCT00307489|455558981|FG000|Baseline Through Week 48|Physician Decision|1|||
126746676|NCT02415595|456022042|FG001|Overall Study|Other|1|||
126746677|NCT02415595|456022043|FG002|Overall Study|Other|1|||
126781900|NCT03111147|456156300|FG001|Overall Study|Death|1|||
126618002|NCT00307489|455558982|FG001|Baseline Through Week 48|Physician Decision|0|||
126618003|NCT00307489|455558981|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
126618004|NCT00307489|455558982|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
126618005|NCT00307489|455558981|FG000|Week 48 Through Week 168|Adverse Event|1|||
126618006|NCT00307489|455558982|FG001|Week 48 Through Week 168|Adverse Event|0|||
126618007|NCT00307489|455558981|FG000|Week 48 Through Week 168|Physician Decision|1|||
126618008|NCT00307489|455558982|FG001|Week 48 Through Week 168|Physician Decision|0|||
126618009|NCT00307489|455558981|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
126618010|NCT00307489|455558982|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
126618011|NCT00307489|455558981|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
126618012|NCT00307489|455558982|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
126618013|NCT00307489|455558981|FG000|Week 48 Through Week 168|Death|0|||
126618014|NCT00307489|455558982|FG001|Week 48 Through Week 168|Death|1|||
126618015|NCT00307489|455558981|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
126618016|NCT00307489|455558982|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
126618017|NCT00307489|455558981|FG000|Week 48 Through Week 168|Seroconversion|1|||
126618018|NCT00307489|455558982|FG001|Week 48 Through Week 168|Seroconversion|0|||
126618019|NCT04425252|455558983|FG000|Overall Study|Withdrawal by Subject|2|||
126618020|NCT04425252|455558984|FG001|Overall Study|Withdrawal by Subject|1|||
126618021|NCT04425252|455558983|FG000|Overall Study|Lost to Follow-up|1|||
126618022|NCT04425252|455558984|FG001|Overall Study|Lost to Follow-up|0|||
126618023|NCT04425252|455558983|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
126618024|NCT04425252|455558984|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
126618025|NCT01945593|455558988|FG000|Overall Study|Adverse Event|0|||
126618026|NCT01945593|455558989|FG001|Overall Study|Adverse Event|0|||
126618027|NCT01945593|455558990|FG002|Overall Study|Adverse Event|0|||
126618028|NCT01945593|455558991|FG003|Overall Study|Adverse Event|5|||
126618029|NCT01945593|455558988|FG000|Overall Study|Physician Decision|0|||
126618030|NCT01945593|455558989|FG001|Overall Study|Physician Decision|0|||
126618031|NCT01945593|455558990|FG002|Overall Study|Physician Decision|1|||
126618032|NCT01945593|455558991|FG003|Overall Study|Physician Decision|1|||
126618033|NCT01945593|455558988|FG000|Overall Study|Withdrawal by Subject|0|||
126618034|NCT01945593|455558989|FG001|Overall Study|Withdrawal by Subject|2|||
126618035|NCT01945593|455558990|FG002|Overall Study|Withdrawal by Subject|0|||
126618036|NCT01945593|455558991|FG003|Overall Study|Withdrawal by Subject|4|||
126618037|NCT01945593|455558988|FG000|Overall Study|Protocol Violation|0|||
126618038|NCT01945593|455558989|FG001|Overall Study|Protocol Violation|2|||
126618039|NCT01945593|455558990|FG002|Overall Study|Protocol Violation|1|||
126618040|NCT01945593|455558991|FG003|Overall Study|Protocol Violation|3|||
126618041|NCT01945593|455558988|FG000|Overall Study|Death|0|||
126618042|NCT01945593|455558989|FG001|Overall Study|Death|0|||
126618043|NCT01945593|455558990|FG002|Overall Study|Death|1|||
126618044|NCT01945593|455558991|FG003|Overall Study|Death|0|||
126618045|NCT01945593|455558988|FG000|Overall Study|Other: Terminated|0|||
126618046|NCT01945593|455558989|FG001|Overall Study|Other: Terminated|0|||
126618047|NCT01945593|455558990|FG002|Overall Study|Other: Terminated|0|||
126618048|NCT01945593|455558991|FG003|Overall Study|Other: Terminated|1|||
126618049|NCT01945593|455558988|FG000|Overall Study|Other: Surgical Procedure|0|||
126618050|NCT01945593|455558989|FG001|Overall Study|Other: Surgical Procedure|2|||
126618051|NCT01945593|455558990|FG002|Overall Study|Other: Surgical Procedure|0|||
126618052|NCT01945593|455558991|FG003|Overall Study|Other: Surgical Procedure|6|||
126618053|NCT01945593|455558988|FG000|Overall Study|Other: Screen Failure|0|||
126618054|NCT01945593|455558989|FG001|Overall Study|Other: Screen Failure|2|||
126618055|NCT01945593|455558990|FG002|Overall Study|Other: Screen Failure|0|||
126618056|NCT01945593|455558991|FG003|Overall Study|Other: Screen Failure|0|||
126618057|NCT02446015|455558992|FG000|Overall Study|Adverse Event|0|||
126618058|NCT02446015|455558993|FG001|Overall Study|Adverse Event|1|||
126618059|NCT02446015|455558992|FG000|Overall Study|Withdrawal by Subject|1|||
126618060|NCT02446015|455558993|FG001|Overall Study|Withdrawal by Subject|0|||
126618061|NCT03344458|455558995|FG000|Overall Study|Physician Decision|1|||
126618062|NCT03344458|455558995|FG000|Overall Study|Withdrawal by Subject|16|||
126618063|NCT03344458|455558995|FG000|Overall Study|Other reasons|10|||
126618064|NCT03344458|455558995|FG000|Overall Study|Lost to Follow-up|9|||
126618065|NCT03344458|455558995|FG000|Overall Study|Protocol Violation|3|||
126618066|NCT02964234|455558996|FG000|Overall Study|Lost to Follow-up|22|||
126618067|NCT02964234|455558997|FG001|Overall Study|Lost to Follow-up|13|||
126618068|NCT02163499|455559000|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
126618069|NCT02163499|455559000|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
126618070|NCT02163499|455559000|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
126618071|NCT02163499|455559000|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
126618072|NCT02163499|455559000|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
126618073|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
126618074|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
126618075|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
126618076|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
126618077|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
126618078|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
126618079|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
126618080|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
126618081|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
126618082|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Death|8|||
126618083|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
126618084|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
126618085|NCT02163499|455559000|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
126618086|NCT01540474|455559001|FG000|Vaccination Period|Lost to Follow-up|0|||
126618087|NCT01540474|455559002|FG001|Vaccination Period|Lost to Follow-up|1|||
126618088|NCT01540474|455559003|FG002|Vaccination Period|Lost to Follow-up|0|||
126618089|NCT01540474|455559004|FG003|Vaccination Period|Lost to Follow-up|0|||
126618090|NCT00857311|455559005|FG000|Overall Study|Lost to Follow-up|1|||
126618091|NCT00857311|455559006|FG001|Overall Study|Lost to Follow-up|0|||
126618092|NCT00857311|455559007|FG002|Overall Study|Lost to Follow-up|0|||
126618093|NCT00857311|455559008|FG003|Overall Study|Lost to Follow-up|0|||
126618094|NCT04454125|455559009|FG000|Overall Study|Lost to Follow-up|0|||
126618095|NCT04454125|455559010|FG001|Overall Study|Lost to Follow-up|1|||
126618096|NCT01587703|455559011|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
126618097|NCT01587703|455559012|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618098|NCT01587703|455559013|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618099|NCT01587703|455559014|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618100|NCT01587703|455559015|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618101|NCT01587703|455559016|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618102|NCT01587703|455559017|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618103|NCT01587703|455559018|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618104|NCT01587703|455559019|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618105|NCT01587703|455559020|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618106|NCT01587703|455559021|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618107|NCT01587703|455559022|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618108|NCT01587703|455559023|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618109|NCT01587703|455559024|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618110|NCT01587703|455559025|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618111|NCT01587703|455559026|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618112|NCT01587703|455559027|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618113|NCT01587703|455559028|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618114|NCT01587703|455559029|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
126618115|NCT01587703|455559011|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618116|NCT01587703|455559012|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618117|NCT01587703|455559013|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618118|NCT01587703|455559014|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618119|NCT01587703|455559015|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618120|NCT01587703|455559016|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
126618121|NCT01587703|455559017|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618122|NCT01587703|455559018|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
126618123|NCT01587703|455559019|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618124|NCT01587703|455559020|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618125|NCT01587703|455559021|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618126|NCT01587703|455559022|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618127|NCT01587703|455559023|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618128|NCT01587703|455559024|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618129|NCT01587703|455559025|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618130|NCT01587703|455559026|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618131|NCT01587703|455559027|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618132|NCT01587703|455559028|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618133|NCT01587703|455559029|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
126618134|NCT01587703|455559011|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618135|NCT01587703|455559012|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618136|NCT01587703|455559013|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618137|NCT01587703|455559014|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618138|NCT01587703|455559015|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618139|NCT01587703|455559016|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618140|NCT01587703|455559017|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
126618141|NCT01587703|455559018|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618142|NCT01587703|455559019|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618143|NCT01587703|455559020|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618144|NCT01587703|455559021|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618145|NCT01587703|455559022|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618146|NCT01587703|455559023|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618147|NCT01587703|455559024|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618148|NCT01587703|455559025|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618149|NCT01587703|455559026|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618150|NCT01587703|455559027|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618151|NCT01587703|455559028|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618152|NCT01587703|455559029|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
126618153|NCT01587703|455559011|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
126618154|NCT01587703|455559012|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
126618155|NCT01587703|455559013|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
126618156|NCT01587703|455559014|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
126618157|NCT01587703|455559015|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
126618158|NCT01587703|455559016|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
126618159|NCT01587703|455559017|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
126618160|NCT01587703|455559018|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
126618161|NCT01587703|455559019|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126618162|NCT01587703|455559020|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126618163|NCT01587703|455559021|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126618164|NCT01587703|455559022|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126618165|NCT01587703|455559023|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126618166|NCT01587703|455559024|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126618167|NCT01587703|455559025|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126618168|NCT01587703|455559026|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126618169|NCT01587703|455559027|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126618170|NCT01587703|455559028|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126618171|NCT01587703|455559029|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
126618172|NCT01587703|455559011|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618173|NCT01587703|455559012|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618174|NCT01587703|455559013|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618175|NCT01587703|455559014|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618176|NCT01587703|455559015|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618177|NCT01587703|455559016|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618178|NCT01587703|455559017|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618179|NCT01587703|455559018|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618180|NCT01587703|455559019|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
126618181|NCT01587703|455559020|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
126618182|NCT01587703|455559021|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
126618183|NCT01587703|455559022|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618184|NCT01587703|455559023|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618185|NCT01587703|455559024|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618186|NCT01587703|455559025|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618187|NCT01587703|455559026|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618188|NCT01587703|455559027|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618189|NCT01587703|455559028|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618190|NCT01587703|455559029|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
126618191|NCT01587703|455559011|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618192|NCT01587703|455559012|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618193|NCT01587703|455559013|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618194|NCT01587703|455559014|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618195|NCT01587703|455559015|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618196|NCT01587703|455559016|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618197|NCT01587703|455559017|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618198|NCT01587703|455559018|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618199|NCT01587703|455559019|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
126618200|NCT01587703|455559020|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618201|NCT01587703|455559021|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
126618202|NCT01587703|455559022|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618203|NCT01587703|455559023|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618204|NCT01587703|455559024|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618205|NCT01587703|455559025|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126746678|NCT02415595|456022044|FG003|Overall Study|Other|0|||
126746679|NCT02614261|456022045|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
126618206|NCT01587703|455559026|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618207|NCT01587703|455559027|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618208|NCT01587703|455559028|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618209|NCT01587703|455559029|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
126618210|NCT01587703|455559011|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618211|NCT01587703|455559012|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618212|NCT01587703|455559013|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618213|NCT01587703|455559014|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618214|NCT01587703|455559015|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618215|NCT01587703|455559016|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618216|NCT01587703|455559017|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618217|NCT01587703|455559018|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618218|NCT01587703|455559019|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618219|NCT01587703|455559020|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
126618220|NCT01587703|455559021|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
126618221|NCT01587703|455559022|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618222|NCT01587703|455559023|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618223|NCT01587703|455559024|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618224|NCT01587703|455559025|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618225|NCT01587703|455559026|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618226|NCT01587703|455559027|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618227|NCT01587703|455559028|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618228|NCT01587703|455559029|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
126618229|NCT01587703|455559011|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618230|NCT01587703|455559012|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618231|NCT01587703|455559013|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618232|NCT01587703|455559014|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618233|NCT01587703|455559015|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618234|NCT01587703|455559016|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618235|NCT01587703|455559017|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618236|NCT01587703|455559018|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618237|NCT01587703|455559019|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
126618238|NCT01587703|455559020|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618239|NCT01587703|455559021|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618240|NCT01587703|455559022|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618241|NCT01587703|455559023|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618242|NCT01587703|455559024|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618243|NCT01587703|455559025|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618244|NCT01587703|455559026|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618245|NCT01587703|455559027|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618246|NCT01587703|455559028|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618247|NCT01587703|455559029|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
126618248|NCT01587703|455559011|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618249|NCT01587703|455559012|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618250|NCT01587703|455559013|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618251|NCT01587703|455559014|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618252|NCT01587703|455559015|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618253|NCT01587703|455559016|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618254|NCT01587703|455559017|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618255|NCT01587703|455559018|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618256|NCT01587703|455559019|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618257|NCT01587703|455559020|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618258|NCT01587703|455559021|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618259|NCT01587703|455559022|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618260|NCT01587703|455559023|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618261|NCT01587703|455559024|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618262|NCT01587703|455559025|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618263|NCT01587703|455559026|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618264|NCT01587703|455559027|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618265|NCT01587703|455559028|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
126618266|NCT01587703|455559029|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
126618267|NCT01587703|455559011|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618268|NCT01587703|455559012|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618269|NCT01587703|455559013|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618270|NCT01587703|455559014|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618271|NCT01587703|455559015|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618272|NCT01587703|455559016|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126781901|NCT00095199|456156303|FG000|Overall Study|Adverse Event|40|||
126781902|NCT00095199|456156304|FG001|Overall Study|Adverse Event|22|||
126781903|NCT00095199|456156305|FG002|Overall Study|Adverse Event|26|||
126781904|NCT00095199|456156306|FG003|Overall Study|Adverse Event|11|||
126781905|NCT00095199|456156303|FG000|Overall Study|Progressive disease|213|||
126781906|NCT00095199|456156304|FG001|Overall Study|Progressive disease|179|||
126781907|NCT00095199|456156305|FG002|Overall Study|Progressive disease|105|||
126781908|NCT00095199|456156306|FG003|Overall Study|Progressive disease|98|||
126781909|NCT00095199|456156303|FG000|Overall Study|Death|10|||
126781910|NCT00095199|456156304|FG001|Overall Study|Death|6|||
126781911|NCT00095199|456156305|FG002|Overall Study|Death|11|||
126781912|NCT00095199|456156306|FG003|Overall Study|Death|9|||
126781913|NCT00095199|456156303|FG000|Overall Study|Withdrawal by Subject|21|||
126781914|NCT00095199|456156304|FG001|Overall Study|Withdrawal by Subject|16|||
126781915|NCT00095199|456156305|FG002|Overall Study|Withdrawal by Subject|13|||
126781916|NCT00095199|456156306|FG003|Overall Study|Withdrawal by Subject|22|||
126781917|NCT00095199|456156303|FG000|Overall Study|Protocol Violation|4|||
126781918|NCT00095199|456156304|FG001|Overall Study|Protocol Violation|4|||
126781919|NCT00095199|456156305|FG002|Overall Study|Protocol Violation|2|||
126781920|NCT00095199|456156306|FG003|Overall Study|Protocol Violation|0|||
126781921|NCT00095199|456156303|FG000|Overall Study|Liver function test results elevated|0|||
126781922|NCT00095199|456156304|FG001|Overall Study|Liver function test results elevated|0|||
126781923|NCT00095199|456156305|FG002|Overall Study|Liver function test results elevated|1|||
126781924|NCT00095199|456156306|FG003|Overall Study|Liver function test results elevated|1|||
126781925|NCT00095199|456156303|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
126618273|NCT01587703|455559017|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618274|NCT01587703|455559018|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618275|NCT01587703|455559019|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618276|NCT01587703|455559020|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618277|NCT01587703|455559021|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618278|NCT01587703|455559022|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618279|NCT01587703|455559023|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618280|NCT01587703|455559024|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618281|NCT01587703|455559025|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618282|NCT01587703|455559026|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618283|NCT01587703|455559027|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
126618284|NCT01587703|455559028|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
126618285|NCT01587703|455559029|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
126618286|NCT01587703|455559011|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618287|NCT01587703|455559012|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618288|NCT01587703|455559013|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618289|NCT01587703|455559014|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618290|NCT01587703|455559015|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618291|NCT01587703|455559016|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618292|NCT01587703|455559017|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618293|NCT01587703|455559018|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618294|NCT01587703|455559019|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618295|NCT01587703|455559020|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618296|NCT01587703|455559021|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618297|NCT01587703|455559022|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618298|NCT01587703|455559023|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618299|NCT01587703|455559024|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618300|NCT01587703|455559025|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618301|NCT01587703|455559026|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
126618302|NCT01587703|455559027|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618303|NCT01587703|455559028|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618304|NCT01587703|455559029|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
126618305|NCT01587703|455559011|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126781926|NCT00095199|456156304|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
126781927|NCT00095199|456156305|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
126781928|NCT00095199|456156306|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
126781929|NCT00095199|456156303|FG000|Overall Study|Physician Decision|5|||
126781930|NCT00095199|456156304|FG001|Overall Study|Physician Decision|6|||
126781931|NCT00095199|456156305|FG002|Overall Study|Physician Decision|1|||
126781932|NCT00095199|456156306|FG003|Overall Study|Physician Decision|1|||
126781933|NCT00095199|456156303|FG000|Overall Study|Not eligible|1|||
126781934|NCT00095199|456156304|FG001|Overall Study|Not eligible|7|||
126781935|NCT00095199|456156305|FG002|Overall Study|Not eligible|0|||
126781936|NCT00095199|456156306|FG003|Overall Study|Not eligible|1|||
126781937|NCT00095199|456156303|FG000|Overall Study|Started Palliative Radiotherapy|1|||
126781938|NCT00095199|456156304|FG001|Overall Study|Started Palliative Radiotherapy|0|||
126781939|NCT00095199|456156305|FG002|Overall Study|Started Palliative Radiotherapy|0|||
126781940|NCT00095199|456156306|FG003|Overall Study|Started Palliative Radiotherapy|0|||
126781941|NCT00095199|456156303|FG000|Overall Study|Started radiotherapy regimen|0|||
126781942|NCT00095199|456156304|FG001|Overall Study|Started radiotherapy regimen|1|||
126781943|NCT00095199|456156305|FG002|Overall Study|Started radiotherapy regimen|0|||
126781944|NCT00095199|456156306|FG003|Overall Study|Started radiotherapy regimen|0|||
126781945|NCT00095199|456156303|FG000|Overall Study|Primary tumor removed in other surgery|0|||
126781946|NCT00095199|456156304|FG001|Overall Study|Primary tumor removed in other surgery|1|||
126618306|NCT01587703|455559012|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618307|NCT01587703|455559013|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618308|NCT01587703|455559014|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618309|NCT01587703|455559015|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618310|NCT01587703|455559016|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618311|NCT01587703|455559017|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618312|NCT01587703|455559018|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618313|NCT01587703|455559019|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618314|NCT01587703|455559020|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618315|NCT01587703|455559021|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618316|NCT01587703|455559022|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
126618317|NCT01587703|455559023|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618318|NCT01587703|455559024|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618319|NCT01587703|455559025|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
126618320|NCT01587703|455559026|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618321|NCT01587703|455559027|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618322|NCT01587703|455559028|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618323|NCT01587703|455559029|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
126618324|NCT01587703|455559011|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618325|NCT01587703|455559012|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618326|NCT01587703|455559013|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618327|NCT01587703|455559014|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618328|NCT01587703|455559015|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618329|NCT01587703|455559016|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618330|NCT01587703|455559017|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618331|NCT01587703|455559018|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618332|NCT01587703|455559019|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618333|NCT01587703|455559020|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618334|NCT01587703|455559021|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618335|NCT01587703|455559022|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
126618336|NCT01587703|455559023|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
126618337|NCT01587703|455559024|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
126618338|NCT01587703|455559025|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
126618339|NCT01587703|455559026|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
126618340|NCT01587703|455559027|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
126618341|NCT01587703|455559028|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618342|NCT01587703|455559029|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
126618343|NCT01587703|455559011|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618344|NCT01587703|455559012|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618345|NCT01587703|455559013|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618346|NCT01587703|455559014|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618347|NCT01587703|455559015|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618348|NCT01587703|455559016|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618349|NCT01587703|455559017|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618350|NCT01587703|455559018|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618351|NCT01587703|455559019|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618352|NCT01587703|455559020|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618353|NCT01587703|455559021|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618354|NCT01587703|455559022|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
126618355|NCT01587703|455559023|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
126618356|NCT01587703|455559024|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
126618357|NCT01587703|455559025|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
126618358|NCT01587703|455559026|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
126618359|NCT01587703|455559027|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
126781947|NCT00095199|456156305|FG002|Overall Study|Primary tumor removed in other surgery|0|||
126781948|NCT00095199|456156306|FG003|Overall Study|Primary tumor removed in other surgery|0|||
126781949|NCT00095199|456156303|FG000|Overall Study|Data inadvertently lost by site|1|||
126781950|NCT00095199|456156304|FG001|Overall Study|Data inadvertently lost by site|0|||
126781951|NCT00095199|456156305|FG002|Overall Study|Data inadvertently lost by site|0|||
126618360|NCT01587703|455559028|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618361|NCT01587703|455559029|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
126618362|NCT01587703|455559011|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618363|NCT01587703|455559012|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618364|NCT01587703|455559013|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618365|NCT01587703|455559014|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618366|NCT01587703|455559015|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618367|NCT01587703|455559016|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618368|NCT01587703|455559017|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618369|NCT01587703|455559018|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618370|NCT01587703|455559019|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618371|NCT01587703|455559020|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618372|NCT01587703|455559021|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618373|NCT01587703|455559022|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
126618374|NCT01587703|455559023|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618375|NCT01587703|455559024|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618376|NCT01587703|455559025|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618377|NCT01587703|455559026|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618378|NCT01587703|455559027|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618379|NCT01587703|455559028|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618380|NCT01587703|455559029|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
126618381|NCT01714947|455559030|FG000|Part B|Progressive Disease|3|||
126618382|NCT01922102|455559031|FG000|Overall Study|Withdrawal by Subject|7|||
126618383|NCT01922102|455559032|FG001|Overall Study|Withdrawal by Subject|3|||
126618384|NCT01922102|455559033|FG002|Overall Study|Withdrawal by Subject|7|||
126618385|NCT01922102|455559031|FG000|Overall Study|Physician Decision|0|||
126618386|NCT01922102|455559032|FG001|Overall Study|Physician Decision|2|||
126618387|NCT01922102|455559033|FG002|Overall Study|Physician Decision|1|||
126618388|NCT01922102|455559031|FG000|Overall Study|Adverse Event|1|||
126618389|NCT01922102|455559032|FG001|Overall Study|Adverse Event|2|||
126618390|NCT01922102|455559033|FG002|Overall Study|Adverse Event|0|||
126618391|NCT01922102|455559031|FG000|Overall Study|Lost to Follow-up|1|||
126618392|NCT01922102|455559032|FG001|Overall Study|Lost to Follow-up|0|||
126618393|NCT01922102|455559033|FG002|Overall Study|Lost to Follow-up|0|||
126618394|NCT01922102|455559031|FG000|Overall Study|Administrative problems|0|||
126618395|NCT01922102|455559032|FG001|Overall Study|Administrative problems|2|||
126618396|NCT01922102|455559033|FG002|Overall Study|Administrative problems|0|||
126618397|NCT01799993|455559037|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
126618398|NCT01799993|455559038|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
126618399|NCT01799993|455559037|FG000|Overall Study|Death|61|||
126618400|NCT01799993|455559038|FG001|Overall Study|Death|45|||
126618401|NCT01799993|455559037|FG000|Overall Study|Withdrawal by Subject|23|||
126618402|NCT01799993|455559038|FG001|Overall Study|Withdrawal by Subject|24|||
126618403|NCT01799993|455559037|FG000|Overall Study|Lost to Follow-up|5|||
126618404|NCT01799993|455559038|FG001|Overall Study|Lost to Follow-up|8|||
126618405|NCT01799993|455559037|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
126618406|NCT01799993|455559038|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
126618407|NCT01799993|455559037|FG000|Overall Study|Protocol driven decision point|0|||
126618408|NCT01799993|455559038|FG001|Overall Study|Protocol driven decision point|3|||
126618409|NCT01799993|455559037|FG000|Overall Study|Protocol Violation|1|||
126618410|NCT01799993|455559038|FG001|Overall Study|Protocol Violation|1|||
126618411|NCT01799993|455559037|FG000|Overall Study|Deterioration of general conditions|2|||
126618412|NCT01799993|455559038|FG001|Overall Study|Deterioration of general conditions|0|||
126618413|NCT01799993|455559037|FG000|Overall Study|Screen failure|0|||
126618414|NCT01799993|455559038|FG001|Overall Study|Screen failure|1|||
126618415|NCT01799993|455559037|FG000|Overall Study|Adverse Event|1|||
126618416|NCT01799993|455559038|FG001|Overall Study|Adverse Event|0|||
126618417|NCT01799993|455559037|FG000|Overall Study|Lack of Efficacy|1|||
126618418|NCT01799993|455559038|FG001|Overall Study|Lack of Efficacy|0|||
126618419|NCT01799993|455559037|FG000|Overall Study|Recovery|0|||
126618420|NCT01799993|455559038|FG001|Overall Study|Recovery|1|||
126618421|NCT01799993|455559037|FG000|Overall Study|Logistical difficulties|1|||
126618422|NCT01799993|455559038|FG001|Overall Study|Logistical difficulties|0|||
126618423|NCT01799993|455559037|FG000|Overall Study|Protocol deviation|1|||
126618424|NCT01799993|455559038|FG001|Overall Study|Protocol deviation|0|||
126618425|NCT01799993|455559037|FG000|Overall Study|Non-compliance with medical device|1|||
126618426|NCT01799993|455559038|FG001|Overall Study|Non-compliance with medical device|0|||
126618427|NCT01799993|455559037|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126618428|NCT01799993|455559038|FG001|Overall Study|Withdrawal by parent/guardian|1|||
126618429|NCT01799993|455559037|FG000|Overall Study|Other|1|||
126618430|NCT01799993|455559038|FG001|Overall Study|Other|0|||
126618431|NCT01799993|455559037|FG000|Overall Study|Subject didn't return for follow-up|0|||
126618432|NCT01799993|455559038|FG001|Overall Study|Subject didn't return for follow-up|1|||
126618433|NCT04271254|455559039|FG000|Overall Study|Withdrawal by Subject|3|||
126618434|NCT04410445|455559040|FG000|Overall Study|Lost to Follow-up|3|||
126618435|NCT04410445|455559041|FG001|Overall Study|Lost to Follow-up|9|||
126618436|NCT04410445|455559040|FG000|Overall Study|Withdrawal by Subject|27|||
126618437|NCT04410445|455559041|FG001|Overall Study|Withdrawal by Subject|15|||
126618438|NCT01123356|455559042|FG000|Overall Study|Adverse Event|2|||
126618439|NCT01123356|455559042|FG000|Overall Study|Lack of Efficacy|4|||
126618440|NCT01123356|455559042|FG000|Overall Study|Withdrawal by Subject|1|||
126618441|NCT02823574|455559047|FG000|Randomization|Disease Progression|0|||
126618442|NCT02823574|455559048|FG001|Randomization|Disease Progression|0|||
126618443|NCT02823574|455559049|FG002|Randomization|Disease Progression|1|||
126618444|NCT02823574|455559050|FG003|Randomization|Disease Progression|0|||
126618445|NCT02823574|455559047|FG000|Randomization|AE unrelated to Study Drug|1|||
126618446|NCT02823574|455559048|FG001|Randomization|AE unrelated to Study Drug|0|||
126618447|NCT02823574|455559049|FG002|Randomization|AE unrelated to Study Drug|0|||
126618448|NCT02823574|455559050|FG003|Randomization|AE unrelated to Study Drug|0|||
126618449|NCT02823574|455559047|FG000|Treatment Period|Poor/Non Compliance|1|||
126618450|NCT02823574|455559048|FG001|Treatment Period|Poor/Non Compliance|0|||
126618451|NCT02823574|455559049|FG002|Treatment Period|Poor/Non Compliance|0|||
126618452|NCT02823574|455559050|FG003|Treatment Period|Poor/Non Compliance|1|||
126618453|NCT02823574|455559047|FG000|Treatment Period|Maximum Clinical Benefit|8|||
126618454|NCT02823574|455559048|FG001|Treatment Period|Maximum Clinical Benefit|4|||
126618455|NCT02823574|455559049|FG002|Treatment Period|Maximum Clinical Benefit|7|||
126618456|NCT02823574|455559050|FG003|Treatment Period|Maximum Clinical Benefit|1|||
126618457|NCT02823574|455559047|FG000|Treatment Period|Lost to Follow-up|1|||
126618458|NCT02823574|455559048|FG001|Treatment Period|Lost to Follow-up|1|||
126618459|NCT02823574|455559049|FG002|Treatment Period|Lost to Follow-up|0|||
126618460|NCT02823574|455559050|FG003|Treatment Period|Lost to Follow-up|0|||
126618461|NCT02823574|455559047|FG000|Treatment Period|Participant withdrew consent|4|||
126618462|NCT02823574|455559048|FG001|Treatment Period|Participant withdrew consent|0|||
126618463|NCT02823574|455559049|FG002|Treatment Period|Participant withdrew consent|0|||
126618464|NCT02823574|455559050|FG003|Treatment Period|Participant withdrew consent|1|||
126618465|NCT02823574|455559047|FG000|Treatment Period|Participant request to discontinue|5|||
126618466|NCT02823574|455559048|FG001|Treatment Period|Participant request to discontinue|0|||
126618467|NCT02823574|455559049|FG002|Treatment Period|Participant request to discontinue|3|||
126618468|NCT02823574|455559050|FG003|Treatment Period|Participant request to discontinue|2|||
126618469|NCT02823574|455559047|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
126618470|NCT02823574|455559048|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
126618471|NCT02823574|455559049|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
126618472|NCT02823574|455559050|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
126618473|NCT02823574|455559047|FG000|Treatment Period|Study Drug Toxicity|11|||
126618474|NCT02823574|455559048|FG001|Treatment Period|Study Drug Toxicity|2|||
126618475|NCT02823574|455559049|FG002|Treatment Period|Study Drug Toxicity|14|||
126618476|NCT02823574|455559050|FG003|Treatment Period|Study Drug Toxicity|4|||
126618477|NCT02823574|455559047|FG000|Treatment Period|Disease Progression|113|||
126618478|NCT02823574|455559048|FG001|Treatment Period|Disease Progression|64|||
126618479|NCT02823574|455559049|FG002|Treatment Period|Disease Progression|82|||
126618480|NCT02823574|455559050|FG003|Treatment Period|Disease Progression|43|||
126618481|NCT02823574|455559047|FG000|Treatment Period|Other reasons|5|||
126618482|NCT02823574|455559048|FG001|Treatment Period|Other reasons|9|||
126618483|NCT02823574|455559049|FG002|Treatment Period|Other reasons|3|||
126618484|NCT02823574|455559050|FG003|Treatment Period|Other reasons|6|||
126618485|NCT02823574|455559047|FG000|Treatment Period|Participant no longer meets study criteria|0|||
126618486|NCT02823574|455559048|FG001|Treatment Period|Participant no longer meets study criteria|0|||
126618487|NCT02823574|455559049|FG002|Treatment Period|Participant no longer meets study criteria|1|||
126618488|NCT02823574|455559050|FG003|Treatment Period|Participant no longer meets study criteria|0|||
126618489|NCT02823574|455559047|FG000|Treatment Period|Death|0|||
126618490|NCT02823574|455559048|FG001|Treatment Period|Death|0|||
126618491|NCT02823574|455559049|FG002|Treatment Period|Death|3|||
126618492|NCT02823574|455559050|FG003|Treatment Period|Death|1|||
126618493|NCT01494467|455559051|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
126618494|NCT01494467|455559052|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
126618495|NCT01494467|455559051|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
126618496|NCT01494467|455559052|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
126618497|NCT01494467|455559051|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
126618498|NCT01494467|455559052|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
126618499|NCT01494467|455559051|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
126618500|NCT01494467|455559052|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
126618501|NCT01494467|455559051|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
126618502|NCT01494467|455559052|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
126618503|NCT01494467|455559051|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
126618504|NCT01494467|455559052|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
126618505|NCT01494467|455559051|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
126618506|NCT01494467|455559052|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
126618507|NCT01494467|455559051|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
126618508|NCT01494467|455559052|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
126618509|NCT01494467|455559051|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
126618510|NCT01494467|455559052|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
126618511|NCT01494467|455559051|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
126618512|NCT01494467|455559052|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
126618513|NCT01494467|455559051|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
126618514|NCT01494467|455559052|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
126618515|NCT01494467|455559051|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
126618516|NCT01494467|455559052|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
126618517|NCT01494467|455559051|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
126618518|NCT01494467|455559052|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
126618519|NCT01494467|455559051|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
126618520|NCT01494467|455559052|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
126618521|NCT00417885|455559053|FG000|Overall Study|Adverse Event|1|||
126618522|NCT00417885|455559053|FG000|Overall Study|Objective Progression or Relapse|3|||
126618523|NCT00417885|455559053|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
126618524|NCT03262389|455559054|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
126618525|NCT03262389|455559054|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
126618526|NCT03262389|455559054|FG000|Overall Study|opted out of PET/MR|1|||
126618527|NCT01190436|455559055|FG000|Overall Study|Lost to Follow-up|35|||
126618528|NCT01190436|455559055|FG000|Overall Study|Other|4|||
126618529|NCT02721147|455559056|FG000|Overall Study|Lost to Follow-up|2|||
126618530|NCT02721147|455559057|FG001|Overall Study|Lost to Follow-up|0|||
126618531|NCT02721147|455559058|FG002|Overall Study|Lost to Follow-up|0|||
126618532|NCT01052272|455559059|FG000|Overall Study|Death|0|||
126618533|NCT01052272|455559060|FG001|Overall Study|Death|0|||
126618534|NCT01052272|455559061|FG002|Overall Study|Death|1|||
126618535|NCT01052272|455559062|FG003|Overall Study|Death|1|||
126618536|NCT01052272|455559059|FG000|Overall Study|Physician Decision|0|||
126618537|NCT01052272|455559060|FG001|Overall Study|Physician Decision|1|||
126618538|NCT01052272|455559061|FG002|Overall Study|Physician Decision|0|||
126618539|NCT01052272|455559062|FG003|Overall Study|Physician Decision|0|||
126618540|NCT01052272|455559059|FG000|Overall Study|patient refuses follow-up|5|||
126618541|NCT01052272|455559060|FG001|Overall Study|patient refuses follow-up|4|||
126618542|NCT01052272|455559061|FG002|Overall Study|patient refuses follow-up|2|||
126618543|NCT01052272|455559062|FG003|Overall Study|patient refuses follow-up|4|||
126618544|NCT01052272|455559059|FG000|Overall Study|Withdrawal by Subject|0|||
126618545|NCT01052272|455559060|FG001|Overall Study|Withdrawal by Subject|2|||
126618546|NCT01052272|455559061|FG002|Overall Study|Withdrawal by Subject|3|||
126618547|NCT01052272|455559062|FG003|Overall Study|Withdrawal by Subject|2|||
126618548|NCT01052272|455559059|FG000|Overall Study|placed in long-term care|0|||
126618549|NCT01052272|455559060|FG001|Overall Study|placed in long-term care|0|||
126618550|NCT01052272|455559061|FG002|Overall Study|placed in long-term care|1|||
126618551|NCT01052272|455559062|FG003|Overall Study|placed in long-term care|0|||
126618552|NCT01052272|455559059|FG000|Overall Study|decline in health|0|||
126618553|NCT01052272|455559060|FG001|Overall Study|decline in health|0|||
126618554|NCT01052272|455559061|FG002|Overall Study|decline in health|1|||
126618555|NCT01052272|455559062|FG003|Overall Study|decline in health|0|||
126618556|NCT01722097|455559064|FG000|Overall Study|Patient sheets not returned|6|||
126618557|NCT01722097|455559065|FG001|Overall Study|Patient sheets not returned|5|||
126618558|NCT02009332|455559066|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
126618559|NCT02009332|455559067|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
126618560|NCT02009332|455559068|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
126618561|NCT02009332|455559069|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
126618562|NCT02009332|455559070|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
126618563|NCT02009332|455559071|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
126618564|NCT02009332|455559066|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
126618565|NCT02009332|455559067|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
126618566|NCT02009332|455559068|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
126618567|NCT02009332|455559069|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
126618568|NCT02009332|455559070|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
126618569|NCT02009332|455559071|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
126618570|NCT02009332|455559066|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
126618571|NCT02009332|455559067|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
126618572|NCT02009332|455559068|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
126618573|NCT02009332|455559069|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
126618574|NCT02009332|455559070|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
126618575|NCT02009332|455559071|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
126618576|NCT04739306|455559072|FG000|Main Study Period|Adverse Event|6|||
126618577|NCT04739306|455559073|FG001|Main Study Period|Adverse Event|7|||
126618578|NCT04739306|455559072|FG000|Main Study Period|Lost to Follow-up|4|||
126618579|NCT04739306|455559073|FG001|Main Study Period|Lost to Follow-up|6|||
126618580|NCT04739306|455559072|FG000|Main Study Period|Physician Decision|1|||
126618581|NCT04739306|455559073|FG001|Main Study Period|Physician Decision|1|||
126618582|NCT04739306|455559072|FG000|Main Study Period|Withdrawal by Subject|8|||
126618583|NCT04739306|455559073|FG001|Main Study Period|Withdrawal by Subject|6|||
126618584|NCT04739306|455559072|FG000|Main Study Period|Protocol Violation|0|||
126618585|NCT04739306|455559073|FG001|Main Study Period|Protocol Violation|1|||
126618586|NCT04739306|455559072|FG000|Main Study Period|War in Ukraine|1|||
126618587|NCT04739306|455559073|FG001|Main Study Period|War in Ukraine|1|||
126618588|NCT01077284|455559074|FG000|Overall Study|Adverse Event|2|||
126618589|NCT01077284|455559075|FG001|Overall Study|Adverse Event|0|||
126618590|NCT01077284|455559076|FG002|Overall Study|Adverse Event|1|||
126618591|NCT01077284|455559074|FG000|Overall Study|Lost to Follow-up|1|||
126618592|NCT01077284|455559075|FG001|Overall Study|Lost to Follow-up|2|||
126618593|NCT01077284|455559076|FG002|Overall Study|Lost to Follow-up|0|||
126618594|NCT01077284|455559074|FG000|Overall Study|Withdrawal by Subject|2|||
126618595|NCT01077284|455559075|FG001|Overall Study|Withdrawal by Subject|3|||
126618596|NCT01077284|455559076|FG002|Overall Study|Withdrawal by Subject|1|||
126618597|NCT01077284|455559074|FG000|Overall Study|Other|0|||
126618598|NCT01077284|455559075|FG001|Overall Study|Other|0|||
126618599|NCT01077284|455559076|FG002|Overall Study|Other|1|||
126618600|NCT01180400|455559077|FG000|Overall Study|Withdrawal by Subject|5|||
126618601|NCT01180400|455559078|FG001|Overall Study|Withdrawal by Subject|6|||
126618602|NCT01180400|455559077|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126618603|NCT01180400|455559078|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
126618604|NCT01180400|455559077|FG000|Overall Study|Adverse Event|12|||
126618605|NCT01180400|455559078|FG001|Overall Study|Adverse Event|10|||
126618606|NCT01180400|455559077|FG000|Overall Study|Severe non-compliance to protocol|1|||
126618607|NCT01180400|455559078|FG001|Overall Study|Severe non-compliance to protocol|2|||
126618608|NCT01180400|455559077|FG000|Overall Study|Condition under investigation worsened|2|||
126618609|NCT01180400|455559078|FG001|Overall Study|Condition under investigation worsened|1|||
126618610|NCT01180400|455559077|FG000|Overall Study|Lack of Efficacy|2|||
126618611|NCT01180400|455559078|FG001|Overall Study|Lack of Efficacy|0|||
126618612|NCT01180400|455559077|FG000|Overall Study|Study-specific withdrawal criteria|1|||
126618613|NCT01180400|455559078|FG001|Overall Study|Study-specific withdrawal criteria|2|||
126618614|NCT01180400|455559077|FG000|Overall Study|Lost to Follow-up|2|||
126618615|NCT01180400|455559078|FG001|Overall Study|Lost to Follow-up|3|||
126618616|NCT01180400|455559077|FG000|Overall Study|Other|0|||
126618617|NCT01180400|455559078|FG001|Overall Study|Other|1|||
126618618|NCT00096278|455559080|FG000|Overall Study|No follow-up data|15|||
126618619|NCT00096278|455559081|FG001|Overall Study|No follow-up data|18|||
126618620|NCT00096278|455559080|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
126618621|NCT00096278|455559081|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
126618622|NCT00248794|455559082|FG000|Overall Study|Lost to Follow-up|6|||
126618623|NCT00248794|455559083|FG001|Overall Study|Lost to Follow-up|8|||
126618624|NCT00248794|455559084|FG002|Overall Study|Lost to Follow-up|3|||
126618625|NCT00821093|455559091|FG000|Overall Study|Adverse Event|20|||
126618626|NCT00821093|455559092|FG001|Overall Study|Adverse Event|12|||
126618627|NCT00821093|455559091|FG000|Overall Study|Withdrawal by Subject|9|||
126618628|NCT00821093|455559092|FG001|Overall Study|Withdrawal by Subject|13|||
126618629|NCT00821093|455559091|FG000|Overall Study|Lost to Follow-up|9|||
126618630|NCT00821093|455559092|FG001|Overall Study|Lost to Follow-up|3|||
126618631|NCT00821093|455559091|FG000|Overall Study|Protocol deviation|3|||
126618632|NCT00821093|455559092|FG001|Overall Study|Protocol deviation|6|||
126618633|NCT00821093|455559091|FG000|Overall Study|Abnormal laboratory value(s)|2|||
126618634|NCT00821093|455559092|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126618635|NCT00821093|455559091|FG000|Overall Study|Lack of Efficacy|2|||
126618636|NCT00821093|455559092|FG001|Overall Study|Lack of Efficacy|2|||
126618637|NCT00821093|455559091|FG000|Overall Study|Death|2|||
126618638|NCT00821093|455559092|FG001|Overall Study|Death|1|||
126618639|NCT00821093|455559091|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126618640|NCT00821093|455559092|FG001|Overall Study|Abnormal test procedure result(s)|1|||
126618641|NCT00821093|455559091|FG000|Overall Study|Administrative problems|1|||
126618642|NCT00821093|455559092|FG001|Overall Study|Administrative problems|2|||
126618643|NCT03444155|455559093|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
126618644|NCT03444155|455559094|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
126618645|NCT02877680|455559099|FG000|Overall Study|Lost to Follow-up|1|||
126618646|NCT02877680|455559100|FG001|Overall Study|Lost to Follow-up|1|||
126618647|NCT01133678|455559101|FG000|Overall Study|Death|1|||
126618648|NCT01133678|455559102|FG001|Overall Study|Death|1|||
126618649|NCT05104242|455559103|FG000|Overall Study|Withdrawal by Subject|1|||
126618650|NCT05104242|455559104|FG001|Overall Study|Withdrawal by Subject|5|||
126618651|NCT05104242|455559103|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
126618652|NCT05104242|455559104|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
126618653|NCT00424476|455559106|FG000|Overall Study|Withdrawal by Subject|7|||
126618654|NCT00424476|455559107|FG001|Overall Study|Withdrawal by Subject|6|||
126618655|NCT00424476|455559108|FG002|Overall Study|Withdrawal by Subject|3|||
126618656|NCT00424476|455559106|FG000|Overall Study|Adverse Event|19|||
126618657|NCT00424476|455559107|FG001|Overall Study|Adverse Event|16|||
126618658|NCT00424476|455559108|FG002|Overall Study|Adverse Event|15|||
126618659|NCT00424476|455559106|FG000|Overall Study|Lack of Efficacy|16|||
126618660|NCT00424476|455559107|FG001|Overall Study|Lack of Efficacy|12|||
126618661|NCT00424476|455559108|FG002|Overall Study|Lack of Efficacy|12|||
126618662|NCT00424476|455559106|FG000|Overall Study|Lack of Compliance|1|||
126618663|NCT00424476|455559107|FG001|Overall Study|Lack of Compliance|1|||
126618664|NCT00424476|455559108|FG002|Overall Study|Lack of Compliance|1|||
126618665|NCT00424476|455559106|FG000|Overall Study|Lost to Follow-up|4|||
126618666|NCT00424476|455559107|FG001|Overall Study|Lost to Follow-up|6|||
126618667|NCT00424476|455559108|FG002|Overall Study|Lost to Follow-up|3|||
126618668|NCT00424476|455559106|FG000|Overall Study|Protocol Violation|7|||
126618669|NCT00424476|455559107|FG001|Overall Study|Protocol Violation|2|||
126618670|NCT00424476|455559108|FG002|Overall Study|Protocol Violation|3|||
126618671|NCT00424476|455559106|FG000|Overall Study|Physician Decision|3|||
126618672|NCT00424476|455559107|FG001|Overall Study|Physician Decision|2|||
126618673|NCT00424476|455559108|FG002|Overall Study|Physician Decision|3|||
126618674|NCT00424476|455559106|FG000|Overall Study|Other|4|||
126618675|NCT00424476|455559107|FG001|Overall Study|Other|3|||
126618676|NCT00424476|455559108|FG002|Overall Study|Other|9|||
126618677|NCT02574286|455559109|FG000|Overall Study|Adverse Event|3|||
126618678|NCT02574286|455559109|FG000|Overall Study|Withdrawal by Subject|2|||
126618679|NCT01280656|455559110|FG000|Overall Study|Adverse Event|1|||
126618680|NCT01280656|455559111|FG001|Overall Study|Adverse Event|14|||
126618681|NCT01280656|455559112|FG002|Overall Study|Adverse Event|13|||
126618682|NCT01280656|455559110|FG000|Overall Study|Lack of Efficacy|1|||
126618683|NCT01280656|455559111|FG001|Overall Study|Lack of Efficacy|22|||
126618684|NCT01280656|455559112|FG002|Overall Study|Lack of Efficacy|38|||
126618685|NCT01280656|455559110|FG000|Overall Study|Treatment shortening (RGT)|0|||
126618686|NCT01280656|455559111|FG001|Overall Study|Treatment shortening (RGT)|4|||
126618687|NCT01280656|455559112|FG002|Overall Study|Treatment shortening (RGT)|5|||
126618688|NCT01280656|455559110|FG000|Overall Study|Other|1|||
126618689|NCT01280656|455559111|FG001|Overall Study|Other|7|||
126618690|NCT01280656|455559112|FG002|Overall Study|Other|7|||
126618691|NCT00736502|455559113|FG000|Overall Study|Adverse Event|22|||
126618692|NCT00736502|455559113|FG000|Overall Study|Lack of Efficacy|16|||
126618693|NCT00736502|455559113|FG000|Overall Study|Lost to Follow-up|27|||
126618694|NCT00608959|455561084|FG000|Part 1|Did not meet eligibility criteria|1|||
126618695|NCT01005602|455561087|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
126618696|NCT01005602|455561088|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
126618697|NCT01248715|455561089|FG000|Overall Study|Not influenza positive|501|||
126618698|NCT01248715|455561090|FG001|Overall Study|Not influenza positive|510|||
126618699|NCT03409276|455561096|FG000|Overall Study|Withdrawal by Subject|0|||
126618700|NCT03409276|455561097|FG001|Overall Study|Withdrawal by Subject|0|||
126618701|NCT03409276|455561098|FG002|Overall Study|Withdrawal by Subject|0|||
126618702|NCT03409276|455561099|FG003|Overall Study|Withdrawal by Subject|0|||
126618703|NCT03409276|455561100|FG004|Overall Study|Withdrawal by Subject|1|||
126618704|NCT03409276|455561096|FG000|Overall Study|Lost to Follow-up|0|||
126618705|NCT03409276|455561097|FG001|Overall Study|Lost to Follow-up|0|||
126618706|NCT03409276|455561098|FG002|Overall Study|Lost to Follow-up|0|||
126618707|NCT03409276|455561099|FG003|Overall Study|Lost to Follow-up|2|||
126618708|NCT03409276|455561100|FG004|Overall Study|Lost to Follow-up|2|||
126618709|NCT03605745|455561101|FG000|Overall Study|Study was terminated for business reasons|47|||
126618710|NCT01279447|455561102|FG000|Overall Study|Lost to Follow-up|3|||
126618711|NCT01279447|455561103|FG001|Overall Study|Lost to Follow-up|1|||
126618712|NCT01215253|455561104|FG000|Overall Study|Withdrawal by Subject|57|||
126618713|NCT01215253|455561105|FG001|Overall Study|Withdrawal by Subject|35|||
126618714|NCT01215253|455561104|FG000|Overall Study|Physician Decision|9|||
126618715|NCT01215253|455561105|FG001|Overall Study|Physician Decision|12|||
126618716|NCT01215253|455561104|FG000|Overall Study|Lost to Follow-up|6|||
126618717|NCT01215253|455561105|FG001|Overall Study|Lost to Follow-up|4|||
126618718|NCT01215253|455561104|FG000|Overall Study|Other|14|||
126618719|NCT01215253|455561105|FG001|Overall Study|Other|12|||
126618720|NCT00828139|455561110|FG000|Overall Study|Adverse Event|8|||
126618721|NCT00828139|455561111|FG001|Overall Study|Adverse Event|1|||
126618722|NCT00828139|455561112|FG002|Overall Study|Adverse Event|10|||
126618723|NCT00828139|455561113|FG003|Overall Study|Adverse Event|5|||
126618724|NCT00828139|455561110|FG000|Overall Study|Death|2|||
126618725|NCT00828139|455561111|FG001|Overall Study|Death|1|||
126618726|NCT00828139|455561112|FG002|Overall Study|Death|0|||
126618727|NCT00828139|455561113|FG003|Overall Study|Death|2|||
126618728|NCT00828139|455561110|FG000|Overall Study|Refusal unrelated to toxicity|3|||
126618729|NCT00828139|455561111|FG001|Overall Study|Refusal unrelated to toxicity|4|||
126618730|NCT00828139|455561112|FG002|Overall Study|Refusal unrelated to toxicity|5|||
126618731|NCT00828139|455561113|FG003|Overall Study|Refusal unrelated to toxicity|3|||
126618732|NCT00828139|455561110|FG000|Overall Study|Disease Progression|24|||
126618733|NCT00828139|455561111|FG001|Overall Study|Disease Progression|33|||
126618734|NCT00828139|455561112|FG002|Overall Study|Disease Progression|35|||
126618735|NCT00828139|455561113|FG003|Overall Study|Disease Progression|39|||
126618736|NCT00828139|455561110|FG000|Overall Study|Other|4|||
126618737|NCT00828139|455561111|FG001|Overall Study|Other|2|||
126618738|NCT00828139|455561112|FG002|Overall Study|Other|5|||
126618739|NCT00828139|455561113|FG003|Overall Study|Other|2|||
126618740|NCT01320683|455561114|FG000|Overall Study|Positive antibody response|1|||
126618741|NCT00759681|455561115|FG000|Overall Study|Death|2|||
126618742|NCT00759681|455561116|FG001|Overall Study|Death|5|||
126618743|NCT00759681|455561115|FG000|Overall Study|Lost to Follow-up|8|||
126618744|NCT00759681|455561116|FG001|Overall Study|Lost to Follow-up|5|||
126618745|NCT00476151|455561117|FG000|Overall Study|Adverse Event|0|||
126618746|NCT00476151|455561118|FG001|Overall Study|Adverse Event|2|||
126618747|NCT00476151|455561117|FG000|Overall Study|Protocol Violation|1|||
126618748|NCT00476151|455561118|FG001|Overall Study|Protocol Violation|3|||
126618749|NCT00476151|455561117|FG000|Overall Study|Withdrawal by Subject|2|||
126618750|NCT00476151|455561118|FG001|Overall Study|Withdrawal by Subject|0|||
126618751|NCT00476151|455561117|FG000|Overall Study|Physician Decision|0|||
126618752|NCT00476151|455561118|FG001|Overall Study|Physician Decision|2|||
126618753|NCT02005484|455561123|FG000|Overall Study|Death|1|||
126618754|NCT02005484|455561123|FG000|Overall Study|Disease progression|1|||
126618755|NCT02005484|455561123|FG000|Overall Study|Changed to a Different Study|1|||
126618756|NCT02005484|455561123|FG000|Overall Study|Sponsor decision|1|||
126618757|NCT01129011|455561124|FG000|Overall Study|Adverse Event|20|||
126618758|NCT01129011|455561125|FG001|Overall Study|Adverse Event|30|||
126618759|NCT01129011|455561124|FG000|Overall Study|Withdrawal by Subject|24|||
126618760|NCT01129011|455561125|FG001|Overall Study|Withdrawal by Subject|8|||
126618761|NCT01129011|455561124|FG000|Overall Study|Lost to Follow-up|6|||
126618762|NCT01129011|455561125|FG001|Overall Study|Lost to Follow-up|7|||
126618763|NCT01129011|455561124|FG000|Overall Study|Duodenal Ulcer|2|||
126618764|NCT01129011|455561125|FG001|Overall Study|Duodenal Ulcer|8|||
126618765|NCT01129011|455561124|FG000|Overall Study|misc|7|||
126618766|NCT01129011|455561125|FG001|Overall Study|misc|4|||
126618767|NCT01113541|455561129|FG000|Overall Study|Withdrawal by Subject|1|||
126618768|NCT01113541|455561129|FG000|Overall Study|Protocol Violation|1|||
126618769|NCT01113541|455561129|FG000|Overall Study|Study Terminated by Sponsor|7|||
126618770|NCT01113541|455561129|FG000|Overall Study|Adverse Event|4|||
126618771|NCT03745651|455561130|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
126618772|NCT03745651|455561131|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
126618773|NCT03745651|455561132|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126618774|NCT03745651|455561133|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126618775|NCT03745651|455561134|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126618776|NCT03745651|455561135|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126618777|NCT03745651|455561136|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
126618778|NCT03745651|455561130|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
126618779|NCT03745651|455561131|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
126618780|NCT03745651|455561132|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
126618781|NCT03745651|455561133|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126618782|NCT03745651|455561134|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126618783|NCT03745651|455561135|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126618784|NCT03745651|455561136|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
126618785|NCT03745651|455561130|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
126618786|NCT03745651|455561131|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126618787|NCT03745651|455561132|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
126618788|NCT03745651|455561133|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126618789|NCT03745651|455561134|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126618790|NCT03745651|455561135|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126618791|NCT03745651|455561136|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
126618792|NCT03745651|455561130|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126618793|NCT03745651|455561131|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
126618794|NCT03745651|455561132|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126618795|NCT03745651|455561133|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126618796|NCT03745651|455561134|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126618797|NCT03745651|455561135|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126618798|NCT03745651|455561136|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
126618799|NCT03745651|455561130|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
126618800|NCT03745651|455561131|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
126618801|NCT03745651|455561132|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
126618802|NCT03745651|455561133|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126618803|NCT03745651|455561134|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126618804|NCT03745651|455561135|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126618805|NCT03745651|455561136|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
126618806|NCT03745651|455561130|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
126618807|NCT03745651|455561131|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
126618808|NCT03745651|455561132|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
126618809|NCT03745651|455561133|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
126618810|NCT03745651|455561134|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
126618811|NCT03745651|455561135|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
126618812|NCT03745651|455561136|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
126618813|NCT03745651|455561130|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126618814|NCT03745651|455561131|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126618815|NCT03745651|455561132|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126618816|NCT03745651|455561133|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126618817|NCT03745651|455561134|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126618818|NCT03745651|455561135|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
126618819|NCT03745651|455561136|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
126618820|NCT03745651|455561130|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126618821|NCT03745651|455561131|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126618822|NCT03745651|455561132|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126618823|NCT03745651|455561133|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
126618824|NCT03745651|455561134|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
126618825|NCT03745651|455561135|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
126618826|NCT03745651|455561136|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
126618827|NCT03745651|455561130|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126618828|NCT03745651|455561131|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126618829|NCT03745651|455561132|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
126618830|NCT03745651|455561133|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
126618831|NCT03745651|455561134|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
126618832|NCT03745651|455561135|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
126618833|NCT03745651|455561136|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
126618834|NCT03745651|455561130|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126618835|NCT03745651|455561131|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126618836|NCT03745651|455561132|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126618837|NCT03745651|455561133|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
126618838|NCT03745651|455561134|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
126618839|NCT03745651|455561135|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
126618840|NCT03745651|455561136|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
126618841|NCT03745651|455561130|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
126618842|NCT03745651|455561131|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
126618843|NCT03745651|455561132|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
126618844|NCT03745651|455561133|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
126618845|NCT03745651|455561134|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
126618846|NCT03745651|455561135|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
126618847|NCT03745651|455561136|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
126618848|NCT03745651|455561130|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126618849|NCT03745651|455561131|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126618850|NCT03745651|455561132|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126618851|NCT03745651|455561133|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126618852|NCT03745651|455561134|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126618853|NCT03745651|455561135|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
126618854|NCT03745651|455561136|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
126618855|NCT03745651|455561130|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126618856|NCT03745651|455561131|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126618857|NCT03745651|455561132|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
126618858|NCT03745651|455561133|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
126618859|NCT03745651|455561134|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
126618860|NCT03745651|455561135|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
126618861|NCT03745651|455561136|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
126618862|NCT03745651|455561130|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
126618863|NCT03745651|455561131|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
126618864|NCT03745651|455561132|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
126618865|NCT03745651|455561133|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
126618866|NCT03745651|455561134|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
126618867|NCT03745651|455561135|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
126618868|NCT03745651|455561136|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
126618869|NCT02309892|455561139|FG000|Overall Study|Physician Decision|1|||
126781952|NCT00095199|456156306|FG003|Overall Study|Data inadvertently lost by site|0|||
126781953|NCT01896297|456156309|FG000|Overall Study|Died in post treatment phase|1|||
126781954|NCT01070394|456156310|FG000|Overall Study|Adverse Event|6|||
126781955|NCT01070394|456156310|FG000|Overall Study|Withdrawal by Subject|1|||
126781956|NCT01098240|456156311|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
126781957|NCT01098240|456156312|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
126781958|NCT01098240|456156313|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
126781959|NCT01098240|456156311|FG000|Open-Label Phase|Protocol Violation|4|||
126781960|NCT01098240|456156312|FG001|Open-Label Phase|Protocol Violation|0|||
126781961|NCT01098240|456156313|FG002|Open-Label Phase|Protocol Violation|0|||
126781962|NCT01098240|456156311|FG000|Open-Label Phase|Lost to Follow-up|13|||
126781963|NCT01098240|456156312|FG001|Open-Label Phase|Lost to Follow-up|0|||
126618870|NCT02309892|455561140|FG001|Overall Study|Physician Decision|0|||
126618871|NCT02309892|455561141|FG002|Overall Study|Physician Decision|0|||
126618872|NCT02309892|455561142|FG003|Overall Study|Physician Decision|0|||
126618873|NCT02309892|455561143|FG004|Overall Study|Physician Decision|0|||
126618874|NCT02309892|455561144|FG005|Overall Study|Physician Decision|0|||
126618875|NCT02309892|455561145|FG006|Overall Study|Physician Decision|0|||
126781964|NCT01098240|456156313|FG002|Open-Label Phase|Lost to Follow-up|0|||
126781965|NCT01098240|456156311|FG000|Open-Label Phase|Other|19|||
126781966|NCT01098240|456156312|FG001|Open-Label Phase|Other|0|||
126781967|NCT01098240|456156313|FG002|Open-Label Phase|Other|0|||
126781968|NCT01098240|456156311|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
126618876|NCT02309892|455561139|FG000|Overall Study|Adverse Event|1|||
126618877|NCT02309892|455561140|FG001|Overall Study|Adverse Event|0|||
126618878|NCT02309892|455561141|FG002|Overall Study|Adverse Event|1|||
126618879|NCT02309892|455561142|FG003|Overall Study|Adverse Event|0|||
126618880|NCT02309892|455561143|FG004|Overall Study|Adverse Event|0|||
126618881|NCT02309892|455561144|FG005|Overall Study|Adverse Event|0|||
126618882|NCT02309892|455561145|FG006|Overall Study|Adverse Event|0|||
126618883|NCT02309892|455561139|FG000|Overall Study|Progressive Disease|0|||
126618884|NCT02309892|455561140|FG001|Overall Study|Progressive Disease|1|||
126618885|NCT02309892|455561141|FG002|Overall Study|Progressive Disease|0|||
126618886|NCT02309892|455561142|FG003|Overall Study|Progressive Disease|0|||
126618887|NCT02309892|455561143|FG004|Overall Study|Progressive Disease|1|||
126618888|NCT02309892|455561144|FG005|Overall Study|Progressive Disease|0|||
126618889|NCT02309892|455561145|FG006|Overall Study|Progressive Disease|0|||
126618890|NCT02309892|455561139|FG000|Overall Study|Death|0|||
126618891|NCT02309892|455561140|FG001|Overall Study|Death|0|||
126618892|NCT02309892|455561141|FG002|Overall Study|Death|0|||
126618893|NCT02309892|455561142|FG003|Overall Study|Death|0|||
126746680|NCT02614261|456022046|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
126746681|NCT02614261|456022047|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
126746682|NCT02614261|456022048|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
126746683|NCT02614261|456022045|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
126746684|NCT02614261|456022046|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126746685|NCT02614261|456022047|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126746686|NCT02614261|456022048|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
126746687|NCT02614261|456022045|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
126746688|NCT02614261|456022046|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
126746689|NCT02614261|456022047|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
126746690|NCT02614261|456022048|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
126746691|NCT02614261|456022045|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
126746692|NCT02614261|456022046|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
126746693|NCT02614261|456022047|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
126746694|NCT02614261|456022048|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
126746695|NCT02614261|456022045|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
126746696|NCT02614261|456022046|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
126746697|NCT02614261|456022047|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
126746698|NCT02614261|456022048|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
126746699|NCT02614261|456022045|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
126746700|NCT02614261|456022046|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
126746701|NCT02614261|456022047|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
126746702|NCT02614261|456022048|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
126618894|NCT02309892|455561143|FG004|Overall Study|Death|0|||
126746703|NCT02614261|456022045|FG000|Double-Blind Treatment Phase|Screen failure|0|||
126746704|NCT02614261|456022046|FG001|Double-Blind Treatment Phase|Screen failure|1|||
126746705|NCT02614261|456022047|FG002|Double-Blind Treatment Phase|Screen failure|2|||
126746706|NCT02614261|456022048|FG003|Double-Blind Treatment Phase|Screen failure|0|||
126746707|NCT02614261|456022045|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
126746708|NCT02614261|456022046|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
126618895|NCT02309892|455561144|FG005|Overall Study|Death|1|||
126618896|NCT02309892|455561145|FG006|Overall Study|Death|0|||
126618897|NCT01894620|455561146|FG000|Overall Study|Withdrawal by Subject|0|||
126618898|NCT01894620|455561147|FG001|Overall Study|Withdrawal by Subject|1|||
126618899|NCT01124916|455561148|FG000|Overall Study|Lost to Follow-up|3|||
126618900|NCT01124916|455561149|FG001|Overall Study|Lost to Follow-up|2|||
126618901|NCT00657709|455561154|FG000|Overall Study|AE or Death|7|||
126618902|NCT00657709|455561155|FG001|Overall Study|AE or Death|7|||
126618903|NCT00657709|455561156|FG002|Overall Study|AE or Death|6|||
126618904|NCT00657709|455561157|FG003|Overall Study|AE or Death|7|||
126618905|NCT00657709|455561158|FG004|Overall Study|AE or Death|1|||
126618906|NCT00657709|455561154|FG000|Overall Study|Withdrawal by Subject|7|||
126618907|NCT00657709|455561155|FG001|Overall Study|Withdrawal by Subject|15|||
126618908|NCT00657709|455561156|FG002|Overall Study|Withdrawal by Subject|15|||
126618909|NCT00657709|455561157|FG003|Overall Study|Withdrawal by Subject|5|||
126618910|NCT00657709|455561158|FG004|Overall Study|Withdrawal by Subject|9|||
126618911|NCT00657709|455561154|FG000|Overall Study|Lost to Follow-up|9|||
126618912|NCT00657709|455561155|FG001|Overall Study|Lost to Follow-up|9|||
126618913|NCT00657709|455561156|FG002|Overall Study|Lost to Follow-up|7|||
126618914|NCT00657709|455561157|FG003|Overall Study|Lost to Follow-up|1|||
126618915|NCT00657709|455561158|FG004|Overall Study|Lost to Follow-up|21|||
126618916|NCT00657709|455561154|FG000|Overall Study|Protocol Violation|0|||
126618917|NCT00657709|455561155|FG001|Overall Study|Protocol Violation|2|||
126618918|NCT00657709|455561156|FG002|Overall Study|Protocol Violation|0|||
126618919|NCT00657709|455561157|FG003|Overall Study|Protocol Violation|1|||
126618920|NCT00657709|455561158|FG004|Overall Study|Protocol Violation|2|||
126618921|NCT05265247|455561159|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
126618922|NCT05265247|455561160|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
126618923|NCT05265247|455561159|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
126618924|NCT05265247|455561160|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
126618925|NCT05265247|455561159|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
126618926|NCT05265247|455561160|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
126618927|NCT00134056|455561163|FG000|Randomization|Not eligible for assigned treatment|22|||
126618928|NCT00134056|455561164|FG001|Randomization|Not eligible for assigned treatment|20|||
126618929|NCT00134056|455561163|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
126618930|NCT00134056|455561164|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
126618931|NCT00134056|455561163|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
126618932|NCT00134056|455561164|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
126618933|NCT00134056|455561163|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
126618934|NCT00134056|455561164|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
126618935|NCT00134056|455561163|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
126618936|NCT00134056|455561164|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
126618937|NCT02555397|455561168|FG000|Overall Study|Withdrawal by Subject|1|||
126618938|NCT02555397|455561169|FG001|Overall Study|Withdrawal by Subject|0|||
126618939|NCT02555397|455561170|FG002|Overall Study|Withdrawal by Subject|0|||
126618940|NCT02555397|455561171|FG003|Overall Study|Withdrawal by Subject|0|||
126618941|NCT02555397|455561172|FG004|Overall Study|Withdrawal by Subject|0|||
126618942|NCT00537914|455561176|FG000|Overall Study|Death|1|||
126618943|NCT00537914|455561176|FG000|Overall Study|Adverse Event|7|||
126618944|NCT00537914|455561176|FG000|Overall Study|Treatment failure|10|||
126618945|NCT00537914|455561176|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
126618946|NCT00537914|455561176|FG000|Overall Study|Lost to Follow-up|19|||
126618947|NCT00537914|455561176|FG000|Overall Study|Withdrawal of informed consent|59|||
126618948|NCT02312258|455561177|FG000|Overall Study|Lost to Follow-up|8|||
126618949|NCT02312258|455561178|FG001|Overall Study|Lost to Follow-up|8|||
126618950|NCT02312258|455561177|FG000|Overall Study|Withdrawal by Patient|49|||
126618951|NCT02312258|455561178|FG001|Overall Study|Withdrawal by Patient|76|||
126618952|NCT02312258|455561177|FG000|Overall Study|Reason not Specified|107|||
126618953|NCT02312258|455561178|FG001|Overall Study|Reason not Specified|159|||
126618954|NCT02312258|455561177|FG000|Overall Study|Missing|2|||
126618955|NCT02312258|455561178|FG001|Overall Study|Missing|1|||
126618956|NCT02312258|455561177|FG000|Overall Study|Death|115|||
126618957|NCT02312258|455561178|FG001|Overall Study|Death|181|||
126618958|NCT01468597|455561180|FG000|Overall Study|Found ineligible|17|||
126618959|NCT01468597|455561180|FG000|Overall Study|concomitant valves|12|||
126618960|NCT01468597|455561180|FG000|Overall Study|off-pump CABG|1|||
126618961|NCT01468597|455561180|FG000|Overall Study|no platelet function data|5|||
126618962|NCT02260154|455561181|FG000|Overall Study|Screening failure|2|||
126618963|NCT02561195|455561183|FG000|Vaccination 1 to 3|Adverse Event|4|||
126618964|NCT02561195|455561184|FG001|Vaccination 1 to 3|Adverse Event|5|||
126618965|NCT02561195|455561185|FG002|Vaccination 1 to 3|Adverse Event|0|||
126618966|NCT02561195|455561186|FG003|Vaccination 1 to 3|Adverse Event|3|||
126618967|NCT02561195|455561187|FG004|Vaccination 1 to 3|Adverse Event|4|||
126618968|NCT02561195|455561188|FG005|Vaccination 1 to 3|Adverse Event|0|||
126618969|NCT02561195|455561189|FG006|Vaccination 1 to 3|Adverse Event|0|||
126618970|NCT02561195|455561190|FG007|Vaccination 1 to 3|Adverse Event|0|||
126618971|NCT02561195|455561191|FG008|Vaccination 1 to 3|Adverse Event|0|||
126618972|NCT02561195|455561192|FG009|Vaccination 1 to 3|Adverse Event|0|||
126618973|NCT02561195|455561193|FG010|Vaccination 1 to 3|Adverse Event|0|||
126618974|NCT02561195|455561194|FG011|Vaccination 1 to 3|Adverse Event|0|||
126618975|NCT02561195|455561195|FG012|Vaccination 1 to 3|Adverse Event|0|||
126618976|NCT02561195|455561196|FG013|Vaccination 1 to 3|Adverse Event|0|||
126618977|NCT02561195|455561183|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
126618978|NCT02561195|455561184|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
126618979|NCT02561195|455561185|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
126618980|NCT02561195|455561186|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
126618981|NCT02561195|455561187|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
126618982|NCT02561195|455561188|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
126618983|NCT02561195|455561189|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
126618984|NCT02561195|455561190|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
126618985|NCT02561195|455561191|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
126618986|NCT02561195|455561192|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
126618987|NCT02561195|455561193|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
126618988|NCT02561195|455561194|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
126618989|NCT02561195|455561195|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
126618990|NCT02561195|455561196|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
126618991|NCT02561195|455561183|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126618992|NCT02561195|455561184|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
126618993|NCT02561195|455561185|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126618994|NCT02561195|455561186|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
126618995|NCT02561195|455561187|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
126618996|NCT02561195|455561188|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
126618997|NCT02561195|455561189|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126618998|NCT02561195|455561190|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126618999|NCT02561195|455561191|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126619000|NCT02561195|455561192|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126619001|NCT02561195|455561193|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126619002|NCT02561195|455561194|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126619003|NCT02561195|455561195|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126619004|NCT02561195|455561196|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
126619005|NCT02561195|455561183|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
126619006|NCT02561195|455561184|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
126619007|NCT02561195|455561185|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
126619008|NCT02561195|455561186|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
126619009|NCT02561195|455561187|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
126619010|NCT02561195|455561188|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
126619011|NCT02561195|455561189|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
126619012|NCT02561195|455561190|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
126619013|NCT02561195|455561191|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
126619014|NCT02561195|455561192|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
126619015|NCT02561195|455561193|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
126619016|NCT02561195|455561194|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
126619017|NCT02561195|455561195|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
126619018|NCT02561195|455561196|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
126619019|NCT02561195|455561183|FG000|Vaccination 1 to 3|Other|7|||
126619020|NCT02561195|455561184|FG001|Vaccination 1 to 3|Other|3|||
126619021|NCT02561195|455561185|FG002|Vaccination 1 to 3|Other|1|||
126619022|NCT02561195|455561186|FG003|Vaccination 1 to 3|Other|7|||
126619023|NCT02561195|455561187|FG004|Vaccination 1 to 3|Other|5|||
126619024|NCT02561195|455561188|FG005|Vaccination 1 to 3|Other|1|||
126619025|NCT02561195|455561189|FG006|Vaccination 1 to 3|Other|0|||
126619026|NCT02561195|455561190|FG007|Vaccination 1 to 3|Other|0|||
126619027|NCT02561195|455561191|FG008|Vaccination 1 to 3|Other|0|||
126619028|NCT02561195|455561192|FG009|Vaccination 1 to 3|Other|0|||
126619029|NCT02561195|455561193|FG010|Vaccination 1 to 3|Other|0|||
126619030|NCT02561195|455561194|FG011|Vaccination 1 to 3|Other|0|||
126619031|NCT02561195|455561195|FG012|Vaccination 1 to 3|Other|0|||
126619032|NCT02561195|455561196|FG013|Vaccination 1 to 3|Other|0|||
126619033|NCT02561195|455561183|FG000|Vaccination 1 to 3|Protocol Violation|1|||
126619034|NCT02561195|455561184|FG001|Vaccination 1 to 3|Protocol Violation|0|||
126619035|NCT02561195|455561185|FG002|Vaccination 1 to 3|Protocol Violation|1|||
126619036|NCT02561195|455561186|FG003|Vaccination 1 to 3|Protocol Violation|2|||
126781969|NCT01098240|456156312|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
126619037|NCT02561195|455561187|FG004|Vaccination 1 to 3|Protocol Violation|5|||
126619038|NCT02561195|455561188|FG005|Vaccination 1 to 3|Protocol Violation|2|||
126619039|NCT02561195|455561189|FG006|Vaccination 1 to 3|Protocol Violation|0|||
126619040|NCT02561195|455561190|FG007|Vaccination 1 to 3|Protocol Violation|0|||
126619041|NCT02561195|455561191|FG008|Vaccination 1 to 3|Protocol Violation|0|||
126619042|NCT02561195|455561192|FG009|Vaccination 1 to 3|Protocol Violation|0|||
126619043|NCT02561195|455561193|FG010|Vaccination 1 to 3|Protocol Violation|0|||
126781970|NCT01098240|456156313|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
126781971|NCT01098240|456156311|FG000|Open-Label Phase|Pregnancy|1|||
126619044|NCT02561195|455561194|FG011|Vaccination 1 to 3|Protocol Violation|0|||
126619045|NCT02561195|455561195|FG012|Vaccination 1 to 3|Protocol Violation|0|||
126781972|NCT01098240|456156312|FG001|Open-Label Phase|Pregnancy|0|||
126781973|NCT01098240|456156313|FG002|Open-Label Phase|Pregnancy|0|||
126781974|NCT01098240|456156311|FG000|Open-Label Phase|Withdrawal by Subject|9|||
126619046|NCT02561195|455561196|FG013|Vaccination 1 to 3|Protocol Violation|0|||
126619047|NCT02561195|455561183|FG000|Vaccination 1 to 3|Death|2|||
126619048|NCT02561195|455561184|FG001|Vaccination 1 to 3|Death|1|||
126619049|NCT02561195|455561185|FG002|Vaccination 1 to 3|Death|0|||
126619050|NCT02561195|455561186|FG003|Vaccination 1 to 3|Death|2|||
126619051|NCT02561195|455561187|FG004|Vaccination 1 to 3|Death|0|||
126619052|NCT02561195|455561188|FG005|Vaccination 1 to 3|Death|0|||
126619053|NCT02561195|455561189|FG006|Vaccination 1 to 3|Death|0|||
126781975|NCT01098240|456156312|FG001|Open-Label Phase|Withdrawal by Subject|0|||
126781976|NCT01098240|456156313|FG002|Open-Label Phase|Withdrawal by Subject|0|||
126781977|NCT01098240|456156311|FG000|Open-Label Phase|Adverse Event|12|||
126781978|NCT01098240|456156312|FG001|Open-Label Phase|Adverse Event|0|||
126781979|NCT01098240|456156313|FG002|Open-Label Phase|Adverse Event|0|||
126781980|NCT01098240|456156311|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
126781981|NCT01098240|456156312|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
126781982|NCT01098240|456156313|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
126781983|NCT01098240|456156311|FG000|Double-Blind Phase|Protocol Violation|0|||
126781984|NCT01098240|456156312|FG001|Double-Blind Phase|Protocol Violation|2|||
126619054|NCT02561195|455561190|FG007|Vaccination 1 to 3|Death|0|||
126619055|NCT02561195|455561191|FG008|Vaccination 1 to 3|Death|0|||
126619056|NCT02561195|455561192|FG009|Vaccination 1 to 3|Death|0|||
126619057|NCT02561195|455561193|FG010|Vaccination 1 to 3|Death|0|||
126619058|NCT02561195|455561194|FG011|Vaccination 1 to 3|Death|0|||
126619059|NCT02561195|455561195|FG012|Vaccination 1 to 3|Death|0|||
126619060|NCT02561195|455561196|FG013|Vaccination 1 to 3|Death|0|||
126619061|NCT02561195|455561183|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
126619062|NCT02561195|455561184|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
126619063|NCT02561195|455561185|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
126619064|NCT02561195|455561186|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
126619065|NCT02561195|455561187|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
126619066|NCT02561195|455561188|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
126781985|NCT01098240|456156313|FG002|Double-Blind Phase|Protocol Violation|4|||
126781986|NCT01098240|456156311|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126781987|NCT01098240|456156312|FG001|Double-Blind Phase|Lost to Follow-up|2|||
126781988|NCT01098240|456156313|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126781989|NCT01098240|456156311|FG000|Double-Blind Phase|Other|0|||
126781990|NCT01098240|456156312|FG001|Double-Blind Phase|Other|2|||
126781991|NCT01098240|456156313|FG002|Double-Blind Phase|Other|2|||
126781992|NCT01098240|456156311|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
126781993|NCT01098240|456156312|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
126619067|NCT02561195|455561189|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
126619068|NCT02561195|455561190|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
126619069|NCT02561195|455561191|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
126781994|NCT01098240|456156313|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
126781995|NCT01098240|456156311|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
126781996|NCT01098240|456156312|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
126781997|NCT01098240|456156313|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
126781998|NCT01098240|456156311|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
126781999|NCT01098240|456156312|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
126782000|NCT01098240|456156313|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
126782001|NCT01098240|456156311|FG000|Double-Blind Phase|Adverse Event|0|||
126782002|NCT01098240|456156312|FG001|Double-Blind Phase|Adverse Event|3|||
126782003|NCT01098240|456156313|FG002|Double-Blind Phase|Adverse Event|3|||
126782004|NCT03280537|456156314|FG000|Overall Study|Withdrawal by Subject|2|||
126782005|NCT03280537|456156315|FG001|Overall Study|Withdrawal by Subject|4|||
126782006|NCT01588106|456156317|FG000|Overall Study|Withdrawal by Subject|5|||
126782007|NCT01588106|456156318|FG001|Overall Study|Withdrawal by Subject|4|||
126782008|NCT03083132|456156319|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
126782009|NCT03083132|456156320|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
126782010|NCT03083132|456156319|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
126782011|NCT03083132|456156320|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
126782012|NCT03083132|456156319|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
126782013|NCT03083132|456156320|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
126782014|NCT02995837|456156321|FG000|Overall Study|Lost to Follow-up|9|||
126782015|NCT02995837|456156322|FG001|Overall Study|Lost to Follow-up|8|||
126782016|NCT03118739|456156323|FG000|Overall Study|Physician Decision|0|||
126782017|NCT03118739|456156324|FG001|Overall Study|Physician Decision|1|||
126782018|NCT03118739|456156323|FG000|Overall Study|Withdrawal by Subject|5|||
126782019|NCT03118739|456156324|FG001|Overall Study|Withdrawal by Subject|3|||
126619070|NCT02561195|455561192|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
126619071|NCT02561195|455561193|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
126619072|NCT02561195|455561194|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
126619073|NCT02561195|455561195|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
126619074|NCT02561195|455561196|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
126782020|NCT03118739|456156323|FG000|Overall Study|Lost to Follow-up|2|||
126782021|NCT03118739|456156324|FG001|Overall Study|Lost to Follow-up|0|||
126782022|NCT00669955|456156325|FG000|Overall Study|Adverse Event|3|||
126782023|NCT00669955|456156326|FG001|Overall Study|Adverse Event|5|||
126619075|NCT02561195|455561183|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
126619076|NCT02561195|455561184|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
126619077|NCT02561195|455561185|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
126619078|NCT02561195|455561186|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
126619079|NCT02561195|455561187|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
126619080|NCT02561195|455561188|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
126619081|NCT02561195|455561189|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
126619082|NCT02561195|455561190|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
126619083|NCT02561195|455561191|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
126619084|NCT02561195|455561192|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
126619085|NCT02561195|455561193|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
126619086|NCT02561195|455561194|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
126619087|NCT02561195|455561195|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
126619088|NCT02561195|455561196|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
126619089|NCT02561195|455561183|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126619090|NCT02561195|455561184|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126619091|NCT02561195|455561185|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126619092|NCT02561195|455561186|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126619093|NCT02561195|455561187|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126619094|NCT02561195|455561188|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126619095|NCT02561195|455561189|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126619096|NCT02561195|455561190|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126619097|NCT02561195|455561191|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
126619098|NCT02561195|455561192|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
126619099|NCT02561195|455561193|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
126619100|NCT02561195|455561194|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
126619101|NCT02561195|455561195|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
126619102|NCT02561195|455561196|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
126619103|NCT02561195|455561183|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619104|NCT02561195|455561184|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619105|NCT02561195|455561185|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619106|NCT02561195|455561186|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619107|NCT02561195|455561187|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619108|NCT02561195|455561188|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619109|NCT02561195|455561189|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619110|NCT02561195|455561190|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619111|NCT02561195|455561191|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619112|NCT02561195|455561192|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619113|NCT02561195|455561193|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619114|NCT02561195|455561194|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619115|NCT02561195|455561195|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
126619116|NCT02561195|455561196|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
126619117|NCT02561195|455561183|FG000|Extension Stage (Vaccination 4)|Death|0|||
126619118|NCT02561195|455561184|FG001|Extension Stage (Vaccination 4)|Death|0|||
126619119|NCT02561195|455561185|FG002|Extension Stage (Vaccination 4)|Death|0|||
126619120|NCT02561195|455561186|FG003|Extension Stage (Vaccination 4)|Death|0|||
126619121|NCT02561195|455561187|FG004|Extension Stage (Vaccination 4)|Death|0|||
126619122|NCT02561195|455561188|FG005|Extension Stage (Vaccination 4)|Death|0|||
126619123|NCT02561195|455561189|FG006|Extension Stage (Vaccination 4)|Death|0|||
126619124|NCT02561195|455561190|FG007|Extension Stage (Vaccination 4)|Death|0|||
126619125|NCT02561195|455561191|FG008|Extension Stage (Vaccination 4)|Death|0|||
126619126|NCT02561195|455561192|FG009|Extension Stage (Vaccination 4)|Death|1|||
126619127|NCT02561195|455561193|FG010|Extension Stage (Vaccination 4)|Death|0|||
126619128|NCT02561195|455561194|FG011|Extension Stage (Vaccination 4)|Death|0|||
126619129|NCT02561195|455561195|FG012|Extension Stage (Vaccination 4)|Death|0|||
126619130|NCT02561195|455561196|FG013|Extension Stage (Vaccination 4)|Death|0|||
126619131|NCT02561195|455561183|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126782024|NCT00669955|456156325|FG000|Overall Study|Death|0|||
126782025|NCT00669955|456156326|FG001|Overall Study|Death|1|||
126619132|NCT02561195|455561184|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126619133|NCT02561195|455561185|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126619134|NCT02561195|455561186|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126619135|NCT02561195|455561187|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126619136|NCT02561195|455561188|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126619137|NCT02561195|455561189|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
126619138|NCT02561195|455561190|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
126619139|NCT02561195|455561191|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126782026|NCT00669955|456156325|FG000|Overall Study|Withdrawal by Subject|2|||
126619140|NCT02561195|455561192|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
126619141|NCT02561195|455561193|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
126619142|NCT02561195|455561194|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
126619143|NCT02561195|455561195|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
126619144|NCT02561195|455561196|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
126619145|NCT02561195|455561183|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126619146|NCT02561195|455561184|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126619147|NCT02561195|455561185|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126619148|NCT02561195|455561186|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126619149|NCT02561195|455561187|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126619150|NCT02561195|455561188|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126619151|NCT02561195|455561189|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126619152|NCT02561195|455561190|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126619153|NCT02561195|455561191|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126619154|NCT02561195|455561192|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126619155|NCT02561195|455561193|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
126619156|NCT02561195|455561194|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
126619157|NCT02561195|455561195|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
126619158|NCT02561195|455561196|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
126619159|NCT02561195|455561183|FG000|Extension Stage (Vaccination 4)|Other|0|||
126619160|NCT02561195|455561184|FG001|Extension Stage (Vaccination 4)|Other|0|||
126619161|NCT02561195|455561185|FG002|Extension Stage (Vaccination 4)|Other|0|||
126619162|NCT02561195|455561186|FG003|Extension Stage (Vaccination 4)|Other|0|||
126619163|NCT02561195|455561187|FG004|Extension Stage (Vaccination 4)|Other|0|||
126619164|NCT02561195|455561188|FG005|Extension Stage (Vaccination 4)|Other|0|||
126619165|NCT02561195|455561189|FG006|Extension Stage (Vaccination 4)|Other|0|||
126619166|NCT02561195|455561190|FG007|Extension Stage (Vaccination 4)|Other|0|||
126619167|NCT02561195|455561191|FG008|Extension Stage (Vaccination 4)|Other|0|||
126619168|NCT02561195|455561192|FG009|Extension Stage (Vaccination 4)|Other|0|||
126619169|NCT02561195|455561193|FG010|Extension Stage (Vaccination 4)|Other|2|||
126619170|NCT02561195|455561194|FG011|Extension Stage (Vaccination 4)|Other|2|||
126619171|NCT02561195|455561195|FG012|Extension Stage (Vaccination 4)|Other|1|||
126619172|NCT02561195|455561196|FG013|Extension Stage (Vaccination 4)|Other|0|||
126619173|NCT02561195|455561183|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126619174|NCT02561195|455561184|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126619175|NCT02561195|455561185|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126619176|NCT02561195|455561186|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126619177|NCT02561195|455561187|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126619178|NCT02561195|455561188|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126619179|NCT02561195|455561189|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
126619180|NCT02561195|455561190|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126619181|NCT02561195|455561191|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126619182|NCT02561195|455561192|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126619183|NCT02561195|455561193|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
126619184|NCT02561195|455561194|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
126619185|NCT02561195|455561195|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
126619186|NCT02561195|455561196|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
126619187|NCT03905512|455561197|FG000|Overall Study|Withdrawal by Subject|9|||
126619188|NCT03905512|455561198|FG001|Overall Study|Withdrawal by Subject|8|||
126619189|NCT03905512|455561197|FG000|Overall Study|Adverse Event|1|||
126619190|NCT03905512|455561198|FG001|Overall Study|Adverse Event|2|||
126619191|NCT03905512|455561197|FG000|Overall Study|Lost to Follow-up|4|||
126619192|NCT03905512|455561198|FG001|Overall Study|Lost to Follow-up|3|||
126619193|NCT03905512|455561197|FG000|Overall Study|Other than Specified|7|||
126619194|NCT03905512|455561198|FG001|Overall Study|Other than Specified|4|||
126746709|NCT02614261|456022047|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
126746710|NCT02614261|456022048|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126746711|NCT02614261|456022045|FG000|Open-Label Extension Phase|Adverse Event|23|||
126746712|NCT02614261|456022046|FG001|Open-Label Extension Phase|Adverse Event|12|||
126746713|NCT02614261|456022047|FG002|Open-Label Extension Phase|Adverse Event|11|||
126746714|NCT02614261|456022048|FG003|Open-Label Extension Phase|Adverse Event|0|||
126746715|NCT02614261|456022045|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
126619195|NCT00866619|455561199|FG000|Overall Study|Adverse Event|112|||
126619196|NCT00866619|455561200|FG001|Overall Study|Adverse Event|106|||
126619197|NCT00866619|455561201|FG002|Overall Study|Adverse Event|47|||
126619198|NCT00866619|455561202|FG003|Overall Study|Adverse Event|44|||
126619199|NCT00866619|455561199|FG000|Overall Study|Protocol Violation|2|||
126619200|NCT00866619|455561200|FG001|Overall Study|Protocol Violation|39|||
126746716|NCT02614261|456022046|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
126619201|NCT00866619|455561201|FG002|Overall Study|Protocol Violation|2|||
126619202|NCT00866619|455561202|FG003|Overall Study|Protocol Violation|17|||
126619203|NCT00866619|455561199|FG000|Overall Study|Withdrawal by Subject|587|||
126619204|NCT00866619|455561200|FG001|Overall Study|Withdrawal by Subject|295|||
126782027|NCT00669955|456156326|FG001|Overall Study|Withdrawal by Subject|3|||
126782028|NCT00669955|456156325|FG000|Overall Study|Lost to Follow-up|5|||
126782029|NCT00669955|456156326|FG001|Overall Study|Lost to Follow-up|7|||
126782030|NCT00669955|456156325|FG000|Overall Study|Protocol Violation|2|||
126782031|NCT00669955|456156326|FG001|Overall Study|Protocol Violation|7|||
126782032|NCT00669955|456156325|FG000|Overall Study|Investigator Sponsor Judgement|0|||
126782033|NCT00669955|456156326|FG001|Overall Study|Investigator Sponsor Judgement|1|||
126782034|NCT00669955|456156325|FG000|Overall Study|not compliant with study drug/visit|2|||
126782035|NCT00669955|456156326|FG001|Overall Study|not compliant with study drug/visit|3|||
126782036|NCT01077713|456156331|FG000|Overall Study|Withdrawal by Subject|1|||
126782037|NCT01077713|456156332|FG001|Overall Study|Withdrawal by Subject|2|||
126782038|NCT01077713|456156331|FG000|Overall Study|Progressive Disease (PD)|0|||
126782039|NCT01077713|456156332|FG001|Overall Study|Progressive Disease (PD)|1|||
126782040|NCT01077713|456156331|FG000|Overall Study|Death|28|||
126782041|NCT01077713|456156332|FG001|Overall Study|Death|29|||
126782042|NCT01077713|456156331|FG000|Overall Study|Lost to Follow-up|1|||
126782043|NCT01077713|456156332|FG001|Overall Study|Lost to Follow-up|1|||
126782044|NCT01077713|456156331|FG000|Overall Study|Adverse Event|2|||
126782045|NCT01077713|456156332|FG001|Overall Study|Adverse Event|1|||
126782046|NCT01077713|456156331|FG000|Overall Study|Other|4|||
126782047|NCT01077713|456156332|FG001|Overall Study|Other|2|||
126782048|NCT04274192|456156333|FG000|Overall Study|Protocol Violation|1|||
126619205|NCT00866619|455561201|FG002|Overall Study|Withdrawal by Subject|272|||
126619206|NCT00866619|455561202|FG003|Overall Study|Withdrawal by Subject|144|||
126619207|NCT00866619|455561199|FG000|Overall Study|Lost to Follow-up|1145|||
126619208|NCT00866619|455561200|FG001|Overall Study|Lost to Follow-up|830|||
126619209|NCT00866619|455561201|FG002|Overall Study|Lost to Follow-up|568|||
126619210|NCT00866619|455561202|FG003|Overall Study|Lost to Follow-up|425|||
126619211|NCT00645411|455561203|FG000|Overall Study|Adverse Event|0|||
126619212|NCT00645411|455561204|FG001|Overall Study|Adverse Event|0|||
126619213|NCT00645411|455561205|FG002|Overall Study|Adverse Event|0|||
126619214|NCT00645411|455561206|FG003|Overall Study|Adverse Event|2|||
126619215|NCT00645411|455561203|FG000|Overall Study|Withdrawal by Subject|2|||
126619216|NCT00645411|455561204|FG001|Overall Study|Withdrawal by Subject|1|||
126619217|NCT00645411|455561205|FG002|Overall Study|Withdrawal by Subject|19|||
126619218|NCT00645411|455561206|FG003|Overall Study|Withdrawal by Subject|21|||
126619219|NCT00645411|455561203|FG000|Overall Study|Lost to Follow-up|10|||
126619220|NCT00645411|455561204|FG001|Overall Study|Lost to Follow-up|5|||
126619221|NCT00645411|455561205|FG002|Overall Study|Lost to Follow-up|124|||
126619222|NCT00645411|455561206|FG003|Overall Study|Lost to Follow-up|75|||
126619223|NCT00645411|455561203|FG000|Overall Study|Protocol Violation|1|||
126619224|NCT00645411|455561204|FG001|Overall Study|Protocol Violation|0|||
126619225|NCT00645411|455561205|FG002|Overall Study|Protocol Violation|1|||
126619226|NCT00645411|455561206|FG003|Overall Study|Protocol Violation|0|||
126619227|NCT00645411|455561203|FG000|Overall Study|Inappropriate enrollment|0|||
126619228|NCT00645411|455561204|FG001|Overall Study|Inappropriate enrollment|0|||
126619229|NCT00645411|455561205|FG002|Overall Study|Inappropriate enrollment|4|||
126619230|NCT00645411|455561206|FG003|Overall Study|Inappropriate enrollment|1|||
126619231|NCT00645411|455561203|FG000|Overall Study|Unable to classify|0|||
126619232|NCT00645411|455561204|FG001|Overall Study|Unable to classify|0|||
126619233|NCT00645411|455561205|FG002|Overall Study|Unable to classify|3|||
126619234|NCT00645411|455561206|FG003|Overall Study|Unable to classify|4|||
126619235|NCT03560206|455561207|FG000|Overall Study|Lost to Follow-up|19|||
126619236|NCT03560206|455561208|FG001|Overall Study|Lost to Follow-up|11|||
126619237|NCT03560206|455561207|FG000|Overall Study|Withdrawal by Subject|2|||
126619238|NCT03560206|455561208|FG001|Overall Study|Withdrawal by Subject|4|||
126782049|NCT04274192|456156334|FG001|Overall Study|Protocol Violation|0|||
126782050|NCT03507439|456156335|FG000|Overall Study|Other|2|||
126782051|NCT03507439|456156336|FG001|Overall Study|Other|1|||
126782052|NCT03507439|456156335|FG000|Overall Study|Withdrawal by Subject|1|||
126782053|NCT03507439|456156336|FG001|Overall Study|Withdrawal by Subject|0|||
126619239|NCT03560206|455561207|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
126782054|NCT03507439|456156335|FG000|Overall Study|Death|1|||
126619240|NCT03560206|455561208|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
126619241|NCT03560206|455561207|FG000|Overall Study|Busy schedule|14|||
126619242|NCT03560206|455561208|FG001|Overall Study|Busy schedule|2|||
126619243|NCT03560206|455561207|FG000|Overall Study|patients' new health condition such as cancer|10|||
126619244|NCT03560206|455561208|FG001|Overall Study|patients' new health condition such as cancer|1|||
126619245|NCT03987074|455561209|FG000|Overall Study|Withdrew Consent|1|||
126619246|NCT03987074|455561210|FG001|Overall Study|Withdrew Consent|1|||
126782055|NCT03507439|456156336|FG001|Overall Study|Death|1|||
126782056|NCT00289458|456156337|FG000|Overall Study|Death|1|||
126782057|NCT00289458|456156338|FG001|Overall Study|Death|0|||
126782058|NCT00289458|456156339|FG002|Overall Study|Death|0|||
126619247|NCT03987074|455561211|FG002|Overall Study|Withdrew Consent|0|||
126619248|NCT03987074|455561212|FG003|Overall Study|Withdrew Consent|2|||
126619249|NCT03987074|455561213|FG004|Overall Study|Withdrew Consent|1|||
126619250|NCT03987074|455561209|FG000|Overall Study|Adverse Event|2|||
126619251|NCT03987074|455561210|FG001|Overall Study|Adverse Event|1|||
126619252|NCT03987074|455561211|FG002|Overall Study|Adverse Event|0|||
126619253|NCT03987074|455561212|FG003|Overall Study|Adverse Event|0|||
126619254|NCT03987074|455561213|FG004|Overall Study|Adverse Event|1|||
126619255|NCT03987074|455561209|FG000|Overall Study|Lost to Follow-up|0|||
126619256|NCT03987074|455561210|FG001|Overall Study|Lost to Follow-up|0|||
126619257|NCT03987074|455561211|FG002|Overall Study|Lost to Follow-up|1|||
126619258|NCT03987074|455561212|FG003|Overall Study|Lost to Follow-up|1|||
126619259|NCT03987074|455561213|FG004|Overall Study|Lost to Follow-up|0|||
126619260|NCT03987074|455561209|FG000|Overall Study|Investigator's Discretion|0|||
126619261|NCT03987074|455561210|FG001|Overall Study|Investigator's Discretion|0|||
126619262|NCT03987074|455561211|FG002|Overall Study|Investigator's Discretion|0|||
126619263|NCT03987074|455561212|FG003|Overall Study|Investigator's Discretion|1|||
126619264|NCT03987074|455561213|FG004|Overall Study|Investigator's Discretion|0|||
126619265|NCT01334606|455561218|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
126619266|NCT02138838|455561219|FG000|Overall Study|Study Closure|7|||
126619267|NCT02138838|455561220|FG001|Overall Study|Study Closure|6|||
126619268|NCT02138838|455561219|FG000|Overall Study|Withdrawal by Subject|1|||
126619269|NCT02138838|455561220|FG001|Overall Study|Withdrawal by Subject|5|||
126619270|NCT02993926|455561223|FG000|Enantone Treatment Phase|Adverse Event|1|||
126619271|NCT02993926|455561224|FG001|Enantone Treatment Phase|Adverse Event|0|||
126619272|NCT02993926|455561225|FG002|Enantone Treatment Phase|Adverse Event|0|||
126619273|NCT02993926|455561223|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
126619274|NCT02993926|455561224|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
126619275|NCT02993926|455561225|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
126619276|NCT02993926|455561223|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
126619277|NCT02993926|455561224|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
126619278|NCT02993926|455561225|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
126619279|NCT02993926|455561223|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
126619280|NCT02993926|455561224|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
126619281|NCT02993926|455561225|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
126619282|NCT01084772|455561227|FG000|Baseline|Withdrawal by Subject|7|||
126619283|NCT01084772|455561228|FG001|Baseline|Withdrawal by Subject|6|||
126619284|NCT01084772|455561227|FG000|3 Months|Death|1|||
126619285|NCT01084772|455561228|FG001|3 Months|Death|0|||
126619286|NCT01084772|455561227|FG000|3 Months|Study Termination|2|||
126619287|NCT01084772|455561228|FG001|3 Months|Study Termination|2|||
126619288|NCT01084772|455561227|FG000|1 Year|Withdrawal by Subject|0|||
126619289|NCT01084772|455561228|FG001|1 Year|Withdrawal by Subject|1|||
126619290|NCT01084772|455561227|FG000|1 Year|Lost to Follow-up|3|||
126619291|NCT01084772|455561228|FG001|1 Year|Lost to Follow-up|0|||
126619292|NCT01084772|455561227|FG000|1 Year|Study Termination|0|||
126619293|NCT01084772|455561228|FG001|1 Year|Study Termination|7|||
126619294|NCT01084772|455561227|FG000|2 Years|Withdrawal by Subject|1|||
126619295|NCT01084772|455561228|FG001|2 Years|Withdrawal by Subject|0|||
126619296|NCT01084772|455561227|FG000|2 Years|Lost to Follow-up|5|||
126619297|NCT01084772|455561228|FG001|2 Years|Lost to Follow-up|2|||
126619298|NCT01084772|455561227|FG000|2 Years|Study Termination|3|||
126619299|NCT01084772|455561228|FG001|2 Years|Study Termination|2|||
126619300|NCT01867307|455561229|FG000|Overall Study|Protocol Violation|2|||
126619301|NCT01867307|455561230|FG001|Overall Study|Protocol Violation|0|||
126619302|NCT01867307|455561229|FG000|Overall Study|Other Adverse Event|1|||
126619303|NCT01867307|455561230|FG001|Overall Study|Other Adverse Event|3|||
126619304|NCT00518206|455561231|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
126619305|NCT00518206|455561232|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
126619306|NCT00518206|455561231|FG000|Overall Study|Withdrawal by Subject|2|||
126619307|NCT00518206|455561232|FG001|Overall Study|Withdrawal by Subject|0|||
126619308|NCT00518206|455561231|FG000|Overall Study|Drug Supply Issue|1|||
126619309|NCT00518206|455561232|FG001|Overall Study|Drug Supply Issue|0|||
126619310|NCT00518206|455561231|FG000|Overall Study|Reason Unknown|1|||
126619311|NCT00518206|455561232|FG001|Overall Study|Reason Unknown|0|||
126619312|NCT00518206|455561231|FG000|Overall Study|Completion Status Unknown|1|||
126619313|NCT00518206|455561232|FG001|Overall Study|Completion Status Unknown|0|||
126619314|NCT01199302|455561244|FG000|Overall Study|Adverse Event|1|||
126619315|NCT01199302|455561245|FG001|Overall Study|Adverse Event|1|||
126619316|NCT01199302|455561246|FG002|Overall Study|Adverse Event|2|||
126619317|NCT01199302|455561247|FG003|Overall Study|Adverse Event|0|||
126619318|NCT01199302|455561244|FG000|Overall Study|Withdrawal by Subject|2|||
126619319|NCT01199302|455561245|FG001|Overall Study|Withdrawal by Subject|2|||
126619320|NCT01199302|455561246|FG002|Overall Study|Withdrawal by Subject|3|||
126619321|NCT01199302|455561247|FG003|Overall Study|Withdrawal by Subject|0|||
126619322|NCT01199302|455561244|FG000|Overall Study|Disease Progression|3|||
126619323|NCT01199302|455561245|FG001|Overall Study|Disease Progression|4|||
126619324|NCT01199302|455561246|FG002|Overall Study|Disease Progression|4|||
126619325|NCT01199302|455561247|FG003|Overall Study|Disease Progression|2|||
126619326|NCT01199302|455561244|FG000|Overall Study|Study Termination|13|||
126619327|NCT01199302|455561245|FG001|Overall Study|Study Termination|8|||
126619328|NCT01199302|455561246|FG002|Overall Study|Study Termination|11|||
126619329|NCT01199302|455561247|FG003|Overall Study|Study Termination|9|||
126619330|NCT01199302|455561244|FG000|Overall Study|Lost to Follow-up|0|||
126619331|NCT01199302|455561245|FG001|Overall Study|Lost to Follow-up|1|||
126619332|NCT01199302|455561246|FG002|Overall Study|Lost to Follow-up|0|||
126619333|NCT01199302|455561247|FG003|Overall Study|Lost to Follow-up|0|||
126619334|NCT01199302|455561244|FG000|Overall Study|Other|1|||
126619335|NCT01199302|455561245|FG001|Overall Study|Other|0|||
126619336|NCT01199302|455561246|FG002|Overall Study|Other|0|||
126619337|NCT01199302|455561247|FG003|Overall Study|Other|0|||
126619338|NCT01634165|455561250|FG000|Period 2|Adverse Event|0|||
126619339|NCT01634165|455561251|FG001|Period 2|Adverse Event|1|||
126619340|NCT01634165|455561252|FG002|Period 2|Adverse Event|0|||
126619341|NCT01634165|455561253|FG003|Period 2|Adverse Event|0|||
126619342|NCT03820024|455561254|FG000|Overall Study|Physician Decision|1|||
126619343|NCT03820024|455561255|FG001|Overall Study|Physician Decision|2|||
126619344|NCT05379400|455562559|FG000|Overall Study|Lost to Follow-up|1|||
126619345|NCT05379400|455562560|FG001|Overall Study|Lost to Follow-up|1|||
126619346|NCT03978130|455562562|FG000|Overall Study|Lost to Follow-up|13|||
126619347|NCT03978130|455562563|FG001|Overall Study|Lost to Follow-up|14|||
126619348|NCT03978130|455562562|FG000|Overall Study|Withdrawal by Subject|12|||
126619349|NCT03978130|455562563|FG001|Overall Study|Withdrawal by Subject|2|||
126619350|NCT03978130|455562562|FG000|Overall Study|Adverse Event|2|||
126619351|NCT03978130|455562563|FG001|Overall Study|Adverse Event|1|||
126619352|NCT00515112|455562564|FG000|Overall Study|Death|0|||
126619353|NCT00515112|455562565|FG001|Overall Study|Death|1|||
126619354|NCT00515112|455562564|FG000|Overall Study|The study was terminated|3|||
126619355|NCT00515112|455562565|FG001|Overall Study|The study was terminated|2|||
126619356|NCT00507429|455562568|FG000|Treatment Phase|Disease Progression|12|||
126619357|NCT00507429|455562569|FG001|Treatment Phase|Disease Progression|5|||
126619358|NCT00507429|455562568|FG000|Treatment Phase|Adverse Event|12|||
126619359|NCT00507429|455562569|FG001|Treatment Phase|Adverse Event|5|||
126619360|NCT00507429|455562568|FG000|Treatment Phase|Withdrawal by Subject|3|||
126619361|NCT00507429|455562569|FG001|Treatment Phase|Withdrawal by Subject|3|||
126619362|NCT00507429|455562568|FG000|Treatment Phase|Physician Decision|4|||
126619363|NCT00507429|455562569|FG001|Treatment Phase|Physician Decision|2|||
126619364|NCT00507429|455562568|FG000|Treatment Phase|Other|6|||
126619365|NCT00507429|455562569|FG001|Treatment Phase|Other|3|||
126619366|NCT00507429|455562568|FG000|Maintenance Phase|Progressive Disease|14|||
126619367|NCT00507429|455562569|FG001|Maintenance Phase|Progressive Disease|0|||
126619368|NCT04025762|455562571|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
126619369|NCT04025762|455562572|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
126619370|NCT01131325|455562579|FG000|Overall Study|Adverse Event|1|||
126619371|NCT01131325|455562579|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
126619372|NCT03884478|455562580|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
126619373|NCT03884478|455562581|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
126619374|NCT03884478|455562582|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
126619375|NCT03884478|455562580|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
126619376|NCT03884478|455562581|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
126619377|NCT03884478|455562582|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
126619378|NCT03884478|455562580|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
126619379|NCT03884478|455562581|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
126619380|NCT03884478|455562582|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
126619381|NCT03884478|455562580|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
126619382|NCT03884478|455562581|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
126619383|NCT03884478|455562582|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
126619384|NCT02213094|455562585|FG000|Overall Study|Adverse Event|1|||
126619385|NCT02213094|455562586|FG001|Overall Study|Adverse Event|0|||
126619386|NCT01807234|455562587|FG000|Overall Study|Lost to Follow-up|2|||
126619387|NCT01807234|455562588|FG001|Overall Study|Lost to Follow-up|5|||
126619388|NCT01807234|455562589|FG002|Overall Study|Lost to Follow-up|1|||
126619389|NCT01807234|455562590|FG003|Overall Study|Lost to Follow-up|1|||
126619390|NCT01807234|455562591|FG004|Overall Study|Lost to Follow-up|1|||
126746717|NCT02614261|456022047|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
126619391|NCT01807234|455562592|FG005|Overall Study|Lost to Follow-up|2|||
126619392|NCT01807234|455562587|FG000|Overall Study|Withdrawal by Subject|3|||
126782059|NCT00289458|456156337|FG000|Overall Study|Physician Decision|3|||
126619393|NCT01807234|455562588|FG001|Overall Study|Withdrawal by Subject|1|||
126619394|NCT01807234|455562589|FG002|Overall Study|Withdrawal by Subject|1|||
126619395|NCT01807234|455562590|FG003|Overall Study|Withdrawal by Subject|1|||
126619396|NCT01807234|455562591|FG004|Overall Study|Withdrawal by Subject|2|||
126619397|NCT01807234|455562592|FG005|Overall Study|Withdrawal by Subject|1|||
126619398|NCT01807234|455562587|FG000|Overall Study|Lack of Efficacy|0|||
126619399|NCT01807234|455562588|FG001|Overall Study|Lack of Efficacy|0|||
126619400|NCT01807234|455562589|FG002|Overall Study|Lack of Efficacy|0|||
126619401|NCT01807234|455562590|FG003|Overall Study|Lack of Efficacy|0|||
126619402|NCT01807234|455562591|FG004|Overall Study|Lack of Efficacy|1|||
126619403|NCT01807234|455562592|FG005|Overall Study|Lack of Efficacy|1|||
126619404|NCT00538629|455562593|FG000|Overall Study|At subject's request|1|||
126619405|NCT00538629|455562593|FG000|Overall Study|Adverse Event|2|||
126619406|NCT00538629|455562593|FG000|Overall Study|Lack of Efficacy|12|||
126619407|NCT00538629|455562593|FG000|Overall Study|Lost to Follow-up|6|||
126619408|NCT00538629|455562593|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
126619409|NCT00555620|455562595|FG000|Overall Study|Death|0|||
126619410|NCT00555620|455562596|FG001|Overall Study|Death|1|||
126619411|NCT00555620|455562597|FG002|Overall Study|Death|0|||
126619412|NCT00555620|455562598|FG003|Overall Study|Death|0|||
126619413|NCT00555620|455562599|FG004|Overall Study|Death|0|||
126619414|NCT00555620|455562600|FG005|Overall Study|Death|1|||
126619415|NCT00555620|455562595|FG000|Overall Study|Study terminated by sponsor|0|||
126619416|NCT00555620|455562596|FG001|Overall Study|Study terminated by sponsor|0|||
126619417|NCT00555620|455562597|FG002|Overall Study|Study terminated by sponsor|1|||
126619418|NCT00555620|455562598|FG003|Overall Study|Study terminated by sponsor|0|||
126619419|NCT00555620|455562599|FG004|Overall Study|Study terminated by sponsor|0|||
126619420|NCT00555620|455562600|FG005|Overall Study|Study terminated by sponsor|0|||
126619421|NCT00555620|455562595|FG000|Overall Study|Adverse Event|0|||
126619422|NCT00555620|455562596|FG001|Overall Study|Adverse Event|0|||
126619423|NCT00555620|455562597|FG002|Overall Study|Adverse Event|1|||
126619424|NCT00555620|455562598|FG003|Overall Study|Adverse Event|5|||
126619425|NCT00555620|455562599|FG004|Overall Study|Adverse Event|0|||
126619426|NCT00555620|455562600|FG005|Overall Study|Adverse Event|1|||
126619427|NCT00555620|455562595|FG000|Overall Study|Objective progression or relapse|6|||
126619428|NCT00555620|455562596|FG001|Overall Study|Objective progression or relapse|5|||
126619429|NCT00555620|455562597|FG002|Overall Study|Objective progression or relapse|12|||
126619430|NCT00555620|455562598|FG003|Overall Study|Objective progression or relapse|17|||
126619431|NCT00555620|455562599|FG004|Overall Study|Objective progression or relapse|3|||
126619432|NCT00555620|455562600|FG005|Overall Study|Objective progression or relapse|16|||
126619433|NCT00555620|455562595|FG000|Overall Study|Participant refused treatment|0|||
126619434|NCT00555620|455562596|FG001|Overall Study|Participant refused treatment|1|||
126619435|NCT00555620|455562597|FG002|Overall Study|Participant refused treatment|1|||
126619436|NCT00555620|455562598|FG003|Overall Study|Participant refused treatment|0|||
126619437|NCT00555620|455562599|FG004|Overall Study|Participant refused treatment|0|||
126619438|NCT00555620|455562600|FG005|Overall Study|Participant refused treatment|1|||
126619439|NCT00555620|455562595|FG000|Overall Study|Other|0|||
126619440|NCT00555620|455562596|FG001|Overall Study|Other|0|||
126619441|NCT00555620|455562597|FG002|Overall Study|Other|0|||
126619442|NCT00555620|455562598|FG003|Overall Study|Other|1|||
126619443|NCT00555620|455562599|FG004|Overall Study|Other|0|||
126619444|NCT00555620|455562600|FG005|Overall Study|Other|3|||
126619445|NCT05203822|455562601|FG000|Overall Study|Adverse Event|1|||
126619446|NCT05203822|455562601|FG000|Overall Study|Withdrawal by Subject|1|||
126619447|NCT01345253|455562603|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
126619448|NCT01345253|455562604|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
126619449|NCT01345253|455562603|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
126619450|NCT01345253|455562604|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
126619451|NCT01345253|455562603|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
126619452|NCT01345253|455562604|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
126619453|NCT01345253|455562603|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
126619454|NCT01345253|455562604|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
126619455|NCT01345253|455562603|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
126619456|NCT01345253|455562604|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
126619457|NCT01345253|455562603|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
126619458|NCT01345253|455562604|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
126619459|NCT01345253|455562603|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
126619460|NCT01345253|455562604|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
126619461|NCT01345253|455562603|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
126619462|NCT01345253|455562604|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
126619463|NCT01345253|455562603|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
126619464|NCT01345253|455562604|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
126619465|NCT01345253|455562603|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
126619466|NCT01345253|455562604|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
126619467|NCT01345253|455562603|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
126619468|NCT01345253|455562604|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
126619469|NCT01345253|455562603|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
126619470|NCT01345253|455562604|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
126619471|NCT01345253|455562603|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
126619472|NCT01345253|455562604|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
126619473|NCT01345253|455562603|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
126619474|NCT01345253|455562604|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
126619475|NCT01345253|455562603|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
126619476|NCT01345253|455562604|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
126619477|NCT01767376|455562611|FG000|Overall Study|Lost to Follow-up|3|||
126619478|NCT01767376|455562612|FG001|Overall Study|Lost to Follow-up|2|||
126619479|NCT01767376|455562613|FG002|Overall Study|Lost to Follow-up|0|||
126619480|NCT01767376|455562611|FG000|Overall Study|Withdrawal by Subject|1|||
126619481|NCT01767376|455562612|FG001|Overall Study|Withdrawal by Subject|1|||
126619482|NCT01767376|455562613|FG002|Overall Study|Withdrawal by Subject|0|||
126619483|NCT00946088|455562614|FG000|Overall Study|Withdrawal by Subject|0|||
126619484|NCT00946088|455562615|FG001|Overall Study|Withdrawal by Subject|1|||
126782060|NCT00289458|456156338|FG001|Overall Study|Physician Decision|4|||
126782061|NCT00289458|456156339|FG002|Overall Study|Physician Decision|2|||
126782062|NCT00289458|456156337|FG000|Overall Study|Withdrawal by Subject|2|||
126782063|NCT00289458|456156338|FG001|Overall Study|Withdrawal by Subject|2|||
126782064|NCT00289458|456156339|FG002|Overall Study|Withdrawal by Subject|4|||
126619485|NCT04883541|455562616|FG000|Overall Study|Not attending regular yoga class|16|||
126619486|NCT04883541|455562617|FG001|Overall Study|Not attending regular yoga class|0|||
126619487|NCT04883541|455562616|FG000|Overall Study|Not attending the pregnancy school|0|||
126619488|NCT04883541|455562617|FG001|Overall Study|Not attending the pregnancy school|9|||
126619489|NCT00648895|455562625|FG000|Overall Study|Lack of Efficacy|0|||
126619490|NCT00648895|455562626|FG001|Overall Study|Lack of Efficacy|1|||
126619491|NCT02865083|455562627|FG000|Overall Study|Early Termination|3|||
126619492|NCT02865083|455562628|FG001|Overall Study|Early Termination|1|||
126619493|NCT00841321|455562629|FG000|Overall Study|Lost to Follow-up|1|||
126619494|NCT00841321|455562630|FG001|Overall Study|Lost to Follow-up|1|||
126619495|NCT00841321|455562629|FG000|Overall Study|Adverse Event|0|||
126619496|NCT00841321|455562630|FG001|Overall Study|Adverse Event|2|||
126619497|NCT01358175|455562631|FG000|Overall Study|Death|1|||
126619498|NCT01358175|455562632|FG001|Overall Study|Death|0|||
126619499|NCT01358175|455562633|FG002|Overall Study|Death|1|||
126619500|NCT01358175|455562631|FG000|Overall Study|Withdrawal by Subject|9|||
126619501|NCT01358175|455562632|FG001|Overall Study|Withdrawal by Subject|5|||
126619502|NCT01358175|455562633|FG002|Overall Study|Withdrawal by Subject|10|||
126619503|NCT01358175|455562631|FG000|Overall Study|Technical issues|0|||
126619504|NCT01358175|455562632|FG001|Overall Study|Technical issues|1|||
126619505|NCT01358175|455562633|FG002|Overall Study|Technical issues|0|||
126619506|NCT01358175|455562631|FG000|Overall Study|Pregnancy|0|||
126619507|NCT01358175|455562632|FG001|Overall Study|Pregnancy|1|||
126619508|NCT01358175|455562633|FG002|Overall Study|Pregnancy|0|||
126619509|NCT01358175|455562631|FG000|Overall Study|Physician Decision|1|||
126619510|NCT01358175|455562632|FG001|Overall Study|Physician Decision|0|||
126619511|NCT01358175|455562633|FG002|Overall Study|Physician Decision|0|||
126619512|NCT01358175|455562631|FG000|Overall Study|Non Compliance with Study Treatment|0|||
126619513|NCT01358175|455562632|FG001|Overall Study|Non Compliance with Study Treatment|1|||
126619514|NCT01358175|455562633|FG002|Overall Study|Non Compliance with Study Treatment|1|||
126619515|NCT01358175|455562631|FG000|Overall Study|Lost to Follow-up|1|||
126619516|NCT01358175|455562632|FG001|Overall Study|Lost to Follow-up|1|||
126619517|NCT01358175|455562633|FG002|Overall Study|Lost to Follow-up|3|||
126619518|NCT01358175|455562631|FG000|Overall Study|Lack of Efficacy|3|||
126619519|NCT01358175|455562632|FG001|Overall Study|Lack of Efficacy|8|||
126619520|NCT01358175|455562633|FG002|Overall Study|Lack of Efficacy|6|||
126619521|NCT01358175|455562631|FG000|Overall Study|Adverse Event|6|||
126619522|NCT01358175|455562632|FG001|Overall Study|Adverse Event|11|||
126619523|NCT01358175|455562633|FG002|Overall Study|Adverse Event|11|||
126619524|NCT02379078|455562634|FG000|Overall Study|Lost to Follow-up|33|||
126619525|NCT02379078|455562635|FG001|Overall Study|Lost to Follow-up|30|||
126619526|NCT02379078|455562634|FG000|Overall Study|Withdrawal by Subject|6|||
126619527|NCT02379078|455562635|FG001|Overall Study|Withdrawal by Subject|5|||
126619528|NCT04908488|455562636|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
126619529|NCT04908488|455562637|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
126619530|NCT04908488|455562636|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
126619531|NCT04908488|455562637|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
126619532|NCT01901302|455562641|FG000|Overall Study|Adverse Event|2|||
126782065|NCT01144663|456158071|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
126619533|NCT01901302|455562642|FG001|Overall Study|Adverse Event|1|||
126619534|NCT01901302|455562641|FG000|Overall Study|Lack of Efficacy|0|||
126619535|NCT01901302|455562642|FG001|Overall Study|Lack of Efficacy|2|||
126619536|NCT01901302|455562641|FG000|Overall Study|Study Terminated by Sponsor|23|||
126782066|NCT01144663|456158072|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
126619537|NCT01901302|455562642|FG001|Overall Study|Study Terminated by Sponsor|20|||
126619538|NCT01901302|455562641|FG000|Overall Study|Withdrawal by Subject|2|||
126619539|NCT01901302|455562642|FG001|Overall Study|Withdrawal by Subject|0|||
126619540|NCT00901459|455562644|FG000|Overall Study|Withdrawal by Subject|6|||
126619541|NCT04765046|455562645|FG000|Overall Study|Screen Failure|2|||
126619542|NCT04765046|455562645|FG000|Overall Study|Withdrawal by Subject|4|||
126619543|NCT04765046|455562645|FG000|Overall Study|Physician Decision|4|||
126619544|NCT04765046|455562645|FG000|Overall Study|Surgery Cancelled|8|||
126619545|NCT02959866|455562647|FG000|Overall Study|Withdrawal by Subject|1|||
126619546|NCT00952523|455562648|FG000|Overall Study|Withdrawal by Subject|7|||
126619547|NCT00848198|455562649|FG000|Overall Study|Incomplete Case Report Forms|15|||
126619548|NCT03708744|455562653|FG000|Overall Study|Withdrawal by Subject|0|||
126619549|NCT03708744|455562654|FG001|Overall Study|Withdrawal by Subject|0|||
126619550|NCT03708744|455562655|FG002|Overall Study|Withdrawal by Subject|1|||
126619551|NCT03708744|455562656|FG003|Overall Study|Withdrawal by Subject|0|||
126619552|NCT01029925|455562657|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
126619553|NCT01029925|455562657|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
126619554|NCT01029925|455562657|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
126619555|NCT04930263|455562658|FG000|Overall Study|Withdrawal by Subject|3|||
126619556|NCT04930263|455562659|FG001|Overall Study|Withdrawal by Subject|5|||
126619557|NCT03529942|455562660|FG000|Overall Study|Withdrawal by Subject|13|||
126619558|NCT03529942|455562660|FG000|Overall Study|Physician Decision|1|||
126619559|NCT03529942|455562660|FG000|Overall Study|Lost to Follow-up|7|||
126619560|NCT03529942|455562660|FG000|Overall Study|Needle inserted but no drug administered|1|||
126619561|NCT03529942|455562660|FG000|Overall Study|Personal reasons|1|||
126619562|NCT03138499|455562670|FG000|Overall Study|Lost to Follow-up|1|||
126619563|NCT03138499|455562671|FG001|Overall Study|Lost to Follow-up|0|||
126619564|NCT03138499|455562670|FG000|Overall Study|Participants withdrew consent|1|||
126619565|NCT03138499|455562671|FG001|Overall Study|Participants withdrew consent|0|||
126619566|NCT03138499|455562670|FG000|Overall Study|Participant discontinued study before treatment|0|||
126619567|NCT03138499|455562671|FG001|Overall Study|Participant discontinued study before treatment|1|||
126619568|NCT03138499|455562670|FG000|Overall Study|Disease Progression|2|||
126619569|NCT03138499|455562671|FG001|Overall Study|Disease Progression|6|||
126619570|NCT03138499|455562670|FG000|Overall Study|Study drug toxicity|2|||
126619571|NCT03138499|455562671|FG001|Overall Study|Study drug toxicity|2|||
126619572|NCT03138499|455562670|FG000|Overall Study|Participant request to discontinue study treatment|1|||
126619573|NCT03138499|455562671|FG001|Overall Study|Participant request to discontinue study treatment|1|||
126619574|NCT03138499|455562670|FG000|Overall Study|Other reasons|2|||
126619575|NCT03138499|455562671|FG001|Overall Study|Other reasons|0|||
126619576|NCT02674399|455562672|FG000|Overall Study|Lost to Follow-up|2|||
126619577|NCT02674399|455562673|FG001|Overall Study|Lost to Follow-up|0|||
126619578|NCT01661972|455562674|FG000|Overall Study|Adverse Event|1|||
126619579|NCT01661972|455562675|FG001|Overall Study|Adverse Event|2|||
126619580|NCT01661972|455562674|FG000|Overall Study|Death during Treatment period|1|||
126619581|NCT01661972|455562675|FG001|Overall Study|Death during Treatment period|1|||
126619582|NCT01661972|455562674|FG000|Overall Study|Withdrawal by Subject|0|||
126619583|NCT01661972|455562675|FG001|Overall Study|Withdrawal by Subject|1|||
126619584|NCT00760877|455564063|FG000|Overall Study|Protocol Violation|1|||
126619585|NCT00760877|455564064|FG001|Overall Study|Protocol Violation|0|||
126619586|NCT00760877|455564063|FG000|Overall Study|Non-compliance with protocol treatment|2|||
126619587|NCT00760877|455564064|FG001|Overall Study|Non-compliance with protocol treatment|1|||
126619588|NCT00760877|455564063|FG000|Overall Study|Pregnancy|1|||
126619589|NCT00760877|455564064|FG001|Overall Study|Pregnancy|4|||
126619590|NCT00760877|455564063|FG000|Overall Study|Death|2|||
126619591|NCT00760877|455564064|FG001|Overall Study|Death|1|||
126619592|NCT00760877|455564063|FG000|Overall Study|Withdrawal by Subject|7|||
126619593|NCT00760877|455564064|FG001|Overall Study|Withdrawal by Subject|3|||
126619594|NCT00760877|455564063|FG000|Overall Study|Adverse Event|19|||
126619595|NCT00760877|455564064|FG001|Overall Study|Adverse Event|12|||
126619596|NCT00760877|455564063|FG000|Overall Study|Participant diagnosed with AML|0|||
126619597|NCT00760877|455564064|FG001|Overall Study|Participant diagnosed with AML|1|||
126619598|NCT00760877|455564063|FG000|Overall Study|Participant not eligible to cross-over|0|||
126619599|NCT00760877|455564064|FG001|Overall Study|Participant not eligible to cross-over|1|||
126619600|NCT00760877|455564063|FG000|Overall Study|Physician Decision|1|||
126619601|NCT00760877|455564064|FG001|Overall Study|Physician Decision|2|||
126619602|NCT00760877|455564063|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
126619603|NCT00760877|455564064|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
126619604|NCT00760877|455564063|FG000|Overall Study|Treatment failure|1|||
126619605|NCT00760877|455564064|FG001|Overall Study|Treatment failure|0|||
126619606|NCT00711555|455564067|FG000|Overall Study|Adverse Event|3|||
126619607|NCT00946998|455564068|FG000|Overall Study|Exited prior to first outcome assessment|5|||
126619608|NCT00946998|455564069|FG001|Overall Study|Exited prior to first outcome assessment|3|||
126619609|NCT00304278|455564071|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
126619610|NCT00304278|455564071|FG000|Overall Study|PT had medical condition preventing TX|1|||
126619611|NCT00409006|455564072|FG000|Overall Study|Death|15|||
126619612|NCT00409006|455564073|FG001|Overall Study|Death|6|||
126619613|NCT00409006|455564072|FG000|Overall Study|Lost to Follow-up|1|||
126619614|NCT00409006|455564073|FG001|Overall Study|Lost to Follow-up|2|||
126619615|NCT00409006|455564072|FG000|Overall Study|Withdrawal by Subject|3|||
126619616|NCT00409006|455564073|FG001|Overall Study|Withdrawal by Subject|2|||
126619617|NCT00409006|455564072|FG000|Overall Study|Physician Decision|1|||
126619618|NCT00409006|455564073|FG001|Overall Study|Physician Decision|2|||
126619619|NCT00228813|455564074|FG000|Overall Study|Death|4|||
126619620|NCT00668746|455564078|FG000|Overall Study|Lost to Follow-up|2|||
126619621|NCT00668746|455564079|FG001|Overall Study|Lost to Follow-up|1|||
126619622|NCT01816165|455564081|FG000|Overall Study|Adverse Event|1|||
126619623|NCT01816165|455564082|FG001|Overall Study|Adverse Event|0|||
126619624|NCT01816165|455564083|FG002|Overall Study|Adverse Event|0|||
126619625|NCT01816165|455564084|FG003|Overall Study|Adverse Event|0|||
126619626|NCT01263223|455564090|FG000|Period 2|Withdrawal by Subject|0|||
126619627|NCT01263223|455564091|FG001|Period 2|Withdrawal by Subject|1|||
126619628|NCT01263223|455564090|FG000|7-day Follow-up|Withdrawal by Subject|0|||
126619629|NCT01263223|455564091|FG001|7-day Follow-up|Withdrawal by Subject|1|||
126782067|NCT01144663|456158073|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
126782068|NCT01144663|456158074|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
126782069|NCT01144663|456158071|FG000|Primary Vaccination Phase|Adverse Event|1|||
126782070|NCT01144663|456158072|FG001|Primary Vaccination Phase|Adverse Event|0|||
126619630|NCT01263223|455564090|FG000|7-day Follow-up|Lost to Follow-up|1|||
126619631|NCT01263223|455564091|FG001|7-day Follow-up|Lost to Follow-up|0|||
126619632|NCT04175834|455564093|FG000|Overall Study|Withdrawal by Subject|1|||
126619633|NCT04175834|455564094|FG001|Overall Study|Withdrawal by Subject|0|||
126619634|NCT04239911|455564096|FG000|Overall Study|Lost to Follow-up|2|||
126619635|NCT04239911|455564097|FG001|Overall Study|Lost to Follow-up|1|||
126619636|NCT01525875|455564102|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
126619637|NCT01525875|455564103|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
126619638|NCT01525875|455564102|FG000|Open-label Period|Lost to Follow-up|0|||
126619639|NCT01525875|455564103|FG001|Open-label Period|Lost to Follow-up|2|||
126619640|NCT05072795|455564104|FG000|Overall Study|Lost to Follow-up|5|||
126619641|NCT01107912|455564107|FG000|Period 1|Adverse Event|0|||
126619642|NCT01107912|455564108|FG001|Period 1|Adverse Event|0|||
126619643|NCT01107912|455564109|FG002|Period 1|Adverse Event|0|||
126619644|NCT01107912|455564110|FG003|Period 1|Adverse Event|0|||
126619645|NCT01107912|455564111|FG004|Period 1|Adverse Event|2|||
126619646|NCT01107912|455564112|FG005|Period 1|Adverse Event|0|||
126619647|NCT01107912|455564107|FG000|Period 1|Physician Decision|0|||
126619648|NCT01107912|455564108|FG001|Period 1|Physician Decision|0|||
126619649|NCT01107912|455564109|FG002|Period 1|Physician Decision|0|||
126619650|NCT01107912|455564110|FG003|Period 1|Physician Decision|0|||
126619651|NCT01107912|455564111|FG004|Period 1|Physician Decision|1|||
126619652|NCT01107912|455564112|FG005|Period 1|Physician Decision|0|||
126619653|NCT01107912|455564107|FG000|Period 1|Withdrawal by Subject|1|||
126619654|NCT01107912|455564108|FG001|Period 1|Withdrawal by Subject|0|||
126619655|NCT01107912|455564109|FG002|Period 1|Withdrawal by Subject|0|||
126619656|NCT01107912|455564110|FG003|Period 1|Withdrawal by Subject|0|||
126619657|NCT01107912|455564111|FG004|Period 1|Withdrawal by Subject|0|||
126619658|NCT01107912|455564112|FG005|Period 1|Withdrawal by Subject|0|||
126619659|NCT01107912|455564107|FG000|Period 2|Physician Decision|0|||
126619660|NCT01107912|455564108|FG001|Period 2|Physician Decision|0|||
126619661|NCT01107912|455564109|FG002|Period 2|Physician Decision|1|||
126619662|NCT01107912|455564110|FG003|Period 2|Physician Decision|0|||
126619663|NCT01107912|455564111|FG004|Period 2|Physician Decision|0|||
126619664|NCT01107912|455564112|FG005|Period 2|Physician Decision|0|||
126619665|NCT01107912|455564107|FG000|Period 3|Adverse Event|0|||
126619666|NCT01107912|455564108|FG001|Period 3|Adverse Event|1|||
126619667|NCT01107912|455564109|FG002|Period 3|Adverse Event|1|||
126619668|NCT01107912|455564110|FG003|Period 3|Adverse Event|0|||
126619669|NCT01107912|455564111|FG004|Period 3|Adverse Event|0|||
126619670|NCT01107912|455564112|FG005|Period 3|Adverse Event|0|||
126619671|NCT01107912|455564107|FG000|Period 3|Withdrawal by Subject|0|||
126619672|NCT01107912|455564108|FG001|Period 3|Withdrawal by Subject|0|||
126619673|NCT01107912|455564109|FG002|Period 3|Withdrawal by Subject|0|||
126619674|NCT01107912|455564110|FG003|Period 3|Withdrawal by Subject|1|||
126619675|NCT01107912|455564111|FG004|Period 3|Withdrawal by Subject|0|||
126619676|NCT01107912|455564112|FG005|Period 3|Withdrawal by Subject|0|||
126619677|NCT00753896|455564121|FG000|Overall Study|Adverse Event|4|||
126619678|NCT00753896|455564121|FG000|Overall Study|Death|1|||
126619679|NCT00753896|455564121|FG000|Overall Study|Lost to Follow-up|2|||
126619680|NCT00753896|455564121|FG000|Overall Study|Protocol Violation|1|||
126619681|NCT00753896|455564121|FG000|Overall Study|Withdrawal by Subject|4|||
126619682|NCT00753896|455564121|FG000|Overall Study|Entry Criteria Not Met|4|||
126619683|NCT01989156|455564122|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
126619684|NCT01989156|455564123|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
126619685|NCT01989156|455564124|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
126619686|NCT01989156|455564122|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
126619687|NCT01989156|455564123|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
126619688|NCT01989156|455564124|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
126619689|NCT01989156|455564122|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
126619690|NCT01989156|455564123|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
126619691|NCT01989156|455564124|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
126619692|NCT01989156|455564122|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
126619693|NCT01989156|455564123|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
126619694|NCT01989156|455564124|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
126619695|NCT01989156|455564122|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
126619696|NCT01989156|455564123|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
126619697|NCT01989156|455564124|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
126619698|NCT01989156|455564122|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
126619699|NCT01989156|455564123|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
126619700|NCT01989156|455564124|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
126619701|NCT01989156|455564122|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
126619702|NCT01989156|455564123|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
126619703|NCT01989156|455564124|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
126619704|NCT01989156|455564122|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
126619705|NCT01989156|455564123|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
126619706|NCT01989156|455564124|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
126619707|NCT00850993|455564125|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
126619708|NCT00850993|455564126|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
126619709|NCT00850993|455564127|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
126619710|NCT00850993|455564128|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
126619711|NCT03839355|455564129|FG000|Overall Study|Withdrawal by Subject|1|||
126619712|NCT03839355|455564130|FG001|Overall Study|Withdrawal by Subject|0|||
126619713|NCT01721109|455564139|FG000|Overall Study|Lack of Efficacy|1|||
126619714|NCT01721109|455564139|FG000|Overall Study|Non- Compliance with Study Drug|3|||
126619715|NCT01721109|455564139|FG000|Overall Study|Withdrew Consent|1|||
126619716|NCT01721109|455564139|FG000|Overall Study|Lost to Follow-up|2|||
126619717|NCT04362176|455564140|FG000|Overall Study|Lost to Follow-up|5|||
126619718|NCT04362176|455564141|FG001|Overall Study|Lost to Follow-up|8|||
126619719|NCT04362176|455564140|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
126619720|NCT04362176|455564141|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
126619721|NCT00742560|455564142|FG000|Overall Study|Adverse Event|0|||
126619722|NCT00742560|455564143|FG001|Overall Study|Adverse Event|0|||
126619723|NCT00742560|455564144|FG002|Overall Study|Adverse Event|1|||
126619724|NCT00742560|455564145|FG003|Overall Study|Adverse Event|1|||
126619725|NCT00742560|455564146|FG004|Overall Study|Adverse Event|1|||
126619726|NCT00742560|455564142|FG000|Overall Study|Death|0|||
126619727|NCT00742560|455564143|FG001|Overall Study|Death|2|||
126619728|NCT00742560|455564144|FG002|Overall Study|Death|0|||
126619729|NCT00742560|455564145|FG003|Overall Study|Death|2|||
126619730|NCT00742560|455564146|FG004|Overall Study|Death|3|||
126619731|NCT00742560|455564142|FG000|Overall Study|Subject's Decision|1|||
126619732|NCT00742560|455564143|FG001|Overall Study|Subject's Decision|0|||
126619733|NCT00742560|455564144|FG002|Overall Study|Subject's Decision|2|||
126619734|NCT00742560|455564145|FG003|Overall Study|Subject's Decision|3|||
126619735|NCT00742560|455564146|FG004|Overall Study|Subject's Decision|3|||
126619736|NCT00742560|455564142|FG000|Overall Study|Investigator's Decision|0|||
126619737|NCT00742560|455564143|FG001|Overall Study|Investigator's Decision|0|||
126619738|NCT00742560|455564144|FG002|Overall Study|Investigator's Decision|4|||
126619739|NCT00742560|455564145|FG003|Overall Study|Investigator's Decision|1|||
126619740|NCT00742560|455564146|FG004|Overall Study|Investigator's Decision|0|||
126619741|NCT00742560|455564142|FG000|Overall Study|Disease Progression|1|||
126619742|NCT00742560|455564143|FG001|Overall Study|Disease Progression|0|||
126619743|NCT00742560|455564144|FG002|Overall Study|Disease Progression|5|||
126619744|NCT00742560|455564145|FG003|Overall Study|Disease Progression|17|||
126619745|NCT00742560|455564146|FG004|Overall Study|Disease Progression|16|||
126619746|NCT00742560|455564142|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
126619747|NCT00742560|455564143|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
126619748|NCT00742560|455564144|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
126619749|NCT00742560|455564145|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
126619750|NCT00742560|455564146|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
126619751|NCT00742560|455564142|FG000|Overall Study|Other|0|||
126619752|NCT00742560|455564143|FG001|Overall Study|Other|1|||
126619753|NCT00742560|455564144|FG002|Overall Study|Other|8|||
126782071|NCT01144663|456158073|FG002|Primary Vaccination Phase|Adverse Event|0|||
126782072|NCT01144663|456158074|FG003|Primary Vaccination Phase|Adverse Event|1|||
126782073|NCT01144663|456158071|FG000|Primary Vaccination Phase|Protocol Violation|2|||
126619754|NCT00742560|455564145|FG003|Overall Study|Other|9|||
126619755|NCT00742560|455564146|FG004|Overall Study|Other|9|||
126619756|NCT00742560|455564142|FG000|Overall Study|MIssing|0|||
126619757|NCT00742560|455564143|FG001|Overall Study|MIssing|0|||
126782074|NCT01144663|456158072|FG001|Primary Vaccination Phase|Protocol Violation|0|||
126782075|NCT01144663|456158073|FG002|Primary Vaccination Phase|Protocol Violation|1|||
126619758|NCT00742560|455564144|FG002|Overall Study|MIssing|0|||
126619759|NCT00742560|455564145|FG003|Overall Study|MIssing|0|||
126619760|NCT00742560|455564146|FG004|Overall Study|MIssing|1|||
126782076|NCT01144663|456158074|FG003|Primary Vaccination Phase|Protocol Violation|0|||
126782077|NCT01144663|456158071|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
126619761|NCT01426217|455564148|FG000|Overall Study|lost sample|8|||
126619762|NCT01426217|455564149|FG001|Overall Study|lost sample|14|||
126619763|NCT01536795|455564150|FG000|Overall Study|Lost to Follow-up|0|||
126782078|NCT01144663|456158072|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
126782079|NCT01144663|456158073|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
126782080|NCT01144663|456158074|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
126782081|NCT01144663|456158071|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
126782082|NCT01144663|456158072|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
126782083|NCT01144663|456158073|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
126782084|NCT01144663|456158074|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
126782085|NCT01144663|456158071|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
126782086|NCT01144663|456158072|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
126782087|NCT01144663|456158073|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
126782088|NCT01144663|456158074|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
126782089|NCT01144663|456158071|FG000|Primary Vaccination Phase|Other|0|||
126782090|NCT01144663|456158072|FG001|Primary Vaccination Phase|Other|1|||
126782091|NCT01144663|456158073|FG002|Primary Vaccination Phase|Other|0|||
126619764|NCT01536795|455564151|FG001|Overall Study|Lost to Follow-up|2|||
126619765|NCT01536795|455564150|FG000|Overall Study|Lack of Efficacy|1|||
126619766|NCT01536795|455564151|FG001|Overall Study|Lack of Efficacy|0|||
126619767|NCT01812837|455564152|FG000|Overall Study|Lost to Follow-up|1|||
126619768|NCT01812837|455564153|FG001|Overall Study|Lost to Follow-up|1|||
126619769|NCT01812837|455564154|FG002|Overall Study|Lost to Follow-up|0|||
126619770|NCT01812837|455564152|FG000|Overall Study|Protocol Violation|1|||
126619771|NCT01812837|455564153|FG001|Overall Study|Protocol Violation|0|||
126619772|NCT01812837|455564154|FG002|Overall Study|Protocol Violation|0|||
126619773|NCT05008224|455564156|FG000|Overall Study|Death|3|||
126619774|NCT05008224|455564156|FG000|Overall Study|Lost to Follow-up|2|||
126619775|NCT05008224|455564156|FG000|Overall Study|Did Not Continue on Extension Study|39|||
126619776|NCT05008224|455564156|FG000|Overall Study|Transferred to Extension Study|100|||
126619777|NCT05008224|455564156|FG000|Overall Study|Withdrawal by Subject|2|||
126619778|NCT05234632|455564157|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
126619779|NCT05234632|455564158|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
126619780|NCT05234632|455564157|FG000|Overall Study|Withdrawal by Subject|2|||
126619781|NCT05234632|455564158|FG001|Overall Study|Withdrawal by Subject|0|||
126619782|NCT05234632|455564157|FG000|Overall Study|Adverse Event|0|||
126619783|NCT05234632|455564158|FG001|Overall Study|Adverse Event|4|||
126619784|NCT05234632|455564157|FG000|Overall Study|Physician Decision|1|||
126619785|NCT05234632|455564158|FG001|Overall Study|Physician Decision|1|||
126619786|NCT05234632|455564157|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
126619787|NCT05234632|455564158|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
126619788|NCT05234632|455564157|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
126619789|NCT05234632|455564158|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
126619790|NCT00658632|455564159|FG000|Overall Study|Adverse Event|13|||
126619791|NCT00658632|455564160|FG001|Overall Study|Adverse Event|11|||
126619792|NCT00658632|455564159|FG000|Overall Study|Lost to Follow-up|25|||
126619793|NCT00658632|455564160|FG001|Overall Study|Lost to Follow-up|23|||
126619794|NCT00658632|455564159|FG000|Overall Study|Withdrawal by Subject|10|||
126619795|NCT00658632|455564160|FG001|Overall Study|Withdrawal by Subject|7|||
126619796|NCT00658632|455564159|FG000|Overall Study|Lack of Efficacy|0|||
126619797|NCT00658632|455564160|FG001|Overall Study|Lack of Efficacy|1|||
126619798|NCT00658632|455564159|FG000|Overall Study|Withdrawal of consent|8|||
126619799|NCT00658632|455564160|FG001|Overall Study|Withdrawal of consent|14|||
126619800|NCT00658632|455564159|FG000|Overall Study|Pregnancy|1|||
126619801|NCT00658632|455564160|FG001|Overall Study|Pregnancy|1|||
126782092|NCT01144663|456158074|FG003|Primary Vaccination Phase|Other|2|||
126782093|NCT01144663|456158071|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
126782094|NCT01144663|456158072|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
126782095|NCT01144663|456158073|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
126782096|NCT01144663|456158074|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
126619802|NCT00658632|455564159|FG000|Overall Study|Other|7|||
126619803|NCT00658632|455564160|FG001|Overall Study|Other|8|||
126619804|NCT02991456|455564162|FG000|Overall Study|Adverse Event|2|||
126619805|NCT02991456|455564163|FG001|Overall Study|Adverse Event|0|||
126619806|NCT02991456|455564162|FG000|Overall Study|Lost to Follow-up|0|||
126782097|NCT01144663|456158071|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
126619807|NCT02991456|455564163|FG001|Overall Study|Lost to Follow-up|2|||
126619808|NCT02991456|455564162|FG000|Overall Study|Withdrawal by Subject|1|||
126619809|NCT02991456|455564163|FG001|Overall Study|Withdrawal by Subject|0|||
126619810|NCT01699178|455564164|FG000|Overall Study|Adverse Event|1|||
126619811|NCT01699178|455564165|FG001|Overall Study|Adverse Event|5|||
126619812|NCT01699178|455564164|FG000|Overall Study|Lost to Follow-up|1|||
126782098|NCT01144663|456158072|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
126619813|NCT01699178|455564165|FG001|Overall Study|Lost to Follow-up|6|||
126619814|NCT01699178|455564164|FG000|Overall Study|Non-compliance with Study Drug|3|||
126619815|NCT01699178|455564165|FG001|Overall Study|Non-compliance with Study Drug|1|||
126619816|NCT01699178|455564164|FG000|Overall Study|Physician Decision|1|||
126619817|NCT01699178|455564165|FG001|Overall Study|Physician Decision|0|||
126619818|NCT01699178|455564164|FG000|Overall Study|Withdrawal by Subject|4|||
126619819|NCT01699178|455564165|FG001|Overall Study|Withdrawal by Subject|12|||
126619820|NCT01699178|455564164|FG000|Overall Study|Hematocrit >54%|1|||
126619821|NCT01699178|455564165|FG001|Overall Study|Hematocrit >54%|1|||
126619822|NCT01699178|455564164|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
126619823|NCT01699178|455564165|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
126619824|NCT01699178|455564164|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
126619825|NCT01699178|455564165|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
126619826|NCT00321555|455564167|FG000|Overall Study|Developed antibodies|1|||
126619827|NCT00321555|455564167|FG000|Overall Study|Switched to alternative treatment|3|||
126619828|NCT00321555|455564167|FG000|Overall Study|Physician Decision|1|||
126619829|NCT00321555|455564167|FG000|Overall Study|Disease progression on study|1|||
126619830|NCT02066389|455564169|FG000|Overall Study|Adverse Event|1|||
126619831|NCT02066389|455564170|FG001|Overall Study|Adverse Event|1|||
126619832|NCT02066389|455564171|FG002|Overall Study|Adverse Event|1|||
126619833|NCT02066389|455564172|FG003|Overall Study|Adverse Event|1|||
126619834|NCT02066389|455564173|FG004|Overall Study|Adverse Event|5|||
126619835|NCT02066389|455564174|FG005|Overall Study|Adverse Event|1|||
126619836|NCT02066389|455564169|FG000|Overall Study|Withdrawal by Subject|4|||
126619837|NCT02066389|455564170|FG001|Overall Study|Withdrawal by Subject|0|||
126619838|NCT02066389|455564171|FG002|Overall Study|Withdrawal by Subject|5|||
126619839|NCT02066389|455564172|FG003|Overall Study|Withdrawal by Subject|1|||
126619840|NCT02066389|455564173|FG004|Overall Study|Withdrawal by Subject|1|||
126619841|NCT02066389|455564174|FG005|Overall Study|Withdrawal by Subject|2|||
126619842|NCT02066389|455564169|FG000|Overall Study|Lost to Follow-up|0|||
126619843|NCT02066389|455564170|FG001|Overall Study|Lost to Follow-up|0|||
126619844|NCT02066389|455564171|FG002|Overall Study|Lost to Follow-up|0|||
126619845|NCT02066389|455564172|FG003|Overall Study|Lost to Follow-up|1|||
126619846|NCT02066389|455564173|FG004|Overall Study|Lost to Follow-up|1|||
126619847|NCT02066389|455564174|FG005|Overall Study|Lost to Follow-up|1|||
126619848|NCT02066389|455564169|FG000|Overall Study|Randomized in Error|0|||
126619849|NCT02066389|455564170|FG001|Overall Study|Randomized in Error|0|||
126619850|NCT02066389|455564171|FG002|Overall Study|Randomized in Error|0|||
126619851|NCT02066389|455564172|FG003|Overall Study|Randomized in Error|0|||
126619852|NCT02066389|455564173|FG004|Overall Study|Randomized in Error|0|||
126619853|NCT02066389|455564174|FG005|Overall Study|Randomized in Error|1|||
126619854|NCT01755598|455564179|FG000|Overall Study|Other|109|||
126619855|NCT01755598|455564180|FG001|Overall Study|Other|109|||
126619856|NCT01755598|455564179|FG000|Overall Study|Lost to Follow-up|32|||
126619857|NCT01755598|455564180|FG001|Overall Study|Lost to Follow-up|43|||
126619858|NCT01755598|455564179|FG000|Overall Study|Migrated/moved from study area|76|||
126619859|NCT01755598|455564180|FG001|Overall Study|Migrated/moved from study area|65|||
126619860|NCT01755598|455564179|FG000|Overall Study|Withdrawal by Subject|22|||
126619861|NCT01755598|455564180|FG001|Overall Study|Withdrawal by Subject|31|||
126619862|NCT01755598|455564179|FG000|Overall Study|Protocol Violation|7|||
126619863|NCT01755598|455564180|FG001|Overall Study|Protocol Violation|7|||
126619864|NCT01755598|455564179|FG000|Overall Study|Adverse Event|19|||
126619865|NCT01755598|455564180|FG001|Overall Study|Adverse Event|28|||
126619866|NCT02924051|455564183|FG000|Overall Study|Withdrawal by Subject|1|||
126619867|NCT02924051|455564184|FG001|Overall Study|Withdrawal by Subject|9|||
126619868|NCT03547167|455564189|FG000|Overall Study|Withdrawal by Subject|34|||
126619869|NCT03547167|455564190|FG001|Overall Study|Withdrawal by Subject|12|||
126619870|NCT03547167|455564189|FG000|Overall Study|Screen Failure|0|||
126619871|NCT03547167|455564190|FG001|Overall Study|Screen Failure|1|||
126619872|NCT03547167|455564189|FG000|Overall Study|Lost to Follow-up|59|||
126619873|NCT03547167|455564190|FG001|Overall Study|Lost to Follow-up|15|||
126619874|NCT03547167|455564189|FG000|Overall Study|Death|4|||
126619875|NCT03547167|455564190|FG001|Overall Study|Death|2|||
126619876|NCT00738400|455564194|FG000|Overall Study|Adverse Event|3|||
126619877|NCT00738400|455564195|FG001|Overall Study|Adverse Event|1|||
126619878|NCT00738400|455564194|FG000|Overall Study|Withdrawal by Subject|0|||
126619879|NCT00738400|455564195|FG001|Overall Study|Withdrawal by Subject|1|||
126619880|NCT00738400|455564194|FG000|Overall Study|Lack of Efficacy|0|||
126619881|NCT00738400|455564195|FG001|Overall Study|Lack of Efficacy|1|||
126619882|NCT00738400|455564194|FG000|Overall Study|Lost to Follow-up|0|||
126619883|NCT00738400|455564195|FG001|Overall Study|Lost to Follow-up|3|||
126619884|NCT00738400|455564194|FG000|Overall Study|Protocol Violation|1|||
126619885|NCT00738400|455564195|FG001|Overall Study|Protocol Violation|0|||
126619886|NCT00738400|455564194|FG000|Overall Study|Non-compliant with study medication|0|||
126619887|NCT00738400|455564195|FG001|Overall Study|Non-compliant with study medication|1|||
126619888|NCT00508144|455564196|FG000|Overall Study|Not eligible|6|||
126619889|NCT00508144|455564196|FG000|Overall Study|Death|5|||
126619890|NCT02009865|455564197|FG000|Overall Study|Adverse Event|0|||
126619891|NCT02009865|455564198|FG001|Overall Study|Adverse Event|2|||
126619892|NCT02009865|455564197|FG000|Overall Study|Protocol Violation|0|||
126619893|NCT02009865|455564198|FG001|Overall Study|Protocol Violation|2|||
126619894|NCT02009865|455564197|FG000|Overall Study|Withdrawal by Subject|1|||
126619895|NCT02009865|455564198|FG001|Overall Study|Withdrawal by Subject|1|||
126619896|NCT01760876|455564199|FG000|Overall Study|Non-cardiac death (head injury)|1|||
126619897|NCT01760876|455564199|FG000|Overall Study|Carcinoma of prostate|1|||
126619898|NCT01760876|455564199|FG000|Overall Study|Impaired renal function|1|||
126619899|NCT01760876|455564199|FG000|Overall Study|Major depression|1|||
126619900|NCT01760876|455564199|FG000|Overall Study|Very poor baseline OCT quality|2|||
126619901|NCT01517282|455564202|FG000|Overall Study|Consent withdrawn|0|||
126619902|NCT01517282|455564203|FG001|Overall Study|Consent withdrawn|1|||
126619903|NCT01517282|455564204|FG002|Overall Study|Consent withdrawn|1|||
126619904|NCT01517282|455564205|FG003|Overall Study|Consent withdrawn|1|||
126619905|NCT01517282|455564202|FG000|Overall Study|Physician Decision|1|||
126619906|NCT01517282|455564203|FG001|Overall Study|Physician Decision|0|||
126619907|NCT01517282|455564204|FG002|Overall Study|Physician Decision|0|||
126619908|NCT01517282|455564205|FG003|Overall Study|Physician Decision|0|||
126619909|NCT00525915|455564206|FG000|Overall Study|Non-Compliance|0|||
126619910|NCT00525915|455564207|FG001|Overall Study|Non-Compliance|1|||
126619911|NCT00525915|455564206|FG000|Overall Study|Disease Progression|5|||
126619912|NCT00525915|455564207|FG001|Overall Study|Disease Progression|6|||
126619913|NCT00525915|455564206|FG000|Overall Study|Withdrawal by Subject|1|||
126619914|NCT00525915|455564207|FG001|Overall Study|Withdrawal by Subject|0|||
126619915|NCT00525915|455564206|FG000|Overall Study|Refused Surgery|1|||
126619916|NCT00525915|455564207|FG001|Overall Study|Refused Surgery|2|||
126619917|NCT00525915|455564206|FG000|Overall Study|Unrelated illness|1|||
126619918|NCT00525915|455564207|FG001|Overall Study|Unrelated illness|0|||
126619919|NCT02332889|455564211|FG000|Overall Study|Physician Decision|1|||
126619920|NCT05356130|455565688|FG000|Overall Study|Withdrawal by Subject|0|||
126619921|NCT05356130|455565689|FG001|Overall Study|Withdrawal by Subject|0|||
126619922|NCT05356130|455565690|FG002|Overall Study|Withdrawal by Subject|3|||
126619923|NCT03141177|455565691|FG000|Overall Study|Death|62|||
126619924|NCT03141177|455565692|FG001|Overall Study|Death|13|||
126619925|NCT03141177|455565693|FG002|Overall Study|Death|84|||
126619926|NCT03141177|455565691|FG000|Overall Study|Participant withdrew consent|9|||
126619927|NCT03141177|455565692|FG001|Overall Study|Participant withdrew consent|2|||
126619928|NCT03141177|455565693|FG002|Overall Study|Participant withdrew consent|13|||
126619929|NCT03141177|455565691|FG000|Overall Study|Not reported|1|||
126619930|NCT03141177|455565692|FG001|Overall Study|Not reported|0|||
126619931|NCT03141177|455565693|FG002|Overall Study|Not reported|1|||
126619932|NCT03141177|455565691|FG000|Overall Study|Lost to Follow-up|2|||
126619933|NCT03141177|455565692|FG001|Overall Study|Lost to Follow-up|1|||
126619934|NCT03141177|455565693|FG002|Overall Study|Lost to Follow-up|1|||
126619935|NCT03141177|455565691|FG000|Overall Study|Other reasons|4|||
126619936|NCT03141177|455565692|FG001|Overall Study|Other reasons|0|||
126619937|NCT03141177|455565693|FG002|Overall Study|Other reasons|11|||
126619938|NCT03141177|455565691|FG000|Overall Study|Participants did not start treatment period|3|||
126619939|NCT03141177|455565692|FG001|Overall Study|Participants did not start treatment period|0|||
126619940|NCT03141177|455565693|FG002|Overall Study|Participants did not start treatment period|8|||
126619941|NCT03020914|455565696|FG000|Overall Study|Surgery Cancelled|1|||
126619942|NCT03020914|455565697|FG001|Overall Study|Surgery Cancelled|0|||
126619943|NCT02109172|455565702|FG000|Overall Study|Withdrawal by Subject|1|||
126782099|NCT01144663|456158073|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
126619944|NCT02109172|455565703|FG001|Overall Study|Withdrawal by Subject|0|||
126619945|NCT02109172|455565704|FG002|Overall Study|Withdrawal by Subject|0|||
126619946|NCT02109172|455565705|FG003|Overall Study|Withdrawal by Subject|1|||
126619947|NCT02109172|455565706|FG004|Overall Study|Withdrawal by Subject|0|||
126619948|NCT02109172|455565707|FG005|Overall Study|Withdrawal by Subject|0|||
126619949|NCT02109172|455565702|FG000|Overall Study|Adverse Event|0|||
126619950|NCT02109172|455565703|FG001|Overall Study|Adverse Event|0|||
126619951|NCT02109172|455565704|FG002|Overall Study|Adverse Event|1|||
126619952|NCT02109172|455565705|FG003|Overall Study|Adverse Event|0|||
126619953|NCT02109172|455565706|FG004|Overall Study|Adverse Event|0|||
126619954|NCT02109172|455565707|FG005|Overall Study|Adverse Event|1|||
126619955|NCT02109172|455565702|FG000|Overall Study|Death|0|||
126619956|NCT02109172|455565703|FG001|Overall Study|Death|0|||
126619957|NCT02109172|455565704|FG002|Overall Study|Death|0|||
126619958|NCT02109172|455565705|FG003|Overall Study|Death|0|||
126619959|NCT02109172|455565706|FG004|Overall Study|Death|1|||
126619960|NCT02109172|455565707|FG005|Overall Study|Death|0|||
126619961|NCT02011568|455565708|FG000|Overall Study|Withdrawal by Subject|8|||
126619962|NCT02011568|455565709|FG001|Overall Study|Withdrawal by Subject|10|||
126619963|NCT02011568|455565708|FG000|Overall Study|Physician Decision|1|||
126619964|NCT02011568|455565709|FG001|Overall Study|Physician Decision|3|||
126619965|NCT03696342|455565712|FG000|Overall Study|Lost to Follow-up|1|||
126619966|NCT03696342|455565713|FG001|Overall Study|Lost to Follow-up|0|||
126619967|NCT05361304|455565716|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
126619968|NCT05361304|455565717|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
126619969|NCT05361304|455565716|FG000|Overall Study|COVID-19 Related|1|||
126619970|NCT05361304|455565717|FG001|Overall Study|COVID-19 Related|2|||
126619971|NCT05361304|455565716|FG000|Overall Study|Withdrawal by Subject|1|||
126619972|NCT05361304|455565717|FG001|Overall Study|Withdrawal by Subject|0|||
126619973|NCT02409732|455565718|FG000|Overall Study|Withdrawal by Subject|4|||
126619974|NCT02409732|455565718|FG000|Overall Study|Lost to Follow-up|2|||
126619975|NCT00376259|455565719|FG000|Overall Study|Sponsor request - study termination|21|||
126619976|NCT00376259|455565720|FG001|Overall Study|Sponsor request - study termination|21|||
126619977|NCT00376259|455565719|FG000|Overall Study|Patient request|1|||
126619978|NCT00376259|455565720|FG001|Overall Study|Patient request|0|||
126619979|NCT01877720|455565721|FG000|Overall Study|Adverse Event|1|||
126619980|NCT01877720|455565722|FG001|Overall Study|Adverse Event|0|||
126619981|NCT00447499|455565723|FG000|Overall Study|Adverse Event|1|||
126619982|NCT00447499|455565723|FG000|Overall Study|Patient Decision|4|||
126619983|NCT00447499|455565723|FG000|Overall Study|Sponsor Decision|1|||
126619984|NCT00447499|455565723|FG000|Overall Study|Physician Decision|1|||
126619985|NCT02068352|455565725|FG000|Overall Study|Lost to Follow-up|0|||
126619986|NCT02068352|455565726|FG001|Overall Study|Lost to Follow-up|2|||
126619987|NCT02068352|455565727|FG002|Overall Study|Lost to Follow-up|0|||
126619988|NCT02068352|455565725|FG000|Overall Study|Adverse Event|4|||
126619989|NCT02068352|455565726|FG001|Overall Study|Adverse Event|2|||
126619990|NCT02068352|455565727|FG002|Overall Study|Adverse Event|7|||
126619991|NCT02068352|455565725|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
126619992|NCT02068352|455565726|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
126619993|NCT02068352|455565727|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
126619994|NCT02068352|455565725|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
126619995|NCT02068352|455565726|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
126619996|NCT02068352|455565727|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
126619997|NCT02068352|455565725|FG000|Overall Study|Protocol Deviation|0|||
126619998|NCT02068352|455565726|FG001|Overall Study|Protocol Deviation|0|||
126619999|NCT02068352|455565727|FG002|Overall Study|Protocol Deviation|1|||
126620000|NCT03960437|455565728|FG000|Overall Study|Removed by PI|4|||
126620001|NCT03960437|455565728|FG000|Overall Study|Lost to Follow-up|2|||
126620002|NCT03960437|455565728|FG000|Overall Study|Withdrawal by Subject|1|||
126620003|NCT03960437|455565728|FG000|Overall Study|Death|2|||
126620004|NCT00473512|455565731|FG000|Period 1 (Phase 1)|Adverse Event|0|||
126620005|NCT00473512|455565732|FG001|Period 1 (Phase 1)|Adverse Event|0|||
126620006|NCT00473512|455565733|FG002|Period 1 (Phase 1)|Adverse Event|0|||
126620007|NCT00473512|455565734|FG003|Period 1 (Phase 1)|Adverse Event|5|||
126620008|NCT00473512|455565735|FG004|Period 1 (Phase 1)|Adverse Event|0|||
126620009|NCT00473512|455565731|FG000|Period 1 (Phase 1)|Death|0|||
126620010|NCT00473512|455565732|FG001|Period 1 (Phase 1)|Death|0|||
126620011|NCT00473512|455565733|FG002|Period 1 (Phase 1)|Death|0|||
126620012|NCT00473512|455565734|FG003|Period 1 (Phase 1)|Death|1|||
126620013|NCT00473512|455565735|FG004|Period 1 (Phase 1)|Death|0|||
126620014|NCT00473512|455565731|FG000|Period 1 (Phase 1)|Disease Progression|1|||
126620015|NCT00473512|455565732|FG001|Period 1 (Phase 1)|Disease Progression|1|||
126620016|NCT00473512|455565733|FG002|Period 1 (Phase 1)|Disease Progression|0|||
126620017|NCT00473512|455565734|FG003|Period 1 (Phase 1)|Disease Progression|10|||
126620018|NCT00473512|455565735|FG004|Period 1 (Phase 1)|Disease Progression|1|||
126620019|NCT00473512|455565731|FG000|Period 1 (Phase 1)|Other|0|||
126620020|NCT00473512|455565732|FG001|Period 1 (Phase 1)|Other|0|||
126620021|NCT00473512|455565733|FG002|Period 1 (Phase 1)|Other|0|||
126620022|NCT00473512|455565734|FG003|Period 1 (Phase 1)|Other|1|||
126620023|NCT00473512|455565735|FG004|Period 1 (Phase 1)|Other|0|||
126620024|NCT00473512|455565731|FG000|Period 2 (Phase 2)|Adverse Event|0|||
126620025|NCT00473512|455565732|FG001|Period 2 (Phase 2)|Adverse Event|0|||
126620026|NCT00473512|455565733|FG002|Period 2 (Phase 2)|Adverse Event|0|||
126620027|NCT00473512|455565734|FG003|Period 2 (Phase 2)|Adverse Event|1|||
126620028|NCT00473512|455565735|FG004|Period 2 (Phase 2)|Adverse Event|0|||
126620029|NCT00473512|455565731|FG000|Period 2 (Phase 2)|Death|0|||
126620030|NCT00473512|455565732|FG001|Period 2 (Phase 2)|Death|0|||
126620031|NCT00473512|455565733|FG002|Period 2 (Phase 2)|Death|0|||
126782100|NCT01144663|456158074|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
126620032|NCT00473512|455565734|FG003|Period 2 (Phase 2)|Death|1|||
126620033|NCT00473512|455565735|FG004|Period 2 (Phase 2)|Death|1|||
126620034|NCT00473512|455565731|FG000|Period 2 (Phase 2)|Disease Progression|0|||
126620035|NCT00473512|455565732|FG001|Period 2 (Phase 2)|Disease Progression|2|||
126620036|NCT00473512|455565733|FG002|Period 2 (Phase 2)|Disease Progression|2|||
126620037|NCT00473512|455565734|FG003|Period 2 (Phase 2)|Disease Progression|17|||
126620038|NCT00473512|455565735|FG004|Period 2 (Phase 2)|Disease Progression|1|||
126620039|NCT00473512|455565731|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
126782101|NCT01144663|456158071|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
126620040|NCT00473512|455565732|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
126620041|NCT00473512|455565733|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
126620042|NCT00473512|455565734|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
126782102|NCT01144663|456158072|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
126782103|NCT01144663|456158073|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
126782104|NCT01144663|456158074|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
126782105|NCT01144663|456158071|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
126782106|NCT01144663|456158072|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
126782107|NCT01144663|456158073|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
126782108|NCT01144663|456158074|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
126782109|NCT01144663|456158071|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
126782110|NCT01144663|456158072|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
126782111|NCT01144663|456158073|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
126782112|NCT01144663|456158074|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
126782113|NCT01144663|456158071|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
126782114|NCT01144663|456158072|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
126782115|NCT01144663|456158073|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
126782116|NCT01144663|456158074|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
126782117|NCT01335477|456158075|FG000|Overall Study|Adverse Event|30|||
126782118|NCT01335477|456158076|FG001|Overall Study|Adverse Event|42|||
126782119|NCT01335477|456158075|FG000|Overall Study|Non compliant with protocol|0|||
126782120|NCT01335477|456158076|FG001|Overall Study|Non compliant with protocol|2|||
126782121|NCT01335477|456158075|FG000|Overall Study|Lost to Follow-up|1|||
126782122|NCT01335477|456158076|FG001|Overall Study|Lost to Follow-up|2|||
126782123|NCT01335477|456158075|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
126782124|NCT01335477|456158076|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
126782125|NCT01335477|456158075|FG000|Overall Study|Not treated|1|||
126782126|NCT01335477|456158076|FG001|Overall Study|Not treated|2|||
126782127|NCT01335477|456158075|FG000|Overall Study|Reason other than those stated above|2|||
126782128|NCT01335477|456158076|FG001|Overall Study|Reason other than those stated above|2|||
126782129|NCT03031899|456158079|FG000|Overall Study|Protocol Violation|1|||
126782130|NCT03031899|456158079|FG000|Overall Study|lesion disappeared after stopping habit|1|||
126782131|NCT03740698|456158080|FG000|Overall Study|Physician Decision|0|||
126782132|NCT03740698|456158081|FG001|Overall Study|Physician Decision|1|||
126782133|NCT03740698|456158082|FG002|Overall Study|Physician Decision|1|||
126782134|NCT01469364|456158083|FG000|Overall Study|Adverse Event|1|||
126782135|NCT01469364|456158083|FG000|Overall Study|Withdrawal by Subject|1|||
126782136|NCT03433001|456158084|FG000|Overall Study|Lack of Efficacy|109|||
126782137|NCT03433001|456158084|FG000|Overall Study|Adverse Event|69|||
126782138|NCT03433001|456158084|FG000|Overall Study|Withdrawal by Subject|10|||
126782139|NCT03433001|456158084|FG000|Overall Study|Death|12|||
126782140|NCT03433001|456158084|FG000|Overall Study|Lost to Follow-up|4|||
126782141|NCT03433001|456158084|FG000|Overall Study|Other|25|||
126782142|NCT01162499|456158087|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
126782143|NCT01162499|456158088|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
126782144|NCT02040428|456158089|FG000|Overall Study|Death|4|||
126782145|NCT02040428|456158090|FG001|Overall Study|Death|3|||
126782146|NCT02040428|456158089|FG000|Overall Study|Withdrawal by Subject|1|||
126782147|NCT02040428|456158090|FG001|Overall Study|Withdrawal by Subject|1|||
126782148|NCT00449072|456158108|FG000|Overall Study|Adverse Event|3|||
126782149|NCT00449072|456158109|FG001|Overall Study|Adverse Event|1|||
126782150|NCT00449072|456158108|FG000|Overall Study|Protocol Violation|14|||
126782151|NCT00449072|456158109|FG001|Overall Study|Protocol Violation|12|||
126782152|NCT00449072|456158108|FG000|Overall Study|Lost to Follow-up|5|||
126782153|NCT00449072|456158109|FG001|Overall Study|Lost to Follow-up|7|||
126782154|NCT00449072|456158108|FG000|Overall Study|Withdrawal by Subject|11|||
126782155|NCT00449072|456158109|FG001|Overall Study|Withdrawal by Subject|8|||
126782156|NCT00449072|456158108|FG000|Overall Study|Lack of Efficacy|1|||
126782157|NCT00449072|456158109|FG001|Overall Study|Lack of Efficacy|1|||
126782158|NCT00449072|456158108|FG000|Overall Study|Physician Decision|1|||
126782159|NCT00449072|456158109|FG001|Overall Study|Physician Decision|0|||
126782160|NCT00449072|456158108|FG000|Overall Study|Not treated|0|||
126782161|NCT00449072|456158109|FG001|Overall Study|Not treated|1|||
126782162|NCT00449072|456158108|FG000|Overall Study|Excluded medication|0|||
126782163|NCT00449072|456158109|FG001|Overall Study|Excluded medication|2|||
126782164|NCT00449072|456158108|FG000|Overall Study|Non-compliance|2|||
126782165|NCT00449072|456158109|FG001|Overall Study|Non-compliance|5|||
126782166|NCT00449072|456158108|FG000|Overall Study|Sponsor decision|1|||
126782167|NCT00449072|456158109|FG001|Overall Study|Sponsor decision|3|||
126782168|NCT00449072|456158108|FG000|Overall Study|Relocation|3|||
126782169|NCT00449072|456158109|FG001|Overall Study|Relocation|2|||
126782170|NCT00989261|456158110|FG000|Overall Study|Still in follow up|12|||
126782171|NCT00989261|456158111|FG001|Overall Study|Still in follow up|21|||
126782172|NCT00989261|456158110|FG000|Overall Study|Withdrawal by Subject|0|||
126782173|NCT00989261|456158111|FG001|Overall Study|Withdrawal by Subject|1|||
126620043|NCT00473512|455565735|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
126782174|NCT00989261|456158110|FG000|Overall Study|Lost to Follow-up|3|||
126782175|NCT00989261|456158111|FG001|Overall Study|Lost to Follow-up|0|||
126782176|NCT00718159|456158112|FG000|Overall Study|Progressive Disease|3|||
126620044|NCT00473512|455565731|FG000|Period 2 (Phase 2)|Other|1|||
126620045|NCT00473512|455565732|FG001|Period 2 (Phase 2)|Other|0|||
126620046|NCT00473512|455565733|FG002|Period 2 (Phase 2)|Other|0|||
126620047|NCT00473512|455565734|FG003|Period 2 (Phase 2)|Other|3|||
126620048|NCT00473512|455565735|FG004|Period 2 (Phase 2)|Other|0|||
126620049|NCT00267956|455565736|FG000|Controlled Period|Adverse Event|4|||
126620050|NCT00267956|455565737|FG001|Controlled Period|Adverse Event|1|||
126620051|NCT00267956|455565738|FG002|Controlled Period|Adverse Event|0|||
126620052|NCT00267956|455565739|FG003|Controlled Period|Adverse Event|0|||
126620053|NCT00267956|455565736|FG000|Controlled Period|Lack of Efficacy|4|||
126620054|NCT00267956|455565737|FG001|Controlled Period|Lack of Efficacy|2|||
126620055|NCT00267956|455565738|FG002|Controlled Period|Lack of Efficacy|0|||
126620056|NCT00267956|455565739|FG003|Controlled Period|Lack of Efficacy|0|||
126620057|NCT00267956|455565736|FG000|Controlled Period|Lost to Follow-up|2|||
126620058|NCT00267956|455565737|FG001|Controlled Period|Lost to Follow-up|0|||
126620059|NCT00267956|455565738|FG002|Controlled Period|Lost to Follow-up|0|||
126620060|NCT00267956|455565739|FG003|Controlled Period|Lost to Follow-up|0|||
126620061|NCT00267956|455565736|FG000|Controlled Period|Withdrew consent|3|||
126620062|NCT00267956|455565737|FG001|Controlled Period|Withdrew consent|1|||
126620063|NCT00267956|455565738|FG002|Controlled Period|Withdrew consent|0|||
126620064|NCT00267956|455565739|FG003|Controlled Period|Withdrew consent|0|||
126620065|NCT00267956|455565736|FG000|After Controlled Period|Adverse Event|0|||
126620066|NCT00267956|455565737|FG001|After Controlled Period|Adverse Event|0|||
126620067|NCT00267956|455565738|FG002|After Controlled Period|Adverse Event|2|||
126620068|NCT00267956|455565739|FG003|After Controlled Period|Adverse Event|1|||
126620069|NCT00267956|455565736|FG000|After Controlled Period|Lack of Efficacy|0|||
126620070|NCT00267956|455565737|FG001|After Controlled Period|Lack of Efficacy|0|||
126620071|NCT00267956|455565738|FG002|After Controlled Period|Lack of Efficacy|1|||
126620072|NCT00267956|455565739|FG003|After Controlled Period|Lack of Efficacy|1|||
126620073|NCT00267956|455565736|FG000|After Controlled Period|Lost to Follow-up|0|||
126620074|NCT00267956|455565737|FG001|After Controlled Period|Lost to Follow-up|0|||
126746718|NCT02614261|456022048|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
126746719|NCT02614261|456022045|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
126746720|NCT02614261|456022046|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
126746721|NCT02614261|456022047|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
126746722|NCT02614261|456022048|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
126746723|NCT02614261|456022045|FG000|Open-Label Extension Phase|Physician Decision|2|||
126746724|NCT02614261|456022046|FG001|Open-Label Extension Phase|Physician Decision|0|||
126746725|NCT02614261|456022047|FG002|Open-Label Extension Phase|Physician Decision|0|||
126746726|NCT02614261|456022048|FG003|Open-Label Extension Phase|Physician Decision|0|||
126746727|NCT02614261|456022045|FG000|Open-Label Extension Phase|Pregnancy|1|||
126746728|NCT02614261|456022046|FG001|Open-Label Extension Phase|Pregnancy|2|||
126746729|NCT02614261|456022047|FG002|Open-Label Extension Phase|Pregnancy|1|||
126746730|NCT02614261|456022048|FG003|Open-Label Extension Phase|Pregnancy|0|||
126746731|NCT02614261|456022045|FG000|Open-Label Extension Phase|Protocol Violation|3|||
126746732|NCT02614261|456022046|FG001|Open-Label Extension Phase|Protocol Violation|4|||
126746733|NCT02614261|456022047|FG002|Open-Label Extension Phase|Protocol Violation|1|||
126746734|NCT02614261|456022048|FG003|Open-Label Extension Phase|Protocol Violation|0|||
126746735|NCT02614261|456022045|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
126746736|NCT02614261|456022046|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
126746737|NCT02614261|456022047|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
126746738|NCT02614261|456022048|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
126746739|NCT02614261|456022045|FG000|Follow-up Phase|Adverse Event|2|||
126746740|NCT02614261|456022046|FG001|Follow-up Phase|Adverse Event|0|||
126746741|NCT02614261|456022047|FG002|Follow-up Phase|Adverse Event|1|||
126746742|NCT02614261|456022048|FG003|Follow-up Phase|Adverse Event|0|||
126746743|NCT02614261|456022045|FG000|Follow-up Phase|Lost to Follow-up|12|||
126746744|NCT02614261|456022046|FG001|Follow-up Phase|Lost to Follow-up|5|||
126746745|NCT02614261|456022047|FG002|Follow-up Phase|Lost to Follow-up|2|||
126746746|NCT02614261|456022048|FG003|Follow-up Phase|Lost to Follow-up|0|||
126746747|NCT02614261|456022045|FG000|Follow-up Phase|Physician Decision|5|||
126746748|NCT02614261|456022046|FG001|Follow-up Phase|Physician Decision|1|||
126746749|NCT02614261|456022047|FG002|Follow-up Phase|Physician Decision|0|||
126620075|NCT00267956|455565738|FG002|After Controlled Period|Lost to Follow-up|1|||
126620076|NCT00267956|455565739|FG003|After Controlled Period|Lost to Follow-up|0|||
126746750|NCT02614261|456022048|FG003|Follow-up Phase|Physician Decision|0|||
126746751|NCT02614261|456022045|FG000|Follow-up Phase|Pregnancy|0|||
126620077|NCT00267956|455565736|FG000|After Controlled Period|Withdrew consent|0|||
126620078|NCT00267956|455565737|FG001|After Controlled Period|Withdrew consent|0|||
126620079|NCT00267956|455565738|FG002|After Controlled Period|Withdrew consent|1|||
126620080|NCT00267956|455565739|FG003|After Controlled Period|Withdrew consent|0|||
126620081|NCT02246647|455565740|FG000|Overall Study|Withdrawal by Subject|1|||
126746752|NCT02614261|456022046|FG001|Follow-up Phase|Pregnancy|1|||
126746753|NCT02614261|456022047|FG002|Follow-up Phase|Pregnancy|0|||
126746754|NCT02614261|456022048|FG003|Follow-up Phase|Pregnancy|0|||
126746755|NCT02614261|456022045|FG000|Follow-up Phase|Protocol Violation|1|||
126782177|NCT00718159|456158113|FG001|Overall Study|Progressive Disease|3|||
126782178|NCT00718159|456158114|FG002|Overall Study|Progressive Disease|2|||
126782179|NCT00718159|456158115|FG003|Overall Study|Progressive Disease|0|||
126782180|NCT00718159|456158116|FG004|Overall Study|Progressive Disease|6|||
126782181|NCT00718159|456158117|FG005|Overall Study|Progressive Disease|0|||
126782182|NCT00718159|456158118|FG006|Overall Study|Progressive Disease|0|||
126782183|NCT00718159|456158112|FG000|Overall Study|Death due to Adverse Event|0|||
126782184|NCT00718159|456158113|FG001|Overall Study|Death due to Adverse Event|0|||
126782185|NCT00718159|456158114|FG002|Overall Study|Death due to Adverse Event|0|||
126782186|NCT00718159|456158115|FG003|Overall Study|Death due to Adverse Event|2|||
126782187|NCT00718159|456158116|FG004|Overall Study|Death due to Adverse Event|2|||
126782188|NCT00718159|456158117|FG005|Overall Study|Death due to Adverse Event|0|||
126782189|NCT00718159|456158118|FG006|Overall Study|Death due to Adverse Event|0|||
126620082|NCT02246647|455565741|FG001|Overall Study|Withdrawal by Subject|1|||
126620083|NCT01012999|455565742|FG000|Overall Study|Protocol Violation|1|||
126620084|NCT03557307|455565743|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
126620085|NCT03557307|455565743|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
126620086|NCT03557307|455565743|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
126620087|NCT03557307|455565743|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
126620088|NCT03557307|455565743|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
126620089|NCT03557307|455565743|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
126620090|NCT03557307|455565743|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
126620091|NCT03557307|455565743|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
126620092|NCT03557307|455565743|FG000|Period 2: Maintenance Phase|Death|3|||
126620093|NCT03557307|455565743|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
126620094|NCT03557307|455565743|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
126620095|NCT03557307|455565743|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
126620096|NCT03557307|455565743|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
126620097|NCT03557307|455565743|FG000|Period 2: Maintenance Phase|other|3|||
126620098|NCT01322347|455565744|FG000|Overall Study|Adverse Event|7|||
126620099|NCT01322347|455565745|FG001|Overall Study|Adverse Event|2|||
126620100|NCT01322347|455565744|FG000|Overall Study|Death|5|||
126620101|NCT01322347|455565745|FG001|Overall Study|Death|3|||
126620102|NCT01322347|455565744|FG000|Overall Study|Physician Decision|2|||
126620103|NCT01322347|455565745|FG001|Overall Study|Physician Decision|1|||
126620104|NCT01322347|455565744|FG000|Overall Study|Protocol Violation|5|||
126620105|NCT01322347|455565745|FG001|Overall Study|Protocol Violation|2|||
126620106|NCT01322347|455565744|FG000|Overall Study|Withdrawal by Subject|1|||
126620107|NCT01322347|455565745|FG001|Overall Study|Withdrawal by Subject|4|||
126620108|NCT01322347|455565744|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
126620109|NCT01322347|455565745|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
126620110|NCT01322347|455565744|FG000|Overall Study|blood transfusion|5|||
126620111|NCT01322347|455565745|FG001|Overall Study|blood transfusion|5|||
126620112|NCT01322347|455565744|FG000|Overall Study|sponsor decision|1|||
126620113|NCT01322347|455565745|FG001|Overall Study|sponsor decision|3|||
126620114|NCT01322347|455565744|FG000|Overall Study|ineligible|6|||
126620115|NCT01322347|455565745|FG001|Overall Study|ineligible|3|||
126620116|NCT01322347|455565744|FG000|Overall Study|kidney transplant|3|||
126620117|NCT01322347|455565745|FG001|Overall Study|kidney transplant|1|||
126620118|NCT01322347|455565744|FG000|Overall Study|study drug withheld > 12 wks|0|||
126620119|NCT01322347|455565745|FG001|Overall Study|study drug withheld > 12 wks|1|||
126620120|NCT01322347|455565744|FG000|Overall Study|moved/changed dialysis|2|||
126620121|NCT01322347|455565745|FG001|Overall Study|moved/changed dialysis|4|||
126620122|NCT01369147|455565746|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
126620123|NCT01369147|455565747|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
126620124|NCT01369147|455565748|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
126620125|NCT03184519|455565749|FG000|Overall Study|Lost to Follow-up|6|||
126620126|NCT03184519|455565749|FG000|Overall Study|Physician Decision|21|||
126620127|NCT00584909|455565751|FG000|Overall Study|Adverse Event|4|||
126620128|NCT03345407|455565752|FG000|Overall Study|Withdrawal by Subject|11|||
126620129|NCT03345407|455565753|FG001|Overall Study|Withdrawal by Subject|1|||
126782190|NCT00718159|456158112|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
126782191|NCT00718159|456158113|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
126620130|NCT03345407|455565754|FG002|Overall Study|Withdrawal by Subject|5|||
126782192|NCT00718159|456158114|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
126782193|NCT00718159|456158115|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
126620131|NCT03345407|455565755|FG003|Overall Study|Withdrawal by Subject|6|||
126620132|NCT03345407|455565756|FG004|Overall Study|Withdrawal by Subject|3|||
126620133|NCT03345407|455565757|FG005|Overall Study|Withdrawal by Subject|6|||
126620134|NCT03345407|455565758|FG006|Overall Study|Withdrawal by Subject|16|||
126620135|NCT03345407|455565752|FG000|Overall Study|Physician Decision|3|||
126620136|NCT03345407|455565753|FG001|Overall Study|Physician Decision|1|||
126782194|NCT00718159|456158116|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
126782195|NCT00718159|456158117|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
126620137|NCT03345407|455565754|FG002|Overall Study|Physician Decision|0|||
126620138|NCT03345407|455565755|FG003|Overall Study|Physician Decision|0|||
126620139|NCT03345407|455565756|FG004|Overall Study|Physician Decision|1|||
126620140|NCT03345407|455565757|FG005|Overall Study|Physician Decision|2|||
126620141|NCT03345407|455565758|FG006|Overall Study|Physician Decision|3|||
126620142|NCT03345407|455565752|FG000|Overall Study|Lost to Follow-up|2|||
126620143|NCT03345407|455565753|FG001|Overall Study|Lost to Follow-up|0|||
126620144|NCT03345407|455565754|FG002|Overall Study|Lost to Follow-up|1|||
126620145|NCT03345407|455565755|FG003|Overall Study|Lost to Follow-up|0|||
126620146|NCT03345407|455565756|FG004|Overall Study|Lost to Follow-up|1|||
126620147|NCT03345407|455565757|FG005|Overall Study|Lost to Follow-up|2|||
126620148|NCT03345407|455565758|FG006|Overall Study|Lost to Follow-up|3|||
126620149|NCT03345407|455565752|FG000|Overall Study|Protocol-defined stopping criteria|9|||
126620150|NCT03345407|455565753|FG001|Overall Study|Protocol-defined stopping criteria|0|||
126620151|NCT03345407|455565754|FG002|Overall Study|Protocol-defined stopping criteria|0|||
126620152|NCT03345407|455565755|FG003|Overall Study|Protocol-defined stopping criteria|0|||
126620153|NCT03345407|455565756|FG004|Overall Study|Protocol-defined stopping criteria|2|||
126620154|NCT03345407|455565757|FG005|Overall Study|Protocol-defined stopping criteria|1|||
126620155|NCT03345407|455565758|FG006|Overall Study|Protocol-defined stopping criteria|1|||
126620156|NCT03345407|455565752|FG000|Overall Study|Protocol Violation|2|||
126620157|NCT03345407|455565753|FG001|Overall Study|Protocol Violation|0|||
126620158|NCT03345407|455565754|FG002|Overall Study|Protocol Violation|0|||
126746756|NCT02614261|456022046|FG001|Follow-up Phase|Protocol Violation|0|||
126746757|NCT02614261|456022047|FG002|Follow-up Phase|Protocol Violation|0|||
126746758|NCT02614261|456022048|FG003|Follow-up Phase|Protocol Violation|0|||
126746759|NCT02614261|456022045|FG000|Follow-up Phase|Withdrawal by Subject|12|||
126746760|NCT02614261|456022046|FG001|Follow-up Phase|Withdrawal by Subject|4|||
126746761|NCT02614261|456022047|FG002|Follow-up Phase|Withdrawal by Subject|11|||
126746762|NCT02614261|456022048|FG003|Follow-up Phase|Withdrawal by Subject|0|||
126746763|NCT02614261|456022045|FG000|Israel Addendum|Withdrawal by Subject|0|||
126746764|NCT02614261|456022046|FG001|Israel Addendum|Withdrawal by Subject|0|||
126746765|NCT02614261|456022047|FG002|Israel Addendum|Withdrawal by Subject|0|||
126746766|NCT02614261|456022048|FG003|Israel Addendum|Withdrawal by Subject|4|||
126746767|NCT03512275|456022051|FG000|Overall Study|Withdrawal by Subject|1|||
126746768|NCT03512275|456022052|FG001|Overall Study|Withdrawal by Subject|3|||
126746769|NCT03512275|456022051|FG000|Overall Study|Physician Decision|0|||
126746770|NCT03512275|456022052|FG001|Overall Study|Physician Decision|1|||
126746771|NCT03512275|456022051|FG000|Overall Study|Lost to Follow-up|0|||
126746772|NCT03512275|456022052|FG001|Overall Study|Lost to Follow-up|3|||
126746773|NCT03512275|456022051|FG000|Overall Study|Other|1|||
126746774|NCT03512275|456022052|FG001|Overall Study|Other|0|||
126746775|NCT01307046|456022053|FG000|Overall Study|Adverse Event|3|||
126746776|NCT01307046|456022054|FG001|Overall Study|Adverse Event|3|||
126746777|NCT01307046|456022053|FG000|Overall Study|Lack of Efficacy|0|||
126746778|NCT01307046|456022054|FG001|Overall Study|Lack of Efficacy|2|||
126746779|NCT01307046|456022053|FG000|Overall Study|Physician Decision|2|||
126746780|NCT01307046|456022054|FG001|Overall Study|Physician Decision|0|||
126746781|NCT01307046|456022053|FG000|Overall Study|Withdrawal by Subject|1|||
126746782|NCT01307046|456022054|FG001|Overall Study|Withdrawal by Subject|1|||
126746783|NCT01307046|456022053|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
126746784|NCT01307046|456022054|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
126746785|NCT01307046|456022053|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
126746786|NCT01307046|456022054|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
126746787|NCT00609167|456022055|FG000|Overall Study|Withdrawal by Subject|1|||
126746788|NCT00609167|456022056|FG001|Overall Study|Withdrawal by Subject|0|||
126746789|NCT00609167|456022055|FG000|Overall Study|Lack of Efficacy|1|||
126746790|NCT00609167|456022056|FG001|Overall Study|Lack of Efficacy|0|||
126746791|NCT00609167|456022055|FG000|Overall Study|Adverse Event|5|||
126746792|NCT00609167|456022056|FG001|Overall Study|Adverse Event|1|||
126746793|NCT00609167|456022055|FG000|Overall Study|Disease Progression|1|||
126746794|NCT00609167|456022056|FG001|Overall Study|Disease Progression|0|||
126746795|NCT00609167|456022055|FG000|Overall Study|Stem Cell Transplant|0|||
126746796|NCT00609167|456022056|FG001|Overall Study|Stem Cell Transplant|6|||
126746797|NCT02574520|456022057|FG000|Overall Study|Not dosed|2|||
126746798|NCT02574520|456022058|FG001|Overall Study|Not dosed|0|||
126620159|NCT03345407|455565755|FG003|Overall Study|Protocol Violation|0|||
126620160|NCT03345407|455565756|FG004|Overall Study|Protocol Violation|1|||
126746799|NCT02574520|456022059|FG002|Overall Study|Not dosed|5|||
126746800|NCT02574520|456022060|FG003|Overall Study|Not dosed|4|||
126746801|NCT02574520|456022057|FG000|Overall Study|Adverse Event|0|||
126746802|NCT02574520|456022058|FG001|Overall Study|Adverse Event|0|||
126746803|NCT02574520|456022059|FG002|Overall Study|Adverse Event|0|||
126746804|NCT02574520|456022060|FG003|Overall Study|Adverse Event|1|||
126746805|NCT02574520|456022057|FG000|Overall Study|Withdrawal by Subject|0|||
126620161|NCT03345407|455565757|FG005|Overall Study|Protocol Violation|0|||
126746806|NCT02574520|456022058|FG001|Overall Study|Withdrawal by Subject|0|||
126746807|NCT02574520|456022059|FG002|Overall Study|Withdrawal by Subject|0|||
126746808|NCT02574520|456022060|FG003|Overall Study|Withdrawal by Subject|1|||
126620162|NCT03345407|455565758|FG006|Overall Study|Protocol Violation|3|||
126620163|NCT03345407|455565752|FG000|Overall Study|Lack of Efficacy|1|||
126620164|NCT03345407|455565753|FG001|Overall Study|Lack of Efficacy|1|||
126746809|NCT02574520|456022057|FG000|Overall Study|Other|0|||
126746810|NCT02574520|456022058|FG001|Overall Study|Other|0|||
126746811|NCT02574520|456022059|FG002|Overall Study|Other|0|||
126746812|NCT02574520|456022060|FG003|Overall Study|Other|2|||
126620165|NCT03345407|455565754|FG002|Overall Study|Lack of Efficacy|1|||
126620166|NCT03345407|455565755|FG003|Overall Study|Lack of Efficacy|1|||
126620167|NCT03345407|455565756|FG004|Overall Study|Lack of Efficacy|1|||
126620168|NCT03345407|455565757|FG005|Overall Study|Lack of Efficacy|0|||
126620169|NCT03345407|455565758|FG006|Overall Study|Lack of Efficacy|3|||
126620170|NCT03345407|455565752|FG000|Overall Study|Adverse Event|4|||
126620171|NCT03345407|455565753|FG001|Overall Study|Adverse Event|0|||
126620172|NCT03345407|455565754|FG002|Overall Study|Adverse Event|5|||
126620173|NCT03345407|455565755|FG003|Overall Study|Adverse Event|4|||
126620174|NCT03345407|455565756|FG004|Overall Study|Adverse Event|6|||
126620175|NCT03345407|455565757|FG005|Overall Study|Adverse Event|5|||
126620176|NCT03345407|455565758|FG006|Overall Study|Adverse Event|16|||
126620177|NCT02256553|455565761|FG000|Period I|Adverse Event|5|||
126620178|NCT02256553|455565761|FG000|Period I|Protocol Violation|1|||
126620179|NCT02256553|455565761|FG000|Period II|Adverse Event|1|||
126620180|NCT02256553|455565761|FG000|Period II|Subject Moved|1|||
126620181|NCT02256553|455565761|FG000|Period III|Adverse Event|3|||
126620182|NCT02092909|455565762|FG000|Overall Study|Adverse Event|0|||
126620183|NCT02092909|455565763|FG001|Overall Study|Adverse Event|0|||
126620184|NCT02092909|455565764|FG002|Overall Study|Adverse Event|4|||
126620185|NCT02092909|455565765|FG003|Overall Study|Adverse Event|2|||
126620186|NCT02092909|455565762|FG000|Overall Study|Lack of Efficacy|0|||
126620187|NCT02092909|455565763|FG001|Overall Study|Lack of Efficacy|2|||
126620188|NCT02092909|455565764|FG002|Overall Study|Lack of Efficacy|1|||
126620189|NCT02092909|455565765|FG003|Overall Study|Lack of Efficacy|0|||
126620190|NCT02092909|455565762|FG000|Overall Study|Withdrawal by Subject|0|||
126620191|NCT02092909|455565763|FG001|Overall Study|Withdrawal by Subject|0|||
126620192|NCT02092909|455565764|FG002|Overall Study|Withdrawal by Subject|2|||
126620193|NCT02092909|455565765|FG003|Overall Study|Withdrawal by Subject|1|||
126620194|NCT02092909|455565762|FG000|Overall Study|Study terminated by Sponsor|0|||
126620195|NCT02092909|455565763|FG001|Overall Study|Study terminated by Sponsor|0|||
126620196|NCT02092909|455565764|FG002|Overall Study|Study terminated by Sponsor|0|||
126620197|NCT02092909|455565765|FG003|Overall Study|Study terminated by Sponsor|2|||
126620198|NCT02092909|455565762|FG000|Overall Study|Miscellaneous|1|||
126620199|NCT02092909|455565763|FG001|Overall Study|Miscellaneous|1|||
126620200|NCT02092909|455565764|FG002|Overall Study|Miscellaneous|2|||
126620201|NCT02092909|455565765|FG003|Overall Study|Miscellaneous|1|||
126620202|NCT03436797|455565766|FG000|Main Study|Withdrawal by Subject|2|||
126620203|NCT03436797|455565766|FG000|Main Study|Adverse Event|4|||
126620204|NCT03436797|455565766|FG000|Main Study|Lost to Follow-up|1|||
126620205|NCT03436797|455565766|FG000|Main Study|Death|1|||
126620206|NCT03436797|455565766|FG000|Main Study|Non-Specific|2|||
126620207|NCT03436797|455565766|FG000|Extended Dosing|Patient decision|1|||
126620208|NCT04626128|455565769|FG000|Overall Study|Withdrawal by Subject|0|||
126620209|NCT04626128|455565770|FG001|Overall Study|Withdrawal by Subject|1|||
126620210|NCT04626128|455565771|FG002|Overall Study|Withdrawal by Subject|0|||
126620211|NCT04626128|455565772|FG003|Overall Study|Withdrawal by Subject|0|||
126620212|NCT01182285|455565773|FG000|First Intervention Week 1-10|Disease progression|1|||
126620213|NCT01182285|455565774|FG001|First Intervention Week 1-10|Disease progression|0|||
126620214|NCT01182285|455565775|FG002|First Intervention Week 1-10|Disease progression|0|||
126620215|NCT01182285|455565773|FG000|First Intervention Week 1-10|Adverse Event|1|||
126620216|NCT01182285|455565774|FG001|First Intervention Week 1-10|Adverse Event|0|||
126620217|NCT01182285|455565775|FG002|First Intervention Week 1-10|Adverse Event|0|||
126620218|NCT01182285|455565773|FG000|First Intervention Week 1-10|Non-compliance|1|||
126746813|NCT03935594|456022065|FG000|Overall Study|Physician Decision|3|||
126746814|NCT01435122|456022066|FG000|Overall Study|Early withdrawal due to toxicity|8|||
126620219|NCT01182285|455565774|FG001|First Intervention Week 1-10|Non-compliance|0|||
126620220|NCT01182285|455565775|FG002|First Intervention Week 1-10|Non-compliance|0|||
126620221|NCT01182285|455565773|FG000|Third Intervention Week 11-52|Disease Progression|0|||
126620222|NCT01182285|455565774|FG001|Third Intervention Week 11-52|Disease Progression|0|||
126620223|NCT01182285|455565775|FG002|Third Intervention Week 11-52|Disease Progression|6|||
126620224|NCT01182285|455565773|FG000|Third Intervention Week 11-52|Other|0|||
126620225|NCT01182285|455565774|FG001|Third Intervention Week 11-52|Other|0|||
126620226|NCT01182285|455565775|FG002|Third Intervention Week 11-52|Other|2|||
126620227|NCT01951105|455565778|FG000|Overall Study|Adverse Event|0|||
126620228|NCT01951105|455565779|FG001|Overall Study|Adverse Event|5|||
126746815|NCT04412668|456022067|FG000|Overall Study|Death - multiple comorbidities|2|||
126620229|NCT01951105|455565780|FG002|Overall Study|Adverse Event|0|||
126620230|NCT01951105|455565778|FG000|Overall Study|Lost to Follow-up|0|||
126620231|NCT01951105|455565779|FG001|Overall Study|Lost to Follow-up|1|||
126620232|NCT01951105|455565780|FG002|Overall Study|Lost to Follow-up|0|||
126746816|NCT04412668|456022068|FG001|Overall Study|Death - multiple comorbidities|0|||
126620233|NCT01951105|455565778|FG000|Overall Study|Protocol Violation|1|||
126620234|NCT01951105|455565779|FG001|Overall Study|Protocol Violation|1|||
126620235|NCT01951105|455565780|FG002|Overall Study|Protocol Violation|1|||
126620236|NCT01951105|455565778|FG000|Overall Study|Withdrawal by Subject|0|||
126620237|NCT01951105|455565779|FG001|Overall Study|Withdrawal by Subject|3|||
126620238|NCT01951105|455565780|FG002|Overall Study|Withdrawal by Subject|1|||
126620239|NCT00379210|455565781|FG000|Overall Study|Withdrawal by Subject|10|||
126620240|NCT00379210|455565782|FG001|Overall Study|Withdrawal by Subject|7|||
126620241|NCT03209492|455565783|FG000|Overall Study|Case Report Forms Uncollected|5|||
126620242|NCT01762345|455565784|FG000|Overall Study|Adverse Event|5|||
126620243|NCT01762345|455565784|FG000|Overall Study|Protocol Violation|2|||
126620244|NCT01601821|455565785|FG000|Overall Study|Death|2|||
126620245|NCT01601821|455565786|FG001|Overall Study|Death|5|||
126620246|NCT01601821|455565785|FG000|Overall Study|Protocol Violation|2|||
126620247|NCT01601821|455565786|FG001|Overall Study|Protocol Violation|2|||
126620248|NCT01601821|455565785|FG000|Overall Study|Lost to Follow-up|6|||
126620249|NCT01601821|455565786|FG001|Overall Study|Lost to Follow-up|14|||
126620250|NCT01601821|455565785|FG000|Overall Study|Withdrawal by Subject|1|||
126620251|NCT01601821|455565786|FG001|Overall Study|Withdrawal by Subject|0|||
126620252|NCT01601821|455565785|FG000|Overall Study|Graft Loss|6|||
126620253|NCT01601821|455565786|FG001|Overall Study|Graft Loss|6|||
126620254|NCT01601821|455565785|FG000|Overall Study|Study Events|7|||
126620255|NCT01601821|455565786|FG001|Overall Study|Study Events|1|||
126620256|NCT01601821|455565785|FG000|Overall Study|Other|5|||
126620257|NCT01601821|455565786|FG001|Overall Study|Other|1|||
126620258|NCT00442559|455565789|FG000|Overall Study|Lost to Follow-up|32|||
126620259|NCT00442559|455565790|FG001|Overall Study|Lost to Follow-up|34|||
126620260|NCT00442559|455565789|FG000|Overall Study|Protocol Violation|1|||
126620261|NCT00442559|455565790|FG001|Overall Study|Protocol Violation|1|||
126620262|NCT00442559|455565789|FG000|Overall Study|Withdrawal by Subject|1|||
126620263|NCT00442559|455565790|FG001|Overall Study|Withdrawal by Subject|0|||
126620264|NCT02604199|455565800|FG000|Overall Study|Pregnancy|0|||
126620265|NCT02604199|455565801|FG001|Overall Study|Pregnancy|0|||
126620266|NCT02604199|455565802|FG002|Overall Study|Pregnancy|0|||
126620267|NCT02604199|455565803|FG003|Overall Study|Pregnancy|1|||
126620268|NCT02604199|455565800|FG000|Overall Study|Study terminated by sponsor|0|||
126620269|NCT02604199|455565801|FG001|Overall Study|Study terminated by sponsor|2|||
126620270|NCT02604199|455565802|FG002|Overall Study|Study terminated by sponsor|0|||
126620271|NCT02604199|455565803|FG003|Overall Study|Study terminated by sponsor|2|||
126620272|NCT02604199|455565800|FG000|Overall Study|Withdrawal by Subject|0|||
126620273|NCT02604199|455565801|FG001|Overall Study|Withdrawal by Subject|1|||
126620274|NCT02604199|455565802|FG002|Overall Study|Withdrawal by Subject|0|||
126620275|NCT02604199|455565803|FG003|Overall Study|Withdrawal by Subject|0|||
126620276|NCT02812706|455565804|FG000|Phase 1|Adverse Event|0|||
126620277|NCT02812706|455565805|FG001|Phase 1|Adverse Event|2|||
126620278|NCT02812706|455565806|FG002|Phase 1|Adverse Event|0|||
126620279|NCT02812706|455565804|FG000|Phase 1|Progressive disease|3|||
126620280|NCT02812706|455565805|FG001|Phase 1|Progressive disease|3|||
126620281|NCT02812706|455565806|FG002|Phase 1|Progressive disease|0|||
126620282|NCT02812706|455565804|FG000|Phase 2|Adverse Event|0|||
126620283|NCT02812706|455565805|FG001|Phase 2|Adverse Event|0|||
126620284|NCT02812706|455565806|FG002|Phase 2|Adverse Event|2|||
126620285|NCT02812706|455565804|FG000|Phase 2|Progressive disease|0|||
126620286|NCT02812706|455565805|FG001|Phase 2|Progressive disease|0|||
126620287|NCT02812706|455565806|FG002|Phase 2|Progressive disease|22|||
126620288|NCT02812706|455565804|FG000|Phase 2|Other-Unspecified|0|||
126620289|NCT02812706|455565805|FG001|Phase 2|Other-Unspecified|0|||
126620290|NCT02812706|455565806|FG002|Phase 2|Other-Unspecified|4|||
126620291|NCT03166215|455565812|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
126620292|NCT03166215|455565813|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
126620293|NCT03166215|455565814|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
126620294|NCT03166215|455565812|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
126620295|NCT03166215|455565813|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
126620296|NCT03166215|455565814|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
126620297|NCT02632045|455565815|FG000|Overall Study|Withdrawal by Subject|1|||
126620298|NCT02632045|455565816|FG001|Overall Study|Withdrawal by Subject|2|||
126620299|NCT05878522|455565817|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126620300|NCT05878522|455565818|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126620301|NCT05878522|455565819|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126620302|NCT05878522|455565820|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126620303|NCT05878522|455565821|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126620304|NCT05878522|455565822|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126620305|NCT05878522|455565823|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126620306|NCT05878522|455565824|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126620307|NCT05878522|455565825|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
126620308|NCT05878522|455565826|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126620309|NCT05878522|455565827|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126620310|NCT05878522|455565828|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
126620311|NCT05878522|455565817|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
126620312|NCT05878522|455565818|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126620313|NCT05878522|455565819|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126620314|NCT05878522|455565820|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126620315|NCT05878522|455565821|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126620316|NCT05878522|455565822|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126620317|NCT05878522|455565823|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126620318|NCT05878522|455565824|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126620319|NCT05878522|455565825|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126620320|NCT05878522|455565826|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
126620321|NCT05878522|455565827|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126620322|NCT05878522|455565828|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
126620323|NCT05878522|455565817|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126620324|NCT05878522|455565818|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
126620325|NCT05878522|455565819|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126620326|NCT05878522|455565820|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
126620327|NCT05878522|455565821|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126620328|NCT05878522|455565822|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126620329|NCT05878522|455565823|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126620330|NCT05878522|455565824|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126620331|NCT05878522|455565825|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126620332|NCT05878522|455565826|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126620333|NCT05878522|455565827|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126620334|NCT05878522|455565828|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
126620335|NCT05878522|455565817|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126620336|NCT05878522|455565818|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126620337|NCT05878522|455565819|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126620338|NCT05878522|455565820|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126620339|NCT05878522|455565821|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
126620340|NCT05878522|455565822|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126620341|NCT05878522|455565823|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126620342|NCT05878522|455565824|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126620343|NCT05878522|455565825|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126620344|NCT05878522|455565826|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126620345|NCT05878522|455565827|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126620346|NCT05878522|455565828|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
126620347|NCT02252172|455565829|FG000|Overall Study|Lost to Follow-up|3|||
126620348|NCT02252172|455565830|FG001|Overall Study|Lost to Follow-up|1|||
126620349|NCT02252172|455565829|FG000|Overall Study|Ongoing|276|||
126620350|NCT02252172|455565830|FG001|Overall Study|Ongoing|298|||
126620351|NCT05740371|455565831|FG000|Overall Study|Death|1|||
126620352|NCT01613599|455565833|FG000|Overall Study|Death|9|||
126620353|NCT01613599|455565833|FG000|Overall Study|Lost to Follow-up|5|||
126620354|NCT01613599|455565833|FG000|Overall Study|Withdrawal by Subject|8|||
126620355|NCT01613599|455565833|FG000|Overall Study|Reason not specified|3|||
126620356|NCT03747575|455565835|FG000|Overall Study|Withdrawal by Subject|6|||
126620357|NCT03747575|455565836|FG001|Overall Study|Withdrawal by Subject|3|||
126620358|NCT03747575|455565835|FG000|Overall Study|Lost to Follow-up|3|||
126620359|NCT03747575|455565836|FG001|Overall Study|Lost to Follow-up|3|||
126620360|NCT03747575|455565835|FG000|Overall Study|Adverse Event|0|||
126620361|NCT03747575|455565836|FG001|Overall Study|Adverse Event|1|||
126620362|NCT01549951|455565842|FG000|Overall Study|Adverse Event|15|||
126620363|NCT01549951|455565842|FG000|Overall Study|Withdrawal by Subject|2|||
126620364|NCT01549951|455565842|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
126620365|NCT01549951|455565842|FG000|Overall Study|Progressive disease|29|||
126620366|NCT01549951|455565842|FG000|Overall Study|Symptomatic deterioration|1|||
126620367|NCT01549951|455565842|FG000|Overall Study|Other|2|||
126620368|NCT02312245|455565843|FG000|Overall Study|Death|0|||
126620369|NCT02312245|455565844|FG001|Overall Study|Death|0|||
126620370|NCT02312245|455565845|FG002|Overall Study|Death|0|||
126620371|NCT02312245|455565846|FG003|Overall Study|Death|1|||
126620372|NCT02312245|455565843|FG000|Overall Study|Withdrawal by Subject|1|||
126620373|NCT02312245|455565844|FG001|Overall Study|Withdrawal by Subject|1|||
126620374|NCT02312245|455565845|FG002|Overall Study|Withdrawal by Subject|0|||
126620375|NCT02312245|455565846|FG003|Overall Study|Withdrawal by Subject|2|||
126746817|NCT04412668|456022069|FG002|Overall Study|Death - multiple comorbidities|0|||
126746818|NCT04412668|456022067|FG000|Overall Study|Withdrawal by Subject|3|||
126620376|NCT02312245|455565843|FG000|Overall Study|Alternative Therapy|1|||
126620377|NCT02312245|455565844|FG001|Overall Study|Alternative Therapy|0|||
126620378|NCT02312245|455565845|FG002|Overall Study|Alternative Therapy|0|||
126620379|NCT02312245|455565846|FG003|Overall Study|Alternative Therapy|0|||
126620380|NCT02312245|455565843|FG000|Overall Study|Progression|0|||
126620381|NCT02312245|455565844|FG001|Overall Study|Progression|0|||
126620382|NCT02312245|455565845|FG002|Overall Study|Progression|0|||
126620383|NCT02312245|455565846|FG003|Overall Study|Progression|5|||
126620384|NCT02312245|455565843|FG000|Overall Study|Patient went to hospice|0|||
126620385|NCT02312245|455565844|FG001|Overall Study|Patient went to hospice|0|||
126620386|NCT02312245|455565845|FG002|Overall Study|Patient went to hospice|0|||
126620387|NCT02312245|455565846|FG003|Overall Study|Patient went to hospice|1|||
126620388|NCT02312245|455565843|FG000|Overall Study|Ineligible|1|||
126620389|NCT02312245|455565844|FG001|Overall Study|Ineligible|0|||
126620390|NCT02312245|455565845|FG002|Overall Study|Ineligible|0|||
126620391|NCT02312245|455565846|FG003|Overall Study|Ineligible|0|||
126620392|NCT03689452|455565848|FG000|Overall Study|Lost to Follow-up|1|||
126620393|NCT03689452|455565849|FG001|Overall Study|Lost to Follow-up|1|||
126620394|NCT02676778|455565850|FG000|Overall Study|Disease Progression|7|||
126620395|NCT02676778|455565851|FG001|Overall Study|Disease Progression|3|||
126620396|NCT02676778|455565852|FG002|Overall Study|Disease Progression|1|||
126620397|NCT02676778|455565850|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
126620398|NCT02676778|455565851|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
126620399|NCT02676778|455565852|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
126620400|NCT02676778|455565850|FG000|Overall Study|Withdrawal by Subject|3|||
126620401|NCT02676778|455565851|FG001|Overall Study|Withdrawal by Subject|2|||
126620402|NCT02676778|455565852|FG002|Overall Study|Withdrawal by Subject|0|||
126620403|NCT02676778|455565850|FG000|Overall Study|Other|4|||
126620404|NCT02676778|455565851|FG001|Overall Study|Other|3|||
126620405|NCT02676778|455565852|FG002|Overall Study|Other|0|||
126620406|NCT02676778|455565850|FG000|Overall Study|Adverse Event|2|||
126620407|NCT02676778|455565851|FG001|Overall Study|Adverse Event|3|||
126620408|NCT02676778|455565852|FG002|Overall Study|Adverse Event|0|||
126620409|NCT01288729|455565856|FG000|Overall Study|Withdrawal by Subject|1|||
126620410|NCT01288729|455565857|FG001|Overall Study|Withdrawal by Subject|0|||
126620411|NCT03122548|455565858|FG000|Overall Study|Death|2|||
126620412|NCT03122548|455565858|FG000|Overall Study|Progression - subject went into hospice|1|||
126620413|NCT03122548|455565858|FG000|Overall Study|Study Terminated by Sponsor|2|||
126620414|NCT04448561|455565859|FG000|Overall Study|Noncompliance|1|||
126620415|NCT04448561|455565860|FG001|Overall Study|Noncompliance|0|||
126620416|NCT01730118|455566986|FG000|Dose Escalation|Death on study|5|||
126620417|NCT01730118|455566987|FG001|Dose Escalation|Death on study|7|||
126620418|NCT01730118|455566988|FG002|Dose Escalation|Death on study|2|||
126620419|NCT01730118|455566989|FG003|Dose Escalation|Death on study|6|||
126620420|NCT01730118|455566990|FG004|Dose Escalation|Death on study|0|||
126620421|NCT01730118|455566991|FG005|Dose Escalation|Death on study|0|||
126620422|NCT01730118|455566992|FG006|Dose Escalation|Death on study|0|||
126620423|NCT01730118|455566986|FG000|Dose Escalation|Died before treatment|0|||
126620424|NCT01730118|455566987|FG001|Dose Escalation|Died before treatment|0|||
126620425|NCT01730118|455566988|FG002|Dose Escalation|Died before treatment|0|||
126620426|NCT01730118|455566989|FG003|Dose Escalation|Died before treatment|0|||
126620427|NCT01730118|455566990|FG004|Dose Escalation|Died before treatment|0|||
126620428|NCT01730118|455566991|FG005|Dose Escalation|Died before treatment|0|||
126620429|NCT01730118|455566992|FG006|Dose Escalation|Died before treatment|1|||
126620430|NCT01730118|455566986|FG000|Dose Escalation|Chose to start a different treatment|1|||
126620431|NCT01730118|455566987|FG001|Dose Escalation|Chose to start a different treatment|0|||
126620432|NCT01730118|455566988|FG002|Dose Escalation|Chose to start a different treatment|0|||
126620433|NCT01730118|455566989|FG003|Dose Escalation|Chose to start a different treatment|0|||
126620434|NCT01730118|455566990|FG004|Dose Escalation|Chose to start a different treatment|0|||
126620435|NCT01730118|455566991|FG005|Dose Escalation|Chose to start a different treatment|0|||
126620436|NCT01730118|455566992|FG006|Dose Escalation|Chose to start a different treatment|0|||
126620437|NCT01730118|455566986|FG000|Dose Escalation|Withdrawal by Subject|0|||
126620438|NCT01730118|455566987|FG001|Dose Escalation|Withdrawal by Subject|0|||
126620439|NCT01730118|455566988|FG002|Dose Escalation|Withdrawal by Subject|1|||
126620440|NCT01730118|455566989|FG003|Dose Escalation|Withdrawal by Subject|0|||
126620441|NCT01730118|455566990|FG004|Dose Escalation|Withdrawal by Subject|0|||
126620442|NCT01730118|455566991|FG005|Dose Escalation|Withdrawal by Subject|0|||
126620443|NCT01730118|455566992|FG006|Dose Escalation|Withdrawal by Subject|0|||
126620444|NCT01730118|455566986|FG000|Dose Escalation|Disease progression prior to treatment|0|||
126620445|NCT01730118|455566987|FG001|Dose Escalation|Disease progression prior to treatment|0|||
126620446|NCT01730118|455566988|FG002|Dose Escalation|Disease progression prior to treatment|0|||
126620447|NCT01730118|455566989|FG003|Dose Escalation|Disease progression prior to treatment|0|||
126620448|NCT01730118|455566990|FG004|Dose Escalation|Disease progression prior to treatment|0|||
126620449|NCT01730118|455566991|FG005|Dose Escalation|Disease progression prior to treatment|0|||
126620450|NCT01730118|455566992|FG006|Dose Escalation|Disease progression prior to treatment|1|||
126620451|NCT01730118|455566986|FG000|Dose Expansion|Death|0|||
126620452|NCT01730118|455566987|FG001|Dose Expansion|Death|0|||
126620453|NCT01730118|455566988|FG002|Dose Expansion|Death|0|||
126620454|NCT01730118|455566989|FG003|Dose Expansion|Death|0|||
126620455|NCT01730118|455566990|FG004|Dose Expansion|Death|1|||
126620456|NCT01730118|455566991|FG005|Dose Expansion|Death|0|||
126620457|NCT01730118|455566992|FG006|Dose Expansion|Death|0|||
126620458|NCT01730118|455566986|FG000|Dose Expansion|Other medical condition|0|||
126620459|NCT01730118|455566987|FG001|Dose Expansion|Other medical condition|0|||
126620460|NCT01730118|455566988|FG002|Dose Expansion|Other medical condition|0|||
126620461|NCT01730118|455566989|FG003|Dose Expansion|Other medical condition|0|||
126620462|NCT01730118|455566990|FG004|Dose Expansion|Other medical condition|1|||
126620463|NCT01730118|455566991|FG005|Dose Expansion|Other medical condition|0|||
126620464|NCT01730118|455566992|FG006|Dose Expansion|Other medical condition|0|||
126620465|NCT01730118|455566986|FG000|Dose Expansion|Withdrawal by Subject|0|||
126620466|NCT01730118|455566987|FG001|Dose Expansion|Withdrawal by Subject|0|||
126620467|NCT01730118|455566988|FG002|Dose Expansion|Withdrawal by Subject|0|||
126620468|NCT01730118|455566989|FG003|Dose Expansion|Withdrawal by Subject|0|||
126620469|NCT01730118|455566990|FG004|Dose Expansion|Withdrawal by Subject|1|||
126620470|NCT01730118|455566991|FG005|Dose Expansion|Withdrawal by Subject|0|||
126620471|NCT01730118|455566992|FG006|Dose Expansion|Withdrawal by Subject|0|||
126620472|NCT01730118|455566986|FG000|Dose Expansion|Disease progression|0|||
126620473|NCT01730118|455566987|FG001|Dose Expansion|Disease progression|0|||
126620474|NCT01730118|455566988|FG002|Dose Expansion|Disease progression|0|||
126620475|NCT01730118|455566989|FG003|Dose Expansion|Disease progression|0|||
126620476|NCT01730118|455566990|FG004|Dose Expansion|Disease progression|0|||
126620477|NCT01730118|455566991|FG005|Dose Expansion|Disease progression|1|||
126620478|NCT01730118|455566992|FG006|Dose Expansion|Disease progression|0|||
126620479|NCT01730118|455566986|FG000|Dose Expansion|Inability to return|0|||
126620480|NCT01730118|455566987|FG001|Dose Expansion|Inability to return|0|||
126620481|NCT01730118|455566988|FG002|Dose Expansion|Inability to return|0|||
126620482|NCT01730118|455566989|FG003|Dose Expansion|Inability to return|0|||
126620483|NCT01730118|455566990|FG004|Dose Expansion|Inability to return|0|||
126620484|NCT01730118|455566991|FG005|Dose Expansion|Inability to return|1|||
126620485|NCT01730118|455566992|FG006|Dose Expansion|Inability to return|0|||
126620486|NCT01730118|455566986|FG000|Dose Expansion|Physician Decision|0|||
126620487|NCT01730118|455566987|FG001|Dose Expansion|Physician Decision|0|||
126620488|NCT01730118|455566988|FG002|Dose Expansion|Physician Decision|0|||
126620489|NCT01730118|455566989|FG003|Dose Expansion|Physician Decision|0|||
126620490|NCT01730118|455566990|FG004|Dose Expansion|Physician Decision|0|||
126620491|NCT01730118|455566991|FG005|Dose Expansion|Physician Decision|1|||
126620492|NCT01730118|455566992|FG006|Dose Expansion|Physician Decision|0|||
126620493|NCT00489489|455566993|FG000|Overall Study|Not treated due to protocol violation|0|||
126620494|NCT00489489|455566994|FG001|Overall Study|Not treated due to protocol violation|1|||
126620495|NCT00489489|455566995|FG002|Overall Study|Not treated due to protocol violation|1|||
126620496|NCT00489489|455566993|FG000|Overall Study|Adverse Event|1|||
126620497|NCT00489489|455566994|FG001|Overall Study|Adverse Event|1|||
126620498|NCT00489489|455566995|FG002|Overall Study|Adverse Event|1|||
126620499|NCT00489489|455566993|FG000|Overall Study|Protocol Violation|1|||
126620500|NCT00489489|455566994|FG001|Overall Study|Protocol Violation|0|||
126620501|NCT00489489|455566995|FG002|Overall Study|Protocol Violation|1|||
126620502|NCT00489489|455566993|FG000|Overall Study|Progressive disease|0|||
126620503|NCT00489489|455566994|FG001|Overall Study|Progressive disease|1|||
126620504|NCT00489489|455566995|FG002|Overall Study|Progressive disease|0|||
126620505|NCT00489489|455566993|FG000|Overall Study|Participant did not wish to continue|1|||
126620506|NCT00489489|455566994|FG001|Overall Study|Participant did not wish to continue|1|||
126620507|NCT00489489|455566995|FG002|Overall Study|Participant did not wish to continue|0|||
126620508|NCT00489489|455566993|FG000|Overall Study|Other than above|0|||
126620509|NCT00489489|455566994|FG001|Overall Study|Other than above|1|||
126620510|NCT00489489|455566995|FG002|Overall Study|Other than above|0|||
126620511|NCT02101554|455566997|FG000|Overall Study|Protocol Violation|0|||
126620512|NCT02101554|455566998|FG001|Overall Study|Protocol Violation|1|||
126620513|NCT02101554|455566999|FG002|Overall Study|Protocol Violation|0|||
126620514|NCT02101554|455566997|FG000|Overall Study|Insufficient Clinical Response|0|||
126620515|NCT02101554|455566998|FG001|Overall Study|Insufficient Clinical Response|2|||
126620516|NCT02101554|455566999|FG002|Overall Study|Insufficient Clinical Response|0|||
126620517|NCT02101554|455566997|FG000|Overall Study|Adverse Event|2|||
126620518|NCT02101554|455566998|FG001|Overall Study|Adverse Event|1|||
126620519|NCT02101554|455566999|FG002|Overall Study|Adverse Event|1|||
126620520|NCT02101554|455566997|FG000|Overall Study|Lost to Follow-up|0|||
126620521|NCT02101554|455566998|FG001|Overall Study|Lost to Follow-up|1|||
126620522|NCT02101554|455566999|FG002|Overall Study|Lost to Follow-up|0|||
126620523|NCT02101554|455566997|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
126620524|NCT02101554|455566998|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
126620525|NCT02101554|455566999|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
126620526|NCT04523571|455567002|FG000|Received 2 Doses|Withdrawal by Subject|0|||
126620527|NCT04523571|455567003|FG001|Received 2 Doses|Withdrawal by Subject|0|||
126620528|NCT04523571|455567004|FG002|Received 2 Doses|Withdrawal by Subject|0|||
126620529|NCT04523571|455567005|FG003|Received 2 Doses|Withdrawal by Subject|1|||
126620530|NCT04523571|455567006|FG004|Received 2 Doses|Withdrawal by Subject|1|||
126620531|NCT04523571|455567007|FG005|Received 2 Doses|Withdrawal by Subject|0|||
126620532|NCT04523571|455567002|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
126620533|NCT04523571|455567003|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
126620534|NCT04523571|455567004|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
126620535|NCT04523571|455567005|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
126620536|NCT04523571|455567006|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
126620537|NCT04523571|455567007|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
126620538|NCT04523571|455567002|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
126620539|NCT04523571|455567003|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
126620540|NCT04523571|455567004|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
126620541|NCT04523571|455567005|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
126620542|NCT04523571|455567006|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
126620543|NCT04523571|455567007|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
126620544|NCT04523571|455567002|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
126620545|NCT04523571|455567003|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
126620546|NCT04523571|455567004|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
126620547|NCT04523571|455567005|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
126620548|NCT04523571|455567006|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
126620549|NCT04523571|455567007|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
126620550|NCT03694210|455567009|FG000|Overall Study|Death|1|||
126620551|NCT03694210|455567009|FG000|Overall Study|Screen Failure|7|||
126620552|NCT04385849|455567010|FG000|Overall Study|Lost to Follow-up|1|||
126620553|NCT04385849|455567011|FG001|Overall Study|Lost to Follow-up|0|||
126620554|NCT01375777|455567012|FG000|Overall Study|Withdrawal by Subject|0|||
126620555|NCT01375777|455567013|FG001|Overall Study|Withdrawal by Subject|2|||
126620556|NCT01375777|455567014|FG002|Overall Study|Withdrawal by Subject|1|||
126620557|NCT01375777|455567015|FG003|Overall Study|Withdrawal by Subject|0|||
126620558|NCT01375777|455567016|FG004|Overall Study|Withdrawal by Subject|1|||
126620559|NCT01375777|455567017|FG005|Overall Study|Withdrawal by Subject|1|||
126620560|NCT01375777|455567018|FG006|Overall Study|Withdrawal by Subject|1|||
126620561|NCT01375777|455567019|FG007|Overall Study|Withdrawal by Subject|2|||
126620562|NCT01375777|455567020|FG008|Overall Study|Withdrawal by Subject|1|||
126620563|NCT01375777|455567012|FG000|Overall Study|Lost to Follow-up|1|||
126620564|NCT01375777|455567013|FG001|Overall Study|Lost to Follow-up|0|||
126620565|NCT01375777|455567014|FG002|Overall Study|Lost to Follow-up|0|||
126620566|NCT01375777|455567015|FG003|Overall Study|Lost to Follow-up|0|||
126620567|NCT01375777|455567016|FG004|Overall Study|Lost to Follow-up|0|||
126620568|NCT01375777|455567017|FG005|Overall Study|Lost to Follow-up|0|||
126620569|NCT01375777|455567018|FG006|Overall Study|Lost to Follow-up|1|||
126620570|NCT01375777|455567019|FG007|Overall Study|Lost to Follow-up|0|||
126620571|NCT01375777|455567020|FG008|Overall Study|Lost to Follow-up|0|||
126620572|NCT01375777|455567012|FG000|Overall Study|Other|1|||
126620573|NCT01375777|455567013|FG001|Overall Study|Other|1|||
126620574|NCT01375777|455567014|FG002|Overall Study|Other|0|||
126620575|NCT01375777|455567015|FG003|Overall Study|Other|0|||
126620576|NCT01375777|455567016|FG004|Overall Study|Other|0|||
126620577|NCT01375777|455567017|FG005|Overall Study|Other|0|||
126620578|NCT01375777|455567018|FG006|Overall Study|Other|0|||
126620579|NCT01375777|455567019|FG007|Overall Study|Other|0|||
126620580|NCT01375777|455567020|FG008|Overall Study|Other|1|||
126620581|NCT05878990|455567021|FG000|Overall Study|Lost to Follow-up|7|||
126620582|NCT05878990|455567021|FG000|Overall Study|Withdrawal by Subject|1|||
126620583|NCT01838499|455567026|FG000|Overall Study|Protocol Violation|0|||
126620584|NCT01838499|455567027|FG001|Overall Study|Protocol Violation|1|||
126620585|NCT01838499|455567026|FG000|Overall Study|Lost to Follow-up|2|||
126620586|NCT01838499|455567027|FG001|Overall Study|Lost to Follow-up|4|||
126620587|NCT01838499|455567026|FG000|Overall Study|Lack of Efficacy|1|||
126620588|NCT01838499|455567027|FG001|Overall Study|Lack of Efficacy|2|||
126620589|NCT01838499|455567026|FG000|Overall Study|Adverse Event|2|||
126620590|NCT01838499|455567027|FG001|Overall Study|Adverse Event|1|||
126620591|NCT01838499|455567026|FG000|Overall Study|Withdrawal by Subject|19|||
126620592|NCT01838499|455567027|FG001|Overall Study|Withdrawal by Subject|9|||
126620593|NCT03614923|455567028|FG000|Overall Study|Withdrawal by Subject|2|||
126620594|NCT03614923|455567029|FG001|Overall Study|Withdrawal by Subject|1|||
126620595|NCT03614923|455567030|FG002|Overall Study|Withdrawal by Subject|1|||
126620596|NCT03614923|455567028|FG000|Overall Study|Adverse Event|0|||
126620597|NCT03614923|455567029|FG001|Overall Study|Adverse Event|2|||
126620598|NCT03614923|455567030|FG002|Overall Study|Adverse Event|1|||
126620599|NCT03614923|455567028|FG000|Overall Study|Lost to Follow-up|1|||
126620600|NCT03614923|455567029|FG001|Overall Study|Lost to Follow-up|0|||
126620601|NCT03614923|455567030|FG002|Overall Study|Lost to Follow-up|1|||
126620602|NCT03614923|455567028|FG000|Overall Study|Lack of Efficacy|2|||
126620603|NCT03614923|455567029|FG001|Overall Study|Lack of Efficacy|0|||
126620604|NCT03614923|455567030|FG002|Overall Study|Lack of Efficacy|1|||
126620605|NCT03614923|455567028|FG000|Overall Study|Non-compliance|0|||
126620606|NCT03614923|455567029|FG001|Overall Study|Non-compliance|1|||
126620607|NCT03614923|455567030|FG002|Overall Study|Non-compliance|0|||
126620608|NCT03614923|455567028|FG000|Overall Study|Other|0|||
126620609|NCT03614923|455567029|FG001|Overall Study|Other|1|||
126620610|NCT03614923|455567030|FG002|Overall Study|Other|1|||
126620611|NCT01107353|455567031|FG000|Overall Study|Positive Drug Screen|1|||
126620612|NCT01107353|455567032|FG001|Overall Study|Positive Drug Screen|0|||
126620613|NCT01136733|455567033|FG000|Phase 1b|Adverse Event|0|||
126620614|NCT01136733|455567034|FG001|Phase 1b|Adverse Event|3|||
126620615|NCT01136733|455567035|FG002|Phase 1b|Adverse Event|1|||
126620616|NCT01136733|455567036|FG003|Phase 1b|Adverse Event|0|||
126620617|NCT01136733|455567037|FG004|Phase 1b|Adverse Event|0|||
126620618|NCT01136733|455567038|FG005|Phase 1b|Adverse Event|0|||
126620619|NCT01136733|455567039|FG006|Phase 1b|Adverse Event|0|||
126620620|NCT01136733|455567033|FG000|Phase 1b|Participant Choice|0|||
126620621|NCT01136733|455567034|FG001|Phase 1b|Participant Choice|0|||
126620622|NCT01136733|455567035|FG002|Phase 1b|Participant Choice|1|||
126620623|NCT01136733|455567036|FG003|Phase 1b|Participant Choice|0|||
126620624|NCT01136733|455567037|FG004|Phase 1b|Participant Choice|0|||
126620625|NCT01136733|455567038|FG005|Phase 1b|Participant Choice|0|||
126620626|NCT01136733|455567039|FG006|Phase 1b|Participant Choice|0|||
126620627|NCT01136733|455567033|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
126620628|NCT01136733|455567034|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
126620629|NCT01136733|455567035|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
126620630|NCT01136733|455567036|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
126620631|NCT01136733|455567037|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
126620632|NCT01136733|455567038|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
126620633|NCT01136733|455567039|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
126620634|NCT01136733|455567033|FG000|Phase 1b|Clinical Progression|1|||
126620635|NCT01136733|455567034|FG001|Phase 1b|Clinical Progression|1|||
126620636|NCT01136733|455567035|FG002|Phase 1b|Clinical Progression|0|||
126620637|NCT01136733|455567036|FG003|Phase 1b|Clinical Progression|0|||
126620638|NCT01136733|455567037|FG004|Phase 1b|Clinical Progression|0|||
126620639|NCT01136733|455567038|FG005|Phase 1b|Clinical Progression|0|||
126620640|NCT01136733|455567039|FG006|Phase 1b|Clinical Progression|0|||
126620641|NCT01136733|455567033|FG000|Phase 2|Disease Progression|0|||
126620642|NCT01136733|455567034|FG001|Phase 2|Disease Progression|0|||
126620643|NCT01136733|455567035|FG002|Phase 2|Disease Progression|0|||
126620644|NCT01136733|455567036|FG003|Phase 2|Disease Progression|0|||
126620645|NCT01136733|455567037|FG004|Phase 2|Disease Progression|30|||
126620646|NCT01136733|455567038|FG005|Phase 2|Disease Progression|32|||
126620647|NCT01136733|455567039|FG006|Phase 2|Disease Progression|38|||
126620648|NCT01136733|455567033|FG000|Phase 2|Adverse Event|0|||
126620649|NCT01136733|455567034|FG001|Phase 2|Adverse Event|0|||
126620650|NCT01136733|455567035|FG002|Phase 2|Adverse Event|0|||
126620651|NCT01136733|455567036|FG003|Phase 2|Adverse Event|0|||
126620652|NCT01136733|455567037|FG004|Phase 2|Adverse Event|11|||
126620653|NCT01136733|455567038|FG005|Phase 2|Adverse Event|13|||
126620654|NCT01136733|455567039|FG006|Phase 2|Adverse Event|5|||
126620655|NCT01136733|455567033|FG000|Phase 2|Participant Choice|0|||
126620656|NCT01136733|455567034|FG001|Phase 2|Participant Choice|0|||
126620657|NCT01136733|455567035|FG002|Phase 2|Participant Choice|0|||
126620658|NCT01136733|455567036|FG003|Phase 2|Participant Choice|0|||
126620659|NCT01136733|455567037|FG004|Phase 2|Participant Choice|3|||
126620660|NCT01136733|455567038|FG005|Phase 2|Participant Choice|0|||
126620661|NCT01136733|455567039|FG006|Phase 2|Participant Choice|1|||
126620662|NCT01136733|455567033|FG000|Phase 2|Administrative-Withdrew Consent|0|||
126620663|NCT01136733|455567034|FG001|Phase 2|Administrative-Withdrew Consent|0|||
126620664|NCT01136733|455567035|FG002|Phase 2|Administrative-Withdrew Consent|0|||
126620665|NCT01136733|455567036|FG003|Phase 2|Administrative-Withdrew Consent|0|||
126620666|NCT01136733|455567037|FG004|Phase 2|Administrative-Withdrew Consent|1|||
126620667|NCT01136733|455567038|FG005|Phase 2|Administrative-Withdrew Consent|0|||
126620668|NCT01136733|455567039|FG006|Phase 2|Administrative-Withdrew Consent|0|||
126620669|NCT01136733|455567033|FG000|Phase 2|Other|0|||
126620670|NCT01136733|455567034|FG001|Phase 2|Other|0|||
126620671|NCT01136733|455567035|FG002|Phase 2|Other|0|||
126620672|NCT01136733|455567036|FG003|Phase 2|Other|0|||
126620673|NCT01136733|455567037|FG004|Phase 2|Other|6|||
126620674|NCT01136733|455567038|FG005|Phase 2|Other|7|||
126620675|NCT01136733|455567039|FG006|Phase 2|Other|6|||
126620676|NCT03360071|455567041|FG000|Overall Study|Lost to Follow-up|1|||
126620677|NCT03360071|455567042|FG001|Overall Study|Lost to Follow-up|0|||
126620678|NCT02368691|455567046|FG000|Overall Study|Death|13|||
126620679|NCT02368691|455567046|FG000|Overall Study|Lack of Efficacy|15|||
126620680|NCT02368691|455567046|FG000|Overall Study|Physician Decision|4|||
126620681|NCT03314233|455567049|FG000|Overall Study|No longer eligible at time of delivery|1|||
126620682|NCT01114217|455567051|FG000|Overall Study|Adverse Event|5|||
126620683|NCT01114217|455567052|FG001|Overall Study|Adverse Event|3|||
126620684|NCT01114217|455567051|FG000|Overall Study|Lost to Follow-up|17|||
126620685|NCT01114217|455567052|FG001|Overall Study|Lost to Follow-up|33|||
126620686|NCT01114217|455567051|FG000|Overall Study|Withdrawal by Subject|21|||
126620687|NCT01114217|455567052|FG001|Overall Study|Withdrawal by Subject|28|||
126620688|NCT01114217|455567051|FG000|Overall Study|Other-Clerical Error|3|||
126620689|NCT01114217|455567052|FG001|Overall Study|Other-Clerical Error|0|||
126620690|NCT01114217|455567051|FG000|Overall Study|Other-Early termination|6|||
126620691|NCT01114217|455567052|FG001|Overall Study|Other-Early termination|10|||
126620692|NCT01114217|455567051|FG000|Overall Study|Other-Procedure|1|||
126620693|NCT01114217|455567052|FG001|Overall Study|Other-Procedure|1|||
126620694|NCT01114217|455567051|FG000|Overall Study|Other-Pregnancy|2|||
126620695|NCT01114217|455567052|FG001|Overall Study|Other-Pregnancy|4|||
126620696|NCT01114217|455567051|FG000|Overall Study|Other-Protocol Violation|1|||
126620697|NCT01114217|455567052|FG001|Overall Study|Other-Protocol Violation|3|||
126620698|NCT01114217|455567051|FG000|Overall Study|Other-Lack of Efficacy|1|||
126620699|NCT01114217|455567052|FG001|Overall Study|Other-Lack of Efficacy|0|||
126620700|NCT01114217|455567051|FG000|Overall Study|Other-Non Compliance|2|||
126620701|NCT01114217|455567052|FG001|Overall Study|Other-Non Compliance|0|||
126620702|NCT01114217|455567051|FG000|Overall Study|Other-Physician Decision|1|||
126620703|NCT01114217|455567052|FG001|Overall Study|Other-Physician Decision|1|||
126620704|NCT01114217|455567051|FG000|Overall Study|Other-Sponsor Decision|10|||
126620705|NCT01114217|455567052|FG001|Overall Study|Other-Sponsor Decision|12|||
126620706|NCT01114217|455567051|FG000|Overall Study|Other-Study Termination|0|||
126620707|NCT01114217|455567052|FG001|Overall Study|Other-Study Termination|1|||
126620708|NCT01114217|455567051|FG000|Overall Study|Other-Study Withdrawn|1|||
126620709|NCT01114217|455567052|FG001|Overall Study|Other-Study Withdrawn|1|||
126620710|NCT01114217|455567051|FG000|Overall Study|Other-Site Stopped Communicating|2|||
126620711|NCT01114217|455567052|FG001|Overall Study|Other-Site Stopped Communicating|0|||
126620712|NCT01114217|455567051|FG000|Overall Study|Other-Lost to Follow-up|1|||
126620713|NCT01114217|455567052|FG001|Overall Study|Other-Lost to Follow-up|0|||
126620714|NCT01114217|455567051|FG000|Overall Study|Other-Withdrawal by Subject|1|||
126620715|NCT01114217|455567052|FG001|Overall Study|Other-Withdrawal by Subject|1|||
126620716|NCT02722278|455567055|FG000|Overall Study|Withdrawal by Subject|5|||
126620717|NCT02722278|455567056|FG001|Overall Study|Withdrawal by Subject|3|||
126620718|NCT02722278|455567055|FG000|Overall Study|Adverse Event|4|||
126620719|NCT02722278|455567056|FG001|Overall Study|Adverse Event|1|||
126620720|NCT02722278|455567055|FG000|Overall Study|Lost to Follow-up|2|||
126620721|NCT02722278|455567056|FG001|Overall Study|Lost to Follow-up|0|||
126620722|NCT02722278|455567055|FG000|Overall Study|Protocol Violation|1|||
126620723|NCT02722278|455567056|FG001|Overall Study|Protocol Violation|0|||
126620724|NCT02722278|455567055|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
126620725|NCT02722278|455567056|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
126620726|NCT02722278|455567055|FG000|Overall Study|Subject declined after tx assignment|0|||
126620727|NCT02722278|455567056|FG001|Overall Study|Subject declined after tx assignment|1|||
126620728|NCT02722278|455567055|FG000|Overall Study|Site closure not study related|0|||
126620729|NCT02722278|455567056|FG001|Overall Study|Site closure not study related|1|||
126620730|NCT04175392|455567057|FG000|Overall Study|Withdrawal by Subject|3|||
126620731|NCT04175392|455567058|FG001|Overall Study|Withdrawal by Subject|2|||
126620732|NCT02727998|455567059|FG000|Overall Study|Lost to Follow-up|3|||
126620733|NCT02727998|455567060|FG001|Overall Study|Lost to Follow-up|3|||
126620734|NCT02727998|455567059|FG000|Overall Study|Withdrawal by Subject|0|||
126620735|NCT02727998|455567060|FG001|Overall Study|Withdrawal by Subject|1|||
126620736|NCT02105688|455567061|FG000|Part A: Double-Blind|Adverse Event|1|||
126620737|NCT02105688|455567062|FG001|Part A: Double-Blind|Adverse Event|0|||
126620738|NCT02105688|455567061|FG000|Part A: Double-Blind|Death|0|||
126620739|NCT02105688|455567062|FG001|Part A: Double-Blind|Death|1|||
126620740|NCT02105688|455567061|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
126620741|NCT02105688|455567062|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
126620742|NCT02105688|455567061|FG000|Part A: Double-Blind|Physician Decision|0|||
126620743|NCT02105688|455567062|FG001|Part A: Double-Blind|Physician Decision|1|||
126620744|NCT02105688|455567061|FG000|Part A: Double-Blind|Status Unknown|0|||
126620745|NCT02105688|455567062|FG001|Part A: Double-Blind|Status Unknown|2|||
126620746|NCT02105688|455567061|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
126620747|NCT02105688|455567062|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
126620748|NCT02105688|455567061|FG000|Part B: Observational Follow-up|Death|2|||
126620749|NCT02105688|455567062|FG001|Part B: Observational Follow-up|Death|1|||
126620750|NCT02105688|455567061|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
126620751|NCT02105688|455567062|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
126782196|NCT00718159|456158118|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
126620752|NCT02105688|455567061|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
126620753|NCT02105688|455567062|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
126620754|NCT02105688|455567061|FG000|Part B: Observational Follow-up|Physician Decision|3|||
126620755|NCT02105688|455567062|FG001|Part B: Observational Follow-up|Physician Decision|1|||
126620756|NCT01075815|455567066|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
126620757|NCT01075815|455567067|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
126620758|NCT01075815|455567066|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
126620759|NCT01075815|455567067|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
126782197|NCT00718159|456158112|FG000|Overall Study|Investigator Decision|0|||
126620760|NCT01075815|455567066|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
126620761|NCT01075815|455567067|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
126620762|NCT00617708|455567068|FG000|Overall Study|Adverse Event|0|||
126620763|NCT00617708|455567069|FG001|Overall Study|Adverse Event|6|||
126620764|NCT00617708|455567070|FG002|Overall Study|Adverse Event|9|||
126620765|NCT00617708|455567068|FG000|Overall Study|Withdrawal by Subject|1|||
126620766|NCT00617708|455567069|FG001|Overall Study|Withdrawal by Subject|1|||
126620767|NCT00617708|455567070|FG002|Overall Study|Withdrawal by Subject|7|||
126620768|NCT00617708|455567068|FG000|Overall Study|Death|0|||
126620769|NCT00617708|455567069|FG001|Overall Study|Death|6|||
126620770|NCT00617708|455567070|FG002|Overall Study|Death|5|||
126620771|NCT00617708|455567068|FG000|Overall Study|Progression/Relapse|7|||
126620772|NCT00617708|455567069|FG001|Overall Study|Progression/Relapse|40|||
126620773|NCT00617708|455567070|FG002|Overall Study|Progression/Relapse|36|||
126620774|NCT00617708|455567068|FG000|Overall Study|Not protocol specified|1|||
126620775|NCT00617708|455567069|FG001|Overall Study|Not protocol specified|4|||
126620776|NCT00617708|455567070|FG002|Overall Study|Not protocol specified|2|||
126620777|NCT00617708|455567068|FG000|Overall Study|Not eligible|1|||
126620778|NCT00617708|455567069|FG001|Overall Study|Not eligible|3|||
126620779|NCT00617708|455567070|FG002|Overall Study|Not eligible|5|||
126620780|NCT02058992|455567071|FG000|Overall Study|Lost to Follow-up|4|||
126620781|NCT02058992|455567071|FG000|Overall Study|Protocol Violation|92|||
126620782|NCT02058992|455567071|FG000|Overall Study|CRF Uncollected|20|||
126620783|NCT03503188|455567072|FG000|Overall Study|Non eligible in the sub study|0|||
126620784|NCT03503188|455567073|FG001|Overall Study|Non eligible in the sub study|1|||
126620785|NCT03005106|455567080|FG000|Overall Study|Lost to Follow-up|16|||
126620786|NCT03005106|455567080|FG000|Overall Study|Adverse Event|1|||
126620787|NCT03005106|455567080|FG000|Overall Study|Physician Decision|1|||
126620788|NCT03005106|455567080|FG000|Overall Study|Death|2|||
126620789|NCT00321672|455567081|FG000|Overall Study|Withdrawal by Subject|5|||
126620790|NCT00321672|455567082|FG001|Overall Study|Withdrawal by Subject|1|||
126620791|NCT00321672|455567083|FG002|Overall Study|Withdrawal by Subject|2|||
126620792|NCT00321672|455567084|FG003|Overall Study|Withdrawal by Subject|0|||
126620793|NCT00321672|455567081|FG000|Overall Study|Noncompliance|1|||
126620794|NCT00321672|455567082|FG001|Overall Study|Noncompliance|2|||
126620795|NCT00321672|455567083|FG002|Overall Study|Noncompliance|1|||
126620796|NCT00321672|455567084|FG003|Overall Study|Noncompliance|0|||
126620797|NCT00321672|455567081|FG000|Overall Study|Adverse Event|1|||
126620798|NCT00321672|455567082|FG001|Overall Study|Adverse Event|1|||
126620799|NCT00321672|455567083|FG002|Overall Study|Adverse Event|0|||
126620800|NCT00321672|455567084|FG003|Overall Study|Adverse Event|0|||
126620801|NCT00321672|455567081|FG000|Overall Study|Lack of Efficacy|1|||
126620802|NCT00321672|455567082|FG001|Overall Study|Lack of Efficacy|1|||
126620803|NCT00321672|455567083|FG002|Overall Study|Lack of Efficacy|0|||
126620804|NCT00321672|455567084|FG003|Overall Study|Lack of Efficacy|0|||
126620805|NCT00321672|455567081|FG000|Overall Study|Lost to Follow-up|2|||
126620806|NCT00321672|455567082|FG001|Overall Study|Lost to Follow-up|0|||
126620807|NCT00321672|455567083|FG002|Overall Study|Lost to Follow-up|4|||
126620808|NCT00321672|455567084|FG003|Overall Study|Lost to Follow-up|2|||
126620809|NCT00321672|455567081|FG000|Overall Study|Death|1|||
126620810|NCT00321672|455567082|FG001|Overall Study|Death|0|||
126620811|NCT00321672|455567083|FG002|Overall Study|Death|0|||
126620812|NCT00321672|455567084|FG003|Overall Study|Death|0|||
126620813|NCT00321672|455567081|FG000|Overall Study|Too far to travel for visits|1|||
126620814|NCT00321672|455567082|FG001|Overall Study|Too far to travel for visits|0|||
126620815|NCT00321672|455567083|FG002|Overall Study|Too far to travel for visits|0|||
126620816|NCT00321672|455567084|FG003|Overall Study|Too far to travel for visits|0|||
126620817|NCT00321672|455567081|FG000|Overall Study|Incarcerated|0|||
126746819|NCT04412668|456022068|FG001|Overall Study|Withdrawal by Subject|0|||
126746820|NCT04412668|456022069|FG002|Overall Study|Withdrawal by Subject|0|||
126746821|NCT04412668|456022067|FG000|Overall Study|Other than Specified|2|||
126746822|NCT04412668|456022068|FG001|Overall Study|Other than Specified|0|||
126746823|NCT04412668|456022069|FG002|Overall Study|Other than Specified|0|||
126746824|NCT04964557|456022071|FG000|Overall Study|Withdrawal by Subject|3|||
126620818|NCT00321672|455567082|FG001|Overall Study|Incarcerated|0|||
126620819|NCT00321672|455567083|FG002|Overall Study|Incarcerated|2|||
126620820|NCT00321672|455567084|FG003|Overall Study|Incarcerated|0|||
126620821|NCT00321672|455567081|FG000|Overall Study|Moved out of state|0|||
126620822|NCT00321672|455567082|FG001|Overall Study|Moved out of state|1|||
126620823|NCT00321672|455567083|FG002|Overall Study|Moved out of state|1|||
126620824|NCT00321672|455567084|FG003|Overall Study|Moved out of state|0|||
126620825|NCT00321672|455567081|FG000|Overall Study|Protocol Violation|0|||
126620826|NCT00321672|455567082|FG001|Overall Study|Protocol Violation|0|||
126620827|NCT00321672|455567083|FG002|Overall Study|Protocol Violation|1|||
126746825|NCT04964557|456022072|FG001|Overall Study|Withdrawal by Subject|2|||
126746826|NCT04964557|456022071|FG000|Overall Study|Lost to Follow-up|1|||
126746827|NCT04964557|456022072|FG001|Overall Study|Lost to Follow-up|2|||
126620828|NCT00321672|455567084|FG003|Overall Study|Protocol Violation|0|||
126620829|NCT00321672|455567081|FG000|Overall Study|Diagnosis of testicular cancer|0|||
126620830|NCT00321672|455567082|FG001|Overall Study|Diagnosis of testicular cancer|1|||
126620831|NCT00321672|455567083|FG002|Overall Study|Diagnosis of testicular cancer|0|||
126620832|NCT00321672|455567084|FG003|Overall Study|Diagnosis of testicular cancer|0|||
126620833|NCT00321672|455567081|FG000|Overall Study|Extensive travel required for new job|0|||
126620834|NCT00321672|455567082|FG001|Overall Study|Extensive travel required for new job|1|||
126620835|NCT00321672|455567083|FG002|Overall Study|Extensive travel required for new job|0|||
126620836|NCT00321672|455567084|FG003|Overall Study|Extensive travel required for new job|0|||
126620837|NCT00512902|455567085|FG000|Overall Study|Adverse Event|7|||
126620838|NCT00512902|455567085|FG000|Overall Study|Lost to Follow-up|1|||
126620839|NCT03019289|455567086|FG000|Overall Study|Adverse Event|1|||
126620840|NCT03019289|455567087|FG001|Overall Study|Adverse Event|0|||
126620841|NCT03019289|455567088|FG002|Overall Study|Adverse Event|0|||
126620842|NCT03019289|455567089|FG003|Overall Study|Adverse Event|0|||
126620843|NCT03019289|455567090|FG004|Overall Study|Adverse Event|0|||
126620844|NCT03019289|455567091|FG005|Overall Study|Adverse Event|0|||
126620845|NCT03019289|455567092|FG006|Overall Study|Adverse Event|0|||
126620846|NCT03019289|455567093|FG007|Overall Study|Adverse Event|0|||
126620847|NCT03019289|455567094|FG008|Overall Study|Adverse Event|1|||
126620848|NCT03019289|455567086|FG000|Overall Study|Other|1|||
126620849|NCT03019289|455567087|FG001|Overall Study|Other|0|||
126620850|NCT03019289|455567088|FG002|Overall Study|Other|0|||
126620851|NCT03019289|455567089|FG003|Overall Study|Other|0|||
126620852|NCT03019289|455567090|FG004|Overall Study|Other|0|||
126620853|NCT03019289|455567091|FG005|Overall Study|Other|0|||
126620854|NCT03019289|455567092|FG006|Overall Study|Other|0|||
126620855|NCT03019289|455567093|FG007|Overall Study|Other|0|||
126620856|NCT03019289|455567094|FG008|Overall Study|Other|0|||
126620857|NCT00070317|455567097|FG000|Overall Study|Inevaluable (Never Treated)|1|||
126620858|NCT00070317|455567097|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
126620859|NCT00070317|455567097|FG000|Overall Study|Ineligible required test not done|1|||
126620860|NCT00070317|455567097|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
126620861|NCT00070317|455567097|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
126620862|NCT01429285|455567098|FG000|Overall Study|Protocol Violation|9|||
126620863|NCT01429285|455567099|FG001|Overall Study|Protocol Violation|4|||
126620864|NCT01429285|455567098|FG000|Overall Study|Missing Data|5|||
126620865|NCT01429285|455567099|FG001|Overall Study|Missing Data|3|||
126620866|NCT01429285|455567098|FG000|Overall Study|Erroneously Enrolled Twice|8|||
126620867|NCT01429285|455567099|FG001|Overall Study|Erroneously Enrolled Twice|2|||
126620868|NCT01885559|455567100|FG000|Overall Study|Lost to Follow-up|15|||
126620869|NCT01885559|455567101|FG001|Overall Study|Lost to Follow-up|16|||
126620870|NCT01885559|455567100|FG000|Overall Study|Less than full participation|9|||
126620871|NCT01885559|455567101|FG001|Overall Study|Less than full participation|19|||
126620872|NCT01885559|455567100|FG000|Overall Study|Protocol Violation|0|||
126620873|NCT01885559|455567101|FG001|Overall Study|Protocol Violation|1|||
126620874|NCT01123200|455567103|FG000|Overall Study|Withdrawal by Subject|1|||
126620875|NCT00732498|455567111|FG000|Overall Study|Ineligible|1|||
126620876|NCT00732498|455567111|FG000|Overall Study|Adverse Event|2|||
126620877|NCT00732498|455567111|FG000|Overall Study|Physician Decision|3|||
126620878|NCT03394508|455567114|FG000|Overall Study|Protocol Violation|0|||
126620879|NCT03394508|455567115|FG001|Overall Study|Protocol Violation|3|||
126620880|NCT03394508|455567114|FG000|Overall Study|Lost to Follow-up|1|||
126620881|NCT03394508|455567115|FG001|Overall Study|Lost to Follow-up|0|||
126620882|NCT03214198|455567118|FG000|Overall Study|Case Report Forms Uncollected|18|||
126620883|NCT03214198|455567118|FG000|Overall Study|Protocol Deviation|18|||
126620884|NCT04295499|455567119|FG000|Overall Study|moving out of state|1|||
126620885|NCT04295499|455567120|FG001|Overall Study|moving out of state|0|||
126620886|NCT04295499|455567119|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
126620887|NCT04295499|455567120|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
126620888|NCT02135445|455567121|FG000|Overall Study|Lost to Follow-up|1|||
126620889|NCT02135445|455567122|FG001|Overall Study|Lost to Follow-up|0|||
126620890|NCT02135445|455567121|FG000|Overall Study|Withdrawal by Subject|1|||
126620891|NCT02135445|455567122|FG001|Overall Study|Withdrawal by Subject|0|||
126620892|NCT04851587|455568461|FG000|Overall Study|Lost to Follow-up|18|||
126620893|NCT01350102|455568464|FG000|Overall Study|Adverse Event|0|||
126620894|NCT01350102|455568465|FG001|Overall Study|Adverse Event|0|||
126620895|NCT01350102|455568466|FG002|Overall Study|Adverse Event|1|||
126620896|NCT01350102|455568467|FG003|Overall Study|Adverse Event|0|||
126746828|NCT04964557|456022071|FG000|Overall Study|Physician Decision|2|||
126746829|NCT04964557|456022072|FG001|Overall Study|Physician Decision|0|||
126746830|NCT04964557|456022071|FG000|Overall Study|Death|3|||
126620897|NCT02136797|455568468|FG000|Overall Study|Not Treated|8|||
126620898|NCT03050372|455568469|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
126620899|NCT03050372|455568470|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
126620900|NCT03050372|455568469|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
126620901|NCT03050372|455568470|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
126620902|NCT03672188|455568473|FG000|Overall Study|Withdrawal by Subject|0|||
126620903|NCT03672188|455568474|FG001|Overall Study|Withdrawal by Subject|0|||
126620904|NCT03672188|455568475|FG002|Overall Study|Withdrawal by Subject|0|||
126620905|NCT03672188|455568476|FG003|Overall Study|Withdrawal by Subject|3|||
126620906|NCT03672188|455568477|FG004|Overall Study|Withdrawal by Subject|0|||
126620907|NCT03672188|455568478|FG005|Overall Study|Withdrawal by Subject|0|||
126620908|NCT03672188|455568479|FG006|Overall Study|Withdrawal by Subject|0|||
126620909|NCT03672188|455568480|FG007|Overall Study|Withdrawal by Subject|0|||
126620910|NCT03672188|455568481|FG008|Overall Study|Withdrawal by Subject|0|||
126620911|NCT03672188|455568482|FG009|Overall Study|Withdrawal by Subject|0|||
126620912|NCT03672188|455568483|FG010|Overall Study|Withdrawal by Subject|0|||
126620913|NCT03672188|455568484|FG011|Overall Study|Withdrawal by Subject|0|||
126620914|NCT03672188|455568485|FG012|Overall Study|Withdrawal by Subject|0|||
126620915|NCT03672188|455568486|FG013|Overall Study|Withdrawal by Subject|0|||
126620916|NCT03672188|455568487|FG014|Overall Study|Withdrawal by Subject|0|||
126620917|NCT03672188|455568473|FG000|Overall Study|Death|0|||
126620918|NCT03672188|455568474|FG001|Overall Study|Death|0|||
126620919|NCT03672188|455568475|FG002|Overall Study|Death|0|||
126620920|NCT03672188|455568476|FG003|Overall Study|Death|0|||
126620921|NCT03672188|455568477|FG004|Overall Study|Death|0|||
126620922|NCT03672188|455568478|FG005|Overall Study|Death|0|||
126620923|NCT03672188|455568479|FG006|Overall Study|Death|0|||
126620924|NCT03672188|455568480|FG007|Overall Study|Death|0|||
126620925|NCT03672188|455568481|FG008|Overall Study|Death|0|||
126620926|NCT03672188|455568482|FG009|Overall Study|Death|0|||
126620927|NCT03672188|455568483|FG010|Overall Study|Death|0|||
126620928|NCT03672188|455568484|FG011|Overall Study|Death|0|||
126620929|NCT03672188|455568485|FG012|Overall Study|Death|1|||
126620930|NCT03672188|455568486|FG013|Overall Study|Death|0|||
126620931|NCT03672188|455568487|FG014|Overall Study|Death|0|||
126620932|NCT03672188|455568473|FG000|Overall Study|Lost to Follow-up|0|||
126620933|NCT03672188|455568474|FG001|Overall Study|Lost to Follow-up|0|||
126620934|NCT03672188|455568475|FG002|Overall Study|Lost to Follow-up|1|||
126620935|NCT03672188|455568476|FG003|Overall Study|Lost to Follow-up|0|||
126620936|NCT03672188|455568477|FG004|Overall Study|Lost to Follow-up|0|||
126620937|NCT03672188|455568478|FG005|Overall Study|Lost to Follow-up|0|||
126620938|NCT03672188|455568479|FG006|Overall Study|Lost to Follow-up|0|||
126620939|NCT03672188|455568480|FG007|Overall Study|Lost to Follow-up|0|||
126620940|NCT03672188|455568481|FG008|Overall Study|Lost to Follow-up|0|||
126620941|NCT03672188|455568482|FG009|Overall Study|Lost to Follow-up|0|||
126620942|NCT03672188|455568483|FG010|Overall Study|Lost to Follow-up|0|||
126620943|NCT03672188|455568484|FG011|Overall Study|Lost to Follow-up|0|||
126620944|NCT03672188|455568485|FG012|Overall Study|Lost to Follow-up|0|||
126620945|NCT03672188|455568486|FG013|Overall Study|Lost to Follow-up|0|||
126620946|NCT03672188|455568487|FG014|Overall Study|Lost to Follow-up|0|||
126620947|NCT03320941|455568493|FG000|Overall Study|subject/guardian decision|0|||
126620948|NCT03320941|455568494|FG001|Overall Study|subject/guardian decision|0|||
126620949|NCT03320941|455568495|FG002|Overall Study|subject/guardian decision|0|||
126620950|NCT03320941|455568496|FG003|Overall Study|subject/guardian decision|1|||
126620951|NCT03320941|455568497|FG004|Overall Study|subject/guardian decision|0|||
126620952|NCT01183013|455568498|FG000|Overall Study|Adverse Event|6|||
126620953|NCT01183013|455568499|FG001|Overall Study|Adverse Event|8|||
126620954|NCT01183013|455568500|FG002|Overall Study|Adverse Event|5|||
126620955|NCT01183013|455568501|FG003|Overall Study|Adverse Event|5|||
126620956|NCT01183013|455568502|FG004|Overall Study|Adverse Event|10|||
126620957|NCT01183013|455568503|FG005|Overall Study|Adverse Event|10|||
126620958|NCT01183013|455568504|FG006|Overall Study|Adverse Event|6|||
126620959|NCT01183013|455568498|FG000|Overall Study|Lack of Efficacy|3|||
126620960|NCT01183013|455568499|FG001|Overall Study|Lack of Efficacy|2|||
126620961|NCT01183013|455568500|FG002|Overall Study|Lack of Efficacy|1|||
126620962|NCT01183013|455568501|FG003|Overall Study|Lack of Efficacy|2|||
126620963|NCT01183013|455568502|FG004|Overall Study|Lack of Efficacy|1|||
126620964|NCT01183013|455568503|FG005|Overall Study|Lack of Efficacy|2|||
126620965|NCT01183013|455568504|FG006|Overall Study|Lack of Efficacy|0|||
126620966|NCT01183013|455568498|FG000|Overall Study|Protocol Violation|5|||
126620967|NCT01183013|455568499|FG001|Overall Study|Protocol Violation|2|||
126620968|NCT01183013|455568500|FG002|Overall Study|Protocol Violation|4|||
126620969|NCT01183013|455568501|FG003|Overall Study|Protocol Violation|0|||
126620970|NCT01183013|455568502|FG004|Overall Study|Protocol Violation|4|||
126620971|NCT01183013|455568503|FG005|Overall Study|Protocol Violation|3|||
126620972|NCT01183013|455568504|FG006|Overall Study|Protocol Violation|3|||
126620973|NCT01183013|455568498|FG000|Overall Study|Lost to Follow-up|7|||
126620974|NCT01183013|455568499|FG001|Overall Study|Lost to Follow-up|3|||
126620975|NCT01183013|455568500|FG002|Overall Study|Lost to Follow-up|4|||
126620976|NCT01183013|455568501|FG003|Overall Study|Lost to Follow-up|3|||
126620977|NCT01183013|455568502|FG004|Overall Study|Lost to Follow-up|2|||
126620978|NCT01183013|455568503|FG005|Overall Study|Lost to Follow-up|6|||
126620979|NCT01183013|455568504|FG006|Overall Study|Lost to Follow-up|5|||
126620980|NCT01183013|455568498|FG000|Overall Study|Withdrawal by Subject|9|||
126620981|NCT01183013|455568499|FG001|Overall Study|Withdrawal by Subject|13|||
126620982|NCT01183013|455568500|FG002|Overall Study|Withdrawal by Subject|10|||
126620983|NCT01183013|455568501|FG003|Overall Study|Withdrawal by Subject|8|||
126620984|NCT01183013|455568502|FG004|Overall Study|Withdrawal by Subject|7|||
126620985|NCT01183013|455568503|FG005|Overall Study|Withdrawal by Subject|9|||
126620986|NCT01183013|455568504|FG006|Overall Study|Withdrawal by Subject|10|||
126620987|NCT01183013|455568498|FG000|Overall Study|Reasons other than stated above|15|||
126620988|NCT01183013|455568499|FG001|Overall Study|Reasons other than stated above|11|||
126620989|NCT01183013|455568500|FG002|Overall Study|Reasons other than stated above|17|||
126620990|NCT01183013|455568501|FG003|Overall Study|Reasons other than stated above|12|||
126620991|NCT01183013|455568502|FG004|Overall Study|Reasons other than stated above|12|||
126620992|NCT01183013|455568503|FG005|Overall Study|Reasons other than stated above|15|||
126620993|NCT01183013|455568504|FG006|Overall Study|Reasons other than stated above|13|||
126620994|NCT01757171|455568505|FG000|Overall Study|Adverse Event|5|||
126620995|NCT01757171|455568506|FG001|Overall Study|Adverse Event|1|||
126620996|NCT01757171|455568505|FG000|Overall Study|Disease Progression|1|||
126620997|NCT01757171|455568506|FG001|Overall Study|Disease Progression|0|||
126620998|NCT01757171|455568505|FG000|Overall Study|Hospitalization|1|||
126620999|NCT01757171|455568506|FG001|Overall Study|Hospitalization|0|||
126621000|NCT01757171|455568505|FG000|Overall Study|ECOG decline|1|||
126621001|NCT01757171|455568506|FG001|Overall Study|ECOG decline|0|||
126621002|NCT01014013|455568508|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
126621003|NCT01014013|455568509|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
126621004|NCT01014013|455568508|FG000|Overall Study|Clinical adverse experience|4|||
126621005|NCT01014013|455568509|FG001|Overall Study|Clinical adverse experience|2|||
126621006|NCT01014013|455568508|FG000|Overall Study|Laboratory adverse experience|1|||
126621007|NCT01014013|455568509|FG001|Overall Study|Laboratory adverse experience|1|||
126621008|NCT01014013|455568508|FG000|Overall Study|Protocol Violation|1|||
126621009|NCT01014013|455568509|FG001|Overall Study|Protocol Violation|3|||
126621010|NCT01014013|455568508|FG000|Overall Study|Withdrawal by Subject|7|||
126621011|NCT01014013|455568509|FG001|Overall Study|Withdrawal by Subject|4|||
126621012|NCT01014013|455568508|FG000|Overall Study|Clinical/microbiologic failure|1|||
126621013|NCT01014013|455568509|FG001|Overall Study|Clinical/microbiologic failure|2|||
126621014|NCT01014013|455568508|FG000|Overall Study|Pathogen culture = no growth|26|||
126621015|NCT01014013|455568509|FG001|Overall Study|Pathogen culture = no growth|34|||
126621016|NCT01014013|455568508|FG000|Overall Study|Negative urine culture|2|||
126621017|NCT01014013|455568509|FG001|Overall Study|Negative urine culture|0|||
126621018|NCT01014013|455568508|FG000|Overall Study|Pathogen resistant|7|||
126621019|NCT01014013|455568509|FG001|Overall Study|Pathogen resistant|4|||
126621020|NCT01014013|455568508|FG000|Overall Study|Physician Decision|0|||
126621021|NCT01014013|455568509|FG001|Overall Study|Physician Decision|1|||
126621022|NCT01014013|455568508|FG000|Overall Study|Another antibiotic therapy required|0|||
126621023|NCT01014013|455568509|FG001|Overall Study|Another antibiotic therapy required|1|||
126621024|NCT01014013|455568508|FG000|Overall Study|Appendectomy|1|||
126621025|NCT01014013|455568509|FG001|Overall Study|Appendectomy|0|||
126621026|NCT01014013|455568508|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
126621027|NCT01014013|455568509|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
126621028|NCT00316121|455568510|FG000|Overall Study|Death|1|||
126621029|NCT00316121|455568511|FG001|Overall Study|Death|0|||
126621030|NCT00316121|455568510|FG000|Overall Study|Lost to Follow-up|14|||
126621031|NCT00316121|455568511|FG001|Overall Study|Lost to Follow-up|8|||
126621032|NCT00316121|455568510|FG000|Overall Study|Withdrawal by Subject|2|||
126621033|NCT00316121|455568511|FG001|Overall Study|Withdrawal by Subject|0|||
126621034|NCT00316121|455568510|FG000|Overall Study|Reason is missing|1|||
126621035|NCT00316121|455568511|FG001|Overall Study|Reason is missing|0|||
126621036|NCT00316121|455568510|FG000|Overall Study|Subject relocated|1|||
126621037|NCT00316121|455568511|FG001|Overall Study|Subject relocated|1|||
126621038|NCT00316121|455568510|FG000|Overall Study|Subject refused to return|1|||
126621039|NCT00316121|455568511|FG001|Overall Study|Subject refused to return|0|||
126621040|NCT00316121|455568510|FG000|Overall Study|Subject no show for visit x 3|1|||
126621041|NCT00316121|455568511|FG001|Overall Study|Subject no show for visit x 3|0|||
126621042|NCT00316121|455568510|FG000|Overall Study|Subject did not have 24 month visit|1|||
126621043|NCT00316121|455568511|FG001|Overall Study|Subject did not have 24 month visit|0|||
126621044|NCT02305797|455568512|FG000|Overall Study|Adverse Event|11|||
126621045|NCT02305797|455568513|FG001|Overall Study|Adverse Event|2|||
126621046|NCT02305797|455568512|FG000|Overall Study|Withdrawal by Subject|9|||
126621047|NCT02305797|455568513|FG001|Overall Study|Withdrawal by Subject|10|||
126621048|NCT02305797|455568512|FG000|Overall Study|Lack of Efficacy|6|||
126621049|NCT02305797|455568513|FG001|Overall Study|Lack of Efficacy|0|||
126621050|NCT02305797|455568512|FG000|Overall Study|Lost to Follow-up|5|||
126621051|NCT02305797|455568513|FG001|Overall Study|Lost to Follow-up|11|||
126621052|NCT02305797|455568512|FG000|Overall Study|Pregnancy|0|||
126621053|NCT02305797|455568513|FG001|Overall Study|Pregnancy|2|||
126621054|NCT02305797|455568512|FG000|Overall Study|Noncompliance|14|||
126621055|NCT02305797|455568513|FG001|Overall Study|Noncompliance|12|||
126621056|NCT02305797|455568512|FG000|Overall Study|Reason not collected|0|||
126621057|NCT02305797|455568513|FG001|Overall Study|Reason not collected|1|||
126621058|NCT00460577|455568516|FG000|Overall Study|Protocol Violation|2|||
126621059|NCT00460577|455568517|FG001|Overall Study|Protocol Violation|6|||
126621060|NCT02213458|455568518|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
126621061|NCT02213458|455568519|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
126621062|NCT02213458|455568518|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
126621063|NCT02213458|455568519|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
126621064|NCT02213458|455568518|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
126621065|NCT02213458|455568519|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
126621066|NCT02213458|455568518|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
126621067|NCT02213458|455568519|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
126621068|NCT02213458|455568518|FG000|Overall Study|Refused re-consent|6|||
126621069|NCT02213458|455568519|FG001|Overall Study|Refused re-consent|0|||
126621070|NCT02213458|455568518|FG000|Overall Study|Lost to Follow-up|2|||
126621071|NCT02213458|455568519|FG001|Overall Study|Lost to Follow-up|2|||
126621072|NCT02213458|455568518|FG000|Overall Study|Withdrawal by Subject|26|||
126621073|NCT02213458|455568519|FG001|Overall Study|Withdrawal by Subject|8|||
126621074|NCT00910871|455568520|FG000|Overall Study|Adverse Event|5|||
126621075|NCT00910871|455568520|FG000|Overall Study|Death|12|||
126621076|NCT00910871|455568520|FG000|Overall Study|Lost to Follow-up|8|||
126621077|NCT00910871|455568520|FG000|Overall Study|Protocol Violation|11|||
126621078|NCT00910871|455568520|FG000|Overall Study|Withdrawal by Subject|12|||
126621079|NCT00910871|455568520|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
126621080|NCT00910871|455568520|FG000|Overall Study|Undefined|1|||
126621081|NCT01878253|455568521|FG000|Overall Study|Death|1|||
126621082|NCT01878253|455568521|FG000|Overall Study|SIdus System Removal|3|||
126621083|NCT01878253|455568521|FG000|Overall Study|Withdrawal by Subject|1|||
126621084|NCT01878253|455568521|FG000|Overall Study|Lost to Follow-up|2|||
126621085|NCT01878253|455568521|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
126621086|NCT04043806|455568522|FG000|Overall Study|Commercial drug is available for participants|13|||
126621087|NCT04043806|455568522|FG000|Overall Study|Physician Decision|2|||
126621088|NCT04043806|455568522|FG000|Overall Study|Other|12|||
126621089|NCT04043806|455568522|FG000|Overall Study|Adverse Event|2|||
126621090|NCT04043806|455568522|FG000|Overall Study|Lost to Follow-up|6|||
126621091|NCT04043806|455568522|FG000|Overall Study|Other non-compliance|2|||
126621092|NCT04043806|455568522|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
126621093|NCT04043806|455568522|FG000|Overall Study|Never Dosed|1|||
126621094|NCT01622088|455568523|FG000|Overall Study|Adverse Event|20|||
126621095|NCT01622088|455568523|FG000|Overall Study|Lost to Follow-up|1|||
126621096|NCT01622088|455568523|FG000|Overall Study|Withdrawal by Subject|20|||
126621097|NCT01622088|455568523|FG000|Overall Study|Investigator Decision|1|||
126621098|NCT01622088|455568523|FG000|Overall Study|Death|53|||
126621099|NCT01622088|455568523|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
126621100|NCT04799587|455568525|FG000|Overall Study|Withdrawal by Subject|0|||
126621101|NCT04799587|455568526|FG001|Overall Study|Withdrawal by Subject|1|||
126621102|NCT04598776|455568527|FG000|Overall Study|Protocol Violation|5|||
126621103|NCT04598776|455568527|FG000|Overall Study|Physician Decision|4|||
126621104|NCT06312566|455568534|FG000|Overall Study|Protocol Violation|0|||
126621105|NCT06312566|455568535|FG001|Overall Study|Protocol Violation|1|||
126621106|NCT04736472|455568536|FG000|Overall Study|Lost to Follow-up|1|||
126621107|NCT04736472|455568537|FG001|Overall Study|Lost to Follow-up|0|||
126621108|NCT04736472|455568538|FG002|Overall Study|Lost to Follow-up|0|||
126621109|NCT04736472|455568536|FG000|Overall Study|Withdrawal by Subject|2|||
126621110|NCT04736472|455568537|FG001|Overall Study|Withdrawal by Subject|0|||
126621111|NCT04736472|455568538|FG002|Overall Study|Withdrawal by Subject|0|||
126621112|NCT04736472|455568536|FG000|Overall Study|Protocol Violation|48|||
126621113|NCT04736472|455568537|FG001|Overall Study|Protocol Violation|0|||
126621114|NCT04736472|455568538|FG002|Overall Study|Protocol Violation|6|||
126621115|NCT03861078|455568539|FG000|Overall Study|COVID-19 shut down|4|||
126621116|NCT03861078|455568539|FG000|Overall Study|Lost to Follow-up|1|||
126621117|NCT03861078|455568539|FG000|Overall Study|Protocol Violation|2|||
126621118|NCT03861078|455568539|FG000|Overall Study|lack of venous access|1|||
126621119|NCT02971683|455568540|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
126621120|NCT02971683|455568541|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
126621121|NCT02971683|455568540|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
126621122|NCT02971683|455568541|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
126621123|NCT02971683|455568540|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
126621124|NCT02971683|455568541|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
126621125|NCT02971683|455568540|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
126621126|NCT02971683|455568541|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
126621127|NCT02971683|455568540|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
126621128|NCT02971683|455568541|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
126621129|NCT02971683|455568540|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
126621130|NCT02971683|455568541|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
126621131|NCT02971683|455568540|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
126621132|NCT02971683|455568541|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
126621133|NCT02971683|455568540|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
126621134|NCT02971683|455568541|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
126621135|NCT02971683|455568540|FG000|Open-Label|Lost to Follow-up|1|||
126782198|NCT00718159|456158113|FG001|Overall Study|Investigator Decision|0|||
126782199|NCT00718159|456158114|FG002|Overall Study|Investigator Decision|0|||
126782200|NCT00718159|456158115|FG003|Overall Study|Investigator Decision|0|||
126782201|NCT00718159|456158116|FG004|Overall Study|Investigator Decision|0|||
126782202|NCT00718159|456158117|FG005|Overall Study|Investigator Decision|1|||
126782203|NCT00718159|456158118|FG006|Overall Study|Investigator Decision|1|||
126782204|NCT01798485|456158123|FG000|Overall Study|Adverse Event|32|||
126782205|NCT01798485|456158124|FG001|Overall Study|Adverse Event|40|||
126782206|NCT01798485|456158123|FG000|Overall Study|Withdrawal by Subject|27|||
126782207|NCT01798485|456158124|FG001|Overall Study|Withdrawal by Subject|31|||
126782208|NCT01798485|456158123|FG000|Overall Study|Lost to Follow-up|0|||
126782209|NCT01798485|456158124|FG001|Overall Study|Lost to Follow-up|3|||
126782210|NCT01798485|456158123|FG000|Overall Study|Physician Decision|14|||
126782211|NCT01798485|456158124|FG001|Overall Study|Physician Decision|10|||
126782212|NCT01798485|456158123|FG000|Overall Study|Objective Disease Progression|152|||
126782213|NCT01798485|456158124|FG001|Overall Study|Objective Disease Progression|106|||
126782214|NCT01798485|456158123|FG000|Overall Study|Death|25|||
126782215|NCT01798485|456158124|FG001|Overall Study|Death|22|||
126782216|NCT01798485|456158123|FG000|Overall Study|Sponsor Decision|61|||
126782217|NCT01798485|456158124|FG001|Overall Study|Sponsor Decision|54|||
126782218|NCT01798485|456158123|FG000|Overall Study|Clinical Progression|35|||
126782219|NCT01798485|456158124|FG001|Overall Study|Clinical Progression|24|||
126782220|NCT00681863|456158125|FG000|Overall Study|Adverse Event|1|||
126782221|NCT00681863|456158125|FG000|Overall Study|Lost to Follow-up|2|||
126782222|NCT00681863|456158125|FG000|Overall Study|Lack of Efficacy|2|||
126782223|NCT00681863|456158125|FG000|Overall Study|Other|18|||
126621136|NCT02971683|455568541|FG001|Open-Label|Lost to Follow-up|0|||
126621137|NCT02971683|455568540|FG000|Open-Label|Participants withdrew consent|0|||
126621138|NCT02971683|455568541|FG001|Open-Label|Participants withdrew consent|2|||
126746831|NCT04964557|456022072|FG001|Overall Study|Death|0|||
126746832|NCT04964557|456022071|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
126746833|NCT04964557|456022072|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
126746834|NCT02358863|456023490|FG000|Overall Study|Physician Decision|3|||
126746835|NCT03793010|456023497|FG000|Overall Study|Withdrawal by Subject|5|||
126746836|NCT03793010|456023498|FG001|Overall Study|Withdrawal by Subject|7|||
126746837|NCT03793010|456023497|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
126746838|NCT03793010|456023498|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
126746839|NCT03793010|456023497|FG000|Overall Study|Lost to Follow-up|1|||
126746840|NCT03793010|456023498|FG001|Overall Study|Lost to Follow-up|2|||
126746841|NCT03793010|456023497|FG000|Overall Study|Patient couldn't sit still for injection|1|||
126746842|NCT03793010|456023498|FG001|Overall Study|Patient couldn't sit still for injection|0|||
126746843|NCT03793010|456023497|FG000|Overall Study|Withdrew to pursue other treatment|1|||
126746844|NCT03793010|456023498|FG001|Overall Study|Withdrew to pursue other treatment|0|||
126746845|NCT03793010|456023497|FG000|Overall Study|Did not meet eligibility criteria|1|||
126746846|NCT03793010|456023498|FG001|Overall Study|Did not meet eligibility criteria|0|||
126746847|NCT04924114|456023500|FG000|Overall Study|Withdrawal by Subject|0|||
126746848|NCT04924114|456023501|FG001|Overall Study|Withdrawal by Subject|2|||
126746849|NCT04924114|456023502|FG002|Overall Study|Withdrawal by Subject|2|||
126746850|NCT04924114|456023503|FG003|Overall Study|Withdrawal by Subject|0|||
126746851|NCT04924114|456023504|FG004|Overall Study|Withdrawal by Subject|2|||
126746852|NCT00378534|456023505|FG000|Overall Study|Participants did not receive transplant|3|||
126746853|NCT00378534|456023506|FG001|Overall Study|Participants did not receive transplant|0|||
126746854|NCT04969900|456023507|FG000|Overall Study|Physician Decision|1|||
126746855|NCT04969900|456023508|FG001|Overall Study|Physician Decision|1|||
126746856|NCT04969900|456023507|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
126746857|NCT04969900|456023508|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
126746858|NCT03657576|456023513|FG000|Overall Study|Death|0|||
126746859|NCT03657576|456023514|FG001|Overall Study|Death|1|||
126746860|NCT03657576|456023515|FG002|Overall Study|Death|1|||
126746861|NCT03657576|456023516|FG003|Overall Study|Death|0|||
126746862|NCT03657576|456023517|FG004|Overall Study|Death|0|||
126746863|NCT03657576|456023518|FG005|Overall Study|Death|0|||
126746864|NCT03657576|456023513|FG000|Overall Study|Withdrawal by Subject|0|||
126782224|NCT01333033|456158126|FG000|Overall Study|Ineligible|0|||
126782225|NCT01333033|456158127|FG001|Overall Study|Ineligible|0|||
126782226|NCT01333033|456158128|FG002|Overall Study|Ineligible|0|||
126782227|NCT01333033|456158129|FG003|Overall Study|Ineligible|0|||
126782228|NCT01333033|456158130|FG004|Overall Study|Ineligible|6|||
126782229|NCT01333033|456158131|FG005|Overall Study|Ineligible|8|||
126782230|NCT01333033|456158126|FG000|Overall Study|Withdrawal by Subject|0|||
126621139|NCT02971683|455568540|FG000|Open-Label|Participant request to discontinue study treatment|1|||
126746865|NCT03657576|456023514|FG001|Overall Study|Withdrawal by Subject|0|||
126746866|NCT03657576|456023515|FG002|Overall Study|Withdrawal by Subject|0|||
126782231|NCT01333033|456158127|FG001|Overall Study|Withdrawal by Subject|0|||
126782232|NCT01333033|456158128|FG002|Overall Study|Withdrawal by Subject|0|||
126746867|NCT03657576|456023516|FG003|Overall Study|Withdrawal by Subject|1|||
126746868|NCT03657576|456023517|FG004|Overall Study|Withdrawal by Subject|0|||
126746869|NCT03657576|456023518|FG005|Overall Study|Withdrawal by Subject|0|||
126746870|NCT03657576|456023513|FG000|Overall Study|Screen Fail|0|||
126746871|NCT03657576|456023514|FG001|Overall Study|Screen Fail|0|||
126746872|NCT03657576|456023515|FG002|Overall Study|Screen Fail|0|||
126746873|NCT03657576|456023516|FG003|Overall Study|Screen Fail|0|||
126746874|NCT03657576|456023517|FG004|Overall Study|Screen Fail|0|||
126746875|NCT03657576|456023518|FG005|Overall Study|Screen Fail|5|||
126746876|NCT03657576|456023513|FG000|Overall Study|Disease Progression|1|||
126746877|NCT03657576|456023514|FG001|Overall Study|Disease Progression|1|||
126746878|NCT03657576|456023515|FG002|Overall Study|Disease Progression|0|||
126746879|NCT03657576|456023516|FG003|Overall Study|Disease Progression|5|||
126746880|NCT03657576|456023517|FG004|Overall Study|Disease Progression|0|||
126782233|NCT01333033|456158129|FG003|Overall Study|Withdrawal by Subject|0|||
126621140|NCT02971683|455568541|FG001|Open-Label|Participant request to discontinue study treatment|0|||
126621141|NCT02971683|455568540|FG000|Open-Label|Lack of Efficacy|2|||
126621142|NCT02971683|455568541|FG001|Open-Label|Lack of Efficacy|0|||
126621143|NCT02971683|455568540|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
126621144|NCT02971683|455568541|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
126621145|NCT02971683|455568540|FG000|Long-Term Open Label|Participant withdrew consent|1|||
126621146|NCT02971683|455568541|FG001|Long-Term Open Label|Participant withdrew consent|0|||
126621147|NCT02971683|455568540|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
126621148|NCT02971683|455568541|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
126621149|NCT02971683|455568540|FG000|Long-Term Open Label|Adverse Event|1|||
126621150|NCT02971683|455568541|FG001|Long-Term Open Label|Adverse Event|2|||
126621151|NCT02971683|455568540|FG000|Long-Term Open Label|Lack of Efficacy|1|||
126621152|NCT02971683|455568541|FG001|Long-Term Open Label|Lack of Efficacy|1|||
126621153|NCT02130401|455568551|FG000|Overall Study|Poor enrollment|6|||
126621154|NCT00936065|455568552|FG000|Overall Study|Adverse Event|1|||
126621155|NCT00936065|455568553|FG001|Overall Study|Adverse Event|0|||
126621156|NCT00936065|455568554|FG002|Overall Study|Adverse Event|1|||
126621157|NCT00936065|455568552|FG000|Overall Study|Lack of Efficacy|1|||
126621158|NCT00936065|455568553|FG001|Overall Study|Lack of Efficacy|0|||
126621159|NCT00936065|455568554|FG002|Overall Study|Lack of Efficacy|1|||
126621160|NCT00936065|455568552|FG000|Overall Study|Lost to Follow-up|1|||
126621161|NCT00936065|455568553|FG001|Overall Study|Lost to Follow-up|0|||
126621162|NCT00936065|455568554|FG002|Overall Study|Lost to Follow-up|0|||
126621163|NCT00936065|455568552|FG000|Overall Study|Protocol Violation|1|||
126621164|NCT00936065|455568553|FG001|Overall Study|Protocol Violation|2|||
126621165|NCT00936065|455568554|FG002|Overall Study|Protocol Violation|1|||
126621166|NCT00936065|455568552|FG000|Overall Study|Withdrawal by Subject|0|||
126621167|NCT00936065|455568553|FG001|Overall Study|Withdrawal by Subject|2|||
126621168|NCT00936065|455568554|FG002|Overall Study|Withdrawal by Subject|4|||
126621169|NCT02389894|455568555|FG000|Overall Study|Death|4|||
126621170|NCT02389894|455568556|FG001|Overall Study|Death|5|||
126621171|NCT02389894|455568557|FG002|Overall Study|Death|3|||
126621172|NCT02389894|455568555|FG000|Overall Study|Withdrawal by Subject|2|||
126621173|NCT02389894|455568556|FG001|Overall Study|Withdrawal by Subject|4|||
126621174|NCT02389894|455568557|FG002|Overall Study|Withdrawal by Subject|5|||
126621175|NCT02389894|455568555|FG000|Overall Study|Lost to Follow-up|2|||
126621176|NCT02389894|455568556|FG001|Overall Study|Lost to Follow-up|1|||
126621177|NCT02389894|455568557|FG002|Overall Study|Lost to Follow-up|1|||
126621178|NCT00145496|455568558|FG000|Overall Study|Adverse Event|42|||
126621179|NCT00145496|455568559|FG001|Overall Study|Adverse Event|30|||
126621180|NCT00145496|455568558|FG000|Overall Study|Lack of Efficacy|12|||
126621181|NCT00145496|455568559|FG001|Overall Study|Lack of Efficacy|7|||
126621182|NCT00145496|455568558|FG000|Overall Study|Withdrawal by Subject|32|||
126621183|NCT00145496|455568559|FG001|Overall Study|Withdrawal by Subject|26|||
126621184|NCT00145496|455568558|FG000|Overall Study|Lost to Follow-up|12|||
126621185|NCT00145496|455568559|FG001|Overall Study|Lost to Follow-up|5|||
126621186|NCT00145496|455568558|FG000|Overall Study|Other|25|||
126621187|NCT00145496|455568559|FG001|Overall Study|Other|13|||
126621188|NCT01052714|455568560|FG000|Overall Study|Adverse Event|6|||
126621189|NCT01052714|455568561|FG001|Overall Study|Adverse Event|3|||
126782234|NCT01333033|456158130|FG004|Overall Study|Withdrawal by Subject|4|||
126782235|NCT01333033|456158131|FG005|Overall Study|Withdrawal by Subject|2|||
126621190|NCT01052714|455568562|FG002|Overall Study|Adverse Event|0|||
126621191|NCT01052714|455568560|FG000|Overall Study|Death|1|||
126621192|NCT01052714|455568561|FG001|Overall Study|Death|2|||
126621193|NCT01052714|455568562|FG002|Overall Study|Death|0|||
126621194|NCT01052714|455568560|FG000|Overall Study|Lost to Follow-up|2|||
126621195|NCT01052714|455568561|FG001|Overall Study|Lost to Follow-up|3|||
126621196|NCT01052714|455568562|FG002|Overall Study|Lost to Follow-up|0|||
126621197|NCT01052714|455568560|FG000|Overall Study|Physician Decision|9|||
126621198|NCT01052714|455568561|FG001|Overall Study|Physician Decision|9|||
126746881|NCT03657576|456023518|FG005|Overall Study|Disease Progression|0|||
126746882|NCT03657576|456023513|FG000|Overall Study|Insurance Coverage|0|||
126746883|NCT03657576|456023514|FG001|Overall Study|Insurance Coverage|0|||
126746884|NCT03657576|456023515|FG002|Overall Study|Insurance Coverage|0|||
126746885|NCT03657576|456023516|FG003|Overall Study|Insurance Coverage|1|||
126746886|NCT03657576|456023517|FG004|Overall Study|Insurance Coverage|0|||
126746887|NCT03657576|456023518|FG005|Overall Study|Insurance Coverage|0|||
126746888|NCT04284787|456023521|FG000|Overall Study|Disease Progression|9|||
126746889|NCT04284787|456023522|FG001|Overall Study|Disease Progression|12|||
126746890|NCT04284787|456023521|FG000|Overall Study|Physician Decision|12|||
126746891|NCT04284787|456023522|FG001|Overall Study|Physician Decision|7|||
126746892|NCT04284787|456023521|FG000|Overall Study|Transplant|5|||
126746893|NCT04284787|456023522|FG001|Overall Study|Transplant|4|||
126746894|NCT04284787|456023521|FG000|Overall Study|Death|1|||
126746895|NCT04284787|456023522|FG001|Overall Study|Death|2|||
126746896|NCT04284787|456023521|FG000|Overall Study|Adverse Event|0|||
126746897|NCT04284787|456023522|FG001|Overall Study|Adverse Event|4|||
126746898|NCT04284787|456023521|FG000|Overall Study|Non-adherence|2|||
126746899|NCT04284787|456023522|FG001|Overall Study|Non-adherence|0|||
126746900|NCT04284787|456023521|FG000|Overall Study|Lack of Efficacy|2|||
126621199|NCT01052714|455568562|FG002|Overall Study|Physician Decision|1|||
126621200|NCT01052714|455568560|FG000|Overall Study|Withdrawal by Subject|7|||
126621201|NCT01052714|455568561|FG001|Overall Study|Withdrawal by Subject|12|||
126621202|NCT01052714|455568562|FG002|Overall Study|Withdrawal by Subject|1|||
126621203|NCT00267865|455568565|FG000|Induction Treatment|Died before completing.|2|||
126621204|NCT00267865|455568565|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
126621205|NCT03686176|455568566|FG000|Overall Study|Procedure cancelled|1|||
126621206|NCT03686176|455568567|FG001|Overall Study|Procedure cancelled|0|||
126621207|NCT03686176|455568568|FG002|Overall Study|Procedure cancelled|0|||
126621208|NCT03686176|455568566|FG000|Overall Study|VR Malfunction|1|||
126621209|NCT03686176|455568567|FG001|Overall Study|VR Malfunction|0|||
126621210|NCT03686176|455568568|FG002|Overall Study|VR Malfunction|0|||
126621211|NCT01636778|455568571|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
126621212|NCT01636778|455568572|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
126621213|NCT01636778|455568573|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
126621214|NCT01636778|455568571|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
126621215|NCT01636778|455568572|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
126621216|NCT01636778|455568573|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
126621217|NCT01636778|455568571|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
126621218|NCT01636778|455568572|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
126621219|NCT01636778|455568573|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
126621220|NCT01636778|455568571|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
126621221|NCT01636778|455568572|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
126621222|NCT01636778|455568573|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
126621223|NCT01636778|455568571|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
126621224|NCT01636778|455568572|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
126621225|NCT01636778|455568573|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
126621226|NCT01636778|455568571|FG000|Follow-up Period After Part 2|Other|0|||
126621227|NCT01636778|455568572|FG001|Follow-up Period After Part 2|Other|0|||
126621228|NCT01636778|455568573|FG002|Follow-up Period After Part 2|Other|1|||
126621229|NCT01636778|455568571|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
126621230|NCT01636778|455568572|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
126621231|NCT01636778|455568573|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
126621232|NCT01636778|455568571|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
126621233|NCT01636778|455568572|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
126621234|NCT01636778|455568573|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
126621235|NCT03530345|455568582|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
126621236|NCT03530345|455568583|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
126621237|NCT03530345|455568582|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
126621238|NCT03530345|455568583|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
126621239|NCT03530345|455568582|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
126621240|NCT03530345|455568583|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
126621241|NCT03530345|455568582|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
126621242|NCT03530345|455568583|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
126621243|NCT02661490|455570592|FG000|Overall Study|Lost to Follow-up|0|||
126621244|NCT02661490|455570593|FG001|Overall Study|Lost to Follow-up|1|||
126621245|NCT02661490|455570594|FG002|Overall Study|Lost to Follow-up|0|||
126621246|NCT02661490|455570595|FG003|Overall Study|Lost to Follow-up|0|||
126621247|NCT02661490|455570596|FG004|Overall Study|Lost to Follow-up|2|||
126746901|NCT04284787|456023522|FG001|Overall Study|Lack of Efficacy|0|||
126746902|NCT01874353|456023523|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
126746903|NCT01874353|456023524|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
126746904|NCT01874353|456023525|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
126621248|NCT02661490|455570592|FG000|Overall Study|Withdrawal by Subject|2|||
126621249|NCT02661490|455570593|FG001|Overall Study|Withdrawal by Subject|0|||
126621250|NCT02661490|455570594|FG002|Overall Study|Withdrawal by Subject|2|||
126621251|NCT02661490|455570595|FG003|Overall Study|Withdrawal by Subject|0|||
126621252|NCT02661490|455570596|FG004|Overall Study|Withdrawal by Subject|0|||
126621253|NCT02661490|455570592|FG000|Overall Study|Death|1|||
126621254|NCT02661490|455570593|FG001|Overall Study|Death|1|||
126621255|NCT02661490|455570594|FG002|Overall Study|Death|0|||
126621256|NCT02661490|455570595|FG003|Overall Study|Death|1|||
126621257|NCT02661490|455570596|FG004|Overall Study|Death|0|||
126621258|NCT02661490|455570592|FG000|Overall Study|Reason not Specified|0|||
126621259|NCT02661490|455570593|FG001|Overall Study|Reason not Specified|0|||
126621260|NCT02661490|455570594|FG002|Overall Study|Reason not Specified|0|||
126621261|NCT02661490|455570595|FG003|Overall Study|Reason not Specified|0|||
126621262|NCT02661490|455570596|FG004|Overall Study|Reason not Specified|1|||
126621263|NCT00644332|455570597|FG000|Overall Study|Adverse Event|11|||
126621264|NCT00644332|455570597|FG000|Overall Study|Withdrawal by Subject|6|||
126621265|NCT00644332|455570597|FG000|Overall Study|Completion Status Unknown|2|||
126621266|NCT00644332|455570597|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
126621267|NCT00644332|455570597|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
126621268|NCT02706834|455570601|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126621269|NCT02706834|455570602|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
126621270|NCT02706834|455570603|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
126621271|NCT02706834|455570604|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
126621272|NCT02706834|455570605|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
126621273|NCT02706834|455570606|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
126621274|NCT02706834|455570607|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
126621275|NCT02706834|455570608|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
126621276|NCT02706834|455570609|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
126621277|NCT02706834|455570610|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
126621278|NCT02706834|455570611|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
126621279|NCT02706834|455570601|FG000|Overall Study|Lost to Follow-up|0|||
126621280|NCT02706834|455570602|FG001|Overall Study|Lost to Follow-up|0|||
126621281|NCT02706834|455570603|FG002|Overall Study|Lost to Follow-up|1|||
126621282|NCT02706834|455570604|FG003|Overall Study|Lost to Follow-up|0|||
126621283|NCT02706834|455570605|FG004|Overall Study|Lost to Follow-up|0|||
126621284|NCT02706834|455570606|FG005|Overall Study|Lost to Follow-up|0|||
126621285|NCT02706834|455570607|FG006|Overall Study|Lost to Follow-up|0|||
126621286|NCT02706834|455570608|FG007|Overall Study|Lost to Follow-up|0|||
126621287|NCT02706834|455570609|FG008|Overall Study|Lost to Follow-up|0|||
126621288|NCT02706834|455570610|FG009|Overall Study|Lost to Follow-up|0|||
126621289|NCT02706834|455570611|FG010|Overall Study|Lost to Follow-up|0|||
126621290|NCT02706834|455570601|FG000|Overall Study|Voluntary Withdrawal|1|||
126621291|NCT02706834|455570602|FG001|Overall Study|Voluntary Withdrawal|0|||
126621292|NCT02706834|455570603|FG002|Overall Study|Voluntary Withdrawal|0|||
126621293|NCT02706834|455570604|FG003|Overall Study|Voluntary Withdrawal|0|||
126621294|NCT02706834|455570605|FG004|Overall Study|Voluntary Withdrawal|0|||
126621295|NCT02706834|455570606|FG005|Overall Study|Voluntary Withdrawal|0|||
126621296|NCT02706834|455570607|FG006|Overall Study|Voluntary Withdrawal|0|||
126621297|NCT02706834|455570608|FG007|Overall Study|Voluntary Withdrawal|0|||
126621298|NCT02706834|455570609|FG008|Overall Study|Voluntary Withdrawal|0|||
126621299|NCT02706834|455570610|FG009|Overall Study|Voluntary Withdrawal|1|||
126621300|NCT02706834|455570611|FG010|Overall Study|Voluntary Withdrawal|0|||
126621301|NCT02706834|455570601|FG000|Overall Study|Other Reason Not Specified|1|||
126621302|NCT02706834|455570602|FG001|Overall Study|Other Reason Not Specified|0|||
126621303|NCT02706834|455570603|FG002|Overall Study|Other Reason Not Specified|0|||
126621304|NCT02706834|455570604|FG003|Overall Study|Other Reason Not Specified|0|||
126621305|NCT02706834|455570605|FG004|Overall Study|Other Reason Not Specified|1|||
126621306|NCT02706834|455570606|FG005|Overall Study|Other Reason Not Specified|0|||
126621307|NCT02706834|455570607|FG006|Overall Study|Other Reason Not Specified|0|||
126621308|NCT02706834|455570608|FG007|Overall Study|Other Reason Not Specified|0|||
126621309|NCT02706834|455570609|FG008|Overall Study|Other Reason Not Specified|0|||
126621310|NCT02706834|455570610|FG009|Overall Study|Other Reason Not Specified|0|||
126621311|NCT02706834|455570611|FG010|Overall Study|Other Reason Not Specified|0|||
126621312|NCT00627523|455570615|FG000|Overall Study|Lack of Efficacy|1|||
126621313|NCT00627523|455570616|FG001|Overall Study|Lack of Efficacy|0|||
126621314|NCT00627523|455570615|FG000|Overall Study|Withdrawal by Subject|0|||
126621315|NCT00627523|455570616|FG001|Overall Study|Withdrawal by Subject|2|||
126621316|NCT00627523|455570615|FG000|Overall Study|Other|1|||
126621317|NCT00627523|455570616|FG001|Overall Study|Other|0|||
126621318|NCT03451292|455570617|FG000|Overall Study|Death|44|||
126621319|NCT03451292|455570618|FG001|Overall Study|Death|59|||
126621320|NCT03451292|455570617|FG000|Overall Study|Withdrawal by Subject|18|||
126621321|NCT03451292|455570618|FG001|Overall Study|Withdrawal by Subject|13|||
126621322|NCT03451292|455570617|FG000|Overall Study|Transplantation|18|||
126621323|NCT03451292|455570618|FG001|Overall Study|Transplantation|12|||
126621324|NCT03451292|455570617|FG000|Overall Study|Lost to Follow-up|4|||
126746905|NCT01874353|456023526|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
126746906|NCT01874353|456023523|FG000|Overall Study|Lost to Follow-up|2|||
126746907|NCT01874353|456023524|FG001|Overall Study|Lost to Follow-up|2|||
126746908|NCT01874353|456023525|FG002|Overall Study|Lost to Follow-up|2|||
126746909|NCT01874353|456023526|FG003|Overall Study|Lost to Follow-up|0|||
126746910|NCT01874353|456023523|FG000|Overall Study|Death|110|||
126746911|NCT01874353|456023524|FG001|Overall Study|Death|60|||
126746912|NCT01874353|456023525|FG002|Overall Study|Death|13|||
126746913|NCT01874353|456023526|FG003|Overall Study|Death|7|||
126746914|NCT01874353|456023523|FG000|Overall Study|Withdrawal by Subject|13|||
126746915|NCT01874353|456023524|FG001|Overall Study|Withdrawal by Subject|11|||
126746916|NCT01874353|456023525|FG002|Overall Study|Withdrawal by Subject|0|||
126746917|NCT01874353|456023526|FG003|Overall Study|Withdrawal by Subject|0|||
126746918|NCT04392154|456023527|FG000|Overall Study|Adverse Event|3|||
126746919|NCT04392154|456023528|FG001|Overall Study|Adverse Event|46|||
126746920|NCT04392154|456023527|FG000|Overall Study|Due to epidemic/pandemic|0|||
126746921|NCT04392154|456023528|FG001|Overall Study|Due to epidemic/pandemic|1|||
126746922|NCT04392154|456023527|FG000|Overall Study|Lack of Efficacy|1|||
126746923|NCT04392154|456023528|FG001|Overall Study|Lack of Efficacy|47|||
126746924|NCT04392154|456023527|FG000|Overall Study|Lost to Follow-up|11|||
126746925|NCT04392154|456023528|FG001|Overall Study|Lost to Follow-up|61|||
126746926|NCT04392154|456023527|FG000|Overall Study|Geopolitical conflict|1|||
126746927|NCT04392154|456023528|FG001|Overall Study|Geopolitical conflict|1|||
126746928|NCT04392154|456023527|FG000|Overall Study|Physician Decision|1|||
126746929|NCT04392154|456023528|FG001|Overall Study|Physician Decision|5|||
126746930|NCT04392154|456023527|FG000|Overall Study|Pregnancy|1|||
126746931|NCT04392154|456023528|FG001|Overall Study|Pregnancy|8|||
126746932|NCT04392154|456023527|FG000|Overall Study|Protocol deviation|1|||
126746933|NCT04392154|456023528|FG001|Overall Study|Protocol deviation|12|||
126746934|NCT04392154|456023527|FG000|Overall Study|Withdrawal by Subject|18|||
126746935|NCT04392154|456023528|FG001|Overall Study|Withdrawal by Subject|138|||
126746936|NCT04392154|456023527|FG000|Overall Study|Sponsor Decision|1|||
126746937|NCT04392154|456023528|FG001|Overall Study|Sponsor Decision|14|||
126746938|NCT04392154|456023527|FG000|Overall Study|Site Closure|0|||
126746939|NCT04392154|456023528|FG001|Overall Study|Site Closure|4|||
126746940|NCT04992507|456023531|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
126746941|NCT04992507|456023532|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
126746942|NCT04992507|456023531|FG000|Overall Study|Death|0|||
126746943|NCT04992507|456023532|FG001|Overall Study|Death|1|||
126746944|NCT03774875|456023533|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
126746945|NCT03774875|456023534|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
126746946|NCT03774875|456023533|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
126746947|NCT03774875|456023534|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
126746948|NCT03774875|456023533|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
126746949|NCT03774875|456023534|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
126746950|NCT03774875|456023533|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
126746951|NCT03774875|456023534|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
126746952|NCT03774875|456023533|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
126746953|NCT03774875|456023534|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
126746954|NCT03774875|456023533|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
126746955|NCT03774875|456023534|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
126746956|NCT03774875|456023533|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
126746957|NCT03774875|456023534|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
126746958|NCT03774875|456023533|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
126746959|NCT03774875|456023534|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
126746960|NCT03774875|456023533|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
126782236|NCT01333033|456158126|FG000|Overall Study|PET inevaluable|0|||
126782237|NCT01333033|456158127|FG001|Overall Study|PET inevaluable|0|||
126782238|NCT01333033|456158128|FG002|Overall Study|PET inevaluable|0|||
126782239|NCT01333033|456158129|FG003|Overall Study|PET inevaluable|0|||
126782240|NCT01333033|456158130|FG004|Overall Study|PET inevaluable|2|||
126782241|NCT01333033|456158131|FG005|Overall Study|PET inevaluable|4|||
126782242|NCT01333033|456158126|FG000|Overall Study|Adverse Event|0|||
126621325|NCT03451292|455570618|FG001|Overall Study|Lost to Follow-up|12|||
126746961|NCT03774875|456023534|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
126746962|NCT03774875|456023533|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
126746963|NCT03774875|456023534|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
126746964|NCT03774875|456023533|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
126746965|NCT03774875|456023534|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
126746966|NCT03774875|456023533|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
126746967|NCT03774875|456023534|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
126746968|NCT03774875|456023533|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
126746969|NCT03774875|456023534|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
126746970|NCT03149029|456023537|FG000|Overall Study|Adverse Event|2|||
126746971|NCT03149029|456023538|FG001|Overall Study|Adverse Event|0|||
126746972|NCT03233308|456023539|FG000|Overall Study|Adverse Event|1|||
126746973|NCT03233308|456023539|FG000|Overall Study|Protocol Violation|1|||
126746974|NCT03287830|456023540|FG000|Overall Study|Withdrawal by Subject|1|||
126746975|NCT03287830|456023541|FG001|Overall Study|Withdrawal by Subject|1|||
126746976|NCT03287830|456023540|FG000|Overall Study|not meeting inclusion criteria|5|||
126746977|NCT03287830|456023541|FG001|Overall Study|not meeting inclusion criteria|12|||
126746978|NCT02974621|456023542|FG000|Overall Study|Didn't receive study treatment|1|||
126746979|NCT02974621|456023543|FG001|Overall Study|Didn't receive study treatment|10|||
126746980|NCT05016037|456023544|FG000|Overall Study|Lost to Follow-up|2|||
126746981|NCT00557323|456023550|FG000|Overall Study|Death|3|||
126746982|NCT00557323|456023550|FG000|Overall Study|Withdrawal by Subject|2|||
126746983|NCT00557323|456023550|FG000|Overall Study|Administrative change|2|||
126746984|NCT01196091|456023553|FG000|Overall Study|Adverse Event|22|||
126746985|NCT01196091|456023554|FG001|Overall Study|Adverse Event|27|||
126746986|NCT01196091|456023555|FG002|Overall Study|Adverse Event|26|||
126746987|NCT01196091|456023553|FG000|Overall Study|Death|3|||
126746988|NCT01196091|456023554|FG001|Overall Study|Death|2|||
126746989|NCT01196091|456023555|FG002|Overall Study|Death|2|||
126746990|NCT01196091|456023553|FG000|Overall Study|Entry Criteria Not Met|11|||
126746991|NCT01196091|456023554|FG001|Overall Study|Entry Criteria Not Met|11|||
126746992|NCT01196091|456023555|FG002|Overall Study|Entry Criteria Not Met|10|||
126746993|NCT01196091|456023553|FG000|Overall Study|Lack of Efficacy|15|||
126746994|NCT01196091|456023554|FG001|Overall Study|Lack of Efficacy|12|||
126746995|NCT01196091|456023555|FG002|Overall Study|Lack of Efficacy|17|||
126746996|NCT01196091|456023553|FG000|Overall Study|Lost to Follow-up|5|||
126746997|NCT01196091|456023554|FG001|Overall Study|Lost to Follow-up|5|||
126746998|NCT01196091|456023555|FG002|Overall Study|Lost to Follow-up|6|||
126746999|NCT01196091|456023553|FG000|Overall Study|Parent/Caregiver Decision|0|||
126747000|NCT01196091|456023554|FG001|Overall Study|Parent/Caregiver Decision|0|||
126747001|NCT01196091|456023555|FG002|Overall Study|Parent/Caregiver Decision|1|||
126747002|NCT01196091|456023553|FG000|Overall Study|Withdrawal by Subject|16|||
126747003|NCT01196091|456023554|FG001|Overall Study|Withdrawal by Subject|19|||
126747004|NCT01196091|456023555|FG002|Overall Study|Withdrawal by Subject|22|||
126747005|NCT01196091|456023553|FG000|Overall Study|Physician Decision|3|||
126747006|NCT01196091|456023554|FG001|Overall Study|Physician Decision|3|||
126747007|NCT01196091|456023555|FG002|Overall Study|Physician Decision|4|||
126747008|NCT01196091|456023553|FG000|Overall Study|Protocol Violation|1|||
126747009|NCT01196091|456023554|FG001|Overall Study|Protocol Violation|3|||
126747010|NCT01196091|456023555|FG002|Overall Study|Protocol Violation|3|||
126747011|NCT01196091|456023553|FG000|Overall Study|Sponsor Decision|6|||
126747012|NCT01196091|456023554|FG001|Overall Study|Sponsor Decision|5|||
126747013|NCT01196091|456023555|FG002|Overall Study|Sponsor Decision|4|||
126747014|NCT01196091|456023553|FG000|Overall Study|Excluded Site|5|||
126747015|NCT01196091|456023554|FG001|Overall Study|Excluded Site|11|||
126747016|NCT01196091|456023555|FG002|Overall Study|Excluded Site|8|||
126747017|NCT01196091|456023553|FG000|Overall Study|Randomized, No Study Drug Received|1|||
126747018|NCT01196091|456023554|FG001|Overall Study|Randomized, No Study Drug Received|0|||
126747019|NCT01196091|456023555|FG002|Overall Study|Randomized, No Study Drug Received|1|||
126747020|NCT03797144|456023556|FG000|Enrollment|Protocol Violation|4|||
126747021|NCT03797144|456023557|FG001|Enrollment|Protocol Violation|1|||
126747022|NCT03797144|456023556|FG000|Surgery|Protocol Violation|1|||
126747023|NCT03797144|456023557|FG001|Surgery|Protocol Violation|0|||
126747024|NCT03797144|456023556|FG000|3 Month|Early termination cut-off date|2|||
126747025|NCT03797144|456023557|FG001|3 Month|Early termination cut-off date|0|||
126747026|NCT03797144|456023556|FG000|12 Month|Early termination cut-off date|8|||
126747027|NCT03797144|456023557|FG001|12 Month|Early termination cut-off date|9|||
126747028|NCT03797144|456023556|FG000|24 Month|Early termination cut-off date|1|||
126747029|NCT03797144|456023557|FG001|24 Month|Early termination cut-off date|1|||
126747030|NCT03077711|456023558|FG000|Overall Study|Lost to Follow-up|2|||
126747031|NCT03077711|456023559|FG001|Overall Study|Lost to Follow-up|2|||
126747032|NCT03077711|456023558|FG000|Overall Study|noncompliant taking medication|2|||
126747033|NCT03077711|456023559|FG001|Overall Study|noncompliant taking medication|0|||
126747034|NCT00376675|456023560|FG000|Overall Study|Withdrawal by Subject|9|||
126747035|NCT00376675|456023561|FG001|Overall Study|Withdrawal by Subject|2|||
126747036|NCT00376675|456023560|FG000|Overall Study|Adverse Event|10|||
126747037|NCT00376675|456023561|FG001|Overall Study|Adverse Event|5|||
126747038|NCT00376675|456023560|FG000|Overall Study|Other Reason|1|||
126747039|NCT00376675|456023561|FG001|Overall Study|Other Reason|7|||
126747040|NCT02943668|456023563|FG000|Overall Study|Disease Progression|1|||
126747041|NCT02201251|456023564|FG000|Overall Study|Adverse Event|1|||
126747042|NCT02201251|456023565|FG001|Overall Study|Adverse Event|1|||
126747043|NCT02201251|456023564|FG000|Overall Study|Protocol Violation|1|||
126747044|NCT02201251|456023565|FG001|Overall Study|Protocol Violation|0|||
126747045|NCT02201251|456023564|FG000|Overall Study|Noncompliance with Study Drug|0|||
126747046|NCT02201251|456023565|FG001|Overall Study|Noncompliance with Study Drug|1|||
126621326|NCT03451292|455570617|FG000|Overall Study|Physician Decision|4|||
126621327|NCT03451292|455570618|FG001|Overall Study|Physician Decision|3|||
126621328|NCT03451292|455570617|FG000|Overall Study|Adverse Event|3|||
126621329|NCT03451292|455570618|FG001|Overall Study|Adverse Event|3|||
126621330|NCT03451292|455570617|FG000|Overall Study|Non-compliance with Study Drug|2|||
126621331|NCT03451292|455570618|FG001|Overall Study|Non-compliance with Study Drug|0|||
126621332|NCT00355784|455570622|FG000|Overall Study|Withdrawal by Subject|0|||
126621333|NCT00355784|455570623|FG001|Overall Study|Withdrawal by Subject|0|||
126621334|NCT00355784|455570624|FG002|Overall Study|Withdrawal by Subject|2|||
126621335|NCT02543294|455570625|FG000|Overall Study|Lost to Follow-up|3|||
126621336|NCT02543294|455570625|FG000|Overall Study|Physician Decision|2|||
126621337|NCT02543294|455570625|FG000|Overall Study|Withdrawal by Subject|7|||
126621338|NCT03602053|455570629|FG000|Overall Study|Withdrawal by Subject|7|||
126621339|NCT03602053|455570630|FG001|Overall Study|Withdrawal by Subject|9|||
126621340|NCT03602053|455570631|FG002|Overall Study|Withdrawal by Subject|7|||
126621341|NCT03602053|455570629|FG000|Overall Study|Lost to Follow-up|5|||
126621342|NCT03602053|455570630|FG001|Overall Study|Lost to Follow-up|6|||
126621343|NCT03602053|455570631|FG002|Overall Study|Lost to Follow-up|0|||
126621344|NCT03602053|455570629|FG000|Overall Study|Protocol Violation|3|||
126621345|NCT03602053|455570630|FG001|Overall Study|Protocol Violation|0|||
126621346|NCT03602053|455570631|FG002|Overall Study|Protocol Violation|4|||
126621347|NCT03602053|455570629|FG000|Overall Study|Physician Decision|1|||
126621348|NCT03602053|455570630|FG001|Overall Study|Physician Decision|0|||
126621349|NCT03602053|455570631|FG002|Overall Study|Physician Decision|0|||
126621350|NCT03602053|455570629|FG000|Overall Study|migration|2|||
126621351|NCT03602053|455570630|FG001|Overall Study|migration|3|||
126621352|NCT03602053|455570631|FG002|Overall Study|migration|0|||
126621353|NCT03602053|455570629|FG000|Overall Study|Other|1|||
126621354|NCT03602053|455570630|FG001|Overall Study|Other|0|||
126621355|NCT03602053|455570631|FG002|Overall Study|Other|0|||
126621356|NCT01038128|455570632|FG000|Overall Study|Lack of Efficacy|1|||
126621357|NCT01038128|455570632|FG000|Overall Study|Lost to Follow-up|1|||
126621358|NCT01038128|455570632|FG000|Overall Study|Withdrawal by Subject|2|||
126621359|NCT00396409|455570639|FG000|Period 1 - 2007|Adverse Event|0|||
126621360|NCT00396409|455570640|FG001|Period 1 - 2007|Adverse Event|1|||
126621361|NCT00396409|455570639|FG000|Period 1 - 2007|Lack of Efficacy|0|||
126621362|NCT00396409|455570640|FG001|Period 1 - 2007|Lack of Efficacy|1|||
126621363|NCT00396409|455570639|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
126621364|NCT00396409|455570640|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
126621365|NCT00396409|455570639|FG000|Period 1 - 2007|Lost to Follow-up|2|||
126621366|NCT00396409|455570640|FG001|Period 1 - 2007|Lost to Follow-up|3|||
126621367|NCT00396409|455570639|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
126621368|NCT00396409|455570640|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
126621369|NCT00396409|455570639|FG000|Period 2 - 2008|Protocol Violation|1|||
126621370|NCT00396409|455570640|FG001|Period 2 - 2008|Protocol Violation|0|||
126621371|NCT00396409|455570639|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
126621372|NCT00396409|455570640|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
126621373|NCT00396409|455570639|FG000|Period 2 - 2008|Lost to Follow-up|3|||
126621374|NCT00396409|455570640|FG001|Period 2 - 2008|Lost to Follow-up|1|||
126621375|NCT04203199|455570643|FG000|First Intervention Period|Lost to Follow-up|0|||
126621376|NCT04203199|455570644|FG001|First Intervention Period|Lost to Follow-up|1|||
126621377|NCT04203199|455570643|FG000|Second Intervention Period|Medication change|1|||
126621378|NCT04203199|455570644|FG001|Second Intervention Period|Medication change|0|||
126621379|NCT01745380|455570645|FG000|Overall Study|Lost to Follow-up|1|||
126621380|NCT01745380|455570646|FG001|Overall Study|Lost to Follow-up|0|||
126621381|NCT01745380|455570645|FG000|Overall Study|Lack of Efficacy|0|||
126621382|NCT01745380|455570646|FG001|Overall Study|Lack of Efficacy|1|||
126621383|NCT01882088|455570647|FG000|Overall Study|Intolerance of esophageal manometry|1|||
126621384|NCT01882088|455570647|FG000|Overall Study|no possibility to place the catheter|1|||
126621385|NCT01882088|455570647|FG000|Overall Study|Protocol Violation|1|||
126621386|NCT01882088|455570647|FG000|Overall Study|inadequate pH-impedance tracings|2|||
126621387|NCT01193283|455570648|FG000|Overall Study|Death|1|||
126621388|NCT00168805|455570652|FG000|Overall Study|Adverse Event|7|||
126621389|NCT00168805|455570653|FG001|Overall Study|Adverse Event|11|||
126621390|NCT00168805|455570654|FG002|Overall Study|Adverse Event|16|||
126621391|NCT00168805|455570652|FG000|Overall Study|Protocol Violation|12|||
126621392|NCT00168805|455570653|FG001|Overall Study|Protocol Violation|11|||
126621393|NCT00168805|455570654|FG002|Overall Study|Protocol Violation|8|||
126621394|NCT00168805|455570652|FG000|Overall Study|Lost to Follow-up|12|||
126621395|NCT00168805|455570653|FG001|Overall Study|Lost to Follow-up|17|||
126621396|NCT00168805|455570654|FG002|Overall Study|Lost to Follow-up|11|||
126782243|NCT01333033|456158127|FG001|Overall Study|Adverse Event|0|||
126621397|NCT00168805|455570652|FG000|Overall Study|Withdrawal by Subject|16|||
126621398|NCT00168805|455570653|FG001|Overall Study|Withdrawal by Subject|18|||
126621399|NCT00168805|455570654|FG002|Overall Study|Withdrawal by Subject|21|||
126621400|NCT00168805|455570652|FG000|Overall Study|Other|24|||
126621401|NCT00168805|455570653|FG001|Overall Study|Other|21|||
126621402|NCT00168805|455570654|FG002|Overall Study|Other|22|||
126621403|NCT00168805|455570652|FG000|Treatment|Adverse Event|25|||
126621404|NCT00168805|455570653|FG001|Treatment|Adverse Event|26|||
126621405|NCT00168805|455570654|FG002|Treatment|Adverse Event|32|||
126621406|NCT00168805|455570652|FG000|Treatment|Protocol Violation|3|||
126621407|NCT00168805|455570653|FG001|Treatment|Protocol Violation|5|||
126621408|NCT00168805|455570654|FG002|Treatment|Protocol Violation|5|||
126621409|NCT00168805|455570652|FG000|Treatment|Withdrawal by Subject|3|||
126621410|NCT00168805|455570653|FG001|Treatment|Withdrawal by Subject|7|||
126621411|NCT00168805|455570654|FG002|Treatment|Withdrawal by Subject|8|||
126621412|NCT00168805|455570652|FG000|Treatment|Other|18|||
126621413|NCT00168805|455570653|FG001|Treatment|Other|18|||
126621414|NCT00168805|455570654|FG002|Treatment|Other|17|||
126621415|NCT04879823|455570655|FG000|Overall Study|Physician Decision|3|||
126621416|NCT04879823|455570656|FG001|Overall Study|Physician Decision|1|||
126621417|NCT04879823|455570655|FG000|Overall Study|Protocol Violation|2|||
126621418|NCT04879823|455570656|FG001|Overall Study|Protocol Violation|3|||
126621419|NCT04879823|455570655|FG000|Overall Study|Lost to Follow-up|43|||
126621420|NCT04879823|455570656|FG001|Overall Study|Lost to Follow-up|35|||
126621421|NCT04468633|455570659|FG000|Overall Study|Withdrawal by Subject|4|||
126621422|NCT04468633|455570660|FG001|Overall Study|Withdrawal by Subject|0|||
126621423|NCT00460434|455570663|FG000|Overall Study|Lost to Follow-up|3|||
126621424|NCT00460434|455570664|FG001|Overall Study|Lost to Follow-up|7|||
126621425|NCT00472199|455570687|FG000|Overall Study|Adverse Event|19|||
126621426|NCT00472199|455570688|FG001|Overall Study|Adverse Event|23|||
126621427|NCT00472199|455570687|FG000|Overall Study|Lack of Efficacy|4|||
126621428|NCT00472199|455570688|FG001|Overall Study|Lack of Efficacy|25|||
126621429|NCT00472199|455570687|FG000|Overall Study|Lost to Follow-up|2|||
126621430|NCT00472199|455570688|FG001|Overall Study|Lost to Follow-up|4|||
126621431|NCT00472199|455570687|FG000|Overall Study|Protocol Violation|3|||
126621432|NCT00472199|455570688|FG001|Overall Study|Protocol Violation|2|||
126621433|NCT00472199|455570687|FG000|Overall Study|Withdrawal by Subject|6|||
126621434|NCT00472199|455570688|FG001|Overall Study|Withdrawal by Subject|5|||
126621435|NCT00472199|455570687|FG000|Overall Study|personal reason|0|||
126621436|NCT00472199|455570688|FG001|Overall Study|personal reason|1|||
126621437|NCT00472199|455570687|FG000|Overall Study|patient was asymptomatic|1|||
126621438|NCT00472199|455570688|FG001|Overall Study|patient was asymptomatic|0|||
126621439|NCT02446912|455570690|FG000|Overall Study|Adverse Event|3|||
126621440|NCT02446912|455570691|FG001|Overall Study|Adverse Event|13|||
126621441|NCT02446912|455570692|FG002|Overall Study|Adverse Event|5|||
126621442|NCT02446912|455570690|FG000|Overall Study|Condition under investigation worsened|0|||
126621443|NCT02446912|455570691|FG001|Overall Study|Condition under investigation worsened|1|||
126621444|NCT02446912|455570692|FG002|Overall Study|Condition under investigation worsened|1|||
126621445|NCT02446912|455570690|FG000|Overall Study|Study-specific withdrawal criteria|1|||
126621446|NCT02446912|455570691|FG001|Overall Study|Study-specific withdrawal criteria|0|||
126621447|NCT02446912|455570692|FG002|Overall Study|Study-specific withdrawal criteria|0|||
126621448|NCT02446912|455570690|FG000|Overall Study|Lack of Efficacy|1|||
126621449|NCT02446912|455570691|FG001|Overall Study|Lack of Efficacy|4|||
126621450|NCT02446912|455570692|FG002|Overall Study|Lack of Efficacy|7|||
126621451|NCT02446912|455570690|FG000|Overall Study|Lost to Follow-up|0|||
126621452|NCT02446912|455570691|FG001|Overall Study|Lost to Follow-up|0|||
126621453|NCT02446912|455570692|FG002|Overall Study|Lost to Follow-up|2|||
126621454|NCT02446912|455570690|FG000|Overall Study|Severe non-compliance to protocol|1|||
126621455|NCT02446912|455570691|FG001|Overall Study|Severe non-compliance to protocol|0|||
126621456|NCT02446912|455570692|FG002|Overall Study|Severe non-compliance to protocol|1|||
126621457|NCT02446912|455570690|FG000|Overall Study|Withdrawal by Subject|10|||
126621458|NCT02446912|455570691|FG001|Overall Study|Withdrawal by Subject|15|||
126621459|NCT02446912|455570692|FG002|Overall Study|Withdrawal by Subject|15|||
126621460|NCT02446912|455570690|FG000|Overall Study|Miscellaneous|2|||
126621461|NCT02446912|455570691|FG001|Overall Study|Miscellaneous|2|||
126621462|NCT02446912|455570692|FG002|Overall Study|Miscellaneous|4|||
126621463|NCT01268488|455570693|FG000|Overall Study|Adverse Event|3|||
126621464|NCT01268488|455570693|FG000|Overall Study|Physician Decision|2|||
126621465|NCT00147745|455570696|FG000|Overall Study|Withdrawal by Subject|1|||
126747047|NCT02201251|456023564|FG000|Overall Study|Withdrawal by Subject|2|||
126747048|NCT02201251|456023565|FG001|Overall Study|Withdrawal by Subject|1|||
126621466|NCT00147745|455570697|FG001|Overall Study|Withdrawal by Subject|0|||
126621467|NCT00147745|455570698|FG002|Overall Study|Withdrawal by Subject|0|||
126621468|NCT02504502|455570699|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
126621469|NCT02504502|455570700|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
126621470|NCT02504502|455570699|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
126621471|NCT02504502|455570700|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
126621472|NCT00422162|455570704|FG000|Overall Study|Adverse Event|11|||
126621473|NCT00422162|455570705|FG001|Overall Study|Adverse Event|9|||
126621474|NCT00422162|455570704|FG000|Overall Study|Lack of Efficacy|4|||
126621475|NCT00422162|455570705|FG001|Overall Study|Lack of Efficacy|10|||
126621476|NCT00422162|455570704|FG000|Overall Study|Withdrawal by Subject|7|||
126621477|NCT00422162|455570705|FG001|Overall Study|Withdrawal by Subject|6|||
126621478|NCT00422162|455570704|FG000|Overall Study|Lost to Follow-up|1|||
126621479|NCT00422162|455570705|FG001|Overall Study|Lost to Follow-up|2|||
126747049|NCT01332851|456023566|FG000|Overall Study|Withdrawal by Subject|4|||
126747050|NCT01332851|456023567|FG001|Overall Study|Withdrawal by Subject|2|||
126747051|NCT01332851|456023566|FG000|Overall Study|Lost to Follow-up|7|||
126747052|NCT01332851|456023567|FG001|Overall Study|Lost to Follow-up|11|||
126747053|NCT00255008|456023568|FG000|Overall Study|Adverse Event|1|||
126747054|NCT00255008|456023569|FG001|Overall Study|Adverse Event|1|||
126747055|NCT00255008|456023570|FG002|Overall Study|Adverse Event|2|||
126747056|NCT00255008|456023571|FG003|Overall Study|Adverse Event|0|||
126747057|NCT00255008|456023568|FG000|Overall Study|Lost to Follow-up|1|||
126747058|NCT00255008|456023569|FG001|Overall Study|Lost to Follow-up|0|||
126747059|NCT00255008|456023570|FG002|Overall Study|Lost to Follow-up|1|||
126747060|NCT00255008|456023571|FG003|Overall Study|Lost to Follow-up|2|||
126747061|NCT00255008|456023568|FG000|Overall Study|Did not meet viral reduction criteria|4|||
126747062|NCT00255008|456023569|FG001|Overall Study|Did not meet viral reduction criteria|5|||
126747063|NCT00255008|456023570|FG002|Overall Study|Did not meet viral reduction criteria|0|||
126747064|NCT00255008|456023571|FG003|Overall Study|Did not meet viral reduction criteria|1|||
126747065|NCT00255008|456023568|FG000|Overall Study|Withdrew consent|0|||
126747066|NCT00255008|456023569|FG001|Overall Study|Withdrew consent|0|||
126747067|NCT00255008|456023570|FG002|Overall Study|Withdrew consent|2|||
126747068|NCT00255008|456023571|FG003|Overall Study|Withdrew consent|0|||
126747069|NCT00255008|456023568|FG000|Overall Study|Sponsor request|18|||
126747070|NCT00255008|456023569|FG001|Overall Study|Sponsor request|3|||
126747071|NCT00255008|456023570|FG002|Overall Study|Sponsor request|8|||
126747072|NCT00255008|456023571|FG003|Overall Study|Sponsor request|17|||
126747073|NCT00255008|456023568|FG000|Overall Study|Adverse lab experience|1|||
126747074|NCT00255008|456023569|FG001|Overall Study|Adverse lab experience|0|||
126747075|NCT00255008|456023570|FG002|Overall Study|Adverse lab experience|0|||
126747076|NCT00255008|456023571|FG003|Overall Study|Adverse lab experience|0|||
126747077|NCT00255008|456023568|FG000|Overall Study|Other|7|||
126747078|NCT00255008|456023569|FG001|Overall Study|Other|0|||
126747079|NCT00255008|456023570|FG002|Overall Study|Other|3|||
126747080|NCT00255008|456023571|FG003|Overall Study|Other|2|||
126747081|NCT01833806|456023572|FG000|Overall Study|Alternative treatment|2|||
126747082|NCT01833806|456023572|FG000|Overall Study|Death|5|||
126747083|NCT01833806|456023572|FG000|Overall Study|Physician Decision|1|||
126747084|NCT01833806|456023572|FG000|Overall Study|Lost to Follow-up|1|||
126747085|NCT02724111|456023573|FG000|Overall Study|Protocol Violation|2|||
126747086|NCT02724111|456023574|FG001|Overall Study|Protocol Violation|5|||
126747087|NCT02996500|456023575|FG000|Overall Study|Adverse Event|1|||
126747088|NCT02996500|456023576|FG001|Overall Study|Adverse Event|1|||
126747089|NCT02996500|456023577|FG002|Overall Study|Adverse Event|4|||
126747090|NCT02996500|456023578|FG003|Overall Study|Adverse Event|3|||
126747091|NCT02996500|456023579|FG004|Overall Study|Adverse Event|1|||
126747092|NCT02996500|456023580|FG005|Overall Study|Adverse Event|2|||
126747093|NCT02996500|456023575|FG000|Overall Study|Lack of Efficacy|0|||
126747094|NCT02996500|456023576|FG001|Overall Study|Lack of Efficacy|0|||
126747095|NCT02996500|456023577|FG002|Overall Study|Lack of Efficacy|0|||
126747096|NCT02996500|456023578|FG003|Overall Study|Lack of Efficacy|0|||
126747097|NCT02996500|456023579|FG004|Overall Study|Lack of Efficacy|2|||
126747098|NCT02996500|456023580|FG005|Overall Study|Lack of Efficacy|0|||
126747099|NCT02996500|456023575|FG000|Overall Study|Lost to Follow-up|1|||
126747100|NCT02996500|456023576|FG001|Overall Study|Lost to Follow-up|0|||
126747101|NCT02996500|456023577|FG002|Overall Study|Lost to Follow-up|0|||
126747102|NCT02996500|456023578|FG003|Overall Study|Lost to Follow-up|0|||
126747103|NCT02996500|456023579|FG004|Overall Study|Lost to Follow-up|0|||
126747104|NCT02996500|456023580|FG005|Overall Study|Lost to Follow-up|1|||
126747105|NCT02996500|456023575|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
126747106|NCT02996500|456023576|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
126747107|NCT02996500|456023577|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
126747108|NCT02996500|456023578|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
126747109|NCT02996500|456023579|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
126747110|NCT02996500|456023580|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
126747111|NCT02996500|456023575|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126747112|NCT02996500|456023576|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126747113|NCT02996500|456023577|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126747114|NCT02996500|456023578|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126747115|NCT02996500|456023579|FG004|Overall Study|Non-Compliance With Study Drug|0|||
126747116|NCT02996500|456023580|FG005|Overall Study|Non-Compliance With Study Drug|1|||
126747117|NCT02996500|456023575|FG000|Overall Study|Progressive Disease|1|||
126747118|NCT02996500|456023576|FG001|Overall Study|Progressive Disease|0|||
126747119|NCT02996500|456023577|FG002|Overall Study|Progressive Disease|0|||
126747120|NCT02996500|456023578|FG003|Overall Study|Progressive Disease|0|||
126747121|NCT02996500|456023579|FG004|Overall Study|Progressive Disease|0|||
126747122|NCT02996500|456023580|FG005|Overall Study|Progressive Disease|0|||
126747123|NCT02996500|456023575|FG000|Overall Study|Other|2|||
126747124|NCT02996500|456023576|FG001|Overall Study|Other|0|||
126747125|NCT02996500|456023577|FG002|Overall Study|Other|2|||
126747126|NCT02996500|456023578|FG003|Overall Study|Other|0|||
126747127|NCT02996500|456023579|FG004|Overall Study|Other|0|||
126747128|NCT02996500|456023580|FG005|Overall Study|Other|0|||
126747129|NCT02996500|456023575|FG000|Overall Study|Protocol Violation|0|||
126747130|NCT02996500|456023576|FG001|Overall Study|Protocol Violation|0|||
126747131|NCT02996500|456023577|FG002|Overall Study|Protocol Violation|0|||
126747132|NCT02996500|456023578|FG003|Overall Study|Protocol Violation|1|||
126747133|NCT02996500|456023579|FG004|Overall Study|Protocol Violation|0|||
126747134|NCT02996500|456023580|FG005|Overall Study|Protocol Violation|0|||
126747135|NCT02996500|456023575|FG000|Overall Study|Withdrawal by Subject|3|||
126747136|NCT02996500|456023576|FG001|Overall Study|Withdrawal by Subject|0|||
126747137|NCT02996500|456023577|FG002|Overall Study|Withdrawal by Subject|3|||
126747138|NCT02996500|456023578|FG003|Overall Study|Withdrawal by Subject|0|||
126747139|NCT02996500|456023579|FG004|Overall Study|Withdrawal by Subject|2|||
126747140|NCT02996500|456023580|FG005|Overall Study|Withdrawal by Subject|0|||
126782244|NCT01333033|456158128|FG002|Overall Study|Adverse Event|0|||
126782245|NCT01333033|456158129|FG003|Overall Study|Adverse Event|0|||
126621480|NCT00422162|455570704|FG000|Overall Study|Non-Compliant with Protocol|1|||
126621481|NCT00422162|455570705|FG001|Overall Study|Non-Compliant with Protocol|1|||
126621482|NCT00422162|455570704|FG000|Overall Study|Other|0|||
126621483|NCT00422162|455570705|FG001|Overall Study|Other|1|||
126621484|NCT00422162|455570704|FG000|Overall Study|Didn't Receive Treatment|0|||
126621485|NCT00422162|455570705|FG001|Overall Study|Didn't Receive Treatment|1|||
126621486|NCT05274906|455570706|FG000|Overall Study|Withdrawal by Subject|2|||
126621487|NCT05274906|455570707|FG001|Overall Study|Withdrawal by Subject|1|||
126621488|NCT03508830|455570708|FG000|Overall Study|Withdrawal by Subject|3|||
126621489|NCT03508830|455570709|FG001|Overall Study|Withdrawal by Subject|4|||
126621490|NCT03508830|455570708|FG000|Overall Study|Physician Decision|2|||
126621491|NCT03508830|455570709|FG001|Overall Study|Physician Decision|2|||
126621492|NCT02522299|455570710|FG000|Overall Study|Adverse Event|2|||
126621493|NCT02522299|455570711|FG001|Overall Study|Adverse Event|0|||
126621494|NCT02522299|455570710|FG000|Overall Study|Physician Decision|0|||
126621495|NCT02522299|455570711|FG001|Overall Study|Physician Decision|1|||
126621496|NCT02522299|455570710|FG000|Overall Study|Withdrawal by Subject|2|||
126621497|NCT02522299|455570711|FG001|Overall Study|Withdrawal by Subject|0|||
126621498|NCT04908800|455570714|FG000|Overall Study|Adverse Event|0|||
126621499|NCT04908800|455570715|FG001|Overall Study|Adverse Event|0|||
126621500|NCT04908800|455570716|FG002|Overall Study|Adverse Event|0|||
126621501|NCT04908800|455570717|FG003|Overall Study|Adverse Event|0|||
126621502|NCT04908800|455570718|FG004|Overall Study|Adverse Event|0|||
126621503|NCT04908800|455570719|FG005|Overall Study|Adverse Event|0|||
126621504|NCT04908800|455570720|FG006|Overall Study|Adverse Event|0|||
126621505|NCT04908800|455570721|FG007|Overall Study|Adverse Event|0|||
126621506|NCT04908800|455570722|FG008|Overall Study|Adverse Event|0|||
126621507|NCT04908800|455570723|FG009|Overall Study|Adverse Event|0|||
126621508|NCT04908800|455570724|FG010|Overall Study|Adverse Event|1|||
126621509|NCT04908800|455570725|FG011|Overall Study|Adverse Event|0|||
126621510|NCT04908800|455570726|FG012|Overall Study|Adverse Event|0|||
126621511|NCT02267746|455570727|FG000|Overall Study|Adverse Event|0|||
126621512|NCT02267746|455570728|FG001|Overall Study|Adverse Event|2|||
126621513|NCT02267746|455570729|FG002|Overall Study|Adverse Event|1|||
126621514|NCT02267746|455570727|FG000|Overall Study|Protocol Violation|8|||
126621515|NCT02267746|455570728|FG001|Overall Study|Protocol Violation|7|||
126621516|NCT02267746|455570729|FG002|Overall Study|Protocol Violation|3|||
126621517|NCT02267746|455570727|FG000|Overall Study|Lack of Efficacy|11|||
126621518|NCT02267746|455570728|FG001|Overall Study|Lack of Efficacy|11|||
126621519|NCT02267746|455570729|FG002|Overall Study|Lack of Efficacy|15|||
126621520|NCT02267746|455570727|FG000|Overall Study|Protocol Violation|1|||
126621521|NCT02267746|455570728|FG001|Overall Study|Protocol Violation|2|||
126621522|NCT02267746|455570729|FG002|Overall Study|Protocol Violation|1|||
126621523|NCT02267746|455570727|FG000|Overall Study|Miscellaneous|1|||
126621524|NCT02267746|455570728|FG001|Overall Study|Miscellaneous|0|||
126621525|NCT02267746|455570729|FG002|Overall Study|Miscellaneous|1|||
126621526|NCT00728884|455570734|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
126621527|NCT00728884|455570734|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
126621528|NCT02116582|455570738|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
126621529|NCT02116582|455570738|FG000|Overall Study|Adverse Event|22|||
126782246|NCT01333033|456158130|FG004|Overall Study|Adverse Event|2|||
126621530|NCT02116582|455570738|FG000|Overall Study|Death|9|||
126747141|NCT01828567|456023581|FG000|Overall Study|Lost to Follow-up|27|||
126747142|NCT01828567|456023582|FG001|Overall Study|Lost to Follow-up|9|||
126747143|NCT01828567|456023581|FG000|Overall Study|Excluded - did not meet criteria|4|||
126621531|NCT02116582|455570738|FG000|Overall Study|Progressive Disease|148|||
126621532|NCT02116582|455570738|FG000|Overall Study|Protocol Violation|3|||
126621533|NCT02116582|455570738|FG000|Overall Study|Withdrawal by Subject|8|||
126621534|NCT02116582|455570738|FG000|Overall Study|Other: Miscellaneous|11|||
126621535|NCT02116582|455570738|FG000|Overall Study|Lost to Follow-up|1|||
126621536|NCT02116582|455570738|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
126621537|NCT02268526|455570739|FG000|Overall Study|Adverse Event|0|||
126747144|NCT01828567|456023582|FG001|Overall Study|Excluded - did not meet criteria|1|||
126747145|NCT00707486|456023583|FG000|Overall Study|Withdrawal by Subject|1|||
126747146|NCT00959699|456023584|FG000|Treatment Period|Adverse Event|3|||
126747147|NCT00959699|456023585|FG001|Treatment Period|Adverse Event|13|||
126747148|NCT00959699|456023584|FG000|Treatment Period|Lack of Efficacy|15|||
126747149|NCT00959699|456023585|FG001|Treatment Period|Lack of Efficacy|6|||
126747150|NCT00959699|456023584|FG000|Treatment Period|Lost to Follow-up|0|||
126747151|NCT00959699|456023585|FG001|Treatment Period|Lost to Follow-up|1|||
126747152|NCT00959699|456023584|FG000|Treatment Period|Withdrawal by Subject|1|||
126747153|NCT00959699|456023585|FG001|Treatment Period|Withdrawal by Subject|3|||
126747154|NCT00959699|456023584|FG000|Treatment Period|Non-Compliance with Protocol|0|||
126782247|NCT01333033|456158131|FG005|Overall Study|Adverse Event|1|||
126782248|NCT01333033|456158126|FG000|Overall Study|Progression|0|||
126782249|NCT01333033|456158127|FG001|Overall Study|Progression|0|||
126782250|NCT01333033|456158128|FG002|Overall Study|Progression|0|||
126782251|NCT01333033|456158129|FG003|Overall Study|Progression|0|||
126782252|NCT01333033|456158130|FG004|Overall Study|Progression|0|||
126782253|NCT01333033|456158131|FG005|Overall Study|Progression|1|||
126782254|NCT01333033|456158126|FG000|Overall Study|MD Decision|0|||
126782255|NCT01333033|456158127|FG001|Overall Study|MD Decision|0|||
126782256|NCT01333033|456158128|FG002|Overall Study|MD Decision|0|||
126782257|NCT01333033|456158129|FG003|Overall Study|MD Decision|0|||
126782258|NCT01333033|456158130|FG004|Overall Study|MD Decision|0|||
126782259|NCT01333033|456158131|FG005|Overall Study|MD Decision|2|||
126782260|NCT03687125|456158132|FG000|Overall Study|Progressive Disease|2|||
126782261|NCT03687125|456158133|FG001|Overall Study|Progressive Disease|1|||
126782262|NCT03687125|456158132|FG000|Overall Study|Protocol Violation|1|||
126782263|NCT03687125|456158133|FG001|Overall Study|Protocol Violation|0|||
126782264|NCT01992107|456158134|FG000|Overall Study|Administrative reasons|2|||
126782265|NCT01992107|456158135|FG001|Overall Study|Administrative reasons|0|||
126782266|NCT01992107|456158136|FG002|Overall Study|Administrative reasons|0|||
126782267|NCT01992107|456158134|FG000|Overall Study|Adverse Event|0|||
126782268|NCT01992107|456158135|FG001|Overall Study|Adverse Event|1|||
126782269|NCT01992107|456158136|FG002|Overall Study|Adverse Event|0|||
126782270|NCT01992107|456158134|FG000|Overall Study|Lost to Follow-up|46|||
126782271|NCT01992107|456158135|FG001|Overall Study|Lost to Follow-up|22|||
126782272|NCT01992107|456158136|FG002|Overall Study|Lost to Follow-up|26|||
126782273|NCT01992107|456158134|FG000|Overall Study|noncompliance and were unavailable|7|||
126782274|NCT01992107|456158135|FG001|Overall Study|noncompliance and were unavailable|3|||
126782275|NCT01992107|456158136|FG002|Overall Study|noncompliance and were unavailable|2|||
126782276|NCT01992107|456158134|FG000|Overall Study|Withdrawal by Subject|13|||
126782277|NCT01992107|456158135|FG001|Overall Study|Withdrawal by Subject|7|||
126782278|NCT01992107|456158136|FG002|Overall Study|Withdrawal by Subject|8|||
126782279|NCT02035137|456158139|FG000|Overall Study|Physician Decision|0|||
126782280|NCT02035137|456158140|FG001|Overall Study|Physician Decision|0|||
126782281|NCT02035137|456158141|FG002|Overall Study|Physician Decision|1|||
126782282|NCT02035137|456158139|FG000|Overall Study|Withdrawal by Subject|0|||
126782283|NCT02035137|456158140|FG001|Overall Study|Withdrawal by Subject|1|||
126782284|NCT02035137|456158141|FG002|Overall Study|Withdrawal by Subject|2|||
126782285|NCT02035137|456158139|FG000|Overall Study|Ineligible|0|||
126782286|NCT02035137|456158140|FG001|Overall Study|Ineligible|1|||
126782287|NCT02035137|456158141|FG002|Overall Study|Ineligible|2|||
126782288|NCT02035137|456158139|FG000|Overall Study|Disease progression prior to treatment start|2|||
126782289|NCT02035137|456158140|FG001|Overall Study|Disease progression prior to treatment start|0|||
126782290|NCT02035137|456158141|FG002|Overall Study|Disease progression prior to treatment start|0|||
126782291|NCT02087046|456158148|FG000|Overall Study|Adverse Event|4|||
126782292|NCT02087046|456158148|FG000|Overall Study|Death|1|||
126782293|NCT02087046|456158148|FG000|Overall Study|Lost to Follow-up|3|||
126782294|NCT02087046|456158148|FG000|Overall Study|Withdrawal by Subject|2|||
126782295|NCT02087046|456158148|FG000|Overall Study|Physician Decision|1|||
126782296|NCT01214603|456158149|FG000|Overall Study|Adverse Event|0|||
126782297|NCT01214603|456158150|FG001|Overall Study|Adverse Event|0|||
126782298|NCT01214603|456158151|FG002|Overall Study|Adverse Event|1|||
126782299|NCT01214603|456158149|FG000|Overall Study|Death|1|||
126621538|NCT02268526|455570740|FG001|Overall Study|Adverse Event|2|||
126747155|NCT00959699|456023585|FG001|Treatment Period|Non-Compliance with Protocol|1|||
126782300|NCT01214603|456158150|FG001|Overall Study|Death|0|||
126782301|NCT01214603|456158151|FG002|Overall Study|Death|0|||
126782302|NCT01214603|456158149|FG000|Overall Study|Progressive Disease|4|||
126782303|NCT01214603|456158150|FG001|Overall Study|Progressive Disease|1|||
126782304|NCT01214603|456158151|FG002|Overall Study|Progressive Disease|3|||
126782305|NCT01388647|456158152|FG000|Overall Study|Adverse Event|1|||
126747156|NCT00959699|456023584|FG000|Treatment Period|Did not receive treatment|0|||
126782306|NCT01388647|456158153|FG001|Overall Study|Adverse Event|2|||
126782307|NCT02444533|456158154|FG000|Overall Study|Not able to complete forms|0|||
126782308|NCT02444533|456158155|FG001|Overall Study|Not able to complete forms|2|||
126782309|NCT02444533|456158154|FG000|Overall Study|Only gave post-procedure complications|2|||
126782310|NCT02444533|456158155|FG001|Overall Study|Only gave post-procedure complications|2|||
126747157|NCT00959699|456023585|FG001|Treatment Period|Did not receive treatment|1|||
126782311|NCT03567057|456158157|FG000|Overall Study|Adverse Event|56|||
126747158|NCT00959699|456023584|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
126747159|NCT00959699|456023585|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
126747160|NCT00959699|456023584|FG000|Follow-up Period|Lost to Follow-up|3|||
126747161|NCT00959699|456023585|FG001|Follow-up Period|Lost to Follow-up|2|||
126747162|NCT00959699|456023584|FG000|Follow-up Period|Withdrawal by Subject|3|||
126747163|NCT00959699|456023585|FG001|Follow-up Period|Withdrawal by Subject|4|||
126747164|NCT02485860|456023588|FG000|Overall Study|Lost to Follow-up|4|||
126747165|NCT02485860|456023589|FG001|Overall Study|Lost to Follow-up|1|||
126747166|NCT02485860|456023588|FG000|Overall Study|Physician Decision|1|||
126747167|NCT02485860|456023589|FG001|Overall Study|Physician Decision|2|||
126747168|NCT02485860|456023588|FG000|Overall Study|Health context (COVID-19)|1|||
126747169|NCT02485860|456023589|FG001|Overall Study|Health context (COVID-19)|0|||
126747170|NCT03325010|456023590|FG000|Overall Study|Adverse Event|3|||
126747171|NCT03325010|456023591|FG001|Overall Study|Adverse Event|8|||
126747172|NCT03325010|456023590|FG000|Overall Study|Protocol Violation|1|||
126747173|NCT03325010|456023591|FG001|Overall Study|Protocol Violation|8|||
126747174|NCT03325010|456023590|FG000|Overall Study|Withdrawal by Subject|1|||
126747175|NCT03325010|456023591|FG001|Overall Study|Withdrawal by Subject|3|||
126747176|NCT03325010|456023590|FG000|Overall Study|Lost to Follow-up|1|||
126747177|NCT03325010|456023591|FG001|Overall Study|Lost to Follow-up|0|||
126747178|NCT03325010|456023590|FG000|Overall Study|Physician Decision|1|||
126747179|NCT03325010|456023591|FG001|Overall Study|Physician Decision|1|||
126747180|NCT03325010|456023590|FG000|Overall Study|Lack of Efficacy|2|||
126747181|NCT03325010|456023591|FG001|Overall Study|Lack of Efficacy|0|||
126747182|NCT00471315|456023594|FG000|Overall Study|Adverse Event|7|||
126747183|NCT00471315|456023594|FG000|Overall Study|Withdrawal by Subject|1|||
126747184|NCT03073200|456023601|FG000|Double Blind Treatment Period|Protocol Violation|1|||
126747185|NCT03073200|456023602|FG001|Double Blind Treatment Period|Protocol Violation|0|||
126747186|NCT03073200|456023603|FG002|Double Blind Treatment Period|Protocol Violation|0|||
126747187|NCT03073200|456023604|FG003|Double Blind Treatment Period|Protocol Violation|0|||
126747188|NCT03073200|456023605|FG004|Double Blind Treatment Period|Protocol Violation|0|||
126747189|NCT03073200|456023606|FG005|Double Blind Treatment Period|Protocol Violation|0|||
126747190|NCT03073200|456023607|FG006|Double Blind Treatment Period|Protocol Violation|0|||
126747191|NCT03073200|456023608|FG007|Double Blind Treatment Period|Protocol Violation|0|||
126747192|NCT03073200|456023609|FG008|Double Blind Treatment Period|Protocol Violation|0|||
126747193|NCT03073200|456023610|FG009|Double Blind Treatment Period|Protocol Violation|0|||
126747194|NCT03073200|456023611|FG010|Double Blind Treatment Period|Protocol Violation|0|||
126747195|NCT03073200|456023612|FG011|Double Blind Treatment Period|Protocol Violation|0|||
126747196|NCT03073200|456023613|FG012|Double Blind Treatment Period|Protocol Violation|0|||
126747197|NCT03073200|456023614|FG013|Double Blind Treatment Period|Protocol Violation|0|||
126747198|NCT03073200|456023615|FG014|Double Blind Treatment Period|Protocol Violation|0|||
126747199|NCT03073200|456023601|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747200|NCT03073200|456023602|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
126747201|NCT03073200|456023603|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747202|NCT03073200|456023604|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747203|NCT03073200|456023605|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747204|NCT03073200|456023606|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747205|NCT03073200|456023607|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747206|NCT03073200|456023608|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747207|NCT03073200|456023609|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747208|NCT03073200|456023610|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747209|NCT03073200|456023611|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747210|NCT03073200|456023612|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747211|NCT03073200|456023613|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747212|NCT03073200|456023614|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747213|NCT03073200|456023615|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
126747214|NCT03073200|456023601|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
126747215|NCT03073200|456023602|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747216|NCT03073200|456023603|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747217|NCT03073200|456023604|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747218|NCT03073200|456023605|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747219|NCT03073200|456023606|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747220|NCT03073200|456023607|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747221|NCT03073200|456023608|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747222|NCT03073200|456023609|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747223|NCT03073200|456023610|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747224|NCT03073200|456023611|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747225|NCT03073200|456023612|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747226|NCT03073200|456023613|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
126782312|NCT03567057|456158158|FG001|Overall Study|Adverse Event|53|||
126747227|NCT03073200|456023614|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747228|NCT03073200|456023615|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
126747229|NCT03073200|456023601|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747230|NCT03073200|456023602|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747231|NCT03073200|456023603|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747232|NCT03073200|456023604|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
126747233|NCT03073200|456023605|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
126747234|NCT03073200|456023606|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747235|NCT03073200|456023607|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747236|NCT03073200|456023608|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747237|NCT03073200|456023609|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747238|NCT03073200|456023610|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747239|NCT03073200|456023611|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747240|NCT03073200|456023612|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747241|NCT03073200|456023613|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747242|NCT03073200|456023614|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747243|NCT03073200|456023615|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
126747244|NCT03073200|456023601|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
126747245|NCT03073200|456023602|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
126747246|NCT03073200|456023603|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
126747247|NCT03073200|456023604|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
126747248|NCT03073200|456023605|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
126747249|NCT03073200|456023606|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
126747250|NCT03073200|456023607|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
126747251|NCT03073200|456023608|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
126747252|NCT03073200|456023609|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
126747253|NCT03073200|456023610|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
126747254|NCT03073200|456023611|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
126747255|NCT03073200|456023612|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
126747256|NCT03073200|456023613|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
126747257|NCT03073200|456023614|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
126747258|NCT03073200|456023615|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
126747259|NCT03073200|456023601|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747260|NCT03073200|456023602|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747261|NCT03073200|456023603|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747262|NCT03073200|456023604|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747263|NCT03073200|456023605|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
126747264|NCT03073200|456023606|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747265|NCT03073200|456023607|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747266|NCT03073200|456023608|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747267|NCT03073200|456023609|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747268|NCT03073200|456023610|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747269|NCT03073200|456023611|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747270|NCT03073200|456023612|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747271|NCT03073200|456023613|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747272|NCT03073200|456023614|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747273|NCT03073200|456023615|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
126747274|NCT03073200|456023601|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126747275|NCT03073200|456023602|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126747276|NCT03073200|456023603|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126747277|NCT03073200|456023604|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
126747278|NCT03073200|456023605|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
126747279|NCT03073200|456023606|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126747280|NCT03073200|456023607|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126747281|NCT03073200|456023608|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126782313|NCT03567057|456158159|FG002|Overall Study|Adverse Event|28|||
126621539|NCT02268526|455570741|FG002|Overall Study|Adverse Event|1|||
126621540|NCT02268526|455570739|FG000|Overall Study|Death|1|||
126621541|NCT02268526|455570740|FG001|Overall Study|Death|11|||
126621542|NCT02268526|455570741|FG002|Overall Study|Death|0|||
126621543|NCT02268526|455570739|FG000|Overall Study|protocol deviation|0|||
126621544|NCT02268526|455570740|FG001|Overall Study|protocol deviation|1|||
126621545|NCT02268526|455570741|FG002|Overall Study|protocol deviation|0|||
126621546|NCT02268526|455570739|FG000|Overall Study|Physician Decision|0|||
126621547|NCT02268526|455570740|FG001|Overall Study|Physician Decision|0|||
126621548|NCT02268526|455570741|FG002|Overall Study|Physician Decision|1|||
126621549|NCT02268526|455570739|FG000|Overall Study|Subject/guardian decision|0|||
126621550|NCT02268526|455570740|FG001|Overall Study|Subject/guardian decision|7|||
126621551|NCT02268526|455570741|FG002|Overall Study|Subject/guardian decision|3|||
126747282|NCT03073200|456023609|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126747283|NCT03073200|456023610|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126747284|NCT03073200|456023611|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126747285|NCT03073200|456023612|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126747286|NCT03073200|456023613|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126747287|NCT03073200|456023614|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126747288|NCT03073200|456023615|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
126747289|NCT03073200|456023601|FG000|Extension Period|Lost to Follow-up|0|||
126747290|NCT03073200|456023602|FG001|Extension Period|Lost to Follow-up|0|||
126747291|NCT03073200|456023603|FG002|Extension Period|Lost to Follow-up|0|||
126747292|NCT03073200|456023604|FG003|Extension Period|Lost to Follow-up|0|||
126747293|NCT03073200|456023605|FG004|Extension Period|Lost to Follow-up|0|||
126747294|NCT03073200|456023606|FG005|Extension Period|Lost to Follow-up|0|||
126747295|NCT03073200|456023607|FG006|Extension Period|Lost to Follow-up|1|||
126747296|NCT03073200|456023608|FG007|Extension Period|Lost to Follow-up|1|||
126747297|NCT03073200|456023609|FG008|Extension Period|Lost to Follow-up|0|||
126747298|NCT03073200|456023610|FG009|Extension Period|Lost to Follow-up|0|||
126747299|NCT03073200|456023611|FG010|Extension Period|Lost to Follow-up|0|||
126747300|NCT03073200|456023612|FG011|Extension Period|Lost to Follow-up|0|||
126747301|NCT03073200|456023613|FG012|Extension Period|Lost to Follow-up|0|||
126747302|NCT03073200|456023614|FG013|Extension Period|Lost to Follow-up|0|||
126747303|NCT03073200|456023615|FG014|Extension Period|Lost to Follow-up|0|||
126747304|NCT03073200|456023601|FG000|Extension Period|Sponsor Decision|0|||
126747305|NCT03073200|456023602|FG001|Extension Period|Sponsor Decision|0|||
126747306|NCT03073200|456023603|FG002|Extension Period|Sponsor Decision|0|||
126747307|NCT03073200|456023604|FG003|Extension Period|Sponsor Decision|0|||
126747308|NCT03073200|456023605|FG004|Extension Period|Sponsor Decision|0|||
126747309|NCT03073200|456023606|FG005|Extension Period|Sponsor Decision|0|||
126747310|NCT03073200|456023607|FG006|Extension Period|Sponsor Decision|0|||
126747311|NCT03073200|456023608|FG007|Extension Period|Sponsor Decision|0|||
126747312|NCT03073200|456023609|FG008|Extension Period|Sponsor Decision|1|||
126747313|NCT03073200|456023610|FG009|Extension Period|Sponsor Decision|0|||
126747314|NCT03073200|456023611|FG010|Extension Period|Sponsor Decision|0|||
126747315|NCT03073200|456023612|FG011|Extension Period|Sponsor Decision|0|||
126747316|NCT03073200|456023613|FG012|Extension Period|Sponsor Decision|0|||
126747317|NCT03073200|456023614|FG013|Extension Period|Sponsor Decision|0|||
126747318|NCT03073200|456023615|FG014|Extension Period|Sponsor Decision|0|||
126747319|NCT03073200|456023601|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
126747320|NCT03073200|456023602|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
126747321|NCT03073200|456023603|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
126747322|NCT03073200|456023604|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
126747323|NCT03073200|456023605|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
126747324|NCT03073200|456023606|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
126747325|NCT03073200|456023607|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
126747326|NCT03073200|456023608|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
126747327|NCT03073200|456023609|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
126747328|NCT03073200|456023610|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
126747329|NCT03073200|456023611|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
126747330|NCT03073200|456023612|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
126747331|NCT03073200|456023613|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
126747332|NCT03073200|456023614|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
126747333|NCT03073200|456023615|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
126747334|NCT03073200|456023601|FG000|Extension Period|Withdrawal by Subject|0|||
126747335|NCT03073200|456023602|FG001|Extension Period|Withdrawal by Subject|0|||
126747336|NCT03073200|456023603|FG002|Extension Period|Withdrawal by Subject|0|||
126747337|NCT03073200|456023604|FG003|Extension Period|Withdrawal by Subject|0|||
126747338|NCT03073200|456023605|FG004|Extension Period|Withdrawal by Subject|0|||
126747339|NCT03073200|456023606|FG005|Extension Period|Withdrawal by Subject|0|||
126747340|NCT03073200|456023607|FG006|Extension Period|Withdrawal by Subject|1|||
126747341|NCT03073200|456023608|FG007|Extension Period|Withdrawal by Subject|2|||
126747342|NCT03073200|456023609|FG008|Extension Period|Withdrawal by Subject|0|||
126747343|NCT03073200|456023610|FG009|Extension Period|Withdrawal by Subject|0|||
126747344|NCT03073200|456023611|FG010|Extension Period|Withdrawal by Subject|0|||
126747345|NCT03073200|456023612|FG011|Extension Period|Withdrawal by Subject|0|||
126747346|NCT03073200|456023613|FG012|Extension Period|Withdrawal by Subject|0|||
126747347|NCT03073200|456023614|FG013|Extension Period|Withdrawal by Subject|0|||
126747348|NCT03073200|456023615|FG014|Extension Period|Withdrawal by Subject|0|||
126747349|NCT03073200|456023601|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747350|NCT03073200|456023602|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747351|NCT03073200|456023603|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747352|NCT03073200|456023604|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747353|NCT03073200|456023605|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747354|NCT03073200|456023606|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747355|NCT03073200|456023607|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747356|NCT03073200|456023608|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747357|NCT03073200|456023609|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747358|NCT03073200|456023610|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747359|NCT03073200|456023611|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747360|NCT03073200|456023612|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
126747361|NCT03073200|456023613|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747362|NCT03073200|456023614|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747363|NCT03073200|456023615|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
126747364|NCT03073200|456023601|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747365|NCT03073200|456023602|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747366|NCT03073200|456023603|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747367|NCT03073200|456023604|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747368|NCT03073200|456023605|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747369|NCT03073200|456023606|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747370|NCT03073200|456023607|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747371|NCT03073200|456023608|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747372|NCT03073200|456023609|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747373|NCT03073200|456023610|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747374|NCT03073200|456023611|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747375|NCT03073200|456023612|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
126747376|NCT03073200|456023613|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747377|NCT03073200|456023614|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747378|NCT03073200|456023615|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
126747379|NCT03073200|456023601|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747380|NCT03073200|456023602|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747381|NCT03073200|456023603|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747382|NCT03073200|456023604|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747383|NCT03073200|456023605|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747384|NCT03073200|456023606|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747385|NCT03073200|456023607|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747386|NCT03073200|456023608|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747387|NCT03073200|456023609|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747388|NCT03073200|456023610|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747389|NCT03073200|456023611|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
126747390|NCT03073200|456023612|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
126747391|NCT03073200|456023613|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747392|NCT03073200|456023614|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747393|NCT03073200|456023615|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
126747394|NCT03073200|456023601|FG000|Randomized Withdrawal Period|Adverse Event|0|||
126747395|NCT03073200|456023602|FG001|Randomized Withdrawal Period|Adverse Event|0|||
126747396|NCT03073200|456023603|FG002|Randomized Withdrawal Period|Adverse Event|0|||
126747397|NCT03073200|456023604|FG003|Randomized Withdrawal Period|Adverse Event|0|||
126747398|NCT03073200|456023605|FG004|Randomized Withdrawal Period|Adverse Event|0|||
126747399|NCT03073200|456023606|FG005|Randomized Withdrawal Period|Adverse Event|0|||
126747400|NCT03073200|456023607|FG006|Randomized Withdrawal Period|Adverse Event|0|||
126747401|NCT03073200|456023608|FG007|Randomized Withdrawal Period|Adverse Event|0|||
126747402|NCT03073200|456023609|FG008|Randomized Withdrawal Period|Adverse Event|0|||
126747403|NCT03073200|456023610|FG009|Randomized Withdrawal Period|Adverse Event|0|||
126747404|NCT03073200|456023611|FG010|Randomized Withdrawal Period|Adverse Event|1|||
126747405|NCT03073200|456023612|FG011|Randomized Withdrawal Period|Adverse Event|0|||
126747406|NCT03073200|456023613|FG012|Randomized Withdrawal Period|Adverse Event|0|||
126747407|NCT03073200|456023614|FG013|Randomized Withdrawal Period|Adverse Event|0|||
126747408|NCT03073200|456023615|FG014|Randomized Withdrawal Period|Adverse Event|0|||
126747409|NCT03073200|456023601|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747410|NCT03073200|456023602|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747411|NCT03073200|456023603|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747412|NCT03073200|456023604|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747413|NCT03073200|456023605|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747414|NCT03073200|456023606|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747415|NCT03073200|456023607|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747416|NCT03073200|456023608|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747417|NCT03073200|456023609|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747418|NCT03073200|456023610|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747419|NCT03073200|456023611|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747420|NCT03073200|456023612|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747421|NCT03073200|456023613|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
126782314|NCT03567057|456158157|FG000|Overall Study|Withdrawal by Subject|22|||
126747422|NCT03073200|456023614|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
126747423|NCT03073200|456023615|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
126747424|NCT03073200|456023601|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747425|NCT03073200|456023602|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747426|NCT03073200|456023603|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747427|NCT03073200|456023604|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747428|NCT03073200|456023605|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747429|NCT03073200|456023606|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747430|NCT03073200|456023607|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747431|NCT03073200|456023608|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747432|NCT03073200|456023609|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747433|NCT03073200|456023610|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747434|NCT03073200|456023611|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747435|NCT03073200|456023612|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747436|NCT03073200|456023613|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747437|NCT03073200|456023614|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
126747438|NCT03073200|456023615|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
126747439|NCT03073200|456023601|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747440|NCT03073200|456023602|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747441|NCT03073200|456023603|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747442|NCT03073200|456023604|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747443|NCT03073200|456023605|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747444|NCT03073200|456023606|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747445|NCT03073200|456023607|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747446|NCT03073200|456023608|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747447|NCT03073200|456023609|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747448|NCT03073200|456023610|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747449|NCT03073200|456023611|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747450|NCT03073200|456023612|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747451|NCT03073200|456023613|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747452|NCT03073200|456023614|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
126747453|NCT03073200|456023615|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
126747454|NCT03073200|456023601|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747455|NCT03073200|456023602|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747456|NCT03073200|456023603|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747457|NCT03073200|456023604|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747458|NCT03073200|456023605|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747459|NCT03073200|456023606|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747460|NCT03073200|456023607|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747461|NCT03073200|456023608|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747462|NCT03073200|456023609|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747463|NCT03073200|456023610|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747464|NCT03073200|456023611|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747465|NCT03073200|456023612|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747466|NCT03073200|456023613|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747467|NCT03073200|456023614|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
126747468|NCT03073200|456023615|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
126747469|NCT03073200|456023601|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747470|NCT03073200|456023602|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747471|NCT03073200|456023603|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747472|NCT03073200|456023604|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747473|NCT03073200|456023605|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747474|NCT03073200|456023606|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747475|NCT03073200|456023607|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747476|NCT03073200|456023608|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747477|NCT03073200|456023609|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747478|NCT03073200|456023610|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747479|NCT03073200|456023611|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747480|NCT03073200|456023612|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747481|NCT03073200|456023613|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126747482|NCT03073200|456023614|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
126621552|NCT00596960|455570742|FG000|Overall Study|Death|1|||
126621553|NCT00596960|455570743|FG001|Overall Study|Death|2|||
126621554|NCT00596960|455570742|FG000|Overall Study|Lost to Follow-up|6|||
126621555|NCT00596960|455570743|FG001|Overall Study|Lost to Follow-up|5|||
126747483|NCT03073200|456023615|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
126747484|NCT03073200|456023601|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747485|NCT03073200|456023602|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747486|NCT03073200|456023603|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747487|NCT03073200|456023604|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747488|NCT03073200|456023605|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747489|NCT03073200|456023606|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747490|NCT03073200|456023607|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747491|NCT03073200|456023608|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747492|NCT03073200|456023609|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747493|NCT03073200|456023610|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747494|NCT03073200|456023611|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747495|NCT03073200|456023612|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747496|NCT03073200|456023613|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747497|NCT03073200|456023614|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
126747498|NCT03073200|456023615|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
126747499|NCT03073200|456023601|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747500|NCT03073200|456023602|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747501|NCT03073200|456023603|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747502|NCT03073200|456023604|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747503|NCT03073200|456023605|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747504|NCT03073200|456023606|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747505|NCT03073200|456023607|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747506|NCT03073200|456023608|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747507|NCT03073200|456023609|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747508|NCT03073200|456023610|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747509|NCT03073200|456023611|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747510|NCT03073200|456023612|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747511|NCT03073200|456023613|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747512|NCT03073200|456023614|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
126747513|NCT03073200|456023615|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
126747514|NCT03073200|456023601|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747515|NCT03073200|456023602|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747516|NCT03073200|456023603|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747517|NCT03073200|456023604|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747518|NCT03073200|456023605|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747519|NCT03073200|456023606|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747520|NCT03073200|456023607|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747521|NCT03073200|456023608|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747522|NCT03073200|456023609|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747523|NCT03073200|456023610|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747524|NCT03073200|456023611|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747525|NCT03073200|456023612|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747526|NCT03073200|456023613|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747527|NCT03073200|456023614|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
126747528|NCT03073200|456023615|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
126747529|NCT04757376|456023616|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
126747530|NCT04757376|456023617|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
126747531|NCT04757376|456023618|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
126747532|NCT04757376|456023619|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
126747533|NCT04757376|456023620|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
126747534|NCT04757376|456023616|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
126747535|NCT04757376|456023617|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
126747536|NCT04757376|456023618|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
126747537|NCT04757376|456023619|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
126747538|NCT04757376|456023620|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
126747539|NCT04757376|456023616|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
126747540|NCT04757376|456023617|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
126747541|NCT04757376|456023618|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
126747542|NCT04757376|456023619|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
126747543|NCT04757376|456023620|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
126621556|NCT00596960|455570742|FG000|Overall Study|Withdrawal by Subject|1|||
126621557|NCT00596960|455570743|FG001|Overall Study|Withdrawal by Subject|0|||
126782315|NCT03567057|456158158|FG001|Overall Study|Withdrawal by Subject|24|||
126621558|NCT00596960|455570742|FG000|Overall Study|Incarcerated|2|||
126621559|NCT00596960|455570743|FG001|Overall Study|Incarcerated|0|||
126621560|NCT00596960|455570742|FG000|Overall Study|Physician Decision|1|||
126621561|NCT00596960|455570743|FG001|Overall Study|Physician Decision|0|||
126621562|NCT00596960|455570742|FG000|Overall Study|Protocol Violation|0|||
126621563|NCT00596960|455570743|FG001|Overall Study|Protocol Violation|1|||
126621564|NCT00596960|455570742|FG000|Overall Study|No alcohol use data|0|||
126621565|NCT00596960|455570743|FG001|Overall Study|No alcohol use data|1|||
126621566|NCT02374476|455570745|FG000|VT Induced Ablation|Screening Failures|36|||
126621567|NCT02374476|455570746|FG001|VT Induced Ablation|Screening Failures|0|||
126621568|NCT02374476|455570747|FG002|VT Induced Ablation|Screening Failures|0|||
126621569|NCT02374476|455570745|FG000|Arm Assignment|Withdrawal by Subject|0|||
126621570|NCT02374476|455570746|FG001|Arm Assignment|Withdrawal by Subject|0|||
126621571|NCT02374476|455570747|FG002|Arm Assignment|Withdrawal by Subject|1|||
126621572|NCT03305458|455570748|FG000|Overall Study|Withdrawal by Subject|50|||
126621573|NCT03305458|455570749|FG001|Overall Study|Withdrawal by Subject|46|||
126621574|NCT03305458|455570750|FG002|Overall Study|Withdrawal by Subject|93|||
126621575|NCT03305458|455570748|FG000|Overall Study|Lost to Follow-up|85|||
126621576|NCT03305458|455570749|FG001|Overall Study|Lost to Follow-up|85|||
126621577|NCT03305458|455570750|FG002|Overall Study|Lost to Follow-up|35|||
126621578|NCT05431543|455570751|FG000|Overall Study|Medical History|1|||
126621579|NCT05431543|455570752|FG001|Overall Study|Medical History|0|||
126621580|NCT05431543|455570753|FG002|Overall Study|Medical History|0|||
126621581|NCT00440037|455570754|FG000|Overall Study|Withdrawal by Subject|6|||
126621582|NCT00440037|455570754|FG000|Overall Study|Administrative decision|3|||
126621583|NCT00498797|455570755|FG000|Overall Study|Withdrawal by Subject|4|||
126621584|NCT00498797|455570756|FG001|Overall Study|Withdrawal by Subject|2|||
126621585|NCT00498797|455570755|FG000|Overall Study|Adverse Event|12|||
126621586|NCT00498797|455570756|FG001|Overall Study|Adverse Event|5|||
126621587|NCT00498797|455570755|FG000|Overall Study|Condition under investigation worsened|19|||
126621588|NCT00498797|455570756|FG001|Overall Study|Condition under investigation worsened|21|||
126621589|NCT00498797|455570755|FG000|Overall Study|Other|3|||
126621590|NCT00498797|455570756|FG001|Overall Study|Other|1|||
126621591|NCT01855399|455570757|FG000|6 Month|Lost to Follow-up|12|||
126621592|NCT01855399|455570758|FG001|6 Month|Lost to Follow-up|9|||
126621593|NCT01855399|455570757|FG000|6 Month|Withdrawal by Subject|8|||
126621594|NCT01855399|455570758|FG001|6 Month|Withdrawal by Subject|6|||
126621595|NCT01855399|455570757|FG000|12 Month|Lost to Follow-up|7|||
126621596|NCT01855399|455570758|FG001|12 Month|Lost to Follow-up|11|||
126621597|NCT03953079|455570759|FG000|Core Study|Withdrawal by Subject|1|||
126621598|NCT03953079|455570760|FG001|Core Study|Withdrawal by Subject|2|||
126621599|NCT03953079|455570761|FG002|Core Study|Withdrawal by Subject|1|||
126621600|NCT03953079|455570759|FG000|Core Study|COVID-19|0|||
126621601|NCT03953079|455570760|FG001|Core Study|COVID-19|1|||
126621602|NCT03953079|455570761|FG002|Core Study|COVID-19|0|||
126621603|NCT03953079|455570759|FG000|Core Study|Difficulties leaving the house|0|||
126621604|NCT03953079|455570760|FG001|Core Study|Difficulties leaving the house|1|||
126621605|NCT03953079|455570761|FG002|Core Study|Difficulties leaving the house|0|||
126621606|NCT03953079|455570759|FG000|Extension Study|Withdrawal by Subject|1|||
126621607|NCT03953079|455570760|FG001|Extension Study|Withdrawal by Subject|0|||
126621608|NCT03953079|455570761|FG002|Extension Study|Withdrawal by Subject|0|||
126621609|NCT03953079|455570759|FG000|Extension Study|Received Rescue Treatment|5|||
126621610|NCT03953079|455570760|FG001|Extension Study|Received Rescue Treatment|6|||
126621611|NCT03953079|455570761|FG002|Extension Study|Received Rescue Treatment|5|||
126621612|NCT04394624|455570762|FG000|Overall Study|Adverse Event|6|||
126621613|NCT04394624|455570763|FG001|Overall Study|Adverse Event|0|||
126621614|NCT04394624|455570762|FG000|Overall Study|Progressive disease|24|||
126621615|NCT04394624|455570763|FG001|Overall Study|Progressive disease|0|||
126621616|NCT04394624|455570762|FG000|Overall Study|Not related to COVID-19|1|||
126621617|NCT04394624|455570763|FG001|Overall Study|Not related to COVID-19|0|||
126621618|NCT00448344|455570769|FG000|Overall Study|Lost to Follow-up|20|||
126621619|NCT00448344|455570770|FG001|Overall Study|Lost to Follow-up|22|||
126621620|NCT00448344|455570769|FG000|Overall Study|Withdrawal by Subject|6|||
126621621|NCT00448344|455570770|FG001|Overall Study|Withdrawal by Subject|8|||
126621622|NCT00448344|455570769|FG000|Overall Study|Death|3|||
126621623|NCT00448344|455570770|FG001|Overall Study|Death|4|||
126621624|NCT00448344|455570769|FG000|Overall Study|Physician Decision|1|||
126621625|NCT00448344|455570770|FG001|Overall Study|Physician Decision|2|||
126621626|NCT00141271|455570773|FG000|Overall Study|Adverse Event|31|||
126621627|NCT00141271|455570774|FG001|Overall Study|Adverse Event|19|||
126621628|NCT00141271|455570775|FG002|Overall Study|Adverse Event|17|||
126621629|NCT00141271|455570773|FG000|Overall Study|Laboratory Abnormality|2|||
126621630|NCT00141271|455570774|FG001|Overall Study|Laboratory Abnormality|1|||
126621631|NCT00141271|455570775|FG002|Overall Study|Laboratory Abnormality|1|||
126621632|NCT00141271|455570773|FG000|Overall Study|Lack of Efficacy|7|||
126621633|NCT00141271|455570774|FG001|Overall Study|Lack of Efficacy|7|||
126621634|NCT00141271|455570775|FG002|Overall Study|Lack of Efficacy|3|||
126621635|NCT00141271|455570773|FG000|Overall Study|Lost to Follow-up|15|||
126621636|NCT00141271|455570774|FG001|Overall Study|Lost to Follow-up|15|||
126621637|NCT00141271|455570775|FG002|Overall Study|Lost to Follow-up|21|||
126621638|NCT00141271|455570773|FG000|Overall Study|Withdrawal by Subject|14|||
126621639|NCT00141271|455570774|FG001|Overall Study|Withdrawal by Subject|9|||
126621640|NCT00141271|455570775|FG002|Overall Study|Withdrawal by Subject|10|||
126621641|NCT00141271|455570773|FG000|Overall Study|Other|11|||
126621642|NCT00141271|455570774|FG001|Overall Study|Other|12|||
126621643|NCT00141271|455570775|FG002|Overall Study|Other|5|||
126621644|NCT00990314|455570779|FG000|Overall Study|Death|2|||
126621645|NCT00990314|455570779|FG000|Overall Study|Adverse Event|2|||
126621646|NCT00990314|455570779|FG000|Overall Study|Withdrawal by Subject|3|||
126621647|NCT00990314|455570779|FG000|Overall Study|Non-Compliance|1|||
126621648|NCT00990314|455570779|FG000|Overall Study|Physician Decision|3|||
126621649|NCT00990314|455570779|FG000|Overall Study|Lack of Efficacy|1|||
126621650|NCT00705614|455572439|FG000|Initial Intervention|Adverse Event|40|||
126621651|NCT00705614|455572440|FG001|Initial Intervention|Adverse Event|21|||
126621652|NCT00705614|455572439|FG000|Initial Intervention|Lost to Follow-up|310|||
126621653|NCT00705614|455572440|FG001|Initial Intervention|Lost to Follow-up|191|||
126621654|NCT00705614|455572439|FG000|Initial Intervention|Withdrawal by Subject|114|||
126621655|NCT00705614|455572440|FG001|Initial Intervention|Withdrawal by Subject|71|||
126621656|NCT00705614|455572439|FG000|Initial Intervention|Administrative Reason|51|||
126621657|NCT00705614|455572440|FG001|Initial Intervention|Administrative Reason|38|||
126621658|NCT00705614|455572439|FG000|Initial Intervention|Status completion unknown|3|||
126621659|NCT00705614|455572440|FG001|Initial Intervention|Status completion unknown|0|||
126621660|NCT00705614|455572439|FG000|Switch to Remicade|Adverse Event|0|||
126621661|NCT00705614|455572440|FG001|Switch to Remicade|Adverse Event|5|||
126621662|NCT00705614|455572439|FG000|Switch to Remicade|Lost to Follow-up|0|||
126621663|NCT00705614|455572440|FG001|Switch to Remicade|Lost to Follow-up|23|||
126621664|NCT00705614|455572439|FG000|Switch to Remicade|Withdrawal by Subject|0|||
126621665|NCT00705614|455572440|FG001|Switch to Remicade|Withdrawal by Subject|12|||
126621666|NCT00705614|455572439|FG000|Switch to Remicade|Administrative Reason|0|||
126621667|NCT00705614|455572440|FG001|Switch to Remicade|Administrative Reason|9|||
126621668|NCT00676195|455572443|FG000|Overall Study|Lost to Follow-up|1|||
126621669|NCT00676195|455572443|FG000|Overall Study|Adverse Event|1|||
126621670|NCT00676195|455572443|FG000|Overall Study|Physician Decision|1|||
126621671|NCT02878590|455572444|FG000|Overall Study|Withdrawal by Subject|2|||
126621672|NCT00116584|455572458|FG000|Overall Study|Withdrawal by Subject|1|||
126621673|NCT00116584|455572459|FG001|Overall Study|Withdrawal by Subject|0|||
126621674|NCT00116584|455572458|FG000|Overall Study|Protocol Violation|1|||
126621675|NCT00116584|455572459|FG001|Overall Study|Protocol Violation|1|||
126621676|NCT03034772|455572460|FG000|Overall Study|Adverse Event|0|||
126621677|NCT03034772|455572461|FG001|Overall Study|Adverse Event|1|||
126621678|NCT03034772|455572460|FG000|Overall Study|Withdrawal by Subject|0|||
126621679|NCT03034772|455572461|FG001|Overall Study|Withdrawal by Subject|1|||
126621680|NCT02660034|455572464|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
126621681|NCT02660034|455572465|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
126621682|NCT02660034|455572466|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
126621683|NCT02660034|455572467|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
126621684|NCT02660034|455572468|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
126621685|NCT02660034|455572469|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
126621686|NCT02660034|455572470|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
126621687|NCT02660034|455572471|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
126621688|NCT02660034|455572472|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
126621689|NCT02660034|455572473|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
126621690|NCT02660034|455572474|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
126621691|NCT02660034|455572475|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
126621692|NCT02660034|455572476|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
126621693|NCT02660034|455572477|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
126621694|NCT02660034|455572464|FG000|Overall Study|Progressive Disease (Clinical)|7|||
126621695|NCT02660034|455572465|FG001|Overall Study|Progressive Disease (Clinical)|8|||
126621696|NCT02660034|455572466|FG002|Overall Study|Progressive Disease (Clinical)|3|||
126621697|NCT02660034|455572467|FG003|Overall Study|Progressive Disease (Clinical)|9|||
126621698|NCT02660034|455572468|FG004|Overall Study|Progressive Disease (Clinical)|3|||
126621699|NCT02660034|455572469|FG005|Overall Study|Progressive Disease (Clinical)|0|||
126621700|NCT02660034|455572470|FG006|Overall Study|Progressive Disease (Clinical)|0|||
126621701|NCT02660034|455572471|FG007|Overall Study|Progressive Disease (Clinical)|0|||
126621702|NCT02660034|455572472|FG008|Overall Study|Progressive Disease (Clinical)|0|||
126621703|NCT02660034|455572473|FG009|Overall Study|Progressive Disease (Clinical)|0|||
126621704|NCT02660034|455572474|FG010|Overall Study|Progressive Disease (Clinical)|0|||
126621705|NCT02660034|455572475|FG011|Overall Study|Progressive Disease (Clinical)|0|||
126621706|NCT02660034|455572476|FG012|Overall Study|Progressive Disease (Clinical)|0|||
126621707|NCT02660034|455572477|FG013|Overall Study|Progressive Disease (Clinical)|0|||
126621708|NCT02660034|455572464|FG000|Overall Study|Lost to Follow-up|0|||
126621709|NCT02660034|455572465|FG001|Overall Study|Lost to Follow-up|0|||
126621710|NCT02660034|455572466|FG002|Overall Study|Lost to Follow-up|1|||
126747544|NCT04757376|456023616|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
126747545|NCT04757376|456023617|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
126747546|NCT04757376|456023618|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
126747547|NCT04757376|456023619|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
126747548|NCT04757376|456023620|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
126747549|NCT04757376|456023616|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
126747550|NCT04757376|456023617|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
126747551|NCT04757376|456023618|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
126747552|NCT04757376|456023619|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
126747553|NCT04757376|456023620|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
126747554|NCT04757376|456023616|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
126747555|NCT04757376|456023617|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
126747556|NCT04757376|456023618|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
126747557|NCT04757376|456023619|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
126747558|NCT04757376|456023620|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
126747559|NCT04757376|456023616|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
126747560|NCT04757376|456023617|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
126747561|NCT04757376|456023618|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
126747562|NCT04757376|456023619|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
126747563|NCT04757376|456023620|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
126747564|NCT04757376|456023616|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
126747565|NCT04757376|456023617|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
126747566|NCT04757376|456023618|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
126747567|NCT04757376|456023619|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
126747568|NCT04757376|456023620|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
126747569|NCT04474366|456023621|FG000|Overall Study|Lost to Follow-up|2|||
126747570|NCT04474366|456023622|FG001|Overall Study|Lost to Follow-up|5|||
126747571|NCT01365091|456023625|FG000|Period 1|Adverse Event|1|||
126747572|NCT01365091|456023626|FG001|Period 1|Adverse Event|0|||
126747573|NCT01365091|456023627|FG002|Period 1|Adverse Event|2|||
126747574|NCT01365091|456023628|FG003|Period 1|Adverse Event|3|||
126747575|NCT01365091|456023625|FG000|Period 1|Positive test result for drugs of abuse|1|||
126747576|NCT01365091|456023626|FG001|Period 1|Positive test result for drugs of abuse|0|||
126747577|NCT01365091|456023627|FG002|Period 1|Positive test result for drugs of abuse|0|||
126747578|NCT01365091|456023628|FG003|Period 1|Positive test result for drugs of abuse|0|||
126747579|NCT01365091|456023625|FG000|Period 1|No longer met study criteria|0|||
126747580|NCT01365091|456023626|FG001|Period 1|No longer met study criteria|1|||
126747581|NCT01365091|456023627|FG002|Period 1|No longer met study criteria|0|||
126747582|NCT01365091|456023628|FG003|Period 1|No longer met study criteria|0|||
126747583|NCT01365091|456023625|FG000|Period 1|Withdrawal by Subject|0|||
126747584|NCT01365091|456023626|FG001|Period 1|Withdrawal by Subject|1|||
126747585|NCT01365091|456023627|FG002|Period 1|Withdrawal by Subject|0|||
126747586|NCT01365091|456023628|FG003|Period 1|Withdrawal by Subject|0|||
126747587|NCT01365091|456023625|FG000|Period 1|Personal reasons|0|||
126747588|NCT01365091|456023626|FG001|Period 1|Personal reasons|0|||
126747589|NCT01365091|456023627|FG002|Period 1|Personal reasons|1|||
126747590|NCT01365091|456023628|FG003|Period 1|Personal reasons|0|||
126747591|NCT01365091|456023625|FG000|Period 2|Withdrawal by Subject|1|||
126747592|NCT01365091|456023626|FG001|Period 2|Withdrawal by Subject|0|||
126747593|NCT01365091|456023627|FG002|Period 2|Withdrawal by Subject|0|||
126747594|NCT01365091|456023628|FG003|Period 2|Withdrawal by Subject|0|||
126747595|NCT01365091|456023625|FG000|Period 2|Adverse Event|0|||
126747596|NCT01365091|456023626|FG001|Period 2|Adverse Event|0|||
126747597|NCT01365091|456023627|FG002|Period 2|Adverse Event|1|||
126747598|NCT01365091|456023628|FG003|Period 2|Adverse Event|0|||
126747599|NCT05116683|456023629|FG000|Overall Study|Physician Decision|4|||
126747600|NCT01474889|456023630|FG000|Overall Study|Physician Decision|1|||
126621711|NCT02660034|455572467|FG003|Overall Study|Lost to Follow-up|1|||
126747601|NCT01474889|456023631|FG001|Overall Study|Physician Decision|0|||
126747602|NCT01474889|456023632|FG002|Overall Study|Physician Decision|0|||
126747603|NCT01474889|456023630|FG000|Overall Study|Did not meet inclusion|1|||
126747604|NCT01474889|456023631|FG001|Overall Study|Did not meet inclusion|0|||
126747605|NCT01474889|456023632|FG002|Overall Study|Did not meet inclusion|0|||
126747606|NCT01474889|456023630|FG000|Overall Study|Withdrawal by Subject|0|||
126747607|NCT01474889|456023631|FG001|Overall Study|Withdrawal by Subject|1|||
126621712|NCT02660034|455572468|FG004|Overall Study|Lost to Follow-up|0|||
126747608|NCT01474889|456023632|FG002|Overall Study|Withdrawal by Subject|0|||
126747609|NCT03695471|456025342|FG000|Overall Study|Cancellation|1|||
126747610|NCT02859558|456025343|FG000|Step 1|Not Eligible|0|||
126747611|NCT02859558|456025344|FG001|Step 1|Not Eligible|0|||
126747612|NCT02859558|456025345|FG002|Step 1|Not Eligible|0|||
126747613|NCT02859558|456025346|FG003|Step 1|Not Eligible|0|||
126747614|NCT02859558|456025347|FG004|Step 1|Not Eligible|3|||
126747615|NCT02859558|456025343|FG000|Step 1|Lost to Follow-up|1|||
126747616|NCT02859558|456025344|FG001|Step 1|Lost to Follow-up|3|||
126747617|NCT02859558|456025345|FG002|Step 1|Lost to Follow-up|3|||
126747618|NCT02859558|456025346|FG003|Step 1|Lost to Follow-up|0|||
126747619|NCT02859558|456025347|FG004|Step 1|Lost to Follow-up|0|||
126747620|NCT02859558|456025343|FG000|Step 1|Did Not Return to Clinic|2|||
126747621|NCT02859558|456025344|FG001|Step 1|Did Not Return to Clinic|3|||
126747622|NCT02859558|456025345|FG002|Step 1|Did Not Return to Clinic|4|||
126747623|NCT02859558|456025346|FG003|Step 1|Did Not Return to Clinic|0|||
126747624|NCT02859558|456025347|FG004|Step 1|Did Not Return to Clinic|0|||
126747625|NCT02859558|456025343|FG000|Step 1|Moved|0|||
126747626|NCT02859558|456025344|FG001|Step 1|Moved|1|||
126747627|NCT02859558|456025345|FG002|Step 1|Moved|1|||
126747628|NCT02859558|456025346|FG003|Step 1|Moved|0|||
126747629|NCT02859558|456025347|FG004|Step 1|Moved|0|||
126747630|NCT02859558|456025343|FG000|Step 1|Withdrawal By Participant|1|||
126747631|NCT02859558|456025344|FG001|Step 1|Withdrawal By Participant|2|||
126747632|NCT02859558|456025345|FG002|Step 1|Withdrawal By Participant|1|||
126747633|NCT02859558|456025346|FG003|Step 1|Withdrawal By Participant|0|||
126747634|NCT02859558|456025347|FG004|Step 1|Withdrawal By Participant|0|||
126747635|NCT02859558|456025343|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
126747636|NCT02859558|456025344|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
126747637|NCT02859558|456025345|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
126747638|NCT02859558|456025346|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
126747639|NCT02859558|456025347|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
126747640|NCT02859558|456025343|FG000|Step 1|Incarceration|0|||
126747641|NCT02859558|456025344|FG001|Step 1|Incarceration|1|||
126747642|NCT02859558|456025345|FG002|Step 1|Incarceration|0|||
126747643|NCT02859558|456025346|FG003|Step 1|Incarceration|0|||
126747644|NCT02859558|456025347|FG004|Step 1|Incarceration|0|||
126747645|NCT02859558|456025343|FG000|Step 1|Non-Adherence to Study Drug|2|||
126747646|NCT02859558|456025344|FG001|Step 1|Non-Adherence to Study Drug|0|||
126747647|NCT02859558|456025345|FG002|Step 1|Non-Adherence to Study Drug|1|||
126747648|NCT02859558|456025346|FG003|Step 1|Non-Adherence to Study Drug|0|||
126747649|NCT02859558|456025347|FG004|Step 1|Non-Adherence to Study Drug|0|||
126747650|NCT02859558|456025343|FG000|Step 1|Non-Adherence to Study Requirements|3|||
126747651|NCT02859558|456025344|FG001|Step 1|Non-Adherence to Study Requirements|1|||
126747652|NCT02859558|456025345|FG002|Step 1|Non-Adherence to Study Requirements|0|||
126747653|NCT02859558|456025346|FG003|Step 1|Non-Adherence to Study Requirements|0|||
126747654|NCT02859558|456025347|FG004|Step 1|Non-Adherence to Study Requirements|0|||
126747655|NCT02859558|456025343|FG000|Step 1|Virologic Failure|2|||
126747656|NCT02859558|456025344|FG001|Step 1|Virologic Failure|1|||
126747657|NCT02859558|456025345|FG002|Step 1|Virologic Failure|1|||
126747658|NCT02859558|456025346|FG003|Step 1|Virologic Failure|0|||
126747659|NCT02859558|456025347|FG004|Step 1|Virologic Failure|0|||
126747660|NCT02859558|456025343|FG000|Step 2|Lost to Follow-up|3|||
126747661|NCT02859558|456025344|FG001|Step 2|Lost to Follow-up|3|||
126747662|NCT02859558|456025345|FG002|Step 2|Lost to Follow-up|1|||
126747663|NCT02859558|456025346|FG003|Step 2|Lost to Follow-up|0|||
126747664|NCT02859558|456025347|FG004|Step 2|Lost to Follow-up|0|||
126747665|NCT02859558|456025343|FG000|Step 2|Withdrawal by Subject|0|||
126747666|NCT02859558|456025344|FG001|Step 2|Withdrawal by Subject|1|||
126747667|NCT02859558|456025345|FG002|Step 2|Withdrawal by Subject|1|||
126747668|NCT02859558|456025346|FG003|Step 2|Withdrawal by Subject|0|||
126747669|NCT02859558|456025347|FG004|Step 2|Withdrawal by Subject|0|||
126747670|NCT02859558|456025343|FG000|Step 2|Unexpected Closure of Site|0|||
126747671|NCT02859558|456025344|FG001|Step 2|Unexpected Closure of Site|1|||
126747672|NCT02859558|456025345|FG002|Step 2|Unexpected Closure of Site|1|||
126621713|NCT02660034|455572469|FG005|Overall Study|Lost to Follow-up|0|||
126621714|NCT02660034|455572470|FG006|Overall Study|Lost to Follow-up|0|||
126747673|NCT02859558|456025346|FG003|Step 2|Unexpected Closure of Site|0|||
126747674|NCT02859558|456025347|FG004|Step 2|Unexpected Closure of Site|0|||
126747675|NCT02859558|456025343|FG000|Step 2|Death|1|||
126747676|NCT02859558|456025344|FG001|Step 2|Death|0|||
126747677|NCT02859558|456025345|FG002|Step 2|Death|0|||
126747678|NCT02859558|456025346|FG003|Step 2|Death|0|||
126747679|NCT02859558|456025347|FG004|Step 2|Death|0|||
126747680|NCT02859558|456025343|FG000|Step 2|Incarceration|0|||
126747681|NCT02859558|456025344|FG001|Step 2|Incarceration|0|||
126747682|NCT02859558|456025345|FG002|Step 2|Incarceration|1|||
126747683|NCT02859558|456025346|FG003|Step 2|Incarceration|0|||
126747684|NCT02859558|456025347|FG004|Step 2|Incarceration|0|||
126747685|NCT05665595|456025348|FG000|Overall Study|Ongoing|692|||
126747686|NCT05665595|456025349|FG001|Overall Study|Ongoing|698|||
126747687|NCT05665595|456025348|FG000|Overall Study|Withdrawal by Subject|2|||
126747688|NCT05665595|456025349|FG001|Overall Study|Withdrawal by Subject|2|||
126747689|NCT05665595|456025348|FG000|Overall Study|Lost to Follow-up|1|||
126747690|NCT05665595|456025349|FG001|Overall Study|Lost to Follow-up|0|||
126747691|NCT05665595|456025348|FG000|Overall Study|Death|6|||
126747692|NCT05665595|456025349|FG001|Overall Study|Death|1|||
126747693|NCT00766142|456025350|FG000|Overall Study|Protocol Violation|4|||
126747694|NCT02903966|456025355|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
126747695|NCT02903966|456025356|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
126747696|NCT02903966|456025355|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
126747697|NCT02903966|456025356|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
126747698|NCT02903966|456025355|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
126747699|NCT02903966|456025356|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
126747700|NCT04423718|456025357|FG000|Main Study|Adverse Event|9|||
126747701|NCT04423718|456025358|FG001|Main Study|Adverse Event|5|||
126747702|NCT04423718|456025359|FG002|Main Study|Adverse Event|8|||
126747703|NCT04423718|456025357|FG000|Main Study|Physician Decision|3|||
126747704|NCT04423718|456025358|FG001|Main Study|Physician Decision|3|||
126747705|NCT04423718|456025359|FG002|Main Study|Physician Decision|2|||
126747706|NCT04423718|456025357|FG000|Main Study|Protocol Violation|0|||
126747707|NCT04423718|456025358|FG001|Main Study|Protocol Violation|0|||
126747708|NCT04423718|456025359|FG002|Main Study|Protocol Violation|1|||
126747709|NCT04423718|456025357|FG000|Main Study|Lost to Follow-up|3|||
126747710|NCT04423718|456025358|FG001|Main Study|Lost to Follow-up|3|||
126747711|NCT04423718|456025359|FG002|Main Study|Lost to Follow-up|4|||
126747712|NCT04423718|456025357|FG000|Main Study|Lack of Efficacy|2|||
126747713|NCT04423718|456025358|FG001|Main Study|Lack of Efficacy|1|||
126747714|NCT04423718|456025359|FG002|Main Study|Lack of Efficacy|0|||
126747715|NCT04423718|456025357|FG000|Main Study|Withdrawal by Subject|14|||
126747716|NCT04423718|456025358|FG001|Main Study|Withdrawal by Subject|20|||
126747717|NCT04423718|456025359|FG002|Main Study|Withdrawal by Subject|20|||
126747718|NCT04423718|456025357|FG000|Main Study|Death|10|||
126747719|NCT04423718|456025358|FG001|Main Study|Death|7|||
126747720|NCT04423718|456025359|FG002|Main Study|Death|7|||
126747721|NCT04423718|456025357|FG000|Main Study|COVID-19 pandemic|2|||
126747722|NCT04423718|456025358|FG001|Main Study|COVID-19 pandemic|2|||
126747723|NCT04423718|456025359|FG002|Main Study|COVID-19 pandemic|2|||
126747724|NCT04423718|456025357|FG000|Main Study|Other|7|||
126747725|NCT04423718|456025358|FG001|Main Study|Other|3|||
126747726|NCT04423718|456025359|FG002|Main Study|Other|2|||
126747727|NCT04423718|456025357|FG000|Extension Phase|Other|1|||
126747728|NCT04423718|456025358|FG001|Extension Phase|Other|0|||
126747729|NCT04423718|456025359|FG002|Extension Phase|Other|0|||
126747730|NCT04423718|456025357|FG000|Extension Phase|Logistical problems|0|||
126747731|NCT04423718|456025358|FG001|Extension Phase|Logistical problems|1|||
126747732|NCT04423718|456025359|FG002|Extension Phase|Logistical problems|1|||
126747733|NCT04423718|456025357|FG000|Extension Phase|Physician Decision|1|||
126747734|NCT04423718|456025358|FG001|Extension Phase|Physician Decision|0|||
126747735|NCT04423718|456025359|FG002|Extension Phase|Physician Decision|1|||
126747736|NCT04423718|456025357|FG000|Extension Phase|Lack of Efficacy|2|||
126747737|NCT04423718|456025358|FG001|Extension Phase|Lack of Efficacy|0|||
126747738|NCT04423718|456025359|FG002|Extension Phase|Lack of Efficacy|1|||
126747739|NCT04423718|456025357|FG000|Extension Phase|Lost to Follow-up|0|||
126747740|NCT04423718|456025358|FG001|Extension Phase|Lost to Follow-up|2|||
126747741|NCT04423718|456025359|FG002|Extension Phase|Lost to Follow-up|3|||
126747742|NCT04423718|456025357|FG000|Extension Phase|Adverse Event|2|||
126747743|NCT04423718|456025358|FG001|Extension Phase|Adverse Event|3|||
126747744|NCT04423718|456025359|FG002|Extension Phase|Adverse Event|1|||
126747745|NCT04423718|456025357|FG000|Extension Phase|Death|4|||
126747746|NCT04423718|456025358|FG001|Extension Phase|Death|7|||
126747747|NCT04423718|456025359|FG002|Extension Phase|Death|2|||
126747748|NCT04423718|456025357|FG000|Extension Phase|Withdrawal by Subject|11|||
126747749|NCT04423718|456025358|FG001|Extension Phase|Withdrawal by Subject|11|||
126747750|NCT04423718|456025359|FG002|Extension Phase|Withdrawal by Subject|7|||
126747751|NCT00425945|456025360|FG000|Overall Study|Concern about Supplement|2|||
126747752|NCT00425945|456025361|FG001|Overall Study|Concern about Supplement|0|||
126747753|NCT00425945|456025360|FG000|Overall Study|Inconvenience|0|||
126747754|NCT00425945|456025361|FG001|Overall Study|Inconvenience|2|||
126747755|NCT00425945|456025360|FG000|Overall Study|Lost to Follow-up|0|||
126747756|NCT00425945|456025361|FG001|Overall Study|Lost to Follow-up|2|||
126747757|NCT00425945|456025360|FG000|Overall Study|Began hypertension medication|1|||
126747758|NCT00425945|456025361|FG001|Overall Study|Began hypertension medication|0|||
126747759|NCT00425945|456025360|FG000|Overall Study|Began cancer treatments|1|||
126747760|NCT00425945|456025361|FG001|Overall Study|Began cancer treatments|0|||
126621715|NCT02660034|455572471|FG007|Overall Study|Lost to Follow-up|0|||
126621716|NCT02660034|455572472|FG008|Overall Study|Lost to Follow-up|0|||
126747761|NCT00425945|456025360|FG000|Overall Study|Moved from area|0|||
126621717|NCT02660034|455572473|FG009|Overall Study|Lost to Follow-up|1|||
126747762|NCT00425945|456025361|FG001|Overall Study|Moved from area|1|||
126747763|NCT05618808|456025362|FG000|Overall Study|Withdrawal by Subject|3|||
126747764|NCT05618808|456025363|FG001|Overall Study|Withdrawal by Subject|1|||
126747765|NCT05618808|456025364|FG002|Overall Study|Withdrawal by Subject|3|||
126621718|NCT02660034|455572474|FG010|Overall Study|Lost to Follow-up|1|||
126747766|NCT03381274|456025365|FG000|Overall Study|Death|2|||
126747767|NCT03381274|456025366|FG001|Overall Study|Death|9|||
126747768|NCT03381274|456025367|FG002|Overall Study|Death|3|||
126747769|NCT03381274|456025368|FG003|Overall Study|Death|2|||
126747770|NCT03381274|456025369|FG004|Overall Study|Death|3|||
126747771|NCT03381274|456025365|FG000|Overall Study|Lost to Follow-up|0|||
126747772|NCT03381274|456025366|FG001|Overall Study|Lost to Follow-up|0|||
126747773|NCT03381274|456025367|FG002|Overall Study|Lost to Follow-up|0|||
126747774|NCT03381274|456025368|FG003|Overall Study|Lost to Follow-up|1|||
126747775|NCT03381274|456025369|FG004|Overall Study|Lost to Follow-up|0|||
126747776|NCT03381274|456025365|FG000|Overall Study|Withdrawal by Subject|2|||
126747777|NCT03381274|456025366|FG001|Overall Study|Withdrawal by Subject|1|||
126747778|NCT03381274|456025367|FG002|Overall Study|Withdrawal by Subject|3|||
126747779|NCT03381274|456025368|FG003|Overall Study|Withdrawal by Subject|1|||
126747780|NCT03381274|456025369|FG004|Overall Study|Withdrawal by Subject|0|||
126747781|NCT03381274|456025365|FG000|Overall Study|Other|1|||
126747782|NCT03381274|456025366|FG001|Overall Study|Other|11|||
126747783|NCT03381274|456025367|FG002|Overall Study|Other|0|||
126747784|NCT03381274|456025368|FG003|Overall Study|Other|2|||
126747785|NCT03381274|456025369|FG004|Overall Study|Other|2|||
126747786|NCT06048367|456025370|FG000|Overall Study|Withdrawal by Subject|0|||
126747787|NCT06048367|456025371|FG001|Overall Study|Withdrawal by Subject|1|||
126747788|NCT06048367|456025372|FG002|Overall Study|Withdrawal by Subject|0|||
126747789|NCT06048367|456025373|FG003|Overall Study|Withdrawal by Subject|0|||
126747790|NCT06048367|456025374|FG004|Overall Study|Withdrawal by Subject|0|||
126747791|NCT06048367|456025370|FG000|Overall Study|Withdrawal by Subject|0|||
126747792|NCT06048367|456025371|FG001|Overall Study|Withdrawal by Subject|0|||
126747793|NCT06048367|456025372|FG002|Overall Study|Withdrawal by Subject|1|||
126747794|NCT06048367|456025373|FG003|Overall Study|Withdrawal by Subject|0|||
126747795|NCT06048367|456025374|FG004|Overall Study|Withdrawal by Subject|0|||
126747796|NCT06048367|456025370|FG000|Overall Study|Withdrawal by Subject|0|||
126747797|NCT06048367|456025371|FG001|Overall Study|Withdrawal by Subject|0|||
126747798|NCT06048367|456025372|FG002|Overall Study|Withdrawal by Subject|0|||
126747799|NCT06048367|456025373|FG003|Overall Study|Withdrawal by Subject|1|||
126747800|NCT06048367|456025374|FG004|Overall Study|Withdrawal by Subject|0|||
126747801|NCT06048367|456025370|FG000|Overall Study|Withdrawal by Subject|0|||
126747802|NCT06048367|456025371|FG001|Overall Study|Withdrawal by Subject|0|||
126747803|NCT06048367|456025372|FG002|Overall Study|Withdrawal by Subject|0|||
126747804|NCT06048367|456025373|FG003|Overall Study|Withdrawal by Subject|1|||
126747805|NCT06048367|456025374|FG004|Overall Study|Withdrawal by Subject|0|||
126747806|NCT00129376|456025375|FG000|Overall Study|Adverse Event|1|||
126747807|NCT00129376|456025375|FG000|Overall Study|Lack of Efficacy|1|||
126747808|NCT03218826|456025376|FG000|Overall Study|Non-compliance with protocol|1|||
126747809|NCT03218826|456025377|FG001|Overall Study|Non-compliance with protocol|0|||
126747810|NCT03218826|456025378|FG002|Overall Study|Non-compliance with protocol|2|||
126747811|NCT03218826|456025379|FG003|Overall Study|Non-compliance with protocol|1|||
126747812|NCT03218826|456025380|FG004|Overall Study|Non-compliance with protocol|1|||
126747813|NCT01426009|456025381|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
126747814|NCT01426009|456025381|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
126747815|NCT01426009|456025381|FG000|Washout 1|Withdrawal by Subject|1|||
126747816|NCT01426009|456025381|FG000|Washout 1|Personal Reasons|1|||
126747817|NCT01426009|456025381|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
126747818|NCT01426009|456025381|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
126747819|NCT01426009|456025381|FG000|Washout 2|electrive surgery|1|||
126747820|NCT01426009|456025381|FG000|Washout 3|personal reasons|1|||
126747821|NCT01426009|456025381|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
126747822|NCT01426009|456025381|FG000|Washout 4|Lost to Follow-up|1|||
126747823|NCT00796549|456025394|FG000|Overall Study|Adverse Event|11|||
126747824|NCT00796549|456025394|FG000|Overall Study|not entered|149|||
126747825|NCT00796549|456025394|FG000|Overall Study|Other|2|||
126747826|NCT00796549|456025394|FG000|Overall Study|Progressive disease|56|||
126747827|NCT01878175|456025396|FG000|Overall Study|Developed contraindicated health problem|2|||
126747828|NCT03083470|456025397|FG000|Overall Study|Lost to Follow-up|0|||
126747829|NCT03083470|456025398|FG001|Overall Study|Lost to Follow-up|0|||
126747830|NCT03083470|456025399|FG002|Overall Study|Lost to Follow-up|0|||
126621719|NCT02660034|455572475|FG011|Overall Study|Lost to Follow-up|1|||
126621720|NCT02660034|455572476|FG012|Overall Study|Lost to Follow-up|0|||
126747831|NCT03083470|456025400|FG003|Overall Study|Lost to Follow-up|0|||
126747832|NCT03083470|456025401|FG004|Overall Study|Lost to Follow-up|1|||
126747833|NCT03083470|456025397|FG000|Overall Study|Withdrawal by Subject|0|||
126621721|NCT02660034|455572477|FG013|Overall Study|Lost to Follow-up|0|||
126621722|NCT02660034|455572464|FG000|Overall Study|Participant moved into special access scheme|1|||
126747834|NCT03083470|456025398|FG001|Overall Study|Withdrawal by Subject|0|||
126621723|NCT02660034|455572465|FG001|Overall Study|Participant moved into special access scheme|2|||
126621724|NCT02660034|455572466|FG002|Overall Study|Participant moved into special access scheme|0|||
126747835|NCT03083470|456025399|FG002|Overall Study|Withdrawal by Subject|0|||
126747836|NCT03083470|456025400|FG003|Overall Study|Withdrawal by Subject|0|||
126747837|NCT03083470|456025401|FG004|Overall Study|Withdrawal by Subject|1|||
126621725|NCT02660034|455572467|FG003|Overall Study|Participant moved into special access scheme|0|||
126621726|NCT02660034|455572468|FG004|Overall Study|Participant moved into special access scheme|0|||
126621727|NCT02660034|455572469|FG005|Overall Study|Participant moved into special access scheme|0|||
126621728|NCT02660034|455572470|FG006|Overall Study|Participant moved into special access scheme|0|||
126621729|NCT02660034|455572471|FG007|Overall Study|Participant moved into special access scheme|0|||
126621730|NCT02660034|455572472|FG008|Overall Study|Participant moved into special access scheme|0|||
126621731|NCT02660034|455572473|FG009|Overall Study|Participant moved into special access scheme|0|||
126621732|NCT02660034|455572474|FG010|Overall Study|Participant moved into special access scheme|0|||
126621733|NCT02660034|455572475|FG011|Overall Study|Participant moved into special access scheme|0|||
126621734|NCT02660034|455572476|FG012|Overall Study|Participant moved into special access scheme|0|||
126621735|NCT02660034|455572477|FG013|Overall Study|Participant moved into special access scheme|0|||
126621736|NCT02660034|455572464|FG000|Overall Study|Adverse Event|1|||
126621737|NCT02660034|455572465|FG001|Overall Study|Adverse Event|0|||
126621738|NCT02660034|455572466|FG002|Overall Study|Adverse Event|0|||
126621739|NCT02660034|455572467|FG003|Overall Study|Adverse Event|0|||
126621740|NCT02660034|455572468|FG004|Overall Study|Adverse Event|0|||
126621741|NCT02660034|455572469|FG005|Overall Study|Adverse Event|0|||
126621742|NCT02660034|455572470|FG006|Overall Study|Adverse Event|0|||
126621743|NCT02660034|455572471|FG007|Overall Study|Adverse Event|0|||
126621744|NCT02660034|455572472|FG008|Overall Study|Adverse Event|0|||
126621745|NCT02660034|455572473|FG009|Overall Study|Adverse Event|0|||
126621746|NCT02660034|455572474|FG010|Overall Study|Adverse Event|0|||
126621747|NCT02660034|455572475|FG011|Overall Study|Adverse Event|0|||
126621748|NCT02660034|455572476|FG012|Overall Study|Adverse Event|0|||
126621749|NCT02660034|455572477|FG013|Overall Study|Adverse Event|0|||
126621750|NCT02660034|455572464|FG000|Overall Study|Sponsor Decision|0|||
126621751|NCT02660034|455572465|FG001|Overall Study|Sponsor Decision|1|||
126621752|NCT02660034|455572466|FG002|Overall Study|Sponsor Decision|2|||
126621753|NCT02660034|455572467|FG003|Overall Study|Sponsor Decision|2|||
126621754|NCT02660034|455572468|FG004|Overall Study|Sponsor Decision|3|||
126621755|NCT02660034|455572469|FG005|Overall Study|Sponsor Decision|0|||
126621756|NCT02660034|455572470|FG006|Overall Study|Sponsor Decision|0|||
126621757|NCT02660034|455572471|FG007|Overall Study|Sponsor Decision|0|||
126621758|NCT02660034|455572472|FG008|Overall Study|Sponsor Decision|0|||
126621759|NCT02660034|455572473|FG009|Overall Study|Sponsor Decision|0|||
126621760|NCT02660034|455572474|FG010|Overall Study|Sponsor Decision|0|||
126621761|NCT02660034|455572475|FG011|Overall Study|Sponsor Decision|0|||
126621762|NCT02660034|455572476|FG012|Overall Study|Sponsor Decision|0|||
126621763|NCT02660034|455572477|FG013|Overall Study|Sponsor Decision|1|||
126621764|NCT02660034|455572464|FG000|Overall Study|Withdrawal by Subject|0|||
126621765|NCT02660034|455572465|FG001|Overall Study|Withdrawal by Subject|0|||
126621766|NCT02660034|455572466|FG002|Overall Study|Withdrawal by Subject|0|||
126621767|NCT02660034|455572467|FG003|Overall Study|Withdrawal by Subject|0|||
126621768|NCT02660034|455572468|FG004|Overall Study|Withdrawal by Subject|0|||
126621769|NCT02660034|455572469|FG005|Overall Study|Withdrawal by Subject|0|||
126621770|NCT02660034|455572470|FG006|Overall Study|Withdrawal by Subject|1|||
126621771|NCT02660034|455572471|FG007|Overall Study|Withdrawal by Subject|1|||
126621772|NCT02660034|455572472|FG008|Overall Study|Withdrawal by Subject|1|||
126621773|NCT02660034|455572473|FG009|Overall Study|Withdrawal by Subject|0|||
126621774|NCT02660034|455572474|FG010|Overall Study|Withdrawal by Subject|0|||
126621775|NCT02660034|455572475|FG011|Overall Study|Withdrawal by Subject|1|||
126621776|NCT02660034|455572476|FG012|Overall Study|Withdrawal by Subject|2|||
126621777|NCT02660034|455572477|FG013|Overall Study|Withdrawal by Subject|0|||
126621778|NCT02660034|455572464|FG000|Overall Study|Death|0|||
126621779|NCT02660034|455572465|FG001|Overall Study|Death|0|||
126621780|NCT02660034|455572466|FG002|Overall Study|Death|0|||
126621781|NCT02660034|455572467|FG003|Overall Study|Death|0|||
126621782|NCT02660034|455572468|FG004|Overall Study|Death|0|||
126621783|NCT02660034|455572469|FG005|Overall Study|Death|13|||
126621784|NCT02660034|455572470|FG006|Overall Study|Death|14|||
126621785|NCT02660034|455572471|FG007|Overall Study|Death|10|||
126621786|NCT02660034|455572472|FG008|Overall Study|Death|9|||
126621787|NCT02660034|455572473|FG009|Overall Study|Death|21|||
126621788|NCT02660034|455572474|FG010|Overall Study|Death|17|||
126621789|NCT02660034|455572475|FG011|Overall Study|Death|15|||
126621790|NCT02660034|455572476|FG012|Overall Study|Death|18|||
126621791|NCT02660034|455572477|FG013|Overall Study|Death|7|||
126621792|NCT02660034|455572464|FG000|Overall Study|Physician Decision|0|||
126621793|NCT02660034|455572465|FG001|Overall Study|Physician Decision|0|||
126621794|NCT02660034|455572466|FG002|Overall Study|Physician Decision|0|||
126621795|NCT02660034|455572467|FG003|Overall Study|Physician Decision|0|||
126621796|NCT02660034|455572468|FG004|Overall Study|Physician Decision|0|||
126621797|NCT02660034|455572469|FG005|Overall Study|Physician Decision|0|||
126621798|NCT02660034|455572470|FG006|Overall Study|Physician Decision|0|||
126621799|NCT02660034|455572471|FG007|Overall Study|Physician Decision|0|||
126621800|NCT02660034|455572472|FG008|Overall Study|Physician Decision|0|||
126621801|NCT02660034|455572473|FG009|Overall Study|Physician Decision|0|||
126621802|NCT02660034|455572474|FG010|Overall Study|Physician Decision|0|||
126747838|NCT00606229|456025402|FG000|Overall Study|Adverse Event|11|||
126747839|NCT00606229|456025402|FG000|Overall Study|Lack of Efficacy|1|||
126747840|NCT00606229|456025402|FG000|Overall Study|Withdrawal by Subject|4|||
126747841|NCT00606229|456025402|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
126747842|NCT00606229|456025402|FG000|Overall Study|change of residence or other commitments|2|||
126747843|NCT01526928|456025403|FG000|Overall Study|Progressive Disease|35|||
126747844|NCT01526928|456025404|FG001|Overall Study|Progressive Disease|17|||
126747845|NCT01526928|456025405|FG002|Overall Study|Progressive Disease|150|||
126747846|NCT01526928|456025406|FG003|Overall Study|Progressive Disease|182|||
126747847|NCT01526928|456025407|FG004|Overall Study|Progressive Disease|76|||
126747848|NCT01526928|456025408|FG005|Overall Study|Progressive Disease|4|||
126747849|NCT01526928|456025403|FG000|Overall Study|Adverse Event|2|||
126747850|NCT01526928|456025404|FG001|Overall Study|Adverse Event|1|||
126747851|NCT01526928|456025405|FG002|Overall Study|Adverse Event|29|||
126747852|NCT01526928|456025406|FG003|Overall Study|Adverse Event|40|||
126747853|NCT01526928|456025407|FG004|Overall Study|Adverse Event|13|||
126747854|NCT01526928|456025408|FG005|Overall Study|Adverse Event|2|||
126747855|NCT01526928|456025403|FG000|Overall Study|Death|0|||
126747856|NCT01526928|456025404|FG001|Overall Study|Death|0|||
126747857|NCT01526928|456025405|FG002|Overall Study|Death|3|||
126747858|NCT01526928|456025406|FG003|Overall Study|Death|0|||
126747859|NCT01526928|456025407|FG004|Overall Study|Death|0|||
126747860|NCT01526928|456025408|FG005|Overall Study|Death|0|||
126747861|NCT01526928|456025403|FG000|Overall Study|Withdrawal by Subject|1|||
126747862|NCT01526928|456025404|FG001|Overall Study|Withdrawal by Subject|0|||
126747863|NCT01526928|456025405|FG002|Overall Study|Withdrawal by Subject|13|||
126747864|NCT01526928|456025406|FG003|Overall Study|Withdrawal by Subject|11|||
126747865|NCT01526928|456025407|FG004|Overall Study|Withdrawal by Subject|3|||
126747866|NCT01526928|456025408|FG005|Overall Study|Withdrawal by Subject|0|||
126747867|NCT01526928|456025403|FG000|Overall Study|Physician Decision|0|||
126747868|NCT01526928|456025404|FG001|Overall Study|Physician Decision|0|||
126747869|NCT01526928|456025405|FG002|Overall Study|Physician Decision|2|||
126747870|NCT01526928|456025406|FG003|Overall Study|Physician Decision|5|||
126747871|NCT01526928|456025407|FG004|Overall Study|Physician Decision|0|||
126621803|NCT02660034|455572475|FG011|Overall Study|Physician Decision|0|||
126621804|NCT02660034|455572476|FG012|Overall Study|Physician Decision|0|||
126621805|NCT02660034|455572477|FG013|Overall Study|Physician Decision|1|||
126621806|NCT02660034|455572464|FG000|Overall Study|Participants transferred to LTE|0|||
126621807|NCT02660034|455572465|FG001|Overall Study|Participants transferred to LTE|0|||
126621808|NCT02660034|455572466|FG002|Overall Study|Participants transferred to LTE|0|||
126621809|NCT02660034|455572467|FG003|Overall Study|Participants transferred to LTE|0|||
126621810|NCT02660034|455572468|FG004|Overall Study|Participants transferred to LTE|0|||
126621811|NCT02660034|455572469|FG005|Overall Study|Participants transferred to LTE|10|||
126621812|NCT02660034|455572470|FG006|Overall Study|Participants transferred to LTE|8|||
126621813|NCT02660034|455572471|FG007|Overall Study|Participants transferred to LTE|8|||
126621814|NCT02660034|455572472|FG008|Overall Study|Participants transferred to LTE|10|||
126621815|NCT02660034|455572473|FG009|Overall Study|Participants transferred to LTE|1|||
126621816|NCT02660034|455572474|FG010|Overall Study|Participants transferred to LTE|2|||
126621817|NCT02660034|455572475|FG011|Overall Study|Participants transferred to LTE|4|||
126621818|NCT02660034|455572476|FG012|Overall Study|Participants transferred to LTE|1|||
126621819|NCT02660034|455572477|FG013|Overall Study|Participants transferred to LTE|1|||
126621820|NCT01797705|455572481|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
126621821|NCT01797705|455572481|FG000|Overall Study|Withdrawal by Subject|1|||
126621822|NCT01838447|455572482|FG000|Overall Study|Change in surgical plan|1|||
126621823|NCT01838447|455572483|FG001|Overall Study|Change in surgical plan|2|||
126621824|NCT01838447|455572482|FG000|Overall Study|Withdrawal by Subject|1|||
126621825|NCT01838447|455572483|FG001|Overall Study|Withdrawal by Subject|1|||
126621826|NCT01533181|455572486|FG000|Overall Study|Disease progression pre-active treatment|0|||
126621827|NCT01533181|455572487|FG001|Overall Study|Disease progression pre-active treatment|1|||
126621828|NCT01533181|455572486|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
126621829|NCT01533181|455572487|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
126621830|NCT02030847|455572488|FG000|Overall Study|Death|10|||
126621831|NCT02030847|455572488|FG000|Overall Study|Disease Progression|15|||
126621832|NCT02030847|455572488|FG000|Overall Study|New Cancer Therapy|8|||
126621833|NCT02030847|455572488|FG000|Overall Study|Physician Decision|3|||
126621834|NCT02030847|455572488|FG000|Overall Study|Withdrawal by Subject|1|||
126621835|NCT01837719|455572491|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
126621836|NCT01837719|455572491|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
126747872|NCT01526928|456025408|FG005|Overall Study|Physician Decision|0|||
126747873|NCT01526928|456025403|FG000|Overall Study|Other Reason|0|||
126747874|NCT01526928|456025404|FG001|Overall Study|Other Reason|1|||
126747875|NCT01526928|456025405|FG002|Overall Study|Other Reason|11|||
126747876|NCT01526928|456025406|FG003|Overall Study|Other Reason|4|||
126747877|NCT01526928|456025407|FG004|Overall Study|Other Reason|1|||
126747878|NCT01526928|456025408|FG005|Overall Study|Other Reason|0|||
126747879|NCT01526928|456025403|FG000|Overall Study|Lost to Follow-up|0|||
126747880|NCT01526928|456025404|FG001|Overall Study|Lost to Follow-up|0|||
126747881|NCT01526928|456025405|FG002|Overall Study|Lost to Follow-up|0|||
126747882|NCT01526928|456025406|FG003|Overall Study|Lost to Follow-up|1|||
126747883|NCT01526928|456025407|FG004|Overall Study|Lost to Follow-up|0|||
126747884|NCT01526928|456025408|FG005|Overall Study|Lost to Follow-up|0|||
126747885|NCT01526928|456025403|FG000|Overall Study|Protocol Deviation|0|||
126747886|NCT01526928|456025404|FG001|Overall Study|Protocol Deviation|0|||
126747887|NCT01526928|456025405|FG002|Overall Study|Protocol Deviation|0|||
126747888|NCT01526928|456025406|FG003|Overall Study|Protocol Deviation|2|||
126747889|NCT01526928|456025407|FG004|Overall Study|Protocol Deviation|0|||
126747890|NCT01526928|456025408|FG005|Overall Study|Protocol Deviation|0|||
126747891|NCT01526928|456025403|FG000|Overall Study|Missing|0|||
126747892|NCT01526928|456025404|FG001|Overall Study|Missing|0|||
126747893|NCT01526928|456025405|FG002|Overall Study|Missing|1|||
126747894|NCT01526928|456025406|FG003|Overall Study|Missing|0|||
126747895|NCT01526928|456025407|FG004|Overall Study|Missing|2|||
126747896|NCT01526928|456025408|FG005|Overall Study|Missing|0|||
126747897|NCT01108068|456025409|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
126747898|NCT01108068|456025410|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
126747899|NCT00836953|456025411|FG000|Overall Study|Withdrawal by Subject|1|||
126747900|NCT00836953|456025411|FG000|Overall Study|Lost to Follow-up|1|||
126747901|NCT02877134|456025415|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
126747902|NCT02877134|456025416|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
126747903|NCT02877134|456025417|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
126747904|NCT02877134|456025418|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
126747905|NCT02877134|456025419|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
126747906|NCT02877134|456025420|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
126747907|NCT02877134|456025421|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
126747908|NCT02877134|456025422|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
126747909|NCT02877134|456025423|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
126747910|NCT02877134|456025424|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
126747911|NCT02877134|456025425|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
126747912|NCT02877134|456025426|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
126747913|NCT02877134|456025415|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126747914|NCT02877134|456025416|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
126747915|NCT02877134|456025417|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126747916|NCT02877134|456025418|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
126747917|NCT02877134|456025419|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126747918|NCT02877134|456025420|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126747919|NCT02877134|456025421|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
126747920|NCT02877134|456025422|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126747921|NCT02877134|456025423|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126747922|NCT02877134|456025424|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126747923|NCT02877134|456025425|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126747924|NCT02877134|456025426|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
126747925|NCT02877134|456025415|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
126747926|NCT02877134|456025416|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
126747927|NCT02877134|456025417|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
126747928|NCT02877134|456025418|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
126747929|NCT02877134|456025419|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
126747930|NCT02877134|456025420|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
126747931|NCT02877134|456025421|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
126747932|NCT02877134|456025422|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
126747933|NCT02877134|456025423|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
126747934|NCT02877134|456025424|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
126747935|NCT02877134|456025425|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
126747936|NCT02877134|456025426|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
126747937|NCT02877134|456025415|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
126747938|NCT02877134|456025416|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
126782316|NCT03567057|456158159|FG002|Overall Study|Withdrawal by Subject|13|||
126782317|NCT03567057|456158157|FG000|Overall Study|Lost to Follow-up|3|||
126782318|NCT03567057|456158158|FG001|Overall Study|Lost to Follow-up|5|||
126782319|NCT03567057|456158159|FG002|Overall Study|Lost to Follow-up|2|||
126782320|NCT03567057|456158157|FG000|Overall Study|COVID-19 pandemic|4|||
126621837|NCT01703988|455572492|FG000|Overall Study|Investigator Judgment|0|||
126621838|NCT01703988|455572493|FG001|Overall Study|Investigator Judgment|0|||
126621839|NCT01703988|455572494|FG002|Overall Study|Investigator Judgment|0|||
126621840|NCT01703988|455572495|FG003|Overall Study|Investigator Judgment|1|||
126621841|NCT06247488|455572496|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
126621842|NCT06247488|455572497|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
126621843|NCT06247488|455572498|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
126747939|NCT02877134|456025417|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
126747940|NCT02877134|456025418|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
126747941|NCT02877134|456025419|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
126747942|NCT02877134|456025420|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
126747943|NCT02877134|456025421|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
126747944|NCT02877134|456025422|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
126747945|NCT02877134|456025423|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
126747946|NCT02877134|456025424|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
126747947|NCT02877134|456025425|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
126747948|NCT02877134|456025426|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
126747949|NCT02877134|456025415|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126747950|NCT02877134|456025416|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126747951|NCT02877134|456025417|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126747952|NCT02877134|456025418|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126747953|NCT02877134|456025419|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126747954|NCT02877134|456025420|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126747955|NCT02877134|456025421|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126747956|NCT02877134|456025422|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126747957|NCT02877134|456025423|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
126747958|NCT02877134|456025424|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126747959|NCT02877134|456025425|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126747960|NCT02877134|456025426|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
126747961|NCT02877134|456025415|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126747962|NCT02877134|456025416|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126747963|NCT02877134|456025417|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126747964|NCT02877134|456025418|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126747965|NCT02877134|456025419|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126747966|NCT02877134|456025420|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126747967|NCT02877134|456025421|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
126747968|NCT02877134|456025422|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
126747969|NCT02877134|456025423|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
126747970|NCT02877134|456025424|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
126747971|NCT02877134|456025425|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
126747972|NCT02877134|456025426|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
126747973|NCT02877134|456025415|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126747974|NCT02877134|456025416|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126747975|NCT02877134|456025417|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126747976|NCT02877134|456025418|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126747977|NCT02877134|456025419|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126747978|NCT02877134|456025420|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126747979|NCT02877134|456025421|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126747980|NCT02877134|456025422|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
126747981|NCT02877134|456025423|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
126747982|NCT02877134|456025424|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
126747983|NCT02877134|456025425|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126747984|NCT02877134|456025426|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
126747985|NCT02877134|456025415|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
126747986|NCT02877134|456025416|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
126747987|NCT02877134|456025417|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
126747988|NCT02877134|456025418|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
126747989|NCT02877134|456025419|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
126747990|NCT02877134|456025420|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
126747991|NCT02877134|456025421|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
126747992|NCT02877134|456025422|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
126747993|NCT02877134|456025423|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
126747994|NCT02877134|456025424|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
126747995|NCT02877134|456025425|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
126747996|NCT02877134|456025426|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
126747997|NCT01197794|456025429|FG000|Overall Study|Adverse Event|3|||
126747998|NCT01197794|456025430|FG001|Overall Study|Adverse Event|2|||
126747999|NCT01197794|456025431|FG002|Overall Study|Adverse Event|4|||
126748000|NCT01197794|456025432|FG003|Overall Study|Adverse Event|4|||
126748001|NCT01197794|456025433|FG004|Overall Study|Adverse Event|4|||
126748002|NCT01197794|456025434|FG005|Overall Study|Adverse Event|2|||
126748003|NCT01197794|456025435|FG006|Overall Study|Adverse Event|3|||
126748004|NCT01197794|456025429|FG000|Overall Study|Protocol Violation|0|||
126748005|NCT01197794|456025430|FG001|Overall Study|Protocol Violation|0|||
126748006|NCT01197794|456025431|FG002|Overall Study|Protocol Violation|0|||
126748007|NCT01197794|456025432|FG003|Overall Study|Protocol Violation|0|||
126621844|NCT06247488|455572499|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
126621845|NCT06247488|455572500|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
126621846|NCT06247488|455572501|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
126621847|NCT06247488|455572496|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
126621848|NCT06247488|455572497|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
126621849|NCT06247488|455572498|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
126621850|NCT06247488|455572499|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
126621851|NCT06247488|455572500|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
126621852|NCT06247488|455572501|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
126621853|NCT06247488|455572496|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
126621854|NCT06247488|455572497|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
126621855|NCT06247488|455572498|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
126621856|NCT06247488|455572499|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
126621857|NCT06247488|455572500|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
126621858|NCT06247488|455572501|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
126621859|NCT06247488|455572496|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
126621860|NCT06247488|455572497|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
126621861|NCT06247488|455572498|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
126621862|NCT06247488|455572499|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
126621863|NCT06247488|455572500|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
126621864|NCT06247488|455572501|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
126621865|NCT06247488|455572496|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
126621866|NCT06247488|455572497|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
126621867|NCT06247488|455572498|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
126621868|NCT06247488|455572499|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
126621869|NCT06247488|455572500|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
126621870|NCT06247488|455572501|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
126621871|NCT06247488|455572496|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
126621872|NCT06247488|455572497|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
126621873|NCT06247488|455572498|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
126621874|NCT06247488|455572499|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
126621875|NCT06247488|455572500|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
126621876|NCT06247488|455572501|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
126621877|NCT06247488|455572496|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
126621878|NCT06247488|455572497|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
126621879|NCT06247488|455572498|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
126621880|NCT06247488|455572499|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
126621881|NCT06247488|455572500|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
126621882|NCT06247488|455572501|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
126621883|NCT02995733|455572502|FG000|Overall Study|Study site closed|9|||
126621884|NCT02995733|455572503|FG001|Overall Study|Study site closed|10|||
126621885|NCT02995733|455572502|FG000|Overall Study|Death|3|||
126621886|NCT02995733|455572503|FG001|Overall Study|Death|4|||
126621887|NCT02995733|455572502|FG000|Overall Study|Withdrawal by Subject|6|||
126621888|NCT02995733|455572503|FG001|Overall Study|Withdrawal by Subject|2|||
126621889|NCT02995733|455572502|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
126621890|NCT02995733|455572503|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
126621891|NCT02995733|455572502|FG000|Overall Study|Lost to Follow-up|48|||
126621892|NCT02995733|455572503|FG001|Overall Study|Lost to Follow-up|37|||
126621893|NCT02995733|455572502|FG000|Overall Study|Other|0|||
126621894|NCT02995733|455572503|FG001|Overall Study|Other|1|||
126621895|NCT03785210|455572509|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
126621896|NCT03785210|455572510|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
126621897|NCT02720198|455572511|FG000|Overall Study|Withdrawal by Subject|0|||
126621898|NCT02720198|455572512|FG001|Overall Study|Withdrawal by Subject|1|||
126621899|NCT02465866|455572515|FG000|Period 3|Withdrawal by Subject|0|||
126621900|NCT02465866|455572516|FG001|Period 3|Withdrawal by Subject|1|||
126621901|NCT02465866|455572517|FG002|Period 3|Withdrawal by Subject|0|||
126621902|NCT02465866|455572518|FG003|Period 3|Withdrawal by Subject|0|||
126621903|NCT00203502|455572519|FG000|Overall Study|Death|1|||
126621904|NCT02023099|455572520|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
126621905|NCT02023099|455572521|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
126621906|NCT02023099|455572522|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
126621907|NCT02023099|455572520|FG000|Overall Study|Withdrawn Consent|3|||
126621908|NCT02023099|455572521|FG001|Overall Study|Withdrawn Consent|0|||
126621909|NCT02023099|455572522|FG002|Overall Study|Withdrawn Consent|1|||
126621910|NCT02023099|455572520|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
126621911|NCT02023099|455572521|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
126621912|NCT02023099|455572522|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
126621913|NCT02592434|455572523|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
126621914|NCT02592434|455572524|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
126748008|NCT01197794|456025433|FG004|Overall Study|Protocol Violation|2|||
126748009|NCT01197794|456025434|FG005|Overall Study|Protocol Violation|0|||
126748010|NCT01197794|456025435|FG006|Overall Study|Protocol Violation|1|||
126748011|NCT01197794|456025429|FG000|Overall Study|Development of study withdrawal criteria|3|||
126748012|NCT01197794|456025430|FG001|Overall Study|Development of study withdrawal criteria|0|||
126748013|NCT01197794|456025431|FG002|Overall Study|Development of study withdrawal criteria|0|||
126748014|NCT01197794|456025432|FG003|Overall Study|Development of study withdrawal criteria|1|||
126748015|NCT01197794|456025433|FG004|Overall Study|Development of study withdrawal criteria|0|||
126748016|NCT01197794|456025434|FG005|Overall Study|Development of study withdrawal criteria|0|||
126748017|NCT01197794|456025435|FG006|Overall Study|Development of study withdrawal criteria|1|||
126748018|NCT01197794|456025429|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
126748019|NCT01197794|456025430|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
126748020|NCT01197794|456025431|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
126748021|NCT01197794|456025432|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
126748022|NCT01197794|456025433|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
126748023|NCT01197794|456025434|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
126748024|NCT01197794|456025435|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
126748025|NCT01197794|456025429|FG000|Overall Study|Withdrawal by Subject|3|||
126748026|NCT01197794|456025430|FG001|Overall Study|Withdrawal by Subject|3|||
126748027|NCT01197794|456025431|FG002|Overall Study|Withdrawal by Subject|4|||
126748028|NCT01197794|456025432|FG003|Overall Study|Withdrawal by Subject|1|||
126748029|NCT01197794|456025433|FG004|Overall Study|Withdrawal by Subject|1|||
126748030|NCT01197794|456025434|FG005|Overall Study|Withdrawal by Subject|5|||
126748031|NCT01197794|456025435|FG006|Overall Study|Withdrawal by Subject|6|||
126748032|NCT01197794|456025429|FG000|Overall Study|Lost to Follow-up|1|||
126748033|NCT01197794|456025430|FG001|Overall Study|Lost to Follow-up|1|||
126748034|NCT01197794|456025431|FG002|Overall Study|Lost to Follow-up|0|||
126748035|NCT01197794|456025432|FG003|Overall Study|Lost to Follow-up|1|||
126748036|NCT01197794|456025433|FG004|Overall Study|Lost to Follow-up|0|||
126748037|NCT01197794|456025434|FG005|Overall Study|Lost to Follow-up|1|||
126748038|NCT01197794|456025435|FG006|Overall Study|Lost to Follow-up|0|||
126748039|NCT01197794|456025429|FG000|Overall Study|Other|1|||
126748040|NCT01197794|456025430|FG001|Overall Study|Other|1|||
126748041|NCT01197794|456025431|FG002|Overall Study|Other|3|||
126748042|NCT01197794|456025432|FG003|Overall Study|Other|0|||
126748043|NCT01197794|456025433|FG004|Overall Study|Other|2|||
126748044|NCT01197794|456025434|FG005|Overall Study|Other|2|||
126748045|NCT01197794|456025435|FG006|Overall Study|Other|4|||
126748046|NCT01055457|456025436|FG000|Overall Study|Lost to Follow-up|0|||
126748047|NCT01055457|456025437|FG001|Overall Study|Lost to Follow-up|1|||
126748048|NCT01055457|456025438|FG002|Overall Study|Lost to Follow-up|0|||
126748049|NCT01055457|456025439|FG003|Overall Study|Lost to Follow-up|0|||
126748050|NCT01055457|456025440|FG004|Overall Study|Lost to Follow-up|0|||
126748051|NCT01055457|456025441|FG005|Overall Study|Lost to Follow-up|1|||
126748052|NCT01055457|456025442|FG006|Overall Study|Lost to Follow-up|0|||
126748053|NCT01055457|456025443|FG007|Overall Study|Lost to Follow-up|0|||
126748054|NCT01055457|456025444|FG008|Overall Study|Lost to Follow-up|0|||
126748055|NCT01055457|456025445|FG009|Overall Study|Lost to Follow-up|0|||
126748056|NCT01055457|456025436|FG000|Overall Study|Protocol Violation|0|||
126748057|NCT01055457|456025437|FG001|Overall Study|Protocol Violation|0|||
126748058|NCT01055457|456025438|FG002|Overall Study|Protocol Violation|1|||
126748059|NCT01055457|456025439|FG003|Overall Study|Protocol Violation|1|||
126748060|NCT01055457|456025440|FG004|Overall Study|Protocol Violation|1|||
126748061|NCT01055457|456025441|FG005|Overall Study|Protocol Violation|2|||
126748062|NCT01055457|456025442|FG006|Overall Study|Protocol Violation|1|||
126748063|NCT01055457|456025443|FG007|Overall Study|Protocol Violation|0|||
126748064|NCT01055457|456025444|FG008|Overall Study|Protocol Violation|0|||
126748065|NCT01055457|456025445|FG009|Overall Study|Protocol Violation|1|||
126748066|NCT01055457|456025436|FG000|Overall Study|Subject Disinterest|0|||
126748067|NCT01055457|456025437|FG001|Overall Study|Subject Disinterest|0|||
126748068|NCT01055457|456025438|FG002|Overall Study|Subject Disinterest|0|||
126748069|NCT01055457|456025439|FG003|Overall Study|Subject Disinterest|0|||
126748070|NCT01055457|456025440|FG004|Overall Study|Subject Disinterest|0|||
126748071|NCT01055457|456025441|FG005|Overall Study|Subject Disinterest|0|||
126748072|NCT01055457|456025442|FG006|Overall Study|Subject Disinterest|0|||
126748073|NCT01055457|456025443|FG007|Overall Study|Subject Disinterest|1|||
126748074|NCT01055457|456025444|FG008|Overall Study|Subject Disinterest|0|||
126748075|NCT01055457|456025445|FG009|Overall Study|Subject Disinterest|0|||
126748076|NCT01055457|456025436|FG000|Overall Study|Subject Ineligible|1|||
126748077|NCT01055457|456025437|FG001|Overall Study|Subject Ineligible|0|||
126748078|NCT01055457|456025438|FG002|Overall Study|Subject Ineligible|1|||
126748079|NCT01055457|456025439|FG003|Overall Study|Subject Ineligible|0|||
126748080|NCT01055457|456025440|FG004|Overall Study|Subject Ineligible|1|||
126748081|NCT01055457|456025441|FG005|Overall Study|Subject Ineligible|0|||
126748082|NCT01055457|456025442|FG006|Overall Study|Subject Ineligible|0|||
126748083|NCT01055457|456025443|FG007|Overall Study|Subject Ineligible|0|||
126748084|NCT01055457|456025444|FG008|Overall Study|Subject Ineligible|0|||
126748085|NCT01055457|456025445|FG009|Overall Study|Subject Ineligible|0|||
126748086|NCT01055457|456025436|FG000|Overall Study|Discomfort|0|||
126748087|NCT01055457|456025437|FG001|Overall Study|Discomfort|0|||
126748088|NCT01055457|456025438|FG002|Overall Study|Discomfort|0|||
126748089|NCT01055457|456025439|FG003|Overall Study|Discomfort|0|||
126748090|NCT01055457|456025440|FG004|Overall Study|Discomfort|1|||
126748091|NCT01055457|456025441|FG005|Overall Study|Discomfort|0|||
126748092|NCT01055457|456025442|FG006|Overall Study|Discomfort|0|||
126748093|NCT01055457|456025443|FG007|Overall Study|Discomfort|0|||
126748094|NCT01055457|456025444|FG008|Overall Study|Discomfort|0|||
126748095|NCT01055457|456025445|FG009|Overall Study|Discomfort|0|||
126748096|NCT01055457|456025436|FG000|Overall Study|Pregnancy|0|||
126748097|NCT01055457|456025437|FG001|Overall Study|Pregnancy|0|||
126748098|NCT01055457|456025438|FG002|Overall Study|Pregnancy|0|||
126748099|NCT01055457|456025439|FG003|Overall Study|Pregnancy|1|||
126748100|NCT01055457|456025440|FG004|Overall Study|Pregnancy|0|||
126748101|NCT01055457|456025441|FG005|Overall Study|Pregnancy|0|||
126748102|NCT01055457|456025442|FG006|Overall Study|Pregnancy|0|||
126748103|NCT01055457|456025443|FG007|Overall Study|Pregnancy|0|||
126748104|NCT01055457|456025444|FG008|Overall Study|Pregnancy|0|||
126748105|NCT01055457|456025445|FG009|Overall Study|Pregnancy|0|||
126748106|NCT01055457|456025436|FG000|Overall Study|Adverse Event|0|||
126748107|NCT01055457|456025437|FG001|Overall Study|Adverse Event|0|||
126748108|NCT01055457|456025438|FG002|Overall Study|Adverse Event|0|||
126748109|NCT01055457|456025439|FG003|Overall Study|Adverse Event|1|||
126748110|NCT01055457|456025440|FG004|Overall Study|Adverse Event|0|||
126748111|NCT01055457|456025441|FG005|Overall Study|Adverse Event|0|||
126748112|NCT01055457|456025442|FG006|Overall Study|Adverse Event|0|||
126748113|NCT01055457|456025443|FG007|Overall Study|Adverse Event|0|||
126748114|NCT01055457|456025444|FG008|Overall Study|Adverse Event|0|||
126748115|NCT01055457|456025445|FG009|Overall Study|Adverse Event|0|||
126748116|NCT04055844|456025446|FG000|Overall Study|Adverse Event|12|||
126748117|NCT04055844|456025446|FG000|Overall Study|Poor Performance|1|||
126748118|NCT04055844|456025446|FG000|Overall Study|Death|1|||
126748119|NCT03630016|456025455|FG000|Overall Study|Poor Sensor Placement|1|||
126748120|NCT04063865|456025456|FG000|Overall Study|Physician Decision|1|||
126748121|NCT04063865|456025457|FG001|Overall Study|Physician Decision|3|||
126748122|NCT04063865|456025456|FG000|Overall Study|Study Closed Prior to Completion|4|||
126748123|NCT04063865|456025457|FG001|Overall Study|Study Closed Prior to Completion|4|||
126748124|NCT04063865|456025456|FG000|Overall Study|Withdrawal by Subject|1|||
126748125|NCT04063865|456025457|FG001|Overall Study|Withdrawal by Subject|1|||
126748126|NCT03898323|456025458|FG000|Overall Study|Physician Decision|1|||
126748127|NCT00320190|456025460|FG000|First 12 Months|Completed but did not enter extension|5|||
126748128|NCT00320190|456025461|FG001|First 12 Months|Completed but did not enter extension|3|||
126748129|NCT00320190|456025460|FG000|First 12 Months|Sponsor terminated study|2|||
126621915|NCT02592434|455572525|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
126621916|NCT02592434|455572523|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
126621917|NCT02592434|455572524|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
126621918|NCT02592434|455572525|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
126621919|NCT02592434|455572523|FG000|Open-Label Phase (18 Weeks)|Other|3|||
126621920|NCT02592434|455572524|FG001|Open-Label Phase (18 Weeks)|Other|0|||
126621921|NCT02592434|455572525|FG002|Open-Label Phase (18 Weeks)|Other|0|||
126621922|NCT02592434|455572523|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
126621923|NCT02592434|455572524|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
126621924|NCT02592434|455572525|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
126621925|NCT02592434|455572523|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
126621926|NCT02592434|455572524|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
126621927|NCT02592434|455572525|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
126621928|NCT02592434|455572523|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
126621929|NCT02592434|455572524|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
126748130|NCT00320190|456025461|FG001|First 12 Months|Sponsor terminated study|2|||
126748131|NCT00320190|456025460|FG000|First 12 Months|Lost to Follow-up|0|||
126748132|NCT00320190|456025461|FG001|First 12 Months|Lost to Follow-up|1|||
126748133|NCT00320190|456025460|FG000|First 12 Months|Enrollment failure|0|||
126748134|NCT00320190|456025461|FG001|First 12 Months|Enrollment failure|1|||
126748135|NCT00320190|456025460|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
126748136|NCT00320190|456025461|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
126748137|NCT00320190|456025460|FG000|First 12 Months|Investigator request|0|||
126748138|NCT00320190|456025461|FG001|First 12 Months|Investigator request|1|||
126748139|NCT00320190|456025460|FG000|First 12 Months|Study drug toxicity|0|||
126748140|NCT00320190|456025461|FG001|First 12 Months|Study drug toxicity|1|||
126748141|NCT00320190|456025460|FG000|First 12 Months|Withdrawal by Subject|0|||
126748142|NCT00320190|456025461|FG001|First 12 Months|Withdrawal by Subject|1|||
126748143|NCT00320190|456025460|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
126748144|NCT00320190|456025461|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
126748145|NCT00320190|456025460|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
126748146|NCT00320190|456025461|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
126748147|NCT00320190|456025460|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
126748148|NCT00320190|456025461|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
126748149|NCT00712270|456025462|FG000|Overall Study|Withdrawal by Subject|11|||
126748150|NCT00712270|456025462|FG000|Overall Study|Screen Failure|3|||
126748151|NCT03954704|456025475|FG000|Overall Study|Death|1|||
126748152|NCT03954704|456025476|FG001|Overall Study|Death|1|||
126748153|NCT03954704|456025477|FG002|Overall Study|Death|1|||
126748154|NCT03954704|456025478|FG003|Overall Study|Death|3|||
126748155|NCT03954704|456025479|FG004|Overall Study|Death|2|||
126748156|NCT03954704|456025480|FG005|Overall Study|Death|2|||
126748157|NCT03954704|456025481|FG006|Overall Study|Death|0|||
126748158|NCT03954704|456025475|FG000|Overall Study|Withdrew Consent|0|||
126748159|NCT03954704|456025476|FG001|Overall Study|Withdrew Consent|0|||
126748160|NCT03954704|456025477|FG002|Overall Study|Withdrew Consent|1|||
126748161|NCT03954704|456025478|FG003|Overall Study|Withdrew Consent|0|||
126748162|NCT03954704|456025479|FG004|Overall Study|Withdrew Consent|0|||
126748163|NCT03954704|456025480|FG005|Overall Study|Withdrew Consent|1|||
126748164|NCT03954704|456025481|FG006|Overall Study|Withdrew Consent|0|||
126748165|NCT03954704|456025475|FG000|Overall Study|Lost to Follow-up|0|||
126748166|NCT03954704|456025476|FG001|Overall Study|Lost to Follow-up|0|||
126748167|NCT03954704|456025477|FG002|Overall Study|Lost to Follow-up|0|||
126748168|NCT03954704|456025478|FG003|Overall Study|Lost to Follow-up|0|||
126748169|NCT03954704|456025479|FG004|Overall Study|Lost to Follow-up|0|||
126748170|NCT03954704|456025480|FG005|Overall Study|Lost to Follow-up|0|||
126748171|NCT03954704|456025481|FG006|Overall Study|Lost to Follow-up|1|||
126748172|NCT03954704|456025475|FG000|Overall Study|Study Terminated by Sponsor|0|||
126748173|NCT03954704|456025476|FG001|Overall Study|Study Terminated by Sponsor|0|||
126748174|NCT03954704|456025477|FG002|Overall Study|Study Terminated by Sponsor|1|||
126748175|NCT03954704|456025478|FG003|Overall Study|Study Terminated by Sponsor|0|||
126748176|NCT03954704|456025479|FG004|Overall Study|Study Terminated by Sponsor|1|||
126748177|NCT03954704|456025480|FG005|Overall Study|Study Terminated by Sponsor|4|||
126748178|NCT03954704|456025481|FG006|Overall Study|Study Terminated by Sponsor|2|||
126748179|NCT03954704|456025475|FG000|Overall Study|Enrolled but not Treated|0|||
126748180|NCT03954704|456025476|FG001|Overall Study|Enrolled but not Treated|0|||
126748181|NCT03954704|456025477|FG002|Overall Study|Enrolled but not Treated|0|||
126748182|NCT03954704|456025478|FG003|Overall Study|Enrolled but not Treated|0|||
126748183|NCT03954704|456025479|FG004|Overall Study|Enrolled but not Treated|0|||
126748184|NCT03954704|456025480|FG005|Overall Study|Enrolled but not Treated|1|||
126748185|NCT03954704|456025481|FG006|Overall Study|Enrolled but not Treated|0|||
126748186|NCT00102804|456025482|FG000|Overall Study|Progressive Disease (PD)|307|||
126748187|NCT00102804|456025483|FG001|Overall Study|Progressive Disease (PD)|196|||
126748188|NCT00102804|456025482|FG000|Overall Study|Withdrawal by Subject|46|||
126748189|NCT00102804|456025483|FG001|Overall Study|Withdrawal by Subject|7|||
126748190|NCT00102804|456025482|FG000|Overall Study|Adverse Event|37|||
126748191|NCT00102804|456025483|FG001|Overall Study|Adverse Event|3|||
126748192|NCT00102804|456025482|FG000|Overall Study|Physician Decision|24|||
126748193|NCT00102804|456025483|FG001|Overall Study|Physician Decision|6|||
126748194|NCT00102804|456025482|FG000|Overall Study|Death|5|||
126748195|NCT00102804|456025483|FG001|Overall Study|Death|6|||
126748196|NCT00102804|456025482|FG000|Overall Study|Enrollment Criteria Not Met|6|||
126748197|NCT00102804|456025483|FG001|Overall Study|Enrollment Criteria Not Met|0|||
126748198|NCT00102804|456025482|FG000|Overall Study|Lost to Follow-up|4|||
126748199|NCT00102804|456025483|FG001|Overall Study|Lost to Follow-up|1|||
126748200|NCT00102804|456025482|FG000|Overall Study|Protocol Violation|2|||
126748201|NCT00102804|456025483|FG001|Overall Study|Protocol Violation|1|||
126748202|NCT00102804|456025482|FG000|Overall Study|Satisfactory Response|2|||
126748203|NCT00102804|456025483|FG001|Overall Study|Satisfactory Response|0|||
126748204|NCT00102804|456025482|FG000|Overall Study|Sponsor Decision|1|||
126748205|NCT00102804|456025483|FG001|Overall Study|Sponsor Decision|0|||
126748206|NCT00102804|456025482|FG000|Overall Study|Alive, Receiving Treatment|7|||
126748207|NCT00102804|456025483|FG001|Overall Study|Alive, Receiving Treatment|2|||
126748208|NCT00374127|456025487|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
126748209|NCT00374127|456025487|FG000|Overall Study|Blood could not be drawn.|2|||
126748210|NCT00374127|456025487|FG000|Overall Study|Protocol Violation|5|||
126748211|NCT00374127|456025487|FG000|Overall Study|Pregnancy|1|||
126748212|NCT00683774|456025488|FG000|Overall Study|Withdrawal by Subject|0|||
126748213|NCT00683774|456025489|FG001|Overall Study|Withdrawal by Subject|1|||
126748214|NCT00683774|456025488|FG000|Overall Study|Physician Decision|3|||
126748215|NCT00683774|456025489|FG001|Overall Study|Physician Decision|0|||
126748216|NCT00691054|456025490|FG000|Overall Study|Withdrawal by Subject|1|||
126748217|NCT02735044|456025491|FG000|Overall Study|Adverse Event|3|||
126748218|NCT02735044|456025492|FG001|Overall Study|Adverse Event|3|||
126748219|NCT02735044|456025491|FG000|Overall Study|Lack of Efficacy|1|||
126748220|NCT02735044|456025492|FG001|Overall Study|Lack of Efficacy|0|||
126748221|NCT02735044|456025491|FG000|Overall Study|Poor compliance to protocol|7|||
126748222|NCT02735044|456025492|FG001|Overall Study|Poor compliance to protocol|7|||
126748223|NCT02735044|456025491|FG000|Overall Study|Randomized and not treated|0|||
126748224|NCT02735044|456025492|FG001|Overall Study|Randomized and not treated|2|||
126748225|NCT02735044|456025491|FG000|Overall Study|Other, not specified above|5|||
126748226|NCT02735044|456025492|FG001|Overall Study|Other, not specified above|11|||
126748227|NCT01868594|456025494|FG000|Overall Study|Do not meet inclusion criteria|4|||
126748228|NCT01868594|456025495|FG001|Overall Study|Do not meet inclusion criteria|3|||
126748229|NCT02659098|456025500|FG000|Overall Study|Withdrawal by Subject|7|||
126748230|NCT04363944|456025501|FG000|Overall Study|Withdrawal by Subject|2|||
126748231|NCT04363944|456025502|FG001|Overall Study|Withdrawal by Subject|0|||
126748232|NCT02632344|456027180|FG000|Overall Study|Adverse Event|3|||
126748233|NCT02632344|456027180|FG000|Overall Study|Lack of Efficacy|3|||
126748234|NCT02632344|456027180|FG000|Overall Study|Withdrawal by Subject|2|||
126748235|NCT04076579|456027182|FG000|Overall Study|Adverse Event|2|||
126748236|NCT04076579|456027183|FG001|Overall Study|Adverse Event|0|||
126748237|NCT04076579|456027182|FG000|Overall Study|discontinued due to toxicity|1|||
126748238|NCT04076579|456027183|FG001|Overall Study|discontinued due to toxicity|0|||
126748239|NCT04076579|456027182|FG000|Overall Study|Physician Decision|1|||
126748240|NCT04076579|456027183|FG001|Overall Study|Physician Decision|0|||
126748241|NCT04076579|456027182|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
126748242|NCT04076579|456027183|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
126748243|NCT04076579|456027182|FG000|Overall Study|Noncompliance|0|||
126748244|NCT04076579|456027183|FG001|Overall Study|Noncompliance|1|||
126748245|NCT04076579|456027182|FG000|Overall Study|Withdrawal by Subject|0|||
126748246|NCT04076579|456027183|FG001|Overall Study|Withdrawal by Subject|2|||
126748247|NCT03991936|456027186|FG000|Overall Study|Lost to Follow-up|1|||
126748248|NCT03991936|456027187|FG001|Overall Study|Lost to Follow-up|1|||
126748249|NCT03991936|456027188|FG002|Overall Study|Lost to Follow-up|1|||
126748250|NCT03991936|456027189|FG003|Overall Study|Lost to Follow-up|1|||
126748251|NCT03991936|456027190|FG004|Overall Study|Lost to Follow-up|1|||
126748252|NCT00939055|456027191|FG000|Overall Study|Discontinuation prior to procedure|4|||
126748253|NCT00939055|456027192|FG001|Overall Study|Discontinuation prior to procedure|0|||
126748254|NCT00584987|456027195|FG000|Overall Study|Protocol Violation|1|||
126748255|NCT00584987|456027196|FG001|Overall Study|Protocol Violation|1|||
126748256|NCT00584987|456027197|FG002|Overall Study|Protocol Violation|1|||
126748257|NCT00584987|456027198|FG003|Overall Study|Protocol Violation|0|||
126748258|NCT00584987|456027195|FG000|Overall Study|Adverse Event|0|||
126748259|NCT00584987|456027196|FG001|Overall Study|Adverse Event|0|||
126748260|NCT00584987|456027197|FG002|Overall Study|Adverse Event|0|||
126748261|NCT00584987|456027198|FG003|Overall Study|Adverse Event|1|||
126748262|NCT02881151|456027199|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
126748263|NCT03225833|456027200|FG000|Overall Study|Adverse Event|0|||
126748264|NCT03225833|456027201|FG001|Overall Study|Adverse Event|1|||
126748265|NCT03225833|456027202|FG002|Overall Study|Adverse Event|2|||
126748266|NCT03225833|456027203|FG003|Overall Study|Adverse Event|0|||
126748267|NCT03225833|456027204|FG004|Overall Study|Adverse Event|0|||
126748268|NCT03225833|456027205|FG005|Overall Study|Adverse Event|2|||
126748269|NCT03225833|456027200|FG000|Overall Study|Withdrawal by Subject|1|||
126748270|NCT03225833|456027201|FG001|Overall Study|Withdrawal by Subject|0|||
126748271|NCT03225833|456027202|FG002|Overall Study|Withdrawal by Subject|0|||
126748272|NCT03225833|456027203|FG003|Overall Study|Withdrawal by Subject|0|||
126748273|NCT03225833|456027204|FG004|Overall Study|Withdrawal by Subject|1|||
126748274|NCT03225833|456027205|FG005|Overall Study|Withdrawal by Subject|0|||
126748275|NCT03225833|456027200|FG000|Overall Study|Termination of Study by Sponsor|4|||
126748276|NCT03225833|456027201|FG001|Overall Study|Termination of Study by Sponsor|0|||
126748277|NCT03225833|456027202|FG002|Overall Study|Termination of Study by Sponsor|0|||
126748278|NCT03225833|456027203|FG003|Overall Study|Termination of Study by Sponsor|0|||
126748279|NCT03225833|456027204|FG004|Overall Study|Termination of Study by Sponsor|0|||
126748280|NCT03225833|456027205|FG005|Overall Study|Termination of Study by Sponsor|7|||
126748281|NCT03225833|456027200|FG000|Overall Study|Sponsor Decision|0|||
126748282|NCT03225833|456027201|FG001|Overall Study|Sponsor Decision|0|||
126748283|NCT03225833|456027202|FG002|Overall Study|Sponsor Decision|0|||
126748284|NCT03225833|456027203|FG003|Overall Study|Sponsor Decision|0|||
126748285|NCT03225833|456027204|FG004|Overall Study|Sponsor Decision|0|||
126748286|NCT03225833|456027205|FG005|Overall Study|Sponsor Decision|1|||
126748287|NCT03258593|456027206|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
126748288|NCT03258593|456027207|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
126748289|NCT03258593|456027208|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
126748290|NCT03258593|456027209|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
126748291|NCT03258593|456027206|FG000|Run-In Maintenance Phase|Disease progression|3|||
126748292|NCT03258593|456027207|FG001|Run-In Maintenance Phase|Disease progression|0|||
126748293|NCT03258593|456027208|FG002|Run-In Maintenance Phase|Disease progression|0|||
126748294|NCT03258593|456027209|FG003|Run-In Maintenance Phase|Disease progression|0|||
126748295|NCT03258593|456027206|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
126748296|NCT03258593|456027207|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
126748297|NCT03258593|456027208|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
126748298|NCT03258593|456027209|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
126748299|NCT03258593|456027206|FG000|Expansion Maintenance Phase|Physician Decision|0|||
126748300|NCT03258593|456027207|FG001|Expansion Maintenance Phase|Physician Decision|1|||
126748301|NCT03258593|456027208|FG002|Expansion Maintenance Phase|Physician Decision|0|||
126748302|NCT03258593|456027209|FG003|Expansion Maintenance Phase|Physician Decision|0|||
126748303|NCT05318183|456027210|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
126748304|NCT05318183|456027211|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
126748305|NCT05318183|456027210|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
126748306|NCT05318183|456027211|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126748307|NCT05298774|456027218|FG000|Overall Study|Physician Decision|3|||
126748308|NCT05298774|456027218|FG000|Overall Study|Withdrawal by Subject|2|||
126748309|NCT05298774|456027218|FG000|Overall Study|Lost to Follow-up|3|||
126748310|NCT05298774|456027218|FG000|Overall Study|Screen failure|1|||
126748311|NCT01327573|456027227|FG000|Overall Study|Physician Decision|3|||
126748312|NCT01327573|456027228|FG001|Overall Study|Physician Decision|1|||
126748313|NCT02136134|456027229|FG000|Overall Study|Death|170|||
126748314|NCT02136134|456027230|FG001|Overall Study|Death|148|||
126748315|NCT02136134|456027229|FG000|Overall Study|Withdrawal by Subject|19|||
126748316|NCT02136134|456027230|FG001|Overall Study|Withdrawal by Subject|10|||
126748317|NCT02136134|456027229|FG000|Overall Study|Lost to Follow-up|3|||
126748318|NCT02136134|456027230|FG001|Overall Study|Lost to Follow-up|3|||
126748319|NCT02136134|456027229|FG000|Overall Study|Uspecified|55|||
126748320|NCT02136134|456027230|FG001|Overall Study|Uspecified|90|||
126748321|NCT03070119|456027233|FG000|Overall Study|Adverse Event|0|||
126748322|NCT03070119|456027234|FG001|Overall Study|Adverse Event|0|||
126748323|NCT03070119|456027235|FG002|Overall Study|Adverse Event|1|||
126748324|NCT03070119|456027233|FG000|Overall Study|Lost to Follow-up|0|||
126748325|NCT03070119|456027234|FG001|Overall Study|Lost to Follow-up|1|||
126748326|NCT03070119|456027235|FG002|Overall Study|Lost to Follow-up|0|||
126748327|NCT03070119|456027233|FG000|Overall Study|Consent Withdrawn|6|||
126748328|NCT03070119|456027234|FG001|Overall Study|Consent Withdrawn|5|||
126748329|NCT03070119|456027235|FG002|Overall Study|Consent Withdrawn|3|||
126748330|NCT03070119|456027233|FG000|Overall Study|Investigator Decision|0|||
126748331|NCT03070119|456027234|FG001|Overall Study|Investigator Decision|0|||
126748332|NCT03070119|456027235|FG002|Overall Study|Investigator Decision|1|||
126748333|NCT03070119|456027233|FG000|Overall Study|Death|7|||
126748334|NCT03070119|456027234|FG001|Overall Study|Death|14|||
126748335|NCT03070119|456027235|FG002|Overall Study|Death|5|||
126748336|NCT03070119|456027233|FG000|Overall Study|Disease Progression|5|||
126748337|NCT03070119|456027234|FG001|Overall Study|Disease Progression|7|||
126748338|NCT03070119|456027235|FG002|Overall Study|Disease Progression|7|||
126748339|NCT03070119|456027233|FG000|Overall Study|Reason not Specified|2|||
126748340|NCT03070119|456027234|FG001|Overall Study|Reason not Specified|2|||
126748341|NCT03070119|456027235|FG002|Overall Study|Reason not Specified|1|||
126748342|NCT00732472|456027236|FG000|Overall Study|Adverse Event|0|||
126748343|NCT00732472|456027237|FG001|Overall Study|Adverse Event|1|||
126748344|NCT00732472|456027238|FG002|Overall Study|Adverse Event|1|||
126748345|NCT00732472|456027239|FG003|Overall Study|Adverse Event|1|||
126748346|NCT00732472|456027236|FG000|Overall Study|Protocol Violation|0|||
126748347|NCT00732472|456027237|FG001|Overall Study|Protocol Violation|0|||
126748348|NCT00732472|456027238|FG002|Overall Study|Protocol Violation|0|||
126748349|NCT00732472|456027239|FG003|Overall Study|Protocol Violation|1|||
126748350|NCT00732472|456027236|FG000|Overall Study|Withdrawal by Subject|0|||
126748351|NCT00732472|456027237|FG001|Overall Study|Withdrawal by Subject|2|||
126748352|NCT00732472|456027238|FG002|Overall Study|Withdrawal by Subject|0|||
126748353|NCT00732472|456027239|FG003|Overall Study|Withdrawal by Subject|1|||
126748354|NCT01266876|456027241|FG000|Overall Study|Adverse Event|0|||
126748355|NCT01266876|456027242|FG001|Overall Study|Adverse Event|0|||
126748356|NCT01266876|456027243|FG002|Overall Study|Adverse Event|0|||
126748357|NCT01266876|456027244|FG003|Overall Study|Adverse Event|1|||
126748358|NCT01266876|456027245|FG004|Overall Study|Adverse Event|0|||
126748359|NCT05180721|456027246|FG000|Overall Study|Lost to Follow-up|4|||
126748360|NCT01996865|456027248|FG000|Induction Period|Protocol Violation|1|||
126748361|NCT01996865|456027249|FG001|Induction Period|Protocol Violation|0|||
126748362|NCT01996865|456027250|FG002|Induction Period|Protocol Violation|0|||
126748363|NCT01996865|456027248|FG000|Induction Period|Progressive Disease|4|||
126748364|NCT01996865|456027249|FG001|Induction Period|Progressive Disease|0|||
126748365|NCT01996865|456027250|FG002|Induction Period|Progressive Disease|0|||
126748366|NCT01996865|456027248|FG000|Induction Period|Lost to Follow-up|10|||
126748367|NCT01996865|456027249|FG001|Induction Period|Lost to Follow-up|0|||
126748368|NCT01996865|456027250|FG002|Induction Period|Lost to Follow-up|0|||
126748369|NCT01996865|456027248|FG000|Induction Period|Other Reasons|13|||
126748370|NCT01996865|456027249|FG001|Induction Period|Other Reasons|0|||
126748371|NCT01996865|456027250|FG002|Induction Period|Other Reasons|0|||
126748372|NCT01996865|456027248|FG000|Induction Period|Adverse Event|20|||
126748373|NCT01996865|456027249|FG001|Induction Period|Adverse Event|0|||
126748374|NCT01996865|456027250|FG002|Induction Period|Adverse Event|0|||
126748375|NCT01996865|456027248|FG000|Induction Period|Withdrawal by Subject|60|||
126748376|NCT01996865|456027249|FG001|Induction Period|Withdrawal by Subject|0|||
126748377|NCT01996865|456027250|FG002|Induction Period|Withdrawal by Subject|0|||
126748378|NCT01996865|456027248|FG000|Induction Period|Death|111|||
126748379|NCT01996865|456027249|FG001|Induction Period|Death|0|||
126748380|NCT01996865|456027250|FG002|Induction Period|Death|0|||
126621930|NCT02592434|455572525|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
126621931|NCT02592434|455572523|FG000|Double Blind Phase (26 Weeks)|Other|0|||
126621932|NCT02592434|455572524|FG001|Double Blind Phase (26 Weeks)|Other|1|||
126621933|NCT02592434|455572525|FG002|Double Blind Phase (26 Weeks)|Other|0|||
126621934|NCT02592434|455572523|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
126621935|NCT02592434|455572524|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
126621936|NCT02592434|455572525|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
126621937|NCT02592434|455572523|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
126621938|NCT02592434|455572524|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
126621939|NCT02592434|455572525|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
126621940|NCT02592434|455572523|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
126621941|NCT02592434|455572524|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
126621942|NCT02592434|455572525|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
126621943|NCT01469819|455572526|FG000|Overall Study|Withdrawal by Subject|1|||
126621944|NCT01469819|455572526|FG000|Overall Study|Did not meet inclusionary criteria|2|||
126621945|NCT01469819|455572526|FG000|Overall Study|Could not swallow SmartPill|2|||
126621946|NCT01469819|455572526|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
126621947|NCT01103141|455572527|FG000|Overall Study|Death|0|||
126621948|NCT01103141|455572528|FG001|Overall Study|Death|1|||
126621949|NCT01103141|455572527|FG000|Overall Study|Lost to Follow-up|2|||
126621950|NCT01103141|455572528|FG001|Overall Study|Lost to Follow-up|1|||
126621951|NCT01403805|455572529|FG000|Overall Study|Withdrawal by Subject|0|||
126621952|NCT01403805|455572530|FG001|Overall Study|Withdrawal by Subject|4|||
126621953|NCT01403805|455572529|FG000|Overall Study|Lost to Follow-up|0|||
126621954|NCT01403805|455572530|FG001|Overall Study|Lost to Follow-up|2|||
126621955|NCT01403805|455572529|FG000|Overall Study|Death|0|||
126621956|NCT01403805|455572530|FG001|Overall Study|Death|1|||
126621957|NCT01695993|455572533|FG000|Overall Study|Lost to Follow-up|2|||
126621958|NCT01695993|455572534|FG001|Overall Study|Lost to Follow-up|1|||
126621959|NCT01695993|455572535|FG002|Overall Study|Lost to Follow-up|3|||
126621960|NCT01695993|455572533|FG000|Overall Study|Withdrawal by Subject|2|||
126621961|NCT01695993|455572534|FG001|Overall Study|Withdrawal by Subject|2|||
126621962|NCT01695993|455572535|FG002|Overall Study|Withdrawal by Subject|2|||
126621963|NCT01695993|455572533|FG000|Overall Study|To ill to continue|1|||
126621964|NCT01695993|455572534|FG001|Overall Study|To ill to continue|2|||
126621965|NCT01695993|455572535|FG002|Overall Study|To ill to continue|0|||
126621966|NCT01695993|455572533|FG000|Overall Study|Changed Medical Facility|0|||
126621967|NCT01695993|455572534|FG001|Overall Study|Changed Medical Facility|0|||
126621968|NCT01695993|455572535|FG002|Overall Study|Changed Medical Facility|1|||
126621969|NCT04057937|455572536|FG000|Placebo-controlled Phase|Adverse Event|3|||
126621970|NCT04057937|455572537|FG001|Placebo-controlled Phase|Adverse Event|0|||
126621971|NCT04057937|455572536|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
126621972|NCT04057937|455572537|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
126621973|NCT04057937|455572536|FG000|Active-treatment Phase|Pregnancy|0|||
126621974|NCT04057937|455572537|FG001|Active-treatment Phase|Pregnancy|1|||
126621975|NCT04057937|455572536|FG000|Active-treatment Phase|Physician Decision|0|||
126621976|NCT04057937|455572537|FG001|Active-treatment Phase|Physician Decision|1|||
126621977|NCT02029521|455572539|FG000|Overall Study|Protocol Violation|1|||
126621978|NCT02029521|455572540|FG001|Overall Study|Protocol Violation|0|||
126621979|NCT02029521|455572539|FG000|Overall Study|Withdrawal by Subject|1|||
126621980|NCT02029521|455572540|FG001|Overall Study|Withdrawal by Subject|1|||
126621981|NCT00428441|455572543|FG000|Overall Study|Lost to Follow-up|1|||
126621982|NCT00510783|455572550|FG000|Overall Study|Lost to Follow-up|29|||
126621983|NCT00510783|455572551|FG001|Overall Study|Lost to Follow-up|25|||
126621984|NCT00510783|455572550|FG000|Overall Study|Withdrawal by Subject|2|||
126621985|NCT00510783|455572551|FG001|Overall Study|Withdrawal by Subject|3|||
126621986|NCT00510783|455572550|FG000|Overall Study|Protocol Violation|0|||
126621987|NCT00510783|455572551|FG001|Overall Study|Protocol Violation|1|||
126621988|NCT01047306|455572561|FG000|Overall Study|Withdrawal by Subject|2|||
126621989|NCT01047306|455572562|FG001|Overall Study|Withdrawal by Subject|0|||
126621990|NCT01047306|455572561|FG000|Overall Study|Lost to Follow-up|1|||
126621991|NCT01047306|455572562|FG001|Overall Study|Lost to Follow-up|0|||
126621992|NCT00274846|455572565|FG000|Overall Study|Did not receive adequate NK cells|1|||
126621993|NCT01648699|455572568|FG000|Overall Study|Death|1|||
126621994|NCT01648699|455572568|FG000|Overall Study|Lost to Follow-up|2|||
126621995|NCT01648699|455572568|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
126621996|NCT02038803|455572569|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
126621997|NCT02038803|455572569|FG000|Overall Study|Lost to Follow-up|1|||
126621998|NCT00348283|455572570|FG000|Induction|Adverse Event|0|||
126621999|NCT00348283|455572571|FG001|Induction|Adverse Event|2|||
126622000|NCT00348283|455572570|FG000|Induction|Protocol Violation|0|||
126622001|NCT00348283|455572571|FG001|Induction|Protocol Violation|4|||
126622002|NCT00348283|455572570|FG000|Double Blind|Adverse Event|2|||
126622003|NCT00348283|455572571|FG001|Double Blind|Adverse Event|5|||
126622004|NCT00348283|455572570|FG000|Double Blind|Withdrawal by Subject|1|||
126748381|NCT01996865|456027248|FG000|Maintenance Period|Protocol Violation|0|||
126748382|NCT01996865|456027249|FG001|Maintenance Period|Protocol Violation|1|||
126748383|NCT01996865|456027250|FG002|Maintenance Period|Protocol Violation|1|||
126748384|NCT01996865|456027248|FG000|Maintenance Period|Other reasons|0|||
126748385|NCT01996865|456027249|FG001|Maintenance Period|Other reasons|8|||
126748386|NCT01996865|456027250|FG002|Maintenance Period|Other reasons|5|||
126748387|NCT01996865|456027248|FG000|Maintenance Period|Progressive Disease|0|||
126748388|NCT01996865|456027249|FG001|Maintenance Period|Progressive Disease|6|||
126748389|NCT01996865|456027250|FG002|Maintenance Period|Progressive Disease|23|||
126748390|NCT01996865|456027248|FG000|Maintenance Period|Withdrawal by Subject|0|||
126748391|NCT01996865|456027249|FG001|Maintenance Period|Withdrawal by Subject|18|||
126748392|NCT01996865|456027250|FG002|Maintenance Period|Withdrawal by Subject|4|||
126748393|NCT01996865|456027248|FG000|Maintenance Period|Adverse Event|0|||
126748394|NCT01996865|456027249|FG001|Maintenance Period|Adverse Event|7|||
126748395|NCT01996865|456027250|FG002|Maintenance Period|Adverse Event|7|||
126748396|NCT01996865|456027248|FG000|Maintenance Period|Death|0|||
126748397|NCT01996865|456027249|FG001|Maintenance Period|Death|15|||
126748398|NCT01996865|456027250|FG002|Maintenance Period|Death|3|||
126748399|NCT01996865|456027248|FG000|Maintenance Period|Lost to Follow-up|0|||
126748400|NCT01996865|456027249|FG001|Maintenance Period|Lost to Follow-up|2|||
126748401|NCT01996865|456027250|FG002|Maintenance Period|Lost to Follow-up|0|||
126748402|NCT03575351|456027253|FG000|Overall Study|Adverse Event|1|||
126748403|NCT03575351|456027254|FG001|Overall Study|Adverse Event|0|||
126748404|NCT03575351|456027253|FG000|Overall Study|Death|2|||
126748405|NCT03575351|456027254|FG001|Overall Study|Death|2|||
126748406|NCT03575351|456027253|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
126748407|NCT03575351|456027254|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
126748408|NCT03575351|456027253|FG000|Overall Study|Lack of Efficacy|28|||
126748409|NCT03575351|456027254|FG001|Overall Study|Lack of Efficacy|0|||
126748410|NCT03575351|456027253|FG000|Overall Study|Withdrawal by Subject|1|||
126748411|NCT03575351|456027254|FG001|Overall Study|Withdrawal by Subject|1|||
126748412|NCT03575351|456027253|FG000|Overall Study|Physician Decision|3|||
126748413|NCT03575351|456027254|FG001|Overall Study|Physician Decision|0|||
126748414|NCT03575351|456027253|FG000|Overall Study|Disease relapse|15|||
126748415|NCT03575351|456027254|FG001|Overall Study|Disease relapse|6|||
126748416|NCT03575351|456027253|FG000|Overall Study|Study drug manufacturing failure|0|||
126748417|NCT03575351|456027254|FG001|Overall Study|Study drug manufacturing failure|1|||
126748418|NCT03575351|456027253|FG000|Overall Study|other reasons|5|||
126748419|NCT03575351|456027254|FG001|Overall Study|other reasons|0|||
126748420|NCT04288089|456027260|FG000|Overall Study|Ongoing Treatment|2|||
126748421|NCT04288089|456027261|FG001|Overall Study|Ongoing Treatment|1|||
126748422|NCT04288089|456027262|FG002|Overall Study|Ongoing Treatment|1|||
126748423|NCT04288089|456027263|FG003|Overall Study|Ongoing Treatment|4|||
126748424|NCT03715205|456027264|FG000|Overall Study|Death|13|||
126748425|NCT03715205|456027264|FG000|Overall Study|Lost to Follow-up|2|||
126748426|NCT03715205|456027264|FG000|Overall Study|Physician Decision|93|||
126748427|NCT03715205|456027264|FG000|Overall Study|Withdrawal by Subject|26|||
126748428|NCT05492877|456027267|FG000|Overall Study|Adverse Event|11|||
126748429|NCT05492877|456027268|FG001|Overall Study|Adverse Event|7|||
126748430|NCT05492877|456027267|FG000|Overall Study|Death|1|||
126748431|NCT05492877|456027268|FG001|Overall Study|Death|0|||
126748432|NCT05492877|456027267|FG000|Overall Study|Lost to Follow-up|1|||
126748433|NCT05492877|456027268|FG001|Overall Study|Lost to Follow-up|1|||
126748434|NCT05492877|456027267|FG000|Overall Study|Physician Decision|1|||
126748435|NCT05492877|456027268|FG001|Overall Study|Physician Decision|2|||
126748436|NCT05492877|456027267|FG000|Overall Study|Protocol Violation|1|||
126748437|NCT05492877|456027268|FG001|Overall Study|Protocol Violation|1|||
126748438|NCT05492877|456027267|FG000|Overall Study|Withdrawal by Subject|3|||
126748439|NCT05492877|456027268|FG001|Overall Study|Withdrawal by Subject|7|||
126748440|NCT05492877|456027267|FG000|Overall Study|Reason not specified|6|||
126782321|NCT03567057|456158158|FG001|Overall Study|COVID-19 pandemic|3|||
126748441|NCT05492877|456027268|FG001|Overall Study|Reason not specified|4|||
126748442|NCT02286089|456027269|FG000|Overall Study|Ongoing in Study|1|||
126748443|NCT02286089|456027270|FG001|Overall Study|Ongoing in Study|1|||
126748444|NCT02286089|456027271|FG002|Overall Study|Ongoing in Study|4|||
126748445|NCT02286089|456027272|FG003|Overall Study|Ongoing in Study|10|||
126748446|NCT02286089|456027269|FG000|Overall Study|Withdrawal by Subject|0|||
126782322|NCT03567057|456158159|FG002|Overall Study|COVID-19 pandemic|0|||
126622005|NCT00348283|455572571|FG001|Double Blind|Withdrawal by Subject|1|||
126622006|NCT00348283|455572570|FG000|Double Blind|Protocol Violation|0|||
126748447|NCT02286089|456027270|FG001|Overall Study|Withdrawal by Subject|0|||
126748448|NCT02286089|456027271|FG002|Overall Study|Withdrawal by Subject|2|||
126748449|NCT02286089|456027272|FG003|Overall Study|Withdrawal by Subject|2|||
126748450|NCT03733249|456027279|FG000|Overall Study|Death|7|||
126748451|NCT03733249|456027279|FG000|Overall Study|Disease relapse|16|||
126748452|NCT03733249|456027279|FG000|Overall Study|Lost to Follow-up|4|||
126748453|NCT03733249|456027279|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
126748454|NCT03733249|456027279|FG000|Overall Study|Withdrawal by Subject|1|||
126748455|NCT04476108|456027280|FG000|Overall Study|Adverse Event|4|||
126748456|NCT04476108|456027281|FG001|Overall Study|Adverse Event|1|||
126748457|NCT04476108|456027280|FG000|Overall Study|Lost to Follow-up|1|||
126748458|NCT04476108|456027281|FG001|Overall Study|Lost to Follow-up|0|||
126748459|NCT04476108|456027280|FG000|Overall Study|Inadvertent Enrollment|1|||
126748460|NCT04476108|456027281|FG001|Overall Study|Inadvertent Enrollment|0|||
126748461|NCT04476108|456027280|FG000|Overall Study|Protocol Violation|1|||
126748462|NCT04476108|456027281|FG001|Overall Study|Protocol Violation|1|||
126748463|NCT04476108|456027280|FG000|Overall Study|Withdrawal by Subject|1|||
126748464|NCT04476108|456027281|FG001|Overall Study|Withdrawal by Subject|1|||
126748465|NCT02253992|456027282|FG000|Overall Study|Study drug toxicity|1|||
126748466|NCT02253992|456027283|FG001|Overall Study|Study drug toxicity|0|||
126748467|NCT02253992|456027284|FG002|Overall Study|Study drug toxicity|10|||
126748468|NCT02253992|456027282|FG000|Overall Study|Disease progression|4|||
126748469|NCT02253992|456027283|FG001|Overall Study|Disease progression|3|||
126748470|NCT02253992|456027284|FG002|Overall Study|Disease progression|98|||
126748471|NCT02253992|456027282|FG000|Overall Study|Withdrawal by Subject|0|||
126748472|NCT02253992|456027283|FG001|Overall Study|Withdrawal by Subject|0|||
126748473|NCT02253992|456027284|FG002|Overall Study|Withdrawal by Subject|3|||
126748474|NCT02253992|456027282|FG000|Overall Study|Adverse Event|0|||
126748475|NCT02253992|456027283|FG001|Overall Study|Adverse Event|0|||
126748476|NCT02253992|456027284|FG002|Overall Study|Adverse Event|8|||
126748477|NCT02253992|456027282|FG000|Overall Study|Death|0|||
126748478|NCT02253992|456027283|FG001|Overall Study|Death|0|||
126748479|NCT02253992|456027284|FG002|Overall Study|Death|1|||
126748480|NCT02253992|456027282|FG000|Overall Study|Subject discontinued study drug|1|||
126748481|NCT02253992|456027283|FG001|Overall Study|Subject discontinued study drug|0|||
126748482|NCT02253992|456027284|FG002|Overall Study|Subject discontinued study drug|1|||
126748483|NCT02253992|456027282|FG000|Overall Study|Completed treatment as per protocol|0|||
126748484|NCT02253992|456027283|FG001|Overall Study|Completed treatment as per protocol|1|||
126748485|NCT02253992|456027284|FG002|Overall Study|Completed treatment as per protocol|22|||
126748486|NCT02253992|456027282|FG000|Overall Study|Other|0|||
126748487|NCT02253992|456027283|FG001|Overall Study|Other|0|||
126748488|NCT02253992|456027284|FG002|Overall Study|Other|1|||
126748489|NCT00772889|456027285|FG000|Overall Study|Adverse Event|7|||
126748490|NCT00772889|456027286|FG001|Overall Study|Adverse Event|4|||
126748491|NCT00772889|456027287|FG002|Overall Study|Adverse Event|0|||
126748492|NCT00772889|456027285|FG000|Overall Study|Withdrawal by Subject|9|||
126748493|NCT00772889|456027286|FG001|Overall Study|Withdrawal by Subject|8|||
126748494|NCT00772889|456027287|FG002|Overall Study|Withdrawal by Subject|9|||
126748495|NCT00772889|456027285|FG000|Overall Study|Lost to Follow-up|6|||
126748496|NCT00772889|456027286|FG001|Overall Study|Lost to Follow-up|6|||
126748497|NCT00772889|456027287|FG002|Overall Study|Lost to Follow-up|7|||
126748498|NCT03323086|456027288|FG000|Overall Study|Lost to Follow-up|3|||
126748499|NCT03323086|456027289|FG001|Overall Study|Lost to Follow-up|2|||
126748500|NCT00355615|456027290|FG000|Randomized Double Blind Period|Adverse Event|1|||
126748501|NCT00355615|456027291|FG001|Randomized Double Blind Period|Adverse Event|0|||
126748502|NCT00355615|456027292|FG002|Randomized Double Blind Period|Adverse Event|0|||
126748503|NCT00355615|456027293|FG003|Randomized Double Blind Period|Adverse Event|0|||
126748504|NCT00355615|456027294|FG004|Randomized Double Blind Period|Adverse Event|0|||
126748505|NCT00355615|456027290|FG000|Randomized Double Blind Period|Protocol Violation|0|||
126748506|NCT00355615|456027291|FG001|Randomized Double Blind Period|Protocol Violation|0|||
126748507|NCT00355615|456027292|FG002|Randomized Double Blind Period|Protocol Violation|1|||
126748508|NCT00355615|456027293|FG003|Randomized Double Blind Period|Protocol Violation|1|||
126622007|NCT00348283|455572571|FG001|Double Blind|Protocol Violation|1|||
126622008|NCT00348283|455572570|FG000|Double Blind|Lack of Efficacy|2|||
126622009|NCT00348283|455572571|FG001|Double Blind|Lack of Efficacy|2|||
126622010|NCT00348283|455572570|FG000|Double Blind|Pregnancy|0|||
126622011|NCT00348283|455572571|FG001|Double Blind|Pregnancy|1|||
126622012|NCT00348283|455572570|FG000|Open Label|Adverse Event|0|||
126622013|NCT00348283|455572571|FG001|Open Label|Adverse Event|8|||
126622014|NCT00348283|455572570|FG000|Open Label|Withdrawal by Subject|0|||
126622015|NCT00348283|455572571|FG001|Open Label|Withdrawal by Subject|4|||
126622016|NCT00348283|455572570|FG000|Open Label|Lost to Follow-up|0|||
126622017|NCT00348283|455572571|FG001|Open Label|Lost to Follow-up|1|||
126622018|NCT00348283|455572570|FG000|Open Label|Lack of Efficacy|0|||
126748509|NCT00355615|456027294|FG004|Randomized Double Blind Period|Protocol Violation|0|||
126748510|NCT00355615|456027290|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
126622019|NCT00348283|455572571|FG001|Open Label|Lack of Efficacy|13|||
126622020|NCT00348283|455572570|FG000|Open Label|Administrative reasons|0|||
126622021|NCT00348283|455572571|FG001|Open Label|Administrative reasons|5|||
126748511|NCT00355615|456027291|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
126748512|NCT00355615|456027292|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
126748513|NCT00355615|456027293|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
126748514|NCT00355615|456027294|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
126748515|NCT00355615|456027290|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
126748516|NCT00355615|456027291|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
126748517|NCT00355615|456027292|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
126622022|NCT00348283|455572570|FG000|Open Label|Subject moved to the United States|0|||
126622023|NCT00348283|455572571|FG001|Open Label|Subject moved to the United States|1|||
126622024|NCT00348283|455572570|FG000|Open Label|Pregnancy|0|||
126748518|NCT00355615|456027293|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
126748519|NCT00355615|456027294|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
126748520|NCT00355615|456027290|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
126748521|NCT00355615|456027291|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
126748522|NCT00355615|456027292|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
126748523|NCT00355615|456027293|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
126748524|NCT00355615|456027294|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
126748525|NCT00355615|456027290|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
126748526|NCT00355615|456027291|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
126748527|NCT00355615|456027292|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
126748528|NCT00355615|456027293|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
126748529|NCT00355615|456027294|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
126748530|NCT04247828|456027296|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
126748531|NCT02159365|456027297|FG000|Overall Study|Disease Progression|23|||
126748532|NCT02159365|456027297|FG000|Overall Study|Other reasons|11|||
126748533|NCT02159365|456027297|FG000|Overall Study|Administrative reason by Sponsor|9|||
126748534|NCT02159365|456027297|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
126748535|NCT02159365|456027297|FG000|Overall Study|Study drug toxicity|7|||
126748536|NCT02159365|456027297|FG000|Overall Study|Maximum clinical benefit|3|||
126748537|NCT02159365|456027297|FG000|Overall Study|Subject request to discontinue treatment|3|||
126748538|NCT02159365|456027297|FG000|Overall Study|Subject withdrew consent|3|||
126748539|NCT02159365|456027297|FG000|Overall Study|Death|1|||
126748540|NCT02159365|456027297|FG000|Overall Study|Lost to Follow-up|1|||
126748541|NCT03523715|456027298|FG000|Overall Study|Lost to Follow-up|11|||
126748542|NCT03523715|456027299|FG001|Overall Study|Lost to Follow-up|14|||
126748543|NCT03523715|456027298|FG000|Overall Study|Did not meet inclusion criteria|1|||
126748544|NCT03523715|456027299|FG001|Overall Study|Did not meet inclusion criteria|0|||
126748545|NCT03523715|456027298|FG000|Overall Study|Internally inconsistent reporting|0|||
126748546|NCT03523715|456027299|FG001|Overall Study|Internally inconsistent reporting|2|||
126748547|NCT03299166|456027300|FG000|Overall Study|Adverse Event|9|||
126748548|NCT03299166|456027301|FG001|Overall Study|Adverse Event|4|||
126748549|NCT03299166|456027300|FG000|Overall Study|Withdrawal by Subject|6|||
126748550|NCT03299166|456027301|FG001|Overall Study|Withdrawal by Subject|5|||
126748551|NCT03299166|456027300|FG000|Overall Study|Physician Decision|1|||
126748552|NCT03299166|456027301|FG001|Overall Study|Physician Decision|1|||
126748553|NCT03299166|456027300|FG000|Overall Study|Sponsor Decision|3|||
126748554|NCT03299166|456027301|FG001|Overall Study|Sponsor Decision|0|||
126748555|NCT03299166|456027300|FG000|Overall Study|Lost to Follow-up|2|||
126748556|NCT03299166|456027301|FG001|Overall Study|Lost to Follow-up|4|||
126748557|NCT03299166|456027300|FG000|Overall Study|Randomization Error|0|||
126748558|NCT03299166|456027301|FG001|Overall Study|Randomization Error|1|||
126748559|NCT03299166|456027300|FG000|Overall Study|Subject unable to return due to COVID|1|||
126748560|NCT03299166|456027301|FG001|Overall Study|Subject unable to return due to COVID|0|||
126748561|NCT03299166|456027300|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
126748562|NCT03299166|456027301|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
126748563|NCT03457636|456027302|FG000|Overall Study|Lost to Follow-up|2|||
126748564|NCT04035473|456027313|FG000|Screening/Baseline|Death|0|||
126748565|NCT04035473|456027314|FG001|Screening/Baseline|Death|1|||
126748566|NCT04035473|456027313|FG000|Screening/Baseline|Adverse Event|0|||
126748567|NCT04035473|456027314|FG001|Screening/Baseline|Adverse Event|1|||
126748568|NCT04035473|456027313|FG000|Follow-up Period|Adverse Event|2|||
126748569|NCT04035473|456027314|FG001|Follow-up Period|Adverse Event|0|||
126748570|NCT00112840|456027315|FG000|Overall Study|Physician Decision|1|||
126748571|NCT00112840|456027316|FG001|Overall Study|Physician Decision|0|||
126748572|NCT00112840|456027317|FG002|Overall Study|Physician Decision|0|||
126748573|NCT00112840|456027315|FG000|Overall Study|Withdrawal by Subject|1|||
126748574|NCT00112840|456027316|FG001|Overall Study|Withdrawal by Subject|0|||
126748575|NCT00112840|456027317|FG002|Overall Study|Withdrawal by Subject|1|||
126748576|NCT00112840|456027315|FG000|Overall Study|Protocol Violation|0|||
126622025|NCT00348283|455572571|FG001|Open Label|Pregnancy|1|||
126622026|NCT00348283|455572570|FG000|Open Label|Sponsor decision|0|||
126748577|NCT00112840|456027316|FG001|Overall Study|Protocol Violation|0|||
126748578|NCT00112840|456027317|FG002|Overall Study|Protocol Violation|5|||
126748579|NCT02299206|456027318|FG000|Overall Study|Lost to Follow-up|1|||
126748580|NCT02299206|456027318|FG000|Overall Study|Withdrawal by Subject|1|||
126748581|NCT02875366|456027319|FG000|Overall Study|Adverse Event|0|||
126748582|NCT02875366|456027320|FG001|Overall Study|Adverse Event|2|||
126748583|NCT02875366|456027319|FG000|Overall Study|Noncompliance|0|||
126748584|NCT02875366|456027320|FG001|Overall Study|Noncompliance|1|||
126622027|NCT00348283|455572571|FG001|Open Label|Sponsor decision|1|||
126748585|NCT03595176|456027321|FG000|Overall Study|Death|0|||
126748586|NCT03595176|456027322|FG001|Overall Study|Death|2|||
126622028|NCT02588027|455572572|FG000|Overall Study|Withdrawal by Subject|1|||
126622029|NCT02588027|455572573|FG001|Overall Study|Withdrawal by Subject|3|||
126622030|NCT02588027|455572572|FG000|Overall Study|Protocol Violation|4|||
126622031|NCT02588027|455572573|FG001|Overall Study|Protocol Violation|1|||
126622032|NCT04853394|455572579|FG000|Follow-up Interviews|Lost to Follow-up|22|||
126622033|NCT04853394|455572580|FG001|Follow-up Interviews|Lost to Follow-up|15|||
126622034|NCT04212299|455572581|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
126622035|NCT04413149|455574052|FG000|Overall Study|Death|10|||
126622036|NCT04413149|455574053|FG001|Overall Study|Death|5|||
126622037|NCT04413149|455574052|FG000|Overall Study|Lung transplantation|1|||
126622038|NCT04413149|455574053|FG001|Overall Study|Lung transplantation|0|||
126622039|NCT05335005|455574057|FG000|Overall Study|Lost to Follow-up|1|||
126622040|NCT04050722|455574058|FG000|Overall Study|Withdrawal by Subject|1|||
126622041|NCT04050722|455574059|FG001|Overall Study|Withdrawal by Subject|0|||
126622042|NCT02339506|455574066|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
126622043|NCT02339506|455574067|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
126622044|NCT02339506|455574066|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
126622045|NCT02339506|455574067|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
126622046|NCT01572493|455574068|FG000|Overall Study|Physician Decision|1|||
126622047|NCT01572493|455574069|FG001|Overall Study|Physician Decision|0|||
126622048|NCT01572493|455574070|FG002|Overall Study|Physician Decision|0|||
126622049|NCT01572493|455574071|FG003|Overall Study|Physician Decision|0|||
126622050|NCT01572493|455574072|FG004|Overall Study|Physician Decision|0|||
126622051|NCT01572493|455574073|FG005|Overall Study|Physician Decision|0|||
126622052|NCT01572493|455574074|FG006|Overall Study|Physician Decision|0|||
126622053|NCT01572493|455574075|FG007|Overall Study|Physician Decision|0|||
126622054|NCT01572493|455574076|FG008|Overall Study|Physician Decision|0|||
126622055|NCT01572493|455574068|FG000|Overall Study|Switched to alternative treatment|0|||
126622056|NCT01572493|455574069|FG001|Overall Study|Switched to alternative treatment|1|||
126622057|NCT01572493|455574070|FG002|Overall Study|Switched to alternative treatment|2|||
126622058|NCT01572493|455574071|FG003|Overall Study|Switched to alternative treatment|1|||
126622059|NCT01572493|455574072|FG004|Overall Study|Switched to alternative treatment|2|||
126622060|NCT01572493|455574073|FG005|Overall Study|Switched to alternative treatment|0|||
126622061|NCT01572493|455574074|FG006|Overall Study|Switched to alternative treatment|2|||
126622062|NCT01572493|455574075|FG007|Overall Study|Switched to alternative treatment|0|||
126622063|NCT01572493|455574076|FG008|Overall Study|Switched to alternative treatment|2|||
126622064|NCT01572493|455574068|FG000|Overall Study|Death|0|||
126622065|NCT01572493|455574069|FG001|Overall Study|Death|0|||
126622066|NCT01572493|455574070|FG002|Overall Study|Death|0|||
126622067|NCT01572493|455574071|FG003|Overall Study|Death|1|||
126622068|NCT01572493|455574072|FG004|Overall Study|Death|0|||
126622069|NCT01572493|455574073|FG005|Overall Study|Death|1|||
126622070|NCT01572493|455574074|FG006|Overall Study|Death|0|||
126622071|NCT01572493|455574075|FG007|Overall Study|Death|0|||
126622072|NCT01572493|455574076|FG008|Overall Study|Death|0|||
126622073|NCT01572493|455574068|FG000|Overall Study|Adverse Event|0|||
126622074|NCT01572493|455574069|FG001|Overall Study|Adverse Event|0|||
126622075|NCT01572493|455574070|FG002|Overall Study|Adverse Event|0|||
126622076|NCT01572493|455574071|FG003|Overall Study|Adverse Event|0|||
126622077|NCT01572493|455574072|FG004|Overall Study|Adverse Event|0|||
126622078|NCT01572493|455574073|FG005|Overall Study|Adverse Event|0|||
126622079|NCT01572493|455574074|FG006|Overall Study|Adverse Event|1|||
126622080|NCT01572493|455574075|FG007|Overall Study|Adverse Event|0|||
126622081|NCT01572493|455574076|FG008|Overall Study|Adverse Event|0|||
126622082|NCT00609245|455574077|FG000|Overall Study|Adverse Event|1|||
126622083|NCT01234675|455574078|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
126622084|NCT01234675|455574079|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
126622085|NCT01234675|455574078|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
126622086|NCT01234675|455574079|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
126622087|NCT00331799|455574080|FG000|Overall Study|Withdrawal by Subject|2|||
126622088|NCT00331799|455574080|FG000|Overall Study|Sedation|1|||
126622089|NCT02889809|455574081|FG000|Overall Study|Withdrawal by Subject|30|||
126622090|NCT02889809|455574082|FG001|Overall Study|Withdrawal by Subject|21|||
126622091|NCT02889809|455574081|FG000|Overall Study|Lost to Follow-up|1|||
126622092|NCT02889809|455574082|FG001|Overall Study|Lost to Follow-up|1|||
126622093|NCT02889809|455574081|FG000|Overall Study|Site Closed|12|||
126748587|NCT03595176|456027321|FG000|Overall Study|Lost to Follow-up|0|||
126622094|NCT02889809|455574082|FG001|Overall Study|Site Closed|11|||
126622095|NCT01090076|455574085|FG000|Overall Study|Death|1|||
126622096|NCT01090076|455574086|FG001|Overall Study|Death|1|||
126748588|NCT03595176|456027322|FG001|Overall Study|Lost to Follow-up|1|||
126622097|NCT01090076|455574085|FG000|Overall Study|Withdrawal by Subject|0|||
126622098|NCT01090076|455574086|FG001|Overall Study|Withdrawal by Subject|1|||
126622099|NCT01116440|455574088|FG000|Treatment|Withdrawal by Subject|2|||
126622100|NCT01116440|455574089|FG001|Treatment|Withdrawal by Subject|2|||
126622101|NCT01116440|455574088|FG000|Treatment|Lost to Follow-up|1|||
126622102|NCT01116440|455574089|FG001|Treatment|Lost to Follow-up|1|||
126748589|NCT01682759|456027326|FG000|Overall Study|Death|2|||
126748590|NCT01682759|456027327|FG001|Overall Study|Death|1|||
126748591|NCT01682759|456027326|FG000|Overall Study|Lost to Follow-up|10|||
126748592|NCT01682759|456027327|FG001|Overall Study|Lost to Follow-up|13|||
126748593|NCT01682759|456027326|FG000|Overall Study|Physician Decision|1|||
126748594|NCT01682759|456027327|FG001|Overall Study|Physician Decision|1|||
126748595|NCT01682759|456027326|FG000|Overall Study|Withdrawal by Subject|56|||
126748596|NCT01682759|456027327|FG001|Overall Study|Withdrawal by Subject|55|||
126748597|NCT02141854|456027328|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
126748598|NCT02141854|456027329|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126748599|NCT02141854|456027330|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126748600|NCT02141854|456027331|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126748601|NCT02141854|456027332|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126748602|NCT02141854|456027333|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
126748603|NCT02141854|456027328|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
126748604|NCT02141854|456027329|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126748605|NCT02141854|456027330|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126748606|NCT02141854|456027331|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126748607|NCT02141854|456027332|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126748608|NCT02141854|456027333|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
126748609|NCT02141854|456027328|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
126748610|NCT02141854|456027329|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126748611|NCT02141854|456027330|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126748612|NCT02141854|456027331|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126748613|NCT02141854|456027332|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126748614|NCT02141854|456027333|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
126748615|NCT02141854|456027328|FG000|Run-In Period (Pre-assignment)|Other|14|||
126748616|NCT02141854|456027329|FG001|Run-In Period (Pre-assignment)|Other|0|||
126748617|NCT02141854|456027330|FG002|Run-In Period (Pre-assignment)|Other|0|||
126748618|NCT02141854|456027331|FG003|Run-In Period (Pre-assignment)|Other|0|||
126748619|NCT02141854|456027332|FG004|Run-In Period (Pre-assignment)|Other|0|||
126748620|NCT02141854|456027333|FG005|Run-In Period (Pre-assignment)|Other|0|||
126748621|NCT02141854|456027328|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
126748622|NCT02141854|456027329|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
126748623|NCT02141854|456027330|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
126748624|NCT02141854|456027331|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
126748625|NCT02141854|456027332|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
126748626|NCT02141854|456027333|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
126748627|NCT02141854|456027328|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
126748628|NCT02141854|456027329|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126748629|NCT02141854|456027330|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126748630|NCT02141854|456027331|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126748631|NCT02141854|456027332|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126748632|NCT02141854|456027333|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
126748633|NCT02141854|456027328|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
126748634|NCT02141854|456027329|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126748635|NCT02141854|456027330|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126748636|NCT02141854|456027331|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126748637|NCT02141854|456027332|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126748638|NCT02141854|456027333|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
126748639|NCT02141854|456027328|FG000|Treatment Period|Protocol Violation|0|||
126748640|NCT02141854|456027329|FG001|Treatment Period|Protocol Violation|1|||
126748641|NCT02141854|456027330|FG002|Treatment Period|Protocol Violation|0|||
126748642|NCT02141854|456027331|FG003|Treatment Period|Protocol Violation|2|||
126782323|NCT03567057|456158157|FG000|Overall Study|Non-compliance with study drug|4|||
126748643|NCT02141854|456027332|FG004|Treatment Period|Protocol Violation|2|||
126748644|NCT02141854|456027333|FG005|Treatment Period|Protocol Violation|1|||
126748645|NCT02141854|456027328|FG000|Treatment Period|Noncompliance|0|||
126748646|NCT02141854|456027329|FG001|Treatment Period|Noncompliance|0|||
126748647|NCT02141854|456027330|FG002|Treatment Period|Noncompliance|0|||
126748648|NCT02141854|456027331|FG003|Treatment Period|Noncompliance|1|||
126748649|NCT02141854|456027332|FG004|Treatment Period|Noncompliance|0|||
126748650|NCT02141854|456027333|FG005|Treatment Period|Noncompliance|0|||
126748651|NCT02141854|456027328|FG000|Treatment Period|Lack of Efficacy|0|||
126748652|NCT02141854|456027329|FG001|Treatment Period|Lack of Efficacy|0|||
126748653|NCT02141854|456027330|FG002|Treatment Period|Lack of Efficacy|0|||
126748654|NCT02141854|456027331|FG003|Treatment Period|Lack of Efficacy|1|||
126748655|NCT02141854|456027332|FG004|Treatment Period|Lack of Efficacy|1|||
126748656|NCT02141854|456027333|FG005|Treatment Period|Lack of Efficacy|7|||
126748657|NCT02141854|456027328|FG000|Treatment Period|Pregnancy|0|||
126782324|NCT03567057|456158158|FG001|Overall Study|Non-compliance with study drug|2|||
126622103|NCT01116440|455574088|FG000|Treatment|Protocol Violation|0|||
126748658|NCT02141854|456027329|FG001|Treatment Period|Pregnancy|1|||
126748659|NCT02141854|456027330|FG002|Treatment Period|Pregnancy|0|||
126748660|NCT02141854|456027331|FG003|Treatment Period|Pregnancy|0|||
126748661|NCT02141854|456027332|FG004|Treatment Period|Pregnancy|0|||
126748662|NCT02141854|456027333|FG005|Treatment Period|Pregnancy|0|||
126748663|NCT02141854|456027328|FG000|Treatment Period|Other|0|||
126748664|NCT02141854|456027329|FG001|Treatment Period|Other|1|||
126748665|NCT02141854|456027330|FG002|Treatment Period|Other|2|||
126748666|NCT02141854|456027331|FG003|Treatment Period|Other|0|||
126748667|NCT02141854|456027332|FG004|Treatment Period|Other|1|||
126748668|NCT02141854|456027333|FG005|Treatment Period|Other|2|||
126748669|NCT02141854|456027328|FG000|Treatment Period|Adverse Event|0|||
126748670|NCT02141854|456027329|FG001|Treatment Period|Adverse Event|2|||
126748671|NCT02141854|456027330|FG002|Treatment Period|Adverse Event|2|||
126748672|NCT02141854|456027331|FG003|Treatment Period|Adverse Event|0|||
126748673|NCT02141854|456027332|FG004|Treatment Period|Adverse Event|2|||
126748674|NCT02141854|456027333|FG005|Treatment Period|Adverse Event|2|||
126748675|NCT02141854|456027328|FG000|Treatment Period|Withdrawal by Subject|0|||
126748676|NCT02141854|456027329|FG001|Treatment Period|Withdrawal by Subject|2|||
126748677|NCT02141854|456027330|FG002|Treatment Period|Withdrawal by Subject|3|||
126748678|NCT02141854|456027331|FG003|Treatment Period|Withdrawal by Subject|3|||
126748679|NCT02141854|456027332|FG004|Treatment Period|Withdrawal by Subject|4|||
126748680|NCT02141854|456027333|FG005|Treatment Period|Withdrawal by Subject|7|||
126748681|NCT02141854|456027328|FG000|Treatment Period|Disease progression|0|||
126748682|NCT02141854|456027329|FG001|Treatment Period|Disease progression|2|||
126748683|NCT02141854|456027330|FG002|Treatment Period|Disease progression|1|||
126748684|NCT02141854|456027331|FG003|Treatment Period|Disease progression|3|||
126748685|NCT02141854|456027332|FG004|Treatment Period|Disease progression|0|||
126748686|NCT02141854|456027333|FG005|Treatment Period|Disease progression|18|||
126748687|NCT02141854|456027328|FG000|Treatment Period|Lost to Follow-up|0|||
126748688|NCT02141854|456027329|FG001|Treatment Period|Lost to Follow-up|1|||
126748689|NCT02141854|456027330|FG002|Treatment Period|Lost to Follow-up|1|||
126748690|NCT02141854|456027331|FG003|Treatment Period|Lost to Follow-up|1|||
126748691|NCT02141854|456027332|FG004|Treatment Period|Lost to Follow-up|0|||
126748692|NCT02141854|456027333|FG005|Treatment Period|Lost to Follow-up|1|||
126748693|NCT01201967|456027336|FG000|Overall Study|Lost to Follow-up|6|||
126748694|NCT01201967|456027337|FG001|Overall Study|Lost to Follow-up|5|||
126748695|NCT03128307|456027343|FG000|Overall Study|Lost to Follow-up|29|||
126748696|NCT03128307|456027343|FG000|Overall Study|Withdrawal by Subject|5|||
126748697|NCT01693562|456029131|FG000|Escalation Phase|Withdrawal by Subject|0|||
126748698|NCT01693562|456029132|FG001|Escalation Phase|Withdrawal by Subject|1|||
126748699|NCT01693562|456029133|FG002|Escalation Phase|Withdrawal by Subject|0|||
126748700|NCT01693562|456029134|FG003|Escalation Phase|Withdrawal by Subject|0|||
126748701|NCT01693562|456029135|FG004|Escalation Phase|Withdrawal by Subject|0|||
126748702|NCT01693562|456029136|FG005|Escalation Phase|Withdrawal by Subject|2|||
126748703|NCT01693562|456029137|FG006|Escalation Phase|Withdrawal by Subject|0|||
126748704|NCT01693562|456029138|FG007|Escalation Phase|Withdrawal by Subject|0|||
126748705|NCT01693562|456029139|FG008|Escalation Phase|Withdrawal by Subject|0|||
126748706|NCT01693562|456029140|FG009|Escalation Phase|Withdrawal by Subject|0|||
126748707|NCT01693562|456029141|FG010|Escalation Phase|Withdrawal by Subject|0|||
126748708|NCT01693562|456029142|FG011|Escalation Phase|Withdrawal by Subject|0|||
126748709|NCT01693562|456029143|FG012|Escalation Phase|Withdrawal by Subject|0|||
126748710|NCT01693562|456029144|FG013|Escalation Phase|Withdrawal by Subject|0|||
126748711|NCT01693562|456029145|FG014|Escalation Phase|Withdrawal by Subject|0|||
126748712|NCT01693562|456029146|FG015|Escalation Phase|Withdrawal by Subject|0|||
126748713|NCT01693562|456029147|FG016|Escalation Phase|Withdrawal by Subject|0|||
126748714|NCT01693562|456029148|FG017|Escalation Phase|Withdrawal by Subject|0|||
126748715|NCT01693562|456029149|FG018|Escalation Phase|Withdrawal by Subject|0|||
126748716|NCT01693562|456029150|FG019|Escalation Phase|Withdrawal by Subject|0|||
126748717|NCT01693562|456029151|FG020|Escalation Phase|Withdrawal by Subject|0|||
126748718|NCT01693562|456029152|FG021|Escalation Phase|Withdrawal by Subject|0|||
126748719|NCT01693562|456029153|FG022|Escalation Phase|Withdrawal by Subject|0|||
126748720|NCT01693562|456029131|FG000|Escalation Phase|Death|4|||
126748721|NCT01693562|456029132|FG001|Escalation Phase|Death|2|||
126748722|NCT01693562|456029133|FG002|Escalation Phase|Death|0|||
126748723|NCT01693562|456029134|FG003|Escalation Phase|Death|3|||
126748724|NCT01693562|456029135|FG004|Escalation Phase|Death|6|||
126748725|NCT01693562|456029136|FG005|Escalation Phase|Death|4|||
126748726|NCT01693562|456029137|FG006|Escalation Phase|Death|0|||
126748727|NCT01693562|456029138|FG007|Escalation Phase|Death|0|||
126748728|NCT01693562|456029139|FG008|Escalation Phase|Death|0|||
126748729|NCT01693562|456029140|FG009|Escalation Phase|Death|0|||
126748730|NCT01693562|456029141|FG010|Escalation Phase|Death|0|||
126748731|NCT01693562|456029142|FG011|Escalation Phase|Death|0|||
126748732|NCT01693562|456029143|FG012|Escalation Phase|Death|0|||
126748733|NCT01693562|456029144|FG013|Escalation Phase|Death|0|||
126748734|NCT01693562|456029145|FG014|Escalation Phase|Death|0|||
126748735|NCT01693562|456029146|FG015|Escalation Phase|Death|0|||
126748736|NCT01693562|456029147|FG016|Escalation Phase|Death|0|||
126748737|NCT01693562|456029148|FG017|Escalation Phase|Death|0|||
126748738|NCT01693562|456029149|FG018|Escalation Phase|Death|0|||
126748739|NCT01693562|456029150|FG019|Escalation Phase|Death|0|||
126748740|NCT01693562|456029151|FG020|Escalation Phase|Death|0|||
126748741|NCT01693562|456029152|FG021|Escalation Phase|Death|0|||
126748742|NCT01693562|456029153|FG022|Escalation Phase|Death|0|||
126748743|NCT01693562|456029131|FG000|Escalation Phase|Lost to Follow-up|0|||
126748744|NCT01693562|456029132|FG001|Escalation Phase|Lost to Follow-up|1|||
126748745|NCT01693562|456029133|FG002|Escalation Phase|Lost to Follow-up|1|||
126748746|NCT01693562|456029134|FG003|Escalation Phase|Lost to Follow-up|0|||
126748747|NCT01693562|456029135|FG004|Escalation Phase|Lost to Follow-up|0|||
126748748|NCT01693562|456029136|FG005|Escalation Phase|Lost to Follow-up|0|||
126748749|NCT01693562|456029137|FG006|Escalation Phase|Lost to Follow-up|0|||
126748750|NCT01693562|456029138|FG007|Escalation Phase|Lost to Follow-up|0|||
126748751|NCT01693562|456029139|FG008|Escalation Phase|Lost to Follow-up|0|||
126748752|NCT01693562|456029140|FG009|Escalation Phase|Lost to Follow-up|0|||
126748753|NCT01693562|456029141|FG010|Escalation Phase|Lost to Follow-up|0|||
126748754|NCT01693562|456029142|FG011|Escalation Phase|Lost to Follow-up|0|||
126748755|NCT01693562|456029143|FG012|Escalation Phase|Lost to Follow-up|0|||
126748756|NCT01693562|456029144|FG013|Escalation Phase|Lost to Follow-up|0|||
126748757|NCT01693562|456029145|FG014|Escalation Phase|Lost to Follow-up|0|||
126748758|NCT01693562|456029146|FG015|Escalation Phase|Lost to Follow-up|0|||
126748759|NCT01693562|456029147|FG016|Escalation Phase|Lost to Follow-up|0|||
126748760|NCT01693562|456029148|FG017|Escalation Phase|Lost to Follow-up|0|||
126748761|NCT01693562|456029149|FG018|Escalation Phase|Lost to Follow-up|0|||
126748762|NCT01693562|456029150|FG019|Escalation Phase|Lost to Follow-up|0|||
126748763|NCT01693562|456029151|FG020|Escalation Phase|Lost to Follow-up|0|||
126748764|NCT01693562|456029152|FG021|Escalation Phase|Lost to Follow-up|0|||
126748765|NCT01693562|456029153|FG022|Escalation Phase|Lost to Follow-up|0|||
126748766|NCT01693562|456029131|FG000|Escalation Phase|Other|0|||
126748767|NCT01693562|456029132|FG001|Escalation Phase|Other|0|||
126748768|NCT01693562|456029133|FG002|Escalation Phase|Other|2|||
126748769|NCT01693562|456029134|FG003|Escalation Phase|Other|0|||
126748770|NCT01693562|456029135|FG004|Escalation Phase|Other|0|||
126748771|NCT01693562|456029136|FG005|Escalation Phase|Other|1|||
126748772|NCT01693562|456029137|FG006|Escalation Phase|Other|0|||
126748773|NCT01693562|456029138|FG007|Escalation Phase|Other|0|||
126748774|NCT01693562|456029139|FG008|Escalation Phase|Other|0|||
126748775|NCT01693562|456029140|FG009|Escalation Phase|Other|0|||
126748776|NCT01693562|456029141|FG010|Escalation Phase|Other|0|||
126748777|NCT01693562|456029142|FG011|Escalation Phase|Other|0|||
126748778|NCT01693562|456029143|FG012|Escalation Phase|Other|0|||
126748779|NCT01693562|456029144|FG013|Escalation Phase|Other|0|||
126748780|NCT01693562|456029145|FG014|Escalation Phase|Other|0|||
126748781|NCT01693562|456029146|FG015|Escalation Phase|Other|0|||
126748782|NCT01693562|456029147|FG016|Escalation Phase|Other|0|||
126748783|NCT01693562|456029148|FG017|Escalation Phase|Other|0|||
126748784|NCT01693562|456029149|FG018|Escalation Phase|Other|0|||
126748785|NCT01693562|456029150|FG019|Escalation Phase|Other|0|||
126748786|NCT01693562|456029151|FG020|Escalation Phase|Other|0|||
126748787|NCT01693562|456029152|FG021|Escalation Phase|Other|0|||
126748788|NCT01693562|456029153|FG022|Escalation Phase|Other|0|||
126748789|NCT01693562|456029131|FG000|Exploration Phase|Withdrawal by Subject|0|||
126748790|NCT01693562|456029132|FG001|Exploration Phase|Withdrawal by Subject|0|||
126748791|NCT01693562|456029133|FG002|Exploration Phase|Withdrawal by Subject|0|||
126748792|NCT01693562|456029134|FG003|Exploration Phase|Withdrawal by Subject|0|||
126622104|NCT01116440|455574089|FG001|Treatment|Protocol Violation|2|||
126622105|NCT01116440|455574088|FG000|Treatment|Lack of Efficacy|0|||
126748793|NCT01693562|456029135|FG004|Exploration Phase|Withdrawal by Subject|0|||
126748794|NCT01693562|456029136|FG005|Exploration Phase|Withdrawal by Subject|0|||
126748795|NCT01693562|456029137|FG006|Exploration Phase|Withdrawal by Subject|2|||
126748796|NCT01693562|456029138|FG007|Exploration Phase|Withdrawal by Subject|0|||
126748797|NCT01693562|456029139|FG008|Exploration Phase|Withdrawal by Subject|0|||
126748798|NCT01693562|456029140|FG009|Exploration Phase|Withdrawal by Subject|0|||
126748799|NCT01693562|456029141|FG010|Exploration Phase|Withdrawal by Subject|0|||
126748800|NCT01693562|456029142|FG011|Exploration Phase|Withdrawal by Subject|0|||
126748801|NCT01693562|456029143|FG012|Exploration Phase|Withdrawal by Subject|0|||
126748802|NCT01693562|456029144|FG013|Exploration Phase|Withdrawal by Subject|0|||
126748803|NCT01693562|456029145|FG014|Exploration Phase|Withdrawal by Subject|0|||
126748804|NCT01693562|456029146|FG015|Exploration Phase|Withdrawal by Subject|0|||
126748805|NCT01693562|456029147|FG016|Exploration Phase|Withdrawal by Subject|0|||
126748806|NCT01693562|456029148|FG017|Exploration Phase|Withdrawal by Subject|0|||
126748807|NCT01693562|456029149|FG018|Exploration Phase|Withdrawal by Subject|0|||
126748808|NCT01693562|456029150|FG019|Exploration Phase|Withdrawal by Subject|0|||
126748809|NCT01693562|456029151|FG020|Exploration Phase|Withdrawal by Subject|0|||
126748810|NCT01693562|456029152|FG021|Exploration Phase|Withdrawal by Subject|0|||
126748811|NCT01693562|456029153|FG022|Exploration Phase|Withdrawal by Subject|0|||
126748812|NCT01693562|456029131|FG000|Exploration Phase|Death|0|||
126748813|NCT01693562|456029132|FG001|Exploration Phase|Death|0|||
126748814|NCT01693562|456029133|FG002|Exploration Phase|Death|0|||
126748815|NCT01693562|456029134|FG003|Exploration Phase|Death|0|||
126748816|NCT01693562|456029135|FG004|Exploration Phase|Death|0|||
126748817|NCT01693562|456029136|FG005|Exploration Phase|Death|0|||
126748818|NCT01693562|456029137|FG006|Exploration Phase|Death|17|||
126748819|NCT01693562|456029138|FG007|Exploration Phase|Death|0|||
126748820|NCT01693562|456029139|FG008|Exploration Phase|Death|0|||
126748821|NCT01693562|456029140|FG009|Exploration Phase|Death|0|||
126748822|NCT01693562|456029141|FG010|Exploration Phase|Death|0|||
126748823|NCT01693562|456029142|FG011|Exploration Phase|Death|0|||
126748824|NCT01693562|456029143|FG012|Exploration Phase|Death|0|||
126748825|NCT01693562|456029144|FG013|Exploration Phase|Death|0|||
126748826|NCT01693562|456029145|FG014|Exploration Phase|Death|0|||
126748827|NCT01693562|456029146|FG015|Exploration Phase|Death|0|||
126748828|NCT01693562|456029147|FG016|Exploration Phase|Death|0|||
126748829|NCT01693562|456029148|FG017|Exploration Phase|Death|0|||
126748830|NCT01693562|456029149|FG018|Exploration Phase|Death|0|||
126748831|NCT01693562|456029150|FG019|Exploration Phase|Death|0|||
126748832|NCT01693562|456029151|FG020|Exploration Phase|Death|0|||
126748833|NCT01693562|456029152|FG021|Exploration Phase|Death|0|||
126748834|NCT01693562|456029153|FG022|Exploration Phase|Death|0|||
126748835|NCT01693562|456029131|FG000|Exploration Phase|Other|0|||
126748836|NCT01693562|456029132|FG001|Exploration Phase|Other|0|||
126748837|NCT01693562|456029133|FG002|Exploration Phase|Other|0|||
126748838|NCT01693562|456029134|FG003|Exploration Phase|Other|0|||
126748839|NCT01693562|456029135|FG004|Exploration Phase|Other|0|||
126748840|NCT01693562|456029136|FG005|Exploration Phase|Other|0|||
126748841|NCT01693562|456029137|FG006|Exploration Phase|Other|2|||
126748842|NCT01693562|456029138|FG007|Exploration Phase|Other|0|||
126748843|NCT01693562|456029139|FG008|Exploration Phase|Other|0|||
126748844|NCT01693562|456029140|FG009|Exploration Phase|Other|0|||
126748845|NCT01693562|456029141|FG010|Exploration Phase|Other|0|||
126748846|NCT01693562|456029142|FG011|Exploration Phase|Other|0|||
126748847|NCT01693562|456029143|FG012|Exploration Phase|Other|0|||
126748848|NCT01693562|456029144|FG013|Exploration Phase|Other|0|||
126748849|NCT01693562|456029145|FG014|Exploration Phase|Other|0|||
126748850|NCT01693562|456029146|FG015|Exploration Phase|Other|0|||
126748851|NCT01693562|456029147|FG016|Exploration Phase|Other|0|||
126748852|NCT01693562|456029148|FG017|Exploration Phase|Other|0|||
126748853|NCT01693562|456029149|FG018|Exploration Phase|Other|0|||
126748854|NCT01693562|456029150|FG019|Exploration Phase|Other|0|||
126748855|NCT01693562|456029151|FG020|Exploration Phase|Other|0|||
126748856|NCT01693562|456029152|FG021|Exploration Phase|Other|0|||
126748857|NCT01693562|456029153|FG022|Exploration Phase|Other|0|||
126748858|NCT01693562|456029131|FG000|Expansion Phase|Withdrawal by Subject|0|||
126748859|NCT01693562|456029132|FG001|Expansion Phase|Withdrawal by Subject|0|||
126748860|NCT01693562|456029133|FG002|Expansion Phase|Withdrawal by Subject|0|||
126748861|NCT01693562|456029134|FG003|Expansion Phase|Withdrawal by Subject|0|||
126748862|NCT01693562|456029135|FG004|Expansion Phase|Withdrawal by Subject|0|||
126748863|NCT01693562|456029136|FG005|Expansion Phase|Withdrawal by Subject|0|||
126748864|NCT01693562|456029137|FG006|Expansion Phase|Withdrawal by Subject|0|||
126748865|NCT01693562|456029138|FG007|Expansion Phase|Withdrawal by Subject|16|||
126748866|NCT01693562|456029139|FG008|Expansion Phase|Withdrawal by Subject|2|||
126748867|NCT01693562|456029140|FG009|Expansion Phase|Withdrawal by Subject|54|||
126748868|NCT01693562|456029141|FG010|Expansion Phase|Withdrawal by Subject|2|||
126748869|NCT01693562|456029142|FG011|Expansion Phase|Withdrawal by Subject|2|||
126748870|NCT01693562|456029143|FG012|Expansion Phase|Withdrawal by Subject|3|||
126748871|NCT01693562|456029144|FG013|Expansion Phase|Withdrawal by Subject|5|||
126748872|NCT01693562|456029145|FG014|Expansion Phase|Withdrawal by Subject|16|||
126748873|NCT01693562|456029146|FG015|Expansion Phase|Withdrawal by Subject|7|||
126748874|NCT01693562|456029147|FG016|Expansion Phase|Withdrawal by Subject|40|||
126748875|NCT01693562|456029148|FG017|Expansion Phase|Withdrawal by Subject|4|||
126782325|NCT03567057|456158159|FG002|Overall Study|Non-compliance with study drug|0|||
126782326|NCT03567057|456158157|FG000|Overall Study|Lack of Efficacy|3|||
126748876|NCT01693562|456029149|FG018|Expansion Phase|Withdrawal by Subject|8|||
126748877|NCT01693562|456029150|FG019|Expansion Phase|Withdrawal by Subject|3|||
126748878|NCT01693562|456029151|FG020|Expansion Phase|Withdrawal by Subject|1|||
126748879|NCT01693562|456029152|FG021|Expansion Phase|Withdrawal by Subject|8|||
126748880|NCT01693562|456029153|FG022|Expansion Phase|Withdrawal by Subject|1|||
126748881|NCT01693562|456029131|FG000|Expansion Phase|Death|0|||
126748882|NCT01693562|456029132|FG001|Expansion Phase|Death|0|||
126748883|NCT01693562|456029133|FG002|Expansion Phase|Death|0|||
126748884|NCT01693562|456029134|FG003|Expansion Phase|Death|0|||
126748885|NCT01693562|456029135|FG004|Expansion Phase|Death|0|||
126748886|NCT01693562|456029136|FG005|Expansion Phase|Death|0|||
126748887|NCT01693562|456029137|FG006|Expansion Phase|Death|0|||
126748888|NCT01693562|456029138|FG007|Expansion Phase|Death|42|||
126748889|NCT01693562|456029139|FG008|Expansion Phase|Death|17|||
126748890|NCT01693562|456029140|FG009|Expansion Phase|Death|208|||
126748891|NCT01693562|456029141|FG010|Expansion Phase|Death|30|||
126748892|NCT01693562|456029142|FG011|Expansion Phase|Death|8|||
126748893|NCT01693562|456029143|FG012|Expansion Phase|Death|19|||
126748894|NCT01693562|456029144|FG013|Expansion Phase|Death|42|||
126748895|NCT01693562|456029145|FG014|Expansion Phase|Death|23|||
126748896|NCT01693562|456029146|FG015|Expansion Phase|Death|23|||
126748897|NCT01693562|456029147|FG016|Expansion Phase|Death|128|||
126622106|NCT01116440|455574089|FG001|Treatment|Lack of Efficacy|1|||
126622107|NCT01116440|455574088|FG000|Treatment|Adverse Event|0|||
126622108|NCT01116440|455574089|FG001|Treatment|Adverse Event|1|||
126622109|NCT01116440|455574088|FG000|Withdrawal|Withdrawal by Subject|0|||
126622110|NCT01116440|455574089|FG001|Withdrawal|Withdrawal by Subject|1|||
126622111|NCT01116440|455574088|FG000|Withdrawal|Lost to Follow-up|0|||
126622112|NCT01116440|455574089|FG001|Withdrawal|Lost to Follow-up|1|||
126622113|NCT01116440|455574088|FG000|Follow-up|Lost to Follow-up|0|||
126622114|NCT01116440|455574089|FG001|Follow-up|Lost to Follow-up|1|||
126622115|NCT01116440|455574088|FG000|Follow-up|Withdrawal by Subject|0|||
126622116|NCT01116440|455574089|FG001|Follow-up|Withdrawal by Subject|1|||
126622117|NCT01870999|455574095|FG000|Overall Study|Adverse Event|0|||
126622118|NCT01870999|455574096|FG001|Overall Study|Adverse Event|4|||
126622119|NCT01870999|455574097|FG002|Overall Study|Adverse Event|1|||
126622120|NCT01870999|455574095|FG000|Overall Study|Subject met withdrawal criteria|3|||
126622121|NCT01870999|455574096|FG001|Overall Study|Subject met withdrawal criteria|2|||
126622122|NCT01870999|455574097|FG002|Overall Study|Subject met withdrawal criteria|0|||
126622123|NCT01870999|455574095|FG000|Overall Study|Subject withdrawn by Investigator|1|||
126622124|NCT01870999|455574096|FG001|Overall Study|Subject withdrawn by Investigator|0|||
126622125|NCT01870999|455574097|FG002|Overall Study|Subject withdrawn by Investigator|0|||
126622126|NCT01870999|455574095|FG000|Overall Study|Withdrawal by Subject|0|||
126622127|NCT01870999|455574096|FG001|Overall Study|Withdrawal by Subject|2|||
126622128|NCT01870999|455574097|FG002|Overall Study|Withdrawal by Subject|5|||
126622129|NCT01870999|455574095|FG000|Overall Study|Protocol Violation|0|||
126622130|NCT01870999|455574096|FG001|Overall Study|Protocol Violation|0|||
126622131|NCT01870999|455574097|FG002|Overall Study|Protocol Violation|1|||
126622132|NCT01636258|455574098|FG000|Overall Study|Lost to Follow-up|1|||
126622133|NCT01636258|455574099|FG001|Overall Study|Lost to Follow-up|0|||
126622134|NCT02798861|455574102|FG000|Overall Study|Lost to Follow-up|22|||
126622135|NCT02798861|455574102|FG000|Overall Study|Withdrawal by Subject|1|||
126622136|NCT02186015|455574103|FG000|Overall Study|Physician Decision|1|||
126622137|NCT02186015|455574104|FG001|Overall Study|Physician Decision|0|||
126622138|NCT00907517|455574105|FG000|Overall Study|Progressive Disease|3|||
126622139|NCT00907517|455574106|FG001|Overall Study|Progressive Disease|3|||
126622140|NCT00907517|455574107|FG002|Overall Study|Progressive Disease|4|||
126622141|NCT00907517|455574108|FG003|Overall Study|Progressive Disease|4|||
126622142|NCT00907517|455574109|FG004|Overall Study|Progressive Disease|4|||
126622143|NCT00907517|455574105|FG000|Overall Study|Symptomatic Deterioration|0|||
126622144|NCT00907517|455574106|FG001|Overall Study|Symptomatic Deterioration|0|||
126622145|NCT00907517|455574107|FG002|Overall Study|Symptomatic Deterioration|0|||
126622146|NCT00907517|455574108|FG003|Overall Study|Symptomatic Deterioration|0|||
126622147|NCT00907517|455574109|FG004|Overall Study|Symptomatic Deterioration|1|||
126622148|NCT02744898|455574110|FG000|Overall Study|Progressive Disease|2|||
126622149|NCT02744898|455574110|FG000|Overall Study|Physician Decision|1|||
126622150|NCT02744898|455574110|FG000|Overall Study|Toxicity|1|||
126622151|NCT01348763|455574113|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
126622152|NCT01348763|455574113|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
126622153|NCT01078571|455574114|FG000|Overall Study|Adverse Event|36|||
126622154|NCT01078571|455574114|FG000|Overall Study|Lack of effectiveness|36|||
126622155|NCT01078571|455574114|FG000|Overall Study|Reason not reported|21|||
126622156|NCT01078571|455574114|FG000|Overall Study|Withdrawal by Subject|12|||
126622157|NCT01078571|455574114|FG000|Overall Study|Lost to Follow-up|8|||
126622158|NCT01078571|455574114|FG000|Overall Study|Protocol Violation|2|||
126622159|NCT03802513|455574116|FG000|Overall Study|Lost to Follow-up|1|||
126622160|NCT03045302|455574133|FG000|Overall Study|Pre-treatment adverse event|1|||
126622161|NCT05287178|455574134|FG000|Overall Study|Lost to Follow-up|2|||
126622162|NCT04372186|455574135|FG000|Overall Study|Death|24|||
126622163|NCT04372186|455574136|FG001|Overall Study|Death|11|||
126622164|NCT04372186|455574135|FG000|Overall Study|Transferred to a different facility for care|0|||
126622165|NCT04372186|455574136|FG001|Overall Study|Transferred to a different facility for care|2|||
126622166|NCT03219216|455574137|FG000|Overall Study|Lost to Follow-up|0|||
126622167|NCT03219216|455574138|FG001|Overall Study|Lost to Follow-up|1|||
126622168|NCT02332824|455574139|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
126622169|NCT02332824|455574140|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
126622170|NCT02332824|455574141|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
126622171|NCT02332824|455574142|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
126622172|NCT02332824|455574143|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
126622173|NCT02332824|455574144|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
126622174|NCT02332824|455574139|FG000|Overall Study|Voluntary Withdrawal|1|||
126622175|NCT02332824|455574140|FG001|Overall Study|Voluntary Withdrawal|0|||
126622176|NCT02332824|455574141|FG002|Overall Study|Voluntary Withdrawal|0|||
126622177|NCT02332824|455574142|FG003|Overall Study|Voluntary Withdrawal|0|||
126622178|NCT02332824|455574143|FG004|Overall Study|Voluntary Withdrawal|0|||
126622179|NCT02332824|455574144|FG005|Overall Study|Voluntary Withdrawal|0|||
126622180|NCT02332824|455574139|FG000|Overall Study|Inconvenient schedule|1|||
126622181|NCT02332824|455574140|FG001|Overall Study|Inconvenient schedule|1|||
126622182|NCT02332824|455574141|FG002|Overall Study|Inconvenient schedule|0|||
126748898|NCT01693562|456029148|FG017|Expansion Phase|Death|16|||
126748899|NCT01693562|456029149|FG018|Expansion Phase|Death|36|||
126748900|NCT01693562|456029150|FG019|Expansion Phase|Death|16|||
126748901|NCT01693562|456029151|FG020|Expansion Phase|Death|17|||
126748902|NCT01693562|456029152|FG021|Expansion Phase|Death|35|||
126748903|NCT01693562|456029153|FG022|Expansion Phase|Death|7|||
126748904|NCT01693562|456029131|FG000|Expansion Phase|Lost to Follow-up|0|||
126748905|NCT01693562|456029132|FG001|Expansion Phase|Lost to Follow-up|0|||
126748906|NCT01693562|456029133|FG002|Expansion Phase|Lost to Follow-up|0|||
126748907|NCT01693562|456029134|FG003|Expansion Phase|Lost to Follow-up|0|||
126748908|NCT01693562|456029135|FG004|Expansion Phase|Lost to Follow-up|0|||
126748909|NCT01693562|456029136|FG005|Expansion Phase|Lost to Follow-up|0|||
126748910|NCT01693562|456029137|FG006|Expansion Phase|Lost to Follow-up|0|||
126748911|NCT01693562|456029138|FG007|Expansion Phase|Lost to Follow-up|1|||
126748912|NCT01693562|456029139|FG008|Expansion Phase|Lost to Follow-up|2|||
126748913|NCT01693562|456029140|FG009|Expansion Phase|Lost to Follow-up|10|||
126748914|NCT01693562|456029141|FG010|Expansion Phase|Lost to Follow-up|4|||
126748915|NCT01693562|456029142|FG011|Expansion Phase|Lost to Follow-up|4|||
126748916|NCT01693562|456029143|FG012|Expansion Phase|Lost to Follow-up|1|||
126748917|NCT01693562|456029144|FG013|Expansion Phase|Lost to Follow-up|3|||
126748918|NCT01693562|456029145|FG014|Expansion Phase|Lost to Follow-up|0|||
126748919|NCT01693562|456029146|FG015|Expansion Phase|Lost to Follow-up|1|||
126748920|NCT01693562|456029147|FG016|Expansion Phase|Lost to Follow-up|1|||
126748921|NCT01693562|456029148|FG017|Expansion Phase|Lost to Follow-up|0|||
126748922|NCT01693562|456029149|FG018|Expansion Phase|Lost to Follow-up|2|||
126748923|NCT01693562|456029150|FG019|Expansion Phase|Lost to Follow-up|1|||
126748924|NCT01693562|456029151|FG020|Expansion Phase|Lost to Follow-up|2|||
126748925|NCT01693562|456029152|FG021|Expansion Phase|Lost to Follow-up|2|||
126748926|NCT01693562|456029153|FG022|Expansion Phase|Lost to Follow-up|1|||
126748927|NCT01693562|456029131|FG000|Expansion Phase|Other|0|||
126748928|NCT01693562|456029132|FG001|Expansion Phase|Other|0|||
126748929|NCT01693562|456029133|FG002|Expansion Phase|Other|0|||
126748930|NCT01693562|456029134|FG003|Expansion Phase|Other|0|||
126748931|NCT01693562|456029135|FG004|Expansion Phase|Other|0|||
126748932|NCT01693562|456029136|FG005|Expansion Phase|Other|0|||
126748933|NCT01693562|456029137|FG006|Expansion Phase|Other|0|||
126748934|NCT01693562|456029138|FG007|Expansion Phase|Other|3|||
126748935|NCT01693562|456029139|FG008|Expansion Phase|Other|1|||
126748936|NCT01693562|456029140|FG009|Expansion Phase|Other|28|||
126748937|NCT01693562|456029141|FG010|Expansion Phase|Other|4|||
126748938|NCT01693562|456029142|FG011|Expansion Phase|Other|7|||
126748939|NCT01693562|456029143|FG012|Expansion Phase|Other|0|||
126748940|NCT01693562|456029144|FG013|Expansion Phase|Other|1|||
126748941|NCT01693562|456029145|FG014|Expansion Phase|Other|1|||
126748942|NCT01693562|456029146|FG015|Expansion Phase|Other|0|||
126748943|NCT01693562|456029147|FG016|Expansion Phase|Other|28|||
126748944|NCT01693562|456029148|FG017|Expansion Phase|Other|0|||
126748945|NCT01693562|456029149|FG018|Expansion Phase|Other|1|||
126748946|NCT01693562|456029150|FG019|Expansion Phase|Other|0|||
126748947|NCT01693562|456029151|FG020|Expansion Phase|Other|1|||
126748948|NCT01693562|456029152|FG021|Expansion Phase|Other|17|||
126748949|NCT01693562|456029153|FG022|Expansion Phase|Other|1|||
126748950|NCT05815758|456029158|FG000|Overall Study|Adverse Event|6|||
126748951|NCT05815758|456029159|FG001|Overall Study|Adverse Event|2|||
126748952|NCT05815758|456029158|FG000|Overall Study|Lost to Follow-up|14|||
126748953|NCT05815758|456029159|FG001|Overall Study|Lost to Follow-up|1|||
126748954|NCT05815758|456029158|FG000|Overall Study|Withdrawal by Subject|6|||
126748955|NCT05815758|456029159|FG001|Overall Study|Withdrawal by Subject|6|||
126748956|NCT05815758|456029158|FG000|Overall Study|Protocol Violation|1|||
126748957|NCT05815758|456029159|FG001|Overall Study|Protocol Violation|1|||
126748958|NCT05815758|456029158|FG000|Overall Study|Discontinued|4|||
126748959|NCT05815758|456029159|FG001|Overall Study|Discontinued|4|||
126748960|NCT02987205|456029160|FG000|Overall Study|Adverse Event|1|||
126748961|NCT02987205|456029160|FG000|Overall Study|Withdrawal by Subject|3|||
126748962|NCT04167514|456029163|FG000|Overall Study|Adverse event, not serious|0|||
126748963|NCT04167514|456029164|FG001|Overall Study|Adverse event, not serious|1|||
126748964|NCT04167514|456029163|FG000|Overall Study|Lost to Follow-up|1|||
126748965|NCT04167514|456029164|FG001|Overall Study|Lost to Follow-up|0|||
126748966|NCT04167514|456029163|FG000|Overall Study|Participant Decision|2|||
126748967|NCT04167514|456029164|FG001|Overall Study|Participant Decision|4|||
126748968|NCT04167514|456029163|FG000|Overall Study|Physician Decision|3|||
126748969|NCT04167514|456029164|FG001|Overall Study|Physician Decision|2|||
126748970|NCT04167514|456029163|FG000|Overall Study|Death|14|||
126748971|NCT04167514|456029164|FG001|Overall Study|Death|18|||
126748972|NCT04167514|456029163|FG000|Overall Study|Enrolled but treatment not administered|2|||
126748973|NCT04167514|456029164|FG001|Overall Study|Enrolled but treatment not administered|0|||
126748974|NCT04167514|456029163|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
126748975|NCT04167514|456029164|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
126748976|NCT04167514|456029163|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
126756589|NCT01856920|456059495|FG000|Overall Study|Disease Progression before Treatment|1|||
126748977|NCT04167514|456029164|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
126748978|NCT04437511|456029167|FG000|Overall Study|Adverse Event|50|||
126748979|NCT04437511|456029168|FG001|Overall Study|Adverse Event|21|||
126748980|NCT04437511|456029167|FG000|Overall Study|Death|15|||
126748981|NCT04437511|456029168|FG001|Overall Study|Death|10|||
126748982|NCT04437511|456029167|FG000|Overall Study|Lost to Follow-up|11|||
126748983|NCT04437511|456029168|FG001|Overall Study|Lost to Follow-up|11|||
126748984|NCT04437511|456029167|FG000|Overall Study|Physician Decision|19|||
126748985|NCT04437511|456029168|FG001|Overall Study|Physician Decision|10|||
126748986|NCT04437511|456029167|FG000|Overall Study|Progressive Disease|4|||
126748987|NCT04437511|456029168|FG001|Overall Study|Progressive Disease|7|||
126748988|NCT04437511|456029167|FG000|Overall Study|Withdrawal by Subject|111|||
126748989|NCT04437511|456029168|FG001|Overall Study|Withdrawal by Subject|94|||
126748990|NCT04437511|456029167|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
126748991|NCT04437511|456029168|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
126748992|NCT04437511|456029167|FG000|Overall Study|Continuing Study|7|||
126748993|NCT04437511|456029168|FG001|Overall Study|Continuing Study|5|||
126748994|NCT05564039|456029186|FG000|Overall Study|Adverse Event|1|||
126748995|NCT05564039|456029187|FG001|Overall Study|Adverse Event|0|||
126748996|NCT05564039|456029186|FG000|Overall Study|Death|1|||
126748997|NCT05564039|456029187|FG001|Overall Study|Death|1|||
126748998|NCT05564039|456029186|FG000|Overall Study|Lost to Follow-up|3|||
126748999|NCT05564039|456029187|FG001|Overall Study|Lost to Follow-up|2|||
126749000|NCT05564039|456029186|FG000|Overall Study|Withdrawal by Subject|2|||
126749001|NCT05564039|456029187|FG001|Overall Study|Withdrawal by Subject|0|||
126749002|NCT05564039|456029186|FG000|Overall Study|Inadvertent enrollment|3|||
126749003|NCT05564039|456029187|FG001|Overall Study|Inadvertent enrollment|6|||
126749004|NCT01263470|456029190|FG000|Overall Study|Adverse Event|2|||
126749005|NCT01263470|456029191|FG001|Overall Study|Adverse Event|2|||
126749006|NCT01263470|456029192|FG002|Overall Study|Adverse Event|1|||
126749007|NCT01263470|456029193|FG003|Overall Study|Adverse Event|1|||
126749008|NCT01263470|456029194|FG004|Overall Study|Adverse Event|2|||
126749009|NCT01263470|456029195|FG005|Overall Study|Adverse Event|2|||
126749010|NCT01263470|456029190|FG000|Overall Study|Protocol Violation|0|||
126749011|NCT01263470|456029191|FG001|Overall Study|Protocol Violation|1|||
126749012|NCT01263470|456029192|FG002|Overall Study|Protocol Violation|0|||
126749013|NCT01263470|456029193|FG003|Overall Study|Protocol Violation|0|||
126749014|NCT01263470|456029194|FG004|Overall Study|Protocol Violation|0|||
126749015|NCT01263470|456029195|FG005|Overall Study|Protocol Violation|1|||
126749016|NCT01263470|456029190|FG000|Overall Study|Withdrawal by Subject|0|||
126749017|NCT01263470|456029191|FG001|Overall Study|Withdrawal by Subject|1|||
126749018|NCT01263470|456029192|FG002|Overall Study|Withdrawal by Subject|1|||
126749019|NCT01263470|456029193|FG003|Overall Study|Withdrawal by Subject|2|||
126749020|NCT01263470|456029194|FG004|Overall Study|Withdrawal by Subject|0|||
126749021|NCT01263470|456029195|FG005|Overall Study|Withdrawal by Subject|2|||
126749022|NCT01263470|456029190|FG000|Overall Study|Lack of Efficacy|0|||
126749023|NCT01263470|456029191|FG001|Overall Study|Lack of Efficacy|0|||
126749024|NCT01263470|456029192|FG002|Overall Study|Lack of Efficacy|2|||
126749025|NCT01263470|456029193|FG003|Overall Study|Lack of Efficacy|0|||
126749026|NCT01263470|456029194|FG004|Overall Study|Lack of Efficacy|0|||
126749027|NCT01263470|456029195|FG005|Overall Study|Lack of Efficacy|0|||
126749028|NCT01263470|456029190|FG000|Overall Study|Participant Unavailability|0|||
126749029|NCT01263470|456029191|FG001|Overall Study|Participant Unavailability|1|||
126749030|NCT01263470|456029192|FG002|Overall Study|Participant Unavailability|0|||
126749031|NCT01263470|456029193|FG003|Overall Study|Participant Unavailability|0|||
126749032|NCT01263470|456029194|FG004|Overall Study|Participant Unavailability|0|||
126749033|NCT01263470|456029195|FG005|Overall Study|Participant Unavailability|0|||
126749034|NCT01263470|456029190|FG000|Overall Study|Study Drug Non-compliance|0|||
126749035|NCT01263470|456029191|FG001|Overall Study|Study Drug Non-compliance|0|||
126749036|NCT01263470|456029192|FG002|Overall Study|Study Drug Non-compliance|0|||
126749037|NCT01263470|456029193|FG003|Overall Study|Study Drug Non-compliance|0|||
126749038|NCT01263470|456029194|FG004|Overall Study|Study Drug Non-compliance|1|||
126749039|NCT01263470|456029195|FG005|Overall Study|Study Drug Non-compliance|0|||
126749040|NCT00610714|456029196|FG000|Overall Study|Adverse Event|3|||
126749041|NCT00610714|456029197|FG001|Overall Study|Adverse Event|1|||
126749042|NCT00610714|456029196|FG000|Overall Study|Death|12|||
126749043|NCT00610714|456029197|FG001|Overall Study|Death|18|||
126749044|NCT00610714|456029196|FG000|Overall Study|Withdrawal by Subject|9|||
126749045|NCT00610714|456029197|FG001|Overall Study|Withdrawal by Subject|3|||
126749046|NCT00610714|456029196|FG000|Overall Study|Study completion at 120 PFS events|2|||
126749047|NCT00610714|456029197|FG001|Overall Study|Study completion at 120 PFS events|2|||
126749048|NCT00712712|456029198|FG000|Overall Study|Protocol Violation|11|||
126749049|NCT00712712|456029198|FG000|Overall Study|Radiofrequency not done|3|||
126749050|NCT00712712|456029198|FG000|Overall Study|Death|8|||
126749051|NCT00712712|456029198|FG000|Overall Study|Withdrawal by Subject|1|||
126749052|NCT03598140|456029199|FG000|Overall Study|enrolled but didn't start|1|||
126749053|NCT03598140|456029200|FG001|Overall Study|enrolled but didn't start|0|||
126749054|NCT01058395|456029202|FG000|Overall Study|Death|2|||
126749055|NCT01058395|456029203|FG001|Overall Study|Death|1|||
126749056|NCT01058395|456029202|FG000|Overall Study|Lost to Follow-up|1|||
126749057|NCT01058395|456029203|FG001|Overall Study|Lost to Follow-up|0|||
126749058|NCT04083781|456029204|FG000|Main Part|Physician Decision|0|||
126749059|NCT04083781|456029205|FG001|Main Part|Physician Decision|1|||
126749060|NCT04083781|456029206|FG002|Main Part|Physician Decision|2|||
126749061|NCT04083781|456029207|FG003|Main Part|Physician Decision|0|||
126749062|NCT04083781|456029204|FG000|Main Part|Death|1|||
126749063|NCT04083781|456029205|FG001|Main Part|Death|3|||
126749064|NCT04083781|456029206|FG002|Main Part|Death|1|||
126749065|NCT04083781|456029207|FG003|Main Part|Death|0|||
126749066|NCT04083781|456029204|FG000|Main Part|Withdrawal by Subject|5|||
126749067|NCT04083781|456029205|FG001|Main Part|Withdrawal by Subject|2|||
126749068|NCT04083781|456029206|FG002|Main Part|Withdrawal by Subject|3|||
126749069|NCT04083781|456029207|FG003|Main Part|Withdrawal by Subject|7|||
126749070|NCT04083781|456029204|FG000|Extension Part|Physician Decision|0|||
126749071|NCT04083781|456029205|FG001|Extension Part|Physician Decision|0|||
126749072|NCT04083781|456029206|FG002|Extension Part|Physician Decision|0|||
126749073|NCT04083781|456029207|FG003|Extension Part|Physician Decision|1|||
126749074|NCT04083781|456029204|FG000|Extension Part|Death|0|||
126749075|NCT04083781|456029205|FG001|Extension Part|Death|1|||
126749076|NCT04083781|456029206|FG002|Extension Part|Death|0|||
126749077|NCT04083781|456029207|FG003|Extension Part|Death|1|||
126749078|NCT04083781|456029204|FG000|Extension Part|Withdrawal by Subject|0|||
126749079|NCT04083781|456029205|FG001|Extension Part|Withdrawal by Subject|1|||
126749080|NCT04083781|456029206|FG002|Extension Part|Withdrawal by Subject|0|||
126749081|NCT04083781|456029207|FG003|Extension Part|Withdrawal by Subject|0|||
126749082|NCT04083781|456029204|FG000|Extension Part|Ongoing|13|||
126749083|NCT04083781|456029205|FG001|Extension Part|Ongoing|25|||
126749084|NCT04083781|456029206|FG002|Extension Part|Ongoing|15|||
126749085|NCT04083781|456029207|FG003|Extension Part|Ongoing|51|||
126749086|NCT05304611|456029208|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
126749087|NCT05304611|456029209|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
126749088|NCT05304611|456029210|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
126749089|NCT05304611|456029211|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
126749090|NCT05304611|456029212|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
126749091|NCT05304611|456029213|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
126749092|NCT05304611|456029214|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
126749093|NCT05304611|456029215|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
126749094|NCT05304611|456029216|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
126749095|NCT05304611|456029217|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
126749096|NCT05304611|456029218|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
126749097|NCT05304611|456029219|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
126749098|NCT05304611|456029208|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
126749099|NCT05304611|456029209|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
126749100|NCT05304611|456029210|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
126749101|NCT05304611|456029211|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
126749102|NCT05304611|456029212|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
126749103|NCT05304611|456029213|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
126749104|NCT05304611|456029214|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
126749105|NCT05304611|456029215|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
126749106|NCT05304611|456029216|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
126749107|NCT05304611|456029217|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
126749108|NCT05304611|456029218|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
126749109|NCT05304611|456029219|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
126749110|NCT05304611|456029208|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
126749111|NCT05304611|456029209|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
126749112|NCT05304611|456029210|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
126749113|NCT05304611|456029211|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
126749114|NCT05304611|456029212|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
126749115|NCT05304611|456029213|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
126749116|NCT05304611|456029214|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
126749117|NCT05304611|456029215|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
126749118|NCT05304611|456029216|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
126749119|NCT05304611|456029217|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
126749120|NCT05304611|456029218|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
126749121|NCT05304611|456029219|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
126749122|NCT00963820|456029220|FG000|Dose Escalation Phase|Progressive Disease|3|||
126749123|NCT00963820|456029221|FG001|Dose Escalation Phase|Progressive Disease|3|||
126749124|NCT00963820|456029222|FG002|Dose Escalation Phase|Progressive Disease|3|||
126749125|NCT00963820|456029223|FG003|Dose Escalation Phase|Progressive Disease|3|||
126749126|NCT00963820|456029224|FG004|Dose Escalation Phase|Progressive Disease|4|||
126749127|NCT00963820|456029225|FG005|Dose Escalation Phase|Progressive Disease|3|||
126749128|NCT00963820|456029226|FG006|Dose Escalation Phase|Progressive Disease|3|||
126749129|NCT00963820|456029227|FG007|Dose Escalation Phase|Progressive Disease|2|||
126749130|NCT00963820|456029228|FG008|Dose Escalation Phase|Progressive Disease|0|||
126749131|NCT00963820|456029229|FG009|Dose Escalation Phase|Progressive Disease|0|||
126749132|NCT00963820|456029230|FG010|Dose Escalation Phase|Progressive Disease|0|||
126749133|NCT00963820|456029231|FG011|Dose Escalation Phase|Progressive Disease|0|||
126749134|NCT00963820|456029220|FG000|Dose Escalation Phase|Adverse Event|0|||
126749135|NCT00963820|456029221|FG001|Dose Escalation Phase|Adverse Event|0|||
126749136|NCT00963820|456029222|FG002|Dose Escalation Phase|Adverse Event|0|||
126749137|NCT00963820|456029223|FG003|Dose Escalation Phase|Adverse Event|0|||
126622183|NCT02332824|455574142|FG003|Overall Study|Inconvenient schedule|0|||
126622184|NCT02332824|455574143|FG004|Overall Study|Inconvenient schedule|0|||
126622185|NCT02332824|455574144|FG005|Overall Study|Inconvenient schedule|0|||
126622186|NCT02332824|455574139|FG000|Overall Study|Transfer|0|||
126622187|NCT02332824|455574140|FG001|Overall Study|Transfer|0|||
126622188|NCT02332824|455574141|FG002|Overall Study|Transfer|1|||
126622189|NCT02332824|455574142|FG003|Overall Study|Transfer|1|||
126622190|NCT02332824|455574143|FG004|Overall Study|Transfer|0|||
126622191|NCT02332824|455574144|FG005|Overall Study|Transfer|0|||
126622192|NCT00914732|455574145|FG000|Overall Study|Lost to Follow-up|6|||
126622193|NCT00914732|455574146|FG001|Overall Study|Lost to Follow-up|7|||
126622194|NCT00914732|455574147|FG002|Overall Study|Lost to Follow-up|9|||
126622195|NCT00914732|455574145|FG000|Overall Study|Withdrawal by Subject|3|||
126622196|NCT00914732|455574146|FG001|Overall Study|Withdrawal by Subject|0|||
126622197|NCT00914732|455574147|FG002|Overall Study|Withdrawal by Subject|2|||
126622198|NCT00914732|455574145|FG000|Overall Study|Adverse Event|1|||
126622199|NCT00914732|455574146|FG001|Overall Study|Adverse Event|0|||
126622200|NCT00914732|455574147|FG002|Overall Study|Adverse Event|0|||
126622201|NCT03840148|455574150|FG000|Study Drug Disposition|Adverse Event|13|||
126622202|NCT03840148|455574151|FG001|Study Drug Disposition|Adverse Event|2|||
126622203|NCT03840148|455574150|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
126622204|NCT03840148|455574151|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
126622205|NCT03840148|455574150|FG000|Study Drug Disposition|Lack of Efficacy|3|||
126622206|NCT03840148|455574151|FG001|Study Drug Disposition|Lack of Efficacy|0|||
126622207|NCT03840148|455574150|FG000|Study Drug Disposition|Physician Decision|2|||
126622208|NCT03840148|455574151|FG001|Study Drug Disposition|Physician Decision|0|||
126622209|NCT03840148|455574150|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
126622210|NCT03840148|455574151|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
126622211|NCT03840148|455574150|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
126622212|NCT03840148|455574151|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
126622213|NCT03840148|455574150|FG000|Study Completion Disposition|Physician Decision|2|||
126622214|NCT03840148|455574151|FG001|Study Completion Disposition|Physician Decision|0|||
126622215|NCT03840148|455574150|FG000|Study Completion Disposition|Covid-19 related|2|||
126622216|NCT03840148|455574151|FG001|Study Completion Disposition|Covid-19 related|0|||
126622217|NCT03840148|455574150|FG000|Study Completion Disposition|Lost to Follow-up|1|||
126622218|NCT03840148|455574151|FG001|Study Completion Disposition|Lost to Follow-up|1|||
126622219|NCT03840148|455574150|FG000|Study Completion Disposition|Death|1|||
126622220|NCT03840148|455574151|FG001|Study Completion Disposition|Death|0|||
126622221|NCT03840148|455574150|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
126622222|NCT03840148|455574151|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
126622223|NCT03615404|455574152|FG000|Overall Study|Death|1|||
126622224|NCT03615404|455574152|FG000|Overall Study|vaccine did not pass quality assurance|1|||
126622225|NCT01774929|455574153|FG000|Overall Study|Adverse Event|3|||
126622226|NCT00603278|455574155|FG000|Overall Study|Lack of Efficacy|35|||
126622227|NCT00603278|455574156|FG001|Overall Study|Lack of Efficacy|10|||
126622228|NCT00603278|455574157|FG002|Overall Study|Lack of Efficacy|11|||
126622229|NCT00603278|455574158|FG003|Overall Study|Lack of Efficacy|8|||
126622230|NCT00603278|455574159|FG004|Overall Study|Lack of Efficacy|7|||
126622231|NCT00603278|455574160|FG005|Overall Study|Lack of Efficacy|14|||
126622232|NCT00603278|455574155|FG000|Overall Study|Adverse Event|0|||
126622233|NCT00603278|455574156|FG001|Overall Study|Adverse Event|3|||
126622234|NCT00603278|455574157|FG002|Overall Study|Adverse Event|1|||
126622235|NCT00603278|455574158|FG003|Overall Study|Adverse Event|0|||
126622236|NCT00603278|455574159|FG004|Overall Study|Adverse Event|2|||
126622237|NCT00603278|455574160|FG005|Overall Study|Adverse Event|1|||
126622238|NCT00603278|455574155|FG000|Overall Study|Withdrawal by Subject|2|||
126622239|NCT00603278|455574156|FG001|Overall Study|Withdrawal by Subject|3|||
126622240|NCT00603278|455574157|FG002|Overall Study|Withdrawal by Subject|1|||
126622241|NCT00603278|455574158|FG003|Overall Study|Withdrawal by Subject|2|||
126622242|NCT00603278|455574159|FG004|Overall Study|Withdrawal by Subject|1|||
126622243|NCT00603278|455574160|FG005|Overall Study|Withdrawal by Subject|2|||
126749138|NCT00963820|456029224|FG004|Dose Escalation Phase|Adverse Event|0|||
126749139|NCT00963820|456029225|FG005|Dose Escalation Phase|Adverse Event|0|||
126749140|NCT00963820|456029226|FG006|Dose Escalation Phase|Adverse Event|3|||
126622244|NCT00603278|455574155|FG000|Overall Study|Protocol Violation|3|||
126622245|NCT00603278|455574156|FG001|Overall Study|Protocol Violation|0|||
126622246|NCT00603278|455574157|FG002|Overall Study|Protocol Violation|1|||
126622247|NCT00603278|455574158|FG003|Overall Study|Protocol Violation|1|||
126749141|NCT00963820|456029227|FG007|Dose Escalation Phase|Adverse Event|1|||
126749142|NCT00963820|456029228|FG008|Dose Escalation Phase|Adverse Event|0|||
126749143|NCT00963820|456029229|FG009|Dose Escalation Phase|Adverse Event|0|||
126749144|NCT00963820|456029230|FG010|Dose Escalation Phase|Adverse Event|0|||
126749145|NCT00963820|456029231|FG011|Dose Escalation Phase|Adverse Event|0|||
126749146|NCT00963820|456029220|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
126749147|NCT00963820|456029221|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
126749148|NCT00963820|456029222|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
126749149|NCT00963820|456029223|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
126749150|NCT00963820|456029224|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
126749151|NCT00963820|456029225|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
126749152|NCT00963820|456029226|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
126749153|NCT00963820|456029227|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
126749154|NCT00963820|456029228|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
126749155|NCT00963820|456029229|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
126749156|NCT00963820|456029230|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
126749157|NCT00963820|456029231|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
126749158|NCT00963820|456029220|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126749159|NCT00963820|456029221|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126749160|NCT00963820|456029222|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126749161|NCT00963820|456029223|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126749162|NCT00963820|456029224|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126749163|NCT00963820|456029225|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126749164|NCT00963820|456029226|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
126749165|NCT00963820|456029227|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126749166|NCT00963820|456029228|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126749167|NCT00963820|456029229|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126749168|NCT00963820|456029230|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126749169|NCT00963820|456029231|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
126749170|NCT00963820|456029220|FG000|Expansion Phase|Progressive Disease|0|||
126749171|NCT00963820|456029221|FG001|Expansion Phase|Progressive Disease|0|||
126749172|NCT00963820|456029222|FG002|Expansion Phase|Progressive Disease|0|||
126749173|NCT00963820|456029223|FG003|Expansion Phase|Progressive Disease|0|||
126749174|NCT00963820|456029224|FG004|Expansion Phase|Progressive Disease|0|||
126749175|NCT00963820|456029225|FG005|Expansion Phase|Progressive Disease|0|||
126749176|NCT00963820|456029226|FG006|Expansion Phase|Progressive Disease|0|||
126749177|NCT00963820|456029227|FG007|Expansion Phase|Progressive Disease|0|||
126749178|NCT00963820|456029228|FG008|Expansion Phase|Progressive Disease|8|||
126749179|NCT00963820|456029229|FG009|Expansion Phase|Progressive Disease|6|||
126749180|NCT00963820|456029230|FG010|Expansion Phase|Progressive Disease|4|||
126749181|NCT00963820|456029231|FG011|Expansion Phase|Progressive Disease|2|||
126749182|NCT00963820|456029220|FG000|Expansion Phase|Adverse Event|0|||
126749183|NCT00963820|456029221|FG001|Expansion Phase|Adverse Event|0|||
126749184|NCT00963820|456029222|FG002|Expansion Phase|Adverse Event|0|||
126749185|NCT00963820|456029223|FG003|Expansion Phase|Adverse Event|0|||
126749186|NCT00963820|456029224|FG004|Expansion Phase|Adverse Event|0|||
126749187|NCT00963820|456029225|FG005|Expansion Phase|Adverse Event|0|||
126749188|NCT00963820|456029226|FG006|Expansion Phase|Adverse Event|0|||
126749189|NCT00963820|456029227|FG007|Expansion Phase|Adverse Event|0|||
126749190|NCT00963820|456029228|FG008|Expansion Phase|Adverse Event|1|||
126749191|NCT00963820|456029229|FG009|Expansion Phase|Adverse Event|3|||
126749192|NCT00963820|456029230|FG010|Expansion Phase|Adverse Event|0|||
126749193|NCT00963820|456029231|FG011|Expansion Phase|Adverse Event|0|||
126749194|NCT00963820|456029220|FG000|Expansion Phase|Withdrawal by Subject|0|||
126749195|NCT00963820|456029221|FG001|Expansion Phase|Withdrawal by Subject|0|||
126749196|NCT00963820|456029222|FG002|Expansion Phase|Withdrawal by Subject|0|||
126749197|NCT00963820|456029223|FG003|Expansion Phase|Withdrawal by Subject|0|||
126749198|NCT00963820|456029224|FG004|Expansion Phase|Withdrawal by Subject|0|||
126749199|NCT00963820|456029225|FG005|Expansion Phase|Withdrawal by Subject|0|||
126749200|NCT00963820|456029226|FG006|Expansion Phase|Withdrawal by Subject|0|||
126622248|NCT00603278|455574159|FG004|Overall Study|Protocol Violation|0|||
126622249|NCT00603278|455574160|FG005|Overall Study|Protocol Violation|1|||
126749201|NCT00963820|456029227|FG007|Expansion Phase|Withdrawal by Subject|0|||
126749202|NCT00963820|456029228|FG008|Expansion Phase|Withdrawal by Subject|1|||
126749203|NCT00963820|456029229|FG009|Expansion Phase|Withdrawal by Subject|0|||
126749204|NCT00963820|456029230|FG010|Expansion Phase|Withdrawal by Subject|1|||
126749205|NCT00963820|456029231|FG011|Expansion Phase|Withdrawal by Subject|1|||
126749206|NCT00963820|456029220|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126749207|NCT00963820|456029221|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126749208|NCT00963820|456029222|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126622250|NCT00603278|455574155|FG000|Overall Study|Physician Decision|0|||
126622251|NCT00603278|455574156|FG001|Overall Study|Physician Decision|1|||
126622252|NCT00603278|455574157|FG002|Overall Study|Physician Decision|0|||
126622253|NCT00603278|455574158|FG003|Overall Study|Physician Decision|0|||
126622254|NCT00603278|455574159|FG004|Overall Study|Physician Decision|2|||
126622255|NCT00603278|455574160|FG005|Overall Study|Physician Decision|1|||
126622256|NCT00603278|455574155|FG000|Overall Study|Lost to Follow-up|1|||
126622257|NCT00603278|455574156|FG001|Overall Study|Lost to Follow-up|0|||
126622258|NCT00603278|455574157|FG002|Overall Study|Lost to Follow-up|0|||
126622259|NCT00603278|455574158|FG003|Overall Study|Lost to Follow-up|0|||
126622260|NCT00603278|455574159|FG004|Overall Study|Lost to Follow-up|1|||
126622261|NCT00603278|455574160|FG005|Overall Study|Lost to Follow-up|0|||
126622262|NCT04374253|455574164|FG000|Overall Study|Adverse Event|0|||
126622263|NCT04374253|455574165|FG001|Overall Study|Adverse Event|26|||
126622264|NCT04374253|455574166|FG002|Overall Study|Adverse Event|2|||
126622265|NCT04374253|455574167|FG003|Overall Study|Adverse Event|12|||
126622266|NCT04374253|455574164|FG000|Overall Study|Study terminated by sponsor|13|||
126622267|NCT04374253|455574165|FG001|Overall Study|Study terminated by sponsor|593|||
126622268|NCT04374253|455574166|FG002|Overall Study|Study terminated by sponsor|21|||
126622269|NCT04374253|455574167|FG003|Overall Study|Study terminated by sponsor|567|||
126622270|NCT04374253|455574164|FG000|Overall Study|Withdrawal by Subject|0|||
126622271|NCT04374253|455574165|FG001|Overall Study|Withdrawal by Subject|55|||
126622272|NCT04374253|455574166|FG002|Overall Study|Withdrawal by Subject|3|||
126622273|NCT04374253|455574167|FG003|Overall Study|Withdrawal by Subject|40|||
126622274|NCT04374253|455574164|FG000|Overall Study|Physician Decision|1|||
126622275|NCT04374253|455574165|FG001|Overall Study|Physician Decision|10|||
126622276|NCT04374253|455574166|FG002|Overall Study|Physician Decision|1|||
126622277|NCT04374253|455574167|FG003|Overall Study|Physician Decision|10|||
126622278|NCT04374253|455574164|FG000|Overall Study|Protocol Violation|0|||
126622279|NCT04374253|455574165|FG001|Overall Study|Protocol Violation|0|||
126622280|NCT04374253|455574166|FG002|Overall Study|Protocol Violation|0|||
126622281|NCT04374253|455574167|FG003|Overall Study|Protocol Violation|2|||
126622282|NCT04374253|455574164|FG000|Overall Study|Death|0|||
126622283|NCT04374253|455574165|FG001|Overall Study|Death|3|||
126622284|NCT04374253|455574166|FG002|Overall Study|Death|1|||
126622285|NCT04374253|455574167|FG003|Overall Study|Death|1|||
126622286|NCT04374253|455574164|FG000|Overall Study|Lack of Efficacy|0|||
126622287|NCT04374253|455574165|FG001|Overall Study|Lack of Efficacy|0|||
126622288|NCT04374253|455574166|FG002|Overall Study|Lack of Efficacy|0|||
126622289|NCT04374253|455574167|FG003|Overall Study|Lack of Efficacy|1|||
126622290|NCT04374253|455574164|FG000|Overall Study|Lost to Follow-up|1|||
126622291|NCT04374253|455574165|FG001|Overall Study|Lost to Follow-up|1|||
126622292|NCT04374253|455574166|FG002|Overall Study|Lost to Follow-up|0|||
126622293|NCT04374253|455574167|FG003|Overall Study|Lost to Follow-up|2|||
126622294|NCT04374253|455574164|FG000|Overall Study|Reason Not Specified|0|||
126622295|NCT04374253|455574165|FG001|Overall Study|Reason Not Specified|8|||
126622296|NCT04374253|455574166|FG002|Overall Study|Reason Not Specified|0|||
126622297|NCT04374253|455574167|FG003|Overall Study|Reason Not Specified|8|||
126622298|NCT01207453|455574168|FG000|First Intervention|Adverse Event|2|||
126622299|NCT01207453|455574169|FG001|First Intervention|Adverse Event|1|||
126622300|NCT01207453|455574168|FG000|Washout|Adverse Event|1|||
126622301|NCT01207453|455574169|FG001|Washout|Adverse Event|0|||
126622302|NCT01207453|455574168|FG000|Washout|Lost to Follow-up|1|||
126622303|NCT01207453|455574169|FG001|Washout|Lost to Follow-up|0|||
126622304|NCT01207453|455574168|FG000|2nd Intervention|Adverse Event|1|||
126622305|NCT01207453|455574169|FG001|2nd Intervention|Adverse Event|2|||
126622306|NCT01207453|455574168|FG000|2nd Intervention|Lost to Follow-up|1|||
126622307|NCT01207453|455574169|FG001|2nd Intervention|Lost to Follow-up|0|||
126622308|NCT02577315|455574170|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
126622309|NCT02577315|455574171|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
126622310|NCT00990821|455574174|FG000|Overall Study|Withdrawal by Subject|0|||
126622311|NCT00990821|455574175|FG001|Overall Study|Withdrawal by Subject|2|||
126622312|NCT00990821|455574176|FG002|Overall Study|Withdrawal by Subject|0|||
126622313|NCT00990821|455574177|FG003|Overall Study|Withdrawal by Subject|0|||
126622314|NCT00990821|455574178|FG004|Overall Study|Withdrawal by Subject|3|||
126622315|NCT00990821|455574179|FG005|Overall Study|Withdrawal by Subject|3|||
126622316|NCT00990821|455574180|FG006|Overall Study|Withdrawal by Subject|1|||
126622317|NCT00990821|455574181|FG007|Overall Study|Withdrawal by Subject|0|||
126622318|NCT00990821|455574182|FG008|Overall Study|Withdrawal by Subject|0|||
126622319|NCT00990821|455574183|FG009|Overall Study|Withdrawal by Subject|1|||
126622320|NCT00990821|455574184|FG010|Overall Study|Withdrawal by Subject|3|||
126622321|NCT00990821|455574185|FG011|Overall Study|Withdrawal by Subject|5|||
126622322|NCT00990821|455574186|FG012|Overall Study|Withdrawal by Subject|2|||
126622323|NCT00990821|455574187|FG013|Overall Study|Withdrawal by Subject|1|||
126622324|NCT04150250|455574188|FG000|Overall Study|Lost to Follow-up|0|||
126622325|NCT04150250|455574189|FG001|Overall Study|Lost to Follow-up|2|||
126622326|NCT01786551|455574190|FG000|Overall Study|Participant withdrew consent|2|||
126622327|NCT01945086|455574191|FG000|Overall Study|Withdrawal by Subject|1|||
126622328|NCT01945086|455574192|FG001|Overall Study|Withdrawal by Subject|0|||
126622329|NCT01945086|455574193|FG002|Overall Study|Withdrawal by Subject|1|||
126622330|NCT01945086|455574191|FG000|Overall Study|Adverse Event|0|||
126622331|NCT01945086|455574192|FG001|Overall Study|Adverse Event|0|||
126749209|NCT00963820|456029223|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126749210|NCT00963820|456029224|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126749211|NCT00963820|456029225|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126749212|NCT00963820|456029226|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126749213|NCT00963820|456029227|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126749214|NCT00963820|456029228|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126749215|NCT00963820|456029229|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126749216|NCT00963820|456029230|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
126749217|NCT00963820|456029231|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
126749218|NCT02354690|456029232|FG000|Overall Study|Physician Decision|1|||
126749219|NCT04556175|456029240|FG000|Overall Study|Study terminated due to COVID-19|8|||
126749220|NCT04556175|456029241|FG001|Overall Study|Study terminated due to COVID-19|8|||
126749221|NCT05549505|456029243|FG000|Overall Study|Lost to Follow-up|2|||
126749222|NCT05549505|456029244|FG001|Overall Study|Lost to Follow-up|0|||
126749223|NCT05549505|456029243|FG000|Overall Study|Withdrawal by Subject|3|||
126749224|NCT05549505|456029244|FG001|Overall Study|Withdrawal by Subject|3|||
126749225|NCT05549505|456029243|FG000|Overall Study|Other: Miscellaneous|3|||
126749226|NCT05549505|456029244|FG001|Overall Study|Other: Miscellaneous|6|||
126749227|NCT01602822|456029247|FG000|Overall Study|Adverse Event|11|||
126749228|NCT02871791|456029249|FG000|Phase 1b|Death|0|||
126749229|NCT02871791|456029250|FG001|Phase 1b|Death|1|||
126749230|NCT02871791|456029249|FG000|Phase 1b|progressive disease|6|||
126749231|NCT02871791|456029250|FG001|Phase 1b|progressive disease|2|||
126749232|NCT02871791|456029249|FG000|Phase 2|Death|1|||
126749233|NCT02871791|456029250|FG001|Phase 2|Death|0|||
126749234|NCT02871791|456029249|FG000|Phase 2|Lost to Follow-up|2|||
126749235|NCT02871791|456029250|FG001|Phase 2|Lost to Follow-up|0|||
126749236|NCT04005755|456029251|FG000|Overall Study|Adverse Event|6|||
126749237|NCT04005755|456029251|FG000|Overall Study|Physician Decision|3|||
126749238|NCT04005755|456029251|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
126749239|NCT04005755|456029251|FG000|Overall Study|Withdrawal by Subject|3|||
126749240|NCT04005755|456029251|FG000|Overall Study|Lost to Follow-up|1|||
126749241|NCT02723019|456029252|FG000|Overall Study|Death|17|||
126749242|NCT02723019|456029253|FG001|Overall Study|Death|13|||
126749243|NCT02723019|456029252|FG000|Overall Study|Withdrawal by Subject|11|||
126749244|NCT02723019|456029253|FG001|Overall Study|Withdrawal by Subject|7|||
126749245|NCT02723019|456029252|FG000|Overall Study|Lost to Follow-up|57|||
126749246|NCT02723019|456029253|FG001|Overall Study|Lost to Follow-up|70|||
126749247|NCT00515099|456029257|FG000|Overall Study|Lost to Follow-up|0|||
126749248|NCT00515099|456029258|FG001|Overall Study|Lost to Follow-up|4|||
126749249|NCT00515099|456029257|FG000|Overall Study|Withdrawal by Subject|2|||
126749250|NCT00515099|456029258|FG001|Overall Study|Withdrawal by Subject|0|||
126749251|NCT00515099|456029257|FG000|Overall Study|IRB Recommendation|1|||
126749252|NCT00515099|456029258|FG001|Overall Study|IRB Recommendation|0|||
126749253|NCT05333289|456029259|FG000|Overall Study|Other|1|||
126749254|NCT05333289|456029260|FG001|Overall Study|Other|0|||
126749255|NCT05333289|456029261|FG002|Overall Study|Other|0|||
126749256|NCT05333289|456029262|FG003|Overall Study|Other|1|||
126749257|NCT05333289|456029263|FG004|Overall Study|Other|1|||
126749258|NCT05333289|456029264|FG005|Overall Study|Other|2|||
126749259|NCT05333289|456029265|FG006|Overall Study|Other|2|||
126749260|NCT05333289|456029266|FG007|Overall Study|Other|0|||
126749261|NCT05333289|456029259|FG000|Overall Study|Withdrawal by Subject|1|||
126749262|NCT05333289|456029260|FG001|Overall Study|Withdrawal by Subject|2|||
126749263|NCT05333289|456029261|FG002|Overall Study|Withdrawal by Subject|2|||
126749264|NCT05333289|456029262|FG003|Overall Study|Withdrawal by Subject|1|||
126749265|NCT05333289|456029263|FG004|Overall Study|Withdrawal by Subject|1|||
126749266|NCT05333289|456029264|FG005|Overall Study|Withdrawal by Subject|2|||
126749267|NCT05333289|456029265|FG006|Overall Study|Withdrawal by Subject|1|||
126749268|NCT05333289|456029266|FG007|Overall Study|Withdrawal by Subject|3|||
126749269|NCT05333289|456029259|FG000|Overall Study|Protocol Violation|1|||
126749270|NCT05333289|456029260|FG001|Overall Study|Protocol Violation|0|||
126749271|NCT05333289|456029261|FG002|Overall Study|Protocol Violation|0|||
126749272|NCT05333289|456029262|FG003|Overall Study|Protocol Violation|0|||
126749273|NCT05333289|456029263|FG004|Overall Study|Protocol Violation|0|||
126749274|NCT05333289|456029264|FG005|Overall Study|Protocol Violation|0|||
126749275|NCT05333289|456029265|FG006|Overall Study|Protocol Violation|0|||
126749276|NCT05333289|456029266|FG007|Overall Study|Protocol Violation|0|||
126749277|NCT05333289|456029259|FG000|Overall Study|Physician Decision|0|||
126749278|NCT05333289|456029260|FG001|Overall Study|Physician Decision|0|||
126749279|NCT05333289|456029261|FG002|Overall Study|Physician Decision|1|||
126749280|NCT05333289|456029262|FG003|Overall Study|Physician Decision|0|||
126749281|NCT05333289|456029263|FG004|Overall Study|Physician Decision|0|||
126749282|NCT05333289|456029264|FG005|Overall Study|Physician Decision|2|||
126749283|NCT05333289|456029265|FG006|Overall Study|Physician Decision|0|||
126749284|NCT05333289|456029266|FG007|Overall Study|Physician Decision|0|||
126749285|NCT05333289|456029259|FG000|Overall Study|Lost to Follow-up|6|||
126749286|NCT05333289|456029260|FG001|Overall Study|Lost to Follow-up|0|||
126749287|NCT05333289|456029261|FG002|Overall Study|Lost to Follow-up|1|||
126749288|NCT05333289|456029262|FG003|Overall Study|Lost to Follow-up|6|||
126749289|NCT05333289|456029263|FG004|Overall Study|Lost to Follow-up|3|||
126749290|NCT05333289|456029264|FG005|Overall Study|Lost to Follow-up|3|||
126749291|NCT05333289|456029265|FG006|Overall Study|Lost to Follow-up|2|||
126749292|NCT05333289|456029266|FG007|Overall Study|Lost to Follow-up|1|||
126749293|NCT05333289|456029259|FG000|Overall Study|Death|1|||
126749294|NCT05333289|456029260|FG001|Overall Study|Death|0|||
126749295|NCT05333289|456029261|FG002|Overall Study|Death|0|||
126749296|NCT05333289|456029262|FG003|Overall Study|Death|0|||
126749297|NCT05333289|456029263|FG004|Overall Study|Death|0|||
126749298|NCT05333289|456029264|FG005|Overall Study|Death|0|||
126749299|NCT05333289|456029265|FG006|Overall Study|Death|0|||
126749300|NCT05333289|456029266|FG007|Overall Study|Death|0|||
126749301|NCT03685643|456029269|FG000|Overall Study|Lost to Follow-up|14|||
126749302|NCT03685643|456029270|FG001|Overall Study|Lost to Follow-up|22|||
126749303|NCT04430036|456029271|FG000|Safety Run in Phase|Progression of disease|2|||
126749304|NCT01842334|456029272|FG000|Overall Study|Withdrawal by Subject|3|||
126749305|NCT01842334|456029273|FG001|Overall Study|Withdrawal by Subject|3|||
126749306|NCT01842334|456029272|FG000|Overall Study|Moved away mid-study|0|||
126749307|NCT01842334|456029273|FG001|Overall Study|Moved away mid-study|1|||
126749308|NCT00572728|456029281|FG000|Overall Study|Withdrawal by Subject|10|||
126749309|NCT00572728|456029281|FG000|Overall Study|Ineligible|3|||
126749310|NCT00572728|456029281|FG000|Overall Study|Enrolled under Amendment 4|5|||
126749311|NCT00572728|456029281|FG000|Overall Study|Offstudy due to complicating disease|1|||
126749312|NCT00572728|456029281|FG000|Overall Study|FLT1 not completed|4|||
126749313|NCT00572728|456029281|FG000|Overall Study|First Chemotherapy not initiated|2|||
126749314|NCT00572728|456029281|FG000|Overall Study|FLT2 not completed|5|||
126749315|NCT00572728|456029281|FG000|Overall Study|Second chemotherapy not initiated|1|||
126749316|NCT00572728|456029281|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
126749317|NCT00572728|456029281|FG000|Overall Study|Pathology missing|1|||
126749318|NCT00002981|456029282|FG000|Overall Study|Inevaluable|6|||
126749319|NCT01885104|456029285|FG000|Overall Study|Withdrawal of Consent|1|||
126749320|NCT01885104|456029286|FG001|Overall Study|Withdrawal of Consent|0|||
126749321|NCT01885104|456029285|FG000|Overall Study|Lost to Follow-up|0|||
126749322|NCT01885104|456029286|FG001|Overall Study|Lost to Follow-up|1|||
126749323|NCT01885104|456029285|FG000|Overall Study|Physician Decision|1|||
126749324|NCT01885104|456029286|FG001|Overall Study|Physician Decision|0|||
126749325|NCT00113555|456029287|FG000|Overall Study|Baseline Failure|59|||
126749326|NCT00113555|456029287|FG000|Overall Study|Permanently Explanted|7|||
126749327|NCT00113555|456029287|FG000|Overall Study|Death|1|||
126749328|NCT00113555|456029287|FG000|Overall Study|Missed Followup|4|||
126749329|NCT00113555|456029287|FG000|Overall Study|Lost to Follow-up|8|||
126749330|NCT01060124|456029288|FG000|Overall Study|Other|16|||
126749331|NCT01060124|456029288|FG000|Overall Study|Adverse Event|14|||
126749332|NCT01060124|456029288|FG000|Overall Study|Withdrawal by Subject|7|||
126749333|NCT03858686|456029291|FG000|Period 1|Adverse Event|1|||
126749334|NCT03858686|456029292|FG001|Period 1|Adverse Event|1|||
126749335|NCT03858686|456029291|FG000|Period 1|Lack of compliance|0|||
126749336|NCT03858686|456029292|FG001|Period 1|Lack of compliance|1|||
126749337|NCT03858686|456029291|FG000|Period 1|Adverse Event|0|||
126749338|NCT03858686|456029292|FG001|Period 1|Adverse Event|1|||
126749339|NCT03858686|456029291|FG000|Period 2|Adverse Event|0|||
126749340|NCT03858686|456029292|FG001|Period 2|Adverse Event|1|||
126749341|NCT04191096|456029294|FG000|Overall Study|Death|102|||
126749342|NCT04191096|456029295|FG001|Overall Study|Death|89|||
126749343|NCT04191096|456029294|FG000|Overall Study|Lost to Follow-up|1|||
126749344|NCT04191096|456029295|FG001|Overall Study|Lost to Follow-up|1|||
126749345|NCT04191096|456029294|FG000|Overall Study|Withdrawal by Subject|5|||
126622332|NCT01945086|455574193|FG002|Overall Study|Adverse Event|1|||
126622333|NCT00170950|455574195|FG000|Overall Study|Death|236|||
126622334|NCT00170950|455574196|FG001|Overall Study|Death|274|||
126622335|NCT00170950|455574195|FG000|Overall Study|Withdrawal by Subject|496|||
126749346|NCT04191096|456029295|FG001|Overall Study|Withdrawal by Subject|5|||
126749347|NCT04191096|456029294|FG000|Overall Study|Participants Ongoing|518|||
126749348|NCT04191096|456029295|FG001|Overall Study|Participants Ongoing|530|||
126749349|NCT02683668|456029297|FG000|Period 2|Withdrawal by Subject|0|||
126749350|NCT02683668|456029298|FG001|Period 2|Withdrawal by Subject|1|||
126749351|NCT02683668|456029299|FG002|Period 2|Withdrawal by Subject|0|||
126749352|NCT04418427|456030645|FG000|Overall Study|Death|0|||
126749353|NCT04418427|456030646|FG001|Overall Study|Death|1|||
126749354|NCT04418427|456030647|FG002|Overall Study|Death|0|||
126749355|NCT04418427|456030645|FG000|Overall Study|Lost to Follow-up|0|||
126749356|NCT04418427|456030646|FG001|Overall Study|Lost to Follow-up|2|||
126749357|NCT04418427|456030647|FG002|Overall Study|Lost to Follow-up|2|||
126749358|NCT04418427|456030645|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
126749359|NCT04418427|456030646|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
126749360|NCT04418427|456030647|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
126749361|NCT04418427|456030645|FG000|Overall Study|Pre-existing medical condition|0|||
126749362|NCT04418427|456030646|FG001|Overall Study|Pre-existing medical condition|1|||
126749363|NCT04418427|456030647|FG002|Overall Study|Pre-existing medical condition|0|||
126749364|NCT02554721|456030652|FG000|Overall Study|Adverse Event|1|||
126749365|NCT02554721|456030653|FG001|Overall Study|Adverse Event|0|||
126749366|NCT02554721|456030654|FG002|Overall Study|Adverse Event|0|||
126749367|NCT02554721|456030655|FG003|Overall Study|Adverse Event|0|||
126749368|NCT02554721|456030656|FG004|Overall Study|Adverse Event|1|||
126749369|NCT02554721|456030652|FG000|Overall Study|Noncompliance|0|||
126749370|NCT02554721|456030653|FG001|Overall Study|Noncompliance|0|||
126749371|NCT02554721|456030654|FG002|Overall Study|Noncompliance|0|||
126749372|NCT02554721|456030655|FG003|Overall Study|Noncompliance|0|||
126749373|NCT02554721|456030656|FG004|Overall Study|Noncompliance|1|||
126749374|NCT01888965|456030658|FG000|Overall Study|Adverse Event|5|||
126749375|NCT01888965|456030658|FG000|Overall Study|Lack of Efficacy|4|||
126749376|NCT00908895|456030659|FG000|Overall Study|Lost to Follow-up|1|||
126749377|NCT00908895|456030660|FG001|Overall Study|Lost to Follow-up|3|||
126749378|NCT00908895|456030659|FG000|Overall Study|algodystrophy|2|||
126749379|NCT00908895|456030660|FG001|Overall Study|algodystrophy|2|||
126749380|NCT00908895|456030659|FG000|Overall Study|Adverse Event|1|||
126749381|NCT00908895|456030660|FG001|Overall Study|Adverse Event|1|||
126749382|NCT03661983|456030662|FG000|Open Label Stabilization Phase|Adverse Event|5|||
126749383|NCT03661983|456030663|FG001|Open Label Stabilization Phase|Adverse Event|0|||
126749384|NCT03661983|456030664|FG002|Open Label Stabilization Phase|Adverse Event|0|||
126749385|NCT03661983|456030665|FG003|Open Label Stabilization Phase|Adverse Event|0|||
126749386|NCT03661983|456030662|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
126749387|NCT03661983|456030663|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
126749388|NCT03661983|456030664|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
126749389|NCT03661983|456030665|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
126749390|NCT03661983|456030662|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
126749391|NCT03661983|456030663|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
126749392|NCT03661983|456030664|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
126749393|NCT03661983|456030665|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
126749394|NCT03661983|456030662|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
126749395|NCT03661983|456030663|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
126749396|NCT03661983|456030664|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
126749397|NCT03661983|456030665|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
126749398|NCT03661983|456030662|FG000|Double-blind Randomized Phase|Adverse Event|0|||
126749399|NCT03661983|456030663|FG001|Double-blind Randomized Phase|Adverse Event|1|||
126749400|NCT03661983|456030664|FG002|Double-blind Randomized Phase|Adverse Event|0|||
126749401|NCT03661983|456030665|FG003|Double-blind Randomized Phase|Adverse Event|0|||
126749402|NCT03661983|456030662|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
126749403|NCT03661983|456030663|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
126749404|NCT03661983|456030664|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
126749405|NCT03661983|456030665|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
126749406|NCT03661983|456030662|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
126749407|NCT03661983|456030663|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
126749408|NCT03661983|456030664|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
126749409|NCT03661983|456030665|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
126749410|NCT03661983|456030662|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
126749411|NCT03661983|456030663|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
126749412|NCT03661983|456030664|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
126749413|NCT03661983|456030665|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
126749414|NCT04124952|456030666|FG000|Overall Study|Lost to Follow-up|1|||
126749415|NCT01654224|456030670|FG000|Overall Study|Lost to Follow-up|2|||
126749416|NCT01654224|456030671|FG001|Overall Study|Lost to Follow-up|2|||
126749417|NCT01654224|456030670|FG000|Overall Study|Did not receive allocation|1|||
126749418|NCT01654224|456030671|FG001|Overall Study|Did not receive allocation|8|||
126749419|NCT01654224|456030670|FG000|Overall Study|Insufficient blood sample|3|||
126749420|NCT01654224|456030671|FG001|Overall Study|Insufficient blood sample|2|||
126749421|NCT00166504|456030672|FG000|Overall Study|Adverse Event|3|||
126782327|NCT03567057|456158158|FG001|Overall Study|Lack of Efficacy|0|||
126782328|NCT03567057|456158159|FG002|Overall Study|Lack of Efficacy|1|||
126782329|NCT03567057|456158157|FG000|Overall Study|Death|1|||
126782330|NCT03567057|456158158|FG001|Overall Study|Death|0|||
126782331|NCT03567057|456158159|FG002|Overall Study|Death|0|||
126782332|NCT03567057|456158157|FG000|Overall Study|Physician Decision|1|||
126782333|NCT03567057|456158158|FG001|Overall Study|Physician Decision|0|||
126749422|NCT00166504|456030673|FG001|Overall Study|Adverse Event|3|||
126749423|NCT00166504|456030672|FG000|Overall Study|Lost to Follow-up|1|||
126749424|NCT00166504|456030673|FG001|Overall Study|Lost to Follow-up|1|||
126749425|NCT00166504|456030672|FG000|Overall Study|Withdrawal by Subject|1|||
126749426|NCT00166504|456030673|FG001|Overall Study|Withdrawal by Subject|0|||
126749427|NCT02094612|456030674|FG000|Overall Study|Lost to Follow-up|47|||
126782334|NCT03567057|456158159|FG002|Overall Study|Physician Decision|0|||
126749428|NCT02094612|456030675|FG001|Overall Study|Lost to Follow-up|47|||
126749429|NCT02094612|456030674|FG000|Overall Study|Never started ADHD medication|32|||
126749430|NCT02094612|456030675|FG001|Overall Study|Never started ADHD medication|23|||
126749431|NCT03345849|456030676|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
126749432|NCT03345849|456030677|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
126749433|NCT03345849|456030678|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
126749434|NCT03345849|456030679|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
126749435|NCT03345849|456030676|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
126749436|NCT03345849|456030677|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
126749437|NCT03345849|456030678|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
126749438|NCT03345849|456030679|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
126749439|NCT03345849|456030676|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
126749440|NCT03345849|456030677|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
126749441|NCT03345849|456030678|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
126749442|NCT03345849|456030679|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
126749443|NCT03345849|456030676|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
126749444|NCT03345849|456030677|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
126749445|NCT03345849|456030678|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
126749446|NCT03345849|456030679|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
126749447|NCT03345849|456030676|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
126749448|NCT03345849|456030677|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
126749449|NCT03345849|456030678|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
126749450|NCT03345849|456030679|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
126749451|NCT03345849|456030676|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
126749452|NCT03345849|456030677|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
126749453|NCT03345849|456030678|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
126749454|NCT03345849|456030679|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
126749455|NCT03345849|456030676|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
126749456|NCT03345849|456030677|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
126749457|NCT03345849|456030678|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
126749458|NCT03345849|456030679|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
126749459|NCT03345849|456030676|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
126749460|NCT03345849|456030677|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
126749461|NCT03345849|456030678|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
126749462|NCT03345849|456030679|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
126749463|NCT03345849|456030676|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
126749464|NCT03345849|456030677|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
126749465|NCT03345849|456030678|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
126749466|NCT03345849|456030679|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
126749467|NCT03345849|456030676|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
126749468|NCT03345849|456030677|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
126749469|NCT03345849|456030678|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
126749470|NCT03345849|456030679|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
126749471|NCT03345849|456030676|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
126749472|NCT03345849|456030677|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
126749473|NCT03345849|456030678|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
126749474|NCT03345849|456030679|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
126749475|NCT03261037|456030680|FG000|Overall Study|Withdrawal by Subject|2|||
126749476|NCT03261037|456030681|FG001|Overall Study|Withdrawal by Subject|13|||
126749477|NCT03261037|456030682|FG002|Overall Study|Withdrawal by Subject|0|||
126749478|NCT03261037|456030683|FG003|Overall Study|Withdrawal by Subject|18|||
126749479|NCT03261037|456030680|FG000|Overall Study|Non-compliance with study procedures|0|||
126749480|NCT03261037|456030681|FG001|Overall Study|Non-compliance with study procedures|2|||
126749481|NCT03261037|456030682|FG002|Overall Study|Non-compliance with study procedures|0|||
126749482|NCT03261037|456030683|FG003|Overall Study|Non-compliance with study procedures|6|||
126749483|NCT03261037|456030680|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
126749484|NCT03261037|456030681|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
126749485|NCT03261037|456030682|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
126749486|NCT03261037|456030683|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
126749487|NCT03261037|456030680|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
126749488|NCT03261037|456030681|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
126749489|NCT03261037|456030682|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
126749490|NCT03261037|456030683|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
126749491|NCT03261037|456030680|FG000|Overall Study|Diagnosed but protocol deviation|1|||
126749492|NCT03261037|456030681|FG001|Overall Study|Diagnosed but protocol deviation|0|||
126749493|NCT03261037|456030682|FG002|Overall Study|Diagnosed but protocol deviation|0|||
126749494|NCT03261037|456030683|FG003|Overall Study|Diagnosed but protocol deviation|0|||
126749495|NCT03261037|456030680|FG000|Overall Study|Participant did not want to continue the study|0|||
126749496|NCT03261037|456030681|FG001|Overall Study|Participant did not want to continue the study|1|||
126749497|NCT03261037|456030682|FG002|Overall Study|Participant did not want to continue the study|0|||
126749498|NCT03261037|456030683|FG003|Overall Study|Participant did not want to continue the study|0|||
126749499|NCT03261037|456030680|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
126749500|NCT03261037|456030681|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
126749501|NCT03261037|456030682|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
126749502|NCT03261037|456030683|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
126749503|NCT03261037|456030680|FG000|Overall Study|Participant presented clinical improvement|0|||
126749504|NCT03261037|456030681|FG001|Overall Study|Participant presented clinical improvement|2|||
126749505|NCT03261037|456030682|FG002|Overall Study|Participant presented clinical improvement|0|||
126749506|NCT03261037|456030683|FG003|Overall Study|Participant presented clinical improvement|0|||
126749507|NCT03261037|456030680|FG000|Overall Study|Technical difficulties|0|||
126749508|NCT03261037|456030681|FG001|Overall Study|Technical difficulties|0|||
126749509|NCT03261037|456030682|FG002|Overall Study|Technical difficulties|0|||
126749510|NCT03261037|456030683|FG003|Overall Study|Technical difficulties|1|||
126749511|NCT03261037|456030680|FG000|Overall Study|Equipment failed to work|0|||
126749512|NCT03261037|456030681|FG001|Overall Study|Equipment failed to work|0|||
126749513|NCT03261037|456030682|FG002|Overall Study|Equipment failed to work|0|||
126749514|NCT03261037|456030683|FG003|Overall Study|Equipment failed to work|1|||
126749515|NCT03261037|456030680|FG000|Overall Study|End of study for participant and no follow up|0|||
126749516|NCT03261037|456030681|FG001|Overall Study|End of study for participant and no follow up|0|||
126749517|NCT03261037|456030682|FG002|Overall Study|End of study for participant and no follow up|0|||
126749518|NCT03261037|456030683|FG003|Overall Study|End of study for participant and no follow up|1|||
126749519|NCT03261037|456030680|FG000|Overall Study|Participant was too weak to continue in study|1|||
126749520|NCT03261037|456030681|FG001|Overall Study|Participant was too weak to continue in study|0|||
126749521|NCT03261037|456030682|FG002|Overall Study|Participant was too weak to continue in study|0|||
126749522|NCT03261037|456030683|FG003|Overall Study|Participant was too weak to continue in study|0|||
126749523|NCT02943577|456030684|FG000|Overall Study|Protocol Violation|0|||
126749524|NCT02943577|456030685|FG001|Overall Study|Protocol Violation|1|||
126749525|NCT02943577|456030684|FG000|Overall Study|Adverse Event|3|||
126749526|NCT02943577|456030685|FG001|Overall Study|Adverse Event|2|||
126749527|NCT02943577|456030684|FG000|Overall Study|Lost to Follow-up|0|||
126749528|NCT02943577|456030685|FG001|Overall Study|Lost to Follow-up|1|||
126749529|NCT02943577|456030684|FG000|Overall Study|Withdrawal by Subject|1|||
126749530|NCT02943577|456030685|FG001|Overall Study|Withdrawal by Subject|1|||
126749531|NCT02943577|456030684|FG000|Overall Study|Pregnancy|1|||
126749532|NCT02943577|456030685|FG001|Overall Study|Pregnancy|0|||
126749533|NCT04654468|456030692|FG000|Overall Study|Death|1|||
126749534|NCT04654468|456030692|FG000|Overall Study|Ongoing in the Study|50|||
126749535|NCT03093350|456030697|FG000|Overall Study|Death|1|||
126749536|NCT03093350|456030697|FG000|Overall Study|Signed consent, never began treartment|1|||
126749537|NCT04564027|456030702|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
126749538|NCT04564027|456030703|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
126749539|NCT04564027|456030704|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
126749540|NCT04564027|456030705|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
126749541|NCT01267955|456030706|FG000|Stage 1 (6 Months)|Death|3|||
126749542|NCT01267955|456030706|FG000|Stage 2 (6 Months)|Death|5|||
126749543|NCT01267955|456030706|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
126749544|NCT04517253|456030707|FG000|Primary Treatment Period|Adverse Event|1|||
126749545|NCT04517253|456030708|FG001|Primary Treatment Period|Adverse Event|0|||
126749546|NCT04517253|456030709|FG002|Primary Treatment Period|Adverse Event|0|||
126749547|NCT04517253|456030707|FG000|Primary Treatment Period|Death|0|||
126749548|NCT04517253|456030708|FG001|Primary Treatment Period|Death|1|||
126749549|NCT04517253|456030709|FG002|Primary Treatment Period|Death|0|||
126749550|NCT04517253|456030707|FG000|Maintenance Period|Withdrawal by Subject|1|||
126622336|NCT00170950|455574196|FG001|Overall Study|Withdrawal by Subject|498|||
126749551|NCT04517253|456030708|FG001|Maintenance Period|Withdrawal by Subject|0|||
126749552|NCT04517253|456030709|FG002|Maintenance Period|Withdrawal by Subject|0|||
126749553|NCT04517253|456030707|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
126749554|NCT04517253|456030708|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
126749555|NCT04517253|456030709|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
126749556|NCT04651777|456030710|FG000|Overall Study|Adverse Event|1|||
126622337|NCT00170950|455574195|FG000|Overall Study|Lost to Follow-up|134|||
126749557|NCT04651777|456030710|FG000|Overall Study|Withdrawal by Subject|2|||
126749558|NCT04785144|456030711|FG000|Overall Study|Withdrawal by Subject|4|||
126749559|NCT04785144|456030712|FG001|Overall Study|Withdrawal by Subject|1|||
126749560|NCT04785144|456030713|FG002|Overall Study|Withdrawal by Subject|0|||
126749561|NCT04785144|456030714|FG003|Overall Study|Withdrawal by Subject|0|||
126749562|NCT04785144|456030715|FG004|Overall Study|Withdrawal by Subject|0|||
126749563|NCT04785144|456030716|FG005|Overall Study|Withdrawal by Subject|2|||
126749564|NCT04785144|456030717|FG006|Overall Study|Withdrawal by Subject|2|||
126749565|NCT04785144|456030718|FG007|Overall Study|Withdrawal by Subject|0|||
126749566|NCT04785144|456030719|FG008|Overall Study|Withdrawal by Subject|1|||
126749567|NCT04785144|456030720|FG009|Overall Study|Withdrawal by Subject|0|||
126749568|NCT04785144|456030711|FG000|Overall Study|Lost to Follow-up|1|||
126749569|NCT04785144|456030712|FG001|Overall Study|Lost to Follow-up|0|||
126749570|NCT04785144|456030713|FG002|Overall Study|Lost to Follow-up|0|||
126749571|NCT04785144|456030714|FG003|Overall Study|Lost to Follow-up|0|||
126749572|NCT04785144|456030715|FG004|Overall Study|Lost to Follow-up|1|||
126749573|NCT04785144|456030716|FG005|Overall Study|Lost to Follow-up|2|||
126749574|NCT04785144|456030717|FG006|Overall Study|Lost to Follow-up|1|||
126749575|NCT04785144|456030718|FG007|Overall Study|Lost to Follow-up|2|||
126749576|NCT04785144|456030719|FG008|Overall Study|Lost to Follow-up|4|||
126749577|NCT04785144|456030720|FG009|Overall Study|Lost to Follow-up|1|||
126749578|NCT04785144|456030711|FG000|Overall Study|Protocol Violation|0|||
126749579|NCT04785144|456030712|FG001|Overall Study|Protocol Violation|0|||
126749580|NCT04785144|456030713|FG002|Overall Study|Protocol Violation|0|||
126749581|NCT04785144|456030714|FG003|Overall Study|Protocol Violation|0|||
126749582|NCT04785144|456030715|FG004|Overall Study|Protocol Violation|0|||
126749583|NCT04785144|456030716|FG005|Overall Study|Protocol Violation|0|||
126749584|NCT04785144|456030717|FG006|Overall Study|Protocol Violation|1|||
126749585|NCT04785144|456030718|FG007|Overall Study|Protocol Violation|0|||
126749586|NCT04785144|456030719|FG008|Overall Study|Protocol Violation|0|||
126749587|NCT04785144|456030720|FG009|Overall Study|Protocol Violation|0|||
126749588|NCT04785144|456030711|FG000|Overall Study|Physician Decision|0|||
126749589|NCT04785144|456030712|FG001|Overall Study|Physician Decision|0|||
126749590|NCT04785144|456030713|FG002|Overall Study|Physician Decision|0|||
126749591|NCT04785144|456030714|FG003|Overall Study|Physician Decision|0|||
126749592|NCT04785144|456030715|FG004|Overall Study|Physician Decision|0|||
126749593|NCT04785144|456030716|FG005|Overall Study|Physician Decision|0|||
126749594|NCT04785144|456030717|FG006|Overall Study|Physician Decision|0|||
126749595|NCT04785144|456030718|FG007|Overall Study|Physician Decision|0|||
126749596|NCT04785144|456030719|FG008|Overall Study|Physician Decision|0|||
126749597|NCT04785144|456030720|FG009|Overall Study|Physician Decision|1|||
126749598|NCT04785144|456030711|FG000|Overall Study|Unable to continue due to work schedule|0|||
126749599|NCT04785144|456030712|FG001|Overall Study|Unable to continue due to work schedule|0|||
126749600|NCT04785144|456030713|FG002|Overall Study|Unable to continue due to work schedule|0|||
126749601|NCT04785144|456030714|FG003|Overall Study|Unable to continue due to work schedule|0|||
126749602|NCT04785144|456030715|FG004|Overall Study|Unable to continue due to work schedule|0|||
126749603|NCT04785144|456030716|FG005|Overall Study|Unable to continue due to work schedule|0|||
126749604|NCT04785144|456030717|FG006|Overall Study|Unable to continue due to work schedule|0|||
126749605|NCT04785144|456030718|FG007|Overall Study|Unable to continue due to work schedule|0|||
126749606|NCT04785144|456030719|FG008|Overall Study|Unable to continue due to work schedule|0|||
126749607|NCT04785144|456030720|FG009|Overall Study|Unable to continue due to work schedule|1|||
126749608|NCT05245071|456030724|FG000|Overall Study|Progressive disease|18|||
126749609|NCT05245071|456030724|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
126749610|NCT05245071|456030724|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
126749611|NCT00592072|456030727|FG000|Wash Out Period|Lost to Follow-up|1|||
126749612|NCT00592072|456030728|FG001|Wash Out Period|Lost to Follow-up|1|||
126749613|NCT02750501|456030732|FG000|Overall Study|Adverse Event|4|||
126749614|NCT02750501|456030732|FG000|Overall Study|Physician Decision|1|||
126749615|NCT02750501|456030732|FG000|Overall Study|Protocol Violation|1|||
126749616|NCT02750501|456030732|FG000|Overall Study|G-tube came out|1|||
126782335|NCT03567057|456158157|FG000|Overall Study|Unstable medical condition|1|||
126622338|NCT00170950|455574196|FG001|Overall Study|Lost to Follow-up|115|||
126749617|NCT02750501|456030732|FG000|Overall Study|Non-compliant use of PERT|1|||
126749618|NCT01738594|456030733|FG000|Registration and Treatment Start|Adverse Event|0|||
126749619|NCT01738594|456030734|FG001|Registration and Treatment Start|Adverse Event|1|||
126749620|NCT01738594|456030735|FG002|Registration and Treatment Start|Adverse Event|0|||
126749621|NCT01738594|456030736|FG003|Registration and Treatment Start|Adverse Event|0|||
126782336|NCT03567057|456158158|FG001|Overall Study|Unstable medical condition|0|||
126749622|NCT01738594|456030737|FG004|Registration and Treatment Start|Adverse Event|0|||
126749623|NCT01738594|456030738|FG005|Registration and Treatment Start|Adverse Event|0|||
126749624|NCT01738594|456030739|FG006|Registration and Treatment Start|Adverse Event|0|||
126749625|NCT01738594|456030740|FG007|Registration and Treatment Start|Adverse Event|0|||
126749626|NCT01738594|456030733|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126749627|NCT01738594|456030734|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126749628|NCT01738594|456030735|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126749629|NCT01738594|456030736|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126782337|NCT03567057|456158159|FG002|Overall Study|Unstable medical condition|0|||
126782338|NCT03567057|456158157|FG000|Overall Study|Medical history event|0|||
126749630|NCT01738594|456030737|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126749631|NCT01738594|456030738|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
126749632|NCT01738594|456030739|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126749633|NCT01738594|456030740|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
126749634|NCT01738594|456030733|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
126749635|NCT01738594|456030734|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
126749636|NCT01738594|456030735|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
126749637|NCT01738594|456030736|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
126749638|NCT01738594|456030737|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
126749639|NCT01738594|456030738|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
126749640|NCT01738594|456030739|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
126749641|NCT01738594|456030740|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
126749642|NCT01738594|456030733|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126749643|NCT01738594|456030734|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126749644|NCT01738594|456030735|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126749645|NCT01738594|456030736|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126749646|NCT01738594|456030737|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126749647|NCT01738594|456030738|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
126749648|NCT01738594|456030739|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126749649|NCT01738594|456030740|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
126749650|NCT01738594|456030733|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126749651|NCT01738594|456030734|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126749652|NCT01738594|456030735|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126749653|NCT01738594|456030736|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126749654|NCT01738594|456030737|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126749655|NCT01738594|456030738|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
126749656|NCT01738594|456030739|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126749657|NCT01738594|456030740|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
126749658|NCT01738594|456030733|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126749659|NCT01738594|456030734|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126749660|NCT01738594|456030735|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126749661|NCT01738594|456030736|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126749662|NCT01738594|456030737|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
126749663|NCT01738594|456030738|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126749664|NCT01738594|456030739|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126749665|NCT01738594|456030740|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
126749666|NCT01738594|456030733|FG000|Follow up for 1 Year|Death|0|||
126749667|NCT01738594|456030734|FG001|Follow up for 1 Year|Death|0|||
126749668|NCT01738594|456030735|FG002|Follow up for 1 Year|Death|0|||
126749669|NCT01738594|456030736|FG003|Follow up for 1 Year|Death|0|||
126749670|NCT01738594|456030737|FG004|Follow up for 1 Year|Death|0|||
126749671|NCT01738594|456030738|FG005|Follow up for 1 Year|Death|1|||
126749672|NCT01738594|456030739|FG006|Follow up for 1 Year|Death|0|||
126749673|NCT01738594|456030740|FG007|Follow up for 1 Year|Death|0|||
126749674|NCT01738594|456030733|FG000|Follow up for 1 Year|Other|0|||
126749675|NCT01738594|456030734|FG001|Follow up for 1 Year|Other|0|||
126749676|NCT01738594|456030735|FG002|Follow up for 1 Year|Other|0|||
126749677|NCT01738594|456030736|FG003|Follow up for 1 Year|Other|0|||
126749678|NCT01738594|456030737|FG004|Follow up for 1 Year|Other|0|||
126749679|NCT01738594|456030738|FG005|Follow up for 1 Year|Other|2|||
126749680|NCT01738594|456030739|FG006|Follow up for 1 Year|Other|0|||
126622339|NCT00170950|455574195|FG000|Overall Study|Missing|2|||
126749681|NCT01738594|456030740|FG007|Follow up for 1 Year|Other|0|||
126782339|NCT03567057|456158158|FG001|Overall Study|Medical history event|0|||
126622340|NCT00170950|455574196|FG001|Overall Study|Missing|1|||
126749682|NCT00403390|456030741|FG000|Overall Study|Withdrawal by Subject|1|||
126749683|NCT00403390|456030742|FG001|Overall Study|Withdrawal by Subject|0|||
126749684|NCT00403390|456030741|FG000|Overall Study|samples lost|1|||
126749685|NCT00403390|456030742|FG001|Overall Study|samples lost|0|||
126749686|NCT00403390|456030741|FG000|Overall Study|non-compliant|1|||
126749687|NCT00403390|456030742|FG001|Overall Study|non-compliant|0|||
126749688|NCT01347840|456030753|FG000|Overall Study|Withdrawal by Subject|1|||
126749689|NCT05307523|456030757|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
126749690|NCT05307523|456030758|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
126782340|NCT03567057|456158159|FG002|Overall Study|Medical history event|1|||
126622341|NCT00170950|455574195|FG000|Overall Study|Termination Data Not Recorded|17|||
126749691|NCT05307523|456030757|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
126782341|NCT03567057|456158157|FG000|Overall Study|Other|0|||
126622342|NCT00170950|455574196|FG001|Overall Study|Termination Data Not Recorded|22|||
126622343|NCT02442622|455574199|FG000|Overall Study|Withdrawal by Subject|3|||
126749692|NCT05307523|456030758|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
126749693|NCT01708915|456030763|FG000|Overall Study|Adverse Event|1|||
126749694|NCT01708915|456030764|FG001|Overall Study|Adverse Event|0|||
126749695|NCT01708915|456030765|FG002|Overall Study|Adverse Event|9|||
126749696|NCT01708915|456030766|FG003|Overall Study|Adverse Event|13|||
126749697|NCT01708915|456030763|FG000|Overall Study|Lack of Efficacy|84|||
126749698|NCT01708915|456030764|FG001|Overall Study|Lack of Efficacy|60|||
126749699|NCT01708915|456030765|FG002|Overall Study|Lack of Efficacy|35|||
126749700|NCT01708915|456030766|FG003|Overall Study|Lack of Efficacy|15|||
126749701|NCT01708915|456030763|FG000|Overall Study|Protocol Violation|0|||
126749702|NCT01708915|456030764|FG001|Overall Study|Protocol Violation|0|||
126749703|NCT01708915|456030765|FG002|Overall Study|Protocol Violation|0|||
126749704|NCT01708915|456030766|FG003|Overall Study|Protocol Violation|1|||
126749705|NCT01708915|456030763|FG000|Overall Study|Withdrawal by Subject|0|||
126749706|NCT01708915|456030764|FG001|Overall Study|Withdrawal by Subject|1|||
126749707|NCT01708915|456030765|FG002|Overall Study|Withdrawal by Subject|2|||
126749708|NCT01708915|456030766|FG003|Overall Study|Withdrawal by Subject|2|||
126749709|NCT01708915|456030763|FG000|Overall Study|Other reasons than stated above|1|||
126749710|NCT01708915|456030764|FG001|Overall Study|Other reasons than stated above|1|||
126749711|NCT01708915|456030765|FG002|Overall Study|Other reasons than stated above|0|||
126749712|NCT01708915|456030766|FG003|Overall Study|Other reasons than stated above|2|||
126749713|NCT01432938|456030768|FG000|First Intervention|Protocol Violation|1|||
126749714|NCT01432938|456030769|FG001|First Intervention|Protocol Violation|0|||
126749715|NCT01432938|456030768|FG000|First Intervention|Physician Decision|1|||
126749716|NCT01432938|456030769|FG001|First Intervention|Physician Decision|0|||
126749717|NCT01432938|456030768|FG000|Second Intervention|Adverse Event|1|||
126622344|NCT02442622|455574200|FG001|Overall Study|Withdrawal by Subject|1|||
126622345|NCT01123642|455575850|FG000|Overall Study|Lost to Follow-up|23|||
126622346|NCT01123642|455575850|FG000|Overall Study|Withdrawal by Subject|9|||
126622347|NCT01123642|455575850|FG000|Overall Study|ineligible at baseline assessment|36|||
126622348|NCT03322514|455575851|FG000|Overall Study|Withdrawal by Subject|1|||
126749718|NCT01432938|456030769|FG001|Second Intervention|Adverse Event|0|||
126749719|NCT03231228|456030770|FG000|Overall Study|Lost to Follow-up|2|||
126749720|NCT03231228|456030771|FG001|Overall Study|Lost to Follow-up|0|||
126749721|NCT03231228|456030770|FG000|Overall Study|Physician Decision|1|||
126749722|NCT03231228|456030771|FG001|Overall Study|Physician Decision|0|||
126749723|NCT04223778|456030772|FG000|Overall Study|Death|1|||
126749724|NCT04223778|456030773|FG001|Overall Study|Death|1|||
126749725|NCT04223778|456030772|FG000|Overall Study|Lost to Follow-up|4|||
126749726|NCT04223778|456030773|FG001|Overall Study|Lost to Follow-up|5|||
126749727|NCT04223778|456030772|FG000|Overall Study|Physician Decision|10|||
126749728|NCT04223778|456030773|FG001|Overall Study|Physician Decision|6|||
126749729|NCT04223778|456030772|FG000|Overall Study|Withdrawal by Subject|35|||
126622349|NCT03322514|455575852|FG001|Overall Study|Withdrawal by Subject|1|||
126622350|NCT01184859|455575853|FG000|Period 1: Single Dose|Insufficient urine production|0|||
126622351|NCT01184859|455575854|FG001|Period 1: Single Dose|Insufficient urine production|1|||
126622352|NCT01184859|455575855|FG002|Period 1: Single Dose|Insufficient urine production|0|||
126622353|NCT01184859|455575856|FG003|Period 1: Single Dose|Insufficient urine production|0|||
126622354|NCT01184859|455575857|FG004|Period 1: Single Dose|Insufficient urine production|0|||
126622355|NCT01184859|455575853|FG000|Period 1: Single Dose|Protocol Violation|0|||
126622356|NCT01184859|455575854|FG001|Period 1: Single Dose|Protocol Violation|1|||
126622357|NCT01184859|455575855|FG002|Period 1: Single Dose|Protocol Violation|0|||
126622358|NCT01184859|455575856|FG003|Period 1: Single Dose|Protocol Violation|0|||
126622359|NCT01184859|455575857|FG004|Period 1: Single Dose|Protocol Violation|0|||
126749730|NCT04223778|456030773|FG001|Overall Study|Withdrawal by Subject|17|||
126749731|NCT04223778|456030772|FG000|Overall Study|Not Reported|7|||
126749732|NCT04223778|456030773|FG001|Overall Study|Not Reported|8|||
126749733|NCT03893630|456030774|FG000|Overall Study|Lost to Follow-up|5|||
126749734|NCT03893630|456030775|FG001|Overall Study|Lost to Follow-up|4|||
126749735|NCT03893630|456030776|FG002|Overall Study|Lost to Follow-up|2|||
126749736|NCT03893630|456030774|FG000|Overall Study|Withdrawal by Subject|3|||
126749737|NCT03893630|456030775|FG001|Overall Study|Withdrawal by Subject|6|||
126749738|NCT03893630|456030776|FG002|Overall Study|Withdrawal by Subject|3|||
126749739|NCT03893630|456030774|FG000|Overall Study|Discontinued Intervention|0|||
126749740|NCT03893630|456030775|FG001|Overall Study|Discontinued Intervention|4|||
126749741|NCT03893630|456030776|FG002|Overall Study|Discontinued Intervention|2|||
126749742|NCT00887822|456032834|FG000|Overall Study|Insufficient therapeutic response|53|||
126749743|NCT00887822|456032835|FG001|Overall Study|Insufficient therapeutic response|55|||
126749744|NCT00887822|456032834|FG000|Overall Study|Adverse Event|14|||
126749745|NCT00887822|456032835|FG001|Overall Study|Adverse Event|17|||
126749746|NCT00887822|456032834|FG000|Overall Study|Failure to return|11|||
126749747|NCT00887822|456032835|FG001|Overall Study|Failure to return|11|||
126622360|NCT01184859|455575853|FG000|Period 1: Single Dose|Adverse Event|0|||
126749748|NCT00887822|456032834|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
126749749|NCT00887822|456032835|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
126749750|NCT00887822|456032834|FG000|Overall Study|Administrative/Other than specified|5|||
126749751|NCT00887822|456032835|FG001|Overall Study|Administrative/Other than specified|4|||
126749752|NCT00887822|456032834|FG000|Overall Study|Death|2|||
126749753|NCT00887822|456032835|FG001|Overall Study|Death|3|||
126749754|NCT00887822|456032834|FG000|Overall Study|Protocol Violation|0|||
126749755|NCT00887822|456032835|FG001|Overall Study|Protocol Violation|1|||
126749756|NCT00887822|456032834|FG000|Overall Study|Randomized but not treated|0|||
126749757|NCT00887822|456032835|FG001|Overall Study|Randomized but not treated|1|||
126749758|NCT02045979|456032836|FG000|Overall Study|Informed Consent Withdrawn|2|||
126749759|NCT02045979|456032837|FG001|Overall Study|Informed Consent Withdrawn|0|||
126749760|NCT02045979|456032838|FG002|Overall Study|Informed Consent Withdrawn|1|||
126749761|NCT02045979|456032836|FG000|Overall Study|not specified above|0|||
126749762|NCT02045979|456032837|FG001|Overall Study|not specified above|1|||
126749763|NCT02045979|456032838|FG002|Overall Study|not specified above|0|||
126749764|NCT02425891|456032839|FG000|Overall Study|Death|333|||
126749765|NCT02425891|456032840|FG001|Overall Study|Death|314|||
126749766|NCT02425891|456032839|FG000|Overall Study|Lost to Follow-up|4|||
126749767|NCT02425891|456032840|FG001|Overall Study|Lost to Follow-up|6|||
126749768|NCT02425891|456032839|FG000|Overall Study|Non-Compliance|1|||
126622361|NCT01184859|455575854|FG001|Period 1: Single Dose|Adverse Event|0|||
126622362|NCT01184859|455575855|FG002|Period 1: Single Dose|Adverse Event|0|||
126749769|NCT02425891|456032840|FG001|Overall Study|Non-Compliance|1|||
126749770|NCT02425891|456032839|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
126749771|NCT02425891|456032840|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
126749772|NCT02425891|456032839|FG000|Overall Study|Physician Decision|0|||
126749773|NCT02425891|456032840|FG001|Overall Study|Physician Decision|1|||
126749774|NCT02425891|456032839|FG000|Overall Study|Protocol Violation|1|||
126749775|NCT02425891|456032840|FG001|Overall Study|Protocol Violation|1|||
126749776|NCT02425891|456032839|FG000|Overall Study|Study Terminated By Sponsor|85|||
126749777|NCT02425891|456032840|FG001|Overall Study|Study Terminated By Sponsor|95|||
126749778|NCT02425891|456032839|FG000|Overall Study|Withdrawal by Subject|27|||
126749779|NCT02425891|456032840|FG001|Overall Study|Withdrawal by Subject|32|||
126749780|NCT02145429|456032842|FG000|Overall Study|Death|4|||
126749781|NCT02145429|456032843|FG001|Overall Study|Death|5|||
126749782|NCT02145429|456032842|FG000|Overall Study|Lost to Follow-up|4|||
126749783|NCT02145429|456032843|FG001|Overall Study|Lost to Follow-up|3|||
126749784|NCT02145429|456032842|FG000|Overall Study|Withdrawal by Subject|8|||
126749785|NCT02145429|456032843|FG001|Overall Study|Withdrawal by Subject|3|||
126749786|NCT01944462|456032844|FG000|PPPP Educational Program|Lost to Follow-up|60|||
126749787|NCT01222767|456032845|FG000|Overall Study|Progressive disease|13|||
126749788|NCT01222767|456032845|FG000|Overall Study|Adverse Event|2|||
126749789|NCT01222767|456032845|FG000|Overall Study|Surgical resection|1|||
126749790|NCT01222767|456032845|FG000|Overall Study|Never treated|1|||
126749791|NCT00723489|456032846|FG000|Overall Study|Physician Decision|0|||
126749792|NCT00723489|456032847|FG001|Overall Study|Physician Decision|1|||
126749793|NCT00723489|456032848|FG002|Overall Study|Physician Decision|0|||
126749794|NCT00723489|456032849|FG003|Overall Study|Physician Decision|0|||
126749795|NCT00723489|456032846|FG000|Overall Study|Pregnancy|0|||
126749796|NCT00723489|456032847|FG001|Overall Study|Pregnancy|0|||
126749797|NCT00723489|456032848|FG002|Overall Study|Pregnancy|0|||
126749798|NCT00723489|456032849|FG003|Overall Study|Pregnancy|1|||
126749799|NCT00723489|456032846|FG000|Overall Study|Withdrawal by Subject|0|||
126749800|NCT00723489|456032847|FG001|Overall Study|Withdrawal by Subject|0|||
126749801|NCT00723489|456032848|FG002|Overall Study|Withdrawal by Subject|0|||
126749802|NCT00723489|456032849|FG003|Overall Study|Withdrawal by Subject|1|||
126749803|NCT00723489|456032846|FG000|Overall Study|Seropositive at baseline|1|||
126749804|NCT00723489|456032847|FG001|Overall Study|Seropositive at baseline|0|||
126749805|NCT00723489|456032848|FG002|Overall Study|Seropositive at baseline|0|||
126749806|NCT00723489|456032849|FG003|Overall Study|Seropositive at baseline|0|||
126749807|NCT00723489|456032846|FG000|Overall Study|Prohibited Medication|0|||
126749808|NCT00723489|456032847|FG001|Overall Study|Prohibited Medication|0|||
126749809|NCT00723489|456032848|FG002|Overall Study|Prohibited Medication|0|||
126749810|NCT00723489|456032849|FG003|Overall Study|Prohibited Medication|1|||
126749811|NCT00723489|456032846|FG000|Overall Study|Samples Collected Out of Window|0|||
126749812|NCT00723489|456032847|FG001|Overall Study|Samples Collected Out of Window|3|||
126622363|NCT01184859|455575856|FG003|Period 1: Single Dose|Adverse Event|0|||
126749813|NCT00723489|456032848|FG002|Overall Study|Samples Collected Out of Window|0|||
126749814|NCT00723489|456032849|FG003|Overall Study|Samples Collected Out of Window|0|||
126749815|NCT01599585|456032850|FG000|Overall Study|Withdrawal by Subject|16|||
126749816|NCT01599585|456032851|FG001|Overall Study|Withdrawal by Subject|9|||
126749817|NCT01599585|456032850|FG000|Overall Study|Lost to Follow-up|3|||
126749818|NCT01599585|456032851|FG001|Overall Study|Lost to Follow-up|5|||
126749819|NCT01599585|456032850|FG000|Overall Study|randomized did not start treatment|3|||
126749820|NCT01599585|456032851|FG001|Overall Study|randomized did not start treatment|3|||
126749821|NCT00081263|456032852|FG000|Overall Study|clerical error|1|||
126749822|NCT00081263|456032853|FG001|Overall Study|clerical error|0|||
126749823|NCT00081263|456032852|FG000|Overall Study|wrong cell type|7|||
126749824|NCT00081263|456032853|FG001|Overall Study|wrong cell type|5|||
126749825|NCT00081263|456032852|FG000|Overall Study|improper pre-protocol therapy|0|||
126749826|NCT00081263|456032853|FG001|Overall Study|improper pre-protocol therapy|1|||
126749827|NCT00081263|456032852|FG000|Overall Study|Inadequate pathology|0|||
126749828|NCT00081263|456032853|FG001|Overall Study|Inadequate pathology|1|||
126749829|NCT00081263|456032852|FG000|Overall Study|Never treated|4|||
126749830|NCT00081263|456032853|FG001|Overall Study|Never treated|5|||
126749831|NCT00081263|456032852|FG000|Overall Study|Inadequate data|5|||
126749832|NCT00081263|456032853|FG001|Overall Study|Inadequate data|10|||
126749833|NCT00777036|456032854|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
126622364|NCT01184859|455575857|FG004|Period 1: Single Dose|Adverse Event|1|||
126622365|NCT01184859|455575853|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
126749834|NCT00777036|456032855|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
126756590|NCT01856920|456059496|FG001|Overall Study|Disease Progression before Treatment|0|||
126756591|NCT01856920|456059495|FG000|Overall Study|Ineligible|0|||
126756592|NCT01856920|456059496|FG001|Overall Study|Ineligible|1|||
126756593|NCT01856920|456059495|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
126756594|NCT01856920|456059496|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
126756595|NCT01856920|456059495|FG000|Overall Study|Refused further Treatment|5|||
126756596|NCT01856920|456059496|FG001|Overall Study|Refused further Treatment|1|||
126756597|NCT01856920|456059495|FG000|Overall Study|Other Reasons|0|||
126756598|NCT01856920|456059496|FG001|Overall Study|Other Reasons|1|||
126756599|NCT01856920|456059495|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
126756600|NCT01856920|456059496|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
126756601|NCT02074059|456059498|FG000|Overall Study|Death|0|||
126756602|NCT02074059|456059499|FG001|Overall Study|Death|0|||
126756603|NCT02074059|456059500|FG002|Overall Study|Death|0|||
126756604|NCT02074059|456059501|FG003|Overall Study|Death|0|||
126756605|NCT02074059|456059502|FG004|Overall Study|Death|1|||
126756606|NCT02074059|456059503|FG005|Overall Study|Death|1|||
126756607|NCT00779506|456059505|FG000|Overall Study|Screening Failed|2|||
126756608|NCT00779506|456059505|FG000|Overall Study|Adverse Event|4|||
126756609|NCT00779506|456059505|FG000|Overall Study|Lack of Efficacy|11|||
126756610|NCT00779506|456059505|FG000|Overall Study|Protocol Violation|5|||
126756611|NCT00779506|456059505|FG000|Overall Study|Withdrawal by Subject|6|||
126756612|NCT00779506|456059505|FG000|Overall Study|Lost to Follow-up|1|||
126756613|NCT01632345|456059508|FG000|Treatment: Part I|Adverse Event|1|||
126756614|NCT01632345|456059509|FG001|Treatment: Part I|Adverse Event|4|||
126756615|NCT01632345|456059510|FG002|Treatment: Part I|Adverse Event|2|||
126756616|NCT01632345|456059511|FG003|Treatment: Part I|Adverse Event|1|||
126756617|NCT01632345|456059512|FG004|Treatment: Part I|Adverse Event|3|||
126756618|NCT01632345|456059513|FG005|Treatment: Part I|Adverse Event|0|||
126756619|NCT01632345|456059514|FG006|Treatment: Part I|Adverse Event|0|||
126756620|NCT01632345|456059508|FG000|Treatment: Part I|Lack of Efficacy|0|||
126756621|NCT01632345|456059509|FG001|Treatment: Part I|Lack of Efficacy|1|||
126756622|NCT01632345|456059510|FG002|Treatment: Part I|Lack of Efficacy|0|||
126756623|NCT01632345|456059511|FG003|Treatment: Part I|Lack of Efficacy|1|||
126756624|NCT01632345|456059512|FG004|Treatment: Part I|Lack of Efficacy|1|||
126756625|NCT01632345|456059513|FG005|Treatment: Part I|Lack of Efficacy|0|||
126756626|NCT01632345|456059514|FG006|Treatment: Part I|Lack of Efficacy|0|||
126756627|NCT01632345|456059508|FG000|Treatment: Part I|Lost to Follow-up|3|||
126756628|NCT01632345|456059509|FG001|Treatment: Part I|Lost to Follow-up|2|||
126756629|NCT01632345|456059510|FG002|Treatment: Part I|Lost to Follow-up|1|||
126756630|NCT01632345|456059511|FG003|Treatment: Part I|Lost to Follow-up|3|||
126756631|NCT01632345|456059512|FG004|Treatment: Part I|Lost to Follow-up|4|||
126756632|NCT01632345|456059513|FG005|Treatment: Part I|Lost to Follow-up|0|||
126756633|NCT01632345|456059514|FG006|Treatment: Part I|Lost to Follow-up|0|||
126756634|NCT01632345|456059508|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
126756635|NCT01632345|456059509|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
126756636|NCT01632345|456059510|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
126756637|NCT01632345|456059511|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
126756638|NCT01632345|456059512|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
126756639|NCT01632345|456059513|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
126756640|NCT01632345|456059514|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
126756641|NCT01632345|456059508|FG000|Treatment: Part I|Physician Decision|2|||
126756642|NCT01632345|456059509|FG001|Treatment: Part I|Physician Decision|1|||
126756643|NCT01632345|456059510|FG002|Treatment: Part I|Physician Decision|0|||
126756644|NCT01632345|456059511|FG003|Treatment: Part I|Physician Decision|0|||
126756645|NCT01632345|456059512|FG004|Treatment: Part I|Physician Decision|1|||
126756646|NCT01632345|456059513|FG005|Treatment: Part I|Physician Decision|0|||
126756647|NCT01632345|456059514|FG006|Treatment: Part I|Physician Decision|0|||
126756648|NCT01632345|456059508|FG000|Treatment: Part I|Pregnancy|0|||
126756649|NCT01632345|456059509|FG001|Treatment: Part I|Pregnancy|1|||
126756650|NCT01632345|456059510|FG002|Treatment: Part I|Pregnancy|0|||
126756651|NCT01632345|456059511|FG003|Treatment: Part I|Pregnancy|0|||
126749835|NCT00777036|456032856|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
126749836|NCT00777036|456032857|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
126749837|NCT00777036|456032854|FG000|On Treatment|Administrative Reason By Sponsor|1|||
126749838|NCT00777036|456032855|FG001|On Treatment|Administrative Reason By Sponsor|0|||
126749839|NCT00777036|456032856|FG002|On Treatment|Administrative Reason By Sponsor|9|||
126749840|NCT00777036|456032857|FG003|On Treatment|Administrative Reason By Sponsor|0|||
126749841|NCT00777036|456032854|FG000|On Treatment|Failure to Meet Study Criteria|0|||
126749842|NCT00777036|456032855|FG001|On Treatment|Failure to Meet Study Criteria|1|||
126749843|NCT00777036|456032856|FG002|On Treatment|Failure to Meet Study Criteria|4|||
126749844|NCT00777036|456032857|FG003|On Treatment|Failure to Meet Study Criteria|0|||
126749845|NCT00777036|456032854|FG000|On Treatment|Pregnancy|1|||
126749846|NCT00777036|456032855|FG001|On Treatment|Pregnancy|0|||
126749847|NCT00777036|456032856|FG002|On Treatment|Pregnancy|1|||
126749848|NCT00777036|456032857|FG003|On Treatment|Pregnancy|0|||
126749849|NCT00777036|456032854|FG000|On Treatment|Non-compliance with Study Drug|1|||
126749850|NCT00777036|456032855|FG001|On Treatment|Non-compliance with Study Drug|0|||
126749851|NCT00777036|456032856|FG002|On Treatment|Non-compliance with Study Drug|1|||
126749852|NCT00777036|456032857|FG003|On Treatment|Non-compliance with Study Drug|0|||
126749853|NCT00777036|456032854|FG000|On Treatment|Maximum Clinical Benefit|2|||
126749854|NCT00777036|456032855|FG001|On Treatment|Maximum Clinical Benefit|0|||
126749855|NCT00777036|456032856|FG002|On Treatment|Maximum Clinical Benefit|5|||
126749856|NCT00777036|456032857|FG003|On Treatment|Maximum Clinical Benefit|0|||
126749857|NCT00777036|456032854|FG000|On Treatment|Withdrawal by Subject|0|||
126749858|NCT00777036|456032855|FG001|On Treatment|Withdrawal by Subject|2|||
126749859|NCT00777036|456032856|FG002|On Treatment|Withdrawal by Subject|2|||
126749860|NCT00777036|456032857|FG003|On Treatment|Withdrawal by Subject|0|||
126749861|NCT00777036|456032854|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
126749862|NCT00777036|456032855|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
126749863|NCT00777036|456032856|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
126749864|NCT00777036|456032857|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
126749865|NCT00777036|456032854|FG000|On Treatment|Death|0|||
126749866|NCT00777036|456032855|FG001|On Treatment|Death|2|||
126749867|NCT00777036|456032856|FG002|On Treatment|Death|0|||
126749868|NCT00777036|456032857|FG003|On Treatment|Death|0|||
126749869|NCT00777036|456032854|FG000|On Treatment|Study Drug Toxicity|1|||
126749870|NCT00777036|456032855|FG001|On Treatment|Study Drug Toxicity|0|||
126749871|NCT00777036|456032856|FG002|On Treatment|Study Drug Toxicity|4|||
126749872|NCT00777036|456032857|FG003|On Treatment|Study Drug Toxicity|0|||
126749873|NCT00777036|456032854|FG000|On Treatment|Progressive Disease|6|||
126749874|NCT00777036|456032855|FG001|On Treatment|Progressive Disease|4|||
126749875|NCT00777036|456032856|FG002|On Treatment|Progressive Disease|7|||
126749876|NCT00777036|456032857|FG003|On Treatment|Progressive Disease|0|||
126749877|NCT00777036|456032854|FG000|On Treatment|Not Reported|0|||
126749878|NCT00777036|456032855|FG001|On Treatment|Not Reported|0|||
126749879|NCT00777036|456032856|FG002|On Treatment|Not Reported|2|||
126749880|NCT00777036|456032857|FG003|On Treatment|Not Reported|0|||
126749881|NCT00777036|456032854|FG000|On Treatment|Site Closed|0|||
126749882|NCT00777036|456032855|FG001|On Treatment|Site Closed|1|||
126749883|NCT00777036|456032856|FG002|On Treatment|Site Closed|1|||
126749884|NCT00777036|456032857|FG003|On Treatment|Site Closed|0|||
126749885|NCT00777036|456032854|FG000|Follow-Up|Withdrawal by Subject|0|||
126749886|NCT00777036|456032855|FG001|Follow-Up|Withdrawal by Subject|0|||
126749887|NCT00777036|456032856|FG002|Follow-Up|Withdrawal by Subject|5|||
126749888|NCT00777036|456032857|FG003|Follow-Up|Withdrawal by Subject|0|||
126749889|NCT00777036|456032854|FG000|Follow-Up|Death|1|||
126749890|NCT00777036|456032855|FG001|Follow-Up|Death|9|||
126749891|NCT00777036|456032856|FG002|Follow-Up|Death|0|||
126749892|NCT00777036|456032857|FG003|Follow-Up|Death|0|||
126749893|NCT00777036|456032854|FG000|Follow-Up|Lost to Follow-up|3|||
126749894|NCT00777036|456032855|FG001|Follow-Up|Lost to Follow-up|0|||
126749895|NCT00777036|456032856|FG002|Follow-Up|Lost to Follow-up|0|||
126749896|NCT00777036|456032857|FG003|Follow-Up|Lost to Follow-up|0|||
126749897|NCT00777036|456032854|FG000|Follow-Up|Reason Not Specified|4|||
126749898|NCT00777036|456032855|FG001|Follow-Up|Reason Not Specified|0|||
126749899|NCT00777036|456032856|FG002|Follow-Up|Reason Not Specified|13|||
126749900|NCT00777036|456032857|FG003|Follow-Up|Reason Not Specified|0|||
126749901|NCT00777036|456032854|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
126749902|NCT00777036|456032855|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
126749903|NCT00777036|456032856|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
126749904|NCT00777036|456032857|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
126749905|NCT05827978|456032858|FG000|Overall Study|Adverse Event|1|||
126749906|NCT05827978|456032859|FG001|Overall Study|Adverse Event|0|||
126749907|NCT05827978|456032860|FG002|Overall Study|Adverse Event|0|||
126749908|NCT05827978|456032861|FG003|Overall Study|Adverse Event|1|||
126749909|NCT05827978|456032862|FG004|Overall Study|Adverse Event|0|||
126749910|NCT05827978|456032863|FG005|Overall Study|Adverse Event|0|||
126749911|NCT05827978|456032858|FG000|Overall Study|Death|1|||
126749912|NCT05827978|456032859|FG001|Overall Study|Death|5|||
126749913|NCT05827978|456032860|FG002|Overall Study|Death|2|||
126749914|NCT05827978|456032861|FG003|Overall Study|Death|3|||
126749915|NCT05827978|456032862|FG004|Overall Study|Death|1|||
126749916|NCT05827978|456032863|FG005|Overall Study|Death|3|||
126749917|NCT05827978|456032858|FG000|Overall Study|Lost to Follow-up|57|||
126749918|NCT05827978|456032859|FG001|Overall Study|Lost to Follow-up|88|||
126749919|NCT05827978|456032860|FG002|Overall Study|Lost to Follow-up|54|||
126749920|NCT05827978|456032861|FG003|Overall Study|Lost to Follow-up|47|||
126749921|NCT05827978|456032862|FG004|Overall Study|Lost to Follow-up|25|||
126749922|NCT05827978|456032863|FG005|Overall Study|Lost to Follow-up|10|||
126749923|NCT05827978|456032858|FG000|Overall Study|Noncompliance with Study Procedures|0|||
126749924|NCT05827978|456032859|FG001|Overall Study|Noncompliance with Study Procedures|1|||
126749925|NCT05827978|456032860|FG002|Overall Study|Noncompliance with Study Procedures|1|||
126749926|NCT05827978|456032861|FG003|Overall Study|Noncompliance with Study Procedures|1|||
126749927|NCT05827978|456032862|FG004|Overall Study|Noncompliance with Study Procedures|1|||
126749928|NCT05827978|456032863|FG005|Overall Study|Noncompliance with Study Procedures|0|||
126749929|NCT05827978|456032858|FG000|Overall Study|Physician Decision|2|||
126749930|NCT05827978|456032859|FG001|Overall Study|Physician Decision|0|||
126749931|NCT05827978|456032860|FG002|Overall Study|Physician Decision|1|||
126749932|NCT05827978|456032861|FG003|Overall Study|Physician Decision|2|||
126749933|NCT05827978|456032862|FG004|Overall Study|Physician Decision|1|||
126749934|NCT05827978|456032863|FG005|Overall Study|Physician Decision|1|||
126749935|NCT05827978|456032858|FG000|Overall Study|Protocol Violation|5|||
126749936|NCT05827978|456032859|FG001|Overall Study|Protocol Violation|2|||
126749937|NCT05827978|456032860|FG002|Overall Study|Protocol Violation|0|||
126749938|NCT05827978|456032861|FG003|Overall Study|Protocol Violation|0|||
126749939|NCT05827978|456032862|FG004|Overall Study|Protocol Violation|0|||
126749940|NCT05827978|456032863|FG005|Overall Study|Protocol Violation|0|||
126749941|NCT05827978|456032858|FG000|Overall Study|Withdrawal by Subject|17|||
126749942|NCT05827978|456032859|FG001|Overall Study|Withdrawal by Subject|16|||
126749943|NCT05827978|456032860|FG002|Overall Study|Withdrawal by Subject|10|||
126749944|NCT05827978|456032861|FG003|Overall Study|Withdrawal by Subject|12|||
126749945|NCT05827978|456032862|FG004|Overall Study|Withdrawal by Subject|10|||
126749946|NCT05827978|456032863|FG005|Overall Study|Withdrawal by Subject|9|||
126749947|NCT05827978|456032858|FG000|Overall Study|Other Than Specified|0|||
126749948|NCT05827978|456032859|FG001|Overall Study|Other Than Specified|0|||
126749949|NCT05827978|456032860|FG002|Overall Study|Other Than Specified|1|||
126749950|NCT05827978|456032861|FG003|Overall Study|Other Than Specified|0|||
126749951|NCT05827978|456032862|FG004|Overall Study|Other Than Specified|2|||
126749952|NCT05827978|456032863|FG005|Overall Study|Other Than Specified|0|||
126749953|NCT04566445|456032864|FG000|Overall Study|Death|4|||
126749954|NCT04566445|456032865|FG001|Overall Study|Death|1|||
126749955|NCT04566445|456032866|FG002|Overall Study|Death|1|||
126749956|NCT04566445|456032864|FG000|Overall Study|Lost to Follow-up|3|||
126749957|NCT04566445|456032865|FG001|Overall Study|Lost to Follow-up|1|||
126749958|NCT04566445|456032866|FG002|Overall Study|Lost to Follow-up|1|||
126749959|NCT04566445|456032864|FG000|Overall Study|Study terminated by sponsor|11|||
126749960|NCT04566445|456032865|FG001|Overall Study|Study terminated by sponsor|17|||
126749961|NCT04566445|456032866|FG002|Overall Study|Study terminated by sponsor|32|||
126749962|NCT04566445|456032864|FG000|Overall Study|Withdrawal by Subject|12|||
126749963|NCT04566445|456032865|FG001|Overall Study|Withdrawal by Subject|14|||
126749964|NCT04566445|456032866|FG002|Overall Study|Withdrawal by Subject|13|||
126749965|NCT04566445|456032864|FG000|Overall Study|Randomized but not treated due to AE|2|||
126749966|NCT04566445|456032865|FG001|Overall Study|Randomized but not treated due to AE|1|||
126749967|NCT04566445|456032866|FG002|Overall Study|Randomized but not treated due to AE|0|||
126749968|NCT04566445|456032864|FG000|Overall Study|Adverse Event|1|||
126749969|NCT04566445|456032865|FG001|Overall Study|Adverse Event|1|||
126749970|NCT04566445|456032866|FG002|Overall Study|Adverse Event|0|||
126749971|NCT02421939|456032867|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
126749972|NCT02421939|456032868|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
126749973|NCT02421939|456032867|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
126749974|NCT02421939|456032868|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
126749975|NCT02421939|456032867|FG000|Randomization Period: Up to 3 Years|Death|38|||
126749976|NCT02421939|456032868|FG001|Randomization Period: Up to 3 Years|Death|10|||
126749977|NCT02421939|456032867|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
126749978|NCT02421939|456032868|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
126749979|NCT02421939|456032867|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
126749980|NCT02421939|456032868|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
126749981|NCT02421939|456032867|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
126749982|NCT02421939|456032868|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
126749983|NCT02421939|456032867|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
126749984|NCT02421939|456032868|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
126749985|NCT02421939|456032867|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
126749986|NCT02421939|456032868|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
126749987|NCT02421939|456032867|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
126782342|NCT03567057|456158158|FG001|Overall Study|Other|0|||
126782343|NCT03567057|456158159|FG002|Overall Study|Other|1|||
126782344|NCT01507896|456158160|FG000|Overall Study|Withdrawal by Subject|1|||
126782345|NCT01507896|456158160|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
126782346|NCT00490061|456158161|FG000|Overall Study|Physician Decision|1|||
126782347|NCT01155583|456158162|FG000|Phase I|Screen failure - did not start treatment|0|||
126782348|NCT01155583|456158163|FG001|Phase I|Screen failure - did not start treatment|0|||
126782349|NCT01155583|456158164|FG002|Phase I|Screen failure - did not start treatment|0|||
126782350|NCT01155583|456158165|FG003|Phase I|Screen failure - did not start treatment|0|||
126782351|NCT01155583|456158166|FG004|Phase I|Screen failure - did not start treatment|1|||
126782352|NCT01155583|456158167|FG005|Phase I|Screen failure - did not start treatment|0|||
126782353|NCT01155583|456158168|FG006|Phase I|Screen failure - did not start treatment|0|||
126782354|NCT01155583|456158169|FG007|Phase I|Screen failure - did not start treatment|2|||
126782355|NCT01155583|456158170|FG008|Phase I|Screen failure - did not start treatment|0|||
126782356|NCT01155583|456158162|FG000|Phase I|Withdrawal by Subject|0|||
126782357|NCT01155583|456158163|FG001|Phase I|Withdrawal by Subject|0|||
126782358|NCT01155583|456158164|FG002|Phase I|Withdrawal by Subject|0|||
126782359|NCT01155583|456158165|FG003|Phase I|Withdrawal by Subject|0|||
126782360|NCT01155583|456158166|FG004|Phase I|Withdrawal by Subject|0|||
126782361|NCT01155583|456158167|FG005|Phase I|Withdrawal by Subject|0|||
126782362|NCT01155583|456158168|FG006|Phase I|Withdrawal by Subject|0|||
126782363|NCT01155583|456158169|FG007|Phase I|Withdrawal by Subject|1|||
126782364|NCT01155583|456158170|FG008|Phase I|Withdrawal by Subject|0|||
126782365|NCT00952484|456158175|FG000|Overall Study|Withdrawal by Subject|0|||
126782366|NCT00952484|456158176|FG001|Overall Study|Withdrawal by Subject|1|||
126782367|NCT00952484|456158177|FG002|Overall Study|Withdrawal by Subject|0|||
126782368|NCT00886483|456158181|FG000|Overall Study|Lost to Follow-up|0|||
126782369|NCT00886483|456158182|FG001|Overall Study|Lost to Follow-up|1|||
126782370|NCT00886483|456158181|FG000|Overall Study|Pursue medications|1|||
126782371|NCT00886483|456158182|FG001|Overall Study|Pursue medications|2|||
126782372|NCT00886483|456158181|FG000|Overall Study|Distance to center, poor grades|1|||
126782373|NCT00886483|456158182|FG001|Overall Study|Distance to center, poor grades|0|||
126782374|NCT00585351|456158185|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
126782375|NCT00585351|456158186|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
126782376|NCT00585351|456158187|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
126782377|NCT00585351|456158188|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
126782378|NCT00585351|456158189|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
126782379|NCT00585351|456158190|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
126782380|NCT00585351|456158191|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
126782381|NCT00585351|456158192|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
126782382|NCT00585351|456158185|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
126782383|NCT00585351|456158186|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
126782384|NCT00585351|456158187|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
126782385|NCT00585351|456158188|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
126782386|NCT00585351|456158189|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
126782387|NCT00585351|456158190|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
126782388|NCT00585351|456158191|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
126782389|NCT00585351|456158192|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
126782390|NCT00585351|456158185|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
126782391|NCT00585351|456158186|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
126782392|NCT00585351|456158187|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
126749988|NCT02421939|456032868|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
126749989|NCT02421939|456032867|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
126749990|NCT02421939|456032868|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
126749991|NCT02421939|456032867|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
126749992|NCT02421939|456032868|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
126749993|NCT02421939|456032867|FG000|Long Term Follow up: up to 3 Years|Death|118|||
126749994|NCT02421939|456032868|FG001|Long Term Follow up: up to 3 Years|Death|65|||
126749995|NCT02421939|456032867|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
126749996|NCT02421939|456032868|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
126749997|NCT00729560|456032869|FG000|Overall Study|Withdrawal by Subject|3|||
126749998|NCT00103207|456032870|FG000|Overall Study|Adverse Event|3|||
126782393|NCT00585351|456158188|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
126782394|NCT00585351|456158189|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
126749999|NCT00103207|456032870|FG000|Overall Study|Death|1|||
126750000|NCT00103207|456032870|FG000|Overall Study|Withdrawal by Subject|2|||
126750001|NCT00103207|456032870|FG000|Overall Study|Other complicating disease|1|||
126782395|NCT00585351|456158190|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
126782396|NCT00585351|456158191|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
126782397|NCT00585351|456158192|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
126750002|NCT00103207|456032870|FG000|Overall Study|Ineligible|4|||
126750003|NCT00103207|456032870|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
126750004|NCT03662789|456032871|FG000|Overall Study|Lost to Follow-up|1|||
126750005|NCT03662789|456032872|FG001|Overall Study|Lost to Follow-up|2|||
126750006|NCT03662789|456032871|FG000|Overall Study|Could not perform treadmill test|4|||
126750007|NCT03662789|456032872|FG001|Overall Study|Could not perform treadmill test|4|||
126750008|NCT03662789|456032871|FG000|Overall Study|Death|0|||
126750009|NCT03662789|456032872|FG001|Overall Study|Death|1|||
126750010|NCT01029691|456032873|FG000|Continued APAP to Delivery|Death|0|||
126750011|NCT01029691|456032874|FG001|Continued APAP to Delivery|Death|0|||
126750012|NCT01029691|456032875|FG002|Continued APAP to Delivery|Death|1|||
126750013|NCT01023516|456032876|FG000|Overall Study|Voluntary discontinuation|7|||
126750014|NCT01023516|456032877|FG001|Overall Study|Voluntary discontinuation|5|||
126750015|NCT01023516|456032876|FG000|Overall Study|Adverse Event|9|||
126750016|NCT01023516|456032877|FG001|Overall Study|Adverse Event|6|||
126750017|NCT01023516|456032876|FG000|Overall Study|Safety reason|0|||
126750018|NCT01023516|456032877|FG001|Overall Study|Safety reason|3|||
126750019|NCT01023516|456032876|FG000|Overall Study|Study-specific criteria|4|||
126750020|NCT01023516|456032877|FG001|Overall Study|Study-specific criteria|2|||
126750021|NCT01023516|456032876|FG000|Overall Study|Incorrect enrolment|4|||
126750022|NCT01023516|456032877|FG001|Overall Study|Incorrect enrolment|2|||
126750023|NCT02559115|456032878|FG000|Overall Study|Withdrawal by Subject|3|||
126750024|NCT02060903|456032881|FG000|Overall Study|Lost to Follow-up|4|||
126750025|NCT02060903|456032882|FG001|Overall Study|Lost to Follow-up|0|||
126750026|NCT02060903|456032881|FG000|Overall Study|Withdrawal by Subject|0|||
126750027|NCT02060903|456032882|FG001|Overall Study|Withdrawal by Subject|7|||
126750028|NCT00137267|456032883|FG000|Overall Study|Lost to Follow-up|15|||
126750029|NCT00137267|456032884|FG001|Overall Study|Lost to Follow-up|21|||
126750030|NCT00638989|456032885|FG000|Overall Study|Lost to Follow-up|0|||
126750031|NCT00638989|456032886|FG001|Overall Study|Lost to Follow-up|0|||
126750032|NCT00638989|456032887|FG002|Overall Study|Lost to Follow-up|1|||
126750033|NCT00853112|456032892|FG000|Overall Study|Randomized but not treated|0|||
126750034|NCT00853112|456032893|FG001|Overall Study|Randomized but not treated|1|||
126750035|NCT00853112|456032894|FG002|Overall Study|Randomized but not treated|0|||
126750036|NCT00853112|456032895|FG003|Overall Study|Randomized but not treated|2|||
126750037|NCT00853112|456032896|FG004|Overall Study|Randomized but not treated|0|||
126750038|NCT00853112|456032897|FG005|Overall Study|Randomized but not treated|0|||
126750039|NCT00853112|456032898|FG006|Overall Study|Randomized but not treated|1|||
126750040|NCT01553591|456032899|FG000|Overall Study|Voluntarily withdrew|94|||
126750041|NCT01553591|456032900|FG001|Overall Study|Voluntarily withdrew|79|||
126750042|NCT01553591|456032901|FG002|Overall Study|Voluntarily withdrew|96|||
126750043|NCT01553591|456032899|FG000|Overall Study|Adverse Event|36|||
126750044|NCT01553591|456032900|FG001|Overall Study|Adverse Event|45|||
126750045|NCT01553591|456032901|FG002|Overall Study|Adverse Event|16|||
126750046|NCT01553591|456032899|FG000|Overall Study|Lost to Follow-up|25|||
126750047|NCT01553591|456032900|FG001|Overall Study|Lost to Follow-up|23|||
126750048|NCT01553591|456032901|FG002|Overall Study|Lost to Follow-up|16|||
126750049|NCT01553591|456032899|FG000|Overall Study|Physician decision: other|11|||
126750050|NCT01553591|456032900|FG001|Overall Study|Physician decision: other|14|||
126750051|NCT01553591|456032901|FG002|Overall Study|Physician decision: other|16|||
126750052|NCT01553591|456032899|FG000|Overall Study|Physician decision: lack of efficacy|2|||
126750053|NCT01553591|456032900|FG001|Overall Study|Physician decision: lack of efficacy|3|||
126750054|NCT01553591|456032901|FG002|Overall Study|Physician decision: lack of efficacy|7|||
126750055|NCT01553591|456032899|FG000|Overall Study|Protocol Violation|3|||
126750056|NCT01553591|456032900|FG001|Overall Study|Protocol Violation|4|||
126750057|NCT01553591|456032901|FG002|Overall Study|Protocol Violation|4|||
126750058|NCT01553591|456032899|FG000|Overall Study|Sponsor decision|1|||
126750059|NCT01553591|456032900|FG001|Overall Study|Sponsor decision|0|||
126750060|NCT01553591|456032901|FG002|Overall Study|Sponsor decision|3|||
126750061|NCT01553591|456032899|FG000|Overall Study|Randomized and never dispensed drug|0|||
126750062|NCT01553591|456032900|FG001|Overall Study|Randomized and never dispensed drug|1|||
126750063|NCT01553591|456032901|FG002|Overall Study|Randomized and never dispensed drug|0|||
126750064|NCT00958191|456032904|FG000|Overall Study|Death|4|||
126750065|NCT00958191|456032904|FG000|Overall Study|Lost to Follow-up|5|||
126750066|NCT00958191|456032904|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
126750067|NCT00958191|456032904|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
126750068|NCT00958191|456032904|FG000|Overall Study|Revision of study device|4|||
126782398|NCT00585351|456158185|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
126750069|NCT00958191|456032904|FG000|Overall Study|Site termination|11|||
126750070|NCT00958191|456032904|FG000|Overall Study|No 5 yr x-rays|56|||
126750071|NCT00611767|456032905|FG000|Overall Study|Withdrawal by Subject|4|||
126750072|NCT00611767|456032906|FG001|Overall Study|Withdrawal by Subject|1|||
126750073|NCT00611767|456032905|FG000|Overall Study|Thiopental not available|3|||
126750074|NCT00611767|456032906|FG001|Overall Study|Thiopental not available|0|||
126750075|NCT00611767|456032905|FG000|Overall Study|didn't like the medication|1|||
126750076|NCT00611767|456032906|FG001|Overall Study|didn't like the medication|1|||
126750077|NCT00611767|456032905|FG000|Overall Study|Physician Decision|1|||
126750078|NCT00611767|456032906|FG001|Overall Study|Physician Decision|0|||
126750079|NCT01818765|456032907|FG000|Overall Study|Death|2|||
126750080|NCT02010567|456032910|FG000|Overall Study|Adverse Event|0|||
126750081|NCT02010567|456032911|FG001|Overall Study|Adverse Event|0|||
126750082|NCT02010567|456032912|FG002|Overall Study|Adverse Event|1|||
126750083|NCT02010567|456032913|FG003|Overall Study|Adverse Event|0|||
126750084|NCT02010567|456032914|FG004|Overall Study|Adverse Event|1|||
126750085|NCT00118040|456032915|FG000|Overall Study|Adverse Event|0|||
126750086|NCT00118040|456032916|FG001|Overall Study|Adverse Event|1|||
126750087|NCT00118040|456032917|FG002|Overall Study|Adverse Event|0|||
126750088|NCT00118040|456032915|FG000|Overall Study|Withdrawal by Subject|0|||
126750089|NCT00118040|456032916|FG001|Overall Study|Withdrawal by Subject|0|||
126750090|NCT00118040|456032917|FG002|Overall Study|Withdrawal by Subject|2|||
126750091|NCT00118040|456032915|FG000|Overall Study|Medical Contraindication|0|||
126750092|NCT00118040|456032916|FG001|Overall Study|Medical Contraindication|0|||
126750093|NCT00118040|456032917|FG002|Overall Study|Medical Contraindication|1|||
126750094|NCT00118040|456032915|FG000|Overall Study|Non-Compliant Participant|1|||
126750095|NCT00118040|456032916|FG001|Overall Study|Non-Compliant Participant|1|||
126750096|NCT00118040|456032917|FG002|Overall Study|Non-Compliant Participant|2|||
126750097|NCT00118040|456032915|FG000|Overall Study|Other|0|||
126750098|NCT00118040|456032916|FG001|Overall Study|Other|0|||
126750099|NCT00118040|456032917|FG002|Overall Study|Other|1|||
126750100|NCT02005211|456032918|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
126750101|NCT02005211|456032919|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
126750102|NCT02005211|456032920|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
126750103|NCT02005211|456032921|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
126750104|NCT02005211|456032922|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
126750105|NCT02005211|456032923|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
126750106|NCT02005211|456032924|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
126750107|NCT00397631|456032926|FG000|Overall Study|Adverse Event|5|||
126750108|NCT00397631|456032927|FG001|Overall Study|Adverse Event|6|||
126750109|NCT00397631|456032926|FG000|Overall Study|Lack of Efficacy|7|||
126750110|NCT00397631|456032927|FG001|Overall Study|Lack of Efficacy|10|||
126750111|NCT00397631|456032926|FG000|Overall Study|Lost to Follow-up|8|||
126750112|NCT00397631|456032927|FG001|Overall Study|Lost to Follow-up|9|||
126750113|NCT00397631|456032926|FG000|Overall Study|Physician Decision|2|||
126750114|NCT00397631|456032927|FG001|Overall Study|Physician Decision|0|||
126750115|NCT00397631|456032926|FG000|Overall Study|Protocol Violation|0|||
126750116|NCT00397631|456032927|FG001|Overall Study|Protocol Violation|1|||
126750117|NCT00397631|456032926|FG000|Overall Study|Withdrawal by Subject|7|||
126750118|NCT00397631|456032927|FG001|Overall Study|Withdrawal by Subject|14|||
126750119|NCT00397631|456032926|FG000|Overall Study|protocol discontinuation criteria|1|||
126750120|NCT00397631|456032927|FG001|Overall Study|protocol discontinuation criteria|4|||
126750121|NCT02202161|456032928|FG000|Overall Study|Adverse Event|1|||
126750122|NCT02202161|456032929|FG001|Overall Study|Adverse Event|1|||
126750123|NCT02202161|456032930|FG002|Overall Study|Adverse Event|0|||
126750124|NCT02202161|456032931|FG003|Overall Study|Adverse Event|0|||
126750125|NCT02202161|456032932|FG004|Overall Study|Adverse Event|0|||
126750126|NCT02202161|456032933|FG005|Overall Study|Adverse Event|1|||
126622366|NCT01184859|455575854|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
126622367|NCT01184859|455575855|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
126622368|NCT01184859|455575856|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
126622369|NCT01184859|455575857|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
126622370|NCT01184859|455575853|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
126622371|NCT01184859|455575854|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
126622372|NCT01184859|455575855|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
126622373|NCT01184859|455575856|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
126622374|NCT01184859|455575857|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
126622375|NCT00961298|455575858|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
126622376|NCT00961298|455575858|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
126622377|NCT00961298|455575858|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
126750127|NCT02202161|456032934|FG006|Overall Study|Adverse Event|0|||
126750128|NCT02202161|456032935|FG007|Overall Study|Adverse Event|0|||
126750129|NCT02202161|456032928|FG000|Overall Study|Did not meet continuation criteria|0|||
126750130|NCT02202161|456032929|FG001|Overall Study|Did not meet continuation criteria|0|||
126750131|NCT02202161|456032930|FG002|Overall Study|Did not meet continuation criteria|0|||
126750132|NCT02202161|456032931|FG003|Overall Study|Did not meet continuation criteria|0|||
126750133|NCT02202161|456032932|FG004|Overall Study|Did not meet continuation criteria|0|||
126750134|NCT02202161|456032933|FG005|Overall Study|Did not meet continuation criteria|0|||
126750135|NCT02202161|456032934|FG006|Overall Study|Did not meet continuation criteria|0|||
126750136|NCT02202161|456032935|FG007|Overall Study|Did not meet continuation criteria|3|||
126750137|NCT02202161|456032928|FG000|Overall Study|Physician Decision|0|||
126750138|NCT02202161|456032929|FG001|Overall Study|Physician Decision|0|||
126622378|NCT01904019|455575860|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
126622379|NCT01904019|455575860|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
126622380|NCT01904019|455575860|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
126622381|NCT01904019|455575860|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
126622382|NCT01904019|455575860|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
126622383|NCT01904019|455575860|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
126622384|NCT01537120|455575861|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
126622385|NCT01537120|455575861|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
126622386|NCT01503515|455575866|FG000|Overall Study|Adverse Event|4|||
126622387|NCT01503515|455575867|FG001|Overall Study|Adverse Event|5|||
126622388|NCT01503515|455575866|FG000|Overall Study|Death|0|||
126622389|NCT01503515|455575867|FG001|Overall Study|Death|1|||
126622390|NCT01503515|455575866|FG000|Overall Study|Physician Decision|14|||
126622391|NCT01503515|455575867|FG001|Overall Study|Physician Decision|23|||
126622392|NCT01503515|455575866|FG000|Overall Study|Withdrawal by Subject|0|||
126622393|NCT01503515|455575867|FG001|Overall Study|Withdrawal by Subject|1|||
126622394|NCT01503515|455575866|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
126622395|NCT01503515|455575867|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
126622396|NCT01503515|455575866|FG000|Overall Study|Ineligible|1|||
126750139|NCT02202161|456032930|FG002|Overall Study|Physician Decision|0|||
126750140|NCT02202161|456032931|FG003|Overall Study|Physician Decision|0|||
126750141|NCT02202161|456032932|FG004|Overall Study|Physician Decision|0|||
126750142|NCT02202161|456032933|FG005|Overall Study|Physician Decision|0|||
126750143|NCT02202161|456032934|FG006|Overall Study|Physician Decision|0|||
126750144|NCT02202161|456032935|FG007|Overall Study|Physician Decision|3|||
126750145|NCT02202161|456032928|FG000|Overall Study|Withdrawal by Subject|0|||
126750146|NCT02202161|456032929|FG001|Overall Study|Withdrawal by Subject|0|||
126750147|NCT02202161|456032930|FG002|Overall Study|Withdrawal by Subject|0|||
126750148|NCT02202161|456032931|FG003|Overall Study|Withdrawal by Subject|0|||
126750149|NCT02202161|456032932|FG004|Overall Study|Withdrawal by Subject|1|||
126750150|NCT02202161|456032933|FG005|Overall Study|Withdrawal by Subject|0|||
126750151|NCT02202161|456032934|FG006|Overall Study|Withdrawal by Subject|0|||
126750152|NCT02202161|456032935|FG007|Overall Study|Withdrawal by Subject|0|||
126750153|NCT00832091|456032936|FG000|Overall Study|Adverse Event|1|||
126750154|NCT00832091|456032937|FG001|Overall Study|Adverse Event|1|||
126750155|NCT00832091|456032936|FG000|Overall Study|Protocol Violation|1|||
126750156|NCT00832091|456032937|FG001|Overall Study|Protocol Violation|0|||
126750157|NCT00832091|456032936|FG000|Overall Study|Withdrawal by Subject|2|||
126750158|NCT00832091|456032937|FG001|Overall Study|Withdrawal by Subject|1|||
126750159|NCT00832091|456032936|FG000|Overall Study|Prohibited Medication|1|||
126750160|NCT00832091|456032937|FG001|Overall Study|Prohibited Medication|0|||
126750161|NCT00942422|456032943|FG000|Overall Study|Withdrawal by Subject|1|||
126750162|NCT00942422|456032943|FG000|Overall Study|Death|1|||
126750163|NCT00942422|456032943|FG000|Overall Study|Progressive diease|1|||
126750164|NCT02711553|456032946|FG000|Overall Study|Withdrawal by Subject|2|||
126750165|NCT02711553|456032947|FG001|Overall Study|Withdrawal by Subject|1|||
126750166|NCT02711553|456032948|FG002|Overall Study|Withdrawal by Subject|1|||
126750167|NCT02711553|456032949|FG003|Overall Study|Withdrawal by Subject|0|||
126750168|NCT02711553|456032946|FG000|Overall Study|Lost to Follow-up|3|||
126750169|NCT02711553|456032947|FG001|Overall Study|Lost to Follow-up|3|||
126750170|NCT02711553|456032948|FG002|Overall Study|Lost to Follow-up|6|||
126750171|NCT02711553|456032949|FG003|Overall Study|Lost to Follow-up|3|||
126750172|NCT02711553|456032946|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
126750173|NCT02711553|456032947|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
126750174|NCT02711553|456032948|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
126750175|NCT02711553|456032949|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
126750176|NCT05559203|456032950|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
126750177|NCT03117309|456032951|FG000|Overall Study|Not meeting inclusion criteria|0|||
126750178|NCT03117309|456032952|FG001|Overall Study|Not meeting inclusion criteria|1|||
126750179|NCT04048876|456032953|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
126750180|NCT04048876|456032954|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
126750181|NCT04048876|456032955|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
126750182|NCT04048876|456032956|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
126750183|NCT04048876|456032953|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
126750184|NCT04048876|456032954|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
126750185|NCT04048876|456032955|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
126750186|NCT04048876|456032956|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
126750187|NCT04048876|456032953|FG000|Placebo Controlled Phase|Adverse Event|0|||
126750188|NCT04048876|456032954|FG001|Placebo Controlled Phase|Adverse Event|1|||
126622397|NCT01503515|455575867|FG001|Overall Study|Ineligible|1|||
126750189|NCT04048876|456032955|FG002|Placebo Controlled Phase|Adverse Event|0|||
126750190|NCT04048876|456032956|FG003|Placebo Controlled Phase|Adverse Event|0|||
126750191|NCT04048876|456032953|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
126750192|NCT04048876|456032954|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
126622398|NCT03087851|455575872|FG000|Overall Study|Withdraw on medical grounds|0|||
126622399|NCT03087851|455575873|FG001|Overall Study|Withdraw on medical grounds|1|||
126622400|NCT03087851|455575874|FG002|Overall Study|Withdraw on medical grounds|2|||
126622401|NCT02123797|455575877|FG000|Baseline Intervention|Death|9|||
126622402|NCT02123797|455575878|FG001|Baseline Intervention|Death|16|||
126622403|NCT02123797|455575879|FG002|Baseline Intervention|Death|0|||
126622404|NCT02123797|455575880|FG003|Baseline Intervention|Death|0|||
126622405|NCT02123797|455575881|FG004|Baseline Intervention|Death|0|||
126622406|NCT02123797|455575877|FG000|Baseline Intervention|Withdrawal by Subject|2|||
126622407|NCT02123797|455575878|FG001|Baseline Intervention|Withdrawal by Subject|8|||
126622408|NCT02123797|455575879|FG002|Baseline Intervention|Withdrawal by Subject|0|||
126622409|NCT02123797|455575880|FG003|Baseline Intervention|Withdrawal by Subject|0|||
126622410|NCT02123797|455575881|FG004|Baseline Intervention|Withdrawal by Subject|0|||
126622411|NCT02123797|455575877|FG000|Baseline Intervention|Relocation|2|||
126622412|NCT02123797|455575878|FG001|Baseline Intervention|Relocation|0|||
126622413|NCT02123797|455575879|FG002|Baseline Intervention|Relocation|0|||
126622414|NCT02123797|455575880|FG003|Baseline Intervention|Relocation|0|||
126622415|NCT02123797|455575881|FG004|Baseline Intervention|Relocation|0|||
126622416|NCT02123797|455575877|FG000|Baseline Intervention|Out of window for initial survey|6|||
126622417|NCT02123797|455575878|FG001|Baseline Intervention|Out of window for initial survey|13|||
126622418|NCT02123797|455575879|FG002|Baseline Intervention|Out of window for initial survey|0|||
126622419|NCT02123797|455575880|FG003|Baseline Intervention|Out of window for initial survey|0|||
126622420|NCT02123797|455575881|FG004|Baseline Intervention|Out of window for initial survey|0|||
126622421|NCT02123797|455575877|FG000|Baseline Intervention|Lost to Follow-up|0|||
126622422|NCT02123797|455575878|FG001|Baseline Intervention|Lost to Follow-up|5|||
126622423|NCT02123797|455575879|FG002|Baseline Intervention|Lost to Follow-up|0|||
126622424|NCT02123797|455575880|FG003|Baseline Intervention|Lost to Follow-up|0|||
126622425|NCT02123797|455575881|FG004|Baseline Intervention|Lost to Follow-up|0|||
126622426|NCT02123797|455575877|FG000|Baseline Intervention|Other Disease|3|||
126622427|NCT02123797|455575878|FG001|Baseline Intervention|Other Disease|0|||
126622428|NCT02123797|455575879|FG002|Baseline Intervention|Other Disease|0|||
126622429|NCT02123797|455575880|FG003|Baseline Intervention|Other Disease|0|||
126622430|NCT02123797|455575881|FG004|Baseline Intervention|Other Disease|0|||
126622431|NCT02123797|455575877|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
126622432|NCT02123797|455575878|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
126622433|NCT02123797|455575879|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
126622434|NCT02123797|455575880|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
126622435|NCT02123797|455575881|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
126622436|NCT02123797|455575877|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
126622437|NCT02123797|455575878|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
126622438|NCT02123797|455575879|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
126622439|NCT02123797|455575880|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
126622440|NCT02123797|455575881|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
126782399|NCT00585351|456158186|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
126782400|NCT00585351|456158187|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
126782401|NCT00585351|456158188|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
126782402|NCT00585351|456158189|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
126782403|NCT00585351|456158190|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
126782404|NCT00585351|456158191|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
126782405|NCT00585351|456158192|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
126782406|NCT00585351|456158185|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
126782407|NCT00585351|456158186|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
126782408|NCT00585351|456158187|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
126782409|NCT00585351|456158188|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
126782410|NCT00585351|456158189|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
126782411|NCT00585351|456158190|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
126782412|NCT00585351|456158191|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
126782413|NCT00585351|456158192|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
126782414|NCT00585351|456158185|FG000|Enrollment Period (Intervention)|Death|0|||
126782415|NCT00585351|456158186|FG001|Enrollment Period (Intervention)|Death|0|||
126782416|NCT00585351|456158187|FG002|Enrollment Period (Intervention)|Death|0|||
126782417|NCT00585351|456158188|FG003|Enrollment Period (Intervention)|Death|0|||
126782418|NCT00585351|456158189|FG004|Enrollment Period (Intervention)|Death|1|||
126782419|NCT00585351|456158190|FG005|Enrollment Period (Intervention)|Death|0|||
126782420|NCT00585351|456158191|FG006|Enrollment Period (Intervention)|Death|1|||
126622441|NCT02123797|455575877|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
126622442|NCT02123797|455575878|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
126622443|NCT02123797|455575879|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
126622444|NCT02123797|455575880|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
126622445|NCT02123797|455575881|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
126622446|NCT02123797|455575877|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
126622447|NCT02123797|455575878|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
126622448|NCT02123797|455575879|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
126622449|NCT02123797|455575880|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
126622450|NCT02123797|455575881|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
126622451|NCT02123797|455575877|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
126622452|NCT02123797|455575878|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
126622453|NCT02123797|455575879|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
126622454|NCT02123797|455575880|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
126622455|NCT02123797|455575881|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
126622456|NCT02123797|455575877|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
126622457|NCT02123797|455575878|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
126622458|NCT02123797|455575879|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
126622459|NCT02123797|455575880|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
126622460|NCT02123797|455575881|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
126622461|NCT02123797|455575877|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
126622462|NCT02123797|455575878|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
126622463|NCT02123797|455575879|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
126622464|NCT02123797|455575880|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
126622465|NCT02123797|455575881|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
126622466|NCT02123797|455575877|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
126622467|NCT02123797|455575878|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
126622468|NCT02123797|455575879|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
126622469|NCT02123797|455575880|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
126622470|NCT02123797|455575881|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
126622471|NCT02123797|455575877|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
126622472|NCT02123797|455575878|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
126622473|NCT02123797|455575879|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
126622474|NCT02123797|455575880|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
126622475|NCT02123797|455575881|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
126622476|NCT00443755|455575882|FG000|Overall Study|Withdrawal by Subject|2|||
126622477|NCT00443755|455575883|FG001|Overall Study|Withdrawal by Subject|1|||
126622478|NCT00678899|455575886|FG000|Overall Study|Adverse Event|1|||
126622479|NCT03997409|455575892|FG000|Overall Study|Protocol Violation|1|||
126622480|NCT03997409|455575893|FG001|Overall Study|Protocol Violation|1|||
126622481|NCT03997409|455575894|FG002|Overall Study|Protocol Violation|0|||
126622482|NCT03997409|455575892|FG000|Overall Study|Withdrawal by Subject|3|||
126622483|NCT03997409|455575893|FG001|Overall Study|Withdrawal by Subject|0|||
126622484|NCT03997409|455575894|FG002|Overall Study|Withdrawal by Subject|0|||
126622485|NCT03997409|455575892|FG000|Overall Study|Lost to Follow-up|0|||
126622486|NCT03997409|455575893|FG001|Overall Study|Lost to Follow-up|0|||
126622487|NCT03997409|455575894|FG002|Overall Study|Lost to Follow-up|1|||
126622488|NCT01753323|455575895|FG000|Overall Study|Lack of Efficacy|0|||
126622489|NCT01753323|455575896|FG001|Overall Study|Lack of Efficacy|0|||
126622490|NCT01753323|455575897|FG002|Overall Study|Lack of Efficacy|8|||
126622491|NCT01753323|455575895|FG000|Overall Study|Protocol deviation|1|||
126622492|NCT01753323|455575896|FG001|Overall Study|Protocol deviation|0|||
126622493|NCT01753323|455575897|FG002|Overall Study|Protocol deviation|0|||
126622494|NCT01753323|455575895|FG000|Overall Study|Adverse Event|0|||
126622495|NCT01753323|455575896|FG001|Overall Study|Adverse Event|0|||
126622496|NCT01753323|455575897|FG002|Overall Study|Adverse Event|1|||
126622497|NCT01498445|455575899|FG000|Overall Study|Lack of Efficacy|0|||
126622498|NCT01498445|455575900|FG001|Overall Study|Lack of Efficacy|0|||
126622499|NCT01498445|455575901|FG002|Overall Study|Lack of Efficacy|1|||
126622500|NCT01498445|455575902|FG003|Overall Study|Lack of Efficacy|2|||
126622501|NCT01498445|455575903|FG004|Overall Study|Lack of Efficacy|0|||
126622502|NCT01498445|455575904|FG005|Overall Study|Lack of Efficacy|0|||
126622503|NCT01498445|455575899|FG000|Overall Study|Screen Failure|0|||
126622504|NCT01498445|455575900|FG001|Overall Study|Screen Failure|0|||
126622505|NCT01498445|455575901|FG002|Overall Study|Screen Failure|0|||
126622506|NCT01498445|455575902|FG003|Overall Study|Screen Failure|0|||
126750193|NCT04048876|456032955|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
126750194|NCT04048876|456032956|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
126750195|NCT02187224|456032957|FG000|Overall Study|Did not show up for test day|1|||
126750196|NCT02187224|456032958|FG001|Overall Study|Did not show up for test day|0|||
126750197|NCT01010776|456032961|FG000|Main Phase|Withdrawal by Subject|14|||
126750198|NCT01010776|456032961|FG000|Main Phase|Lack of Efficacy|8|||
126750199|NCT01010776|456032961|FG000|Main Phase|Adverse Event|7|||
126750200|NCT01010776|456032961|FG000|Main Phase|Lost to Follow-up|6|||
126622507|NCT01498445|455575903|FG004|Overall Study|Screen Failure|1|||
126622508|NCT01498445|455575904|FG005|Overall Study|Screen Failure|1|||
126756652|NCT01632345|456059512|FG004|Treatment: Part I|Pregnancy|0|||
126750201|NCT01010776|456032961|FG000|Main Phase|Non-compliance to study medication|5|||
126750202|NCT01010776|456032961|FG000|Main Phase|Selection failure|2|||
126750203|NCT01010776|456032961|FG000|Main Phase|Inform consent withdrawal|1|||
126750204|NCT01010776|456032961|FG000|Main Phase|Other|1|||
126750205|NCT01010776|456032961|FG000|Main Phase|Did not received study medication|5|||
126750206|NCT01010776|456032961|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
126750207|NCT01010776|456032961|FG000|Extension Phase|Other|3|||
126750208|NCT01012037|456032965|FG000|Overall Study|Adverse Event|0|||
126750209|NCT01012037|456032966|FG001|Overall Study|Adverse Event|8|||
126750210|NCT01012037|456032967|FG002|Overall Study|Adverse Event|3|||
126750211|NCT01012037|456032965|FG000|Overall Study|Protocol Violation|0|||
126750212|NCT01012037|456032966|FG001|Overall Study|Protocol Violation|3|||
126750213|NCT01012037|456032967|FG002|Overall Study|Protocol Violation|5|||
126750214|NCT01012037|456032965|FG000|Overall Study|Withdrawal by Subject|0|||
126750215|NCT01012037|456032966|FG001|Overall Study|Withdrawal by Subject|4|||
126750216|NCT01012037|456032967|FG002|Overall Study|Withdrawal by Subject|1|||
126750217|NCT01012037|456032965|FG000|Overall Study|Other reason (not specified)|1|||
126750218|NCT01012037|456032966|FG001|Overall Study|Other reason (not specified)|1|||
126750219|NCT01012037|456032967|FG002|Overall Study|Other reason (not specified)|1|||
126750220|NCT02583711|456032968|FG000|Overall Study|Withdrawal by Subject|0|||
126750221|NCT02583711|456032969|FG001|Overall Study|Withdrawal by Subject|10|||
126750222|NCT02583711|456032970|FG002|Overall Study|Withdrawal by Subject|0|||
126750223|NCT00415623|456032972|FG000|Overall Study|Adverse Event|3|||
126750224|NCT00415623|456032973|FG001|Overall Study|Adverse Event|4|||
126750225|NCT00415623|456032972|FG000|Overall Study|Death|1|||
126750226|NCT00415623|456032973|FG001|Overall Study|Death|0|||
126750227|NCT00415623|456032972|FG000|Overall Study|Withdrawal by Subject|1|||
126750228|NCT00415623|456032973|FG001|Overall Study|Withdrawal by Subject|1|||
126750229|NCT00542425|456032974|FG000|Initial 24 Weeks|Administrative reasons|0|||
126750230|NCT00542425|456032975|FG001|Initial 24 Weeks|Administrative reasons|0|||
126750231|NCT00542425|456032976|FG002|Initial 24 Weeks|Administrative reasons|1|||
126750232|NCT00542425|456032977|FG003|Initial 24 Weeks|Administrative reasons|1|||
126750233|NCT00542425|456032978|FG004|Initial 24 Weeks|Administrative reasons|0|||
126750234|NCT00542425|456032974|FG000|Initial 24 Weeks|Adverse Event|0|||
126750235|NCT00542425|456032975|FG001|Initial 24 Weeks|Adverse Event|1|||
126750236|NCT00542425|456032976|FG002|Initial 24 Weeks|Adverse Event|1|||
126750237|NCT00542425|456032977|FG003|Initial 24 Weeks|Adverse Event|3|||
126750238|NCT00542425|456032978|FG004|Initial 24 Weeks|Adverse Event|2|||
126750239|NCT00542425|456032974|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
126750240|NCT00542425|456032975|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
126750241|NCT00542425|456032976|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
126750242|NCT00542425|456032977|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
126750243|NCT00542425|456032978|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
126750244|NCT00542425|456032974|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
126750245|NCT00542425|456032975|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
126750246|NCT00542425|456032976|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
126750247|NCT00542425|456032977|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
126750248|NCT00542425|456032978|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
126750249|NCT00542425|456032974|FG000|Initial 24 Weeks|Non-compliance|0|||
126750250|NCT00542425|456032975|FG001|Initial 24 Weeks|Non-compliance|0|||
126750251|NCT00542425|456032976|FG002|Initial 24 Weeks|Non-compliance|0|||
126750252|NCT00542425|456032977|FG003|Initial 24 Weeks|Non-compliance|1|||
126750253|NCT00542425|456032978|FG004|Initial 24 Weeks|Non-compliance|1|||
126750254|NCT00542425|456032974|FG000|Initial 24 Weeks|Protocol Violation|0|||
126750255|NCT00542425|456032975|FG001|Initial 24 Weeks|Protocol Violation|0|||
126750256|NCT00542425|456032976|FG002|Initial 24 Weeks|Protocol Violation|0|||
126750257|NCT00542425|456032977|FG003|Initial 24 Weeks|Protocol Violation|1|||
126750258|NCT00542425|456032978|FG004|Initial 24 Weeks|Protocol Violation|0|||
126750259|NCT00542425|456032974|FG000|Initial 24 Weeks|Refusal of treatment|2|||
126750260|NCT00542425|456032975|FG001|Initial 24 Weeks|Refusal of treatment|2|||
126750261|NCT00542425|456032976|FG002|Initial 24 Weeks|Refusal of treatment|1|||
126750262|NCT00542425|456032977|FG003|Initial 24 Weeks|Refusal of treatment|4|||
126750263|NCT00542425|456032978|FG004|Initial 24 Weeks|Refusal of treatment|1|||
126750264|NCT00542425|456032974|FG000|Initial 24 Weeks|Other|0|||
126750265|NCT00542425|456032975|FG001|Initial 24 Weeks|Other|2|||
126750266|NCT00542425|456032976|FG002|Initial 24 Weeks|Other|1|||
126750267|NCT00542425|456032977|FG003|Initial 24 Weeks|Other|0|||
126782421|NCT00585351|456158192|FG007|Enrollment Period (Intervention)|Death|0|||
126750268|NCT00542425|456032978|FG004|Initial 24 Weeks|Other|0|||
126782422|NCT00585351|456158185|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
126750269|NCT00542425|456032974|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
126750270|NCT00542425|456032975|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
126750271|NCT00542425|456032976|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
126750272|NCT00542425|456032977|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
126750273|NCT00542425|456032978|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
126750274|NCT00542425|456032974|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
126622509|NCT00561678|455575905|FG000|Overall Study|Withdrawal by Subject|4|||
126622510|NCT00561678|455575906|FG001|Overall Study|Withdrawal by Subject|3|||
126622511|NCT00561678|455575905|FG000|Overall Study|surgery cancelled|1|||
126622512|NCT00561678|455575906|FG001|Overall Study|surgery cancelled|1|||
126622513|NCT00561678|455575905|FG000|Overall Study|surgery rescheduled to different site|2|||
126622514|NCT00561678|455575906|FG001|Overall Study|surgery rescheduled to different site|2|||
126622515|NCT00561678|455575905|FG000|Overall Study|anesthesia provider refusal|1|||
126622516|NCT00561678|455575906|FG001|Overall Study|anesthesia provider refusal|0|||
126622517|NCT01072396|455575907|FG000|Period One|Adverse Event|1|||
126622518|NCT01072396|455575908|FG001|Period One|Adverse Event|1|||
126622519|NCT01072396|455575907|FG000|Period One|Protocol Violation|2|||
126622520|NCT01072396|455575908|FG001|Period One|Protocol Violation|1|||
126622521|NCT01072396|455575907|FG000|Period One|Withdrawal by Subject|2|||
126622522|NCT01072396|455575908|FG001|Period One|Withdrawal by Subject|0|||
126622523|NCT01072396|455575907|FG000|Washout Period|Missing termination information|0|||
126622524|NCT01072396|455575908|FG001|Washout Period|Missing termination information|1|||
126622525|NCT01072396|455575907|FG000|Period Two|Adverse Event|0|||
126622526|NCT01072396|455575908|FG001|Period Two|Adverse Event|3|||
126622527|NCT01072396|455575907|FG000|Period Two|Lost to Follow-up|1|||
126622528|NCT01072396|455575908|FG001|Period Two|Lost to Follow-up|0|||
126622529|NCT00005908|455575909|FG000|Overall Study|Withdrawal by Subject|1|||
126622530|NCT00005908|455575910|FG001|Overall Study|Withdrawal by Subject|0|||
126622531|NCT01106586|455575911|FG000|Overall Study|Adverse Event|9|||
126622532|NCT01106586|455575912|FG001|Overall Study|Adverse Event|15|||
126622533|NCT01106586|455575911|FG000|Overall Study|Death|1|||
126622534|NCT01106586|455575912|FG001|Overall Study|Death|3|||
126622535|NCT01106586|455575911|FG000|Overall Study|Pregnancy|2|||
126622536|NCT01106586|455575912|FG001|Overall Study|Pregnancy|2|||
126622537|NCT01106586|455575911|FG000|Overall Study|Lack of Efficacy|1|||
126622538|NCT01106586|455575912|FG001|Overall Study|Lack of Efficacy|0|||
126622539|NCT01106586|455575911|FG000|Overall Study|Investigator's Discretion|5|||
126622540|NCT01106586|455575912|FG001|Overall Study|Investigator's Discretion|8|||
126622541|NCT01106586|455575911|FG000|Overall Study|Withdrew Consent|18|||
126622542|NCT01106586|455575912|FG001|Overall Study|Withdrew Consent|30|||
126622543|NCT01106586|455575911|FG000|Overall Study|Lost to Follow-up|24|||
126622544|NCT01106586|455575912|FG001|Overall Study|Lost to Follow-up|20|||
126622545|NCT01106586|455575911|FG000|Overall Study|Participant Noncompliance|12|||
126622546|NCT01106586|455575912|FG001|Overall Study|Participant Noncompliance|10|||
126622547|NCT01106586|455575911|FG000|Overall Study|Protocol Violation|1|||
126622548|NCT01106586|455575912|FG001|Overall Study|Protocol Violation|0|||
126622549|NCT01106586|455575911|FG000|Overall Study|Participant Transferred to Another Study|212|||
126622550|NCT01106586|455575912|FG001|Overall Study|Participant Transferred to Another Study|197|||
126622551|NCT01379521|455575913|FG000|Overall Study -Treatment Period|Adverse Event|3|||
126622552|NCT01379521|455575914|FG001|Overall Study -Treatment Period|Adverse Event|0|||
126622553|NCT01379521|455575913|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
126622554|NCT01379521|455575914|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
126622555|NCT01379521|455575913|FG000|Overall Study -Treatment Period|Disease Progression|23|||
126622556|NCT01379521|455575914|FG001|Overall Study -Treatment Period|Disease Progression|22|||
126622557|NCT01379521|455575913|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
126622558|NCT01379521|455575914|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
126622559|NCT01379521|455575913|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
126622560|NCT01379521|455575914|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
126622561|NCT01379521|455575913|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
126622562|NCT01379521|455575914|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
126622563|NCT01379521|455575913|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
126622564|NCT01379521|455575914|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
126622565|NCT01379521|455575913|FG000|Overall Study -Treatment Period|Death|2|||
126622566|NCT01379521|455575914|FG001|Overall Study -Treatment Period|Death|1|||
126622567|NCT01379521|455575913|FG000|Post-Treatment Evaluations|Disease Progression|22|||
126622568|NCT01379521|455575914|FG001|Post-Treatment Evaluations|Disease Progression|20|||
126622569|NCT01379521|455575913|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
126782423|NCT00585351|456158186|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
126622570|NCT01379521|455575914|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
126622571|NCT01379521|455575913|FG000|Post-Treatment Evaluations|Death|1|||
126622572|NCT01379521|455575914|FG001|Post-Treatment Evaluations|Death|0|||
126622573|NCT00938041|455575915|FG000|Overall Study|Lost to Follow-up|6|||
126622574|NCT00938041|455575915|FG000|Overall Study|Received Alternative Therapy|1|||
126622575|NCT00938041|455575915|FG000|Overall Study|Progressive Disease|5|||
126622576|NCT00938041|455575915|FG000|Overall Study|Death|12|||
126622577|NCT00938041|455575915|FG000|Overall Study|Adrenal Insufficiency|3|||
126622578|NCT01026103|455575916|FG000|Overall Study|Physician Decision|1|||
126622579|NCT01026103|455575916|FG000|Overall Study|did not receive study device bc of error|1|||
126622580|NCT00105521|455575917|FG000|Overall Study|Other|1|||
126622581|NCT00105521|455575918|FG001|Overall Study|Other|1|||
126622582|NCT00105521|455575919|FG002|Overall Study|Other|2|||
126750275|NCT00542425|456032975|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
126750276|NCT00542425|456032976|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
126750277|NCT00542425|456032977|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
126750278|NCT00542425|456032978|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
126750279|NCT00542425|456032974|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
126750280|NCT00542425|456032975|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
126750281|NCT00542425|456032976|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
126750282|NCT00542425|456032977|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
126750283|NCT00542425|456032978|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
126750284|NCT00542425|456032974|FG000|Extended 24 Weeks of Treatment|Other|1|||
126750285|NCT00542425|456032975|FG001|Extended 24 Weeks of Treatment|Other|1|||
126750286|NCT00542425|456032976|FG002|Extended 24 Weeks of Treatment|Other|0|||
126750287|NCT00542425|456032977|FG003|Extended 24 Weeks of Treatment|Other|0|||
126750288|NCT00542425|456032978|FG004|Extended 24 Weeks of Treatment|Other|1|||
126750289|NCT04610827|456034130|FG000|Overall Study|Withdrawal by Subject|1|||
126750290|NCT04610827|456034131|FG001|Overall Study|Withdrawal by Subject|1|||
126750291|NCT04610827|456034132|FG002|Overall Study|Withdrawal by Subject|0|||
126750292|NCT02059174|456034139|FG000|Period 1|Withdrawal by Subject|0|||
126750293|NCT02059174|456034140|FG001|Period 1|Withdrawal by Subject|2|||
126750294|NCT02059174|456034139|FG000|Period 2|Withdrawal by Subject|0|||
126750295|NCT02059174|456034140|FG001|Period 2|Withdrawal by Subject|2|||
126750296|NCT02059174|456034139|FG000|Period 2|Protocol Violation|1|||
126750297|NCT02059174|456034140|FG001|Period 2|Protocol Violation|0|||
126750298|NCT02059174|456034139|FG000|Period 3|Physician Decision|1|||
126750299|NCT02059174|456034140|FG001|Period 3|Physician Decision|0|||
126750300|NCT02306148|456034141|FG000|Overall Study|Adverse Event|12|||
126750301|NCT02306148|456034142|FG001|Overall Study|Adverse Event|6|||
126750302|NCT02306148|456034141|FG000|Overall Study|Lost to Follow-up|1|||
126750303|NCT02306148|456034142|FG001|Overall Study|Lost to Follow-up|4|||
126750304|NCT00087594|456034143|FG000|Overall Study|Adverse Event|2|||
126750305|NCT00087594|456034144|FG001|Overall Study|Adverse Event|3|||
126750306|NCT00087594|456034143|FG000|Overall Study|Lost to Follow-up|0|||
126750307|NCT00087594|456034144|FG001|Overall Study|Lost to Follow-up|2|||
126750308|NCT00087594|456034143|FG000|Overall Study|Withdrawal by Subject|4|||
126750309|NCT00087594|456034144|FG001|Overall Study|Withdrawal by Subject|2|||
126750310|NCT00087594|456034143|FG000|Overall Study|Lack of Efficacy|2|||
126750311|NCT00087594|456034144|FG001|Overall Study|Lack of Efficacy|5|||
126750312|NCT01952041|456034149|FG000|Overall Study|Lost to Follow-up|9|||
126750313|NCT01952041|456034150|FG001|Overall Study|Lost to Follow-up|16|||
126750314|NCT01952041|456034149|FG000|Overall Study|Withdrawal by Subject|7|||
126750315|NCT01952041|456034150|FG001|Overall Study|Withdrawal by Subject|5|||
126750316|NCT01952041|456034149|FG000|Overall Study|Death|1|||
126750317|NCT01952041|456034150|FG001|Overall Study|Death|0|||
126750318|NCT00186121|456034151|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
126750319|NCT00186121|456034151|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
126750320|NCT00186121|456034151|FG000|Overall Study|Not eligible (no treatment)|1|||
126750321|NCT03650387|456034152|FG000|Overall Study|Withdrawal by Subject|13|||
126750322|NCT03650387|456034152|FG000|Overall Study|Lost to Follow-up|12|||
126750323|NCT03650387|456034152|FG000|Overall Study|Adverse Event (Not related)|1|||
126750324|NCT03650387|456034152|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
126750325|NCT01569568|456034153|FG000|Overall Study|Physician Decision|0|||
126750326|NCT01569568|456034154|FG001|Overall Study|Physician Decision|2|||
126750327|NCT01370499|456034155|FG000|Overall Study|Adverse Event|38|||
126750328|NCT01370499|456034156|FG001|Overall Study|Adverse Event|12|||
126750329|NCT01370499|456034155|FG000|Overall Study|Lack of Efficacy|4|||
126750330|NCT01370499|456034156|FG001|Overall Study|Lack of Efficacy|2|||
126750331|NCT01370499|456034155|FG000|Overall Study|Lost to Follow-up|2|||
126750332|NCT01370499|456034156|FG001|Overall Study|Lost to Follow-up|1|||
126750333|NCT01370499|456034155|FG000|Overall Study|Physician Decision|3|||
126750334|NCT01370499|456034156|FG001|Overall Study|Physician Decision|3|||
126750335|NCT01370499|456034155|FG000|Overall Study|Protocol Violation|5|||
126750336|NCT01370499|456034156|FG001|Overall Study|Protocol Violation|4|||
126750337|NCT01370499|456034155|FG000|Overall Study|Withdrawal by Subject|18|||
126750338|NCT01370499|456034156|FG001|Overall Study|Withdrawal by Subject|7|||
126750339|NCT01370499|456034155|FG000|Overall Study|Sponsor Decision|41|||
126750340|NCT01370499|456034156|FG001|Overall Study|Sponsor Decision|15|||
126750341|NCT03763942|456034157|FG000|Overall Study|Lost to Follow-up|114|||
126750342|NCT03763942|456034158|FG001|Overall Study|Lost to Follow-up|54|||
126750343|NCT03763942|456034157|FG000|Overall Study|Protocol Violation|1|||
126750344|NCT03763942|456034158|FG001|Overall Study|Protocol Violation|0|||
126750345|NCT03763942|456034157|FG000|Overall Study|Withdrawal by Subject|2|||
126750346|NCT03763942|456034158|FG001|Overall Study|Withdrawal by Subject|0|||
126750347|NCT03763942|456034157|FG000|Overall Study|Other|2|||
126750348|NCT03763942|456034158|FG001|Overall Study|Other|3|||
126782424|NCT00585351|456158187|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
126750349|NCT03558503|456034159|FG000|Overall Study|Adverse Event|1|||
126750350|NCT03558503|456034159|FG000|Overall Study|Death|1|||
126782425|NCT00585351|456158188|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
126782426|NCT00585351|456158189|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
126782427|NCT00585351|456158190|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
126782428|NCT00585351|456158191|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
126782429|NCT00585351|456158192|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
126782430|NCT01842958|456158194|FG000|Overall Study|Lost to Follow-up|1|||
126782431|NCT01842958|456158195|FG001|Overall Study|Lost to Follow-up|1|||
126782432|NCT01829477|456158196|FG000|Overall Study|Study Terminated by Sponsor|15|||
126782433|NCT01829477|456158197|FG001|Overall Study|Study Terminated by Sponsor|15|||
126782434|NCT01829477|456158196|FG000|Overall Study|Withdrawal by Subject|1|||
126782435|NCT01829477|456158197|FG001|Overall Study|Withdrawal by Subject|0|||
126782436|NCT00818623|456158202|FG000|Overall Study|Adverse Event|1|||
126782437|NCT00818623|456158203|FG001|Overall Study|Adverse Event|0|||
126782438|NCT00818623|456158204|FG002|Overall Study|Adverse Event|1|||
126782439|NCT00818623|456158205|FG003|Overall Study|Adverse Event|0|||
126782440|NCT00818623|456158206|FG004|Overall Study|Adverse Event|0|||
126782441|NCT00818623|456158207|FG005|Overall Study|Adverse Event|1|||
126782442|NCT00818623|456158208|FG006|Overall Study|Adverse Event|0|||
126782443|NCT00818623|456158209|FG007|Overall Study|Adverse Event|0|||
126782444|NCT00818623|456158202|FG000|Overall Study|Bad prostate specific antigen response|0|||
126782445|NCT00818623|456158203|FG001|Overall Study|Bad prostate specific antigen response|3|||
126782446|NCT00818623|456158204|FG002|Overall Study|Bad prostate specific antigen response|2|||
126782447|NCT00818623|456158205|FG003|Overall Study|Bad prostate specific antigen response|5|||
126782448|NCT00818623|456158206|FG004|Overall Study|Bad prostate specific antigen response|0|||
126782449|NCT00818623|456158207|FG005|Overall Study|Bad prostate specific antigen response|1|||
126782450|NCT00818623|456158208|FG006|Overall Study|Bad prostate specific antigen response|0|||
126782451|NCT00818623|456158209|FG007|Overall Study|Bad prostate specific antigen response|0|||
126782452|NCT00818623|456158202|FG000|Overall Study|Withdrawal by Subject|0|||
126782453|NCT00818623|456158203|FG001|Overall Study|Withdrawal by Subject|1|||
126782454|NCT00818623|456158204|FG002|Overall Study|Withdrawal by Subject|1|||
126782455|NCT00818623|456158205|FG003|Overall Study|Withdrawal by Subject|0|||
126782456|NCT00818623|456158206|FG004|Overall Study|Withdrawal by Subject|0|||
126782457|NCT00818623|456158207|FG005|Overall Study|Withdrawal by Subject|1|||
126782458|NCT00818623|456158208|FG006|Overall Study|Withdrawal by Subject|1|||
126782459|NCT00818623|456158209|FG007|Overall Study|Withdrawal by Subject|1|||
126782460|NCT00818623|456158202|FG000|Overall Study|Protocol Violation|1|||
126782461|NCT00818623|456158203|FG001|Overall Study|Protocol Violation|0|||
126782462|NCT00818623|456158204|FG002|Overall Study|Protocol Violation|0|||
126782463|NCT00818623|456158205|FG003|Overall Study|Protocol Violation|0|||
126782464|NCT00818623|456158206|FG004|Overall Study|Protocol Violation|1|||
126782465|NCT00818623|456158207|FG005|Overall Study|Protocol Violation|0|||
126782466|NCT00818623|456158208|FG006|Overall Study|Protocol Violation|1|||
126782467|NCT00818623|456158209|FG007|Overall Study|Protocol Violation|0|||
126782468|NCT00818623|456158202|FG000|Overall Study|Need of additional treatment|0|||
126782469|NCT00818623|456158203|FG001|Overall Study|Need of additional treatment|0|||
126782470|NCT00818623|456158204|FG002|Overall Study|Need of additional treatment|0|||
126782471|NCT00818623|456158205|FG003|Overall Study|Need of additional treatment|0|||
126782472|NCT00818623|456158206|FG004|Overall Study|Need of additional treatment|1|||
126782473|NCT00818623|456158207|FG005|Overall Study|Need of additional treatment|0|||
126782474|NCT00818623|456158208|FG006|Overall Study|Need of additional treatment|0|||
126622583|NCT00105521|455575920|FG003|Overall Study|Other|0|||
126622584|NCT00105521|455575917|FG000|Overall Study|Adverse Event|10|||
126622585|NCT00105521|455575918|FG001|Overall Study|Adverse Event|4|||
126622586|NCT00105521|455575919|FG002|Overall Study|Adverse Event|10|||
126622587|NCT00105521|455575920|FG003|Overall Study|Adverse Event|8|||
126622588|NCT00105521|455575917|FG000|Overall Study|Withdrawal by Subject|1|||
126622589|NCT00105521|455575918|FG001|Overall Study|Withdrawal by Subject|0|||
126622590|NCT00105521|455575919|FG002|Overall Study|Withdrawal by Subject|1|||
126622591|NCT00105521|455575920|FG003|Overall Study|Withdrawal by Subject|4|||
126622592|NCT00105521|455575917|FG000|Overall Study|Lack of Efficacy|0|||
126622593|NCT00105521|455575918|FG001|Overall Study|Lack of Efficacy|0|||
126622594|NCT00105521|455575919|FG002|Overall Study|Lack of Efficacy|0|||
126622595|NCT00105521|455575920|FG003|Overall Study|Lack of Efficacy|1|||
126622596|NCT00105521|455575917|FG000|Overall Study|Protocol Violation|3|||
126622597|NCT00105521|455575918|FG001|Overall Study|Protocol Violation|5|||
126622598|NCT00105521|455575919|FG002|Overall Study|Protocol Violation|4|||
126622599|NCT00105521|455575920|FG003|Overall Study|Protocol Violation|4|||
126622600|NCT00105521|455575917|FG000|Overall Study|Lost to Follow-up|0|||
126622601|NCT00105521|455575918|FG001|Overall Study|Lost to Follow-up|1|||
126622602|NCT00105521|455575919|FG002|Overall Study|Lost to Follow-up|0|||
126622603|NCT00105521|455575920|FG003|Overall Study|Lost to Follow-up|0|||
126622604|NCT02475733|455575921|FG000|Overall Study|Withdrawal by Subject|1|||
126782475|NCT00818623|456158209|FG007|Overall Study|Need of additional treatment|0|||
126782476|NCT00818623|456158202|FG000|Overall Study|Lack of trial drug at site|0|||
126782477|NCT00818623|456158203|FG001|Overall Study|Lack of trial drug at site|0|||
126622605|NCT02475733|455575922|FG001|Overall Study|Withdrawal by Subject|0|||
126622606|NCT02475733|455575921|FG000|Overall Study|Physician Decision|1|||
126622607|NCT02475733|455575922|FG001|Overall Study|Physician Decision|0|||
126622608|NCT00404547|455575925|FG000|Overall Study|Adverse Event|39|||
126622609|NCT00404547|455575926|FG001|Overall Study|Adverse Event|6|||
126622610|NCT00404547|455575925|FG000|Overall Study|Withdrawal by Subject|19|||
126622611|NCT00404547|455575926|FG001|Overall Study|Withdrawal by Subject|2|||
126622612|NCT00404547|455575925|FG000|Overall Study|Protocol Violation|0|||
126622613|NCT00404547|455575926|FG001|Overall Study|Protocol Violation|1|||
126622614|NCT00404547|455575925|FG000|Overall Study|Lost to Follow-up|20|||
126622615|NCT00404547|455575926|FG001|Overall Study|Lost to Follow-up|9|||
126622616|NCT00404547|455575925|FG000|Overall Study|Lack of compliance|5|||
126622617|NCT00404547|455575926|FG001|Overall Study|Lack of compliance|1|||
126622618|NCT00404547|455575925|FG000|Overall Study|Other|4|||
126622619|NCT00404547|455575926|FG001|Overall Study|Other|0|||
126622620|NCT00404547|455575925|FG000|Overall Study|Reason not stated|3|||
126622621|NCT00404547|455575926|FG001|Overall Study|Reason not stated|6|||
126622622|NCT02131155|455575927|FG000|Overall Study|Adverse Event|1|||
126622623|NCT02131155|455575928|FG001|Overall Study|Adverse Event|0|||
126622624|NCT02131155|455575927|FG000|Overall Study|Treatment completed|1|||
126622625|NCT02131155|455575928|FG001|Overall Study|Treatment completed|0|||
126622626|NCT02131155|455575927|FG000|Overall Study|Primary tumour recurrence|2|||
126622627|NCT02131155|455575928|FG001|Overall Study|Primary tumour recurrence|1|||
126622628|NCT02131155|455575927|FG000|Overall Study|Refused to continue study medication|1|||
126622629|NCT02131155|455575928|FG001|Overall Study|Refused to continue study medication|0|||
126622630|NCT02131155|455575927|FG000|Overall Study|Study early termination|20|||
126622631|NCT02131155|455575928|FG001|Overall Study|Study early termination|10|||
126622632|NCT02350127|455575932|FG000|4-Month Assessment|Withdrawal by Subject|10|||
126622633|NCT02350127|455575933|FG001|4-Month Assessment|Withdrawal by Subject|9|||
126622634|NCT02350127|455575932|FG000|4-Month Assessment|Death|1|||
126622635|NCT02350127|455575933|FG001|4-Month Assessment|Death|0|||
126622636|NCT02350127|455575932|FG000|8-Month Assessment|Death|1|||
126622637|NCT02350127|455575933|FG001|8-Month Assessment|Death|1|||
126622638|NCT02350127|455575932|FG000|8-Month Assessment|Withdrawal by Subject|5|||
126622639|NCT02350127|455575933|FG001|8-Month Assessment|Withdrawal by Subject|8|||
126622640|NCT03906240|455575934|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
126622641|NCT03906240|455575935|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
126622642|NCT03906240|455575934|FG000|Overall Study|Lost to Follow-up|1|||
126622643|NCT03906240|455575935|FG001|Overall Study|Lost to Follow-up|0|||
126622644|NCT03906240|455575934|FG000|Overall Study|Withdrawal by Subject|0|||
126622645|NCT03906240|455575935|FG001|Overall Study|Withdrawal by Subject|1|||
126622646|NCT01446042|455575936|FG000|Overall Study|Withdrawal by Subject|12|||
126622647|NCT01446042|455575937|FG001|Overall Study|Withdrawal by Subject|2|||
126622648|NCT01446042|455575938|FG002|Overall Study|Withdrawal by Subject|4|||
126622649|NCT01446042|455575936|FG000|Overall Study|Adverse Event|1|||
126622650|NCT01446042|455575937|FG001|Overall Study|Adverse Event|0|||
126622651|NCT01446042|455575938|FG002|Overall Study|Adverse Event|4|||
126622652|NCT01446042|455575936|FG000|Overall Study|Lost to Follow-up|5|||
126622653|NCT01446042|455575937|FG001|Overall Study|Lost to Follow-up|0|||
126622654|NCT01446042|455575938|FG002|Overall Study|Lost to Follow-up|0|||
126622655|NCT01446042|455575936|FG000|Overall Study|Other reasons|2|||
126622656|NCT01446042|455575937|FG001|Overall Study|Other reasons|1|||
126622657|NCT01446042|455575938|FG002|Overall Study|Other reasons|1|||
126622658|NCT03751280|455575948|FG000|Overall Study|Adverse Event|0|||
126622659|NCT03751280|455575949|FG001|Overall Study|Adverse Event|1|||
126622660|NCT03751280|455575948|FG000|Overall Study|Lost to Follow-up|3|||
126622661|NCT03751280|455575949|FG001|Overall Study|Lost to Follow-up|5|||
126622662|NCT03751280|455575948|FG000|Overall Study|Physician Decision|0|||
126622663|NCT03751280|455575949|FG001|Overall Study|Physician Decision|2|||
126622664|NCT03751280|455575948|FG000|Overall Study|Protocol Violation|0|||
126622665|NCT03751280|455575949|FG001|Overall Study|Protocol Violation|2|||
126622666|NCT03751280|455575948|FG000|Overall Study|Withdrawal by Subject|5|||
126622667|NCT03751280|455575949|FG001|Overall Study|Withdrawal by Subject|2|||
126622668|NCT00296504|455575950|FG000|Interim Analysis|Withdrawal by Subject|8|||
126622669|NCT00296504|455575951|FG001|Interim Analysis|Withdrawal by Subject|0|||
126622670|NCT00296504|455575952|FG002|Interim Analysis|Withdrawal by Subject|12|||
126622671|NCT00296504|455575953|FG003|Interim Analysis|Withdrawal by Subject|0|||
126622672|NCT00296504|455575954|FG004|Interim Analysis|Withdrawal by Subject|5|||
126622673|NCT00296504|455575955|FG005|Interim Analysis|Withdrawal by Subject|5|||
126622674|NCT00296504|455575956|FG006|Interim Analysis|Withdrawal by Subject|9|||
126622675|NCT00296504|455575957|FG007|Interim Analysis|Withdrawal by Subject|3|||
126622676|NCT00296504|455575958|FG008|Interim Analysis|Withdrawal by Subject|0|||
126622677|NCT00296504|455575950|FG000|Interim Analysis|Lost to Follow-up|13|||
126622678|NCT00296504|455575951|FG001|Interim Analysis|Lost to Follow-up|3|||
126622679|NCT00296504|455575952|FG002|Interim Analysis|Lost to Follow-up|26|||
126622680|NCT00296504|455575953|FG003|Interim Analysis|Lost to Follow-up|8|||
126622681|NCT00296504|455575954|FG004|Interim Analysis|Lost to Follow-up|14|||
126750351|NCT03558503|456034159|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
126750352|NCT02274311|456034160|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
126750353|NCT02477800|456034162|FG000|Placebo-Controlled Period|Adverse Event|16|||
126750354|NCT02477800|456034163|FG001|Placebo-Controlled Period|Adverse Event|25|||
126750355|NCT02477800|456034164|FG002|Placebo-Controlled Period|Adverse Event|28|||
126750356|NCT02477800|456034165|FG003|Placebo-Controlled Period|Adverse Event|0|||
126750357|NCT02477800|456034166|FG004|Placebo-Controlled Period|Adverse Event|0|||
126750358|NCT02477800|456034167|FG005|Placebo-Controlled Period|Adverse Event|0|||
126750359|NCT02477800|456034168|FG006|Placebo-Controlled Period|Adverse Event|0|||
126750360|NCT02477800|456034162|FG000|Placebo-Controlled Period|Change of Treatment|1|||
126750361|NCT02477800|456034163|FG001|Placebo-Controlled Period|Change of Treatment|2|||
126750362|NCT02477800|456034164|FG002|Placebo-Controlled Period|Change of Treatment|1|||
126750363|NCT02477800|456034165|FG003|Placebo-Controlled Period|Change of Treatment|0|||
126750364|NCT02477800|456034166|FG004|Placebo-Controlled Period|Change of Treatment|0|||
126750365|NCT02477800|456034167|FG005|Placebo-Controlled Period|Change of Treatment|0|||
126750366|NCT02477800|456034168|FG006|Placebo-Controlled Period|Change of Treatment|0|||
126750367|NCT02477800|456034162|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
126750368|NCT02477800|456034163|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
126750369|NCT02477800|456034164|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
126750370|NCT02477800|456034165|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
126750371|NCT02477800|456034166|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
126750372|NCT02477800|456034167|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
126750373|NCT02477800|456034168|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
126750374|NCT02477800|456034162|FG000|Placebo-Controlled Period|Death|0|||
126750375|NCT02477800|456034163|FG001|Placebo-Controlled Period|Death|3|||
126750376|NCT02477800|456034164|FG002|Placebo-Controlled Period|Death|2|||
126750377|NCT02477800|456034165|FG003|Placebo-Controlled Period|Death|0|||
126750378|NCT02477800|456034166|FG004|Placebo-Controlled Period|Death|0|||
126750379|NCT02477800|456034167|FG005|Placebo-Controlled Period|Death|0|||
126750380|NCT02477800|456034168|FG006|Placebo-Controlled Period|Death|0|||
126750381|NCT02477800|456034162|FG000|Placebo-Controlled Period|Disease Progression|1|||
126750382|NCT02477800|456034163|FG001|Placebo-Controlled Period|Disease Progression|0|||
126750383|NCT02477800|456034164|FG002|Placebo-Controlled Period|Disease Progression|1|||
126750384|NCT02477800|456034165|FG003|Placebo-Controlled Period|Disease Progression|0|||
126750385|NCT02477800|456034166|FG004|Placebo-Controlled Period|Disease Progression|0|||
126750386|NCT02477800|456034167|FG005|Placebo-Controlled Period|Disease Progression|0|||
126750387|NCT02477800|456034168|FG006|Placebo-Controlled Period|Disease Progression|0|||
126750388|NCT02477800|456034162|FG000|Placebo-Controlled Period|Investigator Decision|3|||
126750389|NCT02477800|456034163|FG001|Placebo-Controlled Period|Investigator Decision|2|||
126750390|NCT02477800|456034164|FG002|Placebo-Controlled Period|Investigator Decision|1|||
126750391|NCT02477800|456034165|FG003|Placebo-Controlled Period|Investigator Decision|0|||
126750392|NCT02477800|456034166|FG004|Placebo-Controlled Period|Investigator Decision|0|||
126750393|NCT02477800|456034167|FG005|Placebo-Controlled Period|Investigator Decision|0|||
126750394|NCT02477800|456034168|FG006|Placebo-Controlled Period|Investigator Decision|0|||
126750395|NCT02477800|456034162|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
126750396|NCT02477800|456034163|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
126750397|NCT02477800|456034164|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
126750398|NCT02477800|456034165|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
126750399|NCT02477800|456034166|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
126750400|NCT02477800|456034167|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
126750401|NCT02477800|456034168|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
126750402|NCT02477800|456034162|FG000|Placebo-Controlled Period|Relocation|2|||
126750403|NCT02477800|456034163|FG001|Placebo-Controlled Period|Relocation|0|||
126750404|NCT02477800|456034164|FG002|Placebo-Controlled Period|Relocation|0|||
126750405|NCT02477800|456034165|FG003|Placebo-Controlled Period|Relocation|0|||
126750406|NCT02477800|456034166|FG004|Placebo-Controlled Period|Relocation|0|||
126750407|NCT02477800|456034167|FG005|Placebo-Controlled Period|Relocation|0|||
126750408|NCT02477800|456034168|FG006|Placebo-Controlled Period|Relocation|0|||
126750409|NCT02477800|456034162|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
126750410|NCT02477800|456034163|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
126750411|NCT02477800|456034164|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
126750412|NCT02477800|456034165|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
126750413|NCT02477800|456034166|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
126750414|NCT02477800|456034167|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
126750415|NCT02477800|456034168|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
126750416|NCT02477800|456034162|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
126750417|NCT02477800|456034163|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
126750418|NCT02477800|456034164|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
126750419|NCT02477800|456034165|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
126750420|NCT02477800|456034166|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
126750421|NCT02477800|456034167|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
126750422|NCT02477800|456034168|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
126750423|NCT02477800|456034162|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
126750424|NCT02477800|456034163|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
126750425|NCT02477800|456034164|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
126750426|NCT02477800|456034165|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
126750427|NCT02477800|456034166|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
126750428|NCT02477800|456034167|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
126750429|NCT02477800|456034168|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
126750430|NCT02477800|456034162|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
126750431|NCT02477800|456034163|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
126750432|NCT02477800|456034164|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
126750433|NCT02477800|456034165|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126750434|NCT02477800|456034166|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126750435|NCT02477800|456034167|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126750436|NCT02477800|456034168|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126750437|NCT02477800|456034162|FG000|Placebo-Controlled Period|Reason not Specified|161|||
126750438|NCT02477800|456034163|FG001|Placebo-Controlled Period|Reason not Specified|161|||
126750439|NCT02477800|456034164|FG002|Placebo-Controlled Period|Reason not Specified|189|||
126750440|NCT02477800|456034165|FG003|Placebo-Controlled Period|Reason not Specified|0|||
126750441|NCT02477800|456034166|FG004|Placebo-Controlled Period|Reason not Specified|0|||
126750442|NCT02477800|456034167|FG005|Placebo-Controlled Period|Reason not Specified|0|||
126750443|NCT02477800|456034168|FG006|Placebo-Controlled Period|Reason not Specified|0|||
126750444|NCT02477800|456034162|FG000|Long Term Extension Period|Adverse Event|0|||
126750445|NCT02477800|456034163|FG001|Long Term Extension Period|Adverse Event|0|||
126750446|NCT02477800|456034164|FG002|Long Term Extension Period|Adverse Event|0|||
126750447|NCT02477800|456034165|FG003|Long Term Extension Period|Adverse Event|6|||
126750448|NCT02477800|456034166|FG004|Long Term Extension Period|Adverse Event|2|||
126750449|NCT02477800|456034167|FG005|Long Term Extension Period|Adverse Event|4|||
126750450|NCT02477800|456034168|FG006|Long Term Extension Period|Adverse Event|3|||
126750451|NCT02477800|456034162|FG000|Long Term Extension Period|Death|0|||
126750452|NCT02477800|456034163|FG001|Long Term Extension Period|Death|0|||
126750453|NCT02477800|456034164|FG002|Long Term Extension Period|Death|0|||
126750454|NCT02477800|456034165|FG003|Long Term Extension Period|Death|1|||
126750455|NCT02477800|456034166|FG004|Long Term Extension Period|Death|1|||
126750456|NCT02477800|456034167|FG005|Long Term Extension Period|Death|1|||
126750457|NCT02477800|456034168|FG006|Long Term Extension Period|Death|2|||
126750458|NCT02477800|456034162|FG000|Long Term Extension Period|Consent Withdrawn|0|||
126750459|NCT02477800|456034163|FG001|Long Term Extension Period|Consent Withdrawn|0|||
126750460|NCT02477800|456034164|FG002|Long Term Extension Period|Consent Withdrawn|0|||
126750461|NCT02477800|456034165|FG003|Long Term Extension Period|Consent Withdrawn|10|||
126750462|NCT02477800|456034166|FG004|Long Term Extension Period|Consent Withdrawn|4|||
126750463|NCT02477800|456034167|FG005|Long Term Extension Period|Consent Withdrawn|13|||
126750464|NCT02477800|456034168|FG006|Long Term Extension Period|Consent Withdrawn|16|||
126750465|NCT02477800|456034162|FG000|Long Term Extension Period|Disease Progression|0|||
126750466|NCT02477800|456034163|FG001|Long Term Extension Period|Disease Progression|0|||
126750467|NCT02477800|456034164|FG002|Long Term Extension Period|Disease Progression|0|||
126750468|NCT02477800|456034165|FG003|Long Term Extension Period|Disease Progression|3|||
126750469|NCT02477800|456034166|FG004|Long Term Extension Period|Disease Progression|1|||
126750470|NCT02477800|456034167|FG005|Long Term Extension Period|Disease Progression|1|||
126750471|NCT02477800|456034168|FG006|Long Term Extension Period|Disease Progression|0|||
126750472|NCT02477800|456034162|FG000|Long Term Extension Period|Investigator Decision|0|||
126750473|NCT02477800|456034163|FG001|Long Term Extension Period|Investigator Decision|0|||
126750474|NCT02477800|456034164|FG002|Long Term Extension Period|Investigator Decision|0|||
126750475|NCT02477800|456034165|FG003|Long Term Extension Period|Investigator Decision|0|||
126750476|NCT02477800|456034166|FG004|Long Term Extension Period|Investigator Decision|0|||
126750477|NCT02477800|456034167|FG005|Long Term Extension Period|Investigator Decision|0|||
126750478|NCT02477800|456034168|FG006|Long Term Extension Period|Investigator Decision|2|||
126750479|NCT02477800|456034162|FG000|Long Term Extension Period|Lost to Follow-up|0|||
126750480|NCT02477800|456034163|FG001|Long Term Extension Period|Lost to Follow-up|0|||
126750481|NCT02477800|456034164|FG002|Long Term Extension Period|Lost to Follow-up|0|||
126750482|NCT02477800|456034165|FG003|Long Term Extension Period|Lost to Follow-up|0|||
126750483|NCT02477800|456034166|FG004|Long Term Extension Period|Lost to Follow-up|1|||
126750484|NCT02477800|456034167|FG005|Long Term Extension Period|Lost to Follow-up|3|||
126750485|NCT02477800|456034168|FG006|Long Term Extension Period|Lost to Follow-up|0|||
126750486|NCT02477800|456034162|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
126782478|NCT00818623|456158204|FG002|Overall Study|Lack of trial drug at site|0|||
126782479|NCT00818623|456158205|FG003|Overall Study|Lack of trial drug at site|0|||
126750487|NCT02477800|456034163|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
126750488|NCT02477800|456034164|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
126750489|NCT02477800|456034165|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
126750490|NCT02477800|456034166|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
126750491|NCT02477800|456034167|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
126750492|NCT02477800|456034168|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
126750493|NCT02477800|456034162|FG000|Long Term Extension Period|Study Visit Burden|0|||
126750494|NCT02477800|456034163|FG001|Long Term Extension Period|Study Visit Burden|0|||
126750495|NCT02477800|456034164|FG002|Long Term Extension Period|Study Visit Burden|0|||
126750496|NCT02477800|456034165|FG003|Long Term Extension Period|Study Visit Burden|3|||
126750497|NCT02477800|456034166|FG004|Long Term Extension Period|Study Visit Burden|0|||
126750498|NCT02477800|456034167|FG005|Long Term Extension Period|Study Visit Burden|2|||
126750499|NCT02477800|456034168|FG006|Long Term Extension Period|Study Visit Burden|2|||
126750500|NCT02477800|456034162|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
126750501|NCT02477800|456034163|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
126750502|NCT02477800|456034164|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
126750503|NCT02477800|456034165|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
126750504|NCT02477800|456034166|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
126750505|NCT02477800|456034167|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
126750506|NCT02477800|456034168|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
126750507|NCT02477800|456034162|FG000|Long Term Extension Period|Reason not Specified|0|||
126750508|NCT02477800|456034163|FG001|Long Term Extension Period|Reason not Specified|0|||
126750509|NCT02477800|456034164|FG002|Long Term Extension Period|Reason not Specified|0|||
126750510|NCT02477800|456034165|FG003|Long Term Extension Period|Reason not Specified|126|||
126750511|NCT02477800|456034166|FG004|Long Term Extension Period|Reason not Specified|140|||
126750512|NCT02477800|456034167|FG005|Long Term Extension Period|Reason not Specified|270|||
126750513|NCT02477800|456034168|FG006|Long Term Extension Period|Reason not Specified|224|||
126750514|NCT00170846|456034173|FG000|Overall Study|Subject withdrew Informed Consent|5|||
126750515|NCT00170846|456034174|FG001|Overall Study|Subject withdrew Informed Consent|12|||
126750516|NCT00170846|456034175|FG002|Overall Study|Subject withdrew Informed Consent|8|||
126750517|NCT00170846|456034173|FG000|Overall Study|Lost to Follow-up|6|||
126750518|NCT00170846|456034174|FG001|Overall Study|Lost to Follow-up|3|||
126750519|NCT00170846|456034175|FG002|Overall Study|Lost to Follow-up|2|||
126622682|NCT00296504|455575955|FG005|Interim Analysis|Lost to Follow-up|4|||
126622683|NCT00296504|455575956|FG006|Interim Analysis|Lost to Follow-up|11|||
126622684|NCT00296504|455575957|FG007|Interim Analysis|Lost to Follow-up|4|||
126622685|NCT00296504|455575958|FG008|Interim Analysis|Lost to Follow-up|0|||
126622686|NCT00296504|455575950|FG000|Interim Analysis|Clinical Progression|1|||
126622687|NCT00296504|455575951|FG001|Interim Analysis|Clinical Progression|0|||
126622688|NCT00296504|455575952|FG002|Interim Analysis|Clinical Progression|1|||
126622689|NCT00296504|455575953|FG003|Interim Analysis|Clinical Progression|1|||
126622690|NCT00296504|455575954|FG004|Interim Analysis|Clinical Progression|0|||
126622691|NCT00296504|455575955|FG005|Interim Analysis|Clinical Progression|2|||
126622692|NCT00296504|455575956|FG006|Interim Analysis|Clinical Progression|1|||
126622693|NCT00296504|455575957|FG007|Interim Analysis|Clinical Progression|2|||
126622694|NCT00296504|455575958|FG008|Interim Analysis|Clinical Progression|0|||
126622695|NCT00296504|455575950|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
126622696|NCT00296504|455575951|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
126622697|NCT00296504|455575952|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
126622698|NCT00296504|455575953|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
126622699|NCT00296504|455575954|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
126622700|NCT00296504|455575955|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
126622701|NCT00296504|455575956|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
126622702|NCT00296504|455575957|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
126622703|NCT00296504|455575958|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
126622704|NCT00296504|455575950|FG000|Interim Analysis|Adverse Event|0|||
126622705|NCT00296504|455575951|FG001|Interim Analysis|Adverse Event|0|||
126622706|NCT00296504|455575952|FG002|Interim Analysis|Adverse Event|13|||
126622707|NCT00296504|455575953|FG003|Interim Analysis|Adverse Event|4|||
126622708|NCT00296504|455575954|FG004|Interim Analysis|Adverse Event|6|||
126622709|NCT00296504|455575955|FG005|Interim Analysis|Adverse Event|3|||
126622710|NCT00296504|455575956|FG006|Interim Analysis|Adverse Event|4|||
126622711|NCT00296504|455575957|FG007|Interim Analysis|Adverse Event|5|||
126622712|NCT00296504|455575958|FG008|Interim Analysis|Adverse Event|0|||
126622713|NCT00296504|455575950|FG000|Interim Analysis|Protocol Violation|0|||
126622714|NCT00296504|455575951|FG001|Interim Analysis|Protocol Violation|0|||
126622715|NCT00296504|455575952|FG002|Interim Analysis|Protocol Violation|2|||
126622716|NCT00296504|455575953|FG003|Interim Analysis|Protocol Violation|0|||
126750520|NCT00170846|456034173|FG000|Overall Study|Death|0|||
126750521|NCT00170846|456034174|FG001|Overall Study|Death|3|||
126750522|NCT00170846|456034175|FG002|Overall Study|Death|3|||
126750523|NCT00170846|456034173|FG000|Overall Study|Reason Missing|0|||
126750524|NCT00170846|456034174|FG001|Overall Study|Reason Missing|1|||
126750525|NCT00170846|456034175|FG002|Overall Study|Reason Missing|0|||
126622717|NCT00296504|455575954|FG004|Interim Analysis|Protocol Violation|1|||
126622718|NCT00296504|455575955|FG005|Interim Analysis|Protocol Violation|0|||
126622719|NCT00296504|455575956|FG006|Interim Analysis|Protocol Violation|0|||
126750526|NCT01756833|456034177|FG000|Overall Study|Withdrawal by Subject|4|||
126750527|NCT01756833|456034178|FG001|Overall Study|Withdrawal by Subject|3|||
126750528|NCT01700140|456034181|FG000|Overall Study|Use of rescue drugs|3|||
126750529|NCT01700140|456034182|FG001|Overall Study|Use of rescue drugs|3|||
126750530|NCT01700140|456034183|FG002|Overall Study|Use of rescue drugs|1|||
126750531|NCT01700140|456034181|FG000|Overall Study|Discontinuation of radiotherapy|1|||
126750532|NCT01700140|456034182|FG001|Overall Study|Discontinuation of radiotherapy|0|||
126750533|NCT01700140|456034183|FG002|Overall Study|Discontinuation of radiotherapy|0|||
126750534|NCT01700140|456034181|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
126750535|NCT01700140|456034182|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
126750536|NCT01700140|456034183|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
126750537|NCT01700140|456034181|FG000|Overall Study|Aggravation of symptoms|1|||
126750538|NCT01700140|456034182|FG001|Overall Study|Aggravation of symptoms|0|||
126750539|NCT01700140|456034183|FG002|Overall Study|Aggravation of symptoms|0|||
126750540|NCT01700140|456034181|FG000|Overall Study|Adverse Event|0|||
126750541|NCT01700140|456034182|FG001|Overall Study|Adverse Event|1|||
126750542|NCT01700140|456034183|FG002|Overall Study|Adverse Event|0|||
126750543|NCT01700140|456034181|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
126750544|NCT01700140|456034182|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
126750545|NCT01700140|456034183|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
126750546|NCT02573012|456034184|FG000|Overall Study|Adverse Event|5|||
126750547|NCT02573012|456034185|FG001|Overall Study|Adverse Event|5|||
126750548|NCT02573012|456034184|FG000|Overall Study|Lack of Efficacy|5|||
126750549|NCT02573012|456034185|FG001|Overall Study|Lack of Efficacy|4|||
126750550|NCT02573012|456034184|FG000|Overall Study|Non-compliance|1|||
126750551|NCT02573012|456034185|FG001|Overall Study|Non-compliance|2|||
126750552|NCT02573012|456034184|FG000|Overall Study|Withdrawal by Subject|2|||
126750553|NCT02573012|456034185|FG001|Overall Study|Withdrawal by Subject|2|||
126750554|NCT02573012|456034184|FG000|Overall Study|Study Ended per Protocol|1|||
126750555|NCT02573012|456034185|FG001|Overall Study|Study Ended per Protocol|0|||
126750556|NCT02573012|456034184|FG000|Overall Study|Physician Decision|1|||
126750557|NCT02573012|456034185|FG001|Overall Study|Physician Decision|2|||
126750558|NCT01601873|456034186|FG000|Overall Study|Lost to Follow-up|2|||
126750559|NCT01601873|456034187|FG001|Overall Study|Lost to Follow-up|3|||
126750560|NCT02096471|456034188|FG000|Overall Study|Adverse Event|1|||
126750561|NCT02096471|456034188|FG000|Overall Study|Lack of Efficacy|7|||
126750562|NCT02096471|456034188|FG000|Overall Study|Withdrawal by Subject|3|||
126750563|NCT02096471|456034188|FG000|Overall Study|Non-Compliant|2|||
126750564|NCT01610414|456034189|FG000|Study Start - Month 13|Serious Adverse Event|65|||
126750565|NCT01610414|456034190|FG001|Study Start - Month 13|Serious Adverse Event|67|||
126750566|NCT01610414|456034189|FG000|Study Start - Month 13|Adverse Event|14|||
126750567|NCT01610414|456034190|FG001|Study Start - Month 13|Adverse Event|14|||
126750568|NCT01610414|456034189|FG000|Study Start - Month 13|Protocol Violation|3|||
126750569|NCT01610414|456034190|FG001|Study Start - Month 13|Protocol Violation|1|||
126750570|NCT01610414|456034189|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
126750571|NCT01610414|456034190|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
126750572|NCT01610414|456034189|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
126750573|NCT01610414|456034190|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
126750574|NCT01610414|456034189|FG000|Study Start - Month 13|Lost to Follow-up|4|||
126750575|NCT01610414|456034190|FG001|Study Start - Month 13|Lost to Follow-up|6|||
126750576|NCT01610414|456034189|FG000|Study Start - Month 13|Suspected HZ episode|1|||
126750577|NCT01610414|456034190|FG001|Study Start - Month 13|Suspected HZ episode|3|||
126750578|NCT01610414|456034189|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
126750579|NCT01610414|456034190|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
126750580|NCT01610414|456034189|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
126750581|NCT01610414|456034190|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
126750582|NCT01610414|456034189|FG000|Month 13 - Month 25|Adverse Event|8|||
126750583|NCT01610414|456034190|FG001|Month 13 - Month 25|Adverse Event|4|||
126750584|NCT01610414|456034189|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
126750585|NCT01610414|456034190|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
126750586|NCT01610414|456034189|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
126750587|NCT01610414|456034190|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
126750588|NCT01610414|456034189|FG000|Month 13 - Month 25|Protocol Violation|0|||
126750589|NCT01610414|456034190|FG001|Month 13 - Month 25|Protocol Violation|2|||
126750590|NCT01610414|456034189|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
126782480|NCT00818623|456158206|FG004|Overall Study|Lack of trial drug at site|2|||
126782481|NCT00818623|456158207|FG005|Overall Study|Lack of trial drug at site|0|||
126750591|NCT01610414|456034190|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
126750592|NCT01610414|456034189|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
126750593|NCT01610414|456034190|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
126750594|NCT01610414|456034189|FG000|After Month 25|Study end not reached|48|||
126750595|NCT01610414|456034190|FG001|After Month 25|Study end not reached|53|||
126750596|NCT02736474|456034191|FG000|Overall Study|Lost to Follow-up|0|||
126750597|NCT02736474|456034192|FG001|Overall Study|Lost to Follow-up|1|||
126782482|NCT00818623|456158208|FG006|Overall Study|Lack of trial drug at site|1|||
126782483|NCT00818623|456158209|FG007|Overall Study|Lack of trial drug at site|0|||
126782484|NCT00818623|456158202|FG000|Overall Study|Disease progression|0|||
126782485|NCT00818623|456158203|FG001|Overall Study|Disease progression|0|||
126782486|NCT00818623|456158204|FG002|Overall Study|Disease progression|0|||
126782487|NCT00818623|456158205|FG003|Overall Study|Disease progression|0|||
126782488|NCT00818623|456158206|FG004|Overall Study|Disease progression|0|||
126782489|NCT00818623|456158207|FG005|Overall Study|Disease progression|0|||
126782490|NCT00818623|456158208|FG006|Overall Study|Disease progression|1|||
126782491|NCT00818623|456158209|FG007|Overall Study|Disease progression|0|||
126782492|NCT00602030|456158210|FG000|Lead-in Phase|Disease Progression|2|||
126782493|NCT00602030|456158211|FG001|Lead-in Phase|Disease Progression|3|||
126782494|NCT00602030|456158212|FG002|Lead-in Phase|Disease Progression|0|||
126782495|NCT00602030|456158213|FG003|Lead-in Phase|Disease Progression|0|||
126782496|NCT00602030|456158214|FG004|Lead-in Phase|Disease Progression|0|||
126782497|NCT00602030|456158210|FG000|Lead-in Phase|Adverse Event|0|||
126782498|NCT00602030|456158211|FG001|Lead-in Phase|Adverse Event|2|||
126782499|NCT00602030|456158212|FG002|Lead-in Phase|Adverse Event|0|||
126782500|NCT00602030|456158213|FG003|Lead-in Phase|Adverse Event|0|||
126782501|NCT00602030|456158214|FG004|Lead-in Phase|Adverse Event|0|||
126782502|NCT00602030|456158210|FG000|Double-blind Phase|Disease progression|0|||
126782503|NCT00602030|456158211|FG001|Double-blind Phase|Disease progression|0|||
126782504|NCT00602030|456158212|FG002|Double-blind Phase|Disease progression|33|||
126782505|NCT00602030|456158213|FG003|Double-blind Phase|Disease progression|30|||
126782506|NCT00602030|456158214|FG004|Double-blind Phase|Disease progression|0|||
126782507|NCT00602030|456158210|FG000|Double-blind Phase|Adverse Event|0|||
126782508|NCT00602030|456158211|FG001|Double-blind Phase|Adverse Event|0|||
126782509|NCT00602030|456158212|FG002|Double-blind Phase|Adverse Event|9|||
126782510|NCT00602030|456158213|FG003|Double-blind Phase|Adverse Event|18|||
126782511|NCT00602030|456158214|FG004|Double-blind Phase|Adverse Event|0|||
126782512|NCT00602030|456158210|FG000|Double-blind Phase|Consent withdrawal|0|||
126782513|NCT00602030|456158211|FG001|Double-blind Phase|Consent withdrawal|0|||
126782514|NCT00602030|456158212|FG002|Double-blind Phase|Consent withdrawal|4|||
126782515|NCT00602030|456158213|FG003|Double-blind Phase|Consent withdrawal|3|||
126782516|NCT00602030|456158214|FG004|Double-blind Phase|Consent withdrawal|0|||
126782517|NCT00602030|456158210|FG000|Double-blind Phase|Death|0|||
126782518|NCT00602030|456158211|FG001|Double-blind Phase|Death|0|||
126782519|NCT00602030|456158212|FG002|Double-blind Phase|Death|3|||
126782520|NCT00602030|456158213|FG003|Double-blind Phase|Death|3|||
126782521|NCT00602030|456158214|FG004|Double-blind Phase|Death|0|||
126782522|NCT00602030|456158210|FG000|Double-blind Phase|Administrative decision|0|||
126782523|NCT00602030|456158211|FG001|Double-blind Phase|Administrative decision|0|||
126782524|NCT00602030|456158212|FG002|Double-blind Phase|Administrative decision|0|||
126782525|NCT00602030|456158213|FG003|Double-blind Phase|Administrative decision|2|||
126782526|NCT00602030|456158214|FG004|Double-blind Phase|Administrative decision|0|||
126782527|NCT00602030|456158210|FG000|Double-blind Phase|Ineligibility|0|||
126782528|NCT00602030|456158211|FG001|Double-blind Phase|Ineligibility|0|||
126782529|NCT00602030|456158212|FG002|Double-blind Phase|Ineligibility|0|||
126782530|NCT00602030|456158213|FG003|Double-blind Phase|Ineligibility|1|||
126782531|NCT00602030|456158214|FG004|Double-blind Phase|Ineligibility|0|||
126782532|NCT00602030|456158210|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
126782533|NCT00602030|456158211|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
126782534|NCT00602030|456158212|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
126782535|NCT00602030|456158213|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
126622720|NCT00296504|455575957|FG007|Interim Analysis|Protocol Violation|1|||
126622721|NCT00296504|455575958|FG008|Interim Analysis|Protocol Violation|0|||
126622722|NCT00296504|455575950|FG000|Interim Analysis|Insufficient CD4 Response|0|||
126622723|NCT00296504|455575951|FG001|Interim Analysis|Insufficient CD4 Response|0|||
126622724|NCT00296504|455575952|FG002|Interim Analysis|Insufficient CD4 Response|0|||
126782536|NCT00602030|456158214|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
126782537|NCT00602030|456158210|FG000|Double-blind Phase|Reason not specified|0|||
126782538|NCT00602030|456158211|FG001|Double-blind Phase|Reason not specified|0|||
126782539|NCT00602030|456158212|FG002|Double-blind Phase|Reason not specified|4|||
126782540|NCT00602030|456158213|FG003|Double-blind Phase|Reason not specified|2|||
126782541|NCT00602030|456158214|FG004|Double-blind Phase|Reason not specified|0|||
126782542|NCT00602030|456158210|FG000|Crossover Phase|Disease Progression|0|||
126782543|NCT00602030|456158211|FG001|Crossover Phase|Disease Progression|0|||
126782544|NCT00602030|456158212|FG002|Crossover Phase|Disease Progression|0|||
126782545|NCT00602030|456158213|FG003|Crossover Phase|Disease Progression|0|||
126622725|NCT00296504|455575953|FG003|Interim Analysis|Insufficient CD4 Response|0|||
126622726|NCT00296504|455575954|FG004|Interim Analysis|Insufficient CD4 Response|1|||
126622727|NCT00296504|455575955|FG005|Interim Analysis|Insufficient CD4 Response|1|||
126782546|NCT00602030|456158214|FG004|Crossover Phase|Disease Progression|11|||
126782547|NCT00602030|456158210|FG000|Crossover Phase|Adverse Event|0|||
126782548|NCT00602030|456158211|FG001|Crossover Phase|Adverse Event|0|||
126782549|NCT00602030|456158212|FG002|Crossover Phase|Adverse Event|0|||
126782550|NCT00602030|456158213|FG003|Crossover Phase|Adverse Event|0|||
126750598|NCT02483611|456034193|FG000|Overall Study|Protocol Violation|0|||
126750599|NCT02483611|456034194|FG001|Overall Study|Protocol Violation|0|||
126750600|NCT02483611|456034195|FG002|Overall Study|Protocol Violation|1|||
126750601|NCT02382276|456034196|FG000|Overall Study|Withdrawal by Subject|4|||
126750602|NCT02382276|456034197|FG001|Overall Study|Withdrawal by Subject|8|||
126750603|NCT02382276|456034198|FG002|Overall Study|Withdrawal by Subject|5|||
126750604|NCT02382276|456034196|FG000|Overall Study|Adverse Event|7|||
126750605|NCT02382276|456034197|FG001|Overall Study|Adverse Event|2|||
126750606|NCT02382276|456034198|FG002|Overall Study|Adverse Event|32|||
126750607|NCT02382276|456034196|FG000|Overall Study|Physician Decision|0|||
126750608|NCT02382276|456034197|FG001|Overall Study|Physician Decision|0|||
126750609|NCT02382276|456034198|FG002|Overall Study|Physician Decision|2|||
126750610|NCT01222416|456034199|FG000|Overall Study|ineligible;metastasis|3|||
126750611|NCT01222416|456034200|FG001|Overall Study|ineligible;metastasis|0|||
126750612|NCT01222416|456034199|FG000|Overall Study|Adverse Event|4|||
126750613|NCT01222416|456034200|FG001|Overall Study|Adverse Event|0|||
126750614|NCT01222416|456034199|FG000|Overall Study|Withdrawal by Subject|5|||
126750615|NCT01222416|456034200|FG001|Overall Study|Withdrawal by Subject|0|||
126750616|NCT01222416|456034199|FG000|Overall Study|scheduling|6|||
126750617|NCT01222416|456034200|FG001|Overall Study|scheduling|0|||
126750618|NCT01222416|456034199|FG000|Overall Study|missed view/scan|1|||
126750619|NCT01222416|456034200|FG001|Overall Study|missed view/scan|0|||
126750620|NCT01222416|456034199|FG000|Overall Study|Death|1|||
126750621|NCT01222416|456034200|FG001|Overall Study|Death|0|||
126750622|NCT00518336|456034201|FG000|Year 7|Lost to Follow-up|2|||
126750623|NCT00518336|456034202|FG001|Year 7|Lost to Follow-up|0|||
126750624|NCT00518336|456034201|FG000|Year 7|Could not attend in time|0|||
126750625|NCT00518336|456034202|FG001|Year 7|Could not attend in time|3|||
126750626|NCT00518336|456034201|FG000|Year 8|Lost to Follow-up|1|||
126750627|NCT00518336|456034202|FG001|Year 8|Lost to Follow-up|1|||
126750628|NCT00518336|456034201|FG000|Year 8|Could not attend in time|0|||
126750629|NCT00518336|456034202|FG001|Year 8|Could not attend in time|1|||
126750630|NCT00518336|456034201|FG000|Year 9|Migrated/moved from study area|1|||
126750631|NCT00518336|456034202|FG001|Year 9|Migrated/moved from study area|1|||
126750632|NCT00518336|456034201|FG000|Year 9|Lost to Follow-up|3|||
126750633|NCT00518336|456034202|FG001|Year 9|Lost to Follow-up|0|||
126750634|NCT00518336|456034201|FG000|Year 9|Personal reasons|1|||
126750635|NCT00518336|456034202|FG001|Year 9|Personal reasons|0|||
126750636|NCT00125268|456034203|FG000|Overall Study|Withdrawal by Subject|1|||
126750637|NCT00125268|456034204|FG001|Overall Study|Withdrawal by Subject|1|||
126750638|NCT00286156|456034205|FG000|Overall Study|Missed 12 month visit|0|||
126750639|NCT00286156|456034206|FG001|Overall Study|Missed 12 month visit|0|||
126750640|NCT00286156|456034207|FG002|Overall Study|Missed 12 month visit|1|||
126750641|NCT00286156|456034205|FG000|Overall Study|AE: pulmonary embolus|0|||
126750642|NCT00286156|456034206|FG001|Overall Study|AE: pulmonary embolus|1|||
126750643|NCT00286156|456034207|FG002|Overall Study|AE: pulmonary embolus|0|||
126750644|NCT00286156|456034205|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
126750645|NCT00286156|456034206|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
126750646|NCT00286156|456034207|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
126750647|NCT00286156|456034205|FG000|Overall Study|AE: pneumonia|1|||
126750648|NCT00286156|456034206|FG001|Overall Study|AE: pneumonia|0|||
126750649|NCT00286156|456034207|FG002|Overall Study|AE: pneumonia|0|||
126750650|NCT02449915|456034211|FG000|Overall Study|Exclusion criteria - drug use|1|||
126750651|NCT02449915|456034212|FG001|Overall Study|Exclusion criteria - drug use|0|||
126750652|NCT02449915|456034211|FG000|Overall Study|Withdrawal by Subject|0|||
126750653|NCT02449915|456034212|FG001|Overall Study|Withdrawal by Subject|2|||
126750654|NCT02449915|456034211|FG000|Overall Study|Intraoperative surgical findings|1|||
126750655|NCT02449915|456034212|FG001|Overall Study|Intraoperative surgical findings|1|||
126750656|NCT02449915|456034211|FG000|Overall Study|Abnormal preop lab|0|||
126750657|NCT02449915|456034212|FG001|Overall Study|Abnormal preop lab|1|||
126750658|NCT01855919|456035807|FG000|Overall Study|Adverse Event|16|||
126750659|NCT01855919|456035808|FG001|Overall Study|Adverse Event|8|||
126750660|NCT01855919|456035807|FG000|Overall Study|Lack of Efficacy|1|||
126750661|NCT01855919|456035808|FG001|Overall Study|Lack of Efficacy|3|||
126750662|NCT01855919|456035807|FG000|Overall Study|Withdrawal by Subject|4|||
126750663|NCT01855919|456035808|FG001|Overall Study|Withdrawal by Subject|10|||
126750664|NCT01855919|456035807|FG000|Overall Study|Entry Criteria Not Met|1|||
126750665|NCT01855919|456035808|FG001|Overall Study|Entry Criteria Not Met|1|||
126750666|NCT01855919|456035807|FG000|Overall Study|Protocol Violation|1|||
126750667|NCT01855919|456035808|FG001|Overall Study|Protocol Violation|4|||
126750668|NCT04459416|456035809|FG000|Overall Study|Lost to Follow-up|2|||
126750669|NCT04459416|456035810|FG001|Overall Study|Lost to Follow-up|0|||
126750670|NCT04459416|456035809|FG000|Overall Study|Withdrawal by Subject|8|||
126750671|NCT04459416|456035810|FG001|Overall Study|Withdrawal by Subject|10|||
126750672|NCT04459416|456035809|FG000|Overall Study|Disease progression|0|||
126750673|NCT04459416|456035810|FG001|Overall Study|Disease progression|3|||
126750674|NCT03455530|456035811|FG000|Overall Study|Withdrawal by Subject|9|||
126750675|NCT03455530|456035812|FG001|Overall Study|Withdrawal by Subject|1|||
126750676|NCT03455530|456035813|FG002|Overall Study|Withdrawal by Subject|3|||
126750677|NCT03455530|456035814|FG003|Overall Study|Withdrawal by Subject|3|||
126750678|NCT01592773|456035815|FG000|Overall Study|Study Terminated by Sponsor|582|||
126750679|NCT01592773|456035815|FG000|Overall Study|Withdrawal by Subject|35|||
126750680|NCT01592773|456035815|FG000|Overall Study|Lost to Follow-up|19|||
126750681|NCT01592773|456035815|FG000|Overall Study|Adverse Event|17|||
126750682|NCT01592773|456035815|FG000|Overall Study|Lack of Efficacy|9|||
126750683|NCT01592773|456035815|FG000|Overall Study|Protocol Violation|2|||
126750684|NCT01592773|456035815|FG000|Overall Study|Inclusion/exclusion not meet|1|||
126750685|NCT01592773|456035815|FG000|Overall Study|Other Reason|1|||
126750686|NCT00740116|456035819|FG000|Overall Study|Withdrawal by Subject|1|||
126750687|NCT00740116|456035820|FG001|Overall Study|Withdrawal by Subject|1|||
126750688|NCT00740116|456035819|FG000|Overall Study|Protocol Violation|1|||
126750689|NCT00740116|456035820|FG001|Overall Study|Protocol Violation|4|||
126750690|NCT03037489|456035821|FG000|Overall Study|Adverse Event|4|||
126750691|NCT03037489|456035822|FG001|Overall Study|Adverse Event|0|||
126750692|NCT03037489|456035821|FG000|Overall Study|Withdrawal by Subject|3|||
126750693|NCT03037489|456035822|FG001|Overall Study|Withdrawal by Subject|0|||
126750694|NCT00121485|456035823|FG000|Overall Study|Not implanted|1|||
126750695|NCT00121485|456035824|FG001|Overall Study|Not implanted|5|||
126750696|NCT00121485|456035823|FG000|Overall Study|Crossover|0|||
126750697|NCT00121485|456035824|FG001|Overall Study|Crossover|2|||
126750698|NCT00724243|456035827|FG000|Overall Study|Lack of Efficacy|10|||
126750699|NCT00724243|456035827|FG000|Overall Study|Adverse Event|5|||
126750700|NCT03031327|456035828|FG000|Overall Study|Withdrawal by Subject|0|||
126750701|NCT03031327|456035829|FG001|Overall Study|Withdrawal by Subject|1|||
126750702|NCT03031327|456035830|FG002|Overall Study|Withdrawal by Subject|1|||
126750703|NCT01004861|456035831|FG000|Overall Study|Disease progression|3|||
126750704|NCT01004861|456035832|FG001|Overall Study|Disease progression|4|||
126750705|NCT01004861|456035833|FG002|Overall Study|Disease progression|5|||
126750706|NCT01004861|456035834|FG003|Overall Study|Disease progression|4|||
126750707|NCT01004861|456035835|FG004|Overall Study|Disease progression|4|||
126750708|NCT01004861|456035836|FG005|Overall Study|Disease progression|4|||
126750709|NCT01004861|456035837|FG006|Overall Study|Disease progression|5|||
126750710|NCT01004861|456035838|FG007|Overall Study|Disease progression|1|||
126750711|NCT01004861|456035839|FG008|Overall Study|Disease progression|4|||
126750712|NCT01004861|456035840|FG009|Overall Study|Disease progression|7|||
126750713|NCT01004861|456035841|FG010|Overall Study|Disease progression|6|||
126750714|NCT01004861|456035842|FG011|Overall Study|Disease progression|3|||
126750715|NCT01004861|456035843|FG012|Overall Study|Disease progression|8|||
126750716|NCT01004861|456035831|FG000|Overall Study|Physician Decision|0|||
126750717|NCT01004861|456035832|FG001|Overall Study|Physician Decision|2|||
126750718|NCT01004861|456035833|FG002|Overall Study|Physician Decision|1|||
126750719|NCT01004861|456035834|FG003|Overall Study|Physician Decision|1|||
126750720|NCT01004861|456035835|FG004|Overall Study|Physician Decision|1|||
126750721|NCT01004861|456035836|FG005|Overall Study|Physician Decision|0|||
126750722|NCT01004861|456035837|FG006|Overall Study|Physician Decision|0|||
126750723|NCT01004861|456035838|FG007|Overall Study|Physician Decision|1|||
126750724|NCT01004861|456035839|FG008|Overall Study|Physician Decision|0|||
126750725|NCT01004861|456035840|FG009|Overall Study|Physician Decision|0|||
126750726|NCT01004861|456035841|FG010|Overall Study|Physician Decision|0|||
126750727|NCT01004861|456035842|FG011|Overall Study|Physician Decision|0|||
126750728|NCT01004861|456035843|FG012|Overall Study|Physician Decision|3|||
126750729|NCT01004861|456035831|FG000|Overall Study|Adverse Event|0|||
126750730|NCT01004861|456035832|FG001|Overall Study|Adverse Event|0|||
126750731|NCT01004861|456035833|FG002|Overall Study|Adverse Event|0|||
126750732|NCT01004861|456035834|FG003|Overall Study|Adverse Event|1|||
126750733|NCT01004861|456035835|FG004|Overall Study|Adverse Event|0|||
126750734|NCT01004861|456035836|FG005|Overall Study|Adverse Event|2|||
126750735|NCT01004861|456035837|FG006|Overall Study|Adverse Event|1|||
126750736|NCT01004861|456035838|FG007|Overall Study|Adverse Event|1|||
126750737|NCT01004861|456035839|FG008|Overall Study|Adverse Event|13|||
126782551|NCT00602030|456158214|FG004|Crossover Phase|Adverse Event|3|||
126782552|NCT00602030|456158210|FG000|Crossover Phase|Consent withdrawal|0|||
126782553|NCT00602030|456158211|FG001|Crossover Phase|Consent withdrawal|0|||
126782554|NCT00602030|456158212|FG002|Crossover Phase|Consent withdrawal|0|||
126750738|NCT01004861|456035840|FG009|Overall Study|Adverse Event|1|||
126750739|NCT01004861|456035841|FG010|Overall Study|Adverse Event|1|||
126750740|NCT01004861|456035842|FG011|Overall Study|Adverse Event|0|||
126750741|NCT01004861|456035843|FG012|Overall Study|Adverse Event|2|||
126750742|NCT01004861|456035831|FG000|Overall Study|Protocol Violation|0|||
126750743|NCT01004861|456035832|FG001|Overall Study|Protocol Violation|0|||
126750744|NCT01004861|456035833|FG002|Overall Study|Protocol Violation|0|||
126750745|NCT01004861|456035834|FG003|Overall Study|Protocol Violation|0|||
126750746|NCT01004861|456035835|FG004|Overall Study|Protocol Violation|1|||
126750747|NCT01004861|456035836|FG005|Overall Study|Protocol Violation|0|||
126750748|NCT01004861|456035837|FG006|Overall Study|Protocol Violation|0|||
126750749|NCT01004861|456035838|FG007|Overall Study|Protocol Violation|0|||
126750750|NCT01004861|456035839|FG008|Overall Study|Protocol Violation|0|||
126750751|NCT01004861|456035840|FG009|Overall Study|Protocol Violation|0|||
126782555|NCT00602030|456158213|FG003|Crossover Phase|Consent withdrawal|0|||
126622728|NCT00296504|455575956|FG006|Interim Analysis|Insufficient CD4 Response|0|||
126622729|NCT00296504|455575957|FG007|Interim Analysis|Insufficient CD4 Response|0|||
126622730|NCT00296504|455575958|FG008|Interim Analysis|Insufficient CD4 Response|0|||
126622731|NCT00296504|455575950|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
126622732|NCT00296504|455575951|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
126622733|NCT00296504|455575952|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
126622734|NCT00296504|455575953|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
126622735|NCT00296504|455575954|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
126622736|NCT00296504|455575955|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
126622737|NCT00296504|455575956|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
126622738|NCT00296504|455575957|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
126622739|NCT00296504|455575958|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
126622740|NCT00296504|455575950|FG000|Interim Analysis|Pregnancy|4|||
126622741|NCT00296504|455575951|FG001|Interim Analysis|Pregnancy|1|||
126622742|NCT00296504|455575952|FG002|Interim Analysis|Pregnancy|4|||
126622743|NCT00296504|455575953|FG003|Interim Analysis|Pregnancy|2|||
126622744|NCT00296504|455575954|FG004|Interim Analysis|Pregnancy|0|||
126622745|NCT00296504|455575955|FG005|Interim Analysis|Pregnancy|1|||
126622746|NCT00296504|455575956|FG006|Interim Analysis|Pregnancy|1|||
126622747|NCT00296504|455575957|FG007|Interim Analysis|Pregnancy|1|||
126622748|NCT00296504|455575958|FG008|Interim Analysis|Pregnancy|0|||
126622749|NCT00296504|455575950|FG000|Interim Analysis|Death|1|||
126622750|NCT00296504|455575951|FG001|Interim Analysis|Death|0|||
126622751|NCT00296504|455575952|FG002|Interim Analysis|Death|3|||
126622752|NCT00296504|455575953|FG003|Interim Analysis|Death|0|||
126622753|NCT00296504|455575954|FG004|Interim Analysis|Death|0|||
126622754|NCT00296504|455575955|FG005|Interim Analysis|Death|0|||
126622755|NCT00296504|455575956|FG006|Interim Analysis|Death|0|||
126622756|NCT00296504|455575957|FG007|Interim Analysis|Death|0|||
126622757|NCT00296504|455575958|FG008|Interim Analysis|Death|0|||
126622758|NCT00296504|455575950|FG000|Interim Analysis|Participant Non-compliant|0|||
126622759|NCT00296504|455575951|FG001|Interim Analysis|Participant Non-compliant|1|||
126622760|NCT00296504|455575952|FG002|Interim Analysis|Participant Non-compliant|2|||
126622761|NCT00296504|455575953|FG003|Interim Analysis|Participant Non-compliant|1|||
126622762|NCT00296504|455575954|FG004|Interim Analysis|Participant Non-compliant|1|||
126622763|NCT00296504|455575955|FG005|Interim Analysis|Participant Non-compliant|3|||
126622764|NCT00296504|455575956|FG006|Interim Analysis|Participant Non-compliant|6|||
126622765|NCT00296504|455575957|FG007|Interim Analysis|Participant Non-compliant|2|||
126622766|NCT00296504|455575958|FG008|Interim Analysis|Participant Non-compliant|0|||
126622767|NCT00296504|455575950|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126622768|NCT00296504|455575951|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126622769|NCT00296504|455575952|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
126622770|NCT00296504|455575953|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126622771|NCT00296504|455575954|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126622772|NCT00296504|455575955|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
126622773|NCT00296504|455575956|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126622774|NCT00296504|455575957|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126622775|NCT00296504|455575958|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
126622776|NCT00296504|455575950|FG000|Interim Analysis|To Simplify Treatment|0|||
126622777|NCT00296504|455575951|FG001|Interim Analysis|To Simplify Treatment|0|||
126622778|NCT00296504|455575952|FG002|Interim Analysis|To Simplify Treatment|1|||
126622779|NCT00296504|455575953|FG003|Interim Analysis|To Simplify Treatment|0|||
126622780|NCT00296504|455575954|FG004|Interim Analysis|To Simplify Treatment|0|||
126622781|NCT00296504|455575955|FG005|Interim Analysis|To Simplify Treatment|0|||
126622782|NCT00296504|455575956|FG006|Interim Analysis|To Simplify Treatment|2|||
126622783|NCT00296504|455575957|FG007|Interim Analysis|To Simplify Treatment|0|||
126622784|NCT00296504|455575958|FG008|Interim Analysis|To Simplify Treatment|0|||
126622785|NCT00296504|455575950|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
126622786|NCT00296504|455575951|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
126622787|NCT00296504|455575952|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
126622788|NCT00296504|455575953|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
126622789|NCT00296504|455575954|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
126622790|NCT00296504|455575955|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
126622791|NCT00296504|455575956|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
126622792|NCT00296504|455575957|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
126622793|NCT00296504|455575958|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
126622794|NCT00296504|455575950|FG000|Interim Analysis|Participant Moved|1|||
126622795|NCT00296504|455575951|FG001|Interim Analysis|Participant Moved|0|||
126622796|NCT00296504|455575952|FG002|Interim Analysis|Participant Moved|1|||
126622797|NCT00296504|455575953|FG003|Interim Analysis|Participant Moved|0|||
126622798|NCT00296504|455575954|FG004|Interim Analysis|Participant Moved|0|||
126622799|NCT00296504|455575955|FG005|Interim Analysis|Participant Moved|1|||
126750752|NCT01004861|456035841|FG010|Overall Study|Protocol Violation|0|||
126750753|NCT01004861|456035842|FG011|Overall Study|Protocol Violation|0|||
126750754|NCT01004861|456035843|FG012|Overall Study|Protocol Violation|0|||
126750755|NCT01004861|456035831|FG000|Overall Study|Lost to Follow-up|0|||
126750756|NCT01004861|456035832|FG001|Overall Study|Lost to Follow-up|0|||
126750757|NCT01004861|456035833|FG002|Overall Study|Lost to Follow-up|0|||
126750758|NCT01004861|456035834|FG003|Overall Study|Lost to Follow-up|0|||
126750759|NCT01004861|456035835|FG004|Overall Study|Lost to Follow-up|0|||
126750760|NCT01004861|456035836|FG005|Overall Study|Lost to Follow-up|0|||
126750761|NCT01004861|456035837|FG006|Overall Study|Lost to Follow-up|0|||
126750762|NCT01004861|456035838|FG007|Overall Study|Lost to Follow-up|1|||
126750763|NCT01004861|456035839|FG008|Overall Study|Lost to Follow-up|3|||
126750764|NCT01004861|456035840|FG009|Overall Study|Lost to Follow-up|0|||
126750765|NCT01004861|456035841|FG010|Overall Study|Lost to Follow-up|0|||
126750766|NCT01004861|456035842|FG011|Overall Study|Lost to Follow-up|1|||
126750767|NCT01004861|456035843|FG012|Overall Study|Lost to Follow-up|0|||
126750768|NCT01004861|456035831|FG000|Overall Study|Non-compliance|0|||
126750769|NCT01004861|456035832|FG001|Overall Study|Non-compliance|0|||
126750770|NCT01004861|456035833|FG002|Overall Study|Non-compliance|0|||
126750771|NCT01004861|456035834|FG003|Overall Study|Non-compliance|0|||
126750772|NCT01004861|456035835|FG004|Overall Study|Non-compliance|0|||
126750773|NCT01004861|456035836|FG005|Overall Study|Non-compliance|0|||
126750774|NCT01004861|456035837|FG006|Overall Study|Non-compliance|0|||
126750775|NCT01004861|456035838|FG007|Overall Study|Non-compliance|0|||
126750776|NCT01004861|456035839|FG008|Overall Study|Non-compliance|5|||
126750777|NCT01004861|456035840|FG009|Overall Study|Non-compliance|0|||
126750778|NCT01004861|456035841|FG010|Overall Study|Non-compliance|0|||
126750779|NCT01004861|456035842|FG011|Overall Study|Non-compliance|0|||
126750780|NCT01004861|456035843|FG012|Overall Study|Non-compliance|1|||
126750781|NCT01004861|456035831|FG000|Overall Study|Other|0|||
126750782|NCT01004861|456035832|FG001|Overall Study|Other|0|||
126750783|NCT01004861|456035833|FG002|Overall Study|Other|0|||
126750784|NCT01004861|456035834|FG003|Overall Study|Other|0|||
126750785|NCT01004861|456035835|FG004|Overall Study|Other|0|||
126750786|NCT01004861|456035836|FG005|Overall Study|Other|0|||
126750787|NCT01004861|456035837|FG006|Overall Study|Other|0|||
126750788|NCT01004861|456035838|FG007|Overall Study|Other|0|||
126750789|NCT01004861|456035839|FG008|Overall Study|Other|0|||
126750790|NCT01004861|456035840|FG009|Overall Study|Other|2|||
126750791|NCT01004861|456035841|FG010|Overall Study|Other|1|||
126750792|NCT01004861|456035842|FG011|Overall Study|Other|2|||
126750793|NCT01004861|456035843|FG012|Overall Study|Other|3|||
126750794|NCT01004861|456035831|FG000|Overall Study|Patient decision|0|||
126750795|NCT01004861|456035832|FG001|Overall Study|Patient decision|0|||
126750796|NCT01004861|456035833|FG002|Overall Study|Patient decision|0|||
126750797|NCT01004861|456035834|FG003|Overall Study|Patient decision|0|||
126750798|NCT01004861|456035835|FG004|Overall Study|Patient decision|1|||
126750799|NCT01004861|456035836|FG005|Overall Study|Patient decision|0|||
126750800|NCT01004861|456035837|FG006|Overall Study|Patient decision|1|||
126750801|NCT01004861|456035838|FG007|Overall Study|Patient decision|0|||
126750802|NCT01004861|456035839|FG008|Overall Study|Patient decision|7|||
126750803|NCT01004861|456035840|FG009|Overall Study|Patient decision|1|||
126750804|NCT01004861|456035841|FG010|Overall Study|Patient decision|1|||
126750805|NCT01004861|456035842|FG011|Overall Study|Patient decision|2|||
126750806|NCT01004861|456035843|FG012|Overall Study|Patient decision|3|||
126750807|NCT01004861|456035831|FG000|Overall Study|Transitioned to Phase 4 study|0|||
126750808|NCT01004861|456035832|FG001|Overall Study|Transitioned to Phase 4 study|0|||
126750809|NCT01004861|456035833|FG002|Overall Study|Transitioned to Phase 4 study|0|||
126750810|NCT01004861|456035834|FG003|Overall Study|Transitioned to Phase 4 study|0|||
126750811|NCT01004861|456035835|FG004|Overall Study|Transitioned to Phase 4 study|0|||
126782556|NCT00602030|456158214|FG004|Crossover Phase|Consent withdrawal|2|||
126782557|NCT02649231|456158237|FG000|Overall Study|Adverse Event|0|||
126782558|NCT02649231|456158238|FG001|Overall Study|Adverse Event|0|||
126782559|NCT02649231|456158239|FG002|Overall Study|Adverse Event|0|||
126782560|NCT02649231|456158240|FG003|Overall Study|Adverse Event|1|||
126782561|NCT02649231|456158237|FG000|Overall Study|Lost to Follow-up|2|||
126782562|NCT02649231|456158238|FG001|Overall Study|Lost to Follow-up|1|||
126750812|NCT01004861|456035836|FG005|Overall Study|Transitioned to Phase 4 study|0|||
126750813|NCT01004861|456035837|FG006|Overall Study|Transitioned to Phase 4 study|0|||
126750814|NCT01004861|456035838|FG007|Overall Study|Transitioned to Phase 4 study|0|||
126750815|NCT01004861|456035839|FG008|Overall Study|Transitioned to Phase 4 study|2|||
126750816|NCT01004861|456035840|FG009|Overall Study|Transitioned to Phase 4 study|0|||
126750817|NCT01004861|456035841|FG010|Overall Study|Transitioned to Phase 4 study|0|||
126750818|NCT01004861|456035842|FG011|Overall Study|Transitioned to Phase 4 study|0|||
126750819|NCT01004861|456035843|FG012|Overall Study|Transitioned to Phase 4 study|0|||
126750820|NCT01004861|456035831|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126750821|NCT01004861|456035832|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126750822|NCT01004861|456035833|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126750823|NCT01004861|456035834|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126750824|NCT01004861|456035835|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126750825|NCT01004861|456035836|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126750826|NCT01004861|456035837|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126750827|NCT01004861|456035838|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126750828|NCT01004861|456035839|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
126750829|NCT01004861|456035840|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126750830|NCT01004861|456035841|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126750831|NCT01004861|456035842|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126750832|NCT01004861|456035843|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
126750833|NCT01004861|456035831|FG000|Overall Study|Patient withdrew|0|||
126750834|NCT01004861|456035832|FG001|Overall Study|Patient withdrew|0|||
126750835|NCT01004861|456035833|FG002|Overall Study|Patient withdrew|0|||
126750836|NCT01004861|456035834|FG003|Overall Study|Patient withdrew|0|||
126750837|NCT01004861|456035835|FG004|Overall Study|Patient withdrew|0|||
126750838|NCT01004861|456035836|FG005|Overall Study|Patient withdrew|0|||
126750839|NCT01004861|456035837|FG006|Overall Study|Patient withdrew|0|||
126750840|NCT01004861|456035838|FG007|Overall Study|Patient withdrew|0|||
126750841|NCT01004861|456035839|FG008|Overall Study|Patient withdrew|1|||
126750842|NCT01004861|456035840|FG009|Overall Study|Patient withdrew|0|||
126750843|NCT01004861|456035841|FG010|Overall Study|Patient withdrew|0|||
126750844|NCT01004861|456035842|FG011|Overall Study|Patient withdrew|0|||
126750845|NCT01004861|456035843|FG012|Overall Study|Patient withdrew|0|||
126750846|NCT01004861|456035831|FG000|Overall Study|Surgical resection|0|||
126750847|NCT01004861|456035832|FG001|Overall Study|Surgical resection|0|||
126750848|NCT01004861|456035833|FG002|Overall Study|Surgical resection|0|||
126750849|NCT01004861|456035834|FG003|Overall Study|Surgical resection|0|||
126622800|NCT00296504|455575956|FG006|Interim Analysis|Participant Moved|1|||
126622801|NCT00296504|455575957|FG007|Interim Analysis|Participant Moved|0|||
126622802|NCT00296504|455575958|FG008|Interim Analysis|Participant Moved|0|||
126622803|NCT00296504|455575950|FG000|Interim Analysis|Participant Was Incarcerated|2|||
126622804|NCT00296504|455575951|FG001|Interim Analysis|Participant Was Incarcerated|0|||
126622805|NCT00296504|455575952|FG002|Interim Analysis|Participant Was Incarcerated|1|||
126622806|NCT00296504|455575953|FG003|Interim Analysis|Participant Was Incarcerated|0|||
126622807|NCT00296504|455575954|FG004|Interim Analysis|Participant Was Incarcerated|0|||
126622808|NCT00296504|455575955|FG005|Interim Analysis|Participant Was Incarcerated|0|||
126622809|NCT00296504|455575956|FG006|Interim Analysis|Participant Was Incarcerated|0|||
126622810|NCT00296504|455575957|FG007|Interim Analysis|Participant Was Incarcerated|0|||
126622811|NCT00296504|455575958|FG008|Interim Analysis|Participant Was Incarcerated|0|||
126750850|NCT01004861|456035835|FG004|Overall Study|Surgical resection|0|||
126750851|NCT01004861|456035836|FG005|Overall Study|Surgical resection|0|||
126750852|NCT01004861|456035837|FG006|Overall Study|Surgical resection|0|||
126750853|NCT01004861|456035838|FG007|Overall Study|Surgical resection|0|||
126750854|NCT01004861|456035839|FG008|Overall Study|Surgical resection|1|||
126750855|NCT01004861|456035840|FG009|Overall Study|Surgical resection|0|||
126750856|NCT01004861|456035841|FG010|Overall Study|Surgical resection|0|||
126750857|NCT01004861|456035842|FG011|Overall Study|Surgical resection|0|||
126750858|NCT01004861|456035843|FG012|Overall Study|Surgical resection|0|||
126750859|NCT01004861|456035831|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126750860|NCT01004861|456035832|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126750861|NCT01004861|456035833|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126750862|NCT01004861|456035834|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126750863|NCT01004861|456035835|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126750864|NCT01004861|456035836|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126750865|NCT01004861|456035837|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126750866|NCT01004861|456035838|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126750867|NCT01004861|456035839|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
126750868|NCT01004861|456035840|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126750869|NCT01004861|456035841|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126750870|NCT01004861|456035842|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126622812|NCT00296504|455575950|FG000|Interim Analysis|Resistance to FPV|0|||
126750871|NCT01004861|456035843|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
126750872|NCT01004861|456035831|FG000|Overall Study|Study termination by Sponsor|0|||
126750873|NCT01004861|456035832|FG001|Overall Study|Study termination by Sponsor|0|||
126622813|NCT00296504|455575951|FG001|Interim Analysis|Resistance to FPV|0|||
126622814|NCT00296504|455575952|FG002|Interim Analysis|Resistance to FPV|1|||
126750874|NCT01004861|456035833|FG002|Overall Study|Study termination by Sponsor|0|||
126750875|NCT01004861|456035834|FG003|Overall Study|Study termination by Sponsor|0|||
126750876|NCT01004861|456035835|FG004|Overall Study|Study termination by Sponsor|0|||
126750877|NCT01004861|456035836|FG005|Overall Study|Study termination by Sponsor|0|||
126750878|NCT01004861|456035837|FG006|Overall Study|Study termination by Sponsor|0|||
126750879|NCT01004861|456035838|FG007|Overall Study|Study termination by Sponsor|0|||
126750880|NCT01004861|456035839|FG008|Overall Study|Study termination by Sponsor|1|||
126750881|NCT01004861|456035840|FG009|Overall Study|Study termination by Sponsor|0|||
126750882|NCT01004861|456035841|FG010|Overall Study|Study termination by Sponsor|0|||
126750883|NCT01004861|456035842|FG011|Overall Study|Study termination by Sponsor|0|||
126750884|NCT01004861|456035843|FG012|Overall Study|Study termination by Sponsor|0|||
126750885|NCT00686699|456035844|FG000|Treatment Period 1|Adverse Event|0|||
126750886|NCT00686699|456035845|FG001|Treatment Period 1|Adverse Event|2|||
126750887|NCT04657003|456035870|FG000|Overall Study|Adverse Event|5|||
126750888|NCT04657003|456035871|FG001|Overall Study|Adverse Event|1|||
126750889|NCT04657003|456035872|FG002|Overall Study|Adverse Event|5|||
126750890|NCT04657003|456035870|FG000|Overall Study|Death|0|||
126750891|NCT04657003|456035871|FG001|Overall Study|Death|2|||
126750892|NCT04657003|456035872|FG002|Overall Study|Death|0|||
126750893|NCT04657003|456035870|FG000|Overall Study|Lost to Follow-up|8|||
126750894|NCT04657003|456035871|FG001|Overall Study|Lost to Follow-up|4|||
126750895|NCT04657003|456035872|FG002|Overall Study|Lost to Follow-up|10|||
126750896|NCT04657003|456035870|FG000|Overall Study|Other - As Reported by Investigator|3|||
126750897|NCT04657003|456035871|FG001|Overall Study|Other - As Reported by Investigator|2|||
126750898|NCT04657003|456035872|FG002|Overall Study|Other - As Reported by Investigator|2|||
126750899|NCT04657003|456035870|FG000|Overall Study|Pregnancy|2|||
126750900|NCT04657003|456035871|FG001|Overall Study|Pregnancy|0|||
126750901|NCT04657003|456035872|FG002|Overall Study|Pregnancy|2|||
126750902|NCT04657003|456035870|FG000|Overall Study|Withdrawal by Subject|16|||
126750903|NCT04657003|456035871|FG001|Overall Study|Withdrawal by Subject|7|||
126750904|NCT04657003|456035872|FG002|Overall Study|Withdrawal by Subject|10|||
126750905|NCT01736176|456035873|FG000|Overall Study|Adverse Event|3|||
126750906|NCT01736176|456035873|FG000|Overall Study|Withdrawal by Subject|4|||
126750907|NCT01736176|456035873|FG000|Overall Study|Lack of Efficacy|3|||
126750908|NCT01736176|456035873|FG000|Overall Study|Unable to Complete PEG Placement|1|||
126750909|NCT00934791|456035874|FG000|Overall Study|Withdrawal by Subject|1|||
126750910|NCT00934791|456035875|FG001|Overall Study|Withdrawal by Subject|0|||
126750911|NCT02646891|456035877|FG000|Overall Study|Adverse Event|0|||
126750912|NCT02646891|456035878|FG001|Overall Study|Adverse Event|1|||
126750913|NCT02646891|456035879|FG002|Overall Study|Adverse Event|0|||
126750914|NCT02646891|456035880|FG003|Overall Study|Adverse Event|0|||
126750915|NCT02646891|456035881|FG004|Overall Study|Adverse Event|0|||
126750916|NCT02646891|456035882|FG005|Overall Study|Adverse Event|0|||
126750917|NCT02646891|456035883|FG006|Overall Study|Adverse Event|0|||
126750918|NCT02646891|456035884|FG007|Overall Study|Adverse Event|0|||
126750919|NCT02646891|456035885|FG008|Overall Study|Adverse Event|0|||
126750920|NCT02646891|456035886|FG009|Overall Study|Adverse Event|0|||
126750921|NCT02646891|456035877|FG000|Overall Study|Lost to Follow-up|0|||
126750922|NCT02646891|456035878|FG001|Overall Study|Lost to Follow-up|0|||
126750923|NCT02646891|456035879|FG002|Overall Study|Lost to Follow-up|0|||
126750924|NCT02646891|456035880|FG003|Overall Study|Lost to Follow-up|0|||
126750925|NCT02646891|456035881|FG004|Overall Study|Lost to Follow-up|0|||
126750926|NCT02646891|456035882|FG005|Overall Study|Lost to Follow-up|0|||
126750927|NCT02646891|456035883|FG006|Overall Study|Lost to Follow-up|2|||
126750928|NCT02646891|456035884|FG007|Overall Study|Lost to Follow-up|2|||
126750929|NCT02646891|456035885|FG008|Overall Study|Lost to Follow-up|2|||
126750930|NCT02646891|456035886|FG009|Overall Study|Lost to Follow-up|2|||
126750931|NCT02646891|456035877|FG000|Overall Study|Protocol Violation|0|||
126750932|NCT02646891|456035878|FG001|Overall Study|Protocol Violation|0|||
126750933|NCT02646891|456035879|FG002|Overall Study|Protocol Violation|0|||
126750934|NCT02646891|456035880|FG003|Overall Study|Protocol Violation|0|||
126750935|NCT02646891|456035881|FG004|Overall Study|Protocol Violation|0|||
126750936|NCT02646891|456035882|FG005|Overall Study|Protocol Violation|0|||
126750937|NCT02646891|456035883|FG006|Overall Study|Protocol Violation|1|||
126750938|NCT02646891|456035884|FG007|Overall Study|Protocol Violation|1|||
126750939|NCT02646891|456035885|FG008|Overall Study|Protocol Violation|0|||
126750940|NCT02646891|456035886|FG009|Overall Study|Protocol Violation|0|||
126750941|NCT02646891|456035877|FG000|Overall Study|Withdrawal by Subject|2|||
126750942|NCT02646891|456035878|FG001|Overall Study|Withdrawal by Subject|0|||
126750943|NCT02646891|456035879|FG002|Overall Study|Withdrawal by Subject|1|||
126750944|NCT02646891|456035880|FG003|Overall Study|Withdrawal by Subject|0|||
126750945|NCT02646891|456035881|FG004|Overall Study|Withdrawal by Subject|0|||
126750946|NCT02646891|456035882|FG005|Overall Study|Withdrawal by Subject|0|||
126750947|NCT02646891|456035883|FG006|Overall Study|Withdrawal by Subject|5|||
126750948|NCT02646891|456035884|FG007|Overall Study|Withdrawal by Subject|9|||
126750949|NCT02646891|456035885|FG008|Overall Study|Withdrawal by Subject|7|||
126750950|NCT02646891|456035886|FG009|Overall Study|Withdrawal by Subject|3|||
126750951|NCT02646891|456035877|FG000|Overall Study|Death|0|||
126750952|NCT02646891|456035878|FG001|Overall Study|Death|0|||
126750953|NCT02646891|456035879|FG002|Overall Study|Death|0|||
126750954|NCT02646891|456035880|FG003|Overall Study|Death|0|||
126750955|NCT02646891|456035881|FG004|Overall Study|Death|0|||
126750956|NCT02646891|456035882|FG005|Overall Study|Death|0|||
126750957|NCT02646891|456035883|FG006|Overall Study|Death|1|||
126750958|NCT02646891|456035884|FG007|Overall Study|Death|1|||
126750959|NCT02646891|456035885|FG008|Overall Study|Death|1|||
126750960|NCT02646891|456035886|FG009|Overall Study|Death|0|||
126750961|NCT02607865|456035891|FG000|Overall Study|Lost to Follow-up|9|||
126750962|NCT02607865|456035892|FG001|Overall Study|Lost to Follow-up|7|||
126750963|NCT02607865|456035893|FG002|Overall Study|Lost to Follow-up|7|||
126750964|NCT02607865|456035894|FG003|Overall Study|Lost to Follow-up|5|||
126750965|NCT02607865|456035891|FG000|Overall Study|Withdrawal by Subject|18|||
126750966|NCT02607865|456035892|FG001|Overall Study|Withdrawal by Subject|18|||
126750967|NCT02607865|456035893|FG002|Overall Study|Withdrawal by Subject|17|||
126750968|NCT02607865|456035894|FG003|Overall Study|Withdrawal by Subject|8|||
126750969|NCT02607865|456035891|FG000|Overall Study|Death|5|||
126750970|NCT02607865|456035892|FG001|Overall Study|Death|4|||
126750971|NCT02607865|456035893|FG002|Overall Study|Death|1|||
126750972|NCT02607865|456035894|FG003|Overall Study|Death|3|||
126750973|NCT02607865|456035891|FG000|Overall Study|Unclassified|1|||
126750974|NCT02607865|456035892|FG001|Overall Study|Unclassified|1|||
126750975|NCT02607865|456035893|FG002|Overall Study|Unclassified|2|||
126750976|NCT02607865|456035894|FG003|Overall Study|Unclassified|0|||
126750977|NCT00528840|456035895|FG000|Overall Study|Lost to Follow-up|10|||
126750978|NCT00528840|456035895|FG000|Overall Study|Adverse Event|1|||
126750979|NCT00528840|456035895|FG000|Overall Study|Withdrawal by Subject|17|||
126750980|NCT00528840|456035895|FG000|Overall Study|Death|2|||
126750981|NCT00528840|456035895|FG000|Overall Study|Administrative Reasons|1|||
126750982|NCT00528840|456035895|FG000|Overall Study|Other|2|||
126750983|NCT01766401|456035900|FG000|Overall Study|Adverse Event|7|||
126750984|NCT01766401|456035901|FG001|Overall Study|Adverse Event|22|||
126750985|NCT01766401|456035900|FG000|Overall Study|Lack of Efficacy|1|||
126750986|NCT01766401|456035901|FG001|Overall Study|Lack of Efficacy|2|||
126750987|NCT01766401|456035900|FG000|Overall Study|Protocol Violation|3|||
126750988|NCT01766401|456035901|FG001|Overall Study|Protocol Violation|8|||
126750989|NCT01766401|456035900|FG000|Overall Study|Withdrawal by Subject|15|||
126750990|NCT01766401|456035901|FG001|Overall Study|Withdrawal by Subject|12|||
126750991|NCT01766401|456035900|FG000|Overall Study|Lost to Follow-up|10|||
126750992|NCT01766401|456035901|FG001|Overall Study|Lost to Follow-up|11|||
126750993|NCT01766401|456035900|FG000|Overall Study|Pregnancy|1|||
126750994|NCT01766401|456035901|FG001|Overall Study|Pregnancy|1|||
126750995|NCT00398086|456035905|FG000|Overall Study|Unacceptable Toxicity|2|||
126750996|NCT00398086|456035906|FG001|Overall Study|Unacceptable Toxicity|8|||
126750997|NCT00398086|456035907|FG002|Overall Study|Unacceptable Toxicity|2|||
126750998|NCT00398086|456035905|FG000|Overall Study|Adverse Event|1|||
126750999|NCT00398086|456035906|FG001|Overall Study|Adverse Event|4|||
126751000|NCT00398086|456035907|FG002|Overall Study|Adverse Event|0|||
126751001|NCT00398086|456035905|FG000|Overall Study|Physician Decision|1|||
126751002|NCT00398086|456035906|FG001|Overall Study|Physician Decision|4|||
126751003|NCT00398086|456035907|FG002|Overall Study|Physician Decision|0|||
126751004|NCT00398086|456035905|FG000|Overall Study|Withdrawal by Subject|5|||
126751005|NCT00398086|456035906|FG001|Overall Study|Withdrawal by Subject|7|||
126751006|NCT00398086|456035907|FG002|Overall Study|Withdrawal by Subject|0|||
126751007|NCT01950364|456035908|FG000|Overall Study|Adverse Event|3|||
126751008|NCT01950364|456035909|FG001|Overall Study|Adverse Event|0|||
126751009|NCT01950364|456035908|FG000|Overall Study|Stem Cell Transplant|2|||
126782563|NCT02649231|456158239|FG002|Overall Study|Lost to Follow-up|1|||
126782564|NCT02649231|456158240|FG003|Overall Study|Lost to Follow-up|0|||
126782565|NCT02649231|456158237|FG000|Overall Study|Withdrawal by Subject|0|||
126782566|NCT02649231|456158238|FG001|Overall Study|Withdrawal by Subject|1|||
126782567|NCT02649231|456158239|FG002|Overall Study|Withdrawal by Subject|0|||
126751010|NCT01950364|456035909|FG001|Overall Study|Stem Cell Transplant|6|||
126751011|NCT01950364|456035908|FG000|Overall Study|Disease Progression|5|||
126751012|NCT01950364|456035909|FG001|Overall Study|Disease Progression|2|||
126751013|NCT01950364|456035908|FG000|Overall Study|Withdrawal by Subject|0|||
126751014|NCT01950364|456035909|FG001|Overall Study|Withdrawal by Subject|1|||
126782568|NCT02649231|456158240|FG003|Overall Study|Withdrawal by Subject|1|||
126782569|NCT02649231|456158237|FG000|Overall Study|Protocol Violation|2|||
126751015|NCT01950364|456035908|FG000|Overall Study|Protocol Violation|0|||
126751016|NCT01950364|456035909|FG001|Overall Study|Protocol Violation|1|||
126751017|NCT00998985|456035913|FG000|Overall Study|Withdrawal by Subject|0|||
126751018|NCT00998985|456035914|FG001|Overall Study|Withdrawal by Subject|0|||
126751019|NCT00998985|456035915|FG002|Overall Study|Withdrawal by Subject|0|||
126751020|NCT00998985|456035916|FG003|Overall Study|Withdrawal by Subject|0|||
126751021|NCT00998985|456035917|FG004|Overall Study|Withdrawal by Subject|0|||
126751022|NCT00998985|456035918|FG005|Overall Study|Withdrawal by Subject|0|||
126751023|NCT00998985|456035919|FG006|Overall Study|Withdrawal by Subject|0|||
126751024|NCT00998985|456035920|FG007|Overall Study|Withdrawal by Subject|0|||
126782570|NCT02649231|456158238|FG001|Overall Study|Protocol Violation|1|||
126782571|NCT02649231|456158239|FG002|Overall Study|Protocol Violation|1|||
126782572|NCT02649231|456158240|FG003|Overall Study|Protocol Violation|0|||
126782573|NCT00638157|456158241|FG000|Overall Study|Adverse Event|0|||
126782574|NCT00638157|456158242|FG001|Overall Study|Adverse Event|1|||
126782575|NCT00638157|456158241|FG000|Overall Study|Clinical (symptomatic) failure|1|||
126782576|NCT00638157|456158242|FG001|Overall Study|Clinical (symptomatic) failure|1|||
126782577|NCT00638157|456158241|FG000|Overall Study|Microbiological failure|1|||
126782578|NCT00638157|456158242|FG001|Overall Study|Microbiological failure|0|||
126782579|NCT00638157|456158241|FG000|Overall Study|Lost to Follow-up|1|||
126782580|NCT00638157|456158242|FG001|Overall Study|Lost to Follow-up|0|||
126782581|NCT00638157|456158241|FG000|Overall Study|Physician Decision|1|||
126782582|NCT00638157|456158242|FG001|Overall Study|Physician Decision|0|||
126782583|NCT00638157|456158241|FG000|Overall Study|Other|1|||
126782584|NCT00638157|456158242|FG001|Overall Study|Other|2|||
126782585|NCT00638157|456158241|FG000|Overall Study|Randomized, not treated|2|||
126782586|NCT00638157|456158242|FG001|Overall Study|Randomized, not treated|0|||
126782587|NCT05476679|456158243|FG000|Overall Study|Withdrawal by Subject|0|||
126782588|NCT05476679|456158244|FG001|Overall Study|Withdrawal by Subject|0|||
126782589|NCT05476679|456158245|FG002|Overall Study|Withdrawal by Subject|0|||
126782590|NCT05476679|456158246|FG003|Overall Study|Withdrawal by Subject|1|||
126782591|NCT05476679|456158247|FG004|Overall Study|Withdrawal by Subject|0|||
126782592|NCT05476679|456158243|FG000|Overall Study|Lost to Follow-up|0|||
126782593|NCT05476679|456158244|FG001|Overall Study|Lost to Follow-up|0|||
126782594|NCT05476679|456158245|FG002|Overall Study|Lost to Follow-up|0|||
126782595|NCT05476679|456158246|FG003|Overall Study|Lost to Follow-up|1|||
126782596|NCT05476679|456158247|FG004|Overall Study|Lost to Follow-up|0|||
126782597|NCT00319956|456158250|FG000|Overall Study|Death|20|||
126782598|NCT00319956|456158251|FG001|Overall Study|Death|24|||
126782599|NCT02607800|456158253|FG000|Overall Study|Lost to Follow-up|7|||
126782600|NCT02607800|456158254|FG001|Overall Study|Lost to Follow-up|10|||
126782601|NCT02607800|456158253|FG000|Overall Study|Withdrew Consent|2|||
126782602|NCT02607800|456158254|FG001|Overall Study|Withdrew Consent|0|||
126782603|NCT02607800|456158253|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
126782604|NCT02607800|456158254|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
126782605|NCT00753714|456158255|FG000|Overall Study|Lack of Efficacy|21|||
126782606|NCT00753714|456158256|FG001|Overall Study|Lack of Efficacy|34|||
126782607|NCT00753714|456158255|FG000|Overall Study|Adverse Event|26|||
126782608|NCT00753714|456158256|FG001|Overall Study|Adverse Event|18|||
126782609|NCT00753714|456158255|FG000|Overall Study|Protocol Violation|1|||
126782610|NCT00753714|456158256|FG001|Overall Study|Protocol Violation|0|||
126782611|NCT00753714|456158255|FG000|Overall Study|Lost to Follow-up|0|||
126782612|NCT00753714|456158256|FG001|Overall Study|Lost to Follow-up|1|||
126782613|NCT00753714|456158255|FG000|Overall Study|Withdrawal by Subject|2|||
126782614|NCT00753714|456158256|FG001|Overall Study|Withdrawal by Subject|1|||
126782615|NCT00753714|456158255|FG000|Overall Study|Death|3|||
126782616|NCT00753714|456158256|FG001|Overall Study|Death|3|||
126782617|NCT00753714|456158255|FG000|Overall Study|Other|7|||
126782618|NCT00753714|456158256|FG001|Overall Study|Other|5|||
126782619|NCT01185288|456158257|FG000|Overall Study|Adverse Event|7|||
126782620|NCT01185288|456158258|FG001|Overall Study|Adverse Event|6|||
126782621|NCT01185288|456158257|FG000|Overall Study|Withdrawal by Subject|6|||
126782622|NCT01185288|456158258|FG001|Overall Study|Withdrawal by Subject|4|||
126782623|NCT01185288|456158257|FG000|Overall Study|Lost to Follow-up|2|||
126782624|NCT01185288|456158258|FG001|Overall Study|Lost to Follow-up|5|||
126782625|NCT01185288|456158257|FG000|Overall Study|Lack of Efficacy|2|||
126782626|NCT01185288|456158258|FG001|Overall Study|Lack of Efficacy|0|||
126782627|NCT01185288|456158257|FG000|Overall Study|Investigator discretion|1|||
126782628|NCT01185288|456158258|FG001|Overall Study|Investigator discretion|0|||
126782629|NCT01185288|456158257|FG000|Overall Study|Did not meet inclusion criteria|1|||
126782630|NCT01185288|456158258|FG001|Overall Study|Did not meet inclusion criteria|0|||
126782631|NCT01185288|456158257|FG000|Overall Study|Noncompliance|0|||
126782632|NCT01185288|456158258|FG001|Overall Study|Noncompliance|1|||
126782633|NCT01626885|456158261|FG000|Overall Study|Adverse Event|8|||
126782634|NCT01626885|456158261|FG000|Overall Study|Withdrawal by Subject|4|||
126782635|NCT00673790|456158262|FG000|Overall Study|Adverse Event|23|||
126782636|NCT00673790|456158263|FG001|Overall Study|Adverse Event|14|||
126782637|NCT00673790|456158264|FG002|Overall Study|Adverse Event|2|||
126782638|NCT00673790|456158262|FG000|Overall Study|Lack of Efficacy|2|||
126782639|NCT00673790|456158263|FG001|Overall Study|Lack of Efficacy|2|||
126782640|NCT00673790|456158264|FG002|Overall Study|Lack of Efficacy|2|||
126782641|NCT00673790|456158262|FG000|Overall Study|Protocol Violation|6|||
126782642|NCT00673790|456158263|FG001|Overall Study|Protocol Violation|9|||
126782643|NCT00673790|456158264|FG002|Overall Study|Protocol Violation|1|||
126782644|NCT00673790|456158262|FG000|Overall Study|Withdrawal by Subject|7|||
126782645|NCT00673790|456158263|FG001|Overall Study|Withdrawal by Subject|4|||
126782646|NCT00673790|456158264|FG002|Overall Study|Withdrawal by Subject|1|||
126782647|NCT00673790|456158262|FG000|Overall Study|Lost to Follow-up|6|||
126782648|NCT00673790|456158263|FG001|Overall Study|Lost to Follow-up|6|||
126751025|NCT00998985|456035921|FG008|Overall Study|Withdrawal by Subject|1|||
126751026|NCT00998985|456035922|FG009|Overall Study|Withdrawal by Subject|0|||
126751027|NCT00998985|456035923|FG010|Overall Study|Withdrawal by Subject|0|||
126751028|NCT00998985|456035924|FG011|Overall Study|Withdrawal by Subject|0|||
126751029|NCT00998985|456035925|FG012|Overall Study|Withdrawal by Subject|0|||
126751030|NCT00998985|456035926|FG013|Overall Study|Withdrawal by Subject|0|||
126751031|NCT00998985|456035913|FG000|Overall Study|Protocol Violation|0|||
126751032|NCT00998985|456035914|FG001|Overall Study|Protocol Violation|0|||
126751033|NCT00998985|456035915|FG002|Overall Study|Protocol Violation|0|||
126751034|NCT00998985|456035916|FG003|Overall Study|Protocol Violation|0|||
126751035|NCT00998985|456035917|FG004|Overall Study|Protocol Violation|0|||
126751036|NCT00998985|456035918|FG005|Overall Study|Protocol Violation|1|||
126751037|NCT00998985|456035919|FG006|Overall Study|Protocol Violation|0|||
126751038|NCT00998985|456035920|FG007|Overall Study|Protocol Violation|0|||
126751039|NCT00998985|456035921|FG008|Overall Study|Protocol Violation|0|||
126751040|NCT00998985|456035922|FG009|Overall Study|Protocol Violation|0|||
126751041|NCT00998985|456035923|FG010|Overall Study|Protocol Violation|0|||
126751042|NCT00998985|456035924|FG011|Overall Study|Protocol Violation|0|||
126751043|NCT00998985|456035925|FG012|Overall Study|Protocol Violation|0|||
126751044|NCT00998985|456035926|FG013|Overall Study|Protocol Violation|0|||
126751045|NCT01040728|456035928|FG000|Overall Study|Adverse Event|4|||
126751046|NCT01040728|456035929|FG001|Overall Study|Adverse Event|8|||
126751047|NCT01040728|456035930|FG002|Overall Study|Adverse Event|0|||
126751048|NCT01040728|456035931|FG003|Overall Study|Adverse Event|4|||
126751049|NCT01040728|456035928|FG000|Overall Study|Withdrawal by Subject|0|||
126751050|NCT01040728|456035929|FG001|Overall Study|Withdrawal by Subject|1|||
126751051|NCT01040728|456035930|FG002|Overall Study|Withdrawal by Subject|1|||
126751052|NCT01040728|456035931|FG003|Overall Study|Withdrawal by Subject|0|||
126751053|NCT01040728|456035928|FG000|Overall Study|Protocol Violation|0|||
126751054|NCT01040728|456035929|FG001|Overall Study|Protocol Violation|0|||
126751055|NCT01040728|456035930|FG002|Overall Study|Protocol Violation|0|||
126751056|NCT01040728|456035931|FG003|Overall Study|Protocol Violation|1|||
126751057|NCT01040728|456035928|FG000|Overall Study|Lack of Efficacy|0|||
126751058|NCT01040728|456035929|FG001|Overall Study|Lack of Efficacy|1|||
126751059|NCT01040728|456035930|FG002|Overall Study|Lack of Efficacy|0|||
126751060|NCT01040728|456035931|FG003|Overall Study|Lack of Efficacy|1|||
126751061|NCT01040728|456035928|FG000|Overall Study|Other reasons not listed above|0|||
126751062|NCT01040728|456035929|FG001|Overall Study|Other reasons not listed above|1|||
126751063|NCT01040728|456035930|FG002|Overall Study|Other reasons not listed above|0|||
126751064|NCT01040728|456035931|FG003|Overall Study|Other reasons not listed above|0|||
126751065|NCT01875874|456035934|FG000|Overall Study|Death|3|||
126751066|NCT00590031|456035935|FG000|Overall Study|Adverse Event|3|||
126751067|NCT00590031|456035935|FG000|Overall Study|Withdrawal by Subject|1|||
126751068|NCT00590031|456035935|FG000|Overall Study|Metastatic Disease|1|||
126751069|NCT00590031|456035935|FG000|Overall Study|Admin Hold|1|||
126751070|NCT00826540|456035942|FG000|Overall Study|ineligible|3|||
126751071|NCT00826540|456035942|FG000|Overall Study|Withdrawal by Subject|1|||
126751072|NCT01166386|456035943|FG000|Overall Study|Withdrawal by Subject|3|||
126751073|NCT01166386|456035944|FG001|Overall Study|Withdrawal by Subject|5|||
126751074|NCT02178592|456035947|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
126751075|NCT02178592|456035948|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
126751076|NCT02178592|456035947|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
126751077|NCT02178592|456035948|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
126751078|NCT02178592|456035947|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
126751079|NCT02178592|456035948|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
126751080|NCT02178592|456035947|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
126751081|NCT02178592|456035948|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
126751082|NCT02178592|456035947|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
126751083|NCT02178592|456035948|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
126751084|NCT02178592|456035947|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
126751085|NCT02178592|456035948|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
126751086|NCT02178592|456035947|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
126751087|NCT02178592|456035948|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
126782649|NCT00673790|456158264|FG002|Overall Study|Lost to Follow-up|5|||
126751088|NCT02178592|456035947|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
126751089|NCT02178592|456035948|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
126751090|NCT02178592|456035947|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
126751091|NCT02178592|456035948|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
126751092|NCT02178592|456035947|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
126751093|NCT02178592|456035948|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
126751094|NCT02178592|456035947|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
126751095|NCT02178592|456035948|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
126751096|NCT02178592|456035947|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
126751097|NCT02178592|456035948|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
126751098|NCT02520141|456035951|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
126751099|NCT00703781|456035952|FG000|Overall Study|Withdrawal by Subject|1|||
126751100|NCT00703781|456035953|FG001|Overall Study|Withdrawal by Subject|2|||
126751101|NCT00703781|456035952|FG000|Overall Study|Cancelled surgery|1|||
126751102|NCT00703781|456035953|FG001|Overall Study|Cancelled surgery|0|||
126751103|NCT03452397|456035956|FG000|Overall Study|Adverse Event|1|||
126751104|NCT03452397|456035957|FG001|Overall Study|Adverse Event|0|||
126751105|NCT03452397|456035958|FG002|Overall Study|Adverse Event|0|||
126751106|NCT03452397|456035959|FG003|Overall Study|Adverse Event|0|||
126751107|NCT03452397|456035956|FG000|Overall Study|Administrative reason|0|||
126751108|NCT03452397|456035957|FG001|Overall Study|Administrative reason|0|||
126751109|NCT03452397|456035958|FG002|Overall Study|Administrative reason|1|||
126751110|NCT03452397|456035959|FG003|Overall Study|Administrative reason|1|||
126751111|NCT03452397|456035956|FG000|Overall Study|Withdrawal by Subject|0|||
126751112|NCT03452397|456035957|FG001|Overall Study|Withdrawal by Subject|0|||
126751113|NCT03452397|456035958|FG002|Overall Study|Withdrawal by Subject|1|||
126751114|NCT03452397|456035959|FG003|Overall Study|Withdrawal by Subject|0|||
126751115|NCT02691468|456035960|FG000|Overall Study|Bronchial blocker use|2|||
126751116|NCT02691468|456035961|FG001|Overall Study|Bronchial blocker use|1|||
126751117|NCT02691468|456035960|FG000|Overall Study|Lost to Follow-up|2|||
126751118|NCT02691468|456035961|FG001|Overall Study|Lost to Follow-up|1|||
126751119|NCT02691468|456035960|FG000|Overall Study|Failure to advance FOB|2|||
126751120|NCT02691468|456035961|FG001|Overall Study|Failure to advance FOB|0|||
126751121|NCT06334055|456035963|FG000|Overall Study|Adverse Event|4|||
126751122|NCT06334055|456035963|FG000|Overall Study|Disqualified|72|||
126751123|NCT02545049|456035964|FG000|Overall Study|Withdrawal by Subject|1|||
126751124|NCT02545049|456035965|FG001|Overall Study|Withdrawal by Subject|7|||
126751125|NCT02545049|456035964|FG000|Overall Study|Lost to Follow-up|4|||
126751126|NCT02545049|456035965|FG001|Overall Study|Lost to Follow-up|6|||
126751127|NCT02545049|456035964|FG000|Overall Study|GCP violations|37|||
126751128|NCT02545049|456035965|FG001|Overall Study|GCP violations|48|||
126751129|NCT02972658|456037524|FG000|Overall Study|Adverse Event|0|||
126751130|NCT02972658|456037525|FG001|Overall Study|Adverse Event|3|||
126751131|NCT02972658|456037526|FG002|Overall Study|Adverse Event|0|||
126751132|NCT02972658|456037527|FG003|Overall Study|Adverse Event|2|||
126751133|NCT02972658|456037524|FG000|Overall Study|Other-determined by Investigator|1|||
126751134|NCT02972658|456037525|FG001|Overall Study|Other-determined by Investigator|1|||
126751135|NCT02972658|456037526|FG002|Overall Study|Other-determined by Investigator|0|||
126751136|NCT02972658|456037527|FG003|Overall Study|Other-determined by Investigator|0|||
126751137|NCT02972658|456037524|FG000|Overall Study|Death|0|||
126751138|NCT02972658|456037525|FG001|Overall Study|Death|0|||
126751139|NCT02972658|456037526|FG002|Overall Study|Death|0|||
126751140|NCT02972658|456037527|FG003|Overall Study|Death|1|||
126751141|NCT02972658|456037524|FG000|Overall Study|Lost to Follow-up|0|||
126751142|NCT02972658|456037525|FG001|Overall Study|Lost to Follow-up|1|||
126751143|NCT02972658|456037526|FG002|Overall Study|Lost to Follow-up|1|||
126751144|NCT02972658|456037527|FG003|Overall Study|Lost to Follow-up|2|||
126751145|NCT02972658|456037524|FG000|Overall Study|Progressive Disease|0|||
126751146|NCT02972658|456037525|FG001|Overall Study|Progressive Disease|1|||
126751147|NCT02972658|456037526|FG002|Overall Study|Progressive Disease|0|||
126751148|NCT02972658|456037527|FG003|Overall Study|Progressive Disease|1|||
126751149|NCT02972658|456037524|FG000|Overall Study|Withdrawal by Subject|4|||
126751150|NCT02972658|456037525|FG001|Overall Study|Withdrawal by Subject|4|||
126751151|NCT02972658|456037526|FG002|Overall Study|Withdrawal by Subject|1|||
126751152|NCT02972658|456037527|FG003|Overall Study|Withdrawal by Subject|6|||
126751153|NCT02972658|456037524|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
126751154|NCT02972658|456037525|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
126751155|NCT02972658|456037526|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
126751156|NCT02972658|456037527|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
126751157|NCT02972658|456037524|FG000|Overall Study|Sponsor Decision|70|||
126751158|NCT02972658|456037525|FG001|Overall Study|Sponsor Decision|127|||
126751159|NCT02972658|456037526|FG002|Overall Study|Sponsor Decision|72|||
126751160|NCT02972658|456037527|FG003|Overall Study|Sponsor Decision|119|||
126751161|NCT03958149|456037528|FG000|Overall Study|Withdrawal by Subject|0|||
126751162|NCT03958149|456037529|FG001|Overall Study|Withdrawal by Subject|1|||
126751163|NCT02785588|456037530|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
126751164|NCT02785588|456037530|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
126751165|NCT00621764|456037532|FG000|Overall Study|Protocol Violation|0|||
126751166|NCT00621764|456037533|FG001|Overall Study|Protocol Violation|0|||
126751167|NCT00621764|456037534|FG002|Overall Study|Protocol Violation|0|||
126751168|NCT00621764|456037535|FG003|Overall Study|Protocol Violation|1|||
126751169|NCT02499172|456037536|FG000|Overall Study|Financial reason|0|||
126751170|NCT02499172|456037537|FG001|Overall Study|Financial reason|0|||
126751171|NCT02499172|456037538|FG002|Overall Study|Financial reason|523|||
126751172|NCT02499172|456037539|FG003|Overall Study|Financial reason|436|||
126751173|NCT02499172|456037536|FG000|Overall Study|Lost to Follow-up|65|||
126751174|NCT02499172|456037537|FG001|Overall Study|Lost to Follow-up|64|||
126751175|NCT02499172|456037538|FG002|Overall Study|Lost to Follow-up|0|||
126751176|NCT02499172|456037539|FG003|Overall Study|Lost to Follow-up|0|||
126751177|NCT01293123|456037540|FG000|Overall Study|Lost to Follow-up|0|||
126751178|NCT01293123|456037541|FG001|Overall Study|Lost to Follow-up|1|||
126751179|NCT00211536|456037544|FG000|Overall Study|Withdrawal by Subject|2|||
126751180|NCT00211536|456037545|FG001|Overall Study|Withdrawal by Subject|2|||
126751181|NCT00211536|456037544|FG000|Overall Study|Physician Decision|0|||
126751182|NCT00211536|456037545|FG001|Overall Study|Physician Decision|5|||
126751183|NCT00211536|456037544|FG000|Overall Study|Adverse Event|2|||
126751184|NCT00211536|456037545|FG001|Overall Study|Adverse Event|0|||
126751185|NCT00003389|456037546|FG000|Overall Study|Disease progression|6|||
126751186|NCT00003389|456037547|FG001|Overall Study|Disease progression|1|||
126751187|NCT00003389|456037546|FG000|Overall Study|Adverse Event|13|||
126751188|NCT00003389|456037547|FG001|Overall Study|Adverse Event|2|||
126751189|NCT00003389|456037546|FG000|Overall Study|Death|0|||
126751190|NCT00003389|456037547|FG001|Overall Study|Death|3|||
126751191|NCT00003389|456037546|FG000|Overall Study|Withdrawal by Subject|12|||
126751192|NCT00003389|456037547|FG001|Overall Study|Withdrawal by Subject|5|||
126751193|NCT00003389|456037546|FG000|Overall Study|Alternative therapy|2|||
126751194|NCT00003389|456037547|FG001|Overall Study|Alternative therapy|1|||
126751195|NCT00003389|456037546|FG000|Overall Study|Complicating disease|1|||
126751196|NCT00003389|456037547|FG001|Overall Study|Complicating disease|0|||
126751197|NCT00003389|456037546|FG000|Overall Study|Off-treatment reason missing|31|||
126751198|NCT00003389|456037547|FG001|Overall Study|Off-treatment reason missing|21|||
126751199|NCT00003389|456037546|FG000|Overall Study|Ineligible|33|||
126751200|NCT00003389|456037547|FG001|Overall Study|Ineligible|27|||
126751201|NCT01997892|456037550|FG000|Overall Study|Physician Decision|2|||
126751202|NCT01997892|456037550|FG000|Overall Study|Lost to Follow-up|6|||
126751203|NCT01997892|456037550|FG000|Overall Study|Death|14|||
126751204|NCT01997892|456037550|FG000|Overall Study|Renal transplant|8|||
126751205|NCT01997892|456037550|FG000|Overall Study|Other|3|||
126751206|NCT01997892|456037550|FG000|Overall Study|Study completion data not recorded|35|||
126751207|NCT02710422|456037551|FG000|Overall Study|Termination of study|9|||
126751208|NCT02710422|456037552|FG001|Overall Study|Termination of study|9|||
126751209|NCT02608099|456037553|FG000|Overall Study|Ablation procedure not initiated|3|||
126751210|NCT02608099|456037554|FG001|Overall Study|Ablation procedure not initiated|2|||
126751211|NCT00768040|456037557|FG000|Overall Study|Adverse Event|3|||
126751212|NCT00768040|456037558|FG001|Overall Study|Adverse Event|2|||
126751213|NCT00768040|456037557|FG000|Overall Study|Abnormal laboratory value|1|||
126751214|NCT00768040|456037558|FG001|Overall Study|Abnormal laboratory value|1|||
126751215|NCT00417248|456037560|FG000|Overall Study|Study Terminated|6|||
126751216|NCT00417248|456037560|FG000|Overall Study|Death|1|||
126751217|NCT00417248|456037560|FG000|Overall Study|Lack of Efficacy|1|||
126751218|NCT02185040|456037561|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
126751219|NCT02185040|456037562|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
126751220|NCT02185040|456037563|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
126751221|NCT02185040|456037564|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
126751222|NCT02185040|456037565|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
126751223|NCT02185040|456037566|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
126751224|NCT02185040|456037567|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
126751225|NCT02185040|456037561|FG000|Part 1 Treatment Phase|Adverse Event|1|||
126751226|NCT02185040|456037562|FG001|Part 1 Treatment Phase|Adverse Event|0|||
126751227|NCT02185040|456037563|FG002|Part 1 Treatment Phase|Adverse Event|0|||
126751228|NCT02185040|456037564|FG003|Part 1 Treatment Phase|Adverse Event|2|||
126751229|NCT02185040|456037565|FG004|Part 1 Treatment Phase|Adverse Event|3|||
126751230|NCT02185040|456037566|FG005|Part 1 Treatment Phase|Adverse Event|0|||
126751231|NCT02185040|456037567|FG006|Part 1 Treatment Phase|Adverse Event|0|||
126751232|NCT02185040|456037561|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
126751233|NCT02185040|456037562|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
126751234|NCT02185040|456037563|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
126751235|NCT02185040|456037564|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
126751236|NCT02185040|456037565|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
126751237|NCT02185040|456037566|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
126751238|NCT02185040|456037567|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
126751239|NCT02185040|456037561|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
126751240|NCT02185040|456037562|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
126751241|NCT02185040|456037563|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
126751242|NCT02185040|456037564|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
126751243|NCT02185040|456037565|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
126751244|NCT02185040|456037566|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
126751245|NCT02185040|456037567|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
126751246|NCT02185040|456037561|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
126751247|NCT02185040|456037562|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
126751248|NCT02185040|456037563|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
126751249|NCT02185040|456037564|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
126751250|NCT02185040|456037565|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
126756653|NCT01632345|456059513|FG005|Treatment: Part I|Pregnancy|0|||
126622815|NCT00296504|455575953|FG003|Interim Analysis|Resistance to FPV|0|||
126622816|NCT00296504|455575954|FG004|Interim Analysis|Resistance to FPV|0|||
126622817|NCT00296504|455575955|FG005|Interim Analysis|Resistance to FPV|0|||
126622818|NCT00296504|455575956|FG006|Interim Analysis|Resistance to FPV|0|||
126622819|NCT00296504|455575957|FG007|Interim Analysis|Resistance to FPV|0|||
126622820|NCT00296504|455575958|FG008|Interim Analysis|Resistance to FPV|0|||
126622821|NCT00296504|455575950|FG000|Interim Analysis|Physician Decision|0|||
126622822|NCT00296504|455575951|FG001|Interim Analysis|Physician Decision|0|||
126622823|NCT00296504|455575952|FG002|Interim Analysis|Physician Decision|1|||
126622824|NCT00296504|455575953|FG003|Interim Analysis|Physician Decision|0|||
126622825|NCT00296504|455575954|FG004|Interim Analysis|Physician Decision|0|||
126622826|NCT00296504|455575955|FG005|Interim Analysis|Physician Decision|0|||
126622827|NCT00296504|455575956|FG006|Interim Analysis|Physician Decision|0|||
126622828|NCT00296504|455575957|FG007|Interim Analysis|Physician Decision|0|||
126622829|NCT00296504|455575958|FG008|Interim Analysis|Physician Decision|0|||
126622830|NCT00296504|455575950|FG000|Interim Analysis|Principle Investigator Discretion|2|||
126622831|NCT00296504|455575951|FG001|Interim Analysis|Principle Investigator Discretion|0|||
126622832|NCT00296504|455575952|FG002|Interim Analysis|Principle Investigator Discretion|1|||
126622833|NCT00296504|455575953|FG003|Interim Analysis|Principle Investigator Discretion|1|||
126622834|NCT00296504|455575954|FG004|Interim Analysis|Principle Investigator Discretion|0|||
126622835|NCT00296504|455575955|FG005|Interim Analysis|Principle Investigator Discretion|0|||
126622836|NCT00296504|455575956|FG006|Interim Analysis|Principle Investigator Discretion|0|||
126622837|NCT00296504|455575957|FG007|Interim Analysis|Principle Investigator Discretion|0|||
126622838|NCT00296504|455575958|FG008|Interim Analysis|Principle Investigator Discretion|0|||
126622839|NCT00296504|455575950|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
126622840|NCT00296504|455575951|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
126622841|NCT00296504|455575952|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
126622842|NCT00296504|455575953|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
126622843|NCT00296504|455575954|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
126622844|NCT00296504|455575955|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
126622845|NCT00296504|455575956|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
126622846|NCT00296504|455575957|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
126622847|NCT00296504|455575958|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
126622848|NCT00296504|455575950|FG000|Interim Analysis|Non-adherence|2|||
126622849|NCT00296504|455575951|FG001|Interim Analysis|Non-adherence|0|||
126622850|NCT00296504|455575952|FG002|Interim Analysis|Non-adherence|0|||
126622851|NCT00296504|455575953|FG003|Interim Analysis|Non-adherence|0|||
126622852|NCT00296504|455575954|FG004|Interim Analysis|Non-adherence|1|||
126622853|NCT00296504|455575955|FG005|Interim Analysis|Non-adherence|0|||
126622854|NCT00296504|455575956|FG006|Interim Analysis|Non-adherence|0|||
126622855|NCT00296504|455575957|FG007|Interim Analysis|Non-adherence|1|||
126622856|NCT00296504|455575958|FG008|Interim Analysis|Non-adherence|0|||
126622857|NCT00296504|455575950|FG000|Interim Analysis|Site Closing|1|||
126622858|NCT00296504|455575951|FG001|Interim Analysis|Site Closing|0|||
126622859|NCT00296504|455575952|FG002|Interim Analysis|Site Closing|0|||
126622860|NCT00296504|455575953|FG003|Interim Analysis|Site Closing|0|||
126622861|NCT00296504|455575954|FG004|Interim Analysis|Site Closing|0|||
126622862|NCT00296504|455575955|FG005|Interim Analysis|Site Closing|1|||
126622863|NCT00296504|455575956|FG006|Interim Analysis|Site Closing|2|||
126622864|NCT00296504|455575957|FG007|Interim Analysis|Site Closing|0|||
126622865|NCT00296504|455575958|FG008|Interim Analysis|Site Closing|0|||
126622866|NCT00296504|455575950|FG000|Interim Analysis|Lack of Personnel at Site|1|||
126622867|NCT00296504|455575951|FG001|Interim Analysis|Lack of Personnel at Site|0|||
126622868|NCT00296504|455575952|FG002|Interim Analysis|Lack of Personnel at Site|0|||
126622869|NCT00296504|455575953|FG003|Interim Analysis|Lack of Personnel at Site|0|||
126622870|NCT00296504|455575954|FG004|Interim Analysis|Lack of Personnel at Site|0|||
126622871|NCT00296504|455575955|FG005|Interim Analysis|Lack of Personnel at Site|0|||
126622872|NCT00296504|455575956|FG006|Interim Analysis|Lack of Personnel at Site|0|||
126622873|NCT00296504|455575957|FG007|Interim Analysis|Lack of Personnel at Site|0|||
126622874|NCT00296504|455575958|FG008|Interim Analysis|Lack of Personnel at Site|0|||
126622875|NCT00296504|455575950|FG000|Interim Analysis|Missed Schedule Date|1|||
126622876|NCT00296504|455575951|FG001|Interim Analysis|Missed Schedule Date|0|||
126622877|NCT00296504|455575952|FG002|Interim Analysis|Missed Schedule Date|0|||
126622878|NCT00296504|455575953|FG003|Interim Analysis|Missed Schedule Date|0|||
126622879|NCT00296504|455575954|FG004|Interim Analysis|Missed Schedule Date|0|||
126622880|NCT00296504|455575955|FG005|Interim Analysis|Missed Schedule Date|0|||
126622881|NCT00296504|455575956|FG006|Interim Analysis|Missed Schedule Date|0|||
126622882|NCT00296504|455575957|FG007|Interim Analysis|Missed Schedule Date|0|||
126622883|NCT00296504|455575958|FG008|Interim Analysis|Missed Schedule Date|0|||
126622884|NCT00296504|455575950|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
126622885|NCT00296504|455575951|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
126622886|NCT00296504|455575952|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
126622887|NCT00296504|455575953|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
126782650|NCT00673790|456158262|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
126782651|NCT00673790|456158263|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
126782652|NCT00673790|456158264|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
126782653|NCT00673790|456158262|FG000|Overall Study|Poor compliance|1|||
126751251|NCT02185040|456037566|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
126751252|NCT02185040|456037567|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
126751253|NCT02185040|456037561|FG000|Active Treatment Extension Phase|Adverse Event|0|||
126751254|NCT02185040|456037562|FG001|Active Treatment Extension Phase|Adverse Event|0|||
126751255|NCT02185040|456037563|FG002|Active Treatment Extension Phase|Adverse Event|0|||
126751256|NCT02185040|456037564|FG003|Active Treatment Extension Phase|Adverse Event|0|||
126751257|NCT02185040|456037565|FG004|Active Treatment Extension Phase|Adverse Event|0|||
126751258|NCT02185040|456037566|FG005|Active Treatment Extension Phase|Adverse Event|1|||
126751259|NCT02185040|456037567|FG006|Active Treatment Extension Phase|Adverse Event|4|||
126751260|NCT02185040|456037561|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
126751261|NCT02185040|456037562|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
126751262|NCT02185040|456037563|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
126751263|NCT02185040|456037564|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
126751264|NCT02185040|456037565|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
126751265|NCT02185040|456037566|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
126751266|NCT02185040|456037567|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
126751267|NCT02185040|456037561|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
126751268|NCT02185040|456037562|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
126751269|NCT02185040|456037563|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
126751270|NCT02185040|456037564|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
126751271|NCT02185040|456037565|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
126751272|NCT02185040|456037566|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
126751273|NCT02185040|456037567|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
126751274|NCT03347279|456037568|FG000|Overall Study|Withdrawal by Subject|8|||
126751275|NCT03347279|456037569|FG001|Overall Study|Withdrawal by Subject|15|||
126751276|NCT03347279|456037568|FG000|Overall Study|Death|0|||
126751277|NCT03347279|456037569|FG001|Overall Study|Death|2|||
126751278|NCT03347279|456037568|FG000|Overall Study|Lost to Follow-up|5|||
126751279|NCT03347279|456037569|FG001|Overall Study|Lost to Follow-up|2|||
126751280|NCT03347279|456037568|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
126751281|NCT03347279|456037569|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
126751282|NCT03557801|456037570|FG000|Overall Study|Protocol Violation|1|||
126751283|NCT03557801|456037571|FG001|Overall Study|Protocol Violation|0|||
126751284|NCT03557801|456037572|FG002|Overall Study|Protocol Violation|0|||
126751285|NCT03557801|456037570|FG000|Overall Study|Withdrawal by Subject|1|||
126751286|NCT03557801|456037571|FG001|Overall Study|Withdrawal by Subject|0|||
126751287|NCT03557801|456037572|FG002|Overall Study|Withdrawal by Subject|3|||
126751288|NCT03557801|456037570|FG000|Overall Study|Lost to Follow-up|0|||
126751289|NCT03557801|456037571|FG001|Overall Study|Lost to Follow-up|1|||
126751290|NCT03557801|456037572|FG002|Overall Study|Lost to Follow-up|0|||
126751291|NCT02200510|456037573|FG000|Overall Study|Death|1|||
126751292|NCT02200510|456037574|FG001|Overall Study|Death|1|||
126751293|NCT02200510|456037573|FG000|Overall Study|Protocol Violation|0|||
126751294|NCT02200510|456037574|FG001|Overall Study|Protocol Violation|1|||
126751295|NCT02200510|456037573|FG000|Overall Study|Lost to Follow-up|7|||
126751296|NCT02200510|456037574|FG001|Overall Study|Lost to Follow-up|1|||
126751297|NCT02200510|456037573|FG000|Overall Study|potential COI - joined study team|1|||
126751298|NCT02200510|456037574|FG001|Overall Study|potential COI - joined study team|0|||
126751299|NCT01108263|456037583|FG000|Overall Study|Adverse Event|0|||
126751300|NCT01108263|456037584|FG001|Overall Study|Adverse Event|1|||
126751301|NCT01685372|456037585|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
126751302|NCT01685372|456037586|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
126751303|NCT01488994|456037587|FG000|Overall Study|Withdrawal by Subject|0|||
126751304|NCT01488994|456037588|FG001|Overall Study|Withdrawal by Subject|1|||
126751305|NCT00829010|456037591|FG000|Overall Study|Adverse Event|1|||
126782654|NCT00673790|456158263|FG001|Overall Study|Poor compliance|0|||
126782655|NCT00673790|456158264|FG002|Overall Study|Poor compliance|0|||
126782656|NCT00673790|456158262|FG000|Overall Study|Participated in two Nebivolol studies|0|||
126622888|NCT00296504|455575954|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
126622889|NCT00296504|455575955|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
126622890|NCT00296504|455575956|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
126782657|NCT00673790|456158263|FG001|Overall Study|Participated in two Nebivolol studies|0|||
126751306|NCT00829010|456037592|FG001|Overall Study|Adverse Event|0|||
126751307|NCT00829010|456037593|FG002|Overall Study|Adverse Event|0|||
126622891|NCT00296504|455575957|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
126751308|NCT00829010|456037594|FG003|Overall Study|Adverse Event|0|||
126751309|NCT00829010|456037595|FG004|Overall Study|Adverse Event|0|||
126751310|NCT00829010|456037591|FG000|Overall Study|Withdrawal by Subject|0|||
126751311|NCT00829010|456037592|FG001|Overall Study|Withdrawal by Subject|1|||
126751312|NCT00829010|456037593|FG002|Overall Study|Withdrawal by Subject|1|||
126751313|NCT00829010|456037594|FG003|Overall Study|Withdrawal by Subject|0|||
126751314|NCT00829010|456037595|FG004|Overall Study|Withdrawal by Subject|2|||
126751315|NCT00829010|456037591|FG000|Overall Study|Lost to Follow-up|1|||
126751316|NCT00829010|456037592|FG001|Overall Study|Lost to Follow-up|0|||
126751317|NCT00829010|456037593|FG002|Overall Study|Lost to Follow-up|2|||
126751318|NCT00829010|456037594|FG003|Overall Study|Lost to Follow-up|0|||
126751319|NCT00829010|456037595|FG004|Overall Study|Lost to Follow-up|0|||
126751320|NCT00829010|456037591|FG000|Overall Study|Fatality|5|||
126751321|NCT00829010|456037592|FG001|Overall Study|Fatality|4|||
126751322|NCT00829010|456037593|FG002|Overall Study|Fatality|0|||
126751323|NCT00829010|456037594|FG003|Overall Study|Fatality|3|||
126751324|NCT00829010|456037595|FG004|Overall Study|Fatality|0|||
126751325|NCT00829010|456037591|FG000|Overall Study|Migrated/Moved from study area|3|||
126751326|NCT00829010|456037592|FG001|Overall Study|Migrated/Moved from study area|4|||
126751327|NCT00829010|456037593|FG002|Overall Study|Migrated/Moved from study area|0|||
126751328|NCT00829010|456037594|FG003|Overall Study|Migrated/Moved from study area|5|||
126751329|NCT00829010|456037595|FG004|Overall Study|Migrated/Moved from study area|0|||
126751330|NCT00474539|456037598|FG000|Infant Series|Withdrawal by Subject|3|||
126751331|NCT00474539|456037599|FG001|Infant Series|Withdrawal by Subject|4|||
126751332|NCT00474539|456037598|FG000|Infant Series|Randomization error|5|||
126751333|NCT00474539|456037599|FG001|Infant Series|Randomization error|0|||
126751334|NCT00474539|456037598|FG000|Infant Series|Lost to Follow-up|2|||
126751335|NCT00474539|456037599|FG001|Infant Series|Lost to Follow-up|1|||
126751336|NCT00474539|456037598|FG000|Infant Series|Protocol Violation|0|||
126751337|NCT00474539|456037599|FG001|Infant Series|Protocol Violation|1|||
126751338|NCT00474539|456037598|FG000|After Infant Series|Lost to Follow-up|3|||
126751339|NCT00474539|456037599|FG001|After Infant Series|Lost to Follow-up|0|||
126751340|NCT00474539|456037598|FG000|After Infant Series|Withdrawal by Subject|1|||
126751341|NCT00474539|456037599|FG001|After Infant Series|Withdrawal by Subject|0|||
126751342|NCT00474539|456037598|FG000|Toddler Dose|Protocol Violation|1|||
126751343|NCT00474539|456037599|FG001|Toddler Dose|Protocol Violation|0|||
126751344|NCT02061540|456037600|FG000|Overall Study|Adverse Event|2|||
126751345|NCT02061540|456037600|FG000|Overall Study|Withdrawal by Subject|2|||
126751346|NCT02289833|456037602|FG000|Overall Study|Study discontinuation|0|||
126751347|NCT02289833|456037603|FG001|Overall Study|Study discontinuation|1|||
126751348|NCT02289833|456037602|FG000|Overall Study|Lost to Follow-up|4|||
126751349|NCT02289833|456037603|FG001|Overall Study|Lost to Follow-up|0|||
126751350|NCT02289833|456037602|FG000|Overall Study|Death|23|||
126751351|NCT02289833|456037603|FG001|Overall Study|Death|16|||
126751352|NCT01227252|456037604|FG000|Overall Study|Sponsor Decision|0|||
126751353|NCT01227252|456037605|FG001|Overall Study|Sponsor Decision|1|||
126751354|NCT01227252|456037606|FG002|Overall Study|Sponsor Decision|0|||
126751355|NCT01227252|456037607|FG003|Overall Study|Sponsor Decision|0|||
126751356|NCT01227252|456037604|FG000|Overall Study|Lost to Follow-up|0|||
126751357|NCT01227252|456037605|FG001|Overall Study|Lost to Follow-up|1|||
126751358|NCT01227252|456037606|FG002|Overall Study|Lost to Follow-up|0|||
126751359|NCT01227252|456037607|FG003|Overall Study|Lost to Follow-up|0|||
126751360|NCT01227252|456037604|FG000|Overall Study|Withdrawal by Subject|0|||
126751361|NCT01227252|456037605|FG001|Overall Study|Withdrawal by Subject|1|||
126751362|NCT01227252|456037606|FG002|Overall Study|Withdrawal by Subject|0|||
126751363|NCT01227252|456037607|FG003|Overall Study|Withdrawal by Subject|0|||
126751364|NCT02561273|456037614|FG000|Overall Study|Protocol Violation|1|||
126751365|NCT02561273|456037615|FG001|Overall Study|Protocol Violation|0|||
126751366|NCT03442595|456037616|FG000|Overall Study|Lost to Follow-up|94|||
126751367|NCT03442595|456037617|FG001|Overall Study|Lost to Follow-up|0|||
126751368|NCT01642004|456037618|FG000|Randomization|Adverse Event unrelated to study drug|1|||
126751369|NCT01642004|456037619|FG001|Randomization|Adverse Event unrelated to study drug|0|||
126751370|NCT01642004|456037618|FG000|Randomization|Participant withdrew consent|1|||
126751371|NCT01642004|456037619|FG001|Randomization|Participant withdrew consent|6|||
126751372|NCT01642004|456037618|FG000|Randomization|No longer meets study criteria|2|||
126751373|NCT01642004|456037619|FG001|Randomization|No longer meets study criteria|2|||
126751374|NCT01642004|456037618|FG000|Treatment|Disease progression|95|||
126751375|NCT01642004|456037619|FG001|Treatment|Disease progression|79|||
126751376|NCT01642004|456037618|FG000|Treatment|Study drug toxicity|10|||
126751377|NCT01642004|456037619|FG001|Treatment|Study drug toxicity|13|||
126751378|NCT01642004|456037618|FG000|Treatment|Death|1|||
126751379|NCT01642004|456037619|FG001|Treatment|Death|1|||
126751380|NCT01642004|456037618|FG000|Treatment|Adverse event unrelated to study drug|9|||
126751381|NCT01642004|456037619|FG001|Treatment|Adverse event unrelated to study drug|13|||
126751382|NCT01642004|456037618|FG000|Treatment|Maximum clinical benefit|1|||
126751383|NCT01642004|456037619|FG001|Treatment|Maximum clinical benefit|9|||
126751384|NCT01642004|456037618|FG000|Treatment|Poor/non-compliance|1|||
126751385|NCT01642004|456037619|FG001|Treatment|Poor/non-compliance|0|||
126751386|NCT01642004|456037618|FG000|Treatment|No longer meets study criteria|1|||
126751387|NCT01642004|456037619|FG001|Treatment|No longer meets study criteria|2|||
126751388|NCT01642004|456037618|FG000|Treatment|Other reasons|2|||
126622892|NCT00296504|455575958|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
126622893|NCT00296504|455575950|FG000|Interim Analysis|Participant Stopped|0|||
126751389|NCT01642004|456037619|FG001|Treatment|Other reasons|0|||
126751390|NCT01642004|456037618|FG000|Treatment|Not reported|0|||
126751391|NCT01642004|456037619|FG001|Treatment|Not reported|3|||
126751392|NCT01642004|456037618|FG000|Treatment|Participant request to discontinue study treatment|6|||
126751393|NCT01642004|456037619|FG001|Treatment|Participant request to discontinue study treatment|4|||
126751394|NCT01642004|456037618|FG000|Treatment|Participant withdrew consent|5|||
126751395|NCT01642004|456037619|FG001|Treatment|Participant withdrew consent|5|||
126751396|NCT00811395|456037620|FG000|Extension Treatment|Adverse Event|1|||
126751397|NCT00811395|456037621|FG001|Extension Treatment|Adverse Event|2|||
126751398|NCT00811395|456037622|FG002|Extension Treatment|Adverse Event|2|||
126751399|NCT00811395|456037623|FG003|Extension Treatment|Adverse Event|2|||
126751400|NCT00811395|456037624|FG004|Extension Treatment|Adverse Event|0|||
126751401|NCT00811395|456037625|FG005|Extension Treatment|Adverse Event|1|||
126751402|NCT00811395|456037620|FG000|Extension Treatment|Progressive disease|1|||
126751403|NCT00811395|456037621|FG001|Extension Treatment|Progressive disease|1|||
126751404|NCT00811395|456037622|FG002|Extension Treatment|Progressive disease|0|||
126751405|NCT00811395|456037623|FG003|Extension Treatment|Progressive disease|0|||
126751406|NCT00811395|456037624|FG004|Extension Treatment|Progressive disease|0|||
126751407|NCT00811395|456037625|FG005|Extension Treatment|Progressive disease|0|||
126751408|NCT00811395|456037620|FG000|Extension Treatment|Participant did not wish to continue|0|||
126751409|NCT00811395|456037621|FG001|Extension Treatment|Participant did not wish to continue|3|||
126751410|NCT00811395|456037622|FG002|Extension Treatment|Participant did not wish to continue|0|||
126751411|NCT00811395|456037623|FG003|Extension Treatment|Participant did not wish to continue|1|||
126751412|NCT00811395|456037624|FG004|Extension Treatment|Participant did not wish to continue|0|||
126751413|NCT00811395|456037625|FG005|Extension Treatment|Participant did not wish to continue|1|||
126751414|NCT00811395|456037620|FG000|Extension Treatment|Other than above|0|||
126751415|NCT00811395|456037621|FG001|Extension Treatment|Other than above|0|||
126751416|NCT00811395|456037622|FG002|Extension Treatment|Other than above|1|||
126751417|NCT00811395|456037623|FG003|Extension Treatment|Other than above|0|||
126751418|NCT00811395|456037624|FG004|Extension Treatment|Other than above|0|||
126751419|NCT00811395|456037625|FG005|Extension Treatment|Other than above|0|||
126751420|NCT02192190|456037634|FG000|Overall Study|Adverse Event|1|||
126751421|NCT02192190|456037635|FG001|Overall Study|Adverse Event|1|||
126751422|NCT02192190|456037636|FG002|Overall Study|Adverse Event|0|||
126751423|NCT02192190|456037637|FG003|Overall Study|Adverse Event|0|||
126751424|NCT02192190|456037638|FG004|Overall Study|Adverse Event|0|||
126751425|NCT02192190|456037639|FG005|Overall Study|Adverse Event|0|||
126751426|NCT02192190|456037634|FG000|Overall Study|Lost to Follow-up|3|||
126751427|NCT02192190|456037635|FG001|Overall Study|Lost to Follow-up|3|||
126751428|NCT02192190|456037636|FG002|Overall Study|Lost to Follow-up|2|||
126751429|NCT02192190|456037637|FG003|Overall Study|Lost to Follow-up|1|||
126751430|NCT02192190|456037638|FG004|Overall Study|Lost to Follow-up|4|||
126751431|NCT02192190|456037639|FG005|Overall Study|Lost to Follow-up|3|||
126751432|NCT02192190|456037634|FG000|Overall Study|Physician Decision|2|||
126751433|NCT02192190|456037635|FG001|Overall Study|Physician Decision|0|||
126751434|NCT02192190|456037636|FG002|Overall Study|Physician Decision|0|||
126751435|NCT02192190|456037637|FG003|Overall Study|Physician Decision|0|||
126751436|NCT02192190|456037638|FG004|Overall Study|Physician Decision|0|||
126751437|NCT02192190|456037639|FG005|Overall Study|Physician Decision|0|||
126751438|NCT02192190|456037634|FG000|Overall Study|Terminated by Sponsor|43|||
126751439|NCT02192190|456037635|FG001|Overall Study|Terminated by Sponsor|23|||
126751440|NCT02192190|456037636|FG002|Overall Study|Terminated by Sponsor|20|||
126751441|NCT02192190|456037637|FG003|Overall Study|Terminated by Sponsor|23|||
126751442|NCT02192190|456037638|FG004|Overall Study|Terminated by Sponsor|21|||
126751443|NCT02192190|456037639|FG005|Overall Study|Terminated by Sponsor|23|||
126751444|NCT02192190|456037634|FG000|Overall Study|Withdrawal by Subject|4|||
126751445|NCT02192190|456037635|FG001|Overall Study|Withdrawal by Subject|1|||
126751446|NCT02192190|456037636|FG002|Overall Study|Withdrawal by Subject|2|||
126751447|NCT02192190|456037637|FG003|Overall Study|Withdrawal by Subject|1|||
126751448|NCT02192190|456037638|FG004|Overall Study|Withdrawal by Subject|5|||
126751449|NCT02192190|456037639|FG005|Overall Study|Withdrawal by Subject|3|||
126751450|NCT02192190|456037634|FG000|Overall Study|Could not Keep Visit Schedule|1|||
126751451|NCT02192190|456037635|FG001|Overall Study|Could not Keep Visit Schedule|0|||
126751452|NCT02192190|456037636|FG002|Overall Study|Could not Keep Visit Schedule|0|||
126751453|NCT02192190|456037637|FG003|Overall Study|Could not Keep Visit Schedule|0|||
126751454|NCT02192190|456037638|FG004|Overall Study|Could not Keep Visit Schedule|0|||
126751455|NCT02192190|456037639|FG005|Overall Study|Could not Keep Visit Schedule|0|||
126751456|NCT02192190|456037634|FG000|Overall Study|Positive Drug Screen|0|||
126751457|NCT02192190|456037635|FG001|Overall Study|Positive Drug Screen|0|||
126751458|NCT02192190|456037636|FG002|Overall Study|Positive Drug Screen|0|||
126751459|NCT02192190|456037637|FG003|Overall Study|Positive Drug Screen|1|||
126622894|NCT00296504|455575951|FG001|Interim Analysis|Participant Stopped|0|||
126622895|NCT00296504|455575952|FG002|Interim Analysis|Participant Stopped|0|||
126622896|NCT00296504|455575953|FG003|Interim Analysis|Participant Stopped|0|||
126622897|NCT00296504|455575954|FG004|Interim Analysis|Participant Stopped|1|||
126622898|NCT00296504|455575955|FG005|Interim Analysis|Participant Stopped|0|||
126622899|NCT00296504|455575956|FG006|Interim Analysis|Participant Stopped|0|||
126622900|NCT00296504|455575957|FG007|Interim Analysis|Participant Stopped|0|||
126622901|NCT00296504|455575958|FG008|Interim Analysis|Participant Stopped|0|||
126622902|NCT00296504|455575950|FG000|Interim Analysis|Physician and Participant Decision|0|||
126622903|NCT00296504|455575951|FG001|Interim Analysis|Physician and Participant Decision|0|||
126622904|NCT00296504|455575952|FG002|Interim Analysis|Physician and Participant Decision|0|||
126622905|NCT00296504|455575953|FG003|Interim Analysis|Physician and Participant Decision|0|||
126622906|NCT00296504|455575954|FG004|Interim Analysis|Physician and Participant Decision|0|||
126622907|NCT00296504|455575955|FG005|Interim Analysis|Physician and Participant Decision|1|||
126622908|NCT00296504|455575956|FG006|Interim Analysis|Physician and Participant Decision|0|||
126622909|NCT00296504|455575957|FG007|Interim Analysis|Physician and Participant Decision|0|||
126622910|NCT00296504|455575958|FG008|Interim Analysis|Physician and Participant Decision|0|||
126622911|NCT00296504|455575950|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
126622912|NCT00296504|455575951|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
126622913|NCT00296504|455575952|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
126622914|NCT00296504|455575953|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
126622915|NCT00296504|455575954|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
126622916|NCT00296504|455575955|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
126622917|NCT00296504|455575956|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
126622918|NCT00296504|455575957|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
126622919|NCT00296504|455575958|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
126622920|NCT00296504|455575950|FG000|Interim Analysis|Study Ended|0|||
126622921|NCT00296504|455575951|FG001|Interim Analysis|Study Ended|0|||
126622922|NCT00296504|455575952|FG002|Interim Analysis|Study Ended|0|||
126622923|NCT00296504|455575953|FG003|Interim Analysis|Study Ended|0|||
126622924|NCT00296504|455575954|FG004|Interim Analysis|Study Ended|0|||
126622925|NCT00296504|455575955|FG005|Interim Analysis|Study Ended|0|||
126622926|NCT00296504|455575956|FG006|Interim Analysis|Study Ended|1|||
126622927|NCT00296504|455575957|FG007|Interim Analysis|Study Ended|0|||
126622928|NCT00296504|455575958|FG008|Interim Analysis|Study Ended|0|||
126622929|NCT00296504|455575950|FG000|Interim Analysis|Participant Needed Interferon|0|||
126622930|NCT00296504|455575951|FG001|Interim Analysis|Participant Needed Interferon|0|||
126622931|NCT00296504|455575952|FG002|Interim Analysis|Participant Needed Interferon|0|||
126622932|NCT00296504|455575953|FG003|Interim Analysis|Participant Needed Interferon|0|||
126622933|NCT00296504|455575954|FG004|Interim Analysis|Participant Needed Interferon|0|||
126622934|NCT00296504|455575955|FG005|Interim Analysis|Participant Needed Interferon|0|||
126622935|NCT00296504|455575956|FG006|Interim Analysis|Participant Needed Interferon|0|||
126622936|NCT00296504|455575957|FG007|Interim Analysis|Participant Needed Interferon|1|||
126622937|NCT00296504|455575958|FG008|Interim Analysis|Participant Needed Interferon|0|||
126622938|NCT00296504|455575950|FG000|Interim Analysis|Ongoing|32|||
126622939|NCT00296504|455575951|FG001|Interim Analysis|Ongoing|12|||
126622940|NCT00296504|455575952|FG002|Interim Analysis|Ongoing|16|||
126622941|NCT00296504|455575953|FG003|Interim Analysis|Ongoing|22|||
126622942|NCT00296504|455575954|FG004|Interim Analysis|Ongoing|0|||
126622943|NCT00296504|455575955|FG005|Interim Analysis|Ongoing|0|||
126622944|NCT00296504|455575956|FG006|Interim Analysis|Ongoing|30|||
126622945|NCT00296504|455575957|FG007|Interim Analysis|Ongoing|1|||
126622946|NCT00296504|455575958|FG008|Interim Analysis|Ongoing|0|||
126622947|NCT00296504|455575950|FG000|Final Analysis|Withdrawal by Subject|0|||
126622948|NCT00296504|455575951|FG001|Final Analysis|Withdrawal by Subject|0|||
126622949|NCT00296504|455575952|FG002|Final Analysis|Withdrawal by Subject|0|||
126622950|NCT00296504|455575953|FG003|Final Analysis|Withdrawal by Subject|0|||
126622951|NCT00296504|455575954|FG004|Final Analysis|Withdrawal by Subject|0|||
126622952|NCT00296504|455575955|FG005|Final Analysis|Withdrawal by Subject|0|||
126622953|NCT00296504|455575956|FG006|Final Analysis|Withdrawal by Subject|0|||
126751460|NCT02192190|456037638|FG004|Overall Study|Positive Drug Screen|0|||
126622954|NCT00296504|455575957|FG007|Final Analysis|Withdrawal by Subject|0|||
126622955|NCT00296504|455575958|FG008|Final Analysis|Withdrawal by Subject|1|||
126622956|NCT00296504|455575950|FG000|Final Analysis|Lost to Follow-up|0|||
126751461|NCT02192190|456037639|FG005|Overall Study|Positive Drug Screen|0|||
126622957|NCT00296504|455575951|FG001|Final Analysis|Lost to Follow-up|0|||
126622958|NCT00296504|455575952|FG002|Final Analysis|Lost to Follow-up|0|||
126622959|NCT00296504|455575953|FG003|Final Analysis|Lost to Follow-up|0|||
126622960|NCT00296504|455575954|FG004|Final Analysis|Lost to Follow-up|0|||
126622961|NCT00296504|455575955|FG005|Final Analysis|Lost to Follow-up|0|||
126622962|NCT00296504|455575956|FG006|Final Analysis|Lost to Follow-up|0|||
126622963|NCT00296504|455575957|FG007|Final Analysis|Lost to Follow-up|0|||
126622964|NCT00296504|455575958|FG008|Final Analysis|Lost to Follow-up|5|||
126622965|NCT00296504|455575950|FG000|Final Analysis|Insufficient Viral Load Response|0|||
126751462|NCT02192190|456037634|FG000|Overall Study|Inadequate Pain Relief|0|||
126751463|NCT02192190|456037635|FG001|Overall Study|Inadequate Pain Relief|1|||
126751464|NCT02192190|456037636|FG002|Overall Study|Inadequate Pain Relief|1|||
126751465|NCT02192190|456037637|FG003|Overall Study|Inadequate Pain Relief|0|||
126751466|NCT02192190|456037638|FG004|Overall Study|Inadequate Pain Relief|0|||
126751467|NCT02192190|456037639|FG005|Overall Study|Inadequate Pain Relief|0|||
126751468|NCT03227692|456037640|FG000|Overall Study|Protocol Violation|1|||
126751469|NCT03227692|456037641|FG001|Overall Study|Protocol Violation|1|||
126751470|NCT03227692|456037640|FG000|Overall Study|Lost to Follow-up|4|||
126751471|NCT03227692|456037641|FG001|Overall Study|Lost to Follow-up|2|||
126751472|NCT03227692|456037640|FG000|Overall Study|Adverse Event|0|||
126751473|NCT03227692|456037641|FG001|Overall Study|Adverse Event|2|||
126751474|NCT02447952|456037642|FG000|Overall Study|Adverse Event|2|||
126751475|NCT02447952|456037642|FG000|Overall Study|Physician Decision|1|||
126751476|NCT02447952|456037642|FG000|Overall Study|Withdrawal by Subject|4|||
126751477|NCT01657253|456037643|FG000|Overall Study|Lost to Follow-up|6|||
126751478|NCT01657253|456037644|FG001|Overall Study|Lost to Follow-up|5|||
126751479|NCT01657253|456037643|FG000|Overall Study|Withdrawal by Subject|11|||
126751480|NCT01657253|456037644|FG001|Overall Study|Withdrawal by Subject|12|||
126751481|NCT01657253|456037643|FG000|Overall Study|Adverse Event|0|||
126751482|NCT01657253|456037644|FG001|Overall Study|Adverse Event|1|||
126751483|NCT01970540|456037647|FG000|Overall Study|Non-treatment-related AE|0|||
126751484|NCT01970540|456037648|FG001|Overall Study|Non-treatment-related AE|0|||
126751485|NCT01970540|456037649|FG002|Overall Study|Non-treatment-related AE|1|||
126751486|NCT01970540|456037647|FG000|Overall Study|Progressive disease|55|||
126751487|NCT01970540|456037648|FG001|Overall Study|Progressive disease|23|||
126751488|NCT01970540|456037649|FG002|Overall Study|Progressive disease|10|||
126751489|NCT01970540|456037647|FG000|Overall Study|Treatment delay over protocol|0|||
126751490|NCT01970540|456037648|FG001|Overall Study|Treatment delay over protocol|0|||
126751491|NCT01970540|456037649|FG002|Overall Study|Treatment delay over protocol|1|||
126751492|NCT01970540|456037647|FG000|Overall Study|Physician Decision|7|||
126751493|NCT01970540|456037648|FG001|Overall Study|Physician Decision|2|||
126751494|NCT01970540|456037649|FG002|Overall Study|Physician Decision|0|||
126751495|NCT01970540|456037647|FG000|Overall Study|Clinical progression|0|||
126751496|NCT01970540|456037648|FG001|Overall Study|Clinical progression|1|||
126751497|NCT01970540|456037649|FG002|Overall Study|Clinical progression|1|||
126751498|NCT01970540|456037647|FG000|Overall Study|End of study|2|||
126751499|NCT01970540|456037648|FG001|Overall Study|End of study|0|||
126751500|NCT01970540|456037649|FG002|Overall Study|End of study|2|||
126751501|NCT01970540|456037647|FG000|Overall Study|Adverse Event|0|||
126751502|NCT01970540|456037648|FG001|Overall Study|Adverse Event|2|||
126751503|NCT01970540|456037649|FG002|Overall Study|Adverse Event|1|||
126751504|NCT01970540|456037647|FG000|Overall Study|Treatment-related AE|4|||
126751505|NCT01970540|456037648|FG001|Overall Study|Treatment-related AE|0|||
126751506|NCT01970540|456037649|FG002|Overall Study|Treatment-related AE|2|||
126751507|NCT01970540|456037647|FG000|Overall Study|Withdrawal by Subject|4|||
126751508|NCT01970540|456037648|FG001|Overall Study|Withdrawal by Subject|0|||
126751509|NCT01970540|456037649|FG002|Overall Study|Withdrawal by Subject|1|||
126751510|NCT01970540|456037647|FG000|Overall Study|Clinical deterioration|1|||
126751511|NCT01970540|456037648|FG001|Overall Study|Clinical deterioration|0|||
126751512|NCT01970540|456037649|FG002|Overall Study|Clinical deterioration|0|||
126751513|NCT01603628|456037650|FG000|Overall Study|Personal Reasons|1|||
126751514|NCT01603628|456037651|FG001|Overall Study|Personal Reasons|1|||
126751515|NCT01603628|456037652|FG002|Overall Study|Personal Reasons|2|||
126751516|NCT01603628|456037650|FG000|Overall Study|Protocol Violation|1|||
126751517|NCT01603628|456037651|FG001|Overall Study|Protocol Violation|1|||
126751518|NCT01603628|456037652|FG002|Overall Study|Protocol Violation|0|||
126751519|NCT01603628|456037650|FG000|Overall Study|Lost to Follow-up|0|||
126751520|NCT01603628|456037651|FG001|Overall Study|Lost to Follow-up|1|||
126751521|NCT01603628|456037652|FG002|Overall Study|Lost to Follow-up|0|||
126751522|NCT01603628|456037650|FG000|Overall Study|Other Miscellaneous Reason|1|||
126751523|NCT01603628|456037651|FG001|Overall Study|Other Miscellaneous Reason|0|||
126751524|NCT01603628|456037652|FG002|Overall Study|Other Miscellaneous Reason|0|||
126751525|NCT00952588|456037654|FG000|Overall Study|Death|28|||
126751526|NCT00952588|456037655|FG001|Overall Study|Death|13|||
126751527|NCT00952588|456037654|FG000|Overall Study|Withdrawal by Subject|2|||
126751528|NCT00952588|456037655|FG001|Overall Study|Withdrawal by Subject|5|||
126751529|NCT00952588|456037654|FG000|Overall Study|Adverse Event|2|||
126751530|NCT00952588|456037655|FG001|Overall Study|Adverse Event|3|||
126751531|NCT00952588|456037654|FG000|Overall Study|Lost to Follow-up|2|||
126751532|NCT00952588|456037655|FG001|Overall Study|Lost to Follow-up|0|||
126751533|NCT00952588|456037654|FG000|Overall Study|Physician Decision|0|||
126751534|NCT00952588|456037655|FG001|Overall Study|Physician Decision|1|||
126751535|NCT00952588|456037654|FG000|Overall Study|Lack of Efficacy|2|||
126751536|NCT00952588|456037655|FG001|Overall Study|Lack of Efficacy|2|||
126751537|NCT01796106|456037656|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
126751538|NCT01796106|456037657|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
126782658|NCT00673790|456158264|FG002|Overall Study|Participated in two Nebivolol studies|1|||
126782659|NCT00673790|456158262|FG000|Overall Study|Unconfirmed pregnancy|0|||
126782660|NCT00673790|456158263|FG001|Overall Study|Unconfirmed pregnancy|1|||
126782661|NCT00673790|456158264|FG002|Overall Study|Unconfirmed pregnancy|0|||
126782662|NCT00673790|456158262|FG000|Overall Study|Randomization criteria not met|0|||
126782663|NCT00673790|456158263|FG001|Overall Study|Randomization criteria not met|1|||
126782664|NCT00673790|456158264|FG002|Overall Study|Randomization criteria not met|0|||
126782665|NCT01533428|456158267|FG000|Overall Study|Adverse Event|0|||
126782666|NCT01533428|456158268|FG001|Overall Study|Adverse Event|1|||
126782667|NCT01533428|456158267|FG000|Overall Study|Lost to Follow-up|2|||
126782668|NCT01533428|456158268|FG001|Overall Study|Lost to Follow-up|1|||
126782669|NCT01533428|456158267|FG000|Overall Study|Withdrawal by Subject|7|||
126782670|NCT01533428|456158268|FG001|Overall Study|Withdrawal by Subject|6|||
126782671|NCT01364870|456158269|FG000|Overall Study|Withdrawal by Subject|13|||
126782672|NCT01364870|456158270|FG001|Overall Study|Withdrawal by Subject|24|||
126782673|NCT01364870|456158271|FG002|Overall Study|Withdrawal by Subject|10|||
126782674|NCT01364870|456158269|FG000|Overall Study|Adverse Event|8|||
126782675|NCT01364870|456158270|FG001|Overall Study|Adverse Event|6|||
126782676|NCT01364870|456158271|FG002|Overall Study|Adverse Event|4|||
126782677|NCT01364870|456158269|FG000|Overall Study|Protocol Violation|1|||
126782678|NCT01364870|456158270|FG001|Overall Study|Protocol Violation|0|||
126782679|NCT01364870|456158271|FG002|Overall Study|Protocol Violation|0|||
126782680|NCT01200394|456158272|FG000|Overall Study|Adverse Event|0|||
126782681|NCT01200394|456158273|FG001|Overall Study|Adverse Event|14|||
126782682|NCT01200394|456158272|FG000|Overall Study|Death|1|||
126782683|NCT01200394|456158273|FG001|Overall Study|Death|0|||
126782684|NCT01200394|456158272|FG000|Overall Study|Lost to Follow-up|0|||
126782685|NCT01200394|456158273|FG001|Overall Study|Lost to Follow-up|1|||
126782686|NCT01200394|456158272|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
126782687|NCT01200394|456158273|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
126782688|NCT01200394|456158272|FG000|Overall Study|Protocol Violation|0|||
126782689|NCT01200394|456158273|FG001|Overall Study|Protocol Violation|3|||
126782690|NCT01200394|456158272|FG000|Overall Study|Withdrawal by Subject|0|||
126782691|NCT01200394|456158273|FG001|Overall Study|Withdrawal by Subject|5|||
126782692|NCT01200394|456158272|FG000|Overall Study|Other|0|||
126751539|NCT02795182|456037658|FG000|Overall Study|Death|5|||
126751540|NCT02795182|456037659|FG001|Overall Study|Death|4|||
126751541|NCT02795182|456037660|FG002|Overall Study|Death|4|||
126751542|NCT02795182|456037661|FG003|Overall Study|Death|18|||
126751543|NCT02795182|456037658|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
126751544|NCT02795182|456037659|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
126751545|NCT02795182|456037660|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
126751546|NCT02795182|456037661|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
126751547|NCT02795182|456037658|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
126751548|NCT02795182|456037659|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
126751549|NCT02795182|456037660|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
126751550|NCT02795182|456037661|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
126751551|NCT02795182|456037658|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
126751552|NCT02795182|456037659|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
126751553|NCT02795182|456037660|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
126751554|NCT02795182|456037661|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
126751555|NCT02795182|456037658|FG000|Overall Study|Withdrawal by Subject|4|||
126751556|NCT02795182|456037659|FG001|Overall Study|Withdrawal by Subject|0|||
126751557|NCT02795182|456037660|FG002|Overall Study|Withdrawal by Subject|0|||
126751558|NCT02795182|456037661|FG003|Overall Study|Withdrawal by Subject|3|||
126751559|NCT02795182|456037658|FG000|Overall Study|Lost to Follow-up|0|||
126751560|NCT02795182|456037659|FG001|Overall Study|Lost to Follow-up|0|||
126751561|NCT02795182|456037660|FG002|Overall Study|Lost to Follow-up|1|||
126751562|NCT02795182|456037661|FG003|Overall Study|Lost to Follow-up|1|||
126751563|NCT02795182|456037658|FG000|Overall Study|Roll Over to Long Term Extension|3|||
126751564|NCT02795182|456037659|FG001|Overall Study|Roll Over to Long Term Extension|3|||
126751565|NCT02795182|456037660|FG002|Overall Study|Roll Over to Long Term Extension|2|||
126751566|NCT02795182|456037661|FG003|Overall Study|Roll Over to Long Term Extension|5|||
126751567|NCT02795182|456037658|FG000|Overall Study|Progressive Disease|0|||
126751568|NCT02795182|456037659|FG001|Overall Study|Progressive Disease|1|||
126751569|NCT02795182|456037660|FG002|Overall Study|Progressive Disease|0|||
126751570|NCT02795182|456037661|FG003|Overall Study|Progressive Disease|4|||
126782693|NCT01200394|456158273|FG001|Overall Study|Other|1|||
126782694|NCT02666430|456158274|FG000|Period 1|Lost to Follow-up|1|||
126782695|NCT02666430|456158275|FG001|Period 1|Lost to Follow-up|0|||
126782696|NCT02666430|456158274|FG000|Period 1|Adverse Event|0|||
126751571|NCT02795182|456037658|FG000|Overall Study|Physician Decision|0|||
126782697|NCT02666430|456158275|FG001|Period 1|Adverse Event|1|||
126751572|NCT02795182|456037659|FG001|Overall Study|Physician Decision|0|||
126751573|NCT02795182|456037660|FG002|Overall Study|Physician Decision|0|||
126751574|NCT02795182|456037661|FG003|Overall Study|Physician Decision|1|||
126751575|NCT04107935|456037662|FG000|Overall Study|Death|1|||
126751576|NCT04107935|456037663|FG001|Overall Study|Death|0|||
126751577|NCT01021553|456037664|FG000|Overall Study|Adverse Event|1|||
126751578|NCT01021553|456037665|FG001|Overall Study|Adverse Event|0|||
126751579|NCT01021553|456037666|FG002|Overall Study|Adverse Event|0|||
126751580|NCT01021553|456037664|FG000|Overall Study|Lack of Efficacy|2|||
126751581|NCT01021553|456037665|FG001|Overall Study|Lack of Efficacy|2|||
126751582|NCT01021553|456037666|FG002|Overall Study|Lack of Efficacy|0|||
126751583|NCT01021553|456037664|FG000|Overall Study|Protocol Violation|0|||
126751584|NCT01021553|456037665|FG001|Overall Study|Protocol Violation|2|||
126751585|NCT01021553|456037666|FG002|Overall Study|Protocol Violation|2|||
126751586|NCT01021553|456037664|FG000|Overall Study|Lost to Follow-up|0|||
126751587|NCT01021553|456037665|FG001|Overall Study|Lost to Follow-up|0|||
126751588|NCT01021553|456037666|FG002|Overall Study|Lost to Follow-up|1|||
126751589|NCT01021553|456037664|FG000|Overall Study|Withdrawal by Subject|1|||
126751590|NCT01021553|456037665|FG001|Overall Study|Withdrawal by Subject|1|||
126751591|NCT01021553|456037666|FG002|Overall Study|Withdrawal by Subject|0|||
126751592|NCT00033293|456037667|FG000|Overall Study|Death|0|||
126751593|NCT00033293|456037668|FG001|Overall Study|Death|1|||
126751594|NCT00033293|456037667|FG000|Overall Study|Lack of Efficacy|5|||
126751595|NCT00033293|456037668|FG001|Overall Study|Lack of Efficacy|8|||
126751596|NCT00033293|456037667|FG000|Overall Study|Lost to Follow-up|0|||
126751597|NCT00033293|456037668|FG001|Overall Study|Lost to Follow-up|1|||
126751598|NCT00033293|456037667|FG000|Overall Study|Physician Decision|3|||
126751599|NCT00033293|456037668|FG001|Overall Study|Physician Decision|1|||
126751600|NCT00033293|456037667|FG000|Overall Study|Withdrawal by Subject|1|||
126751601|NCT00033293|456037668|FG001|Overall Study|Withdrawal by Subject|0|||
126751602|NCT00033293|456037667|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
126751603|NCT00033293|456037668|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
126751604|NCT00033293|456037667|FG000|Overall Study|Treatment refused|0|||
126751605|NCT00033293|456037668|FG001|Overall Study|Treatment refused|6|||
126751606|NCT00890201|456037669|FG000|Overall Study|Protocol Violation|5|||
126751607|NCT00890201|456037670|FG001|Overall Study|Protocol Violation|56|||
126751608|NCT00935701|456037671|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
126751609|NCT02087241|456037672|FG000|Overall Study|Death|2|||
126751610|NCT02087241|456037673|FG001|Overall Study|Death|1|||
126751611|NCT02087241|456037674|FG002|Overall Study|Death|1|||
126751612|NCT02087241|456037675|FG003|Overall Study|Death|1|||
126751613|NCT02087241|456037672|FG000|Overall Study|Withdrawal by Subject|1|||
126751614|NCT02087241|456037673|FG001|Overall Study|Withdrawal by Subject|0|||
126751615|NCT02087241|456037674|FG002|Overall Study|Withdrawal by Subject|0|||
126751616|NCT02087241|456037675|FG003|Overall Study|Withdrawal by Subject|1|||
126751617|NCT02087241|456037672|FG000|Overall Study|Progressive Disease|0|||
126751618|NCT02087241|456037673|FG001|Overall Study|Progressive Disease|0|||
126751619|NCT02087241|456037674|FG002|Overall Study|Progressive Disease|0|||
126751620|NCT02087241|456037675|FG003|Overall Study|Progressive Disease|1|||
126751621|NCT02087241|456037672|FG000|Overall Study|Study Terminated by Sponsor|0|||
126751622|NCT02087241|456037673|FG001|Overall Study|Study Terminated by Sponsor|2|||
126751623|NCT02087241|456037674|FG002|Overall Study|Study Terminated by Sponsor|0|||
126751624|NCT02087241|456037675|FG003|Overall Study|Study Terminated by Sponsor|4|||
126751625|NCT02181504|456037676|FG000|Overall Study|Adverse Event|1|||
126751626|NCT02181504|456037677|FG001|Overall Study|Adverse Event|1|||
126751627|NCT02181504|456037678|FG002|Overall Study|Adverse Event|1|||
126751628|NCT02463331|456037686|FG000|Overall Study|Adverse Event|4|||
126751629|NCT02463331|456037687|FG001|Overall Study|Adverse Event|2|||
126751630|NCT02463331|456037686|FG000|Overall Study|Lost to Follow-up|1|||
126751631|NCT02463331|456037687|FG001|Overall Study|Lost to Follow-up|1|||
126751632|NCT02463331|456037686|FG000|Overall Study|Pregnancy|2|||
126622966|NCT00296504|455575951|FG001|Final Analysis|Insufficient Viral Load Response|0|||
126751633|NCT02463331|456037687|FG001|Overall Study|Pregnancy|3|||
126751634|NCT02463331|456037686|FG000|Overall Study|Lack of Efficacy|6|||
126751635|NCT02463331|456037687|FG001|Overall Study|Lack of Efficacy|0|||
126622967|NCT00296504|455575952|FG002|Final Analysis|Insufficient Viral Load Response|0|||
126751636|NCT02463331|456037686|FG000|Overall Study|Physician Decision|3|||
126751637|NCT02463331|456037687|FG001|Overall Study|Physician Decision|0|||
126751638|NCT02274766|456037688|FG000|Overall Study|Withdrawal by Subject|3|||
126751639|NCT02274766|456037689|FG001|Overall Study|Withdrawal by Subject|6|||
126751640|NCT02274766|456037688|FG000|Overall Study|Did Not Receive Study Drug|1|||
126751641|NCT02274766|456037689|FG001|Overall Study|Did Not Receive Study Drug|1|||
126751642|NCT02274766|456037688|FG000|Overall Study|Subject Unwilling to Proceed|0|||
126751643|NCT02274766|456037689|FG001|Overall Study|Subject Unwilling to Proceed|1|||
126751644|NCT02274766|456037688|FG000|Overall Study|Adverse Event|0|||
126751645|NCT02274766|456037689|FG001|Overall Study|Adverse Event|1|||
126751646|NCT03818399|456039615|FG000|Overall Study|Lost to Follow-up|11|||
126751647|NCT03818399|456039615|FG000|Overall Study|Withdrawal by Subject|1|||
126751648|NCT03818399|456039615|FG000|Overall Study|Protocol Violation|2|||
126782698|NCT02666430|456158274|FG000|Period 2|Withdrawal by Subject|1|||
126782699|NCT02666430|456158275|FG001|Period 2|Withdrawal by Subject|4|||
126782700|NCT02666430|456158274|FG000|Period 3|Lost to Follow-up|1|||
126782701|NCT02666430|456158275|FG001|Period 3|Lost to Follow-up|0|||
126782702|NCT03828461|456158276|FG000|Overall Study|Lost to Follow-up|1|||
126782703|NCT03828461|456158276|FG000|Overall Study|Withdrawal by Subject|3|||
126782704|NCT00576199|456158277|FG000|Overall Study|Adverse Event|12|||
126782705|NCT00576199|456158277|FG000|Overall Study|Insufficient Therapeutic Response|14|||
126782706|NCT00576199|456158277|FG000|Overall Study|Refused Treatment|2|||
126782707|NCT00576199|456158277|FG000|Overall Study|Reason Unspecified|2|||
126782708|NCT04317053|456158278|FG000|Overall Study|Withdrawn (screen failure)|4|||
126782709|NCT04317053|456158279|FG001|Overall Study|Withdrawn (screen failure)|2|||
126782710|NCT01621490|456160072|FG000|Overall Study|Subject no longer meets study criteria|0|||
126782711|NCT01621490|456160073|FG001|Overall Study|Subject no longer meets study criteria|0|||
126782712|NCT01621490|456160074|FG002|Overall Study|Subject no longer meets study criteria|0|||
126782713|NCT01621490|456160075|FG003|Overall Study|Subject no longer meets study criteria|0|||
126782714|NCT01621490|456160076|FG004|Overall Study|Subject no longer meets study criteria|1|||
126782715|NCT01621490|456160077|FG005|Overall Study|Subject no longer meets study criteria|0|||
126782716|NCT01621490|456160078|FG006|Overall Study|Subject no longer meets study criteria|0|||
126782717|NCT01621490|456160079|FG007|Overall Study|Subject no longer meets study criteria|0|||
126782718|NCT01621490|456160080|FG008|Overall Study|Subject no longer meets study criteria|0|||
126782719|NCT01621490|456160081|FG009|Overall Study|Subject no longer meets study criteria|0|||
126782720|NCT01621490|456160082|FG010|Overall Study|Subject no longer meets study criteria|0|||
126782721|NCT01621490|456160072|FG000|Overall Study|Maximum clinical benefit|3|||
126782722|NCT01621490|456160073|FG001|Overall Study|Maximum clinical benefit|2|||
126782723|NCT01621490|456160074|FG002|Overall Study|Maximum clinical benefit|0|||
126782724|NCT01621490|456160075|FG003|Overall Study|Maximum clinical benefit|0|||
126782725|NCT01621490|456160076|FG004|Overall Study|Maximum clinical benefit|0|||
126782726|NCT01621490|456160077|FG005|Overall Study|Maximum clinical benefit|0|||
126782727|NCT01621490|456160078|FG006|Overall Study|Maximum clinical benefit|1|||
126782728|NCT01621490|456160079|FG007|Overall Study|Maximum clinical benefit|2|||
126782729|NCT01621490|456160080|FG008|Overall Study|Maximum clinical benefit|2|||
126782730|NCT01621490|456160081|FG009|Overall Study|Maximum clinical benefit|0|||
126782731|NCT01621490|456160082|FG010|Overall Study|Maximum clinical benefit|0|||
126782732|NCT01621490|456160072|FG000|Overall Study|Withdrawal by Subject|1|||
126782733|NCT01621490|456160073|FG001|Overall Study|Withdrawal by Subject|0|||
126782734|NCT01621490|456160074|FG002|Overall Study|Withdrawal by Subject|0|||
126782735|NCT01621490|456160075|FG003|Overall Study|Withdrawal by Subject|0|||
126782736|NCT01621490|456160076|FG004|Overall Study|Withdrawal by Subject|0|||
126782737|NCT01621490|456160077|FG005|Overall Study|Withdrawal by Subject|1|||
126782738|NCT01621490|456160078|FG006|Overall Study|Withdrawal by Subject|0|||
126782739|NCT01621490|456160079|FG007|Overall Study|Withdrawal by Subject|0|||
126782740|NCT01621490|456160080|FG008|Overall Study|Withdrawal by Subject|0|||
126782741|NCT01621490|456160081|FG009|Overall Study|Withdrawal by Subject|0|||
126782742|NCT01621490|456160082|FG010|Overall Study|Withdrawal by Subject|0|||
126782743|NCT01621490|456160072|FG000|Overall Study|Subject request to discontinue study|1|||
126751649|NCT00535236|456039618|FG000|Overall Study|Adverse Event|1|||
126751650|NCT00535236|456039619|FG001|Overall Study|Adverse Event|0|||
126751651|NCT00535236|456039620|FG002|Overall Study|Adverse Event|9|||
126751652|NCT00535236|456039621|FG003|Overall Study|Adverse Event|3|||
126751653|NCT00535236|456039622|FG004|Overall Study|Adverse Event|3|||
126751654|NCT00535236|456039623|FG005|Overall Study|Adverse Event|0|||
126751655|NCT00535236|456039624|FG006|Overall Study|Adverse Event|5|||
126751656|NCT00535236|456039625|FG007|Overall Study|Adverse Event|1|||
126751657|NCT00535236|456039626|FG008|Overall Study|Adverse Event|2|||
126751658|NCT00535236|456039627|FG009|Overall Study|Adverse Event|1|||
126751659|NCT00535236|456039618|FG000|Overall Study|Lost to Follow-up|1|||
126751660|NCT00535236|456039619|FG001|Overall Study|Lost to Follow-up|2|||
126751661|NCT00535236|456039620|FG002|Overall Study|Lost to Follow-up|0|||
126751662|NCT00535236|456039621|FG003|Overall Study|Lost to Follow-up|0|||
126782744|NCT01621490|456160073|FG001|Overall Study|Subject request to discontinue study|3|||
126782745|NCT01621490|456160074|FG002|Overall Study|Subject request to discontinue study|1|||
126782746|NCT01621490|456160075|FG003|Overall Study|Subject request to discontinue study|1|||
126782747|NCT01621490|456160076|FG004|Overall Study|Subject request to discontinue study|0|||
126782748|NCT01621490|456160077|FG005|Overall Study|Subject request to discontinue study|2|||
126751663|NCT00535236|456039622|FG004|Overall Study|Lost to Follow-up|2|||
126751664|NCT00535236|456039623|FG005|Overall Study|Lost to Follow-up|0|||
126782749|NCT01621490|456160078|FG006|Overall Study|Subject request to discontinue study|1|||
126782750|NCT01621490|456160079|FG007|Overall Study|Subject request to discontinue study|0|||
126751665|NCT00535236|456039624|FG006|Overall Study|Lost to Follow-up|0|||
126751666|NCT00535236|456039625|FG007|Overall Study|Lost to Follow-up|0|||
126751667|NCT00535236|456039626|FG008|Overall Study|Lost to Follow-up|6|||
126751668|NCT00535236|456039627|FG009|Overall Study|Lost to Follow-up|1|||
126751669|NCT00535236|456039618|FG000|Overall Study|Physician Decision|0|||
126622968|NCT00296504|455575953|FG003|Final Analysis|Insufficient Viral Load Response|0|||
126622969|NCT00296504|455575954|FG004|Final Analysis|Insufficient Viral Load Response|0|||
126622970|NCT00296504|455575955|FG005|Final Analysis|Insufficient Viral Load Response|0|||
126622971|NCT00296504|455575956|FG006|Final Analysis|Insufficient Viral Load Response|0|||
126622972|NCT00296504|455575957|FG007|Final Analysis|Insufficient Viral Load Response|0|||
126622973|NCT00296504|455575958|FG008|Final Analysis|Insufficient Viral Load Response|6|||
126622974|NCT00296504|455575950|FG000|Final Analysis|Adverse Event|0|||
126622975|NCT00296504|455575951|FG001|Final Analysis|Adverse Event|0|||
126622976|NCT00296504|455575952|FG002|Final Analysis|Adverse Event|0|||
126622977|NCT00296504|455575953|FG003|Final Analysis|Adverse Event|0|||
126622978|NCT00296504|455575954|FG004|Final Analysis|Adverse Event|0|||
126622979|NCT00296504|455575955|FG005|Final Analysis|Adverse Event|0|||
126622980|NCT00296504|455575956|FG006|Final Analysis|Adverse Event|0|||
126622981|NCT00296504|455575957|FG007|Final Analysis|Adverse Event|0|||
126622982|NCT00296504|455575958|FG008|Final Analysis|Adverse Event|2|||
126622983|NCT00296504|455575950|FG000|Final Analysis|Pregnancy|0|||
126622984|NCT00296504|455575951|FG001|Final Analysis|Pregnancy|0|||
126622985|NCT00296504|455575952|FG002|Final Analysis|Pregnancy|0|||
126622986|NCT00296504|455575953|FG003|Final Analysis|Pregnancy|0|||
126622987|NCT00296504|455575954|FG004|Final Analysis|Pregnancy|0|||
126622988|NCT00296504|455575955|FG005|Final Analysis|Pregnancy|0|||
126622989|NCT00296504|455575956|FG006|Final Analysis|Pregnancy|0|||
126622990|NCT00296504|455575957|FG007|Final Analysis|Pregnancy|0|||
126622991|NCT00296504|455575958|FG008|Final Analysis|Pregnancy|4|||
126622992|NCT00296504|455575950|FG000|Final Analysis|Tuberculosis|0|||
126622993|NCT00296504|455575951|FG001|Final Analysis|Tuberculosis|0|||
126622994|NCT00296504|455575952|FG002|Final Analysis|Tuberculosis|0|||
126622995|NCT00296504|455575953|FG003|Final Analysis|Tuberculosis|0|||
126622996|NCT00296504|455575954|FG004|Final Analysis|Tuberculosis|0|||
126622997|NCT00296504|455575955|FG005|Final Analysis|Tuberculosis|0|||
126622998|NCT00296504|455575956|FG006|Final Analysis|Tuberculosis|0|||
126622999|NCT00296504|455575957|FG007|Final Analysis|Tuberculosis|0|||
126623000|NCT00296504|455575958|FG008|Final Analysis|Tuberculosis|1|||
126623001|NCT00296504|455575950|FG000|Final Analysis|Participant Moved to Another Country|0|||
126623002|NCT00296504|455575951|FG001|Final Analysis|Participant Moved to Another Country|0|||
126623003|NCT00296504|455575952|FG002|Final Analysis|Participant Moved to Another Country|0|||
126623004|NCT00296504|455575953|FG003|Final Analysis|Participant Moved to Another Country|0|||
126623005|NCT00296504|455575954|FG004|Final Analysis|Participant Moved to Another Country|0|||
126623006|NCT00296504|455575955|FG005|Final Analysis|Participant Moved to Another Country|0|||
126623007|NCT00296504|455575956|FG006|Final Analysis|Participant Moved to Another Country|0|||
126623008|NCT00296504|455575957|FG007|Final Analysis|Participant Moved to Another Country|0|||
126623009|NCT00296504|455575958|FG008|Final Analysis|Participant Moved to Another Country|1|||
126623010|NCT00296504|455575950|FG000|Final Analysis|Poor Adherence|0|||
126623011|NCT00296504|455575951|FG001|Final Analysis|Poor Adherence|0|||
126623012|NCT00296504|455575952|FG002|Final Analysis|Poor Adherence|0|||
126623013|NCT00296504|455575953|FG003|Final Analysis|Poor Adherence|0|||
126623014|NCT00296504|455575954|FG004|Final Analysis|Poor Adherence|0|||
126623015|NCT00296504|455575955|FG005|Final Analysis|Poor Adherence|0|||
126623016|NCT00296504|455575956|FG006|Final Analysis|Poor Adherence|0|||
126623017|NCT00296504|455575957|FG007|Final Analysis|Poor Adherence|0|||
126623018|NCT00296504|455575958|FG008|Final Analysis|Poor Adherence|1|||
126623019|NCT02162771|455575965|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
126623020|NCT02162771|455575966|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
126623021|NCT02162771|455575965|FG000|Core Study Period (Part 2)|Adverse Event|4|||
126623022|NCT02162771|455575966|FG001|Core Study Period (Part 2)|Adverse Event|1|||
126623023|NCT02162771|455575965|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
126623024|NCT02162771|455575966|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
126623025|NCT02162771|455575965|FG000|Core Study Period (Part 2)|Physician Decision|0|||
126623026|NCT02162771|455575966|FG001|Core Study Period (Part 2)|Physician Decision|2|||
126623027|NCT02162771|455575965|FG000|Core Study Period (Part 2)|Death|1|||
126623028|NCT02162771|455575966|FG001|Core Study Period (Part 2)|Death|0|||
126623029|NCT02162771|455575965|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
126623030|NCT02162771|455575966|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
126623031|NCT02162771|455575965|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
126623032|NCT02162771|455575966|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
126751670|NCT00535236|456039619|FG001|Overall Study|Physician Decision|0|||
126751671|NCT00535236|456039620|FG002|Overall Study|Physician Decision|0|||
126623033|NCT02162771|455575965|FG000|Maintenance Study Period (Part 2)|Death|2|||
126623034|NCT02162771|455575966|FG001|Maintenance Study Period (Part 2)|Death|1|||
126623035|NCT02162771|455575965|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
126751672|NCT00535236|456039621|FG003|Overall Study|Physician Decision|0|||
126623036|NCT02162771|455575966|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
126623037|NCT02162771|455575965|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
126623038|NCT02162771|455575966|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
126623039|NCT02162771|455575965|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
126751673|NCT00535236|456039622|FG004|Overall Study|Physician Decision|1|||
126623040|NCT02162771|455575966|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
126623041|NCT03647709|455575983|FG000|Overall Study|Lost to Follow-up|5|||
126623042|NCT03647709|455575983|FG000|Overall Study|Physician Decision|6|||
126623043|NCT03647709|455575983|FG000|Overall Study|Withdrawal by Subject|3|||
126623044|NCT00449033|455575986|FG000|Treatment Period|Adverse Event|117|||
126623045|NCT00449033|455575987|FG001|Treatment Period|Adverse Event|83|||
126623046|NCT00449033|455575986|FG000|Treatment Period|Death|21|||
126623047|NCT00449033|455575987|FG001|Treatment Period|Death|12|||
126623048|NCT00449033|455575986|FG000|Treatment Period|Lost to Follow-up|0|||
126623049|NCT00449033|455575987|FG001|Treatment Period|Lost to Follow-up|2|||
126623050|NCT00449033|455575986|FG000|Treatment Period|Physician Decision|4|||
126623051|NCT00449033|455575987|FG001|Treatment Period|Physician Decision|5|||
126623052|NCT00449033|455575986|FG000|Treatment Period|Protocol Violation|8|||
126623053|NCT00449033|455575987|FG001|Treatment Period|Protocol Violation|7|||
126623054|NCT00449033|455575986|FG000|Treatment Period|Disease Progression|231|||
126623055|NCT00449033|455575987|FG001|Treatment Period|Disease Progression|288|||
126623056|NCT00449033|455575986|FG000|Treatment Period|Consent Withdrawn|36|||
126623057|NCT00449033|455575987|FG001|Treatment Period|Consent Withdrawn|20|||
126623058|NCT00449033|455575986|FG000|Treatment Period|Amended Protocol Criteria|22|||
126623059|NCT00449033|455575987|FG001|Treatment Period|Amended Protocol Criteria|18|||
126623060|NCT00449033|455575986|FG000|Treatment Period|Non-compliance|7|||
126623061|NCT00449033|455575987|FG001|Treatment Period|Non-compliance|8|||
126623062|NCT00449033|455575986|FG000|Treatment Period|Second Malignancy|0|||
126623063|NCT00449033|455575987|FG001|Treatment Period|Second Malignancy|1|||
126623064|NCT00449033|455575986|FG000|Treatment Period|Reason Missing|0|||
126623065|NCT00449033|455575987|FG001|Treatment Period|Reason Missing|4|||
126623066|NCT00449033|455575986|FG000|Treatment Period|Treatment Ongoing|6|||
126623067|NCT00449033|455575987|FG001|Treatment Period|Treatment Ongoing|4|||
126623068|NCT00449033|455575986|FG000|Follow-up Period|Death|299|||
126623069|NCT00449033|455575987|FG001|Follow-up Period|Death|311|||
126623070|NCT00449033|455575986|FG000|Follow-up Period|Lost to Follow-up|6|||
126623071|NCT00449033|455575987|FG001|Follow-up Period|Lost to Follow-up|10|||
126623072|NCT00449033|455575986|FG000|Follow-up Period|Reason Missing|120|||
126623073|NCT00449033|455575987|FG001|Follow-up Period|Reason Missing|113|||
126623074|NCT01257698|455575988|FG000|Overall Study|Protocol Violation|4|||
126623075|NCT01257698|455575989|FG001|Overall Study|Protocol Violation|0|||
126623076|NCT04393779|455575990|FG000|Overall Study|Death|1|||
126623077|NCT04393779|455575990|FG000|Overall Study|Device reintervention or explant|4|||
126623078|NCT01190228|455575991|FG000|Overall Study|Protocol Violation|4|||
126623079|NCT01190228|455575992|FG001|Overall Study|Protocol Violation|0|||
126623080|NCT01190228|455575993|FG002|Overall Study|Protocol Violation|0|||
126623081|NCT01190228|455575991|FG000|Overall Study|Withdrawal by Subject|1|||
126623082|NCT01190228|455575992|FG001|Overall Study|Withdrawal by Subject|0|||
126623083|NCT01190228|455575993|FG002|Overall Study|Withdrawal by Subject|0|||
126623084|NCT01876823|455575997|FG000|Overall Study|Withdrawal by Subject|5|||
126623085|NCT01876823|455575997|FG000|Overall Study|Physician Decision|2|||
126623086|NCT01876823|455575997|FG000|Overall Study|Patients moved|2|||
126623087|NCT01770509|455575998|FG000|Overall Study|Injury|0|||
126623088|NCT01770509|455575999|FG001|Overall Study|Injury|1|||
126623089|NCT01770509|455575998|FG000|Overall Study|Lost to Follow-up|1|||
126623090|NCT01770509|455575999|FG001|Overall Study|Lost to Follow-up|2|||
126623091|NCT00308113|455576000|FG000|Overall Study|Protocol closure|0|||
126623092|NCT00308113|455576001|FG001|Overall Study|Protocol closure|0|||
126623093|NCT00308113|455576002|FG002|Overall Study|Protocol closure|0|||
126623094|NCT00308113|455576003|FG003|Overall Study|Protocol closure|1|||
126623095|NCT00748098|455576004|FG000|First Treatment Intervention Period|Adverse Event|1|||
126623096|NCT00748098|455576005|FG001|First Treatment Intervention Period|Adverse Event|1|||
126623097|NCT00748098|455576004|FG000|First Treatment Intervention Period|Protocol Violation|1|||
126623098|NCT00748098|455576005|FG001|First Treatment Intervention Period|Protocol Violation|0|||
126623099|NCT00748098|455576004|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
126623100|NCT00748098|455576005|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
126623101|NCT00748098|455576004|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
126623102|NCT00748098|455576005|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
126751674|NCT00535236|456039623|FG005|Overall Study|Physician Decision|0|||
126751675|NCT00535236|456039624|FG006|Overall Study|Physician Decision|1|||
126751676|NCT00535236|456039625|FG007|Overall Study|Physician Decision|0|||
126623103|NCT00748098|455576004|FG000|First Taper Period|Protocol Violation|1|||
126623104|NCT00748098|455576005|FG001|First Taper Period|Protocol Violation|0|||
126623105|NCT00748098|455576004|FG000|First Taper Period|Withdrawal by Subject|2|||
126623106|NCT00748098|455576005|FG001|First Taper Period|Withdrawal by Subject|0|||
126623107|NCT00748098|455576004|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
126751677|NCT00535236|456039626|FG008|Overall Study|Physician Decision|0|||
126623108|NCT00748098|455576005|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
126623109|NCT00748098|455576004|FG000|1-Week Washout Period|Adverse Event|0|||
126623110|NCT00748098|455576005|FG001|1-Week Washout Period|Adverse Event|1|||
126623111|NCT00748098|455576004|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
126751678|NCT00535236|456039627|FG009|Overall Study|Physician Decision|0|||
126751679|NCT00535236|456039618|FG000|Overall Study|Protocol Violation|2|||
126751680|NCT00535236|456039619|FG001|Overall Study|Protocol Violation|0|||
126751681|NCT00535236|456039620|FG002|Overall Study|Protocol Violation|1|||
126751682|NCT00535236|456039621|FG003|Overall Study|Protocol Violation|0|||
126751683|NCT00535236|456039622|FG004|Overall Study|Protocol Violation|0|||
126751684|NCT00535236|456039623|FG005|Overall Study|Protocol Violation|0|||
126751685|NCT00535236|456039624|FG006|Overall Study|Protocol Violation|0|||
126751686|NCT00535236|456039625|FG007|Overall Study|Protocol Violation|0|||
126751687|NCT00535236|456039626|FG008|Overall Study|Protocol Violation|1|||
126751688|NCT00535236|456039627|FG009|Overall Study|Protocol Violation|0|||
126751689|NCT00535236|456039618|FG000|Overall Study|Withdrawal by Subject|3|||
126751690|NCT00535236|456039619|FG001|Overall Study|Withdrawal by Subject|0|||
126751691|NCT00535236|456039620|FG002|Overall Study|Withdrawal by Subject|2|||
126751692|NCT00535236|456039621|FG003|Overall Study|Withdrawal by Subject|1|||
126751693|NCT00535236|456039622|FG004|Overall Study|Withdrawal by Subject|6|||
126751694|NCT00535236|456039623|FG005|Overall Study|Withdrawal by Subject|1|||
126751695|NCT00535236|456039624|FG006|Overall Study|Withdrawal by Subject|5|||
126751696|NCT00535236|456039625|FG007|Overall Study|Withdrawal by Subject|0|||
126751697|NCT00535236|456039626|FG008|Overall Study|Withdrawal by Subject|4|||
126751698|NCT00535236|456039627|FG009|Overall Study|Withdrawal by Subject|2|||
126751699|NCT00141297|456039629|FG000|Overall Study|Adverse Event|0|||
126751700|NCT00141297|456039630|FG001|Overall Study|Adverse Event|0|||
126751701|NCT00141297|456039631|FG002|Overall Study|Adverse Event|1|||
126751702|NCT00141297|456039632|FG003|Overall Study|Adverse Event|0|||
126751703|NCT00141297|456039633|FG004|Overall Study|Adverse Event|1|||
126751704|NCT00141297|456039634|FG005|Overall Study|Adverse Event|1|||
126751705|NCT00141297|456039635|FG006|Overall Study|Adverse Event|0|||
126751706|NCT00141297|456039636|FG007|Overall Study|Adverse Event|1|||
126751707|NCT00141297|456039637|FG008|Overall Study|Adverse Event|1|||
126751708|NCT00141297|456039638|FG009|Overall Study|Adverse Event|0|||
126751709|NCT00141297|456039629|FG000|Overall Study|Death|1|||
126751710|NCT00141297|456039630|FG001|Overall Study|Death|0|||
126751711|NCT00141297|456039631|FG002|Overall Study|Death|0|||
126751712|NCT00141297|456039632|FG003|Overall Study|Death|0|||
126751713|NCT00141297|456039633|FG004|Overall Study|Death|0|||
126751714|NCT00141297|456039634|FG005|Overall Study|Death|0|||
126751715|NCT00141297|456039635|FG006|Overall Study|Death|0|||
126751716|NCT00141297|456039636|FG007|Overall Study|Death|0|||
126751717|NCT00141297|456039637|FG008|Overall Study|Death|1|||
126751718|NCT00141297|456039638|FG009|Overall Study|Death|0|||
126751719|NCT00141297|456039629|FG000|Overall Study|Withdrawal by Subject|0|||
126751720|NCT00141297|456039630|FG001|Overall Study|Withdrawal by Subject|0|||
126751721|NCT00141297|456039631|FG002|Overall Study|Withdrawal by Subject|0|||
126751722|NCT00141297|456039632|FG003|Overall Study|Withdrawal by Subject|0|||
126751723|NCT00141297|456039633|FG004|Overall Study|Withdrawal by Subject|0|||
126751724|NCT00141297|456039634|FG005|Overall Study|Withdrawal by Subject|0|||
126751725|NCT00141297|456039635|FG006|Overall Study|Withdrawal by Subject|0|||
126751726|NCT00141297|456039636|FG007|Overall Study|Withdrawal by Subject|0|||
126751727|NCT00141297|456039637|FG008|Overall Study|Withdrawal by Subject|1|||
126751728|NCT00141297|456039638|FG009|Overall Study|Withdrawal by Subject|0|||
126751729|NCT00141297|456039629|FG000|Overall Study|Other|0|||
126751730|NCT00141297|456039630|FG001|Overall Study|Other|0|||
126751731|NCT00141297|456039631|FG002|Overall Study|Other|0|||
126751732|NCT00141297|456039632|FG003|Overall Study|Other|1|||
126751733|NCT00141297|456039633|FG004|Overall Study|Other|5|||
126751734|NCT00141297|456039634|FG005|Overall Study|Other|0|||
126751735|NCT00141297|456039635|FG006|Overall Study|Other|0|||
126751736|NCT00141297|456039636|FG007|Overall Study|Other|0|||
126751737|NCT00141297|456039637|FG008|Overall Study|Other|2|||
126751738|NCT00141297|456039638|FG009|Overall Study|Other|0|||
126751739|NCT00141297|456039629|FG000|Overall Study|Progressive Disease|2|||
126751740|NCT00141297|456039630|FG001|Overall Study|Progressive Disease|3|||
126751741|NCT00141297|456039631|FG002|Overall Study|Progressive Disease|6|||
126751742|NCT00141297|456039632|FG003|Overall Study|Progressive Disease|2|||
126782751|NCT01621490|456160080|FG008|Overall Study|Subject request to discontinue study|1|||
126782752|NCT01621490|456160081|FG009|Overall Study|Subject request to discontinue study|0|||
126782753|NCT01621490|456160082|FG010|Overall Study|Subject request to discontinue study|0|||
126751743|NCT00141297|456039633|FG004|Overall Study|Progressive Disease|15|||
126751744|NCT00141297|456039634|FG005|Overall Study|Progressive Disease|2|||
126751745|NCT00141297|456039635|FG006|Overall Study|Progressive Disease|3|||
126751746|NCT00141297|456039636|FG007|Overall Study|Progressive Disease|3|||
126751747|NCT00141297|456039637|FG008|Overall Study|Progressive Disease|15|||
126751748|NCT00141297|456039638|FG009|Overall Study|Progressive Disease|6|||
126751749|NCT00141297|456039629|FG000|Overall Study|Transitioned|0|||
126751750|NCT00141297|456039630|FG001|Overall Study|Transitioned|0|||
126751751|NCT00141297|456039631|FG002|Overall Study|Transitioned|0|||
126751752|NCT00141297|456039632|FG003|Overall Study|Transitioned|0|||
126751753|NCT00141297|456039633|FG004|Overall Study|Transitioned|1|||
126751754|NCT00141297|456039634|FG005|Overall Study|Transitioned|0|||
126751755|NCT00141297|456039635|FG006|Overall Study|Transitioned|0|||
126751756|NCT00141297|456039636|FG007|Overall Study|Transitioned|0|||
126751757|NCT00141297|456039637|FG008|Overall Study|Transitioned|0|||
126751758|NCT00141297|456039638|FG009|Overall Study|Transitioned|0|||
126751759|NCT00290355|456039639|FG000|Overall Study|Serious adverse event|7|||
126751760|NCT00290355|456039640|FG001|Overall Study|Serious adverse event|4|||
126751761|NCT00290355|456039639|FG000|Overall Study|Study product reactogenicity|1|||
126751762|NCT00290355|456039640|FG001|Overall Study|Study product reactogenicity|0|||
126751763|NCT00290355|456039639|FG000|Overall Study|Protocol Violation|1|||
126751764|NCT00290355|456039640|FG001|Overall Study|Protocol Violation|0|||
126751765|NCT00290355|456039639|FG000|Overall Study|Withdrawal by Subject|2|||
126751766|NCT00290355|456039640|FG001|Overall Study|Withdrawal by Subject|0|||
126751767|NCT00290355|456039639|FG000|Overall Study|Migrated / moved from the study area|1|||
126751768|NCT00290355|456039640|FG001|Overall Study|Migrated / moved from the study area|0|||
126751769|NCT00290355|456039639|FG000|Overall Study|Lost to Follow-up|3|||
126751770|NCT00290355|456039640|FG001|Overall Study|Lost to Follow-up|1|||
126751771|NCT00290355|456039639|FG000|Overall Study|Other|2|||
126751772|NCT00290355|456039640|FG001|Overall Study|Other|0|||
126751773|NCT01542632|456039641|FG000|Overall Study|Withdrawal of Consent|0|||
126751774|NCT01542632|456039642|FG001|Overall Study|Withdrawal of Consent|0|||
126751775|NCT01542632|456039643|FG002|Overall Study|Withdrawal of Consent|0|||
126751776|NCT01542632|456039644|FG003|Overall Study|Withdrawal of Consent|2|||
126751777|NCT01542632|456039645|FG004|Overall Study|Withdrawal of Consent|3|||
126751778|NCT01542632|456039646|FG005|Overall Study|Withdrawal of Consent|0|||
126751779|NCT01542632|456039641|FG000|Overall Study|Adverse Event|0|||
126751780|NCT01542632|456039642|FG001|Overall Study|Adverse Event|0|||
126751781|NCT01542632|456039643|FG002|Overall Study|Adverse Event|1|||
126751782|NCT01542632|456039644|FG003|Overall Study|Adverse Event|0|||
126751783|NCT01542632|456039645|FG004|Overall Study|Adverse Event|0|||
126751784|NCT01542632|456039646|FG005|Overall Study|Adverse Event|0|||
126751785|NCT01542632|456039641|FG000|Overall Study|Lost to Follow-up|0|||
126751786|NCT01542632|456039642|FG001|Overall Study|Lost to Follow-up|1|||
126751787|NCT01542632|456039643|FG002|Overall Study|Lost to Follow-up|0|||
126751788|NCT01542632|456039644|FG003|Overall Study|Lost to Follow-up|0|||
126751789|NCT01542632|456039645|FG004|Overall Study|Lost to Follow-up|0|||
126751790|NCT01542632|456039646|FG005|Overall Study|Lost to Follow-up|0|||
126751791|NCT01542632|456039641|FG000|Overall Study|Sponsor/Investigator Decision|0|||
126751792|NCT01542632|456039642|FG001|Overall Study|Sponsor/Investigator Decision|0|||
126751793|NCT01542632|456039643|FG002|Overall Study|Sponsor/Investigator Decision|0|||
126751794|NCT01542632|456039644|FG003|Overall Study|Sponsor/Investigator Decision|0|||
126751795|NCT01542632|456039645|FG004|Overall Study|Sponsor/Investigator Decision|1|||
126751796|NCT01542632|456039646|FG005|Overall Study|Sponsor/Investigator Decision|0|||
126751797|NCT00033514|456039647|FG000|Overall Study|Lost to Follow-up|1|||
126751798|NCT00033514|456039648|FG001|Overall Study|Lost to Follow-up|1|||
126751799|NCT00033514|456039647|FG000|Overall Study|Withdrawal by Subject|0|||
126751800|NCT00033514|456039648|FG001|Overall Study|Withdrawal by Subject|3|||
126751801|NCT01072500|456039652|FG000|Overall Study|Death|2|||
126751802|NCT01072500|456039653|FG001|Overall Study|Death|2|||
126751803|NCT01072500|456039652|FG000|Overall Study|Lost to Follow-up|5|||
126751804|NCT01072500|456039653|FG001|Overall Study|Lost to Follow-up|2|||
126751805|NCT01072500|456039652|FG000|Overall Study|Withdrawal by Subject|17|||
126751806|NCT01072500|456039653|FG001|Overall Study|Withdrawal by Subject|10|||
126751807|NCT03798366|456039654|FG000|Overall Study|Lost to Follow-up|0|||
126751808|NCT03798366|456039655|FG001|Overall Study|Lost to Follow-up|1|||
126751809|NCT01289028|456039660|FG000|Overall Study|Progressive Disease|49|||
126751810|NCT01289028|456039660|FG000|Overall Study|Adverse Event|14|||
126751811|NCT01289028|456039660|FG000|Overall Study|Withdrawal by Subject|6|||
126751812|NCT01289028|456039660|FG000|Overall Study|Death|4|||
126751813|NCT01289028|456039660|FG000|Overall Study|Lack of Efficacy|2|||
126751814|NCT01289028|456039660|FG000|Overall Study|No longer required|2|||
126751815|NCT01289028|456039660|FG000|Overall Study|Lost to Follow-up|2|||
126751816|NCT01289028|456039660|FG000|Overall Study|New Cancer Therapy|2|||
126751817|NCT01289028|456039660|FG000|Overall Study|Abnormal Lab Value|1|||
126751818|NCT01289028|456039660|FG000|Overall Study|Missing reason for discon|1|||
126751819|NCT02120469|456039661|FG000|Overall Study|HER-2/neu-amplified|1|||
126751820|NCT02120469|456039662|FG001|Overall Study|HER-2/neu-amplified|0|||
126751821|NCT02120469|456039663|FG002|Overall Study|HER-2/neu-amplified|1|||
126751822|NCT03267576|456039668|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
126751823|NCT03267576|456039669|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
126751824|NCT03267576|456039668|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
126751825|NCT03267576|456039669|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
126751826|NCT01369069|456039670|FG000|Overall Study|Lost to Follow-up|8|||
126751827|NCT01369069|456039671|FG001|Overall Study|Lost to Follow-up|9|||
126751828|NCT01369069|456039670|FG000|Overall Study|Withdrawal by Subject|9|||
126751829|NCT01369069|456039671|FG001|Overall Study|Withdrawal by Subject|7|||
126751830|NCT00882362|456039672|FG000|Overall Study|Adverse Event|13|||
126751831|NCT00882362|456039673|FG001|Overall Study|Adverse Event|10|||
126751832|NCT00882362|456039672|FG000|Overall Study|Withdrawal by Subject|13|||
126751833|NCT00882362|456039673|FG001|Overall Study|Withdrawal by Subject|10|||
126623112|NCT00748098|455576005|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
126623113|NCT00748098|455576004|FG000|Second Treatment Intervention Period|Adverse Event|4|||
126623114|NCT00748098|455576005|FG001|Second Treatment Intervention Period|Adverse Event|1|||
126623115|NCT00748098|455576004|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
126623116|NCT00748098|455576005|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
126623117|NCT00748098|455576004|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
126623118|NCT00748098|455576005|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
126623119|NCT00925288|455577589|FG000|Overall Study|Lost to Follow-up|9|||
126623120|NCT00925288|455577590|FG001|Overall Study|Lost to Follow-up|7|||
126623121|NCT01232569|455577591|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
126623122|NCT01232569|455577592|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
126623123|NCT01232569|455577593|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
126623124|NCT01232569|455577594|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
126623125|NCT01232569|455577591|FG000|Double-blind Treatment Period|Escape|2|||
126623126|NCT01232569|455577592|FG001|Double-blind Treatment Period|Escape|2|||
126623127|NCT01232569|455577593|FG002|Double-blind Treatment Period|Escape|0|||
126623128|NCT01232569|455577594|FG003|Double-blind Treatment Period|Escape|0|||
126623129|NCT01232569|455577591|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
126623130|NCT01232569|455577592|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
126623131|NCT01232569|455577593|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
126623132|NCT01232569|455577594|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
126623133|NCT01232569|455577591|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
126623134|NCT01232569|455577592|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
126623135|NCT01232569|455577593|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
126623136|NCT01232569|455577594|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
126623137|NCT01232569|455577591|FG000|Double-blind Treatment Period|Physician Decision|1|||
126623138|NCT01232569|455577592|FG001|Double-blind Treatment Period|Physician Decision|0|||
126623139|NCT01232569|455577593|FG002|Double-blind Treatment Period|Physician Decision|0|||
126623140|NCT01232569|455577594|FG003|Double-blind Treatment Period|Physician Decision|0|||
126623141|NCT01232569|455577591|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
126623142|NCT01232569|455577592|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
126623143|NCT01232569|455577593|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
126623144|NCT01232569|455577594|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
126623145|NCT01232569|455577591|FG000|Double-blind Treatment Period|Death|2|||
126623146|NCT01232569|455577592|FG001|Double-blind Treatment Period|Death|0|||
126623147|NCT01232569|455577593|FG002|Double-blind Treatment Period|Death|0|||
126623148|NCT01232569|455577594|FG003|Double-blind Treatment Period|Death|0|||
126623149|NCT04044352|455577595|FG000|Overall Study|Lost to Follow-up|9|||
126623150|NCT04044352|455577595|FG000|Overall Study|Withdrawal by Subject|2|||
126623151|NCT00651937|455577596|FG000|Overall Study|Withdrawal by Subject|4|||
126623152|NCT00651937|455577597|FG001|Overall Study|Withdrawal by Subject|1|||
126623153|NCT00814632|455577598|FG000|Overall Study|Lack of Efficacy|2|||
126623154|NCT00635570|455577600|FG000|Overall Study|Lost to Follow-up|8|||
126623155|NCT00635570|455577601|FG001|Overall Study|Lost to Follow-up|8|||
126623156|NCT00635570|455577600|FG000|Overall Study|Withdrawal by Subject|1|||
126623157|NCT00635570|455577601|FG001|Overall Study|Withdrawal by Subject|1|||
126623158|NCT00635570|455577600|FG000|Overall Study|Adverse Event|2|||
126623159|NCT00635570|455577601|FG001|Overall Study|Adverse Event|0|||
126623160|NCT00635570|455577600|FG000|Overall Study|Physician Decision|1|||
126623161|NCT00635570|455577601|FG001|Overall Study|Physician Decision|0|||
126623162|NCT00635570|455577600|FG000|Overall Study|Did not complete survey|2|||
126623163|NCT00635570|455577601|FG001|Overall Study|Did not complete survey|1|||
126623164|NCT00635570|455577600|FG000|Overall Study|Early termination(No sexual activity)|1|||
126623165|NCT00635570|455577601|FG001|Overall Study|Early termination(No sexual activity)|1|||
126623166|NCT02514577|455577612|FG000|Overall Study|Lost to Follow-up|6|||
126623167|NCT02514577|455577613|FG001|Overall Study|Lost to Follow-up|6|||
126623168|NCT02514577|455577612|FG000|Overall Study|Protocol Violation|1|||
126623169|NCT02514577|455577613|FG001|Overall Study|Protocol Violation|0|||
126623170|NCT02514577|455577612|FG000|Overall Study|Withdrawal by Subject|6|||
126623171|NCT02514577|455577613|FG001|Overall Study|Withdrawal by Subject|6|||
126623172|NCT02514577|455577612|FG000|Overall Study|Adverse Event|1|||
126623173|NCT02514577|455577613|FG001|Overall Study|Adverse Event|1|||
126623174|NCT04816708|455577616|FG000|Overall Study|Lost to Follow-up|10|||
126623175|NCT04816708|455577617|FG001|Overall Study|Lost to Follow-up|4|||
126751834|NCT00882362|456039672|FG000|Overall Study|Lack of Efficacy|3|||
126751835|NCT00882362|456039673|FG001|Overall Study|Lack of Efficacy|0|||
126751836|NCT00882362|456039672|FG000|Overall Study|Protocol Violation|7|||
126623176|NCT02388932|455577618|FG000|Overall Study|Death|1|||
126623177|NCT03568708|455577621|FG000|Overall Study|Withdrawal by Subject|1|||
126623178|NCT03568708|455577622|FG001|Overall Study|Withdrawal by Subject|1|||
126623179|NCT03568708|455577621|FG000|Overall Study|Lost to Follow-up|0|||
126623180|NCT03568708|455577622|FG001|Overall Study|Lost to Follow-up|1|||
126751837|NCT00882362|456039673|FG001|Overall Study|Protocol Violation|2|||
126623181|NCT00511147|455577623|FG000|Overall Study|Withdrawal by Subject|1|||
126623182|NCT00511147|455577623|FG000|Overall Study|Disease progression|5|||
126623183|NCT00511147|455577623|FG000|Overall Study|Required platelet transfusion|1|||
126623184|NCT00809783|455577624|FG000|Overall Study|Death|1|||
126623185|NCT00809783|455577625|FG001|Overall Study|Death|0|||
126623186|NCT00809783|455577626|FG002|Overall Study|Death|0|||
126623187|NCT00809783|455577624|FG000|Overall Study|Adverse Event|34|||
126623188|NCT00809783|455577625|FG001|Overall Study|Adverse Event|52|||
126623189|NCT00809783|455577626|FG002|Overall Study|Adverse Event|71|||
126623190|NCT00809783|455577624|FG000|Overall Study|Lack of Efficacy|39|||
126623191|NCT00809783|455577625|FG001|Overall Study|Lack of Efficacy|52|||
126623192|NCT00809783|455577626|FG002|Overall Study|Lack of Efficacy|63|||
126623193|NCT00809783|455577624|FG000|Overall Study|Lost to Follow-up|0|||
126623194|NCT00809783|455577625|FG001|Overall Study|Lost to Follow-up|3|||
126623195|NCT00809783|455577626|FG002|Overall Study|Lost to Follow-up|4|||
126623196|NCT00809783|455577624|FG000|Overall Study|Withdrawal by Subject|47|||
126623197|NCT00809783|455577625|FG001|Overall Study|Withdrawal by Subject|72|||
126623198|NCT00809783|455577626|FG002|Overall Study|Withdrawal by Subject|64|||
126623199|NCT00809783|455577624|FG000|Overall Study|Protocol Violation|2|||
126623200|NCT00809783|455577625|FG001|Overall Study|Protocol Violation|6|||
126623201|NCT00809783|455577626|FG002|Overall Study|Protocol Violation|5|||
126623202|NCT00809783|455577624|FG000|Overall Study|Randomized, but not treated|3|||
126623203|NCT00809783|455577625|FG001|Overall Study|Randomized, but not treated|0|||
126623204|NCT00809783|455577626|FG002|Overall Study|Randomized, but not treated|2|||
126623205|NCT00809783|455577624|FG000|Overall Study|Study Terminated by Sponsor|378|||
126623206|NCT00809783|455577625|FG001|Overall Study|Study Terminated by Sponsor|626|||
126623207|NCT00809783|455577626|FG002|Overall Study|Study Terminated by Sponsor|565|||
126623208|NCT00809783|455577624|FG000|Overall Study|Other|21|||
126623209|NCT00809783|455577625|FG001|Overall Study|Other|21|||
126623210|NCT00809783|455577626|FG002|Overall Study|Other|16|||
126623211|NCT00126555|455577627|FG000|Overall Study|Withdrawal by Subject|1|||
126623212|NCT00126555|455577627|FG000|Overall Study|Adverse Event|2|||
126623213|NCT00126555|455577627|FG000|Overall Study|Progressive Disease|3|||
126623214|NCT00396097|455577631|FG000|Overall Study|Withdrawal by Subject|17|||
126623215|NCT00396097|455577632|FG001|Overall Study|Withdrawal by Subject|17|||
126623216|NCT00396097|455577631|FG000|Overall Study|Lost to Follow-up|4|||
126623217|NCT00396097|455577632|FG001|Overall Study|Lost to Follow-up|9|||
126623218|NCT00396097|455577631|FG000|Overall Study|Other|3|||
126623219|NCT00396097|455577632|FG001|Overall Study|Other|5|||
126623220|NCT00396097|455577631|FG000|Overall Study|Protocol Violation|0|||
126623221|NCT00396097|455577632|FG001|Overall Study|Protocol Violation|6|||
126623222|NCT00396097|455577631|FG000|Overall Study|Adverse Event|1|||
126623223|NCT00396097|455577632|FG001|Overall Study|Adverse Event|5|||
126623224|NCT00396097|455577631|FG000|Overall Study|Insufficient Clinical Response|1|||
126623225|NCT00396097|455577632|FG001|Overall Study|Insufficient Clinical Response|4|||
126623226|NCT03461211|455577633|FG000|Overall Study|Adverse Event|1|||
126623227|NCT03461211|455577634|FG001|Overall Study|Adverse Event|1|||
126623228|NCT03461211|455577633|FG000|Overall Study|Lack of Efficacy|0|||
126623229|NCT03461211|455577634|FG001|Overall Study|Lack of Efficacy|1|||
126623230|NCT00730925|455577637|FG000|Overall Study|Progressive Disease|21|||
126623231|NCT00730925|455577637|FG000|Overall Study|Dose reducing Event|2|||
126623232|NCT00730925|455577637|FG000|Overall Study|Other Averse Event|7|||
126623233|NCT00730925|455577637|FG000|Overall Study|Protocol Violation|1|||
126623234|NCT00730925|455577637|FG000|Overall Study|Withdrawal by Subject|1|||
126623235|NCT00730925|455577637|FG000|Overall Study|Switch to combination therapy|8|||
126623236|NCT00730925|455577637|FG000|Overall Study|Other|1|||
126623237|NCT01732627|455577638|FG000|Overall Study|Withdrawal by Subject|1|||
126623238|NCT01732627|455577639|FG001|Overall Study|Withdrawal by Subject|0|||
126623239|NCT04736602|455577648|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
126623240|NCT04736602|455577648|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
126623241|NCT01887418|455577650|FG000|Overall Study|Travelling difficulties|0|||
126623242|NCT01887418|455577651|FG001|Overall Study|Travelling difficulties|0|||
126623243|NCT01887418|455577652|FG002|Overall Study|Travelling difficulties|1|||
126623244|NCT00475735|455577653|FG000|Treatment Period 1|Adverse Event|2|||
126623245|NCT00475735|455577654|FG001|Treatment Period 1|Adverse Event|0|||
126623246|NCT00475735|455577655|FG002|Treatment Period 1|Adverse Event|0|||
126623247|NCT00475735|455577656|FG003|Treatment Period 1|Adverse Event|0|||
126623248|NCT00475735|455577657|FG004|Treatment Period 1|Adverse Event|0|||
126623249|NCT00475735|455577658|FG005|Treatment Period 1|Adverse Event|0|||
126623250|NCT00475735|455577653|FG000|Treatment Period 1|Lack of Efficacy|1|||
126623251|NCT00475735|455577654|FG001|Treatment Period 1|Lack of Efficacy|0|||
126623252|NCT00475735|455577655|FG002|Treatment Period 1|Lack of Efficacy|0|||
126623253|NCT00475735|455577656|FG003|Treatment Period 1|Lack of Efficacy|0|||
126623254|NCT00475735|455577657|FG004|Treatment Period 1|Lack of Efficacy|0|||
126623255|NCT00475735|455577658|FG005|Treatment Period 1|Lack of Efficacy|0|||
126623256|NCT00475735|455577653|FG000|Treatment Period 1|Lost to Follow-up|0|||
126623257|NCT00475735|455577654|FG001|Treatment Period 1|Lost to Follow-up|0|||
126623258|NCT00475735|455577655|FG002|Treatment Period 1|Lost to Follow-up|0|||
126623259|NCT00475735|455577656|FG003|Treatment Period 1|Lost to Follow-up|0|||
126751838|NCT00882362|456039672|FG000|Overall Study|Pregnancy|1|||
126751839|NCT00882362|456039673|FG001|Overall Study|Pregnancy|0|||
126623260|NCT00475735|455577657|FG004|Treatment Period 1|Lost to Follow-up|0|||
126623261|NCT00475735|455577658|FG005|Treatment Period 1|Lost to Follow-up|1|||
126623262|NCT00475735|455577653|FG000|Treatment Period 1|Protocol Violation|0|||
126623263|NCT00475735|455577654|FG001|Treatment Period 1|Protocol Violation|0|||
126623264|NCT00475735|455577655|FG002|Treatment Period 1|Protocol Violation|0|||
126623265|NCT00475735|455577656|FG003|Treatment Period 1|Protocol Violation|1|||
126623266|NCT00475735|455577657|FG004|Treatment Period 1|Protocol Violation|0|||
126623267|NCT00475735|455577658|FG005|Treatment Period 1|Protocol Violation|0|||
126623268|NCT00475735|455577653|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126623269|NCT00475735|455577654|FG001|Treatment Period 1|Withdrawal by Subject|1|||
126623270|NCT00475735|455577655|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126623271|NCT00475735|455577656|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126623272|NCT00475735|455577657|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126623273|NCT00475735|455577658|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126623274|NCT00475735|455577653|FG000|Treatment Period 1|DC due to AE but continuing|0|||
126623275|NCT00475735|455577654|FG001|Treatment Period 1|DC due to AE but continuing|0|||
126623276|NCT00475735|455577655|FG002|Treatment Period 1|DC due to AE but continuing|0|||
126623277|NCT00475735|455577656|FG003|Treatment Period 1|DC due to AE but continuing|1|||
126623278|NCT00475735|455577657|FG004|Treatment Period 1|DC due to AE but continuing|2|||
126623279|NCT00475735|455577658|FG005|Treatment Period 1|DC due to AE but continuing|2|||
126623280|NCT00475735|455577653|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
126623281|NCT00475735|455577654|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
126623282|NCT00475735|455577655|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
126623283|NCT00475735|455577656|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
126623284|NCT00475735|455577657|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
126623285|NCT00475735|455577658|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
126623286|NCT00475735|455577653|FG000|Treatment Washout|Lost to Follow-up|0|||
126623287|NCT00475735|455577654|FG001|Treatment Washout|Lost to Follow-up|1|||
126623288|NCT00475735|455577655|FG002|Treatment Washout|Lost to Follow-up|0|||
126623289|NCT00475735|455577656|FG003|Treatment Washout|Lost to Follow-up|0|||
126623290|NCT00475735|455577657|FG004|Treatment Washout|Lost to Follow-up|0|||
126623291|NCT00475735|455577658|FG005|Treatment Washout|Lost to Follow-up|0|||
126623292|NCT00475735|455577653|FG000|Treatment Washout|Protocol Violation|0|||
126623293|NCT00475735|455577654|FG001|Treatment Washout|Protocol Violation|1|||
126623294|NCT00475735|455577655|FG002|Treatment Washout|Protocol Violation|0|||
126623295|NCT00475735|455577656|FG003|Treatment Washout|Protocol Violation|0|||
126623296|NCT00475735|455577657|FG004|Treatment Washout|Protocol Violation|0|||
126623297|NCT00475735|455577658|FG005|Treatment Washout|Protocol Violation|0|||
126623298|NCT00475735|455577653|FG000|Treatment Period 2|Adverse Event|0|||
126623299|NCT00475735|455577654|FG001|Treatment Period 2|Adverse Event|1|||
126623300|NCT00475735|455577655|FG002|Treatment Period 2|Adverse Event|0|||
126623301|NCT00475735|455577656|FG003|Treatment Period 2|Adverse Event|2|||
126623302|NCT00475735|455577657|FG004|Treatment Period 2|Adverse Event|0|||
126623303|NCT00475735|455577658|FG005|Treatment Period 2|Adverse Event|0|||
126623304|NCT00475735|455577653|FG000|Treatment Period 2|Lack of Efficacy|0|||
126623305|NCT00475735|455577654|FG001|Treatment Period 2|Lack of Efficacy|0|||
126623306|NCT00475735|455577655|FG002|Treatment Period 2|Lack of Efficacy|0|||
126623307|NCT00475735|455577656|FG003|Treatment Period 2|Lack of Efficacy|0|||
126623308|NCT00475735|455577657|FG004|Treatment Period 2|Lack of Efficacy|0|||
126623309|NCT00475735|455577658|FG005|Treatment Period 2|Lack of Efficacy|1|||
126623310|NCT00475735|455577653|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126623311|NCT00475735|455577654|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126623312|NCT00475735|455577655|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126623313|NCT00475735|455577656|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126623314|NCT00475735|455577657|FG004|Treatment Period 2|Withdrawal by Subject|1|||
126623315|NCT00475735|455577658|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126623316|NCT03132753|455577659|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
126623317|NCT03132753|455577660|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
126623318|NCT03132753|455577659|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
126751840|NCT00882362|456039672|FG000|Overall Study|Physician Decision|5|||
126751841|NCT00882362|456039673|FG001|Overall Study|Physician Decision|1|||
126751842|NCT00882362|456039672|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
126623319|NCT03132753|455577660|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
126623320|NCT00125853|455577661|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
126623321|NCT00125853|455577662|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
126623322|NCT03575572|455577663|FG000|Overall Study|Withdrawal by Subject|2|||
126623323|NCT03575572|455577663|FG000|Overall Study|Physician Decision|2|||
126623324|NCT00157209|455577666|FG000|Overall Study|Ongoing at data cut-off|10|||
126623325|NCT00157209|455577667|FG001|Overall Study|Ongoing at data cut-off|0|||
126623326|NCT03023878|455577675|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
126623327|NCT03023878|455577675|FG000|Pre-Study Run-In Period|Death|1|||
126751843|NCT00882362|456039673|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
126623328|NCT03023878|455577675|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
126623329|NCT03023878|455577675|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
126623330|NCT03023878|455577675|FG000|Treatment Period|Disease Progression|1|||
126623331|NCT03023878|455577675|FG000|Treatment Period|Withdrawal by Subject|1|||
126623332|NCT03023878|455577675|FG000|Treatment Period|Adverse Event|1|||
126623333|NCT03023878|455577675|FG000|Long Term Follow-Up Period|Death|2|||
126623334|NCT01247922|455577676|FG000|Overall Study|Disease progression|4|||
126623335|NCT00577096|455577679|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
126623336|NCT00577096|455577680|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
126623337|NCT00577096|455577679|FG000|Short Term Participation|Withdrawal by Subject|3|||
126623338|NCT00577096|455577680|FG001|Short Term Participation|Withdrawal by Subject|5|||
126623339|NCT00577096|455577679|FG000|Short Term Participation|Death|1|||
126623340|NCT00577096|455577680|FG001|Short Term Participation|Death|1|||
126623341|NCT02784535|455577682|FG000|Overall Study|Adverse Event|1|||
126623342|NCT02784535|455577683|FG001|Overall Study|Adverse Event|0|||
126623343|NCT02784535|455577682|FG000|Overall Study|Withdrawal by Subject|0|||
126623344|NCT02784535|455577683|FG001|Overall Study|Withdrawal by Subject|1|||
126623345|NCT02784535|455577682|FG000|Overall Study|Physician Decision|0|||
126623346|NCT02784535|455577683|FG001|Overall Study|Physician Decision|1|||
126623347|NCT00985621|455577687|FG000|Overall Study|Adverse Event|2|||
126623348|NCT00985621|455577688|FG001|Overall Study|Adverse Event|3|||
126623349|NCT00985621|455577689|FG002|Overall Study|Adverse Event|4|||
126623350|NCT00985621|455577690|FG003|Overall Study|Adverse Event|16|||
126623351|NCT00985621|455577687|FG000|Overall Study|Lack of Efficacy|10|||
126623352|NCT00985621|455577688|FG001|Overall Study|Lack of Efficacy|6|||
126623353|NCT00985621|455577689|FG002|Overall Study|Lack of Efficacy|5|||
126623354|NCT00985621|455577690|FG003|Overall Study|Lack of Efficacy|12|||
126623355|NCT00985621|455577687|FG000|Overall Study|Lost to Follow-up|2|||
126623356|NCT00985621|455577688|FG001|Overall Study|Lost to Follow-up|3|||
126623357|NCT00985621|455577689|FG002|Overall Study|Lost to Follow-up|4|||
126623358|NCT00985621|455577690|FG003|Overall Study|Lost to Follow-up|4|||
126623359|NCT00985621|455577687|FG000|Overall Study|Study Terminated by Sponsor|89|||
126623360|NCT00985621|455577688|FG001|Overall Study|Study Terminated by Sponsor|108|||
126623361|NCT00985621|455577689|FG002|Overall Study|Study Terminated by Sponsor|99|||
126751844|NCT00882362|456039672|FG000|Overall Study|change of residence or other commitments|5|||
126751845|NCT00882362|456039673|FG001|Overall Study|change of residence or other commitments|0|||
126751846|NCT01268514|456039674|FG000|Overall Study|Adverse Event|20|||
126751847|NCT01268514|456039674|FG000|Overall Study|Death|8|||
126751848|NCT01268514|456039674|FG000|Overall Study|Lost to Follow-up|5|||
126751849|NCT01268514|456039674|FG000|Overall Study|Withdrawal by Subject|3|||
126751850|NCT01268514|456039674|FG000|Overall Study|Withdrawal by Surgeon|5|||
126751851|NCT01846208|456039675|FG000|Overall Study|Withdrew prior to treatment|1|||
126751852|NCT01846208|456039676|FG001|Overall Study|Withdrew prior to treatment|1|||
126751853|NCT01846208|456039677|FG002|Overall Study|Withdrew prior to treatment|1|||
126751854|NCT01846208|456039675|FG000|Overall Study|Dosing Symptoms|1|||
126751855|NCT01846208|456039676|FG001|Overall Study|Dosing Symptoms|2|||
126751856|NCT01846208|456039677|FG002|Overall Study|Dosing Symptoms|6|||
126751857|NCT01846208|456039675|FG000|Overall Study|Withdrawal by Subject|5|||
126751858|NCT01846208|456039676|FG001|Overall Study|Withdrawal by Subject|0|||
126751859|NCT01846208|456039677|FG002|Overall Study|Withdrawal by Subject|0|||
126751860|NCT01846208|456039675|FG000|Overall Study|Non-compliance|1|||
126751861|NCT01846208|456039676|FG001|Overall Study|Non-compliance|1|||
126751862|NCT01846208|456039677|FG002|Overall Study|Non-compliance|0|||
126751863|NCT01846208|456039675|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
126751864|NCT01846208|456039676|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
126751865|NCT01846208|456039677|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
126751866|NCT01846208|456039675|FG000|Overall Study|Refused SU OFC|0|||
126751867|NCT01846208|456039676|FG001|Overall Study|Refused SU OFC|0|||
126751868|NCT01846208|456039677|FG002|Overall Study|Refused SU OFC|1|||
126751869|NCT01424306|456039678|FG000|Overall Study|Protocol Violation|0|||
126751870|NCT01424306|456039679|FG001|Overall Study|Protocol Violation|0|||
126751871|NCT01424306|456039680|FG002|Overall Study|Protocol Violation|0|||
126751872|NCT01424306|456039681|FG003|Overall Study|Protocol Violation|0|||
126751873|NCT01424306|456039682|FG004|Overall Study|Protocol Violation|1|||
126751874|NCT01424306|456039683|FG005|Overall Study|Protocol Violation|0|||
126751875|NCT01809327|456039691|FG000|Overall Study|Lost to Follow-up|5|||
126751876|NCT01809327|456039692|FG001|Overall Study|Lost to Follow-up|2|||
126751877|NCT01809327|456039693|FG002|Overall Study|Lost to Follow-up|4|||
126623362|NCT00985621|455577690|FG003|Overall Study|Study Terminated by Sponsor|92|||
126623363|NCT00985621|455577687|FG000|Overall Study|Protocol Violation|1|||
126623364|NCT00985621|455577688|FG001|Overall Study|Protocol Violation|1|||
126623365|NCT00985621|455577689|FG002|Overall Study|Protocol Violation|1|||
126623366|NCT00985621|455577690|FG003|Overall Study|Protocol Violation|0|||
126751878|NCT01809327|456039694|FG003|Overall Study|Lost to Follow-up|2|||
126751879|NCT01809327|456039695|FG004|Overall Study|Lost to Follow-up|3|||
126751880|NCT01809327|456039691|FG000|Overall Study|Withdrawal by Subject|6|||
126751881|NCT01809327|456039692|FG001|Overall Study|Withdrawal by Subject|4|||
126751882|NCT01809327|456039693|FG002|Overall Study|Withdrawal by Subject|4|||
126751883|NCT01809327|456039694|FG003|Overall Study|Withdrawal by Subject|2|||
126751884|NCT01809327|456039695|FG004|Overall Study|Withdrawal by Subject|5|||
126751885|NCT01809327|456039691|FG000|Overall Study|Adverse Event|4|||
126751886|NCT01809327|456039692|FG001|Overall Study|Adverse Event|3|||
126751887|NCT01809327|456039693|FG002|Overall Study|Adverse Event|7|||
126751888|NCT01809327|456039694|FG003|Overall Study|Adverse Event|4|||
126751889|NCT01809327|456039695|FG004|Overall Study|Adverse Event|8|||
126751890|NCT01809327|456039691|FG000|Overall Study|Death|1|||
126751891|NCT01809327|456039692|FG001|Overall Study|Death|0|||
126751892|NCT01809327|456039693|FG002|Overall Study|Death|0|||
126751893|NCT01809327|456039694|FG003|Overall Study|Death|0|||
126751894|NCT01809327|456039695|FG004|Overall Study|Death|0|||
126751895|NCT01809327|456039691|FG000|Overall Study|Protocol Violation|0|||
126751896|NCT01809327|456039692|FG001|Overall Study|Protocol Violation|1|||
126751897|NCT01809327|456039693|FG002|Overall Study|Protocol Violation|0|||
126751898|NCT01809327|456039694|FG003|Overall Study|Protocol Violation|0|||
126751899|NCT01809327|456039695|FG004|Overall Study|Protocol Violation|0|||
126751900|NCT01809327|456039691|FG000|Overall Study|Physician Decision|1|||
126751901|NCT01809327|456039692|FG001|Overall Study|Physician Decision|1|||
126751902|NCT01809327|456039693|FG002|Overall Study|Physician Decision|0|||
126751903|NCT01809327|456039694|FG003|Overall Study|Physician Decision|0|||
126751904|NCT01809327|456039695|FG004|Overall Study|Physician Decision|0|||
126751905|NCT01809327|456039691|FG000|Overall Study|Pregnancy|1|||
126751906|NCT01809327|456039692|FG001|Overall Study|Pregnancy|0|||
126751907|NCT01809327|456039693|FG002|Overall Study|Pregnancy|0|||
126751908|NCT01809327|456039694|FG003|Overall Study|Pregnancy|0|||
126751909|NCT01809327|456039695|FG004|Overall Study|Pregnancy|0|||
126751910|NCT01809327|456039691|FG000|Overall Study|Other|14|||
126751911|NCT01809327|456039692|FG001|Overall Study|Other|15|||
126751912|NCT01809327|456039693|FG002|Overall Study|Other|7|||
126751913|NCT01809327|456039694|FG003|Overall Study|Other|4|||
126751914|NCT01809327|456039695|FG004|Overall Study|Other|9|||
126751915|NCT03196973|456039696|FG000|Overall Study|Adverse Event|1|||
126751916|NCT03196973|456039697|FG001|Overall Study|Adverse Event|1|||
126751917|NCT03196973|456039698|FG002|Overall Study|Adverse Event|2|||
126751918|NCT03196973|456039696|FG000|Overall Study|Lack of Efficacy|2|||
126751919|NCT03196973|456039697|FG001|Overall Study|Lack of Efficacy|6|||
126751920|NCT03196973|456039698|FG002|Overall Study|Lack of Efficacy|1|||
126751921|NCT03196973|456039696|FG000|Overall Study|Lost to Follow-up|4|||
126751922|NCT03196973|456039697|FG001|Overall Study|Lost to Follow-up|3|||
126751923|NCT03196973|456039698|FG002|Overall Study|Lost to Follow-up|2|||
126751924|NCT03196973|456039696|FG000|Overall Study|Consent withdrawn|2|||
126751925|NCT03196973|456039697|FG001|Overall Study|Consent withdrawn|1|||
126751926|NCT03196973|456039698|FG002|Overall Study|Consent withdrawn|0|||
126751927|NCT03196973|456039696|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
126751928|NCT03196973|456039697|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
126751929|NCT03196973|456039698|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
126751930|NCT03344562|456039699|FG000|Overall Study|Withdrawal by Subject|2|||
126751931|NCT03344562|456039700|FG001|Overall Study|Withdrawal by Subject|0|||
126751932|NCT02390362|456039707|FG000|Overall Study|Withdrawal by Subject|0|||
126751933|NCT02390362|456039708|FG001|Overall Study|Withdrawal by Subject|1|||
126751934|NCT04009824|456039709|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
126751935|NCT04009824|456039710|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
126751936|NCT04009824|456039711|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
126751937|NCT04009824|456039712|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
126751938|NCT04009824|456039713|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
126751939|NCT01142791|456039725|FG000|Overall Study|Alternative Treatment|1|||
126751940|NCT01142791|456039726|FG001|Overall Study|Alternative Treatment|0|||
126751941|NCT01142791|456039725|FG000|Overall Study|Lost to Follow-up|1|||
126751942|NCT01142791|456039726|FG001|Overall Study|Lost to Follow-up|0|||
126751943|NCT01142791|456039725|FG000|Overall Study|Withdrawal by Subject|5|||
126751944|NCT01142791|456039726|FG001|Overall Study|Withdrawal by Subject|0|||
126751945|NCT01142791|456039725|FG000|Overall Study|Received only 1 sonication|0|||
126751946|NCT01142791|456039726|FG001|Overall Study|Received only 1 sonication|6|||
126751947|NCT02608892|456039727|FG000|Overall Study|Lost to Follow-up|1|||
126751948|NCT02608892|456039728|FG001|Overall Study|Lost to Follow-up|0|||
126751949|NCT03032523|456039729|FG000|Overall Study|Withdrawal by Subject|2|||
126751950|NCT03032523|456039730|FG001|Overall Study|Withdrawal by Subject|2|||
126751951|NCT03032523|456039729|FG000|Overall Study|Physician Decision|1|||
126751952|NCT03032523|456039730|FG001|Overall Study|Physician Decision|0|||
126751953|NCT02590406|456039733|FG000|Overall Study|Adverse Event|1|||
126751954|NCT02590406|456039734|FG001|Overall Study|Adverse Event|0|||
126751955|NCT02590406|456039733|FG000|Overall Study|Saturometer malfunction|0|||
126751956|NCT02590406|456039734|FG001|Overall Study|Saturometer malfunction|1|||
126751957|NCT00957723|456039735|FG000|Overall Study|Death|3|||
126751958|NCT00957723|456039735|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
126751959|NCT00957723|456039735|FG000|Overall Study|Lost to Follow-up|8|||
126751960|NCT00957723|456039735|FG000|Overall Study|Withdrawal by Subject|24|||
126751961|NCT00957723|456039735|FG000|Overall Study|Investigative Site Terminated|61|||
126751962|NCT00957723|456039735|FG000|Overall Study|Intercurrent Illness|2|||
126751963|NCT00957723|456039735|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
126751964|NCT00984009|456039736|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
126751965|NCT00281528|456039737|FG000|Overall Study|Progressive Disease|28|||
126751966|NCT00281528|456039738|FG001|Overall Study|Progressive Disease|18|||
126751967|NCT00281528|456039739|FG002|Overall Study|Progressive Disease|27|||
126751968|NCT00281528|456039737|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
126751969|NCT00281528|456039738|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
126751970|NCT00281528|456039739|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
126751971|NCT00281528|456039737|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
126751972|NCT00281528|456039738|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
126751973|NCT00281528|456039739|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
126751974|NCT00281528|456039737|FG000|Overall Study|Physician Decision|11|||
126751975|NCT00281528|456039738|FG001|Overall Study|Physician Decision|4|||
126751976|NCT00281528|456039739|FG002|Overall Study|Physician Decision|5|||
126751977|NCT00281528|456039737|FG000|Overall Study|Protocol Violation|1|||
126751978|NCT00281528|456039738|FG001|Overall Study|Protocol Violation|0|||
126751979|NCT00281528|456039739|FG002|Overall Study|Protocol Violation|1|||
126751980|NCT00281528|456039737|FG000|Overall Study|Withdrawal by Subject|5|||
126751981|NCT00281528|456039738|FG001|Overall Study|Withdrawal by Subject|5|||
126751982|NCT00281528|456039739|FG002|Overall Study|Withdrawal by Subject|7|||
126751983|NCT00281528|456039737|FG000|Overall Study|Other|6|||
126751984|NCT00281528|456039738|FG001|Overall Study|Other|3|||
126751985|NCT00281528|456039739|FG002|Overall Study|Other|5|||
126751986|NCT02036476|456039749|FG000|Overall Study|Withdrawal by Subject|2|||
126751987|NCT02036476|456039749|FG000|Overall Study|Progressive Disease|4|||
126751988|NCT02036476|456039749|FG000|Overall Study|Unacceptable Toxicity|2|||
126751989|NCT02168816|456039750|FG000|Overall Study|Lost to Follow-up|2|||
126751990|NCT02168816|456039751|FG001|Overall Study|Lost to Follow-up|2|||
126751991|NCT01984294|456039752|FG000|Overall Study|Randomized but Never Treated|0|||
126751992|NCT01984294|456039753|FG001|Overall Study|Randomized but Never Treated|0|||
126751993|NCT01984294|456039754|FG002|Overall Study|Randomized but Never Treated|1|||
126751994|NCT01984294|456039752|FG000|Overall Study|Lack of Efficacy|4|||
126751995|NCT01984294|456039753|FG001|Overall Study|Lack of Efficacy|2|||
126751996|NCT01984294|456039754|FG002|Overall Study|Lack of Efficacy|6|||
126751997|NCT01984294|456039752|FG000|Overall Study|Adverse Event|0|||
126751998|NCT01984294|456039753|FG001|Overall Study|Adverse Event|1|||
126751999|NCT01984294|456039754|FG002|Overall Study|Adverse Event|0|||
126752000|NCT01987609|456039757|FG000|Overall Study|Adverse Event|1|||
126752001|NCT02610231|456039758|FG000|Overall Study|Withdrawal by Subject|27|||
126752002|NCT02610231|456039758|FG000|Overall Study|Adverse Event|20|||
126752003|NCT02610231|456039758|FG000|Overall Study|Death|5|||
126752004|NCT02610231|456039758|FG000|Overall Study|Surgery|2|||
126752005|NCT02610231|456039758|FG000|Overall Study|Physician Decision|1|||
126752006|NCT02610231|456039758|FG000|Overall Study|Non Compliance|2|||
126752007|NCT02610231|456039758|FG000|Overall Study|Other|3|||
126752008|NCT00806494|456039759|FG000|Overall Study|Adverse Event|29|||
126752009|NCT00806494|456039759|FG000|Overall Study|Lack of Efficacy|6|||
126752010|NCT00806494|456039759|FG000|Overall Study|Lost to Follow-up|10|||
126752011|NCT00806494|456039759|FG000|Overall Study|Other|30|||
126752012|NCT00806494|456039759|FG000|Overall Study|Withdrawal by Subject|5|||
126752013|NCT01279954|456039760|FG000|Overall Study|Lack of Efficacy|3|||
126752014|NCT01279954|456039761|FG001|Overall Study|Lack of Efficacy|4|||
126752015|NCT02709889|456039762|FG000|Overall Study|Withdrawal by Subject|11|||
126752016|NCT02709889|456039763|FG001|Overall Study|Withdrawal by Subject|10|||
126752017|NCT02709889|456039764|FG002|Overall Study|Withdrawal by Subject|2|||
126752018|NCT02709889|456039765|FG003|Overall Study|Withdrawal by Subject|12|||
126752019|NCT02709889|456039762|FG000|Overall Study|Death|25|||
126752020|NCT02709889|456039763|FG001|Overall Study|Death|38|||
126752021|NCT02709889|456039764|FG002|Overall Study|Death|4|||
126752022|NCT02709889|456039765|FG003|Overall Study|Death|44|||
126752023|NCT02709889|456039762|FG000|Overall Study|Physician Decision|1|||
126782754|NCT01621490|456160072|FG000|Overall Study|Adverse event unrelated to study drug|1|||
126782755|NCT01621490|456160073|FG001|Overall Study|Adverse event unrelated to study drug|1|||
126752024|NCT02709889|456039763|FG001|Overall Study|Physician Decision|2|||
126752025|NCT02709889|456039764|FG002|Overall Study|Physician Decision|3|||
126752026|NCT02709889|456039765|FG003|Overall Study|Physician Decision|5|||
126752027|NCT02709889|456039762|FG000|Overall Study|Lost to Follow-up|2|||
126752028|NCT02709889|456039763|FG001|Overall Study|Lost to Follow-up|0|||
126782756|NCT01621490|456160074|FG002|Overall Study|Adverse event unrelated to study drug|0|||
126623367|NCT00985621|455577687|FG000|Overall Study|Withdrawal by Subject|8|||
126752029|NCT02709889|456039764|FG002|Overall Study|Lost to Follow-up|0|||
126752030|NCT02709889|456039765|FG003|Overall Study|Lost to Follow-up|4|||
126752031|NCT02709889|456039762|FG000|Overall Study|Study Terminated by Sponsor|4|||
126752032|NCT02709889|456039763|FG001|Overall Study|Study Terminated by Sponsor|6|||
126752033|NCT02709889|456039764|FG002|Overall Study|Study Terminated by Sponsor|2|||
126752034|NCT02709889|456039765|FG003|Overall Study|Study Terminated by Sponsor|17|||
126752035|NCT02709889|456039762|FG000|Overall Study|Other, Not Specified|0|||
126752036|NCT02709889|456039763|FG001|Overall Study|Other, Not Specified|1|||
126752037|NCT02709889|456039764|FG002|Overall Study|Other, Not Specified|1|||
126752038|NCT02709889|456039765|FG003|Overall Study|Other, Not Specified|6|||
126752039|NCT00537810|456039766|FG000|Overall Study|Withdrawal by Subject|4|||
126752040|NCT00537810|456039767|FG001|Overall Study|Withdrawal by Subject|11|||
126752041|NCT00537810|456039768|FG002|Overall Study|Withdrawal by Subject|4|||
126752042|NCT00537810|456039769|FG003|Overall Study|Withdrawal by Subject|3|||
126752043|NCT00537810|456039766|FG000|Overall Study|Medically withdrawn|2|||
126752044|NCT00537810|456039767|FG001|Overall Study|Medically withdrawn|2|||
126752045|NCT00537810|456039768|FG002|Overall Study|Medically withdrawn|0|||
126752046|NCT00537810|456039769|FG003|Overall Study|Medically withdrawn|1|||
126752047|NCT01066546|456039770|FG000|Overall Study|Study terminated by sponsor|5|||
126752048|NCT03258762|456039771|FG000|Overall Study|Lost to Follow-up|0|||
126752049|NCT03258762|456039772|FG001|Overall Study|Lost to Follow-up|1|||
126752050|NCT01711359|456039773|FG000|Treatment Period|Withdrawal by Subject|18|||
126752051|NCT01711359|456039774|FG001|Treatment Period|Withdrawal by Subject|7|||
126752052|NCT01711359|456039775|FG002|Treatment Period|Withdrawal by Subject|13|||
126752053|NCT01711359|456039773|FG000|Treatment Period|Lack of Efficacy|13|||
126752054|NCT01711359|456039774|FG001|Treatment Period|Lack of Efficacy|2|||
126752055|NCT01711359|456039775|FG002|Treatment Period|Lack of Efficacy|2|||
126752056|NCT01711359|456039773|FG000|Treatment Period|Adverse Event|8|||
126752057|NCT01711359|456039774|FG001|Treatment Period|Adverse Event|10|||
126752058|NCT01711359|456039775|FG002|Treatment Period|Adverse Event|24|||
126752059|NCT01711359|456039773|FG000|Treatment Period|Physician Decision|4|||
126752060|NCT01711359|456039774|FG001|Treatment Period|Physician Decision|3|||
126752061|NCT01711359|456039775|FG002|Treatment Period|Physician Decision|2|||
126752062|NCT01711359|456039773|FG000|Treatment Period|Death|3|||
126752063|NCT01711359|456039774|FG001|Treatment Period|Death|0|||
126752064|NCT01711359|456039775|FG002|Treatment Period|Death|0|||
126752065|NCT01711359|456039773|FG000|Treatment Period|Entry Criteria Not Met|1|||
126752066|NCT01711359|456039774|FG001|Treatment Period|Entry Criteria Not Met|0|||
126752067|NCT01711359|456039775|FG002|Treatment Period|Entry Criteria Not Met|0|||
126752068|NCT01711359|456039773|FG000|Treatment Period|Sponsor Decision|1|||
126752069|NCT01711359|456039774|FG001|Treatment Period|Sponsor Decision|0|||
126752070|NCT01711359|456039775|FG002|Treatment Period|Sponsor Decision|0|||
126752071|NCT01711359|456039773|FG000|Treatment Period|Lost to Follow-up|1|||
126752072|NCT01711359|456039774|FG001|Treatment Period|Lost to Follow-up|1|||
126752073|NCT01711359|456039775|FG002|Treatment Period|Lost to Follow-up|1|||
126752074|NCT01711359|456039773|FG000|Treatment Period|Randomized, Not Treated|3|||
126752075|NCT01711359|456039774|FG001|Treatment Period|Randomized, Not Treated|1|||
126752076|NCT01711359|456039775|FG002|Treatment Period|Randomized, Not Treated|0|||
126752077|NCT02698176|456039776|FG000|Overall Study|Progressive disease|4|||
126752078|NCT02698176|456039777|FG001|Overall Study|Progressive disease|3|||
126752079|NCT02698176|456039778|FG002|Overall Study|Progressive disease|1|||
126752080|NCT02698176|456039779|FG003|Overall Study|Progressive disease|0|||
126752081|NCT02698176|456039776|FG000|Overall Study|Adverse Event|2|||
126752082|NCT02698176|456039777|FG001|Overall Study|Adverse Event|0|||
126752083|NCT02698176|456039778|FG002|Overall Study|Adverse Event|0|||
126752084|NCT02698176|456039779|FG003|Overall Study|Adverse Event|0|||
126752085|NCT02698176|456039776|FG000|Overall Study|Clinical progression|3|||
126752086|NCT02698176|456039777|FG001|Overall Study|Clinical progression|0|||
126752087|NCT02698176|456039778|FG002|Overall Study|Clinical progression|0|||
126782757|NCT01621490|456160075|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126782758|NCT01621490|456160076|FG004|Overall Study|Adverse event unrelated to study drug|0|||
126782759|NCT01621490|456160077|FG005|Overall Study|Adverse event unrelated to study drug|0|||
126782760|NCT01621490|456160078|FG006|Overall Study|Adverse event unrelated to study drug|0|||
126782761|NCT01621490|456160079|FG007|Overall Study|Adverse event unrelated to study drug|2|||
126782762|NCT01621490|456160080|FG008|Overall Study|Adverse event unrelated to study drug|0|||
126752088|NCT02698176|456039779|FG003|Overall Study|Clinical progression|0|||
126752089|NCT02561572|456039782|FG000|Overall Study|Inadequate time before surgery|2|||
126752090|NCT02561572|456039783|FG001|Overall Study|Inadequate time before surgery|1|||
126752091|NCT02561572|456039782|FG000|Overall Study|Protocol Violation|0|||
126752092|NCT02561572|456039783|FG001|Overall Study|Protocol Violation|1|||
126782763|NCT01621490|456160081|FG009|Overall Study|Adverse event unrelated to study drug|0|||
126752093|NCT00795717|456039784|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
126782764|NCT01621490|456160082|FG010|Overall Study|Adverse event unrelated to study drug|0|||
126752094|NCT00795717|456039785|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
126782765|NCT01621490|456160072|FG000|Overall Study|Disease progression|27|||
126782766|NCT01621490|456160073|FG001|Overall Study|Disease progression|28|||
126782767|NCT01621490|456160074|FG002|Overall Study|Disease progression|1|||
126752095|NCT00795717|456039784|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
126752096|NCT00795717|456039785|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
126752097|NCT00795717|456039784|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
126752098|NCT00795717|456039785|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
126752099|NCT00795717|456039784|FG000|Phase II|too busy|0|||
126623368|NCT00985621|455577688|FG001|Overall Study|Withdrawal by Subject|10|||
126623369|NCT00985621|455577689|FG002|Overall Study|Withdrawal by Subject|8|||
126623370|NCT00985621|455577690|FG003|Overall Study|Withdrawal by Subject|12|||
126623371|NCT00985621|455577687|FG000|Overall Study|Other|1|||
126623372|NCT00985621|455577688|FG001|Overall Study|Other|0|||
126623373|NCT00985621|455577689|FG002|Overall Study|Other|0|||
126623374|NCT00985621|455577690|FG003|Overall Study|Other|0|||
126623375|NCT00985621|455577687|FG000|Overall Study|Randomized but not Treated|1|||
126623376|NCT00985621|455577688|FG001|Overall Study|Randomized but not Treated|0|||
126623377|NCT00985621|455577689|FG002|Overall Study|Randomized but not Treated|2|||
126623378|NCT00985621|455577690|FG003|Overall Study|Randomized but not Treated|1|||
126623379|NCT01911819|455577691|FG000|Overall Study|Adverse Event|0|||
126623380|NCT01911819|455577692|FG001|Overall Study|Adverse Event|1|||
126623381|NCT01911819|455577693|FG002|Overall Study|Adverse Event|0|||
126623382|NCT01911819|455577691|FG000|Overall Study|Withdrawal by Subject|1|||
126623383|NCT01911819|455577692|FG001|Overall Study|Withdrawal by Subject|1|||
126623384|NCT01911819|455577693|FG002|Overall Study|Withdrawal by Subject|0|||
126623385|NCT03849300|455577694|FG000|Overall Study|move out to different area|1|||
126623386|NCT03849300|455577695|FG001|Overall Study|move out to different area|3|||
126623387|NCT03849300|455577696|FG002|Overall Study|move out to different area|1|||
126623388|NCT03849300|455577697|FG003|Overall Study|move out to different area|4|||
126623389|NCT03849300|455577694|FG000|Overall Study|scheduling/transportation conflict|4|||
126623390|NCT03849300|455577695|FG001|Overall Study|scheduling/transportation conflict|4|||
126623391|NCT03849300|455577696|FG002|Overall Study|scheduling/transportation conflict|3|||
126623392|NCT03849300|455577697|FG003|Overall Study|scheduling/transportation conflict|2|||
126623393|NCT00464737|455577698|FG000|Overall Study|Adverse Event|12|||
126623394|NCT00464737|455577699|FG001|Overall Study|Adverse Event|17|||
126623395|NCT00464737|455577700|FG002|Overall Study|Adverse Event|33|||
126623396|NCT00464737|455577698|FG000|Overall Study|Lack of Efficacy|7|||
126623397|NCT00464737|455577699|FG001|Overall Study|Lack of Efficacy|7|||
126623398|NCT00464737|455577700|FG002|Overall Study|Lack of Efficacy|4|||
126623399|NCT00464737|455577698|FG000|Overall Study|Withdrawal by Subject|5|||
126623400|NCT00464737|455577699|FG001|Overall Study|Withdrawal by Subject|3|||
126623401|NCT00464737|455577700|FG002|Overall Study|Withdrawal by Subject|5|||
126623402|NCT00464737|455577698|FG000|Overall Study|Protocol Violation|1|||
126623403|NCT00464737|455577699|FG001|Overall Study|Protocol Violation|1|||
126623404|NCT00464737|455577700|FG002|Overall Study|Protocol Violation|5|||
126623405|NCT00464737|455577698|FG000|Overall Study|Non-compliance|0|||
126623406|NCT00464737|455577699|FG001|Overall Study|Non-compliance|1|||
126623407|NCT00464737|455577700|FG002|Overall Study|Non-compliance|1|||
126623408|NCT00464737|455577698|FG000|Overall Study|Lost to Follow-up|5|||
126623409|NCT00464737|455577699|FG001|Overall Study|Lost to Follow-up|2|||
126623410|NCT00464737|455577700|FG002|Overall Study|Lost to Follow-up|5|||
126623411|NCT00464737|455577698|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
126623412|NCT00464737|455577699|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
126623413|NCT00464737|455577700|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
126623414|NCT00464737|455577698|FG000|Overall Study|Other: Subject left town; family illness|1|||
126623415|NCT00464737|455577699|FG001|Overall Study|Other: Subject left town; family illness|0|||
126623416|NCT00464737|455577700|FG002|Overall Study|Other: Subject left town; family illness|0|||
126623417|NCT00464737|455577698|FG000|Overall Study|Other: Study demands too great|0|||
126623418|NCT00464737|455577699|FG001|Overall Study|Other: Study demands too great|1|||
126623419|NCT00464737|455577700|FG002|Overall Study|Other: Study demands too great|0|||
126623420|NCT00464737|455577698|FG000|Overall Study|Other: Personal family reasons|0|||
126623421|NCT00464737|455577699|FG001|Overall Study|Other: Personal family reasons|0|||
126623422|NCT00464737|455577700|FG002|Overall Study|Other: Personal family reasons|1|||
126623423|NCT00464737|455577698|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
126623424|NCT00464737|455577699|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
126623425|NCT00464737|455577700|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
126623426|NCT00676663|455577703|FG000|Overall Study|Death|43|||
126623427|NCT00676663|455577704|FG001|Overall Study|Death|27|||
126623428|NCT00676663|455577703|FG000|Overall Study|Withdrew Consent|1|||
126623429|NCT00676663|455577704|FG001|Overall Study|Withdrew Consent|8|||
126623430|NCT00676663|455577703|FG000|Overall Study|Lost to Follow-up|1|||
126623431|NCT00676663|455577704|FG001|Overall Study|Lost to Follow-up|3|||
126752100|NCT00795717|456039785|FG001|Phase II|too busy|1|||
126752101|NCT02985684|456039791|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
126752102|NCT02985684|456039791|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
126756654|NCT01632345|456059514|FG006|Treatment: Part I|Pregnancy|0|||
126623432|NCT00580047|455577705|FG000|Overall Study|Lost to Follow-up|1|||
126623433|NCT00580047|455577706|FG001|Overall Study|Lost to Follow-up|1|||
126623434|NCT00580047|455577707|FG002|Overall Study|Lost to Follow-up|0|||
126623435|NCT00580047|455577705|FG000|Overall Study|Withdrawal by Subject|1|||
126623436|NCT00580047|455577706|FG001|Overall Study|Withdrawal by Subject|1|||
126623437|NCT00580047|455577707|FG002|Overall Study|Withdrawal by Subject|2|||
126623438|NCT00580047|455577705|FG000|Overall Study|Withdrawal by Subject|1|||
126623439|NCT00580047|455577706|FG001|Overall Study|Withdrawal by Subject|0|||
126752103|NCT02985684|456039791|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
126752104|NCT00424463|456039792|FG000|Overall Study|Adverse Event|2|||
126752105|NCT00424463|456039793|FG001|Overall Study|Adverse Event|3|||
126752106|NCT00424463|456039794|FG002|Overall Study|Adverse Event|2|||
126752107|NCT00424463|456039792|FG000|Overall Study|Physician Decision|0|||
126752108|NCT00424463|456039793|FG001|Overall Study|Physician Decision|2|||
126752109|NCT00424463|456039794|FG002|Overall Study|Physician Decision|2|||
126752110|NCT00424463|456039792|FG000|Overall Study|Withdrawal by Subject|4|||
126752111|NCT00424463|456039793|FG001|Overall Study|Withdrawal by Subject|2|||
126752112|NCT00424463|456039794|FG002|Overall Study|Withdrawal by Subject|5|||
126752113|NCT00424463|456039792|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
126752114|NCT00424463|456039793|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
126752115|NCT00424463|456039794|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
126752116|NCT00424463|456039792|FG000|Overall Study|Patient's convenience|0|||
126752117|NCT00424463|456039793|FG001|Overall Study|Patient's convenience|0|||
126752118|NCT00424463|456039794|FG002|Overall Study|Patient's convenience|1|||
126752119|NCT01436357|456039795|FG000|Overall Study|Death|5|||
126752120|NCT01436357|456039796|FG001|Overall Study|Death|1|||
126752121|NCT01436357|456039795|FG000|Overall Study|Enrolled but not vaccinated|1|||
126752122|NCT01436357|456039796|FG001|Overall Study|Enrolled but not vaccinated|1|||
126752123|NCT01436357|456039795|FG000|Overall Study|Incarceration|18|||
126752124|NCT01436357|456039796|FG001|Overall Study|Incarceration|20|||
126752125|NCT01436357|456039795|FG000|Overall Study|Lost to Follow-up|67|||
126752126|NCT01436357|456039796|FG001|Overall Study|Lost to Follow-up|61|||
126752127|NCT01436357|456039795|FG000|Overall Study|Protocol Violation|1|||
126752128|NCT01436357|456039796|FG001|Overall Study|Protocol Violation|0|||
126752129|NCT01436357|456039795|FG000|Overall Study|Withdrawal by Subject|26|||
126752130|NCT01436357|456039796|FG001|Overall Study|Withdrawal by Subject|38|||
126752131|NCT01436357|456039795|FG000|Overall Study|Physician Decision|3|||
126752132|NCT01436357|456039796|FG001|Overall Study|Physician Decision|4|||
126752133|NCT01436357|456039795|FG000|Overall Study|Moved out of area|1|||
126752134|NCT01436357|456039796|FG001|Overall Study|Moved out of area|2|||
126752135|NCT01436357|456039795|FG000|Overall Study|Subject in rehab|0|||
126752136|NCT01436357|456039796|FG001|Overall Study|Subject in rehab|1|||
126752137|NCT05281094|456039797|FG000|Overall Study|Adverse Event|1|||
126752138|NCT05281094|456039798|FG001|Overall Study|Adverse Event|0|||
126752139|NCT05281094|456039797|FG000|Overall Study|Lost to Follow-up|29|||
126752140|NCT05281094|456039798|FG001|Overall Study|Lost to Follow-up|22|||
126752141|NCT05281094|456039797|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
126752142|NCT05281094|456039798|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
126752143|NCT05281094|456039797|FG000|Overall Study|Death|1|||
126752144|NCT05281094|456039798|FG001|Overall Study|Death|2|||
126752145|NCT05281094|456039797|FG000|Overall Study|Not pre-specified reason|8|||
126752146|NCT05281094|456039798|FG001|Overall Study|Not pre-specified reason|5|||
126752147|NCT05315297|456039799|FG000|Overall Study|Lost to Follow-up|6|||
126752148|NCT05315297|456039800|FG001|Overall Study|Lost to Follow-up|4|||
126752149|NCT05315297|456039799|FG000|Overall Study|Withdrawal by Subject|0|||
126752150|NCT05315297|456039800|FG001|Overall Study|Withdrawal by Subject|1|||
126752151|NCT02583399|456041654|FG000|Overall Study|Able to be discharged|3|||
126752152|NCT02583399|456041654|FG000|Overall Study|Wanted to use a restricted medication|3|||
126752153|NCT02759939|456041659|FG000|Overall Study|Missing data on first outcome assessed|11|||
126752154|NCT02759939|456041660|FG001|Overall Study|Missing data on first outcome assessed|2|||
126752155|NCT02759939|456041661|FG002|Overall Study|Missing data on first outcome assessed|5|||
126752156|NCT02759939|456041662|FG003|Overall Study|Missing data on first outcome assessed|2|||
126752157|NCT02759939|456041659|FG000|Overall Study|Ineligible for T2 and T3|310|||
126752158|NCT02759939|456041660|FG001|Overall Study|Ineligible for T2 and T3|179|||
126752159|NCT02759939|456041661|FG002|Overall Study|Ineligible for T2 and T3|366|||
126752160|NCT02759939|456041662|FG003|Overall Study|Ineligible for T2 and T3|391|||
126752161|NCT02759939|456041659|FG000|Overall Study|Lost to Follow-up|735|||
126752162|NCT02759939|456041660|FG001|Overall Study|Lost to Follow-up|791|||
126752163|NCT02759939|456041661|FG002|Overall Study|Lost to Follow-up|783|||
126752164|NCT02759939|456041662|FG003|Overall Study|Lost to Follow-up|650|||
126752165|NCT03288987|456041663|FG000|Overall Study|Protocol Violation|10|||
126752166|NCT03288987|456041664|FG001|Overall Study|Protocol Violation|4|||
126752167|NCT04905563|456041667|FG000|Overall Study|Withdrawal by Subject|1|||
126752168|NCT04905563|456041668|FG001|Overall Study|Withdrawal by Subject|0|||
126752169|NCT04905563|456041667|FG000|Overall Study|Standard of care orders entered by resident|1|||
126752170|NCT04905563|456041668|FG001|Overall Study|Standard of care orders entered by resident|0|||
126752171|NCT04905563|456041667|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
126752172|NCT04905563|456041668|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
126752173|NCT04905563|456041667|FG000|Overall Study|Withdrawal by Subject|0|||
126752174|NCT04905563|456041668|FG001|Overall Study|Withdrawal by Subject|1|||
126752175|NCT04652102|456041680|FG000|Overall Study|Adverse Event|14|||
126752176|NCT04652102|456041681|FG001|Overall Study|Adverse Event|13|||
126752177|NCT04652102|456041680|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
126782768|NCT01621490|456160075|FG003|Overall Study|Disease progression|5|||
126752178|NCT04652102|456041681|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
126752179|NCT04652102|456041680|FG000|Overall Study|Physician Decision|78|||
126752180|NCT04652102|456041681|FG001|Overall Study|Physician Decision|40|||
126752181|NCT04652102|456041680|FG000|Overall Study|Study Ended by Sponsor|64|||
126752182|NCT04652102|456041681|FG001|Overall Study|Study Ended by Sponsor|17|||
126752183|NCT04652102|456041680|FG000|Overall Study|Withdrawal by Subject|4625|||
126752184|NCT04652102|456041681|FG001|Overall Study|Withdrawal by Subject|5594|||
126752185|NCT04652102|456041680|FG000|Overall Study|Lost to Follow-up|2019|||
126752186|NCT04652102|456041681|FG001|Overall Study|Lost to Follow-up|1082|||
126752187|NCT04652102|456041680|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
126752188|NCT04652102|456041681|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
126752189|NCT04652102|456041680|FG000|Overall Study|Miscellaneous|80|||
126752190|NCT04652102|456041681|FG001|Overall Study|Miscellaneous|64|||
126752191|NCT04554394|456041682|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
126752192|NCT04554394|456041683|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
126752193|NCT04554394|456041682|FG000|Overall Study|Withdrawal by Subject|2|||
126752194|NCT04554394|456041683|FG001|Overall Study|Withdrawal by Subject|2|||
126752195|NCT04554394|456041682|FG000|Overall Study|Lost to Follow-up|2|||
126752196|NCT04554394|456041683|FG001|Overall Study|Lost to Follow-up|2|||
126752197|NCT04554394|456041682|FG000|Overall Study|Physician Decision|1|||
126752198|NCT04554394|456041683|FG001|Overall Study|Physician Decision|1|||
126752199|NCT00886587|456041687|FG000|Overall Study|Adverse Event|2|||
126752200|NCT00886587|456041688|FG001|Overall Study|Adverse Event|1|||
126752201|NCT00886587|456041687|FG000|Overall Study|Protocol Violation|2|||
126752202|NCT00886587|456041688|FG001|Overall Study|Protocol Violation|0|||
126752203|NCT00886587|456041687|FG000|Overall Study|Withdrawal by Subject|0|||
126752204|NCT00886587|456041688|FG001|Overall Study|Withdrawal by Subject|1|||
126752205|NCT00696774|456041694|FG000|Period II|Adverse Event|0|||
126752206|NCT00696774|456041695|FG001|Period II|Adverse Event|0|||
126752207|NCT00696774|456041696|FG002|Period II|Adverse Event|15|||
126752208|NCT00696774|456041694|FG000|Period II|Lost to Follow-up|0|||
126752209|NCT00696774|456041695|FG001|Period II|Lost to Follow-up|0|||
126752210|NCT00696774|456041696|FG002|Period II|Lost to Follow-up|4|||
126752211|NCT00696774|456041694|FG000|Period II|Protocol Violation|0|||
126752212|NCT00696774|456041695|FG001|Period II|Protocol Violation|0|||
126752213|NCT00696774|456041696|FG002|Period II|Protocol Violation|11|||
126752214|NCT00696774|456041694|FG000|Period II|Withdrawal by Subject|0|||
126752215|NCT00696774|456041695|FG001|Period II|Withdrawal by Subject|0|||
126752216|NCT00696774|456041696|FG002|Period II|Withdrawal by Subject|4|||
126752217|NCT00696774|456041694|FG000|Period II|Sponsor Decision|0|||
126752218|NCT00696774|456041695|FG001|Period II|Sponsor Decision|0|||
126752219|NCT00696774|456041696|FG002|Period II|Sponsor Decision|0|||
126752220|NCT00696774|456041694|FG000|Period II|Lack of Efficacy|0|||
126752221|NCT00696774|456041695|FG001|Period II|Lack of Efficacy|0|||
126752222|NCT00696774|456041696|FG002|Period II|Lack of Efficacy|2|||
126752223|NCT00696774|456041694|FG000|Period III|Adverse Event|1|||
126752224|NCT00696774|456041695|FG001|Period III|Adverse Event|1|||
126752225|NCT00696774|456041696|FG002|Period III|Adverse Event|0|||
126752226|NCT00696774|456041694|FG000|Period III|Lost to Follow-up|2|||
126752227|NCT00696774|456041695|FG001|Period III|Lost to Follow-up|1|||
126752228|NCT00696774|456041696|FG002|Period III|Lost to Follow-up|0|||
126752229|NCT00696774|456041694|FG000|Period III|Protocol Violation|1|||
126752230|NCT00696774|456041695|FG001|Period III|Protocol Violation|1|||
126752231|NCT00696774|456041696|FG002|Period III|Protocol Violation|0|||
126752232|NCT00696774|456041694|FG000|Period III|Withdrawal by Subject|1|||
126752233|NCT00696774|456041695|FG001|Period III|Withdrawal by Subject|2|||
126752234|NCT00696774|456041696|FG002|Period III|Withdrawal by Subject|0|||
126752235|NCT00696774|456041694|FG000|Period III|Sponsor Decision|2|||
126752236|NCT00696774|456041695|FG001|Period III|Sponsor Decision|0|||
126752237|NCT00696774|456041696|FG002|Period III|Sponsor Decision|0|||
126752238|NCT00696774|456041694|FG000|Period III|Lack of Efficacy|0|||
126752239|NCT00696774|456041695|FG001|Period III|Lack of Efficacy|2|||
126752240|NCT00696774|456041696|FG002|Period III|Lack of Efficacy|0|||
126752241|NCT03490734|456041704|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
126752242|NCT03490734|456041705|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
126752243|NCT03490734|456041706|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
126752244|NCT03490734|456041707|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
126752245|NCT03490734|456041704|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
126752246|NCT03490734|456041705|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
126752247|NCT03490734|456041706|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
126752248|NCT03490734|456041707|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
126752249|NCT03490734|456041704|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
126752250|NCT03490734|456041705|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
126752251|NCT03490734|456041706|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
126752252|NCT03490734|456041707|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
126752253|NCT03490734|456041704|FG000|Post-intervention Scan Visit|Adverse Event|2|||
126752254|NCT03490734|456041705|FG001|Post-intervention Scan Visit|Adverse Event|0|||
126752255|NCT03490734|456041706|FG002|Post-intervention Scan Visit|Adverse Event|0|||
126752256|NCT03490734|456041707|FG003|Post-intervention Scan Visit|Adverse Event|0|||
126752257|NCT03490734|456041704|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
126752258|NCT03490734|456041705|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
126752259|NCT03490734|456041706|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
126752260|NCT03490734|456041707|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
126752261|NCT03490734|456041704|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
126752262|NCT03490734|456041705|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
126752263|NCT03490734|456041706|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
126752264|NCT03490734|456041707|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
126752265|NCT00887913|456041708|FG000|Overall Study|Withdrawal by Subject|6|||
126752266|NCT02442765|456041711|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
126752267|NCT02442765|456041712|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
126752268|NCT02442765|456041713|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
126752269|NCT02442765|456041714|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
126752270|NCT02442765|456041715|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
126752271|NCT02442765|456041716|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
126752272|NCT02442765|456041717|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
126752273|NCT02442765|456041718|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
126752274|NCT02442765|456041711|FG000|Stage 2- (Days 43 to 85)|Death|0|||
126752275|NCT02442765|456041712|FG001|Stage 2- (Days 43 to 85)|Death|0|||
126752276|NCT02442765|456041713|FG002|Stage 2- (Days 43 to 85)|Death|0|||
126752277|NCT02442765|456041714|FG003|Stage 2- (Days 43 to 85)|Death|1|||
126752278|NCT02442765|456041715|FG004|Stage 2- (Days 43 to 85)|Death|1|||
126752279|NCT02442765|456041716|FG005|Stage 2- (Days 43 to 85)|Death|0|||
126752280|NCT02442765|456041717|FG006|Stage 2- (Days 43 to 85)|Death|2|||
126752281|NCT02442765|456041718|FG007|Stage 2- (Days 43 to 85)|Death|0|||
126752282|NCT02442765|456041711|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126752283|NCT02442765|456041712|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126752284|NCT02442765|456041713|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126752285|NCT02442765|456041714|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
126752286|NCT02442765|456041715|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126752287|NCT02442765|456041716|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126752288|NCT02442765|456041717|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126752289|NCT02442765|456041718|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
126752290|NCT02442765|456041711|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126752291|NCT02442765|456041712|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126752292|NCT02442765|456041713|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126752293|NCT02442765|456041714|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
126752294|NCT02442765|456041715|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126752295|NCT02442765|456041716|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126752296|NCT02442765|456041717|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126752297|NCT02442765|456041718|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
126752298|NCT02442765|456041711|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
126752299|NCT02442765|456041712|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
126752300|NCT02442765|456041713|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
126752301|NCT02442765|456041714|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
126752302|NCT02442765|456041715|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
126752303|NCT02442765|456041716|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
126752304|NCT02442765|456041717|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
126752305|NCT02442765|456041718|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
126752306|NCT02442765|456041711|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
126752307|NCT02442765|456041712|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
126752308|NCT02442765|456041713|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
126752309|NCT02442765|456041714|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
126752310|NCT02442765|456041715|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
126752311|NCT02442765|456041716|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
126752312|NCT02442765|456041717|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
126752313|NCT02442765|456041718|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
126752314|NCT02442765|456041711|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
126752315|NCT02442765|456041712|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
126752316|NCT02442765|456041713|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
126752317|NCT02442765|456041714|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
126752318|NCT02442765|456041715|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
126752319|NCT02442765|456041716|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
126752320|NCT02442765|456041717|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
126752321|NCT02442765|456041718|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
126752322|NCT02442765|456041711|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
126752323|NCT02442765|456041712|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
126752324|NCT02442765|456041713|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
126623440|NCT00580047|455577707|FG002|Overall Study|Withdrawal by Subject|0|||
126623441|NCT04382053|455577713|FG000|Overall Study|Death|6|||
126623442|NCT04382053|455577714|FG001|Overall Study|Death|8|||
126623443|NCT04382053|455577713|FG000|Overall Study|Lost to Follow-up|0|||
126623444|NCT04382053|455577714|FG001|Overall Study|Lost to Follow-up|2|||
126623445|NCT04382053|455577713|FG000|Overall Study|Protocol Deviation|1|||
126623446|NCT04382053|455577714|FG001|Overall Study|Protocol Deviation|2|||
126623447|NCT04382053|455577713|FG000|Overall Study|Withdrawal by Subject|2|||
126623448|NCT04382053|455577714|FG001|Overall Study|Withdrawal by Subject|1|||
126623449|NCT00417989|455577720|FG000|Overall Study|Withdrawal by Subject|13|||
126623450|NCT00417989|455577721|FG001|Overall Study|Withdrawal by Subject|13|||
126623451|NCT00417989|455577720|FG000|Overall Study|Lost to Follow-up|1|||
126623452|NCT00417989|455577721|FG001|Overall Study|Lost to Follow-up|6|||
126623453|NCT00417989|455577720|FG000|Overall Study|Protocol Violation|1|||
126623454|NCT00417989|455577721|FG001|Overall Study|Protocol Violation|0|||
126623455|NCT00417989|455577720|FG000|Overall Study|Death|0|||
126623456|NCT00417989|455577721|FG001|Overall Study|Death|1|||
126623457|NCT00417989|455577720|FG000|Overall Study|Physician Decision|5|||
126623458|NCT00417989|455577721|FG001|Overall Study|Physician Decision|2|||
126623459|NCT00390806|455577724|FG000|Overall Study|Lost to Follow-up|7|||
126623460|NCT00390806|455577725|FG001|Overall Study|Lost to Follow-up|6|||
126623461|NCT00390806|455577724|FG000|Overall Study|Protocol Violation|2|||
126623462|NCT00390806|455577725|FG001|Overall Study|Protocol Violation|2|||
126623463|NCT00390806|455577724|FG000|Overall Study|Withdrawal by Subject|12|||
126623464|NCT00390806|455577725|FG001|Overall Study|Withdrawal by Subject|15|||
126623465|NCT00390806|455577724|FG000|Overall Study|Investigator Decision|4|||
126623466|NCT00390806|455577725|FG001|Overall Study|Investigator Decision|6|||
126623467|NCT00390806|455577724|FG000|Overall Study|Death|1|||
126623468|NCT00390806|455577725|FG001|Overall Study|Death|0|||
126623469|NCT00390806|455577724|FG000|Overall Study|Physician Decision|0|||
126623470|NCT00390806|455577725|FG001|Overall Study|Physician Decision|1|||
126623471|NCT00390806|455577724|FG000|Overall Study|Ongoing|4|||
126623472|NCT00390806|455577725|FG001|Overall Study|Ongoing|2|||
126623473|NCT01902381|455579310|FG000|Overall Study|Withdrawal by Subject|1|||
126623474|NCT00755716|455579311|FG000|Overall Study|Adverse Event|1|||
126623475|NCT00755716|455579312|FG001|Overall Study|Adverse Event|4|||
126623476|NCT00755716|455579313|FG002|Overall Study|Adverse Event|1|||
126623477|NCT00755716|455579311|FG000|Overall Study|Lack of Efficacy|2|||
126623478|NCT00755716|455579312|FG001|Overall Study|Lack of Efficacy|0|||
126623479|NCT00755716|455579313|FG002|Overall Study|Lack of Efficacy|0|||
126623480|NCT00755716|455579311|FG000|Overall Study|Lost to Follow-up|5|||
126623481|NCT00755716|455579312|FG001|Overall Study|Lost to Follow-up|3|||
126623482|NCT00755716|455579313|FG002|Overall Study|Lost to Follow-up|1|||
126623483|NCT00755716|455579311|FG000|Overall Study|work schedule issues|0|||
126623484|NCT00755716|455579312|FG001|Overall Study|work schedule issues|1|||
126623485|NCT00755716|455579313|FG002|Overall Study|work schedule issues|1|||
126623486|NCT01284634|455579323|FG000|Overall Study|Adverse Event|1|||
126623487|NCT01284634|455579324|FG001|Overall Study|Adverse Event|0|||
126623488|NCT01284634|455579325|FG002|Overall Study|Adverse Event|2|||
126623489|NCT01284634|455579326|FG003|Overall Study|Adverse Event|1|||
126623490|NCT01059526|455579327|FG000|Overall Study|Patient enrolled but not treated|20|||
126623491|NCT01059526|455579328|FG001|Overall Study|Patient enrolled but not treated|17|||
126623492|NCT01059526|455579327|FG000|Overall Study|Adverse Event|2|||
126623493|NCT01059526|455579328|FG001|Overall Study|Adverse Event|2|||
126623494|NCT01059526|455579327|FG000|Overall Study|Protocol Violation|0|||
126623495|NCT01059526|455579328|FG001|Overall Study|Protocol Violation|1|||
126623496|NCT01059526|455579327|FG000|Overall Study|Withdrawal by Subject|3|||
126623497|NCT01059526|455579328|FG001|Overall Study|Withdrawal by Subject|1|||
126623498|NCT01059526|455579327|FG000|Overall Study|Lost to Follow-up|4|||
126623499|NCT01059526|455579328|FG001|Overall Study|Lost to Follow-up|1|||
126623500|NCT01059526|455579327|FG000|Overall Study|Patient found to be dermatographic|1|||
126623501|NCT01059526|455579328|FG001|Overall Study|Patient found to be dermatographic|0|||
126623502|NCT01732588|455579329|FG000|First Intervention (7 Days)|Adverse Event|0|||
126623503|NCT01732588|455579330|FG001|First Intervention (7 Days)|Adverse Event|1|||
126623504|NCT01732588|455579331|FG002|First Intervention (7 Days)|Adverse Event|0|||
126623505|NCT02720081|455579332|FG000|Overall Study|Adverse Event|0|||
126623506|NCT02720081|455579333|FG001|Overall Study|Adverse Event|3|||
126623507|NCT02720081|455579332|FG000|Overall Study|Protocol Violation|4|||
126623508|NCT02720081|455579333|FG001|Overall Study|Protocol Violation|1|||
126623509|NCT05012397|455579337|FG000|Overall Study|Death|10|||
126623510|NCT05012397|455579337|FG000|Overall Study|Physician Decision|9|||
126623511|NCT05012397|455579337|FG000|Overall Study|Withdrawal by Subject|5|||
126623512|NCT05012397|455579337|FG000|Overall Study|Lost to Follow-up|2|||
126623513|NCT03334747|455579338|FG000|Treatment Phase|Technical problems|0|||
126623514|NCT03334747|455579339|FG001|Treatment Phase|Technical problems|0|||
126623515|NCT03334747|455579340|FG002|Treatment Phase|Technical problems|0|||
126623516|NCT03334747|455579341|FG003|Treatment Phase|Technical problems|0|||
126623517|NCT03334747|455579342|FG004|Treatment Phase|Technical problems|1|||
126623518|NCT03334747|455579343|FG005|Treatment Phase|Technical problems|0|||
126752325|NCT02442765|456041714|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
126752326|NCT02442765|456041715|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
126752327|NCT02442765|456041716|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
126752328|NCT02442765|456041717|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
126752329|NCT02442765|456041718|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
126752330|NCT01200758|456041719|FG000|Stage I|Death|0|||
126752331|NCT01200758|456041720|FG001|Stage I|Death|1|||
126752332|NCT01200758|456041721|FG002|Stage I|Death|0|||
126752333|NCT01200758|456041722|FG003|Stage I|Death|0|||
126752334|NCT01200758|456041719|FG000|Stage I|Physician Decision|1|||
126752335|NCT01200758|456041720|FG001|Stage I|Physician Decision|1|||
126752336|NCT01200758|456041721|FG002|Stage I|Physician Decision|0|||
126752337|NCT01200758|456041722|FG003|Stage I|Physician Decision|0|||
126752338|NCT01200758|456041719|FG000|Stage I|Lack of Efficacy|2|||
126752339|NCT01200758|456041720|FG001|Stage I|Lack of Efficacy|1|||
126752340|NCT01200758|456041721|FG002|Stage I|Lack of Efficacy|0|||
126752341|NCT01200758|456041722|FG003|Stage I|Lack of Efficacy|0|||
126752342|NCT01200758|456041719|FG000|Stage I|Adverse Event|5|||
126752343|NCT01200758|456041720|FG001|Stage I|Adverse Event|5|||
126752344|NCT01200758|456041721|FG002|Stage I|Adverse Event|0|||
126752345|NCT01200758|456041722|FG003|Stage I|Adverse Event|0|||
126752346|NCT01200758|456041719|FG000|Stage I|Withdrawal by Subject|1|||
126752347|NCT01200758|456041720|FG001|Stage I|Withdrawal by Subject|2|||
126752348|NCT01200758|456041721|FG002|Stage I|Withdrawal by Subject|0|||
126752349|NCT01200758|456041722|FG003|Stage I|Withdrawal by Subject|0|||
126752350|NCT01200758|456041719|FG000|Stage I|Disease Progression|9|||
126752351|NCT01200758|456041720|FG001|Stage I|Disease Progression|7|||
126752352|NCT01200758|456041721|FG002|Stage I|Disease Progression|0|||
126752353|NCT01200758|456041722|FG003|Stage I|Disease Progression|0|||
126752354|NCT01200758|456041719|FG000|Stage 2|Disease Progression|0|||
126752355|NCT01200758|456041720|FG001|Stage 2|Disease Progression|0|||
126752356|NCT01200758|456041721|FG002|Stage 2|Disease Progression|16|||
126752357|NCT01200758|456041722|FG003|Stage 2|Disease Progression|21|||
126752358|NCT01200758|456041719|FG000|Stage 2|Lack of Efficacy|0|||
126752359|NCT01200758|456041720|FG001|Stage 2|Lack of Efficacy|0|||
126752360|NCT01200758|456041721|FG002|Stage 2|Lack of Efficacy|4|||
126752361|NCT01200758|456041722|FG003|Stage 2|Lack of Efficacy|2|||
126782769|NCT01621490|456160076|FG004|Overall Study|Disease progression|3|||
126782770|NCT01621490|456160077|FG005|Overall Study|Disease progression|8|||
126782771|NCT01621490|456160078|FG006|Overall Study|Disease progression|7|||
126782772|NCT01621490|456160079|FG007|Overall Study|Disease progression|1|||
126782773|NCT01621490|456160080|FG008|Overall Study|Disease progression|4|||
126782774|NCT01621490|456160081|FG009|Overall Study|Disease progression|1|||
126782775|NCT01621490|456160082|FG010|Overall Study|Disease progression|1|||
126752362|NCT01200758|456041719|FG000|Stage 2|Physician Decision|0|||
126752363|NCT01200758|456041720|FG001|Stage 2|Physician Decision|0|||
126752364|NCT01200758|456041721|FG002|Stage 2|Physician Decision|5|||
126752365|NCT01200758|456041722|FG003|Stage 2|Physician Decision|7|||
126752366|NCT01200758|456041719|FG000|Stage 2|Adverse Event|0|||
126752367|NCT01200758|456041720|FG001|Stage 2|Adverse Event|0|||
126752368|NCT01200758|456041721|FG002|Stage 2|Adverse Event|5|||
126752369|NCT01200758|456041722|FG003|Stage 2|Adverse Event|9|||
126752370|NCT01200758|456041719|FG000|Stage 2|Withdrawal by Subject|0|||
126782776|NCT01621490|456160072|FG000|Overall Study|Study drug toxicity|1|||
126782777|NCT01621490|456160073|FG001|Overall Study|Study drug toxicity|4|||
126782778|NCT01621490|456160074|FG002|Overall Study|Study drug toxicity|5|||
126752371|NCT01200758|456041720|FG001|Stage 2|Withdrawal by Subject|0|||
126752372|NCT01200758|456041721|FG002|Stage 2|Withdrawal by Subject|4|||
126752373|NCT01200758|456041722|FG003|Stage 2|Withdrawal by Subject|1|||
126752374|NCT01200758|456041719|FG000|Stage 2|Lost to Follow-up|0|||
126752375|NCT01200758|456041720|FG001|Stage 2|Lost to Follow-up|0|||
126752376|NCT01200758|456041721|FG002|Stage 2|Lost to Follow-up|3|||
126752377|NCT01200758|456041722|FG003|Stage 2|Lost to Follow-up|1|||
126782779|NCT01621490|456160075|FG003|Overall Study|Study drug toxicity|3|||
126782780|NCT01621490|456160076|FG004|Overall Study|Study drug toxicity|1|||
126782781|NCT01621490|456160077|FG005|Overall Study|Study drug toxicity|10|||
126752378|NCT01200758|456041719|FG000|Stage 2|Protocol Violation|0|||
126752379|NCT01200758|456041720|FG001|Stage 2|Protocol Violation|0|||
126752380|NCT01200758|456041721|FG002|Stage 2|Protocol Violation|1|||
126752381|NCT01200758|456041722|FG003|Stage 2|Protocol Violation|4|||
126752382|NCT01200758|456041719|FG000|Stage 2|Death|0|||
126752383|NCT01200758|456041720|FG001|Stage 2|Death|0|||
126752384|NCT01200758|456041721|FG002|Stage 2|Death|3|||
126752385|NCT01200758|456041722|FG003|Stage 2|Death|5|||
126752386|NCT01371721|456041723|FG000|Overall Study|Adverse Event|5|||
126752387|NCT01371721|456041724|FG001|Overall Study|Adverse Event|4|||
126752388|NCT01371721|456041725|FG002|Overall Study|Adverse Event|5|||
126752389|NCT01371721|456041723|FG000|Overall Study|Protocol Violation|6|||
126752390|NCT01371721|456041724|FG001|Overall Study|Protocol Violation|4|||
126752391|NCT01371721|456041725|FG002|Overall Study|Protocol Violation|5|||
126752392|NCT01371721|456041723|FG000|Overall Study|Lost to Follow-up|8|||
126782782|NCT01621490|456160078|FG006|Overall Study|Study drug toxicity|1|||
126782783|NCT01621490|456160079|FG007|Overall Study|Study drug toxicity|4|||
126752393|NCT01371721|456041724|FG001|Overall Study|Lost to Follow-up|2|||
126752394|NCT01371721|456041725|FG002|Overall Study|Lost to Follow-up|6|||
126752395|NCT01371721|456041723|FG000|Overall Study|Withdrawal by Subject|5|||
126752396|NCT01371721|456041724|FG001|Overall Study|Withdrawal by Subject|7|||
126752397|NCT01371721|456041725|FG002|Overall Study|Withdrawal by Subject|11|||
126752398|NCT01371721|456041723|FG000|Overall Study|Other|2|||
126752399|NCT01371721|456041724|FG001|Overall Study|Other|3|||
126752400|NCT01371721|456041725|FG002|Overall Study|Other|0|||
126752401|NCT01371721|456041723|FG000|Overall Study|Lack of Efficacy|2|||
126752402|NCT01371721|456041724|FG001|Overall Study|Lack of Efficacy|4|||
126752403|NCT01371721|456041725|FG002|Overall Study|Lack of Efficacy|3|||
126752404|NCT01371721|456041723|FG000|Overall Study|Randomized but not treated|1|||
126752405|NCT01371721|456041724|FG001|Overall Study|Randomized but not treated|0|||
126752406|NCT01371721|456041725|FG002|Overall Study|Randomized but not treated|0|||
126752407|NCT00545584|456041726|FG000|Overall Study|Only one reason for discontinuation|62|||
126752408|NCT00545584|456041727|FG001|Overall Study|Only one reason for discontinuation|61|||
126752409|NCT00545584|456041728|FG002|Overall Study|Only one reason for discontinuation|48|||
126752410|NCT00545584|456041726|FG000|Overall Study|Two or more reasons for discontinuation|17|||
126752411|NCT00545584|456041727|FG001|Overall Study|Two or more reasons for discontinuation|19|||
126752412|NCT00545584|456041728|FG002|Overall Study|Two or more reasons for discontinuation|8|||
126752413|NCT03525613|456041731|FG000|Overall Study|Adverse Event|11|||
126752414|NCT03525613|456041732|FG001|Overall Study|Adverse Event|8|||
126752415|NCT03525613|456041733|FG002|Overall Study|Adverse Event|3|||
126752416|NCT03525613|456041734|FG003|Overall Study|Adverse Event|3|||
126752417|NCT03525613|456041731|FG000|Overall Study|Lost to Follow-up|4|||
126752418|NCT03525613|456041732|FG001|Overall Study|Lost to Follow-up|5|||
126752419|NCT03525613|456041733|FG002|Overall Study|Lost to Follow-up|3|||
126752420|NCT03525613|456041734|FG003|Overall Study|Lost to Follow-up|2|||
126752421|NCT03525613|456041731|FG000|Overall Study|Physician Decision|0|||
126752422|NCT03525613|456041732|FG001|Overall Study|Physician Decision|1|||
126752423|NCT03525613|456041733|FG002|Overall Study|Physician Decision|0|||
126752424|NCT03525613|456041734|FG003|Overall Study|Physician Decision|1|||
126752425|NCT03525613|456041731|FG000|Overall Study|Consent Withdrawal|25|||
126752426|NCT03525613|456041732|FG001|Overall Study|Consent Withdrawal|16|||
126752427|NCT03525613|456041733|FG002|Overall Study|Consent Withdrawal|12|||
126752428|NCT03525613|456041734|FG003|Overall Study|Consent Withdrawal|9|||
126752429|NCT03525613|456041731|FG000|Overall Study|Death|20|||
126752430|NCT03525613|456041732|FG001|Overall Study|Death|9|||
126752431|NCT03525613|456041733|FG002|Overall Study|Death|7|||
126752432|NCT03525613|456041734|FG003|Overall Study|Death|1|||
126752433|NCT03525613|456041731|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
126752434|NCT03525613|456041732|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
126752435|NCT03525613|456041733|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
126752436|NCT03525613|456041734|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
126752437|NCT02584660|456041738|FG000|Overall Study|Adverse Event|4|||
126752438|NCT02584660|456041739|FG001|Overall Study|Adverse Event|0|||
126752439|NCT02584660|456041738|FG000|Overall Study|Lost to Follow-up|3|||
126752440|NCT02584660|456041739|FG001|Overall Study|Lost to Follow-up|4|||
126752441|NCT02584660|456041738|FG000|Overall Study|Protocol Violation|0|||
126752442|NCT02584660|456041739|FG001|Overall Study|Protocol Violation|1|||
126752443|NCT02584660|456041738|FG000|Overall Study|Withdrawal by Subject|0|||
126752444|NCT02584660|456041739|FG001|Overall Study|Withdrawal by Subject|2|||
126752445|NCT02584660|456041738|FG000|Overall Study|Other|0|||
126752446|NCT02584660|456041739|FG001|Overall Study|Other|1|||
126752447|NCT00461552|456041740|FG000|Overall Study|Drug Dispensing error|0|||
126752448|NCT00461552|456041741|FG001|Overall Study|Drug Dispensing error|2|||
126752449|NCT00374452|456041742|FG000|Overall Study|Left clinic before intervention started|4|||
126752450|NCT00374452|456041743|FG001|Overall Study|Left clinic before intervention started|1|||
126752451|NCT00374452|456041742|FG000|Overall Study|Change in job role before intervention|0|||
126752452|NCT00374452|456041743|FG001|Overall Study|Change in job role before intervention|1|||
126752453|NCT00374452|456041742|FG000|Overall Study|Left clinic after intervention started|1|||
126782784|NCT01621490|456160080|FG008|Overall Study|Study drug toxicity|1|||
126623519|NCT03334747|455579344|FG006|Treatment Phase|Technical problems|0|||
126752454|NCT00374452|456041743|FG001|Overall Study|Left clinic after intervention started|1|||
126752455|NCT00374452|456041742|FG000|Overall Study|Withdrawal by Subject|0|||
126752456|NCT00374452|456041743|FG001|Overall Study|Withdrawal by Subject|2|||
126752457|NCT00523744|456041745|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
126752458|NCT00523744|456041745|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
126752459|NCT00523744|456041745|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
126752460|NCT00523744|456041745|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
126752461|NCT00523744|456041745|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
126752462|NCT00523744|456041745|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
126752463|NCT03099304|456041748|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
126752464|NCT03099304|456041749|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
126752465|NCT03099304|456041750|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
126782785|NCT01621490|456160081|FG009|Overall Study|Study drug toxicity|0|||
126752466|NCT03099304|456041751|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
126752467|NCT03099304|456041752|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
126752468|NCT03099304|456041753|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
126752469|NCT03099304|456041748|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
126752470|NCT03099304|456041749|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
126752471|NCT03099304|456041750|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
126752472|NCT03099304|456041751|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
126752473|NCT03099304|456041752|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
126752474|NCT03099304|456041753|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
126752475|NCT03099304|456041748|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
126752476|NCT03099304|456041749|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
126752477|NCT03099304|456041750|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
126752478|NCT03099304|456041751|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
126752479|NCT03099304|456041752|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
126752480|NCT03099304|456041753|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
126752481|NCT03099304|456041748|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
126752482|NCT03099304|456041749|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
126752483|NCT03099304|456041750|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
126752484|NCT03099304|456041751|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
126752485|NCT03099304|456041752|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
126752486|NCT03099304|456041753|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
126752487|NCT03099304|456041748|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
126752488|NCT03099304|456041749|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
126752489|NCT03099304|456041750|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
126752490|NCT03099304|456041751|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
126752491|NCT03099304|456041752|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
126752492|NCT03099304|456041753|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
126752493|NCT03099304|456041748|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
126752494|NCT03099304|456041749|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
126752495|NCT03099304|456041750|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
126752496|NCT03099304|456041751|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
126752497|NCT03099304|456041752|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
126752498|NCT03099304|456041753|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
126752499|NCT03099304|456041748|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
126752500|NCT03099304|456041749|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
126752501|NCT03099304|456041750|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
126752502|NCT03099304|456041751|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
126752503|NCT03099304|456041752|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
126752504|NCT03099304|456041753|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
126752505|NCT03099304|456041748|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
126752506|NCT03099304|456041749|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
126752507|NCT03099304|456041750|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
126752508|NCT03099304|456041751|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
126752509|NCT03099304|456041752|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
126752510|NCT03099304|456041753|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
126752511|NCT03099304|456041748|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
126752512|NCT03099304|456041749|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
126752513|NCT03099304|456041750|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
126752514|NCT03099304|456041751|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
126752515|NCT03099304|456041752|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
126752516|NCT03099304|456041753|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
126752517|NCT03099304|456041748|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
126752518|NCT03099304|456041749|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
126752519|NCT03099304|456041750|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
126752520|NCT03099304|456041751|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
126752521|NCT03099304|456041752|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
126752522|NCT03099304|456041753|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
126752523|NCT03099304|456041748|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
126752524|NCT03099304|456041749|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
126752525|NCT03099304|456041750|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
126752526|NCT03099304|456041751|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
126752527|NCT03099304|456041752|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
126752528|NCT03099304|456041753|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
126752529|NCT03099304|456041748|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
126752530|NCT03099304|456041749|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
126752531|NCT03099304|456041750|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
126752532|NCT03099304|456041751|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
126623520|NCT03334747|455579345|FG007|Treatment Phase|Technical problems|0|||
126623521|NCT03334747|455579346|FG008|Treatment Phase|Technical problems|0|||
126623522|NCT03334747|455579338|FG000|Treatment Phase|Subject/guardian decision|1|||
126752533|NCT03099304|456041752|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
126752534|NCT03099304|456041753|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
126752535|NCT03099304|456041748|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
126752536|NCT03099304|456041749|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
126752537|NCT03099304|456041750|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
126752538|NCT03099304|456041751|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
126752539|NCT03099304|456041752|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
126752540|NCT03099304|456041753|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
126752541|NCT03099304|456041748|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
126752542|NCT03099304|456041749|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
126752543|NCT03099304|456041750|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
126752544|NCT03099304|456041751|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
126752545|NCT03099304|456041752|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
126752546|NCT03099304|456041753|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
126752547|NCT03099304|456041748|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
126752548|NCT03099304|456041749|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
126752549|NCT03099304|456041750|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
126752550|NCT03099304|456041751|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
126752551|NCT03099304|456041752|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
126752552|NCT03099304|456041753|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
126752553|NCT03099304|456041748|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
126752554|NCT03099304|456041749|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
126752555|NCT03099304|456041750|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
126752556|NCT03099304|456041751|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
126752557|NCT03099304|456041752|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
126752558|NCT03099304|456041753|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
126752559|NCT03099304|456041748|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
126752560|NCT03099304|456041749|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
126752561|NCT03099304|456041750|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
126752562|NCT03099304|456041751|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
126752563|NCT03099304|456041752|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
126752564|NCT03099304|456041753|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
126752565|NCT00715949|456041756|FG000|Overall Study|could not finish first test|4|||
126752566|NCT01024946|456041757|FG000|Overall Study|Screen Failure|3|||
126752567|NCT01024946|456041757|FG000|Overall Study|Withdrawal by Subject|1|||
126752568|NCT01024946|456041757|FG000|Overall Study|Adverse Event|1|||
126752569|NCT05375838|456041758|FG000|Overall Study|Other|0|||
126752570|NCT05375838|456041759|FG001|Overall Study|Other|0|||
126752571|NCT05375838|456041760|FG002|Overall Study|Other|0|||
126752572|NCT05375838|456041761|FG003|Overall Study|Other|1|||
126752573|NCT05375838|456041762|FG004|Overall Study|Other|1|||
126752574|NCT05375838|456041763|FG005|Overall Study|Other|0|||
126752575|NCT05375838|456041758|FG000|Overall Study|Withdrawal by Subject|2|||
126752576|NCT05375838|456041759|FG001|Overall Study|Withdrawal by Subject|1|||
126752577|NCT05375838|456041760|FG002|Overall Study|Withdrawal by Subject|3|||
126752578|NCT05375838|456041761|FG003|Overall Study|Withdrawal by Subject|2|||
126752579|NCT05375838|456041762|FG004|Overall Study|Withdrawal by Subject|2|||
126752580|NCT05375838|456041763|FG005|Overall Study|Withdrawal by Subject|0|||
126752581|NCT05375838|456041758|FG000|Overall Study|Protocol Violation|0|||
126752582|NCT05375838|456041759|FG001|Overall Study|Protocol Violation|0|||
126752583|NCT05375838|456041760|FG002|Overall Study|Protocol Violation|0|||
126752584|NCT05375838|456041761|FG003|Overall Study|Protocol Violation|0|||
126752585|NCT05375838|456041762|FG004|Overall Study|Protocol Violation|1|||
126752586|NCT05375838|456041763|FG005|Overall Study|Protocol Violation|0|||
126752587|NCT05375838|456041758|FG000|Overall Study|Physician Decision|0|||
126752588|NCT05375838|456041759|FG001|Overall Study|Physician Decision|1|||
126752589|NCT05375838|456041760|FG002|Overall Study|Physician Decision|0|||
126752590|NCT05375838|456041761|FG003|Overall Study|Physician Decision|0|||
126752591|NCT05375838|456041762|FG004|Overall Study|Physician Decision|0|||
126752592|NCT05375838|456041763|FG005|Overall Study|Physician Decision|1|||
126752593|NCT05375838|456041758|FG000|Overall Study|Lost to Follow-up|2|||
126752594|NCT05375838|456041759|FG001|Overall Study|Lost to Follow-up|7|||
126752595|NCT05375838|456041760|FG002|Overall Study|Lost to Follow-up|0|||
126752596|NCT05375838|456041761|FG003|Overall Study|Lost to Follow-up|4|||
126752597|NCT05375838|456041762|FG004|Overall Study|Lost to Follow-up|2|||
126752598|NCT05375838|456041763|FG005|Overall Study|Lost to Follow-up|3|||
126752599|NCT02993783|456041770|FG000|Overall Study|Reason not Specified|6|||
126752600|NCT02993783|456041771|FG001|Overall Study|Reason not Specified|9|||
126752601|NCT00554840|456041781|FG000|Overall Study|Physician Decision|0|||
126782786|NCT01621490|456160082|FG010|Overall Study|Study drug toxicity|0|||
126752602|NCT00554840|456041782|FG001|Overall Study|Physician Decision|1|||
126752603|NCT01385098|456041783|FG000|Overall Study|Adverse Event|10|||
126752604|NCT01385098|456041783|FG000|Overall Study|Lost to Follow-up|4|||
126752605|NCT00925522|456041784|FG000|Overall Study|study closed -- business decision|20|||
126752606|NCT00410514|456041789|FG000|Overall Study|Adverse Event|2|||
126752607|NCT00410514|456041790|FG001|Overall Study|Adverse Event|2|||
126752608|NCT00410514|456041791|FG002|Overall Study|Adverse Event|2|||
126752609|NCT00410514|456041789|FG000|Overall Study|Protocol Violation|0|||
126752610|NCT00410514|456041790|FG001|Overall Study|Protocol Violation|1|||
126752611|NCT00410514|456041791|FG002|Overall Study|Protocol Violation|1|||
126752612|NCT00410514|456041789|FG000|Overall Study|Lost to Follow-up|0|||
126752613|NCT00410514|456041790|FG001|Overall Study|Lost to Follow-up|0|||
126752614|NCT00410514|456041791|FG002|Overall Study|Lost to Follow-up|2|||
126752615|NCT00410514|456041789|FG000|Overall Study|Non-compliant with study procedures|0|||
126752616|NCT00410514|456041790|FG001|Overall Study|Non-compliant with study procedures|0|||
126752617|NCT00410514|456041791|FG002|Overall Study|Non-compliant with study procedures|2|||
126752618|NCT00656799|456041794|FG000|Overall Study|Death|2|||
126752619|NCT04728815|456041802|FG000|Overall Study|Lost to Follow-up|3|||
126752620|NCT04728815|456041803|FG001|Overall Study|Lost to Follow-up|0|||
126752621|NCT04728815|456041804|FG002|Overall Study|Lost to Follow-up|0|||
126752622|NCT04728815|456041805|FG003|Overall Study|Lost to Follow-up|1|||
126752623|NCT04728815|456041806|FG004|Overall Study|Lost to Follow-up|1|||
126752624|NCT04728815|456041807|FG005|Overall Study|Lost to Follow-up|0|||
126752625|NCT04728815|456041808|FG006|Overall Study|Lost to Follow-up|2|||
126752626|NCT04728815|456041809|FG007|Overall Study|Lost to Follow-up|0|||
126752627|NCT04728815|456041802|FG000|Overall Study|Physician Decision|0|||
126752628|NCT04728815|456041803|FG001|Overall Study|Physician Decision|0|||
126752629|NCT04728815|456041804|FG002|Overall Study|Physician Decision|1|||
126752630|NCT04728815|456041805|FG003|Overall Study|Physician Decision|0|||
126752631|NCT04728815|456041806|FG004|Overall Study|Physician Decision|0|||
126752632|NCT04728815|456041807|FG005|Overall Study|Physician Decision|0|||
126752633|NCT04728815|456041808|FG006|Overall Study|Physician Decision|0|||
126752634|NCT04728815|456041809|FG007|Overall Study|Physician Decision|0|||
126752635|NCT04728815|456041802|FG000|Overall Study|Treatment drop|0|||
126752636|NCT04728815|456041803|FG001|Overall Study|Treatment drop|2|||
126752637|NCT04728815|456041804|FG002|Overall Study|Treatment drop|1|||
126752638|NCT04728815|456041805|FG003|Overall Study|Treatment drop|0|||
126752639|NCT04728815|456041806|FG004|Overall Study|Treatment drop|3|||
126752640|NCT04728815|456041807|FG005|Overall Study|Treatment drop|1|||
126752641|NCT04728815|456041808|FG006|Overall Study|Treatment drop|3|||
126752642|NCT04728815|456041809|FG007|Overall Study|Treatment drop|0|||
126752643|NCT04728815|456041802|FG000|Overall Study|Study drop|0|||
126752644|NCT04728815|456041803|FG001|Overall Study|Study drop|3|||
126752645|NCT04728815|456041804|FG002|Overall Study|Study drop|3|||
126752646|NCT04728815|456041805|FG003|Overall Study|Study drop|0|||
126752647|NCT04728815|456041806|FG004|Overall Study|Study drop|0|||
126752648|NCT04728815|456041807|FG005|Overall Study|Study drop|0|||
126752649|NCT04728815|456041808|FG006|Overall Study|Study drop|7|||
126752650|NCT04728815|456041809|FG007|Overall Study|Study drop|0|||
126752651|NCT00631969|456041810|FG000|Overall Study|Adverse Event|3|||
126752652|NCT00631969|456041811|FG001|Overall Study|Adverse Event|1|||
126752653|NCT00631969|456041810|FG000|Overall Study|Lack of Efficacy|2|||
126752654|NCT00631969|456041811|FG001|Overall Study|Lack of Efficacy|8|||
126752655|NCT00631969|456041810|FG000|Overall Study|Lost to Follow-up|2|||
126752656|NCT00631969|456041811|FG001|Overall Study|Lost to Follow-up|1|||
126752657|NCT00631969|456041810|FG000|Overall Study|Protocol Violation|1|||
126752658|NCT00631969|456041811|FG001|Overall Study|Protocol Violation|1|||
126752659|NCT00631969|456041810|FG000|Overall Study|Consent Withdrawn|5|||
126752660|NCT00631969|456041811|FG001|Overall Study|Consent Withdrawn|7|||
126752661|NCT00631969|456041810|FG000|Overall Study|Noncompliant With Study Medication|0|||
126752662|NCT00631969|456041811|FG001|Overall Study|Noncompliant With Study Medication|1|||
126752663|NCT00631969|456041810|FG000|Overall Study|No Drug Exposure|2|||
126752664|NCT00631969|456041811|FG001|Overall Study|No Drug Exposure|2|||
126752665|NCT03053180|456043371|FG000|Overall Study|Failure to Return|1|||
126752666|NCT04144140|456043376|FG000|Overall Study|Other|0|||
126752667|NCT04144140|456043377|FG001|Overall Study|Other|0|||
126752668|NCT04144140|456043378|FG002|Overall Study|Other|0|||
126752669|NCT04144140|456043379|FG003|Overall Study|Other|0|||
126752670|NCT04144140|456043380|FG004|Overall Study|Other|0|||
126752671|NCT04144140|456043381|FG005|Overall Study|Other|1|||
126752672|NCT04144140|456043382|FG006|Overall Study|Other|0|||
126752673|NCT01465958|456043383|FG000|Run-in Phase|Protocol Violation|1|||
126752674|NCT01465958|456043384|FG001|Run-in Phase|Protocol Violation|0|||
126752675|NCT01465958|456043383|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
126752676|NCT01465958|456043384|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
126752677|NCT00669240|456043393|FG000|Overall Study|Lack of Efficacy|33|||
126752678|NCT00669240|456043393|FG000|Overall Study|Withdrawal by Subject|42|||
126752679|NCT00669240|456043393|FG000|Overall Study|Lost to Follow-up|34|||
126752680|NCT00669240|456043393|FG000|Overall Study|Adverse Event|21|||
126752681|NCT00669240|456043393|FG000|Overall Study|Other|19|||
126752682|NCT00669240|456043393|FG000|Overall Study|Enrolled but not treated|15|||
126752683|NCT00669240|456043393|FG000|Overall Study|Enrolled but no dosing record|1|||
126752684|NCT00959192|456043398|FG000|Overall Study|Adverse Event|1|||
126752685|NCT00959192|456043399|FG001|Overall Study|Adverse Event|1|||
126623523|NCT03334747|455579339|FG001|Treatment Phase|Subject/guardian decision|0|||
126623524|NCT03334747|455579340|FG002|Treatment Phase|Subject/guardian decision|0|||
126623525|NCT03334747|455579341|FG003|Treatment Phase|Subject/guardian decision|0|||
126623526|NCT03334747|455579342|FG004|Treatment Phase|Subject/guardian decision|0|||
126623527|NCT03334747|455579343|FG005|Treatment Phase|Subject/guardian decision|1|||
126623528|NCT03334747|455579344|FG006|Treatment Phase|Subject/guardian decision|0|||
126623529|NCT03334747|455579345|FG007|Treatment Phase|Subject/guardian decision|0|||
126623530|NCT03334747|455579346|FG008|Treatment Phase|Subject/guardian decision|0|||
126623531|NCT03334747|455579338|FG000|Follow-Up Phase|Subject/guardian decision|0|||
126623532|NCT03334747|455579339|FG001|Follow-Up Phase|Subject/guardian decision|0|||
126623533|NCT03334747|455579340|FG002|Follow-Up Phase|Subject/guardian decision|0|||
126623534|NCT03334747|455579341|FG003|Follow-Up Phase|Subject/guardian decision|0|||
126623535|NCT03334747|455579342|FG004|Follow-Up Phase|Subject/guardian decision|0|||
126623536|NCT03334747|455579343|FG005|Follow-Up Phase|Subject/guardian decision|0|||
126623537|NCT03334747|455579344|FG006|Follow-Up Phase|Subject/guardian decision|1|||
126623538|NCT03334747|455579345|FG007|Follow-Up Phase|Subject/guardian decision|0|||
126623539|NCT03334747|455579346|FG008|Follow-Up Phase|Subject/guardian decision|1|||
126623540|NCT02567227|455579347|FG000|9 Weeks|Adverse Event|5|||
126623541|NCT02567227|455579348|FG001|9 Weeks|Adverse Event|5|||
126623542|NCT02567227|455579347|FG000|9 Weeks|Withdrawal by Subject|18|||
126623543|NCT02567227|455579348|FG001|9 Weeks|Withdrawal by Subject|8|||
126623544|NCT02567227|455579347|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
126623545|NCT02567227|455579348|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
126623546|NCT02567227|455579347|FG000|6 Month|Death|2|||
126623547|NCT02567227|455579348|FG001|6 Month|Death|0|||
126623548|NCT02567227|455579347|FG000|6 Month|Lost to Follow-up|43|||
126623549|NCT02567227|455579348|FG001|6 Month|Lost to Follow-up|40|||
126623550|NCT02567227|455579347|FG000|12 Months|Lost to Follow-up|31|||
126623551|NCT02567227|455579348|FG001|12 Months|Lost to Follow-up|32|||
126623552|NCT02567227|455579347|FG000|12 Months|Death|0|||
126623553|NCT02567227|455579348|FG001|12 Months|Death|2|||
126623554|NCT04748445|455579349|FG000|Overall Study|No longer met eligibility criteria|12|||
126623555|NCT04748445|455579349|FG000|Overall Study|Other|36|||
126623556|NCT04748445|455579349|FG000|Overall Study|Withdrawal by Subject|553|||
126623557|NCT04748445|455579349|FG000|Overall Study|Lost to Follow-up|30|||
126623558|NCT02498418|455579353|FG000|Overall Study|Lack of Efficacy|0|||
126623559|NCT02498418|455579354|FG001|Overall Study|Lack of Efficacy|0|||
126623560|NCT02498418|455579355|FG002|Overall Study|Lack of Efficacy|1|||
126623561|NCT02498418|455579353|FG000|Overall Study|Withdrawal by Subject|2|||
126623562|NCT02498418|455579354|FG001|Overall Study|Withdrawal by Subject|0|||
126623563|NCT02498418|455579355|FG002|Overall Study|Withdrawal by Subject|3|||
126623564|NCT02498418|455579353|FG000|Overall Study|Lost to Follow-up|0|||
126623565|NCT02498418|455579354|FG001|Overall Study|Lost to Follow-up|1|||
126623566|NCT02498418|455579355|FG002|Overall Study|Lost to Follow-up|1|||
126623567|NCT02498418|455579353|FG000|Overall Study|Participant taken prohibited medication|0|||
126623568|NCT02498418|455579354|FG001|Overall Study|Participant taken prohibited medication|1|||
126623569|NCT02498418|455579355|FG002|Overall Study|Participant taken prohibited medication|1|||
126623570|NCT00762502|455579356|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
126623571|NCT00762502|455579357|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
126623572|NCT00762502|455579358|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
126623573|NCT00762502|455579356|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
126623574|NCT00762502|455579357|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
126623575|NCT00762502|455579358|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
126623576|NCT00762502|455579356|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
126623577|NCT00762502|455579357|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
126623578|NCT00762502|455579358|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
126623579|NCT03042559|455579359|FG000|Overall Study|drop out|1|||
126623580|NCT03042559|455579360|FG001|Overall Study|drop out|1|||
126623581|NCT01536535|455579363|FG000|Overall Study|Withdrawal by Subject|10|||
126623582|NCT01536535|455579364|FG001|Overall Study|Withdrawal by Subject|5|||
126623583|NCT01536535|455579363|FG000|Overall Study|Lost to Follow-up|4|||
126623584|NCT01536535|455579364|FG001|Overall Study|Lost to Follow-up|6|||
126623585|NCT01536535|455579363|FG000|Overall Study|Physician Decision|1|||
126623586|NCT01536535|455579364|FG001|Overall Study|Physician Decision|1|||
126623587|NCT01536535|455579363|FG000|Overall Study|Participant moved|0|||
126623588|NCT01536535|455579364|FG001|Overall Study|Participant moved|1|||
126623589|NCT00385697|455579367|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
126623590|NCT00385697|455579368|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
126623591|NCT00385697|455579369|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
126623592|NCT00385697|455579370|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
126623593|NCT00385697|455579371|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
126623594|NCT00385697|455579367|FG000|Open-label Segment 1|Lost to Follow-up|1|||
126623595|NCT00385697|455579368|FG001|Open-label Segment 1|Lost to Follow-up|0|||
126623596|NCT00385697|455579369|FG002|Open-label Segment 1|Lost to Follow-up|0|||
126623597|NCT00385697|455579370|FG003|Open-label Segment 1|Lost to Follow-up|0|||
126623598|NCT00385697|455579371|FG004|Open-label Segment 1|Lost to Follow-up|0|||
126623599|NCT00385697|455579367|FG000|Double-blind Segment 2|Adverse Event|0|||
126752686|NCT00959192|456043400|FG002|Overall Study|Adverse Event|1|||
126752687|NCT00959192|456043401|FG003|Overall Study|Adverse Event|0|||
126752688|NCT00959192|456043398|FG000|Overall Study|Investigator Request|1|||
126752689|NCT00959192|456043399|FG001|Overall Study|Investigator Request|0|||
126752690|NCT00959192|456043400|FG002|Overall Study|Investigator Request|0|||
126752691|NCT00959192|456043401|FG003|Overall Study|Investigator Request|0|||
126752692|NCT00959192|456043398|FG000|Overall Study|Caregiver Request|0|||
126752693|NCT00959192|456043399|FG001|Overall Study|Caregiver Request|0|||
126752694|NCT00959192|456043400|FG002|Overall Study|Caregiver Request|2|||
126752695|NCT00959192|456043401|FG003|Overall Study|Caregiver Request|1|||
126752696|NCT00532441|456043402|FG000|Overall Study|Death|1|||
126752697|NCT00532441|456043403|FG001|Overall Study|Death|0|||
126752698|NCT01967134|456043404|FG000|Overall Study|Lost to Follow-up|0|||
126752699|NCT01967134|456043405|FG001|Overall Study|Lost to Follow-up|1|||
126752700|NCT01967134|456043406|FG002|Overall Study|Lost to Follow-up|0|||
126752701|NCT00443534|456043407|FG000|Overall Study|Lack of Efficacy|67|||
126752702|NCT00443534|456043407|FG000|Overall Study|Adverse Event|16|||
126752703|NCT00443534|456043407|FG000|Overall Study|Death|9|||
126752704|NCT00443534|456043407|FG000|Overall Study|Withdrawal by Subject|8|||
126752705|NCT00443534|456043407|FG000|Overall Study|Study Terminated by Sponsor|12|||
126752706|NCT00443534|456043407|FG000|Overall Study|Other|10|||
126752707|NCT00443534|456043407|FG000|Overall Study|Enrolled, Not Treated|1|||
126752708|NCT00364611|456043409|FG000|Overall Study|Did not receive study medication|0|||
126752709|NCT00364611|456043410|FG001|Overall Study|Did not receive study medication|1|||
126752710|NCT00364611|456043409|FG000|Overall Study|Adverse Event|7|||
126752711|NCT00364611|456043410|FG001|Overall Study|Adverse Event|4|||
126752712|NCT00364611|456043409|FG000|Overall Study|Participant's Request|3|||
126752713|NCT00364611|456043410|FG001|Overall Study|Participant's Request|4|||
126752714|NCT00364611|456043409|FG000|Overall Study|Disease Progression|38|||
126752715|NCT00364611|456043410|FG001|Overall Study|Disease Progression|8|||
126752716|NCT00364611|456043409|FG000|Overall Study|Investigator decision|2|||
126752717|NCT00364611|456043410|FG001|Overall Study|Investigator decision|2|||
126752718|NCT00364611|456043409|FG000|Overall Study|Found Ineligible|1|||
126752719|NCT00364611|456043410|FG001|Overall Study|Found Ineligible|0|||
126752720|NCT00364611|456043409|FG000|Overall Study|Presumed CR on Study|0|||
126752721|NCT00364611|456043410|FG001|Overall Study|Presumed CR on Study|1|||
126752722|NCT00364611|456043409|FG000|Overall Study|Receiving Liver Ablation|0|||
126752723|NCT00364611|456043410|FG001|Overall Study|Receiving Liver Ablation|1|||
126752724|NCT05466240|456043411|FG000|Overall Study|Adverse Event|1|||
126752725|NCT05466240|456043412|FG001|Overall Study|Adverse Event|0|||
126752726|NCT05466240|456043411|FG000|Overall Study|Withdrawal by Subject|1|||
126752727|NCT05466240|456043412|FG001|Overall Study|Withdrawal by Subject|0|||
126752728|NCT00305773|456043413|FG000|Overall Study|Death|3|||
126752729|NCT00305773|456043414|FG001|Overall Study|Death|2|||
126752730|NCT00305773|456043413|FG000|Overall Study|Adverse Event|1|||
126752731|NCT00305773|456043414|FG001|Overall Study|Adverse Event|2|||
126752732|NCT00305773|456043413|FG000|Overall Study|Alternative Treatment|4|||
126752733|NCT00305773|456043414|FG001|Overall Study|Alternative Treatment|4|||
126752734|NCT00305773|456043413|FG000|Overall Study|Physician Decision|1|||
126752735|NCT00305773|456043414|FG001|Overall Study|Physician Decision|1|||
126752736|NCT00305773|456043413|FG000|Overall Study|Withdrawal by Subject|1|||
126752737|NCT00305773|456043414|FG001|Overall Study|Withdrawal by Subject|4|||
126752738|NCT00305773|456043413|FG000|Overall Study|Disease Progression|1|||
126752739|NCT00305773|456043414|FG001|Overall Study|Disease Progression|3|||
126752740|NCT00305773|456043413|FG000|Overall Study|All other reasons|3|||
126752741|NCT00305773|456043414|FG001|Overall Study|All other reasons|2|||
126752742|NCT02679222|456043415|FG000|Overall Study|No time for project|1|||
126752743|NCT04097925|456043416|FG000|Overall Study|Withdrawal by Subject|1|||
126752744|NCT04735432|456043421|FG000|Overall Study|Other - due to personal reason|1|||
126752745|NCT04735432|456043422|FG001|Overall Study|Other - due to personal reason|0|||
126752746|NCT04735432|456043421|FG000|Overall Study|Adverse Event|2|||
126752747|NCT04735432|456043422|FG001|Overall Study|Adverse Event|0|||
126752748|NCT04397757|456043423|FG000|Overall Study|Death|3|||
126752749|NCT04397757|456043424|FG001|Overall Study|Death|11|||
126752750|NCT04397757|456043423|FG000|Overall Study|Withdrawal by Subject|2|||
126752751|NCT04397757|456043424|FG001|Overall Study|Withdrawal by Subject|0|||
126752752|NCT04397757|456043423|FG000|Overall Study|Lost to Follow-up|4|||
126752753|NCT04397757|456043424|FG001|Overall Study|Lost to Follow-up|3|||
126752754|NCT00413231|456043425|FG000|0 to 30-day Post Treatment|Death|5|||
126752755|NCT00413231|456043425|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
126752756|NCT00413231|456043425|FG000|30-day to 365-day Post Treatment|Death|13|||
126752757|NCT00413231|456043425|FG000|365-day to 60-month Post Treatment|Death|36|||
126752758|NCT00413231|456043425|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
126752759|NCT00413231|456043425|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
126752760|NCT00413231|456043425|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
126752761|NCT00945945|456043430|FG000|Overall Study|Adverse Event|15|||
126752762|NCT00945945|456043431|FG001|Overall Study|Adverse Event|35|||
126752763|NCT00945945|456043430|FG000|Overall Study|Withdrawal by Subject|7|||
126752764|NCT00945945|456043431|FG001|Overall Study|Withdrawal by Subject|10|||
126752765|NCT00945945|456043430|FG000|Overall Study|Lost to Follow-up|4|||
126752766|NCT00945945|456043431|FG001|Overall Study|Lost to Follow-up|5|||
126752767|NCT00945945|456043430|FG000|Overall Study|Lack of Efficacy|6|||
126752768|NCT00945945|456043431|FG001|Overall Study|Lack of Efficacy|2|||
126752769|NCT00945945|456043430|FG000|Overall Study|Protocol Violation|4|||
126752770|NCT00945945|456043431|FG001|Overall Study|Protocol Violation|2|||
126752771|NCT00945945|456043430|FG000|Overall Study|Entry Criteria Not Met|0|||
126752772|NCT00945945|456043431|FG001|Overall Study|Entry Criteria Not Met|1|||
126752773|NCT00626327|456043432|FG000|Overall Study|Withdrawal by Subject|21|||
126752774|NCT00626327|456043433|FG001|Overall Study|Withdrawal by Subject|29|||
126752775|NCT00626327|456043434|FG002|Overall Study|Withdrawal by Subject|30|||
126752776|NCT00626327|456043432|FG000|Overall Study|Adverse Event|1|||
126752777|NCT00626327|456043433|FG001|Overall Study|Adverse Event|0|||
126752778|NCT00626327|456043434|FG002|Overall Study|Adverse Event|0|||
126752779|NCT00626327|456043432|FG000|Overall Study|Lost to Follow-up|24|||
126752780|NCT00626327|456043433|FG001|Overall Study|Lost to Follow-up|21|||
126752781|NCT00626327|456043434|FG002|Overall Study|Lost to Follow-up|23|||
126752782|NCT00626327|456043432|FG000|Overall Study|Inappropriate enrollment|4|||
126752783|NCT00626327|456043433|FG001|Overall Study|Inappropriate enrollment|5|||
126752784|NCT00626327|456043434|FG002|Overall Study|Inappropriate enrollment|3|||
126752785|NCT00626327|456043432|FG000|Overall Study|Administrative Reason|2|||
126752786|NCT00626327|456043433|FG001|Overall Study|Administrative Reason|0|||
126752787|NCT00626327|456043434|FG002|Overall Study|Administrative Reason|6|||
126752788|NCT00626327|456043432|FG000|Overall Study|Protocol Violation|26|||
126752789|NCT00626327|456043433|FG001|Overall Study|Protocol Violation|4|||
126752790|NCT00626327|456043434|FG002|Overall Study|Protocol Violation|26|||
126752791|NCT01823991|456043435|FG000|Overall Study|Withdrawal by Subject|8|||
126752792|NCT01823991|456043436|FG001|Overall Study|Withdrawal by Subject|5|||
126752793|NCT05158244|456043437|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
126752794|NCT05158244|456043438|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
126752795|NCT05158244|456043439|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
126752796|NCT05158244|456043440|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
126752797|NCT05158244|456043441|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
126752798|NCT05158244|456043437|FG000|Overall Study|Withdrawal by Subject|0|||
126752799|NCT05158244|456043438|FG001|Overall Study|Withdrawal by Subject|0|||
126752800|NCT05158244|456043439|FG002|Overall Study|Withdrawal by Subject|1|||
126752801|NCT05158244|456043440|FG003|Overall Study|Withdrawal by Subject|0|||
126752802|NCT05158244|456043441|FG004|Overall Study|Withdrawal by Subject|0|||
126752803|NCT01066819|456043442|FG000|Overall Study|Adverse Event|18|||
126752804|NCT01066819|456043443|FG001|Overall Study|Adverse Event|1|||
126752805|NCT01066819|456043444|FG002|Overall Study|Adverse Event|6|||
126752806|NCT01066819|456043445|FG003|Overall Study|Adverse Event|0|||
126752807|NCT01066819|456043446|FG004|Overall Study|Adverse Event|0|||
126752808|NCT01066819|456043447|FG005|Overall Study|Adverse Event|0|||
126752809|NCT01066819|456043442|FG000|Overall Study|Death|5|||
126752810|NCT01066819|456043443|FG001|Overall Study|Death|0|||
126752811|NCT01066819|456043444|FG002|Overall Study|Death|1|||
126752812|NCT01066819|456043445|FG003|Overall Study|Death|0|||
126752813|NCT01066819|456043446|FG004|Overall Study|Death|0|||
126752814|NCT01066819|456043447|FG005|Overall Study|Death|0|||
126752815|NCT01066819|456043442|FG000|Overall Study|Lack of Efficacy|22|||
126752816|NCT01066819|456043443|FG001|Overall Study|Lack of Efficacy|1|||
126752817|NCT01066819|456043444|FG002|Overall Study|Lack of Efficacy|2|||
126623600|NCT00385697|455579368|FG001|Double-blind Segment 2|Adverse Event|3|||
126752818|NCT01066819|456043445|FG003|Overall Study|Lack of Efficacy|1|||
126752819|NCT01066819|456043446|FG004|Overall Study|Lack of Efficacy|0|||
126752820|NCT01066819|456043447|FG005|Overall Study|Lack of Efficacy|0|||
126752821|NCT01066819|456043442|FG000|Overall Study|Physician Decision|6|||
126752822|NCT01066819|456043443|FG001|Overall Study|Physician Decision|2|||
126752823|NCT01066819|456043444|FG002|Overall Study|Physician Decision|3|||
126752824|NCT01066819|456043445|FG003|Overall Study|Physician Decision|0|||
126752825|NCT01066819|456043446|FG004|Overall Study|Physician Decision|0|||
126623601|NCT00385697|455579369|FG002|Double-blind Segment 2|Adverse Event|1|||
126623602|NCT00385697|455579370|FG003|Double-blind Segment 2|Adverse Event|0|||
126752826|NCT01066819|456043447|FG005|Overall Study|Physician Decision|0|||
126752827|NCT01066819|456043442|FG000|Overall Study|Protocol Violation|12|||
126752828|NCT01066819|456043443|FG001|Overall Study|Protocol Violation|6|||
126752829|NCT01066819|456043444|FG002|Overall Study|Protocol Violation|0|||
126752830|NCT01066819|456043445|FG003|Overall Study|Protocol Violation|0|||
126752831|NCT01066819|456043446|FG004|Overall Study|Protocol Violation|0|||
126752832|NCT01066819|456043447|FG005|Overall Study|Protocol Violation|0|||
126752833|NCT01066819|456043442|FG000|Overall Study|Withdrawal by Subject|29|||
126752834|NCT01066819|456043443|FG001|Overall Study|Withdrawal by Subject|11|||
126752835|NCT01066819|456043444|FG002|Overall Study|Withdrawal by Subject|6|||
126752836|NCT01066819|456043445|FG003|Overall Study|Withdrawal by Subject|0|||
126623603|NCT00385697|455579371|FG004|Double-blind Segment 2|Adverse Event|0|||
126752837|NCT01066819|456043446|FG004|Overall Study|Withdrawal by Subject|0|||
126752838|NCT01066819|456043447|FG005|Overall Study|Withdrawal by Subject|0|||
126752839|NCT01066819|456043442|FG000|Overall Study|Administrative|6|||
126752840|NCT01066819|456043443|FG001|Overall Study|Administrative|4|||
126752841|NCT01066819|456043444|FG002|Overall Study|Administrative|2|||
126752842|NCT01066819|456043445|FG003|Overall Study|Administrative|0|||
126752843|NCT01066819|456043446|FG004|Overall Study|Administrative|0|||
126752844|NCT01066819|456043447|FG005|Overall Study|Administrative|0|||
126752845|NCT01066819|456043442|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
126752846|NCT01066819|456043443|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
126752847|NCT01066819|456043444|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
126623604|NCT00385697|455579367|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
126623605|NCT00385697|455579368|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
126623606|NCT00385697|455579369|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
126623607|NCT00385697|455579370|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
126623608|NCT00385697|455579371|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
126623609|NCT00385697|455579367|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
126623610|NCT00385697|455579368|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
126623611|NCT00385697|455579369|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
126623612|NCT00385697|455579370|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
126623613|NCT00385697|455579371|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
126623614|NCT00385697|455579367|FG000|Double-blind Segment 2|Other|0|||
126623615|NCT00385697|455579368|FG001|Double-blind Segment 2|Other|2|||
126623616|NCT00385697|455579369|FG002|Double-blind Segment 2|Other|0|||
126623617|NCT00385697|455579370|FG003|Double-blind Segment 2|Other|0|||
126623618|NCT00385697|455579371|FG004|Double-blind Segment 2|Other|0|||
126623619|NCT01485991|455579372|FG000|Overall Study|Adverse Event|0|||
126623620|NCT01485991|455579373|FG001|Overall Study|Adverse Event|4|||
126623621|NCT01485991|455579372|FG000|Overall Study|Lost to Follow-up|13|||
126623622|NCT01485991|455579373|FG001|Overall Study|Lost to Follow-up|10|||
126623623|NCT01485991|455579372|FG000|Overall Study|Withdrawal by Subject|13|||
126623624|NCT01485991|455579373|FG001|Overall Study|Withdrawal by Subject|20|||
126623625|NCT01485991|455579372|FG000|Overall Study|randomized but not treated|6|||
126623626|NCT01485991|455579373|FG001|Overall Study|randomized but not treated|2|||
126623627|NCT01475370|455579375|FG000|Overall Study|Exacerbation of primary disease|2|||
126623628|NCT01475370|455579376|FG001|Overall Study|Exacerbation of primary disease|2|||
126623629|NCT01475370|455579377|FG002|Overall Study|Exacerbation of primary disease|2|||
126623630|NCT01475370|455579375|FG000|Overall Study|Study drug administration difficult|0|||
126623631|NCT01475370|455579376|FG001|Overall Study|Study drug administration difficult|1|||
126623632|NCT01475370|455579377|FG002|Overall Study|Study drug administration difficult|1|||
126623633|NCT01475370|455579375|FG000|Overall Study|Other than specified|1|||
126623634|NCT01475370|455579376|FG001|Overall Study|Other than specified|0|||
126623635|NCT01475370|455579377|FG002|Overall Study|Other than specified|0|||
126623636|NCT02538471|455579378|FG000|Overall Study|Progression of disease|2|||
126623637|NCT01675050|455579381|FG000|Period One Treatment|Withdrawal by Subject|1|||
126623638|NCT01675050|455579382|FG001|Period One Treatment|Withdrawal by Subject|0|||
126623639|NCT00084747|455579383|FG000|Overall Study|Relapsed|8|||
126623640|NCT00084747|455579383|FG000|Overall Study|Death|3|||
126623641|NCT00084747|455579383|FG000|Overall Study|Withdrawal by Subject|2|||
126623642|NCT02382406|455579388|FG000|Study Treatment|Disease Progression|8|||
126623643|NCT02382406|455579389|FG001|Study Treatment|Disease Progression|0|||
126623644|NCT02382406|455579390|FG002|Study Treatment|Disease Progression|20|||
126623645|NCT02382406|455579388|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
126623646|NCT02382406|455579389|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
126623647|NCT02382406|455579390|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
126623648|NCT02382406|455579388|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
126623649|NCT02382406|455579389|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
126623650|NCT02382406|455579390|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
126623651|NCT02382406|455579388|FG000|Study Treatment|symptomatic deterioration|1|||
126623652|NCT02382406|455579389|FG001|Study Treatment|symptomatic deterioration|0|||
126623653|NCT02382406|455579390|FG002|Study Treatment|symptomatic deterioration|1|||
126623654|NCT02382406|455579388|FG000|Study Treatment|Death|0|||
126623655|NCT02382406|455579389|FG001|Study Treatment|Death|0|||
126623656|NCT02382406|455579390|FG002|Study Treatment|Death|2|||
126752848|NCT01066819|456043445|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
126752849|NCT01066819|456043446|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
126623657|NCT02382406|455579388|FG000|Follow up|Death|11|||
126623658|NCT02382406|455579389|FG001|Follow up|Death|0|||
126623659|NCT02382406|455579390|FG002|Follow up|Death|19|||
126623660|NCT02382406|455579388|FG000|Follow up|Symptomatic deterioration|1|||
126623661|NCT02382406|455579389|FG001|Follow up|Symptomatic deterioration|0|||
126623662|NCT02382406|455579390|FG002|Follow up|Symptomatic deterioration|1|||
126623663|NCT02382406|455579388|FG000|Follow up|Patient Refused Follow-up|1|||
126623664|NCT02382406|455579389|FG001|Follow up|Patient Refused Follow-up|0|||
126623665|NCT02382406|455579390|FG002|Follow up|Patient Refused Follow-up|0|||
126752850|NCT01066819|456043447|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
126752851|NCT01066819|456043442|FG000|Overall Study|Early termination|2|||
126752852|NCT01066819|456043443|FG001|Overall Study|Early termination|0|||
126752853|NCT01066819|456043444|FG002|Overall Study|Early termination|0|||
126752854|NCT01066819|456043445|FG003|Overall Study|Early termination|0|||
126752855|NCT01066819|456043446|FG004|Overall Study|Early termination|0|||
126752856|NCT01066819|456043447|FG005|Overall Study|Early termination|0|||
126752857|NCT01066819|456043442|FG000|Overall Study|Failed to return|298|||
126752858|NCT01066819|456043443|FG001|Overall Study|Failed to return|107|||
126752859|NCT01066819|456043444|FG002|Overall Study|Failed to return|68|||
126752860|NCT01066819|456043445|FG003|Overall Study|Failed to return|7|||
126752861|NCT01066819|456043446|FG004|Overall Study|Failed to return|2|||
126752862|NCT01066819|456043447|FG005|Overall Study|Failed to return|3|||
126752863|NCT01066819|456043442|FG000|Overall Study|Lab test not done|9|||
126752864|NCT01066819|456043443|FG001|Overall Study|Lab test not done|0|||
126752865|NCT01066819|456043444|FG002|Overall Study|Lab test not done|2|||
126752866|NCT01066819|456043445|FG003|Overall Study|Lab test not done|1|||
126752867|NCT01066819|456043446|FG004|Overall Study|Lab test not done|0|||
126752868|NCT01066819|456043447|FG005|Overall Study|Lab test not done|0|||
126752869|NCT01066819|456043442|FG000|Overall Study|Miscellaneous|28|||
126752870|NCT01066819|456043443|FG001|Overall Study|Miscellaneous|10|||
126752871|NCT01066819|456043444|FG002|Overall Study|Miscellaneous|18|||
126752872|NCT01066819|456043445|FG003|Overall Study|Miscellaneous|1|||
126752873|NCT01066819|456043446|FG004|Overall Study|Miscellaneous|0|||
126752874|NCT01066819|456043447|FG005|Overall Study|Miscellaneous|0|||
126752875|NCT01066819|456043442|FG000|Overall Study|Non responders|123|||
126752876|NCT01066819|456043443|FG001|Overall Study|Non responders|2|||
126752877|NCT01066819|456043444|FG002|Overall Study|Non responders|7|||
126752878|NCT01066819|456043445|FG003|Overall Study|Non responders|2|||
126752879|NCT01066819|456043446|FG004|Overall Study|Non responders|0|||
126752880|NCT01066819|456043447|FG005|Overall Study|Non responders|1|||
126752881|NCT01066819|456043442|FG000|Overall Study|Not categorised|9|||
126752882|NCT01066819|456043443|FG001|Overall Study|Not categorised|2|||
126752883|NCT01066819|456043444|FG002|Overall Study|Not categorised|6|||
126752884|NCT01066819|456043445|FG003|Overall Study|Not categorised|1|||
126752885|NCT01066819|456043446|FG004|Overall Study|Not categorised|0|||
126752886|NCT01066819|456043447|FG005|Overall Study|Not categorised|0|||
126752887|NCT01066819|456043442|FG000|Overall Study|Relapse|16|||
126752888|NCT01066819|456043443|FG001|Overall Study|Relapse|4|||
126752889|NCT01066819|456043444|FG002|Overall Study|Relapse|3|||
126752890|NCT01066819|456043445|FG003|Overall Study|Relapse|0|||
126752891|NCT01066819|456043446|FG004|Overall Study|Relapse|0|||
126752892|NCT01066819|456043447|FG005|Overall Study|Relapse|0|||
126752893|NCT01066819|456043442|FG000|Overall Study|Results not available|1|||
126752894|NCT01066819|456043443|FG001|Overall Study|Results not available|0|||
126752895|NCT01066819|456043444|FG002|Overall Study|Results not available|0|||
126752896|NCT01066819|456043445|FG003|Overall Study|Results not available|0|||
126752897|NCT01066819|456043446|FG004|Overall Study|Results not available|0|||
126752898|NCT01066819|456043447|FG005|Overall Study|Results not available|0|||
126752899|NCT01066819|456043442|FG000|Overall Study|Screen failure|1|||
126752900|NCT01066819|456043443|FG001|Overall Study|Screen failure|0|||
126752901|NCT01066819|456043444|FG002|Overall Study|Screen failure|0|||
126752902|NCT01066819|456043445|FG003|Overall Study|Screen failure|0|||
126752903|NCT01066819|456043446|FG004|Overall Study|Screen failure|0|||
126752904|NCT01066819|456043447|FG005|Overall Study|Screen failure|0|||
126752905|NCT01066819|456043442|FG000|Overall Study|Spontaneous cure|1|||
126752906|NCT01066819|456043443|FG001|Overall Study|Spontaneous cure|0|||
126752907|NCT01066819|456043444|FG002|Overall Study|Spontaneous cure|0|||
126752908|NCT01066819|456043445|FG003|Overall Study|Spontaneous cure|0|||
126752909|NCT01066819|456043446|FG004|Overall Study|Spontaneous cure|0|||
126752910|NCT01066819|456043447|FG005|Overall Study|Spontaneous cure|0|||
126752911|NCT01066819|456043442|FG000|Overall Study|Treatment never started|85|||
126752912|NCT01066819|456043443|FG001|Overall Study|Treatment never started|19|||
126752913|NCT01066819|456043444|FG002|Overall Study|Treatment never started|19|||
126752914|NCT01066819|456043445|FG003|Overall Study|Treatment never started|3|||
126752915|NCT01066819|456043446|FG004|Overall Study|Treatment never started|2|||
126752916|NCT01066819|456043447|FG005|Overall Study|Treatment never started|2|||
126752917|NCT01066819|456043442|FG000|Overall Study|Treatment stopped|12|||
126752918|NCT01066819|456043443|FG001|Overall Study|Treatment stopped|1|||
126752919|NCT01066819|456043444|FG002|Overall Study|Treatment stopped|2|||
126752920|NCT01066819|456043445|FG003|Overall Study|Treatment stopped|1|||
126752921|NCT01066819|456043446|FG004|Overall Study|Treatment stopped|0|||
126752922|NCT01066819|456043447|FG005|Overall Study|Treatment stopped|0|||
126752923|NCT01066819|456043442|FG000|Overall Study|Other|5|||
126752924|NCT01066819|456043443|FG001|Overall Study|Other|1|||
126752925|NCT01066819|456043444|FG002|Overall Study|Other|1|||
126752926|NCT01066819|456043445|FG003|Overall Study|Other|0|||
126752927|NCT01066819|456043446|FG004|Overall Study|Other|0|||
126752928|NCT01066819|456043447|FG005|Overall Study|Other|0|||
126752929|NCT00805194|456043449|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
126782787|NCT01621490|456160072|FG000|Overall Study|Death|0|||
126782788|NCT01621490|456160073|FG001|Overall Study|Death|0|||
126782789|NCT01621490|456160074|FG002|Overall Study|Death|0|||
126782790|NCT01621490|456160075|FG003|Overall Study|Death|0|||
126782791|NCT01621490|456160076|FG004|Overall Study|Death|0|||
126782792|NCT01621490|456160077|FG005|Overall Study|Death|0|||
126782793|NCT01621490|456160078|FG006|Overall Study|Death|0|||
126782794|NCT01621490|456160079|FG007|Overall Study|Death|0|||
126782795|NCT01621490|456160080|FG008|Overall Study|Death|1|||
126782796|NCT01621490|456160081|FG009|Overall Study|Death|0|||
126782797|NCT01621490|456160082|FG010|Overall Study|Death|0|||
126782798|NCT01621490|456160072|FG000|Overall Study|Other reasons|7|||
126782799|NCT01621490|456160073|FG001|Overall Study|Other reasons|6|||
126782800|NCT01621490|456160074|FG002|Overall Study|Other reasons|4|||
126782801|NCT01621490|456160075|FG003|Overall Study|Other reasons|1|||
126782802|NCT01621490|456160076|FG004|Overall Study|Other reasons|1|||
126782803|NCT01621490|456160077|FG005|Overall Study|Other reasons|3|||
126782804|NCT01621490|456160078|FG006|Overall Study|Other reasons|1|||
126782805|NCT01621490|456160079|FG007|Overall Study|Other reasons|1|||
126782806|NCT01621490|456160080|FG008|Overall Study|Other reasons|1|||
126782807|NCT01621490|456160081|FG009|Overall Study|Other reasons|0|||
126782808|NCT01621490|456160082|FG010|Overall Study|Other reasons|0|||
126782809|NCT00461500|456160083|FG000|Overall Study|Adverse Event|1|||
126782810|NCT00461500|456160084|FG001|Overall Study|Adverse Event|0|||
126782811|NCT00461500|456160083|FG000|Overall Study|Lack of Efficacy|0|||
126782812|NCT00461500|456160084|FG001|Overall Study|Lack of Efficacy|1|||
126782813|NCT00461500|456160083|FG000|Overall Study|Expired Drug Treatment|1|||
126782814|NCT00461500|456160084|FG001|Overall Study|Expired Drug Treatment|1|||
126782815|NCT00461500|456160083|FG000|Overall Study|Study Stopped|1|||
126782816|NCT00461500|456160084|FG001|Overall Study|Study Stopped|2|||
126782817|NCT00461500|456160083|FG000|Overall Study|Drug Treatment Misuse|1|||
126782818|NCT00461500|456160084|FG001|Overall Study|Drug Treatment Misuse|0|||
126782819|NCT00461500|456160083|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
126782820|NCT00461500|456160084|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
126782821|NCT00461500|456160083|FG000|Overall Study|Lost to Follow-up|2|||
126782822|NCT00461500|456160084|FG001|Overall Study|Lost to Follow-up|2|||
126782823|NCT01806597|456160085|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
126782824|NCT01806597|456160086|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
126782825|NCT01806597|456160087|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
126623666|NCT02382406|455579388|FG000|Follow up|Study Terminated|1|||
126623667|NCT02382406|455579389|FG001|Follow up|Study Terminated|0|||
126623668|NCT02382406|455579390|FG002|Follow up|Study Terminated|8|||
126623669|NCT02382406|455579388|FG000|Follow up|Withdrawal by Subject|0|||
126623670|NCT02382406|455579389|FG001|Follow up|Withdrawal by Subject|0|||
126623671|NCT02382406|455579390|FG002|Follow up|Withdrawal by Subject|2|||
126623672|NCT03794609|455579393|FG000|Overall Study|Other|10|||
126623673|NCT03794609|455579393|FG000|Overall Study|Withdrawal by Subject|66|||
126623674|NCT03794609|455579393|FG000|Overall Study|The child is enrolled in an interventional study|70|||
126623675|NCT03794609|455579393|FG000|Overall Study|Inclusion/exclusion criteria|8|||
126623676|NCT03794609|455579393|FG000|Overall Study|At sponsor's request|151|||
126623677|NCT03794609|455579393|FG000|Overall Study|Physician Decision|1|||
126623678|NCT03794609|455579393|FG000|Overall Study|Lost to Follow-up|5|||
126623679|NCT04543942|455579394|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
126623680|NCT04543942|455579395|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
126623681|NCT04543942|455579394|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
126623682|NCT04543942|455579395|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
126623683|NCT02097056|455579400|FG000|Overall Study|Protocol Violation|2|||
126623684|NCT02097056|455579400|FG000|Overall Study|Withdrawal by Subject|15|||
126623685|NCT02097056|455579400|FG000|Overall Study|Lost to Follow-up|2|||
126623686|NCT02097056|455579400|FG000|Overall Study|Adverse Event|37|||
126623687|NCT02097056|455579400|FG000|Overall Study|Other|2|||
126623688|NCT00794573|455579417|FG000|Overall Study|Death|3|||
126623689|NCT00794573|455579418|FG001|Overall Study|Death|0|||
126623690|NCT00794573|455579417|FG000|Overall Study|Withdrawal by Subject|9|||
126623691|NCT00794573|455579418|FG001|Overall Study|Withdrawal by Subject|12|||
126623692|NCT00794573|455579417|FG000|Overall Study|Lost to Follow-up|26|||
126782826|NCT01806597|456160088|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
126623693|NCT00794573|455579418|FG001|Overall Study|Lost to Follow-up|33|||
126623694|NCT03928821|455579419|FG000|Overall Study|Death|0|||
126623695|NCT03928821|455579420|FG001|Overall Study|Death|1|||
126623696|NCT03928821|455579421|FG002|Overall Study|Death|0|||
126623697|NCT03928821|455579422|FG003|Overall Study|Death|0|||
126623698|NCT03928821|455579419|FG000|Overall Study|Lost to Follow-up|0|||
126623699|NCT03928821|455579420|FG001|Overall Study|Lost to Follow-up|2|||
126623700|NCT03928821|455579421|FG002|Overall Study|Lost to Follow-up|3|||
126782827|NCT01806597|456160089|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
126782828|NCT01806597|456160090|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
126782829|NCT01806597|456160085|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
126782830|NCT01806597|456160086|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
126782831|NCT01806597|456160087|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
126752930|NCT00805194|456043450|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
126752931|NCT00805194|456043449|FG000|Overall Study|Worsening or AE of underlying disease|64|||
126752932|NCT00805194|456043450|FG001|Overall Study|Worsening or AE of underlying disease|70|||
126752933|NCT00805194|456043449|FG000|Overall Study|Other AE|84|||
126752934|NCT00805194|456043450|FG001|Overall Study|Other AE|73|||
126752935|NCT00805194|456043449|FG000|Overall Study|Protocol Violation|9|||
126752936|NCT00805194|456043450|FG001|Overall Study|Protocol Violation|9|||
126752937|NCT00805194|456043449|FG000|Overall Study|Lost to Follow-up|5|||
126752938|NCT00805194|456043450|FG001|Overall Study|Lost to Follow-up|5|||
126752939|NCT00805194|456043449|FG000|Overall Study|Withdrawal by Subject|60|||
126752940|NCT00805194|456043450|FG001|Overall Study|Withdrawal by Subject|42|||
126752941|NCT00805194|456043449|FG000|Overall Study|Not treated|3|||
126752942|NCT00805194|456043450|FG001|Overall Study|Not treated|4|||
126752943|NCT00805194|456043449|FG000|Overall Study|Reasons other than stated above|20|||
126752944|NCT00805194|456043450|FG001|Overall Study|Reasons other than stated above|16|||
126752945|NCT02275052|456043457|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126752946|NCT02275052|456043458|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
126752947|NCT02275052|456043459|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126752948|NCT02275052|456043460|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
126752949|NCT02275052|456043457|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
126752950|NCT02275052|456043458|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
126752951|NCT02275052|456043459|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
126752952|NCT02275052|456043460|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
126752953|NCT02275052|456043457|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
126752954|NCT02275052|456043458|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
126752955|NCT02275052|456043459|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126752956|NCT02275052|456043460|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
126752957|NCT02275052|456043457|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
126752958|NCT02275052|456043458|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
126752959|NCT02275052|456043459|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
126752960|NCT02275052|456043460|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
126752961|NCT02275052|456043457|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
126752962|NCT02275052|456043458|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
126752963|NCT02275052|456043459|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
126752964|NCT02275052|456043460|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
126752965|NCT02275052|456043457|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
126752966|NCT02275052|456043458|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
126752967|NCT02275052|456043459|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
126752968|NCT02275052|456043460|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
126752969|NCT02275052|456043457|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
126752970|NCT02275052|456043458|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
126752971|NCT02275052|456043459|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
126752972|NCT02275052|456043460|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
126752973|NCT02275052|456043457|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
126752974|NCT02275052|456043458|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
126752975|NCT02275052|456043459|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
126752976|NCT02275052|456043460|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
126752977|NCT02275052|456043457|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126752978|NCT02275052|456043458|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
126752979|NCT02275052|456043459|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
126752980|NCT02275052|456043460|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
126752981|NCT02275052|456043457|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
126752982|NCT02275052|456043458|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
126752983|NCT02275052|456043459|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
126752984|NCT02275052|456043460|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
126752985|NCT02275052|456043457|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126752986|NCT02275052|456043458|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126752987|NCT02275052|456043459|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
126752988|NCT02275052|456043460|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
126752989|NCT02807376|456043463|FG000|Overall Study|Intra-operative exclusion criteria|3|||
126752990|NCT02807376|456043464|FG001|Overall Study|Intra-operative exclusion criteria|0|||
126752991|NCT02807376|456043463|FG000|Overall Study|Lost to Follow-up|0|||
126752992|NCT02807376|456043464|FG001|Overall Study|Lost to Follow-up|1|||
126752993|NCT00846027|456043465|FG000|Overall Study|Death|3|||
126752994|NCT00846027|456043465|FG000|Overall Study|Disease Progression|30|||
126752995|NCT00846027|456043465|FG000|Overall Study|Toxicity|12|||
126623701|NCT03928821|455579422|FG003|Overall Study|Lost to Follow-up|0|||
126752996|NCT00846027|456043465|FG000|Overall Study|Patient Decision|7|||
126752997|NCT00846027|456043465|FG000|Overall Study|Investigator Discretion|29|||
126752998|NCT00846027|456043465|FG000|Overall Study|Protocol Violation|2|||
126752999|NCT00846027|456043465|FG000|Overall Study|Subject Not Treated|7|||
126753000|NCT00808028|456043468|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
126753001|NCT00808028|456043469|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
126753002|NCT00808028|456043470|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
126753003|NCT00808028|456043471|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
126753004|NCT00808028|456043468|FG000|Stage 1 (6 Months)|Other|1|||
126753005|NCT00808028|456043469|FG001|Stage 1 (6 Months)|Other|0|||
126753006|NCT00808028|456043470|FG002|Stage 1 (6 Months)|Other|2|||
126753007|NCT00808028|456043471|FG003|Stage 1 (6 Months)|Other|4|||
126753008|NCT00808028|456043468|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
126753009|NCT00808028|456043469|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
126753010|NCT00808028|456043470|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
126753011|NCT00808028|456043471|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
126753012|NCT00808028|456043468|FG000|Stage 1 (6 Months)|Adverse Event|0|||
126753013|NCT00808028|456043469|FG001|Stage 1 (6 Months)|Adverse Event|0|||
126753014|NCT00808028|456043470|FG002|Stage 1 (6 Months)|Adverse Event|1|||
126753015|NCT00808028|456043471|FG003|Stage 1 (6 Months)|Adverse Event|2|||
126753016|NCT00808028|456043468|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
126753017|NCT00808028|456043469|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
126753018|NCT00808028|456043470|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
126753019|NCT00808028|456043471|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
126753020|NCT00808028|456043468|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
126753021|NCT00808028|456043469|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
126753022|NCT00808028|456043470|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
126753023|NCT00808028|456043471|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
126753024|NCT00808028|456043468|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
126753025|NCT00808028|456043469|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
126753026|NCT00808028|456043470|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
126753027|NCT00808028|456043471|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
126753028|NCT00808028|456043468|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
126753029|NCT00808028|456043469|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
126753030|NCT00808028|456043470|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
126753031|NCT00808028|456043471|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
126753032|NCT00808028|456043468|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
126753033|NCT00808028|456043469|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
126753034|NCT00808028|456043470|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
126753035|NCT00808028|456043471|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
126753036|NCT00808028|456043468|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
126753037|NCT00808028|456043469|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
126753038|NCT00808028|456043470|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
126753039|NCT00808028|456043471|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
126753040|NCT00808028|456043468|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
126753041|NCT00808028|456043469|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
126753042|NCT00808028|456043470|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
126753043|NCT00808028|456043471|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
126753044|NCT00808028|456043468|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
126753045|NCT00808028|456043469|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
126753046|NCT00808028|456043470|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
126753047|NCT00808028|456043471|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
126753048|NCT00808028|456043468|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
126753049|NCT00808028|456043469|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
126753050|NCT00808028|456043470|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
126753051|NCT00808028|456043471|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
126753052|NCT00808028|456043468|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
126753053|NCT00808028|456043469|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
126753054|NCT00808028|456043470|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
126753055|NCT00808028|456043471|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
126753056|NCT00808028|456043468|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
126753057|NCT00808028|456043469|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
126753058|NCT00808028|456043470|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
126753059|NCT00808028|456043471|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
126753060|NCT01611558|456043472|FG000|Induction Phase|Study drug toxicity|15|||
126753061|NCT01611558|456043472|FG000|Induction Phase|Disease progression|18|||
126753062|NCT01611558|456043472|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
126753063|NCT01611558|456043472|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
126753064|NCT01611558|456043472|FG000|Induction Phase|Death|1|||
126753065|NCT01611558|456043472|FG000|Maintenance Phase|Withdrawal by Subject|1|||
126753066|NCT01611558|456043472|FG000|Maintenance Phase|Elevated Uric acid|1|||
126753067|NCT04005885|456043474|FG000|First Intervention|Withdrawal by Subject|1|||
126782832|NCT01806597|456160088|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
126782833|NCT01806597|456160089|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
126782834|NCT01806597|456160090|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
126782835|NCT01806597|456160085|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
126782836|NCT01806597|456160086|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
126782837|NCT01806597|456160087|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
126782838|NCT01806597|456160088|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
126782839|NCT01806597|456160089|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
126782840|NCT01806597|456160090|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
126782841|NCT01806597|456160085|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
126782842|NCT01806597|456160086|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
126782843|NCT01806597|456160087|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
126782844|NCT01806597|456160088|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
126782845|NCT01806597|456160089|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
126782846|NCT01806597|456160090|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
126782847|NCT01806597|456160085|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
126782848|NCT01806597|456160086|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
126782849|NCT01806597|456160087|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
126782850|NCT01806597|456160088|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
126782851|NCT01806597|456160089|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
126782852|NCT01806597|456160090|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
126782853|NCT01806597|456160085|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
126782854|NCT01806597|456160086|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
126782855|NCT01806597|456160087|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
126782856|NCT01806597|456160088|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
126782857|NCT01806597|456160089|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
126782858|NCT01806597|456160090|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
126782859|NCT01806597|456160085|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
126782860|NCT01806597|456160086|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
126782861|NCT01806597|456160087|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
126782862|NCT01806597|456160088|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
126782863|NCT01806597|456160089|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
126782864|NCT01806597|456160090|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
126782865|NCT01806597|456160085|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
126782866|NCT01806597|456160086|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
126782867|NCT01806597|456160087|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
126782868|NCT01806597|456160088|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
126782869|NCT01806597|456160089|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
126782870|NCT01806597|456160090|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
126782871|NCT01806597|456160085|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
126782872|NCT01806597|456160086|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
126782873|NCT01806597|456160087|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
126782874|NCT01806597|456160088|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
126782875|NCT01806597|456160089|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
126782876|NCT01806597|456160090|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
126782877|NCT01806597|456160085|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
126782878|NCT01806597|456160086|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
126782879|NCT01806597|456160087|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
126782880|NCT01806597|456160088|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
126782881|NCT01806597|456160089|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
126782882|NCT01806597|456160090|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
126782883|NCT01806597|456160085|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
126782884|NCT01806597|456160086|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
126782885|NCT01806597|456160087|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
126782886|NCT01806597|456160088|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
126782887|NCT01806597|456160089|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
126782888|NCT01806597|456160090|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
126782889|NCT01806597|456160085|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
126782890|NCT01806597|456160086|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
126782891|NCT01806597|456160087|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
126782892|NCT01806597|456160088|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
126782893|NCT01806597|456160089|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
126782894|NCT01806597|456160090|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
126623702|NCT03928821|455579419|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
126753068|NCT04005885|456043475|FG001|First Intervention|Withdrawal by Subject|1|||
126753069|NCT04005885|456043474|FG000|Second Intervention|Withdrawal by Subject|0|||
126753070|NCT04005885|456043475|FG001|Second Intervention|Withdrawal by Subject|2|||
126753071|NCT00750867|456043476|FG000|Overall Study|Adverse Event|2|||
126753072|NCT02718625|456043477|FG000|Overall Study|Adverse Event|0|||
126753073|NCT02718625|456043478|FG001|Overall Study|Adverse Event|1|||
126753074|NCT02718625|456043477|FG000|Overall Study|Termination of Study by Sponsor|0|||
126753075|NCT02718625|456043478|FG001|Overall Study|Termination of Study by Sponsor|1|||
126753076|NCT01947127|456043483|FG000|Overall Study|Protocol Violation|18|||
126753077|NCT01947127|456043484|FG001|Overall Study|Protocol Violation|38|||
126753078|NCT01947127|456043483|FG000|Overall Study|Withdrawal by Subject|1|||
126753079|NCT01947127|456043484|FG001|Overall Study|Withdrawal by Subject|1|||
126753080|NCT01947127|456043483|FG000|Overall Study|Data loss|4|||
126753081|NCT01947127|456043484|FG001|Overall Study|Data loss|4|||
126753082|NCT01836549|456043485|FG000|Overall Study|Did not receive study drug|0|||
126753083|NCT01836549|456043486|FG001|Overall Study|Did not receive study drug|0|||
126753084|NCT01836549|456043487|FG002|Overall Study|Did not receive study drug|1|||
126753085|NCT01836549|456043488|FG003|Overall Study|Did not receive study drug|0|||
126753086|NCT01836549|456043489|FG004|Overall Study|Did not receive study drug|0|||
126753087|NCT01836549|456043490|FG005|Overall Study|Did not receive study drug|0|||
126753088|NCT01836549|456043491|FG006|Overall Study|Did not receive study drug|0|||
126753089|NCT01836549|456043485|FG000|Overall Study|Patient declared ineligible|0|||
126753090|NCT01836549|456043486|FG001|Overall Study|Patient declared ineligible|0|||
126753091|NCT01836549|456043487|FG002|Overall Study|Patient declared ineligible|0|||
126753092|NCT01836549|456043488|FG003|Overall Study|Patient declared ineligible|1|||
126753093|NCT01836549|456043489|FG004|Overall Study|Patient declared ineligible|0|||
126753094|NCT01836549|456043490|FG005|Overall Study|Patient declared ineligible|0|||
126753095|NCT01836549|456043491|FG006|Overall Study|Patient declared ineligible|0|||
126753096|NCT01836549|456043485|FG000|Overall Study|Patient inevaluable to start therapy|0|||
126753097|NCT01836549|456043486|FG001|Overall Study|Patient inevaluable to start therapy|0|||
126753098|NCT01836549|456043487|FG002|Overall Study|Patient inevaluable to start therapy|0|||
126753099|NCT01836549|456043488|FG003|Overall Study|Patient inevaluable to start therapy|0|||
126753100|NCT01836549|456043489|FG004|Overall Study|Patient inevaluable to start therapy|0|||
126753101|NCT01836549|456043490|FG005|Overall Study|Patient inevaluable to start therapy|0|||
126753102|NCT01836549|456043491|FG006|Overall Study|Patient inevaluable to start therapy|1|||
126753103|NCT02516306|456043492|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
126753104|NCT02516306|456043493|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
126753105|NCT01969565|456043497|FG000|Overall Study|Withdrawal by Subject|1|||
126753106|NCT00242710|456043498|FG000|Core Study (up to Year 1)|Adverse Event|30|||
126753107|NCT00242710|456043499|FG001|Core Study (up to Year 1)|Adverse Event|25|||
126753108|NCT00242710|456043500|FG002|Core Study (up to Year 1)|Adverse Event|23|||
126753109|NCT00242710|456043501|FG003|Core Study (up to Year 1)|Adverse Event|14|||
126753110|NCT00242710|456043498|FG000|Core Study (up to Year 1)|Death|0|||
126753111|NCT00242710|456043499|FG001|Core Study (up to Year 1)|Death|0|||
126753112|NCT00242710|456043500|FG002|Core Study (up to Year 1)|Death|1|||
126753113|NCT00242710|456043501|FG003|Core Study (up to Year 1)|Death|0|||
126753114|NCT00242710|456043498|FG000|Core Study (up to Year 1)|Physician Decision|0|||
126753115|NCT00242710|456043499|FG001|Core Study (up to Year 1)|Physician Decision|1|||
126753116|NCT00242710|456043500|FG002|Core Study (up to Year 1)|Physician Decision|0|||
126753117|NCT00242710|456043501|FG003|Core Study (up to Year 1)|Physician Decision|1|||
126753118|NCT00242710|456043498|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
126753119|NCT00242710|456043499|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
126753120|NCT00242710|456043500|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
126753121|NCT00242710|456043501|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
126753122|NCT00242710|456043498|FG000|Core Study (up to Year 1)|Other|6|||
126753123|NCT00242710|456043499|FG001|Core Study (up to Year 1)|Other|1|||
126753124|NCT00242710|456043500|FG002|Core Study (up to Year 1)|Other|0|||
126753125|NCT00242710|456043501|FG003|Core Study (up to Year 1)|Other|2|||
126753126|NCT00242710|456043498|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
126753127|NCT00242710|456043499|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
126753128|NCT00242710|456043500|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
126753129|NCT00242710|456043501|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
126753130|NCT00242710|456043498|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
126753131|NCT00242710|456043499|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
126782895|NCT01806597|456160085|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
126782896|NCT01806597|456160086|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
126782897|NCT01806597|456160087|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
126753132|NCT00242710|456043500|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
126753133|NCT00242710|456043501|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
126753134|NCT00242710|456043498|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
126753135|NCT00242710|456043499|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
126753136|NCT00242710|456043500|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
126753137|NCT00242710|456043501|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
126623703|NCT03928821|455579420|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
126623704|NCT03928821|455579421|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
126623705|NCT03928821|455579422|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
126623706|NCT02335242|455579427|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
126623707|NCT02335242|455579428|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
126623708|NCT02335242|455579427|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
126623709|NCT02335242|455579428|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
126623710|NCT02335242|455579427|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
126623711|NCT02335242|455579428|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
126623712|NCT00257556|455579431|FG000|Overall Study|Adverse Event|1|||
126623713|NCT00257556|455579432|FG001|Overall Study|Adverse Event|4|||
126623714|NCT00257556|455579431|FG000|Overall Study|Physician Decision|6|||
126623715|NCT00257556|455579432|FG001|Overall Study|Physician Decision|0|||
126623716|NCT00257556|455579431|FG000|Overall Study|Did not meet hCG criterion|3|||
126623717|NCT00257556|455579432|FG001|Overall Study|Did not meet hCG criterion|0|||
126623718|NCT00257556|455579431|FG000|Overall Study|other reason|4|||
126623719|NCT00257556|455579432|FG001|Overall Study|other reason|6|||
126623720|NCT00905255|455579436|FG000|Overall Study|Adverse Event|7|||
126623721|NCT00905255|455579437|FG001|Overall Study|Adverse Event|5|||
126623722|NCT00905255|455579436|FG000|Overall Study|Withdrawal by Subject|5|||
126623723|NCT00905255|455579437|FG001|Overall Study|Withdrawal by Subject|4|||
126623724|NCT00905255|455579436|FG000|Overall Study|Familial and Personal Reasons|1|||
126623725|NCT00905255|455579437|FG001|Overall Study|Familial and Personal Reasons|0|||
126623726|NCT04839289|455579440|FG000|Overall Study|Withdrawal by Subject|1|||
126623727|NCT04839289|455579441|FG001|Overall Study|Withdrawal by Subject|0|||
126623728|NCT02418819|455579443|FG000|Overall Study|Adverse Event|0|||
126623729|NCT02418819|455579444|FG001|Overall Study|Adverse Event|0|||
126623730|NCT02418819|455579445|FG002|Overall Study|Adverse Event|1|||
126623731|NCT02418819|455579446|FG003|Overall Study|Adverse Event|0|||
126623732|NCT02418819|455579443|FG000|Overall Study|Lost to Follow-up|1|||
126623733|NCT02418819|455579444|FG001|Overall Study|Lost to Follow-up|0|||
126623734|NCT02418819|455579445|FG002|Overall Study|Lost to Follow-up|0|||
126623735|NCT02418819|455579446|FG003|Overall Study|Lost to Follow-up|0|||
126623736|NCT02418819|455579443|FG000|Overall Study|No longer meets eligibility criteria|0|||
126623737|NCT02418819|455579444|FG001|Overall Study|No longer meets eligibility criteria|0|||
126623738|NCT02418819|455579445|FG002|Overall Study|No longer meets eligibility criteria|1|||
126623739|NCT02418819|455579446|FG003|Overall Study|No longer meets eligibility criteria|0|||
126623740|NCT02418819|455579443|FG000|Overall Study|No longer willing to participate|0|||
126623741|NCT02418819|455579444|FG001|Overall Study|No longer willing to participate|0|||
126623742|NCT02418819|455579445|FG002|Overall Study|No longer willing to participate|2|||
126623743|NCT02418819|455579446|FG003|Overall Study|No longer willing to participate|1|||
126623744|NCT04743999|455579447|FG000|3-month Questionnaire|Death|1|||
126623745|NCT04743999|455579447|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
126623746|NCT04743999|455579447|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
126623747|NCT04743999|455579447|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
126623748|NCT01721759|455579448|FG000|Treatment Period|Disease Progression|85|||
126623749|NCT01721759|455579448|FG000|Treatment Period|Study drug toxicity|14|||
126623750|NCT01721759|455579448|FG000|Treatment Period|Death|1|||
126623751|NCT01721759|455579448|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
126623752|NCT01721759|455579448|FG000|Treatment Period|Participant request to withdraw|3|||
126623753|NCT01721759|455579448|FG000|Treatment Period|Other Reasons|3|||
126623754|NCT01721759|455579448|FG000|End of Study Period|Participant Withdrew Consent|5|||
126623755|NCT01721759|455579448|FG000|End of Study Period|Death|101|||
126623756|NCT01721759|455579448|FG000|End of Study Period|Lost to Follow-up|1|||
126623757|NCT01721759|455579448|FG000|End of Study Period|Other Reasons|10|||
126623758|NCT01399905|455579449|FG000|Overall Study|Withdrawal by Subject|1|||
126623759|NCT01399905|455579450|FG001|Overall Study|Withdrawal by Subject|1|||
126623760|NCT01804140|455579456|FG000|Overall Study|No sampling or biopsy procedures done|114|||
126753138|NCT00242710|456043498|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
126623761|NCT02785900|455579457|FG000|Overall Study|Study Termination by Sponsor|64|||
126623762|NCT02785900|455579458|FG001|Overall Study|Study Termination by Sponsor|81|||
126623763|NCT02785900|455579457|FG000|Overall Study|Death|46|||
126623764|NCT02785900|455579458|FG001|Overall Study|Death|32|||
126623765|NCT02785900|455579457|FG000|Overall Study|Withdrawal by Subject|4|||
126623766|NCT02785900|455579458|FG001|Overall Study|Withdrawal by Subject|8|||
126623767|NCT02785900|455579457|FG000|Overall Study|Physician Decision|3|||
126623768|NCT02785900|455579458|FG001|Overall Study|Physician Decision|2|||
126623769|NCT01808144|455579459|FG000|Overall Study|Death|1|||
126623770|NCT01808144|455579460|FG001|Overall Study|Death|0|||
126623771|NCT01808144|455579459|FG000|Overall Study|Withdrawal by Subject|16|||
126623772|NCT01808144|455579460|FG001|Overall Study|Withdrawal by Subject|23|||
126623773|NCT01808144|455579459|FG000|Overall Study|Lost to Follow-up|6|||
126623774|NCT01808144|455579460|FG001|Overall Study|Lost to Follow-up|3|||
126623775|NCT01808144|455579459|FG000|Overall Study|Protocol Violation|6|||
126753139|NCT00242710|456043499|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
126753140|NCT00242710|456043500|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
126753141|NCT00242710|456043501|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
126753142|NCT00242710|456043498|FG000|Period Between Core Study and Extension|Adverse Event|2|||
126753143|NCT00242710|456043499|FG001|Period Between Core Study and Extension|Adverse Event|3|||
126753144|NCT00242710|456043500|FG002|Period Between Core Study and Extension|Adverse Event|5|||
126753145|NCT00242710|456043501|FG003|Period Between Core Study and Extension|Adverse Event|2|||
126753146|NCT00242710|456043498|FG000|Period Between Core Study and Extension|Physician Decision|1|||
126753147|NCT00242710|456043499|FG001|Period Between Core Study and Extension|Physician Decision|1|||
126753148|NCT00242710|456043500|FG002|Period Between Core Study and Extension|Physician Decision|0|||
126753149|NCT00242710|456043501|FG003|Period Between Core Study and Extension|Physician Decision|0|||
126753150|NCT00242710|456043498|FG000|Period Between Core Study and Extension|Other|24|||
126753151|NCT00242710|456043499|FG001|Period Between Core Study and Extension|Other|24|||
126753152|NCT00242710|456043500|FG002|Period Between Core Study and Extension|Other|9|||
126753153|NCT00242710|456043501|FG003|Period Between Core Study and Extension|Other|11|||
126753154|NCT00242710|456043498|FG000|Period Between Core Study and Extension|Extension not Available|17|||
126753155|NCT00242710|456043499|FG001|Period Between Core Study and Extension|Extension not Available|21|||
126753156|NCT00242710|456043500|FG002|Period Between Core Study and Extension|Extension not Available|8|||
126753157|NCT00242710|456043501|FG003|Period Between Core Study and Extension|Extension not Available|7|||
126753158|NCT00242710|456043498|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
126753159|NCT00242710|456043499|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
126753160|NCT00242710|456043500|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
126753161|NCT00242710|456043501|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
126753162|NCT00242710|456043498|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
126753163|NCT00242710|456043499|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
126753164|NCT00242710|456043500|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
126753165|NCT00242710|456043501|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
126753166|NCT00242710|456043498|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
126753167|NCT00242710|456043499|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
126753168|NCT00242710|456043500|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
126753169|NCT00242710|456043501|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
126753170|NCT00242710|456043498|FG000|Study Extension (up to Year 2)|Death|0|||
126753171|NCT00242710|456043499|FG001|Study Extension (up to Year 2)|Death|0|||
126753172|NCT00242710|456043500|FG002|Study Extension (up to Year 2)|Death|0|||
126753173|NCT00242710|456043501|FG003|Study Extension (up to Year 2)|Death|1|||
126753174|NCT00242710|456043498|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
126753175|NCT00242710|456043499|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
126753176|NCT00242710|456043500|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
126753177|NCT00242710|456043501|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
126753178|NCT00242710|456043498|FG000|Study Extension (up to Year 2)|Other|3|||
126753179|NCT00242710|456043499|FG001|Study Extension (up to Year 2)|Other|5|||
126753180|NCT00242710|456043500|FG002|Study Extension (up to Year 2)|Other|4|||
126753181|NCT00242710|456043501|FG003|Study Extension (up to Year 2)|Other|3|||
126753182|NCT00242710|456043498|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
126753183|NCT00242710|456043499|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
126753184|NCT00242710|456043500|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
126753185|NCT00242710|456043501|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
126753186|NCT00242710|456043498|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
126753187|NCT00242710|456043499|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
126753188|NCT00242710|456043500|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
126753189|NCT00242710|456043501|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
126753190|NCT00579527|456043502|FG000|Overall Study|Death|4|||
126753191|NCT03961529|456043503|FG000|Overall Study|Adverse Event|13|||
126753192|NCT03961529|456043504|FG001|Overall Study|Adverse Event|5|||
126753193|NCT03961529|456043505|FG002|Overall Study|Adverse Event|2|||
126753194|NCT03961529|456043503|FG000|Overall Study|Withdrawal by Subject|17|||
126753195|NCT03961529|456043504|FG001|Overall Study|Withdrawal by Subject|2|||
126753196|NCT03961529|456043505|FG002|Overall Study|Withdrawal by Subject|1|||
126753197|NCT03961529|456043503|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126753198|NCT03961529|456043504|FG001|Overall Study|Withdrawal by parent/guardian|7|||
126753199|NCT03961529|456043505|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126753200|NCT03961529|456043503|FG000|Overall Study|Physician Decision|2|||
126753201|NCT03961529|456043504|FG001|Overall Study|Physician Decision|1|||
126753202|NCT03961529|456043505|FG002|Overall Study|Physician Decision|1|||
126753203|NCT03961529|456043503|FG000|Overall Study|Lost to Follow-up|2|||
126753204|NCT03961529|456043504|FG001|Overall Study|Lost to Follow-up|1|||
126753205|NCT03961529|456043505|FG002|Overall Study|Lost to Follow-up|0|||
126753206|NCT03961529|456043503|FG000|Overall Study|Lack of Efficacy|2|||
126753207|NCT03961529|456043504|FG001|Overall Study|Lack of Efficacy|0|||
126753208|NCT03961529|456043505|FG002|Overall Study|Lack of Efficacy|1|||
126753209|NCT03961529|456043503|FG000|Overall Study|Other|6|||
126753210|NCT03961529|456043504|FG001|Overall Study|Other|1|||
126753211|NCT03961529|456043505|FG002|Overall Study|Other|0|||
126753212|NCT03644173|456043506|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
126753213|NCT03644173|456043506|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
126753214|NCT03644173|456043506|FG000|Participants at the 1-month Follow up|Death|2|||
126753215|NCT03644173|456043506|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
126753216|NCT00381706|456043509|FG000|Overall Study|Never treated|7|||
126753217|NCT00381706|456043510|FG001|Overall Study|Never treated|2|||
126753218|NCT00381706|456043511|FG002|Overall Study|Never treated|1|||
126753219|NCT03049852|456043517|FG000|Overall Study|Lost to Follow-up|0|||
126753220|NCT03049852|456043518|FG001|Overall Study|Lost to Follow-up|1|||
126753221|NCT03049852|456043519|FG002|Overall Study|Lost to Follow-up|0|||
126753222|NCT02067104|456043520|FG000|Overall Study|Study termination due to low accrual|4|||
126753223|NCT02067104|456043521|FG001|Overall Study|Study termination due to low accrual|5|||
126753224|NCT00957034|456043529|FG000|Overall Study|Adverse Event|0|||
126753225|NCT00957034|456043530|FG001|Overall Study|Adverse Event|1|||
126753226|NCT00957034|456043531|FG002|Overall Study|Adverse Event|1|||
126753227|NCT00957034|456043529|FG000|Overall Study|Sponsor Terminated Study|6|||
126753228|NCT00957034|456043530|FG001|Overall Study|Sponsor Terminated Study|1|||
126753229|NCT00957034|456043531|FG002|Overall Study|Sponsor Terminated Study|5|||
126753230|NCT00957034|456043529|FG000|Overall Study|Withdrawal by Subject|0|||
126753231|NCT00957034|456043530|FG001|Overall Study|Withdrawal by Subject|2|||
126753232|NCT00957034|456043531|FG002|Overall Study|Withdrawal by Subject|0|||
126753233|NCT02390167|456046056|FG000|Overall Study|Lost to Follow-up|1|||
126753234|NCT02033369|456046057|FG000|Overall Study|Physician Decision|1|||
126753235|NCT02033369|456046058|FG001|Overall Study|Physician Decision|2|||
126753236|NCT02033369|456046057|FG000|Overall Study|Not a good demographic match|0|||
126753237|NCT02033369|456046058|FG001|Overall Study|Not a good demographic match|2|||
126753238|NCT02033369|456046057|FG000|Overall Study|Withdrawal by Subject|1|||
126753239|NCT02033369|456046058|FG001|Overall Study|Withdrawal by Subject|1|||
126753240|NCT02033369|456046057|FG000|Overall Study|Lost to Follow-up|1|||
126753241|NCT02033369|456046058|FG001|Overall Study|Lost to Follow-up|0|||
126753242|NCT02033369|456046057|FG000|Overall Study|Protocol Violation|2|||
126753243|NCT02033369|456046058|FG001|Overall Study|Protocol Violation|0|||
126753244|NCT01265719|456046064|FG000|Overall Study|Does not meet entrance criteria|0|||
126753245|NCT01265719|456046065|FG001|Overall Study|Does not meet entrance criteria|3|||
126753246|NCT01265719|456046064|FG000|Overall Study|Other reasons|2|||
126753247|NCT01265719|456046065|FG001|Overall Study|Other reasons|0|||
126753248|NCT01265719|456046064|FG000|Overall Study|Withdrawal by Subject|8|||
126753249|NCT01265719|456046065|FG001|Overall Study|Withdrawal by Subject|3|||
126753250|NCT01265719|456046064|FG000|Overall Study|Lost to Follow-up|2|||
126753251|NCT01265719|456046065|FG001|Overall Study|Lost to Follow-up|7|||
126753252|NCT01265719|456046064|FG000|Overall Study|Adverse Event|2|||
126753253|NCT01265719|456046065|FG001|Overall Study|Adverse Event|0|||
126753254|NCT04335929|456046066|FG000|Overall Study|Lost to Follow-up|10|||
126753255|NCT01797302|456046067|FG000|Overall Study|Lost to Follow-up|16|||
126753256|NCT01797302|456046068|FG001|Overall Study|Lost to Follow-up|23|||
126753257|NCT01797302|456046069|FG002|Overall Study|Lost to Follow-up|22|||
126753258|NCT01797302|456046067|FG000|Overall Study|Withdrawal by Subject|1|||
126753259|NCT01797302|456046068|FG001|Overall Study|Withdrawal by Subject|3|||
126753260|NCT01797302|456046069|FG002|Overall Study|Withdrawal by Subject|4|||
126753261|NCT03228836|456046070|FG000|Overall Study|Adverse Event|3|||
126753262|NCT03228836|456046070|FG000|Overall Study|Withdrawal by Subject|1|||
126753263|NCT03228836|456046070|FG000|Overall Study|Death|1|||
126753264|NCT03228836|456046070|FG000|Overall Study|Physician Decision|1|||
126753265|NCT03228836|456046070|FG000|Overall Study|Disease Progression|7|||
126753266|NCT03228836|456046070|FG000|Overall Study|Other|4|||
126753267|NCT02773849|456046072|FG000|Overall Study|Lost to Follow-up|11|||
126753268|NCT02773849|456046072|FG000|Overall Study|Death|26|||
126753269|NCT02773849|456046072|FG000|Overall Study|Withdrawal by Subject|5|||
126753270|NCT02773849|456046072|FG000|Overall Study|Withdrawal of Consent|9|||
126753271|NCT02773849|456046072|FG000|Overall Study|Other: not due to lack of tolerability|11|||
126753272|NCT00948389|456046073|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
126753273|NCT00948389|456046074|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
126753274|NCT00948389|456046075|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
126753275|NCT00948389|456046076|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
126753276|NCT00948389|456046077|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
126753277|NCT00948389|456046073|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
126753278|NCT00948389|456046074|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
126753279|NCT00948389|456046075|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
126753280|NCT00948389|456046076|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
126753281|NCT00948389|456046077|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
126753282|NCT00948389|456046073|FG000|Overall Study|Both Progression and Toxicity|1|||
126753283|NCT00948389|456046074|FG001|Overall Study|Both Progression and Toxicity|0|||
126623776|NCT01808144|455579460|FG001|Overall Study|Protocol Violation|6|||
126753284|NCT00948389|456046075|FG002|Overall Study|Both Progression and Toxicity|0|||
126753285|NCT00948389|456046076|FG003|Overall Study|Both Progression and Toxicity|0|||
126753286|NCT00948389|456046077|FG004|Overall Study|Both Progression and Toxicity|0|||
126753287|NCT02418000|456046082|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
126753288|NCT02418000|456046083|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
126753289|NCT02418000|456046084|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
126753290|NCT02418000|456046085|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
126753291|NCT02418000|456046086|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
126753292|NCT02418000|456046082|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
126753293|NCT02418000|456046083|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
126753294|NCT02418000|456046084|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
126753295|NCT02418000|456046085|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
126753296|NCT02418000|456046086|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
126753297|NCT02418000|456046082|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
126753298|NCT02418000|456046083|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
126753299|NCT02418000|456046084|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
126753300|NCT02418000|456046085|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
126753301|NCT02418000|456046086|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
126753302|NCT02418000|456046082|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
126753303|NCT02418000|456046083|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
126753304|NCT02418000|456046084|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
126753305|NCT02418000|456046085|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
126753306|NCT02418000|456046086|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
126753307|NCT02418000|456046082|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
126753308|NCT02418000|456046083|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
126753309|NCT02418000|456046084|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
126753310|NCT02418000|456046085|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
126753311|NCT02418000|456046086|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
126753312|NCT02418000|456046082|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126753313|NCT02418000|456046083|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126753314|NCT02418000|456046084|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
126753315|NCT02418000|456046085|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126753316|NCT02418000|456046086|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126753317|NCT02418000|456046082|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126753318|NCT02418000|456046083|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126753319|NCT02418000|456046084|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126753320|NCT02418000|456046085|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
126753321|NCT02418000|456046086|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126753322|NCT02418000|456046082|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
126753323|NCT02418000|456046083|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
126753324|NCT02418000|456046084|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
126753325|NCT02418000|456046085|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
126753326|NCT02418000|456046086|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
126753327|NCT02418000|456046082|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126753328|NCT02418000|456046083|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126753329|NCT02418000|456046084|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126753330|NCT02418000|456046085|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
126753331|NCT02418000|456046086|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
126753332|NCT00508001|456046087|FG000|Overall Study|Adverse Event|2|||
126753333|NCT00508001|456046088|FG001|Overall Study|Adverse Event|0|||
126753334|NCT00508001|456046089|FG002|Overall Study|Adverse Event|4|||
126753335|NCT00508001|456046087|FG000|Overall Study|condition under investigation worsened|13|||
126753336|NCT00508001|456046088|FG001|Overall Study|condition under investigation worsened|7|||
126753337|NCT00508001|456046089|FG002|Overall Study|condition under investigation worsened|1|||
126753338|NCT00508001|456046087|FG000|Overall Study|Death|0|||
126753339|NCT00508001|456046088|FG001|Overall Study|Death|1|||
126753340|NCT00508001|456046089|FG002|Overall Study|Death|1|||
126753341|NCT00508001|456046087|FG000|Overall Study|Withdrawal by Subject|4|||
126753342|NCT00508001|456046088|FG001|Overall Study|Withdrawal by Subject|4|||
126753343|NCT00508001|456046089|FG002|Overall Study|Withdrawal by Subject|1|||
126753344|NCT01051856|456046111|FG000|Overall Study|Withdrawal by Subject|1|||
126753345|NCT01051856|456046112|FG001|Overall Study|Withdrawal by Subject|0|||
126753346|NCT02381795|456046113|FG000|Overall Study|Withdrawal by Subject|1|||
126753347|NCT02381795|456046113|FG000|Overall Study|Study Terminated|2|||
126753348|NCT02176226|456046114|FG000|Overall Study|Lost to Follow-up|3|||
126753349|NCT02176226|456046114|FG000|Overall Study|Withdrew prior to treatment|6|||
126753350|NCT02908841|456046121|FG000|Overall Study|Physician Decision|4|||
126753351|NCT02908841|456046122|FG001|Overall Study|Physician Decision|0|||
126753352|NCT01412333|456046128|FG000|Overall Study|Adverse Event|40|||
126753353|NCT01412333|456046129|FG001|Overall Study|Adverse Event|42|||
126753354|NCT01412333|456046128|FG000|Overall Study|Death|5|||
126753355|NCT01412333|456046129|FG001|Overall Study|Death|6|||
126753356|NCT01412333|456046128|FG000|Overall Study|Lack of Efficacy|22|||
126753357|NCT01412333|456046129|FG001|Overall Study|Lack of Efficacy|10|||
126753358|NCT01412333|456046128|FG000|Overall Study|Lost to Follow-up|15|||
126753359|NCT01412333|456046129|FG001|Overall Study|Lost to Follow-up|12|||
126753360|NCT01412333|456046128|FG000|Overall Study|Non-Compliance|3|||
126753361|NCT01412333|456046129|FG001|Overall Study|Non-Compliance|7|||
126753362|NCT01412333|456046128|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126753363|NCT01412333|456046129|FG001|Overall Study|Non-Compliance With Study Drug|1|||
126753364|NCT01412333|456046128|FG000|Overall Study|Other|30|||
126753365|NCT01412333|456046129|FG001|Overall Study|Other|33|||
126753366|NCT01412333|456046128|FG000|Overall Study|Physician Decision|11|||
126753367|NCT01412333|456046129|FG001|Overall Study|Physician Decision|16|||
126753368|NCT01412333|456046128|FG000|Overall Study|Pregnancy|6|||
126753369|NCT01412333|456046129|FG001|Overall Study|Pregnancy|4|||
126753370|NCT01412333|456046128|FG000|Overall Study|Protocol Violation|1|||
126753371|NCT01412333|456046129|FG001|Overall Study|Protocol Violation|2|||
126753372|NCT01412333|456046128|FG000|Overall Study|Study Terminated By Sponsor|3|||
126753373|NCT01412333|456046129|FG001|Overall Study|Study Terminated By Sponsor|2|||
126753374|NCT01412333|456046128|FG000|Overall Study|Withdrawal by Subject|51|||
126753375|NCT01412333|456046129|FG001|Overall Study|Withdrawal by Subject|54|||
126753376|NCT01412333|456046128|FG000|Overall Study|Missing|1|||
126753377|NCT01412333|456046129|FG001|Overall Study|Missing|3|||
126753378|NCT01060150|456046130|FG000|Overall Study|Adverse Event|6|||
126753379|NCT01060150|456046130|FG000|Overall Study|Lost to Follow-up|1|||
126753380|NCT01060150|456046130|FG000|Overall Study|Protocol Violation|6|||
126753381|NCT01060150|456046130|FG000|Overall Study|Withdrawal by Subject|8|||
126753382|NCT01060150|456046130|FG000|Overall Study|Enrolled, but not treated|2|||
126753383|NCT04062240|456046131|FG000|Overall Study|equipment malfunction|1|||
126753384|NCT01957111|456046132|FG000|Overall Study|Withdrawal by Subject|1|||
126753385|NCT01957111|456046133|FG001|Overall Study|Withdrawal by Subject|1|||
126753386|NCT01057394|456046134|FG000|Overall Study|Not eligible|0|||
126753387|NCT01057394|456046135|FG001|Overall Study|Not eligible|2|||
126753388|NCT00256204|456046136|FG000|Overall Study|Adverse Event|10|||
126753389|NCT00256204|456046137|FG001|Overall Study|Adverse Event|14|||
126753390|NCT00256204|456046138|FG002|Overall Study|Adverse Event|16|||
126753391|NCT00256204|456046139|FG003|Overall Study|Adverse Event|14|||
126753392|NCT00256204|456046136|FG000|Overall Study|Death|0|||
126753393|NCT00256204|456046137|FG001|Overall Study|Death|1|||
126753394|NCT00256204|456046138|FG002|Overall Study|Death|0|||
126753395|NCT00256204|456046139|FG003|Overall Study|Death|0|||
126753396|NCT00256204|456046136|FG000|Overall Study|Lost to Follow-up|1|||
126753397|NCT00256204|456046137|FG001|Overall Study|Lost to Follow-up|1|||
126753398|NCT00256204|456046138|FG002|Overall Study|Lost to Follow-up|1|||
126753399|NCT00256204|456046139|FG003|Overall Study|Lost to Follow-up|2|||
126753400|NCT00256204|456046136|FG000|Overall Study|Protocol Violation|1|||
126753401|NCT00256204|456046137|FG001|Overall Study|Protocol Violation|0|||
126753402|NCT00256204|456046138|FG002|Overall Study|Protocol Violation|2|||
126753403|NCT00256204|456046139|FG003|Overall Study|Protocol Violation|1|||
126753404|NCT00256204|456046136|FG000|Overall Study|Physician Decision|0|||
126753405|NCT00256204|456046137|FG001|Overall Study|Physician Decision|0|||
126753406|NCT00256204|456046138|FG002|Overall Study|Physician Decision|1|||
126753407|NCT00256204|456046139|FG003|Overall Study|Physician Decision|2|||
126753408|NCT00256204|456046136|FG000|Overall Study|Withdrawal by Subject|17|||
126753409|NCT00256204|456046137|FG001|Overall Study|Withdrawal by Subject|6|||
126753410|NCT00256204|456046138|FG002|Overall Study|Withdrawal by Subject|7|||
126753411|NCT00256204|456046139|FG003|Overall Study|Withdrawal by Subject|5|||
126753412|NCT00256204|456046136|FG000|Overall Study|Need for additional prohibited treatment|38|||
126753413|NCT00256204|456046137|FG001|Overall Study|Need for additional prohibited treatment|28|||
126753414|NCT00256204|456046138|FG002|Overall Study|Need for additional prohibited treatment|27|||
126753415|NCT00256204|456046139|FG003|Overall Study|Need for additional prohibited treatment|25|||
126753416|NCT00808132|456046143|FG000|Overall Study|Adverse Event|34|||
126753417|NCT00808132|456046144|FG001|Overall Study|Adverse Event|33|||
126753418|NCT00808132|456046145|FG002|Overall Study|Adverse Event|16|||
126753419|NCT00808132|456046146|FG003|Overall Study|Adverse Event|31|||
126753420|NCT00808132|456046147|FG004|Overall Study|Adverse Event|33|||
126753421|NCT00808132|456046143|FG000|Overall Study|Death|0|||
126753422|NCT00808132|456046144|FG001|Overall Study|Death|0|||
126753423|NCT00808132|456046145|FG002|Overall Study|Death|0|||
126753424|NCT00808132|456046146|FG003|Overall Study|Death|0|||
126753425|NCT00808132|456046147|FG004|Overall Study|Death|1|||
126753426|NCT00808132|456046143|FG000|Overall Study|Physician Decision|0|||
126753427|NCT00808132|456046144|FG001|Overall Study|Physician Decision|1|||
126753428|NCT00808132|456046145|FG002|Overall Study|Physician Decision|0|||
126753429|NCT00808132|456046146|FG003|Overall Study|Physician Decision|0|||
126753430|NCT00808132|456046147|FG004|Overall Study|Physician Decision|0|||
126753431|NCT00808132|456046143|FG000|Overall Study|Lost to Follow-up|8|||
126753432|NCT00808132|456046144|FG001|Overall Study|Lost to Follow-up|10|||
126753433|NCT00808132|456046145|FG002|Overall Study|Lost to Follow-up|11|||
126753434|NCT00808132|456046146|FG003|Overall Study|Lost to Follow-up|8|||
126753435|NCT00808132|456046147|FG004|Overall Study|Lost to Follow-up|9|||
126753436|NCT00808132|456046143|FG000|Overall Study|Protocol Violation|8|||
126753437|NCT00808132|456046144|FG001|Overall Study|Protocol Violation|9|||
126753438|NCT00808132|456046145|FG002|Overall Study|Protocol Violation|4|||
126753439|NCT00808132|456046146|FG003|Overall Study|Protocol Violation|9|||
126753440|NCT00808132|456046147|FG004|Overall Study|Protocol Violation|5|||
126753441|NCT00808132|456046143|FG000|Overall Study|Withdrawal by Subject|27|||
126753442|NCT00808132|456046144|FG001|Overall Study|Withdrawal by Subject|18|||
126753443|NCT00808132|456046145|FG002|Overall Study|Withdrawal by Subject|2|||
126753444|NCT00808132|456046146|FG003|Overall Study|Withdrawal by Subject|7|||
126753445|NCT00808132|456046147|FG004|Overall Study|Withdrawal by Subject|16|||
126753446|NCT00808132|456046143|FG000|Overall Study|Other|6|||
126753447|NCT00808132|456046144|FG001|Overall Study|Other|4|||
126753448|NCT00808132|456046145|FG002|Overall Study|Other|6|||
126753449|NCT00808132|456046146|FG003|Overall Study|Other|2|||
126753450|NCT00808132|456046147|FG004|Overall Study|Other|15|||
126753451|NCT00808132|456046143|FG000|Overall Study|Randomized, but not treated|10|||
126753452|NCT00808132|456046144|FG001|Overall Study|Randomized, but not treated|7|||
126753453|NCT00808132|456046145|FG002|Overall Study|Randomized, but not treated|9|||
126753454|NCT00808132|456046146|FG003|Overall Study|Randomized, but not treated|8|||
126753455|NCT00808132|456046147|FG004|Overall Study|Randomized, but not treated|9|||
126753456|NCT00808132|456046143|FG000|Overall Study|Unsatisfactory response|5|||
126753457|NCT00808132|456046144|FG001|Overall Study|Unsatisfactory response|6|||
126753458|NCT00808132|456046145|FG002|Overall Study|Unsatisfactory response|6|||
126753459|NCT00808132|456046146|FG003|Overall Study|Unsatisfactory response|4|||
126753460|NCT00808132|456046147|FG004|Overall Study|Unsatisfactory response|12|||
126753461|NCT00550615|456046148|FG000|Overall Study|Withdrawal by Subject|0|||
126753462|NCT00550615|456046149|FG001|Overall Study|Withdrawal by Subject|0|||
126753463|NCT00550615|456046150|FG002|Overall Study|Withdrawal by Subject|2|||
126753464|NCT00550615|456046151|FG003|Overall Study|Withdrawal by Subject|3|||
126753465|NCT00550615|456046148|FG000|Overall Study|Not evaluable|0|||
126753466|NCT00550615|456046149|FG001|Overall Study|Not evaluable|0|||
126753467|NCT00550615|456046150|FG002|Overall Study|Not evaluable|2|||
126753468|NCT00550615|456046151|FG003|Overall Study|Not evaluable|7|||
126753469|NCT02405091|456046154|FG000|Overall Study|Adverse Event|16|||
126753470|NCT02405091|456046155|FG001|Overall Study|Adverse Event|10|||
126753471|NCT02405091|456046156|FG002|Overall Study|Adverse Event|0|||
126753472|NCT02405091|456046154|FG000|Overall Study|Protocol Violation|1|||
126753473|NCT02405091|456046155|FG001|Overall Study|Protocol Violation|0|||
126753474|NCT02405091|456046156|FG002|Overall Study|Protocol Violation|0|||
126753475|NCT02405091|456046154|FG000|Overall Study|Noncompliance|1|||
126753476|NCT02405091|456046155|FG001|Overall Study|Noncompliance|6|||
126753477|NCT02405091|456046156|FG002|Overall Study|Noncompliance|2|||
126753478|NCT02405091|456046154|FG000|Overall Study|Withdrawal by Subject|4|||
126753479|NCT02405091|456046155|FG001|Overall Study|Withdrawal by Subject|8|||
126753480|NCT02405091|456046156|FG002|Overall Study|Withdrawal by Subject|0|||
126753481|NCT02405091|456046154|FG000|Overall Study|Death|0|||
126753482|NCT02405091|456046155|FG001|Overall Study|Death|1|||
126753483|NCT02405091|456046156|FG002|Overall Study|Death|0|||
126753484|NCT02405091|456046154|FG000|Overall Study|Lost to Follow-up|5|||
126753485|NCT02405091|456046155|FG001|Overall Study|Lost to Follow-up|6|||
126753486|NCT02405091|456046156|FG002|Overall Study|Lost to Follow-up|0|||
126753487|NCT02405091|456046154|FG000|Overall Study|Physician Decision|2|||
126753488|NCT02405091|456046155|FG001|Overall Study|Physician Decision|2|||
126753489|NCT02405091|456046156|FG002|Overall Study|Physician Decision|0|||
126753490|NCT01948791|456046163|FG000|Overall Study|Adverse Event|12|||
126753491|NCT01948791|456046163|FG000|Overall Study|Lack of Efficacy|3|||
126753492|NCT01948791|456046163|FG000|Overall Study|Protocol Violation|2|||
126753493|NCT01948791|456046163|FG000|Overall Study|Withdrawal by Subject|5|||
126753494|NCT01948791|456046163|FG000|Overall Study|Lost to Follow-up|6|||
126753495|NCT01948791|456046163|FG000|Overall Study|Management issues|1|||
126753496|NCT01948791|456046163|FG000|Overall Study|Others|7|||
126753497|NCT01948791|456046163|FG000|Overall Study|Screening failure|35|||
126753498|NCT03481634|456046166|FG000|Overall Study|Withdrawal by Subject|16|||
126753499|NCT03481634|456046167|FG001|Overall Study|Withdrawal by Subject|19|||
126753500|NCT03481634|456046168|FG002|Overall Study|Withdrawal by Subject|14|||
126753501|NCT03481634|456046166|FG000|Overall Study|Protocol Violation|1|||
126753502|NCT03481634|456046167|FG001|Overall Study|Protocol Violation|0|||
126753503|NCT03481634|456046168|FG002|Overall Study|Protocol Violation|1|||
126753504|NCT03481634|456046166|FG000|Overall Study|Progressive disease|0|||
126753505|NCT03481634|456046167|FG001|Overall Study|Progressive disease|1|||
126753506|NCT03481634|456046168|FG002|Overall Study|Progressive disease|0|||
126753507|NCT03481634|456046166|FG000|Overall Study|Physician Decision|3|||
126753508|NCT03481634|456046167|FG001|Overall Study|Physician Decision|0|||
126753509|NCT03481634|456046168|FG002|Overall Study|Physician Decision|1|||
126753510|NCT03481634|456046166|FG000|Overall Study|Lost to Follow-up|3|||
126753511|NCT03481634|456046167|FG001|Overall Study|Lost to Follow-up|4|||
126753512|NCT03481634|456046168|FG002|Overall Study|Lost to Follow-up|4|||
126753513|NCT03481634|456046166|FG000|Overall Study|Death|4|||
126753514|NCT03481634|456046167|FG001|Overall Study|Death|8|||
126753515|NCT03481634|456046168|FG002|Overall Study|Death|7|||
126753516|NCT03481634|456046166|FG000|Overall Study|Adverse Event|6|||
126753517|NCT03481634|456046167|FG001|Overall Study|Adverse Event|3|||
126753518|NCT03481634|456046168|FG002|Overall Study|Adverse Event|7|||
126753519|NCT00994890|456046172|FG000|Overall Study|Adverse Event|13|||
126753520|NCT00994890|456046173|FG001|Overall Study|Adverse Event|9|||
126753521|NCT00994890|456046174|FG002|Overall Study|Adverse Event|11|||
126753522|NCT00994890|456046172|FG000|Overall Study|Lack of Efficacy|0|||
126753523|NCT00994890|456046173|FG001|Overall Study|Lack of Efficacy|0|||
126753524|NCT00994890|456046174|FG002|Overall Study|Lack of Efficacy|1|||
126753525|NCT00994890|456046172|FG000|Overall Study|Lost to Follow-up|6|||
126753526|NCT00994890|456046173|FG001|Overall Study|Lost to Follow-up|1|||
126753527|NCT00994890|456046174|FG002|Overall Study|Lost to Follow-up|3|||
126753528|NCT00994890|456046172|FG000|Overall Study|No longer willing to participate|8|||
126753529|NCT00994890|456046173|FG001|Overall Study|No longer willing to participate|5|||
126753530|NCT00994890|456046174|FG002|Overall Study|No longer willing to participate|13|||
126753531|NCT00994890|456046172|FG000|Overall Study|Protocol Violation|2|||
126753532|NCT00994890|456046173|FG001|Overall Study|Protocol Violation|4|||
126753533|NCT00994890|456046174|FG002|Overall Study|Protocol Violation|0|||
126753534|NCT00994890|456046172|FG000|Overall Study|Study terminated by sponsor|199|||
126753535|NCT00994890|456046173|FG001|Overall Study|Study terminated by sponsor|201|||
126753536|NCT00994890|456046174|FG002|Overall Study|Study terminated by sponsor|197|||
126753537|NCT00994890|456046172|FG000|Overall Study|Randomized, but not treated|1|||
126753538|NCT00994890|456046173|FG001|Overall Study|Randomized, but not treated|0|||
126753539|NCT00994890|456046174|FG002|Overall Study|Randomized, but not treated|0|||
126753540|NCT00994890|456046172|FG000|Overall Study|Other|2|||
126753541|NCT00994890|456046173|FG001|Overall Study|Other|2|||
126753542|NCT00994890|456046174|FG002|Overall Study|Other|1|||
126753543|NCT01955005|456046181|FG000|Overall Study|Withdrawal by Subject|3|||
126753544|NCT01955005|456046182|FG001|Overall Study|Withdrawal by Subject|5|||
126753545|NCT02555722|456046187|FG000|Week 2|Adverse Event|0|||
126753546|NCT02555722|456046188|FG001|Week 2|Adverse Event|1|||
126753547|NCT02555722|456046187|FG000|Week 2|Withdrawal by Subject|1|||
126753548|NCT02555722|456046188|FG001|Week 2|Withdrawal by Subject|0|||
126753549|NCT02555722|456046187|FG000|Month 1|Lens Discomfort|1|||
126753550|NCT02555722|456046188|FG001|Month 1|Lens Discomfort|0|||
126753551|NCT02555722|456046187|FG000|Month 2|Withdrawal by Subject|3|||
126753552|NCT02555722|456046188|FG001|Month 2|Withdrawal by Subject|0|||
126753553|NCT02555722|456046187|FG000|Month 2|Lost to Follow-up|1|||
126753554|NCT02555722|456046188|FG001|Month 2|Lost to Follow-up|0|||
126753555|NCT00352027|456046189|FG000|Overall Study|Progressive disease|3|||
126753556|NCT00702949|456046190|FG000|Overall Study|Refusal|3|||
126753557|NCT00702949|456046191|FG001|Overall Study|Refusal|2|||
126753558|NCT00702949|456046192|FG002|Overall Study|Refusal|2|||
126753559|NCT00702949|456046190|FG000|Overall Study|Adverse Event|1|||
126753560|NCT00702949|456046191|FG001|Overall Study|Adverse Event|6|||
126753561|NCT00702949|456046192|FG002|Overall Study|Adverse Event|3|||
126753562|NCT00702949|456046190|FG000|Overall Study|Other Medical Reason/unknown|1|||
126753563|NCT00702949|456046191|FG001|Overall Study|Other Medical Reason/unknown|1|||
126753564|NCT00702949|456046192|FG002|Overall Study|Other Medical Reason/unknown|3|||
126753565|NCT01469637|456046193|FG000|First Intervention|Unacceptable behavior|0|||
126753566|NCT01469637|456046194|FG001|First Intervention|Unacceptable behavior|1|||
126753567|NCT01469637|456046193|FG000|Second Intervention|Incarcerated|1|||
126753568|NCT01469637|456046194|FG001|Second Intervention|Incarcerated|0|||
126753569|NCT00598585|456046195|FG000|Overall Study|Lost to Follow-up|1|||
126782898|NCT01806597|456160088|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
126623777|NCT01808144|455579459|FG000|Overall Study|Gout flare|0|||
126623778|NCT01808144|455579460|FG001|Overall Study|Gout flare|1|||
126623779|NCT01808144|455579459|FG000|Overall Study|Adverse Event|11|||
126623780|NCT01808144|455579460|FG001|Overall Study|Adverse Event|15|||
126753570|NCT00598585|456046196|FG001|Overall Study|Lost to Follow-up|0|||
126753571|NCT04491591|456046198|FG000|Overall Study|Accidently randomized|3|||
126753572|NCT04491591|456046199|FG001|Overall Study|Accidently randomized|1|||
126753573|NCT04491591|456046200|FG002|Overall Study|Accidently randomized|0|||
126753574|NCT04491591|456046198|FG000|Overall Study|Did not complete survey|28|||
126753575|NCT04491591|456046199|FG001|Overall Study|Did not complete survey|20|||
126753576|NCT04491591|456046200|FG002|Overall Study|Did not complete survey|3|||
126623781|NCT00383500|455579461|FG000|Overall Study|Withdrawal by Subject|8|||
126623782|NCT00383500|455579462|FG001|Overall Study|Withdrawal by Subject|3|||
126753577|NCT00135694|456046201|FG000|Overall Study|Adverse Event|17|||
126753578|NCT00135694|456046202|FG001|Overall Study|Adverse Event|4|||
126753579|NCT00135694|456046203|FG002|Overall Study|Adverse Event|0|||
126753580|NCT00135694|456046201|FG000|Overall Study|Death|14|||
126753581|NCT00135694|456046202|FG001|Overall Study|Death|1|||
126753582|NCT00135694|456046203|FG002|Overall Study|Death|2|||
126753583|NCT00135694|456046201|FG000|Overall Study|Lost to Follow-up|8|||
126753584|NCT00135694|456046202|FG001|Overall Study|Lost to Follow-up|7|||
126753585|NCT00135694|456046203|FG002|Overall Study|Lost to Follow-up|1|||
126753586|NCT00135694|456046201|FG000|Overall Study|Withdrawal by Subject|41|||
126753587|NCT00135694|456046202|FG001|Overall Study|Withdrawal by Subject|7|||
126753588|NCT00135694|456046203|FG002|Overall Study|Withdrawal by Subject|4|||
126753589|NCT00135694|456046201|FG000|Overall Study|Protocol Violation|19|||
126753590|NCT00135694|456046202|FG001|Overall Study|Protocol Violation|1|||
126753591|NCT00135694|456046203|FG002|Overall Study|Protocol Violation|0|||
126753592|NCT00135694|456046201|FG000|Overall Study|Hepatitis C related reasons|39|||
126753593|NCT00135694|456046202|FG001|Overall Study|Hepatitis C related reasons|1|||
126753594|NCT00135694|456046203|FG002|Overall Study|Hepatitis C related reasons|0|||
126753595|NCT00135694|456046201|FG000|Overall Study|Ineligible for Random assignment|42|||
126753596|NCT00135694|456046202|FG001|Overall Study|Ineligible for Random assignment|0|||
126753597|NCT00135694|456046203|FG002|Overall Study|Ineligible for Random assignment|0|||
126753598|NCT00472043|456046205|FG000|Overall Study|Withdrawal by Subject|1|||
126753599|NCT00472043|456046206|FG001|Overall Study|Withdrawal by Subject|0|||
126753600|NCT00472043|456046205|FG000|Overall Study|Death|1|||
126753601|NCT00472043|456046206|FG001|Overall Study|Death|0|||
126753602|NCT02802735|456046207|FG000|Overall Study|Withdrawal by Subject|0|||
126753603|NCT02802735|456046208|FG001|Overall Study|Withdrawal by Subject|1|||
126753604|NCT02802735|456046209|FG002|Overall Study|Withdrawal by Subject|0|||
126753605|NCT02802735|456046210|FG003|Overall Study|Withdrawal by Subject|0|||
126753606|NCT02802735|456046211|FG004|Overall Study|Withdrawal by Subject|0|||
126753607|NCT03922711|456046212|FG000|Overall Study|Adverse Event|3|||
126753608|NCT03922711|456046213|FG001|Overall Study|Adverse Event|2|||
126753609|NCT03922711|456046214|FG002|Overall Study|Adverse Event|2|||
126753610|NCT03922711|456046212|FG000|Overall Study|Protocol Violation|1|||
126753611|NCT03922711|456046213|FG001|Overall Study|Protocol Violation|0|||
126753612|NCT03922711|456046214|FG002|Overall Study|Protocol Violation|0|||
126753613|NCT03922711|456046212|FG000|Overall Study|Withdrawal by Subject|0|||
126753614|NCT03922711|456046213|FG001|Overall Study|Withdrawal by Subject|3|||
126753615|NCT03922711|456046214|FG002|Overall Study|Withdrawal by Subject|1|||
126753616|NCT03922711|456046212|FG000|Overall Study|Not further specified|0|||
126753617|NCT03922711|456046213|FG001|Overall Study|Not further specified|0|||
126753618|NCT03922711|456046214|FG002|Overall Study|Not further specified|1|||
126753619|NCT00877890|456046219|FG000|Overall Study|Adverse Event|6|||
126753620|NCT00877890|456046220|FG001|Overall Study|Adverse Event|6|||
126753621|NCT00877890|456046219|FG000|Overall Study|Lost to Follow-up|5|||
126753622|NCT00877890|456046220|FG001|Overall Study|Lost to Follow-up|5|||
126753623|NCT00877890|456046219|FG000|Overall Study|Protocol Violation|0|||
126753624|NCT00877890|456046220|FG001|Overall Study|Protocol Violation|1|||
126753625|NCT00877890|456046219|FG000|Overall Study|Withdrawal of Consent|6|||
126753626|NCT00877890|456046220|FG001|Overall Study|Withdrawal of Consent|12|||
126753627|NCT00877890|456046219|FG000|Overall Study|Investigator Decision|0|||
126753628|NCT00877890|456046220|FG001|Overall Study|Investigator Decision|2|||
126753629|NCT00877890|456046219|FG000|Overall Study|Loss of Glucose Control|3|||
126753630|NCT00877890|456046220|FG001|Overall Study|Loss of Glucose Control|4|||
126753631|NCT02975206|456046222|FG000|Overall Study|Withdrawal by Subject|14|||
126753632|NCT02975206|456046223|FG001|Overall Study|Withdrawal by Subject|11|||
126753633|NCT02975206|456046224|FG002|Overall Study|Withdrawal by Subject|11|||
126753634|NCT02975206|456046222|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
126753635|NCT02975206|456046223|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
126753636|NCT02975206|456046224|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
126753637|NCT00866606|456046225|FG000|Overall Study|Lost to Follow-up|3|||
126753638|NCT00866606|456046225|FG000|Overall Study|Adverse Event|1|||
126753639|NCT00606021|456046240|FG000|Induction Phase|Death|73|||
126753640|NCT00606021|456046241|FG001|Induction Phase|Death|0|||
126753641|NCT00606021|456046242|FG002|Induction Phase|Death|0|||
126753642|NCT00606021|456046240|FG000|Induction Phase|Physician Decision|2|||
126753643|NCT00606021|456046241|FG001|Induction Phase|Physician Decision|0|||
126753644|NCT00606021|456046242|FG002|Induction Phase|Physician Decision|0|||
126753645|NCT00606021|456046240|FG000|Induction Phase|Withdrawal by Subject|2|||
126753646|NCT00606021|456046241|FG001|Induction Phase|Withdrawal by Subject|0|||
126753647|NCT00606021|456046242|FG002|Induction Phase|Withdrawal by Subject|0|||
126753648|NCT00606021|456046240|FG000|Induction Phase|Lost to Follow-up|10|||
126753649|NCT00606021|456046241|FG001|Induction Phase|Lost to Follow-up|0|||
126753650|NCT00606021|456046242|FG002|Induction Phase|Lost to Follow-up|0|||
126753651|NCT00606021|456046240|FG000|Maintenance Phase|Death|0|||
126753652|NCT00606021|456046241|FG001|Maintenance Phase|Death|17|||
126753653|NCT00606021|456046242|FG002|Maintenance Phase|Death|15|||
126753654|NCT00606021|456046240|FG000|Maintenance Phase|Physician Decision|0|||
126753655|NCT00606021|456046241|FG001|Maintenance Phase|Physician Decision|1|||
126753656|NCT00606021|456046242|FG002|Maintenance Phase|Physician Decision|0|||
126753657|NCT00606021|456046240|FG000|Maintenance Phase|Lost to Follow-up|0|||
126753658|NCT00606021|456046241|FG001|Maintenance Phase|Lost to Follow-up|5|||
126753659|NCT00606021|456046242|FG002|Maintenance Phase|Lost to Follow-up|2|||
126753660|NCT01230827|456046250|FG000|Overall Study|Lost to Follow-up|0|||
126753661|NCT01230827|456046251|FG001|Overall Study|Lost to Follow-up|0|||
126753662|NCT01230827|456046252|FG002|Overall Study|Lost to Follow-up|1|||
126753663|NCT01230827|456046253|FG003|Overall Study|Lost to Follow-up|3|||
126753664|NCT01230827|456046250|FG000|Overall Study|Withdrawal by Subject|1|||
126753665|NCT01230827|456046251|FG001|Overall Study|Withdrawal by Subject|0|||
126753666|NCT01230827|456046252|FG002|Overall Study|Withdrawal by Subject|3|||
126753667|NCT01230827|456046253|FG003|Overall Study|Withdrawal by Subject|2|||
126753668|NCT01230827|456046250|FG000|Overall Study|Lack of Efficacy|14|||
126753669|NCT01230827|456046251|FG001|Overall Study|Lack of Efficacy|1|||
126753670|NCT01230827|456046252|FG002|Overall Study|Lack of Efficacy|2|||
126753671|NCT01230827|456046253|FG003|Overall Study|Lack of Efficacy|3|||
126753672|NCT01230827|456046250|FG000|Overall Study|Adverse Event|4|||
126753673|NCT01230827|456046251|FG001|Overall Study|Adverse Event|2|||
126753674|NCT01230827|456046252|FG002|Overall Study|Adverse Event|3|||
126753675|NCT01230827|456046253|FG003|Overall Study|Adverse Event|7|||
126753676|NCT01230827|456046250|FG000|Overall Study|Recovery|0|||
126753677|NCT01230827|456046251|FG001|Overall Study|Recovery|6|||
126753678|NCT01230827|456046252|FG002|Overall Study|Recovery|0|||
126753679|NCT01230827|456046253|FG003|Overall Study|Recovery|0|||
126753680|NCT01230827|456046250|FG000|Overall Study|Study terminated by Sponsor|0|||
126753681|NCT01230827|456046251|FG001|Overall Study|Study terminated by Sponsor|2|||
126753682|NCT01230827|456046252|FG002|Overall Study|Study terminated by Sponsor|56|||
126753683|NCT01230827|456046253|FG003|Overall Study|Study terminated by Sponsor|63|||
126753684|NCT00805142|456046254|FG000|Titration Period|Adverse Event|3|||
126753685|NCT00805142|456046255|FG001|Titration Period|Adverse Event|3|||
126753686|NCT00805142|456046254|FG000|Titration Period|Lack of Efficacy|1|||
126753687|NCT00805142|456046255|FG001|Titration Period|Lack of Efficacy|1|||
126753688|NCT00805142|456046254|FG000|Titration Period|Lost to Follow-up|0|||
126753689|NCT00805142|456046255|FG001|Titration Period|Lost to Follow-up|1|||
126753690|NCT00805142|456046254|FG000|Titration Period|Disease Progression|2|||
126753691|NCT00805142|456046255|FG001|Titration Period|Disease Progression|1|||
126753692|NCT00805142|456046254|FG000|Titration Period|Withdrawal of consent|0|||
126753693|NCT00805142|456046255|FG001|Titration Period|Withdrawal of consent|1|||
126753694|NCT00805142|456046254|FG000|Titration Period|Other|0|||
126753695|NCT00805142|456046255|FG001|Titration Period|Other|3|||
126753696|NCT00805142|456046254|FG000|Maintenance Period|Adverse Event|0|||
126753697|NCT00805142|456046255|FG001|Maintenance Period|Adverse Event|1|||
126753698|NCT00805142|456046254|FG000|Maintenance Period|Other|0|||
126753699|NCT00805142|456046255|FG001|Maintenance Period|Other|1|||
126753700|NCT01021423|456046257|FG000|Overall Study|Study terminated|4|||
126753701|NCT01021423|456046258|FG001|Overall Study|Study terminated|5|||
126753702|NCT01021293|456046262|FG000|Overall Study|Serious Adverse Event|2|||
126753703|NCT01021293|456046263|FG001|Overall Study|Serious Adverse Event|1|||
126753704|NCT01021293|456046262|FG000|Overall Study|Adverse Event|2|||
126753705|NCT01021293|456046263|FG001|Overall Study|Adverse Event|1|||
126753706|NCT01021293|456046262|FG000|Overall Study|Withdrawal by Subject|1|||
126753707|NCT01021293|456046263|FG001|Overall Study|Withdrawal by Subject|3|||
126753708|NCT01021293|456046262|FG000|Overall Study|Migrated/moved from study area|6|||
126753709|NCT01021293|456046263|FG001|Overall Study|Migrated/moved from study area|18|||
126753710|NCT01021293|456046262|FG000|Overall Study|Lost to Follow-up|1|||
126753711|NCT01021293|456046263|FG001|Overall Study|Lost to Follow-up|1|||
126753712|NCT00027846|456048590|FG000|Overall Study|Lost to Follow-up|0|||
126753713|NCT00027846|456048591|FG001|Overall Study|Lost to Follow-up|41|||
126753714|NCT00027846|456048592|FG002|Overall Study|Lost to Follow-up|9|||
126753715|NCT00027846|456048590|FG000|Overall Study|Withdrawal by Subject|0|||
126753716|NCT00027846|456048591|FG001|Overall Study|Withdrawal by Subject|14|||
126753717|NCT00027846|456048592|FG002|Overall Study|Withdrawal by Subject|7|||
126753718|NCT00027846|456048590|FG000|Overall Study|Ineligible for study|2|||
126753719|NCT00027846|456048591|FG001|Overall Study|Ineligible for study|6|||
126753720|NCT00027846|456048592|FG002|Overall Study|Ineligible for study|14|||
126753721|NCT00027846|456048590|FG000|Overall Study|Entry into another COG therapeutic study|0|||
126753722|NCT00027846|456048591|FG001|Overall Study|Entry into another COG therapeutic study|5|||
126753723|NCT00027846|456048592|FG002|Overall Study|Entry into another COG therapeutic study|2|||
126782899|NCT01806597|456160089|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
126782900|NCT01806597|456160090|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
126782901|NCT01806597|456160085|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
126753724|NCT00027846|456048590|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
126753725|NCT00027846|456048591|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
126753726|NCT00027846|456048592|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
126753727|NCT05604781|456048593|FG000|Overall Study|Lost to Follow-up|3|||
126753728|NCT05604781|456048593|FG000|Overall Study|Adverse Event|1|||
126753729|NCT01005966|456048594|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
126753730|NCT01005966|456048595|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
126753731|NCT01005966|456048596|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
126753732|NCT01005966|456048597|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
126753733|NCT01005966|456048598|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
126782902|NCT01806597|456160086|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
126753734|NCT01005966|456048594|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
126753735|NCT01005966|456048595|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
126753736|NCT01005966|456048596|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
126753737|NCT01005966|456048597|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
126753738|NCT01005966|456048598|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
126753739|NCT01005966|456048594|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
126753740|NCT01005966|456048595|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
126753741|NCT01005966|456048596|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
126753742|NCT01005966|456048597|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
126753743|NCT01005966|456048598|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
126753744|NCT01005966|456048594|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
126753745|NCT01005966|456048595|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
126753746|NCT01005966|456048596|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
126753747|NCT01005966|456048597|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
126753748|NCT01005966|456048598|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
126753749|NCT01005966|456048594|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126753750|NCT01005966|456048595|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126753751|NCT01005966|456048596|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126753752|NCT01005966|456048597|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
126753753|NCT01005966|456048598|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
126753754|NCT01005966|456048594|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
126753755|NCT01005966|456048595|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
126753756|NCT01005966|456048596|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
126753757|NCT01005966|456048597|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
126753758|NCT01005966|456048598|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
126753759|NCT01005966|456048594|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
126753760|NCT01005966|456048595|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
126753761|NCT01005966|456048596|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
126753762|NCT01005966|456048597|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
126753763|NCT01005966|456048598|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
126753764|NCT01005966|456048594|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
126753765|NCT01005966|456048595|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
126753766|NCT01005966|456048596|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
126753767|NCT01005966|456048597|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
126753768|NCT01005966|456048598|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
126753769|NCT01005966|456048594|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
126753770|NCT01005966|456048595|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
126753771|NCT01005966|456048596|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
126753772|NCT01005966|456048597|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
126753773|NCT01005966|456048598|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
126753774|NCT01451203|456048599|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
126753775|NCT01451203|456048600|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
126753776|NCT01451203|456048599|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
126753777|NCT01451203|456048600|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
126753778|NCT01451203|456048599|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
126753779|NCT01451203|456048600|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
126753780|NCT01451203|456048599|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
126753781|NCT01451203|456048600|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
126753782|NCT01451203|456048599|FG000|Double-blind Treatment Period|Adverse Event|6|||
126753783|NCT01451203|456048600|FG001|Double-blind Treatment Period|Adverse Event|9|||
126753784|NCT01451203|456048599|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
126753785|NCT01451203|456048600|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
126753786|NCT01451203|456048599|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
126623783|NCT00383500|455579463|FG002|Overall Study|Withdrawal by Subject|0|||
126623784|NCT00383500|455579461|FG000|Overall Study|Lost to Follow-up|0|||
126753787|NCT01451203|456048600|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
126753788|NCT01451203|456048599|FG000|Double-blind Treatment Period|Investigator decision|2|||
126753789|NCT01451203|456048600|FG001|Double-blind Treatment Period|Investigator decision|0|||
126753790|NCT01451203|456048599|FG000|Post-treatment Period|Consent withdrawn|2|||
126753791|NCT01451203|456048600|FG001|Post-treatment Period|Consent withdrawn|4|||
126753792|NCT01451203|456048599|FG000|Post-treatment Period|Lack of Efficacy|12|||
126753793|NCT01451203|456048600|FG001|Post-treatment Period|Lack of Efficacy|28|||
126753794|NCT01451203|456048599|FG000|Post-treatment Period|Adverse Event|0|||
126753795|NCT01451203|456048600|FG001|Post-treatment Period|Adverse Event|1|||
126753796|NCT01451203|456048599|FG000|Post-treatment Period|Investigator decision|0|||
126753797|NCT01451203|456048600|FG001|Post-treatment Period|Investigator decision|1|||
126753798|NCT03890731|456048601|FG000|Overall Study|Progressive disease|1|||
126753799|NCT03890731|456048601|FG000|Overall Study|Patient's decision|1|||
126753800|NCT03890731|456048601|FG000|Overall Study|Adverse Event|4|||
126753801|NCT00027027|456048605|FG000|Overall Study|Adverse Event|0|||
126753802|NCT00027027|456048606|FG001|Overall Study|Adverse Event|0|||
126623785|NCT00383500|455579462|FG001|Overall Study|Lost to Follow-up|0|||
126753803|NCT00027027|456048607|FG002|Overall Study|Adverse Event|1|||
126753804|NCT00027027|456048608|FG003|Overall Study|Adverse Event|0|||
126753805|NCT00027027|456048609|FG004|Overall Study|Adverse Event|1|||
126753806|NCT00027027|456048605|FG000|Overall Study|Admitted for Signs of PD|0|||
126753807|NCT00027027|456048606|FG001|Overall Study|Admitted for Signs of PD|0|||
126753808|NCT00027027|456048607|FG002|Overall Study|Admitted for Signs of PD|0|||
126753809|NCT00027027|456048608|FG003|Overall Study|Admitted for Signs of PD|0|||
126753810|NCT00027027|456048609|FG004|Overall Study|Admitted for Signs of PD|1|||
126753811|NCT00027027|456048605|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
126753812|NCT00027027|456048606|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
126753813|NCT00027027|456048607|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
126753814|NCT00027027|456048608|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
126753815|NCT00027027|456048609|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
126753816|NCT00027027|456048605|FG000|Overall Study|PD Requiring Surgery|0|||
126753817|NCT00027027|456048606|FG001|Overall Study|PD Requiring Surgery|0|||
126753818|NCT00027027|456048607|FG002|Overall Study|PD Requiring Surgery|1|||
126753819|NCT00027027|456048608|FG003|Overall Study|PD Requiring Surgery|0|||
126753820|NCT00027027|456048609|FG004|Overall Study|PD Requiring Surgery|0|||
126753821|NCT00027027|456048605|FG000|Overall Study|Physician Decision Due To PD|2|||
126753822|NCT00027027|456048606|FG001|Overall Study|Physician Decision Due To PD|3|||
126753823|NCT00027027|456048607|FG002|Overall Study|Physician Decision Due To PD|2|||
126753824|NCT00027027|456048608|FG003|Overall Study|Physician Decision Due To PD|3|||
126753825|NCT00027027|456048609|FG004|Overall Study|Physician Decision Due To PD|5|||
126753826|NCT00027027|456048605|FG000|Overall Study|Withdrawal by Subject|0|||
126753827|NCT00027027|456048606|FG001|Overall Study|Withdrawal by Subject|0|||
126753828|NCT00027027|456048607|FG002|Overall Study|Withdrawal by Subject|0|||
126753829|NCT00027027|456048608|FG003|Overall Study|Withdrawal by Subject|0|||
126753830|NCT00027027|456048609|FG004|Overall Study|Withdrawal by Subject|1|||
126753831|NCT02039687|456048615|FG000|Overall Study|Adverse Event|0|||
126753832|NCT02039687|456048616|FG001|Overall Study|Adverse Event|0|||
126753833|NCT02039687|456048617|FG002|Overall Study|Adverse Event|1|||
126782903|NCT01806597|456160087|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
126782904|NCT01806597|456160088|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
126782905|NCT01806597|456160089|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
126782906|NCT01806597|456160090|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
126782907|NCT01806597|456160085|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
126782908|NCT01806597|456160086|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
126782909|NCT01806597|456160087|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
126782910|NCT01806597|456160088|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
126782911|NCT01806597|456160089|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
126782912|NCT01806597|456160090|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
126782913|NCT01806597|456160085|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
126782914|NCT01806597|456160086|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
126782915|NCT01806597|456160087|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
126782916|NCT01806597|456160088|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
126782917|NCT01806597|456160089|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
126782918|NCT01806597|456160090|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
126782919|NCT01806597|456160085|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
126782920|NCT01806597|456160086|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
126782921|NCT01806597|456160087|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
126782922|NCT01806597|456160088|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
126782923|NCT01806597|456160089|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
126782924|NCT01806597|456160090|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
126623786|NCT00383500|455579463|FG002|Overall Study|Lost to Follow-up|2|||
126623787|NCT02176356|455580921|FG000|Overall Study|Screen Failure|14|||
126623788|NCT02176356|455580921|FG000|Overall Study|Lost to Follow-up|4|||
126753834|NCT02039687|456048618|FG003|Overall Study|Adverse Event|0|||
126753835|NCT02039687|456048615|FG000|Overall Study|Withdrawal by Subject|0|||
126753836|NCT02039687|456048616|FG001|Overall Study|Withdrawal by Subject|1|||
126753837|NCT02039687|456048617|FG002|Overall Study|Withdrawal by Subject|0|||
126753838|NCT02039687|456048618|FG003|Overall Study|Withdrawal by Subject|0|||
126753839|NCT02039687|456048615|FG000|Overall Study|treatment assignment could not be confir|0|||
126753840|NCT02039687|456048616|FG001|Overall Study|treatment assignment could not be confir|0|||
126623789|NCT02176356|455580921|FG000|Overall Study|Personal Reasons|3|||
126623790|NCT02176356|455580921|FG000|Overall Study|Other Miscellaneous Reasons|2|||
126753841|NCT02039687|456048617|FG002|Overall Study|treatment assignment could not be confir|2|||
126753842|NCT02039687|456048618|FG003|Overall Study|treatment assignment could not be confir|0|||
126753843|NCT00303329|456048628|FG000|Overall Study|Adverse Event|7|||
126753844|NCT00303329|456048629|FG001|Overall Study|Adverse Event|14|||
126753845|NCT00303329|456048628|FG000|Overall Study|Abnormal Laboratory Values|0|||
126753846|NCT00303329|456048629|FG001|Overall Study|Abnormal Laboratory Values|1|||
126753847|NCT00303329|456048628|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
126753848|NCT00303329|456048629|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126753849|NCT00303329|456048628|FG000|Overall Study|Condition no longer requires study drug|0|||
126753850|NCT00303329|456048629|FG001|Overall Study|Condition no longer requires study drug|8|||
126753851|NCT00303329|456048628|FG000|Overall Study|Protocol Violation|3|||
126753852|NCT00303329|456048629|FG001|Overall Study|Protocol Violation|0|||
126753853|NCT00303329|456048628|FG000|Overall Study|Withdrawal by Subject|9|||
126753854|NCT00303329|456048629|FG001|Overall Study|Withdrawal by Subject|15|||
126753855|NCT00303329|456048628|FG000|Overall Study|Lost to Follow-up|0|||
126753856|NCT00303329|456048629|FG001|Overall Study|Lost to Follow-up|1|||
126753857|NCT00303329|456048628|FG000|Overall Study|Administrative problems|1|||
126753858|NCT00303329|456048629|FG001|Overall Study|Administrative problems|0|||
126753859|NCT00303329|456048628|FG000|Overall Study|Death|2|||
126753860|NCT00303329|456048629|FG001|Overall Study|Death|12|||
126753861|NCT00303329|456048628|FG000|Overall Study|Stopped at end of core|3|||
126753862|NCT00303329|456048629|FG001|Overall Study|Stopped at end of core|9|||
126753863|NCT00303329|456048628|FG000|Overall Study|Stopped at end of extension 1|1|||
126753864|NCT00303329|456048629|FG001|Overall Study|Stopped at end of extension 1|0|||
126753865|NCT02408016|456048632|FG000|Overall Study|Death|6|||
126753866|NCT02408016|456048633|FG001|Overall Study|Death|1|||
126753867|NCT02408016|456048634|FG002|Overall Study|Death|0|||
126753868|NCT02408016|456048632|FG000|Overall Study|Physician Decision|0|||
126753869|NCT02408016|456048633|FG001|Overall Study|Physician Decision|2|||
126753870|NCT02408016|456048634|FG002|Overall Study|Physician Decision|0|||
126753871|NCT02967562|456048636|FG000|Overall Study|Consent not obtained|1|||
126753872|NCT02967562|456048637|FG001|Overall Study|Consent not obtained|0|||
126753873|NCT02967562|456048636|FG000|Overall Study|High leak precluding analysis|1|||
126753874|NCT02967562|456048637|FG001|Overall Study|High leak precluding analysis|1|||
126753875|NCT00106626|456048638|FG000|Overall Study|Adverse Event|5|||
126753876|NCT00106626|456048639|FG001|Overall Study|Adverse Event|4|||
126753877|NCT00106626|456048640|FG002|Overall Study|Adverse Event|3|||
126753878|NCT00106626|456048641|FG003|Overall Study|Adverse Event|3|||
126753879|NCT00106626|456048638|FG000|Overall Study|Progressive Disease|4|||
126753880|NCT00106626|456048639|FG001|Overall Study|Progressive Disease|1|||
126753881|NCT00106626|456048640|FG002|Overall Study|Progressive Disease|9|||
126753882|NCT00106626|456048641|FG003|Overall Study|Progressive Disease|10|||
126753883|NCT00106626|456048638|FG000|Overall Study|Received radiation on new therapy|1|||
126753884|NCT00106626|456048639|FG001|Overall Study|Received radiation on new therapy|0|||
126753885|NCT00106626|456048640|FG002|Overall Study|Received radiation on new therapy|0|||
126753886|NCT00106626|456048641|FG003|Overall Study|Received radiation on new therapy|0|||
126753887|NCT00106626|456048638|FG000|Overall Study|> 14 day delay in therapy start|0|||
126753888|NCT00106626|456048639|FG001|Overall Study|> 14 day delay in therapy start|1|||
126753889|NCT00106626|456048640|FG002|Overall Study|> 14 day delay in therapy start|0|||
126753890|NCT00106626|456048641|FG003|Overall Study|> 14 day delay in therapy start|0|||
126753891|NCT00732199|456048642|FG000|Overall Study|Withdrawal by Subject|25|||
126753892|NCT00732199|456048643|FG001|Overall Study|Withdrawal by Subject|18|||
126753893|NCT00732199|456048642|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
126753894|NCT00732199|456048643|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
126753895|NCT02870348|456048648|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
126753896|NCT00672139|456048649|FG000|Overall Study|Death|14|||
126753897|NCT00672139|456048650|FG001|Overall Study|Death|23|||
126753898|NCT00672139|456048649|FG000|Overall Study|Withdrawal by Subject|2|||
126753899|NCT00672139|456048650|FG001|Overall Study|Withdrawal by Subject|11|||
126753900|NCT00672139|456048649|FG000|Overall Study|Adverse Event|4|||
126753901|NCT00672139|456048650|FG001|Overall Study|Adverse Event|7|||
126753902|NCT00672139|456048649|FG000|Overall Study|Physician Decision|2|||
126753903|NCT00672139|456048650|FG001|Overall Study|Physician Decision|0|||
126753904|NCT00672139|456048649|FG000|Overall Study|Lack of Efficacy|4|||
126753905|NCT00672139|456048650|FG001|Overall Study|Lack of Efficacy|1|||
126782925|NCT01806597|456160085|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
126753906|NCT00672139|456048649|FG000|Overall Study|Protocol Violation|1|||
126753907|NCT00672139|456048650|FG001|Overall Study|Protocol Violation|1|||
126753908|NCT00672139|456048649|FG000|Overall Study|hospice discharge, caregiver requests|3|||
126753909|NCT00672139|456048650|FG001|Overall Study|hospice discharge, caregiver requests|2|||
126753910|NCT01038635|456048657|FG000|Overall Study|Disease Progression|2|||
126753911|NCT01038635|456048658|FG001|Overall Study|Disease Progression|0|||
126753912|NCT01038635|456048659|FG002|Overall Study|Disease Progression|0|||
126753913|NCT01038635|456048660|FG003|Overall Study|Disease Progression|0|||
126753914|NCT01038635|456048661|FG004|Overall Study|Disease Progression|0|||
126753915|NCT01038635|456048662|FG005|Overall Study|Disease Progression|0|||
126753916|NCT01038635|456048663|FG006|Overall Study|Disease Progression|1|||
126753917|NCT01038635|456048664|FG007|Overall Study|Disease Progression|4|||
126753918|NCT01038635|456048665|FG008|Overall Study|Disease Progression|0|||
126753919|NCT01038635|456048657|FG000|Overall Study|Death|0|||
126753920|NCT01038635|456048658|FG001|Overall Study|Death|0|||
126753921|NCT01038635|456048659|FG002|Overall Study|Death|0|||
126753922|NCT01038635|456048660|FG003|Overall Study|Death|0|||
126753923|NCT01038635|456048661|FG004|Overall Study|Death|1|||
126753924|NCT01038635|456048662|FG005|Overall Study|Death|0|||
126753925|NCT01038635|456048663|FG006|Overall Study|Death|1|||
126753926|NCT01038635|456048664|FG007|Overall Study|Death|1|||
126753927|NCT01038635|456048665|FG008|Overall Study|Death|2|||
126753928|NCT01562327|456048666|FG000|Overall Study|Adverse Event|2|||
126753929|NCT01562327|456048666|FG000|Overall Study|Lack of Efficacy|1|||
126753930|NCT01562327|456048666|FG000|Overall Study|Participant drop-out|1|||
126753931|NCT01562327|456048666|FG000|Overall Study|Infusion not received at 6 month window|4|||
126753932|NCT03018340|456048667|FG000|Overall Study|Adverse Event|1|||
126753933|NCT03018340|456048668|FG001|Overall Study|Adverse Event|2|||
126753934|NCT03018340|456048667|FG000|Overall Study|Withdrawal by Subject|0|||
126753935|NCT03018340|456048668|FG001|Overall Study|Withdrawal by Subject|8|||
126753936|NCT03018340|456048667|FG000|Overall Study|Lack of Efficacy|0|||
126753937|NCT03018340|456048668|FG001|Overall Study|Lack of Efficacy|1|||
126753938|NCT03018340|456048667|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
126753939|NCT03018340|456048668|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
126753940|NCT03018340|456048667|FG000|Overall Study|Lost to Follow-up|1|||
126753941|NCT03018340|456048668|FG001|Overall Study|Lost to Follow-up|7|||
126753942|NCT03018340|456048667|FG000|Overall Study|Protocol Violation|3|||
126753943|NCT03018340|456048668|FG001|Overall Study|Protocol Violation|7|||
126753944|NCT03018340|456048667|FG000|Overall Study|Not further specified|0|||
126753945|NCT03018340|456048668|FG001|Overall Study|Not further specified|1|||
126753946|NCT01683058|456048670|FG000|Overall Study|Lost to Follow-up|9|||
126753947|NCT01683058|456048670|FG000|Overall Study|Adverse Event|6|||
126753948|NCT01683058|456048670|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
126753949|NCT01683058|456048670|FG000|Overall Study|Withdrawal by Subject|7|||
126753950|NCT01683058|456048670|FG000|Overall Study|Lack of Efficacy|2|||
126753951|NCT01195636|456048674|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
126753952|NCT01195636|456048675|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
126753953|NCT01195636|456048674|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
126753954|NCT01195636|456048675|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
126753955|NCT01195636|456048674|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
126753956|NCT01195636|456048675|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
126753957|NCT01195636|456048674|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
126753958|NCT01195636|456048675|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
126753959|NCT01195636|456048674|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
126753960|NCT01195636|456048675|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
126753961|NCT01195636|456048674|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
126753962|NCT01195636|456048675|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
126753963|NCT01195636|456048674|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
126753964|NCT01195636|456048675|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
126753965|NCT01195636|456048674|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
126753966|NCT01195636|456048675|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
126753967|NCT03500419|456048676|FG000|Overall Study|Withdrawal by Subject|2|||
126753968|NCT03500419|456048677|FG001|Overall Study|Withdrawal by Subject|25|||
126753969|NCT00203294|456048678|FG000|Overall Study|Withdrawal by Subject|8|||
126753970|NCT00203294|456048679|FG001|Overall Study|Withdrawal by Subject|13|||
126753971|NCT00247962|456048680|FG000|Overall Study|Adverse Event|15|||
126753972|NCT00247962|456048681|FG001|Overall Study|Adverse Event|12|||
126753973|NCT00247962|456048680|FG000|Overall Study|Lost to Follow-up|3|||
126753974|NCT00247962|456048681|FG001|Overall Study|Lost to Follow-up|1|||
126753975|NCT00247962|456048680|FG000|Overall Study|Physician Decision|0|||
126753976|NCT00247962|456048681|FG001|Overall Study|Physician Decision|1|||
126753977|NCT00247962|456048680|FG000|Overall Study|Protocol Violation|1|||
126753978|NCT00247962|456048681|FG001|Overall Study|Protocol Violation|1|||
126753979|NCT00247962|456048680|FG000|Overall Study|Withdrawal by Subject|3|||
126753980|NCT00247962|456048681|FG001|Overall Study|Withdrawal by Subject|2|||
126753981|NCT00247962|456048680|FG000|Overall Study|Lack of Efficacy|4|||
126753982|NCT00247962|456048681|FG001|Overall Study|Lack of Efficacy|2|||
126753983|NCT03147495|456048682|FG000|Overall Study|Physician Decision|0|||
126753984|NCT03147495|456048683|FG001|Overall Study|Physician Decision|6|||
126753985|NCT02607735|456048684|FG000|Primary Study|Randomized but Never Treated|1|||
126753986|NCT02607735|456048685|FG001|Primary Study|Randomized but Never Treated|0|||
126753987|NCT02607735|456048686|FG002|Primary Study|Randomized but Never Treated|0|||
126753988|NCT02607735|456048684|FG000|Primary Study|Lost to Follow-up|4|||
126753989|NCT02607735|456048685|FG001|Primary Study|Lost to Follow-up|0|||
126753990|NCT02607735|456048686|FG002|Primary Study|Lost to Follow-up|0|||
126753991|NCT02607735|456048684|FG000|Primary Study|Withdrew Consent|2|||
126753992|NCT02607735|456048685|FG001|Primary Study|Withdrew Consent|0|||
126753993|NCT02607735|456048686|FG002|Primary Study|Withdrew Consent|0|||
126753994|NCT02607735|456048684|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
126753995|NCT02607735|456048685|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
126753996|NCT02607735|456048686|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
126753997|NCT02607735|456048684|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
126623791|NCT00792259|455580922|FG000|Overall Study|Poor Quality Scans|1|||
126623792|NCT00792259|455580923|FG001|Overall Study|Poor Quality Scans|0|||
126623793|NCT00792259|455580924|FG002|Overall Study|Poor Quality Scans|0|||
126623794|NCT00332488|455580925|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
126623795|NCT00332488|455580926|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
126623796|NCT00332488|455580927|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
126623797|NCT00332488|455580925|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
126623798|NCT00332488|455580926|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
126623799|NCT00332488|455580927|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
126623800|NCT00332488|455580925|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
126623801|NCT00332488|455580926|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
126623802|NCT00332488|455580927|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
126623803|NCT00332488|455580925|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
126623804|NCT00332488|455580926|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
126623805|NCT00332488|455580927|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
126623806|NCT00332488|455580925|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
126623807|NCT00332488|455580926|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
126623808|NCT00332488|455580927|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
126623809|NCT00332488|455580925|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
126623810|NCT00332488|455580926|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
126623811|NCT00332488|455580927|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
126623812|NCT00332488|455580925|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
126623813|NCT00332488|455580926|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
126623814|NCT00332488|455580927|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
126623815|NCT00332488|455580925|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
126623816|NCT00332488|455580926|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
126623817|NCT00332488|455580927|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
126623818|NCT00332488|455580925|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
126623819|NCT00332488|455580926|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
126623820|NCT00332488|455580927|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
126623821|NCT00332488|455580925|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
126623822|NCT00332488|455580926|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
126623823|NCT00332488|455580927|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
126623824|NCT00332488|455580925|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
126623825|NCT00332488|455580926|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
126623826|NCT00332488|455580927|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
126623827|NCT00332488|455580925|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
126623828|NCT00332488|455580926|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
126623829|NCT00332488|455580927|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
126623830|NCT00371462|455580928|FG000|Overall Study|Withdrawal by Subject|1|||
126623831|NCT00371462|455580929|FG001|Overall Study|Withdrawal by Subject|0|||
126623832|NCT00371462|455580928|FG000|Overall Study|Other|7|||
126623833|NCT00371462|455580929|FG001|Overall Study|Other|8|||
126623834|NCT03721978|455580931|FG000|Overall Study|Withdrawal by Subject|6|||
126623835|NCT03721978|455580932|FG001|Overall Study|Withdrawal by Subject|1|||
126623836|NCT03721978|455580931|FG000|Overall Study|Adverse Event|1|||
126623837|NCT03721978|455580932|FG001|Overall Study|Adverse Event|1|||
126623838|NCT03721978|455580931|FG000|Overall Study|Progressive Disease|1|||
126623839|NCT03721978|455580932|FG001|Overall Study|Progressive Disease|0|||
126623840|NCT03721978|455580931|FG000|Overall Study|Lost to Follow-up|5|||
126623841|NCT03721978|455580932|FG001|Overall Study|Lost to Follow-up|1|||
126623842|NCT03721978|455580931|FG000|Overall Study|Reason not Specified|0|||
126623843|NCT03721978|455580932|FG001|Overall Study|Reason not Specified|2|||
126623844|NCT05244226|455580933|FG000|Overall Study|Adverse Event|1|||
126623845|NCT05244226|455580934|FG001|Overall Study|Adverse Event|0|||
126623846|NCT05244226|455580935|FG002|Overall Study|Adverse Event|0|||
126623847|NCT05244226|455580933|FG000|Overall Study|Lost to Follow-up|0|||
126623848|NCT05244226|455580934|FG001|Overall Study|Lost to Follow-up|0|||
126623849|NCT05244226|455580935|FG002|Overall Study|Lost to Follow-up|1|||
126623850|NCT05244226|455580933|FG000|Overall Study|Protocol Violation|0|||
126623851|NCT05244226|455580934|FG001|Overall Study|Protocol Violation|2|||
126623852|NCT05244226|455580935|FG002|Overall Study|Protocol Violation|2|||
126623853|NCT00733226|455580936|FG000|Overall Study|Withdrawal by Subject|1|||
126623854|NCT00733226|455580937|FG001|Overall Study|Withdrawal by Subject|0|||
126623855|NCT00733226|455580936|FG000|Overall Study|Lost to Follow-up|2|||
126623856|NCT00733226|455580937|FG001|Overall Study|Lost to Follow-up|0|||
126623857|NCT00733226|455580936|FG000|Overall Study|moved to another place|2|||
126623858|NCT00733226|455580937|FG001|Overall Study|moved to another place|0|||
126623859|NCT03722485|455580938|FG000|Overall Study|Withdrawal by Subject|1|||
126623860|NCT03722485|455580939|FG001|Overall Study|Withdrawal by Subject|0|||
126623861|NCT03722485|455580938|FG000|Overall Study|Adverse Event|0|||
126623862|NCT03722485|455580939|FG001|Overall Study|Adverse Event|2|||
126623863|NCT03722485|455580938|FG000|Overall Study|subject discharged prior to study completion|1|||
126623864|NCT03722485|455580939|FG001|Overall Study|subject discharged prior to study completion|5|||
126623865|NCT03722485|455580938|FG000|Overall Study|eligibility criteria not met|2|||
126623866|NCT03722485|455580939|FG001|Overall Study|eligibility criteria not met|0|||
126623867|NCT00349622|455580940|FG000|Overall Study|Death|168|||
126623868|NCT00349622|455580941|FG001|Overall Study|Death|86|||
126623869|NCT00349622|455580940|FG000|Overall Study|Lost to Follow-up|5|||
126623870|NCT00349622|455580941|FG001|Overall Study|Lost to Follow-up|1|||
126753998|NCT02607735|456048685|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
126753999|NCT02607735|456048686|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
126754000|NCT00742391|456048689|FG000|Overall Study|Adverse Event|2|||
126754001|NCT00742391|456048690|FG001|Overall Study|Adverse Event|1|||
126754002|NCT00742391|456048689|FG000|Overall Study|Lost to Follow-up|1|||
126754003|NCT00742391|456048690|FG001|Overall Study|Lost to Follow-up|0|||
126754004|NCT00742391|456048689|FG000|Overall Study|Protocol Violation|1|||
126754005|NCT00742391|456048690|FG001|Overall Study|Protocol Violation|0|||
126754006|NCT01981096|456048697|FG000|Overall Study|Parent illness|1|||
126754007|NCT01981096|456048698|FG001|Overall Study|Parent illness|0|||
126754008|NCT01981096|456048697|FG000|Overall Study|Withdrawal by Subject|0|||
126754009|NCT01981096|456048698|FG001|Overall Study|Withdrawal by Subject|1|||
126754010|NCT01981096|456048697|FG000|Overall Study|Lost to Follow-up|2|||
126754011|NCT01981096|456048698|FG001|Overall Study|Lost to Follow-up|0|||
126754012|NCT01225211|456048699|FG000|Overall Study|Adverse Event|0|||
126754013|NCT01225211|456048700|FG001|Overall Study|Adverse Event|0|||
126754014|NCT01225211|456048701|FG002|Overall Study|Adverse Event|1|||
126754015|NCT01225211|456048702|FG003|Overall Study|Adverse Event|0|||
126754016|NCT01225211|456048703|FG004|Overall Study|Adverse Event|0|||
126754017|NCT01225211|456048704|FG005|Overall Study|Adverse Event|0|||
126754018|NCT01225211|456048705|FG006|Overall Study|Adverse Event|0|||
126754019|NCT01225211|456048706|FG007|Overall Study|Adverse Event|0|||
126754020|NCT01225211|456048707|FG008|Overall Study|Adverse Event|0|||
126754021|NCT01225211|456048708|FG009|Overall Study|Adverse Event|1|||
126754022|NCT01225211|456048699|FG000|Overall Study|Withdrawal by Subject|0|||
126754023|NCT01225211|456048700|FG001|Overall Study|Withdrawal by Subject|0|||
126754024|NCT01225211|456048701|FG002|Overall Study|Withdrawal by Subject|0|||
126754025|NCT01225211|456048702|FG003|Overall Study|Withdrawal by Subject|0|||
126754026|NCT01225211|456048703|FG004|Overall Study|Withdrawal by Subject|0|||
126754027|NCT01225211|456048704|FG005|Overall Study|Withdrawal by Subject|0|||
126754028|NCT01225211|456048705|FG006|Overall Study|Withdrawal by Subject|1|||
126754029|NCT01225211|456048706|FG007|Overall Study|Withdrawal by Subject|0|||
126754030|NCT01225211|456048707|FG008|Overall Study|Withdrawal by Subject|1|||
126754031|NCT01225211|456048708|FG009|Overall Study|Withdrawal by Subject|3|||
126754032|NCT01225211|456048699|FG000|Overall Study|Other|0|||
126754033|NCT01225211|456048700|FG001|Overall Study|Other|0|||
126754034|NCT01225211|456048701|FG002|Overall Study|Other|0|||
126754035|NCT01225211|456048702|FG003|Overall Study|Other|0|||
126754036|NCT01225211|456048703|FG004|Overall Study|Other|0|||
126754037|NCT01225211|456048704|FG005|Overall Study|Other|0|||
126754038|NCT01225211|456048705|FG006|Overall Study|Other|0|||
126754039|NCT01225211|456048706|FG007|Overall Study|Other|0|||
126754040|NCT01225211|456048707|FG008|Overall Study|Other|0|||
126754041|NCT01225211|456048708|FG009|Overall Study|Other|1|||
126754042|NCT01241318|456048713|FG000|Overall Study|Woman: false pregnancies|27|||
126754043|NCT01241318|456048714|FG001|Overall Study|Woman: false pregnancies|15|||
126754044|NCT01241318|456048713|FG000|Overall Study|Woman: miscarriage/abortion|46|||
126782926|NCT01806597|456160086|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
126782927|NCT01806597|456160087|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
126782928|NCT01806597|456160088|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
126623871|NCT00349622|455580940|FG000|Overall Study|Withdrawal by Subject|5|||
126623872|NCT00349622|455580941|FG001|Overall Study|Withdrawal by Subject|9|||
126623873|NCT02762500|455580942|FG000|Overall Study|Lack of Efficacy|1|||
126623874|NCT02762500|455580943|FG001|Overall Study|Lack of Efficacy|0|||
126623875|NCT02762500|455580942|FG000|Overall Study|Withdrawal by Subject|1|||
126623876|NCT02762500|455580943|FG001|Overall Study|Withdrawal by Subject|1|||
126623877|NCT02762500|455580942|FG000|Overall Study|Adverse Event|0|||
126623878|NCT02762500|455580943|FG001|Overall Study|Adverse Event|2|||
126754045|NCT01241318|456048714|FG001|Overall Study|Woman: miscarriage/abortion|38|||
126754046|NCT01241318|456048713|FG000|Overall Study|Withdrawal by Subject|175|||
126754047|NCT01241318|456048714|FG001|Overall Study|Withdrawal by Subject|46|||
126754048|NCT01241318|456048713|FG000|Overall Study|Lost to Follow-up|740|||
126754049|NCT01241318|456048714|FG001|Overall Study|Lost to Follow-up|455|||
126754050|NCT01241318|456048713|FG000|Overall Study|Death|2|||
126754051|NCT01241318|456048714|FG001|Overall Study|Death|4|||
126754052|NCT01241318|456048713|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
126754053|NCT01241318|456048714|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
126754054|NCT01241318|456048713|FG000|Overall Study|Woman: Stillborn infant|129|||
126754055|NCT01241318|456048714|FG001|Overall Study|Woman: Stillborn infant|146|||
126782929|NCT01806597|456160089|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
126782930|NCT01806597|456160090|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
126782931|NCT01806597|456160085|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
126782932|NCT01806597|456160086|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
126782933|NCT01806597|456160087|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
126782934|NCT01806597|456160088|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
126782935|NCT01806597|456160089|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
126782936|NCT01806597|456160090|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
126782937|NCT02247479|456160092|FG000|Overall Study|Adverse Event|8|||
126782938|NCT02247479|456160093|FG001|Overall Study|Adverse Event|9|||
126782939|NCT02247479|456160094|FG002|Overall Study|Adverse Event|8|||
126782940|NCT02247479|456160092|FG000|Overall Study|Death|5|||
126782941|NCT02247479|456160093|FG001|Overall Study|Death|4|||
126782942|NCT02247479|456160094|FG002|Overall Study|Death|6|||
126782943|NCT02247479|456160092|FG000|Overall Study|Lost to Follow-up|3|||
126782944|NCT02247479|456160093|FG001|Overall Study|Lost to Follow-up|3|||
126782945|NCT02247479|456160094|FG002|Overall Study|Lost to Follow-up|1|||
126782946|NCT02247479|456160092|FG000|Overall Study|Non-compliance|0|||
126782947|NCT02247479|456160093|FG001|Overall Study|Non-compliance|0|||
126782948|NCT02247479|456160094|FG002|Overall Study|Non-compliance|1|||
126782949|NCT02247479|456160092|FG000|Overall Study|Withdrawal by Subject|25|||
126782950|NCT02247479|456160093|FG001|Overall Study|Withdrawal by Subject|29|||
126782951|NCT02247479|456160094|FG002|Overall Study|Withdrawal by Subject|24|||
126782952|NCT02247479|456160092|FG000|Overall Study|Study Terminated by Sponsor|98|||
126782953|NCT02247479|456160093|FG001|Overall Study|Study Terminated by Sponsor|88|||
126782954|NCT02247479|456160094|FG002|Overall Study|Study Terminated by Sponsor|94|||
126782955|NCT02247479|456160092|FG000|Overall Study|Physician Decision|1|||
126782956|NCT02247479|456160093|FG001|Overall Study|Physician Decision|0|||
126782957|NCT02247479|456160094|FG002|Overall Study|Physician Decision|2|||
126782958|NCT02247479|456160092|FG000|Overall Study|Unspecified Reason|2|||
126782959|NCT02247479|456160093|FG001|Overall Study|Unspecified Reason|5|||
126782960|NCT02247479|456160094|FG002|Overall Study|Unspecified Reason|2|||
126782961|NCT01073020|456160095|FG000|Overall Study|Withdrawal by Subject|6|||
126782962|NCT01073020|456160096|FG001|Overall Study|Withdrawal by Subject|4|||
126782963|NCT01073020|456160097|FG002|Overall Study|Withdrawal by Subject|1|||
126782964|NCT01073020|456160098|FG003|Overall Study|Withdrawal by Subject|2|||
126782965|NCT01073020|456160095|FG000|Overall Study|Physician Decision|1|||
126782966|NCT01073020|456160096|FG001|Overall Study|Physician Decision|0|||
126782967|NCT01073020|456160097|FG002|Overall Study|Physician Decision|2|||
126782968|NCT01073020|456160098|FG003|Overall Study|Physician Decision|0|||
126782969|NCT01073020|456160095|FG000|Overall Study|Death|0|||
126782970|NCT01073020|456160096|FG001|Overall Study|Death|1|||
126782971|NCT01073020|456160097|FG002|Overall Study|Death|0|||
126782972|NCT01073020|456160098|FG003|Overall Study|Death|0|||
126782973|NCT01590433|456160105|FG000|Overall Study|Lost to Follow-up|20|||
126782974|NCT01590433|456160106|FG001|Overall Study|Lost to Follow-up|8|||
126782975|NCT01590433|456160105|FG000|Overall Study|Withdrawal by Subject|21|||
126782976|NCT01590433|456160106|FG001|Overall Study|Withdrawal by Subject|11|||
126782977|NCT01590433|456160105|FG000|Overall Study|Adverse Event|11|||
126782978|NCT01590433|456160106|FG001|Overall Study|Adverse Event|3|||
126782979|NCT00555009|456160107|FG000|Overall Study|Withdrawal by Subject|0|||
126782980|NCT00555009|456160108|FG001|Overall Study|Withdrawal by Subject|1|||
126782981|NCT00555009|456160107|FG000|Overall Study|Terminated by Sponsor|2|||
126782982|NCT00555009|456160108|FG001|Overall Study|Terminated by Sponsor|5|||
126782983|NCT01787825|456160110|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
126782984|NCT01787825|456160111|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
126782985|NCT01787825|456160110|FG000|Overall Study|Data Not Analyzable|5|||
126782986|NCT01787825|456160111|FG001|Overall Study|Data Not Analyzable|1|||
126782987|NCT01338636|456160120|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
126782988|NCT02385526|456160121|FG000|Overall Study|Withdrawal by Subject|0|||
126782989|NCT02385526|456160122|FG001|Overall Study|Withdrawal by Subject|2|||
126782990|NCT02385526|456160123|FG002|Overall Study|Withdrawal by Subject|0|||
126782991|NCT02385526|456160121|FG000|Overall Study|Lost to Follow-up|0|||
126782992|NCT02385526|456160122|FG001|Overall Study|Lost to Follow-up|1|||
126782993|NCT02385526|456160123|FG002|Overall Study|Lost to Follow-up|0|||
126782994|NCT02385526|456160121|FG000|Overall Study|Physician Decision|1|||
126782995|NCT02385526|456160122|FG001|Overall Study|Physician Decision|0|||
126782996|NCT02385526|456160123|FG002|Overall Study|Physician Decision|0|||
126782997|NCT02385526|456160121|FG000|Overall Study|Protocol Violation|1|||
126782998|NCT02385526|456160122|FG001|Overall Study|Protocol Violation|0|||
126782999|NCT02385526|456160123|FG002|Overall Study|Protocol Violation|0|||
126783000|NCT03532009|456160126|FG000|Overall Study|Other|1|||
126783001|NCT03532009|456160127|FG001|Overall Study|Other|1|||
126783002|NCT03532009|456160126|FG000|Overall Study|Death|1|||
126783003|NCT03532009|456160127|FG001|Overall Study|Death|1|||
126783004|NCT03532009|456160126|FG000|Overall Study|Withdrawal by Patient|0|||
126783005|NCT03532009|456160127|FG001|Overall Study|Withdrawal by Patient|2|||
126783006|NCT01006707|456160141|FG000|Study Session 1|Lost to Follow-up|2|||
126783007|NCT01006707|456160142|FG001|Study Session 1|Lost to Follow-up|0|||
126783008|NCT01006707|456160143|FG002|Study Session 1|Lost to Follow-up|0|||
126783009|NCT01006707|456160141|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
126783010|NCT01006707|456160142|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
126783011|NCT01006707|456160143|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
126783012|NCT05034731|456160144|FG000|Overall Study|Screen fail|1|||
126783013|NCT05034731|456160145|FG001|Overall Study|Screen fail|1|||
126783014|NCT00283686|456160147|FG000|Overall Study|Death|1|||
126783015|NCT00283686|456160148|FG001|Overall Study|Death|1|||
126783016|NCT00283686|456160149|FG002|Overall Study|Death|1|||
126783017|NCT00283686|456160150|FG003|Overall Study|Death|0|||
126783018|NCT00283686|456160147|FG000|Overall Study|Lost to Follow-up|21|||
126783019|NCT00283686|456160148|FG001|Overall Study|Lost to Follow-up|31|||
126783020|NCT00283686|456160149|FG002|Overall Study|Lost to Follow-up|26|||
126783021|NCT00283686|456160150|FG003|Overall Study|Lost to Follow-up|20|||
126783022|NCT00283686|456160147|FG000|Overall Study|Less than full participation|7|||
126783023|NCT00283686|456160148|FG001|Overall Study|Less than full participation|9|||
126783024|NCT00283686|456160149|FG002|Overall Study|Less than full participation|6|||
126783025|NCT00283686|456160150|FG003|Overall Study|Less than full participation|12|||
126783026|NCT01076166|456160151|FG000|Overall Study|Adverse Event|3|||
126783027|NCT01076166|456160151|FG000|Overall Study|Symptoms improved/resolved|6|||
126754056|NCT02355665|456048720|FG000|Overall Study|Adverse Event|16|||
126754057|NCT02355665|456048721|FG001|Overall Study|Adverse Event|24|||
126754058|NCT02355665|456048720|FG000|Overall Study|Protocol Violation|2|||
126754059|NCT02355665|456048721|FG001|Overall Study|Protocol Violation|0|||
126754060|NCT02355665|456048720|FG000|Overall Study|Withdrawal by Subject|90|||
126754061|NCT02355665|456048721|FG001|Overall Study|Withdrawal by Subject|100|||
126754062|NCT02355665|456048720|FG000|Overall Study|Lost to Follow-up|131|||
126754063|NCT02355665|456048721|FG001|Overall Study|Lost to Follow-up|103|||
126754064|NCT02355665|456048720|FG000|Overall Study|Death|4|||
126754065|NCT02355665|456048721|FG001|Overall Study|Death|2|||
126754066|NCT02355665|456048720|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
126754067|NCT02355665|456048721|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
126754068|NCT04129242|456048722|FG000|Overall Study|Physician Decision|1|||
126754069|NCT04129242|456048723|FG001|Overall Study|Physician Decision|1|||
126754070|NCT04129242|456048722|FG000|Overall Study|Protocol Violation|0|||
126754071|NCT04129242|456048723|FG001|Overall Study|Protocol Violation|1|||
126754072|NCT01058356|456048725|FG000|Overall Study|Adverse Event|5|||
126754073|NCT01058356|456048725|FG000|Overall Study|Administration of contraindicated drugs|12|||
126754074|NCT01058356|456048725|FG000|Overall Study|Withdrawal by Subject|21|||
126754075|NCT01058356|456048725|FG000|Overall Study|Lost to Follow-up|4|||
126754076|NCT00392210|456048728|FG000|First Voiding Trial|Physician Decision|2|||
126754077|NCT00392210|456048729|FG001|First Voiding Trial|Physician Decision|2|||
126754078|NCT04815291|456048730|FG000|Overall Study|Lost to Follow-up|1|||
126754079|NCT04815291|456048730|FG000|Overall Study|Physician Decision|4|||
126754080|NCT04815291|456048730|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
126754081|NCT02140762|456048731|FG000|Overall Study|Adverse Event|1|||
126754082|NCT02140762|456048732|FG001|Overall Study|Adverse Event|1|||
126754083|NCT02140762|456048731|FG000|Overall Study|Lost to Follow-up|9|||
126754084|NCT02140762|456048732|FG001|Overall Study|Lost to Follow-up|5|||
126754085|NCT02140762|456048731|FG000|Overall Study|Protocol Violation|1|||
126754086|NCT02140762|456048732|FG001|Overall Study|Protocol Violation|1|||
126754087|NCT02140762|456048731|FG000|Overall Study|Withdrawal by Subject|6|||
126754088|NCT02140762|456048732|FG001|Overall Study|Withdrawal by Subject|4|||
126754089|NCT02140762|456048731|FG000|Overall Study|Other|0|||
126783028|NCT02970669|456160156|FG000|Double-blind Period|Adverse Event|4|||
126783029|NCT02970669|456160157|FG001|Double-blind Period|Adverse Event|0|||
126783030|NCT02970669|456160156|FG000|Double-blind Period|Death|1|||
126783031|NCT02970669|456160157|FG001|Double-blind Period|Death|0|||
126783032|NCT02970669|456160156|FG000|Double-blind Period|Study terminated by sponsor|1|||
126783033|NCT02970669|456160157|FG001|Double-blind Period|Study terminated by sponsor|2|||
126783034|NCT02970669|456160156|FG000|Double-blind Period|Physician Decision|0|||
126783035|NCT02970669|456160157|FG001|Double-blind Period|Physician Decision|2|||
126783036|NCT02970669|456160156|FG000|Double-blind Period|Withdrawal by Subject|2|||
126783037|NCT02970669|456160157|FG001|Double-blind Period|Withdrawal by Subject|2|||
126754090|NCT02140762|456048732|FG001|Overall Study|Other|1|||
126754091|NCT00989664|456048733|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
126754092|NCT00989664|456048733|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
126754093|NCT00989664|456048733|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
126754094|NCT00989664|456048733|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
126754095|NCT00989664|456048733|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
126754096|NCT00989664|456048733|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
126783038|NCT02970669|456160156|FG000|Open-label Period|Withdrawal by Subject|2|||
126783039|NCT02970669|456160157|FG001|Open-label Period|Withdrawal by Subject|2|||
126783040|NCT02970669|456160156|FG000|Open-label Period|Adverse Event|1|||
126754097|NCT00989664|456048733|FG000|Long-Term Follow-Up|Death|3|||
126754098|NCT00095836|456048734|FG000|Overall Study|Lost to Follow-up|1|||
126754099|NCT00095836|456048734|FG000|Overall Study|Adverse Event|1|||
126754100|NCT00095836|456048734|FG000|Overall Study|Death|2|||
126754101|NCT00962780|456048738|FG000|Overall Study|Death|0|||
126754102|NCT00962780|456048739|FG001|Overall Study|Death|1|||
126754103|NCT00962780|456048738|FG000|Overall Study|Protocol Violation|9|||
126754104|NCT00962780|456048739|FG001|Overall Study|Protocol Violation|4|||
126754105|NCT00962780|456048738|FG000|Overall Study|Withdrawal by Subject|1|||
126754106|NCT00962780|456048739|FG001|Overall Study|Withdrawal by Subject|8|||
126754107|NCT00962780|456048738|FG000|Overall Study|Other|0|||
126754108|NCT00962780|456048739|FG001|Overall Study|Other|1|||
126754109|NCT02363322|456048740|FG000|Overall Study|Lost to Follow-up|1|||
126754110|NCT02363322|456048741|FG001|Overall Study|Lost to Follow-up|0|||
126754111|NCT01775995|456048742|FG000|Overall Study|Lost to Follow-up|1|||
126754112|NCT01775995|456048743|FG001|Overall Study|Lost to Follow-up|1|||
126754113|NCT02055976|456048744|FG000|Overall Study|Other|0|||
126754114|NCT02055976|456048745|FG001|Overall Study|Other|0|||
126754115|NCT02055976|456048746|FG002|Overall Study|Other|1|||
126754116|NCT02055976|456048747|FG003|Overall Study|Other|0|||
126754117|NCT02055976|456048748|FG004|Overall Study|Other|0|||
126754118|NCT02055976|456048749|FG005|Overall Study|Other|0|||
126754119|NCT02055976|456048750|FG006|Overall Study|Other|0|||
126754120|NCT02055976|456048751|FG007|Overall Study|Other|0|||
126754121|NCT02055976|456048752|FG008|Overall Study|Other|0|||
126754122|NCT02055976|456048744|FG000|Overall Study|Adverse Event|0|||
126754123|NCT02055976|456048745|FG001|Overall Study|Adverse Event|0|||
126754124|NCT02055976|456048746|FG002|Overall Study|Adverse Event|0|||
126754125|NCT02055976|456048747|FG003|Overall Study|Adverse Event|0|||
126754126|NCT02055976|456048748|FG004|Overall Study|Adverse Event|0|||
126754127|NCT02055976|456048749|FG005|Overall Study|Adverse Event|1|||
126754128|NCT02055976|456048750|FG006|Overall Study|Adverse Event|1|||
126754129|NCT02055976|456048751|FG007|Overall Study|Adverse Event|0|||
126754130|NCT02055976|456048752|FG008|Overall Study|Adverse Event|0|||
126754131|NCT02055976|456048744|FG000|Overall Study|Does not meet entrance criteria|0|||
126754132|NCT02055976|456048745|FG001|Overall Study|Does not meet entrance criteria|0|||
126754133|NCT02055976|456048746|FG002|Overall Study|Does not meet entrance criteria|0|||
126754134|NCT02055976|456048747|FG003|Overall Study|Does not meet entrance criteria|0|||
126754135|NCT02055976|456048748|FG004|Overall Study|Does not meet entrance criteria|0|||
126754136|NCT02055976|456048749|FG005|Overall Study|Does not meet entrance criteria|0|||
126754137|NCT02055976|456048750|FG006|Overall Study|Does not meet entrance criteria|1|||
126754138|NCT02055976|456048751|FG007|Overall Study|Does not meet entrance criteria|0|||
126754139|NCT02055976|456048752|FG008|Overall Study|Does not meet entrance criteria|0|||
126754140|NCT02055976|456048744|FG000|Overall Study|Lost to Follow-up|0|||
126754141|NCT02055976|456048745|FG001|Overall Study|Lost to Follow-up|0|||
126754142|NCT02055976|456048746|FG002|Overall Study|Lost to Follow-up|0|||
126754143|NCT02055976|456048747|FG003|Overall Study|Lost to Follow-up|1|||
126754144|NCT02055976|456048748|FG004|Overall Study|Lost to Follow-up|0|||
126754145|NCT02055976|456048749|FG005|Overall Study|Lost to Follow-up|0|||
126754146|NCT02055976|456048750|FG006|Overall Study|Lost to Follow-up|0|||
126754147|NCT02055976|456048751|FG007|Overall Study|Lost to Follow-up|0|||
126754148|NCT02055976|456048752|FG008|Overall Study|Lost to Follow-up|0|||
126754149|NCT00394654|456048753|FG000|Overall Study|Lost to Follow-up|1|||
126754150|NCT00394654|456048754|FG001|Overall Study|Lost to Follow-up|0|||
126754151|NCT00394654|456048753|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
126754152|NCT00394654|456048754|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
126754153|NCT00122317|456048755|FG000|Overall Study|Death|3|||
126754154|NCT00122317|456048755|FG000|Overall Study|Adverse Event|4|||
126754155|NCT00122317|456048755|FG000|Overall Study|Physician Decision|2|||
126754156|NCT00122317|456048755|FG000|Overall Study|patient non-compliance|1|||
126623879|NCT02229396|455580944|FG000|Overall Study|Adverse Event|6|||
126754157|NCT00122317|456048755|FG000|Overall Study|Withdrawal by Subject|1|||
126754158|NCT02886338|456048756|FG000|Overall Study|Withdrawal by Subject|1|||
126754159|NCT03756285|456048757|FG000|Overall Study|Lost to Follow-up|0|||
126623880|NCT02229396|455580945|FG001|Overall Study|Adverse Event|12|||
126754160|NCT03756285|456048758|FG001|Overall Study|Lost to Follow-up|1|||
126754161|NCT03756285|456048757|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
126754162|NCT03756285|456048758|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
126754163|NCT03756285|456048757|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
126754164|NCT03756285|456048758|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
126754165|NCT02705755|456048759|FG000|Part A (6 Days)|Adverse Event|1|||
126754166|NCT02705755|456048760|FG001|Part A (6 Days)|Adverse Event|0|||
126754167|NCT02705755|456048761|FG002|Part A (6 Days)|Adverse Event|0|||
126754168|NCT02705755|456048762|FG003|Part A (6 Days)|Adverse Event|0|||
126754169|NCT02705755|456048759|FG000|Part A (6 Days)|Physician Decision|3|||
126754170|NCT02705755|456048760|FG001|Part A (6 Days)|Physician Decision|0|||
126754171|NCT02705755|456048761|FG002|Part A (6 Days)|Physician Decision|0|||
126783041|NCT02970669|456160157|FG001|Open-label Period|Adverse Event|0|||
126623881|NCT02229396|455580946|FG002|Overall Study|Adverse Event|12|||
126623882|NCT02229396|455580944|FG000|Overall Study|Death|2|||
126623883|NCT02229396|455580945|FG001|Overall Study|Death|3|||
126754172|NCT02705755|456048762|FG003|Part A (6 Days)|Physician Decision|0|||
126754173|NCT02705755|456048759|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
126754174|NCT02705755|456048760|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
126754175|NCT02705755|456048761|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
126754176|NCT02705755|456048762|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
126754177|NCT02705755|456048759|FG000|Part C (20 Weeks)|Physician Decision|0|||
126754178|NCT02705755|456048760|FG001|Part C (20 Weeks)|Physician Decision|0|||
126754179|NCT02705755|456048761|FG002|Part C (20 Weeks)|Physician Decision|0|||
126754180|NCT02705755|456048762|FG003|Part C (20 Weeks)|Physician Decision|2|||
126754181|NCT02705755|456048759|FG000|Part C (20 Weeks)|Adverse Event|0|||
126754182|NCT02705755|456048760|FG001|Part C (20 Weeks)|Adverse Event|0|||
126754183|NCT02705755|456048761|FG002|Part C (20 Weeks)|Adverse Event|0|||
126754184|NCT02705755|456048762|FG003|Part C (20 Weeks)|Adverse Event|6|||
126754185|NCT02705755|456048759|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
126754186|NCT02705755|456048760|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
126754187|NCT02705755|456048761|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
126754188|NCT02705755|456048762|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
126754189|NCT01084096|456051199|FG000|Overall Study|Lost to Follow-up|1501|||
126754190|NCT01084096|456051200|FG001|Overall Study|Lost to Follow-up|1833|||
126754191|NCT01084096|456051199|FG000|Overall Study|Withdrawal by Subject|3|||
126754192|NCT01084096|456051200|FG001|Overall Study|Withdrawal by Subject|0|||
126754193|NCT01084096|456051199|FG000|Overall Study|Woman had a miscarriage|21|||
126754194|NCT01084096|456051200|FG001|Overall Study|Woman had a miscarriage|17|||
126754195|NCT01354964|456051201|FG000|Overall Study|Lost to Follow-up|2|||
126754196|NCT01354964|456051202|FG001|Overall Study|Lost to Follow-up|0|||
126754197|NCT01354964|456051201|FG000|Overall Study|IV access issues|1|||
126754198|NCT01354964|456051202|FG001|Overall Study|IV access issues|1|||
126754199|NCT01354964|456051201|FG000|Overall Study|Physician Decision|1|||
126754200|NCT01354964|456051202|FG001|Overall Study|Physician Decision|0|||
126754201|NCT02889861|456051217|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
126754202|NCT01864746|456051218|FG000|Overall Study|Disease recurrence|25|||
126754203|NCT01864746|456051219|FG001|Overall Study|Disease recurrence|40|||
126754204|NCT01864746|456051218|FG000|Overall Study|Second primary invasive nonbreast|2|||
126754205|NCT01864746|456051219|FG001|Overall Study|Second primary invasive nonbreast|3|||
126754206|NCT01864746|456051218|FG000|Overall Study|Death|2|||
126754207|NCT01864746|456051219|FG001|Overall Study|Death|1|||
126754208|NCT01864746|456051218|FG000|Overall Study|Adverse Event|33|||
126754209|NCT01864746|456051219|FG001|Overall Study|Adverse Event|5|||
126754210|NCT01864746|456051218|FG000|Overall Study|Withdrawal by Subject|56|||
126754211|NCT01864746|456051219|FG001|Overall Study|Withdrawal by Subject|41|||
126754212|NCT01864746|456051218|FG000|Overall Study|Physician Decision|5|||
126754213|NCT01864746|456051219|FG001|Overall Study|Physician Decision|6|||
126754214|NCT04450394|456051220|FG000|Overall Study|Adverse Event|2|||
126754215|NCT04450394|456051221|FG001|Overall Study|Adverse Event|0|||
126754216|NCT04450394|456051222|FG002|Overall Study|Adverse Event|0|||
126754217|NCT04450394|456051220|FG000|Overall Study|Death|0|||
126754218|NCT04450394|456051221|FG001|Overall Study|Death|1|||
126754219|NCT04450394|456051222|FG002|Overall Study|Death|0|||
126754220|NCT04450394|456051220|FG000|Overall Study|Lost to Follow-up|0|||
126754221|NCT04450394|456051221|FG001|Overall Study|Lost to Follow-up|3|||
126754222|NCT04450394|456051222|FG002|Overall Study|Lost to Follow-up|0|||
126623884|NCT02229396|455580946|FG002|Overall Study|Death|1|||
126623885|NCT02229396|455580944|FG000|Overall Study|Lost to Follow-up|14|||
126623886|NCT02229396|455580945|FG001|Overall Study|Lost to Follow-up|14|||
126623887|NCT02229396|455580946|FG002|Overall Study|Lost to Follow-up|21|||
126623888|NCT02229396|455580944|FG000|Overall Study|Protocol Violation|2|||
126623889|NCT02229396|455580945|FG001|Overall Study|Protocol Violation|1|||
126623890|NCT02229396|455580946|FG002|Overall Study|Protocol Violation|0|||
126623891|NCT02229396|455580944|FG000|Overall Study|Patient Incorrectly Randomized|0|||
126623892|NCT02229396|455580945|FG001|Overall Study|Patient Incorrectly Randomized|0|||
126623893|NCT02229396|455580946|FG002|Overall Study|Patient Incorrectly Randomized|1|||
126623894|NCT02229396|455580944|FG000|Overall Study|Other|10|||
126623895|NCT02229396|455580945|FG001|Overall Study|Other|18|||
126623896|NCT02229396|455580946|FG002|Overall Study|Other|15|||
126623897|NCT02229396|455580944|FG000|Overall Study|Withdrawal by Subject|42|||
126623898|NCT02229396|455580945|FG001|Overall Study|Withdrawal by Subject|28|||
126623899|NCT02229396|455580946|FG002|Overall Study|Withdrawal by Subject|41|||
126754223|NCT04450394|456051220|FG000|Overall Study|Physician Decision|0|||
126754224|NCT04450394|456051221|FG001|Overall Study|Physician Decision|1|||
126754225|NCT04450394|456051222|FG002|Overall Study|Physician Decision|0|||
126754226|NCT04450394|456051220|FG000|Overall Study|Protocol Violation|2|||
126754227|NCT04450394|456051221|FG001|Overall Study|Protocol Violation|0|||
126754228|NCT04450394|456051222|FG002|Overall Study|Protocol Violation|0|||
126754229|NCT04450394|456051220|FG000|Overall Study|Withdrawal by Subject|6|||
126754230|NCT04450394|456051221|FG001|Overall Study|Withdrawal by Subject|9|||
126754231|NCT04450394|456051222|FG002|Overall Study|Withdrawal by Subject|0|||
126754232|NCT02155660|456051227|FG000|Overall Study|Other Reason|8|||
126754233|NCT02155660|456051228|FG001|Overall Study|Other Reason|6|||
126754234|NCT02155660|456051229|FG002|Overall Study|Other Reason|10|||
126754235|NCT02155660|456051230|FG003|Overall Study|Other Reason|10|||
126754236|NCT02155660|456051227|FG000|Overall Study|Study-specific withdrawal criteria|0|||
126754237|NCT02155660|456051228|FG001|Overall Study|Study-specific withdrawal criteria|1|||
126754238|NCT02155660|456051229|FG002|Overall Study|Study-specific withdrawal criteria|1|||
126754239|NCT02155660|456051230|FG003|Overall Study|Study-specific withdrawal criteria|1|||
126754240|NCT02155660|456051227|FG000|Overall Study|Severe non-compliance|0|||
126754241|NCT02155660|456051228|FG001|Overall Study|Severe non-compliance|4|||
126754242|NCT02155660|456051229|FG002|Overall Study|Severe non-compliance|0|||
126754243|NCT02155660|456051230|FG003|Overall Study|Severe non-compliance|1|||
126754244|NCT02155660|456051227|FG000|Overall Study|Adverse Event|2|||
126754245|NCT02155660|456051228|FG001|Overall Study|Adverse Event|6|||
126754246|NCT02155660|456051229|FG002|Overall Study|Adverse Event|3|||
126754247|NCT02155660|456051230|FG003|Overall Study|Adverse Event|1|||
126754248|NCT02155660|456051227|FG000|Overall Study|Lost to Follow-up|3|||
126754249|NCT02155660|456051228|FG001|Overall Study|Lost to Follow-up|6|||
126754250|NCT02155660|456051229|FG002|Overall Study|Lost to Follow-up|5|||
126754251|NCT02155660|456051230|FG003|Overall Study|Lost to Follow-up|8|||
126754252|NCT02155660|456051227|FG000|Overall Study|Death|17|||
126754253|NCT02155660|456051228|FG001|Overall Study|Death|19|||
126754254|NCT02155660|456051229|FG002|Overall Study|Death|17|||
126754255|NCT02155660|456051230|FG003|Overall Study|Death|19|||
126754256|NCT02155660|456051227|FG000|Overall Study|Withdrawal by Subject|28|||
126754257|NCT02155660|456051228|FG001|Overall Study|Withdrawal by Subject|31|||
126754258|NCT02155660|456051229|FG002|Overall Study|Withdrawal by Subject|24|||
126754259|NCT02155660|456051230|FG003|Overall Study|Withdrawal by Subject|21|||
126754260|NCT03812224|456051237|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
126754261|NCT03812224|456051238|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
126754262|NCT03812224|456051237|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
126754263|NCT03812224|456051238|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
126754264|NCT03812224|456051237|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
126754265|NCT03812224|456051238|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
126754266|NCT03812224|456051237|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
126754267|NCT03812224|456051238|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
126754268|NCT00303719|456051239|FG000|Overall Study|Not evaluable, prior therapies|0|||
126754269|NCT00303719|456051240|FG001|Overall Study|Not evaluable, prior therapies|30|||
126754270|NCT00303719|456051239|FG000|Overall Study|Lost to Follow-up|0|||
126754271|NCT00303719|456051240|FG001|Overall Study|Lost to Follow-up|7|||
126754272|NCT01641952|456051241|FG000|Overall Study|Lost to Follow-up|28|||
126754273|NCT01641952|456051241|FG000|Overall Study|Adverse Event|6|||
126754274|NCT02500901|456051242|FG000|Overall Study|Disease ProgressionDD|2|||
126754275|NCT00561912|456051253|FG000|Overall Study|ineligible|1|||
126754276|NCT02643420|456051255|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
126754277|NCT02643420|456051256|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
126754278|NCT02643420|456051255|FG000|Overall Study|Withdrawal by Subject|25|||
126754279|NCT02643420|456051256|FG001|Overall Study|Withdrawal by Subject|19|||
126754280|NCT02643420|456051255|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
126754281|NCT02643420|456051256|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
126754282|NCT02643420|456051255|FG000|Overall Study|Lost to Follow-up|6|||
126754283|NCT02643420|456051256|FG001|Overall Study|Lost to Follow-up|10|||
126754284|NCT02643420|456051255|FG000|Overall Study|Investigator Decision|2|||
126754285|NCT02643420|456051256|FG001|Overall Study|Investigator Decision|4|||
126783042|NCT02970669|456160156|FG000|Open-label Period|Physician Decision|1|||
126783043|NCT02970669|456160157|FG001|Open-label Period|Physician Decision|0|||
126783044|NCT00876733|456160158|FG000|Overall Study|Adverse Event|34|||
126783045|NCT00876733|456160159|FG001|Overall Study|Adverse Event|20|||
126754286|NCT02643420|456051255|FG000|Overall Study|Sponsor decision|1|||
126754287|NCT02643420|456051256|FG001|Overall Study|Sponsor decision|1|||
126754288|NCT02643420|456051255|FG000|Overall Study|Death|0|||
126754289|NCT02643420|456051256|FG001|Overall Study|Death|2|||
126754290|NCT02643420|456051255|FG000|Overall Study|Reason not Specified|8|||
126754291|NCT02643420|456051256|FG001|Overall Study|Reason not Specified|7|||
126754292|NCT00718887|456051270|FG000|Overall Study|Withdrawal by Subject|3|||
126754293|NCT00718887|456051271|FG001|Overall Study|Withdrawal by Subject|2|||
126754294|NCT00718887|456051270|FG000|Overall Study|Not identified|2|||
126754295|NCT00718887|456051271|FG001|Overall Study|Not identified|7|||
126754296|NCT05102734|456051272|FG000|Overall Study|Did not require vasopressors|1|||
126754297|NCT05102734|456051273|FG001|Overall Study|Did not require vasopressors|0|||
126754298|NCT05102734|456051272|FG000|Overall Study|Did not have functioning PA catheter|1|||
126754299|NCT05102734|456051273|FG001|Overall Study|Did not have functioning PA catheter|0|||
126754300|NCT05102734|456051272|FG000|Overall Study|Inadequate video quality|2|||
126783046|NCT00876733|456160160|FG002|Overall Study|Adverse Event|10|||
126783047|NCT00876733|456160161|FG003|Overall Study|Adverse Event|3|||
126623900|NCT02229396|455580944|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
126623901|NCT02229396|455580945|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
126623902|NCT02229396|455580946|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
126623903|NCT02229396|455580944|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
126623904|NCT02229396|455580945|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
126623905|NCT02229396|455580946|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
126623906|NCT00377312|455580949|FG000|Overall Study|Adverse Event|1|||
126623907|NCT00377312|455580950|FG001|Overall Study|Adverse Event|1|||
126623908|NCT02775214|455580951|FG000|Overall Study|Withdrawal by Subject|2|||
126623909|NCT02775214|455580952|FG001|Overall Study|Withdrawal by Subject|0|||
126623910|NCT01145417|455580953|FG000|Overall Study|Death|1|||
126623911|NCT01145417|455580954|FG001|Overall Study|Death|0|||
126623912|NCT01145417|455580953|FG000|Overall Study|Lost to Follow-up|2|||
126623913|NCT01145417|455580954|FG001|Overall Study|Lost to Follow-up|1|||
126623914|NCT01145417|455580953|FG000|Overall Study|Withdrawal by Subject|1|||
126623915|NCT01145417|455580954|FG001|Overall Study|Withdrawal by Subject|2|||
126623916|NCT01145417|455580953|FG000|Overall Study|Pregnancy|1|||
126623917|NCT01145417|455580954|FG001|Overall Study|Pregnancy|0|||
126623918|NCT01145417|455580953|FG000|Overall Study|Adverse Event|0|||
126623919|NCT01145417|455580954|FG001|Overall Study|Adverse Event|1|||
126623920|NCT01145417|455580953|FG000|Overall Study|Study terminated by sponsor|35|||
126623921|NCT01145417|455580954|FG001|Overall Study|Study terminated by sponsor|43|||
126623922|NCT01145417|455580953|FG000|Overall Study|Other|1|||
126623923|NCT01145417|455580954|FG001|Overall Study|Other|0|||
126623924|NCT01191697|455580955|FG000|Overall Study|Death|1|||
126623925|NCT01191697|455580955|FG000|Overall Study|Physician Decision|2|||
126623926|NCT01191697|455580955|FG000|Overall Study|Pursue chemoradiation|2|||
126623927|NCT01191697|455580955|FG000|Overall Study|Break from chemotherapy|2|||
126623928|NCT01191697|455580955|FG000|Overall Study|Withdrawal by Subject|1|||
126623929|NCT01191697|455580955|FG000|Overall Study|Surveillance|1|||
126623930|NCT01191697|455580955|FG000|Overall Study|Adverse Event|2|||
126623931|NCT01191697|455580955|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
126623932|NCT01191697|455580955|FG000|Overall Study|Not completed but analyzed|25|||
126623933|NCT01066897|455580959|FG000|Overall Study|Withdrawal by Subject|1|||
126623934|NCT01066897|455580960|FG001|Overall Study|Withdrawal by Subject|0|||
126623935|NCT01066897|455580959|FG000|Overall Study|stopped study after developing the flu.|1|||
126623936|NCT01066897|455580960|FG001|Overall Study|stopped study after developing the flu.|0|||
126623937|NCT05372913|455580967|FG000|Overall Study|Withdrawal by Subject|0|||
126623938|NCT05372913|455580968|FG001|Overall Study|Withdrawal by Subject|2|||
126623939|NCT05372913|455580967|FG000|Overall Study|Protocol Violation|2|||
126623940|NCT05372913|455580968|FG001|Overall Study|Protocol Violation|2|||
126623941|NCT05372913|455580967|FG000|Overall Study|Adverse Event|0|||
126623942|NCT05372913|455580968|FG001|Overall Study|Adverse Event|1|||
126623943|NCT03275402|455580969|FG000|Overall Study|Death|17|||
126623944|NCT03275402|455580969|FG000|Overall Study|Study terminated by sponsor|21|||
126623945|NCT03275402|455580969|FG000|Overall Study|Withdrawal by Subject|1|||
126623946|NCT05135156|455580970|FG000|Overall Study|Lost to Follow-up|0|||
126623947|NCT05135156|455580971|FG001|Overall Study|Lost to Follow-up|0|||
126623948|NCT05135156|455580972|FG002|Overall Study|Lost to Follow-up|2|||
126623949|NCT02986659|455580976|FG000|First Intervention Period|Adverse Event|3|||
126623950|NCT02986659|455580977|FG001|First Intervention Period|Adverse Event|1|||
126623951|NCT02986659|455580976|FG000|First Intervention Period|Lost to Follow-up|1|||
126623952|NCT02986659|455580977|FG001|First Intervention Period|Lost to Follow-up|0|||
126623953|NCT02986659|455580976|FG000|First Intervention Period|Withdrawal by Subject|0|||
126623954|NCT02986659|455580977|FG001|First Intervention Period|Withdrawal by Subject|1|||
126623955|NCT02986659|455580976|FG000|Second Intervention Period|Adverse Event|0|||
126754301|NCT05102734|456051273|FG001|Overall Study|Inadequate video quality|0|||
126754302|NCT03055806|456051274|FG000|Overall Study|Adverse Event|0|||
126754303|NCT03055806|456051275|FG001|Overall Study|Adverse Event|0|||
126754304|NCT03055806|456051276|FG002|Overall Study|Adverse Event|1|||
126754305|NCT03055806|456051277|FG003|Overall Study|Adverse Event|1|||
126623956|NCT02986659|455580977|FG001|Second Intervention Period|Adverse Event|6|||
126623957|NCT02402465|455580983|FG000|Overall Study|Withdrawal by Subject|0|||
126623958|NCT02402465|455580984|FG001|Overall Study|Withdrawal by Subject|0|||
126623959|NCT02402465|455580985|FG002|Overall Study|Withdrawal by Subject|0|||
126623960|NCT02402465|455580986|FG003|Overall Study|Withdrawal by Subject|0|||
126623961|NCT02402465|455580987|FG004|Overall Study|Withdrawal by Subject|0|||
126623962|NCT02402465|455580988|FG005|Overall Study|Withdrawal by Subject|1|||
126623963|NCT02402465|455580983|FG000|Overall Study|Lost to Follow-up|0|||
126623964|NCT02402465|455580984|FG001|Overall Study|Lost to Follow-up|1|||
126623965|NCT02402465|455580985|FG002|Overall Study|Lost to Follow-up|0|||
126623966|NCT02402465|455580986|FG003|Overall Study|Lost to Follow-up|0|||
126623967|NCT02402465|455580987|FG004|Overall Study|Lost to Follow-up|1|||
126623968|NCT02402465|455580988|FG005|Overall Study|Lost to Follow-up|0|||
126623969|NCT03807700|455580989|FG000|Overall Study|Withdrawal by Subject|2|||
126623970|NCT03807700|455580990|FG001|Overall Study|Withdrawal by Subject|1|||
126754306|NCT03055806|456051274|FG000|Overall Study|Lost to Follow-up|0|||
126623971|NCT02005029|455580991|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
126623972|NCT02005029|455580992|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
126623973|NCT01370018|455580993|FG000|Overall Study|Did not meet criteria for analysis|1|||
126623974|NCT03772041|455580994|FG000|Overall Study|Adverse Event|8|||
126623975|NCT03772041|455580995|FG001|Overall Study|Adverse Event|3|||
126623976|NCT03772041|455580994|FG000|Overall Study|Withdrawal by Subject|0|||
126623977|NCT03772041|455580995|FG001|Overall Study|Withdrawal by Subject|2|||
126623978|NCT03772041|455580994|FG000|Overall Study|Protocol Violation|4|||
126623979|NCT03772041|455580995|FG001|Overall Study|Protocol Violation|2|||
126623980|NCT03772041|455580994|FG000|Overall Study|Physician Decision|2|||
126623981|NCT03772041|455580995|FG001|Overall Study|Physician Decision|3|||
126623982|NCT01525641|455580996|FG000|Overall Study|Case report form not collected|25|||
126623983|NCT01525641|455580996|FG000|Overall Study|No visit since the first visit|16|||
126623984|NCT01525641|455580996|FG000|Overall Study|Adverse Event|73|||
126623985|NCT01525641|455580996|FG000|Overall Study|Lack of Efficacy|24|||
126623986|NCT01525641|455580996|FG000|Overall Study|Improvement|5|||
126623987|NCT01525641|455580996|FG000|Overall Study|Lost to follow-up (relocation)|1|||
126623988|NCT01525641|455580996|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
126623989|NCT01525641|455580996|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
126623990|NCT01525641|455580996|FG000|Overall Study|Other than stated above|7|||
126623991|NCT00191984|455581012|FG000|Overall Study|Disease Progression|21|||
126623992|NCT00191984|455581012|FG000|Overall Study|Adverse Event|4|||
126623993|NCT00191984|455581012|FG000|Overall Study|Death|2|||
126623994|NCT00191984|455581012|FG000|Overall Study|Entry Criteria Exclusion|1|||
126623995|NCT00191984|455581012|FG000|Overall Study|Withdrawal by Subject|7|||
126623996|NCT00191984|455581012|FG000|Overall Study|Physician Decision|4|||
126623997|NCT02137239|455581013|FG000|Overall Study|Discontinued Study Treatment|0|||
126623998|NCT02137239|455581014|FG001|Overall Study|Discontinued Study Treatment|3|||
126623999|NCT02137239|455581013|FG000|Overall Study|Withdrew Consent|1|||
126624000|NCT02137239|455581014|FG001|Overall Study|Withdrew Consent|1|||
126624001|NCT02137239|455581013|FG000|Overall Study|Adverse Event|2|||
126624002|NCT02137239|455581014|FG001|Overall Study|Adverse Event|2|||
126624003|NCT04474691|455581016|FG000|Overall Study|Withdrawal by Subject|9|||
126624004|NCT01323309|455581017|FG000|Overall Study|Death|9|||
126624005|NCT01323309|455581018|FG001|Overall Study|Death|15|||
126624006|NCT01323309|455581019|FG002|Overall Study|Death|5|||
126624007|NCT01323309|455581017|FG000|Overall Study|Lost to Follow-up|11|||
126624008|NCT01323309|455581018|FG001|Overall Study|Lost to Follow-up|14|||
126624009|NCT01323309|455581019|FG002|Overall Study|Lost to Follow-up|24|||
126624010|NCT01323309|455581017|FG000|Overall Study|Withdrawal by Subject|14|||
126624011|NCT01323309|455581018|FG001|Overall Study|Withdrawal by Subject|14|||
126624012|NCT01323309|455581019|FG002|Overall Study|Withdrawal by Subject|18|||
126624013|NCT01323309|455581017|FG000|Overall Study|Disease progression|5|||
126624014|NCT01323309|455581018|FG001|Overall Study|Disease progression|11|||
126624015|NCT01323309|455581019|FG002|Overall Study|Disease progression|4|||
126624016|NCT03048058|455581021|FG000|Overall Study|Lost to Follow-up|4|||
126624017|NCT03048058|455581022|FG001|Overall Study|Lost to Follow-up|0|||
126624018|NCT03048058|455581021|FG000|Overall Study|Withdrawal by Subject|0|||
126624019|NCT03048058|455581022|FG001|Overall Study|Withdrawal by Subject|4|||
126624020|NCT02625922|455581023|FG000|Overall Study|Non-availability of IMP|1|||
126624021|NCT02625922|455581024|FG001|Overall Study|Non-availability of IMP|1|||
126624022|NCT02625922|455581023|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
126624023|NCT02625922|455581024|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
126624024|NCT02359552|455581025|FG000|Overall Study|Lost to Follow-up|3|||
126624025|NCT02359552|455581026|FG001|Overall Study|Lost to Follow-up|4|||
126624026|NCT02391116|455581027|FG000|Treatment|Withdrawal by Subject|1|||
126624027|NCT02391116|455581027|FG000|Treatment|Protocol Violation|1|||
126624028|NCT02391116|455581027|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
126624029|NCT02391116|455581027|FG000|Treatment|AE with Clinical PD|3|||
126624030|NCT02391116|455581027|FG000|Safety Follow-up|Adverse Event|1|||
126624031|NCT02391116|455581027|FG000|Safety Follow-up|Withdrawal by Subject|4|||
126624032|NCT02391116|455581027|FG000|Safety Follow-up|Switching to Other Therapy|4|||
126624033|NCT02391116|455581027|FG000|Safety Follow-up|No Follow Up|1|||
126624034|NCT02391116|455581027|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
126624035|NCT02391116|455581027|FG000|Active Follow-up|Withdrawal by Subject|1|||
126624036|NCT02391116|455581027|FG000|Active Follow-up|Switching to Other Therapy|2|||
126624037|NCT02391116|455581027|FG000|Survival Follow-up|Withdrawal by Subject|3|||
126624038|NCT02391116|455581027|FG000|Survival Follow-up|Switching to Other Therapy|1|||
126624039|NCT01261793|455581031|FG000|Overall Study|Lack of Efficacy|44|||
126624040|NCT01261793|455581032|FG001|Overall Study|Lack of Efficacy|37|||
126624041|NCT01261793|455581033|FG002|Overall Study|Lack of Efficacy|32|||
126624042|NCT01261793|455581031|FG000|Overall Study|Protocol Violation|3|||
126624043|NCT01261793|455581032|FG001|Overall Study|Protocol Violation|5|||
126624044|NCT01261793|455581033|FG002|Overall Study|Protocol Violation|6|||
126624045|NCT01261793|455581031|FG000|Overall Study|Lost to Follow-up|10|||
126624046|NCT01261793|455581032|FG001|Overall Study|Lost to Follow-up|3|||
126624047|NCT01261793|455581033|FG002|Overall Study|Lost to Follow-up|7|||
126624048|NCT01261793|455581031|FG000|Overall Study|Withdrawal by Subject|12|||
126624049|NCT01261793|455581032|FG001|Overall Study|Withdrawal by Subject|14|||
126624050|NCT01261793|455581033|FG002|Overall Study|Withdrawal by Subject|14|||
126624051|NCT01261793|455581031|FG000|Overall Study|Death|3|||
126624052|NCT01261793|455581032|FG001|Overall Study|Death|1|||
126624053|NCT01261793|455581033|FG002|Overall Study|Death|0|||
126624054|NCT01261793|455581031|FG000|Overall Study|Adverse Event|9|||
126624055|NCT01261793|455581032|FG001|Overall Study|Adverse Event|24|||
126624056|NCT01261793|455581033|FG002|Overall Study|Adverse Event|19|||
126624057|NCT01261793|455581031|FG000|Overall Study|Patient non-availability|1|||
126624058|NCT01261793|455581032|FG001|Overall Study|Patient non-availability|1|||
126624059|NCT01261793|455581033|FG002|Overall Study|Patient non-availability|1|||
126624060|NCT01261793|455581031|FG000|Overall Study|Suspected pregnancy|1|||
126624061|NCT01261793|455581032|FG001|Overall Study|Suspected pregnancy|1|||
126624062|NCT01261793|455581033|FG002|Overall Study|Suspected pregnancy|0|||
126624063|NCT01261793|455581031|FG000|Overall Study|Patient non-compliance|1|||
126624064|NCT01261793|455581032|FG001|Overall Study|Patient non-compliance|0|||
126624065|NCT01261793|455581033|FG002|Overall Study|Patient non-compliance|1|||
126624066|NCT01261793|455581031|FG000|Overall Study|Patient pregnant|1|||
126624067|NCT01261793|455581032|FG001|Overall Study|Patient pregnant|0|||
126624068|NCT01261793|455581033|FG002|Overall Study|Patient pregnant|0|||
126624069|NCT01261793|455581031|FG000|Overall Study|Outside the study area|0|||
126624070|NCT01261793|455581032|FG001|Overall Study|Outside the study area|2|||
126624071|NCT01261793|455581033|FG002|Overall Study|Outside the study area|1|||
126624072|NCT01261793|455581031|FG000|Overall Study|Lack of efficacy & patient not available|0|||
126624073|NCT01261793|455581032|FG001|Overall Study|Lack of efficacy & patient not available|1|||
126624074|NCT01261793|455581033|FG002|Overall Study|Lack of efficacy & patient not available|0|||
126624075|NCT01261793|455581031|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
126754307|NCT03055806|456051275|FG001|Overall Study|Lost to Follow-up|3|||
126754308|NCT03055806|456051276|FG002|Overall Study|Lost to Follow-up|6|||
126754309|NCT03055806|456051277|FG003|Overall Study|Lost to Follow-up|7|||
126754310|NCT03055806|456051274|FG000|Overall Study|Physician Decision|1|||
126754311|NCT03055806|456051275|FG001|Overall Study|Physician Decision|0|||
126754312|NCT03055806|456051276|FG002|Overall Study|Physician Decision|0|||
126754313|NCT03055806|456051277|FG003|Overall Study|Physician Decision|1|||
126754314|NCT03055806|456051274|FG000|Overall Study|Protocol Violation|1|||
126754315|NCT03055806|456051275|FG001|Overall Study|Protocol Violation|0|||
126754316|NCT03055806|456051276|FG002|Overall Study|Protocol Violation|0|||
126754317|NCT03055806|456051277|FG003|Overall Study|Protocol Violation|0|||
126754318|NCT03055806|456051274|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
126754319|NCT03055806|456051275|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
126754320|NCT03055806|456051276|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
126754321|NCT03055806|456051277|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
126754322|NCT03055806|456051274|FG000|Overall Study|Withdrawal of consent to continue study|2|||
126754323|NCT03055806|456051275|FG001|Overall Study|Withdrawal of consent to continue study|3|||
126754324|NCT03055806|456051276|FG002|Overall Study|Withdrawal of consent to continue study|4|||
126754325|NCT03055806|456051277|FG003|Overall Study|Withdrawal of consent to continue study|6|||
126754326|NCT03055806|456051274|FG000|Overall Study|Partner not willing to try intercourse|1|||
126754327|NCT03055806|456051275|FG001|Overall Study|Partner not willing to try intercourse|0|||
126754328|NCT03055806|456051276|FG002|Overall Study|Partner not willing to try intercourse|0|||
126754329|NCT03055806|456051277|FG003|Overall Study|Partner not willing to try intercourse|0|||
126754330|NCT00125138|456051278|FG000|Overall Study|Adverse Event|1|||
126754331|NCT00125138|456051279|FG001|Overall Study|Adverse Event|0|||
126754332|NCT00125138|456051280|FG002|Overall Study|Adverse Event|3|||
126754333|NCT00125138|456051281|FG003|Overall Study|Adverse Event|2|||
126754334|NCT00125138|456051278|FG000|Overall Study|Withdrawal by Subject|2|||
126754335|NCT00125138|456051279|FG001|Overall Study|Withdrawal by Subject|3|||
126754336|NCT00125138|456051280|FG002|Overall Study|Withdrawal by Subject|1|||
126754337|NCT00125138|456051281|FG003|Overall Study|Withdrawal by Subject|1|||
126754338|NCT00125138|456051278|FG000|Overall Study|Lack of Efficacy|0|||
126754339|NCT00125138|456051279|FG001|Overall Study|Lack of Efficacy|0|||
126754340|NCT00125138|456051280|FG002|Overall Study|Lack of Efficacy|0|||
126754341|NCT00125138|456051281|FG003|Overall Study|Lack of Efficacy|1|||
126754342|NCT00125138|456051278|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
126754343|NCT00125138|456051279|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
126754344|NCT00125138|456051280|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
126754345|NCT00125138|456051281|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
126754346|NCT00348686|456051286|FG000|Overall Study|Withdrawal by Subject|45|||
126754347|NCT00348686|456051286|FG000|Overall Study|Adverse Event|5|||
126754348|NCT00348686|456051286|FG000|Overall Study|Protocol Violation|6|||
126624076|NCT01261793|455581032|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
126624077|NCT01261793|455581033|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
126624078|NCT01261793|455581031|FG000|Overall Study|Randomization error|0|||
126624079|NCT01261793|455581032|FG001|Overall Study|Randomization error|1|||
126624080|NCT01261793|455581033|FG002|Overall Study|Randomization error|0|||
126624081|NCT01261793|455581031|FG000|Overall Study|Patient unable to start IV line|0|||
126624082|NCT01261793|455581032|FG001|Overall Study|Patient unable to start IV line|0|||
126624083|NCT01261793|455581033|FG002|Overall Study|Patient unable to start IV line|1|||
126624084|NCT00832650|455581037|FG000|Overall Study|Randomized but not treated|0|||
126624085|NCT00832650|455581038|FG001|Overall Study|Randomized but not treated|0|||
126624086|NCT00832650|455581039|FG002|Overall Study|Randomized but not treated|1|||
126624087|NCT02133131|455581040|FG000|Overall Study|Adverse Event|0|||
126624088|NCT02133131|455581041|FG001|Overall Study|Adverse Event|0|||
126624089|NCT02133131|455581042|FG002|Overall Study|Adverse Event|0|||
126624090|NCT02133131|455581043|FG003|Overall Study|Adverse Event|1|||
126624091|NCT02133131|455581044|FG004|Overall Study|Adverse Event|0|||
126624092|NCT02133131|455581045|FG005|Overall Study|Adverse Event|0|||
126624093|NCT02133131|455581046|FG006|Overall Study|Adverse Event|0|||
126624094|NCT02133131|455581040|FG000|Overall Study|Lost to Follow-up|1|||
126624095|NCT02133131|455581041|FG001|Overall Study|Lost to Follow-up|0|||
126624096|NCT02133131|455581042|FG002|Overall Study|Lost to Follow-up|0|||
126624097|NCT02133131|455581043|FG003|Overall Study|Lost to Follow-up|1|||
126624098|NCT02133131|455581044|FG004|Overall Study|Lost to Follow-up|0|||
126624099|NCT02133131|455581045|FG005|Overall Study|Lost to Follow-up|0|||
126624100|NCT02133131|455581046|FG006|Overall Study|Lost to Follow-up|0|||
126624101|NCT02133131|455581040|FG000|Overall Study|Status not recorded|4|||
126624102|NCT02133131|455581041|FG001|Overall Study|Status not recorded|5|||
126624103|NCT02133131|455581042|FG002|Overall Study|Status not recorded|1|||
126624104|NCT02133131|455581043|FG003|Overall Study|Status not recorded|4|||
126624105|NCT02133131|455581044|FG004|Overall Study|Status not recorded|0|||
126624106|NCT02133131|455581045|FG005|Overall Study|Status not recorded|0|||
126624107|NCT02133131|455581046|FG006|Overall Study|Status not recorded|0|||
126624108|NCT02133131|455581040|FG000|Overall Study|Ongoing in study|0|||
126624109|NCT02133131|455581041|FG001|Overall Study|Ongoing in study|0|||
126624110|NCT02133131|455581042|FG002|Overall Study|Ongoing in study|0|||
126624111|NCT02133131|455581043|FG003|Overall Study|Ongoing in study|0|||
126624112|NCT02133131|455581044|FG004|Overall Study|Ongoing in study|15|||
126624113|NCT02133131|455581045|FG005|Overall Study|Ongoing in study|14|||
126624114|NCT02133131|455581046|FG006|Overall Study|Ongoing in study|11|||
126624115|NCT02133131|455581040|FG000|Overall Study|Protocol Violation|0|||
126624116|NCT02133131|455581041|FG001|Overall Study|Protocol Violation|0|||
126624117|NCT02133131|455581042|FG002|Overall Study|Protocol Violation|0|||
126624118|NCT02133131|455581043|FG003|Overall Study|Protocol Violation|0|||
126624119|NCT02133131|455581044|FG004|Overall Study|Protocol Violation|0|||
126624120|NCT02133131|455581045|FG005|Overall Study|Protocol Violation|0|||
126624121|NCT02133131|455581046|FG006|Overall Study|Protocol Violation|1|||
126624122|NCT01544153|455581047|FG000|Overall Study|Under 18|0|||
126624123|NCT01544153|455581048|FG001|Overall Study|Under 18|1|||
126624124|NCT01544153|455581049|FG002|Overall Study|Under 18|0|||
126624125|NCT01544153|455581050|FG003|Overall Study|Under 18|0|||
126624126|NCT01544153|455581047|FG000|Overall Study|Non-smoker|0|||
126624127|NCT01544153|455581048|FG001|Overall Study|Non-smoker|0|||
126624128|NCT01544153|455581049|FG002|Overall Study|Non-smoker|1|||
126624129|NCT01544153|455581050|FG003|Overall Study|Non-smoker|0|||
126624130|NCT00884793|455581055|FG000|Overall Study|Withdrawal by Subject|1|||
126624131|NCT01032200|455581056|FG000|Overall Study|Death|1|||
126624132|NCT01032200|455581057|FG001|Overall Study|Death|1|||
126624133|NCT01032200|455581056|FG000|Overall Study|Withdrawal by Subject|1|||
126624134|NCT01032200|455581057|FG001|Overall Study|Withdrawal by Subject|3|||
126624135|NCT01032200|455581056|FG000|Overall Study|Toxicity|0|||
126624136|NCT01032200|455581057|FG001|Overall Study|Toxicity|2|||
126624137|NCT01032200|455581056|FG000|Overall Study|Progression|1|||
126624138|NCT01032200|455581057|FG001|Overall Study|Progression|0|||
126624139|NCT01032200|455581056|FG000|Overall Study|Multiple|1|||
126783048|NCT00876733|456160158|FG000|Overall Study|Lack of Efficacy|17|||
126783049|NCT00876733|456160159|FG001|Overall Study|Lack of Efficacy|9|||
126783050|NCT00876733|456160160|FG002|Overall Study|Lack of Efficacy|10|||
126624140|NCT01032200|455581057|FG001|Overall Study|Multiple|1|||
126624141|NCT00714688|455581061|FG000|Overall Study|Lack of Efficacy|14|||
126624142|NCT00714688|455581062|FG001|Overall Study|Lack of Efficacy|1|||
126624143|NCT00714688|455581063|FG002|Overall Study|Lack of Efficacy|4|||
126624144|NCT00714688|455581061|FG000|Overall Study|Withdrawal by Subject|4|||
126624145|NCT00714688|455581062|FG001|Overall Study|Withdrawal by Subject|3|||
126624146|NCT00714688|455581063|FG002|Overall Study|Withdrawal by Subject|3|||
126624147|NCT00714688|455581061|FG000|Overall Study|Lost to Follow-up|5|||
126624148|NCT00714688|455581062|FG001|Overall Study|Lost to Follow-up|2|||
126624149|NCT00714688|455581063|FG002|Overall Study|Lost to Follow-up|0|||
126624150|NCT00714688|455581061|FG000|Overall Study|Adverse Event|2|||
126624151|NCT00714688|455581062|FG001|Overall Study|Adverse Event|15|||
126624152|NCT00714688|455581063|FG002|Overall Study|Adverse Event|19|||
126624153|NCT00714688|455581061|FG000|Overall Study|Subject Non-compliant|3|||
126624154|NCT00714688|455581062|FG001|Overall Study|Subject Non-compliant|5|||
126624155|NCT00714688|455581063|FG002|Overall Study|Subject Non-compliant|5|||
126624156|NCT00714688|455581061|FG000|Overall Study|Ineligible to Continue the Study|0|||
126624157|NCT00714688|455581062|FG001|Overall Study|Ineligible to Continue the Study|1|||
126624158|NCT00714688|455581063|FG002|Overall Study|Ineligible to Continue the Study|1|||
126624159|NCT00714688|455581061|FG000|Overall Study|Sponsor's Decision|0|||
126624160|NCT00714688|455581062|FG001|Overall Study|Sponsor's Decision|2|||
126783051|NCT00876733|456160161|FG003|Overall Study|Lack of Efficacy|1|||
126783052|NCT00876733|456160158|FG000|Overall Study|Lost to Follow-up|26|||
126783053|NCT00876733|456160159|FG001|Overall Study|Lost to Follow-up|10|||
126783054|NCT00876733|456160160|FG002|Overall Study|Lost to Follow-up|3|||
126783055|NCT00876733|456160161|FG003|Overall Study|Lost to Follow-up|2|||
126783056|NCT00876733|456160158|FG000|Overall Study|Data not available|14|||
126783057|NCT00876733|456160159|FG001|Overall Study|Data not available|3|||
126783058|NCT00876733|456160160|FG002|Overall Study|Data not available|7|||
126783059|NCT00876733|456160161|FG003|Overall Study|Data not available|1|||
126783060|NCT03521999|456160162|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
126783061|NCT03521999|456160163|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
126783062|NCT03521999|456160162|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
126783063|NCT03521999|456160163|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
126783064|NCT03521999|456160162|FG000|Completed 3 Month Follow up|Death|0|||
126783065|NCT03521999|456160163|FG001|Completed 3 Month Follow up|Death|1|||
126783066|NCT03521999|456160162|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
126783067|NCT03521999|456160163|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
126783068|NCT00543439|456160164|FG000|Period 1|Adverse Event|0|||
126783069|NCT00543439|456160165|FG001|Period 1|Adverse Event|2|||
126783070|NCT00543439|456160166|FG002|Period 1|Adverse Event|1|||
126783071|NCT00543439|456160164|FG000|Period 1|Withdrawal by Subject|1|||
126783072|NCT00543439|456160165|FG001|Period 1|Withdrawal by Subject|1|||
126624161|NCT00714688|455581063|FG002|Overall Study|Sponsor's Decision|0|||
126624162|NCT00714688|455581061|FG000|Overall Study|Other|1|||
126624163|NCT00714688|455581062|FG001|Overall Study|Other|6|||
126624164|NCT00714688|455581063|FG002|Overall Study|Other|5|||
126624165|NCT04341584|455581066|FG000|Overall Study|Withdrew consent|0|||
126624166|NCT04341584|455581067|FG001|Overall Study|Withdrew consent|2|||
126624167|NCT04341584|455581068|FG002|Overall Study|Withdrew consent|2|||
126624168|NCT04341584|455581069|FG003|Overall Study|Withdrew consent|1|||
126624169|NCT00497198|455581071|FG000|Overall Study|Adverse Event|4|||
126624170|NCT00497198|455581072|FG001|Overall Study|Adverse Event|2|||
126624171|NCT00497198|455581071|FG000|Overall Study|Physician Decision|1|||
126624172|NCT00497198|455581072|FG001|Overall Study|Physician Decision|2|||
126624173|NCT00497198|455581071|FG000|Overall Study|Withdrawal by Subject|0|||
126624174|NCT00497198|455581072|FG001|Overall Study|Withdrawal by Subject|1|||
126624175|NCT02799745|455581073|FG000|Overall Study|Participant moved out of state|1|||
126624176|NCT02799745|455581074|FG001|Overall Study|Participant moved out of state|0|||
126624177|NCT02799745|455581073|FG000|Overall Study|Discontinued due to planned surgery|1|||
126624178|NCT02799745|455581074|FG001|Overall Study|Discontinued due to planned surgery|0|||
126624179|NCT02799745|455581073|FG000|Overall Study|Withdrawal by Subject|16|||
126624180|NCT02799745|455581074|FG001|Overall Study|Withdrawal by Subject|25|||
126624181|NCT02799745|455581073|FG000|Overall Study|Protocol Deviation|4|||
126624182|NCT02799745|455581074|FG001|Overall Study|Protocol Deviation|5|||
126624183|NCT02799745|455581073|FG000|Overall Study|Progressive Disease|28|||
126624184|NCT02799745|455581074|FG001|Overall Study|Progressive Disease|38|||
126624185|NCT02799745|455581073|FG000|Overall Study|Lost to Follow-up|3|||
126624186|NCT02799745|455581074|FG001|Overall Study|Lost to Follow-up|2|||
126624187|NCT02799745|455581073|FG000|Overall Study|Death|3|||
126624188|NCT02799745|455581074|FG001|Overall Study|Death|0|||
126624189|NCT02799745|455581073|FG000|Overall Study|Adverse Event|0|||
126624190|NCT02799745|455581074|FG001|Overall Study|Adverse Event|1|||
126624191|NCT04853238|455581075|FG000|Overall Study|Death|4|||
126754349|NCT00348686|456051286|FG000|Overall Study|Lost to Follow-up|2|||
126754350|NCT00348686|456051286|FG000|Overall Study|Multiple Reasons|8|||
126754351|NCT01258738|456051287|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
126754352|NCT01258738|456051288|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
126754353|NCT01258738|456051287|FG000|Double-blind Period|Withdrawal by Subject|2|||
126754354|NCT01258738|456051288|FG001|Double-blind Period|Withdrawal by Subject|2|||
126754355|NCT01258738|456051287|FG000|Double-blind Period|Protocol Violation|1|||
126754356|NCT01258738|456051288|FG001|Double-blind Period|Protocol Violation|1|||
126754357|NCT01258738|456051287|FG000|Double-blind Period|Adverse Event|3|||
126754358|NCT01258738|456051288|FG001|Double-blind Period|Adverse Event|1|||
126754359|NCT01258738|456051287|FG000|Open-label Period|Did not meet inclusion criteria|0|||
126754360|NCT01258738|456051288|FG001|Open-label Period|Did not meet inclusion criteria|1|||
126754361|NCT01258738|456051287|FG000|Open-label Period|Insufficient clinical response|5|||
126783073|NCT00543439|456160166|FG002|Period 1|Withdrawal by Subject|0|||
126783074|NCT00543439|456160164|FG000|Period 1|Physician Decision|0|||
126783075|NCT00543439|456160165|FG001|Period 1|Physician Decision|0|||
126624192|NCT04853238|455581076|FG001|Overall Study|Death|0|||
126624193|NCT04853238|455581077|FG002|Overall Study|Death|2|||
126624194|NCT04853238|455581075|FG000|Overall Study|Lost to Follow-up|16|||
126624195|NCT04853238|455581076|FG001|Overall Study|Lost to Follow-up|2|||
126624196|NCT04853238|455581077|FG002|Overall Study|Lost to Follow-up|37|||
126624197|NCT04853238|455581075|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
126624198|NCT04853238|455581076|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
126624199|NCT04853238|455581077|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
126624200|NCT04853238|455581075|FG000|Overall Study|Withdrawal by Subject|6|||
126624201|NCT04853238|455581076|FG001|Overall Study|Withdrawal by Subject|0|||
126624202|NCT04853238|455581077|FG002|Overall Study|Withdrawal by Subject|21|||
126624203|NCT04853238|455581075|FG000|Overall Study|Physician Decision|0|||
126624204|NCT04853238|455581076|FG001|Overall Study|Physician Decision|0|||
126624205|NCT04853238|455581077|FG002|Overall Study|Physician Decision|2|||
126624206|NCT04853238|455581075|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
126624207|NCT04853238|455581076|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
126624208|NCT04853238|455581077|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
126624209|NCT01002547|455582768|FG000|Overall Study|Withdrawal by Subject|4|||
126624210|NCT01002547|455582769|FG001|Overall Study|Withdrawal by Subject|0|||
126624211|NCT01002547|455582770|FG002|Overall Study|Withdrawal by Subject|5|||
126624212|NCT01002547|455582768|FG000|Overall Study|Lost to Follow-up|2|||
126624213|NCT01002547|455582769|FG001|Overall Study|Lost to Follow-up|1|||
126624214|NCT01002547|455582770|FG002|Overall Study|Lost to Follow-up|1|||
126624215|NCT01002547|455582768|FG000|Overall Study|Physician Decision|1|||
126624216|NCT01002547|455582769|FG001|Overall Study|Physician Decision|0|||
126624217|NCT01002547|455582770|FG002|Overall Study|Physician Decision|0|||
126624218|NCT01002547|455582768|FG000|Overall Study|Death|0|||
126624219|NCT01002547|455582769|FG001|Overall Study|Death|2|||
126624220|NCT01002547|455582770|FG002|Overall Study|Death|2|||
126624221|NCT01002547|455582768|FG000|Overall Study|Adverse Event|1|||
126624222|NCT01002547|455582769|FG001|Overall Study|Adverse Event|0|||
126624223|NCT01002547|455582770|FG002|Overall Study|Adverse Event|0|||
126624224|NCT00434577|455582775|FG000|Months 0-3|Serious Adverse Event|0|||
126624225|NCT00434577|455582776|FG001|Months 0-3|Serious Adverse Event|0|||
126624226|NCT00434577|455582777|FG002|Months 0-3|Serious Adverse Event|1|||
126624227|NCT00434577|455582778|FG003|Months 0-3|Serious Adverse Event|0|||
126624228|NCT00434577|455582779|FG004|Months 0-3|Serious Adverse Event|0|||
126624229|NCT00434577|455582775|FG000|Months 0-3|Adverse Event|0|||
126624230|NCT00434577|455582776|FG001|Months 0-3|Adverse Event|1|||
126624231|NCT00434577|455582777|FG002|Months 0-3|Adverse Event|1|||
126624232|NCT00434577|455582778|FG003|Months 0-3|Adverse Event|0|||
126624233|NCT00434577|455582779|FG004|Months 0-3|Adverse Event|0|||
126624234|NCT00434577|455582775|FG000|Months 0-3|Lost to Follow-up|0|||
126624235|NCT00434577|455582776|FG001|Months 0-3|Lost to Follow-up|0|||
126624236|NCT00434577|455582777|FG002|Months 0-3|Lost to Follow-up|0|||
126624237|NCT00434577|455582778|FG003|Months 0-3|Lost to Follow-up|0|||
126624238|NCT00434577|455582779|FG004|Months 0-3|Lost to Follow-up|2|||
126624239|NCT00434577|455582775|FG000|Months 0-3|Protocol Violation|1|||
126624240|NCT00434577|455582776|FG001|Months 0-3|Protocol Violation|0|||
126624241|NCT00434577|455582777|FG002|Months 0-3|Protocol Violation|1|||
126624242|NCT00434577|455582778|FG003|Months 0-3|Protocol Violation|0|||
126624243|NCT00434577|455582779|FG004|Months 0-3|Protocol Violation|0|||
126624244|NCT00434577|455582775|FG000|Months 0-3|Withdrawal by Subject|2|||
126624245|NCT00434577|455582776|FG001|Months 0-3|Withdrawal by Subject|1|||
126624246|NCT00434577|455582777|FG002|Months 0-3|Withdrawal by Subject|1|||
126624247|NCT00434577|455582778|FG003|Months 0-3|Withdrawal by Subject|1|||
126624248|NCT00434577|455582779|FG004|Months 0-3|Withdrawal by Subject|1|||
126624249|NCT02329223|455582780|FG000|Overall Study|Withdrawal by Subject|1|||
126624250|NCT02329223|455582781|FG001|Overall Study|Withdrawal by Subject|2|||
126624251|NCT02329223|455582782|FG002|Overall Study|Withdrawal by Subject|5|||
126624252|NCT02329223|455582780|FG000|Overall Study|Physician Decision|0|||
126624253|NCT02329223|455582781|FG001|Overall Study|Physician Decision|0|||
126624254|NCT02329223|455582782|FG002|Overall Study|Physician Decision|1|||
126624255|NCT02329223|455582780|FG000|Overall Study|Adverse Event|0|||
126624256|NCT02329223|455582781|FG001|Overall Study|Adverse Event|1|||
126624257|NCT02329223|455582782|FG002|Overall Study|Adverse Event|0|||
126624258|NCT01231464|455582790|FG000|Overall Study|Adverse Event|0|||
126624259|NCT01231464|455582791|FG001|Overall Study|Adverse Event|1|||
126624260|NCT01231464|455582790|FG000|Overall Study|Protocol Violation|1|||
126624261|NCT01231464|455582791|FG001|Overall Study|Protocol Violation|2|||
126624262|NCT01231464|455582790|FG000|Overall Study|Lost to Follow-up|1|||
126624263|NCT01231464|455582791|FG001|Overall Study|Lost to Follow-up|2|||
126624264|NCT01231464|455582790|FG000|Overall Study|Withdrawal by Subject|3|||
126624265|NCT01231464|455582791|FG001|Overall Study|Withdrawal by Subject|2|||
126624266|NCT01589523|455582795|FG000|Overall Study|Withdrawal by Subject|1|||
126624267|NCT00961896|455582796|FG000|Overall Study|Abnormal laboratory value|0|||
126624268|NCT00961896|455582797|FG001|Overall Study|Abnormal laboratory value|0|||
126624269|NCT00961896|455582798|FG002|Overall Study|Abnormal laboratory value|1|||
126624270|NCT00506922|455582799|FG000|Overall Study|Physician Decision|0|||
126624271|NCT00506922|455582800|FG001|Overall Study|Physician Decision|0|||
126624272|NCT00506922|455582801|FG002|Overall Study|Physician Decision|0|||
126624273|NCT00506922|455582802|FG003|Overall Study|Physician Decision|2|||
126624274|NCT00506922|455582803|FG004|Overall Study|Physician Decision|0|||
126624275|NCT00506922|455582799|FG000|Overall Study|Withdrawal by Subject|0|||
126624276|NCT00506922|455582800|FG001|Overall Study|Withdrawal by Subject|0|||
126624277|NCT00506922|455582801|FG002|Overall Study|Withdrawal by Subject|0|||
126624278|NCT00506922|455582802|FG003|Overall Study|Withdrawal by Subject|0|||
126624279|NCT00506922|455582803|FG004|Overall Study|Withdrawal by Subject|1|||
126624280|NCT02507687|455582810|FG000|Overall Study|Adverse Event|3|||
126624281|NCT02507687|455582811|FG001|Overall Study|Adverse Event|2|||
126624282|NCT02507687|455582812|FG002|Overall Study|Adverse Event|2|||
126624283|NCT02507687|455582813|FG003|Overall Study|Adverse Event|2|||
126624284|NCT02507687|455582810|FG000|Overall Study|Withdrawal by Subject|1|||
126624285|NCT02507687|455582811|FG001|Overall Study|Withdrawal by Subject|4|||
126624286|NCT02507687|455582812|FG002|Overall Study|Withdrawal by Subject|6|||
126624287|NCT02507687|455582813|FG003|Overall Study|Withdrawal by Subject|6|||
126624288|NCT02507687|455582810|FG000|Overall Study|Protocol Violation|1|||
126624289|NCT02507687|455582811|FG001|Overall Study|Protocol Violation|0|||
126624290|NCT02507687|455582812|FG002|Overall Study|Protocol Violation|2|||
126624291|NCT02507687|455582813|FG003|Overall Study|Protocol Violation|0|||
126624292|NCT02507687|455582810|FG000|Overall Study|Lost to Follow-up|0|||
126624293|NCT02507687|455582811|FG001|Overall Study|Lost to Follow-up|0|||
126624294|NCT02507687|455582812|FG002|Overall Study|Lost to Follow-up|2|||
126624295|NCT02507687|455582813|FG003|Overall Study|Lost to Follow-up|1|||
126624296|NCT02507687|455582810|FG000|Overall Study|Screen Failure|0|||
126624297|NCT02507687|455582811|FG001|Overall Study|Screen Failure|0|||
126624298|NCT02507687|455582812|FG002|Overall Study|Screen Failure|1|||
126624299|NCT02507687|455582813|FG003|Overall Study|Screen Failure|0|||
126624300|NCT02507687|455582810|FG000|Overall Study|Other, Not Specified|0|||
126624301|NCT02507687|455582811|FG001|Overall Study|Other, Not Specified|0|||
126624302|NCT02507687|455582812|FG002|Overall Study|Other, Not Specified|2|||
126624303|NCT02507687|455582813|FG003|Overall Study|Other, Not Specified|4|||
126624304|NCT02675998|455582814|FG000|8-Week Treatment Period|Adverse Event|6|||
126624305|NCT02675998|455582815|FG001|8-Week Treatment Period|Adverse Event|5|||
126624306|NCT02675998|455582816|FG002|8-Week Treatment Period|Adverse Event|6|||
126624307|NCT02675998|455582817|FG003|8-Week Treatment Period|Adverse Event|0|||
126624308|NCT02675998|455582814|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
126624309|NCT02675998|455582815|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
126624310|NCT02675998|455582816|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
126624311|NCT02675998|455582817|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
126624312|NCT02675998|455582814|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
126624313|NCT02675998|455582815|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
126624314|NCT02675998|455582816|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
126624315|NCT02675998|455582817|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
126624316|NCT02675998|455582814|FG000|8-Week Treatment Period|Physician Decision|1|||
126624317|NCT02675998|455582815|FG001|8-Week Treatment Period|Physician Decision|0|||
126624318|NCT02675998|455582816|FG002|8-Week Treatment Period|Physician Decision|2|||
126624319|NCT02675998|455582817|FG003|8-Week Treatment Period|Physician Decision|0|||
126624320|NCT02675998|455582814|FG000|8-Week Treatment Period|GI side Effects|1|||
126624321|NCT02675998|455582815|FG001|8-Week Treatment Period|GI side Effects|4|||
126624322|NCT02675998|455582816|FG002|8-Week Treatment Period|GI side Effects|2|||
126624323|NCT02675998|455582817|FG003|8-Week Treatment Period|GI side Effects|0|||
126624324|NCT02675998|455582814|FG000|8-Week Treatment Period|Protocol Violation|1|||
126624325|NCT02675998|455582815|FG001|8-Week Treatment Period|Protocol Violation|1|||
126624326|NCT02675998|455582816|FG002|8-Week Treatment Period|Protocol Violation|1|||
126624327|NCT02675998|455582817|FG003|8-Week Treatment Period|Protocol Violation|0|||
126624328|NCT02675998|455582814|FG000|8-Week Treatment Period|Other|3|||
126624329|NCT02675998|455582815|FG001|8-Week Treatment Period|Other|1|||
126624330|NCT02675998|455582816|FG002|8-Week Treatment Period|Other|2|||
126624331|NCT02675998|455582817|FG003|8-Week Treatment Period|Other|0|||
126624332|NCT02675998|455582814|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
126624333|NCT02675998|455582815|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
126624334|NCT02675998|455582816|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
126754362|NCT01258738|456051288|FG001|Open-label Period|Insufficient clinical response|3|||
126624335|NCT02675998|455582817|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
126624336|NCT02675998|455582814|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
126624337|NCT02675998|455582815|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
126624338|NCT02675998|455582816|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
126624339|NCT02675998|455582817|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
126624340|NCT02675998|455582814|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
126624341|NCT02675998|455582815|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
126624342|NCT02675998|455582816|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
126754363|NCT01258738|456051287|FG000|Open-label Period|Lost to Follow-up|0|||
126754364|NCT01258738|456051288|FG001|Open-label Period|Lost to Follow-up|2|||
126624343|NCT02675998|455582817|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
126624344|NCT02675998|455582814|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
126624345|NCT02675998|455582815|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
126624346|NCT02675998|455582816|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
126624347|NCT02675998|455582817|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
126754365|NCT01258738|456051287|FG000|Open-label Period|Withdrawal by Subject|5|||
126624348|NCT02675998|455582814|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
126624349|NCT02675998|455582815|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
126624350|NCT02675998|455582816|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
126624351|NCT02675998|455582817|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
126624352|NCT04357964|455582818|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
126754366|NCT01258738|456051288|FG001|Open-label Period|Withdrawal by Subject|6|||
126754367|NCT01258738|456051287|FG000|Open-label Period|Protocol Violation|2|||
126754368|NCT01258738|456051288|FG001|Open-label Period|Protocol Violation|2|||
126624353|NCT04357964|455582819|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
126624354|NCT04357964|455582818|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
126624355|NCT04357964|455582819|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
126624356|NCT04357964|455582818|FG000|Overall Study|Adipose sample was insufficient quality|0|||
126624357|NCT04357964|455582819|FG001|Overall Study|Adipose sample was insufficient quality|1|||
126624358|NCT00848393|455582820|FG000|Overall Study|Protocol Violation|0|||
126624359|NCT00848393|455582821|FG001|Overall Study|Protocol Violation|0|||
126624360|NCT00848393|455582822|FG002|Overall Study|Protocol Violation|1|||
126624361|NCT00848393|455582820|FG000|Overall Study|surgical complications unrelated to stud|0|||
126624362|NCT00848393|455582821|FG001|Overall Study|surgical complications unrelated to stud|0|||
126624363|NCT00848393|455582822|FG002|Overall Study|surgical complications unrelated to stud|2|||
126624364|NCT00043186|455582827|FG000|Overall Study|Physician Decision|0|||
126624365|NCT00043186|455582828|FG001|Overall Study|Physician Decision|0|||
126624366|NCT00043186|455582829|FG002|Overall Study|Physician Decision|3|||
126624367|NCT00043186|455582830|FG003|Overall Study|Physician Decision|0|||
126624368|NCT00043186|455582831|FG004|Overall Study|Physician Decision|1|||
126624369|NCT00043186|455582832|FG005|Overall Study|Physician Decision|0|||
126624370|NCT00043186|455582833|FG006|Overall Study|Physician Decision|0|||
126624371|NCT00043186|455582834|FG007|Overall Study|Physician Decision|1|||
126624372|NCT00043186|455582835|FG008|Overall Study|Physician Decision|1|||
126624373|NCT00043186|455582827|FG000|Overall Study|Adverse Event|2|||
126624374|NCT00043186|455582828|FG001|Overall Study|Adverse Event|2|||
126624375|NCT00043186|455582829|FG002|Overall Study|Adverse Event|2|||
126624376|NCT00043186|455582830|FG003|Overall Study|Adverse Event|3|||
126624377|NCT00043186|455582831|FG004|Overall Study|Adverse Event|2|||
126624378|NCT00043186|455582832|FG005|Overall Study|Adverse Event|1|||
126624379|NCT00043186|455582833|FG006|Overall Study|Adverse Event|2|||
126624380|NCT00043186|455582834|FG007|Overall Study|Adverse Event|1|||
126624381|NCT00043186|455582835|FG008|Overall Study|Adverse Event|3|||
126624382|NCT00043186|455582827|FG000|Overall Study|Withdrawal by Subject|11|||
126624383|NCT00043186|455582828|FG001|Overall Study|Withdrawal by Subject|8|||
126624384|NCT00043186|455582829|FG002|Overall Study|Withdrawal by Subject|11|||
126624385|NCT00043186|455582830|FG003|Overall Study|Withdrawal by Subject|13|||
126624386|NCT00043186|455582831|FG004|Overall Study|Withdrawal by Subject|14|||
126624387|NCT00043186|455582832|FG005|Overall Study|Withdrawal by Subject|6|||
126624388|NCT00043186|455582833|FG006|Overall Study|Withdrawal by Subject|12|||
126624389|NCT00043186|455582834|FG007|Overall Study|Withdrawal by Subject|9|||
126624390|NCT00043186|455582835|FG008|Overall Study|Withdrawal by Subject|10|||
126624391|NCT00043186|455582827|FG000|Overall Study|Death|0|||
126624392|NCT00043186|455582828|FG001|Overall Study|Death|0|||
126624393|NCT00043186|455582829|FG002|Overall Study|Death|1|||
126624394|NCT00043186|455582830|FG003|Overall Study|Death|0|||
126624395|NCT00043186|455582831|FG004|Overall Study|Death|0|||
126624396|NCT00043186|455582832|FG005|Overall Study|Death|0|||
126624397|NCT00043186|455582833|FG006|Overall Study|Death|2|||
126624398|NCT00043186|455582834|FG007|Overall Study|Death|0|||
126624399|NCT00043186|455582835|FG008|Overall Study|Death|0|||
126624400|NCT00043186|455582827|FG000|Overall Study|Disease progression|1|||
126624401|NCT00043186|455582828|FG001|Overall Study|Disease progression|0|||
126624402|NCT00043186|455582829|FG002|Overall Study|Disease progression|0|||
126624403|NCT00043186|455582830|FG003|Overall Study|Disease progression|3|||
126624404|NCT00043186|455582831|FG004|Overall Study|Disease progression|0|||
126624405|NCT00043186|455582832|FG005|Overall Study|Disease progression|0|||
126624406|NCT00043186|455582833|FG006|Overall Study|Disease progression|0|||
126624407|NCT00043186|455582834|FG007|Overall Study|Disease progression|4|||
126624408|NCT00043186|455582835|FG008|Overall Study|Disease progression|0|||
126624409|NCT00043186|455582827|FG000|Overall Study|Ineligibility determined|0|||
126624410|NCT00043186|455582828|FG001|Overall Study|Ineligibility determined|0|||
126624411|NCT00043186|455582829|FG002|Overall Study|Ineligibility determined|0|||
126624412|NCT00043186|455582830|FG003|Overall Study|Ineligibility determined|0|||
126624413|NCT00043186|455582831|FG004|Overall Study|Ineligibility determined|0|||
126624414|NCT00043186|455582832|FG005|Overall Study|Ineligibility determined|0|||
126624415|NCT00043186|455582833|FG006|Overall Study|Ineligibility determined|0|||
126624416|NCT00043186|455582834|FG007|Overall Study|Ineligibility determined|0|||
126624417|NCT00043186|455582835|FG008|Overall Study|Ineligibility determined|1|||
126624418|NCT00043186|455582827|FG000|Overall Study|Lost to Follow-up|3|||
126624419|NCT00043186|455582828|FG001|Overall Study|Lost to Follow-up|5|||
126624420|NCT00043186|455582829|FG002|Overall Study|Lost to Follow-up|1|||
126624421|NCT00043186|455582830|FG003|Overall Study|Lost to Follow-up|1|||
126624422|NCT00043186|455582831|FG004|Overall Study|Lost to Follow-up|1|||
126624423|NCT00043186|455582832|FG005|Overall Study|Lost to Follow-up|1|||
126624424|NCT00043186|455582833|FG006|Overall Study|Lost to Follow-up|1|||
126624425|NCT00043186|455582834|FG007|Overall Study|Lost to Follow-up|1|||
126624426|NCT00043186|455582835|FG008|Overall Study|Lost to Follow-up|2|||
126624427|NCT00043186|455582827|FG000|Overall Study|Noncompliance|0|||
126624428|NCT00043186|455582828|FG001|Overall Study|Noncompliance|0|||
126624429|NCT00043186|455582829|FG002|Overall Study|Noncompliance|1|||
126624430|NCT00043186|455582830|FG003|Overall Study|Noncompliance|1|||
126624431|NCT00043186|455582831|FG004|Overall Study|Noncompliance|0|||
126624432|NCT00043186|455582832|FG005|Overall Study|Noncompliance|0|||
126624433|NCT00043186|455582833|FG006|Overall Study|Noncompliance|0|||
126624434|NCT00043186|455582834|FG007|Overall Study|Noncompliance|0|||
126624435|NCT00043186|455582835|FG008|Overall Study|Noncompliance|0|||
126624436|NCT00043186|455582827|FG000|Overall Study|Other|0|||
126624437|NCT00043186|455582828|FG001|Overall Study|Other|0|||
126624438|NCT00043186|455582829|FG002|Overall Study|Other|1|||
126624439|NCT00043186|455582830|FG003|Overall Study|Other|1|||
126624440|NCT00043186|455582831|FG004|Overall Study|Other|0|||
126624441|NCT00043186|455582832|FG005|Overall Study|Other|0|||
126624442|NCT00043186|455582833|FG006|Overall Study|Other|0|||
126624443|NCT00043186|455582834|FG007|Overall Study|Other|0|||
126624444|NCT00043186|455582835|FG008|Overall Study|Other|0|||
126624445|NCT03681353|455582846|FG000|Overall Study|Lost to Follow-up|2|||
126624446|NCT03681353|455582846|FG000|Overall Study|Withdrawal by Subject|3|||
126624447|NCT03681353|455582846|FG000|Overall Study|withdrawn by PI|2|||
126624448|NCT00726388|455582852|FG000|Overall Study|Withdrawal by Subject|5|||
126624449|NCT00726388|455582852|FG000|Overall Study|Adverse Event|3|||
126624450|NCT00726388|455582852|FG000|Overall Study|Lost to Follow-up|10|||
126624451|NCT00726388|455582852|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
126624452|NCT00726388|455582852|FG000|Overall Study|Other|5|||
126624453|NCT00726388|455582852|FG000|Overall Study|Enrolled, Not Treated|79|||
126624454|NCT00111839|455582853|FG000|Overall Study|Disease Progression|30|||
126624455|NCT00111839|455582854|FG001|Overall Study|Disease Progression|33|||
126624456|NCT00111839|455582855|FG002|Overall Study|Disease Progression|33|||
126624457|NCT00111839|455582853|FG000|Overall Study|Adverse Event|5|||
126624458|NCT00111839|455582854|FG001|Overall Study|Adverse Event|3|||
126624459|NCT00111839|455582855|FG002|Overall Study|Adverse Event|1|||
126624460|NCT00111839|455582853|FG000|Overall Study|Protocol Violation|2|||
126624461|NCT00111839|455582854|FG001|Overall Study|Protocol Violation|4|||
126624462|NCT00111839|455582855|FG002|Overall Study|Protocol Violation|2|||
126624463|NCT00111839|455582853|FG000|Overall Study|Death|1|||
126624464|NCT00111839|455582854|FG001|Overall Study|Death|1|||
126624465|NCT00111839|455582855|FG002|Overall Study|Death|6|||
126624466|NCT00111839|455582853|FG000|Overall Study|Withdrawal by Subject|2|||
126624467|NCT00111839|455582854|FG001|Overall Study|Withdrawal by Subject|2|||
126624468|NCT00111839|455582855|FG002|Overall Study|Withdrawal by Subject|2|||
126624469|NCT00111839|455582853|FG000|Overall Study|Lost to Follow-up|1|||
126624470|NCT00111839|455582854|FG001|Overall Study|Lost to Follow-up|0|||
126624471|NCT00111839|455582855|FG002|Overall Study|Lost to Follow-up|0|||
126624472|NCT00111839|455582853|FG000|Overall Study|Logistical Constraint|1|||
126624473|NCT00111839|455582854|FG001|Overall Study|Logistical Constraint|0|||
126624474|NCT00111839|455582855|FG002|Overall Study|Logistical Constraint|0|||
126624475|NCT00111839|455582853|FG000|Overall Study|Other|6|||
126624476|NCT00111839|455582854|FG001|Overall Study|Other|3|||
126624477|NCT00111839|455582855|FG002|Overall Study|Other|3|||
126624478|NCT00111839|455582853|FG000|Overall Study|Randomized but Not Treated|0|||
126624479|NCT00111839|455582854|FG001|Overall Study|Randomized but Not Treated|0|||
126624480|NCT00111839|455582855|FG002|Overall Study|Randomized but Not Treated|2|||
126624481|NCT00762723|455582856|FG000|Overall Study|Study Terminated slow enrollement|5|||
126624482|NCT00762723|455582857|FG001|Overall Study|Study Terminated slow enrollement|5|||
126624483|NCT00762723|455582858|FG002|Overall Study|Study Terminated slow enrollement|3|||
126783076|NCT00543439|456160166|FG002|Period 1|Physician Decision|1|||
126624484|NCT00382408|455582859|FG000|Overall Study|Did not meet protocol requirement|3|||
126624485|NCT00382408|455582860|FG001|Overall Study|Did not meet protocol requirement|3|||
126624486|NCT00382408|455582859|FG000|Overall Study|Protocol Violation|2|||
126624487|NCT00382408|455582860|FG001|Overall Study|Protocol Violation|2|||
126783077|NCT00543439|456160164|FG000|Period 2|Protocol Violation|1|||
126624488|NCT00382408|455582859|FG000|Overall Study|Physician Decision|1|||
126624489|NCT00382408|455582860|FG001|Overall Study|Physician Decision|0|||
126624490|NCT00382408|455582859|FG000|Overall Study|Withdrawal by Subject|17|||
126624491|NCT00382408|455582860|FG001|Overall Study|Withdrawal by Subject|6|||
126624492|NCT00382408|455582859|FG000|Overall Study|Pregnancy|2|||
126624493|NCT00382408|455582860|FG001|Overall Study|Pregnancy|0|||
126624494|NCT00382408|455582859|FG000|Overall Study|Lost to Follow-up|19|||
126624495|NCT00382408|455582860|FG001|Overall Study|Lost to Follow-up|8|||
126624496|NCT00382408|455582859|FG000|Overall Study|Other|100|||
126624497|NCT00382408|455582860|FG001|Overall Study|Other|35|||
126783078|NCT00543439|456160165|FG001|Period 2|Protocol Violation|0|||
126783079|NCT00543439|456160166|FG002|Period 2|Protocol Violation|1|||
126624498|NCT02435381|455582861|FG000|Overall Study|Lost to Follow-up|2|||
126624499|NCT02435381|455582862|FG001|Overall Study|Lost to Follow-up|1|||
126624500|NCT02316847|455582864|FG000|Overall Study|Adverse Event|0|||
126624501|NCT02316847|455582865|FG001|Overall Study|Adverse Event|3|||
126624502|NCT02316847|455582864|FG000|Overall Study|Lost to Follow-up|0|||
126624503|NCT02316847|455582865|FG001|Overall Study|Lost to Follow-up|2|||
126624504|NCT02316847|455582864|FG000|Overall Study|Physician Decision|0|||
126624505|NCT02316847|455582865|FG001|Overall Study|Physician Decision|1|||
126624506|NCT02316847|455582864|FG000|Overall Study|Pregnancy|0|||
126624507|NCT02316847|455582865|FG001|Overall Study|Pregnancy|1|||
126624508|NCT02316847|455582864|FG000|Overall Study|Withdrawal by Subject|2|||
126624509|NCT02316847|455582865|FG001|Overall Study|Withdrawal by Subject|9|||
126624510|NCT02316847|455582864|FG000|Overall Study|Noncompliance with study drug|0|||
126624511|NCT02316847|455582865|FG001|Overall Study|Noncompliance with study drug|3|||
126624512|NCT02316847|455582864|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
126624513|NCT02316847|455582865|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
126624514|NCT00139659|455582866|FG000|Overall Study|Adverse Event|12|||
126624515|NCT00139659|455582867|FG001|Overall Study|Adverse Event|1|||
126624516|NCT00139659|455582866|FG000|Overall Study|Lack of Efficacy|1|||
126624517|NCT00139659|455582867|FG001|Overall Study|Lack of Efficacy|1|||
126624518|NCT00139659|455582866|FG000|Overall Study|Lost to Follow-up|7|||
126624519|NCT00139659|455582867|FG001|Overall Study|Lost to Follow-up|3|||
126624520|NCT00139659|455582866|FG000|Overall Study|Reason not Specified|6|||
126624521|NCT00139659|455582867|FG001|Overall Study|Reason not Specified|3|||
126624522|NCT00139659|455582866|FG000|Overall Study|Withdrawal by Subject|14|||
126624523|NCT00139659|455582867|FG001|Overall Study|Withdrawal by Subject|10|||
126754369|NCT01258738|456051287|FG000|Open-label Period|Adverse Event|4|||
126754370|NCT01258738|456051288|FG001|Open-label Period|Adverse Event|5|||
126754371|NCT01258738|456051287|FG000|Open-label Period|Other Reasons|0|||
126754372|NCT01258738|456051288|FG001|Open-label Period|Other Reasons|1|||
126754373|NCT01258738|456051287|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
126754374|NCT01258738|456051288|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
126754375|NCT00689611|456051289|FG000|Overall Study|Death|6|||
126754376|NCT00689611|456051290|FG001|Overall Study|Death|9|||
126754377|NCT00689611|456051289|FG000|Overall Study|Withdrawal by Subject|8|||
126754378|NCT00689611|456051290|FG001|Overall Study|Withdrawal by Subject|9|||
126754379|NCT00689611|456051289|FG000|Overall Study|Lost to Follow-up|27|||
126754380|NCT00689611|456051290|FG001|Overall Study|Lost to Follow-up|28|||
126754381|NCT00568399|456051291|FG000|Overall Study|Death|2|||
126754382|NCT00568399|456051291|FG000|Overall Study|Adverse Event|5|||
126754383|NCT00568399|456051291|FG000|Overall Study|Withdrawal by Subject|8|||
126754384|NCT01904760|456051298|FG000|Overall Study|Protocol Violation|1|||
126754385|NCT01904760|456051299|FG001|Overall Study|Protocol Violation|0|||
126754386|NCT04249076|456051309|FG000|Overall Study|Adverse Event|1|||
126754387|NCT04249076|456051310|FG001|Overall Study|Adverse Event|1|||
126754388|NCT04249076|456051309|FG000|Overall Study|Protocol Violation|1|||
126754389|NCT04249076|456051310|FG001|Overall Study|Protocol Violation|2|||
126754390|NCT04249076|456051309|FG000|Overall Study|Lack of Efficacy|0|||
126754391|NCT04249076|456051310|FG001|Overall Study|Lack of Efficacy|1|||
126754392|NCT04249076|456051309|FG000|Overall Study|Withdrawal by Subject|0|||
126754393|NCT04249076|456051310|FG001|Overall Study|Withdrawal by Subject|1|||
126754394|NCT00783263|456051311|FG000|Overall Study|Adverse Event|3|||
126754395|NCT00783263|456051312|FG001|Overall Study|Adverse Event|0|||
126754396|NCT00783263|456051313|FG002|Overall Study|Adverse Event|2|||
126754397|NCT00783263|456051314|FG003|Overall Study|Adverse Event|1|||
126754398|NCT00783263|456051311|FG000|Overall Study|Lost to Follow-up|1|||
126754399|NCT00783263|456051312|FG001|Overall Study|Lost to Follow-up|1|||
126754400|NCT00783263|456051313|FG002|Overall Study|Lost to Follow-up|0|||
126754401|NCT00783263|456051314|FG003|Overall Study|Lost to Follow-up|0|||
126754402|NCT00783263|456051311|FG000|Overall Study|Withdrawal by Subject|0|||
126754403|NCT00783263|456051312|FG001|Overall Study|Withdrawal by Subject|1|||
126754404|NCT00783263|456051313|FG002|Overall Study|Withdrawal by Subject|1|||
126754405|NCT00783263|456051314|FG003|Overall Study|Withdrawal by Subject|2|||
126754406|NCT00405756|456051315|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
126754407|NCT00405756|456051316|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
126754408|NCT00405756|456051317|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
126754409|NCT00405756|456051315|FG000|Double-blind Treatment|Adverse Event|31|||
126754410|NCT00405756|456051316|FG001|Double-blind Treatment|Adverse Event|27|||
126754411|NCT00405756|456051317|FG002|Double-blind Treatment|Adverse Event|12|||
126754412|NCT00405756|456051315|FG000|Double-blind Treatment|Disease Progression|47|||
126754413|NCT00405756|456051316|FG001|Double-blind Treatment|Disease Progression|81|||
126754414|NCT00405756|456051317|FG002|Double-blind Treatment|Disease Progression|102|||
126754415|NCT00405756|456051315|FG000|Double-blind Treatment|Lack of Efficacy|1|||
126754416|NCT00405756|456051316|FG001|Double-blind Treatment|Lack of Efficacy|4|||
126754417|NCT00405756|456051317|FG002|Double-blind Treatment|Lack of Efficacy|2|||
126624524|NCT02282917|455582868|FG000|Overall Study|Withdrawal by Subject|1|||
126624525|NCT02282917|455582868|FG000|Overall Study|Screen Failure/Not Eligible|1|||
126624526|NCT01747629|455582869|FG000|Overall Study|Adverse Event|1|||
126624527|NCT01747629|455582870|FG001|Overall Study|Adverse Event|2|||
126624528|NCT01747629|455582869|FG000|Overall Study|Withdrawal by Subject|2|||
126624529|NCT01747629|455582870|FG001|Overall Study|Withdrawal by Subject|2|||
126624530|NCT01747629|455582869|FG000|Overall Study|Noncompliance|1|||
126624531|NCT01747629|455582870|FG001|Overall Study|Noncompliance|1|||
126624532|NCT01747629|455582869|FG000|Overall Study|Inclusion criteria not met|1|||
126624533|NCT01747629|455582870|FG001|Overall Study|Inclusion criteria not met|0|||
126624534|NCT01747629|455582869|FG000|Overall Study|Not treated|1|||
126624535|NCT01747629|455582870|FG001|Overall Study|Not treated|0|||
126624536|NCT01747629|455582869|FG000|Overall Study|Other|2|||
126624537|NCT01747629|455582870|FG001|Overall Study|Other|1|||
126624538|NCT01395914|455582871|FG000|Overall Study|Unrelated to study drug AE|6|||
126624539|NCT01395914|455582872|FG001|Overall Study|Unrelated to study drug AE|1|||
126624540|NCT01395914|455582871|FG000|Overall Study|Death|23|||
126624541|NCT01395914|455582872|FG001|Overall Study|Death|17|||
126624542|NCT01395914|455582871|FG000|Overall Study|Other|9|||
126624543|NCT01395914|455582872|FG001|Overall Study|Other|3|||
126624544|NCT01395914|455582871|FG000|Overall Study|Withdrawal by patient|27|||
126624545|NCT01395914|455582872|FG001|Overall Study|Withdrawal by patient|14|||
126624546|NCT01395914|455582871|FG000|Overall Study|Study drug-related AE|1|||
126624547|NCT01395914|455582872|FG001|Overall Study|Study drug-related AE|0|||
126624548|NCT01395914|455582871|FG000|Overall Study|Lost to Follow-up|6|||
126624549|NCT01395914|455582872|FG001|Overall Study|Lost to Follow-up|2|||
126624550|NCT04414397|455582873|FG000|Control Period|Withdrawal by Subject|2|||
126624551|NCT04414397|455582874|FG001|Control Period|Withdrawal by Subject|2|||
126624552|NCT04414397|455582873|FG000|Control Period|Lost to Follow-up|0|||
126624553|NCT04414397|455582874|FG001|Control Period|Lost to Follow-up|4|||
126624554|NCT04414397|455582873|FG000|Control Period|Protocol deviation|0|||
126624555|NCT04414397|455582874|FG001|Control Period|Protocol deviation|1|||
126624556|NCT04414397|455582873|FG000|Post-Control Period|Withdrawal by Subject|3|||
126624557|NCT04414397|455582874|FG001|Post-Control Period|Withdrawal by Subject|6|||
126624558|NCT04414397|455582873|FG000|Post-Control Period|Lost to Follow-up|4|||
126624559|NCT04414397|455582874|FG001|Post-Control Period|Lost to Follow-up|9|||
126624560|NCT04414397|455582873|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
126624561|NCT04414397|455582874|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
126624562|NCT04414397|455582873|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
126624563|NCT04414397|455582874|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
126624564|NCT01920178|455582879|FG000|Overall Study|Lost to Follow-up|2|||
126624565|NCT01920178|455582880|FG001|Overall Study|Lost to Follow-up|1|||
126624566|NCT02391545|455582881|FG000|Overall Study|Death|0|||
126624567|NCT02391545|455582882|FG001|Overall Study|Death|2|||
126624568|NCT02391545|455582881|FG000|Overall Study|Lost to Follow-up|0|||
126624569|NCT02391545|455582882|FG001|Overall Study|Lost to Follow-up|1|||
126624570|NCT02391545|455582881|FG000|Overall Study|Termination of study by sponsor|20|||
126624571|NCT02391545|455582882|FG001|Overall Study|Termination of study by sponsor|20|||
126624572|NCT02391545|455582881|FG000|Overall Study|Withdrawal by Subject|0|||
126624573|NCT02391545|455582882|FG001|Overall Study|Withdrawal by Subject|1|||
126624574|NCT02391545|455582881|FG000|Overall Study|Other Reasons|6|||
126624575|NCT02391545|455582882|FG001|Overall Study|Other Reasons|4|||
126624576|NCT04754594|455582886|FG000|Blinded Period|Withdrawal by Subject|4|||
126624577|NCT04754594|455582887|FG001|Blinded Period|Withdrawal by Subject|9|||
126624578|NCT04754594|455582888|FG002|Blinded Period|Withdrawal by Subject|0|||
126624579|NCT04754594|455582889|FG003|Blinded Period|Withdrawal by Subject|0|||
126624580|NCT04754594|455582886|FG000|Blinded Period|Protocol Violation|2|||
126624581|NCT04754594|455582887|FG001|Blinded Period|Protocol Violation|2|||
126624582|NCT04754594|455582888|FG002|Blinded Period|Protocol Violation|0|||
126624583|NCT04754594|455582889|FG003|Blinded Period|Protocol Violation|0|||
126624584|NCT04754594|455582886|FG000|Blinded Period|Lost to Follow-up|1|||
126624585|NCT04754594|455582887|FG001|Blinded Period|Lost to Follow-up|1|||
126624586|NCT04754594|455582888|FG002|Blinded Period|Lost to Follow-up|0|||
126624587|NCT04754594|455582889|FG003|Blinded Period|Lost to Follow-up|0|||
126624588|NCT04754594|455582886|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
126624589|NCT04754594|455582887|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
126624590|NCT04754594|455582888|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
126624591|NCT04754594|455582889|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
126624592|NCT04754594|455582886|FG000|Unblinded Period|Withdrawal by Subject|6|||
126624593|NCT04754594|455582887|FG001|Unblinded Period|Withdrawal by Subject|8|||
126624594|NCT04754594|455582888|FG002|Unblinded Period|Withdrawal by Subject|0|||
126624595|NCT04754594|455582889|FG003|Unblinded Period|Withdrawal by Subject|0|||
126624596|NCT04754594|455582886|FG000|Unblinded Period|Lost to Follow-up|5|||
126624597|NCT04754594|455582887|FG001|Unblinded Period|Lost to Follow-up|3|||
126624598|NCT04754594|455582888|FG002|Unblinded Period|Lost to Follow-up|0|||
126624599|NCT04754594|455582889|FG003|Unblinded Period|Lost to Follow-up|0|||
126624600|NCT04754594|455582886|FG000|Unblinded Period|Protocol Violation|2|||
126624601|NCT04754594|455582887|FG001|Unblinded Period|Protocol Violation|4|||
126624602|NCT04754594|455582888|FG002|Unblinded Period|Protocol Violation|0|||
126624603|NCT04754594|455582889|FG003|Unblinded Period|Protocol Violation|0|||
126624604|NCT04754594|455582886|FG000|Unblinded Period|Other|3|||
126624605|NCT04754594|455582887|FG001|Unblinded Period|Other|0|||
126624606|NCT04754594|455582888|FG002|Unblinded Period|Other|0|||
126624607|NCT04754594|455582889|FG003|Unblinded Period|Other|0|||
126624608|NCT04754594|455582886|FG000|Infant Participants|Withdrawal by Subject|0|||
126624609|NCT04754594|455582887|FG001|Infant Participants|Withdrawal by Subject|0|||
126624610|NCT04754594|455582888|FG002|Infant Participants|Withdrawal by Subject|9|||
126624611|NCT04754594|455582889|FG003|Infant Participants|Withdrawal by Subject|17|||
126624612|NCT04754594|455582886|FG000|Infant Participants|Lost to Follow-up|0|||
126624613|NCT04754594|455582887|FG001|Infant Participants|Lost to Follow-up|0|||
126624614|NCT04754594|455582888|FG002|Infant Participants|Lost to Follow-up|4|||
126624615|NCT04754594|455582889|FG003|Infant Participants|Lost to Follow-up|10|||
126624616|NCT04754594|455582886|FG000|Infant Participants|Death|0|||
126624617|NCT04754594|455582887|FG001|Infant Participants|Death|0|||
126624618|NCT04754594|455582888|FG002|Infant Participants|Death|1|||
126624619|NCT04754594|455582889|FG003|Infant Participants|Death|1|||
126624620|NCT04754594|455582886|FG000|Infant Participants|Other|0|||
126624621|NCT04754594|455582887|FG001|Infant Participants|Other|0|||
126624622|NCT04754594|455582888|FG002|Infant Participants|Other|1|||
126624623|NCT04754594|455582889|FG003|Infant Participants|Other|1|||
126624624|NCT03340766|455582892|FG000|Overall Study|Withdrawal by Subject|2|||
126624625|NCT03340766|455582893|FG001|Overall Study|Withdrawal by Subject|1|||
126624626|NCT03340766|455582894|FG002|Overall Study|Withdrawal by Subject|3|||
126624627|NCT03340766|455582892|FG000|Overall Study|Lost to Follow-up|0|||
126624628|NCT03340766|455582893|FG001|Overall Study|Lost to Follow-up|0|||
126754418|NCT00405756|456051315|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
126754419|NCT00405756|456051316|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
126754420|NCT00405756|456051317|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
126754421|NCT00405756|456051315|FG000|Double-blind Treatment|Lost to Follow-up|1|||
126754422|NCT00405756|456051316|FG001|Double-blind Treatment|Lost to Follow-up|0|||
126754423|NCT00405756|456051317|FG002|Double-blind Treatment|Lost to Follow-up|0|||
126754424|NCT00405756|456051315|FG000|Double-blind Treatment|Death|4|||
126754425|NCT00405756|456051316|FG001|Double-blind Treatment|Death|4|||
126754426|NCT00405756|456051317|FG002|Double-blind Treatment|Death|4|||
126754427|NCT00405756|456051315|FG000|Double-blind Treatment|Protocol Violation|1|||
126754428|NCT00405756|456051316|FG001|Double-blind Treatment|Protocol Violation|0|||
126754429|NCT00405756|456051317|FG002|Double-blind Treatment|Protocol Violation|2|||
126754430|NCT00405756|456051315|FG000|Double-blind Treatment|Other|7|||
126754431|NCT00405756|456051316|FG001|Double-blind Treatment|Other|4|||
126754432|NCT00405756|456051317|FG002|Double-blind Treatment|Other|4|||
126754433|NCT00405756|456051315|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
126754434|NCT00405756|456051316|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
126754435|NCT00405756|456051317|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
126754436|NCT00405756|456051315|FG000|Open-label Extension|Adverse Event|1|||
126754437|NCT00405756|456051316|FG001|Open-label Extension|Adverse Event|3|||
126754438|NCT00405756|456051317|FG002|Open-label Extension|Adverse Event|7|||
126754439|NCT00405756|456051315|FG000|Open-label Extension|Disease Progression|8|||
126754440|NCT00405756|456051316|FG001|Open-label Extension|Disease Progression|23|||
126754441|NCT00405756|456051317|FG002|Open-label Extension|Disease Progression|26|||
126754442|NCT00405756|456051315|FG000|Open-label Extension|Withdrawal by Subject|2|||
126754443|NCT00405756|456051316|FG001|Open-label Extension|Withdrawal by Subject|3|||
126754444|NCT00405756|456051317|FG002|Open-label Extension|Withdrawal by Subject|3|||
126754445|NCT00405756|456051315|FG000|Open-label Extension|Death|1|||
126754446|NCT00405756|456051316|FG001|Open-label Extension|Death|2|||
126754447|NCT00405756|456051317|FG002|Open-label Extension|Death|4|||
126754448|NCT00405756|456051315|FG000|Open-label Extension|Other|0|||
126754449|NCT00405756|456051316|FG001|Open-label Extension|Other|1|||
126754450|NCT00405756|456051317|FG002|Open-label Extension|Other|7|||
126754451|NCT00405756|456051315|FG000|Follow-up|Ongoing in Follow-up Period|52|||
126754452|NCT00405756|456051316|FG001|Follow-up|Ongoing in Follow-up Period|51|||
126754453|NCT00405756|456051317|FG002|Follow-up|Ongoing in Follow-up Period|60|||
126624629|NCT03340766|455582894|FG002|Overall Study|Lost to Follow-up|1|||
126624630|NCT03340766|455582892|FG000|Overall Study|Death|6|||
126624631|NCT03340766|455582893|FG001|Overall Study|Death|7|||
126624632|NCT03340766|455582894|FG002|Overall Study|Death|4|||
126624633|NCT02849509|455582897|FG000|Overall Study|Worsening of disease under study|1|||
126754454|NCT00405756|456051315|FG000|Follow-up|Death|21|||
126754455|NCT00405756|456051316|FG001|Follow-up|Death|31|||
126754456|NCT00405756|456051317|FG002|Follow-up|Death|24|||
126754457|NCT00405756|456051315|FG000|Follow-up|Lost to Follow-up|2|||
126754458|NCT00405756|456051316|FG001|Follow-up|Lost to Follow-up|8|||
126624634|NCT02849509|455582898|FG001|Overall Study|Worsening of disease under study|1|||
126754459|NCT00405756|456051317|FG002|Follow-up|Lost to Follow-up|4|||
126754460|NCT00089505|456051318|FG000|Overall Study|Death|4|||
126624635|NCT02849509|455582899|FG002|Overall Study|Worsening of disease under study|1|||
126754461|NCT00089505|456051319|FG001|Overall Study|Death|1|||
126624636|NCT02849509|455582897|FG000|Overall Study|Worsening of other pre-existing disease|0|||
126624637|NCT02849509|455582898|FG001|Overall Study|Worsening of other pre-existing disease|1|||
126624638|NCT02849509|455582899|FG002|Overall Study|Worsening of other pre-existing disease|2|||
126624639|NCT02849509|455582897|FG000|Overall Study|Other adverse event|36|||
126624640|NCT02849509|455582898|FG001|Overall Study|Other adverse event|41|||
126624641|NCT02849509|455582899|FG002|Overall Study|Other adverse event|8|||
126624642|NCT02849509|455582897|FG000|Overall Study|Withdrawal by Subject|6|||
126624643|NCT02849509|455582898|FG001|Overall Study|Withdrawal by Subject|17|||
126624644|NCT02849509|455582899|FG002|Overall Study|Withdrawal by Subject|12|||
126624645|NCT02849509|455582897|FG000|Overall Study|Lost to Follow-up|27|||
126624646|NCT02849509|455582898|FG001|Overall Study|Lost to Follow-up|67|||
126624647|NCT02849509|455582899|FG002|Overall Study|Lost to Follow-up|36|||
126624648|NCT02849509|455582897|FG000|Overall Study|Other, reason not specified|14|||
126624649|NCT02849509|455582898|FG001|Overall Study|Other, reason not specified|29|||
126624650|NCT02849509|455582899|FG002|Overall Study|Other, reason not specified|25|||
126624651|NCT02849509|455582897|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
126624652|NCT02849509|455582898|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
126624653|NCT02849509|455582899|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
126624654|NCT02256488|455582900|FG000|Overall Study|Lost to Follow-up|6|||
126624655|NCT02256488|455582901|FG001|Overall Study|Lost to Follow-up|6|||
126624656|NCT02256488|455582902|FG002|Overall Study|Lost to Follow-up|9|||
126624657|NCT02256488|455582903|FG003|Overall Study|Lost to Follow-up|3|||
126624658|NCT02256488|455582900|FG000|Overall Study|OTHER|1|||
126624659|NCT02256488|455582901|FG001|Overall Study|OTHER|0|||
126624660|NCT02256488|455582902|FG002|Overall Study|OTHER|1|||
126624661|NCT02256488|455582903|FG003|Overall Study|OTHER|1|||
126624662|NCT02256488|455582900|FG000|Overall Study|Withdrawal by Subject|1|||
126624663|NCT02256488|455582901|FG001|Overall Study|Withdrawal by Subject|0|||
126624664|NCT02256488|455582902|FG002|Overall Study|Withdrawal by Subject|0|||
126624665|NCT02256488|455582903|FG003|Overall Study|Withdrawal by Subject|2|||
126624666|NCT00500539|455582904|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
126624667|NCT00500539|455582904|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
126624668|NCT00500539|455582904|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
126624669|NCT00500539|455582904|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
126624670|NCT00500539|455582904|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
126624671|NCT00500539|455582904|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
126624672|NCT00500539|455582904|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
126624673|NCT00500539|455582904|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
126624674|NCT00500539|455582904|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
126624675|NCT00500539|455582904|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
126624676|NCT00500539|455582904|FG000|Follow-up Period (16 Weeks)|Death|1|||
126624677|NCT00500539|455582904|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
126624678|NCT00500539|455582904|FG000|Follow-up Period (16 Weeks)|Missing|3|||
126624679|NCT02316171|455582906|FG000|Overall Study|difficulties with urinary catheter|1|||
126624680|NCT02316171|455582907|FG001|Overall Study|difficulties with urinary catheter|0|||
126624681|NCT02316171|455582908|FG002|Overall Study|difficulties with urinary catheter|0|||
126624682|NCT02316171|455582909|FG003|Overall Study|difficulties with urinary catheter|0|||
126624683|NCT01524887|455582910|FG000|Overall Study|Withdrawal by Subject|6|||
126624684|NCT01524887|455582911|FG001|Overall Study|Withdrawal by Subject|2|||
126624685|NCT01524887|455582912|FG002|Overall Study|Withdrawal by Subject|3|||
126624686|NCT01524887|455582910|FG000|Overall Study|Adverse Event|5|||
126624687|NCT01524887|455582911|FG001|Overall Study|Adverse Event|1|||
126624688|NCT01524887|455582912|FG002|Overall Study|Adverse Event|1|||
126624689|NCT01524887|455582910|FG000|Overall Study|Protocol Violation|0|||
126624690|NCT01524887|455582911|FG001|Overall Study|Protocol Violation|0|||
126624691|NCT01524887|455582912|FG002|Overall Study|Protocol Violation|1|||
126624692|NCT01524887|455582910|FG000|Overall Study|Study termination|73|||
126624693|NCT01524887|455582911|FG001|Overall Study|Study termination|87|||
126624694|NCT01524887|455582912|FG002|Overall Study|Study termination|79|||
126624695|NCT01524887|455582910|FG000|Overall Study|Withdrawal by Caregiver|0|||
126624696|NCT01524887|455582911|FG001|Overall Study|Withdrawal by Caregiver|0|||
126624697|NCT01524887|455582912|FG002|Overall Study|Withdrawal by Caregiver|2|||
126624698|NCT01524887|455582910|FG000|Overall Study|Use of prohibited medication|1|||
126624699|NCT01524887|455582911|FG001|Overall Study|Use of prohibited medication|0|||
126624700|NCT01524887|455582912|FG002|Overall Study|Use of prohibited medication|0|||
126624701|NCT00547300|455582913|FG000|Overall Study|Study was Administratively Terminated|25|||
126624702|NCT00547300|455582914|FG001|Overall Study|Study was Administratively Terminated|24|||
126624703|NCT00547300|455582913|FG000|Overall Study|Did not Meet Entry Criteria|0|||
126624704|NCT00547300|455582914|FG001|Overall Study|Did not Meet Entry Criteria|2|||
126624705|NCT04380688|455582915|FG000|Overall Study|Death|2|||
126624706|NCT04380688|455582916|FG001|Overall Study|Death|2|||
126624707|NCT04380688|455582915|FG000|Overall Study|Lost to Follow-up|2|||
126624708|NCT04380688|455582916|FG001|Overall Study|Lost to Follow-up|4|||
126624709|NCT04380688|455582915|FG000|Overall Study|Withdrawal by Subject|3|||
126624710|NCT04380688|455582916|FG001|Overall Study|Withdrawal by Subject|3|||
126624711|NCT03993054|455582917|FG000|Overall Study|PI Decision|1|||
126624712|NCT04267393|455582920|FG000|Randomization|Adverse Event|1|||
126624713|NCT04267393|455582921|FG001|Randomization|Adverse Event|0|||
126624714|NCT04267393|455582922|FG002|Randomization|Adverse Event|0|||
126624715|NCT04267393|455582920|FG000|Randomization|Administrative Reasons by Sponsor|0|||
126624716|NCT04267393|455582921|FG001|Randomization|Administrative Reasons by Sponsor|1|||
126624717|NCT04267393|455582922|FG002|Randomization|Administrative Reasons by Sponsor|0|||
126624718|NCT04267393|455582920|FG000|Treatment Period|Adverse Event|0|||
126624719|NCT04267393|455582921|FG001|Treatment Period|Adverse Event|2|||
126624720|NCT04267393|455582922|FG002|Treatment Period|Adverse Event|3|||
126624721|NCT04267393|455582920|FG000|Treatment Period|Participant Withdrew Consent|0|||
126624722|NCT04267393|455582921|FG001|Treatment Period|Participant Withdrew Consent|0|||
126783080|NCT00543439|456160164|FG000|Period 2|Adverse Event|0|||
126783081|NCT00543439|456160165|FG001|Period 2|Adverse Event|1|||
126783082|NCT00543439|456160166|FG002|Period 2|Adverse Event|1|||
126783083|NCT00249821|456160167|FG000|Overall Study|Technical problem|0|||
126783084|NCT00249821|456160168|FG001|Overall Study|Technical problem|1|||
126783085|NCT00467584|456160173|FG000|Overall Study|Withdrawal by Subject|4|||
126783086|NCT00467584|456160174|FG001|Overall Study|Withdrawal by Subject|5|||
126783087|NCT00467584|456160175|FG002|Overall Study|Withdrawal by Subject|1|||
126783088|NCT01498484|456160179|FG000|Overall Study|Death|6|||
126783089|NCT01498484|456160180|FG001|Overall Study|Death|3|||
126783090|NCT01498484|456160181|FG002|Overall Study|Death|1|||
126783091|NCT01498484|456160182|FG003|Overall Study|Death|1|||
126783092|NCT01498484|456160183|FG004|Overall Study|Death|0|||
126783093|NCT01498484|456160184|FG005|Overall Study|Death|0|||
126783094|NCT01498484|456160185|FG006|Overall Study|Death|10|||
126783095|NCT01498484|456160186|FG007|Overall Study|Death|1|||
126783096|NCT01498484|456160187|FG008|Overall Study|Death|0|||
126783097|NCT01498484|456160179|FG000|Overall Study|Physician Decision|3|||
126783098|NCT01498484|456160180|FG001|Overall Study|Physician Decision|2|||
126783099|NCT01498484|456160181|FG002|Overall Study|Physician Decision|1|||
126783100|NCT01498484|456160182|FG003|Overall Study|Physician Decision|1|||
126783101|NCT01498484|456160183|FG004|Overall Study|Physician Decision|0|||
126783102|NCT01498484|456160184|FG005|Overall Study|Physician Decision|0|||
126783103|NCT01498484|456160185|FG006|Overall Study|Physician Decision|8|||
126783104|NCT01498484|456160186|FG007|Overall Study|Physician Decision|13|||
126783105|NCT01498484|456160187|FG008|Overall Study|Physician Decision|1|||
126783106|NCT01498484|456160179|FG000|Overall Study|Adverse Event|0|||
126783107|NCT01498484|456160180|FG001|Overall Study|Adverse Event|0|||
126783108|NCT01498484|456160181|FG002|Overall Study|Adverse Event|0|||
126783109|NCT01498484|456160182|FG003|Overall Study|Adverse Event|0|||
126783110|NCT01498484|456160183|FG004|Overall Study|Adverse Event|0|||
126783111|NCT01498484|456160184|FG005|Overall Study|Adverse Event|1|||
126783112|NCT01498484|456160185|FG006|Overall Study|Adverse Event|0|||
126783113|NCT01498484|456160186|FG007|Overall Study|Adverse Event|0|||
126783114|NCT01498484|456160187|FG008|Overall Study|Adverse Event|0|||
126783115|NCT01498484|456160179|FG000|Overall Study|Withdrawal by Subject|0|||
126783116|NCT01498484|456160180|FG001|Overall Study|Withdrawal by Subject|0|||
126783117|NCT01498484|456160181|FG002|Overall Study|Withdrawal by Subject|0|||
126783118|NCT01498484|456160182|FG003|Overall Study|Withdrawal by Subject|1|||
126783119|NCT01498484|456160183|FG004|Overall Study|Withdrawal by Subject|0|||
126783120|NCT01498484|456160184|FG005|Overall Study|Withdrawal by Subject|0|||
126783121|NCT01498484|456160185|FG006|Overall Study|Withdrawal by Subject|1|||
126783122|NCT01498484|456160186|FG007|Overall Study|Withdrawal by Subject|0|||
126783123|NCT01498484|456160187|FG008|Overall Study|Withdrawal by Subject|0|||
126783124|NCT01498484|456160179|FG000|Overall Study|Other|5|||
126783125|NCT01498484|456160180|FG001|Overall Study|Other|2|||
126783126|NCT01498484|456160181|FG002|Overall Study|Other|0|||
126783127|NCT01498484|456160182|FG003|Overall Study|Other|0|||
126783128|NCT01498484|456160183|FG004|Overall Study|Other|1|||
126783129|NCT01498484|456160184|FG005|Overall Study|Other|0|||
126783130|NCT01498484|456160185|FG006|Overall Study|Other|3|||
126783131|NCT01498484|456160186|FG007|Overall Study|Other|0|||
126783132|NCT01498484|456160187|FG008|Overall Study|Other|1|||
126624723|NCT04267393|455582922|FG002|Treatment Period|Participant Withdrew Consent|1|||
126624724|NCT04267393|455582920|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
126783133|NCT02486796|456160188|FG000|Overall Study|Withdrawal by Subject|1|||
126783134|NCT02486796|456160189|FG001|Overall Study|Withdrawal by Subject|1|||
126624725|NCT04267393|455582921|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
126624726|NCT04267393|455582922|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
126783135|NCT02486796|456160188|FG000|Overall Study|Physician Decision|1|||
126783136|NCT02486796|456160189|FG001|Overall Study|Physician Decision|0|||
126783137|NCT00278512|456160190|FG000|Overall Study|Death|1|||
126783138|NCT00278512|456160191|FG001|Overall Study|Death|0|||
126783139|NCT01202747|456160192|FG000|Overall Study|Withdrawal by Subject|1|||
126783140|NCT01620177|456160193|FG000|Overall Study|Failure at Screening Visit|43|||
126624727|NCT02093897|455585398|FG000|Overall Study|Physician Decision|1|||
126783141|NCT01620177|456160193|FG000|Overall Study|Withdrawal by Subject|26|||
126783142|NCT01620177|456160193|FG000|Overall Study|Lost to Follow-up|7|||
126624728|NCT02093897|455585398|FG000|Overall Study|Planned age group closure - no's reached|17|||
126783143|NCT01620177|456160193|FG000|Overall Study|Physician Decision|2|||
126783144|NCT01620177|456160193|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
126624729|NCT02093897|455585398|FG000|Overall Study|Adverse event, non-fatal|1|||
126624730|NCT00088452|455585399|FG000|Overall Study|Did not receive intervention|1|||
126624731|NCT00088452|455585400|FG001|Overall Study|Did not receive intervention|0|||
126624732|NCT00088452|455585401|FG002|Overall Study|Did not receive intervention|1|||
126624733|NCT02081196|455585403|FG000|Overall Study|Lost to Follow-up|1|||
126624734|NCT03098797|455585406|FG000|Part 2 Open Label Extension|Adverse Event|2|||
126624735|NCT03098797|455585407|FG001|Part 2 Open Label Extension|Adverse Event|0|||
126624736|NCT01967719|455585410|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
126624737|NCT01967719|455585411|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
126624738|NCT01967719|455585412|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
126624739|NCT01967719|455585413|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
126624740|NCT01967719|455585410|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
126624741|NCT01967719|455585411|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
126624742|NCT01967719|455585412|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
126624743|NCT01967719|455585413|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
126624744|NCT00381888|455585414|FG000|Overall Study|Death|1|||
126624745|NCT00381888|455585414|FG000|Overall Study|Withdrawal by Subject|1|||
126624746|NCT00381888|455585414|FG000|Overall Study|Physician Decision|1|||
126624747|NCT00381888|455585414|FG000|Overall Study|Protocol Violation|9|||
126624748|NCT00381888|455585414|FG000|Overall Study|Had laparoscopic surgery|2|||
126624749|NCT00381888|455585414|FG000|Overall Study|Surgery was cancelled|2|||
126624750|NCT00381888|455585414|FG000|Overall Study|Adverse Event|1|||
126624751|NCT02916706|455585425|FG000|Overall Study|Adverse Event|0|||
126624752|NCT02916706|455585426|FG001|Overall Study|Adverse Event|1|||
126624753|NCT02916706|455585425|FG000|Overall Study|Lost to Follow-up|0|||
126624754|NCT02916706|455585426|FG001|Overall Study|Lost to Follow-up|1|||
126624755|NCT02916706|455585425|FG000|Overall Study|Physician Decision|1|||
126624756|NCT02916706|455585426|FG001|Overall Study|Physician Decision|0|||
126624757|NCT02916706|455585425|FG000|Overall Study|Protocol Violation|3|||
126624758|NCT02916706|455585426|FG001|Overall Study|Protocol Violation|1|||
126624759|NCT02916706|455585425|FG000|Overall Study|Withdrawal by Subject|6|||
126624760|NCT02916706|455585426|FG001|Overall Study|Withdrawal by Subject|9|||
126624761|NCT02916706|455585425|FG000|Overall Study|Other|5|||
126624762|NCT02916706|455585426|FG001|Overall Study|Other|19|||
126624763|NCT01194271|455585433|FG000|Overall Study|Withdrawal by Subject|1|||
126624764|NCT01194271|455585433|FG000|Overall Study|Ineligible, Screen Failure|1|||
126624765|NCT01194271|455585433|FG000|Overall Study|Death|1|||
126624766|NCT00381797|455585434|FG000|Overall Study|Withdrawal by Subject|1|||
126624767|NCT00381797|455585435|FG001|Overall Study|Withdrawal by Subject|1|||
126624768|NCT00381797|455585436|FG002|Overall Study|Withdrawal by Subject|0|||
126624769|NCT00381797|455585437|FG003|Overall Study|Withdrawal by Subject|0|||
126624770|NCT00381797|455585438|FG004|Overall Study|Withdrawal by Subject|2|||
126783145|NCT02292238|456160197|FG000|Overall Study|Protocol Violation|1|||
126783146|NCT02292238|456160198|FG001|Overall Study|Protocol Violation|2|||
126783147|NCT02292238|456160197|FG000|Overall Study|Withdrawal by Subject|2|||
126783148|NCT02292238|456160198|FG001|Overall Study|Withdrawal by Subject|1|||
126783149|NCT02292238|456160197|FG000|Overall Study|Lost to Follow-up|1|||
126783150|NCT02292238|456160198|FG001|Overall Study|Lost to Follow-up|0|||
126783151|NCT02292238|456160197|FG000|Overall Study|Physician Decision|0|||
126783152|NCT02292238|456160198|FG001|Overall Study|Physician Decision|1|||
126783153|NCT01789320|456160199|FG000|Overall Study|Re-enrolled into study|1|||
126783154|NCT01789320|456160199|FG000|Overall Study|Lost to Follow-up|1|||
126783155|NCT00814320|456160202|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
126624771|NCT00381797|455585434|FG000|Overall Study|Ineligible|0|||
126624772|NCT00381797|455585435|FG001|Overall Study|Ineligible|0|||
126624773|NCT00381797|455585436|FG002|Overall Study|Ineligible|0|||
126624774|NCT00381797|455585437|FG003|Overall Study|Ineligible|1|||
126624775|NCT00381797|455585438|FG004|Overall Study|Ineligible|0|||
126624776|NCT00443898|455585439|FG000|Overall Study|Adverse Event|0|||
126624777|NCT00443898|455585440|FG001|Overall Study|Adverse Event|0|||
126783156|NCT00814320|456160203|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
126783157|NCT00814320|456160202|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
126783158|NCT00814320|456160203|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
126624778|NCT00443898|455585441|FG002|Overall Study|Adverse Event|1|||
126624779|NCT00443898|455585442|FG003|Overall Study|Adverse Event|1|||
126624780|NCT00443898|455585439|FG000|Overall Study|Lack of Efficacy|2|||
126624781|NCT00443898|455585440|FG001|Overall Study|Lack of Efficacy|3|||
126624782|NCT00443898|455585441|FG002|Overall Study|Lack of Efficacy|3|||
126624783|NCT00443898|455585442|FG003|Overall Study|Lack of Efficacy|1|||
126624784|NCT00443898|455585439|FG000|Overall Study|Protocol Violation|1|||
126624785|NCT00443898|455585440|FG001|Overall Study|Protocol Violation|1|||
126624786|NCT00443898|455585441|FG002|Overall Study|Protocol Violation|1|||
126624787|NCT00443898|455585442|FG003|Overall Study|Protocol Violation|0|||
126783159|NCT00814320|456160202|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
126624788|NCT00443898|455585439|FG000|Overall Study|Withdrawal by Subject|11|||
126624789|NCT00443898|455585440|FG001|Overall Study|Withdrawal by Subject|10|||
126624790|NCT00443898|455585441|FG002|Overall Study|Withdrawal by Subject|10|||
126624791|NCT00443898|455585442|FG003|Overall Study|Withdrawal by Subject|6|||
126624792|NCT00443898|455585439|FG000|Overall Study|Lost to Follow-up|10|||
126624793|NCT00443898|455585440|FG001|Overall Study|Lost to Follow-up|10|||
126624794|NCT00443898|455585441|FG002|Overall Study|Lost to Follow-up|14|||
126624795|NCT00443898|455585442|FG003|Overall Study|Lost to Follow-up|10|||
126624796|NCT00443898|455585439|FG000|Overall Study|Death|0|||
126624797|NCT00443898|455585440|FG001|Overall Study|Death|1|||
126624798|NCT00443898|455585441|FG002|Overall Study|Death|0|||
126624799|NCT00443898|455585442|FG003|Overall Study|Death|0|||
126624800|NCT00958711|455585443|FG000|Overall Study|Withdrawal by Subject|0|||
126624801|NCT00958711|455585444|FG001|Overall Study|Withdrawal by Subject|4|||
126624802|NCT00958711|455585443|FG000|Overall Study|Physician Decision|5|||
126624803|NCT00958711|455585444|FG001|Overall Study|Physician Decision|7|||
126624804|NCT00958711|455585443|FG000|Overall Study|Lost to Follow-up|4|||
126624805|NCT00958711|455585444|FG001|Overall Study|Lost to Follow-up|1|||
126624806|NCT00958711|455585443|FG000|Overall Study|Other|2|||
126624807|NCT00958711|455585444|FG001|Overall Study|Other|5|||
126624808|NCT00958711|455585443|FG000|Overall Study|Death|1|||
126624809|NCT00958711|455585444|FG001|Overall Study|Death|2|||
126624810|NCT00958711|455585443|FG000|Overall Study|Adverse Event|1|||
126624811|NCT00958711|455585444|FG001|Overall Study|Adverse Event|2|||
126624812|NCT00550771|455585445|FG000|Overall Study|Adverse Event|11|||
126624813|NCT00550771|455585446|FG001|Overall Study|Adverse Event|3|||
126624814|NCT00550771|455585445|FG000|Overall Study|Discontinued for study-related reasons|0|||
126624815|NCT00550771|455585446|FG001|Overall Study|Discontinued for study-related reasons|1|||
126624816|NCT00550771|455585445|FG000|Overall Study|Physician Decision|2|||
126624817|NCT00550771|455585446|FG001|Overall Study|Physician Decision|0|||
126624818|NCT00550771|455585445|FG000|Overall Study|Withdrawal by Subject|0|||
126624819|NCT00550771|455585446|FG001|Overall Study|Withdrawal by Subject|1|||
126624820|NCT00550771|455585445|FG000|Overall Study|Protocol Violation|4|||
126624821|NCT00550771|455585446|FG001|Overall Study|Protocol Violation|5|||
126624822|NCT00730847|455585448|FG000|Overall Study|Adverse Event|1|||
126624823|NCT00730847|455585448|FG000|Overall Study|Protocol Violation|2|||
126624824|NCT00730847|455585448|FG000|Overall Study|Withdrawal by Subject|16|||
126624825|NCT00730847|455585448|FG000|Overall Study|Lost to Follow-up|67|||
126624826|NCT00730847|455585448|FG000|Overall Study|Unknown completion status|21|||
126624827|NCT00730847|455585448|FG000|Overall Study|Other|24|||
126624828|NCT03022578|455585449|FG000|Overall Study|Adverse Event|1|||
126624829|NCT03022578|455585449|FG000|Overall Study|Lack of Efficacy|2|||
126624830|NCT03022578|455585449|FG000|Overall Study|Withdrawal by Subject|1|||
126624831|NCT01011049|455585450|FG000|Overall Study|Protocol Violation|0|||
126624832|NCT01011049|455585451|FG001|Overall Study|Protocol Violation|0|||
126624833|NCT01011049|455585452|FG002|Overall Study|Protocol Violation|2|||
126624834|NCT01011049|455585453|FG003|Overall Study|Protocol Violation|0|||
126624835|NCT01011049|455585450|FG000|Overall Study|Lost to Follow-up|1|||
126624836|NCT01011049|455585451|FG001|Overall Study|Lost to Follow-up|2|||
126624837|NCT01011049|455585452|FG002|Overall Study|Lost to Follow-up|1|||
126624838|NCT01011049|455585453|FG003|Overall Study|Lost to Follow-up|0|||
126624839|NCT01011049|455585450|FG000|Overall Study|Withdrawal by Subject|0|||
126624840|NCT01011049|455585451|FG001|Overall Study|Withdrawal by Subject|0|||
126624841|NCT01011049|455585452|FG002|Overall Study|Withdrawal by Subject|1|||
126624842|NCT01011049|455585453|FG003|Overall Study|Withdrawal by Subject|0|||
126624843|NCT00352053|455585459|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
126624844|NCT00352053|455585460|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
126624845|NCT00352053|455585459|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
126624846|NCT00352053|455585460|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
126624847|NCT00352053|455585459|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
126624848|NCT00352053|455585460|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
126624849|NCT00352053|455585459|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
126624850|NCT00352053|455585460|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
126624851|NCT00352053|455585459|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
126624852|NCT00352053|455585460|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
126624853|NCT00352053|455585459|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
126783160|NCT00814320|456160203|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
126783161|NCT00814320|456160202|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
126624854|NCT00352053|455585460|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
126624855|NCT00352053|455585459|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
126624856|NCT00352053|455585460|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
126624857|NCT00352053|455585459|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
126624858|NCT00352053|455585460|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
126624859|NCT00352053|455585459|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
126624860|NCT00352053|455585460|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
126624861|NCT00352053|455585459|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
126624862|NCT00352053|455585460|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
126624863|NCT00352053|455585459|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
126624864|NCT00352053|455585460|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
126624865|NCT00352053|455585459|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
126624866|NCT00352053|455585460|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
126624867|NCT00352053|455585459|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
126624868|NCT00352053|455585460|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
126624869|NCT00520403|455585461|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
126624870|NCT00520403|455585461|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
126624871|NCT00520403|455585461|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
126624872|NCT00520403|455585461|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
126624873|NCT00520403|455585461|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
126624874|NCT00520403|455585461|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
126624875|NCT00520403|455585461|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
126624876|NCT00520403|455585461|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
126624877|NCT00405912|455585464|FG000|Overall Study|Withdrawal by Subject|12|||
126624878|NCT00405912|455585465|FG001|Overall Study|Withdrawal by Subject|11|||
126624879|NCT00405912|455585466|FG002|Overall Study|Withdrawal by Subject|12|||
126624880|NCT00405912|455585464|FG000|Overall Study|Lost to Follow-up|4|||
126624881|NCT00405912|455585465|FG001|Overall Study|Lost to Follow-up|8|||
126624882|NCT00405912|455585466|FG002|Overall Study|Lost to Follow-up|4|||
126624883|NCT03730662|455585467|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
126624884|NCT03730662|455585468|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
126624885|NCT03730662|455585469|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
126624886|NCT03730662|455585470|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
126624887|NCT03730662|455585467|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
126624888|NCT03730662|455585468|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
126624889|NCT03730662|455585469|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
126624890|NCT03730662|455585470|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
126624891|NCT03730662|455585467|FG000|Treatment Period (52 Weeks)|Death|6|||
126624892|NCT03730662|455585468|FG001|Treatment Period (52 Weeks)|Death|2|||
126624893|NCT03730662|455585469|FG002|Treatment Period (52 Weeks)|Death|2|||
126624894|NCT03730662|455585470|FG003|Treatment Period (52 Weeks)|Death|9|||
126624895|NCT03730662|455585467|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
126624896|NCT03730662|455585468|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
126624897|NCT03730662|455585469|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
126624898|NCT03730662|455585470|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
126624899|NCT03730662|455585467|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
126624900|NCT03730662|455585468|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
126624901|NCT03730662|455585469|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
126624902|NCT03730662|455585470|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
126624903|NCT03730662|455585467|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
126624904|NCT03730662|455585468|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
126624905|NCT03730662|455585469|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
126624906|NCT03730662|455585470|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
126624907|NCT03730662|455585467|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
126624908|NCT03730662|455585468|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
126624909|NCT03730662|455585469|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
126624910|NCT03730662|455585470|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
126624911|NCT03730662|455585467|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
126624912|NCT03730662|455585468|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
126624913|NCT03730662|455585469|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
126624914|NCT03730662|455585470|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
126624915|NCT03730662|455585467|FG000|Variable Treatment Period|Adverse Event|1|||
126624916|NCT03730662|455585468|FG001|Variable Treatment Period|Adverse Event|2|||
126624917|NCT03730662|455585469|FG002|Variable Treatment Period|Adverse Event|0|||
126624918|NCT03730662|455585470|FG003|Variable Treatment Period|Adverse Event|7|||
126624919|NCT03730662|455585467|FG000|Variable Treatment Period|Death|9|||
126624920|NCT03730662|455585468|FG001|Variable Treatment Period|Death|0|||
126624921|NCT03730662|455585469|FG002|Variable Treatment Period|Death|6|||
126624922|NCT03730662|455585470|FG003|Variable Treatment Period|Death|26|||
126624923|NCT03730662|455585467|FG000|Variable Treatment Period|Lost to Follow-up|2|||
126754462|NCT00089505|456051320|FG002|Overall Study|Death|5|||
126754463|NCT00089505|456051321|FG003|Overall Study|Death|8|||
126754464|NCT00089505|456051318|FG000|Overall Study|Withdrawal by Subject|3|||
126624924|NCT03730662|455585468|FG001|Variable Treatment Period|Lost to Follow-up|1|||
126624925|NCT03730662|455585469|FG002|Variable Treatment Period|Lost to Follow-up|4|||
126624926|NCT03730662|455585470|FG003|Variable Treatment Period|Lost to Follow-up|11|||
126624927|NCT03730662|455585467|FG000|Variable Treatment Period|Personal Reason|0|||
126624928|NCT03730662|455585468|FG001|Variable Treatment Period|Personal Reason|2|||
126624929|NCT03730662|455585469|FG002|Variable Treatment Period|Personal Reason|1|||
126624930|NCT03730662|455585470|FG003|Variable Treatment Period|Personal Reason|6|||
126624931|NCT03730662|455585467|FG000|Variable Treatment Period|Physician Decision|0|||
126624932|NCT03730662|455585468|FG001|Variable Treatment Period|Physician Decision|0|||
126624933|NCT03730662|455585469|FG002|Variable Treatment Period|Physician Decision|0|||
126624934|NCT03730662|455585470|FG003|Variable Treatment Period|Physician Decision|3|||
126624935|NCT03730662|455585467|FG000|Variable Treatment Period|Protocol Violation|0|||
126624936|NCT03730662|455585468|FG001|Variable Treatment Period|Protocol Violation|1|||
126624937|NCT03730662|455585469|FG002|Variable Treatment Period|Protocol Violation|1|||
126624938|NCT03730662|455585470|FG003|Variable Treatment Period|Protocol Violation|1|||
126624939|NCT03730662|455585467|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
126624940|NCT03730662|455585468|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
126624941|NCT03730662|455585469|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
126624942|NCT03730662|455585470|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
126624943|NCT01797562|455585471|FG000|Overall Study|Protocol Violation|5|||
126624944|NCT01309243|455585472|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
126624945|NCT01309243|455585473|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
126624946|NCT01309243|455585472|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
126624947|NCT01309243|455585473|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
126624948|NCT01309243|455585472|FG000|Randomized Phase Through Week 96|Death|0|||
126624949|NCT01309243|455585473|FG001|Randomized Phase Through Week 96|Death|1|||
126624950|NCT01309243|455585472|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
126624951|NCT01309243|455585473|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
126624952|NCT01309243|455585472|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
126624953|NCT01309243|455585473|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
126624954|NCT01309243|455585472|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
126624955|NCT01309243|455585473|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
126624956|NCT01309243|455585472|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
126624957|NCT01309243|455585473|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
126624958|NCT01309243|455585472|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
126624959|NCT01309243|455585473|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
126624960|NCT01309243|455585472|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
126624961|NCT01309243|455585473|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
126624962|NCT01309243|455585472|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
126624963|NCT01309243|455585473|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
126624964|NCT01309243|455585472|FG000|Extension Phase|Lost to Follow-up|6|||
126624965|NCT01309243|455585473|FG001|Extension Phase|Lost to Follow-up|0|||
126624966|NCT00632931|455585476|FG000|Part 1, Period 1|Protocol Violation|1|||
126624967|NCT00632931|455585477|FG001|Part 1, Period 1|Protocol Violation|0|||
126624968|NCT00632931|455585478|FG002|Part 1, Period 1|Protocol Violation|0|||
126624969|NCT00632931|455585476|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
126624970|NCT00632931|455585477|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
126624971|NCT00632931|455585478|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
126624972|NCT00632931|455585476|FG000|Part 2|Adverse Event|0|||
126624973|NCT00632931|455585477|FG001|Part 2|Adverse Event|0|||
126624974|NCT00632931|455585478|FG002|Part 2|Adverse Event|3|||
126754465|NCT00089505|456051319|FG001|Overall Study|Withdrawal by Subject|0|||
126754466|NCT00089505|456051320|FG002|Overall Study|Withdrawal by Subject|6|||
126754467|NCT00089505|456051321|FG003|Overall Study|Withdrawal by Subject|6|||
126754468|NCT00089505|456051318|FG000|Overall Study|Lost to Follow-up|1|||
126754469|NCT00089505|456051319|FG001|Overall Study|Lost to Follow-up|1|||
126754470|NCT00089505|456051320|FG002|Overall Study|Lost to Follow-up|9|||
126754471|NCT00089505|456051321|FG003|Overall Study|Lost to Follow-up|7|||
126754472|NCT00089505|456051318|FG000|Overall Study|Physician Decision|1|||
126754473|NCT00089505|456051319|FG001|Overall Study|Physician Decision|0|||
126754474|NCT00089505|456051320|FG002|Overall Study|Physician Decision|0|||
126754475|NCT00089505|456051321|FG003|Overall Study|Physician Decision|0|||
126754476|NCT00089505|456051318|FG000|Overall Study|Protocol Violation|0|||
126754477|NCT00089505|456051319|FG001|Overall Study|Protocol Violation|0|||
126754478|NCT00089505|456051320|FG002|Overall Study|Protocol Violation|1|||
126754479|NCT00089505|456051321|FG003|Overall Study|Protocol Violation|0|||
126754480|NCT01117428|456051322|FG000|Overall Study|Lack of Efficacy|1|||
126754481|NCT01117428|456051323|FG001|Overall Study|Lack of Efficacy|0|||
126754482|NCT01117428|456051324|FG002|Overall Study|Lack of Efficacy|0|||
126754483|NCT01117428|456051325|FG003|Overall Study|Lack of Efficacy|0|||
126754484|NCT01117428|456051326|FG004|Overall Study|Lack of Efficacy|0|||
126754485|NCT01117428|456051327|FG005|Overall Study|Lack of Efficacy|0|||
126624975|NCT00632931|455585476|FG000|Part 2|Death|0|||
126624976|NCT00632931|455585477|FG001|Part 2|Death|0|||
126624977|NCT00632931|455585478|FG002|Part 2|Death|1|||
126754486|NCT01117428|456051322|FG000|Overall Study|Adverse Event|4|||
126754487|NCT01117428|456051323|FG001|Overall Study|Adverse Event|0|||
126754488|NCT01117428|456051324|FG002|Overall Study|Adverse Event|0|||
126754489|NCT01117428|456051325|FG003|Overall Study|Adverse Event|0|||
126754490|NCT01117428|456051326|FG004|Overall Study|Adverse Event|1|||
126624978|NCT00632931|455585476|FG000|Part 2|Lack of Efficacy|0|||
126624979|NCT00632931|455585477|FG001|Part 2|Lack of Efficacy|0|||
126624980|NCT00632931|455585478|FG002|Part 2|Lack of Efficacy|17|||
126624981|NCT00632931|455585476|FG000|Part 2|Withdrawal by Subject|0|||
126624982|NCT00632931|455585477|FG001|Part 2|Withdrawal by Subject|0|||
126624983|NCT00632931|455585478|FG002|Part 2|Withdrawal by Subject|3|||
126624984|NCT01441583|455585481|FG000|Overall Study|Withdrawal by Subject|1|||
126624985|NCT01441583|455585482|FG001|Overall Study|Withdrawal by Subject|1|||
126624986|NCT01441583|455585483|FG002|Overall Study|Withdrawal by Subject|1|||
126624987|NCT01441583|455585481|FG000|Overall Study|Death|1|||
126624988|NCT01441583|455585482|FG001|Overall Study|Death|0|||
126624989|NCT01441583|455585483|FG002|Overall Study|Death|4|||
126624990|NCT01441583|455585481|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
126624991|NCT01441583|455585482|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
126624992|NCT01441583|455585483|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
126624993|NCT03341312|455585484|FG000|Period 1|Withdrawal by Subject|0|||
126624994|NCT03341312|455585485|FG001|Period 1|Withdrawal by Subject|1|||
126624995|NCT03341312|455585486|FG002|Period 1|Withdrawal by Subject|0|||
126624996|NCT03341312|455585487|FG003|Period 1|Withdrawal by Subject|0|||
126624997|NCT00839306|455585488|FG000|Overall Study|Adverse Event|3|||
126624998|NCT00839306|455585489|FG001|Overall Study|Adverse Event|5|||
126624999|NCT00839306|455585488|FG000|Overall Study|Lost to Follow-up|6|||
126625000|NCT00839306|455585489|FG001|Overall Study|Lost to Follow-up|9|||
126625001|NCT00839306|455585488|FG000|Overall Study|Withdrawal by Subject|5|||
126625002|NCT00839306|455585489|FG001|Overall Study|Withdrawal by Subject|7|||
126625003|NCT00839306|455585488|FG000|Overall Study|Lack of Efficacy|5|||
126625004|NCT00839306|455585489|FG001|Overall Study|Lack of Efficacy|4|||
126625005|NCT00839306|455585488|FG000|Overall Study|Other|6|||
126625006|NCT00839306|455585489|FG001|Overall Study|Other|18|||
126625007|NCT01812707|455585490|FG000|Overall Study|Adverse Event|0|||
126625008|NCT01812707|455585491|FG001|Overall Study|Adverse Event|0|||
126625009|NCT01812707|455585492|FG002|Overall Study|Adverse Event|0|||
126625010|NCT01812707|455585493|FG003|Overall Study|Adverse Event|2|||
126625011|NCT01812707|455585490|FG000|Overall Study|Poor compliance to protocol|1|||
126625012|NCT01812707|455585491|FG001|Overall Study|Poor compliance to protocol|0|||
126625013|NCT01812707|455585492|FG002|Overall Study|Poor compliance to protocol|0|||
126625014|NCT01812707|455585493|FG003|Overall Study|Poor compliance to protocol|0|||
126625015|NCT01812707|455585490|FG000|Overall Study|Consent withdrawn by participant|1|||
126625016|NCT01812707|455585491|FG001|Overall Study|Consent withdrawn by participant|0|||
126625017|NCT01812707|455585492|FG002|Overall Study|Consent withdrawn by participant|0|||
126625018|NCT01812707|455585493|FG003|Overall Study|Consent withdrawn by participant|0|||
126625019|NCT05060237|455585494|FG000|Overall Study|Withdrawal by Subject|4|||
126625020|NCT05060237|455585494|FG000|Overall Study|Screening failure|8|||
126625021|NCT01697592|455585495|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
126625022|NCT01697592|455585496|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126625023|NCT01697592|455585497|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126625024|NCT01697592|455585498|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126625025|NCT01697592|455585499|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126625026|NCT01697592|455585500|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126625027|NCT01697592|455585501|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126625028|NCT01697592|455585502|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126625029|NCT01697592|455585503|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126625030|NCT01697592|455585504|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
126625031|NCT01697592|455585495|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126625032|NCT01697592|455585496|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126625033|NCT01697592|455585497|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126625034|NCT01697592|455585498|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126625035|NCT01697592|455585499|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126625036|NCT01697592|455585500|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
126625037|NCT01697592|455585501|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126625038|NCT01697592|455585502|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126625039|NCT01697592|455585503|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126625040|NCT01697592|455585504|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
126625041|NCT01697592|455585495|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
126625042|NCT01697592|455585496|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126625043|NCT01697592|455585497|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126625044|NCT01697592|455585498|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126625045|NCT01697592|455585499|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126625046|NCT01697592|455585500|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126625047|NCT01697592|455585501|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126625048|NCT01697592|455585502|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126625049|NCT01697592|455585503|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126625050|NCT01697592|455585504|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
126625051|NCT01697592|455585495|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
126625052|NCT01697592|455585496|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
126625053|NCT01697592|455585497|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126625054|NCT01697592|455585498|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126625055|NCT01697592|455585499|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126625056|NCT01697592|455585500|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126625057|NCT01697592|455585501|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
126625058|NCT01697592|455585502|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126625059|NCT01697592|455585503|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
126625060|NCT01697592|455585504|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
126625061|NCT01697592|455585495|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
126625062|NCT01697592|455585496|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
126625063|NCT01697592|455585497|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
126625064|NCT01697592|455585498|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
126625065|NCT01697592|455585499|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
126625066|NCT01697592|455585500|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
126625067|NCT01697592|455585501|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
126625068|NCT01697592|455585502|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
126625069|NCT01697592|455585503|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
126625070|NCT01697592|455585504|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
126625071|NCT01697592|455585495|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
126625072|NCT01697592|455585496|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126625073|NCT01697592|455585497|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126625074|NCT01697592|455585498|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
126625075|NCT01697592|455585499|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126625076|NCT01697592|455585500|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126625077|NCT01697592|455585501|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126625078|NCT01697592|455585502|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126625079|NCT01697592|455585503|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126625080|NCT01697592|455585504|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
126625081|NCT01697592|455585495|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
126625082|NCT01697592|455585496|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126625083|NCT01697592|455585497|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126625084|NCT01697592|455585498|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126625085|NCT01697592|455585499|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126625086|NCT01697592|455585500|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
126625087|NCT01697592|455585501|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126625088|NCT01697592|455585502|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
126625089|NCT01697592|455585503|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126625090|NCT01697592|455585504|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
126625091|NCT01697592|455585495|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
126625092|NCT01697592|455585496|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
126625093|NCT01697592|455585497|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
126625094|NCT01697592|455585498|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
126625095|NCT01697592|455585499|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
126625096|NCT01697592|455585500|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
126625097|NCT01697592|455585501|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
126625098|NCT01697592|455585502|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
126625099|NCT01697592|455585503|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
126625100|NCT01697592|455585504|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
126625101|NCT02396758|455585505|FG000|Overall Study|Withdrawal by Subject|2|||
126625102|NCT02396758|455585506|FG001|Overall Study|Withdrawal by Subject|0|||
126625103|NCT02396758|455585507|FG002|Overall Study|Withdrawal by Subject|0|||
126625104|NCT02396758|455585508|FG003|Overall Study|Withdrawal by Subject|1|||
126625105|NCT02396758|455585505|FG000|Overall Study|Lost to Follow-up|8|||
126625106|NCT02396758|455585506|FG001|Overall Study|Lost to Follow-up|5|||
126625107|NCT02396758|455585507|FG002|Overall Study|Lost to Follow-up|3|||
126625108|NCT02396758|455585508|FG003|Overall Study|Lost to Follow-up|3|||
126625109|NCT02396758|455585505|FG000|Overall Study|Death|1|||
126625110|NCT02396758|455585506|FG001|Overall Study|Death|1|||
126625111|NCT02396758|455585507|FG002|Overall Study|Death|0|||
126625112|NCT02396758|455585508|FG003|Overall Study|Death|1|||
126625113|NCT02396758|455585505|FG000|Overall Study|Randomized but not treated|1|||
126625114|NCT02396758|455585506|FG001|Overall Study|Randomized but not treated|0|||
126625115|NCT02396758|455585507|FG002|Overall Study|Randomized but not treated|1|||
126625116|NCT02396758|455585508|FG003|Overall Study|Randomized but not treated|0|||
126625117|NCT00265096|455585509|FG000|Overall Study|Adverse Event|14|||
126625118|NCT00265096|455585510|FG001|Overall Study|Adverse Event|18|||
126625119|NCT00265096|455585511|FG002|Overall Study|Adverse Event|18|||
126625120|NCT00265096|455585509|FG000|Overall Study|Lost to Follow-up|2|||
126625121|NCT00265096|455585510|FG001|Overall Study|Lost to Follow-up|5|||
126625122|NCT00265096|455585511|FG002|Overall Study|Lost to Follow-up|3|||
126625123|NCT00265096|455585509|FG000|Overall Study|Death|0|||
126625124|NCT00265096|455585510|FG001|Overall Study|Death|1|||
126625125|NCT00265096|455585511|FG002|Overall Study|Death|2|||
126625126|NCT00265096|455585509|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
126625127|NCT00265096|455585510|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
126625128|NCT00265096|455585511|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
126625129|NCT00265096|455585509|FG000|Overall Study|Other|11|||
126625130|NCT00265096|455585510|FG001|Overall Study|Other|19|||
126625131|NCT00265096|455585511|FG002|Overall Study|Other|10|||
126625132|NCT00774306|455585512|FG000|Overall Study|Adverse Event|3|||
126625133|NCT00774306|455585513|FG001|Overall Study|Adverse Event|0|||
126625134|NCT00774306|455585514|FG002|Overall Study|Adverse Event|0|||
126625135|NCT00774306|455585515|FG003|Overall Study|Adverse Event|0|||
126625136|NCT00774306|455585512|FG000|Overall Study|Protocol Violation|2|||
126625137|NCT00774306|455585513|FG001|Overall Study|Protocol Violation|0|||
126625138|NCT00774306|455585514|FG002|Overall Study|Protocol Violation|3|||
126625139|NCT00774306|455585515|FG003|Overall Study|Protocol Violation|0|||
126625140|NCT00774306|455585512|FG000|Overall Study|Withdrawal by Subject|6|||
126625141|NCT00774306|455585513|FG001|Overall Study|Withdrawal by Subject|1|||
126625142|NCT00774306|455585514|FG002|Overall Study|Withdrawal by Subject|1|||
126625143|NCT00774306|455585515|FG003|Overall Study|Withdrawal by Subject|0|||
126625144|NCT00774306|455585512|FG000|Overall Study|Lost to Follow-up|6|||
126625145|NCT00774306|455585513|FG001|Overall Study|Lost to Follow-up|0|||
126625146|NCT00774306|455585514|FG002|Overall Study|Lost to Follow-up|4|||
126625147|NCT00774306|455585515|FG003|Overall Study|Lost to Follow-up|5|||
126625148|NCT00774306|455585512|FG000|Overall Study|Death|1|||
126625149|NCT00774306|455585513|FG001|Overall Study|Death|1|||
126625150|NCT00774306|455585514|FG002|Overall Study|Death|0|||
126625151|NCT00774306|455585515|FG003|Overall Study|Death|0|||
126625152|NCT00666835|455585516|FG000|Overall Study|Withdrawal by Subject|5|||
126625153|NCT00666835|455585517|FG001|Overall Study|Withdrawal by Subject|2|||
126625154|NCT00666835|455585516|FG000|Overall Study|Lack of Efficacy|0|||
126625155|NCT00666835|455585517|FG001|Overall Study|Lack of Efficacy|1|||
126625156|NCT00666835|455585516|FG000|Overall Study|Incl./excl. not fulfilled|7|||
126625157|NCT00666835|455585517|FG001|Overall Study|Incl./excl. not fulfilled|2|||
126625158|NCT00666835|455585516|FG000|Overall Study|Adverse Event|7|||
126625159|NCT00666835|455585517|FG001|Overall Study|Adverse Event|6|||
126625160|NCT00666835|455585516|FG000|Overall Study|Protocol Violation|2|||
126625161|NCT00666835|455585517|FG001|Overall Study|Protocol Violation|0|||
126625162|NCT00666835|455585516|FG000|Overall Study|Death|15|||
126625163|NCT00666835|455585517|FG001|Overall Study|Death|4|||
126625164|NCT00666835|455585516|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
126625165|NCT00666835|455585517|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
126625166|NCT00666835|455585516|FG000|Overall Study|Hemoglobulin concentration|4|||
126625167|NCT00666835|455585517|FG001|Overall Study|Hemoglobulin concentration|3|||
126625168|NCT00666835|455585516|FG000|Overall Study|Planned operation|2|||
126625169|NCT00666835|455585517|FG001|Overall Study|Planned operation|0|||
126625170|NCT00666835|455585516|FG000|Overall Study|Physician Decision|1|||
126625171|NCT00666835|455585517|FG001|Overall Study|Physician Decision|2|||
126625172|NCT01126879|455585518|FG000|Overall Study|Progressive Disease|3|||
126625173|NCT01126879|455585519|FG001|Overall Study|Progressive Disease|1|||
126625174|NCT01126879|455585518|FG000|Overall Study|Withdrawal by Subject|1|||
126625175|NCT01126879|455585519|FG001|Overall Study|Withdrawal by Subject|0|||
126625176|NCT01126879|455585518|FG000|Overall Study|Adverse Event|0|||
126625177|NCT01126879|455585519|FG001|Overall Study|Adverse Event|1|||
126625178|NCT01126879|455585518|FG000|Overall Study|Physician Decision|1|||
126625179|NCT01126879|455585519|FG001|Overall Study|Physician Decision|0|||
126625180|NCT03319719|455585522|FG000|Overall Study|Lost to Follow-up|1|||
126625181|NCT03193216|455585526|FG000|Overall Study|Lost to Follow-up|1|||
126625182|NCT03193216|455585527|FG001|Overall Study|Lost to Follow-up|0|||
126625183|NCT03193216|455585526|FG000|Overall Study|Withdrawal by Subject|5|||
126625184|NCT03193216|455585527|FG001|Overall Study|Withdrawal by Subject|0|||
126625185|NCT03193216|455585526|FG000|Overall Study|Physician Decision|4|||
126625186|NCT03193216|455585527|FG001|Overall Study|Physician Decision|0|||
126625187|NCT02236598|455585531|FG000|Overall Study|Adverse Event|0|||
126625188|NCT02236598|455585532|FG001|Overall Study|Adverse Event|1|||
126625189|NCT02236598|455585531|FG000|Overall Study|Withdrawal by Subject|0|||
126625190|NCT02236598|455585532|FG001|Overall Study|Withdrawal by Subject|1|||
126625191|NCT01264887|455585534|FG000|Overall Study|Adverse Event|5|||
126625192|NCT01264887|455585534|FG000|Overall Study|Death|7|||
126625193|NCT01264887|455585534|FG000|Overall Study|Lack of Efficacy|5|||
126625194|NCT01264887|455585534|FG000|Overall Study|Physician Decision|4|||
126625195|NCT01264887|455585534|FG000|Overall Study|Withdrawal by Subject|6|||
126625196|NCT01264887|455585534|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
126625197|NCT01264887|455585534|FG000|Overall Study|Other|2|||
126625198|NCT01061775|455585535|FG000|Overall Study|Physician Decision|2|||
126625199|NCT01061775|455585535|FG000|Overall Study|Lost to Follow-up|1|||
126625200|NCT01313299|455585538|FG000|Overall Study|Adverse Event|3|||
126625201|NCT01313299|455585539|FG001|Overall Study|Adverse Event|1|||
126625202|NCT01313299|455585540|FG002|Overall Study|Adverse Event|1|||
126625203|NCT01313299|455585538|FG000|Overall Study|Lost to Follow-up|1|||
126625204|NCT01313299|455585539|FG001|Overall Study|Lost to Follow-up|0|||
126625205|NCT01313299|455585540|FG002|Overall Study|Lost to Follow-up|0|||
126625206|NCT01313299|455585538|FG000|Overall Study|Protocol Violation|2|||
126625207|NCT01313299|455585539|FG001|Overall Study|Protocol Violation|0|||
126625208|NCT01313299|455585540|FG002|Overall Study|Protocol Violation|0|||
126625209|NCT01313299|455585538|FG000|Overall Study|Withdrawal by Subject|1|||
126625210|NCT01313299|455585539|FG001|Overall Study|Withdrawal by Subject|0|||
126625211|NCT01313299|455585540|FG002|Overall Study|Withdrawal by Subject|2|||
126625212|NCT01313299|455585538|FG000|Overall Study|Family reason and moved out of state|0|||
126625213|NCT01313299|455585539|FG001|Overall Study|Family reason and moved out of state|2|||
126625214|NCT01313299|455585540|FG002|Overall Study|Family reason and moved out of state|0|||
126625215|NCT01313299|455585538|FG000|Overall Study|Lack of subject compliance|0|||
126625216|NCT01313299|455585539|FG001|Overall Study|Lack of subject compliance|0|||
126625217|NCT01313299|455585540|FG002|Overall Study|Lack of subject compliance|1|||
126625218|NCT04089332|455585544|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
126625219|NCT04089332|455585544|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
126625220|NCT04089332|455585544|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
126625221|NCT00975130|455585548|FG000|Study Part 1|Adverse Event|150|||
126625222|NCT00975130|455585549|FG001|Study Part 1|Adverse Event|0|||
126625223|NCT00975130|455585550|FG002|Study Part 1|Adverse Event|0|||
126625224|NCT00975130|455585548|FG000|Study Part 1|Lost to Follow-up|19|||
126625225|NCT00975130|455585549|FG001|Study Part 1|Lost to Follow-up|0|||
126625226|NCT00975130|455585550|FG002|Study Part 1|Lost to Follow-up|0|||
126625227|NCT00975130|455585548|FG000|Study Part 1|Withdrawal by Subject|61|||
126625228|NCT00975130|455585549|FG001|Study Part 1|Withdrawal by Subject|0|||
126625229|NCT00975130|455585550|FG002|Study Part 1|Withdrawal by Subject|0|||
126625230|NCT00975130|455585548|FG000|Study Part 1|Protocol Violation|13|||
126625231|NCT00975130|455585549|FG001|Study Part 1|Protocol Violation|0|||
126625232|NCT00975130|455585550|FG002|Study Part 1|Protocol Violation|0|||
126625233|NCT00975130|455585548|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
126625234|NCT00975130|455585549|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
126625235|NCT00975130|455585550|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
126625236|NCT00975130|455585548|FG000|Study Part 1|Administrative|4|||
126625237|NCT00975130|455585549|FG001|Study Part 1|Administrative|0|||
126625238|NCT00975130|455585550|FG002|Study Part 1|Administrative|0|||
126625239|NCT00975130|455585548|FG000|Study Part 1|Withdrew Consent|24|||
126625240|NCT00975130|455585549|FG001|Study Part 1|Withdrew Consent|0|||
126625241|NCT00975130|455585550|FG002|Study Part 1|Withdrew Consent|0|||
126625242|NCT00975130|455585548|FG000|Study Part 2|Adverse Event|0|||
126625243|NCT00975130|455585549|FG001|Study Part 2|Adverse Event|14|||
126625244|NCT00975130|455585550|FG002|Study Part 2|Adverse Event|7|||
126625245|NCT00975130|455585548|FG000|Study Part 2|Lost to Follow-up|0|||
126625246|NCT00975130|455585549|FG001|Study Part 2|Lost to Follow-up|0|||
126625247|NCT00975130|455585550|FG002|Study Part 2|Lost to Follow-up|1|||
126625248|NCT00975130|455585548|FG000|Study Part 2|Withdrawal by Subject|0|||
126625249|NCT00975130|455585549|FG001|Study Part 2|Withdrawal by Subject|13|||
126625250|NCT00975130|455585550|FG002|Study Part 2|Withdrawal by Subject|5|||
126625251|NCT00975130|455585548|FG000|Study Part 2|Withdrew Consent|0|||
126625252|NCT00975130|455585549|FG001|Study Part 2|Withdrew Consent|6|||
126625253|NCT00975130|455585550|FG002|Study Part 2|Withdrew Consent|2|||
126625254|NCT00975130|455585548|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
126625255|NCT00975130|455585549|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
126625256|NCT00975130|455585550|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
126625257|NCT00975130|455585548|FG000|Study Part 2|Administrative|0|||
126625258|NCT00975130|455585549|FG001|Study Part 2|Administrative|1|||
126625259|NCT00975130|455585550|FG002|Study Part 2|Administrative|0|||
126625260|NCT00975130|455585548|FG000|Study Part 2|Protocol Violation|0|||
126625261|NCT00975130|455585549|FG001|Study Part 2|Protocol Violation|0|||
126625262|NCT00975130|455585550|FG002|Study Part 2|Protocol Violation|1|||
126625263|NCT00240097|455585551|FG000|Part I|Adverse Event|1|||
126625264|NCT00240097|455585551|FG000|Part I|Death|1|||
126625265|NCT00240097|455585551|FG000|Part I|histology|1|||
126625266|NCT00240097|455585551|FG000|Part I|unevaluable|1|||
126625267|NCT00240097|455585551|FG000|Part II|did not continue from Part I|23|||
126625268|NCT00734851|455585552|FG000|Overall Study|Withdrawal by Subject|2|||
126625269|NCT00734851|455585552|FG000|Overall Study|Lost to Follow-up|1|||
126625270|NCT00734851|455585552|FG000|Overall Study|Physician Decision|18|||
126625271|NCT00818519|455585553|FG000|Overall Study|Adverse Event|2|||
126625272|NCT00818519|455585554|FG001|Overall Study|Adverse Event|2|||
126625273|NCT00818519|455585553|FG000|Overall Study|Lost to Follow-up|4|||
126625274|NCT00818519|455585554|FG001|Overall Study|Lost to Follow-up|6|||
126625275|NCT00818519|455585553|FG000|Overall Study|Protocol Violation|2|||
126625276|NCT00818519|455585554|FG001|Overall Study|Protocol Violation|1|||
126625277|NCT00818519|455585553|FG000|Overall Study|Pregnancy|0|||
126625278|NCT00818519|455585554|FG001|Overall Study|Pregnancy|1|||
126625279|NCT00818519|455585553|FG000|Overall Study|Withdrawal by Subject|4|||
126625280|NCT00818519|455585554|FG001|Overall Study|Withdrawal by Subject|9|||
126625281|NCT00818519|455585553|FG000|Overall Study|participant recovered completely|1|||
126625282|NCT00818519|455585554|FG001|Overall Study|participant recovered completely|0|||
126625283|NCT00818519|455585553|FG000|Overall Study|participant will leave for long tme|1|||
126625284|NCT00818519|455585554|FG001|Overall Study|participant will leave for long tme|0|||
126625285|NCT03562117|455585555|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
126625286|NCT03562117|455585556|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
126625287|NCT03562117|455585557|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
126625288|NCT01294358|455585558|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
126625289|NCT01294358|455585559|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
126625290|NCT01294358|455585560|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
126625291|NCT01294358|455585561|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
126625292|NCT01294358|455585562|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
126625293|NCT01294358|455585558|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
126625294|NCT01294358|455585559|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
126625295|NCT01294358|455585560|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
126625296|NCT01294358|455585561|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
126625297|NCT01294358|455585562|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
126625298|NCT01294358|455585558|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
126625299|NCT01294358|455585559|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
126625300|NCT01294358|455585560|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
126625301|NCT01294358|455585561|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
126625302|NCT01294358|455585562|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
126625303|NCT01294358|455585558|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
126625304|NCT01294358|455585559|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
126625305|NCT01294358|455585560|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
126625306|NCT01294358|455585561|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
126625307|NCT01294358|455585562|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
126625308|NCT03356145|455585563|FG000|Overall Study|Withdrawal by Subject|2|||
126625309|NCT03356145|455585564|FG001|Overall Study|Withdrawal by Subject|1|||
126625310|NCT03356145|455585563|FG000|Overall Study|Did not meet inclusion criteria|1|||
126625311|NCT03356145|455585564|FG001|Overall Study|Did not meet inclusion criteria|0|||
126625312|NCT02963922|455585565|FG000|Overall Study|Adverse Event|15|||
126625313|NCT02963922|455585566|FG001|Overall Study|Adverse Event|6|||
126625314|NCT02963922|455585565|FG000|Overall Study|Protocol deviation|6|||
126625315|NCT02963922|455585566|FG001|Overall Study|Protocol deviation|6|||
126625316|NCT02963922|455585565|FG000|Overall Study|Lack of Efficacy|1|||
126625317|NCT02963922|455585566|FG001|Overall Study|Lack of Efficacy|1|||
126625318|NCT02963922|455585565|FG000|Overall Study|Lost to Follow-up|2|||
126625319|NCT02963922|455585566|FG001|Overall Study|Lost to Follow-up|3|||
126625320|NCT02963922|455585565|FG000|Overall Study|Other|8|||
126625321|NCT02963922|455585566|FG001|Overall Study|Other|14|||
126625322|NCT00655668|455585580|FG000|Overall Study|Adverse Event|6|||
126625323|NCT00655668|455585580|FG000|Overall Study|Death|5|||
126625324|NCT00655668|455585580|FG000|Overall Study|Disease Progression|27|||
126625325|NCT00655668|455585580|FG000|Overall Study|Study Terminated|9|||
126625326|NCT00655668|455585580|FG000|Overall Study|Other|1|||
126625327|NCT00655668|455585580|FG000|Overall Study|New Lymphoma Treatment Started|4|||
126625328|NCT00655668|455585580|FG000|Overall Study|Withdrawal by Subject|2|||
126625329|NCT03740919|455585581|FG000|Lead-in Period|Lost to Follow-up|1|||
126625330|NCT03740919|455585582|FG001|Lead-in Period|Lost to Follow-up|0|||
126625331|NCT03740919|455585583|FG002|Lead-in Period|Lost to Follow-up|0|||
126625332|NCT03740919|455585584|FG003|Lead-in Period|Lost to Follow-up|0|||
126625333|NCT03740919|455585581|FG000|Lead-in Period|Physician Decision|2|||
126625334|NCT03740919|455585582|FG001|Lead-in Period|Physician Decision|0|||
126625335|NCT03740919|455585583|FG002|Lead-in Period|Physician Decision|0|||
126625336|NCT03740919|455585584|FG003|Lead-in Period|Physician Decision|0|||
126625337|NCT03740919|455585581|FG000|Lead-in Period|Protocol Violation|1|||
126625338|NCT03740919|455585582|FG001|Lead-in Period|Protocol Violation|0|||
126625339|NCT03740919|455585583|FG002|Lead-in Period|Protocol Violation|0|||
126625340|NCT03740919|455585584|FG003|Lead-in Period|Protocol Violation|0|||
126625341|NCT03740919|455585581|FG000|Lead-in Period|Withdrawal by Subject|10|||
126625342|NCT03740919|455585582|FG001|Lead-in Period|Withdrawal by Subject|0|||
126625343|NCT03740919|455585583|FG002|Lead-in Period|Withdrawal by Subject|0|||
126625344|NCT03740919|455585584|FG003|Lead-in Period|Withdrawal by Subject|0|||
126625345|NCT03740919|455585581|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
126625346|NCT03740919|455585582|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
126625347|NCT03740919|455585583|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
126625348|NCT03740919|455585584|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
126625349|NCT03740919|455585581|FG000|Lead-in Period|Study Task Too Burdensome|1|||
126625350|NCT03740919|455585582|FG001|Lead-in Period|Study Task Too Burdensome|0|||
126625351|NCT03740919|455585583|FG002|Lead-in Period|Study Task Too Burdensome|0|||
126625352|NCT03740919|455585584|FG003|Lead-in Period|Study Task Too Burdensome|0|||
126625353|NCT03740919|455585581|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
126625354|NCT03740919|455585582|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
126625355|NCT03740919|455585583|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
126625356|NCT03740919|455585584|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
126625357|NCT03740919|455585581|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
126625358|NCT03740919|455585582|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
126625359|NCT03740919|455585583|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
126625360|NCT03740919|455585584|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
126625361|NCT03740919|455585581|FG000|Treatment Period|Adverse Event|0|||
126625362|NCT03740919|455585582|FG001|Treatment Period|Adverse Event|0|||
126625363|NCT03740919|455585583|FG002|Treatment Period|Adverse Event|2|||
126625364|NCT03740919|455585584|FG003|Treatment Period|Adverse Event|0|||
126625365|NCT03740919|455585581|FG000|Treatment Period|Protocol Violation|0|||
126625366|NCT03740919|455585582|FG001|Treatment Period|Protocol Violation|1|||
126625367|NCT03740919|455585583|FG002|Treatment Period|Protocol Violation|0|||
126625368|NCT03740919|455585584|FG003|Treatment Period|Protocol Violation|0|||
126625369|NCT03740919|455585581|FG000|Treatment Period|Withdrawal by Subject|0|||
126625370|NCT03740919|455585582|FG001|Treatment Period|Withdrawal by Subject|7|||
126625371|NCT03740919|455585583|FG002|Treatment Period|Withdrawal by Subject|6|||
126625372|NCT03740919|455585584|FG003|Treatment Period|Withdrawal by Subject|2|||
126625373|NCT03740919|455585581|FG000|Treatment Period|Terminated by Sponsor|0|||
126625374|NCT03740919|455585582|FG001|Treatment Period|Terminated by Sponsor|1|||
126625375|NCT03740919|455585583|FG002|Treatment Period|Terminated by Sponsor|0|||
126625376|NCT03740919|455585584|FG003|Treatment Period|Terminated by Sponsor|0|||
126625377|NCT03740919|455585581|FG000|Treatment Period|Issue with Insulin Pump|0|||
126625378|NCT03740919|455585582|FG001|Treatment Period|Issue with Insulin Pump|1|||
126625379|NCT03740919|455585583|FG002|Treatment Period|Issue with Insulin Pump|0|||
126625380|NCT03740919|455585584|FG003|Treatment Period|Issue with Insulin Pump|0|||
126625381|NCT03740919|455585581|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
126625382|NCT03740919|455585582|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
126625383|NCT03740919|455585583|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
126625384|NCT03740919|455585584|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
126625385|NCT03740919|455585581|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
126625386|NCT03740919|455585582|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
126625387|NCT03740919|455585583|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
126625388|NCT03740919|455585584|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
126625389|NCT03740919|455585581|FG000|Treatment Period|Not Completing Diary|0|||
126625390|NCT03740919|455585582|FG001|Treatment Period|Not Completing Diary|0|||
126625391|NCT03740919|455585583|FG002|Treatment Period|Not Completing Diary|1|||
126625392|NCT03740919|455585584|FG003|Treatment Period|Not Completing Diary|0|||
126625393|NCT03740919|455585581|FG000|Treatment Period|Insulin Painful to Participant|0|||
126625394|NCT03740919|455585582|FG001|Treatment Period|Insulin Painful to Participant|0|||
126625395|NCT03740919|455585583|FG002|Treatment Period|Insulin Painful to Participant|1|||
126625396|NCT03740919|455585584|FG003|Treatment Period|Insulin Painful to Participant|0|||
126625397|NCT03873038|455585587|FG000|Part 2|Withdrawal by Subject|0|||
126625398|NCT03873038|455585588|FG001|Part 2|Withdrawal by Subject|0|||
126625399|NCT03873038|455585589|FG002|Part 2|Withdrawal by Subject|0|||
126625400|NCT03873038|455585590|FG003|Part 2|Withdrawal by Subject|0|||
126625401|NCT03873038|455585591|FG004|Part 2|Withdrawal by Subject|0|||
126625402|NCT03873038|455585592|FG005|Part 2|Withdrawal by Subject|1|||
126625403|NCT03873038|455585587|FG000|Part 2|Unknon|0|||
126625404|NCT03873038|455585588|FG001|Part 2|Unknon|0|||
126625405|NCT03873038|455585589|FG002|Part 2|Unknon|0|||
126754491|NCT01117428|456051327|FG005|Overall Study|Adverse Event|2|||
126754492|NCT01117428|456051322|FG000|Overall Study|Death|0|||
126754493|NCT01117428|456051323|FG001|Overall Study|Death|1|||
126754494|NCT01117428|456051324|FG002|Overall Study|Death|2|||
126754495|NCT01117428|456051325|FG003|Overall Study|Death|0|||
126754496|NCT01117428|456051326|FG004|Overall Study|Death|0|||
126754497|NCT01117428|456051327|FG005|Overall Study|Death|1|||
126754498|NCT01117428|456051322|FG000|Overall Study|Physician Decision|0|||
126754499|NCT01117428|456051323|FG001|Overall Study|Physician Decision|1|||
126754500|NCT01117428|456051324|FG002|Overall Study|Physician Decision|0|||
126754501|NCT01117428|456051325|FG003|Overall Study|Physician Decision|0|||
126754502|NCT01117428|456051326|FG004|Overall Study|Physician Decision|0|||
126754503|NCT01117428|456051327|FG005|Overall Study|Physician Decision|0|||
126754504|NCT01117428|456051322|FG000|Overall Study|Withdrawal by Subject|0|||
126754505|NCT01117428|456051323|FG001|Overall Study|Withdrawal by Subject|0|||
126754506|NCT01117428|456051324|FG002|Overall Study|Withdrawal by Subject|1|||
126754507|NCT01117428|456051325|FG003|Overall Study|Withdrawal by Subject|0|||
126754508|NCT01117428|456051326|FG004|Overall Study|Withdrawal by Subject|0|||
126783162|NCT00814320|456160203|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
126625406|NCT03873038|455585590|FG003|Part 2|Unknon|0|||
126625407|NCT03873038|455585591|FG004|Part 2|Unknon|1|||
126625408|NCT03873038|455585592|FG005|Part 2|Unknon|0|||
126625409|NCT00595764|455585593|FG000|Overall Study|Protocol Violation|24|||
126754509|NCT01117428|456051327|FG005|Overall Study|Withdrawal by Subject|0|||
126625410|NCT00595764|455585594|FG001|Overall Study|Protocol Violation|19|||
126754510|NCT01117428|456051322|FG000|Overall Study|Progressive disease|15|||
126754511|NCT01117428|456051323|FG001|Overall Study|Progressive disease|27|||
126625411|NCT00595764|455585593|FG000|Overall Study|Missed Medication >1 week|10|||
126625412|NCT00595764|455585594|FG001|Overall Study|Missed Medication >1 week|17|||
126625413|NCT00595764|455585593|FG000|Overall Study|Missed 3 PM visits|1|||
126625414|NCT00595764|455585594|FG001|Overall Study|Missed 3 PM visits|7|||
126625415|NCT00595764|455585593|FG000|Overall Study|Withdrawal by Subject|4|||
126625416|NCT00595764|455585594|FG001|Overall Study|Withdrawal by Subject|0|||
126625417|NCT04222088|455585595|FG000|Overall Study|Lost to Follow-up|5|||
126625418|NCT04222088|455585596|FG001|Overall Study|Lost to Follow-up|1|||
126625419|NCT04222088|455585595|FG000|Overall Study|Withdrawal by Subject|4|||
126625420|NCT04222088|455585596|FG001|Overall Study|Withdrawal by Subject|0|||
126625421|NCT01332318|455585597|FG000|Overall Study|Adverse Event|0|||
126625422|NCT01332318|455585598|FG001|Overall Study|Adverse Event|3|||
126625423|NCT01332318|455585599|FG002|Overall Study|Adverse Event|0|||
126625424|NCT01332318|455585600|FG003|Overall Study|Adverse Event|0|||
126625425|NCT01332318|455585597|FG000|Overall Study|Withdrawal by Subject|1|||
126625426|NCT01332318|455585598|FG001|Overall Study|Withdrawal by Subject|1|||
126625427|NCT01332318|455585599|FG002|Overall Study|Withdrawal by Subject|0|||
126625428|NCT01332318|455585600|FG003|Overall Study|Withdrawal by Subject|1|||
126625429|NCT01332318|455585597|FG000|Overall Study|Protocol Violation|1|||
126625430|NCT01332318|455585598|FG001|Overall Study|Protocol Violation|0|||
126625431|NCT01332318|455585599|FG002|Overall Study|Protocol Violation|1|||
126625432|NCT01332318|455585600|FG003|Overall Study|Protocol Violation|1|||
126625433|NCT02820298|455585603|FG000|Overall Study|Withdrawal by Subject|0|||
126625434|NCT02820298|455585604|FG001|Overall Study|Withdrawal by Subject|1|||
126625435|NCT02820298|455585603|FG000|Overall Study|Physician Decision|1|||
126625436|NCT02820298|455585604|FG001|Overall Study|Physician Decision|0|||
126625437|NCT02820298|455585603|FG000|Overall Study|Protocol Violation|0|||
126625438|NCT02820298|455585604|FG001|Overall Study|Protocol Violation|1|||
126625439|NCT01894256|455585605|FG000|Part A|Adverse Event|0|||
126625440|NCT01894256|455585606|FG001|Part A|Adverse Event|1|||
126625441|NCT01894256|455585607|FG002|Part A|Adverse Event|0|||
126625442|NCT01894256|455585605|FG000|Part B|Death|0|||
126625443|NCT01894256|455585606|FG001|Part B|Death|1|||
126625444|NCT01894256|455585607|FG002|Part B|Death|1|||
126625445|NCT01894256|455585605|FG000|Part B|Withdrawal by Subject|0|||
126625446|NCT01894256|455585606|FG001|Part B|Withdrawal by Subject|1|||
126625447|NCT01894256|455585607|FG002|Part B|Withdrawal by Subject|0|||
126625448|NCT01894256|455585605|FG000|Part B|Lack of Efficacy|15|||
126625449|NCT01894256|455585606|FG001|Part B|Lack of Efficacy|12|||
126625450|NCT01894256|455585607|FG002|Part B|Lack of Efficacy|13|||
126625451|NCT01780584|455585608|FG000|Overall Study|Death|1|||
126625452|NCT01780584|455585609|FG001|Overall Study|Death|0|||
126625453|NCT01780584|455585610|FG002|Overall Study|Death|1|||
126625454|NCT01780584|455585608|FG000|Overall Study|Adverse Event|0|||
126625455|NCT01780584|455585609|FG001|Overall Study|Adverse Event|1|||
126625456|NCT01780584|455585610|FG002|Overall Study|Adverse Event|0|||
126625457|NCT01780584|455585608|FG000|Overall Study|Protocol Violation|0|||
126625458|NCT01780584|455585609|FG001|Overall Study|Protocol Violation|0|||
126625459|NCT01780584|455585610|FG002|Overall Study|Protocol Violation|1|||
126625460|NCT01679613|455585613|FG000|Overall Study|other than stated above|0|||
126625461|NCT01679613|455585614|FG001|Overall Study|other than stated above|1|||
126625462|NCT01679613|455585615|FG002|Overall Study|other than stated above|2|||
126625463|NCT01679613|455585616|FG003|Overall Study|other than stated above|2|||
126625464|NCT03169530|455585617|FG000|Overall Study|Study ended by NIH|15|||
126625465|NCT03169530|455585618|FG001|Overall Study|Study ended by NIH|17|||
126625466|NCT04783519|455585619|FG000|Overall Study|Withdrawal by Subject|2|||
126625467|NCT04783519|455585620|FG001|Overall Study|Withdrawal by Subject|7|||
126625468|NCT04783519|455585621|FG002|Overall Study|Withdrawal by Subject|3|||
126625469|NCT04783519|455585619|FG000|Overall Study|Lost to Follow-up|9|||
126625470|NCT04783519|455585620|FG001|Overall Study|Lost to Follow-up|7|||
126625471|NCT04783519|455585621|FG002|Overall Study|Lost to Follow-up|6|||
126625472|NCT00727259|455585622|FG000|Overall Study|Not all questionnaires completed|1055|||
126625473|NCT01021683|455585623|FG000|Overall Study|Lack of Efficacy|12|||
126625474|NCT01021683|455585623|FG000|Overall Study|Recovery of neutrophil count|51|||
126625475|NCT01021683|455585623|FG000|Overall Study|Other|8|||
126625476|NCT00645099|455585624|FG000|Overall Study|Lack of Efficacy|15|||
126625477|NCT00645099|455585625|FG001|Overall Study|Lack of Efficacy|6|||
126625478|NCT00645099|455585624|FG000|Overall Study|Withdrawal by Subject|30|||
126625479|NCT00645099|455585625|FG001|Overall Study|Withdrawal by Subject|22|||
126625480|NCT00645099|455585624|FG000|Overall Study|Lost to Follow-up|6|||
126625481|NCT00645099|455585625|FG001|Overall Study|Lost to Follow-up|4|||
126625482|NCT00645099|455585624|FG000|Overall Study|Adverse Event|11|||
126625483|NCT00645099|455585625|FG001|Overall Study|Adverse Event|5|||
126625484|NCT00645099|455585624|FG000|Overall Study|Other|9|||
126625485|NCT00645099|455585625|FG001|Overall Study|Other|5|||
126625486|NCT01201915|455585626|FG000|Overall Study|Adverse Event|2|||
126625487|NCT01201915|455585627|FG001|Overall Study|Adverse Event|1|||
126625488|NCT01201915|455585628|FG002|Overall Study|Adverse Event|1|||
126625489|NCT01201915|455585626|FG000|Overall Study|Lost to Follow-up|0|||
126625490|NCT01201915|455585627|FG001|Overall Study|Lost to Follow-up|4|||
126625491|NCT01201915|455585628|FG002|Overall Study|Lost to Follow-up|0|||
126625492|NCT01201915|455585626|FG000|Overall Study|Physician Decision|3|||
126625493|NCT01201915|455585627|FG001|Overall Study|Physician Decision|0|||
126625494|NCT01201915|455585628|FG002|Overall Study|Physician Decision|0|||
126625495|NCT01201915|455585626|FG000|Overall Study|Subject Decision|3|||
126625496|NCT01201915|455585627|FG001|Overall Study|Subject Decision|3|||
126625497|NCT01201915|455585628|FG002|Overall Study|Subject Decision|5|||
126625498|NCT01201915|455585626|FG000|Overall Study|Target Lesion Progression|0|||
126625499|NCT01201915|455585627|FG001|Overall Study|Target Lesion Progression|3|||
126625500|NCT01201915|455585628|FG002|Overall Study|Target Lesion Progression|0|||
126625501|NCT00796614|455586912|FG000|Overall Study|Adverse Event|1|||
126625502|NCT00796614|455586913|FG001|Overall Study|Adverse Event|2|||
126625503|NCT00796614|455586914|FG002|Overall Study|Adverse Event|0|||
126625504|NCT00796614|455586915|FG003|Overall Study|Adverse Event|0|||
126625505|NCT00796614|455586912|FG000|Overall Study|Protocol Violation|0|||
126625506|NCT00796614|455586913|FG001|Overall Study|Protocol Violation|0|||
126625507|NCT00796614|455586914|FG002|Overall Study|Protocol Violation|2|||
126625508|NCT00796614|455586915|FG003|Overall Study|Protocol Violation|0|||
126625509|NCT00796614|455586912|FG000|Overall Study|Lost to Follow-up|2|||
126625510|NCT00796614|455586913|FG001|Overall Study|Lost to Follow-up|2|||
126625511|NCT00796614|455586914|FG002|Overall Study|Lost to Follow-up|1|||
126625512|NCT00796614|455586915|FG003|Overall Study|Lost to Follow-up|0|||
126625513|NCT00796614|455586912|FG000|Overall Study|Withdrawal by Subject|1|||
126625514|NCT00796614|455586913|FG001|Overall Study|Withdrawal by Subject|0|||
126625515|NCT00796614|455586914|FG002|Overall Study|Withdrawal by Subject|0|||
126625516|NCT00796614|455586915|FG003|Overall Study|Withdrawal by Subject|1|||
126625517|NCT00796614|455586912|FG000|Overall Study|Other than stated|1|||
126625518|NCT00796614|455586913|FG001|Overall Study|Other than stated|0|||
126625519|NCT00796614|455586914|FG002|Overall Study|Other than stated|0|||
126625520|NCT00796614|455586915|FG003|Overall Study|Other than stated|0|||
126625521|NCT01580995|455586918|FG000|Overall Study|Lost to Follow-up|2|||
126625522|NCT01580995|455586919|FG001|Overall Study|Lost to Follow-up|2|||
126625523|NCT01631825|455586924|FG000|Overall Study|Adverse Event|42|||
126625524|NCT01631825|455586924|FG000|Overall Study|Lack of Efficacy|7|||
126625525|NCT01631825|455586924|FG000|Overall Study|Withdrawal by Subject|9|||
126625526|NCT01631825|455586924|FG000|Overall Study|Protocol Violation|4|||
126625527|NCT01631825|455586924|FG000|Overall Study|Discontinuation criteria|1|||
126625528|NCT01631825|455586924|FG000|Overall Study|Physician Decision|2|||
126625529|NCT05109117|455586925|FG000|Overall Study|Lost to Follow-up|1|||
126625530|NCT05109117|455586925|FG000|Overall Study|Discontinued for non-compliance|1|||
126625531|NCT03226353|455586926|FG000|Overall Study|Withdrawal by Subject|1|||
126625532|NCT03226353|455586926|FG000|Overall Study|Screen Failure|5|||
126625533|NCT00498433|455586927|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
126625534|NCT00498433|455586928|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
126625535|NCT00498433|455586929|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
126625536|NCT00498433|455586927|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
126625537|NCT00498433|455586928|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
126625538|NCT00498433|455586929|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
126625539|NCT00498433|455586927|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
126625540|NCT00498433|455586928|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
126625541|NCT00498433|455586929|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
126625542|NCT00498433|455586927|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
126625543|NCT00498433|455586928|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
126625544|NCT00498433|455586929|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
126625545|NCT00744796|455586931|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
126625546|NCT01514864|455586932|FG000|Overall Study|Disease progression|7|||
126625547|NCT01514864|455586933|FG001|Overall Study|Disease progression|5|||
126625548|NCT01514864|455586932|FG000|Overall Study|Study drug toxicity|2|||
126625549|NCT01514864|455586933|FG001|Overall Study|Study drug toxicity|0|||
126625550|NCT02253147|455586934|FG000|Overall Study|Protocol Violation|30|||
126625551|NCT02253147|455586934|FG000|Overall Study|Did not consent to study extension|9|||
126625552|NCT02253147|455586934|FG000|Overall Study|Conditional re-treatment at W52|5|||
126625553|NCT02253147|455586934|FG000|Overall Study|Lost to Follow-up|2|||
126625554|NCT02253147|455586934|FG000|Overall Study|Withdrawal by Subject|1|||
126625555|NCT02254681|455586936|FG000|Overall Study|Lack of Efficacy|6|||
126625556|NCT00797511|455586937|FG000|Overall Study|Withdrawal by Subject|1|||
126625557|NCT00843115|455586938|FG000|Overall Study|Death|4|||
126625558|NCT00843115|455586938|FG000|Overall Study|Adverse Event|30|||
126625559|NCT00843115|455586938|FG000|Overall Study|Lost to Follow-up|4|||
126783163|NCT00814320|456160202|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
126625560|NCT00843115|455586938|FG000|Overall Study|Withdrawal by Subject|17|||
126625561|NCT00843115|455586938|FG000|Overall Study|Family wanted meds stopped|1|||
126783164|NCT00814320|456160203|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
126625562|NCT00843115|455586938|FG000|Overall Study|Family does not want continuation|1|||
126625563|NCT00843115|455586938|FG000|Overall Study|Patient forgot to take meds|1|||
126783165|NCT00814320|456160202|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
126625564|NCT00843115|455586938|FG000|Overall Study|Does not meet entrance criteria|1|||
126625565|NCT00843115|455586938|FG000|Overall Study|Physician Decision|1|||
126625566|NCT00843115|455586938|FG000|Overall Study|Family discontinued meds|1|||
126625567|NCT00843115|455586938|FG000|Overall Study|patient took for 2 days then stopped|1|||
126625568|NCT00843115|455586938|FG000|Overall Study|patient never took the medication|1|||
126625569|NCT00843115|455586938|FG000|Overall Study|hospitalized due to deterioration|1|||
126625570|NCT00843115|455586938|FG000|Overall Study|week 12 not done|1|||
126625571|NCT00843115|455586938|FG000|Overall Study|Syndrome De Glissement|1|||
126625572|NCT02621047|455586939|FG000|Overall Study|Adverse Event|0|||
126625573|NCT02621047|455586940|FG001|Overall Study|Adverse Event|0|||
126625574|NCT02621047|455586941|FG002|Overall Study|Adverse Event|1|||
126625575|NCT02959177|455586942|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
126625576|NCT02959177|455586943|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
126625577|NCT02959177|455586944|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
126625578|NCT02959177|455586942|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
126625579|NCT02959177|455586943|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
126625580|NCT02959177|455586944|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
126625581|NCT02959177|455586942|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
126625582|NCT02959177|455586943|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
126625583|NCT02959177|455586944|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
126625584|NCT02959177|455586942|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
126625585|NCT02959177|455586943|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
126625586|NCT02959177|455586944|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
126625587|NCT02959177|455586942|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
126625588|NCT02959177|455586943|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
126625589|NCT02959177|455586944|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
126625590|NCT02959177|455586942|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
126625591|NCT02959177|455586943|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
126625592|NCT02959177|455586944|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
126625593|NCT02959177|455586942|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
126625594|NCT02959177|455586943|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
126625595|NCT02959177|455586944|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
126625596|NCT01951261|455586947|FG000|Overall Study|Death|1|||
126625597|NCT01951261|455586948|FG001|Overall Study|Death|0|||
126625598|NCT01951261|455586947|FG000|Overall Study|Lost to Follow-up|4|||
126625599|NCT01951261|455586948|FG001|Overall Study|Lost to Follow-up|3|||
126625600|NCT01951261|455586947|FG000|Overall Study|Protocol Violation|4|||
126625601|NCT01951261|455586948|FG001|Overall Study|Protocol Violation|3|||
126625602|NCT01924806|455586949|FG000|Overall Study|Physician Decision|2|||
126625603|NCT01924806|455586950|FG001|Overall Study|Physician Decision|1|||
126625604|NCT01954771|455586951|FG000|Overall Study|Missing HbA1c of end-point|1|||
126625605|NCT01954771|455586952|FG001|Overall Study|Missing HbA1c of end-point|1|||
126625606|NCT01954771|455586953|FG002|Overall Study|Missing HbA1c of end-point|0|||
126625607|NCT01954771|455586951|FG000|Overall Study|Missing CGMS of end-point|1|||
126625608|NCT01954771|455586952|FG001|Overall Study|Missing CGMS of end-point|1|||
126625609|NCT01954771|455586953|FG002|Overall Study|Missing CGMS of end-point|0|||
126625610|NCT01954771|455586951|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
126625611|NCT01954771|455586952|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
126783166|NCT00814320|456160203|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
126783167|NCT00814320|456160202|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
126783168|NCT00814320|456160203|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
126783169|NCT00814320|456160202|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
126783170|NCT00814320|456160203|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
126783171|NCT00814320|456160202|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
126783172|NCT00814320|456160203|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
126783173|NCT00814320|456160202|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
126783174|NCT00814320|456160203|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
126783175|NCT00491504|456160204|FG000|Overall Study|Adverse Event|0|||
126783176|NCT00491504|456160205|FG001|Overall Study|Adverse Event|1|||
126783177|NCT00491504|456160206|FG002|Overall Study|Adverse Event|0|||
126783178|NCT00491504|456160207|FG003|Overall Study|Adverse Event|0|||
126783179|NCT00491504|456160204|FG000|Overall Study|Withdrawal by Subject|0|||
126783180|NCT00491504|456160205|FG001|Overall Study|Withdrawal by Subject|0|||
126783181|NCT00491504|456160206|FG002|Overall Study|Withdrawal by Subject|1|||
126783182|NCT00491504|456160207|FG003|Overall Study|Withdrawal by Subject|2|||
126783183|NCT00491504|456160204|FG000|Overall Study|Protocol Violation|0|||
126783184|NCT00491504|456160205|FG001|Overall Study|Protocol Violation|0|||
126783185|NCT00491504|456160206|FG002|Overall Study|Protocol Violation|3|||
126783186|NCT00491504|456160207|FG003|Overall Study|Protocol Violation|2|||
126625612|NCT01954771|455586953|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
126625613|NCT03635775|455586956|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
126625614|NCT03635775|455586957|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
126783187|NCT02789111|456160210|FG000|Overall Study|Withdrawal by Subject|1|||
126625615|NCT03635775|455586958|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
126625616|NCT03635775|455586959|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
126625617|NCT00050167|455586964|FG000|Overall Study|not eligible not invasive|1|||
126625618|NCT00050167|455586965|FG001|Overall Study|not eligible not invasive|1|||
126625619|NCT00495612|455586966|FG000|Overall Study|Lost to Follow-up|1|||
126625620|NCT00495612|455586967|FG001|Overall Study|Lost to Follow-up|0|||
126625621|NCT00495612|455586966|FG000|Overall Study|Subject's Decision to Withdraw|3|||
126625622|NCT00495612|455586967|FG001|Overall Study|Subject's Decision to Withdraw|0|||
126625623|NCT02864147|455586970|FG000|Overall Study|Withdrawal by Subject|3|||
126625624|NCT02864147|455586971|FG001|Overall Study|Withdrawal by Subject|2|||
126625625|NCT02864147|455586972|FG002|Overall Study|Withdrawal by Subject|1|||
126625626|NCT02864147|455586970|FG000|Overall Study|Lost to Follow-up|0|||
126625627|NCT02864147|455586971|FG001|Overall Study|Lost to Follow-up|4|||
126625628|NCT02864147|455586972|FG002|Overall Study|Lost to Follow-up|0|||
126625629|NCT02864147|455586970|FG000|Overall Study|Adverse Event|0|||
126625630|NCT02864147|455586971|FG001|Overall Study|Adverse Event|1|||
126625631|NCT02864147|455586972|FG002|Overall Study|Adverse Event|0|||
126625632|NCT02864147|455586970|FG000|Overall Study|Pregnancy|4|||
126625633|NCT02864147|455586971|FG001|Overall Study|Pregnancy|0|||
126625634|NCT02864147|455586972|FG002|Overall Study|Pregnancy|0|||
126625635|NCT02864147|455586970|FG000|Overall Study|Physician Decision|0|||
126625636|NCT02864147|455586971|FG001|Overall Study|Physician Decision|0|||
126625637|NCT02864147|455586972|FG002|Overall Study|Physician Decision|1|||
126625638|NCT02864147|455586970|FG000|Overall Study|Opted for excisional procedures|0|||
126625639|NCT02864147|455586971|FG001|Overall Study|Opted for excisional procedures|0|||
126625640|NCT02864147|455586972|FG002|Overall Study|Opted for excisional procedures|3|||
126625641|NCT02383927|455586973|FG000|Overall Study|Disease Progression|8|||
126625642|NCT02383927|455586974|FG001|Overall Study|Disease Progression|8|||
126625643|NCT02383927|455586975|FG002|Overall Study|Disease Progression|15|||
126625644|NCT02383927|455586976|FG003|Overall Study|Disease Progression|4|||
126625645|NCT02383927|455586973|FG000|Overall Study|Physician Decision|0|||
126625646|NCT02383927|455586974|FG001|Overall Study|Physician Decision|0|||
126625647|NCT02383927|455586975|FG002|Overall Study|Physician Decision|2|||
126625648|NCT02383927|455586976|FG003|Overall Study|Physician Decision|0|||
126625649|NCT02383927|455586973|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
126625650|NCT02383927|455586974|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
126625651|NCT02383927|455586975|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
126625652|NCT02383927|455586976|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
126625653|NCT02383927|455586973|FG000|Overall Study|Adverse Event|4|||
126625654|NCT02383927|455586974|FG001|Overall Study|Adverse Event|1|||
126625655|NCT02383927|455586975|FG002|Overall Study|Adverse Event|3|||
126625656|NCT02383927|455586976|FG003|Overall Study|Adverse Event|5|||
126625657|NCT02383927|455586973|FG000|Overall Study|Miscellaneous|1|||
126625658|NCT02383927|455586974|FG001|Overall Study|Miscellaneous|0|||
126625659|NCT02383927|455586975|FG002|Overall Study|Miscellaneous|0|||
126625660|NCT02383927|455586976|FG003|Overall Study|Miscellaneous|1|||
126625661|NCT02383927|455586973|FG000|Overall Study|Withdrawal by Subject|0|||
126625662|NCT02383927|455586974|FG001|Overall Study|Withdrawal by Subject|1|||
126625663|NCT02383927|455586975|FG002|Overall Study|Withdrawal by Subject|4|||
126625664|NCT02383927|455586976|FG003|Overall Study|Withdrawal by Subject|0|||
126625665|NCT03613454|455586979|FG000|Overall Study|Protocol Violation|1|||
126625666|NCT03613454|455586980|FG001|Overall Study|Protocol Violation|0|||
126625667|NCT03613454|455586979|FG000|Overall Study|Protocol Violation|0|||
126625668|NCT03613454|455586980|FG001|Overall Study|Protocol Violation|1|||
126625669|NCT01071317|455586982|FG000|Overall Study|Lost to Follow-up|2|||
126625670|NCT01071317|455586983|FG001|Overall Study|Lost to Follow-up|2|||
126625671|NCT02040532|455586985|FG000|Overall Study|Lost to Follow-up|1|||
126625672|NCT02040532|455586985|FG000|Overall Study|Physician Decision|4|||
126625673|NCT02040532|455586985|FG000|Overall Study|Adverse Event|4|||
126625674|NCT02040532|455586985|FG000|Overall Study|Withdrawal by Subject|3|||
126625675|NCT03640754|455586988|FG000|Overall Study|Withdrawal by Subject|1|||
126625676|NCT03640754|455586989|FG001|Overall Study|Withdrawal by Subject|0|||
126625677|NCT03640754|455586988|FG000|Overall Study|Lost to Follow-up|0|||
126625678|NCT03640754|455586989|FG001|Overall Study|Lost to Follow-up|1|||
126625679|NCT02154516|455586993|FG000|Overall Study|Withdrawal by Subject|0|||
126625680|NCT02154516|455586994|FG001|Overall Study|Withdrawal by Subject|1|||
126625681|NCT02154516|455586993|FG000|Overall Study|Lost to Follow-up|1|||
126625682|NCT02154516|455586994|FG001|Overall Study|Lost to Follow-up|0|||
126625683|NCT02154516|455586993|FG000|Overall Study|Removal/revision of device|1|||
126625684|NCT02154516|455586994|FG001|Overall Study|Removal/revision of device|0|||
126625685|NCT02154516|455586993|FG000|Overall Study|Death|2|||
126625686|NCT02154516|455586994|FG001|Overall Study|Death|1|||
126625687|NCT03406507|455586995|FG000|Extension Period|Lack of Efficacy|0|||
126625688|NCT03406507|455586996|FG001|Extension Period|Lack of Efficacy|1|||
126754512|NCT01117428|456051324|FG002|Overall Study|Progressive disease|10|||
126625689|NCT00663923|455586997|FG000|Overall Study|Lost to Follow-up|2|||
126625690|NCT02965599|455586998|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
126625691|NCT02965599|455586999|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
126625692|NCT00230971|455587000|FG000|Randomization|No study drug administered|3|||
126625693|NCT00230971|455587001|FG001|Randomization|No study drug administered|3|||
126625694|NCT00230971|455587000|FG000|Baseline Participants|Lost to Follow-up|5|||
126625695|NCT00230971|455587001|FG001|Baseline Participants|Lost to Follow-up|12|||
126625696|NCT00230971|455587000|FG000|Baseline Participants|Death|6|||
126625697|NCT00230971|455587001|FG001|Baseline Participants|Death|5|||
126625698|NCT00230971|455587000|FG000|Baseline Participants|Withdrawal by Subject|7|||
126625699|NCT00230971|455587001|FG001|Baseline Participants|Withdrawal by Subject|1|||
126625700|NCT00230971|455587000|FG000|Baseline Participants|Adverse Event|1|||
126625701|NCT00230971|455587001|FG001|Baseline Participants|Adverse Event|0|||
126625702|NCT00230971|455587000|FG000|Baseline Participants|No bacteria observed|1|||
126625703|NCT00230971|455587001|FG001|Baseline Participants|No bacteria observed|0|||
126625704|NCT00230971|455587000|FG000|Baseline Participants|Failure to return|1|||
126625705|NCT00230971|455587001|FG001|Baseline Participants|Failure to return|1|||
126625706|NCT00230971|455587000|FG000|Baseline Participants|Reintervention|1|||
126625707|NCT00230971|455587001|FG001|Baseline Participants|Reintervention|0|||
126625708|NCT01772147|455588580|FG000|Overall Study|Adverse Event|13|||
126625709|NCT01772147|455588581|FG001|Overall Study|Adverse Event|10|||
126625710|NCT01772147|455588582|FG002|Overall Study|Adverse Event|6|||
126625711|NCT01772147|455588580|FG000|Overall Study|Withdrew Consent|7|||
126625712|NCT01772147|455588581|FG001|Overall Study|Withdrew Consent|8|||
126625713|NCT01772147|455588582|FG002|Overall Study|Withdrew Consent|4|||
126625714|NCT01772147|455588580|FG000|Overall Study|Lost to Follow-up|1|||
126625715|NCT01772147|455588581|FG001|Overall Study|Lost to Follow-up|0|||
126625716|NCT01772147|455588582|FG002|Overall Study|Lost to Follow-up|1|||
126625717|NCT01772147|455588580|FG000|Overall Study|Protocol Deviation|2|||
126625718|NCT01772147|455588581|FG001|Overall Study|Protocol Deviation|1|||
126625719|NCT01772147|455588582|FG002|Overall Study|Protocol Deviation|1|||
126625720|NCT01772147|455588580|FG000|Overall Study|Lack of Efficacy|8|||
126625721|NCT01772147|455588581|FG001|Overall Study|Lack of Efficacy|6|||
126625722|NCT01772147|455588582|FG002|Overall Study|Lack of Efficacy|6|||
126625723|NCT00509821|455588584|FG000|Study Period 1 (Induction)|Death|0|||
126625724|NCT00509821|455588585|FG001|Study Period 1 (Induction)|Death|1|||
126625725|NCT00509821|455588584|FG000|Study Period 1 (Induction)|Adverse Event|0|||
126625726|NCT00509821|455588585|FG001|Study Period 1 (Induction)|Adverse Event|2|||
126625727|NCT00509821|455588584|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
126625728|NCT00509821|455588585|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
126625729|NCT01816685|455588586|FG000|Overall Study|Lost to Follow-up|7|||
126625730|NCT01816685|455588587|FG001|Overall Study|Lost to Follow-up|9|||
126625731|NCT01816685|455588586|FG000|Overall Study|Surgery Cancelled|3|||
126625732|NCT01816685|455588587|FG001|Overall Study|Surgery Cancelled|2|||
126625733|NCT03449134|455588588|FG000|52-Week Treatment Period|Death|2|||
126625734|NCT03449134|455588589|FG001|52-Week Treatment Period|Death|1|||
126625735|NCT03449134|455588590|FG002|52-Week Treatment Period|Death|0|||
126625736|NCT03449134|455588588|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
126625737|NCT03449134|455588589|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
126625738|NCT03449134|455588590|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
126625739|NCT03449134|455588588|FG000|52-Week Treatment Period|Physician Decision|2|||
126625740|NCT03449134|455588589|FG001|52-Week Treatment Period|Physician Decision|3|||
126625741|NCT03449134|455588590|FG002|52-Week Treatment Period|Physician Decision|3|||
126625742|NCT03449134|455588588|FG000|52-Week Treatment Period|Screen Failure|1|||
126625743|NCT03449134|455588589|FG001|52-Week Treatment Period|Screen Failure|0|||
126625744|NCT03449134|455588590|FG002|52-Week Treatment Period|Screen Failure|1|||
126625745|NCT03449134|455588588|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
126625746|NCT03449134|455588589|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
126625747|NCT03449134|455588590|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
126625748|NCT03449134|455588588|FG000|52-Week Treatment Period|Site Closure|1|||
126625749|NCT03449134|455588589|FG001|52-Week Treatment Period|Site Closure|0|||
126625750|NCT03449134|455588590|FG002|52-Week Treatment Period|Site Closure|0|||
126625751|NCT00957996|455588591|FG000|Overall Study|Death|4|||
126625752|NCT00957996|455588592|FG001|Overall Study|Death|10|||
126625753|NCT00957996|455588591|FG000|Overall Study|Lost to Follow-up|4|||
126625754|NCT00957996|455588592|FG001|Overall Study|Lost to Follow-up|7|||
126625755|NCT00957996|455588591|FG000|Overall Study|Withdrawal by Subject|9|||
126625756|NCT00957996|455588592|FG001|Overall Study|Withdrawal by Subject|2|||
126625757|NCT00957996|455588591|FG000|Overall Study|Adverse Event|2|||
126625758|NCT00957996|455588592|FG001|Overall Study|Adverse Event|1|||
126625759|NCT00957996|455588591|FG000|Overall Study|Physician Decision|1|||
126625760|NCT00957996|455588592|FG001|Overall Study|Physician Decision|1|||
126625761|NCT00957996|455588591|FG000|Overall Study|Influenza-related complication|0|||
126625762|NCT00957996|455588592|FG001|Overall Study|Influenza-related complication|1|||
126625763|NCT00957996|455588591|FG000|Overall Study|Missing|1|||
126625764|NCT00957996|455588592|FG001|Overall Study|Missing|0|||
126625765|NCT00957996|455588591|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
126625766|NCT00957996|455588592|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
126625767|NCT01960348|455588593|FG000|Overall Study|Adverse event, not serious|2|||
126625768|NCT01960348|455588594|FG001|Overall Study|Adverse event, not serious|2|||
126625769|NCT01960348|455588593|FG000|Overall Study|Adverse event, serious fatal|6|||
126625770|NCT01960348|455588594|FG001|Overall Study|Adverse event, serious fatal|5|||
126625771|NCT01960348|455588593|FG000|Overall Study|Adverse event, serious non-fatal|0|||
126625772|NCT01960348|455588594|FG001|Overall Study|Adverse event, serious non-fatal|3|||
126625773|NCT01960348|455588593|FG000|Overall Study|Withdrawal by Subject|1|||
126625774|NCT01960348|455588594|FG001|Overall Study|Withdrawal by Subject|11|||
126625775|NCT01960348|455588593|FG000|Overall Study|Physician Decision|0|||
126625776|NCT01960348|455588594|FG001|Overall Study|Physician Decision|1|||
126625777|NCT01960348|455588593|FG000|Overall Study|Protocol Violation|1|||
126625778|NCT01960348|455588594|FG001|Overall Study|Protocol Violation|0|||
126625779|NCT00275301|455588595|FG000|Overall Study|Adverse Event|5|||
126625780|NCT02561078|455588600|FG000|Overall Study|Adverse Event|5|||
126625781|NCT02561078|455588601|FG001|Overall Study|Adverse Event|2|||
126625782|NCT02561078|455588600|FG000|Overall Study|Death|2|||
126625783|NCT02561078|455588601|FG001|Overall Study|Death|1|||
126625784|NCT02561078|455588600|FG000|Overall Study|Lost to Follow-up|2|||
126625785|NCT02561078|455588601|FG001|Overall Study|Lost to Follow-up|6|||
126625786|NCT02561078|455588600|FG000|Overall Study|Non-Compliance with Study Drug|6|||
126625787|NCT02561078|455588601|FG001|Overall Study|Non-Compliance with Study Drug|3|||
126625788|NCT02561078|455588600|FG000|Overall Study|Physician Decision|2|||
126625789|NCT02561078|455588601|FG001|Overall Study|Physician Decision|3|||
126625790|NCT02561078|455588600|FG000|Overall Study|Withdrawal by Subject|13|||
126625791|NCT02561078|455588601|FG001|Overall Study|Withdrawal by Subject|10|||
126625792|NCT00598871|455588602|FG000|Overall Study|Adverse Event|0|||
126625793|NCT00598871|455588603|FG001|Overall Study|Adverse Event|1|||
126625794|NCT01983462|455588604|FG000|Overall Study|Adverse Event|1|||
126625795|NCT01983462|455588605|FG001|Overall Study|Adverse Event|0|||
126625796|NCT01983462|455588606|FG002|Overall Study|Adverse Event|0|||
126625797|NCT00684203|455588607|FG000|Overall Study|Adverse Event|6|||
126625798|NCT00684203|455588608|FG001|Overall Study|Adverse Event|4|||
126625799|NCT00684203|455588609|FG002|Overall Study|Adverse Event|8|||
126625800|NCT00684203|455588610|FG003|Overall Study|Adverse Event|0|||
126625801|NCT00684203|455588611|FG004|Overall Study|Adverse Event|0|||
126625802|NCT00684203|455588612|FG005|Overall Study|Adverse Event|0|||
126625803|NCT00684203|455588607|FG000|Overall Study|Protocol-defined clinical event|3|||
126625804|NCT00684203|455588608|FG001|Overall Study|Protocol-defined clinical event|1|||
126625805|NCT00684203|455588609|FG002|Overall Study|Protocol-defined clinical event|0|||
126625806|NCT00684203|455588610|FG003|Overall Study|Protocol-defined clinical event|0|||
126625807|NCT00684203|455588611|FG004|Overall Study|Protocol-defined clinical event|0|||
126625808|NCT00684203|455588612|FG005|Overall Study|Protocol-defined clinical event|0|||
126625809|NCT00684203|455588607|FG000|Overall Study|Withdrawal by Subject|0|||
126625810|NCT00684203|455588608|FG001|Overall Study|Withdrawal by Subject|2|||
126625811|NCT00684203|455588609|FG002|Overall Study|Withdrawal by Subject|1|||
126625812|NCT00684203|455588610|FG003|Overall Study|Withdrawal by Subject|0|||
126625813|NCT00684203|455588611|FG004|Overall Study|Withdrawal by Subject|0|||
126625814|NCT00684203|455588612|FG005|Overall Study|Withdrawal by Subject|0|||
126625815|NCT00684203|455588607|FG000|Overall Study|Did not meet protocol eligibility|0|||
126625816|NCT00684203|455588608|FG001|Overall Study|Did not meet protocol eligibility|1|||
126625817|NCT00684203|455588609|FG002|Overall Study|Did not meet protocol eligibility|0|||
126625818|NCT00684203|455588610|FG003|Overall Study|Did not meet protocol eligibility|0|||
126625819|NCT00684203|455588611|FG004|Overall Study|Did not meet protocol eligibility|0|||
126625820|NCT00684203|455588612|FG005|Overall Study|Did not meet protocol eligibility|0|||
126625821|NCT00719212|455588615|FG000|Overall Study|Death|41|||
126625822|NCT00719212|455588615|FG000|Overall Study|Lost to Follow-up|2|||
126625823|NCT00719212|455588615|FG000|Overall Study|Withdrawal by Subject|1|||
126625824|NCT02151643|455588618|FG000|Overall Study|Adverse Event|2|||
126625825|NCT02151643|455588619|FG001|Overall Study|Adverse Event|0|||
126625826|NCT02151643|455588620|FG002|Overall Study|Adverse Event|1|||
126625827|NCT02151643|455588621|FG003|Overall Study|Adverse Event|4|||
126625828|NCT02151643|455588622|FG004|Overall Study|Adverse Event|0|||
126625829|NCT02151643|455588618|FG000|Overall Study|Withdrawal by Subject|0|||
126625830|NCT02151643|455588619|FG001|Overall Study|Withdrawal by Subject|1|||
126625831|NCT02151643|455588620|FG002|Overall Study|Withdrawal by Subject|1|||
126625832|NCT02151643|455588621|FG003|Overall Study|Withdrawal by Subject|1|||
126625833|NCT02151643|455588622|FG004|Overall Study|Withdrawal by Subject|1|||
126625834|NCT02151643|455588618|FG000|Overall Study|Hyperphosphataemia|1|||
126625835|NCT02151643|455588619|FG001|Overall Study|Hyperphosphataemia|0|||
126625836|NCT02151643|455588620|FG002|Overall Study|Hyperphosphataemia|0|||
126625837|NCT02151643|455588621|FG003|Overall Study|Hyperphosphataemia|0|||
126625838|NCT02151643|455588622|FG004|Overall Study|Hyperphosphataemia|1|||
126625839|NCT02151643|455588618|FG000|Overall Study|High Ferritin levels|3|||
126625840|NCT02151643|455588619|FG001|Overall Study|High Ferritin levels|3|||
126625841|NCT02151643|455588620|FG002|Overall Study|High Ferritin levels|2|||
126625842|NCT02151643|455588621|FG003|Overall Study|High Ferritin levels|2|||
126625843|NCT02151643|455588622|FG004|Overall Study|High Ferritin levels|1|||
126625844|NCT00508274|455588625|FG000|Overall Study|Adverse Event|5|||
126625845|NCT00508274|455588625|FG000|Overall Study|Death|7|||
126625846|NCT00508274|455588625|FG000|Overall Study|Disease progression|32|||
126625847|NCT00508274|455588625|FG000|Overall Study|Withdrawal by Subject|1|||
126625848|NCT00508274|455588625|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
126625849|NCT00508274|455588625|FG000|Overall Study|Missing|3|||
126625850|NCT03296566|455588626|FG000|Overall Study|Lost to Follow-up|19|||
126625851|NCT03296566|455588627|FG001|Overall Study|Lost to Follow-up|46|||
126625852|NCT03296566|455588626|FG000|Overall Study|Withdrawal by Subject|0|||
126625853|NCT03296566|455588627|FG001|Overall Study|Withdrawal by Subject|3|||
126625854|NCT01084239|455588630|FG000|28-Day Follow-up|Lost to Follow-up|4|||
126625855|NCT01084239|455588631|FG001|28-Day Follow-up|Lost to Follow-up|9|||
126625856|NCT02396953|455588632|FG000|Overall Study|Withdrawal by Subject|0|||
126625857|NCT02396953|455588633|FG001|Overall Study|Withdrawal by Subject|0|||
126625858|NCT02396953|455588634|FG002|Overall Study|Withdrawal by Subject|1|||
126625859|NCT02396953|455588632|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
126625860|NCT02396953|455588633|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
126625861|NCT02396953|455588634|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
126625862|NCT02396953|455588632|FG000|Overall Study|Personal Reasons|1|||
126625863|NCT02396953|455588633|FG001|Overall Study|Personal Reasons|1|||
126625864|NCT02396953|455588634|FG002|Overall Study|Personal Reasons|0|||
126625865|NCT03924947|455588635|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
126625866|NCT03924947|455588636|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
126625867|NCT03924947|455588637|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
126625868|NCT03924947|455588638|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
126625869|NCT03924947|455588639|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
126625870|NCT03924947|455588640|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
126625871|NCT02499835|455588641|FG000|Overall Study|Withdrawal by Subject|1|||
126625872|NCT02499835|455588642|FG001|Overall Study|Withdrawal by Subject|0|||
126625873|NCT02499835|455588643|FG002|Overall Study|Withdrawal by Subject|0|||
126625874|NCT02499835|455588644|FG003|Overall Study|Withdrawal by Subject|1|||
126625875|NCT02499835|455588641|FG000|Overall Study|Physician Decision|0|||
126625876|NCT02499835|455588642|FG001|Overall Study|Physician Decision|3|||
126625877|NCT02499835|455588643|FG002|Overall Study|Physician Decision|18|||
126625878|NCT02499835|455588644|FG003|Overall Study|Physician Decision|7|||
126625879|NCT02499835|455588641|FG000|Overall Study|Adverse Event|0|||
126625880|NCT02499835|455588642|FG001|Overall Study|Adverse Event|0|||
126625881|NCT02499835|455588643|FG002|Overall Study|Adverse Event|0|||
126625882|NCT02499835|455588644|FG003|Overall Study|Adverse Event|1|||
126625883|NCT02499835|455588641|FG000|Overall Study|Disease progression|2|||
126625884|NCT02499835|455588642|FG001|Overall Study|Disease progression|1|||
126625885|NCT02499835|455588643|FG002|Overall Study|Disease progression|0|||
126625886|NCT02499835|455588644|FG003|Overall Study|Disease progression|7|||
126625887|NCT04491006|455588646|FG000|Overall Study|Adverse Event|0|||
126625888|NCT04491006|455588647|FG001|Overall Study|Adverse Event|3|||
126625889|NCT04491006|455588648|FG002|Overall Study|Adverse Event|5|||
126625890|NCT04491006|455588646|FG000|Overall Study|Withdrawal by Subject|1|||
126625891|NCT04491006|455588647|FG001|Overall Study|Withdrawal by Subject|0|||
126625892|NCT04491006|455588648|FG002|Overall Study|Withdrawal by Subject|2|||
126625893|NCT02581189|455588653|FG000|Overall Study|Failure to return|36|||
126625894|NCT02581189|455588653|FG000|Overall Study|Withdrew consent|5|||
126625895|NCT02581189|455588653|FG000|Overall Study|Death|3|||
126625896|NCT02581189|455588653|FG000|Overall Study|Insufficient virological response|2|||
126625897|NCT02581189|455588653|FG000|Overall Study|Other, not specified|7|||
126625898|NCT03371485|455588659|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
126625899|NCT03371485|455588659|FG000|2-year Follow-up|Death|5|||
126625900|NCT02204319|455588664|FG000|Overall Study|Pregnancy|1|||
126625901|NCT02204319|455588664|FG000|Overall Study|Withdrawal by Subject|2|||
126625902|NCT04531813|455588669|FG000|Overall Study|Protocol Violation|1|||
126625903|NCT04531813|455588669|FG000|Overall Study|Withdrawal by Subject|1|||
126625904|NCT02171130|455588670|FG000|Overall Study|Death|1|||
126625905|NCT02171130|455588670|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
126783188|NCT02789111|456160211|FG001|Overall Study|Withdrawal by Subject|4|||
126783189|NCT00601484|456160217|FG000|Overall Study|Adverse Event|0|||
126783190|NCT00601484|456160218|FG001|Overall Study|Adverse Event|1|||
126783191|NCT00601484|456160217|FG000|Overall Study|Lost to Follow-up|4|||
126625906|NCT02171130|455588670|FG000|Overall Study|Discontinued; Site Termination|5|||
126625907|NCT02171130|455588670|FG000|Overall Study|Withdrawal by Subject|3|||
126625908|NCT02171130|455588670|FG000|Overall Study|Physician Decision|1|||
126625909|NCT02171130|455588670|FG000|Overall Study|Lost to Follow-up|1|||
126625910|NCT02171130|455588670|FG000|Overall Study|Met Exclusion Criteria|1|||
126625911|NCT02853305|455588673|FG000|Overall Study|Death|287|||
126625912|NCT02853305|455588674|FG001|Overall Study|Death|249|||
126625913|NCT02853305|455588675|FG002|Overall Study|Death|300|||
126625914|NCT02853305|455588673|FG000|Overall Study|Withdrawal by Subject|2|||
126625915|NCT02853305|455588674|FG001|Overall Study|Withdrawal by Subject|8|||
126625916|NCT02853305|455588675|FG002|Overall Study|Withdrawal by Subject|3|||
126625917|NCT02853305|455588673|FG000|Overall Study|Transferred to Extension Study|46|||
126625918|NCT02853305|455588674|FG001|Overall Study|Transferred to Extension Study|30|||
126625919|NCT02853305|455588675|FG002|Overall Study|Transferred to Extension Study|25|||
126625920|NCT02853305|455588673|FG000|Overall Study|Did Not Continue on Extension Study|16|||
126625921|NCT02853305|455588674|FG001|Overall Study|Did Not Continue on Extension Study|20|||
126625922|NCT02853305|455588675|FG002|Overall Study|Did Not Continue on Extension Study|24|||
126625923|NCT02381652|455588678|FG000|Overall Study|Withdrawal by Subject|0|||
126625924|NCT02381652|455588679|FG001|Overall Study|Withdrawal by Subject|0|||
126625925|NCT02381652|455588680|FG002|Overall Study|Withdrawal by Subject|1|||
126625926|NCT01340300|455588681|FG000|Overall Study|Lost to Follow-up|3|||
126625927|NCT01340300|455588682|FG001|Overall Study|Lost to Follow-up|0|||
126625928|NCT01340300|455588683|FG002|Overall Study|Lost to Follow-up|5|||
126625929|NCT01340300|455588684|FG003|Overall Study|Lost to Follow-up|10|||
126625930|NCT01340300|455588681|FG000|Overall Study|Withdrawal by Subject|5|||
126625931|NCT01340300|455588682|FG001|Overall Study|Withdrawal by Subject|6|||
126625932|NCT01340300|455588683|FG002|Overall Study|Withdrawal by Subject|6|||
126625933|NCT01340300|455588684|FG003|Overall Study|Withdrawal by Subject|3|||
126625934|NCT01340300|455588681|FG000|Overall Study|Adverse Event|1|||
126625935|NCT01340300|455588682|FG001|Overall Study|Adverse Event|0|||
126625936|NCT01340300|455588683|FG002|Overall Study|Adverse Event|4|||
126625937|NCT01340300|455588684|FG003|Overall Study|Adverse Event|0|||
126625938|NCT01340300|455588681|FG000|Overall Study|Physician Decision|0|||
126625939|NCT01340300|455588682|FG001|Overall Study|Physician Decision|1|||
126625940|NCT01340300|455588683|FG002|Overall Study|Physician Decision|0|||
126625941|NCT01340300|455588684|FG003|Overall Study|Physician Decision|0|||
126625942|NCT01340300|455588681|FG000|Overall Study|Unrelated sickness|0|||
126625943|NCT01340300|455588682|FG001|Overall Study|Unrelated sickness|2|||
126625944|NCT01340300|455588683|FG002|Overall Study|Unrelated sickness|0|||
126625945|NCT01340300|455588684|FG003|Overall Study|Unrelated sickness|1|||
126625946|NCT03544229|455588685|FG000|Overall Study|Adverse Event|1|||
126625947|NCT03544229|455588686|FG001|Overall Study|Adverse Event|0|||
126625948|NCT03544229|455588687|FG002|Overall Study|Adverse Event|1|||
126625949|NCT03544229|455588688|FG003|Overall Study|Adverse Event|0|||
126625950|NCT03544229|455588685|FG000|Overall Study|Protocol Deviation|0|||
126625951|NCT03544229|455588686|FG001|Overall Study|Protocol Deviation|0|||
126625952|NCT03544229|455588687|FG002|Overall Study|Protocol Deviation|1|||
126625953|NCT03544229|455588688|FG003|Overall Study|Protocol Deviation|0|||
126625954|NCT03544229|455588685|FG000|Overall Study|Lost to Follow-up|3|||
126625955|NCT03544229|455588686|FG001|Overall Study|Lost to Follow-up|0|||
126625956|NCT03544229|455588687|FG002|Overall Study|Lost to Follow-up|0|||
126625957|NCT03544229|455588688|FG003|Overall Study|Lost to Follow-up|2|||
126625958|NCT03544229|455588685|FG000|Overall Study|Voluntary Withdrawal|2|||
126625959|NCT03544229|455588686|FG001|Overall Study|Voluntary Withdrawal|1|||
126625960|NCT03544229|455588687|FG002|Overall Study|Voluntary Withdrawal|3|||
126625961|NCT03544229|455588688|FG003|Overall Study|Voluntary Withdrawal|0|||
126625962|NCT03544229|455588685|FG000|Overall Study|Lack of Efficacy|0|||
126625963|NCT03544229|455588686|FG001|Overall Study|Lack of Efficacy|1|||
126625964|NCT03544229|455588687|FG002|Overall Study|Lack of Efficacy|0|||
126625965|NCT03544229|455588688|FG003|Overall Study|Lack of Efficacy|0|||
126625966|NCT04772313|455588689|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
126625967|NCT04772313|455588689|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
126625968|NCT01836198|455588691|FG000|Part A, Period 2|Protocol Violation|0|||
126625969|NCT01836198|455588692|FG001|Part A, Period 2|Protocol Violation|1|||
126625970|NCT01836198|455588693|FG002|Part A, Period 2|Protocol Violation|0|||
126625971|NCT03187353|455588694|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
126625972|NCT03187353|455588695|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
126625973|NCT03187353|455588694|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
126625974|NCT03187353|455588695|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
126625975|NCT03187353|455588694|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
126625976|NCT03187353|455588695|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
126625977|NCT03187353|455588694|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
126625978|NCT03187353|455588695|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
126625979|NCT03187353|455588694|FG000|Washout (2 Weeks)|Adverse Event|2|||
126625980|NCT03187353|455588695|FG001|Washout (2 Weeks)|Adverse Event|0|||
126625981|NCT03187353|455588694|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
126625982|NCT03187353|455588695|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
126625983|NCT02215954|455588696|FG000|Overall Study|Adverse Event|0|||
126625984|NCT02215954|455588697|FG001|Overall Study|Adverse Event|0|||
126625985|NCT02215954|455588698|FG002|Overall Study|Adverse Event|1|||
126625986|NCT02215954|455588696|FG000|Overall Study|Withdrawal by Subject|0|||
126625987|NCT02215954|455588697|FG001|Overall Study|Withdrawal by Subject|0|||
126625988|NCT02215954|455588698|FG002|Overall Study|Withdrawal by Subject|2|||
126625989|NCT02215954|455588696|FG000|Overall Study|Not exposed|1|||
126625990|NCT02215954|455588697|FG001|Overall Study|Not exposed|1|||
126625991|NCT02215954|455588698|FG002|Overall Study|Not exposed|3|||
126625992|NCT02460562|455588700|FG000|Overall Study|Lost to Follow-up|15|||
126625993|NCT02460562|455588701|FG001|Overall Study|Lost to Follow-up|16|||
126625994|NCT03303521|455588702|FG000|Overall Study|Withdrawal by Subject|2|||
126625995|NCT03303521|455588703|FG001|Overall Study|Withdrawal by Subject|0|||
126625996|NCT03303521|455588702|FG000|Overall Study|Death|1|||
126625997|NCT03303521|455588703|FG001|Overall Study|Death|0|||
126625998|NCT03303521|455588702|FG000|Overall Study|Kidney transplantation|0|||
126625999|NCT03303521|455588703|FG001|Overall Study|Kidney transplantation|1|||
126626000|NCT03303521|455588702|FG000|Overall Study|Investigational product discontinuation|0|||
126626001|NCT03303521|455588703|FG001|Overall Study|Investigational product discontinuation|1|||
126626002|NCT03303521|455588702|FG000|Overall Study|Transferred to non-study dialysis center|1|||
126626003|NCT03303521|455588703|FG001|Overall Study|Transferred to non-study dialysis center|0|||
126626004|NCT03303521|455588702|FG000|Overall Study|Non-comliance to study protocol|0|||
126626005|NCT03303521|455588703|FG001|Overall Study|Non-comliance to study protocol|1|||
126626006|NCT03303521|455588702|FG000|Overall Study|Adverse Event|1|||
126626007|NCT03303521|455588703|FG001|Overall Study|Adverse Event|0|||
126626008|NCT01654289|455588704|FG000|Overall Study|Withdrawal by Subject|10|||
126626009|NCT01654289|455588705|FG001|Overall Study|Withdrawal by Subject|8|||
126626010|NCT01654289|455588706|FG002|Overall Study|Withdrawal by Subject|5|||
126626011|NCT01654289|455588704|FG000|Overall Study|Withdrew from intervention only|17|||
126626012|NCT01654289|455588705|FG001|Overall Study|Withdrew from intervention only|20|||
126626013|NCT01654289|455588706|FG002|Overall Study|Withdrew from intervention only|0|||
126626014|NCT04194541|455588707|FG000|Day 1 Through 13|Lost to Follow-up|3|||
126626015|NCT04194541|455588707|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
126626016|NCT04194541|455588707|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
126626017|NCT02642159|455588708|FG000|Overall Study|Randomized but not treated|1|||
126626018|NCT02642159|455588709|FG001|Overall Study|Randomized but not treated|0|||
126626019|NCT02642159|455588708|FG000|Overall Study|Adverse Event|10|||
126626020|NCT02642159|455588709|FG001|Overall Study|Adverse Event|4|||
126626021|NCT02642159|455588708|FG000|Overall Study|Withdrawal by Subject|9|||
126626022|NCT02642159|455588709|FG001|Overall Study|Withdrawal by Subject|1|||
126626023|NCT02642159|455588708|FG000|Overall Study|Poor compliance to study protocol|1|||
126626024|NCT02642159|455588709|FG001|Overall Study|Poor compliance to study protocol|0|||
126626025|NCT02642159|455588708|FG000|Overall Study|Other than specified above|10|||
126626026|NCT02642159|455588709|FG001|Overall Study|Other than specified above|3|||
126626027|NCT03746483|455588710|FG000|Overall Study|Adverse Event|0|||
126626028|NCT03746483|455588711|FG001|Overall Study|Adverse Event|1|||
126626029|NCT03746483|455588710|FG000|Overall Study|Lack of Efficacy|3|||
126626030|NCT03746483|455588711|FG001|Overall Study|Lack of Efficacy|2|||
126626031|NCT03746483|455588710|FG000|Overall Study|Lost to Follow-up|1|||
126626032|NCT03746483|455588711|FG001|Overall Study|Lost to Follow-up|0|||
126626033|NCT03746483|455588710|FG000|Overall Study|Protocol Violation|2|||
126626034|NCT03746483|455588711|FG001|Overall Study|Protocol Violation|0|||
126626035|NCT00187135|455588712|FG000|Visit One|Withdrawal by Subject|1|||
126626036|NCT00187135|455588713|FG001|Visit One|Withdrawal by Subject|0|||
126626037|NCT00187135|455588714|FG002|Visit One|Withdrawal by Subject|0|||
126626038|NCT00187135|455588715|FG003|Visit One|Withdrawal by Subject|0|||
126626039|NCT00187135|455588716|FG004|Visit One|Withdrawal by Subject|0|||
126626040|NCT00187135|455588717|FG005|Visit One|Withdrawal by Subject|1|||
126626041|NCT00187135|455588712|FG000|Visit One|Physician Decision|3|||
126626042|NCT00187135|455588713|FG001|Visit One|Physician Decision|1|||
126626043|NCT00187135|455588714|FG002|Visit One|Physician Decision|0|||
126626044|NCT00187135|455588715|FG003|Visit One|Physician Decision|0|||
126626045|NCT00187135|455588716|FG004|Visit One|Physician Decision|0|||
126626046|NCT00187135|455588717|FG005|Visit One|Physician Decision|1|||
126626047|NCT00187135|455588712|FG000|Visit Two|Death|0|||
126626048|NCT00187135|455588713|FG001|Visit Two|Death|0|||
126626049|NCT00187135|455588714|FG002|Visit Two|Death|0|||
126626050|NCT00187135|455588715|FG003|Visit Two|Death|1|||
126626051|NCT00187135|455588716|FG004|Visit Two|Death|0|||
126626052|NCT00187135|455588717|FG005|Visit Two|Death|1|||
126626053|NCT00187135|455588712|FG000|Visit Two|Physician Decision|1|||
126626054|NCT00187135|455588713|FG001|Visit Two|Physician Decision|0|||
126626055|NCT00187135|455588714|FG002|Visit Two|Physician Decision|0|||
126626056|NCT00187135|455588715|FG003|Visit Two|Physician Decision|0|||
126626057|NCT00187135|455588716|FG004|Visit Two|Physician Decision|0|||
126626058|NCT00187135|455588717|FG005|Visit Two|Physician Decision|0|||
126626059|NCT00187135|455588712|FG000|Visit Two|Withdrawal by Subject|1|||
126626060|NCT00187135|455588713|FG001|Visit Two|Withdrawal by Subject|1|||
126626061|NCT00187135|455588714|FG002|Visit Two|Withdrawal by Subject|1|||
126626062|NCT00187135|455588715|FG003|Visit Two|Withdrawal by Subject|0|||
126783192|NCT00601484|456160218|FG001|Overall Study|Lost to Follow-up|3|||
126783193|NCT00601484|456160217|FG000|Overall Study|Lack of Efficacy|0|||
126626063|NCT00187135|455588716|FG004|Visit Two|Withdrawal by Subject|1|||
126626064|NCT00187135|455588717|FG005|Visit Two|Withdrawal by Subject|1|||
126626065|NCT00187135|455588712|FG000|Visit Two|Study Discontinued|3|||
126626066|NCT00187135|455588713|FG001|Visit Two|Study Discontinued|2|||
126626067|NCT00187135|455588714|FG002|Visit Two|Study Discontinued|1|||
126626068|NCT00187135|455588715|FG003|Visit Two|Study Discontinued|7|||
126626069|NCT00187135|455588716|FG004|Visit Two|Study Discontinued|5|||
126626070|NCT00187135|455588717|FG005|Visit Two|Study Discontinued|6|||
126783194|NCT00601484|456160218|FG001|Overall Study|Lack of Efficacy|2|||
126783195|NCT00601484|456160217|FG000|Overall Study|Withdrawal by Subject|1|||
126783196|NCT00601484|456160218|FG001|Overall Study|Withdrawal by Subject|1|||
126783197|NCT00601484|456160217|FG000|Overall Study|Randomized, but not treated|0|||
126783198|NCT00601484|456160218|FG001|Overall Study|Randomized, but not treated|1|||
126783199|NCT01463683|456160222|FG000|Overall Study|Adverse Event|2|||
126783200|NCT01463683|456160223|FG001|Overall Study|Adverse Event|0|||
126783201|NCT01463683|456160224|FG002|Overall Study|Adverse Event|0|||
126783202|NCT01463683|456160222|FG000|Overall Study|Lost to Follow-up|10|||
126783203|NCT01463683|456160223|FG001|Overall Study|Lost to Follow-up|9|||
126783204|NCT01463683|456160224|FG002|Overall Study|Lost to Follow-up|7|||
126783205|NCT01463683|456160222|FG000|Overall Study|Physician Decision|0|||
126783206|NCT01463683|456160223|FG001|Overall Study|Physician Decision|3|||
126783207|NCT01463683|456160224|FG002|Overall Study|Physician Decision|1|||
126783208|NCT01463683|456160222|FG000|Overall Study|Pregnancy|2|||
126783209|NCT01463683|456160223|FG001|Overall Study|Pregnancy|2|||
126783210|NCT01463683|456160224|FG002|Overall Study|Pregnancy|1|||
126783211|NCT01463683|456160222|FG000|Overall Study|Withdrawal by Subject|5|||
126783212|NCT01463683|456160223|FG001|Overall Study|Withdrawal by Subject|17|||
126783213|NCT01463683|456160224|FG002|Overall Study|Withdrawal by Subject|2|||
126783214|NCT04345471|456160229|FG000|Overall Study|Adverse Event|8|||
126783215|NCT04345471|456160230|FG001|Overall Study|Adverse Event|5|||
126783216|NCT04345471|456160231|FG002|Overall Study|Adverse Event|6|||
126783217|NCT04345471|456160229|FG000|Overall Study|Lack of Efficacy|1|||
126783218|NCT04345471|456160230|FG001|Overall Study|Lack of Efficacy|1|||
126783219|NCT04345471|456160231|FG002|Overall Study|Lack of Efficacy|0|||
126783220|NCT04345471|456160229|FG000|Overall Study|Protocol Violation|0|||
126783221|NCT04345471|456160230|FG001|Overall Study|Protocol Violation|1|||
126783222|NCT04345471|456160231|FG002|Overall Study|Protocol Violation|2|||
126783223|NCT04345471|456160229|FG000|Overall Study|Withdrawal by Subject|10|||
126783224|NCT04345471|456160230|FG001|Overall Study|Withdrawal by Subject|5|||
126783225|NCT04345471|456160231|FG002|Overall Study|Withdrawal by Subject|10|||
126783226|NCT03896490|456160266|FG000|Overall Study|Withdrawal by Subject|1|||
126783227|NCT03896490|456160267|FG001|Overall Study|Withdrawal by Subject|1|||
126783228|NCT00003782|456160268|FG000|Overall Study|No follow up data|30|||
126783229|NCT00003782|456160269|FG001|Overall Study|No follow up data|31|||
126783230|NCT00003782|456160270|FG002|Overall Study|No follow up data|26|||
126783231|NCT01890707|456160271|FG000|Overall Study|Lost to Follow-up|1|||
126783232|NCT01890707|456160272|FG001|Overall Study|Lost to Follow-up|1|||
126783233|NCT01326026|456160274|FG000|Overall Study|Adverse Event|4|||
126783234|NCT01326026|456160275|FG001|Overall Study|Adverse Event|3|||
126783235|NCT01326026|456160274|FG000|Overall Study|Withdrawal Criteria|5|||
126783236|NCT01326026|456160275|FG001|Overall Study|Withdrawal Criteria|7|||
126783237|NCT01326026|456160274|FG000|Overall Study|Other|3|||
126783238|NCT01326026|456160275|FG001|Overall Study|Other|3|||
126783239|NCT00506753|456162145|FG000|Overall Study|Lost to Follow-up|21|||
126783240|NCT00506753|456162146|FG001|Overall Study|Lost to Follow-up|15|||
126783241|NCT00125359|456162147|FG000|Overall Study|Death|4|||
126783242|NCT00125359|456162147|FG000|Overall Study|Adverse Event|5|||
126783243|NCT00125359|456162147|FG000|Overall Study|Physician Decision|14|||
126783244|NCT02451670|456162148|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
126783245|NCT02451670|456162149|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
126783246|NCT01513551|456162150|FG000|Overall Study|Death|0|||
126783247|NCT01513551|456162151|FG001|Overall Study|Death|1|||
126783248|NCT01513551|456162152|FG002|Overall Study|Death|0|||
126783249|NCT01513551|456162150|FG000|Overall Study|Lost to Follow-up|3|||
126783250|NCT01513551|456162151|FG001|Overall Study|Lost to Follow-up|5|||
126783251|NCT01513551|456162152|FG002|Overall Study|Lost to Follow-up|2|||
126783252|NCT01513551|456162150|FG000|Overall Study|Withdrawal by Subject|1|||
126783253|NCT01513551|456162151|FG001|Overall Study|Withdrawal by Subject|0|||
126783254|NCT01513551|456162152|FG002|Overall Study|Withdrawal by Subject|2|||
126783255|NCT01513551|456162150|FG000|Overall Study|Randomized but not vaccinated|0|||
126783256|NCT01513551|456162151|FG001|Overall Study|Randomized but not vaccinated|0|||
126783257|NCT01513551|456162152|FG002|Overall Study|Randomized but not vaccinated|1|||
126783258|NCT00094302|456162154|FG000|Overall Study|Lost to Follow-up|43|||
126783259|NCT00094302|456162155|FG001|Overall Study|Lost to Follow-up|41|||
126783260|NCT00094302|456162154|FG000|Overall Study|Physician Decision|5|||
126783261|NCT00094302|456162155|FG001|Overall Study|Physician Decision|8|||
126783262|NCT00094302|456162154|FG000|Overall Study|Withdrawal by Subject|103|||
126783263|NCT00094302|456162155|FG001|Overall Study|Withdrawal by Subject|111|||
126783264|NCT00094302|456162154|FG000|Overall Study|Death|266|||
126783265|NCT00094302|456162155|FG001|Overall Study|Death|246|||
126783266|NCT03705351|456162156|FG000|Overall Study|Study termination|3|||
126783267|NCT03705351|456162156|FG000|Overall Study|Death|1|||
126783268|NCT03705351|456162156|FG000|Overall Study|Lack of Efficacy|2|||
126783269|NCT03705351|456162156|FG000|Overall Study|Withdrawal by Subject|1|||
126783270|NCT00322556|456162168|FG000|Overall Study|Adverse Event|1|||
126783271|NCT00322556|456162168|FG000|Overall Study|Withdrawal by Subject|1|||
126783272|NCT00322556|456162168|FG000|Overall Study|Lost to Follow-up|3|||
126783273|NCT00322556|456162168|FG000|Overall Study|Other Reason|7|||
126626071|NCT00187135|455588712|FG000|Visit Three|Death|0|||
126626072|NCT00187135|455588713|FG001|Visit Three|Death|0|||
126626073|NCT00187135|455588714|FG002|Visit Three|Death|1|||
126626074|NCT00187135|455588715|FG003|Visit Three|Death|0|||
126626075|NCT00187135|455588716|FG004|Visit Three|Death|1|||
126626076|NCT00187135|455588717|FG005|Visit Three|Death|0|||
126626077|NCT00187135|455588712|FG000|Visit Three|Withdrawal by Subject|0|||
126626078|NCT00187135|455588713|FG001|Visit Three|Withdrawal by Subject|1|||
126626079|NCT00187135|455588714|FG002|Visit Three|Withdrawal by Subject|1|||
126626080|NCT00187135|455588715|FG003|Visit Three|Withdrawal by Subject|2|||
126626081|NCT00187135|455588716|FG004|Visit Three|Withdrawal by Subject|0|||
126626082|NCT00187135|455588717|FG005|Visit Three|Withdrawal by Subject|0|||
126626083|NCT00187135|455588712|FG000|Visit Three|Study Discontinued|7|||
126626084|NCT00187135|455588713|FG001|Visit Three|Study Discontinued|6|||
126626085|NCT00187135|455588714|FG002|Visit Three|Study Discontinued|7|||
126626086|NCT00187135|455588715|FG003|Visit Three|Study Discontinued|7|||
126626087|NCT00187135|455588716|FG004|Visit Three|Study Discontinued|7|||
126626088|NCT00187135|455588717|FG005|Visit Three|Study Discontinued|6|||
126626089|NCT00297778|455588718|FG000|Overall Study|Adverse Event|16|||
126626090|NCT00297778|455588719|FG001|Overall Study|Adverse Event|10|||
126626091|NCT00297778|455588718|FG000|Overall Study|Withdrawal by Subject|1|||
126626092|NCT00297778|455588719|FG001|Overall Study|Withdrawal by Subject|5|||
126626093|NCT00297778|455588718|FG000|Overall Study|Lack of Efficacy|2|||
126626094|NCT00297778|455588719|FG001|Overall Study|Lack of Efficacy|1|||
126626095|NCT00297778|455588718|FG000|Overall Study|Non-compliant with trial protocol|0|||
126626096|NCT00297778|455588719|FG001|Overall Study|Non-compliant with trial protocol|3|||
126626097|NCT00297778|455588718|FG000|Overall Study|Other|0|||
126626098|NCT00297778|455588719|FG001|Overall Study|Other|1|||
126626099|NCT00679549|455588720|FG000|Overall Study|dropout|2|||
126626100|NCT00679549|455588721|FG001|Overall Study|dropout|4|||
126626101|NCT00679549|455588720|FG000|Overall Study|missing outcome echocardiograms|4|||
126626102|NCT00679549|455588721|FG001|Overall Study|missing outcome echocardiograms|5|||
126626103|NCT03280108|455588722|FG000|Overall Study|Lost to Follow-up|2|||
126626104|NCT03280108|455588723|FG001|Overall Study|Lost to Follow-up|0|||
126626105|NCT02996097|455588724|FG000|Overall Study|Lost to Follow-up|11|||
126626106|NCT02996097|455588725|FG001|Overall Study|Lost to Follow-up|11|||
126626107|NCT02201771|455588726|FG000|Overall Study|Death|3|||
126626108|NCT02201771|455588727|FG001|Overall Study|Death|2|||
126626109|NCT02201771|455588728|FG002|Overall Study|Death|0|||
126626110|NCT02201771|455588726|FG000|Overall Study|Protocol Violation|10|||
126626111|NCT02201771|455588727|FG001|Overall Study|Protocol Violation|8|||
126626112|NCT02201771|455588728|FG002|Overall Study|Protocol Violation|10|||
126626113|NCT01820637|455588729|FG000|Overall Study|Death|2|||
126626114|NCT01820637|455588729|FG000|Overall Study|Withdrawal by Subject|1|||
126626115|NCT00264498|455588730|FG000|Randomized Treatment|Death|0|||
126626116|NCT00264498|455588731|FG001|Randomized Treatment|Death|3|||
126626117|NCT00264498|455588730|FG000|Randomized Treatment|Withdrawal by Subject|0|||
126626118|NCT00264498|455588731|FG001|Randomized Treatment|Withdrawal by Subject|1|||
126626119|NCT00264498|455588730|FG000|Randomized Treatment|Objective disease Progression|13|||
126626120|NCT00264498|455588731|FG001|Randomized Treatment|Objective disease Progression|14|||
126626121|NCT00264498|455588730|FG000|Randomized Treatment|Physician Decision|1|||
126626122|NCT00264498|455588731|FG001|Randomized Treatment|Physician Decision|0|||
126626123|NCT00264498|455588730|FG000|Randomized Treatment|Incorrectly randomized|1|||
126626124|NCT00264498|455588731|FG001|Randomized Treatment|Incorrectly randomized|0|||
126626125|NCT00264498|455588730|FG000|Randomized Treatment|Study Closure|1|||
126626126|NCT00264498|455588731|FG001|Randomized Treatment|Study Closure|0|||
126626127|NCT00264498|455588730|FG000|Randomized Treatment|Protocol Violation|1|||
126626128|NCT00264498|455588731|FG001|Randomized Treatment|Protocol Violation|0|||
126626129|NCT00264498|455588730|FG000|Crossover Treatment|Death|1|||
126626130|NCT00264498|455588731|FG001|Crossover Treatment|Death|3|||
126626131|NCT00264498|455588730|FG000|Crossover Treatment|Objective disease progression|4|||
126626132|NCT00264498|455588731|FG001|Crossover Treatment|Objective disease progression|5|||
126626133|NCT00264498|455588730|FG000|Crossover Treatment|Study closure|0|||
126626134|NCT00264498|455588731|FG001|Crossover Treatment|Study closure|1|||
126626135|NCT00264498|455588730|FG000|Crossover Treatment|Withdrawal by Subject|1|||
126626136|NCT00264498|455588731|FG001|Crossover Treatment|Withdrawal by Subject|0|||
126626137|NCT00583115|455588732|FG000|Overall Study|Death|1|||
126626138|NCT02205476|455588733|FG000|Overall Study|Study termination by Sponsor|7|||
126626139|NCT02205476|455588734|FG001|Overall Study|Study termination by Sponsor|3|||
126626140|NCT02109107|455588735|FG000|Overall Study|Lost to Follow-up|2|||
126626141|NCT00607789|455588741|FG000|Overall Study|Adverse Event|3|||
126626142|NCT00607789|455588742|FG001|Overall Study|Adverse Event|0|||
126626143|NCT00607789|455588741|FG000|Overall Study|Lack of Efficacy|0|||
126626144|NCT00607789|455588742|FG001|Overall Study|Lack of Efficacy|1|||
126626145|NCT00607789|455588741|FG000|Overall Study|Inadequate adherence|3|||
126626146|NCT00607789|455588742|FG001|Overall Study|Inadequate adherence|0|||
126626147|NCT00607789|455588741|FG000|Overall Study|Lost to Follow-up|0|||
126626148|NCT00607789|455588742|FG001|Overall Study|Lost to Follow-up|5|||
126626149|NCT00607789|455588741|FG000|Overall Study|Withdrawal by Subject|1|||
126754513|NCT01117428|456051325|FG003|Overall Study|Progressive disease|12|||
126783274|NCT02058628|456162169|FG000|Overall Study|Adverse Event|1|||
126783275|NCT02058628|456162170|FG001|Overall Study|Adverse Event|0|||
126783276|NCT02058628|456162169|FG000|Overall Study|Withdrawal by Subject|2|||
126783277|NCT02058628|456162170|FG001|Overall Study|Withdrawal by Subject|2|||
126783278|NCT02058628|456162169|FG000|Overall Study|Lost to Follow-up|2|||
126783279|NCT02058628|456162170|FG001|Overall Study|Lost to Follow-up|4|||
126783280|NCT02058628|456162169|FG000|Overall Study|Not in time schedule|0|||
126783281|NCT02058628|456162170|FG001|Overall Study|Not in time schedule|1|||
126783282|NCT02058628|456162169|FG000|Overall Study|The visit date was not in timeline|0|||
126783283|NCT02058628|456162170|FG001|Overall Study|The visit date was not in timeline|1|||
126783284|NCT02058628|456162169|FG000|Overall Study|A lot of time for study for participant|1|||
126783285|NCT02058628|456162170|FG001|Overall Study|A lot of time for study for participant|0|||
126783286|NCT02058628|456162169|FG000|Overall Study|Non compliance|1|||
126783287|NCT02058628|456162170|FG001|Overall Study|Non compliance|0|||
126783288|NCT01767597|456162171|FG000|Overall Study|Incomplete intervention|3|||
126783289|NCT01767597|456162172|FG001|Overall Study|Incomplete intervention|1|||
126783290|NCT01767597|456162171|FG000|Overall Study|Withdrawal by Subject|1|||
126783291|NCT01767597|456162172|FG001|Overall Study|Withdrawal by Subject|0|||
126783292|NCT03355742|456162173|FG000|Overall Study|Lost to Follow-up|4|||
126783293|NCT03355742|456162173|FG000|Overall Study|Withdrawal by Subject|29|||
126783294|NCT03355742|456162173|FG000|Overall Study|Physician Decision|6|||
126783295|NCT03355742|456162173|FG000|Overall Study|Death|55|||
126783296|NCT03355742|456162173|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
126783297|NCT02961920|456162174|FG000|Overall Study|did not achive stydy protocol schedule|1|||
126783298|NCT02961920|456162175|FG001|Overall Study|did not achive stydy protocol schedule|1|||
126783299|NCT04527471|456162178|FG000|Overall Study|Adverse Event|1|||
126783300|NCT04527471|456162179|FG001|Overall Study|Adverse Event|0|||
126783301|NCT04527471|456162178|FG000|Overall Study|Lost to Follow-up|1|||
126783302|NCT04527471|456162179|FG001|Overall Study|Lost to Follow-up|0|||
126783303|NCT00096265|456162187|FG000|Overall Study|Ineligible|1|||
126783304|NCT00096265|456162188|FG001|Overall Study|Ineligible|0|||
126783305|NCT00096265|456162189|FG002|Overall Study|Ineligible|0|||
126783306|NCT01506323|456162190|FG000|Overall Study|Lost to Follow-up|5|||
126783307|NCT01506323|456162191|FG001|Overall Study|Lost to Follow-up|4|||
126783308|NCT01506323|456162190|FG000|Overall Study|Withdrawal by Subject|4|||
126783309|NCT01506323|456162191|FG001|Overall Study|Withdrawal by Subject|4|||
126783310|NCT01506323|456162190|FG000|Overall Study|Lack of Efficacy|1|||
126783311|NCT01506323|456162191|FG001|Overall Study|Lack of Efficacy|3|||
126783312|NCT01506323|456162190|FG000|Overall Study|Moved out of area|5|||
126783313|NCT01506323|456162191|FG001|Overall Study|Moved out of area|2|||
126626150|NCT00607789|455588742|FG001|Overall Study|Withdrawal by Subject|0|||
126626151|NCT01919398|455588743|FG000|Overall Study|Progressive Disease|0|||
126626152|NCT01919398|455588744|FG001|Overall Study|Progressive Disease|0|||
126626153|NCT01919398|455588745|FG002|Overall Study|Progressive Disease|4|||
126626154|NCT02016690|455588746|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
126626155|NCT02016690|455588746|FG000|Overall Study|Excluded from SAS: Duplication|2|||
126626156|NCT02016690|455588746|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
126626157|NCT02016690|455588746|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
126626158|NCT02016690|455588746|FG000|Overall Study|Did not meet inclusion criteria|13|||
126626159|NCT02016690|455588746|FG000|Overall Study|Hospitalized for RSV at study start|3|||
126626160|NCT06016127|455588751|FG000|Overall Study|Withdrawal by Subject|4|||
126626161|NCT06016127|455588752|FG001|Overall Study|Withdrawal by Subject|3|||
126626162|NCT03915951|455588755|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
126626163|NCT03915951|455588756|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
126626164|NCT03915951|455588755|FG000|Overall Study|Adverse Event|12|||
126626165|NCT03915951|455588756|FG001|Overall Study|Adverse Event|6|||
126626166|NCT03915951|455588755|FG000|Overall Study|Disease progression (radiological)|17|||
126626167|NCT03915951|455588756|FG001|Overall Study|Disease progression (radiological)|15|||
126626168|NCT03915951|455588755|FG000|Overall Study|Disease progression (clinical)|4|||
126626169|NCT03915951|455588756|FG001|Overall Study|Disease progression (clinical)|1|||
126626170|NCT03915951|455588755|FG000|Overall Study|Patient decision|0|||
126626171|NCT03915951|455588756|FG001|Overall Study|Patient decision|4|||
126626172|NCT03915951|455588755|FG000|Overall Study|Investigator decision|0|||
126626173|NCT03915951|455588756|FG001|Overall Study|Investigator decision|1|||
126626174|NCT03915951|455588755|FG000|Overall Study|Consent withdrawn|1|||
126626175|NCT03915951|455588756|FG001|Overall Study|Consent withdrawn|1|||
126626176|NCT03915951|455588755|FG000|Overall Study|Death|0|||
126626177|NCT03915951|455588756|FG001|Overall Study|Death|3|||
126626178|NCT02269917|455588758|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
126783314|NCT01506323|456162190|FG000|Overall Study|Schedule or Transportation conflict|8|||
126783315|NCT01506323|456162191|FG001|Overall Study|Schedule or Transportation conflict|0|||
126783316|NCT01506323|456162190|FG000|Overall Study|Started another treatment|1|||
126783317|NCT01506323|456162191|FG001|Overall Study|Started another treatment|0|||
126783318|NCT02891200|456162192|FG000|Overall Study|Lost to Follow-up|31|||
126783319|NCT02891200|456162193|FG001|Overall Study|Lost to Follow-up|36|||
126626179|NCT02269917|455588759|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
126626180|NCT02269917|455588760|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
126626181|NCT02269917|455588758|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
126626182|NCT02269917|455588759|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
126626183|NCT02269917|455588760|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
126626184|NCT02269917|455588758|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
126626185|NCT02269917|455588759|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
126626186|NCT02269917|455588760|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
126626187|NCT02269917|455588758|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
126626188|NCT02269917|455588759|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
126626189|NCT02269917|455588760|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
126626190|NCT02269917|455588758|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
126626191|NCT02269917|455588759|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
126626192|NCT02269917|455588760|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
126626193|NCT02269917|455588758|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
126626194|NCT02269917|455588759|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
126626195|NCT02269917|455588760|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
126626196|NCT02269917|455588758|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
126626197|NCT02269917|455588759|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
126626198|NCT02269917|455588760|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
126626199|NCT02269917|455588758|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
126626200|NCT02269917|455588759|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
126626201|NCT02269917|455588760|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
126626202|NCT02269917|455588758|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
126626203|NCT02269917|455588759|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
126626204|NCT02269917|455588760|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
126626205|NCT02269917|455588758|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
126626206|NCT02269917|455588759|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
126626207|NCT02269917|455588760|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
126626208|NCT02269917|455588758|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
126626209|NCT02269917|455588759|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
126626210|NCT02269917|455588760|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
126626211|NCT02269917|455588758|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
126626212|NCT02269917|455588759|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
126626213|NCT02269917|455588760|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
126626214|NCT02269917|455588758|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
126626215|NCT02269917|455588759|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
126626216|NCT02269917|455588760|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
126626217|NCT02269917|455588758|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
126626218|NCT02269917|455588759|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
126626219|NCT02269917|455588760|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
126626220|NCT02269917|455588758|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
126626221|NCT02269917|455588759|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
126626222|NCT02269917|455588760|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
126626223|NCT02269917|455588758|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
126626224|NCT02269917|455588759|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
126626225|NCT02269917|455588760|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
126626226|NCT02865135|455588764|FG000|Overall Study|Death|0|||
126626227|NCT02865135|455588765|FG001|Overall Study|Death|1|||
126626228|NCT02865135|455588766|FG002|Overall Study|Death|0|||
126626229|NCT02865135|455588764|FG000|Overall Study|Progression|6|||
126626230|NCT02865135|455588765|FG001|Overall Study|Progression|2|||
126626231|NCT02865135|455588766|FG002|Overall Study|Progression|2|||
126626232|NCT02972242|455590806|FG000|Overall Study|Withdrawal by Subject|1|||
126783320|NCT02891200|456162192|FG000|Overall Study|Death|10|||
126783321|NCT02891200|456162193|FG001|Overall Study|Death|9|||
126783322|NCT02891200|456162192|FG000|Overall Study|Withdrawal by Subject|1|||
126783323|NCT02891200|456162193|FG001|Overall Study|Withdrawal by Subject|4|||
126783324|NCT04480463|456162194|FG000|Overall Study|Death|0|||
126783325|NCT04480463|456162195|FG001|Overall Study|Death|1|||
126783326|NCT04480463|456162194|FG000|Overall Study|Adverse Event|6|||
126626233|NCT02972242|455590807|FG001|Overall Study|Withdrawal by Subject|0|||
126626234|NCT04572997|455590808|FG000|Overall Study|Adverse Event|1|||
126626235|NCT02956278|455590809|FG000|Overall Study|Withdrawal by Subject|6|||
126626236|NCT02956278|455590810|FG001|Overall Study|Withdrawal by Subject|2|||
126626237|NCT02956278|455590811|FG002|Overall Study|Withdrawal by Subject|0|||
126626238|NCT00740597|455590820|FG000|Overall Study|insurance would not cover treatment|1|||
126626239|NCT00552513|455590824|FG000|Overall Study|Lost to Follow-up|5|||
126626240|NCT00552513|455590825|FG001|Overall Study|Lost to Follow-up|1|||
126626241|NCT02720185|455590826|FG000|Overall Study|Lost to Follow-up|1|||
126626242|NCT01157351|455590827|FG000|Overall Study|Adverse Event|5|||
126626243|NCT01157351|455590828|FG001|Overall Study|Adverse Event|4|||
126626244|NCT01157351|455590827|FG000|Overall Study|Death|1|||
126626245|NCT01157351|455590828|FG001|Overall Study|Death|0|||
126626246|NCT01157351|455590827|FG000|Overall Study|Lost to Follow-up|53|||
126626247|NCT01157351|455590828|FG001|Overall Study|Lost to Follow-up|55|||
126626248|NCT01157351|455590827|FG000|Overall Study|Withdrawal by Subject|37|||
126626249|NCT01157351|455590828|FG001|Overall Study|Withdrawal by Subject|27|||
126626250|NCT01157351|455590827|FG000|Overall Study|Physician Decision|5|||
126626251|NCT01157351|455590828|FG001|Overall Study|Physician Decision|4|||
126626252|NCT01157351|455590827|FG000|Overall Study|Protocol Violation|0|||
126626253|NCT01157351|455590828|FG001|Overall Study|Protocol Violation|1|||
126626254|NCT01157351|455590827|FG000|Overall Study|Other|32|||
126626255|NCT01157351|455590828|FG001|Overall Study|Other|36|||
126626256|NCT01157351|455590827|FG000|Overall Study|Noncompliance with Study Drug|0|||
126626257|NCT01157351|455590828|FG001|Overall Study|Noncompliance with Study Drug|3|||
126626258|NCT01157351|455590827|FG000|Overall Study|Randomized but not Treated|4|||
126626259|NCT01157351|455590828|FG001|Overall Study|Randomized but not Treated|2|||
126626260|NCT03418493|455590829|FG000|Overall Study|Adverse Event|1|||
126626261|NCT03418493|455590830|FG001|Overall Study|Adverse Event|0|||
126626262|NCT03418493|455590831|FG002|Overall Study|Adverse Event|0|||
126626263|NCT03418493|455590832|FG003|Overall Study|Adverse Event|0|||
126626264|NCT03418493|455590833|FG004|Overall Study|Adverse Event|0|||
126626265|NCT03418493|455590834|FG005|Overall Study|Adverse Event|0|||
126626266|NCT03418493|455590835|FG006|Overall Study|Adverse Event|0|||
126626267|NCT03418493|455590836|FG007|Overall Study|Adverse Event|0|||
126626268|NCT03418493|455590837|FG008|Overall Study|Adverse Event|0|||
126626269|NCT03418493|455590838|FG009|Overall Study|Adverse Event|0|||
126626270|NCT03418493|455590839|FG010|Overall Study|Adverse Event|0|||
126626271|NCT03418493|455590829|FG000|Overall Study|Protocol Violation|0|||
126626272|NCT03418493|455590830|FG001|Overall Study|Protocol Violation|0|||
126626273|NCT03418493|455590831|FG002|Overall Study|Protocol Violation|0|||
126626274|NCT03418493|455590832|FG003|Overall Study|Protocol Violation|0|||
126626275|NCT03418493|455590833|FG004|Overall Study|Protocol Violation|0|||
126626276|NCT03418493|455590834|FG005|Overall Study|Protocol Violation|0|||
126626277|NCT03418493|455590835|FG006|Overall Study|Protocol Violation|0|||
126626278|NCT03418493|455590836|FG007|Overall Study|Protocol Violation|0|||
126626279|NCT03418493|455590837|FG008|Overall Study|Protocol Violation|0|||
126626280|NCT03418493|455590838|FG009|Overall Study|Protocol Violation|1|||
126626281|NCT03418493|455590839|FG010|Overall Study|Protocol Violation|0|||
126626282|NCT05446714|455590840|FG000|Overall Study|Lost to Follow-up|1|||
126626283|NCT05446714|455590841|FG001|Overall Study|Lost to Follow-up|3|||
126626284|NCT05446714|455590842|FG002|Overall Study|Lost to Follow-up|2|||
126626285|NCT05446714|455590840|FG000|Overall Study|Protocol Violation|2|||
126626286|NCT05446714|455590841|FG001|Overall Study|Protocol Violation|0|||
126626287|NCT05446714|455590842|FG002|Overall Study|Protocol Violation|0|||
126626288|NCT00197106|455590845|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
126626289|NCT00197106|455590846|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
126626290|NCT00197106|455590847|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
126626291|NCT00197106|455590845|FG000|Overall Treatment Period|Lack of Efficacy|0|||
126626292|NCT00197106|455590846|FG001|Overall Treatment Period|Lack of Efficacy|1|||
126626293|NCT00197106|455590847|FG002|Overall Treatment Period|Lack of Efficacy|0|||
126626294|NCT00197106|455590845|FG000|Overall Treatment Period|Lost to Follow-up|0|||
126626295|NCT00197106|455590846|FG001|Overall Treatment Period|Lost to Follow-up|0|||
126626296|NCT00197106|455590847|FG002|Overall Treatment Period|Lost to Follow-up|2|||
126626297|NCT00197106|455590845|FG000|Overall Treatment Period|Protocol Violation|0|||
126626298|NCT00197106|455590846|FG001|Overall Treatment Period|Protocol Violation|0|||
126626299|NCT00197106|455590847|FG002|Overall Treatment Period|Protocol Violation|2|||
126626300|NCT00197106|455590845|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
126626301|NCT00197106|455590846|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
126626302|NCT00197106|455590847|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
126626303|NCT00329550|455590850|FG000|Overall Study|Adverse Event|3|||
126626304|NCT00329550|455590851|FG001|Overall Study|Adverse Event|4|||
126626305|NCT00329550|455590852|FG002|Overall Study|Adverse Event|2|||
126626306|NCT00329550|455590850|FG000|Overall Study|Withdrawal of Consent|1|||
126626307|NCT00329550|455590851|FG001|Overall Study|Withdrawal of Consent|0|||
126626308|NCT00329550|455590852|FG002|Overall Study|Withdrawal of Consent|1|||
126626309|NCT00329550|455590850|FG000|Overall Study|Due to Relocation|0|||
126783327|NCT04480463|456162195|FG001|Overall Study|Adverse Event|8|||
126626310|NCT00329550|455590851|FG001|Overall Study|Due to Relocation|0|||
126783328|NCT04480463|456162194|FG000|Overall Study|Lost to Follow-up|3|||
126626311|NCT00329550|455590852|FG002|Overall Study|Due to Relocation|1|||
126626312|NCT02679079|455590853|FG000|Overall Study|Adverse Event|2|||
126626313|NCT02679079|455590854|FG001|Overall Study|Adverse Event|0|||
126626314|NCT02679079|455590855|FG002|Overall Study|Adverse Event|2|||
126626315|NCT02679079|455590853|FG000|Overall Study|Protocol Violation|0|||
126626316|NCT02679079|455590854|FG001|Overall Study|Protocol Violation|1|||
126626317|NCT02679079|455590855|FG002|Overall Study|Protocol Violation|0|||
126626318|NCT02679079|455590853|FG000|Overall Study|Withdrawal by Subject|2|||
126626319|NCT02679079|455590854|FG001|Overall Study|Withdrawal by Subject|1|||
126626320|NCT02679079|455590855|FG002|Overall Study|Withdrawal by Subject|0|||
126626321|NCT04150341|455590856|FG000|Overall Study|Physician Decision|0|||
126626322|NCT04150341|455590857|FG001|Overall Study|Physician Decision|0|||
126626323|NCT04150341|455590858|FG002|Overall Study|Physician Decision|1|||
126626324|NCT04150341|455590859|FG003|Overall Study|Physician Decision|0|||
126626325|NCT04150341|455590860|FG004|Overall Study|Physician Decision|0|||
126626326|NCT04150341|455590861|FG005|Overall Study|Physician Decision|0|||
126626327|NCT04150341|455590856|FG000|Overall Study|Adverse Event|0|||
126626328|NCT04150341|455590857|FG001|Overall Study|Adverse Event|0|||
126626329|NCT04150341|455590858|FG002|Overall Study|Adverse Event|0|||
126626330|NCT04150341|455590859|FG003|Overall Study|Adverse Event|0|||
126626331|NCT04150341|455590860|FG004|Overall Study|Adverse Event|1|||
126626332|NCT04150341|455590861|FG005|Overall Study|Adverse Event|0|||
126626333|NCT00833898|455590868|FG000|Overall Study|Withdrawal by Subject|33|||
126626334|NCT00833898|455590869|FG001|Overall Study|Withdrawal by Subject|27|||
126626335|NCT00833898|455590868|FG000|Overall Study|Lost to Follow-up|7|||
126626336|NCT00833898|455590869|FG001|Overall Study|Lost to Follow-up|7|||
126626337|NCT00833898|455590868|FG000|Overall Study|Patient did not receive transplant|0|||
126626338|NCT00833898|455590869|FG001|Overall Study|Patient did not receive transplant|2|||
126626339|NCT00805285|455590870|FG000|Overall Study|Lack of Efficacy|1|||
126626340|NCT00917462|455590871|FG000|Overall Study|Clinical Deterioration|1|||
126626341|NCT01402063|455590872|FG000|Overall Study|Withdrawal by Subject|3|||
126626342|NCT01402063|455590873|FG001|Overall Study|Withdrawal by Subject|3|||
126626343|NCT02110225|455590877|FG000|Overall Study|Lost to Follow-up|0|||
126626344|NCT02110225|455590878|FG001|Overall Study|Lost to Follow-up|1|||
126626345|NCT02110225|455590879|FG002|Overall Study|Lost to Follow-up|0|||
126626346|NCT02176018|455590880|FG000|Overall Study|Adverse Event|0|||
126626347|NCT02176018|455590881|FG001|Overall Study|Adverse Event|2|||
126626348|NCT02176018|455590880|FG000|Overall Study|Lost to Follow-up|3|||
126626349|NCT02176018|455590881|FG001|Overall Study|Lost to Follow-up|1|||
126626350|NCT02176018|455590880|FG000|Overall Study|Protocol Violation|1|||
126626351|NCT02176018|455590881|FG001|Overall Study|Protocol Violation|1|||
126626352|NCT02176018|455590880|FG000|Overall Study|Withdrawal by Subject|1|||
126626353|NCT02176018|455590881|FG001|Overall Study|Withdrawal by Subject|2|||
126626354|NCT03022045|455590882|FG000|Overall Study|Adverse Event|0|||
126626355|NCT03022045|455590883|FG001|Overall Study|Adverse Event|1|||
126626356|NCT03022045|455590882|FG000|Overall Study|Withdrawal by Subject|1|||
126626357|NCT03022045|455590883|FG001|Overall Study|Withdrawal by Subject|1|||
126626358|NCT03972137|455590890|FG000|Overall Study|Lost to Follow-up|2|||
126626359|NCT03972137|455590890|FG000|Overall Study|Withdrawal by Subject|4|||
126626360|NCT00899379|455590891|FG000|Overall Study|Adverse Event|2|||
126626361|NCT00899379|455590892|FG001|Overall Study|Adverse Event|2|||
126626362|NCT00899379|455590893|FG002|Overall Study|Adverse Event|1|||
126626363|NCT00899379|455590894|FG003|Overall Study|Adverse Event|1|||
126626364|NCT00899379|455590895|FG004|Overall Study|Adverse Event|2|||
126626365|NCT00899379|455590891|FG000|Overall Study|Lack of Efficacy|0|||
126626366|NCT00899379|455590892|FG001|Overall Study|Lack of Efficacy|4|||
126626367|NCT00899379|455590893|FG002|Overall Study|Lack of Efficacy|3|||
126626368|NCT00899379|455590894|FG003|Overall Study|Lack of Efficacy|0|||
126626369|NCT00899379|455590895|FG004|Overall Study|Lack of Efficacy|1|||
126626370|NCT00899379|455590891|FG000|Overall Study|Lost to Follow-up|9|||
126626371|NCT00899379|455590892|FG001|Overall Study|Lost to Follow-up|3|||
126626372|NCT00899379|455590893|FG002|Overall Study|Lost to Follow-up|0|||
126626373|NCT00899379|455590894|FG003|Overall Study|Lost to Follow-up|6|||
126626374|NCT00899379|455590895|FG004|Overall Study|Lost to Follow-up|2|||
126626375|NCT00899379|455590891|FG000|Overall Study|Protocol Violation|0|||
126626376|NCT00899379|455590892|FG001|Overall Study|Protocol Violation|0|||
126626377|NCT00899379|455590893|FG002|Overall Study|Protocol Violation|1|||
126626378|NCT00899379|455590894|FG003|Overall Study|Protocol Violation|1|||
126626379|NCT00899379|455590895|FG004|Overall Study|Protocol Violation|0|||
126626380|NCT00899379|455590891|FG000|Overall Study|Withdrawal by Subject|2|||
126626381|NCT00899379|455590892|FG001|Overall Study|Withdrawal by Subject|4|||
126626382|NCT00899379|455590893|FG002|Overall Study|Withdrawal by Subject|2|||
126626383|NCT00899379|455590894|FG003|Overall Study|Withdrawal by Subject|3|||
126626384|NCT00899379|455590895|FG004|Overall Study|Withdrawal by Subject|6|||
126626385|NCT00899379|455590891|FG000|Overall Study|Pregnancy|0|||
126626386|NCT00899379|455590892|FG001|Overall Study|Pregnancy|0|||
126626387|NCT00899379|455590893|FG002|Overall Study|Pregnancy|1|||
126626388|NCT00899379|455590894|FG003|Overall Study|Pregnancy|0|||
126626389|NCT00899379|455590895|FG004|Overall Study|Pregnancy|1|||
126626390|NCT00899379|455590891|FG000|Overall Study|Patient Uncooperative|0|||
126626391|NCT00899379|455590892|FG001|Overall Study|Patient Uncooperative|1|||
126626392|NCT00899379|455590893|FG002|Overall Study|Patient Uncooperative|0|||
126626393|NCT00899379|455590894|FG003|Overall Study|Patient Uncooperative|1|||
126626394|NCT00899379|455590895|FG004|Overall Study|Patient Uncooperative|2|||
126754514|NCT01117428|456051326|FG004|Overall Study|Progressive disease|16|||
126754515|NCT01117428|456051327|FG005|Overall Study|Progressive disease|17|||
126754516|NCT03018028|456051328|FG000|Overall Study|Withdrawal by Subject|3|||
126626395|NCT00899379|455590891|FG000|Overall Study|Abnormal Baseline ECG|0|||
126626396|NCT00899379|455590892|FG001|Overall Study|Abnormal Baseline ECG|0|||
126626397|NCT00899379|455590893|FG002|Overall Study|Abnormal Baseline ECG|0|||
126626398|NCT00899379|455590894|FG003|Overall Study|Abnormal Baseline ECG|1|||
126626399|NCT00899379|455590895|FG004|Overall Study|Abnormal Baseline ECG|0|||
126626400|NCT00899379|455590891|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
126626401|NCT00899379|455590892|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
126626402|NCT00899379|455590893|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
126626403|NCT00899379|455590894|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126626404|NCT00899379|455590895|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126626405|NCT00899379|455590891|FG000|Overall Study|Not Completed/Entered Extn|5|||
126626406|NCT00899379|455590892|FG001|Overall Study|Not Completed/Entered Extn|1|||
126626407|NCT00899379|455590893|FG002|Overall Study|Not Completed/Entered Extn|6|||
126626408|NCT00899379|455590894|FG003|Overall Study|Not Completed/Entered Extn|4|||
126626409|NCT00899379|455590895|FG004|Overall Study|Not Completed/Entered Extn|3|||
126626410|NCT00899379|455590891|FG000|Overall Study|Study Terminated|3|||
126626411|NCT00899379|455590892|FG001|Overall Study|Study Terminated|0|||
126626412|NCT00899379|455590893|FG002|Overall Study|Study Terminated|3|||
126626413|NCT00899379|455590894|FG003|Overall Study|Study Terminated|3|||
126626414|NCT00899379|455590895|FG004|Overall Study|Study Terminated|1|||
126626415|NCT00899379|455590891|FG000|Overall Study|Lost to Follow-up|3|||
126626416|NCT00899379|455590892|FG001|Overall Study|Lost to Follow-up|1|||
126626417|NCT00899379|455590893|FG002|Overall Study|Lost to Follow-up|0|||
126626418|NCT00899379|455590894|FG003|Overall Study|Lost to Follow-up|2|||
126626419|NCT00899379|455590895|FG004|Overall Study|Lost to Follow-up|5|||
126626420|NCT00899379|455590891|FG000|Overall Study|Withdrawal by Subject|4|||
126626421|NCT00899379|455590892|FG001|Overall Study|Withdrawal by Subject|7|||
126626422|NCT00899379|455590893|FG002|Overall Study|Withdrawal by Subject|4|||
126626423|NCT00899379|455590894|FG003|Overall Study|Withdrawal by Subject|7|||
126626424|NCT00899379|455590895|FG004|Overall Study|Withdrawal by Subject|2|||
126626425|NCT00899379|455590891|FG000|Overall Study|Pregnancy|1|||
126626426|NCT00899379|455590892|FG001|Overall Study|Pregnancy|0|||
126626427|NCT00899379|455590893|FG002|Overall Study|Pregnancy|0|||
126626428|NCT00899379|455590894|FG003|Overall Study|Pregnancy|0|||
126626429|NCT00899379|455590895|FG004|Overall Study|Pregnancy|0|||
126626430|NCT00899379|455590891|FG000|Overall Study|Patient Uncooperative|0|||
126626431|NCT00899379|455590892|FG001|Overall Study|Patient Uncooperative|0|||
126626432|NCT00899379|455590893|FG002|Overall Study|Patient Uncooperative|0|||
126626433|NCT00899379|455590894|FG003|Overall Study|Patient Uncooperative|1|||
126626434|NCT00899379|455590895|FG004|Overall Study|Patient Uncooperative|0|||
126626435|NCT00899379|455590891|FG000|Overall Study|Abnormal Prestudy Labs|0|||
126626436|NCT00899379|455590892|FG001|Overall Study|Abnormal Prestudy Labs|0|||
126626437|NCT00899379|455590893|FG002|Overall Study|Abnormal Prestudy Labs|0|||
126626438|NCT00899379|455590894|FG003|Overall Study|Abnormal Prestudy Labs|0|||
126626439|NCT00899379|455590895|FG004|Overall Study|Abnormal Prestudy Labs|2|||
126626440|NCT00899379|455590891|FG000|Overall Study|Abnormal Baseline ECG|0|||
126626441|NCT00899379|455590892|FG001|Overall Study|Abnormal Baseline ECG|0|||
126626442|NCT00899379|455590893|FG002|Overall Study|Abnormal Baseline ECG|1|||
126626443|NCT00899379|455590894|FG003|Overall Study|Abnormal Baseline ECG|1|||
126626444|NCT00899379|455590895|FG004|Overall Study|Abnormal Baseline ECG|0|||
126626445|NCT00899379|455590891|FG000|Overall Study|No Attack Pretreatment|3|||
126626446|NCT00899379|455590892|FG001|Overall Study|No Attack Pretreatment|5|||
126626447|NCT00899379|455590893|FG002|Overall Study|No Attack Pretreatment|5|||
126626448|NCT00899379|455590894|FG003|Overall Study|No Attack Pretreatment|6|||
126626449|NCT00899379|455590895|FG004|Overall Study|No Attack Pretreatment|4|||
126626450|NCT00899379|455590891|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
126626451|NCT00899379|455590892|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126626452|NCT00899379|455590893|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126626453|NCT00899379|455590894|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126626454|NCT00899379|455590895|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
126626455|NCT00899379|455590891|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
126626456|NCT00899379|455590892|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
126626457|NCT00899379|455590893|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
126626458|NCT00899379|455590894|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
126626459|NCT00899379|455590895|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
126626460|NCT03220776|455590900|FG000|Overall Study|Claustrophobia|0|||
126626461|NCT03220776|455590901|FG001|Overall Study|Claustrophobia|1|||
126626462|NCT03220776|455590902|FG002|Overall Study|Claustrophobia|1|||
126626463|NCT03220776|455590903|FG003|Overall Study|Claustrophobia|0|||
126626464|NCT03220776|455590904|FG004|Overall Study|Claustrophobia|1|||
126626465|NCT03220776|455590905|FG005|Overall Study|Claustrophobia|0|||
126626466|NCT03220776|455590900|FG000|Overall Study|MRI Equipment Failure|1|||
126626467|NCT03220776|455590901|FG001|Overall Study|MRI Equipment Failure|0|||
126626468|NCT03220776|455590902|FG002|Overall Study|MRI Equipment Failure|0|||
126626469|NCT03220776|455590903|FG003|Overall Study|MRI Equipment Failure|0|||
126626470|NCT03220776|455590904|FG004|Overall Study|MRI Equipment Failure|0|||
126626471|NCT03220776|455590905|FG005|Overall Study|MRI Equipment Failure|0|||
126626472|NCT03220776|455590900|FG000|Overall Study|Inclimate Weather|0|||
126626473|NCT03220776|455590901|FG001|Overall Study|Inclimate Weather|0|||
126626474|NCT03220776|455590902|FG002|Overall Study|Inclimate Weather|0|||
126626475|NCT03220776|455590903|FG003|Overall Study|Inclimate Weather|0|||
126626476|NCT03220776|455590904|FG004|Overall Study|Inclimate Weather|0|||
126626477|NCT03220776|455590905|FG005|Overall Study|Inclimate Weather|1|||
126626478|NCT03220776|455590900|FG000|Overall Study|Physician Decision|0|||
126626479|NCT03220776|455590901|FG001|Overall Study|Physician Decision|0|||
126626480|NCT03220776|455590902|FG002|Overall Study|Physician Decision|0|||
126626481|NCT03220776|455590903|FG003|Overall Study|Physician Decision|1|||
126626482|NCT03220776|455590904|FG004|Overall Study|Physician Decision|0|||
126626483|NCT03220776|455590905|FG005|Overall Study|Physician Decision|0|||
126626484|NCT03220776|455590900|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
126626485|NCT03220776|455590901|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
126626486|NCT03220776|455590902|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
126626487|NCT03220776|455590903|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
126626488|NCT03220776|455590904|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
126626489|NCT03220776|455590905|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
126626490|NCT03220776|455590900|FG000|Overall Study|Protocol Violation|0|||
126626491|NCT03220776|455590901|FG001|Overall Study|Protocol Violation|0|||
126626492|NCT03220776|455590902|FG002|Overall Study|Protocol Violation|0|||
126626493|NCT03220776|455590903|FG003|Overall Study|Protocol Violation|2|||
126626494|NCT03220776|455590904|FG004|Overall Study|Protocol Violation|0|||
126626495|NCT03220776|455590905|FG005|Overall Study|Protocol Violation|1|||
126626496|NCT03220776|455590900|FG000|Overall Study|Withdrawal by Subject|1|||
126626497|NCT03220776|455590901|FG001|Overall Study|Withdrawal by Subject|0|||
126626498|NCT03220776|455590902|FG002|Overall Study|Withdrawal by Subject|0|||
126626499|NCT03220776|455590903|FG003|Overall Study|Withdrawal by Subject|0|||
126626500|NCT03220776|455590904|FG004|Overall Study|Withdrawal by Subject|0|||
126626501|NCT03220776|455590905|FG005|Overall Study|Withdrawal by Subject|0|||
126626502|NCT03441789|455590906|FG000|Overall Study|Withdrawal by Subject|1|||
126626503|NCT03441789|455590907|FG001|Overall Study|Withdrawal by Subject|1|||
126626504|NCT03441789|455590906|FG000|Overall Study|Adverse Event|0|||
126626505|NCT03441789|455590907|FG001|Overall Study|Adverse Event|1|||
126626506|NCT03441789|455590906|FG000|Overall Study|Protocol Violation|0|||
126626507|NCT03441789|455590907|FG001|Overall Study|Protocol Violation|1|||
126626508|NCT03441789|455590906|FG000|Overall Study|Lost to Follow-up|0|||
126626509|NCT03441789|455590907|FG001|Overall Study|Lost to Follow-up|1|||
126626510|NCT01780545|455590908|FG000|Overall Study|Withdrawal by Subject|3|||
126626511|NCT01780545|455590909|FG001|Overall Study|Withdrawal by Subject|1|||
126626512|NCT01780545|455590908|FG000|Overall Study|Lost to Follow-up|1|||
126626513|NCT01780545|455590909|FG001|Overall Study|Lost to Follow-up|1|||
126626514|NCT03029234|455590910|FG000|Overall Study|Sponsor Decision|1|||
126626515|NCT03029234|455590910|FG000|Overall Study|Withdrawal by Subject|5|||
126626516|NCT03029234|455590910|FG000|Overall Study|Death|91|||
126626517|NCT03029234|455590910|FG000|Overall Study|Lost to Follow-up|2|||
126626518|NCT02166047|455590914|FG000|Overall Study|Withdrawal by Participant|0|||
126626519|NCT02166047|455590915|FG001|Overall Study|Withdrawal by Participant|1|||
126626520|NCT02166047|455590916|FG002|Overall Study|Withdrawal by Participant|2|||
126626521|NCT02166047|455590917|FG003|Overall Study|Withdrawal by Participant|0|||
126626522|NCT02166047|455590918|FG004|Overall Study|Withdrawal by Participant|0|||
126626523|NCT02166047|455590919|FG005|Overall Study|Withdrawal by Participant|0|||
126626524|NCT02166047|455590920|FG006|Overall Study|Withdrawal by Participant|1|||
126626525|NCT02166047|455590921|FG007|Overall Study|Withdrawal by Participant|0|||
126626526|NCT02166047|455590922|FG008|Overall Study|Withdrawal by Participant|0|||
126626527|NCT02166047|455590923|FG009|Overall Study|Withdrawal by Participant|0|||
126626528|NCT02166047|455590924|FG010|Overall Study|Withdrawal by Participant|0|||
126626529|NCT02166047|455590925|FG011|Overall Study|Withdrawal by Participant|0|||
126626530|NCT02166047|455590914|FG000|Overall Study|Adverse Event|0|||
126626531|NCT02166047|455590915|FG001|Overall Study|Adverse Event|0|||
126626532|NCT02166047|455590916|FG002|Overall Study|Adverse Event|0|||
126626533|NCT02166047|455590917|FG003|Overall Study|Adverse Event|0|||
126783329|NCT04480463|456162195|FG001|Overall Study|Lost to Follow-up|2|||
126783330|NCT04480463|456162194|FG000|Overall Study|Physician Decision|2|||
126626534|NCT02166047|455590918|FG004|Overall Study|Adverse Event|1|||
126626535|NCT02166047|455590919|FG005|Overall Study|Adverse Event|0|||
126626536|NCT02166047|455590920|FG006|Overall Study|Adverse Event|1|||
126626537|NCT02166047|455590921|FG007|Overall Study|Adverse Event|0|||
126626538|NCT02166047|455590922|FG008|Overall Study|Adverse Event|0|||
126626539|NCT02166047|455590923|FG009|Overall Study|Adverse Event|0|||
126626540|NCT02166047|455590924|FG010|Overall Study|Adverse Event|2|||
126626541|NCT02166047|455590925|FG011|Overall Study|Adverse Event|0|||
126626542|NCT01960114|455590926|FG000|Overall Study|Adverse Event|1|||
126626543|NCT01960114|455590927|FG001|Overall Study|Adverse Event|0|||
126626544|NCT01960114|455590926|FG000|Overall Study|Could not swallow study medication|0|||
126626545|NCT01960114|455590927|FG001|Overall Study|Could not swallow study medication|1|||
126626546|NCT02469077|455590928|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
126626547|NCT02469077|455590929|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
126626548|NCT02469077|455590928|FG000|Post Randomization/Intervention Period|Relocated|1|||
126626549|NCT02469077|455590929|FG001|Post Randomization/Intervention Period|Relocated|1|||
126626550|NCT02469077|455590928|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
126626551|NCT02469077|455590929|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
126626552|NCT02469077|455590928|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
126626553|NCT02469077|455590929|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
126626554|NCT00053352|455590935|FG000|Overall Study|Lost to Follow-up|0|||
126626555|NCT00053352|455590936|FG001|Overall Study|Lost to Follow-up|1|||
126626556|NCT00053352|455590935|FG000|Overall Study|Physician Decision|11|||
126626557|NCT00053352|455590936|FG001|Overall Study|Physician Decision|1|||
126626558|NCT00053352|455590935|FG000|Overall Study|Withdrawal by Subject|1|||
126626559|NCT00053352|455590936|FG001|Overall Study|Withdrawal by Subject|0|||
126626560|NCT00053352|455590935|FG000|Overall Study|Ineligible|8|||
126626561|NCT00053352|455590936|FG001|Overall Study|Ineligible|8|||
126626562|NCT00053352|455590935|FG000|Overall Study|Disease at new site|1|||
126626563|NCT00053352|455590936|FG001|Overall Study|Disease at new site|0|||
126626564|NCT00439647|455590937|FG000|Overall Study|Withdrawal by Subject|25|||
126626565|NCT00439647|455590938|FG001|Overall Study|Withdrawal by Subject|22|||
126626566|NCT00439647|455590937|FG000|Overall Study|Death|15|||
126626567|NCT00439647|455590938|FG001|Overall Study|Death|18|||
126626568|NCT00439647|455590937|FG000|Overall Study|Adverse Event|11|||
126626569|NCT00439647|455590938|FG001|Overall Study|Adverse Event|11|||
126626570|NCT00439647|455590937|FG000|Overall Study|Lost to Follow-up|4|||
126626571|NCT00439647|455590938|FG001|Overall Study|Lost to Follow-up|12|||
126626572|NCT00439647|455590937|FG000|Overall Study|Protocol Violation|3|||
126626573|NCT00439647|455590938|FG001|Overall Study|Protocol Violation|4|||
126626574|NCT00439647|455590937|FG000|Overall Study|Lack of Efficacy|0|||
126626575|NCT00439647|455590938|FG001|Overall Study|Lack of Efficacy|4|||
126626576|NCT02845375|455590939|FG000|Overall Study|upper airway obstruction|1|||
126626577|NCT02845375|455590940|FG001|Overall Study|upper airway obstruction|2|||
126626578|NCT02845375|455590941|FG002|Overall Study|upper airway obstruction|1|||
126626579|NCT01177137|455590945|FG000|Overall Study|Withdrawal by Subject|10|||
126626580|NCT01177137|455590946|FG001|Overall Study|Withdrawal by Subject|10|||
126626581|NCT01177137|455590947|FG002|Overall Study|Withdrawal by Subject|2|||
126626582|NCT01287416|455590948|FG000|Pre-post Training|Withdrawal by Subject|17|||
126626583|NCT01287416|455590949|FG001|Pre-post Training|Withdrawal by Subject|24|||
126626584|NCT01287416|455590948|FG000|Pre-post Training|Lost to Follow-up|5|||
126626585|NCT01287416|455590949|FG001|Pre-post Training|Lost to Follow-up|1|||
126626586|NCT01287416|455590948|FG000|6 Month Follow-up|Lost to Follow-up|3|||
126626587|NCT01287416|455590949|FG001|6 Month Follow-up|Lost to Follow-up|2|||
126626588|NCT02506881|455590950|FG000|First Intervention (Day 1)|Protocol Violation|0|||
126626589|NCT02506881|455590951|FG001|First Intervention (Day 1)|Protocol Violation|0|||
126626590|NCT02506881|455590952|FG002|First Intervention (Day 1)|Protocol Violation|1|||
126626591|NCT02506881|455590953|FG003|First Intervention (Day 1)|Protocol Violation|0|||
126626592|NCT02506881|455590950|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
126626593|NCT02506881|455590951|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
126626594|NCT02506881|455590952|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
126626595|NCT02506881|455590953|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
126626596|NCT02506881|455590950|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
126626597|NCT02506881|455590951|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
126626598|NCT02506881|455590952|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
126626599|NCT02506881|455590953|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
126626600|NCT02515097|455590956|FG000|Overall Study|Lost to Follow-up|4|||
126626601|NCT02515097|455590957|FG001|Overall Study|Lost to Follow-up|2|||
126626602|NCT02515097|455590956|FG000|Overall Study|Withdrawal by Subject|1|||
126626603|NCT02515097|455590957|FG001|Overall Study|Withdrawal by Subject|3|||
126626604|NCT02515097|455590956|FG000|Overall Study|Adverse Event|2|||
126626605|NCT02515097|455590957|FG001|Overall Study|Adverse Event|1|||
126626606|NCT01121185|455590961|FG000|Overall Study|Not infused|0|||
126626607|NCT01121185|455590962|FG001|Overall Study|Not infused|1|||
126626608|NCT01121185|455590961|FG000|Overall Study|Not transplanted|1|||
126626609|NCT01121185|455590962|FG001|Overall Study|Not transplanted|0|||
126626610|NCT01196741|455590965|FG000|Overall Study|Disease progression|34|||
126783331|NCT04480463|456162195|FG001|Overall Study|Physician Decision|5|||
126783332|NCT04480463|456162194|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
126626611|NCT01196741|455590966|FG001|Overall Study|Disease progression|14|||
126783333|NCT04480463|456162195|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
126783334|NCT04480463|456162194|FG000|Overall Study|Protocol Violation|2|||
126626612|NCT01196741|455590965|FG000|Overall Study|Adverse Event|10|||
126626613|NCT01196741|455590966|FG001|Overall Study|Adverse Event|6|||
126626614|NCT01196741|455590965|FG000|Overall Study|Serious Adverse Event|3|||
126626615|NCT01196741|455590966|FG001|Overall Study|Serious Adverse Event|1|||
126626616|NCT01196741|455590965|FG000|Overall Study|Dose limiting Adverse Event|2|||
126626617|NCT01196741|455590966|FG001|Overall Study|Dose limiting Adverse Event|1|||
126626618|NCT01196741|455590965|FG000|Overall Study|Withdrawal by Subject|3|||
126626619|NCT01196741|455590966|FG001|Overall Study|Withdrawal by Subject|0|||
126626620|NCT01196741|455590965|FG000|Overall Study|Other reason|3|||
126626621|NCT01196741|455590966|FG001|Overall Study|Other reason|3|||
126626622|NCT01196741|455590965|FG000|Overall Study|Other|3|||
126626623|NCT01196741|455590966|FG001|Overall Study|Other|2|||
126626624|NCT01196741|455590965|FG000|Overall Study|Protocol Violation|2|||
126626625|NCT01196741|455590966|FG001|Overall Study|Protocol Violation|1|||
126626626|NCT01204775|455590972|FG000|Overall Study|Poor/non-compliance|0|||
126626627|NCT01204775|455590973|FG001|Overall Study|Poor/non-compliance|1|||
126626628|NCT01204775|455590972|FG000|Overall Study|Withdrawal by Subject|1|||
126626629|NCT01204775|455590973|FG001|Overall Study|Withdrawal by Subject|0|||
126626630|NCT02273180|455590974|FG000|Overall Study|Adverse Event|2|||
126626631|NCT02273180|455590975|FG001|Overall Study|Adverse Event|2|||
126626632|NCT02273180|455590974|FG000|Overall Study|Lack of Efficacy|1|||
126626633|NCT02273180|455590975|FG001|Overall Study|Lack of Efficacy|0|||
126626634|NCT02273180|455590974|FG000|Overall Study|Protocol Violation|1|||
126626635|NCT02273180|455590975|FG001|Overall Study|Protocol Violation|7|||
126626636|NCT02273180|455590974|FG000|Overall Study|Randomized but not treated|1|||
126626637|NCT02273180|455590975|FG001|Overall Study|Randomized but not treated|0|||
126626638|NCT02273180|455590974|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
126626639|NCT02273180|455590975|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
126626640|NCT02273180|455590974|FG000|Overall Study|Other than specified above|21|||
126626641|NCT02273180|455590975|FG001|Overall Study|Other than specified above|10|||
126626642|NCT00509925|455590976|FG000|Overall Study|Personal reasons|0|||
126626643|NCT00509925|455590977|FG001|Overall Study|Personal reasons|1|||
126626644|NCT03749616|455590980|FG000|Overall Study|Lost to Follow-up|4|||
126626645|NCT03749616|455590981|FG001|Overall Study|Lost to Follow-up|7|||
126626646|NCT03749616|455590980|FG000|Overall Study|Screen Failure|1|||
126626647|NCT03749616|455590981|FG001|Overall Study|Screen Failure|1|||
126626648|NCT03749616|455590980|FG000|Overall Study|Withdrawal by Subject|2|||
126626649|NCT03749616|455590981|FG001|Overall Study|Withdrawal by Subject|0|||
126626650|NCT04435522|455590984|FG000|Overall Study|Withdrawal by Subject|2|||
126626651|NCT03302559|455590985|FG000|Overall Study|Adverse Event|2|||
126626652|NCT03302559|455590985|FG000|Overall Study|Lost to Follow-up|1|||
126626653|NCT03302559|455590985|FG000|Overall Study|Withdrew Consent|3|||
126626654|NCT00951171|455590986|FG000|Overall Study|Adverse Event|2|||
126626655|NCT00951171|455590987|FG001|Overall Study|Adverse Event|0|||
126626656|NCT00919061|455590988|FG000|Overall Study|Adverse Event|1|||
126626657|NCT00919061|455590988|FG000|Overall Study|Withdrawal by Subject|1|||
126626658|NCT05294328|455590997|FG000|Overall Study|Adverse Event|1|||
126626659|NCT05294328|455590998|FG001|Overall Study|Adverse Event|0|||
126626660|NCT05294328|455590999|FG002|Overall Study|Adverse Event|0|||
126626661|NCT05294328|455590997|FG000|Overall Study|Physician Decision|1|||
126626662|NCT05294328|455590998|FG001|Overall Study|Physician Decision|1|||
126626663|NCT05294328|455590999|FG002|Overall Study|Physician Decision|0|||
126626664|NCT05294328|455590997|FG000|Overall Study|Withdrawal by Subject|0|||
126626665|NCT05294328|455590998|FG001|Overall Study|Withdrawal by Subject|2|||
126626666|NCT05294328|455590999|FG002|Overall Study|Withdrawal by Subject|1|||
126626667|NCT05294328|455590997|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
126626668|NCT05294328|455590998|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
126626669|NCT05294328|455590999|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
126626670|NCT02056873|455591000|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
126626671|NCT01990313|455592864|FG000|Overall Study|Lost to Follow-up|1|||
126626672|NCT03511378|455592865|FG000|Overall Study|Withdrawal by Subject|2|||
126626673|NCT03511378|455592866|FG001|Overall Study|Withdrawal by Subject|2|||
126626674|NCT03511378|455592865|FG000|Overall Study|Patient not coming or schedule visit|1|||
126626675|NCT03511378|455592866|FG001|Overall Study|Patient not coming or schedule visit|0|||
126626676|NCT00837096|455592867|FG000|Overall Study|Physician Decision|1|||
126626677|NCT00837096|455592868|FG001|Overall Study|Physician Decision|1|||
126626678|NCT00837096|455592867|FG000|Overall Study|Not reported|9|||
126626679|NCT00837096|455592868|FG001|Overall Study|Not reported|8|||
126626680|NCT00280683|455592869|FG000|Overall Study|Withdrawal by Subject|1|||
126626681|NCT00280683|455592870|FG001|Overall Study|Withdrawal by Subject|2|||
126626682|NCT00280683|455592869|FG000|Overall Study|Adverse Event|1|||
126626683|NCT00280683|455592870|FG001|Overall Study|Adverse Event|1|||
126626684|NCT00510198|455592873|FG000|Overall Study|Withdrawal by Subject|5|||
126626685|NCT00510198|455592874|FG001|Overall Study|Withdrawal by Subject|4|||
126626686|NCT01649557|455592882|FG000|Overall Study|Lost to Follow-up|5|||
126626687|NCT01649557|455592883|FG001|Overall Study|Lost to Follow-up|0|||
126626688|NCT01649557|455592884|FG002|Overall Study|Lost to Follow-up|3|||
126626689|NCT01649557|455592882|FG000|Overall Study|Adverse Event|7|||
126626690|NCT01649557|455592883|FG001|Overall Study|Adverse Event|5|||
126626691|NCT01649557|455592884|FG002|Overall Study|Adverse Event|1|||
126626692|NCT01649557|455592882|FG000|Overall Study|Met withdrawal criteria|4|||
126783335|NCT04480463|456162195|FG001|Overall Study|Protocol Violation|1|||
126783336|NCT04480463|456162194|FG000|Overall Study|Withdrawal by Subject|6|||
126783337|NCT04480463|456162195|FG001|Overall Study|Withdrawal by Subject|7|||
126626693|NCT01649557|455592883|FG001|Overall Study|Met withdrawal criteria|0|||
126626694|NCT01649557|455592884|FG002|Overall Study|Met withdrawal criteria|0|||
126626695|NCT01649557|455592882|FG000|Overall Study|Physician Decision|8|||
126626696|NCT01649557|455592883|FG001|Overall Study|Physician Decision|2|||
126626697|NCT01649557|455592884|FG002|Overall Study|Physician Decision|1|||
126626698|NCT01649557|455592882|FG000|Overall Study|Withdrawal by Subject|15|||
126626699|NCT01649557|455592883|FG001|Overall Study|Withdrawal by Subject|5|||
126626700|NCT01649557|455592884|FG002|Overall Study|Withdrawal by Subject|4|||
126626701|NCT01649557|455592882|FG000|Overall Study|Protocol deviation|0|||
126626702|NCT01649557|455592883|FG001|Overall Study|Protocol deviation|2|||
126626703|NCT01649557|455592884|FG002|Overall Study|Protocol deviation|0|||
126626704|NCT01649557|455592882|FG000|Overall Study|Lack of Efficacy|5|||
126626705|NCT01649557|455592883|FG001|Overall Study|Lack of Efficacy|0|||
126626706|NCT01649557|455592884|FG002|Overall Study|Lack of Efficacy|0|||
126626707|NCT00666198|455592891|FG000|Overall Study|Protocol Violation|10|||
126626708|NCT00666198|455592891|FG000|Overall Study|No Visit After First Day of Treatment|13|||
126626709|NCT00666198|455592891|FG000|Overall Study|Safety Not Assessable|6|||
126626710|NCT00666198|455592891|FG000|Overall Study|No Drug Administration|4|||
126626711|NCT05153499|455592892|FG000|Overall Study|Withdrawal by Subject|1|||
126626712|NCT05153499|455592893|FG001|Overall Study|Withdrawal by Subject|0|||
126626713|NCT05153499|455592892|FG000|Overall Study|Clinical Hold|1|||
126626714|NCT05153499|455592893|FG001|Overall Study|Clinical Hold|0|||
126626715|NCT05153499|455592892|FG000|Overall Study|Study Termination|6|||
126626716|NCT05153499|455592893|FG001|Overall Study|Study Termination|5|||
126626717|NCT03168425|455592897|FG000|Overall Study|Lost to Follow-up|5|||
126626718|NCT03168425|455592898|FG001|Overall Study|Lost to Follow-up|8|||
126626719|NCT03168425|455592897|FG000|Overall Study|unable to confirm post op opioids|2|||
126626720|NCT03168425|455592898|FG001|Overall Study|unable to confirm post op opioids|3|||
126626721|NCT01649297|455592899|FG000|Overall Study|Adverse Event|5|||
126626722|NCT01649297|455592900|FG001|Overall Study|Adverse Event|5|||
126626723|NCT01649297|455592901|FG002|Overall Study|Adverse Event|4|||
126626724|NCT01649297|455592902|FG003|Overall Study|Adverse Event|13|||
126626725|NCT01649297|455592903|FG004|Overall Study|Adverse Event|1|||
126626726|NCT01649297|455592899|FG000|Overall Study|Lack of Efficacy|0|||
126626727|NCT01649297|455592900|FG001|Overall Study|Lack of Efficacy|0|||
126626728|NCT01649297|455592901|FG002|Overall Study|Lack of Efficacy|0|||
126626729|NCT01649297|455592902|FG003|Overall Study|Lack of Efficacy|0|||
126626730|NCT01649297|455592903|FG004|Overall Study|Lack of Efficacy|1|||
126626731|NCT01649297|455592899|FG000|Overall Study|Non compliant with Protocol|1|||
126626732|NCT01649297|455592900|FG001|Overall Study|Non compliant with Protocol|0|||
126626733|NCT01649297|455592901|FG002|Overall Study|Non compliant with Protocol|3|||
126626734|NCT01649297|455592902|FG003|Overall Study|Non compliant with Protocol|2|||
126626735|NCT01649297|455592903|FG004|Overall Study|Non compliant with Protocol|1|||
126626736|NCT01649297|455592899|FG000|Overall Study|Lost to Follow-up|1|||
126626737|NCT01649297|455592900|FG001|Overall Study|Lost to Follow-up|1|||
126626738|NCT01649297|455592901|FG002|Overall Study|Lost to Follow-up|4|||
126626739|NCT01649297|455592902|FG003|Overall Study|Lost to Follow-up|3|||
126626740|NCT01649297|455592903|FG004|Overall Study|Lost to Follow-up|0|||
126626741|NCT01649297|455592899|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
126626742|NCT01649297|455592900|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
126626743|NCT01649297|455592901|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
126626744|NCT01649297|455592902|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
126626745|NCT01649297|455592903|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
126626746|NCT01649297|455592899|FG000|Overall Study|For other reason|4|||
126626747|NCT01649297|455592900|FG001|Overall Study|For other reason|1|||
126626748|NCT01649297|455592901|FG002|Overall Study|For other reason|2|||
126626749|NCT01649297|455592902|FG003|Overall Study|For other reason|0|||
126626750|NCT01649297|455592903|FG004|Overall Study|For other reason|0|||
126626751|NCT01685047|455592904|FG000|Overall Study|Withdrawal by Subject|20|||
126626752|NCT01685047|455592904|FG000|Overall Study|Death|26|||
126626753|NCT01685047|455592904|FG000|Overall Study|Lost to Follow-up|8|||
126626754|NCT01685047|455592904|FG000|Overall Study|Physician Decision|25|||
126626755|NCT01685047|455592904|FG000|Overall Study|Adverse Event|5|||
126626756|NCT01685047|455592904|FG000|Overall Study|patient withdrawn by sponsor|1|||
126626757|NCT00922441|455592908|FG000|Overall Study|Protocol Violation|0|||
126626758|NCT00922441|455592909|FG001|Overall Study|Protocol Violation|0|||
126626759|NCT00922441|455592910|FG002|Overall Study|Protocol Violation|2|||
126626760|NCT00922441|455592908|FG000|Overall Study|Withdrawal by Subject|0|||
126626761|NCT00922441|455592909|FG001|Overall Study|Withdrawal by Subject|0|||
126626762|NCT00922441|455592910|FG002|Overall Study|Withdrawal by Subject|1|||
126626763|NCT01040403|455592913|FG000|Overall Study|Adverse Event|10|||
126626764|NCT01040403|455592913|FG000|Overall Study|Protocol Violation|2|||
126626765|NCT01040403|455592913|FG000|Overall Study|Lost to Follow-up|1|||
126626766|NCT01040403|455592913|FG000|Overall Study|Not treated|1|||
126626767|NCT01040403|455592913|FG000|Overall Study|Other reason not defined above|6|||
126626768|NCT02973477|455592914|FG000|First Intervention|Lost to Follow-up|0|||
126626769|NCT02973477|455592915|FG001|First Intervention|Lost to Follow-up|2|||
126626770|NCT02973477|455592914|FG000|Washout|Withdrawal by Subject|1|||
126626771|NCT02973477|455592915|FG001|Washout|Withdrawal by Subject|0|||
126626772|NCT02973477|455592914|FG000|Second Intervention|Lost to Follow-up|1|||
126626773|NCT02973477|455592915|FG001|Second Intervention|Lost to Follow-up|0|||
126626774|NCT01885936|455592916|FG000|Overall Study|Withdrawal by Subject|1|||
126626775|NCT01885936|455592917|FG001|Overall Study|Withdrawal by Subject|0|||
126626776|NCT03036150|455592918|FG000|Overall Study|Withdrawal by Subject|8|||
126626777|NCT03036150|455592919|FG001|Overall Study|Withdrawal by Subject|3|||
126626778|NCT03036150|455592918|FG000|Overall Study|Lost to Follow-up|2|||
126626779|NCT03036150|455592919|FG001|Overall Study|Lost to Follow-up|2|||
126626780|NCT00317603|455592920|FG000|Overall Study|Progressive Disease|3|||
126626781|NCT00523549|455592921|FG000|Overall Study|Adverse Event|6|||
126626782|NCT00523549|455592922|FG001|Overall Study|Adverse Event|3|||
126626783|NCT00523549|455592921|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126626784|NCT00523549|455592922|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126626785|NCT00523549|455592921|FG000|Overall Study|Protocol Deviation|3|||
126626786|NCT00523549|455592922|FG001|Overall Study|Protocol Deviation|1|||
126626787|NCT00523549|455592921|FG000|Overall Study|Patient withdrew consent|7|||
126626788|NCT00523549|455592922|FG001|Overall Study|Patient withdrew consent|6|||
126626789|NCT00523549|455592921|FG000|Overall Study|Lost to Follow-up|3|||
126626790|NCT00523549|455592922|FG001|Overall Study|Lost to Follow-up|5|||
126626791|NCT00427778|455592927|FG000|First Intervention (4 Weeks)|no longer interested|1|||
126626792|NCT00427778|455592928|FG001|First Intervention (4 Weeks)|no longer interested|0|||
126626793|NCT00427778|455592927|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
126626794|NCT00427778|455592928|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
126626795|NCT00427778|455592927|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
126626796|NCT00427778|455592928|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
126626797|NCT00427778|455592927|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
126626798|NCT00427778|455592928|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
126626799|NCT01388478|455592929|FG000|Overall Study|Adverse Event|4|||
126626800|NCT01388478|455592929|FG000|Overall Study|Withdrawal by Subject|1|||
126626801|NCT01037413|455592930|FG000|Part A: Skin Testing|Adverse Event|1|||
126626802|NCT01037413|455592931|FG001|Part A: Skin Testing|Adverse Event|0|||
126626803|NCT01037413|455592930|FG000|Part A: Skin Testing|Protocol Violation|1|||
126626804|NCT01037413|455592931|FG001|Part A: Skin Testing|Protocol Violation|0|||
126626805|NCT01037413|455592930|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
126626806|NCT01037413|455592931|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
126626807|NCT01037413|455592930|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
126626808|NCT01037413|455592931|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
126626809|NCT01990664|455592932|FG000|Overall Study|Lost to Follow-up|2|||
126626810|NCT01990664|455592933|FG001|Overall Study|Lost to Follow-up|6|||
126626811|NCT01990664|455592932|FG000|Overall Study|Withdrawal by Subject|2|||
126626812|NCT01990664|455592933|FG001|Overall Study|Withdrawal by Subject|3|||
126626813|NCT01990664|455592932|FG000|Overall Study|Protocol Violation|1|||
126626814|NCT01990664|455592933|FG001|Overall Study|Protocol Violation|0|||
126626815|NCT01990664|455592932|FG000|Overall Study|Lens Discomfort|1|||
126626816|NCT01990664|455592933|FG001|Overall Study|Lens Discomfort|1|||
126626817|NCT01990664|455592932|FG000|Overall Study|Lens Handling Difficulties|1|||
126626818|NCT01990664|455592933|FG001|Overall Study|Lens Handling Difficulties|0|||
126626819|NCT01990664|455592932|FG000|Overall Study|Unsatisfactory Visual Response|0|||
126626820|NCT01990664|455592933|FG001|Overall Study|Unsatisfactory Visual Response|1|||
126626821|NCT00619983|455592934|FG000|Test Drug Alone|Withdrawal by Subject|1|||
126626822|NCT00619983|455592935|FG001|Test Drug Alone|Withdrawal by Subject|0|||
126626823|NCT00619983|455592936|FG002|Test Drug Alone|Withdrawal by Subject|0|||
126626824|NCT00619983|455592937|FG003|Test Drug Alone|Withdrawal by Subject|1|||
126626825|NCT00619983|455592934|FG000|Test Drug Alone|Failure of daily diary device|1|||
126626826|NCT00619983|455592935|FG001|Test Drug Alone|Failure of daily diary device|1|||
126626827|NCT00619983|455592936|FG002|Test Drug Alone|Failure of daily diary device|2|||
126626828|NCT00619983|455592937|FG003|Test Drug Alone|Failure of daily diary device|2|||
126626829|NCT00931918|455592938|FG000|Overall Study|Adverse Event|4|||
126626830|NCT00931918|455592939|FG001|Overall Study|Adverse Event|6|||
126626831|NCT00931918|455592938|FG000|Overall Study|Progressive Disease|2|||
126783338|NCT04480463|456162194|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
126626832|NCT00931918|455592939|FG001|Overall Study|Progressive Disease|1|||
126626833|NCT00931918|455592938|FG000|Overall Study|Symptomatic Deterioration|1|||
126626834|NCT00931918|455592939|FG001|Overall Study|Symptomatic Deterioration|0|||
126626835|NCT00931918|455592938|FG000|Overall Study|Withdrawal by Patient|3|||
126626836|NCT00931918|455592939|FG001|Overall Study|Withdrawal by Patient|4|||
126626837|NCT00931918|455592938|FG000|Overall Study|Other Reason not Specified|4|||
126626838|NCT00931918|455592939|FG001|Overall Study|Other Reason not Specified|4|||
126626839|NCT00931918|455592938|FG000|Overall Study|Did not receive study drug|3|||
126626840|NCT00931918|455592939|FG001|Overall Study|Did not receive study drug|2|||
126626841|NCT00570921|455592940|FG000|Overall Study|Protocol Violation|1|||
126626842|NCT00570921|455592940|FG000|Overall Study|Physician Decision|1|||
126626843|NCT00784277|455592942|FG000|IR Treatment|Adverse Event|4|||
126626844|NCT00784277|455592943|FG001|IR Treatment|Adverse Event|8|||
126626845|NCT00784277|455592944|FG002|IR Treatment|Adverse Event|19|||
126626846|NCT00784277|455592945|FG003|IR Treatment|Adverse Event|35|||
126626847|NCT00784277|455592946|FG004|IR Treatment|Adverse Event|0|||
126626848|NCT00784277|455592947|FG005|IR Treatment|Adverse Event|0|||
126626849|NCT00784277|455592948|FG006|IR Treatment|Adverse Event|0|||
126626850|NCT00784277|455592942|FG000|IR Treatment|Lack of Efficacy|4|||
126626851|NCT00784277|455592943|FG001|IR Treatment|Lack of Efficacy|4|||
126626852|NCT00784277|455592944|FG002|IR Treatment|Lack of Efficacy|1|||
126626853|NCT00784277|455592945|FG003|IR Treatment|Lack of Efficacy|0|||
126626854|NCT00784277|455592946|FG004|IR Treatment|Lack of Efficacy|0|||
126626855|NCT00784277|455592947|FG005|IR Treatment|Lack of Efficacy|0|||
126626856|NCT00784277|455592948|FG006|IR Treatment|Lack of Efficacy|0|||
126626857|NCT00784277|455592942|FG000|IR Treatment|Lost to Follow-up|1|||
126626858|NCT00784277|455592943|FG001|IR Treatment|Lost to Follow-up|0|||
126626859|NCT00784277|455592944|FG002|IR Treatment|Lost to Follow-up|1|||
126626860|NCT00784277|455592945|FG003|IR Treatment|Lost to Follow-up|0|||
126626861|NCT00784277|455592946|FG004|IR Treatment|Lost to Follow-up|0|||
126626862|NCT00784277|455592947|FG005|IR Treatment|Lost to Follow-up|0|||
126626863|NCT00784277|455592948|FG006|IR Treatment|Lost to Follow-up|0|||
126626864|NCT00784277|455592942|FG000|IR Treatment|Withdrawal by Subject|5|||
126626865|NCT00784277|455592943|FG001|IR Treatment|Withdrawal by Subject|1|||
126626866|NCT00784277|455592944|FG002|IR Treatment|Withdrawal by Subject|4|||
126626867|NCT00784277|455592945|FG003|IR Treatment|Withdrawal by Subject|6|||
126626868|NCT00784277|455592946|FG004|IR Treatment|Withdrawal by Subject|0|||
126626869|NCT00784277|455592947|FG005|IR Treatment|Withdrawal by Subject|0|||
126626870|NCT00784277|455592948|FG006|IR Treatment|Withdrawal by Subject|0|||
126626871|NCT00784277|455592942|FG000|IR Treatment|Resolution Of Pain|0|||
126626872|NCT00784277|455592943|FG001|IR Treatment|Resolution Of Pain|1|||
126626873|NCT00784277|455592944|FG002|IR Treatment|Resolution Of Pain|0|||
126626874|NCT00784277|455592945|FG003|IR Treatment|Resolution Of Pain|0|||
126626875|NCT00784277|455592946|FG004|IR Treatment|Resolution Of Pain|0|||
126626876|NCT00784277|455592947|FG005|IR Treatment|Resolution Of Pain|0|||
126626877|NCT00784277|455592948|FG006|IR Treatment|Resolution Of Pain|0|||
126626878|NCT00784277|455592942|FG000|IR Treatment|Other|2|||
126626879|NCT00784277|455592943|FG001|IR Treatment|Other|3|||
126626880|NCT00784277|455592944|FG002|IR Treatment|Other|3|||
126626881|NCT00784277|455592945|FG003|IR Treatment|Other|2|||
126626882|NCT00784277|455592946|FG004|IR Treatment|Other|0|||
126626883|NCT00784277|455592947|FG005|IR Treatment|Other|0|||
126626884|NCT00784277|455592948|FG006|IR Treatment|Other|0|||
126626885|NCT00784277|455592942|FG000|ER Treatment|Adverse Event|0|||
126626886|NCT00784277|455592943|FG001|ER Treatment|Adverse Event|0|||
126626887|NCT00784277|455592944|FG002|ER Treatment|Adverse Event|0|||
126626888|NCT00784277|455592945|FG003|ER Treatment|Adverse Event|0|||
126626889|NCT00784277|455592946|FG004|ER Treatment|Adverse Event|1|||
126626890|NCT00784277|455592947|FG005|ER Treatment|Adverse Event|7|||
126626891|NCT00784277|455592948|FG006|ER Treatment|Adverse Event|7|||
126626892|NCT00784277|455592942|FG000|ER Treatment|Lack of Efficacy|0|||
126626893|NCT00784277|455592943|FG001|ER Treatment|Lack of Efficacy|0|||
126783339|NCT04480463|456162195|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
126783340|NCT04480463|456162194|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
126783341|NCT04480463|456162195|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
126783342|NCT04480463|456162194|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
126626894|NCT00784277|455592944|FG002|ER Treatment|Lack of Efficacy|0|||
126626895|NCT00784277|455592945|FG003|ER Treatment|Lack of Efficacy|0|||
126626896|NCT00784277|455592946|FG004|ER Treatment|Lack of Efficacy|3|||
126626897|NCT00784277|455592947|FG005|ER Treatment|Lack of Efficacy|4|||
126626898|NCT00784277|455592948|FG006|ER Treatment|Lack of Efficacy|0|||
126626899|NCT00784277|455592942|FG000|ER Treatment|Lost to Follow-up|0|||
126626900|NCT00784277|455592943|FG001|ER Treatment|Lost to Follow-up|0|||
126626901|NCT00784277|455592944|FG002|ER Treatment|Lost to Follow-up|0|||
126626902|NCT00784277|455592945|FG003|ER Treatment|Lost to Follow-up|0|||
126626903|NCT00784277|455592946|FG004|ER Treatment|Lost to Follow-up|0|||
126626904|NCT00784277|455592947|FG005|ER Treatment|Lost to Follow-up|2|||
126626905|NCT00784277|455592948|FG006|ER Treatment|Lost to Follow-up|0|||
126626906|NCT00784277|455592942|FG000|ER Treatment|Withdrawal by Subject|0|||
126626907|NCT00784277|455592943|FG001|ER Treatment|Withdrawal by Subject|0|||
126626908|NCT00784277|455592944|FG002|ER Treatment|Withdrawal by Subject|0|||
126626909|NCT00784277|455592945|FG003|ER Treatment|Withdrawal by Subject|0|||
126626910|NCT00784277|455592946|FG004|ER Treatment|Withdrawal by Subject|2|||
126626911|NCT00784277|455592947|FG005|ER Treatment|Withdrawal by Subject|5|||
126626912|NCT00784277|455592948|FG006|ER Treatment|Withdrawal by Subject|3|||
126626913|NCT00784277|455592942|FG000|ER Treatment|Study Medication Non-Compliant|0|||
126626914|NCT00784277|455592943|FG001|ER Treatment|Study Medication Non-Compliant|0|||
126626915|NCT00784277|455592944|FG002|ER Treatment|Study Medication Non-Compliant|0|||
126626916|NCT00784277|455592945|FG003|ER Treatment|Study Medication Non-Compliant|0|||
126626917|NCT00784277|455592946|FG004|ER Treatment|Study Medication Non-Compliant|2|||
126626918|NCT00784277|455592947|FG005|ER Treatment|Study Medication Non-Compliant|3|||
126626919|NCT00784277|455592948|FG006|ER Treatment|Study Medication Non-Compliant|3|||
126626920|NCT00784277|455592942|FG000|ER Treatment|Other|0|||
126626921|NCT00784277|455592943|FG001|ER Treatment|Other|0|||
126626922|NCT00784277|455592944|FG002|ER Treatment|Other|0|||
126626923|NCT00784277|455592945|FG003|ER Treatment|Other|0|||
126626924|NCT00784277|455592946|FG004|ER Treatment|Other|1|||
126626925|NCT00784277|455592947|FG005|ER Treatment|Other|3|||
126626926|NCT00784277|455592948|FG006|ER Treatment|Other|2|||
126626927|NCT02025985|455592957|FG000|Overall Study|Consent withdrawn|0|||
126626928|NCT02025985|455592958|FG001|Overall Study|Consent withdrawn|0|||
126626929|NCT02025985|455592959|FG002|Overall Study|Consent withdrawn|1|||
126626930|NCT02025985|455592960|FG003|Overall Study|Consent withdrawn|0|||
126626931|NCT02025985|455592961|FG004|Overall Study|Consent withdrawn|0|||
126626932|NCT02025985|455592957|FG000|Overall Study|Termination of study by Sponsor|4|||
126626933|NCT02025985|455592958|FG001|Overall Study|Termination of study by Sponsor|3|||
126626934|NCT02025985|455592959|FG002|Overall Study|Termination of study by Sponsor|1|||
126626935|NCT02025985|455592960|FG003|Overall Study|Termination of study by Sponsor|1|||
126626936|NCT02025985|455592961|FG004|Overall Study|Termination of study by Sponsor|3|||
126626937|NCT02025985|455592957|FG000|Overall Study|Death|21|||
126626938|NCT02025985|455592958|FG001|Overall Study|Death|20|||
126626939|NCT02025985|455592959|FG002|Overall Study|Death|23|||
126626940|NCT02025985|455592960|FG003|Overall Study|Death|20|||
126626941|NCT02025985|455592961|FG004|Overall Study|Death|17|||
126626942|NCT03041701|455592962|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
126626943|NCT03041701|455592963|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
126626944|NCT03041701|455592964|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
126626945|NCT03041701|455592962|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
126626946|NCT03041701|455592963|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
126626947|NCT03041701|455592964|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
126626948|NCT00745121|455592965|FG000|Overall Study|Death|3|||
126626949|NCT00745121|455592966|FG001|Overall Study|Death|0|||
126626950|NCT00745121|455592965|FG000|Overall Study|Adverse Event|1|||
126626951|NCT00745121|455592966|FG001|Overall Study|Adverse Event|0|||
126626952|NCT00745121|455592965|FG000|Overall Study|Lost to Follow-up|1|||
126626953|NCT00745121|455592966|FG001|Overall Study|Lost to Follow-up|0|||
126626954|NCT00745121|455592965|FG000|Overall Study|Withdrawal by Subject|4|||
126626955|NCT00745121|455592966|FG001|Overall Study|Withdrawal by Subject|2|||
126626956|NCT01713998|455592967|FG000|Overall Study|Lost to Follow-up|2|||
126626957|NCT01713998|455592968|FG001|Overall Study|Lost to Follow-up|0|||
126626958|NCT01713998|455592969|FG002|Overall Study|Lost to Follow-up|2|||
126626959|NCT01713998|455592967|FG000|Overall Study|Withdrawal by Subject|1|||
126626960|NCT01713998|455592968|FG001|Overall Study|Withdrawal by Subject|0|||
126626961|NCT01713998|455592969|FG002|Overall Study|Withdrawal by Subject|0|||
126626962|NCT02101268|455592970|FG000|Randomized Treatment Phase|Subject Decision|8|||
126626963|NCT02101268|455592971|FG001|Randomized Treatment Phase|Subject Decision|4|||
126626964|NCT02101268|455592972|FG002|Randomized Treatment Phase|Subject Decision|0|||
126626965|NCT02101268|455592973|FG003|Randomized Treatment Phase|Subject Decision|0|||
126626966|NCT02101268|455592970|FG000|Randomized Treatment Phase|Physician Decision|4|||
126626967|NCT02101268|455592971|FG001|Randomized Treatment Phase|Physician Decision|1|||
126626968|NCT02101268|455592972|FG002|Randomized Treatment Phase|Physician Decision|0|||
126626969|NCT02101268|455592973|FG003|Randomized Treatment Phase|Physician Decision|0|||
126626970|NCT02101268|455592970|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
126626971|NCT02101268|455592971|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
126626972|NCT02101268|455592972|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
126626973|NCT02101268|455592973|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
126626974|NCT02101268|455592970|FG000|Randomized Treatment Phase|Adverse Event|6|||
126626975|NCT02101268|455592971|FG001|Randomized Treatment Phase|Adverse Event|0|||
126626976|NCT02101268|455592972|FG002|Randomized Treatment Phase|Adverse Event|0|||
126626977|NCT02101268|455592973|FG003|Randomized Treatment Phase|Adverse Event|0|||
126626978|NCT02101268|455592970|FG000|Randomized Treatment Phase|Death|5|||
126783343|NCT04480463|456162195|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
126783344|NCT04480463|456162194|FG000|Overall Study|Other|6|||
126626979|NCT02101268|455592971|FG001|Randomized Treatment Phase|Death|4|||
126626980|NCT02101268|455592972|FG002|Randomized Treatment Phase|Death|0|||
126626981|NCT02101268|455592973|FG003|Randomized Treatment Phase|Death|0|||
126626982|NCT02101268|455592970|FG000|Randomized Treatment Phase|Disease Progression|4|||
126626983|NCT02101268|455592971|FG001|Randomized Treatment Phase|Disease Progression|1|||
126626984|NCT02101268|455592972|FG002|Randomized Treatment Phase|Disease Progression|0|||
126626985|NCT02101268|455592973|FG003|Randomized Treatment Phase|Disease Progression|0|||
126626986|NCT02101268|455592970|FG000|Extended Treatment Phase|Subject Decision|0|||
126626987|NCT02101268|455592971|FG001|Extended Treatment Phase|Subject Decision|0|||
126626988|NCT02101268|455592972|FG002|Extended Treatment Phase|Subject Decision|3|||
126626989|NCT02101268|455592973|FG003|Extended Treatment Phase|Subject Decision|2|||
126626990|NCT02101268|455592970|FG000|Extended Treatment Phase|Physician Decision|0|||
126626991|NCT02101268|455592971|FG001|Extended Treatment Phase|Physician Decision|0|||
126626992|NCT02101268|455592972|FG002|Extended Treatment Phase|Physician Decision|5|||
126626993|NCT02101268|455592973|FG003|Extended Treatment Phase|Physician Decision|2|||
126626994|NCT02101268|455592970|FG000|Extended Treatment Phase|Adverse Event|0|||
126626995|NCT02101268|455592971|FG001|Extended Treatment Phase|Adverse Event|0|||
126626996|NCT02101268|455592972|FG002|Extended Treatment Phase|Adverse Event|14|||
126626997|NCT02101268|455592973|FG003|Extended Treatment Phase|Adverse Event|18|||
126626998|NCT02101268|455592970|FG000|Extended Treatment Phase|Death|0|||
126626999|NCT02101268|455592971|FG001|Extended Treatment Phase|Death|0|||
126627000|NCT02101268|455592972|FG002|Extended Treatment Phase|Death|5|||
126627001|NCT02101268|455592973|FG003|Extended Treatment Phase|Death|1|||
126627002|NCT02101268|455592970|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
126627003|NCT02101268|455592971|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
126627004|NCT02101268|455592972|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
126627005|NCT02101268|455592973|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
126627006|NCT02101268|455592970|FG000|Extended Treatment Phase|Disease Progression|0|||
126627007|NCT02101268|455592971|FG001|Extended Treatment Phase|Disease Progression|0|||
126627008|NCT02101268|455592972|FG002|Extended Treatment Phase|Disease Progression|13|||
126627009|NCT02101268|455592973|FG003|Extended Treatment Phase|Disease Progression|6|||
126627010|NCT02101268|455592970|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
126627011|NCT02101268|455592971|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
126627012|NCT02101268|455592972|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
126627013|NCT02101268|455592973|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
126627014|NCT00740870|455592974|FG000|Overall Study|Not Catheterized|4|||
126627015|NCT00740870|455592974|FG000|Overall Study|Further testing contraindicated implant|17|||
126627016|NCT00839332|455592976|FG000|Phase 1|Disease Progression|38|||
126627017|NCT00839332|455592977|FG001|Phase 1|Disease Progression|0|||
126627018|NCT00839332|455592978|FG002|Phase 1|Disease Progression|0|||
126627019|NCT00839332|455592976|FG000|Phase 1|Adverse Event|6|||
126627020|NCT00839332|455592977|FG001|Phase 1|Adverse Event|0|||
126627021|NCT00839332|455592978|FG002|Phase 1|Adverse Event|0|||
126627022|NCT00839332|455592976|FG000|Phase 1|Withdrawal by Subject|4|||
126627023|NCT00839332|455592977|FG001|Phase 1|Withdrawal by Subject|0|||
126627024|NCT00839332|455592978|FG002|Phase 1|Withdrawal by Subject|0|||
126627025|NCT00839332|455592976|FG000|Phase 1|Physician Decision|2|||
126627026|NCT00839332|455592977|FG001|Phase 1|Physician Decision|0|||
126627027|NCT00839332|455592978|FG002|Phase 1|Physician Decision|0|||
126627028|NCT00839332|455592976|FG000|Phase 2|Protocol Violation|0|||
126627029|NCT00839332|455592977|FG001|Phase 2|Protocol Violation|1|||
126627030|NCT00839332|455592978|FG002|Phase 2|Protocol Violation|0|||
126627031|NCT00839332|455592976|FG000|Phase 2|Disease Progression|0|||
126783345|NCT04480463|456162195|FG001|Overall Study|Other|4|||
126783346|NCT00444795|456162197|FG000|Overall Study|Not Treated|1|||
126783347|NCT00444795|456162197|FG000|Overall Study|Treated Prior to the Contract Date|2|||
126783348|NCT00988169|456162198|FG000|Overall Study|Withdrawal by Subject|1|||
126783349|NCT02637076|456162199|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
126783350|NCT02637076|456162200|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
126783351|NCT02637076|456162199|FG000|Overall Study|Withdrawal by Subject|0|||
126783352|NCT02637076|456162200|FG001|Overall Study|Withdrawal by Subject|4|||
126783353|NCT02710071|456162205|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
126783354|NCT02710071|456162206|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
126783355|NCT02710071|456162205|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
126783356|NCT02710071|456162206|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
126783357|NCT02637557|456162213|FG000|Overall Study|Adverse Event|3|||
126783358|NCT02637557|456162214|FG001|Overall Study|Adverse Event|1|||
126783359|NCT02637557|456162215|FG002|Overall Study|Adverse Event|3|||
126627032|NCT00839332|455592977|FG001|Phase 2|Disease Progression|46|||
126627033|NCT00839332|455592978|FG002|Phase 2|Disease Progression|21|||
126627034|NCT00839332|455592976|FG000|Phase 2|Adverse Event|0|||
126627035|NCT00839332|455592977|FG001|Phase 2|Adverse Event|8|||
126627036|NCT00839332|455592978|FG002|Phase 2|Adverse Event|6|||
126627037|NCT00839332|455592976|FG000|Phase 2|Death|0|||
126627038|NCT00839332|455592977|FG001|Phase 2|Death|4|||
126627039|NCT00839332|455592978|FG002|Phase 2|Death|2|||
126627040|NCT00839332|455592976|FG000|Phase 2|Withdrawal by Subject|0|||
126627041|NCT00839332|455592977|FG001|Phase 2|Withdrawal by Subject|5|||
126783360|NCT02637557|456162216|FG003|Overall Study|Adverse Event|3|||
126783361|NCT02637557|456162213|FG000|Overall Study|Lost to Follow-up|1|||
126627042|NCT00839332|455592978|FG002|Phase 2|Withdrawal by Subject|8|||
126627043|NCT00839332|455592976|FG000|Phase 2|Physician Decision|0|||
126627044|NCT00839332|455592977|FG001|Phase 2|Physician Decision|4|||
126627045|NCT00839332|455592978|FG002|Phase 2|Physician Decision|1|||
126627046|NCT00839332|455592976|FG000|Phase 2|Lost to Follow-up|0|||
126627047|NCT00839332|455592977|FG001|Phase 2|Lost to Follow-up|0|||
126627048|NCT00839332|455592978|FG002|Phase 2|Lost to Follow-up|1|||
126627049|NCT01200485|455592979|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
126627050|NCT01200485|455592980|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
126627051|NCT01200485|455592981|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
126627052|NCT01200485|455592979|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
126627053|NCT01200485|455592980|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
126627054|NCT01200485|455592981|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
126627055|NCT06080438|455592982|FG000|Overall Study|Lost to Follow-up|2|||
126627056|NCT03569475|455592983|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
126627057|NCT03569475|455592984|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
126627058|NCT03569475|455592985|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
126627059|NCT03569475|455592983|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
126627060|NCT03569475|455592984|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
126627061|NCT03569475|455592985|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
126627062|NCT03569475|455592983|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
126627063|NCT03569475|455592984|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
126627064|NCT03569475|455592985|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
126627065|NCT03569475|455592983|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
126627066|NCT03569475|455592984|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
126627067|NCT03569475|455592985|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
126627068|NCT03569475|455592983|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
126627069|NCT03569475|455592984|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
126627070|NCT03569475|455592985|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
126627071|NCT03569475|455592983|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
126627072|NCT03569475|455592984|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
126627073|NCT03569475|455592985|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
126627074|NCT03569475|455592983|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
126627075|NCT03569475|455592984|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
126627076|NCT03569475|455592985|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
126627077|NCT03569475|455592983|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
126627078|NCT03569475|455592984|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
126627079|NCT03569475|455592985|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
126627080|NCT03569475|455592983|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
126627081|NCT03569475|455592984|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
126627082|NCT03569475|455592985|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
126627083|NCT03638258|455592987|FG000|Overall Study|Adverse Event|1|||
126627084|NCT03638258|455592988|FG001|Overall Study|Adverse Event|0|||
126627085|NCT03638258|455592989|FG002|Overall Study|Adverse Event|2|||
126627086|NCT03638258|455592987|FG000|Overall Study|Lost to Follow-up|2|||
126627087|NCT03638258|455592988|FG001|Overall Study|Lost to Follow-up|4|||
126627088|NCT03638258|455592989|FG002|Overall Study|Lost to Follow-up|5|||
126627089|NCT03638258|455592987|FG000|Overall Study|Pregnancy|0|||
126627090|NCT03638258|455592988|FG001|Overall Study|Pregnancy|0|||
126627091|NCT03638258|455592989|FG002|Overall Study|Pregnancy|1|||
126627092|NCT03638258|455592987|FG000|Overall Study|Protocol Violation|0|||
126627093|NCT03638258|455592988|FG001|Overall Study|Protocol Violation|0|||
126627094|NCT03638258|455592989|FG002|Overall Study|Protocol Violation|1|||
126627095|NCT03638258|455592987|FG000|Overall Study|Withdrawal by Subject|4|||
126627096|NCT03638258|455592988|FG001|Overall Study|Withdrawal by Subject|5|||
126627097|NCT03638258|455592989|FG002|Overall Study|Withdrawal by Subject|12|||
126627098|NCT03638258|455592987|FG000|Overall Study|Lack of Efficacy|0|||
126627099|NCT03638258|455592988|FG001|Overall Study|Lack of Efficacy|0|||
126627100|NCT03638258|455592989|FG002|Overall Study|Lack of Efficacy|2|||
126627101|NCT02630706|455592990|FG000|Overall Study|Adverse Event|2|||
126627102|NCT02630706|455592991|FG001|Overall Study|Adverse Event|1|||
126627103|NCT02630706|455592992|FG002|Overall Study|Adverse Event|1|||
126627104|NCT02630706|455592990|FG000|Overall Study|Lost to Follow-up|0|||
126627105|NCT02630706|455592991|FG001|Overall Study|Lost to Follow-up|1|||
126627106|NCT02630706|455592992|FG002|Overall Study|Lost to Follow-up|2|||
126627107|NCT02630706|455592990|FG000|Overall Study|Physician Decision|1|||
126627108|NCT02630706|455592991|FG001|Overall Study|Physician Decision|1|||
126627109|NCT02630706|455592992|FG002|Overall Study|Physician Decision|0|||
126627110|NCT02630706|455592990|FG000|Overall Study|Pregnancy|0|||
126627111|NCT02630706|455592991|FG001|Overall Study|Pregnancy|1|||
126627112|NCT02630706|455592992|FG002|Overall Study|Pregnancy|0|||
126754517|NCT03018028|456051329|FG001|Overall Study|Withdrawal by Subject|0|||
126627113|NCT02630706|455592990|FG000|Overall Study|Withdrawal by Subject|4|||
126627114|NCT02630706|455592991|FG001|Overall Study|Withdrawal by Subject|5|||
126627115|NCT02630706|455592992|FG002|Overall Study|Withdrawal by Subject|7|||
126627116|NCT01678898|455592993|FG000|PB-102-F01|Adverse Event|0|||
126627117|NCT01678898|455592994|FG001|PB-102-F01|Adverse Event|1|||
126627118|NCT01678898|455592995|FG002|PB-102-F01|Adverse Event|0|||
126627119|NCT01678898|455592993|FG000|PB-102-F01|Physician Decision|0|||
126627120|NCT01678898|455592994|FG001|PB-102-F01|Physician Decision|1|||
126627121|NCT01678898|455592995|FG002|PB-102-F01|Physician Decision|0|||
126627122|NCT01527500|455592998|FG000|Part A|Administrative|11|||
126627123|NCT01527500|455592999|FG001|Part A|Administrative|7|||
126627124|NCT01527500|455592998|FG000|Part A|Adverse Event|4|||
126627125|NCT01527500|455592999|FG001|Part A|Adverse Event|2|||
126627126|NCT01527500|455592998|FG000|Part A|Death|4|||
126627127|NCT01527500|455592999|FG001|Part A|Death|1|||
126627128|NCT01527500|455592998|FG000|Part A|Lost to Follow-up|0|||
126627129|NCT01527500|455592999|FG001|Part A|Lost to Follow-up|1|||
126627130|NCT01527500|455592998|FG000|Part A|Protocol Deviation|9|||
126627131|NCT01527500|455592999|FG001|Part A|Protocol Deviation|2|||
126627132|NCT01527500|455592998|FG000|Part A|Withdrawal by Subject|2|||
126627133|NCT01527500|455592999|FG001|Part A|Withdrawal by Subject|0|||
126627134|NCT01527500|455592998|FG000|Part B|Adverse Event|1|||
126627135|NCT01527500|455592999|FG001|Part B|Adverse Event|0|||
126627136|NCT03078751|455593007|FG000|Overall Study|Adverse Event|4|||
126627137|NCT03078751|455593008|FG001|Overall Study|Adverse Event|0|||
126627138|NCT03078751|455593007|FG000|Overall Study|Physician Decision|1|||
126627139|NCT03078751|455593008|FG001|Overall Study|Physician Decision|0|||
126627140|NCT03078751|455593007|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
126627141|NCT03078751|455593008|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
126627142|NCT03078751|455593007|FG000|Overall Study|Subject/guardian decision|8|||
126627143|NCT03078751|455593008|FG001|Overall Study|Subject/guardian decision|1|||
126627144|NCT03078751|455593007|FG000|Overall Study|Untreated|0|||
126627145|NCT03078751|455593008|FG001|Overall Study|Untreated|4|||
126627146|NCT01209286|455593009|FG000|Overall Study|Adverse Event|4|||
126627147|NCT01209286|455593010|FG001|Overall Study|Adverse Event|3|||
126627148|NCT01209286|455593011|FG002|Overall Study|Adverse Event|1|||
126627149|NCT01209286|455593009|FG000|Overall Study|Hematological Relapse After Remission|0|||
126627150|NCT01209286|455593010|FG001|Overall Study|Hematological Relapse After Remission|1|||
126627151|NCT01209286|455593011|FG002|Overall Study|Hematological Relapse After Remission|1|||
126627152|NCT01209286|455593009|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
126627153|NCT01209286|455593010|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
126627154|NCT01209286|455593011|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
126627155|NCT01209286|455593009|FG000|Overall Study|Physician Decision|0|||
126627156|NCT01209286|455593010|FG001|Overall Study|Physician Decision|2|||
126627157|NCT01209286|455593011|FG002|Overall Study|Physician Decision|0|||
126627158|NCT01209286|455593009|FG000|Overall Study|Other|0|||
126627159|NCT01209286|455593010|FG001|Overall Study|Other|1|||
126627160|NCT01209286|455593011|FG002|Overall Study|Other|0|||
126627161|NCT01363297|455593015|FG000|Overall Study|Other|0|||
126627162|NCT01363297|455593016|FG001|Overall Study|Other|0|||
126627163|NCT01363297|455593017|FG002|Overall Study|Other|0|||
126627164|NCT01363297|455593018|FG003|Overall Study|Other|0|||
126627165|NCT01363297|455593019|FG004|Overall Study|Other|1|||
126627166|NCT01363297|455593015|FG000|Overall Study|Death|3|||
126627167|NCT01363297|455593016|FG001|Overall Study|Death|6|||
126627168|NCT01363297|455593017|FG002|Overall Study|Death|6|||
126627169|NCT01363297|455593018|FG003|Overall Study|Death|10|||
126627170|NCT01363297|455593019|FG004|Overall Study|Death|30|||
126627171|NCT00981578|455593020|FG000|Overall Study|Death|1|||
126627172|NCT00981578|455593020|FG000|Overall Study|Withdrawal by Subject|2|||
126627173|NCT03015181|455593021|FG000|Overall Study|Enrolled, but product never administered|1|||
126627174|NCT03015181|455593022|FG001|Overall Study|Enrolled, but product never administered|0|||
126627175|NCT03015181|455593023|FG002|Overall Study|Enrolled, but product never administered|0|||
126627176|NCT03015181|455593024|FG003|Overall Study|Enrolled, but product never administered|0|||
126627177|NCT03015181|455593025|FG004|Overall Study|Enrolled, but product never administered|0|||
126627178|NCT03015181|455593026|FG005|Overall Study|Enrolled, but product never administered|0|||
126627179|NCT03015181|455593027|FG006|Overall Study|Enrolled, but product never administered|0|||
126627180|NCT03015181|455593021|FG000|Overall Study|Withdrawal by Subject|0|||
126627181|NCT03015181|455593022|FG001|Overall Study|Withdrawal by Subject|0|||
126627182|NCT03015181|455593023|FG002|Overall Study|Withdrawal by Subject|0|||
126627183|NCT03015181|455593024|FG003|Overall Study|Withdrawal by Subject|0|||
126627184|NCT03015181|455593025|FG004|Overall Study|Withdrawal by Subject|0|||
126627185|NCT03015181|455593026|FG005|Overall Study|Withdrawal by Subject|1|||
126627186|NCT03015181|455593027|FG006|Overall Study|Withdrawal by Subject|0|||
126627187|NCT03015181|455593021|FG000|Overall Study|Physician Decision|0|||
126627188|NCT03015181|455593022|FG001|Overall Study|Physician Decision|0|||
126627189|NCT03015181|455593023|FG002|Overall Study|Physician Decision|0|||
126627190|NCT03015181|455593024|FG003|Overall Study|Physician Decision|0|||
126627191|NCT03015181|455593025|FG004|Overall Study|Physician Decision|0|||
126627192|NCT03015181|455593026|FG005|Overall Study|Physician Decision|0|||
126627193|NCT03015181|455593027|FG006|Overall Study|Physician Decision|1|||
126627194|NCT01180790|455593028|FG000|Overall Study|Adverse Event|1|||
126627195|NCT01180790|455593029|FG001|Overall Study|Adverse Event|1|||
126627196|NCT01180790|455593030|FG002|Overall Study|Adverse Event|2|||
126627197|NCT01180790|455593031|FG003|Overall Study|Adverse Event|0|||
126627198|NCT01180790|455593032|FG004|Overall Study|Adverse Event|1|||
126627199|NCT01180790|455593033|FG005|Overall Study|Adverse Event|3|||
126627200|NCT01180790|455593034|FG006|Overall Study|Adverse Event|0|||
126627201|NCT01180790|455593028|FG000|Overall Study|Withdrawal by Subject|3|||
126627202|NCT01180790|455593029|FG001|Overall Study|Withdrawal by Subject|0|||
126627203|NCT01180790|455593030|FG002|Overall Study|Withdrawal by Subject|5|||
126627204|NCT01180790|455593031|FG003|Overall Study|Withdrawal by Subject|0|||
126627205|NCT01180790|455593032|FG004|Overall Study|Withdrawal by Subject|2|||
126627206|NCT01180790|455593033|FG005|Overall Study|Withdrawal by Subject|1|||
126627207|NCT01180790|455593034|FG006|Overall Study|Withdrawal by Subject|0|||
126627208|NCT01180790|455593028|FG000|Overall Study|Lost to Follow-up|3|||
126627209|NCT01180790|455593029|FG001|Overall Study|Lost to Follow-up|1|||
126627210|NCT01180790|455593030|FG002|Overall Study|Lost to Follow-up|0|||
126627211|NCT01180790|455593031|FG003|Overall Study|Lost to Follow-up|2|||
126627212|NCT01180790|455593032|FG004|Overall Study|Lost to Follow-up|1|||
126627213|NCT01180790|455593033|FG005|Overall Study|Lost to Follow-up|0|||
126627214|NCT01180790|455593034|FG006|Overall Study|Lost to Follow-up|1|||
126627215|NCT01180790|455593028|FG000|Overall Study|Physician Decision|1|||
126627216|NCT01180790|455593029|FG001|Overall Study|Physician Decision|0|||
126627217|NCT01180790|455593030|FG002|Overall Study|Physician Decision|0|||
126627218|NCT01180790|455593031|FG003|Overall Study|Physician Decision|1|||
126627219|NCT01180790|455593032|FG004|Overall Study|Physician Decision|0|||
126627220|NCT01180790|455593033|FG005|Overall Study|Physician Decision|0|||
126627221|NCT01180790|455593034|FG006|Overall Study|Physician Decision|0|||
126627222|NCT01180790|455593028|FG000|Overall Study|Lack of Efficacy|1|||
126627223|NCT01180790|455593029|FG001|Overall Study|Lack of Efficacy|2|||
126627224|NCT01180790|455593030|FG002|Overall Study|Lack of Efficacy|5|||
126627225|NCT01180790|455593031|FG003|Overall Study|Lack of Efficacy|6|||
126627226|NCT01180790|455593032|FG004|Overall Study|Lack of Efficacy|1|||
126627227|NCT01180790|455593033|FG005|Overall Study|Lack of Efficacy|3|||
126627228|NCT01180790|455593034|FG006|Overall Study|Lack of Efficacy|0|||
126627229|NCT01180790|455593028|FG000|Overall Study|compliance|0|||
126627230|NCT01180790|455593029|FG001|Overall Study|compliance|1|||
126627231|NCT01180790|455593030|FG002|Overall Study|compliance|0|||
126627232|NCT01180790|455593031|FG003|Overall Study|compliance|0|||
126627233|NCT01180790|455593032|FG004|Overall Study|compliance|0|||
126627234|NCT01180790|455593033|FG005|Overall Study|compliance|0|||
126627235|NCT01180790|455593034|FG006|Overall Study|compliance|0|||
126627236|NCT01180790|455593028|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
126627237|NCT01180790|455593029|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
126627238|NCT01180790|455593030|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
126627239|NCT01180790|455593031|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
126627240|NCT01180790|455593032|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
126627241|NCT01180790|455593033|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
126627242|NCT01180790|455593034|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
126627243|NCT04582864|455593035|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
126627244|NCT04582864|455593035|FG000|Overall Study|Death|1|||
126627245|NCT01482819|455593036|FG000|Overall Study|Lost to Follow-up|2|||
126627246|NCT01064856|455593039|FG000|Double-blind (DB) Period|Adverse Event|1|||
126627247|NCT01064856|455593040|FG001|Double-blind (DB) Period|Adverse Event|0|||
126627248|NCT01064856|455593041|FG002|Double-blind (DB) Period|Adverse Event|0|||
126627249|NCT01064856|455593042|FG003|Double-blind (DB) Period|Adverse Event|0|||
126627250|NCT01064856|455593039|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
126627251|NCT01064856|455593040|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
126627252|NCT01064856|455593041|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
126627253|NCT01064856|455593042|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
126627254|NCT01064856|455593039|FG000|Open-label (OL) Period|Adverse Event|0|||
126627255|NCT01064856|455593040|FG001|Open-label (OL) Period|Adverse Event|0|||
126627256|NCT01064856|455593041|FG002|Open-label (OL) Period|Adverse Event|12|||
126627257|NCT01064856|455593042|FG003|Open-label (OL) Period|Adverse Event|6|||
126627258|NCT01064856|455593039|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
126627259|NCT01064856|455593040|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
126627260|NCT01064856|455593041|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
126627261|NCT01064856|455593042|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
126627262|NCT01064856|455593039|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
126627263|NCT01064856|455593040|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
126627264|NCT01064856|455593041|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
126627265|NCT01064856|455593042|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
126627266|NCT01064856|455593039|FG000|Open-label (OL) Period|Other|0|||
126754518|NCT03018028|456051330|FG002|Overall Study|Withdrawal by Subject|1|||
126627267|NCT01064856|455593040|FG001|Open-label (OL) Period|Other|0|||
126627268|NCT01064856|455593041|FG002|Open-label (OL) Period|Other|7|||
126627269|NCT01064856|455593042|FG003|Open-label (OL) Period|Other|7|||
126627270|NCT00746785|455594739|FG000|Overall Study|Lost to Follow-up|29|||
126627271|NCT00746785|455594740|FG001|Overall Study|Lost to Follow-up|25|||
126627272|NCT00746785|455594741|FG002|Overall Study|Lost to Follow-up|27|||
126627273|NCT00113269|455594742|FG000|Overall Study|Not transplanted, donor issues|4|||
126627274|NCT00113269|455594743|FG001|Overall Study|Not transplanted, donor issues|0|||
126627275|NCT00113269|455594744|FG002|Overall Study|Not transplanted, donor issues|2|||
126627276|NCT00113269|455594745|FG003|Overall Study|Not transplanted, donor issues|2|||
126627277|NCT00113269|455594742|FG000|Overall Study|Not transplanted, recipient issues|2|||
126627278|NCT00113269|455594743|FG001|Overall Study|Not transplanted, recipient issues|1|||
126627279|NCT00113269|455594744|FG002|Overall Study|Not transplanted, recipient issues|7|||
126627280|NCT00113269|455594745|FG003|Overall Study|Not transplanted, recipient issues|4|||
126627281|NCT00113269|455594742|FG000|Overall Study|Early graft loss, technical|0|||
126627282|NCT00113269|455594743|FG001|Overall Study|Early graft loss, technical|0|||
126627283|NCT00113269|455594744|FG002|Overall Study|Early graft loss, technical|2|||
126627284|NCT00113269|455594745|FG003|Overall Study|Early graft loss, technical|0|||
126627285|NCT00113269|455594742|FG000|Overall Study|Death in operating room|0|||
126627286|NCT00113269|455594743|FG001|Overall Study|Death in operating room|0|||
126627287|NCT00113269|455594744|FG002|Overall Study|Death in operating room|0|||
126627288|NCT00113269|455594745|FG003|Overall Study|Death in operating room|1|||
126627289|NCT00113269|455594742|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
126627290|NCT00113269|455594743|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
126627291|NCT00113269|455594744|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
126627292|NCT00113269|455594745|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
126627293|NCT00113269|455594742|FG000|Overall Study|Adverse Event|2|||
126627294|NCT00113269|455594743|FG001|Overall Study|Adverse Event|7|||
126627295|NCT00113269|455594744|FG002|Overall Study|Adverse Event|11|||
126627296|NCT00113269|455594745|FG003|Overall Study|Adverse Event|7|||
126627297|NCT00113269|455594742|FG000|Overall Study|Withdrawal by Subject|4|||
126783362|NCT02637557|456162214|FG001|Overall Study|Lost to Follow-up|1|||
126783363|NCT02637557|456162215|FG002|Overall Study|Lost to Follow-up|0|||
126783364|NCT02637557|456162216|FG003|Overall Study|Lost to Follow-up|1|||
126783365|NCT02637557|456162213|FG000|Overall Study|Physician Decision|1|||
126783366|NCT02637557|456162214|FG001|Overall Study|Physician Decision|0|||
126783367|NCT02637557|456162215|FG002|Overall Study|Physician Decision|0|||
126783368|NCT02637557|456162216|FG003|Overall Study|Physician Decision|0|||
126783369|NCT02637557|456162213|FG000|Overall Study|Protocol Violation|2|||
126783370|NCT02637557|456162214|FG001|Overall Study|Protocol Violation|0|||
126783371|NCT02637557|456162215|FG002|Overall Study|Protocol Violation|2|||
126783372|NCT02637557|456162216|FG003|Overall Study|Protocol Violation|1|||
126783373|NCT02637557|456162213|FG000|Overall Study|Withdrawal by Subject|1|||
126783374|NCT02637557|456162214|FG001|Overall Study|Withdrawal by Subject|3|||
126783375|NCT02637557|456162215|FG002|Overall Study|Withdrawal by Subject|4|||
126783376|NCT02637557|456162216|FG003|Overall Study|Withdrawal by Subject|2|||
126783377|NCT00613574|456162217|FG000|Overall Study|Adverse Event|3|||
126783378|NCT00613574|456162217|FG000|Overall Study|Lost to Follow-up|2|||
126783379|NCT00613574|456162217|FG000|Overall Study|Other|1|||
126783380|NCT04604184|456162224|FG000|Overall Study|Adverse Event|5|||
126783381|NCT04604184|456162225|FG001|Overall Study|Adverse Event|5|||
126783382|NCT04604184|456162224|FG000|Overall Study|Death|2|||
126783383|NCT04604184|456162225|FG001|Overall Study|Death|1|||
126783384|NCT04604184|456162224|FG000|Overall Study|Withdrawal by Subject|1|||
126783385|NCT04604184|456162225|FG001|Overall Study|Withdrawal by Subject|3|||
126783386|NCT04604184|456162224|FG000|Overall Study|Not treated|2|||
126783387|NCT04604184|456162225|FG001|Overall Study|Not treated|2|||
126783388|NCT04604184|456162224|FG000|Overall Study|Due to sponsor decision|9|||
126783389|NCT04604184|456162225|FG001|Overall Study|Due to sponsor decision|7|||
126783390|NCT04604184|456162224|FG000|Overall Study|Physician Decision|0|||
126783391|NCT04604184|456162225|FG001|Overall Study|Physician Decision|1|||
126783392|NCT04604184|456162224|FG000|Overall Study|Transfer to healthcare|1|||
126783393|NCT04604184|456162225|FG001|Overall Study|Transfer to healthcare|0|||
126783394|NCT01751412|456162226|FG000|Overall Study|Disease Progression Before Treatment|1|||
126783395|NCT01844583|456162229|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
126783396|NCT01844583|456162230|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
126783397|NCT01625377|456162231|FG000|Overall Study|Death|1|||
126783398|NCT01625377|456162232|FG001|Overall Study|Death|1|||
126783399|NCT01625377|456162231|FG000|Overall Study|Administrative Problem|1|||
126783400|NCT01625377|456162232|FG001|Overall Study|Administrative Problem|1|||
126627298|NCT00113269|455594743|FG001|Overall Study|Withdrawal by Subject|3|||
126627299|NCT00113269|455594744|FG002|Overall Study|Withdrawal by Subject|4|||
126627300|NCT00113269|455594745|FG003|Overall Study|Withdrawal by Subject|2|||
126783401|NCT01625377|456162231|FG000|Overall Study|Protocol Violation|0|||
126783402|NCT01625377|456162232|FG001|Overall Study|Protocol Violation|3|||
126783403|NCT01625377|456162231|FG000|Overall Study|Adverse Event|3|||
126783404|NCT01625377|456162232|FG001|Overall Study|Adverse Event|16|||
126627301|NCT00113269|455594742|FG000|Overall Study|Graft loss|6|||
126627302|NCT00113269|455594743|FG001|Overall Study|Graft loss|6|||
126627303|NCT00113269|455594744|FG002|Overall Study|Graft loss|4|||
126627304|NCT00113269|455594745|FG003|Overall Study|Graft loss|9|||
126627305|NCT00113269|455594742|FG000|Overall Study|Protocol Violation|1|||
126627306|NCT00113269|455594743|FG001|Overall Study|Protocol Violation|0|||
126627307|NCT00113269|455594744|FG002|Overall Study|Protocol Violation|4|||
126627308|NCT00113269|455594745|FG003|Overall Study|Protocol Violation|2|||
126627309|NCT00113269|455594742|FG000|Overall Study|Lost to Follow-up|2|||
126627310|NCT00113269|455594743|FG001|Overall Study|Lost to Follow-up|3|||
126627311|NCT00113269|455594744|FG002|Overall Study|Lost to Follow-up|6|||
126627312|NCT00113269|455594745|FG003|Overall Study|Lost to Follow-up|3|||
126627313|NCT00113269|455594742|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
126627314|NCT00113269|455594743|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
126627315|NCT00113269|455594744|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
126627316|NCT00113269|455594745|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
126627317|NCT00113269|455594742|FG000|Overall Study|Discontinued due to rejection|0|||
126627318|NCT00113269|455594743|FG001|Overall Study|Discontinued due to rejection|0|||
126627319|NCT00113269|455594744|FG002|Overall Study|Discontinued due to rejection|1|||
126627320|NCT00113269|455594745|FG003|Overall Study|Discontinued due to rejection|0|||
126627321|NCT00113269|455594742|FG000|Overall Study|Moved|0|||
126627322|NCT00113269|455594743|FG001|Overall Study|Moved|1|||
126627323|NCT00113269|455594744|FG002|Overall Study|Moved|0|||
126627324|NCT00113269|455594745|FG003|Overall Study|Moved|3|||
126627325|NCT00113269|455594742|FG000|Overall Study|Received pancreas transplant|0|||
126627326|NCT00113269|455594743|FG001|Overall Study|Received pancreas transplant|0|||
126627327|NCT00113269|455594744|FG002|Overall Study|Received pancreas transplant|0|||
126627328|NCT00113269|455594745|FG003|Overall Study|Received pancreas transplant|2|||
126627329|NCT00113269|455594742|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
126627330|NCT00113269|455594743|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
126627331|NCT00113269|455594744|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
126627332|NCT00113269|455594745|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
126627333|NCT00113269|455594742|FG000|Overall Study|Did not meet eligibility criteria|1|||
126627334|NCT00113269|455594743|FG001|Overall Study|Did not meet eligibility criteria|0|||
126627335|NCT00113269|455594744|FG002|Overall Study|Did not meet eligibility criteria|0|||
126627336|NCT00113269|455594745|FG003|Overall Study|Did not meet eligibility criteria|1|||
126627337|NCT00113269|455594742|FG000|Overall Study|Unable to return for follow up|2|||
126627338|NCT00113269|455594743|FG001|Overall Study|Unable to return for follow up|1|||
126627339|NCT00113269|455594744|FG002|Overall Study|Unable to return for follow up|0|||
126627340|NCT00113269|455594745|FG003|Overall Study|Unable to return for follow up|0|||
126627341|NCT00966979|455594747|FG000|Overall Study|Death|1|||
126627342|NCT00966979|455594747|FG000|Overall Study|Lost to Follow-up|6|||
126627343|NCT00966979|455594747|FG000|Overall Study|Withdrawal by Subject|14|||
126627344|NCT00966979|455594747|FG000|Overall Study|Adverse Event|5|||
126627345|NCT00966979|455594747|FG000|Overall Study|Sponsor terminated early|49|||
126627346|NCT00966979|455594747|FG000|Overall Study|Censored because surgery not done|2|||
126627347|NCT00966979|455594747|FG000|Overall Study|Censored because study device was not implanted|14|||
126627348|NCT00966979|455594747|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
126627349|NCT04140266|455594748|FG000|Overall Study|Physician Decision|2|||
126627350|NCT04140266|455594749|FG001|Overall Study|Physician Decision|0|||
126627351|NCT04140266|455594748|FG000|Overall Study|Withdrawal by Subject|4|||
126627352|NCT04140266|455594749|FG001|Overall Study|Withdrawal by Subject|2|||
126627353|NCT03119688|455594753|FG000|Overall Study|Adverse Event|4|||
126627354|NCT03226106|455594754|FG000|Overall Study|Withdrawal by Subject|2|||
126627355|NCT03226106|455594755|FG001|Overall Study|Withdrawal by Subject|0|||
126627356|NCT03226106|455594754|FG000|Overall Study|Adverse Event|1|||
126783405|NCT01625377|456162231|FG000|Overall Study|Graft loss|1|||
126783406|NCT01625377|456162232|FG001|Overall Study|Graft loss|0|||
126783407|NCT01625377|456162231|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
126783408|NCT01625377|456162232|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
126783409|NCT01625377|456162231|FG000|Overall Study|Abnormal laboratory values|1|||
126783410|NCT01625377|456162232|FG001|Overall Study|Abnormal laboratory values|0|||
126783411|NCT03294538|456162237|FG000|Overall Study|Adverse Event|0|||
126783412|NCT03294538|456162238|FG001|Overall Study|Adverse Event|1|||
126783413|NCT03294538|456162239|FG002|Overall Study|Adverse Event|1|||
126783414|NCT03294538|456162237|FG000|Overall Study|Lost to Follow-up|1|||
126783415|NCT03294538|456162238|FG001|Overall Study|Lost to Follow-up|0|||
126627357|NCT03226106|455594755|FG001|Overall Study|Adverse Event|0|||
126627358|NCT03226106|455594754|FG000|Overall Study|Lost to Follow-up|2|||
126627359|NCT03226106|455594755|FG001|Overall Study|Lost to Follow-up|0|||
126627360|NCT00721214|455594756|FG000|Overall Study|Chose another center for transplant|1|||
126627361|NCT00721214|455594756|FG000|Overall Study|Death|3|||
126627362|NCT05006417|455594757|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
126627363|NCT01243411|455594758|FG000|Overall Study|Withdrawal by Subject|18|||
126783416|NCT03294538|456162239|FG002|Overall Study|Lost to Follow-up|0|||
126627364|NCT01243411|455594758|FG000|Overall Study|Lost to Follow-up|10|||
126627365|NCT01243411|455594758|FG000|Overall Study|Adverse Event|5|||
126627366|NCT01243411|455594758|FG000|Overall Study|Other|8|||
126627367|NCT00488319|455594761|FG000|Overall Study|Adverse Event|1|||
126627368|NCT00488319|455594762|FG001|Overall Study|Adverse Event|2|||
126627369|NCT00488319|455594763|FG002|Overall Study|Adverse Event|23|||
126627370|NCT00488319|455594761|FG000|Overall Study|Lack of Efficacy|6|||
126627371|NCT00488319|455594762|FG001|Overall Study|Lack of Efficacy|12|||
126627372|NCT00488319|455594763|FG002|Overall Study|Lack of Efficacy|27|||
126627373|NCT00488319|455594761|FG000|Overall Study|Lost to Follow-up|3|||
126627374|NCT00488319|455594762|FG001|Overall Study|Lost to Follow-up|5|||
126627375|NCT00488319|455594763|FG002|Overall Study|Lost to Follow-up|16|||
126627376|NCT00488319|455594761|FG000|Overall Study|Withdrawal by Subject|5|||
126627377|NCT00488319|455594762|FG001|Overall Study|Withdrawal by Subject|20|||
126627378|NCT00488319|455594763|FG002|Overall Study|Withdrawal by Subject|44|||
126627379|NCT00488319|455594761|FG000|Overall Study|Other reasons for withdrawal|0|||
126627380|NCT00488319|455594762|FG001|Overall Study|Other reasons for withdrawal|4|||
126627381|NCT00488319|455594763|FG002|Overall Study|Other reasons for withdrawal|12|||
126627382|NCT02158247|455594764|FG000|Overall Study|Invisible vocal cords|5|||
126627383|NCT00875615|455594771|FG000|Overall Study|Withdrawal by Subject|1|||
126627384|NCT01772823|455594772|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
126627385|NCT01772823|455594773|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
126627386|NCT01772823|455594772|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
126627387|NCT01772823|455594773|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
126627388|NCT01772823|455594772|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
126627389|NCT01772823|455594773|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
126627390|NCT01772823|455594772|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
126627391|NCT01772823|455594773|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
126627392|NCT01772823|455594772|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
126627393|NCT01772823|455594773|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
126627394|NCT01772823|455594772|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
126627395|NCT01772823|455594773|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
126627396|NCT01772823|455594772|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
126627397|NCT01772823|455594773|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
126627398|NCT01772823|455594772|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
126627399|NCT01772823|455594773|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
126627400|NCT01772823|455594772|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
126627401|NCT01772823|455594773|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
126627402|NCT01772823|455594772|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
126627403|NCT01772823|455594773|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
126627404|NCT01772823|455594772|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
126627405|NCT01772823|455594773|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
126627406|NCT01772823|455594772|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
126627407|NCT01772823|455594773|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
126627408|NCT01772823|455594772|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
126627409|NCT01772823|455594773|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
126627410|NCT01772823|455594772|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
126627411|NCT01772823|455594773|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
126627412|NCT01772823|455594772|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
126627413|NCT01772823|455594773|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
126627414|NCT01772823|455594772|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
126627415|NCT01772823|455594773|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
126627416|NCT03712449|455594776|FG000|Overall Study|Withdraw Consent|0|||
126627417|NCT03712449|455594777|FG001|Overall Study|Withdraw Consent|1|||
126627418|NCT02490878|455594782|FG000|Overall Study|deemed ineligible|0|||
126627419|NCT02490878|455594783|FG001|Overall Study|deemed ineligible|1|||
126627420|NCT02490878|455594782|FG000|Overall Study|progression prior to treatment|0|||
126627421|NCT02490878|455594783|FG001|Overall Study|progression prior to treatment|1|||
126627422|NCT02490878|455594782|FG000|Overall Study|only submitted baseline QOL|0|||
126627423|NCT02490878|455594783|FG001|Overall Study|only submitted baseline QOL|1|||
126627424|NCT02544113|455594785|FG000|Overall Study|Death|3|||
126627425|NCT02544113|455594786|FG001|Overall Study|Death|4|||
126627426|NCT00451555|455594787|FG000|Overall Study|Protocol Violation|2|||
126627427|NCT00451555|455594788|FG001|Overall Study|Protocol Violation|2|||
126627428|NCT00451555|455594787|FG000|Overall Study|Adverse Event|3|||
126627429|NCT00451555|455594788|FG001|Overall Study|Adverse Event|1|||
126627430|NCT00451555|455594787|FG000|Overall Study|Withdrawal by Subject|6|||
126627431|NCT00451555|455594788|FG001|Overall Study|Withdrawal by Subject|0|||
126627432|NCT00451555|455594787|FG000|Overall Study|Physician Decision|2|||
126627433|NCT00451555|455594788|FG001|Overall Study|Physician Decision|1|||
126783417|NCT03294538|456162237|FG000|Overall Study|Outside of Visit Window|4|||
126783418|NCT03294538|456162238|FG001|Overall Study|Outside of Visit Window|4|||
126783419|NCT03294538|456162239|FG002|Overall Study|Outside of Visit Window|1|||
126783420|NCT02207621|456162242|FG000|Overall Study|Adverse Event|71|||
126783421|NCT02207621|456162243|FG001|Overall Study|Adverse Event|15|||
126783422|NCT02207621|456162244|FG002|Overall Study|Adverse Event|132|||
126783423|NCT02207621|456162242|FG000|Overall Study|Withdrawal by Subject|9|||
126783424|NCT02207621|456162243|FG001|Overall Study|Withdrawal by Subject|9|||
126783425|NCT02207621|456162244|FG002|Overall Study|Withdrawal by Subject|13|||
126783426|NCT02207621|456162242|FG000|Overall Study|Non-Compliant|3|||
126783427|NCT02207621|456162243|FG001|Overall Study|Non-Compliant|3|||
126783428|NCT02207621|456162244|FG002|Overall Study|Non-Compliant|1|||
126783429|NCT02207621|456162242|FG000|Overall Study|Lost to Follow-up|1|||
126783430|NCT02207621|456162243|FG001|Overall Study|Lost to Follow-up|0|||
126783431|NCT02207621|456162244|FG002|Overall Study|Lost to Follow-up|3|||
126783432|NCT02207621|456162242|FG000|Overall Study|Lack of Efficacy|10|||
126783433|NCT02207621|456162243|FG001|Overall Study|Lack of Efficacy|2|||
126783434|NCT02207621|456162244|FG002|Overall Study|Lack of Efficacy|4|||
126783435|NCT02207621|456162242|FG000|Overall Study|Disallowed Concurrent Medication|2|||
126783436|NCT02207621|456162243|FG001|Overall Study|Disallowed Concurrent Medication|5|||
126783437|NCT02207621|456162244|FG002|Overall Study|Disallowed Concurrent Medication|2|||
126627434|NCT02847637|455594789|FG000|Overall Study|Withdrawal by Subject|0|||
126627435|NCT02847637|455594790|FG001|Overall Study|Withdrawal by Subject|1|||
126627436|NCT02847637|455594791|FG002|Overall Study|Withdrawal by Subject|1|||
126627437|NCT02847637|455594792|FG003|Overall Study|Withdrawal by Subject|0|||
126627438|NCT02847637|455594789|FG000|Overall Study|Lost to Follow-up|1|||
126627439|NCT02847637|455594790|FG001|Overall Study|Lost to Follow-up|1|||
126627440|NCT02847637|455594791|FG002|Overall Study|Lost to Follow-up|0|||
126627441|NCT02847637|455594792|FG003|Overall Study|Lost to Follow-up|0|||
126627442|NCT00588341|455594795|FG000|Overall Study|Withdrawal by Subject|3|||
126627443|NCT00588341|455594795|FG000|Overall Study|Not treated due to metastatic disease|1|||
126627444|NCT00588341|455594795|FG000|Overall Study|Patient ineligible|1|||
126627445|NCT01281917|455594803|FG000|Overall Study|Withdrawal by Subject|1|||
126627446|NCT01187407|455594805|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
126627447|NCT01187407|455594806|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126627448|NCT01187407|455594807|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126627449|NCT01187407|455594808|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126627450|NCT01187407|455594809|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
126627451|NCT01187407|455594805|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
126627452|NCT01187407|455594806|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126627453|NCT01187407|455594807|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126627454|NCT01187407|455594808|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126627455|NCT01187407|455594809|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
126627456|NCT01187407|455594805|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
126627457|NCT01187407|455594806|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126627458|NCT01187407|455594807|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126627459|NCT01187407|455594808|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126627460|NCT01187407|455594809|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
126627461|NCT01187407|455594805|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
126627462|NCT01187407|455594806|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126627463|NCT01187407|455594807|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126627464|NCT01187407|455594808|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126627465|NCT01187407|455594809|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
126627466|NCT01187407|455594805|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
126627467|NCT01187407|455594806|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126627468|NCT01187407|455594807|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126627469|NCT01187407|455594808|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126627470|NCT01187407|455594809|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
126627471|NCT01187407|455594805|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
126627472|NCT01187407|455594806|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126627473|NCT01187407|455594807|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126783438|NCT02207621|456162242|FG000|Overall Study|Physician Decision|1|||
126783439|NCT02207621|456162243|FG001|Overall Study|Physician Decision|2|||
126783440|NCT02207621|456162244|FG002|Overall Study|Physician Decision|2|||
126783441|NCT02207621|456162242|FG000|Overall Study|Protocol Violation|4|||
126783442|NCT02207621|456162243|FG001|Overall Study|Protocol Violation|10|||
126627474|NCT01187407|455594808|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126627475|NCT01187407|455594809|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
126783443|NCT02207621|456162244|FG002|Overall Study|Protocol Violation|6|||
126783444|NCT02207621|456162242|FG000|Overall Study|Death|2|||
126783445|NCT02207621|456162243|FG001|Overall Study|Death|0|||
126627476|NCT01187407|455594805|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
126783446|NCT02207621|456162244|FG002|Overall Study|Death|0|||
126783447|NCT02207621|456162242|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
126783448|NCT02207621|456162243|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
126783449|NCT02207621|456162244|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
126783450|NCT01769378|456162247|FG000|Overall Study|Adverse Event|10|||
126783451|NCT01769378|456162248|FG001|Overall Study|Adverse Event|0|||
126783452|NCT01769378|456162247|FG000|Overall Study|Entry criteria not met|1|||
126783453|NCT01769378|456162248|FG001|Overall Study|Entry criteria not met|0|||
126783454|NCT01769378|456162247|FG000|Overall Study|Protocol Violation|1|||
126783455|NCT01769378|456162248|FG001|Overall Study|Protocol Violation|1|||
126783456|NCT01769378|456162247|FG000|Overall Study|Withdrawal by Subject|10|||
126783457|NCT01769378|456162248|FG001|Overall Study|Withdrawal by Subject|3|||
126783458|NCT01769378|456162247|FG000|Overall Study|Sponsor Decision|1|||
126783459|NCT01769378|456162248|FG001|Overall Study|Sponsor Decision|0|||
126783460|NCT01769378|456162247|FG000|Overall Study|Lost to Follow-up|2|||
126783461|NCT01769378|456162248|FG001|Overall Study|Lost to Follow-up|0|||
126783462|NCT01238848|456162252|FG000|Overall Study|Physician Decision|13|||
126783463|NCT01238848|456162253|FG001|Overall Study|Physician Decision|5|||
126783464|NCT00576901|456162255|FG000|Overall Study|Withdrawal by Subject|1|||
126783465|NCT00576901|456162255|FG000|Overall Study|Disease course|1|||
126783466|NCT00576901|456162255|FG000|Overall Study|Protocol Violation|1|||
126783467|NCT01755858|456162258|FG000|Overall Study|Adverse Event|1|||
126783468|NCT01755858|456162259|FG001|Overall Study|Adverse Event|1|||
126783469|NCT01259869|456162260|FG000|Overall Study|Duplicated registration|1|||
126783470|NCT00175019|456162261|FG000|Overall Study|Adverse Event|54|||
126783471|NCT00175019|456162262|FG001|Overall Study|Adverse Event|22|||
126783472|NCT00175019|456162263|FG002|Overall Study|Adverse Event|2|||
126783473|NCT00175019|456162261|FG000|Overall Study|Protocol Violation|6|||
126783474|NCT00175019|456162262|FG001|Overall Study|Protocol Violation|3|||
126783475|NCT00175019|456162263|FG002|Overall Study|Protocol Violation|3|||
126783476|NCT00175019|456162261|FG000|Overall Study|Lost to Follow-up|42|||
126783477|NCT00175019|456162262|FG001|Overall Study|Lost to Follow-up|39|||
126783478|NCT00175019|456162263|FG002|Overall Study|Lost to Follow-up|9|||
126783479|NCT00175019|456162261|FG000|Overall Study|Did not continue under Amendment 4|1|||
126783480|NCT00175019|456162262|FG001|Overall Study|Did not continue under Amendment 4|1|||
126783481|NCT00175019|456162263|FG002|Overall Study|Did not continue under Amendment 4|2|||
126783482|NCT00175019|456162261|FG000|Overall Study|Personal Reason(s)|39|||
126783483|NCT00175019|456162262|FG001|Overall Study|Personal Reason(s)|31|||
126783484|NCT00175019|456162263|FG002|Overall Study|Personal Reason(s)|8|||
126783485|NCT00175019|456162261|FG000|Overall Study|Therapeutic Failure|10|||
126783486|NCT00175019|456162262|FG001|Overall Study|Therapeutic Failure|38|||
126783487|NCT00175019|456162263|FG002|Overall Study|Therapeutic Failure|22|||
126783488|NCT00175019|456162261|FG000|Overall Study|Gout Flare|2|||
126783489|NCT00175019|456162262|FG001|Overall Study|Gout Flare|3|||
126783490|NCT00175019|456162263|FG002|Overall Study|Gout Flare|0|||
126783491|NCT00175019|456162261|FG000|Overall Study|Reason Not Specified|40|||
126783492|NCT00175019|456162262|FG001|Overall Study|Reason Not Specified|34|||
126783493|NCT00175019|456162263|FG002|Overall Study|Reason Not Specified|11|||
126783494|NCT03209570|456162264|FG000|Overall Study|Death|1|||
126783495|NCT03209570|456162265|FG001|Overall Study|Death|0|||
126783496|NCT03209570|456162264|FG000|Overall Study|Incomplete Data|8|||
126783497|NCT03209570|456162265|FG001|Overall Study|Incomplete Data|10|||
126783498|NCT03209570|456162264|FG000|Overall Study|Protocol Violation|1|||
126783499|NCT03209570|456162265|FG001|Overall Study|Protocol Violation|0|||
126783500|NCT03209570|456162264|FG000|Overall Study|Withdrawal by Subject|0|||
126783501|NCT03209570|456162265|FG001|Overall Study|Withdrawal by Subject|3|||
126783502|NCT00220701|456162276|FG000|Overall Study|Lost to Follow-up|5|||
126783503|NCT00220701|456162277|FG001|Overall Study|Lost to Follow-up|4|||
126783504|NCT00755326|456162278|FG000|Overall Study|Lost to Follow-up|2|||
126783505|NCT00755326|456162279|FG001|Overall Study|Lost to Follow-up|3|||
126783506|NCT03361423|456162283|FG000|Overall Study|Withdrawal by Subject|4|||
126783507|NCT03361423|456162284|FG001|Overall Study|Withdrawal by Subject|3|||
126783508|NCT03361423|456162283|FG000|Overall Study|Did not treat|19|||
126783509|NCT03361423|456162284|FG001|Overall Study|Did not treat|18|||
126783510|NCT03361423|456162283|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
126627477|NCT01187407|455594806|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126627478|NCT01187407|455594807|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126783511|NCT03361423|456162284|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
126783512|NCT03361423|456162283|FG000|Overall Study|Missing data|4|||
126783513|NCT03361423|456162284|FG001|Overall Study|Missing data|1|||
126783514|NCT01336894|456162285|FG000|Follow-up|Study terminated prematurely|2|||
126783515|NCT01336894|456162286|FG001|Follow-up|Study terminated prematurely|7|||
126783516|NCT01325207|456162287|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
126783517|NCT01325207|456162288|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
126783518|NCT01325207|456162289|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
126783519|NCT01325207|456162290|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
126783520|NCT01325207|456162291|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
126783521|NCT01325207|456162292|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
126783522|NCT01325207|456162287|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
126783523|NCT01325207|456162288|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
126783524|NCT01325207|456162289|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
126783525|NCT01325207|456162290|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
126783526|NCT01325207|456162291|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
126783527|NCT01325207|456162292|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
126783528|NCT01325207|456162287|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
126783529|NCT01325207|456162288|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
126783530|NCT01325207|456162289|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
126783531|NCT01325207|456162290|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
126783532|NCT01325207|456162291|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
126783533|NCT01325207|456162292|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
126783534|NCT01325207|456162287|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
126783535|NCT01325207|456162288|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
126783536|NCT01325207|456162289|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
126783537|NCT01325207|456162290|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
126783538|NCT01325207|456162291|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
126783539|NCT01325207|456162292|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
126783540|NCT01325207|456162287|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
126783541|NCT01325207|456162288|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
126783542|NCT01325207|456162289|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
126783543|NCT01325207|456162290|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
126783544|NCT01325207|456162291|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
126783545|NCT01325207|456162292|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
126783546|NCT01325207|456162287|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
126783547|NCT01325207|456162288|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
126783548|NCT01325207|456162289|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
126783549|NCT01325207|456162290|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
126783550|NCT01325207|456162291|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
126783551|NCT01325207|456162292|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
126783552|NCT01325207|456162287|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
126783553|NCT01325207|456162288|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
126783554|NCT01325207|456162289|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
126783555|NCT01325207|456162290|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
126783556|NCT01325207|456162291|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
126783557|NCT01325207|456162292|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
126783558|NCT01254409|456162293|FG000|Overall Study|Adverse Event|0|||
126783559|NCT01254409|456162294|FG001|Overall Study|Adverse Event|1|||
126783560|NCT01254409|456162295|FG002|Overall Study|Adverse Event|0|||
126783561|NCT01254409|456162296|FG003|Overall Study|Adverse Event|0|||
126783562|NCT01564758|456162298|FG000|Overall Study|Death|8|||
126783563|NCT01564758|456162298|FG000|Overall Study|Adverse Event|3|||
126783564|NCT01564758|456162298|FG000|Overall Study|Other|3|||
126783565|NCT02482571|456162299|FG000|Overall Study|Adverse Event|1|||
126783566|NCT02482571|456162299|FG000|Overall Study|Scanner or Respiract failure|3|||
126783567|NCT02482571|456162299|FG000|Overall Study|Withdrawal by Subject|4|||
126783568|NCT01446913|456162300|FG000|Overall Study|Significant illness|1|||
126783569|NCT01446913|456162301|FG001|Overall Study|Significant illness|1|||
126783570|NCT01446913|456162302|FG002|Overall Study|Significant illness|1|||
126627479|NCT01187407|455594808|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126627480|NCT01187407|455594809|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
126627481|NCT01187407|455594805|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
126627482|NCT01187407|455594806|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
126627483|NCT01187407|455594807|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
126627484|NCT01187407|455594808|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
126627485|NCT01187407|455594809|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
126627486|NCT01187407|455594805|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
126627487|NCT01187407|455594806|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
126627488|NCT01187407|455594807|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
126627489|NCT01187407|455594808|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
126627490|NCT01187407|455594809|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
126627491|NCT01187407|455594805|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
126783571|NCT01446913|456162300|FG000|Overall Study|Withdrawal by Subject|5|||
126783572|NCT01446913|456162301|FG001|Overall Study|Withdrawal by Subject|3|||
126783573|NCT01446913|456162302|FG002|Overall Study|Withdrawal by Subject|5|||
126783574|NCT01446913|456162300|FG000|Overall Study|Physician Decision|0|||
126627492|NCT01187407|455594806|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
126627493|NCT01187407|455594807|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
126627494|NCT01187407|455594808|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
126627495|NCT01187407|455594809|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
126627496|NCT01187407|455594805|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126627497|NCT01187407|455594806|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126627498|NCT01187407|455594807|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
126627499|NCT01187407|455594808|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
126627500|NCT01187407|455594809|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
126627501|NCT01187407|455594805|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
126627502|NCT01187407|455594806|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
126627503|NCT01187407|455594807|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
126627504|NCT01187407|455594808|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
126627505|NCT01187407|455594809|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
126627506|NCT01187407|455594805|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
126627507|NCT01187407|455594806|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
126627508|NCT01187407|455594807|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
126627509|NCT01187407|455594808|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
126627510|NCT01187407|455594809|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
126627511|NCT01187407|455594805|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
126627512|NCT01187407|455594806|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
126627513|NCT01187407|455594807|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
126627514|NCT01187407|455594808|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
126627515|NCT01187407|455594809|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
126627516|NCT00776984|455594812|FG000|Overall Study|Adverse Event|8|||
126627517|NCT00776984|455594813|FG001|Overall Study|Adverse Event|2|||
126627518|NCT00776984|455594812|FG000|Overall Study|Protocol Violation|4|||
126627519|NCT00776984|455594813|FG001|Overall Study|Protocol Violation|2|||
126627520|NCT00776984|455594812|FG000|Overall Study|Lost to Follow-up|2|||
126627521|NCT00776984|455594813|FG001|Overall Study|Lost to Follow-up|0|||
126627522|NCT00776984|455594812|FG000|Overall Study|Withdrawal by Subject|12|||
126627523|NCT00776984|455594813|FG001|Overall Study|Withdrawal by Subject|7|||
126627524|NCT00776984|455594812|FG000|Overall Study|Lack of Efficacy|0|||
126627525|NCT00776984|455594813|FG001|Overall Study|Lack of Efficacy|1|||
126627526|NCT00776984|455594812|FG000|Overall Study|Other|5|||
126627527|NCT00776984|455594813|FG001|Overall Study|Other|9|||
126627528|NCT02573883|455594821|FG000|Six Month Follow Up|Lost to Follow-up|1|||
126627529|NCT02573883|455594822|FG001|Six Month Follow Up|Lost to Follow-up|0|||
126627530|NCT02573883|455594823|FG002|Six Month Follow Up|Lost to Follow-up|0|||
126627531|NCT02573883|455594824|FG003|Six Month Follow Up|Lost to Follow-up|0|||
126627532|NCT02573883|455594821|FG000|One Year Follow Up|Lost to Follow-up|2|||
126627533|NCT02573883|455594822|FG001|One Year Follow Up|Lost to Follow-up|1|||
126627534|NCT02573883|455594823|FG002|One Year Follow Up|Lost to Follow-up|0|||
126627535|NCT02573883|455594824|FG003|One Year Follow Up|Lost to Follow-up|0|||
126627536|NCT01544309|455594825|FG000|Overall Study|Withdrawal by Subject|12|||
126627537|NCT01544309|455594826|FG001|Overall Study|Withdrawal by Subject|7|||
126627538|NCT01544309|455594825|FG000|Overall Study|Protocol Violation|2|||
126627539|NCT01544309|455594826|FG001|Overall Study|Protocol Violation|1|||
126627540|NCT01544309|455594825|FG000|Overall Study|Physician Decision|4|||
126627541|NCT01544309|455594826|FG001|Overall Study|Physician Decision|1|||
126627542|NCT01544309|455594825|FG000|Overall Study|Not performed pre-dose examination|1|||
126627543|NCT01544309|455594826|FG001|Overall Study|Not performed pre-dose examination|2|||
126627544|NCT01544309|455594825|FG000|Overall Study|Administered prohibit prior medication|1|||
126627545|NCT01544309|455594826|FG001|Overall Study|Administered prohibit prior medication|0|||
126627546|NCT03796208|455594831|FG000|Overall Study|Withdrawal by Subject|3|||
126627547|NCT03796208|455594832|FG001|Overall Study|Withdrawal by Subject|0|||
126627548|NCT03796208|455594831|FG000|Overall Study|Loss of pregnancy|1|||
126783575|NCT01446913|456162301|FG001|Overall Study|Physician Decision|0|||
126783576|NCT01446913|456162302|FG002|Overall Study|Physician Decision|2|||
126783577|NCT01446913|456162300|FG000|Overall Study|Lost to Follow-up|3|||
126783578|NCT01446913|456162301|FG001|Overall Study|Lost to Follow-up|5|||
126783579|NCT01446913|456162302|FG002|Overall Study|Lost to Follow-up|3|||
126783580|NCT00745251|456162303|FG000|Overall Study|Adverse Event|1|||
126627549|NCT03796208|455594832|FG001|Overall Study|Loss of pregnancy|1|||
126627550|NCT03796208|455594831|FG000|Overall Study|Changed prenatal clinics|0|||
126627551|NCT03796208|455594832|FG001|Overall Study|Changed prenatal clinics|5|||
126627552|NCT03796208|455594831|FG000|Overall Study|Lost to Follow-up|20|||
126627553|NCT03796208|455594832|FG001|Overall Study|Lost to Follow-up|16|||
126627554|NCT02725008|455594833|FG000|Overall Study|Lost to Follow-up|7|||
126627555|NCT02725008|455594834|FG001|Overall Study|Lost to Follow-up|9|||
126627556|NCT02725008|455594833|FG000|Overall Study|Withdrawal by Subject|2|||
126783581|NCT00745251|456162304|FG001|Overall Study|Adverse Event|2|||
126783582|NCT00745251|456162303|FG000|Overall Study|Withdrawal by Subject|1|||
126627557|NCT02725008|455594834|FG001|Overall Study|Withdrawal by Subject|2|||
126627558|NCT02725008|455594833|FG000|Overall Study|Admitted to hospital|0|||
126627559|NCT02725008|455594834|FG001|Overall Study|Admitted to hospital|1|||
126627560|NCT02175745|455594835|FG000|Overall Study|Not Eligible|1|||
126627561|NCT00562484|455594840|FG000|Overall Study|Adverse Event|6|||
126627562|NCT00562484|455594841|FG001|Overall Study|Adverse Event|1|||
126627563|NCT00562484|455594840|FG000|Overall Study|Protocol Violation|11|||
126627564|NCT00562484|455594841|FG001|Overall Study|Protocol Violation|2|||
126627565|NCT00562484|455594840|FG000|Overall Study|Withdrawal by Subject|12|||
126627566|NCT00562484|455594841|FG001|Overall Study|Withdrawal by Subject|9|||
126627567|NCT00562484|455594840|FG000|Overall Study|Moved away from the study area|20|||
126627568|NCT00562484|455594841|FG001|Overall Study|Moved away from the study area|9|||
126627569|NCT00562484|455594840|FG000|Overall Study|Lost to Follow-up|132|||
126627570|NCT00562484|455594841|FG001|Overall Study|Lost to Follow-up|71|||
126627571|NCT00562484|455594840|FG000|Overall Study|Reason not provided or not specified|25|||
126627572|NCT00562484|455594841|FG001|Overall Study|Reason not provided or not specified|12|||
126627573|NCT00702520|455594843|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
126627574|NCT00702520|455594844|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
126627575|NCT00702520|455594845|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
126627576|NCT00702520|455594846|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
126627577|NCT00702520|455594843|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
126627578|NCT00702520|455594844|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
126627579|NCT00702520|455594845|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
126627580|NCT00702520|455594846|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
126627581|NCT00702520|455594843|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
126627582|NCT00702520|455594844|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
126627583|NCT00702520|455594845|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
126627584|NCT00702520|455594846|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
126627585|NCT02481934|455594847|FG000|Overall Study|Death|2|||
126627586|NCT00942188|455594848|FG000|Overall Study|Adverse Event|0|||
126627587|NCT00942188|455594849|FG001|Overall Study|Adverse Event|3|||
126627588|NCT00942188|455594850|FG002|Overall Study|Adverse Event|2|||
126627589|NCT00942188|455594851|FG003|Overall Study|Adverse Event|0|||
126627590|NCT00942188|455594848|FG000|Overall Study|Lack of Efficacy|0|||
126627591|NCT00942188|455594849|FG001|Overall Study|Lack of Efficacy|0|||
126627592|NCT00942188|455594850|FG002|Overall Study|Lack of Efficacy|0|||
126627593|NCT00942188|455594851|FG003|Overall Study|Lack of Efficacy|1|||
126627594|NCT00942188|455594848|FG000|Overall Study|Protocol Violation|1|||
126627595|NCT00942188|455594849|FG001|Overall Study|Protocol Violation|1|||
126627596|NCT00942188|455594850|FG002|Overall Study|Protocol Violation|0|||
126627597|NCT00942188|455594851|FG003|Overall Study|Protocol Violation|0|||
126627598|NCT00942188|455594848|FG000|Overall Study|Lost to Follow-up|2|||
126627599|NCT00942188|455594849|FG001|Overall Study|Lost to Follow-up|1|||
126627600|NCT00942188|455594850|FG002|Overall Study|Lost to Follow-up|2|||
126627601|NCT00942188|455594851|FG003|Overall Study|Lost to Follow-up|0|||
126627602|NCT00942188|455594848|FG000|Overall Study|Withdrawal by Subject|1|||
126627603|NCT00942188|455594849|FG001|Overall Study|Withdrawal by Subject|3|||
126627604|NCT00942188|455594850|FG002|Overall Study|Withdrawal by Subject|4|||
126627605|NCT00942188|455594851|FG003|Overall Study|Withdrawal by Subject|2|||
126627606|NCT00942188|455594848|FG000|Overall Study|Physician Decision|0|||
126627607|NCT00942188|455594849|FG001|Overall Study|Physician Decision|0|||
126627608|NCT00942188|455594850|FG002|Overall Study|Physician Decision|1|||
126627609|NCT00942188|455594851|FG003|Overall Study|Physician Decision|0|||
126627610|NCT00942188|455594848|FG000|Overall Study|Sponsor Decision|0|||
126627611|NCT00942188|455594849|FG001|Overall Study|Sponsor Decision|2|||
126627612|NCT00942188|455594850|FG002|Overall Study|Sponsor Decision|0|||
126627613|NCT00942188|455594851|FG003|Overall Study|Sponsor Decision|1|||
126627614|NCT00276016|455594852|FG000|Intervention 1|Withdrawal by Subject|0|||
126627615|NCT00276016|455594853|FG001|Intervention 1|Withdrawal by Subject|1|||
126627616|NCT00276016|455594854|FG002|Intervention 1|Withdrawal by Subject|0|||
126627617|NCT00276016|455594855|FG003|Intervention 1|Withdrawal by Subject|0|||
126627618|NCT00276016|455594856|FG004|Intervention 1|Withdrawal by Subject|0|||
126627619|NCT00276016|455594857|FG005|Intervention 1|Withdrawal by Subject|0|||
126627620|NCT05041439|455594858|FG000|Overall Study|Withdrawal by Subject|1|||
126627621|NCT05041439|455594859|FG001|Overall Study|Withdrawal by Subject|1|||
126627622|NCT05041439|455594858|FG000|Overall Study|Death|1|||
126627623|NCT05041439|455594859|FG001|Overall Study|Death|0|||
126627624|NCT01374971|455594860|FG000|Overall Study|Withdrawal by Subject|1|||
126627625|NCT04130061|455594869|FG000|Overall Study|OR team forgot to request membrane|1|||
126627626|NCT04130061|455594870|FG001|Overall Study|OR team forgot to request membrane|0|||
126627627|NCT01568112|455594871|FG000|Overall Study|Randomized But Not Treated|0|||
126627628|NCT01568112|455594872|FG001|Overall Study|Randomized But Not Treated|1|||
126627629|NCT01568112|455594873|FG002|Overall Study|Randomized But Not Treated|0|||
126627630|NCT01568112|455594874|FG003|Overall Study|Randomized But Not Treated|0|||
126627631|NCT01568112|455594871|FG000|Overall Study|Withdrew due to Adverse Event|2|||
126783583|NCT00745251|456162304|FG001|Overall Study|Withdrawal by Subject|1|||
126783584|NCT01618305|456162306|FG000|Overall Study|Death|0|||
126783585|NCT01618305|456162307|FG001|Overall Study|Death|1|||
126783586|NCT01618305|456162306|FG000|Overall Study|Lost to Follow-up|11|||
126783587|NCT01618305|456162307|FG001|Overall Study|Lost to Follow-up|7|||
126783588|NCT01618305|456162306|FG000|Overall Study|Protocol Violation|1|||
126783589|NCT01618305|456162307|FG001|Overall Study|Protocol Violation|0|||
126783590|NCT01618305|456162306|FG000|Overall Study|Withdrawal by Subject|3|||
126783591|NCT01618305|456162307|FG001|Overall Study|Withdrawal by Subject|2|||
126783592|NCT02708277|456162308|FG000|Overall Study|Lost to Follow-up|7|||
126783593|NCT02708277|456162309|FG001|Overall Study|Lost to Follow-up|4|||
126783594|NCT01960816|456162310|FG000|Overall Study|Lost to Follow-up|1|||
126783595|NCT01118728|456162311|FG000|Overall Study|Adverse Event|17|||
126783596|NCT01118728|456162311|FG000|Overall Study|Lack of Efficacy|27|||
126783597|NCT01118728|456162311|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
126783598|NCT01118728|456162311|FG000|Overall Study|Withdrawal by Subject|3|||
126783599|NCT01118728|456162311|FG000|Overall Study|Lost to Follow-up|4|||
126783600|NCT00385541|456162312|FG000|Overall Study|severe pain, clinician requested unblind|0|||
126783601|NCT00385541|456162313|FG001|Overall Study|severe pain, clinician requested unblind|1|||
126783602|NCT00929708|456162314|FG000|Overall Study|Protocol Violation|2|||
126783603|NCT00929708|456162315|FG001|Overall Study|Protocol Violation|1|||
126783604|NCT00929708|456162316|FG002|Overall Study|Protocol Violation|1|||
126783605|NCT00929708|456162317|FG003|Overall Study|Protocol Violation|1|||
126783606|NCT00929708|456162318|FG004|Overall Study|Protocol Violation|1|||
126783607|NCT00929708|456162314|FG000|Overall Study|Withdrawal by Subject|2|||
126783608|NCT00929708|456162315|FG001|Overall Study|Withdrawal by Subject|0|||
126783609|NCT00929708|456162316|FG002|Overall Study|Withdrawal by Subject|0|||
126783610|NCT00929708|456162317|FG003|Overall Study|Withdrawal by Subject|2|||
126783611|NCT00929708|456162318|FG004|Overall Study|Withdrawal by Subject|1|||
126783612|NCT00929708|456162314|FG000|Overall Study|Adverse Event|0|||
126783613|NCT00929708|456162315|FG001|Overall Study|Adverse Event|0|||
126783614|NCT00929708|456162316|FG002|Overall Study|Adverse Event|0|||
126783615|NCT00929708|456162317|FG003|Overall Study|Adverse Event|0|||
126783616|NCT00929708|456162318|FG004|Overall Study|Adverse Event|3|||
126783617|NCT00929708|456162314|FG000|Overall Study|Physician Decision|0|||
126783618|NCT00929708|456162315|FG001|Overall Study|Physician Decision|2|||
126783619|NCT00929708|456162316|FG002|Overall Study|Physician Decision|2|||
126783620|NCT00929708|456162317|FG003|Overall Study|Physician Decision|2|||
126783621|NCT00929708|456162318|FG004|Overall Study|Physician Decision|1|||
126783622|NCT00929708|456162314|FG000|Overall Study|Lost to Follow-up|0|||
126783623|NCT00929708|456162315|FG001|Overall Study|Lost to Follow-up|0|||
126783624|NCT00929708|456162316|FG002|Overall Study|Lost to Follow-up|0|||
126783625|NCT00929708|456162317|FG003|Overall Study|Lost to Follow-up|1|||
126783626|NCT00929708|456162318|FG004|Overall Study|Lost to Follow-up|0|||
126783627|NCT01893138|456162319|FG000|Double-Blind Period|Withdrawal by Subject|1|||
126783628|NCT01893138|456162320|FG001|Double-Blind Period|Withdrawal by Subject|1|||
126783629|NCT01893138|456162319|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
126783630|NCT01893138|456162320|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
126783631|NCT01893138|456162319|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
126783632|NCT01893138|456162320|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
126783633|NCT01893138|456162319|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
126783634|NCT01893138|456162320|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
126783635|NCT01893138|456162319|FG000|Open Label - Unblinded Period|Adverse Event|1|||
126783636|NCT01893138|456162320|FG001|Open Label - Unblinded Period|Adverse Event|0|||
126783637|NCT05188521|456164292|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
126783638|NCT05188521|456164293|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
126627632|NCT01568112|455594872|FG001|Overall Study|Withdrew due to Adverse Event|4|||
126627633|NCT01568112|455594873|FG002|Overall Study|Withdrew due to Adverse Event|6|||
126627634|NCT01568112|455594874|FG003|Overall Study|Withdrew due to Adverse Event|3|||
126627635|NCT01568112|455594871|FG000|Overall Study|Lost to Follow-up|0|||
126627636|NCT01568112|455594872|FG001|Overall Study|Lost to Follow-up|0|||
126627637|NCT01568112|455594873|FG002|Overall Study|Lost to Follow-up|0|||
126627638|NCT01568112|455594874|FG003|Overall Study|Lost to Follow-up|1|||
126627639|NCT01568112|455594871|FG000|Overall Study|Withdrawal by Subject|2|||
126627640|NCT01568112|455594872|FG001|Overall Study|Withdrawal by Subject|3|||
126627641|NCT01568112|455594873|FG002|Overall Study|Withdrawal by Subject|0|||
126627642|NCT01568112|455594874|FG003|Overall Study|Withdrawal by Subject|7|||
126627643|NCT01568112|455594871|FG000|Overall Study|Withdrawal by Physician|1|||
126627644|NCT01568112|455594872|FG001|Overall Study|Withdrawal by Physician|0|||
126627645|NCT01568112|455594873|FG002|Overall Study|Withdrawal by Physician|1|||
126627646|NCT01568112|455594874|FG003|Overall Study|Withdrawal by Physician|1|||
126627647|NCT00560313|455596059|FG000|Overall Study|Adverse Events or Death|2|||
126627648|NCT00560313|455596059|FG000|Overall Study|Withdrawal by Subject|2|||
126627649|NCT00560313|455596059|FG000|Overall Study|Lost to Follow-up|1|||
126783639|NCT01341639|456164294|FG000|Infant Series|Protocol Violation|1|||
126783640|NCT01341639|456164295|FG001|Infant Series|Protocol Violation|0|||
126627650|NCT00560313|455596059|FG000|Overall Study|Protocol Violation|1|||
126783641|NCT01341639|456164294|FG000|Infant Series|Not Vaccinated|0|||
126783642|NCT01341639|456164295|FG001|Infant Series|Not Vaccinated|1|||
126783643|NCT01341639|456164294|FG000|Infant Series|Adverse Event|0|||
126783644|NCT01341639|456164295|FG001|Infant Series|Adverse Event|5|||
126783645|NCT01341639|456164294|FG000|Infant Series|Withdrawal by Subject|11|||
126783646|NCT01341639|456164295|FG001|Infant Series|Withdrawal by Subject|8|||
126783647|NCT01341639|456164294|FG000|Infant Series|Lost to Follow-up|0|||
126783648|NCT01341639|456164295|FG001|Infant Series|Lost to Follow-up|2|||
126783649|NCT01341639|456164294|FG000|Infant Series|Site 0048 Participants|17|||
126783650|NCT01341639|456164295|FG001|Infant Series|Site 0048 Participants|16|||
126783651|NCT01341639|456164294|FG000|Interim Period|Withdrawal by Subject|6|||
126783652|NCT01341639|456164295|FG001|Interim Period|Withdrawal by Subject|7|||
126783653|NCT01341639|456164294|FG000|Interim Period|Lost to Follow-up|2|||
126783654|NCT01341639|456164295|FG001|Interim Period|Lost to Follow-up|0|||
126783655|NCT01341639|456164294|FG000|Interim Period|Physician Decision|0|||
126783656|NCT01341639|456164295|FG001|Interim Period|Physician Decision|1|||
126783657|NCT01341639|456164294|FG000|Interim Period|Protocol Violation|0|||
126783658|NCT01341639|456164295|FG001|Interim Period|Protocol Violation|1|||
126783659|NCT01341639|456164294|FG000|Post-Treatment|Withdrawal by Subject|0|||
126783660|NCT01341639|456164295|FG001|Post-Treatment|Withdrawal by Subject|1|||
126783661|NCT01341639|456164294|FG000|Post-Treatment|Adverse Event|0|||
126783662|NCT01341639|456164295|FG001|Post-Treatment|Adverse Event|2|||
126783663|NCT04582266|456164296|FG000|Overall Study|Lost to Follow-up|7|||
126783664|NCT04582266|456164297|FG001|Overall Study|Lost to Follow-up|5|||
126783665|NCT04582266|456164296|FG000|Overall Study|Withdrawal by Subject|1|||
126783666|NCT04582266|456164297|FG001|Overall Study|Withdrawal by Subject|0|||
126783667|NCT04582266|456164296|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
126627651|NCT01821729|455596060|FG000|Overall Study|Withdrawal by Subject|1|||
126627652|NCT02517528|455596061|FG000|Overall Study|Withdrawal by Subject|1|||
126627653|NCT03503162|455596070|FG000|Overall Study|did not meet eligibility|1|||
126627654|NCT02246218|455596071|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126627655|NCT02246218|455596072|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126627656|NCT02246218|455596071|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
126627657|NCT02246218|455596072|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
126627658|NCT02246218|455596071|FG000|Overall Study|Adverse Event|1|||
126627659|NCT02246218|455596072|FG001|Overall Study|Adverse Event|1|||
126627660|NCT02246218|455596071|FG000|Overall Study|Lost to Follow-up|1|||
126627661|NCT02246218|455596072|FG001|Overall Study|Lost to Follow-up|0|||
126627662|NCT03891641|455596075|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
126627663|NCT03891641|455596076|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
126627664|NCT01093222|455596077|FG000|Overall Study|Ineligible|6|||
126627665|NCT01093222|455596077|FG000|Overall Study|Adverse Event|7|||
126627666|NCT01093222|455596077|FG000|Overall Study|Progression/relapse|24|||
126627667|NCT01093222|455596077|FG000|Overall Study|Death|2|||
126627668|NCT01093222|455596077|FG000|Overall Study|Not protocol specified|1|||
126627669|NCT01670188|455596078|FG000|Overall Study|Death|0|||
126627670|NCT01670188|455596079|FG001|Overall Study|Death|1|||
126627671|NCT00866918|455596084|FG000|Overall Study|Death|1|||
126627672|NCT00866918|455596085|FG001|Overall Study|Death|5|||
126627673|NCT00866918|455596084|FG000|Overall Study|Lack of Efficacy|1|||
126627674|NCT00866918|455596085|FG001|Overall Study|Lack of Efficacy|1|||
126627675|NCT00866918|455596084|FG000|Overall Study|Physician Decision|10|||
126627676|NCT00866918|455596085|FG001|Overall Study|Physician Decision|2|||
126627677|NCT00866918|455596084|FG000|Overall Study|Ineligible|2|||
126627678|NCT00866918|455596085|FG001|Overall Study|Ineligible|4|||
126627679|NCT00866918|455596084|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
126627680|NCT00866918|455596085|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
126627681|NCT00866918|455596084|FG000|Overall Study|Secondary malignancy|1|||
126627682|NCT00866918|455596085|FG001|Overall Study|Secondary malignancy|0|||
126783668|NCT04582266|456164297|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
126627683|NCT03723915|455596090|FG000|Screening|Failed to meet screening requirements.|2|||
126627684|NCT03723915|455596090|FG000|On Treatment|Failed to meet treatment requirements|2|||
126627685|NCT01978236|455596091|FG000|Overall Study|Discontinued due to study close|2|||
126627686|NCT00634920|455596093|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
126627687|NCT00634920|455596094|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
126627688|NCT00634920|455596095|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
126783669|NCT01132118|456164298|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
126783670|NCT01132118|456164299|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
126783671|NCT01132118|456164298|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
126627689|NCT00634920|455596093|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
126627690|NCT00634920|455596094|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
126627691|NCT00634920|455596095|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
126783672|NCT01132118|456164299|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
126783673|NCT01132118|456164298|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
126783674|NCT01132118|456164299|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
126627692|NCT00634920|455596093|FG000|Period 1 - Pre-Randomization|Rejections|0|||
126627693|NCT00634920|455596094|FG001|Period 1 - Pre-Randomization|Rejections|0|||
126627694|NCT00634920|455596095|FG002|Period 1 - Pre-Randomization|Rejections|55|||
126627695|NCT00634920|455596093|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
126627696|NCT00634920|455596094|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
126627697|NCT00634920|455596095|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
126627698|NCT00634920|455596093|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
126627699|NCT00634920|455596094|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
126627700|NCT00634920|455596095|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
126627701|NCT00634920|455596093|FG000|Period 1 - Pre-Randomization|Other issues|0|||
126627702|NCT00634920|455596094|FG001|Period 1 - Pre-Randomization|Other issues|0|||
126627703|NCT00634920|455596095|FG002|Period 1 - Pre-Randomization|Other issues|6|||
126627704|NCT00634920|455596093|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
126627705|NCT00634920|455596094|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
126627706|NCT00634920|455596095|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
126627707|NCT00634920|455596093|FG000|Period 2 - Post-Randomization|Rejection|11|||
126627708|NCT00634920|455596094|FG001|Period 2 - Post-Randomization|Rejection|5|||
126627709|NCT00634920|455596095|FG002|Period 2 - Post-Randomization|Rejection|0|||
126627710|NCT00634920|455596093|FG000|Period 2 - Post-Randomization|Death|2|||
126627711|NCT00634920|455596094|FG001|Period 2 - Post-Randomization|Death|5|||
126627712|NCT00634920|455596095|FG002|Period 2 - Post-Randomization|Death|0|||
126627713|NCT00634920|455596093|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
126627714|NCT00634920|455596094|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
126627715|NCT00634920|455596095|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
126627716|NCT00634920|455596093|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
126627717|NCT00634920|455596094|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
126627718|NCT00634920|455596095|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
126627719|NCT00607997|455596098|FG000|Overall Study|Lack of Efficacy|6|||
126627720|NCT00607997|455596099|FG001|Overall Study|Lack of Efficacy|20|||
126627721|NCT00607997|455596100|FG002|Overall Study|Lack of Efficacy|14|||
126627722|NCT00607997|455596101|FG003|Overall Study|Lack of Efficacy|10|||
126627723|NCT00607997|455596098|FG000|Overall Study|Death|8|||
126627724|NCT00607997|455596099|FG001|Overall Study|Death|5|||
126627725|NCT00607997|455596100|FG002|Overall Study|Death|2|||
126627726|NCT00607997|455596101|FG003|Overall Study|Death|5|||
126627727|NCT00607997|455596098|FG000|Overall Study|Adverse Event|3|||
126627728|NCT00607997|455596099|FG001|Overall Study|Adverse Event|1|||
126627729|NCT00607997|455596100|FG002|Overall Study|Adverse Event|2|||
126627730|NCT00607997|455596101|FG003|Overall Study|Adverse Event|0|||
126627731|NCT00607997|455596098|FG000|Overall Study|Physician Decision|4|||
126627732|NCT00607997|455596099|FG001|Overall Study|Physician Decision|1|||
126627733|NCT00607997|455596100|FG002|Overall Study|Physician Decision|0|||
126627734|NCT00607997|455596101|FG003|Overall Study|Physician Decision|0|||
126627735|NCT00607997|455596098|FG000|Overall Study|Relapse, recurrent illness|4|||
126627736|NCT00607997|455596099|FG001|Overall Study|Relapse, recurrent illness|0|||
126627737|NCT00607997|455596100|FG002|Overall Study|Relapse, recurrent illness|2|||
126627738|NCT00607997|455596101|FG003|Overall Study|Relapse, recurrent illness|0|||
126627739|NCT00607997|455596098|FG000|Overall Study|Other without explanation|2|||
126627740|NCT00607997|455596099|FG001|Overall Study|Other without explanation|0|||
126627741|NCT00607997|455596100|FG002|Overall Study|Other without explanation|4|||
126627742|NCT00607997|455596101|FG003|Overall Study|Other without explanation|1|||
126627743|NCT00576823|455596102|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
126627744|NCT00576823|455596103|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
126627745|NCT00576823|455596104|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
126627746|NCT00576823|455596102|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
126627747|NCT00576823|455596103|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
126627748|NCT00576823|455596104|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
126627749|NCT00510146|455596110|FG000|Double-Blind Treatment|Adverse Event|30|||
126627750|NCT00510146|455596111|FG001|Double-Blind Treatment|Adverse Event|13|||
126627751|NCT00510146|455596110|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
126627752|NCT00510146|455596111|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
126627753|NCT00510146|455596110|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
126627754|NCT00510146|455596111|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
126627755|NCT00510146|455596110|FG000|Double-Blind Treatment|Physician Decision|6|||
126627756|NCT00510146|455596111|FG001|Double-Blind Treatment|Physician Decision|0|||
126627757|NCT00510146|455596110|FG000|Double-Blind Treatment|Protocol Violation|1|||
126627758|NCT00510146|455596111|FG001|Double-Blind Treatment|Protocol Violation|2|||
126627759|NCT00510146|455596110|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
126627760|NCT00510146|455596111|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
126627761|NCT00510146|455596110|FG000|Double-Blind Treatment|Clinical Relapse|0|||
126627762|NCT00510146|455596111|FG001|Double-Blind Treatment|Clinical Relapse|1|||
126627763|NCT00510146|455596110|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
126627764|NCT00510146|455596111|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
126627765|NCT00510146|455596110|FG000|Open-Label Treatment|Adverse Event|22|||
126627766|NCT00510146|455596111|FG001|Open-Label Treatment|Adverse Event|8|||
126627767|NCT00510146|455596110|FG000|Open-Label Treatment|Death|1|||
126627768|NCT00510146|455596111|FG001|Open-Label Treatment|Death|1|||
126627769|NCT00510146|455596110|FG000|Open-Label Treatment|Lack of Efficacy|4|||
126627770|NCT00510146|455596111|FG001|Open-Label Treatment|Lack of Efficacy|0|||
126627771|NCT00510146|455596110|FG000|Open-Label Treatment|Lost to Follow-up|10|||
126627772|NCT00510146|455596111|FG001|Open-Label Treatment|Lost to Follow-up|1|||
126627773|NCT00510146|455596110|FG000|Open-Label Treatment|Physician Decision|3|||
126627774|NCT00510146|455596111|FG001|Open-Label Treatment|Physician Decision|1|||
126627775|NCT00510146|455596110|FG000|Open-Label Treatment|Protocol Violation|4|||
126627776|NCT00510146|455596111|FG001|Open-Label Treatment|Protocol Violation|2|||
126627777|NCT00510146|455596110|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
126627778|NCT00510146|455596111|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
126627779|NCT00510146|455596110|FG000|Open-Label Treatment|Clinical Relapse|1|||
126627780|NCT00510146|455596111|FG001|Open-Label Treatment|Clinical Relapse|1|||
126627781|NCT00510146|455596110|FG000|Open-Label Treatment|Sponsor Decision|2|||
126627782|NCT00510146|455596111|FG001|Open-Label Treatment|Sponsor Decision|0|||
126627783|NCT01930214|455596113|FG000|Overall Study|Death|4|||
126627784|NCT01930214|455596114|FG001|Overall Study|Death|4|||
126627785|NCT01930214|455596115|FG002|Overall Study|Death|11|||
126627786|NCT01930214|455596113|FG000|Overall Study|Lost to Follow-up|12|||
126627787|NCT01930214|455596114|FG001|Overall Study|Lost to Follow-up|13|||
126627788|NCT01930214|455596115|FG002|Overall Study|Lost to Follow-up|12|||
126627789|NCT01930214|455596113|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
126627790|NCT01930214|455596114|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
126627791|NCT01930214|455596115|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
126627792|NCT01930214|455596113|FG000|Overall Study|Physician Decision|2|||
126627793|NCT01930214|455596114|FG001|Overall Study|Physician Decision|0|||
126627794|NCT01930214|455596115|FG002|Overall Study|Physician Decision|0|||
126627795|NCT02132117|455596116|FG000|Overall Study|Adverse Event|6|||
126627796|NCT02132117|455596117|FG001|Overall Study|Adverse Event|1|||
126627797|NCT02132117|455596116|FG000|Overall Study|Lost to Follow-up|2|||
126627798|NCT02132117|455596117|FG001|Overall Study|Lost to Follow-up|2|||
126627799|NCT02132117|455596116|FG000|Overall Study|Personal Reasons|1|||
126627800|NCT02132117|455596117|FG001|Overall Study|Personal Reasons|2|||
126627801|NCT02132117|455596116|FG000|Overall Study|Other Miscellaneous Reasons|2|||
126627802|NCT02132117|455596117|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126627803|NCT03589300|455596118|FG000|Overall Study|Adverse Event|2|||
126627804|NCT03589300|455596118|FG000|Overall Study|Death|4|||
126627805|NCT03589300|455596118|FG000|Overall Study|Lost to Follow-up|12|||
126627806|NCT03589300|455596118|FG000|Overall Study|Withdrawal by Subject|5|||
126627807|NCT00640042|455596124|FG000|Enrollment|Did not receive study drug|83|||
126627808|NCT02864342|455596125|FG000|Overall Study|Eligibility Criteria Deviation|2|||
126627809|NCT02864342|455596126|FG001|Overall Study|Eligibility Criteria Deviation|3|||
126627810|NCT02864342|455596125|FG000|Overall Study|Withdrawal by Subject|4|||
126627811|NCT02864342|455596126|FG001|Overall Study|Withdrawal by Subject|2|||
126627812|NCT02864342|455596125|FG000|Overall Study|Device Technology Issue|6|||
126627813|NCT02864342|455596126|FG001|Overall Study|Device Technology Issue|7|||
126627814|NCT02864342|455596125|FG000|Overall Study|Death|0|||
126627815|NCT02864342|455596126|FG001|Overall Study|Death|1|||
126627816|NCT02864342|455596125|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
126627817|NCT02864342|455596126|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
126627818|NCT02864342|455596125|FG000|Overall Study|Lost to Follow-up|1|||
126627819|NCT02864342|455596126|FG001|Overall Study|Lost to Follow-up|5|||
126627820|NCT02864342|455596125|FG000|Overall Study|Lost Device|1|||
126627821|NCT02864342|455596126|FG001|Overall Study|Lost Device|0|||
126627822|NCT02864342|455596125|FG000|Overall Study|Adverse Event|1|||
126627823|NCT02864342|455596126|FG001|Overall Study|Adverse Event|0|||
126783675|NCT01299038|456164302|FG000|Overall Study|Withdrawal by Subject|1|||
126627824|NCT00118703|455596129|FG000|Overall Study|Protocol Violation|1|||
126627825|NCT00118703|455596130|FG001|Overall Study|Protocol Violation|0|||
126627826|NCT00118703|455596129|FG000|Overall Study|Adverse Event|1|||
126627827|NCT00118703|455596130|FG001|Overall Study|Adverse Event|1|||
126627828|NCT00118703|455596129|FG000|Overall Study|Participant took two different treatment|0|||
126627829|NCT00118703|455596130|FG001|Overall Study|Participant took two different treatment|1|||
126627830|NCT00118703|455596129|FG000|Overall Study|Withdrawal by Subject|2|||
126627831|NCT00118703|455596130|FG001|Overall Study|Withdrawal by Subject|5|||
126627832|NCT00118703|455596129|FG000|Overall Study|Lost to Follow-up|1|||
126627833|NCT00118703|455596130|FG001|Overall Study|Lost to Follow-up|2|||
126627834|NCT01560585|455596133|FG000|Overall Study|Physician Decision|3|||
126627835|NCT00519285|455596134|FG000|Overall Study|Adverse Event|127|||
126627836|NCT00519285|455596135|FG001|Overall Study|Adverse Event|266|||
126627837|NCT00519285|455596134|FG000|Overall Study|Disease progression|334|||
126627838|NCT00519285|455596135|FG001|Overall Study|Disease progression|186|||
126627839|NCT00519285|455596134|FG000|Overall Study|Physician Decision|75|||
126627840|NCT00519285|455596135|FG001|Overall Study|Physician Decision|47|||
126627841|NCT00519285|455596134|FG000|Overall Study|Participant's request|53|||
126627842|NCT00519285|455596135|FG001|Overall Study|Participant's request|84|||
126627843|NCT00519285|455596134|FG000|Overall Study|Consent withdrawn|4|||
126627844|NCT00519285|455596135|FG001|Overall Study|Consent withdrawn|5|||
126627845|NCT00519285|455596134|FG000|Overall Study|Poor compliance to protocol|5|||
126627846|NCT00519285|455596135|FG001|Overall Study|Poor compliance to protocol|7|||
126627847|NCT00519285|455596134|FG000|Overall Study|Reason unspecified|5|||
126627848|NCT00519285|455596135|FG001|Overall Study|Reason unspecified|8|||
126627849|NCT00519285|455596134|FG000|Overall Study|Not treated|8|||
126627850|NCT00519285|455596135|FG001|Overall Study|Not treated|7|||
126627851|NCT00519285|455596134|FG000|Overall Study|Treatment ongoing|1|||
126627852|NCT00519285|455596135|FG001|Overall Study|Treatment ongoing|2|||
126627853|NCT04688086|455596140|FG000|Overall Study|Lost to Follow-up|164|||
126627854|NCT04688086|455596140|FG000|Overall Study|Imaging error;|64|||
126627855|NCT00853021|455596141|FG000|Overall Study|Adverse Event|2|||
126627856|NCT00853021|455596141|FG000|Overall Study|Withdrawal by Subject|2|||
126627857|NCT00853021|455596141|FG000|Overall Study|Death|1|||
126627858|NCT01329419|455596142|FG000|Overall Study|Protocol Violation|235|||
126627859|NCT04206384|455596148|FG000|Overall Study|Withdrawal by Subject|8|||
126627860|NCT04206384|455596148|FG000|Overall Study|Adverse Event|2|||
126627861|NCT02212197|455596149|FG000|Overall Study|Need for radiotherapy|1|||
126627862|NCT02212197|455596150|FG001|Overall Study|Need for radiotherapy|0|||
126627863|NCT02212197|455596151|FG002|Overall Study|Need for radiotherapy|0|||
126627864|NCT02551692|455596153|FG000|Overall Study|Lost to Follow-up|0|||
126627865|NCT02551692|455596154|FG001|Overall Study|Lost to Follow-up|1|||
126627866|NCT02551692|455596155|FG002|Overall Study|Lost to Follow-up|4|||
126627867|NCT02551692|455596153|FG000|Overall Study|Withdrawal by Subject|1|||
126627868|NCT02551692|455596154|FG001|Overall Study|Withdrawal by Subject|0|||
126627869|NCT02551692|455596155|FG002|Overall Study|Withdrawal by Subject|1|||
126627870|NCT01091519|455596156|FG000|Overall Study|Adverse Event|12|||
126627871|NCT01091519|455596157|FG001|Overall Study|Adverse Event|16|||
126627872|NCT01091519|455596156|FG000|Overall Study|Death|1|||
126627873|NCT01091519|455596157|FG001|Overall Study|Death|0|||
126627874|NCT01091519|455596156|FG000|Overall Study|Lack of Efficacy|16|||
126627875|NCT01091519|455596157|FG001|Overall Study|Lack of Efficacy|19|||
126627876|NCT01091519|455596156|FG000|Overall Study|Lost to Follow-up|14|||
126627877|NCT01091519|455596157|FG001|Overall Study|Lost to Follow-up|24|||
126627878|NCT01091519|455596156|FG000|Overall Study|Withdrawal by Subject|2|||
126627879|NCT01091519|455596157|FG001|Overall Study|Withdrawal by Subject|2|||
126627880|NCT01091519|455596156|FG000|Overall Study|Other|6|||
126627881|NCT01091519|455596157|FG001|Overall Study|Other|8|||
126627882|NCT01091519|455596156|FG000|Overall Study|Randomized not treated|4|||
126627883|NCT01091519|455596157|FG001|Overall Study|Randomized not treated|4|||
126627884|NCT03030599|455596160|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
126627885|NCT03030599|455596161|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
126627886|NCT03030599|455596162|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
126627887|NCT03030599|455596160|FG000|Open Label Treatment and Titration|Other|1|||
126627888|NCT03030599|455596161|FG001|Open Label Treatment and Titration|Other|0|||
126627889|NCT03030599|455596162|FG002|Open Label Treatment and Titration|Other|0|||
126627890|NCT03030599|455596160|FG000|Open Label Treatment and Titration|Physician Decision|3|||
126627891|NCT03030599|455596161|FG001|Open Label Treatment and Titration|Physician Decision|0|||
126627892|NCT03030599|455596162|FG002|Open Label Treatment and Titration|Physician Decision|0|||
126627893|NCT03030599|455596160|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
126627894|NCT03030599|455596161|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
126627895|NCT03030599|455596162|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
126627896|NCT03030599|455596160|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
126627897|NCT03030599|455596161|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
126627898|NCT03030599|455596162|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
126627899|NCT03030599|455596160|FG000|Open Label Treatment and Titration|Adverse Event|18|||
126627900|NCT03030599|455596161|FG001|Open Label Treatment and Titration|Adverse Event|0|||
126627901|NCT03030599|455596162|FG002|Open Label Treatment and Titration|Adverse Event|0|||
126627902|NCT03030599|455596160|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
126627903|NCT03030599|455596161|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
126627904|NCT03030599|455596162|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
126627905|NCT03030599|455596160|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
126627906|NCT03030599|455596161|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
126627907|NCT03030599|455596162|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
126627908|NCT03030599|455596160|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
126627909|NCT03030599|455596161|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
126627910|NCT03030599|455596162|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
126627911|NCT03030599|455596160|FG000|Stable Dose|Protocol deviation|3|||
126627912|NCT03030599|455596161|FG001|Stable Dose|Protocol deviation|0|||
126627913|NCT03030599|455596162|FG002|Stable Dose|Protocol deviation|0|||
126627914|NCT03030599|455596160|FG000|Stable Dose|Adverse Event|1|||
126627915|NCT03030599|455596161|FG001|Stable Dose|Adverse Event|0|||
126627916|NCT03030599|455596162|FG002|Stable Dose|Adverse Event|0|||
126627917|NCT03030599|455596160|FG000|Stable Dose|Lost to Follow-up|1|||
126627918|NCT03030599|455596161|FG001|Stable Dose|Lost to Follow-up|0|||
126627919|NCT03030599|455596162|FG002|Stable Dose|Lost to Follow-up|0|||
126627920|NCT03030599|455596160|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
126627921|NCT03030599|455596161|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
126627922|NCT03030599|455596162|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
126627923|NCT03030599|455596160|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
126627924|NCT03030599|455596161|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
126627925|NCT03030599|455596162|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
126627926|NCT03030599|455596160|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
126627927|NCT03030599|455596161|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
126627928|NCT03030599|455596162|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
126627929|NCT03030599|455596160|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
126627930|NCT03030599|455596161|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
126627931|NCT03030599|455596162|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
126627932|NCT03030599|455596160|FG000|Open-label Extension|Adverse Event|3|||
126627933|NCT03030599|455596161|FG001|Open-label Extension|Adverse Event|0|||
126627934|NCT03030599|455596162|FG002|Open-label Extension|Adverse Event|0|||
126627935|NCT03030599|455596160|FG000|Open-label Extension|Lost to Follow-up|2|||
126627936|NCT03030599|455596161|FG001|Open-label Extension|Lost to Follow-up|0|||
126627937|NCT03030599|455596162|FG002|Open-label Extension|Lost to Follow-up|0|||
126627938|NCT03030599|455596160|FG000|Open-label Extension|Lack of Efficacy|1|||
126627939|NCT03030599|455596161|FG001|Open-label Extension|Lack of Efficacy|0|||
126627940|NCT03030599|455596162|FG002|Open-label Extension|Lack of Efficacy|0|||
126627941|NCT03030599|455596160|FG000|Open-label Extension|Other Reason|1|||
126627942|NCT03030599|455596161|FG001|Open-label Extension|Other Reason|0|||
126627943|NCT03030599|455596162|FG002|Open-label Extension|Other Reason|0|||
126627944|NCT01177228|455596163|FG000|Overall Study|Positive tuberculosis test|0|||
126627945|NCT01177228|455596164|FG001|Overall Study|Positive tuberculosis test|1|||
126627946|NCT01177228|455596165|FG002|Overall Study|Positive tuberculosis test|0|||
126627947|NCT01177228|455596166|FG003|Overall Study|Positive tuberculosis test|0|||
126627948|NCT01177228|455596163|FG000|Overall Study|Worsening disease activity|1|||
126627949|NCT01177228|455596164|FG001|Overall Study|Worsening disease activity|0|||
126627950|NCT01177228|455596165|FG002|Overall Study|Worsening disease activity|0|||
126627951|NCT01177228|455596166|FG003|Overall Study|Worsening disease activity|0|||
126627952|NCT01177228|455596163|FG000|Overall Study|Withdrawal by Subject|0|||
126627953|NCT01177228|455596164|FG001|Overall Study|Withdrawal by Subject|1|||
126627954|NCT01177228|455596165|FG002|Overall Study|Withdrawal by Subject|0|||
126627955|NCT01177228|455596166|FG003|Overall Study|Withdrawal by Subject|0|||
126627956|NCT00006436|455596168|FG000|Overall Study|Refused further treatment|2|||
126627957|NCT00006436|455596168|FG000|Overall Study|Declined to participate (before treatment started)|1|||
126627958|NCT00316589|455596169|FG000|Overall Study|Withdrawal by Subject|0|||
126627959|NCT00316589|455596170|FG001|Overall Study|Withdrawal by Subject|5|||
126627960|NCT00316589|455596171|FG002|Overall Study|Withdrawal by Subject|0|||
126627961|NCT00316589|455596172|FG003|Overall Study|Withdrawal by Subject|1|||
126627962|NCT00316589|455596169|FG000|Overall Study|Subject unwilling/unable to comply|0|||
126627963|NCT00316589|455596170|FG001|Overall Study|Subject unwilling/unable to comply|6|||
126627964|NCT00316589|455596171|FG002|Overall Study|Subject unwilling/unable to comply|0|||
126627965|NCT00316589|455596172|FG003|Overall Study|Subject unwilling/unable to comply|2|||
126627966|NCT00316589|455596169|FG000|Overall Study|Adverse Event|1|||
126627967|NCT00316589|455596170|FG001|Overall Study|Adverse Event|0|||
126627968|NCT00316589|455596171|FG002|Overall Study|Adverse Event|0|||
126627969|NCT00316589|455596172|FG003|Overall Study|Adverse Event|1|||
126627970|NCT00316589|455596169|FG000|Overall Study|Physician Decision|0|||
126627971|NCT00316589|455596170|FG001|Overall Study|Physician Decision|1|||
126627972|NCT00316589|455596171|FG002|Overall Study|Physician Decision|0|||
126627973|NCT00316589|455596172|FG003|Overall Study|Physician Decision|0|||
126627974|NCT00316589|455596169|FG000|Overall Study|Other reason|0|||
126627975|NCT00316589|455596170|FG001|Overall Study|Other reason|12|||
126627976|NCT00316589|455596171|FG002|Overall Study|Other reason|1|||
126627977|NCT00316589|455596172|FG003|Overall Study|Other reason|1|||
126627978|NCT01093599|455598208|FG000|Overall Study|Lost to Follow-up|32|||
126627979|NCT01093599|455598209|FG001|Overall Study|Lost to Follow-up|46|||
126627980|NCT01703845|455598210|FG000|Overall Study|Adverse Event|1|||
126627981|NCT01703845|455598211|FG001|Overall Study|Adverse Event|0|||
126627982|NCT01703845|455598210|FG000|Overall Study|Protocol Violation|1|||
126627983|NCT01703845|455598211|FG001|Overall Study|Protocol Violation|0|||
126627984|NCT01703845|455598210|FG000|Overall Study|other than stated above|1|||
126627985|NCT01703845|455598211|FG001|Overall Study|other than stated above|0|||
126627986|NCT01644188|455598212|FG000|Overall Study|Adverse Event|44|||
126627987|NCT01644188|455598213|FG001|Overall Study|Adverse Event|20|||
126627988|NCT01644188|455598212|FG000|Overall Study|Poor compliance to protocol|26|||
126627989|NCT01644188|455598213|FG001|Overall Study|Poor compliance to protocol|14|||
126627990|NCT01644188|455598212|FG000|Overall Study|Physician Decision|1|||
126627991|NCT01644188|455598213|FG001|Overall Study|Physician Decision|3|||
126627992|NCT01644188|455598212|FG000|Overall Study|Participant moved|7|||
126627993|NCT01644188|455598213|FG001|Overall Study|Participant moved|2|||
126627994|NCT01644188|455598212|FG000|Overall Study|Related to auto-injector administration|2|||
126627995|NCT01644188|455598213|FG001|Overall Study|Related to auto-injector administration|2|||
126627996|NCT01644188|455598212|FG000|Overall Study|Consent withdrawn by participant|14|||
126627997|NCT01644188|455598213|FG001|Overall Study|Consent withdrawn by participant|7|||
126627998|NCT01644188|455598212|FG000|Overall Study|Selection criteria finally not met|2|||
126627999|NCT01644188|455598213|FG001|Overall Study|Selection criteria finally not met|0|||
126628000|NCT01644188|455598212|FG000|Overall Study|Lost to Follow-up|1|||
126628001|NCT01644188|455598213|FG001|Overall Study|Lost to Follow-up|0|||
126628002|NCT01644188|455598212|FG000|Overall Study|Death|4|||
126628003|NCT01644188|455598213|FG001|Overall Study|Death|3|||
126628004|NCT01644188|455598212|FG000|Overall Study|Last visit outside protocol visit window|14|||
126628005|NCT01644188|455598213|FG001|Overall Study|Last visit outside protocol visit window|16|||
126628006|NCT01644188|455598212|FG000|Overall Study|Site closure|1|||
126628007|NCT01644188|455598213|FG001|Overall Study|Site closure|1|||
126628008|NCT01644188|455598212|FG000|Overall Study|Other than specified above|6|||
126628009|NCT01644188|455598213|FG001|Overall Study|Other than specified above|7|||
126628010|NCT03713281|455598217|FG000|Overall Study|Lens handling difficuluties|2|||
126628011|NCT03713281|455598217|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
126628012|NCT00320398|455598218|FG000|Overall Study|Adverse Event|1|||
126628013|NCT00320398|455598219|FG001|Overall Study|Adverse Event|4|||
126628014|NCT00320398|455598218|FG000|Overall Study|Other|1|||
126628015|NCT00320398|455598219|FG001|Overall Study|Other|0|||
126628016|NCT00494026|455598222|FG000|Overall Study|Sponsor Decision|4|||
126628017|NCT01057251|455598224|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
126628018|NCT01057251|455598225|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
126628019|NCT01057251|455598224|FG000|Overall Study|Adverse Event|4|||
126628020|NCT01057251|455598225|FG001|Overall Study|Adverse Event|2|||
126628021|NCT01057251|455598224|FG000|Overall Study|Lack of Efficacy|2|||
126628022|NCT01057251|455598225|FG001|Overall Study|Lack of Efficacy|11|||
126628023|NCT01057251|455598224|FG000|Overall Study|Protocol Violation|6|||
126628024|NCT01057251|455598225|FG001|Overall Study|Protocol Violation|2|||
126628025|NCT01057251|455598224|FG000|Overall Study|Withdrawal by Subject|4|||
126628026|NCT01057251|455598225|FG001|Overall Study|Withdrawal by Subject|5|||
126628027|NCT01057251|455598224|FG000|Overall Study|Lost to Follow-up|7|||
126628028|NCT01057251|455598225|FG001|Overall Study|Lost to Follow-up|6|||
126628029|NCT01057251|455598224|FG000|Overall Study|Other Reason|1|||
126628030|NCT01057251|455598225|FG001|Overall Study|Other Reason|1|||
126628031|NCT02637856|455598226|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
126628032|NCT02637856|455598227|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
126628033|NCT02637856|455598226|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
126628034|NCT02637856|455598227|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
126628035|NCT02637856|455598226|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
126628036|NCT02637856|455598227|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
126628037|NCT02637856|455598226|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
126628038|NCT02637856|455598227|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
126628039|NCT02637856|455598226|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
126628040|NCT02637856|455598227|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
126628041|NCT02637856|455598226|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
126628042|NCT02637856|455598227|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
126628043|NCT02637856|455598226|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
126628044|NCT02637856|455598227|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
126628045|NCT02637856|455598226|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
126628046|NCT02637856|455598227|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
126628047|NCT02637856|455598226|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
126628048|NCT02637856|455598227|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
126628049|NCT02637856|455598226|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
126628050|NCT02637856|455598227|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
126628051|NCT02637856|455598226|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
126628052|NCT02637856|455598227|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
126628053|NCT02637856|455598226|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
126628054|NCT02637856|455598227|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
126628055|NCT02637856|455598226|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
126628056|NCT02637856|455598227|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
126628057|NCT00784147|455598228|FG000|Overall Study|Lost to Follow-up|2|||
126628058|NCT00784147|455598229|FG001|Overall Study|Lost to Follow-up|4|||
126628059|NCT00784147|455598228|FG000|Overall Study|Withdrawal by Subject|1|||
126628060|NCT00784147|455598229|FG001|Overall Study|Withdrawal by Subject|3|||
126628061|NCT00784147|455598228|FG000|Overall Study|Physician Decision|2|||
126628062|NCT00784147|455598229|FG001|Overall Study|Physician Decision|1|||
126628063|NCT00784147|455598228|FG000|Overall Study|Protocol Violation|1|||
126628064|NCT00784147|455598229|FG001|Overall Study|Protocol Violation|1|||
126628065|NCT00784147|455598228|FG000|Overall Study|Death|2|||
126628066|NCT00784147|455598229|FG001|Overall Study|Death|0|||
126628067|NCT04544865|455598233|FG000|Overall Study|Death|0|||
126628068|NCT04544865|455598234|FG001|Overall Study|Death|2|||
126628069|NCT04544865|455598233|FG000|Overall Study|Lost to Follow-up|11|||
126628070|NCT04544865|455598234|FG001|Overall Study|Lost to Follow-up|7|||
126628071|NCT04544865|455598233|FG000|Overall Study|Withdrawal by Subject|0|||
126628072|NCT04544865|455598234|FG001|Overall Study|Withdrawal by Subject|1|||
126628073|NCT04544865|455598233|FG000|Overall Study|Other|0|||
126628074|NCT04544865|455598234|FG001|Overall Study|Other|1|||
126628075|NCT02815735|455598235|FG000|First Intervention (4 Weeks)|Discomfort|1|||
126628076|NCT02815735|455598236|FG001|First Intervention (4 Weeks)|Discomfort|0|||
126628077|NCT02815735|455598235|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
126628078|NCT02815735|455598236|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
126628079|NCT02815735|455598235|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
126628080|NCT02815735|455598236|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
126628081|NCT02815735|455598235|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
126628082|NCT02815735|455598236|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
126628083|NCT01732926|455598240|FG000|Overall Study|Study Terminated by Sponsor|168|||
126628084|NCT01732926|455598241|FG001|Overall Study|Study Terminated by Sponsor|80|||
126628085|NCT01732926|455598240|FG000|Overall Study|Withdrawal by Subject|46|||
126628086|NCT01732926|455598241|FG001|Overall Study|Withdrawal by Subject|8|||
126628087|NCT01732926|455598240|FG000|Overall Study|Physician Decision|24|||
126628088|NCT01732926|455598241|FG001|Overall Study|Physician Decision|11|||
126628089|NCT01732926|455598240|FG000|Overall Study|Other Reason|21|||
126628090|NCT01732926|455598241|FG001|Overall Study|Other Reason|4|||
126628091|NCT01732926|455598240|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
126628092|NCT01732926|455598241|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
126628093|NCT01732926|455598240|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
126628094|NCT01732926|455598241|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
126628095|NCT02262364|455598245|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
126628096|NCT01049984|455598246|FG000|Overall Study|Withdrawal by Subject|1|||
126628097|NCT01049984|455598247|FG001|Overall Study|Withdrawal by Subject|5|||
126628098|NCT01049984|455598246|FG000|Overall Study|Protocol Violation|3|||
126628099|NCT01049984|455598247|FG001|Overall Study|Protocol Violation|4|||
126628100|NCT01049984|455598246|FG000|Overall Study|Lost to Follow-up|2|||
126628101|NCT01049984|455598247|FG001|Overall Study|Lost to Follow-up|1|||
126628102|NCT01049984|455598246|FG000|Overall Study|Adverse Event|13|||
126628103|NCT01049984|455598247|FG001|Overall Study|Adverse Event|7|||
126628104|NCT01049984|455598246|FG000|Overall Study|Treatment failure|0|||
126628105|NCT01049984|455598247|FG001|Overall Study|Treatment failure|2|||
126628106|NCT01746108|455598250|FG000|Overall Study|Migrated /moved from study area|0|||
126628107|NCT01746108|455598251|FG001|Overall Study|Migrated /moved from study area|1|||
126628108|NCT01746108|455598252|FG002|Overall Study|Migrated /moved from study area|0|||
126628109|NCT01746108|455598250|FG000|Overall Study|Adverse event, non-fatal|0|||
126628110|NCT01746108|455598251|FG001|Overall Study|Adverse event, non-fatal|1|||
126628111|NCT01746108|455598252|FG002|Overall Study|Adverse event, non-fatal|0|||
126628112|NCT01746108|455598250|FG000|Overall Study|Withdrawal by Subject|0|||
126628113|NCT01746108|455598251|FG001|Overall Study|Withdrawal by Subject|1|||
126628114|NCT01746108|455598252|FG002|Overall Study|Withdrawal by Subject|0|||
126628115|NCT01746108|455598250|FG000|Overall Study|Lost to Follow-up|0|||
126628116|NCT01746108|455598251|FG001|Overall Study|Lost to Follow-up|1|||
126628117|NCT01746108|455598252|FG002|Overall Study|Lost to Follow-up|0|||
126628118|NCT00468858|455598254|FG000|Overall Study|Adverse Event|0|||
126628119|NCT00468858|455598255|FG001|Overall Study|Adverse Event|1|||
126628120|NCT00468858|455598256|FG002|Overall Study|Adverse Event|0|||
126628121|NCT00468858|455598254|FG000|Overall Study|Withdrawal by Subject|7|||
126628122|NCT00468858|455598255|FG001|Overall Study|Withdrawal by Subject|4|||
126628123|NCT00468858|455598256|FG002|Overall Study|Withdrawal by Subject|5|||
126628124|NCT00468858|455598254|FG000|Overall Study|Relocation|1|||
126628125|NCT00468858|455598255|FG001|Overall Study|Relocation|3|||
126628126|NCT00468858|455598256|FG002|Overall Study|Relocation|3|||
126628127|NCT00468858|455598254|FG000|Overall Study|Lost to Follow-up|1|||
126628128|NCT00468858|455598255|FG001|Overall Study|Lost to Follow-up|2|||
126628129|NCT00468858|455598256|FG002|Overall Study|Lost to Follow-up|5|||
126628130|NCT00468858|455598254|FG000|Overall Study|Other|0|||
126628131|NCT00468858|455598255|FG001|Overall Study|Other|0|||
126628132|NCT00468858|455598256|FG002|Overall Study|Other|1|||
126628133|NCT02741713|455598260|FG000|Overall Study|Surgery type changed intra-operatively|2|||
126628134|NCT02741713|455598261|FG001|Overall Study|Surgery type changed intra-operatively|1|||
126628135|NCT00809341|455598264|FG000|Overall Study|Physician Decision|0|||
126628136|NCT00809341|455598265|FG001|Overall Study|Physician Decision|1|||
126628137|NCT00225277|455598269|FG000|Overall Study|Adverse Event|30|||
126628138|NCT00225277|455598270|FG001|Overall Study|Adverse Event|34|||
126628139|NCT00225277|455598269|FG000|Overall Study|Lack of Efficacy|4|||
126628140|NCT00225277|455598270|FG001|Overall Study|Lack of Efficacy|1|||
126628141|NCT00225277|455598269|FG000|Overall Study|Lost to Follow-up|4|||
126628142|NCT00225277|455598270|FG001|Overall Study|Lost to Follow-up|6|||
126628143|NCT00225277|455598269|FG000|Overall Study|Physician Decision|6|||
126628144|NCT00225277|455598270|FG001|Overall Study|Physician Decision|8|||
126628145|NCT00225277|455598269|FG000|Overall Study|Protocol Violation|6|||
126628146|NCT00225277|455598270|FG001|Overall Study|Protocol Violation|3|||
126628147|NCT00225277|455598269|FG000|Overall Study|Withdrawal by Subject|40|||
126628148|NCT00225277|455598270|FG001|Overall Study|Withdrawal by Subject|34|||
126628149|NCT00225277|455598269|FG000|Overall Study|Other|7|||
126628150|NCT00225277|455598270|FG001|Overall Study|Other|9|||
126628151|NCT04582669|455598277|FG000|Overall Study|Subject missed appointment(s).|1|||
126628152|NCT04582669|455598278|FG001|Overall Study|Subject missed appointment(s).|0|||
126628153|NCT04582669|455598279|FG002|Overall Study|Subject missed appointment(s).|1|||
126628154|NCT04582669|455598280|FG003|Overall Study|Subject missed appointment(s).|2|||
126628155|NCT04582669|455598277|FG000|Overall Study|Protocol Violation|0|||
126628156|NCT04582669|455598278|FG001|Overall Study|Protocol Violation|1|||
126628157|NCT04582669|455598279|FG002|Overall Study|Protocol Violation|1|||
126628158|NCT04582669|455598280|FG003|Overall Study|Protocol Violation|0|||
126628159|NCT00591409|455598281|FG000|Overall Study|Not Treated|0|||
126628160|NCT00591409|455598282|FG001|Overall Study|Not Treated|0|||
126628161|NCT00591409|455598283|FG002|Overall Study|Not Treated|0|||
126628162|NCT00591409|455598284|FG003|Overall Study|Not Treated|0|||
126628163|NCT00591409|455598285|FG004|Overall Study|Not Treated|1|||
126628164|NCT00591409|455598286|FG005|Overall Study|Not Treated|0|||
126628165|NCT00591409|455598287|FG006|Overall Study|Not Treated|0|||
126628166|NCT00591409|455598288|FG007|Overall Study|Not Treated|0|||
126628167|NCT00591409|455598289|FG008|Overall Study|Not Treated|0|||
126628168|NCT00591409|455598290|FG009|Overall Study|Not Treated|1|||
126628169|NCT00677092|455598291|FG000|Overall Study|Adverse Event|1|||
126628170|NCT00677092|455598291|FG000|Overall Study|Lost to Follow-up|1|||
126628171|NCT00677092|455598291|FG000|Overall Study|Withdrawal by Subject|3|||
126628172|NCT00677092|455598291|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
126628173|NCT00550446|455598292|FG000|Up To Week 12|Adverse Event|2|||
126628174|NCT00550446|455598293|FG001|Up To Week 12|Adverse Event|2|||
126628175|NCT00550446|455598294|FG002|Up To Week 12|Adverse Event|0|||
126628176|NCT00550446|455598295|FG003|Up To Week 12|Adverse Event|0|||
126628177|NCT00550446|455598296|FG004|Up To Week 12|Adverse Event|2|||
126628178|NCT00550446|455598297|FG005|Up To Week 12|Adverse Event|2|||
126628179|NCT00550446|455598298|FG006|Up To Week 12|Adverse Event|1|||
126628180|NCT00550446|455598299|FG007|Up To Week 12|Adverse Event|0|||
126628181|NCT00550446|455598300|FG008|Up To Week 12|Adverse Event|0|||
126628182|NCT00550446|455598301|FG009|Up To Week 12|Adverse Event|0|||
126628183|NCT00550446|455598302|FG010|Up To Week 12|Adverse Event|0|||
126628184|NCT00550446|455598292|FG000|Up To Week 12|Lack of Efficacy|3|||
126628185|NCT00550446|455598293|FG001|Up To Week 12|Lack of Efficacy|1|||
126628186|NCT00550446|455598294|FG002|Up To Week 12|Lack of Efficacy|0|||
126628187|NCT00550446|455598295|FG003|Up To Week 12|Lack of Efficacy|1|||
126628188|NCT00550446|455598296|FG004|Up To Week 12|Lack of Efficacy|0|||
126628189|NCT00550446|455598297|FG005|Up To Week 12|Lack of Efficacy|3|||
126628190|NCT00550446|455598298|FG006|Up To Week 12|Lack of Efficacy|3|||
126628191|NCT00550446|455598299|FG007|Up To Week 12|Lack of Efficacy|0|||
126628192|NCT00550446|455598300|FG008|Up To Week 12|Lack of Efficacy|0|||
126628193|NCT00550446|455598301|FG009|Up To Week 12|Lack of Efficacy|0|||
126628194|NCT00550446|455598302|FG010|Up To Week 12|Lack of Efficacy|0|||
126628195|NCT00550446|455598292|FG000|Up To Week 12|Lost to Follow-up|0|||
126628196|NCT00550446|455598293|FG001|Up To Week 12|Lost to Follow-up|1|||
126628197|NCT00550446|455598294|FG002|Up To Week 12|Lost to Follow-up|0|||
126628198|NCT00550446|455598295|FG003|Up To Week 12|Lost to Follow-up|0|||
126628199|NCT00550446|455598296|FG004|Up To Week 12|Lost to Follow-up|1|||
126628200|NCT00550446|455598297|FG005|Up To Week 12|Lost to Follow-up|1|||
126628201|NCT00550446|455598298|FG006|Up To Week 12|Lost to Follow-up|2|||
126628202|NCT00550446|455598299|FG007|Up To Week 12|Lost to Follow-up|0|||
126628203|NCT00550446|455598300|FG008|Up To Week 12|Lost to Follow-up|0|||
126628204|NCT00550446|455598301|FG009|Up To Week 12|Lost to Follow-up|0|||
126628205|NCT00550446|455598302|FG010|Up To Week 12|Lost to Follow-up|0|||
126628206|NCT00550446|455598292|FG000|Up To Week 12|Withdrawal by Subject|2|||
126628207|NCT00550446|455598293|FG001|Up To Week 12|Withdrawal by Subject|0|||
126628208|NCT00550446|455598294|FG002|Up To Week 12|Withdrawal by Subject|3|||
126628209|NCT00550446|455598295|FG003|Up To Week 12|Withdrawal by Subject|2|||
126628210|NCT00550446|455598296|FG004|Up To Week 12|Withdrawal by Subject|0|||
126628211|NCT00550446|455598297|FG005|Up To Week 12|Withdrawal by Subject|1|||
126628212|NCT00550446|455598298|FG006|Up To Week 12|Withdrawal by Subject|3|||
126628213|NCT00550446|455598299|FG007|Up To Week 12|Withdrawal by Subject|0|||
126628214|NCT00550446|455598300|FG008|Up To Week 12|Withdrawal by Subject|0|||
126628215|NCT00550446|455598301|FG009|Up To Week 12|Withdrawal by Subject|0|||
126628216|NCT00550446|455598302|FG010|Up To Week 12|Withdrawal by Subject|0|||
126628217|NCT00550446|455598292|FG000|Up To Week 12|Other|3|||
126628218|NCT00550446|455598293|FG001|Up To Week 12|Other|0|||
126628219|NCT00550446|455598294|FG002|Up To Week 12|Other|0|||
126628220|NCT00550446|455598295|FG003|Up To Week 12|Other|0|||
126628221|NCT00550446|455598296|FG004|Up To Week 12|Other|0|||
126628222|NCT00550446|455598297|FG005|Up To Week 12|Other|1|||
126628223|NCT00550446|455598298|FG006|Up To Week 12|Other|4|||
126628224|NCT00550446|455598299|FG007|Up To Week 12|Other|0|||
126628225|NCT00550446|455598300|FG008|Up To Week 12|Other|0|||
126628226|NCT00550446|455598301|FG009|Up To Week 12|Other|0|||
126628227|NCT00550446|455598302|FG010|Up To Week 12|Other|0|||
126628228|NCT00550446|455598292|FG000|Up To Week 12|Randomized not treated|0|||
126628229|NCT00550446|455598293|FG001|Up To Week 12|Randomized not treated|1|||
126628230|NCT00550446|455598294|FG002|Up To Week 12|Randomized not treated|1|||
126628231|NCT00550446|455598295|FG003|Up To Week 12|Randomized not treated|0|||
126628232|NCT00550446|455598296|FG004|Up To Week 12|Randomized not treated|0|||
126628233|NCT00550446|455598297|FG005|Up To Week 12|Randomized not treated|0|||
126628234|NCT00550446|455598298|FG006|Up To Week 12|Randomized not treated|0|||
126628235|NCT00550446|455598299|FG007|Up To Week 12|Randomized not treated|0|||
126628236|NCT00550446|455598300|FG008|Up To Week 12|Randomized not treated|0|||
126628237|NCT00550446|455598301|FG009|Up To Week 12|Randomized not treated|0|||
126628238|NCT00550446|455598302|FG010|Up To Week 12|Randomized not treated|0|||
126628239|NCT00550446|455598292|FG000|Post Week 12|Adverse Event|2|||
126628240|NCT00550446|455598293|FG001|Post Week 12|Adverse Event|1|||
126628241|NCT00550446|455598294|FG002|Post Week 12|Adverse Event|1|||
126628242|NCT00550446|455598295|FG003|Post Week 12|Adverse Event|1|||
126628243|NCT00550446|455598296|FG004|Post Week 12|Adverse Event|1|||
126628244|NCT00550446|455598297|FG005|Post Week 12|Adverse Event|1|||
126628245|NCT00550446|455598298|FG006|Post Week 12|Adverse Event|0|||
126628246|NCT00550446|455598299|FG007|Post Week 12|Adverse Event|0|||
126628247|NCT00550446|455598300|FG008|Post Week 12|Adverse Event|0|||
126628248|NCT00550446|455598301|FG009|Post Week 12|Adverse Event|4|||
126628249|NCT00550446|455598302|FG010|Post Week 12|Adverse Event|0|||
126628250|NCT00550446|455598292|FG000|Post Week 12|Lack of Efficacy|0|||
126628251|NCT00550446|455598293|FG001|Post Week 12|Lack of Efficacy|0|||
126628252|NCT00550446|455598294|FG002|Post Week 12|Lack of Efficacy|1|||
126628253|NCT00550446|455598295|FG003|Post Week 12|Lack of Efficacy|0|||
126628254|NCT00550446|455598296|FG004|Post Week 12|Lack of Efficacy|0|||
126628255|NCT00550446|455598297|FG005|Post Week 12|Lack of Efficacy|0|||
126628256|NCT00550446|455598298|FG006|Post Week 12|Lack of Efficacy|0|||
126628257|NCT00550446|455598299|FG007|Post Week 12|Lack of Efficacy|1|||
126628258|NCT00550446|455598300|FG008|Post Week 12|Lack of Efficacy|1|||
126628259|NCT00550446|455598301|FG009|Post Week 12|Lack of Efficacy|2|||
126628260|NCT00550446|455598302|FG010|Post Week 12|Lack of Efficacy|1|||
126628261|NCT00550446|455598292|FG000|Post Week 12|Lost to Follow-up|0|||
126628262|NCT00550446|455598293|FG001|Post Week 12|Lost to Follow-up|0|||
126628263|NCT00550446|455598294|FG002|Post Week 12|Lost to Follow-up|1|||
126628264|NCT00550446|455598295|FG003|Post Week 12|Lost to Follow-up|1|||
126628265|NCT00550446|455598296|FG004|Post Week 12|Lost to Follow-up|0|||
126628266|NCT00550446|455598297|FG005|Post Week 12|Lost to Follow-up|0|||
126628267|NCT00550446|455598298|FG006|Post Week 12|Lost to Follow-up|1|||
126628268|NCT00550446|455598299|FG007|Post Week 12|Lost to Follow-up|0|||
126628269|NCT00550446|455598300|FG008|Post Week 12|Lost to Follow-up|0|||
126628270|NCT00550446|455598301|FG009|Post Week 12|Lost to Follow-up|0|||
126628271|NCT00550446|455598302|FG010|Post Week 12|Lost to Follow-up|0|||
126628272|NCT00550446|455598292|FG000|Post Week 12|Withdrawal by Subject|0|||
126628273|NCT00550446|455598293|FG001|Post Week 12|Withdrawal by Subject|0|||
126628274|NCT00550446|455598294|FG002|Post Week 12|Withdrawal by Subject|0|||
126628275|NCT00550446|455598295|FG003|Post Week 12|Withdrawal by Subject|0|||
126628276|NCT00550446|455598296|FG004|Post Week 12|Withdrawal by Subject|1|||
126628277|NCT00550446|455598297|FG005|Post Week 12|Withdrawal by Subject|0|||
126628278|NCT00550446|455598298|FG006|Post Week 12|Withdrawal by Subject|0|||
126628279|NCT00550446|455598299|FG007|Post Week 12|Withdrawal by Subject|0|||
126628280|NCT00550446|455598300|FG008|Post Week 12|Withdrawal by Subject|0|||
126628281|NCT00550446|455598301|FG009|Post Week 12|Withdrawal by Subject|0|||
126628282|NCT00550446|455598302|FG010|Post Week 12|Withdrawal by Subject|0|||
126628283|NCT00550446|455598292|FG000|Post Week 12|Other|1|||
126628284|NCT00550446|455598293|FG001|Post Week 12|Other|1|||
126628285|NCT00550446|455598294|FG002|Post Week 12|Other|0|||
126628286|NCT00550446|455598295|FG003|Post Week 12|Other|1|||
126783676|NCT01299038|456164303|FG001|Overall Study|Withdrawal by Subject|0|||
126783677|NCT00832078|456164304|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
126628287|NCT00550446|455598296|FG004|Post Week 12|Other|0|||
126628288|NCT00550446|455598297|FG005|Post Week 12|Other|0|||
126783678|NCT00832078|456164305|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
126783679|NCT00832078|456164304|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
126628289|NCT00550446|455598298|FG006|Post Week 12|Other|1|||
126628290|NCT00550446|455598299|FG007|Post Week 12|Other|0|||
126628291|NCT00550446|455598300|FG008|Post Week 12|Other|1|||
126628292|NCT00550446|455598301|FG009|Post Week 12|Other|1|||
126628293|NCT00550446|455598302|FG010|Post Week 12|Other|0|||
126628294|NCT02716298|455598303|FG000|First Intervention (1 Month)|Lens discomfort|1|||
126628295|NCT02716298|455598304|FG001|First Intervention (1 Month)|Lens discomfort|1|||
126628296|NCT04952701|455598305|FG000|Control Lens|Physician Decision|4|||
126628297|NCT04952701|455598305|FG000|Test Lens|Physician Decision|1|||
126628298|NCT02212301|455598306|FG000|Period 1|Lost to Follow-up|0|||
126628299|NCT02212301|455598307|FG001|Period 1|Lost to Follow-up|1|||
126628300|NCT03927222|455598308|FG000|Overall Study|Progression|3|||
126628301|NCT03927222|455598308|FG000|Overall Study|CMV testing results inconclusive|1|||
126628302|NCT03927222|455598308|FG000|Overall Study|Unable to generate enough vaccines|1|||
126628303|NCT03927222|455598308|FG000|Overall Study|Early study termination|1|||
126628304|NCT00578318|455598309|FG000|Overall Study|Lost to Follow-up|2|||
126628305|NCT00578318|455598310|FG001|Overall Study|Lost to Follow-up|0|||
126628306|NCT00578318|455598309|FG000|Overall Study|Physician Decision|1|||
126628307|NCT00578318|455598310|FG001|Overall Study|Physician Decision|0|||
126628308|NCT00527514|455598311|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
126628309|NCT00527514|455598311|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
126628310|NCT00527514|455598311|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
126628311|NCT00527514|455598311|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
126628312|NCT00527514|455598311|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
126628313|NCT00527514|455598311|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
126628314|NCT00527514|455598311|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
126628315|NCT00920699|455598316|FG000|Overall Study|Withdrawal by Subject|2|||
126628316|NCT00920699|455598317|FG001|Overall Study|Withdrawal by Subject|0|||
126628317|NCT00920699|455598318|FG002|Overall Study|Withdrawal by Subject|2|||
126628318|NCT00920699|455598316|FG000|Overall Study|no longer met eligibility|0|||
126628319|NCT00920699|455598317|FG001|Overall Study|no longer met eligibility|1|||
126628320|NCT00920699|455598318|FG002|Overall Study|no longer met eligibility|0|||
126783680|NCT00832078|456164305|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
126783681|NCT01628120|456164306|FG000|Overall Study|Withdrawal by Subject|7|||
126783682|NCT01628120|456164306|FG000|Overall Study|Adverse Event|12|||
126783683|NCT01628120|456164306|FG000|Overall Study|Lost to Follow-up|1|||
126783684|NCT01628120|456164306|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
126783685|NCT01628120|456164306|FG000|Overall Study|Non-compliant with Study Procedures|1|||
126783686|NCT01628120|456164306|FG000|Overall Study|Not Treated|3|||
126783687|NCT01628120|456164306|FG000|Overall Study|Sponsor Decision|5|||
126783688|NCT01628120|456164306|FG000|Overall Study|Switched Dialysis Method|2|||
126783689|NCT01628120|456164306|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
126783690|NCT01628120|456164306|FG000|Overall Study|Moved or Relocated|5|||
126783691|NCT01628120|456164306|FG000|Overall Study|Kidney Transplant|2|||
126783692|NCT01628120|456164306|FG000|Overall Study|Use of Standard of Care|1|||
126783693|NCT02192905|456164311|FG000|Overall Study|Lost to Follow-up|1|||
126783694|NCT02232074|456164312|FG000|Overall Study|Withdrawal by Subject|5|||
126783695|NCT02232074|456164313|FG001|Overall Study|Withdrawal by Subject|3|||
126783696|NCT02232074|456164312|FG000|Overall Study|No legal concerns at baseline|36|||
126783697|NCT02232074|456164313|FG001|Overall Study|No legal concerns at baseline|41|||
126783698|NCT02232074|456164312|FG000|Overall Study|deemed ineligible|0|||
126783699|NCT02232074|456164313|FG001|Overall Study|deemed ineligible|1|||
126783700|NCT00704418|456164317|FG000|Overall Study|Withdrawal by Subject|2|||
126783701|NCT00704418|456164318|FG001|Overall Study|Withdrawal by Subject|0|||
126783702|NCT00704418|456164317|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
126783703|NCT00704418|456164318|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
126783704|NCT02322879|456164319|FG000|First Intervention|Physician Decision|1|||
126783705|NCT02322879|456164320|FG001|First Intervention|Physician Decision|0|||
126783706|NCT01579474|456164321|FG000|Overall Study|Adverse Event|1|||
126783707|NCT01579474|456164322|FG001|Overall Study|Adverse Event|13|||
126783708|NCT01579474|456164323|FG002|Overall Study|Adverse Event|2|||
126783709|NCT01579474|456164324|FG003|Overall Study|Adverse Event|0|||
126783710|NCT01579474|456164325|FG004|Overall Study|Adverse Event|0|||
126783711|NCT01579474|456164326|FG005|Overall Study|Adverse Event|1|||
126783712|NCT01579474|456164321|FG000|Overall Study|Lack of Efficacy|1|||
126783713|NCT01579474|456164322|FG001|Overall Study|Lack of Efficacy|0|||
126783714|NCT01579474|456164323|FG002|Overall Study|Lack of Efficacy|0|||
126628321|NCT00920699|455598316|FG000|Overall Study|Lost to Follow-up|0|||
126628322|NCT00920699|455598317|FG001|Overall Study|Lost to Follow-up|0|||
126628323|NCT00920699|455598318|FG002|Overall Study|Lost to Follow-up|2|||
126628324|NCT00001941|455598329|FG000|Overall Study|not treated- rapidly progressing disease|0|||
126628325|NCT00001941|455598330|FG001|Overall Study|not treated- rapidly progressing disease|0|||
126628326|NCT00001941|455598331|FG002|Overall Study|not treated- rapidly progressing disease|0|||
126628327|NCT00001941|455598332|FG003|Overall Study|not treated- rapidly progressing disease|0|||
126628328|NCT00001941|455598333|FG004|Overall Study|not treated- rapidly progressing disease|1|||
126628329|NCT00819013|455598342|FG000|Overall Study|Not meeting continuing study eligibility|2|||
126628330|NCT00819013|455598343|FG001|Overall Study|Not meeting continuing study eligibility|1|||
126628331|NCT00819013|455598344|FG002|Overall Study|Not meeting continuing study eligibility|2|||
126628332|NCT00819013|455598345|FG003|Overall Study|Not meeting continuing study eligibility|1|||
126628333|NCT00819013|455598342|FG000|Overall Study|Adverse Event|0|||
126783715|NCT01579474|456164324|FG003|Overall Study|Lack of Efficacy|0|||
126783716|NCT01579474|456164325|FG004|Overall Study|Lack of Efficacy|1|||
126783717|NCT01579474|456164326|FG005|Overall Study|Lack of Efficacy|0|||
126628334|NCT00819013|455598343|FG001|Overall Study|Adverse Event|0|||
126628335|NCT00819013|455598344|FG002|Overall Study|Adverse Event|1|||
126628336|NCT00819013|455598345|FG003|Overall Study|Adverse Event|0|||
126628337|NCT00819013|455598342|FG000|Overall Study|Withdrawal by Subject|1|||
126628338|NCT00819013|455598343|FG001|Overall Study|Withdrawal by Subject|0|||
126628339|NCT00819013|455598344|FG002|Overall Study|Withdrawal by Subject|1|||
126628340|NCT00819013|455598345|FG003|Overall Study|Withdrawal by Subject|0|||
126628341|NCT00819013|455598342|FG000|Overall Study|Lost to Follow-up|0|||
126628342|NCT00819013|455598343|FG001|Overall Study|Lost to Follow-up|0|||
126628343|NCT00819013|455598344|FG002|Overall Study|Lost to Follow-up|1|||
126628344|NCT00819013|455598345|FG003|Overall Study|Lost to Follow-up|2|||
126628345|NCT00819013|455598342|FG000|Overall Study|Death|0|||
126628346|NCT00819013|455598343|FG001|Overall Study|Death|0|||
126628347|NCT00819013|455598344|FG002|Overall Study|Death|0|||
126628348|NCT00819013|455598345|FG003|Overall Study|Death|1|||
126628349|NCT00363649|455598346|FG000|Overall Study|Withdrawal by Subject|1|||
126628350|NCT00363649|455598347|FG001|Overall Study|Withdrawal by Subject|1|||
126628351|NCT00363649|455598346|FG000|Overall Study|Adverse Event|6|||
126628352|NCT00363649|455598347|FG001|Overall Study|Adverse Event|0|||
126628353|NCT01020747|455598348|FG000|Overall Study|Withdrawal by Subject|1|||
126628354|NCT01222078|455598349|FG000|Overall Study|Early termination of the study|1|||
126628355|NCT02970305|455598350|FG000|Overall Study|Adverse Event|10|||
126628356|NCT02970305|455598351|FG001|Overall Study|Adverse Event|6|||
126628357|NCT02970305|455598350|FG000|Overall Study|Lack of Efficacy|1|||
126628358|NCT02970305|455598351|FG001|Overall Study|Lack of Efficacy|1|||
126628359|NCT02970305|455598350|FG000|Overall Study|Noncompliance with study drug|2|||
126628360|NCT02970305|455598351|FG001|Overall Study|Noncompliance with study drug|4|||
126628361|NCT02970305|455598350|FG000|Overall Study|Protocol Violation|2|||
126783718|NCT01579474|456164321|FG000|Overall Study|Withdrawal by Subject|1|||
126783719|NCT01579474|456164322|FG001|Overall Study|Withdrawal by Subject|0|||
126783720|NCT01579474|456164323|FG002|Overall Study|Withdrawal by Subject|0|||
126783721|NCT01579474|456164324|FG003|Overall Study|Withdrawal by Subject|0|||
126783722|NCT01579474|456164325|FG004|Overall Study|Withdrawal by Subject|0|||
126783723|NCT01579474|456164326|FG005|Overall Study|Withdrawal by Subject|0|||
126783724|NCT00130520|456164327|FG000|Overall Study|Adverse Event|11|||
126783725|NCT00130520|456164327|FG000|Overall Study|Death|1|||
126783726|NCT00130520|456164327|FG000|Overall Study|Physician Decision|1|||
126783727|NCT00130520|456164327|FG000|Overall Study|Withdrawal by Subject|1|||
126783728|NCT00130520|456164327|FG000|Overall Study|Disease Progression|23|||
126783729|NCT00130520|456164327|FG000|Overall Study|Protocol non-compliance|1|||
126783730|NCT00130520|456164327|FG000|Overall Study|Did not meet re-treatment criteria|1|||
126783731|NCT03083483|456164334|FG000|Overall Study|Adverse Event|1|||
126783732|NCT03083483|456164335|FG001|Overall Study|Adverse Event|1|||
126783733|NCT03083483|456164336|FG002|Overall Study|Adverse Event|1|||
126783734|NCT03083483|456164334|FG000|Overall Study|Lost to Follow-up|2|||
126783735|NCT03083483|456164335|FG001|Overall Study|Lost to Follow-up|1|||
126783736|NCT03083483|456164336|FG002|Overall Study|Lost to Follow-up|1|||
126783737|NCT03083483|456164334|FG000|Overall Study|technological issues|1|||
126783738|NCT03083483|456164335|FG001|Overall Study|technological issues|0|||
126783739|NCT03083483|456164336|FG002|Overall Study|technological issues|1|||
126783740|NCT02711956|456164337|FG000|Overall Study|Adverse Event|0|||
126783741|NCT02711956|456164338|FG001|Overall Study|Adverse Event|0|||
126783742|NCT02711956|456164339|FG002|Overall Study|Adverse Event|0|||
126783743|NCT02711956|456164340|FG003|Overall Study|Adverse Event|1|||
126783744|NCT02711956|456164341|FG004|Overall Study|Adverse Event|2|||
126783745|NCT02711956|456164342|FG005|Overall Study|Adverse Event|0|||
126783746|NCT02711956|456164343|FG006|Overall Study|Adverse Event|0|||
126783747|NCT02711956|456164344|FG007|Overall Study|Adverse Event|1|||
126754519|NCT03018028|456051331|FG003|Overall Study|Withdrawal by Subject|2|||
126754520|NCT03018028|456051332|FG004|Overall Study|Withdrawal by Subject|0|||
126754521|NCT02519777|456051334|FG000|Overall Study|Death|1|||
126754522|NCT02519777|456051335|FG001|Overall Study|Death|0|||
126754523|NCT02519777|456051336|FG002|Overall Study|Death|0|||
126754524|NCT02519777|456051334|FG000|Overall Study|Lost to Follow-up|0|||
126754525|NCT02519777|456051335|FG001|Overall Study|Lost to Follow-up|4|||
126754526|NCT02519777|456051336|FG002|Overall Study|Lost to Follow-up|2|||
126754527|NCT02519777|456051334|FG000|Overall Study|Withdrawal by Subject|3|||
126754528|NCT02519777|456051335|FG001|Overall Study|Withdrawal by Subject|1|||
126628362|NCT02970305|455598351|FG001|Overall Study|Protocol Violation|2|||
126628363|NCT02970305|455598350|FG000|Overall Study|Withdrawal by Subject|12|||
126783748|NCT02711956|456164345|FG008|Overall Study|Adverse Event|1|||
126783749|NCT02711956|456164346|FG009|Overall Study|Adverse Event|1|||
126783750|NCT02711956|456164347|FG010|Overall Study|Adverse Event|1|||
126783751|NCT02711956|456164348|FG011|Overall Study|Adverse Event|0|||
126783752|NCT02711956|456164349|FG012|Overall Study|Adverse Event|0|||
126628364|NCT02970305|455598351|FG001|Overall Study|Withdrawal by Subject|11|||
126754529|NCT02519777|456051336|FG002|Overall Study|Withdrawal by Subject|0|||
126783753|NCT02711956|456164350|FG013|Overall Study|Adverse Event|0|||
126783754|NCT02711956|456164351|FG014|Overall Study|Adverse Event|2|||
126783755|NCT02711956|456164337|FG000|Overall Study|Physician Decision|0|||
126783756|NCT02711956|456164338|FG001|Overall Study|Physician Decision|0|||
126783757|NCT02711956|456164339|FG002|Overall Study|Physician Decision|0|||
126783758|NCT02711956|456164340|FG003|Overall Study|Physician Decision|2|||
126628365|NCT02970305|455598350|FG000|Overall Study|Not further specified|1|||
126628366|NCT02970305|455598351|FG001|Overall Study|Not further specified|2|||
126628367|NCT02970305|455598350|FG000|Overall Study|Lost to Follow-up|1|||
126628368|NCT02970305|455598351|FG001|Overall Study|Lost to Follow-up|2|||
126628369|NCT00983892|455598352|FG000|Overall Study|Withdrawal by Subject|10|||
126628370|NCT00983892|455598353|FG001|Overall Study|Withdrawal by Subject|12|||
126628371|NCT00808899|455598355|FG000|Overall Study|Death|1|||
126628372|NCT00808899|455598355|FG000|Overall Study|Physician Decision|3|||
126628373|NCT03120949|455598360|FG000|Overall Study|randomized in error|1|||
126628374|NCT03120949|455598361|FG001|Overall Study|randomized in error|0|||
126628375|NCT03120949|455598360|FG000|Overall Study|Death|13|||
126628376|NCT03120949|455598361|FG001|Overall Study|Death|13|||
126628377|NCT03120949|455598360|FG000|Overall Study|Lost to Follow-up|23|||
126628378|NCT03120949|455598361|FG001|Overall Study|Lost to Follow-up|13|||
126628379|NCT03120949|455598360|FG000|Overall Study|Withdrawal by Subject|139|||
126628380|NCT03120949|455598361|FG001|Overall Study|Withdrawal by Subject|124|||
126628381|NCT03120949|455598360|FG000|Overall Study|Covid-19|43|||
126628382|NCT03120949|455598361|FG001|Overall Study|Covid-19|34|||
126628383|NCT03120949|455598360|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
126628384|NCT03120949|455598361|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
126628385|NCT03120949|455598360|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
126628386|NCT03120949|455598361|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
126628387|NCT03120949|455598360|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
126628388|NCT03120949|455598361|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
126628389|NCT03120949|455598360|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
126628390|NCT03120949|455598361|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
126628391|NCT03120949|455598360|FG000|Overall Study|Site was closed|2|||
126628392|NCT03120949|455598361|FG001|Overall Study|Site was closed|3|||
126628393|NCT03120949|455598360|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
126628394|NCT03120949|455598361|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
126628395|NCT03120949|455598360|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
126628396|NCT03120949|455598361|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
126628397|NCT03120949|455598360|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
126628398|NCT03120949|455598361|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
126628399|NCT03120949|455598360|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
126628400|NCT03120949|455598361|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
126628401|NCT03120949|455598360|FG000|Overall Study|Other: Adverse Event|0|||
126628402|NCT03120949|455598361|FG001|Overall Study|Other: Adverse Event|1|||
126628403|NCT03120949|455598360|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
126628404|NCT03120949|455598361|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
126628405|NCT03120949|455598360|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
126628406|NCT03120949|455598361|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
126628407|NCT03120949|455598360|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
126628408|NCT03120949|455598361|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
126628409|NCT03120949|455598360|FG000|Overall Study|Personal Reasons|0|||
126628410|NCT03120949|455598361|FG001|Overall Study|Personal Reasons|1|||
126628411|NCT03120949|455598360|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
126628412|NCT03120949|455598361|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
126628413|NCT03120949|455598360|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
126628414|NCT03120949|455598361|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
126628415|NCT03120949|455598360|FG000|Overall Study|Compliance With Medication|0|||
126628416|NCT03120949|455598361|FG001|Overall Study|Compliance With Medication|1|||
126628417|NCT03120949|455598360|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
126628418|NCT03120949|455598361|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
126628419|NCT03120949|455598360|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
126628420|NCT03120949|455598361|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
126628421|NCT03120949|455598360|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
126783759|NCT02711956|456164341|FG004|Overall Study|Physician Decision|0|||
126783760|NCT02711956|456164342|FG005|Overall Study|Physician Decision|0|||
126628422|NCT03120949|455598361|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
126628423|NCT00988117|455598362|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
126628424|NCT00988117|455598362|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
126628425|NCT04522778|455598365|FG000|Overall Study|Patient did not want to wear the device|1|||
126628426|NCT04522778|455598366|FG001|Overall Study|Patient did not want to wear the device|0|||
126628427|NCT04522778|455598365|FG000|Overall Study|Lost to Follow-up|0|||
126628428|NCT04522778|455598366|FG001|Overall Study|Lost to Follow-up|1|||
126628429|NCT01225159|455598367|FG000|Overall Study|Change operation|1|||
126628430|NCT01225159|455598368|FG001|Overall Study|Change operation|0|||
126628431|NCT00312845|455598369|FG000|Overall Study|Adverse Event|19|||
126628432|NCT00312845|455598370|FG001|Overall Study|Adverse Event|5|||
126628433|NCT00312845|455598369|FG000|Overall Study|Death|2|||
126628434|NCT00312845|455598370|FG001|Overall Study|Death|2|||
126628435|NCT00312845|455598369|FG000|Overall Study|Withdrawal by Subject|14|||
126628436|NCT00312845|455598370|FG001|Overall Study|Withdrawal by Subject|6|||
126628437|NCT00312845|455598369|FG000|Overall Study|Disease Progression|56|||
126628438|NCT00312845|455598370|FG001|Overall Study|Disease Progression|77|||
126628439|NCT00312845|455598369|FG000|Overall Study|Lost to Follow-up|2|||
126628440|NCT00312845|455598370|FG001|Overall Study|Lost to Follow-up|0|||
126628441|NCT00312845|455598369|FG000|Overall Study|Other|6|||
126628442|NCT00312845|455598370|FG001|Overall Study|Other|5|||
126628443|NCT01220856|455598371|FG000|Overall Study|graft loss|3|||
126628444|NCT01220856|455598372|FG001|Overall Study|graft loss|3|||
126628445|NCT01220856|455598371|FG000|Overall Study|Lost to Follow-up|1|||
126628446|NCT01220856|455598372|FG001|Overall Study|Lost to Follow-up|0|||
126628447|NCT04088500|455598373|FG000|Overall Study|Reason unknown|1|||
126628448|NCT04088500|455598373|FG000|Overall Study|Participant withdrew consent|1|||
126628449|NCT04088500|455598373|FG000|Overall Study|Disease progression|3|||
126628450|NCT01592383|455598374|FG000|Overall Study|Adverse Event|1|||
126628451|NCT04159805|455598375|FG000|Overall Study|Withdrawal by Subject|0|||
126628452|NCT04159805|455598376|FG001|Overall Study|Withdrawal by Subject|2|||
126628453|NCT04159805|455598377|FG002|Overall Study|Withdrawal by Subject|2|||
126628454|NCT04167085|455598378|FG000|Baseline|Withdrawal by Subject|2|||
126628455|NCT04167085|455598379|FG001|Baseline|Withdrawal by Subject|1|||
126628456|NCT04167085|455598378|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
126628457|NCT04167085|455598379|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
126628458|NCT01171183|455600197|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
126628459|NCT01171183|455600198|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
126628460|NCT01171183|455600197|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
126628461|NCT01171183|455600198|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
126628462|NCT01171183|455600197|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
126628463|NCT01171183|455600198|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
126628464|NCT01171183|455600197|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
126628465|NCT01171183|455600198|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
126628466|NCT01171183|455600197|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
126628467|NCT01171183|455600198|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
126628468|NCT01171183|455600197|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
126628469|NCT01171183|455600198|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
126628470|NCT01904136|455600199|FG000|Overall Study|Physician Decision|0|||
126628471|NCT01904136|455600200|FG001|Overall Study|Physician Decision|0|||
126628472|NCT01904136|455600201|FG002|Overall Study|Physician Decision|0|||
126628473|NCT01904136|455600202|FG003|Overall Study|Physician Decision|0|||
126628474|NCT01904136|455600203|FG004|Overall Study|Physician Decision|0|||
126628475|NCT01904136|455600204|FG005|Overall Study|Physician Decision|1|||
126628476|NCT01904136|455600205|FG006|Overall Study|Physician Decision|0|||
126628477|NCT01904136|455600206|FG007|Overall Study|Physician Decision|0|||
126628478|NCT01904136|455600207|FG008|Overall Study|Physician Decision|0|||
126628479|NCT00853372|455600208|FG000|Overall Study|Death|30|||
126628480|NCT00853372|455600209|FG001|Overall Study|Death|26|||
126628481|NCT00853372|455600208|FG000|Overall Study|Lost to Follow-up|1|||
126628482|NCT00853372|455600209|FG001|Overall Study|Lost to Follow-up|2|||
126628483|NCT00853372|455600208|FG000|Overall Study|Full Consent Withdrawn|1|||
126628484|NCT00853372|455600209|FG001|Overall Study|Full Consent Withdrawn|1|||
126783761|NCT02711956|456164343|FG006|Overall Study|Physician Decision|0|||
126783762|NCT02711956|456164344|FG007|Overall Study|Physician Decision|0|||
126628485|NCT01268098|455600212|FG000|Overall Study|Adverse Event|1|||
126628486|NCT01268098|455600213|FG001|Overall Study|Adverse Event|0|||
126628487|NCT01929876|455600215|FG000|Period 2|Non-Compliance|1|||
126628488|NCT01845649|455600216|FG000|Overall Study|Adverse Event|7|||
126628489|NCT01845649|455600217|FG001|Overall Study|Adverse Event|10|||
126628490|NCT01845649|455600216|FG000|Overall Study|Lack of Efficacy|1|||
126628491|NCT01845649|455600217|FG001|Overall Study|Lack of Efficacy|1|||
126628492|NCT01845649|455600216|FG000|Overall Study|Lost to Follow-up|2|||
126628493|NCT01845649|455600217|FG001|Overall Study|Lost to Follow-up|2|||
126628494|NCT01845649|455600216|FG000|Overall Study|Withdrew Consent|12|||
126628495|NCT01845649|455600217|FG001|Overall Study|Withdrew Consent|4|||
126628496|NCT01845649|455600216|FG000|Overall Study|Protocol Deviation|7|||
126628497|NCT01845649|455600217|FG001|Overall Study|Protocol Deviation|4|||
126628498|NCT01845649|455600216|FG000|Overall Study|Reason not Specified|2|||
126628499|NCT01845649|455600217|FG001|Overall Study|Reason not Specified|1|||
126628500|NCT03991988|455600218|FG000|Overall Study|Withdrawal by Subject|2|||
126628501|NCT03991988|455600219|FG001|Overall Study|Withdrawal by Subject|2|||
126628502|NCT01222533|455600221|FG000|Overall Study|Adverse Event|5|||
126628503|NCT01222533|455600221|FG000|Overall Study|Withdrawal by Subject|5|||
126628504|NCT01222533|455600221|FG000|Overall Study|Other|4|||
126628505|NCT01947517|455600222|FG000|Overall Study|Withdrawal by Subject|1|||
126628506|NCT01947517|455600223|FG001|Overall Study|Withdrawal by Subject|1|||
126628507|NCT02418845|455600227|FG000|Overall Study|Lost to Follow-up|7|||
126628508|NCT02418845|455600228|FG001|Overall Study|Lost to Follow-up|2|||
126628509|NCT02418845|455600227|FG000|Overall Study|Lack of Efficacy|0|||
126628510|NCT02418845|455600228|FG001|Overall Study|Lack of Efficacy|3|||
126628511|NCT02418845|455600227|FG000|Overall Study|Physician Decision|5|||
126628512|NCT02418845|455600228|FG001|Overall Study|Physician Decision|5|||
126628513|NCT02418845|455600227|FG000|Overall Study|Protocol Violation|1|||
126628514|NCT02418845|455600228|FG001|Overall Study|Protocol Violation|0|||
126628515|NCT02418845|455600227|FG000|Overall Study|Withdrawal by Subject|3|||
126628516|NCT02418845|455600228|FG001|Overall Study|Withdrawal by Subject|2|||
126628517|NCT00526097|455600229|FG000|Overall Study|Adverse Event|6|||
126628518|NCT00526097|455600230|FG001|Overall Study|Adverse Event|44|||
126628519|NCT00526097|455600229|FG000|Overall Study|Protocol Violation|4|||
126628520|NCT00526097|455600230|FG001|Overall Study|Protocol Violation|10|||
126628521|NCT00526097|455600229|FG000|Overall Study|Withdrawal by Subject|3|||
126628522|NCT00526097|455600230|FG001|Overall Study|Withdrawal by Subject|1|||
126628523|NCT00526097|455600229|FG000|Overall Study|Other|2|||
126628524|NCT00526097|455600230|FG001|Overall Study|Other|1|||
126628525|NCT00460564|455600231|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
126628526|NCT00460564|455600232|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
126628527|NCT00460564|455600233|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126628528|NCT00460564|455600234|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126628529|NCT00460564|455600235|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126628530|NCT00460564|455600236|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126628531|NCT00460564|455600237|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126628532|NCT00460564|455600238|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
126628533|NCT00460564|455600231|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
126628534|NCT00460564|455600232|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126628535|NCT00460564|455600233|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126628536|NCT00460564|455600234|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126628537|NCT00460564|455600235|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126628538|NCT00460564|455600236|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126628539|NCT00460564|455600237|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126628540|NCT00460564|455600238|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
126628541|NCT00460564|455600231|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126628542|NCT00460564|455600232|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126628543|NCT00460564|455600233|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126628544|NCT00460564|455600234|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126628545|NCT00460564|455600235|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
126628546|NCT00460564|455600236|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
126628547|NCT00460564|455600237|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
126628548|NCT00460564|455600238|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
126628549|NCT00460564|455600231|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126628550|NCT00460564|455600232|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126628551|NCT00460564|455600233|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126628552|NCT00460564|455600234|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126628553|NCT00460564|455600235|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
126628554|NCT00460564|455600236|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
126628555|NCT00460564|455600237|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126628556|NCT00460564|455600238|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
126628557|NCT00460564|455600231|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126628558|NCT00460564|455600232|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126628559|NCT00460564|455600233|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126628560|NCT00460564|455600234|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126754530|NCT02519777|456051334|FG000|Overall Study|Severe Debilitation|1|||
126754531|NCT02519777|456051335|FG001|Overall Study|Severe Debilitation|1|||
126754532|NCT02519777|456051336|FG002|Overall Study|Severe Debilitation|1|||
126754533|NCT02519777|456051334|FG000|Overall Study|Not able to get to clinic|1|||
126754534|NCT02519777|456051335|FG001|Overall Study|Not able to get to clinic|2|||
126754535|NCT02519777|456051336|FG002|Overall Study|Not able to get to clinic|1|||
126628561|NCT00460564|455600235|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
126754536|NCT02195531|456051337|FG000|Overall Study|Withdrawal by Subject|1|||
126783763|NCT02711956|456164345|FG008|Overall Study|Physician Decision|0|||
126628562|NCT00460564|455600236|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126628563|NCT00460564|455600237|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126628564|NCT00460564|455600238|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
126628565|NCT00943618|455600239|FG000|Overall Study|Lost to Follow-up|38|||
126628566|NCT00943618|455600240|FG001|Overall Study|Lost to Follow-up|48|||
126628567|NCT00943618|455600241|FG002|Overall Study|Lost to Follow-up|20|||
126628568|NCT00943618|455600239|FG000|Overall Study|Discontinued Medication|17|||
126628569|NCT00943618|455600240|FG001|Overall Study|Discontinued Medication|29|||
126628570|NCT00943618|455600241|FG002|Overall Study|Discontinued Medication|11|||
126628571|NCT02412111|455600256|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
126628572|NCT02412111|455600257|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
126628573|NCT02412111|455600258|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
126628574|NCT02412111|455600256|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
126628575|NCT02412111|455600257|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
126628576|NCT02412111|455600258|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
126628577|NCT02412111|455600256|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
126628578|NCT02412111|455600257|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
126628579|NCT02412111|455600258|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
126628580|NCT02412111|455600256|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
126754537|NCT02195531|456051338|FG001|Overall Study|Withdrawal by Subject|1|||
126754538|NCT02195531|456051339|FG002|Overall Study|Withdrawal by Subject|1|||
126754539|NCT02543801|456051341|FG000|Overall Study|Protocol Violation|1|||
126754540|NCT02543801|456051342|FG001|Overall Study|Protocol Violation|2|||
126754541|NCT02543801|456051343|FG002|Overall Study|Protocol Violation|0|||
126754542|NCT02543801|456051344|FG003|Overall Study|Protocol Violation|0|||
126754543|NCT01034709|456051347|FG000|Overall Study|Protocol Violation|9|||
126754544|NCT01034709|456051348|FG001|Overall Study|Protocol Violation|16|||
126754545|NCT00082628|456051362|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
126754546|NCT00082628|456051363|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
126754547|NCT00082628|456051364|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
126754548|NCT00082628|456051365|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
126754549|NCT00082628|456051366|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
126754550|NCT00082628|456051362|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
126754551|NCT00082628|456051363|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
126754552|NCT00082628|456051364|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
126754553|NCT00082628|456051365|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
126754554|NCT00082628|456051366|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
126754555|NCT00082628|456051362|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
126754556|NCT00082628|456051363|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
126754557|NCT00082628|456051364|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
126754558|NCT00082628|456051365|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
126754559|NCT00082628|456051366|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
126754560|NCT00082628|456051362|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
126754561|NCT00082628|456051363|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
126754562|NCT00082628|456051364|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
126754563|NCT00082628|456051365|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
126754564|NCT00082628|456051366|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
126754565|NCT00082628|456051362|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
126754566|NCT00082628|456051363|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
126754567|NCT00082628|456051364|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
126754568|NCT00082628|456051365|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
126754569|NCT00082628|456051366|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
126754570|NCT00082628|456051362|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
126754571|NCT00082628|456051363|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
126754572|NCT00082628|456051364|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
126754573|NCT00082628|456051365|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
126754574|NCT00082628|456051366|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
126754575|NCT00082628|456051362|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
126754576|NCT00082628|456051363|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
126754577|NCT00082628|456051364|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
126754578|NCT00082628|456051365|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
126754579|NCT00082628|456051366|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
126783764|NCT02711956|456164346|FG009|Overall Study|Physician Decision|0|||
126628581|NCT02412111|455600257|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
126628582|NCT02412111|455600258|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
126628583|NCT02412111|455600256|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
126628584|NCT02412111|455600257|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
126628585|NCT02412111|455600258|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
126628586|NCT02412111|455600256|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
126628587|NCT02412111|455600257|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
126628588|NCT02412111|455600258|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
126628589|NCT02412111|455600256|FG000|Active Comparator Period (8 Weeks)|Other|0|||
126628590|NCT02412111|455600257|FG001|Active Comparator Period (8 Weeks)|Other|0|||
126628591|NCT02412111|455600258|FG002|Active Comparator Period (8 Weeks)|Other|2|||
126628592|NCT00487552|455600259|FG000|Overall Study|Unsuccessful magnet placements|3|||
126628593|NCT00487552|455600259|FG000|Overall Study|Death due to progressive malignancy|2|||
126628594|NCT00487552|455600259|FG000|Overall Study|Stent not placed|1|||
126628595|NCT00630552|455600260|FG000|Overall Study|Adverse Event|0|||
126628596|NCT00630552|455600261|FG001|Overall Study|Adverse Event|1|||
126628597|NCT00630552|455600262|FG002|Overall Study|Adverse Event|5|||
126628598|NCT00630552|455600263|FG003|Overall Study|Adverse Event|4|||
126628599|NCT00630552|455600264|FG004|Overall Study|Adverse Event|2|||
126628600|NCT00630552|455600260|FG000|Overall Study|Disease progression|5|||
126628601|NCT00630552|455600261|FG001|Overall Study|Disease progression|6|||
126628602|NCT00630552|455600262|FG002|Overall Study|Disease progression|27|||
126628603|NCT00630552|455600263|FG003|Overall Study|Disease progression|22|||
126628604|NCT00630552|455600264|FG004|Overall Study|Disease progression|31|||
126628605|NCT00630552|455600260|FG000|Overall Study|Never received IP|0|||
126628606|NCT00630552|455600261|FG001|Overall Study|Never received IP|0|||
126628607|NCT00630552|455600262|FG002|Overall Study|Never received IP|0|||
126628608|NCT00630552|455600263|FG003|Overall Study|Never received IP|2|||
126628609|NCT00630552|455600264|FG004|Overall Study|Never received IP|2|||
126628610|NCT00630552|455600260|FG000|Overall Study|Ineligibility determined|0|||
126628611|NCT00630552|455600261|FG001|Overall Study|Ineligibility determined|0|||
126628612|NCT00630552|455600262|FG002|Overall Study|Ineligibility determined|0|||
126628613|NCT00630552|455600263|FG003|Overall Study|Ineligibility determined|0|||
126628614|NCT00630552|455600264|FG004|Overall Study|Ineligibility determined|1|||
126628615|NCT00630552|455600260|FG000|Overall Study|Protocol Violation|0|||
126628616|NCT00630552|455600261|FG001|Overall Study|Protocol Violation|0|||
126628617|NCT00630552|455600262|FG002|Overall Study|Protocol Violation|0|||
126628618|NCT00630552|455600263|FG003|Overall Study|Protocol Violation|1|||
126628619|NCT00630552|455600264|FG004|Overall Study|Protocol Violation|0|||
126628620|NCT00630552|455600260|FG000|Overall Study|Physician Decision|0|||
126628621|NCT00630552|455600261|FG001|Overall Study|Physician Decision|0|||
126628622|NCT00630552|455600262|FG002|Overall Study|Physician Decision|0|||
126628623|NCT00630552|455600263|FG003|Overall Study|Physician Decision|0|||
126628624|NCT00630552|455600264|FG004|Overall Study|Physician Decision|1|||
126628625|NCT00630552|455600260|FG000|Overall Study|Death|0|||
126628626|NCT00630552|455600261|FG001|Overall Study|Death|0|||
126628627|NCT00630552|455600262|FG002|Overall Study|Death|1|||
126628628|NCT00630552|455600263|FG003|Overall Study|Death|2|||
126628629|NCT00630552|455600264|FG004|Overall Study|Death|2|||
126628630|NCT00630552|455600260|FG000|Overall Study|Withdrawal by Subject|0|||
126628631|NCT00630552|455600261|FG001|Overall Study|Withdrawal by Subject|0|||
126628632|NCT00630552|455600262|FG002|Overall Study|Withdrawal by Subject|0|||
126628633|NCT00630552|455600263|FG003|Overall Study|Withdrawal by Subject|1|||
126628634|NCT00630552|455600264|FG004|Overall Study|Withdrawal by Subject|0|||
126628635|NCT00630552|455600260|FG000|Overall Study|Other|0|||
126628636|NCT00630552|455600261|FG001|Overall Study|Other|0|||
126628637|NCT00630552|455600262|FG002|Overall Study|Other|4|||
126628638|NCT00630552|455600263|FG003|Overall Study|Other|2|||
126628639|NCT00630552|455600264|FG004|Overall Study|Other|0|||
126628640|NCT04349644|455600265|FG000|Allocation/Pretest|Lost to pretest|0|||
126628641|NCT04349644|455600266|FG001|Allocation/Pretest|Lost to pretest|3|||
126628642|NCT04349644|455600265|FG000|Posttest|Lost to posttest|0|||
126628643|NCT04349644|455600266|FG001|Posttest|Lost to posttest|8|||
126628644|NCT04349644|455600265|FG000|Posttest|Discontinued intervention|6|||
126628645|NCT04349644|455600266|FG001|Posttest|Discontinued intervention|0|||
126628646|NCT04349644|455600265|FG000|Follow-up|Lost to Follow-up|0|||
126628647|NCT04349644|455600266|FG001|Follow-up|Lost to Follow-up|2|||
126754580|NCT02364999|456051367|FG000|Overall Study|Death|136|||
126754581|NCT02364999|456051368|FG001|Overall Study|Death|138|||
126628648|NCT00983905|455600267|FG000|Theophylline Alone|Adverse Event|1|||
126628649|NCT00983905|455600267|FG000|Colchicine Alone|Adverse Event|2|||
126628650|NCT01114139|455600268|FG000|Overall Study|Adverse Event|3|||
126628651|NCT01114139|455600269|FG001|Overall Study|Adverse Event|2|||
126628652|NCT01114139|455600268|FG000|Overall Study|Lost to Follow-up|15|||
126628653|NCT01114139|455600269|FG001|Overall Study|Lost to Follow-up|3|||
126628654|NCT01114139|455600268|FG000|Overall Study|Withdrawal by Subject|17|||
126628655|NCT01114139|455600269|FG001|Overall Study|Withdrawal by Subject|6|||
126628656|NCT01114139|455600268|FG000|Overall Study|Other-Missed 1 visit|1|||
126628657|NCT01114139|455600269|FG001|Overall Study|Other-Missed 1 visit|0|||
126628658|NCT01114139|455600268|FG000|Overall Study|Other-Protocol Violation|1|||
126628659|NCT01114139|455600269|FG001|Overall Study|Other-Protocol Violation|0|||
126628660|NCT01114139|455600268|FG000|Overall Study|Other-Out of window for study drug dose|1|||
126628661|NCT01114139|455600269|FG001|Overall Study|Other-Out of window for study drug dose|0|||
126628662|NCT01114139|455600268|FG000|Overall Study|Other-Participant falsified records|0|||
126628663|NCT01114139|455600269|FG001|Overall Study|Other-Participant falsified records|1|||
126628664|NCT01114139|455600268|FG000|Overall Study|Other-Participant went on hospice|0|||
126628665|NCT01114139|455600269|FG001|Overall Study|Other-Participant went on hospice|1|||
126628666|NCT01114139|455600268|FG000|Overall Study|Other-Physician changed treatment|1|||
126628667|NCT01114139|455600269|FG001|Overall Study|Other-Physician changed treatment|0|||
126628668|NCT01114139|455600268|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
126628669|NCT01114139|455600269|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
126628670|NCT01169636|455600270|FG000|Overall Study|Adverse Event|0|||
126628671|NCT01169636|455600271|FG001|Overall Study|Adverse Event|0|||
126628672|NCT01169636|455600272|FG002|Overall Study|Adverse Event|1|||
126628673|NCT01169636|455600273|FG003|Overall Study|Adverse Event|1|||
126628674|NCT01169636|455600274|FG004|Overall Study|Adverse Event|0|||
126628675|NCT01169636|455600270|FG000|Overall Study|Screen failure|0|||
126628676|NCT01169636|455600271|FG001|Overall Study|Screen failure|0|||
126628677|NCT01169636|455600272|FG002|Overall Study|Screen failure|2|||
126628678|NCT01169636|455600273|FG003|Overall Study|Screen failure|0|||
126628679|NCT01169636|455600274|FG004|Overall Study|Screen failure|0|||
126628680|NCT01169636|455600270|FG000|Overall Study|Withdrawal by Subject|0|||
126628681|NCT01169636|455600271|FG001|Overall Study|Withdrawal by Subject|0|||
126628682|NCT01169636|455600272|FG002|Overall Study|Withdrawal by Subject|0|||
126628683|NCT01169636|455600273|FG003|Overall Study|Withdrawal by Subject|0|||
126628684|NCT01169636|455600274|FG004|Overall Study|Withdrawal by Subject|3|||
126628685|NCT02705625|455600275|FG000|Overall Study|Protocol Violation|1|||
126628686|NCT02705625|455600276|FG001|Overall Study|Protocol Violation|0|||
126628687|NCT02705625|455600277|FG002|Overall Study|Protocol Violation|0|||
126628688|NCT02705625|455600275|FG000|Overall Study|Adverse Event|6|||
126628689|NCT02705625|455600276|FG001|Overall Study|Adverse Event|5|||
126628690|NCT02705625|455600277|FG002|Overall Study|Adverse Event|2|||
126628691|NCT02705625|455600275|FG000|Overall Study|Death|0|||
126628692|NCT02705625|455600276|FG001|Overall Study|Death|0|||
126628693|NCT02705625|455600277|FG002|Overall Study|Death|1|||
126628694|NCT02705625|455600275|FG000|Overall Study|Withdrawal by Subject|1|||
126628695|NCT02705625|455600276|FG001|Overall Study|Withdrawal by Subject|4|||
126628696|NCT02705625|455600277|FG002|Overall Study|Withdrawal by Subject|5|||
126628697|NCT02705625|455600275|FG000|Overall Study|Lost to Follow-up|0|||
126628698|NCT02705625|455600276|FG001|Overall Study|Lost to Follow-up|0|||
126628699|NCT02705625|455600277|FG002|Overall Study|Lost to Follow-up|1|||
126628700|NCT02705625|455600275|FG000|Overall Study|Non-compliance|0|||
126628701|NCT02705625|455600276|FG001|Overall Study|Non-compliance|1|||
126628702|NCT02705625|455600277|FG002|Overall Study|Non-compliance|1|||
126628703|NCT02705625|455600275|FG000|Overall Study|Overdosing|0|||
126628704|NCT02705625|455600276|FG001|Overall Study|Overdosing|0|||
126628705|NCT02705625|455600277|FG002|Overall Study|Overdosing|1|||
126628706|NCT02287883|455600282|FG000|Overall Study|Death|8|||
126628707|NCT02287883|455600283|FG001|Overall Study|Death|7|||
126628708|NCT02287883|455600282|FG000|Overall Study|No longer eligible|222|||
126628709|NCT02287883|455600283|FG001|Overall Study|No longer eligible|182|||
126628710|NCT02287883|455600282|FG000|Overall Study|Non-response to survey|229|||
126628711|NCT02287883|455600283|FG001|Overall Study|Non-response to survey|237|||
126628712|NCT00802438|455600284|FG000|Overall Study|Screen Failure|20|||
126628713|NCT00802438|455600284|FG000|Overall Study|Withdrawal by Subject|7|||
126628714|NCT00802438|455600284|FG000|Overall Study|Physician Decision|1|||
126628715|NCT03175198|455600285|FG000|Overall Study|Adverse Event|480|||
126628716|NCT03175198|455600285|FG000|Overall Study|No actual visit|120|||
126628717|NCT03175198|455600285|FG000|Overall Study|Registration rule not followed|4|||
126628718|NCT03175198|455600285|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
126628719|NCT03175198|455600285|FG000|Overall Study|Other personal reason|509|||
126628720|NCT03175198|455600285|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
126628721|NCT03175198|455600285|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
126628722|NCT03175198|455600285|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
126628723|NCT03175198|455600285|FG000|Overall Study|To conduct invasive treatment of operation|53|||
126628724|NCT03175198|455600285|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
126628725|NCT03811834|455600287|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
126628726|NCT03188536|455600288|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
126628727|NCT03188536|455600288|FG000|Overall Study|Not participated/met inclusion criteria|1|||
126628728|NCT04947436|455600289|FG000|Overall Study|Lost to Follow-up|3|||
126628729|NCT04947436|455600290|FG001|Overall Study|Lost to Follow-up|7|||
126628730|NCT04947436|455600291|FG002|Overall Study|Lost to Follow-up|5|||
126628731|NCT04947436|455600289|FG000|Overall Study|Death|1|||
126628732|NCT04947436|455600290|FG001|Overall Study|Death|1|||
126628733|NCT04947436|455600291|FG002|Overall Study|Death|1|||
126628734|NCT02161185|455600295|FG000|Treatment Phase|Administrative/Other|7|||
126754582|NCT02364999|456051367|FG000|Overall Study|Lost to Follow-up|10|||
126754583|NCT02364999|456051368|FG001|Overall Study|Lost to Follow-up|15|||
126754584|NCT02364999|456051367|FG000|Overall Study|Protocol Violation|3|||
126754585|NCT02364999|456051368|FG001|Overall Study|Protocol Violation|2|||
126754586|NCT02364999|456051367|FG000|Overall Study|Withdrawal by Subject|14|||
126754587|NCT02364999|456051368|FG001|Overall Study|Withdrawal by Subject|14|||
126754588|NCT02364999|456051367|FG000|Overall Study|Other|0|||
126754589|NCT02364999|456051368|FG001|Overall Study|Other|1|||
126754590|NCT02364999|456051367|FG000|Overall Study|Randomized but did not receive treatment|2|||
126754591|NCT02364999|456051368|FG001|Overall Study|Randomized but did not receive treatment|3|||
126754592|NCT01566981|456051369|FG000|Overall Study|Lost to Follow-up|5|||
126754593|NCT01566981|456051370|FG001|Overall Study|Lost to Follow-up|8|||
126754594|NCT03323385|456051377|FG000|Overall Study|Withdrawal by Subject|1|||
126754595|NCT03323385|456051378|FG001|Overall Study|Withdrawal by Subject|2|||
126754596|NCT03323385|456051377|FG000|Overall Study|Noncompliance|0|||
126754597|NCT03323385|456051378|FG001|Overall Study|Noncompliance|1|||
126754598|NCT01849289|456051379|FG000|Overall Study|Adverse Event|3|||
126754599|NCT01849289|456051380|FG001|Overall Study|Adverse Event|3|||
126754600|NCT01849289|456051379|FG000|Overall Study|Protocol Violation|3|||
126754601|NCT01849289|456051380|FG001|Overall Study|Protocol Violation|3|||
126754602|NCT01849289|456051379|FG000|Overall Study|Withdrawal criteria|1|||
126754603|NCT01849289|456051380|FG001|Overall Study|Withdrawal criteria|0|||
126754604|NCT01849289|456051379|FG000|Overall Study|Unclassified|25|||
126754605|NCT01849289|456051380|FG001|Overall Study|Unclassified|18|||
126754606|NCT00660816|456051384|FG000|Overall Study|Adverse Event|1|||
126754607|NCT00660816|456051385|FG001|Overall Study|Adverse Event|2|||
126754608|NCT00660816|456051384|FG000|Overall Study|Withdrawal by Subject|1|||
126754609|NCT00660816|456051385|FG001|Overall Study|Withdrawal by Subject|0|||
126754610|NCT00660816|456051384|FG000|Overall Study|Death|0|||
126754611|NCT00660816|456051385|FG001|Overall Study|Death|2|||
126754612|NCT00660816|456051384|FG000|Overall Study|Lack of Efficacy|1|||
126754613|NCT00660816|456051385|FG001|Overall Study|Lack of Efficacy|0|||
126754614|NCT00660816|456051384|FG000|Overall Study|Physician Decision|0|||
126754615|NCT00660816|456051385|FG001|Overall Study|Physician Decision|2|||
126754616|NCT00660816|456051384|FG000|Overall Study|Protocol Violation|1|||
126754617|NCT00660816|456051385|FG001|Overall Study|Protocol Violation|0|||
126754618|NCT00660816|456051384|FG000|Overall Study|Disease Progression|16|||
126754619|NCT00660816|456051385|FG001|Overall Study|Disease Progression|12|||
126754620|NCT00660816|456051384|FG000|Overall Study|Complicating Disease|0|||
126754621|NCT00660816|456051385|FG001|Overall Study|Complicating Disease|1|||
126754622|NCT02692560|456051386|FG000|Overall Study|Withdrawal by Subject|0|||
126754623|NCT02692560|456051387|FG001|Overall Study|Withdrawal by Subject|6|||
126754624|NCT00420212|456051390|FG000|Overall Study|Adverse Event|22|||
126754625|NCT00420212|456051391|FG001|Overall Study|Adverse Event|40|||
126754626|NCT00420212|456051392|FG002|Overall Study|Adverse Event|36|||
126754627|NCT00420212|456051390|FG000|Overall Study|Lost to Follow-up|9|||
126754628|NCT00420212|456051391|FG001|Overall Study|Lost to Follow-up|11|||
126754629|NCT00420212|456051392|FG002|Overall Study|Lost to Follow-up|11|||
126754630|NCT00420212|456051390|FG000|Overall Study|Withdrawal by Subject|31|||
126754631|NCT00420212|456051391|FG001|Overall Study|Withdrawal by Subject|22|||
126754632|NCT00420212|456051392|FG002|Overall Study|Withdrawal by Subject|19|||
126754633|NCT00420212|456051390|FG000|Overall Study|Physician Decision|4|||
126754634|NCT00420212|456051391|FG001|Overall Study|Physician Decision|4|||
126754635|NCT00420212|456051392|FG002|Overall Study|Physician Decision|3|||
126754636|NCT00420212|456051390|FG000|Overall Study|Protocol Violation|4|||
126754637|NCT00420212|456051391|FG001|Overall Study|Protocol Violation|4|||
126754638|NCT00420212|456051392|FG002|Overall Study|Protocol Violation|8|||
126754639|NCT00420212|456051390|FG000|Overall Study|Death|0|||
126754640|NCT00420212|456051391|FG001|Overall Study|Death|0|||
126754641|NCT00420212|456051392|FG002|Overall Study|Death|1|||
126754642|NCT00420212|456051390|FG000|Overall Study|Other-Unspecified|21|||
126754643|NCT00420212|456051391|FG001|Overall Study|Other-Unspecified|14|||
126754644|NCT00420212|456051392|FG002|Overall Study|Other-Unspecified|18|||
126754645|NCT01326910|456051393|FG000|Overall Study|Withdrawal by Subject|3|||
126754646|NCT01326910|456051394|FG001|Overall Study|Withdrawal by Subject|2|||
126754647|NCT01326910|456051393|FG000|Overall Study|Protocol Violation|1|||
126754648|NCT01326910|456051394|FG001|Overall Study|Protocol Violation|1|||
126754649|NCT02394028|456051395|FG000|Induction Phase|Adverse Event|2|||
126754650|NCT02394028|456051396|FG001|Induction Phase|Adverse Event|4|||
126754651|NCT02394028|456051397|FG002|Induction Phase|Adverse Event|1|||
126754652|NCT02394028|456051398|FG003|Induction Phase|Adverse Event|2|||
126754653|NCT02394028|456051399|FG004|Induction Phase|Adverse Event|5|||
126754654|NCT02394028|456051400|FG005|Induction Phase|Adverse Event|2|||
126754655|NCT02394028|456051401|FG006|Induction Phase|Adverse Event|0|||
126754656|NCT02394028|456051402|FG007|Induction Phase|Adverse Event|0|||
126754657|NCT02394028|456051403|FG008|Induction Phase|Adverse Event|0|||
126628735|NCT00372255|455600296|FG000|Overall Study|Withdrawn for other reasons|2|||
126628736|NCT00372255|455600297|FG001|Overall Study|Withdrawn for other reasons|1|||
126628737|NCT01215032|455600303|FG000|Overall Study|Adverse Event|3|||
126628738|NCT01215032|455600303|FG000|Overall Study|Lack of Efficacy|17|||
126628739|NCT00361842|455600308|FG000|Overall Study|Withdrawal by Subject|2|||
126628740|NCT00361842|455600309|FG001|Overall Study|Withdrawal by Subject|3|||
126628741|NCT00361842|455600308|FG000|Overall Study|Death|2|||
126628742|NCT00361842|455600309|FG001|Overall Study|Death|1|||
126628743|NCT00361842|455600308|FG000|Overall Study|Disease progression|19|||
126628744|NCT00361842|455600309|FG001|Overall Study|Disease progression|20|||
126628745|NCT00361842|455600308|FG000|Overall Study|Adverse Event|2|||
126628746|NCT00361842|455600309|FG001|Overall Study|Adverse Event|3|||
126628747|NCT00361842|455600308|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
126628748|NCT00361842|455600309|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
126628749|NCT00361842|455600308|FG000|Overall Study|Other|1|||
126628750|NCT00361842|455600309|FG001|Overall Study|Other|0|||
126628751|NCT00361842|455600308|FG000|Overall Study|Other|0|||
126628752|NCT00361842|455600309|FG001|Overall Study|Other|2|||
126628753|NCT04814992|455600310|FG000|Overall Study|Withdrawal by Subject|6|||
126628754|NCT04814992|455600311|FG001|Overall Study|Withdrawal by Subject|3|||
126628755|NCT04814992|455600310|FG000|Overall Study|Lost to Follow-up|1|||
126628756|NCT04814992|455600311|FG001|Overall Study|Lost to Follow-up|4|||
126628757|NCT01078584|455600312|FG000|Overall Study|Final Status Unknown|1073|||
126628758|NCT01078584|455600312|FG000|Overall Study|Lost to Follow-up|670|||
126628759|NCT01078584|455600312|FG000|Overall Study|Non-serious Adverse Event|577|||
126628760|NCT01078584|455600312|FG000|Overall Study|Withdrawal of Consent|244|||
126628761|NCT01078584|455600312|FG000|Overall Study|Physician Withdrew from Study|90|||
126628762|NCT01078584|455600312|FG000|Overall Study|Non-compliance|67|||
126628763|NCT01078584|455600312|FG000|Overall Study|Blood Pressure Controlled|49|||
126628764|NCT01078584|455600312|FG000|Overall Study|Physician Switched Medication|26|||
126628765|NCT01078584|455600312|FG000|Overall Study|Physician Discontinued Patient|12|||
126628766|NCT01078584|455600312|FG000|Overall Study|Lack of Efficacy|98|||
126628767|NCT01078584|455600312|FG000|Overall Study|Protocol Violation|75|||
126628768|NCT01078584|455600312|FG000|Overall Study|Serious Adverse Event|27|||
126628769|NCT01078584|455600312|FG000|Overall Study|Multiple Reasons|2|||
126628770|NCT01208870|455600315|FG000|Overall Study|Lost to Follow-up|2|||
126628771|NCT01208870|455600316|FG001|Overall Study|Lost to Follow-up|8|||
126628772|NCT01260142|455600317|FG000|Treatment Period 1|Study on hold|1|||
126628773|NCT01260142|455600318|FG001|Treatment Period 1|Study on hold|1|||
126628774|NCT01260142|455600319|FG002|Treatment Period 1|Study on hold|0|||
126628775|NCT01260142|455600320|FG003|Treatment Period 1|Study on hold|0|||
126628776|NCT01260142|455600321|FG004|Treatment Period 1|Study on hold|1|||
126628777|NCT01260142|455600322|FG005|Treatment Period 1|Study on hold|2|||
126628778|NCT01260142|455600317|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
126628779|NCT01260142|455600318|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
126628780|NCT01260142|455600319|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
126628781|NCT01260142|455600320|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
126628782|NCT01260142|455600321|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
126628783|NCT01260142|455600322|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
126628784|NCT01260142|455600317|FG000|Treatment Period 1|Withdrawal by Subject|0|||
126628785|NCT01260142|455600318|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126628786|NCT01260142|455600319|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126628787|NCT01260142|455600320|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126628788|NCT01260142|455600321|FG004|Treatment Period 1|Withdrawal by Subject|0|||
126628789|NCT01260142|455600322|FG005|Treatment Period 1|Withdrawal by Subject|1|||
126628790|NCT00424177|455600323|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
126628791|NCT00424177|455600323|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
126628792|NCT00424177|455600323|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
126628793|NCT00424177|455600323|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
126628794|NCT00424177|455600323|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
126628795|NCT00424177|455600323|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
126628796|NCT00424177|455600323|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
126628797|NCT00424177|455600323|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
126628798|NCT00424177|455600323|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
126628799|NCT00424177|455600323|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
126628800|NCT00691678|455600328|FG000|Overall Study|Adverse Event|5|||
126628801|NCT00691678|455600328|FG000|Overall Study|life events, pain|11|||
126628802|NCT00496834|455600329|FG000|Overall Study|Withdrawal by Subject|4|||
126628803|NCT00496834|455600330|FG001|Overall Study|Withdrawal by Subject|6|||
126628804|NCT00496834|455600329|FG000|Overall Study|Contraindicated medication administered|0|||
126628805|NCT00496834|455600330|FG001|Overall Study|Contraindicated medication administered|1|||
126628806|NCT00496834|455600329|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
126628807|NCT00496834|455600330|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
126783765|NCT02711956|456164347|FG010|Overall Study|Physician Decision|0|||
126628808|NCT00496834|455600329|FG000|Overall Study|Adverse Event|5|||
126783766|NCT02711956|456164348|FG011|Overall Study|Physician Decision|0|||
126783767|NCT02711956|456164349|FG012|Overall Study|Physician Decision|0|||
126783768|NCT02711956|456164350|FG013|Overall Study|Physician Decision|0|||
126783769|NCT02711956|456164351|FG014|Overall Study|Physician Decision|0|||
126783770|NCT02711956|456164337|FG000|Overall Study|Withdrawal by Subject|0|||
126783771|NCT02711956|456164338|FG001|Overall Study|Withdrawal by Subject|0|||
126783772|NCT02711956|456164339|FG002|Overall Study|Withdrawal by Subject|0|||
126783773|NCT02711956|456164340|FG003|Overall Study|Withdrawal by Subject|0|||
126783774|NCT02711956|456164341|FG004|Overall Study|Withdrawal by Subject|0|||
126783775|NCT02711956|456164342|FG005|Overall Study|Withdrawal by Subject|0|||
126783776|NCT02711956|456164343|FG006|Overall Study|Withdrawal by Subject|1|||
126783777|NCT02711956|456164344|FG007|Overall Study|Withdrawal by Subject|0|||
126783778|NCT02711956|456164345|FG008|Overall Study|Withdrawal by Subject|0|||
126783779|NCT02711956|456164346|FG009|Overall Study|Withdrawal by Subject|0|||
126783780|NCT02711956|456164347|FG010|Overall Study|Withdrawal by Subject|0|||
126628809|NCT00496834|455600330|FG001|Overall Study|Adverse Event|3|||
126628810|NCT00496834|455600329|FG000|Overall Study|IP administration violation|2|||
126628811|NCT00496834|455600330|FG001|Overall Study|IP administration violation|0|||
126628812|NCT00496834|455600329|FG000|Overall Study|Lost to Follow-up|2|||
126628813|NCT00496834|455600330|FG001|Overall Study|Lost to Follow-up|0|||
126628814|NCT00496834|455600329|FG000|Overall Study|Blood Pressure control failure|2|||
126628815|NCT00496834|455600330|FG001|Overall Study|Blood Pressure control failure|1|||
126628816|NCT01227928|455600331|FG000|Overall Study|Lost to Follow-up|4|||
126628817|NCT01227928|455600332|FG001|Overall Study|Lost to Follow-up|2|||
126628818|NCT01227928|455600331|FG000|Overall Study|Withdrawal by Subject|4|||
126628819|NCT01227928|455600332|FG001|Overall Study|Withdrawal by Subject|3|||
126628820|NCT01227928|455600331|FG000|Overall Study|Death|14|||
126628821|NCT01227928|455600332|FG001|Overall Study|Death|12|||
126783781|NCT02711956|456164348|FG011|Overall Study|Withdrawal by Subject|1|||
126783782|NCT02711956|456164349|FG012|Overall Study|Withdrawal by Subject|6|||
126783783|NCT02711956|456164350|FG013|Overall Study|Withdrawal by Subject|0|||
126783784|NCT02711956|456164351|FG014|Overall Study|Withdrawal by Subject|1|||
126783785|NCT02711956|456164337|FG000|Overall Study|Clinical progression|1|||
126783786|NCT02711956|456164338|FG001|Overall Study|Clinical progression|0|||
126783787|NCT02711956|456164339|FG002|Overall Study|Clinical progression|0|||
126783788|NCT02711956|456164340|FG003|Overall Study|Clinical progression|0|||
126783789|NCT02711956|456164341|FG004|Overall Study|Clinical progression|0|||
126783790|NCT02711956|456164342|FG005|Overall Study|Clinical progression|0|||
126783791|NCT02711956|456164343|FG006|Overall Study|Clinical progression|1|||
126783792|NCT02711956|456164344|FG007|Overall Study|Clinical progression|0|||
126783793|NCT02711956|456164345|FG008|Overall Study|Clinical progression|1|||
126783794|NCT02711956|456164346|FG009|Overall Study|Clinical progression|0|||
126783795|NCT02711956|456164347|FG010|Overall Study|Clinical progression|0|||
126783796|NCT02711956|456164348|FG011|Overall Study|Clinical progression|2|||
126783797|NCT02711956|456164349|FG012|Overall Study|Clinical progression|4|||
126783798|NCT02711956|456164350|FG013|Overall Study|Clinical progression|1|||
126783799|NCT02711956|456164351|FG014|Overall Study|Clinical progression|1|||
126783800|NCT02711956|456164337|FG000|Overall Study|Radiographic progression|1|||
126783801|NCT02711956|456164338|FG001|Overall Study|Radiographic progression|1|||
126783802|NCT02711956|456164339|FG002|Overall Study|Radiographic progression|2|||
126783803|NCT02711956|456164340|FG003|Overall Study|Radiographic progression|0|||
126783804|NCT02711956|456164341|FG004|Overall Study|Radiographic progression|1|||
126783805|NCT02711956|456164342|FG005|Overall Study|Radiographic progression|0|||
126783806|NCT02711956|456164343|FG006|Overall Study|Radiographic progression|0|||
126783807|NCT02711956|456164344|FG007|Overall Study|Radiographic progression|0|||
126783808|NCT02711956|456164345|FG008|Overall Study|Radiographic progression|2|||
126783809|NCT02711956|456164346|FG009|Overall Study|Radiographic progression|1|||
126783810|NCT02711956|456164347|FG010|Overall Study|Radiographic progression|0|||
126783811|NCT02711956|456164348|FG011|Overall Study|Radiographic progression|5|||
126783812|NCT02711956|456164349|FG012|Overall Study|Radiographic progression|3|||
126783813|NCT02711956|456164350|FG013|Overall Study|Radiographic progression|0|||
126783814|NCT02711956|456164351|FG014|Overall Study|Radiographic progression|1|||
126783815|NCT02711956|456164337|FG000|Overall Study|PSA progression with clinical progression|0|||
126783816|NCT02711956|456164338|FG001|Overall Study|PSA progression with clinical progression|0|||
126783817|NCT02711956|456164339|FG002|Overall Study|PSA progression with clinical progression|0|||
126783818|NCT02711956|456164340|FG003|Overall Study|PSA progression with clinical progression|0|||
126783819|NCT02711956|456164341|FG004|Overall Study|PSA progression with clinical progression|1|||
126783820|NCT02711956|456164342|FG005|Overall Study|PSA progression with clinical progression|0|||
126783821|NCT02711956|456164343|FG006|Overall Study|PSA progression with clinical progression|0|||
126783822|NCT02711956|456164344|FG007|Overall Study|PSA progression with clinical progression|0|||
126783823|NCT02711956|456164345|FG008|Overall Study|PSA progression with clinical progression|0|||
126783824|NCT02711956|456164346|FG009|Overall Study|PSA progression with clinical progression|0|||
126783825|NCT02711956|456164347|FG010|Overall Study|PSA progression with clinical progression|0|||
126628822|NCT01494298|455600333|FG000|Overall Study|Protocol Violation|2|||
126628823|NCT01494298|455600334|FG001|Overall Study|Protocol Violation|8|||
126628824|NCT02930837|455600335|FG000|Overall Study|Adverse Event|6|||
126628825|NCT02930837|455600335|FG000|Overall Study|Lost to Follow-up|5|||
126628826|NCT02930837|455600335|FG000|Overall Study|Withdrawal by Subject|1|||
126628827|NCT01393613|455600336|FG000|Overall Study|Adverse Event|11|||
126628828|NCT01393613|455600337|FG001|Overall Study|Adverse Event|11|||
126628829|NCT01393613|455600338|FG002|Overall Study|Adverse Event|13|||
126628830|NCT01393613|455600339|FG003|Overall Study|Adverse Event|22|||
126628831|NCT01393613|455600336|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
126628832|NCT01393613|455600337|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
126628833|NCT01393613|455600338|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
126628834|NCT01393613|455600339|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
126628835|NCT01393613|455600336|FG000|Overall Study|Physician Decision|2|||
126628836|NCT01393613|455600337|FG001|Overall Study|Physician Decision|0|||
126628837|NCT01393613|455600338|FG002|Overall Study|Physician Decision|0|||
126628838|NCT01393613|455600339|FG003|Overall Study|Physician Decision|1|||
126628839|NCT01393613|455600336|FG000|Overall Study|Withdrawal by Subject|15|||
126628840|NCT01393613|455600337|FG001|Overall Study|Withdrawal by Subject|25|||
126628841|NCT01393613|455600338|FG002|Overall Study|Withdrawal by Subject|23|||
126628842|NCT01393613|455600339|FG003|Overall Study|Withdrawal by Subject|21|||
126628843|NCT01393613|455600336|FG000|Overall Study|Protocol Deviation|2|||
126628844|NCT01393613|455600337|FG001|Overall Study|Protocol Deviation|1|||
126628845|NCT01393613|455600338|FG002|Overall Study|Protocol Deviation|0|||
126628846|NCT01393613|455600339|FG003|Overall Study|Protocol Deviation|0|||
126628847|NCT01393613|455600336|FG000|Overall Study|Lack of Efficacy|9|||
126628848|NCT01393613|455600337|FG001|Overall Study|Lack of Efficacy|20|||
126628849|NCT01393613|455600338|FG002|Overall Study|Lack of Efficacy|16|||
126628850|NCT01393613|455600339|FG003|Overall Study|Lack of Efficacy|21|||
126628851|NCT03821064|455600340|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
126628852|NCT02598934|455600349|FG000|Overall Study|Adverse Event|11|||
126628853|NCT02598934|455600350|FG001|Overall Study|Adverse Event|13|||
126628854|NCT02598934|455600349|FG000|Overall Study|Failure to Return|3|||
126628855|NCT02598934|455600350|FG001|Overall Study|Failure to Return|3|||
126628856|NCT02598934|455600349|FG000|Overall Study|Withdrawal by Subject|2|||
126628857|NCT02598934|455600350|FG001|Overall Study|Withdrawal by Subject|3|||
126628858|NCT02598934|455600349|FG000|Overall Study|Administrative|2|||
126628859|NCT02598934|455600350|FG001|Overall Study|Administrative|1|||
126628860|NCT02598934|455600349|FG000|Overall Study|Protocol Violation|1|||
126628861|NCT02598934|455600350|FG001|Overall Study|Protocol Violation|2|||
126628862|NCT03325608|455600353|FG000|Overall Study|Lost to Follow-up|23|||
126628863|NCT03325608|455600354|FG001|Overall Study|Lost to Follow-up|23|||
126628864|NCT03325608|455600355|FG002|Overall Study|Lost to Follow-up|30|||
126628865|NCT03325608|455600356|FG003|Overall Study|Lost to Follow-up|30|||
126628866|NCT03325608|455600353|FG000|Overall Study|Death of Caregiver|0|||
126628867|NCT03325608|455600354|FG001|Overall Study|Death of Caregiver|0|||
126628868|NCT03325608|455600355|FG002|Overall Study|Death of Caregiver|2|||
126628869|NCT03325608|455600356|FG003|Overall Study|Death of Caregiver|2|||
126628870|NCT03325608|455600353|FG000|Overall Study|Death of Care Recipient|34|||
126628871|NCT03325608|455600354|FG001|Overall Study|Death of Care Recipient|34|||
126628872|NCT03325608|455600355|FG002|Overall Study|Death of Care Recipient|28|||
126628873|NCT03325608|455600356|FG003|Overall Study|Death of Care Recipient|28|||
126628874|NCT03325608|455600353|FG000|Overall Study|Withdrawal by Subject|49|||
126628875|NCT03325608|455600354|FG001|Overall Study|Withdrawal by Subject|49|||
126628876|NCT03325608|455600355|FG002|Overall Study|Withdrawal by Subject|35|||
126628877|NCT03325608|455600356|FG003|Overall Study|Withdrawal by Subject|35|||
126628878|NCT03325608|455600353|FG000|Overall Study|Ineligible|7|||
126628879|NCT03325608|455600354|FG001|Overall Study|Ineligible|7|||
126628880|NCT03325608|455600355|FG002|Overall Study|Ineligible|5|||
126628881|NCT03325608|455600356|FG003|Overall Study|Ineligible|5|||
126628882|NCT02188784|455600357|FG000|Overall Study|Death|3|||
126628883|NCT02188784|455600358|FG001|Overall Study|Death|1|||
126628884|NCT02188784|455600357|FG000|Overall Study|Lost to Follow-up|1|||
126628885|NCT02188784|455600358|FG001|Overall Study|Lost to Follow-up|0|||
126628886|NCT02188784|455600357|FG000|Overall Study|Withdrawal by Subject|3|||
126628887|NCT02188784|455600358|FG001|Overall Study|Withdrawal by Subject|9|||
126628888|NCT02188784|455600357|FG000|Overall Study|Physician Decision|2|||
126628889|NCT02188784|455600358|FG001|Overall Study|Physician Decision|3|||
126628890|NCT01190449|455600361|FG000|Overall Study|Ineligible|0|||
126628891|NCT01190449|455600362|FG001|Overall Study|Ineligible|4|||
126628892|NCT04944784|455600363|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
126628893|NCT04944784|455600364|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
126628894|NCT04944784|455600365|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
126628895|NCT04944784|455600366|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
126628896|NCT04944784|455600363|FG000|Double-blind Period|Adverse Event|20|||
126628897|NCT04944784|455600364|FG001|Double-blind Period|Adverse Event|4|||
126628898|NCT04944784|455600365|FG002|Double-blind Period|Adverse Event|0|||
126628899|NCT04944784|455600366|FG003|Double-blind Period|Adverse Event|0|||
126628900|NCT04944784|455600363|FG000|Double-blind Period|Withdrawal by Subject|15|||
126783826|NCT02711956|456164348|FG011|Overall Study|PSA progression with clinical progression|0|||
126783827|NCT02711956|456164349|FG012|Overall Study|PSA progression with clinical progression|1|||
126783828|NCT02711956|456164350|FG013|Overall Study|PSA progression with clinical progression|1|||
126783829|NCT02711956|456164351|FG014|Overall Study|PSA progression with clinical progression|0|||
126783830|NCT02711956|456164337|FG000|Overall Study|PSA progression with radiographic progression|0|||
126783831|NCT02711956|456164338|FG001|Overall Study|PSA progression with radiographic progression|1|||
126783832|NCT02711956|456164339|FG002|Overall Study|PSA progression with radiographic progression|0|||
126783833|NCT02711956|456164340|FG003|Overall Study|PSA progression with radiographic progression|0|||
126783834|NCT02711956|456164341|FG004|Overall Study|PSA progression with radiographic progression|0|||
126783835|NCT02711956|456164342|FG005|Overall Study|PSA progression with radiographic progression|2|||
126783836|NCT02711956|456164343|FG006|Overall Study|PSA progression with radiographic progression|2|||
126783837|NCT02711956|456164344|FG007|Overall Study|PSA progression with radiographic progression|1|||
126783838|NCT02711956|456164345|FG008|Overall Study|PSA progression with radiographic progression|0|||
126783839|NCT02711956|456164346|FG009|Overall Study|PSA progression with radiographic progression|1|||
126783840|NCT02711956|456164347|FG010|Overall Study|PSA progression with radiographic progression|0|||
126783841|NCT02711956|456164348|FG011|Overall Study|PSA progression with radiographic progression|1|||
126783842|NCT02711956|456164349|FG012|Overall Study|PSA progression with radiographic progression|2|||
126783843|NCT02711956|456164350|FG013|Overall Study|PSA progression with radiographic progression|3|||
126783844|NCT02711956|456164351|FG014|Overall Study|PSA progression with radiographic progression|3|||
126783845|NCT03734237|456164352|FG000|Overall Study|Lost to Follow-up|1|||
126783846|NCT03734237|456164353|FG001|Overall Study|Lost to Follow-up|3|||
126783847|NCT03734237|456164354|FG002|Overall Study|Lost to Follow-up|0|||
126783848|NCT03734237|456164352|FG000|Overall Study|Withdrawal by Subject|7|||
126783849|NCT03734237|456164353|FG001|Overall Study|Withdrawal by Subject|9|||
126783850|NCT03734237|456164354|FG002|Overall Study|Withdrawal by Subject|10|||
126783851|NCT01673009|456164355|FG000|Overall Study|Physician Decision|5|||
126628901|NCT04944784|455600364|FG001|Double-blind Period|Withdrawal by Subject|4|||
126628902|NCT04944784|455600365|FG002|Double-blind Period|Withdrawal by Subject|0|||
126628903|NCT04944784|455600366|FG003|Double-blind Period|Withdrawal by Subject|0|||
126628904|NCT04944784|455600363|FG000|Double-blind Period|Death|7|||
126628905|NCT04944784|455600364|FG001|Double-blind Period|Death|2|||
126628906|NCT04944784|455600365|FG002|Double-blind Period|Death|0|||
126628907|NCT04944784|455600366|FG003|Double-blind Period|Death|0|||
126628908|NCT04944784|455600363|FG000|Double-blind Period|Physician Decision|2|||
126628909|NCT04944784|455600364|FG001|Double-blind Period|Physician Decision|1|||
126628910|NCT04944784|455600365|FG002|Double-blind Period|Physician Decision|0|||
126628911|NCT04944784|455600366|FG003|Double-blind Period|Physician Decision|0|||
126628912|NCT04944784|455600363|FG000|Double-blind Period|Lack of Efficacy|0|||
126628913|NCT04944784|455600364|FG001|Double-blind Period|Lack of Efficacy|1|||
126628914|NCT04944784|455600365|FG002|Double-blind Period|Lack of Efficacy|0|||
126628915|NCT04944784|455600366|FG003|Double-blind Period|Lack of Efficacy|0|||
126628916|NCT04944784|455600363|FG000|Double-blind Period|Sponsor Request|2|||
126628917|NCT04944784|455600364|FG001|Double-blind Period|Sponsor Request|1|||
126628918|NCT04944784|455600365|FG002|Double-blind Period|Sponsor Request|0|||
126628919|NCT04944784|455600366|FG003|Double-blind Period|Sponsor Request|0|||
126628920|NCT04944784|455600363|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
126628921|NCT04944784|455600364|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
126628922|NCT04944784|455600365|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
126628923|NCT04944784|455600366|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
126628924|NCT04944784|455600363|FG000|Double-blind Period|Participant Choice|1|||
126628925|NCT04944784|455600364|FG001|Double-blind Period|Participant Choice|1|||
126628926|NCT04944784|455600365|FG002|Double-blind Period|Participant Choice|0|||
126628927|NCT04944784|455600366|FG003|Double-blind Period|Participant Choice|0|||
126628928|NCT04944784|455600363|FG000|Double-blind Period|Progressive Disease|2|||
126628929|NCT04944784|455600364|FG001|Double-blind Period|Progressive Disease|2|||
126628930|NCT04944784|455600365|FG002|Double-blind Period|Progressive Disease|0|||
126628931|NCT04944784|455600366|FG003|Double-blind Period|Progressive Disease|0|||
126628932|NCT04944784|455600363|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
126628933|NCT04944784|455600364|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
126628934|NCT04944784|455600365|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
126628935|NCT04944784|455600366|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
126628936|NCT04944784|455600363|FG000|Active Drug Period|Adverse Event|0|||
126628937|NCT04944784|455600364|FG001|Active Drug Period|Adverse Event|0|||
126628938|NCT04944784|455600365|FG002|Active Drug Period|Adverse Event|3|||
126628939|NCT04944784|455600366|FG003|Active Drug Period|Adverse Event|6|||
126628940|NCT04944784|455600363|FG000|Active Drug Period|Withdrawal by Subject|0|||
126628941|NCT04944784|455600364|FG001|Active Drug Period|Withdrawal by Subject|0|||
126628942|NCT04944784|455600365|FG002|Active Drug Period|Withdrawal by Subject|4|||
126628943|NCT04944784|455600366|FG003|Active Drug Period|Withdrawal by Subject|7|||
126628944|NCT04944784|455600363|FG000|Active Drug Period|Death|0|||
126628945|NCT04944784|455600364|FG001|Active Drug Period|Death|0|||
126628946|NCT04944784|455600365|FG002|Active Drug Period|Death|3|||
126628947|NCT04944784|455600366|FG003|Active Drug Period|Death|4|||
126628948|NCT04944784|455600363|FG000|Active Drug Period|Lack of Efficacy|0|||
126628949|NCT04944784|455600364|FG001|Active Drug Period|Lack of Efficacy|0|||
126628950|NCT04944784|455600365|FG002|Active Drug Period|Lack of Efficacy|2|||
126628951|NCT04944784|455600366|FG003|Active Drug Period|Lack of Efficacy|2|||
126628952|NCT04944784|455600363|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
126628953|NCT04944784|455600364|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
126628954|NCT04944784|455600365|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
126628955|NCT04944784|455600366|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
126628956|NCT04944784|455600363|FG000|Active Drug Period|Participant Choice|0|||
126628957|NCT04944784|455600364|FG001|Active Drug Period|Participant Choice|0|||
126628958|NCT04944784|455600365|FG002|Active Drug Period|Participant Choice|0|||
126628959|NCT04944784|455600366|FG003|Active Drug Period|Participant Choice|1|||
126628960|NCT04944784|455600363|FG000|Active Drug Period|Progressive Disease|0|||
126628961|NCT04944784|455600364|FG001|Active Drug Period|Progressive Disease|0|||
126628962|NCT04944784|455600365|FG002|Active Drug Period|Progressive Disease|4|||
126628963|NCT04944784|455600366|FG003|Active Drug Period|Progressive Disease|4|||
126628964|NCT04944784|455600363|FG000|Active Drug Period|Lost to Follow-up|0|||
126628965|NCT04944784|455600364|FG001|Active Drug Period|Lost to Follow-up|0|||
126628966|NCT04944784|455600365|FG002|Active Drug Period|Lost to Follow-up|0|||
126628967|NCT04944784|455600366|FG003|Active Drug Period|Lost to Follow-up|1|||
126628968|NCT02210208|455602220|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
126628969|NCT02210208|455602220|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
126628970|NCT02210208|455602220|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
126628971|NCT01066936|455602221|FG000|Overall Study|Death|2|||
126628972|NCT01066936|455602221|FG000|Overall Study|Device revised/removed|1|||
126628973|NCT01066936|455602221|FG000|Overall Study|Lost to Follow-up|3|||
126628974|NCT01066936|455602221|FG000|Overall Study|Withdrawal by Subject|4|||
126628975|NCT00511836|455602224|FG000|Double-blind Period|Lost to Follow-up|1|||
126628976|NCT00511836|455602225|FG001|Double-blind Period|Lost to Follow-up|0|||
126628977|NCT04984239|455602229|FG000|Overall Study|Lost to Follow-up|1|||
126628978|NCT04190225|455602230|FG000|Overall Study|Lost to Follow-up|2|||
126628979|NCT04190225|455602231|FG001|Overall Study|Lost to Follow-up|3|||
126628980|NCT04190225|455602230|FG000|Overall Study|Withdrawal by Subject|3|||
126628981|NCT04190225|455602231|FG001|Overall Study|Withdrawal by Subject|2|||
126628982|NCT04190225|455602230|FG000|Overall Study|Unrelated health condition|2|||
126628983|NCT04190225|455602231|FG001|Overall Study|Unrelated health condition|0|||
126628984|NCT02994784|455602232|FG000|6 Months Follow-up|Lost to Follow-up|3|||
126628985|NCT02466243|455602234|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
126628986|NCT02466243|455602235|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
126628987|NCT02466243|455602234|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
126628988|NCT02466243|455602235|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
126628989|NCT02466243|455602234|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
126628990|NCT02466243|455602235|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
126628991|NCT02466243|455602234|FG000|Part B Open-label Treatment Period|Missing|2|||
126628992|NCT02466243|455602235|FG001|Part B Open-label Treatment Period|Missing|2|||
126628993|NCT00477464|455602236|FG000|Overall Study|Lost to Follow-up|1|||
126628994|NCT00477464|455602236|FG000|Overall Study|Death|36|||
126628995|NCT00477464|455602236|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
126628996|NCT00639769|455602237|FG000|Overall Study|Death|2|||
126628997|NCT00639769|455602237|FG000|Overall Study|Adverse Event|7|||
126628998|NCT00639769|455602237|FG000|Overall Study|Lack of Efficacy|1|||
126628999|NCT00639769|455602237|FG000|Overall Study|Disease progression|26|||
126629000|NCT00639769|455602237|FG000|Overall Study|Withdrawal by Subject|4|||
126629001|NCT00863798|455602238|FG000|Overall Study|Adverse Event|5|||
126629002|NCT00863798|455602239|FG001|Overall Study|Adverse Event|2|||
126629003|NCT00863798|455602240|FG002|Overall Study|Adverse Event|4|||
126629004|NCT00863798|455602238|FG000|Overall Study|Participant failed to return|2|||
126629005|NCT00863798|455602239|FG001|Overall Study|Participant failed to return|1|||
126629006|NCT00863798|455602240|FG002|Overall Study|Participant failed to return|0|||
126629007|NCT00863798|455602238|FG000|Overall Study|Investigator request|1|||
126629008|NCT00863798|455602239|FG001|Overall Study|Investigator request|2|||
126629009|NCT00863798|455602240|FG002|Overall Study|Investigator request|1|||
126629010|NCT00863798|455602238|FG000|Overall Study|Lack of Efficacy|4|||
126629011|NCT00863798|455602239|FG001|Overall Study|Lack of Efficacy|3|||
126629012|NCT00863798|455602240|FG002|Overall Study|Lack of Efficacy|6|||
126629013|NCT00863798|455602238|FG000|Overall Study|Lost to Follow-up|6|||
126629014|NCT00863798|455602239|FG001|Overall Study|Lost to Follow-up|9|||
126629015|NCT00863798|455602240|FG002|Overall Study|Lost to Follow-up|5|||
126629016|NCT00863798|455602238|FG000|Overall Study|Other|2|||
126629017|NCT00863798|455602239|FG001|Overall Study|Other|3|||
126629018|NCT00863798|455602240|FG002|Overall Study|Other|1|||
126629019|NCT00863798|455602238|FG000|Overall Study|Protocol Violation|0|||
126629020|NCT00863798|455602239|FG001|Overall Study|Protocol Violation|1|||
126629021|NCT00863798|455602240|FG002|Overall Study|Protocol Violation|1|||
126629022|NCT00863798|455602238|FG000|Overall Study|Withdrawal by Subject|8|||
126629023|NCT00863798|455602239|FG001|Overall Study|Withdrawal by Subject|7|||
126629024|NCT00863798|455602240|FG002|Overall Study|Withdrawal by Subject|4|||
126629025|NCT00863798|455602238|FG000|Overall Study|Randomized not treated|4|||
126629026|NCT00863798|455602239|FG001|Overall Study|Randomized not treated|2|||
126629027|NCT00863798|455602240|FG002|Overall Study|Randomized not treated|3|||
126629028|NCT04238520|455602241|FG000|Overall Study|Withdrawal by Subject|1|||
126629029|NCT04238520|455602242|FG001|Overall Study|Withdrawal by Subject|1|||
126629030|NCT04238520|455602241|FG000|Overall Study|Lost to Follow-up|1|||
126629031|NCT04238520|455602242|FG001|Overall Study|Lost to Follow-up|2|||
126629032|NCT04238520|455602241|FG000|Overall Study|Death|0|||
126629033|NCT04238520|455602242|FG001|Overall Study|Death|2|||
126629034|NCT04238520|455602241|FG000|Overall Study|Unsafe home environment for research staff|0|||
126629035|NCT04238520|455602242|FG001|Overall Study|Unsafe home environment for research staff|1|||
126629036|NCT01470599|455602243|FG000|Overall Study|Did not meet entrance criteria|1|||
126629037|NCT01470599|455602244|FG001|Overall Study|Did not meet entrance criteria|0|||
126629038|NCT01470599|455602243|FG000|Overall Study|Lost to Follow-up|2|||
126629039|NCT01470599|455602244|FG001|Overall Study|Lost to Follow-up|1|||
126629040|NCT01470599|455602243|FG000|Overall Study|Withdrawal by Subject|3|||
126629041|NCT01470599|455602244|FG001|Overall Study|Withdrawal by Subject|4|||
126629042|NCT01470599|455602243|FG000|Overall Study|Other|1|||
126629043|NCT01470599|455602244|FG001|Overall Study|Other|0|||
126629044|NCT01470599|455602243|FG000|Overall Study|Protocol Violation|3|||
126629045|NCT01470599|455602244|FG001|Overall Study|Protocol Violation|1|||
126629046|NCT01470599|455602243|FG000|Overall Study|Adverse event related to study drug|2|||
126629047|NCT01470599|455602244|FG001|Overall Study|Adverse event related to study drug|5|||
126629048|NCT01470599|455602243|FG000|Overall Study|Insufficient clinical response|6|||
126629049|NCT01470599|455602244|FG001|Overall Study|Insufficient clinical response|27|||
126629050|NCT01470599|455602243|FG000|Overall Study|Adverse event not related to study drug|1|||
126629051|NCT01470599|455602244|FG001|Overall Study|Adverse event not related to study drug|5|||
126629052|NCT00195442|455602245|FG000|Overall Study|Less than expected therapeutic effect|38|||
126629053|NCT00195442|455602245|FG000|Overall Study|Lost to Follow-up|27|||
126629054|NCT00195442|455602245|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
126629055|NCT00195442|455602245|FG000|Overall Study|Intermittent product shortage|21|||
126629056|NCT00195442|455602245|FG000|Overall Study|Death|7|||
126629057|NCT00195442|455602245|FG000|Overall Study|No reason specified|4|||
126629058|NCT00195442|455602245|FG000|Overall Study|Poor cooperation|2|||
126629059|NCT00195442|455602245|FG000|Overall Study|Other|14|||
126629060|NCT01917006|455602246|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
126629061|NCT01917006|455602247|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
126629062|NCT01917006|455602248|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
126629063|NCT01917006|455602249|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
126629064|NCT01917006|455602250|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
126629065|NCT01917006|455602251|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
126629066|NCT01917006|455602252|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
126629067|NCT01917006|455602253|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
126629068|NCT01917006|455602246|FG000|Randomized-treatment Period|Personal Reasons|0|||
126629069|NCT01917006|455602247|FG001|Randomized-treatment Period|Personal Reasons|0|||
126629070|NCT01917006|455602248|FG002|Randomized-treatment Period|Personal Reasons|0|||
126629071|NCT01917006|455602249|FG003|Randomized-treatment Period|Personal Reasons|0|||
126629072|NCT01917006|455602250|FG004|Randomized-treatment Period|Personal Reasons|0|||
126629073|NCT01917006|455602251|FG005|Randomized-treatment Period|Personal Reasons|1|||
126629074|NCT01917006|455602252|FG006|Randomized-treatment Period|Personal Reasons|0|||
126629075|NCT01917006|455602253|FG007|Randomized-treatment Period|Personal Reasons|0|||
126629076|NCT01917006|455602246|FG000|Randomized-treatment Period|Protocol Violation|1|||
126629077|NCT01917006|455602247|FG001|Randomized-treatment Period|Protocol Violation|0|||
126629078|NCT01917006|455602248|FG002|Randomized-treatment Period|Protocol Violation|0|||
126629079|NCT01917006|455602249|FG003|Randomized-treatment Period|Protocol Violation|0|||
126629080|NCT01917006|455602250|FG004|Randomized-treatment Period|Protocol Violation|0|||
126629081|NCT01917006|455602251|FG005|Randomized-treatment Period|Protocol Violation|0|||
126629082|NCT01917006|455602252|FG006|Randomized-treatment Period|Protocol Violation|0|||
126629083|NCT01917006|455602253|FG007|Randomized-treatment Period|Protocol Violation|0|||
126629084|NCT01917006|455602246|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126629085|NCT01917006|455602247|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126629086|NCT01917006|455602248|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126754658|NCT02394028|456051404|FG009|Induction Phase|Adverse Event|0|||
126629087|NCT01917006|455602249|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126629088|NCT01917006|455602250|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126629089|NCT01917006|455602251|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126629090|NCT01917006|455602252|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
126629091|NCT01917006|455602253|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
126629092|NCT01917006|455602246|FG000|Open-label Period|Adverse Event|0|||
126754659|NCT02394028|456051405|FG010|Induction Phase|Adverse Event|0|||
126629093|NCT01917006|455602247|FG001|Open-label Period|Adverse Event|0|||
126629094|NCT01917006|455602248|FG002|Open-label Period|Adverse Event|0|||
126629095|NCT01917006|455602249|FG003|Open-label Period|Adverse Event|0|||
126629096|NCT01917006|455602250|FG004|Open-label Period|Adverse Event|0|||
126629097|NCT01917006|455602251|FG005|Open-label Period|Adverse Event|0|||
126629098|NCT01917006|455602252|FG006|Open-label Period|Adverse Event|0|||
126629099|NCT01917006|455602253|FG007|Open-label Period|Adverse Event|1|||
126629100|NCT01917006|455602246|FG000|Open-label Period|Lost to Follow-up|0|||
126629101|NCT01917006|455602247|FG001|Open-label Period|Lost to Follow-up|0|||
126629102|NCT01917006|455602248|FG002|Open-label Period|Lost to Follow-up|0|||
126629103|NCT01917006|455602249|FG003|Open-label Period|Lost to Follow-up|0|||
126629104|NCT01917006|455602250|FG004|Open-label Period|Lost to Follow-up|0|||
126629105|NCT01917006|455602251|FG005|Open-label Period|Lost to Follow-up|0|||
126629106|NCT01917006|455602252|FG006|Open-label Period|Lost to Follow-up|0|||
126629107|NCT01917006|455602253|FG007|Open-label Period|Lost to Follow-up|1|||
126629108|NCT00847132|455602256|FG000|Overall Study|Death|1|||
126629109|NCT00847132|455602257|FG001|Overall Study|Death|1|||
126629110|NCT03357471|455602263|FG000|Overall Study|Adverse Event|1|||
126629111|NCT03357471|455602264|FG001|Overall Study|Adverse Event|0|||
126629112|NCT03357471|455602263|FG000|Overall Study|Lost to Follow-up|1|||
126629113|NCT03357471|455602264|FG001|Overall Study|Lost to Follow-up|0|||
126629114|NCT02973802|455602265|FG000|Overall Study|Lost to Follow-up|1|||
126629115|NCT02973802|455602265|FG000|Overall Study|Withdrawal by Subject|1|||
126629116|NCT00706914|455602266|FG000|Overall Study|Lack of Efficacy|0|||
126629117|NCT00706914|455602267|FG001|Overall Study|Lack of Efficacy|1|||
126629118|NCT00706914|455602268|FG002|Overall Study|Lack of Efficacy|0|||
126629119|NCT00706914|455602266|FG000|Overall Study|Lost to Follow-up|1|||
126629120|NCT00706914|455602267|FG001|Overall Study|Lost to Follow-up|0|||
126629121|NCT00706914|455602268|FG002|Overall Study|Lost to Follow-up|0|||
126629122|NCT00706914|455602266|FG000|Overall Study|Adverse Event|2|||
126629123|NCT00706914|455602267|FG001|Overall Study|Adverse Event|2|||
126629124|NCT00706914|455602268|FG002|Overall Study|Adverse Event|0|||
126629125|NCT00706914|455602266|FG000|Overall Study|Protocol Violation|3|||
126629126|NCT00706914|455602267|FG001|Overall Study|Protocol Violation|1|||
126629127|NCT00706914|455602268|FG002|Overall Study|Protocol Violation|1|||
126629128|NCT01850823|455602270|FG000|Overall Study|Early Visit Window|0|||
126629129|NCT01850823|455602271|FG001|Overall Study|Early Visit Window|1|||
126629130|NCT01850823|455602272|FG002|Overall Study|Early Visit Window|4|||
126629131|NCT01850823|455602270|FG000|Overall Study|Enrolled in Error|0|||
126629132|NCT01850823|455602271|FG001|Overall Study|Enrolled in Error|1|||
126629133|NCT01850823|455602272|FG002|Overall Study|Enrolled in Error|2|||
126629134|NCT01850823|455602270|FG000|Overall Study|Lack of Efficacy|1|||
126629135|NCT01850823|455602271|FG001|Overall Study|Lack of Efficacy|0|||
126629136|NCT01850823|455602272|FG002|Overall Study|Lack of Efficacy|0|||
126629137|NCT01850823|455602270|FG000|Overall Study|Lost to Follow-up|0|||
126629138|NCT01850823|455602271|FG001|Overall Study|Lost to Follow-up|0|||
126629139|NCT01850823|455602272|FG002|Overall Study|Lost to Follow-up|1|||
126629140|NCT01850823|455602270|FG000|Overall Study|Restricted Medication|0|||
126629141|NCT01850823|455602271|FG001|Overall Study|Restricted Medication|0|||
126629142|NCT01850823|455602272|FG002|Overall Study|Restricted Medication|2|||
126629143|NCT01850823|455602270|FG000|Overall Study|Significant worstening of SAR|0|||
126629144|NCT01850823|455602271|FG001|Overall Study|Significant worstening of SAR|1|||
126629145|NCT01850823|455602272|FG002|Overall Study|Significant worstening of SAR|0|||
126629146|NCT01850823|455602270|FG000|Overall Study|Withdrawal by Subject|2|||
126629147|NCT01850823|455602271|FG001|Overall Study|Withdrawal by Subject|0|||
126629148|NCT01850823|455602272|FG002|Overall Study|Withdrawal by Subject|1|||
126629149|NCT01751165|455602273|FG000|Overall Study|Adverse event, serious fatal|1|||
126629150|NCT01751165|455602274|FG001|Overall Study|Adverse event, serious fatal|0|||
126629151|NCT01751165|455602275|FG002|Overall Study|Adverse event, serious fatal|1|||
126629152|NCT01751165|455602273|FG000|Overall Study|Withdrawal by Subject|0|||
126754660|NCT02394028|456051395|FG000|Induction Phase|Lack of Efficacy|3|||
126629153|NCT01751165|455602274|FG001|Overall Study|Withdrawal by Subject|0|||
126629154|NCT01751165|455602275|FG002|Overall Study|Withdrawal by Subject|1|||
126629155|NCT01751165|455602273|FG000|Overall Study|Serious adverse event|0|||
126629156|NCT01751165|455602274|FG001|Overall Study|Serious adverse event|2|||
126629157|NCT01751165|455602275|FG002|Overall Study|Serious adverse event|0|||
126629158|NCT01751165|455602273|FG000|Overall Study|Lost to Follow-up|1|||
126629159|NCT01751165|455602274|FG001|Overall Study|Lost to Follow-up|1|||
126629160|NCT01751165|455602275|FG002|Overall Study|Lost to Follow-up|1|||
126629161|NCT00988533|455602278|FG000|Overall Study|Lost to Follow-up|3|||
126629162|NCT00943722|455602283|FG000|Base Study|Adverse Event|0|||
126629163|NCT00943722|455602284|FG001|Base Study|Adverse Event|0|||
126629164|NCT00943722|455602285|FG002|Base Study|Adverse Event|0|||
126629165|NCT00943722|455602286|FG003|Base Study|Adverse Event|1|||
126629166|NCT00943722|455602287|FG004|Base Study|Adverse Event|0|||
126629167|NCT00943722|455602288|FG005|Base Study|Adverse Event|0|||
126629168|NCT00943722|455602289|FG006|Base Study|Adverse Event|0|||
126629169|NCT00943722|455602283|FG000|Base Study|Lost to Follow-up|12|||
126629170|NCT00943722|455602284|FG001|Base Study|Lost to Follow-up|8|||
126629171|NCT00943722|455602285|FG002|Base Study|Lost to Follow-up|10|||
126629172|NCT00943722|455602286|FG003|Base Study|Lost to Follow-up|8|||
126629173|NCT00943722|455602287|FG004|Base Study|Lost to Follow-up|11|||
126629174|NCT00943722|455602288|FG005|Base Study|Lost to Follow-up|0|||
126629175|NCT00943722|455602289|FG006|Base Study|Lost to Follow-up|0|||
126629176|NCT00943722|455602283|FG000|Base Study|Physician Decision|1|||
126629177|NCT00943722|455602284|FG001|Base Study|Physician Decision|0|||
126629178|NCT00943722|455602285|FG002|Base Study|Physician Decision|0|||
126629179|NCT00943722|455602286|FG003|Base Study|Physician Decision|0|||
126629180|NCT00943722|455602287|FG004|Base Study|Physician Decision|1|||
126629181|NCT00943722|455602288|FG005|Base Study|Physician Decision|0|||
126629182|NCT00943722|455602289|FG006|Base Study|Physician Decision|0|||
126629183|NCT00943722|455602283|FG000|Base Study|Pregnancy|0|||
126629184|NCT00943722|455602284|FG001|Base Study|Pregnancy|0|||
126629185|NCT00943722|455602285|FG002|Base Study|Pregnancy|1|||
126629186|NCT00943722|455602286|FG003|Base Study|Pregnancy|0|||
126629187|NCT00943722|455602287|FG004|Base Study|Pregnancy|2|||
126629188|NCT00943722|455602288|FG005|Base Study|Pregnancy|0|||
126629189|NCT00943722|455602289|FG006|Base Study|Pregnancy|0|||
126629190|NCT00943722|455602283|FG000|Base Study|Protocol Violation|0|||
126629191|NCT00943722|455602284|FG001|Base Study|Protocol Violation|1|||
126629192|NCT00943722|455602285|FG002|Base Study|Protocol Violation|0|||
126629193|NCT00943722|455602286|FG003|Base Study|Protocol Violation|0|||
126629194|NCT00943722|455602287|FG004|Base Study|Protocol Violation|2|||
126629195|NCT00943722|455602288|FG005|Base Study|Protocol Violation|0|||
126629196|NCT00943722|455602289|FG006|Base Study|Protocol Violation|0|||
126629197|NCT00943722|455602283|FG000|Base Study|Withdrawal by Subject|12|||
126629198|NCT00943722|455602284|FG001|Base Study|Withdrawal by Subject|13|||
126629199|NCT00943722|455602285|FG002|Base Study|Withdrawal by Subject|2|||
126629200|NCT00943722|455602286|FG003|Base Study|Withdrawal by Subject|13|||
126629201|NCT00943722|455602287|FG004|Base Study|Withdrawal by Subject|8|||
126629202|NCT00943722|455602288|FG005|Base Study|Withdrawal by Subject|0|||
126629203|NCT00943722|455602289|FG006|Base Study|Withdrawal by Subject|0|||
126629204|NCT00943722|455602283|FG000|Base Study|Month 12 visit not completed|0|||
126629205|NCT00943722|455602284|FG001|Base Study|Month 12 visit not completed|0|||
126629206|NCT00943722|455602285|FG002|Base Study|Month 12 visit not completed|0|||
126629207|NCT00943722|455602286|FG003|Base Study|Month 12 visit not completed|0|||
126629208|NCT00943722|455602287|FG004|Base Study|Month 12 visit not completed|2|||
126629209|NCT00943722|455602288|FG005|Base Study|Month 12 visit not completed|0|||
126629210|NCT00943722|455602289|FG006|Base Study|Month 12 visit not completed|0|||
126629211|NCT00943722|455602283|FG000|First Extension Study: EXT 1|Adverse Event|0|||
126629212|NCT00943722|455602284|FG001|First Extension Study: EXT 1|Adverse Event|0|||
126629213|NCT00943722|455602285|FG002|First Extension Study: EXT 1|Adverse Event|0|||
126629214|NCT00943722|455602286|FG003|First Extension Study: EXT 1|Adverse Event|0|||
126629215|NCT00943722|455602287|FG004|First Extension Study: EXT 1|Adverse Event|0|||
126629216|NCT00943722|455602288|FG005|First Extension Study: EXT 1|Adverse Event|1|||
126629217|NCT00943722|455602289|FG006|First Extension Study: EXT 1|Adverse Event|0|||
126629218|NCT00943722|455602283|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
126629219|NCT00943722|455602284|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
126629220|NCT00943722|455602285|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
126629221|NCT00943722|455602286|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
126629222|NCT00943722|455602287|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
126629223|NCT00943722|455602288|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
126629224|NCT00943722|455602289|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
126629225|NCT00943722|455602283|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
126783852|NCT01673009|456164355|FG000|Overall Study|Withdrawal by Subject|8|||
126783853|NCT02398188|456164358|FG000|Overall Study|Adverse Event|2|||
126783854|NCT02398188|456164359|FG001|Overall Study|Adverse Event|3|||
126629226|NCT00943722|455602284|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
126783855|NCT02398188|456164358|FG000|Overall Study|Lost to Follow-up|5|||
126783856|NCT02398188|456164359|FG001|Overall Study|Lost to Follow-up|0|||
126783857|NCT02398188|456164358|FG000|Overall Study|Non-compliance|4|||
126629227|NCT00943722|455602285|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
126629228|NCT00943722|455602286|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
126629229|NCT00943722|455602287|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
126629230|NCT00943722|455602288|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
126629231|NCT00943722|455602289|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
126629232|NCT00943722|455602283|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
126629233|NCT00943722|455602284|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
126783858|NCT02398188|456164359|FG001|Overall Study|Non-compliance|4|||
126629234|NCT00943722|455602285|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
126629235|NCT00943722|455602286|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
126629236|NCT00943722|455602287|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
126629237|NCT00943722|455602288|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
126629238|NCT00943722|455602289|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
126783859|NCT02398188|456164358|FG000|Overall Study|Protocol Violation|6|||
126629239|NCT00943722|455602283|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
126629240|NCT00943722|455602284|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
126629241|NCT00943722|455602285|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
126629242|NCT00943722|455602286|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
126629243|NCT00943722|455602287|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
126629244|NCT00943722|455602288|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
126629245|NCT00943722|455602289|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
126629246|NCT00943722|455602283|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
126629247|NCT00943722|455602284|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
126629248|NCT00943722|455602285|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
126629249|NCT00943722|455602286|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
126629250|NCT00943722|455602287|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
126629251|NCT00943722|455602288|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
126629252|NCT00943722|455602289|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
126629253|NCT00943722|455602283|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
126629254|NCT00943722|455602284|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
126629255|NCT00943722|455602285|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
126629256|NCT00943722|455602286|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
126629257|NCT00943722|455602287|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
126629258|NCT00943722|455602288|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
126629259|NCT00943722|455602289|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
126629260|NCT00943722|455602283|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
126629261|NCT00943722|455602284|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
126629262|NCT00943722|455602285|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
126629263|NCT00943722|455602286|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
126629264|NCT00943722|455602287|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
126629265|NCT00943722|455602288|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
126629266|NCT00943722|455602289|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
126629267|NCT00943722|455602283|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
126754661|NCT02394028|456051396|FG001|Induction Phase|Lack of Efficacy|6|||
126754662|NCT02394028|456051397|FG002|Induction Phase|Lack of Efficacy|2|||
126754663|NCT02394028|456051398|FG003|Induction Phase|Lack of Efficacy|17|||
126754664|NCT02394028|456051399|FG004|Induction Phase|Lack of Efficacy|14|||
126754665|NCT02394028|456051400|FG005|Induction Phase|Lack of Efficacy|8|||
126754666|NCT02394028|456051401|FG006|Induction Phase|Lack of Efficacy|17|||
126754667|NCT02394028|456051402|FG007|Induction Phase|Lack of Efficacy|23|||
126754668|NCT02394028|456051403|FG008|Induction Phase|Lack of Efficacy|0|||
126754669|NCT02394028|456051404|FG009|Induction Phase|Lack of Efficacy|0|||
126754670|NCT02394028|456051405|FG010|Induction Phase|Lack of Efficacy|0|||
126754671|NCT02394028|456051395|FG000|Induction Phase|Lost to Follow-up|1|||
126754672|NCT02394028|456051396|FG001|Induction Phase|Lost to Follow-up|0|||
126754673|NCT02394028|456051397|FG002|Induction Phase|Lost to Follow-up|0|||
126754674|NCT02394028|456051398|FG003|Induction Phase|Lost to Follow-up|1|||
126754675|NCT02394028|456051399|FG004|Induction Phase|Lost to Follow-up|0|||
126754676|NCT02394028|456051400|FG005|Induction Phase|Lost to Follow-up|0|||
126754677|NCT02394028|456051401|FG006|Induction Phase|Lost to Follow-up|1|||
126754678|NCT02394028|456051402|FG007|Induction Phase|Lost to Follow-up|0|||
126754679|NCT02394028|456051403|FG008|Induction Phase|Lost to Follow-up|0|||
126754680|NCT02394028|456051404|FG009|Induction Phase|Lost to Follow-up|0|||
126754681|NCT02394028|456051405|FG010|Induction Phase|Lost to Follow-up|0|||
126754682|NCT02394028|456051395|FG000|Induction Phase|Non-compliance|0|||
126754683|NCT02394028|456051396|FG001|Induction Phase|Non-compliance|1|||
126754684|NCT02394028|456051397|FG002|Induction Phase|Non-compliance|3|||
126754685|NCT02394028|456051398|FG003|Induction Phase|Non-compliance|1|||
126754686|NCT02394028|456051399|FG004|Induction Phase|Non-compliance|3|||
126754687|NCT02394028|456051400|FG005|Induction Phase|Non-compliance|0|||
126754688|NCT02394028|456051401|FG006|Induction Phase|Non-compliance|1|||
126754689|NCT02394028|456051402|FG007|Induction Phase|Non-compliance|1|||
126754690|NCT02394028|456051403|FG008|Induction Phase|Non-compliance|0|||
126754691|NCT02394028|456051404|FG009|Induction Phase|Non-compliance|0|||
126754692|NCT02394028|456051405|FG010|Induction Phase|Non-compliance|0|||
126754693|NCT02394028|456051395|FG000|Induction Phase|Physician Decision|0|||
126754694|NCT02394028|456051396|FG001|Induction Phase|Physician Decision|0|||
126754695|NCT02394028|456051397|FG002|Induction Phase|Physician Decision|1|||
126754696|NCT02394028|456051398|FG003|Induction Phase|Physician Decision|4|||
126754697|NCT02394028|456051399|FG004|Induction Phase|Physician Decision|0|||
126629268|NCT00943722|455602284|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
126754698|NCT02394028|456051400|FG005|Induction Phase|Physician Decision|2|||
126754699|NCT02394028|456051401|FG006|Induction Phase|Physician Decision|1|||
126629269|NCT00943722|455602285|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
126629270|NCT00943722|455602286|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
126629271|NCT00943722|455602287|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
126754700|NCT02394028|456051402|FG007|Induction Phase|Physician Decision|0|||
126754701|NCT02394028|456051403|FG008|Induction Phase|Physician Decision|0|||
126754702|NCT02394028|456051404|FG009|Induction Phase|Physician Decision|0|||
126629272|NCT00943722|455602288|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
126629273|NCT00943722|455602289|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
126629274|NCT01036165|455602290|FG000|Overall Study|Adverse Event|6|||
126629275|NCT01036165|455602290|FG000|Overall Study|Lost to Follow-up|2|||
126629276|NCT01036165|455602290|FG000|Overall Study|Withdrawal by Subject|3|||
126629277|NCT01036165|455602290|FG000|Overall Study|Device Related Issues|3|||
126629278|NCT01036165|455602290|FG000|Overall Study|Problems finding proper area to inject|1|||
126629279|NCT00913523|455602296|FG000|Overall Study|Withdrawal by Subject|3|||
126629280|NCT00913523|455602297|FG001|Overall Study|Withdrawal by Subject|2|||
126629281|NCT00913523|455602298|FG002|Overall Study|Withdrawal by Subject|2|||
126629282|NCT00913523|455602296|FG000|Overall Study|Lost to Follow-up|1|||
126629283|NCT00913523|455602297|FG001|Overall Study|Lost to Follow-up|1|||
126629284|NCT00913523|455602298|FG002|Overall Study|Lost to Follow-up|1|||
126629285|NCT00913523|455602296|FG000|Overall Study|Adverse Event|1|||
126629286|NCT00913523|455602297|FG001|Overall Study|Adverse Event|0|||
126629287|NCT00913523|455602298|FG002|Overall Study|Adverse Event|0|||
126629288|NCT00913523|455602296|FG000|Overall Study|Protocol Violation|5|||
126629289|NCT00913523|455602297|FG001|Overall Study|Protocol Violation|8|||
126629290|NCT00913523|455602298|FG002|Overall Study|Protocol Violation|8|||
126629291|NCT00913523|455602296|FG000|Overall Study|Pregnancy|1|||
126629292|NCT00913523|455602297|FG001|Overall Study|Pregnancy|3|||
126629293|NCT00913523|455602298|FG002|Overall Study|Pregnancy|0|||
126629294|NCT00913523|455602296|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
126629295|NCT00913523|455602297|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
126629296|NCT00913523|455602298|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
126629297|NCT02895360|455602299|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
126629298|NCT02895360|455602300|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
126629299|NCT02895360|455602301|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
126629300|NCT02895360|455602302|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
126629301|NCT02895360|455602303|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
126629302|NCT02895360|455602304|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
126629303|NCT02895360|455602299|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
126629304|NCT02895360|455602300|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
126629305|NCT02895360|455602301|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
126629306|NCT02895360|455602302|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
126629307|NCT02895360|455602303|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
126629308|NCT02895360|455602304|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
126629309|NCT02895360|455602299|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
126629310|NCT02895360|455602300|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
126629311|NCT02895360|455602301|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
126629312|NCT02895360|455602302|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
126629313|NCT02895360|455602303|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
126629314|NCT02895360|455602304|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
126629315|NCT02895360|455602299|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
126629316|NCT02895360|455602300|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
126629317|NCT02895360|455602301|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
126629318|NCT02895360|455602302|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
126629319|NCT02895360|455602303|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
126629320|NCT02895360|455602304|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
126629321|NCT02895360|455602299|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
126629322|NCT02895360|455602300|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
126629323|NCT02895360|455602301|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
126629324|NCT02895360|455602302|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
126629325|NCT02895360|455602303|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
126629326|NCT02895360|455602304|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
126629327|NCT02895360|455602299|FG000|Phase 2a|Adverse Event|0|||
126629328|NCT02895360|455602300|FG001|Phase 2a|Adverse Event|0|||
126629329|NCT02895360|455602301|FG002|Phase 2a|Adverse Event|0|||
126629330|NCT02895360|455602302|FG003|Phase 2a|Adverse Event|0|||
126629331|NCT02895360|455602303|FG004|Phase 2a|Adverse Event|0|||
126629332|NCT02895360|455602304|FG005|Phase 2a|Adverse Event|1|||
126629333|NCT02895360|455602299|FG000|Phase 2a|Progressive disease|0|||
126754703|NCT02394028|456051405|FG010|Induction Phase|Physician Decision|0|||
126754704|NCT02394028|456051395|FG000|Induction Phase|Protocol Violation|0|||
126754705|NCT02394028|456051396|FG001|Induction Phase|Protocol Violation|2|||
126754706|NCT02394028|456051397|FG002|Induction Phase|Protocol Violation|0|||
126754707|NCT02394028|456051398|FG003|Induction Phase|Protocol Violation|3|||
126754708|NCT02394028|456051399|FG004|Induction Phase|Protocol Violation|0|||
126754709|NCT02394028|456051400|FG005|Induction Phase|Protocol Violation|1|||
126754710|NCT02394028|456051401|FG006|Induction Phase|Protocol Violation|1|||
126754711|NCT02394028|456051402|FG007|Induction Phase|Protocol Violation|0|||
126629334|NCT02895360|455602300|FG001|Phase 2a|Progressive disease|0|||
126629335|NCT02895360|455602301|FG002|Phase 2a|Progressive disease|0|||
126629336|NCT02895360|455602302|FG003|Phase 2a|Progressive disease|0|||
126629337|NCT02895360|455602303|FG004|Phase 2a|Progressive disease|11|||
126754712|NCT02394028|456051403|FG008|Induction Phase|Protocol Violation|0|||
126754713|NCT02394028|456051404|FG009|Induction Phase|Protocol Violation|0|||
126754714|NCT02394028|456051405|FG010|Induction Phase|Protocol Violation|0|||
126754715|NCT02394028|456051395|FG000|Induction Phase|Withdrawal by Subject|1|||
126754716|NCT02394028|456051396|FG001|Induction Phase|Withdrawal by Subject|2|||
126754717|NCT02394028|456051397|FG002|Induction Phase|Withdrawal by Subject|4|||
126754718|NCT02394028|456051398|FG003|Induction Phase|Withdrawal by Subject|6|||
126754719|NCT02394028|456051399|FG004|Induction Phase|Withdrawal by Subject|7|||
126754720|NCT02394028|456051400|FG005|Induction Phase|Withdrawal by Subject|4|||
126754721|NCT02394028|456051401|FG006|Induction Phase|Withdrawal by Subject|3|||
126754722|NCT02394028|456051402|FG007|Induction Phase|Withdrawal by Subject|6|||
126754723|NCT02394028|456051403|FG008|Induction Phase|Withdrawal by Subject|0|||
126754724|NCT02394028|456051404|FG009|Induction Phase|Withdrawal by Subject|0|||
126754725|NCT02394028|456051405|FG010|Induction Phase|Withdrawal by Subject|0|||
126754726|NCT02394028|456051395|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
126754727|NCT02394028|456051396|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
126754728|NCT02394028|456051397|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
126754729|NCT02394028|456051398|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
126754730|NCT02394028|456051399|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
126754731|NCT02394028|456051400|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
126754732|NCT02394028|456051401|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
126754733|NCT02394028|456051402|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
126783860|NCT02398188|456164359|FG001|Overall Study|Protocol Violation|10|||
126783861|NCT02398188|456164358|FG000|Overall Study|Sponsor Decision|2|||
126783862|NCT02398188|456164359|FG001|Overall Study|Sponsor Decision|1|||
126783863|NCT02398188|456164358|FG000|Overall Study|Pregnancy|1|||
126783864|NCT02398188|456164359|FG001|Overall Study|Pregnancy|0|||
126783865|NCT02398188|456164358|FG000|Overall Study|Withdrawal by Subject|7|||
126783866|NCT02398188|456164359|FG001|Overall Study|Withdrawal by Subject|16|||
126783867|NCT00782509|456164360|FG000|Overall Study|Adverse Event|20|||
126783868|NCT00782509|456164361|FG001|Overall Study|Adverse Event|10|||
126783869|NCT00782509|456164362|FG002|Overall Study|Adverse Event|20|||
126783870|NCT00782509|456164360|FG000|Overall Study|Lost to Follow-up|1|||
126783871|NCT00782509|456164361|FG001|Overall Study|Lost to Follow-up|2|||
126783872|NCT00782509|456164362|FG002|Overall Study|Lost to Follow-up|3|||
126783873|NCT00782509|456164360|FG000|Overall Study|Withdrawal by Subject|3|||
126783874|NCT00782509|456164361|FG001|Overall Study|Withdrawal by Subject|5|||
126783875|NCT00782509|456164362|FG002|Overall Study|Withdrawal by Subject|8|||
126783876|NCT00782509|456164360|FG000|Overall Study|Non compliance with protocol|2|||
126783877|NCT00782509|456164361|FG001|Overall Study|Non compliance with protocol|0|||
126783878|NCT00782509|456164362|FG002|Overall Study|Non compliance with protocol|0|||
126783879|NCT00782509|456164360|FG000|Overall Study|Other reasons not stated above|5|||
126783880|NCT00782509|456164361|FG001|Overall Study|Other reasons not stated above|2|||
126783881|NCT00782509|456164362|FG002|Overall Study|Other reasons not stated above|3|||
126783882|NCT00782509|456164360|FG000|Overall Study|Lack of Efficacy|10|||
126783883|NCT00782509|456164361|FG001|Overall Study|Lack of Efficacy|5|||
126783884|NCT00782509|456164362|FG002|Overall Study|Lack of Efficacy|2|||
126783885|NCT04041570|456164367|FG000|Overall Study|Moved from Area|0|||
126783886|NCT04041570|456164368|FG001|Overall Study|Moved from Area|2|||
126783887|NCT00384033|456164371|FG000|Overall Study|Adverse Event|10|||
126783888|NCT00384033|456164372|FG001|Overall Study|Adverse Event|8|||
126783889|NCT00384033|456164373|FG002|Overall Study|Adverse Event|11|||
126783890|NCT00384033|456164374|FG003|Overall Study|Adverse Event|20|||
126783891|NCT00384033|456164371|FG000|Overall Study|Failed to return|1|||
126783892|NCT00384033|456164372|FG001|Overall Study|Failed to return|3|||
126783893|NCT00384033|456164373|FG002|Overall Study|Failed to return|2|||
126783894|NCT00384033|456164374|FG003|Overall Study|Failed to return|2|||
126783895|NCT00384033|456164371|FG000|Overall Study|Physician Decision|1|||
126783896|NCT00384033|456164372|FG001|Overall Study|Physician Decision|0|||
126783897|NCT00384033|456164373|FG002|Overall Study|Physician Decision|0|||
126783898|NCT00384033|456164374|FG003|Overall Study|Physician Decision|0|||
126783899|NCT00384033|456164371|FG000|Overall Study|Lost to Follow-up|6|||
126783900|NCT00384033|456164372|FG001|Overall Study|Lost to Follow-up|12|||
126783901|NCT00384033|456164373|FG002|Overall Study|Lost to Follow-up|7|||
126754734|NCT02394028|456051403|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
126783902|NCT00384033|456164374|FG003|Overall Study|Lost to Follow-up|7|||
126783903|NCT00384033|456164371|FG000|Overall Study|Other|2|||
126783904|NCT00384033|456164372|FG001|Overall Study|Other|0|||
126783905|NCT00384033|456164373|FG002|Overall Study|Other|0|||
126783906|NCT00384033|456164374|FG003|Overall Study|Other|0|||
126783907|NCT00384033|456164371|FG000|Overall Study|Protocol Violation|5|||
126783908|NCT00384033|456164372|FG001|Overall Study|Protocol Violation|0|||
126783909|NCT00384033|456164373|FG002|Overall Study|Protocol Violation|5|||
126783910|NCT00384033|456164374|FG003|Overall Study|Protocol Violation|6|||
126783911|NCT00384033|456164371|FG000|Overall Study|Withdrawal by Subject|6|||
126783912|NCT00384033|456164372|FG001|Overall Study|Withdrawal by Subject|2|||
126783913|NCT00384033|456164373|FG002|Overall Study|Withdrawal by Subject|5|||
126783914|NCT00384033|456164374|FG003|Overall Study|Withdrawal by Subject|2|||
126783915|NCT00384033|456164371|FG000|Overall Study|Lack of Efficacy|7|||
126783916|NCT00384033|456164372|FG001|Overall Study|Lack of Efficacy|3|||
126783917|NCT00384033|456164373|FG002|Overall Study|Lack of Efficacy|3|||
126783918|NCT00384033|456164374|FG003|Overall Study|Lack of Efficacy|1|||
126783919|NCT00384033|456164371|FG000|Overall Study|Randomized but not treated|3|||
126783920|NCT00384033|456164372|FG001|Overall Study|Randomized but not treated|7|||
126783921|NCT00384033|456164373|FG002|Overall Study|Randomized but not treated|10|||
126783922|NCT00384033|456164374|FG003|Overall Study|Randomized but not treated|2|||
126783923|NCT03349333|456164375|FG000|Overall Study|Progression of Disease|36|||
126783924|NCT03349333|456164375|FG000|Overall Study|Adverse Event|11|||
126783925|NCT03349333|456164375|FG000|Overall Study|Other|6|||
126783926|NCT03349333|456164375|FG000|Overall Study|Withdrawal by Subject|5|||
126783927|NCT03349333|456164375|FG000|Overall Study|Conditions interfere with participation|2|||
126783928|NCT03349333|456164375|FG000|Overall Study|Physician Decision|2|||
126783929|NCT03349333|456164375|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
126783930|NCT03349333|456164375|FG000|Overall Study|Patients in treatment less than 24 month|8|||
126783931|NCT00290745|456164376|FG000|Overall Study|Withdrawal by Subject|4|||
126783932|NCT00290745|456164376|FG000|Overall Study|Physician Decision|2|||
126783933|NCT00290745|456164376|FG000|Overall Study|Surgery after 3 months for progression|3|||
126783934|NCT00290745|456164376|FG000|Overall Study|Baseline MRI not available|3|||
126783935|NCT02750306|456164377|FG000|Overall Study|Withdrawal by Subject|5|||
126783936|NCT02750306|456164378|FG001|Overall Study|Withdrawal by Subject|2|||
126783937|NCT02750306|456164377|FG000|Overall Study|Protocol Violation|1|||
126783938|NCT02750306|456164378|FG001|Overall Study|Protocol Violation|0|||
126783939|NCT02737306|456164379|FG000|Overall Study|Adverse Event|3|||
126783940|NCT02737306|456164380|FG001|Overall Study|Adverse Event|0|||
126783941|NCT02737306|456164379|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
126783942|NCT02737306|456164380|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
126783943|NCT03937466|456164381|FG000|Overall Study|not eligbile after the 2-week diary|9|||
126783944|NCT03937466|456164381|FG000|Overall Study|never returned their diary|6|||
126783945|NCT03937466|456164381|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
126783946|NCT03937466|456164381|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
126783947|NCT00622908|456164382|FG000|Overall Study|Protocol Violation|1|||
126783948|NCT00622908|456164383|FG001|Overall Study|Protocol Violation|0|||
126629338|NCT02895360|455602304|FG005|Phase 2a|Progressive disease|11|||
126629339|NCT00916305|455602305|FG000|Overall Study|Lost to Follow-up|21|||
126629340|NCT00916305|455602306|FG001|Overall Study|Lost to Follow-up|27|||
126629341|NCT00916305|455602305|FG000|Overall Study|Withdrawal by Subject|0|||
126629342|NCT00916305|455602306|FG001|Overall Study|Withdrawal by Subject|1|||
126629343|NCT01844726|455602307|FG000|Overall Study|Withdrawal by Subject|0|||
126629344|NCT01844726|455602308|FG001|Overall Study|Withdrawal by Subject|1|||
126629345|NCT01844726|455602307|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
126629346|NCT01844726|455602308|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
126629347|NCT00307164|455602311|FG000|Overall Study|Death|1|||
126629348|NCT00307164|455602312|FG001|Overall Study|Death|0|||
126629349|NCT00307164|455602311|FG000|Overall Study|Severe debilitation, unable to continue|1|||
126629350|NCT00307164|455602312|FG001|Overall Study|Severe debilitation, unable to continue|0|||
126629351|NCT00307164|455602311|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
126629352|NCT00307164|455602312|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
126629353|NCT00307164|455602311|FG000|Overall Study|Withdrawal by Subject|1|||
126629354|NCT00307164|455602312|FG001|Overall Study|Withdrawal by Subject|8|||
126629355|NCT00307164|455602311|FG000|Overall Study|Not compliant with requirements|4|||
126629356|NCT00307164|455602312|FG001|Overall Study|Not compliant with requirements|4|||
126629357|NCT00307164|455602311|FG000|Overall Study|Lost to Follow-up|6|||
126629358|NCT00307164|455602312|FG001|Overall Study|Lost to Follow-up|1|||
126629359|NCT04191148|455602318|FG000|Overall Study|Withdrawal by Subject|1|||
126629360|NCT04191148|455602319|FG001|Overall Study|Withdrawal by Subject|0|||
126629361|NCT04191148|455602318|FG000|Overall Study|Adverse Event|1|||
126629362|NCT04191148|455602319|FG001|Overall Study|Adverse Event|0|||
126783949|NCT00622908|456164382|FG000|Overall Study|Adverse Event|0|||
126783950|NCT00622908|456164383|FG001|Overall Study|Adverse Event|1|||
126629363|NCT01274559|455602322|FG000|Overall Study|Adverse Event|57|||
126629364|NCT01274559|455602323|FG001|Overall Study|Adverse Event|13|||
126629365|NCT01274559|455602322|FG000|Overall Study|Death|1|||
126783951|NCT00622908|456164382|FG000|Overall Study|Lack of Efficacy|1|||
126783952|NCT00622908|456164383|FG001|Overall Study|Lack of Efficacy|7|||
126783953|NCT00622908|456164382|FG000|Overall Study|Lost to Follow-up|1|||
126629366|NCT01274559|455602323|FG001|Overall Study|Death|1|||
126629367|NCT01274559|455602322|FG000|Overall Study|Lost to Follow-up|3|||
126629368|NCT01274559|455602323|FG001|Overall Study|Lost to Follow-up|3|||
126629369|NCT01274559|455602322|FG000|Overall Study|Non-compliance with Study Drug|2|||
126783954|NCT00622908|456164383|FG001|Overall Study|Lost to Follow-up|0|||
126783955|NCT00622908|456164382|FG000|Overall Study|Refusal|0|||
126783956|NCT00622908|456164383|FG001|Overall Study|Refusal|1|||
126783957|NCT00622908|456164382|FG000|Overall Study|Termination by study sponser|0|||
126783958|NCT00622908|456164383|FG001|Overall Study|Termination by study sponser|1|||
126783959|NCT00113490|456164384|FG000|Overall Study|Withdrawal by Subject|1|||
126783960|NCT00113490|456164385|FG001|Overall Study|Withdrawal by Subject|3|||
126783961|NCT00113490|456164384|FG000|Overall Study|Lost to Follow-up|1|||
126783962|NCT00113490|456164385|FG001|Overall Study|Lost to Follow-up|0|||
126783963|NCT02162758|456164386|FG000|Overall Study|Study termination|0|||
126783964|NCT02162758|456164387|FG001|Overall Study|Study termination|1|||
126783965|NCT04471935|456164388|FG000|Overall Study|Withdrawal by Subject|1|||
126783966|NCT04471935|456164388|FG000|Overall Study|Deemed ineligible to participate|1|||
126783967|NCT03213210|456164391|FG000|Overall Study|Lost to Follow-up|2|||
126783968|NCT03213210|456164391|FG000|Overall Study|Study termination|3|||
126783969|NCT00708422|456164399|FG000|Overall Study|Adverse Event|3|||
126783970|NCT00708422|456164400|FG001|Overall Study|Adverse Event|1|||
126783971|NCT00708422|456164399|FG000|Overall Study|Withdrawal by Subject|1|||
126783972|NCT00708422|456164400|FG001|Overall Study|Withdrawal by Subject|0|||
126783973|NCT00299156|456164403|FG000|Period 2 (Randomized)|Screen Failure|0|||
126783974|NCT00299156|456164404|FG001|Period 2 (Randomized)|Screen Failure|1|||
126783975|NCT00299156|456164405|FG002|Period 2 (Randomized)|Screen Failure|0|||
126783976|NCT01166568|456164419|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
126783977|NCT01166568|456164420|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
126783978|NCT01166568|456164421|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
126783979|NCT01166568|456164419|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
126783980|NCT01166568|456164420|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
126783981|NCT01166568|456164421|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
126783982|NCT01166568|456164419|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
126783983|NCT01166568|456164420|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
126783984|NCT01166568|456164421|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
126783985|NCT01654380|456164422|FG000|Part B, Period 1|Physician Decision|0|||
126783986|NCT01654380|456164423|FG001|Part B, Period 1|Physician Decision|0|||
126783987|NCT01654380|456164424|FG002|Part B, Period 1|Physician Decision|1|||
126783988|NCT01654380|456164425|FG003|Part B, Period 1|Physician Decision|0|||
126783989|NCT00684671|456164426|FG000|Overall Study|Adverse Event|1|||
126783990|NCT00684671|456164427|FG001|Overall Study|Adverse Event|0|||
126783991|NCT00684671|456164428|FG002|Overall Study|Adverse Event|0|||
126783992|NCT00684671|456164426|FG000|Overall Study|Lost to Follow-up|1|||
126783993|NCT00684671|456164427|FG001|Overall Study|Lost to Follow-up|0|||
126783994|NCT00684671|456164428|FG002|Overall Study|Lost to Follow-up|0|||
126783995|NCT00684671|456164426|FG000|Overall Study|Alcoholic dependance|1|||
126783996|NCT00684671|456164427|FG001|Overall Study|Alcoholic dependance|0|||
126783997|NCT00684671|456164428|FG002|Overall Study|Alcoholic dependance|0|||
126783998|NCT03335371|456164429|FG000|Overall Study|Lost to Follow-up|0|||
126783999|NCT03335371|456164430|FG001|Overall Study|Lost to Follow-up|0|||
126784000|NCT03335371|456164431|FG002|Overall Study|Lost to Follow-up|0|||
126784001|NCT03335371|456164432|FG003|Overall Study|Lost to Follow-up|0|||
126784002|NCT03335371|456164433|FG004|Overall Study|Lost to Follow-up|1|||
126784003|NCT03335371|456164429|FG000|Overall Study|Withdrawal by Subject|0|||
126784004|NCT03335371|456164430|FG001|Overall Study|Withdrawal by Subject|0|||
126784005|NCT03335371|456164431|FG002|Overall Study|Withdrawal by Subject|0|||
126784006|NCT03335371|456164432|FG003|Overall Study|Withdrawal by Subject|0|||
126784007|NCT03335371|456164433|FG004|Overall Study|Withdrawal by Subject|1|||
126784008|NCT03335371|456164429|FG000|Overall Study|Randomization Error|0|||
126784009|NCT03335371|456164430|FG001|Overall Study|Randomization Error|0|||
126784010|NCT03335371|456164431|FG002|Overall Study|Randomization Error|1|||
126784011|NCT03335371|456164432|FG003|Overall Study|Randomization Error|0|||
126784012|NCT03335371|456164433|FG004|Overall Study|Randomization Error|0|||
126784013|NCT01725451|456164435|FG000|Period 1|Withdrawal by Subject|1|||
126784014|NCT01725451|456164436|FG001|Period 1|Withdrawal by Subject|0|||
126784015|NCT01725451|456164437|FG002|Period 1|Withdrawal by Subject|0|||
126784016|NCT01725451|456164438|FG003|Period 1|Withdrawal by Subject|0|||
126784017|NCT01725451|456164435|FG000|Washout From Period 3|Protocol Violation|0|||
126784018|NCT01725451|456164436|FG001|Washout From Period 3|Protocol Violation|0|||
126784019|NCT01725451|456164437|FG002|Washout From Period 3|Protocol Violation|1|||
126784020|NCT01725451|456164438|FG003|Washout From Period 3|Protocol Violation|0|||
126784021|NCT01725451|456164435|FG000|Washout From Period 3|Adverse Event|0|||
126784022|NCT01725451|456164436|FG001|Washout From Period 3|Adverse Event|1|||
126784023|NCT01725451|456164437|FG002|Washout From Period 3|Adverse Event|0|||
126784024|NCT01725451|456164438|FG003|Washout From Period 3|Adverse Event|0|||
126784025|NCT01725451|456164435|FG000|Period 4|Adverse Event|0|||
126784026|NCT01725451|456164436|FG001|Period 4|Adverse Event|0|||
126784027|NCT01725451|456164437|FG002|Period 4|Adverse Event|1|||
126784028|NCT01725451|456164438|FG003|Period 4|Adverse Event|0|||
126784029|NCT00437281|456164439|FG000|Overall Study|Adverse Event|0|||
126784030|NCT00437281|456164440|FG001|Overall Study|Adverse Event|0|||
126784031|NCT00437281|456164441|FG002|Overall Study|Adverse Event|0|||
126784032|NCT00437281|456164442|FG003|Overall Study|Adverse Event|1|||
126784033|NCT00437281|456164443|FG004|Overall Study|Adverse Event|0|||
126784034|NCT00437281|456164444|FG005|Overall Study|Adverse Event|1|||
126784035|NCT00437281|456164445|FG006|Overall Study|Adverse Event|0|||
126784036|NCT00437281|456164446|FG007|Overall Study|Adverse Event|0|||
126784037|NCT00437281|456164447|FG008|Overall Study|Adverse Event|0|||
126784038|NCT00437281|456164448|FG009|Overall Study|Adverse Event|1|||
126784039|NCT00437281|456164449|FG010|Overall Study|Adverse Event|0|||
126784040|NCT00437281|456164450|FG011|Overall Study|Adverse Event|0|||
126784041|NCT00437281|456164451|FG012|Overall Study|Adverse Event|0|||
126784042|NCT00437281|456164452|FG013|Overall Study|Adverse Event|1|||
126754735|NCT02394028|456051404|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
126784043|NCT00437281|456164453|FG014|Overall Study|Adverse Event|1|||
126784044|NCT00437281|456164454|FG015|Overall Study|Adverse Event|0|||
126784045|NCT00437281|456164455|FG016|Overall Study|Adverse Event|0|||
126784046|NCT00437281|456164456|FG017|Overall Study|Adverse Event|0|||
126784047|NCT00437281|456164457|FG018|Overall Study|Adverse Event|1|||
126784048|NCT00437281|456164458|FG019|Overall Study|Adverse Event|0|||
126784049|NCT00437281|456164439|FG000|Overall Study|Lost to Follow-up|0|||
126784050|NCT00437281|456164440|FG001|Overall Study|Lost to Follow-up|0|||
126784051|NCT00437281|456164441|FG002|Overall Study|Lost to Follow-up|0|||
126784052|NCT00437281|456164442|FG003|Overall Study|Lost to Follow-up|0|||
126784053|NCT00437281|456164443|FG004|Overall Study|Lost to Follow-up|0|||
126784054|NCT00437281|456164444|FG005|Overall Study|Lost to Follow-up|0|||
126784055|NCT00437281|456164445|FG006|Overall Study|Lost to Follow-up|0|||
126784056|NCT00437281|456164446|FG007|Overall Study|Lost to Follow-up|0|||
126784057|NCT00437281|456164447|FG008|Overall Study|Lost to Follow-up|0|||
126784058|NCT00437281|456164448|FG009|Overall Study|Lost to Follow-up|0|||
126784059|NCT00437281|456164449|FG010|Overall Study|Lost to Follow-up|0|||
126784060|NCT00437281|456164450|FG011|Overall Study|Lost to Follow-up|0|||
126784061|NCT00437281|456164451|FG012|Overall Study|Lost to Follow-up|0|||
126784062|NCT00437281|456164452|FG013|Overall Study|Lost to Follow-up|0|||
126784063|NCT00437281|456164453|FG014|Overall Study|Lost to Follow-up|0|||
126784064|NCT00437281|456164454|FG015|Overall Study|Lost to Follow-up|0|||
126784065|NCT00437281|456164455|FG016|Overall Study|Lost to Follow-up|0|||
126784066|NCT00437281|456164456|FG017|Overall Study|Lost to Follow-up|0|||
126784067|NCT00437281|456164457|FG018|Overall Study|Lost to Follow-up|0|||
126784068|NCT00437281|456164458|FG019|Overall Study|Lost to Follow-up|1|||
126784069|NCT01862328|456164459|FG000|Overall Study|Progressive Disease|3|||
126784070|NCT01862328|456164460|FG001|Overall Study|Progressive Disease|11|||
126784071|NCT01862328|456164461|FG002|Overall Study|Progressive Disease|5|||
126784072|NCT01862328|456164462|FG003|Overall Study|Progressive Disease|6|||
126784073|NCT01862328|456164463|FG004|Overall Study|Progressive Disease|7|||
126784074|NCT01862328|456164464|FG005|Overall Study|Progressive Disease|4|||
126784075|NCT01862328|456164465|FG006|Overall Study|Progressive Disease|3|||
126784076|NCT01862328|456164459|FG000|Overall Study|Adverse Event|0|||
126784077|NCT01862328|456164460|FG001|Overall Study|Adverse Event|4|||
126784078|NCT01862328|456164461|FG002|Overall Study|Adverse Event|0|||
126784079|NCT01862328|456164462|FG003|Overall Study|Adverse Event|1|||
126784080|NCT01862328|456164463|FG004|Overall Study|Adverse Event|0|||
126784081|NCT01862328|456164464|FG005|Overall Study|Adverse Event|2|||
126784082|NCT01862328|456164465|FG006|Overall Study|Adverse Event|4|||
126784083|NCT01862328|456164459|FG000|Overall Study|Other|0|||
126784084|NCT01862328|456164460|FG001|Overall Study|Other|2|||
126784085|NCT01862328|456164461|FG002|Overall Study|Other|1|||
126784086|NCT01862328|456164462|FG003|Overall Study|Other|0|||
126784087|NCT01862328|456164463|FG004|Overall Study|Other|4|||
126754736|NCT02394028|456051405|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
126754737|NCT02394028|456051395|FG000|Induction Phase|Sponsor decision|0|||
126754738|NCT02394028|456051396|FG001|Induction Phase|Sponsor decision|1|||
126754739|NCT02394028|456051397|FG002|Induction Phase|Sponsor decision|2|||
126754740|NCT02394028|456051398|FG003|Induction Phase|Sponsor decision|0|||
126754741|NCT02394028|456051399|FG004|Induction Phase|Sponsor decision|0|||
126754742|NCT02394028|456051400|FG005|Induction Phase|Sponsor decision|0|||
126754743|NCT02394028|456051401|FG006|Induction Phase|Sponsor decision|0|||
126754744|NCT02394028|456051402|FG007|Induction Phase|Sponsor decision|0|||
126754745|NCT02394028|456051403|FG008|Induction Phase|Sponsor decision|0|||
126754746|NCT02394028|456051404|FG009|Induction Phase|Sponsor decision|0|||
126754747|NCT02394028|456051405|FG010|Induction Phase|Sponsor decision|0|||
126754748|NCT02394028|456051395|FG000|Induction Phase|Technical reason|0|||
126754749|NCT02394028|456051396|FG001|Induction Phase|Technical reason|0|||
126784088|NCT01862328|456164464|FG005|Overall Study|Other|0|||
126784089|NCT01862328|456164465|FG006|Overall Study|Other|1|||
126754750|NCT02394028|456051397|FG002|Induction Phase|Technical reason|0|||
126754751|NCT02394028|456051398|FG003|Induction Phase|Technical reason|1|||
126754752|NCT02394028|456051399|FG004|Induction Phase|Technical reason|0|||
126784090|NCT01862328|456164459|FG000|Overall Study|Withdrawal by Subject|1|||
126784091|NCT01862328|456164460|FG001|Overall Study|Withdrawal by Subject|1|||
126784092|NCT01862328|456164461|FG002|Overall Study|Withdrawal by Subject|0|||
126784093|NCT01862328|456164462|FG003|Overall Study|Withdrawal by Subject|0|||
126784094|NCT01862328|456164463|FG004|Overall Study|Withdrawal by Subject|1|||
126629370|NCT01274559|455602323|FG001|Overall Study|Non-compliance with Study Drug|4|||
126629371|NCT01274559|455602322|FG000|Overall Study|Physician Decision|2|||
126629372|NCT01274559|455602323|FG001|Overall Study|Physician Decision|1|||
126629373|NCT01274559|455602322|FG000|Overall Study|Protocol Violation|28|||
126629374|NCT01274559|455602323|FG001|Overall Study|Protocol Violation|23|||
126629375|NCT01274559|455602322|FG000|Overall Study|Study Terminated by Sponsor|79|||
126629376|NCT01274559|455602323|FG001|Overall Study|Study Terminated by Sponsor|87|||
126629377|NCT01274559|455602322|FG000|Overall Study|Withdrawal by Subject|25|||
126629378|NCT01274559|455602323|FG001|Overall Study|Withdrawal by Subject|13|||
126629379|NCT02971228|455602324|FG000|Overall Study|Withdrawal by Subject|1|||
126629380|NCT02971228|455602325|FG001|Overall Study|Withdrawal by Subject|1|||
126629381|NCT02971228|455602326|FG002|Overall Study|Withdrawal by Subject|0|||
126629382|NCT02971228|455602327|FG003|Overall Study|Withdrawal by Subject|0|||
126629383|NCT02971228|455602328|FG004|Overall Study|Withdrawal by Subject|0|||
126629384|NCT02971228|455602324|FG000|Overall Study|Logistical challenges|0|||
126629385|NCT02971228|455602325|FG001|Overall Study|Logistical challenges|1|||
126629386|NCT02971228|455602326|FG002|Overall Study|Logistical challenges|0|||
126629387|NCT02971228|455602327|FG003|Overall Study|Logistical challenges|0|||
126629388|NCT02971228|455602328|FG004|Overall Study|Logistical challenges|0|||
126629389|NCT01167192|455602329|FG000|Overall Study|Adverse Event|1|||
126629390|NCT01167192|455602329|FG000|Overall Study|Death|1|||
126629391|NCT01167192|455602329|FG000|Overall Study|Withdrawal by Subject|1|||
126629392|NCT01167192|455602329|FG000|Overall Study|Insurance denial|1|||
126629393|NCT02560389|455602330|FG000|Overall Study|Lost to Follow-up|1|||
126629394|NCT02560389|455602331|FG001|Overall Study|Lost to Follow-up|2|||
126629395|NCT02560389|455602332|FG002|Overall Study|Lost to Follow-up|2|||
126754753|NCT02394028|456051400|FG005|Induction Phase|Technical reason|0|||
126754754|NCT02394028|456051401|FG006|Induction Phase|Technical reason|0|||
126754755|NCT02394028|456051402|FG007|Induction Phase|Technical reason|0|||
126754756|NCT02394028|456051403|FG008|Induction Phase|Technical reason|0|||
126754757|NCT02394028|456051404|FG009|Induction Phase|Technical reason|0|||
126754758|NCT02394028|456051405|FG010|Induction Phase|Technical reason|0|||
126754759|NCT02394028|456051395|FG000|Induction Phase|:ack of calculation|0|||
126754760|NCT02394028|456051396|FG001|Induction Phase|:ack of calculation|0|||
126754761|NCT02394028|456051397|FG002|Induction Phase|:ack of calculation|0|||
126754762|NCT02394028|456051398|FG003|Induction Phase|:ack of calculation|0|||
126754763|NCT02394028|456051399|FG004|Induction Phase|:ack of calculation|0|||
126754764|NCT02394028|456051400|FG005|Induction Phase|:ack of calculation|0|||
126754765|NCT02394028|456051401|FG006|Induction Phase|:ack of calculation|0|||
126754766|NCT02394028|456051402|FG007|Induction Phase|:ack of calculation|1|||
126754767|NCT02394028|456051403|FG008|Induction Phase|:ack of calculation|0|||
126754768|NCT02394028|456051404|FG009|Induction Phase|:ack of calculation|0|||
126754769|NCT02394028|456051405|FG010|Induction Phase|:ack of calculation|0|||
126754770|NCT02394028|456051395|FG000|Maintenance Phase|Protocol Violation|0|||
126754771|NCT02394028|456051396|FG001|Maintenance Phase|Protocol Violation|0|||
126754772|NCT02394028|456051397|FG002|Maintenance Phase|Protocol Violation|0|||
126754773|NCT02394028|456051398|FG003|Maintenance Phase|Protocol Violation|0|||
126754774|NCT02394028|456051399|FG004|Maintenance Phase|Protocol Violation|0|||
126754775|NCT02394028|456051400|FG005|Maintenance Phase|Protocol Violation|0|||
126754776|NCT02394028|456051401|FG006|Maintenance Phase|Protocol Violation|0|||
126754777|NCT02394028|456051402|FG007|Maintenance Phase|Protocol Violation|0|||
126754778|NCT02394028|456051403|FG008|Maintenance Phase|Protocol Violation|0|||
126754779|NCT02394028|456051404|FG009|Maintenance Phase|Protocol Violation|0|||
126754780|NCT02394028|456051405|FG010|Maintenance Phase|Protocol Violation|1|||
126754781|NCT02394028|456051395|FG000|Maintenance Phase|Physician Decision|0|||
126754782|NCT02394028|456051396|FG001|Maintenance Phase|Physician Decision|0|||
126754783|NCT02394028|456051397|FG002|Maintenance Phase|Physician Decision|0|||
126754784|NCT02394028|456051398|FG003|Maintenance Phase|Physician Decision|0|||
126754785|NCT02394028|456051399|FG004|Maintenance Phase|Physician Decision|0|||
126754786|NCT02394028|456051400|FG005|Maintenance Phase|Physician Decision|0|||
126754787|NCT02394028|456051401|FG006|Maintenance Phase|Physician Decision|0|||
126754788|NCT02394028|456051402|FG007|Maintenance Phase|Physician Decision|0|||
126754789|NCT02394028|456051403|FG008|Maintenance Phase|Physician Decision|1|||
126754790|NCT02394028|456051404|FG009|Maintenance Phase|Physician Decision|3|||
126754791|NCT02394028|456051405|FG010|Maintenance Phase|Physician Decision|2|||
126754792|NCT02394028|456051395|FG000|Maintenance Phase|Lack of Efficacy|0|||
126754793|NCT02394028|456051396|FG001|Maintenance Phase|Lack of Efficacy|0|||
126754794|NCT02394028|456051397|FG002|Maintenance Phase|Lack of Efficacy|0|||
126754795|NCT02394028|456051398|FG003|Maintenance Phase|Lack of Efficacy|0|||
126754796|NCT02394028|456051399|FG004|Maintenance Phase|Lack of Efficacy|0|||
126754797|NCT02394028|456051400|FG005|Maintenance Phase|Lack of Efficacy|0|||
126754798|NCT02394028|456051401|FG006|Maintenance Phase|Lack of Efficacy|0|||
126754799|NCT02394028|456051402|FG007|Maintenance Phase|Lack of Efficacy|0|||
126754800|NCT02394028|456051403|FG008|Maintenance Phase|Lack of Efficacy|7|||
126784095|NCT01862328|456164464|FG005|Overall Study|Withdrawal by Subject|1|||
126784096|NCT01862328|456164465|FG006|Overall Study|Withdrawal by Subject|1|||
126784097|NCT01862328|456164459|FG000|Overall Study|Symptomatic Deterioration|0|||
126784098|NCT01862328|456164460|FG001|Overall Study|Symptomatic Deterioration|0|||
126784099|NCT01862328|456164461|FG002|Overall Study|Symptomatic Deterioration|0|||
126784100|NCT01862328|456164462|FG003|Overall Study|Symptomatic Deterioration|0|||
126784101|NCT01862328|456164463|FG004|Overall Study|Symptomatic Deterioration|0|||
126784102|NCT01862328|456164464|FG005|Overall Study|Symptomatic Deterioration|0|||
126784103|NCT01862328|456164465|FG006|Overall Study|Symptomatic Deterioration|1|||
126784104|NCT01656889|456164467|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
126784105|NCT01656889|456164468|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
126784106|NCT01656889|456164467|FG000|Treatment Period, 12 Weeks|Death|0|||
126784107|NCT01656889|456164468|FG001|Treatment Period, 12 Weeks|Death|1|||
126784108|NCT01656889|456164467|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
126784109|NCT01656889|456164468|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
126784110|NCT01656889|456164467|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
126784111|NCT01656889|456164468|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
126784112|NCT01656889|456164467|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
126784113|NCT01656889|456164468|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
126784114|NCT01656889|456164467|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
126784115|NCT01656889|456164468|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
126784116|NCT01656889|456164467|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
126784117|NCT01656889|456164468|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
126784118|NCT01656889|456164467|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
126784119|NCT01656889|456164468|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
126784120|NCT01656889|456164467|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
126784121|NCT01656889|456164468|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
126784122|NCT01656889|456164467|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
126784123|NCT01656889|456164468|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
126784124|NCT02521948|456164469|FG000|Overall Study|Adverse Event|2|||
126784125|NCT02521948|456164469|FG000|Overall Study|Death|4|||
126784126|NCT02521948|456164469|FG000|Overall Study|Lost to Follow-up|1|||
126784127|NCT02521948|456164469|FG000|Overall Study|Did not attend one or both follow-ups|6|||
126784128|NCT02427607|456164470|FG000|Overall Study|Withdrawal by Subject|1|||
126784129|NCT00423800|456164471|FG000|Overall Study|Protocol Violation|0|||
126784130|NCT00423800|456164472|FG001|Overall Study|Protocol Violation|1|||
126784131|NCT04000009|456164473|FG000|Overall Study|Adverse Event|13|||
126784132|NCT04000009|456164473|FG000|Overall Study|Lack of Efficacy|7|||
126784133|NCT04000009|456164473|FG000|Overall Study|Lost to Follow-up|8|||
126784134|NCT04000009|456164473|FG000|Overall Study|Noncompliance with study drug|4|||
126784135|NCT04000009|456164473|FG000|Overall Study|Physician Decision|1|||
126784136|NCT04000009|456164473|FG000|Overall Study|Use of prohibited medication|3|||
126784137|NCT04000009|456164473|FG000|Overall Study|Pregnancy|1|||
126784138|NCT04000009|456164473|FG000|Overall Study|Withdrawal by Subject|22|||
126784139|NCT04000009|456164473|FG000|Overall Study|Study terminated by sponsor|98|||
126784140|NCT04000009|456164473|FG000|Overall Study|Not further specified|8|||
126784141|NCT00679783|456164475|FG000|Overall Study|Adverse Event|0|||
126784142|NCT00679783|456164476|FG001|Overall Study|Adverse Event|0|||
126784143|NCT00679783|456164477|FG002|Overall Study|Adverse Event|0|||
126784144|NCT00679783|456164478|FG003|Overall Study|Adverse Event|3|||
126784145|NCT00679783|456164479|FG004|Overall Study|Adverse Event|0|||
126784146|NCT00679783|456164480|FG005|Overall Study|Adverse Event|0|||
126784147|NCT00679783|456164481|FG006|Overall Study|Adverse Event|1|||
126784148|NCT00679783|456164475|FG000|Overall Study|Lack of Efficacy|0|||
126784149|NCT00679783|456164476|FG001|Overall Study|Lack of Efficacy|1|||
126784150|NCT00679783|456164477|FG002|Overall Study|Lack of Efficacy|0|||
126784151|NCT00679783|456164478|FG003|Overall Study|Lack of Efficacy|2|||
126784152|NCT00679783|456164479|FG004|Overall Study|Lack of Efficacy|0|||
126784153|NCT00679783|456164480|FG005|Overall Study|Lack of Efficacy|0|||
126784154|NCT00679783|456164481|FG006|Overall Study|Lack of Efficacy|0|||
126784155|NCT00679783|456164475|FG000|Overall Study|Withdrawal by Subject|0|||
126784156|NCT00679783|456164476|FG001|Overall Study|Withdrawal by Subject|0|||
126784157|NCT00679783|456164477|FG002|Overall Study|Withdrawal by Subject|1|||
126784158|NCT00679783|456164478|FG003|Overall Study|Withdrawal by Subject|1|||
126784159|NCT00679783|456164479|FG004|Overall Study|Withdrawal by Subject|0|||
126784160|NCT00679783|456164480|FG005|Overall Study|Withdrawal by Subject|0|||
126784161|NCT00679783|456164481|FG006|Overall Study|Withdrawal by Subject|0|||
126784162|NCT00679783|456164475|FG000|Overall Study|Not Captured|0|||
126784163|NCT00679783|456164476|FG001|Overall Study|Not Captured|0|||
126784164|NCT00679783|456164477|FG002|Overall Study|Not Captured|0|||
126784165|NCT00679783|456164478|FG003|Overall Study|Not Captured|5|||
126784166|NCT00679783|456164479|FG004|Overall Study|Not Captured|0|||
126784167|NCT00679783|456164480|FG005|Overall Study|Not Captured|0|||
126784168|NCT00679783|456164481|FG006|Overall Study|Not Captured|0|||
126784169|NCT00679783|456164475|FG000|Overall Study|Ongoing at data cut-off|2|||
126784170|NCT00679783|456164476|FG001|Overall Study|Ongoing at data cut-off|2|||
126784171|NCT00679783|456164477|FG002|Overall Study|Ongoing at data cut-off|0|||
126784172|NCT00679783|456164478|FG003|Overall Study|Ongoing at data cut-off|9|||
126784173|NCT00679783|456164479|FG004|Overall Study|Ongoing at data cut-off|1|||
126784174|NCT00679783|456164480|FG005|Overall Study|Ongoing at data cut-off|0|||
126784175|NCT00679783|456164481|FG006|Overall Study|Ongoing at data cut-off|0|||
126784176|NCT01754259|456164484|FG000|Overall Study|Withdrawal by Subject|2|||
126784177|NCT01754259|456164485|FG001|Overall Study|Withdrawal by Subject|4|||
126784178|NCT01754259|456164484|FG000|Overall Study|Adverse Event|3|||
126784179|NCT01754259|456164485|FG001|Overall Study|Adverse Event|1|||
126784180|NCT01754259|456164484|FG000|Overall Study|Lost to Follow-up|0|||
126784181|NCT01754259|456164485|FG001|Overall Study|Lost to Follow-up|1|||
126784182|NCT00306384|456164486|FG000|Overall Study|Adverse Event|103|||
126784183|NCT00306384|456164487|FG001|Overall Study|Adverse Event|87|||
126784184|NCT00306384|456164488|FG002|Overall Study|Adverse Event|40|||
126784185|NCT00306384|456164486|FG000|Overall Study|Major protocol deviation|43|||
126784186|NCT00306384|456164487|FG001|Overall Study|Major protocol deviation|51|||
126784187|NCT00306384|456164488|FG002|Overall Study|Major protocol deviation|18|||
126784188|NCT00306384|456164486|FG000|Overall Study|Lost to Follow-up|57|||
126784189|NCT00306384|456164487|FG001|Overall Study|Lost to Follow-up|41|||
126784190|NCT00306384|456164488|FG002|Overall Study|Lost to Follow-up|35|||
126784191|NCT00306384|456164486|FG000|Overall Study|Voluntary withdrawal|199|||
126784192|NCT00306384|456164487|FG001|Overall Study|Voluntary withdrawal|187|||
126784193|NCT00306384|456164488|FG002|Overall Study|Voluntary withdrawal|91|||
126784194|NCT00306384|456164486|FG000|Overall Study|Study termination|1|||
126784195|NCT00306384|456164487|FG001|Overall Study|Study termination|0|||
126784196|NCT00306384|456164488|FG002|Overall Study|Study termination|1|||
126784197|NCT00306384|456164486|FG000|Overall Study|Pregnancy|3|||
126784198|NCT00306384|456164487|FG001|Overall Study|Pregnancy|1|||
126784199|NCT00306384|456164488|FG002|Overall Study|Pregnancy|1|||
126784200|NCT00306384|456164486|FG000|Overall Study|Lack of Efficacy|26|||
126784201|NCT00306384|456164487|FG001|Overall Study|Lack of Efficacy|40|||
126784202|NCT00306384|456164488|FG002|Overall Study|Lack of Efficacy|38|||
126784203|NCT00306384|456164486|FG000|Overall Study|Investigator discretion|28|||
126784204|NCT00306384|456164487|FG001|Overall Study|Investigator discretion|31|||
126784205|NCT00306384|456164488|FG002|Overall Study|Investigator discretion|21|||
126784206|NCT00306384|456164486|FG000|Overall Study|Other|80|||
126784207|NCT00306384|456164487|FG001|Overall Study|Other|70|||
126784208|NCT00306384|456164488|FG002|Overall Study|Other|32|||
126784209|NCT00306384|456164486|FG000|Overall Study|Site closure|2|||
126784210|NCT00306384|456164487|FG001|Overall Study|Site closure|0|||
126784211|NCT00306384|456164488|FG002|Overall Study|Site closure|0|||
126784212|NCT02154529|456164489|FG000|Overall Study|Death|1|||
126784213|NCT02154529|456164490|FG001|Overall Study|Death|1|||
126784214|NCT02154529|456164491|FG002|Overall Study|Death|5|||
126784215|NCT02154529|456164492|FG003|Overall Study|Death|1|||
126784216|NCT02154529|456164489|FG000|Overall Study|Termination of study by sponsor|2|||
126784217|NCT02154529|456164490|FG001|Overall Study|Termination of study by sponsor|2|||
126784218|NCT02154529|456164491|FG002|Overall Study|Termination of study by sponsor|3|||
126784219|NCT02154529|456164492|FG003|Overall Study|Termination of study by sponsor|1|||
126784220|NCT02154529|456164489|FG000|Overall Study|Lost to Follow-up|1|||
126784221|NCT02154529|456164490|FG001|Overall Study|Lost to Follow-up|0|||
126784222|NCT02154529|456164491|FG002|Overall Study|Lost to Follow-up|0|||
126784223|NCT02154529|456164492|FG003|Overall Study|Lost to Follow-up|0|||
126784224|NCT01241461|456165697|FG000|Overall Study|Progressive Disease|3|||
126784225|NCT01241461|456165698|FG001|Overall Study|Progressive Disease|6|||
126784226|NCT01379781|456165702|FG000|Overall Study|Lost to Follow-up|11|||
126784227|NCT01379781|456165703|FG001|Overall Study|Lost to Follow-up|8|||
126784228|NCT03329027|456165706|FG000|Overall Study|Lost to Follow-up|1|||
126629396|NCT02560389|455602330|FG000|Overall Study|Tested positive for illicit substance|0|||
126629397|NCT02560389|455602331|FG001|Overall Study|Tested positive for illicit substance|1|||
126784229|NCT03329027|456165707|FG001|Overall Study|Lost to Follow-up|0|||
126784230|NCT03329027|456165708|FG002|Overall Study|Lost to Follow-up|1|||
126784231|NCT03329027|456165706|FG000|Overall Study|Protocol Violation|9|||
126784232|NCT03329027|456165707|FG001|Overall Study|Protocol Violation|5|||
126784233|NCT03329027|456165708|FG002|Overall Study|Protocol Violation|7|||
126784234|NCT02742090|456165720|FG000|Overall Study|Adverse Event|10|||
126784235|NCT02742090|456165720|FG000|Overall Study|Death|3|||
126784236|NCT02742090|456165720|FG000|Overall Study|Disease Progression|25|||
126784237|NCT02742090|456165720|FG000|Overall Study|Investigator's Decision|1|||
126784238|NCT02742090|456165720|FG000|Overall Study|Lost to Follow-up|1|||
126784239|NCT02742090|456165720|FG000|Overall Study|Non-compliance with Study|1|||
126784240|NCT02742090|456165720|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
126784241|NCT02742090|456165720|FG000|Overall Study|Withdrawal by Subject|4|||
126784242|NCT02742090|456165720|FG000|Overall Study|Reason Not Specified|1|||
126629398|NCT02560389|455602332|FG002|Overall Study|Tested positive for illicit substance|0|||
126784243|NCT00836927|456165721|FG000|Overall Study|Progressive disease|2|||
126784244|NCT00836927|456165722|FG001|Overall Study|Progressive disease|0|||
126784245|NCT00836927|456165723|FG002|Overall Study|Progressive disease|0|||
126784246|NCT00836927|456165724|FG003|Overall Study|Progressive disease|1|||
126629399|NCT03409731|455602343|FG000|Overall Study|Withdrawal by Subject|17|||
126629400|NCT03409731|455602343|FG000|Overall Study|Death|4|||
126629401|NCT04016805|455602349|FG000|Overall Study|Sponsor's Discretion|30|||
126629402|NCT04016805|455602350|FG001|Overall Study|Sponsor's Discretion|6|||
126629403|NCT04016805|455602351|FG002|Overall Study|Sponsor's Discretion|5|||
126629404|NCT01193218|455602352|FG000|0-12 Weeks|Adverse Event|6|||
126629405|NCT01193218|455602353|FG001|0-12 Weeks|Adverse Event|0|||
126629406|NCT01193218|455602354|FG002|0-12 Weeks|Adverse Event|1|||
126629407|NCT01193218|455602355|FG003|0-12 Weeks|Adverse Event|0|||
126629408|NCT01193218|455602356|FG004|0-12 Weeks|Adverse Event|0|||
126629409|NCT01193218|455602357|FG005|0-12 Weeks|Adverse Event|2|||
126629410|NCT01193218|455602358|FG006|0-12 Weeks|Adverse Event|2|||
126629411|NCT01193218|455602359|FG007|0-12 Weeks|Adverse Event|0|||
126629412|NCT01193218|455602352|FG000|0-12 Weeks|Protocol Violation|0|||
126629413|NCT01193218|455602353|FG001|0-12 Weeks|Protocol Violation|0|||
126629414|NCT01193218|455602354|FG002|0-12 Weeks|Protocol Violation|0|||
126629415|NCT01193218|455602355|FG003|0-12 Weeks|Protocol Violation|0|||
126629416|NCT01193218|455602356|FG004|0-12 Weeks|Protocol Violation|1|||
126629417|NCT01193218|455602357|FG005|0-12 Weeks|Protocol Violation|1|||
126629418|NCT01193218|455602358|FG006|0-12 Weeks|Protocol Violation|0|||
126629419|NCT01193218|455602359|FG007|0-12 Weeks|Protocol Violation|0|||
126629420|NCT01193218|455602352|FG000|0-12 Weeks|Withdrawal by Subject|3|||
126629421|NCT01193218|455602353|FG001|0-12 Weeks|Withdrawal by Subject|0|||
126629422|NCT01193218|455602354|FG002|0-12 Weeks|Withdrawal by Subject|2|||
126629423|NCT01193218|455602355|FG003|0-12 Weeks|Withdrawal by Subject|0|||
126629424|NCT01193218|455602356|FG004|0-12 Weeks|Withdrawal by Subject|0|||
126629425|NCT01193218|455602357|FG005|0-12 Weeks|Withdrawal by Subject|0|||
126629426|NCT01193218|455602358|FG006|0-12 Weeks|Withdrawal by Subject|1|||
126629427|NCT01193218|455602359|FG007|0-12 Weeks|Withdrawal by Subject|0|||
126629428|NCT01193218|455602352|FG000|12-52 Weeks|Adverse Event|1|||
126629429|NCT01193218|455602353|FG001|12-52 Weeks|Adverse Event|0|||
126629430|NCT01193218|455602354|FG002|12-52 Weeks|Adverse Event|1|||
126629431|NCT01193218|455602355|FG003|12-52 Weeks|Adverse Event|2|||
126629432|NCT01193218|455602356|FG004|12-52 Weeks|Adverse Event|3|||
126629433|NCT01193218|455602357|FG005|12-52 Weeks|Adverse Event|3|||
126629434|NCT01193218|455602358|FG006|12-52 Weeks|Adverse Event|1|||
126629435|NCT01193218|455602359|FG007|12-52 Weeks|Adverse Event|2|||
126629436|NCT01193218|455602352|FG000|12-52 Weeks|Lack of Efficacy|0|||
126629437|NCT01193218|455602353|FG001|12-52 Weeks|Lack of Efficacy|0|||
126629438|NCT01193218|455602354|FG002|12-52 Weeks|Lack of Efficacy|0|||
126629439|NCT01193218|455602355|FG003|12-52 Weeks|Lack of Efficacy|0|||
126629440|NCT01193218|455602356|FG004|12-52 Weeks|Lack of Efficacy|0|||
126629441|NCT01193218|455602357|FG005|12-52 Weeks|Lack of Efficacy|0|||
126629442|NCT01193218|455602358|FG006|12-52 Weeks|Lack of Efficacy|1|||
126629443|NCT01193218|455602359|FG007|12-52 Weeks|Lack of Efficacy|0|||
126629444|NCT01193218|455602352|FG000|12-52 Weeks|Withdrawal by Subject|3|||
126629445|NCT01193218|455602353|FG001|12-52 Weeks|Withdrawal by Subject|0|||
126629446|NCT01193218|455602354|FG002|12-52 Weeks|Withdrawal by Subject|3|||
126629447|NCT01193218|455602355|FG003|12-52 Weeks|Withdrawal by Subject|0|||
126629448|NCT01193218|455602356|FG004|12-52 Weeks|Withdrawal by Subject|0|||
126629449|NCT01193218|455602357|FG005|12-52 Weeks|Withdrawal by Subject|2|||
126629450|NCT01193218|455602358|FG006|12-52 Weeks|Withdrawal by Subject|1|||
126629451|NCT01193218|455602359|FG007|12-52 Weeks|Withdrawal by Subject|2|||
126629452|NCT01193218|455602352|FG000|12-52 Weeks|Other reason than above|1|||
126629453|NCT01193218|455602353|FG001|12-52 Weeks|Other reason than above|0|||
126629454|NCT01193218|455602354|FG002|12-52 Weeks|Other reason than above|0|||
126629455|NCT01193218|455602355|FG003|12-52 Weeks|Other reason than above|1|||
126629456|NCT01193218|455602356|FG004|12-52 Weeks|Other reason than above|1|||
126629457|NCT01193218|455602357|FG005|12-52 Weeks|Other reason than above|0|||
126629458|NCT01193218|455602358|FG006|12-52 Weeks|Other reason than above|0|||
126629459|NCT01193218|455602359|FG007|12-52 Weeks|Other reason than above|0|||
126629460|NCT01424189|455602362|FG000|Overall Study|Adverse Event|1|||
126629461|NCT01424189|455602363|FG001|Overall Study|Adverse Event|0|||
126629462|NCT01424189|455602362|FG000|Overall Study|Lost to Follow-up|4|||
126629463|NCT01424189|455602363|FG001|Overall Study|Lost to Follow-up|1|||
126629464|NCT01424189|455602362|FG000|Overall Study|Withdrawal by Subject|4|||
126629465|NCT01424189|455602363|FG001|Overall Study|Withdrawal by Subject|4|||
126629466|NCT01424189|455602362|FG000|Overall Study|Subject moved|1|||
126629467|NCT01424189|455602363|FG001|Overall Study|Subject moved|0|||
126629468|NCT01424189|455602362|FG000|Overall Study|Death|3|||
126629469|NCT01424189|455602363|FG001|Overall Study|Death|1|||
126629470|NCT01203956|455602364|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
126629471|NCT01203956|455602365|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
126629472|NCT00069277|455602366|FG000|Overall Study|Adverse Event|3|||
126629473|NCT00069277|455602366|FG000|Overall Study|Withdrawal by Subject|1|||
126629474|NCT00069277|455602366|FG000|Overall Study|Progressive Disease|15|||
126629475|NCT00069277|455602366|FG000|Overall Study|Physician Decision|2|||
126629476|NCT02230306|455602367|FG000|Overall Study|Did not receive study treatment|1|||
126629477|NCT03512288|455602370|FG000|Overall Study|Adverse Event|1|||
126629478|NCT03512288|455602371|FG001|Overall Study|Adverse Event|0|||
126629479|NCT03512288|455602370|FG000|Overall Study|Lost to Follow-up|12|||
126784247|NCT00836927|456165725|FG004|Overall Study|Progressive disease|1|||
126784248|NCT00836927|456165721|FG000|Overall Study|Withdrawal by Subject|1|||
126784249|NCT00836927|456165722|FG001|Overall Study|Withdrawal by Subject|0|||
126784250|NCT00836927|456165723|FG002|Overall Study|Withdrawal by Subject|0|||
126784251|NCT00836927|456165724|FG003|Overall Study|Withdrawal by Subject|0|||
126784252|NCT00836927|456165725|FG004|Overall Study|Withdrawal by Subject|0|||
126784253|NCT02688400|456165735|FG000|Overall Study|Protocol Violation|2|||
126784254|NCT02688400|456165736|FG001|Overall Study|Protocol Violation|5|||
126784255|NCT02688400|456165735|FG000|Overall Study|Lack of Efficacy|7|||
126784256|NCT02688400|456165736|FG001|Overall Study|Lack of Efficacy|7|||
126784257|NCT02688400|456165735|FG000|Overall Study|Adverse Event|21|||
126784258|NCT02688400|456165736|FG001|Overall Study|Adverse Event|12|||
126784259|NCT02688400|456165735|FG000|Overall Study|Withdrawal by Subject|15|||
126784260|NCT02688400|456165736|FG001|Overall Study|Withdrawal by Subject|13|||
126784261|NCT02688400|456165735|FG000|Overall Study|No study medication intake|1|||
126784262|NCT02688400|456165736|FG001|Overall Study|No study medication intake|4|||
126784263|NCT02688400|456165735|FG000|Overall Study|Lost to Follow-up|0|||
126784264|NCT02688400|456165736|FG001|Overall Study|Lost to Follow-up|3|||
126784265|NCT02295774|456165738|FG000|Overall Study|Physician Decision|1|||
126784266|NCT02295774|456165738|FG000|Overall Study|Withdrawal by Subject|2|||
126784267|NCT01075763|456165739|FG000|Overall Study|Lost to Follow-up|2|||
126784268|NCT01075763|456165740|FG001|Overall Study|Lost to Follow-up|1|||
126784269|NCT01075763|456165739|FG000|Overall Study|Lack of Efficacy|0|||
126784270|NCT01075763|456165740|FG001|Overall Study|Lack of Efficacy|1|||
126784271|NCT01075763|456165739|FG000|Overall Study|Withdrawal by Subject|2|||
126784272|NCT01075763|456165740|FG001|Overall Study|Withdrawal by Subject|2|||
126784273|NCT00586521|456165741|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
126784274|NCT03731182|456165749|FG000|Overall Study|Lost to Follow-up|2|||
126784275|NCT03731182|456165750|FG001|Overall Study|Lost to Follow-up|0|||
126784276|NCT03731182|456165749|FG000|Overall Study|Physician Decision|1|||
126784277|NCT03731182|456165750|FG001|Overall Study|Physician Decision|0|||
126784278|NCT03731182|456165749|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
126784279|NCT03731182|456165750|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
126784280|NCT02006706|456165751|FG000|Overall Study|Lost to Follow-up|1|||
126784281|NCT00582036|456165752|FG000|Overall Study|Withdrawal by Subject|0|||
126784282|NCT00582036|456165753|FG001|Overall Study|Withdrawal by Subject|1|||
126784283|NCT04161144|456165755|FG000|Overall Study|Withdrawal by Subject|0|||
126784284|NCT04161144|456165756|FG001|Overall Study|Withdrawal by Subject|1|||
126784285|NCT04161144|456165755|FG000|Overall Study|Protocol Violation|1|||
126784286|NCT04161144|456165756|FG001|Overall Study|Protocol Violation|0|||
126784287|NCT00958256|456165758|FG000|Overall Study|Adverse Event|3|||
126784288|NCT03036579|456165761|FG000|2 Years|Lost to Follow-up|1|||
126784289|NCT03036579|456165762|FG001|2 Years|Lost to Follow-up|0|||
126784290|NCT03036579|456165761|FG000|3 Years|Lost to Follow-up|0|||
126784291|NCT03036579|456165762|FG001|3 Years|Lost to Follow-up|1|||
126784292|NCT00992407|456165765|FG000|Overall Study|Protocol Violation|2|||
126784293|NCT00992407|456165766|FG001|Overall Study|Protocol Violation|1|||
126784294|NCT00992407|456165765|FG000|Overall Study|Lost to Follow-up|3|||
126784295|NCT00992407|456165766|FG001|Overall Study|Lost to Follow-up|3|||
126784296|NCT00992407|456165765|FG000|Overall Study|Adverse Event|3|||
126784297|NCT00992407|456165766|FG001|Overall Study|Adverse Event|2|||
126784298|NCT00992407|456165765|FG000|Overall Study|protocol Violation & Adverse events|2|||
126784299|NCT00992407|456165766|FG001|Overall Study|protocol Violation & Adverse events|4|||
126784300|NCT00992407|456165765|FG000|Overall Study|Other|2|||
126784301|NCT00992407|456165766|FG001|Overall Study|Other|0|||
126784302|NCT00992407|456165765|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
126784303|NCT00992407|456165766|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
126784304|NCT00992407|456165765|FG000|Overall Study|Study medication not administered|17|||
126784305|NCT00992407|456165766|FG001|Overall Study|Study medication not administered|13|||
126784306|NCT02918162|456165768|FG000|Overall Study|Withdrawal by Subject|1|||
126784307|NCT02918162|456165768|FG000|Overall Study|Omental Disease|1|||
126784308|NCT00395226|456165769|FG000|Overall Study|Adverse Event|4|||
126784309|NCT00395226|456165770|FG001|Overall Study|Adverse Event|3|||
126784310|NCT00395226|456165769|FG000|Overall Study|Withdrawal by Subject|0|||
126784311|NCT00395226|456165770|FG001|Overall Study|Withdrawal by Subject|1|||
126784312|NCT00395226|456165769|FG000|Overall Study|Lost to Follow-up|0|||
126784313|NCT00395226|456165770|FG001|Overall Study|Lost to Follow-up|1|||
126784314|NCT01000337|456165774|FG000|Overall Study|Lost to Follow-up|4|||
126784315|NCT01000337|456165775|FG001|Overall Study|Lost to Follow-up|3|||
126784316|NCT01612000|456165776|FG000|Overall Study|Lost to Follow-up|6|||
126784317|NCT01612000|456165777|FG001|Overall Study|Lost to Follow-up|4|||
126784318|NCT01612000|456165778|FG002|Overall Study|Lost to Follow-up|4|||
126784319|NCT01612000|456165779|FG003|Overall Study|Lost to Follow-up|8|||
126784320|NCT01612000|456165776|FG000|Overall Study|Physician Decision|0|||
126784321|NCT01612000|456165777|FG001|Overall Study|Physician Decision|0|||
126784322|NCT01612000|456165778|FG002|Overall Study|Physician Decision|1|||
126784323|NCT01612000|456165779|FG003|Overall Study|Physician Decision|0|||
126784324|NCT01612000|456165776|FG000|Overall Study|Withdrawal by Subject|3|||
126784325|NCT01612000|456165777|FG001|Overall Study|Withdrawal by Subject|1|||
126784326|NCT01612000|456165778|FG002|Overall Study|Withdrawal by Subject|2|||
126784327|NCT01612000|456165779|FG003|Overall Study|Withdrawal by Subject|2|||
126784328|NCT02173704|456165780|FG000|Overall Study|Adverse Event|1|||
126784329|NCT02173704|456165781|FG001|Overall Study|Adverse Event|0|||
126784330|NCT02173704|456165780|FG000|Overall Study|Lost to Follow-up|1|||
126784331|NCT02173704|456165781|FG001|Overall Study|Lost to Follow-up|0|||
126784332|NCT02173704|456165780|FG000|Overall Study|Other|1|||
126784333|NCT02173704|456165781|FG001|Overall Study|Other|0|||
126784334|NCT02173704|456165780|FG000|Overall Study|Protocol Violation|1|||
126784335|NCT02173704|456165781|FG001|Overall Study|Protocol Violation|0|||
126784336|NCT02173704|456165780|FG000|Overall Study|Withdrawal by Subject|9|||
126784337|NCT02173704|456165781|FG001|Overall Study|Withdrawal by Subject|4|||
126784338|NCT00419926|456165782|FG000|Overall Study|Withdrawal by Subject|7|||
126784339|NCT00419926|456165783|FG001|Overall Study|Withdrawal by Subject|3|||
126784340|NCT00419926|456165782|FG000|Overall Study|Administrative Problem|4|||
126784341|NCT00419926|456165783|FG001|Overall Study|Administrative Problem|4|||
126784342|NCT00419926|456165782|FG000|Overall Study|Lost to Follow-up|1|||
126784343|NCT00419926|456165783|FG001|Overall Study|Lost to Follow-up|2|||
126784344|NCT00419926|456165782|FG000|Overall Study|Death|2|||
126784345|NCT00419926|456165783|FG001|Overall Study|Death|1|||
126784346|NCT02374918|456165788|FG000|Overall Study|Protocol Violation|2|||
126784347|NCT02374918|456165789|FG001|Overall Study|Protocol Violation|0|||
126784348|NCT02374918|456165790|FG002|Overall Study|Protocol Violation|2|||
126784349|NCT02374918|456165791|FG003|Overall Study|Protocol Violation|1|||
126784350|NCT02374918|456165788|FG000|Overall Study|Withdrawal by Subject|1|||
126784351|NCT02374918|456165789|FG001|Overall Study|Withdrawal by Subject|1|||
126784352|NCT02374918|456165790|FG002|Overall Study|Withdrawal by Subject|1|||
126784353|NCT02374918|456165791|FG003|Overall Study|Withdrawal by Subject|0|||
126784354|NCT02374918|456165788|FG000|Overall Study|Lack of Efficacy|0|||
126784355|NCT02374918|456165789|FG001|Overall Study|Lack of Efficacy|0|||
126784356|NCT02374918|456165790|FG002|Overall Study|Lack of Efficacy|1|||
126784357|NCT02374918|456165791|FG003|Overall Study|Lack of Efficacy|1|||
126784358|NCT01180244|456165792|FG000|Overall Study|Lack of Efficacy|0|||
126784359|NCT01180244|456165793|FG001|Overall Study|Lack of Efficacy|7|||
126784360|NCT01180244|456165792|FG000|Overall Study|Physician Decision|3|||
126784361|NCT01180244|456165793|FG001|Overall Study|Physician Decision|0|||
126784362|NCT01180244|456165792|FG000|Overall Study|Adverse Event|1|||
126784363|NCT01180244|456165793|FG001|Overall Study|Adverse Event|0|||
126784364|NCT01180244|456165792|FG000|Overall Study|Withdrawal by Subject|0|||
126784365|NCT01180244|456165793|FG001|Overall Study|Withdrawal by Subject|1|||
126784366|NCT01180244|456165792|FG000|Overall Study|Protocol Violation|1|||
126784367|NCT01180244|456165793|FG001|Overall Study|Protocol Violation|0|||
126784368|NCT01180244|456165792|FG000|Overall Study|Lost to Follow-up|1|||
126784369|NCT01180244|456165793|FG001|Overall Study|Lost to Follow-up|0|||
126784370|NCT00729859|456165794|FG000|Overall Study|Adverse Event|0|||
126784371|NCT00729859|456165795|FG001|Overall Study|Adverse Event|1|||
126784372|NCT00729859|456165796|FG002|Overall Study|Adverse Event|0|||
126784373|NCT00729859|456165794|FG000|Overall Study|Withdrawal by Subject|0|||
126784374|NCT00729859|456165795|FG001|Overall Study|Withdrawal by Subject|1|||
126784375|NCT00729859|456165796|FG002|Overall Study|Withdrawal by Subject|0|||
126784376|NCT02623829|456165797|FG000|Overall Study|Lost to Follow-up|1|||
126784377|NCT02623829|456165798|FG001|Overall Study|Lost to Follow-up|1|||
126784378|NCT00783796|456165799|FG000|Overall Study|Did not receive any stent|4|||
126784379|NCT00783796|456165799|FG000|Overall Study|Received non-XIENCE V stent|1|||
126784380|NCT00783796|456165799|FG000|Overall Study|Received commercial XIENCE V stent|1|||
126784381|NCT03267264|456165801|FG000|Overall Study|Withdrawal by Subject|1|||
126784382|NCT03267264|456165802|FG001|Overall Study|Withdrawal by Subject|0|||
126629480|NCT03512288|455602371|FG001|Overall Study|Lost to Follow-up|15|||
126629481|NCT03512288|455602370|FG000|Overall Study|Physician Decision|0|||
126629482|NCT03512288|455602371|FG001|Overall Study|Physician Decision|2|||
126629483|NCT03512288|455602370|FG000|Overall Study|Protocol Violation|6|||
126629484|NCT03512288|455602371|FG001|Overall Study|Protocol Violation|4|||
126629485|NCT03512288|455602370|FG000|Overall Study|Medication error without associated adverse event|1|||
126629486|NCT03512288|455602371|FG001|Overall Study|Medication error without associated adverse event|0|||
126629487|NCT03512288|455602370|FG000|Overall Study|No longer met eligibility criteria|5|||
126629488|NCT03512288|455602371|FG001|Overall Study|No longer met eligibility criteria|2|||
126784383|NCT03267264|456165803|FG002|Overall Study|Withdrawal by Subject|2|||
126784384|NCT03267264|456165804|FG003|Overall Study|Withdrawal by Subject|4|||
126784385|NCT01766921|456165805|FG000|Overall Study|Administrative Reason|5|||
126784386|NCT01766921|456165806|FG001|Overall Study|Administrative Reason|5|||
126784387|NCT01766921|456165805|FG000|Overall Study|Death|1|||
126784388|NCT01766921|456165806|FG001|Overall Study|Death|1|||
126629489|NCT03512288|455602370|FG000|Overall Study|Withdrawal by parent/guardian|14|||
126784389|NCT01766921|456165805|FG000|Overall Study|Lost to Follow-up|1|||
126784390|NCT01766921|456165806|FG001|Overall Study|Lost to Follow-up|3|||
126784391|NCT01766921|456165805|FG000|Overall Study|Unclassified|2|||
126784392|NCT01766921|456165806|FG001|Overall Study|Unclassified|2|||
126629490|NCT03512288|455602371|FG001|Overall Study|Withdrawal by parent/guardian|18|||
126629491|NCT03512288|455602370|FG000|Overall Study|Other|1|||
126629492|NCT03512288|455602371|FG001|Overall Study|Other|1|||
126629493|NCT03512288|455602370|FG000|Overall Study|Randomized but not treated|1|||
126629494|NCT03512288|455602371|FG001|Overall Study|Randomized but not treated|1|||
126629495|NCT01077622|455602372|FG000|Overall Study|Physician Decision|2|||
126629496|NCT01077622|455602372|FG000|Overall Study|Withdrawal by Subject|1|||
126629497|NCT01831726|455602376|FG000|Overall Study|Adverse Event|16|||
126629498|NCT01831726|455602376|FG000|Overall Study|Death|7|||
126629499|NCT01831726|455602376|FG000|Overall Study|Disease Progression|49|||
126784393|NCT01766921|456165805|FG000|Overall Study|Protocol Violation|1|||
126784394|NCT01766921|456165806|FG001|Overall Study|Protocol Violation|1|||
126784395|NCT01766921|456165805|FG000|Overall Study|Withdrawal by Subject|14|||
126784396|NCT01766921|456165806|FG001|Overall Study|Withdrawal by Subject|5|||
126784397|NCT01659567|456165809|FG000|Overall Study|Lack of Efficacy|22|||
126784398|NCT01659567|456165809|FG000|Overall Study|Switched to Pegferon|6|||
126784399|NCT01659567|456165809|FG000|Overall Study|Adverse Event|12|||
126784400|NCT01659567|456165809|FG000|Overall Study|Good result at early stage of treatment|5|||
126784401|NCT01659567|456165809|FG000|Overall Study|Withdrawal by Subject|64|||
126784402|NCT01659567|456165809|FG000|Overall Study|Progression of the main disease|1|||
126784403|NCT01659567|456165809|FG000|Overall Study|Other|13|||
126784404|NCT03019965|456165810|FG000|Overall Study|Withdrawal by Subject|1|||
126784405|NCT03019965|456165811|FG001|Overall Study|Withdrawal by Subject|0|||
126784406|NCT03019965|456165810|FG000|Overall Study|Protocol Violation|1|||
126784407|NCT03019965|456165811|FG001|Overall Study|Protocol Violation|3|||
126784408|NCT03019965|456165810|FG000|Overall Study|viral or fungal infection|3|||
126784409|NCT03019965|456165811|FG001|Overall Study|viral or fungal infection|4|||
126784410|NCT03019965|456165810|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
126784411|NCT03019965|456165811|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
126784412|NCT03019965|456165810|FG000|Overall Study|Physician Decision|1|||
126784413|NCT03019965|456165811|FG001|Overall Study|Physician Decision|1|||
126784414|NCT01915732|456165812|FG000|Overall Study|Withdrawal by Subject|18|||
126784415|NCT01915732|456165813|FG001|Overall Study|Withdrawal by Subject|18|||
126784416|NCT01915732|456165812|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
126784417|NCT01915732|456165813|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
126784418|NCT01915732|456165812|FG000|Overall Study|Adverse Event|12|||
126784419|NCT01915732|456165813|FG001|Overall Study|Adverse Event|4|||
126784420|NCT01915732|456165812|FG000|Overall Study|Protocol Violation|5|||
126784421|NCT01915732|456165813|FG001|Overall Study|Protocol Violation|5|||
126784422|NCT01915732|456165812|FG000|Overall Study|Lack of Efficacy|6|||
126784423|NCT01915732|456165813|FG001|Overall Study|Lack of Efficacy|11|||
126784424|NCT01915732|456165812|FG000|Overall Study|Lost to Follow-up|22|||
126784425|NCT01915732|456165813|FG001|Overall Study|Lost to Follow-up|26|||
126784426|NCT01915732|456165812|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
126784427|NCT01915732|456165813|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
126784428|NCT01915732|456165812|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
126784429|NCT01915732|456165813|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
126784430|NCT01915732|456165812|FG000|Overall Study|Drug Release Error|1|||
126784431|NCT01915732|456165813|FG001|Overall Study|Drug Release Error|0|||
126784432|NCT01915732|456165812|FG000|Overall Study|Recovered|1|||
126784433|NCT01915732|456165813|FG001|Overall Study|Recovered|0|||
126784434|NCT01915732|456165812|FG000|Overall Study|Pregnancy|1|||
126784435|NCT01915732|456165813|FG001|Overall Study|Pregnancy|0|||
126784436|NCT01915732|456165812|FG000|Overall Study|Poor Perceived Efficacy|1|||
126784437|NCT01915732|456165813|FG001|Overall Study|Poor Perceived Efficacy|0|||
126784438|NCT01915732|456165812|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
126784439|NCT01915732|456165813|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
126784440|NCT01915732|456165812|FG000|Overall Study|Got Well|0|||
126784441|NCT01915732|456165813|FG001|Overall Study|Got Well|1|||
126784442|NCT01915732|456165812|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
126784443|NCT01915732|456165813|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
126784444|NCT01915732|456165812|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
126784445|NCT01915732|456165813|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
126784446|NCT01915732|456165812|FG000|Overall Study|Job Transfer|0|||
126629500|NCT01831726|455602376|FG000|Overall Study|Physician Decision|1|||
126629501|NCT01831726|455602376|FG000|Overall Study|Subject/guardian decision|7|||
126629502|NCT01283971|455602383|FG000|Overall Study|Adverse Event|3|||
126629503|NCT01283971|455602384|FG001|Overall Study|Adverse Event|5|||
126629504|NCT01283971|455602383|FG000|Overall Study|Insufficient therapeutic responses|3|||
126629505|NCT01283971|455602384|FG001|Overall Study|Insufficient therapeutic responses|3|||
126629506|NCT01283971|455602383|FG000|Overall Study|Protocol Violation|5|||
126784447|NCT01915732|456165813|FG001|Overall Study|Job Transfer|1|||
126784448|NCT01915732|456165812|FG000|Overall Study|Improper Facial Procedure|0|||
126784449|NCT01915732|456165813|FG001|Overall Study|Improper Facial Procedure|1|||
126784450|NCT01915732|456165812|FG000|Overall Study|Poor Conscious Effect|0|||
126784451|NCT01915732|456165813|FG001|Overall Study|Poor Conscious Effect|1|||
126784452|NCT02015793|456165820|FG000|Overall Study|Adverse Event|3|||
126784453|NCT02015793|456165821|FG001|Overall Study|Adverse Event|3|||
126784454|NCT02015793|456165820|FG000|Overall Study|Withdrawal by Subject|1|||
126784455|NCT02015793|456165821|FG001|Overall Study|Withdrawal by Subject|1|||
126784456|NCT00601354|456165822|FG000|Overall Study|Lost to Follow-up|4|||
126784457|NCT00601354|456165823|FG001|Overall Study|Lost to Follow-up|5|||
126784458|NCT00619385|456165826|FG000|Overall Study|Adverse Event|0|||
126784459|NCT00619385|456165827|FG001|Overall Study|Adverse Event|0|||
126784460|NCT00619385|456165828|FG002|Overall Study|Adverse Event|3|||
126784461|NCT00619385|456165826|FG000|Overall Study|Other|1|||
126784462|NCT00619385|456165827|FG001|Overall Study|Other|2|||
126784463|NCT00619385|456165828|FG002|Overall Study|Other|1|||
126784464|NCT02041702|456165831|FG000|Overall Study|Lost to Follow-up|1|||
126784465|NCT02041702|456165832|FG001|Overall Study|Lost to Follow-up|6|||
126784466|NCT02041702|456165831|FG000|Overall Study|Death|4|||
126784467|NCT02041702|456165832|FG001|Overall Study|Death|0|||
126784468|NCT02041702|456165831|FG000|Overall Study|Withdrawal by Subject|4|||
126784469|NCT02041702|456165832|FG001|Overall Study|Withdrawal by Subject|3|||
126784470|NCT02041702|456165831|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
126784471|NCT02041702|456165832|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
126784472|NCT02041702|456165831|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
126784473|NCT02041702|456165832|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
126784474|NCT00717756|456165836|FG000|Overall Study|Withdrawal by Subject|1|||
126784475|NCT03977584|456165837|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
126784476|NCT03977584|456165838|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
126784477|NCT03977584|456165839|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
126784478|NCT00458302|456167790|FG000|Overall Study|Adverse Event|4|||
126784479|NCT00458302|456167791|FG001|Overall Study|Adverse Event|14|||
126784480|NCT00458302|456167790|FG000|Overall Study|Pregnancy|2|||
126784481|NCT00458302|456167791|FG001|Overall Study|Pregnancy|1|||
126784482|NCT00458302|456167790|FG000|Overall Study|Protocol Violation|0|||
126784483|NCT00458302|456167791|FG001|Overall Study|Protocol Violation|2|||
126784484|NCT00458302|456167790|FG000|Overall Study|Withdrawal by Subject|6|||
126784485|NCT00458302|456167791|FG001|Overall Study|Withdrawal by Subject|4|||
126784486|NCT00458302|456167790|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
126784487|NCT00458302|456167791|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
126784488|NCT00458302|456167790|FG000|Overall Study|Study Termination By Sponsor|1|||
126784489|NCT00458302|456167791|FG001|Overall Study|Study Termination By Sponsor|0|||
126784490|NCT00458302|456167790|FG000|Overall Study|Lost to Follow-up|2|||
126784491|NCT00458302|456167791|FG001|Overall Study|Lost to Follow-up|0|||
126784492|NCT00458302|456167790|FG000|Overall Study|Other|4|||
126784493|NCT00458302|456167791|FG001|Overall Study|Other|2|||
126784494|NCT02178709|456167792|FG000|Overall Study|Adverse Event|5|||
126784495|NCT02178709|456167792|FG000|Overall Study|Death|2|||
126784496|NCT02178709|456167792|FG000|Overall Study|Withdrawal by Subject|2|||
126784497|NCT02178709|456167792|FG000|Overall Study|Physician Decision|2|||
126784498|NCT02178709|456167792|FG000|Overall Study|Disease Progression|5|||
126784499|NCT04849988|456167793|FG000|Overall Study|Lack of Efficacy|3|||
126784500|NCT04849988|456167794|FG001|Overall Study|Lack of Efficacy|4|||
126784501|NCT04849988|456167795|FG002|Overall Study|Lack of Efficacy|1|||
126784502|NCT04849988|456167796|FG003|Overall Study|Lack of Efficacy|4|||
126784503|NCT04849988|456167793|FG000|Overall Study|Other reasons|1|||
126784504|NCT04849988|456167794|FG001|Overall Study|Other reasons|2|||
126784505|NCT04849988|456167795|FG002|Overall Study|Other reasons|2|||
126784506|NCT04849988|456167796|FG003|Overall Study|Other reasons|1|||
126784507|NCT01052116|456167801|FG000|Overall Study|Lost to Follow-up|11|||
126784508|NCT01052116|456167802|FG001|Overall Study|Lost to Follow-up|17|||
126784509|NCT01052116|456167801|FG000|Overall Study|Withdrawal by Subject|3|||
126784510|NCT01052116|456167802|FG001|Overall Study|Withdrawal by Subject|6|||
126784511|NCT01052116|456167801|FG000|Overall Study|Spirometry not performed|0|||
126784512|NCT01052116|456167802|FG001|Overall Study|Spirometry not performed|4|||
126784513|NCT02146430|456167803|FG000|Overall Study|Protocol Violation|5|||
126784514|NCT02146430|456167804|FG001|Overall Study|Protocol Violation|4|||
126784515|NCT02146430|456167805|FG002|Overall Study|Protocol Violation|8|||
126784516|NCT02146430|456167806|FG003|Overall Study|Protocol Violation|6|||
126784517|NCT02146430|456167803|FG000|Overall Study|Lack of Efficacy|13|||
126784518|NCT02146430|456167804|FG001|Overall Study|Lack of Efficacy|11|||
126784519|NCT02146430|456167805|FG002|Overall Study|Lack of Efficacy|8|||
126784520|NCT02146430|456167806|FG003|Overall Study|Lack of Efficacy|5|||
126784521|NCT02146430|456167803|FG000|Overall Study|Adverse Event|20|||
126784522|NCT02146430|456167804|FG001|Overall Study|Adverse Event|40|||
126784523|NCT02146430|456167805|FG002|Overall Study|Adverse Event|32|||
126784524|NCT02146430|456167806|FG003|Overall Study|Adverse Event|49|||
126784525|NCT02146430|456167803|FG000|Overall Study|Reason missing or not reported|2|||
126784526|NCT02146430|456167804|FG001|Overall Study|Reason missing or not reported|3|||
126784527|NCT02146430|456167805|FG002|Overall Study|Reason missing or not reported|4|||
126784528|NCT02146430|456167806|FG003|Overall Study|Reason missing or not reported|5|||
126784529|NCT02146430|456167803|FG000|Overall Study|Withdrawal by Subject|27|||
126784530|NCT02146430|456167804|FG001|Overall Study|Withdrawal by Subject|29|||
126784531|NCT02146430|456167805|FG002|Overall Study|Withdrawal by Subject|30|||
126784532|NCT02146430|456167806|FG003|Overall Study|Withdrawal by Subject|34|||
126784533|NCT01893905|456167807|FG000|Overall Study|Withdrawal by Subject|1|||
126784534|NCT01893905|456167808|FG001|Overall Study|Withdrawal by Subject|0|||
126784535|NCT01893905|456167807|FG000|Overall Study|Adverse Event|9|||
126784536|NCT01893905|456167808|FG001|Overall Study|Adverse Event|3|||
126784537|NCT01893905|456167807|FG000|Overall Study|Lack of Efficacy|5|||
126784538|NCT01893905|456167808|FG001|Overall Study|Lack of Efficacy|7|||
126784539|NCT01893905|456167807|FG000|Overall Study|Lost to Follow-up|1|||
126784540|NCT01893905|456167808|FG001|Overall Study|Lost to Follow-up|0|||
126784541|NCT01893905|456167807|FG000|Overall Study|Protocol Violation|6|||
126784542|NCT01893905|456167808|FG001|Overall Study|Protocol Violation|1|||
126784543|NCT01893905|456167807|FG000|Overall Study|Lack of adherence to treatment|2|||
126784544|NCT01893905|456167808|FG001|Overall Study|Lack of adherence to treatment|0|||
126784545|NCT01893905|456167807|FG000|Overall Study|Other reason|1|||
126784546|NCT01893905|456167808|FG001|Overall Study|Other reason|3|||
126784547|NCT01768858|456167809|FG000|Overall Study|Lost to Follow-up|9|||
126784548|NCT01768858|456167809|FG000|Overall Study|Lack of Efficacy|8|||
126784549|NCT01768858|456167809|FG000|Overall Study|Serious Adverse Event|1|||
126784550|NCT01768858|456167809|FG000|Overall Study|Participant moved to Germany|1|||
126784551|NCT01768858|456167809|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
126784552|NCT01768858|456167809|FG000|Overall Study|Exanthema|1|||
126784553|NCT01768858|456167809|FG000|Overall Study|Withdrawal by Subject|1|||
126784554|NCT00614055|456167813|FG000|Overall Study|Adverse Event|1|||
126784555|NCT00614055|456167814|FG001|Overall Study|Adverse Event|0|||
126784556|NCT00614055|456167815|FG002|Overall Study|Adverse Event|0|||
126784557|NCT00614055|456167813|FG000|Overall Study|Protocol Violation|2|||
126784558|NCT00614055|456167814|FG001|Overall Study|Protocol Violation|2|||
126784559|NCT00614055|456167815|FG002|Overall Study|Protocol Violation|1|||
126784560|NCT00614055|456167813|FG000|Overall Study|Lack of Efficacy|0|||
126784561|NCT00614055|456167814|FG001|Overall Study|Lack of Efficacy|0|||
126784562|NCT00614055|456167815|FG002|Overall Study|Lack of Efficacy|2|||
126784563|NCT00614055|456167813|FG000|Overall Study|Unclassified|1|||
126784564|NCT00614055|456167814|FG001|Overall Study|Unclassified|4|||
126784565|NCT00614055|456167815|FG002|Overall Study|Unclassified|2|||
126784566|NCT04820842|456167818|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
126784567|NCT04820842|456167819|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
126784568|NCT04820842|456167820|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
126784569|NCT04820842|456167821|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
126784570|NCT04820842|456167822|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
126784571|NCT04820842|456167823|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
126784572|NCT04820842|456167824|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
126784573|NCT04820842|456167818|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
126784574|NCT04820842|456167819|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
126784575|NCT04820842|456167820|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
126784576|NCT04820842|456167821|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126784577|NCT04820842|456167822|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126784578|NCT04820842|456167823|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126784579|NCT04820842|456167824|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126784580|NCT04820842|456167818|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126784581|NCT04820842|456167819|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
126784582|NCT04820842|456167820|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126784583|NCT04820842|456167821|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126784584|NCT04820842|456167822|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126784585|NCT04820842|456167823|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126784586|NCT04820842|456167824|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
126784587|NCT04820842|456167818|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126784588|NCT04820842|456167819|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126784589|NCT04820842|456167820|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126784590|NCT04820842|456167821|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
126784591|NCT04820842|456167822|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126784592|NCT04820842|456167823|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
126784593|NCT04820842|456167824|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
126784594|NCT01296932|456167825|FG000|Overall Study|Dose limiting toxicity|0|||
126784595|NCT01296932|456167826|FG001|Overall Study|Dose limiting toxicity|0|||
126784596|NCT01296932|456167827|FG002|Overall Study|Dose limiting toxicity|0|||
126784597|NCT01296932|456167828|FG003|Overall Study|Dose limiting toxicity|0|||
126784598|NCT01296932|456167829|FG004|Overall Study|Dose limiting toxicity|0|||
126784599|NCT01296932|456167830|FG005|Overall Study|Dose limiting toxicity|0|||
126784600|NCT01296932|456167831|FG006|Overall Study|Dose limiting toxicity|1|||
126784601|NCT01296932|456167832|FG007|Overall Study|Dose limiting toxicity|0|||
126784602|NCT01296932|456167833|FG008|Overall Study|Dose limiting toxicity|1|||
126784603|NCT01296932|456167825|FG000|Overall Study|Progressive disease|2|||
126784604|NCT01296932|456167826|FG001|Overall Study|Progressive disease|0|||
126784605|NCT01296932|456167827|FG002|Overall Study|Progressive disease|1|||
126784606|NCT01296932|456167828|FG003|Overall Study|Progressive disease|1|||
126784607|NCT01296932|456167829|FG004|Overall Study|Progressive disease|2|||
126784608|NCT01296932|456167830|FG005|Overall Study|Progressive disease|3|||
126784609|NCT01296932|456167831|FG006|Overall Study|Progressive disease|1|||
126784610|NCT01296932|456167832|FG007|Overall Study|Progressive disease|0|||
126784611|NCT01296932|456167833|FG008|Overall Study|Progressive disease|0|||
126784612|NCT01296932|456167825|FG000|Overall Study|Withdrawal by Subject|0|||
126784613|NCT01296932|456167826|FG001|Overall Study|Withdrawal by Subject|0|||
126784614|NCT01296932|456167827|FG002|Overall Study|Withdrawal by Subject|1|||
126784615|NCT01296932|456167828|FG003|Overall Study|Withdrawal by Subject|1|||
126784616|NCT01296932|456167829|FG004|Overall Study|Withdrawal by Subject|0|||
126784617|NCT01296932|456167830|FG005|Overall Study|Withdrawal by Subject|0|||
126784618|NCT01296932|456167831|FG006|Overall Study|Withdrawal by Subject|3|||
126784619|NCT01296932|456167832|FG007|Overall Study|Withdrawal by Subject|0|||
126784620|NCT01296932|456167833|FG008|Overall Study|Withdrawal by Subject|0|||
126784621|NCT01296932|456167825|FG000|Overall Study|Adverse Event|1|||
126784622|NCT01296932|456167826|FG001|Overall Study|Adverse Event|1|||
126784623|NCT01296932|456167827|FG002|Overall Study|Adverse Event|1|||
126784624|NCT01296932|456167828|FG003|Overall Study|Adverse Event|2|||
126784625|NCT01296932|456167829|FG004|Overall Study|Adverse Event|1|||
126784626|NCT01296932|456167830|FG005|Overall Study|Adverse Event|0|||
126784627|NCT01296932|456167831|FG006|Overall Study|Adverse Event|0|||
126784628|NCT01296932|456167832|FG007|Overall Study|Adverse Event|0|||
126784629|NCT01296932|456167833|FG008|Overall Study|Adverse Event|1|||
126784630|NCT01296932|456167825|FG000|Overall Study|Investigator decision|0|||
126784631|NCT01296932|456167826|FG001|Overall Study|Investigator decision|1|||
126784632|NCT01296932|456167827|FG002|Overall Study|Investigator decision|0|||
126784633|NCT01296932|456167828|FG003|Overall Study|Investigator decision|1|||
126784634|NCT01296932|456167829|FG004|Overall Study|Investigator decision|0|||
126784635|NCT01296932|456167830|FG005|Overall Study|Investigator decision|0|||
126784636|NCT01296932|456167831|FG006|Overall Study|Investigator decision|1|||
126784637|NCT01296932|456167832|FG007|Overall Study|Investigator decision|0|||
126784638|NCT01296932|456167833|FG008|Overall Study|Investigator decision|1|||
126784639|NCT01296932|456167825|FG000|Overall Study|No clinical benefit anymore|0|||
126784640|NCT01296932|456167826|FG001|Overall Study|No clinical benefit anymore|1|||
126784641|NCT01296932|456167827|FG002|Overall Study|No clinical benefit anymore|0|||
126784642|NCT01296932|456167828|FG003|Overall Study|No clinical benefit anymore|0|||
126784643|NCT01296932|456167829|FG004|Overall Study|No clinical benefit anymore|0|||
126784644|NCT01296932|456167830|FG005|Overall Study|No clinical benefit anymore|0|||
126784645|NCT01296932|456167831|FG006|Overall Study|No clinical benefit anymore|0|||
126784646|NCT01296932|456167832|FG007|Overall Study|No clinical benefit anymore|0|||
126784647|NCT01296932|456167833|FG008|Overall Study|No clinical benefit anymore|0|||
126784648|NCT01296932|456167825|FG000|Overall Study|Physician Decision|0|||
126784649|NCT01296932|456167826|FG001|Overall Study|Physician Decision|0|||
126784650|NCT01296932|456167827|FG002|Overall Study|Physician Decision|1|||
126784651|NCT01296932|456167828|FG003|Overall Study|Physician Decision|0|||
126784652|NCT01296932|456167829|FG004|Overall Study|Physician Decision|0|||
126784653|NCT01296932|456167830|FG005|Overall Study|Physician Decision|0|||
126784654|NCT01296932|456167831|FG006|Overall Study|Physician Decision|0|||
126784655|NCT01296932|456167832|FG007|Overall Study|Physician Decision|0|||
126784656|NCT01296932|456167833|FG008|Overall Study|Physician Decision|0|||
126784657|NCT01296932|456167825|FG000|Overall Study|IV problems, administration not possible|0|||
126784658|NCT01296932|456167826|FG001|Overall Study|IV problems, administration not possible|0|||
126784659|NCT01296932|456167827|FG002|Overall Study|IV problems, administration not possible|1|||
126784660|NCT01296932|456167828|FG003|Overall Study|IV problems, administration not possible|0|||
126784661|NCT01296932|456167829|FG004|Overall Study|IV problems, administration not possible|0|||
126784662|NCT01296932|456167830|FG005|Overall Study|IV problems, administration not possible|0|||
126784663|NCT01296932|456167831|FG006|Overall Study|IV problems, administration not possible|0|||
126784664|NCT01296932|456167832|FG007|Overall Study|IV problems, administration not possible|0|||
126784665|NCT01296932|456167833|FG008|Overall Study|IV problems, administration not possible|0|||
126784666|NCT01296932|456167825|FG000|Overall Study|per protocol|0|||
126784667|NCT01296932|456167826|FG001|Overall Study|per protocol|0|||
126784668|NCT01296932|456167827|FG002|Overall Study|per protocol|1|||
126784669|NCT01296932|456167828|FG003|Overall Study|per protocol|1|||
126784670|NCT01296932|456167829|FG004|Overall Study|per protocol|0|||
126784671|NCT01296932|456167830|FG005|Overall Study|per protocol|0|||
126784672|NCT01296932|456167831|FG006|Overall Study|per protocol|0|||
126784673|NCT01296932|456167832|FG007|Overall Study|per protocol|0|||
126784674|NCT01296932|456167833|FG008|Overall Study|per protocol|0|||
126784675|NCT01296932|456167825|FG000|Overall Study|Low benefit and too many side effects|0|||
126784676|NCT01296932|456167826|FG001|Overall Study|Low benefit and too many side effects|0|||
126784677|NCT01296932|456167827|FG002|Overall Study|Low benefit and too many side effects|0|||
126784678|NCT01296932|456167828|FG003|Overall Study|Low benefit and too many side effects|0|||
126784679|NCT01296932|456167829|FG004|Overall Study|Low benefit and too many side effects|0|||
126784680|NCT01296932|456167830|FG005|Overall Study|Low benefit and too many side effects|0|||
126784681|NCT01296932|456167831|FG006|Overall Study|Low benefit and too many side effects|0|||
126784682|NCT01296932|456167832|FG007|Overall Study|Low benefit and too many side effects|1|||
126784683|NCT01296932|456167833|FG008|Overall Study|Low benefit and too many side effects|0|||
126784684|NCT01296932|456167825|FG000|Overall Study|No adequate treatment response|0|||
126784685|NCT01296932|456167826|FG001|Overall Study|No adequate treatment response|0|||
126784686|NCT01296932|456167827|FG002|Overall Study|No adequate treatment response|0|||
126784687|NCT01296932|456167828|FG003|Overall Study|No adequate treatment response|0|||
126784688|NCT01296932|456167829|FG004|Overall Study|No adequate treatment response|0|||
126784689|NCT01296932|456167830|FG005|Overall Study|No adequate treatment response|0|||
126784690|NCT01296932|456167831|FG006|Overall Study|No adequate treatment response|0|||
126784691|NCT01296932|456167832|FG007|Overall Study|No adequate treatment response|1|||
126784692|NCT01296932|456167833|FG008|Overall Study|No adequate treatment response|0|||
126784693|NCT01296932|456167825|FG000|Overall Study|Dosage already reduced, AE still present|0|||
126784694|NCT01296932|456167826|FG001|Overall Study|Dosage already reduced, AE still present|0|||
126784695|NCT01296932|456167827|FG002|Overall Study|Dosage already reduced, AE still present|0|||
126784696|NCT01296932|456167828|FG003|Overall Study|Dosage already reduced, AE still present|0|||
126784697|NCT01296932|456167829|FG004|Overall Study|Dosage already reduced, AE still present|0|||
126784698|NCT01296932|456167830|FG005|Overall Study|Dosage already reduced, AE still present|0|||
126784699|NCT01296932|456167831|FG006|Overall Study|Dosage already reduced, AE still present|0|||
126784700|NCT01296932|456167832|FG007|Overall Study|Dosage already reduced, AE still present|0|||
126784701|NCT01296932|456167833|FG008|Overall Study|Dosage already reduced, AE still present|1|||
126784702|NCT02848599|456167836|FG000|Overall Study|Protocol Violation|7|||
126784703|NCT02848599|456167837|FG001|Overall Study|Protocol Violation|9|||
126784704|NCT02352337|456167838|FG000|Overall Study|Patients never treated|4|||
126784705|NCT02352337|456167839|FG001|Overall Study|Patients never treated|1|||
126784706|NCT02352337|456167840|FG002|Overall Study|Patients never treated|2|||
126784707|NCT01090765|456167841|FG000|Overall Study|Patient withdrew consent|0|||
126784708|NCT01090765|456167842|FG001|Overall Study|Patient withdrew consent|0|||
126784709|NCT01090765|456167843|FG002|Overall Study|Patient withdrew consent|0|||
126784710|NCT01090765|456167844|FG003|Overall Study|Patient withdrew consent|0|||
126784711|NCT01090765|456167845|FG004|Overall Study|Patient withdrew consent|1|||
126784712|NCT01090765|456167846|FG005|Overall Study|Patient withdrew consent|1|||
126784713|NCT01090765|456167841|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
126784714|NCT01090765|456167842|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
126784715|NCT01090765|456167843|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
126784716|NCT01090765|456167844|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
126784717|NCT01090765|456167845|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
126784718|NCT01090765|456167846|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
126784719|NCT01090765|456167841|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
126784720|NCT01090765|456167842|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
126784721|NCT01090765|456167843|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
126784722|NCT01090765|456167844|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
126784723|NCT01090765|456167845|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
126784724|NCT01090765|456167846|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
126784725|NCT02623959|456167850|FG000|Overall Study|Progression|0|||
126784726|NCT02623959|456167851|FG001|Overall Study|Progression|1|||
126784727|NCT02336737|456167854|FG000|Overall Study|Withdrawal by Subject|5|||
126784728|NCT02336737|456167854|FG000|Overall Study|Physician Decision|8|||
126784729|NCT00635778|456167856|FG000|Overall Study|Adverse Event|1|||
126784730|NCT00635778|456167857|FG001|Overall Study|Adverse Event|0|||
126784731|NCT00635778|456167858|FG002|Overall Study|Adverse Event|0|||
126784732|NCT00635778|456167859|FG003|Overall Study|Adverse Event|3|||
126784733|NCT00635778|456167860|FG004|Overall Study|Adverse Event|3|||
126784734|NCT00635778|456167861|FG005|Overall Study|Adverse Event|6|||
126784735|NCT00635778|456167862|FG006|Overall Study|Adverse Event|1|||
126784736|NCT00635778|456167856|FG000|Overall Study|Withdrawal by Subject|0|||
126784737|NCT00635778|456167857|FG001|Overall Study|Withdrawal by Subject|0|||
126629507|NCT01283971|455602384|FG001|Overall Study|Protocol Violation|1|||
126629508|NCT01283971|455602383|FG000|Overall Study|Refused treatment|3|||
126784738|NCT00635778|456167858|FG002|Overall Study|Withdrawal by Subject|0|||
126784739|NCT00635778|456167859|FG003|Overall Study|Withdrawal by Subject|1|||
126784740|NCT00635778|456167860|FG004|Overall Study|Withdrawal by Subject|0|||
126784741|NCT00635778|456167861|FG005|Overall Study|Withdrawal by Subject|1|||
126784742|NCT00635778|456167862|FG006|Overall Study|Withdrawal by Subject|1|||
126784743|NCT00635778|456167856|FG000|Overall Study|Progressive disease|0|||
126784744|NCT00635778|456167857|FG001|Overall Study|Progressive disease|3|||
126784745|NCT00635778|456167858|FG002|Overall Study|Progressive disease|3|||
126784746|NCT00635778|456167859|FG003|Overall Study|Progressive disease|4|||
126784747|NCT00635778|456167860|FG004|Overall Study|Progressive disease|5|||
126784748|NCT00635778|456167861|FG005|Overall Study|Progressive disease|14|||
126784749|NCT00635778|456167862|FG006|Overall Study|Progressive disease|4|||
126784750|NCT01884025|456167863|FG000|Overall Study|Lost to Follow-up|3|||
126784751|NCT01884025|456167864|FG001|Overall Study|Lost to Follow-up|4|||
126784752|NCT02324465|456167865|FG000|Overall Study|device failure|0|||
126784753|NCT02324465|456167866|FG001|Overall Study|device failure|1|||
126784754|NCT02655237|456167869|FG000|Overall Study|Adverse Event|10|||
126784755|NCT02655237|456167870|FG001|Overall Study|Adverse Event|7|||
126784756|NCT02655237|456167869|FG000|Overall Study|Protocol Deviation|2|||
126784757|NCT02655237|456167870|FG001|Overall Study|Protocol Deviation|0|||
126784758|NCT02655237|456167869|FG000|Overall Study|Withdrawal by Participant|1|||
126784759|NCT02655237|456167870|FG001|Overall Study|Withdrawal by Participant|2|||
126784760|NCT02655237|456167869|FG000|Overall Study|Lack of Efficacy|0|||
126784761|NCT02655237|456167870|FG001|Overall Study|Lack of Efficacy|1|||
126784762|NCT02655237|456167869|FG000|Overall Study|Recovery Leading to Surgery|2|||
126784763|NCT02655237|456167870|FG001|Overall Study|Recovery Leading to Surgery|1|||
126784764|NCT02655237|456167869|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
126784765|NCT02655237|456167870|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
126784766|NCT02655237|456167869|FG000|Overall Study|Randomized but Not Treated|1|||
126784767|NCT02655237|456167870|FG001|Overall Study|Randomized but Not Treated|0|||
126784768|NCT01860976|456167873|FG000|Blinded Treatment|Adverse Event|1|||
126784769|NCT01860976|456167874|FG001|Blinded Treatment|Adverse Event|3|||
126784770|NCT01860976|456167873|FG000|Blinded Treatment|Lack of Efficacy|5|||
126784771|NCT01860976|456167874|FG001|Blinded Treatment|Lack of Efficacy|12|||
126784772|NCT01860976|456167873|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
126784773|NCT01860976|456167874|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
126784774|NCT01860976|456167873|FG000|Blinded Treatment|Withdrawal by Subject|3|||
126784775|NCT01860976|456167874|FG001|Blinded Treatment|Withdrawal by Subject|5|||
126784776|NCT01860976|456167873|FG000|Blinded Treatment|Subject no longer met criteria|1|||
126784777|NCT01860976|456167874|FG001|Blinded Treatment|Subject no longer met criteria|0|||
126784778|NCT01860976|456167873|FG000|Blinded Treatment|Entered Open-Label in error|0|||
126784779|NCT01860976|456167874|FG001|Blinded Treatment|Entered Open-Label in error|1|||
126784780|NCT01860976|456167873|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
126784781|NCT01860976|456167874|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
126784782|NCT01860976|456167873|FG000|Open-Label|Adverse Event|2|||
126784783|NCT01860976|456167874|FG001|Open-Label|Adverse Event|4|||
126784784|NCT01860976|456167873|FG000|Open-Label|Lack of Efficacy|16|||
126784785|NCT01860976|456167874|FG001|Open-Label|Lack of Efficacy|8|||
126784786|NCT01860976|456167873|FG000|Open-Label|Lost to Follow-up|1|||
126784787|NCT01860976|456167874|FG001|Open-Label|Lost to Follow-up|2|||
126784788|NCT01860976|456167873|FG000|Open-Label|Subject request discontinue treatment|4|||
126784789|NCT01860976|456167874|FG001|Open-Label|Subject request discontinue treatment|3|||
126784790|NCT01860976|456167873|FG000|Open-Label|Withdrawal by Subject|4|||
126784791|NCT01860976|456167874|FG001|Open-Label|Withdrawal by Subject|1|||
126784792|NCT01860976|456167873|FG000|Open-Label|Other Reasons|1|||
126784793|NCT01860976|456167874|FG001|Open-Label|Other Reasons|1|||
126784794|NCT01860976|456167873|FG000|Long Term Extension|Adverse Event|4|||
126784795|NCT01860976|456167874|FG001|Long Term Extension|Adverse Event|0|||
126784796|NCT01860976|456167873|FG000|Long Term Extension|Lack of Efficacy|2|||
126784797|NCT01860976|456167874|FG001|Long Term Extension|Lack of Efficacy|0|||
126784798|NCT01860976|456167873|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
126784799|NCT01860976|456167874|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
126784800|NCT01860976|456167873|FG000|Long Term Extension|Lost to Follow-up|2|||
126784801|NCT01860976|456167874|FG001|Long Term Extension|Lost to Follow-up|0|||
126784802|NCT01860976|456167873|FG000|Long Term Extension|subject withdrew consent|7|||
126784803|NCT01860976|456167874|FG001|Long Term Extension|subject withdrew consent|0|||
126784804|NCT02227862|456167875|FG000|Overall Study|Protocol Violation|7|||
126784805|NCT02227862|456167876|FG001|Overall Study|Protocol Violation|9|||
126784806|NCT02227862|456167875|FG000|Overall Study|Other|0|||
126784807|NCT02227862|456167876|FG001|Overall Study|Other|2|||
126784808|NCT02227862|456167875|FG000|Overall Study|Adverse Event|4|||
126784809|NCT02227862|456167876|FG001|Overall Study|Adverse Event|3|||
126784810|NCT02227862|456167875|FG000|Overall Study|Withdrawal by Subject|7|||
126784811|NCT02227862|456167876|FG001|Overall Study|Withdrawal by Subject|6|||
126784812|NCT02227862|456167875|FG000|Overall Study|Lost to Follow-up|1|||
126784813|NCT02227862|456167876|FG001|Overall Study|Lost to Follow-up|2|||
126784814|NCT02907203|456167881|FG000|Overall Study|Death|1|||
126784815|NCT02907203|456167881|FG000|Overall Study|Lost to Follow-up|3|||
126784816|NCT02907203|456167881|FG000|Overall Study|Withdrawal by Subject|3|||
126784817|NCT02907203|456167881|FG000|Overall Study|Surgical bypass|1|||
126784818|NCT00760383|456167882|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
126784819|NCT00760383|456167883|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
126784820|NCT01816477|456167885|FG000|Overall Study|Withdrawal by Subject|13|||
126784821|NCT01816477|456167886|FG001|Overall Study|Withdrawal by Subject|1|||
126784822|NCT01816477|456167885|FG000|Overall Study|Unable to tolerate catheter placement|3|||
126784823|NCT01816477|456167886|FG001|Overall Study|Unable to tolerate catheter placement|0|||
126784824|NCT00819247|456167887|FG000|Overall Study|Adverse Event|0|||
126784825|NCT00819247|456167888|FG001|Overall Study|Adverse Event|5|||
126784826|NCT00819247|456167889|FG002|Overall Study|Adverse Event|3|||
126784827|NCT00819247|456167887|FG000|Overall Study|Insufficient testosterone response|5|||
126784828|NCT00819247|456167888|FG001|Overall Study|Insufficient testosterone response|8|||
126784829|NCT00819247|456167889|FG002|Overall Study|Insufficient testosterone response|10|||
126784830|NCT00819247|456167887|FG000|Overall Study|Withdrawal by Subject|1|||
126784831|NCT00819247|456167888|FG001|Overall Study|Withdrawal by Subject|0|||
126784832|NCT00819247|456167889|FG002|Overall Study|Withdrawal by Subject|0|||
126784833|NCT00819247|456167887|FG000|Overall Study|Protocol Violation|1|||
126784834|NCT00819247|456167888|FG001|Overall Study|Protocol Violation|0|||
126784835|NCT00819247|456167889|FG002|Overall Study|Protocol Violation|1|||
126784836|NCT00819247|456167887|FG000|Overall Study|Mistakenly withdrawn|0|||
126784837|NCT00819247|456167888|FG001|Overall Study|Mistakenly withdrawn|1|||
126784838|NCT00819247|456167889|FG002|Overall Study|Mistakenly withdrawn|0|||
126784839|NCT00819247|456167887|FG000|Overall Study|Bad prostate-specific antigen response|3|||
126784840|NCT00819247|456167888|FG001|Overall Study|Bad prostate-specific antigen response|2|||
126784841|NCT00819247|456167889|FG002|Overall Study|Bad prostate-specific antigen response|0|||
126784842|NCT00819247|456167887|FG000|Overall Study|Other|1|||
126784843|NCT00819247|456167888|FG001|Overall Study|Other|0|||
126784844|NCT00819247|456167889|FG002|Overall Study|Other|0|||
126784845|NCT02540356|456167893|FG000|Overall Study|Terminated due to disease progression|1|||
126784846|NCT02540356|456167894|FG001|Overall Study|Terminated due to disease progression|0|||
126784847|NCT01513148|456167895|FG000|Overall Study|Protocol Violation|2|||
126784848|NCT01513148|456167896|FG001|Overall Study|Protocol Violation|2|||
126784849|NCT04652453|456167897|FG000|Overall Study|Death|8|||
126784850|NCT04652453|456167898|FG001|Overall Study|Death|2|||
126784851|NCT04652453|456167899|FG002|Overall Study|Death|0|||
126784852|NCT04652453|456167897|FG000|Overall Study|Hospice|5|||
126784853|NCT04652453|456167898|FG001|Overall Study|Hospice|5|||
126784854|NCT04652453|456167899|FG002|Overall Study|Hospice|0|||
126784855|NCT04652453|456167897|FG000|Overall Study|Withdrawal by Subject|2|||
126784856|NCT04652453|456167898|FG001|Overall Study|Withdrawal by Subject|0|||
126784857|NCT04652453|456167899|FG002|Overall Study|Withdrawal by Subject|0|||
126784858|NCT02978326|456167905|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
126784859|NCT02978326|456167906|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
126784860|NCT02978326|456167907|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
126784861|NCT02978326|456167905|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
126784862|NCT02978326|456167906|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
126784863|NCT02978326|456167907|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
126784864|NCT02978326|456167905|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
126784865|NCT02978326|456167906|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
126784866|NCT02978326|456167907|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
126784867|NCT02978326|456167905|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
126784868|NCT02978326|456167906|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
126784869|NCT02978326|456167907|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
126784870|NCT00947427|456167911|FG000|Overall Study|Withdrawal by Subject|1|||
126784871|NCT00947427|456167912|FG001|Overall Study|Withdrawal by Subject|3|||
126784872|NCT00947427|456167911|FG000|Overall Study|Protocol Violation|0|||
126784873|NCT00947427|456167912|FG001|Overall Study|Protocol Violation|1|||
126784874|NCT01411995|456167915|FG000|Overall Study|Failed IUD insertion|0|||
126784875|NCT01411995|456167916|FG001|Overall Study|Failed IUD insertion|1|||
126784876|NCT01937364|456167917|FG000|Overall Study|Adverse Event|2|||
126784877|NCT01937364|456167918|FG001|Overall Study|Adverse Event|1|||
126784878|NCT00936975|456167919|FG000|Overall Study|Withdrawal by Subject|1|||
126784879|NCT00936975|456167919|FG000|Overall Study|Disease progression|3|||
126784880|NCT00936975|456167919|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
126629509|NCT01283971|455602384|FG001|Overall Study|Refused treatment|1|||
126629510|NCT01283971|455602383|FG000|Overall Study|Failure to return|0|||
126784881|NCT04104646|456167920|FG000|Overall Study|Withdrawal by Subject|1|||
126784882|NCT04104646|456167921|FG001|Overall Study|Withdrawal by Subject|1|||
126784883|NCT04104646|456167920|FG000|Overall Study|Lost to Follow-up|1|||
126784884|NCT04104646|456167921|FG001|Overall Study|Lost to Follow-up|0|||
126784885|NCT04104646|456167920|FG000|Overall Study|Physician Decision|2|||
126784886|NCT04104646|456167921|FG001|Overall Study|Physician Decision|0|||
126784887|NCT02974153|456167922|FG000|Overall Study|Adverse Event|6|||
126784888|NCT02974153|456167923|FG001|Overall Study|Adverse Event|0|||
126784889|NCT02974153|456167924|FG002|Overall Study|Adverse Event|1|||
126784890|NCT02974153|456167922|FG000|Overall Study|Lack of Efficacy|6|||
126784891|NCT02974153|456167923|FG001|Overall Study|Lack of Efficacy|5|||
126784892|NCT02974153|456167924|FG002|Overall Study|Lack of Efficacy|10|||
126784893|NCT02974153|456167922|FG000|Overall Study|Lost to Follow-up|9|||
126784894|NCT02974153|456167923|FG001|Overall Study|Lost to Follow-up|10|||
126784895|NCT02974153|456167924|FG002|Overall Study|Lost to Follow-up|17|||
126784896|NCT02974153|456167922|FG000|Overall Study|Physician Decision|0|||
126784897|NCT02974153|456167923|FG001|Overall Study|Physician Decision|2|||
126784898|NCT02974153|456167924|FG002|Overall Study|Physician Decision|1|||
126784899|NCT02974153|456167922|FG000|Overall Study|Withdrawal by Subject|9|||
126784900|NCT02974153|456167923|FG001|Overall Study|Withdrawal by Subject|16|||
126784901|NCT02974153|456167924|FG002|Overall Study|Withdrawal by Subject|11|||
126784902|NCT02974153|456167922|FG000|Overall Study|Study Burden|8|||
126784903|NCT02974153|456167923|FG001|Overall Study|Study Burden|7|||
126784904|NCT02974153|456167924|FG002|Overall Study|Study Burden|3|||
126784905|NCT02974153|456167922|FG000|Overall Study|Other|14|||
126784906|NCT02974153|456167923|FG001|Overall Study|Other|8|||
126784907|NCT02974153|456167924|FG002|Overall Study|Other|7|||
126784908|NCT02277769|456167925|FG000|Overall Study|Protocol Violation|3|||
126784909|NCT02277769|456167926|FG001|Overall Study|Protocol Violation|3|||
126784910|NCT02277769|456167927|FG002|Overall Study|Protocol Violation|5|||
126784911|NCT02277769|456167925|FG000|Overall Study|Lack of Efficacy|17|||
126784912|NCT02277769|456167926|FG001|Overall Study|Lack of Efficacy|0|||
126784913|NCT02277769|456167927|FG002|Overall Study|Lack of Efficacy|4|||
126784914|NCT02277769|456167925|FG000|Overall Study|Adverse Event|14|||
126784915|NCT02277769|456167926|FG001|Overall Study|Adverse Event|2|||
126784916|NCT02277769|456167927|FG002|Overall Study|Adverse Event|4|||
126784917|NCT02277769|456167925|FG000|Overall Study|Other than specified above|12|||
126784918|NCT02277769|456167926|FG001|Overall Study|Other than specified above|8|||
126784919|NCT02277769|456167927|FG002|Overall Study|Other than specified above|5|||
126784920|NCT03730103|456167930|FG000|Overall Study|Did not meet inclusion criteria|0|||
126784921|NCT03730103|456167931|FG001|Overall Study|Did not meet inclusion criteria|5|||
126784922|NCT01488578|456167932|FG000|Overall Study|Protocol Violation|1836|||
126784923|NCT02308111|456167933|FG000|Overall Study|Adverse Event|31|||
126784924|NCT02308111|456167934|FG001|Overall Study|Adverse Event|19|||
126784925|NCT02308111|456167933|FG000|Overall Study|Death|9|||
126784926|NCT02308111|456167934|FG001|Overall Study|Death|6|||
126784927|NCT02308111|456167933|FG000|Overall Study|Lost to Follow-up|2|||
126784928|NCT02308111|456167934|FG001|Overall Study|Lost to Follow-up|7|||
126784929|NCT02308111|456167933|FG000|Overall Study|Physician Decision|6|||
126784930|NCT02308111|456167934|FG001|Overall Study|Physician Decision|17|||
126784931|NCT02308111|456167933|FG000|Overall Study|Protocol Violation|0|||
126784932|NCT02308111|456167934|FG001|Overall Study|Protocol Violation|1|||
126784933|NCT02308111|456167933|FG000|Overall Study|Withdrawal by Subject|28|||
126784934|NCT02308111|456167934|FG001|Overall Study|Withdrawal by Subject|38|||
126784935|NCT02308111|456167933|FG000|Overall Study|Study Terminated by Sponsor|72|||
126784936|NCT02308111|456167934|FG001|Overall Study|Study Terminated by Sponsor|61|||
126784937|NCT02308111|456167933|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
126784938|NCT02308111|456167934|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
126784939|NCT02308111|456167933|FG000|Overall Study|Site Closure|3|||
126784940|NCT02308111|456167934|FG001|Overall Study|Site Closure|3|||
126784941|NCT02308111|456167933|FG000|Overall Study|Non-compliance with Study Drug|3|||
126784942|NCT02308111|456167934|FG001|Overall Study|Non-compliance with Study Drug|1|||
126784943|NCT02308111|456167933|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
126784944|NCT02308111|456167934|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
126784945|NCT02308111|456167933|FG000|Overall Study|Liver Transplant|3|||
126784946|NCT02308111|456167934|FG001|Overall Study|Liver Transplant|3|||
126784947|NCT02308111|456167933|FG000|Overall Study|Liver Transplant Waitlist|2|||
126784948|NCT02308111|456167934|FG001|Overall Study|Liver Transplant Waitlist|2|||
126784949|NCT02308111|456167933|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
126784950|NCT02308111|456167934|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
126784951|NCT03271528|456167935|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
126784952|NCT03271528|456167936|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
126784953|NCT03271528|456167935|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
126784954|NCT03271528|456167936|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
126784955|NCT03271528|456167935|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
126784956|NCT03271528|456167936|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
126784957|NCT03271528|456167935|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
126784958|NCT03271528|456167936|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
126784959|NCT03271528|456167935|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
126784960|NCT03271528|456167936|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
126784961|NCT03271528|456167935|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
126784962|NCT03271528|456167936|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
126784963|NCT03271528|456167935|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
126784964|NCT03271528|456167936|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
126784965|NCT01873859|456167939|FG000|Overall Study|Withdrawal by Subject|0|||
126784966|NCT01873859|456167940|FG001|Overall Study|Withdrawal by Subject|4|||
126784967|NCT03504852|456167944|FG000|Overall Study|Withdrawal of informed consent|2|||
126784968|NCT03504852|456167945|FG001|Overall Study|Withdrawal of informed consent|1|||
126784969|NCT03504852|456167946|FG002|Overall Study|Withdrawal of informed consent|0|||
126784970|NCT03504852|456167944|FG000|Overall Study|Withdrawal by Subject|5|||
126784971|NCT03504852|456167945|FG001|Overall Study|Withdrawal by Subject|5|||
126784972|NCT03504852|456167946|FG002|Overall Study|Withdrawal by Subject|1|||
126784973|NCT03504852|456167944|FG000|Overall Study|Lost to Follow-up|4|||
126784974|NCT03504852|456167945|FG001|Overall Study|Lost to Follow-up|1|||
126784975|NCT03504852|456167946|FG002|Overall Study|Lost to Follow-up|0|||
126784976|NCT03504852|456167944|FG000|Overall Study|New therapy for study indication|1|||
126784977|NCT03504852|456167945|FG001|Overall Study|New therapy for study indication|0|||
126784978|NCT03504852|456167946|FG002|Overall Study|New therapy for study indication|0|||
126784979|NCT03504852|456167944|FG000|Overall Study|Lack of Efficacy|1|||
126784980|NCT03504852|456167945|FG001|Overall Study|Lack of Efficacy|2|||
126784981|NCT03504852|456167946|FG002|Overall Study|Lack of Efficacy|0|||
126784982|NCT03504852|456167944|FG000|Overall Study|Death|0|||
126784983|NCT03504852|456167945|FG001|Overall Study|Death|1|||
126784984|NCT03504852|456167946|FG002|Overall Study|Death|0|||
126784985|NCT03504852|456167944|FG000|Overall Study|Adverse Event|4|||
126784986|NCT03504852|456167945|FG001|Overall Study|Adverse Event|8|||
126784987|NCT03504852|456167946|FG002|Overall Study|Adverse Event|2|||
126784988|NCT01066052|456167947|FG000|Overall Study|Enrolled But Not Treated|3|||
126784989|NCT01066052|456167948|FG001|Overall Study|Enrolled But Not Treated|0|||
126784990|NCT02928848|456167949|FG000|Arm 2|Withdrawal by Subject|1|||
126784991|NCT02928848|456167950|FG001|Arm 2|Withdrawal by Subject|0|||
126784992|NCT03850509|456167951|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
126784993|NCT03850509|456167952|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
126784994|NCT00969332|456167953|FG000|Overall Study|Physician Decision|8|||
126784995|NCT00969332|456167953|FG000|Overall Study|Withdrawal by Subject|3|||
126784996|NCT01835145|456167956|FG000|Overall Study|Ineligible prior to treatment|1|||
126784997|NCT01835145|456167957|FG001|Overall Study|Ineligible prior to treatment|0|||
126784998|NCT02729896|456167958|FG000|Overall Study|Death|0|||
126784999|NCT02729896|456167959|FG001|Overall Study|Death|2|||
126785000|NCT02729896|456167960|FG002|Overall Study|Death|13|||
126785001|NCT02729896|456167958|FG000|Overall Study|Lost to Follow-up|0|||
126785002|NCT02729896|456167959|FG001|Overall Study|Lost to Follow-up|2|||
126785003|NCT02729896|456167960|FG002|Overall Study|Lost to Follow-up|3|||
126785004|NCT02729896|456167958|FG000|Overall Study|Other|0|||
126785005|NCT02729896|456167959|FG001|Overall Study|Other|2|||
126785006|NCT02729896|456167960|FG002|Overall Study|Other|0|||
126785007|NCT02729896|456167958|FG000|Overall Study|Physician Decision|1|||
126785008|NCT02729896|456167959|FG001|Overall Study|Physician Decision|2|||
126785009|NCT02729896|456167960|FG002|Overall Study|Physician Decision|3|||
126785010|NCT02729896|456167958|FG000|Overall Study|Progressive Disease|0|||
126785011|NCT02729896|456167959|FG001|Overall Study|Progressive Disease|1|||
126785012|NCT02729896|456167960|FG002|Overall Study|Progressive Disease|0|||
126785013|NCT02729896|456167958|FG000|Overall Study|Withdrawal by Subject|1|||
126785014|NCT02729896|456167959|FG001|Overall Study|Withdrawal by Subject|0|||
126785015|NCT02729896|456167960|FG002|Overall Study|Withdrawal by Subject|3|||
126785016|NCT00582309|456167961|FG000|Overall Study|Protocol Violation|0|||
126785017|NCT00582309|456167962|FG001|Overall Study|Protocol Violation|0|||
126785018|NCT00582309|456167963|FG002|Overall Study|Protocol Violation|2|||
126785019|NCT01565083|456167964|FG000|Overall Study|Withdrawal by Subject|6|||
126785020|NCT01565083|456167965|FG001|Overall Study|Withdrawal by Subject|4|||
126785021|NCT01565083|456167964|FG000|Overall Study|Lost to Follow-up|2|||
126785022|NCT01565083|456167965|FG001|Overall Study|Lost to Follow-up|7|||
126785023|NCT01565083|456167964|FG000|Overall Study|Death|22|||
126785024|NCT01565083|456167965|FG001|Overall Study|Death|23|||
126785025|NCT01565083|456167964|FG000|Overall Study|Other|3|||
126785026|NCT01565083|456167965|FG001|Overall Study|Other|5|||
126785027|NCT01058421|456167966|FG000|1 Month Outcomes|Death|10|||
126785028|NCT01058421|456167967|FG001|1 Month Outcomes|Death|6|||
126785029|NCT01058421|456167966|FG000|1 Month Outcomes|Lost to Follow-up|8|||
126785030|NCT01058421|456167967|FG001|1 Month Outcomes|Lost to Follow-up|7|||
126785031|NCT01058421|456167966|FG000|1 Month Outcomes|Remained in Hospital|5|||
126785032|NCT01058421|456167967|FG001|1 Month Outcomes|Remained in Hospital|12|||
126785033|NCT01058421|456167966|FG000|1 Month Outcomes|Remained in Other Facility|16|||
126785034|NCT01058421|456167967|FG001|1 Month Outcomes|Remained in Other Facility|17|||
126785035|NCT01058421|456167966|FG000|3 Month Outcomes|Death|3|||
126785036|NCT01058421|456167967|FG001|3 Month Outcomes|Death|5|||
126785037|NCT01058421|456167966|FG000|3 Month Outcomes|Lost to Follow-up|12|||
126785038|NCT01058421|456167967|FG001|3 Month Outcomes|Lost to Follow-up|11|||
126785039|NCT01058421|456167966|FG000|3 Month Outcomes|Remained in Hospital|0|||
126785040|NCT01058421|456167967|FG001|3 Month Outcomes|Remained in Hospital|2|||
126785041|NCT01058421|456167966|FG000|3 Month Outcomes|Remained in Other Facility|5|||
126785042|NCT01058421|456167967|FG001|3 Month Outcomes|Remained in Other Facility|8|||
126785043|NCT01058421|456167966|FG000|6 Month Outcomes|Death|2|||
126785044|NCT01058421|456167967|FG001|6 Month Outcomes|Death|2|||
126785045|NCT01058421|456167966|FG000|6 Month Outcomes|Lost to Follow-up|16|||
126785046|NCT01058421|456167967|FG001|6 Month Outcomes|Lost to Follow-up|21|||
126785047|NCT01058421|456167966|FG000|6 Month Outcomes|Remained in Other Facility|1|||
126785048|NCT01058421|456167967|FG001|6 Month Outcomes|Remained in Other Facility|3|||
126785049|NCT01309919|456167988|FG000|Overall Study|Did not receive a postpartum IUD|17|||
126785050|NCT01309919|456167989|FG001|Overall Study|Did not receive a postpartum IUD|48|||
126785051|NCT00319449|456167990|FG000|Overall Study|Subject did not wish to continue|1|||
126785052|NCT00319449|456167991|FG001|Overall Study|Subject did not wish to continue|0|||
126785053|NCT00319449|456167990|FG000|Overall Study|Noncompliance with the protocol|1|||
126785054|NCT00319449|456167991|FG001|Overall Study|Noncompliance with the protocol|0|||
126785055|NCT02102490|456167992|FG000|Overall Study|Death|6|||
126785056|NCT02102490|456167992|FG000|Overall Study|Lost to Follow-up|1|||
126785057|NCT01346410|456167993|FG000|Overall Study|Death|1|||
126785058|NCT00979628|456167994|FG000|Overall Study|received regimen < 24 hours|7|||
126785059|NCT00979628|456167995|FG001|Overall Study|received regimen < 24 hours|6|||
126785060|NCT00979628|456167996|FG002|Overall Study|received regimen < 24 hours|5|||
126785061|NCT00979628|456167994|FG000|Overall Study|received steroids|1|||
126785062|NCT00979628|456167995|FG001|Overall Study|received steroids|1|||
126785063|NCT00979628|456167996|FG002|Overall Study|received steroids|0|||
126785064|NCT00979628|456167994|FG000|Overall Study|transferred to ICU|1|||
126785065|NCT00979628|456167995|FG001|Overall Study|transferred to ICU|2|||
126785066|NCT00979628|456167996|FG002|Overall Study|transferred to ICU|1|||
126785067|NCT02224456|456169810|FG000|Overall Study|Lack of Efficacy|1|||
126785068|NCT02224456|456169810|FG000|Overall Study|Lost to Follow-up|15|||
126785069|NCT02224456|456169810|FG000|Overall Study|Withdrawal by Subject|9|||
126785070|NCT02224456|456169810|FG000|Overall Study|Physician Decision|3|||
126785071|NCT02224456|456169810|FG000|Overall Study|Death|2|||
126785072|NCT02224456|456169810|FG000|Overall Study|Pregnancy|4|||
126785073|NCT02224456|456169810|FG000|Overall Study|Protocol Violation|1|||
126785074|NCT02224456|456169810|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
126785075|NCT01644890|456169811|FG000|Overall Study|Adverse Event|7|||
126785076|NCT01644890|456169812|FG001|Overall Study|Adverse Event|20|||
126785077|NCT01644890|456169811|FG000|Overall Study|Death|1|||
126785078|NCT01644890|456169812|FG001|Overall Study|Death|3|||
126785079|NCT01644890|456169811|FG000|Overall Study|Physician Decision|3|||
126785080|NCT01644890|456169812|FG001|Overall Study|Physician Decision|9|||
126785081|NCT01644890|456169811|FG000|Overall Study|Protocol Violation|6|||
126785082|NCT01644890|456169812|FG001|Overall Study|Protocol Violation|7|||
126785083|NCT01644890|456169811|FG000|Overall Study|Withdrawal by Subject|19|||
126785084|NCT01644890|456169812|FG001|Overall Study|Withdrawal by Subject|27|||
126785085|NCT01644890|456169811|FG000|Overall Study|Progression Disease|160|||
126785086|NCT01644890|456169812|FG001|Overall Study|Progression Disease|131|||
126785087|NCT01644890|456169811|FG000|Overall Study|Clinical Progression|6|||
126785088|NCT01644890|456169812|FG001|Overall Study|Clinical Progression|6|||
126785089|NCT01644890|456169811|FG000|Overall Study|> 28 days since last dose of study drug|6|||
126785090|NCT01644890|456169812|FG001|Overall Study|> 28 days since last dose of study drug|3|||
126785091|NCT01644890|456169811|FG000|Overall Study|Other|8|||
126785092|NCT01644890|456169812|FG001|Overall Study|Other|9|||
126785093|NCT02761980|456169815|FG000|Overall Study|Adverse Event|4|||
126785094|NCT02761980|456169816|FG001|Overall Study|Adverse Event|6|||
126785095|NCT02761980|456169817|FG002|Overall Study|Adverse Event|5|||
126785096|NCT02761980|456169818|FG003|Overall Study|Adverse Event|6|||
126785097|NCT02761980|456169815|FG000|Overall Study|Withdrawal by Subject|0|||
126785098|NCT02761980|456169816|FG001|Overall Study|Withdrawal by Subject|1|||
126785099|NCT02761980|456169817|FG002|Overall Study|Withdrawal by Subject|0|||
126785100|NCT02761980|456169818|FG003|Overall Study|Withdrawal by Subject|0|||
126785101|NCT02761980|456169815|FG000|Overall Study|Other|0|||
126785102|NCT02761980|456169816|FG001|Overall Study|Other|0|||
126785103|NCT02761980|456169817|FG002|Overall Study|Other|1|||
126785104|NCT02761980|456169818|FG003|Overall Study|Other|0|||
126785105|NCT00101582|456169819|FG000|Overall Study|Ineligibility determined|0|||
126785106|NCT00101582|456169820|FG001|Overall Study|Ineligibility determined|1|||
126785107|NCT00101582|456169819|FG000|Overall Study|Adverse Event|1|||
126785108|NCT00101582|456169820|FG001|Overall Study|Adverse Event|4|||
126785109|NCT00101582|456169819|FG000|Overall Study|Withdrawal by Subject|6|||
126785110|NCT00101582|456169820|FG001|Overall Study|Withdrawal by Subject|4|||
126785111|NCT00101582|456169819|FG000|Overall Study|Physician Decision|1|||
126785112|NCT00101582|456169820|FG001|Overall Study|Physician Decision|0|||
126785113|NCT00101582|456169819|FG000|Overall Study|Death|3|||
126785114|NCT00101582|456169820|FG001|Overall Study|Death|5|||
126785115|NCT00101582|456169819|FG000|Overall Study|Other|0|||
126785116|NCT00101582|456169820|FG001|Overall Study|Other|1|||
126629511|NCT01283971|455602384|FG001|Overall Study|Failure to return|1|||
126785117|NCT00056160|456169821|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
126785118|NCT00056160|456169822|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
126785119|NCT00056160|456169821|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
126785120|NCT00056160|456169822|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
126785121|NCT00056160|456169821|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
126785122|NCT00056160|456169822|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
126785123|NCT00056160|456169821|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
126785124|NCT00056160|456169822|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
126785125|NCT00056160|456169821|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
126785126|NCT00056160|456169822|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
126785127|NCT00056160|456169821|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
126785128|NCT00056160|456169822|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
126785129|NCT00056160|456169821|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
126785130|NCT00056160|456169822|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
126785131|NCT00056160|456169821|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
126785132|NCT00056160|456169822|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
126785133|NCT00056160|456169821|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
126785134|NCT00056160|456169822|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
126785135|NCT00056160|456169821|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
126785136|NCT00056160|456169822|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
126785137|NCT00056160|456169821|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
126785138|NCT00056160|456169822|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
126785139|NCT00056160|456169821|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
126785140|NCT00056160|456169822|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
126785141|NCT00056160|456169821|FG000|Final Follow-up|Transferred into expanded access study.|3|||
126785142|NCT00056160|456169822|FG001|Final Follow-up|Transferred into expanded access study.|0|||
126785143|NCT00056160|456169821|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
126785144|NCT00056160|456169822|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
126785145|NCT00056160|456169821|FG000|Final Follow-up|Adverse Event|1|||
126785146|NCT00056160|456169822|FG001|Final Follow-up|Adverse Event|0|||
126785147|NCT03312530|456169824|FG000|Overall Study|Death|5|||
126785148|NCT03312530|456169825|FG001|Overall Study|Death|5|||
126785149|NCT03312530|456169826|FG002|Overall Study|Death|4|||
126785150|NCT03312530|456169827|FG003|Overall Study|Death|10|||
126785151|NCT03312530|456169828|FG004|Overall Study|Death|8|||
126785152|NCT03312530|456169824|FG000|Overall Study|Lost to Follow-up|0|||
126785153|NCT03312530|456169825|FG001|Overall Study|Lost to Follow-up|0|||
126785154|NCT03312530|456169826|FG002|Overall Study|Lost to Follow-up|0|||
126785155|NCT03312530|456169827|FG003|Overall Study|Lost to Follow-up|1|||
126785156|NCT03312530|456169828|FG004|Overall Study|Lost to Follow-up|0|||
126785157|NCT03312530|456169824|FG000|Overall Study|Participant in another sponsor study.|0|||
126785158|NCT03312530|456169825|FG001|Overall Study|Participant in another sponsor study.|0|||
126785159|NCT03312530|456169826|FG002|Overall Study|Participant in another sponsor study.|0|||
126785160|NCT03312530|456169827|FG003|Overall Study|Participant in another sponsor study.|1|||
126785161|NCT03312530|456169828|FG004|Overall Study|Participant in another sponsor study.|0|||
126785162|NCT03312530|456169824|FG000|Overall Study|Study terminated by sponsor|1|||
126785163|NCT03312530|456169825|FG001|Overall Study|Study terminated by sponsor|0|||
126785164|NCT03312530|456169826|FG002|Overall Study|Study terminated by sponsor|2|||
126785165|NCT03312530|456169827|FG003|Overall Study|Study terminated by sponsor|3|||
126785166|NCT03312530|456169828|FG004|Overall Study|Study terminated by sponsor|7|||
126785167|NCT03312530|456169824|FG000|Overall Study|Withdrawal by Subject|0|||
126785168|NCT03312530|456169825|FG001|Overall Study|Withdrawal by Subject|1|||
126785169|NCT03312530|456169826|FG002|Overall Study|Withdrawal by Subject|0|||
126785170|NCT03312530|456169827|FG003|Overall Study|Withdrawal by Subject|0|||
126785171|NCT03312530|456169828|FG004|Overall Study|Withdrawal by Subject|0|||
126785172|NCT03312530|456169824|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
126785173|NCT03312530|456169825|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
126785174|NCT03312530|456169826|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
126785175|NCT03312530|456169827|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
126785176|NCT03312530|456169828|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
126785177|NCT03093324|456169829|FG000|Overall Study|Adverse Event|4|||
126785178|NCT03093324|456169830|FG001|Overall Study|Adverse Event|15|||
126785179|NCT03093324|456169829|FG000|Overall Study|Lost to Follow-up|1|||
126629512|NCT01283971|455602383|FG000|Overall Study|Administrative reasons|1|||
126629513|NCT01283971|455602384|FG001|Overall Study|Administrative reasons|1|||
126629514|NCT01502371|455602385|FG000|Overall Study|Withdrawal by Subject|1|||
126785180|NCT03093324|456169830|FG001|Overall Study|Lost to Follow-up|0|||
126785181|NCT03093324|456169829|FG000|Overall Study|Protocol Deviation|2|||
126785182|NCT03093324|456169830|FG001|Overall Study|Protocol Deviation|2|||
126785183|NCT03093324|456169829|FG000|Overall Study|Withdrawal by Subject|2|||
126629515|NCT01502371|455602386|FG001|Overall Study|Withdrawal by Subject|2|||
126785184|NCT03093324|456169830|FG001|Overall Study|Withdrawal by Subject|2|||
126785185|NCT01691859|456169831|FG000|Overall Study|Adverse Event|19|||
126785186|NCT01691859|456169831|FG000|Overall Study|Lack of Efficacy|11|||
126785187|NCT01691859|456169831|FG000|Overall Study|Protocol Violation|4|||
126785188|NCT01691859|456169831|FG000|Overall Study|Product commercially available|221|||
126785189|NCT01691859|456169831|FG000|Overall Study|Study closed/terminated|50|||
126785190|NCT01691859|456169831|FG000|Overall Study|Lost to Follow-up|5|||
126785191|NCT01691859|456169831|FG000|Overall Study|Physician Decision|6|||
126785192|NCT01691859|456169831|FG000|Overall Study|Withdrawal by Subject|31|||
126785193|NCT04583579|456169832|FG000|Overall Study|Lost to Follow-up|4|||
126785194|NCT00278200|456169833|FG000|Overall Study|Death|1|||
126785195|NCT00278200|456169834|FG001|Overall Study|Death|3|||
126785196|NCT00278200|456169833|FG000|Overall Study|Physician Decision|0|||
126785197|NCT00278200|456169834|FG001|Overall Study|Physician Decision|1|||
126785198|NCT00135707|456169839|FG000|Overall Study|Lost to Follow-up|94|||
126785199|NCT00135707|456169840|FG001|Overall Study|Lost to Follow-up|89|||
126785200|NCT00135707|456169839|FG000|Overall Study|Withdrawal by Subject|0|||
126785201|NCT00135707|456169840|FG001|Overall Study|Withdrawal by Subject|1|||
126785202|NCT00135707|456169839|FG000|Overall Study|Institutional review board request|1|||
126785203|NCT00135707|456169840|FG001|Overall Study|Institutional review board request|0|||
126785204|NCT00421174|456169844|FG000|Overall Study|Withdrawal by Subject|0|||
126785205|NCT00421174|456169845|FG001|Overall Study|Withdrawal by Subject|1|||
126785206|NCT00421174|456169844|FG000|Overall Study|Ineligible due to infection|2|||
126785207|NCT00421174|456169845|FG001|Overall Study|Ineligible due to infection|0|||
126785208|NCT02524379|456169846|FG000|Overall Study|Death|1|||
126785209|NCT01829464|456169847|FG000|Overall Study|Adverse Event|1|||
126785210|NCT01829464|456169848|FG001|Overall Study|Adverse Event|0|||
126785211|NCT01829464|456169849|FG002|Overall Study|Adverse Event|0|||
126785212|NCT01829464|456169847|FG000|Overall Study|Lost to Follow-up|0|||
126785213|NCT01829464|456169848|FG001|Overall Study|Lost to Follow-up|0|||
126785214|NCT01829464|456169849|FG002|Overall Study|Lost to Follow-up|1|||
126785215|NCT01829464|456169847|FG000|Overall Study|Withdrawal by Subject|2|||
126785216|NCT01829464|456169848|FG001|Overall Study|Withdrawal by Subject|0|||
126785217|NCT01829464|456169849|FG002|Overall Study|Withdrawal by Subject|0|||
126785218|NCT01829464|456169847|FG000|Overall Study|Study terminated by sponsor|25|||
126785219|NCT01829464|456169848|FG001|Overall Study|Study terminated by sponsor|28|||
126785220|NCT01829464|456169849|FG002|Overall Study|Study terminated by sponsor|25|||
126785221|NCT01829464|456169847|FG000|Overall Study|Lack of Efficacy|0|||
126785222|NCT01829464|456169848|FG001|Overall Study|Lack of Efficacy|1|||
126785223|NCT01829464|456169849|FG002|Overall Study|Lack of Efficacy|0|||
126785224|NCT02228382|456169854|FG000|Overall Study|Death|5|||
126785225|NCT02228382|456169855|FG001|Overall Study|Death|7|||
126785226|NCT02228382|456169856|FG002|Overall Study|Death|5|||
126785227|NCT02228382|456169857|FG003|Overall Study|Death|0|||
126785228|NCT02228382|456169858|FG004|Overall Study|Death|2|||
126785229|NCT02228382|456169854|FG000|Overall Study|Participant refused further follow-up|0|||
126785230|NCT02228382|456169855|FG001|Overall Study|Participant refused further follow-up|0|||
126785231|NCT02228382|456169856|FG002|Overall Study|Participant refused further follow-up|1|||
126785232|NCT02228382|456169857|FG003|Overall Study|Participant refused further follow-up|0|||
126785233|NCT02228382|456169858|FG004|Overall Study|Participant refused further follow-up|0|||
126785234|NCT02228382|456169854|FG000|Overall Study|Study terminated by sponsor|3|||
126785235|NCT02228382|456169855|FG001|Overall Study|Study terminated by sponsor|5|||
126785236|NCT02228382|456169856|FG002|Overall Study|Study terminated by sponsor|7|||
126785237|NCT02228382|456169857|FG003|Overall Study|Study terminated by sponsor|0|||
126785238|NCT02228382|456169858|FG004|Overall Study|Study terminated by sponsor|0|||
126785239|NCT02228382|456169854|FG000|Overall Study|Lost to Follow-up|0|||
126785240|NCT02228382|456169855|FG001|Overall Study|Lost to Follow-up|0|||
126785241|NCT02228382|456169856|FG002|Overall Study|Lost to Follow-up|3|||
126785242|NCT02228382|456169857|FG003|Overall Study|Lost to Follow-up|1|||
126785243|NCT02228382|456169858|FG004|Overall Study|Lost to Follow-up|0|||
126785244|NCT02228382|456169854|FG000|Overall Study|Withdrawal by Subject|0|||
126785245|NCT02228382|456169855|FG001|Overall Study|Withdrawal by Subject|3|||
126785246|NCT02228382|456169856|FG002|Overall Study|Withdrawal by Subject|2|||
126785247|NCT02228382|456169857|FG003|Overall Study|Withdrawal by Subject|1|||
126785248|NCT02228382|456169858|FG004|Overall Study|Withdrawal by Subject|0|||
126785249|NCT02228382|456169854|FG000|Overall Study|Other|2|||
126785250|NCT02228382|456169855|FG001|Overall Study|Other|3|||
126785251|NCT02228382|456169856|FG002|Overall Study|Other|3|||
126785252|NCT02228382|456169857|FG003|Overall Study|Other|0|||
126785253|NCT02228382|456169858|FG004|Overall Study|Other|0|||
126785254|NCT02396381|456169860|FG000|Overall Study|Adverse Event|3|||
126785255|NCT02396381|456169861|FG001|Overall Study|Adverse Event|2|||
126785256|NCT02396381|456169860|FG000|Overall Study|Withdrawal by Subject|33|||
126785257|NCT02396381|456169861|FG001|Overall Study|Withdrawal by Subject|24|||
126785258|NCT02396381|456169860|FG000|Overall Study|Lost to Follow-up|49|||
126785259|NCT02396381|456169861|FG001|Overall Study|Lost to Follow-up|31|||
126785260|NCT02396381|456169860|FG000|Overall Study|Protocol Violation|1|||
126785261|NCT02396381|456169861|FG001|Overall Study|Protocol Violation|0|||
126785262|NCT02396381|456169860|FG000|Overall Study|Site terminated by sponsor|7|||
126785263|NCT02396381|456169861|FG001|Overall Study|Site terminated by sponsor|8|||
126785264|NCT02396381|456169860|FG000|Overall Study|Physician Decision|5|||
126785265|NCT02396381|456169861|FG001|Overall Study|Physician Decision|5|||
126785266|NCT02396381|456169860|FG000|Overall Study|Pregnancy|2|||
126785267|NCT02396381|456169861|FG001|Overall Study|Pregnancy|0|||
126785268|NCT02396381|456169860|FG000|Overall Study|Non-compliance with study procedures|1|||
126785269|NCT02396381|456169861|FG001|Overall Study|Non-compliance with study procedures|0|||
126785270|NCT02396381|456169860|FG000|Overall Study|Moved out of town/state|1|||
126785271|NCT02396381|456169861|FG001|Overall Study|Moved out of town/state|3|||
126785272|NCT02396381|456169860|FG000|Overall Study|Could not complete visit|1|||
126785273|NCT02396381|456169861|FG001|Overall Study|Could not complete visit|0|||
126785274|NCT02396381|456169860|FG000|Overall Study|Possible conflict of interest|1|||
126785275|NCT02396381|456169861|FG001|Overall Study|Possible conflict of interest|0|||
126785276|NCT02396381|456169860|FG000|Overall Study|Randomization/Screening Error|3|||
126785277|NCT02396381|456169861|FG001|Overall Study|Randomization/Screening Error|1|||
126785278|NCT00356200|456169862|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
126785279|NCT00356200|456169863|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
126785280|NCT00356200|456169862|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
126785281|NCT00356200|456169863|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
126785282|NCT00812253|456169864|FG000|Overall Study|Withdrawal by Subject|3|||
126785283|NCT00812253|456169865|FG001|Overall Study|Withdrawal by Subject|2|||
126785284|NCT00812253|456169864|FG000|Overall Study|Protocol Violation|1|||
126785285|NCT00812253|456169865|FG001|Overall Study|Protocol Violation|1|||
126785286|NCT00812253|456169864|FG000|Overall Study|Lost to Follow-up|2|||
126785287|NCT00812253|456169865|FG001|Overall Study|Lost to Follow-up|0|||
126785288|NCT03679741|456169866|FG000|Period 1|No longer meet eligibility criteria|1|||
126785289|NCT03679741|456169867|FG001|Period 1|No longer meet eligibility criteria|0|||
126785290|NCT03679741|456169866|FG000|Period 1|Lost to Follow-up|0|||
126785291|NCT03679741|456169867|FG001|Period 1|Lost to Follow-up|1|||
126785292|NCT03679741|456169866|FG000|Period 1|Adverse Event|1|||
126785293|NCT03679741|456169867|FG001|Period 1|Adverse Event|1|||
126785294|NCT03679741|456169866|FG000|Period 1|Withdrawal by Subject|0|||
126785295|NCT03679741|456169867|FG001|Period 1|Withdrawal by Subject|1|||
126785296|NCT03679741|456169866|FG000|Period 2|Adverse Event|2|||
126785297|NCT03679741|456169867|FG001|Period 2|Adverse Event|1|||
126785298|NCT03679741|456169866|FG000|Period 2|Withdrawal by Subject|1|||
126785299|NCT03679741|456169867|FG001|Period 2|Withdrawal by Subject|1|||
126785300|NCT02204371|456169878|FG000|Overall Study|Adverse Event|1|||
126785301|NCT02419313|456169879|FG000|First Intervention|Lost to Follow-up|2|||
126785302|NCT02419313|456169880|FG001|First Intervention|Lost to Follow-up|0|||
126785303|NCT02419313|456169879|FG000|Second Intervention|Lost to Follow-up|1|||
126785304|NCT02419313|456169880|FG001|Second Intervention|Lost to Follow-up|0|||
126785305|NCT00620763|456169883|FG000|Period: First Intervention|Withdrawal by Subject|0|||
126785306|NCT00620763|456169884|FG001|Period: First Intervention|Withdrawal by Subject|2|||
126785307|NCT00620763|456169883|FG000|Period: First Intervention|Protocol Violation|0|||
126785308|NCT00620763|456169884|FG001|Period: First Intervention|Protocol Violation|3|||
126785309|NCT00620763|456169883|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
126785310|NCT00620763|456169884|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
126785311|NCT00368966|456169888|FG000|Infant Series|Withdrawal by Subject|11|||
126785312|NCT00368966|456169889|FG001|Infant Series|Withdrawal by Subject|6|||
126785313|NCT00368966|456169888|FG000|Infant Series|Protocol Violation|2|||
126785314|NCT00368966|456169889|FG001|Infant Series|Protocol Violation|1|||
126785315|NCT00368966|456169888|FG000|Infant Series|Lost to Follow-up|2|||
126785316|NCT00368966|456169889|FG001|Infant Series|Lost to Follow-up|0|||
126785317|NCT00368966|456169888|FG000|Infant Series|Randomization error|0|||
126785318|NCT00368966|456169889|FG001|Infant Series|Randomization error|1|||
126785319|NCT00368966|456169888|FG000|Infant Series|Failed to meet eligibility criteria|0|||
126785320|NCT00368966|456169889|FG001|Infant Series|Failed to meet eligibility criteria|1|||
126785321|NCT00368966|456169888|FG000|Infant Series|Adverse Event|0|||
126785322|NCT00368966|456169889|FG001|Infant Series|Adverse Event|1|||
126785323|NCT00368966|456169888|FG000|Infant Series|Failed to return|1|||
126785324|NCT00368966|456169889|FG001|Infant Series|Failed to return|0|||
126785325|NCT00368966|456169888|FG000|After Infant|Failed to return|3|||
126785326|NCT00368966|456169889|FG001|After Infant|Failed to return|1|||
126629516|NCT01502371|455602387|FG002|Overall Study|Withdrawal by Subject|1|||
126785327|NCT00368966|456169888|FG000|After Infant|Adverse Event|1|||
126785328|NCT00368966|456169889|FG001|After Infant|Adverse Event|2|||
126785329|NCT00368966|456169888|FG000|After Infant|Withdrawal by Subject|1|||
126785330|NCT00368966|456169889|FG001|After Infant|Withdrawal by Subject|1|||
126785331|NCT00368966|456169888|FG000|After Infant|Death|1|||
126785332|NCT00368966|456169889|FG001|After Infant|Death|0|||
126785333|NCT00368966|456169888|FG000|After Infant|Lost to Follow-up|0|||
126785334|NCT00368966|456169889|FG001|After Infant|Lost to Follow-up|1|||
126785335|NCT00368966|456169888|FG000|Toddler Dose|Withdrawal by Subject|1|||
126785336|NCT00368966|456169889|FG001|Toddler Dose|Withdrawal by Subject|1|||
126785337|NCT00368966|456169888|FG000|Toddler Dose|Lost to Follow-up|0|||
126785338|NCT00368966|456169889|FG001|Toddler Dose|Lost to Follow-up|2|||
126785339|NCT02866175|456169890|FG000|Overall Study|Adverse Event|56|||
126785340|NCT02866175|456169891|FG001|Overall Study|Adverse Event|54|||
126785341|NCT02866175|456169890|FG000|Overall Study|Withdrawal by Subject|31|||
126785342|NCT02866175|456169891|FG001|Overall Study|Withdrawal by Subject|52|||
126785343|NCT02866175|456169890|FG000|Overall Study|Death|30|||
126785344|NCT02866175|456169891|FG001|Overall Study|Death|23|||
126785345|NCT02866175|456169890|FG000|Overall Study|Other|7|||
126785346|NCT02866175|456169891|FG001|Overall Study|Other|14|||
126785347|NCT02866175|456169890|FG000|Overall Study|Progressive disease|1|||
126785348|NCT02866175|456169891|FG001|Overall Study|Progressive disease|1|||
126785349|NCT02866175|456169890|FG000|Overall Study|Lost to Follow-up|2|||
126785350|NCT02866175|456169891|FG001|Overall Study|Lost to Follow-up|0|||
126785351|NCT02866175|456169890|FG000|Overall Study|Lack of Efficacy|0|||
126785352|NCT02866175|456169891|FG001|Overall Study|Lack of Efficacy|1|||
126785353|NCT02866175|456169890|FG000|Overall Study|Physician Decision|3|||
126785354|NCT02866175|456169891|FG001|Overall Study|Physician Decision|15|||
126785355|NCT02866175|456169890|FG000|Overall Study|Did not receive treatment|5|||
126785356|NCT02866175|456169891|FG001|Overall Study|Did not receive treatment|15|||
126785357|NCT01694485|456169892|FG000|Overall Study|Withdrawal by Subject|20|||
126785358|NCT01694485|456169893|FG001|Overall Study|Withdrawal by Subject|6|||
126785359|NCT01694485|456169894|FG002|Overall Study|Withdrawal by Subject|7|||
126785360|NCT01694485|456169895|FG003|Overall Study|Withdrawal by Subject|25|||
126785361|NCT01694485|456169896|FG004|Overall Study|Withdrawal by Subject|18|||
126785362|NCT01694485|456169892|FG000|Overall Study|Sponsor Decision|3|||
126785363|NCT01694485|456169893|FG001|Overall Study|Sponsor Decision|0|||
126785364|NCT01694485|456169894|FG002|Overall Study|Sponsor Decision|0|||
126785365|NCT01694485|456169895|FG003|Overall Study|Sponsor Decision|2|||
126785366|NCT01694485|456169896|FG004|Overall Study|Sponsor Decision|0|||
126785367|NCT01694485|456169892|FG000|Overall Study|Lost to Follow-up|9|||
126785368|NCT01694485|456169893|FG001|Overall Study|Lost to Follow-up|1|||
126785369|NCT01694485|456169894|FG002|Overall Study|Lost to Follow-up|6|||
126785370|NCT01694485|456169895|FG003|Overall Study|Lost to Follow-up|10|||
126785371|NCT01694485|456169896|FG004|Overall Study|Lost to Follow-up|7|||
126785372|NCT01694485|456169892|FG000|Overall Study|Death|1|||
126785373|NCT01694485|456169893|FG001|Overall Study|Death|0|||
126785374|NCT01694485|456169894|FG002|Overall Study|Death|0|||
126785375|NCT01694485|456169895|FG003|Overall Study|Death|1|||
126785376|NCT01694485|456169896|FG004|Overall Study|Death|0|||
126785377|NCT01595009|456169897|FG000|Core|Patients completed per protocol|85|||
126785378|NCT01595009|456169898|FG001|Core|Patients completed per protocol|44|||
126785379|NCT01595009|456169899|FG002|Core|Patients completed per protocol|0|||
126785380|NCT01595009|456169900|FG003|Core|Patients completed per protocol|0|||
126785381|NCT01595009|456169897|FG000|Core|Adverse Event|19|||
126785382|NCT01595009|456169898|FG001|Core|Adverse Event|23|||
126785383|NCT01595009|456169899|FG002|Core|Adverse Event|0|||
126785384|NCT01595009|456169900|FG003|Core|Adverse Event|0|||
126785385|NCT01595009|456169897|FG000|Core|Disease progression|14|||
126785386|NCT01595009|456169898|FG001|Core|Disease progression|26|||
126785387|NCT01595009|456169899|FG002|Core|Disease progression|0|||
126785388|NCT01595009|456169900|FG003|Core|Disease progression|0|||
126785389|NCT01595009|456169897|FG000|Core|Withdrawal by Subject|4|||
126785390|NCT01595009|456169898|FG001|Core|Withdrawal by Subject|17|||
126785391|NCT01595009|456169899|FG002|Core|Withdrawal by Subject|0|||
126785392|NCT01595009|456169900|FG003|Core|Withdrawal by Subject|0|||
126785393|NCT01595009|456169897|FG000|Core|Death|3|||
126785394|NCT01595009|456169898|FG001|Core|Death|6|||
126785395|NCT01595009|456169899|FG002|Core|Death|0|||
126785396|NCT01595009|456169900|FG003|Core|Death|0|||
126785397|NCT01595009|456169897|FG000|Core|Lost to Follow-up|1|||
126785398|NCT01595009|456169898|FG001|Core|Lost to Follow-up|2|||
126785399|NCT01595009|456169899|FG002|Core|Lost to Follow-up|0|||
126785400|NCT01595009|456169900|FG003|Core|Lost to Follow-up|0|||
126785401|NCT01595009|456169897|FG000|Core|Protocol deviation|0|||
126785402|NCT01595009|456169898|FG001|Core|Protocol deviation|1|||
126785403|NCT01595009|456169899|FG002|Core|Protocol deviation|0|||
126785404|NCT01595009|456169900|FG003|Core|Protocol deviation|0|||
126785405|NCT01595009|456169897|FG000|Core|Administrative problems|0|||
126785406|NCT01595009|456169898|FG001|Core|Administrative problems|1|||
126785407|NCT01595009|456169899|FG002|Core|Administrative problems|0|||
126785408|NCT01595009|456169900|FG003|Core|Administrative problems|0|||
126785409|NCT01595009|456169897|FG000|Extension|Administrative problems|0|||
126785410|NCT01595009|456169898|FG001|Extension|Administrative problems|0|||
126785411|NCT01595009|456169899|FG002|Extension|Administrative problems|0|||
126785412|NCT01595009|456169900|FG003|Extension|Administrative problems|1|||
126785413|NCT01595009|456169897|FG000|Extension|Patients completed per protocol|0|||
126785414|NCT01595009|456169898|FG001|Extension|Patients completed per protocol|0|||
126785415|NCT01595009|456169899|FG002|Extension|Patients completed per protocol|0|||
126785416|NCT01595009|456169900|FG003|Extension|Patients completed per protocol|2|||
126785417|NCT01595009|456169897|FG000|Extension|Disease progression|0|||
126785418|NCT01595009|456169898|FG001|Extension|Disease progression|0|||
126785419|NCT01595009|456169899|FG002|Extension|Disease progression|4|||
126785420|NCT01595009|456169900|FG003|Extension|Disease progression|7|||
126785421|NCT01595009|456169897|FG000|Extension|Adverse Event|0|||
126785422|NCT01595009|456169898|FG001|Extension|Adverse Event|0|||
126785423|NCT01595009|456169899|FG002|Extension|Adverse Event|0|||
126785424|NCT01595009|456169900|FG003|Extension|Adverse Event|1|||
126785425|NCT04956666|456169902|FG000|Overall Study|Adverse Event|18|||
126785426|NCT04956666|456169902|FG000|Overall Study|Physician Decision|5|||
126785427|NCT00662025|456169906|FG000|Overall Study|Objective progression or relapse|51|||
126785428|NCT00662025|456169906|FG000|Overall Study|Adverse Event|7|||
126785429|NCT00662025|456169906|FG000|Overall Study|Withdrawal by Subject|1|||
126785430|NCT00662025|456169906|FG000|Overall Study|Results of other clinical study|2|||
126785431|NCT00662025|456169906|FG000|Overall Study|Target lesion cannot be evaluated|1|||
126785432|NCT00662025|456169906|FG000|Overall Study|Domestic circumstances|1|||
126785433|NCT00626925|456169915|FG000|Overall Study|Lost to Follow-up|1|||
126785434|NCT00626925|456169916|FG001|Overall Study|Lost to Follow-up|2|||
126785435|NCT00626925|456169915|FG000|Overall Study|relapse|1|||
126785436|NCT00626925|456169916|FG001|Overall Study|relapse|0|||
126785437|NCT00626925|456169915|FG000|Overall Study|Adverse effect|6|||
126785438|NCT00626925|456169916|FG001|Overall Study|Adverse effect|2|||
126785439|NCT00626925|456169915|FG000|Overall Study|Lack of Efficacy|1|||
126785440|NCT00626925|456169916|FG001|Overall Study|Lack of Efficacy|4|||
126785441|NCT00626925|456169915|FG000|Overall Study|Time constraints|3|||
126785442|NCT00626925|456169916|FG001|Overall Study|Time constraints|1|||
126785443|NCT01215942|456169922|FG000|Treatment Period|Adverse Event|15|||
126785444|NCT01215942|456169923|FG001|Treatment Period|Adverse Event|26|||
126785445|NCT01215942|456169922|FG000|Treatment Period|Death|2|||
126785446|NCT01215942|456169923|FG001|Treatment Period|Death|4|||
126785447|NCT01215942|456169922|FG000|Treatment Period|Lack of Efficacy|23|||
126785448|NCT01215942|456169923|FG001|Treatment Period|Lack of Efficacy|62|||
126785449|NCT01215942|456169922|FG000|Treatment Period|Lost to Follow-up|3|||
126785450|NCT01215942|456169923|FG001|Treatment Period|Lost to Follow-up|4|||
126785451|NCT01215942|456169922|FG000|Treatment Period|Withdrawal by Subject|17|||
126785452|NCT01215942|456169923|FG001|Treatment Period|Withdrawal by Subject|40|||
126785453|NCT01215942|456169922|FG000|Treatment Period|Physician Decision|5|||
126785454|NCT01215942|456169923|FG001|Treatment Period|Physician Decision|5|||
126785455|NCT01215942|456169922|FG000|Treatment Period|Protocol Violation|0|||
126785456|NCT01215942|456169923|FG001|Treatment Period|Protocol Violation|1|||
126785457|NCT01215942|456169922|FG000|Treatment Period|Sponsor Decision|349|||
126785458|NCT01215942|456169923|FG001|Treatment Period|Sponsor Decision|530|||
126785459|NCT01215942|456169922|FG000|Post-Treatment Follow-Up Period|Death|0|||
126785460|NCT01215942|456169923|FG001|Post-Treatment Follow-Up Period|Death|1|||
126785461|NCT01215942|456169922|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
126785462|NCT01215942|456169923|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
126785463|NCT01215942|456169922|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
126785464|NCT01215942|456169923|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
126785465|NCT01215942|456169922|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
126785466|NCT01215942|456169923|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
126785467|NCT01215942|456169922|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
126785468|NCT01215942|456169923|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
126785469|NCT01966042|456169924|FG000|Overall Study|Death|2|||
126785470|NCT03522948|456169925|FG000|Overall Study|Lost to Follow-up|1|||
126785471|NCT03305055|456169926|FG000|Overall Study|Withdrawal by Subject|0|||
126785472|NCT03305055|456169927|FG001|Overall Study|Withdrawal by Subject|1|||
126785473|NCT03305055|456169926|FG000|Overall Study|Adverse Event|1|||
126785474|NCT03305055|456169927|FG001|Overall Study|Adverse Event|1|||
126785475|NCT01802879|456169928|FG000|Overall Study|Administrative problems|2|||
126785476|NCT01802879|456169928|FG000|Overall Study|Disease progression|6|||
126785477|NCT01047345|456169935|FG000|Base Study|Adverse Event|3|||
126785478|NCT01047345|456169936|FG001|Base Study|Adverse Event|0|||
126785479|NCT01047345|456169937|FG002|Base Study|Adverse Event|0|||
126785480|NCT01047345|456169935|FG000|Base Study|Lost to Follow-up|4|||
126785481|NCT01047345|456169936|FG001|Base Study|Lost to Follow-up|1|||
126785482|NCT01047345|456169937|FG002|Base Study|Lost to Follow-up|0|||
126785483|NCT01047345|456169935|FG000|Base Study|Protocol Violation|3|||
126785484|NCT01047345|456169936|FG001|Base Study|Protocol Violation|1|||
126785485|NCT01047345|456169937|FG002|Base Study|Protocol Violation|0|||
126785486|NCT01047345|456169935|FG000|Base Study|Withdrawal by Subject|12|||
126785487|NCT01047345|456169936|FG001|Base Study|Withdrawal by Subject|4|||
126785488|NCT01047345|456169937|FG002|Base Study|Withdrawal by Subject|0|||
126785489|NCT01047345|456169935|FG000|Extension|Withdrawal by Subject|0|||
126785490|NCT01047345|456169936|FG001|Extension|Withdrawal by Subject|0|||
126785491|NCT01047345|456169937|FG002|Extension|Withdrawal by Subject|1|||
126785492|NCT01047345|456169935|FG000|Extension|Lost to Follow-up|0|||
126785493|NCT01047345|456169936|FG001|Extension|Lost to Follow-up|0|||
126785494|NCT01047345|456169937|FG002|Extension|Lost to Follow-up|5|||
126785495|NCT00282256|456169938|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
126785496|NCT00282256|456169938|FG000|Extension Treatment Period|Adverse Event|2|||
126785497|NCT00698685|456169939|FG000|Overall Study|Sister withdrew as donor|1|||
126785498|NCT00698685|456169939|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
126785499|NCT00203307|456169941|FG000|First Intervention|Adverse Event|2|||
126785500|NCT00203307|456169942|FG001|First Intervention|Adverse Event|0|||
126785501|NCT00455533|456169943|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
126785502|NCT00455533|456169944|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
126785503|NCT00455533|456169945|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
126785504|NCT00455533|456169943|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
126785505|NCT00455533|456169944|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
126785506|NCT00455533|456169945|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
126785507|NCT00455533|456169943|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
126785508|NCT00455533|456169944|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
126785509|NCT00455533|456169945|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
126785510|NCT00455533|456169943|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
126785511|NCT00455533|456169944|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
126785512|NCT00455533|456169945|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
126785513|NCT00455533|456169943|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
126785514|NCT00455533|456169944|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
126785515|NCT00455533|456169945|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
126785516|NCT00455533|456169943|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
126785517|NCT00455533|456169944|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
126785518|NCT00455533|456169945|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
126785519|NCT00455533|456169943|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
126785520|NCT00455533|456169944|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
126785521|NCT00455533|456169945|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
126785522|NCT00455533|456169943|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
126785523|NCT00455533|456169944|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
126785524|NCT00455533|456169945|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
126785525|NCT00455533|456169943|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
126785526|NCT00455533|456169944|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
126785527|NCT00455533|456169945|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
126785528|NCT00455533|456169943|FG000|Period Two: Randomized Period|Death|0|||
126785529|NCT00455533|456169944|FG001|Period Two: Randomized Period|Death|0|||
126785530|NCT00455533|456169945|FG002|Period Two: Randomized Period|Death|3|||
126785531|NCT00455533|456169943|FG000|Period Two: Randomized Period|Disease Progression|0|||
126785532|NCT00455533|456169944|FG001|Period Two: Randomized Period|Disease Progression|1|||
126785533|NCT00455533|456169945|FG002|Period Two: Randomized Period|Disease Progression|1|||
126785534|NCT00455533|456169943|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
126785535|NCT00455533|456169944|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
126785536|NCT00455533|456169945|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
126785537|NCT00455533|456169943|FG000|Period Two: Randomized Period|Other - need reasons|0|||
126785538|NCT00455533|456169944|FG001|Period Two: Randomized Period|Other - need reasons|1|||
126785539|NCT00455533|456169945|FG002|Period Two: Randomized Period|Other - need reasons|0|||
126785540|NCT00455533|456169943|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
126785541|NCT00455533|456169944|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
126785542|NCT00455533|456169945|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
126785543|NCT00455533|456169943|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
126785544|NCT00455533|456169944|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
126785545|NCT00455533|456169945|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
126785546|NCT02576990|456169950|FG000|Overall Study|Death|29|||
126785547|NCT02576990|456169951|FG001|Overall Study|Death|18|||
126785548|NCT02576990|456169950|FG000|Overall Study|Physician Decision|1|||
126785549|NCT02576990|456169951|FG001|Overall Study|Physician Decision|0|||
126785550|NCT02576990|456169950|FG000|Overall Study|Screen failure|2|||
126785551|NCT02576990|456169951|FG001|Overall Study|Screen failure|0|||
126785552|NCT02576990|456169950|FG000|Overall Study|Sponsor's decision|24|||
126785553|NCT02576990|456169951|FG001|Overall Study|Sponsor's decision|4|||
126785554|NCT02576990|456169950|FG000|Overall Study|Withdrawal by Subject|0|||
126785555|NCT02576990|456169951|FG001|Overall Study|Withdrawal by Subject|2|||
126785556|NCT01736553|456169956|FG000|Overall Study|Death|12|||
126785557|NCT01736553|456169957|FG001|Overall Study|Death|0|||
126785558|NCT01736553|456169956|FG000|Overall Study|Withdrawal by Subject|5|||
126785559|NCT01736553|456169957|FG001|Overall Study|Withdrawal by Subject|2|||
126785560|NCT01736553|456169956|FG000|Overall Study|Lost to Follow-up|2|||
126785561|NCT01736553|456169957|FG001|Overall Study|Lost to Follow-up|2|||
126785562|NCT03538756|456169960|FG000|Long-Term Follow-up|Adverse Event|0|||
126785563|NCT03538756|456169961|FG001|Long-Term Follow-up|Adverse Event|0|||
126785564|NCT03538756|456169962|FG002|Long-Term Follow-up|Adverse Event|6|||
126785565|NCT03538756|456169960|FG000|Long-Term Follow-up|Death|0|||
126785566|NCT03538756|456169961|FG001|Long-Term Follow-up|Death|0|||
126785567|NCT03538756|456169962|FG002|Long-Term Follow-up|Death|1|||
126785568|NCT03538756|456169960|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
126785569|NCT03538756|456169961|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
126785570|NCT03538756|456169962|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
126785571|NCT03538756|456169960|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
126785572|NCT03538756|456169961|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
126785573|NCT03538756|456169962|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
126785574|NCT03538756|456169960|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
126785575|NCT03538756|456169961|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
126785576|NCT03538756|456169962|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
126785577|NCT00752856|456169963|FG000|Overall Study|randomized but did not do viral kinetics|0|||
126785578|NCT00752856|456169964|FG001|Overall Study|randomized but did not do viral kinetics|1|||
126785579|NCT02260492|456169965|FG000|Overall Study|Adverse Event|6|||
126785580|NCT02260492|456169966|FG001|Overall Study|Adverse Event|1|||
126785581|NCT02260492|456169967|FG002|Overall Study|Adverse Event|2|||
126785582|NCT02260492|456169965|FG000|Overall Study|Death|0|||
126785583|NCT02260492|456169966|FG001|Overall Study|Death|1|||
126785584|NCT02260492|456169967|FG002|Overall Study|Death|0|||
126785585|NCT02260492|456169965|FG000|Overall Study|Lost to Follow-up|12|||
126785586|NCT02260492|456169966|FG001|Overall Study|Lost to Follow-up|9|||
126785587|NCT02260492|456169967|FG002|Overall Study|Lost to Follow-up|0|||
126785588|NCT02260492|456169965|FG000|Overall Study|Physician Decision|2|||
126785589|NCT02260492|456169966|FG001|Overall Study|Physician Decision|0|||
126785590|NCT02260492|456169967|FG002|Overall Study|Physician Decision|1|||
126785591|NCT02260492|456169965|FG000|Overall Study|Withdrawal by Subject|3|||
126785592|NCT02260492|456169966|FG001|Overall Study|Withdrawal by Subject|2|||
126785593|NCT02260492|456169967|FG002|Overall Study|Withdrawal by Subject|2|||
126785594|NCT03131999|456169968|FG000|Overall Study|Withdrawal by Subject|0|||
126785595|NCT03131999|456169969|FG001|Overall Study|Withdrawal by Subject|1|||
126785596|NCT02688608|456169970|FG000|Overall Study|Lost to Follow-up|1|||
126785597|NCT02456909|456169971|FG000|Overall Study|Did not receive allocated intervention|24|||
126785598|NCT02456909|456169972|FG001|Overall Study|Did not receive allocated intervention|26|||
126785599|NCT02456909|456169971|FG000|Overall Study|Did not complete the primary outcome|0|||
126785600|NCT02456909|456169972|FG001|Overall Study|Did not complete the primary outcome|1|||
126785601|NCT01497938|456169973|FG000|Overall Study|Adverse Event|0|||
126785602|NCT01497938|456169974|FG001|Overall Study|Adverse Event|1|||
126785603|NCT01497938|456169973|FG000|Overall Study|Physician Decision|0|||
126785604|NCT01497938|456169974|FG001|Overall Study|Physician Decision|1|||
126785605|NCT01497938|456169973|FG000|Overall Study|Withdrawal by Subject|4|||
126785606|NCT01497938|456169974|FG001|Overall Study|Withdrawal by Subject|0|||
126785607|NCT01497938|456169973|FG000|Overall Study|Device Violation|1|||
126785608|NCT01497938|456169974|FG001|Overall Study|Device Violation|0|||
126785609|NCT00365352|456169975|FG000|Overall Study|Adverse Event|6|||
126785610|NCT00365352|456169976|FG001|Overall Study|Adverse Event|7|||
126785611|NCT00365352|456169977|FG002|Overall Study|Adverse Event|8|||
126785612|NCT00365352|456169975|FG000|Overall Study|Participant Withdrew Consent|8|||
126785613|NCT00365352|456169976|FG001|Overall Study|Participant Withdrew Consent|3|||
126785614|NCT00365352|456169977|FG002|Overall Study|Participant Withdrew Consent|4|||
126785615|NCT00365352|456169975|FG000|Overall Study|Lack of Efficacy|3|||
126785616|NCT00365352|456169976|FG001|Overall Study|Lack of Efficacy|0|||
126785617|NCT00365352|456169977|FG002|Overall Study|Lack of Efficacy|0|||
126785618|NCT00365352|456169975|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
126785619|NCT00365352|456169976|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
126785620|NCT00365352|456169977|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
126785621|NCT00365352|456169975|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
126785622|NCT00365352|456169976|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
126785623|NCT00365352|456169977|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
126785624|NCT00365352|456169975|FG000|Overall Study|Lost to Follow-up|1|||
126785625|NCT00365352|456169976|FG001|Overall Study|Lost to Follow-up|1|||
126785626|NCT00365352|456169977|FG002|Overall Study|Lost to Follow-up|0|||
126629517|NCT01502371|455602388|FG003|Overall Study|Withdrawal by Subject|1|||
126785627|NCT00365352|456169975|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
126785628|NCT00365352|456169976|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
126785629|NCT00365352|456169977|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
126629518|NCT01502371|455602389|FG004|Overall Study|Withdrawal by Subject|1|||
126785630|NCT02946385|456171554|FG000|Overall Study|Lost to Follow-up|0|||
126785631|NCT02946385|456171555|FG001|Overall Study|Lost to Follow-up|0|||
126785632|NCT02946385|456171556|FG002|Overall Study|Lost to Follow-up|3|||
126785633|NCT02946385|456171557|FG003|Overall Study|Lost to Follow-up|0|||
126785634|NCT02946385|456171558|FG004|Overall Study|Lost to Follow-up|2|||
126785635|NCT02946385|456171559|FG005|Overall Study|Lost to Follow-up|1|||
126785636|NCT01060670|456171560|FG000|Run In|screen failure|0|||
126785637|NCT01060670|456171561|FG001|Run In|screen failure|238|||
126785638|NCT03519256|456171565|FG000|Overall Study|Disease recurrence|4|||
126785639|NCT03519256|456171566|FG001|Overall Study|Disease recurrence|4|||
126785640|NCT03519256|456171567|FG002|Overall Study|Disease recurrence|5|||
126785641|NCT03519256|456171568|FG003|Overall Study|Disease recurrence|2|||
126785642|NCT03519256|456171565|FG000|Overall Study|Study drug toxicity|0|||
126785643|NCT03519256|456171566|FG001|Overall Study|Study drug toxicity|2|||
126785644|NCT03519256|456171567|FG002|Overall Study|Study drug toxicity|5|||
126785645|NCT03519256|456171568|FG003|Overall Study|Study drug toxicity|2|||
126785646|NCT03519256|456171565|FG000|Overall Study|Adverse event unrelated to study drug|0|||
126785647|NCT03519256|456171566|FG001|Overall Study|Adverse event unrelated to study drug|1|||
126785648|NCT03519256|456171567|FG002|Overall Study|Adverse event unrelated to study drug|1|||
126785649|NCT03519256|456171568|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126785650|NCT03519256|456171565|FG000|Overall Study|Participant request to discontinue study treatment|0|||
126785651|NCT03519256|456171566|FG001|Overall Study|Participant request to discontinue study treatment|0|||
126785652|NCT03519256|456171567|FG002|Overall Study|Participant request to discontinue study treatment|0|||
126785653|NCT03519256|456171568|FG003|Overall Study|Participant request to discontinue study treatment|2|||
126785654|NCT03519256|456171565|FG000|Overall Study|Other reasons|0|||
126785655|NCT03519256|456171566|FG001|Overall Study|Other reasons|0|||
126785656|NCT03519256|456171567|FG002|Overall Study|Other reasons|2|||
126785657|NCT03519256|456171568|FG003|Overall Study|Other reasons|0|||
126785658|NCT03519256|456171565|FG000|Overall Study|Disease progression|6|||
126785659|NCT03519256|456171566|FG001|Overall Study|Disease progression|3|||
126785660|NCT03519256|456171567|FG002|Overall Study|Disease progression|2|||
126785661|NCT03519256|456171568|FG003|Overall Study|Disease progression|1|||
126785662|NCT03519256|456171565|FG000|Overall Study|Lost to Follow-up|0|||
126785663|NCT03519256|456171566|FG001|Overall Study|Lost to Follow-up|1|||
126785664|NCT03519256|456171567|FG002|Overall Study|Lost to Follow-up|0|||
126785665|NCT03519256|456171568|FG003|Overall Study|Lost to Follow-up|0|||
126785666|NCT05431153|456171569|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126785667|NCT05431153|456171570|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126785668|NCT05431153|456171571|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126785669|NCT05431153|456171572|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126785670|NCT05431153|456171573|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
126785671|NCT05431153|456171574|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
126785672|NCT04828161|456171575|FG000|Overall Study|Withdrawal by Subject|0|||
126785673|NCT04828161|456171576|FG001|Overall Study|Withdrawal by Subject|3|||
126785674|NCT04828161|456171577|FG002|Overall Study|Withdrawal by Subject|3|||
126785675|NCT04828161|456171578|FG003|Overall Study|Withdrawal by Subject|4|||
126785676|NCT04828161|456171575|FG000|Overall Study|Lost to Follow-up|1|||
126785677|NCT04828161|456171576|FG001|Overall Study|Lost to Follow-up|4|||
126785678|NCT04828161|456171577|FG002|Overall Study|Lost to Follow-up|2|||
126785679|NCT04828161|456171578|FG003|Overall Study|Lost to Follow-up|2|||
126785680|NCT04828161|456171575|FG000|Overall Study|Other|2|||
126785681|NCT04828161|456171576|FG001|Overall Study|Other|0|||
126785682|NCT04828161|456171577|FG002|Overall Study|Other|2|||
126785683|NCT04828161|456171578|FG003|Overall Study|Other|0|||
126785684|NCT04828161|456171575|FG000|Overall Study|Death|0|||
126785685|NCT04828161|456171576|FG001|Overall Study|Death|0|||
126785686|NCT04828161|456171577|FG002|Overall Study|Death|0|||
126785687|NCT04828161|456171578|FG003|Overall Study|Death|2|||
126785688|NCT02458638|456171581|FG000|Overall Study|Death|309|||
126785689|NCT02458638|456171581|FG000|Overall Study|End of Cohort/End of Study|67|||
126785690|NCT02458638|456171581|FG000|Overall Study|Lost to Follow-up|31|||
126785691|NCT02458638|456171581|FG000|Overall Study|Other Reasons|4|||
126785692|NCT02458638|456171581|FG000|Overall Study|Physician Decision|1|||
126785693|NCT02458638|456171581|FG000|Overall Study|Withdrawal by Subject|47|||
126785694|NCT03093454|456171590|FG000|Overall Study|Withdrawal by Subject|1|||
126785695|NCT03093454|456171591|FG001|Overall Study|Withdrawal by Subject|1|||
126785696|NCT03093454|456171590|FG000|Overall Study|Scheduling conflict|3|||
126785697|NCT03093454|456171591|FG001|Overall Study|Scheduling conflict|1|||
126785698|NCT03093454|456171590|FG000|Overall Study|Physician Decision|2|||
126785699|NCT03093454|456171591|FG001|Overall Study|Physician Decision|1|||
126785700|NCT04540497|456171592|FG000|Overall Study|Adverse Event|0|||
126785701|NCT04540497|456171593|FG001|Overall Study|Adverse Event|2|||
126785702|NCT04540497|456171592|FG000|Overall Study|Lost to Follow-up|1|||
126785703|NCT04540497|456171593|FG001|Overall Study|Lost to Follow-up|0|||
126785704|NCT04540497|456171592|FG000|Overall Study|Withdrawal by Subject|1|||
126785705|NCT04540497|456171593|FG001|Overall Study|Withdrawal by Subject|1|||
126785706|NCT04540497|456171592|FG000|Overall Study|Miscellaneous|2|||
126785707|NCT04540497|456171593|FG001|Overall Study|Miscellaneous|1|||
126785708|NCT01290263|456171600|FG000|Overall Study|Adverse Event|0|||
126785709|NCT01290263|456171601|FG001|Overall Study|Adverse Event|0|||
126785710|NCT01290263|456171602|FG002|Overall Study|Adverse Event|0|||
126785711|NCT01290263|456171603|FG003|Overall Study|Adverse Event|1|||
126785712|NCT01290263|456171604|FG004|Overall Study|Adverse Event|1|||
126785713|NCT01290263|456171600|FG000|Overall Study|Lack of Efficacy|8|||
126785714|NCT01290263|456171601|FG001|Overall Study|Lack of Efficacy|2|||
126785715|NCT01290263|456171602|FG002|Overall Study|Lack of Efficacy|7|||
126785716|NCT01290263|456171603|FG003|Overall Study|Lack of Efficacy|24|||
126785717|NCT01290263|456171604|FG004|Overall Study|Lack of Efficacy|33|||
126785718|NCT01290263|456171600|FG000|Overall Study|Withdrawal by Subject|3|||
126785719|NCT01290263|456171601|FG001|Overall Study|Withdrawal by Subject|1|||
126785720|NCT01290263|456171602|FG002|Overall Study|Withdrawal by Subject|0|||
126785721|NCT01290263|456171603|FG003|Overall Study|Withdrawal by Subject|1|||
126785722|NCT01290263|456171604|FG004|Overall Study|Withdrawal by Subject|2|||
126785723|NCT01290263|456171600|FG000|Overall Study|Participant Non-Compliance|0|||
126785724|NCT01290263|456171601|FG001|Overall Study|Participant Non-Compliance|0|||
126785725|NCT01290263|456171602|FG002|Overall Study|Participant Non-Compliance|0|||
126785726|NCT01290263|456171603|FG003|Overall Study|Participant Non-Compliance|1|||
126785727|NCT01290263|456171604|FG004|Overall Study|Participant Non-Compliance|1|||
126785728|NCT03738332|456171605|FG000|Overall Study|Withdrawal by Subject|1|||
126785729|NCT04700449|456171606|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
126785730|NCT04700449|456171607|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
126785731|NCT04700449|456171608|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
126785732|NCT04700449|456171609|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
126785733|NCT04700449|456171606|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
126785734|NCT04700449|456171607|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
126785735|NCT04700449|456171608|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
126785736|NCT04700449|456171609|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
126785737|NCT04700449|456171606|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
126785738|NCT04700449|456171607|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
126785739|NCT04700449|456171608|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
126785740|NCT04700449|456171609|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
126785741|NCT04700449|456171606|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
126785742|NCT04700449|456171607|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
126785743|NCT04700449|456171608|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
126785744|NCT04700449|456171609|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
126785745|NCT04700449|456171606|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
126785746|NCT04700449|456171607|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
126785747|NCT04700449|456171608|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
126785748|NCT04700449|456171609|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
126785749|NCT04700449|456171606|FG000|Stage 1: Double-Blind Period|Other|0|||
126785750|NCT04700449|456171607|FG001|Stage 1: Double-Blind Period|Other|0|||
126785751|NCT04700449|456171608|FG002|Stage 1: Double-Blind Period|Other|1|||
126785752|NCT04700449|456171609|FG003|Stage 1: Double-Blind Period|Other|0|||
126785753|NCT04700449|456171606|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
126785754|NCT04700449|456171607|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
126785755|NCT04700449|456171608|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
126785756|NCT04700449|456171609|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
126785757|NCT04700449|456171606|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
126785758|NCT04700449|456171607|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
126785759|NCT04700449|456171608|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
126785760|NCT04700449|456171609|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
126785761|NCT04700449|456171606|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
126785762|NCT04700449|456171607|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
126785763|NCT04700449|456171608|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
126785764|NCT04700449|456171609|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
126785765|NCT04700449|456171606|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
126785766|NCT04700449|456171607|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
126785767|NCT04700449|456171608|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
126785768|NCT04700449|456171609|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
126785769|NCT04700449|456171606|FG000|Stage 2 Sub-study 1|Other|1|||
126785770|NCT04700449|456171607|FG001|Stage 2 Sub-study 1|Other|2|||
126785771|NCT04700449|456171608|FG002|Stage 2 Sub-study 1|Other|0|||
126785772|NCT04700449|456171609|FG003|Stage 2 Sub-study 1|Other|0|||
126785773|NCT04700449|456171606|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
126785774|NCT04700449|456171607|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
126785775|NCT04700449|456171608|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
126785776|NCT04700449|456171609|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
126785777|NCT04700449|456171606|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
126785778|NCT04700449|456171607|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
126785779|NCT04700449|456171608|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
126785780|NCT04700449|456171609|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
126785781|NCT04700449|456171606|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
126785782|NCT04700449|456171607|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
126785783|NCT04700449|456171608|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
126785784|NCT04700449|456171609|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
126785785|NCT04700449|456171606|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
126785786|NCT04700449|456171607|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
126785787|NCT04700449|456171608|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
126785788|NCT04700449|456171609|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
126785789|NCT04700449|456171606|FG000|Stage 2 Sub-study 2|Other|0|||
126785790|NCT04700449|456171607|FG001|Stage 2 Sub-study 2|Other|0|||
126785791|NCT04700449|456171608|FG002|Stage 2 Sub-study 2|Other|0|||
126785792|NCT04700449|456171609|FG003|Stage 2 Sub-study 2|Other|5|||
126785793|NCT01521559|456171610|FG000|Overall Study|Adverse Event|0|||
126785794|NCT01521559|456171611|FG001|Overall Study|Adverse Event|4|||
126785795|NCT01521559|456171610|FG000|Overall Study|Death|1|||
126785796|NCT01521559|456171611|FG001|Overall Study|Death|0|||
126785797|NCT01521559|456171610|FG000|Overall Study|Withdrawal by Subject|9|||
126785798|NCT01521559|456171611|FG001|Overall Study|Withdrawal by Subject|11|||
126785799|NCT01521559|456171610|FG000|Overall Study|Lost to Follow-up|3|||
126785800|NCT01521559|456171611|FG001|Overall Study|Lost to Follow-up|1|||
126785801|NCT01521559|456171610|FG000|Overall Study|Protocol Violation|1|||
126785802|NCT01521559|456171611|FG001|Overall Study|Protocol Violation|0|||
126785803|NCT01521559|456171610|FG000|Overall Study|Other|1|||
126785804|NCT01521559|456171611|FG001|Overall Study|Other|2|||
126785805|NCT00275002|456171612|FG000|Overall Study|Death|1|||
126785806|NCT00275002|456171613|FG001|Overall Study|Death|0|||
126785807|NCT00275002|456171612|FG000|Overall Study|Disease progression|21|||
126785808|NCT00275002|456171613|FG001|Overall Study|Disease progression|15|||
126785809|NCT00275002|456171612|FG000|Overall Study|Adverse Event|0|||
126785810|NCT00275002|456171613|FG001|Overall Study|Adverse Event|1|||
126785811|NCT00576381|456171620|FG000|Overall Study|Reoperation|3|||
126785812|NCT00576381|456171620|FG000|Overall Study|Adverse Event|4|||
126785813|NCT01031537|456171624|FG000|Overall Study|medical reasons not related to study|3|||
126785814|NCT01031537|456171624|FG000|Overall Study|Lack of Efficacy|1|||
126785815|NCT01031537|456171624|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
126785816|NCT01031537|456171624|FG000|Overall Study|moved, met exclusion criteria|10|||
126785817|NCT01031537|456171624|FG000|Overall Study|Withdrawal by Subject|5|||
126785818|NCT01031537|456171624|FG000|Overall Study|PI removal, no longer met eligibility|12|||
126785819|NCT02132247|456171625|FG000|Overall Study|Protocol Violation|1|||
126785820|NCT02132247|456171626|FG001|Overall Study|Protocol Violation|0|||
126785821|NCT00520741|456171627|FG000|Overall Study|Adverse Event|16|||
126785822|NCT00520741|456171628|FG001|Overall Study|Adverse Event|56|||
126785823|NCT00520741|456171627|FG000|Overall Study|Lack of Efficacy|11|||
126785824|NCT00520741|456171628|FG001|Overall Study|Lack of Efficacy|30|||
126785825|NCT00520741|456171627|FG000|Overall Study|Withdrawal by Subject|0|||
126785826|NCT00520741|456171628|FG001|Overall Study|Withdrawal by Subject|11|||
126785827|NCT00520741|456171627|FG000|Overall Study|Protocol Violation|2|||
126785828|NCT00520741|456171628|FG001|Overall Study|Protocol Violation|15|||
126785829|NCT00520741|456171627|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
126785830|NCT00520741|456171628|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
126785831|NCT00520741|456171627|FG000|Overall Study|Lost to Follow-up|4|||
126785832|NCT00520741|456171628|FG001|Overall Study|Lost to Follow-up|4|||
126785833|NCT00520741|456171627|FG000|Overall Study|Other reasons for premature termination|0|||
126785834|NCT00520741|456171628|FG001|Overall Study|Other reasons for premature termination|6|||
126785835|NCT02750761|456171629|FG000|Overall Study|Lost to Follow-up|0|||
126785836|NCT02750761|456171630|FG001|Overall Study|Lost to Follow-up|0|||
126785837|NCT02750761|456171631|FG002|Overall Study|Lost to Follow-up|1|||
126785838|NCT02750761|456171632|FG003|Overall Study|Lost to Follow-up|0|||
126785839|NCT02750761|456171633|FG004|Overall Study|Lost to Follow-up|0|||
126785840|NCT02750761|456171634|FG005|Overall Study|Lost to Follow-up|0|||
126785841|NCT02354586|456171637|FG000|Overall Study|Death|230|||
126785842|NCT02354586|456171637|FG000|Overall Study|Withdrawal by Subject|59|||
126785843|NCT02354586|456171637|FG000|Overall Study|Lost to Follow-up|11|||
126785844|NCT02354586|456171637|FG000|Overall Study|Sponsor decision|51|||
126629519|NCT01502371|455602385|FG000|Overall Study|Adverse Event|2|||
126629520|NCT01502371|455602386|FG001|Overall Study|Adverse Event|1|||
126785845|NCT02354586|456171637|FG000|Overall Study|Site closure|2|||
126785846|NCT02354586|456171637|FG000|Overall Study|Intercurrent illness|1|||
126785847|NCT02354586|456171637|FG000|Overall Study|Protocol Violation|3|||
126785848|NCT02354586|456171637|FG000|Overall Study|Physician Decision|13|||
126785849|NCT02354586|456171637|FG000|Overall Study|Lack of Efficacy|86|||
126785850|NCT02354586|456171637|FG000|Overall Study|Adverse Event|7|||
126785851|NCT00634907|456171638|FG000|Overall Study|Withdrawal by Subject|3|||
126785852|NCT00634907|456171639|FG001|Overall Study|Withdrawal by Subject|0|||
126785853|NCT00634907|456171638|FG000|Overall Study|Physician Decision|3|||
126785854|NCT00634907|456171639|FG001|Overall Study|Physician Decision|9|||
126785855|NCT00634907|456171638|FG000|Overall Study|Withdrawal by Subject|11|||
126785856|NCT00634907|456171639|FG001|Overall Study|Withdrawal by Subject|8|||
126785857|NCT02720510|456171640|FG000|Overall Study|Study Terminated by the sponsor|2|||
126785858|NCT02720510|456171641|FG001|Overall Study|Study Terminated by the sponsor|0|||
126785859|NCT02720510|456171640|FG000|Overall Study|Adverse Event|0|||
126785860|NCT02720510|456171641|FG001|Overall Study|Adverse Event|1|||
126785861|NCT02720510|456171640|FG000|Overall Study|Physician Decision|1|||
126785862|NCT02720510|456171641|FG001|Overall Study|Physician Decision|2|||
126785863|NCT02985151|456171645|FG000|Original Randomization|Withdrawal by Subject|0|||
126785864|NCT02985151|456171646|FG001|Original Randomization|Withdrawal by Subject|1|||
126785865|NCT00625807|456171649|FG000|Overall Study|schedule conflict|2|||
126785866|NCT00625807|456171650|FG001|Overall Study|schedule conflict|8|||
126785867|NCT00108732|456171652|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
126785868|NCT00108732|456171652|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
126785869|NCT00108732|456171652|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
126785870|NCT00108732|456171652|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
126785871|NCT00108732|456171652|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
126785872|NCT00108732|456171652|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
126785873|NCT00108732|456171652|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
126785874|NCT02116803|456171653|FG000|Overall Study|Adverse Event|2|||
126785875|NCT02116803|456171654|FG001|Overall Study|Adverse Event|1|||
126785876|NCT02116803|456171653|FG000|Overall Study|Physician Decision|1|||
126785877|NCT02116803|456171654|FG001|Overall Study|Physician Decision|0|||
126785878|NCT02116803|456171653|FG000|Overall Study|Progressive disease|4|||
126785879|NCT02116803|456171654|FG001|Overall Study|Progressive disease|0|||
126785880|NCT02116803|456171653|FG000|Overall Study|Study terminated by sponsor|2|||
126785881|NCT02116803|456171654|FG001|Overall Study|Study terminated by sponsor|1|||
126785882|NCT02116803|456171653|FG000|Overall Study|Death|1|||
126785883|NCT02116803|456171654|FG001|Overall Study|Death|0|||
126785884|NCT01974895|456171657|FG000|Overall Study|Protocol Violation|1|||
126785885|NCT01974895|456171658|FG001|Overall Study|Protocol Violation|0|||
126785886|NCT01974895|456171657|FG000|Overall Study|Lost to Follow-up|4|||
126785887|NCT01974895|456171658|FG001|Overall Study|Lost to Follow-up|6|||
126785888|NCT01974895|456171657|FG000|Overall Study|Withdrawal by Subject|0|||
126785889|NCT01974895|456171658|FG001|Overall Study|Withdrawal by Subject|1|||
126785890|NCT01974895|456171657|FG000|Overall Study|Other (Missed Visit)|1|||
126785891|NCT01974895|456171658|FG001|Overall Study|Other (Missed Visit)|0|||
126785892|NCT01974895|456171657|FG000|Overall Study|Other (Reason unknown)|9|||
126785893|NCT01974895|456171658|FG001|Overall Study|Other (Reason unknown)|8|||
126785894|NCT01984242|456171659|FG000|Overall Study|Death|52|||
126785895|NCT01984242|456171660|FG001|Overall Study|Death|50|||
126785896|NCT01984242|456171661|FG002|Overall Study|Death|52|||
126785897|NCT01984242|456171659|FG000|Overall Study|Withdrawal by Subject|5|||
126785898|NCT01984242|456171660|FG001|Overall Study|Withdrawal by Subject|3|||
126785899|NCT01984242|456171661|FG002|Overall Study|Withdrawal by Subject|10|||
126785900|NCT01984242|456171659|FG000|Overall Study|Physician Decision|0|||
126785901|NCT01984242|456171660|FG001|Overall Study|Physician Decision|0|||
126785902|NCT01984242|456171661|FG002|Overall Study|Physician Decision|1|||
126785903|NCT01984242|456171659|FG000|Overall Study|Lost to Follow-up|4|||
126785904|NCT01984242|456171660|FG001|Overall Study|Lost to Follow-up|0|||
126785905|NCT01984242|456171661|FG002|Overall Study|Lost to Follow-up|3|||
126785906|NCT01984242|456171659|FG000|Overall Study|Sponsor Decision|1|||
126785907|NCT01984242|456171660|FG001|Overall Study|Sponsor Decision|0|||
126785908|NCT01984242|456171661|FG002|Overall Study|Sponsor Decision|0|||
126785909|NCT01984242|456171659|FG000|Overall Study|Non-Compliance|1|||
126785910|NCT01984242|456171660|FG001|Overall Study|Non-Compliance|0|||
126785911|NCT01984242|456171661|FG002|Overall Study|Non-Compliance|0|||
126785912|NCT01984242|456171659|FG000|Overall Study|Study terminated by Sponsor|38|||
126785913|NCT01984242|456171660|FG001|Overall Study|Study terminated by Sponsor|50|||
126785914|NCT01984242|456171661|FG002|Overall Study|Study terminated by Sponsor|34|||
126785915|NCT01984242|456171659|FG000|Overall Study|Disease Progression|0|||
126785916|NCT01984242|456171660|FG001|Overall Study|Disease Progression|0|||
126785917|NCT01984242|456171661|FG002|Overall Study|Disease Progression|1|||
126785918|NCT04543136|456171664|FG000|Overall Study|Withdrawal by Subject|0|||
126785919|NCT04543136|456171665|FG001|Overall Study|Withdrawal by Subject|1|||
126785920|NCT04543136|456171666|FG002|Overall Study|Withdrawal by Subject|0|||
126785921|NCT04543136|456171667|FG003|Overall Study|Withdrawal by Subject|1|||
126785922|NCT04543136|456171668|FG004|Overall Study|Withdrawal by Subject|0|||
126785923|NCT04543136|456171669|FG005|Overall Study|Withdrawal by Subject|0|||
126785924|NCT00865709|456171670|FG000|Treatment|Adverse Event|9|||
126785925|NCT00865709|456171671|FG001|Treatment|Adverse Event|6|||
126785926|NCT00865709|456171670|FG000|Treatment|Withdrawal by Subject|10|||
126785927|NCT00865709|456171671|FG001|Treatment|Withdrawal by Subject|7|||
126785928|NCT00865709|456171670|FG000|Treatment|Physician Decision|3|||
126785929|NCT00865709|456171671|FG001|Treatment|Physician Decision|2|||
126785930|NCT00865709|456171670|FG000|Treatment|Surgery|8|||
126785931|NCT00865709|456171671|FG001|Treatment|Surgery|3|||
126785932|NCT00429923|456171672|FG000|Overall Study|Adverse Event|0|||
126785933|NCT00429923|456171673|FG001|Overall Study|Adverse Event|2|||
126785934|NCT00429923|456171674|FG002|Overall Study|Adverse Event|3|||
126785935|NCT00429923|456171672|FG000|Overall Study|Lack of Efficacy|4|||
126785936|NCT00429923|456171673|FG001|Overall Study|Lack of Efficacy|1|||
126785937|NCT00429923|456171674|FG002|Overall Study|Lack of Efficacy|33|||
126785938|NCT00429923|456171672|FG000|Overall Study|Lost to Follow-up|0|||
126785939|NCT00429923|456171673|FG001|Overall Study|Lost to Follow-up|0|||
126785940|NCT00429923|456171674|FG002|Overall Study|Lost to Follow-up|2|||
126785941|NCT00429923|456171672|FG000|Overall Study|Withdrew Consent|1|||
126785942|NCT00429923|456171673|FG001|Overall Study|Withdrew Consent|0|||
126785943|NCT00429923|456171674|FG002|Overall Study|Withdrew Consent|1|||
126785944|NCT00429923|456171672|FG000|Overall Study|Early Termination|0|||
126785945|NCT00429923|456171673|FG001|Overall Study|Early Termination|1|||
126785946|NCT00429923|456171674|FG002|Overall Study|Early Termination|0|||
126785947|NCT00662129|456171681|FG000|Overall Study|Protocol Violation|1|||
126785948|NCT00662129|456171681|FG000|Overall Study|Cancel prior to beginning treatment|1|||
126785949|NCT00662129|456171681|FG000|Overall Study|Ineligible|1|||
126785950|NCT02153736|456171682|FG000|Overall Study|Lost to Follow-up|1|||
126785951|NCT02153736|456171683|FG001|Overall Study|Lost to Follow-up|0|||
126785952|NCT02153736|456171682|FG000|Overall Study|Medical status change made ineligible|1|||
126785953|NCT02153736|456171683|FG001|Overall Study|Medical status change made ineligible|0|||
126785954|NCT02153736|456171682|FG000|Overall Study|Death|0|||
126785955|NCT02153736|456171683|FG001|Overall Study|Death|1|||
126785956|NCT02153736|456171682|FG000|Overall Study|Withdrawal by Subject|0|||
126785957|NCT02153736|456171683|FG001|Overall Study|Withdrawal by Subject|1|||
126785958|NCT00720122|456171696|FG000|Overall Study|Lost to Follow-up|1|||
126785959|NCT00720122|456171696|FG000|Overall Study|Physician Decision|1|||
126785960|NCT00720122|456171696|FG000|Overall Study|Withdrawal by Subject|7|||
126785961|NCT02415959|456171697|FG000|Overall Study|Adverse Event|0|||
126785962|NCT02415959|456171698|FG001|Overall Study|Adverse Event|1|||
126785963|NCT02415959|456171699|FG002|Overall Study|Adverse Event|0|||
126785964|NCT02415959|456171700|FG003|Overall Study|Adverse Event|0|||
126785965|NCT02415959|456171701|FG004|Overall Study|Adverse Event|0|||
126785966|NCT02415959|456171697|FG000|Overall Study|Protocol Violation|0|||
126785967|NCT02415959|456171698|FG001|Overall Study|Protocol Violation|0|||
126785968|NCT02415959|456171699|FG002|Overall Study|Protocol Violation|0|||
126785969|NCT02415959|456171700|FG003|Overall Study|Protocol Violation|1|||
126785970|NCT02415959|456171701|FG004|Overall Study|Protocol Violation|0|||
126785971|NCT00911859|456171702|FG000|Treatment Period|Adverse Event|3|||
126785972|NCT00911859|456171703|FG001|Treatment Period|Adverse Event|3|||
126785973|NCT00911859|456171704|FG002|Treatment Period|Adverse Event|7|||
126785974|NCT00911859|456171702|FG000|Treatment Period|Death|1|||
126785975|NCT00911859|456171703|FG001|Treatment Period|Death|3|||
126785976|NCT00911859|456171704|FG002|Treatment Period|Death|5|||
126785977|NCT00911859|456171702|FG000|Treatment Period|Lack of Efficacy|1|||
126785978|NCT00911859|456171703|FG001|Treatment Period|Lack of Efficacy|7|||
126785979|NCT00911859|456171704|FG002|Treatment Period|Lack of Efficacy|5|||
126785980|NCT00911859|456171702|FG000|Treatment Period|Physician Decision|3|||
126785981|NCT00911859|456171703|FG001|Treatment Period|Physician Decision|3|||
126785982|NCT00911859|456171704|FG002|Treatment Period|Physician Decision|3|||
126785983|NCT00911859|456171702|FG000|Treatment Period|Withdrawal by Subject|0|||
126785984|NCT00911859|456171703|FG001|Treatment Period|Withdrawal by Subject|4|||
126785985|NCT00911859|456171704|FG002|Treatment Period|Withdrawal by Subject|5|||
126785986|NCT00911859|456171702|FG000|Treatment Period|Did not receive study treatment|0|||
126785987|NCT00911859|456171703|FG001|Treatment Period|Did not receive study treatment|1|||
126785988|NCT00911859|456171704|FG002|Treatment Period|Did not receive study treatment|0|||
126785989|NCT00911859|456171702|FG000|Maintainance Period|Lack of Efficacy|0|||
126785990|NCT00911859|456171703|FG001|Maintainance Period|Lack of Efficacy|0|||
126785991|NCT00911859|456171704|FG002|Maintainance Period|Lack of Efficacy|9|||
126785992|NCT00911859|456171702|FG000|Maintainance Period|Physician Decision|0|||
126785993|NCT00911859|456171703|FG001|Maintainance Period|Physician Decision|0|||
126785994|NCT00911859|456171704|FG002|Maintainance Period|Physician Decision|9|||
126785995|NCT00911859|456171702|FG000|Maintainance Period|Withdrawal by Subject|0|||
126785996|NCT00911859|456171703|FG001|Maintainance Period|Withdrawal by Subject|0|||
126785997|NCT00911859|456171704|FG002|Maintainance Period|Withdrawal by Subject|3|||
126785998|NCT00911859|456171702|FG000|Follow-up Period|Death|5|||
126785999|NCT00911859|456171703|FG001|Follow-up Period|Death|8|||
126786000|NCT00911859|456171704|FG002|Follow-up Period|Death|10|||
126786001|NCT00911859|456171702|FG000|Follow-up Period|Lost to Follow-up|1|||
126786002|NCT00911859|456171703|FG001|Follow-up Period|Lost to Follow-up|1|||
126786003|NCT00911859|456171704|FG002|Follow-up Period|Lost to Follow-up|0|||
126786004|NCT00911859|456171702|FG000|Follow-up Period|Withdrawal by Subject|0|||
126786005|NCT00911859|456171703|FG001|Follow-up Period|Withdrawal by Subject|4|||
126786006|NCT00911859|456171704|FG002|Follow-up Period|Withdrawal by Subject|4|||
126786007|NCT00911859|456171702|FG000|Follow-up Period|Study terminated by sponsor|5|||
126786008|NCT00911859|456171703|FG001|Follow-up Period|Study terminated by sponsor|33|||
126786009|NCT00911859|456171704|FG002|Follow-up Period|Study terminated by sponsor|27|||
126786010|NCT01048333|456171705|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
126629521|NCT01502371|455602387|FG002|Overall Study|Adverse Event|0|||
126786011|NCT01048333|456171706|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
126786012|NCT01048333|456171707|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
126786013|NCT01048333|456171708|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
126786014|NCT01048333|456171709|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
126786015|NCT01048333|456171710|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
126786016|NCT00634179|456171718|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
126786017|NCT00767325|456171719|FG000|Overall Study|Lack of Efficacy|2|||
126786018|NCT00767325|456171719|FG000|Overall Study|Adverse Event|7|||
126786019|NCT00767325|456171719|FG000|Overall Study|Lost to Follow-up|3|||
126786020|NCT00767325|456171719|FG000|Overall Study|No longer met study criteria|2|||
126786021|NCT00767325|456171719|FG000|Overall Study|Missed visit due to family reasons|1|||
126786022|NCT00996736|456171725|FG000|Overall Study|Death|1|||
126786023|NCT00996736|456171726|FG001|Overall Study|Death|1|||
126786024|NCT00996736|456171725|FG000|Overall Study|Lost to Follow-up|15|||
126786025|NCT00996736|456171726|FG001|Overall Study|Lost to Follow-up|14|||
126786026|NCT00996736|456171725|FG000|Overall Study|Visit not within 3-month window|5|||
126786027|NCT00996736|456171726|FG001|Overall Study|Visit not within 3-month window|3|||
126786028|NCT00313703|456173862|FG000|Overall Study|Lost to Follow-up|11|||
126786029|NCT00313703|456173863|FG001|Overall Study|Lost to Follow-up|2|||
126786030|NCT00313703|456173864|FG002|Overall Study|Lost to Follow-up|5|||
126786031|NCT00313703|456173865|FG003|Overall Study|Lost to Follow-up|12|||
126786032|NCT01691508|456173869|FG000|Overall Study|Adverse Event|3|||
126786033|NCT01691508|456173870|FG001|Overall Study|Adverse Event|3|||
126786034|NCT01691508|456173869|FG000|Overall Study|Withdrawal by Subject|1|||
126786035|NCT01691508|456173870|FG001|Overall Study|Withdrawal by Subject|0|||
126786036|NCT00527423|456173888|FG000|Overall Study|Protocol Violation|1|||
126786037|NCT00527423|456173888|FG000|Overall Study|Adverse Event|5|||
126786038|NCT00527423|456173888|FG000|Overall Study|Physician Decision|4|||
126786039|NCT00527423|456173888|FG000|Overall Study|Withdrawal by Subject|10|||
126786040|NCT00527423|456173888|FG000|Overall Study|Lost to Follow-up|4|||
126786041|NCT00527423|456173888|FG000|Overall Study|OTHER|4|||
126786042|NCT00527423|456173888|FG000|Overall Study|Death|9|||
126786043|NCT01957488|456173889|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
126786044|NCT01957488|456173890|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
126786045|NCT01957488|456173891|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
126786046|NCT01957488|456173892|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
126786047|NCT01957488|456173893|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
126786048|NCT01957488|456173894|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
126786049|NCT01957488|456173889|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
126786050|NCT01957488|456173890|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
126786051|NCT01957488|456173891|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
126786052|NCT01957488|456173892|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
126786053|NCT01957488|456173893|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
126786054|NCT01957488|456173894|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
126786055|NCT01957488|456173889|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
126786056|NCT01957488|456173890|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
126786057|NCT01957488|456173891|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
126786058|NCT01957488|456173892|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
126786059|NCT01957488|456173893|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
126786060|NCT01957488|456173894|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
126786061|NCT01957488|456173889|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
126786062|NCT01957488|456173890|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
126786063|NCT01957488|456173891|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
126786064|NCT01957488|456173892|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
126786065|NCT01957488|456173893|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
126786066|NCT01957488|456173894|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
126786067|NCT01957488|456173889|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
126786068|NCT01957488|456173890|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
126786069|NCT01957488|456173891|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
126786070|NCT01957488|456173892|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
126786071|NCT01957488|456173893|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
126786072|NCT01957488|456173894|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
126786073|NCT01957488|456173889|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
126786074|NCT01957488|456173890|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
126786075|NCT01957488|456173891|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
126786076|NCT01957488|456173892|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
126786077|NCT01957488|456173893|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
126786078|NCT01957488|456173894|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
126786079|NCT01957488|456173889|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
126786080|NCT01957488|456173890|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
126786081|NCT01957488|456173891|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
126786082|NCT01957488|456173892|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
126786083|NCT01957488|456173893|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
126786084|NCT01957488|456173894|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
126786085|NCT01957488|456173889|FG000|Test Period 2 (2 Weeks)|Other|1|||
126786086|NCT01957488|456173890|FG001|Test Period 2 (2 Weeks)|Other|0|||
126786087|NCT01957488|456173891|FG002|Test Period 2 (2 Weeks)|Other|0|||
126786088|NCT01957488|456173892|FG003|Test Period 2 (2 Weeks)|Other|0|||
126786089|NCT01957488|456173893|FG004|Test Period 2 (2 Weeks)|Other|0|||
126786090|NCT01957488|456173894|FG005|Test Period 2 (2 Weeks)|Other|0|||
126786091|NCT01957488|456173889|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
126786092|NCT01957488|456173890|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
126786093|NCT01957488|456173891|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
126786094|NCT01957488|456173892|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
126786095|NCT01957488|456173893|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
126786096|NCT01957488|456173894|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
126786097|NCT01957488|456173889|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
126786098|NCT01957488|456173890|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
126786099|NCT01957488|456173891|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
126786100|NCT01957488|456173892|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
126786101|NCT01957488|456173893|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
126786102|NCT01957488|456173894|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
126786103|NCT01957488|456173889|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
126786104|NCT01957488|456173890|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
126786105|NCT01957488|456173891|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
126786106|NCT01957488|456173892|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
126786107|NCT01957488|456173893|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
126786108|NCT01957488|456173894|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
126786109|NCT01957488|456173889|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
126786110|NCT01957488|456173890|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
126786111|NCT01957488|456173891|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
126786112|NCT01957488|456173892|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
126786113|NCT01957488|456173893|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
126786114|NCT01957488|456173894|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
126786115|NCT01957488|456173889|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
126786116|NCT01957488|456173890|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
126786117|NCT01957488|456173891|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
126786118|NCT01957488|456173892|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
126786119|NCT01957488|456173893|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
126786120|NCT01957488|456173894|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
126786121|NCT01439165|456173896|FG000|Overall Study|Protocol Violation|3|||
126786122|NCT01439165|456173897|FG001|Overall Study|Protocol Violation|0|||
126786123|NCT01439165|456173896|FG000|Overall Study|Lost to Follow-up|11|||
126786124|NCT01439165|456173897|FG001|Overall Study|Lost to Follow-up|1|||
126786125|NCT01439165|456173896|FG000|Overall Study|Withdrawal by Subject|7|||
126786126|NCT01439165|456173897|FG001|Overall Study|Withdrawal by Subject|1|||
126786127|NCT00623103|456173898|FG000|Overall Study|Adverse Event|70|||
126786128|NCT00623103|456173899|FG001|Overall Study|Adverse Event|60|||
126786129|NCT00623103|456173898|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126786130|NCT00623103|456173899|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
126786131|NCT00623103|456173898|FG000|Overall Study|Withdrawal by Subject|18|||
126786132|NCT00623103|456173899|FG001|Overall Study|Withdrawal by Subject|24|||
126786133|NCT00623103|456173898|FG000|Overall Study|Lost to Follow-up|4|||
126786134|NCT00623103|456173899|FG001|Overall Study|Lost to Follow-up|1|||
126786135|NCT00623103|456173898|FG000|Overall Study|Administrative problems|2|||
126786136|NCT00623103|456173899|FG001|Overall Study|Administrative problems|4|||
126786137|NCT00623103|456173898|FG000|Overall Study|Death|11|||
126786138|NCT00623103|456173899|FG001|Overall Study|Death|11|||
126786139|NCT00623103|456173898|FG000|Overall Study|Protocol deviation|2|||
126786140|NCT00623103|456173899|FG001|Overall Study|Protocol deviation|1|||
126786141|NCT01506947|456173903|FG000|Overall Study|Lost to Follow-up|7|||
126786142|NCT01506947|456173903|FG000|Overall Study|Adverse Event|5|||
126786143|NCT01506947|456173903|FG000|Overall Study|Death|1|||
126786144|NCT01506947|456173903|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
126786145|NCT01700621|456173904|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
126786146|NCT01700621|456173905|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
126786147|NCT01700621|456173904|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
126786148|NCT01700621|456173905|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
126786149|NCT01700621|456173904|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
126786150|NCT01700621|456173905|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
126786151|NCT02166697|456173906|FG000|Overall Study|Protocol Violation|347|||
126786152|NCT01618266|456173912|FG000|Overall Study|Lost to Follow-up|9|||
126786153|NCT01618266|456173912|FG000|Overall Study|Treatment satisfaction|10|||
126786154|NCT01618266|456173912|FG000|Overall Study|Other reasons|11|||
126786155|NCT01618266|456173912|FG000|Overall Study|Lack of Efficacy|23|||
126786156|NCT01618266|456173912|FG000|Overall Study|Protocol Violation|43|||
126786157|NCT02224391|456173913|FG000|Overall Study|Lost to Follow-up|26|||
126786158|NCT02224391|456173914|FG001|Overall Study|Lost to Follow-up|19|||
126786159|NCT02224391|456173913|FG000|Overall Study|Withdrawal by Subject|6|||
126786160|NCT02224391|456173914|FG001|Overall Study|Withdrawal by Subject|5|||
126786161|NCT00084084|456173915|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
126786162|NCT00084084|456173915|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
126786163|NCT02187042|456173919|FG000|Overall Study|Death|1|||
126786164|NCT02187042|456173920|FG001|Overall Study|Death|1|||
126786165|NCT02187042|456173919|FG000|Overall Study|Toxicity|6|||
126786166|NCT02187042|456173920|FG001|Overall Study|Toxicity|5|||
126786167|NCT02187042|456173919|FG000|Overall Study|Participant choice|1|||
126786168|NCT02187042|456173920|FG001|Overall Study|Participant choice|0|||
126786169|NCT02187042|456173919|FG000|Overall Study|Doctor choice|1|||
126786170|NCT02187042|456173920|FG001|Overall Study|Doctor choice|0|||
126786171|NCT02187042|456173919|FG000|Overall Study|Progressive disease|4|||
126786172|NCT02187042|456173920|FG001|Overall Study|Progressive disease|8|||
126786173|NCT01626079|456173922|FG000|Overall Study|Death|167|||
126786174|NCT01626079|456173923|FG001|Overall Study|Death|192|||
126786175|NCT01626079|456173924|FG002|Overall Study|Death|39|||
126786176|NCT01626079|456173922|FG000|Overall Study|Withdrawal by Subject|23|||
126786177|NCT01626079|456173923|FG001|Overall Study|Withdrawal by Subject|37|||
126786178|NCT01626079|456173924|FG002|Overall Study|Withdrawal by Subject|5|||
126786179|NCT01626079|456173922|FG000|Overall Study|Lost to Follow-up|7|||
126786180|NCT01626079|456173923|FG001|Overall Study|Lost to Follow-up|4|||
126786181|NCT01626079|456173924|FG002|Overall Study|Lost to Follow-up|2|||
126786182|NCT01626079|456173922|FG000|Overall Study|Missed Visits|1|||
126786183|NCT01626079|456173923|FG001|Overall Study|Missed Visits|4|||
126786184|NCT01626079|456173924|FG002|Overall Study|Missed Visits|6|||
126786185|NCT01457053|456173926|FG000|Overall Study|Unable to undergo selected treatment|1|||
126786186|NCT01457053|456173927|FG001|Overall Study|Unable to undergo selected treatment|1|||
126786187|NCT03922477|456173928|FG000|Overall Study|Death|9|||
126786188|NCT03922477|456173928|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
126786189|NCT03922477|456173928|FG000|Overall Study|Physician Decision|1|||
126786190|NCT03922477|456173928|FG000|Overall Study|Withdrawal by Subject|2|||
126786191|NCT00788957|456173934|FG000|Part 1|Death|8|||
126786192|NCT00788957|456173935|FG001|Part 1|Death|0|||
126786193|NCT00788957|456173936|FG002|Part 1|Death|0|||
126786194|NCT00788957|456173937|FG003|Part 1|Death|0|||
126786195|NCT00788957|456173938|FG004|Part 1|Death|0|||
126786196|NCT00788957|456173939|FG005|Part 1|Death|0|||
126786197|NCT00788957|456173934|FG000|Part 1|Lost to Follow-up|1|||
126786198|NCT00788957|456173935|FG001|Part 1|Lost to Follow-up|0|||
126786199|NCT00788957|456173936|FG002|Part 1|Lost to Follow-up|0|||
126786200|NCT00788957|456173937|FG003|Part 1|Lost to Follow-up|0|||
126786201|NCT00788957|456173938|FG004|Part 1|Lost to Follow-up|0|||
126786202|NCT00788957|456173939|FG005|Part 1|Lost to Follow-up|0|||
126786203|NCT00788957|456173934|FG000|Part 2|Withdrawal by Subject|0|||
126786204|NCT00788957|456173935|FG001|Part 2|Withdrawal by Subject|9|||
126786205|NCT00788957|456173936|FG002|Part 2|Withdrawal by Subject|5|||
126786206|NCT00788957|456173937|FG003|Part 2|Withdrawal by Subject|3|||
126786207|NCT00788957|456173938|FG004|Part 2|Withdrawal by Subject|0|||
126786208|NCT00788957|456173939|FG005|Part 2|Withdrawal by Subject|0|||
126786209|NCT00788957|456173934|FG000|Part 2|Death|0|||
126786210|NCT00788957|456173935|FG001|Part 2|Death|32|||
126786211|NCT00788957|456173936|FG002|Part 2|Death|35|||
126786212|NCT00788957|456173937|FG003|Part 2|Death|37|||
126786213|NCT00788957|456173938|FG004|Part 2|Death|0|||
126786214|NCT00788957|456173939|FG005|Part 2|Death|0|||
126786215|NCT00788957|456173934|FG000|Part 2|Lost to Follow-up|0|||
126786216|NCT00788957|456173935|FG001|Part 2|Lost to Follow-up|0|||
126786217|NCT00788957|456173936|FG002|Part 2|Lost to Follow-up|3|||
126786218|NCT00788957|456173937|FG003|Part 2|Lost to Follow-up|0|||
126786219|NCT00788957|456173938|FG004|Part 2|Lost to Follow-up|0|||
126786220|NCT00788957|456173939|FG005|Part 2|Lost to Follow-up|0|||
126786221|NCT00788957|456173934|FG000|Part 2|On-study at time of data cut-off|0|||
126786222|NCT00788957|456173935|FG001|Part 2|On-study at time of data cut-off|1|||
126786223|NCT00788957|456173936|FG002|Part 2|On-study at time of data cut-off|1|||
126786224|NCT00788957|456173937|FG003|Part 2|On-study at time of data cut-off|1|||
126786225|NCT00788957|456173938|FG004|Part 2|On-study at time of data cut-off|0|||
126786226|NCT00788957|456173939|FG005|Part 2|On-study at time of data cut-off|0|||
126786227|NCT00788957|456173934|FG000|Part 3|Withdrawal by Subject|0|||
126786228|NCT00788957|456173935|FG001|Part 3|Withdrawal by Subject|0|||
126786229|NCT00788957|456173936|FG002|Part 3|Withdrawal by Subject|0|||
126786230|NCT00788957|456173937|FG003|Part 3|Withdrawal by Subject|0|||
126786231|NCT00788957|456173938|FG004|Part 3|Withdrawal by Subject|0|||
126786232|NCT00788957|456173939|FG005|Part 3|Withdrawal by Subject|2|||
126786233|NCT00788957|456173934|FG000|Part 3|Death|0|||
126786234|NCT00788957|456173935|FG001|Part 3|Death|0|||
126786235|NCT00788957|456173936|FG002|Part 3|Death|0|||
126786236|NCT00788957|456173937|FG003|Part 3|Death|0|||
126786237|NCT00788957|456173938|FG004|Part 3|Death|8|||
126786238|NCT00788957|456173939|FG005|Part 3|Death|8|||
126786239|NCT00788957|456173934|FG000|Part 3|On-study at time of data cut-off|0|||
126786240|NCT00788957|456173935|FG001|Part 3|On-study at time of data cut-off|0|||
126786241|NCT00788957|456173936|FG002|Part 3|On-study at time of data cut-off|0|||
126786242|NCT00788957|456173937|FG003|Part 3|On-study at time of data cut-off|0|||
126786243|NCT00788957|456173938|FG004|Part 3|On-study at time of data cut-off|1|||
126786244|NCT00788957|456173939|FG005|Part 3|On-study at time of data cut-off|0|||
126786245|NCT03387098|456173940|FG000|Overall Study|progressive disease|1|||
126786246|NCT03387098|456173940|FG000|Overall Study|Withdrawal by Subject|2|||
126786247|NCT03387098|456173940|FG000|Overall Study|study terminated by sponsor|1|||
126786248|NCT03276975|456173941|FG000|Overall Study|Withdrawal by Subject|1|||
126786249|NCT03276975|456173942|FG001|Overall Study|Withdrawal by Subject|0|||
126786250|NCT00918567|456173945|FG000|Overall Study|Lack of Efficacy|3|||
126786251|NCT00918567|456173946|FG001|Overall Study|Lack of Efficacy|1|||
126786252|NCT00918567|456173945|FG000|Overall Study|Withdrawal by Subject|1|||
126786253|NCT00918567|456173946|FG001|Overall Study|Withdrawal by Subject|1|||
126786254|NCT00918567|456173945|FG000|Overall Study|Adverse Event|1|||
126786255|NCT00918567|456173946|FG001|Overall Study|Adverse Event|0|||
126786256|NCT02568384|456173947|FG000|Overall Study|Mobile devices incompatible with App|2|||
126786257|NCT01485536|456173949|FG000|Overall Study|Withdrawal by Subject|3|||
126786258|NCT01485536|456173949|FG000|Overall Study|Adverse Event|1|||
126786259|NCT00796510|456173950|FG000|Overall Study|Death|1|||
126786260|NCT00796510|456173951|FG001|Overall Study|Death|0|||
126786261|NCT00796510|456173950|FG000|Overall Study|Study Terminated|2|||
126786262|NCT00796510|456173951|FG001|Overall Study|Study Terminated|0|||
126786263|NCT02799602|456173952|FG000|Overall Study|Protocol Violation|1|||
126786264|NCT02799602|456173953|FG001|Overall Study|Protocol Violation|0|||
126786265|NCT02799602|456173952|FG000|Overall Study|Physician Decision|5|||
126786266|NCT02799602|456173953|FG001|Overall Study|Physician Decision|6|||
126786267|NCT02799602|456173952|FG000|Overall Study|Lost to Follow-up|4|||
126786268|NCT02799602|456173953|FG001|Overall Study|Lost to Follow-up|2|||
126786269|NCT02799602|456173952|FG000|Overall Study|Additional primary malignancy|11|||
126786270|NCT02799602|456173953|FG001|Overall Study|Additional primary malignancy|6|||
126786271|NCT02799602|456173952|FG000|Overall Study|Non-compliance with study drug|14|||
126786272|NCT02799602|456173953|FG001|Overall Study|Non-compliance with study drug|12|||
126786273|NCT02799602|456173952|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
126786274|NCT02799602|456173953|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
126786275|NCT02799602|456173952|FG000|Overall Study|Withdrawal by Subject|26|||
126786276|NCT02799602|456173953|FG001|Overall Study|Withdrawal by Subject|40|||
126786277|NCT02799602|456173952|FG000|Overall Study|Progressive disease - clinical progression|131|||
126786278|NCT02799602|456173953|FG001|Overall Study|Progressive disease - clinical progression|276|||
126786279|NCT02799602|456173952|FG000|Overall Study|Progressive disease - radiological progression|90|||
126786280|NCT02799602|456173953|FG001|Overall Study|Progressive disease - radiological progression|133|||
126786281|NCT02799602|456173952|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
126786282|NCT02799602|456173953|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
126786283|NCT02799602|456173952|FG000|Overall Study|Death|9|||
126786284|NCT02799602|456173953|FG001|Overall Study|Death|5|||
126786285|NCT02799602|456173952|FG000|Overall Study|Other|287|||
126786286|NCT02799602|456173953|FG001|Overall Study|Other|118|||
126786287|NCT02799602|456173952|FG000|Overall Study|Study drug never administered|0|||
126786288|NCT02799602|456173953|FG001|Overall Study|Study drug never administered|3|||
126786289|NCT02626949|456173954|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
126786290|NCT02626949|456173955|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
126786291|NCT02626949|456173954|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
126786292|NCT02626949|456173955|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
126786293|NCT02626949|456173954|FG000|Enrolled|Lost to Follow-up|7|||
126786294|NCT02626949|456173955|FG001|Enrolled|Lost to Follow-up|6|||
126786295|NCT02626949|456173954|FG000|Enrolled|Withdrawal by Subject|3|||
126786296|NCT02626949|456173955|FG001|Enrolled|Withdrawal by Subject|2|||
126786297|NCT03072459|456173956|FG000|Overall Study|Device revised/removed|1|||
126786298|NCT03072459|456173956|FG000|Overall Study|Subject not able to return|1|||
126786299|NCT00329602|456173957|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
126786300|NCT00329602|456173958|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
126786301|NCT00329602|456173959|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
126786302|NCT00329602|456173957|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
126786303|NCT00329602|456173958|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
126786304|NCT00329602|456173959|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
126786305|NCT00329602|456173957|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
126786306|NCT00329602|456173958|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
126786307|NCT00329602|456173959|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
126786308|NCT00329602|456173957|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
126786309|NCT00329602|456173958|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
126786310|NCT00329602|456173959|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
126786311|NCT00329602|456173957|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
126786312|NCT00329602|456173958|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
126786313|NCT00329602|456173959|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
126786314|NCT00329602|456173957|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
126786315|NCT00329602|456173958|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
126786316|NCT00329602|456173959|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
126786317|NCT02579096|456173960|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
126786318|NCT02579096|456173961|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
126786319|NCT02579096|456173960|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
126786320|NCT02579096|456173961|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
126786321|NCT02579096|456173960|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
126786322|NCT02579096|456173961|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
126786323|NCT02579096|456173960|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
126786324|NCT02579096|456173961|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
126786325|NCT02579096|456173960|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
126786326|NCT02579096|456173961|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
126786327|NCT02579096|456173960|FG000|Phase 2, Weeks 25 - 48|Death|2|||
126786328|NCT02579096|456173961|FG001|Phase 2, Weeks 25 - 48|Death|4|||
126786329|NCT02579096|456173960|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
126786330|NCT02579096|456173961|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
126786331|NCT02579096|456173960|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
126786332|NCT02579096|456173961|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
126786333|NCT02579096|456173960|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
126786334|NCT02579096|456173961|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
126786335|NCT02579096|456173960|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
126786336|NCT02579096|456173961|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
126786337|NCT02579096|456173960|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
126786338|NCT02579096|456173961|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
126786339|NCT02579096|456173960|FG000|Phase 3, Weeks 49 - 72|Death|3|||
126786340|NCT02579096|456173961|FG001|Phase 3, Weeks 49 - 72|Death|2|||
126786341|NCT02579096|456173960|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
126786342|NCT02579096|456173961|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
126786343|NCT02579096|456173960|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
126786344|NCT02579096|456173961|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
126786345|NCT02579096|456173960|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
126786346|NCT02579096|456173961|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
126786347|NCT02579096|456173960|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
126786348|NCT02579096|456173961|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
126786349|NCT02579096|456173960|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
126786350|NCT02579096|456173961|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
126786351|NCT02579096|456173960|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
126786352|NCT02579096|456173961|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
126786353|NCT02275364|456173962|FG000|Period 1|Withdrawal by Subject|1|||
126786354|NCT02275364|456173963|FG001|Period 1|Withdrawal by Subject|0|||
126786355|NCT02275364|456173962|FG000|Period 1|Other reason|1|||
126786356|NCT02275364|456173963|FG001|Period 1|Other reason|0|||
126786357|NCT01361126|456173968|FG000|Overall Study|Sponsor decision|0|||
126786358|NCT01361126|456173969|FG001|Overall Study|Sponsor decision|2|||
126786359|NCT00663871|456173971|FG000|Overall Study|Lost to Follow-up|5|||
126786360|NCT00663871|456173972|FG001|Overall Study|Lost to Follow-up|5|||
126786361|NCT00663871|456173971|FG000|Overall Study|Withdrawal by Subject|5|||
126786362|NCT00663871|456173972|FG001|Overall Study|Withdrawal by Subject|2|||
126786363|NCT04094870|456173973|FG000|Overall Study|Lost to Follow-up|1|||
126786364|NCT04094870|456173974|FG001|Overall Study|Lost to Follow-up|1|||
126786365|NCT03384745|456173975|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
126786366|NCT03384745|456173976|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
126786367|NCT03384745|456173977|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
126786368|NCT03384745|456173978|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
126786369|NCT03384745|456173979|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
126786370|NCT03384745|456173980|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
126786371|NCT03384745|456173975|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
126786372|NCT03384745|456173976|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
126786373|NCT03384745|456173977|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
126786374|NCT03384745|456173978|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
126786375|NCT03384745|456173979|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
126786376|NCT03384745|456173980|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
126786377|NCT03384745|456173975|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
126786378|NCT03384745|456173976|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
126786379|NCT03384745|456173977|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
126786380|NCT03384745|456173978|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
126786381|NCT03384745|456173979|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
126786382|NCT03384745|456173980|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
126786383|NCT03384745|456173975|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
126786384|NCT03384745|456173976|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
126786385|NCT03384745|456173977|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
126786386|NCT03384745|456173978|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
126786387|NCT03384745|456173979|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
126786388|NCT03384745|456173980|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
126786389|NCT03384745|456173975|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
126786390|NCT03384745|456173976|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
126786391|NCT03384745|456173977|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
126786392|NCT03384745|456173978|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
126786393|NCT03384745|456173979|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
126786394|NCT03384745|456173980|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
126786395|NCT03384745|456173975|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
126786396|NCT03384745|456173976|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
126786397|NCT03384745|456173977|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
126786398|NCT03384745|456173978|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
126786399|NCT03384745|456173979|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
126786400|NCT03384745|456173980|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
126786401|NCT03384745|456173975|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
126786402|NCT03384745|456173976|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
126786403|NCT03384745|456173977|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
126786404|NCT03384745|456173978|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
126786405|NCT03384745|456173979|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
126786406|NCT03384745|456173980|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
126786407|NCT03384745|456173975|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
126786408|NCT03384745|456173976|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
126786409|NCT03384745|456173977|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
126786410|NCT03384745|456173978|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
126786411|NCT03384745|456173979|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
126786412|NCT03384745|456173980|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
126786413|NCT03384745|456173975|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
126786414|NCT03384745|456173976|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
126786415|NCT03384745|456173977|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
126786416|NCT03384745|456173978|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
126786417|NCT03384745|456173979|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
126786418|NCT03384745|456173980|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
126786419|NCT03384745|456173975|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
126786420|NCT03384745|456173976|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
126786421|NCT03384745|456173977|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
126786422|NCT03384745|456173978|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
126786423|NCT03384745|456173979|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
126786424|NCT03384745|456173980|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
126786425|NCT03384745|456173975|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
126786426|NCT03384745|456173976|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
126786427|NCT03384745|456173977|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
126786428|NCT03384745|456173978|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
126786429|NCT03384745|456173979|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
126786430|NCT03384745|456173980|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
126786431|NCT02984683|456173985|FG000|Overall Study|Adverse Event|3|||
126786432|NCT02984683|456173986|FG001|Overall Study|Adverse Event|3|||
126786433|NCT02984683|456173985|FG000|Overall Study|Withdrawal by Subject|1|||
126786434|NCT02984683|456173986|FG001|Overall Study|Withdrawal by Subject|0|||
126786435|NCT02984683|456173985|FG000|Overall Study|Disease progression|7|||
126786436|NCT02984683|456173986|FG001|Overall Study|Disease progression|9|||
126786437|NCT02742181|456173987|FG000|Overall Study|Physician Decision|1|||
126786438|NCT02742181|456173988|FG001|Overall Study|Physician Decision|0|||
126786439|NCT02739984|456173989|FG000|Overall Study|Sponsor Decision|1|||
126786440|NCT02739984|456173990|FG001|Overall Study|Sponsor Decision|0|||
126786441|NCT02739984|456173989|FG000|Overall Study|Withdrawal by Subject|1|||
126786442|NCT02739984|456173990|FG001|Overall Study|Withdrawal by Subject|1|||
126786443|NCT02739984|456173989|FG000|Overall Study|Death|0|||
126786444|NCT02739984|456173990|FG001|Overall Study|Death|1|||
126786445|NCT02739984|456173989|FG000|Overall Study|Lost to Follow-up|3|||
126786446|NCT02739984|456173990|FG001|Overall Study|Lost to Follow-up|0|||
126786447|NCT03008460|456173991|FG000|Overall Study|Protocol deviation|0|||
126786448|NCT03008460|456173992|FG001|Overall Study|Protocol deviation|2|||
126786449|NCT03008460|456173991|FG000|Overall Study|Study drug not dispensed|0|||
126786450|NCT03008460|456173992|FG001|Overall Study|Study drug not dispensed|1|||
126786451|NCT03008460|456173991|FG000|Overall Study|Adverse Event|0|||
126786452|NCT03008460|456173992|FG001|Overall Study|Adverse Event|1|||
126786453|NCT03008460|456173991|FG000|Overall Study|Withdrawal by Subject|5|||
126786454|NCT03008460|456173992|FG001|Overall Study|Withdrawal by Subject|6|||
126786455|NCT03008460|456173991|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
126786456|NCT03008460|456173992|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
126786457|NCT03008460|456173991|FG000|Overall Study|End of study visit outside permitted time window|0|||
126786458|NCT03008460|456173992|FG001|Overall Study|End of study visit outside permitted time window|1|||
126786459|NCT03008460|456173991|FG000|Overall Study|Lost to Follow-up|1|||
126786460|NCT03008460|456173992|FG001|Overall Study|Lost to Follow-up|3|||
126786461|NCT04947579|456173995|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
126786462|NCT04947579|456173996|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
126786463|NCT04947579|456173997|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
126786464|NCT04947579|456173998|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
126786465|NCT04947579|456173999|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
126786466|NCT04947579|456174000|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
126786467|NCT04947579|456173995|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
126786468|NCT04947579|456173996|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
126786469|NCT04947579|456173997|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
126786470|NCT04947579|456173998|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
126786471|NCT04947579|456173999|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
126786472|NCT04947579|456174000|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
126786473|NCT04947579|456173995|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
126786474|NCT04947579|456173996|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
126786475|NCT04947579|456173997|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
126786476|NCT04947579|456173998|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
126786477|NCT04947579|456173999|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
126786478|NCT04947579|456174000|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
126786479|NCT04947579|456173995|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
126786480|NCT04947579|456173996|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
126786481|NCT04947579|456173997|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
126786482|NCT04947579|456173998|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
126786483|NCT04947579|456173999|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
126786484|NCT04947579|456174000|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
126786485|NCT04947579|456173995|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
126786486|NCT04947579|456173996|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
126786487|NCT04947579|456173997|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
126786488|NCT04947579|456173998|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
126786489|NCT04947579|456173999|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
126786490|NCT04947579|456174000|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
126786491|NCT04947579|456173995|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
126786492|NCT04947579|456173996|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
126786493|NCT04947579|456173997|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
126786494|NCT04947579|456173998|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
126786495|NCT04947579|456173999|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
126786496|NCT04947579|456174000|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
126786497|NCT04947579|456173995|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
126786498|NCT04947579|456173996|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
126786499|NCT04947579|456173997|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
126786500|NCT04947579|456173998|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
126786501|NCT04947579|456173999|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
126786502|NCT04947579|456174000|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
126786503|NCT04947579|456173995|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
126786504|NCT04947579|456173996|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
126786505|NCT04947579|456173997|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
126786506|NCT04947579|456173998|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
126786507|NCT04947579|456173999|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
126786508|NCT04947579|456174000|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
126786509|NCT04947579|456173995|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
126786510|NCT04947579|456173996|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
126786511|NCT04947579|456173997|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
126786512|NCT04947579|456173998|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
126786513|NCT04947579|456173999|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
126786514|NCT04947579|456174000|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
126786515|NCT04947579|456173995|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
126786516|NCT04947579|456173996|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
126786517|NCT04947579|456173997|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
126786518|NCT04947579|456173998|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
126786519|NCT04947579|456173999|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
126786520|NCT04947579|456174000|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
126786521|NCT04947579|456173995|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
126786522|NCT04947579|456173996|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
126786523|NCT04947579|456173997|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
126786524|NCT04947579|456173998|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
126786525|NCT04947579|456173999|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
126786526|NCT04947579|456174000|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
126786527|NCT01575054|456174001|FG000|Overall Study|Other Reasons|5|||
126786528|NCT01575054|456174002|FG001|Overall Study|Other Reasons|3|||
126786529|NCT01575054|456174001|FG000|Overall Study|Protocol Violation|2|||
126786530|NCT01575054|456174002|FG001|Overall Study|Protocol Violation|1|||
126786531|NCT01575054|456174001|FG000|Overall Study|Personal Reasons|10|||
126786532|NCT01575054|456174002|FG001|Overall Study|Personal Reasons|11|||
126786533|NCT01575054|456174001|FG000|Overall Study|Lost to Follow-up|3|||
126786534|NCT01575054|456174002|FG001|Overall Study|Lost to Follow-up|3|||
126786535|NCT01575054|456174001|FG000|Overall Study|Adverse Event|9|||
126786536|NCT01575054|456174002|FG001|Overall Study|Adverse Event|8|||
126786537|NCT00462982|456174011|FG000|Overall Study|Adverse Event|1|||
126786538|NCT00462982|456174011|FG000|Overall Study|Patient Not Treated|2|||
126786539|NCT00409578|456174012|FG000|Overall Study|Adverse Event|27|||
126786540|NCT00409578|456174013|FG001|Overall Study|Adverse Event|37|||
126786541|NCT00409578|456174014|FG002|Overall Study|Adverse Event|25|||
126786542|NCT00409578|456174015|FG003|Overall Study|Adverse Event|33|||
126786543|NCT00409578|456174012|FG000|Overall Study|Abnormal laboratory value(s)|2|||
126786544|NCT00409578|456174013|FG001|Overall Study|Abnormal laboratory value(s)|2|||
126786545|NCT00409578|456174014|FG002|Overall Study|Abnormal laboratory value(s)|2|||
126786546|NCT00409578|456174015|FG003|Overall Study|Abnormal laboratory value(s)|4|||
126786547|NCT00409578|456174012|FG000|Overall Study|Lack of Efficacy|0|||
126786548|NCT00409578|456174013|FG001|Overall Study|Lack of Efficacy|0|||
126786549|NCT00409578|456174014|FG002|Overall Study|Lack of Efficacy|0|||
126786550|NCT00409578|456174015|FG003|Overall Study|Lack of Efficacy|2|||
126786551|NCT00409578|456174012|FG000|Overall Study|Subject no longer requires study drug|0|||
126786552|NCT00409578|456174013|FG001|Overall Study|Subject no longer requires study drug|0|||
126786553|NCT00409578|456174014|FG002|Overall Study|Subject no longer requires study drug|0|||
126786554|NCT00409578|456174015|FG003|Overall Study|Subject no longer requires study drug|1|||
126786555|NCT00409578|456174012|FG000|Overall Study|Withdrawal by Subject|8|||
126786556|NCT00409578|456174013|FG001|Overall Study|Withdrawal by Subject|15|||
126786557|NCT00409578|456174014|FG002|Overall Study|Withdrawal by Subject|16|||
126786558|NCT00409578|456174015|FG003|Overall Study|Withdrawal by Subject|17|||
126786559|NCT00409578|456174012|FG000|Overall Study|Lost to Follow-up|2|||
126786560|NCT00409578|456174013|FG001|Overall Study|Lost to Follow-up|0|||
126786561|NCT00409578|456174014|FG002|Overall Study|Lost to Follow-up|2|||
126786562|NCT00409578|456174015|FG003|Overall Study|Lost to Follow-up|2|||
126786563|NCT00409578|456174012|FG000|Overall Study|Administrative problems|8|||
126786564|NCT00409578|456174013|FG001|Overall Study|Administrative problems|9|||
126786565|NCT00409578|456174014|FG002|Overall Study|Administrative problems|2|||
126786566|NCT00409578|456174015|FG003|Overall Study|Administrative problems|4|||
126786567|NCT00409578|456174012|FG000|Overall Study|Death|2|||
126786568|NCT00409578|456174013|FG001|Overall Study|Death|4|||
126786569|NCT00409578|456174014|FG002|Overall Study|Death|4|||
126786570|NCT00409578|456174015|FG003|Overall Study|Death|2|||
126786571|NCT00409578|456174012|FG000|Overall Study|Protocol Violation|3|||
126786572|NCT00409578|456174013|FG001|Overall Study|Protocol Violation|2|||
126786573|NCT00409578|456174014|FG002|Overall Study|Protocol Violation|3|||
126786574|NCT00409578|456174015|FG003|Overall Study|Protocol Violation|1|||
126786575|NCT00409578|456174012|FG000|Overall Study|Missing|0|||
126786576|NCT00409578|456174013|FG001|Overall Study|Missing|1|||
126786577|NCT00409578|456174014|FG002|Overall Study|Missing|0|||
126786578|NCT00409578|456174015|FG003|Overall Study|Missing|1|||
126786579|NCT02109133|456174016|FG000|Overall Study|Lost to Follow-up|1|||
126786580|NCT02109133|456174017|FG001|Overall Study|Lost to Follow-up|0|||
126786581|NCT05200858|456174018|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
126786582|NCT05200858|456174019|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
126786583|NCT05200858|456174020|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
126786584|NCT05200858|456174021|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
126786585|NCT00770315|456174024|FG000|Overall Study|Adverse Event|11|||
126786586|NCT00770315|456174025|FG001|Overall Study|Adverse Event|17|||
126786587|NCT00770315|456174026|FG002|Overall Study|Adverse Event|16|||
126786588|NCT00770315|456174027|FG003|Overall Study|Adverse Event|6|||
126786589|NCT00770315|456174024|FG000|Overall Study|Lost to Follow-up|9|||
126786590|NCT00770315|456174025|FG001|Overall Study|Lost to Follow-up|5|||
126786591|NCT00770315|456174026|FG002|Overall Study|Lost to Follow-up|10|||
126786592|NCT00770315|456174027|FG003|Overall Study|Lost to Follow-up|3|||
126786593|NCT00770315|456174024|FG000|Overall Study|Withdrawal by Subject|13|||
126786594|NCT00770315|456174025|FG001|Overall Study|Withdrawal by Subject|17|||
126786595|NCT00770315|456174026|FG002|Overall Study|Withdrawal by Subject|24|||
126786596|NCT00770315|456174027|FG003|Overall Study|Withdrawal by Subject|20|||
126786597|NCT00770315|456174024|FG000|Overall Study|Noncompliance with Protocol|7|||
126786598|NCT00770315|456174025|FG001|Overall Study|Noncompliance with Protocol|4|||
126786599|NCT00770315|456174026|FG002|Overall Study|Noncompliance with Protocol|7|||
126786600|NCT00770315|456174027|FG003|Overall Study|Noncompliance with Protocol|9|||
126786601|NCT02322047|456175974|FG000|Overall Study|Physician Decision|1|||
126786602|NCT02322047|456175975|FG001|Overall Study|Physician Decision|0|||
126786603|NCT02322047|456175976|FG002|Overall Study|Physician Decision|0|||
126786604|NCT02322047|456175977|FG003|Overall Study|Physician Decision|0|||
126786605|NCT02322047|456175974|FG000|Overall Study|Withdrawal by Subject|1|||
126786606|NCT02322047|456175975|FG001|Overall Study|Withdrawal by Subject|0|||
126786607|NCT02322047|456175976|FG002|Overall Study|Withdrawal by Subject|0|||
126786608|NCT02322047|456175977|FG003|Overall Study|Withdrawal by Subject|1|||
126786609|NCT02322047|456175974|FG000|Overall Study|Adverse Event|0|||
126786610|NCT02322047|456175975|FG001|Overall Study|Adverse Event|1|||
126786611|NCT02322047|456175976|FG002|Overall Study|Adverse Event|0|||
126786612|NCT02322047|456175977|FG003|Overall Study|Adverse Event|0|||
126786613|NCT02322047|456175974|FG000|Overall Study|Lost to Follow-up|0|||
126786614|NCT02322047|456175975|FG001|Overall Study|Lost to Follow-up|0|||
126786615|NCT02322047|456175976|FG002|Overall Study|Lost to Follow-up|1|||
126786616|NCT02322047|456175977|FG003|Overall Study|Lost to Follow-up|1|||
126786617|NCT02207231|456175978|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
126786618|NCT02207231|456175979|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
126786619|NCT02207231|456175980|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
126786620|NCT02207231|456175981|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
126786621|NCT02207231|456175978|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
126786622|NCT02207231|456175979|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
126786623|NCT02207231|456175980|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
126786624|NCT02207231|456175981|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
126786625|NCT02207231|456175978|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
126786626|NCT02207231|456175979|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
126786627|NCT02207231|456175980|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
126786628|NCT02207231|456175981|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
126786629|NCT02207231|456175978|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
126786630|NCT02207231|456175979|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
126786631|NCT02207231|456175980|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
126786632|NCT02207231|456175981|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
126786633|NCT02207231|456175978|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
126786634|NCT02207231|456175979|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
126786635|NCT02207231|456175980|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
126786636|NCT02207231|456175981|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
126786637|NCT02207231|456175978|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
126786638|NCT02207231|456175979|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
126786639|NCT02207231|456175980|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
126786640|NCT02207231|456175981|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
126786641|NCT02207231|456175978|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
126786642|NCT02207231|456175979|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
126786643|NCT02207231|456175980|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
126786644|NCT02207231|456175981|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
126786645|NCT02207231|456175978|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
126786646|NCT02207231|456175979|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
126786647|NCT02207231|456175980|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
126786648|NCT02207231|456175981|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
126786649|NCT02207231|456175978|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
126786650|NCT02207231|456175979|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
126786651|NCT02207231|456175980|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
126786652|NCT02207231|456175981|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
126786653|NCT02207231|456175978|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
126786654|NCT02207231|456175979|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
126786655|NCT02207231|456175980|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
126786656|NCT02207231|456175981|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
126786657|NCT02207231|456175978|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
126786658|NCT02207231|456175979|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
126786659|NCT02207231|456175980|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
126786660|NCT02207231|456175981|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
126786661|NCT02207231|456175978|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
126786662|NCT02207231|456175979|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
126786663|NCT02207231|456175980|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
126786664|NCT02207231|456175981|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
126786665|NCT02207231|456175978|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
126786666|NCT02207231|456175979|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
126786667|NCT02207231|456175980|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
126786668|NCT02207231|456175981|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
126786669|NCT02207231|456175978|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
126786670|NCT02207231|456175979|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
126786671|NCT02207231|456175980|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
126786672|NCT02207231|456175981|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
126786673|NCT02207231|456175978|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
126786674|NCT02207231|456175979|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
126786675|NCT02207231|456175980|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
126786676|NCT02207231|456175981|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
126786677|NCT02207231|456175978|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
126786678|NCT02207231|456175979|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
126786679|NCT02207231|456175980|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
126786680|NCT02207231|456175981|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
126786681|NCT02207231|456175978|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
126786682|NCT02207231|456175979|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
126786683|NCT02207231|456175980|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
126786684|NCT02207231|456175981|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
126786685|NCT02207231|456175978|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
126786686|NCT02207231|456175979|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
126786687|NCT02207231|456175980|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
126786688|NCT02207231|456175981|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
126786689|NCT02207231|456175978|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
126786690|NCT02207231|456175979|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
126786691|NCT02207231|456175980|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
126786692|NCT02207231|456175981|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
126786693|NCT02207231|456175978|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
126786694|NCT02207231|456175979|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
126786695|NCT02207231|456175980|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
126786696|NCT02207231|456175981|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
126786697|NCT02207231|456175978|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
126786698|NCT02207231|456175979|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
126786699|NCT02207231|456175980|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
126786700|NCT02207231|456175981|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
126786701|NCT02309099|456175985|FG000|Overall Study|Adverse Event|2|||
126786702|NCT02309099|456175986|FG001|Overall Study|Adverse Event|0|||
126786703|NCT02016300|456175987|FG000|Overall Study|Lost to Follow-up|0|||
126786704|NCT02016300|456175988|FG001|Overall Study|Lost to Follow-up|3|||
126786705|NCT06165744|456175989|FG000|Overall Study|Non device-related adverse event|1|||
126786706|NCT05456529|456175990|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
126786707|NCT05456529|456175990|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
126786708|NCT05456529|456175990|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
126786709|NCT05456529|456175990|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
126629522|NCT01502371|455602388|FG003|Overall Study|Adverse Event|4|||
126629523|NCT01502371|455602389|FG004|Overall Study|Adverse Event|3|||
126786710|NCT05456529|456175990|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
126786711|NCT05456529|456175990|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
126786712|NCT05456529|456175990|FG000|44-week Long-term Safety Period|Physician Decision|2|||
126786713|NCT05456529|456175990|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
126786714|NCT05456529|456175990|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
126786715|NCT05456529|456175990|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
126786716|NCT05456529|456175990|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
126786717|NCT01631864|456175991|FG000|Overall Study|Withdrawal by Subject|0|||
126786718|NCT01631864|456175992|FG001|Overall Study|Withdrawal by Subject|1|||
126786719|NCT01631864|456175991|FG000|Overall Study|Adverse Event|2|||
126786720|NCT01631864|456175992|FG001|Overall Study|Adverse Event|3|||
126786721|NCT03702621|456175993|FG000|Overall Study|Physician Decision|6|||
126786722|NCT03702621|456175994|FG001|Overall Study|Physician Decision|6|||
126786723|NCT03103100|456175995|FG000|Overall Study|Adverse Event|1|||
126786724|NCT03103100|456175996|FG001|Overall Study|Adverse Event|0|||
126786725|NCT03103100|456175997|FG002|Overall Study|Adverse Event|0|||
126786726|NCT03103100|456175995|FG000|Overall Study|Physician Decision|1|||
126786727|NCT03103100|456175996|FG001|Overall Study|Physician Decision|0|||
126786728|NCT03103100|456175997|FG002|Overall Study|Physician Decision|2|||
126786729|NCT00436007|456176000|FG000|Overall Study|Withdrawal by Subject|5|||
126786730|NCT00436007|456176001|FG001|Overall Study|Withdrawal by Subject|3|||
126786731|NCT00436007|456176002|FG002|Overall Study|Withdrawal by Subject|4|||
126629524|NCT01502371|455602385|FG000|Overall Study|Treatment Failure|22|||
126629525|NCT01502371|455602386|FG001|Overall Study|Treatment Failure|20|||
126786732|NCT00436007|456176000|FG000|Overall Study|Lost to Follow-up|14|||
126786733|NCT00436007|456176001|FG001|Overall Study|Lost to Follow-up|10|||
126786734|NCT00436007|456176002|FG002|Overall Study|Lost to Follow-up|13|||
126786735|NCT00436007|456176000|FG000|Overall Study|Physician Decision|0|||
126786736|NCT00436007|456176001|FG001|Overall Study|Physician Decision|0|||
126786737|NCT00436007|456176002|FG002|Overall Study|Physician Decision|2|||
126786738|NCT00436007|456176000|FG000|Overall Study|Death|0|||
126786739|NCT00436007|456176001|FG001|Overall Study|Death|1|||
126786740|NCT00436007|456176002|FG002|Overall Study|Death|3|||
126786741|NCT00436007|456176000|FG000|Overall Study|Other|0|||
126786742|NCT00436007|456176001|FG001|Overall Study|Other|0|||
126786743|NCT00436007|456176002|FG002|Overall Study|Other|1|||
126786744|NCT00810368|456176003|FG000|Overall Study|Lost to Follow-up|4|||
126786745|NCT00810368|456176004|FG001|Overall Study|Lost to Follow-up|2|||
126786746|NCT00810368|456176003|FG000|Overall Study|Lack of Efficacy|2|||
126786747|NCT00810368|456176004|FG001|Overall Study|Lack of Efficacy|0|||
126786748|NCT00688064|456176006|FG000|Overall Study|Protocol Violation|0|||
126786749|NCT00688064|456176007|FG001|Overall Study|Protocol Violation|1|||
126786750|NCT00688064|456176006|FG000|Overall Study|Adverse Event|2|||
126786751|NCT00688064|456176007|FG001|Overall Study|Adverse Event|4|||
126786752|NCT00688064|456176006|FG000|Overall Study|Withdrawal by Subject|7|||
126786753|NCT00688064|456176007|FG001|Overall Study|Withdrawal by Subject|7|||
126786754|NCT00688064|456176006|FG000|Overall Study|Lost to Follow-up|10|||
126786755|NCT00688064|456176007|FG001|Overall Study|Lost to Follow-up|10|||
126786756|NCT00688064|456176006|FG000|Overall Study|Lack of Efficacy|0|||
126786757|NCT00688064|456176007|FG001|Overall Study|Lack of Efficacy|1|||
126786758|NCT00688064|456176006|FG000|Overall Study|Pregnancy|1|||
126786759|NCT00688064|456176007|FG001|Overall Study|Pregnancy|0|||
126786760|NCT00688064|456176006|FG000|Overall Study|Any other reasons|1|||
126786761|NCT00688064|456176007|FG001|Overall Study|Any other reasons|3|||
126786762|NCT00001849|456176010|FG000|Overall Study|Death|4|||
126786763|NCT00001849|456176010|FG000|Overall Study|Lost to Follow-up|2|||
126786764|NCT00001849|456176010|FG000|Overall Study|Withdrawal by Subject|2|||
126786765|NCT00001849|456176010|FG000|Overall Study|tumor remained occult|6|||
126786766|NCT00442936|456176011|FG000|Overall Study|Protocol Violation|1|||
126786767|NCT00442936|456176012|FG001|Overall Study|Protocol Violation|0|||
126786768|NCT00442936|456176013|FG002|Overall Study|Protocol Violation|1|||
126786769|NCT00442936|456176014|FG003|Overall Study|Protocol Violation|1|||
126786770|NCT02433678|456176016|FG000|Overall Study|Lost to Follow-up|1|||
126786771|NCT02433678|456176017|FG001|Overall Study|Lost to Follow-up|2|||
126786772|NCT03365375|456176020|FG000|Overall Study|Withdrawal by Subject|0|||
126786773|NCT03365375|456176021|FG001|Overall Study|Withdrawal by Subject|1|||
126786774|NCT03365375|456176020|FG000|Overall Study|Lost to Follow-up|0|||
126786775|NCT03365375|456176021|FG001|Overall Study|Lost to Follow-up|4|||
126786776|NCT00266409|456176025|FG000|Overall Study|Lack of Efficacy|2|||
126786777|NCT00266409|456176026|FG001|Overall Study|Lack of Efficacy|6|||
126786778|NCT00266409|456176027|FG002|Overall Study|Lack of Efficacy|1|||
126786779|NCT00266409|456176028|FG003|Overall Study|Lack of Efficacy|2|||
126786780|NCT00266409|456176025|FG000|Overall Study|Adverse Event|7|||
126786781|NCT00266409|456176026|FG001|Overall Study|Adverse Event|2|||
126786782|NCT00266409|456176027|FG002|Overall Study|Adverse Event|1|||
126786783|NCT00266409|456176028|FG003|Overall Study|Adverse Event|1|||
126786784|NCT00266409|456176025|FG000|Overall Study|Lost to Follow-up|18|||
126786785|NCT00266409|456176026|FG001|Overall Study|Lost to Follow-up|21|||
126786786|NCT00266409|456176027|FG002|Overall Study|Lost to Follow-up|6|||
126786787|NCT00266409|456176028|FG003|Overall Study|Lost to Follow-up|8|||
126786788|NCT00266409|456176025|FG000|Overall Study|Withdrawal by Subject|6|||
126786789|NCT00266409|456176026|FG001|Overall Study|Withdrawal by Subject|10|||
126786790|NCT00266409|456176027|FG002|Overall Study|Withdrawal by Subject|3|||
126786791|NCT00266409|456176028|FG003|Overall Study|Withdrawal by Subject|9|||
126786792|NCT00266409|456176025|FG000|Overall Study|Protocol Violation|5|||
126786793|NCT00266409|456176026|FG001|Overall Study|Protocol Violation|3|||
126786794|NCT00266409|456176027|FG002|Overall Study|Protocol Violation|4|||
126786795|NCT00266409|456176028|FG003|Overall Study|Protocol Violation|2|||
126786796|NCT00266409|456176025|FG000|Overall Study|Other|7|||
126786797|NCT00266409|456176026|FG001|Overall Study|Other|4|||
126786798|NCT00266409|456176027|FG002|Overall Study|Other|2|||
126786799|NCT00266409|456176028|FG003|Overall Study|Other|0|||
126786800|NCT00635154|456176029|FG000|Overall Study|Alternative Treatment|8|||
126786801|NCT00635154|456176029|FG000|Overall Study|Other|4|||
126786802|NCT00635154|456176029|FG000|Overall Study|Still on treatment|21|||
126786803|NCT01399736|456176030|FG000|Overall Study|Withdrawal by Subject|4|||
126786804|NCT01399736|456176031|FG001|Overall Study|Withdrawal by Subject|2|||
126786805|NCT01399736|456176030|FG000|Overall Study|Lost to Follow-up|0|||
126786806|NCT01399736|456176031|FG001|Overall Study|Lost to Follow-up|2|||
126786807|NCT03500484|456176032|FG000|Overall Study|Adverse Event|2|||
126786808|NCT03500484|456176033|FG001|Overall Study|Adverse Event|0|||
126786809|NCT03500484|456176032|FG000|Overall Study|Physician Decision|1|||
126786810|NCT03500484|456176033|FG001|Overall Study|Physician Decision|0|||
126786811|NCT03500484|456176032|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
126786812|NCT03500484|456176033|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
126786813|NCT00770510|456176034|FG000|Overall Study|Lost to Follow-up|2|||
126786814|NCT00770510|456176034|FG000|Overall Study|Pregnancy|1|||
126786815|NCT00770510|456176034|FG000|Overall Study|Withdrawal by Subject|2|||
126786816|NCT00536575|456176035|FG000|Overall Study|Withdrawal by Subject|1|||
126786817|NCT00536575|456176035|FG000|Overall Study|Death|1|||
126786818|NCT00995553|456176039|FG000|Overall Study|Withdrawal by Subject|2|||
126786819|NCT00995553|456176040|FG001|Overall Study|Withdrawal by Subject|6|||
126786820|NCT01089647|456176041|FG000|Overall Study|Lost to Follow-up|2|||
126786821|NCT01089647|456176042|FG001|Overall Study|Lost to Follow-up|2|||
126786822|NCT01089647|456176041|FG000|Overall Study|Withdrawal by Subject|2|||
126786823|NCT01089647|456176042|FG001|Overall Study|Withdrawal by Subject|1|||
126786824|NCT01089647|456176041|FG000|Overall Study|Adverse Event|0|||
126786825|NCT01089647|456176042|FG001|Overall Study|Adverse Event|1|||
126786826|NCT00927810|456176043|FG000|Overall Study|Withdrawal by Subject|0|||
126786827|NCT00927810|456176044|FG001|Overall Study|Withdrawal by Subject|3|||
126786828|NCT00927810|456176045|FG002|Overall Study|Withdrawal by Subject|0|||
126786829|NCT00927810|456176046|FG003|Overall Study|Withdrawal by Subject|1|||
126786830|NCT00927810|456176043|FG000|Overall Study|Lost to Follow-up|0|||
126786831|NCT00927810|456176044|FG001|Overall Study|Lost to Follow-up|2|||
126786832|NCT00927810|456176045|FG002|Overall Study|Lost to Follow-up|1|||
126786833|NCT00927810|456176046|FG003|Overall Study|Lost to Follow-up|1|||
126786834|NCT00927810|456176043|FG000|Overall Study|Death|0|||
126786835|NCT00927810|456176044|FG001|Overall Study|Death|2|||
126786836|NCT00927810|456176045|FG002|Overall Study|Death|0|||
126786837|NCT00927810|456176046|FG003|Overall Study|Death|0|||
126786838|NCT00927810|456176043|FG000|Overall Study|Abnormal laboratory value(s)|0|||
126786839|NCT00927810|456176044|FG001|Overall Study|Abnormal laboratory value(s)|1|||
126786840|NCT00927810|456176045|FG002|Overall Study|Abnormal laboratory value(s)|0|||
126786841|NCT00927810|456176046|FG003|Overall Study|Abnormal laboratory value(s)|0|||
126786842|NCT00198029|456176052|FG000|Overall Study|Withdrawal by Subject|4|||
126786843|NCT00814463|456176055|FG000|Overall Study|Lost to Follow-up|1|||
126786844|NCT03982433|456176056|FG000|Overall Study|Lost to Follow-up|1|||
126786845|NCT00368277|456176059|FG000|Overall Study|Adverse Event|33|||
126786846|NCT00368277|456176060|FG001|Overall Study|Adverse Event|49|||
126786847|NCT00368277|456176059|FG000|Overall Study|Death|2|||
126786848|NCT00368277|456176060|FG001|Overall Study|Death|1|||
126786849|NCT00368277|456176059|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
126786850|NCT00368277|456176060|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
126786851|NCT00368277|456176059|FG000|Overall Study|Protocol deviation|7|||
126786852|NCT00368277|456176060|FG001|Overall Study|Protocol deviation|0|||
126786853|NCT00368277|456176059|FG000|Overall Study|Patient withdrew consent|32|||
126786854|NCT00368277|456176060|FG001|Overall Study|Patient withdrew consent|28|||
126786855|NCT00368277|456176059|FG000|Overall Study|Lost to Follow-up|8|||
126786856|NCT00368277|456176060|FG001|Overall Study|Lost to Follow-up|6|||
126786857|NCT00984295|456176061|FG000|Overall Study|Lost to Follow-up|31|||
126786858|NCT00984295|456176062|FG001|Overall Study|Lost to Follow-up|12|||
126786859|NCT00984295|456176063|FG002|Overall Study|Lost to Follow-up|13|||
126786860|NCT00984295|456176061|FG000|Overall Study|Protocol Violation|2|||
126786861|NCT00984295|456176062|FG001|Overall Study|Protocol Violation|1|||
126786862|NCT00984295|456176063|FG002|Overall Study|Protocol Violation|4|||
126786863|NCT00984295|456176061|FG000|Overall Study|Withdrawal by Subject|18|||
126786864|NCT00984295|456176062|FG001|Overall Study|Withdrawal by Subject|9|||
126786865|NCT00984295|456176063|FG002|Overall Study|Withdrawal by Subject|12|||
126786866|NCT00984295|456176061|FG000|Overall Study|CAE - discontinued test vaccine|0|||
126786867|NCT00984295|456176062|FG001|Overall Study|CAE - discontinued test vaccine|1|||
126786868|NCT00984295|456176063|FG002|Overall Study|CAE - discontinued test vaccine|3|||
126786869|NCT00984295|456176061|FG000|Overall Study|Missed one or more blood samplings|3|||
126786870|NCT00984295|456176062|FG001|Overall Study|Missed one or more blood samplings|7|||
126786871|NCT00984295|456176063|FG002|Overall Study|Missed one or more blood samplings|2|||
126786872|NCT00984295|456176061|FG000|Overall Study|Incomplete safety follow-up|11|||
126786873|NCT00984295|456176062|FG001|Overall Study|Incomplete safety follow-up|2|||
126786874|NCT00984295|456176063|FG002|Overall Study|Incomplete safety follow-up|3|||
126786875|NCT04799158|456176064|FG000|Run-In Period|Adverse Event|6|||
126786876|NCT04799158|456176065|FG001|Run-In Period|Adverse Event|0|||
126786877|NCT04799158|456176066|FG002|Run-In Period|Adverse Event|0|||
126786878|NCT04799158|456176067|FG003|Run-In Period|Adverse Event|0|||
126786879|NCT04799158|456176068|FG004|Run-In Period|Adverse Event|0|||
126786880|NCT04799158|456176064|FG000|Run-In Period|Lost to Follow-up|4|||
126786881|NCT04799158|456176065|FG001|Run-In Period|Lost to Follow-up|0|||
126786882|NCT04799158|456176066|FG002|Run-In Period|Lost to Follow-up|0|||
126786883|NCT04799158|456176067|FG003|Run-In Period|Lost to Follow-up|0|||
126786884|NCT04799158|456176068|FG004|Run-In Period|Lost to Follow-up|0|||
126786885|NCT04799158|456176064|FG000|Run-In Period|Significant Protocol Deviation|1|||
126786886|NCT04799158|456176065|FG001|Run-In Period|Significant Protocol Deviation|0|||
126786887|NCT04799158|456176066|FG002|Run-In Period|Significant Protocol Deviation|0|||
126786888|NCT04799158|456176067|FG003|Run-In Period|Significant Protocol Deviation|0|||
126786889|NCT04799158|456176068|FG004|Run-In Period|Significant Protocol Deviation|0|||
126786890|NCT04799158|456176064|FG000|Run-In Period|Withdrawal by Subject|11|||
126786891|NCT04799158|456176065|FG001|Run-In Period|Withdrawal by Subject|0|||
126786892|NCT04799158|456176066|FG002|Run-In Period|Withdrawal by Subject|0|||
126786893|NCT04799158|456176067|FG003|Run-In Period|Withdrawal by Subject|0|||
126786894|NCT04799158|456176068|FG004|Run-In Period|Withdrawal by Subject|0|||
126786895|NCT04799158|456176064|FG000|Run-In Period|Miscellaneous|3|||
126786896|NCT04799158|456176065|FG001|Run-In Period|Miscellaneous|0|||
126786897|NCT04799158|456176066|FG002|Run-In Period|Miscellaneous|0|||
126786898|NCT04799158|456176067|FG003|Run-In Period|Miscellaneous|0|||
126786899|NCT04799158|456176068|FG004|Run-In Period|Miscellaneous|0|||
126786900|NCT04799158|456176064|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
126786901|NCT04799158|456176065|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
126754801|NCT02394028|456051404|FG009|Maintenance Phase|Lack of Efficacy|25|||
126754802|NCT02394028|456051405|FG010|Maintenance Phase|Lack of Efficacy|33|||
126754803|NCT02394028|456051395|FG000|Maintenance Phase|Death|0|||
126754804|NCT02394028|456051396|FG001|Maintenance Phase|Death|0|||
126754805|NCT02394028|456051397|FG002|Maintenance Phase|Death|0|||
126754806|NCT02394028|456051398|FG003|Maintenance Phase|Death|0|||
126754807|NCT02394028|456051399|FG004|Maintenance Phase|Death|0|||
126754808|NCT02394028|456051400|FG005|Maintenance Phase|Death|0|||
126754809|NCT02394028|456051401|FG006|Maintenance Phase|Death|0|||
126754810|NCT02394028|456051402|FG007|Maintenance Phase|Death|0|||
126754811|NCT02394028|456051403|FG008|Maintenance Phase|Death|0|||
126754812|NCT02394028|456051404|FG009|Maintenance Phase|Death|0|||
126754813|NCT02394028|456051405|FG010|Maintenance Phase|Death|1|||
126754814|NCT02394028|456051395|FG000|Maintenance Phase|Adverse Event|0|||
126754815|NCT02394028|456051396|FG001|Maintenance Phase|Adverse Event|0|||
126754816|NCT02394028|456051397|FG002|Maintenance Phase|Adverse Event|0|||
126754817|NCT02394028|456051398|FG003|Maintenance Phase|Adverse Event|0|||
126754818|NCT02394028|456051399|FG004|Maintenance Phase|Adverse Event|0|||
126754819|NCT02394028|456051400|FG005|Maintenance Phase|Adverse Event|0|||
126754820|NCT02394028|456051401|FG006|Maintenance Phase|Adverse Event|0|||
126754821|NCT02394028|456051402|FG007|Maintenance Phase|Adverse Event|0|||
126754822|NCT02394028|456051403|FG008|Maintenance Phase|Adverse Event|1|||
126754823|NCT02394028|456051404|FG009|Maintenance Phase|Adverse Event|1|||
126754824|NCT02394028|456051405|FG010|Maintenance Phase|Adverse Event|3|||
126754825|NCT02394028|456051395|FG000|Maintenance Phase|Site closure|0|||
126754826|NCT02394028|456051396|FG001|Maintenance Phase|Site closure|0|||
126754827|NCT02394028|456051397|FG002|Maintenance Phase|Site closure|0|||
126754828|NCT02394028|456051398|FG003|Maintenance Phase|Site closure|0|||
126754829|NCT02394028|456051399|FG004|Maintenance Phase|Site closure|0|||
126754830|NCT02394028|456051400|FG005|Maintenance Phase|Site closure|0|||
126754831|NCT02394028|456051401|FG006|Maintenance Phase|Site closure|0|||
126754832|NCT02394028|456051402|FG007|Maintenance Phase|Site closure|0|||
126754833|NCT02394028|456051403|FG008|Maintenance Phase|Site closure|0|||
126754834|NCT02394028|456051404|FG009|Maintenance Phase|Site closure|1|||
126754835|NCT02394028|456051405|FG010|Maintenance Phase|Site closure|0|||
126754836|NCT02394028|456051395|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126754837|NCT02394028|456051396|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126754838|NCT02394028|456051397|FG002|Maintenance Phase|Withdrawal by Subject|0|||
126754839|NCT02394028|456051398|FG003|Maintenance Phase|Withdrawal by Subject|0|||
126754840|NCT02394028|456051399|FG004|Maintenance Phase|Withdrawal by Subject|0|||
126754841|NCT02394028|456051400|FG005|Maintenance Phase|Withdrawal by Subject|0|||
126754842|NCT02394028|456051401|FG006|Maintenance Phase|Withdrawal by Subject|0|||
126754843|NCT02394028|456051402|FG007|Maintenance Phase|Withdrawal by Subject|0|||
126754844|NCT02394028|456051403|FG008|Maintenance Phase|Withdrawal by Subject|3|||
126754845|NCT02394028|456051404|FG009|Maintenance Phase|Withdrawal by Subject|12|||
126754846|NCT02394028|456051405|FG010|Maintenance Phase|Withdrawal by Subject|12|||
126754847|NCT03458234|456051414|FG000|Overall Study|Withdrawal by Subject|1|||
126754848|NCT01640353|456052935|FG000|Overall Study|Withdrew prior to treatment|10|||
126754849|NCT01640353|456052935|FG000|Overall Study|Withdrawn from analysis at term site|12|||
126754850|NCT01640353|456052935|FG000|Overall Study|Withdrawal by Subject|5|||
126754851|NCT01640353|456052935|FG000|Overall Study|Death|2|||
126754852|NCT01640353|456052935|FG000|Overall Study|Early site termination|3|||
126754853|NCT01640353|456052935|FG000|Overall Study|Lost to Follow-up|12|||
126754854|NCT01640353|456052935|FG000|Overall Study|Physician Decision|1|||
126754855|NCT03758612|456052936|FG000|Washout Period|Withdrawal by Subject|0|||
126754856|NCT03758612|456052937|FG001|Washout Period|Withdrawal by Subject|0|||
126754857|NCT03758612|456052938|FG002|Washout Period|Withdrawal by Subject|2|||
126786902|NCT04799158|456176066|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
126786903|NCT04799158|456176067|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
126754858|NCT03758612|456052939|FG003|Washout Period|Withdrawal by Subject|0|||
126754859|NCT03758612|456052940|FG004|Washout Period|Withdrawal by Subject|0|||
126754860|NCT03758612|456052941|FG005|Washout Period|Withdrawal by Subject|0|||
126754861|NCT03758612|456052942|FG006|Washout Period|Withdrawal by Subject|0|||
126754862|NCT03758612|456052943|FG007|Washout Period|Withdrawal by Subject|0|||
126754863|NCT03758612|456052944|FG008|Washout Period|Withdrawal by Subject|0|||
126754864|NCT03758612|456052945|FG009|Washout Period|Withdrawal by Subject|0|||
126754865|NCT03758612|456052946|FG010|Washout Period|Withdrawal by Subject|0|||
126786904|NCT04799158|456176068|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
126786905|NCT04799158|456176064|FG000|On-Demand Treatment Period|Adverse Event|0|||
126786906|NCT04799158|456176065|FG001|On-Demand Treatment Period|Adverse Event|1|||
126786907|NCT04799158|456176066|FG002|On-Demand Treatment Period|Adverse Event|0|||
126786908|NCT04799158|456176067|FG003|On-Demand Treatment Period|Adverse Event|0|||
126786909|NCT04799158|456176068|FG004|On-Demand Treatment Period|Adverse Event|1|||
126786910|NCT04799158|456176064|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
126786911|NCT04799158|456176065|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
126786912|NCT04799158|456176066|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
126786913|NCT04799158|456176067|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
126786914|NCT04799158|456176068|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
126786915|NCT04799158|456176064|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
126786916|NCT04799158|456176065|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
126786917|NCT04799158|456176066|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
126786918|NCT04799158|456176067|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
126786919|NCT04799158|456176068|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
126786920|NCT04799158|456176064|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
126786921|NCT04799158|456176065|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
126786922|NCT04799158|456176066|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
126786923|NCT04799158|456176067|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
126786924|NCT04799158|456176068|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
126786925|NCT04799158|456176064|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
126786926|NCT04799158|456176065|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
126786927|NCT04799158|456176066|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
126786928|NCT04799158|456176067|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
126786929|NCT04799158|456176068|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
126786930|NCT04799158|456176064|FG000|On-Demand Treatment Period|Miscellaneous|0|||
126786931|NCT04799158|456176065|FG001|On-Demand Treatment Period|Miscellaneous|0|||
126786932|NCT04799158|456176066|FG002|On-Demand Treatment Period|Miscellaneous|0|||
126786933|NCT04799158|456176067|FG003|On-Demand Treatment Period|Miscellaneous|0|||
126786934|NCT04799158|456176068|FG004|On-Demand Treatment Period|Miscellaneous|1|||
126786935|NCT03283709|456176086|FG000|Overall Study|trial terminated|0|||
126786936|NCT03283709|456176087|FG001|Overall Study|trial terminated|1|||
126786937|NCT01734772|456176088|FG000|Overall Study|Adverse Event|1|||
126786938|NCT01734772|456176089|FG001|Overall Study|Adverse Event|2|||
126786939|NCT01734772|456176088|FG000|Overall Study|Withdrawal by Subject|0|||
126786940|NCT01734772|456176089|FG001|Overall Study|Withdrawal by Subject|1|||
126786941|NCT02097121|456176092|FG000|Overall Study|Other, not specified|4|||
126786942|NCT02097121|456176093|FG001|Overall Study|Other, not specified|2|||
126786943|NCT02097121|456176094|FG002|Overall Study|Other, not specified|3|||
126786944|NCT02097121|456176092|FG000|Overall Study|Lack of Efficacy|2|||
126786945|NCT02097121|456176093|FG001|Overall Study|Lack of Efficacy|1|||
126786946|NCT02097121|456176094|FG002|Overall Study|Lack of Efficacy|3|||
126786947|NCT02097121|456176092|FG000|Overall Study|Withdrawal by Subject|0|||
126786948|NCT02097121|456176093|FG001|Overall Study|Withdrawal by Subject|1|||
126786949|NCT02097121|456176094|FG002|Overall Study|Withdrawal by Subject|2|||
126786950|NCT02097121|456176092|FG000|Overall Study|Adverse Event|0|||
126786951|NCT02097121|456176093|FG001|Overall Study|Adverse Event|1|||
126786952|NCT02097121|456176094|FG002|Overall Study|Adverse Event|0|||
126786953|NCT02097121|456176092|FG000|Overall Study|Lost to Follow-up|1|||
126786954|NCT02097121|456176093|FG001|Overall Study|Lost to Follow-up|1|||
126786955|NCT02097121|456176094|FG002|Overall Study|Lost to Follow-up|2|||
126786956|NCT03066999|456176095|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
126786957|NCT03066999|456176096|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
126786958|NCT00661999|456176097|FG000|Overall Study|Adverse Event|11|||
126786959|NCT00661999|456176098|FG001|Overall Study|Adverse Event|5|||
126786960|NCT00661999|456176099|FG002|Overall Study|Adverse Event|8|||
126786961|NCT00661999|456176097|FG000|Overall Study|Death|8|||
126786962|NCT00661999|456176098|FG001|Overall Study|Death|6|||
126786963|NCT00661999|456176099|FG002|Overall Study|Death|3|||
126786964|NCT00661999|456176097|FG000|Overall Study|Other Reasons|5|||
126786965|NCT00661999|456176098|FG001|Overall Study|Other Reasons|12|||
126786966|NCT00661999|456176099|FG002|Overall Study|Other Reasons|23|||
126786967|NCT00661999|456176097|FG000|Overall Study|Withdrawal by Subject|30|||
126786968|NCT00661999|456176098|FG001|Overall Study|Withdrawal by Subject|23|||
126786969|NCT00661999|456176099|FG002|Overall Study|Withdrawal by Subject|14|||
126786970|NCT00661999|456176097|FG000|Overall Study|Alternative Treatment|1|||
126786971|NCT00661999|456176098|FG001|Overall Study|Alternative Treatment|0|||
126786972|NCT00661999|456176099|FG002|Overall Study|Alternative Treatment|0|||
126786973|NCT00661999|456176097|FG000|Overall Study|Other Medical Problems|4|||
126786974|NCT00661999|456176098|FG001|Overall Study|Other Medical Problems|4|||
126786975|NCT00661999|456176099|FG002|Overall Study|Other Medical Problems|9|||
126786976|NCT00510510|456176100|FG000|Overall Study|Adverse Event|4|||
126786977|NCT00510510|456176101|FG001|Overall Study|Adverse Event|3|||
126786978|NCT00510510|456176102|FG002|Overall Study|Adverse Event|6|||
126786979|NCT00510510|456176100|FG000|Overall Study|Lack of Efficacy|0|||
126786980|NCT00510510|456176101|FG001|Overall Study|Lack of Efficacy|1|||
126786981|NCT00510510|456176102|FG002|Overall Study|Lack of Efficacy|1|||
126786982|NCT00510510|456176100|FG000|Overall Study|Subjects no longer requires study drug|0|||
126786983|NCT00510510|456176101|FG001|Overall Study|Subjects no longer requires study drug|0|||
126786984|NCT00510510|456176102|FG002|Overall Study|Subjects no longer requires study drug|2|||
126786985|NCT00510510|456176100|FG000|Overall Study|Withdrawal by Subject|1|||
126786986|NCT00510510|456176101|FG001|Overall Study|Withdrawal by Subject|2|||
126786987|NCT00510510|456176102|FG002|Overall Study|Withdrawal by Subject|3|||
126786988|NCT00510510|456176100|FG000|Overall Study|Lost to Follow-up|0|||
126786989|NCT00510510|456176101|FG001|Overall Study|Lost to Follow-up|0|||
126786990|NCT00510510|456176102|FG002|Overall Study|Lost to Follow-up|1|||
126786991|NCT00510510|456176100|FG000|Overall Study|Protocol Violation|0|||
126786992|NCT00510510|456176101|FG001|Overall Study|Protocol Violation|3|||
126786993|NCT00510510|456176102|FG002|Overall Study|Protocol Violation|4|||
126786994|NCT01790568|456176103|FG000|Overall Study|Progression prior to transplant|0|||
126786995|NCT01790568|456176104|FG001|Overall Study|Progression prior to transplant|1|||
126786996|NCT03595657|456176105|FG000|Overall Study|Adverse Event|14|||
126786997|NCT03595657|456176105|FG000|Overall Study|Death|1|||
126786998|NCT03595657|456176105|FG000|Overall Study|Lack of Efficacy|40|||
126786999|NCT03595657|456176105|FG000|Overall Study|Withdrawal by Subject|10|||
126787000|NCT03595657|456176105|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
126787001|NCT03595657|456176105|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
126787002|NCT02994056|456176106|FG000|Overall Study|Death|8|||
126787003|NCT02994056|456176106|FG000|Overall Study|Withdrew Consent|1|||
126787004|NCT03481309|456176112|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
126787005|NCT03481309|456176113|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
126787006|NCT03481309|456176114|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
126787007|NCT03481309|456176115|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
126787008|NCT03481309|456176116|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
126787009|NCT03481309|456176117|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
126787010|NCT03495869|456176118|FG000|Overall Study|Lost to Follow-up|4|||
126787011|NCT03495869|456176119|FG001|Overall Study|Lost to Follow-up|17|||
126787012|NCT03495869|456176120|FG002|Overall Study|Lost to Follow-up|8|||
126787013|NCT03495869|456176121|FG003|Overall Study|Lost to Follow-up|14|||
126787014|NCT03495869|456176118|FG000|Overall Study|Withdrawal by Subject|0|||
126787015|NCT03495869|456176119|FG001|Overall Study|Withdrawal by Subject|3|||
126787016|NCT03495869|456176120|FG002|Overall Study|Withdrawal by Subject|0|||
126787017|NCT03495869|456176121|FG003|Overall Study|Withdrawal by Subject|3|||
126787018|NCT03495869|456176118|FG000|Overall Study|Dropped from study|0|||
126787019|NCT03495869|456176119|FG001|Overall Study|Dropped from study|7|||
126787020|NCT03495869|456176120|FG002|Overall Study|Dropped from study|2|||
126787021|NCT03495869|456176121|FG003|Overall Study|Dropped from study|4|||
126787022|NCT02346201|456176123|FG000|Overall Study|Adverse Event|3|||
126787023|NCT02346201|456176124|FG001|Overall Study|Adverse Event|2|||
126787024|NCT02346201|456176123|FG000|Overall Study|Lost to Follow-up|1|||
126787025|NCT02346201|456176124|FG001|Overall Study|Lost to Follow-up|0|||
126787026|NCT02346201|456176123|FG000|Overall Study|Withdrawal by Subject|6|||
126787027|NCT02346201|456176124|FG001|Overall Study|Withdrawal by Subject|3|||
126787028|NCT02346201|456176123|FG000|Overall Study|Unavailable for future follow-up|0|||
126787029|NCT02346201|456176124|FG001|Overall Study|Unavailable for future follow-up|1|||
126787030|NCT02346201|456176123|FG000|Overall Study|Physician Decision|0|||
126787031|NCT02346201|456176124|FG001|Overall Study|Physician Decision|1|||
126787032|NCT02346201|456176123|FG000|Overall Study|Missed final visit|0|||
126787033|NCT02346201|456176124|FG001|Overall Study|Missed final visit|2|||
126787034|NCT03708211|456176125|FG000|Overall Study|Progressive Disease|10|||
126787035|NCT03708211|456176126|FG001|Overall Study|Progressive Disease|7|||
126787036|NCT03708211|456176125|FG000|Overall Study|Withdrawal by Subject|0|||
126787037|NCT03708211|456176126|FG001|Overall Study|Withdrawal by Subject|1|||
126787038|NCT03708211|456176125|FG000|Overall Study|Other|2|||
126787039|NCT03708211|456176126|FG001|Overall Study|Other|0|||
126787040|NCT01508936|456176127|FG000|Overall Study|Adverse Event|11|||
126787041|NCT01508936|456176128|FG001|Overall Study|Adverse Event|32|||
126787042|NCT01508936|456176127|FG000|Overall Study|Lack of Efficacy|0|||
126787043|NCT01508936|456176128|FG001|Overall Study|Lack of Efficacy|1|||
126787044|NCT01508936|456176127|FG000|Overall Study|Withdrawal by Subject|4|||
126787045|NCT01508936|456176128|FG001|Overall Study|Withdrawal by Subject|18|||
126629526|NCT01502371|455602387|FG002|Overall Study|Treatment Failure|12|||
126787046|NCT01508936|456176127|FG000|Overall Study|Protocol Violation|2|||
126787047|NCT01508936|456176128|FG001|Overall Study|Protocol Violation|3|||
126787048|NCT01508936|456176127|FG000|Overall Study|Lost to Follow-up|2|||
126787049|NCT01508936|456176128|FG001|Overall Study|Lost to Follow-up|9|||
126787050|NCT01508936|456176127|FG000|Overall Study|Other|0|||
126787051|NCT01508936|456176128|FG001|Overall Study|Other|5|||
126787052|NCT01508936|456176127|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
126787053|NCT01508936|456176128|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
126787054|NCT00679367|456176129|FG000|Overall Study|Adverse Event|7|||
126754866|NCT03758612|456052947|FG011|Washout Period|Withdrawal by Subject|0|||
126754867|NCT03758612|456052936|FG000|Period 2|Protocol Violation|0|||
126754868|NCT03758612|456052937|FG001|Period 2|Protocol Violation|0|||
126754869|NCT03758612|456052938|FG002|Period 2|Protocol Violation|0|||
126754870|NCT03758612|456052939|FG003|Period 2|Protocol Violation|0|||
126754871|NCT03758612|456052940|FG004|Period 2|Protocol Violation|1|||
126754872|NCT03758612|456052941|FG005|Period 2|Protocol Violation|0|||
126754873|NCT03758612|456052942|FG006|Period 2|Protocol Violation|0|||
126754874|NCT03758612|456052943|FG007|Period 2|Protocol Violation|0|||
126754875|NCT03758612|456052944|FG008|Period 2|Protocol Violation|0|||
126754876|NCT03758612|456052945|FG009|Period 2|Protocol Violation|0|||
126754877|NCT03758612|456052946|FG010|Period 2|Protocol Violation|0|||
126754878|NCT03758612|456052947|FG011|Period 2|Protocol Violation|0|||
126754879|NCT01603615|456052949|FG000|Overall Study|Did not Receive Treatment|7|||
126754880|NCT01603615|456052949|FG000|Overall Study|Lost to Follow-up|9|||
126754881|NCT01603615|456052949|FG000|Overall Study|Personal Reasons|17|||
126754882|NCT01603615|456052949|FG000|Overall Study|Other Miscellaneous|1|||
126754883|NCT03419741|456052950|FG000|Overall Study|Adverse Event|1|||
126754884|NCT03419741|456052951|FG001|Overall Study|Adverse Event|0|||
126754885|NCT03419741|456052950|FG000|Overall Study|Withdrawal by Subject|1|||
126754886|NCT03419741|456052951|FG001|Overall Study|Withdrawal by Subject|2|||
126754887|NCT04354870|456052952|FG000|Overall Study|Lost to Follow-up|32|||
126754888|NCT04354870|456052953|FG001|Overall Study|Lost to Follow-up|12|||
126754889|NCT04354870|456052952|FG000|Overall Study|Withdrawal by Subject|10|||
126754890|NCT04354870|456052953|FG001|Overall Study|Withdrawal by Subject|16|||
126754891|NCT04354870|456052952|FG000|Overall Study|Did not complete all study visits|6|||
126754892|NCT04354870|456052953|FG001|Overall Study|Did not complete all study visits|5|||
126754893|NCT03384316|456052954|FG000|Overall Study|Screen failure|0|||
126754894|NCT03384316|456052955|FG001|Overall Study|Screen failure|1|||
126754895|NCT02194699|456052966|FG000|Randomised|Did not receive treatment|1|||
126754896|NCT02194699|456052967|FG001|Randomised|Did not receive treatment|5|||
126754897|NCT02194699|456052966|FG000|Randomised|Without potential for 52 weeks of IP|5|||
126754898|NCT02194699|456052967|FG001|Randomised|Without potential for 52 weeks of IP|5|||
126754899|NCT02194699|456052966|FG000|Randomised|Duplicate patient|2|||
126754900|NCT02194699|456052967|FG001|Randomised|Duplicate patient|1|||
126754901|NCT02194699|456052966|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
126754902|NCT02194699|456052967|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
126754903|NCT02194699|456052966|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
126754904|NCT02194699|456052967|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
126754905|NCT02194699|456052966|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
126754906|NCT02194699|456052967|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
126754907|NCT02194699|456052966|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
126754908|NCT02194699|456052967|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
126754909|NCT02194699|456052966|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
126754910|NCT02194699|456052967|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
126754911|NCT02194699|456052966|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
126754912|NCT02194699|456052967|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
126754913|NCT02127970|456052977|FG000|Overall Study|Adverse Event|2|||
126754914|NCT02127970|456052978|FG001|Overall Study|Adverse Event|1|||
126754915|NCT02127970|456052977|FG000|Overall Study|Death|1|||
126754916|NCT02127970|456052978|FG001|Overall Study|Death|1|||
126754917|NCT02127970|456052977|FG000|Overall Study|Lost to Follow-up|14|||
126754918|NCT02127970|456052978|FG001|Overall Study|Lost to Follow-up|14|||
126754919|NCT02127970|456052977|FG000|Overall Study|Reason not Specified|4|||
126754920|NCT02127970|456052978|FG001|Overall Study|Reason not Specified|7|||
126754921|NCT02127970|456052977|FG000|Overall Study|Pregnancy|0|||
126754922|NCT02127970|456052978|FG001|Overall Study|Pregnancy|1|||
126754923|NCT02127970|456052977|FG000|Overall Study|Subject Withdrew Consent|5|||
126754924|NCT02127970|456052978|FG001|Overall Study|Subject Withdrew Consent|3|||
126754925|NCT01710709|456052979|FG000|Overall Study|Lost to Follow-up|29|||
126754926|NCT01710709|456052979|FG000|Overall Study|Adverse Event|48|||
126754927|NCT01710709|456052979|FG000|Overall Study|Participant met withdrawal criteria|33|||
126754928|NCT01710709|456052979|FG000|Overall Study|Participant withdrawn by investigator|2|||
126754929|NCT01710709|456052979|FG000|Overall Study|Withdrawal by Subject|53|||
126754930|NCT01710709|456052979|FG000|Overall Study|Protocol Violation|5|||
126754931|NCT01710709|456052979|FG000|Overall Study|Lack of Efficacy|3|||
126754932|NCT01398176|456052980|FG000|Overall Study|Lost to Follow-up|1|||
126754933|NCT01398176|456052981|FG001|Overall Study|Lost to Follow-up|3|||
126754934|NCT01398176|456052980|FG000|Overall Study|Physician Decision|2|||
126754935|NCT01398176|456052981|FG001|Overall Study|Physician Decision|3|||
126754936|NCT00542321|456052982|FG000|Overall Study|Death|0|||
126754937|NCT00542321|456052983|FG001|Overall Study|Death|1|||
126754938|NCT04601194|456052984|FG000|Overall Study|Lost to Follow-up|7|||
126754939|NCT00545740|456052989|FG000|Overall Study|Lack of Efficacy|34|||
126754940|NCT00545740|456052990|FG001|Overall Study|Lack of Efficacy|35|||
126754941|NCT00545740|456052991|FG002|Overall Study|Lack of Efficacy|47|||
126754942|NCT00545740|456052992|FG003|Overall Study|Lack of Efficacy|36|||
126787055|NCT00679367|456176129|FG000|Overall Study|inability to swallow oral drugs|1|||
126787056|NCT00679367|456176129|FG000|Overall Study|Lack of Efficacy|3|||
126787057|NCT00679367|456176129|FG000|Overall Study|Withdrawal by Subject|1|||
126787058|NCT04603937|456176130|FG000|Overall Study|Adverse Event|9|||
126787059|NCT04603937|456176131|FG001|Overall Study|Adverse Event|10|||
126787060|NCT04603937|456176130|FG000|Overall Study|Withdrawal by Subject|7|||
126787061|NCT04603937|456176131|FG001|Overall Study|Withdrawal by Subject|6|||
126787062|NCT04603937|456176130|FG000|Overall Study|Lost to Follow-up|5|||
126787063|NCT04603937|456176131|FG001|Overall Study|Lost to Follow-up|6|||
126787064|NCT04603937|456176130|FG000|Overall Study|Physician Decision|0|||
126787065|NCT04603937|456176131|FG001|Overall Study|Physician Decision|1|||
126787066|NCT04603937|456176130|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
126787067|NCT04603937|456176131|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
126787068|NCT00922779|456176132|FG000|Overall Study|Adverse Event|67|||
126787069|NCT00922779|456176132|FG000|Overall Study|Pregnancy|7|||
126787070|NCT00922779|456176132|FG000|Overall Study|Withdrawal by Subject|308|||
126787071|NCT00922779|456176132|FG000|Overall Study|Lost to Follow-up|44|||
126787072|NCT00922779|456176132|FG000|Overall Study|Other|27|||
126787073|NCT00922779|456176132|FG000|Overall Study|Missing|1874|||
126787074|NCT01922349|456176133|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
126787075|NCT01922349|456176134|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
126787076|NCT01922349|456176135|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
126787077|NCT01922349|456176136|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
126787078|NCT02683187|456176137|FG000|Overall Study|Failed IV access|3|||
126787079|NCT02683187|456176137|FG000|Overall Study|Withdrawal by Subject|5|||
126787080|NCT02585258|456176138|FG000|Overall Study|Adverse Event|28|||
126787081|NCT02585258|456176139|FG001|Overall Study|Adverse Event|29|||
126787082|NCT02585258|456176138|FG000|Overall Study|Death|3|||
126787083|NCT02585258|456176139|FG001|Overall Study|Death|2|||
126787084|NCT02585258|456176138|FG000|Overall Study|Lack of Efficacy|7|||
126787085|NCT02585258|456176139|FG001|Overall Study|Lack of Efficacy|9|||
126787086|NCT02585258|456176138|FG000|Overall Study|includes covid-related access problems|42|||
126787087|NCT02585258|456176139|FG001|Overall Study|includes covid-related access problems|46|||
126787088|NCT02585258|456176138|FG000|Overall Study|Lost to Follow-up|5|||
126787089|NCT02585258|456176139|FG001|Overall Study|Lost to Follow-up|2|||
126787090|NCT01919190|456178547|FG000|Overall Study|Intra-op findings, etc.|3|||
126787091|NCT01919190|456178548|FG001|Overall Study|Intra-op findings, etc.|0|||
126787092|NCT00797108|456178553|FG000|Overall Study|Adverse Event|1|||
126787093|NCT00797108|456178554|FG001|Overall Study|Adverse Event|0|||
126787094|NCT00797108|456178555|FG002|Overall Study|Adverse Event|3|||
126787095|NCT00797108|456178553|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
126787096|NCT00797108|456178554|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
126787097|NCT00797108|456178555|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
126787098|NCT00797108|456178553|FG000|Overall Study|Global Deterioration of Health Status|0|||
126787099|NCT00797108|456178554|FG001|Overall Study|Global Deterioration of Health Status|1|||
126787100|NCT00797108|456178555|FG002|Overall Study|Global Deterioration of Health Status|0|||
126787101|NCT00797108|456178553|FG000|Overall Study|Lack of Efficacy|1|||
126787102|NCT00797108|456178554|FG001|Overall Study|Lack of Efficacy|0|||
126787103|NCT00797108|456178555|FG002|Overall Study|Lack of Efficacy|1|||
126787104|NCT00797108|456178553|FG000|Overall Study|Other|0|||
126787105|NCT00797108|456178554|FG001|Overall Study|Other|0|||
126787106|NCT00797108|456178555|FG002|Overall Study|Other|2|||
126787107|NCT00797108|456178553|FG000|Overall Study|Randomized but not Treated|2|||
126787108|NCT00797108|456178554|FG001|Overall Study|Randomized but not Treated|0|||
126787109|NCT00797108|456178555|FG002|Overall Study|Randomized but not Treated|0|||
126787110|NCT02518113|456178556|FG000|Overall Study|Adverse Event|1|||
126787111|NCT02518113|456178557|FG001|Overall Study|Adverse Event|0|||
126787112|NCT02518113|456178558|FG002|Overall Study|Adverse Event|1|||
126787113|NCT02518113|456178559|FG003|Overall Study|Adverse Event|0|||
126787114|NCT02518113|456178556|FG000|Overall Study|Death|1|||
126787115|NCT02518113|456178557|FG001|Overall Study|Death|2|||
126787116|NCT02518113|456178558|FG002|Overall Study|Death|0|||
126787117|NCT02518113|456178559|FG003|Overall Study|Death|0|||
126787118|NCT02518113|456178556|FG000|Overall Study|Physician Decision|0|||
126787119|NCT02518113|456178557|FG001|Overall Study|Physician Decision|1|||
126787120|NCT02518113|456178558|FG002|Overall Study|Physician Decision|0|||
126787121|NCT02518113|456178559|FG003|Overall Study|Physician Decision|0|||
126787122|NCT02518113|456178556|FG000|Overall Study|Progressive Disease|1|||
126787123|NCT02518113|456178557|FG001|Overall Study|Progressive Disease|2|||
126787124|NCT02518113|456178558|FG002|Overall Study|Progressive Disease|3|||
126787125|NCT02518113|456178559|FG003|Overall Study|Progressive Disease|0|||
126787126|NCT02270736|456178560|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
126787127|NCT02270736|456178561|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
126787128|NCT02270736|456178562|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
126787129|NCT02270736|456178563|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
126787130|NCT02270736|456178564|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
126787131|NCT02270736|456178560|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
126787132|NCT02270736|456178561|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
126787133|NCT02270736|456178562|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
126787134|NCT02270736|456178563|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
126787135|NCT02270736|456178564|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
126787136|NCT02270736|456178560|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
126787137|NCT02270736|456178561|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
126787138|NCT02270736|456178562|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
126787139|NCT02270736|456178563|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
126787140|NCT02270736|456178564|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
126787141|NCT02270736|456178560|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
126787142|NCT02270736|456178561|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
126787143|NCT02270736|456178562|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
126787144|NCT02270736|456178563|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
126787145|NCT02270736|456178564|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
126787146|NCT02270736|456178560|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
126787147|NCT02270736|456178561|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
126787148|NCT02270736|456178562|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
126787149|NCT02270736|456178563|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
126787150|NCT02270736|456178564|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
126787151|NCT02270736|456178560|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
126787152|NCT02270736|456178561|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
126787153|NCT02270736|456178562|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
126787154|NCT02270736|456178563|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
126787155|NCT02270736|456178564|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
126787156|NCT02270736|456178560|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
126787157|NCT02270736|456178561|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
126787158|NCT02270736|456178562|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
126787159|NCT02270736|456178563|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
126787160|NCT02270736|456178564|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
126787161|NCT02270736|456178560|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
126787162|NCT02270736|456178561|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
126787163|NCT02270736|456178562|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
126787164|NCT02270736|456178563|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
126787165|NCT02270736|456178564|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
126787166|NCT02270736|456178560|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
126787167|NCT02270736|456178561|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
126787168|NCT02270736|456178562|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
126787169|NCT02270736|456178563|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
126787170|NCT02270736|456178564|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
126787171|NCT03194464|456178584|FG000|Overall Study|data not usable|2|||
126787172|NCT02153398|456178585|FG000|Overall Study|Withdrawal by Subject|1|||
126787173|NCT02153398|456178586|FG001|Overall Study|Withdrawal by Subject|0|||
126787174|NCT02153398|456178587|FG002|Overall Study|Withdrawal by Subject|0|||
126787175|NCT02153398|456178588|FG003|Overall Study|Withdrawal by Subject|0|||
126787176|NCT02153398|456178589|FG004|Overall Study|Withdrawal by Subject|0|||
126787177|NCT02153398|456178585|FG000|Overall Study|Adverse Event|0|||
126787178|NCT02153398|456178586|FG001|Overall Study|Adverse Event|0|||
126787179|NCT02153398|456178587|FG002|Overall Study|Adverse Event|1|||
126787180|NCT02153398|456178588|FG003|Overall Study|Adverse Event|1|||
126787181|NCT02153398|456178589|FG004|Overall Study|Adverse Event|0|||
126787182|NCT02402166|456178590|FG000|Overall Study|Adverse Event|2|||
126787183|NCT02402166|456178590|FG000|Overall Study|Withdrawal by Subject|2|||
126787184|NCT02402166|456178590|FG000|Overall Study|Lost to Follow-up|1|||
126787185|NCT03331042|456178594|FG000|Overall Study|Protocol Violation|1|||
126787186|NCT03331042|456178595|FG001|Overall Study|Protocol Violation|0|||
126787187|NCT03331042|456178596|FG002|Overall Study|Protocol Violation|0|||
126787188|NCT03331042|456178597|FG003|Overall Study|Protocol Violation|0|||
126787189|NCT03331042|456178594|FG000|Overall Study|Physician Decision|0|||
126787190|NCT03331042|456178595|FG001|Overall Study|Physician Decision|0|||
126787191|NCT03331042|456178596|FG002|Overall Study|Physician Decision|1|||
126787192|NCT03331042|456178597|FG003|Overall Study|Physician Decision|0|||
126787193|NCT03331042|456178594|FG000|Overall Study|Lost to Follow-up|0|||
126787194|NCT03331042|456178595|FG001|Overall Study|Lost to Follow-up|0|||
126787195|NCT03331042|456178596|FG002|Overall Study|Lost to Follow-up|0|||
126787196|NCT03331042|456178597|FG003|Overall Study|Lost to Follow-up|1|||
126787197|NCT00720096|456178601|FG000|Overall Study|Withdrawal by Subject|0|||
126787198|NCT00720096|456178602|FG001|Overall Study|Withdrawal by Subject|2|||
126787199|NCT00524459|456178603|FG000|Overall Study|Withdrawal by Subject|1|||
126787200|NCT00524459|456178603|FG000|Overall Study|Other|1|||
126787201|NCT02428699|456178604|FG000|Washout Period 1|Screen Failure|1|||
126787202|NCT02428699|456178605|FG001|Washout Period 1|Screen Failure|2|||
126787203|NCT01574248|456178606|FG000|Overall Study|Withdrawal by Subject|2|||
126787204|NCT01574248|456178607|FG001|Overall Study|Withdrawal by Subject|0|||
126787205|NCT01574248|456178606|FG000|Overall Study|Missing primary endpoint data|1|||
126787206|NCT01574248|456178607|FG001|Overall Study|Missing primary endpoint data|0|||
126787207|NCT01424722|456178608|FG000|Overall Study|Sponsor terminated investigation|2258|||
126787208|NCT01781286|456178611|FG000|Overall Study|Lost to Follow-up|0|||
126787209|NCT01781286|456178612|FG001|Overall Study|Lost to Follow-up|0|||
126787210|NCT01781286|456178613|FG002|Overall Study|Lost to Follow-up|0|||
126787211|NCT01781286|456178614|FG003|Overall Study|Lost to Follow-up|0|||
126787212|NCT01781286|456178615|FG004|Overall Study|Lost to Follow-up|0|||
126787213|NCT01781286|456178616|FG005|Overall Study|Lost to Follow-up|1|||
126787214|NCT01781286|456178611|FG000|Overall Study|Time Constraints|2|||
126787215|NCT01781286|456178612|FG001|Overall Study|Time Constraints|0|||
126787216|NCT01781286|456178613|FG002|Overall Study|Time Constraints|2|||
126787217|NCT01781286|456178614|FG003|Overall Study|Time Constraints|0|||
126787218|NCT01781286|456178615|FG004|Overall Study|Time Constraints|0|||
126787219|NCT01781286|456178616|FG005|Overall Study|Time Constraints|0|||
126787220|NCT01781286|456178611|FG000|Overall Study|Noncompliance|0|||
126787221|NCT01781286|456178612|FG001|Overall Study|Noncompliance|0|||
126787222|NCT01781286|456178613|FG002|Overall Study|Noncompliance|0|||
126787223|NCT01781286|456178614|FG003|Overall Study|Noncompliance|1|||
126787224|NCT01781286|456178615|FG004|Overall Study|Noncompliance|0|||
126787225|NCT01781286|456178616|FG005|Overall Study|Noncompliance|0|||
126787226|NCT00995410|456178617|FG000|Overall Study|Adverse Event|51|||
126787227|NCT00995410|456178617|FG000|Overall Study|Withdrawal by Subject|7|||
126787228|NCT00995410|456178617|FG000|Overall Study|Lost to Follow-up|2|||
126787229|NCT00995410|456178617|FG000|Overall Study|Misc|28|||
126787230|NCT03594123|456178618|FG000|Overall Study|Lost to Follow-up|0|||
126787231|NCT03594123|456178619|FG001|Overall Study|Lost to Follow-up|1|||
126787232|NCT03594123|456178618|FG000|Overall Study|Adverse Event|8|||
126787233|NCT03594123|456178619|FG001|Overall Study|Adverse Event|5|||
126787234|NCT03594123|456178618|FG000|Overall Study|Site Terminated by Sponsor|4|||
126787235|NCT03594123|456178619|FG001|Overall Study|Site Terminated by Sponsor|1|||
126787236|NCT03594123|456178618|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
126787237|NCT03594123|456178619|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
126787238|NCT03594123|456178618|FG000|Overall Study|Lack of Efficacy|1|||
126787239|NCT03594123|456178619|FG001|Overall Study|Lack of Efficacy|0|||
126787240|NCT03594123|456178618|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
126787241|NCT03594123|456178619|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
126787242|NCT02483975|456178620|FG000|Overall Study|Adverse Event|0|||
126787243|NCT02483975|456178621|FG001|Overall Study|Adverse Event|1|||
126787244|NCT02483975|456178620|FG000|Overall Study|Lost to Follow-up|0|||
126787245|NCT02483975|456178621|FG001|Overall Study|Lost to Follow-up|1|||
126787246|NCT02483975|456178620|FG000|Overall Study|Physician Decision|2|||
126787247|NCT02483975|456178621|FG001|Overall Study|Physician Decision|0|||
126787248|NCT00818883|456178622|FG000|Overall Study|Adverse Event|28|||
126787249|NCT00818883|456178623|FG001|Overall Study|Adverse Event|19|||
126787250|NCT00818883|456178622|FG000|Overall Study|Protocol Violation|2|||
126787251|NCT00818883|456178623|FG001|Overall Study|Protocol Violation|2|||
126787252|NCT00818883|456178622|FG000|Overall Study|Lost to Follow-up|3|||
126787253|NCT00818883|456178623|FG001|Overall Study|Lost to Follow-up|2|||
126787254|NCT00818883|456178622|FG000|Overall Study|Withdrawal by Subject|16|||
126787255|NCT00818883|456178623|FG001|Overall Study|Withdrawal by Subject|14|||
126787256|NCT00818883|456178622|FG000|Overall Study|Lack of Efficacy|0|||
126787257|NCT00818883|456178623|FG001|Overall Study|Lack of Efficacy|2|||
126787258|NCT00818883|456178622|FG000|Overall Study|Other|2|||
126787259|NCT00818883|456178623|FG001|Overall Study|Other|7|||
126787260|NCT03992196|456178624|FG000|Enrollment|lost to follow-up prior dosing|1|||
126787261|NCT03992196|456178625|FG001|Enrollment|lost to follow-up prior dosing|0|||
126787262|NCT03992196|456178626|FG002|Enrollment|lost to follow-up prior dosing|0|||
126787263|NCT03992196|456178624|FG000|Treatment|Protocol Violation|0|||
126787264|NCT03992196|456178625|FG001|Treatment|Protocol Violation|0|||
126787265|NCT03992196|456178626|FG002|Treatment|Protocol Violation|1|||
126787266|NCT03992196|456178624|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
126787267|NCT03992196|456178625|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
126787268|NCT03992196|456178626|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
126787269|NCT03992196|456178624|FG000|Treatment|Withdrawal due to non-compliance|0|||
126787270|NCT03992196|456178625|FG001|Treatment|Withdrawal due to non-compliance|0|||
126787271|NCT03992196|456178626|FG002|Treatment|Withdrawal due to non-compliance|1|||
126787272|NCT03992196|456178624|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
126787273|NCT03992196|456178625|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
126787274|NCT03992196|456178626|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
126787275|NCT03992196|456178624|FG000|Treatment|Withdrawal by parent/guardian|0|||
126787276|NCT03992196|456178625|FG001|Treatment|Withdrawal by parent/guardian|0|||
126787277|NCT03992196|456178626|FG002|Treatment|Withdrawal by parent/guardian|2|||
126787278|NCT02684578|456178629|FG000|Overall Study|Withdrawal by Subject|10|||
126787279|NCT02684578|456178630|FG001|Overall Study|Withdrawal by Subject|7|||
126787280|NCT02684578|456178629|FG000|Overall Study|Lost to Follow-up|0|||
126787281|NCT02684578|456178630|FG001|Overall Study|Lost to Follow-up|3|||
126787282|NCT02684578|456178629|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
126787283|NCT02684578|456178630|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
126787284|NCT02684578|456178629|FG000|Overall Study|Missing follow-up data|0|||
126787285|NCT02684578|456178630|FG001|Overall Study|Missing follow-up data|1|||
126787286|NCT01505530|456178631|FG000|Overall Study|Progressive Disease|19|||
126787287|NCT01505530|456178632|FG001|Overall Study|Progressive Disease|17|||
126787288|NCT01505530|456178633|FG002|Overall Study|Progressive Disease|18|||
126787289|NCT01505530|456178631|FG000|Overall Study|Adverse Event|1|||
126787290|NCT01505530|456178632|FG001|Overall Study|Adverse Event|1|||
126787291|NCT01505530|456178633|FG002|Overall Study|Adverse Event|0|||
126787292|NCT01505530|456178631|FG000|Overall Study|Withdrawal by Subject|7|||
126787293|NCT01505530|456178632|FG001|Overall Study|Withdrawal by Subject|8|||
126787294|NCT01505530|456178633|FG002|Overall Study|Withdrawal by Subject|6|||
126787295|NCT01505530|456178631|FG000|Overall Study|Physician Decision|6|||
126787296|NCT01505530|456178632|FG001|Overall Study|Physician Decision|2|||
126787297|NCT01505530|456178633|FG002|Overall Study|Physician Decision|5|||
126787298|NCT01505530|456178631|FG000|Overall Study|Sponsor Decision|1|||
126787299|NCT01505530|456178632|FG001|Overall Study|Sponsor Decision|8|||
126787300|NCT01505530|456178633|FG002|Overall Study|Sponsor Decision|7|||
126787301|NCT01505530|456178631|FG000|Overall Study|Death|7|||
126787302|NCT01505530|456178632|FG001|Overall Study|Death|6|||
126787303|NCT01505530|456178633|FG002|Overall Study|Death|5|||
126787304|NCT01505530|456178631|FG000|Overall Study|entry criteria not met|0|||
126787305|NCT01505530|456178632|FG001|Overall Study|entry criteria not met|1|||
126787306|NCT01505530|456178633|FG002|Overall Study|entry criteria not met|0|||
126787307|NCT00973700|456178634|FG000|Overall Study|Withdrawal by Subject|2|||
126787308|NCT00973700|456178635|FG001|Overall Study|Withdrawal by Subject|2|||
126787309|NCT00973700|456178636|FG002|Overall Study|Withdrawal by Subject|8|||
126787310|NCT00973700|456178637|FG003|Overall Study|Withdrawal by Subject|4|||
126787311|NCT00973700|456178638|FG004|Overall Study|Withdrawal by Subject|4|||
126787312|NCT00973700|456178634|FG000|Overall Study|Lost to Follow-up|5|||
126787313|NCT00973700|456178635|FG001|Overall Study|Lost to Follow-up|0|||
126787314|NCT00973700|456178636|FG002|Overall Study|Lost to Follow-up|1|||
126787315|NCT00973700|456178637|FG003|Overall Study|Lost to Follow-up|8|||
126787316|NCT00973700|456178638|FG004|Overall Study|Lost to Follow-up|5|||
126787317|NCT00973700|456178634|FG000|Overall Study|Inappropriate enrolment|0|||
126787318|NCT00973700|456178635|FG001|Overall Study|Inappropriate enrolment|0|||
126787319|NCT00973700|456178636|FG002|Overall Study|Inappropriate enrolment|0|||
126787320|NCT00973700|456178637|FG003|Overall Study|Inappropriate enrolment|4|||
126787321|NCT00973700|456178638|FG004|Overall Study|Inappropriate enrolment|0|||
126787322|NCT00973700|456178634|FG000|Overall Study|Unable to Classify|0|||
126787323|NCT00973700|456178635|FG001|Overall Study|Unable to Classify|0|||
126787324|NCT00973700|456178636|FG002|Overall Study|Unable to Classify|1|||
126787325|NCT00973700|456178637|FG003|Overall Study|Unable to Classify|2|||
126787326|NCT00973700|456178638|FG004|Overall Study|Unable to Classify|1|||
126787327|NCT02492958|456178639|FG000|Overall Study|Withdrawal by Subject|0|||
126787328|NCT02492958|456178640|FG001|Overall Study|Withdrawal by Subject|0|||
126787329|NCT02492958|456178641|FG002|Overall Study|Withdrawal by Subject|1|||
126787330|NCT02492958|456178642|FG003|Overall Study|Withdrawal by Subject|0|||
126787331|NCT02492958|456178639|FG000|Overall Study|Adverse Event|1|||
126787332|NCT02492958|456178640|FG001|Overall Study|Adverse Event|0|||
126787333|NCT02492958|456178641|FG002|Overall Study|Adverse Event|1|||
126787334|NCT02492958|456178642|FG003|Overall Study|Adverse Event|0|||
126787335|NCT01193608|456178643|FG000|Overall Study|Other|0|||
126787336|NCT01193608|456178644|FG001|Overall Study|Other|1|||
126787337|NCT01193608|456178645|FG002|Overall Study|Other|0|||
126787338|NCT01193608|456178646|FG003|Overall Study|Other|0|||
126787339|NCT01193608|456178647|FG004|Overall Study|Other|0|||
126787340|NCT01193608|456178648|FG005|Overall Study|Other|0|||
126787341|NCT01193608|456178643|FG000|Overall Study|Withdrawal by Subject|0|||
126787342|NCT01193608|456178644|FG001|Overall Study|Withdrawal by Subject|1|||
126787343|NCT01193608|456178645|FG002|Overall Study|Withdrawal by Subject|2|||
126787344|NCT01193608|456178646|FG003|Overall Study|Withdrawal by Subject|3|||
126787345|NCT01193608|456178647|FG004|Overall Study|Withdrawal by Subject|3|||
126787346|NCT01193608|456178648|FG005|Overall Study|Withdrawal by Subject|0|||
126787347|NCT01193608|456178643|FG000|Overall Study|Lost to Follow-up|0|||
126787348|NCT01193608|456178644|FG001|Overall Study|Lost to Follow-up|0|||
126629527|NCT01502371|455602388|FG003|Overall Study|Treatment Failure|19|||
126629528|NCT01502371|455602389|FG004|Overall Study|Treatment Failure|30|||
126787349|NCT01193608|456178645|FG002|Overall Study|Lost to Follow-up|0|||
126787350|NCT01193608|456178646|FG003|Overall Study|Lost to Follow-up|0|||
126787351|NCT01193608|456178647|FG004|Overall Study|Lost to Follow-up|1|||
126787352|NCT01193608|456178648|FG005|Overall Study|Lost to Follow-up|2|||
126787353|NCT01193608|456178643|FG000|Overall Study|Adverse Event|0|||
126787354|NCT01193608|456178644|FG001|Overall Study|Adverse Event|0|||
126787355|NCT01193608|456178645|FG002|Overall Study|Adverse Event|0|||
126787356|NCT01193608|456178646|FG003|Overall Study|Adverse Event|0|||
126787357|NCT01193608|456178647|FG004|Overall Study|Adverse Event|1|||
126787358|NCT01193608|456178648|FG005|Overall Study|Adverse Event|0|||
126787359|NCT02795104|456178649|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
126629529|NCT01502371|455602385|FG000|Overall Study|Lack of Efficacy|3|||
126629530|NCT01502371|455602386|FG001|Overall Study|Lack of Efficacy|3|||
126629531|NCT01502371|455602387|FG002|Overall Study|Lack of Efficacy|2|||
126629532|NCT01502371|455602388|FG003|Overall Study|Lack of Efficacy|2|||
126629533|NCT01502371|455602389|FG004|Overall Study|Lack of Efficacy|4|||
126629534|NCT01502371|455602385|FG000|Overall Study|Physician Decision|3|||
126629535|NCT01502371|455602386|FG001|Overall Study|Physician Decision|0|||
126629536|NCT01502371|455602387|FG002|Overall Study|Physician Decision|0|||
126629537|NCT01502371|455602388|FG003|Overall Study|Physician Decision|0|||
126629538|NCT01502371|455602389|FG004|Overall Study|Physician Decision|1|||
126629539|NCT01502371|455602385|FG000|Overall Study|Noncompliance with Study Drug|0|||
126629540|NCT01502371|455602386|FG001|Overall Study|Noncompliance with Study Drug|0|||
126629541|NCT01502371|455602387|FG002|Overall Study|Noncompliance with Study Drug|1|||
126629542|NCT01502371|455602388|FG003|Overall Study|Noncompliance with Study Drug|2|||
126629543|NCT01502371|455602389|FG004|Overall Study|Noncompliance with Study Drug|1|||
126629544|NCT01502371|455602385|FG000|Overall Study|Technical Problems|1|||
126629545|NCT01502371|455602386|FG001|Overall Study|Technical Problems|0|||
126629546|NCT01502371|455602387|FG002|Overall Study|Technical Problems|2|||
126629547|NCT01502371|455602388|FG003|Overall Study|Technical Problems|4|||
126629548|NCT01502371|455602389|FG004|Overall Study|Technical Problems|1|||
126629549|NCT01502371|455602385|FG000|Overall Study|Protocol Violation|9|||
126629550|NCT01502371|455602386|FG001|Overall Study|Protocol Violation|5|||
126629551|NCT01502371|455602387|FG002|Overall Study|Protocol Violation|6|||
126629552|NCT01502371|455602388|FG003|Overall Study|Protocol Violation|5|||
126629553|NCT01502371|455602389|FG004|Overall Study|Protocol Violation|10|||
126629554|NCT01502371|455602385|FG000|Overall Study|Excluded Medication|0|||
126629555|NCT01502371|455602386|FG001|Overall Study|Excluded Medication|1|||
126629556|NCT01502371|455602387|FG002|Overall Study|Excluded Medication|1|||
126629557|NCT01502371|455602388|FG003|Overall Study|Excluded Medication|0|||
126787360|NCT02795104|456178650|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
126787361|NCT02795104|456178651|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
126787362|NCT02795104|456178649|FG000|Overall Study|Withdrawal by Subject|0|||
126787363|NCT02795104|456178650|FG001|Overall Study|Withdrawal by Subject|2|||
126787364|NCT02795104|456178651|FG002|Overall Study|Withdrawal by Subject|0|||
126787365|NCT02795104|456178649|FG000|Overall Study|Lost to Follow-up|0|||
126787366|NCT02795104|456178650|FG001|Overall Study|Lost to Follow-up|0|||
126787367|NCT02795104|456178651|FG002|Overall Study|Lost to Follow-up|1|||
126787368|NCT00948675|456178652|FG000|Overall Study|Lost to Follow-up|1|||
126787369|NCT00948675|456178653|FG001|Overall Study|Lost to Follow-up|0|||
126787370|NCT03830164|456178660|FG000|Overall Study|Adverse Event|0|||
126787371|NCT03830164|456178661|FG001|Overall Study|Adverse Event|2|||
126787372|NCT03830164|456178662|FG002|Overall Study|Adverse Event|0|||
126787373|NCT03830164|456178660|FG000|Overall Study|Lack of Efficacy|1|||
126787374|NCT03830164|456178661|FG001|Overall Study|Lack of Efficacy|5|||
126787375|NCT03830164|456178662|FG002|Overall Study|Lack of Efficacy|0|||
126787376|NCT03830164|456178660|FG000|Overall Study|Lost to Follow-up|0|||
126787377|NCT03830164|456178661|FG001|Overall Study|Lost to Follow-up|1|||
126787378|NCT03830164|456178662|FG002|Overall Study|Lost to Follow-up|0|||
126787379|NCT03830164|456178660|FG000|Overall Study|Withdrawal by Subject|1|||
126787380|NCT03830164|456178661|FG001|Overall Study|Withdrawal by Subject|0|||
126787381|NCT03830164|456178662|FG002|Overall Study|Withdrawal by Subject|0|||
126787382|NCT02192099|456178663|FG000|Overall Study|Adverse Event|1|||
126787383|NCT02192099|456178663|FG000|Overall Study|Lost to Follow-up|2|||
126787384|NCT02192099|456178663|FG000|Overall Study|Physician Decision|1|||
126787385|NCT02192099|456178663|FG000|Overall Study|Pregnancy|1|||
126787386|NCT02192099|456178663|FG000|Overall Study|Protocol Violation|8|||
126787387|NCT02192099|456178663|FG000|Overall Study|Study Terminated by Sponsor|32|||
126787388|NCT02192099|456178663|FG000|Overall Study|Withdrawal by Subject|11|||
126787389|NCT02192099|456178663|FG000|Overall Study|Miscellaneous Reasons|5|||
126787390|NCT02796664|456178666|FG000|Overall Study|Withdrawal by Subject|0|||
126629558|NCT01502371|455602389|FG004|Overall Study|Excluded Medication|1|||
126629559|NCT02154347|455602390|FG000|Double-blind Period|Adverse Event|1|||
126629560|NCT02154347|455602391|FG001|Double-blind Period|Adverse Event|2|||
126629561|NCT02154347|455602390|FG000|Double-blind Period|Lack of Efficacy|1|||
126629562|NCT02154347|455602391|FG001|Double-blind Period|Lack of Efficacy|0|||
126629563|NCT02154347|455602390|FG000|Double-blind Period|Physician Decision|0|||
126629564|NCT02154347|455602391|FG001|Double-blind Period|Physician Decision|1|||
126629565|NCT02154347|455602390|FG000|Double-blind Period|Withdrawal by Subject|1|||
126629566|NCT02154347|455602391|FG001|Double-blind Period|Withdrawal by Subject|1|||
126629567|NCT02154347|455602390|FG000|Open-label Period|Adverse Event|3|||
126629568|NCT02154347|455602391|FG001|Open-label Period|Adverse Event|4|||
126787391|NCT02796664|456178667|FG001|Overall Study|Withdrawal by Subject|3|||
126787392|NCT02796664|456178666|FG000|Overall Study|Noncompliance|1|||
126787393|NCT02796664|456178667|FG001|Overall Study|Noncompliance|1|||
126787394|NCT02796664|456178666|FG000|Overall Study|Death|0|||
126787395|NCT02796664|456178667|FG001|Overall Study|Death|1|||
126787396|NCT02246478|456178668|FG000|Multiple-dose Phase|Protocol Violation|1|||
126787397|NCT02246478|456178669|FG001|Multiple-dose Phase|Protocol Violation|0|||
126787398|NCT02246478|456178670|FG002|Multiple-dose Phase|Protocol Violation|0|||
126787399|NCT02246478|456178671|FG003|Multiple-dose Phase|Protocol Violation|1|||
126787400|NCT01531205|456178676|FG000|Overall Study|Did not proceed to surgery|1|||
126787401|NCT02001558|456178677|FG000|Overall Study|Lost to Follow-up|8|||
126787402|NCT02001558|456178678|FG001|Overall Study|Lost to Follow-up|14|||
126787403|NCT04128007|456178679|FG000|Overall Study|Withdrawal by Subject|9|||
126787404|NCT04128007|456178680|FG001|Overall Study|Withdrawal by Subject|6|||
126787405|NCT04128007|456178679|FG000|Overall Study|Protocol Violation|1|||
126787406|NCT04128007|456178680|FG001|Overall Study|Protocol Violation|0|||
126787407|NCT04128007|456178679|FG000|Overall Study|Lost to Follow-up|8|||
126787408|NCT04128007|456178680|FG001|Overall Study|Lost to Follow-up|7|||
126787409|NCT04128007|456178679|FG000|Overall Study|Adverse Event|5|||
126787410|NCT04128007|456178680|FG001|Overall Study|Adverse Event|2|||
126787411|NCT04128007|456178679|FG000|Overall Study|Not reported|0|||
126787412|NCT04128007|456178680|FG001|Overall Study|Not reported|2|||
126787413|NCT04117607|456178681|FG000|Overall Study|Early Termination|0|||
126787414|NCT04117607|456178682|FG001|Overall Study|Early Termination|1|||
126787415|NCT04117607|456178683|FG002|Overall Study|Early Termination|0|||
126787416|NCT04117607|456178684|FG003|Overall Study|Early Termination|0|||
126787417|NCT04117607|456178685|FG004|Overall Study|Early Termination|0|||
126787418|NCT04117607|456178686|FG005|Overall Study|Early Termination|0|||
126787419|NCT04117607|456178687|FG006|Overall Study|Early Termination|1|||
126787420|NCT04117607|456178688|FG007|Overall Study|Early Termination|0|||
126787421|NCT04117607|456178689|FG008|Overall Study|Early Termination|0|||
126787422|NCT04117607|456178690|FG009|Overall Study|Early Termination|0|||
126787423|NCT04117607|456178691|FG010|Overall Study|Early Termination|0|||
126787424|NCT04117607|456178692|FG011|Overall Study|Early Termination|0|||
126787425|NCT04117607|456178693|FG012|Overall Study|Early Termination|0|||
126787426|NCT04117607|456178694|FG013|Overall Study|Early Termination|0|||
126787427|NCT00950807|456178698|FG000|Treatment Period 1|Lack of Efficacy|1|||
126787428|NCT00950807|456178699|FG001|Treatment Period 1|Lack of Efficacy|0|||
126787429|NCT00950807|456178700|FG002|Treatment Period 1|Lack of Efficacy|0|||
126787430|NCT00950807|456178701|FG003|Treatment Period 1|Lack of Efficacy|0|||
126787431|NCT00950807|456178702|FG004|Treatment Period 1|Lack of Efficacy|0|||
126787432|NCT00950807|456178703|FG005|Treatment Period 1|Lack of Efficacy|1|||
126787433|NCT00950807|456178704|FG006|Treatment Period 1|Lack of Efficacy|0|||
126787434|NCT00950807|456178705|FG007|Treatment Period 1|Lack of Efficacy|0|||
126787435|NCT00950807|456178706|FG008|Treatment Period 1|Lack of Efficacy|0|||
126787436|NCT00950807|456178707|FG009|Treatment Period 1|Lack of Efficacy|0|||
126787437|NCT00950807|456178698|FG000|Treatment Period 1|Protocol Violation|1|||
126787438|NCT00950807|456178699|FG001|Treatment Period 1|Protocol Violation|0|||
126787439|NCT00950807|456178700|FG002|Treatment Period 1|Protocol Violation|0|||
126787440|NCT00950807|456178701|FG003|Treatment Period 1|Protocol Violation|0|||
126787441|NCT00950807|456178702|FG004|Treatment Period 1|Protocol Violation|0|||
126787442|NCT00950807|456178703|FG005|Treatment Period 1|Protocol Violation|0|||
126787443|NCT00950807|456178704|FG006|Treatment Period 1|Protocol Violation|0|||
126787444|NCT00950807|456178705|FG007|Treatment Period 1|Protocol Violation|0|||
126787445|NCT00950807|456178706|FG008|Treatment Period 1|Protocol Violation|0|||
126787446|NCT00950807|456178707|FG009|Treatment Period 1|Protocol Violation|0|||
126787447|NCT00950807|456178698|FG000|Treatment Period 1|Lost to Follow-up|0|||
126787448|NCT00950807|456178699|FG001|Treatment Period 1|Lost to Follow-up|0|||
126787449|NCT00950807|456178700|FG002|Treatment Period 1|Lost to Follow-up|1|||
126787450|NCT00950807|456178701|FG003|Treatment Period 1|Lost to Follow-up|0|||
126787451|NCT00950807|456178702|FG004|Treatment Period 1|Lost to Follow-up|0|||
126787452|NCT00950807|456178703|FG005|Treatment Period 1|Lost to Follow-up|0|||
126787453|NCT00950807|456178704|FG006|Treatment Period 1|Lost to Follow-up|0|||
126787454|NCT00950807|456178705|FG007|Treatment Period 1|Lost to Follow-up|0|||
126787455|NCT00950807|456178706|FG008|Treatment Period 1|Lost to Follow-up|0|||
126787456|NCT00950807|456178707|FG009|Treatment Period 1|Lost to Follow-up|0|||
126787457|NCT00950807|456178698|FG000|Treatment Period 1|Withdrawal by Subject|1|||
126787458|NCT00950807|456178699|FG001|Treatment Period 1|Withdrawal by Subject|0|||
126787459|NCT00950807|456178700|FG002|Treatment Period 1|Withdrawal by Subject|0|||
126787460|NCT00950807|456178701|FG003|Treatment Period 1|Withdrawal by Subject|0|||
126787461|NCT00950807|456178702|FG004|Treatment Period 1|Withdrawal by Subject|1|||
126787462|NCT00950807|456178703|FG005|Treatment Period 1|Withdrawal by Subject|0|||
126787463|NCT00950807|456178704|FG006|Treatment Period 1|Withdrawal by Subject|0|||
126787464|NCT00950807|456178705|FG007|Treatment Period 1|Withdrawal by Subject|0|||
126787465|NCT00950807|456178706|FG008|Treatment Period 1|Withdrawal by Subject|1|||
126787466|NCT00950807|456178707|FG009|Treatment Period 1|Withdrawal by Subject|0|||
126787467|NCT00950807|456178698|FG000|Treatment Period 1|Adverse Event|0|||
126787468|NCT00950807|456178699|FG001|Treatment Period 1|Adverse Event|0|||
126787469|NCT00950807|456178700|FG002|Treatment Period 1|Adverse Event|0|||
126787470|NCT00950807|456178701|FG003|Treatment Period 1|Adverse Event|0|||
126787471|NCT00950807|456178702|FG004|Treatment Period 1|Adverse Event|0|||
126787472|NCT00950807|456178703|FG005|Treatment Period 1|Adverse Event|1|||
126787473|NCT00950807|456178704|FG006|Treatment Period 1|Adverse Event|0|||
126787474|NCT00950807|456178705|FG007|Treatment Period 1|Adverse Event|0|||
126787475|NCT00950807|456178706|FG008|Treatment Period 1|Adverse Event|0|||
126787476|NCT00950807|456178707|FG009|Treatment Period 1|Adverse Event|0|||
126787477|NCT00950807|456178698|FG000|Washout Period 1|Lack of Efficacy|0|||
126787478|NCT00950807|456178699|FG001|Washout Period 1|Lack of Efficacy|0|||
126787479|NCT00950807|456178700|FG002|Washout Period 1|Lack of Efficacy|0|||
126787480|NCT00950807|456178701|FG003|Washout Period 1|Lack of Efficacy|0|||
126787481|NCT00950807|456178702|FG004|Washout Period 1|Lack of Efficacy|0|||
126787482|NCT00950807|456178703|FG005|Washout Period 1|Lack of Efficacy|0|||
126787483|NCT00950807|456178704|FG006|Washout Period 1|Lack of Efficacy|1|||
126787484|NCT00950807|456178705|FG007|Washout Period 1|Lack of Efficacy|0|||
126787485|NCT00950807|456178706|FG008|Washout Period 1|Lack of Efficacy|0|||
126787486|NCT00950807|456178707|FG009|Washout Period 1|Lack of Efficacy|0|||
126787487|NCT00950807|456178698|FG000|Washout Period 1|Withdrawal by Subject|0|||
126787488|NCT00950807|456178699|FG001|Washout Period 1|Withdrawal by Subject|0|||
126787489|NCT00950807|456178700|FG002|Washout Period 1|Withdrawal by Subject|0|||
126787490|NCT00950807|456178701|FG003|Washout Period 1|Withdrawal by Subject|0|||
126787491|NCT00950807|456178702|FG004|Washout Period 1|Withdrawal by Subject|0|||
126787492|NCT00950807|456178703|FG005|Washout Period 1|Withdrawal by Subject|0|||
126787493|NCT00950807|456178704|FG006|Washout Period 1|Withdrawal by Subject|0|||
126787494|NCT00950807|456178705|FG007|Washout Period 1|Withdrawal by Subject|0|||
126787495|NCT00950807|456178706|FG008|Washout Period 1|Withdrawal by Subject|1|||
126787496|NCT00950807|456178707|FG009|Washout Period 1|Withdrawal by Subject|0|||
126787497|NCT00950807|456178698|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
126787498|NCT00950807|456178699|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126787499|NCT00950807|456178700|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126787500|NCT00950807|456178701|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126787501|NCT00950807|456178702|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126787502|NCT00950807|456178703|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126787503|NCT00950807|456178704|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
126787504|NCT00950807|456178705|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
126787505|NCT00950807|456178706|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126787506|NCT00950807|456178707|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
126787507|NCT00950807|456178698|FG000|Washout Period 1|Adverse Event|2|||
126787508|NCT00950807|456178699|FG001|Washout Period 1|Adverse Event|0|||
126787509|NCT00950807|456178700|FG002|Washout Period 1|Adverse Event|0|||
126787510|NCT00950807|456178701|FG003|Washout Period 1|Adverse Event|1|||
126787511|NCT00950807|456178702|FG004|Washout Period 1|Adverse Event|1|||
126787512|NCT00950807|456178703|FG005|Washout Period 1|Adverse Event|0|||
126787513|NCT00950807|456178704|FG006|Washout Period 1|Adverse Event|0|||
126787514|NCT00950807|456178705|FG007|Washout Period 1|Adverse Event|0|||
126787515|NCT00950807|456178706|FG008|Washout Period 1|Adverse Event|0|||
126787516|NCT00950807|456178707|FG009|Washout Period 1|Adverse Event|0|||
126787517|NCT00950807|456178698|FG000|Treatment Period 2|Lack of Efficacy|1|||
126787518|NCT00950807|456178699|FG001|Treatment Period 2|Lack of Efficacy|0|||
126787519|NCT00950807|456178700|FG002|Treatment Period 2|Lack of Efficacy|0|||
126787520|NCT00950807|456178701|FG003|Treatment Period 2|Lack of Efficacy|0|||
126787521|NCT00950807|456178702|FG004|Treatment Period 2|Lack of Efficacy|0|||
126787522|NCT00950807|456178703|FG005|Treatment Period 2|Lack of Efficacy|0|||
126787523|NCT00950807|456178704|FG006|Treatment Period 2|Lack of Efficacy|0|||
126787524|NCT00950807|456178705|FG007|Treatment Period 2|Lack of Efficacy|0|||
126787525|NCT00950807|456178706|FG008|Treatment Period 2|Lack of Efficacy|0|||
126787526|NCT00950807|456178707|FG009|Treatment Period 2|Lack of Efficacy|0|||
126787527|NCT00950807|456178698|FG000|Treatment Period 2|Withdrawal by Subject|0|||
126787528|NCT00950807|456178699|FG001|Treatment Period 2|Withdrawal by Subject|0|||
126787529|NCT00950807|456178700|FG002|Treatment Period 2|Withdrawal by Subject|0|||
126787530|NCT00950807|456178701|FG003|Treatment Period 2|Withdrawal by Subject|0|||
126787531|NCT00950807|456178702|FG004|Treatment Period 2|Withdrawal by Subject|0|||
126787532|NCT00950807|456178703|FG005|Treatment Period 2|Withdrawal by Subject|0|||
126787533|NCT00950807|456178704|FG006|Treatment Period 2|Withdrawal by Subject|1|||
126787534|NCT00950807|456178705|FG007|Treatment Period 2|Withdrawal by Subject|2|||
126787535|NCT00950807|456178706|FG008|Treatment Period 2|Withdrawal by Subject|0|||
126787536|NCT00950807|456178707|FG009|Treatment Period 2|Withdrawal by Subject|0|||
126787537|NCT00950807|456178698|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
126787538|NCT00950807|456178699|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126787539|NCT00950807|456178700|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126787540|NCT00950807|456178701|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126787541|NCT00950807|456178702|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126787542|NCT00950807|456178703|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126787543|NCT00950807|456178704|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126787544|NCT00950807|456178705|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126787545|NCT00950807|456178706|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126787546|NCT00950807|456178707|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
126787547|NCT00950807|456178698|FG000|Treatment Period 2|Adverse Event|0|||
126787548|NCT00950807|456178699|FG001|Treatment Period 2|Adverse Event|1|||
126787549|NCT00950807|456178700|FG002|Treatment Period 2|Adverse Event|0|||
126787550|NCT00950807|456178701|FG003|Treatment Period 2|Adverse Event|1|||
126787551|NCT00950807|456178702|FG004|Treatment Period 2|Adverse Event|0|||
126787552|NCT00950807|456178703|FG005|Treatment Period 2|Adverse Event|1|||
126787553|NCT00950807|456178704|FG006|Treatment Period 2|Adverse Event|0|||
126787554|NCT00950807|456178705|FG007|Treatment Period 2|Adverse Event|1|||
126787555|NCT00950807|456178706|FG008|Treatment Period 2|Adverse Event|0|||
126787556|NCT00950807|456178707|FG009|Treatment Period 2|Adverse Event|0|||
126787557|NCT00950807|456178698|FG000|Washout Period 2|Lack of Efficacy|1|||
126787558|NCT00950807|456178699|FG001|Washout Period 2|Lack of Efficacy|0|||
126787559|NCT00950807|456178700|FG002|Washout Period 2|Lack of Efficacy|0|||
126787560|NCT00950807|456178701|FG003|Washout Period 2|Lack of Efficacy|0|||
126787561|NCT00950807|456178702|FG004|Washout Period 2|Lack of Efficacy|0|||
126787562|NCT00950807|456178703|FG005|Washout Period 2|Lack of Efficacy|0|||
126787563|NCT00950807|456178704|FG006|Washout Period 2|Lack of Efficacy|0|||
126787564|NCT00950807|456178705|FG007|Washout Period 2|Lack of Efficacy|0|||
126787565|NCT00950807|456178706|FG008|Washout Period 2|Lack of Efficacy|0|||
126787566|NCT00950807|456178707|FG009|Washout Period 2|Lack of Efficacy|0|||
126787567|NCT00950807|456178698|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
126787568|NCT00950807|456178699|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
126787569|NCT00950807|456178700|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
126787570|NCT00950807|456178701|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
126787571|NCT00950807|456178702|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
126787572|NCT00950807|456178703|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
126787573|NCT00950807|456178704|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
126787574|NCT00950807|456178705|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
126787575|NCT00950807|456178706|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
126787576|NCT00950807|456178707|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
126787577|NCT00950807|456178698|FG000|Washout Period 2|Adverse Event|3|||
126787578|NCT00950807|456178699|FG001|Washout Period 2|Adverse Event|0|||
126787579|NCT00950807|456178700|FG002|Washout Period 2|Adverse Event|0|||
126787580|NCT00950807|456178701|FG003|Washout Period 2|Adverse Event|1|||
126787581|NCT00950807|456178702|FG004|Washout Period 2|Adverse Event|0|||
126787582|NCT00950807|456178703|FG005|Washout Period 2|Adverse Event|0|||
126787583|NCT00950807|456178704|FG006|Washout Period 2|Adverse Event|0|||
126787584|NCT00950807|456178705|FG007|Washout Period 2|Adverse Event|0|||
126787585|NCT00950807|456178706|FG008|Washout Period 2|Adverse Event|0|||
126787586|NCT00950807|456178707|FG009|Washout Period 2|Adverse Event|0|||
126787587|NCT00950807|456178698|FG000|Treatment Period 3|Withdrawal by Subject|0|||
126787588|NCT00950807|456178699|FG001|Treatment Period 3|Withdrawal by Subject|0|||
126787589|NCT00950807|456178700|FG002|Treatment Period 3|Withdrawal by Subject|0|||
126787590|NCT00950807|456178701|FG003|Treatment Period 3|Withdrawal by Subject|0|||
126787591|NCT00950807|456178702|FG004|Treatment Period 3|Withdrawal by Subject|0|||
126787592|NCT00950807|456178703|FG005|Treatment Period 3|Withdrawal by Subject|0|||
126787593|NCT00950807|456178704|FG006|Treatment Period 3|Withdrawal by Subject|0|||
126787594|NCT00950807|456178705|FG007|Treatment Period 3|Withdrawal by Subject|0|||
126787595|NCT00950807|456178706|FG008|Treatment Period 3|Withdrawal by Subject|0|||
126787596|NCT00950807|456178707|FG009|Treatment Period 3|Withdrawal by Subject|1|||
126787597|NCT00950807|456178698|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
126787598|NCT00950807|456178699|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126787599|NCT00950807|456178700|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126787600|NCT00950807|456178701|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126787601|NCT00950807|456178702|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126787602|NCT00950807|456178703|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126787603|NCT00950807|456178704|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126787604|NCT00950807|456178705|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
126787605|NCT00950807|456178706|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126787606|NCT00950807|456178707|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
126787607|NCT00950807|456178698|FG000|Treatment Period 3|Adverse Event|0|||
126787608|NCT00950807|456178699|FG001|Treatment Period 3|Adverse Event|0|||
126787609|NCT00950807|456178700|FG002|Treatment Period 3|Adverse Event|0|||
126787610|NCT00950807|456178701|FG003|Treatment Period 3|Adverse Event|0|||
126787611|NCT00950807|456178702|FG004|Treatment Period 3|Adverse Event|0|||
126787612|NCT00950807|456178703|FG005|Treatment Period 3|Adverse Event|0|||
126787613|NCT00950807|456178704|FG006|Treatment Period 3|Adverse Event|1|||
126787614|NCT00950807|456178705|FG007|Treatment Period 3|Adverse Event|0|||
126787615|NCT00950807|456178706|FG008|Treatment Period 3|Adverse Event|0|||
126787616|NCT00950807|456178707|FG009|Treatment Period 3|Adverse Event|0|||
126787617|NCT00337077|456178708|FG000|Overall Study|Progressive disease|25|||
126787618|NCT00337077|456178709|FG001|Overall Study|Progressive disease|37|||
126787619|NCT00337077|456178710|FG002|Overall Study|Progressive disease|19|||
126787620|NCT00337077|456178708|FG000|Overall Study|Adverse Event|7|||
126787621|NCT00337077|456178709|FG001|Overall Study|Adverse Event|7|||
126787622|NCT00337077|456178710|FG002|Overall Study|Adverse Event|1|||
126787623|NCT00337077|456178708|FG000|Overall Study|Death|0|||
126754943|NCT00545740|456052989|FG000|Overall Study|Withdrawal by Subject|17|||
126754944|NCT00545740|456052990|FG001|Overall Study|Withdrawal by Subject|15|||
126754945|NCT00545740|456052991|FG002|Overall Study|Withdrawal by Subject|16|||
126754946|NCT00545740|456052992|FG003|Overall Study|Withdrawal by Subject|18|||
126754947|NCT00545740|456052989|FG000|Overall Study|Adverse Event|10|||
126754948|NCT00545740|456052990|FG001|Overall Study|Adverse Event|18|||
126754949|NCT00545740|456052991|FG002|Overall Study|Adverse Event|19|||
126754950|NCT00545740|456052992|FG003|Overall Study|Adverse Event|9|||
126754951|NCT00545740|456052989|FG000|Overall Study|Lost to Follow-up|7|||
126754952|NCT00545740|456052990|FG001|Overall Study|Lost to Follow-up|5|||
126754953|NCT00545740|456052991|FG002|Overall Study|Lost to Follow-up|5|||
126754954|NCT00545740|456052992|FG003|Overall Study|Lost to Follow-up|6|||
126754955|NCT00545740|456052989|FG000|Overall Study|Protocol Violation|1|||
126754956|NCT00545740|456052990|FG001|Overall Study|Protocol Violation|3|||
126754957|NCT00545740|456052991|FG002|Overall Study|Protocol Violation|1|||
126754958|NCT00545740|456052992|FG003|Overall Study|Protocol Violation|0|||
126754959|NCT00545740|456052989|FG000|Overall Study|Non-compliance|0|||
126754960|NCT00545740|456052990|FG001|Overall Study|Non-compliance|2|||
126754961|NCT00545740|456052991|FG002|Overall Study|Non-compliance|1|||
126754962|NCT00545740|456052992|FG003|Overall Study|Non-compliance|0|||
126754963|NCT00545740|456052989|FG000|Overall Study|Moved|2|||
126754964|NCT00545740|456052990|FG001|Overall Study|Moved|0|||
126754965|NCT00545740|456052991|FG002|Overall Study|Moved|1|||
126754966|NCT00545740|456052992|FG003|Overall Study|Moved|0|||
126754967|NCT00545740|456052989|FG000|Overall Study|Diverticulitis attack|0|||
126754968|NCT00545740|456052990|FG001|Overall Study|Diverticulitis attack|0|||
126754969|NCT00545740|456052991|FG002|Overall Study|Diverticulitis attack|1|||
126754970|NCT00545740|456052992|FG003|Overall Study|Diverticulitis attack|1|||
126754971|NCT00545740|456052989|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
126754972|NCT00545740|456052990|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
126754973|NCT00545740|456052991|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
126754974|NCT00545740|456052992|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
126754975|NCT00545740|456052989|FG000|Overall Study|Site closure|1|||
126754976|NCT00545740|456052990|FG001|Overall Study|Site closure|0|||
126754977|NCT00545740|456052991|FG002|Overall Study|Site closure|0|||
126754978|NCT00545740|456052992|FG003|Overall Study|Site closure|0|||
126754979|NCT00545740|456052989|FG000|Overall Study|Missed visit|1|||
126754980|NCT00545740|456052990|FG001|Overall Study|Missed visit|0|||
126754981|NCT00545740|456052991|FG002|Overall Study|Missed visit|0|||
126754982|NCT00545740|456052992|FG003|Overall Study|Missed visit|0|||
126754983|NCT00545740|456052989|FG000|Overall Study|Physician Decision|0|||
126754984|NCT00545740|456052990|FG001|Overall Study|Physician Decision|0|||
126754985|NCT00545740|456052991|FG002|Overall Study|Physician Decision|3|||
126754986|NCT00545740|456052992|FG003|Overall Study|Physician Decision|0|||
126754987|NCT00545740|456052989|FG000|Overall Study|Accepted only monthly telephone calls|1|||
126754988|NCT00545740|456052990|FG001|Overall Study|Accepted only monthly telephone calls|0|||
126754989|NCT00545740|456052991|FG002|Overall Study|Accepted only monthly telephone calls|0|||
126754990|NCT00545740|456052992|FG003|Overall Study|Accepted only monthly telephone calls|0|||
126754991|NCT00545740|456052989|FG000|Overall Study|Sponsor decision|0|||
126754992|NCT00545740|456052990|FG001|Overall Study|Sponsor decision|1|||
126754993|NCT00545740|456052991|FG002|Overall Study|Sponsor decision|0|||
126754994|NCT00545740|456052992|FG003|Overall Study|Sponsor decision|0|||
126754995|NCT00545740|456052989|FG000|Overall Study|Lack of time|0|||
126754996|NCT00545740|456052990|FG001|Overall Study|Lack of time|1|||
126754997|NCT00545740|456052991|FG002|Overall Study|Lack of time|0|||
126754998|NCT00545740|456052992|FG003|Overall Study|Lack of time|0|||
126754999|NCT00545740|456052989|FG000|Overall Study|Non-adherence to visits|0|||
126755000|NCT00545740|456052990|FG001|Overall Study|Non-adherence to visits|1|||
126755001|NCT00545740|456052991|FG002|Overall Study|Non-adherence to visits|0|||
126755002|NCT00545740|456052992|FG003|Overall Study|Non-adherence to visits|0|||
126755003|NCT00545740|456052989|FG000|Overall Study|Patient difficulties|0|||
126755004|NCT00545740|456052990|FG001|Overall Study|Patient difficulties|1|||
126755005|NCT00545740|456052991|FG002|Overall Study|Patient difficulties|0|||
126755006|NCT00545740|456052992|FG003|Overall Study|Patient difficulties|0|||
126755007|NCT00545740|456052989|FG000|Overall Study|Husband against study|0|||
126755008|NCT00545740|456052990|FG001|Overall Study|Husband against study|0|||
126755009|NCT00545740|456052991|FG002|Overall Study|Husband against study|1|||
126755010|NCT00545740|456052992|FG003|Overall Study|Husband against study|0|||
126755011|NCT01234337|456052995|FG000|Overall Study|Adverse Event|58|||
126755012|NCT01234337|456052996|FG001|Overall Study|Adverse Event|21|||
126755013|NCT01234337|456052995|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
126755014|NCT01234337|456052996|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
126755015|NCT01234337|456052995|FG000|Overall Study|Investi. decision not protocol driven|5|||
126755016|NCT01234337|456052996|FG001|Overall Study|Investi. decision not protocol driven|6|||
126755017|NCT01234337|456052995|FG000|Overall Study|Non-compliant with study medication|3|||
126755018|NCT01234337|456052996|FG001|Overall Study|Non-compliant with study medication|2|||
126787624|NCT00337077|456178709|FG001|Overall Study|Death|1|||
126787625|NCT00337077|456178710|FG002|Overall Study|Death|0|||
126787626|NCT00337077|456178708|FG000|Overall Study|Withdrawal by Subject|7|||
126787627|NCT00337077|456178709|FG001|Overall Study|Withdrawal by Subject|2|||
126787628|NCT00337077|456178710|FG002|Overall Study|Withdrawal by Subject|2|||
126787629|NCT00337077|456178708|FG000|Overall Study|Alternative therapy|1|||
126787630|NCT00337077|456178709|FG001|Overall Study|Alternative therapy|0|||
126787631|NCT00337077|456178710|FG002|Overall Study|Alternative therapy|0|||
126787632|NCT00337077|456178708|FG000|Overall Study|Physician Decision|1|||
126787633|NCT00337077|456178709|FG001|Overall Study|Physician Decision|4|||
126787634|NCT00337077|456178710|FG002|Overall Study|Physician Decision|2|||
126787635|NCT00337077|456178708|FG000|Overall Study|Never started treatment|1|||
126787636|NCT00337077|456178709|FG001|Overall Study|Never started treatment|1|||
126787637|NCT00337077|456178710|FG002|Overall Study|Never started treatment|0|||
126787638|NCT00337077|456178708|FG000|Overall Study|Ineligible|1|||
126787639|NCT00337077|456178709|FG001|Overall Study|Ineligible|1|||
126787640|NCT00337077|456178710|FG002|Overall Study|Ineligible|1|||
126787641|NCT02430870|456178723|FG000|Part 2|Voluntary Withdrawal|0|||
126787642|NCT02430870|456178724|FG001|Part 2|Voluntary Withdrawal|0|||
126787643|NCT02430870|456178725|FG002|Part 2|Voluntary Withdrawal|0|||
126787644|NCT02430870|456178726|FG003|Part 2|Voluntary Withdrawal|0|||
126787645|NCT02430870|456178727|FG004|Part 2|Voluntary Withdrawal|0|||
126787646|NCT02430870|456178728|FG005|Part 2|Voluntary Withdrawal|0|||
126787647|NCT02430870|456178729|FG006|Part 2|Voluntary Withdrawal|1|||
126787648|NCT02430870|456178730|FG007|Part 2|Voluntary Withdrawal|0|||
126787649|NCT02430870|456178723|FG000|Part 2|Other Reason Not Specified|0|||
126787650|NCT02430870|456178724|FG001|Part 2|Other Reason Not Specified|0|||
126787651|NCT02430870|456178725|FG002|Part 2|Other Reason Not Specified|0|||
126787652|NCT02430870|456178726|FG003|Part 2|Other Reason Not Specified|0|||
126787653|NCT02430870|456178727|FG004|Part 2|Other Reason Not Specified|0|||
126787654|NCT02430870|456178728|FG005|Part 2|Other Reason Not Specified|0|||
126787655|NCT02430870|456178729|FG006|Part 2|Other Reason Not Specified|0|||
126787656|NCT02430870|456178730|FG007|Part 2|Other Reason Not Specified|1|||
126787657|NCT01265784|456178731|FG000|Overall Study|Lost to Follow-up|5|||
126787658|NCT01265784|456178732|FG001|Overall Study|Lost to Follow-up|3|||
126787659|NCT01265784|456178733|FG002|Overall Study|Lost to Follow-up|2|||
126787660|NCT01265784|456178731|FG000|Overall Study|Withdrawal by Subject|0|||
126787661|NCT01265784|456178732|FG001|Overall Study|Withdrawal by Subject|5|||
126787662|NCT01265784|456178733|FG002|Overall Study|Withdrawal by Subject|0|||
126787663|NCT01265784|456178731|FG000|Overall Study|Physician Decision|1|||
126787664|NCT01265784|456178732|FG001|Overall Study|Physician Decision|0|||
126787665|NCT01265784|456178733|FG002|Overall Study|Physician Decision|1|||
126787666|NCT01265784|456178731|FG000|Overall Study|Adverse Event|1|||
126787667|NCT01265784|456178732|FG001|Overall Study|Adverse Event|0|||
126787668|NCT01265784|456178733|FG002|Overall Study|Adverse Event|0|||
126787669|NCT01265784|456178731|FG000|Overall Study|Death|3|||
126787670|NCT01265784|456178732|FG001|Overall Study|Death|0|||
126787671|NCT01265784|456178733|FG002|Overall Study|Death|0|||
126787672|NCT01265784|456178731|FG000|Overall Study|Protocol Violation|2|||
126787673|NCT01265784|456178732|FG001|Overall Study|Protocol Violation|0|||
126787674|NCT01265784|456178733|FG002|Overall Study|Protocol Violation|0|||
126787675|NCT01265784|456178731|FG000|Overall Study|Incorrectly Randomized|0|||
126787676|NCT01265784|456178732|FG001|Overall Study|Incorrectly Randomized|0|||
126787677|NCT01265784|456178733|FG002|Overall Study|Incorrectly Randomized|1|||
126787678|NCT01867242|456178734|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
126787679|NCT01867242|456178735|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
126787680|NCT01867242|456178736|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
126787681|NCT00264810|456178740|FG000|Baseline|Withdrawal by Subject|10|||
126787682|NCT00264810|456178741|FG001|Baseline|Withdrawal by Subject|10|||
126787683|NCT00264810|456178740|FG000|Baseline|Physician Decision|7|||
126787684|NCT00264810|456178741|FG001|Baseline|Physician Decision|8|||
126787685|NCT00264810|456178740|FG000|Baseline|Subject Compliance Failure|3|||
126787686|NCT00264810|456178741|FG001|Baseline|Subject Compliance Failure|3|||
126787687|NCT00264810|456178740|FG000|Baseline|Insufficient Seizure Frequency|2|||
126787688|NCT00264810|456178741|FG001|Baseline|Insufficient Seizure Frequency|2|||
126787689|NCT00264810|456178740|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
126787690|NCT00264810|456178741|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
126787691|NCT00264810|456178740|FG000|Baseline|Other|0|||
126787692|NCT00264810|456178741|FG001|Baseline|Other|1|||
126787693|NCT00264810|456178740|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
126787694|NCT00264810|456178741|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
126787695|NCT00264810|456178740|FG000|Stimulation Optimization Period|Death|0|||
126787696|NCT00264810|456178741|FG001|Stimulation Optimization Period|Death|1|||
126787697|NCT00264810|456178740|FG000|Blinded Evaluation Period|Explant due to infection|1|||
126787698|NCT00264810|456178741|FG001|Blinded Evaluation Period|Explant due to infection|1|||
126787699|NCT00264810|456178740|FG000|Open Label Evaluation Period|Explant due to infection|1|||
126787700|NCT00264810|456178741|FG001|Open Label Evaluation Period|Explant due to infection|1|||
126787701|NCT00264810|456178740|FG000|Open Label Evaluation Period|Death|3|||
126787702|NCT00264810|456178741|FG001|Open Label Evaluation Period|Death|2|||
126787703|NCT00264810|456178740|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
126787704|NCT00264810|456178741|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
126787705|NCT02199509|456178742|FG000|Overall Study|Suicidal Ideation|0|||
126787706|NCT02199509|456178743|FG001|Overall Study|Suicidal Ideation|1|||
126787707|NCT02199509|456178742|FG000|Overall Study|Misunderstood titration schedule|1|||
126787708|NCT02199509|456178743|FG001|Overall Study|Misunderstood titration schedule|0|||
126787709|NCT02093689|456178744|FG000|Overall Study|Physician Decision|4|||
126787710|NCT02093689|456178745|FG001|Overall Study|Physician Decision|0|||
126787711|NCT02093689|456178746|FG002|Overall Study|Physician Decision|0|||
126787712|NCT03309956|456178747|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
126787713|NCT02768298|456178748|FG000|Overall Study|Adverse Event|1|||
126787714|NCT02768298|456178749|FG001|Overall Study|Adverse Event|4|||
126787715|NCT02768298|456178748|FG000|Overall Study|Death|2|||
126787716|NCT02768298|456178749|FG001|Overall Study|Death|1|||
126787717|NCT02768298|456178748|FG000|Overall Study|Non-compliance with study treatment|0|||
126787718|NCT02768298|456178749|FG001|Overall Study|Non-compliance with study treatment|1|||
126787719|NCT02768298|456178748|FG000|Overall Study|Subject/guardian decision|1|||
126787720|NCT02768298|456178749|FG001|Overall Study|Subject/guardian decision|0|||
126787721|NCT02768298|456178748|FG000|Overall Study|Withdrawal of informed consent|0|||
126787722|NCT02768298|456178749|FG001|Overall Study|Withdrawal of informed consent|1|||
126787723|NCT04634409|456178750|FG000|Overall Study|Death|0|||
126787724|NCT04634409|456178751|FG001|Overall Study|Death|0|||
126787725|NCT04634409|456178752|FG002|Overall Study|Death|0|||
126787726|NCT04634409|456178753|FG003|Overall Study|Death|0|||
126787727|NCT04634409|456178754|FG004|Overall Study|Death|0|||
126787728|NCT04634409|456178755|FG005|Overall Study|Death|0|||
126787729|NCT04634409|456178756|FG006|Overall Study|Death|0|||
126787730|NCT04634409|456178757|FG007|Overall Study|Death|0|||
126787731|NCT04634409|456178758|FG008|Overall Study|Death|0|||
126787732|NCT04634409|456178759|FG009|Overall Study|Death|0|||
126787733|NCT04634409|456178760|FG010|Overall Study|Death|1|||
126787734|NCT04634409|456178761|FG011|Overall Study|Death|0|||
126787735|NCT04634409|456178762|FG012|Overall Study|Death|1|||
126787736|NCT04634409|456178763|FG013|Overall Study|Death|0|||
126787737|NCT04634409|456178764|FG014|Overall Study|Death|0|||
126787738|NCT04634409|456178765|FG015|Overall Study|Death|0|||
126787739|NCT04634409|456178766|FG016|Overall Study|Death|0|||
126787740|NCT04634409|456178767|FG017|Overall Study|Death|0|||
126787741|NCT04634409|456178768|FG018|Overall Study|Death|0|||
126787742|NCT04634409|456178769|FG019|Overall Study|Death|0|||
126787743|NCT04634409|456178770|FG020|Overall Study|Death|0|||
126787744|NCT04634409|456178771|FG021|Overall Study|Death|0|||
126787745|NCT04634409|456178772|FG022|Overall Study|Death|0|||
126787746|NCT04634409|456178773|FG023|Overall Study|Death|0|||
126787747|NCT04634409|456178774|FG024|Overall Study|Death|0|||
126787748|NCT04634409|456178775|FG025|Overall Study|Death|0|||
126787749|NCT04634409|456178776|FG026|Overall Study|Death|0|||
126787750|NCT04634409|456178750|FG000|Overall Study|Adverse Event|0|||
126787751|NCT04634409|456178751|FG001|Overall Study|Adverse Event|0|||
126787752|NCT04634409|456178752|FG002|Overall Study|Adverse Event|1|||
126787753|NCT04634409|456178753|FG003|Overall Study|Adverse Event|0|||
126787754|NCT04634409|456178754|FG004|Overall Study|Adverse Event|0|||
126787755|NCT04634409|456178755|FG005|Overall Study|Adverse Event|1|||
126787756|NCT04634409|456178756|FG006|Overall Study|Adverse Event|0|||
126787757|NCT04634409|456178757|FG007|Overall Study|Adverse Event|0|||
126787758|NCT04634409|456178758|FG008|Overall Study|Adverse Event|0|||
126787759|NCT04634409|456178759|FG009|Overall Study|Adverse Event|0|||
126787760|NCT04634409|456178760|FG010|Overall Study|Adverse Event|0|||
126787761|NCT04634409|456178761|FG011|Overall Study|Adverse Event|0|||
126787762|NCT04634409|456178762|FG012|Overall Study|Adverse Event|0|||
126787763|NCT04634409|456178763|FG013|Overall Study|Adverse Event|0|||
126787764|NCT04634409|456178764|FG014|Overall Study|Adverse Event|0|||
126787765|NCT04634409|456178765|FG015|Overall Study|Adverse Event|0|||
126787766|NCT04634409|456178766|FG016|Overall Study|Adverse Event|0|||
126787767|NCT04634409|456178767|FG017|Overall Study|Adverse Event|0|||
126787768|NCT04634409|456178768|FG018|Overall Study|Adverse Event|0|||
126787769|NCT04634409|456178769|FG019|Overall Study|Adverse Event|0|||
126787770|NCT04634409|456178770|FG020|Overall Study|Adverse Event|0|||
126787771|NCT04634409|456178771|FG021|Overall Study|Adverse Event|0|||
126787772|NCT04634409|456178772|FG022|Overall Study|Adverse Event|0|||
126787773|NCT04634409|456178773|FG023|Overall Study|Adverse Event|0|||
126787774|NCT04634409|456178774|FG024|Overall Study|Adverse Event|0|||
126787775|NCT04634409|456178775|FG025|Overall Study|Adverse Event|0|||
126787776|NCT04634409|456178776|FG026|Overall Study|Adverse Event|0|||
126787777|NCT04634409|456178750|FG000|Overall Study|Lost to Follow-up|3|||
126787778|NCT04634409|456178751|FG001|Overall Study|Lost to Follow-up|1|||
126787779|NCT04634409|456178752|FG002|Overall Study|Lost to Follow-up|1|||
126787780|NCT04634409|456178753|FG003|Overall Study|Lost to Follow-up|3|||
126787781|NCT04634409|456178754|FG004|Overall Study|Lost to Follow-up|1|||
126787782|NCT04634409|456178755|FG005|Overall Study|Lost to Follow-up|1|||
126755019|NCT01234337|456052995|FG000|Overall Study|Randomized but not treated|6|||
126755020|NCT01234337|456052996|FG001|Overall Study|Randomized but not treated|4|||
126755021|NCT01234337|456052995|FG000|Overall Study|Lost to Follow-up|0|||
126755022|NCT01234337|456052996|FG001|Overall Study|Lost to Follow-up|1|||
126755023|NCT01234337|456052995|FG000|Overall Study|Protocol Violation|2|||
126755024|NCT01234337|456052996|FG001|Overall Study|Protocol Violation|3|||
126755025|NCT01234337|456052995|FG000|Overall Study|Withdrawal by Subject|11|||
126755026|NCT01234337|456052996|FG001|Overall Study|Withdrawal by Subject|9|||
126755027|NCT01234337|456052995|FG000|Overall Study|Death|0|||
126755028|NCT01234337|456052996|FG001|Overall Study|Death|1|||
126755029|NCT01234337|456052995|FG000|Overall Study|Switch to commercial drug|0|||
126755030|NCT01234337|456052996|FG001|Overall Study|Switch to commercial drug|1|||
126755031|NCT04118127|456052999|FG000|Overall Study|Trial terminated by sponsor|0|||
126755032|NCT04118127|456053000|FG001|Overall Study|Trial terminated by sponsor|12|||
126755033|NCT04118127|456052999|FG000|Overall Study|Adverse Event|1|||
126755034|NCT04118127|456053000|FG001|Overall Study|Adverse Event|2|||
126755035|NCT04118127|456052999|FG000|Overall Study|Physician Decision|0|||
126755036|NCT04118127|456053000|FG001|Overall Study|Physician Decision|1|||
126755037|NCT04118127|456052999|FG000|Overall Study|Withdrawal by Subject|2|||
126755038|NCT04118127|456053000|FG001|Overall Study|Withdrawal by Subject|1|||
126755039|NCT03480360|456053001|FG000|Overall Study|Death|2|||
126755040|NCT01646255|456053006|FG000|Overall Study|Adverse Event|7|||
126755041|NCT01646255|456053007|FG001|Overall Study|Adverse Event|8|||
126755042|NCT01646255|456053006|FG000|Overall Study|Lack of Efficacy|2|||
126755043|NCT01646255|456053007|FG001|Overall Study|Lack of Efficacy|0|||
126755044|NCT01646255|456053006|FG000|Overall Study|Withdrawal by Subject|10|||
126755045|NCT01646255|456053007|FG001|Overall Study|Withdrawal by Subject|6|||
126755046|NCT01646255|456053006|FG000|Overall Study|Compliance is not well|1|||
126755047|NCT01646255|456053007|FG001|Overall Study|Compliance is not well|0|||
126755048|NCT01646255|456053006|FG000|Overall Study|Inclusion Criteria Deviation|1|||
126755049|NCT01646255|456053007|FG001|Overall Study|Inclusion Criteria Deviation|0|||
126755050|NCT01376908|456053008|FG000|Overall Study|Protocol Violation|1|||
126755051|NCT01376908|456053009|FG001|Overall Study|Protocol Violation|1|||
126755052|NCT01376908|456053008|FG000|Overall Study|Withdrawal by Subject|1|||
126755053|NCT01376908|456053009|FG001|Overall Study|Withdrawal by Subject|2|||
126755054|NCT01681836|456053012|FG000|Second Intervention|Withdrawal by Subject|0|||
126755055|NCT01681836|456053013|FG001|Second Intervention|Withdrawal by Subject|1|||
126755056|NCT01468844|456053014|FG000|Overall Study|Adverse Event|1|||
126755057|NCT01468844|456053015|FG001|Overall Study|Adverse Event|0|||
126755058|NCT01468844|456053014|FG000|Overall Study|Withdrawal by Subject|1|||
126755059|NCT01468844|456053015|FG001|Overall Study|Withdrawal by Subject|0|||
126755060|NCT02142712|456053016|FG000|Overall Study|Lost to Follow-up|1|||
126755061|NCT02142712|456053017|FG001|Overall Study|Lost to Follow-up|1|||
126755062|NCT02142712|456053018|FG002|Overall Study|Lost to Follow-up|1|||
126755063|NCT02142712|456053019|FG003|Overall Study|Lost to Follow-up|0|||
126755064|NCT03480841|456053022|FG000|Overall Study|Lost to Follow-up|2|||
126755065|NCT02380703|456053023|FG000|Overall Study|Withdrawal by Subject|12|||
126755066|NCT02380703|456053024|FG001|Overall Study|Withdrawal by Subject|9|||
126755067|NCT02380703|456053023|FG000|Overall Study|Lost to Follow-up|12|||
126755068|NCT02380703|456053024|FG001|Overall Study|Lost to Follow-up|12|||
126755069|NCT02380703|456053023|FG000|Overall Study|Caregiver death|1|||
126755070|NCT02380703|456053024|FG001|Overall Study|Caregiver death|0|||
126755071|NCT02380703|456053023|FG000|Overall Study|Person with dementia (PWD) death|7|||
126755072|NCT02380703|456053024|FG001|Overall Study|Person with dementia (PWD) death|8|||
126755073|NCT02380703|456053023|FG000|Overall Study|Entered Long-term Care|4|||
126755074|NCT02380703|456053024|FG001|Overall Study|Entered Long-term Care|7|||
126755075|NCT00266695|456053025|FG000|Overall Study|Adverse Event|1|||
126755076|NCT00266695|456053025|FG000|Overall Study|Death|9|||
126755077|NCT00266695|456053025|FG000|Overall Study|Physician Decision|1|||
126755078|NCT00266695|456053025|FG000|Overall Study|Lost to Follow-up|3|||
126755079|NCT00266695|456053025|FG000|Overall Study|Withdrawal by Subject|15|||
126755080|NCT01362049|456053026|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
126755081|NCT01362049|456053027|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
126755082|NCT01362049|456053028|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
126755083|NCT01362049|456053029|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
126755084|NCT01362049|456053026|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
126755085|NCT01362049|456053027|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
126755086|NCT01362049|456053028|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
126755087|NCT01362049|456053029|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
126755088|NCT03607994|456053030|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
126755089|NCT03607994|456053031|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
126755090|NCT02417935|456053032|FG000|Treatment Period|Adverse Event|12|||
126755091|NCT02417935|456053033|FG001|Treatment Period|Adverse Event|10|||
126755092|NCT02417935|456053032|FG000|Treatment Period|Lost to Follow-up|1|||
126755093|NCT02417935|456053033|FG001|Treatment Period|Lost to Follow-up|0|||
126755094|NCT02417935|456053032|FG000|Treatment Period|Entry Criteria not met|0|||
126787783|NCT04634409|456178756|FG006|Overall Study|Lost to Follow-up|1|||
126787784|NCT04634409|456178757|FG007|Overall Study|Lost to Follow-up|3|||
126787785|NCT04634409|456178758|FG008|Overall Study|Lost to Follow-up|3|||
126787786|NCT04634409|456178759|FG009|Overall Study|Lost to Follow-up|11|||
126787787|NCT04634409|456178760|FG010|Overall Study|Lost to Follow-up|8|||
126787788|NCT04634409|456178761|FG011|Overall Study|Lost to Follow-up|15|||
126787789|NCT04634409|456178762|FG012|Overall Study|Lost to Follow-up|3|||
126787790|NCT04634409|456178763|FG013|Overall Study|Lost to Follow-up|2|||
126787791|NCT04634409|456178764|FG014|Overall Study|Lost to Follow-up|7|||
126787792|NCT04634409|456178765|FG015|Overall Study|Lost to Follow-up|0|||
126787793|NCT04634409|456178766|FG016|Overall Study|Lost to Follow-up|0|||
126787794|NCT04634409|456178767|FG017|Overall Study|Lost to Follow-up|0|||
126787795|NCT04634409|456178768|FG018|Overall Study|Lost to Follow-up|0|||
126787796|NCT04634409|456178769|FG019|Overall Study|Lost to Follow-up|0|||
126787797|NCT04634409|456178770|FG020|Overall Study|Lost to Follow-up|0|||
126787798|NCT04634409|456178771|FG021|Overall Study|Lost to Follow-up|0|||
126787799|NCT04634409|456178772|FG022|Overall Study|Lost to Follow-up|0|||
126787800|NCT04634409|456178773|FG023|Overall Study|Lost to Follow-up|0|||
126787801|NCT04634409|456178774|FG024|Overall Study|Lost to Follow-up|0|||
126787802|NCT04634409|456178775|FG025|Overall Study|Lost to Follow-up|0|||
126787803|NCT04634409|456178776|FG026|Overall Study|Lost to Follow-up|0|||
126787804|NCT04634409|456178750|FG000|Overall Study|Withdrawal by Subject|3|||
126787805|NCT04634409|456178751|FG001|Overall Study|Withdrawal by Subject|1|||
126787806|NCT04634409|456178752|FG002|Overall Study|Withdrawal by Subject|6|||
126787807|NCT04634409|456178753|FG003|Overall Study|Withdrawal by Subject|4|||
126787808|NCT04634409|456178754|FG004|Overall Study|Withdrawal by Subject|2|||
126787809|NCT04634409|456178755|FG005|Overall Study|Withdrawal by Subject|0|||
126787810|NCT04634409|456178756|FG006|Overall Study|Withdrawal by Subject|0|||
126787811|NCT04634409|456178757|FG007|Overall Study|Withdrawal by Subject|2|||
126787812|NCT04634409|456178758|FG008|Overall Study|Withdrawal by Subject|3|||
126787813|NCT04634409|456178759|FG009|Overall Study|Withdrawal by Subject|2|||
126787814|NCT04634409|456178760|FG010|Overall Study|Withdrawal by Subject|3|||
126787815|NCT04634409|456178761|FG011|Overall Study|Withdrawal by Subject|2|||
126787816|NCT04634409|456178762|FG012|Overall Study|Withdrawal by Subject|2|||
126787817|NCT04634409|456178763|FG013|Overall Study|Withdrawal by Subject|1|||
126787818|NCT04634409|456178764|FG014|Overall Study|Withdrawal by Subject|5|||
126787819|NCT04634409|456178765|FG015|Overall Study|Withdrawal by Subject|0|||
126787820|NCT04634409|456178766|FG016|Overall Study|Withdrawal by Subject|0|||
126787821|NCT04634409|456178767|FG017|Overall Study|Withdrawal by Subject|1|||
126787822|NCT04634409|456178768|FG018|Overall Study|Withdrawal by Subject|0|||
126787823|NCT04634409|456178769|FG019|Overall Study|Withdrawal by Subject|0|||
126787824|NCT04634409|456178770|FG020|Overall Study|Withdrawal by Subject|0|||
126787825|NCT04634409|456178771|FG021|Overall Study|Withdrawal by Subject|0|||
126787826|NCT04634409|456178772|FG022|Overall Study|Withdrawal by Subject|0|||
126787827|NCT04634409|456178773|FG023|Overall Study|Withdrawal by Subject|1|||
126787828|NCT04634409|456178774|FG024|Overall Study|Withdrawal by Subject|0|||
126787829|NCT04634409|456178775|FG025|Overall Study|Withdrawal by Subject|0|||
126787830|NCT04634409|456178776|FG026|Overall Study|Withdrawal by Subject|0|||
126787831|NCT04634409|456178750|FG000|Overall Study|Other - As reported by Investigator|1|||
126787832|NCT04634409|456178751|FG001|Overall Study|Other - As reported by Investigator|0|||
126787833|NCT04634409|456178752|FG002|Overall Study|Other - As reported by Investigator|0|||
126787834|NCT04634409|456178753|FG003|Overall Study|Other - As reported by Investigator|0|||
126787835|NCT04634409|456178754|FG004|Overall Study|Other - As reported by Investigator|0|||
126787836|NCT04634409|456178755|FG005|Overall Study|Other - As reported by Investigator|0|||
126787837|NCT04634409|456178756|FG006|Overall Study|Other - As reported by Investigator|0|||
126787838|NCT04634409|456178757|FG007|Overall Study|Other - As reported by Investigator|6|||
126787839|NCT04634409|456178758|FG008|Overall Study|Other - As reported by Investigator|4|||
126787840|NCT04634409|456178759|FG009|Overall Study|Other - As reported by Investigator|0|||
126787841|NCT04634409|456178760|FG010|Overall Study|Other - As reported by Investigator|1|||
126787842|NCT04634409|456178761|FG011|Overall Study|Other - As reported by Investigator|2|||
126787843|NCT04634409|456178762|FG012|Overall Study|Other - As reported by Investigator|2|||
126787844|NCT04634409|456178763|FG013|Overall Study|Other - As reported by Investigator|1|||
126787845|NCT04634409|456178764|FG014|Overall Study|Other - As reported by Investigator|0|||
126787846|NCT04634409|456178765|FG015|Overall Study|Other - As reported by Investigator|0|||
126787847|NCT04634409|456178766|FG016|Overall Study|Other - As reported by Investigator|0|||
126787848|NCT04634409|456178767|FG017|Overall Study|Other - As reported by Investigator|0|||
126787849|NCT04634409|456178768|FG018|Overall Study|Other - As reported by Investigator|0|||
126787850|NCT04634409|456178769|FG019|Overall Study|Other - As reported by Investigator|0|||
126787851|NCT04634409|456178770|FG020|Overall Study|Other - As reported by Investigator|0|||
126787852|NCT04634409|456178771|FG021|Overall Study|Other - As reported by Investigator|0|||
126787853|NCT04634409|456178772|FG022|Overall Study|Other - As reported by Investigator|0|||
126787854|NCT04634409|456178773|FG023|Overall Study|Other - As reported by Investigator|0|||
126787855|NCT04634409|456178774|FG024|Overall Study|Other - As reported by Investigator|0|||
126787856|NCT04634409|456178775|FG025|Overall Study|Other - As reported by Investigator|0|||
126787857|NCT04634409|456178776|FG026|Overall Study|Other - As reported by Investigator|0|||
126787858|NCT02518685|456178779|FG000|Overall Study|Adverse Event|29|||
126787859|NCT02518685|456178780|FG001|Overall Study|Adverse Event|1|||
126787860|NCT02518685|456178779|FG000|Overall Study|Withdrawal by Subject|10|||
126787861|NCT02518685|456178780|FG001|Overall Study|Withdrawal by Subject|3|||
126787862|NCT02518685|456178779|FG000|Overall Study|relocation, study fatigue|7|||
126787863|NCT02518685|456178780|FG001|Overall Study|relocation, study fatigue|2|||
126787864|NCT02518685|456178779|FG000|Overall Study|Pregnancy|1|||
126787865|NCT02518685|456178780|FG001|Overall Study|Pregnancy|0|||
126787866|NCT02518685|456178779|FG000|Overall Study|Physician Decision|1|||
126787867|NCT02518685|456178780|FG001|Overall Study|Physician Decision|0|||
126787868|NCT02518685|456178779|FG000|Overall Study|Lost to Follow-up|1|||
126787869|NCT02518685|456178780|FG001|Overall Study|Lost to Follow-up|4|||
126787870|NCT01611090|456178781|FG000|Randomized Period|Lost to Follow-up|8|||
126787871|NCT01611090|456178782|FG001|Randomized Period|Lost to Follow-up|3|||
126787872|NCT01611090|456178783|FG002|Randomized Period|Lost to Follow-up|0|||
126787873|NCT01611090|456178781|FG000|Randomized Period|Withdrawal by Subject|22|||
126787874|NCT01611090|456178782|FG001|Randomized Period|Withdrawal by Subject|26|||
126787875|NCT01611090|456178783|FG002|Randomized Period|Withdrawal by Subject|0|||
126787876|NCT01611090|456178781|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
126787877|NCT01611090|456178782|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
126787878|NCT01611090|456178783|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
126787879|NCT01611090|456178781|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
126787880|NCT01611090|456178782|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
126787881|NCT01611090|456178783|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
126787882|NCT02448771|456178784|FG000|Overall Study|Disease Progression|30|||
126787883|NCT02448771|456178784|FG000|Overall Study|Unacceptable Toxicity|1|||
126787884|NCT02448771|456178784|FG000|Overall Study|Physician Decision|3|||
126787885|NCT02448771|456178784|FG000|Overall Study|Started new therapy|2|||
126787886|NCT00502775|456180404|FG000|Overall Study|Adverse Event|1|||
126787887|NCT00502775|456180405|FG001|Overall Study|Adverse Event|2|||
126787888|NCT00502775|456180406|FG002|Overall Study|Adverse Event|1|||
126787889|NCT00502775|456180404|FG000|Overall Study|Protocol Violation|1|||
126787890|NCT00502775|456180405|FG001|Overall Study|Protocol Violation|5|||
126787891|NCT00502775|456180406|FG002|Overall Study|Protocol Violation|2|||
126787892|NCT00502775|456180404|FG000|Overall Study|Withdrawal by Subject|1|||
126787893|NCT00502775|456180405|FG001|Overall Study|Withdrawal by Subject|1|||
126787894|NCT00502775|456180406|FG002|Overall Study|Withdrawal by Subject|2|||
126787895|NCT00502775|456180404|FG000|Overall Study|Sponsor Terminated Study|1|||
126787896|NCT00502775|456180405|FG001|Overall Study|Sponsor Terminated Study|0|||
126787897|NCT00502775|456180406|FG002|Overall Study|Sponsor Terminated Study|1|||
126787898|NCT00502775|456180404|FG000|Overall Study|Non-compliance with eDiary|4|||
126787899|NCT00502775|456180405|FG001|Overall Study|Non-compliance with eDiary|1|||
126787900|NCT00502775|456180406|FG002|Overall Study|Non-compliance with eDiary|1|||
126787901|NCT00502775|456180404|FG000|Overall Study|Subject unable to swallow capsule|1|||
126787902|NCT00502775|456180405|FG001|Overall Study|Subject unable to swallow capsule|0|||
126787903|NCT00502775|456180406|FG002|Overall Study|Subject unable to swallow capsule|1|||
126787904|NCT00502775|456180404|FG000|Overall Study|Logpad compliance <80%|1|||
126787905|NCT00502775|456180405|FG001|Overall Study|Logpad compliance <80%|0|||
126787906|NCT00502775|456180406|FG002|Overall Study|Logpad compliance <80%|0|||
126787907|NCT00502775|456180404|FG000|Overall Study|Randomized in error|0|||
126787908|NCT00502775|456180405|FG001|Overall Study|Randomized in error|1|||
126787909|NCT00502775|456180406|FG002|Overall Study|Randomized in error|1|||
126787910|NCT00502775|456180404|FG000|Overall Study|Non-compliance|0|||
126787911|NCT00502775|456180405|FG001|Overall Study|Non-compliance|2|||
126787912|NCT00502775|456180406|FG002|Overall Study|Non-compliance|2|||
126787913|NCT00502775|456180404|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
126787914|NCT00502775|456180405|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
126787915|NCT00502775|456180406|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
126787916|NCT00502775|456180404|FG000|Overall Study|Declining pollen counts|0|||
126787917|NCT00502775|456180405|FG001|Overall Study|Declining pollen counts|1|||
126787918|NCT00502775|456180406|FG002|Overall Study|Declining pollen counts|1|||
126787919|NCT00502775|456180404|FG000|Overall Study|Subject in jail|0|||
126787920|NCT00502775|456180405|FG001|Overall Study|Subject in jail|1|||
126787921|NCT00502775|456180406|FG002|Overall Study|Subject in jail|0|||
126787922|NCT00502775|456180404|FG000|Overall Study|Subject took disallowed drug|0|||
126787923|NCT00502775|456180405|FG001|Overall Study|Subject took disallowed drug|0|||
126787924|NCT00502775|456180406|FG002|Overall Study|Subject took disallowed drug|1|||
126787925|NCT00287118|456180408|FG000|Overall Study|Adverse Event|30|||
126787926|NCT00287118|456180408|FG000|Overall Study|Death|1|||
126787927|NCT00287118|456180408|FG000|Overall Study|Lack of Efficacy|11|||
126787928|NCT00287118|456180408|FG000|Overall Study|Lost to Follow-up|1|||
126787929|NCT00287118|456180408|FG000|Overall Study|Protocol Violation|2|||
126787930|NCT00287118|456180408|FG000|Overall Study|Other|7|||
126787931|NCT00262600|456180409|FG000|Overall Study|Lost to Follow-up|17|||
126787932|NCT00262600|456180410|FG001|Overall Study|Lost to Follow-up|31|||
126787933|NCT00262600|456180411|FG002|Overall Study|Lost to Follow-up|41|||
126787934|NCT00262600|456180409|FG000|Overall Study|Withdrawal by Subject|128|||
126787935|NCT00262600|456180410|FG001|Overall Study|Withdrawal by Subject|145|||
126787936|NCT00262600|456180411|FG002|Overall Study|Withdrawal by Subject|139|||
126787937|NCT00262600|456180409|FG000|Overall Study|Not Treated|32|||
126787938|NCT00262600|456180410|FG001|Overall Study|Not Treated|17|||
126787939|NCT00262600|456180411|FG002|Overall Study|Not Treated|24|||
126787940|NCT00262600|456180409|FG000|Overall Study|Other|58|||
126787941|NCT00262600|456180410|FG001|Overall Study|Other|59|||
126787942|NCT00262600|456180411|FG002|Overall Study|Other|62|||
126787943|NCT04471207|456180412|FG000|Overall Study|Lost to Follow-up|4|||
126787944|NCT04471207|456180413|FG001|Overall Study|Lost to Follow-up|1|||
126787945|NCT04471207|456180412|FG000|Overall Study|Medication Contraindication|0|||
126787946|NCT04471207|456180413|FG001|Overall Study|Medication Contraindication|1|||
126787947|NCT04471207|456180412|FG000|Overall Study|Loss of Interest|2|||
126787948|NCT04471207|456180413|FG001|Overall Study|Loss of Interest|1|||
126787949|NCT04471207|456180412|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
126787950|NCT04471207|456180413|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
126787951|NCT04471207|456180412|FG000|Overall Study|Scheduling Conflicts|3|||
126787952|NCT04471207|456180413|FG001|Overall Study|Scheduling Conflicts|1|||
126787953|NCT04471207|456180412|FG000|Overall Study|Physician Decision|1|||
126787954|NCT04471207|456180413|FG001|Overall Study|Physician Decision|0|||
126787955|NCT04471207|456180412|FG000|Overall Study|Unwilling to Use System|0|||
126787956|NCT04471207|456180413|FG001|Overall Study|Unwilling to Use System|1|||
126787957|NCT00561730|456180414|FG000|Overall Study|Adverse Event|2|||
126787958|NCT00561730|456180414|FG000|Overall Study|Handling of the drug|1|||
126787959|NCT00561730|456180414|FG000|Overall Study|Lost to Follow-up|5|||
126787960|NCT00561730|456180414|FG000|Overall Study|Not specified reasons|1|||
126787961|NCT00376220|456180415|FG000|Overall Study|Lost to Follow-up|7|||
126787962|NCT00376220|456180416|FG001|Overall Study|Lost to Follow-up|10|||
126787963|NCT00376220|456180415|FG000|Overall Study|Withdrawal by Subject|3|||
126787964|NCT00376220|456180416|FG001|Overall Study|Withdrawal by Subject|2|||
126787965|NCT00531206|456180421|FG000|Overall Study|Adverse Event related|5|||
126787966|NCT00531206|456180421|FG000|Overall Study|Lack of Efficacy|2|||
126787967|NCT00531206|456180421|FG000|Overall Study|Lost to Follow-up|5|||
126787968|NCT00531206|456180421|FG000|Overall Study|including non-related adverse events|8|||
126787969|NCT02906709|456180428|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
126787970|NCT02906709|456180429|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
126787971|NCT02906709|456180428|FG000|Phase A (Week 0 to Week 16)|Death|0|||
126787972|NCT02906709|456180429|FG001|Phase A (Week 0 to Week 16)|Death|1|||
126787973|NCT02906709|456180428|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
126787974|NCT02906709|456180429|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
126787975|NCT02906709|456180428|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
126787976|NCT02906709|456180429|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
126787977|NCT00920140|456180431|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
126787978|NCT00920140|456180432|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
126787979|NCT00920140|456180433|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
126787980|NCT00920140|456180434|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
126787981|NCT00920140|456180435|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
126787982|NCT00920140|456180431|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
126787983|NCT00920140|456180432|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
126787984|NCT00920140|456180433|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
126787985|NCT00920140|456180434|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
126787986|NCT00920140|456180435|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
126787987|NCT00920140|456180431|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126787988|NCT00920140|456180432|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
126787989|NCT00920140|456180433|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126787990|NCT00920140|456180434|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126787991|NCT00920140|456180435|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
126787992|NCT00920140|456180431|FG000|Phase 2|Adverse Event|0|||
126787993|NCT00920140|456180432|FG001|Phase 2|Adverse Event|0|||
126787994|NCT00920140|456180433|FG002|Phase 2|Adverse Event|14|||
126787995|NCT00920140|456180434|FG003|Phase 2|Adverse Event|2|||
126787996|NCT00920140|456180435|FG004|Phase 2|Adverse Event|3|||
126787997|NCT00920140|456180431|FG000|Phase 2|Lack of Efficacy|0|||
126787998|NCT00920140|456180432|FG001|Phase 2|Lack of Efficacy|0|||
126787999|NCT00920140|456180433|FG002|Phase 2|Lack of Efficacy|29|||
126788000|NCT00920140|456180434|FG003|Phase 2|Lack of Efficacy|14|||
126788001|NCT00920140|456180435|FG004|Phase 2|Lack of Efficacy|5|||
126788002|NCT00920140|456180431|FG000|Phase 2|Lost to Follow-up|0|||
126788003|NCT00920140|456180432|FG001|Phase 2|Lost to Follow-up|0|||
126629569|NCT02154347|455602390|FG000|Open-label Period|Lack of Efficacy|4|||
126629570|NCT02154347|455602391|FG001|Open-label Period|Lack of Efficacy|19|||
126788004|NCT00920140|456180433|FG002|Phase 2|Lost to Follow-up|0|||
126788005|NCT00920140|456180434|FG003|Phase 2|Lost to Follow-up|1|||
126788006|NCT00920140|456180435|FG004|Phase 2|Lost to Follow-up|0|||
126788007|NCT00920140|456180431|FG000|Phase 2|Physician Decision|0|||
126788008|NCT00920140|456180432|FG001|Phase 2|Physician Decision|0|||
126788009|NCT00920140|456180433|FG002|Phase 2|Physician Decision|3|||
126788010|NCT00920140|456180434|FG003|Phase 2|Physician Decision|3|||
126788011|NCT00920140|456180435|FG004|Phase 2|Physician Decision|2|||
126788012|NCT00920140|456180431|FG000|Phase 2|Withdrawal by Subject|0|||
126788013|NCT00920140|456180432|FG001|Phase 2|Withdrawal by Subject|0|||
126788014|NCT00920140|456180433|FG002|Phase 2|Withdrawal by Subject|4|||
126788015|NCT00920140|456180434|FG003|Phase 2|Withdrawal by Subject|2|||
126788016|NCT00920140|456180435|FG004|Phase 2|Withdrawal by Subject|1|||
126788017|NCT01124149|456180436|FG000|Acute Phase|Withdrawal by Subject|22|||
126788018|NCT01124149|456180436|FG000|Acute Phase|Adverse Event|21|||
126788019|NCT01124149|456180436|FG000|Acute Phase|Lack of Efficacy|17|||
126788020|NCT01124149|456180436|FG000|Acute Phase|Protocol Violation|14|||
126788021|NCT01124149|456180436|FG000|Acute Phase|Lost to Follow-up|2|||
126788022|NCT01124149|456180436|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
126788023|NCT01124149|456180436|FG000|Acute Phase|Sponsor request|1|||
126788024|NCT01124149|456180436|FG000|Acute Phase|UC symptoms not ameliorated|1|||
126788025|NCT01124149|456180436|FG000|Acute Phase|Non-compliance|1|||
126788026|NCT01124149|456180436|FG000|Acute Phase|Low hemoglobin|1|||
126788027|NCT01124149|456180436|FG000|Acute Phase|Travelling to another country|1|||
126788028|NCT01124149|456180436|FG000|Acute Phase|Sponsor decision|1|||
126788029|NCT01124149|456180436|FG000|Maintenance Phase|Lack of Efficacy|40|||
126788030|NCT01124149|456180436|FG000|Maintenance Phase|Adverse Event|24|||
126788031|NCT01124149|456180436|FG000|Maintenance Phase|Lost to Follow-up|15|||
126788032|NCT01124149|456180436|FG000|Maintenance Phase|Withdrawal by Subject|10|||
126788033|NCT01124149|456180436|FG000|Maintenance Phase|Protocol Violation|5|||
126788034|NCT01124149|456180436|FG000|Maintenance Phase|Coordinator error|1|||
126788035|NCT01124149|456180436|FG000|Maintenance Phase|Non-compliance|1|||
126788036|NCT00977106|456180437|FG000|Overall Study|Adverse Event|5|||
126788037|NCT00977106|456180438|FG001|Overall Study|Adverse Event|6|||
126788038|NCT00977106|456180437|FG000|Overall Study|Withdrawal by Subject|2|||
126788039|NCT00977106|456180438|FG001|Overall Study|Withdrawal by Subject|2|||
126788040|NCT00977106|456180437|FG000|Overall Study|Lack of Efficacy|2|||
126788041|NCT00977106|456180438|FG001|Overall Study|Lack of Efficacy|2|||
126788042|NCT00977106|456180437|FG000|Overall Study|Protocol Violation|0|||
126788043|NCT00977106|456180438|FG001|Overall Study|Protocol Violation|1|||
126629571|NCT02154347|455602390|FG000|Open-label Period|Protocol Violation|0|||
126629572|NCT02154347|455602391|FG001|Open-label Period|Protocol Violation|1|||
126629573|NCT02154347|455602390|FG000|Open-label Period|Withdrawal by Subject|0|||
126629574|NCT02154347|455602391|FG001|Open-label Period|Withdrawal by Subject|1|||
126629575|NCT02473913|455602393|FG000|Overall Study|Lost to Follow-up|3|||
126629576|NCT02473913|455602394|FG001|Overall Study|Lost to Follow-up|3|||
126629577|NCT00605566|455603780|FG000|Overall Study|Adverse Event|1|||
126629578|NCT00605566|455603780|FG000|Overall Study|Clinical deterioration|1|||
126629579|NCT00605566|455603780|FG000|Overall Study|Poor compliance in run-in period|1|||
126629580|NCT04156399|455603781|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
126629581|NCT04156399|455603781|FG000|Overall Study|study suspension due to COVID pandemic|3|||
126629582|NCT03440047|455603782|FG000|Overall Study|Withdrawal by Subject|2|||
126629583|NCT01181609|455603783|FG000|Overall Study|Adverse Event|1|||
126629584|NCT01181609|455603783|FG000|Overall Study|Withdrawal by Subject|1|||
126629585|NCT01181609|455603783|FG000|Overall Study|Lost to Follow-up|1|||
126629586|NCT01181609|455603783|FG000|Overall Study|Death|50|||
126629587|NCT01333111|455603784|FG000|Overall Study|patient undergoing major surgery|0|||
126629588|NCT01333111|455603785|FG001|Overall Study|patient undergoing major surgery|2|||
126629589|NCT01333111|455603786|FG002|Overall Study|patient undergoing major surgery|0|||
126629590|NCT01333111|455603784|FG000|Overall Study|personal reasons|0|||
126629591|NCT01333111|455603785|FG001|Overall Study|personal reasons|0|||
126788044|NCT00977106|456180437|FG000|Overall Study|Other|1|||
126788045|NCT00977106|456180438|FG001|Overall Study|Other|0|||
126788046|NCT01644500|456180439|FG000|Overall Study|Adverse Event|6|||
126788047|NCT01644500|456180440|FG001|Overall Study|Adverse Event|1|||
126788048|NCT01644500|456180441|FG002|Overall Study|Adverse Event|2|||
126788049|NCT01644500|456180439|FG000|Overall Study|Death|0|||
126629592|NCT01333111|455603786|FG002|Overall Study|personal reasons|1|||
126629593|NCT01333111|455603784|FG000|Overall Study|unclassified|1|||
126788050|NCT01644500|456180440|FG001|Overall Study|Death|1|||
126788051|NCT01644500|456180441|FG002|Overall Study|Death|0|||
126788052|NCT01644500|456180439|FG000|Overall Study|Lost to Follow-up|3|||
126788053|NCT01644500|456180440|FG001|Overall Study|Lost to Follow-up|8|||
126788054|NCT01644500|456180441|FG002|Overall Study|Lost to Follow-up|0|||
126788055|NCT01644500|456180439|FG000|Overall Study|Protocol Violation|1|||
126788056|NCT01644500|456180440|FG001|Overall Study|Protocol Violation|1|||
126629594|NCT01333111|455603785|FG001|Overall Study|unclassified|0|||
126629595|NCT01333111|455603786|FG002|Overall Study|unclassified|0|||
126629596|NCT01333111|455603784|FG000|Overall Study|withdrawal criteria|0|||
126629597|NCT01333111|455603785|FG001|Overall Study|withdrawal criteria|1|||
126629598|NCT01333111|455603786|FG002|Overall Study|withdrawal criteria|0|||
126629599|NCT01333111|455603784|FG000|Overall Study|Non-compliance|1|||
126788057|NCT01644500|456180441|FG002|Overall Study|Protocol Violation|0|||
126788058|NCT01644500|456180439|FG000|Overall Study|Withdrawal by Subject|11|||
126788059|NCT01644500|456180440|FG001|Overall Study|Withdrawal by Subject|12|||
126629600|NCT01333111|455603785|FG001|Overall Study|Non-compliance|0|||
126629601|NCT01333111|455603786|FG002|Overall Study|Non-compliance|0|||
126629602|NCT01333111|455603784|FG000|Overall Study|Ineffective therapy|0|||
126629603|NCT01333111|455603785|FG001|Overall Study|Ineffective therapy|0|||
126629604|NCT01333111|455603786|FG002|Overall Study|Ineffective therapy|1|||
126629605|NCT04732871|455603787|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
126629606|NCT04732871|455603788|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
126629607|NCT04732871|455603789|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
126629608|NCT04732871|455603787|FG000|Overall Study|Lost to Follow-up|7|||
126629609|NCT04732871|455603788|FG001|Overall Study|Lost to Follow-up|4|||
126629610|NCT04732871|455603789|FG002|Overall Study|Lost to Follow-up|3|||
126629611|NCT04732871|455603787|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
126629612|NCT04732871|455603788|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
126629613|NCT04732871|455603789|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
126629614|NCT04732871|455603787|FG000|Overall Study|Migrated / moved from the study area|5|||
126629615|NCT04732871|455603788|FG001|Overall Study|Migrated / moved from the study area|0|||
126629616|NCT04732871|455603789|FG002|Overall Study|Migrated / moved from the study area|0|||
126629617|NCT04732871|455603787|FG000|Overall Study|Other|1|||
126629618|NCT04732871|455603788|FG001|Overall Study|Other|0|||
126629619|NCT04732871|455603789|FG002|Overall Study|Other|1|||
126629620|NCT04732871|455603787|FG000|Overall Study|Ongoing|6|||
126629621|NCT04732871|455603788|FG001|Overall Study|Ongoing|0|||
126629622|NCT04732871|455603789|FG002|Overall Study|Ongoing|1|||
126788060|NCT01644500|456180441|FG002|Overall Study|Withdrawal by Subject|12|||
126788061|NCT01644500|456180439|FG000|Overall Study|Physician Decision|1|||
126788062|NCT01644500|456180440|FG001|Overall Study|Physician Decision|1|||
126788063|NCT01644500|456180441|FG002|Overall Study|Physician Decision|1|||
126788064|NCT00721409|456180448|FG000|Overall Study|Global deterioration of health status|2|||
126788065|NCT00721409|456180449|FG001|Overall Study|Global deterioration of health status|6|||
126788066|NCT00721409|456180450|FG002|Overall Study|Global deterioration of health status|3|||
126788067|NCT00721409|456180448|FG000|Overall Study|Death|0|||
126788068|NCT00721409|456180449|FG001|Overall Study|Death|1|||
126788069|NCT00721409|456180450|FG002|Overall Study|Death|0|||
126629623|NCT04732871|455603787|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
126629624|NCT04732871|455603788|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
126629625|NCT04732871|455603789|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
126629626|NCT00478647|455603794|FG000|Overall Study|Adverse Event|1|||
126629627|NCT00478647|455603794|FG000|Overall Study|Withdrawal by Subject|1|||
126629628|NCT03596242|455603799|FG000|Overall Study|Lost to Follow-up|2|||
126629629|NCT03596242|455603800|FG001|Overall Study|Lost to Follow-up|2|||
126788070|NCT00721409|456180448|FG000|Overall Study|Randomized not Treated|0|||
126788071|NCT00721409|456180449|FG001|Overall Study|Randomized not Treated|1|||
126629630|NCT02509312|455603801|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
126629631|NCT02509312|455603802|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
126629632|NCT02509312|455603801|FG000|Overall Study|Obstetrician refusal|0|||
126629633|NCT02509312|455603802|FG001|Overall Study|Obstetrician refusal|1|||
126629634|NCT02509312|455603801|FG000|Overall Study|Patient elected for TOLAC|1|||
126629635|NCT02509312|455603802|FG001|Overall Study|Patient elected for TOLAC|0|||
126629636|NCT02509312|455603801|FG000|Overall Study|Cesarean deemed stat|1|||
126629637|NCT02509312|455603802|FG001|Overall Study|Cesarean deemed stat|0|||
126629638|NCT02509312|455603801|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
126629639|NCT02509312|455603802|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
126629640|NCT00702650|455603803|FG000|Overall Study|Withdrawal by Subject|9|||
126629641|NCT00702650|455603803|FG000|Overall Study|Non-Compliance of Study Drug|3|||
126629642|NCT00702650|455603803|FG000|Overall Study|Lost to Follow-up|2|||
126629643|NCT00702650|455603803|FG000|Overall Study|Non-Compliance with Site Directives|1|||
126629644|NCT00702650|455603803|FG000|Overall Study|Sponsor Request|1|||
126629645|NCT00702650|455603803|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
126788072|NCT00721409|456180450|FG002|Overall Study|Randomized not Treated|4|||
126629646|NCT00702650|455603803|FG000|Overall Study|Adverse Event|3|||
126629647|NCT01475461|455603814|FG000|Run-in Period|Not meet eligibility criteria|16|||
126629648|NCT01475461|455603815|FG001|Run-in Period|Not meet eligibility criteria|0|||
126629649|NCT01475461|455603816|FG002|Run-in Period|Not meet eligibility criteria|0|||
126629650|NCT01475461|455603817|FG003|Run-in Period|Not meet eligibility criteria|0|||
126629651|NCT01475461|455603818|FG004|Run-in Period|Not meet eligibility criteria|0|||
126629652|NCT01475461|455603819|FG005|Run-in Period|Not meet eligibility criteria|0|||
126629653|NCT01475461|455603820|FG006|Run-in Period|Not meet eligibility criteria|0|||
126629654|NCT01475461|455603814|FG000|Run-in Period|Lost to Follow-up|7|||
126788073|NCT00721409|456180448|FG000|Overall Study|Reason not specified|1|||
126788074|NCT00721409|456180449|FG001|Overall Study|Reason not specified|0|||
126788075|NCT00721409|456180450|FG002|Overall Study|Reason not specified|2|||
126788076|NCT00721409|456180448|FG000|Overall Study|Adverse Event|0|||
126629655|NCT01475461|455603815|FG001|Run-in Period|Lost to Follow-up|0|||
126629656|NCT01475461|455603816|FG002|Run-in Period|Lost to Follow-up|0|||
126629657|NCT01475461|455603817|FG003|Run-in Period|Lost to Follow-up|0|||
126629658|NCT01475461|455603818|FG004|Run-in Period|Lost to Follow-up|0|||
126629659|NCT01475461|455603819|FG005|Run-in Period|Lost to Follow-up|0|||
126629660|NCT01475461|455603820|FG006|Run-in Period|Lost to Follow-up|0|||
126629661|NCT01475461|455603814|FG000|Run-in Period|Withdrawal by Subject|11|||
126629662|NCT01475461|455603815|FG001|Run-in Period|Withdrawal by Subject|0|||
126629663|NCT01475461|455603816|FG002|Run-in Period|Withdrawal by Subject|0|||
126629664|NCT01475461|455603817|FG003|Run-in Period|Withdrawal by Subject|0|||
126629665|NCT01475461|455603818|FG004|Run-in Period|Withdrawal by Subject|0|||
126629666|NCT01475461|455603819|FG005|Run-in Period|Withdrawal by Subject|0|||
126629667|NCT01475461|455603820|FG006|Run-in Period|Withdrawal by Subject|0|||
126629668|NCT01475461|455603814|FG000|Run-in Period|Other|3|||
126629669|NCT01475461|455603815|FG001|Run-in Period|Other|0|||
126629670|NCT01475461|455603816|FG002|Run-in Period|Other|0|||
126629671|NCT01475461|455603817|FG003|Run-in Period|Other|0|||
126629672|NCT01475461|455603818|FG004|Run-in Period|Other|0|||
126629673|NCT01475461|455603819|FG005|Run-in Period|Other|0|||
126629674|NCT01475461|455603820|FG006|Run-in Period|Other|0|||
126629675|NCT01475461|455603814|FG000|Run-in Period|Protocol Violation|4|||
126629676|NCT01475461|455603815|FG001|Run-in Period|Protocol Violation|0|||
126629677|NCT01475461|455603816|FG002|Run-in Period|Protocol Violation|0|||
126629678|NCT01475461|455603817|FG003|Run-in Period|Protocol Violation|0|||
126629679|NCT01475461|455603818|FG004|Run-in Period|Protocol Violation|0|||
126629680|NCT01475461|455603819|FG005|Run-in Period|Protocol Violation|0|||
126629681|NCT01475461|455603820|FG006|Run-in Period|Protocol Violation|0|||
126629682|NCT01475461|455603814|FG000|Treatment Period|Death|0|||
126629683|NCT01475461|455603815|FG001|Treatment Period|Death|0|||
126629684|NCT01475461|455603816|FG002|Treatment Period|Death|0|||
126629685|NCT01475461|455603817|FG003|Treatment Period|Death|1|||
126629686|NCT01475461|455603818|FG004|Treatment Period|Death|0|||
126629687|NCT01475461|455603819|FG005|Treatment Period|Death|0|||
126629688|NCT01475461|455603820|FG006|Treatment Period|Death|0|||
126629689|NCT01475461|455603814|FG000|Treatment Period|Lost to Follow-up|0|||
126629690|NCT01475461|455603815|FG001|Treatment Period|Lost to Follow-up|3|||
126629691|NCT01475461|455603816|FG002|Treatment Period|Lost to Follow-up|2|||
126629692|NCT01475461|455603817|FG003|Treatment Period|Lost to Follow-up|3|||
126629693|NCT01475461|455603818|FG004|Treatment Period|Lost to Follow-up|1|||
126629694|NCT01475461|455603819|FG005|Treatment Period|Lost to Follow-up|2|||
126629695|NCT01475461|455603820|FG006|Treatment Period|Lost to Follow-up|1|||
126629696|NCT01475461|455603814|FG000|Treatment Period|Withdrawal by Subject|0|||
126629697|NCT01475461|455603815|FG001|Treatment Period|Withdrawal by Subject|2|||
126629698|NCT01475461|455603816|FG002|Treatment Period|Withdrawal by Subject|2|||
126629699|NCT01475461|455603817|FG003|Treatment Period|Withdrawal by Subject|0|||
126629700|NCT01475461|455603818|FG004|Treatment Period|Withdrawal by Subject|2|||
126629701|NCT01475461|455603819|FG005|Treatment Period|Withdrawal by Subject|2|||
126629702|NCT01475461|455603820|FG006|Treatment Period|Withdrawal by Subject|0|||
126629703|NCT01475461|455603814|FG000|Treatment Period|Other|0|||
126629704|NCT01475461|455603815|FG001|Treatment Period|Other|1|||
126629705|NCT01475461|455603816|FG002|Treatment Period|Other|0|||
126629706|NCT01475461|455603817|FG003|Treatment Period|Other|0|||
126629707|NCT01475461|455603818|FG004|Treatment Period|Other|0|||
126629708|NCT01475461|455603819|FG005|Treatment Period|Other|0|||
126629709|NCT01475461|455603820|FG006|Treatment Period|Other|0|||
126629710|NCT01475461|455603814|FG000|Treatment Period|Protocol Violation|0|||
126629711|NCT01475461|455603815|FG001|Treatment Period|Protocol Violation|1|||
126629712|NCT01475461|455603816|FG002|Treatment Period|Protocol Violation|0|||
126629713|NCT01475461|455603817|FG003|Treatment Period|Protocol Violation|0|||
126629714|NCT01475461|455603818|FG004|Treatment Period|Protocol Violation|0|||
126629715|NCT01475461|455603819|FG005|Treatment Period|Protocol Violation|0|||
126629716|NCT01475461|455603820|FG006|Treatment Period|Protocol Violation|1|||
126788077|NCT00721409|456180449|FG001|Overall Study|Adverse Event|13|||
126788078|NCT00721409|456180450|FG002|Overall Study|Adverse Event|2|||
126629717|NCT01475461|455603814|FG000|Treatment Period|Lack of Efficacy|0|||
126629718|NCT01475461|455603815|FG001|Treatment Period|Lack of Efficacy|2|||
126629719|NCT01475461|455603816|FG002|Treatment Period|Lack of Efficacy|0|||
126629720|NCT01475461|455603817|FG003|Treatment Period|Lack of Efficacy|2|||
126629721|NCT01475461|455603818|FG004|Treatment Period|Lack of Efficacy|1|||
126629722|NCT01475461|455603819|FG005|Treatment Period|Lack of Efficacy|1|||
126629723|NCT01475461|455603820|FG006|Treatment Period|Lack of Efficacy|0|||
126629724|NCT01475461|455603814|FG000|Treatment Period|Medication Error|0|||
126629725|NCT01475461|455603815|FG001|Treatment Period|Medication Error|0|||
126788079|NCT00721409|456180448|FG000|Overall Study|Lost to Follow-up|0|||
126629726|NCT01475461|455603816|FG002|Treatment Period|Medication Error|0|||
126629727|NCT01475461|455603817|FG003|Treatment Period|Medication Error|1|||
126629728|NCT01475461|455603818|FG004|Treatment Period|Medication Error|0|||
126629729|NCT01475461|455603819|FG005|Treatment Period|Medication Error|0|||
126629730|NCT01475461|455603820|FG006|Treatment Period|Medication Error|0|||
126629731|NCT01475461|455603814|FG000|Treatment Period|Adverse Event|0|||
126629732|NCT01475461|455603815|FG001|Treatment Period|Adverse Event|0|||
126629733|NCT01475461|455603816|FG002|Treatment Period|Adverse Event|0|||
126629734|NCT01475461|455603817|FG003|Treatment Period|Adverse Event|1|||
126629735|NCT01475461|455603818|FG004|Treatment Period|Adverse Event|0|||
126629736|NCT01475461|455603819|FG005|Treatment Period|Adverse Event|0|||
126629737|NCT01475461|455603820|FG006|Treatment Period|Adverse Event|0|||
126629738|NCT02512861|455603823|FG000|Overall Study|Protocol Violation|3|||
126629739|NCT02512861|455603824|FG001|Overall Study|Protocol Violation|7|||
126629740|NCT02512861|455603823|FG000|Overall Study|Physician Decision|3|||
126629741|NCT02512861|455603824|FG001|Overall Study|Physician Decision|1|||
126629742|NCT02512861|455603823|FG000|Overall Study|Withdrawal by Subject|0|||
126629743|NCT02512861|455603824|FG001|Overall Study|Withdrawal by Subject|1|||
126629744|NCT03214250|455603827|FG000|Overall Study|Death|5|||
126629745|NCT03214250|455603828|FG001|Overall Study|Death|5|||
126629746|NCT03214250|455603829|FG002|Overall Study|Death|7|||
126629747|NCT03214250|455603830|FG003|Overall Study|Death|4|||
126629748|NCT03214250|455603831|FG004|Overall Study|Death|23|||
126629749|NCT03214250|455603832|FG005|Overall Study|Death|23|||
126629750|NCT03214250|455603833|FG006|Overall Study|Death|24|||
126629751|NCT03214250|455603827|FG000|Overall Study|Lost to Follow-up|0|||
126629752|NCT03214250|455603828|FG001|Overall Study|Lost to Follow-up|0|||
126629753|NCT03214250|455603829|FG002|Overall Study|Lost to Follow-up|0|||
126629754|NCT03214250|455603830|FG003|Overall Study|Lost to Follow-up|1|||
126629755|NCT03214250|455603831|FG004|Overall Study|Lost to Follow-up|1|||
126629756|NCT03214250|455603832|FG005|Overall Study|Lost to Follow-up|2|||
126629757|NCT03214250|455603833|FG006|Overall Study|Lost to Follow-up|0|||
126629758|NCT03214250|455603827|FG000|Overall Study|Other|0|||
126629759|NCT03214250|455603828|FG001|Overall Study|Other|0|||
126629760|NCT03214250|455603829|FG002|Overall Study|Other|0|||
126629761|NCT03214250|455603830|FG003|Overall Study|Other|0|||
126629762|NCT03214250|455603831|FG004|Overall Study|Other|1|||
126629763|NCT03214250|455603832|FG005|Overall Study|Other|1|||
126629764|NCT03214250|455603833|FG006|Overall Study|Other|2|||
126629765|NCT03214250|455603827|FG000|Overall Study|Remains on Study|2|||
126629766|NCT03214250|455603828|FG001|Overall Study|Remains on Study|2|||
126629767|NCT03214250|455603829|FG002|Overall Study|Remains on Study|0|||
126629768|NCT03214250|455603830|FG003|Overall Study|Remains on Study|1|||
126629769|NCT03214250|455603831|FG004|Overall Study|Remains on Study|7|||
126629770|NCT03214250|455603832|FG005|Overall Study|Remains on Study|5|||
126629771|NCT03214250|455603833|FG006|Overall Study|Remains on Study|3|||
126629772|NCT03214250|455603827|FG000|Overall Study|Withdrawal by Subject|0|||
126629773|NCT03214250|455603828|FG001|Overall Study|Withdrawal by Subject|0|||
126629774|NCT03214250|455603829|FG002|Overall Study|Withdrawal by Subject|1|||
126629775|NCT03214250|455603830|FG003|Overall Study|Withdrawal by Subject|2|||
126629776|NCT03214250|455603831|FG004|Overall Study|Withdrawal by Subject|5|||
126629777|NCT03214250|455603832|FG005|Overall Study|Withdrawal by Subject|0|||
126629778|NCT03214250|455603833|FG006|Overall Study|Withdrawal by Subject|2|||
126629779|NCT00292981|455603837|FG000|Overall Study|Adverse Event|1|||
126629780|NCT00292981|455603837|FG000|Overall Study|Lost to Follow-up|13|||
126629781|NCT00292981|455603837|FG000|Overall Study|Withdrawal by Subject|22|||
126629782|NCT00292981|455603837|FG000|Overall Study|Other|3|||
126629783|NCT00594178|455603838|FG000|Overall Study|Physician Decision|5|||
126629784|NCT00496626|455603839|FG000|Overall Study|Lost to Follow-up|0|||
126629785|NCT00496626|455603840|FG001|Overall Study|Lost to Follow-up|1|||
126629786|NCT00496626|455603839|FG000|Overall Study|Protocol Violation|1|||
126629787|NCT00496626|455603840|FG001|Overall Study|Protocol Violation|0|||
126629788|NCT00496626|455603839|FG000|Overall Study|Withdrawal by Subject|5|||
126629789|NCT00496626|455603840|FG001|Overall Study|Withdrawal by Subject|4|||
126629790|NCT00496626|455603839|FG000|Overall Study|Relocated|0|||
126629791|NCT00496626|455603840|FG001|Overall Study|Relocated|1|||
126629792|NCT00727415|455603841|FG000|Phase I|Dose Limiting Toxicity|2|||
126629793|NCT00827775|455603845|FG000|Overall Study|Withdrawal by Subject|0|||
126629794|NCT00827775|455603846|FG001|Overall Study|Withdrawal by Subject|5|||
126788080|NCT00721409|456180449|FG001|Overall Study|Lost to Follow-up|0|||
126788081|NCT00721409|456180450|FG002|Overall Study|Lost to Follow-up|1|||
126629795|NCT00545571|455603851|FG000|Overall Study|Administrative Reasons|1|||
126629796|NCT00545571|455603851|FG000|Overall Study|Adverse Event|2|||
126629797|NCT00545571|455603851|FG000|Overall Study|Death|5|||
126629798|NCT00545571|455603851|FG000|Overall Study|Lack of Efficacy|1|||
126629799|NCT00545571|455603851|FG000|Overall Study|Protocol Violation|2|||
126629800|NCT00545571|455603851|FG000|Overall Study|Refused Treatment|1|||
126629801|NCT00545571|455603851|FG000|Overall Study|Screen Failure|16|||
126629802|NCT00545571|455603851|FG000|Overall Study|Transfusion|12|||
126629803|NCT00545571|455603851|FG000|Overall Study|Early Termination of Study|24|||
126629804|NCT00545571|455603851|FG000|Overall Study|Kidney Transplantation|3|||
126629805|NCT01013740|455603852|FG000|Overall Study|Lost to Follow-up|3|||
126629806|NCT01013740|455603853|FG001|Overall Study|Lost to Follow-up|5|||
126629807|NCT01013740|455603852|FG000|Overall Study|Physician Decision|2|||
126629808|NCT01013740|455603853|FG001|Overall Study|Physician Decision|0|||
126629809|NCT01013740|455603852|FG000|Overall Study|Withdrawal by Subject|2|||
126629810|NCT01013740|455603853|FG001|Overall Study|Withdrawal by Subject|10|||
126629811|NCT01013740|455603852|FG000|Overall Study|study close / terminated : done in error|2|||
126629812|NCT01013740|455603853|FG001|Overall Study|study close / terminated : done in error|1|||
126629813|NCT01013740|455603852|FG000|Overall Study|Missing|2|||
126629814|NCT01013740|455603853|FG001|Overall Study|Missing|1|||
126629815|NCT01013740|455603852|FG000|Overall Study|Ongoing: Study records not completed|0|||
126629816|NCT01013740|455603853|FG001|Overall Study|Ongoing: Study records not completed|2|||
126629817|NCT00338949|455603854|FG000|Subject Screening|Screen failures|11|||
126629818|NCT00338949|455603855|FG001|Subject Screening|Screen failures|11|||
126629819|NCT00338949|455603854|FG000|Randomization|Withdrawal by Subject|1|||
126629820|NCT00338949|455603855|FG001|Randomization|Withdrawal by Subject|0|||
126629821|NCT00338949|455603854|FG000|Randomization|Adverse Event|0|||
126629822|NCT00338949|455603855|FG001|Randomization|Adverse Event|5|||
126629823|NCT01242371|455603856|FG000|Overall Study|Withdrawal by Subject|2|||
126629824|NCT01242371|455603857|FG001|Overall Study|Withdrawal by Subject|2|||
126629825|NCT01242371|455603856|FG000|Overall Study|Protocol Violation|0|||
126629826|NCT01242371|455603857|FG001|Overall Study|Protocol Violation|3|||
126629827|NCT00025662|455603858|FG000|Overall Study|Withdrawal by Subject|2|||
126629828|NCT00025662|455603858|FG000|Overall Study|Technical failure of manipulation|1|||
126629829|NCT00582114|455603859|FG000|Overall Study|Death|4|||
126629830|NCT00582114|455603860|FG001|Overall Study|Death|4|||
126629831|NCT00582114|455603859|FG000|Overall Study|Kidney Transplant|3|||
126629832|NCT00582114|455603860|FG001|Overall Study|Kidney Transplant|1|||
126629833|NCT00582114|455603859|FG000|Overall Study|Lost to Follow-up|7|||
126629834|NCT00582114|455603860|FG001|Overall Study|Lost to Follow-up|6|||
126629835|NCT00582114|455603859|FG000|Overall Study|Withdrawal by Subject|8|||
126629836|NCT00582114|455603860|FG001|Overall Study|Withdrawal by Subject|16|||
126629837|NCT00582114|455603859|FG000|Overall Study|Adverse Event|1|||
126629838|NCT00582114|455603860|FG001|Overall Study|Adverse Event|1|||
126629839|NCT00582114|455603859|FG000|Overall Study|Physician Decision|0|||
126629840|NCT00582114|455603860|FG001|Overall Study|Physician Decision|6|||
126629841|NCT00582114|455603859|FG000|Overall Study|Stopped by data safety monitoring board|19|||
126629842|NCT00582114|455603860|FG001|Overall Study|Stopped by data safety monitoring board|20|||
126629843|NCT02604342|455603861|FG000|Overall Study|Death|32|||
126629844|NCT02604342|455603862|FG001|Overall Study|Death|16|||
126629845|NCT02604342|455603861|FG000|Overall Study|Progression of disease|1|||
126629846|NCT02604342|455603862|FG001|Overall Study|Progression of disease|0|||
126629847|NCT02604342|455603861|FG000|Overall Study|Withdrawal by Subject|5|||
126629848|NCT02604342|455603862|FG001|Overall Study|Withdrawal by Subject|6|||
126629849|NCT02604342|455603861|FG000|Overall Study|Other|1|||
126629850|NCT02604342|455603862|FG001|Overall Study|Other|0|||
126629851|NCT02604342|455603861|FG000|Overall Study|Study Termination by Sponsor|1|||
126629852|NCT02604342|455603862|FG001|Overall Study|Study Termination by Sponsor|0|||
126629853|NCT02604342|455603861|FG000|Overall Study|Lost to Follow-up|1|||
126629854|NCT02604342|455603862|FG001|Overall Study|Lost to Follow-up|1|||
126629855|NCT02604342|455603861|FG000|Overall Study|Physician Decision|2|||
126629856|NCT02604342|455603862|FG001|Overall Study|Physician Decision|0|||
126629857|NCT02024750|455603863|FG000|Overall Study|Withdrawal by Subject|2|||
126629858|NCT02024750|455603864|FG001|Overall Study|Withdrawal by Subject|1|||
126629859|NCT00130728|455603865|FG000|Overall Study|Death|258|||
126629860|NCT00130728|455603866|FG001|Overall Study|Death|258|||
126629861|NCT00130728|455603865|FG000|Overall Study|Lost to Follow-up|4|||
126629862|NCT00130728|455603866|FG001|Overall Study|Lost to Follow-up|0|||
126629863|NCT00130728|455603865|FG000|Overall Study|Withdrawal by Subject|0|||
126629864|NCT00130728|455603866|FG001|Overall Study|Withdrawal by Subject|2|||
126629865|NCT01349036|455603867|FG000|Overall Study|Disease progression|13|||
126629866|NCT01349036|455603868|FG001|Overall Study|Disease progression|22|||
126629867|NCT01349036|455603867|FG000|Overall Study|Other|1|||
126629868|NCT01349036|455603868|FG001|Overall Study|Other|0|||
126629869|NCT01349036|455603867|FG000|Overall Study|Withdrawal by Subject|0|||
126629870|NCT01349036|455603868|FG001|Overall Study|Withdrawal by Subject|2|||
126629871|NCT00746356|455603869|FG000|Overall Study|Withdrawal by Subject|2|||
126629872|NCT00746356|455603870|FG001|Overall Study|Withdrawal by Subject|3|||
126629873|NCT00746356|455603869|FG000|Overall Study|Death|7|||
126629874|NCT00746356|455603870|FG001|Overall Study|Death|3|||
126629875|NCT00746356|455603869|FG000|Overall Study|Lost to Follow-up|1|||
126629876|NCT00746356|455603870|FG001|Overall Study|Lost to Follow-up|0|||
126629877|NCT00746356|455603869|FG000|Overall Study|Removal of Device|0|||
126629878|NCT00746356|455603870|FG001|Overall Study|Removal of Device|1|||
126629879|NCT00746356|455603869|FG000|Overall Study|Patient relocated|1|||
126629880|NCT00746356|455603870|FG001|Overall Study|Patient relocated|0|||
126629881|NCT01125566|455603875|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
126629882|NCT01125566|455603876|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
126629883|NCT01125566|455603877|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
126629884|NCT01125566|455603875|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
126629885|NCT01125566|455603876|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
126629886|NCT01125566|455603877|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
126629887|NCT01125566|455603875|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
126629888|NCT01125566|455603876|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
126629889|NCT01125566|455603877|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
126629890|NCT01125566|455603875|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
126629891|NCT01125566|455603876|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
126629892|NCT01125566|455603877|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
126629893|NCT01125566|455603875|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
126629894|NCT01125566|455603876|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
126629895|NCT01125566|455603877|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
126629896|NCT01125566|455603875|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
126629897|NCT01125566|455603876|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
126629898|NCT01125566|455603877|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
126629899|NCT01125566|455603875|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
126629900|NCT01125566|455603876|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
126629901|NCT01125566|455603877|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
126629902|NCT01125566|455603875|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
126629903|NCT01125566|455603876|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
126629904|NCT01125566|455603877|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
126629905|NCT01125566|455603875|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
126629906|NCT01125566|455603876|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
126629907|NCT01125566|455603877|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
126629908|NCT01125566|455603875|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
126629909|NCT01125566|455603876|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
126629910|NCT01125566|455603877|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
126629911|NCT01125566|455603875|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
126629912|NCT01125566|455603876|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
126629913|NCT01125566|455603877|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
126629914|NCT01125566|455603875|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
126629915|NCT01125566|455603876|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
126629916|NCT01125566|455603877|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
126629917|NCT02881047|455603878|FG000|Overall Study|Adverse Event|1|||
126629918|NCT02881047|455603878|FG000|Overall Study|Withdrawal by Subject|1|||
126629919|NCT03028012|455603879|FG000|Overall Study|Lost to Follow-up|2|||
126629920|NCT03028012|455603880|FG001|Overall Study|Lost to Follow-up|3|||
126629921|NCT03028012|455603881|FG002|Overall Study|Lost to Follow-up|3|||
126629922|NCT02484547|455603890|FG000|Placebo-Controlled Period|Adverse Event|10|||
126629923|NCT02484547|455603891|FG001|Placebo-Controlled Period|Adverse Event|13|||
126629924|NCT02484547|455603892|FG002|Placebo-Controlled Period|Adverse Event|20|||
126629925|NCT02484547|455603893|FG003|Placebo-Controlled Period|Adverse Event|0|||
126629926|NCT02484547|455603894|FG004|Placebo-Controlled Period|Adverse Event|0|||
126629927|NCT02484547|455603895|FG005|Placebo-Controlled Period|Adverse Event|0|||
126629928|NCT02484547|455603896|FG006|Placebo-Controlled Period|Adverse Event|0|||
126629929|NCT02484547|455603890|FG000|Placebo-Controlled Period|Change of Treatment|0|||
126629930|NCT02484547|455603891|FG001|Placebo-Controlled Period|Change of Treatment|0|||
126629931|NCT02484547|455603892|FG002|Placebo-Controlled Period|Change of Treatment|1|||
126629932|NCT02484547|455603893|FG003|Placebo-Controlled Period|Change of Treatment|0|||
126629933|NCT02484547|455603894|FG004|Placebo-Controlled Period|Change of Treatment|0|||
126629934|NCT02484547|455603895|FG005|Placebo-Controlled Period|Change of Treatment|0|||
126629935|NCT02484547|455603896|FG006|Placebo-Controlled Period|Change of Treatment|0|||
126629936|NCT02484547|455603890|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
126629937|NCT02484547|455603891|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
126629938|NCT02484547|455603892|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
126629939|NCT02484547|455603893|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
126629940|NCT02484547|455603894|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
126629941|NCT02484547|455603895|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
126629942|NCT02484547|455603896|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
126629943|NCT02484547|455603890|FG000|Placebo-Controlled Period|Death|5|||
126629944|NCT02484547|455603891|FG001|Placebo-Controlled Period|Death|0|||
126629945|NCT02484547|455603892|FG002|Placebo-Controlled Period|Death|6|||
126788082|NCT00721409|456180448|FG000|Overall Study|Withdrawal by Subject|1|||
126788083|NCT00721409|456180449|FG001|Overall Study|Withdrawal by Subject|6|||
126788084|NCT00721409|456180450|FG002|Overall Study|Withdrawal by Subject|5|||
126788085|NCT00721409|456180448|FG000|Overall Study|Objective progression or relapse|8|||
126629946|NCT02484547|455603893|FG003|Placebo-Controlled Period|Death|0|||
126629947|NCT02484547|455603894|FG004|Placebo-Controlled Period|Death|0|||
126629948|NCT02484547|455603895|FG005|Placebo-Controlled Period|Death|0|||
126629949|NCT02484547|455603896|FG006|Placebo-Controlled Period|Death|0|||
126629950|NCT02484547|455603890|FG000|Placebo-Controlled Period|Disease Progression|2|||
126788086|NCT00721409|456180449|FG001|Overall Study|Objective progression or relapse|55|||
126788087|NCT00721409|456180450|FG002|Overall Study|Objective progression or relapse|62|||
126629951|NCT02484547|455603891|FG001|Placebo-Controlled Period|Disease Progression|0|||
126629952|NCT02484547|455603892|FG002|Placebo-Controlled Period|Disease Progression|1|||
126629953|NCT02484547|455603893|FG003|Placebo-Controlled Period|Disease Progression|0|||
126629954|NCT02484547|455603894|FG004|Placebo-Controlled Period|Disease Progression|0|||
126629955|NCT02484547|455603895|FG005|Placebo-Controlled Period|Disease Progression|0|||
126629956|NCT02484547|455603896|FG006|Placebo-Controlled Period|Disease Progression|0|||
126629957|NCT02484547|455603890|FG000|Placebo-Controlled Period|Investigator Decision|2|||
126629958|NCT02484547|455603891|FG001|Placebo-Controlled Period|Investigator Decision|2|||
126629959|NCT02484547|455603892|FG002|Placebo-Controlled Period|Investigator Decision|5|||
126629960|NCT02484547|455603893|FG003|Placebo-Controlled Period|Investigator Decision|0|||
126629961|NCT02484547|455603894|FG004|Placebo-Controlled Period|Investigator Decision|0|||
126629962|NCT02484547|455603895|FG005|Placebo-Controlled Period|Investigator Decision|0|||
126629963|NCT02484547|455603896|FG006|Placebo-Controlled Period|Investigator Decision|0|||
126629964|NCT02484547|455603890|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
126629965|NCT02484547|455603891|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
126629966|NCT02484547|455603892|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
126629967|NCT02484547|455603893|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
126629968|NCT02484547|455603894|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
126629969|NCT02484547|455603895|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
126629970|NCT02484547|455603896|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
126629971|NCT02484547|455603890|FG000|Placebo-Controlled Period|Relocation|1|||
126629972|NCT02484547|455603891|FG001|Placebo-Controlled Period|Relocation|1|||
126629973|NCT02484547|455603892|FG002|Placebo-Controlled Period|Relocation|1|||
126629974|NCT02484547|455603893|FG003|Placebo-Controlled Period|Relocation|0|||
126629975|NCT02484547|455603894|FG004|Placebo-Controlled Period|Relocation|0|||
126629976|NCT02484547|455603895|FG005|Placebo-Controlled Period|Relocation|0|||
126629977|NCT02484547|455603896|FG006|Placebo-Controlled Period|Relocation|0|||
126629978|NCT02484547|455603890|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
126629979|NCT02484547|455603891|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
126629980|NCT02484547|455603892|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
126629981|NCT02484547|455603893|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
126629982|NCT02484547|455603894|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
126629983|NCT02484547|455603895|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
126629984|NCT02484547|455603896|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
126629985|NCT02484547|455603890|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
126629986|NCT02484547|455603891|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
126629987|NCT02484547|455603892|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
126629988|NCT02484547|455603893|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126629989|NCT02484547|455603894|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126629990|NCT02484547|455603895|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126629991|NCT02484547|455603896|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
126629992|NCT02484547|455603890|FG000|Placebo-Controlled Period|Reason not Specified|216|||
126629993|NCT02484547|455603891|FG001|Placebo-Controlled Period|Reason not Specified|194|||
126629994|NCT02484547|455603892|FG002|Placebo-Controlled Period|Reason not Specified|183|||
126629995|NCT02484547|455603893|FG003|Placebo-Controlled Period|Reason not Specified|0|||
126629996|NCT02484547|455603894|FG004|Placebo-Controlled Period|Reason not Specified|0|||
126629997|NCT02484547|455603895|FG005|Placebo-Controlled Period|Reason not Specified|0|||
126629998|NCT02484547|455603896|FG006|Placebo-Controlled Period|Reason not Specified|0|||
126629999|NCT02484547|455603890|FG000|Long-Term Extension Period|Adverse Event|0|||
126630000|NCT02484547|455603891|FG001|Long-Term Extension Period|Adverse Event|0|||
126630001|NCT02484547|455603892|FG002|Long-Term Extension Period|Adverse Event|0|||
126630002|NCT02484547|455603893|FG003|Long-Term Extension Period|Adverse Event|0|||
126630003|NCT02484547|455603894|FG004|Long-Term Extension Period|Adverse Event|1|||
126788088|NCT00322491|456180452|FG000|Overall Study|Adverse Event|1|||
126788089|NCT00322491|456180453|FG001|Overall Study|Adverse Event|0|||
126788090|NCT00322491|456180452|FG000|Overall Study|Death|1|||
126630004|NCT02484547|455603895|FG005|Long-Term Extension Period|Adverse Event|3|||
126630005|NCT02484547|455603896|FG006|Long-Term Extension Period|Adverse Event|2|||
126630006|NCT02484547|455603890|FG000|Long-Term Extension Period|Death|0|||
126630007|NCT02484547|455603891|FG001|Long-Term Extension Period|Death|0|||
126630008|NCT02484547|455603892|FG002|Long-Term Extension Period|Death|0|||
126630009|NCT02484547|455603893|FG003|Long-Term Extension Period|Death|0|||
126630010|NCT02484547|455603894|FG004|Long-Term Extension Period|Death|0|||
126630011|NCT02484547|455603895|FG005|Long-Term Extension Period|Death|3|||
126630012|NCT02484547|455603896|FG006|Long-Term Extension Period|Death|0|||
126630013|NCT02484547|455603890|FG000|Long-Term Extension Period|Disease Progression|0|||
126630014|NCT02484547|455603891|FG001|Long-Term Extension Period|Disease Progression|0|||
126630015|NCT02484547|455603892|FG002|Long-Term Extension Period|Disease Progression|0|||
126788091|NCT00322491|456180453|FG001|Overall Study|Death|2|||
126630016|NCT02484547|455603893|FG003|Long-Term Extension Period|Disease Progression|0|||
126630017|NCT02484547|455603894|FG004|Long-Term Extension Period|Disease Progression|2|||
126630018|NCT02484547|455603895|FG005|Long-Term Extension Period|Disease Progression|4|||
126788092|NCT01400425|456180454|FG000|Overall Study|Withdrawal by Subject|10|||
126788093|NCT00048048|456180455|FG000|Core Treatment|Withdrawal by Subject|0|||
126788094|NCT00048048|456180456|FG001|Core Treatment|Withdrawal by Subject|0|||
126788095|NCT00048048|456180457|FG002|Core Treatment|Withdrawal by Subject|1|||
126788096|NCT00048048|456180458|FG003|Core Treatment|Withdrawal by Subject|0|||
126788097|NCT00048048|456180459|FG004|Core Treatment|Withdrawal by Subject|0|||
126788098|NCT00048048|456180460|FG005|Core Treatment|Withdrawal by Subject|0|||
126788099|NCT00048048|456180461|FG006|Core Treatment|Withdrawal by Subject|0|||
126788100|NCT00048048|456180462|FG007|Core Treatment|Withdrawal by Subject|0|||
126788101|NCT00048048|456180463|FG008|Core Treatment|Withdrawal by Subject|0|||
126788102|NCT00048048|456180464|FG009|Core Treatment|Withdrawal by Subject|0|||
126788103|NCT00048048|456180465|FG010|Core Treatment|Withdrawal by Subject|0|||
126788104|NCT00048048|456180466|FG011|Core Treatment|Withdrawal by Subject|0|||
126788105|NCT00048048|456180455|FG000|Core Treatment|Adverse Event|0|||
126788106|NCT00048048|456180456|FG001|Core Treatment|Adverse Event|0|||
126788107|NCT00048048|456180457|FG002|Core Treatment|Adverse Event|0|||
126788108|NCT00048048|456180458|FG003|Core Treatment|Adverse Event|0|||
126630019|NCT02484547|455603896|FG006|Long-Term Extension Period|Disease Progression|0|||
126630020|NCT02484547|455603890|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
126630021|NCT02484547|455603891|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
126630022|NCT02484547|455603892|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
126630023|NCT02484547|455603893|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
126630024|NCT02484547|455603894|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
126630025|NCT02484547|455603895|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
126630026|NCT02484547|455603896|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
126630027|NCT02484547|455603890|FG000|Long-Term Extension Period|Loss of Capacity|0|||
126630028|NCT02484547|455603891|FG001|Long-Term Extension Period|Loss of Capacity|0|||
126630029|NCT02484547|455603892|FG002|Long-Term Extension Period|Loss of Capacity|0|||
126630030|NCT02484547|455603893|FG003|Long-Term Extension Period|Loss of Capacity|0|||
126630031|NCT02484547|455603894|FG004|Long-Term Extension Period|Loss of Capacity|1|||
126630032|NCT02484547|455603895|FG005|Long-Term Extension Period|Loss of Capacity|0|||
126630033|NCT02484547|455603896|FG006|Long-Term Extension Period|Loss of Capacity|0|||
126630034|NCT02484547|455603890|FG000|Long-Term Extension Period|Change of Treatment|0|||
126630035|NCT02484547|455603891|FG001|Long-Term Extension Period|Change of Treatment|0|||
126630036|NCT02484547|455603892|FG002|Long-Term Extension Period|Change of Treatment|0|||
126630037|NCT02484547|455603893|FG003|Long-Term Extension Period|Change of Treatment|0|||
126630038|NCT02484547|455603894|FG004|Long-Term Extension Period|Change of Treatment|0|||
126630039|NCT02484547|455603895|FG005|Long-Term Extension Period|Change of Treatment|0|||
126630040|NCT02484547|455603896|FG006|Long-Term Extension Period|Change of Treatment|1|||
126630041|NCT02484547|455603890|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
126630042|NCT02484547|455603891|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
126630043|NCT02484547|455603892|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
126630044|NCT02484547|455603893|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
126630045|NCT02484547|455603894|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
126630046|NCT02484547|455603895|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
126630047|NCT02484547|455603896|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
126630048|NCT02484547|455603890|FG000|Long-Term Extension Period|Investigator Decision|0|||
126630049|NCT02484547|455603891|FG001|Long-Term Extension Period|Investigator Decision|0|||
126630050|NCT02484547|455603892|FG002|Long-Term Extension Period|Investigator Decision|0|||
126630051|NCT02484547|455603893|FG003|Long-Term Extension Period|Investigator Decision|2|||
126630052|NCT02484547|455603894|FG004|Long-Term Extension Period|Investigator Decision|1|||
126630053|NCT02484547|455603895|FG005|Long-Term Extension Period|Investigator Decision|0|||
126630054|NCT02484547|455603896|FG006|Long-Term Extension Period|Investigator Decision|1|||
126630055|NCT02484547|455603890|FG000|Long-Term Extension Period|Relocation|0|||
126630056|NCT02484547|455603891|FG001|Long-Term Extension Period|Relocation|0|||
126630057|NCT02484547|455603892|FG002|Long-Term Extension Period|Relocation|0|||
126630058|NCT02484547|455603893|FG003|Long-Term Extension Period|Relocation|1|||
126630059|NCT02484547|455603894|FG004|Long-Term Extension Period|Relocation|1|||
126630060|NCT02484547|455603895|FG005|Long-Term Extension Period|Relocation|0|||
126630061|NCT02484547|455603896|FG006|Long-Term Extension Period|Relocation|0|||
126630062|NCT02484547|455603890|FG000|Long-Term Extension Period|Study Visit Burden|0|||
126630063|NCT02484547|455603891|FG001|Long-Term Extension Period|Study Visit Burden|0|||
126630064|NCT02484547|455603892|FG002|Long-Term Extension Period|Study Visit Burden|0|||
126630065|NCT02484547|455603893|FG003|Long-Term Extension Period|Study Visit Burden|2|||
126788109|NCT00048048|456180459|FG004|Core Treatment|Adverse Event|0|||
126630066|NCT02484547|455603894|FG004|Long-Term Extension Period|Study Visit Burden|0|||
126630067|NCT02484547|455603895|FG005|Long-Term Extension Period|Study Visit Burden|0|||
126630068|NCT02484547|455603896|FG006|Long-Term Extension Period|Study Visit Burden|3|||
126630069|NCT02484547|455603890|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
126630070|NCT02484547|455603891|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
126630071|NCT02484547|455603892|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
126630072|NCT02484547|455603893|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
126630073|NCT02484547|455603894|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
126630074|NCT02484547|455603895|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
126630075|NCT02484547|455603896|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
126630076|NCT02484547|455603890|FG000|Long-Term Extension Period|Reason not Specified|0|||
126630077|NCT02484547|455603891|FG001|Long-Term Extension Period|Reason not Specified|0|||
126630078|NCT02484547|455603892|FG002|Long-Term Extension Period|Reason not Specified|0|||
126630079|NCT02484547|455603893|FG003|Long-Term Extension Period|Reason not Specified|119|||
126630080|NCT02484547|455603894|FG004|Long-Term Extension Period|Reason not Specified|117|||
126630081|NCT02484547|455603895|FG005|Long-Term Extension Period|Reason not Specified|223|||
126630082|NCT02484547|455603896|FG006|Long-Term Extension Period|Reason not Specified|231|||
126630083|NCT01813305|455603897|FG000|Overall Study|Withdrawal by Subject|12|||
126630084|NCT01813305|455603898|FG001|Overall Study|Withdrawal by Subject|5|||
126630085|NCT01813305|455603897|FG000|Overall Study|Safety Concern|4|||
126630086|NCT01813305|455603898|FG001|Overall Study|Safety Concern|0|||
126630087|NCT01813305|455603897|FG000|Overall Study|Ulcer became worse|4|||
126630088|NCT01813305|455603898|FG001|Overall Study|Ulcer became worse|0|||
126630089|NCT01813305|455603897|FG000|Overall Study|Physician Decision|4|||
126630090|NCT01813305|455603898|FG001|Overall Study|Physician Decision|0|||
126630091|NCT01813305|455603897|FG000|Overall Study|Lost to Follow-up|3|||
126630092|NCT01813305|455603898|FG001|Overall Study|Lost to Follow-up|1|||
126630093|NCT01813305|455603897|FG000|Overall Study|Protocol Violation|1|||
126630094|NCT01813305|455603898|FG001|Overall Study|Protocol Violation|0|||
126630095|NCT01813305|455603897|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
126630096|NCT01813305|455603898|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
126630097|NCT01665599|455603902|FG000|Overall Study|Adverse Event|1|||
126630098|NCT01665599|455603902|FG000|Overall Study|Consent Withdrawn|1|||
126630099|NCT01665599|455603902|FG000|Overall Study|Investigator/Sponsor decision|1|||
126630100|NCT01665599|455603902|FG000|Overall Study|Death|1|||
126630101|NCT01665599|455603902|FG000|Overall Study|Lost to Follow-up|2|||
126630102|NCT01665599|455603902|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
126630103|NCT01665599|455603902|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
126630104|NCT01705145|455603903|FG000|Part B|Adverse Event|1|||
126630105|NCT01503164|455603910|FG000|Overall Study|Withdrawal by Subject|2|||
126630106|NCT01503164|455603911|FG001|Overall Study|Withdrawal by Subject|1|||
126630107|NCT00934700|455603912|FG000|Overall Study|missing scan|5|||
126630108|NCT00934700|455603913|FG001|Overall Study|missing scan|9|||
126630109|NCT00934700|455603912|FG000|Overall Study|Death|8|||
126630110|NCT00934700|455603913|FG001|Overall Study|Death|3|||
126630111|NCT03049306|455603916|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
126630112|NCT03049306|455603917|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
126630113|NCT03151551|455603918|FG000|Open-Label Treatment Period|Adverse Event|0|||
126630114|NCT03151551|455603919|FG001|Open-Label Treatment Period|Adverse Event|2|||
126630115|NCT03151551|455603918|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
126630116|NCT03151551|455603919|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
126630117|NCT03151551|455603918|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
126630118|NCT03151551|455603919|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
126630119|NCT03151551|455603918|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
126630120|NCT03151551|455603919|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
126630121|NCT03151551|455603918|FG000|Open-Label Treatment Period|Physician Decision|3|||
126630122|NCT03151551|455603919|FG001|Open-Label Treatment Period|Physician Decision|0|||
126630123|NCT03151551|455603918|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
126630124|NCT03151551|455603919|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
126630125|NCT03151551|455603918|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
126630126|NCT03151551|455603919|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
126630127|NCT03151551|455603918|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
126788110|NCT00048048|456180460|FG005|Core Treatment|Adverse Event|0|||
126788111|NCT00048048|456180461|FG006|Core Treatment|Adverse Event|0|||
126630128|NCT03151551|455603919|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
126630129|NCT03151551|455603918|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
126630130|NCT03151551|455603919|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
126630131|NCT03151551|455603918|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
126630132|NCT03151551|455603919|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
126630133|NCT03282799|455603926|FG000|Overall Study|Pregnancy|1|||
126630134|NCT03282799|455603927|FG001|Overall Study|Pregnancy|0|||
126630135|NCT03282799|455603926|FG000|Overall Study|Physician Decision|1|||
126630136|NCT03282799|455603927|FG001|Overall Study|Physician Decision|0|||
126630137|NCT00143598|455603932|FG000|Overall Study|Lost to Follow-up|23|||
126630138|NCT00143598|455603933|FG001|Overall Study|Lost to Follow-up|21|||
126630139|NCT00143598|455603932|FG000|Overall Study|Withdrawal by Subject|33|||
126630140|NCT00143598|455603933|FG001|Overall Study|Withdrawal by Subject|37|||
126630141|NCT00143598|455603932|FG000|Overall Study|Death|36|||
126630142|NCT00143598|455603933|FG001|Overall Study|Death|36|||
126630143|NCT03900715|455603936|FG000|Overall Study|Protocol Deviation|1|||
126630144|NCT03900715|455603936|FG000|Overall Study|Lack of Efficacy|1|||
126630145|NCT03900715|455603936|FG000|Overall Study|Progressive Disease|6|||
126630146|NCT03900715|455603936|FG000|Overall Study|Adverse Event|2|||
126630147|NCT03900715|455603936|FG000|Overall Study|Other reasons|11|||
126630148|NCT00695136|455605472|FG000|Overall Study|Withdrawal by Subject|1|||
126630149|NCT00695136|455605472|FG000|Overall Study|unrelated adverse event|1|||
126630150|NCT01726049|455605474|FG000|Overall Study|Death|1|||
126630151|NCT01726049|455605475|FG001|Overall Study|Death|1|||
126630152|NCT01726049|455605474|FG000|Overall Study|Adverse Event|4|||
126630153|NCT01726049|455605475|FG001|Overall Study|Adverse Event|1|||
126630154|NCT01726049|455605474|FG000|Overall Study|refused second HC|0|||
126630155|NCT01726049|455605475|FG001|Overall Study|refused second HC|2|||
126630156|NCT02806505|455605477|FG000|Overall Study|Adverse event/intercurrent illness|1|||
126630157|NCT02806505|455605478|FG001|Overall Study|Adverse event/intercurrent illness|3|||
126630158|NCT02806505|455605477|FG000|Overall Study|Death|4|||
126630159|NCT02806505|455605478|FG001|Overall Study|Death|0|||
126630160|NCT02806505|455605477|FG000|Overall Study|Did not cooperate/refused treatment|3|||
126630161|NCT02806505|455605478|FG001|Overall Study|Did not cooperate/refused treatment|3|||
126630162|NCT02806505|455605477|FG000|Overall Study|Failure to return|0|||
126630163|NCT02806505|455605478|FG001|Overall Study|Failure to return|1|||
126630164|NCT02806505|455605477|FG000|Overall Study|Insufficient therapeutic response|2|||
126630165|NCT02806505|455605478|FG001|Overall Study|Insufficient therapeutic response|4|||
126630166|NCT01722045|455605485|FG000|Overall Study|Adverse Event|8|||
126630167|NCT01722045|455605485|FG000|Overall Study|Death|3|||
126630168|NCT01722045|455605485|FG000|Overall Study|Withdrawal by Subject|8|||
126630169|NCT01722045|455605485|FG000|Overall Study|Lost to Follow-up|4|||
126630170|NCT01722045|455605485|FG000|Overall Study|Protocol Deviation|1|||
126630171|NCT01722045|455605485|FG000|Overall Study|Physician Decision|3|||
126630172|NCT01722045|455605485|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
126630173|NCT03834623|455605495|FG000|Overall Study|Progression|0|||
126630174|NCT03834623|455605496|FG001|Overall Study|Progression|1|||
126630175|NCT01755546|455605497|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
126630176|NCT01755546|455605497|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
126630177|NCT01755546|455605497|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
126630178|NCT01755546|455605497|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
126630179|NCT01755546|455605497|FG000|Titration Phase|Adverse Event|11|||
126630180|NCT01755546|455605497|FG000|Titration Phase|Lack of Efficacy|18|||
126630181|NCT01755546|455605497|FG000|Titration Phase|Protocol Violation|9|||
126630182|NCT01755546|455605497|FG000|Titration Phase|Lost to Follow-up|2|||
126630183|NCT01755546|455605497|FG000|Titration Phase|Other and Continuing|22|||
126630184|NCT01755546|455605497|FG000|Titration Phase|Withdrawal by Subject|8|||
126630185|NCT01755546|455605497|FG000|Long Term Treatment|Adverse Event|12|||
126630186|NCT01755546|455605497|FG000|Long Term Treatment|Lack of Efficacy|6|||
126630187|NCT01755546|455605497|FG000|Long Term Treatment|Protocol Violation|10|||
126630188|NCT01755546|455605497|FG000|Long Term Treatment|Withdrawal by Subject|35|||
126630189|NCT01755546|455605497|FG000|Long Term Treatment|Lost to Follow-up|17|||
126630190|NCT01755546|455605497|FG000|Long Term Treatment|other and ongoing|41|||
126630191|NCT04606199|455605498|FG000|Overall Study|Withdrawal by Subject|2|||
126630192|NCT03294941|455605503|FG000|Overall Study|Withdrawal by Subject|0|||
126630193|NCT03294941|455605504|FG001|Overall Study|Withdrawal by Subject|2|||
126630194|NCT03927690|455605505|FG000|Overall Study|Withdrawal by Subject|3|||
126630195|NCT03927690|455605506|FG001|Overall Study|Withdrawal by Subject|1|||
126630196|NCT03927690|455605507|FG002|Overall Study|Withdrawal by Subject|1|||
126630197|NCT03927690|455605505|FG000|Overall Study|Adverse Event|1|||
126630198|NCT03927690|455605506|FG001|Overall Study|Adverse Event|0|||
126630199|NCT03927690|455605507|FG002|Overall Study|Adverse Event|0|||
126630200|NCT03927690|455605505|FG000|Overall Study|Death|1|||
126630201|NCT03927690|455605506|FG001|Overall Study|Death|0|||
126630202|NCT03927690|455605507|FG002|Overall Study|Death|0|||
126630203|NCT03927690|455605505|FG000|Overall Study|Lost to Follow-up|2|||
126630204|NCT03927690|455605506|FG001|Overall Study|Lost to Follow-up|2|||
126630205|NCT03927690|455605507|FG002|Overall Study|Lost to Follow-up|1|||
126630206|NCT04051242|455605511|FG000|Overall Study|Withdrawal by Subject|1|||
126788112|NCT00048048|456180462|FG007|Core Treatment|Adverse Event|1|||
126630207|NCT04051242|455605511|FG000|Overall Study|Physician Decision|1|||
126630208|NCT01774019|455605512|FG000|Overall Study|No longer meets protocol criteria|2|||
126630209|NCT01774019|455605513|FG001|Overall Study|No longer meets protocol criteria|0|||
126788113|NCT00048048|456180463|FG008|Core Treatment|Adverse Event|0|||
126630210|NCT01774019|455605512|FG000|Overall Study|Withdrawal by Subject|1|||
126630211|NCT01774019|455605513|FG001|Overall Study|Withdrawal by Subject|0|||
126630212|NCT01774019|455605512|FG000|Overall Study|Surgery delayed > 120 days|1|||
126630213|NCT01774019|455605513|FG001|Overall Study|Surgery delayed > 120 days|0|||
126630214|NCT01774019|455605512|FG000|Overall Study|Patient refused surgery|1|||
126630215|NCT01774019|455605513|FG001|Overall Study|Patient refused surgery|1|||
126630216|NCT01774019|455605512|FG000|Overall Study|Unable to implant study device|1|||
126630217|NCT01774019|455605513|FG001|Overall Study|Unable to implant study device|0|||
126788114|NCT00048048|456180464|FG009|Core Treatment|Adverse Event|0|||
126630218|NCT01774019|455605512|FG000|Overall Study|Lost to Follow-up|0|||
126630219|NCT01774019|455605513|FG001|Overall Study|Lost to Follow-up|3|||
126630220|NCT03463577|455605516|FG000|Overall Study|Lost to Follow-up|238|||
126630221|NCT03463577|455605517|FG001|Overall Study|Lost to Follow-up|435|||
126630222|NCT03463577|455605518|FG002|Overall Study|Lost to Follow-up|0|||
126630223|NCT03463577|455605519|FG003|Overall Study|Lost to Follow-up|0|||
126630224|NCT03463577|455605520|FG004|Overall Study|Lost to Follow-up|0|||
126630225|NCT03463577|455605521|FG005|Overall Study|Lost to Follow-up|0|||
126630226|NCT03463577|455605516|FG000|Overall Study|With unknown pregnancy outcome|0|||
126630227|NCT03463577|455605517|FG001|Overall Study|With unknown pregnancy outcome|5|||
126630228|NCT03463577|455605518|FG002|Overall Study|With unknown pregnancy outcome|0|||
126630229|NCT03463577|455605519|FG003|Overall Study|With unknown pregnancy outcome|0|||
126630230|NCT03463577|455605520|FG004|Overall Study|With unknown pregnancy outcome|0|||
126630231|NCT03463577|455605521|FG005|Overall Study|With unknown pregnancy outcome|0|||
126630232|NCT03463577|455605516|FG000|Overall Study|Maternal death|2|||
126630233|NCT03463577|455605517|FG001|Overall Study|Maternal death|0|||
126630234|NCT03463577|455605518|FG002|Overall Study|Maternal death|0|||
126630235|NCT03463577|455605519|FG003|Overall Study|Maternal death|0|||
126630236|NCT03463577|455605520|FG004|Overall Study|Maternal death|0|||
126630237|NCT03463577|455605521|FG005|Overall Study|Maternal death|0|||
126630238|NCT03463577|455605516|FG000|Overall Study|Neonatal death|0|||
126630239|NCT03463577|455605517|FG001|Overall Study|Neonatal death|0|||
126630240|NCT03463577|455605518|FG002|Overall Study|Neonatal death|0|||
126630241|NCT03463577|455605519|FG003|Overall Study|Neonatal death|15|||
126630242|NCT03463577|455605520|FG004|Overall Study|Neonatal death|17|||
126630243|NCT03463577|455605521|FG005|Overall Study|Neonatal death|0|||
126630244|NCT02172950|455605523|FG000|Overall Study|Physician Decision|3|||
126630245|NCT02172950|455605524|FG001|Overall Study|Physician Decision|3|||
126630246|NCT02172950|455605523|FG000|Overall Study|Lack of Efficacy|1|||
126630247|NCT02172950|455605524|FG001|Overall Study|Lack of Efficacy|0|||
126630248|NCT02172950|455605523|FG000|Overall Study|Adverse Event|4|||
126630249|NCT02172950|455605524|FG001|Overall Study|Adverse Event|1|||
126630250|NCT02172950|455605523|FG000|Overall Study|Withdrawal by Subject|10|||
126630251|NCT02172950|455605524|FG001|Overall Study|Withdrawal by Subject|0|||
126630252|NCT02172950|455605523|FG000|Overall Study|Protocol Violation|1|||
126630253|NCT02172950|455605524|FG001|Overall Study|Protocol Violation|0|||
126630254|NCT02172950|455605523|FG000|Overall Study|Lost to Follow-up|1|||
126630255|NCT02172950|455605524|FG001|Overall Study|Lost to Follow-up|0|||
126630256|NCT02172950|455605523|FG000|Overall Study|Death|1|||
126630257|NCT02172950|455605524|FG001|Overall Study|Death|0|||
126630258|NCT02172950|455605523|FG000|Overall Study|Patient traveling|1|||
126630259|NCT02172950|455605524|FG001|Overall Study|Patient traveling|0|||
126630260|NCT02172950|455605523|FG000|Overall Study|Patient went to other country|1|||
126630261|NCT02172950|455605524|FG001|Overall Study|Patient went to other country|0|||
126630262|NCT02172950|455605523|FG000|Overall Study|Patient relocated overseas|1|||
126630263|NCT02172950|455605524|FG001|Overall Study|Patient relocated overseas|1|||
126630264|NCT02172950|455605523|FG000|Overall Study|Patient moving|1|||
126630265|NCT02172950|455605524|FG001|Overall Study|Patient moving|0|||
126630266|NCT00611715|455605525|FG000|Overall Study|Disease Progression|24|||
126630267|NCT00611715|455605526|FG001|Overall Study|Disease Progression|4|||
126630268|NCT00611715|455605525|FG000|Overall Study|Withdrawal by Subject|5|||
126630269|NCT00611715|455605526|FG001|Overall Study|Withdrawal by Subject|1|||
126630270|NCT00611715|455605525|FG000|Overall Study|Adverse Event|9|||
126630271|NCT00611715|455605526|FG001|Overall Study|Adverse Event|1|||
126630272|NCT00611715|455605525|FG000|Overall Study|Death|1|||
126630273|NCT00611715|455605526|FG001|Overall Study|Death|0|||
126630274|NCT00611715|455605525|FG000|Overall Study|two patients are still on treatment|2|||
126630275|NCT00611715|455605526|FG001|Overall Study|two patients are still on treatment|0|||
126630276|NCT00107978|455605527|FG000|Overall Study|Adverse Event|1|||
126630277|NCT00107978|455605528|FG001|Overall Study|Adverse Event|5|||
126630278|NCT00107978|455605527|FG000|Overall Study|Death|3|||
126630279|NCT00107978|455605528|FG001|Overall Study|Death|3|||
126630280|NCT00107978|455605527|FG000|Overall Study|Lost to Follow-up|20|||
126630281|NCT00107978|455605528|FG001|Overall Study|Lost to Follow-up|28|||
126630282|NCT00107978|455605527|FG000|Overall Study|Withdrawal by Subject|4|||
126630283|NCT00107978|455605528|FG001|Overall Study|Withdrawal by Subject|9|||
126630284|NCT00107978|455605527|FG000|Overall Study|Protocol Violation|0|||
126630285|NCT00107978|455605528|FG001|Overall Study|Protocol Violation|1|||
126630286|NCT00107978|455605527|FG000|Overall Study|Other|5|||
126630287|NCT00107978|455605528|FG001|Overall Study|Other|4|||
126630288|NCT00704171|455605529|FG000|Overall Study|Withdrawal by Subject|1|||
126630289|NCT00704171|455605530|FG001|Overall Study|Withdrawal by Subject|0|||
126630290|NCT01874665|455605531|FG000|Overall Study|Adverse Event|6|||
126630291|NCT01874665|455605532|FG001|Overall Study|Adverse Event|2|||
126630292|NCT01874665|455605531|FG000|Overall Study|Withdrawal by Subject|4|||
126630293|NCT01874665|455605532|FG001|Overall Study|Withdrawal by Subject|1|||
126630294|NCT01874665|455605531|FG000|Overall Study|Physician Decision|3|||
126630295|NCT01874665|455605532|FG001|Overall Study|Physician Decision|0|||
126630296|NCT01874665|455605531|FG000|Overall Study|Clinical Progressive Disease|4|||
126630297|NCT01874665|455605532|FG001|Overall Study|Clinical Progressive Disease|3|||
126630298|NCT01874665|455605531|FG000|Overall Study|Study Terminated by Sponsor|0|||
126630299|NCT01874665|455605532|FG001|Overall Study|Study Terminated by Sponsor|2|||
126630300|NCT01874665|455605531|FG000|Overall Study|Documented Progressive Disease|11|||
126630301|NCT01874665|455605532|FG001|Overall Study|Documented Progressive Disease|7|||
126630302|NCT01874665|455605531|FG000|Overall Study|Other|2|||
126630303|NCT01874665|455605532|FG001|Overall Study|Other|0|||
126630304|NCT04962698|455605537|FG000|Motor Imagery|Technical difficulty|1|||
126630305|NCT04962698|455605538|FG001|Motor Imagery|Technical difficulty|0|||
126630306|NCT04962698|455605537|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
126630307|NCT04962698|455605538|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
126630308|NCT04962698|455605537|FG000|Kinesthetic MI|Technical difficulty|1|||
126630309|NCT04962698|455605538|FG001|Kinesthetic MI|Technical difficulty|0|||
126630310|NCT04962698|455605537|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
126630311|NCT04962698|455605538|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
126630312|NCT04962698|455605537|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
126630313|NCT04962698|455605538|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
126630314|NCT04962698|455605537|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
126630315|NCT04962698|455605538|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
126630316|NCT04962698|455605537|FG000|Virtual-hand Interaction|Technical difficulty|1|||
126630317|NCT04962698|455605538|FG001|Virtual-hand Interaction|Technical difficulty|0|||
126630318|NCT04962698|455605537|FG000|Robotic Action Observation|Technical difficulty|1|||
126630319|NCT04962698|455605538|FG001|Robotic Action Observation|Technical difficulty|0|||
126630320|NCT04962698|455605537|FG000|Rest|Technical difficulty|1|||
126630321|NCT04962698|455605538|FG001|Rest|Technical difficulty|0|||
126630322|NCT04962698|455605537|FG000|Rest|Exclusion criteria met after enrollment|0|||
126630323|NCT04962698|455605538|FG001|Rest|Exclusion criteria met after enrollment|2|||
126630324|NCT00853229|455605539|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
126788115|NCT00048048|456180465|FG010|Core Treatment|Adverse Event|0|||
126788116|NCT00048048|456180466|FG011|Core Treatment|Adverse Event|0|||
126788117|NCT00048048|456180455|FG000|Extension Year 1|Early withdrawals|0|||
126788118|NCT00048048|456180456|FG001|Extension Year 1|Early withdrawals|0|||
126788119|NCT00048048|456180457|FG002|Extension Year 1|Early withdrawals|0|||
126788120|NCT00048048|456180458|FG003|Extension Year 1|Early withdrawals|0|||
126630325|NCT00853229|455605540|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
126630326|NCT03201900|455605541|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
126630327|NCT03201900|455605541|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
126630328|NCT03201900|455605541|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
126630329|NCT03201900|455605541|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
126630330|NCT03201900|455605541|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
126630331|NCT03201900|455605541|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
126630332|NCT03201900|455605541|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
126630333|NCT03201900|455605541|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
126630334|NCT03201900|455605541|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
126630335|NCT03201900|455605541|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
126630336|NCT03201900|455605541|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
126630337|NCT03201900|455605541|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
126630338|NCT03201900|455605541|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
126630339|NCT00776659|455605563|FG000|Overall Study|Lost to Follow-up|15|||
126630340|NCT00776659|455605563|FG000|Overall Study|Withdrawal by Subject|10|||
126630341|NCT00776659|455605563|FG000|Overall Study|Study Terminated by Sponsor|1|||
126630342|NCT01664923|455605564|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
126630343|NCT01664923|455605565|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
126630344|NCT01664923|455605564|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
126630345|NCT01664923|455605565|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
126630346|NCT01664923|455605564|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
126630347|NCT01664923|455605565|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
126630348|NCT01664923|455605564|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
126630349|NCT01664923|455605565|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
126788121|NCT00048048|456180459|FG004|Extension Year 1|Early withdrawals|0|||
126788122|NCT00048048|456180460|FG005|Extension Year 1|Early withdrawals|0|||
126788123|NCT00048048|456180461|FG006|Extension Year 1|Early withdrawals|0|||
126788124|NCT00048048|456180462|FG007|Extension Year 1|Early withdrawals|0|||
126630350|NCT01664923|455605564|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
126630351|NCT01664923|455605565|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
126630352|NCT01664923|455605564|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
126630353|NCT01664923|455605565|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
126630354|NCT01664923|455605564|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
126630355|NCT01664923|455605565|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
126788125|NCT00048048|456180463|FG008|Extension Year 1|Early withdrawals|0|||
126788126|NCT00048048|456180464|FG009|Extension Year 1|Early withdrawals|2|||
126788127|NCT00048048|456180465|FG010|Extension Year 1|Early withdrawals|2|||
126788128|NCT00048048|456180466|FG011|Extension Year 1|Early withdrawals|4|||
126788129|NCT00048048|456180455|FG000|Extension Year 2|Early withdrawals|0|||
126788130|NCT00048048|456180456|FG001|Extension Year 2|Early withdrawals|0|||
126788131|NCT00048048|456180457|FG002|Extension Year 2|Early withdrawals|0|||
126788132|NCT00048048|456180458|FG003|Extension Year 2|Early withdrawals|0|||
126788133|NCT00048048|456180459|FG004|Extension Year 2|Early withdrawals|0|||
126788134|NCT00048048|456180460|FG005|Extension Year 2|Early withdrawals|0|||
126788135|NCT00048048|456180461|FG006|Extension Year 2|Early withdrawals|0|||
126788136|NCT00048048|456180462|FG007|Extension Year 2|Early withdrawals|0|||
126788137|NCT00048048|456180463|FG008|Extension Year 2|Early withdrawals|0|||
126788138|NCT00048048|456180464|FG009|Extension Year 2|Early withdrawals|0|||
126788139|NCT00048048|456180465|FG010|Extension Year 2|Early withdrawals|4|||
126788140|NCT00048048|456180466|FG011|Extension Year 2|Early withdrawals|2|||
126788141|NCT05518487|456180467|FG000|Overall Study|Withdrawal by Subject|3|||
126788142|NCT02752776|456180469|FG000|Overall Study|Adverse Event|15|||
126788143|NCT02752776|456180470|FG001|Overall Study|Adverse Event|23|||
126788144|NCT02752776|456180471|FG002|Overall Study|Adverse Event|11|||
126788145|NCT02752776|456180469|FG000|Overall Study|Lack of Efficacy|2|||
126788146|NCT02752776|456180470|FG001|Overall Study|Lack of Efficacy|6|||
126788147|NCT02752776|456180471|FG002|Overall Study|Lack of Efficacy|14|||
126788148|NCT02752776|456180469|FG000|Overall Study|Lost to Follow-up|11|||
126788149|NCT02752776|456180470|FG001|Overall Study|Lost to Follow-up|12|||
126788150|NCT02752776|456180471|FG002|Overall Study|Lost to Follow-up|4|||
126788151|NCT02752776|456180469|FG000|Overall Study|Non-compliance with study treatment|0|||
126630356|NCT01664923|455605564|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
126630357|NCT01664923|455605565|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
126630358|NCT01664923|455605564|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
126630359|NCT01664923|455605565|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
126630360|NCT01664923|455605564|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
126630361|NCT01664923|455605565|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
126630362|NCT01664923|455605564|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
126630363|NCT01664923|455605565|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
126630364|NCT01664923|455605564|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
126630365|NCT01664923|455605565|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
126630366|NCT01664923|455605564|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
126630367|NCT01664923|455605565|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
126630368|NCT01664923|455605564|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
126788152|NCT02752776|456180470|FG001|Overall Study|Non-compliance with study treatment|0|||
126788153|NCT02752776|456180471|FG002|Overall Study|Non-compliance with study treatment|1|||
126788154|NCT02752776|456180469|FG000|Overall Study|Physician Decision|2|||
126788155|NCT02752776|456180470|FG001|Overall Study|Physician Decision|6|||
126788156|NCT02752776|456180471|FG002|Overall Study|Physician Decision|2|||
126788157|NCT02752776|456180469|FG000|Overall Study|Pregnancy|1|||
126788158|NCT02752776|456180470|FG001|Overall Study|Pregnancy|6|||
126788159|NCT02752776|456180471|FG002|Overall Study|Pregnancy|3|||
126788160|NCT02752776|456180469|FG000|Overall Study|Protocol Violation|10|||
126788161|NCT02752776|456180470|FG001|Overall Study|Protocol Violation|13|||
126788162|NCT02752776|456180471|FG002|Overall Study|Protocol Violation|6|||
126788163|NCT02752776|456180469|FG000|Overall Study|Subject/guardian decision|8|||
126788164|NCT02752776|456180470|FG001|Overall Study|Subject/guardian decision|6|||
126788165|NCT02752776|456180471|FG002|Overall Study|Subject/guardian decision|4|||
126788166|NCT02752776|456180469|FG000|Overall Study|Death|0|||
126788167|NCT02752776|456180470|FG001|Overall Study|Death|0|||
126788168|NCT02752776|456180471|FG002|Overall Study|Death|1|||
126788169|NCT02752776|456180469|FG000|Overall Study|Withdrawal by Subject|3|||
126788170|NCT02752776|456180470|FG001|Overall Study|Withdrawal by Subject|4|||
126788171|NCT02752776|456180471|FG002|Overall Study|Withdrawal by Subject|2|||
126788172|NCT00712010|456180472|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
126788173|NCT01946165|456180473|FG000|Overall Study|Physician Decision|2|||
126788174|NCT01946165|456180474|FG001|Overall Study|Physician Decision|0|||
126788175|NCT01946165|456180473|FG000|Overall Study|Withdrawal by Subject|0|||
126788176|NCT01946165|456180474|FG001|Overall Study|Withdrawal by Subject|2|||
126788177|NCT01901055|456180475|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
126630369|NCT01664923|455605565|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
126788178|NCT01901055|456180476|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
126788179|NCT01901055|456180475|FG000|Randomization But Not Titrated|Physician Decision|0|||
126788180|NCT01901055|456180476|FG001|Randomization But Not Titrated|Physician Decision|1|||
126788181|NCT01901055|456180475|FG000|Started Protocol to Week 6|Physician Decision|2|||
126788182|NCT01901055|456180476|FG001|Started Protocol to Week 6|Physician Decision|1|||
126788183|NCT01901055|456180475|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
126630370|NCT01233999|455605566|FG000|Overall Study|Withdrawal by Subject|1|||
126630371|NCT01233999|455605566|FG000|Overall Study|Lost to Follow-up|1|||
126630372|NCT00129649|455605573|FG000|Overall Study|Withdrawal by Subject|76|||
126788184|NCT01901055|456180476|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
126788185|NCT01901055|456180475|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
126788186|NCT01901055|456180476|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
126788187|NCT01901055|456180475|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
126788188|NCT01901055|456180476|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
126788189|NCT01901055|456180475|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
126788190|NCT01901055|456180476|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
126630373|NCT00129649|455605574|FG001|Overall Study|Withdrawal by Subject|65|||
126630374|NCT02835092|455605578|FG000|Overall Study|Withdrawal by Subject|3|||
126630375|NCT02835092|455605579|FG001|Overall Study|Withdrawal by Subject|6|||
126630376|NCT02835092|455605580|FG002|Overall Study|Withdrawal by Subject|3|||
126630377|NCT02835092|455605578|FG000|Overall Study|Lost to Follow-up|0|||
126630378|NCT02835092|455605579|FG001|Overall Study|Lost to Follow-up|2|||
126630379|NCT02835092|455605580|FG002|Overall Study|Lost to Follow-up|0|||
126630380|NCT01321723|455605582|FG000|Overall Study|Adverse Event|3|||
126630381|NCT01321723|455605583|FG001|Overall Study|Adverse Event|5|||
126630382|NCT01321723|455605584|FG002|Overall Study|Adverse Event|2|||
126630383|NCT01321723|455605582|FG000|Overall Study|Withdrawal by Subject|2|||
126630384|NCT01321723|455605583|FG001|Overall Study|Withdrawal by Subject|0|||
126630385|NCT01321723|455605584|FG002|Overall Study|Withdrawal by Subject|2|||
126630386|NCT00025506|455605585|FG000|Overall Study|Ineligible: clerical error|1|||
126630387|NCT00025506|455605585|FG000|Overall Study|Ineligible: wrong cell type|5|||
126755095|NCT02417935|456053033|FG001|Treatment Period|Entry Criteria not met|1|||
126755096|NCT02417935|456053032|FG000|Treatment Period|Protocol Violation|2|||
126755097|NCT02417935|456053033|FG001|Treatment Period|Protocol Violation|1|||
126755098|NCT02417935|456053032|FG000|Treatment Period|Withdrawal by Subject|3|||
126755099|NCT02417935|456053033|FG001|Treatment Period|Withdrawal by Subject|3|||
126755100|NCT02417935|456053032|FG000|Treatment Period|Physician Decision|3|||
126755101|NCT02417935|456053033|FG001|Treatment Period|Physician Decision|1|||
126755102|NCT02850276|456053038|FG000|Overall Study|screen failure|43|||
126755103|NCT02850276|456053038|FG000|Overall Study|Withdrawal by Subject|14|||
126755104|NCT02850276|456053038|FG000|Overall Study|Physician Decision|2|||
126755105|NCT02850276|456053038|FG000|Overall Study|Lost to Follow-up|2|||
126755106|NCT01899729|456053039|FG000|Overall Study|Adverse Event|1|||
126755107|NCT01899729|456053040|FG001|Overall Study|Adverse Event|0|||
126755108|NCT01899729|456053041|FG002|Overall Study|Adverse Event|0|||
126755109|NCT01899729|456053042|FG003|Overall Study|Adverse Event|0|||
126755110|NCT01899729|456053043|FG004|Overall Study|Adverse Event|1|||
126755111|NCT01899729|456053039|FG000|Overall Study|Withdrawal by Subject|1|||
126755112|NCT01899729|456053040|FG001|Overall Study|Withdrawal by Subject|2|||
126755113|NCT01899729|456053041|FG002|Overall Study|Withdrawal by Subject|0|||
126755114|NCT01899729|456053042|FG003|Overall Study|Withdrawal by Subject|0|||
126755115|NCT01899729|456053043|FG004|Overall Study|Withdrawal by Subject|0|||
126755116|NCT01899729|456053039|FG000|Overall Study|Lack of Efficacy|0|||
126755117|NCT01899729|456053040|FG001|Overall Study|Lack of Efficacy|0|||
126755118|NCT01899729|456053041|FG002|Overall Study|Lack of Efficacy|2|||
126755119|NCT01899729|456053042|FG003|Overall Study|Lack of Efficacy|0|||
126755120|NCT01899729|456053043|FG004|Overall Study|Lack of Efficacy|1|||
126755121|NCT01454531|456053046|FG000|Overall Study|Adverse Event|14|||
126755122|NCT01454531|456053046|FG000|Overall Study|Withdrawal by Subject|5|||
126755123|NCT01454531|456053046|FG000|Overall Study|Lost to Follow-up|1|||
126755124|NCT01454531|456053046|FG000|Overall Study|Physician Decision|1|||
126755125|NCT01454531|456053046|FG000|Overall Study|Delay in IMP administration|1|||
126755126|NCT01454531|456053046|FG000|Overall Study|Other|1|||
126755127|NCT02504424|456053052|FG000|Overall Study|Withdrawal by Subject|2|||
126755128|NCT00440232|456053053|FG000|Overall Study|Lost to Follow-up|1|||
126755129|NCT00440232|456053054|FG001|Overall Study|Lost to Follow-up|1|||
126755130|NCT00440232|456053053|FG000|Overall Study|Unable to treat within allowed time|0|||
126755131|NCT00440232|456053054|FG001|Overall Study|Unable to treat within allowed time|1|||
126755132|NCT00440232|456053053|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
126755133|NCT00440232|456053054|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
126755134|NCT00426842|456053055|FG000|Overall Study|Lost to Follow-up|1|||
126755135|NCT00362297|456053056|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
126755136|NCT00362297|456053057|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
126755137|NCT01070381|456053058|FG000|Period 2, 1 Week of Wear|Handling|0|||
126755138|NCT01070381|456053059|FG001|Period 2, 1 Week of Wear|Handling|1|||
126755139|NCT01070381|456053058|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
126755140|NCT01070381|456053059|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
126755141|NCT01259388|456053061|FG000|Overall Study|Adverse Event|3|||
126630388|NCT00025506|455605585|FG000|Overall Study|Ineligible: inadequate pathology|2|||
126630389|NCT00025506|455605585|FG000|Overall Study|Never Treated|2|||
126755142|NCT01259388|456053062|FG001|Overall Study|Adverse Event|0|||
126755143|NCT01259388|456053061|FG000|Overall Study|Withdrawal by Subject|1|||
126755144|NCT01259388|456053062|FG001|Overall Study|Withdrawal by Subject|1|||
126630390|NCT00713206|455605586|FG000|Overall Study|Lost to Follow-up|4|||
126630391|NCT00713206|455605587|FG001|Overall Study|Lost to Follow-up|4|||
126630392|NCT00713206|455605586|FG000|Overall Study|Death|1|||
126630393|NCT00713206|455605587|FG001|Overall Study|Death|0|||
126630394|NCT02561806|455605588|FG000|Induction Period|Adverse Event|0|||
126630395|NCT02561806|455605589|FG001|Induction Period|Adverse Event|2|||
126630396|NCT02561806|455605588|FG000|Induction Period|Lack of Efficacy|1|||
126630397|NCT02561806|455605589|FG001|Induction Period|Lack of Efficacy|0|||
126630398|NCT02561806|455605588|FG000|Induction Period|Withdrawal by Subject|0|||
126630399|NCT02561806|455605589|FG001|Induction Period|Withdrawal by Subject|2|||
126630400|NCT02561806|455605588|FG000|Induction Period|Site staff became unblinded|1|||
126630401|NCT02561806|455605589|FG001|Induction Period|Site staff became unblinded|0|||
126630402|NCT02561806|455605588|FG000|Induction Period|Randomized but not treated|0|||
126630403|NCT02561806|455605589|FG001|Induction Period|Randomized but not treated|1|||
126630404|NCT02561806|455605588|FG000|Maintenance Period|Adverse Event|2|||
126630405|NCT02561806|455605589|FG001|Maintenance Period|Adverse Event|1|||
126630406|NCT02561806|455605588|FG000|Maintenance Period|Lack of Efficacy|3|||
126630407|NCT02561806|455605589|FG001|Maintenance Period|Lack of Efficacy|1|||
126630408|NCT02561806|455605588|FG000|Maintenance Period|Lost to Follow-up|2|||
126630409|NCT02561806|455605589|FG001|Maintenance Period|Lost to Follow-up|2|||
126630410|NCT02561806|455605588|FG000|Maintenance Period|Protocol Violation|1|||
126630411|NCT02561806|455605589|FG001|Maintenance Period|Protocol Violation|0|||
126630412|NCT02561806|455605588|FG000|Maintenance Period|Withdrawal by Subject|5|||
126630413|NCT02561806|455605589|FG001|Maintenance Period|Withdrawal by Subject|3|||
126630414|NCT02561806|455605588|FG000|Maintenance Period|Site staff became unblinded|0|||
126630415|NCT02561806|455605589|FG001|Maintenance Period|Site staff became unblinded|1|||
126630416|NCT02561806|455605588|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
126630417|NCT02561806|455605589|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
126630418|NCT02561806|455605588|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
126630419|NCT02561806|455605589|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
126630420|NCT02547441|455605590|FG000|Double-Blind Study Period|Adverse Event|4|||
126630421|NCT02547441|455605591|FG001|Double-Blind Study Period|Adverse Event|9|||
126630422|NCT02547441|455605590|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
126630423|NCT02547441|455605591|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
126630424|NCT02547441|455605590|FG000|Double-Blind Study Period|Physician Decision|1|||
126630425|NCT02547441|455605591|FG001|Double-Blind Study Period|Physician Decision|0|||
126630426|NCT02547441|455605590|FG000|Double-Blind Study Period|Protocol Violation|1|||
126630427|NCT02547441|455605591|FG001|Double-Blind Study Period|Protocol Violation|2|||
126630428|NCT02547441|455605590|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
126630429|NCT02547441|455605591|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
126630430|NCT02547441|455605590|FG000|Double-Blind Study Period|Sponsor Decision|1|||
126630431|NCT02547441|455605591|FG001|Double-Blind Study Period|Sponsor Decision|0|||
126630432|NCT02547441|455605590|FG000|Open-Label Study Period|Adverse Event|10|||
126630433|NCT02547441|455605591|FG001|Open-Label Study Period|Adverse Event|11|||
126630434|NCT02547441|455605590|FG000|Open-Label Study Period|Lack of Efficacy|3|||
126630435|NCT02547441|455605591|FG001|Open-Label Study Period|Lack of Efficacy|2|||
126630436|NCT02547441|455605590|FG000|Open-Label Study Period|Lost to Follow-up|7|||
126630437|NCT02547441|455605591|FG001|Open-Label Study Period|Lost to Follow-up|8|||
126630438|NCT02547441|455605590|FG000|Open-Label Study Period|Physician Decision|1|||
126630439|NCT02547441|455605591|FG001|Open-Label Study Period|Physician Decision|0|||
126630440|NCT02547441|455605590|FG000|Open-Label Study Period|Protocol Violation|2|||
126630441|NCT02547441|455605591|FG001|Open-Label Study Period|Protocol Violation|0|||
126630442|NCT02547441|455605590|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
126630443|NCT02547441|455605591|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
126630444|NCT02547441|455605590|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
126630445|NCT02547441|455605591|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
126630446|NCT01322009|455605593|FG000|Overall Study|Death|0|||
126630447|NCT01322009|455605594|FG001|Overall Study|Death|1|||
126630448|NCT01322009|455605593|FG000|Overall Study|Adverse Event|0|||
126630449|NCT01322009|455605594|FG001|Overall Study|Adverse Event|1|||
126630450|NCT01322009|455605593|FG000|Overall Study|ng tube discontinued|0|||
126630451|NCT01322009|455605594|FG001|Overall Study|ng tube discontinued|1|||
126630452|NCT00905034|455605595|FG000|Overall Study|Withdrawal by Subject|1|||
126630453|NCT00394589|455605596|FG000|Overall Study|Adverse Event|2|||
126630454|NCT00394589|455605597|FG001|Overall Study|Adverse Event|1|||
126630455|NCT00394589|455605598|FG002|Overall Study|Adverse Event|2|||
126630456|NCT00394589|455605596|FG000|Overall Study|Lack of Efficacy|2|||
126630457|NCT00394589|455605597|FG001|Overall Study|Lack of Efficacy|2|||
126630458|NCT00394589|455605598|FG002|Overall Study|Lack of Efficacy|3|||
126630459|NCT00394589|455605596|FG000|Overall Study|Protocol Violation|4|||
126630460|NCT00394589|455605597|FG001|Overall Study|Protocol Violation|0|||
126630461|NCT00394589|455605598|FG002|Overall Study|Protocol Violation|2|||
126630462|NCT04081389|455605599|FG000|Overall Study|Withdrawal by Subject|0|||
126630463|NCT04081389|455605600|FG001|Overall Study|Withdrawal by Subject|0|||
126630464|NCT04081389|455605601|FG002|Overall Study|Withdrawal by Subject|1|||
126630465|NCT04081389|455605602|FG003|Overall Study|Withdrawal by Subject|0|||
126630466|NCT01710800|455605603|FG000|Overall Study|Withdrawal by Subject|21|||
126630467|NCT01710800|455605603|FG000|Overall Study|Protocol Violation|1|||
126630468|NCT02427958|455605607|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
126630469|NCT02427958|455605607|FG000|Overall Study|Lost to Follow-up|6|||
126630470|NCT02427958|455605607|FG000|Overall Study|Withdrawal by Subject|14|||
126630471|NCT02427958|455605607|FG000|Overall Study|Lack of Efficacy|1|||
126630472|NCT00511797|455605608|FG000|Overall Study|Adverse Event|1|||
126630473|NCT00511797|455605609|FG001|Overall Study|Adverse Event|2|||
126630474|NCT00511797|455605610|FG002|Overall Study|Adverse Event|2|||
126630475|NCT00511797|455605611|FG003|Overall Study|Adverse Event|2|||
126630476|NCT00511797|455605608|FG000|Overall Study|Lost to Follow-up|1|||
126630477|NCT00511797|455605609|FG001|Overall Study|Lost to Follow-up|0|||
126630478|NCT00511797|455605610|FG002|Overall Study|Lost to Follow-up|0|||
126630479|NCT00511797|455605611|FG003|Overall Study|Lost to Follow-up|1|||
126630480|NCT00511797|455605608|FG000|Overall Study|Pregnancy|0|||
126630481|NCT00511797|455605609|FG001|Overall Study|Pregnancy|0|||
126630482|NCT00511797|455605610|FG002|Overall Study|Pregnancy|0|||
126630483|NCT00511797|455605611|FG003|Overall Study|Pregnancy|1|||
126630484|NCT00511797|455605608|FG000|Overall Study|Protocol Violation|0|||
126630485|NCT00511797|455605609|FG001|Overall Study|Protocol Violation|2|||
126630486|NCT00511797|455605610|FG002|Overall Study|Protocol Violation|2|||
126630487|NCT00511797|455605611|FG003|Overall Study|Protocol Violation|3|||
126630488|NCT00511797|455605608|FG000|Overall Study|Withdrawal by Subject|3|||
126630489|NCT00511797|455605609|FG001|Overall Study|Withdrawal by Subject|3|||
126630490|NCT00511797|455605610|FG002|Overall Study|Withdrawal by Subject|4|||
126630491|NCT00511797|455605611|FG003|Overall Study|Withdrawal by Subject|2|||
126630492|NCT00511797|455605608|FG000|Overall Study|Never dispensed|1|||
126630493|NCT00511797|455605609|FG001|Overall Study|Never dispensed|0|||
126630494|NCT00511797|455605610|FG002|Overall Study|Never dispensed|1|||
126630495|NCT00511797|455605611|FG003|Overall Study|Never dispensed|3|||
126630496|NCT00511797|455605608|FG000|Overall Study|Study drug not taken|0|||
126630497|NCT00511797|455605609|FG001|Overall Study|Study drug not taken|1|||
126630498|NCT00511797|455605610|FG002|Overall Study|Study drug not taken|0|||
126630499|NCT00511797|455605611|FG003|Overall Study|Study drug not taken|1|||
126630500|NCT00511797|455605608|FG000|Overall Study|Partially missing diary|0|||
126630501|NCT00511797|455605609|FG001|Overall Study|Partially missing diary|0|||
126630502|NCT00511797|455605610|FG002|Overall Study|Partially missing diary|1|||
126630503|NCT00511797|455605611|FG003|Overall Study|Partially missing diary|0|||
126630504|NCT00511797|455605608|FG000|Overall Study|Other (moving etc)|1|||
126630505|NCT00511797|455605609|FG001|Overall Study|Other (moving etc)|0|||
126630506|NCT00511797|455605610|FG002|Overall Study|Other (moving etc)|1|||
126630507|NCT00511797|455605611|FG003|Overall Study|Other (moving etc)|2|||
126630508|NCT03974100|455605612|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
126630509|NCT03974100|455605613|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
126788191|NCT01901055|456180475|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
126630510|NCT03974100|455605614|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
126630511|NCT03974100|455605615|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
126630512|NCT03974100|455605616|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
126630513|NCT03974100|455605612|FG000|TP1 - Day 1 to Week 52|Death|1|||
126630514|NCT03974100|455605613|FG001|TP1 - Day 1 to Week 52|Death|0|||
126630515|NCT03974100|455605614|FG002|TP1 - Day 1 to Week 52|Death|0|||
126630516|NCT03974100|455605615|FG003|TP1 - Day 1 to Week 52|Death|0|||
126630517|NCT03974100|455605616|FG004|TP1 - Day 1 to Week 52|Death|0|||
126788192|NCT01901055|456180476|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
126788193|NCT01901055|456180475|FG000|Week 24|Withdrawal by Subject|13|||
126788194|NCT01901055|456180476|FG001|Week 24|Withdrawal by Subject|19|||
126630518|NCT03974100|455605612|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
126630519|NCT03974100|455605613|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
126630520|NCT03974100|455605614|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
126630521|NCT03974100|455605615|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
126630522|NCT03974100|455605616|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
126630523|NCT03974100|455605612|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
126788195|NCT01901055|456180475|FG000|Week 24|Physician Decision|1|||
126788196|NCT01901055|456180476|FG001|Week 24|Physician Decision|0|||
126630524|NCT03974100|455605613|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
126630525|NCT03974100|455605614|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
126630526|NCT03974100|455605615|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
126630527|NCT03974100|455605616|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
126630528|NCT03974100|455605612|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
126630529|NCT03974100|455605613|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
126630530|NCT03974100|455605614|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
126630531|NCT03974100|455605615|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
126630532|NCT03974100|455605616|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
126630533|NCT03974100|455605612|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
126630534|NCT03974100|455605613|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
126630535|NCT03974100|455605614|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
126630536|NCT03974100|455605615|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
126630537|NCT03974100|455605616|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
126630538|NCT03974100|455605612|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
126630539|NCT03974100|455605613|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
126630540|NCT03974100|455605614|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
126630541|NCT03974100|455605615|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
126630542|NCT03974100|455605616|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
126630543|NCT02019641|455605617|FG000|10-Week Follow up|Withdrawal by investigator|2|||
126630544|NCT02019641|455605618|FG001|10-Week Follow up|Withdrawal by investigator|0|||
126630545|NCT02019641|455605619|FG002|10-Week Follow up|Withdrawal by investigator|0|||
126630546|NCT02019641|455605617|FG000|10-Week Follow up|Withdrawal by Subject|1|||
126630547|NCT02019641|455605618|FG001|10-Week Follow up|Withdrawal by Subject|1|||
126630548|NCT02019641|455605619|FG002|10-Week Follow up|Withdrawal by Subject|0|||
126630549|NCT02019641|455605617|FG000|20-Week Follow up|Withdrawal by investigator|0|||
126630550|NCT02019641|455605618|FG001|20-Week Follow up|Withdrawal by investigator|0|||
126630551|NCT02019641|455605619|FG002|20-Week Follow up|Withdrawal by investigator|1|||
126630552|NCT03410108|455605620|FG000|Overall Study|Ongoing|41|||
126630553|NCT03410108|455605620|FG000|Overall Study|Adverse Event|4|||
126630554|NCT03410108|455605620|FG000|Overall Study|Progressive Disease|58|||
126630555|NCT03410108|455605620|FG000|Overall Study|Withdrawal by Subject|1|||
126630556|NCT03269695|455605621|FG000|Overall Study|Adverse Event|2|||
126630557|NCT03269695|455605622|FG001|Overall Study|Adverse Event|1|||
126630558|NCT03269695|455605621|FG000|Overall Study|Lack of Efficacy|0|||
126630559|NCT03269695|455605622|FG001|Overall Study|Lack of Efficacy|1|||
126630560|NCT03269695|455605621|FG000|Overall Study|Withdrawal by Subject|0|||
126630561|NCT03269695|455605622|FG001|Overall Study|Withdrawal by Subject|1|||
126630562|NCT01560871|455605623|FG000|Overall Study|transportation issues|2|||
126630563|NCT01560871|455605624|FG001|Overall Study|transportation issues|1|||
126630564|NCT01560871|455605623|FG000|Overall Study|relocation|1|||
126630565|NCT01560871|455605624|FG001|Overall Study|relocation|0|||
126630566|NCT01560871|455605623|FG000|Overall Study|readmission to a hospital|2|||
126630567|NCT01560871|455605624|FG001|Overall Study|readmission to a hospital|1|||
126630568|NCT01560871|455605623|FG000|Overall Study|Lost to Follow-up|1|||
126630569|NCT01560871|455605624|FG001|Overall Study|Lost to Follow-up|0|||
126630570|NCT03605368|455605625|FG000|Overall Study|Lost to Follow-up|2|||
126630571|NCT03605368|455605626|FG001|Overall Study|Lost to Follow-up|1|||
126630572|NCT03605368|455605627|FG002|Overall Study|Lost to Follow-up|3|||
126630573|NCT03605368|455605628|FG003|Overall Study|Lost to Follow-up|2|||
126630574|NCT03605368|455605625|FG000|Overall Study|Withdrawal by Subject|0|||
126630575|NCT03605368|455605626|FG001|Overall Study|Withdrawal by Subject|0|||
126630576|NCT03605368|455605627|FG002|Overall Study|Withdrawal by Subject|4|||
126630577|NCT03605368|455605628|FG003|Overall Study|Withdrawal by Subject|3|||
126630578|NCT04088136|455605635|FG000|Overall Study|Withdrawal by Subject|5|||
126630579|NCT04088136|455605636|FG001|Overall Study|Withdrawal by Subject|0|||
126630580|NCT04088136|455605635|FG000|Overall Study|Lack of Efficacy|0|||
126630581|NCT04088136|455605636|FG001|Overall Study|Lack of Efficacy|1|||
126630582|NCT00514813|455605637|FG000|Overall Study|Study terminated|14|||
126630583|NCT00514813|455605638|FG001|Overall Study|Study terminated|74|||
126630584|NCT00514813|455605639|FG002|Overall Study|Study terminated|40|||
126630585|NCT00514813|455605640|FG003|Overall Study|Study terminated|2|||
126630586|NCT00514813|455605637|FG000|Overall Study|Adverse Event|0|||
126630587|NCT00514813|455605638|FG001|Overall Study|Adverse Event|2|||
126630588|NCT00514813|455605639|FG002|Overall Study|Adverse Event|2|||
126630589|NCT00514813|455605640|FG003|Overall Study|Adverse Event|0|||
126630590|NCT00514813|455605637|FG000|Overall Study|Protocol Violation|1|||
126630591|NCT00514813|455605638|FG001|Overall Study|Protocol Violation|0|||
126630592|NCT00514813|455605639|FG002|Overall Study|Protocol Violation|0|||
126630593|NCT00514813|455605640|FG003|Overall Study|Protocol Violation|0|||
126630594|NCT00514813|455605637|FG000|Overall Study|Withdrawal by Subject|0|||
126630595|NCT00514813|455605638|FG001|Overall Study|Withdrawal by Subject|1|||
126630596|NCT00514813|455605639|FG002|Overall Study|Withdrawal by Subject|0|||
126630597|NCT00514813|455605640|FG003|Overall Study|Withdrawal by Subject|0|||
126630598|NCT00514813|455605637|FG000|Overall Study|Lack of Efficacy|0|||
126630599|NCT00514813|455605638|FG001|Overall Study|Lack of Efficacy|1|||
126630600|NCT00514813|455605639|FG002|Overall Study|Lack of Efficacy|0|||
126630601|NCT00514813|455605640|FG003|Overall Study|Lack of Efficacy|0|||
126630602|NCT00514813|455605637|FG000|Overall Study|Kidney transplant|0|||
126630603|NCT00514813|455605638|FG001|Overall Study|Kidney transplant|6|||
126630604|NCT00514813|455605639|FG002|Overall Study|Kidney transplant|2|||
126630605|NCT00514813|455605640|FG003|Overall Study|Kidney transplant|0|||
126630606|NCT00514813|455605637|FG000|Overall Study|Death|0|||
126630607|NCT00514813|455605638|FG001|Overall Study|Death|2|||
126630608|NCT00514813|455605639|FG002|Overall Study|Death|3|||
126630609|NCT00514813|455605640|FG003|Overall Study|Death|2|||
126630610|NCT02979613|455605641|FG000|Double-Blind Phase|Withdrew Consent|2|||
126755145|NCT01259388|456053061|FG000|Overall Study|Physician Decision|1|||
126755146|NCT01259388|456053062|FG001|Overall Study|Physician Decision|0|||
126755147|NCT02743494|456053065|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
126755148|NCT02743494|456053066|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
126630611|NCT02979613|455605642|FG001|Double-Blind Phase|Withdrew Consent|4|||
126630612|NCT02979613|455605641|FG000|Double-Blind Phase|Pregnancy|2|||
126630613|NCT02979613|455605642|FG001|Double-Blind Phase|Pregnancy|2|||
126630614|NCT02979613|455605641|FG000|Double-Blind Phase|Adverse Event|2|||
126630615|NCT02979613|455605642|FG001|Double-Blind Phase|Adverse Event|0|||
126630616|NCT02979613|455605641|FG000|Double-Blind Phase|Lost to Follow-up|1|||
126630617|NCT02979613|455605642|FG001|Double-Blind Phase|Lost to Follow-up|1|||
126630618|NCT02979613|455605641|FG000|Double-Blind Phase|Protocol Violation|1|||
126630619|NCT02979613|455605642|FG001|Double-Blind Phase|Protocol Violation|1|||
126630620|NCT02979613|455605641|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
126630621|NCT02979613|455605642|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
126630622|NCT02979613|455605641|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
126630623|NCT02979613|455605642|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
126630624|NCT02979613|455605641|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
126630625|NCT02979613|455605642|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
126630626|NCT02979613|455605641|FG000|Open-Label Extension (OLE) Phase|Death|0|||
126630627|NCT02979613|455605642|FG001|Open-Label Extension (OLE) Phase|Death|1|||
126630628|NCT02979613|455605641|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
126630629|NCT02979613|455605642|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
126630630|NCT00092521|455607261|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
126630631|NCT00092521|455607262|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
126630632|NCT00092521|455607263|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
126630633|NCT00092521|455607264|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
126630634|NCT00092521|455607261|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
126630635|NCT00092521|455607262|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
126630636|NCT00092521|455607263|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
126630637|NCT00092521|455607264|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
126630638|NCT00092521|455607261|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
126630639|NCT00092521|455607262|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
126630640|NCT00092521|455607263|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
126630641|NCT00092521|455607264|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
126630642|NCT00092521|455607261|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
126630643|NCT00092521|455607262|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
126630644|NCT00092521|455607263|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
126630645|NCT00092521|455607264|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
126630646|NCT00092521|455607261|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
126630647|NCT00092521|455607262|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
126630648|NCT00092521|455607263|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
126630649|NCT00092521|455607264|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
126630650|NCT00092521|455607261|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
126630651|NCT00092521|455607262|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
126630652|NCT00092521|455607263|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
126630653|NCT00092521|455607264|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
126630654|NCT00092521|455607261|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
126630655|NCT00092521|455607262|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
126630656|NCT00092521|455607263|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
126630657|NCT00092521|455607264|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
126630658|NCT00092521|455607261|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
126630659|NCT00092521|455607262|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
126630660|NCT00092521|455607263|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
126630661|NCT00092521|455607264|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
126630662|NCT00092521|455607261|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
126630663|NCT00092521|455607262|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
126630664|NCT00092521|455607263|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
126630665|NCT00092521|455607264|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
126630666|NCT00092521|455607261|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
126630667|NCT00092521|455607262|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
126630668|NCT00092521|455607263|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
126630669|NCT00092521|455607264|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
126630670|NCT00092521|455607261|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
126630671|NCT00092521|455607262|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
126630672|NCT00092521|455607263|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
126630673|NCT00092521|455607264|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
126630674|NCT00092521|455607261|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
126630675|NCT00092521|455607262|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
126630676|NCT00092521|455607263|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
126630677|NCT00092521|455607264|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
126630678|NCT00092521|455607261|FG000|Follow-Up (After Month 7)|Death|2|||
126630679|NCT00092521|455607262|FG001|Follow-Up (After Month 7)|Death|0|||
126630680|NCT00092521|455607263|FG002|Follow-Up (After Month 7)|Death|1|||
126630681|NCT00092521|455607264|FG003|Follow-Up (After Month 7)|Death|0|||
126630682|NCT00092521|455607261|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
126630683|NCT00092521|455607262|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
126630684|NCT00092521|455607263|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
126630685|NCT00092521|455607264|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
126630686|NCT00092521|455607261|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
126630687|NCT00092521|455607262|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
126630688|NCT00092521|455607263|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
126630689|NCT00092521|455607264|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
126630690|NCT00092521|455607261|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
126630691|NCT00092521|455607262|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
126630692|NCT00092521|455607263|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
126630693|NCT00092521|455607264|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
126630694|NCT00092521|455607261|FG000|Follow-Up (After Month 7)|Moved|32|||
126630695|NCT00092521|455607262|FG001|Follow-Up (After Month 7)|Moved|2|||
126630696|NCT00092521|455607263|FG002|Follow-Up (After Month 7)|Moved|28|||
126630697|NCT00092521|455607264|FG003|Follow-Up (After Month 7)|Moved|0|||
126630698|NCT00092521|455607261|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
126630699|NCT00092521|455607262|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
126630700|NCT00092521|455607263|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
126630701|NCT00092521|455607264|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
126630702|NCT00092521|455607261|FG000|Follow-Up (After Month 7)|Travel|2|||
126630703|NCT00092521|455607262|FG001|Follow-Up (After Month 7)|Travel|0|||
126630704|NCT00092521|455607263|FG002|Follow-Up (After Month 7)|Travel|0|||
126630705|NCT00092521|455607264|FG003|Follow-Up (After Month 7)|Travel|0|||
126788197|NCT01901055|456180475|FG000|Week 36|Withdrawal by Subject|0|||
126788198|NCT01901055|456180476|FG001|Week 36|Withdrawal by Subject|5|||
126788199|NCT01179919|456180479|FG000|Overall Study|Protocol Violation|1|||
126788200|NCT01179919|456180479|FG000|Overall Study|Adverse Event|1|||
126630706|NCT00092521|455607261|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
126630707|NCT00092521|455607262|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
126630708|NCT00092521|455607263|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
126630709|NCT00092521|455607264|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
126630710|NCT00092521|455607261|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
126630711|NCT00092521|455607262|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
126630712|NCT00092521|455607263|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
126630713|NCT00092521|455607264|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
126630714|NCT00092521|455607261|FG000|Extension Study (Group 4)|Adverse Event|0|||
126630715|NCT00092521|455607262|FG001|Extension Study (Group 4)|Adverse Event|0|||
126630716|NCT00092521|455607263|FG002|Extension Study (Group 4)|Adverse Event|0|||
126630717|NCT00092521|455607264|FG003|Extension Study (Group 4)|Adverse Event|2|||
126630718|NCT00092521|455607261|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
126630719|NCT00092521|455607262|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
126630720|NCT00092521|455607263|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
126788201|NCT00806156|456180483|FG000|Overall Study|Death|35|||
126630721|NCT00092521|455607264|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
126630722|NCT00092521|455607261|FG000|Extension Study (Group 4)|Pregnancy|0|||
126630723|NCT00092521|455607262|FG001|Extension Study (Group 4)|Pregnancy|0|||
126630724|NCT00092521|455607263|FG002|Extension Study (Group 4)|Pregnancy|0|||
126630725|NCT00092521|455607264|FG003|Extension Study (Group 4)|Pregnancy|4|||
126630726|NCT00092521|455607261|FG000|Extension Study (Group 4)|Protocol Violation|0|||
126630727|NCT00092521|455607262|FG001|Extension Study (Group 4)|Protocol Violation|0|||
126630728|NCT00092521|455607263|FG002|Extension Study (Group 4)|Protocol Violation|0|||
126630729|NCT00092521|455607264|FG003|Extension Study (Group 4)|Protocol Violation|2|||
126630730|NCT00092521|455607261|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
126630731|NCT00092521|455607262|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
126788202|NCT00806156|456180484|FG001|Overall Study|Death|95|||
126788203|NCT00806156|456180483|FG000|Overall Study|Did not meet eligibility criteria|1|||
126788204|NCT00806156|456180484|FG001|Overall Study|Did not meet eligibility criteria|0|||
126788205|NCT00806156|456180483|FG000|Overall Study|Study terminated by Sponsor|2|||
126788206|NCT00806156|456180484|FG001|Overall Study|Study terminated by Sponsor|40|||
126630732|NCT00092521|455607263|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
126630733|NCT00092521|455607264|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
126788207|NCT00806156|456180483|FG000|Overall Study|Consent withdrawn by subject|1|||
126788208|NCT00806156|456180484|FG001|Overall Study|Consent withdrawn by subject|3|||
126630734|NCT00092521|455607261|FG000|Extension Study (Group 4)|Moved|0|||
126630735|NCT00092521|455607262|FG001|Extension Study (Group 4)|Moved|0|||
126630736|NCT00092521|455607263|FG002|Extension Study (Group 4)|Moved|0|||
126630737|NCT00092521|455607264|FG003|Extension Study (Group 4)|Moved|16|||
126630738|NCT00092521|455607261|FG000|Extension Study (Group 4)|Site Terminated|0|||
126630739|NCT00092521|455607262|FG001|Extension Study (Group 4)|Site Terminated|0|||
126630740|NCT00092521|455607263|FG002|Extension Study (Group 4)|Site Terminated|0|||
126630741|NCT00092521|455607264|FG003|Extension Study (Group 4)|Site Terminated|4|||
126630742|NCT00092521|455607261|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
126630743|NCT00092521|455607262|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
126630744|NCT00092521|455607263|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
126630745|NCT00092521|455607264|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
126630746|NCT01878383|455607265|FG000|Overall Study|Lost to Follow-up|0|||
126630747|NCT01878383|455607266|FG001|Overall Study|Lost to Follow-up|1499|||
126630748|NCT03464383|455607267|FG000|Overall Study|Lost to Follow-up|1|||
126630749|NCT03464383|455607268|FG001|Overall Study|Lost to Follow-up|0|||
126630750|NCT03464383|455607269|FG002|Overall Study|Lost to Follow-up|0|||
126630751|NCT03464383|455607267|FG000|Overall Study|Withdrawal by Subject|0|||
126630752|NCT03464383|455607268|FG001|Overall Study|Withdrawal by Subject|1|||
126630753|NCT03464383|455607269|FG002|Overall Study|Withdrawal by Subject|0|||
126630754|NCT03475056|455607270|FG000|Overall Study|Lost to Follow-up|0|||
126630755|NCT03475056|455607271|FG001|Overall Study|Lost to Follow-up|1|||
126630756|NCT03475056|455607270|FG000|Overall Study|Moved from Area|0|||
126630757|NCT03475056|455607271|FG001|Overall Study|Moved from Area|2|||
126630758|NCT01932762|455607272|FG000|Overall Study|Withdrawal by Subject|1|||
126630759|NCT01932762|455607273|FG001|Overall Study|Withdrawal by Subject|2|||
126630760|NCT01932762|455607274|FG002|Overall Study|Withdrawal by Subject|0|||
126630761|NCT01932762|455607275|FG003|Overall Study|Withdrawal by Subject|0|||
126630762|NCT01932762|455607272|FG000|Overall Study|Lost to Follow-up|4|||
126630763|NCT01932762|455607273|FG001|Overall Study|Lost to Follow-up|0|||
126630764|NCT01932762|455607274|FG002|Overall Study|Lost to Follow-up|0|||
126630765|NCT01932762|455607275|FG003|Overall Study|Lost to Follow-up|1|||
126630766|NCT01932762|455607272|FG000|Overall Study|Physician Decision|1|||
126630767|NCT01932762|455607273|FG001|Overall Study|Physician Decision|0|||
126630768|NCT01932762|455607274|FG002|Overall Study|Physician Decision|0|||
126630769|NCT01932762|455607275|FG003|Overall Study|Physician Decision|0|||
126630770|NCT01101334|455607279|FG000|Overall Study|Adverse Event|9|||
126630771|NCT01101334|455607280|FG001|Overall Study|Adverse Event|4|||
126630772|NCT01101334|455607279|FG000|Overall Study|Death|7|||
126630773|NCT01101334|455607280|FG001|Overall Study|Death|1|||
126630774|NCT01101334|455607279|FG000|Overall Study|Withdrawal by Subject|4|||
126630775|NCT01101334|455607280|FG001|Overall Study|Withdrawal by Subject|3|||
126630776|NCT01101334|455607279|FG000|Overall Study|Withdrawal by Sponsor|1|||
126630777|NCT01101334|455607280|FG001|Overall Study|Withdrawal by Sponsor|1|||
126630778|NCT01101334|455607279|FG000|Overall Study|Progressive Disease|22|||
126630779|NCT01101334|455607280|FG001|Overall Study|Progressive Disease|35|||
126630780|NCT01101334|455607279|FG000|Overall Study|Other|2|||
126630781|NCT01101334|455607280|FG001|Overall Study|Other|1|||
126630782|NCT03864341|455607283|FG000|Overall Study|Withdrawal by Subject|1|||
126630783|NCT02826798|455607285|FG000|Overall Study|Withdrawal by Subject|0|||
126630784|NCT02826798|455607286|FG001|Overall Study|Withdrawal by Subject|1|||
126630785|NCT02826798|455607287|FG002|Overall Study|Withdrawal by Subject|0|||
126630786|NCT02826798|455607288|FG003|Overall Study|Withdrawal by Subject|1|||
126630787|NCT02826798|455607289|FG004|Overall Study|Withdrawal by Subject|0|||
126630788|NCT02161406|455607292|FG000|Overall Study|Death|2|||
126630789|NCT02161406|455607293|FG001|Overall Study|Death|1|||
126630790|NCT02161406|455607292|FG000|Overall Study|Lost to Follow-up|2|||
126630791|NCT02161406|455607293|FG001|Overall Study|Lost to Follow-up|1|||
126630792|NCT02161406|455607292|FG000|Overall Study|Withdrawal by Subject|2|||
126630793|NCT02161406|455607293|FG001|Overall Study|Withdrawal by Subject|4|||
126630794|NCT02161406|455607292|FG000|Overall Study|investigator withdrew subject|3|||
126630795|NCT02161406|455607293|FG001|Overall Study|investigator withdrew subject|1|||
126630796|NCT02161406|455607292|FG000|Overall Study|Lack of Efficacy|1|||
126630797|NCT02161406|455607293|FG001|Overall Study|Lack of Efficacy|1|||
126630798|NCT02161406|455607292|FG000|Overall Study|relocation|0|||
126630799|NCT02161406|455607293|FG001|Overall Study|relocation|1|||
126630800|NCT00263211|455607294|FG000|Overall Study|Death|1|||
126630801|NCT00263211|455607295|FG001|Overall Study|Death|0|||
126630802|NCT00263211|455607294|FG000|Overall Study|Withdrawal by Subject|3|||
126630803|NCT00263211|455607295|FG001|Overall Study|Withdrawal by Subject|0|||
126630804|NCT00263211|455607294|FG000|Overall Study|Protocol Violation|1|||
126630805|NCT00263211|455607295|FG001|Overall Study|Protocol Violation|0|||
126630806|NCT00263211|455607294|FG000|Overall Study|Disease Progression|0|||
126630807|NCT00263211|455607295|FG001|Overall Study|Disease Progression|1|||
126630808|NCT00760513|455607296|FG000|Overall Study|Withdrawal by Subject|5|||
126630809|NCT00760513|455607297|FG001|Overall Study|Withdrawal by Subject|7|||
126630810|NCT03458728|455607299|FG000|Overall Study|Adverse Event|1|||
126788209|NCT00806156|456180483|FG000|Overall Study|Lost to Follow-up|0|||
126788210|NCT00806156|456180484|FG001|Overall Study|Lost to Follow-up|1|||
126630811|NCT03458728|455607300|FG001|Overall Study|Adverse Event|0|||
126630812|NCT03458728|455607299|FG000|Overall Study|Physician Decision|1|||
126630813|NCT03458728|455607300|FG001|Overall Study|Physician Decision|0|||
126630814|NCT03458728|455607299|FG000|Overall Study|Progressive disease - clinical assessment|1|||
126630815|NCT03458728|455607300|FG001|Overall Study|Progressive disease - clinical assessment|0|||
126630816|NCT03458728|455607299|FG000|Overall Study|Progressive disease - radiological progression|21|||
126630817|NCT03458728|455607300|FG001|Overall Study|Progressive disease - radiological progression|6|||
126630818|NCT03458728|455607299|FG000|Overall Study|Withdrawal by Subject|0|||
126630819|NCT03458728|455607300|FG001|Overall Study|Withdrawal by Subject|1|||
126630820|NCT00908349|455607301|FG000|Overall Study|Adverse Event|10|||
126630821|NCT00908349|455607301|FG000|Overall Study|Withdrawal by Subject|9|||
126630822|NCT00908349|455607301|FG000|Overall Study|Physician Decision|5|||
126630823|NCT00908349|455607301|FG000|Overall Study|Lost to Follow-up|5|||
126630824|NCT00908349|455607301|FG000|Overall Study|Various|6|||
126630825|NCT00362375|455607302|FG000|Overall Study|Lost to Follow-up|40|||
126630826|NCT00362375|455607303|FG001|Overall Study|Lost to Follow-up|35|||
126630827|NCT01951378|455607304|FG000|Overall Study|Study Terminated-Not completed|23|||
126630828|NCT01951378|455607305|FG001|Overall Study|Study Terminated-Not completed|17|||
126630829|NCT02624869|455607306|FG000|Overall Study|Lost to Follow-up|0|||
126630830|NCT02624869|455607307|FG001|Overall Study|Lost to Follow-up|0|||
126630831|NCT02624869|455607308|FG002|Overall Study|Lost to Follow-up|1|||
126630832|NCT02624869|455607306|FG000|Overall Study|Withdrawal by Subject|1|||
126630833|NCT02624869|455607307|FG001|Overall Study|Withdrawal by Subject|3|||
126630834|NCT02624869|455607308|FG002|Overall Study|Withdrawal by Subject|1|||
126630835|NCT03491215|455607310|FG000|Overall Study|Death|6|||
126630836|NCT03491215|455607311|FG001|Overall Study|Death|2|||
126630837|NCT03491215|455607312|FG002|Overall Study|Death|1|||
126630838|NCT03491215|455607313|FG003|Overall Study|Death|0|||
126788211|NCT00525590|456180488|FG000|Overall Study|Adverse Event|3|||
126788212|NCT00525590|456180488|FG000|Overall Study|Physician Decision|3|||
126788213|NCT00525590|456180488|FG000|Overall Study|Withdrawal by Subject|16|||
126788214|NCT00525590|456180488|FG000|Overall Study|Lost to Follow-up|1|||
126788215|NCT00525590|456180488|FG000|Overall Study|Death|9|||
126788216|NCT00525590|456180488|FG000|Overall Study|Other|13|||
126788217|NCT00337571|456180489|FG000|Overall Study|Lack of Efficacy|3|||
126788218|NCT00337571|456180490|FG001|Overall Study|Lack of Efficacy|0|||
126788219|NCT00337571|456180491|FG002|Overall Study|Lack of Efficacy|0|||
126788220|NCT00337571|456180492|FG003|Overall Study|Lack of Efficacy|0|||
126788221|NCT00337571|456180489|FG000|Overall Study|Adverse Event|4|||
126788222|NCT00337571|456180490|FG001|Overall Study|Adverse Event|5|||
126788223|NCT00337571|456180491|FG002|Overall Study|Adverse Event|8|||
126788224|NCT00337571|456180492|FG003|Overall Study|Adverse Event|4|||
126788225|NCT00337571|456180489|FG000|Overall Study|Withdrawal by Subject|2|||
126788226|NCT00337571|456180490|FG001|Overall Study|Withdrawal by Subject|2|||
126788227|NCT00337571|456180491|FG002|Overall Study|Withdrawal by Subject|1|||
126788228|NCT00337571|456180492|FG003|Overall Study|Withdrawal by Subject|0|||
126788229|NCT00337571|456180489|FG000|Overall Study|Lost to Follow-up|3|||
126788230|NCT00337571|456180490|FG001|Overall Study|Lost to Follow-up|1|||
126630839|NCT03491215|455607310|FG000|Overall Study|Physician Decision|1|||
126630840|NCT03491215|455607311|FG001|Overall Study|Physician Decision|0|||
126630841|NCT03491215|455607312|FG002|Overall Study|Physician Decision|0|||
126630842|NCT03491215|455607313|FG003|Overall Study|Physician Decision|0|||
126630843|NCT00337285|455607315|FG000|Overall Study|Withdrawal by Subject|42|||
126630844|NCT00337285|455607315|FG000|Overall Study|Lost to Follow-up|41|||
126630845|NCT00337285|455607315|FG000|Overall Study|Adverse Event|28|||
126630846|NCT00337285|455607315|FG000|Overall Study|Protocol Violation|27|||
126630847|NCT00337285|455607315|FG000|Overall Study|Lack of Efficacy|11|||
126630848|NCT00337285|455607315|FG000|Overall Study|Death|1|||
126788231|NCT00337571|456180491|FG002|Overall Study|Lost to Follow-up|0|||
126788232|NCT00337571|456180492|FG003|Overall Study|Lost to Follow-up|1|||
126630849|NCT00337285|455607315|FG000|Overall Study|Physician Decision|1|||
126630850|NCT00337285|455607315|FG000|Overall Study|Lack of protocol compliance|7|||
126630851|NCT01004185|455607316|FG000|Overall Study|Adverse Event|1|||
126630852|NCT01004185|455607317|FG001|Overall Study|Adverse Event|1|||
126630853|NCT01004185|455607316|FG000|Overall Study|Lost to Follow-up|0|||
126630854|NCT01004185|455607317|FG001|Overall Study|Lost to Follow-up|1|||
126630855|NCT01004185|455607316|FG000|Overall Study|Lack of Efficacy|2|||
126788233|NCT00337571|456180489|FG000|Overall Study|Poor/noncompliance|1|||
126788234|NCT00337571|456180490|FG001|Overall Study|Poor/noncompliance|1|||
126788235|NCT00337571|456180491|FG002|Overall Study|Poor/noncompliance|1|||
126788236|NCT00337571|456180492|FG003|Overall Study|Poor/noncompliance|1|||
126788237|NCT00337571|456180489|FG000|Overall Study|No longer met study criteria|1|||
126630856|NCT01004185|455607317|FG001|Overall Study|Lack of Efficacy|1|||
126630857|NCT01004185|455607316|FG000|Overall Study|Sponsor Terminated Study|4|||
126630858|NCT01004185|455607317|FG001|Overall Study|Sponsor Terminated Study|5|||
126630859|NCT01004185|455607316|FG000|Overall Study|Withdrawal by Subject|2|||
126788238|NCT00337571|456180490|FG001|Overall Study|No longer met study criteria|0|||
126788239|NCT00337571|456180491|FG002|Overall Study|No longer met study criteria|0|||
126630860|NCT01004185|455607317|FG001|Overall Study|Withdrawal by Subject|1|||
126630861|NCT03481556|455607320|FG000|Overall Study|Adverse Event|1|||
126788240|NCT00337571|456180492|FG003|Overall Study|No longer met study criteria|0|||
126630862|NCT03481556|455607321|FG001|Overall Study|Adverse Event|0|||
126630863|NCT03481556|455607322|FG002|Overall Study|Adverse Event|0|||
126630864|NCT03481556|455607323|FG003|Overall Study|Adverse Event|0|||
126788241|NCT00337571|456180489|FG000|Overall Study|High Potassium level|0|||
126788242|NCT00337571|456180490|FG001|Overall Study|High Potassium level|0|||
126630865|NCT03481556|455607320|FG000|Overall Study|Death|4|||
126630866|NCT03481556|455607321|FG001|Overall Study|Death|2|||
126630867|NCT03481556|455607322|FG002|Overall Study|Death|3|||
126630868|NCT03481556|455607323|FG003|Overall Study|Death|16|||
126630869|NCT03481556|455607320|FG000|Overall Study|Study Terminated by Sponsor|10|||
126630870|NCT03481556|455607321|FG001|Overall Study|Study Terminated by Sponsor|5|||
126630871|NCT03481556|455607322|FG002|Overall Study|Study Terminated by Sponsor|2|||
126630872|NCT03481556|455607323|FG003|Overall Study|Study Terminated by Sponsor|9|||
126630873|NCT01085812|455607324|FG000|Open-Label Period|Adverse Event|0|||
126630874|NCT01085812|455607325|FG001|Open-Label Period|Adverse Event|80|||
126630875|NCT01085812|455607324|FG000|Open-Label Period|Lack of Efficacy|0|||
126630876|NCT01085812|455607325|FG001|Open-Label Period|Lack of Efficacy|26|||
126630877|NCT01085812|455607324|FG000|Open-Label Period|Protocol Violation|0|||
126630878|NCT01085812|455607325|FG001|Open-Label Period|Protocol Violation|39|||
126630879|NCT01085812|455607324|FG000|Open-Label Period|Withdrawal by Subject|0|||
126630880|NCT01085812|455607325|FG001|Open-Label Period|Withdrawal by Subject|53|||
126630881|NCT01085812|455607324|FG000|Open-Label Period|Lost to Follow-up|0|||
126630882|NCT01085812|455607325|FG001|Open-Label Period|Lost to Follow-up|42|||
126630883|NCT01085812|455607324|FG000|Double-Blind Period|Adverse Event|3|||
126630884|NCT01085812|455607325|FG001|Double-Blind Period|Adverse Event|8|||
126630885|NCT01085812|455607324|FG000|Double-Blind Period|Protocol Violation|2|||
126630886|NCT01085812|455607325|FG001|Double-Blind Period|Protocol Violation|7|||
126630887|NCT01085812|455607324|FG000|Double-Blind Period|Withdrawal by Subject|11|||
126630888|NCT01085812|455607325|FG001|Double-Blind Period|Withdrawal by Subject|24|||
126630889|NCT01085812|455607324|FG000|Double-Blind Period|Lost to Follow-up|5|||
126630890|NCT01085812|455607325|FG001|Double-Blind Period|Lost to Follow-up|17|||
126630891|NCT01085812|455607324|FG000|Double-Blind Period|Other Reasons|0|||
126630892|NCT01085812|455607325|FG001|Double-Blind Period|Other Reasons|2|||
126630893|NCT01085812|455607324|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
126630894|NCT01085812|455607325|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
126630895|NCT01085812|455607324|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
126630896|NCT01085812|455607325|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
126630897|NCT01085812|455607324|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
126630898|NCT01085812|455607325|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
126630899|NCT01085812|455607324|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
126630900|NCT01085812|455607325|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
126630901|NCT01085812|455607324|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
126630902|NCT01085812|455607325|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
126630903|NCT01101997|455607326|FG000|Overall Study|Withdrawal by Subject|2|||
126630904|NCT01172639|455607329|FG000|Overall Study|Death|1|||
126630905|NCT01172639|455607330|FG001|Overall Study|Death|1|||
126630906|NCT01172639|455607331|FG002|Overall Study|Death|0|||
126630907|NCT01172639|455607332|FG003|Overall Study|Death|0|||
126630908|NCT01172639|455607333|FG004|Overall Study|Death|0|||
126630909|NCT01172639|455607329|FG000|Overall Study|Lost to Follow-up|9|||
126630910|NCT01172639|455607330|FG001|Overall Study|Lost to Follow-up|7|||
126630911|NCT01172639|455607331|FG002|Overall Study|Lost to Follow-up|11|||
126630912|NCT01172639|455607332|FG003|Overall Study|Lost to Follow-up|6|||
126788243|NCT00337571|456180491|FG002|Overall Study|High Potassium level|0|||
126788244|NCT00337571|456180492|FG003|Overall Study|High Potassium level|1|||
126788245|NCT00449150|456180493|FG000|Overall Study|Adverse Event|11|||
126788246|NCT00449150|456180494|FG001|Overall Study|Adverse Event|18|||
126788247|NCT00449150|456180495|FG002|Overall Study|Adverse Event|9|||
126788248|NCT00449150|456180493|FG000|Overall Study|Lack of Efficacy|1|||
126788249|NCT00449150|456180494|FG001|Overall Study|Lack of Efficacy|2|||
126788250|NCT00449150|456180495|FG002|Overall Study|Lack of Efficacy|2|||
126788251|NCT00449150|456180493|FG000|Overall Study|Other|16|||
126788252|NCT00449150|456180494|FG001|Overall Study|Other|13|||
126788253|NCT00449150|456180495|FG002|Overall Study|Other|14|||
126630913|NCT01172639|455607333|FG004|Overall Study|Lost to Follow-up|6|||
126630914|NCT01172639|455607329|FG000|Overall Study|Withdrawal by Subject|3|||
126630915|NCT01172639|455607330|FG001|Overall Study|Withdrawal by Subject|3|||
126630916|NCT01172639|455607331|FG002|Overall Study|Withdrawal by Subject|5|||
126630917|NCT01172639|455607332|FG003|Overall Study|Withdrawal by Subject|5|||
126630918|NCT01172639|455607333|FG004|Overall Study|Withdrawal by Subject|0|||
126630919|NCT00469456|455607334|FG000|Overall Study|Adverse Event|4|||
126630920|NCT00469456|455607335|FG001|Overall Study|Adverse Event|3|||
126630921|NCT00469456|455607334|FG000|Overall Study|Protocol Violation|1|||
126788254|NCT00449150|456180493|FG000|Overall Study|Withdrawal by Subject|17|||
126788255|NCT00449150|456180494|FG001|Overall Study|Withdrawal by Subject|18|||
126630922|NCT00469456|455607335|FG001|Overall Study|Protocol Violation|0|||
126630923|NCT00469456|455607334|FG000|Overall Study|Withdrawal by Subject|4|||
126630924|NCT00469456|455607335|FG001|Overall Study|Withdrawal by Subject|1|||
126630925|NCT00350298|455607338|FG000|Overall Study|Death|7|||
126630926|NCT00350298|455607339|FG001|Overall Study|Death|8|||
126630927|NCT00350298|455607338|FG000|Overall Study|Lost to Follow-up|1|||
126788256|NCT00449150|456180495|FG002|Overall Study|Withdrawal by Subject|21|||
126788257|NCT00449150|456180493|FG000|Overall Study|Protocol Violation|1|||
126788258|NCT00449150|456180494|FG001|Overall Study|Protocol Violation|2|||
126788259|NCT00449150|456180495|FG002|Overall Study|Protocol Violation|1|||
126788260|NCT01345019|456180503|FG000|Blinded Treatment Phase|Death|147|||
126788261|NCT01345019|456180504|FG001|Blinded Treatment Phase|Death|137|||
126788262|NCT01345019|456180503|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
126788263|NCT01345019|456180504|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
126788264|NCT01345019|456180503|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
126788265|NCT01345019|456180504|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
126788266|NCT01345019|456180503|FG000|Blinded Treatment Phase|Disease Progression|12|||
126788267|NCT01345019|456180504|FG001|Blinded Treatment Phase|Disease Progression|10|||
126788268|NCT01345019|456180503|FG000|Blinded Treatment Phase|Adverse Event|6|||
126788269|NCT01345019|456180504|FG001|Blinded Treatment Phase|Adverse Event|13|||
126788270|NCT01345019|456180503|FG000|Blinded Treatment Phase|Administrative Decision|10|||
126788271|NCT01345019|456180504|FG001|Blinded Treatment Phase|Administrative Decision|8|||
126788272|NCT01345019|456180503|FG000|Blinded Treatment Phase|Noncompliance|5|||
126788273|NCT01345019|456180504|FG001|Blinded Treatment Phase|Noncompliance|3|||
126788274|NCT01345019|456180503|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
126788275|NCT01345019|456180504|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
126788276|NCT01345019|456180503|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
126788277|NCT01345019|456180504|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
126788278|NCT01345019|456180503|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
126788279|NCT01345019|456180504|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
126788280|NCT01345019|456180503|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
126788281|NCT01345019|456180504|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
126788282|NCT01345019|456180503|FG000|Open Label Treatment Phase|Death|49|||
126788283|NCT01345019|456180504|FG001|Open Label Treatment Phase|Death|48|||
126788284|NCT01345019|456180503|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
126788285|NCT01345019|456180504|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
126788286|NCT01345019|456180503|FG000|Open Label Treatment Phase|Adverse Event|30|||
126788287|NCT01345019|456180504|FG001|Open Label Treatment Phase|Adverse Event|51|||
126788288|NCT01345019|456180503|FG000|Open Label Treatment Phase|Administrative Decision|30|||
126630928|NCT00350298|455607339|FG001|Overall Study|Lost to Follow-up|2|||
126630929|NCT00350298|455607338|FG000|Overall Study|Withdrawal by Subject|1|||
126630930|NCT00350298|455607339|FG001|Overall Study|Withdrawal by Subject|3|||
126630931|NCT03634839|455607340|FG000|First Intervention (2 Hours)|Adverse Event|0|||
126630932|NCT03634839|455607341|FG001|First Intervention (2 Hours)|Adverse Event|2|||
126630933|NCT02447432|455607342|FG000|Epoch 001|Adverse Event|1|||
126630934|NCT02447432|455607343|FG001|Epoch 001|Adverse Event|1|||
126630935|NCT02447432|455607342|FG000|Epoch 001|Withdrawal by Subject|0|||
126630936|NCT02447432|455607343|FG001|Epoch 001|Withdrawal by Subject|4|||
126630937|NCT02447432|455607342|FG000|Epoch 001|Migrated/moved from study area|3|||
126630938|NCT02447432|455607343|FG001|Epoch 001|Migrated/moved from study area|5|||
126630939|NCT02447432|455607342|FG000|Epoch 001|Lost to Follow-up|1|||
126630940|NCT02447432|455607343|FG001|Epoch 001|Lost to Follow-up|3|||
126630941|NCT00233389|455607346|FG000|Overall Study|Adverse Event|5|||
126630942|NCT00233389|455607347|FG001|Overall Study|Adverse Event|5|||
126630943|NCT00233389|455607346|FG000|Overall Study|Lack of Efficacy|11|||
126630944|NCT00233389|455607347|FG001|Overall Study|Lack of Efficacy|8|||
126630945|NCT00233389|455607346|FG000|Overall Study|Lost to Follow-up|1|||
126630946|NCT00233389|455607347|FG001|Overall Study|Lost to Follow-up|1|||
126630947|NCT00233389|455607346|FG000|Overall Study|Physician Decision|1|||
126630948|NCT00233389|455607347|FG001|Overall Study|Physician Decision|0|||
126630949|NCT00233389|455607346|FG000|Overall Study|Protocol Violation|0|||
126630950|NCT00233389|455607347|FG001|Overall Study|Protocol Violation|1|||
126630951|NCT00233389|455607346|FG000|Overall Study|Withdrawal by Subject|0|||
126630952|NCT00233389|455607347|FG001|Overall Study|Withdrawal by Subject|1|||
126630953|NCT00302159|455607350|FG000|Overall Study|pt declined before treatment started|1|||
126630954|NCT00302159|455607350|FG000|Overall Study|pt started Avastin|1|||
126788289|NCT01345019|456180504|FG001|Open Label Treatment Phase|Administrative Decision|15|||
126788290|NCT01345019|456180503|FG000|Open Label Treatment Phase|Disease Progression|17|||
126788291|NCT01345019|456180504|FG001|Open Label Treatment Phase|Disease Progression|18|||
126630955|NCT01657877|455607355|FG000|Overall Study|Withdrawal by Subject|4|||
126630956|NCT01657877|455607355|FG000|Overall Study|Protocol Violation|6|||
126630957|NCT01657877|455607355|FG000|Overall Study|Adverse Event|2|||
126630958|NCT01657877|455607355|FG000|Overall Study|Other Reason|2|||
126630959|NCT01114672|455607357|FG000|Overall Study|Death|0|||
126630960|NCT01114672|455607358|FG001|Overall Study|Death|1|||
126630961|NCT01114672|455607357|FG000|Overall Study|Withdrawal by Subject|2|||
126788292|NCT01345019|456180503|FG000|Open Label Treatment Phase|Noncompliance|5|||
126788293|NCT01345019|456180504|FG001|Open Label Treatment Phase|Noncompliance|4|||
126630962|NCT01114672|455607358|FG001|Overall Study|Withdrawal by Subject|1|||
126788294|NCT01345019|456180503|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
126630963|NCT01114672|455607357|FG000|Overall Study|Lost to Follow-up|1|||
126630964|NCT01114672|455607358|FG001|Overall Study|Lost to Follow-up|0|||
126630965|NCT01114672|455607357|FG000|Overall Study|transplanted|1|||
126630966|NCT01114672|455607358|FG001|Overall Study|transplanted|0|||
126630967|NCT03318783|455607361|FG000|Overall Study|Withdrawal by Subject|0|||
126630968|NCT03318783|455607362|FG001|Overall Study|Withdrawal by Subject|1|||
126630969|NCT03318783|455607361|FG000|Overall Study|Death|0|||
126630970|NCT03318783|455607362|FG001|Overall Study|Death|1|||
126630971|NCT04035577|455607367|FG000|Overall Study|Lost to Follow-up|1|||
126630972|NCT04035577|455607367|FG000|Overall Study|Withdrawal by Subject|1|||
126630973|NCT01313624|455607369|FG000|Double-Blind Phase|Adverse Event|27|||
126630974|NCT01313624|455607370|FG001|Double-Blind Phase|Adverse Event|4|||
126630975|NCT01313624|455607369|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
126630976|NCT01313624|455607370|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
126630977|NCT01313624|455607369|FG000|Double-Blind Phase|Lost to Follow-up|0|||
126630978|NCT01313624|455607370|FG001|Double-Blind Phase|Lost to Follow-up|2|||
126630979|NCT01313624|455607369|FG000|Double-Blind Phase|Physician Decision|1|||
126630980|NCT01313624|455607370|FG001|Double-Blind Phase|Physician Decision|0|||
126630981|NCT01313624|455607369|FG000|Double-Blind Phase|Lack of Efficacy|1|||
126630982|NCT01313624|455607370|FG001|Double-Blind Phase|Lack of Efficacy|0|||
126630983|NCT01313624|455607369|FG000|Open-Label Phase|Adverse Event|1|||
126630984|NCT01313624|455607370|FG001|Open-Label Phase|Adverse Event|10|||
126630985|NCT01313624|455607369|FG000|Open-Label Phase|Withdrawal by Subject|2|||
126630986|NCT01313624|455607370|FG001|Open-Label Phase|Withdrawal by Subject|2|||
126630987|NCT01313624|455607369|FG000|Open-Label Phase|Lost to Follow-up|1|||
126630988|NCT01313624|455607370|FG001|Open-Label Phase|Lost to Follow-up|1|||
126630989|NCT00104637|455607371|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
126630990|NCT00104637|455607372|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
126630991|NCT00505414|455607373|FG000|Titration Phase|Adverse Event|0|||
126630992|NCT00505414|455607374|FG001|Titration Phase|Adverse Event|0|||
126788295|NCT01345019|456180504|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
126788296|NCT01345019|456180503|FG000|Open Label Treatment Phase|Pregnancy|1|||
126788297|NCT01345019|456180504|FG001|Open Label Treatment Phase|Pregnancy|0|||
126788298|NCT01345019|456180503|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
126788299|NCT01345019|456180504|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
126788300|NCT01345019|456180503|FG000|Open Label Treatment Phase|Protocol Violation|0|||
126788301|NCT01345019|456180504|FG001|Open Label Treatment Phase|Protocol Violation|1|||
126788302|NCT04646109|456180512|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
126788303|NCT04646109|456180513|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
126788304|NCT00577460|456180514|FG000|Overall Study|Adverse Event|11|||
126788305|NCT00577460|456180515|FG001|Overall Study|Adverse Event|7|||
126788306|NCT00577460|456180516|FG002|Overall Study|Adverse Event|14|||
126788307|NCT00577460|456180514|FG000|Overall Study|Protocol Violation|0|||
126630993|NCT00505414|455607375|FG002|Titration Phase|Adverse Event|0|||
126630994|NCT00505414|455607376|FG003|Titration Phase|Adverse Event|8|||
126630995|NCT00505414|455607377|FG004|Titration Phase|Adverse Event|3|||
126630996|NCT00505414|455607373|FG000|Titration Phase|Death|0|||
126630997|NCT00505414|455607374|FG001|Titration Phase|Death|0|||
126630998|NCT00505414|455607375|FG002|Titration Phase|Death|0|||
126630999|NCT00505414|455607376|FG003|Titration Phase|Death|2|||
126631000|NCT00505414|455607377|FG004|Titration Phase|Death|0|||
126631001|NCT00505414|455607373|FG000|Titration Phase|Lack of Efficacy|0|||
126631002|NCT00505414|455607374|FG001|Titration Phase|Lack of Efficacy|0|||
126631003|NCT00505414|455607375|FG002|Titration Phase|Lack of Efficacy|0|||
126631004|NCT00505414|455607376|FG003|Titration Phase|Lack of Efficacy|10|||
126631005|NCT00505414|455607377|FG004|Titration Phase|Lack of Efficacy|1|||
126631006|NCT00505414|455607373|FG000|Titration Phase|Protocol Violation|0|||
126631007|NCT00505414|455607374|FG001|Titration Phase|Protocol Violation|0|||
126631008|NCT00505414|455607375|FG002|Titration Phase|Protocol Violation|0|||
126631009|NCT00505414|455607376|FG003|Titration Phase|Protocol Violation|0|||
126631010|NCT00505414|455607377|FG004|Titration Phase|Protocol Violation|1|||
126788308|NCT00577460|456180515|FG001|Overall Study|Protocol Violation|1|||
126631011|NCT00505414|455607373|FG000|Titration Phase|Withdrawal by Subject|0|||
126631012|NCT00505414|455607374|FG001|Titration Phase|Withdrawal by Subject|0|||
126631013|NCT00505414|455607375|FG002|Titration Phase|Withdrawal by Subject|0|||
126631014|NCT00505414|455607376|FG003|Titration Phase|Withdrawal by Subject|3|||
126631015|NCT00505414|455607377|FG004|Titration Phase|Withdrawal by Subject|4|||
126631016|NCT00505414|455607373|FG000|Titration Phase|Underlying disease and therapy required|0|||
126631017|NCT00505414|455607374|FG001|Titration Phase|Underlying disease and therapy required|0|||
126631018|NCT00505414|455607375|FG002|Titration Phase|Underlying disease and therapy required|0|||
126631019|NCT00505414|455607376|FG003|Titration Phase|Underlying disease and therapy required|7|||
126631020|NCT00505414|455607377|FG004|Titration Phase|Underlying disease and therapy required|3|||
126788309|NCT00577460|456180516|FG002|Overall Study|Protocol Violation|1|||
126631021|NCT00505414|455607373|FG000|Maintenance Phase|Adverse Event|2|||
126631022|NCT00505414|455607374|FG001|Maintenance Phase|Adverse Event|2|||
126631023|NCT00505414|455607375|FG002|Maintenance Phase|Adverse Event|3|||
126631024|NCT00505414|455607376|FG003|Maintenance Phase|Adverse Event|0|||
126631025|NCT00505414|455607377|FG004|Maintenance Phase|Adverse Event|0|||
126631026|NCT00505414|455607373|FG000|Maintenance Phase|Death|2|||
126631027|NCT00505414|455607374|FG001|Maintenance Phase|Death|0|||
126631028|NCT00505414|455607375|FG002|Maintenance Phase|Death|1|||
126631029|NCT00505414|455607376|FG003|Maintenance Phase|Death|0|||
126631030|NCT00505414|455607377|FG004|Maintenance Phase|Death|0|||
126631031|NCT00505414|455607373|FG000|Maintenance Phase|Lack of Efficacy|2|||
126631032|NCT00505414|455607374|FG001|Maintenance Phase|Lack of Efficacy|1|||
126631033|NCT00505414|455607375|FG002|Maintenance Phase|Lack of Efficacy|1|||
126631034|NCT00505414|455607376|FG003|Maintenance Phase|Lack of Efficacy|0|||
126631035|NCT00505414|455607377|FG004|Maintenance Phase|Lack of Efficacy|0|||
126631036|NCT00505414|455607373|FG000|Maintenance Phase|Withdrawal by Subject|0|||
126631037|NCT00505414|455607374|FG001|Maintenance Phase|Withdrawal by Subject|0|||
126631038|NCT00505414|455607375|FG002|Maintenance Phase|Withdrawal by Subject|1|||
126631039|NCT00505414|455607376|FG003|Maintenance Phase|Withdrawal by Subject|0|||
126631040|NCT00505414|455607377|FG004|Maintenance Phase|Withdrawal by Subject|0|||
126631041|NCT00505414|455607373|FG000|Maintenance Phase|underlying disease and therapy required|0|||
126631042|NCT00505414|455607374|FG001|Maintenance Phase|underlying disease and therapy required|2|||
126631043|NCT00505414|455607375|FG002|Maintenance Phase|underlying disease and therapy required|2|||
126631044|NCT00505414|455607376|FG003|Maintenance Phase|underlying disease and therapy required|0|||
126631045|NCT00505414|455607377|FG004|Maintenance Phase|underlying disease and therapy required|0|||
126631046|NCT00644878|455607378|FG000|Overall Study|Adverse Event|2|||
126631047|NCT00644878|455607378|FG000|Overall Study|Abnormal laboratory value|3|||
126631048|NCT00644878|455607378|FG000|Overall Study|Protocol deviation|2|||
126631049|NCT00644878|455607378|FG000|Overall Study|Treatment duration completed as per protocol|11|||
126631050|NCT00591591|455607381|FG000|Overall Study|Withdrawal by Subject|1|||
126631051|NCT00591591|455607382|FG001|Overall Study|Withdrawal by Subject|37|||
126631052|NCT00591591|455607381|FG000|Overall Study|Lack of Efficacy|10|||
126631053|NCT00591591|455607382|FG001|Overall Study|Lack of Efficacy|2|||
126631054|NCT01841112|455607388|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
126631055|NCT01841112|455607389|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
126631056|NCT01841112|455607390|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
126631057|NCT01841112|455607391|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
126631058|NCT01841112|455607392|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
126631059|NCT00878553|455607393|FG000|Sleep Study|Withdrawal by Subject|2|||
126631060|NCT00878553|455607394|FG001|Sleep Study|Withdrawal by Subject|0|||
126631061|NCT00878553|455607395|FG002|Sleep Study|Withdrawal by Subject|0|||
126631062|NCT00878553|455607396|FG003|Sleep Study|Withdrawal by Subject|0|||
126631063|NCT00878553|455607397|FG004|Sleep Study|Withdrawal by Subject|0|||
126631064|NCT00878553|455607393|FG000|Sleep Study|Lost to Follow-up|1|||
126631065|NCT00878553|455607394|FG001|Sleep Study|Lost to Follow-up|0|||
126631066|NCT00878553|455607395|FG002|Sleep Study|Lost to Follow-up|0|||
126631067|NCT00878553|455607396|FG003|Sleep Study|Lost to Follow-up|0|||
126631068|NCT00878553|455607397|FG004|Sleep Study|Lost to Follow-up|0|||
126631069|NCT00878553|455607393|FG000|Sleep Study|car accident|1|||
126631070|NCT00878553|455607394|FG001|Sleep Study|car accident|0|||
126631071|NCT00878553|455607395|FG002|Sleep Study|car accident|0|||
126631072|NCT00878553|455607396|FG003|Sleep Study|car accident|0|||
126631073|NCT00878553|455607397|FG004|Sleep Study|car accident|0|||
126631074|NCT00878553|455607393|FG000|Sleep Study|family emergency|1|||
126631075|NCT00878553|455607394|FG001|Sleep Study|family emergency|0|||
126631076|NCT00878553|455607395|FG002|Sleep Study|family emergency|0|||
126631077|NCT00878553|455607396|FG003|Sleep Study|family emergency|0|||
126631078|NCT00878553|455607397|FG004|Sleep Study|family emergency|0|||
126631079|NCT00878553|455607393|FG000|PK Study|Withdrawal by Subject|0|||
126631080|NCT00878553|455607394|FG001|PK Study|Withdrawal by Subject|0|||
126631081|NCT00878553|455607395|FG002|PK Study|Withdrawal by Subject|0|||
126631082|NCT00878553|455607396|FG003|PK Study|Withdrawal by Subject|1|||
126631083|NCT00878553|455607397|FG004|PK Study|Withdrawal by Subject|0|||
126631084|NCT00461123|455607398|FG000|Overall Study|Adverse Event|1|||
126631085|NCT00461123|455607399|FG001|Overall Study|Adverse Event|0|||
126631086|NCT00461123|455607398|FG000|Overall Study|Lost to Follow-up|1|||
126631087|NCT00461123|455607399|FG001|Overall Study|Lost to Follow-up|1|||
126631088|NCT00461123|455607398|FG000|Overall Study|Protocol Violation|3|||
126631089|NCT00461123|455607399|FG001|Overall Study|Protocol Violation|2|||
126631090|NCT00461123|455607398|FG000|Overall Study|Withdrawal by Subject|1|||
126631091|NCT00461123|455607399|FG001|Overall Study|Withdrawal by Subject|3|||
126631092|NCT01837797|455607400|FG000|Period 1|Adverse Event|9|||
126631093|NCT01837797|455607401|FG001|Period 1|Adverse Event|0|||
126631094|NCT01837797|455607402|FG002|Period 1|Adverse Event|0|||
126631095|NCT01837797|455607403|FG003|Period 1|Adverse Event|0|||
126631096|NCT01837797|455607404|FG004|Period 1|Adverse Event|0|||
126631097|NCT01837797|455607400|FG000|Period 1|Withdrawal by Subject|6|||
126631098|NCT01837797|455607401|FG001|Period 1|Withdrawal by Subject|0|||
126631099|NCT01837797|455607402|FG002|Period 1|Withdrawal by Subject|0|||
126631100|NCT01837797|455607403|FG003|Period 1|Withdrawal by Subject|0|||
126631101|NCT01837797|455607404|FG004|Period 1|Withdrawal by Subject|0|||
126631102|NCT01837797|455607400|FG000|Period 1|Administrative reasons|76|||
126631103|NCT01837797|455607401|FG001|Period 1|Administrative reasons|0|||
126631104|NCT01837797|455607402|FG002|Period 1|Administrative reasons|0|||
126631105|NCT01837797|455607403|FG003|Period 1|Administrative reasons|0|||
126631106|NCT01837797|455607404|FG004|Period 1|Administrative reasons|0|||
126631107|NCT01837797|455607400|FG000|Period 1|Withdrawal of consent before treatment|1|||
126631108|NCT01837797|455607401|FG001|Period 1|Withdrawal of consent before treatment|0|||
126631109|NCT01837797|455607402|FG002|Period 1|Withdrawal of consent before treatment|0|||
126631110|NCT01837797|455607403|FG003|Period 1|Withdrawal of consent before treatment|0|||
126631111|NCT01837797|455607404|FG004|Period 1|Withdrawal of consent before treatment|0|||
126631112|NCT01837797|455607400|FG000|Period 1|Other|10|||
126631113|NCT01837797|455607401|FG001|Period 1|Other|0|||
126631114|NCT01837797|455607402|FG002|Period 1|Other|0|||
126631115|NCT01837797|455607403|FG003|Period 1|Other|0|||
126631116|NCT01837797|455607404|FG004|Period 1|Other|0|||
126631117|NCT01837797|455607400|FG000|Period 2|Administrative or other reasons|0|||
126631118|NCT01837797|455607401|FG001|Period 2|Administrative or other reasons|5|||
126631119|NCT01837797|455607402|FG002|Period 2|Administrative or other reasons|2|||
126631120|NCT01837797|455607403|FG003|Period 2|Administrative or other reasons|4|||
126631121|NCT01837797|455607404|FG004|Period 2|Administrative or other reasons|0|||
126631122|NCT01837797|455607400|FG000|Period 2|Adverse Event|0|||
126631123|NCT01837797|455607401|FG001|Period 2|Adverse Event|0|||
126631124|NCT01837797|455607402|FG002|Period 2|Adverse Event|0|||
126631125|NCT01837797|455607403|FG003|Period 2|Adverse Event|1|||
126631126|NCT01837797|455607404|FG004|Period 2|Adverse Event|0|||
126631127|NCT01837797|455607400|FG000|Period 3|Adverse Event|0|||
126631128|NCT01837797|455607401|FG001|Period 3|Adverse Event|0|||
126631129|NCT01837797|455607402|FG002|Period 3|Adverse Event|0|||
126631130|NCT01837797|455607403|FG003|Period 3|Adverse Event|0|||
126631131|NCT01837797|455607404|FG004|Period 3|Adverse Event|1|||
126631132|NCT01837797|455607400|FG000|Period 3|Administrative reasons|0|||
126631133|NCT01837797|455607401|FG001|Period 3|Administrative reasons|0|||
126631134|NCT01837797|455607402|FG002|Period 3|Administrative reasons|0|||
126631135|NCT01837797|455607403|FG003|Period 3|Administrative reasons|0|||
126631136|NCT01837797|455607404|FG004|Period 3|Administrative reasons|20|||
126631137|NCT01837797|455607400|FG000|Period 3|Other|0|||
126631138|NCT01837797|455607401|FG001|Period 3|Other|0|||
126631139|NCT01837797|455607402|FG002|Period 3|Other|0|||
126631140|NCT01837797|455607403|FG003|Period 3|Other|0|||
126631141|NCT01837797|455607404|FG004|Period 3|Other|2|||
126631142|NCT01075100|455607406|FG000|Overall Study|Adverse Event|15|||
126631143|NCT01075100|455607407|FG001|Overall Study|Adverse Event|18|||
126631144|NCT01075100|455607406|FG000|Overall Study|Patient Request|4|||
126631145|NCT01075100|455607407|FG001|Overall Study|Patient Request|4|||
126631146|NCT01075100|455607406|FG000|Overall Study|Investigator Request|2|||
126631147|NCT01075100|455607407|FG001|Overall Study|Investigator Request|1|||
126631148|NCT01075100|455607406|FG000|Overall Study|Disease Progression|25|||
126631149|NCT01075100|455607407|FG001|Overall Study|Disease Progression|29|||
126631150|NCT01075100|455607406|FG000|Overall Study|Other|3|||
126631151|NCT01075100|455607407|FG001|Overall Study|Other|1|||
126631152|NCT02250183|455607408|FG000|Overall Study|Withdrawal by Subject|2|||
126631153|NCT02250183|455607408|FG000|Overall Study|Adverse Event|5|||
126631154|NCT02250183|455607408|FG000|Overall Study|Lost to Follow-up|1|||
126631155|NCT05896696|455607409|FG000|Overall Study|Screening Failure|7|||
126631156|NCT05896696|455607409|FG000|Overall Study|Withdrawal by Subject|2|||
126631157|NCT02080403|455609749|FG000|Overall Study|Adverse Event|5|||
126631158|NCT02080403|455609750|FG001|Overall Study|Adverse Event|1|||
126631159|NCT02080403|455609749|FG000|Overall Study|Death|0|||
126631160|NCT02080403|455609750|FG001|Overall Study|Death|2|||
126631161|NCT02080403|455609749|FG000|Overall Study|Lost to Follow-up|2|||
126631162|NCT02080403|455609750|FG001|Overall Study|Lost to Follow-up|0|||
126631163|NCT02080403|455609749|FG000|Overall Study|Pregnancy|0|||
126631164|NCT02080403|455609750|FG001|Overall Study|Pregnancy|1|||
126631165|NCT02080403|455609749|FG000|Overall Study|Protocol Violation|3|||
126631166|NCT02080403|455609750|FG001|Overall Study|Protocol Violation|7|||
126631167|NCT02080403|455609749|FG000|Overall Study|Withdrawal by Subject|5|||
126631168|NCT02080403|455609750|FG001|Overall Study|Withdrawal by Subject|1|||
126631169|NCT01999972|455609751|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
126788310|NCT00577460|456180514|FG000|Overall Study|Lost to Follow-up|0|||
126788311|NCT00577460|456180515|FG001|Overall Study|Lost to Follow-up|3|||
126788312|NCT00577460|456180516|FG002|Overall Study|Lost to Follow-up|4|||
126631170|NCT01999972|455609752|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
126631171|NCT01999972|455609753|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
126631172|NCT01999972|455609754|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
126631173|NCT01999972|455609755|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
126631174|NCT01999972|455609756|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
126631175|NCT01999972|455609751|FG000|Dose Escalation Part|Death|0|||
126631176|NCT01999972|455609752|FG001|Dose Escalation Part|Death|1|||
126631177|NCT01999972|455609753|FG002|Dose Escalation Part|Death|0|||
126631178|NCT01999972|455609754|FG003|Dose Escalation Part|Death|0|||
126631179|NCT01999972|455609755|FG004|Dose Escalation Part|Death|0|||
126631180|NCT01999972|455609756|FG005|Dose Escalation Part|Death|0|||
126631181|NCT01999972|455609751|FG000|Dose Escalation Part|Enrolled but not treated|0|||
126631182|NCT01999972|455609752|FG001|Dose Escalation Part|Enrolled but not treated|0|||
126631183|NCT01999972|455609753|FG002|Dose Escalation Part|Enrolled but not treated|1|||
126631184|NCT01999972|455609754|FG003|Dose Escalation Part|Enrolled but not treated|1|||
126631185|NCT01999972|455609755|FG004|Dose Escalation Part|Enrolled but not treated|0|||
126631186|NCT01999972|455609756|FG005|Dose Escalation Part|Enrolled but not treated|0|||
126631187|NCT01999972|455609751|FG000|Dose Escalation Part|Disease progression|3|||
126631188|NCT01999972|455609752|FG001|Dose Escalation Part|Disease progression|2|||
126631189|NCT01999972|455609753|FG002|Dose Escalation Part|Disease progression|3|||
126631190|NCT01999972|455609754|FG003|Dose Escalation Part|Disease progression|6|||
126631191|NCT01999972|455609755|FG004|Dose Escalation Part|Disease progression|0|||
126631192|NCT01999972|455609756|FG005|Dose Escalation Part|Disease progression|0|||
126631193|NCT01999972|455609751|FG000|Dose Escalation Part|Adverse Event|0|||
126631194|NCT01999972|455609752|FG001|Dose Escalation Part|Adverse Event|0|||
126631195|NCT01999972|455609753|FG002|Dose Escalation Part|Adverse Event|0|||
126631196|NCT01999972|455609754|FG003|Dose Escalation Part|Adverse Event|2|||
126631197|NCT01999972|455609755|FG004|Dose Escalation Part|Adverse Event|0|||
126631198|NCT01999972|455609756|FG005|Dose Escalation Part|Adverse Event|0|||
126631199|NCT01999972|455609751|FG000|Dose Escalation Part|Global deterioration of health status|1|||
126631200|NCT01999972|455609752|FG001|Dose Escalation Part|Global deterioration of health status|0|||
126631201|NCT01999972|455609753|FG002|Dose Escalation Part|Global deterioration of health status|0|||
126631202|NCT01999972|455609754|FG003|Dose Escalation Part|Global deterioration of health status|1|||
126631203|NCT01999972|455609755|FG004|Dose Escalation Part|Global deterioration of health status|0|||
126631204|NCT01999972|455609756|FG005|Dose Escalation Part|Global deterioration of health status|0|||
126631205|NCT01999972|455609751|FG000|Dose Expansion Part|Death|0|||
126631206|NCT01999972|455609752|FG001|Dose Expansion Part|Death|0|||
126631207|NCT01999972|455609753|FG002|Dose Expansion Part|Death|0|||
126631208|NCT01999972|455609754|FG003|Dose Expansion Part|Death|0|||
126631209|NCT01999972|455609755|FG004|Dose Expansion Part|Death|2|||
126631210|NCT01999972|455609756|FG005|Dose Expansion Part|Death|1|||
126631211|NCT01999972|455609751|FG000|Dose Expansion Part|Disease progression|0|||
126631212|NCT01999972|455609752|FG001|Dose Expansion Part|Disease progression|0|||
126631213|NCT01999972|455609753|FG002|Dose Expansion Part|Disease progression|0|||
126631214|NCT01999972|455609754|FG003|Dose Expansion Part|Disease progression|0|||
126631215|NCT01999972|455609755|FG004|Dose Expansion Part|Disease progression|9|||
126631216|NCT01999972|455609756|FG005|Dose Expansion Part|Disease progression|3|||
126631217|NCT01999972|455609751|FG000|Dose Expansion Part|Sponsor decision|0|||
126631218|NCT01999972|455609752|FG001|Dose Expansion Part|Sponsor decision|0|||
126631219|NCT01999972|455609753|FG002|Dose Expansion Part|Sponsor decision|0|||
126631220|NCT01999972|455609754|FG003|Dose Expansion Part|Sponsor decision|0|||
126631221|NCT01999972|455609755|FG004|Dose Expansion Part|Sponsor decision|1|||
126631222|NCT01999972|455609756|FG005|Dose Expansion Part|Sponsor decision|0|||
126631223|NCT01999972|455609751|FG000|Dose Expansion Part|Adverse Event|0|||
126631224|NCT01999972|455609752|FG001|Dose Expansion Part|Adverse Event|0|||
126631225|NCT01999972|455609753|FG002|Dose Expansion Part|Adverse Event|0|||
126631226|NCT01999972|455609754|FG003|Dose Expansion Part|Adverse Event|0|||
126631227|NCT01999972|455609755|FG004|Dose Expansion Part|Adverse Event|4|||
126631228|NCT01999972|455609756|FG005|Dose Expansion Part|Adverse Event|2|||
126631229|NCT01999972|455609751|FG000|Dose Expansion Part|Participant's non-compliance|0|||
126631230|NCT01999972|455609752|FG001|Dose Expansion Part|Participant's non-compliance|0|||
126631231|NCT01999972|455609753|FG002|Dose Expansion Part|Participant's non-compliance|0|||
126631232|NCT01999972|455609754|FG003|Dose Expansion Part|Participant's non-compliance|0|||
126631233|NCT01999972|455609755|FG004|Dose Expansion Part|Participant's non-compliance|0|||
126631234|NCT01999972|455609756|FG005|Dose Expansion Part|Participant's non-compliance|1|||
126631235|NCT01999972|455609751|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
126631236|NCT01999972|455609752|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
126631237|NCT01999972|455609753|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
126631238|NCT01999972|455609754|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
126631239|NCT01999972|455609755|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
126631240|NCT01999972|455609756|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
126631241|NCT01999972|455609751|FG000|Dose Expansion Part|Changed to standard of care|0|||
126631242|NCT01999972|455609752|FG001|Dose Expansion Part|Changed to standard of care|0|||
126631243|NCT01999972|455609753|FG002|Dose Expansion Part|Changed to standard of care|0|||
126631244|NCT01999972|455609754|FG003|Dose Expansion Part|Changed to standard of care|0|||
126631245|NCT01999972|455609755|FG004|Dose Expansion Part|Changed to standard of care|1|||
126631246|NCT01999972|455609756|FG005|Dose Expansion Part|Changed to standard of care|0|||
126631247|NCT02202109|455609757|FG000|Overall Study|Lost to Follow-up|88|||
126631248|NCT02202109|455609758|FG001|Overall Study|Lost to Follow-up|87|||
126631249|NCT02202109|455609757|FG000|Overall Study|Withdrawal by Subject|2|||
126631250|NCT02202109|455609758|FG001|Overall Study|Withdrawal by Subject|0|||
126631251|NCT01468077|455609760|FG000|Overall Study|Adverse Event|2|||
126631252|NCT01468077|455609761|FG001|Overall Study|Adverse Event|2|||
126631253|NCT01468077|455609760|FG000|Overall Study|Lack of Efficacy|1|||
126631254|NCT01468077|455609761|FG001|Overall Study|Lack of Efficacy|1|||
126631255|NCT01468077|455609760|FG000|Overall Study|Physician Decision|1|||
126631256|NCT01468077|455609761|FG001|Overall Study|Physician Decision|0|||
126631257|NCT00761956|455609762|FG000|Overall Study|Lost to Follow-up|6|||
126631258|NCT00761956|455609763|FG001|Overall Study|Lost to Follow-up|11|||
126631259|NCT00761956|455609762|FG000|Overall Study|Withdrawal by Subject|3|||
126631260|NCT00761956|455609763|FG001|Overall Study|Withdrawal by Subject|8|||
126631261|NCT00761956|455609762|FG000|Overall Study|Death|0|||
126631262|NCT00761956|455609763|FG001|Overall Study|Death|1|||
126631263|NCT00761956|455609762|FG000|Overall Study|Adverse Event|26|||
126788313|NCT00577460|456180514|FG000|Overall Study|Withdrawal by Subject|5|||
126788314|NCT00577460|456180515|FG001|Overall Study|Withdrawal by Subject|5|||
126788315|NCT00577460|456180516|FG002|Overall Study|Withdrawal by Subject|6|||
126788316|NCT00577460|456180514|FG000|Overall Study|Other|0|||
126788317|NCT00577460|456180515|FG001|Overall Study|Other|3|||
126788318|NCT00577460|456180516|FG002|Overall Study|Other|2|||
126788319|NCT03184441|456180525|FG000|Overall Study|Withdrawal by Subject|1|||
126788320|NCT00182091|456180526|FG000|Overall Study|Withdrawal by Subject|1|||
126788321|NCT00182091|456180527|FG001|Overall Study|Withdrawal by Subject|0|||
126631264|NCT00761956|455609763|FG001|Overall Study|Adverse Event|34|||
126631265|NCT03024996|455609764|FG000|Overall Study|Death|57|||
126631266|NCT03024996|455609765|FG001|Overall Study|Death|55|||
126631267|NCT03024996|455609764|FG000|Overall Study|Disease relapse|1|||
126631268|NCT03024996|455609765|FG001|Overall Study|Disease relapse|0|||
126631269|NCT03024996|455609764|FG000|Overall Study|Lost to Follow-up|5|||
126631270|NCT03024996|455609765|FG001|Overall Study|Lost to Follow-up|10|||
126631271|NCT03024996|455609764|FG000|Overall Study|Other|3|||
126631272|NCT03024996|455609765|FG001|Overall Study|Other|3|||
126631273|NCT03024996|455609764|FG000|Overall Study|Physician Decision|0|||
126631274|NCT03024996|455609765|FG001|Overall Study|Physician Decision|1|||
126631275|NCT03024996|455609764|FG000|Overall Study|Study terminated by sponsor|303|||
126631276|NCT03024996|455609765|FG001|Overall Study|Study terminated by sponsor|283|||
126631277|NCT03024996|455609764|FG000|Overall Study|Withdrawal by Subject|21|||
126631278|NCT03024996|455609765|FG001|Overall Study|Withdrawal by Subject|36|||
126631279|NCT02106195|455609768|FG000|Overall Study|Adverse Event|2|||
126631280|NCT02106195|455609768|FG000|Overall Study|Protocol Violation|1|||
126631281|NCT04469465|455609769|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
126631282|NCT04469465|455609770|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
126631283|NCT04469465|455609769|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
126631284|NCT04469465|455609770|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
126631285|NCT04469465|455609769|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
126631286|NCT04469465|455609770|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
126631287|NCT04469465|455609769|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
126631288|NCT04469465|455609770|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
126631289|NCT04469465|455609769|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
126631290|NCT04469465|455609770|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
126631291|NCT04469465|455609769|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
126631292|NCT04469465|455609770|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
126631293|NCT04469465|455609769|FG000|Long-Term Extension (LTE)|Death|0|||
126631294|NCT04469465|455609770|FG001|Long-Term Extension (LTE)|Death|1|||
126631295|NCT04469465|455609769|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
126631296|NCT04469465|455609770|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
126631297|NCT01660256|455609771|FG000|Overall Study|Adverse Event|4|||
126631298|NCT01660256|455609772|FG001|Overall Study|Adverse Event|0|||
126631299|NCT01660256|455609773|FG002|Overall Study|Adverse Event|2|||
126631300|NCT01660256|455609771|FG000|Overall Study|Withdrawal by Subject|1|||
126631301|NCT01660256|455609772|FG001|Overall Study|Withdrawal by Subject|0|||
126631302|NCT01660256|455609773|FG002|Overall Study|Withdrawal by Subject|2|||
126631303|NCT00551135|455609778|FG000|Overall Study|Adverse Event|1|||
126631304|NCT00551135|455609779|FG001|Overall Study|Adverse Event|0|||
126788322|NCT00182091|456180528|FG002|Overall Study|Withdrawal by Subject|0|||
126788323|NCT00182091|456180529|FG003|Overall Study|Withdrawal by Subject|0|||
126788324|NCT00993616|456180533|FG000|Overall Study|No tumor at entry|1|||
126788325|NCT00993616|456180533|FG000|Overall Study|Never treated|1|||
126631305|NCT00551135|455609780|FG002|Overall Study|Adverse Event|1|||
126631306|NCT00551135|455609781|FG003|Overall Study|Adverse Event|1|||
126631307|NCT00551135|455609778|FG000|Overall Study|Lost to Follow-up|0|||
126631308|NCT00551135|455609779|FG001|Overall Study|Lost to Follow-up|0|||
126788326|NCT03815942|456182010|FG000|Overall Study|Withdrawal by Subject|0|||
126788327|NCT03815942|456182011|FG001|Overall Study|Withdrawal by Subject|17|||
126631309|NCT00551135|455609780|FG002|Overall Study|Lost to Follow-up|0|||
126631310|NCT00551135|455609781|FG003|Overall Study|Lost to Follow-up|1|||
126631311|NCT00551135|455609778|FG000|Overall Study|Other|3|||
126631312|NCT00551135|455609779|FG001|Overall Study|Other|2|||
126631313|NCT00551135|455609780|FG002|Overall Study|Other|1|||
126631314|NCT00551135|455609781|FG003|Overall Study|Other|2|||
126631315|NCT00551135|455609778|FG000|Overall Study|Withdrawal by Subject|1|||
126631316|NCT00551135|455609779|FG001|Overall Study|Withdrawal by Subject|0|||
126631317|NCT00551135|455609780|FG002|Overall Study|Withdrawal by Subject|3|||
126631318|NCT00551135|455609781|FG003|Overall Study|Withdrawal by Subject|1|||
126788328|NCT03717064|456182012|FG000|Period 2|Adverse Event|1|||
126631319|NCT01202409|455609782|FG000|Overall Study|Adverse Event|1|||
126631320|NCT01202409|455609782|FG000|Overall Study|Ineligible - KRAS mutants|7|||
126631321|NCT00858247|455609783|FG000|Baseline Assessment|Withdrawal by Subject|1|||
126631322|NCT00858247|455609784|FG001|Baseline Assessment|Withdrawal by Subject|1|||
126631323|NCT00858247|455609783|FG000|Baseline Assessment|Poor IV access|1|||
126631324|NCT00858247|455609784|FG001|Baseline Assessment|Poor IV access|0|||
126631325|NCT00858247|455609783|FG000|Baseline Assessment|Protocol Violation|0|||
126631326|NCT00858247|455609784|FG001|Baseline Assessment|Protocol Violation|1|||
126631327|NCT00858247|455609783|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
126631328|NCT00858247|455609784|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
126631329|NCT00553605|455609785|FG000|Overall Study|Did not meet entrance criteria|1|||
126631330|NCT00553605|455609786|FG001|Overall Study|Did not meet entrance criteria|3|||
126631331|NCT00553605|455609785|FG000|Overall Study|Did not receive full dose|1|||
126631332|NCT00553605|455609786|FG001|Overall Study|Did not receive full dose|0|||
126631333|NCT00553605|455609785|FG000|Overall Study|Randomized but not treated|2|||
126631334|NCT00553605|455609786|FG001|Overall Study|Randomized but not treated|0|||
126631335|NCT02669407|455609789|FG000|Overall Study|Physician Decision|3|||
126631336|NCT02647788|455609795|FG000|Overall Study|Lost to Follow-up|13|||
126631337|NCT02647788|455609796|FG001|Overall Study|Lost to Follow-up|11|||
126631338|NCT02647788|455609795|FG000|Overall Study|Did not want opiate|0|||
126631339|NCT02647788|455609796|FG001|Overall Study|Did not want opiate|1|||
126631340|NCT02647788|455609795|FG000|Overall Study|Withdrawal by Subject|1|||
126631341|NCT02647788|455609796|FG001|Overall Study|Withdrawal by Subject|0|||
126631342|NCT02647788|455609795|FG000|Overall Study|Felt itchy with assigned medication|1|||
126631343|NCT02647788|455609796|FG001|Overall Study|Felt itchy with assigned medication|0|||
126631344|NCT02647788|455609795|FG000|Overall Study|Felt nauseous with assigned medication|1|||
126631345|NCT02647788|455609796|FG001|Overall Study|Felt nauseous with assigned medication|1|||
126631346|NCT00719043|455609802|FG000|Overall Study|Adverse Event|5|||
126631347|NCT00719043|455609803|FG001|Overall Study|Adverse Event|1|||
126631348|NCT00719043|455609804|FG002|Overall Study|Adverse Event|2|||
126631349|NCT00719043|455609805|FG003|Overall Study|Adverse Event|2|||
126631350|NCT00719043|455609806|FG004|Overall Study|Adverse Event|1|||
126631351|NCT00719043|455609807|FG005|Overall Study|Adverse Event|4|||
126631352|NCT00719043|455609808|FG006|Overall Study|Adverse Event|4|||
126631353|NCT00719043|455609802|FG000|Overall Study|Lost to Follow-up|14|||
126631354|NCT00719043|455609803|FG001|Overall Study|Lost to Follow-up|10|||
126631355|NCT00719043|455609804|FG002|Overall Study|Lost to Follow-up|8|||
126631356|NCT00719043|455609805|FG003|Overall Study|Lost to Follow-up|9|||
126631357|NCT00719043|455609806|FG004|Overall Study|Lost to Follow-up|10|||
126631358|NCT00719043|455609807|FG005|Overall Study|Lost to Follow-up|9|||
126631359|NCT00719043|455609808|FG006|Overall Study|Lost to Follow-up|9|||
126631360|NCT00719043|455609802|FG000|Overall Study|Protocol Violation|0|||
126631361|NCT00719043|455609803|FG001|Overall Study|Protocol Violation|0|||
126631362|NCT00719043|455609804|FG002|Overall Study|Protocol Violation|0|||
126631363|NCT00719043|455609805|FG003|Overall Study|Protocol Violation|0|||
126631364|NCT00719043|455609806|FG004|Overall Study|Protocol Violation|0|||
126631365|NCT00719043|455609807|FG005|Overall Study|Protocol Violation|1|||
126631366|NCT00719043|455609808|FG006|Overall Study|Protocol Violation|0|||
126631367|NCT00719043|455609802|FG000|Overall Study|Other|1|||
126631368|NCT00719043|455609803|FG001|Overall Study|Other|0|||
126631369|NCT00719043|455609804|FG002|Overall Study|Other|1|||
126631370|NCT00719043|455609805|FG003|Overall Study|Other|2|||
126631371|NCT00719043|455609806|FG004|Overall Study|Other|0|||
126631372|NCT00719043|455609807|FG005|Overall Study|Other|2|||
126631373|NCT00719043|455609808|FG006|Overall Study|Other|1|||
126631374|NCT00719043|455609802|FG000|Overall Study|Withdrawal by Subject|12|||
126631375|NCT00719043|455609803|FG001|Overall Study|Withdrawal by Subject|14|||
126631376|NCT00719043|455609804|FG002|Overall Study|Withdrawal by Subject|9|||
126631377|NCT00719043|455609805|FG003|Overall Study|Withdrawal by Subject|10|||
126631378|NCT00719043|455609806|FG004|Overall Study|Withdrawal by Subject|16|||
126631379|NCT00719043|455609807|FG005|Overall Study|Withdrawal by Subject|18|||
126631380|NCT00719043|455609808|FG006|Overall Study|Withdrawal by Subject|14|||
126788329|NCT01298570|456182013|FG000|Overall Study|Disease progression, relapse during acti|64|||
126788330|NCT01298570|456182014|FG001|Overall Study|Disease progression, relapse during acti|40|||
126788331|NCT01298570|456182013|FG000|Overall Study|Adverse Event|20|||
126788332|NCT01298570|456182014|FG001|Overall Study|Adverse Event|2|||
126631381|NCT01588366|455609809|FG000|Overall Study|Adverse Event|0|||
126631382|NCT01588366|455609810|FG001|Overall Study|Adverse Event|1|||
126631383|NCT01588366|455609811|FG002|Overall Study|Adverse Event|0|||
126631384|NCT01588366|455609812|FG003|Overall Study|Adverse Event|1|||
126631385|NCT01588366|455609813|FG004|Overall Study|Adverse Event|0|||
126631386|NCT01588366|455609814|FG005|Overall Study|Adverse Event|2|||
126631387|NCT03245619|455609815|FG000|Part A (Up to Day 22)|Physician Decision|4|||
126631388|NCT03245619|455609816|FG001|Part A (Up to Day 22)|Physician Decision|6|||
126631389|NCT03245619|455609817|FG002|Part A (Up to Day 22)|Physician Decision|6|||
126631390|NCT03245619|455609818|FG003|Part A (Up to Day 22)|Physician Decision|0|||
126631391|NCT03245619|455609819|FG004|Part A (Up to Day 22)|Physician Decision|0|||
126631392|NCT03245619|455609820|FG005|Part A (Up to Day 22)|Physician Decision|0|||
126631393|NCT03245619|455609821|FG006|Part A (Up to Day 22)|Physician Decision|0|||
126631394|NCT03245619|455609822|FG007|Part A (Up to Day 22)|Physician Decision|0|||
126631395|NCT03245619|455609823|FG008|Part A (Up to Day 22)|Physician Decision|0|||
126631396|NCT03245619|455609824|FG009|Part A (Up to Day 22)|Physician Decision|0|||
126631397|NCT03245619|455609825|FG010|Part A (Up to Day 22)|Physician Decision|0|||
126631398|NCT03245619|455609826|FG011|Part A (Up to Day 22)|Physician Decision|0|||
126631399|NCT03245619|455609827|FG012|Part A (Up to Day 22)|Physician Decision|0|||
126631400|NCT03245619|455609828|FG013|Part A (Up to Day 22)|Physician Decision|0|||
126631401|NCT03245619|455609829|FG014|Part A (Up to Day 22)|Physician Decision|0|||
126788333|NCT01298570|456182013|FG000|Overall Study|Withdrawal by Subject|21|||
126788334|NCT01298570|456182014|FG001|Overall Study|Withdrawal by Subject|6|||
126788335|NCT01298570|456182013|FG000|Overall Study|Treatment delay > 4 weeks|4|||
126788336|NCT01298570|456182014|FG001|Overall Study|Treatment delay > 4 weeks|5|||
126788337|NCT01298570|456182013|FG000|Overall Study|Physician Decision|4|||
126788338|NCT01298570|456182014|FG001|Overall Study|Physician Decision|2|||
126788339|NCT01298570|456182013|FG000|Overall Study|Other complicating disease|2|||
126788340|NCT01298570|456182014|FG001|Overall Study|Other complicating disease|1|||
126788341|NCT01298570|456182013|FG000|Overall Study|Surgery|2|||
126788342|NCT01298570|456182014|FG001|Overall Study|Surgery|1|||
126788343|NCT01298570|456182013|FG000|Overall Study|Symptomatic progression/deterioration|3|||
126788344|NCT01298570|456182014|FG001|Overall Study|Symptomatic progression/deterioration|2|||
126788345|NCT01298570|456182013|FG000|Overall Study|Death|0|||
126788346|NCT01298570|456182014|FG001|Overall Study|Death|1|||
126788347|NCT01298570|456182013|FG000|Overall Study|Ineligibility|0|||
126788348|NCT01298570|456182014|FG001|Overall Study|Ineligibility|1|||
126788349|NCT02841709|456182015|FG000|5th Intervention|Adverse Event|2|||
126788350|NCT02841709|456182016|FG001|5th Intervention|Adverse Event|0|||
126788351|NCT02841709|456182017|FG002|5th Intervention|Adverse Event|0|||
126788352|NCT02841709|456182018|FG003|5th Intervention|Adverse Event|0|||
126788353|NCT02841709|456182019|FG004|5th Intervention|Adverse Event|2|||
126788354|NCT01929109|456182020|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
126788355|NCT01929109|456182021|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
126788356|NCT01929109|456182022|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
126788357|NCT01929109|456182023|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
126788358|NCT01929109|456182024|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
126788359|NCT00076102|456182025|FG000|Overall Study|Clinical progression|1|||
126788360|NCT00076102|456182025|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
126788361|NCT00076102|456182025|FG000|Overall Study|plexiform neurofibroma surgery|1|||
126788362|NCT00076102|456182025|FG000|Overall Study|refusal of further therapy|2|||
126788363|NCT01210001|456182026|FG000|Overall Study|Not treated|1|||
126788364|NCT01210001|456182027|FG001|Overall Study|Not treated|0|||
126788365|NCT01210001|456182028|FG002|Overall Study|Not treated|0|||
126788366|NCT01210001|456182026|FG000|Overall Study|Adverse Event|4|||
126788367|NCT01210001|456182027|FG001|Overall Study|Adverse Event|2|||
126788368|NCT01210001|456182028|FG002|Overall Study|Adverse Event|5|||
126788369|NCT01210001|456182026|FG000|Overall Study|Non compliant with protocol|2|||
126788370|NCT01210001|456182027|FG001|Overall Study|Non compliant with protocol|2|||
126788371|NCT01210001|456182028|FG002|Overall Study|Non compliant with protocol|3|||
126788372|NCT01210001|456182026|FG000|Overall Study|Lost to Follow-up|4|||
126788373|NCT01210001|456182027|FG001|Overall Study|Lost to Follow-up|3|||
126788374|NCT01210001|456182028|FG002|Overall Study|Lost to Follow-up|2|||
126788375|NCT01210001|456182026|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
126788376|NCT01210001|456182027|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
126788377|NCT01210001|456182028|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
126788378|NCT01210001|456182026|FG000|Overall Study|Other reason not defined above|2|||
126788379|NCT01210001|456182027|FG001|Overall Study|Other reason not defined above|2|||
126788380|NCT01210001|456182028|FG002|Overall Study|Other reason not defined above|1|||
126788381|NCT01402908|456182029|FG000|Overall Study|Withdrawal by Subject|30|||
126788382|NCT01402908|456182030|FG001|Overall Study|Withdrawal by Subject|17|||
126788383|NCT01402908|456182029|FG000|Overall Study|Lost to Follow-up|3|||
126788384|NCT01402908|456182030|FG001|Overall Study|Lost to Follow-up|1|||
126788385|NCT01402908|456182029|FG000|Overall Study|Physician Decision|1|||
126788386|NCT01402908|456182030|FG001|Overall Study|Physician Decision|0|||
126788387|NCT01739790|456182032|FG000|Overall Study|Early Trial Termination|2|||
126788388|NCT01739790|456182033|FG001|Overall Study|Early Trial Termination|4|||
126788389|NCT02581345|456182034|FG000|Part 1: up to Week 16|Adverse Event|3|||
126788390|NCT02581345|456182035|FG001|Part 1: up to Week 16|Adverse Event|8|||
126788391|NCT02581345|456182036|FG002|Part 1: up to Week 16|Adverse Event|0|||
126788392|NCT02581345|456182037|FG003|Part 1: up to Week 16|Adverse Event|0|||
126788393|NCT02581345|456182034|FG000|Part 1: up to Week 16|Physician Decision|2|||
126788394|NCT02581345|456182035|FG001|Part 1: up to Week 16|Physician Decision|4|||
126788395|NCT02581345|456182036|FG002|Part 1: up to Week 16|Physician Decision|0|||
126788396|NCT02581345|456182037|FG003|Part 1: up to Week 16|Physician Decision|0|||
126788397|NCT02581345|456182034|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
126788398|NCT02581345|456182035|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
126631402|NCT03245619|455609830|FG015|Part A (Up to Day 22)|Physician Decision|0|||
126788399|NCT02581345|456182036|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
126788400|NCT02581345|456182037|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
126788401|NCT02581345|456182034|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
126788402|NCT02581345|456182035|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
126788403|NCT02581345|456182036|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
126788404|NCT02581345|456182037|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
126788405|NCT02581345|456182034|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
126788406|NCT02581345|456182035|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
126788407|NCT02581345|456182036|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
126788408|NCT02581345|456182037|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
126788409|NCT02581345|456182034|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
126788410|NCT02581345|456182035|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
126788411|NCT02581345|456182036|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
126788412|NCT02581345|456182037|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
126788413|NCT02581345|456182034|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
126788414|NCT02581345|456182035|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
126788415|NCT02581345|456182036|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
126788416|NCT02581345|456182037|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
126788417|NCT02581345|456182034|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
126788418|NCT02581345|456182035|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
126788419|NCT02581345|456182036|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
126788420|NCT02581345|456182037|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
126788421|NCT02581345|456182034|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
126788422|NCT02581345|456182035|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
126788423|NCT02581345|456182036|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
126788424|NCT02581345|456182037|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
126788425|NCT02581345|456182034|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
126788426|NCT02581345|456182035|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
126788427|NCT02581345|456182036|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
126788428|NCT02581345|456182037|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
126788429|NCT02581345|456182034|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
126788430|NCT02581345|456182035|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
126788431|NCT02581345|456182036|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
126788432|NCT02581345|456182037|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
126788433|NCT02581345|456182034|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
126788434|NCT02581345|456182035|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
126788435|NCT02581345|456182036|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
126788436|NCT02581345|456182037|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
126788437|NCT01244126|456182043|FG000|Overall Study|Protocol Violation|3|||
126788438|NCT01244126|456182044|FG001|Overall Study|Protocol Violation|3|||
126788439|NCT01244126|456182045|FG002|Overall Study|Protocol Violation|9|||
126788440|NCT01451762|456182046|FG000|Overall Study|Lost to Follow-up|3|||
126788441|NCT01451762|456182047|FG001|Overall Study|Lost to Follow-up|6|||
126788442|NCT01451762|456182048|FG002|Overall Study|Lost to Follow-up|6|||
126788443|NCT00863746|456182053|FG000|Treatment|Not treated|4|||
126788444|NCT00863746|456182054|FG001|Treatment|Not treated|2|||
126788445|NCT00863746|456182053|FG000|Treatment|Adverse Event|41|||
126788446|NCT00863746|456182054|FG001|Treatment|Adverse Event|16|||
126788447|NCT00863746|456182053|FG000|Treatment|non-compliant with study medication|4|||
126788448|NCT00863746|456182054|FG001|Treatment|non-compliant with study medication|0|||
126788449|NCT00863746|456182053|FG000|Treatment|Consent withdrawn|15|||
126788450|NCT00863746|456182054|FG001|Treatment|Consent withdrawn|14|||
126788451|NCT00863746|456182053|FG000|Treatment|Lost to Follow-up|1|||
126788452|NCT00863746|456182054|FG001|Treatment|Lost to Follow-up|0|||
126788453|NCT00863746|456182053|FG000|Treatment|Protocol Violation|5|||
126788454|NCT00863746|456182054|FG001|Treatment|Protocol Violation|3|||
126788455|NCT00863746|456182053|FG000|Treatment|Other|1|||
126788456|NCT00863746|456182054|FG001|Treatment|Other|0|||
126788457|NCT00863746|456182053|FG000|Survival Follow up|Death|244|||
126788458|NCT00863746|456182054|FG001|Survival Follow up|Death|271|||
126788459|NCT00863746|456182053|FG000|Survival Follow up|Lost to Follow-up|2|||
126788460|NCT00863746|456182054|FG001|Survival Follow up|Lost to Follow-up|1|||
126788461|NCT00863746|456182053|FG000|Survival Follow up|Consent Withdrawn|7|||
126788462|NCT00863746|456182054|FG001|Survival Follow up|Consent Withdrawn|8|||
126631403|NCT03245619|455609831|FG016|Part A (Up to Day 22)|Physician Decision|0|||
126631404|NCT02586415|455609834|FG000|Overall Study|Death|13|||
126788463|NCT00862979|456182060|FG000|Overall Study|Adverse Event|6|||
126788464|NCT00862979|456182061|FG001|Overall Study|Adverse Event|3|||
126788465|NCT00862979|456182060|FG000|Overall Study|Protocol Violation|0|||
126788466|NCT00862979|456182061|FG001|Overall Study|Protocol Violation|1|||
126788467|NCT00862979|456182060|FG000|Overall Study|Patient withdrew consent|2|||
126788468|NCT00862979|456182061|FG001|Overall Study|Patient withdrew consent|1|||
126788469|NCT00862979|456182060|FG000|Overall Study|Administrative problems|0|||
126788470|NCT00862979|456182061|FG001|Overall Study|Administrative problems|1|||
126788471|NCT00862979|456182060|FG000|Overall Study|Death|0|||
126755149|NCT02743494|456053065|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
126755150|NCT02743494|456053066|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
126755151|NCT02743494|456053065|FG000|Treatment Period|Completed treatment|229|||
126755152|NCT02743494|456053066|FG001|Treatment Period|Completed treatment|99|||
126755153|NCT02743494|456053065|FG000|Treatment Period|Disease recurrence|149|||
126755154|NCT02743494|456053066|FG001|Treatment Period|Disease recurrence|113|||
126755155|NCT02743494|456053065|FG000|Treatment Period|Study drug toxicity|57|||
126755156|NCT02743494|456053066|FG001|Treatment Period|Study drug toxicity|8|||
126755157|NCT02743494|456053065|FG000|Treatment Period|Death|1|||
126755158|NCT02743494|456053066|FG001|Treatment Period|Death|0|||
126755159|NCT02743494|456053065|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
126755160|NCT02743494|456053066|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
126755161|NCT02743494|456053065|FG000|Treatment Period|Participant request to discontinue treatment|30|||
126755162|NCT02743494|456053066|FG001|Treatment Period|Participant request to discontinue treatment|5|||
126755163|NCT02743494|456053065|FG000|Treatment Period|Participant withdrew consent|12|||
126755164|NCT02743494|456053066|FG001|Treatment Period|Participant withdrew consent|4|||
126755165|NCT02743494|456053065|FG000|Treatment Period|Lost to Follow-up|0|||
126755166|NCT02743494|456053066|FG001|Treatment Period|Lost to Follow-up|1|||
126755167|NCT02743494|456053065|FG000|Treatment Period|Poor/Non-compliance|1|||
126755168|NCT02743494|456053066|FG001|Treatment Period|Poor/Non-compliance|0|||
126755169|NCT02743494|456053065|FG000|Treatment Period|Other reasons|7|||
126755170|NCT02743494|456053066|FG001|Treatment Period|Other reasons|2|||
126755171|NCT03529162|456053067|FG000|Overall Study|Lost to Follow-up|2|||
126755172|NCT03529162|456053068|FG001|Overall Study|Lost to Follow-up|2|||
126755173|NCT00983827|456053069|FG000|Overall Study|Withdrawal by Subject|1|||
126755174|NCT01521494|456053070|FG000|Overall Study|Adverse Event|1|||
126755175|NCT01521494|456053071|FG001|Overall Study|Adverse Event|2|||
126755176|NCT01521494|456053072|FG002|Overall Study|Adverse Event|9|||
126755177|NCT01521494|456053073|FG003|Overall Study|Adverse Event|6|||
126755178|NCT01521494|456053074|FG004|Overall Study|Adverse Event|2|||
126755179|NCT01521494|456053070|FG000|Overall Study|Lack of Efficacy|0|||
126755180|NCT01521494|456053071|FG001|Overall Study|Lack of Efficacy|0|||
126755181|NCT01521494|456053072|FG002|Overall Study|Lack of Efficacy|0|||
126755182|NCT01521494|456053073|FG003|Overall Study|Lack of Efficacy|0|||
126755183|NCT01521494|456053074|FG004|Overall Study|Lack of Efficacy|2|||
126755184|NCT01521494|456053070|FG000|Overall Study|Withdrawal by Subject|1|||
126755185|NCT01521494|456053071|FG001|Overall Study|Withdrawal by Subject|1|||
126755186|NCT01521494|456053072|FG002|Overall Study|Withdrawal by Subject|0|||
126755187|NCT01521494|456053073|FG003|Overall Study|Withdrawal by Subject|2|||
126755188|NCT01521494|456053074|FG004|Overall Study|Withdrawal by Subject|0|||
126755189|NCT01521494|456053070|FG000|Overall Study|Decrease in serum phosphate|0|||
126755190|NCT01521494|456053071|FG001|Overall Study|Decrease in serum phosphate|2|||
126755191|NCT01521494|456053072|FG002|Overall Study|Decrease in serum phosphate|3|||
126755192|NCT01521494|456053073|FG003|Overall Study|Decrease in serum phosphate|12|||
126755193|NCT01521494|456053074|FG004|Overall Study|Decrease in serum phosphate|0|||
126755194|NCT01521494|456053070|FG000|Overall Study|Decrease in serum calcium|0|||
126755195|NCT01521494|456053071|FG001|Overall Study|Decrease in serum calcium|0|||
126755196|NCT01521494|456053072|FG002|Overall Study|Decrease in serum calcium|0|||
126755197|NCT01521494|456053073|FG003|Overall Study|Decrease in serum calcium|1|||
126755198|NCT01521494|456053074|FG004|Overall Study|Decrease in serum calcium|1|||
126755199|NCT01521494|456053070|FG000|Overall Study|Physician Decision|0|||
126755200|NCT01521494|456053071|FG001|Overall Study|Physician Decision|0|||
126755201|NCT01521494|456053072|FG002|Overall Study|Physician Decision|0|||
126755202|NCT01521494|456053073|FG003|Overall Study|Physician Decision|0|||
126755203|NCT01521494|456053074|FG004|Overall Study|Physician Decision|2|||
126755204|NCT02728804|456053080|FG000|Overall Study|Ineligible|3|||
126755205|NCT02728804|456053080|FG000|Overall Study|Did not complete baseline questionnaire|9|||
126755206|NCT02728804|456053080|FG000|Overall Study|Death|99|||
126755207|NCT02918006|456053086|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
126755208|NCT02918006|456053087|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
126755209|NCT02918006|456053088|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
126755210|NCT02918006|456053086|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
126755211|NCT02918006|456053087|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
126755212|NCT02918006|456053088|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
126755213|NCT02918006|456053086|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
126755214|NCT02918006|456053087|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
126755215|NCT02918006|456053088|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
126755216|NCT02918006|456053086|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
126755217|NCT02918006|456053087|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
126755218|NCT02918006|456053088|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
126755219|NCT02918006|456053086|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
126755220|NCT02918006|456053087|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
126755221|NCT02918006|456053088|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
126755222|NCT02918006|456053086|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
126788472|NCT00862979|456182061|FG001|Overall Study|Death|1|||
126788473|NCT01367275|456182064|FG000|Overall Study|Ineligible|1|||
126788474|NCT01367275|456182064|FG000|Overall Study|Disease Progression|2|||
126788475|NCT01545076|456182067|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
126788476|NCT01545076|456182068|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
126788477|NCT01545076|456182069|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
126788478|NCT01545076|456182070|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
126788479|NCT01545076|456182071|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
126788480|NCT01545076|456182067|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
126788481|NCT01545076|456182068|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
126788482|NCT01545076|456182069|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
126788483|NCT01545076|456182070|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
126788484|NCT01545076|456182071|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
126788485|NCT01545076|456182067|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
126788486|NCT01545076|456182068|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
126788487|NCT01545076|456182069|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
126788488|NCT01545076|456182070|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
126788489|NCT01545076|456182071|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
126788490|NCT01545076|456182067|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
126788491|NCT01545076|456182068|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
126788492|NCT01545076|456182069|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
126788493|NCT01545076|456182070|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
126788494|NCT01545076|456182071|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
126788495|NCT01545076|456182067|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
126788496|NCT01545076|456182068|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
126788497|NCT01545076|456182069|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
126788498|NCT01545076|456182070|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
126788499|NCT01545076|456182071|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
126788500|NCT01545076|456182067|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
126788501|NCT01545076|456182068|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
126788502|NCT01545076|456182069|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
126788503|NCT01545076|456182070|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
126788504|NCT01545076|456182071|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
126788505|NCT01545076|456182067|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
126788506|NCT01545076|456182068|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
126788507|NCT01545076|456182069|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
126788508|NCT01545076|456182070|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
126788509|NCT01545076|456182071|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
126788510|NCT01545076|456182067|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
126788511|NCT01545076|456182068|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
126788512|NCT01545076|456182069|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
126788513|NCT01545076|456182070|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
126788514|NCT01545076|456182071|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
126788515|NCT01545076|456182067|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
126788516|NCT01545076|456182068|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
126788517|NCT01545076|456182069|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
126788518|NCT01545076|456182070|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
126788519|NCT01545076|456182071|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
126788520|NCT02388763|456182081|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
126788521|NCT02388763|456182082|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
126788522|NCT02388763|456182081|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
126788523|NCT02388763|456182082|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
126788524|NCT01153984|456182083|FG000|Overall Study|Withdrawal by Subject|1|||
126788525|NCT01153984|456182083|FG000|Overall Study|Adverse Event|1|||
126788526|NCT02460159|456182084|FG000|Overall Study|Adverse Event|4|||
126788527|NCT02460159|456182085|FG001|Overall Study|Adverse Event|1|||
126788528|NCT02460159|456182084|FG000|Overall Study|Withdrawal by Subject|2|||
126788529|NCT02460159|456182085|FG001|Overall Study|Withdrawal by Subject|0|||
126788530|NCT02194998|456182096|FG000|On-HCV Treatment|Did not pick up study medication|0|||
126788531|NCT02194998|456182097|FG001|On-HCV Treatment|Did not pick up study medication|1|||
126788532|NCT02194998|456182098|FG002|On-HCV Treatment|Did not pick up study medication|0|||
126788533|NCT02194998|456182099|FG003|On-HCV Treatment|Did not pick up study medication|0|||
126788534|NCT02194998|456182096|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
126788535|NCT02194998|456182097|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
126788536|NCT02194998|456182098|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
126788537|NCT02194998|456182099|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
126788538|NCT01458405|456182100|FG000|Phase 1 (up to 12 Months)|Other|0|||
126788539|NCT01458405|456182101|FG001|Phase 1 (up to 12 Months)|Other|1|||
126788540|NCT01458405|456182102|FG002|Phase 1 (up to 12 Months)|Other|0|||
126788541|NCT01458405|456182103|FG003|Phase 1 (up to 12 Months)|Other|0|||
126788542|NCT01458405|456182100|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
126788543|NCT01458405|456182101|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
126788544|NCT01458405|456182102|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
126788545|NCT01458405|456182103|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
126788546|NCT01458405|456182100|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
126788547|NCT01458405|456182101|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
126788548|NCT01458405|456182102|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
126788549|NCT01458405|456182103|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
126788550|NCT01458405|456182100|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
126788551|NCT01458405|456182101|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
126788552|NCT01458405|456182102|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
126788553|NCT01458405|456182103|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
126788554|NCT02497781|456182104|FG000|Overall Study|Withdrawal by Subject|2|||
126788555|NCT02497781|456182105|FG001|Overall Study|Withdrawal by Subject|0|||
126788556|NCT02497781|456182104|FG000|Overall Study|Lack of Efficacy|0|||
126788557|NCT02497781|456182105|FG001|Overall Study|Lack of Efficacy|1|||
126788558|NCT02497781|456182104|FG000|Overall Study|Randomised but not treated|1|||
126788559|NCT02497781|456182105|FG001|Overall Study|Randomised but not treated|1|||
126788560|NCT02497781|456182104|FG000|Overall Study|Lost to Follow-up|1|||
126788561|NCT02497781|456182105|FG001|Overall Study|Lost to Follow-up|1|||
126788562|NCT02236130|456182106|FG000|Overall Study|Lost to Follow-up|7|||
126788563|NCT02236130|456182107|FG001|Overall Study|Lost to Follow-up|12|||
126788564|NCT00454636|456182108|FG000|Overall Study|Adverse Event|10|||
126788565|NCT00454636|456182109|FG001|Overall Study|Adverse Event|6|||
126788566|NCT00454636|456182110|FG002|Overall Study|Adverse Event|9|||
126788567|NCT00454636|456182111|FG003|Overall Study|Adverse Event|15|||
126788568|NCT00454636|456182108|FG000|Overall Study|Disease Progression|11|||
126788569|NCT00454636|456182109|FG001|Overall Study|Disease Progression|12|||
126788570|NCT00454636|456182110|FG002|Overall Study|Disease Progression|4|||
126788571|NCT00454636|456182111|FG003|Overall Study|Disease Progression|11|||
126788572|NCT00454636|456182108|FG000|Overall Study|Protocol Violation|3|||
126788573|NCT00454636|456182109|FG001|Overall Study|Protocol Violation|2|||
126788574|NCT00454636|456182110|FG002|Overall Study|Protocol Violation|3|||
126788575|NCT00454636|456182111|FG003|Overall Study|Protocol Violation|3|||
126788576|NCT00454636|456182108|FG000|Overall Study|Death|6|||
126788577|NCT00454636|456182109|FG001|Overall Study|Death|1|||
126788578|NCT00454636|456182110|FG002|Overall Study|Death|1|||
126788579|NCT00454636|456182111|FG003|Overall Study|Death|1|||
126788580|NCT00454636|456182108|FG000|Overall Study|Patient refusal|1|||
126788581|NCT00454636|456182109|FG001|Overall Study|Patient refusal|1|||
126788582|NCT00454636|456182110|FG002|Overall Study|Patient refusal|3|||
126788583|NCT00454636|456182111|FG003|Overall Study|Patient refusal|2|||
126788584|NCT00454636|456182108|FG000|Overall Study|Lost to Follow-up|0|||
126788585|NCT00454636|456182109|FG001|Overall Study|Lost to Follow-up|1|||
126788586|NCT00454636|456182110|FG002|Overall Study|Lost to Follow-up|0|||
126788587|NCT00454636|456182111|FG003|Overall Study|Lost to Follow-up|0|||
126788588|NCT01400113|456182112|FG000|Overall Study|Withdrawal by Subject|1|||
126788589|NCT01400113|456182113|FG001|Overall Study|Withdrawal by Subject|1|||
126788590|NCT01025037|456182118|FG000|Overall Study|Adverse Event|3|||
126788591|NCT01025037|456182118|FG000|Overall Study|Lost to Follow-up|7|||
126788592|NCT01025037|456182118|FG000|Overall Study|Withdrawal by Subject|1|||
126788593|NCT01890915|456182120|FG000|Overall Study|Adverse Event|1|||
126788594|NCT01890915|456182121|FG001|Overall Study|Adverse Event|0|||
126788595|NCT01890915|456182120|FG000|Overall Study|Protocol Violation|2|||
126788596|NCT01890915|456182121|FG001|Overall Study|Protocol Violation|0|||
126788597|NCT01890915|456182120|FG000|Overall Study|Equipment Malfunction|0|||
126788598|NCT01890915|456182121|FG001|Overall Study|Equipment Malfunction|1|||
126788599|NCT02114697|456182122|FG000|Overall Study|Study terminated|5|||
126788600|NCT02114697|456182123|FG001|Overall Study|Study terminated|4|||
126788601|NCT00424489|456182124|FG000|Overall Study|Death|3|||
126788602|NCT03552757|456182131|FG000|Overall Study|Withdrawal by Subject|10|||
126788603|NCT03552757|456182132|FG001|Overall Study|Withdrawal by Subject|5|||
126788604|NCT03552757|456182133|FG002|Overall Study|Withdrawal by Subject|12|||
126788605|NCT03552757|456182131|FG000|Overall Study|Lost to Follow-up|2|||
126788606|NCT03552757|456182132|FG001|Overall Study|Lost to Follow-up|7|||
126788607|NCT03552757|456182133|FG002|Overall Study|Lost to Follow-up|7|||
126788608|NCT03552757|456182131|FG000|Overall Study|Death|1|||
126788609|NCT03552757|456182132|FG001|Overall Study|Death|1|||
126788610|NCT03552757|456182133|FG002|Overall Study|Death|1|||
126788611|NCT02674334|456182134|FG000|Overall Study|Lost to Follow-up|5|||
126788612|NCT02674334|456182135|FG001|Overall Study|Lost to Follow-up|3|||
126788613|NCT02674334|456182134|FG000|Overall Study|participant difficulty breathing|1|||
126788614|NCT02674334|456182135|FG001|Overall Study|participant difficulty breathing|0|||
126788615|NCT02674334|456182134|FG000|Overall Study|NIRS not recording|1|||
126788616|NCT02674334|456182135|FG001|Overall Study|NIRS not recording|0|||
126788617|NCT02660242|456182139|FG000|Glucose Tabs|Lost to Follow-up|1|||
126788618|NCT02660242|456182139|FG000|Glucagon Injection|Lost to Follow-up|1|||
126788619|NCT00386009|456182143|FG000|Overall Study|Adverse Event|0|||
126788620|NCT00386009|456182144|FG001|Overall Study|Adverse Event|2|||
126788621|NCT00386009|456182143|FG000|Overall Study|Death|1|||
126788622|NCT00386009|456182144|FG001|Overall Study|Death|0|||
126631405|NCT02586415|455609835|FG001|Overall Study|Death|23|||
126631406|NCT02586415|455609834|FG000|Overall Study|Lost to Follow-up|1|||
126631407|NCT02586415|455609835|FG001|Overall Study|Lost to Follow-up|2|||
126755223|NCT02918006|456053087|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
126755224|NCT02918006|456053088|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
126755225|NCT02918006|456053086|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
126755226|NCT02918006|456053087|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
126755227|NCT02918006|456053088|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
126755228|NCT02918006|456053086|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
126755229|NCT02918006|456053087|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
126755230|NCT02918006|456053088|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
126755231|NCT02918006|456053086|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
126755232|NCT02918006|456053087|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
126755233|NCT02918006|456053088|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
126755234|NCT02475564|456053090|FG000|Overall Study|Withdrawal by Subject|1|||
126755235|NCT02475564|456053091|FG001|Overall Study|Withdrawal by Subject|0|||
126755236|NCT02475564|456053090|FG000|Overall Study|Lost to Follow-up|2|||
126755237|NCT02475564|456053091|FG001|Overall Study|Lost to Follow-up|1|||
126755238|NCT02475564|456053090|FG000|Overall Study|Intense Menstrual bleeding|1|||
126755239|NCT02475564|456053091|FG001|Overall Study|Intense Menstrual bleeding|0|||
126755240|NCT01156012|456053092|FG000|Overall Study|Adverse Event|3|||
126755241|NCT01156012|456053093|FG001|Overall Study|Adverse Event|1|||
126755242|NCT01156012|456053092|FG000|Overall Study|Lost to Follow-up|1|||
126755243|NCT01156012|456053093|FG001|Overall Study|Lost to Follow-up|0|||
126755244|NCT01156012|456053092|FG000|Overall Study|Withdrawal by Subject|1|||
126755245|NCT01156012|456053093|FG001|Overall Study|Withdrawal by Subject|0|||
126755246|NCT01156012|456053092|FG000|Overall Study|use of commercial drug instead of study|0|||
126755247|NCT01156012|456053093|FG001|Overall Study|use of commercial drug instead of study|1|||
126755248|NCT01156012|456053092|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
126755249|NCT01156012|456053093|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
126755250|NCT01503229|456054674|FG000|Overall Study|Withdrew consent|1|||
126755251|NCT01524900|456054675|FG000|Overall Study|Lost to Follow-up|3|||
126755252|NCT01524900|456054676|FG001|Overall Study|Lost to Follow-up|12|||
126755253|NCT01524900|456054677|FG002|Overall Study|Lost to Follow-up|1|||
126755254|NCT01524900|456054678|FG003|Overall Study|Lost to Follow-up|0|||
126755255|NCT01524900|456054679|FG004|Overall Study|Lost to Follow-up|0|||
126755256|NCT01524900|456054675|FG000|Overall Study|Other reason than stated above|1|||
126755257|NCT01524900|456054676|FG001|Overall Study|Other reason than stated above|1|||
126755258|NCT01524900|456054677|FG002|Overall Study|Other reason than stated above|0|||
126755259|NCT01524900|456054678|FG003|Overall Study|Other reason than stated above|0|||
126755260|NCT01524900|456054679|FG004|Overall Study|Other reason than stated above|0|||
126755261|NCT01524900|456054675|FG000|Overall Study|No reason documented|2|||
126755262|NCT01524900|456054676|FG001|Overall Study|No reason documented|1|||
126755263|NCT01524900|456054677|FG002|Overall Study|No reason documented|0|||
126755264|NCT01524900|456054678|FG003|Overall Study|No reason documented|1|||
126755265|NCT01524900|456054679|FG004|Overall Study|No reason documented|0|||
126755266|NCT03824704|456054680|FG000|Overall Study|Study Terminated by Sponsor|1|||
126755267|NCT00298766|456054681|FG000|Overall Study|Adverse Event|18|||
126755268|NCT00298766|456054681|FG000|Overall Study|Death|2|||
126755269|NCT00298766|456054681|FG000|Overall Study|Withdrawal by Subject|9|||
126755270|NCT00298766|456054681|FG000|Overall Study|Treatment ongoing|4|||
126755271|NCT00298766|456054681|FG000|Overall Study|Progression of amyloid markers|4|||
126755272|NCT00298766|456054681|FG000|Overall Study|Deterioration in KPS and organ function|1|||
126755273|NCT00298766|456054681|FG000|Overall Study|Subjects overall condition deterioration|4|||
126755274|NCT00298766|456054681|FG000|Overall Study|Other|4|||
126755275|NCT02988115|456054683|FG000|Overall Study|Adverse Event|6|||
126755276|NCT02988115|456054684|FG001|Overall Study|Adverse Event|1|||
126755277|NCT02988115|456054683|FG000|Overall Study|Sponsor Decision|5|||
126755278|NCT02988115|456054684|FG001|Overall Study|Sponsor Decision|2|||
126755279|NCT02988115|456054683|FG000|Overall Study|Withdrawal by Subject|1|||
126755280|NCT02988115|456054684|FG001|Overall Study|Withdrawal by Subject|1|||
126755281|NCT02988115|456054683|FG000|Overall Study|Withdrawn by Mistake|1|||
126755282|NCT02988115|456054684|FG001|Overall Study|Withdrawn by Mistake|0|||
126755283|NCT02988115|456054683|FG000|Overall Study|Lost to Follow-up|1|||
126755284|NCT02988115|456054684|FG001|Overall Study|Lost to Follow-up|0|||
126755285|NCT01731951|456054685|FG000|Overall Study|Documented Disease Progression|1|||
126755286|NCT01731951|456054686|FG001|Overall Study|Documented Disease Progression|0|||
126755287|NCT01731951|456054687|FG002|Overall Study|Documented Disease Progression|0|||
126755288|NCT01731951|456054688|FG003|Overall Study|Documented Disease Progression|0|||
126788623|NCT00386009|456182143|FG000|Overall Study|Entry Criteria Not Met|0|||
126788624|NCT00386009|456182144|FG001|Overall Study|Entry Criteria Not Met|2|||
126788625|NCT00386009|456182143|FG000|Overall Study|Lost to Follow-up|1|||
126788626|NCT00386009|456182144|FG001|Overall Study|Lost to Follow-up|1|||
126788627|NCT00386009|456182143|FG000|Overall Study|Protocol Violation|1|||
126788628|NCT00386009|456182144|FG001|Overall Study|Protocol Violation|0|||
126788629|NCT00386009|456182143|FG000|Overall Study|Sponsor Decision|1|||
126788630|NCT00386009|456182144|FG001|Overall Study|Sponsor Decision|1|||
126788631|NCT00386009|456182143|FG000|Overall Study|Withdrawal by Subject|5|||
126788632|NCT00386009|456182144|FG001|Overall Study|Withdrawal by Subject|4|||
126788633|NCT00860405|456182147|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
126788634|NCT00860405|456182148|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
126788635|NCT00604500|456182153|FG000|Overall Study|Adverse Event|2|||
126788636|NCT00604500|456182153|FG000|Overall Study|Protocol Violation|2|||
126788637|NCT00604500|456182153|FG000|Overall Study|Treatment Failure|1|||
126788638|NCT00604500|456182153|FG000|Overall Study|Withdrawal by Subject|4|||
126788639|NCT00604500|456182153|FG000|Overall Study|Administrative|1|||
126788640|NCT00604500|456182153|FG000|Overall Study|Did not meet protocol eligibility|1|||
126788641|NCT01492400|456182154|FG000|Overall Study|Miscellaneous Reasons|2|||
126788642|NCT01492400|456182155|FG001|Overall Study|Miscellaneous Reasons|3|||
126788643|NCT01492400|456182154|FG000|Overall Study|Personal Reasons|0|||
126788644|NCT01492400|456182155|FG001|Overall Study|Personal Reasons|5|||
126788645|NCT01492400|456182154|FG000|Overall Study|Lost to Follow-up|3|||
126788646|NCT01492400|456182155|FG001|Overall Study|Lost to Follow-up|1|||
126788647|NCT01492400|456182154|FG000|Overall Study|Pregnancy|0|||
126788648|NCT01492400|456182155|FG001|Overall Study|Pregnancy|1|||
126788649|NCT01492400|456182154|FG000|Overall Study|Lack of Efficacy|1|||
126788650|NCT01492400|456182155|FG001|Overall Study|Lack of Efficacy|1|||
126788651|NCT01492400|456182154|FG000|Overall Study|Adverse Event|10|||
126788652|NCT01492400|456182155|FG001|Overall Study|Adverse Event|5|||
126788653|NCT00320112|456182157|FG000|Overall Study|Lost to Follow-up|3|||
126788654|NCT00320112|456182158|FG001|Overall Study|Lost to Follow-up|4|||
126788655|NCT00320112|456182157|FG000|Overall Study|Withdrawal by Subject|3|||
126788656|NCT00320112|456182158|FG001|Overall Study|Withdrawal by Subject|0|||
126788657|NCT00320112|456182157|FG000|Overall Study|Death|2|||
126788658|NCT00320112|456182158|FG001|Overall Study|Death|1|||
126788659|NCT02899338|456182159|FG000|Overall Study|Adverse Event|1|||
126788660|NCT02899338|456182160|FG001|Overall Study|Adverse Event|2|||
126788661|NCT02899338|456182159|FG000|Overall Study|Withdrawal by Subject|2|||
126788662|NCT02899338|456182160|FG001|Overall Study|Withdrawal by Subject|0|||
126788663|NCT02780687|456182162|FG000|Overall Study|Adverse Event|1|||
126788664|NCT02780687|456182163|FG001|Overall Study|Adverse Event|1|||
126788665|NCT02780687|456182162|FG000|Overall Study|Withdrawal by Subject|2|||
126788666|NCT02780687|456182163|FG001|Overall Study|Withdrawal by Subject|1|||
126788667|NCT02780687|456182162|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
126788668|NCT02780687|456182163|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
126788669|NCT02780687|456182162|FG000|Overall Study|progressive disease|29|||
126788670|NCT02780687|456182163|FG001|Overall Study|progressive disease|6|||
126788671|NCT02353169|456182164|FG000|Overall Study|QTc > 450 msec|1|||
126788672|NCT02353169|456182165|FG001|Overall Study|QTc > 450 msec|1|||
126788673|NCT02353169|456182166|FG002|Overall Study|QTc > 450 msec|1|||
126788674|NCT02353169|456182167|FG003|Overall Study|QTc > 450 msec|1|||
126788675|NCT02353169|456182164|FG000|Overall Study|OR team declined|2|||
126788676|NCT02353169|456182165|FG001|Overall Study|OR team declined|0|||
126788677|NCT02353169|456182166|FG002|Overall Study|OR team declined|0|||
126788678|NCT02353169|456182167|FG003|Overall Study|OR team declined|0|||
126788679|NCT02353169|456182164|FG000|Overall Study|Inhalational induction|0|||
126788680|NCT02353169|456182165|FG001|Overall Study|Inhalational induction|2|||
126788681|NCT02353169|456182166|FG002|Overall Study|Inhalational induction|0|||
126788682|NCT02353169|456182167|FG003|Overall Study|Inhalational induction|0|||
126788683|NCT02353169|456182164|FG000|Overall Study|ECG data error|0|||
126788684|NCT02353169|456182165|FG001|Overall Study|ECG data error|3|||
126788685|NCT02353169|456182166|FG002|Overall Study|ECG data error|2|||
126788686|NCT02353169|456182167|FG003|Overall Study|ECG data error|2|||
126788687|NCT02353169|456182164|FG000|Overall Study|Pre-op medication|0|||
126788688|NCT02353169|456182165|FG001|Overall Study|Pre-op medication|0|||
126788689|NCT02353169|456182166|FG002|Overall Study|Pre-op medication|1|||
126788690|NCT02353169|456182167|FG003|Overall Study|Pre-op medication|0|||
126788691|NCT00796822|456182168|FG000|Overall Study|Lost to Follow-up|2|||
126788692|NCT00796822|456182169|FG001|Overall Study|Lost to Follow-up|0|||
126788693|NCT00796822|456182168|FG000|Overall Study|Adverse Event|1|||
126788694|NCT00796822|456182169|FG001|Overall Study|Adverse Event|0|||
126788695|NCT02603952|456182170|FG000|Overall Study|Withdrawal by Subject|1|||
126788696|NCT02603952|456182171|FG001|Overall Study|Withdrawal by Subject|0|||
126788697|NCT02603952|456182172|FG002|Overall Study|Withdrawal by Subject|0|||
126788698|NCT02603952|456182173|FG003|Overall Study|Withdrawal by Subject|0|||
126788699|NCT02603952|456182170|FG000|Overall Study|Received oseltamivir by error|0|||
126788700|NCT02603952|456182171|FG001|Overall Study|Received oseltamivir by error|0|||
126788701|NCT02603952|456182172|FG002|Overall Study|Received oseltamivir by error|0|||
126788702|NCT02603952|456182173|FG003|Overall Study|Received oseltamivir by error|1|||
126788703|NCT02785913|456183436|FG000|Overall Study|Adverse Event|5|||
126788704|NCT02785913|456183436|FG000|Overall Study|Death|2|||
126788705|NCT02785913|456183436|FG000|Overall Study|Progression|18|||
126788706|NCT02785913|456183436|FG000|Overall Study|Not protocol specified|1|||
126788707|NCT00453362|456183442|FG000|Overall Study|Adverse Event|5|||
126788708|NCT00453362|456183442|FG000|Overall Study|Death|7|||
126788709|NCT00453362|456183442|FG000|Overall Study|Physician Decision|2|||
126788710|NCT00453362|456183442|FG000|Overall Study|Withdrawal by Subject|3|||
126788711|NCT00453362|456183442|FG000|Overall Study|Progression of disease|56|||
126788712|NCT00453362|456183442|FG000|Overall Study|Screening Failure|14|||
126788713|NCT04885296|456183443|FG000|Period 1|Covid-19 Related|1|||
126788714|NCT04885296|456183444|FG001|Period 1|Covid-19 Related|0|||
126788715|NCT04885296|456183443|FG000|Period 1|Adverse Event|0|||
126788716|NCT04885296|456183444|FG001|Period 1|Adverse Event|1|||
126788717|NCT04885296|456183443|FG000|Period 1|Withdrawal by Subject|1|||
126788718|NCT04885296|456183444|FG001|Period 1|Withdrawal by Subject|1|||
126788719|NCT04885296|456183443|FG000|Period 1|Test Article No Longer Available|1|||
126788720|NCT04885296|456183444|FG001|Period 1|Test Article No Longer Available|0|||
126788721|NCT04885296|456183443|FG000|Period 1|Dispensed Study lens in Error|1|||
126788722|NCT04885296|456183444|FG001|Period 1|Dispensed Study lens in Error|0|||
126788723|NCT04885296|456183443|FG000|Period 1|Lost to Follow-up|1|||
126788724|NCT04885296|456183444|FG001|Period 1|Lost to Follow-up|0|||
126788725|NCT04885296|456183443|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
126788726|NCT04885296|456183444|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
126788727|NCT01027143|456183446|FG000|Overall Study|Lost to Follow-up|9|||
126788728|NCT01027143|456183447|FG001|Overall Study|Lost to Follow-up|4|||
126788729|NCT05346055|456183448|FG000|Overall Study|Withdrawal by Subject|1|||
126788730|NCT05346055|456183448|FG000|Overall Study|Protocol Violation|1|||
126788731|NCT05346055|456183448|FG000|Overall Study|Therapist decision|1|||
126788732|NCT02564263|456183449|FG000|Overall Study|Adverse Event|31|||
126788733|NCT02564263|456183450|FG001|Overall Study|Adverse Event|29|||
126788734|NCT02564263|456183449|FG000|Overall Study|Death|270|||
126788735|NCT02564263|456183450|FG001|Overall Study|Death|262|||
126788736|NCT02564263|456183449|FG000|Overall Study|Withdrawal by Subject|4|||
126788737|NCT02564263|456183450|FG001|Overall Study|Withdrawal by Subject|19|||
126788738|NCT02564263|456183449|FG000|Overall Study|Sponsor's decision|9|||
126788739|NCT02564263|456183450|FG001|Overall Study|Sponsor's decision|4|||
126788740|NCT02319148|456183451|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
126788741|NCT02319148|456183452|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
126788742|NCT02319148|456183453|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
126788743|NCT02319148|456183454|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
126788744|NCT02319148|456183451|FG000|Second Intervention Period|No longer willing to participate|0|||
126788745|NCT02319148|456183452|FG001|Second Intervention Period|No longer willing to participate|1|||
126788746|NCT02319148|456183453|FG002|Second Intervention Period|No longer willing to participate|0|||
126788747|NCT02319148|456183454|FG003|Second Intervention Period|No longer willing to participate|0|||
126788748|NCT02319148|456183451|FG000|Second Intervention Period|Other|0|||
126788749|NCT02319148|456183452|FG001|Second Intervention Period|Other|0|||
126788750|NCT02319148|456183453|FG002|Second Intervention Period|Other|0|||
126788751|NCT02319148|456183454|FG003|Second Intervention Period|Other|1|||
126788752|NCT01087970|456183456|FG000|Overall Study|Protocol Violation|2|||
126788753|NCT00264797|456183457|FG000|Overall Study|Withdrawal by Subject|11|||
126788754|NCT00264797|456183458|FG001|Overall Study|Withdrawal by Subject|11|||
126788755|NCT00264797|456183457|FG000|Overall Study|Lost to Follow-up|9|||
126788756|NCT00264797|456183458|FG001|Overall Study|Lost to Follow-up|17|||
126788757|NCT00264797|456183457|FG000|Overall Study|Moved from area|3|||
126788758|NCT00264797|456183458|FG001|Overall Study|Moved from area|1|||
126788759|NCT00264797|456183457|FG000|Overall Study|Practical Problems|2|||
126788760|NCT00264797|456183458|FG001|Overall Study|Practical Problems|3|||
126788761|NCT00264797|456183457|FG000|Overall Study|Incarceration|4|||
126788762|NCT00264797|456183458|FG001|Overall Study|Incarceration|5|||
126788763|NCT00264797|456183457|FG000|Overall Study|Pressure/advice from Outsiders|1|||
126788764|NCT00264797|456183458|FG001|Overall Study|Pressure/advice from Outsiders|1|||
126788765|NCT00264797|456183457|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
126788766|NCT00264797|456183458|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
126788767|NCT00264797|456183457|FG000|Overall Study|Other|3|||
126788768|NCT00264797|456183458|FG001|Overall Study|Other|4|||
126788769|NCT02636907|456183461|FG000|Autoinjector Assessment Period|Adverse Event|2|||
126788770|NCT02636907|456183461|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
126788771|NCT02636907|456183461|FG000|Extension Phase|Adverse Event|2|||
126788772|NCT02636907|456183461|FG000|Extension Phase|Withdrawal by Subject|4|||
126788773|NCT02636907|456183461|FG000|Extension Phase|Physician Decision|1|||
126788774|NCT02636907|456183461|FG000|Extension Phase|Lost to Follow-up|2|||
126788775|NCT02636907|456183461|FG000|Extension Phase|Lack of Efficacy|1|||
126788776|NCT00762086|456183462|FG000|Overall Study|Adverse Event|2|||
126788777|NCT00762086|456183463|FG001|Overall Study|Adverse Event|0|||
126788778|NCT00762086|456183462|FG000|Overall Study|Lost to Follow-up|0|||
126788779|NCT00762086|456183463|FG001|Overall Study|Lost to Follow-up|2|||
126788780|NCT00762086|456183462|FG000|Overall Study|Non compliance|1|||
126788781|NCT00762086|456183463|FG001|Overall Study|Non compliance|0|||
126788782|NCT00762086|456183462|FG000|Overall Study|Withdrawal by Subject|2|||
126788783|NCT00762086|456183463|FG001|Overall Study|Withdrawal by Subject|2|||
126788784|NCT00762086|456183462|FG000|Overall Study|Ineligible to participate in the study|1|||
126788785|NCT00762086|456183463|FG001|Overall Study|Ineligible to participate in the study|0|||
126788786|NCT02465567|456183466|FG000|Overall Study|Adverse Event|118|||
126788787|NCT02465567|456183467|FG001|Overall Study|Adverse Event|113|||
126788788|NCT02465567|456183468|FG002|Overall Study|Adverse Event|147|||
126788789|NCT02465567|456183469|FG003|Overall Study|Adverse Event|138|||
126788790|NCT02465567|456183466|FG000|Overall Study|Lack of Efficacy|103|||
126788791|NCT02465567|456183467|FG001|Overall Study|Lack of Efficacy|102|||
126788792|NCT02465567|456183468|FG002|Overall Study|Lack of Efficacy|171|||
126788793|NCT02465567|456183469|FG003|Overall Study|Lack of Efficacy|135|||
126788794|NCT02465567|456183466|FG000|Overall Study|Withdrawal by Subject|104|||
126788795|NCT02465567|456183467|FG001|Overall Study|Withdrawal by Subject|94|||
126788796|NCT02465567|456183468|FG002|Overall Study|Withdrawal by Subject|123|||
126788797|NCT02465567|456183469|FG003|Overall Study|Withdrawal by Subject|130|||
126788798|NCT02465567|456183466|FG000|Overall Study|Physician Decision|23|||
126788799|NCT02465567|456183467|FG001|Overall Study|Physician Decision|33|||
126788800|NCT02465567|456183468|FG002|Overall Study|Physician Decision|38|||
126788801|NCT02465567|456183469|FG003|Overall Study|Physician Decision|28|||
126788802|NCT02465567|456183466|FG000|Overall Study|Major Protocol Deviation|24|||
126788803|NCT02465567|456183467|FG001|Overall Study|Major Protocol Deviation|26|||
126788804|NCT02465567|456183468|FG002|Overall Study|Major Protocol Deviation|22|||
126788805|NCT02465567|456183469|FG003|Overall Study|Major Protocol Deviation|25|||
126788806|NCT02465567|456183466|FG000|Overall Study|Lost to Follow-up|25|||
126788807|NCT02465567|456183467|FG001|Overall Study|Lost to Follow-up|21|||
126788808|NCT02465567|456183468|FG002|Overall Study|Lost to Follow-up|19|||
126788809|NCT02465567|456183469|FG003|Overall Study|Lost to Follow-up|15|||
126788810|NCT02465567|456183466|FG000|Overall Study|Protocol Specified Criteria|20|||
126788811|NCT02465567|456183467|FG001|Overall Study|Protocol Specified Criteria|10|||
126788812|NCT02465567|456183468|FG002|Overall Study|Protocol Specified Criteria|9|||
126788813|NCT02465567|456183469|FG003|Overall Study|Protocol Specified Criteria|12|||
126788814|NCT02465567|456183466|FG000|Overall Study|Administrative Reasons|12|||
126788815|NCT02465567|456183467|FG001|Overall Study|Administrative Reasons|9|||
126788816|NCT02465567|456183468|FG002|Overall Study|Administrative Reasons|11|||
126788817|NCT02465567|456183469|FG003|Overall Study|Administrative Reasons|5|||
126788818|NCT02465567|456183466|FG000|Overall Study|Randomized but not treated|1|||
126788819|NCT02465567|456183467|FG001|Overall Study|Randomized but not treated|5|||
126788820|NCT02465567|456183468|FG002|Overall Study|Randomized but not treated|4|||
126788821|NCT02465567|456183469|FG003|Overall Study|Randomized but not treated|5|||
126788822|NCT02465567|456183466|FG000|Overall Study|enrolled in >1 studies|18|||
126788823|NCT02465567|456183467|FG001|Overall Study|enrolled in >1 studies|11|||
126788824|NCT02465567|456183468|FG002|Overall Study|enrolled in >1 studies|19|||
126788825|NCT02465567|456183469|FG003|Overall Study|enrolled in >1 studies|15|||
126788826|NCT02465567|456183466|FG000|Overall Study|missing PI Signature|1|||
126788827|NCT02465567|456183467|FG001|Overall Study|missing PI Signature|0|||
126788828|NCT02465567|456183468|FG002|Overall Study|missing PI Signature|0|||
126788829|NCT02465567|456183469|FG003|Overall Study|missing PI Signature|0|||
126788830|NCT00497796|456183470|FG000|Overall Study|Adverse event (not related)|9|||
126788831|NCT00497796|456183471|FG001|Overall Study|Adverse event (not related)|9|||
126788832|NCT00497796|456183470|FG000|Overall Study|Adverse event (related)|5|||
126788833|NCT00497796|456183471|FG001|Overall Study|Adverse event (related)|4|||
126788834|NCT00497796|456183470|FG000|Overall Study|CMV infection or disease treatment|30|||
126788835|NCT00497796|456183471|FG001|Overall Study|CMV infection or disease treatment|4|||
126788836|NCT00497796|456183470|FG000|Overall Study|Consent withdrawn|10|||
126788837|NCT00497796|456183471|FG001|Overall Study|Consent withdrawn|3|||
126788838|NCT00497796|456183470|FG000|Overall Study|Investigator/sponsor discretion|31|||
126788839|NCT00497796|456183471|FG001|Overall Study|Investigator/sponsor discretion|34|||
126788840|NCT00497796|456183470|FG000|Overall Study|Lost to Follow-up|0|||
126788841|NCT00497796|456183471|FG001|Overall Study|Lost to Follow-up|1|||
126788842|NCT00497796|456183470|FG000|Overall Study|Not applicable (randomized not treated)|0|||
126788843|NCT00497796|456183471|FG001|Overall Study|Not applicable (randomized not treated)|4|||
126788844|NCT01074554|456183472|FG000|Overall Study|Adverse Event|3|||
126788845|NCT01074554|456183473|FG001|Overall Study|Adverse Event|3|||
126788846|NCT01074554|456183472|FG000|Overall Study|Lost to Follow-up|0|||
126788847|NCT01074554|456183473|FG001|Overall Study|Lost to Follow-up|1|||
126788848|NCT04276883|456183474|FG000|Overall Study|Withdrawal by Subject|2|||
126788849|NCT04276883|456183475|FG001|Overall Study|Withdrawal by Subject|3|||
126788850|NCT04276883|456183476|FG002|Overall Study|Withdrawal by Subject|6|||
126788851|NCT04276883|456183474|FG000|Overall Study|Lost to Follow-up|1|||
126788852|NCT04276883|456183475|FG001|Overall Study|Lost to Follow-up|3|||
126788853|NCT04276883|456183476|FG002|Overall Study|Lost to Follow-up|0|||
126631408|NCT02872311|455609836|FG000|Overall Study|Death|2|||
126755289|NCT01731951|456054689|FG004|Overall Study|Documented Disease Progression|0|||
126755290|NCT01731951|456054690|FG005|Overall Study|Documented Disease Progression|0|||
126755291|NCT01731951|456054685|FG000|Overall Study|Lost to Follow-up|2|||
126755292|NCT01731951|456054686|FG001|Overall Study|Lost to Follow-up|0|||
126755293|NCT01731951|456054687|FG002|Overall Study|Lost to Follow-up|0|||
126755294|NCT01731951|456054688|FG003|Overall Study|Lost to Follow-up|1|||
126755295|NCT01731951|456054689|FG004|Overall Study|Lost to Follow-up|3|||
126755296|NCT01731951|456054690|FG005|Overall Study|Lost to Follow-up|1|||
126755297|NCT01731951|456054685|FG000|Overall Study|Withdrawal of Consent|1|||
126755298|NCT01731951|456054686|FG001|Overall Study|Withdrawal of Consent|0|||
126755299|NCT01731951|456054687|FG002|Overall Study|Withdrawal of Consent|0|||
126755300|NCT01731951|456054688|FG003|Overall Study|Withdrawal of Consent|0|||
126755301|NCT01731951|456054689|FG004|Overall Study|Withdrawal of Consent|0|||
126755302|NCT01731951|456054690|FG005|Overall Study|Withdrawal of Consent|2|||
126755303|NCT01731951|456054685|FG000|Overall Study|Death|13|||
126755304|NCT01731951|456054686|FG001|Overall Study|Death|15|||
126755305|NCT01731951|456054687|FG002|Overall Study|Death|9|||
126755306|NCT01731951|456054688|FG003|Overall Study|Death|8|||
126755307|NCT01731951|456054689|FG004|Overall Study|Death|9|||
126755308|NCT01731951|456054690|FG005|Overall Study|Death|6|||
126755309|NCT00253747|456054691|FG000|Overall Study|Lost to Follow-up|13|||
126755310|NCT00253747|456054692|FG001|Overall Study|Lost to Follow-up|14|||
126755311|NCT00253747|456054691|FG000|Overall Study|Withdrawal by Subject|10|||
126755312|NCT00253747|456054692|FG001|Overall Study|Withdrawal by Subject|11|||
126755313|NCT00253747|456054691|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
126755314|NCT00253747|456054692|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
126755315|NCT01977651|456054693|FG000|4 Month Treatment Period|Adverse Event|34|||
126755316|NCT01977651|456054693|FG000|4 Month Treatment Period|Death|3|||
126755317|NCT01977651|456054693|FG000|4 Month Treatment Period|Progressive Disease|43|||
126755318|NCT01977651|456054693|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
126755319|NCT01977651|456054693|FG000|4 Month Treatment Period|Physician Decision|4|||
126755320|NCT01977651|456054693|FG000|1 Year Extension Period|Adverse Event|14|||
126755321|NCT01977651|456054693|FG000|1 Year Extension Period|Death|10|||
126755322|NCT01977651|456054693|FG000|1 Year Extension Period|Lost to Follow-up|2|||
126755323|NCT01977651|456054693|FG000|1 Year Extension Period|Progressive Disease|86|||
126755324|NCT01977651|456054693|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
126755325|NCT01977651|456054693|FG000|1 Year Extension Period|Physician Decision|6|||
126755326|NCT01977651|456054693|FG000|1 Year Extension Period|Miscellaneous|1|||
126755327|NCT01977651|456054693|FG000|Post 1 Year Extension Period|Adverse Event|5|||
126755328|NCT01977651|456054693|FG000|Post 1 Year Extension Period|Death|13|||
126755329|NCT01977651|456054693|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
126755330|NCT01977651|456054693|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
126755331|NCT01977651|456054693|FG000|Post 1 Year Extension Period|Physician Decision|4|||
126755332|NCT01977651|456054693|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
126755333|NCT03287089|456054694|FG000|Overall Study|Lost to Follow-up|0|||
126755334|NCT03287089|456054695|FG001|Overall Study|Lost to Follow-up|2|||
126755335|NCT03287089|456054694|FG000|Overall Study|Physician Decision|0|||
126755336|NCT03287089|456054695|FG001|Overall Study|Physician Decision|2|||
126755337|NCT03287089|456054694|FG000|Overall Study|Withdrawal by Subject|0|||
126755338|NCT03287089|456054695|FG001|Overall Study|Withdrawal by Subject|2|||
126755339|NCT00661362|456054696|FG000|Overall Study|Adverse Event|5|||
126755340|NCT00661362|456054697|FG001|Overall Study|Adverse Event|4|||
126755341|NCT00661362|456054696|FG000|Overall Study|Incorrect enrollment|2|||
126755342|NCT00661362|456054697|FG001|Overall Study|Incorrect enrollment|0|||
126755343|NCT00661362|456054696|FG000|Overall Study|Study specific discontinuation criteria|4|||
126755344|NCT00661362|456054697|FG001|Overall Study|Study specific discontinuation criteria|11|||
126755345|NCT00661362|456054696|FG000|Overall Study|Withdrawal by Subject|13|||
126755346|NCT00661362|456054697|FG001|Overall Study|Withdrawal by Subject|23|||
126755347|NCT00661362|456054696|FG000|Overall Study|Lost to Follow-up|3|||
126755348|NCT00661362|456054697|FG001|Overall Study|Lost to Follow-up|1|||
126755349|NCT00661362|456054696|FG000|Overall Study|Severe non-compliance to protocol|0|||
126755350|NCT00661362|456054697|FG001|Overall Study|Severe non-compliance to protocol|1|||
126755351|NCT00661362|456054696|FG000|Overall Study|Safety reasons|1|||
126755352|NCT00661362|456054697|FG001|Overall Study|Safety reasons|0|||
126755353|NCT00661362|456054696|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
126755354|NCT00661362|456054697|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
126755355|NCT00775138|456054698|FG000|Overall Study|Withdrawal by Subject|0|||
126755356|NCT00775138|456054699|FG001|Overall Study|Withdrawal by Subject|0|||
126755357|NCT00775138|456054700|FG002|Overall Study|Withdrawal by Subject|2|||
126755358|NCT00775138|456054701|FG003|Overall Study|Withdrawal by Subject|2|||
126755359|NCT00775138|456054698|FG000|Overall Study|Adverse Event|0|||
126755360|NCT00775138|456054699|FG001|Overall Study|Adverse Event|0|||
126755361|NCT00775138|456054700|FG002|Overall Study|Adverse Event|1|||
126631409|NCT02872311|455609837|FG001|Overall Study|Death|0|||
126755362|NCT00775138|456054701|FG003|Overall Study|Adverse Event|0|||
126755363|NCT04880642|456054702|FG000|Randomization|Withdrawal by Subject|2|||
126788854|NCT04276883|456183474|FG000|Overall Study|Adverse Event|0|||
126788855|NCT04276883|456183475|FG001|Overall Study|Adverse Event|1|||
126788856|NCT04276883|456183476|FG002|Overall Study|Adverse Event|0|||
126788857|NCT04276883|456183474|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
126788858|NCT04276883|456183475|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
126788859|NCT04276883|456183476|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
126788860|NCT01876706|456183477|FG000|Overall Study|BPH Intervention|9|||
126788861|NCT01876706|456183477|FG000|Overall Study|Lost to Follow-up|7|||
126788862|NCT01876706|456183477|FG000|Overall Study|Withdrawals|6|||
126788863|NCT01876706|456183477|FG000|Overall Study|Death|3|||
126788864|NCT01370408|456183481|FG000|Overall Study|treatment failure|9|||
126788865|NCT02073643|456183483|FG000|Overall Study|Lost to Follow-up|24|||
126788866|NCT01062256|456183486|FG000|Overall Study|Adverse Event|1|||
126788867|NCT01062256|456183487|FG001|Overall Study|Adverse Event|0|||
126788868|NCT01062256|456183488|FG002|Overall Study|Adverse Event|0|||
126788869|NCT01062256|456183486|FG000|Overall Study|Withdrawal by Subject|1|||
126788870|NCT01062256|456183487|FG001|Overall Study|Withdrawal by Subject|1|||
126788871|NCT01062256|456183488|FG002|Overall Study|Withdrawal by Subject|1|||
126788872|NCT01062256|456183486|FG000|Overall Study|Ineligible|1|||
126788873|NCT01062256|456183487|FG001|Overall Study|Ineligible|4|||
126788874|NCT01062256|456183488|FG002|Overall Study|Ineligible|3|||
126788875|NCT01062256|456183486|FG000|Overall Study|Administrative|0|||
126788876|NCT01062256|456183487|FG001|Overall Study|Administrative|2|||
126788877|NCT01062256|456183488|FG002|Overall Study|Administrative|0|||
126788878|NCT03049488|456183489|FG000|Overall Study|Lost to Follow-up|1|||
126788879|NCT03049488|456183490|FG001|Overall Study|Lost to Follow-up|1|||
126788880|NCT03049488|456183491|FG002|Overall Study|Lost to Follow-up|0|||
126788881|NCT03049488|456183492|FG003|Overall Study|Lost to Follow-up|0|||
126788882|NCT03049488|456183493|FG004|Overall Study|Lost to Follow-up|0|||
126788883|NCT03049488|456183494|FG005|Overall Study|Lost to Follow-up|0|||
126788884|NCT03049488|456183489|FG000|Overall Study|Moved from Area|1|||
126788885|NCT03049488|456183490|FG001|Overall Study|Moved from Area|0|||
126788886|NCT03049488|456183491|FG002|Overall Study|Moved from Area|0|||
126788887|NCT03049488|456183492|FG003|Overall Study|Moved from Area|1|||
126788888|NCT03049488|456183493|FG004|Overall Study|Moved from Area|1|||
126788889|NCT03049488|456183494|FG005|Overall Study|Moved from Area|0|||
126788890|NCT03049488|456183489|FG000|Overall Study|Physician Decision|0|||
126788891|NCT03049488|456183490|FG001|Overall Study|Physician Decision|1|||
126788892|NCT03049488|456183491|FG002|Overall Study|Physician Decision|0|||
126788893|NCT03049488|456183492|FG003|Overall Study|Physician Decision|0|||
126788894|NCT03049488|456183493|FG004|Overall Study|Physician Decision|0|||
126788895|NCT03049488|456183494|FG005|Overall Study|Physician Decision|0|||
126788896|NCT03049488|456183489|FG000|Overall Study|Withdrawal by Subject|0|||
126788897|NCT03049488|456183490|FG001|Overall Study|Withdrawal by Subject|0|||
126788898|NCT03049488|456183491|FG002|Overall Study|Withdrawal by Subject|0|||
126788899|NCT03049488|456183492|FG003|Overall Study|Withdrawal by Subject|1|||
126788900|NCT03049488|456183493|FG004|Overall Study|Withdrawal by Subject|1|||
126788901|NCT03049488|456183494|FG005|Overall Study|Withdrawal by Subject|0|||
126788902|NCT00891293|456183497|FG000|Overall Study|Adverse Event|2|||
126788903|NCT00891293|456183497|FG000|Overall Study|Protocol Violation|2|||
126788904|NCT00891293|456183497|FG000|Overall Study|Laboratory abnormality|4|||
126788905|NCT00891293|456183497|FG000|Overall Study|Lost to Follow-up|7|||
126788906|NCT00891293|456183497|FG000|Overall Study|Subject withdrew consent|7|||
126788907|NCT00891293|456183497|FG000|Overall Study|Sponsor termination|62|||
126788908|NCT01448057|456183498|FG000|Overall Study|Protocol Violation|3|||
126788909|NCT01448057|456183499|FG001|Overall Study|Protocol Violation|2|||
126788910|NCT01448057|456183498|FG000|Overall Study|Lost to Follow-up|3|||
126788911|NCT01448057|456183499|FG001|Overall Study|Lost to Follow-up|0|||
126788912|NCT01448057|456183498|FG000|Overall Study|Adverse Event|0|||
126788913|NCT01448057|456183499|FG001|Overall Study|Adverse Event|2|||
126788914|NCT01448057|456183498|FG000|Overall Study|Withdrawal by Subject|2|||
126788915|NCT01448057|456183499|FG001|Overall Study|Withdrawal by Subject|0|||
126788916|NCT03883906|456183504|FG000|Overall Study|Withdrawal by Subject|2|||
126788917|NCT03883906|456183504|FG000|Overall Study|Physician Decision|5|||
126788918|NCT00906347|456183505|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
126788919|NCT00906347|456183506|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
126788920|NCT00906347|456183505|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
126788921|NCT00906347|456183506|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
126788922|NCT00906347|456183505|FG000|Received Study Drug|Refused study drug|1|||
126788923|NCT00906347|456183506|FG001|Received Study Drug|Refused study drug|0|||
126788924|NCT00906347|456183505|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
126788925|NCT00906347|456183506|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
126788926|NCT00117949|456183519|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
126788927|NCT00117949|456183520|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
126788928|NCT00117949|456183521|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
126788929|NCT00117949|456183522|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
126788930|NCT00117949|456183519|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
126788931|NCT00117949|456183520|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
126788932|NCT00117949|456183521|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
126788933|NCT00117949|456183522|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
126788934|NCT00117949|456183519|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
126788935|NCT00117949|456183520|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
126788936|NCT00117949|456183521|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
126788937|NCT00117949|456183522|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
126788938|NCT00117949|456183519|FG000|Overall Study|PSA increase >=10ng/mL|0|||
126788939|NCT00117949|456183520|FG001|Overall Study|PSA increase >=10ng/mL|1|||
126788940|NCT00117949|456183521|FG002|Overall Study|PSA increase >=10ng/mL|1|||
126788941|NCT00117949|456183522|FG003|Overall Study|PSA increase >=10ng/mL|0|||
126788942|NCT00117949|456183519|FG000|Overall Study|PSA reduction <=50%|0|||
126788943|NCT00117949|456183520|FG001|Overall Study|PSA reduction <=50%|2|||
126788944|NCT00117949|456183521|FG002|Overall Study|PSA reduction <=50%|2|||
126788945|NCT00117949|456183522|FG003|Overall Study|PSA reduction <=50%|4|||
126788946|NCT00117949|456183519|FG000|Overall Study|Hepatic abnormalities|0|||
126788947|NCT00117949|456183520|FG001|Overall Study|Hepatic abnormalities|1|||
126788948|NCT00117949|456183521|FG002|Overall Study|Hepatic abnormalities|0|||
126788949|NCT00117949|456183522|FG003|Overall Study|Hepatic abnormalities|1|||
126788950|NCT04591626|456183523|FG000|Overall Study|Adverse Event|4|||
126788951|NCT04591626|456183524|FG001|Overall Study|Adverse Event|0|||
126788952|NCT04591626|456183523|FG000|Overall Study|Withdrawal by Subject|5|||
126788953|NCT04591626|456183524|FG001|Overall Study|Withdrawal by Subject|3|||
126788954|NCT04591626|456183523|FG000|Overall Study|Physician Decision|0|||
126788955|NCT04591626|456183524|FG001|Overall Study|Physician Decision|1|||
126788956|NCT04591626|456183523|FG000|Overall Study|Death|0|||
126788957|NCT04591626|456183524|FG001|Overall Study|Death|1|||
126788958|NCT04591626|456183523|FG000|Overall Study|Non-Compliance with Study Drug|1|||
126788959|NCT04591626|456183524|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126788960|NCT02672553|456183525|FG000|Overall Study|Death|3|||
126788961|NCT02672553|456183526|FG001|Overall Study|Death|5|||
126788962|NCT02672553|456183525|FG000|Overall Study|Valve Explant|1|||
126788963|NCT02672553|456183526|FG001|Overall Study|Valve Explant|0|||
126788964|NCT02672553|456183525|FG000|Overall Study|Conversion to Commercial Valve|3|||
126788965|NCT02672553|456183526|FG001|Overall Study|Conversion to Commercial Valve|0|||
126788966|NCT02672553|456183525|FG000|Overall Study|Withdrawal by Subject|3|||
126788967|NCT02672553|456183526|FG001|Overall Study|Withdrawal by Subject|3|||
126788968|NCT02672553|456183525|FG000|Overall Study|Intraoperative screen failure|2|||
126788969|NCT02672553|456183526|FG001|Overall Study|Intraoperative screen failure|0|||
126788970|NCT00841100|456183529|FG000|Phase 1 (28 Days)|Adverse Event|1|||
126788971|NCT00841100|456183529|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
126788972|NCT01355081|456183530|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
126788973|NCT01355081|456183531|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
126788974|NCT01355081|456183532|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
126788975|NCT01355081|456183530|FG000|Overall Study|Major Protocol Deviation|0|||
126788976|NCT01355081|456183531|FG001|Overall Study|Major Protocol Deviation|1|||
126788977|NCT01355081|456183532|FG002|Overall Study|Major Protocol Deviation|0|||
126788978|NCT01355081|456183530|FG000|Overall Study|Lost to Follow-up|0|||
126788979|NCT01355081|456183531|FG001|Overall Study|Lost to Follow-up|0|||
126788980|NCT01355081|456183532|FG002|Overall Study|Lost to Follow-up|1|||
126788981|NCT01355081|456183530|FG000|Overall Study|Withdrawal of Consent|2|||
126788982|NCT01355081|456183531|FG001|Overall Study|Withdrawal of Consent|3|||
126788983|NCT01355081|456183532|FG002|Overall Study|Withdrawal of Consent|3|||
126788984|NCT01355081|456183530|FG000|Overall Study|Lack of Efficacy|2|||
126788985|NCT01355081|456183531|FG001|Overall Study|Lack of Efficacy|1|||
126788986|NCT01355081|456183532|FG002|Overall Study|Lack of Efficacy|1|||
126788987|NCT01355081|456183530|FG000|Overall Study|Non Compliance with Study Medication|0|||
126788988|NCT01355081|456183531|FG001|Overall Study|Non Compliance with Study Medication|1|||
126788989|NCT01355081|456183532|FG002|Overall Study|Non Compliance with Study Medication|0|||
126788990|NCT01475474|456183533|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
126788991|NCT01475474|456183533|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
126788992|NCT01868009|456183536|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
126788993|NCT01868009|456183537|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
126788994|NCT01868009|456183536|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
126788995|NCT01868009|456183537|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
126788996|NCT01868009|456183536|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
126788997|NCT01868009|456183537|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
126788998|NCT04803357|456183540|FG000|Overall Study|Withdrawal by Subject|31|||
126788999|NCT04803357|456183541|FG001|Overall Study|Withdrawal by Subject|5|||
126789000|NCT01046253|456183544|FG000|Second Intervention|Adverse Event|0|||
126789001|NCT01046253|456183545|FG001|Second Intervention|Adverse Event|1|||
126789002|NCT01046253|456183544|FG000|Second Intervention|Protocol Violation|0|||
126789003|NCT01046253|456183545|FG001|Second Intervention|Protocol Violation|1|||
126789004|NCT02339909|456183546|FG000|Overall Study|Became ineligible after randomisation|89|||
126789005|NCT02339909|456183547|FG001|Overall Study|Became ineligible after randomisation|63|||
126789006|NCT02339909|456183548|FG002|Overall Study|Became ineligible after randomisation|71|||
126789007|NCT00860028|456183553|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
126789008|NCT00860028|456183554|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
126789009|NCT01658943|456183556|FG000|Overall Study|Adverse Event|6|||
126789010|NCT01658943|456183557|FG001|Overall Study|Adverse Event|13|||
126789011|NCT01658943|456183556|FG000|Overall Study|Withdrawal by Subject|9|||
126789012|NCT01658943|456183557|FG001|Overall Study|Withdrawal by Subject|2|||
126789013|NCT01658943|456183556|FG000|Overall Study|Progression/Relapse|39|||
126789014|NCT01658943|456183557|FG001|Overall Study|Progression/Relapse|40|||
126789015|NCT01658943|456183556|FG000|Overall Study|Death|4|||
126789016|NCT01658943|456183557|FG001|Overall Study|Death|2|||
126789017|NCT01658943|456183556|FG000|Overall Study|not protocol specified|4|||
126789018|NCT01658943|456183557|FG001|Overall Study|not protocol specified|1|||
126789019|NCT01658943|456183556|FG000|Overall Study|Not eligible|7|||
126789020|NCT01658943|456183557|FG001|Overall Study|Not eligible|9|||
126789021|NCT01658943|456183556|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
126789022|NCT01658943|456183557|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
126789023|NCT03144687|456183559|FG000|Overall Study|Death|0|||
126789024|NCT03144687|456183560|FG001|Overall Study|Death|2|||
126789025|NCT03144687|456183559|FG000|Overall Study|Lost to Follow-up|0|||
126789026|NCT03144687|456183560|FG001|Overall Study|Lost to Follow-up|1|||
126789027|NCT03144687|456183559|FG000|Overall Study|Physician Decision|0|||
126789028|NCT03144687|456183560|FG001|Overall Study|Physician Decision|1|||
126789029|NCT03144687|456183559|FG000|Overall Study|Withdrawal by Subject|1|||
126789030|NCT03144687|456183560|FG001|Overall Study|Withdrawal by Subject|3|||
126789031|NCT03144687|456183559|FG000|Overall Study|Not Reported|2|||
126789032|NCT03144687|456183560|FG001|Overall Study|Not Reported|0|||
126789033|NCT02507375|456183562|FG000|Overall Study|Progressive Disease|4|||
126789034|NCT02507375|456183563|FG001|Overall Study|Progressive Disease|5|||
126789035|NCT02507375|456183562|FG000|Overall Study|Death|0|||
126789036|NCT02507375|456183563|FG001|Overall Study|Death|1|||
126789037|NCT02507375|456183562|FG000|Overall Study|Refused treatment|0|||
126789038|NCT02507375|456183563|FG001|Overall Study|Refused treatment|1|||
126789039|NCT02507375|456183562|FG000|Overall Study|Adverse Event|0|||
126789040|NCT02507375|456183563|FG001|Overall Study|Adverse Event|1|||
126789041|NCT00522457|456183564|FG000|Overall Study|Due to disease progression|16|||
126789042|NCT00522457|456183564|FG000|Overall Study|Adverse Event|2|||
126789043|NCT01691248|456183565|FG000|Overall Study|Protocol Violation|43|||
126789044|NCT01691248|456183566|FG001|Overall Study|Protocol Violation|27|||
126789045|NCT01691248|456183565|FG000|Overall Study|Adverse Event|24|||
126789046|NCT01691248|456183566|FG001|Overall Study|Adverse Event|22|||
126789047|NCT01691248|456183565|FG000|Overall Study|Withdrawal by Subject|20|||
126631410|NCT02872311|455609838|FG002|Overall Study|Death|0|||
126631411|NCT02872311|455609839|FG003|Overall Study|Death|0|||
126631412|NCT02872311|455609840|FG004|Overall Study|Death|0|||
126631413|NCT02872311|455609836|FG000|Overall Study|Lost to Follow-up|2|||
126631414|NCT02872311|455609837|FG001|Overall Study|Lost to Follow-up|0|||
126631415|NCT02872311|455609838|FG002|Overall Study|Lost to Follow-up|0|||
126631416|NCT02872311|455609839|FG003|Overall Study|Lost to Follow-up|0|||
126631417|NCT02872311|455609840|FG004|Overall Study|Lost to Follow-up|0|||
126631418|NCT02872311|455609836|FG000|Overall Study|Protocol Violation|0|||
126631419|NCT02872311|455609837|FG001|Overall Study|Protocol Violation|2|||
126631420|NCT02872311|455609838|FG002|Overall Study|Protocol Violation|1|||
126631421|NCT02872311|455609839|FG003|Overall Study|Protocol Violation|0|||
126631422|NCT02872311|455609840|FG004|Overall Study|Protocol Violation|0|||
126631423|NCT01585298|455609841|FG000|Overall Study|Study completion was not documented.|1|||
126631424|NCT01585298|455609841|FG000|Overall Study|Protocol deviation|1|||
126631425|NCT01585298|455609841|FG000|Overall Study|Administrative problems|4|||
126631426|NCT01585298|455609841|FG000|Overall Study|Lost to Follow-up|2|||
126631427|NCT01585298|455609841|FG000|Overall Study|Withdrawal by Subject|4|||
126631428|NCT01585298|455609841|FG000|Overall Study|Abnormal test procedure results|1|||
126631429|NCT01585298|455609841|FG000|Overall Study|Adverse Event|24|||
126631430|NCT04545476|455609842|FG000|Overall Study|Lost to Follow-up|1|||
126631431|NCT04545476|455609843|FG001|Overall Study|Lost to Follow-up|1|||
126789048|NCT01691248|456183566|FG001|Overall Study|Withdrawal by Subject|18|||
126789049|NCT01691248|456183565|FG000|Overall Study|Confirmed CDAD|14|||
126789050|NCT01691248|456183566|FG001|Overall Study|Confirmed CDAD|31|||
126789051|NCT01691248|456183565|FG000|Overall Study|Lost to Follow-up|2|||
126789052|NCT01691248|456183566|FG001|Overall Study|Lost to Follow-up|5|||
126789053|NCT01691248|456183565|FG000|Overall Study|Reason not provided|4|||
126789054|NCT01691248|456183566|FG001|Overall Study|Reason not provided|4|||
126789055|NCT01691248|456183565|FG000|Overall Study|Not Treated|4|||
126789056|NCT01691248|456183566|FG001|Overall Study|Not Treated|7|||
126789057|NCT02863575|456183567|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
126789058|NCT02863575|456183568|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
126631432|NCT04545476|455609844|FG002|Overall Study|Lost to Follow-up|0|||
126631433|NCT04545476|455609845|FG003|Overall Study|Lost to Follow-up|0|||
126631434|NCT01704547|455609846|FG000|Overall Study|Physician Decision|4|||
126789059|NCT02863575|456183569|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
126789060|NCT02863575|456183567|FG000|Overall Study|Withdrawal by Subject|0|||
126789061|NCT02863575|456183568|FG001|Overall Study|Withdrawal by Subject|1|||
126789062|NCT02863575|456183569|FG002|Overall Study|Withdrawal by Subject|1|||
126789063|NCT02863575|456183567|FG000|Overall Study|Adverse Event|0|||
126789064|NCT02863575|456183568|FG001|Overall Study|Adverse Event|1|||
126789065|NCT02863575|456183569|FG002|Overall Study|Adverse Event|0|||
126789066|NCT00788125|456185644|FG000|Overall Study|Death|6|||
126789067|NCT01494506|456185649|FG000|Overall Study|Lack of Efficacy|77|||
126789068|NCT01494506|456185650|FG001|Overall Study|Lack of Efficacy|83|||
126789069|NCT01494506|456185651|FG002|Overall Study|Lack of Efficacy|57|||
126789070|NCT01494506|456185649|FG000|Overall Study|Adverse Event|17|||
126789071|NCT01494506|456185650|FG001|Overall Study|Adverse Event|10|||
126789072|NCT01494506|456185651|FG002|Overall Study|Adverse Event|11|||
126789073|NCT01494506|456185649|FG000|Overall Study|Death|9|||
126789074|NCT01494506|456185650|FG001|Overall Study|Death|5|||
126789075|NCT01494506|456185651|FG002|Overall Study|Death|2|||
126789076|NCT01494506|456185649|FG000|Overall Study|Physician Decision|7|||
126789077|NCT01494506|456185650|FG001|Overall Study|Physician Decision|5|||
126789078|NCT01494506|456185651|FG002|Overall Study|Physician Decision|4|||
126789079|NCT01494506|456185649|FG000|Overall Study|Withdrawal by Subject|17|||
126789080|NCT01494506|456185650|FG001|Overall Study|Withdrawal by Subject|20|||
126789081|NCT01494506|456185651|FG002|Overall Study|Withdrawal by Subject|14|||
126789082|NCT01494506|456185649|FG000|Overall Study|Clinical Deterioration|21|||
126789083|NCT01494506|456185650|FG001|Overall Study|Clinical Deterioration|17|||
126789084|NCT01494506|456185651|FG002|Overall Study|Clinical Deterioration|13|||
126789085|NCT01494506|456185649|FG000|Overall Study|Sponsor Decision|0|||
126789086|NCT01494506|456185650|FG001|Overall Study|Sponsor Decision|0|||
126789087|NCT01494506|456185651|FG002|Overall Study|Sponsor Decision|1|||
126789088|NCT01494506|456185649|FG000|Overall Study|Other|0|||
126789089|NCT01494506|456185650|FG001|Overall Study|Other|3|||
126789090|NCT01494506|456185651|FG002|Overall Study|Other|1|||
126789091|NCT02777528|456185652|FG000|Overall Study|Still in study|24|||
126789092|NCT02777528|456185653|FG001|Overall Study|Still in study|10|||
126789093|NCT02777528|456185654|FG002|Overall Study|Still in study|1|||
126789094|NCT02777528|456185652|FG000|Overall Study|Study Device Explanted|1|||
126789095|NCT02777528|456185653|FG001|Overall Study|Study Device Explanted|0|||
126789096|NCT02777528|456185654|FG002|Overall Study|Study Device Explanted|0|||
126789097|NCT02777528|456185652|FG000|Overall Study|Death|14|||
126789098|NCT02777528|456185653|FG001|Overall Study|Death|7|||
126789099|NCT02777528|456185654|FG002|Overall Study|Death|1|||
126789100|NCT02777528|456185652|FG000|Overall Study|Withdrawal by Subject|2|||
126789101|NCT02777528|456185653|FG001|Overall Study|Withdrawal by Subject|2|||
126789102|NCT02777528|456185654|FG002|Overall Study|Withdrawal by Subject|1|||
126789103|NCT02777528|456185652|FG000|Overall Study|Physician Decision|2|||
126789104|NCT02777528|456185653|FG001|Overall Study|Physician Decision|1|||
126789105|NCT02777528|456185654|FG002|Overall Study|Physician Decision|0|||
126789106|NCT02777528|456185652|FG000|Overall Study|Lost to Follow-up|2|||
126789107|NCT02777528|456185653|FG001|Overall Study|Lost to Follow-up|0|||
126789108|NCT02777528|456185654|FG002|Overall Study|Lost to Follow-up|0|||
126789109|NCT02777528|456185652|FG000|Overall Study|Discontinued due to Other|1|||
126789110|NCT02777528|456185653|FG001|Overall Study|Discontinued due to Other|0|||
126789111|NCT02777528|456185654|FG002|Overall Study|Discontinued due to Other|0|||
126789112|NCT01492361|456185655|FG000|Overall Study|Withdrawal by Subject|281|||
126789113|NCT01492361|456185656|FG001|Overall Study|Withdrawal by Subject|297|||
126789114|NCT01492361|456185655|FG000|Overall Study|Physician Decision|12|||
126789115|NCT01492361|456185656|FG001|Overall Study|Physician Decision|12|||
126789116|NCT01492361|456185655|FG000|Overall Study|Lost to Follow-up|6|||
126789117|NCT01492361|456185656|FG001|Overall Study|Lost to Follow-up|13|||
126789118|NCT01492361|456185655|FG000|Overall Study|Other than specified above|106|||
126789119|NCT01492361|456185656|FG001|Overall Study|Other than specified above|138|||
126789120|NCT03444038|456185657|FG000|Overall Study|Adverse Event|12|||
126789121|NCT03444038|456185657|FG000|Overall Study|Withdrawal by Subject|7|||
126789122|NCT03444038|456185657|FG000|Overall Study|Lost to Follow-up|1|||
126789123|NCT03444038|456185657|FG000|Overall Study|Physician Decision|2|||
126789124|NCT03444038|456185657|FG000|Overall Study|Lack of Efficacy|7|||
126789125|NCT00543309|456185658|FG000|Overall Study|Physician Decision|0|||
126789126|NCT00543309|456185659|FG001|Overall Study|Physician Decision|1|||
126789127|NCT00543309|456185660|FG002|Overall Study|Physician Decision|0|||
126789128|NCT02143102|456185663|FG000|Overall Study|Lost to Follow-up|11|||
126789129|NCT02143102|456185664|FG001|Overall Study|Lost to Follow-up|0|||
126789130|NCT03247556|456185669|FG000|Overall Study|Adverse Event|1|||
126789131|NCT03247556|456185670|FG001|Overall Study|Adverse Event|4|||
126789132|NCT03247556|456185671|FG002|Overall Study|Adverse Event|5|||
126789133|NCT03247556|456185669|FG000|Overall Study|Lost to Follow-up|5|||
126789134|NCT03247556|456185670|FG001|Overall Study|Lost to Follow-up|5|||
126789135|NCT03247556|456185671|FG002|Overall Study|Lost to Follow-up|4|||
126789136|NCT03247556|456185669|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
126789137|NCT03247556|456185670|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
126789138|NCT03247556|456185671|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
126789139|NCT03247556|456185669|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
126789140|NCT03247556|456185670|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
126789141|NCT03247556|456185671|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
126789142|NCT03247556|456185669|FG000|Overall Study|Protocol Violation|2|||
126789143|NCT03247556|456185670|FG001|Overall Study|Protocol Violation|0|||
126789144|NCT03247556|456185671|FG002|Overall Study|Protocol Violation|1|||
126789145|NCT03247556|456185669|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
126789146|NCT03247556|456185670|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
126789147|NCT03247556|456185671|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
126789148|NCT01203878|456185672|FG000|Overall Study|Withdrawal by Subject|0|||
126789149|NCT01203878|456185673|FG001|Overall Study|Withdrawal by Subject|0|||
126789150|NCT01203878|456185674|FG002|Overall Study|Withdrawal by Subject|1|||
126789151|NCT01203878|456185672|FG000|Overall Study|Adverse Event|0|||
126789152|NCT01203878|456185673|FG001|Overall Study|Adverse Event|0|||
126789153|NCT01203878|456185674|FG002|Overall Study|Adverse Event|2|||
126789154|NCT01682083|456185677|FG000|Overall Study|Lost to Follow-up|11|||
126789155|NCT01682083|456185678|FG001|Overall Study|Lost to Follow-up|18|||
126789156|NCT01682083|456185677|FG000|Overall Study|Withdrawal by Subject|31|||
126789157|NCT01682083|456185678|FG001|Overall Study|Withdrawal by Subject|40|||
126789158|NCT01682083|456185677|FG000|Overall Study|Death|60|||
126789159|NCT01682083|456185678|FG001|Overall Study|Death|93|||
126789160|NCT01682083|456185677|FG000|Overall Study|Physician Decision|5|||
126789161|NCT01682083|456185678|FG001|Overall Study|Physician Decision|4|||
126789162|NCT03952143|456185679|FG000|Lead-In Period|Adverse Event|2|||
126789163|NCT03952143|456185680|FG001|Lead-In Period|Adverse Event|0|||
126789164|NCT03952143|456185681|FG002|Lead-In Period|Adverse Event|0|||
126789165|NCT03952143|456185679|FG000|Lead-In Period|Lack of Efficacy|2|||
126789166|NCT03952143|456185680|FG001|Lead-In Period|Lack of Efficacy|0|||
126789167|NCT03952143|456185681|FG002|Lead-In Period|Lack of Efficacy|0|||
126789168|NCT03952143|456185679|FG000|Lead-In Period|Physician Decision|5|||
126789169|NCT03952143|456185680|FG001|Lead-In Period|Physician Decision|0|||
126789170|NCT03952143|456185681|FG002|Lead-In Period|Physician Decision|0|||
126789171|NCT03952143|456185679|FG000|Lead-In Period|Protocol Violation|5|||
126789172|NCT03952143|456185680|FG001|Lead-In Period|Protocol Violation|0|||
126789173|NCT03952143|456185681|FG002|Lead-In Period|Protocol Violation|0|||
126789174|NCT03952143|456185679|FG000|Lead-In Period|Withdrawal by Subject|19|||
126789175|NCT03952143|456185680|FG001|Lead-In Period|Withdrawal by Subject|0|||
126789176|NCT03952143|456185681|FG002|Lead-In Period|Withdrawal by Subject|0|||
126789177|NCT03952143|456185679|FG000|Treatment Period|Adverse Event|0|||
126789178|NCT03952143|456185680|FG001|Treatment Period|Adverse Event|0|||
126789179|NCT03952143|456185681|FG002|Treatment Period|Adverse Event|1|||
126789180|NCT03952143|456185679|FG000|Treatment Period|Lost to Follow-up|0|||
126789181|NCT03952143|456185680|FG001|Treatment Period|Lost to Follow-up|2|||
126789182|NCT03952143|456185681|FG002|Treatment Period|Lost to Follow-up|0|||
126789183|NCT03952143|456185679|FG000|Treatment Period|Physician Decision|0|||
126789184|NCT03952143|456185680|FG001|Treatment Period|Physician Decision|0|||
126789185|NCT03952143|456185681|FG002|Treatment Period|Physician Decision|2|||
126789186|NCT03952143|456185679|FG000|Treatment Period|Protocol Violation|0|||
126789187|NCT03952143|456185680|FG001|Treatment Period|Protocol Violation|0|||
126789188|NCT03952143|456185681|FG002|Treatment Period|Protocol Violation|1|||
126789189|NCT03952143|456185679|FG000|Treatment Period|Withdrawal by Subject|0|||
126789190|NCT03952143|456185680|FG001|Treatment Period|Withdrawal by Subject|5|||
126789191|NCT03952143|456185681|FG002|Treatment Period|Withdrawal by Subject|26|||
126789192|NCT03952143|456185679|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
126789193|NCT03952143|456185680|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
126789194|NCT03952143|456185681|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
126789195|NCT03952143|456185679|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
126789196|NCT03952143|456185680|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
126789197|NCT03952143|456185681|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
126789198|NCT01866319|456185682|FG000|Overall Study|Adverse Event|12|||
126789199|NCT01866319|456185683|FG001|Overall Study|Adverse Event|5|||
126789200|NCT01866319|456185684|FG002|Overall Study|Adverse Event|9|||
126789201|NCT01866319|456185682|FG000|Overall Study|Clinical progression|3|||
126789202|NCT01866319|456185683|FG001|Overall Study|Clinical progression|2|||
126789203|NCT01866319|456185684|FG002|Overall Study|Clinical progression|2|||
126789204|NCT01866319|456185682|FG000|Overall Study|Death|153|||
126789205|NCT01866319|456185683|FG001|Overall Study|Death|154|||
126789206|NCT01866319|456185684|FG002|Overall Study|Death|147|||
126789207|NCT01866319|456185682|FG000|Overall Study|Lost to Follow-up|6|||
126789208|NCT01866319|456185683|FG001|Overall Study|Lost to Follow-up|3|||
126789209|NCT01866319|456185684|FG002|Overall Study|Lost to Follow-up|8|||
126789210|NCT01866319|456185682|FG000|Overall Study|Physician Decision|1|||
126789211|NCT01866319|456185683|FG001|Overall Study|Physician Decision|0|||
126789212|NCT01866319|456185684|FG002|Overall Study|Physician Decision|1|||
126789213|NCT01866319|456185682|FG000|Overall Study|Protocol Violation|0|||
126789214|NCT01866319|456185683|FG001|Overall Study|Protocol Violation|0|||
126789215|NCT01866319|456185684|FG002|Overall Study|Protocol Violation|1|||
126789216|NCT01866319|456185682|FG000|Overall Study|Withdrawal by Subject|32|||
126789217|NCT01866319|456185683|FG001|Overall Study|Withdrawal by Subject|14|||
126789218|NCT01866319|456185684|FG002|Overall Study|Withdrawal by Subject|12|||
126789219|NCT03980483|456185688|FG000|Overall Study|Adverse Event|13|||
126789220|NCT03980483|456185689|FG001|Overall Study|Adverse Event|29|||
126789221|NCT03980483|456185690|FG002|Overall Study|Adverse Event|11|||
126789222|NCT03980483|456185691|FG003|Overall Study|Adverse Event|2|||
126789223|NCT03980483|456185692|FG004|Overall Study|Adverse Event|2|||
126789224|NCT03980483|456185693|FG005|Overall Study|Adverse Event|2|||
126789225|NCT03980483|456185688|FG000|Overall Study|Lack of Efficacy|7|||
126789226|NCT03980483|456185689|FG001|Overall Study|Lack of Efficacy|6|||
126789227|NCT03980483|456185690|FG002|Overall Study|Lack of Efficacy|0|||
126789228|NCT03980483|456185691|FG003|Overall Study|Lack of Efficacy|3|||
126789229|NCT03980483|456185692|FG004|Overall Study|Lack of Efficacy|1|||
126789230|NCT03980483|456185693|FG005|Overall Study|Lack of Efficacy|1|||
126789231|NCT03980483|456185688|FG000|Overall Study|Lost to Follow-up|2|||
126789232|NCT03980483|456185689|FG001|Overall Study|Lost to Follow-up|4|||
126789233|NCT03980483|456185690|FG002|Overall Study|Lost to Follow-up|2|||
126789234|NCT03980483|456185691|FG003|Overall Study|Lost to Follow-up|1|||
126789235|NCT03980483|456185692|FG004|Overall Study|Lost to Follow-up|2|||
126789236|NCT03980483|456185693|FG005|Overall Study|Lost to Follow-up|0|||
126789237|NCT03980483|456185688|FG000|Overall Study|Protocol Violation|4|||
126789238|NCT03980483|456185689|FG001|Overall Study|Protocol Violation|2|||
126789239|NCT03980483|456185690|FG002|Overall Study|Protocol Violation|1|||
126789240|NCT03980483|456185691|FG003|Overall Study|Protocol Violation|1|||
126789241|NCT03980483|456185692|FG004|Overall Study|Protocol Violation|0|||
126789242|NCT03980483|456185693|FG005|Overall Study|Protocol Violation|0|||
126789243|NCT03980483|456185688|FG000|Overall Study|Physician Decision|14|||
126789244|NCT03980483|456185689|FG001|Overall Study|Physician Decision|10|||
126789245|NCT03980483|456185690|FG002|Overall Study|Physician Decision|7|||
126789246|NCT03980483|456185691|FG003|Overall Study|Physician Decision|4|||
126789247|NCT03980483|456185692|FG004|Overall Study|Physician Decision|4|||
126789248|NCT03980483|456185693|FG005|Overall Study|Physician Decision|2|||
126789249|NCT03980483|456185688|FG000|Overall Study|Withdrawal by Subject|38|||
126789250|NCT03980483|456185689|FG001|Overall Study|Withdrawal by Subject|21|||
126789251|NCT03980483|456185690|FG002|Overall Study|Withdrawal by Subject|15|||
126789252|NCT03980483|456185691|FG003|Overall Study|Withdrawal by Subject|5|||
126789253|NCT03980483|456185692|FG004|Overall Study|Withdrawal by Subject|3|||
126789254|NCT03980483|456185693|FG005|Overall Study|Withdrawal by Subject|4|||
126789255|NCT03980483|456185688|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
126789256|NCT03980483|456185689|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
126631435|NCT01704547|455609846|FG000|Overall Study|Withdrawal by Subject|1|||
126631436|NCT00690378|455609847|FG000|Overall Study|Adverse Event|1|||
126631437|NCT00690378|455609848|FG001|Overall Study|Adverse Event|0|||
126631438|NCT00690378|455609847|FG000|Overall Study|Withdrawal by Subject|2|||
126631439|NCT00690378|455609848|FG001|Overall Study|Withdrawal by Subject|0|||
126631440|NCT00690378|455609847|FG000|Overall Study|Protocol Violation|1|||
126631441|NCT00690378|455609848|FG001|Overall Study|Protocol Violation|0|||
126631442|NCT00690378|455609847|FG000|Overall Study|Lost to Follow-up|2|||
126631443|NCT00690378|455609848|FG001|Overall Study|Lost to Follow-up|3|||
126631444|NCT00690378|455609847|FG000|Overall Study|Did not meet inc/exc criteria|13|||
126631445|NCT00690378|455609848|FG001|Overall Study|Did not meet inc/exc criteria|11|||
126631446|NCT00690378|455609847|FG000|Overall Study|Social problem|1|||
126631447|NCT00690378|455609848|FG001|Overall Study|Social problem|0|||
126631448|NCT00846768|455609856|FG000|Overall Study|Adverse Event|0|||
126631449|NCT00846768|455609857|FG001|Overall Study|Adverse Event|1|||
126631450|NCT00846768|455609858|FG002|Overall Study|Adverse Event|0|||
126631451|NCT00846768|455609859|FG003|Overall Study|Adverse Event|0|||
126631452|NCT00912223|455609864|FG000|Overall Study|Withdrawal by Subject|1|||
126631453|NCT00912223|455609864|FG000|Overall Study|Not transplanted|1|||
126789257|NCT03980483|456185690|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126789258|NCT03980483|456185691|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
126789259|NCT03980483|456185692|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126789260|NCT03980483|456185693|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
126789261|NCT03980483|456185688|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
126631454|NCT00912223|455609864|FG000|Overall Study|Transformed disease|1|||
126631455|NCT01099579|455609865|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
126789262|NCT03980483|456185689|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
126789263|NCT03980483|456185690|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
126789264|NCT03980483|456185691|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
126789265|NCT03980483|456185692|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
126789266|NCT03980483|456185693|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
126789267|NCT03980483|456185688|FG000|Overall Study|Other|0|||
126789268|NCT03980483|456185689|FG001|Overall Study|Other|1|||
126789269|NCT03980483|456185690|FG002|Overall Study|Other|0|||
126631456|NCT01099579|455609866|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
126631457|NCT01099579|455609867|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
126631458|NCT01099579|455609865|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
126789270|NCT03980483|456185691|FG003|Overall Study|Other|0|||
126631459|NCT01099579|455609866|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
126631460|NCT01099579|455609867|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
126631461|NCT01099579|455609865|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
126631462|NCT01099579|455609866|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
126631463|NCT01099579|455609867|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
126631464|NCT01099579|455609865|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
126631465|NCT01099579|455609866|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
126631466|NCT01099579|455609867|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
126631467|NCT01099579|455609865|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
126631468|NCT01099579|455609866|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
126631469|NCT01099579|455609867|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
126631470|NCT01099579|455609865|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
126631471|NCT01099579|455609866|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
126631472|NCT01099579|455609867|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
126631473|NCT01099579|455609865|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
126631474|NCT01099579|455609866|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
126631475|NCT01099579|455609867|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
126631476|NCT01099579|455609865|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
126631477|NCT01099579|455609866|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
126631478|NCT01099579|455609867|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
126631479|NCT01099579|455609865|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
126631480|NCT01099579|455609866|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
126631481|NCT01099579|455609867|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
126631482|NCT01099579|455609865|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
126631483|NCT01099579|455609866|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
126631484|NCT01099579|455609867|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
126631485|NCT00909532|455609868|FG000|Overall Study|Adverse Event|4|||
126631486|NCT00909532|455609869|FG001|Overall Study|Adverse Event|1|||
126631487|NCT00909532|455609868|FG000|Overall Study|Pregnancy|0|||
126631488|NCT00909532|455609869|FG001|Overall Study|Pregnancy|1|||
126631489|NCT00909532|455609868|FG000|Overall Study|Prohibited Medication|2|||
126631490|NCT00909532|455609869|FG001|Overall Study|Prohibited Medication|1|||
126631491|NCT00909532|455609868|FG000|Overall Study|Withdrawal of Consent|1|||
126631492|NCT00909532|455609869|FG001|Overall Study|Withdrawal of Consent|1|||
126631493|NCT00909532|455609868|FG000|Overall Study|Noncompliance with Study Requirements|0|||
126631494|NCT00909532|455609869|FG001|Overall Study|Noncompliance with Study Requirements|2|||
126631495|NCT00909532|455609868|FG000|Overall Study|Physician Decision|1|||
126631496|NCT00909532|455609869|FG001|Overall Study|Physician Decision|0|||
126631497|NCT00909532|455609868|FG000|Overall Study|Wrong Genotype|1|||
126631498|NCT00909532|455609869|FG001|Overall Study|Wrong Genotype|0|||
126631499|NCT00909532|455609868|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
126631500|NCT00909532|455609869|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
126631501|NCT01157377|455609872|FG000|Overall Study|Lost to Follow-up|0|||
126631502|NCT01157377|455609873|FG001|Overall Study|Lost to Follow-up|0|||
126631503|NCT01157377|455609874|FG002|Overall Study|Lost to Follow-up|1|||
126631504|NCT01157377|455609875|FG003|Overall Study|Lost to Follow-up|0|||
126631505|NCT01157377|455609876|FG004|Overall Study|Lost to Follow-up|1|||
126631506|NCT01157377|455609877|FG005|Overall Study|Lost to Follow-up|1|||
126631507|NCT01157377|455609878|FG006|Overall Study|Lost to Follow-up|0|||
126631508|NCT01157377|455609872|FG000|Overall Study|Personal Reasons|2|||
126631509|NCT01157377|455609873|FG001|Overall Study|Personal Reasons|1|||
126631510|NCT01157377|455609874|FG002|Overall Study|Personal Reasons|0|||
126631511|NCT01157377|455609875|FG003|Overall Study|Personal Reasons|1|||
126631512|NCT01157377|455609876|FG004|Overall Study|Personal Reasons|0|||
126631513|NCT01157377|455609877|FG005|Overall Study|Personal Reasons|0|||
126631514|NCT01157377|455609878|FG006|Overall Study|Personal Reasons|0|||
126631515|NCT01157377|455609872|FG000|Overall Study|Protocol Violation|0|||
126631516|NCT01157377|455609873|FG001|Overall Study|Protocol Violation|0|||
126631517|NCT01157377|455609874|FG002|Overall Study|Protocol Violation|0|||
126631518|NCT01157377|455609875|FG003|Overall Study|Protocol Violation|0|||
126789271|NCT03980483|456185692|FG004|Overall Study|Other|0|||
126631519|NCT01157377|455609876|FG004|Overall Study|Protocol Violation|0|||
126631520|NCT01157377|455609877|FG005|Overall Study|Protocol Violation|1|||
126631521|NCT01157377|455609878|FG006|Overall Study|Protocol Violation|0|||
126631522|NCT01157377|455609872|FG000|Overall Study|Lack of Efficacy|0|||
126631523|NCT01157377|455609873|FG001|Overall Study|Lack of Efficacy|0|||
126631524|NCT01157377|455609874|FG002|Overall Study|Lack of Efficacy|0|||
126631525|NCT01157377|455609875|FG003|Overall Study|Lack of Efficacy|0|||
126631526|NCT01157377|455609876|FG004|Overall Study|Lack of Efficacy|0|||
126631527|NCT01157377|455609877|FG005|Overall Study|Lack of Efficacy|0|||
126631528|NCT01157377|455609878|FG006|Overall Study|Lack of Efficacy|1|||
126631529|NCT01157377|455609872|FG000|Overall Study|Other Miscellaneous Reasons|0|||
126631530|NCT01157377|455609873|FG001|Overall Study|Other Miscellaneous Reasons|2|||
126631531|NCT01157377|455609874|FG002|Overall Study|Other Miscellaneous Reasons|0|||
126631532|NCT01157377|455609875|FG003|Overall Study|Other Miscellaneous Reasons|0|||
126789272|NCT03980483|456185693|FG005|Overall Study|Other|0|||
126631533|NCT01157377|455609876|FG004|Overall Study|Other Miscellaneous Reasons|1|||
126631534|NCT01157377|455609877|FG005|Overall Study|Other Miscellaneous Reasons|1|||
126631535|NCT01157377|455609878|FG006|Overall Study|Other Miscellaneous Reasons|1|||
126631536|NCT00927901|455609879|FG000|Treatment Period 1|Subject withdrew consent|0|||
126631537|NCT00927901|455609880|FG001|Treatment Period 1|Subject withdrew consent|0|||
126631538|NCT00927901|455609881|FG002|Treatment Period 1|Subject withdrew consent|1|||
126631539|NCT00927901|455609882|FG003|Treatment Period 1|Subject withdrew consent|0|||
126631540|NCT00927901|455609879|FG000|Treatment Period 4|Adverse Event|0|||
126631541|NCT00927901|455609880|FG001|Treatment Period 4|Adverse Event|0|||
126631542|NCT00927901|455609881|FG002|Treatment Period 4|Adverse Event|0|||
126631543|NCT00927901|455609882|FG003|Treatment Period 4|Adverse Event|1|||
126631544|NCT00927901|455609879|FG000|Treatment Period 4|Subject withdrew consent|0|||
126631545|NCT00927901|455609880|FG001|Treatment Period 4|Subject withdrew consent|0|||
126631546|NCT00927901|455609881|FG002|Treatment Period 4|Subject withdrew consent|1|||
126631547|NCT00927901|455609882|FG003|Treatment Period 4|Subject withdrew consent|0|||
126631548|NCT01263925|455609887|FG000|Overall Study|Protocol Violation|1|||
126631549|NCT01263925|455609888|FG001|Overall Study|Protocol Violation|0|||
126631550|NCT01263925|455609887|FG000|Overall Study|Lack of Efficacy|0|||
126631551|NCT01263925|455609888|FG001|Overall Study|Lack of Efficacy|1|||
126631552|NCT01263925|455609887|FG000|Overall Study|Adverse Event|23|||
126631553|NCT01263925|455609888|FG001|Overall Study|Adverse Event|22|||
126631554|NCT01263925|455609887|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
126631555|NCT01263925|455609888|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
126631556|NCT01263925|455609887|FG000|Overall Study|Withdrawal by Subject|6|||
126631557|NCT01263925|455609888|FG001|Overall Study|Withdrawal by Subject|8|||
126631558|NCT01263925|455609887|FG000|Overall Study|Other|4|||
126631559|NCT01263925|455609888|FG001|Overall Study|Other|4|||
126631560|NCT01263925|455609887|FG000|Overall Study|Lost to Follow-up|3|||
126631561|NCT01263925|455609888|FG001|Overall Study|Lost to Follow-up|1|||
126631562|NCT01263925|455609887|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
126631563|NCT01263925|455609888|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
126631564|NCT01263925|455609887|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
126631565|NCT01263925|455609888|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
126631566|NCT01263925|455609887|FG000|Overall Study|AE/ Withdrawal|1|||
126631567|NCT01263925|455609888|FG001|Overall Study|AE/ Withdrawal|4|||
126631568|NCT01263925|455609887|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
126631569|NCT01263925|455609888|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
126631570|NCT01263925|455609887|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
126631571|NCT01263925|455609888|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
126631572|NCT01263925|455609887|FG000|Overall Study|Withdrawal/ Not specified|0|||
126631573|NCT01263925|455609888|FG001|Overall Study|Withdrawal/ Not specified|1|||
126631574|NCT03029819|455609889|FG000|Overall Study|Lost to Follow-up|3|||
126631575|NCT03029819|455609890|FG001|Overall Study|Lost to Follow-up|5|||
126631576|NCT03029819|455609889|FG000|Overall Study|Removed due to disruptive behavior|0|||
126631577|NCT03029819|455609890|FG001|Overall Study|Removed due to disruptive behavior|1|||
126631578|NCT02650466|455609897|FG000|Overall Study|Physician Decision|1|||
126631579|NCT02650466|455609897|FG000|Overall Study|Withdrawal by Subject|5|||
126631580|NCT02650466|455609897|FG000|Overall Study|Lost to Follow-up|1|||
126631581|NCT01726517|455609900|FG000|Overall Study|Withdrawal by Subject|0|||
126631582|NCT01726517|455609901|FG001|Overall Study|Withdrawal by Subject|0|||
126631583|NCT01726517|455609902|FG002|Overall Study|Withdrawal by Subject|1|||
126631584|NCT01726517|455609903|FG003|Overall Study|Withdrawal by Subject|0|||
126631585|NCT01726517|455609904|FG004|Overall Study|Withdrawal by Subject|0|||
126631586|NCT00573651|455609905|FG000|Overall Study|Lost to Follow-up|3|||
126631587|NCT00573651|455609905|FG000|Overall Study|Withdrawal by Subject|1|||
126631588|NCT03797989|455609926|FG000|VAC069A|Withdrawal by Subject|0|||
126631589|NCT03797989|455609927|FG001|VAC069A|Withdrawal by Subject|0|||
126631590|NCT03797989|455609928|FG002|VAC069A|Withdrawal by Subject|1|||
126631591|NCT03797989|455609929|FG003|VAC069A|Withdrawal by Subject|0|||
126631592|NCT03797989|455609930|FG004|VAC069A|Withdrawal by Subject|0|||
126631593|NCT03797989|455609931|FG005|VAC069A|Withdrawal by Subject|0|||
126631594|NCT03797989|455609932|FG006|VAC069A|Withdrawal by Subject|0|||
126631595|NCT03797989|455609933|FG007|VAC069A|Withdrawal by Subject|0|||
126631596|NCT03797989|455609934|FG008|VAC069A|Withdrawal by Subject|0|||
126631597|NCT03797989|455609935|FG009|VAC069A|Withdrawal by Subject|0|||
126631598|NCT03797989|455609936|FG010|VAC069A|Withdrawal by Subject|0|||
126631599|NCT03797989|455609937|FG011|VAC069A|Withdrawal by Subject|0|||
126631600|NCT04052997|455609938|FG000|Overall Study|Withdrawal by Subject|17|||
126631601|NCT04052997|455609938|FG000|Overall Study|Physician Decision|50|||
126631602|NCT04052997|455609938|FG000|Overall Study|Death|43|||
126631603|NCT04052997|455609938|FG000|Overall Study|Lost to Follow-up|5|||
126755364|NCT04880642|456054703|FG001|Randomization|Withdrawal by Subject|3|||
126631604|NCT04052997|455609938|FG000|Overall Study|Progression of Disease|1|||
126631605|NCT01024036|455609939|FG000|Blinded Treatment|Adverse Event|1|||
126631606|NCT01024036|455609940|FG001|Blinded Treatment|Adverse Event|1|||
126631607|NCT01024036|455609939|FG000|Blinded Treatment|Lack of Efficacy|16|||
126631608|NCT01024036|455609940|FG001|Blinded Treatment|Lack of Efficacy|14|||
126631609|NCT01024036|455609939|FG000|Blinded Treatment|Physician Decision|1|||
126631610|NCT01024036|455609940|FG001|Blinded Treatment|Physician Decision|0|||
126631611|NCT01024036|455609939|FG000|Blinded Treatment|Death|0|||
126631612|NCT01024036|455609940|FG001|Blinded Treatment|Death|2|||
126631613|NCT01024036|455609939|FG000|Blinded Treatment|Withdrawal by Subject|4|||
126631614|NCT01024036|455609940|FG001|Blinded Treatment|Withdrawal by Subject|3|||
126631615|NCT01024036|455609939|FG000|Unblinded Treatment|Adverse Event|0|||
126631616|NCT01024036|455609940|FG001|Unblinded Treatment|Adverse Event|1|||
126631617|NCT01024036|455609939|FG000|Unblinded Treatment|Lack of Efficacy|0|||
126631618|NCT01024036|455609940|FG001|Unblinded Treatment|Lack of Efficacy|2|||
126631619|NCT01024036|455609939|FG000|Follow-Up Period|Lost to Follow-up|1|||
126631620|NCT01024036|455609940|FG001|Follow-Up Period|Lost to Follow-up|1|||
126631621|NCT01024036|455609939|FG000|Follow-Up Period|Withdrawal by Subject|0|||
126631622|NCT01024036|455609940|FG001|Follow-Up Period|Withdrawal by Subject|1|||
126631623|NCT01024036|455609939|FG000|Follow-Up Period|Adverse Event|4|||
126631624|NCT01024036|455609940|FG001|Follow-Up Period|Adverse Event|1|||
126631625|NCT00604188|455609945|FG000|Overall Study|Adverse Event|1|||
126631626|NCT00604188|455609946|FG001|Overall Study|Adverse Event|4|||
126631627|NCT00604188|455609945|FG000|Overall Study|Lost to Follow-up|17|||
126631628|NCT00604188|455609946|FG001|Overall Study|Lost to Follow-up|15|||
126631629|NCT00604188|455609945|FG000|Overall Study|Withdrawal by Subject|5|||
126631630|NCT00604188|455609946|FG001|Overall Study|Withdrawal by Subject|1|||
126631631|NCT00604188|455609945|FG000|Overall Study|Non-compliance with protocol|4|||
126631632|NCT00604188|455609946|FG001|Overall Study|Non-compliance with protocol|4|||
126631633|NCT00604188|455609945|FG000|Overall Study|Did not receive study drug|0|||
126631634|NCT00604188|455609946|FG001|Overall Study|Did not receive study drug|1|||
126631635|NCT00356759|455609949|FG000|Overall Study|Death|5|||
126631636|NCT00356759|455609950|FG001|Overall Study|Death|2|||
126631637|NCT00356759|455609949|FG000|Overall Study|Withdrawal by Subject|2|||
126631638|NCT00356759|455609950|FG001|Overall Study|Withdrawal by Subject|2|||
126631639|NCT00356759|455609949|FG000|Overall Study|Adverse Event|1|||
126631640|NCT00356759|455609950|FG001|Overall Study|Adverse Event|3|||
126631641|NCT00356759|455609949|FG000|Overall Study|Lost to Follow-up|1|||
126631642|NCT00356759|455609950|FG001|Overall Study|Lost to Follow-up|1|||
126631643|NCT00356759|455609949|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
126631644|NCT00356759|455609950|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
126631645|NCT00474383|455609952|FG000|Main Study|Adverse Event|11|||
126631646|NCT00474383|455609953|FG001|Main Study|Adverse Event|0|||
126631647|NCT00474383|455609952|FG000|Main Study|Symptomatic Deterioration|1|||
126631648|NCT00474383|455609953|FG001|Main Study|Symptomatic Deterioration|0|||
126631649|NCT00474383|455609952|FG000|Main Study|Progressive Disease|23|||
126631650|NCT00474383|455609953|FG001|Main Study|Progressive Disease|0|||
126631651|NCT00474383|455609952|FG000|Main Study|Other|1|||
126631652|NCT00474383|455609953|FG001|Main Study|Other|0|||
126631653|NCT00474383|455609952|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
126631654|NCT00474383|455609953|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
126631655|NCT00474383|455609952|FG000|Extension|Progressive Disease|0|||
126631656|NCT00474383|455609953|FG001|Extension|Progressive Disease|5|||
126631657|NCT02998918|455609954|FG000|Overall Study|Withdrawal by Subject|1|||
126631658|NCT02998918|455609955|FG001|Overall Study|Withdrawal by Subject|0|||
126631659|NCT00443599|455609963|FG000|Overall Study|Physician Decision|2|||
126631660|NCT00443599|455609964|FG001|Overall Study|Physician Decision|1|||
126631661|NCT00443599|455609963|FG000|Overall Study|Death|1|||
126631662|NCT00443599|455609964|FG001|Overall Study|Death|1|||
126631663|NCT00443599|455609963|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
126631664|NCT00443599|455609964|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
126631665|NCT00612352|455611911|FG000|Overall Study|Adverse Event|1|||
126631666|NCT00612352|455611912|FG001|Overall Study|Adverse Event|0|||
126631667|NCT00612352|455611911|FG000|Overall Study|Withdrawal by Subject|3|||
126789273|NCT00760266|456185696|FG000|Overall Study|Adverse Event|13|||
126789274|NCT00760266|456185697|FG001|Overall Study|Adverse Event|7|||
126789275|NCT00760266|456185696|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126789276|NCT00760266|456185697|FG001|Overall Study|Abnormal laboratory value(s)|0|||
126789277|NCT00760266|456185696|FG000|Overall Study|Abnormal test procedure result(s)|1|||
126789278|NCT00760266|456185697|FG001|Overall Study|Abnormal test procedure result(s)|0|||
126789279|NCT00760266|456185696|FG000|Overall Study|Lack of Efficacy|2|||
126789280|NCT00760266|456185697|FG001|Overall Study|Lack of Efficacy|2|||
126789281|NCT00760266|456185696|FG000|Overall Study|Protocol deviation|2|||
126789282|NCT00760266|456185697|FG001|Overall Study|Protocol deviation|4|||
126789283|NCT00760266|456185696|FG000|Overall Study|Patient withdrew consent|3|||
126631668|NCT00612352|455611912|FG001|Overall Study|Withdrawal by Subject|5|||
126631669|NCT00612352|455611911|FG000|Overall Study|moved out of state|1|||
126631670|NCT00612352|455611912|FG001|Overall Study|moved out of state|0|||
126631671|NCT00612352|455611911|FG000|Overall Study|didn't return calls/show up on test date|4|||
126631672|NCT00612352|455611912|FG001|Overall Study|didn't return calls/show up on test date|1|||
126631673|NCT01986114|455611913|FG000|Overall Study|Adverse Event|59|||
126631674|NCT01986114|455611913|FG000|Overall Study|Lack of Efficacy|23|||
126631675|NCT01986114|455611913|FG000|Overall Study|Withdrawal by Subject|58|||
126631676|NCT01986114|455611913|FG000|Overall Study|Noncompliance|3|||
126631677|NCT01986114|455611913|FG000|Overall Study|Protocol Violation|1|||
126631678|NCT01986114|455611913|FG000|Overall Study|Lost to Follow-up|5|||
126631679|NCT01986114|455611913|FG000|Overall Study|Other reason|7|||
126631680|NCT00664105|455611914|FG000|Overall Study|Death|3|||
126631681|NCT00664105|455611914|FG000|Overall Study|Withdrawal by Subject|5|||
126631682|NCT00664105|455611914|FG000|Overall Study|Adverse Event|9|||
126631683|NCT00664105|455611914|FG000|Overall Study|Disease progression|7|||
126631684|NCT02034162|455611915|FG000|Double-blind|Lost to Follow-up|3|||
126631685|NCT02034162|455611916|FG001|Double-blind|Lost to Follow-up|0|||
126631686|NCT02034162|455611917|FG002|Double-blind|Lost to Follow-up|0|||
126631687|NCT02034162|455611915|FG000|Double-blind|Physician Decision|1|||
126631688|NCT02034162|455611916|FG001|Double-blind|Physician Decision|0|||
126631689|NCT02034162|455611917|FG002|Double-blind|Physician Decision|0|||
126631690|NCT02034162|455611915|FG000|Double-blind|Protocol Violation|0|||
126631691|NCT02034162|455611916|FG001|Double-blind|Protocol Violation|1|||
126631692|NCT02034162|455611917|FG002|Double-blind|Protocol Violation|0|||
126631693|NCT02034162|455611915|FG000|Double-blind|Withdrawal by Subject|5|||
126631694|NCT02034162|455611916|FG001|Double-blind|Withdrawal by Subject|7|||
126631695|NCT02034162|455611917|FG002|Double-blind|Withdrawal by Subject|0|||
126631696|NCT00030823|455611926|FG000|Overall Study|Withdrawal by Subject|1|||
126631697|NCT04333147|455611928|FG000|Overall Study|Adverse Event|43|||
126631698|NCT04333147|455611929|FG001|Overall Study|Adverse Event|40|||
126631699|NCT04333147|455611928|FG000|Overall Study|Lack of Efficacy|49|||
126631700|NCT04333147|455611929|FG001|Overall Study|Lack of Efficacy|48|||
126631701|NCT04333147|455611928|FG000|Overall Study|Lost to Follow-up|19|||
126631702|NCT04333147|455611929|FG001|Overall Study|Lost to Follow-up|16|||
126631703|NCT04333147|455611928|FG000|Overall Study|Physician Decision|17|||
126631704|NCT04333147|455611929|FG001|Overall Study|Physician Decision|20|||
126631705|NCT04333147|455611928|FG000|Overall Study|Withdrawal by Subject|65|||
126631706|NCT04333147|455611929|FG001|Overall Study|Withdrawal by Subject|68|||
126631707|NCT04333147|455611928|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
126631708|NCT04333147|455611929|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
126631709|NCT04333147|455611928|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
126631710|NCT04333147|455611929|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
126631711|NCT04333147|455611928|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
126631712|NCT04333147|455611929|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
126631713|NCT04702893|455611930|FG000|Overall Study|Other reasons than listed|11|||
126631714|NCT04702893|455611930|FG000|Overall Study|Withdrawal by Subject|3|||
126631715|NCT04702893|455611930|FG000|Overall Study|Lost to Follow-up|7|||
126631716|NCT04702893|455611930|FG000|Overall Study|Death|10|||
126631717|NCT04702893|455611930|FG000|Overall Study|Not treated|6|||
126631718|NCT00408928|455611931|FG000|Overall Study|Withdrawal by Subject|1|||
126631719|NCT00408928|455611931|FG000|Overall Study|Death|1|||
126631720|NCT00408928|455611931|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
126631721|NCT03305809|455611934|FG000|Overall Study|Adverse Event|2|||
126631722|NCT03305809|455611935|FG001|Overall Study|Adverse Event|2|||
126631723|NCT03305809|455611936|FG002|Overall Study|Adverse Event|6|||
126631724|NCT03305809|455611937|FG003|Overall Study|Adverse Event|6|||
126631725|NCT03305809|455611934|FG000|Overall Study|Death|0|||
126631726|NCT03305809|455611935|FG001|Overall Study|Death|0|||
126631727|NCT03305809|455611936|FG002|Overall Study|Death|1|||
126789284|NCT00760266|456185697|FG001|Overall Study|Patient withdrew consent|3|||
126789285|NCT00760266|456185696|FG000|Overall Study|Lost to Follow-up|2|||
126789286|NCT00760266|456185697|FG001|Overall Study|Lost to Follow-up|1|||
126789287|NCT00760266|456185696|FG000|Overall Study|Administrative Problems|0|||
126789288|NCT00760266|456185697|FG001|Overall Study|Administrative Problems|1|||
126789289|NCT00659607|456185700|FG000|Overall Study|No blood pressure recorded|147|||
126789290|NCT00659607|456185700|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
126789291|NCT00659607|456185700|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
126789292|NCT00659607|456185700|FG000|Overall Study|No recorded efficacy data|15|||
126631728|NCT03305809|455611937|FG003|Overall Study|Death|1|||
126631729|NCT03305809|455611934|FG000|Overall Study|Lost to Follow-up|1|||
126631730|NCT03305809|455611935|FG001|Overall Study|Lost to Follow-up|2|||
126631731|NCT03305809|455611936|FG002|Overall Study|Lost to Follow-up|0|||
126631732|NCT03305809|455611937|FG003|Overall Study|Lost to Follow-up|0|||
126789293|NCT00659607|456185700|FG000|Overall Study|Inconsistent BP measuring date|2|||
126789294|NCT02191891|456185701|FG000|Overall Study|Withdrawal by Subject|0|||
126789295|NCT02191891|456185702|FG001|Overall Study|Withdrawal by Subject|1|||
126631733|NCT03305809|455611934|FG000|Overall Study|Sponsor Decision|1|||
126631734|NCT03305809|455611935|FG001|Overall Study|Sponsor Decision|0|||
126631735|NCT03305809|455611936|FG002|Overall Study|Sponsor Decision|1|||
126631736|NCT03305809|455611937|FG003|Overall Study|Sponsor Decision|8|||
126631737|NCT03305809|455611934|FG000|Overall Study|Physician Decision|0|||
126631738|NCT03305809|455611935|FG001|Overall Study|Physician Decision|0|||
126631739|NCT03305809|455611936|FG002|Overall Study|Physician Decision|2|||
126631740|NCT03305809|455611937|FG003|Overall Study|Physician Decision|4|||
126789296|NCT02191891|456185703|FG002|Overall Study|Withdrawal by Subject|0|||
126789297|NCT02191891|456185704|FG003|Overall Study|Withdrawal by Subject|0|||
126789298|NCT02191891|456185705|FG004|Overall Study|Withdrawal by Subject|1|||
126789299|NCT02191891|456185701|FG000|Overall Study|Adverse Event|0|||
126789300|NCT02191891|456185702|FG001|Overall Study|Adverse Event|1|||
126789301|NCT02191891|456185703|FG002|Overall Study|Adverse Event|0|||
126789302|NCT02191891|456185704|FG003|Overall Study|Adverse Event|0|||
126789303|NCT02191891|456185705|FG004|Overall Study|Adverse Event|2|||
126789304|NCT02191891|456185701|FG000|Overall Study|Disease Progression|4|||
126789305|NCT02191891|456185702|FG001|Overall Study|Disease Progression|10|||
126789306|NCT02191891|456185703|FG002|Overall Study|Disease Progression|4|||
126789307|NCT02191891|456185704|FG003|Overall Study|Disease Progression|2|||
126789308|NCT02191891|456185705|FG004|Overall Study|Disease Progression|7|||
126789309|NCT00486837|456185706|FG000|Overall Study|Withdrawal by Subject|1|||
126789310|NCT00486837|456185707|FG001|Overall Study|Withdrawal by Subject|0|||
126789311|NCT00486837|456185706|FG000|Overall Study|Adverse Event|1|||
126789312|NCT00486837|456185707|FG001|Overall Study|Adverse Event|1|||
126789313|NCT00486837|456185706|FG000|Overall Study|Protocol Violation|4|||
126789314|NCT00486837|456185707|FG001|Overall Study|Protocol Violation|2|||
126789315|NCT00486837|456185706|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
126789316|NCT00486837|456185707|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
126789317|NCT02468778|456185708|FG000|Overall Study|Death|2|||
126789318|NCT02468778|456185709|FG001|Overall Study|Death|1|||
126789319|NCT02468778|456185710|FG002|Overall Study|Death|0|||
126789320|NCT02468778|456185708|FG000|Overall Study|Lost to Follow-up|1|||
126789321|NCT02468778|456185709|FG001|Overall Study|Lost to Follow-up|2|||
126789322|NCT02468778|456185710|FG002|Overall Study|Lost to Follow-up|2|||
126789323|NCT02468778|456185708|FG000|Overall Study|Withdrawal by Subject|0|||
126789324|NCT02468778|456185709|FG001|Overall Study|Withdrawal by Subject|1|||
126631741|NCT03305809|455611934|FG000|Overall Study|Progressive Disease|0|||
126789325|NCT02468778|456185710|FG002|Overall Study|Withdrawal by Subject|1|||
126789326|NCT03130699|456185718|FG000|Overall Study|Lost to Follow-up|34|||
126631742|NCT03305809|455611935|FG001|Overall Study|Progressive Disease|0|||
126631743|NCT03305809|455611936|FG002|Overall Study|Progressive Disease|1|||
126631744|NCT03305809|455611937|FG003|Overall Study|Progressive Disease|0|||
126631745|NCT03305809|455611934|FG000|Overall Study|Protocol Violation|1|||
126789327|NCT03130699|456185719|FG001|Overall Study|Lost to Follow-up|37|||
126789328|NCT03130699|456185720|FG002|Overall Study|Lost to Follow-up|26|||
126789329|NCT03130699|456185718|FG000|Overall Study|Withdrawal by Subject|5|||
126789330|NCT03130699|456185719|FG001|Overall Study|Withdrawal by Subject|1|||
126789331|NCT03130699|456185720|FG002|Overall Study|Withdrawal by Subject|0|||
126789332|NCT03130699|456185718|FG000|Overall Study|Withdrawal by PI|1|||
126789333|NCT03130699|456185719|FG001|Overall Study|Withdrawal by PI|2|||
126789334|NCT03130699|456185720|FG002|Overall Study|Withdrawal by PI|5|||
126789335|NCT03130699|456185718|FG000|Overall Study|Death|0|||
126789336|NCT03130699|456185719|FG001|Overall Study|Death|0|||
126789337|NCT03130699|456185720|FG002|Overall Study|Death|1|||
126631746|NCT03305809|455611935|FG001|Overall Study|Protocol Violation|0|||
126631747|NCT03305809|455611936|FG002|Overall Study|Protocol Violation|2|||
126631748|NCT03305809|455611937|FG003|Overall Study|Protocol Violation|3|||
126631749|NCT03305809|455611934|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
126631750|NCT03305809|455611935|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
126631751|NCT03305809|455611936|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
126631752|NCT03305809|455611937|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
126631753|NCT03305809|455611934|FG000|Overall Study|Withdrawal by Subject|2|||
126631754|NCT03305809|455611935|FG001|Overall Study|Withdrawal by Subject|4|||
126631755|NCT03305809|455611936|FG002|Overall Study|Withdrawal by Subject|5|||
126631756|NCT03305809|455611937|FG003|Overall Study|Withdrawal by Subject|2|||
126631757|NCT03305809|455611934|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
126631758|NCT03305809|455611935|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
126631759|NCT03305809|455611936|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
126789338|NCT01199861|456185721|FG000|Overall Study|Administrative problems|1|||
126789339|NCT01199861|456185722|FG001|Overall Study|Administrative problems|0|||
126789340|NCT01199861|456185721|FG000|Overall Study|Adverse Event|1|||
126789341|NCT01199861|456185722|FG001|Overall Study|Adverse Event|0|||
126789342|NCT00669864|456185725|FG000|Overall Study|Lost to Follow-up|2|||
126789343|NCT00669864|456185725|FG000|Overall Study|Protocol Violation|2|||
126789344|NCT00669864|456185725|FG000|Overall Study|Withdrawal by Subject|3|||
126789345|NCT00669864|456185725|FG000|Overall Study|Other|2|||
126789346|NCT00680121|456185731|FG000|Overall Study|Lost to Follow-up|27|||
126789347|NCT00680121|456185732|FG001|Overall Study|Lost to Follow-up|23|||
126789348|NCT02545998|456185741|FG000|Overall Study|Lost to Follow-up|12|||
126631760|NCT03305809|455611937|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
126631761|NCT00816556|455611938|FG000|Overall Study|Adverse Event|1|||
126789349|NCT02545998|456185742|FG001|Overall Study|Lost to Follow-up|3|||
126789350|NCT02545998|456185741|FG000|Overall Study|Withdrawal by Subject|3|||
126789351|NCT02545998|456185742|FG001|Overall Study|Withdrawal by Subject|2|||
126789352|NCT01226797|456185753|FG000|Overall Study|Adverse Event|1|||
126789353|NCT01226797|456185754|FG001|Overall Study|Adverse Event|0|||
126789354|NCT01226797|456185753|FG000|Overall Study|No longer willing to participate|1|||
126789355|NCT01226797|456185754|FG001|Overall Study|No longer willing to participate|0|||
126789356|NCT01226797|456185753|FG000|Overall Study|Protocol Violation|0|||
126789357|NCT01226797|456185754|FG001|Overall Study|Protocol Violation|1|||
126789358|NCT01318499|456185755|FG000|Overall Study|Adverse Event|16|||
126789359|NCT01318499|456185756|FG001|Overall Study|Adverse Event|11|||
126789360|NCT01318499|456185757|FG002|Overall Study|Adverse Event|6|||
126789361|NCT01318499|456185755|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
126789362|NCT01318499|456185756|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
126789363|NCT01318499|456185757|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
126789364|NCT01318499|456185755|FG000|Overall Study|Noncompliance|2|||
126789365|NCT01318499|456185756|FG001|Overall Study|Noncompliance|3|||
126789366|NCT01318499|456185757|FG002|Overall Study|Noncompliance|0|||
126789367|NCT01318499|456185755|FG000|Overall Study|Treatment Failure|19|||
126789368|NCT01318499|456185756|FG001|Overall Study|Treatment Failure|19|||
126789369|NCT01318499|456185757|FG002|Overall Study|Treatment Failure|101|||
126789370|NCT01318499|456185755|FG000|Overall Study|Protocol Violation|2|||
126789371|NCT01318499|456185756|FG001|Overall Study|Protocol Violation|4|||
126789372|NCT01318499|456185757|FG002|Overall Study|Protocol Violation|2|||
126789373|NCT01318499|456185755|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
126789374|NCT01318499|456185756|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
126789375|NCT01318499|456185757|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
126789376|NCT01318499|456185755|FG000|Overall Study|Other|7|||
126789377|NCT01318499|456185756|FG001|Overall Study|Other|10|||
126789378|NCT01318499|456185757|FG002|Overall Study|Other|22|||
126789379|NCT04977336|456185761|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
126789380|NCT04977336|456185762|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
126789381|NCT04977336|456185763|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
126789382|NCT04977336|456185764|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
126789383|NCT04977336|456185765|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
126789384|NCT04977336|456185761|FG000|Overall Study|Lost to Follow-up|0|||
126789385|NCT04977336|456185762|FG001|Overall Study|Lost to Follow-up|0|||
126789386|NCT04977336|456185763|FG002|Overall Study|Lost to Follow-up|1|||
126789387|NCT04977336|456185764|FG003|Overall Study|Lost to Follow-up|0|||
126789388|NCT04977336|456185765|FG004|Overall Study|Lost to Follow-up|0|||
126789389|NCT01347710|456185766|FG000|Overall Study|Withdrawal by Subject|2|||
126789390|NCT01347710|456185766|FG000|Overall Study|Adverse Event|4|||
126789391|NCT01347710|456185766|FG000|Overall Study|Angio or SPECT not completed|18|||
126789392|NCT01347710|456185766|FG000|Overall Study|issue with vitals prior to dosing|1|||
126789393|NCT01347710|456185766|FG000|Overall Study|Lost to Follow-up|1|||
126789394|NCT01347710|456185766|FG000|Overall Study|Physician Decision|2|||
126789395|NCT01347710|456185766|FG000|Overall Study|Other|3|||
126789396|NCT01004172|456185768|FG000|Overall Study|Progressive Disease in CNS Only|16|||
126789397|NCT01004172|456185768|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
126789398|NCT01004172|456185768|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
126789399|NCT01004172|456185768|FG000|Overall Study|Adverse Event|1|||
126789400|NCT01004172|456185768|FG000|Overall Study|Physician Decision|1|||
126789401|NCT01004172|456185768|FG000|Overall Study|Symptomatic Deterioration|2|||
126789402|NCT01606306|456185769|FG000|Overall Study|Lack of Efficacy|2|||
126789403|NCT01606306|456185770|FG001|Overall Study|Lack of Efficacy|1|||
126789404|NCT01606306|456185771|FG002|Overall Study|Lack of Efficacy|4|||
126789405|NCT01606306|456185772|FG003|Overall Study|Lack of Efficacy|4|||
126789406|NCT01606306|456185773|FG004|Overall Study|Lack of Efficacy|1|||
126789407|NCT01606306|456185774|FG005|Overall Study|Lack of Efficacy|2|||
126789408|NCT01606306|456185769|FG000|Overall Study|Adverse Event|1|||
126789409|NCT01606306|456185770|FG001|Overall Study|Adverse Event|0|||
126789410|NCT01606306|456185771|FG002|Overall Study|Adverse Event|1|||
126789411|NCT01606306|456185772|FG003|Overall Study|Adverse Event|1|||
126789412|NCT01606306|456185773|FG004|Overall Study|Adverse Event|2|||
126789413|NCT01606306|456185774|FG005|Overall Study|Adverse Event|0|||
126789414|NCT01606306|456185769|FG000|Overall Study|Lost to Follow-up|7|||
126789415|NCT01606306|456185770|FG001|Overall Study|Lost to Follow-up|4|||
126789416|NCT01606306|456185771|FG002|Overall Study|Lost to Follow-up|5|||
126789417|NCT01606306|456185772|FG003|Overall Study|Lost to Follow-up|4|||
126789418|NCT01606306|456185773|FG004|Overall Study|Lost to Follow-up|3|||
126789419|NCT01606306|456185774|FG005|Overall Study|Lost to Follow-up|5|||
126789420|NCT01606306|456185769|FG000|Overall Study|Withdrawal by Subject|4|||
126789421|NCT01606306|456185770|FG001|Overall Study|Withdrawal by Subject|3|||
126789422|NCT01606306|456185771|FG002|Overall Study|Withdrawal by Subject|4|||
126789423|NCT01606306|456185772|FG003|Overall Study|Withdrawal by Subject|4|||
126789424|NCT01606306|456185773|FG004|Overall Study|Withdrawal by Subject|5|||
126789425|NCT01606306|456185774|FG005|Overall Study|Withdrawal by Subject|4|||
126789426|NCT01606306|456185769|FG000|Overall Study|Physician Decision|1|||
126789427|NCT01606306|456185770|FG001|Overall Study|Physician Decision|2|||
126789428|NCT01606306|456185771|FG002|Overall Study|Physician Decision|0|||
126789429|NCT01606306|456185772|FG003|Overall Study|Physician Decision|0|||
126789430|NCT01606306|456185773|FG004|Overall Study|Physician Decision|0|||
126789431|NCT01606306|456185774|FG005|Overall Study|Physician Decision|0|||
126789432|NCT00970281|456185777|FG000|Overall Study|Lack of Efficacy|1|||
126789433|NCT00970281|456185778|FG001|Overall Study|Lack of Efficacy|14|||
126789434|NCT00970281|456185777|FG000|Overall Study|Withdrawal by Subject|0|||
126789435|NCT00970281|456185778|FG001|Overall Study|Withdrawal by Subject|1|||
126789436|NCT00970281|456185777|FG000|Overall Study|Physician Decision|1|||
126789437|NCT00970281|456185778|FG001|Overall Study|Physician Decision|1|||
126789438|NCT00408902|456185779|FG000|Overall Study|Lack of Efficacy|7|||
126789439|NCT00408902|456185779|FG000|Overall Study|Adverse Event|3|||
126789440|NCT02003183|456185780|FG000|Overall Study|Lost to Follow-up|0|||
126789441|NCT02003183|456185781|FG001|Overall Study|Lost to Follow-up|2|||
126789442|NCT00878995|456185782|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
126789443|NCT00878995|456185783|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
126789444|NCT03338972|456185784|FG000|Overall Study|Death|1|||
126789445|NCT03338972|456185785|FG001|Overall Study|Death|1|||
126789446|NCT03338972|456185786|FG002|Overall Study|Death|0|||
126789447|NCT03338972|456185787|FG003|Overall Study|Death|0|||
126789448|NCT03338972|456185784|FG000|Overall Study|Withdrawal by Subject|1|||
126789449|NCT03338972|456185785|FG001|Overall Study|Withdrawal by Subject|0|||
126789450|NCT03338972|456185786|FG002|Overall Study|Withdrawal by Subject|0|||
126789451|NCT03338972|456185787|FG003|Overall Study|Withdrawal by Subject|0|||
126789452|NCT02480764|456185788|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
126789453|NCT02480764|456185789|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
126789454|NCT02480764|456185790|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
126789455|NCT02480764|456185788|FG000|Overall Study|Major Protocol Deviation|1|||
126789456|NCT02480764|456185789|FG001|Overall Study|Major Protocol Deviation|4|||
126789457|NCT02480764|456185790|FG002|Overall Study|Major Protocol Deviation|3|||
126789458|NCT02480764|456185788|FG000|Overall Study|Lost to Follow-up|0|||
126789459|NCT02480764|456185789|FG001|Overall Study|Lost to Follow-up|1|||
126789460|NCT02480764|456185790|FG002|Overall Study|Lost to Follow-up|2|||
126631762|NCT00816556|455611939|FG001|Overall Study|Adverse Event|1|||
126631763|NCT00816556|455611940|FG002|Overall Study|Adverse Event|1|||
126631764|NCT00816556|455611938|FG000|Overall Study|Withdrawal by Subject|1|||
126631765|NCT00816556|455611939|FG001|Overall Study|Withdrawal by Subject|1|||
126631766|NCT00816556|455611940|FG002|Overall Study|Withdrawal by Subject|1|||
126631767|NCT00816556|455611938|FG000|Overall Study|Lost to Follow-up|0|||
126631768|NCT00816556|455611939|FG001|Overall Study|Lost to Follow-up|0|||
126631769|NCT00816556|455611940|FG002|Overall Study|Lost to Follow-up|1|||
126631770|NCT03546816|455611941|FG000|Overall Study|Adverse Event|5|||
126631771|NCT03546816|455611942|FG001|Overall Study|Adverse Event|3|||
126631772|NCT03546816|455611941|FG000|Overall Study|Lack of Efficacy|2|||
126631773|NCT03546816|455611942|FG001|Overall Study|Lack of Efficacy|4|||
126631774|NCT03546816|455611941|FG000|Overall Study|Pregnancy|1|||
126631775|NCT03546816|455611942|FG001|Overall Study|Pregnancy|0|||
126631776|NCT03546816|455611941|FG000|Overall Study|Physician Decision|2|||
126631777|NCT03546816|455611942|FG001|Overall Study|Physician Decision|0|||
126631778|NCT03546816|455611941|FG000|Overall Study|Withdrawal by Subject|8|||
126631779|NCT03546816|455611942|FG001|Overall Study|Withdrawal by Subject|10|||
126631780|NCT03546816|455611941|FG000|Overall Study|Lost to Follow-up|3|||
126631781|NCT03546816|455611942|FG001|Overall Study|Lost to Follow-up|2|||
126631782|NCT02438371|455611943|FG000|Overall Study|Lost to Follow-up|3|||
126631783|NCT02438371|455611944|FG001|Overall Study|Lost to Follow-up|2|||
126631784|NCT02438371|455611943|FG000|Overall Study|Withdrawal by Subject|1|||
126631785|NCT02438371|455611944|FG001|Overall Study|Withdrawal by Subject|1|||
126631786|NCT01161446|455611945|FG000|Overall Study|Lost to Follow-up|18|||
126631787|NCT01161446|455611946|FG001|Overall Study|Lost to Follow-up|14|||
126631788|NCT01161446|455611945|FG000|Overall Study|Withdrawal by Subject|0|||
126631789|NCT01161446|455611946|FG001|Overall Study|Withdrawal by Subject|1|||
126631790|NCT03065933|455611947|FG000|Overall Study|study terminated|5|||
126631791|NCT02330562|455611948|FG000|Overall Study|Adverse Event|0|||
126631792|NCT02330562|455611949|FG001|Overall Study|Adverse Event|0|||
126631793|NCT02330562|455611950|FG002|Overall Study|Adverse Event|3|||
126631794|NCT02330562|455611951|FG003|Overall Study|Adverse Event|0|||
126631795|NCT02330562|455611952|FG004|Overall Study|Adverse Event|3|||
126789461|NCT02480764|456185788|FG000|Overall Study|Voluntary Withdrawal|6|||
126789462|NCT02480764|456185789|FG001|Overall Study|Voluntary Withdrawal|5|||
126789463|NCT02480764|456185790|FG002|Overall Study|Voluntary Withdrawal|10|||
126789464|NCT02480764|456185788|FG000|Overall Study|Lack of Efficacy|0|||
126789465|NCT02480764|456185789|FG001|Overall Study|Lack of Efficacy|3|||
126789466|NCT02480764|456185790|FG002|Overall Study|Lack of Efficacy|3|||
126631796|NCT02330562|455611953|FG005|Overall Study|Adverse Event|1|||
126631797|NCT02330562|455611954|FG006|Overall Study|Adverse Event|0|||
126631798|NCT02330562|455611955|FG007|Overall Study|Adverse Event|0|||
126631799|NCT02330562|455611956|FG008|Overall Study|Adverse Event|0|||
126631800|NCT02330562|455611957|FG009|Overall Study|Adverse Event|1|||
126789467|NCT02480764|456185788|FG000|Overall Study|Reason not Specified|0|||
126789468|NCT02480764|456185789|FG001|Overall Study|Reason not Specified|1|||
126789469|NCT02480764|456185790|FG002|Overall Study|Reason not Specified|0|||
126789470|NCT03629249|456185791|FG000|Overall Study|Study terminated by sponsor|197|||
126789471|NCT03629249|456185792|FG001|Overall Study|Study terminated by sponsor|197|||
126789472|NCT03629249|456185793|FG002|Overall Study|Study terminated by sponsor|194|||
126789473|NCT03629249|456185791|FG000|Overall Study|Protocol deviation|0|||
126789474|NCT03629249|456185792|FG001|Overall Study|Protocol deviation|2|||
126789475|NCT03629249|456185793|FG002|Overall Study|Protocol deviation|5|||
126789476|NCT03629249|456185791|FG000|Overall Study|Subject decision|1|||
126789477|NCT03629249|456185792|FG001|Overall Study|Subject decision|1|||
126789478|NCT03629249|456185793|FG002|Overall Study|Subject decision|3|||
126789479|NCT03629249|456185791|FG000|Overall Study|Adverse Event|1|||
126789480|NCT03629249|456185792|FG001|Overall Study|Adverse Event|1|||
126789481|NCT03629249|456185793|FG002|Overall Study|Adverse Event|0|||
126789482|NCT03629249|456185791|FG000|Overall Study|Death|1|||
126789483|NCT03629249|456185792|FG001|Overall Study|Death|0|||
126789484|NCT03629249|456185793|FG002|Overall Study|Death|0|||
126789485|NCT03629249|456185791|FG000|Overall Study|Physician Decision|1|||
126789486|NCT03629249|456185792|FG001|Overall Study|Physician Decision|0|||
126789487|NCT03629249|456185793|FG002|Overall Study|Physician Decision|0|||
126789488|NCT01030965|456185796|FG000|Overall Study|Lack of Efficacy|3|||
126789489|NCT01030965|456185797|FG001|Overall Study|Lack of Efficacy|2|||
126631801|NCT02330562|455611958|FG010|Overall Study|Adverse Event|1|||
126631802|NCT02330562|455611948|FG000|Overall Study|Participant decision|1|||
126631803|NCT02330562|455611949|FG001|Overall Study|Participant decision|0|||
126631804|NCT02330562|455611950|FG002|Overall Study|Participant decision|4|||
126631805|NCT02330562|455611951|FG003|Overall Study|Participant decision|1|||
126631806|NCT02330562|455611952|FG004|Overall Study|Participant decision|5|||
126631807|NCT02330562|455611953|FG005|Overall Study|Participant decision|2|||
126631808|NCT02330562|455611954|FG006|Overall Study|Participant decision|0|||
126631809|NCT02330562|455611955|FG007|Overall Study|Participant decision|0|||
126789490|NCT01030965|456185798|FG002|Overall Study|Lack of Efficacy|0|||
126789491|NCT01030965|456185799|FG003|Overall Study|Lack of Efficacy|3|||
126789492|NCT01030965|456185796|FG000|Overall Study|Protocol Violation|1|||
126789493|NCT01030965|456185797|FG001|Overall Study|Protocol Violation|1|||
126789494|NCT01030965|456185798|FG002|Overall Study|Protocol Violation|1|||
126789495|NCT01030965|456185799|FG003|Overall Study|Protocol Violation|1|||
126789496|NCT01030965|456185796|FG000|Overall Study|Adverse Event|0|||
126789497|NCT01030965|456185797|FG001|Overall Study|Adverse Event|1|||
126789498|NCT01030965|456185798|FG002|Overall Study|Adverse Event|2|||
126789499|NCT01030965|456185799|FG003|Overall Study|Adverse Event|1|||
126789500|NCT01030965|456185796|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
126789501|NCT01030965|456185797|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
126789502|NCT01030965|456185798|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
126789503|NCT01030965|456185799|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
126789504|NCT01030965|456185796|FG000|Overall Study|Withdrawal by Subject|0|||
126789505|NCT01030965|456185797|FG001|Overall Study|Withdrawal by Subject|1|||
126789506|NCT01030965|456185798|FG002|Overall Study|Withdrawal by Subject|0|||
126789507|NCT01030965|456185799|FG003|Overall Study|Withdrawal by Subject|2|||
126789508|NCT02097290|456185800|FG000|Overall Study|Death|6|||
126789509|NCT02097290|456185800|FG000|Overall Study|Total Withdrawals|3|||
126789510|NCT02097290|456185800|FG000|Overall Study|Attempt|8|||
126789511|NCT06096168|456185801|FG000|Overall Study|Death|30|||
126789512|NCT06096168|456185801|FG000|Overall Study|Revision|2|||
126789513|NCT00743197|456185804|FG000|Overall Study|Study terminated due to departure of PI.|1|||
126789514|NCT00743197|456185805|FG001|Overall Study|Study terminated due to departure of PI.|2|||
126789515|NCT01478620|456185806|FG000|Overall Study|Lost to Follow-up|6|||
126789516|NCT00475020|456185807|FG000|Overall Study|Physician Decision|3|||
126789517|NCT00475020|456185807|FG000|Overall Study|Insurance Denial|1|||
126789518|NCT00475020|456185807|FG000|Overall Study|Donor not able to donate the last minute|1|||
126789519|NCT02514174|456185811|FG000|Overall Study|Patient refused to continue medication|1|||
126789520|NCT02514174|456185811|FG000|Overall Study|Adverse Event|2|||
126789521|NCT02514174|456185811|FG000|Overall Study|Study closed by sponsor|9|||
126789522|NCT02514174|456185811|FG000|Overall Study|Progressive disease|11|||
126789523|NCT02514174|456185811|FG000|Overall Study|Treatment change|1|||
126789524|NCT02514174|456185811|FG000|Overall Study|Treated off study with Afatinib.|1|||
126789525|NCT02130466|456185812|FG000|Overall Study|Death|4|||
126789526|NCT02130466|456185813|FG001|Overall Study|Death|1|||
126789527|NCT02130466|456185814|FG002|Overall Study|Death|1|||
126789528|NCT02130466|456185815|FG003|Overall Study|Death|3|||
126789529|NCT02130466|456185816|FG004|Overall Study|Death|2|||
126789530|NCT02130466|456185817|FG005|Overall Study|Death|30|||
126789531|NCT02130466|456185818|FG006|Overall Study|Death|45|||
126789532|NCT02130466|456185819|FG007|Overall Study|Death|2|||
126789533|NCT02130466|456185820|FG008|Overall Study|Death|3|||
126789534|NCT02130466|456185821|FG009|Overall Study|Death|4|||
126631810|NCT02330562|455611956|FG008|Overall Study|Participant decision|0|||
126631811|NCT02330562|455611957|FG009|Overall Study|Participant decision|3|||
126631812|NCT02330562|455611958|FG010|Overall Study|Participant decision|0|||
126789535|NCT02130466|456185822|FG010|Overall Study|Death|5|||
126631813|NCT02330562|455611948|FG000|Overall Study|Disease progression|5|||
126631814|NCT02330562|455611949|FG001|Overall Study|Disease progression|3|||
126631815|NCT02330562|455611950|FG002|Overall Study|Disease progression|20|||
126631816|NCT02330562|455611951|FG003|Overall Study|Disease progression|28|||
126631817|NCT02330562|455611952|FG004|Overall Study|Disease progression|23|||
126631818|NCT02330562|455611953|FG005|Overall Study|Disease progression|7|||
126631819|NCT02330562|455611954|FG006|Overall Study|Disease progression|1|||
126631820|NCT02330562|455611955|FG007|Overall Study|Disease progression|1|||
126631821|NCT02330562|455611956|FG008|Overall Study|Disease progression|1|||
126631822|NCT02330562|455611957|FG009|Overall Study|Disease progression|0|||
126631823|NCT02330562|455611958|FG010|Overall Study|Disease progression|5|||
126631824|NCT02330562|455611948|FG000|Overall Study|Other reasons|0|||
126631825|NCT02330562|455611949|FG001|Overall Study|Other reasons|0|||
126631826|NCT02330562|455611950|FG002|Overall Study|Other reasons|0|||
126631827|NCT02330562|455611951|FG003|Overall Study|Other reasons|1|||
126631828|NCT02330562|455611952|FG004|Overall Study|Other reasons|0|||
126631829|NCT02330562|455611953|FG005|Overall Study|Other reasons|0|||
126631830|NCT02330562|455611954|FG006|Overall Study|Other reasons|0|||
126631831|NCT02330562|455611955|FG007|Overall Study|Other reasons|0|||
126789536|NCT02130466|456185823|FG011|Overall Study|Death|3|||
126789537|NCT02130466|456185824|FG012|Overall Study|Death|11|||
126789538|NCT02130466|456185825|FG013|Overall Study|Death|7|||
126789539|NCT02130466|456185812|FG000|Overall Study|Lost to Follow-up|1|||
126789540|NCT02130466|456185813|FG001|Overall Study|Lost to Follow-up|0|||
126789541|NCT02130466|456185814|FG002|Overall Study|Lost to Follow-up|0|||
126789542|NCT02130466|456185815|FG003|Overall Study|Lost to Follow-up|0|||
126789543|NCT02130466|456185816|FG004|Overall Study|Lost to Follow-up|0|||
126789544|NCT02130466|456185817|FG005|Overall Study|Lost to Follow-up|1|||
126789545|NCT02130466|456185818|FG006|Overall Study|Lost to Follow-up|0|||
126789546|NCT02130466|456185819|FG007|Overall Study|Lost to Follow-up|0|||
126789547|NCT02130466|456185820|FG008|Overall Study|Lost to Follow-up|0|||
126789548|NCT02130466|456185821|FG009|Overall Study|Lost to Follow-up|0|||
126789549|NCT02130466|456185822|FG010|Overall Study|Lost to Follow-up|0|||
126789550|NCT02130466|456185823|FG011|Overall Study|Lost to Follow-up|0|||
126789551|NCT02130466|456185824|FG012|Overall Study|Lost to Follow-up|1|||
126789552|NCT02130466|456185825|FG013|Overall Study|Lost to Follow-up|0|||
126789553|NCT02130466|456185812|FG000|Overall Study|Physician Decision|0|||
126789554|NCT02130466|456185813|FG001|Overall Study|Physician Decision|0|||
126789555|NCT02130466|456185814|FG002|Overall Study|Physician Decision|0|||
126789556|NCT02130466|456185815|FG003|Overall Study|Physician Decision|0|||
126789557|NCT02130466|456185816|FG004|Overall Study|Physician Decision|0|||
126789558|NCT02130466|456185817|FG005|Overall Study|Physician Decision|1|||
126789559|NCT02130466|456185818|FG006|Overall Study|Physician Decision|1|||
126789560|NCT02130466|456185819|FG007|Overall Study|Physician Decision|0|||
126789561|NCT02130466|456185820|FG008|Overall Study|Physician Decision|0|||
126789562|NCT02130466|456185821|FG009|Overall Study|Physician Decision|0|||
126789563|NCT02130466|456185822|FG010|Overall Study|Physician Decision|0|||
126789564|NCT02130466|456185823|FG011|Overall Study|Physician Decision|0|||
126789565|NCT02130466|456185824|FG012|Overall Study|Physician Decision|0|||
126789566|NCT02130466|456185825|FG013|Overall Study|Physician Decision|0|||
126789567|NCT02130466|456185812|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
126789568|NCT02130466|456185813|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
126789569|NCT02130466|456185814|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
126789570|NCT02130466|456185815|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
126789571|NCT02130466|456185816|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
126789572|NCT02130466|456185817|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
126789573|NCT02130466|456185818|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
126789574|NCT02130466|456185819|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
126789575|NCT02130466|456185820|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
126789576|NCT02130466|456185821|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
126789577|NCT02130466|456185822|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
126789578|NCT02130466|456185823|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
126789579|NCT02130466|456185824|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
126789580|NCT02130466|456185825|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
126789581|NCT02130466|456185812|FG000|Overall Study|Withdrawal by Subject|1|||
126789582|NCT02130466|456185813|FG001|Overall Study|Withdrawal by Subject|0|||
126789583|NCT02130466|456185814|FG002|Overall Study|Withdrawal by Subject|0|||
126789584|NCT02130466|456185815|FG003|Overall Study|Withdrawal by Subject|0|||
126789585|NCT02130466|456185816|FG004|Overall Study|Withdrawal by Subject|0|||
126789586|NCT02130466|456185817|FG005|Overall Study|Withdrawal by Subject|1|||
126789587|NCT02130466|456185818|FG006|Overall Study|Withdrawal by Subject|0|||
126631832|NCT02330562|455611956|FG008|Overall Study|Other reasons|0|||
126631833|NCT02330562|455611957|FG009|Overall Study|Other reasons|0|||
126631834|NCT02330562|455611958|FG010|Overall Study|Other reasons|0|||
126631835|NCT02330562|455611948|FG000|Overall Study|Withdrawal by Subject|0|||
126631836|NCT02330562|455611949|FG001|Overall Study|Withdrawal by Subject|0|||
126789588|NCT02130466|456185819|FG007|Overall Study|Withdrawal by Subject|0|||
126789589|NCT02130466|456185820|FG008|Overall Study|Withdrawal by Subject|1|||
126789590|NCT02130466|456185821|FG009|Overall Study|Withdrawal by Subject|0|||
126789591|NCT02130466|456185822|FG010|Overall Study|Withdrawal by Subject|0|||
126789592|NCT02130466|456185823|FG011|Overall Study|Withdrawal by Subject|0|||
126789593|NCT02130466|456185824|FG012|Overall Study|Withdrawal by Subject|0|||
126789594|NCT02130466|456185825|FG013|Overall Study|Withdrawal by Subject|0|||
126789595|NCT04529109|456185826|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
126789596|NCT04529109|456185827|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
126631837|NCT02330562|455611950|FG002|Overall Study|Withdrawal by Subject|0|||
126631838|NCT02330562|455611951|FG003|Overall Study|Withdrawal by Subject|0|||
126631839|NCT02330562|455611952|FG004|Overall Study|Withdrawal by Subject|0|||
126631840|NCT02330562|455611953|FG005|Overall Study|Withdrawal by Subject|0|||
126631841|NCT02330562|455611954|FG006|Overall Study|Withdrawal by Subject|0|||
126631842|NCT02330562|455611955|FG007|Overall Study|Withdrawal by Subject|0|||
126631843|NCT02330562|455611956|FG008|Overall Study|Withdrawal by Subject|0|||
126631844|NCT02330562|455611957|FG009|Overall Study|Withdrawal by Subject|1|||
126631845|NCT02330562|455611958|FG010|Overall Study|Withdrawal by Subject|0|||
126631846|NCT01316887|455611960|FG000|Overall Study|Adverse Event|13|||
126631847|NCT01316887|455611961|FG001|Overall Study|Adverse Event|21|||
126631848|NCT01316887|455611962|FG002|Overall Study|Adverse Event|17|||
126631849|NCT01316887|455611960|FG000|Overall Study|Lack of Efficacy|9|||
126631850|NCT01316887|455611961|FG001|Overall Study|Lack of Efficacy|3|||
126631851|NCT01316887|455611962|FG002|Overall Study|Lack of Efficacy|1|||
126631852|NCT01316887|455611960|FG000|Overall Study|Protocol Violation|2|||
126631853|NCT01316887|455611961|FG001|Overall Study|Protocol Violation|6|||
126631854|NCT01316887|455611962|FG002|Overall Study|Protocol Violation|6|||
126631855|NCT01316887|455611960|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
126631856|NCT01316887|455611961|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
126631857|NCT01316887|455611962|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
126631858|NCT01316887|455611960|FG000|Overall Study|Study Closed/Terminated|2|||
126631859|NCT01316887|455611961|FG001|Overall Study|Study Closed/Terminated|4|||
126631860|NCT01316887|455611962|FG002|Overall Study|Study Closed/Terminated|3|||
126631861|NCT01316887|455611960|FG000|Overall Study|Lost to Follow-up|1|||
126631862|NCT01316887|455611961|FG001|Overall Study|Lost to Follow-up|7|||
126631863|NCT01316887|455611962|FG002|Overall Study|Lost to Follow-up|5|||
126631864|NCT01316887|455611960|FG000|Overall Study|Withdrawal by Subject|8|||
126631865|NCT01316887|455611961|FG001|Overall Study|Withdrawal by Subject|16|||
126631866|NCT01316887|455611962|FG002|Overall Study|Withdrawal by Subject|15|||
126631867|NCT03470545|455611965|FG000|Overall Study|Death|0|||
126631868|NCT03470545|455611966|FG001|Overall Study|Death|1|||
126631869|NCT03470545|455611965|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
126631870|NCT03470545|455611966|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
126631871|NCT03470545|455611965|FG000|Overall Study|Adverse Event|2|||
126631872|NCT03470545|455611966|FG001|Overall Study|Adverse Event|0|||
126631873|NCT03470545|455611965|FG000|Overall Study|Withdrawal by Subject|1|||
126631874|NCT03470545|455611966|FG001|Overall Study|Withdrawal by Subject|1|||
126631875|NCT03470545|455611965|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
126631876|NCT03470545|455611966|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
126631877|NCT00585975|455611967|FG000|Overall Study|Withdrawal by Subject|3|||
126631878|NCT00585975|455611968|FG001|Overall Study|Withdrawal by Subject|3|||
126631879|NCT00585975|455611967|FG000|Overall Study|Lost to Follow-up|2|||
126631880|NCT00585975|455611968|FG001|Overall Study|Lost to Follow-up|1|||
126631881|NCT00585975|455611967|FG000|Overall Study|Enrollment met/over-enrolled|10|||
126631882|NCT00585975|455611968|FG001|Overall Study|Enrollment met/over-enrolled|9|||
126631883|NCT01336205|455611969|FG000|Overall Study|Other|22|||
126631884|NCT01336205|455611970|FG001|Overall Study|Other|9|||
126631885|NCT01336205|455611969|FG000|Overall Study|Lost to Follow-up|40|||
126631886|NCT01336205|455611970|FG001|Overall Study|Lost to Follow-up|20|||
126631887|NCT01336205|455611969|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
126631888|NCT01336205|455611970|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
126631889|NCT01336205|455611969|FG000|Overall Study|Lack of Efficacy|4|||
126631890|NCT01336205|455611970|FG001|Overall Study|Lack of Efficacy|0|||
126631891|NCT01336205|455611969|FG000|Overall Study|Severe noncompliance with protocol|9|||
126789597|NCT02170688|456185828|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
126789598|NCT02170688|456185829|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
126789599|NCT02170688|456185830|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
126631892|NCT01336205|455611970|FG001|Overall Study|Severe noncompliance with protocol|2|||
126631893|NCT01336205|455611969|FG000|Overall Study|Adverse Event|56|||
126631894|NCT01336205|455611970|FG001|Overall Study|Adverse Event|6|||
126789600|NCT02170688|456185831|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
126631895|NCT01336205|455611969|FG000|Overall Study|Death|1|||
126631896|NCT01336205|455611970|FG001|Overall Study|Death|1|||
126631897|NCT01336205|455611969|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
126631898|NCT01336205|455611970|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
126631899|NCT01336205|455611969|FG000|Overall Study|Withdrawal by Subject|72|||
126631900|NCT01336205|455611970|FG001|Overall Study|Withdrawal by Subject|38|||
126631901|NCT01336205|455611969|FG000|Overall Study|Did not receive treatment|4|||
126631902|NCT01336205|455611970|FG001|Overall Study|Did not receive treatment|0|||
126631903|NCT01006616|455611971|FG000|Period 1 (6 Months)|Adverse Event|10|||
126631904|NCT01006616|455611972|FG001|Period 1 (6 Months)|Adverse Event|31|||
126631905|NCT01006616|455611973|FG002|Period 1 (6 Months)|Adverse Event|37|||
126631906|NCT01006616|455611974|FG003|Period 1 (6 Months)|Adverse Event|9|||
126631907|NCT01006616|455611971|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
126631908|NCT01006616|455611972|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
126631909|NCT01006616|455611973|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
126631910|NCT01006616|455611974|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
126631911|NCT01006616|455611971|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
126631912|NCT01006616|455611972|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
126631913|NCT01006616|455611973|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
126631914|NCT01006616|455611974|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
126631915|NCT01006616|455611971|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
126631916|NCT01006616|455611972|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
126631917|NCT01006616|455611973|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
126631918|NCT01006616|455611974|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
126631919|NCT01006616|455611971|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
126631920|NCT01006616|455611972|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
126631921|NCT01006616|455611973|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
126631922|NCT01006616|455611974|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
126789601|NCT02170688|456185832|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
126789602|NCT02170688|456185828|FG000|Overall Study|Full dose not received|0|||
126789603|NCT02170688|456185829|FG001|Overall Study|Full dose not received|1|||
126789604|NCT02170688|456185830|FG002|Overall Study|Full dose not received|0|||
126631923|NCT01006616|455611971|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
126631924|NCT01006616|455611972|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
126631925|NCT01006616|455611973|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
126631926|NCT01006616|455611974|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
126631927|NCT01006616|455611971|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
126631928|NCT01006616|455611972|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
126631929|NCT01006616|455611973|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
126631930|NCT01006616|455611974|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
126631931|NCT01006616|455611971|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
126631932|NCT01006616|455611972|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
126631933|NCT01006616|455611973|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
126631934|NCT01006616|455611974|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
126631935|NCT01006616|455611971|FG000|Period 1 (6 Months)|Not Treated|0|||
126631936|NCT01006616|455611972|FG001|Period 1 (6 Months)|Not Treated|0|||
126631937|NCT01006616|455611973|FG002|Period 1 (6 Months)|Not Treated|1|||
126631938|NCT01006616|455611974|FG003|Period 1 (6 Months)|Not Treated|1|||
126631939|NCT01006616|455611971|FG000|Period 2 (18 Months)|Adverse Event|6|||
126631940|NCT01006616|455611972|FG001|Period 2 (18 Months)|Adverse Event|6|||
126631941|NCT01006616|455611973|FG002|Period 2 (18 Months)|Adverse Event|6|||
126631942|NCT01006616|455611974|FG003|Period 2 (18 Months)|Adverse Event|4|||
126789605|NCT02170688|456185831|FG003|Overall Study|Full dose not received|0|||
126789606|NCT02170688|456185832|FG004|Overall Study|Full dose not received|0|||
126789607|NCT02170688|456185828|FG000|Overall Study|Physician Decision|0|||
126789608|NCT02170688|456185829|FG001|Overall Study|Physician Decision|0|||
126789609|NCT02170688|456185830|FG002|Overall Study|Physician Decision|1|||
126789610|NCT02170688|456185831|FG003|Overall Study|Physician Decision|0|||
126789611|NCT02170688|456185832|FG004|Overall Study|Physician Decision|0|||
126789612|NCT00444145|456187370|FG000|Overall Study|Withdrawal by Subject|2|||
126789613|NCT00444145|456187370|FG000|Overall Study|Lost to Follow-up|1|||
126789614|NCT00444145|456187370|FG000|Overall Study|non-compliant|11|||
126789615|NCT00444145|456187370|FG000|Overall Study|Screen Failures|5|||
126789616|NCT01374919|456187371|FG000|Overall Study|Withdrawal by Subject|2|||
126789617|NCT03100903|456187377|FG000|Overall Study|Withdrawal by Subject|0|||
126789618|NCT03100903|456187378|FG001|Overall Study|Withdrawal by Subject|0|||
126789619|NCT03100903|456187379|FG002|Overall Study|Withdrawal by Subject|1|||
126789620|NCT00433147|456187380|FG000|Overall Study|Adverse Event|0|||
126789621|NCT00433147|456187381|FG001|Overall Study|Adverse Event|1|||
126789622|NCT00433147|456187382|FG002|Overall Study|Adverse Event|0|||
126789623|NCT00433147|456187383|FG003|Overall Study|Adverse Event|0|||
126631943|NCT01006616|455611971|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
126631944|NCT01006616|455611972|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
126631945|NCT01006616|455611973|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
126631946|NCT01006616|455611974|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
126631947|NCT01006616|455611971|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
126631948|NCT01006616|455611972|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
126789624|NCT00728949|456187386|FG000|Overall Study|Adverse Event|8|||
126789625|NCT00728949|456187387|FG001|Overall Study|Adverse Event|0|||
126789626|NCT00728949|456187386|FG000|Overall Study|Withdrawal by Subject|2|||
126789627|NCT00728949|456187387|FG001|Overall Study|Withdrawal by Subject|2|||
126789628|NCT00728949|456187386|FG000|Overall Study|Abnormal Lab Results|0|||
126789629|NCT00728949|456187387|FG001|Overall Study|Abnormal Lab Results|2|||
126789630|NCT00728949|456187386|FG000|Overall Study|On treatment at cutoff date|1|||
126789631|NCT00728949|456187387|FG001|Overall Study|On treatment at cutoff date|0|||
126789632|NCT01996033|456187389|FG000|Overall Study|Death|1|||
126789633|NCT01996033|456187389|FG000|Overall Study|Physician Decision|1|||
126789634|NCT01996033|456187389|FG000|Overall Study|Withdrawal by Subject|4|||
126789635|NCT01996033|456187389|FG000|Overall Study|Lost to Follow-up|3|||
126789636|NCT01249664|456187390|FG000|Overall Study|Withdrawal by Subject|5|||
126789637|NCT01249664|456187391|FG001|Overall Study|Withdrawal by Subject|0|||
126789638|NCT01249664|456187390|FG000|Overall Study|Adverse Event|1|||
126789639|NCT01249664|456187391|FG001|Overall Study|Adverse Event|0|||
126789640|NCT01225146|456187393|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
126789641|NCT01225146|456187394|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
126789642|NCT01239121|456187395|FG000|Overall Study|Withdrawal by Subject|2|||
126789643|NCT01239121|456187396|FG001|Overall Study|Withdrawal by Subject|4|||
126789644|NCT01239121|456187397|FG002|Overall Study|Withdrawal by Subject|0|||
126789645|NCT00220337|456187398|FG000|Overall Study|Adverse Event|70|||
126789646|NCT00220337|456187398|FG000|Overall Study|Lack of Efficacy|17|||
126789647|NCT00220337|456187398|FG000|Overall Study|Withdrawal by Subject|68|||
126789648|NCT00220337|456187398|FG000|Overall Study|Protocol Violation|2|||
126789649|NCT00220337|456187398|FG000|Overall Study|Lost to Follow-up|5|||
126789650|NCT00220337|456187398|FG000|Overall Study|Other|12|||
126789651|NCT00220337|456187398|FG000|Overall Study|Unsatisfactory compliance|5|||
126789652|NCT01273181|456187401|FG000|Phase I, Dose 1|Study termination|1|||
126789653|NCT01273181|456187402|FG001|Phase I, Dose 1|Study termination|0|||
126789654|NCT01273181|456187403|FG002|Phase I, Dose 1|Study termination|0|||
126789655|NCT01273181|456187404|FG003|Phase I, Dose 1|Study termination|0|||
126789656|NCT01273181|456187401|FG000|Phase I, Dose 2|Death during treatment|0|||
126789657|NCT01273181|456187402|FG001|Phase I, Dose 2|Death during treatment|1|||
126789658|NCT01273181|456187403|FG002|Phase I, Dose 2|Death during treatment|0|||
126789659|NCT01273181|456187404|FG003|Phase I, Dose 2|Death during treatment|0|||
126789660|NCT01273181|456187401|FG000|Phase 2, Dose 1|Study termination|0|||
126789661|NCT01273181|456187402|FG001|Phase 2, Dose 1|Study termination|0|||
126789662|NCT01273181|456187403|FG002|Phase 2, Dose 1|Study termination|1|||
126789663|NCT01273181|456187404|FG003|Phase 2, Dose 1|Study termination|0|||
126789664|NCT01273181|456187401|FG000|Phase 2, Dose 2|Death during treatment|0|||
126789665|NCT01273181|456187402|FG001|Phase 2, Dose 2|Death during treatment|0|||
126789666|NCT01273181|456187403|FG002|Phase 2, Dose 2|Death during treatment|0|||
126789667|NCT01273181|456187404|FG003|Phase 2, Dose 2|Death during treatment|1|||
126789668|NCT00944697|456187405|FG000|Overall Study|Withdrawal by Subject|1|||
126789669|NCT00944697|456187406|FG001|Overall Study|Withdrawal by Subject|1|||
126789670|NCT00944697|456187405|FG000|Overall Study|Adverse Event|0|||
126789671|NCT00944697|456187406|FG001|Overall Study|Adverse Event|3|||
126789672|NCT00944697|456187405|FG000|Overall Study|Administrative|1|||
126631949|NCT01006616|455611973|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
126631950|NCT01006616|455611974|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
126631951|NCT01006616|455611971|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
126755365|NCT04880642|456054702|FG000|Treatment Period|Adverse Event|0|||
126755366|NCT04880642|456054703|FG001|Treatment Period|Adverse Event|1|||
126755367|NCT04880642|456054702|FG000|Treatment Period|Death|6|||
126755368|NCT04880642|456054703|FG001|Treatment Period|Death|6|||
126755369|NCT04880642|456054702|FG000|Treatment Period|Lost to Follow-up|1|||
126755370|NCT04880642|456054703|FG001|Treatment Period|Lost to Follow-up|0|||
126755371|NCT04880642|456054702|FG000|Treatment Period|Protocol Violation|0|||
126755372|NCT04880642|456054703|FG001|Treatment Period|Protocol Violation|1|||
126755373|NCT04880642|456054702|FG000|Treatment Period|Withdrawal by Subject|5|||
126755374|NCT04880642|456054703|FG001|Treatment Period|Withdrawal by Subject|3|||
126755375|NCT04880642|456054702|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
126755376|NCT04880642|456054703|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
126755377|NCT04880642|456054702|FG000|Follow-up|Death|4|||
126755378|NCT04880642|456054703|FG001|Follow-up|Death|3|||
126755379|NCT04880642|456054702|FG000|Follow-up|Withdrawal by Subject|1|||
126755380|NCT04880642|456054703|FG001|Follow-up|Withdrawal by Subject|0|||
126755381|NCT00104299|456054704|FG000|Overall Study|Adverse Event|3|||
126755382|NCT00104299|456054705|FG001|Overall Study|Adverse Event|1|||
126755383|NCT00104299|456054704|FG000|Overall Study|Death|2|||
126755384|NCT00104299|456054705|FG001|Overall Study|Death|2|||
126755385|NCT00104299|456054704|FG000|Overall Study|Withdrawal by Subject|2|||
126755386|NCT00104299|456054705|FG001|Overall Study|Withdrawal by Subject|6|||
126755387|NCT00104299|456054704|FG000|Overall Study|Physician Decision|1|||
126755388|NCT00104299|456054705|FG001|Overall Study|Physician Decision|1|||
126755389|NCT00104299|456054704|FG000|Overall Study|To have renal transplant|1|||
126789673|NCT00944697|456187406|FG001|Overall Study|Administrative|1|||
126789674|NCT04638153|456187407|FG000|Overall Study|Withdrawal by parent/guardian|0|||
126631952|NCT01006616|455611972|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
126631953|NCT01006616|455611973|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
126631954|NCT01006616|455611974|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
126631955|NCT01006616|455611971|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
126631956|NCT01006616|455611972|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
126631957|NCT01006616|455611973|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
126631958|NCT01006616|455611974|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
126631959|NCT01006616|455611971|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
126631960|NCT01006616|455611972|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
126631961|NCT01006616|455611973|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
126631962|NCT01006616|455611974|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
126789675|NCT04638153|456187408|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126789676|NCT04638153|456187409|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126789677|NCT04638153|456187407|FG000|Overall Study|Study terminated by sponsor|4|||
126789678|NCT04638153|456187408|FG001|Overall Study|Study terminated by sponsor|2|||
126789679|NCT04638153|456187409|FG002|Overall Study|Study terminated by sponsor|14|||
126789680|NCT04006171|456187410|FG000|Overall Study|Withdrawal by Subject|8|||
126789681|NCT04006171|456187411|FG001|Overall Study|Withdrawal by Subject|7|||
126789682|NCT04006171|456187410|FG000|Overall Study|missing serum samples|2|||
126789683|NCT04006171|456187411|FG001|Overall Study|missing serum samples|2|||
126789684|NCT04006171|456187410|FG000|Overall Study|insufficient sample volume|2|||
126789685|NCT04006171|456187411|FG001|Overall Study|insufficient sample volume|3|||
126631963|NCT01006616|455611971|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
126631964|NCT01006616|455611972|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
126631965|NCT01006616|455611973|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
126631966|NCT01006616|455611974|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
126631967|NCT01006616|455611971|FG000|Period 2 (18 Months)|Study Terminated|63|||
126631968|NCT01006616|455611972|FG001|Period 2 (18 Months)|Study Terminated|46|||
126631969|NCT01006616|455611973|FG002|Period 2 (18 Months)|Study Terminated|44|||
126631970|NCT01006616|455611974|FG003|Period 2 (18 Months)|Study Terminated|70|||
126631971|NCT03672175|455611975|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
126631972|NCT03672175|455611976|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
126631973|NCT03672175|455611977|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
126631974|NCT03672175|455611975|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
126631975|NCT03672175|455611976|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
126631976|NCT03672175|455611977|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
126631977|NCT03672175|455611975|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
126631978|NCT03672175|455611976|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
126631979|NCT03672175|455611977|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
126631980|NCT03672175|455611975|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
126631981|NCT03672175|455611976|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
126631982|NCT03672175|455611977|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
126631983|NCT03672175|455611975|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
126631984|NCT03672175|455611976|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
126631985|NCT03672175|455611977|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
126631986|NCT03672175|455611975|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
126631987|NCT03672175|455611976|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
126631988|NCT03672175|455611977|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
126631989|NCT03672175|455611975|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
126631990|NCT03672175|455611976|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
126631991|NCT03672175|455611977|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
126631992|NCT03672175|455611975|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
126631993|NCT03672175|455611976|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
126631994|NCT03672175|455611977|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
126631995|NCT03672175|455611975|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
126789686|NCT00874237|456187417|FG000|Overall Study|Physician Decision|0|||
126789687|NCT00874237|456187418|FG001|Overall Study|Physician Decision|1|||
126789688|NCT00874237|456187419|FG002|Overall Study|Physician Decision|0|||
126631996|NCT03672175|455611976|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
126631997|NCT03672175|455611977|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
126631998|NCT03672175|455611975|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
126631999|NCT03672175|455611976|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
126632000|NCT03672175|455611977|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
126789689|NCT00874237|456187420|FG003|Overall Study|Physician Decision|0|||
126632001|NCT03672175|455611975|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
126789690|NCT00874237|456187421|FG004|Overall Study|Physician Decision|0|||
126789691|NCT00874237|456187422|FG005|Overall Study|Physician Decision|0|||
126632002|NCT03672175|455611976|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
126632003|NCT03672175|455611977|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
126632004|NCT03672175|455611975|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
126632005|NCT03672175|455611976|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
126632006|NCT03672175|455611977|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
126632007|NCT02482935|455611978|FG000|Period 1|Withdrawal by Subject|1|||
126632008|NCT02482935|455611979|FG001|Period 1|Withdrawal by Subject|0|||
126632009|NCT03414047|455611980|FG000|Overall Study|Adverse Event|0|||
126632010|NCT03414047|455611981|FG001|Overall Study|Adverse Event|0|||
126632011|NCT03414047|455611982|FG002|Overall Study|Adverse Event|1|||
126632012|NCT03414047|455611983|FG003|Overall Study|Adverse Event|1|||
126632013|NCT03414047|455611980|FG000|Overall Study|Physician Decision|1|||
126632014|NCT03414047|455611981|FG001|Overall Study|Physician Decision|0|||
126632015|NCT03414047|455611982|FG002|Overall Study|Physician Decision|0|||
126632016|NCT03414047|455611983|FG003|Overall Study|Physician Decision|1|||
126632017|NCT03414047|455611980|FG000|Overall Study|Withdrawal by Subject|1|||
126632018|NCT03414047|455611981|FG001|Overall Study|Withdrawal by Subject|0|||
126632019|NCT03414047|455611982|FG002|Overall Study|Withdrawal by Subject|2|||
126632020|NCT03414047|455611983|FG003|Overall Study|Withdrawal by Subject|0|||
126632021|NCT02777242|455611991|FG000|Overall Study|Other|2|||
126632022|NCT02777242|455611991|FG000|Overall Study|Lost to Follow-up|1|||
126632023|NCT02777242|455611991|FG000|Overall Study|Multiple|1|||
126632024|NCT02777242|455611991|FG000|Overall Study|Sponsor's request|1|||
126632025|NCT02777242|455611991|FG000|Overall Study|Withdrawal by Subject|1|||
126632026|NCT01898442|455611992|FG000|Overall Study|Hemolysis/technical problems|1|||
126632027|NCT01898442|455611993|FG001|Overall Study|Hemolysis/technical problems|2|||
126632028|NCT01898442|455611994|FG002|Overall Study|Hemolysis/technical problems|2|||
126632029|NCT01898442|455611992|FG000|Overall Study|Patient vomited pills|0|||
126632030|NCT01898442|455611993|FG001|Overall Study|Patient vomited pills|0|||
126632031|NCT01898442|455611994|FG002|Overall Study|Patient vomited pills|1|||
126789692|NCT00874237|456187417|FG000|Overall Study|Withdrawal by Subject|0|||
126789693|NCT00874237|456187418|FG001|Overall Study|Withdrawal by Subject|0|||
126789694|NCT00874237|456187419|FG002|Overall Study|Withdrawal by Subject|1|||
126789695|NCT00874237|456187420|FG003|Overall Study|Withdrawal by Subject|0|||
126789696|NCT00874237|456187421|FG004|Overall Study|Withdrawal by Subject|0|||
126789697|NCT00874237|456187422|FG005|Overall Study|Withdrawal by Subject|0|||
126789698|NCT03912337|456187425|FG000|Overall Study|Withdrawal of Consent From Study|1|||
126789699|NCT03912337|456187426|FG001|Overall Study|Withdrawal of Consent From Study|0|||
126789700|NCT03912337|456187425|FG000|Overall Study|Lost to Follow-up|1|||
126789701|NCT03912337|456187426|FG001|Overall Study|Lost to Follow-up|1|||
126789702|NCT03752528|456187427|FG000|Part A|Lost to Follow-up|1|||
126789703|NCT03752528|456187427|FG000|Part A|Protocol Violation|1|||
126789704|NCT03752528|456187427|FG000|Part B|Protocol Violation|1|||
126789705|NCT03752528|456187427|FG000|Part B|Study terminated by sponsor|3|||
126789706|NCT00537030|456187428|FG000|Overall Study|Physician Decision|2|||
126789707|NCT00537030|456187428|FG000|Overall Study|Withdrawal by Subject|2|||
126789708|NCT00537030|456187428|FG000|Overall Study|≥ Grade 2 allergy|7|||
126755390|NCT00104299|456054705|FG001|Overall Study|To have renal transplant|0|||
126755391|NCT02906644|456054706|FG000|First 2 Weeks|Withdrawal by Subject|0|||
126755392|NCT02906644|456054707|FG001|First 2 Weeks|Withdrawal by Subject|2|||
126755393|NCT02906644|456054706|FG000|First 2 Weeks|Physician Decision|1|||
126789709|NCT00537030|456187428|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
126789710|NCT00537030|456187428|FG000|Overall Study|Ineligible|2|||
126789711|NCT00537030|456187428|FG000|Overall Study|Inevaluable|2|||
126789712|NCT00414765|456187429|FG000|Overall Study|Adverse Event|5|||
126789713|NCT00414765|456187430|FG001|Overall Study|Adverse Event|9|||
126789714|NCT00414765|456187429|FG000|Overall Study|Withdrawal by Subject|1|||
126789715|NCT00414765|456187430|FG001|Overall Study|Withdrawal by Subject|1|||
126789716|NCT00414765|456187429|FG000|Overall Study|Disease Progression|0|||
126789717|NCT00414765|456187430|FG001|Overall Study|Disease Progression|1|||
126789718|NCT02458469|456187431|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126789719|NCT02458469|456187432|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126789720|NCT02458469|456187433|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
126789721|NCT02458469|456187434|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126789722|NCT02458469|456187435|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126789723|NCT02458469|456187436|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
126632032|NCT05178979|455611995|FG000|Overall Study|Death|0|||
126632033|NCT05178979|455611996|FG001|Overall Study|Death|5|||
126755394|NCT02906644|456054707|FG001|First 2 Weeks|Physician Decision|1|||
126755395|NCT02906644|456054706|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
126755396|NCT02906644|456054707|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
126789724|NCT02458469|456187431|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
126789725|NCT02458469|456187432|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
126632034|NCT05178979|455611997|FG002|Overall Study|Death|0|||
126632035|NCT05178979|455611998|FG003|Overall Study|Death|3|||
126632036|NCT05178979|455611995|FG000|Overall Study|Adverse Event|0|||
126755397|NCT02906644|456054706|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
126789726|NCT02458469|456187433|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
126789727|NCT02458469|456187434|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
126789728|NCT02458469|456187435|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
126789729|NCT02458469|456187436|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
126789730|NCT02458469|456187431|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
126789731|NCT02458469|456187432|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
126789732|NCT02458469|456187433|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
126789733|NCT02458469|456187434|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
126789734|NCT02458469|456187435|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
126789735|NCT02458469|456187436|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
126789736|NCT04534283|456187437|FG000|Overall Study|Physician Decision|2|||
126789737|NCT04534283|456187437|FG000|Overall Study|Withdrawal by Subject|1|||
126789738|NCT04534283|456187437|FG000|Overall Study|Disease Progression|12|||
126789739|NCT04534283|456187437|FG000|Overall Study|Adverse Event|1|||
126789740|NCT00661505|456187438|FG000|Overall Study|Adverse Event|3|||
126789741|NCT00661505|456187438|FG000|Overall Study|Protocol Violation|14|||
126789742|NCT00661505|456187438|FG000|Overall Study|Withdrawal by Subject|8|||
126789743|NCT00661505|456187438|FG000|Overall Study|Lost to Follow-up|3|||
126789744|NCT00661505|456187438|FG000|Overall Study|Other|2|||
126789745|NCT03561883|456187439|FG000|Overall Study|Adverse Event|10|||
126789746|NCT03561883|456187440|FG001|Overall Study|Adverse Event|13|||
126789747|NCT03561883|456187439|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126789748|NCT03561883|456187440|FG001|Overall Study|Non-Compliance With Study Drug|2|||
126632037|NCT05178979|455611996|FG001|Overall Study|Adverse Event|1|||
126632038|NCT05178979|455611997|FG002|Overall Study|Adverse Event|0|||
126632039|NCT05178979|455611998|FG003|Overall Study|Adverse Event|0|||
126632040|NCT05178979|455611995|FG000|Overall Study|Lost to Follow-up|1|||
126632041|NCT05178979|455611996|FG001|Overall Study|Lost to Follow-up|8|||
126632042|NCT05178979|455611997|FG002|Overall Study|Lost to Follow-up|3|||
126632043|NCT05178979|455611998|FG003|Overall Study|Lost to Follow-up|8|||
126632044|NCT01747837|455612000|FG000|Overall Study|Lost to Follow-up|5|||
126632045|NCT01747837|455612001|FG001|Overall Study|Lost to Follow-up|2|||
126632046|NCT01747837|455612000|FG000|Overall Study|Death|4|||
126632047|NCT01747837|455612001|FG001|Overall Study|Death|4|||
126632048|NCT01435798|455612002|FG000|Overall Study|Withdrawal by Subject|1|||
126632049|NCT01253447|455612003|FG000|Overall Study|Adverse Event|2|||
126632050|NCT02299427|455612004|FG000|Overall Study|Withdrawal by Subject|1|||
126632051|NCT02299427|455612005|FG001|Overall Study|Withdrawal by Subject|0|||
126632052|NCT02299427|455612004|FG000|Overall Study|Lost to Follow-up|1|||
126632053|NCT02299427|455612005|FG001|Overall Study|Lost to Follow-up|3|||
126632054|NCT02299427|455612004|FG000|Overall Study|not adherent to dog website use|21|||
126632055|NCT02299427|455612005|FG001|Overall Study|not adherent to dog website use|0|||
126632056|NCT00937521|455612014|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
126632057|NCT00937521|455612015|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
126632058|NCT00937521|455612016|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
126632059|NCT00937521|455612017|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
126632060|NCT00937521|455612018|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
126632061|NCT00937521|455612019|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
126632062|NCT00937521|455612020|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
126632063|NCT00937521|455612021|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
126632064|NCT00937521|455612014|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
126632065|NCT00937521|455612015|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
126632066|NCT00937521|455612016|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
126632067|NCT00937521|455612017|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
126632068|NCT00937521|455612018|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
126632069|NCT00937521|455612019|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
126632070|NCT00937521|455612020|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
126632071|NCT00937521|455612021|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
126632072|NCT00937521|455612014|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
126789749|NCT03561883|456187439|FG000|Overall Study|Protocol Violation|2|||
126789750|NCT03561883|456187440|FG001|Overall Study|Protocol Violation|3|||
126789751|NCT03561883|456187439|FG000|Overall Study|Withdrawal by Subject|14|||
126789752|NCT03561883|456187440|FG001|Overall Study|Withdrawal by Subject|6|||
126789753|NCT03561883|456187439|FG000|Overall Study|Lost to Follow-up|2|||
126789754|NCT03561883|456187440|FG001|Overall Study|Lost to Follow-up|6|||
126789755|NCT03561883|456187439|FG000|Overall Study|Study Terminated by Sponsor|12|||
126789756|NCT03561883|456187440|FG001|Overall Study|Study Terminated by Sponsor|11|||
126789757|NCT03561883|456187439|FG000|Overall Study|Physician Decision|1|||
126789758|NCT03561883|456187440|FG001|Overall Study|Physician Decision|0|||
126632073|NCT00937521|455612015|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
126632074|NCT00937521|455612016|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
126789759|NCT03561883|456187439|FG000|Overall Study|Randomized by Mistake|1|||
126789760|NCT03561883|456187440|FG001|Overall Study|Randomized by Mistake|0|||
126632075|NCT00937521|455612017|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
126632076|NCT00937521|455612018|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
126632077|NCT00937521|455612019|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
126632078|NCT00937521|455612020|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
126632079|NCT00937521|455612021|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
126632080|NCT00937521|455612014|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
126632081|NCT00937521|455612015|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
126632082|NCT00937521|455612016|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
126632083|NCT00937521|455612017|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
126632084|NCT00937521|455612018|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
126632085|NCT00937521|455612019|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
126789761|NCT03561883|456187439|FG000|Overall Study|Other, Not Specified|3|||
126789762|NCT03561883|456187440|FG001|Overall Study|Other, Not Specified|2|||
126789763|NCT06354270|456187441|FG000|Overall Study|Withdrawal by Subject|1|||
126789764|NCT06354270|456187442|FG001|Overall Study|Withdrawal by Subject|0|||
126789765|NCT01939197|456187443|FG000|Overall Study|Withdrawal by Subject|1|||
126789766|NCT01939197|456187444|FG001|Overall Study|Withdrawal by Subject|0|||
126789767|NCT01939197|456187445|FG002|Overall Study|Withdrawal by Subject|0|||
126789768|NCT01939197|456187446|FG003|Overall Study|Withdrawal by Subject|0|||
126789769|NCT01939197|456187447|FG004|Overall Study|Withdrawal by Subject|1|||
126789770|NCT01939197|456187448|FG005|Overall Study|Withdrawal by Subject|0|||
126632086|NCT00937521|455612020|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
126632087|NCT00937521|455612021|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
126632088|NCT00937521|455612014|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
126632089|NCT00937521|455612015|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
126632090|NCT00937521|455612016|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
126632091|NCT00937521|455612017|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
126632092|NCT00937521|455612018|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
126632093|NCT00937521|455612019|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
126632094|NCT00937521|455612020|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
126632095|NCT00937521|455612021|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
126632096|NCT00937521|455612014|FG000|Booster Phase|Adverse Event|0|||
126632097|NCT00937521|455612015|FG001|Booster Phase|Adverse Event|0|||
126632098|NCT00937521|455612016|FG002|Booster Phase|Adverse Event|0|||
126632099|NCT00937521|455612017|FG003|Booster Phase|Adverse Event|0|||
126632100|NCT00937521|455612018|FG004|Booster Phase|Adverse Event|0|||
126632101|NCT00937521|455612019|FG005|Booster Phase|Adverse Event|0|||
126632102|NCT00937521|455612020|FG006|Booster Phase|Adverse Event|1|||
126632103|NCT00937521|455612021|FG007|Booster Phase|Adverse Event|0|||
126632104|NCT00937521|455612014|FG000|Booster Phase|Withdrawal by Subject|1|||
126632105|NCT00937521|455612015|FG001|Booster Phase|Withdrawal by Subject|0|||
126632106|NCT00937521|455612016|FG002|Booster Phase|Withdrawal by Subject|0|||
126632107|NCT00937521|455612017|FG003|Booster Phase|Withdrawal by Subject|1|||
126632108|NCT00937521|455612018|FG004|Booster Phase|Withdrawal by Subject|0|||
126632109|NCT00937521|455612019|FG005|Booster Phase|Withdrawal by Subject|0|||
126632110|NCT00937521|455612020|FG006|Booster Phase|Withdrawal by Subject|0|||
126632111|NCT00937521|455612021|FG007|Booster Phase|Withdrawal by Subject|2|||
126632112|NCT00937521|455612014|FG000|Booster Phase|Lost to Follow-up|2|||
126632113|NCT00937521|455612015|FG001|Booster Phase|Lost to Follow-up|2|||
126632114|NCT00937521|455612016|FG002|Booster Phase|Lost to Follow-up|4|||
126632115|NCT00937521|455612017|FG003|Booster Phase|Lost to Follow-up|2|||
126632116|NCT00937521|455612018|FG004|Booster Phase|Lost to Follow-up|4|||
126632117|NCT00937521|455612019|FG005|Booster Phase|Lost to Follow-up|4|||
126632118|NCT00937521|455612020|FG006|Booster Phase|Lost to Follow-up|3|||
126632119|NCT00937521|455612021|FG007|Booster Phase|Lost to Follow-up|0|||
126632120|NCT00937521|455612014|FG000|Booster Phase|Administrative Reason|0|||
126632121|NCT00937521|455612015|FG001|Booster Phase|Administrative Reason|0|||
126632122|NCT00937521|455612016|FG002|Booster Phase|Administrative Reason|1|||
126632123|NCT00937521|455612017|FG003|Booster Phase|Administrative Reason|0|||
126632124|NCT00937521|455612018|FG004|Booster Phase|Administrative Reason|1|||
126632125|NCT00937521|455612019|FG005|Booster Phase|Administrative Reason|1|||
126632126|NCT00937521|455612020|FG006|Booster Phase|Administrative Reason|0|||
126632127|NCT00937521|455612021|FG007|Booster Phase|Administrative Reason|0|||
126632128|NCT00937521|455612014|FG000|Booster Phase|Protocol Deviation|0|||
126632129|NCT00937521|455612015|FG001|Booster Phase|Protocol Deviation|0|||
126632130|NCT00937521|455612016|FG002|Booster Phase|Protocol Deviation|0|||
126632131|NCT00937521|455612017|FG003|Booster Phase|Protocol Deviation|0|||
126632132|NCT00937521|455612018|FG004|Booster Phase|Protocol Deviation|0|||
126632133|NCT00937521|455612019|FG005|Booster Phase|Protocol Deviation|0|||
126632134|NCT00937521|455612020|FG006|Booster Phase|Protocol Deviation|1|||
126789771|NCT01939197|456187449|FG006|Overall Study|Withdrawal by Subject|0|||
126632135|NCT00937521|455612021|FG007|Booster Phase|Protocol Deviation|0|||
126632136|NCT01721746|455612022|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
126632137|NCT01721746|455612023|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
126632138|NCT01721746|455612022|FG000|Pre-Treatment|Withdrawal by Subject|1|||
126632139|NCT01721746|455612023|FG001|Pre-Treatment|Withdrawal by Subject|16|||
126632140|NCT01721746|455612022|FG000|Pre-Treatment|Poor/Non-compliance|1|||
126632141|NCT01721746|455612023|FG001|Pre-Treatment|Poor/Non-compliance|0|||
126632142|NCT01721746|455612022|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
126632143|NCT01721746|455612023|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
126632144|NCT01721746|455612022|FG000|Treatment|Disease Progression|192|||
126789772|NCT01939197|456187443|FG000|Overall Study|Lost to Follow-up|0|||
126789773|NCT01939197|456187444|FG001|Overall Study|Lost to Follow-up|1|||
126789774|NCT01939197|456187445|FG002|Overall Study|Lost to Follow-up|0|||
126789775|NCT01939197|456187446|FG003|Overall Study|Lost to Follow-up|1|||
126789776|NCT01939197|456187447|FG004|Overall Study|Lost to Follow-up|3|||
126789777|NCT01939197|456187448|FG005|Overall Study|Lost to Follow-up|1|||
126632145|NCT01721746|455612023|FG001|Treatment|Disease Progression|74|||
126632146|NCT01721746|455612022|FG000|Treatment|Study Drug Toxicity|19|||
126632147|NCT01721746|455612023|FG001|Treatment|Study Drug Toxicity|11|||
126632148|NCT01721746|455612022|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
126632149|NCT01721746|455612023|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
126632150|NCT01721746|455612022|FG000|Treatment|Participant request to discontinue Study treatment|26|||
126632151|NCT01721746|455612023|FG001|Treatment|Participant request to discontinue Study treatment|7|||
126632152|NCT01721746|455612022|FG000|Treatment|Participant withdrew consent|4|||
126632153|NCT01721746|455612023|FG001|Treatment|Participant withdrew consent|2|||
126632154|NCT01721746|455612022|FG000|Treatment|Maximum Clinical Benefit|9|||
126632155|NCT01721746|455612023|FG001|Treatment|Maximum Clinical Benefit|3|||
126632156|NCT01721746|455612022|FG000|Treatment|Poor/Non-compliance|2|||
126632157|NCT01721746|455612023|FG001|Treatment|Poor/Non-compliance|0|||
126632158|NCT01721746|455612022|FG000|Treatment|Participant no longer met Study criteria|4|||
126632159|NCT01721746|455612023|FG001|Treatment|Participant no longer met Study criteria|0|||
126632160|NCT01721746|455612022|FG000|Treatment|Other reasons|6|||
126632161|NCT01721746|455612023|FG001|Treatment|Other reasons|2|||
126632162|NCT04358068|455612024|FG000|Overall Study|Did not initiate study treatment|2|||
126632163|NCT04358068|455612025|FG001|Overall Study|Did not initiate study treatment|2|||
126632164|NCT02447718|455612026|FG000|Overall Study|Lost to Follow-up|8|||
126632165|NCT02447718|455612027|FG001|Overall Study|Lost to Follow-up|0|||
126632166|NCT02447718|455612026|FG000|Overall Study|Withdrawal by Subject|3|||
126632167|NCT02447718|455612027|FG001|Overall Study|Withdrawal by Subject|0|||
126632168|NCT02447718|455612026|FG000|Overall Study|Screen Failure|1|||
126632169|NCT02447718|455612027|FG001|Overall Study|Screen Failure|0|||
126632170|NCT00239681|455612028|FG000|Overall Study|Adverse Event|100|||
126632171|NCT00239681|455612029|FG001|Overall Study|Adverse Event|99|||
126632172|NCT00239681|455612028|FG000|Overall Study|Withdrawal by Subject|458|||
126632173|NCT00239681|455612029|FG001|Overall Study|Withdrawal by Subject|489|||
126632174|NCT00239681|455612028|FG000|Overall Study|Lost to Follow-up|28|||
126632175|NCT00239681|455612029|FG001|Overall Study|Lost to Follow-up|22|||
126632176|NCT00239681|455612028|FG000|Overall Study|Protocol Violation|4|||
126632177|NCT00239681|455612029|FG001|Overall Study|Protocol Violation|4|||
126632178|NCT00239681|455612028|FG000|Overall Study|Physician Decision|13|||
126632179|NCT00239681|455612029|FG001|Overall Study|Physician Decision|17|||
126632180|NCT00239681|455612028|FG000|Overall Study|No information chacked on CaseReportForm|90|||
126632181|NCT00239681|455612029|FG001|Overall Study|No information chacked on CaseReportForm|84|||
126632182|NCT03599622|455612030|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
126632183|NCT03599622|455612031|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
126632184|NCT03599622|455612032|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
126632185|NCT03599622|455612033|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
126632186|NCT03599622|455612030|FG000|Pre-Treatment Period|Other reasons|1|||
126632187|NCT03599622|455612031|FG001|Pre-Treatment Period|Other reasons|1|||
126632188|NCT03599622|455612032|FG002|Pre-Treatment Period|Other reasons|1|||
126632189|NCT03599622|455612033|FG003|Pre-Treatment Period|Other reasons|0|||
126632190|NCT03599622|455612030|FG000|Treatment Period|Adverse Event|11|||
126632191|NCT03599622|455612031|FG001|Treatment Period|Adverse Event|20|||
126632192|NCT03599622|455612032|FG002|Treatment Period|Adverse Event|18|||
126632193|NCT03599622|455612033|FG003|Treatment Period|Adverse Event|2|||
126789778|NCT01939197|456187449|FG006|Overall Study|Lost to Follow-up|2|||
126789779|NCT00745095|456187450|FG000|Overall Study|Declined to participate|1|||
126789780|NCT00745095|456187451|FG001|Overall Study|Declined to participate|0|||
126789781|NCT00745095|456187452|FG002|Overall Study|Declined to participate|0|||
126789782|NCT00745095|456187453|FG003|Overall Study|Declined to participate|0|||
126789783|NCT00745095|456187454|FG004|Overall Study|Declined to participate|92|||
126789784|NCT00745095|456187455|FG005|Overall Study|Declined to participate|95|||
126789785|NCT00745095|456187450|FG000|Overall Study|Ineligible due to GFR criteria|0|||
126632194|NCT03599622|455612030|FG000|Treatment Period|Lack of Efficacy|18|||
126632195|NCT03599622|455612031|FG001|Treatment Period|Lack of Efficacy|12|||
126632196|NCT03599622|455612032|FG002|Treatment Period|Lack of Efficacy|13|||
126632197|NCT03599622|455612033|FG003|Treatment Period|Lack of Efficacy|2|||
126632198|NCT03599622|455612030|FG000|Treatment Period|Withdrawal by Subject|5|||
126789786|NCT00745095|456187451|FG001|Overall Study|Ineligible due to GFR criteria|2|||
126632199|NCT03599622|455612031|FG001|Treatment Period|Withdrawal by Subject|11|||
126632200|NCT03599622|455612032|FG002|Treatment Period|Withdrawal by Subject|16|||
126632201|NCT03599622|455612033|FG003|Treatment Period|Withdrawal by Subject|1|||
126632202|NCT03599622|455612030|FG000|Treatment Period|Other reasons|4|||
126632203|NCT03599622|455612031|FG001|Treatment Period|Other reasons|6|||
126632204|NCT03599622|455612032|FG002|Treatment Period|Other reasons|7|||
126632205|NCT03599622|455612033|FG003|Treatment Period|Other reasons|0|||
126632206|NCT03599622|455612030|FG000|Treatment Period|Lost to Follow-up|1|||
126632207|NCT03599622|455612031|FG001|Treatment Period|Lost to Follow-up|0|||
126632208|NCT03599622|455612032|FG002|Treatment Period|Lost to Follow-up|0|||
126632209|NCT03599622|455612033|FG003|Treatment Period|Lost to Follow-up|0|||
126632210|NCT03599622|455612030|FG000|Treatment Period|Study terminated by sponsor|7|||
126632211|NCT03599622|455612031|FG001|Treatment Period|Study terminated by sponsor|20|||
126632212|NCT03599622|455612032|FG002|Treatment Period|Study terminated by sponsor|15|||
126632213|NCT03599622|455612033|FG003|Treatment Period|Study terminated by sponsor|0|||
126632214|NCT03599622|455612030|FG000|Treatment Period|Site terminated by sponsor|0|||
126632215|NCT03599622|455612031|FG001|Treatment Period|Site terminated by sponsor|1|||
126632216|NCT03599622|455612032|FG002|Treatment Period|Site terminated by sponsor|0|||
126632217|NCT03599622|455612033|FG003|Treatment Period|Site terminated by sponsor|0|||
126632218|NCT00770588|455612034|FG000|Overall Study|Adverse Event|9|||
126632219|NCT00770588|455612035|FG001|Overall Study|Adverse Event|2|||
126632220|NCT00770588|455612034|FG000|Overall Study|Death caused by progression of disease|70|||
126789787|NCT00745095|456187452|FG002|Overall Study|Ineligible due to GFR criteria|3|||
126789788|NCT00745095|456187453|FG003|Overall Study|Ineligible due to GFR criteria|3|||
126789789|NCT00745095|456187454|FG004|Overall Study|Ineligible due to GFR criteria|30|||
126789790|NCT00745095|456187455|FG005|Overall Study|Ineligible due to GFR criteria|28|||
126632221|NCT00770588|455612035|FG001|Overall Study|Death caused by progression of disease|91|||
126632222|NCT00770588|455612034|FG000|Overall Study|Lost to Follow-up|1|||
126632223|NCT00770588|455612035|FG001|Overall Study|Lost to Follow-up|1|||
126632224|NCT00770588|455612034|FG000|Overall Study|Withdrawal by Subject|1|||
126632225|NCT00770588|455612035|FG001|Overall Study|Withdrawal by Subject|1|||
126632226|NCT00468130|455612037|FG000|Overall Study|Adverse Event|2|||
126632227|NCT00468130|455612038|FG001|Overall Study|Adverse Event|1|||
126632228|NCT00468130|455612037|FG000|Overall Study|Withdrawal by Subject|0|||
126789791|NCT00958243|456187456|FG000|Overall Study|Withdrawal by Subject|0|||
126789792|NCT00958243|456187457|FG001|Overall Study|Withdrawal by Subject|1|||
126789793|NCT00958243|456187458|FG002|Overall Study|Withdrawal by Subject|3|||
126789794|NCT00958243|456187459|FG003|Overall Study|Withdrawal by Subject|1|||
126789795|NCT00958243|456187460|FG004|Overall Study|Withdrawal by Subject|1|||
126789796|NCT00958243|456187461|FG005|Overall Study|Withdrawal by Subject|5|||
126789797|NCT00958243|456187456|FG000|Overall Study|Lost to Follow-up|2|||
126789798|NCT00958243|456187457|FG001|Overall Study|Lost to Follow-up|5|||
126789799|NCT00958243|456187458|FG002|Overall Study|Lost to Follow-up|11|||
126789800|NCT00958243|456187459|FG003|Overall Study|Lost to Follow-up|2|||
126789801|NCT00958243|456187460|FG004|Overall Study|Lost to Follow-up|8|||
126789802|NCT00958243|456187461|FG005|Overall Study|Lost to Follow-up|5|||
126789803|NCT01974141|456187468|FG000|Overall Study|Other Reasons|28|||
126789804|NCT01974141|456187469|FG001|Overall Study|Other Reasons|18|||
126789805|NCT01974141|456187468|FG000|Overall Study|Protocol Violation|2|||
126789806|NCT01974141|456187469|FG001|Overall Study|Protocol Violation|6|||
126632229|NCT00468130|455612038|FG001|Overall Study|Withdrawal by Subject|1|||
126632230|NCT00436956|455612039|FG000|Overall Study|Not evaluable|1|||
126632231|NCT00436956|455612040|FG001|Overall Study|Not evaluable|0|||
126632232|NCT01006889|455612041|FG000|Overall Study|Withdrawal by Subject|3|||
126789807|NCT01974141|456187468|FG000|Overall Study|Personal Reasons|21|||
126789808|NCT01974141|456187469|FG001|Overall Study|Personal Reasons|20|||
126632233|NCT02143063|455612044|FG000|Overall Study|Lost to Follow-up|16|||
126632234|NCT02143063|455612045|FG001|Overall Study|Lost to Follow-up|28|||
126632235|NCT02143063|455612046|FG002|Overall Study|Lost to Follow-up|29|||
126632236|NCT02143063|455612044|FG000|Overall Study|Withdrawal by Subject|0|||
126632237|NCT02143063|455612045|FG001|Overall Study|Withdrawal by Subject|1|||
126632238|NCT02143063|455612046|FG002|Overall Study|Withdrawal by Subject|0|||
126632239|NCT02143063|455612044|FG000|Overall Study|Death|0|||
126632240|NCT02143063|455612045|FG001|Overall Study|Death|1|||
126789809|NCT01974141|456187468|FG000|Overall Study|Lost to Follow-up|38|||
126789810|NCT01974141|456187469|FG001|Overall Study|Lost to Follow-up|29|||
126789811|NCT01974141|456187468|FG000|Overall Study|Pregnancy|3|||
126789812|NCT01974141|456187469|FG001|Overall Study|Pregnancy|3|||
126789813|NCT01974141|456187468|FG000|Overall Study|Lack of Efficacy|0|||
126789814|NCT01974141|456187469|FG001|Overall Study|Lack of Efficacy|1|||
126789815|NCT01974141|456187468|FG000|Overall Study|Adverse Event|4|||
126789816|NCT01974141|456187469|FG001|Overall Study|Adverse Event|5|||
126632241|NCT02143063|455612046|FG002|Overall Study|Death|1|||
126632242|NCT00623363|455612047|FG000|Overall Study|Adverse Event|2|||
126632243|NCT00623363|455612048|FG001|Overall Study|Adverse Event|2|||
126632244|NCT01130168|455612050|FG000|Period 1|Withdrawal by Subject|0|||
126632245|NCT01130168|455612051|FG001|Period 1|Withdrawal by Subject|1|||
126632246|NCT01130168|455612052|FG002|Period 1|Withdrawal by Subject|0|||
126632247|NCT01130168|455612053|FG003|Period 1|Withdrawal by Subject|1|||
126632248|NCT01130168|455612054|FG004|Period 1|Withdrawal by Subject|0|||
126632249|NCT01130168|455612055|FG005|Period 1|Withdrawal by Subject|0|||
126632250|NCT01130168|455612050|FG000|Period 1|Discontinued For Other Reason|0|||
126632251|NCT01130168|455612051|FG001|Period 1|Discontinued For Other Reason|0|||
126632252|NCT01130168|455612052|FG002|Period 1|Discontinued For Other Reason|1|||
126632253|NCT01130168|455612053|FG003|Period 1|Discontinued For Other Reason|1|||
126632254|NCT01130168|455612054|FG004|Period 1|Discontinued For Other Reason|0|||
126632255|NCT01130168|455612055|FG005|Period 1|Discontinued For Other Reason|0|||
126632256|NCT01130168|455612050|FG000|Period 1|Adverse Event|0|||
126632257|NCT01130168|455612051|FG001|Period 1|Adverse Event|0|||
126632258|NCT01130168|455612052|FG002|Period 1|Adverse Event|0|||
126632259|NCT01130168|455612053|FG003|Period 1|Adverse Event|1|||
126632260|NCT01130168|455612054|FG004|Period 1|Adverse Event|0|||
126632261|NCT01130168|455612055|FG005|Period 1|Adverse Event|0|||
126632262|NCT01702519|455612056|FG000|Washout Period|Lost to Follow-up|1|||
126632263|NCT01702519|455612057|FG001|Washout Period|Lost to Follow-up|0|||
126632264|NCT01702519|455612056|FG000|Washout Period|Withdrawal by Subject|0|||
126632265|NCT01702519|455612057|FG001|Washout Period|Withdrawal by Subject|2|||
126632266|NCT03738397|455612060|FG000|Overall Study|Adverse Event|3|||
126632267|NCT03738397|455612061|FG001|Overall Study|Adverse Event|7|||
126632268|NCT03738397|455612060|FG000|Overall Study|Withdrawal by Subject|8|||
126632269|NCT03738397|455612061|FG001|Overall Study|Withdrawal by Subject|11|||
126632270|NCT03738397|455612060|FG000|Overall Study|Lost to Follow-up|7|||
126632271|NCT03738397|455612061|FG001|Overall Study|Lost to Follow-up|5|||
126632272|NCT03738397|455612060|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
126632273|NCT03738397|455612061|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
126632274|NCT03738397|455612060|FG000|Overall Study|Other|4|||
126632275|NCT03738397|455612061|FG001|Overall Study|Other|6|||
126632276|NCT00904722|455612062|FG000|Overall Study|Physician Decision|1|||
126632277|NCT01891890|455612063|FG000|Overall Study|Lost to Follow-up|0|||
126632278|NCT01891890|455612064|FG001|Overall Study|Lost to Follow-up|0|||
126632279|NCT01891890|455612065|FG002|Overall Study|Lost to Follow-up|1|||
126632280|NCT01891890|455612063|FG000|Overall Study|Study ended before endpoint reached|7|||
126632281|NCT01891890|455612064|FG001|Overall Study|Study ended before endpoint reached|3|||
126632282|NCT01891890|455612065|FG002|Overall Study|Study ended before endpoint reached|6|||
126632283|NCT03765164|455612072|FG000|Pre-intervention|Withdrawal by Subject|5|||
126632284|NCT03765164|455612073|FG001|Pre-intervention|Withdrawal by Subject|6|||
126632285|NCT03448536|455612075|FG000|Overall Study|Protocol Violation|2|||
126632286|NCT03448536|455612076|FG001|Overall Study|Protocol Violation|0|||
126632287|NCT03448536|455612075|FG000|Overall Study|Pregnancy|1|||
126632288|NCT03448536|455612076|FG001|Overall Study|Pregnancy|0|||
126632289|NCT03448536|455612075|FG000|Overall Study|Withdrawal by Subject|1|||
126632290|NCT03448536|455612076|FG001|Overall Study|Withdrawal by Subject|2|||
126632291|NCT03448536|455612075|FG000|Overall Study|Lost to Follow-up|3|||
126632292|NCT03448536|455612076|FG001|Overall Study|Lost to Follow-up|2|||
126632293|NCT03448536|455612075|FG000|Overall Study|Inadequate pain reporter|1|||
126632294|NCT03448536|455612076|FG001|Overall Study|Inadequate pain reporter|0|||
126632295|NCT03448536|455612075|FG000|Overall Study|Other|3|||
126632296|NCT03448536|455612076|FG001|Overall Study|Other|0|||
126632297|NCT03448536|455612075|FG000|Overall Study|Physician Decision|1|||
126632298|NCT03448536|455612076|FG001|Overall Study|Physician Decision|0|||
126632299|NCT04811339|455612083|FG000|Overall Study|lack of transportation not wanting to return|4|||
126632300|NCT04811339|455612084|FG001|Overall Study|lack of transportation not wanting to return|8|||
126632301|NCT04811339|455612085|FG002|Overall Study|lack of transportation not wanting to return|0|||
126632302|NCT04811339|455612083|FG000|Overall Study|Adverse Event|3|||
126632303|NCT04811339|455612084|FG001|Overall Study|Adverse Event|0|||
126632304|NCT04811339|455612085|FG002|Overall Study|Adverse Event|0|||
126632305|NCT04811339|455612083|FG000|Overall Study|Lost to Follow-up|1|||
126632306|NCT04811339|455612084|FG001|Overall Study|Lost to Follow-up|0|||
126632307|NCT04811339|455612085|FG002|Overall Study|Lost to Follow-up|0|||
126632308|NCT04811339|455612083|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
126632309|NCT04811339|455612084|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
126632310|NCT04811339|455612085|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
126632311|NCT04811339|455612083|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
126632312|NCT04811339|455612084|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
126632313|NCT04811339|455612085|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
126632314|NCT04811339|455612083|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
126632315|NCT04811339|455612084|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
126632316|NCT04811339|455612085|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
126632317|NCT04811339|455612083|FG000|Overall Study|Withdrawal by Subject|0|||
126632318|NCT04811339|455612084|FG001|Overall Study|Withdrawal by Subject|3|||
126632319|NCT04811339|455612085|FG002|Overall Study|Withdrawal by Subject|0|||
126632320|NCT04811339|455612083|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
126632321|NCT04811339|455612084|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
126632322|NCT04811339|455612085|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
126632323|NCT04811339|455612083|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
126632324|NCT04811339|455612084|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
126632325|NCT04811339|455612085|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
126632326|NCT00497874|455613716|FG000|Overall Study|Withdrawal by Subject|48|||
126632327|NCT00497874|455613717|FG001|Overall Study|Withdrawal by Subject|17|||
126632328|NCT00497874|455613716|FG000|Overall Study|Illness|8|||
126632329|NCT00497874|455613717|FG001|Overall Study|Illness|4|||
126789817|NCT00950872|456187473|FG000|Overall Study|Withdrawal by Subject|1|||
126789818|NCT00950872|456187473|FG000|Overall Study|Did not have surgery|2|||
126632330|NCT00497874|455613716|FG000|Overall Study|Death|2|||
126632331|NCT00497874|455613717|FG001|Overall Study|Death|4|||
126632332|NCT00497874|455613716|FG000|Overall Study|Unable to contact|52|||
126632333|NCT00497874|455613717|FG001|Overall Study|Unable to contact|67|||
126632334|NCT00497874|455613716|FG000|Overall Study|Unable to schedule|37|||
126632335|NCT00497874|455613717|FG001|Overall Study|Unable to schedule|24|||
126632336|NCT01256671|455613721|FG000|Overall Study|Adverse Event|29|||
126632337|NCT01256671|455613721|FG000|Overall Study|Lost to Follow-up|16|||
126632338|NCT01256671|455613721|FG000|Overall Study|Withdrawal by Subject|31|||
126632339|NCT01256671|455613721|FG000|Overall Study|Physician Decision|3|||
126632340|NCT01256671|455613721|FG000|Overall Study|Lack of Efficacy|4|||
126632341|NCT01256671|455613721|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
126632342|NCT04843579|455613725|FG000|Overall Study|Adverse Event|1|||
126632343|NCT04843579|455613725|FG000|Overall Study|Disease Progression|1|||
126632344|NCT04009629|455613726|FG000|Overall Study|Withdrawal by Subject|2|||
126632345|NCT04009629|455613727|FG001|Overall Study|Withdrawal by Subject|0|||
126632346|NCT02808975|455613729|FG000|Overall Study|Adverse Event|3|||
126632347|NCT02808975|455613730|FG001|Overall Study|Adverse Event|4|||
126632348|NCT02808975|455613729|FG000|Overall Study|Withdrew consent|9|||
126632349|NCT02808975|455613730|FG001|Overall Study|Withdrew consent|8|||
126632350|NCT02808975|455613729|FG000|Overall Study|Lost to Follow-up|4|||
126632351|NCT02808975|455613730|FG001|Overall Study|Lost to Follow-up|6|||
126632352|NCT02808975|455613729|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
126632353|NCT02808975|455613730|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
126632354|NCT02808975|455613729|FG000|Overall Study|Other, not specified|5|||
126632355|NCT02808975|455613730|FG001|Overall Study|Other, not specified|1|||
126632356|NCT03602586|455613731|FG000|Overall Study|Withdrawal by Subject|3|||
126632357|NCT03062449|455613732|FG000|Overall Study|Withdrawal by Subject|7|||
126632358|NCT03062449|455613733|FG001|Overall Study|Withdrawal by Subject|1|||
126632359|NCT03568812|455613735|FG000|Overall Study|Physician Decision|0|||
126632360|NCT03568812|455613736|FG001|Overall Study|Physician Decision|1|||
126632361|NCT03194867|455613737|FG000|Overall Study|Incorrect completion of end of study form|0|||
126632362|NCT03194867|455613738|FG001|Overall Study|Incorrect completion of end of study form|0|||
126632363|NCT03194867|455613739|FG002|Overall Study|Incorrect completion of end of study form|1|||
126632364|NCT03194867|455613740|FG003|Overall Study|Incorrect completion of end of study form|0|||
126632365|NCT00464945|455613741|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
126632366|NCT00464945|455613742|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
126632367|NCT00464945|455613741|FG000|Infant Series|Protocol Violation|1|||
126632368|NCT00464945|455613742|FG001|Infant Series|Protocol Violation|0|||
126789819|NCT01139164|456187475|FG000|Overall Study|Withdrawn prior to study start|0|||
126632369|NCT00464945|455613741|FG000|Infant Series|Lost to Follow-up|1|||
126789820|NCT01139164|456187476|FG001|Overall Study|Withdrawn prior to study start|2|||
126789821|NCT01139164|456187477|FG002|Overall Study|Withdrawn prior to study start|0|||
126789822|NCT01759290|456187480|FG000|Overall Study|Subjects withdrawn consent|5|||
126632370|NCT00464945|455613742|FG001|Infant Series|Lost to Follow-up|0|||
126789823|NCT01759290|456187480|FG000|Overall Study|Physician Decision|2|||
126789824|NCT01759290|456187480|FG000|Overall Study|Death|17|||
126789825|NCT01759290|456187480|FG000|Overall Study|Lost to Follow-up|53|||
126789826|NCT01759290|456187480|FG000|Overall Study|Unknown reason|4|||
126789827|NCT00406848|456187483|FG000|Overall Study|Withdrawal by Subject|27|||
126789828|NCT00406848|456187484|FG001|Overall Study|Withdrawal by Subject|22|||
126632371|NCT00464945|455613741|FG000|After Infant Series|Withdrawal by Subject|0|||
126632372|NCT00464945|455613742|FG001|After Infant Series|Withdrawal by Subject|2|||
126632373|NCT00464945|455613741|FG000|Toddler Dose|Lost to Follow-up|0|||
126632374|NCT00464945|455613742|FG001|Toddler Dose|Lost to Follow-up|1|||
126632375|NCT04014790|455613743|FG000|Overall Study|Death|4|||
126632376|NCT04014790|455613743|FG000|Overall Study|Adverse Event|1|||
126632377|NCT04014790|455613743|FG000|Overall Study|Withdrawal by Subject|1|||
126632378|NCT02536742|455613744|FG000|Overall Study|Did not start protocol therapy|1|||
126632379|NCT02536742|455613744|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
126632380|NCT04629443|455613745|FG000|Overall Study|Adverse Event|2|||
126789829|NCT00406848|456187483|FG000|Overall Study|Adverse Event|38|||
126632381|NCT04629443|455613746|FG001|Overall Study|Adverse Event|1|||
126632382|NCT04629443|455613747|FG002|Overall Study|Adverse Event|2|||
126632383|NCT04629443|455613745|FG000|Overall Study|Progressive Disease|2|||
126632384|NCT04629443|455613746|FG001|Overall Study|Progressive Disease|3|||
126632385|NCT04629443|455613747|FG002|Overall Study|Progressive Disease|3|||
126632386|NCT04629443|455613745|FG000|Overall Study|Physician Decision|1|||
126632387|NCT04629443|455613746|FG001|Overall Study|Physician Decision|3|||
126632388|NCT04629443|455613747|FG002|Overall Study|Physician Decision|0|||
126632389|NCT01547117|455613748|FG000|Overall Study|Physician Decision|0|||
126632390|NCT01547117|455613749|FG001|Overall Study|Physician Decision|1|||
126632391|NCT01547117|455613750|FG002|Overall Study|Physician Decision|1|||
126632392|NCT01547117|455613751|FG003|Overall Study|Physician Decision|3|||
126632393|NCT01547117|455613748|FG000|Overall Study|Withdrawal by Subject|1|||
126632394|NCT01547117|455613749|FG001|Overall Study|Withdrawal by Subject|2|||
126632395|NCT01547117|455613750|FG002|Overall Study|Withdrawal by Subject|1|||
126632396|NCT01547117|455613751|FG003|Overall Study|Withdrawal by Subject|2|||
126632397|NCT03021551|455613753|FG000|Overall Study|Equipment Issues|2|||
126632398|NCT03021551|455613753|FG000|Overall Study|Protocol Violation|1|||
126632399|NCT01162135|455613758|FG000|Overall Study|Withdrawal by Subject|1|||
126632400|NCT01162135|455613758|FG000|Overall Study|Severe back pain|1|||
126632401|NCT01162135|455613758|FG000|Overall Study|Ineligible|1|||
126632402|NCT02088554|455613759|FG000|Overall Study|Exited before procedure|130|||
126632403|NCT02088554|455613759|FG000|Overall Study|Attempted but not implanted|31|||
126632404|NCT02088554|455613759|FG000|Overall Study|Implant not attempted|19|||
126632405|NCT02088554|455613759|FG000|Overall Study|Pending next visit|532|||
126632406|NCT02088554|455613759|FG000|Overall Study|Death|170|||
126632407|NCT02088554|455613759|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
126632408|NCT02088554|455613759|FG000|Overall Study|Lost to Follow-up|23|||
126632409|NCT02088554|455613759|FG000|Overall Study|Explanted|32|||
126632410|NCT02088554|455613759|FG000|Overall Study|Any other reason not covered by previous categories|11|||
126632411|NCT03898960|455613762|FG000|Overall Study|Death|10|||
126632412|NCT00548847|455613763|FG000|Overall Study|Disease progression|7|||
126632413|NCT01379703|455613764|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
126632414|NCT01379703|455613765|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
126632415|NCT01379703|455613766|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
126632416|NCT01379703|455613764|FG000|Study Start Through 9 Months|Adverse Event|0|||
126632417|NCT01379703|455613765|FG001|Study Start Through 9 Months|Adverse Event|14|||
126632418|NCT01379703|455613766|FG002|Study Start Through 9 Months|Adverse Event|10|||
126632419|NCT01379703|455613764|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
126632420|NCT01379703|455613765|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
126632421|NCT01379703|455613766|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
126632422|NCT01379703|455613764|FG000|Study Start Through 9 Months|Treatment Failure|0|||
126632423|NCT01379703|455613765|FG001|Study Start Through 9 Months|Treatment Failure|2|||
126632424|NCT01379703|455613766|FG002|Study Start Through 9 Months|Treatment Failure|2|||
126632425|NCT01379703|455613764|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
126632426|NCT01379703|455613765|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
126632427|NCT01379703|455613766|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
126632428|NCT01379703|455613764|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
126632429|NCT01379703|455613765|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
126632430|NCT01379703|455613766|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
126632431|NCT01379703|455613764|FG000|Study Start Through 9 Months|Medication not available|0|||
126632432|NCT01379703|455613765|FG001|Study Start Through 9 Months|Medication not available|2|||
126632433|NCT01379703|455613766|FG002|Study Start Through 9 Months|Medication not available|1|||
126632434|NCT01379703|455613764|FG000|Study Start Through 9 Months|Poor general condition|0|||
126632435|NCT01379703|455613765|FG001|Study Start Through 9 Months|Poor general condition|1|||
126632436|NCT01379703|455613766|FG002|Study Start Through 9 Months|Poor general condition|0|||
126632437|NCT01379703|455613764|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
126632438|NCT01379703|455613765|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
126632439|NCT01379703|455613766|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
126632440|NCT01379703|455613764|FG000|Study Start Through 9 Months|Reason unknown|2|||
126632441|NCT01379703|455613765|FG001|Study Start Through 9 Months|Reason unknown|31|||
126632442|NCT01379703|455613766|FG002|Study Start Through 9 Months|Reason unknown|24|||
126632443|NCT01379703|455613764|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
126632444|NCT01379703|455613765|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
126632445|NCT01379703|455613766|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
126632446|NCT01379703|455613764|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
126632447|NCT01379703|455613765|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
126632448|NCT01379703|455613766|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
126632449|NCT01379703|455613764|FG000|9 Months Through 18 Months|Adverse Event|0|||
126632450|NCT01379703|455613765|FG001|9 Months Through 18 Months|Adverse Event|6|||
126632451|NCT01379703|455613766|FG002|9 Months Through 18 Months|Adverse Event|0|||
126632452|NCT01379703|455613764|FG000|9 Months Through 18 Months|Treatment failure|0|||
126632453|NCT01379703|455613765|FG001|9 Months Through 18 Months|Treatment failure|5|||
126632454|NCT01379703|455613766|FG002|9 Months Through 18 Months|Treatment failure|0|||
126632455|NCT01379703|455613764|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
126632456|NCT01379703|455613765|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
126632457|NCT01379703|455613766|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
126632458|NCT01379703|455613764|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
126632459|NCT01379703|455613765|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
126632460|NCT01379703|455613766|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
126632461|NCT01379703|455613764|FG000|9 Months Through 18 Months|Fatigue|0|||
126632462|NCT01379703|455613765|FG001|9 Months Through 18 Months|Fatigue|1|||
126632463|NCT01379703|455613766|FG002|9 Months Through 18 Months|Fatigue|0|||
126632464|NCT01379703|455613764|FG000|9 Months Through 18 Months|Reason Unknown|0|||
126632465|NCT01379703|455613765|FG001|9 Months Through 18 Months|Reason Unknown|23|||
126632466|NCT01379703|455613766|FG002|9 Months Through 18 Months|Reason Unknown|0|||
126632467|NCT00813098|455613767|FG000|Overall Study|Adverse Event|2|||
126632468|NCT00813098|455613768|FG001|Overall Study|Adverse Event|4|||
126632469|NCT00813098|455613769|FG002|Overall Study|Adverse Event|1|||
126632470|NCT00813098|455613767|FG000|Overall Study|Withdrawal by Subject|0|||
126632471|NCT00813098|455613768|FG001|Overall Study|Withdrawal by Subject|1|||
126632472|NCT00813098|455613769|FG002|Overall Study|Withdrawal by Subject|0|||
126632473|NCT00813098|455613767|FG000|Overall Study|Inability to complete study procedures|1|||
126632474|NCT00813098|455613768|FG001|Overall Study|Inability to complete study procedures|0|||
126632475|NCT00813098|455613769|FG002|Overall Study|Inability to complete study procedures|0|||
126632476|NCT00813098|455613767|FG000|Overall Study|Lost to Follow-up|0|||
126632477|NCT00813098|455613768|FG001|Overall Study|Lost to Follow-up|1|||
126632478|NCT00813098|455613769|FG002|Overall Study|Lost to Follow-up|0|||
126632479|NCT00813098|455613767|FG000|Overall Study|Protocol Violation|0|||
126632480|NCT00813098|455613768|FG001|Overall Study|Protocol Violation|0|||
126632481|NCT00813098|455613769|FG002|Overall Study|Protocol Violation|1|||
126632482|NCT00813098|455613767|FG000|Overall Study|Principal Investigator decision|0|||
126632483|NCT00813098|455613768|FG001|Overall Study|Principal Investigator decision|1|||
126632484|NCT00813098|455613769|FG002|Overall Study|Principal Investigator decision|0|||
126632485|NCT00813098|455613767|FG000|Overall Study|Withdrew Consent|0|||
126632486|NCT00813098|455613768|FG001|Overall Study|Withdrew Consent|1|||
126632487|NCT00813098|455613769|FG002|Overall Study|Withdrew Consent|0|||
126632488|NCT02312206|455613772|FG000|Overall Study|Adverse Event|3|||
126632489|NCT02312206|455613773|FG001|Overall Study|Adverse Event|6|||
126632490|NCT02312206|455613772|FG000|Overall Study|Withdrawal by Subject|6|||
126632491|NCT02312206|455613773|FG001|Overall Study|Withdrawal by Subject|6|||
126632492|NCT02312206|455613772|FG000|Overall Study|Physician Decision|7|||
126632493|NCT02312206|455613773|FG001|Overall Study|Physician Decision|6|||
126632494|NCT02312206|455613772|FG000|Overall Study|Death|31|||
126632495|NCT02312206|455613773|FG001|Overall Study|Death|36|||
126632496|NCT02312206|455613772|FG000|Overall Study|Study Terminated by Sponsor|81|||
126632497|NCT02312206|455613773|FG001|Overall Study|Study Terminated by Sponsor|74|||
126632498|NCT02312206|455613772|FG000|Overall Study|Patient transferred to hospice|0|||
126632499|NCT02312206|455613773|FG001|Overall Study|Patient transferred to hospice|1|||
126632500|NCT02312206|455613772|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
126632501|NCT02312206|455613773|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
126632502|NCT02312206|455613772|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
126632503|NCT02312206|455613773|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
126789830|NCT00406848|456187484|FG001|Overall Study|Adverse Event|7|||
126789831|NCT00406848|456187483|FG000|Overall Study|Lack of Efficacy|9|||
126789832|NCT00406848|456187484|FG001|Overall Study|Lack of Efficacy|14|||
126789833|NCT00406848|456187483|FG000|Overall Study|Protocol Violation|10|||
126789834|NCT00406848|456187484|FG001|Overall Study|Protocol Violation|6|||
126789835|NCT00406848|456187483|FG000|Overall Study|Lost to Follow-up|6|||
126789836|NCT00406848|456187484|FG001|Overall Study|Lost to Follow-up|2|||
126789837|NCT00406848|456187483|FG000|Overall Study|Physician Decision|2|||
126789838|NCT00406848|456187484|FG001|Overall Study|Physician Decision|2|||
126789839|NCT00406848|456187483|FG000|Overall Study|Sponsor Decision|1|||
126789840|NCT00406848|456187484|FG001|Overall Study|Sponsor Decision|1|||
126632504|NCT02312206|455613772|FG000|Overall Study|Disease Progression|1|||
126632505|NCT02312206|455613773|FG001|Overall Study|Disease Progression|0|||
126789841|NCT00352690|456187485|FG000|Overall Study|Determined to be ineligible|2|||
126789842|NCT00352690|456187486|FG001|Overall Study|Determined to be ineligible|0|||
126789843|NCT02719522|456187491|FG000|Overall Study|Implant Failure|4|||
126789844|NCT02719522|456187491|FG000|Overall Study|Death|2|||
126789845|NCT02719522|456187491|FG000|Overall Study|Lost to Follow-up|5|||
126632506|NCT03082612|455613774|FG000|Overall Study|Lost to Follow-up|2|||
126632507|NCT03082612|455613775|FG001|Overall Study|Lost to Follow-up|0|||
126632508|NCT01086384|455613780|FG000|2-week Run-in Period|Adverse Event|1|||
126789846|NCT05277389|456187493|FG000|Overall Study|Lost to Follow-up|1|||
126789847|NCT05277389|456187494|FG001|Overall Study|Lost to Follow-up|4|||
126632509|NCT01086384|455613781|FG001|2-week Run-in Period|Adverse Event|0|||
126789848|NCT01054599|456187497|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
126789849|NCT01054599|456187498|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
126789850|NCT01054599|456187497|FG000|Overall Study|Protocol Violation|1|||
126789851|NCT01054599|456187498|FG001|Overall Study|Protocol Violation|0|||
126789852|NCT01054599|456187497|FG000|Overall Study|Spells/seizure-like episodes|1|||
126789853|NCT01054599|456187498|FG001|Overall Study|Spells/seizure-like episodes|1|||
126789854|NCT01054599|456187497|FG000|Overall Study|Timing/scheduling difficulties|1|||
126789855|NCT01054599|456187498|FG001|Overall Study|Timing/scheduling difficulties|1|||
126789856|NCT01054599|456187497|FG000|Overall Study|Visual impairment, WTAR <80|0|||
126789857|NCT01054599|456187498|FG001|Overall Study|Visual impairment, WTAR <80|1|||
126789858|NCT01054599|456187497|FG000|Overall Study|Lost to Follow-up|0|||
126789859|NCT01054599|456187498|FG001|Overall Study|Lost to Follow-up|2|||
126789860|NCT01054599|456187497|FG000|Overall Study|Adverse Event|0|||
126789861|NCT01054599|456187498|FG001|Overall Study|Adverse Event|1|||
126789862|NCT01054599|456187497|FG000|Overall Study|Withdrawal by Subject|0|||
126789863|NCT01054599|456187498|FG001|Overall Study|Withdrawal by Subject|1|||
126789864|NCT04025879|456187501|FG000|Randomization|Participant withdrew consent|0|||
126789865|NCT04025879|456187502|FG001|Randomization|Participant withdrew consent|1|||
126789866|NCT04025879|456187501|FG000|Randomization|Participant no longer met study criteria|1|||
126789867|NCT04025879|456187502|FG001|Randomization|Participant no longer met study criteria|1|||
126789868|NCT04025879|456187501|FG000|Treatment|Ongoing treatment|10|||
126789869|NCT04025879|456187502|FG001|Treatment|Ongoing treatment|8|||
126789870|NCT04025879|456187501|FG000|Treatment|Disease progression/recurrence|36|||
126789871|NCT04025879|456187502|FG001|Treatment|Disease progression/recurrence|72|||
126789872|NCT04025879|456187501|FG000|Treatment|Study drug toxicity|36|||
126789873|NCT04025879|456187502|FG001|Treatment|Study drug toxicity|13|||
126789874|NCT04025879|456187501|FG000|Treatment|Death|2|||
126789875|NCT04025879|456187502|FG001|Treatment|Death|0|||
126789876|NCT04025879|456187501|FG000|Treatment|Adverse event unrelated to study drug|21|||
126789877|NCT04025879|456187502|FG001|Treatment|Adverse event unrelated to study drug|14|||
126789878|NCT04025879|456187501|FG000|Treatment|Participant request to discontinue study treatment|16|||
126789879|NCT04025879|456187502|FG001|Treatment|Participant request to discontinue study treatment|8|||
126789880|NCT04025879|456187501|FG000|Treatment|Participant withdrew consent|1|||
126789881|NCT04025879|456187502|FG001|Treatment|Participant withdrew consent|3|||
126789882|NCT04025879|456187501|FG000|Treatment|Participant no longer meets study criteria|3|||
126789883|NCT04025879|456187502|FG001|Treatment|Participant no longer meets study criteria|2|||
126789884|NCT04025879|456187501|FG000|Treatment|Lost to Follow-up|1|||
126789885|NCT04025879|456187502|FG001|Treatment|Lost to Follow-up|0|||
126789886|NCT04025879|456187501|FG000|Treatment|Other reasons|15|||
126789887|NCT04025879|456187502|FG001|Treatment|Other reasons|17|||
126789888|NCT04025879|456187501|FG000|Treatment|Administrative reason by sponsor|0|||
126789889|NCT04025879|456187502|FG001|Treatment|Administrative reason by sponsor|1|||
126789890|NCT04025879|456187501|FG000|Treatment|Not reported|2|||
126789891|NCT04025879|456187502|FG001|Treatment|Not reported|0|||
126789892|NCT02888171|456187505|FG000|Overall Study|Lost to Follow-up|2|||
126789893|NCT02888171|456187506|FG001|Overall Study|Lost to Follow-up|1|||
126789894|NCT02888171|456187505|FG000|Overall Study|Withdrawal by Subject|3|||
126789895|NCT02888171|456187506|FG001|Overall Study|Withdrawal by Subject|2|||
126789896|NCT02888171|456187505|FG000|Overall Study|Adverse Event|0|||
126789897|NCT02888171|456187506|FG001|Overall Study|Adverse Event|1|||
126789898|NCT01411332|456187507|FG000|Enrollment|Protocol Violation|0|||
126789899|NCT01411332|456187508|FG001|Enrollment|Protocol Violation|1|||
126789900|NCT01411332|456187507|FG000|Enrollment|Withdrawal by Subject|0|||
126789901|NCT01411332|456187508|FG001|Enrollment|Withdrawal by Subject|1|||
126789902|NCT01411332|456187507|FG000|Treatment|Lost to Follow-up|1|||
126789903|NCT01411332|456187508|FG001|Treatment|Lost to Follow-up|0|||
126789904|NCT01471522|456187510|FG000|Overall Study|Withdrawal by Subject|28|||
126789905|NCT01471522|456187511|FG001|Overall Study|Withdrawal by Subject|22|||
126789906|NCT01471522|456187510|FG000|Overall Study|Lost to Follow-up|36|||
126789907|NCT01471522|456187511|FG001|Overall Study|Lost to Follow-up|26|||
126789908|NCT00419770|456188607|FG000|Overall Study|Withdrawal by Subject|5|||
126789909|NCT00419770|456188608|FG001|Overall Study|Withdrawal by Subject|1|||
126789910|NCT02848326|456188609|FG000|Treatment Period|Adverse Event|5|||
126789911|NCT02848326|456188610|FG001|Treatment Period|Adverse Event|4|||
126789912|NCT02848326|456188611|FG002|Treatment Period|Adverse Event|11|||
126789913|NCT02848326|456188612|FG003|Treatment Period|Adverse Event|6|||
126789914|NCT02848326|456188613|FG004|Treatment Period|Adverse Event|5|||
126789915|NCT02848326|456188614|FG005|Treatment Period|Adverse Event|7|||
126789916|NCT02848326|456188609|FG000|Treatment Period|Withdrawal of Consent|20|||
126789917|NCT02848326|456188610|FG001|Treatment Period|Withdrawal of Consent|6|||
126789918|NCT02848326|456188611|FG002|Treatment Period|Withdrawal of Consent|9|||
126789919|NCT02848326|456188612|FG003|Treatment Period|Withdrawal of Consent|6|||
126789920|NCT02848326|456188613|FG004|Treatment Period|Withdrawal of Consent|9|||
126789921|NCT02848326|456188614|FG005|Treatment Period|Withdrawal of Consent|6|||
126789922|NCT02848326|456188609|FG000|Treatment Period|Lost to Follow-up|5|||
126789923|NCT02848326|456188610|FG001|Treatment Period|Lost to Follow-up|1|||
126789924|NCT02848326|456188611|FG002|Treatment Period|Lost to Follow-up|11|||
126789925|NCT02848326|456188612|FG003|Treatment Period|Lost to Follow-up|7|||
126789926|NCT02848326|456188613|FG004|Treatment Period|Lost to Follow-up|2|||
126789927|NCT02848326|456188614|FG005|Treatment Period|Lost to Follow-up|3|||
126789928|NCT02848326|456188609|FG000|Treatment Period|Pregnancy|0|||
126789929|NCT02848326|456188610|FG001|Treatment Period|Pregnancy|0|||
126789930|NCT02848326|456188611|FG002|Treatment Period|Pregnancy|1|||
126789931|NCT02848326|456188612|FG003|Treatment Period|Pregnancy|1|||
126789932|NCT02848326|456188613|FG004|Treatment Period|Pregnancy|0|||
126789933|NCT02848326|456188614|FG005|Treatment Period|Pregnancy|1|||
126789934|NCT02848326|456188609|FG000|Treatment Period|Protocol Violation|4|||
126789935|NCT02848326|456188610|FG001|Treatment Period|Protocol Violation|3|||
126789936|NCT02848326|456188611|FG002|Treatment Period|Protocol Violation|4|||
126789937|NCT02848326|456188612|FG003|Treatment Period|Protocol Violation|2|||
126789938|NCT02848326|456188613|FG004|Treatment Period|Protocol Violation|3|||
126789939|NCT02848326|456188614|FG005|Treatment Period|Protocol Violation|3|||
126789940|NCT02848326|456188609|FG000|Treatment Period|Non-compliance with Study Drug|4|||
126789941|NCT02848326|456188610|FG001|Treatment Period|Non-compliance with Study Drug|0|||
126789942|NCT02848326|456188611|FG002|Treatment Period|Non-compliance with Study Drug|0|||
126789943|NCT02848326|456188612|FG003|Treatment Period|Non-compliance with Study Drug|1|||
126789944|NCT02848326|456188613|FG004|Treatment Period|Non-compliance with Study Drug|0|||
126789945|NCT02848326|456188614|FG005|Treatment Period|Non-compliance with Study Drug|0|||
126789946|NCT02848326|456188609|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
126789947|NCT02848326|456188610|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
126789948|NCT02848326|456188611|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
126789949|NCT02848326|456188612|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
126789950|NCT02848326|456188613|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
126789951|NCT02848326|456188614|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
126789952|NCT02848326|456188609|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
126789953|NCT02848326|456188610|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
126789954|NCT02848326|456188611|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
126789955|NCT02848326|456188612|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
126789956|NCT02848326|456188613|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
126789957|NCT02848326|456188614|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
126789958|NCT04526210|456188616|FG000|Overall Study|Sponsor decision|7|||
126789959|NCT04526210|456188617|FG001|Overall Study|Sponsor decision|5|||
126789960|NCT04526210|456188616|FG000|Overall Study|Withdrawal by Subject|3|||
126789961|NCT04526210|456188617|FG001|Overall Study|Withdrawal by Subject|2|||
126789962|NCT02637232|456188618|FG000|Overall Study|Lost to Follow-up|42|||
126789963|NCT02637232|456188618|FG000|Overall Study|Adverse Event|11|||
126789964|NCT02637232|456188618|FG000|Overall Study|patient 's decision|2|||
126789965|NCT02999178|456188619|FG000|Overall Study|Adverse Event|85|||
126789966|NCT02999178|456188620|FG001|Overall Study|Adverse Event|62|||
126789967|NCT02999178|456188619|FG000|Overall Study|Protocol Violation|1|||
126789968|NCT02999178|456188620|FG001|Overall Study|Protocol Violation|2|||
126789969|NCT02999178|456188619|FG000|Overall Study|Lost to Follow-up|0|||
126789970|NCT02999178|456188620|FG001|Overall Study|Lost to Follow-up|2|||
126789971|NCT02999178|456188619|FG000|Overall Study|Withdrawal by Subject|21|||
126789972|NCT02999178|456188620|FG001|Overall Study|Withdrawal by Subject|21|||
126789973|NCT02999178|456188619|FG000|Overall Study|Other reason not defined above|7|||
126789974|NCT02999178|456188620|FG001|Overall Study|Other reason not defined above|13|||
126789975|NCT00090857|456188621|FG000|Overall Study|Lost to Follow-up|0|||
126789976|NCT00090857|456188622|FG001|Overall Study|Lost to Follow-up|1|||
126789977|NCT00090857|456188621|FG000|Overall Study|Withdrawal by Subject|2|||
126789978|NCT00090857|456188622|FG001|Overall Study|Withdrawal by Subject|0|||
126789979|NCT00090857|456188621|FG000|Overall Study|Adverse Event|2|||
126789980|NCT00090857|456188622|FG001|Overall Study|Adverse Event|2|||
126789981|NCT05097326|456188623|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
126789982|NCT05097326|456188624|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
126789983|NCT02684344|456188625|FG000|Overall Study|Withdrawal by Subject|0|||
126789984|NCT02684344|456188626|FG001|Overall Study|Withdrawal by Subject|1|||
126789985|NCT03480425|456188627|FG000|Overall Study|Force transducer technical failure|1|||
126789986|NCT02424188|456188629|FG000|Overall Study|Death|2|||
126789987|NCT02424188|456188630|FG001|Overall Study|Death|2|||
126789988|NCT02424188|456188629|FG000|Overall Study|Lost to Follow-up|1|||
126789989|NCT02424188|456188630|FG001|Overall Study|Lost to Follow-up|3|||
126632510|NCT01086384|455613782|FG002|2-week Run-in Period|Adverse Event|0|||
126789990|NCT02424188|456188629|FG000|Overall Study|Incarceration|1|||
126789991|NCT02424188|456188630|FG001|Overall Study|Incarceration|0|||
126789992|NCT00630305|456188631|FG000|Overall Study|Withdrawal by Subject|1|||
126789993|NCT00630305|456188631|FG000|Overall Study|Inability to insert contact lens|1|||
126789994|NCT03471078|456188642|FG000|Overall Study|Withdrawal by Subject|9|||
126789995|NCT03471078|456188643|FG001|Overall Study|Withdrawal by Subject|1|||
126789996|NCT03471078|456188642|FG000|Overall Study|Adverse Event|4|||
126789997|NCT03471078|456188643|FG001|Overall Study|Adverse Event|1|||
126789998|NCT03471078|456188642|FG000|Overall Study|Physician Decision|3|||
126789999|NCT03471078|456188643|FG001|Overall Study|Physician Decision|2|||
126790000|NCT03471078|456188642|FG000|Overall Study|Death|2|||
126790001|NCT03471078|456188643|FG001|Overall Study|Death|0|||
126790002|NCT03471078|456188642|FG000|Overall Study|Other|3|||
126790003|NCT03471078|456188643|FG001|Overall Study|Other|2|||
126790004|NCT02473640|456188647|FG000|Treatment Period 1|Adverse Event|1|||
126790005|NCT02395822|456188648|FG000|Overall Study|Withdrawal by Subject|1|||
126790006|NCT02395822|456188648|FG000|Overall Study|Death|1|||
126790007|NCT01882647|456188651|FG000|Overall Study|Lost to Follow-up|2|||
126790008|NCT01882647|456188652|FG001|Overall Study|Lost to Follow-up|2|||
126790009|NCT01882647|456188651|FG000|Overall Study|Withdrawal by Subject|0|||
126790010|NCT01882647|456188652|FG001|Overall Study|Withdrawal by Subject|4|||
126790011|NCT02937701|456188653|FG000|Day 1 to Week 22|Adverse Event|11|||
126790012|NCT02937701|456188654|FG001|Day 1 to Week 22|Adverse Event|14|||
126790013|NCT02937701|456188655|FG002|Day 1 to Week 22|Adverse Event|0|||
126790014|NCT02937701|456188656|FG003|Day 1 to Week 22|Adverse Event|0|||
126790015|NCT02937701|456188657|FG004|Day 1 to Week 22|Adverse Event|0|||
126790016|NCT02937701|456188653|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
126790017|NCT02937701|456188654|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
126790018|NCT02937701|456188655|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
126790019|NCT02937701|456188656|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
126790020|NCT02937701|456188657|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
126790021|NCT02937701|456188653|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
126790022|NCT02937701|456188654|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
126790023|NCT02937701|456188655|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
126790024|NCT02937701|456188656|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
126790025|NCT02937701|456188657|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
126790026|NCT02937701|456188653|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
126790027|NCT02937701|456188654|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
126790028|NCT02937701|456188655|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
126790029|NCT02937701|456188656|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
126790030|NCT02937701|456188657|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
126790031|NCT02937701|456188653|FG000|Day 1 to Week 22|Death|1|||
126790032|NCT02937701|456188654|FG001|Day 1 to Week 22|Death|1|||
126790033|NCT02937701|456188655|FG002|Day 1 to Week 22|Death|0|||
126790034|NCT02937701|456188656|FG003|Day 1 to Week 22|Death|0|||
126790035|NCT02937701|456188657|FG004|Day 1 to Week 22|Death|0|||
126790036|NCT02937701|456188653|FG000|Day 1 to Week 22|Protocol Violation|1|||
126790037|NCT02937701|456188654|FG001|Day 1 to Week 22|Protocol Violation|1|||
126790038|NCT02937701|456188655|FG002|Day 1 to Week 22|Protocol Violation|0|||
126790039|NCT02937701|456188656|FG003|Day 1 to Week 22|Protocol Violation|0|||
126790040|NCT02937701|456188657|FG004|Day 1 to Week 22|Protocol Violation|0|||
126790041|NCT02937701|456188653|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
126790042|NCT02937701|456188654|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
126790043|NCT02937701|456188655|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
126790044|NCT02937701|456188656|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
126790045|NCT02937701|456188657|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
126790046|NCT02937701|456188653|FG000|Day 1 to Week 22|Physician Decision|2|||
126790047|NCT02937701|456188654|FG001|Day 1 to Week 22|Physician Decision|0|||
126790048|NCT02937701|456188655|FG002|Day 1 to Week 22|Physician Decision|0|||
126790049|NCT02937701|456188656|FG003|Day 1 to Week 22|Physician Decision|0|||
126790050|NCT02937701|456188657|FG004|Day 1 to Week 22|Physician Decision|0|||
126790051|NCT02937701|456188653|FG000|Day 1 to Week 22|Other|1|||
126790052|NCT02937701|456188654|FG001|Day 1 to Week 22|Other|0|||
126790053|NCT02937701|456188655|FG002|Day 1 to Week 22|Other|0|||
126790054|NCT02937701|456188656|FG003|Day 1 to Week 22|Other|0|||
126790055|NCT02937701|456188657|FG004|Day 1 to Week 22|Other|0|||
126790056|NCT02937701|456188653|FG000|Week 22 to Week 50|Adverse Event|0|||
126790057|NCT02937701|456188654|FG001|Week 22 to Week 50|Adverse Event|0|||
126790058|NCT02937701|456188655|FG002|Week 22 to Week 50|Adverse Event|10|||
126790059|NCT02937701|456188656|FG003|Week 22 to Week 50|Adverse Event|3|||
126790060|NCT02937701|456188657|FG004|Week 22 to Week 50|Adverse Event|3|||
126790061|NCT02937701|456188653|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
126790062|NCT02937701|456188654|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
126790063|NCT02937701|456188655|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
126790064|NCT02937701|456188656|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
126790065|NCT02937701|456188657|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
126790066|NCT02937701|456188653|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
126790067|NCT02937701|456188654|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
126790068|NCT02937701|456188655|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
126790069|NCT02937701|456188656|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
126790070|NCT02937701|456188657|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
126790071|NCT02937701|456188653|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
126790072|NCT02937701|456188654|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
126790073|NCT02937701|456188655|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
126790074|NCT02937701|456188656|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
126790075|NCT02937701|456188657|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
126790076|NCT02937701|456188653|FG000|Week 22 to Week 50|Physician Decision|0|||
126790077|NCT02937701|456188654|FG001|Week 22 to Week 50|Physician Decision|0|||
126790078|NCT02937701|456188655|FG002|Week 22 to Week 50|Physician Decision|2|||
126790079|NCT02937701|456188656|FG003|Week 22 to Week 50|Physician Decision|0|||
126790080|NCT02937701|456188657|FG004|Week 22 to Week 50|Physician Decision|1|||
126790081|NCT02937701|456188653|FG000|Week 22 to Week 50|Other|0|||
126790082|NCT02937701|456188654|FG001|Week 22 to Week 50|Other|0|||
126790083|NCT02937701|456188655|FG002|Week 22 to Week 50|Other|0|||
126790084|NCT02937701|456188656|FG003|Week 22 to Week 50|Other|0|||
126790085|NCT02937701|456188657|FG004|Week 22 to Week 50|Other|1|||
126790086|NCT03292653|456188659|FG000|Overall Study|Adverse Event|0|||
126790087|NCT03292653|456188660|FG001|Overall Study|Adverse Event|0|||
126790088|NCT03292653|456188661|FG002|Overall Study|Adverse Event|1|||
126790089|NCT03292653|456188659|FG000|Overall Study|Did not Receive Treatment|1|||
126790090|NCT03292653|456188660|FG001|Overall Study|Did not Receive Treatment|0|||
126790091|NCT03292653|456188661|FG002|Overall Study|Did not Receive Treatment|0|||
126790092|NCT04720664|456188662|FG000|Overall Study|Adverse Event|2|||
126790093|NCT04720664|456188662|FG000|Overall Study|Lack of Efficacy|9|||
126790094|NCT03311646|456188663|FG000|Overall Study|Physician Decision|1|||
126790095|NCT03311646|456188663|FG000|Overall Study|Withdrawal by Subject|5|||
126790096|NCT03311646|456188663|FG000|Overall Study|Lost to Follow-up|5|||
126790097|NCT03311646|456188663|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
126790098|NCT03127137|456188674|FG000|Overall Study|Requested sedation after consent|1|||
126790099|NCT03127137|456188675|FG001|Overall Study|Requested sedation after consent|0|||
126790100|NCT03127137|456188674|FG000|Overall Study|Malfunction in electronic data collection|1|||
126790101|NCT03127137|456188675|FG001|Overall Study|Malfunction in electronic data collection|0|||
126790102|NCT03127137|456188674|FG000|Overall Study|Post procedure testing could not be obtained|0|||
126790103|NCT03127137|456188675|FG001|Overall Study|Post procedure testing could not be obtained|1|||
126790104|NCT00623779|456188676|FG000|Overall Study|Adverse Event|1|||
126790105|NCT00623779|456188677|FG001|Overall Study|Adverse Event|3|||
126790106|NCT00623779|456188678|FG002|Overall Study|Adverse Event|0|||
126790107|NCT00623779|456188676|FG000|Overall Study|Criteria from CSR|2|||
126790108|NCT00623779|456188677|FG001|Overall Study|Criteria from CSR|0|||
126790109|NCT00623779|456188678|FG002|Overall Study|Criteria from CSR|1|||
126790110|NCT03657160|456188679|FG000|Overall Study|Adverse Event|5|||
126790111|NCT03657160|456188680|FG001|Overall Study|Adverse Event|6|||
126790112|NCT03657160|456188679|FG000|Overall Study|Protocol Deviation|3|||
126790113|NCT03657160|456188680|FG001|Overall Study|Protocol Deviation|0|||
126790114|NCT03657160|456188679|FG000|Overall Study|Withdrawal by Subject|18|||
126790115|NCT03657160|456188680|FG001|Overall Study|Withdrawal by Subject|16|||
126790116|NCT03657160|456188679|FG000|Overall Study|Site Termination|1|||
126790117|NCT03657160|456188680|FG001|Overall Study|Site Termination|0|||
126790118|NCT03657160|456188679|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
126790119|NCT03657160|456188680|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
126790120|NCT03657160|456188679|FG000|Overall Study|Death|33|||
126790121|NCT03657160|456188680|FG001|Overall Study|Death|26|||
126790122|NCT03657160|456188679|FG000|Overall Study|Death (COVID-19-Related)|1|||
126790123|NCT03657160|456188680|FG001|Overall Study|Death (COVID-19-Related)|0|||
126790124|NCT03657160|456188679|FG000|Overall Study|Reason Not Specified|5|||
126790125|NCT03657160|456188680|FG001|Overall Study|Reason Not Specified|5|||
126790126|NCT03657160|456188679|FG000|Overall Study|Other (COVID-19-Related)|0|||
126790127|NCT03657160|456188680|FG001|Overall Study|Other (COVID-19-Related)|1|||
126790128|NCT02732210|456188681|FG000|Overall Study|Site Closed|0|||
126790129|NCT02732210|456188682|FG001|Overall Study|Site Closed|11|||
126790130|NCT02732210|456188681|FG000|Overall Study|Study Ended|13|||
126790131|NCT02732210|456188682|FG001|Overall Study|Study Ended|13|||
126790132|NCT02732210|456188681|FG000|Overall Study|Withdrawal by Subject|28|||
126790133|NCT02732210|456188682|FG001|Overall Study|Withdrawal by Subject|87|||
126790134|NCT02732210|456188681|FG000|Overall Study|Lost to Follow-up|5|||
126790135|NCT02732210|456188682|FG001|Overall Study|Lost to Follow-up|57|||
126790136|NCT02732210|456188681|FG000|Overall Study|Death|4|||
126790137|NCT02732210|456188682|FG001|Overall Study|Death|15|||
126790138|NCT02732210|456188681|FG000|Overall Study|Other|35|||
126790139|NCT02732210|456188682|FG001|Overall Study|Other|103|||
126790140|NCT02732210|456188681|FG000|Overall Study|Missing|0|||
126790141|NCT02732210|456188682|FG001|Overall Study|Missing|8|||
126790142|NCT01434693|456188685|FG000|Overall Study|Adverse Event|1|||
126790143|NCT01434693|456188686|FG001|Overall Study|Adverse Event|0|||
126790144|NCT01434693|456188687|FG002|Overall Study|Adverse Event|0|||
126790145|NCT01434693|456188688|FG003|Overall Study|Adverse Event|0|||
126790146|NCT01434693|456188685|FG000|Overall Study|Withdrawal by Subject|1|||
126790147|NCT01434693|456188686|FG001|Overall Study|Withdrawal by Subject|0|||
126790148|NCT01434693|456188687|FG002|Overall Study|Withdrawal by Subject|1|||
126790149|NCT01434693|456188688|FG003|Overall Study|Withdrawal by Subject|1|||
126790150|NCT01434693|456188685|FG000|Overall Study|Lost to Follow-up|1|||
126790151|NCT01434693|456188686|FG001|Overall Study|Lost to Follow-up|0|||
126790152|NCT01434693|456188687|FG002|Overall Study|Lost to Follow-up|0|||
126790153|NCT01434693|456188688|FG003|Overall Study|Lost to Follow-up|0|||
126790154|NCT01440283|456188689|FG000|Overall Study|Death|3|||
126790155|NCT01440283|456188689|FG000|Overall Study|Withdrawal by Subject|4|||
126790156|NCT01440283|456188689|FG000|Overall Study|Physician Decision|3|||
126790157|NCT00440557|456188691|FG000|Overall Study|Withdrawal by Subject|10|||
126790158|NCT00440557|456188692|FG001|Overall Study|Withdrawal by Subject|5|||
126790159|NCT00440557|456188693|FG002|Overall Study|Withdrawal by Subject|11|||
126790160|NCT00440557|456188691|FG000|Overall Study|Lost to Follow-up|1|||
126790161|NCT00440557|456188692|FG001|Overall Study|Lost to Follow-up|2|||
126790162|NCT00440557|456188693|FG002|Overall Study|Lost to Follow-up|6|||
126790163|NCT00440557|456188691|FG000|Overall Study|Adverse Event|3|||
126790164|NCT00440557|456188692|FG001|Overall Study|Adverse Event|3|||
126790165|NCT00440557|456188693|FG002|Overall Study|Adverse Event|5|||
126790166|NCT00440557|456188691|FG000|Overall Study|Death|2|||
126790167|NCT00440557|456188692|FG001|Overall Study|Death|6|||
126790168|NCT00440557|456188693|FG002|Overall Study|Death|3|||
126790169|NCT00440557|456188691|FG000|Overall Study|Began Dialysis|4|||
126790170|NCT00440557|456188692|FG001|Overall Study|Began Dialysis|1|||
126790171|NCT00440557|456188693|FG002|Overall Study|Began Dialysis|4|||
126790172|NCT00440557|456188691|FG000|Overall Study|Principal Investigator decision|0|||
126790173|NCT00440557|456188692|FG001|Overall Study|Principal Investigator decision|3|||
126790174|NCT00440557|456188693|FG002|Overall Study|Principal Investigator decision|1|||
126790175|NCT00440557|456188691|FG000|Overall Study|Patient moved|1|||
126790176|NCT00440557|456188692|FG001|Overall Study|Patient moved|2|||
126790177|NCT00440557|456188693|FG002|Overall Study|Patient moved|1|||
126790178|NCT00440557|456188691|FG000|Overall Study|Principal Investigator's office closed|3|||
126790179|NCT00440557|456188692|FG001|Overall Study|Principal Investigator's office closed|6|||
126790180|NCT00440557|456188693|FG002|Overall Study|Principal Investigator's office closed|4|||
126790181|NCT00440557|456188691|FG000|Overall Study|Patient transferred to nursing home|0|||
126790182|NCT00440557|456188692|FG001|Overall Study|Patient transferred to nursing home|1|||
126790183|NCT00440557|456188693|FG002|Overall Study|Patient transferred to nursing home|0|||
126790184|NCT00440557|456188691|FG000|Overall Study|Patient had surgery|1|||
126790185|NCT00440557|456188692|FG001|Overall Study|Patient had surgery|0|||
126790186|NCT00440557|456188693|FG002|Overall Study|Patient had surgery|0|||
126790187|NCT00162123|456188694|FG000|Overall Study|Disease progression|27|||
126790188|NCT00162123|456188695|FG001|Overall Study|Disease progression|19|||
126790189|NCT00162123|456188696|FG002|Overall Study|Disease progression|10|||
126790190|NCT00162123|456188697|FG003|Overall Study|Disease progression|4|||
126790191|NCT00162123|456188698|FG004|Overall Study|Disease progression|8|||
126790192|NCT00162123|456188699|FG005|Overall Study|Disease progression|3|||
126790193|NCT00162123|456188700|FG006|Overall Study|Disease progression|1|||
126790194|NCT00162123|456188701|FG007|Overall Study|Disease progression|0|||
126790195|NCT00162123|456188694|FG000|Overall Study|Study drug toxicity|6|||
126790196|NCT00162123|456188695|FG001|Overall Study|Study drug toxicity|1|||
126790197|NCT00162123|456188696|FG002|Overall Study|Study drug toxicity|5|||
126790198|NCT00162123|456188697|FG003|Overall Study|Study drug toxicity|0|||
126790199|NCT00162123|456188698|FG004|Overall Study|Study drug toxicity|4|||
126790200|NCT00162123|456188699|FG005|Overall Study|Study drug toxicity|1|||
126790201|NCT00162123|456188700|FG006|Overall Study|Study drug toxicity|1|||
126790202|NCT00162123|456188701|FG007|Overall Study|Study drug toxicity|0|||
126790203|NCT00162123|456188694|FG000|Overall Study|Death|3|||
126790204|NCT00162123|456188695|FG001|Overall Study|Death|3|||
126790205|NCT00162123|456188696|FG002|Overall Study|Death|1|||
126790206|NCT00162123|456188697|FG003|Overall Study|Death|1|||
126790207|NCT00162123|456188698|FG004|Overall Study|Death|1|||
126790208|NCT00162123|456188699|FG005|Overall Study|Death|1|||
126790209|NCT00162123|456188700|FG006|Overall Study|Death|0|||
126790210|NCT00162123|456188701|FG007|Overall Study|Death|0|||
126790211|NCT00162123|456188694|FG000|Overall Study|Withdrawal by Subject|2|||
126790212|NCT00162123|456188695|FG001|Overall Study|Withdrawal by Subject|0|||
126790213|NCT00162123|456188696|FG002|Overall Study|Withdrawal by Subject|2|||
126790214|NCT00162123|456188697|FG003|Overall Study|Withdrawal by Subject|1|||
126790215|NCT00162123|456188698|FG004|Overall Study|Withdrawal by Subject|1|||
126790216|NCT00162123|456188699|FG005|Overall Study|Withdrawal by Subject|2|||
126790217|NCT00162123|456188700|FG006|Overall Study|Withdrawal by Subject|1|||
126790218|NCT00162123|456188701|FG007|Overall Study|Withdrawal by Subject|0|||
126790219|NCT00162123|456188694|FG000|Overall Study|Deterioration without progression|2|||
126790220|NCT00162123|456188695|FG001|Overall Study|Deterioration without progression|2|||
126790221|NCT00162123|456188696|FG002|Overall Study|Deterioration without progression|3|||
126790222|NCT00162123|456188697|FG003|Overall Study|Deterioration without progression|0|||
126790223|NCT00162123|456188698|FG004|Overall Study|Deterioration without progression|1|||
126790224|NCT00162123|456188699|FG005|Overall Study|Deterioration without progression|0|||
126790225|NCT00162123|456188700|FG006|Overall Study|Deterioration without progression|0|||
126790226|NCT00162123|456188701|FG007|Overall Study|Deterioration without progression|0|||
126790227|NCT00162123|456188694|FG000|Overall Study|Adverse Event|1|||
126790228|NCT00162123|456188695|FG001|Overall Study|Adverse Event|2|||
126790229|NCT00162123|456188696|FG002|Overall Study|Adverse Event|0|||
126790230|NCT00162123|456188697|FG003|Overall Study|Adverse Event|2|||
126790231|NCT00162123|456188698|FG004|Overall Study|Adverse Event|1|||
126790232|NCT00162123|456188699|FG005|Overall Study|Adverse Event|0|||
126790233|NCT00162123|456188700|FG006|Overall Study|Adverse Event|0|||
126790234|NCT00162123|456188701|FG007|Overall Study|Adverse Event|0|||
126790235|NCT00162123|456188694|FG000|Overall Study|Not specified (before treatment)|2|||
126790236|NCT00162123|456188695|FG001|Overall Study|Not specified (before treatment)|0|||
126790237|NCT00162123|456188696|FG002|Overall Study|Not specified (before treatment)|0|||
126790238|NCT00162123|456188697|FG003|Overall Study|Not specified (before treatment)|0|||
126790239|NCT00162123|456188698|FG004|Overall Study|Not specified (before treatment)|12|||
126790240|NCT00162123|456188699|FG005|Overall Study|Not specified (before treatment)|1|||
126790241|NCT00162123|456188700|FG006|Overall Study|Not specified (before treatment)|0|||
126790242|NCT00162123|456188701|FG007|Overall Study|Not specified (before treatment)|0|||
126790243|NCT00162123|456188694|FG000|Overall Study|Not specified (after start of treatment)|0|||
126790244|NCT00162123|456188695|FG001|Overall Study|Not specified (after start of treatment)|0|||
126790245|NCT00162123|456188696|FG002|Overall Study|Not specified (after start of treatment)|0|||
126790246|NCT00162123|456188697|FG003|Overall Study|Not specified (after start of treatment)|0|||
126790247|NCT00162123|456188698|FG004|Overall Study|Not specified (after start of treatment)|3|||
126790248|NCT00162123|456188699|FG005|Overall Study|Not specified (after start of treatment)|0|||
126790249|NCT00162123|456188700|FG006|Overall Study|Not specified (after start of treatment)|0|||
126790250|NCT00162123|456188701|FG007|Overall Study|Not specified (after start of treatment)|0|||
126790251|NCT00162123|456188694|FG000|Overall Study|Physician Decision|1|||
126790252|NCT00162123|456188695|FG001|Overall Study|Physician Decision|2|||
126790253|NCT00162123|456188696|FG002|Overall Study|Physician Decision|0|||
126790254|NCT00162123|456188697|FG003|Overall Study|Physician Decision|0|||
126790255|NCT00162123|456188698|FG004|Overall Study|Physician Decision|0|||
126790256|NCT00162123|456188699|FG005|Overall Study|Physician Decision|1|||
126790257|NCT00162123|456188700|FG006|Overall Study|Physician Decision|1|||
126790258|NCT00162123|456188701|FG007|Overall Study|Physician Decision|0|||
126790259|NCT00162123|456188694|FG000|Overall Study|Tumor assessment only (not treated)|0|||
126790260|NCT00162123|456188695|FG001|Overall Study|Tumor assessment only (not treated)|0|||
126790261|NCT00162123|456188696|FG002|Overall Study|Tumor assessment only (not treated)|0|||
126790262|NCT00162123|456188697|FG003|Overall Study|Tumor assessment only (not treated)|0|||
126790263|NCT00162123|456188698|FG004|Overall Study|Tumor assessment only (not treated)|0|||
126790264|NCT00162123|456188699|FG005|Overall Study|Tumor assessment only (not treated)|0|||
126790265|NCT00162123|456188700|FG006|Overall Study|Tumor assessment only (not treated)|0|||
126790266|NCT00162123|456188701|FG007|Overall Study|Tumor assessment only (not treated)|1|||
126790267|NCT00162123|456188694|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
126790268|NCT00162123|456188695|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
126790269|NCT00162123|456188696|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
126790270|NCT00162123|456188697|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
126790271|NCT00162123|456188698|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
126790272|NCT00162123|456188699|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
126790273|NCT00162123|456188700|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
126790274|NCT00162123|456188701|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
126790275|NCT01936948|456188703|FG000|Overall Study|no 30-day follow-up data|0|||
126790276|NCT01936948|456188704|FG001|Overall Study|no 30-day follow-up data|3|||
126790277|NCT01936948|456188705|FG002|Overall Study|no 30-day follow-up data|3|||
126790278|NCT01936948|456188706|FG003|Overall Study|no 30-day follow-up data|3|||
126790279|NCT02781727|456188707|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
126755398|NCT02906644|456054707|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
126755399|NCT02452034|456054708|FG000|Overall Study|Adverse Event|0|||
126755400|NCT02452034|456054709|FG001|Overall Study|Adverse Event|0|||
126755401|NCT02452034|456054710|FG002|Overall Study|Adverse Event|0|||
126755402|NCT02452034|456054711|FG003|Overall Study|Adverse Event|0|||
126755403|NCT02452034|456054712|FG004|Overall Study|Adverse Event|0|||
126755404|NCT02452034|456054713|FG005|Overall Study|Adverse Event|1|||
126755405|NCT02452034|456054708|FG000|Overall Study|Death|0|||
126755406|NCT02452034|456054709|FG001|Overall Study|Death|0|||
126755407|NCT02452034|456054710|FG002|Overall Study|Death|0|||
126755408|NCT02452034|456054711|FG003|Overall Study|Death|0|||
126755409|NCT02452034|456054712|FG004|Overall Study|Death|1|||
126755410|NCT02452034|456054713|FG005|Overall Study|Death|1|||
126755411|NCT02452034|456054708|FG000|Overall Study|Physician Decision|0|||
126755412|NCT02452034|456054709|FG001|Overall Study|Physician Decision|1|||
126755413|NCT02452034|456054710|FG002|Overall Study|Physician Decision|1|||
126755414|NCT02452034|456054711|FG003|Overall Study|Physician Decision|0|||
126755415|NCT02452034|456054712|FG004|Overall Study|Physician Decision|0|||
126755416|NCT02452034|456054713|FG005|Overall Study|Physician Decision|0|||
126755417|NCT02452034|456054708|FG000|Overall Study|Protocol Violation|0|||
126755418|NCT02452034|456054709|FG001|Overall Study|Protocol Violation|0|||
126755419|NCT02452034|456054710|FG002|Overall Study|Protocol Violation|0|||
126755420|NCT02452034|456054711|FG003|Overall Study|Protocol Violation|0|||
126755421|NCT02452034|456054712|FG004|Overall Study|Protocol Violation|0|||
126755422|NCT02452034|456054713|FG005|Overall Study|Protocol Violation|1|||
126755423|NCT02452034|456054708|FG000|Overall Study|Screen Failure|1|||
126790280|NCT02781727|456188708|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
126790281|NCT02781727|456188707|FG000|Treatment Period|Withdrawal by Subject|1|||
126790282|NCT02781727|456188708|FG001|Treatment Period|Withdrawal by Subject|0|||
126790283|NCT02781727|456188707|FG000|Treatment Period|Lost to Follow-up|0|||
126790284|NCT02781727|456188708|FG001|Treatment Period|Lost to Follow-up|1|||
126790285|NCT02327130|456188709|FG000|Overall Study|Discharged in less than 5 days|5|||
126790286|NCT02327130|456188709|FG000|Overall Study|Physician Decision|2|||
126790287|NCT02327130|456188709|FG000|Overall Study|Unable to provide breath sample|1|||
126790288|NCT02327130|456188709|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
126790289|NCT02327130|456188709|FG000|Overall Study|Met exclusion criteria|3|||
126790290|NCT01378975|456188712|FG000|Overall Study|Death|77|||
126790291|NCT01378975|456188713|FG001|Overall Study|Death|46|||
126790292|NCT01378975|456188712|FG000|Overall Study|Investigator Request|1|||
126790293|NCT01378975|456188713|FG001|Overall Study|Investigator Request|0|||
126790294|NCT01378975|456188712|FG000|Overall Study|Lost to Follow-up|4|||
126790295|NCT01378975|456188713|FG001|Overall Study|Lost to Follow-up|1|||
126790296|NCT01378975|456188712|FG000|Overall Study|Withdrew Consent|4|||
126790297|NCT01378975|456188713|FG001|Overall Study|Withdrew Consent|3|||
126790298|NCT02343120|456188717|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
126790299|NCT02343120|456188718|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
126790300|NCT02343120|456188719|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
126790301|NCT02343120|456188720|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
126790302|NCT02343120|456188721|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
126790303|NCT02343120|456188717|FG000|Part 1: Dose Escalation|Death|1|||
126790304|NCT02343120|456188718|FG001|Part 1: Dose Escalation|Death|2|||
126790305|NCT02343120|456188719|FG002|Part 1: Dose Escalation|Death|2|||
126790306|NCT02343120|456188720|FG003|Part 1: Dose Escalation|Death|2|||
126790307|NCT02343120|456188721|FG004|Part 1: Dose Escalation|Death|1|||
126790308|NCT02343120|456188717|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
126790309|NCT02343120|456188718|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
126790310|NCT02343120|456188719|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
126790311|NCT02343120|456188720|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
126790312|NCT02343120|456188721|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
126632511|NCT01086384|455613780|FG000|2-week Run-in Period|Protocol Violation|1|||
126632512|NCT01086384|455613781|FG001|2-week Run-in Period|Protocol Violation|0|||
126632513|NCT01086384|455613782|FG002|2-week Run-in Period|Protocol Violation|0|||
126632514|NCT01086384|455613780|FG000|2-week Run-in Period|Lost to Follow-up|1|||
126632515|NCT01086384|455613781|FG001|2-week Run-in Period|Lost to Follow-up|0|||
126632516|NCT01086384|455613782|FG002|2-week Run-in Period|Lost to Follow-up|0|||
126632517|NCT01086384|455613780|FG000|2-week Run-in Period|Physician Decision|6|||
126632518|NCT01086384|455613781|FG001|2-week Run-in Period|Physician Decision|0|||
126632519|NCT01086384|455613782|FG002|2-week Run-in Period|Physician Decision|0|||
126632520|NCT01086384|455613780|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
126632521|NCT01086384|455613781|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
126632522|NCT01086384|455613782|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
126632523|NCT01086384|455613780|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
126632524|NCT01086384|455613781|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
126632525|NCT01086384|455613782|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
126632526|NCT01086384|455613780|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
126632527|NCT01086384|455613781|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
126632528|NCT01086384|455613782|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
126632529|NCT01086384|455613780|FG000|2-week Run-in Period|Randomized in Error|1|||
126632530|NCT01086384|455613781|FG001|2-week Run-in Period|Randomized in Error|0|||
126632531|NCT01086384|455613782|FG002|2-week Run-in Period|Randomized in Error|0|||
126632532|NCT01086384|455613780|FG000|Treatment Period|Withdrawal by Subject|0|||
126632533|NCT01086384|455613781|FG001|Treatment Period|Withdrawal by Subject|53|||
126632534|NCT01086384|455613782|FG002|Treatment Period|Withdrawal by Subject|55|||
126632535|NCT01086384|455613780|FG000|Treatment Period|Protocol Violation|0|||
126632536|NCT01086384|455613781|FG001|Treatment Period|Protocol Violation|26|||
126632537|NCT01086384|455613782|FG002|Treatment Period|Protocol Violation|17|||
126632538|NCT01086384|455613780|FG000|Treatment Period|Lack of Efficacy|0|||
126632539|NCT01086384|455613781|FG001|Treatment Period|Lack of Efficacy|22|||
126632540|NCT01086384|455613782|FG002|Treatment Period|Lack of Efficacy|13|||
126632541|NCT01086384|455613780|FG000|Treatment Period|Adverse Event|0|||
126790313|NCT02343120|456188717|FG000|Part 2: Expansion|Sponsor decision|0|||
126790314|NCT02343120|456188718|FG001|Part 2: Expansion|Sponsor decision|0|||
126632542|NCT01086384|455613781|FG001|Treatment Period|Adverse Event|19|||
126632543|NCT01086384|455613782|FG002|Treatment Period|Adverse Event|15|||
126632544|NCT01086384|455613780|FG000|Treatment Period|Lost to Follow-up|0|||
126632545|NCT01086384|455613781|FG001|Treatment Period|Lost to Follow-up|11|||
126632546|NCT01086384|455613782|FG002|Treatment Period|Lost to Follow-up|9|||
126632547|NCT01086384|455613780|FG000|Treatment Period|Physician Decision|0|||
126790315|NCT02343120|456188719|FG002|Part 2: Expansion|Sponsor decision|0|||
126790316|NCT02343120|456188720|FG003|Part 2: Expansion|Sponsor decision|165|||
126790317|NCT02343120|456188721|FG004|Part 2: Expansion|Sponsor decision|67|||
126790318|NCT02343120|456188717|FG000|Part 2: Expansion|Death|0|||
126790319|NCT02343120|456188718|FG001|Part 2: Expansion|Death|0|||
126790320|NCT02343120|456188719|FG002|Part 2: Expansion|Death|0|||
126790321|NCT02343120|456188720|FG003|Part 2: Expansion|Death|74|||
126790322|NCT02343120|456188721|FG004|Part 2: Expansion|Death|17|||
126790323|NCT02343120|456188717|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
126790324|NCT02343120|456188718|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
126790325|NCT02343120|456188719|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
126790326|NCT02343120|456188720|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
126790327|NCT02343120|456188721|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
126790328|NCT02343120|456188717|FG000|Part 2: Expansion|Lost to Follow-up|0|||
126790329|NCT02343120|456188718|FG001|Part 2: Expansion|Lost to Follow-up|0|||
126790330|NCT02343120|456188719|FG002|Part 2: Expansion|Lost to Follow-up|0|||
126790331|NCT02343120|456188720|FG003|Part 2: Expansion|Lost to Follow-up|5|||
126790332|NCT02343120|456188721|FG004|Part 2: Expansion|Lost to Follow-up|2|||
126790333|NCT02343120|456188717|FG000|Part 2: Expansion|Other|0|||
126790334|NCT02343120|456188718|FG001|Part 2: Expansion|Other|0|||
126790335|NCT02343120|456188719|FG002|Part 2: Expansion|Other|0|||
126790336|NCT02343120|456188720|FG003|Part 2: Expansion|Other|1|||
126790337|NCT02343120|456188721|FG004|Part 2: Expansion|Other|5|||
126790338|NCT02343120|456188717|FG000|Part 2: Expansion|Adverse Event|0|||
126790339|NCT02343120|456188718|FG001|Part 2: Expansion|Adverse Event|0|||
126790340|NCT02343120|456188719|FG002|Part 2: Expansion|Adverse Event|0|||
126790341|NCT02343120|456188720|FG003|Part 2: Expansion|Adverse Event|1|||
126790342|NCT02343120|456188721|FG004|Part 2: Expansion|Adverse Event|1|||
126790343|NCT03544138|456188722|FG000|Overall Study|Lost to Follow-up|29|||
126632548|NCT01086384|455613781|FG001|Treatment Period|Physician Decision|9|||
126632549|NCT01086384|455613782|FG002|Treatment Period|Physician Decision|6|||
126790344|NCT01766778|456188723|FG000|Overall Study|Adverse Event|4|||
126790345|NCT01766778|456188724|FG001|Overall Study|Adverse Event|4|||
126790346|NCT01766778|456188723|FG000|Overall Study|Withdrawal by Subject|1|||
126790347|NCT01766778|456188724|FG001|Overall Study|Withdrawal by Subject|0|||
126790348|NCT01104662|456188725|FG000|Overall Study|Adverse Event|2|||
126790349|NCT01104662|456188726|FG001|Overall Study|Adverse Event|2|||
126790350|NCT01104662|456188727|FG002|Overall Study|Adverse Event|0|||
126790351|NCT01104662|456188728|FG003|Overall Study|Adverse Event|1|||
126790352|NCT01104662|456188729|FG004|Overall Study|Adverse Event|1|||
126790353|NCT01104662|456188730|FG005|Overall Study|Adverse Event|1|||
126790354|NCT01104662|456188731|FG006|Overall Study|Adverse Event|0|||
126790355|NCT01104662|456188732|FG007|Overall Study|Adverse Event|0|||
126790356|NCT01104662|456188725|FG000|Overall Study|Clinical Failure|1|||
126790357|NCT01104662|456188726|FG001|Overall Study|Clinical Failure|0|||
126790358|NCT01104662|456188727|FG002|Overall Study|Clinical Failure|0|||
126790359|NCT01104662|456188728|FG003|Overall Study|Clinical Failure|0|||
126790360|NCT01104662|456188729|FG004|Overall Study|Clinical Failure|0|||
126790361|NCT01104662|456188730|FG005|Overall Study|Clinical Failure|1|||
126790362|NCT01104662|456188731|FG006|Overall Study|Clinical Failure|0|||
126790363|NCT01104662|456188732|FG007|Overall Study|Clinical Failure|0|||
126790364|NCT01104662|456188725|FG000|Overall Study|Participant left investigator's care|1|||
126790365|NCT01104662|456188726|FG001|Overall Study|Participant left investigator's care|1|||
126790366|NCT01104662|456188727|FG002|Overall Study|Participant left investigator's care|0|||
126790367|NCT01104662|456188728|FG003|Overall Study|Participant left investigator's care|0|||
126790368|NCT01104662|456188729|FG004|Overall Study|Participant left investigator's care|0|||
126790369|NCT01104662|456188730|FG005|Overall Study|Participant left investigator's care|0|||
126790370|NCT01104662|456188731|FG006|Overall Study|Participant left investigator's care|0|||
126790371|NCT01104662|456188732|FG007|Overall Study|Participant left investigator's care|0|||
126790372|NCT01104662|456188725|FG000|Overall Study|Reason not specified|3|||
126790373|NCT01104662|456188726|FG001|Overall Study|Reason not specified|3|||
126790374|NCT01104662|456188727|FG002|Overall Study|Reason not specified|0|||
126790375|NCT01104662|456188728|FG003|Overall Study|Reason not specified|0|||
126790376|NCT01104662|456188729|FG004|Overall Study|Reason not specified|0|||
126790377|NCT01104662|456188730|FG005|Overall Study|Reason not specified|1|||
126790378|NCT01104662|456188731|FG006|Overall Study|Reason not specified|0|||
126790379|NCT01104662|456188732|FG007|Overall Study|Reason not specified|0|||
126790380|NCT01104662|456188725|FG000|Overall Study|Randomized but not treated|3|||
126790381|NCT01104662|456188726|FG001|Overall Study|Randomized but not treated|4|||
126790382|NCT01104662|456188727|FG002|Overall Study|Randomized but not treated|1|||
126632550|NCT01086384|455613780|FG000|Treatment Period|Study Closed/Terminated|0|||
126790383|NCT01104662|456188728|FG003|Overall Study|Randomized but not treated|0|||
126790384|NCT01104662|456188729|FG004|Overall Study|Randomized but not treated|0|||
126790385|NCT01104662|456188730|FG005|Overall Study|Randomized but not treated|1|||
126790386|NCT01104662|456188731|FG006|Overall Study|Randomized but not treated|0|||
126790387|NCT01104662|456188732|FG007|Overall Study|Randomized but not treated|0|||
126632551|NCT01086384|455613781|FG001|Treatment Period|Study Closed/Terminated|7|||
126790388|NCT01706926|456188735|FG000|Overall Study|Lost to Follow-up|0|||
126790389|NCT01706926|456188736|FG001|Overall Study|Lost to Follow-up|0|||
126790390|NCT01706926|456188737|FG002|Overall Study|Lost to Follow-up|1|||
126790391|NCT01706926|456188738|FG003|Overall Study|Lost to Follow-up|0|||
126790392|NCT01706926|456188735|FG000|Overall Study|Withdrawal by Subject|2|||
126790393|NCT01706926|456188736|FG001|Overall Study|Withdrawal by Subject|0|||
126790394|NCT01706926|456188737|FG002|Overall Study|Withdrawal by Subject|1|||
126790395|NCT01706926|456188738|FG003|Overall Study|Withdrawal by Subject|2|||
126790396|NCT01706926|456188735|FG000|Overall Study|Other|4|||
126790397|NCT01706926|456188736|FG001|Overall Study|Other|4|||
126790398|NCT01706926|456188737|FG002|Overall Study|Other|4|||
126790399|NCT01706926|456188738|FG003|Overall Study|Other|3|||
126790400|NCT03805438|456190180|FG000|Overall Study|Lack of Efficacy|1|||
126790401|NCT03805438|456190180|FG000|Overall Study|Protocol Violation|1|||
126790402|NCT00366899|456190181|FG000|Infant Series|Withdrawal by Subject|4|||
126790403|NCT00366899|456190182|FG001|Infant Series|Withdrawal by Subject|7|||
126790404|NCT00366899|456190181|FG000|Infant Series|Protocol Violation|2|||
126790405|NCT00366899|456190182|FG001|Infant Series|Protocol Violation|1|||
126790406|NCT00366899|456190181|FG000|Infant Series|Failed to return|1|||
126790407|NCT00366899|456190182|FG001|Infant Series|Failed to return|1|||
126790408|NCT00366899|456190181|FG000|Infant Series|Lost to Follow-up|0|||
126790409|NCT00366899|456190182|FG001|Infant Series|Lost to Follow-up|2|||
126790410|NCT00366899|456190181|FG000|Infant Series|Adverse Event|0|||
126790411|NCT00366899|456190182|FG001|Infant Series|Adverse Event|1|||
126790412|NCT00366899|456190181|FG000|Infant Series|Physician Decision|1|||
126790413|NCT00366899|456190182|FG001|Infant Series|Physician Decision|0|||
126790414|NCT00366899|456190181|FG000|Infant Series|Randomized but not consented|1|||
126790415|NCT00366899|456190182|FG001|Infant Series|Randomized but not consented|0|||
126790416|NCT00366899|456190181|FG000|After Infant Series|Lost to Follow-up|4|||
126790417|NCT00366899|456190182|FG001|After Infant Series|Lost to Follow-up|3|||
126790418|NCT00366899|456190181|FG000|After Infant Series|Withdrawal by Subject|1|||
126790419|NCT00366899|456190182|FG001|After Infant Series|Withdrawal by Subject|4|||
126790420|NCT00366899|456190181|FG000|After Infant Series|Adverse Event|1|||
126790421|NCT00366899|456190182|FG001|After Infant Series|Adverse Event|2|||
126790422|NCT00366899|456190181|FG000|After Infant Series|Protocol Violation|1|||
126790423|NCT00366899|456190182|FG001|After Infant Series|Protocol Violation|0|||
126790424|NCT00366899|456190181|FG000|Toddler Dose|Withdrawal by Subject|1|||
126790425|NCT00366899|456190182|FG001|Toddler Dose|Withdrawal by Subject|1|||
126790426|NCT00366899|456190181|FG000|Toddler Dose|Protocol Violation|1|||
126790427|NCT00366899|456190182|FG001|Toddler Dose|Protocol Violation|0|||
126790428|NCT01619800|456190183|FG000|Overall Study|study terminated|2|||
126790429|NCT01619800|456190184|FG001|Overall Study|study terminated|0|||
126790430|NCT00414466|456190186|FG000|Overall Study|Adverse Event|0|||
126790431|NCT00414466|456190187|FG001|Overall Study|Adverse Event|0|||
126790432|NCT00414466|456190188|FG002|Overall Study|Adverse Event|1|||
126790433|NCT00414466|456190189|FG003|Overall Study|Adverse Event|1|||
126790434|NCT00414466|456190186|FG000|Overall Study|Lack of Efficacy|1|||
126790435|NCT00414466|456190187|FG001|Overall Study|Lack of Efficacy|0|||
126790436|NCT00414466|456190188|FG002|Overall Study|Lack of Efficacy|0|||
126790437|NCT00414466|456190189|FG003|Overall Study|Lack of Efficacy|0|||
126790438|NCT00414466|456190186|FG000|Overall Study|Withdrawn by Sponsor|1|||
126790439|NCT00414466|456190187|FG001|Overall Study|Withdrawn by Sponsor|0|||
126790440|NCT00414466|456190188|FG002|Overall Study|Withdrawn by Sponsor|0|||
126790441|NCT00414466|456190189|FG003|Overall Study|Withdrawn by Sponsor|0|||
126790442|NCT01781637|456190195|FG000|Overall Study|Adverse Event|1|||
126790443|NCT01781637|456190196|FG001|Overall Study|Adverse Event|0|||
126790444|NCT01781637|456190195|FG000|Overall Study|Lack of Efficacy|2|||
126790445|NCT01781637|456190196|FG001|Overall Study|Lack of Efficacy|6|||
126790446|NCT01781637|456190195|FG000|Overall Study|Withdrawal by Subject|1|||
126790447|NCT01781637|456190196|FG001|Overall Study|Withdrawal by Subject|0|||
126790448|NCT05628675|456190200|FG000|Overall Study|Lost to Follow-up|2|||
126790449|NCT05628675|456190200|FG000|Overall Study|Withdrawal by Subject|1|||
126790450|NCT01648166|456190204|FG000|Overall Study|inadequate toenail samples|53|||
126790451|NCT01648166|456190205|FG001|Overall Study|inadequate toenail samples|100|||
126790452|NCT00883090|456190206|FG000|Overall Study|Sponsor's decision|1|||
126790453|NCT00883090|456190206|FG000|Overall Study|Withdrawal by Subject|1|||
126790454|NCT01475838|456190209|FG000|Randomized Phase|Randomized but Not Treated|0|||
126790455|NCT01475838|456190210|FG001|Randomized Phase|Randomized but Not Treated|5|||
126790456|NCT01475838|456190209|FG000|Randomized Phase|Adverse Event|6|||
126790457|NCT01475838|456190210|FG001|Randomized Phase|Adverse Event|1|||
126790458|NCT01475838|456190209|FG000|Randomized Phase|Pregnancy|0|||
126790459|NCT01475838|456190210|FG001|Randomized Phase|Pregnancy|1|||
126790460|NCT01475838|456190209|FG000|Randomized Phase|Investigators Discretion|1|||
126790461|NCT01475838|456190210|FG001|Randomized Phase|Investigators Discretion|2|||
126790462|NCT01475838|456190209|FG000|Randomized Phase|Withdrew Consent|10|||
126790463|NCT01475838|456190210|FG001|Randomized Phase|Withdrew Consent|14|||
126790464|NCT01475838|456190209|FG000|Randomized Phase|Lost to Follow-up|3|||
126790465|NCT01475838|456190210|FG001|Randomized Phase|Lost to Follow-up|4|||
126790466|NCT01475838|456190209|FG000|Randomized Phase|Participant Noncompliance|1|||
126790467|NCT01475838|456190210|FG001|Randomized Phase|Participant Noncompliance|5|||
126790468|NCT01475838|456190209|FG000|Randomized Phase|Protocol Violation|9|||
126790469|NCT01475838|456190210|FG001|Randomized Phase|Protocol Violation|4|||
126790470|NCT01475838|456190209|FG000|Extension Phase|Participant Noncompliance|1|||
126790471|NCT01475838|456190210|FG001|Extension Phase|Participant Noncompliance|0|||
126755424|NCT02452034|456054709|FG001|Overall Study|Screen Failure|0|||
126755425|NCT02452034|456054710|FG002|Overall Study|Screen Failure|0|||
126755426|NCT02452034|456054711|FG003|Overall Study|Screen Failure|1|||
126755427|NCT02452034|456054712|FG004|Overall Study|Screen Failure|0|||
126755428|NCT02452034|456054713|FG005|Overall Study|Screen Failure|0|||
126755429|NCT02452034|456054708|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
126755430|NCT02452034|456054709|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
126755431|NCT02452034|456054710|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
126755432|NCT02452034|456054711|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
126755433|NCT02452034|456054712|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
126755434|NCT02452034|456054713|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
126755435|NCT00561795|456054715|FG000|Overall Study|Adverse Event|3|||
126755436|NCT00561795|456054716|FG001|Overall Study|Adverse Event|3|||
126755437|NCT00561795|456054717|FG002|Overall Study|Adverse Event|0|||
126755438|NCT00561795|456054718|FG003|Overall Study|Adverse Event|0|||
126755439|NCT00561795|456054715|FG000|Overall Study|Study Closed/Terminated|0|||
126755440|NCT00561795|456054716|FG001|Overall Study|Study Closed/Terminated|3|||
126755441|NCT00561795|456054717|FG002|Overall Study|Study Closed/Terminated|0|||
126755442|NCT00561795|456054718|FG003|Overall Study|Study Closed/Terminated|0|||
126755443|NCT00561795|456054715|FG000|Overall Study|Physician Decision|1|||
126755444|NCT00561795|456054716|FG001|Overall Study|Physician Decision|0|||
126755445|NCT00561795|456054717|FG002|Overall Study|Physician Decision|0|||
126755446|NCT00561795|456054718|FG003|Overall Study|Physician Decision|0|||
126755447|NCT03672006|456054719|FG000|Overall Study|exclusion criteria met|0|||
126755448|NCT03672006|456054720|FG001|Overall Study|exclusion criteria met|1|||
126755449|NCT04235959|456054722|FG000|Overall Study|Protocol Violation|0|||
126755450|NCT04235959|456054723|FG001|Overall Study|Protocol Violation|1|||
126755451|NCT04235959|456054724|FG002|Overall Study|Protocol Violation|0|||
126755452|NCT04235959|456054722|FG000|Overall Study|Adverse Event|1|||
126755453|NCT04235959|456054723|FG001|Overall Study|Adverse Event|0|||
126755454|NCT04235959|456054724|FG002|Overall Study|Adverse Event|0|||
126755455|NCT00608426|456054725|FG000|Overall Study|Death|32|||
126755456|NCT00608426|456054726|FG001|Overall Study|Death|36|||
126755457|NCT00608426|456054725|FG000|Overall Study|Lost to Follow-up|485|||
126755458|NCT00608426|456054726|FG001|Overall Study|Lost to Follow-up|521|||
126755459|NCT00608426|456054725|FG000|Overall Study|refused, health issues, wrong address|319|||
126755460|NCT00608426|456054726|FG001|Overall Study|refused, health issues, wrong address|348|||
126755461|NCT02630459|456054730|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
126755462|NCT02630459|456054731|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
126755463|NCT02630459|456054732|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
126755464|NCT02630459|456054733|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
126755465|NCT02630459|456054734|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
126755466|NCT02630459|456054735|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
126755467|NCT02630459|456054736|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
126755468|NCT02630459|456054737|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
126755469|NCT02630459|456054730|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126755470|NCT02630459|456054731|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126755471|NCT02630459|456054732|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
126755472|NCT02630459|456054733|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126755473|NCT02630459|456054734|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126755474|NCT02630459|456054735|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126755475|NCT02630459|456054736|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126755476|NCT02630459|456054737|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
126755477|NCT02630459|456054730|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
126755478|NCT02630459|456054731|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
126755479|NCT02630459|456054732|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
126755480|NCT02630459|456054733|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
126755481|NCT02630459|456054734|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
126755482|NCT02630459|456054735|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
126755483|NCT02630459|456054736|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
126755484|NCT02630459|456054737|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
126755485|NCT02630459|456054730|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
126755486|NCT02630459|456054731|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126755487|NCT02630459|456054732|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126755488|NCT02630459|456054733|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126755489|NCT02630459|456054734|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126755490|NCT02630459|456054735|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126755491|NCT02630459|456054736|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126755492|NCT02630459|456054737|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
126755493|NCT02630459|456054730|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
126790472|NCT00048568|456190211|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
126790473|NCT00048568|456190212|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
126790474|NCT00048568|456190213|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
126790475|NCT00048568|456190211|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
126790476|NCT00048568|456190212|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
126790477|NCT00048568|456190213|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
126790478|NCT00048568|456190211|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
126790479|NCT00048568|456190212|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
126790480|NCT00048568|456190213|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
126790481|NCT00048568|456190211|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
126790482|NCT00048568|456190212|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
126790483|NCT00048568|456190213|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
126790484|NCT00048568|456190211|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
126790485|NCT00048568|456190212|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
126790486|NCT00048568|456190213|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
126790487|NCT00048568|456190211|FG000|Double-Blind Period Days 170 to 365|Death|1|||
126790488|NCT00048568|456190212|FG001|Double-Blind Period Days 170 to 365|Death|1|||
126790489|NCT00048568|456190213|FG002|Double-Blind Period Days 170 to 365|Death|0|||
126790490|NCT00048568|456190211|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
126790491|NCT00048568|456190212|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
126790492|NCT00048568|456190213|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
126790493|NCT00048568|456190211|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
126790494|NCT00048568|456190212|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
126790495|NCT00048568|456190213|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
126790496|NCT00048568|456190211|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
126790497|NCT00048568|456190212|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
126790498|NCT00048568|456190213|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
126790499|NCT00048568|456190211|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
126790500|NCT00048568|456190212|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
126790501|NCT00048568|456190213|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
126790502|NCT00048568|456190211|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
126790503|NCT00048568|456190212|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
126790504|NCT00048568|456190213|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
126790505|NCT00048568|456190211|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
126790506|NCT00048568|456190212|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
126790507|NCT00048568|456190213|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
126790508|NCT00048568|456190211|FG000|Open-Label Period|Death|0|||
126790509|NCT00048568|456190212|FG001|Open-Label Period|Death|0|||
126790510|NCT00048568|456190213|FG002|Open-Label Period|Death|13|||
126790511|NCT00048568|456190211|FG000|Open-Label Period|Adverse Event|0|||
126790512|NCT00048568|456190212|FG001|Open-Label Period|Adverse Event|0|||
126790513|NCT00048568|456190213|FG002|Open-Label Period|Adverse Event|49|||
126790514|NCT00048568|456190211|FG000|Open-Label Period|Lack of Efficacy|0|||
126790515|NCT00048568|456190212|FG001|Open-Label Period|Lack of Efficacy|0|||
126790516|NCT00048568|456190213|FG002|Open-Label Period|Lack of Efficacy|32|||
126790517|NCT00048568|456190211|FG000|Open-Label Period|Withdrawal by Subject|0|||
126790518|NCT00048568|456190212|FG001|Open-Label Period|Withdrawal by Subject|0|||
126790519|NCT00048568|456190213|FG002|Open-Label Period|Withdrawal by Subject|26|||
126790520|NCT00048568|456190211|FG000|Open-Label Period|Pregnancy|0|||
126790521|NCT00048568|456190212|FG001|Open-Label Period|Pregnancy|0|||
126790522|NCT00048568|456190213|FG002|Open-Label Period|Pregnancy|5|||
126790523|NCT00048568|456190211|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
126790524|NCT00048568|456190212|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
126790525|NCT00048568|456190213|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
126790526|NCT00048568|456190211|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
126790527|NCT00048568|456190212|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
126790528|NCT00048568|456190213|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
126790529|NCT00048568|456190211|FG000|Open-Label Period|Unknown Reasons|0|||
126790530|NCT00048568|456190212|FG001|Open-Label Period|Unknown Reasons|0|||
126790531|NCT00048568|456190213|FG002|Open-Label Period|Unknown Reasons|25|||
126790532|NCT00048568|456190211|FG000|Open-Label Period|Lost to Follow-up|0|||
126632552|NCT01086384|455613782|FG002|Treatment Period|Study Closed/Terminated|8|||
126790533|NCT00048568|456190212|FG001|Open-Label Period|Lost to Follow-up|0|||
126790534|NCT00048568|456190213|FG002|Open-Label Period|Lost to Follow-up|7|||
126790535|NCT03831048|456190214|FG000|Overall Study|Protocol Violation|9|||
126790536|NCT03831048|456190215|FG001|Overall Study|Protocol Violation|3|||
126790537|NCT03831048|456190214|FG000|Overall Study|Death|4|||
126632553|NCT01086384|455613780|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
126790538|NCT03831048|456190215|FG001|Overall Study|Death|9|||
126790539|NCT03831048|456190214|FG000|Overall Study|Re-transplant|0|||
126790540|NCT03831048|456190215|FG001|Overall Study|Re-transplant|2|||
126790541|NCT03831048|456190214|FG000|Overall Study|Protocol violation and death|1|||
126790542|NCT03831048|456190215|FG001|Overall Study|Protocol violation and death|1|||
126790543|NCT00560235|456190219|FG000|Phase 1|Discontinued|8|||
126790544|NCT00560235|456190220|FG001|Phase 1|Discontinued|0|||
126790545|NCT00560235|456190221|FG002|Phase 1|Discontinued|0|||
126790546|NCT00560235|456190219|FG000|Phase 1B|Discontinued|0|||
126790547|NCT00560235|456190220|FG001|Phase 1B|Discontinued|19|||
126790548|NCT00560235|456190221|FG002|Phase 1B|Discontinued|0|||
126790549|NCT00560235|456190219|FG000|Phase 2|Discontinued|0|||
126790550|NCT00560235|456190220|FG001|Phase 2|Discontinued|0|||
126790551|NCT00560235|456190221|FG002|Phase 2|Discontinued|96|||
126790552|NCT00560235|456190219|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
126790553|NCT00560235|456190220|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
126790554|NCT00560235|456190221|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
126790555|NCT01315249|456190224|FG000|Overall Study|Adverse Event|22|||
126790556|NCT01315249|456190225|FG001|Overall Study|Adverse Event|26|||
126790557|NCT01315249|456190224|FG000|Overall Study|Withdrawal by Subject|11|||
126790558|NCT01315249|456190225|FG001|Overall Study|Withdrawal by Subject|10|||
126790559|NCT01315249|456190224|FG000|Overall Study|Protocol Violation|8|||
126790560|NCT01315249|456190225|FG001|Overall Study|Protocol Violation|5|||
126790561|NCT01315249|456190224|FG000|Overall Study|Abnormal test results|1|||
126790562|NCT01315249|456190225|FG001|Overall Study|Abnormal test results|2|||
126790563|NCT01315249|456190224|FG000|Overall Study|Administrative problems|1|||
126790564|NCT01315249|456190225|FG001|Overall Study|Administrative problems|0|||
126790565|NCT01315249|456190224|FG000|Overall Study|inability to use device|1|||
126790566|NCT01315249|456190225|FG001|Overall Study|inability to use device|0|||
126790567|NCT01315249|456190224|FG000|Overall Study|Lack of Efficacy|0|||
126790568|NCT01315249|456190225|FG001|Overall Study|Lack of Efficacy|1|||
126790569|NCT01315249|456190224|FG000|Overall Study|Lost to Follow-up|0|||
126790570|NCT01315249|456190225|FG001|Overall Study|Lost to Follow-up|2|||
126790571|NCT01315249|456190224|FG000|Overall Study|Death|0|||
126790572|NCT01315249|456190225|FG001|Overall Study|Death|1|||
126790573|NCT03227445|456190230|FG000|Period 1 (28 Days)|Adverse Event|1|||
126790574|NCT03227445|456190231|FG001|Period 1 (28 Days)|Adverse Event|2|||
126790575|NCT03227445|456190232|FG002|Period 1 (28 Days)|Adverse Event|0|||
126790576|NCT03227445|456190233|FG003|Period 1 (28 Days)|Adverse Event|1|||
126790577|NCT03227445|456190230|FG000|Period 1 (28 Days)|Protocol Violation|1|||
126790578|NCT03227445|456190231|FG001|Period 1 (28 Days)|Protocol Violation|0|||
126790579|NCT03227445|456190232|FG002|Period 1 (28 Days)|Protocol Violation|0|||
126790580|NCT03227445|456190233|FG003|Period 1 (28 Days)|Protocol Violation|0|||
126790581|NCT03227445|456190230|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
126790582|NCT03227445|456190231|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
126790583|NCT03227445|456190232|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
126790584|NCT03227445|456190233|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
126790585|NCT03227445|456190230|FG000|Period 2 (28 Days)|Adverse Event|1|||
126790586|NCT03227445|456190231|FG001|Period 2 (28 Days)|Adverse Event|0|||
126790587|NCT03227445|456190232|FG002|Period 2 (28 Days)|Adverse Event|2|||
126790588|NCT03227445|456190233|FG003|Period 2 (28 Days)|Adverse Event|1|||
126790589|NCT03227445|456190230|FG000|Period 2 (28 Days)|Protocol Violation|0|||
126790590|NCT03227445|456190231|FG001|Period 2 (28 Days)|Protocol Violation|0|||
126790591|NCT03227445|456190232|FG002|Period 2 (28 Days)|Protocol Violation|0|||
126790592|NCT03227445|456190233|FG003|Period 2 (28 Days)|Protocol Violation|1|||
126790593|NCT03227445|456190230|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
126790594|NCT03227445|456190231|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
126790595|NCT03227445|456190232|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
126790596|NCT03227445|456190233|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
126790597|NCT00755196|456190235|FG000|Overall Study|Lost to Follow-up|1|||
126790598|NCT00755196|456190235|FG000|Overall Study|Lack of Efficiency|1|||
126790599|NCT01703832|456190236|FG000|Overall Study|Withdrawal by Subject|1|||
126790600|NCT01703832|456190237|FG001|Overall Study|Withdrawal by Subject|0|||
126790601|NCT01991470|456190238|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
126790602|NCT01991470|456190238|FG000|Enlite 1 Period|Adverse Event|1|||
126790603|NCT01991470|456190238|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
126790604|NCT01991470|456190238|FG000|Enlite 3 Period|Lost to Follow-up|1|||
126790605|NCT01991470|456190238|FG000|Enlite 3 Period|Physician Decision|2|||
126790606|NCT01991470|456190238|FG000|Enlite 3 Period|Physician Decision|8|||
126790607|NCT01991470|456190238|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
126790608|NCT00243932|456190255|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
126790609|NCT00243932|456190256|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
126790610|NCT00243932|456190257|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
126790611|NCT00880568|456190258|FG000|Overall Study|Disease progression|3|||
126790612|NCT00880568|456190259|FG001|Overall Study|Disease progression|3|||
126790613|NCT00880568|456190260|FG002|Overall Study|Disease progression|3|||
126790614|NCT00880568|456190261|FG003|Overall Study|Disease progression|1|||
126790615|NCT00880568|456190262|FG004|Overall Study|Disease progression|3|||
126790616|NCT00880568|456190263|FG005|Overall Study|Disease progression|3|||
126790617|NCT00880568|456190264|FG006|Overall Study|Disease progression|5|||
126790618|NCT00880568|456190265|FG007|Overall Study|Disease progression|0|||
126790619|NCT00880568|456190266|FG008|Overall Study|Disease progression|3|||
126790620|NCT00880568|456190258|FG000|Overall Study|Adverse Event|0|||
126790621|NCT00880568|456190259|FG001|Overall Study|Adverse Event|0|||
126790622|NCT00880568|456190260|FG002|Overall Study|Adverse Event|0|||
126790623|NCT00880568|456190261|FG003|Overall Study|Adverse Event|0|||
126790624|NCT00880568|456190262|FG004|Overall Study|Adverse Event|0|||
126790625|NCT00880568|456190263|FG005|Overall Study|Adverse Event|0|||
126790626|NCT00880568|456190264|FG006|Overall Study|Adverse Event|1|||
126790627|NCT00880568|456190265|FG007|Overall Study|Adverse Event|1|||
126790628|NCT00880568|456190266|FG008|Overall Study|Adverse Event|0|||
126790629|NCT00880568|456190258|FG000|Overall Study|Withdrawal by Subject|0|||
126790630|NCT00880568|456190259|FG001|Overall Study|Withdrawal by Subject|0|||
126790631|NCT00880568|456190260|FG002|Overall Study|Withdrawal by Subject|0|||
126790632|NCT00880568|456190261|FG003|Overall Study|Withdrawal by Subject|0|||
126790633|NCT00880568|456190262|FG004|Overall Study|Withdrawal by Subject|0|||
126790634|NCT00880568|456190263|FG005|Overall Study|Withdrawal by Subject|0|||
126790635|NCT00880568|456190264|FG006|Overall Study|Withdrawal by Subject|0|||
126790636|NCT00880568|456190265|FG007|Overall Study|Withdrawal by Subject|1|||
126790637|NCT00880568|456190266|FG008|Overall Study|Withdrawal by Subject|0|||
126790638|NCT00437658|456190267|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
126790639|NCT00437658|456190268|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
126790640|NCT00437658|456190269|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
126790641|NCT00437658|456190267|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
126790642|NCT00437658|456190268|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
126790643|NCT00437658|456190269|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
126790644|NCT00437658|456190267|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
126790645|NCT00437658|456190268|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
126790646|NCT00437658|456190269|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
126790647|NCT00437658|456190267|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
126790648|NCT00437658|456190268|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
126790649|NCT00437658|456190269|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
126790650|NCT00437658|456190267|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
126790651|NCT00437658|456190268|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
126790652|NCT00437658|456190269|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
126790653|NCT00437658|456190267|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
126790654|NCT00437658|456190268|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
126790655|NCT00437658|456190269|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
126790656|NCT00437658|456190267|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
126790657|NCT00437658|456190268|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
126790658|NCT00437658|456190269|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
126790659|NCT00437658|456190267|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
126790660|NCT00437658|456190268|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
126790661|NCT00437658|456190269|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
126790662|NCT00437658|456190267|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
126790663|NCT00437658|456190268|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
126790664|NCT00437658|456190269|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
126790665|NCT00437658|456190267|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
126790666|NCT00437658|456190268|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
126790667|NCT00437658|456190269|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
126790668|NCT00437658|456190267|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
126790669|NCT00437658|456190268|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
126790670|NCT00437658|456190269|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
126790671|NCT00437658|456190267|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
126790672|NCT00437658|456190268|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
126790673|NCT00437658|456190269|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
126790674|NCT04407806|456190270|FG000|Overall Study|Withdrawal by Subject|1|||
126790675|NCT04407806|456190271|FG001|Overall Study|Withdrawal by Subject|2|||
126790676|NCT02731157|456190272|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
126790677|NCT01856309|456190276|FG000|Overall Study|Death|4|||
126790678|NCT01856309|456190277|FG001|Overall Study|Death|6|||
126790679|NCT01856309|456190278|FG002|Overall Study|Death|11|||
126790680|NCT01856309|456190279|FG003|Overall Study|Death|6|||
126790681|NCT01856309|456190276|FG000|Overall Study|Lost to Follow-up|6|||
126790682|NCT01856309|456190277|FG001|Overall Study|Lost to Follow-up|2|||
126790683|NCT01856309|456190278|FG002|Overall Study|Lost to Follow-up|4|||
126790684|NCT01856309|456190279|FG003|Overall Study|Lost to Follow-up|8|||
126790685|NCT01856309|456190276|FG000|Overall Study|Withdrawal by Subject|11|||
126790686|NCT01856309|456190277|FG001|Overall Study|Withdrawal by Subject|13|||
126790687|NCT01856309|456190278|FG002|Overall Study|Withdrawal by Subject|28|||
126790688|NCT01856309|456190279|FG003|Overall Study|Withdrawal by Subject|26|||
126790689|NCT01856309|456190276|FG000|Overall Study|Other|227|||
126790690|NCT01856309|456190277|FG001|Overall Study|Other|225|||
126790691|NCT01856309|456190278|FG002|Overall Study|Other|447|||
126790692|NCT01856309|456190279|FG003|Overall Study|Other|469|||
126790693|NCT01856309|456190276|FG000|Overall Study|Lack of Efficacy|14|||
126790694|NCT01856309|456190277|FG001|Overall Study|Lack of Efficacy|9|||
126790695|NCT01856309|456190278|FG002|Overall Study|Lack of Efficacy|40|||
126790696|NCT01856309|456190279|FG003|Overall Study|Lack of Efficacy|25|||
126790697|NCT01856309|456190276|FG000|Overall Study|Adverse Event|31|||
126790698|NCT01856309|456190277|FG001|Overall Study|Adverse Event|31|||
126790699|NCT01856309|456190278|FG002|Overall Study|Adverse Event|55|||
126790700|NCT01856309|456190279|FG003|Overall Study|Adverse Event|65|||
126790701|NCT01856309|456190276|FG000|Overall Study|Pregnancy|0|||
126790702|NCT01856309|456190277|FG001|Overall Study|Pregnancy|0|||
126790703|NCT01856309|456190278|FG002|Overall Study|Pregnancy|0|||
126790704|NCT01856309|456190279|FG003|Overall Study|Pregnancy|1|||
126790705|NCT01856309|456190276|FG000|Overall Study|Physician Decision|6|||
126790706|NCT01856309|456190277|FG001|Overall Study|Physician Decision|1|||
126790707|NCT01856309|456190278|FG002|Overall Study|Physician Decision|6|||
126790708|NCT01856309|456190279|FG003|Overall Study|Physician Decision|8|||
126790709|NCT01856309|456190276|FG000|Overall Study|Noncompliance With Study Drug|0|||
126790710|NCT01856309|456190277|FG001|Overall Study|Noncompliance With Study Drug|1|||
126790711|NCT01856309|456190278|FG002|Overall Study|Noncompliance With Study Drug|4|||
126790712|NCT01856309|456190279|FG003|Overall Study|Noncompliance With Study Drug|1|||
126790713|NCT01449630|456190281|FG000|Period 1|Physician Decision|1|||
126790714|NCT01449630|456190282|FG001|Period 1|Physician Decision|0|||
126790715|NCT01449630|456190283|FG002|Period 1|Physician Decision|0|||
126790716|NCT01449630|456190284|FG003|Period 1|Physician Decision|1|||
126790717|NCT01449630|456190285|FG004|Period 1|Physician Decision|0|||
126790718|NCT01449630|456190286|FG005|Period 1|Physician Decision|0|||
126790719|NCT01449630|456190287|FG006|Period 1|Physician Decision|0|||
126790720|NCT01449630|456190288|FG007|Period 1|Physician Decision|0|||
126790721|NCT01449630|456190289|FG008|Period 1|Physician Decision|0|||
126790722|NCT01449630|456190281|FG000|Period 1|Sponsor Decision|0|||
126790723|NCT01449630|456190282|FG001|Period 1|Sponsor Decision|0|||
126790724|NCT01449630|456190283|FG002|Period 1|Sponsor Decision|0|||
126790725|NCT01449630|456190284|FG003|Period 1|Sponsor Decision|0|||
126790726|NCT01449630|456190285|FG004|Period 1|Sponsor Decision|0|||
126790727|NCT01449630|456190286|FG005|Period 1|Sponsor Decision|1|||
126790728|NCT01449630|456190287|FG006|Period 1|Sponsor Decision|0|||
126790729|NCT01449630|456190288|FG007|Period 1|Sponsor Decision|0|||
126790730|NCT01449630|456190289|FG008|Period 1|Sponsor Decision|0|||
126790731|NCT01449630|456190281|FG000|Period 2|Sponsor Decision|0|||
126790732|NCT01449630|456190282|FG001|Period 2|Sponsor Decision|0|||
126790733|NCT01449630|456190283|FG002|Period 2|Sponsor Decision|0|||
126790734|NCT01449630|456190284|FG003|Period 2|Sponsor Decision|0|||
126790735|NCT01449630|456190285|FG004|Period 2|Sponsor Decision|0|||
126790736|NCT01449630|456190286|FG005|Period 2|Sponsor Decision|0|||
126790737|NCT01449630|456190287|FG006|Period 2|Sponsor Decision|1|||
126790738|NCT01449630|456190288|FG007|Period 2|Sponsor Decision|0|||
126790739|NCT01449630|456190289|FG008|Period 2|Sponsor Decision|0|||
126790740|NCT01735630|456190294|FG000|Overall Study|Adverse Event|8|||
126790741|NCT01735630|456190295|FG001|Overall Study|Adverse Event|7|||
126790742|NCT01735630|456190294|FG000|Overall Study|Lost to Follow-up|1|||
126790743|NCT01735630|456190295|FG001|Overall Study|Lost to Follow-up|0|||
126790744|NCT01735630|456190294|FG000|Overall Study|Physician Decision|0|||
126790745|NCT01735630|456190295|FG001|Overall Study|Physician Decision|1|||
126790746|NCT01735630|456190294|FG000|Overall Study|Sponsor Decision|2|||
126790747|NCT01735630|456190295|FG001|Overall Study|Sponsor Decision|1|||
126790748|NCT01735630|456190294|FG000|Overall Study|Withdrawal by Subject|7|||
126790749|NCT01735630|456190295|FG001|Overall Study|Withdrawal by Subject|9|||
126790750|NCT03099538|456190296|FG000|Overall Study|Lack of Efficacy|3|||
126790751|NCT02930005|456190307|FG000|Overall Study|Lost to Follow-up|1|||
126790752|NCT02930005|456190308|FG001|Overall Study|Lost to Follow-up|5|||
126790753|NCT00822926|456190310|FG000|Second Injection Visit|Lost to Follow-up|1|||
126790754|NCT00822926|456190311|FG001|Second Injection Visit|Lost to Follow-up|0|||
126790755|NCT00822926|456190310|FG000|Second Injection Visit|Withdrawal by Subject|0|||
126790756|NCT00822926|456190311|FG001|Second Injection Visit|Withdrawal by Subject|1|||
126790757|NCT02534493|456190312|FG000|Overall Study|Lost to Follow-up|1|||
126790758|NCT02534493|456190312|FG000|Overall Study|Withdrawal by Subject|1|||
126790759|NCT01469546|456190315|FG000|Received 5 mg Dose|Adverse Event|13|||
126790760|NCT01469546|456190315|FG000|Received 5 mg Dose|Death|2|||
126790761|NCT01469546|456190315|FG000|Received 5 mg Dose|Protocol Violation|2|||
126790762|NCT01469546|456190315|FG000|Received 5 mg Dose|Progressive Disease|3|||
126790763|NCT01469546|456190315|FG000|Received 5 mg Dose|Physician Decision|3|||
126790764|NCT02079532|456190318|FG000|Overall Study|Adverse Event|7|||
126790765|NCT02079532|456190318|FG000|Overall Study|Additional or changed therapy|2|||
126790766|NCT02079532|456190318|FG000|Overall Study|Lack of Efficacy|9|||
126790767|NCT02079532|456190318|FG000|Overall Study|Protocol Violation|3|||
126790768|NCT02079532|456190318|FG000|Overall Study|Withdrawal by Subject|1|||
126790769|NCT02079532|456190318|FG000|Overall Study|Administrative problems|1|||
126790770|NCT02079532|456190318|FG000|Overall Study|Inclusion into ReFIRST|3|||
126790771|NCT02079532|456190318|FG000|Overall Study|Other|3|||
126790772|NCT02158936|456190319|FG000|Overall Study|Study closed/ terminated|57|||
126790773|NCT02158936|456190320|FG001|Overall Study|Study closed/ terminated|77|||
126790774|NCT02158936|456190319|FG000|Overall Study|Azacitidine tx discontinued|53|||
126790775|NCT02158936|456190320|FG001|Overall Study|Azacitidine tx discontinued|46|||
126790776|NCT02158936|456190319|FG000|Overall Study|Adverse Event|39|||
126790777|NCT02158936|456190320|FG001|Overall Study|Adverse Event|24|||
126790778|NCT02158936|456190319|FG000|Overall Study|Withdrawal by Subject|15|||
126790779|NCT02158936|456190320|FG001|Overall Study|Withdrawal by Subject|16|||
126790780|NCT02158936|456190319|FG000|Overall Study|Physician Decision|15|||
126790781|NCT02158936|456190320|FG001|Overall Study|Physician Decision|13|||
126790782|NCT02158936|456190319|FG000|Overall Study|Lost to Follow-up|0|||
126790783|NCT02158936|456190320|FG001|Overall Study|Lost to Follow-up|1|||
126790784|NCT01432171|456190321|FG000|Overall Study|Death|1|||
126790785|NCT01432171|456190322|FG001|Overall Study|Death|2|||
126790786|NCT01432171|456190321|FG000|Overall Study|Lost to Follow-up|6|||
126790787|NCT01432171|456190322|FG001|Overall Study|Lost to Follow-up|5|||
126790788|NCT01432171|456190321|FG000|Overall Study|Withdrawal by Subject|3|||
126790789|NCT01432171|456190322|FG001|Overall Study|Withdrawal by Subject|1|||
126790790|NCT01432171|456190321|FG000|Overall Study|Noncompliance|2|||
126790791|NCT01432171|456190322|FG001|Overall Study|Noncompliance|3|||
126790792|NCT01432171|456190321|FG000|Overall Study|Insurance denial trial coverage|1|||
126790793|NCT01432171|456190322|FG001|Overall Study|Insurance denial trial coverage|0|||
126790794|NCT01432171|456190321|FG000|Overall Study|Patient moved to palliative care|1|||
126790795|NCT01432171|456190322|FG001|Overall Study|Patient moved to palliative care|0|||
126790796|NCT01085045|456192070|FG000|Part A|Withdrawal by Subject|4|||
126790797|NCT01085045|456192070|FG000|Part A|Adverse Event|6|||
126790798|NCT01085045|456192070|FG000|Part A|Protocol Violation|1|||
126790799|NCT01085045|456192070|FG000|Part A|Protocol Specified Criteria|7|||
126790800|NCT01085045|456192070|FG000|Part B|Withdrawal by Subject|2|||
126790801|NCT01085045|456192070|FG000|Part B|Protocol Specified Criteria|6|||
126790802|NCT01085045|456192070|FG000|Part B|Lost to Follow-up|1|||
126790803|NCT01085045|456192070|FG000|Part B|Adverse Event|6|||
126790804|NCT02127281|456192075|FG000|Overall Study|Lost to Follow-up|1|||
126790805|NCT02127281|456192076|FG001|Overall Study|Lost to Follow-up|0|||
126790806|NCT00416520|456192077|FG000|Open-label Period|Adverse Event|28|||
126790807|NCT00416520|456192078|FG001|Open-label Period|Adverse Event|10|||
126790808|NCT00416520|456192079|FG002|Open-label Period|Adverse Event|0|||
126790809|NCT00416520|456192080|FG003|Open-label Period|Adverse Event|0|||
126790810|NCT00416520|456192077|FG000|Open-label Period|Death|2|||
126790811|NCT00416520|456192078|FG001|Open-label Period|Death|1|||
126790812|NCT00416520|456192079|FG002|Open-label Period|Death|0|||
126790813|NCT00416520|456192080|FG003|Open-label Period|Death|0|||
126790814|NCT00416520|456192077|FG000|Open-label Period|Lack of Efficacy|8|||
126790815|NCT00416520|456192078|FG001|Open-label Period|Lack of Efficacy|1|||
126790816|NCT00416520|456192079|FG002|Open-label Period|Lack of Efficacy|0|||
126790817|NCT00416520|456192080|FG003|Open-label Period|Lack of Efficacy|0|||
126790818|NCT00416520|456192077|FG000|Open-label Period|Protocol Violation|3|||
126790819|NCT00416520|456192078|FG001|Open-label Period|Protocol Violation|3|||
126790820|NCT00416520|456192079|FG002|Open-label Period|Protocol Violation|0|||
126790821|NCT00416520|456192080|FG003|Open-label Period|Protocol Violation|0|||
126790822|NCT00416520|456192077|FG000|Open-label Period|Withdrawal by Subject|16|||
126790823|NCT00416520|456192078|FG001|Open-label Period|Withdrawal by Subject|5|||
126790824|NCT00416520|456192079|FG002|Open-label Period|Withdrawal by Subject|0|||
126790825|NCT00416520|456192080|FG003|Open-label Period|Withdrawal by Subject|0|||
126790826|NCT00416520|456192077|FG000|Open-label Period|Other Reasons|3|||
126790827|NCT00416520|456192078|FG001|Open-label Period|Other Reasons|12|||
126790828|NCT00416520|456192079|FG002|Open-label Period|Other Reasons|0|||
126790829|NCT00416520|456192080|FG003|Open-label Period|Other Reasons|0|||
126790830|NCT00416520|456192077|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
126790831|NCT00416520|456192078|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
126790832|NCT00416520|456192079|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
126790833|NCT00416520|456192080|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
126790834|NCT00416520|456192077|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
126790835|NCT00416520|456192078|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
126790836|NCT00416520|456192079|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
126790837|NCT00416520|456192080|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
126790838|NCT00416520|456192077|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
126632554|NCT01086384|455613781|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
126632555|NCT01086384|455613782|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
126632556|NCT01086384|455613780|FG000|Treatment Period|Received Treatment in Error|0|||
126790839|NCT00416520|456192078|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
126790840|NCT00416520|456192079|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
126790841|NCT00416520|456192080|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
126790842|NCT01101022|456192092|FG000|Overall Study|Adverse Event|6|||
126790843|NCT01101022|456192093|FG001|Overall Study|Adverse Event|2|||
126790844|NCT01101022|456192092|FG000|Overall Study|Protocol Violation|4|||
126790845|NCT01101022|456192093|FG001|Overall Study|Protocol Violation|3|||
126790846|NCT01101022|456192092|FG000|Overall Study|Withdrawal by Subject|3|||
126790847|NCT01101022|456192093|FG001|Overall Study|Withdrawal by Subject|8|||
126790848|NCT01101022|456192092|FG000|Overall Study|Lost to Follow-up|1|||
126790849|NCT01101022|456192093|FG001|Overall Study|Lost to Follow-up|4|||
126790850|NCT01101022|456192092|FG000|Overall Study|Lack of Efficacy|0|||
126790851|NCT01101022|456192093|FG001|Overall Study|Lack of Efficacy|7|||
126790852|NCT01101022|456192092|FG000|Overall Study|Sponsor decision|1|||
126790853|NCT01101022|456192093|FG001|Overall Study|Sponsor decision|1|||
126790854|NCT01101022|456192092|FG000|Overall Study|Non-compliance|1|||
126790855|NCT01101022|456192093|FG001|Overall Study|Non-compliance|0|||
126790856|NCT01101022|456192092|FG000|Overall Study|Work schedule|1|||
126790857|NCT01101022|456192093|FG001|Overall Study|Work schedule|1|||
126790858|NCT01101022|456192092|FG000|Overall Study|Vacation|0|||
126790859|NCT01101022|456192093|FG001|Overall Study|Vacation|1|||
126790860|NCT01519661|456192094|FG000|Overall Study|Protocol deviation|6|||
126790861|NCT01519661|456192094|FG000|Overall Study|Lost to Follow-up|3|||
126790862|NCT01519661|456192094|FG000|Overall Study|Withdrawal by Subject|17|||
126790863|NCT01519661|456192094|FG000|Overall Study|Lack of Efficacy|6|||
126790864|NCT01519661|456192094|FG000|Overall Study|Adverse Event|29|||
126790865|NCT01139047|456192095|FG000|Overall Study|Withdrawal by Subject|1|||
126790866|NCT01941095|456192096|FG000|Overall Study|Insufficient therapeutic response|13|||
126790867|NCT01941095|456192096|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
126790868|NCT01941095|456192096|FG000|Overall Study|Adverse Event|11|||
126790869|NCT01941095|456192096|FG000|Overall Study|Physician Decision|3|||
126790870|NCT01941095|456192096|FG000|Overall Study|Withdrawal by Subject|17|||
126790871|NCT01941095|456192096|FG000|Overall Study|Lost to Follow-up|10|||
126790872|NCT02918877|456192099|FG000|Overall Study|Withdrawal by Subject|2|||
126790873|NCT02918877|456192100|FG001|Overall Study|Withdrawal by Subject|2|||
126790874|NCT02918877|456192099|FG000|Overall Study|Surgery cancelled|1|||
126790875|NCT02918877|456192100|FG001|Overall Study|Surgery cancelled|0|||
126790876|NCT02918877|456192099|FG000|Overall Study|Physician Decision|1|||
126790877|NCT02918877|456192100|FG001|Overall Study|Physician Decision|0|||
126790878|NCT02918877|456192099|FG000|Overall Study|Received intraoperative steroids|1|||
126790879|NCT02918877|456192100|FG001|Overall Study|Received intraoperative steroids|0|||
126790880|NCT02918877|456192099|FG000|Overall Study|Unable to obtain lab samples|1|||
126790881|NCT02918877|456192100|FG001|Overall Study|Unable to obtain lab samples|0|||
126790882|NCT02918877|456192099|FG000|Overall Study|Unsafe to perform BAL|0|||
126790883|NCT02918877|456192100|FG001|Overall Study|Unsafe to perform BAL|1|||
126790884|NCT05818137|456192101|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
126790885|NCT05818137|456192101|FG000|Extension Treatment Period|Ongoing participants|44|||
126790886|NCT02532764|456192104|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126790887|NCT02532764|456192105|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126790888|NCT02532764|456192106|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126790889|NCT02532764|456192107|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126790890|NCT02532764|456192108|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126790891|NCT02532764|456192109|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126790892|NCT02532764|456192110|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
126790893|NCT02532764|456192111|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
126790894|NCT02532764|456192112|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
126790895|NCT02532764|456192113|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
126790896|NCT03527745|456192114|FG000|Overall Study|Lost to Follow-up|3|||
126790897|NCT03527745|456192115|FG001|Overall Study|Lost to Follow-up|6|||
126790898|NCT03527745|456192116|FG002|Overall Study|Lost to Follow-up|7|||
126790899|NCT03527745|456192117|FG003|Overall Study|Lost to Follow-up|9|||
126790900|NCT03527745|456192118|FG004|Overall Study|Lost to Follow-up|0|||
126790901|NCT03527745|456192119|FG005|Overall Study|Lost to Follow-up|2|||
126790902|NCT03527745|456192120|FG006|Overall Study|Lost to Follow-up|3|||
126790903|NCT03527745|456192121|FG007|Overall Study|Lost to Follow-up|2|||
126790904|NCT03527745|456192122|FG008|Overall Study|Lost to Follow-up|3|||
126790905|NCT03527745|456192123|FG009|Overall Study|Lost to Follow-up|2|||
126790906|NCT03527745|456192124|FG010|Overall Study|Lost to Follow-up|1|||
126790907|NCT03527745|456192125|FG011|Overall Study|Lost to Follow-up|1|||
126790908|NCT03527745|456192126|FG012|Overall Study|Lost to Follow-up|0|||
126790909|NCT03527745|456192127|FG013|Overall Study|Lost to Follow-up|0|||
126790910|NCT03527745|456192128|FG014|Overall Study|Lost to Follow-up|0|||
126790911|NCT03527745|456192129|FG015|Overall Study|Lost to Follow-up|0|||
126790912|NCT03527745|456192130|FG016|Overall Study|Lost to Follow-up|1|||
126790913|NCT03527745|456192131|FG017|Overall Study|Lost to Follow-up|0|||
126790914|NCT03527745|456192132|FG018|Overall Study|Lost to Follow-up|0|||
126790915|NCT03527745|456192133|FG019|Overall Study|Lost to Follow-up|1|||
126790916|NCT03527745|456192134|FG020|Overall Study|Lost to Follow-up|1|||
126790917|NCT03527745|456192135|FG021|Overall Study|Lost to Follow-up|5|||
126790918|NCT03527745|456192136|FG022|Overall Study|Lost to Follow-up|6|||
126790919|NCT03527745|456192137|FG023|Overall Study|Lost to Follow-up|8|||
126790920|NCT03527745|456192138|FG024|Overall Study|Lost to Follow-up|1|||
126790921|NCT03527745|456192139|FG025|Overall Study|Lost to Follow-up|3|||
126790922|NCT01717976|456192140|FG000|Overall Study|Protocol Violation|0|||
126790923|NCT01717976|456192141|FG001|Overall Study|Protocol Violation|1|||
126790924|NCT01604850|456192142|FG000|Overall Study|Enrolled but never treated|0|||
126790925|NCT01604850|456192143|FG001|Overall Study|Enrolled but never treated|1|||
126790926|NCT01604850|456192142|FG000|Overall Study|Efficacy Failure|50|||
126790927|NCT01604850|456192143|FG001|Overall Study|Efficacy Failure|29|||
126790928|NCT01604850|456192142|FG000|Overall Study|Lost to Follow-up|1|||
126790929|NCT01604850|456192143|FG001|Overall Study|Lost to Follow-up|0|||
126790930|NCT01604850|456192142|FG000|Overall Study|Subject withdrew consent|1|||
126790931|NCT01604850|456192143|FG001|Overall Study|Subject withdrew consent|0|||
126790932|NCT00051025|456192151|FG000|Overall Study|Progressive Disease|1|||
126790933|NCT00051025|456192152|FG001|Overall Study|Progressive Disease|1|||
126790934|NCT00051025|456192151|FG000|Overall Study|Adverse Event|1|||
126790935|NCT00051025|456192152|FG001|Overall Study|Adverse Event|1|||
126790936|NCT00051025|456192151|FG000|Overall Study|Withdrawal by Subject|0|||
126790937|NCT00051025|456192152|FG001|Overall Study|Withdrawal by Subject|1|||
126790938|NCT00051025|456192151|FG000|Overall Study|Death|0|||
126790939|NCT00051025|456192152|FG001|Overall Study|Death|1|||
126790940|NCT00274937|456192153|FG000|Overall Study|Physician Decision|10|||
126790941|NCT00274937|456192153|FG000|Overall Study|Withdrawal by Subject|6|||
126790942|NCT00274937|456192153|FG000|Overall Study|Progressive Disease|4|||
126790943|NCT02189941|456192154|FG000|Overall Study|Non-compliance|0|||
126790944|NCT02189941|456192155|FG001|Overall Study|Non-compliance|0|||
126790945|NCT02189941|456192156|FG002|Overall Study|Non-compliance|1|||
126790946|NCT01471093|456192158|FG000|Overall Study|Adverse Event|1|||
126790947|NCT01471093|456192159|FG001|Overall Study|Adverse Event|0|||
126790948|NCT01471093|456192160|FG002|Overall Study|Adverse Event|0|||
126790949|NCT01471093|456192161|FG003|Overall Study|Adverse Event|0|||
126790950|NCT02475954|456192162|FG000|Overall Study|Withdrawal by Subject|2|||
126790951|NCT02475954|456192163|FG001|Overall Study|Withdrawal by Subject|2|||
126790952|NCT02475954|456192162|FG000|Overall Study|Lost to Follow-up|11|||
126790953|NCT02475954|456192163|FG001|Overall Study|Lost to Follow-up|9|||
126790954|NCT02475954|456192162|FG000|Overall Study|Death|1|||
126790955|NCT02475954|456192163|FG001|Overall Study|Death|1|||
126790956|NCT02932878|456192164|FG000|Overall Study|Due to Lab Results|2|||
126790957|NCT02932878|456192165|FG001|Overall Study|Due to Lab Results|1|||
126790958|NCT01918397|456192168|FG000|Overall Study|Never started treatment|2|||
126790959|NCT01918397|456192169|FG001|Overall Study|Never started treatment|1|||
126790960|NCT01918397|456192170|FG002|Overall Study|Never started treatment|0|||
126790961|NCT01918397|456192171|FG003|Overall Study|Never started treatment|0|||
126790962|NCT01918397|456192168|FG000|Overall Study|Adverse Event|1|||
126790963|NCT01918397|456192169|FG001|Overall Study|Adverse Event|1|||
126790964|NCT01918397|456192170|FG002|Overall Study|Adverse Event|1|||
126790965|NCT01918397|456192171|FG003|Overall Study|Adverse Event|0|||
126790966|NCT01918397|456192168|FG000|Overall Study|Lack of compliance|2|||
126790967|NCT01918397|456192169|FG001|Overall Study|Lack of compliance|2|||
126790968|NCT01918397|456192170|FG002|Overall Study|Lack of compliance|3|||
126790969|NCT01918397|456192171|FG003|Overall Study|Lack of compliance|0|||
126790970|NCT01918397|456192168|FG000|Overall Study|Pregnancy|0|||
126790971|NCT01918397|456192169|FG001|Overall Study|Pregnancy|1|||
126790972|NCT01918397|456192170|FG002|Overall Study|Pregnancy|0|||
126790973|NCT01918397|456192171|FG003|Overall Study|Pregnancy|0|||
126790974|NCT01918397|456192168|FG000|Overall Study|Rifampin susceptible|0|||
126790975|NCT01918397|456192169|FG001|Overall Study|Rifampin susceptible|0|||
126790976|NCT01918397|456192170|FG002|Overall Study|Rifampin susceptible|0|||
126790977|NCT01918397|456192171|FG003|Overall Study|Rifampin susceptible|2|||
126790978|NCT01918397|456192168|FG000|Overall Study|Treatment failure|0|||
126790979|NCT01918397|456192169|FG001|Overall Study|Treatment failure|0|||
126790980|NCT01918397|456192170|FG002|Overall Study|Treatment failure|0|||
126790981|NCT01918397|456192171|FG003|Overall Study|Treatment failure|1|||
126790982|NCT01918397|456192168|FG000|Overall Study|Withdrawal by Subject|3|||
126790983|NCT01918397|456192169|FG001|Overall Study|Withdrawal by Subject|2|||
126790984|NCT01918397|456192170|FG002|Overall Study|Withdrawal by Subject|1|||
126790985|NCT01918397|456192171|FG003|Overall Study|Withdrawal by Subject|1|||
126790986|NCT01918397|456192168|FG000|Overall Study|XDR at baseline|0|||
126790987|NCT01918397|456192169|FG001|Overall Study|XDR at baseline|0|||
126790988|NCT01918397|456192170|FG002|Overall Study|XDR at baseline|1|||
126790989|NCT01918397|456192171|FG003|Overall Study|XDR at baseline|0|||
126790990|NCT01918397|456192168|FG000|Overall Study|Lost to Follow-up|2|||
126790991|NCT01918397|456192169|FG001|Overall Study|Lost to Follow-up|1|||
126790992|NCT01918397|456192170|FG002|Overall Study|Lost to Follow-up|1|||
126790993|NCT01918397|456192171|FG003|Overall Study|Lost to Follow-up|1|||
126790994|NCT01918397|456192168|FG000|Overall Study|Increased QTc|1|||
126790995|NCT01918397|456192169|FG001|Overall Study|Increased QTc|0|||
126790996|NCT01918397|456192170|FG002|Overall Study|Increased QTc|0|||
126790997|NCT01918397|456192171|FG003|Overall Study|Increased QTc|1|||
126790998|NCT01918397|456192168|FG000|Overall Study|Death|0|||
126790999|NCT01918397|456192169|FG001|Overall Study|Death|0|||
126791000|NCT01918397|456192170|FG002|Overall Study|Death|1|||
126791001|NCT01918397|456192171|FG003|Overall Study|Death|0|||
126791002|NCT01918397|456192168|FG000|Overall Study|Involved in another investigative trial|0|||
126791003|NCT01918397|456192169|FG001|Overall Study|Involved in another investigative trial|0|||
126791004|NCT01918397|456192170|FG002|Overall Study|Involved in another investigative trial|0|||
126791005|NCT01918397|456192171|FG003|Overall Study|Involved in another investigative trial|1|||
126791006|NCT00864097|456192172|FG000|Overall Study|Death|0|||
126791007|NCT00864097|456192173|FG001|Overall Study|Death|1|||
126791008|NCT00864097|456192174|FG002|Overall Study|Death|0|||
126791009|NCT00864097|456192175|FG003|Overall Study|Death|0|||
126791010|NCT00864097|456192172|FG000|Overall Study|Adverse Event|6|||
126791011|NCT00864097|456192173|FG001|Overall Study|Adverse Event|8|||
126791012|NCT00864097|456192174|FG002|Overall Study|Adverse Event|11|||
126791013|NCT00864097|456192175|FG003|Overall Study|Adverse Event|9|||
126791014|NCT00864097|456192172|FG000|Overall Study|Lack of Efficacy|9|||
126791015|NCT00864097|456192173|FG001|Overall Study|Lack of Efficacy|3|||
126791016|NCT00864097|456192174|FG002|Overall Study|Lack of Efficacy|7|||
126791017|NCT00864097|456192175|FG003|Overall Study|Lack of Efficacy|2|||
126791018|NCT00864097|456192172|FG000|Overall Study|Lost to Follow-up|0|||
126791019|NCT00864097|456192173|FG001|Overall Study|Lost to Follow-up|1|||
126791020|NCT00864097|456192174|FG002|Overall Study|Lost to Follow-up|0|||
126791021|NCT00864097|456192175|FG003|Overall Study|Lost to Follow-up|1|||
126791022|NCT00864097|456192172|FG000|Overall Study|Withdrawal by Subject|15|||
126791023|NCT00864097|456192173|FG001|Overall Study|Withdrawal by Subject|11|||
126791024|NCT00864097|456192174|FG002|Overall Study|Withdrawal by Subject|11|||
126791025|NCT00864097|456192175|FG003|Overall Study|Withdrawal by Subject|12|||
126791026|NCT00864097|456192172|FG000|Overall Study|Protocol Violation|2|||
126791027|NCT00864097|456192173|FG001|Overall Study|Protocol Violation|1|||
126791028|NCT00864097|456192174|FG002|Overall Study|Protocol Violation|0|||
126791029|NCT00864097|456192175|FG003|Overall Study|Protocol Violation|1|||
126791030|NCT00864097|456192172|FG000|Overall Study|Terminated by sponsor|105|||
126791031|NCT00864097|456192173|FG001|Overall Study|Terminated by sponsor|112|||
126791032|NCT00864097|456192174|FG002|Overall Study|Terminated by sponsor|102|||
126791033|NCT00864097|456192175|FG003|Overall Study|Terminated by sponsor|99|||
126791034|NCT00864097|456192172|FG000|Overall Study|Randomized but not treated|2|||
126791035|NCT00864097|456192173|FG001|Overall Study|Randomized but not treated|0|||
126791036|NCT00864097|456192174|FG002|Overall Study|Randomized but not treated|1|||
126791037|NCT00864097|456192175|FG003|Overall Study|Randomized but not treated|0|||
126791038|NCT00864097|456192172|FG000|Overall Study|Other|0|||
126791039|NCT00864097|456192173|FG001|Overall Study|Other|0|||
126791040|NCT00864097|456192174|FG002|Overall Study|Other|0|||
126791041|NCT00864097|456192175|FG003|Overall Study|Other|1|||
126791042|NCT00620022|456192179|FG000|Treatment Period 1|Adverse Event|4|||
126791043|NCT00620022|456192180|FG001|Treatment Period 1|Adverse Event|6|||
126791044|NCT00620022|456192179|FG000|Treatment Period 1|Subject withdrew consent|1|||
126791045|NCT00620022|456192180|FG001|Treatment Period 1|Subject withdrew consent|0|||
126791046|NCT00620022|456192179|FG000|Treatment Period 2|Adverse Event|2|||
126791047|NCT00620022|456192180|FG001|Treatment Period 2|Adverse Event|2|||
126791048|NCT00849901|456192181|FG000|Acute Treatment Phase|Adverse Event|9|||
126791049|NCT00849901|456192182|FG001|Acute Treatment Phase|Adverse Event|1|||
126791050|NCT00849901|456192183|FG002|Acute Treatment Phase|Adverse Event|3|||
126791051|NCT00849901|456192181|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
126791052|NCT00849901|456192182|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
126791053|NCT00849901|456192183|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
126791054|NCT00849901|456192181|FG000|Acute Treatment Phase|Protocol Violation|0|||
126791055|NCT00849901|456192182|FG001|Acute Treatment Phase|Protocol Violation|2|||
126791056|NCT00849901|456192183|FG002|Acute Treatment Phase|Protocol Violation|1|||
126791057|NCT00849901|456192181|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
126791058|NCT00849901|456192182|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
126791059|NCT00849901|456192183|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
126791060|NCT00849901|456192181|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
126791061|NCT00849901|456192182|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
126791062|NCT00849901|456192183|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
126791063|NCT00849901|456192181|FG000|Acute Treatment Phase|Physician Decision|1|||
126791064|NCT00849901|456192182|FG001|Acute Treatment Phase|Physician Decision|1|||
126791065|NCT00849901|456192183|FG002|Acute Treatment Phase|Physician Decision|1|||
126791066|NCT00849901|456192181|FG000|Acute Treatment Phase|Sponsor Decision|1|||
126791067|NCT00849901|456192182|FG001|Acute Treatment Phase|Sponsor Decision|0|||
126791068|NCT00849901|456192183|FG002|Acute Treatment Phase|Sponsor Decision|0|||
126791069|NCT00849901|456192181|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
126791070|NCT00849901|456192182|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
126791071|NCT00849901|456192183|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
126791072|NCT00849901|456192181|FG000|Extension Phase|Adverse Event|2|||
126791073|NCT00849901|456192182|FG001|Extension Phase|Adverse Event|8|||
126791074|NCT00849901|456192183|FG002|Extension Phase|Adverse Event|4|||
126791075|NCT00849901|456192181|FG000|Extension Phase|Lost to Follow-up|3|||
126791076|NCT00849901|456192182|FG001|Extension Phase|Lost to Follow-up|0|||
126791077|NCT00849901|456192183|FG002|Extension Phase|Lost to Follow-up|1|||
126791078|NCT00849901|456192181|FG000|Extension Phase|Protocol Violation|2|||
126791079|NCT00849901|456192182|FG001|Extension Phase|Protocol Violation|2|||
126791080|NCT00849901|456192183|FG002|Extension Phase|Protocol Violation|4|||
126791081|NCT00849901|456192181|FG000|Extension Phase|Withdrawal by Subject|7|||
126632557|NCT01086384|455613781|FG001|Treatment Period|Received Treatment in Error|1|||
126632558|NCT01086384|455613782|FG002|Treatment Period|Received Treatment in Error|0|||
126632559|NCT00992992|455613785|FG000|Overall Study|Lost to Follow-up|3|||
126632560|NCT00992992|455613785|FG000|Overall Study|Death|16|||
126632561|NCT00992992|455613785|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
126632562|NCT00992992|455613785|FG000|Overall Study|Sponsor Closed the Study|4|||
126632563|NCT02250534|455613786|FG000|Overall Study|Lost to Follow-up|18|||
126755494|NCT02630459|456054731|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
126755495|NCT02630459|456054732|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
126755496|NCT02630459|456054733|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
126755497|NCT02630459|456054734|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
126755498|NCT02630459|456054735|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
126755499|NCT02630459|456054736|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
126755500|NCT02630459|456054737|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
126755501|NCT02630459|456054730|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
126755502|NCT02630459|456054731|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
126755503|NCT02630459|456054732|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
126755504|NCT02630459|456054733|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
126755505|NCT02630459|456054734|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
126755506|NCT02630459|456054735|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
126755507|NCT02630459|456054736|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
126755508|NCT02630459|456054737|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
126755509|NCT02630459|456054730|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126755510|NCT02630459|456054731|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126755511|NCT02630459|456054732|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126755512|NCT02630459|456054733|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126755513|NCT02630459|456054734|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
126755514|NCT02630459|456054735|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126755515|NCT02630459|456054736|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126755516|NCT02630459|456054737|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
126755517|NCT01453439|456054738|FG000|Treatment Phase|Withdrawal by Subject|13|||
126755518|NCT01453439|456054739|FG001|Treatment Phase|Withdrawal by Subject|10|||
126755519|NCT01453439|456054738|FG000|Treatment Phase|Suicidal Ideation|2|||
126755520|NCT01453439|456054739|FG001|Treatment Phase|Suicidal Ideation|0|||
126755521|NCT01453439|456054738|FG000|Treatment Phase|Need for higher level of care|1|||
126755522|NCT01453439|456054739|FG001|Treatment Phase|Need for higher level of care|1|||
126755523|NCT01453439|456054738|FG000|Treatment Phase|Therapist conflict of interest|1|||
126755524|NCT01453439|456054739|FG001|Treatment Phase|Therapist conflict of interest|0|||
126755525|NCT01453439|456054738|FG000|Follow-up|Withdrawal by Subject|0|||
126755526|NCT01453439|456054739|FG001|Follow-up|Withdrawal by Subject|1|||
126755527|NCT01453439|456054738|FG000|Follow-up|Lost to Follow-up|5|||
126755528|NCT01453439|456054739|FG001|Follow-up|Lost to Follow-up|10|||
126755529|NCT01014442|456054740|FG000|Overall Study|Adverse Event|0|||
126755530|NCT01014442|456054741|FG001|Overall Study|Adverse Event|8|||
126755531|NCT01014442|456054740|FG000|Overall Study|Withdrawal by Subject|4|||
126755532|NCT01014442|456054741|FG001|Overall Study|Withdrawal by Subject|4|||
126755533|NCT01014442|456054740|FG000|Overall Study|Protocol Violation|2|||
126755534|NCT01014442|456054741|FG001|Overall Study|Protocol Violation|5|||
126755535|NCT01014442|456054740|FG000|Overall Study|Lack of Compliance|0|||
126755536|NCT01014442|456054741|FG001|Overall Study|Lack of Compliance|1|||
126755537|NCT01014442|456054740|FG000|Overall Study|Unspecified Reason|1|||
126755538|NCT01014442|456054741|FG001|Overall Study|Unspecified Reason|1|||
126755539|NCT02135848|456054748|FG000|Overall Study|Adverse Event|2|||
126755540|NCT02135848|456054749|FG001|Overall Study|Adverse Event|0|||
126755541|NCT02135848|456054748|FG000|Overall Study|Withdrawal by Subject|1|||
126755542|NCT02135848|456054749|FG001|Overall Study|Withdrawal by Subject|1|||
126755543|NCT02177942|456054754|FG000|Overall Study|Adverse Event|1|||
126755544|NCT02177942|456054755|FG001|Overall Study|Adverse Event|0|||
126755545|NCT02177942|456054754|FG000|Overall Study|Lost to Follow-up|1|||
126755546|NCT02177942|456054755|FG001|Overall Study|Lost to Follow-up|1|||
126755547|NCT02177942|456054754|FG000|Overall Study|Protocol Violation|4|||
126755548|NCT02177942|456054755|FG001|Overall Study|Protocol Violation|6|||
126755549|NCT02177942|456054754|FG000|Overall Study|Withdrawal by Subject|71|||
126755550|NCT02177942|456054755|FG001|Overall Study|Withdrawal by Subject|81|||
126755551|NCT01351415|456054756|FG000|Overall Study|Withdrawal by Subject|15|||
126755552|NCT01351415|456054757|FG001|Overall Study|Withdrawal by Subject|17|||
126755553|NCT01351415|456054756|FG000|Overall Study|Trial termination by the Sponsor|28|||
126755554|NCT01351415|456054757|FG001|Overall Study|Trial termination by the Sponsor|19|||
126755555|NCT01351415|456054756|FG000|Overall Study|Lost to Follow-up|5|||
126755556|NCT01351415|456054757|FG001|Overall Study|Lost to Follow-up|7|||
126755557|NCT01351415|456054756|FG000|Overall Study|Death|190|||
126755558|NCT01351415|456054757|FG001|Overall Study|Death|187|||
126755559|NCT01351415|456054756|FG000|Overall Study|Physician Decision|2|||
126755560|NCT01351415|456054757|FG001|Overall Study|Physician Decision|3|||
126791082|NCT00849901|456192182|FG001|Extension Phase|Withdrawal by Subject|6|||
126791083|NCT00849901|456192183|FG002|Extension Phase|Withdrawal by Subject|3|||
126791084|NCT00849901|456192181|FG000|Extension Phase|Parent or Caregiver Decision|10|||
126791085|NCT00849901|456192182|FG001|Extension Phase|Parent or Caregiver Decision|4|||
126791086|NCT00849901|456192183|FG002|Extension Phase|Parent or Caregiver Decision|4|||
126791087|NCT00849901|456192181|FG000|Extension Phase|Physician Decision|1|||
126791088|NCT00849901|456192182|FG001|Extension Phase|Physician Decision|2|||
126791089|NCT00849901|456192183|FG002|Extension Phase|Physician Decision|0|||
126791090|NCT00849901|456192181|FG000|Extension Phase|Lack of Efficacy|2|||
126791091|NCT00849901|456192182|FG001|Extension Phase|Lack of Efficacy|4|||
126791092|NCT00849901|456192183|FG002|Extension Phase|Lack of Efficacy|1|||
126791093|NCT00262223|456192184|FG000|Treatment Phase|Withdrawal by Subject|3|||
126791094|NCT00262223|456192185|FG001|Treatment Phase|Withdrawal by Subject|6|||
126791095|NCT00262223|456192184|FG000|Treatment Phase|Adverse Event|1|||
126791096|NCT00262223|456192185|FG001|Treatment Phase|Adverse Event|2|||
126791097|NCT00262223|456192184|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
126791098|NCT00262223|456192185|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
126791099|NCT00262223|456192184|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
126791100|NCT00262223|456192185|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
126791101|NCT00262223|456192184|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
126791102|NCT00262223|456192185|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
126791103|NCT01804270|456192188|FG000|Overall Study|Withdrawal by Subject|1|||
126791104|NCT01804270|456192189|FG001|Overall Study|Withdrawal by Subject|1|||
126791105|NCT01328093|456192194|FG000|Double-Blind Phase|Adverse Event|78|||
126791106|NCT01328093|456192195|FG001|Double-Blind Phase|Adverse Event|15|||
126791107|NCT01328093|456192194|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
126791108|NCT01328093|456192195|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
126791109|NCT01328093|456192194|FG000|Double-Blind Phase|Lost to Follow-up|39|||
126791110|NCT01328093|456192195|FG001|Double-Blind Phase|Lost to Follow-up|14|||
126791111|NCT01328093|456192194|FG000|Double-Blind Phase|Protocol Violation|30|||
126791112|NCT01328093|456192195|FG001|Double-Blind Phase|Protocol Violation|10|||
126791113|NCT01328093|456192194|FG000|Double-Blind Phase|Lack of Efficacy|55|||
126791114|NCT01328093|456192195|FG001|Double-Blind Phase|Lack of Efficacy|13|||
126791115|NCT01328093|456192194|FG000|Double-Blind Phase|Sponsor Decision|17|||
126791116|NCT01328093|456192195|FG001|Double-Blind Phase|Sponsor Decision|3|||
126791117|NCT01328093|456192194|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
126791118|NCT01328093|456192195|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
126791119|NCT01328093|456192194|FG000|Double-Blind Phase|Scheduling conflict|8|||
126791120|NCT01328093|456192195|FG001|Double-Blind Phase|Scheduling conflict|3|||
126791121|NCT01328093|456192194|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
126791122|NCT01328093|456192195|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
126791123|NCT01328093|456192194|FG000|Double-Blind Phase|Death|1|||
126791124|NCT01328093|456192195|FG001|Double-Blind Phase|Death|0|||
126791125|NCT01328093|456192194|FG000|Open-Label Phase|Sponsor Decision|98|||
126791126|NCT01328093|456192195|FG001|Open-Label Phase|Sponsor Decision|34|||
126791127|NCT01328093|456192194|FG000|Open-Label Phase|Protocol Violation|8|||
126791128|NCT01328093|456192195|FG001|Open-Label Phase|Protocol Violation|3|||
126791129|NCT01328093|456192194|FG000|Open-Label Phase|Lost to Follow-up|10|||
126791130|NCT01328093|456192195|FG001|Open-Label Phase|Lost to Follow-up|1|||
126791131|NCT01328093|456192194|FG000|Open-Label Phase|Adverse Event|10|||
126791132|NCT01328093|456192195|FG001|Open-Label Phase|Adverse Event|4|||
126791133|NCT01328093|456192194|FG000|Open-Label Phase|Lack of Efficacy|5|||
126791134|NCT01328093|456192195|FG001|Open-Label Phase|Lack of Efficacy|6|||
126791135|NCT01328093|456192194|FG000|Open-Label Phase|Withdrawal by Subject|4|||
126791136|NCT01328093|456192195|FG001|Open-Label Phase|Withdrawal by Subject|1|||
126791137|NCT01328093|456192194|FG000|Open-Label Phase|Scheduling conflict|2|||
126791138|NCT01328093|456192195|FG001|Open-Label Phase|Scheduling conflict|1|||
126791139|NCT01328093|456192194|FG000|Open-Label Phase|Subject is moving or has moved|2|||
126632564|NCT02250534|455613787|FG001|Overall Study|Lost to Follow-up|28|||
126632565|NCT02250534|455613788|FG002|Overall Study|Lost to Follow-up|33|||
126632566|NCT02250534|455613786|FG000|Overall Study|Personal reasons|7|||
126791140|NCT01328093|456192195|FG001|Open-Label Phase|Subject is moving or has moved|0|||
126791141|NCT01328093|456192194|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
126791142|NCT01328093|456192195|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
126791143|NCT05150964|456192198|FG000|Overall Study|Lost to Follow-up|2|||
126791144|NCT00832377|456192199|FG000|Overall Study|Protocol Violation|1|||
126791145|NCT01941030|456192202|FG000|Overall Study|Death|3|||
126791146|NCT01941030|456192203|FG001|Overall Study|Death|2|||
126791147|NCT01941030|456192202|FG000|Overall Study|Lost to Follow-up|6|||
126791148|NCT01941030|456192203|FG001|Overall Study|Lost to Follow-up|5|||
126791149|NCT01941030|456192202|FG000|Overall Study|Withdrawal by Subject|4|||
126632567|NCT02250534|455613787|FG001|Overall Study|Personal reasons|8|||
126791150|NCT01941030|456192203|FG001|Overall Study|Withdrawal by Subject|6|||
126791151|NCT03991494|456192213|FG000|Overall Study|Progressive Disease|4|||
126791152|NCT03125200|456192221|FG000|Overall Study|Study Termination|0|||
126791153|NCT03125200|456192222|FG001|Overall Study|Study Termination|0|||
126791154|NCT03125200|456192223|FG002|Overall Study|Study Termination|0|||
126791155|NCT03125200|456192224|FG003|Overall Study|Study Termination|1|||
126791156|NCT03125200|456192225|FG004|Overall Study|Study Termination|1|||
126791157|NCT03125200|456192226|FG005|Overall Study|Study Termination|2|||
126791158|NCT03125200|456192227|FG006|Overall Study|Study Termination|1|||
126791159|NCT03125200|456192221|FG000|Overall Study|Clinical Progression|0|||
126791160|NCT03125200|456192222|FG001|Overall Study|Clinical Progression|0|||
126791161|NCT03125200|456192223|FG002|Overall Study|Clinical Progression|0|||
126791162|NCT03125200|456192224|FG003|Overall Study|Clinical Progression|1|||
126791163|NCT03125200|456192225|FG004|Overall Study|Clinical Progression|0|||
126791164|NCT03125200|456192226|FG005|Overall Study|Clinical Progression|1|||
126791165|NCT03125200|456192227|FG006|Overall Study|Clinical Progression|0|||
126791166|NCT03125200|456192221|FG000|Overall Study|Progressive Disease|2|||
126791167|NCT03125200|456192222|FG001|Overall Study|Progressive Disease|1|||
126791168|NCT03125200|456192223|FG002|Overall Study|Progressive Disease|2|||
126791169|NCT03125200|456192224|FG003|Overall Study|Progressive Disease|1|||
126791170|NCT03125200|456192225|FG004|Overall Study|Progressive Disease|2|||
126791171|NCT03125200|456192226|FG005|Overall Study|Progressive Disease|0|||
126791172|NCT03125200|456192227|FG006|Overall Study|Progressive Disease|1|||
126791173|NCT03125200|456192221|FG000|Overall Study|Lack of Efficacy|0|||
126791174|NCT03125200|456192222|FG001|Overall Study|Lack of Efficacy|0|||
126791175|NCT03125200|456192223|FG002|Overall Study|Lack of Efficacy|0|||
126791176|NCT03125200|456192224|FG003|Overall Study|Lack of Efficacy|1|||
126791177|NCT03125200|456192225|FG004|Overall Study|Lack of Efficacy|0|||
126791178|NCT03125200|456192226|FG005|Overall Study|Lack of Efficacy|0|||
126791179|NCT03125200|456192227|FG006|Overall Study|Lack of Efficacy|0|||
126791180|NCT03125200|456192221|FG000|Overall Study|Toxicity|0|||
126791181|NCT03125200|456192222|FG001|Overall Study|Toxicity|0|||
126791182|NCT03125200|456192223|FG002|Overall Study|Toxicity|0|||
126791183|NCT03125200|456192224|FG003|Overall Study|Toxicity|1|||
126791184|NCT03125200|456192225|FG004|Overall Study|Toxicity|0|||
126791185|NCT03125200|456192226|FG005|Overall Study|Toxicity|0|||
126791186|NCT03125200|456192227|FG006|Overall Study|Toxicity|0|||
126791187|NCT03125200|456192221|FG000|Overall Study|Consent Withdrawn by Subject|0|||
126791188|NCT03125200|456192222|FG001|Overall Study|Consent Withdrawn by Subject|1|||
126791189|NCT03125200|456192223|FG002|Overall Study|Consent Withdrawn by Subject|0|||
126791190|NCT03125200|456192224|FG003|Overall Study|Consent Withdrawn by Subject|0|||
126791191|NCT03125200|456192225|FG004|Overall Study|Consent Withdrawn by Subject|1|||
126791192|NCT03125200|456192226|FG005|Overall Study|Consent Withdrawn by Subject|0|||
126791193|NCT03125200|456192227|FG006|Overall Study|Consent Withdrawn by Subject|1|||
126791194|NCT00119379|456192231|FG000|Overall Study|Adverse Event|4|||
126791195|NCT00119379|456192232|FG001|Overall Study|Adverse Event|1|||
126791196|NCT01937390|456192240|FG000|Overall Study|Death|2|||
126791197|NCT01937390|456192240|FG000|Overall Study|Lost to Follow-up|7|||
126791198|NCT01937390|456192240|FG000|Overall Study|Withdrawal by Subject|5|||
126791199|NCT01937390|456192240|FG000|Overall Study|Fail to return|21|||
126791200|NCT01706536|456192241|FG000|Overall Study|Withdrawal by Subject|1|||
126791201|NCT01706536|456192242|FG001|Overall Study|Withdrawal by Subject|0|||
126791202|NCT01706536|456192243|FG002|Overall Study|Withdrawal by Subject|1|||
126791203|NCT01706536|456192244|FG003|Overall Study|Withdrawal by Subject|0|||
126791204|NCT01706536|456192245|FG004|Overall Study|Withdrawal by Subject|0|||
126791205|NCT01706536|456192241|FG000|Overall Study|Adverse Event|2|||
126791206|NCT01706536|456192242|FG001|Overall Study|Adverse Event|3|||
126791207|NCT01706536|456192243|FG002|Overall Study|Adverse Event|4|||
126791208|NCT01706536|456192244|FG003|Overall Study|Adverse Event|3|||
126791209|NCT01706536|456192245|FG004|Overall Study|Adverse Event|2|||
126791210|NCT01706536|456192241|FG000|Overall Study|Lack of Efficacy|1|||
126791211|NCT01706536|456192242|FG001|Overall Study|Lack of Efficacy|0|||
126791212|NCT01706536|456192243|FG002|Overall Study|Lack of Efficacy|0|||
126791213|NCT01706536|456192244|FG003|Overall Study|Lack of Efficacy|1|||
126791214|NCT01706536|456192245|FG004|Overall Study|Lack of Efficacy|0|||
126791215|NCT01706536|456192241|FG000|Overall Study|non compliance|0|||
126632568|NCT02250534|455613788|FG002|Overall Study|Personal reasons|14|||
126791216|NCT01706536|456192242|FG001|Overall Study|non compliance|1|||
126791217|NCT01706536|456192243|FG002|Overall Study|non compliance|0|||
126791218|NCT01706536|456192244|FG003|Overall Study|non compliance|0|||
126791219|NCT01706536|456192245|FG004|Overall Study|non compliance|0|||
126791220|NCT00683293|456192257|FG000|Overall Study|Withdrawal by Subject|2|||
126791221|NCT00683293|456192258|FG001|Overall Study|Withdrawal by Subject|3|||
126791222|NCT03262012|456192259|FG000|Overall Study|Withdrawal by Subject|15|||
126791223|NCT03262012|456192260|FG001|Overall Study|Withdrawal by Subject|13|||
126791224|NCT03262012|456192261|FG002|Overall Study|Withdrawal by Subject|8|||
126791225|NCT03262012|456192262|FG003|Overall Study|Withdrawal by Subject|7|||
126791226|NCT03262012|456192259|FG000|Overall Study|Adverse Event|10|||
126791227|NCT03262012|456192260|FG001|Overall Study|Adverse Event|12|||
126791228|NCT03262012|456192261|FG002|Overall Study|Adverse Event|4|||
126791229|NCT03262012|456192262|FG003|Overall Study|Adverse Event|6|||
126791230|NCT03262012|456192259|FG000|Overall Study|Physician Decision|2|||
126791231|NCT03262012|456192260|FG001|Overall Study|Physician Decision|5|||
126791232|NCT03262012|456192261|FG002|Overall Study|Physician Decision|1|||
126791233|NCT03262012|456192262|FG003|Overall Study|Physician Decision|0|||
126791234|NCT03262012|456192259|FG000|Overall Study|Lack of Efficacy|0|||
126791235|NCT03262012|456192260|FG001|Overall Study|Lack of Efficacy|5|||
126791236|NCT03262012|456192261|FG002|Overall Study|Lack of Efficacy|1|||
126791237|NCT03262012|456192262|FG003|Overall Study|Lack of Efficacy|2|||
126791238|NCT03262012|456192259|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
126791239|NCT03262012|456192260|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
126791240|NCT03262012|456192261|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
126791241|NCT03262012|456192262|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
126791242|NCT04099888|456193701|FG000|Overall Study|Study terminated by sponsor|9|||
126791243|NCT04099888|456193702|FG001|Overall Study|Study terminated by sponsor|11|||
126791244|NCT04099888|456193701|FG000|Overall Study|Lost to Follow-up|1|||
126791245|NCT04099888|456193702|FG001|Overall Study|Lost to Follow-up|1|||
126791246|NCT04099888|456193701|FG000|Overall Study|Withdrawal by Subject|5|||
126791247|NCT04099888|456193702|FG001|Overall Study|Withdrawal by Subject|6|||
126791248|NCT04099888|456193701|FG000|Overall Study|Death|5|||
126791249|NCT04099888|456193702|FG001|Overall Study|Death|2|||
126791250|NCT04099888|456193701|FG000|Overall Study|Other|1|||
126791251|NCT04099888|456193702|FG001|Overall Study|Other|0|||
126791252|NCT04538170|456193703|FG000|Overall Study|Withdrawal by Subject|104|||
126791253|NCT04538170|456193704|FG001|Overall Study|Withdrawal by Subject|210|||
126791254|NCT00445003|456193705|FG000|Overall Study|Death|1|||
126791255|NCT00445003|456193706|FG001|Overall Study|Death|2|||
126791256|NCT00445003|456193707|FG002|Overall Study|Death|1|||
126791257|NCT00445003|456193705|FG000|Overall Study|Missed Visit|3|||
126791258|NCT00445003|456193706|FG001|Overall Study|Missed Visit|5|||
126791259|NCT00445003|456193707|FG002|Overall Study|Missed Visit|1|||
126791260|NCT00445003|456193705|FG000|Overall Study|Dropped|1|||
126791261|NCT00445003|456193706|FG001|Overall Study|Dropped|3|||
126791262|NCT00445003|456193707|FG002|Overall Study|Dropped|2|||
126791263|NCT02334722|456193708|FG000|Overall Study|Lost to Follow-up|4|||
126791264|NCT02334722|456193709|FG001|Overall Study|Lost to Follow-up|0|||
126791265|NCT02334722|456193708|FG000|Overall Study|6 week questionnaire not completed|2|||
126791266|NCT02334722|456193709|FG001|Overall Study|6 week questionnaire not completed|0|||
126791267|NCT02334722|456193708|FG000|Overall Study|Unable to obtain medication|1|||
126791268|NCT02334722|456193709|FG001|Overall Study|Unable to obtain medication|1|||
126791269|NCT02334722|456193708|FG000|Overall Study|Withdrawal by Subject|0|||
126791270|NCT02334722|456193709|FG001|Overall Study|Withdrawal by Subject|3|||
126791271|NCT02334722|456193708|FG000|Overall Study|Adverse Event|0|||
126791272|NCT02334722|456193709|FG001|Overall Study|Adverse Event|2|||
126791273|NCT02334722|456193708|FG000|Overall Study|Physician Decision|0|||
126791274|NCT02334722|456193709|FG001|Overall Study|Physician Decision|1|||
126791275|NCT00856388|456193710|FG000|Overall Study|Other|1|||
126791276|NCT03661528|456193711|FG000|Overall Study|Death|1|||
126791277|NCT03661528|456193712|FG001|Overall Study|Death|0|||
126791278|NCT03661528|456193711|FG000|Overall Study|Physician Decision|3|||
126791279|NCT03661528|456193712|FG001|Overall Study|Physician Decision|1|||
126791280|NCT03661528|456193711|FG000|Overall Study|Other than Specified|5|||
126791281|NCT03661528|456193712|FG001|Overall Study|Other than Specified|2|||
126791282|NCT03661528|456193711|FG000|Overall Study|Withdrawal by Subject|5|||
126791283|NCT03661528|456193712|FG001|Overall Study|Withdrawal by Subject|3|||
126791284|NCT03661528|456193711|FG000|Overall Study|Disease Progression|8|||
126791285|NCT03661528|456193712|FG001|Overall Study|Disease Progression|13|||
126791286|NCT03661528|456193711|FG000|Overall Study|Adverse Event|61|||
126791287|NCT03661528|456193712|FG001|Overall Study|Adverse Event|55|||
126791288|NCT01617668|456193715|FG000|Overall Study|Adverse Event|7|||
126791289|NCT01617668|456193716|FG001|Overall Study|Adverse Event|0|||
126791290|NCT01617668|456193717|FG002|Overall Study|Adverse Event|12|||
126791291|NCT01617668|456193718|FG003|Overall Study|Adverse Event|5|||
126791292|NCT01617668|456193715|FG000|Overall Study|Physician Decision|1|||
126791293|NCT01617668|456193716|FG001|Overall Study|Physician Decision|2|||
126791294|NCT01617668|456193717|FG002|Overall Study|Physician Decision|3|||
126791295|NCT01617668|456193718|FG003|Overall Study|Physician Decision|0|||
126791296|NCT01617668|456193715|FG000|Overall Study|Progressive Disease|4|||
126791297|NCT01617668|456193716|FG001|Overall Study|Progressive Disease|4|||
126791298|NCT01617668|456193717|FG002|Overall Study|Progressive Disease|6|||
126791299|NCT01617668|456193718|FG003|Overall Study|Progressive Disease|9|||
126791300|NCT01617668|456193715|FG000|Overall Study|Subject/guardian decision|1|||
126791301|NCT01617668|456193716|FG001|Overall Study|Subject/guardian decision|3|||
126791302|NCT01617668|456193717|FG002|Overall Study|Subject/guardian decision|2|||
126791303|NCT01617668|456193718|FG003|Overall Study|Subject/guardian decision|1|||
126791304|NCT00925769|456193719|FG000|Overall Study|Major toxicity|1|||
126791305|NCT00925769|456193720|FG001|Overall Study|Major toxicity|0|||
126791306|NCT00925769|456193721|FG002|Overall Study|Major toxicity|1|||
126791307|NCT00925769|456193722|FG003|Overall Study|Major toxicity|1|||
126791308|NCT00925769|456193723|FG004|Overall Study|Major toxicity|0|||
126791309|NCT00925769|456193724|FG005|Overall Study|Major toxicity|0|||
126791310|NCT00925769|456193719|FG000|Overall Study|Disease progression|4|||
126791311|NCT00925769|456193720|FG001|Overall Study|Disease progression|5|||
126791312|NCT00925769|456193721|FG002|Overall Study|Disease progression|3|||
126791313|NCT00925769|456193722|FG003|Overall Study|Disease progression|4|||
126791314|NCT00925769|456193723|FG004|Overall Study|Disease progression|2|||
126791315|NCT00925769|456193724|FG005|Overall Study|Disease progression|3|||
126791316|NCT00925769|456193719|FG000|Overall Study|Death|0|||
126791317|NCT00925769|456193720|FG001|Overall Study|Death|0|||
126791318|NCT00925769|456193721|FG002|Overall Study|Death|1|||
126791319|NCT00925769|456193722|FG003|Overall Study|Death|0|||
126791320|NCT00925769|456193723|FG004|Overall Study|Death|0|||
126791321|NCT00925769|456193724|FG005|Overall Study|Death|0|||
126791322|NCT00925769|456193719|FG000|Overall Study|Physician Decision|1|||
126791323|NCT00925769|456193720|FG001|Overall Study|Physician Decision|0|||
126791324|NCT00925769|456193721|FG002|Overall Study|Physician Decision|0|||
126791325|NCT00925769|456193722|FG003|Overall Study|Physician Decision|0|||
126791326|NCT00925769|456193723|FG004|Overall Study|Physician Decision|0|||
126791327|NCT00925769|456193724|FG005|Overall Study|Physician Decision|0|||
126791328|NCT00925769|456193719|FG000|Overall Study|Missing documentation|0|||
126791329|NCT00925769|456193720|FG001|Overall Study|Missing documentation|1|||
126791330|NCT00925769|456193721|FG002|Overall Study|Missing documentation|0|||
126791331|NCT00925769|456193722|FG003|Overall Study|Missing documentation|0|||
126791332|NCT00925769|456193723|FG004|Overall Study|Missing documentation|0|||
126791333|NCT00925769|456193724|FG005|Overall Study|Missing documentation|0|||
126791334|NCT00925769|456193719|FG000|Overall Study|End of study visit not done|0|||
126791335|NCT00925769|456193720|FG001|Overall Study|End of study visit not done|0|||
126791336|NCT00925769|456193721|FG002|Overall Study|End of study visit not done|1|||
126791337|NCT00925769|456193722|FG003|Overall Study|End of study visit not done|0|||
126791338|NCT00925769|456193723|FG004|Overall Study|End of study visit not done|0|||
126791339|NCT00925769|456193724|FG005|Overall Study|End of study visit not done|0|||
126791340|NCT00925769|456193719|FG000|Overall Study|Participant is unable to swallow drug|0|||
126791341|NCT00925769|456193720|FG001|Overall Study|Participant is unable to swallow drug|0|||
126791342|NCT00925769|456193721|FG002|Overall Study|Participant is unable to swallow drug|0|||
126791343|NCT00925769|456193722|FG003|Overall Study|Participant is unable to swallow drug|1|||
126791344|NCT00925769|456193723|FG004|Overall Study|Participant is unable to swallow drug|0|||
126791345|NCT00925769|456193724|FG005|Overall Study|Participant is unable to swallow drug|0|||
126791346|NCT00925769|456193719|FG000|Overall Study|Adverse Event|0|||
126791347|NCT00925769|456193720|FG001|Overall Study|Adverse Event|0|||
126791348|NCT00925769|456193721|FG002|Overall Study|Adverse Event|0|||
126791349|NCT00925769|456193722|FG003|Overall Study|Adverse Event|0|||
126791350|NCT00925769|456193723|FG004|Overall Study|Adverse Event|1|||
126791351|NCT00925769|456193724|FG005|Overall Study|Adverse Event|0|||
126791352|NCT02017964|456193725|FG000|Overall Study|Patient deemed ineligible|1|||
126791353|NCT00686959|456193727|FG000|Overall Study|Participants censored (no death events)|124|||
126791354|NCT00686959|456193728|FG001|Overall Study|Participants censored (no death events)|117|||
126791355|NCT00150462|456193729|FG000|Overall Study|Disease Progression or Relapse|3|||
126791356|NCT00150462|456193730|FG001|Overall Study|Disease Progression or Relapse|1|||
126791357|NCT00150462|456193731|FG002|Overall Study|Disease Progression or Relapse|2|||
126791358|NCT00150462|456193732|FG003|Overall Study|Disease Progression or Relapse|1|||
126791359|NCT00150462|456193733|FG004|Overall Study|Disease Progression or Relapse|2|||
126791360|NCT00150462|456193734|FG005|Overall Study|Disease Progression or Relapse|2|||
126791361|NCT00150462|456193735|FG006|Overall Study|Disease Progression or Relapse|3|||
126791362|NCT00150462|456193736|FG007|Overall Study|Disease Progression or Relapse|5|||
126791363|NCT00150462|456193737|FG008|Overall Study|Disease Progression or Relapse|5|||
126791364|NCT00150462|456193738|FG009|Overall Study|Disease Progression or Relapse|3|||
126791365|NCT00150462|456193739|FG010|Overall Study|Disease Progression or Relapse|2|||
126791366|NCT00150462|456193729|FG000|Overall Study|Withdrawal by Subject|0|||
126791367|NCT00150462|456193730|FG001|Overall Study|Withdrawal by Subject|1|||
126791368|NCT00150462|456193731|FG002|Overall Study|Withdrawal by Subject|1|||
126791369|NCT00150462|456193732|FG003|Overall Study|Withdrawal by Subject|0|||
126791370|NCT00150462|456193733|FG004|Overall Study|Withdrawal by Subject|1|||
126632569|NCT02250534|455613786|FG000|Overall Study|Adverse Event|6|||
126791371|NCT00150462|456193734|FG005|Overall Study|Withdrawal by Subject|2|||
126791372|NCT00150462|456193735|FG006|Overall Study|Withdrawal by Subject|0|||
126791373|NCT00150462|456193736|FG007|Overall Study|Withdrawal by Subject|1|||
126791374|NCT00150462|456193737|FG008|Overall Study|Withdrawal by Subject|0|||
126791375|NCT00150462|456193738|FG009|Overall Study|Withdrawal by Subject|1|||
126791376|NCT00150462|456193739|FG010|Overall Study|Withdrawal by Subject|0|||
126791377|NCT00150462|456193729|FG000|Overall Study|Death|0|||
126791378|NCT00150462|456193730|FG001|Overall Study|Death|1|||
126791379|NCT00150462|456193731|FG002|Overall Study|Death|0|||
126791380|NCT00150462|456193732|FG003|Overall Study|Death|0|||
126791381|NCT00150462|456193733|FG004|Overall Study|Death|0|||
126791382|NCT00150462|456193734|FG005|Overall Study|Death|0|||
126791383|NCT00150462|456193735|FG006|Overall Study|Death|0|||
126791384|NCT00150462|456193736|FG007|Overall Study|Death|0|||
126791385|NCT00150462|456193737|FG008|Overall Study|Death|1|||
126791386|NCT00150462|456193738|FG009|Overall Study|Death|0|||
126791387|NCT00150462|456193739|FG010|Overall Study|Death|0|||
126791388|NCT00150462|456193729|FG000|Overall Study|Adverse Event|0|||
126791389|NCT00150462|456193730|FG001|Overall Study|Adverse Event|0|||
126791390|NCT00150462|456193731|FG002|Overall Study|Adverse Event|0|||
126791391|NCT00150462|456193732|FG003|Overall Study|Adverse Event|1|||
126791392|NCT00150462|456193733|FG004|Overall Study|Adverse Event|0|||
126791393|NCT00150462|456193734|FG005|Overall Study|Adverse Event|0|||
126791394|NCT00150462|456193735|FG006|Overall Study|Adverse Event|0|||
126791395|NCT00150462|456193736|FG007|Overall Study|Adverse Event|2|||
126791396|NCT00150462|456193737|FG008|Overall Study|Adverse Event|0|||
126791397|NCT00150462|456193738|FG009|Overall Study|Adverse Event|1|||
126791398|NCT00150462|456193739|FG010|Overall Study|Adverse Event|0|||
126791399|NCT00150462|456193729|FG000|Overall Study|Physician Decision|0|||
126791400|NCT00150462|456193730|FG001|Overall Study|Physician Decision|0|||
126791401|NCT00150462|456193731|FG002|Overall Study|Physician Decision|1|||
126791402|NCT00150462|456193732|FG003|Overall Study|Physician Decision|1|||
126791403|NCT00150462|456193733|FG004|Overall Study|Physician Decision|0|||
126791404|NCT00150462|456193734|FG005|Overall Study|Physician Decision|0|||
126791405|NCT00150462|456193735|FG006|Overall Study|Physician Decision|0|||
126791406|NCT00150462|456193736|FG007|Overall Study|Physician Decision|0|||
126791407|NCT00150462|456193737|FG008|Overall Study|Physician Decision|0|||
126791408|NCT00150462|456193738|FG009|Overall Study|Physician Decision|0|||
126791409|NCT00150462|456193739|FG010|Overall Study|Physician Decision|0|||
126791410|NCT00150462|456193729|FG000|Overall Study|Other|0|||
126791411|NCT00150462|456193730|FG001|Overall Study|Other|0|||
126791412|NCT00150462|456193731|FG002|Overall Study|Other|0|||
126791413|NCT00150462|456193732|FG003|Overall Study|Other|0|||
126791414|NCT00150462|456193733|FG004|Overall Study|Other|0|||
126791415|NCT00150462|456193734|FG005|Overall Study|Other|0|||
126791416|NCT00150462|456193735|FG006|Overall Study|Other|0|||
126791417|NCT00150462|456193736|FG007|Overall Study|Other|0|||
126791418|NCT00150462|456193737|FG008|Overall Study|Other|0|||
126791419|NCT00150462|456193738|FG009|Overall Study|Other|1|||
126791420|NCT00150462|456193739|FG010|Overall Study|Other|1|||
126791421|NCT01196052|456193742|FG000|Overall Study|Adverse Event|9|||
126791422|NCT01196052|456193742|FG000|Overall Study|Lost to Follow-up|1|||
126791423|NCT01196052|456193742|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
126791424|NCT01196052|456193742|FG000|Overall Study|Reason not Specified|5|||
126791425|NCT01196052|456193742|FG000|Overall Study|Withdrawal by Subject|6|||
126791426|NCT02178722|456193743|FG000|Overall Study|Withdrawal by Subject|0|||
126791427|NCT02178722|456193744|FG001|Overall Study|Withdrawal by Subject|0|||
126791428|NCT02178722|456193745|FG002|Overall Study|Withdrawal by Subject|0|||
126791429|NCT02178722|456193746|FG003|Overall Study|Withdrawal by Subject|2|||
126791430|NCT02178722|456193747|FG004|Overall Study|Withdrawal by Subject|33|||
126791431|NCT02178722|456193743|FG000|Overall Study|Death|2|||
126791432|NCT02178722|456193744|FG001|Overall Study|Death|13|||
126791433|NCT02178722|456193745|FG002|Overall Study|Death|12|||
126791434|NCT02178722|456193746|FG003|Overall Study|Death|12|||
126791435|NCT02178722|456193747|FG004|Overall Study|Death|205|||
126791436|NCT02178722|456193743|FG000|Overall Study|Lost to Follow-up|0|||
126791437|NCT02178722|456193744|FG001|Overall Study|Lost to Follow-up|0|||
126791438|NCT02178722|456193745|FG002|Overall Study|Lost to Follow-up|0|||
126791439|NCT02178722|456193746|FG003|Overall Study|Lost to Follow-up|2|||
126791440|NCT02178722|456193747|FG004|Overall Study|Lost to Follow-up|11|||
126791441|NCT02178722|456193743|FG000|Overall Study|Study terminated by Sponsor|2|||
126791442|NCT02178722|456193744|FG001|Overall Study|Study terminated by Sponsor|7|||
126791443|NCT02178722|456193745|FG002|Overall Study|Study terminated by Sponsor|6|||
126791444|NCT02178722|456193746|FG003|Overall Study|Study terminated by Sponsor|4|||
126791445|NCT02178722|456193747|FG004|Overall Study|Study terminated by Sponsor|128|||
126791446|NCT02178722|456193743|FG000|Overall Study|Physician Decision|0|||
126791447|NCT02178722|456193744|FG001|Overall Study|Physician Decision|0|||
126791448|NCT02178722|456193745|FG002|Overall Study|Physician Decision|0|||
126791449|NCT02178722|456193746|FG003|Overall Study|Physician Decision|0|||
126791450|NCT02178722|456193747|FG004|Overall Study|Physician Decision|3|||
126791451|NCT02178722|456193743|FG000|Overall Study|Other|0|||
126791452|NCT02178722|456193744|FG001|Overall Study|Other|0|||
126791453|NCT02178722|456193745|FG002|Overall Study|Other|0|||
126791454|NCT02178722|456193746|FG003|Overall Study|Other|0|||
126791455|NCT02178722|456193747|FG004|Overall Study|Other|2|||
126791456|NCT03553823|456193748|FG000|Overall Study|Physician Decision|0|||
126791457|NCT03553823|456193749|FG001|Overall Study|Physician Decision|1|||
126791458|NCT03340727|456193750|FG000|Overall Study|Death|1|||
126791459|NCT03340727|456193751|FG001|Overall Study|Death|0|||
126791460|NCT03340727|456193750|FG000|Overall Study|Lost to Follow-up|31|||
126791461|NCT03340727|456193751|FG001|Overall Study|Lost to Follow-up|35|||
126791462|NCT03340727|456193750|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
126791463|NCT03340727|456193751|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
126791464|NCT03340727|456193750|FG000|Overall Study|Transferred to another facility|10|||
126791465|NCT03340727|456193751|FG001|Overall Study|Transferred to another facility|7|||
126791466|NCT03340727|456193750|FG000|Overall Study|Withdrawal by Subject|28|||
126791467|NCT03340727|456193751|FG001|Overall Study|Withdrawal by Subject|17|||
126791468|NCT01572948|456193752|FG000|Overall Study|Lost to Follow-up|1|||
126791469|NCT01572948|456193753|FG001|Overall Study|Lost to Follow-up|0|||
126791470|NCT01572948|456193752|FG000|Overall Study|unable to contact|0|||
126791471|NCT01572948|456193753|FG001|Overall Study|unable to contact|1|||
126791472|NCT01720264|456193754|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
126791473|NCT01720264|456193754|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
126791474|NCT01720264|456193754|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
126791475|NCT00877032|456193755|FG000|Overall Study|Did not meet entrance criteria|0|||
126791476|NCT00877032|456193756|FG001|Overall Study|Did not meet entrance criteria|0|||
126791477|NCT00877032|456193757|FG002|Overall Study|Did not meet entrance criteria|0|||
126791478|NCT00877032|456193758|FG003|Overall Study|Did not meet entrance criteria|1|||
126791479|NCT00877032|456193759|FG004|Overall Study|Did not meet entrance criteria|0|||
126791480|NCT00877032|456193760|FG005|Overall Study|Did not meet entrance criteria|0|||
126791481|NCT00877032|456193761|FG006|Overall Study|Did not meet entrance criteria|2|||
126791482|NCT00615069|456193771|FG000|Overall Study|Death|10|||
126791483|NCT00615069|456193771|FG000|Overall Study|Physician Decision|2|||
126791484|NCT00615069|456193771|FG000|Overall Study|Withdrawal by Subject|4|||
126791485|NCT00669942|456193772|FG000|Parts 2 and 3|Adverse Event|0|||
126791486|NCT00669942|456193773|FG001|Parts 2 and 3|Adverse Event|0|||
126791487|NCT00669942|456193774|FG002|Parts 2 and 3|Adverse Event|0|||
126791488|NCT00669942|456193775|FG003|Parts 2 and 3|Adverse Event|0|||
126791489|NCT00669942|456193776|FG004|Parts 2 and 3|Adverse Event|0|||
126791490|NCT00669942|456193777|FG005|Parts 2 and 3|Adverse Event|0|||
126791491|NCT00669942|456193778|FG006|Parts 2 and 3|Adverse Event|0|||
126791492|NCT00669942|456193779|FG007|Parts 2 and 3|Adverse Event|2|||
126791493|NCT00669942|456193780|FG008|Parts 2 and 3|Adverse Event|1|||
126791494|NCT00669942|456193781|FG009|Parts 2 and 3|Adverse Event|0|||
126791495|NCT00669942|456193782|FG010|Parts 2 and 3|Adverse Event|0|||
126791496|NCT00669942|456193783|FG011|Parts 2 and 3|Adverse Event|0|||
126791497|NCT00669942|456193772|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
126791498|NCT00669942|456193773|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
126791499|NCT00669942|456193774|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
126791500|NCT00669942|456193775|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
126791501|NCT00669942|456193776|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
126791502|NCT00669942|456193777|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
126791503|NCT00669942|456193778|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
126791504|NCT00669942|456193779|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
126791505|NCT00669942|456193780|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
126791506|NCT00669942|456193781|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
126791507|NCT00669942|456193782|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
126791508|NCT00669942|456193783|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
126791509|NCT00669942|456193772|FG000|Parts 2 and 3|Protocol Violation|0|||
126791510|NCT00669942|456193773|FG001|Parts 2 and 3|Protocol Violation|0|||
126791511|NCT00669942|456193774|FG002|Parts 2 and 3|Protocol Violation|0|||
126791512|NCT00669942|456193775|FG003|Parts 2 and 3|Protocol Violation|0|||
126791513|NCT00669942|456193776|FG004|Parts 2 and 3|Protocol Violation|0|||
126791514|NCT00669942|456193777|FG005|Parts 2 and 3|Protocol Violation|1|||
126791515|NCT00669942|456193778|FG006|Parts 2 and 3|Protocol Violation|0|||
126791516|NCT00669942|456193779|FG007|Parts 2 and 3|Protocol Violation|0|||
126791517|NCT00669942|456193780|FG008|Parts 2 and 3|Protocol Violation|0|||
126791518|NCT00669942|456193781|FG009|Parts 2 and 3|Protocol Violation|0|||
126791519|NCT00669942|456193782|FG010|Parts 2 and 3|Protocol Violation|0|||
126791520|NCT00669942|456193783|FG011|Parts 2 and 3|Protocol Violation|0|||
126791521|NCT00259012|456193786|FG000|Overall Study|Adverse Event|0|||
126791522|NCT00259012|456193787|FG001|Overall Study|Adverse Event|1|||
126791523|NCT00259012|456193786|FG000|Overall Study|Withdrawal by Subject|1|||
126791524|NCT00259012|456193787|FG001|Overall Study|Withdrawal by Subject|0|||
126791525|NCT00259012|456193786|FG000|Overall Study|Physician Decision|0|||
126791526|NCT00259012|456193787|FG001|Overall Study|Physician Decision|1|||
126791527|NCT00259012|456193786|FG000|Overall Study|Lost to Follow-up|0|||
126791528|NCT00259012|456193787|FG001|Overall Study|Lost to Follow-up|1|||
126791529|NCT00259012|456193786|FG000|Overall Study|Protocol Violation|1|||
126791530|NCT00259012|456193787|FG001|Overall Study|Protocol Violation|1|||
126791531|NCT01496183|456193794|FG000|Overall Study|Physician Decision|3|||
126791532|NCT01496183|456193795|FG001|Overall Study|Physician Decision|1|||
126791533|NCT01496183|456193794|FG000|Overall Study|Withdrawal by Subject|0|||
126791534|NCT01496183|456193795|FG001|Overall Study|Withdrawal by Subject|1|||
126791535|NCT03002077|456193796|FG000|Overall Study|Non-compliance with Study Drug|4|||
126791536|NCT03002077|456193796|FG000|Overall Study|Non-compliance w/Background ADT|1|||
126791537|NCT03002077|456193796|FG000|Overall Study|Study Terminated by Sponsor|257|||
126791538|NCT03002077|456193796|FG000|Overall Study|Site Terminated by Sponsor|5|||
126791539|NCT03002077|456193796|FG000|Overall Study|Miscellaneous Reasons|10|||
126791540|NCT03002077|456193796|FG000|Overall Study|Adverse Event|23|||
126791541|NCT03002077|456193796|FG000|Overall Study|Lack of Efficacy|20|||
126791542|NCT03002077|456193796|FG000|Overall Study|Withdrawal by Subject|72|||
126791543|NCT03002077|456193796|FG000|Overall Study|Lost to Follow-up|21|||
126791544|NCT03002077|456193796|FG000|Overall Study|Pregnancy|4|||
126791545|NCT03002077|456193796|FG000|Overall Study|Protocol Violation|21|||
126791546|NCT04625114|456193797|FG000|Overall Study|Adverse Event|3|||
126791547|NCT04625114|456193798|FG001|Overall Study|Adverse Event|1|||
126791548|NCT04625114|456193797|FG000|Overall Study|Withdrawal by Subject|2|||
126791549|NCT04625114|456193798|FG001|Overall Study|Withdrawal by Subject|0|||
126791550|NCT00472290|456193799|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
126791551|NCT00472290|456193799|FG000|Overall Study|Protocol Specified Criteria|7|||
126791552|NCT00472290|456193799|FG000|Overall Study|Administrative Decision|37|||
126791553|NCT00472290|456193799|FG000|Overall Study|Death|3|||
126791554|NCT00472290|456193799|FG000|Overall Study|Lost to Follow-up|1|||
126791555|NCT00472290|456193799|FG000|Overall Study|Lack of Efficacy|1|||
126791556|NCT00472290|456193799|FG000|Overall Study|Disease Progression|4|||
126791557|NCT00472290|456193799|FG000|Overall Study|Withdrawal by Subject|5|||
126791558|NCT00472290|456193799|FG000|Overall Study|Adverse Event|6|||
126791559|NCT00472290|456193799|FG000|Overall Study|Requirement for alternative therapy|7|||
126791560|NCT00777829|456193800|FG000|Overall Study|Withdrawal by Subject|0|||
126791561|NCT00777829|456193801|FG001|Overall Study|Withdrawal by Subject|2|||
126791562|NCT02016170|456193818|FG000|Overall Study|Adverse Event|1|||
126791563|NCT02016170|456193819|FG001|Overall Study|Adverse Event|1|||
126791564|NCT02016170|456193820|FG002|Overall Study|Adverse Event|0|||
126791565|NCT02016170|456193818|FG000|Overall Study|Protocol Violation|1|||
126791566|NCT02016170|456193819|FG001|Overall Study|Protocol Violation|0|||
126791567|NCT02016170|456193820|FG002|Overall Study|Protocol Violation|0|||
126791568|NCT00336479|456193821|FG000|Overall Study|Adverse Event|8|||
126791569|NCT00336479|456193822|FG001|Overall Study|Adverse Event|11|||
126791570|NCT00336479|456193823|FG002|Overall Study|Adverse Event|18|||
126791571|NCT00336479|456193824|FG003|Overall Study|Adverse Event|4|||
126791572|NCT00336479|456193821|FG000|Overall Study|Noncompliant|1|||
126791573|NCT00336479|456193822|FG001|Overall Study|Noncompliant|7|||
126791574|NCT00336479|456193823|FG002|Overall Study|Noncompliant|3|||
126791575|NCT00336479|456193824|FG003|Overall Study|Noncompliant|0|||
126791576|NCT00336479|456193821|FG000|Overall Study|Physician Decision|2|||
126791577|NCT00336479|456193822|FG001|Overall Study|Physician Decision|3|||
126791578|NCT00336479|456193823|FG002|Overall Study|Physician Decision|1|||
126791579|NCT00336479|456193824|FG003|Overall Study|Physician Decision|0|||
126791580|NCT00336479|456193821|FG000|Overall Study|Lost to Follow-up|3|||
126791581|NCT00336479|456193822|FG001|Overall Study|Lost to Follow-up|2|||
126791582|NCT00336479|456193823|FG002|Overall Study|Lost to Follow-up|0|||
126791583|NCT00336479|456193824|FG003|Overall Study|Lost to Follow-up|0|||
126791584|NCT00336479|456193821|FG000|Overall Study|Withdrawal by Subject|3|||
126791585|NCT00336479|456193822|FG001|Overall Study|Withdrawal by Subject|2|||
126791586|NCT00336479|456193823|FG002|Overall Study|Withdrawal by Subject|3|||
126791587|NCT00336479|456193824|FG003|Overall Study|Withdrawal by Subject|0|||
126791588|NCT00336479|456193821|FG000|Overall Study|Other|0|||
126791589|NCT00336479|456193822|FG001|Overall Study|Other|0|||
126791590|NCT00336479|456193823|FG002|Overall Study|Other|1|||
126791591|NCT00336479|456193824|FG003|Overall Study|Other|0|||
126791592|NCT00336479|456193821|FG000|Overall Study|Virologic Stopping Rule|20|||
126791593|NCT00336479|456193822|FG001|Overall Study|Virologic Stopping Rule|0|||
126791594|NCT00336479|456193823|FG002|Overall Study|Virologic Stopping Rule|0|||
126791595|NCT00336479|456193824|FG003|Overall Study|Virologic Stopping Rule|0|||
126791596|NCT01479439|456193825|FG000|Overall Study|Adverse Event|1|||
126791597|NCT01479439|456193826|FG001|Overall Study|Adverse Event|0|||
126791598|NCT01479439|456193827|FG002|Overall Study|Adverse Event|0|||
126791599|NCT01479439|456193825|FG000|Overall Study|Lost to Follow-up|0|||
126791600|NCT01479439|456193826|FG001|Overall Study|Lost to Follow-up|1|||
126791601|NCT01479439|456193827|FG002|Overall Study|Lost to Follow-up|0|||
126791602|NCT01479439|456193825|FG000|Overall Study|Protocol Violation|0|||
126791603|NCT01479439|456193826|FG001|Overall Study|Protocol Violation|0|||
126791604|NCT01479439|456193827|FG002|Overall Study|Protocol Violation|2|||
126791605|NCT02365207|456193828|FG000|Overall Study|Withdrawal by Subject|1|||
126791606|NCT02365207|456193828|FG000|Overall Study|Physician Decision|1|||
126791607|NCT01722877|456193829|FG000|Overall Study|Death|1|||
126791608|NCT01722877|456193829|FG000|Overall Study|Lost to Follow-up|1|||
126791609|NCT01395030|456193830|FG000|Overall Study|Did not complete FCH PET/CT|7|||
126791610|NCT02079766|456193831|FG000|Overall Study|Physician Decision|1|||
126791611|NCT02079766|456193832|FG001|Overall Study|Physician Decision|0|||
126791612|NCT02079766|456193831|FG000|Overall Study|Withdrawal by Subject|1|||
126791613|NCT02079766|456193832|FG001|Overall Study|Withdrawal by Subject|0|||
126791614|NCT05067647|456193836|FG000|Overall Study|Lost to Follow-up|1|||
126791615|NCT00857623|456193839|FG000|Overall Study|Adverse Event|5|||
126791616|NCT00857623|456193840|FG001|Overall Study|Adverse Event|2|||
126791617|NCT00857623|456193839|FG000|Overall Study|Study-specific discontinuation criteria|5|||
126791618|NCT00857623|456193840|FG001|Overall Study|Study-specific discontinuation criteria|3|||
126791619|NCT00857623|456193839|FG000|Overall Study|Withdrawal by Subject|2|||
126791620|NCT00857623|456193840|FG001|Overall Study|Withdrawal by Subject|1|||
126791621|NCT00857623|456193839|FG000|Overall Study|Lack of Efficacy|1|||
126791622|NCT00857623|456193840|FG001|Overall Study|Lack of Efficacy|1|||
126791623|NCT00857623|456193839|FG000|Overall Study|Severe non-compliance to protocol|1|||
126791624|NCT00857623|456193840|FG001|Overall Study|Severe non-compliance to protocol|1|||
126791625|NCT00857623|456193839|FG000|Overall Study|Intake of prohibited medication|0|||
126791626|NCT00857623|456193840|FG001|Overall Study|Intake of prohibited medication|1|||
126791627|NCT00857623|456193839|FG000|Overall Study|Positive for HEP C|0|||
126791628|NCT00857623|456193840|FG001|Overall Study|Positive for HEP C|1|||
126791629|NCT00870870|456193843|FG000|Overall Study|Withdrawal by Subject|0|||
126791630|NCT00870870|456193844|FG001|Overall Study|Withdrawal by Subject|1|||
126791631|NCT00870870|456193845|FG002|Overall Study|Withdrawal by Subject|1|||
126791632|NCT00870870|456193846|FG003|Overall Study|Withdrawal by Subject|3|||
126791633|NCT00870870|456193843|FG000|Overall Study|Adverse Event|0|||
126791634|NCT00870870|456193844|FG001|Overall Study|Adverse Event|0|||
126791635|NCT00870870|456193845|FG002|Overall Study|Adverse Event|2|||
126791636|NCT00870870|456193846|FG003|Overall Study|Adverse Event|2|||
126791637|NCT00694551|456193849|FG000|Overall Study|Disease Progression|1|||
126791638|NCT00694551|456193850|FG001|Overall Study|Disease Progression|0|||
126791639|NCT00694551|456193851|FG002|Overall Study|Disease Progression|1|||
126791640|NCT01569152|456193852|FG000|Phase IIa, Period 1|Early Escape|5|||
126791641|NCT01569152|456193853|FG001|Phase IIa, Period 1|Early Escape|22|||
126791642|NCT01569152|456193854|FG002|Phase IIa, Period 1|Early Escape|0|||
126791643|NCT01569152|456193852|FG000|Phase IIa, Period 1|Adverse Event|4|||
126791644|NCT01569152|456193853|FG001|Phase IIa, Period 1|Adverse Event|0|||
126791645|NCT01569152|456193854|FG002|Phase IIa, Period 1|Adverse Event|0|||
126791646|NCT01569152|456193852|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
126791647|NCT01569152|456193853|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
126791648|NCT01569152|456193854|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
126791649|NCT01569152|456193852|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
126791650|NCT01569152|456193853|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
126791651|NCT01569152|456193854|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
126791652|NCT01569152|456193852|FG000|Phase IIa, Period 1|Protocol Violation|0|||
126791653|NCT01569152|456193853|FG001|Phase IIa, Period 1|Protocol Violation|1|||
126791654|NCT01569152|456193854|FG002|Phase IIa, Period 1|Protocol Violation|0|||
126791655|NCT01569152|456193852|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
126791656|NCT01569152|456193853|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
126791657|NCT01569152|456193854|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
126791658|NCT01569152|456193852|FG000|Safety Extension, Period 3|Adverse Event|0|||
126791659|NCT01569152|456193853|FG001|Safety Extension, Period 3|Adverse Event|0|||
126791660|NCT01569152|456193854|FG002|Safety Extension, Period 3|Adverse Event|4|||
126791661|NCT01569152|456193852|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
126791662|NCT01569152|456193853|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
126791663|NCT01569152|456193854|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
126791664|NCT01569152|456193852|FG000|Safety Extension, Period 3|Physician Decision|0|||
126791665|NCT01569152|456193853|FG001|Safety Extension, Period 3|Physician Decision|0|||
126791666|NCT01569152|456193854|FG002|Safety Extension, Period 3|Physician Decision|2|||
126791667|NCT01569152|456193852|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
126791668|NCT01569152|456193853|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
126791669|NCT01569152|456193854|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
126791670|NCT02920996|456193861|FG000|Overall Study|Adverse Event|8|||
126791671|NCT02920996|456193862|FG001|Overall Study|Adverse Event|0|||
126791672|NCT02920996|456193861|FG000|Overall Study|Physician Decision|1|||
126791673|NCT02920996|456193862|FG001|Overall Study|Physician Decision|0|||
126791674|NCT02920996|456193861|FG000|Overall Study|Death|1|||
126791675|NCT02920996|456193862|FG001|Overall Study|Death|0|||
126791676|NCT02920996|456193861|FG000|Overall Study|Missing|1|||
126791677|NCT02920996|456193862|FG001|Overall Study|Missing|0|||
126791678|NCT02920996|456193861|FG000|Overall Study|Subject Non-Compliance|1|||
126791679|NCT02920996|456193862|FG001|Overall Study|Subject Non-Compliance|0|||
126791680|NCT00154102|456193863|FG000|Overall Study|investigational study phase ongoing|7|||
126791681|NCT00154102|456193864|FG001|Overall Study|investigational study phase ongoing|2|||
126791682|NCT00463606|456193865|FG000|Overall Study|Adverse Event|21|||
126632570|NCT02250534|455613787|FG001|Overall Study|Adverse Event|3|||
126632571|NCT02250534|455613788|FG002|Overall Study|Adverse Event|8|||
126632572|NCT02250534|455613786|FG000|Overall Study|incarcerated|2|||
126632573|NCT02250534|455613787|FG001|Overall Study|incarcerated|1|||
126632574|NCT02250534|455613788|FG002|Overall Study|incarcerated|2|||
126632575|NCT02250534|455613786|FG000|Overall Study|Withdrawal by Subject|0|||
126632576|NCT02250534|455613787|FG001|Overall Study|Withdrawal by Subject|1|||
126632577|NCT02250534|455613788|FG002|Overall Study|Withdrawal by Subject|2|||
126632578|NCT02250534|455613786|FG000|Overall Study|Death|0|||
126632579|NCT02250534|455613787|FG001|Overall Study|Death|1|||
126791683|NCT00463606|456193866|FG001|Overall Study|Adverse Event|18|||
126791684|NCT00463606|456193867|FG002|Overall Study|Adverse Event|11|||
126791685|NCT00463606|456193865|FG000|Overall Study|Withdrawal by Subject|11|||
126791686|NCT00463606|456193866|FG001|Overall Study|Withdrawal by Subject|11|||
126791687|NCT00463606|456193867|FG002|Overall Study|Withdrawal by Subject|5|||
126791688|NCT00463606|456193865|FG000|Overall Study|Lost to Follow-up|2|||
126791689|NCT00463606|456193866|FG001|Overall Study|Lost to Follow-up|2|||
126791690|NCT00463606|456193867|FG002|Overall Study|Lost to Follow-up|3|||
126791691|NCT00463606|456193865|FG000|Overall Study|Subject noncompliance|1|||
126632580|NCT02250534|455613788|FG002|Overall Study|Death|1|||
126632581|NCT02250534|455613786|FG000|Overall Study|Physician Decision|1|||
126632582|NCT02250534|455613787|FG001|Overall Study|Physician Decision|3|||
126632583|NCT02250534|455613788|FG002|Overall Study|Physician Decision|1|||
126632584|NCT02250534|455613786|FG000|Overall Study|Protocol Violation|1|||
126632585|NCT02250534|455613787|FG001|Overall Study|Protocol Violation|0|||
126632586|NCT02250534|455613788|FG002|Overall Study|Protocol Violation|1|||
126632587|NCT02250534|455613786|FG000|Overall Study|Reason unknown|1|||
126632588|NCT02250534|455613787|FG001|Overall Study|Reason unknown|0|||
126632589|NCT02250534|455613788|FG002|Overall Study|Reason unknown|0|||
126632590|NCT00217022|455613790|FG000|Overall Study|Withdrawal by Subject|1|||
126632591|NCT00217022|455613791|FG001|Overall Study|Withdrawal by Subject|1|||
126632592|NCT02725567|455613793|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
126632593|NCT02725567|455613794|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
126632594|NCT02725567|455613793|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
126632595|NCT02725567|455613794|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
126632596|NCT02725567|455613793|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
126632597|NCT02725567|455613794|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
126791692|NCT00463606|456193866|FG001|Overall Study|Subject noncompliance|1|||
126791693|NCT00463606|456193867|FG002|Overall Study|Subject noncompliance|0|||
126791694|NCT00463606|456193865|FG000|Overall Study|Subject moved out of town|1|||
126791695|NCT00463606|456193866|FG001|Overall Study|Subject moved out of town|0|||
126791696|NCT00463606|456193867|FG002|Overall Study|Subject moved out of town|0|||
126791697|NCT00463606|456193865|FG000|Overall Study|Physician Decision|0|||
126791698|NCT00463606|456193866|FG001|Overall Study|Physician Decision|1|||
126791699|NCT00463606|456193867|FG002|Overall Study|Physician Decision|0|||
126791700|NCT00463606|456193865|FG000|Overall Study|Sponsor request|0|||
126791701|NCT00463606|456193866|FG001|Overall Study|Sponsor request|1|||
126791702|NCT00463606|456193867|FG002|Overall Study|Sponsor request|0|||
126791703|NCT00463606|456193865|FG000|Overall Study|Exclusion criteria violation|2|||
126791704|NCT00463606|456193866|FG001|Overall Study|Exclusion criteria violation|0|||
126791705|NCT00463606|456193867|FG002|Overall Study|Exclusion criteria violation|0|||
126791706|NCT00463606|456193865|FG000|Overall Study|Coordinator error|1|||
126791707|NCT00463606|456193866|FG001|Overall Study|Coordinator error|0|||
126791708|NCT00463606|456193867|FG002|Overall Study|Coordinator error|0|||
126791709|NCT00463606|456193865|FG000|Overall Study|Patient randomized in error|1|||
126791710|NCT00463606|456193866|FG001|Overall Study|Patient randomized in error|0|||
126791711|NCT00463606|456193867|FG002|Overall Study|Patient randomized in error|0|||
126791712|NCT00463606|456193865|FG000|Overall Study|Participation in another ABT-335 trial|1|||
126791713|NCT00463606|456193866|FG001|Overall Study|Participation in another ABT-335 trial|0|||
126791714|NCT00463606|456193867|FG002|Overall Study|Participation in another ABT-335 trial|0|||
126791715|NCT00463606|456193865|FG000|Overall Study|Protocol Violation|0|||
126791716|NCT00463606|456193866|FG001|Overall Study|Protocol Violation|0|||
126791717|NCT00463606|456193867|FG002|Overall Study|Protocol Violation|1|||
126791718|NCT02682602|456193869|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
126791719|NCT02682602|456193870|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
126791720|NCT02682602|456193869|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
126791721|NCT02682602|456193870|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
126791722|NCT02924038|456195053|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
126791723|NCT02924038|456195054|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
126791724|NCT03601637|456195055|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
126791725|NCT03601637|456195056|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
126791726|NCT03601637|456195055|FG000|Overall Study|Adverse Event|1|||
126791727|NCT03601637|456195056|FG001|Overall Study|Adverse Event|1|||
126791728|NCT03601637|456195055|FG000|Overall Study|Other|0|||
126791729|NCT03601637|456195056|FG001|Overall Study|Other|1|||
126791730|NCT01248247|456195057|FG000|Overall Study|Adverse Event|2|||
126791731|NCT01248247|456195058|FG001|Overall Study|Adverse Event|4|||
126791732|NCT01248247|456195059|FG002|Overall Study|Adverse Event|4|||
126791733|NCT01248247|456195060|FG003|Overall Study|Adverse Event|2|||
126791734|NCT01248247|456195057|FG000|Overall Study|Death|0|||
126791735|NCT01248247|456195058|FG001|Overall Study|Death|1|||
126791736|NCT01248247|456195059|FG002|Overall Study|Death|4|||
126791737|NCT01248247|456195060|FG003|Overall Study|Death|7|||
126791738|NCT01248247|456195057|FG000|Overall Study|Lost to Follow-up|0|||
126791739|NCT01248247|456195058|FG001|Overall Study|Lost to Follow-up|1|||
126632598|NCT00255944|455613795|FG000|Overall Study|Lost to Follow-up|797|||
126791740|NCT01248247|456195059|FG002|Overall Study|Lost to Follow-up|1|||
126791741|NCT01248247|456195060|FG003|Overall Study|Lost to Follow-up|0|||
126632599|NCT00255944|455613796|FG001|Overall Study|Lost to Follow-up|834|||
126632600|NCT01129115|455613797|FG000|Overall Study|Adverse Event|1|||
126632601|NCT01129115|455613798|FG001|Overall Study|Adverse Event|2|||
126791742|NCT01248247|456195057|FG000|Overall Study|Alternative treatment|0|||
126791743|NCT01248247|456195058|FG001|Overall Study|Alternative treatment|1|||
126791744|NCT01248247|456195059|FG002|Overall Study|Alternative treatment|0|||
126791745|NCT01248247|456195060|FG003|Overall Study|Alternative treatment|0|||
126791746|NCT01248247|456195057|FG000|Overall Study|Other|2|||
126791747|NCT01248247|456195058|FG001|Overall Study|Other|8|||
126791748|NCT01248247|456195059|FG002|Overall Study|Other|8|||
126791749|NCT01248247|456195060|FG003|Overall Study|Other|5|||
126791750|NCT01248247|456195057|FG000|Overall Study|Progression|18|||
126791751|NCT01248247|456195058|FG001|Overall Study|Progression|27|||
126791752|NCT01248247|456195059|FG002|Overall Study|Progression|56|||
126791753|NCT01248247|456195060|FG003|Overall Study|Progression|44|||
126791754|NCT01248247|456195057|FG000|Overall Study|Refuse further treatment|0|||
126791755|NCT01248247|456195058|FG001|Overall Study|Refuse further treatment|0|||
126791756|NCT01248247|456195059|FG002|Overall Study|Refuse further treatment|1|||
126791757|NCT01248247|456195060|FG003|Overall Study|Refuse further treatment|2|||
126791758|NCT01248247|456195057|FG000|Overall Study|Complicating disease|0|||
126791759|NCT01248247|456195058|FG001|Overall Study|Complicating disease|0|||
126791760|NCT01248247|456195059|FG002|Overall Study|Complicating disease|1|||
126791761|NCT01248247|456195060|FG003|Overall Study|Complicating disease|1|||
126791762|NCT01108094|456195065|FG000|Overall Study|Adverse Event|2|||
126791763|NCT01108094|456195066|FG001|Overall Study|Adverse Event|0|||
126791764|NCT01108094|456195067|FG002|Overall Study|Adverse Event|0|||
126791765|NCT01108094|456195068|FG003|Overall Study|Adverse Event|0|||
126791766|NCT01108094|456195065|FG000|Overall Study|Withdrawal by Subject|1|||
126791767|NCT01108094|456195066|FG001|Overall Study|Withdrawal by Subject|0|||
126791768|NCT01108094|456195067|FG002|Overall Study|Withdrawal by Subject|0|||
126791769|NCT01108094|456195068|FG003|Overall Study|Withdrawal by Subject|0|||
126791770|NCT00420303|456195071|FG000|Overall Study|Serious Adverse Event|1|||
126791771|NCT00420303|456195072|FG001|Overall Study|Serious Adverse Event|0|||
126791772|NCT00420303|456195071|FG000|Overall Study|Lack of Efficacy|0|||
126791773|NCT00420303|456195072|FG001|Overall Study|Lack of Efficacy|3|||
126791774|NCT00420303|456195071|FG000|Overall Study|Physician Decision|0|||
126791775|NCT00420303|456195072|FG001|Overall Study|Physician Decision|1|||
126791776|NCT04455633|456195076|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
126791777|NCT04455633|456195077|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
126791778|NCT04455633|456195078|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
126791779|NCT04455633|456195076|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
126791780|NCT04455633|456195077|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
126791781|NCT04455633|456195078|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
126791782|NCT04455633|456195076|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
126791783|NCT04455633|456195077|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
126791784|NCT04455633|456195078|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
126791785|NCT04455633|456195076|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
126791786|NCT04455633|456195077|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
126791787|NCT04455633|456195078|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
126791788|NCT04015232|456195080|FG000|Overall Study|Withdrawal by Subject|7|||
126791789|NCT04015232|456195081|FG001|Overall Study|Withdrawal by Subject|4|||
126791790|NCT04015232|456195080|FG000|Overall Study|Protocol Violation|1|||
126791791|NCT04015232|456195081|FG001|Overall Study|Protocol Violation|0|||
126791792|NCT04015232|456195080|FG000|Overall Study|Medical Grounds|3|||
126791793|NCT04015232|456195081|FG001|Overall Study|Medical Grounds|3|||
126791794|NCT00727571|456195084|FG000|Overall Study|Ineligibility determined|1|||
126791795|NCT00727571|456195085|FG001|Overall Study|Ineligibility determined|1|||
126791796|NCT00727571|456195086|FG002|Overall Study|Ineligibility determined|1|||
126791797|NCT00727571|456195087|FG003|Overall Study|Ineligibility determined|0|||
126791798|NCT00727571|456195084|FG000|Overall Study|Death|0|||
126791799|NCT00727571|456195085|FG001|Overall Study|Death|19|||
126791800|NCT00727571|456195086|FG002|Overall Study|Death|5|||
126791801|NCT00727571|456195087|FG003|Overall Study|Death|1|||
126791802|NCT00727571|456195084|FG000|Overall Study|Physician Decision|0|||
126791803|NCT00727571|456195085|FG001|Overall Study|Physician Decision|5|||
126791804|NCT00727571|456195086|FG002|Overall Study|Physician Decision|0|||
126791805|NCT00727571|456195087|FG003|Overall Study|Physician Decision|0|||
126791806|NCT00727571|456195084|FG000|Overall Study|Withdrawal by Subject|0|||
126791807|NCT00727571|456195085|FG001|Overall Study|Withdrawal by Subject|10|||
126791808|NCT00727571|456195086|FG002|Overall Study|Withdrawal by Subject|11|||
126791809|NCT00727571|456195087|FG003|Overall Study|Withdrawal by Subject|0|||
126791810|NCT00727571|456195084|FG000|Overall Study|Subject Non Compliance|0|||
126791811|NCT00727571|456195085|FG001|Overall Study|Subject Non Compliance|6|||
126791812|NCT00727571|456195086|FG002|Overall Study|Subject Non Compliance|0|||
126791813|NCT00727571|456195087|FG003|Overall Study|Subject Non Compliance|4|||
126791814|NCT00727571|456195084|FG000|Overall Study|Dismissed from nursing home|0|||
126791815|NCT00727571|456195085|FG001|Overall Study|Dismissed from nursing home|9|||
126791816|NCT00727571|456195086|FG002|Overall Study|Dismissed from nursing home|5|||
126791817|NCT00727571|456195087|FG003|Overall Study|Dismissed from nursing home|0|||
126791818|NCT00727571|456195084|FG000|Overall Study|Hospitalization|0|||
126791819|NCT00727571|456195085|FG001|Overall Study|Hospitalization|1|||
126791820|NCT00727571|456195086|FG002|Overall Study|Hospitalization|0|||
126791821|NCT00727571|456195087|FG003|Overall Study|Hospitalization|1|||
126755561|NCT01351415|456054756|FG000|Overall Study|Reason unknown|0|||
126755562|NCT01351415|456054757|FG001|Overall Study|Reason unknown|2|||
126755563|NCT01351415|456054756|FG000|Overall Study|Never Started|5|||
126755564|NCT01351415|456054757|FG001|Overall Study|Never Started|5|||
126755565|NCT00699582|456054763|FG000|Overall Study|Adverse Event|4|||
126755566|NCT00699582|456054764|FG001|Overall Study|Adverse Event|11|||
126755567|NCT00699582|456054765|FG002|Overall Study|Adverse Event|23|||
126755568|NCT00699582|456054763|FG000|Overall Study|Withdrawal by Subject|6|||
126755569|NCT00699582|456054764|FG001|Overall Study|Withdrawal by Subject|7|||
126755570|NCT00699582|456054765|FG002|Overall Study|Withdrawal by Subject|4|||
126755571|NCT00699582|456054763|FG000|Overall Study|Lack of Efficacy|1|||
126755572|NCT00699582|456054764|FG001|Overall Study|Lack of Efficacy|0|||
126755573|NCT00699582|456054765|FG002|Overall Study|Lack of Efficacy|1|||
126755574|NCT00699582|456054763|FG000|Overall Study|Progressive Disease|1|||
126755575|NCT00699582|456054764|FG001|Overall Study|Progressive Disease|0|||
126755576|NCT00699582|456054765|FG002|Overall Study|Progressive Disease|0|||
126755577|NCT00699582|456054763|FG000|Overall Study|Administrative/Other|4|||
126755578|NCT00699582|456054764|FG001|Overall Study|Administrative/Other|3|||
126755579|NCT00699582|456054765|FG002|Overall Study|Administrative/Other|0|||
126755580|NCT00699582|456054763|FG000|Overall Study|Randomized, Not Treated|2|||
126755581|NCT00699582|456054764|FG001|Overall Study|Randomized, Not Treated|1|||
126755582|NCT00699582|456054765|FG002|Overall Study|Randomized, Not Treated|0|||
126755583|NCT04212221|456054766|FG000|Overall Study|Remained on Treatment|0|||
126755584|NCT04212221|456054767|FG001|Overall Study|Remained on Treatment|0|||
126755585|NCT04212221|456054768|FG002|Overall Study|Remained on Treatment|0|||
126755586|NCT04212221|456054769|FG003|Overall Study|Remained on Treatment|1|||
126755587|NCT04212221|456054770|FG004|Overall Study|Remained on Treatment|0|||
126755588|NCT04212221|456054771|FG005|Overall Study|Remained on Treatment|0|||
126755589|NCT04212221|456054772|FG006|Overall Study|Remained on Treatment|3|||
126755590|NCT04212221|456054773|FG007|Overall Study|Remained on Treatment|9|||
126755591|NCT04212221|456054766|FG000|Overall Study|Adverse Event|0|||
126755592|NCT04212221|456054767|FG001|Overall Study|Adverse Event|0|||
126755593|NCT04212221|456054768|FG002|Overall Study|Adverse Event|0|||
126755594|NCT04212221|456054769|FG003|Overall Study|Adverse Event|0|||
126755595|NCT04212221|456054770|FG004|Overall Study|Adverse Event|0|||
126755596|NCT04212221|456054771|FG005|Overall Study|Adverse Event|0|||
126755597|NCT04212221|456054772|FG006|Overall Study|Adverse Event|2|||
126755598|NCT04212221|456054773|FG007|Overall Study|Adverse Event|3|||
126755599|NCT04212221|456054766|FG000|Overall Study|Death|0|||
126755600|NCT04212221|456054767|FG001|Overall Study|Death|0|||
126755601|NCT04212221|456054768|FG002|Overall Study|Death|0|||
126755602|NCT04212221|456054769|FG003|Overall Study|Death|0|||
126755603|NCT04212221|456054770|FG004|Overall Study|Death|0|||
126755604|NCT04212221|456054771|FG005|Overall Study|Death|0|||
126755605|NCT04212221|456054772|FG006|Overall Study|Death|0|||
126755606|NCT04212221|456054773|FG007|Overall Study|Death|2|||
126755607|NCT04212221|456054766|FG000|Overall Study|Disease progression according to irRECIST|1|||
126755608|NCT04212221|456054767|FG001|Overall Study|Disease progression according to irRECIST|2|||
126755609|NCT04212221|456054768|FG002|Overall Study|Disease progression according to irRECIST|3|||
126755610|NCT04212221|456054769|FG003|Overall Study|Disease progression according to irRECIST|3|||
126755611|NCT04212221|456054770|FG004|Overall Study|Disease progression according to irRECIST|2|||
126755612|NCT04212221|456054771|FG005|Overall Study|Disease progression according to irRECIST|2|||
126755613|NCT04212221|456054772|FG006|Overall Study|Disease progression according to irRECIST|21|||
126755614|NCT04212221|456054773|FG007|Overall Study|Disease progression according to irRECIST|17|||
126755615|NCT04212221|456054766|FG000|Overall Study|Global Deterioration of Health Status|0|||
126755616|NCT04212221|456054767|FG001|Overall Study|Global Deterioration of Health Status|0|||
126755617|NCT04212221|456054768|FG002|Overall Study|Global Deterioration of Health Status|0|||
126755618|NCT04212221|456054769|FG003|Overall Study|Global Deterioration of Health Status|0|||
126755619|NCT04212221|456054770|FG004|Overall Study|Global Deterioration of Health Status|0|||
126755620|NCT04212221|456054771|FG005|Overall Study|Global Deterioration of Health Status|0|||
126755621|NCT04212221|456054772|FG006|Overall Study|Global Deterioration of Health Status|0|||
126755622|NCT04212221|456054773|FG007|Overall Study|Global Deterioration of Health Status|2|||
126755623|NCT04212221|456054766|FG000|Overall Study|Investigator's Decision|0|||
126755624|NCT04212221|456054767|FG001|Overall Study|Investigator's Decision|0|||
126755625|NCT04212221|456054768|FG002|Overall Study|Investigator's Decision|0|||
126755626|NCT04212221|456054769|FG003|Overall Study|Investigator's Decision|1|||
126755627|NCT04212221|456054770|FG004|Overall Study|Investigator's Decision|0|||
126755628|NCT04212221|456054771|FG005|Overall Study|Investigator's Decision|0|||
126755629|NCT04212221|456054772|FG006|Overall Study|Investigator's Decision|3|||
126755630|NCT04212221|456054773|FG007|Overall Study|Investigator's Decision|0|||
126755631|NCT04212221|456054766|FG000|Overall Study|Participant refused to continue treatment|0|||
126755632|NCT04212221|456054767|FG001|Overall Study|Participant refused to continue treatment|1|||
126755633|NCT04212221|456054768|FG002|Overall Study|Participant refused to continue treatment|0|||
126755634|NCT04212221|456054769|FG003|Overall Study|Participant refused to continue treatment|1|||
126755635|NCT04212221|456054770|FG004|Overall Study|Participant refused to continue treatment|1|||
126791822|NCT00727571|456195084|FG000|Overall Study|AE not leading to hospitalization|0|||
126791823|NCT00727571|456195085|FG001|Overall Study|AE not leading to hospitalization|0|||
126791824|NCT00727571|456195086|FG002|Overall Study|AE not leading to hospitalization|2|||
126791825|NCT00727571|456195087|FG003|Overall Study|AE not leading to hospitalization|0|||
126791826|NCT00727571|456195084|FG000|Overall Study|Other|0|||
126791827|NCT00727571|456195085|FG001|Overall Study|Other|4|||
126791828|NCT00727571|456195086|FG002|Overall Study|Other|6|||
126791829|NCT00727571|456195087|FG003|Overall Study|Other|0|||
126791830|NCT03164772|456195088|FG000|Overall Study|Death|4|||
126791831|NCT03164772|456195089|FG001|Overall Study|Death|2|||
126791832|NCT03164772|456195088|FG000|Overall Study|Adverse Event|1|||
126791833|NCT03164772|456195089|FG001|Overall Study|Adverse Event|4|||
126791834|NCT03164772|456195088|FG000|Overall Study|Progressive Disease|11|||
126791835|NCT03164772|456195089|FG001|Overall Study|Progressive Disease|21|||
126791836|NCT03164772|456195088|FG000|Overall Study|Physician Decision|2|||
126791837|NCT03164772|456195089|FG001|Overall Study|Physician Decision|0|||
126791838|NCT03164772|456195088|FG000|Overall Study|Withdrawal by Subject|0|||
126791839|NCT03164772|456195089|FG001|Overall Study|Withdrawal by Subject|4|||
126791840|NCT01029353|456195091|FG000|Overall Study|Lost to Follow-up|4|||
126791841|NCT01029353|456195092|FG001|Overall Study|Lost to Follow-up|5|||
126791842|NCT01029353|456195093|FG002|Overall Study|Lost to Follow-up|5|||
126791843|NCT01029353|456195094|FG003|Overall Study|Lost to Follow-up|4|||
126791844|NCT01029353|456195091|FG000|Overall Study|Consent Withdrawn|2|||
126791845|NCT01029353|456195092|FG001|Overall Study|Consent Withdrawn|0|||
126791846|NCT01029353|456195093|FG002|Overall Study|Consent Withdrawn|0|||
126791847|NCT01029353|456195094|FG003|Overall Study|Consent Withdrawn|0|||
126791848|NCT01029353|456195091|FG000|Overall Study|Primary Outcome Indeterminate|1|||
126791849|NCT01029353|456195092|FG001|Overall Study|Primary Outcome Indeterminate|3|||
126791850|NCT01029353|456195093|FG002|Overall Study|Primary Outcome Indeterminate|2|||
126791851|NCT01029353|456195094|FG003|Overall Study|Primary Outcome Indeterminate|0|||
126791852|NCT01900730|456195095|FG000|Overall Study|Withdrawal by Subject|1|||
126791853|NCT01900730|456195096|FG001|Overall Study|Withdrawal by Subject|0|||
126791854|NCT01900730|456195095|FG000|Overall Study|Screen Failure|1|||
126791855|NCT01900730|456195096|FG001|Overall Study|Screen Failure|0|||
126791856|NCT02152566|456195097|FG000|Overall Study|Lost to Follow-up|1|||
126791857|NCT02152566|456195097|FG000|Overall Study|Withdrawal by Subject|2|||
126791858|NCT03603314|456195100|FG000|Overall Study|Lost to Follow-up|0|||
126791859|NCT03603314|456195101|FG001|Overall Study|Lost to Follow-up|3|||
126791860|NCT03603314|456195102|FG002|Overall Study|Lost to Follow-up|0|||
126791861|NCT03603314|456195100|FG000|Overall Study|Protocol Violation|0|||
126791862|NCT03603314|456195101|FG001|Overall Study|Protocol Violation|1|||
126791863|NCT03603314|456195102|FG002|Overall Study|Protocol Violation|0|||
126791864|NCT03603314|456195100|FG000|Overall Study|Adverse Event|2|||
126791865|NCT03603314|456195101|FG001|Overall Study|Adverse Event|0|||
126791866|NCT03603314|456195102|FG002|Overall Study|Adverse Event|0|||
126791867|NCT03603314|456195100|FG000|Overall Study|Physician Decision|1|||
126791868|NCT03603314|456195101|FG001|Overall Study|Physician Decision|1|||
126791869|NCT03603314|456195102|FG002|Overall Study|Physician Decision|0|||
126791870|NCT03603314|456195100|FG000|Overall Study|Withdrawal by Subject|4|||
126791871|NCT03603314|456195101|FG001|Overall Study|Withdrawal by Subject|5|||
126791872|NCT03603314|456195102|FG002|Overall Study|Withdrawal by Subject|3|||
126791873|NCT03603314|456195100|FG000|Overall Study|Other|0|||
126791874|NCT03603314|456195101|FG001|Overall Study|Other|1|||
126791875|NCT03603314|456195102|FG002|Overall Study|Other|0|||
126791876|NCT03450070|456195103|FG000|Overall Study|Withdrawal by Subject|8|||
126791877|NCT02107092|456195106|FG000|Overall Study|Miscellaneous|3|||
126791878|NCT02107092|456195106|FG000|Overall Study|Subject compliance|3|||
126791879|NCT02107092|456195106|FG000|Overall Study|Hypo-or hyperkalemia|2|||
126791880|NCT02107092|456195106|FG000|Overall Study|Met ECG withdrawal criteria|3|||
126791881|NCT02107092|456195106|FG000|Overall Study|Physician Decision|3|||
126791882|NCT02107092|456195106|FG000|Overall Study|Lost to Follow-up|2|||
126791883|NCT02107092|456195106|FG000|Overall Study|Withdrawal by Subject|9|||
126791884|NCT02107092|456195106|FG000|Overall Study|Adverse Event|7|||
126791885|NCT02107092|456195106|FG000|Overall Study|Expected progression of CKD|12|||
126791886|NCT00707161|456195107|FG000|Overall Study|Physician Decision|6|||
126791887|NCT02661295|456195110|FG000|Overall Study|Death|1|||
126791888|NCT02661295|456195110|FG000|Overall Study|Transferred Out|1|||
126791889|NCT02661295|456195110|FG000|Overall Study|Kidney Transplant|1|||
126791890|NCT02661295|456195110|FG000|Overall Study|Withdrawn due to side effects|8|||
126791891|NCT02661295|456195110|FG000|Overall Study|Withdrawn due to access type|1|||
126791892|NCT02661295|456195110|FG000|Overall Study|Withdrawn due to allergies|1|||
126791893|NCT02661295|456195110|FG000|Overall Study|Withdrawn due to non-compliance|1|||
126791894|NCT02661295|456195110|FG000|Overall Study|Withdrawal by Subject|3|||
126791895|NCT02661295|456195110|FG000|Overall Study|Failed screening|2|||
126791896|NCT00565448|456195116|FG000|Overall Study|Adverse Event|1|||
126791897|NCT00565448|456195117|FG001|Overall Study|Adverse Event|2|||
126791898|NCT00565448|456195116|FG000|Overall Study|Disease progression|1|||
126791899|NCT00565448|456195117|FG001|Overall Study|Disease progression|0|||
126791900|NCT00565448|456195116|FG000|Overall Study|Withdrawal by Subject|1|||
126791901|NCT00565448|456195117|FG001|Overall Study|Withdrawal by Subject|0|||
126791902|NCT00302952|456195118|FG000|Overall Study|Physician Decision|1|||
126791903|NCT00302952|456195119|FG001|Overall Study|Physician Decision|1|||
126791904|NCT00302952|456195118|FG000|Overall Study|Withdrawal by Subject|2|||
126791905|NCT00302952|456195119|FG001|Overall Study|Withdrawal by Subject|3|||
126791906|NCT00302952|456195118|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
126791907|NCT00302952|456195119|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
126791908|NCT02373098|456195122|FG000|Overall Study|Lost to Follow-up|1|||
126791909|NCT02373098|456195123|FG001|Overall Study|Lost to Follow-up|0|||
126791910|NCT02373098|456195122|FG000|Overall Study|Protocol Violation|3|||
126791911|NCT02373098|456195123|FG001|Overall Study|Protocol Violation|0|||
126791912|NCT02373098|456195122|FG000|Overall Study|Withdrawal by Subject|5|||
126791913|NCT02373098|456195123|FG001|Overall Study|Withdrawal by Subject|0|||
126791914|NCT02373098|456195122|FG000|Overall Study|Adverse Event|3|||
126791915|NCT02373098|456195123|FG001|Overall Study|Adverse Event|0|||
126791916|NCT00420238|456195124|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
126791917|NCT00420238|456195125|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
126791918|NCT00420238|456195124|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
126791919|NCT00420238|456195125|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
126791920|NCT00420238|456195124|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
126791921|NCT00420238|456195125|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
126791922|NCT00420238|456195124|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
126791923|NCT00420238|456195125|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
126791924|NCT00420238|456195124|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
126791925|NCT00420238|456195125|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
126791926|NCT00420238|456195124|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
126791927|NCT00420238|456195125|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
126791928|NCT05214560|456195126|FG000|Overall Study|Screening Failure|1|||
126791929|NCT05214560|456195126|FG000|Overall Study|Physician Decision|4|||
126791930|NCT05214560|456195126|FG000|Overall Study|Withdrawal by Subject|1|||
126791931|NCT05214560|456195126|FG000|Overall Study|Lost to Follow-up|2|||
126791932|NCT05214560|456195126|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
126791933|NCT05214560|456195126|FG000|Overall Study|Study physician not available for the anesthesia|3|||
126791934|NCT05214560|456195126|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
126791935|NCT05214560|456195126|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
126791936|NCT05214560|456195126|FG000|Overall Study|Surgery not performed|3|||
126791937|NCT03639311|456195127|FG000|Maintenance Phase|Lost to Follow-up|1|||
126791938|NCT03639311|456195128|FG001|Maintenance Phase|Lost to Follow-up|0|||
126791939|NCT03639311|456195129|FG002|Maintenance Phase|Lost to Follow-up|0|||
126791940|NCT03639311|456195127|FG000|Maintenance Phase|Adverse Event|1|||
126791941|NCT03639311|456195128|FG001|Maintenance Phase|Adverse Event|0|||
126791942|NCT03639311|456195129|FG002|Maintenance Phase|Adverse Event|0|||
126791943|NCT03639311|456195127|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
126791944|NCT03639311|456195128|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
126791945|NCT03639311|456195129|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
126791946|NCT03639311|456195127|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
126791947|NCT03639311|456195128|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
126791948|NCT03639311|456195129|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
126791949|NCT03639311|456195127|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
126791950|NCT03639311|456195128|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
126791951|NCT03639311|456195129|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
126791952|NCT03639311|456195127|FG000|Maintenance Phase|Lack of Efficacy|1|||
126791953|NCT03639311|456195128|FG001|Maintenance Phase|Lack of Efficacy|0|||
126791954|NCT03639311|456195129|FG002|Maintenance Phase|Lack of Efficacy|0|||
126791955|NCT03018249|456195130|FG000|Overall Study|Withdrawal by Subject|2|||
126791956|NCT03018249|456195131|FG001|Overall Study|Withdrawal by Subject|2|||
126791957|NCT00304083|456195139|FG000|Overall Study|Withdrawal by Subject|4|||
126791958|NCT00304083|456195140|FG001|Overall Study|Withdrawal by Subject|2|||
126791959|NCT00304083|456195139|FG000|Overall Study|Physician Decision|8|||
126791960|NCT00304083|456195140|FG001|Overall Study|Physician Decision|3|||
126791961|NCT00304083|456195139|FG000|Overall Study|Disease Progression|5|||
126791962|NCT00304083|456195140|FG001|Overall Study|Disease Progression|1|||
126791963|NCT00304083|456195139|FG000|Overall Study|Other|5|||
126791964|NCT00304083|456195140|FG001|Overall Study|Other|2|||
126791965|NCT03966365|456195143|FG000|Overall Study|Protocol Violation|1|||
126791966|NCT03966365|456195144|FG001|Overall Study|Protocol Violation|0|||
126791967|NCT01044732|456195145|FG000|Overall Study|Lost to Follow-up|2|||
126791968|NCT01044732|456195146|FG001|Overall Study|Lost to Follow-up|1|||
126791969|NCT01044732|456195145|FG000|Overall Study|Physician Decision|5|||
126791970|NCT01044732|456195146|FG001|Overall Study|Physician Decision|3|||
126791971|NCT01044732|456195145|FG000|Overall Study|Protocol Violation|11|||
126791972|NCT01044732|456195146|FG001|Overall Study|Protocol Violation|12|||
126791973|NCT01044732|456195145|FG000|Overall Study|Withdrawal by Subject|0|||
126791974|NCT01044732|456195146|FG001|Overall Study|Withdrawal by Subject|1|||
126791975|NCT01044732|456195145|FG000|Overall Study|Inadequate bowel preparation|11|||
126791976|NCT01044732|456195146|FG001|Overall Study|Inadequate bowel preparation|17|||
126791977|NCT01044732|456195145|FG000|Overall Study|Inability to reach cecum|5|||
126791978|NCT01044732|456195146|FG001|Overall Study|Inability to reach cecum|2|||
126791979|NCT01044732|456195145|FG000|Overall Study|Technical error or malfunction|15|||
126791980|NCT01044732|456195146|FG001|Overall Study|Technical error or malfunction|14|||
126791981|NCT00824265|456195149|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
126791982|NCT00824265|456195150|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
126791983|NCT00824265|456195149|FG000|Treatment Phase|Protocol Violation|1|||
126791984|NCT00824265|456195150|FG001|Treatment Phase|Protocol Violation|0|||
126791985|NCT00824265|456195149|FG000|Treatment Phase|Lost to Follow-up|1|||
126791986|NCT00824265|456195150|FG001|Treatment Phase|Lost to Follow-up|1|||
126791987|NCT00824265|456195149|FG000|Treatment Phase|Physician Decision|6|||
126791988|NCT00824265|456195150|FG001|Treatment Phase|Physician Decision|12|||
126791989|NCT00824265|456195149|FG000|Treatment Phase|Withdrawal by Subject|6|||
126791990|NCT00824265|456195150|FG001|Treatment Phase|Withdrawal by Subject|15|||
126791991|NCT00824265|456195149|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
126791992|NCT00824265|456195150|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
126791993|NCT00824265|456195149|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
126791994|NCT00824265|456195150|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
126791995|NCT01402947|456195153|FG000|First Intervention|Adverse Event|0|||
126791996|NCT01402947|456195154|FG001|First Intervention|Adverse Event|1|||
126791997|NCT00385684|456195155|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
126791998|NCT00385684|456195156|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
126791999|NCT00385684|456195155|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
126792000|NCT00385684|456195156|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
126792001|NCT00385684|456195155|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
126792002|NCT00385684|456195156|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
126792003|NCT02801877|456195157|FG000|Overall Study|Lost to Follow-up|1|||
126792004|NCT02801877|456195158|FG001|Overall Study|Lost to Follow-up|1|||
126792005|NCT02801877|456195159|FG002|Overall Study|Lost to Follow-up|2|||
126792006|NCT02801877|456195160|FG003|Overall Study|Lost to Follow-up|0|||
126792007|NCT02801877|456195157|FG000|Overall Study|Never Started Treatment|2|||
126792008|NCT02801877|456195158|FG001|Overall Study|Never Started Treatment|0|||
126792009|NCT02801877|456195159|FG002|Overall Study|Never Started Treatment|4|||
126792010|NCT02801877|456195160|FG003|Overall Study|Never Started Treatment|0|||
126792011|NCT00591630|456195161|FG000|Overall Study|Death|0|||
126792012|NCT00591630|456195162|FG001|Overall Study|Death|0|||
126792013|NCT00591630|456195163|FG002|Overall Study|Death|1|||
126792014|NCT00591630|456195164|FG003|Overall Study|Death|0|||
126792015|NCT04349917|456196829|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
126792016|NCT04349917|456196830|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
126792017|NCT04349917|456196829|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
126792018|NCT04349917|456196830|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
126792019|NCT04188106|456196831|FG000|Overall Study|Lost to Follow-up|5|||
126792020|NCT04188106|456196831|FG000|Overall Study|Non-Compliance|1|||
126792021|NCT01507051|456196833|FG000|Overall Study|Withdrawal by Subject|1|||
126792022|NCT01507051|456196834|FG001|Overall Study|Withdrawal by Subject|3|||
126792023|NCT01507051|456196835|FG002|Overall Study|Withdrawal by Subject|1|||
126792024|NCT01507051|456196836|FG003|Overall Study|Withdrawal by Subject|6|||
126792025|NCT01507051|456196833|FG000|Overall Study|Physician Decision|0|||
126792026|NCT01507051|456196834|FG001|Overall Study|Physician Decision|0|||
126792027|NCT01507051|456196835|FG002|Overall Study|Physician Decision|0|||
126792028|NCT01507051|456196836|FG003|Overall Study|Physician Decision|1|||
126792029|NCT01507051|456196833|FG000|Overall Study|Adverse Event|1|||
126792030|NCT01507051|456196834|FG001|Overall Study|Adverse Event|0|||
126792031|NCT01507051|456196835|FG002|Overall Study|Adverse Event|0|||
126792032|NCT01507051|456196836|FG003|Overall Study|Adverse Event|0|||
126792033|NCT02311361|456196837|FG000|Overall Study|Did not receive treatment|0|||
126792034|NCT02311361|456196838|FG001|Overall Study|Did not receive treatment|1|||
126792035|NCT02311361|456196839|FG002|Overall Study|Did not receive treatment|0|||
126632602|NCT01129115|455613799|FG002|Overall Study|Adverse Event|3|||
126632603|NCT01129115|455613800|FG003|Overall Study|Adverse Event|3|||
126632604|NCT01129115|455613797|FG000|Overall Study|Withdrawal by Subject|1|||
126632605|NCT01129115|455613798|FG001|Overall Study|Withdrawal by Subject|3|||
126792036|NCT02311361|456196840|FG003|Overall Study|Did not receive treatment|1|||
126792037|NCT00745420|456196842|FG000|Overall Study|Ineligible|1|||
126792038|NCT02653664|456196843|FG000|Post-Treatment|Withdrawal by Subject|6|||
126792039|NCT02653664|456196844|FG001|Post-Treatment|Withdrawal by Subject|5|||
126792040|NCT02653664|456196845|FG002|Post-Treatment|Withdrawal by Subject|7|||
126792041|NCT02653664|456196843|FG000|Post-Treatment|Lost to Follow-up|8|||
126792042|NCT02653664|456196844|FG001|Post-Treatment|Lost to Follow-up|1|||
126792043|NCT02653664|456196845|FG002|Post-Treatment|Lost to Follow-up|7|||
126792044|NCT02653664|456196843|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
126792045|NCT02653664|456196844|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
126792046|NCT02653664|456196845|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
126792047|NCT02653664|456196843|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
126792048|NCT02653664|456196844|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
126792049|NCT02653664|456196845|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
126792050|NCT02653664|456196843|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
126792051|NCT02653664|456196844|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
126792052|NCT02653664|456196845|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
126792053|NCT02653664|456196843|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
126792054|NCT02653664|456196844|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
126792055|NCT02653664|456196845|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
126792056|NCT02653664|456196843|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
126632606|NCT01129115|455613799|FG002|Overall Study|Withdrawal by Subject|1|||
126632607|NCT01129115|455613800|FG003|Overall Study|Withdrawal by Subject|4|||
126632608|NCT01129115|455613797|FG000|Overall Study|Protocol Violation|0|||
126632609|NCT01129115|455613798|FG001|Overall Study|Protocol Violation|2|||
126632610|NCT01129115|455613799|FG002|Overall Study|Protocol Violation|2|||
126632611|NCT01129115|455613800|FG003|Overall Study|Protocol Violation|2|||
126632612|NCT00817336|455613803|FG000|Overall Study|Withdrawal by Subject|1|||
126632613|NCT00817336|455613804|FG001|Overall Study|Withdrawal by Subject|1|||
126792057|NCT02653664|456196844|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
126792058|NCT02653664|456196845|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
126792059|NCT02653664|456196843|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
126792060|NCT02653664|456196844|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
126792061|NCT02653664|456196845|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
126792062|NCT02653664|456196843|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
126792063|NCT02653664|456196844|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
126792064|NCT02653664|456196845|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
126792065|NCT02653664|456196843|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
126792066|NCT02653664|456196844|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
126792067|NCT02653664|456196845|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
126792068|NCT00485472|456196846|FG000|Overall Study|Adverse Event|8|||
126792069|NCT00485472|456196847|FG001|Overall Study|Adverse Event|5|||
126792070|NCT00485472|456196846|FG000|Overall Study|Lack of Efficacy|5|||
126792071|NCT00485472|456196847|FG001|Overall Study|Lack of Efficacy|4|||
126792072|NCT00485472|456196846|FG000|Overall Study|Withdrawal by Subject|1|||
126792073|NCT00485472|456196847|FG001|Overall Study|Withdrawal by Subject|0|||
126792074|NCT00485472|456196846|FG000|Overall Study|Protocol Violation|0|||
126792075|NCT00485472|456196847|FG001|Overall Study|Protocol Violation|1|||
126792076|NCT00485472|456196846|FG000|Overall Study|Other|2|||
126792077|NCT00485472|456196847|FG001|Overall Study|Other|1|||
126792078|NCT00485472|456196846|FG000|Overall Study|Lost to Follow-up|0|||
126792079|NCT00485472|456196847|FG001|Overall Study|Lost to Follow-up|1|||
126792080|NCT00088829|456196849|FG000|Overall Study|PI left institution and study was close|22|||
126792081|NCT00633594|456196850|FG000|Overall Study|Adverse Event|0|||
126792082|NCT00633594|456196851|FG001|Overall Study|Adverse Event|4|||
126792083|NCT00633594|456196852|FG002|Overall Study|Adverse Event|7|||
126792084|NCT00633594|456196850|FG000|Overall Study|Death|0|||
126792085|NCT00633594|456196851|FG001|Overall Study|Death|1|||
126792086|NCT00633594|456196852|FG002|Overall Study|Death|2|||
126792087|NCT00633594|456196850|FG000|Overall Study|Disease Progression|0|||
126792088|NCT00633594|456196851|FG001|Overall Study|Disease Progression|0|||
126792089|NCT00633594|456196852|FG002|Overall Study|Disease Progression|1|||
126792090|NCT00365300|456196857|FG000|Open-label Phase|Adverse Event|4|||
126792091|NCT00365300|456196858|FG001|Open-label Phase|Adverse Event|0|||
126792092|NCT00365300|456196857|FG000|Open-label Phase|Failed to Return|1|||
126792093|NCT00365300|456196858|FG001|Open-label Phase|Failed to Return|0|||
126792094|NCT00365300|456196857|FG000|Open-label Phase|Physician Decision|1|||
126792095|NCT00365300|456196858|FG001|Open-label Phase|Physician Decision|0|||
126792096|NCT00365300|456196857|FG000|Open-label Phase|Noncompliance|9|||
126792097|NCT00365300|456196858|FG001|Open-label Phase|Noncompliance|0|||
126792098|NCT00365300|456196857|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
126792099|NCT00365300|456196858|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
126792100|NCT00365300|456196857|FG000|Open-label Phase|Protocol Violation|1|||
126792101|NCT00365300|456196858|FG001|Open-label Phase|Protocol Violation|0|||
126632614|NCT02108652|455613805|FG000|Overall Study|Death|253|||
126632615|NCT02108652|455613805|FG000|Overall Study|Lost to Follow-up|2|||
126632616|NCT02108652|455613805|FG000|Overall Study|Withdrawal by Subject|16|||
126632617|NCT02108652|455613805|FG000|Overall Study|Study Terminated By Sponsor|31|||
126632618|NCT02108652|455613805|FG000|Overall Study|Non-Compliance|1|||
126632619|NCT02108652|455613805|FG000|Overall Study|Physician Decision|6|||
126792102|NCT00365300|456196857|FG000|Open-label Phase|Lack of Efficacy|1|||
126792103|NCT00365300|456196858|FG001|Open-label Phase|Lack of Efficacy|0|||
126792104|NCT00365300|456196857|FG000|Open-label Phase|Patient skipped open label phase|1|||
126792105|NCT00365300|456196858|FG001|Open-label Phase|Patient skipped open label phase|0|||
126632620|NCT02108652|455613805|FG000|Overall Study|Progression Of Disease|1|||
126792106|NCT00365300|456196857|FG000|Double-blind Phase|Failed to return|1|||
126792107|NCT00365300|456196858|FG001|Double-blind Phase|Failed to return|0|||
126792108|NCT00365300|456196857|FG000|Double-blind Phase|Noncompliance|1|||
126792109|NCT00365300|456196858|FG001|Double-blind Phase|Noncompliance|1|||
126792110|NCT00365300|456196857|FG000|Double-blind Phase|Withdrawal by Subject|0|||
126792111|NCT00365300|456196858|FG001|Double-blind Phase|Withdrawal by Subject|1|||
126792112|NCT00365300|456196857|FG000|Double-blind Phase|Protocol Violation|3|||
126792113|NCT00365300|456196858|FG001|Double-blind Phase|Protocol Violation|1|||
126792114|NCT00365300|456196857|FG000|Double-blind Phase|Lack of Efficacy|6|||
126792115|NCT00365300|456196858|FG001|Double-blind Phase|Lack of Efficacy|6|||
126792116|NCT01287013|456196860|FG000|Overall Study|Non-evaluable|3|||
126792117|NCT01287013|456196861|FG001|Overall Study|Non-evaluable|5|||
126792118|NCT01287013|456196862|FG002|Overall Study|Non-evaluable|21|||
126792119|NCT01179048|456196863|FG000|Overall Study|Withdrawn - does not allow contact|4|||
126792120|NCT01179048|456196864|FG001|Overall Study|Withdrawn - does not allow contact|8|||
126792121|NCT01179048|456196863|FG000|Overall Study|Lost to Follow-up|8|||
126792122|NCT01179048|456196864|FG001|Overall Study|Lost to Follow-up|9|||
126792123|NCT01179048|456196863|FG000|Overall Study|Alive|127|||
126792124|NCT01179048|456196864|FG001|Overall Study|Alive|142|||
126792125|NCT02109042|456196865|FG000|Overall Study|Sponsor Decision|15|||
126792126|NCT03203447|456196866|FG000|Overall Study|Withdrawal by Subject|2|||
126792127|NCT03203447|456196867|FG001|Overall Study|Withdrawal by Subject|1|||
126792128|NCT03203447|456196866|FG000|Overall Study|Lost to Follow-up|1|||
126792129|NCT03203447|456196867|FG001|Overall Study|Lost to Follow-up|10|||
126792130|NCT03203447|456196866|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
126792131|NCT03203447|456196867|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
126792132|NCT00528606|456196869|FG000|Overall Study|Withdrew consent|4|||
126792133|NCT00528606|456196870|FG001|Overall Study|Withdrew consent|3|||
126792134|NCT00528606|456196869|FG000|Overall Study|Lost to Follow-up|4|||
126792135|NCT00528606|456196870|FG001|Overall Study|Lost to Follow-up|1|||
126792136|NCT00528606|456196869|FG000|Overall Study|Adverse Event|3|||
126792137|NCT00528606|456196870|FG001|Overall Study|Adverse Event|0|||
126792138|NCT00528606|456196869|FG000|Overall Study|Other|2|||
126792139|NCT00528606|456196870|FG001|Overall Study|Other|0|||
126792140|NCT01520909|456196879|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
126792141|NCT01520909|456196880|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
126792142|NCT01520909|456196881|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
126792143|NCT01520909|456196879|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
126792144|NCT01520909|456196880|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
126792145|NCT01520909|456196881|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
126792146|NCT01520909|456196879|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
126792147|NCT01520909|456196880|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
126792148|NCT01520909|456196881|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
126792149|NCT01520909|456196879|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
126792150|NCT01520909|456196880|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
126792151|NCT01520909|456196881|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
126792152|NCT03478397|456196882|FG000|Overall Study|Refused to participate|31|||
126792153|NCT03478397|456196883|FG001|Overall Study|Refused to participate|7|||
126792154|NCT02942264|456196884|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126792155|NCT02942264|456196885|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
126792156|NCT02942264|456196886|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126792157|NCT02942264|456196887|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126792158|NCT02942264|456196888|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126792159|NCT02942264|456196889|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126792160|NCT02942264|456196890|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
126792161|NCT02942264|456196891|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126792162|NCT02942264|456196892|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
126792163|NCT02942264|456196884|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126792164|NCT02942264|456196885|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126792165|NCT02942264|456196886|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126792166|NCT02942264|456196887|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126792167|NCT02942264|456196888|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126792168|NCT02942264|456196889|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126792169|NCT02942264|456196890|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126792170|NCT02942264|456196891|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
126632621|NCT01182181|455613806|FG000|First Intervention|Adverse Event|1|||
126632622|NCT01182181|455613807|FG001|First Intervention|Adverse Event|0|||
126632623|NCT01182181|455613806|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
126792171|NCT02942264|456196892|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
126792172|NCT02188303|456196893|FG000|Overall Study|Adverse Event|0|||
126792173|NCT02188303|456196894|FG001|Overall Study|Adverse Event|0|||
126792174|NCT02188303|456196895|FG002|Overall Study|Adverse Event|0|||
126792175|NCT02188303|456196896|FG003|Overall Study|Adverse Event|0|||
126792176|NCT02188303|456196897|FG004|Overall Study|Adverse Event|0|||
126792177|NCT02188303|456196898|FG005|Overall Study|Adverse Event|2|||
126792178|NCT02188303|456196899|FG006|Overall Study|Adverse Event|0|||
126792179|NCT02188303|456196900|FG007|Overall Study|Adverse Event|2|||
126792180|NCT02188303|456196893|FG000|Overall Study|Dose Termination Criteria Met|0|||
126792181|NCT02188303|456196894|FG001|Overall Study|Dose Termination Criteria Met|0|||
126792182|NCT02188303|456196895|FG002|Overall Study|Dose Termination Criteria Met|0|||
126792183|NCT02188303|456196896|FG003|Overall Study|Dose Termination Criteria Met|0|||
126792184|NCT02188303|456196897|FG004|Overall Study|Dose Termination Criteria Met|0|||
126792185|NCT02188303|456196898|FG005|Overall Study|Dose Termination Criteria Met|0|||
126792186|NCT02188303|456196899|FG006|Overall Study|Dose Termination Criteria Met|2|||
126792187|NCT02188303|456196900|FG007|Overall Study|Dose Termination Criteria Met|4|||
126792188|NCT04206332|456196901|FG000|Part A|Lost to Follow-up|0|||
126792189|NCT04206332|456196902|FG001|Part A|Lost to Follow-up|1|||
126792190|NCT04206332|456196903|FG002|Part A|Lost to Follow-up|0|||
126792191|NCT04206332|456196904|FG003|Part A|Lost to Follow-up|0|||
126792192|NCT04206332|456196905|FG004|Part A|Lost to Follow-up|0|||
126792193|NCT04206332|456196906|FG005|Part A|Lost to Follow-up|0|||
126792194|NCT04206332|456196907|FG006|Part A|Lost to Follow-up|0|||
126792195|NCT04206332|456196908|FG007|Part A|Lost to Follow-up|0|||
126792196|NCT04206332|456196909|FG008|Part A|Lost to Follow-up|0|||
126792197|NCT04206332|456196910|FG009|Part A|Lost to Follow-up|0|||
126792198|NCT04206332|456196911|FG010|Part A|Lost to Follow-up|0|||
126792199|NCT04206332|456196912|FG011|Part A|Lost to Follow-up|0|||
126792200|NCT04206332|456196913|FG012|Part A|Lost to Follow-up|0|||
126792201|NCT04206332|456196914|FG013|Part A|Lost to Follow-up|0|||
126792202|NCT04206332|456196915|FG014|Part A|Lost to Follow-up|0|||
126792203|NCT04206332|456196916|FG015|Part A|Lost to Follow-up|0|||
126792204|NCT04206332|456196917|FG016|Part A|Lost to Follow-up|0|||
126792205|NCT04206332|456196901|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792206|NCT04206332|456196902|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792207|NCT04206332|456196903|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792208|NCT04206332|456196904|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792209|NCT04206332|456196905|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792210|NCT04206332|456196906|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
126792211|NCT04206332|456196907|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792212|NCT04206332|456196908|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792213|NCT04206332|456196909|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792214|NCT04206332|456196910|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792215|NCT04206332|456196911|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792216|NCT04206332|456196912|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792217|NCT04206332|456196913|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792218|NCT04206332|456196914|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792219|NCT04206332|456196915|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792220|NCT04206332|456196916|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792221|NCT04206332|456196917|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
126792222|NCT04206332|456196901|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792223|NCT04206332|456196902|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792224|NCT04206332|456196903|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792225|NCT04206332|456196904|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792226|NCT04206332|456196905|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792227|NCT04206332|456196906|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792228|NCT04206332|456196907|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792229|NCT04206332|456196908|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
126792230|NCT04206332|456196909|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792231|NCT04206332|456196910|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126632624|NCT01182181|455613807|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
126632625|NCT01121913|455613808|FG000|First Intervention Period|Adverse Event|0|||
126632626|NCT01121913|455613809|FG001|First Intervention Period|Adverse Event|0|||
126632627|NCT01121913|455613810|FG002|First Intervention Period|Adverse Event|1|||
126632628|NCT01121913|455613811|FG003|First Intervention Period|Adverse Event|0|||
126632629|NCT01121913|455613808|FG000|First Washout Period|Withdrawal by Subject|1|||
126632630|NCT01121913|455613809|FG001|First Washout Period|Withdrawal by Subject|0|||
126792232|NCT04206332|456196911|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
126792233|NCT04206332|456196912|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792234|NCT04206332|456196913|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792235|NCT04206332|456196914|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792236|NCT04206332|456196915|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792237|NCT04206332|456196916|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792238|NCT04206332|456196917|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792239|NCT04206332|456196901|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792240|NCT04206332|456196902|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792241|NCT04206332|456196903|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792242|NCT04206332|456196904|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792243|NCT04206332|456196905|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792244|NCT04206332|456196906|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792245|NCT04206332|456196907|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792246|NCT04206332|456196908|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792247|NCT04206332|456196909|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792248|NCT04206332|456196910|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792249|NCT04206332|456196911|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792250|NCT04206332|456196912|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792251|NCT04206332|456196913|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792252|NCT04206332|456196914|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792253|NCT04206332|456196915|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792254|NCT04206332|456196916|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
126792255|NCT04206332|456196917|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
126792256|NCT04206332|456196901|FG000|Part C|Withdrawal by Subject|0|||
126792257|NCT04206332|456196902|FG001|Part C|Withdrawal by Subject|0|||
126792258|NCT04206332|456196903|FG002|Part C|Withdrawal by Subject|0|||
126792259|NCT04206332|456196904|FG003|Part C|Withdrawal by Subject|0|||
126792260|NCT04206332|456196905|FG004|Part C|Withdrawal by Subject|0|||
126792261|NCT04206332|456196906|FG005|Part C|Withdrawal by Subject|0|||
126792262|NCT04206332|456196907|FG006|Part C|Withdrawal by Subject|0|||
126792263|NCT04206332|456196908|FG007|Part C|Withdrawal by Subject|0|||
126792264|NCT04206332|456196909|FG008|Part C|Withdrawal by Subject|0|||
126792265|NCT04206332|456196910|FG009|Part C|Withdrawal by Subject|0|||
126792266|NCT04206332|456196911|FG010|Part C|Withdrawal by Subject|0|||
126792267|NCT04206332|456196912|FG011|Part C|Withdrawal by Subject|0|||
126792268|NCT04206332|456196913|FG012|Part C|Withdrawal by Subject|0|||
126792269|NCT04206332|456196914|FG013|Part C|Withdrawal by Subject|0|||
126792270|NCT04206332|456196915|FG014|Part C|Withdrawal by Subject|2|||
126792271|NCT04206332|456196916|FG015|Part C|Withdrawal by Subject|0|||
126792272|NCT04206332|456196917|FG016|Part C|Withdrawal by Subject|0|||
126792273|NCT00569374|456196922|FG000|Overall Study|Withdrawal by Subject|4|||
126792274|NCT00912288|456196923|FG000|Overall Study|Death|0|||
126792275|NCT00912288|456196924|FG001|Overall Study|Death|1|||
126792276|NCT00912288|456196923|FG000|Overall Study|Adverse Event|1|||
126792277|NCT00912288|456196924|FG001|Overall Study|Adverse Event|1|||
126792278|NCT00912288|456196923|FG000|Overall Study|Lost to Follow-up|1|||
126792279|NCT00912288|456196924|FG001|Overall Study|Lost to Follow-up|0|||
126792280|NCT00912288|456196923|FG000|Overall Study|Protocol Violation|1|||
126792281|NCT00912288|456196924|FG001|Overall Study|Protocol Violation|0|||
126792282|NCT00912288|456196923|FG000|Overall Study|Withdrawal by Subject|3|||
126792283|NCT00912288|456196924|FG001|Overall Study|Withdrawal by Subject|3|||
126792284|NCT00912288|456196923|FG000|Overall Study|Study terminated by sponsor|34|||
126792285|NCT00912288|456196924|FG001|Overall Study|Study terminated by sponsor|35|||
126792286|NCT00912288|456196923|FG000|Overall Study|Other|1|||
126792287|NCT00912288|456196924|FG001|Overall Study|Other|0|||
126792288|NCT00050778|456196927|FG000|Overall Study|Adverse Event|13|||
126792289|NCT00050778|456196928|FG001|Overall Study|Adverse Event|3|||
126792290|NCT00050778|456196929|FG002|Overall Study|Adverse Event|2|||
126792291|NCT00050778|456196927|FG000|Overall Study|Death|0|||
126792292|NCT00050778|456196928|FG001|Overall Study|Death|1|||
126792293|NCT00050778|456196929|FG002|Overall Study|Death|1|||
126792294|NCT00050778|456196927|FG000|Overall Study|Lack of Efficacy|16|||
126792295|NCT00050778|456196928|FG001|Overall Study|Lack of Efficacy|2|||
126792296|NCT00050778|456196929|FG002|Overall Study|Lack of Efficacy|2|||
126792297|NCT00050778|456196927|FG000|Overall Study|Lost to Follow-up|0|||
126792298|NCT00050778|456196928|FG001|Overall Study|Lost to Follow-up|2|||
126632631|NCT01121913|455613810|FG002|First Washout Period|Withdrawal by Subject|0|||
126632632|NCT01121913|455613811|FG003|First Washout Period|Withdrawal by Subject|0|||
126632633|NCT01121913|455613808|FG000|Second Intervention Period|Adverse Event|0|||
126755636|NCT04212221|456054771|FG005|Overall Study|Participant refused to continue treatment|2|||
126755637|NCT04212221|456054772|FG006|Overall Study|Participant refused to continue treatment|4|||
126755638|NCT04212221|456054773|FG007|Overall Study|Participant refused to continue treatment|2|||
126755639|NCT04212221|456054766|FG000|Overall Study|Protocol Violation|0|||
126755640|NCT04212221|456054767|FG001|Overall Study|Protocol Violation|0|||
126755641|NCT04212221|456054768|FG002|Overall Study|Protocol Violation|0|||
126755642|NCT04212221|456054769|FG003|Overall Study|Protocol Violation|0|||
126755643|NCT04212221|456054770|FG004|Overall Study|Protocol Violation|0|||
126755644|NCT04212221|456054771|FG005|Overall Study|Protocol Violation|0|||
126755645|NCT04212221|456054772|FG006|Overall Study|Protocol Violation|0|||
126755646|NCT04212221|456054773|FG007|Overall Study|Protocol Violation|1|||
126755647|NCT00636506|456054782|FG000|Overall Study|Lost to Follow-up|8|||
126755648|NCT00636506|456054782|FG000|Overall Study|Explanted|1|||
126755649|NCT00636506|456054782|FG000|Overall Study|Withdrawal by Subject|6|||
126755650|NCT00636506|456054782|FG000|Overall Study|Procedure aborted|1|||
126755651|NCT03742271|456054783|FG000|Overall Study|Unsatisfactory Visual Response|1|||
126755652|NCT03742271|456054783|FG000|Overall Study|Withdrawal by Subject|3|||
126755653|NCT03742271|456054783|FG000|Overall Study|Lost to Follow-up|4|||
126755654|NCT03742271|456054783|FG000|Overall Study|Failed Insertion & removal|3|||
126755655|NCT03742271|456054783|FG000|Overall Study|Protocol Violation|1|||
126755656|NCT01624974|456054786|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
126755657|NCT01624974|456054787|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
126755658|NCT01624974|456054786|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
126755659|NCT01624974|456054787|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
126755660|NCT01624974|456054786|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
126755661|NCT01624974|456054787|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
126755662|NCT01624974|456054786|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
126755663|NCT01624974|456054787|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
126755664|NCT01624974|456054786|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
126755665|NCT01624974|456054787|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
126755666|NCT01624974|456054786|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
126755667|NCT01624974|456054787|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
126755668|NCT01624974|456054786|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
126755669|NCT01624974|456054787|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
126755670|NCT01624974|456054786|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
126755671|NCT01624974|456054787|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
126755672|NCT01624974|456054786|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
126755673|NCT01624974|456054787|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
126755674|NCT01624974|456054786|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
126755675|NCT01624974|456054787|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
126755676|NCT01624974|456054786|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
126755677|NCT01624974|456054787|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
126755678|NCT01624974|456054786|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
126755679|NCT01624974|456054787|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
126755680|NCT02646332|456054791|FG000|Overall Study|Lost to Follow-up|0|||
126755681|NCT02646332|456054792|FG001|Overall Study|Lost to Follow-up|3|||
126755682|NCT00252499|456054798|FG000|Overall Study|Lost to Follow-up|1|||
126755683|NCT00252499|456054799|FG001|Overall Study|Lost to Follow-up|0|||
126755684|NCT00252499|456054800|FG002|Overall Study|Lost to Follow-up|0|||
126755685|NCT04490499|456054801|FG000|Overall Study|Withdrawal by Subject|2|||
126755686|NCT01882439|456054804|FG000|Overall Study|Adverse event related to study drug|3|||
126755687|NCT01882439|456054805|FG001|Overall Study|Adverse event related to study drug|8|||
126755688|NCT01882439|456054806|FG002|Overall Study|Adverse event related to study drug|1|||
126755689|NCT01882439|456054807|FG003|Overall Study|Adverse event related to study drug|2|||
126755690|NCT01882439|456054804|FG000|Overall Study|Pregnancy|0|||
126755691|NCT01882439|456054805|FG001|Overall Study|Pregnancy|1|||
126755692|NCT01882439|456054806|FG002|Overall Study|Pregnancy|0|||
126755693|NCT01882439|456054807|FG003|Overall Study|Pregnancy|0|||
126755694|NCT01882439|456054804|FG000|Overall Study|Protocol Violation|2|||
126755695|NCT01882439|456054805|FG001|Overall Study|Protocol Violation|2|||
126755696|NCT01882439|456054806|FG002|Overall Study|Protocol Violation|0|||
126755697|NCT01882439|456054807|FG003|Overall Study|Protocol Violation|1|||
126755698|NCT01882439|456054804|FG000|Overall Study|No longer willing to participate|1|||
126755699|NCT01882439|456054805|FG001|Overall Study|No longer willing to participate|4|||
126755700|NCT01882439|456054806|FG002|Overall Study|No longer willing to participate|2|||
126755701|NCT01882439|456054807|FG003|Overall Study|No longer willing to participate|3|||
126755702|NCT01882439|456054804|FG000|Overall Study|Medication error with no associated AE|0|||
126755703|NCT01882439|456054805|FG001|Overall Study|Medication error with no associated AE|0|||
126755704|NCT01882439|456054806|FG002|Overall Study|Medication error with no associated AE|2|||
126792299|NCT00050778|456196929|FG002|Overall Study|Lost to Follow-up|4|||
126792300|NCT00050778|456196927|FG000|Overall Study|Physician Decision|3|||
126792301|NCT00050778|456196928|FG001|Overall Study|Physician Decision|0|||
126792302|NCT00050778|456196929|FG002|Overall Study|Physician Decision|2|||
126792303|NCT00050778|456196927|FG000|Overall Study|Protocol Violation|2|||
126792304|NCT00050778|456196928|FG001|Overall Study|Protocol Violation|0|||
126792305|NCT00050778|456196929|FG002|Overall Study|Protocol Violation|1|||
126792306|NCT00050778|456196927|FG000|Overall Study|Withdrawal by Subject|6|||
126792307|NCT00050778|456196928|FG001|Overall Study|Withdrawal by Subject|8|||
126792308|NCT00050778|456196929|FG002|Overall Study|Withdrawal by Subject|4|||
126792309|NCT00050778|456196927|FG000|Overall Study|Randomized but not treated|4|||
126792310|NCT00050778|456196928|FG001|Overall Study|Randomized but not treated|5|||
126792311|NCT00050778|456196929|FG002|Overall Study|Randomized but not treated|2|||
126792312|NCT00050778|456196927|FG000|Overall Study|Familial and personal reasons|1|||
126792313|NCT00050778|456196928|FG001|Overall Study|Familial and personal reasons|0|||
126792314|NCT00050778|456196929|FG002|Overall Study|Familial and personal reasons|0|||
126792315|NCT01126736|456196932|FG000|Overall Study|Death|2|||
126792316|NCT01126736|456196933|FG001|Overall Study|Death|2|||
126792317|NCT01126736|456196934|FG002|Overall Study|Death|1|||
126792318|NCT01126736|456196935|FG003|Overall Study|Death|19|||
126792319|NCT01126736|456196936|FG004|Overall Study|Death|19|||
126792320|NCT01126736|456196932|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
126792321|NCT01126736|456196933|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
126792322|NCT01126736|456196934|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
126792323|NCT01126736|456196935|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
126792324|NCT01126736|456196936|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
126792325|NCT01126736|456196932|FG000|Overall Study|Lost to Follow-up|0|||
126792326|NCT01126736|456196933|FG001|Overall Study|Lost to Follow-up|0|||
126792327|NCT01126736|456196934|FG002|Overall Study|Lost to Follow-up|0|||
126792328|NCT01126736|456196935|FG003|Overall Study|Lost to Follow-up|1|||
126792329|NCT01126736|456196936|FG004|Overall Study|Lost to Follow-up|1|||
126792330|NCT01126736|456196932|FG000|Overall Study|Administrative reasons|0|||
126792331|NCT01126736|456196933|FG001|Overall Study|Administrative reasons|0|||
126792332|NCT01126736|456196934|FG002|Overall Study|Administrative reasons|0|||
126792333|NCT01126736|456196935|FG003|Overall Study|Administrative reasons|0|||
126792334|NCT01126736|456196936|FG004|Overall Study|Administrative reasons|1|||
126792335|NCT01126736|456196932|FG000|Overall Study|Progressive disease|0|||
126792336|NCT01126736|456196933|FG001|Overall Study|Progressive disease|0|||
126792337|NCT01126736|456196934|FG002|Overall Study|Progressive disease|0|||
126792338|NCT01126736|456196935|FG003|Overall Study|Progressive disease|2|||
126792339|NCT01126736|456196936|FG004|Overall Study|Progressive disease|1|||
126792340|NCT01126736|456196932|FG000|Overall Study|Withdrawal by Subject|0|||
126792341|NCT01126736|456196933|FG001|Overall Study|Withdrawal by Subject|0|||
126792342|NCT01126736|456196934|FG002|Overall Study|Withdrawal by Subject|0|||
126792343|NCT01126736|456196935|FG003|Overall Study|Withdrawal by Subject|1|||
126792344|NCT01126736|456196936|FG004|Overall Study|Withdrawal by Subject|1|||
126792345|NCT01126736|456196932|FG000|Overall Study|Other|2|||
126792346|NCT01126736|456196933|FG001|Overall Study|Other|4|||
126792347|NCT01126736|456196934|FG002|Overall Study|Other|4|||
126792348|NCT01126736|456196935|FG003|Overall Study|Other|16|||
126792349|NCT01126736|456196936|FG004|Overall Study|Other|15|||
126792350|NCT00064753|456196937|FG000|Overall Study|Death|251|||
126792351|NCT00064753|456196938|FG001|Overall Study|Death|242|||
126792352|NCT00064753|456196937|FG000|Overall Study|Withdrawal by Subject|198|||
126792353|NCT00064753|456196938|FG001|Overall Study|Withdrawal by Subject|171|||
126792354|NCT00064753|456196937|FG000|Overall Study|Lost to Follow-up|225|||
126792355|NCT00064753|456196938|FG001|Overall Study|Lost to Follow-up|235|||
126792356|NCT00813293|456196944|FG000|Overall Study|Intercurrent illness|1|||
126792357|NCT00813293|456196945|FG001|Overall Study|Intercurrent illness|0|||
126792358|NCT00813293|456196944|FG000|Overall Study|Adverse Event|0|||
126792359|NCT00813293|456196945|FG001|Overall Study|Adverse Event|1|||
126792360|NCT01544127|456196946|FG000|Overall Study|Lost to Follow-up|4|||
126792361|NCT01544127|456196947|FG001|Overall Study|Lost to Follow-up|2|||
126792362|NCT01544127|456196948|FG002|Overall Study|Lost to Follow-up|9|||
126792363|NCT01544127|456196946|FG000|Overall Study|Withdrawal by Subject|2|||
126792364|NCT01544127|456196947|FG001|Overall Study|Withdrawal by Subject|2|||
126792365|NCT01544127|456196948|FG002|Overall Study|Withdrawal by Subject|1|||
126792366|NCT01544127|456196946|FG000|Overall Study|Discharged out of catchment area|1|||
126792367|NCT01544127|456196947|FG001|Overall Study|Discharged out of catchment area|1|||
126792368|NCT01544127|456196948|FG002|Overall Study|Discharged out of catchment area|1|||
126792369|NCT01544127|456196946|FG000|Overall Study|Death|1|||
126792370|NCT01544127|456196947|FG001|Overall Study|Death|0|||
126792371|NCT01544127|456196948|FG002|Overall Study|Death|0|||
126792372|NCT01544127|456196946|FG000|Overall Study|Jail or Prison|1|||
126792373|NCT01544127|456196947|FG001|Overall Study|Jail or Prison|1|||
126792374|NCT01544127|456196948|FG002|Overall Study|Jail or Prison|2|||
126792375|NCT01544127|456196946|FG000|Overall Study|Became Psychotic|1|||
126792376|NCT01544127|456196947|FG001|Overall Study|Became Psychotic|0|||
126792377|NCT01544127|456196948|FG002|Overall Study|Became Psychotic|0|||
126792378|NCT01544127|456196946|FG000|Overall Study|Researcher withdrew|1|||
126792379|NCT01544127|456196947|FG001|Overall Study|Researcher withdrew|0|||
126792380|NCT01544127|456196948|FG002|Overall Study|Researcher withdrew|0|||
126792381|NCT01544127|456196946|FG000|Overall Study|Went active duty|0|||
126792382|NCT01544127|456196947|FG001|Overall Study|Went active duty|0|||
126792383|NCT01544127|456196948|FG002|Overall Study|Went active duty|1|||
126792384|NCT00533273|456196949|FG000|Double-blind|Withdrew consent|0|||
126792385|NCT00533273|456196950|FG001|Double-blind|Withdrew consent|2|||
126792386|NCT00533273|456196949|FG000|Open-label|Withdrawal by Subject|6|||
126792387|NCT00533273|456196950|FG001|Open-label|Withdrawal by Subject|0|||
126792388|NCT02914600|456196954|FG000|Overall Study|Adverse Event|298|||
126792389|NCT02914600|456196955|FG001|Overall Study|Adverse Event|35|||
126792390|NCT02914600|456196956|FG002|Overall Study|Adverse Event|25|||
126792391|NCT02914600|456196954|FG000|Overall Study|Sponsors decision|287|||
126792392|NCT02914600|456196955|FG001|Overall Study|Sponsors decision|41|||
126792393|NCT02914600|456196956|FG002|Overall Study|Sponsors decision|12|||
126792394|NCT02914600|456196954|FG000|Overall Study|Withdrawal by Subject|158|||
126792395|NCT02914600|456196955|FG001|Overall Study|Withdrawal by Subject|20|||
126792396|NCT02914600|456196956|FG002|Overall Study|Withdrawal by Subject|18|||
126792397|NCT02914600|456196954|FG000|Overall Study|Investigators discretion|169|||
126792398|NCT02914600|456196955|FG001|Overall Study|Investigators discretion|14|||
126792399|NCT02914600|456196956|FG002|Overall Study|Investigators discretion|13|||
126792400|NCT02914600|456196954|FG000|Overall Study|Lost to Follow-up|10|||
126792401|NCT02914600|456196955|FG001|Overall Study|Lost to Follow-up|4|||
126792402|NCT02914600|456196956|FG002|Overall Study|Lost to Follow-up|0|||
126792403|NCT02914600|456196954|FG000|Overall Study|Pregnancy|8|||
126792404|NCT02914600|456196955|FG001|Overall Study|Pregnancy|0|||
126792405|NCT02914600|456196956|FG002|Overall Study|Pregnancy|0|||
126792406|NCT02914600|456196954|FG000|Overall Study|Protocol Violation|5|||
126792407|NCT02914600|456196955|FG001|Overall Study|Protocol Violation|3|||
126792408|NCT02914600|456196956|FG002|Overall Study|Protocol Violation|0|||
126792409|NCT02914600|456196954|FG000|Overall Study|Non-compliance with study drug|6|||
126632634|NCT01121913|455613809|FG001|Second Intervention Period|Adverse Event|0|||
126632635|NCT01121913|455613810|FG002|Second Intervention Period|Adverse Event|1|||
126632636|NCT01121913|455613811|FG003|Second Intervention Period|Adverse Event|0|||
126632637|NCT01121913|455613808|FG000|Second Washout Period|Withdrawal by Subject|0|||
126632638|NCT01121913|455613809|FG001|Second Washout Period|Withdrawal by Subject|0|||
126632639|NCT01121913|455613810|FG002|Second Washout Period|Withdrawal by Subject|1|||
126632640|NCT01121913|455613811|FG003|Second Washout Period|Withdrawal by Subject|0|||
126632641|NCT01121913|455613808|FG000|Third Washout Period|Adverse Event|1|||
126632642|NCT01121913|455613809|FG001|Third Washout Period|Adverse Event|0|||
126632643|NCT01121913|455613810|FG002|Third Washout Period|Adverse Event|0|||
126632644|NCT01121913|455613811|FG003|Third Washout Period|Adverse Event|0|||
126632645|NCT02564718|455613814|FG000|Overall Study|Withdrew from treatment|0|||
126632646|NCT02564718|455613815|FG001|Overall Study|Withdrew from treatment|1|||
126632647|NCT01017263|455613816|FG000|Overall Study|not eligible|12|||
126632648|NCT02980705|455613817|FG000|Overall Study|Adverse Event|0|||
126632649|NCT02980705|455613818|FG001|Overall Study|Adverse Event|1|||
126632650|NCT02980705|455613817|FG000|Overall Study|Withdrawal by Subject|6|||
126632651|NCT02980705|455613818|FG001|Overall Study|Withdrawal by Subject|9|||
126632652|NCT02980705|455613817|FG000|Overall Study|withdrew participation|0|||
126632653|NCT02980705|455613818|FG001|Overall Study|withdrew participation|1|||
126632654|NCT02980705|455613817|FG000|Overall Study|Lost to Follow-up|2|||
126632655|NCT02980705|455613818|FG001|Overall Study|Lost to Follow-up|0|||
126632656|NCT04353817|455613819|FG000|Overall Study|Adverse Event|0|||
126632657|NCT04353817|455613820|FG001|Overall Study|Adverse Event|1|||
126632658|NCT00002597|455613821|FG000|Overall Study|Protocol Violation|19|||
126632659|NCT00002597|455613822|FG001|Overall Study|Protocol Violation|17|||
126632660|NCT00002597|455613821|FG000|Overall Study|Withdrawal by Subject|7|||
126632661|NCT00002597|455613822|FG001|Overall Study|Withdrawal by Subject|6|||
126632662|NCT02654132|455613823|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
126632663|NCT02654132|455613824|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
126632664|NCT02654132|455613823|FG000|Treatment Period|Disease progression|43|||
126632665|NCT02654132|455613824|FG001|Treatment Period|Disease progression|38|||
126632666|NCT02654132|455613823|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
126632667|NCT02654132|455613824|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
126792410|NCT02914600|456196955|FG001|Overall Study|Non-compliance with study drug|1|||
126792411|NCT02914600|456196956|FG002|Overall Study|Non-compliance with study drug|0|||
126792412|NCT02914600|456196954|FG000|Overall Study|Death|3|||
126632668|NCT02654132|455613823|FG000|Treatment Period|Other reasons|4|||
126632669|NCT02654132|455613824|FG001|Treatment Period|Other reasons|2|||
126792413|NCT02914600|456196955|FG001|Overall Study|Death|1|||
126792414|NCT02914600|456196956|FG002|Overall Study|Death|1|||
126792415|NCT02914600|456196954|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
126792416|NCT02914600|456196955|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
126632670|NCT02654132|455613823|FG000|Treatment Period|Study drug toxicity|2|||
126632671|NCT02654132|455613824|FG001|Treatment Period|Study drug toxicity|2|||
126632672|NCT02654132|455613823|FG000|Treatment Period|Withdrawal by Subject|2|||
126632673|NCT02654132|455613824|FG001|Treatment Period|Withdrawal by Subject|1|||
126632674|NCT02654132|455613823|FG000|Treatment Period|Maximum Clinical Benefit|0|||
126632675|NCT02654132|455613824|FG001|Treatment Period|Maximum Clinical Benefit|2|||
126632676|NCT02654132|455613823|FG000|Treatment Period|Participant request to discontinue|2|||
126632677|NCT02654132|455613824|FG001|Treatment Period|Participant request to discontinue|0|||
126632678|NCT02654132|455613823|FG000|Treatment Period|Administrative reasons by sponsor|0|||
126632679|NCT02654132|455613824|FG001|Treatment Period|Administrative reasons by sponsor|1|||
126632680|NCT02654132|455613823|FG000|Treatment Period|Death|1|||
126632681|NCT02654132|455613824|FG001|Treatment Period|Death|0|||
126632682|NCT02485899|455613826|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
126632683|NCT02485899|455613827|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126632684|NCT02485899|455613826|FG000|Overall Study|Withdrawal by Subject|1|||
126632685|NCT02485899|455613827|FG001|Overall Study|Withdrawal by Subject|0|||
126632686|NCT02485899|455613826|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
126632687|NCT02485899|455613827|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
126632688|NCT01918371|455613828|FG000|Overall Study|Missing Data|1|||
126632689|NCT01918371|455613829|FG001|Overall Study|Missing Data|1|||
126632690|NCT00823836|455613830|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
126632691|NCT00823836|455613831|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
126632692|NCT00823836|455613830|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
126632693|NCT00823836|455613831|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
126632694|NCT00823836|455613830|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
126632695|NCT00823836|455613831|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
126632696|NCT00823836|455613830|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
126632697|NCT00823836|455613831|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
126632698|NCT00823836|455613830|FG000|Long-term Phase|Adverse Event|3|||
126632699|NCT00823836|455613831|FG001|Long-term Phase|Adverse Event|2|||
126632700|NCT00823836|455613830|FG000|Long-term Phase|Physician Decision|1|||
126632701|NCT00823836|455613831|FG001|Long-term Phase|Physician Decision|2|||
126632702|NCT00823836|455613830|FG000|Long-term Phase|Withdrawal by Subject|1|||
126632703|NCT00823836|455613831|FG001|Long-term Phase|Withdrawal by Subject|1|||
126632704|NCT03713320|455613832|FG000|Randomized Period|Adverse Event|1|||
126632705|NCT03713320|455613833|FG001|Randomized Period|Adverse Event|5|||
126632706|NCT03713320|455613834|FG002|Randomized Period|Adverse Event|0|||
126632707|NCT03713320|455613832|FG000|Randomized Period|Physician Decision|1|||
126632708|NCT03713320|455613833|FG001|Randomized Period|Physician Decision|1|||
126792417|NCT02914600|456196956|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
126792418|NCT02914600|456196954|FG000|Overall Study|Enrolled but not treated|1|||
126792419|NCT02914600|456196955|FG001|Overall Study|Enrolled but not treated|0|||
126792420|NCT02914600|456196956|FG002|Overall Study|Enrolled but not treated|0|||
126792421|NCT00454909|456196957|FG000|Overall Study|Withdrawal by Subject|1|||
126792422|NCT00454909|456196958|FG001|Overall Study|Withdrawal by Subject|0|||
126792423|NCT00454909|456196959|FG002|Overall Study|Withdrawal by Subject|0|||
126792424|NCT00454909|456196957|FG000|Overall Study|Migrated/moved from study area|0|||
126792425|NCT00454909|456196958|FG001|Overall Study|Migrated/moved from study area|0|||
126792426|NCT00454909|456196959|FG002|Overall Study|Migrated/moved from study area|1|||
126792427|NCT00454909|456196957|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
126792428|NCT00454909|456196958|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
126792429|NCT00454909|456196959|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
126792430|NCT00454909|456196957|FG000|Overall Study|Others|1|||
126792431|NCT00454909|456196958|FG001|Overall Study|Others|0|||
126792432|NCT00454909|456196959|FG002|Overall Study|Others|0|||
126792433|NCT02457520|456196960|FG000|Active Treatment Phase|Adverse Event|10|||
126792434|NCT02457520|456196960|FG000|Active Treatment Phase|Lost to Follow-up|8|||
126792435|NCT02457520|456196960|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
126792436|NCT02457520|456196960|FG000|Active Treatment Phase|other|4|||
126632709|NCT03713320|455613834|FG002|Randomized Period|Physician Decision|0|||
126632710|NCT03713320|455613832|FG000|Randomized Period|Withdrawal by Subject|4|||
126632711|NCT03713320|455613833|FG001|Randomized Period|Withdrawal by Subject|0|||
126632712|NCT03713320|455613834|FG002|Randomized Period|Withdrawal by Subject|0|||
126632713|NCT03713320|455613832|FG000|Randomized Period|Participant decision|3|||
126632714|NCT03713320|455613833|FG001|Randomized Period|Participant decision|1|||
126632715|NCT03713320|455613834|FG002|Randomized Period|Participant decision|0|||
126632716|NCT03713320|455613832|FG000|Randomized Period|Study terminated by sponsor|6|||
126632717|NCT03713320|455613833|FG001|Randomized Period|Study terminated by sponsor|3|||
126632718|NCT03713320|455613834|FG002|Randomized Period|Study terminated by sponsor|0|||
126632719|NCT03713320|455613832|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
126632720|NCT03713320|455613833|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
126632721|NCT03713320|455613834|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
126792437|NCT02457520|456196960|FG000|Active Treatment Phase|Physician Decision|1|||
126792438|NCT02457520|456196960|FG000|Active Treatment Phase|Protocol Violation|1|||
126792439|NCT02457520|456196960|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
126792440|NCT02457520|456196960|FG000|Post-treatment Period|Other: Retreatment Required|7|||
126792441|NCT02457520|456196960|FG000|Post-treatment Period|Lost to Follow-up|23|||
126792442|NCT02457520|456196960|FG000|Post-treatment Period|Other|3|||
126792443|NCT02457520|456196960|FG000|Post-treatment Period|Physician Decision|1|||
126792444|NCT02457520|456196960|FG000|Post-treatment Period|Withdrawal by Subject|14|||
126792445|NCT00282048|456196961|FG000|Overall Study|Lack of Efficacy|30|||
126792446|NCT00282048|456196961|FG000|Overall Study|Adverse Event|22|||
126792447|NCT00282048|456196961|FG000|Overall Study|Withdrawal by Subject|1|||
126792448|NCT00282048|456196961|FG000|Overall Study|Other|8|||
126792449|NCT00282048|456196961|FG000|Overall Study|Ongoing|1|||
126792450|NCT03522675|456196963|FG000|Overall Study|Screen fail|1|||
126792451|NCT03522675|456196963|FG000|Overall Study|Non-reactive to histamine|1|||
126792452|NCT02076022|456196966|FG000|Overall Study|Withdrawal by Subject|2|||
126792453|NCT02076022|456196967|FG001|Overall Study|Withdrawal by Subject|0|||
126792454|NCT00312663|456196968|FG000|Immunization Phase|Adverse Event|0|||
126792455|NCT00312663|456196969|FG001|Immunization Phase|Adverse Event|1|||
126792456|NCT00312663|456196970|FG002|Immunization Phase|Adverse Event|0|||
126792457|NCT00301366|456196973|FG000|Overall Study|Adverse Event|1|||
126792458|NCT04213326|456196974|FG000|Overall Study|Consent withdrawn|51|||
126792459|NCT04213326|456196975|FG001|Overall Study|Consent withdrawn|241|||
126792460|NCT04213326|456196974|FG000|Overall Study|Lost to Follow-up|50|||
126792461|NCT04213326|456196975|FG001|Overall Study|Lost to Follow-up|902|||
126792462|NCT04213326|456196974|FG000|Overall Study|Protocol Violation|3|||
126792463|NCT04213326|456196975|FG001|Overall Study|Protocol Violation|25|||
126792464|NCT04213326|456196974|FG000|Overall Study|Participant eligibility changed|106|||
126792465|NCT04213326|456196975|FG001|Overall Study|Participant eligibility changed|19|||
126792466|NCT04213326|456196974|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
126792467|NCT04213326|456196975|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
126792468|NCT04213326|456196974|FG000|Overall Study|Incomplete study visit|0|||
126792469|NCT04213326|456196975|FG001|Overall Study|Incomplete study visit|367|||
126792470|NCT02549092|456196978|FG000|Treatment Period|Adverse Event|2|||
126792471|NCT02549092|456196979|FG001|Treatment Period|Adverse Event|2|||
126792472|NCT02549092|456196978|FG000|Treatment Period|Withdrawal by Subject|1|||
126792473|NCT02549092|456196979|FG001|Treatment Period|Withdrawal by Subject|3|||
126792474|NCT02549092|456196978|FG000|Treatment Period|Lack of Efficacy|0|||
126792475|NCT02549092|456196979|FG001|Treatment Period|Lack of Efficacy|2|||
126792476|NCT02549092|456196978|FG000|Extension/Transition Period|Adverse Event|1|||
126792477|NCT02549092|456196979|FG001|Extension/Transition Period|Adverse Event|1|||
126792478|NCT02549092|456196978|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
126792479|NCT02549092|456196979|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
126792480|NCT02549092|456196978|FG000|Extension/Transition Period|Other, Not Specified|4|||
126792481|NCT02549092|456196979|FG001|Extension/Transition Period|Other, Not Specified|2|||
126792482|NCT02511782|456196980|FG000|Overall Study|Withdrawal by Subject|1|||
126792483|NCT02511782|456196981|FG001|Overall Study|Withdrawal by Subject|0|||
126792484|NCT02511782|456196982|FG002|Overall Study|Withdrawal by Subject|0|||
126792485|NCT03627091|456196983|FG000|Overall Study|Adverse Event|0|||
126792486|NCT03627091|456196984|FG001|Overall Study|Adverse Event|0|||
126792487|NCT03627091|456196985|FG002|Overall Study|Adverse Event|2|||
126792488|NCT03627091|456196983|FG000|Overall Study|Withdrawal by Subject|2|||
126792489|NCT03627091|456196984|FG001|Overall Study|Withdrawal by Subject|0|||
126792490|NCT03627091|456196985|FG002|Overall Study|Withdrawal by Subject|2|||
126792491|NCT03627091|456196983|FG000|Overall Study|Physician Decision|2|||
126792492|NCT03627091|456196984|FG001|Overall Study|Physician Decision|0|||
126792493|NCT03627091|456196985|FG002|Overall Study|Physician Decision|0|||
126792494|NCT03627091|456196983|FG000|Overall Study|Site terminated by sponsor|0|||
126792495|NCT03627091|456196984|FG001|Overall Study|Site terminated by sponsor|1|||
126792496|NCT03627091|456196985|FG002|Overall Study|Site terminated by sponsor|0|||
126632722|NCT03713320|455613832|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
126632723|NCT03713320|455613833|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
126792497|NCT03627091|456196983|FG000|Overall Study|Disease relapse|7|||
126792498|NCT03627091|456196984|FG001|Overall Study|Disease relapse|5|||
126792499|NCT03627091|456196985|FG002|Overall Study|Disease relapse|1|||
126792500|NCT03627091|456196983|FG000|Overall Study|Other|1|||
126632724|NCT03713320|455613834|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
126632725|NCT01880437|455613835|FG000|Overall Study|Death|12|||
126632726|NCT01880437|455613836|FG001|Overall Study|Death|4|||
126792501|NCT03627091|456196984|FG001|Overall Study|Other|0|||
126792502|NCT03627091|456196985|FG002|Overall Study|Other|0|||
126792503|NCT01376167|456196986|FG000|Overall Study|Lost to Follow-up|2|||
126792504|NCT01376167|456196987|FG001|Overall Study|Lost to Follow-up|4|||
126792505|NCT01376167|456196988|FG002|Overall Study|Lost to Follow-up|2|||
126792506|NCT01376167|456196986|FG000|Overall Study|Physician Decision|1|||
126792507|NCT01376167|456196987|FG001|Overall Study|Physician Decision|1|||
126792508|NCT01376167|456196988|FG002|Overall Study|Physician Decision|0|||
126792509|NCT01376167|456196986|FG000|Overall Study|Withdrawal by Subject|1|||
126792510|NCT01376167|456196987|FG001|Overall Study|Withdrawal by Subject|5|||
126792511|NCT01376167|456196988|FG002|Overall Study|Withdrawal by Subject|4|||
126792512|NCT02849652|456196996|FG000|Overall Study|Lost to Follow-up|104|||
126792513|NCT02849652|456196997|FG001|Overall Study|Lost to Follow-up|35|||
126792514|NCT02849652|456196998|FG002|Overall Study|Lost to Follow-up|116|||
126792515|NCT02849652|456196999|FG003|Overall Study|Lost to Follow-up|22|||
126792516|NCT02849652|456196996|FG000|Overall Study|Withdrawal by Subject|10|||
126792517|NCT02849652|456196997|FG001|Overall Study|Withdrawal by Subject|2|||
126792518|NCT02849652|456196998|FG002|Overall Study|Withdrawal by Subject|8|||
126792519|NCT02849652|456196999|FG003|Overall Study|Withdrawal by Subject|4|||
126792520|NCT02008565|456197003|FG000|Overall Study|Protocol Violation|1|||
126792521|NCT02008565|456197004|FG001|Overall Study|Protocol Violation|1|||
126792522|NCT02008565|456197005|FG002|Overall Study|Protocol Violation|2|||
126792523|NCT02008565|456197006|FG003|Overall Study|Protocol Violation|0|||
126792524|NCT02193178|456197007|FG000|Overall Study|Lost to Follow-up|1|||
126792525|NCT02193178|456197007|FG000|Overall Study|Dry eyes|1|||
126792526|NCT03435081|456197008|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
126792527|NCT03435081|456197009|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
126792528|NCT03435081|456197010|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
126792529|NCT03435081|456197008|FG000|Week 0 to Week 16|Adverse Event|2|||
126792530|NCT03435081|456197009|FG001|Week 0 to Week 16|Adverse Event|2|||
126792531|NCT03435081|456197010|FG002|Week 0 to Week 16|Adverse Event|2|||
126792532|NCT03435081|456197008|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
126792533|NCT03435081|456197009|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
126792534|NCT03435081|456197010|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
126792535|NCT03435081|456197008|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
126792536|NCT03435081|456197009|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
126792537|NCT03435081|456197010|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
126792538|NCT03435081|456197008|FG000|Week 0 to Week 16|Pregnancy|1|||
126792539|NCT03435081|456197009|FG001|Week 0 to Week 16|Pregnancy|0|||
126792540|NCT03435081|456197010|FG002|Week 0 to Week 16|Pregnancy|0|||
126792541|NCT03435081|456197008|FG000|Week 0 to Week 16|Non-compliance|1|||
126792542|NCT03435081|456197009|FG001|Week 0 to Week 16|Non-compliance|0|||
126792543|NCT03435081|456197010|FG002|Week 0 to Week 16|Non-compliance|2|||
126792544|NCT03435081|456197008|FG000|Week 0 to Week 16|Inadequate Response|0|||
126792545|NCT03435081|456197009|FG001|Week 0 to Week 16|Inadequate Response|1|||
126792546|NCT03435081|456197010|FG002|Week 0 to Week 16|Inadequate Response|0|||
126792547|NCT03435081|456197008|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
126792548|NCT03435081|456197009|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
126792549|NCT03435081|456197010|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
126792550|NCT03435081|456197008|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
126792551|NCT03435081|456197009|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
126792552|NCT03435081|456197010|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
126792553|NCT03435081|456197008|FG000|Week 16 to Week 104|Adverse Event|1|||
126792554|NCT03435081|456197009|FG001|Week 16 to Week 104|Adverse Event|0|||
126792555|NCT03435081|456197010|FG002|Week 16 to Week 104|Adverse Event|2|||
126792556|NCT03435081|456197008|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
126792557|NCT03435081|456197009|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
126792558|NCT03435081|456197010|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
126792559|NCT03435081|456197008|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
126792560|NCT03435081|456197009|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
126792561|NCT03435081|456197010|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
126792562|NCT03435081|456197008|FG000|Week 16 to Week 104|Non--Compliance|0|||
126792563|NCT03435081|456197009|FG001|Week 16 to Week 104|Non--Compliance|0|||
126792564|NCT03435081|456197010|FG002|Week 16 to Week 104|Non--Compliance|1|||
126792565|NCT04320849|456197013|FG000|Overall Study|Withdrawal by Subject|4|||
126792566|NCT04320849|456197013|FG000|Overall Study|Imaging data unavailable|2|||
126792567|NCT04320849|456197013|FG000|Overall Study|Incomplete imaging|2|||
126792568|NCT00705536|456199136|FG000|Start Period 1|Withdrawal by Subject|0|||
126792569|NCT00705536|456199137|FG001|Start Period 1|Withdrawal by Subject|0|||
126792570|NCT00705536|456199138|FG002|Start Period 1|Withdrawal by Subject|0|||
126792571|NCT00705536|456199139|FG003|Start Period 1|Withdrawal by Subject|1|||
126632727|NCT01880437|455613837|FG002|Overall Study|Death|17|||
126792572|NCT00441467|456199140|FG000|Overall Study|Adverse Event|6|||
126632728|NCT01880437|455613835|FG000|Overall Study|Study terminated by Sponsor|3|||
126792573|NCT00441467|456199140|FG000|Overall Study|Withdrawal by Subject|3|||
126792574|NCT00441467|456199140|FG000|Overall Study|Progressive disease|9|||
126792575|NCT02289963|456199141|FG000|Overall Study|Adverse Event|1|||
126792576|NCT02289963|456199142|FG001|Overall Study|Adverse Event|2|||
126792577|NCT02289963|456199141|FG000|Overall Study|Poor compliance to protocol|1|||
126792578|NCT02289963|456199142|FG001|Overall Study|Poor compliance to protocol|0|||
126792579|NCT02289963|456199141|FG000|Overall Study|Withdrawal by Subject|1|||
126792580|NCT02289963|456199142|FG001|Overall Study|Withdrawal by Subject|0|||
126792581|NCT02289963|456199141|FG000|Overall Study|Last injection missed|2|||
126792582|NCT02289963|456199142|FG001|Overall Study|Last injection missed|2|||
126792583|NCT02289963|456199141|FG000|Overall Study|End treatment visit outside visit window|0|||
126792584|NCT02289963|456199142|FG001|Overall Study|End treatment visit outside visit window|4|||
126792585|NCT02289963|456199141|FG000|Overall Study|Other than specified above|0|||
126792586|NCT02289963|456199142|FG001|Overall Study|Other than specified above|2|||
126792587|NCT01042522|456199143|FG000|Overall Study|Adverse Event|1|||
126792588|NCT01042522|456199144|FG001|Overall Study|Adverse Event|2|||
126792589|NCT01042522|456199143|FG000|Overall Study|Disease Progression|5|||
126792590|NCT01042522|456199144|FG001|Overall Study|Disease Progression|0|||
126792591|NCT01042522|456199143|FG000|Overall Study|Death|1|||
126792592|NCT01042522|456199144|FG001|Overall Study|Death|0|||
126792593|NCT01042522|456199143|FG000|Overall Study|Patient Refused|0|||
126792594|NCT01042522|456199144|FG001|Overall Study|Patient Refused|3|||
126792595|NCT01042522|456199143|FG000|Overall Study|Withdrawal by Subject|1|||
126792596|NCT01042522|456199144|FG001|Overall Study|Withdrawal by Subject|1|||
126792597|NCT00549718|456199147|FG000|Overall Study|Insufficient clinical response|20|||
126792598|NCT00549718|456199148|FG001|Overall Study|Insufficient clinical response|7|||
126792599|NCT00549718|456199149|FG002|Overall Study|Insufficient clinical response|18|||
126792600|NCT00549718|456199150|FG003|Overall Study|Insufficient clinical response|32|||
126792601|NCT00549718|456199147|FG000|Overall Study|Adverse Event|6|||
126792602|NCT00549718|456199148|FG001|Overall Study|Adverse Event|8|||
126792603|NCT00549718|456199149|FG002|Overall Study|Adverse Event|7|||
126792604|NCT00549718|456199150|FG003|Overall Study|Adverse Event|3|||
126792605|NCT00549718|456199147|FG000|Overall Study|Lost to Follow-up|4|||
126792606|NCT00549718|456199148|FG001|Overall Study|Lost to Follow-up|2|||
126792607|NCT00549718|456199149|FG002|Overall Study|Lost to Follow-up|0|||
126792608|NCT00549718|456199150|FG003|Overall Study|Lost to Follow-up|6|||
126792609|NCT00549718|456199147|FG000|Overall Study|Withdrawal by Subject|9|||
126792610|NCT00549718|456199148|FG001|Overall Study|Withdrawal by Subject|18|||
126792611|NCT00549718|456199149|FG002|Overall Study|Withdrawal by Subject|12|||
126792612|NCT00549718|456199150|FG003|Overall Study|Withdrawal by Subject|13|||
126792613|NCT00549718|456199147|FG000|Overall Study|Administrative|2|||
126792614|NCT00549718|456199148|FG001|Overall Study|Administrative|2|||
126792615|NCT00549718|456199149|FG002|Overall Study|Administrative|2|||
126792616|NCT00549718|456199150|FG003|Overall Study|Administrative|1|||
126792617|NCT02424097|456199153|FG000|Overall Study|Lost to Follow-up|1|||
126792618|NCT02424097|456199154|FG001|Overall Study|Lost to Follow-up|2|||
126792619|NCT01675622|456199155|FG000|Overall Study|Withdrawal by Subject|2|||
126792620|NCT01675622|456199156|FG001|Overall Study|Withdrawal by Subject|2|||
126792621|NCT01675622|456199155|FG000|Overall Study|Adverse Event|12|||
126792622|NCT01675622|456199156|FG001|Overall Study|Adverse Event|10|||
126792623|NCT01675622|456199155|FG000|Overall Study|Protocol Violation|4|||
126792624|NCT01675622|456199156|FG001|Overall Study|Protocol Violation|1|||
126792625|NCT01675622|456199155|FG000|Overall Study|Lack of Efficacy|2|||
126792626|NCT01675622|456199156|FG001|Overall Study|Lack of Efficacy|4|||
126792627|NCT01675622|456199155|FG000|Overall Study|Lost to Follow-up|1|||
126792628|NCT01675622|456199156|FG001|Overall Study|Lost to Follow-up|3|||
126792629|NCT01675622|456199155|FG000|Overall Study|Other|5|||
126792630|NCT01675622|456199156|FG001|Overall Study|Other|4|||
126792631|NCT04032977|456199157|FG000|Overall Study|Withdrawal by Subject|6|||
126792632|NCT04032977|456199158|FG001|Overall Study|Withdrawal by Subject|1|||
126792633|NCT04032977|456199157|FG000|Overall Study|Lost to Follow-up|2|||
126792634|NCT04032977|456199158|FG001|Overall Study|Lost to Follow-up|7|||
126792635|NCT04032977|456199157|FG000|Overall Study|Pregnancy|1|||
126792636|NCT04032977|456199158|FG001|Overall Study|Pregnancy|0|||
126792637|NCT02880761|456199159|FG000|Overall Study|Death|6|||
126792638|NCT02880761|456199160|FG001|Overall Study|Death|8|||
126792639|NCT02880761|456199159|FG000|Overall Study|Withdrawal by Subject|3|||
126792640|NCT02880761|456199160|FG001|Overall Study|Withdrawal by Subject|6|||
126792641|NCT02880761|456199159|FG000|Overall Study|Protocol Violation|4|||
126792642|NCT02880761|456199160|FG001|Overall Study|Protocol Violation|3|||
126792643|NCT02880761|456199159|FG000|Overall Study|Lost to Follow-up|3|||
126792644|NCT02880761|456199160|FG001|Overall Study|Lost to Follow-up|4|||
126792645|NCT02106156|456199161|FG000|Overall Study|Patient Died|19|||
126792646|NCT02106156|456199162|FG001|Overall Study|Patient Died|0|||
126792647|NCT02106156|456199163|FG002|Overall Study|Patient Died|0|||
126792648|NCT02106156|456199161|FG000|Overall Study|Lack of Tolerability|305|||
126792649|NCT02106156|456199162|FG001|Overall Study|Lack of Tolerability|3|||
126792650|NCT02106156|456199163|FG002|Overall Study|Lack of Tolerability|0|||
126792651|NCT02106156|456199161|FG000|Overall Study|Lack of Virological Response|1044|||
126792652|NCT02106156|456199162|FG001|Overall Study|Lack of Virological Response|8|||
126792653|NCT02106156|456199163|FG002|Overall Study|Lack of Virological Response|0|||
126792654|NCT02106156|456199161|FG000|Overall Study|Concomitant Disease|74|||
126792655|NCT02106156|456199162|FG001|Overall Study|Concomitant Disease|2|||
126792656|NCT02106156|456199163|FG002|Overall Study|Concomitant Disease|0|||
126792657|NCT02106156|456199161|FG000|Overall Study|Lack of Compliance|211|||
126792658|NCT02106156|456199162|FG001|Overall Study|Lack of Compliance|7|||
126792659|NCT02106156|456199163|FG002|Overall Study|Lack of Compliance|0|||
126792660|NCT02106156|456199161|FG000|Overall Study|Patients Request|307|||
126792661|NCT02106156|456199162|FG001|Overall Study|Patients Request|9|||
126792662|NCT02106156|456199163|FG002|Overall Study|Patients Request|0|||
126792663|NCT02106156|456199161|FG000|Overall Study|Lost to Follow-up|451|||
126792664|NCT02106156|456199162|FG001|Overall Study|Lost to Follow-up|8|||
126792665|NCT02106156|456199163|FG002|Overall Study|Lost to Follow-up|0|||
126792666|NCT02106156|456199161|FG000|Overall Study|Unplanned Event|82|||
126792667|NCT02106156|456199162|FG001|Overall Study|Unplanned Event|2|||
126792668|NCT02106156|456199163|FG002|Overall Study|Unplanned Event|0|||
126792669|NCT02106156|456199161|FG000|Overall Study|Change of Laboratory Parameter|10|||
126792670|NCT02106156|456199162|FG001|Overall Study|Change of Laboratory Parameter|0|||
126792671|NCT02106156|456199163|FG002|Overall Study|Change of Laboratory Parameter|0|||
126792672|NCT02106156|456199161|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
126792673|NCT02106156|456199162|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
126792674|NCT02106156|456199163|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
126792675|NCT02106156|456199161|FG000|Overall Study|Relocation/Change of Physician|40|||
126792676|NCT02106156|456199162|FG001|Overall Study|Relocation/Change of Physician|1|||
126792677|NCT02106156|456199163|FG002|Overall Study|Relocation/Change of Physician|0|||
126792678|NCT05017480|456199168|FG000|Stage 1 Study|Withdrawal by Subject|8|||
126792679|NCT05017480|456199169|FG001|Stage 1 Study|Withdrawal by Subject|6|||
126792680|NCT05017480|456199170|FG002|Stage 1 Study|Withdrawal by Subject|0|||
126792681|NCT05017480|456199171|FG003|Stage 1 Study|Withdrawal by Subject|0|||
126792682|NCT05017480|456199172|FG004|Stage 1 Study|Withdrawal by Subject|0|||
126792683|NCT05017480|456199168|FG000|Stage 1 Study|Adverse Event|1|||
126792684|NCT05017480|456199169|FG001|Stage 1 Study|Adverse Event|1|||
126792685|NCT05017480|456199170|FG002|Stage 1 Study|Adverse Event|0|||
126792686|NCT05017480|456199171|FG003|Stage 1 Study|Adverse Event|0|||
126792687|NCT05017480|456199172|FG004|Stage 1 Study|Adverse Event|0|||
126792688|NCT05017480|456199168|FG000|Stage 1 Study|Poor Compliance|1|||
126792689|NCT05017480|456199169|FG001|Stage 1 Study|Poor Compliance|1|||
126792690|NCT05017480|456199170|FG002|Stage 1 Study|Poor Compliance|0|||
126792691|NCT05017480|456199171|FG003|Stage 1 Study|Poor Compliance|0|||
126792692|NCT05017480|456199172|FG004|Stage 1 Study|Poor Compliance|0|||
126792693|NCT05017480|456199168|FG000|Stage 1 Study|Physician Decision|0|||
126792694|NCT05017480|456199169|FG001|Stage 1 Study|Physician Decision|1|||
126792695|NCT05017480|456199170|FG002|Stage 1 Study|Physician Decision|0|||
126792696|NCT05017480|456199171|FG003|Stage 1 Study|Physician Decision|0|||
126792697|NCT05017480|456199172|FG004|Stage 1 Study|Physician Decision|0|||
126792698|NCT05017480|456199168|FG000|Stage 2 Study|Withdrawal by Subject|0|||
126792699|NCT05017480|456199169|FG001|Stage 2 Study|Withdrawal by Subject|0|||
126792700|NCT05017480|456199170|FG002|Stage 2 Study|Withdrawal by Subject|6|||
126792701|NCT05017480|456199171|FG003|Stage 2 Study|Withdrawal by Subject|9|||
126792702|NCT05017480|456199172|FG004|Stage 2 Study|Withdrawal by Subject|11|||
126792703|NCT05017480|456199168|FG000|Stage 2 Study|Lost to Follow-up|0|||
126792704|NCT05017480|456199169|FG001|Stage 2 Study|Lost to Follow-up|0|||
126792705|NCT05017480|456199170|FG002|Stage 2 Study|Lost to Follow-up|0|||
126792706|NCT05017480|456199171|FG003|Stage 2 Study|Lost to Follow-up|2|||
126792707|NCT05017480|456199172|FG004|Stage 2 Study|Lost to Follow-up|1|||
126792708|NCT05017480|456199168|FG000|Stage 2 Study|Adverse Event|0|||
126792709|NCT05017480|456199169|FG001|Stage 2 Study|Adverse Event|0|||
126792710|NCT05017480|456199170|FG002|Stage 2 Study|Adverse Event|0|||
126792711|NCT05017480|456199171|FG003|Stage 2 Study|Adverse Event|1|||
126792712|NCT05017480|456199172|FG004|Stage 2 Study|Adverse Event|0|||
126792713|NCT05017480|456199168|FG000|Stage 2 Study|COVID-19|0|||
126792714|NCT05017480|456199169|FG001|Stage 2 Study|COVID-19|0|||
126792715|NCT05017480|456199170|FG002|Stage 2 Study|COVID-19|0|||
126792716|NCT05017480|456199171|FG003|Stage 2 Study|COVID-19|1|||
126792717|NCT05017480|456199172|FG004|Stage 2 Study|COVID-19|0|||
126792718|NCT05017480|456199168|FG000|Stage 2 Study|Pregnancy|0|||
126792719|NCT05017480|456199169|FG001|Stage 2 Study|Pregnancy|0|||
126792720|NCT05017480|456199170|FG002|Stage 2 Study|Pregnancy|0|||
126792721|NCT05017480|456199171|FG003|Stage 2 Study|Pregnancy|0|||
126792722|NCT05017480|456199172|FG004|Stage 2 Study|Pregnancy|1|||
126792723|NCT01136382|456199173|FG000|Overall Study|Other|8|||
126632729|NCT01880437|455613836|FG001|Overall Study|Study terminated by Sponsor|0|||
126632730|NCT01880437|455613837|FG002|Overall Study|Study terminated by Sponsor|2|||
126632731|NCT04354168|455613842|FG000|Overall Study|Lost to Follow-up|22|||
126632732|NCT01438840|455613845|FG000|Core Study|Adverse Event|0|||
126792724|NCT01136382|456199174|FG001|Overall Study|Other|3|||
126792725|NCT01136382|456199173|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
126792726|NCT01136382|456199174|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
126792727|NCT01136382|456199173|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
126792728|NCT01136382|456199174|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
126792729|NCT01136382|456199173|FG000|Overall Study|Withdrawal by Subject|4|||
126792730|NCT01136382|456199174|FG001|Overall Study|Withdrawal by Subject|1|||
126792731|NCT00746798|456199179|FG000|Overall Study|Protocol Violation|0|||
126792732|NCT00746798|456199180|FG001|Overall Study|Protocol Violation|1|||
126792733|NCT00746798|456199181|FG002|Overall Study|Protocol Violation|0|||
126632733|NCT01438840|455613846|FG001|Core Study|Adverse Event|3|||
126792734|NCT00746798|456199182|FG003|Overall Study|Protocol Violation|0|||
126792735|NCT00746798|456199179|FG000|Overall Study|Withdrawal by Subject|0|||
126792736|NCT00746798|456199180|FG001|Overall Study|Withdrawal by Subject|1|||
126792737|NCT00746798|456199181|FG002|Overall Study|Withdrawal by Subject|1|||
126792738|NCT00746798|456199182|FG003|Overall Study|Withdrawal by Subject|0|||
126792739|NCT00746798|456199179|FG000|Overall Study|Death|0|||
126792740|NCT00746798|456199180|FG001|Overall Study|Death|0|||
126792741|NCT00746798|456199181|FG002|Overall Study|Death|2|||
126792742|NCT00746798|456199182|FG003|Overall Study|Death|0|||
126792743|NCT00746798|456199179|FG000|Overall Study|Participant unable to return for visit|1|||
126792744|NCT00746798|456199180|FG001|Overall Study|Participant unable to return for visit|0|||
126792745|NCT00746798|456199181|FG002|Overall Study|Participant unable to return for visit|0|||
126792746|NCT00746798|456199182|FG003|Overall Study|Participant unable to return for visit|0|||
126792747|NCT02896361|456199183|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
126792748|NCT02896361|456199184|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
126792749|NCT02896361|456199185|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
126792750|NCT02896361|456199183|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
126792751|NCT02896361|456199184|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
126792752|NCT02896361|456199185|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
126792753|NCT01045096|456199187|FG000|Overall Study|Withdrawal by Subject|2|||
126792754|NCT01045096|456199188|FG001|Overall Study|Withdrawal by Subject|0|||
126792755|NCT01045096|456199189|FG002|Overall Study|Withdrawal by Subject|0|||
126792756|NCT01045096|456199187|FG000|Overall Study|Other|1|||
126792757|NCT01045096|456199188|FG001|Overall Study|Other|0|||
126792758|NCT01045096|456199189|FG002|Overall Study|Other|0|||
126792759|NCT01511939|456199190|FG000|Overall Study|Withdrawal by Subject|2|||
126792760|NCT01511939|456199191|FG001|Overall Study|Withdrawal by Subject|1|||
126792761|NCT01511939|456199192|FG002|Overall Study|Withdrawal by Subject|0|||
126792762|NCT00324168|456199193|FG000|Overall Study|Lost to Follow-up|19|||
126792763|NCT00324168|456199194|FG001|Overall Study|Lost to Follow-up|18|||
126792764|NCT00324168|456199193|FG000|Overall Study|Death|3|||
126792765|NCT00324168|456199194|FG001|Overall Study|Death|3|||
126792766|NCT00324168|456199193|FG000|Overall Study|Patient did not visit in f/u window|6|||
126792767|NCT00324168|456199194|FG001|Overall Study|Patient did not visit in f/u window|9|||
126792768|NCT03497897|456199197|FG000|Overall Study|Adverse Event|1|||
126792769|NCT03497897|456199198|FG001|Overall Study|Adverse Event|1|||
126792770|NCT03497897|456199199|FG002|Overall Study|Adverse Event|1|||
126792771|NCT03497897|456199197|FG000|Overall Study|Lost to Follow-up|2|||
126792772|NCT03497897|456199198|FG001|Overall Study|Lost to Follow-up|0|||
126792773|NCT03497897|456199199|FG002|Overall Study|Lost to Follow-up|2|||
126792774|NCT03497897|456199197|FG000|Overall Study|Physician Decision|1|||
126792775|NCT03497897|456199198|FG001|Overall Study|Physician Decision|0|||
126792776|NCT03497897|456199199|FG002|Overall Study|Physician Decision|0|||
126792777|NCT03497897|456199197|FG000|Overall Study|Subject/Guardian Decision|2|||
126792778|NCT03497897|456199198|FG001|Overall Study|Subject/Guardian Decision|1|||
126792779|NCT03497897|456199199|FG002|Overall Study|Subject/Guardian Decision|3|||
126792780|NCT01391793|456199207|FG000|Overall Study|Ineligible|3|||
126792781|NCT01391793|456199208|FG001|Overall Study|Ineligible|0|||
126792782|NCT01391793|456199207|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
126792783|NCT01391793|456199208|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
126792784|NCT01391793|456199207|FG000|Overall Study|No DMSA|73|||
126792785|NCT01391793|456199208|FG001|Overall Study|No DMSA|57|||
126792786|NCT01666730|456199209|FG000|Overall Study|Adverse Event|16|||
126792787|NCT01666730|456199209|FG000|Overall Study|Death|2|||
126792788|NCT01666730|456199209|FG000|Overall Study|Physician Decision|5|||
126792789|NCT01666730|456199209|FG000|Overall Study|Withdrawal by Subject|9|||
126792790|NCT01666730|456199209|FG000|Overall Study|Disease progression/relapse|18|||
126792791|NCT02087904|456199212|FG000|Overall Study|Did Not Receive Study Drug|0|||
126792792|NCT02087904|456199213|FG001|Overall Study|Did Not Receive Study Drug|0|||
126792793|NCT02087904|456199214|FG002|Overall Study|Did Not Receive Study Drug|2|||
126792794|NCT02087904|456199215|FG003|Overall Study|Did Not Receive Study Drug|1|||
126792795|NCT02087904|456199212|FG000|Overall Study|Adverse Event|8|||
126792796|NCT02087904|456199213|FG001|Overall Study|Adverse Event|4|||
126792797|NCT02087904|456199214|FG002|Overall Study|Adverse Event|4|||
126792798|NCT02087904|456199215|FG003|Overall Study|Adverse Event|12|||
126632734|NCT01438840|455613847|FG002|Core Study|Adverse Event|0|||
126792799|NCT02087904|456199212|FG000|Overall Study|Lack of Efficacy|3|||
126792800|NCT02087904|456199213|FG001|Overall Study|Lack of Efficacy|6|||
126792801|NCT02087904|456199214|FG002|Overall Study|Lack of Efficacy|3|||
126792802|NCT02087904|456199215|FG003|Overall Study|Lack of Efficacy|2|||
126792803|NCT02087904|456199212|FG000|Overall Study|Other|6|||
126792804|NCT02087904|456199213|FG001|Overall Study|Other|2|||
126632735|NCT01438840|455613845|FG000|Core Study|Lack of Efficacy|15|||
126632736|NCT01438840|455613846|FG001|Core Study|Lack of Efficacy|7|||
126792805|NCT02087904|456199214|FG002|Overall Study|Other|4|||
126792806|NCT02087904|456199215|FG003|Overall Study|Other|4|||
126792807|NCT02087904|456199212|FG000|Overall Study|Withdrawal by Subject|8|||
126792808|NCT02087904|456199213|FG001|Overall Study|Withdrawal by Subject|3|||
126792809|NCT02087904|456199214|FG002|Overall Study|Withdrawal by Subject|7|||
126792810|NCT02087904|456199215|FG003|Overall Study|Withdrawal by Subject|4|||
126792811|NCT02087904|456199212|FG000|Overall Study|Lost to Follow-up|0|||
126792812|NCT02087904|456199213|FG001|Overall Study|Lost to Follow-up|4|||
126792813|NCT02087904|456199214|FG002|Overall Study|Lost to Follow-up|2|||
126792814|NCT02087904|456199215|FG003|Overall Study|Lost to Follow-up|2|||
126792815|NCT01389102|456199217|FG000|Overall Study|Adverse Event|1|||
126792816|NCT01389102|456199218|FG001|Overall Study|Adverse Event|3|||
126792817|NCT01389102|456199219|FG002|Overall Study|Adverse Event|2|||
126792818|NCT01389102|456199220|FG003|Overall Study|Adverse Event|2|||
126792819|NCT01389102|456199221|FG004|Overall Study|Adverse Event|2|||
126792820|NCT01389102|456199222|FG005|Overall Study|Adverse Event|2|||
126792821|NCT01389102|456199217|FG000|Overall Study|Hurricane Katrina|4|||
126792822|NCT01389102|456199218|FG001|Overall Study|Hurricane Katrina|2|||
126792823|NCT01389102|456199219|FG002|Overall Study|Hurricane Katrina|3|||
126792824|NCT01389102|456199220|FG003|Overall Study|Hurricane Katrina|0|||
126792825|NCT01389102|456199221|FG004|Overall Study|Hurricane Katrina|3|||
126792826|NCT01389102|456199222|FG005|Overall Study|Hurricane Katrina|1|||
126792827|NCT01389102|456199217|FG000|Overall Study|Lost to Follow-up|4|||
126792828|NCT01389102|456199218|FG001|Overall Study|Lost to Follow-up|1|||
126792829|NCT01389102|456199219|FG002|Overall Study|Lost to Follow-up|1|||
126792830|NCT01389102|456199220|FG003|Overall Study|Lost to Follow-up|2|||
126792831|NCT01389102|456199221|FG004|Overall Study|Lost to Follow-up|4|||
126792832|NCT01389102|456199222|FG005|Overall Study|Lost to Follow-up|1|||
126792833|NCT01389102|456199217|FG000|Overall Study|Protocol Violation|0|||
126792834|NCT01389102|456199218|FG001|Overall Study|Protocol Violation|0|||
126792835|NCT01389102|456199219|FG002|Overall Study|Protocol Violation|3|||
126792836|NCT01389102|456199220|FG003|Overall Study|Protocol Violation|0|||
126792837|NCT01389102|456199221|FG004|Overall Study|Protocol Violation|1|||
126792838|NCT01389102|456199222|FG005|Overall Study|Protocol Violation|1|||
126792839|NCT01389102|456199217|FG000|Overall Study|Withdrawal by Subject|7|||
126792840|NCT01389102|456199218|FG001|Overall Study|Withdrawal by Subject|4|||
126792841|NCT01389102|456199219|FG002|Overall Study|Withdrawal by Subject|9|||
126792842|NCT01389102|456199220|FG003|Overall Study|Withdrawal by Subject|2|||
126792843|NCT01389102|456199221|FG004|Overall Study|Withdrawal by Subject|3|||
126792844|NCT01389102|456199222|FG005|Overall Study|Withdrawal by Subject|3|||
126792845|NCT01389102|456199217|FG000|Overall Study|Subject Traveling Out of Country|0|||
126792846|NCT01389102|456199218|FG001|Overall Study|Subject Traveling Out of Country|0|||
126632737|NCT01438840|455613847|FG002|Core Study|Lack of Efficacy|0|||
126632738|NCT01438840|455613845|FG000|Core Study|Withdrawal of consent|1|||
126792847|NCT01389102|456199219|FG002|Overall Study|Subject Traveling Out of Country|0|||
126792848|NCT01389102|456199220|FG003|Overall Study|Subject Traveling Out of Country|1|||
126792849|NCT01389102|456199221|FG004|Overall Study|Subject Traveling Out of Country|0|||
126792850|NCT01389102|456199222|FG005|Overall Study|Subject Traveling Out of Country|0|||
126792851|NCT01389102|456199217|FG000|Overall Study|Subject Moved|2|||
126792852|NCT01389102|456199218|FG001|Overall Study|Subject Moved|0|||
126792853|NCT01389102|456199219|FG002|Overall Study|Subject Moved|1|||
126792854|NCT01389102|456199220|FG003|Overall Study|Subject Moved|0|||
126792855|NCT01389102|456199221|FG004|Overall Study|Subject Moved|0|||
126792856|NCT01389102|456199222|FG005|Overall Study|Subject Moved|0|||
126792857|NCT01389102|456199217|FG000|Overall Study|Unavailable due to husband's illness|0|||
126792858|NCT01389102|456199218|FG001|Overall Study|Unavailable due to husband's illness|1|||
126792859|NCT01389102|456199219|FG002|Overall Study|Unavailable due to husband's illness|0|||
126792860|NCT01389102|456199220|FG003|Overall Study|Unavailable due to husband's illness|0|||
126792861|NCT01389102|456199221|FG004|Overall Study|Unavailable due to husband's illness|0|||
126792862|NCT01389102|456199222|FG005|Overall Study|Unavailable due to husband's illness|0|||
126792863|NCT01389102|456199217|FG000|Overall Study|Investigator Judgement|0|||
126792864|NCT01389102|456199218|FG001|Overall Study|Investigator Judgement|1|||
126792865|NCT01389102|456199219|FG002|Overall Study|Investigator Judgement|0|||
126792866|NCT01389102|456199220|FG003|Overall Study|Investigator Judgement|0|||
126792867|NCT01389102|456199221|FG004|Overall Study|Investigator Judgement|0|||
126792868|NCT01389102|456199222|FG005|Overall Study|Investigator Judgement|0|||
126792869|NCT00893464|456199223|FG000|Overall Study|Did not complete therapy/experience PD|0|||
126792870|NCT00893464|456199224|FG001|Overall Study|Did not complete therapy/experience PD|0|||
126792871|NCT00893464|456199225|FG002|Overall Study|Did not complete therapy/experience PD|0|||
126632739|NCT01438840|455613846|FG001|Core Study|Withdrawal of consent|0|||
126632740|NCT01438840|455613847|FG002|Core Study|Withdrawal of consent|0|||
126792872|NCT00893464|456199226|FG003|Overall Study|Did not complete therapy/experience PD|0|||
126792873|NCT00893464|456199227|FG004|Overall Study|Did not complete therapy/experience PD|0|||
126632741|NCT01438840|455613845|FG000|Extension Phase|Adverse Event|0|||
126632742|NCT01438840|455613846|FG001|Extension Phase|Adverse Event|0|||
126632743|NCT01438840|455613847|FG002|Extension Phase|Adverse Event|3|||
126792874|NCT00893464|456199228|FG005|Overall Study|Did not complete therapy/experience PD|0|||
126792875|NCT00893464|456199229|FG006|Overall Study|Did not complete therapy/experience PD|2|||
126632744|NCT01438840|455613845|FG000|Extension Phase|Lost to Follow-up|0|||
126632745|NCT01438840|455613846|FG001|Extension Phase|Lost to Follow-up|0|||
126792876|NCT00893464|456199230|FG007|Overall Study|Did not complete therapy/experience PD|2|||
126792877|NCT02910037|456199231|FG000|Overall Study|Withdrawal by Subject|4|||
126792878|NCT02910037|456199231|FG000|Overall Study|Lost to Follow-up|6|||
126792879|NCT00436553|456199232|FG000|Overall Study|Adverse Event|4|||
126792880|NCT00436553|456199233|FG001|Overall Study|Adverse Event|3|||
126792881|NCT00436553|456199234|FG002|Overall Study|Adverse Event|4|||
126792882|NCT00436553|456199232|FG000|Overall Study|Death|3|||
126792883|NCT00436553|456199233|FG001|Overall Study|Death|1|||
126792884|NCT00436553|456199234|FG002|Overall Study|Death|3|||
126792885|NCT00436553|456199232|FG000|Overall Study|Lost to Follow-up|0|||
126792886|NCT00436553|456199233|FG001|Overall Study|Lost to Follow-up|2|||
126792887|NCT00436553|456199234|FG002|Overall Study|Lost to Follow-up|0|||
126792888|NCT00436553|456199232|FG000|Overall Study|Protocol Violation|1|||
126792889|NCT00436553|456199233|FG001|Overall Study|Protocol Violation|0|||
126792890|NCT00436553|456199234|FG002|Overall Study|Protocol Violation|0|||
126792891|NCT00436553|456199232|FG000|Overall Study|Withdrawal by Subject|5|||
126792892|NCT00436553|456199233|FG001|Overall Study|Withdrawal by Subject|6|||
126792893|NCT00436553|456199234|FG002|Overall Study|Withdrawal by Subject|3|||
126792894|NCT01661686|456199244|FG000|Overall Study|Lost to Follow-up|2|||
126792895|NCT01661686|456199245|FG001|Overall Study|Lost to Follow-up|1|||
126792896|NCT01661686|456199244|FG000|Overall Study|did not receive allocated intervention|0|||
126792897|NCT01661686|456199245|FG001|Overall Study|did not receive allocated intervention|1|||
126792898|NCT04869787|456199246|FG000|Screening|Physician Decision|1|||
126792899|NCT04869787|456199246|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
126792900|NCT01873586|456199247|FG000|Overall Study|Lost to Follow-up|3|||
126792901|NCT00696020|456199248|FG000|Overall Study|Adverse Event|3|||
126792902|NCT00696020|456199249|FG001|Overall Study|Adverse Event|1|||
126792903|NCT00696020|456199250|FG002|Overall Study|Adverse Event|2|||
126792904|NCT00696020|456199251|FG003|Overall Study|Adverse Event|1|||
126792905|NCT00696020|456199248|FG000|Overall Study|Lack of Efficacy|1|||
126792906|NCT00696020|456199249|FG001|Overall Study|Lack of Efficacy|0|||
126792907|NCT00696020|456199250|FG002|Overall Study|Lack of Efficacy|0|||
126792908|NCT00696020|456199251|FG003|Overall Study|Lack of Efficacy|0|||
126792909|NCT00696020|456199248|FG000|Overall Study|Protocol Violation|0|||
126792910|NCT00696020|456199249|FG001|Overall Study|Protocol Violation|0|||
126792911|NCT00696020|456199250|FG002|Overall Study|Protocol Violation|0|||
126792912|NCT00696020|456199251|FG003|Overall Study|Protocol Violation|1|||
126792913|NCT00696020|456199248|FG000|Overall Study|Withdrawal by Subject|0|||
126792914|NCT00696020|456199249|FG001|Overall Study|Withdrawal by Subject|1|||
126792915|NCT00696020|456199250|FG002|Overall Study|Withdrawal by Subject|0|||
126792916|NCT00696020|456199251|FG003|Overall Study|Withdrawal by Subject|1|||
126792917|NCT00696020|456199248|FG000|Overall Study|Other not stated above|0|||
126792918|NCT00696020|456199249|FG001|Overall Study|Other not stated above|0|||
126792919|NCT00696020|456199250|FG002|Overall Study|Other not stated above|1|||
126792920|NCT00696020|456199251|FG003|Overall Study|Other not stated above|1|||
126792921|NCT01387022|456199252|FG000|Overall Study|Death|1|||
126792922|NCT01387022|456199253|FG001|Overall Study|Death|1|||
126792923|NCT01387022|456199252|FG000|Overall Study|Lost to Follow-up|0|||
126792924|NCT01387022|456199253|FG001|Overall Study|Lost to Follow-up|3|||
126792925|NCT01536405|456199258|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
126792926|NCT01536405|456199259|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
126792927|NCT01536405|456199258|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
126792928|NCT01536405|456199259|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
126792929|NCT01536405|456199258|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
126632746|NCT01438840|455613847|FG002|Extension Phase|Lost to Follow-up|1|||
126632747|NCT01438840|455613845|FG000|Extension Phase|Withdrawal by Subject|0|||
126632748|NCT01438840|455613846|FG001|Extension Phase|Withdrawal by Subject|0|||
126792930|NCT01536405|456199259|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
126792931|NCT01536405|456199258|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
126792932|NCT01536405|456199259|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
126792933|NCT01536405|456199258|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
126792934|NCT01536405|456199259|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
126792935|NCT01536405|456199258|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
126792936|NCT01536405|456199259|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
126792937|NCT01536405|456199258|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
126792938|NCT01536405|456199259|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
126792939|NCT01536405|456199258|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
126792940|NCT01536405|456199259|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
126792941|NCT01536405|456199258|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
126792942|NCT01536405|456199259|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
126792943|NCT01536405|456199258|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
126792944|NCT01536405|456199259|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
126792945|NCT01536405|456199258|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
126792946|NCT01536405|456199259|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
126632749|NCT01438840|455613847|FG002|Extension Phase|Withdrawal by Subject|3|||
126792947|NCT01536405|456199258|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
126792948|NCT01536405|456199259|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
126792949|NCT01536405|456199258|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
126792950|NCT01536405|456199259|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
126792951|NCT00450190|456199260|FG000|Overall Study|Withdrawal by Subject|2|||
126792952|NCT01536574|456199265|FG000|Overall Study|Adverse Event|4|||
126792953|NCT01536574|456199266|FG001|Overall Study|Adverse Event|5|||
126792954|NCT01536574|456199265|FG000|Overall Study|Withdrawal by Subject|1|||
126792955|NCT01536574|456199266|FG001|Overall Study|Withdrawal by Subject|2|||
126792956|NCT01536574|456199265|FG000|Overall Study|Lack of Efficacy|1|||
126792957|NCT01536574|456199266|FG001|Overall Study|Lack of Efficacy|0|||
126792958|NCT02193165|456199269|FG000|4 Week Product Use|Lost to Follow-up|1|||
126792959|NCT02193165|456199270|FG001|4 Week Product Use|Lost to Follow-up|1|||
126792960|NCT02193165|456199271|FG002|4 Week Product Use|Lost to Follow-up|1|||
126792961|NCT02193165|456199269|FG000|6 Week Product Use|Lost to Follow-up|0|||
126792962|NCT02193165|456199270|FG001|6 Week Product Use|Lost to Follow-up|1|||
126792963|NCT02193165|456199271|FG002|6 Week Product Use|Lost to Follow-up|0|||
126792964|NCT01498120|456199272|FG000|Overall Study|Lost to Follow-up|1|||
126792965|NCT01498120|456199272|FG000|Overall Study|Withdrawal by Subject|5|||
126792966|NCT01498120|456199272|FG000|Overall Study|AE, non-serious non-fatal|3|||
126792967|NCT01498120|456199272|FG000|Overall Study|Other|4|||
126792968|NCT01173692|456199273|FG000|Overall Study|Adverse Event|1|||
126792969|NCT01173692|456199274|FG001|Overall Study|Adverse Event|2|||
126792970|NCT01173692|456199273|FG000|Overall Study|Withdrawal by Subject|1|||
126792971|NCT01173692|456199274|FG001|Overall Study|Withdrawal by Subject|3|||
126792972|NCT00678639|456199275|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
126792973|NCT00678639|456199276|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
126792974|NCT00986245|456199279|FG000|First Intervention|Poor compliance|8|||
126792975|NCT00986245|456199280|FG001|First Intervention|Poor compliance|4|||
126792976|NCT00986245|456199279|FG000|First Intervention|Lack of Efficacy|1|||
126792977|NCT00986245|456199280|FG001|First Intervention|Lack of Efficacy|2|||
126792978|NCT00986245|456199279|FG000|First Intervention|Withdrawal by Subject|0|||
126792979|NCT00986245|456199280|FG001|First Intervention|Withdrawal by Subject|1|||
126792980|NCT00986245|456199279|FG000|First Intervention|Protocol Violation|0|||
126792981|NCT00986245|456199280|FG001|First Intervention|Protocol Violation|1|||
126792982|NCT00986245|456199279|FG000|First Intervention|Out of indication|1|||
126792983|NCT00986245|456199280|FG001|First Intervention|Out of indication|0|||
126792984|NCT00986245|456199279|FG000|Second Intervention|Poor compliance|1|||
126792985|NCT00986245|456199280|FG001|Second Intervention|Poor compliance|0|||
126792986|NCT00986245|456199279|FG000|Second Intervention|Lost to Follow-up|1|||
126792987|NCT00986245|456199280|FG001|Second Intervention|Lost to Follow-up|0|||
126792988|NCT00986245|456199279|FG000|Second Intervention|Protocol Violation|0|||
126792989|NCT00986245|456199280|FG001|Second Intervention|Protocol Violation|1|||
126792990|NCT01214850|456199281|FG000|Overall Study|Withdrawal by Subject|38|||
126792991|NCT01214850|456199282|FG001|Overall Study|Withdrawal by Subject|31|||
126792992|NCT01214850|456199283|FG002|Overall Study|Withdrawal by Subject|28|||
126792993|NCT01214850|456199281|FG000|Overall Study|Lost to Follow-up|124|||
126792994|NCT01214850|456199282|FG001|Overall Study|Lost to Follow-up|98|||
126792995|NCT01214850|456199283|FG002|Overall Study|Lost to Follow-up|123|||
126792996|NCT01214850|456199281|FG000|Overall Study|Protocol Violation|5|||
126792997|NCT01214850|456199282|FG001|Overall Study|Protocol Violation|5|||
126792998|NCT01214850|456199283|FG002|Overall Study|Protocol Violation|6|||
126792999|NCT01214850|456199281|FG000|Overall Study|Adverse event or death|11|||
126793000|NCT01214850|456199282|FG001|Overall Study|Adverse event or death|8|||
126793001|NCT01214850|456199283|FG002|Overall Study|Adverse event or death|3|||
126793002|NCT01214850|456199281|FG000|Overall Study|Inappropriate enrollment|2|||
126793003|NCT01214850|456199282|FG001|Overall Study|Inappropriate enrollment|1|||
126793004|NCT01214850|456199283|FG002|Overall Study|Inappropriate enrollment|0|||
126793005|NCT01214850|456199281|FG000|Overall Study|Administrative reason|1|||
126793006|NCT01214850|456199282|FG001|Overall Study|Administrative reason|0|||
126632750|NCT01438840|455613845|FG000|Extension Phase|Lack of Efficacy|0|||
126632751|NCT01438840|455613846|FG001|Extension Phase|Lack of Efficacy|0|||
126632752|NCT01438840|455613847|FG002|Extension Phase|Lack of Efficacy|2|||
126632753|NCT01438840|455613845|FG000|Extension Phase|Other|0|||
126793007|NCT01214850|456199283|FG002|Overall Study|Administrative reason|0|||
126793008|NCT01214850|456199281|FG000|Overall Study|Unable to classify|2|||
126793009|NCT01214850|456199282|FG001|Overall Study|Unable to classify|1|||
126793010|NCT01214850|456199283|FG002|Overall Study|Unable to classify|1|||
126793011|NCT01863745|456199284|FG000|Overall Study|Disease Progression|9|||
126793012|NCT01863745|456199284|FG000|Overall Study|Adverse Event|2|||
126793013|NCT01863745|456199284|FG000|Overall Study|Death|1|||
126793014|NCT01863745|456199284|FG000|Overall Study|Withdrawal by Subject|1|||
126793015|NCT00193609|456199285|FG000|Overall Study|Lack of Efficacy|2|||
126793016|NCT00193609|456199285|FG000|Overall Study|Adverse Event|2|||
126793017|NCT00854308|456199286|FG000|Overall Study|Disease progression|42|||
126793018|NCT00854308|456199287|FG001|Overall Study|Disease progression|50|||
126793019|NCT00854308|456199286|FG000|Overall Study|Adverse Event|8|||
126632754|NCT01438840|455613846|FG001|Extension Phase|Other|0|||
126632755|NCT01438840|455613847|FG002|Extension Phase|Other|1|||
126793020|NCT00854308|456199287|FG001|Overall Study|Adverse Event|3|||
126793021|NCT00854308|456199286|FG000|Overall Study|Death|2|||
126793022|NCT00854308|456199287|FG001|Overall Study|Death|5|||
126793023|NCT00854308|456199286|FG000|Overall Study|Physician Decision|6|||
126793024|NCT00854308|456199287|FG001|Overall Study|Physician Decision|6|||
126793025|NCT00854308|456199286|FG000|Overall Study|Withdrawal by Subject|4|||
126793026|NCT00854308|456199287|FG001|Overall Study|Withdrawal by Subject|2|||
126793027|NCT00854308|456199286|FG000|Overall Study|Sponsor's decision to terminate study|0|||
126793028|NCT00854308|456199287|FG001|Overall Study|Sponsor's decision to terminate study|1|||
126793029|NCT00610363|456199288|FG000|Overall Study|Non-compliance with protocol|0|||
126793030|NCT00610363|456199289|FG001|Overall Study|Non-compliance with protocol|1|||
126793031|NCT00610363|456199288|FG000|Overall Study|Adverse Event|3|||
126793032|NCT00610363|456199289|FG001|Overall Study|Adverse Event|1|||
126793033|NCT00610363|456199288|FG000|Overall Study|Lack of Efficacy|2|||
126793034|NCT00610363|456199289|FG001|Overall Study|Lack of Efficacy|0|||
126793035|NCT00610363|456199288|FG000|Overall Study|Lost to Follow-up|4|||
126793036|NCT00610363|456199289|FG001|Overall Study|Lost to Follow-up|0|||
126793037|NCT00610363|456199288|FG000|Overall Study|Withdrawal by Subject|1|||
126793038|NCT00610363|456199289|FG001|Overall Study|Withdrawal by Subject|0|||
126793039|NCT00610363|456199288|FG000|Overall Study|Other than specified above|1|||
126793040|NCT00610363|456199289|FG001|Overall Study|Other than specified above|1|||
126793041|NCT03048500|456199290|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
126793042|NCT03048500|456199290|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
126793043|NCT03048500|456199290|FG000|Reached 1st Response/Continued Treatment|Death|1|||
126793044|NCT03048500|456199290|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
126793045|NCT03048500|456199290|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
126793046|NCT03048500|456199290|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
126793047|NCT03048500|456199290|FG000|Follow up for 3 Years|Death|12|||
126793048|NCT01171963|456199291|FG000|Overall Study|Adverse Event|10|||
126793049|NCT01171963|456199292|FG001|Overall Study|Adverse Event|15|||
126793050|NCT01171963|456199291|FG000|Overall Study|Lost to Follow-up|23|||
126793051|NCT01171963|456199292|FG001|Overall Study|Lost to Follow-up|24|||
126793052|NCT01171963|456199291|FG000|Overall Study|Other - diarrhoea|1|||
126793053|NCT01171963|456199292|FG001|Overall Study|Other - diarrhoea|0|||
126793054|NCT01171963|456199291|FG000|Overall Study|Withdrawal by Subject|114|||
126793055|NCT01171963|456199292|FG001|Overall Study|Withdrawal by Subject|129|||
126793056|NCT00048581|456199305|FG000|Double-Blind Period|Adverse Event|9|||
126793057|NCT00048581|456199306|FG001|Double-Blind Period|Adverse Event|5|||
126793058|NCT00048581|456199307|FG002|Double-Blind Period|Adverse Event|0|||
126793059|NCT00048581|456199305|FG000|Double-Blind Period|Lack of Efficacy|14|||
126793060|NCT00048581|456199306|FG001|Double-Blind Period|Lack of Efficacy|27|||
126793061|NCT00048581|456199307|FG002|Double-Blind Period|Lack of Efficacy|0|||
126793062|NCT00048581|456199305|FG000|Double-Blind Period|Lost to Follow-up|5|||
126793063|NCT00048581|456199306|FG001|Double-Blind Period|Lost to Follow-up|0|||
126793064|NCT00048581|456199307|FG002|Double-Blind Period|Lost to Follow-up|0|||
126793065|NCT00048581|456199305|FG000|Double-Blind Period|Withdrawal by Subject|5|||
126793066|NCT00048581|456199306|FG001|Double-Blind Period|Withdrawal by Subject|2|||
126793067|NCT00048581|456199307|FG002|Double-Blind Period|Withdrawal by Subject|0|||
126793068|NCT00048581|456199305|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
126793069|NCT00048581|456199306|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
126793070|NCT00048581|456199307|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
126793071|NCT00048581|456199305|FG000|Double-Blind Period|Investigator Decision|1|||
126793072|NCT00048581|456199306|FG001|Double-Blind Period|Investigator Decision|0|||
126793073|NCT00048581|456199307|FG002|Double-Blind Period|Investigator Decision|0|||
126793074|NCT00048581|456199305|FG000|Open-Label Period|Death|0|||
126793075|NCT00048581|456199306|FG001|Open-Label Period|Death|0|||
126793076|NCT00048581|456199307|FG002|Open-Label Period|Death|4|||
126793077|NCT00048581|456199305|FG000|Open-Label Period|Adverse Event|0|||
126793078|NCT00048581|456199306|FG001|Open-Label Period|Adverse Event|0|||
126793079|NCT00048581|456199307|FG002|Open-Label Period|Adverse Event|37|||
126793080|NCT00048581|456199305|FG000|Open-Label Period|Lack of Efficacy|0|||
126793081|NCT00048581|456199306|FG001|Open-Label Period|Lack of Efficacy|0|||
126793082|NCT00048581|456199307|FG002|Open-Label Period|Lack of Efficacy|69|||
126632756|NCT02062645|455613850|FG000|Overall Study|Adverse Event|2|||
126793083|NCT00048581|456199305|FG000|Open-Label Period|Lost to Follow-up|0|||
126793084|NCT00048581|456199306|FG001|Open-Label Period|Lost to Follow-up|0|||
126793085|NCT00048581|456199307|FG002|Open-Label Period|Lost to Follow-up|14|||
126793086|NCT00048581|456199305|FG000|Open-Label Period|Withdrawal by Subject|0|||
126793087|NCT00048581|456199306|FG001|Open-Label Period|Withdrawal by Subject|0|||
126793088|NCT00048581|456199307|FG002|Open-Label Period|Withdrawal by Subject|20|||
126793089|NCT00048581|456199305|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
126793090|NCT00048581|456199306|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
126793091|NCT00048581|456199307|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
126793092|NCT00048581|456199305|FG000|Open-Label Period|Poor/Non-compliance|0|||
126793093|NCT00048581|456199306|FG001|Open-Label Period|Poor/Non-compliance|0|||
126793094|NCT00048581|456199307|FG002|Open-Label Period|Poor/Non-compliance|5|||
126793095|NCT00048581|456199305|FG000|Open-Label Period|Pregnancy|0|||
126793096|NCT00048581|456199306|FG001|Open-Label Period|Pregnancy|0|||
126793097|NCT00048581|456199307|FG002|Open-Label Period|Pregnancy|7|||
126793098|NCT00048581|456199305|FG000|Open-Label Period|Study Site Closure|0|||
126793099|NCT00048581|456199306|FG001|Open-Label Period|Study Site Closure|0|||
126793100|NCT00048581|456199307|FG002|Open-Label Period|Study Site Closure|2|||
126793101|NCT00048581|456199305|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
126793102|NCT00048581|456199306|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
126793103|NCT00048581|456199307|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
126793104|NCT00048581|456199305|FG000|Open-Label Period|Problem With Transportation To Site|0|||
126793105|NCT00048581|456199306|FG001|Open-Label Period|Problem With Transportation To Site|0|||
126793106|NCT00048581|456199307|FG002|Open-Label Period|Problem With Transportation To Site|1|||
126793107|NCT00048581|456199305|FG000|Open-Label Period|Primary Investigator Retired|0|||
126793108|NCT00048581|456199306|FG001|Open-Label Period|Primary Investigator Retired|0|||
126793109|NCT00048581|456199307|FG002|Open-Label Period|Primary Investigator Retired|2|||
126793110|NCT00048581|456199305|FG000|Open-Label Period|Study Ended By Sponsor|0|||
126793111|NCT00048581|456199306|FG001|Open-Label Period|Study Ended By Sponsor|0|||
126793112|NCT00048581|456199307|FG002|Open-Label Period|Study Ended By Sponsor|1|||
126793113|NCT01059903|456199308|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
126793114|NCT01059903|456199309|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
126793115|NCT00214422|456199310|FG000|Overall Study|Physician Decision|2|||
126793116|NCT00214422|456199311|FG001|Overall Study|Physician Decision|0|||
126793117|NCT00214422|456199312|FG002|Overall Study|Physician Decision|0|||
126793118|NCT00214422|456199310|FG000|Overall Study|Developed esophageal ca|1|||
126793119|NCT00214422|456199311|FG001|Overall Study|Developed esophageal ca|0|||
126793120|NCT00214422|456199312|FG002|Overall Study|Developed esophageal ca|0|||
126793121|NCT00214422|456199310|FG000|Overall Study|Pt taken off study|1|||
126793122|NCT00214422|456199311|FG001|Overall Study|Pt taken off study|1|||
126793123|NCT00214422|456199312|FG002|Overall Study|Pt taken off study|0|||
126793124|NCT00214422|456199310|FG000|Overall Study|Disease progression on study|1|||
126793125|NCT00214422|456199311|FG001|Overall Study|Disease progression on study|0|||
126793126|NCT00214422|456199312|FG002|Overall Study|Disease progression on study|0|||
126793127|NCT00214422|456199310|FG000|Overall Study|Unable to make a radiation treatment|0|||
126793128|NCT00214422|456199311|FG001|Overall Study|Unable to make a radiation treatment|0|||
126793129|NCT00214422|456199312|FG002|Overall Study|Unable to make a radiation treatment|1|||
126793130|NCT00319735|456199313|FG000|Overall Study|Death|2|||
126793131|NCT03929393|456199314|FG000|Overall Study|Death|1|||
126793132|NCT03929393|456199315|FG001|Overall Study|Death|0|||
126793133|NCT03929393|456199314|FG000|Overall Study|Time Commitment|2|||
126793134|NCT03929393|456199315|FG001|Overall Study|Time Commitment|5|||
126793135|NCT03929393|456199314|FG000|Overall Study|Motor Vehicle Accident|0|||
126793136|NCT03929393|456199315|FG001|Overall Study|Motor Vehicle Accident|1|||
126793137|NCT03929393|456199314|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
126793138|NCT03929393|456199315|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
126793139|NCT03929393|456199314|FG000|Overall Study|Other|1|||
126793140|NCT03929393|456199315|FG001|Overall Study|Other|3|||
126793141|NCT04149964|456199318|FG000|Overall Study|Lost to Follow-up|19|||
126793142|NCT04149964|456199319|FG001|Overall Study|Lost to Follow-up|18|||
126793143|NCT04753437|456199320|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
126793144|NCT04753437|456199321|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
126793145|NCT04753437|456199320|FG000|Overall Study|Liver Function Test Abnormalities|2|||
126793146|NCT04753437|456199321|FG001|Overall Study|Liver Function Test Abnormalities|4|||
126793147|NCT03075761|456200663|FG000|Overall Study|Lost to Follow-up|1|||
126793148|NCT03075761|456200664|FG001|Overall Study|Lost to Follow-up|6|||
126793149|NCT03597256|456200665|FG000|Overall Study|Lost to Follow-up|3|||
126793150|NCT03597256|456200666|FG001|Overall Study|Lost to Follow-up|1|||
126793151|NCT03597256|456200665|FG000|Overall Study|Withdrawal by Subject|0|||
126793152|NCT03597256|456200666|FG001|Overall Study|Withdrawal by Subject|1|||
126793153|NCT03597256|456200665|FG000|Overall Study|Could not return for treatment|0|||
126632757|NCT02062645|455613850|FG000|Overall Study|Protocol Violation|8|||
126632758|NCT02062645|455613850|FG000|Overall Study|Lost to Follow-up|5|||
126793154|NCT03597256|456200666|FG001|Overall Study|Could not return for treatment|1|||
126793155|NCT03597256|456200665|FG000|Overall Study|Moved from location|0|||
126793156|NCT03597256|456200666|FG001|Overall Study|Moved from location|1|||
126793157|NCT03597256|456200665|FG000|Overall Study|Not accepted the treatment|0|||
126793158|NCT03597256|456200666|FG001|Overall Study|Not accepted the treatment|1|||
126793159|NCT02943447|456200667|FG000|Blinded Study Phase|Withdrew Consent|1|||
126793160|NCT02943447|456200668|FG001|Blinded Study Phase|Withdrew Consent|2|||
126793161|NCT02943447|456200669|FG002|Blinded Study Phase|Withdrew Consent|1|||
126793162|NCT02943447|456200667|FG000|Blinded Study Phase|Adverse Event|3|||
126793163|NCT02943447|456200668|FG001|Blinded Study Phase|Adverse Event|0|||
126793164|NCT02943447|456200669|FG002|Blinded Study Phase|Adverse Event|0|||
126793165|NCT02943447|456200667|FG000|Blinded Study Phase|Investigator's discretion|1|||
126793166|NCT02943447|456200668|FG001|Blinded Study Phase|Investigator's discretion|0|||
126793167|NCT02943447|456200669|FG002|Blinded Study Phase|Investigator's discretion|0|||
126793168|NCT02943447|456200667|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
126793169|NCT02943447|456200668|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
126793170|NCT02943447|456200669|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
126793171|NCT02943447|456200667|FG000|Open-Label Extension Phase|Adverse Event|4|||
126793172|NCT02943447|456200668|FG001|Open-Label Extension Phase|Adverse Event|7|||
126793173|NCT02943447|456200669|FG002|Open-Label Extension Phase|Adverse Event|3|||
126793174|NCT02943447|456200667|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
126793175|NCT02943447|456200668|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
126793176|NCT02943447|456200669|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
126793177|NCT02943447|456200667|FG000|Open-Label Extension Phase|Withdrew consent|1|||
126793178|NCT02943447|456200668|FG001|Open-Label Extension Phase|Withdrew consent|1|||
126793179|NCT02943447|456200669|FG002|Open-Label Extension Phase|Withdrew consent|1|||
126793180|NCT02943447|456200667|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
126793181|NCT02943447|456200668|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
126793182|NCT02943447|456200669|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
126793183|NCT04657770|456200674|FG000|Overall Study|Withdrawal by Subject|3|||
126793184|NCT04657770|456200674|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
126793185|NCT03655106|456200675|FG000|Overall Study|Withdrawal by Subject|3|||
126793186|NCT03655106|456200676|FG001|Overall Study|Withdrawal by Subject|2|||
126793187|NCT03655106|456200675|FG000|Overall Study|Lost to Follow-up|2|||
126793188|NCT03655106|456200676|FG001|Overall Study|Lost to Follow-up|1|||
126793189|NCT03655106|456200675|FG000|Overall Study|Duplicate Enrollment|1|||
126793190|NCT03655106|456200676|FG001|Overall Study|Duplicate Enrollment|1|||
126793191|NCT03655106|456200675|FG000|Overall Study|Protocol Violation|3|||
126793192|NCT03655106|456200676|FG001|Overall Study|Protocol Violation|0|||
126793193|NCT00358449|456200686|FG000|Overall Study|Adverse Event|1|||
126793194|NCT00358449|456200687|FG001|Overall Study|Adverse Event|0|||
126793195|NCT00358449|456200688|FG002|Overall Study|Adverse Event|1|||
126793196|NCT00358449|456200686|FG000|Overall Study|Lost to Follow-up|1|||
126793197|NCT00358449|456200687|FG001|Overall Study|Lost to Follow-up|0|||
126793198|NCT00358449|456200688|FG002|Overall Study|Lost to Follow-up|0|||
126793199|NCT00358449|456200686|FG000|Overall Study|Withdrawal by Subject|2|||
126793200|NCT00358449|456200687|FG001|Overall Study|Withdrawal by Subject|0|||
126793201|NCT00358449|456200688|FG002|Overall Study|Withdrawal by Subject|0|||
126793202|NCT00358449|456200686|FG000|Overall Study|Lack of Efficacy|0|||
126793203|NCT00358449|456200687|FG001|Overall Study|Lack of Efficacy|1|||
126793204|NCT00358449|456200688|FG002|Overall Study|Lack of Efficacy|0|||
126793205|NCT00358449|456200686|FG000|Overall Study|Steriod Inhaler was Increased|0|||
126793206|NCT00358449|456200687|FG001|Overall Study|Steriod Inhaler was Increased|0|||
126793207|NCT00358449|456200688|FG002|Overall Study|Steriod Inhaler was Increased|1|||
126793208|NCT01367457|456200689|FG000|Overall Study|Death|2|||
126793209|NCT01367457|456200690|FG001|Overall Study|Death|0|||
126793210|NCT01367457|456200691|FG002|Overall Study|Death|0|||
126793211|NCT01367457|456200689|FG000|Overall Study|Investigator's decision|2|||
126793212|NCT01367457|456200690|FG001|Overall Study|Investigator's decision|0|||
126793213|NCT01367457|456200691|FG002|Overall Study|Investigator's decision|0|||
126793214|NCT01367457|456200689|FG000|Overall Study|Clinical decline (CD)|2|||
126793215|NCT01367457|456200690|FG001|Overall Study|Clinical decline (CD)|0|||
126793216|NCT01367457|456200691|FG002|Overall Study|Clinical decline (CD)|0|||
126793217|NCT01367457|456200689|FG000|Overall Study|Progression and death|8|||
126793218|NCT01367457|456200690|FG001|Overall Study|Progression and death|0|||
126793219|NCT01367457|456200691|FG002|Overall Study|Progression and death|0|||
126793220|NCT01367457|456200689|FG000|Overall Study|Toxicity|16|||
126793221|NCT01367457|456200690|FG001|Overall Study|Toxicity|0|||
126793222|NCT01367457|456200691|FG002|Overall Study|Toxicity|0|||
126793223|NCT01367457|456200689|FG000|Overall Study|Progression|137|||
126793224|NCT01367457|456200690|FG001|Overall Study|Progression|0|||
126793225|NCT01367457|456200691|FG002|Overall Study|Progression|0|||
126793226|NCT01367457|456200689|FG000|Overall Study|Patient asks for rest + slow progression|1|||
126793227|NCT01367457|456200690|FG001|Overall Study|Patient asks for rest + slow progression|0|||
126793228|NCT01367457|456200691|FG002|Overall Study|Patient asks for rest + slow progression|0|||
126793229|NCT01367457|456200689|FG000|Overall Study|Investigator's opinion, stable disease|1|||
126793230|NCT01367457|456200690|FG001|Overall Study|Investigator's opinion, stable disease|0|||
126793231|NCT01367457|456200691|FG002|Overall Study|Investigator's opinion, stable disease|0|||
126793232|NCT01367457|456200689|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
126793233|NCT01367457|456200690|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
126793234|NCT01367457|456200691|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
126793235|NCT01367457|456200689|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
126793236|NCT01367457|456200690|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
126793237|NCT01367457|456200691|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
126793238|NCT01367457|456200689|FG000|Overall Study|low grade toxicities + stable disease|1|||
126793239|NCT01367457|456200690|FG001|Overall Study|low grade toxicities + stable disease|0|||
126793240|NCT01367457|456200691|FG002|Overall Study|low grade toxicities + stable disease|0|||
126793241|NCT01367457|456200689|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
126793242|NCT01367457|456200690|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
126793243|NCT01367457|456200691|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
126793244|NCT01367457|456200689|FG000|Overall Study|Withdrawal by Subject|1|||
126793245|NCT01367457|456200690|FG001|Overall Study|Withdrawal by Subject|0|||
126793246|NCT01367457|456200691|FG002|Overall Study|Withdrawal by Subject|0|||
126793247|NCT01367457|456200689|FG000|Overall Study|CD, associated leukaemia|1|||
126793248|NCT01367457|456200690|FG001|Overall Study|CD, associated leukaemia|0|||
126793249|NCT01367457|456200691|FG002|Overall Study|CD, associated leukaemia|0|||
126793250|NCT01367457|456200689|FG000|Overall Study|Uncontrolled pain|1|||
126793251|NCT01367457|456200690|FG001|Overall Study|Uncontrolled pain|0|||
126793252|NCT01367457|456200691|FG002|Overall Study|Uncontrolled pain|0|||
126793253|NCT01367457|456200689|FG000|Overall Study|Overall status worsens to grade 4|1|||
126793254|NCT01367457|456200690|FG001|Overall Study|Overall status worsens to grade 4|0|||
126793255|NCT01367457|456200691|FG002|Overall Study|Overall status worsens to grade 4|0|||
126793256|NCT01367457|456200689|FG000|Overall Study|Stabilisation + frequent infections|1|||
126793257|NCT01367457|456200690|FG001|Overall Study|Stabilisation + frequent infections|0|||
126793258|NCT01367457|456200691|FG002|Overall Study|Stabilisation + frequent infections|0|||
126793259|NCT01367457|456200689|FG000|Overall Study|No clinical benefit|1|||
126793260|NCT01367457|456200690|FG001|Overall Study|No clinical benefit|0|||
126793261|NCT01367457|456200691|FG002|Overall Study|No clinical benefit|0|||
126793262|NCT01367457|456200689|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
126793263|NCT01367457|456200690|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
126793264|NCT01367457|456200691|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
126793265|NCT01367457|456200689|FG000|Overall Study|Overall decline|1|||
126793266|NCT01367457|456200690|FG001|Overall Study|Overall decline|0|||
126793267|NCT01367457|456200691|FG002|Overall Study|Overall decline|0|||
126793268|NCT01367457|456200689|FG000|Overall Study|Rejection of treatment|1|||
126793269|NCT01367457|456200690|FG001|Overall Study|Rejection of treatment|0|||
126793270|NCT01367457|456200691|FG002|Overall Study|Rejection of treatment|0|||
126793271|NCT01367457|456200689|FG000|Overall Study|Lost to Follow-up|1|||
126793272|NCT01367457|456200690|FG001|Overall Study|Lost to Follow-up|0|||
126793273|NCT01367457|456200691|FG002|Overall Study|Lost to Follow-up|0|||
126793274|NCT01367457|456200689|FG000|Overall Study|Death from septic shock|1|||
126793275|NCT01367457|456200690|FG001|Overall Study|Death from septic shock|0|||
126793276|NCT01367457|456200691|FG002|Overall Study|Death from septic shock|0|||
126793277|NCT01367457|456200689|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
126793278|NCT01367457|456200690|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
126793279|NCT01367457|456200691|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
126793280|NCT01367457|456200689|FG000|Overall Study|Patient's Wish|1|||
126793281|NCT01367457|456200690|FG001|Overall Study|Patient's Wish|0|||
126793282|NCT01367457|456200691|FG002|Overall Study|Patient's Wish|0|||
126793283|NCT01367457|456200689|FG000|Overall Study|Palliative. Overall decline|1|||
126793284|NCT01367457|456200690|FG001|Overall Study|Palliative. Overall decline|0|||
126793285|NCT01367457|456200691|FG002|Overall Study|Palliative. Overall decline|0|||
126793286|NCT01367457|456200689|FG000|Overall Study|Suspected DP/suspected active infection|1|||
126793287|NCT01367457|456200690|FG001|Overall Study|Suspected DP/suspected active infection|0|||
126793288|NCT01367457|456200691|FG002|Overall Study|Suspected DP/suspected active infection|0|||
126793289|NCT01038856|456200699|FG000|Overall Study|Adverse Event|2|||
126793290|NCT04466111|456200701|FG000|Prior to Trial Phase|Physician Decision|1|||
126793291|NCT00105196|456200702|FG000|Overall Study|Lack of Efficacy|2|||
126793292|NCT00105196|456200703|FG001|Overall Study|Lack of Efficacy|3|||
126793293|NCT00105196|456200702|FG000|Overall Study|Adverse Event|11|||
126793294|NCT00105196|456200703|FG001|Overall Study|Adverse Event|3|||
126793295|NCT00105196|456200702|FG000|Overall Study|Withdrawal by Subject|6|||
126793296|NCT00105196|456200703|FG001|Overall Study|Withdrawal by Subject|6|||
126793297|NCT00105196|456200702|FG000|Overall Study|Lost to Follow-up|3|||
126793298|NCT00105196|456200703|FG001|Overall Study|Lost to Follow-up|2|||
126793299|NCT00105196|456200702|FG000|Overall Study|Poor/noncompliance|3|||
126793300|NCT00105196|456200703|FG001|Overall Study|Poor/noncompliance|4|||
126793301|NCT00105196|456200702|FG000|Overall Study|Protocol Violation|5|||
126793302|NCT00105196|456200703|FG001|Overall Study|Protocol Violation|2|||
126793303|NCT00105196|456200702|FG000|Overall Study|pending surgery|0|||
126793304|NCT00105196|456200703|FG001|Overall Study|pending surgery|1|||
126793305|NCT00105196|456200702|FG000|Overall Study|marijuana use|0|||
126793306|NCT00105196|456200703|FG001|Overall Study|marijuana use|1|||
126793307|NCT00105196|456200702|FG000|Overall Study|Subject became unblinded|0|||
126793308|NCT00105196|456200703|FG001|Overall Study|Subject became unblinded|1|||
126793309|NCT03025880|456200704|FG000|Overall Study|Adverse Event|1|||
126793310|NCT03025880|456200705|FG001|Overall Study|Adverse Event|0|||
126793311|NCT03025880|456200704|FG000|Overall Study|Death|1|||
126793312|NCT03025880|456200705|FG001|Overall Study|Death|1|||
126793313|NCT03025880|456200704|FG000|Overall Study|Withdrawal by Subject|0|||
126793314|NCT03025880|456200705|FG001|Overall Study|Withdrawal by Subject|1|||
126793315|NCT03025880|456200704|FG000|Overall Study|Physician Decision|0|||
126793316|NCT03025880|456200705|FG001|Overall Study|Physician Decision|1|||
126793317|NCT03025880|456200704|FG000|Overall Study|Progressive Disease|12|||
126793318|NCT03025880|456200705|FG001|Overall Study|Progressive Disease|19|||
126793319|NCT01035060|456200706|FG000|Overall Study|Lost to Follow-up|0|||
126793320|NCT01035060|456200707|FG001|Overall Study|Lost to Follow-up|7|||
126793321|NCT01035060|456200706|FG000|Overall Study|Did not quality after 2nd screening|14|||
126793322|NCT01035060|456200707|FG001|Overall Study|Did not quality after 2nd screening|1|||
126793323|NCT01035060|456200706|FG000|Overall Study|Withdrawal by Subject|8|||
126793324|NCT01035060|456200707|FG001|Overall Study|Withdrawal by Subject|6|||
126793325|NCT01035060|456200706|FG000|Overall Study|Physician Decision|2|||
126793326|NCT01035060|456200707|FG001|Overall Study|Physician Decision|0|||
126793327|NCT02015390|456200713|FG000|Overall Study|Lost to Follow-up|1|||
126793328|NCT02015390|456200714|FG001|Overall Study|Lost to Follow-up|0|||
126793329|NCT02015390|456200713|FG000|Overall Study|Adverse Event|0|||
126793330|NCT02015390|456200714|FG001|Overall Study|Adverse Event|3|||
126793331|NCT02015390|456200713|FG000|Overall Study|Physician Decision|0|||
126793332|NCT02015390|456200714|FG001|Overall Study|Physician Decision|1|||
126793333|NCT02193880|456200715|FG000|Overall Study|patients did not collect enough HPC|3|||
126793334|NCT03136380|456200716|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126793335|NCT03136380|456200717|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
126793336|NCT03136380|456200718|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126793337|NCT03136380|456200719|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126793338|NCT03136380|456200720|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
126793339|NCT00553280|456200724|FG000|Overall Study|Adverse Event|19|||
126793340|NCT00553280|456200724|FG000|Overall Study|Lack of Efficacy|3|||
126793341|NCT00553280|456200724|FG000|Overall Study|Withdrawal by Subject|3|||
126793342|NCT00553280|456200724|FG000|Overall Study|Physician Decision|1|||
126793343|NCT02794974|456200725|FG000|Overall Study|Physician Decision|0|||
126793344|NCT02794974|456200726|FG001|Overall Study|Physician Decision|1|||
126793345|NCT02202850|456200727|FG000|Overall Study|Other|2|||
126793346|NCT02202850|456200728|FG001|Overall Study|Other|2|||
126793347|NCT02202850|456200727|FG000|Overall Study|Enbrel treatment discontinued|15|||
126793348|NCT02202850|456200728|FG001|Overall Study|Enbrel treatment discontinued|3|||
126793349|NCT02202850|456200727|FG000|Overall Study|Lost to Follow-up|7|||
126793350|NCT02202850|456200728|FG001|Overall Study|Lost to Follow-up|1|||
126793351|NCT02996682|456200729|FG000|Overall Study|Death|0|||
126793352|NCT02996682|456200730|FG001|Overall Study|Death|3|||
126793353|NCT00624065|456200731|FG000|Overall Study|Adverse Event|5|||
126793354|NCT00624065|456200732|FG001|Overall Study|Adverse Event|6|||
126793355|NCT00624065|456200731|FG000|Overall Study|Lost to Follow-up|4|||
126793356|NCT00624065|456200732|FG001|Overall Study|Lost to Follow-up|1|||
126793357|NCT00624065|456200731|FG000|Overall Study|Consent withdrawn|6|||
126793358|NCT00624065|456200732|FG001|Overall Study|Consent withdrawn|5|||
126793359|NCT00624065|456200731|FG000|Overall Study|Lack of Efficacy|0|||
126793360|NCT00624065|456200732|FG001|Overall Study|Lack of Efficacy|3|||
126793361|NCT00624065|456200731|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
126793362|NCT00624065|456200732|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
126793363|NCT01629381|456200734|FG000|Overall Study|Withdrawal by Subject|2|||
126793364|NCT01629381|456200735|FG001|Overall Study|Withdrawal by Subject|5|||
126793365|NCT00735904|456200736|FG000|Overall Study|Adverse Event|3|||
126793366|NCT00735904|456200736|FG000|Overall Study|Death|20|||
126793367|NCT00735904|456200736|FG000|Overall Study|Protocol Violation|1|||
126793368|NCT00735904|456200736|FG000|Overall Study|Withdrawal by Subject|1|||
126793369|NCT00735904|456200736|FG000|Overall Study|Study Terminated by Sponsor|5|||
126793370|NCT00735904|456200736|FG000|Overall Study|Other|8|||
126793371|NCT01390844|456200739|FG000|Treatment Phase|Adverse Event|12|||
126793372|NCT01390844|456200740|FG001|Treatment Phase|Adverse Event|2|||
126793373|NCT01390844|456200741|FG002|Treatment Phase|Adverse Event|3|||
126632759|NCT02804399|455613851|FG000|Period 2|Adverse Event|0|||
126632760|NCT02804399|455613852|FG001|Period 2|Adverse Event|1|||
126632761|NCT01774305|455613853|FG000|Overall Study|Physician Decision|1|||
126632762|NCT01774305|455613854|FG001|Overall Study|Physician Decision|0|||
126632763|NCT04211389|455613855|FG000|Overall Study|Adverse Event|1|||
126793374|NCT01390844|456200742|FG003|Treatment Phase|Adverse Event|2|||
126793375|NCT01390844|456200739|FG000|Treatment Phase|Treatment Failure|23|||
126793376|NCT01390844|456200740|FG001|Treatment Phase|Treatment Failure|25|||
126793377|NCT01390844|456200741|FG002|Treatment Phase|Treatment Failure|10|||
126793378|NCT01390844|456200742|FG003|Treatment Phase|Treatment Failure|13|||
126632764|NCT04211389|455613856|FG001|Overall Study|Adverse Event|2|||
126632765|NCT04211389|455613855|FG000|Overall Study|Lost to Follow-up|15|||
126793379|NCT01390844|456200739|FG000|Treatment Phase|Non-Medical Reasons|5|||
126793380|NCT01390844|456200740|FG001|Treatment Phase|Non-Medical Reasons|1|||
126793381|NCT01390844|456200741|FG002|Treatment Phase|Non-Medical Reasons|8|||
126793382|NCT01390844|456200742|FG003|Treatment Phase|Non-Medical Reasons|1|||
126793383|NCT01390844|456200739|FG000|Treatment Phase|Non-GCP Compliant|0|||
126793384|NCT01390844|456200740|FG001|Treatment Phase|Non-GCP Compliant|0|||
126793385|NCT01390844|456200741|FG002|Treatment Phase|Non-GCP Compliant|10|||
126632766|NCT04211389|455613856|FG001|Overall Study|Lost to Follow-up|7|||
126793386|NCT01390844|456200742|FG003|Treatment Phase|Non-GCP Compliant|3|||
126793387|NCT01390844|456200739|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
126793388|NCT01390844|456200740|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
126793389|NCT01390844|456200741|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
126793390|NCT01390844|456200742|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
126793391|NCT03204539|456200745|FG000|Overall Study|Loss of funding|0|||
126793392|NCT03204539|456200746|FG001|Overall Study|Loss of funding|1|||
126793393|NCT03693430|456200749|FG000|Overall Study|Lost to Follow-up|3|||
126793394|NCT03693430|456200750|FG001|Overall Study|Lost to Follow-up|14|||
126793395|NCT03693430|456200749|FG000|Overall Study|Death|1|||
126793396|NCT03693430|456200750|FG001|Overall Study|Death|0|||
126793397|NCT03693430|456200749|FG000|Overall Study|Withdrawal by Subject|0|||
126793398|NCT03693430|456200750|FG001|Overall Study|Withdrawal by Subject|4|||
126793399|NCT04185909|456200751|FG000|Overall Study|Lost to Follow-up|1|||
126793400|NCT01417078|456200752|FG000|Overall Study|Withdrawal by Subject|1|||
126793401|NCT00626548|456200753|FG000|Overall Study|Adverse Event|164|||
126793402|NCT00626548|456200754|FG001|Overall Study|Adverse Event|44|||
126793403|NCT00626548|456200753|FG000|Overall Study|Withdrawal by Subject|42|||
126793404|NCT00626548|456200754|FG001|Overall Study|Withdrawal by Subject|46|||
126793405|NCT00626548|456200753|FG000|Overall Study|Protocol Violation|4|||
126793406|NCT00626548|456200754|FG001|Overall Study|Protocol Violation|11|||
126793407|NCT00626548|456200753|FG000|Overall Study|Lost to Follow-up|2|||
126793408|NCT00626548|456200754|FG001|Overall Study|Lost to Follow-up|2|||
126793409|NCT00626548|456200753|FG000|Overall Study|Other termination reason|493|||
126793410|NCT00626548|456200754|FG001|Overall Study|Other termination reason|613|||
126793411|NCT00385593|456200762|FG000|Overall Study|Adverse Event|3|||
126793412|NCT00385593|456200763|FG001|Overall Study|Adverse Event|2|||
126793413|NCT00385593|456200762|FG000|Overall Study|Withdrawal by Subject|17|||
126793414|NCT00385593|456200763|FG001|Overall Study|Withdrawal by Subject|7|||
126793415|NCT00385593|456200762|FG000|Overall Study|Lost to Follow-up|12|||
126793416|NCT00385593|456200763|FG001|Overall Study|Lost to Follow-up|8|||
126793417|NCT00385593|456200762|FG000|Overall Study|Protocol Violation|7|||
126793418|NCT00385593|456200763|FG001|Overall Study|Protocol Violation|4|||
126793419|NCT00385593|456200762|FG000|Overall Study|Several reasons|17|||
126793420|NCT00385593|456200763|FG001|Overall Study|Several reasons|15|||
126793421|NCT00385593|456200762|FG000|Overall Study|Incorrect inclusion|2|||
126793422|NCT00385593|456200763|FG001|Overall Study|Incorrect inclusion|0|||
126793423|NCT00385593|456200762|FG000|Overall Study|Incorrect randomization|0|||
126793424|NCT00385593|456200763|FG001|Overall Study|Incorrect randomization|1|||
126793425|NCT03420300|456200765|FG000|Overall Study|Death|2|||
126793426|NCT01223365|456200766|FG000|Open-label Titration Period|Enrolled but not treated|1|||
126793427|NCT01223365|456200766|FG000|Open-label Titration Period|Adverse Event|23|||
126793428|NCT01223365|456200766|FG000|Open-label Titration Period|Lack of Efficacy|3|||
126793429|NCT01223365|456200766|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
126793430|NCT01223365|456200766|FG000|Open-label Titration Period|Protocol Violation|1|||
126793431|NCT01223365|456200766|FG000|Open-label Titration Period|Lost to Follow-up|2|||
126793432|NCT01223365|456200766|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
126793433|NCT01223365|456200766|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
126793434|NCT01223365|456200766|FG000|Open-label Titration Period|Starting physical therapy|1|||
126793435|NCT01223365|456200766|FG000|Open-label Treatment Period|Adverse Event|39|||
126793436|NCT01223365|456200766|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
126632767|NCT04211389|455613855|FG000|Overall Study|Protocol Violation|0|||
126632768|NCT04211389|455613856|FG001|Overall Study|Protocol Violation|1|||
126632769|NCT04211389|455613855|FG000|Overall Study|Withdrawal by Subject|10|||
126632770|NCT04211389|455613856|FG001|Overall Study|Withdrawal by Subject|11|||
126632771|NCT01062971|455613862|FG000|Overall Study|Protocol Violation|1|||
126793437|NCT01223365|456200766|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
126793438|NCT01223365|456200766|FG000|Open-label Treatment Period|Protocol Violation|15|||
126793439|NCT01223365|456200766|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
126793440|NCT01223365|456200766|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
126793441|NCT01223365|456200766|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
126793442|NCT01223365|456200766|FG000|Open-label Treatment Period|Moved out of area|2|||
126793443|NCT01223365|456200766|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
126793444|NCT01223365|456200766|FG000|Open-label Treatment Period|"Out of window"|1|||
126793445|NCT01223365|456200766|FG000|Open-label Treatment Period|Starting physical therapy|1|||
126793446|NCT01223365|456200766|FG000|Open-label Treatment Period|Physician Decision|2|||
126793447|NCT03567174|456200767|FG000|Overall Study|Death|24|||
126632772|NCT01062971|455613863|FG001|Overall Study|Protocol Violation|3|||
126632773|NCT01062971|455613862|FG000|Overall Study|Lost to Follow-up|3|||
126632774|NCT01062971|455613863|FG001|Overall Study|Lost to Follow-up|4|||
126793448|NCT03567174|456200768|FG001|Overall Study|Death|31|||
126793449|NCT03567174|456200767|FG000|Overall Study|Lost to Follow-up|165|||
126793450|NCT03567174|456200768|FG001|Overall Study|Lost to Follow-up|174|||
126632775|NCT01530087|455613864|FG000|Overall Study|Physician Decision|2|||
126632776|NCT05523219|455613865|FG000|Overall Study|Wrong inclusion|1|||
126793451|NCT03243630|456200769|FG000|Overall Study|Protocol Violation|1|||
126793452|NCT03243630|456200769|FG000|Overall Study|Physician Decision|1|||
126793453|NCT02140060|456200770|FG000|Overall Study|Adverse Event|0|||
126793454|NCT02140060|456200771|FG001|Overall Study|Adverse Event|0|||
126793455|NCT02140060|456200772|FG002|Overall Study|Adverse Event|0|||
126793456|NCT02140060|456200773|FG003|Overall Study|Adverse Event|1|||
126793457|NCT02140060|456200774|FG004|Overall Study|Adverse Event|1|||
126793458|NCT02140060|456200775|FG005|Overall Study|Adverse Event|1|||
126793459|NCT02140060|456200770|FG000|Overall Study|Lack of Efficacy|0|||
126793460|NCT02140060|456200771|FG001|Overall Study|Lack of Efficacy|0|||
126793461|NCT02140060|456200772|FG002|Overall Study|Lack of Efficacy|0|||
126793462|NCT02140060|456200773|FG003|Overall Study|Lack of Efficacy|1|||
126793463|NCT02140060|456200774|FG004|Overall Study|Lack of Efficacy|0|||
126793464|NCT02140060|456200775|FG005|Overall Study|Lack of Efficacy|0|||
126793465|NCT02817841|456202529|FG000|Overall Study|Lost to Follow-up|287|||
126793466|NCT02817841|456202529|FG000|Overall Study|Withdrawal by Subject|183|||
126793467|NCT02817841|456202529|FG000|Overall Study|Adverse event not related to bleeding|131|||
126793468|NCT02817841|456202529|FG000|Overall Study|Adverse event related to bleeding|51|||
126793469|NCT02817841|456202529|FG000|Overall Study|Pregnancy|32|||
126793470|NCT02817841|456202529|FG000|Overall Study|Pregnancy wish|17|||
126793471|NCT02817841|456202529|FG000|Overall Study|Other reasons|53|||
126793472|NCT02817841|456202529|FG000|Overall Study|Protocol Violation|94|||
126793473|NCT01746017|456202536|FG000|Period 1|Withdrawal by Subject|0|||
126793474|NCT01746017|456202537|FG001|Period 1|Withdrawal by Subject|0|||
126793475|NCT01746017|456202538|FG002|Period 1|Withdrawal by Subject|0|||
126793476|NCT01746017|456202539|FG003|Period 1|Withdrawal by Subject|0|||
126793477|NCT01746017|456202540|FG004|Period 1|Withdrawal by Subject|0|||
126793478|NCT01746017|456202541|FG005|Period 1|Withdrawal by Subject|0|||
126793479|NCT01746017|456202542|FG006|Period 1|Withdrawal by Subject|1|||
126793480|NCT01746017|456202543|FG007|Period 1|Withdrawal by Subject|0|||
126793481|NCT01746017|456202544|FG008|Period 1|Withdrawal by Subject|0|||
126793482|NCT01746017|456202545|FG009|Period 1|Withdrawal by Subject|0|||
126793483|NCT01746017|456202546|FG010|Period 1|Withdrawal by Subject|0|||
126793484|NCT01746017|456202536|FG000|Period 3|Withdrawal by Subject|0|||
126793485|NCT01746017|456202537|FG001|Period 3|Withdrawal by Subject|0|||
126793486|NCT01746017|456202538|FG002|Period 3|Withdrawal by Subject|0|||
126793487|NCT01746017|456202539|FG003|Period 3|Withdrawal by Subject|0|||
126793488|NCT01746017|456202540|FG004|Period 3|Withdrawal by Subject|0|||
126632777|NCT05523219|455613865|FG000|Overall Study|Lost to Follow-up|7|||
126632778|NCT02760485|455613866|FG000|Phase 1|Death|3|||
126632779|NCT02760485|455613867|FG001|Phase 1|Death|6|||
126632780|NCT02760485|455613868|FG002|Phase 1|Death|0|||
126632781|NCT02760485|455613866|FG000|Phase 1|Withdrawal by Subject|2|||
126632782|NCT02760485|455613867|FG001|Phase 1|Withdrawal by Subject|0|||
126632783|NCT02760485|455613868|FG002|Phase 1|Withdrawal by Subject|0|||
126632784|NCT02760485|455613866|FG000|Phase 1|Progressive Disease|1|||
126632785|NCT02760485|455613867|FG001|Phase 1|Progressive Disease|0|||
126632786|NCT02760485|455613868|FG002|Phase 1|Progressive Disease|0|||
126632787|NCT02760485|455613866|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
126632788|NCT02760485|455613867|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
126632789|NCT02760485|455613868|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
126632790|NCT02760485|455613866|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
126632791|NCT02760485|455613867|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
126632792|NCT02760485|455613868|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
126632793|NCT02760485|455613866|FG000|Phase 2|Death|0|||
126632794|NCT02760485|455613867|FG001|Phase 2|Death|0|||
126632795|NCT02760485|455613868|FG002|Phase 2|Death|12|||
126632796|NCT02760485|455613866|FG000|Phase 2|Withdrawal by Subject|0|||
126632797|NCT02760485|455613867|FG001|Phase 2|Withdrawal by Subject|0|||
126793489|NCT01746017|456202541|FG005|Period 3|Withdrawal by Subject|1|||
126793490|NCT01746017|456202542|FG006|Period 3|Withdrawal by Subject|0|||
126632798|NCT02760485|455613868|FG002|Phase 2|Withdrawal by Subject|3|||
126632799|NCT02760485|455613866|FG000|Phase 2|Progressive Disease|0|||
126632800|NCT02760485|455613867|FG001|Phase 2|Progressive Disease|0|||
126632801|NCT02760485|455613868|FG002|Phase 2|Progressive Disease|1|||
126632802|NCT02760485|455613866|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
126632803|NCT02760485|455613867|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
126632804|NCT02760485|455613868|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
126632805|NCT02261285|455613869|FG000|Overall Study|Disease progression|0|||
126793491|NCT01746017|456202543|FG007|Period 3|Withdrawal by Subject|0|||
126793492|NCT01746017|456202544|FG008|Period 3|Withdrawal by Subject|0|||
126793493|NCT01746017|456202545|FG009|Period 3|Withdrawal by Subject|0|||
126632806|NCT02261285|455613870|FG001|Overall Study|Disease progression|0|||
126793494|NCT01746017|456202546|FG010|Period 3|Withdrawal by Subject|0|||
126793495|NCT00397488|456202547|FG000|Overall Study|Withdrawal by Subject|3|||
126632807|NCT02261285|455613871|FG002|Overall Study|Disease progression|1|||
126632808|NCT01182207|455613872|FG000|First Intervention|Positive Hepatitis Results|0|||
126793496|NCT00397488|456202547|FG000|Overall Study|Adverse Event|3|||
126793497|NCT00397488|456202547|FG000|Overall Study|Death|1|||
126793498|NCT01294787|456202553|FG000|Period 1|Adverse Event|0|||
126793499|NCT01294787|456202554|FG001|Period 1|Adverse Event|0|||
126793500|NCT01294787|456202555|FG002|Period 1|Adverse Event|0|||
126793501|NCT01294787|456202556|FG003|Period 1|Adverse Event|0|||
126793502|NCT01294787|456202557|FG004|Period 1|Adverse Event|1|||
126793503|NCT01294787|456202558|FG005|Period 1|Adverse Event|0|||
126793504|NCT01294787|456202553|FG000|Period 1|Withdrawal by Subject|0|||
126793505|NCT01294787|456202554|FG001|Period 1|Withdrawal by Subject|0|||
126793506|NCT01294787|456202555|FG002|Period 1|Withdrawal by Subject|0|||
126793507|NCT01294787|456202556|FG003|Period 1|Withdrawal by Subject|1|||
126793508|NCT01294787|456202557|FG004|Period 1|Withdrawal by Subject|1|||
126793509|NCT01294787|456202558|FG005|Period 1|Withdrawal by Subject|1|||
126793510|NCT01294787|456202553|FG000|Period 1|Administrative problem|0|||
126793511|NCT01294787|456202554|FG001|Period 1|Administrative problem|0|||
126793512|NCT01294787|456202555|FG002|Period 1|Administrative problem|1|||
126793513|NCT01294787|456202556|FG003|Period 1|Administrative problem|0|||
126793514|NCT01294787|456202557|FG004|Period 1|Administrative problem|0|||
126793515|NCT01294787|456202558|FG005|Period 1|Administrative problem|1|||
126793516|NCT01294787|456202553|FG000|Period 2|Adverse Event|0|||
126793517|NCT01294787|456202554|FG001|Period 2|Adverse Event|3|||
126793518|NCT01294787|456202555|FG002|Period 2|Adverse Event|0|||
126793519|NCT01294787|456202556|FG003|Period 2|Adverse Event|1|||
126793520|NCT01294787|456202557|FG004|Period 2|Adverse Event|0|||
126793521|NCT01294787|456202558|FG005|Period 2|Adverse Event|0|||
126793522|NCT01294787|456202553|FG000|Period 2|No longer needs study drug|0|||
126793523|NCT01294787|456202554|FG001|Period 2|No longer needs study drug|0|||
126793524|NCT01294787|456202555|FG002|Period 2|No longer needs study drug|0|||
126793525|NCT01294787|456202556|FG003|Period 2|No longer needs study drug|1|||
126793526|NCT01294787|456202557|FG004|Period 2|No longer needs study drug|0|||
126793527|NCT01294787|456202558|FG005|Period 2|No longer needs study drug|0|||
126793528|NCT01294787|456202553|FG000|Period 3|Adverse Event|0|||
126793529|NCT01294787|456202554|FG001|Period 3|Adverse Event|0|||
126793530|NCT01294787|456202555|FG002|Period 3|Adverse Event|0|||
126793531|NCT01294787|456202556|FG003|Period 3|Adverse Event|0|||
126793532|NCT01294787|456202557|FG004|Period 3|Adverse Event|1|||
126793533|NCT01294787|456202558|FG005|Period 3|Adverse Event|0|||
126793534|NCT03785548|456202561|FG000|Overall Study|age > 80|1|||
126793535|NCT03785548|456202562|FG001|Overall Study|age > 80|0|||
126793536|NCT03785548|456202561|FG000|Overall Study|no Postop queries|1|||
126793537|NCT03785548|456202562|FG001|Overall Study|no Postop queries|0|||
126793538|NCT01882257|456202565|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
126793539|NCT01882257|456202566|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
126793540|NCT01882257|456202567|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
126793541|NCT01882257|456202565|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
126793542|NCT01882257|456202566|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
126793543|NCT01882257|456202567|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
126793544|NCT02058498|456202570|FG000|Overall Study|Withdrawal by Subject|4|||
126793545|NCT05327491|456202574|FG000|Periods 1 & 2|Miscellaneous|0|||
126793546|NCT05327491|456202575|FG001|Periods 1 & 2|Miscellaneous|1|||
126793547|NCT05327491|456202576|FG002|Periods 1 & 2|Miscellaneous|0|||
126793548|NCT05327491|456202577|FG003|Periods 1 & 2|Miscellaneous|0|||
126793549|NCT05327491|456202574|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
126793550|NCT05327491|456202575|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
126793551|NCT05327491|456202576|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
126793552|NCT05327491|456202577|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
126793553|NCT05038293|456202578|FG000|Overall Study|device was not operating properly for one subject.|1|||
126793554|NCT05038293|456202579|FG001|Overall Study|device was not operating properly for one subject.|0|||
126793555|NCT05038293|456202578|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
126793556|NCT05038293|456202579|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
126793557|NCT01171989|456202580|FG000|Overall Study|Lost to Follow-up|0|||
126632809|NCT01182207|455613873|FG001|First Intervention|Positive Hepatitis Results|1|||
126632810|NCT01182207|455613872|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
126632811|NCT01182207|455613873|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
126793558|NCT01171989|456202581|FG001|Overall Study|Lost to Follow-up|0|||
126793559|NCT01171989|456202582|FG002|Overall Study|Lost to Follow-up|1|||
126793560|NCT01247701|456202585|FG000|Overall Study|Death|2|||
126793561|NCT01247701|456202585|FG000|Overall Study|Relapsed|8|||
126793562|NCT04166630|456202586|FG000|Overall Study|Withdrawal by Subject|0|||
126793563|NCT04166630|456202587|FG001|Overall Study|Withdrawal by Subject|1|||
126793564|NCT00096447|456202588|FG000|Overall Study|Never treated|1|||
126793565|NCT00834743|456202589|FG000|Second Intervention|Withdrawal by Subject|1|||
126793566|NCT00834743|456202590|FG001|Second Intervention|Withdrawal by Subject|0|||
126793567|NCT04088760|456202591|FG000|Overall Study|Physician Decision|1|||
126793568|NCT02300103|456202592|FG000|Overall Study|Lack of Efficacy|3|||
126793569|NCT02300103|456202592|FG000|Overall Study|Protocol Violation|1|||
126793570|NCT02300103|456202592|FG000|Overall Study|Withdrew Consent|2|||
126793571|NCT04091971|456202593|FG000|Overall Study|Withdrawal by Subject|1|||
126793572|NCT04091971|456202593|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
126793573|NCT04091971|456202593|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
126793574|NCT02419937|456202599|FG000|Overall Study|Lost to Follow-up|1|||
126793575|NCT02419937|456202600|FG001|Overall Study|Lost to Follow-up|0|||
126793576|NCT01981720|456202601|FG000|Overall Study|Adverse Event|1|||
126793577|NCT01981720|456202601|FG000|Overall Study|Withdrawal by Subject|3|||
126793578|NCT01981720|456202601|FG000|Overall Study|Pregnancy|1|||
126793579|NCT00184600|456202602|FG000|Overall Study|Adverse Event|9|||
126793580|NCT00184600|456202603|FG001|Overall Study|Adverse Event|0|||
126793581|NCT00184600|456202604|FG002|Overall Study|Adverse Event|5|||
126793582|NCT00184600|456202602|FG000|Overall Study|Death|3|||
126793583|NCT00184600|456202603|FG001|Overall Study|Death|9|||
126793584|NCT00184600|456202604|FG002|Overall Study|Death|7|||
126793585|NCT00184600|456202602|FG000|Overall Study|Lack of Efficacy|3|||
126793586|NCT00184600|456202603|FG001|Overall Study|Lack of Efficacy|1|||
126793587|NCT00184600|456202604|FG002|Overall Study|Lack of Efficacy|3|||
126793588|NCT00184600|456202602|FG000|Overall Study|Lost to Follow-up|4|||
126793589|NCT00184600|456202603|FG001|Overall Study|Lost to Follow-up|6|||
126793590|NCT00184600|456202604|FG002|Overall Study|Lost to Follow-up|1|||
126793591|NCT00184600|456202602|FG000|Overall Study|Protocol Violation|2|||
126793592|NCT00184600|456202603|FG001|Overall Study|Protocol Violation|2|||
126793593|NCT00184600|456202604|FG002|Overall Study|Protocol Violation|3|||
126793594|NCT00184600|456202602|FG000|Overall Study|Withdrawal by Subject|20|||
126793595|NCT00184600|456202603|FG001|Overall Study|Withdrawal by Subject|28|||
126793596|NCT00184600|456202604|FG002|Overall Study|Withdrawal by Subject|12|||
126793597|NCT00184600|456202602|FG000|Overall Study|Unclassified|4|||
126793598|NCT00184600|456202603|FG001|Overall Study|Unclassified|5|||
126793599|NCT00184600|456202604|FG002|Overall Study|Unclassified|3|||
126793600|NCT02674477|456202605|FG000|Overall Study|Protocol Violation|8|||
126793601|NCT02674477|456202606|FG001|Overall Study|Protocol Violation|2|||
126793602|NCT00004562|456202607|FG000|Overall Study|Lost to Follow-up|102|||
126793603|NCT00004562|456202608|FG001|Overall Study|Lost to Follow-up|91|||
126793604|NCT04274686|456202610|FG000|Overall Study|Physician Decision|1|||
126793605|NCT04274686|456202611|FG001|Overall Study|Physician Decision|0|||
126793606|NCT00376623|456202612|FG000|Overall Study|Progressive disease|35|||
126793607|NCT00376623|456202613|FG001|Overall Study|Progressive disease|22|||
126793608|NCT00376623|456202614|FG002|Overall Study|Progressive disease|17|||
126793609|NCT00376623|456202612|FG000|Overall Study|Lost to Follow-up|0|||
126793610|NCT00376623|456202613|FG001|Overall Study|Lost to Follow-up|1|||
126793611|NCT00376623|456202614|FG002|Overall Study|Lost to Follow-up|0|||
126793612|NCT00376623|456202612|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
126793613|NCT00376623|456202613|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
126793614|NCT00376623|456202614|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
126793615|NCT00376623|456202612|FG000|Overall Study|Not treated with BI 2536|1|||
126793616|NCT00376623|456202613|FG001|Overall Study|Not treated with BI 2536|0|||
126793617|NCT00376623|456202614|FG002|Overall Study|Not treated with BI 2536|0|||
126793618|NCT00376623|456202612|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
126793619|NCT00376623|456202613|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
126793620|NCT00376623|456202614|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
126793621|NCT00376623|456202612|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
126793622|NCT00376623|456202613|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
126793623|NCT00376623|456202614|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
126793624|NCT00376623|456202612|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
126793625|NCT00376623|456202613|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
126793626|NCT00376623|456202614|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
126793627|NCT00376623|456202612|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
126793628|NCT00376623|456202613|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
126793629|NCT00376623|456202614|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
126793630|NCT00376623|456202612|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
126793631|NCT00376623|456202613|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
126793632|NCT00376623|456202614|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
126793633|NCT00376623|456202612|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
126793634|NCT00376623|456202613|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
126793635|NCT00376623|456202614|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
126793636|NCT00376623|456202612|FG000|Overall Study|Increase of tumour markers|0|||
126793637|NCT00376623|456202613|FG001|Overall Study|Increase of tumour markers|1|||
126793638|NCT00376623|456202614|FG002|Overall Study|Increase of tumour markers|0|||
126793639|NCT00376623|456202612|FG000|Overall Study|Bone metastasis|1|||
126793640|NCT00376623|456202613|FG001|Overall Study|Bone metastasis|0|||
126793641|NCT00376623|456202614|FG002|Overall Study|Bone metastasis|0|||
126793642|NCT00286754|456202615|FG000|Overall Study|Adverse Event|2|||
126793643|NCT00286754|456202616|FG001|Overall Study|Adverse Event|2|||
126755705|NCT01882439|456054807|FG003|Overall Study|Medication error with no associated AE|0|||
126755706|NCT01882439|456054804|FG000|Overall Study|Insufficient clinical response|1|||
126755707|NCT01882439|456054805|FG001|Overall Study|Insufficient clinical response|4|||
126755708|NCT01882439|456054806|FG002|Overall Study|Insufficient clinical response|4|||
126755709|NCT01882439|456054807|FG003|Overall Study|Insufficient clinical response|2|||
126755710|NCT01882439|456054804|FG000|Overall Study|Adverse event unrelated to study drug|2|||
126755711|NCT01882439|456054805|FG001|Overall Study|Adverse event unrelated to study drug|2|||
126755712|NCT01882439|456054806|FG002|Overall Study|Adverse event unrelated to study drug|1|||
126755713|NCT01882439|456054807|FG003|Overall Study|Adverse event unrelated to study drug|1|||
126755714|NCT03125902|456054810|FG000|Overall Study|Adverse Event|0|||
126755715|NCT03125902|456054811|FG001|Overall Study|Adverse Event|1|||
126755716|NCT03125902|456054810|FG000|Overall Study|Death|119|||
126755717|NCT03125902|456054811|FG001|Overall Study|Death|229|||
126755718|NCT03125902|456054810|FG000|Overall Study|Lost to Follow-up|4|||
126755719|NCT03125902|456054811|FG001|Overall Study|Lost to Follow-up|13|||
126755720|NCT03125902|456054810|FG000|Overall Study|Other|0|||
126755721|NCT03125902|456054811|FG001|Overall Study|Other|4|||
126755722|NCT03125902|456054810|FG000|Overall Study|Physician Decision|2|||
126755723|NCT03125902|456054811|FG001|Overall Study|Physician Decision|1|||
126755724|NCT03125902|456054810|FG000|Overall Study|Progressive Disease|0|||
126755725|NCT03125902|456054811|FG001|Overall Study|Progressive Disease|3|||
126755726|NCT03125902|456054810|FG000|Overall Study|Study Terminated By Sponsor|74|||
126755727|NCT03125902|456054811|FG001|Overall Study|Study Terminated By Sponsor|143|||
126755728|NCT03125902|456054810|FG000|Overall Study|Withdrawal by Subject|21|||
126755729|NCT03125902|456054811|FG001|Overall Study|Withdrawal by Subject|37|||
126755730|NCT02269709|456054812|FG000|Time of Enrollment|Withdrawal by Subject|3|||
126755731|NCT02269709|456054812|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
126755732|NCT02269709|456054812|FG000|Six Month Follow-up|Lost to Follow-up|12|||
126755733|NCT02909504|456054813|FG000|Overall Study|Adverse Event|2|||
126755734|NCT02909504|456054813|FG000|Overall Study|Lack of Efficacy|3|||
126755735|NCT02909504|456054813|FG000|Overall Study|Withdrawal by Subject|4|||
126755736|NCT02909504|456054813|FG000|Overall Study|Pregnancy|1|||
126755737|NCT02909504|456054813|FG000|Overall Study|Subject moved|1|||
126755738|NCT02909504|456054813|FG000|Overall Study|Lost to Follow-up|1|||
126755739|NCT01843933|456054814|FG000|Overall Study|Data lost|6|||
126755740|NCT01843933|456054815|FG001|Overall Study|Data lost|4|||
126755741|NCT04411472|456054817|FG000|Overall Study|Adverse Event|5|||
126755742|NCT04411472|456054818|FG001|Overall Study|Adverse Event|10|||
126755743|NCT04411472|456054819|FG002|Overall Study|Adverse Event|1|||
126755744|NCT04411472|456054820|FG003|Overall Study|Adverse Event|0|||
126755745|NCT04411472|456054821|FG004|Overall Study|Adverse Event|0|||
126755746|NCT04411472|456054822|FG005|Overall Study|Adverse Event|0|||
126755747|NCT04411472|456054817|FG000|Overall Study|Protocol Violation|1|||
126755748|NCT04411472|456054818|FG001|Overall Study|Protocol Violation|0|||
126755749|NCT04411472|456054819|FG002|Overall Study|Protocol Violation|0|||
126755750|NCT04411472|456054820|FG003|Overall Study|Protocol Violation|0|||
126755751|NCT04411472|456054821|FG004|Overall Study|Protocol Violation|0|||
126755752|NCT04411472|456054822|FG005|Overall Study|Protocol Violation|0|||
126755753|NCT04411472|456054817|FG000|Overall Study|Withdrawal by Subject|0|||
126755754|NCT04411472|456054818|FG001|Overall Study|Withdrawal by Subject|1|||
126755755|NCT04411472|456054819|FG002|Overall Study|Withdrawal by Subject|0|||
126755756|NCT04411472|456054820|FG003|Overall Study|Withdrawal by Subject|1|||
126755757|NCT04411472|456054821|FG004|Overall Study|Withdrawal by Subject|0|||
126755758|NCT04411472|456054822|FG005|Overall Study|Withdrawal by Subject|0|||
126755759|NCT04411472|456054817|FG000|Overall Study|Physician Decision|1|||
126755760|NCT04411472|456054818|FG001|Overall Study|Physician Decision|0|||
126755761|NCT04411472|456054819|FG002|Overall Study|Physician Decision|0|||
126755762|NCT04411472|456054820|FG003|Overall Study|Physician Decision|0|||
126755763|NCT04411472|456054821|FG004|Overall Study|Physician Decision|0|||
126755764|NCT04411472|456054822|FG005|Overall Study|Physician Decision|0|||
126755765|NCT04411472|456054817|FG000|Overall Study|Study terminated by sponsor|17|||
126755766|NCT04411472|456054818|FG001|Overall Study|Study terminated by sponsor|20|||
126755767|NCT04411472|456054819|FG002|Overall Study|Study terminated by sponsor|3|||
126755768|NCT04411472|456054820|FG003|Overall Study|Study terminated by sponsor|0|||
126755769|NCT04411472|456054821|FG004|Overall Study|Study terminated by sponsor|0|||
126755770|NCT04411472|456054822|FG005|Overall Study|Study terminated by sponsor|0|||
126755771|NCT01747655|456054823|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
126755772|NCT01747655|456054824|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
126755773|NCT01747655|456054823|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
126755774|NCT01747655|456054824|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
126755775|NCT01747655|456054823|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
126755776|NCT01747655|456054824|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
126755777|NCT03512028|456054825|FG000|Overall Study|Withdrawal by Subject|2|||
126755778|NCT03512028|456054826|FG001|Overall Study|Withdrawal by Subject|0|||
126755779|NCT03512028|456054825|FG000|Overall Study|Protocol Violation|2|||
126755780|NCT03512028|456054826|FG001|Overall Study|Protocol Violation|0|||
126793644|NCT00286754|456202617|FG002|Overall Study|Adverse Event|3|||
126793645|NCT00286754|456202615|FG000|Overall Study|Withdrawal by Subject|6|||
126793646|NCT00286754|456202616|FG001|Overall Study|Withdrawal by Subject|2|||
126793647|NCT00286754|456202617|FG002|Overall Study|Withdrawal by Subject|0|||
126793648|NCT00286754|456202615|FG000|Overall Study|Lost to Follow-up|12|||
126793649|NCT00286754|456202616|FG001|Overall Study|Lost to Follow-up|14|||
126793650|NCT00286754|456202617|FG002|Overall Study|Lost to Follow-up|6|||
126793651|NCT00286754|456202615|FG000|Overall Study|Moved out of state|0|||
126793652|NCT00286754|456202616|FG001|Overall Study|Moved out of state|0|||
126793653|NCT00286754|456202617|FG002|Overall Study|Moved out of state|1|||
126793654|NCT02336165|456202618|FG000|Overall Study|Death|3|||
126793655|NCT02336165|456202619|FG001|Overall Study|Death|0|||
126793656|NCT02336165|456202620|FG002|Overall Study|Death|0|||
126793657|NCT02336165|456202621|FG003|Overall Study|Death|0|||
126793658|NCT02336165|456202622|FG004|Overall Study|Death|1|||
126793659|NCT02336165|456202618|FG000|Overall Study|Physician Decision|2|||
126793660|NCT02336165|456202619|FG001|Overall Study|Physician Decision|2|||
126793661|NCT02336165|456202620|FG002|Overall Study|Physician Decision|1|||
126793662|NCT02336165|456202621|FG003|Overall Study|Physician Decision|1|||
126793663|NCT02336165|456202622|FG004|Overall Study|Physician Decision|0|||
126793664|NCT02336165|456202618|FG000|Overall Study|Withdrawal by Subject|0|||
126793665|NCT02336165|456202619|FG001|Overall Study|Withdrawal by Subject|0|||
126793666|NCT02336165|456202620|FG002|Overall Study|Withdrawal by Subject|1|||
126793667|NCT02336165|456202621|FG003|Overall Study|Withdrawal by Subject|0|||
126793668|NCT02336165|456202622|FG004|Overall Study|Withdrawal by Subject|1|||
126793669|NCT02336165|456202618|FG000|Overall Study|Adverse Event|4|||
126793670|NCT02336165|456202619|FG001|Overall Study|Adverse Event|1|||
126793671|NCT02336165|456202620|FG002|Overall Study|Adverse Event|2|||
126793672|NCT02336165|456202621|FG003|Overall Study|Adverse Event|4|||
126793673|NCT02336165|456202622|FG004|Overall Study|Adverse Event|1|||
126793674|NCT02336165|456202618|FG000|Overall Study|Progressive disease|23|||
126793675|NCT02336165|456202619|FG001|Overall Study|Progressive disease|22|||
126793676|NCT02336165|456202620|FG002|Overall Study|Progressive disease|27|||
126793677|NCT02336165|456202621|FG003|Overall Study|Progressive disease|24|||
126793678|NCT02336165|456202622|FG004|Overall Study|Progressive disease|19|||
126793679|NCT02336165|456202618|FG000|Overall Study|Non-compliance|1|||
126793680|NCT02336165|456202619|FG001|Overall Study|Non-compliance|0|||
126793681|NCT02336165|456202620|FG002|Overall Study|Non-compliance|0|||
126793682|NCT02336165|456202621|FG003|Overall Study|Non-compliance|1|||
126793683|NCT02336165|456202622|FG004|Overall Study|Non-compliance|0|||
126793684|NCT02336165|456202618|FG000|Overall Study|Other|1|||
126793685|NCT02336165|456202619|FG001|Overall Study|Other|0|||
126793686|NCT02336165|456202620|FG002|Overall Study|Other|0|||
126793687|NCT02336165|456202621|FG003|Overall Study|Other|1|||
126793688|NCT02336165|456202622|FG004|Overall Study|Other|0|||
126793689|NCT00910663|456202629|FG000|Period 1|Withdrawal by Subject|0|||
126793690|NCT00910663|456202630|FG001|Period 1|Withdrawal by Subject|1|||
126793691|NCT02865850|456202631|FG000|Overall Study|Death|15|||
126793692|NCT02865850|456202632|FG001|Overall Study|Death|19|||
126793693|NCT02865850|456202631|FG000|Overall Study|Withdrawal by Subject|3|||
126793694|NCT02865850|456202632|FG001|Overall Study|Withdrawal by Subject|2|||
126793695|NCT02865850|456202631|FG000|Overall Study|Lost to Follow-up|3|||
126793696|NCT02865850|456202632|FG001|Overall Study|Lost to Follow-up|2|||
126793697|NCT02726581|456202633|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
126793698|NCT02726581|456202634|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
126793699|NCT02726581|456202635|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
126793700|NCT02726581|456202633|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
126793701|NCT02726581|456202634|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
126793702|NCT02726581|456202635|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
126793703|NCT02726581|456202633|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
126793704|NCT02726581|456202634|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126793705|NCT02726581|456202635|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
126793706|NCT02726581|456202633|FG000|Treatment Period|Disease progression|47|||
126793707|NCT02726581|456202634|FG001|Treatment Period|Disease progression|50|||
126793708|NCT02726581|456202635|FG002|Treatment Period|Disease progression|16|||
126793709|NCT02726581|456202633|FG000|Treatment Period|Other reasons|9|||
126793710|NCT02726581|456202634|FG001|Treatment Period|Other reasons|8|||
126793711|NCT02726581|456202635|FG002|Treatment Period|Other reasons|2|||
126793712|NCT02726581|456202633|FG000|Treatment Period|Study drug toxicity|6|||
126793713|NCT02726581|456202634|FG001|Treatment Period|Study drug toxicity|3|||
126793714|NCT02726581|456202635|FG002|Treatment Period|Study drug toxicity|2|||
126793715|NCT02726581|456202633|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
126793716|NCT02726581|456202634|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
126793717|NCT02726581|456202635|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
126793718|NCT02726581|456202633|FG000|Treatment Period|Participant withdrew consent|3|||
126793719|NCT02726581|456202634|FG001|Treatment Period|Participant withdrew consent|1|||
126793720|NCT02726581|456202635|FG002|Treatment Period|Participant withdrew consent|1|||
126793721|NCT02726581|456202633|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
126793722|NCT02726581|456202634|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
126793723|NCT02726581|456202635|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
126793724|NCT02726581|456202633|FG000|Treatment Period|Maximum clinical benefit|0|||
126793725|NCT02726581|456202634|FG001|Treatment Period|Maximum clinical benefit|2|||
126793726|NCT02726581|456202635|FG002|Treatment Period|Maximum clinical benefit|0|||
126793727|NCT02726581|456202633|FG000|Treatment Period|Death|1|||
126793728|NCT02726581|456202634|FG001|Treatment Period|Death|0|||
126793729|NCT02726581|456202635|FG002|Treatment Period|Death|0|||
126793730|NCT02726581|456202633|FG000|Treatment Period|Poor/non-compliance|1|||
126793731|NCT02726581|456202634|FG001|Treatment Period|Poor/non-compliance|0|||
126793732|NCT02726581|456202635|FG002|Treatment Period|Poor/non-compliance|0|||
126793733|NCT02726581|456202633|FG000|Treatment Period|Participant no longer meets study criteria|0|||
126793734|NCT02726581|456202634|FG001|Treatment Period|Participant no longer meets study criteria|1|||
126793735|NCT02726581|456202635|FG002|Treatment Period|Participant no longer meets study criteria|0|||
126793736|NCT00552669|456202636|FG000|Overall Study|Death|3|||
126793737|NCT00552669|456202637|FG001|Overall Study|Death|7|||
126793738|NCT01844375|456202641|FG000|Overall Study|Protocol Violation|1|||
126793739|NCT01844375|456202642|FG001|Overall Study|Protocol Violation|1|||
126793740|NCT01772537|456202644|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
126793741|NCT01772537|456202645|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
126793742|NCT01772537|456202646|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
126793743|NCT03195491|456202647|FG000|Overall Study|Study drug toxicity|25|||
126793744|NCT03195491|456202648|FG001|Overall Study|Study drug toxicity|3|||
126793745|NCT03195491|456202647|FG000|Overall Study|Maximum clinical benefit|5|||
126793746|NCT03195491|456202648|FG001|Overall Study|Maximum clinical benefit|0|||
126793747|NCT03195491|456202647|FG000|Overall Study|Lost to Follow-up|1|||
126793748|NCT03195491|456202648|FG001|Overall Study|Lost to Follow-up|0|||
126793749|NCT03195491|456202647|FG000|Overall Study|Death|3|||
126793750|NCT03195491|456202648|FG001|Overall Study|Death|0|||
126793751|NCT03195491|456202647|FG000|Overall Study|Adverse event unrelated to study drug|19|||
126793752|NCT03195491|456202648|FG001|Overall Study|Adverse event unrelated to study drug|2|||
126793753|NCT03195491|456202647|FG000|Overall Study|Disease progression|266|||
126793754|NCT03195491|456202648|FG001|Overall Study|Disease progression|8|||
126793755|NCT03195491|456202647|FG000|Overall Study|Other reasons|10|||
126793756|NCT03195491|456202648|FG001|Overall Study|Other reasons|0|||
126793757|NCT03195491|456202647|FG000|Overall Study|Participant withdrew consent|8|||
126793758|NCT03195491|456202648|FG001|Overall Study|Participant withdrew consent|1|||
126793759|NCT03195491|456202647|FG000|Overall Study|Participant no longer meets study criteria|0|||
126793760|NCT03195491|456202648|FG001|Overall Study|Participant no longer meets study criteria|1|||
126793761|NCT03195491|456202647|FG000|Overall Study|Participant request to discontinue study treatment|10|||
126793762|NCT03195491|456202648|FG001|Overall Study|Participant request to discontinue study treatment|0|||
126793763|NCT01263704|456202649|FG000|Overall Study|Progressive disease|18|||
126793764|NCT01263704|456202649|FG000|Overall Study|Adverse Event|3|||
126793765|NCT01263704|456202649|FG000|Overall Study|Death|2|||
126793766|NCT01263704|456202649|FG000|Overall Study|Patient withdrew consent|2|||
126793767|NCT01263704|456202649|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
126793768|NCT01263704|456202649|FG000|Overall Study|Lost to Follow-up|1|||
126793769|NCT01263704|456202649|FG000|Overall Study|Colon metastases|1|||
126793770|NCT01263704|456202649|FG000|Overall Study|Principal Investigator (PI) decision|1|||
126793771|NCT03020615|456202650|FG000|Overall Study|Physician Decision|3|||
126793772|NCT03020615|456202651|FG001|Overall Study|Physician Decision|1|||
126793773|NCT03020615|456202652|FG002|Overall Study|Physician Decision|2|||
126793774|NCT03020615|456202650|FG000|Overall Study|Parent/guardian/patient choice|3|||
126793775|NCT03020615|456202651|FG001|Overall Study|Parent/guardian/patient choice|0|||
126793776|NCT03020615|456202652|FG002|Overall Study|Parent/guardian/patient choice|4|||
126793777|NCT03020615|456202650|FG000|Overall Study|Screen failure|0|||
126793778|NCT03020615|456202651|FG001|Overall Study|Screen failure|0|||
126793779|NCT03020615|456202652|FG002|Overall Study|Screen failure|1|||
126793780|NCT03020615|456202650|FG000|Overall Study|Death|1|||
126793781|NCT03020615|456202651|FG001|Overall Study|Death|0|||
126793782|NCT03020615|456202652|FG002|Overall Study|Death|0|||
126793783|NCT03020615|456202650|FG000|Overall Study|Lost to Follow-up|0|||
126793784|NCT03020615|456202651|FG001|Overall Study|Lost to Follow-up|1|||
126793785|NCT03020615|456202652|FG002|Overall Study|Lost to Follow-up|0|||
126793786|NCT00252720|456202654|FG000|Overall Study|Withdrawal by Subject|95|||
126793787|NCT00252720|456202655|FG001|Overall Study|Withdrawal by Subject|97|||
126793788|NCT00252720|456202654|FG000|Overall Study|Death|7|||
126793789|NCT00252720|456202655|FG001|Overall Study|Death|8|||
126793790|NCT00252720|456202654|FG000|Overall Study|Moving|23|||
126793791|NCT00252720|456202655|FG001|Overall Study|Moving|42|||
126793792|NCT00252720|456202654|FG000|Overall Study|Mainly patients lost to follow-up|7|||
126793793|NCT00252720|456202655|FG001|Overall Study|Mainly patients lost to follow-up|18|||
126793794|NCT02514122|456202661|FG000|Overall Study|Withdrawal by Subject|2|||
126793795|NCT02514122|456202662|FG001|Overall Study|Withdrawal by Subject|0|||
126793796|NCT04239872|456202663|FG000|Overall Study|Lost to Follow-up|0|||
126793797|NCT04239872|456202664|FG001|Overall Study|Lost to Follow-up|1|||
126793798|NCT00112463|456202667|FG000|Overall Study|Physician Decision|1|||
126793799|NCT00112463|456202667|FG000|Overall Study|Progression|30|||
126793800|NCT00112463|456202667|FG000|Overall Study|Second Primary|1|||
126793801|NCT00112463|456202667|FG000|Overall Study|Toxicity|3|||
126793802|NCT00112463|456202667|FG000|Overall Study|Withdrawal by Subject|2|||
126793803|NCT00112463|456202667|FG000|Overall Study|Never started treatment|2|||
126793804|NCT01118312|456202674|FG000|Overall Study|Lost to Follow-up|33|||
126793805|NCT01118312|456202675|FG001|Overall Study|Lost to Follow-up|32|||
126793806|NCT01118312|456202674|FG000|Overall Study|Withdrawal by Subject|1|||
126793807|NCT01118312|456202675|FG001|Overall Study|Withdrawal by Subject|3|||
126793808|NCT01185821|456202680|FG000|Overall Study|Abnormal laboratory value(s)|1|||
126793809|NCT01185821|456202681|FG001|Overall Study|Abnormal laboratory value(s)|2|||
126793810|NCT01185821|456202682|FG002|Overall Study|Abnormal laboratory value(s)|1|||
126793811|NCT01185821|456202683|FG003|Overall Study|Abnormal laboratory value(s)|0|||
126793812|NCT01185821|456202684|FG004|Overall Study|Abnormal laboratory value(s)|0|||
126793813|NCT01185821|456202680|FG000|Overall Study|Protocol Violation|0|||
126793814|NCT01185821|456202681|FG001|Overall Study|Protocol Violation|0|||
126793815|NCT01185821|456202682|FG002|Overall Study|Protocol Violation|0|||
126793816|NCT01185821|456202683|FG003|Overall Study|Protocol Violation|1|||
126793817|NCT01185821|456202684|FG004|Overall Study|Protocol Violation|1|||
126793818|NCT01185821|456202680|FG000|Overall Study|Abnormal test procedure result|0|||
126793819|NCT01185821|456202681|FG001|Overall Study|Abnormal test procedure result|0|||
126793820|NCT01185821|456202682|FG002|Overall Study|Abnormal test procedure result|0|||
126793821|NCT01185821|456202683|FG003|Overall Study|Abnormal test procedure result|0|||
126793822|NCT01185821|456202684|FG004|Overall Study|Abnormal test procedure result|1|||
126793823|NCT01185821|456202680|FG000|Overall Study|Death|0|||
126793824|NCT01185821|456202681|FG001|Overall Study|Death|1|||
126793825|NCT01185821|456202682|FG002|Overall Study|Death|0|||
126793826|NCT01185821|456202683|FG003|Overall Study|Death|0|||
126793827|NCT01185821|456202684|FG004|Overall Study|Death|0|||
126793828|NCT01185821|456202680|FG000|Overall Study|Condition no longer required study drug|0|||
126793829|NCT01185821|456202681|FG001|Overall Study|Condition no longer required study drug|0|||
126793830|NCT01185821|456202682|FG002|Overall Study|Condition no longer required study drug|0|||
126793831|NCT01185821|456202683|FG003|Overall Study|Condition no longer required study drug|0|||
126793832|NCT01185821|456202684|FG004|Overall Study|Condition no longer required study drug|1|||
126793833|NCT01185821|456202680|FG000|Overall Study|Adverse Event|2|||
126793834|NCT01185821|456202681|FG001|Overall Study|Adverse Event|3|||
126793835|NCT01185821|456202682|FG002|Overall Study|Adverse Event|1|||
126793836|NCT01185821|456202683|FG003|Overall Study|Adverse Event|2|||
126793837|NCT01185821|456202684|FG004|Overall Study|Adverse Event|5|||
126793838|NCT01185821|456202680|FG000|Overall Study|Lack of Efficacy|0|||
126793839|NCT01185821|456202681|FG001|Overall Study|Lack of Efficacy|0|||
126793840|NCT01185821|456202682|FG002|Overall Study|Lack of Efficacy|3|||
126793841|NCT01185821|456202683|FG003|Overall Study|Lack of Efficacy|0|||
126793842|NCT01185821|456202684|FG004|Overall Study|Lack of Efficacy|9|||
126793843|NCT01185821|456202680|FG000|Overall Study|Withdrawal by Subject|3|||
126793844|NCT01185821|456202681|FG001|Overall Study|Withdrawal by Subject|2|||
126793845|NCT01185821|456202682|FG002|Overall Study|Withdrawal by Subject|2|||
126793846|NCT01185821|456202683|FG003|Overall Study|Withdrawal by Subject|1|||
126793847|NCT01185821|456202684|FG004|Overall Study|Withdrawal by Subject|3|||
126793848|NCT01185821|456202680|FG000|Overall Study|Lost to Follow-up|1|||
126793849|NCT01185821|456202681|FG001|Overall Study|Lost to Follow-up|1|||
126793850|NCT01185821|456202682|FG002|Overall Study|Lost to Follow-up|2|||
126793851|NCT01185821|456202683|FG003|Overall Study|Lost to Follow-up|1|||
126793852|NCT01185821|456202684|FG004|Overall Study|Lost to Follow-up|2|||
126793853|NCT01185821|456202680|FG000|Overall Study|Administrative problems|0|||
126793854|NCT01185821|456202681|FG001|Overall Study|Administrative problems|0|||
126793855|NCT01185821|456202682|FG002|Overall Study|Administrative problems|1|||
126793856|NCT01185821|456202683|FG003|Overall Study|Administrative problems|1|||
126793857|NCT01185821|456202684|FG004|Overall Study|Administrative problems|2|||
126632812|NCT01087814|455613874|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
126793858|NCT01546545|456202685|FG000|Overall Study|Withdrawal by Subject|1|||
126793859|NCT00296647|456202686|FG000|Overall Study|Death|4|||
126632813|NCT01087814|455613875|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
126793860|NCT00296647|456202687|FG001|Overall Study|Death|1|||
126793861|NCT00296647|456202688|FG002|Overall Study|Death|2|||
126793862|NCT00296647|456202689|FG003|Overall Study|Death|1|||
126793863|NCT00296647|456202690|FG004|Overall Study|Death|1|||
126793864|NCT00296647|456202686|FG000|Overall Study|Withdrawal by Subject|28|||
126793865|NCT00296647|456202687|FG001|Overall Study|Withdrawal by Subject|27|||
126793866|NCT00296647|456202688|FG002|Overall Study|Withdrawal by Subject|32|||
126793867|NCT00296647|456202689|FG003|Overall Study|Withdrawal by Subject|16|||
126793868|NCT00296647|456202690|FG004|Overall Study|Withdrawal by Subject|19|||
126793869|NCT05093205|456202691|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
126793870|NCT05093205|456202692|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
126793871|NCT05093205|456202693|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
126793872|NCT05093205|456202694|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
126793873|NCT05093205|456202695|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
126793874|NCT05093205|456202696|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
126793875|NCT05093205|456202697|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
126793876|NCT05093205|456202698|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
126793877|NCT05093205|456202699|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
126793878|NCT05093205|456202700|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
126793879|NCT05093205|456202701|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
126793880|NCT05093205|456202702|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
126793881|NCT05093205|456202703|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
126793882|NCT05093205|456202691|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126793883|NCT05093205|456202692|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126793884|NCT05093205|456202693|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
126793885|NCT05093205|456202694|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126793886|NCT05093205|456202695|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126793887|NCT05093205|456202696|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126793888|NCT05093205|456202697|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126793889|NCT05093205|456202698|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126793890|NCT05093205|456202699|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126793891|NCT05093205|456202700|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126793892|NCT05093205|456202701|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126793893|NCT05093205|456202702|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126793894|NCT05093205|456202703|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
126793895|NCT05093205|456202691|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
126793896|NCT05093205|456202692|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
126793897|NCT05093205|456202693|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
126793898|NCT05093205|456202694|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
126793899|NCT05093205|456202695|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
126793900|NCT05093205|456202696|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
126793901|NCT05093205|456202697|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
126793902|NCT05093205|456202698|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
126793903|NCT05093205|456202699|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
126793904|NCT05093205|456202700|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
126793905|NCT05093205|456202701|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
126793906|NCT05093205|456202702|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
126793907|NCT05093205|456202703|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
126793908|NCT05093205|456202691|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
126793909|NCT05093205|456202692|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
126793910|NCT05093205|456202693|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
126793911|NCT05093205|456202694|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
126793912|NCT05093205|456202695|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
126793913|NCT05093205|456202696|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
126793914|NCT05093205|456202697|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
126793915|NCT05093205|456202698|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
126793916|NCT05093205|456202699|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
126793917|NCT05093205|456202700|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
126793918|NCT05093205|456202701|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
126793919|NCT05093205|456202702|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
126793920|NCT05093205|456202703|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
126793921|NCT05093205|456202691|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
126793922|NCT05093205|456202692|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
126793923|NCT05093205|456202693|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
126793924|NCT05093205|456202694|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
126793925|NCT05093205|456202695|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
126793926|NCT05093205|456202696|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
126793927|NCT05093205|456202697|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
126793928|NCT05093205|456202698|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
126793929|NCT05093205|456202699|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
126793930|NCT05093205|456202700|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
126793931|NCT05093205|456202701|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
126793932|NCT05093205|456202702|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
126793933|NCT05093205|456202703|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
126793934|NCT05093205|456202691|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
126793935|NCT05093205|456202692|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
126793936|NCT05093205|456202693|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
126793937|NCT05093205|456202694|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
126793938|NCT05093205|456202695|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
126793939|NCT05093205|456202696|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
126793940|NCT05093205|456202697|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
126793941|NCT05093205|456202698|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
126793942|NCT05093205|456202699|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
126793943|NCT05093205|456202700|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
126793944|NCT05093205|456202701|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
126793945|NCT05093205|456202702|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
126793946|NCT05093205|456202703|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
126793947|NCT05093205|456202691|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
126793948|NCT05093205|456202692|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
126793949|NCT05093205|456202693|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
126793950|NCT05093205|456202694|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
126793951|NCT05093205|456202695|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
126793952|NCT05093205|456202696|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
126793953|NCT05093205|456202697|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
126793954|NCT05093205|456202698|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
126793955|NCT05093205|456202699|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
126793956|NCT05093205|456202700|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
126793957|NCT05093205|456202701|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
126793958|NCT05093205|456202702|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
126793959|NCT05093205|456202703|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
126793960|NCT05093205|456202691|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
126793961|NCT05093205|456202692|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
126793962|NCT05093205|456202693|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
126793963|NCT05093205|456202694|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
126793964|NCT05093205|456202695|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
126793965|NCT05093205|456202696|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
126793966|NCT05093205|456202697|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
126793967|NCT05093205|456202698|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
126793968|NCT05093205|456202699|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
126793969|NCT05093205|456202700|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
126793970|NCT05093205|456202701|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
126793971|NCT05093205|456202702|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
126793972|NCT05093205|456202703|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
126793973|NCT05093205|456202691|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126793974|NCT05093205|456202692|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126793975|NCT05093205|456202693|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126793976|NCT05093205|456202694|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126793977|NCT05093205|456202695|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126793978|NCT05093205|456202696|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126793979|NCT05093205|456202697|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126793980|NCT05093205|456202698|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126793981|NCT05093205|456202699|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126793982|NCT05093205|456202700|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
126793983|NCT05093205|456202701|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126793984|NCT05093205|456202702|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126793985|NCT05093205|456202703|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
126793986|NCT05093205|456202691|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
126793987|NCT05093205|456202692|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
126793988|NCT05093205|456202693|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
126793989|NCT05093205|456202694|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
126793990|NCT05093205|456202695|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
126793991|NCT05093205|456202696|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
126793992|NCT05093205|456202697|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
126793993|NCT05093205|456202698|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
126793994|NCT05093205|456202699|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
126793995|NCT05093205|456202700|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
126793996|NCT05093205|456202701|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
126793997|NCT05093205|456202702|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
126793998|NCT05093205|456202703|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
126793999|NCT05093205|456202691|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126794000|NCT05093205|456202692|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126794001|NCT05093205|456202693|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126794002|NCT05093205|456202694|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126794003|NCT05093205|456202695|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126794004|NCT05093205|456202696|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126794005|NCT05093205|456202697|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126794006|NCT05093205|456202698|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126794007|NCT05093205|456202699|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126794008|NCT05093205|456202700|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126794009|NCT05093205|456202701|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
126794010|NCT05093205|456202702|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126794011|NCT05093205|456202703|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
126794012|NCT05093205|456202691|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126794013|NCT05093205|456202692|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126794014|NCT05093205|456202693|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126794015|NCT05093205|456202694|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126794016|NCT05093205|456202695|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126794017|NCT05093205|456202696|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126794018|NCT05093205|456202697|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126794019|NCT05093205|456202698|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126794020|NCT05093205|456202699|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126794021|NCT05093205|456202700|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126794022|NCT05093205|456202701|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126794023|NCT05093205|456202702|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
126794024|NCT05093205|456202703|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
126794025|NCT05093205|456202691|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
126794026|NCT05093205|456202692|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
126794027|NCT05093205|456202693|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
126794028|NCT05093205|456202694|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
126794029|NCT05093205|456202695|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
126794030|NCT05093205|456202696|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
126794031|NCT05093205|456202697|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
126794032|NCT05093205|456202698|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
126794033|NCT05093205|456202699|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
126794034|NCT05093205|456202700|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
126794035|NCT05093205|456202701|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
126794036|NCT05093205|456202702|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
126794037|NCT05093205|456202703|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
126794038|NCT05093205|456202691|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126794039|NCT05093205|456202692|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126794040|NCT05093205|456202693|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126794041|NCT05093205|456202694|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126794042|NCT05093205|456202695|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126794043|NCT05093205|456202696|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126794044|NCT05093205|456202697|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126794045|NCT05093205|456202698|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126794046|NCT05093205|456202699|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126632814|NCT01087814|455613874|FG000|Second Intervention (5 Days)|Physician Decision|1|||
126632815|NCT01087814|455613875|FG001|Second Intervention (5 Days)|Physician Decision|0|||
126632816|NCT04398368|455615656|FG000|Overall Study|Withdrawal by Subject|2|||
126632817|NCT00891046|455615661|FG000|Overall Study|Protocol Violation|1|||
126632818|NCT00891046|455615662|FG001|Overall Study|Protocol Violation|1|||
126632819|NCT00891046|455615663|FG002|Overall Study|Protocol Violation|0|||
126632820|NCT00891046|455615664|FG003|Overall Study|Protocol Violation|0|||
126632821|NCT00891046|455615665|FG004|Overall Study|Protocol Violation|1|||
126794047|NCT05093205|456202700|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126794048|NCT05093205|456202701|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126794049|NCT05093205|456202702|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
126794050|NCT05093205|456202703|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
126794051|NCT03361228|456202704|FG000|Overall Study|Other|1|||
126794052|NCT03361228|456202705|FG001|Overall Study|Other|1|||
126794053|NCT03361228|456202704|FG000|Overall Study|Death|3|||
126794054|NCT03361228|456202705|FG001|Overall Study|Death|0|||
126794055|NCT02421952|456202706|FG000|Overall Study|Diary Not Returned|93|||
126794056|NCT02421952|456202706|FG000|Overall Study|Failed seriation task|13|||
126794057|NCT02421952|456202706|FG000|Overall Study|Subject uncooperative for baseline test|2|||
126794058|NCT02421952|456202706|FG000|Overall Study|Surgery cancelled|1|||
126794059|NCT01387737|456204178|FG000|Overall Study|Adverse Event|20|||
126794060|NCT01387737|456204179|FG001|Overall Study|Adverse Event|30|||
126794061|NCT01387737|456204178|FG000|Overall Study|Lack of Efficacy|1|||
126794062|NCT01387737|456204179|FG001|Overall Study|Lack of Efficacy|0|||
126794063|NCT01387737|456204178|FG000|Overall Study|Physician Decision|3|||
126794064|NCT01387737|456204179|FG001|Overall Study|Physician Decision|10|||
126632822|NCT00891046|455615661|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
126632823|NCT00891046|455615662|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
126632824|NCT00891046|455615663|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
126632825|NCT00891046|455615664|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
126632826|NCT00891046|455615665|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
126632827|NCT00891046|455615661|FG000|Overall Study|Administrative problems|0|||
126632828|NCT00891046|455615662|FG001|Overall Study|Administrative problems|0|||
126632829|NCT00891046|455615663|FG002|Overall Study|Administrative problems|0|||
126632830|NCT00891046|455615664|FG003|Overall Study|Administrative problems|0|||
126632831|NCT00891046|455615665|FG004|Overall Study|Administrative problems|1|||
126794065|NCT01387737|456204178|FG000|Overall Study|Withdrawal by Subject|27|||
126794066|NCT01387737|456204179|FG001|Overall Study|Withdrawal by Subject|31|||
126794067|NCT01387737|456204178|FG000|Overall Study|Clearly not eligible for the study|1|||
126794068|NCT01387737|456204179|FG001|Overall Study|Clearly not eligible for the study|3|||
126794069|NCT01215981|456204180|FG000|Overall Study|Physician Decision|0|||
126794070|NCT01215981|456204181|FG001|Overall Study|Physician Decision|1|||
126794071|NCT01215981|456204180|FG000|Overall Study|Protocol Violation|1|||
126794072|NCT01215981|456204181|FG001|Overall Study|Protocol Violation|0|||
126794073|NCT01215981|456204180|FG000|Overall Study|Withdrawal by Subject|1|||
126794074|NCT01215981|456204181|FG001|Overall Study|Withdrawal by Subject|0|||
126794075|NCT00840632|456204182|FG000|First Intervention|Withdrawal by Subject|0|||
126794076|NCT00840632|456204183|FG001|First Intervention|Withdrawal by Subject|1|||
126794077|NCT00840632|456204182|FG000|Washout|Withdrawal by Subject|1|||
126794078|NCT00840632|456204183|FG001|Washout|Withdrawal by Subject|1|||
126794079|NCT01725529|456204184|FG000|Overall Study|Adverse Event|1|||
126794080|NCT01725529|456204185|FG001|Overall Study|Adverse Event|0|||
126794081|NCT01725529|456204186|FG002|Overall Study|Adverse Event|0|||
126794082|NCT01725529|456204184|FG000|Overall Study|Lost to Follow-up|2|||
126794083|NCT01725529|456204185|FG001|Overall Study|Lost to Follow-up|1|||
126794084|NCT01725529|456204186|FG002|Overall Study|Lost to Follow-up|1|||
126794085|NCT01725529|456204184|FG000|Overall Study|Protocol Violation|0|||
126794086|NCT01725529|456204185|FG001|Overall Study|Protocol Violation|1|||
126794087|NCT01725529|456204186|FG002|Overall Study|Protocol Violation|1|||
126794088|NCT01725529|456204184|FG000|Overall Study|Withdrawal by Subject|12|||
126794089|NCT01725529|456204185|FG001|Overall Study|Withdrawal by Subject|14|||
126794090|NCT01725529|456204186|FG002|Overall Study|Withdrawal by Subject|8|||
126794091|NCT01948258|456204191|FG000|Overall Study|Pregnancy|41|||
126794092|NCT01948258|456204191|FG000|Overall Study|Did not complete by cut-off date|35|||
126794093|NCT01948258|456204191|FG000|Overall Study|Lost to Follow-up|27|||
126794094|NCT01948258|456204191|FG000|Overall Study|Withdrawal by SPD|8|||
126794095|NCT01948258|456204191|FG000|Overall Study|Withdrawal by Subject|6|||
126794096|NCT01948258|456204191|FG000|Overall Study|Health Care Professional|43|||
126794097|NCT01948258|456204191|FG000|Overall Study|Removed from statistical analysis|2|||
126794098|NCT02262377|456204192|FG000|Overall Study|Lost to Follow-up|5|||
126794099|NCT02262377|456204193|FG001|Overall Study|Lost to Follow-up|6|||
126794100|NCT02262377|456204192|FG000|Overall Study|Found ineligible after enrollment|3|||
126794101|NCT02262377|456204193|FG001|Overall Study|Found ineligible after enrollment|0|||
126794102|NCT02262377|456204192|FG000|Overall Study|Withdrawal by Subject|4|||
126794103|NCT02262377|456204193|FG001|Overall Study|Withdrawal by Subject|0|||
126794104|NCT00723528|456204195|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
126794105|NCT00723528|456204196|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
126794106|NCT00723528|456204197|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
126794107|NCT00723528|456204198|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
126794108|NCT00723528|456204199|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
126794109|NCT00723528|456204200|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
126794110|NCT00723528|456204201|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
126794111|NCT00723528|456204195|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
126794112|NCT00723528|456204196|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
126794113|NCT00723528|456204197|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
126794114|NCT00723528|456204198|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
126794115|NCT00723528|456204199|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
126794116|NCT00723528|456204200|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
126794117|NCT00723528|456204201|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
126794118|NCT00723528|456204195|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
126794119|NCT00723528|456204196|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
126794120|NCT00723528|456204197|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
126794121|NCT00723528|456204198|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
126794122|NCT00723528|456204199|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
126794123|NCT00723528|456204200|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
126794124|NCT00723528|456204201|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
126794125|NCT00723528|456204195|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
126794126|NCT00723528|456204196|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
126794127|NCT00723528|456204197|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
126794128|NCT00723528|456204198|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
126794129|NCT00723528|456204199|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
126794130|NCT00723528|456204200|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
126794131|NCT00723528|456204201|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
126794132|NCT00723528|456204195|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
126794133|NCT00723528|456204196|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
126794134|NCT00723528|456204197|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
126632832|NCT00891046|455615661|FG000|Overall Study|Participant no longer required drug|0|||
126632833|NCT00891046|455615662|FG001|Overall Study|Participant no longer required drug|2|||
126632834|NCT00891046|455615663|FG002|Overall Study|Participant no longer required drug|0|||
126794135|NCT00723528|456204198|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
126794136|NCT00723528|456204199|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
126794137|NCT00723528|456204200|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
126632835|NCT00891046|455615664|FG003|Overall Study|Participant no longer required drug|0|||
126794138|NCT00723528|456204201|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
126794139|NCT00723528|456204195|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
126794140|NCT00723528|456204196|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
126794141|NCT00723528|456204197|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
126794142|NCT00723528|456204198|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
126794143|NCT00723528|456204199|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
126794144|NCT00723528|456204200|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
126794145|NCT00723528|456204201|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
126794146|NCT00723528|456204195|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
126794147|NCT00723528|456204196|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
126794148|NCT00723528|456204197|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
126794149|NCT00723528|456204198|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
126794150|NCT00723528|456204199|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
126794151|NCT00723528|456204200|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
126794152|NCT00723528|456204201|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
126794153|NCT00723528|456204195|FG000|Period 2: After Controlled Period|Other|0|||
126794154|NCT00723528|456204196|FG001|Period 2: After Controlled Period|Other|0|||
126794155|NCT00723528|456204197|FG002|Period 2: After Controlled Period|Other|0|||
126794156|NCT00723528|456204198|FG003|Period 2: After Controlled Period|Other|0|||
126794157|NCT00723528|456204199|FG004|Period 2: After Controlled Period|Other|1|||
126794158|NCT00723528|456204200|FG005|Period 2: After Controlled Period|Other|4|||
126794159|NCT00723528|456204201|FG006|Period 2: After Controlled Period|Other|0|||
126794160|NCT00723528|456204195|FG000|Period 2: After Controlled Period|Adverse Event|0|||
126794161|NCT00723528|456204196|FG001|Period 2: After Controlled Period|Adverse Event|0|||
126794162|NCT00723528|456204197|FG002|Period 2: After Controlled Period|Adverse Event|0|||
126794163|NCT00723528|456204198|FG003|Period 2: After Controlled Period|Adverse Event|0|||
126794164|NCT00723528|456204199|FG004|Period 2: After Controlled Period|Adverse Event|1|||
126794165|NCT00723528|456204200|FG005|Period 2: After Controlled Period|Adverse Event|0|||
126794166|NCT00723528|456204201|FG006|Period 2: After Controlled Period|Adverse Event|1|||
126794167|NCT00723528|456204195|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
126794168|NCT00723528|456204196|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
126794169|NCT00723528|456204197|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
126794170|NCT00723528|456204198|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
126794171|NCT00723528|456204199|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
126794172|NCT00723528|456204200|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
126794173|NCT00723528|456204201|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
126794174|NCT00723528|456204195|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
126794175|NCT00723528|456204196|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
126794176|NCT00723528|456204197|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
126794177|NCT00723528|456204198|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
126794178|NCT00723528|456204199|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
126794179|NCT00723528|456204200|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
126794180|NCT00723528|456204201|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
126794181|NCT01993030|456204202|FG000|Overall Study|Adverse Event|0|||
126794182|NCT01993030|456204203|FG001|Overall Study|Adverse Event|4|||
126794183|NCT01710657|456204204|FG000|Overall Study|Lost to Follow-up|2|||
126794184|NCT01710657|456204205|FG001|Overall Study|Lost to Follow-up|0|||
126794185|NCT01710657|456204206|FG002|Overall Study|Lost to Follow-up|1|||
126794186|NCT01710657|456204204|FG000|Overall Study|Protocol Violation|2|||
126794187|NCT01710657|456204205|FG001|Overall Study|Protocol Violation|2|||
126794188|NCT01710657|456204206|FG002|Overall Study|Protocol Violation|0|||
126794189|NCT01710657|456204204|FG000|Overall Study|Adverse Event|14|||
126794190|NCT01710657|456204205|FG001|Overall Study|Adverse Event|8|||
126794191|NCT01710657|456204206|FG002|Overall Study|Adverse Event|28|||
126794192|NCT01710657|456204204|FG000|Overall Study|Withdrawal by Subject|0|||
126794193|NCT01710657|456204205|FG001|Overall Study|Withdrawal by Subject|1|||
126794194|NCT01710657|456204206|FG002|Overall Study|Withdrawal by Subject|2|||
126794195|NCT01710657|456204204|FG000|Overall Study|Lack of Efficacy|0|||
126794196|NCT01710657|456204205|FG001|Overall Study|Lack of Efficacy|1|||
126794197|NCT01710657|456204206|FG002|Overall Study|Lack of Efficacy|1|||
126794198|NCT01591785|456204209|FG000|Overall Study|worsening condition|1|||
126794199|NCT01591785|456204210|FG001|Overall Study|worsening condition|2|||
126794200|NCT01591785|456204209|FG000|Overall Study|Protocol Violation|2|||
126794201|NCT01591785|456204210|FG001|Overall Study|Protocol Violation|0|||
126794202|NCT01591785|456204209|FG000|Overall Study|Lost to Follow-up|1|||
126794203|NCT01591785|456204210|FG001|Overall Study|Lost to Follow-up|0|||
126794204|NCT00496964|456204217|FG000|Overall Study|Withdrawal by Subject|0|||
126794205|NCT00496964|456204218|FG001|Overall Study|Withdrawal by Subject|1|||
126794206|NCT00909610|456204219|FG000|Period: First Intervention|Adverse Event|0|||
126794207|NCT00909610|456204220|FG001|Period: First Intervention|Adverse Event|1|||
126794208|NCT00909610|456204219|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
126794209|NCT00909610|456204220|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
126794210|NCT00909610|456204219|FG000|Period: Second Intervention|Adverse Event|1|||
126794211|NCT00909610|456204220|FG001|Period: Second Intervention|Adverse Event|0|||
126794212|NCT04123548|456204223|FG000|Overall Study|Withdrawal by Subject|1|||
126794213|NCT04123548|456204223|FG000|Overall Study|Lost to Follow-up|8|||
126794214|NCT04123548|456204223|FG000|Overall Study|Death|4|||
126794215|NCT04123548|456204223|FG000|Overall Study|Reason Not Specified|1|||
126794216|NCT00418184|456204224|FG000|Double-blind Phase|Withdrawal by Subject|22|||
126794217|NCT00418184|456204225|FG001|Double-blind Phase|Withdrawal by Subject|9|||
126794218|NCT00418184|456204224|FG000|Double-blind Phase|Adverse Event|2|||
126794219|NCT00418184|456204225|FG001|Double-blind Phase|Adverse Event|1|||
126794220|NCT00418184|456204224|FG000|Double-blind Phase|Poor compliance|3|||
126794221|NCT00418184|456204225|FG001|Double-blind Phase|Poor compliance|1|||
126794222|NCT01015625|456204226|FG000|Overall Study|Lost to Follow-up|3|||
126794223|NCT01015625|456204227|FG001|Overall Study|Lost to Follow-up|1|||
126794224|NCT01015625|456204226|FG000|Overall Study|Withdrawal by Subject|2|||
126794225|NCT01015625|456204227|FG001|Overall Study|Withdrawal by Subject|3|||
126794226|NCT01015625|456204226|FG000|Overall Study|Physician Decision|2|||
126794227|NCT01015625|456204227|FG001|Overall Study|Physician Decision|0|||
126794228|NCT01015625|456204226|FG000|Overall Study|Death|30|||
126794229|NCT01015625|456204227|FG001|Overall Study|Death|22|||
126794230|NCT02728102|456204228|FG000|Overall Study|Death|3|||
126794231|NCT02728102|456204229|FG001|Overall Study|Death|0|||
126794232|NCT02728102|456204230|FG002|Overall Study|Death|1|||
126794233|NCT02728102|456204228|FG000|Overall Study|Withdrawal by Subject|0|||
126794234|NCT02728102|456204229|FG001|Overall Study|Withdrawal by Subject|2|||
126794235|NCT02728102|456204230|FG002|Overall Study|Withdrawal by Subject|3|||
126794236|NCT02728102|456204228|FG000|Overall Study|Physician Decision|1|||
126794237|NCT02728102|456204229|FG001|Overall Study|Physician Decision|1|||
126794238|NCT02728102|456204230|FG002|Overall Study|Physician Decision|0|||
126794239|NCT02728102|456204228|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
126794240|NCT02728102|456204229|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
126794241|NCT02728102|456204230|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
126794242|NCT02728102|456204228|FG000|Overall Study|Covid|0|||
126794243|NCT02728102|456204229|FG001|Overall Study|Covid|0|||
126794244|NCT02728102|456204230|FG002|Overall Study|Covid|1|||
126794245|NCT02472366|456204231|FG000|Overall Study|Lost to Follow-up|1|||
126794246|NCT02472366|456204232|FG001|Overall Study|Lost to Follow-up|0|||
126794247|NCT01182415|456204233|FG000|Overall Study|Lost to Follow-up|1|||
126794248|NCT02587962|456204234|FG000|Overall Study|Adverse Event|0|||
126794249|NCT02587962|456204235|FG001|Overall Study|Adverse Event|0|||
126794250|NCT02587962|456204236|FG002|Overall Study|Adverse Event|1|||
126794251|NCT02587962|456204237|FG003|Overall Study|Adverse Event|0|||
126794252|NCT02587962|456204238|FG004|Overall Study|Adverse Event|0|||
126794253|NCT02587962|456204234|FG000|Overall Study|Withdrawal by Subject|0|||
126794254|NCT02587962|456204235|FG001|Overall Study|Withdrawal by Subject|0|||
126794255|NCT02587962|456204236|FG002|Overall Study|Withdrawal by Subject|1|||
126794256|NCT02587962|456204237|FG003|Overall Study|Withdrawal by Subject|1|||
126794257|NCT02587962|456204238|FG004|Overall Study|Withdrawal by Subject|4|||
126794258|NCT02587962|456204234|FG000|Overall Study|Radiological progression|2|||
126632836|NCT00891046|455615665|FG004|Overall Study|Participant no longer required drug|1|||
126794259|NCT02587962|456204235|FG001|Overall Study|Radiological progression|2|||
126794260|NCT02587962|456204236|FG002|Overall Study|Radiological progression|2|||
126794261|NCT02587962|456204237|FG003|Overall Study|Radiological progression|5|||
126794262|NCT02587962|456204238|FG004|Overall Study|Radiological progression|10|||
126794263|NCT02587962|456204234|FG000|Overall Study|Clinical progression|0|||
126794264|NCT02587962|456204235|FG001|Overall Study|Clinical progression|1|||
126794265|NCT02587962|456204236|FG002|Overall Study|Clinical progression|2|||
126632837|NCT00891046|455615661|FG000|Overall Study|Adverse Event|4|||
126632838|NCT00891046|455615662|FG001|Overall Study|Adverse Event|3|||
126632839|NCT00891046|455615663|FG002|Overall Study|Adverse Event|2|||
126632840|NCT00891046|455615664|FG003|Overall Study|Adverse Event|0|||
126632841|NCT00891046|455615665|FG004|Overall Study|Adverse Event|14|||
126632842|NCT00891046|455615661|FG000|Overall Study|Withdrawal by Subject|2|||
126632843|NCT00891046|455615662|FG001|Overall Study|Withdrawal by Subject|1|||
126794266|NCT02587962|456204237|FG003|Overall Study|Clinical progression|0|||
126794267|NCT02587962|456204238|FG004|Overall Study|Clinical progression|1|||
126794268|NCT00086996|456204240|FG000|Overall Study|Adverse Event|29|||
126794269|NCT00086996|456204240|FG000|Overall Study|Death|4|||
126794270|NCT00086996|456204240|FG000|Overall Study|progression/relapse|7|||
126794271|NCT00086996|456204240|FG000|Overall Study|Withdrawal by Subject|13|||
126794272|NCT00086996|456204240|FG000|Overall Study|Other|6|||
126794273|NCT00086996|456204240|FG000|Overall Study|not eligible|5|||
126794274|NCT02770820|456204243|FG000|Overall Study|Death|1|||
126794275|NCT02770820|456204243|FG000|Overall Study|Physician Decision|2|||
126794276|NCT02098876|456204245|FG000|Overall Study|Withdrawal by Subject|5|||
126794277|NCT02098876|456204246|FG001|Overall Study|Withdrawal by Subject|5|||
126794278|NCT01061866|456204247|FG000|Overall Study|Adverse Event|2|||
126794279|NCT00834756|456204248|FG000|First Intervention|Adverse Event|1|||
126794280|NCT00834756|456204249|FG001|First Intervention|Adverse Event|0|||
126794281|NCT00834756|456204248|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
126794282|NCT00834756|456204249|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
126794283|NCT01472341|456204250|FG000|Overall Study|Started insulin therapy|55|||
126794284|NCT01472341|456204250|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
126794285|NCT01472341|456204250|FG000|Overall Study|Withdrawal by Subject|39|||
126794286|NCT01472341|456204250|FG000|Overall Study|Lost to Follow-up|52|||
126794287|NCT01472341|456204250|FG000|Overall Study|Laboratory parameters unavailable|25|||
126794288|NCT01472341|456204250|FG000|Overall Study|Death|9|||
126794289|NCT04060147|456204255|FG000|Overall Study|Withdrew consent|1|||
126794290|NCT02057458|456204259|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
126794291|NCT02057458|456204260|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
126794292|NCT02057458|456204261|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
126794293|NCT02057458|456204259|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
126794294|NCT02057458|456204260|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
126794295|NCT02057458|456204261|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
126794296|NCT02057458|456204259|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
126794297|NCT02057458|456204260|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
126794298|NCT02057458|456204261|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
126794299|NCT02979353|456204264|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
126794300|NCT02979353|456204265|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
126794301|NCT02979353|456204264|FG000|Overall Study|Withdrawal by Subject|16|||
126794302|NCT02979353|456204265|FG001|Overall Study|Withdrawal by Subject|12|||
126794303|NCT02979353|456204264|FG000|Overall Study|Death|10|||
126794304|NCT02979353|456204265|FG001|Overall Study|Death|11|||
126794305|NCT02979353|456204264|FG000|Overall Study|Transfer to Hospice Care|19|||
126794306|NCT02979353|456204265|FG001|Overall Study|Transfer to Hospice Care|14|||
126794307|NCT02979353|456204264|FG000|Overall Study|Lost to Follow-up|1|||
126794308|NCT02979353|456204265|FG001|Overall Study|Lost to Follow-up|5|||
126794309|NCT00585689|456204266|FG000|Overall Study|Received different ABI-007 schedule|3|||
126794310|NCT00585689|456204266|FG000|Overall Study|Adverse Event|1|||
126794311|NCT00585689|456204266|FG000|Overall Study|Patient Declined Surgery|1|||
126794312|NCT00585689|456204266|FG000|Overall Study|Patient had unresectable disease|1|||
126794313|NCT00585689|456204266|FG000|Overall Study|Death|1|||
126794314|NCT01079988|456204267|FG000|Overall Study|Lost to Follow-up|0|||
126794315|NCT01079988|456204268|FG001|Overall Study|Lost to Follow-up|0|||
126794316|NCT01079988|456204269|FG002|Overall Study|Lost to Follow-up|0|||
126794317|NCT01079988|456204270|FG003|Overall Study|Lost to Follow-up|1|||
126794318|NCT01079988|456204271|FG004|Overall Study|Lost to Follow-up|0|||
126794319|NCT01079988|456204267|FG000|Overall Study|Lack of Efficacy|1|||
126794320|NCT01079988|456204268|FG001|Overall Study|Lack of Efficacy|0|||
126794321|NCT01079988|456204269|FG002|Overall Study|Lack of Efficacy|0|||
126794322|NCT01079988|456204270|FG003|Overall Study|Lack of Efficacy|0|||
126794323|NCT01079988|456204271|FG004|Overall Study|Lack of Efficacy|0|||
126794324|NCT01079988|456204267|FG000|Overall Study|Other|0|||
126794325|NCT01079988|456204268|FG001|Overall Study|Other|0|||
126794326|NCT01079988|456204269|FG002|Overall Study|Other|0|||
126794327|NCT01079988|456204270|FG003|Overall Study|Other|2|||
126794328|NCT01079988|456204271|FG004|Overall Study|Other|1|||
126794329|NCT00550537|456204272|FG000|Overall Study|Death|18|||
126794330|NCT00550537|456204272|FG000|Overall Study|Adverse Event|20|||
126794331|NCT00550537|456204272|FG000|Overall Study|Disease progression before|46|||
126794332|NCT00550537|456204272|FG000|Overall Study|Withdrawal by Subject|7|||
126794333|NCT00550537|456204272|FG000|Overall Study|Change in treatment plan|4|||
126794334|NCT00550537|456204272|FG000|Overall Study|Other complicating ilness|3|||
126794335|NCT00550537|456204272|FG000|Overall Study|Declining performance status|2|||
126794336|NCT00550537|456204272|FG000|Overall Study|Treated closer to home|4|||
126794337|NCT00268905|456204273|FG000|Overall Study|Adverse Event|3|||
126794338|NCT00268905|456204274|FG001|Overall Study|Adverse Event|0|||
126794339|NCT00268905|456204275|FG002|Overall Study|Adverse Event|4|||
126794340|NCT00268905|456204273|FG000|Overall Study|Lost to Follow-up|0|||
126794341|NCT00268905|456204274|FG001|Overall Study|Lost to Follow-up|1|||
126794342|NCT00268905|456204275|FG002|Overall Study|Lost to Follow-up|0|||
126794343|NCT00268905|456204273|FG000|Overall Study|Withdrawal by Subject|0|||
126794344|NCT00268905|456204274|FG001|Overall Study|Withdrawal by Subject|0|||
126794345|NCT00268905|456204275|FG002|Overall Study|Withdrawal by Subject|3|||
126794346|NCT00268905|456204273|FG000|Overall Study|Progressive Disease|28|||
126794347|NCT00268905|456204274|FG001|Overall Study|Progressive Disease|4|||
126794348|NCT00268905|456204275|FG002|Overall Study|Progressive Disease|3|||
126794349|NCT00268905|456204273|FG000|Overall Study|Physician Decision|3|||
126794350|NCT00268905|456204274|FG001|Overall Study|Physician Decision|0|||
126794351|NCT00268905|456204275|FG002|Overall Study|Physician Decision|1|||
126794352|NCT00268905|456204273|FG000|Overall Study|Clinical Progression|9|||
126794353|NCT00268905|456204274|FG001|Overall Study|Clinical Progression|4|||
126794354|NCT00268905|456204275|FG002|Overall Study|Clinical Progression|1|||
126794355|NCT00617305|456204276|FG000|Overall Study|Adverse Event|4|||
126794356|NCT00617305|456204277|FG001|Overall Study|Adverse Event|0|||
126794357|NCT00617305|456204278|FG002|Overall Study|Adverse Event|0|||
126794358|NCT00617305|456204276|FG000|Overall Study|Death|1|||
126794359|NCT00617305|456204277|FG001|Overall Study|Death|0|||
126794360|NCT00617305|456204278|FG002|Overall Study|Death|0|||
126794361|NCT00617305|456204276|FG000|Overall Study|Physician Decision|1|||
126794362|NCT00617305|456204277|FG001|Overall Study|Physician Decision|0|||
126794363|NCT00617305|456204278|FG002|Overall Study|Physician Decision|0|||
126794364|NCT00617305|456204276|FG000|Overall Study|Protocol Violation|1|||
126794365|NCT00617305|456204277|FG001|Overall Study|Protocol Violation|0|||
126794366|NCT00617305|456204278|FG002|Overall Study|Protocol Violation|1|||
126794367|NCT00617305|456204276|FG000|Overall Study|Withdrawal by Subject|1|||
126794368|NCT00617305|456204277|FG001|Overall Study|Withdrawal by Subject|0|||
126794369|NCT00617305|456204278|FG002|Overall Study|Withdrawal by Subject|0|||
126794370|NCT04510285|456204279|FG000|Overall Study|Death|1|||
126794371|NCT03897088|456204282|FG000|Overall Study|Withdrawal by Subject|12|||
126794372|NCT03897088|456204283|FG001|Overall Study|Withdrawal by Subject|12|||
126794373|NCT03897088|456204282|FG000|Overall Study|Lost to Follow-up|7|||
126794374|NCT03897088|456204283|FG001|Overall Study|Lost to Follow-up|15|||
126794375|NCT03897088|456204282|FG000|Overall Study|Sponsor Decision|1|||
126794376|NCT03897088|456204283|FG001|Overall Study|Sponsor Decision|2|||
126794377|NCT03897088|456204282|FG000|Overall Study|COVID-19|2|||
126794378|NCT03897088|456204283|FG001|Overall Study|COVID-19|0|||
126794379|NCT03897088|456204282|FG000|Overall Study|Other|3|||
126794380|NCT03897088|456204283|FG001|Overall Study|Other|0|||
126794381|NCT03897088|456204282|FG000|Overall Study|Non-compliance with Study Drug|1|||
126794382|NCT03897088|456204283|FG001|Overall Study|Non-compliance with Study Drug|1|||
126794383|NCT03897088|456204282|FG000|Overall Study|Pregnancy|0|||
126794384|NCT03897088|456204283|FG001|Overall Study|Pregnancy|1|||
126794385|NCT02392000|456204286|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
126794386|NCT02392000|456204286|FG000|Overall Study|Withdrawal by Subject|1|||
126794387|NCT02392000|456204286|FG000|Overall Study|Lost to Follow-up|8|||
126794388|NCT04384978|456204287|FG000|Overall Study|Withdrawal by Subject|4|||
126794389|NCT04384978|456204288|FG001|Overall Study|Withdrawal by Subject|0|||
126794390|NCT03555305|456204289|FG000|Period 1|Physician Decision|0|||
126794391|NCT03555305|456204290|FG001|Period 1|Physician Decision|1|||
126794392|NCT03555305|456204289|FG000|Period 1|Adverse Event|0|||
126794393|NCT03555305|456204290|FG001|Period 1|Adverse Event|1|||
126794394|NCT03586726|456204296|FG000|Overall Study|Withdrawal by Subject|1|||
126794395|NCT02100228|456204299|FG000|Overall Study|Other|19|||
126794396|NCT02100228|456204300|FG001|Overall Study|Other|19|||
126794397|NCT02100228|456204299|FG000|Overall Study|Administrative reason|0|||
126794398|NCT02100228|456204300|FG001|Overall Study|Administrative reason|1|||
126794399|NCT02100228|456204299|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
126794400|NCT02100228|456204300|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
126794401|NCT02100228|456204299|FG000|Overall Study|Non-compliance|0|||
126794402|NCT02100228|456204300|FG001|Overall Study|Non-compliance|3|||
126794403|NCT02100228|456204299|FG000|Overall Study|Lost to Follow-up|0|||
126794404|NCT02100228|456204300|FG001|Overall Study|Lost to Follow-up|1|||
126794405|NCT02100228|456204299|FG000|Overall Study|Withdrawal by Subject|27|||
126794406|NCT02100228|456204300|FG001|Overall Study|Withdrawal by Subject|37|||
126794407|NCT02100228|456204299|FG000|Overall Study|Adverse Event|16|||
126794408|NCT02100228|456204300|FG001|Overall Study|Adverse Event|12|||
126794409|NCT02100228|456204299|FG000|Overall Study|Death|1|||
126794410|NCT02100228|456204300|FG001|Overall Study|Death|1|||
126794411|NCT00854100|456204314|FG000|Overall Study|Inability to complete the study visits|0|||
126794412|NCT00854100|456204315|FG001|Overall Study|Inability to complete the study visits|0|||
126794413|NCT00854100|456204316|FG002|Overall Study|Inability to complete the study visits|1|||
126794414|NCT00854100|456204314|FG000|Overall Study|Lost to Follow-up|2|||
126794415|NCT00854100|456204315|FG001|Overall Study|Lost to Follow-up|0|||
126794416|NCT00854100|456204316|FG002|Overall Study|Lost to Follow-up|3|||
126794417|NCT00854100|456204314|FG000|Overall Study|Withdrawal by Subject|3|||
126794418|NCT00854100|456204315|FG001|Overall Study|Withdrawal by Subject|1|||
126794419|NCT00854100|456204316|FG002|Overall Study|Withdrawal by Subject|2|||
126794420|NCT00854100|456204314|FG000|Overall Study|Protocol Violation|2|||
126794421|NCT00854100|456204315|FG001|Overall Study|Protocol Violation|4|||
126794422|NCT00854100|456204316|FG002|Overall Study|Protocol Violation|3|||
126794423|NCT00854100|456204314|FG000|Overall Study|Adverse Event|2|||
126794424|NCT00854100|456204315|FG001|Overall Study|Adverse Event|1|||
126794425|NCT00854100|456204316|FG002|Overall Study|Adverse Event|2|||
126794426|NCT02216071|456204328|FG000|Overall Study|Withdrawal by Subject|7|||
126794427|NCT02216071|456204329|FG001|Overall Study|Withdrawal by Subject|2|||
126794428|NCT02216071|456204328|FG000|Overall Study|Lost to Follow-up|3|||
126794429|NCT02216071|456204329|FG001|Overall Study|Lost to Follow-up|3|||
126794430|NCT02216071|456204328|FG000|Overall Study|Protocol Violation|3|||
126794431|NCT02216071|456204329|FG001|Overall Study|Protocol Violation|5|||
126794432|NCT02216071|456204328|FG000|Overall Study|Other|2|||
126794433|NCT02216071|456204329|FG001|Overall Study|Other|2|||
126794434|NCT00389064|456204330|FG000|Overall Study|Adverse Event|11|||
126794435|NCT00389064|456204331|FG001|Overall Study|Adverse Event|3|||
126794436|NCT00389064|456204330|FG000|Overall Study|Lack of Efficacy|3|||
126794437|NCT00389064|456204331|FG001|Overall Study|Lack of Efficacy|14|||
126794438|NCT00389064|456204330|FG000|Overall Study|Withdrawal by Subject|17|||
126794439|NCT00389064|456204331|FG001|Overall Study|Withdrawal by Subject|27|||
126794440|NCT00389064|456204330|FG000|Overall Study|Physician Decision|2|||
126794441|NCT00389064|456204331|FG001|Overall Study|Physician Decision|2|||
126794442|NCT00389064|456204330|FG000|Overall Study|Lost to Follow-up|1|||
126794443|NCT00389064|456204331|FG001|Overall Study|Lost to Follow-up|2|||
126794444|NCT00389064|456204330|FG000|Overall Study|Protocol Violation|2|||
126794445|NCT00389064|456204331|FG001|Overall Study|Protocol Violation|0|||
126794446|NCT00389064|456204330|FG000|Overall Study|Multiple Reasons|9|||
126794447|NCT00389064|456204331|FG001|Overall Study|Multiple Reasons|11|||
126794448|NCT01811953|456205720|FG000|Overall Study|Adverse Event|0|||
126794449|NCT01811953|456205721|FG001|Overall Study|Adverse Event|0|||
126794450|NCT01811953|456205722|FG002|Overall Study|Adverse Event|0|||
126794451|NCT01811953|456205723|FG003|Overall Study|Adverse Event|1|||
126794452|NCT01811953|456205724|FG004|Overall Study|Adverse Event|0|||
126794453|NCT01811953|456205725|FG005|Overall Study|Adverse Event|1|||
126794454|NCT01811953|456205720|FG000|Overall Study|Protocol Violation|0|||
126794455|NCT01811953|456205721|FG001|Overall Study|Protocol Violation|0|||
126794456|NCT01811953|456205722|FG002|Overall Study|Protocol Violation|0|||
126794457|NCT01811953|456205723|FG003|Overall Study|Protocol Violation|0|||
126794458|NCT01811953|456205724|FG004|Overall Study|Protocol Violation|1|||
126794459|NCT01811953|456205725|FG005|Overall Study|Protocol Violation|0|||
126794460|NCT00371839|456205727|FG000|Overall Study|Death|4|||
126794461|NCT00371839|456205728|FG001|Overall Study|Death|0|||
126794462|NCT00371839|456205729|FG002|Overall Study|Death|0|||
126794463|NCT00371839|456205727|FG000|Overall Study|Withdrawal by Subject|7|||
126794464|NCT00371839|456205728|FG001|Overall Study|Withdrawal by Subject|4|||
126794465|NCT00371839|456205729|FG002|Overall Study|Withdrawal by Subject|0|||
126794466|NCT00371839|456205727|FG000|Overall Study|Lost to Follow-up|6|||
126794467|NCT00371839|456205728|FG001|Overall Study|Lost to Follow-up|3|||
126794468|NCT00371839|456205729|FG002|Overall Study|Lost to Follow-up|2|||
126794469|NCT01049334|456205731|FG000|Overall Study|Withdrawal by Subject|5|||
126794470|NCT01049334|456205732|FG001|Overall Study|Withdrawal by Subject|3|||
126794471|NCT01049334|456205731|FG000|Overall Study|Adverse Event|2|||
126794472|NCT01049334|456205732|FG001|Overall Study|Adverse Event|3|||
126794473|NCT01049334|456205731|FG000|Overall Study|Physician Decision|2|||
126794474|NCT01049334|456205732|FG001|Overall Study|Physician Decision|0|||
126794475|NCT01049334|456205731|FG000|Overall Study|Protocol Violation|0|||
126794476|NCT01049334|456205732|FG001|Overall Study|Protocol Violation|1|||
126794477|NCT00667095|456205740|FG000|Overall Study|Withdrawal by Subject|0|||
126794478|NCT00667095|456205741|FG001|Overall Study|Withdrawal by Subject|1|||
126794479|NCT03447262|456205742|FG000|Overall Study|Adverse Event|7|||
126794480|NCT03447262|456205742|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
126794481|NCT03447262|456205742|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
126794482|NCT03447262|456205742|FG000|Overall Study|Death|2|||
126794483|NCT03447262|456205742|FG000|Overall Study|Study Termination by Sponsor|455|||
126794484|NCT03447262|456205742|FG000|Overall Study|Other|4|||
126794485|NCT03351335|456205746|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
126794486|NCT03351335|456205747|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
126794487|NCT03351335|456205748|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
126794488|NCT00469417|456205749|FG000|Overall Study|Treatment failure all lesions|18|||
126794489|NCT00469417|456205750|FG001|Overall Study|Treatment failure all lesions|11|||
126794490|NCT00469417|456205749|FG000|Overall Study|Consent withdrawn|1|||
126794491|NCT00469417|456205750|FG001|Overall Study|Consent withdrawn|1|||
126794492|NCT00469417|456205749|FG000|Overall Study|Adverse Event|8|||
126794493|NCT00469417|456205750|FG001|Overall Study|Adverse Event|2|||
126794494|NCT00469417|456205749|FG000|Overall Study|Lost to Follow-up|1|||
126794495|NCT00469417|456205750|FG001|Overall Study|Lost to Follow-up|2|||
126794496|NCT00469417|456205749|FG000|Overall Study|Intercurrent disease|0|||
126794497|NCT00469417|456205750|FG001|Overall Study|Intercurrent disease|1|||
126794498|NCT00469417|456205749|FG000|Overall Study|Randomized but not treated|2|||
126794499|NCT00469417|456205750|FG001|Overall Study|Randomized but not treated|0|||
126794500|NCT05612724|456205754|FG000|Overall Study|Lost to Follow-up|4|||
126794501|NCT04000815|456205757|FG000|Overall Study|Lost to Follow-up|9|||
126794502|NCT04000815|456205758|FG001|Overall Study|Lost to Follow-up|2|||
126794503|NCT04000815|456205759|FG002|Overall Study|Lost to Follow-up|3|||
126794504|NCT04000815|456205757|FG000|Overall Study|Withdrawal by Subject|4|||
126794505|NCT04000815|456205758|FG001|Overall Study|Withdrawal by Subject|3|||
126794506|NCT04000815|456205759|FG002|Overall Study|Withdrawal by Subject|2|||
126794507|NCT04000815|456205757|FG000|Overall Study|Right ovarian cyst occured|1|||
126794508|NCT04000815|456205758|FG001|Overall Study|Right ovarian cyst occured|0|||
126794509|NCT04000815|456205759|FG002|Overall Study|Right ovarian cyst occured|0|||
126794510|NCT04000815|456205757|FG000|Overall Study|Hypertension occured on follow up|0|||
126794511|NCT04000815|456205758|FG001|Overall Study|Hypertension occured on follow up|0|||
126794512|NCT04000815|456205759|FG002|Overall Study|Hypertension occured on follow up|2|||
126794513|NCT00239577|456205760|FG000|Primary Phase|Adverse Event|0|||
126794514|NCT00239577|456205761|FG001|Primary Phase|Adverse Event|0|||
126794515|NCT00239577|456205762|FG002|Primary Phase|Adverse Event|1|||
126794516|NCT00239577|456205763|FG003|Primary Phase|Adverse Event|0|||
126794517|NCT00239577|456205760|FG000|Primary Phase|Other|5|||
126794518|NCT00239577|456205761|FG001|Primary Phase|Other|3|||
126794519|NCT00239577|456205762|FG002|Primary Phase|Other|2|||
126794520|NCT00239577|456205763|FG003|Primary Phase|Other|0|||
126794521|NCT02736721|456205766|FG000|Overall Study|Adverse Event|8|||
126794522|NCT02736721|456205766|FG000|Overall Study|Lost to Follow-up|3|||
126794523|NCT02736721|456205766|FG000|Overall Study|Other|5|||
126794524|NCT03988803|456205767|FG000|Period 2|Prematurely discontinued from medication|2|||
126794525|NCT03988803|456205767|FG000|Period 2|Adverse Event|1|||
126794526|NCT03021018|456205768|FG000|Overall Study|Adverse Event|1|||
126794527|NCT03021018|456205769|FG001|Overall Study|Adverse Event|0|||
126794528|NCT03021018|456205770|FG002|Overall Study|Adverse Event|0|||
126794529|NCT03021018|456205768|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
126794530|NCT03021018|456205769|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
126794531|NCT03021018|456205770|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
126794532|NCT00620074|456205781|FG000|Overall Study|Adverse Event|1|||
126794533|NCT00573066|456205782|FG000|Overall Study|Exclusion criteria|18|||
126794534|NCT00573066|456205782|FG000|Overall Study|IV malfunction|1|||
126794535|NCT00573066|456205782|FG000|Overall Study|Postoperative bleeding|1|||
126794536|NCT01838941|456205783|FG000|Overall Study|Adverse Event|1|||
126794537|NCT01838941|456205783|FG000|Overall Study|Withdrawal by Subject|1|||
126794538|NCT02822235|456205784|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
126794539|NCT02822235|456205785|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
126794540|NCT02822235|456205784|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
126794541|NCT02822235|456205785|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
126794542|NCT02822235|456205784|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
126794543|NCT02822235|456205785|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
126794544|NCT02822235|456205784|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
126794545|NCT02822235|456205785|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
126794546|NCT02822235|456205784|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
126794547|NCT02822235|456205785|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
126794548|NCT02822235|456205784|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
126794549|NCT02822235|456205785|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
126794550|NCT03214952|456205786|FG000|Overall Study|Protocol Deviation|45|||
126794551|NCT03214952|456205786|FG000|Overall Study|Case Report Forms Uncollected|13|||
126794552|NCT03769896|456205789|FG000|Open-label Phase|Lack of Efficacy|5|||
126794553|NCT03769896|456205790|FG001|Open-label Phase|Lack of Efficacy|0|||
126794554|NCT03769896|456205789|FG000|Open-label Phase|Adverse Event|3|||
126794555|NCT03769896|456205790|FG001|Open-label Phase|Adverse Event|0|||
126794556|NCT03769896|456205789|FG000|Open-label Phase|Withdrawal by Subject|1|||
126794557|NCT03769896|456205790|FG001|Open-label Phase|Withdrawal by Subject|0|||
126794558|NCT00377260|456205791|FG000|Overall Study|Lost to Follow-up|0|||
126794559|NCT00377260|456205792|FG001|Overall Study|Lost to Follow-up|1|||
126794560|NCT00377260|456205791|FG000|Overall Study|Withdrawal by Subject|2|||
126794561|NCT00377260|456205792|FG001|Overall Study|Withdrawal by Subject|4|||
126794562|NCT00829530|456205793|FG000|First Intervention|Adverse Event|0|||
126794563|NCT00829530|456205794|FG001|First Intervention|Adverse Event|1|||
126794564|NCT00829530|456205793|FG000|First Intervention|Intolerance to Venopuncture|0|||
126794565|NCT00829530|456205794|FG001|First Intervention|Intolerance to Venopuncture|1|||
126794566|NCT00829530|456205793|FG000|Second Intervention|Intolerance to Venopuncture|1|||
126794567|NCT00829530|456205794|FG001|Second Intervention|Intolerance to Venopuncture|0|||
126794568|NCT04112823|456205797|FG000|Overall Study|Lost to Follow-up|2|||
126794569|NCT04112823|456205798|FG001|Overall Study|Lost to Follow-up|3|||
126794570|NCT00625443|456205799|FG000|Overall Study|Adverse Event|1|||
126794571|NCT00625443|456205800|FG001|Overall Study|Adverse Event|4|||
126794572|NCT00625443|456205801|FG002|Overall Study|Adverse Event|0|||
126794573|NCT00625443|456205799|FG000|Overall Study|Non-compliance with protocol|0|||
126794574|NCT00625443|456205800|FG001|Overall Study|Non-compliance with protocol|1|||
126794575|NCT00625443|456205801|FG002|Overall Study|Non-compliance with protocol|0|||
126794576|NCT00625443|456205799|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
126794577|NCT00625443|456205800|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
126794578|NCT00625443|456205801|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
126794579|NCT00625443|456205799|FG000|Overall Study|Withdrawal by Subject|0|||
126794580|NCT00625443|456205800|FG001|Overall Study|Withdrawal by Subject|1|||
126794581|NCT00625443|456205801|FG002|Overall Study|Withdrawal by Subject|2|||
126794582|NCT00625443|456205799|FG000|Overall Study|Physician Decision|0|||
126794583|NCT00625443|456205800|FG001|Overall Study|Physician Decision|4|||
126794584|NCT00625443|456205801|FG002|Overall Study|Physician Decision|2|||
126794585|NCT00625443|456205799|FG000|Overall Study|Other|0|||
126794586|NCT00625443|456205800|FG001|Overall Study|Other|1|||
126794587|NCT00625443|456205801|FG002|Overall Study|Other|1|||
126794588|NCT02924883|456205802|FG000|Overall Study|Death|39|||
126794589|NCT02924883|456205803|FG001|Overall Study|Death|20|||
126794590|NCT02924883|456205802|FG000|Overall Study|Lost to Follow-up|1|||
126794591|NCT02924883|456205803|FG001|Overall Study|Lost to Follow-up|0|||
126794592|NCT02924883|456205802|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
126794593|NCT02924883|456205803|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
126794594|NCT02924883|456205802|FG000|Overall Study|Protocol Violation|1|||
126794595|NCT02924883|456205803|FG001|Overall Study|Protocol Violation|0|||
126794596|NCT02924883|456205802|FG000|Overall Study|Withdrawal by Subject|22|||
126794597|NCT02924883|456205803|FG001|Overall Study|Withdrawal by Subject|16|||
126794598|NCT02924883|456205802|FG000|Overall Study|Progressive Disease|1|||
126794599|NCT02924883|456205803|FG001|Overall Study|Progressive Disease|0|||
126794600|NCT02924883|456205802|FG000|Overall Study|Study Terminated by Sponsor|69|||
126794601|NCT02924883|456205803|FG001|Overall Study|Study Terminated by Sponsor|32|||
126794602|NCT01422538|456205808|FG000|Overall Study|Lost to Follow-up|0|||
126794603|NCT01422538|456205809|FG001|Overall Study|Lost to Follow-up|1|||
126794604|NCT01422538|456205810|FG002|Overall Study|Lost to Follow-up|1|||
126794605|NCT01422538|456205808|FG000|Overall Study|Missed visit|0|||
126794606|NCT01422538|456205809|FG001|Overall Study|Missed visit|1|||
126794607|NCT01422538|456205810|FG002|Overall Study|Missed visit|1|||
126794608|NCT00772941|456205812|FG000|Overall Study|CRFs not available|195|||
126794609|NCT00772941|456205812|FG000|Overall Study|Study not completed|16|||
126794610|NCT00772941|456205812|FG000|Overall Study|Missed Visits|374|||
126794611|NCT00772941|456205812|FG000|Overall Study|Poor Compliance|7|||
126794612|NCT00772941|456205812|FG000|Overall Study|GPSP Violation|90|||
126794613|NCT04786184|456205813|FG000|Overall Study|Adverse Event|4|||
126794614|NCT04786184|456205814|FG001|Overall Study|Adverse Event|0|||
126794615|NCT04786184|456205813|FG000|Overall Study|Withdrawal by Subject|3|||
126794616|NCT04786184|456205814|FG001|Overall Study|Withdrawal by Subject|1|||
126794617|NCT04786184|456205813|FG000|Overall Study|Lost to Follow-up|4|||
126794618|NCT04786184|456205814|FG001|Overall Study|Lost to Follow-up|2|||
126794619|NCT01534520|456205824|FG000|Overall Study|Adverse Event|0|||
126794620|NCT01534520|456205825|FG001|Overall Study|Adverse Event|1|||
126794621|NCT03459807|456205829|FG000|Overall Study|Withdrawal due to transplant|0|||
126794622|NCT03459807|456205830|FG001|Overall Study|Withdrawal due to transplant|1|||
126794623|NCT01406795|456205831|FG000|Overall Study|Withdrawal by Subject|1|||
126794624|NCT00855738|456205834|FG000|Overall Study|Lost to Follow-up|2|||
126794625|NCT00855738|456205834|FG000|Overall Study|Adverse Event|1|||
126794626|NCT00855738|456205834|FG000|Overall Study|Subject Defaulted|1|||
126794627|NCT00855738|456205834|FG000|Overall Study|Death|1|||
126794628|NCT03707912|456205837|FG000|Overall Study|Violation of inclusion criteria|1|||
126794629|NCT03707912|456205838|FG001|Overall Study|Violation of inclusion criteria|0|||
126794630|NCT01802320|456205839|FG000|Overall Study|Death|1|||
126794631|NCT01802320|456205839|FG000|Overall Study|Withdrawal by Subject|1|||
126794632|NCT01066143|456207404|FG000|Overall Study|ineligible for the study|8|||
126794633|NCT00942968|456207405|FG000|Overall Study|Adverse Event|60|||
126794634|NCT00942968|456207405|FG000|Overall Study|Death|76|||
126632844|NCT00891046|455615663|FG002|Overall Study|Withdrawal by Subject|2|||
126632845|NCT00891046|455615664|FG003|Overall Study|Withdrawal by Subject|1|||
126632846|NCT00891046|455615665|FG004|Overall Study|Withdrawal by Subject|1|||
126632847|NCT00891046|455615661|FG000|Overall Study|Lost to Follow-up|0|||
126632848|NCT00891046|455615662|FG001|Overall Study|Lost to Follow-up|0|||
126632849|NCT00891046|455615663|FG002|Overall Study|Lost to Follow-up|0|||
126632850|NCT00891046|455615664|FG003|Overall Study|Lost to Follow-up|0|||
126632851|NCT00891046|455615665|FG004|Overall Study|Lost to Follow-up|1|||
126632852|NCT04523207|455615668|FG000|Overall Study|Adverse Event|5|||
126632853|NCT04523207|455615669|FG001|Overall Study|Adverse Event|1|||
126632854|NCT04523207|455615668|FG000|Overall Study|Lost to Follow-up|2|||
126632855|NCT04523207|455615669|FG001|Overall Study|Lost to Follow-up|0|||
126794635|NCT00942968|456207405|FG000|Overall Study|Protocol Violation|9|||
126632856|NCT04523207|455615668|FG000|Overall Study|Withdrawal by Subject|2|||
126632857|NCT04523207|455615669|FG001|Overall Study|Withdrawal by Subject|0|||
126632858|NCT04523207|455615668|FG000|Overall Study|Progressive Disease|2|||
126632859|NCT04523207|455615669|FG001|Overall Study|Progressive Disease|1|||
126632860|NCT04523207|455615668|FG000|Overall Study|Other|7|||
126632861|NCT04523207|455615669|FG001|Overall Study|Other|1|||
126632862|NCT03113383|455615670|FG000|Overall Study|Death|4|||
126632863|NCT03113383|455615671|FG001|Overall Study|Death|0|||
126632864|NCT02053610|455615673|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
126632865|NCT02053610|455615674|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
126794636|NCT00942968|456207405|FG000|Overall Study|Lost to Follow-up|4|||
126794637|NCT00942968|456207405|FG000|Overall Study|Withdrawal by Subject|44|||
126794638|NCT00942968|456207405|FG000|Overall Study|Sponsor request|5|||
126794639|NCT00942968|456207405|FG000|Overall Study|Physician Decision|11|||
126794640|NCT00942968|456207405|FG000|Overall Study|Progression of disease|12|||
126632866|NCT02053610|455615673|FG000|Overall Study|Withdrew Consent|2|||
126632867|NCT02053610|455615674|FG001|Overall Study|Withdrew Consent|9|||
126632868|NCT02053610|455615673|FG000|Overall Study|Death|5|||
126632869|NCT02053610|455615674|FG001|Overall Study|Death|5|||
126632870|NCT02053610|455615673|FG000|Overall Study|Administrative/Other|1|||
126632871|NCT02053610|455615674|FG001|Overall Study|Administrative/Other|1|||
126632872|NCT02053610|455615673|FG000|Overall Study|Disease Progression|2|||
126632873|NCT02053610|455615674|FG001|Overall Study|Disease Progression|3|||
126632874|NCT02053610|455615673|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
126632875|NCT02053610|455615674|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
126632876|NCT02053610|455615673|FG000|Overall Study|Did not Receive Treatment|4|||
126632877|NCT02053610|455615674|FG001|Overall Study|Did not Receive Treatment|2|||
126632878|NCT02053610|455615673|FG000|Overall Study|Insufficient Therapeutic Response|1|||
126794641|NCT00942968|456207405|FG000|Overall Study|Inferior vena cava filter placement|4|||
126794642|NCT00942968|456207405|FG000|Overall Study|Pulmonary embolism (PE)|1|||
126794643|NCT00942968|456207405|FG000|Overall Study|Participant required pancreatic biopsy|1|||
126794644|NCT00942968|456207405|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
126794645|NCT01466166|456207408|FG000|Overall Study|Death|1|||
126794646|NCT01466166|456207408|FG000|Overall Study|Lost to Follow-up|7|||
126794647|NCT01466166|456207408|FG000|Overall Study|Infusion Reaction (IR)|27|||
126794648|NCT01466166|456207408|FG000|Overall Study|Adverse Event (Other than IR)|11|||
126794649|NCT01466166|456207408|FG000|Overall Study|Elevated Serum Uric Acid|78|||
126794650|NCT01466166|456207408|FG000|Overall Study|Withdrawal by Subject|13|||
126794651|NCT01466166|456207408|FG000|Overall Study|Sponsor Decision|4|||
126794652|NCT01466166|456207408|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
126794653|NCT01466166|456207408|FG000|Overall Study|Other|20|||
126794654|NCT01340495|456207411|FG000|Overall Study|Withdrawal by Subject|1|||
126632879|NCT02053610|455615674|FG001|Overall Study|Insufficient Therapeutic Response|1|||
126794655|NCT00667862|456207414|FG000|Overall Study|Adverse Event|9|||
126794656|NCT00667862|456207414|FG000|Overall Study|Death|1|||
126794657|NCT00667862|456207414|FG000|Overall Study|Disease Progression|22|||
126794658|NCT00667862|456207414|FG000|Overall Study|Withdrawal by Subject|3|||
126794659|NCT02495857|456207416|FG000|Overall Study|Adverse Event|5|||
126794660|NCT02495857|456207417|FG001|Overall Study|Adverse Event|0|||
126794661|NCT02495857|456207418|FG002|Overall Study|Adverse Event|1|||
126794662|NCT02495857|456207416|FG000|Overall Study|Withdrawal by Subject|9|||
126794663|NCT02495857|456207417|FG001|Overall Study|Withdrawal by Subject|6|||
126794664|NCT02495857|456207418|FG002|Overall Study|Withdrawal by Subject|10|||
126794665|NCT02495857|456207416|FG000|Overall Study|Physician Decision|0|||
126794666|NCT02495857|456207417|FG001|Overall Study|Physician Decision|1|||
126794667|NCT02495857|456207418|FG002|Overall Study|Physician Decision|0|||
126794668|NCT02495857|456207416|FG000|Overall Study|Protocol Violation|1|||
126794669|NCT02495857|456207417|FG001|Overall Study|Protocol Violation|1|||
126794670|NCT02495857|456207418|FG002|Overall Study|Protocol Violation|2|||
126794671|NCT02495857|456207416|FG000|Overall Study|Lost to Follow-up|4|||
126794672|NCT02495857|456207417|FG001|Overall Study|Lost to Follow-up|5|||
126794673|NCT02495857|456207418|FG002|Overall Study|Lost to Follow-up|3|||
126794674|NCT02495857|456207416|FG000|Overall Study|Other|3|||
126794675|NCT02495857|456207417|FG001|Overall Study|Other|3|||
126794676|NCT02495857|456207418|FG002|Overall Study|Other|2|||
126794677|NCT00396279|456207419|FG000|Overall Study|Ongoing in study|26|||
126794678|NCT00396279|456207419|FG000|Overall Study|Disease progression|2|||
126794679|NCT00396279|456207419|FG000|Overall Study|Withdrawal by Subject|1|||
126794680|NCT00396279|456207419|FG000|Overall Study|Physician Decision|1|||
126794681|NCT02883452|456207420|FG000|Overall Study|Withdrawal by Subject|1|||
126794682|NCT02883452|456207421|FG001|Overall Study|Withdrawal by Subject|1|||
126794683|NCT02883452|456207422|FG002|Overall Study|Withdrawal by Subject|3|||
126794684|NCT02883452|456207423|FG003|Overall Study|Withdrawal by Subject|0|||
126794685|NCT02883452|456207424|FG004|Overall Study|Withdrawal by Subject|2|||
126794686|NCT02883452|456207425|FG005|Overall Study|Withdrawal by Subject|5|||
126794687|NCT02883452|456207420|FG000|Overall Study|Disease progression|1|||
126794688|NCT02883452|456207421|FG001|Overall Study|Disease progression|0|||
126794689|NCT02883452|456207422|FG002|Overall Study|Disease progression|0|||
126794690|NCT02883452|456207423|FG003|Overall Study|Disease progression|1|||
126794691|NCT02883452|456207424|FG004|Overall Study|Disease progression|4|||
126794692|NCT02883452|456207425|FG005|Overall Study|Disease progression|5|||
126794693|NCT02883452|456207420|FG000|Overall Study|Adverse Event|2|||
126794694|NCT02883452|456207421|FG001|Overall Study|Adverse Event|1|||
126794695|NCT02883452|456207422|FG002|Overall Study|Adverse Event|1|||
126632880|NCT02053610|455615673|FG000|Overall Study|Violation of Selection Criteria|1|||
126632881|NCT02053610|455615674|FG001|Overall Study|Violation of Selection Criteria|0|||
126794696|NCT02883452|456207423|FG003|Overall Study|Adverse Event|1|||
126632882|NCT00543062|455615678|FG000|Overall Study|Withdrawal by Subject|1|||
126794697|NCT02883452|456207424|FG004|Overall Study|Adverse Event|1|||
126794698|NCT02883452|456207425|FG005|Overall Study|Adverse Event|3|||
126794699|NCT02883452|456207420|FG000|Overall Study|Physician Decision|0|||
126794700|NCT02883452|456207421|FG001|Overall Study|Physician Decision|0|||
126794701|NCT02883452|456207422|FG002|Overall Study|Physician Decision|0|||
126794702|NCT02883452|456207423|FG003|Overall Study|Physician Decision|0|||
126794703|NCT02883452|456207424|FG004|Overall Study|Physician Decision|4|||
126794704|NCT02883452|456207425|FG005|Overall Study|Physician Decision|1|||
126794705|NCT02883452|456207420|FG000|Overall Study|Death|1|||
126794706|NCT02883452|456207421|FG001|Overall Study|Death|0|||
126794707|NCT02883452|456207422|FG002|Overall Study|Death|1|||
126794708|NCT02883452|456207423|FG003|Overall Study|Death|0|||
126794709|NCT02883452|456207424|FG004|Overall Study|Death|0|||
126794710|NCT02883452|456207425|FG005|Overall Study|Death|0|||
126794711|NCT02883452|456207420|FG000|Overall Study|Other|0|||
126794712|NCT02883452|456207421|FG001|Overall Study|Other|0|||
126794713|NCT02883452|456207422|FG002|Overall Study|Other|0|||
126794714|NCT02883452|456207423|FG003|Overall Study|Other|0|||
126794715|NCT02883452|456207424|FG004|Overall Study|Other|0|||
126794716|NCT02883452|456207425|FG005|Overall Study|Other|1|||
126794717|NCT00830206|456207426|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
126794718|NCT00830206|456207427|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
126794719|NCT00905346|456207429|FG000|Period 1|Withdrawal by Subject|1|||
126794720|NCT00905346|456207430|FG001|Period 1|Withdrawal by Subject|0|||
126794721|NCT01435265|456207431|FG000|Overall Study|Lost to Follow-up|0|||
126794722|NCT01435265|456207432|FG001|Overall Study|Lost to Follow-up|1|||
126794723|NCT02724462|456207433|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
126794724|NCT02724462|456207434|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
126794725|NCT02724462|456207433|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
126794726|NCT02724462|456207434|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
126794727|NCT02724462|456207433|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
126794728|NCT02724462|456207434|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
126794729|NCT02724462|456207433|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
126794730|NCT02724462|456207434|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
126794731|NCT02724462|456207433|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
126794732|NCT02724462|456207434|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
126794733|NCT02724462|456207433|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
126794734|NCT02724462|456207434|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
126794735|NCT01900691|456207435|FG000|Overall Study|Death|7|||
126794736|NCT01900691|456207435|FG000|Overall Study|Lost to Follow-up|4|||
126794737|NCT01900691|456207435|FG000|Overall Study|Study Device Not Placed|3|||
126794738|NCT01900691|456207435|FG000|Overall Study|Non study stent placed|2|||
126794739|NCT01900691|456207435|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
126794740|NCT01900691|456207435|FG000|Overall Study|Complete stent migration through digestive tract|1|||
126794741|NCT02128997|456207442|FG000|Overall Study|Lost to Follow-up|6|||
126794742|NCT02128997|456207443|FG001|Overall Study|Lost to Follow-up|11|||
126794743|NCT00328926|456207449|FG000|Overall Study|Pregnancy|2|||
126794744|NCT00328926|456207450|FG001|Overall Study|Pregnancy|1|||
126794745|NCT00328926|456207451|FG002|Overall Study|Pregnancy|0|||
126794746|NCT00328926|456207449|FG000|Overall Study|Lost to Follow-up|0|||
126794747|NCT00328926|456207450|FG001|Overall Study|Lost to Follow-up|1|||
126794748|NCT00328926|456207451|FG002|Overall Study|Lost to Follow-up|0|||
126794749|NCT00328926|456207449|FG000|Overall Study|Death|0|||
126794750|NCT00328926|456207450|FG001|Overall Study|Death|0|||
126794751|NCT00328926|456207451|FG002|Overall Study|Death|1|||
126794752|NCT00328926|456207449|FG000|Overall Study|In vitro fertilization treatment|0|||
126794753|NCT00328926|456207450|FG001|Overall Study|In vitro fertilization treatment|0|||
126794754|NCT00328926|456207451|FG002|Overall Study|In vitro fertilization treatment|1|||
126794755|NCT00328926|456207449|FG000|Overall Study|Lack of ovarian response|0|||
126794756|NCT00328926|456207450|FG001|Overall Study|Lack of ovarian response|1|||
126794757|NCT00328926|456207451|FG002|Overall Study|Lack of ovarian response|0|||
126794758|NCT02269657|456207452|FG000|Overall Study|Protocol Violation|3|||
126794759|NCT00851877|456207457|FG000|Phase I-1|Death|1|||
126794760|NCT00851877|456207458|FG001|Phase I-1|Death|0|||
126794761|NCT00851877|456207459|FG002|Phase I-1|Death|0|||
126794762|NCT00851877|456207457|FG000|Phase II|Withdrawal by Subject|0|||
126794763|NCT00851877|456207458|FG001|Phase II|Withdrawal by Subject|0|||
126794764|NCT00851877|456207459|FG002|Phase II|Withdrawal by Subject|3|||
126794765|NCT00829673|456207460|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
126794766|NCT00829673|456207461|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
126794767|NCT03450057|456207462|FG000|Overall Study|Death|17|||
126794768|NCT03450057|456207462|FG000|Overall Study|ICF withdrawal|4|||
126794769|NCT03450057|456207462|FG000|Overall Study|Lost to Follow-up|2|||
126794770|NCT02246166|456207463|FG000|Overall Study|Protocol Violation|1|||
126794771|NCT02246166|456207464|FG001|Overall Study|Protocol Violation|0|||
126794772|NCT01256684|456207467|FG000|Overall Study|Adverse Event|1|||
126794773|NCT01256684|456207468|FG001|Overall Study|Adverse Event|4|||
126794774|NCT01256684|456207469|FG002|Overall Study|Adverse Event|2|||
126794775|NCT01256684|456207467|FG000|Overall Study|Withdrawal by Subject|4|||
126794776|NCT01256684|456207468|FG001|Overall Study|Withdrawal by Subject|0|||
126794777|NCT01256684|456207469|FG002|Overall Study|Withdrawal by Subject|2|||
126794778|NCT01256684|456207467|FG000|Overall Study|Physician Decision|0|||
126794779|NCT01256684|456207468|FG001|Overall Study|Physician Decision|1|||
126794780|NCT01256684|456207469|FG002|Overall Study|Physician Decision|0|||
126794781|NCT01256684|456207467|FG000|Overall Study|Lack of Efficacy|0|||
126794782|NCT01256684|456207468|FG001|Overall Study|Lack of Efficacy|1|||
126794783|NCT01256684|456207469|FG002|Overall Study|Lack of Efficacy|1|||
126794784|NCT01256684|456207467|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
126794785|NCT01256684|456207468|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
126794786|NCT01256684|456207469|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
126794787|NCT02678286|456207471|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
126794788|NCT02678286|456207472|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
126794789|NCT02678286|456207471|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
126794790|NCT02678286|456207472|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
126794791|NCT02678286|456207471|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
126794792|NCT02678286|456207472|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
126794793|NCT02678286|456207471|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
126794794|NCT02678286|456207472|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
126794795|NCT02678286|456207471|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
126794796|NCT02678286|456207472|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
126794797|NCT01313273|456207473|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
126794798|NCT01313273|456207474|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
126794799|NCT01313273|456207473|FG000|Overall Study|Withdrawal by Subject|1|||
126794800|NCT01313273|456207474|FG001|Overall Study|Withdrawal by Subject|0|||
126794801|NCT01313273|456207473|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
126794802|NCT01313273|456207474|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
126794803|NCT03687736|456207475|FG000|Overall Study|Lost to Follow-up|7|||
126794804|NCT03687736|456207475|FG000|Overall Study|Withdrawal by Subject|3|||
126794805|NCT01270503|456207476|FG000|Overall Study|Lost to Follow-up|1|||
126794806|NCT02459951|456207477|FG000|Overall Study|Unable to meet holding requirement|1|||
126794807|NCT02255097|456207481|FG000|Overall Study|Death|151|||
126794808|NCT02255097|456207481|FG000|Overall Study|Lost to Follow-up|5|||
126794809|NCT02255097|456207481|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
126794810|NCT02255097|456207481|FG000|Overall Study|Withdrawal by Subject|7|||
126794811|NCT02255097|456207481|FG000|Overall Study|Allocated but not treated|1|||
126794812|NCT01010542|456207482|FG000|Overall Study|Adverse Event|0|||
126794813|NCT01010542|456207483|FG001|Overall Study|Adverse Event|1|||
126794814|NCT01010542|456207484|FG002|Overall Study|Adverse Event|0|||
126794815|NCT01010542|456207482|FG000|Overall Study|Lost to Follow-up|0|||
126794816|NCT01010542|456207483|FG001|Overall Study|Lost to Follow-up|1|||
126794817|NCT01010542|456207484|FG002|Overall Study|Lost to Follow-up|0|||
126794818|NCT01010542|456207482|FG000|Overall Study|Withdrawal by Subject|0|||
126794819|NCT01010542|456207483|FG001|Overall Study|Withdrawal by Subject|3|||
126794820|NCT01010542|456207484|FG002|Overall Study|Withdrawal by Subject|2|||
126794821|NCT01745120|456207487|FG000|Overall Study|Investigator decision|1|||
126794822|NCT01745120|456207488|FG001|Overall Study|Investigator decision|0|||
126794823|NCT03956862|456207489|FG000|Overall Study|Lost to Follow-up|1|||
126794824|NCT03956862|456207490|FG001|Overall Study|Lost to Follow-up|1|||
126794825|NCT03956862|456207489|FG000|Overall Study|Withdrawal by Subject|1|||
126794826|NCT03956862|456207490|FG001|Overall Study|Withdrawal by Subject|1|||
126794827|NCT00579670|456207493|FG000|Overall Study|Death|1|||
126794828|NCT00579670|456207494|FG001|Overall Study|Death|0|||
126794829|NCT00579670|456207495|FG002|Overall Study|Death|0|||
126794830|NCT00579670|456207496|FG003|Overall Study|Death|0|||
126794831|NCT00579670|456207497|FG004|Overall Study|Death|0|||
126794832|NCT00579670|456207493|FG000|Overall Study|Adverse Event|1|||
126794833|NCT00579670|456207494|FG001|Overall Study|Adverse Event|0|||
126794834|NCT00579670|456207495|FG002|Overall Study|Adverse Event|1|||
126794835|NCT00579670|456207496|FG003|Overall Study|Adverse Event|2|||
126794836|NCT00579670|456207497|FG004|Overall Study|Adverse Event|0|||
126794837|NCT00579670|456207493|FG000|Overall Study|Lack of Efficacy|0|||
126794838|NCT00579670|456207494|FG001|Overall Study|Lack of Efficacy|0|||
126794839|NCT00579670|456207495|FG002|Overall Study|Lack of Efficacy|1|||
126794840|NCT00579670|456207496|FG003|Overall Study|Lack of Efficacy|14|||
126794841|NCT00579670|456207497|FG004|Overall Study|Lack of Efficacy|0|||
126794842|NCT00579670|456207493|FG000|Overall Study|Lost to Follow-up|0|||
126794843|NCT00579670|456207494|FG001|Overall Study|Lost to Follow-up|1|||
126794844|NCT00579670|456207495|FG002|Overall Study|Lost to Follow-up|0|||
126794845|NCT00579670|456207496|FG003|Overall Study|Lost to Follow-up|4|||
126794846|NCT00579670|456207497|FG004|Overall Study|Lost to Follow-up|0|||
126794847|NCT00579670|456207493|FG000|Overall Study|Other|0|||
126794848|NCT00579670|456207494|FG001|Overall Study|Other|0|||
126794849|NCT00579670|456207495|FG002|Overall Study|Other|1|||
126794850|NCT00579670|456207496|FG003|Overall Study|Other|2|||
126794851|NCT00579670|456207497|FG004|Overall Study|Other|0|||
126794852|NCT00579670|456207493|FG000|Overall Study|Withdrawal by Subject|0|||
126794853|NCT00579670|456207494|FG001|Overall Study|Withdrawal by Subject|0|||
126794854|NCT00579670|456207495|FG002|Overall Study|Withdrawal by Subject|1|||
126794855|NCT00579670|456207496|FG003|Overall Study|Withdrawal by Subject|0|||
126794856|NCT00579670|456207497|FG004|Overall Study|Withdrawal by Subject|0|||
126794857|NCT00850174|456207501|FG000|Washout: One Week|Withdrawal by Subject|0|||
126794858|NCT00850174|456207502|FG001|Washout: One Week|Withdrawal by Subject|2|||
126794859|NCT00850174|456207501|FG000|Second Intervention|Withdrawal by Subject|1|||
126794860|NCT00850174|456207502|FG001|Second Intervention|Withdrawal by Subject|0|||
126794861|NCT01363765|456207503|FG000|Overall Study|non-diagnostic|2621|||
126794862|NCT01363765|456207504|FG001|Overall Study|non-diagnostic|1124|||
126794863|NCT01363765|456207503|FG000|Overall Study|duplicate records|736|||
126794864|NCT01363765|456207504|FG001|Overall Study|duplicate records|3177|||
126794865|NCT01363765|456207503|FG000|Overall Study|non-resident|156|||
126794866|NCT01363765|456207504|FG001|Overall Study|non-resident|76|||
126794867|NCT01363765|456207503|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
126794868|NCT01363765|456207504|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
126794869|NCT01363765|456207503|FG000|Overall Study|smear during intervention|2170|||
126794870|NCT01363765|456207504|FG001|Overall Study|smear during intervention|0|||
126794871|NCT01900626|456207505|FG000|Overall Study|study was closed due to low enrollment|1|||
126794872|NCT01900626|456207506|FG001|Overall Study|study was closed due to low enrollment|1|||
126794873|NCT00635492|456207507|FG000|Overall Study|Death|12|||
126794874|NCT00635492|456207508|FG001|Overall Study|Death|40|||
126794875|NCT00635492|456207507|FG000|Overall Study|Lost to Follow-up|151|||
126794876|NCT00635492|456207508|FG001|Overall Study|Lost to Follow-up|172|||
126794877|NCT00635492|456207507|FG000|Overall Study|Physician Decision|32|||
126794878|NCT00635492|456207508|FG001|Overall Study|Physician Decision|22|||
126794879|NCT00635492|456207507|FG000|Overall Study|Sponsor decision|2|||
126794880|NCT00635492|456207508|FG001|Overall Study|Sponsor decision|3|||
126794881|NCT00635492|456207507|FG000|Overall Study|Withdrawal by Subject|82|||
126794882|NCT00635492|456207508|FG001|Overall Study|Withdrawal by Subject|45|||
126794883|NCT01702987|456207509|FG000|Overall Study|Withdrawal by Subject|1|||
126794884|NCT01702987|456207510|FG001|Overall Study|Withdrawal by Subject|0|||
126794885|NCT02017223|456207511|FG000|Overall Study|Algorithm problems|2|||
126794886|NCT04263649|456207513|FG000|Overall Study|Adverse Event|53|||
126794887|NCT04263649|456207513|FG000|Overall Study|Lost to Follow-up|3|||
126794888|NCT04263649|456207513|FG000|Overall Study|Death|29|||
126794889|NCT04263649|456207513|FG000|Overall Study|Device deficiency|19|||
126794890|NCT04263649|456207513|FG000|Overall Study|other reasons|11|||
126794891|NCT05169710|456207514|FG000|Overall Study|Adverse Event|1|||
126794892|NCT05169710|456207515|FG001|Overall Study|Adverse Event|2|||
126794893|NCT05169710|456207516|FG002|Overall Study|Adverse Event|2|||
126794894|NCT05169710|456207514|FG000|Overall Study|Lost to Follow-up|0|||
126794895|NCT05169710|456207515|FG001|Overall Study|Lost to Follow-up|0|||
126794896|NCT05169710|456207516|FG002|Overall Study|Lost to Follow-up|1|||
126794897|NCT05169710|456207514|FG000|Overall Study|Withdrawal by Subject|2|||
126794898|NCT05169710|456207515|FG001|Overall Study|Withdrawal by Subject|1|||
126794899|NCT05169710|456207516|FG002|Overall Study|Withdrawal by Subject|0|||
126794900|NCT05169710|456207514|FG000|Overall Study|Other Study Discontinuation Reason|0|||
126794901|NCT05169710|456207515|FG001|Overall Study|Other Study Discontinuation Reason|2|||
126794902|NCT05169710|456207516|FG002|Overall Study|Other Study Discontinuation Reason|0|||
126794903|NCT00846495|456207521|FG000|Overall Study|Lost to Follow-up|1|||
126794904|NCT00846495|456207522|FG001|Overall Study|Lost to Follow-up|0|||
126794905|NCT00846495|456207521|FG000|Overall Study|Adverse Event|5|||
126794906|NCT00846495|456207522|FG001|Overall Study|Adverse Event|1|||
126794907|NCT00846495|456207521|FG000|Overall Study|Lack of Efficacy|1|||
126794908|NCT00846495|456207522|FG001|Overall Study|Lack of Efficacy|2|||
126794909|NCT00846495|456207521|FG000|Overall Study|Physician Decision|1|||
126794910|NCT00846495|456207522|FG001|Overall Study|Physician Decision|0|||
126794911|NCT01686438|456207523|FG000|Overall Study|Lost to Follow-up|8|||
126794912|NCT01686438|456207524|FG001|Overall Study|Lost to Follow-up|9|||
126794913|NCT01686438|456207525|FG002|Overall Study|Lost to Follow-up|10|||
126794914|NCT01686438|456207523|FG000|Overall Study|Adverse Event|0|||
126794915|NCT01686438|456207524|FG001|Overall Study|Adverse Event|0|||
126794916|NCT01686438|456207525|FG002|Overall Study|Adverse Event|1|||
126794917|NCT01686438|456207523|FG000|Overall Study|Protocol Violation|0|||
126794918|NCT01686438|456207524|FG001|Overall Study|Protocol Violation|0|||
126794919|NCT01686438|456207525|FG002|Overall Study|Protocol Violation|1|||
126794920|NCT01686438|456207523|FG000|Overall Study|Withdrawal by Subject|0|||
126794921|NCT01686438|456207524|FG001|Overall Study|Withdrawal by Subject|0|||
126794922|NCT01686438|456207525|FG002|Overall Study|Withdrawal by Subject|1|||
126794923|NCT01265056|456207528|FG000|Initial Study Period|Withdrawal by Subject|1|||
126794924|NCT01265056|456207529|FG001|Initial Study Period|Withdrawal by Subject|1|||
126794925|NCT01265056|456207528|FG000|Initial Study Period|Withdrawal by Subject|1|||
126794926|NCT01265056|456207529|FG001|Initial Study Period|Withdrawal by Subject|1|||
126794927|NCT01265056|456207528|FG000|Follow up|Lost to Follow-up|7|||
126794928|NCT01265056|456207529|FG001|Follow up|Lost to Follow-up|3|||
126794929|NCT02601560|456207530|FG000|Overall Study|Other|0|||
126794930|NCT02601560|456207531|FG001|Overall Study|Other|0|||
126794931|NCT02601560|456207532|FG002|Overall Study|Other|0|||
126794932|NCT02601560|456207533|FG003|Overall Study|Other|0|||
126794933|NCT02601560|456207534|FG004|Overall Study|Other|0|||
126794934|NCT02601560|456207535|FG005|Overall Study|Other|0|||
126794935|NCT02601560|456207536|FG006|Overall Study|Other|1|||
126794936|NCT02601560|456207537|FG007|Overall Study|Other|0|||
126794937|NCT03725605|456207541|FG000|Overall Study|Unsuccessful TIL expansion|2|||
126794938|NCT00965185|456207542|FG000|Overall Study|Lost to Follow-up|2|||
126794939|NCT00965185|456207543|FG001|Overall Study|Lost to Follow-up|0|||
126794940|NCT00965185|456207542|FG000|Overall Study|Withdrawal by Subject|0|||
126794941|NCT00965185|456207543|FG001|Overall Study|Withdrawal by Subject|1|||
126794942|NCT03500692|456207544|FG000|Overall Study|Death|163|||
126794943|NCT03500692|456207544|FG000|Overall Study|Lost to Follow-up|75|||
126794944|NCT03500692|456207544|FG000|Overall Study|Termination Reasons|3|||
126794945|NCT05275205|456207547|FG000|Overall Study|Adverse Event|1|||
126794946|NCT05275205|456207548|FG001|Overall Study|Adverse Event|2|||
126794947|NCT05275205|456207547|FG000|Overall Study|Physician Decision|1|||
126794948|NCT05275205|456207548|FG001|Overall Study|Physician Decision|1|||
126794949|NCT05275205|456207547|FG000|Overall Study|Withdrawal by Subject|2|||
126794950|NCT05275205|456207548|FG001|Overall Study|Withdrawal by Subject|3|||
126794951|NCT05275205|456207547|FG000|Overall Study|Death|1|||
126794952|NCT05275205|456207548|FG001|Overall Study|Death|0|||
126794953|NCT05275205|456207547|FG000|Overall Study|Patient unable to attend visits|1|||
126794954|NCT05275205|456207548|FG001|Overall Study|Patient unable to attend visits|0|||
126794955|NCT02066922|456207549|FG000|Overall Study|Adverse Event|1|||
126794956|NCT00440297|456207550|FG000|Overall Study|Adverse Event|8|||
126794957|NCT00440297|456207551|FG001|Overall Study|Adverse Event|5|||
126794958|NCT00440297|456207550|FG000|Overall Study|Lost to Follow-up|1|||
126794959|NCT00440297|456207551|FG001|Overall Study|Lost to Follow-up|0|||
126794960|NCT00440297|456207550|FG000|Overall Study|Physician Decision|1|||
126794961|NCT00440297|456207551|FG001|Overall Study|Physician Decision|0|||
126794962|NCT00440297|456207550|FG000|Overall Study|Protocol Violation|11|||
126794963|NCT00440297|456207551|FG001|Overall Study|Protocol Violation|7|||
126794964|NCT00440297|456207550|FG000|Overall Study|Withdrawal by Subject|1|||
126794965|NCT00440297|456207551|FG001|Overall Study|Withdrawal by Subject|6|||
126794966|NCT00440297|456207550|FG000|Overall Study|Randomized by mistake|1|||
126794967|NCT00440297|456207551|FG001|Overall Study|Randomized by mistake|0|||
126794968|NCT02039908|456207555|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
126794969|NCT02039908|456207556|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
126794970|NCT02039908|456207557|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
126794971|NCT02039908|456207558|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
126794972|NCT02039908|456207555|FG000|Phase 1-Summer|Protocol Violation|6|||
126794973|NCT02039908|456207556|FG001|Phase 1-Summer|Protocol Violation|0|||
126794974|NCT02039908|456207557|FG002|Phase 1-Summer|Protocol Violation|0|||
126794975|NCT02039908|456207558|FG003|Phase 1-Summer|Protocol Violation|0|||
126794976|NCT02039908|456207555|FG000|Phase 2-School Year|Lost to Follow-up|0|||
126794977|NCT02039908|456207556|FG001|Phase 2-School Year|Lost to Follow-up|0|||
126794978|NCT02039908|456207557|FG002|Phase 2-School Year|Lost to Follow-up|1|||
126794979|NCT02039908|456207558|FG003|Phase 2-School Year|Lost to Follow-up|3|||
126794980|NCT02039908|456207555|FG000|Phase 2-School Year|Protocol Violation|0|||
126794981|NCT02039908|456207556|FG001|Phase 2-School Year|Protocol Violation|0|||
126794982|NCT02039908|456207557|FG002|Phase 2-School Year|Protocol Violation|3|||
126794983|NCT02039908|456207558|FG003|Phase 2-School Year|Protocol Violation|0|||
126794984|NCT02039908|456207555|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
126794985|NCT02039908|456207556|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
126794986|NCT02039908|456207557|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
126794987|NCT02039908|456207558|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
126794988|NCT06358820|456209230|FG000|Overall Study|Adverse Event|11|||
126794989|NCT06358820|456209230|FG000|Overall Study|kidney transplantation|3|||
126794990|NCT06358820|456209230|FG000|Overall Study|patient voluntary withdrawal|6|||
126794991|NCT06358820|456209230|FG000|Overall Study|Physician Decision|1|||
126794992|NCT05376319|456209231|FG000|Overall Study|Funding termination|2|||
126794993|NCT05376319|456209232|FG001|Overall Study|Funding termination|4|||
126794994|NCT01124175|456209233|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
126794995|NCT01124175|456209234|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
126794996|NCT00218257|456209240|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
126794997|NCT00218257|456209241|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
126794998|NCT00462345|456209244|FG000|Overall Study|Withdrawal by Subject|2|||
126794999|NCT00462345|456209244|FG000|Overall Study|Did not complete second course|1|||
126795000|NCT00070291|456209247|FG000|Step 1|Withdrawal by Subject|1|||
126795001|NCT00070291|456209247|FG000|Step 1|Adverse Event|1|||
126795002|NCT00070291|456209247|FG000|Step 2|Adverse Event|1|||
126795003|NCT02028715|456209248|FG000|Overall Study|Adverse Event|2|||
126795004|NCT02028715|456209249|FG001|Overall Study|Adverse Event|2|||
126795005|NCT02028715|456209248|FG000|Overall Study|Physician Decision|1|||
126795006|NCT02028715|456209249|FG001|Overall Study|Physician Decision|0|||
126795007|NCT02028715|456209248|FG000|Overall Study|Did not complete satisfaction surveys|2|||
126795008|NCT02028715|456209249|FG001|Overall Study|Did not complete satisfaction surveys|2|||
126795009|NCT00520130|456209250|FG000|Overall Study|Disease progression on study|4|||
126795010|NCT00520130|456209251|FG001|Overall Study|Disease progression on study|0|||
126795011|NCT00520130|456209250|FG000|Overall Study|Physician Decision|1|||
126795012|NCT00520130|456209251|FG001|Overall Study|Physician Decision|1|||
126795013|NCT04605094|456209252|FG000|Overall Study|Adverse Event|2|||
126795014|NCT04605094|456209253|FG001|Overall Study|Adverse Event|2|||
126795015|NCT04605094|456209252|FG000|Overall Study|Lost to Follow-up|1|||
126795016|NCT04605094|456209253|FG001|Overall Study|Lost to Follow-up|4|||
126795017|NCT04605094|456209252|FG000|Overall Study|Physician Decision|2|||
126795018|NCT04605094|456209253|FG001|Overall Study|Physician Decision|2|||
126795019|NCT04605094|456209252|FG000|Overall Study|Study terminated by Sponsor|31|||
126795020|NCT04605094|456209253|FG001|Overall Study|Study terminated by Sponsor|33|||
126795021|NCT04605094|456209252|FG000|Overall Study|Withdrawal by Subject|22|||
126795022|NCT04605094|456209253|FG001|Overall Study|Withdrawal by Subject|19|||
126795023|NCT04605094|456209252|FG000|Overall Study|Other|1|||
126795024|NCT04605094|456209253|FG001|Overall Study|Other|1|||
126795025|NCT01954394|456209258|FG000|Overall Study|Enrolled but not treated|1|||
126795026|NCT01954394|456209259|FG001|Overall Study|Enrolled but not treated|0|||
126795027|NCT01954394|456209258|FG000|Overall Study|Adverse Event|10|||
126795028|NCT01954394|456209259|FG001|Overall Study|Adverse Event|23|||
126795029|NCT01954394|456209258|FG000|Overall Study|Poor compliance to protocol|7|||
126795030|NCT01954394|456209259|FG001|Overall Study|Poor compliance to protocol|7|||
126795031|NCT01954394|456209258|FG000|Overall Study|Participant Moved|0|||
126795032|NCT01954394|456209259|FG001|Overall Study|Participant Moved|4|||
126795033|NCT01954394|456209258|FG000|Overall Study|Related to Study Drug administration|2|||
126795034|NCT01954394|456209259|FG001|Overall Study|Related to Study Drug administration|2|||
126795035|NCT01954394|456209258|FG000|Overall Study|Other than specified above|10|||
126795036|NCT01954394|456209259|FG001|Overall Study|Other than specified above|21|||
126795037|NCT02422264|456209264|FG000|Overall Study|Serious Adverse Event|1|||
126795038|NCT02422264|456209265|FG001|Overall Study|Serious Adverse Event|0|||
126795039|NCT02422264|456209264|FG000|Overall Study|Withdrawal by Subject|1|||
126795040|NCT02422264|456209265|FG001|Overall Study|Withdrawal by Subject|2|||
126795041|NCT02422264|456209264|FG000|Overall Study|Migrated/moved from study area|3|||
126795042|NCT02422264|456209265|FG001|Overall Study|Migrated/moved from study area|1|||
126795043|NCT02422264|456209264|FG000|Overall Study|Subject vaccinated outside of the study|0|||
126795044|NCT02422264|456209265|FG001|Overall Study|Subject vaccinated outside of the study|1|||
126795045|NCT01034358|456209266|FG000|Overall Study|Withdrawal by Subject|1|||
126632883|NCT00543062|455615679|FG001|Overall Study|Withdrawal by Subject|0|||
126632884|NCT00543062|455615680|FG002|Overall Study|Withdrawal by Subject|2|||
126632885|NCT00543062|455615681|FG003|Overall Study|Withdrawal by Subject|0|||
126632886|NCT00543062|455615678|FG000|Overall Study|Adverse Event|0|||
126632887|NCT00543062|455615679|FG001|Overall Study|Adverse Event|1|||
126795046|NCT01034358|456209266|FG000|Overall Study|Protocol Violation|1|||
126795047|NCT00829790|456209269|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
126795048|NCT00829790|456209270|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
126795049|NCT01534663|456209271|FG000|Overall Study|Lost to Follow-up|0|||
126795050|NCT01534663|456209272|FG001|Overall Study|Lost to Follow-up|2|||
126795051|NCT01534663|456209271|FG000|Overall Study|Adverse Event|2|||
126795052|NCT01534663|456209272|FG001|Overall Study|Adverse Event|1|||
126795053|NCT00627016|456209273|FG000|Overall Study|Adverse Event|1|||
126795054|NCT00627016|456209274|FG001|Overall Study|Adverse Event|1|||
126795055|NCT00627016|456209273|FG000|Overall Study|Protocol Violation|0|||
126795056|NCT00627016|456209274|FG001|Overall Study|Protocol Violation|2|||
126795057|NCT00627016|456209273|FG000|Overall Study|Lost to Follow-up|0|||
126795058|NCT00627016|456209274|FG001|Overall Study|Lost to Follow-up|1|||
126795059|NCT00627016|456209273|FG000|Overall Study|Withdrawal by Subject|2|||
126795060|NCT00627016|456209274|FG001|Overall Study|Withdrawal by Subject|1|||
126795061|NCT00627016|456209273|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
126795062|NCT00627016|456209274|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
126795063|NCT00627016|456209273|FG000|Overall Study|Lack of Efficacy|1|||
126795064|NCT00627016|456209274|FG001|Overall Study|Lack of Efficacy|0|||
126795065|NCT00627016|456209273|FG000|Overall Study|Placed on Excluded Drugs|1|||
126795066|NCT00627016|456209274|FG001|Overall Study|Placed on Excluded Drugs|0|||
126795067|NCT00627016|456209273|FG000|Overall Study|Pregnancy|1|||
126795068|NCT00627016|456209274|FG001|Overall Study|Pregnancy|0|||
126795069|NCT03107091|456209275|FG000|Overall Study|Physician Decision|1|||
126795070|NCT04567186|456209280|FG000|Period 1|COVID-19 related|1|||
126795071|NCT04567186|456209281|FG001|Period 1|COVID-19 related|0|||
126795072|NCT04567186|456209280|FG000|Period 1|Protocol Violation|0|||
126795073|NCT04567186|456209281|FG001|Period 1|Protocol Violation|1|||
126795074|NCT04567186|456209280|FG000|Period 1|Adverse Event|0|||
126795075|NCT04567186|456209281|FG001|Period 1|Adverse Event|2|||
126632888|NCT00543062|455615680|FG002|Overall Study|Adverse Event|1|||
126632889|NCT00543062|455615681|FG003|Overall Study|Adverse Event|1|||
126632890|NCT00543062|455615678|FG000|Overall Study|Protocol Violation|1|||
126795076|NCT04567186|456209280|FG000|Period 2|COVID-19 Related|0|||
126795077|NCT04567186|456209281|FG001|Period 2|COVID-19 Related|1|||
126795078|NCT04567186|456209280|FG000|Period 2|Protocol Violation|0|||
126795079|NCT04567186|456209281|FG001|Period 2|Protocol Violation|1|||
126795080|NCT04567186|456209280|FG000|Period 2|Lost to Follow-up|0|||
126795081|NCT04567186|456209281|FG001|Period 2|Lost to Follow-up|1|||
126795082|NCT04567186|456209280|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
126795083|NCT04567186|456209281|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
126795084|NCT01185548|456209284|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
126795085|NCT02331394|456209285|FG000|Overall Study|Disease progression|1|||
126795086|NCT02481830|456209286|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
126795087|NCT02481830|456209287|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
126795088|NCT02481830|456209286|FG000|Pre-treatment|Withdrawal by Subject|0|||
126795089|NCT02481830|456209287|FG001|Pre-treatment|Withdrawal by Subject|10|||
126795090|NCT02481830|456209286|FG000|Pre-treatment|Disease Progression|1|||
126795091|NCT02481830|456209287|FG001|Pre-treatment|Disease Progression|1|||
126795092|NCT02481830|456209286|FG000|Pre-treatment|Other reasons|0|||
126795093|NCT02481830|456209287|FG001|Pre-treatment|Other reasons|1|||
126795094|NCT02481830|456209286|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
126795095|NCT02481830|456209287|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
126795096|NCT02481830|456209286|FG000|Treatment|Disease Progression|233|||
126795097|NCT02481830|456209287|FG001|Treatment|Disease Progression|171|||
126795098|NCT02481830|456209286|FG000|Treatment|Study drug toxicity|18|||
126795099|NCT02481830|456209287|FG001|Treatment|Study drug toxicity|38|||
126795100|NCT02481830|456209286|FG000|Treatment|Death|1|||
126795101|NCT02481830|456209287|FG001|Treatment|Death|1|||
126795102|NCT02481830|456209286|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
126795103|NCT02481830|456209287|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
126795104|NCT02481830|456209286|FG000|Treatment|Participants request to discontinue Study treatment|6|||
126795105|NCT02481830|456209287|FG001|Treatment|Participants request to discontinue Study treatment|34|||
126795106|NCT02481830|456209286|FG000|Treatment|Withdrawal by Subject|2|||
126795107|NCT02481830|456209287|FG001|Treatment|Withdrawal by Subject|3|||
126795108|NCT02481830|456209286|FG000|Treatment|Lost to Follow-up|1|||
126795109|NCT02481830|456209287|FG001|Treatment|Lost to Follow-up|0|||
126795110|NCT02481830|456209286|FG000|Treatment|Maximum Clinical Benefit|0|||
126795111|NCT02481830|456209287|FG001|Treatment|Maximum Clinical Benefit|5|||
126795112|NCT02481830|456209286|FG000|Treatment|Administrative reason by sponsor|1|||
126795113|NCT02481830|456209287|FG001|Treatment|Administrative reason by sponsor|1|||
126795114|NCT02481830|456209286|FG000|Treatment|Other reasons|6|||
126795115|NCT02481830|456209287|FG001|Treatment|Other reasons|1|||
126795116|NCT00102440|456209288|FG000|Overall Study|Lost to Follow-up|25|||
126795117|NCT00102440|456209289|FG001|Overall Study|Lost to Follow-up|18|||
126795118|NCT00102440|456209290|FG002|Overall Study|Lost to Follow-up|21|||
126795119|NCT00102440|456209288|FG000|Overall Study|Adverse Event|16|||
126795120|NCT00102440|456209289|FG001|Overall Study|Adverse Event|23|||
126795121|NCT00102440|456209290|FG002|Overall Study|Adverse Event|8|||
126795122|NCT00102440|456209288|FG000|Overall Study|Gout Flare|10|||
126795123|NCT00102440|456209289|FG001|Overall Study|Gout Flare|28|||
126795124|NCT00102440|456209290|FG002|Overall Study|Gout Flare|9|||
126795125|NCT00102440|456209288|FG000|Overall Study|Personal Reason(s)|19|||
126795126|NCT00102440|456209289|FG001|Overall Study|Personal Reason(s)|13|||
126795127|NCT00102440|456209290|FG002|Overall Study|Personal Reason(s)|13|||
126795128|NCT00102440|456209288|FG000|Overall Study|Other|11|||
126795129|NCT00102440|456209289|FG001|Overall Study|Other|14|||
126795130|NCT00102440|456209290|FG002|Overall Study|Other|14|||
126795131|NCT00102440|456209288|FG000|Overall Study|Protocol Violation|7|||
126795132|NCT00102440|456209289|FG001|Overall Study|Protocol Violation|2|||
126795133|NCT00102440|456209290|FG002|Overall Study|Protocol Violation|1|||
126795134|NCT04627038|456209291|FG000|Overall Study|Adverse Event|36|||
126795135|NCT04627038|456209292|FG001|Overall Study|Adverse Event|8|||
126795136|NCT04627038|456209291|FG000|Overall Study|Lost to Follow-up|1|||
126795137|NCT04627038|456209292|FG001|Overall Study|Lost to Follow-up|0|||
126795138|NCT04627038|456209291|FG000|Overall Study|Physician Decision|0|||
126795139|NCT04627038|456209292|FG001|Overall Study|Physician Decision|1|||
126795140|NCT04627038|456209291|FG000|Overall Study|Protocol Violation|3|||
126795141|NCT04627038|456209292|FG001|Overall Study|Protocol Violation|1|||
126795142|NCT04627038|456209291|FG000|Overall Study|Withdrawal by Subject|13|||
126795143|NCT04627038|456209292|FG001|Overall Study|Withdrawal by Subject|3|||
126795144|NCT04627038|456209291|FG000|Overall Study|Non-compliance with study drug|0|||
126795145|NCT04627038|456209292|FG001|Overall Study|Non-compliance with study drug|1|||
126795146|NCT04627038|456209291|FG000|Overall Study|Prohibited Concomitant Medication|1|||
126795147|NCT04627038|456209292|FG001|Overall Study|Prohibited Concomitant Medication|0|||
126795148|NCT03375463|456209293|FG000|Period 1|Lost to Follow-up|0|||
126795149|NCT03375463|456209294|FG001|Period 1|Lost to Follow-up|0|||
126795150|NCT03375463|456209295|FG002|Period 1|Lost to Follow-up|1|||
126632891|NCT00543062|455615679|FG001|Overall Study|Protocol Violation|0|||
126795151|NCT03375463|456209296|FG003|Period 1|Lost to Follow-up|0|||
126795152|NCT03375463|456209297|FG004|Period 1|Lost to Follow-up|0|||
126795153|NCT03375463|456209298|FG005|Period 1|Lost to Follow-up|0|||
126795154|NCT03375463|456209293|FG000|Period 1|Adverse Event|0|||
126795155|NCT03375463|456209294|FG001|Period 1|Adverse Event|0|||
126795156|NCT03375463|456209295|FG002|Period 1|Adverse Event|0|||
126795157|NCT03375463|456209296|FG003|Period 1|Adverse Event|0|||
126795158|NCT03375463|456209297|FG004|Period 1|Adverse Event|1|||
126795159|NCT03375463|456209298|FG005|Period 1|Adverse Event|0|||
126795160|NCT03375463|456209293|FG000|Period 2|Lost to Follow-up|1|||
126795161|NCT03375463|456209294|FG001|Period 2|Lost to Follow-up|1|||
126795162|NCT03375463|456209295|FG002|Period 2|Lost to Follow-up|0|||
126795163|NCT03375463|456209296|FG003|Period 2|Lost to Follow-up|0|||
126795164|NCT03375463|456209297|FG004|Period 2|Lost to Follow-up|0|||
126795165|NCT03375463|456209298|FG005|Period 2|Lost to Follow-up|0|||
126795166|NCT04533594|456209302|FG000|Overall Study|Death|26|||
126795167|NCT01029340|456209312|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
126795168|NCT01029340|456209313|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
126795169|NCT01029340|456209314|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
126795170|NCT01029340|456209315|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
126795171|NCT01029340|456209316|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
126795172|NCT01029340|456209317|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
126795173|NCT01029340|456209312|FG000|Part B Treatment Period|Protocol Violation|0|||
126795174|NCT01029340|456209313|FG001|Part B Treatment Period|Protocol Violation|0|||
126795175|NCT01029340|456209314|FG002|Part B Treatment Period|Protocol Violation|1|||
126795176|NCT01029340|456209315|FG003|Part B Treatment Period|Protocol Violation|0|||
126795177|NCT01029340|456209316|FG004|Part B Treatment Period|Protocol Violation|0|||
126795178|NCT01029340|456209317|FG005|Part B Treatment Period|Protocol Violation|0|||
126795179|NCT01029340|456209312|FG000|Extension Period|Adverse Event|0|||
126795180|NCT01029340|456209313|FG001|Extension Period|Adverse Event|0|||
126795181|NCT01029340|456209314|FG002|Extension Period|Adverse Event|0|||
126795182|NCT01029340|456209315|FG003|Extension Period|Adverse Event|0|||
126795183|NCT01029340|456209316|FG004|Extension Period|Adverse Event|0|||
126795184|NCT01029340|456209317|FG005|Extension Period|Adverse Event|1|||
126795185|NCT01029340|456209312|FG000|Extension Period|starting another study|0|||
126795186|NCT01029340|456209313|FG001|Extension Period|starting another study|0|||
126795187|NCT01029340|456209314|FG002|Extension Period|starting another study|0|||
126795188|NCT01029340|456209315|FG003|Extension Period|starting another study|0|||
126795189|NCT01029340|456209316|FG004|Extension Period|starting another study|0|||
126795190|NCT01029340|456209317|FG005|Extension Period|starting another study|8|||
126795191|NCT01029340|456209312|FG000|Extension Period|non-compliance|0|||
126795192|NCT01029340|456209313|FG001|Extension Period|non-compliance|0|||
126795193|NCT01029340|456209314|FG002|Extension Period|non-compliance|0|||
126795194|NCT01029340|456209315|FG003|Extension Period|non-compliance|0|||
126795195|NCT01029340|456209316|FG004|Extension Period|non-compliance|0|||
126795196|NCT01029340|456209317|FG005|Extension Period|non-compliance|1|||
126795197|NCT01029340|456209312|FG000|Extension Period|Withdrawal by Subject|0|||
126795198|NCT01029340|456209313|FG001|Extension Period|Withdrawal by Subject|0|||
126795199|NCT01029340|456209314|FG002|Extension Period|Withdrawal by Subject|0|||
126795200|NCT01029340|456209315|FG003|Extension Period|Withdrawal by Subject|0|||
126795201|NCT01029340|456209316|FG004|Extension Period|Withdrawal by Subject|0|||
126795202|NCT01029340|456209317|FG005|Extension Period|Withdrawal by Subject|1|||
126795203|NCT01029340|456209312|FG000|Extension Period|Physician Decision|0|||
126795204|NCT01029340|456209313|FG001|Extension Period|Physician Decision|0|||
126795205|NCT01029340|456209314|FG002|Extension Period|Physician Decision|0|||
126795206|NCT01029340|456209315|FG003|Extension Period|Physician Decision|0|||
126795207|NCT01029340|456209316|FG004|Extension Period|Physician Decision|0|||
126795208|NCT01029340|456209317|FG005|Extension Period|Physician Decision|1|||
126795209|NCT02648347|456209318|FG000|Overall Study|Death|174|||
126795210|NCT02648347|456209319|FG001|Overall Study|Death|167|||
126795211|NCT02648347|456209318|FG000|Overall Study|Withdrawal by Subject|16|||
126795212|NCT02648347|456209319|FG001|Overall Study|Withdrawal by Subject|9|||
126795213|NCT02648347|456209318|FG000|Overall Study|Lost to Follow-up|18|||
126795214|NCT02648347|456209319|FG001|Overall Study|Lost to Follow-up|21|||
126795215|NCT02648347|456209318|FG000|Overall Study|Missing|1|||
126795216|NCT02648347|456209319|FG001|Overall Study|Missing|0|||
126795217|NCT03546842|456209321|FG000|Overall Study|Protocol Violation|1|||
126795218|NCT03546842|456209321|FG000|Overall Study|Withdrawal by Subject|2|||
126795219|NCT00833937|456209335|FG000|Washout|Withdrawal by Subject|1|||
126795220|NCT00833937|456209336|FG001|Washout|Withdrawal by Subject|0|||
126795221|NCT04419311|456209337|FG000|Overall Study|Lost to Follow-up|1|||
126795222|NCT04419311|456209338|FG001|Overall Study|Lost to Follow-up|0|||
126795223|NCT03135834|456209339|FG000|Stage 1|Adverse Event|1|||
126795224|NCT03135834|456209340|FG001|Stage 1|Adverse Event|2|||
126795225|NCT03135834|456209341|FG002|Stage 1|Adverse Event|2|||
126795226|NCT03135834|456209342|FG003|Stage 1|Adverse Event|1|||
126795227|NCT03135834|456209339|FG000|Stage 1|Death|1|||
126795228|NCT03135834|456209340|FG001|Stage 1|Death|0|||
126795229|NCT03135834|456209341|FG002|Stage 1|Death|0|||
126795230|NCT03135834|456209342|FG003|Stage 1|Death|0|||
126795231|NCT03135834|456209339|FG000|Stage 1|Lost to Follow-up|17|||
126795232|NCT03135834|456209340|FG001|Stage 1|Lost to Follow-up|24|||
126795233|NCT03135834|456209341|FG002|Stage 1|Lost to Follow-up|21|||
126795234|NCT03135834|456209342|FG003|Stage 1|Lost to Follow-up|38|||
126795235|NCT03135834|456209339|FG000|Stage 1|No longer met eligibility criteria|1|||
126795236|NCT03135834|456209340|FG001|Stage 1|No longer met eligibility criteria|6|||
126795237|NCT03135834|456209341|FG002|Stage 1|No longer met eligibility criteria|2|||
126795238|NCT03135834|456209342|FG003|Stage 1|No longer met eligibility criteria|5|||
126795239|NCT03135834|456209339|FG000|Stage 1|Other|0|||
126795240|NCT03135834|456209340|FG001|Stage 1|Other|2|||
126795241|NCT03135834|456209341|FG002|Stage 1|Other|1|||
126795242|NCT03135834|456209342|FG003|Stage 1|Other|0|||
126795243|NCT03135834|456209339|FG000|Stage 1|Physician Decision|0|||
126795244|NCT03135834|456209340|FG001|Stage 1|Physician Decision|1|||
126795245|NCT03135834|456209341|FG002|Stage 1|Physician Decision|0|||
126795246|NCT03135834|456209342|FG003|Stage 1|Physician Decision|0|||
126795247|NCT03135834|456209339|FG000|Stage 1|Pregnancy|0|||
126795248|NCT03135834|456209340|FG001|Stage 1|Pregnancy|4|||
126795249|NCT03135834|456209341|FG002|Stage 1|Pregnancy|2|||
126795250|NCT03135834|456209342|FG003|Stage 1|Pregnancy|4|||
126795251|NCT03135834|456209339|FG000|Stage 1|Protocol Violation|1|||
126795252|NCT03135834|456209340|FG001|Stage 1|Protocol Violation|1|||
126795253|NCT03135834|456209341|FG002|Stage 1|Protocol Violation|2|||
126795254|NCT03135834|456209342|FG003|Stage 1|Protocol Violation|1|||
126795255|NCT03135834|456209339|FG000|Stage 1|Withdrawal by parent/guardian|2|||
126795256|NCT03135834|456209340|FG001|Stage 1|Withdrawal by parent/guardian|10|||
126795257|NCT03135834|456209341|FG002|Stage 1|Withdrawal by parent/guardian|2|||
126795258|NCT03135834|456209342|FG003|Stage 1|Withdrawal by parent/guardian|1|||
126795259|NCT03135834|456209339|FG000|Stage 1|Withdrawal by Subject|16|||
126795260|NCT03135834|456209340|FG001|Stage 1|Withdrawal by Subject|22|||
126795261|NCT03135834|456209341|FG002|Stage 1|Withdrawal by Subject|7|||
126795262|NCT03135834|456209342|FG003|Stage 1|Withdrawal by Subject|10|||
126795263|NCT03135834|456209339|FG000|Stage 1|Randomized but not Vaccinated|0|||
126795264|NCT03135834|456209340|FG001|Stage 1|Randomized but not Vaccinated|3|||
126795265|NCT03135834|456209341|FG002|Stage 1|Randomized but not Vaccinated|1|||
126795266|NCT03135834|456209342|FG003|Stage 1|Randomized but not Vaccinated|6|||
126795267|NCT03135834|456209339|FG000|Stage 2|Lost to Follow-up|0|||
126795268|NCT03135834|456209340|FG001|Stage 2|Lost to Follow-up|1|||
126795269|NCT03135834|456209341|FG002|Stage 2|Lost to Follow-up|0|||
126795270|NCT03135834|456209342|FG003|Stage 2|Lost to Follow-up|0|||
126795271|NCT03135834|456209339|FG000|Stage 2|Withdrawal by Subject|0|||
126795272|NCT03135834|456209340|FG001|Stage 2|Withdrawal by Subject|1|||
126795273|NCT03135834|456209341|FG002|Stage 2|Withdrawal by Subject|0|||
126795274|NCT03135834|456209342|FG003|Stage 2|Withdrawal by Subject|0|||
126795275|NCT03135834|456209339|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
126795276|NCT03135834|456209340|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
126795277|NCT03135834|456209341|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
126795278|NCT03135834|456209342|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
126795279|NCT03135834|456209339|FG000|Stage 2|Did not receive Booster Vaccination|1|||
126795280|NCT03135834|456209340|FG001|Stage 2|Did not receive Booster Vaccination|1|||
126795281|NCT03135834|456209341|FG002|Stage 2|Did not receive Booster Vaccination|0|||
126795282|NCT03135834|456209342|FG003|Stage 2|Did not receive Booster Vaccination|0|||
126795283|NCT02612337|456209345|FG000|Overall Study|Lack of Efficacy|1|||
126795284|NCT02612337|456209346|FG001|Overall Study|Lack of Efficacy|0|||
126795285|NCT02612337|456209345|FG000|Overall Study|Withdrawal by Subject|2|||
126795286|NCT02612337|456209346|FG001|Overall Study|Withdrawal by Subject|2|||
126795287|NCT02612337|456209345|FG000|Overall Study|Did not receive study drug|0|||
126795288|NCT02612337|456209346|FG001|Overall Study|Did not receive study drug|1|||
126795289|NCT02242201|456209347|FG000|Overall Study|preoperative identified neuropathy|2|||
126795290|NCT02242201|456209348|FG001|Overall Study|preoperative identified neuropathy|0|||
126795291|NCT02242201|456209349|FG002|Overall Study|preoperative identified neuropathy|0|||
126795292|NCT02242201|456209347|FG000|Overall Study|planned post-op anticoagulation|1|||
126795293|NCT02242201|456209348|FG001|Overall Study|planned post-op anticoagulation|0|||
126795294|NCT02242201|456209349|FG002|Overall Study|planned post-op anticoagulation|0|||
126795295|NCT02242201|456209347|FG000|Overall Study|changed surgical procedure|1|||
126795296|NCT02242201|456209348|FG001|Overall Study|changed surgical procedure|0|||
126795297|NCT02242201|456209349|FG002|Overall Study|changed surgical procedure|0|||
126795298|NCT02242201|456209347|FG000|Overall Study|postponed surgery|0|||
126795299|NCT02242201|456209348|FG001|Overall Study|postponed surgery|0|||
126795300|NCT02242201|456209349|FG002|Overall Study|postponed surgery|1|||
126795301|NCT02242201|456209347|FG000|Overall Study|preoperative opioid consumption|0|||
126795302|NCT02242201|456209348|FG001|Overall Study|preoperative opioid consumption|1|||
126795303|NCT02242201|456209349|FG002|Overall Study|preoperative opioid consumption|0|||
126795304|NCT02374853|456209352|FG000|Overall Study|Surgery Cancelled|5|||
126795305|NCT02374853|456209353|FG001|Overall Study|Surgery Cancelled|11|||
126795306|NCT02281084|456209356|FG000|Overall Study|Death|21|||
126795307|NCT02281084|456209357|FG001|Overall Study|Death|18|||
126795308|NCT02281084|456209358|FG002|Overall Study|Death|3|||
126795309|NCT02281084|456209359|FG003|Overall Study|Death|5|||
126795310|NCT02281084|456209356|FG000|Overall Study|Adverse Event|1|||
126632892|NCT00543062|455615680|FG002|Overall Study|Protocol Violation|0|||
126795311|NCT02281084|456209357|FG001|Overall Study|Adverse Event|0|||
126795312|NCT02281084|456209358|FG002|Overall Study|Adverse Event|0|||
126795313|NCT02281084|456209359|FG003|Overall Study|Adverse Event|0|||
126795314|NCT02281084|456209356|FG000|Overall Study|Withdrawal by Subject|2|||
126795315|NCT02281084|456209357|FG001|Overall Study|Withdrawal by Subject|2|||
126795316|NCT02281084|456209358|FG002|Overall Study|Withdrawal by Subject|0|||
126795317|NCT02281084|456209359|FG003|Overall Study|Withdrawal by Subject|0|||
126795318|NCT02281084|456209356|FG000|Overall Study|Site Closure by Sponsor|5|||
126795319|NCT02281084|456209357|FG001|Overall Study|Site Closure by Sponsor|1|||
126795320|NCT02281084|456209358|FG002|Overall Study|Site Closure by Sponsor|2|||
126795321|NCT02281084|456209359|FG003|Overall Study|Site Closure by Sponsor|0|||
126795322|NCT01697696|456209360|FG000|Overall Study|Study terminated by sponsor|0|||
126795323|NCT01697696|456209361|FG001|Overall Study|Study terminated by sponsor|3|||
126795324|NCT01697696|456209360|FG000|Overall Study|Protocol deviation|1|||
126795325|NCT01697696|456209361|FG001|Overall Study|Protocol deviation|0|||
126795326|NCT01697696|456209360|FG000|Overall Study|Physician Decision|1|||
126795327|NCT01697696|456209361|FG001|Overall Study|Physician Decision|0|||
126795328|NCT01697696|456209360|FG000|Overall Study|Death|4|||
126795329|NCT01697696|456209361|FG001|Overall Study|Death|2|||
126795330|NCT01697696|456209360|FG000|Overall Study|Lost to Follow-up|10|||
126795331|NCT01697696|456209361|FG001|Overall Study|Lost to Follow-up|7|||
126795332|NCT01697696|456209360|FG000|Overall Study|Subject/guardian decision|31|||
126795333|NCT01697696|456209361|FG001|Overall Study|Subject/guardian decision|35|||
126795334|NCT01424644|456209362|FG000|Overall Study|Adverse Event|2|||
126795335|NCT01424644|456209363|FG001|Overall Study|Adverse Event|0|||
126795336|NCT01424644|456209362|FG000|Overall Study|Withdrawal by Subject|9|||
126795337|NCT01424644|456209363|FG001|Overall Study|Withdrawal by Subject|12|||
126795338|NCT01424644|456209362|FG000|Overall Study|Lost to Follow-up|16|||
126795339|NCT01424644|456209363|FG001|Overall Study|Lost to Follow-up|12|||
126795340|NCT01424644|456209362|FG000|Overall Study|Protocol Violation|4|||
126795341|NCT01424644|456209363|FG001|Overall Study|Protocol Violation|3|||
126795342|NCT01424644|456209362|FG000|Overall Study|Administrative Reason|1|||
126795343|NCT01424644|456209363|FG001|Overall Study|Administrative Reason|0|||
126795344|NCT01424644|456209362|FG000|Overall Study|Unable to Classify|1|||
126795345|NCT01424644|456209363|FG001|Overall Study|Unable to Classify|0|||
126795346|NCT05593965|456209364|FG000|1st Intervention (1 Day)|Technical error|1|||
126795347|NCT05593965|456209365|FG001|1st Intervention (1 Day)|Technical error|0|||
126795348|NCT01880593|456209378|FG000|Overall Study|Adverse Event|1|||
126795349|NCT01880593|456209379|FG001|Overall Study|Adverse Event|0|||
126795350|NCT01880593|456209378|FG000|Overall Study|Lack of Efficacy|1|||
126795351|NCT01880593|456209379|FG001|Overall Study|Lack of Efficacy|5|||
126795352|NCT01880593|456209378|FG000|Overall Study|Withdrawal by Subject|6|||
126795353|NCT01880593|456209379|FG001|Overall Study|Withdrawal by Subject|1|||
126795354|NCT02272777|456209380|FG000|Overall Study|Adverse Event|0|||
126795355|NCT02272777|456209381|FG001|Overall Study|Adverse Event|1|||
126795356|NCT02272777|456209380|FG000|Overall Study|Withdrawal by Subject|0|||
126795357|NCT02272777|456209381|FG001|Overall Study|Withdrawal by Subject|3|||
126795358|NCT02272777|456209380|FG000|Overall Study|Lost to Follow-up|2|||
126795359|NCT02272777|456209381|FG001|Overall Study|Lost to Follow-up|0|||
126795360|NCT02272777|456209380|FG000|Overall Study|Other|2|||
126795361|NCT02272777|456209381|FG001|Overall Study|Other|0|||
126795362|NCT02024932|456209388|FG000|Overall Study|Adverse Event|2|||
126795363|NCT02024932|456209389|FG001|Overall Study|Adverse Event|3|||
126795364|NCT02024932|456209390|FG002|Overall Study|Adverse Event|0|||
126795365|NCT02024932|456209391|FG003|Overall Study|Adverse Event|0|||
126795366|NCT02024932|456209392|FG004|Overall Study|Adverse Event|2|||
126795367|NCT02024932|456209393|FG005|Overall Study|Adverse Event|0|||
126795368|NCT02024932|456209388|FG000|Overall Study|Abnormal laboratory value|0|||
126795369|NCT02024932|456209389|FG001|Overall Study|Abnormal laboratory value|0|||
126795370|NCT02024932|456209390|FG002|Overall Study|Abnormal laboratory value|0|||
126795371|NCT02024932|456209391|FG003|Overall Study|Abnormal laboratory value|2|||
126795372|NCT02024932|456209392|FG004|Overall Study|Abnormal laboratory value|0|||
126795373|NCT02024932|456209393|FG005|Overall Study|Abnormal laboratory value|0|||
126795374|NCT03020641|456209394|FG000|Overall Study|Lost to Follow-up|0|||
126795375|NCT03020641|456209395|FG001|Overall Study|Lost to Follow-up|1|||
126795376|NCT03020641|456209394|FG000|Overall Study|Converted to open surgery|2|||
126795377|NCT03020641|456209395|FG001|Overall Study|Converted to open surgery|1|||
126795378|NCT03020641|456209394|FG000|Overall Study|for surgery not performed|0|||
126795379|NCT03020641|456209395|FG001|Overall Study|for surgery not performed|1|||
126795380|NCT04915755|456210893|FG000|Overall Study|Physician Decision|3|||
126795381|NCT04915755|456210894|FG001|Overall Study|Physician Decision|2|||
126795382|NCT04915755|456210893|FG000|Overall Study|Withdrawal by Subject|1|||
126795383|NCT04915755|456210894|FG001|Overall Study|Withdrawal by Subject|1|||
126795384|NCT04915755|456210893|FG000|Overall Study|Ongoing for PACT|3|||
126795385|NCT04915755|456210894|FG001|Overall Study|Ongoing for PACT|2|||
126795386|NCT04915755|456210893|FG000|Overall Study|Other|7|||
126795387|NCT04915755|456210894|FG001|Overall Study|Other|11|||
126795388|NCT02533258|456210895|FG000|Overall Study|Adverse Event|1|||
126795389|NCT02533258|456210895|FG000|Overall Study|Death|2|||
126795390|NCT02533258|456210895|FG000|Overall Study|Other|1|||
126795391|NCT02533258|456210895|FG000|Overall Study|Economic factor|1|||
126795392|NCT02533258|456210895|FG000|Overall Study|Progression of pleural effusion|1|||
126795393|NCT02533258|456210895|FG000|Overall Study|Lack of Efficacy|2|||
126795394|NCT01149473|456210896|FG000|First Intervention|Adverse Event|1|||
126795395|NCT01149473|456210897|FG001|First Intervention|Adverse Event|1|||
126795396|NCT01149473|456210896|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
126795397|NCT01149473|456210897|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
126795398|NCT04089735|456210898|FG000|Overall Study|Adverse Event|1|||
126795399|NCT04089735|456210899|FG001|Overall Study|Adverse Event|0|||
126795400|NCT04089735|456210900|FG002|Overall Study|Adverse Event|1|||
126795401|NCT04089735|456210901|FG003|Overall Study|Adverse Event|1|||
126795402|NCT04089735|456210902|FG004|Overall Study|Adverse Event|0|||
126795403|NCT04089735|456210903|FG005|Overall Study|Adverse Event|0|||
126795404|NCT04089735|456210898|FG000|Overall Study|Physician Decision|0|||
126795405|NCT04089735|456210899|FG001|Overall Study|Physician Decision|3|||
126795406|NCT04089735|456210900|FG002|Overall Study|Physician Decision|0|||
126795407|NCT04089735|456210901|FG003|Overall Study|Physician Decision|0|||
126795408|NCT04089735|456210902|FG004|Overall Study|Physician Decision|0|||
126795409|NCT04089735|456210903|FG005|Overall Study|Physician Decision|0|||
126795410|NCT04089735|456210898|FG000|Overall Study|Withdrawal by Subject|0|||
126795411|NCT04089735|456210899|FG001|Overall Study|Withdrawal by Subject|0|||
126795412|NCT04089735|456210900|FG002|Overall Study|Withdrawal by Subject|1|||
126795413|NCT04089735|456210901|FG003|Overall Study|Withdrawal by Subject|0|||
126795414|NCT04089735|456210902|FG004|Overall Study|Withdrawal by Subject|0|||
126795415|NCT04089735|456210903|FG005|Overall Study|Withdrawal by Subject|0|||
126795416|NCT04089735|456210898|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
126795417|NCT04089735|456210899|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
126795418|NCT04089735|456210900|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
126795419|NCT04089735|456210901|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
126795420|NCT04089735|456210902|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
126795421|NCT04089735|456210903|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
126795422|NCT01439880|456210905|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
126795423|NCT01439880|456210906|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
126795424|NCT01439880|456210905|FG000|SOC-controlled Period (Year 1)|Death|2|||
126795425|NCT01439880|456210906|FG001|SOC-controlled Period (Year 1)|Death|1|||
126795426|NCT01439880|456210905|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
126795427|NCT01439880|456210906|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
126795428|NCT01439880|456210905|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
126795429|NCT01439880|456210906|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
126795430|NCT01439880|456210905|FG000|SOC-controlled Period (Year 1)|Other|8|||
126795431|NCT01439880|456210906|FG001|SOC-controlled Period (Year 1)|Other|13|||
126795432|NCT01439880|456210905|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
126795433|NCT01439880|456210906|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
126795434|NCT01439880|456210905|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
126795435|NCT01439880|456210906|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
126795436|NCT01439880|456210905|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
126795437|NCT01439880|456210906|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
126795438|NCT01439880|456210905|FG000|All-IP Period (Years 2 to 5)|Death|3|||
126795439|NCT01439880|456210906|FG001|All-IP Period (Years 2 to 5)|Death|13|||
126795440|NCT01439880|456210905|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
126795441|NCT01439880|456210906|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
126795442|NCT01439880|456210905|FG000|All-IP Period (Years 2 to 5)|Other|14|||
126795443|NCT01439880|456210906|FG001|All-IP Period (Years 2 to 5)|Other|31|||
126795444|NCT01439880|456210905|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
126795445|NCT01439880|456210906|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
126795446|NCT03874715|456210908|FG000|Overall Study|Adverse Event|2|||
126795447|NCT03874715|456210909|FG001|Overall Study|Adverse Event|0|||
126795448|NCT03874715|456210908|FG000|Overall Study|Poor compliance to protocol|5|||
126795449|NCT03874715|456210909|FG001|Overall Study|Poor compliance to protocol|1|||
126795450|NCT03874715|456210908|FG000|Overall Study|Withdrawal by Subject|1|||
126795451|NCT03874715|456210909|FG001|Overall Study|Withdrawal by Subject|0|||
126795452|NCT03874715|456210908|FG000|Overall Study|Other-unspecified|1|||
126795453|NCT03874715|456210909|FG001|Overall Study|Other-unspecified|0|||
126795454|NCT02956460|456210912|FG000|Lens 1|Lost to Follow-up|1|||
126795455|NCT02956460|456210913|FG001|Lens 1|Lost to Follow-up|0|||
126795456|NCT00834067|456210916|FG000|Washout of 21 Days|Protocol Violation|0|||
126795457|NCT00834067|456210917|FG001|Washout of 21 Days|Protocol Violation|1|||
126795458|NCT04129346|456210918|FG000|Overall Study|Death|1|||
126795459|NCT04129346|456210919|FG001|Overall Study|Death|0|||
126795460|NCT01083693|456210920|FG000|Overall Study|Adverse Event|1|||
126795461|NCT01083693|456210921|FG001|Overall Study|Adverse Event|1|||
126795462|NCT01083693|456210922|FG002|Overall Study|Adverse Event|0|||
126795463|NCT01083693|456210920|FG000|Overall Study|Lost to Follow-up|2|||
126795464|NCT01083693|456210921|FG001|Overall Study|Lost to Follow-up|0|||
126795465|NCT01083693|456210922|FG002|Overall Study|Lost to Follow-up|2|||
126795466|NCT01083693|456210920|FG000|Overall Study|Lack of effectiveness|13|||
126795467|NCT01083693|456210921|FG001|Overall Study|Lack of effectiveness|2|||
126795468|NCT01083693|456210922|FG002|Overall Study|Lack of effectiveness|2|||
126795469|NCT01083693|456210920|FG000|Overall Study|Patient Moved|0|||
126795470|NCT01083693|456210921|FG001|Overall Study|Patient Moved|1|||
126795471|NCT01083693|456210922|FG002|Overall Study|Patient Moved|0|||
126795472|NCT01083693|456210920|FG000|Overall Study|Complete remission|0|||
126795473|NCT01083693|456210921|FG001|Overall Study|Complete remission|1|||
126795474|NCT01083693|456210922|FG002|Overall Study|Complete remission|0|||
126795475|NCT01083693|456210920|FG000|Overall Study|Other medical condition/surgery|1|||
126795476|NCT01083693|456210921|FG001|Overall Study|Other medical condition/surgery|1|||
126795477|NCT01083693|456210922|FG002|Overall Study|Other medical condition/surgery|0|||
126795478|NCT01083693|456210920|FG000|Overall Study|Withdrawal by Subject|3|||
126795479|NCT01083693|456210921|FG001|Overall Study|Withdrawal by Subject|0|||
126795480|NCT01083693|456210922|FG002|Overall Study|Withdrawal by Subject|2|||
126795481|NCT01083693|456210920|FG000|Overall Study|Reason unknown|0|||
126795482|NCT01083693|456210921|FG001|Overall Study|Reason unknown|0|||
126795483|NCT01083693|456210922|FG002|Overall Study|Reason unknown|1|||
126795484|NCT01602419|456210925|FG000|Overall Study|Not treated with Wilate|9|||
126795485|NCT01602419|456210925|FG000|Overall Study|Adverse Drug Reaction|4|||
126795486|NCT01602419|456210925|FG000|Overall Study|Insurance issues|3|||
126795487|NCT01602419|456210925|FG000|Overall Study|Changed treatment centre|1|||
126795488|NCT01602419|456210925|FG000|Overall Study|Treatment centre closed|1|||
126795489|NCT01602419|456210925|FG000|Overall Study|Withdrawal by Subject|5|||
126795490|NCT01602419|456210925|FG000|Overall Study|Lost to Follow-up|6|||
126795491|NCT01792635|456210926|FG000|Part B|Adverse Event|0|||
126795492|NCT01792635|456210927|FG001|Part B|Adverse Event|0|||
126795493|NCT01792635|456210928|FG002|Part B|Adverse Event|1|||
126795494|NCT01792635|456210926|FG000|Part B|Study terminated|0|||
126795495|NCT01792635|456210927|FG001|Part B|Study terminated|4|||
126795496|NCT01792635|456210928|FG002|Part B|Study terminated|3|||
126795497|NCT01513174|456210932|FG000|Overall Study|Inclusion Error|1|||
126795498|NCT01513174|456210933|FG001|Overall Study|Inclusion Error|7|||
126795499|NCT01513174|456210932|FG000|Overall Study|Not receive study treatment|3|||
126795500|NCT01513174|456210933|FG001|Overall Study|Not receive study treatment|1|||
126795501|NCT02682784|456210941|FG000|Overall Study|Withdrawal by Subject|0|||
126795502|NCT02682784|456210942|FG001|Overall Study|Withdrawal by Subject|2|||
126795503|NCT02682784|456210943|FG002|Overall Study|Withdrawal by Subject|1|||
126795504|NCT02682784|456210944|FG003|Overall Study|Withdrawal by Subject|2|||
126795505|NCT02682784|456210941|FG000|Overall Study|Physician Decision|1|||
126795506|NCT02682784|456210942|FG001|Overall Study|Physician Decision|0|||
126795507|NCT02682784|456210943|FG002|Overall Study|Physician Decision|1|||
126795508|NCT02682784|456210944|FG003|Overall Study|Physician Decision|1|||
126795509|NCT00467363|456210945|FG000|Overall Study|Lost to Follow-up|80|||
126795510|NCT00467363|456210946|FG001|Overall Study|Lost to Follow-up|70|||
126795511|NCT03138967|456210950|FG000|Overall Study|Death|0|||
126795512|NCT03138967|456210951|FG001|Overall Study|Death|1|||
126795513|NCT03138967|456210950|FG000|Overall Study|Physician Decision|1|||
126795514|NCT03138967|456210951|FG001|Overall Study|Physician Decision|3|||
126795515|NCT00836056|456210953|FG000|First Intervention|Adverse Event|1|||
126795516|NCT00836056|456210954|FG001|First Intervention|Adverse Event|0|||
126795517|NCT02711852|456210956|FG000|Overall Study|Death|5|||
126795518|NCT02711852|456210956|FG000|Overall Study|Lost to Follow-up|1|||
126795519|NCT02711852|456210956|FG000|Overall Study|Completed follow-up|3|||
126795520|NCT02711852|456210956|FG000|Overall Study|Withdrawal by Subject|1|||
126795521|NCT02453386|456210961|FG000|Overall Study|Adverse Event|22|||
126795522|NCT02453386|456210962|FG001|Overall Study|Adverse Event|30|||
126795523|NCT02453386|456210963|FG002|Overall Study|Adverse Event|15|||
126795524|NCT02453386|456210961|FG000|Overall Study|Protocol Violation|1|||
126795525|NCT02453386|456210962|FG001|Overall Study|Protocol Violation|0|||
126795526|NCT02453386|456210963|FG002|Overall Study|Protocol Violation|1|||
126795527|NCT02453386|456210961|FG000|Overall Study|Withdrawal by Subject|10|||
126795528|NCT02453386|456210962|FG001|Overall Study|Withdrawal by Subject|9|||
126795529|NCT02453386|456210963|FG002|Overall Study|Withdrawal by Subject|9|||
126795530|NCT02453386|456210961|FG000|Overall Study|Sponsor Terminated Study|14|||
126795531|NCT02453386|456210962|FG001|Overall Study|Sponsor Terminated Study|8|||
126795532|NCT02453386|456210963|FG002|Overall Study|Sponsor Terminated Study|11|||
126795533|NCT02453386|456210961|FG000|Overall Study|Subject Terminated by Sponsor|1|||
126795534|NCT02453386|456210962|FG001|Overall Study|Subject Terminated by Sponsor|1|||
126795535|NCT02453386|456210963|FG002|Overall Study|Subject Terminated by Sponsor|1|||
126795536|NCT02453386|456210961|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
126795537|NCT02453386|456210962|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
126632893|NCT00543062|455615681|FG003|Overall Study|Protocol Violation|0|||
126795538|NCT02453386|456210963|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
126795539|NCT02453386|456210961|FG000|Overall Study|Lost to Follow-up|0|||
126795540|NCT02453386|456210962|FG001|Overall Study|Lost to Follow-up|0|||
126795541|NCT02453386|456210963|FG002|Overall Study|Lost to Follow-up|1|||
126795542|NCT02453386|456210961|FG000|Overall Study|Other|1|||
126795543|NCT02453386|456210962|FG001|Overall Study|Other|0|||
126795544|NCT02453386|456210963|FG002|Overall Study|Other|1|||
126795545|NCT00465270|456210975|FG000|Overall Study|Death|7|||
126795546|NCT00465270|456210976|FG001|Overall Study|Death|11|||
126795547|NCT00465270|456210975|FG000|Overall Study|Withdrawal by Subject|34|||
126795548|NCT00465270|456210976|FG001|Overall Study|Withdrawal by Subject|78|||
126795549|NCT00465270|456210975|FG000|Overall Study|Lost to Follow-up|60|||
126795550|NCT00465270|456210976|FG001|Overall Study|Lost to Follow-up|67|||
126795551|NCT00465270|456210975|FG000|Overall Study|Investigator request|3|||
126795552|NCT00465270|456210976|FG001|Overall Study|Investigator request|4|||
126795553|NCT03233724|456210988|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
126795554|NCT03233724|456210989|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
126795555|NCT03233724|456210990|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
126795556|NCT03233724|456210991|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
126795557|NCT03233724|456210992|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
126795558|NCT03233724|456210988|FG000|Phase I Dose Escalation|Best interest of participant|1|||
126795559|NCT03233724|456210989|FG001|Phase I Dose Escalation|Best interest of participant|1|||
126795560|NCT03233724|456210990|FG002|Phase I Dose Escalation|Best interest of participant|1|||
126795561|NCT03233724|456210991|FG003|Phase I Dose Escalation|Best interest of participant|0|||
126795562|NCT03233724|456210992|FG004|Phase I Dose Escalation|Best interest of participant|0|||
126795563|NCT03233724|456210988|FG000|Phase I Dose Escalation|Physician Decision|0|||
126795564|NCT03233724|456210989|FG001|Phase I Dose Escalation|Physician Decision|0|||
126795565|NCT03233724|456210990|FG002|Phase I Dose Escalation|Physician Decision|1|||
126795566|NCT03233724|456210991|FG003|Phase I Dose Escalation|Physician Decision|0|||
126795567|NCT03233724|456210992|FG004|Phase I Dose Escalation|Physician Decision|0|||
126795568|NCT03233724|456210988|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
126795569|NCT03233724|456210989|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
126795570|NCT03233724|456210990|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
126795571|NCT03233724|456210991|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
126795572|NCT03233724|456210992|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
126795573|NCT02388191|456210994|FG000|Overall Study|Patient did not receive IUD|1|||
126795574|NCT02388191|456210995|FG001|Overall Study|Patient did not receive IUD|0|||
126795575|NCT03197883|456210996|FG000|Overall Study|Adverse Event|1|||
126795576|NCT03197883|456210997|FG001|Overall Study|Adverse Event|1|||
126795577|NCT03197883|456210996|FG000|Overall Study|Lost to Follow-up|1|||
126795578|NCT03197883|456210997|FG001|Overall Study|Lost to Follow-up|0|||
126795579|NCT03197883|456210996|FG000|Overall Study|Protocol Violation|1|||
126795580|NCT03197883|456210997|FG001|Overall Study|Protocol Violation|0|||
126795581|NCT03197883|456210996|FG000|Overall Study|Other (Not Specified)|0|||
126795582|NCT03197883|456210997|FG001|Overall Study|Other (Not Specified)|5|||
126795583|NCT01045161|456210998|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
126795584|NCT01045161|456210999|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
126795585|NCT01045161|456211000|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
126795586|NCT01045161|456210998|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
126795587|NCT01045161|456210999|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
126795588|NCT01045161|456211000|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
126795589|NCT01045161|456210998|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
126795590|NCT01045161|456210999|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
126795591|NCT01045161|456211000|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
126795592|NCT01045161|456210998|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
126795593|NCT01045161|456210999|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
126795594|NCT01045161|456211000|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
126795595|NCT01045161|456210998|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
126795596|NCT01045161|456210999|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
126795597|NCT01045161|456211000|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
126795598|NCT01045161|456210998|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
126795599|NCT01045161|456210999|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
126795600|NCT01045161|456211000|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
126795601|NCT01045161|456210998|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
126795602|NCT01045161|456210999|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
126795603|NCT01045161|456211000|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
126795604|NCT01045161|456210998|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
126795605|NCT01045161|456210999|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
126795606|NCT01045161|456211000|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
126795607|NCT01045161|456210998|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
126795608|NCT01045161|456210999|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
126795609|NCT01045161|456211000|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
126795610|NCT01045161|456210998|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
126795611|NCT01045161|456210999|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
126795612|NCT01045161|456211000|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
126795613|NCT01045161|456210998|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
126795614|NCT01045161|456210999|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
126795615|NCT01045161|456211000|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
126795616|NCT01045161|456210998|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
126795617|NCT01045161|456210999|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
126795618|NCT01045161|456211000|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
126795619|NCT01045161|456210998|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
126795620|NCT01045161|456210999|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
126795621|NCT01045161|456211000|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
126795622|NCT01045161|456210998|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
126795623|NCT01045161|456210999|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
126795624|NCT01045161|456211000|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
126795625|NCT03686033|456211001|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
126795626|NCT03686033|456211002|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
126795627|NCT03686033|456211003|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
126795628|NCT03686033|456211004|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
126795629|NCT03686033|456211005|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
126795630|NCT03686033|456211006|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
126795631|NCT00858845|456211008|FG000|Overall Study|Patient underwent heart transplant.|0|||
126795632|NCT00858845|456211009|FG001|Overall Study|Patient underwent heart transplant.|1|||
126795633|NCT03031847|456211010|FG000|Overall Study|Death|1|||
126795634|NCT03031847|456211011|FG001|Overall Study|Death|1|||
126795635|NCT03031847|456211012|FG002|Overall Study|Death|2|||
126795636|NCT03031847|456211013|FG003|Overall Study|Death|3|||
126795637|NCT03031847|456211010|FG000|Overall Study|Lost to Follow-up|1|||
126795638|NCT03031847|456211011|FG001|Overall Study|Lost to Follow-up|1|||
126795639|NCT03031847|456211012|FG002|Overall Study|Lost to Follow-up|2|||
126795640|NCT03031847|456211013|FG003|Overall Study|Lost to Follow-up|3|||
126795641|NCT01353664|456211015|FG000|Overall Study|Other|3|||
126795642|NCT01353664|456211015|FG000|Overall Study|Disease Progression|16|||
126795643|NCT02605928|456211018|FG000|Overall Study|Model tuning phase|28|||
126795644|NCT02605928|456211018|FG000|Overall Study|Lack of Efficacy|5|||
126795645|NCT02089997|456211028|FG000|Overall Study|Case report forms uncollected|99|||
126795646|NCT02089997|456211028|FG000|Overall Study|Protocol Violation|147|||
126795647|NCT02441309|456211029|FG000|Overall Study|Disease progression|2|||
126795648|NCT02441309|456211030|FG001|Overall Study|Disease progression|1|||
126795649|NCT02441309|456211031|FG002|Overall Study|Disease progression|2|||
126795650|NCT02441309|456211029|FG000|Overall Study|Adverse Event|0|||
126795651|NCT02441309|456211030|FG001|Overall Study|Adverse Event|1|||
126795652|NCT02441309|456211031|FG002|Overall Study|Adverse Event|0|||
126795653|NCT02441309|456211029|FG000|Overall Study|Withdrawal by Subject|1|||
126795654|NCT02441309|456211030|FG001|Overall Study|Withdrawal by Subject|0|||
126795655|NCT02441309|456211031|FG002|Overall Study|Withdrawal by Subject|1|||
126795656|NCT02335658|456211036|FG000|Overall Study|Adverse Event|18|||
126795657|NCT02335658|456211037|FG001|Overall Study|Adverse Event|12|||
126795658|NCT02335658|456211036|FG000|Overall Study|Lack of Efficacy|4|||
126795659|NCT02335658|456211037|FG001|Overall Study|Lack of Efficacy|5|||
126795660|NCT02335658|456211036|FG000|Overall Study|Pregnancy|1|||
126795661|NCT02335658|456211037|FG001|Overall Study|Pregnancy|0|||
126795662|NCT02335658|456211036|FG000|Overall Study|Withdrawal by Subject|13|||
126795663|NCT02335658|456211037|FG001|Overall Study|Withdrawal by Subject|21|||
126795664|NCT02335658|456211036|FG000|Overall Study|non-compliance|2|||
126795665|NCT02335658|456211037|FG001|Overall Study|non-compliance|3|||
126795666|NCT02335658|456211036|FG000|Overall Study|other reason|2|||
126795667|NCT02335658|456211037|FG001|Overall Study|other reason|3|||
126795668|NCT02305758|456211038|FG000|Overall Study|Death|27|||
126795669|NCT02305758|456211039|FG001|Overall Study|Death|27|||
126795670|NCT02305758|456211038|FG000|Overall Study|Withdrew consent|9|||
126795671|NCT02305758|456211039|FG001|Overall Study|Withdrew consent|2|||
126795672|NCT02305758|456211038|FG000|Overall Study|Lost to Follow-up|6|||
126795673|NCT02305758|456211039|FG001|Overall Study|Lost to Follow-up|1|||
126795674|NCT02305758|456211038|FG000|Overall Study|Study Terminated by Sponsor|21|||
126795675|NCT02305758|456211039|FG001|Overall Study|Study Terminated by Sponsor|34|||
126795676|NCT02305758|456211038|FG000|Overall Study|Other, not specified|2|||
126795677|NCT02305758|456211039|FG001|Overall Study|Other, not specified|1|||
126795678|NCT02032888|456211040|FG000|Treatment Period|Poor compliance/noncompliance|1|||
126795679|NCT02032888|456211041|FG001|Treatment Period|Poor compliance/noncompliance|1|||
126795680|NCT02032888|456211042|FG002|Treatment Period|Poor compliance/noncompliance|0|||
126795681|NCT02032888|456211040|FG000|Treatment Period|Other|1|||
126795682|NCT02032888|456211041|FG001|Treatment Period|Other|1|||
126795683|NCT02032888|456211042|FG002|Treatment Period|Other|0|||
126795684|NCT02032888|456211040|FG000|Follow-up Period|Lost to Follow-up|1|||
126795685|NCT02032888|456211041|FG001|Follow-up Period|Lost to Follow-up|1|||
126795686|NCT02032888|456211042|FG002|Follow-up Period|Lost to Follow-up|0|||
126795687|NCT02032888|456211040|FG000|Follow-up Period|Death|1|||
126795688|NCT02032888|456211041|FG001|Follow-up Period|Death|1|||
126795689|NCT02032888|456211042|FG002|Follow-up Period|Death|0|||
126795690|NCT02032888|456211040|FG000|Follow-up Period|Other|1|||
126795691|NCT02032888|456211041|FG001|Follow-up Period|Other|0|||
126795692|NCT02032888|456211042|FG002|Follow-up Period|Other|0|||
126795693|NCT03616106|456211045|FG000|Overall Study|Removed by PI|6|||
126795694|NCT03616106|456211046|FG001|Overall Study|Removed by PI|0|||
126795695|NCT03616106|456211045|FG000|Overall Study|Withdrawal by Subject|1|||
126795696|NCT03616106|456211046|FG001|Overall Study|Withdrawal by Subject|1|||
126795697|NCT03616106|456211045|FG000|Overall Study|Lost to Follow-up|7|||
126795698|NCT03616106|456211046|FG001|Overall Study|Lost to Follow-up|0|||
126795699|NCT02445339|456211048|FG000|Overall Study|Physician Decision|1|||
126795700|NCT02445339|456211049|FG001|Overall Study|Physician Decision|0|||
126795701|NCT02445339|456211048|FG000|Overall Study|Lost to Follow-up|11|||
126795702|NCT02445339|456211049|FG001|Overall Study|Lost to Follow-up|15|||
126795703|NCT03206177|456211050|FG000|Overall Study|Withdrawal by Subject|1|||
126795704|NCT00939003|456211052|FG000|Double-blind Treatment Period|Adverse Event|1|||
126795705|NCT00939003|456211053|FG001|Double-blind Treatment Period|Adverse Event|1|||
126795706|NCT00939003|456211052|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
126795707|NCT00939003|456211053|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
126795708|NCT00939003|456211052|FG000|Double-blind Treatment Period|Pregnancy|0|||
126795709|NCT00939003|456211053|FG001|Double-blind Treatment Period|Pregnancy|1|||
126795710|NCT00939003|456211052|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
126795711|NCT00939003|456211053|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
126795712|NCT00939003|456211052|FG000|Open-label Treatment Period|Adverse Event|4|||
126795713|NCT00939003|456211053|FG001|Open-label Treatment Period|Adverse Event|8|||
126795714|NCT00939003|456211052|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
126795715|NCT00939003|456211053|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
126795716|NCT00939003|456211052|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
126795717|NCT00939003|456211053|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
126795718|NCT00939003|456211052|FG000|Open-label Treatment Period|Pregnancy|1|||
126795719|NCT00939003|456211053|FG001|Open-label Treatment Period|Pregnancy|1|||
126795720|NCT00939003|456211052|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
126795721|NCT00939003|456211053|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
126795722|NCT00939003|456211052|FG000|Open-label Treatment Period|Site Closure|3|||
126795723|NCT00939003|456211053|FG001|Open-label Treatment Period|Site Closure|4|||
126795724|NCT02131129|456211054|FG000|Overall Study|Withdrawal by Subject|1|||
126795725|NCT02131129|456211055|FG001|Overall Study|Withdrawal by Subject|0|||
126795726|NCT00727961|456211056|FG000|Overall Study|Lost to Follow-up|1|||
126795727|NCT00727961|456211056|FG000|Overall Study|Adverse Event|4|||
126795728|NCT00727961|456211056|FG000|Overall Study|Patient's refusal|2|||
126795729|NCT00727961|456211056|FG000|Overall Study|Progression|30|||
126795730|NCT02865122|456211057|FG000|Overall Study|Adverse Event|1|||
126795731|NCT02865122|456211058|FG001|Overall Study|Adverse Event|0|||
126795732|NCT02865122|456211059|FG002|Overall Study|Adverse Event|0|||
126795733|NCT03880266|456211060|FG000|Overall Study|Withdrawal by Subject|0|||
126795734|NCT03880266|456211061|FG001|Overall Study|Withdrawal by Subject|1|||
126795735|NCT03880266|456211062|FG002|Overall Study|Withdrawal by Subject|1|||
126795736|NCT03880266|456211063|FG003|Overall Study|Withdrawal by Subject|0|||
126795737|NCT03880266|456211064|FG004|Overall Study|Withdrawal by Subject|0|||
126795738|NCT03880266|456211065|FG005|Overall Study|Withdrawal by Subject|0|||
126795739|NCT03880266|456211066|FG006|Overall Study|Withdrawal by Subject|0|||
126795740|NCT03880266|456211067|FG007|Overall Study|Withdrawal by Subject|0|||
126795741|NCT03161405|456211068|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
126795742|NCT00837486|456211069|FG000|Blinded-treatment Phase|Physician Decision|1|||
126795743|NCT00837486|456211070|FG001|Blinded-treatment Phase|Physician Decision|0|||
126795744|NCT00837486|456211069|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
126795745|NCT00837486|456211070|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
126795746|NCT00837486|456211069|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
126795747|NCT00837486|456211070|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
126795748|NCT00837486|456211069|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
126795749|NCT00837486|456211070|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
126795750|NCT01421277|456211072|FG000|Overall Study|Lack of qualifying event|0|||
126795751|NCT01421277|456211073|FG001|Overall Study|Lack of qualifying event|61|||
126795752|NCT01421277|456211072|FG000|Overall Study|Incomplete baseline data|0|||
126795753|NCT01421277|456211073|FG001|Overall Study|Incomplete baseline data|31|||
126795754|NCT00834249|456212757|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
126795755|NCT00834249|456212758|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
126795756|NCT00834249|456212757|FG000|Second Intervention|Adverse Event|1|||
126795757|NCT00834249|456212758|FG001|Second Intervention|Adverse Event|0|||
126795758|NCT01015703|456212761|FG000|Overall Study|Withdrawal by Subject|0|||
126795759|NCT01015703|456212762|FG001|Overall Study|Withdrawal by Subject|1|||
126795760|NCT01015703|456212763|FG002|Overall Study|Withdrawal by Subject|0|||
126795761|NCT01015703|456212764|FG003|Overall Study|Withdrawal by Subject|0|||
126795762|NCT01015703|456212765|FG004|Overall Study|Withdrawal by Subject|0|||
126795763|NCT01015703|456212761|FG000|Overall Study|Adverse Event|1|||
126795764|NCT01015703|456212762|FG001|Overall Study|Adverse Event|0|||
126795765|NCT01015703|456212763|FG002|Overall Study|Adverse Event|0|||
126795766|NCT01015703|456212764|FG003|Overall Study|Adverse Event|0|||
126795767|NCT01015703|456212765|FG004|Overall Study|Adverse Event|0|||
126795768|NCT01015703|456212761|FG000|Overall Study|Protocol Violation|1|||
126795769|NCT01015703|456212762|FG001|Overall Study|Protocol Violation|0|||
126795770|NCT01015703|456212763|FG002|Overall Study|Protocol Violation|0|||
126795771|NCT01015703|456212764|FG003|Overall Study|Protocol Violation|0|||
126795772|NCT01015703|456212765|FG004|Overall Study|Protocol Violation|0|||
126795773|NCT02718326|456212766|FG000|Overall Study|Adverse Event|4|||
126795774|NCT02718326|456212767|FG001|Overall Study|Adverse Event|9|||
126795775|NCT02718326|456212768|FG002|Overall Study|Adverse Event|0|||
126795776|NCT02718326|456212766|FG000|Overall Study|Death|8|||
126795777|NCT02718326|456212767|FG001|Overall Study|Death|1|||
126795778|NCT02718326|456212768|FG002|Overall Study|Death|2|||
126795779|NCT02718326|456212766|FG000|Overall Study|Withdrawal by Subject|4|||
126795780|NCT02718326|456212767|FG001|Overall Study|Withdrawal by Subject|9|||
126795781|NCT02718326|456212768|FG002|Overall Study|Withdrawal by Subject|6|||
126795782|NCT02718326|456212766|FG000|Overall Study|Lost to Follow-up|18|||
126795783|NCT02718326|456212767|FG001|Overall Study|Lost to Follow-up|5|||
126795784|NCT02718326|456212768|FG002|Overall Study|Lost to Follow-up|14|||
126795785|NCT02718326|456212766|FG000|Overall Study|Protocol Deviation|1|||
126795786|NCT02718326|456212767|FG001|Overall Study|Protocol Deviation|0|||
126795787|NCT02718326|456212768|FG002|Overall Study|Protocol Deviation|0|||
126795788|NCT02718326|456212766|FG000|Overall Study|Pregnancy|1|||
126795789|NCT02718326|456212767|FG001|Overall Study|Pregnancy|0|||
126795790|NCT02718326|456212768|FG002|Overall Study|Pregnancy|0|||
126795791|NCT03122535|456212769|FG000|Overall Study|Lost to Follow-up|68|||
126795792|NCT03122535|456212770|FG001|Overall Study|Lost to Follow-up|68|||
126795793|NCT03122535|456212769|FG000|Overall Study|Physician Decision|3|||
126795794|NCT03122535|456212770|FG001|Overall Study|Physician Decision|3|||
126795795|NCT03122535|456212769|FG000|Overall Study|Withdrawal by Subject|2|||
126795796|NCT03122535|456212770|FG001|Overall Study|Withdrawal by Subject|2|||
126795797|NCT01558635|456212774|FG000|Overall Study|Death|1|||
126795798|NCT01558635|456212774|FG000|Overall Study|Withdrawal by Subject|2|||
126795799|NCT01558635|456212774|FG000|Overall Study|Physician Decision|1|||
126795800|NCT01558635|456212774|FG000|Overall Study|Subject received other treatment|1|||
126795801|NCT01558635|456212774|FG000|Overall Study|Reveal XT was explanted|1|||
126795802|NCT00834418|456212777|FG000|Overall Study|Adverse Event|0|||
126795803|NCT00834418|456212778|FG001|Overall Study|Adverse Event|2|||
126795804|NCT01705574|456212779|FG000|Double-Blind Phase|Lost to Follow-up|12|||
126795805|NCT01705574|456212780|FG001|Double-Blind Phase|Lost to Follow-up|16|||
126795806|NCT01705574|456212781|FG002|Double-Blind Phase|Lost to Follow-up|0|||
126795807|NCT01705574|456212782|FG003|Double-Blind Phase|Lost to Follow-up|0|||
126795808|NCT01705574|456212779|FG000|Double-Blind Phase|Adverse Event|3|||
126795809|NCT01705574|456212780|FG001|Double-Blind Phase|Adverse Event|10|||
126795810|NCT01705574|456212781|FG002|Double-Blind Phase|Adverse Event|0|||
126795811|NCT01705574|456212782|FG003|Double-Blind Phase|Adverse Event|0|||
126795812|NCT01705574|456212779|FG000|Double-Blind Phase|Withdrew Consent|8|||
126795813|NCT01705574|456212780|FG001|Double-Blind Phase|Withdrew Consent|5|||
126795814|NCT01705574|456212781|FG002|Double-Blind Phase|Withdrew Consent|0|||
126795815|NCT01705574|456212782|FG003|Double-Blind Phase|Withdrew Consent|0|||
126795816|NCT01705574|456212779|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
126795817|NCT01705574|456212780|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
126795818|NCT01705574|456212781|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
126795819|NCT01705574|456212782|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
126795820|NCT01705574|456212779|FG000|Double-Blind Phase|Pregnancy|1|||
126795821|NCT01705574|456212780|FG001|Double-Blind Phase|Pregnancy|1|||
126795822|NCT01705574|456212781|FG002|Double-Blind Phase|Pregnancy|0|||
126795823|NCT01705574|456212782|FG003|Double-Blind Phase|Pregnancy|0|||
126795824|NCT01705574|456212779|FG000|Double-Blind Phase|Protocol Violation|1|||
126795825|NCT01705574|456212780|FG001|Double-Blind Phase|Protocol Violation|0|||
126795826|NCT01705574|456212781|FG002|Double-Blind Phase|Protocol Violation|0|||
126795827|NCT01705574|456212782|FG003|Double-Blind Phase|Protocol Violation|0|||
126795828|NCT01705574|456212779|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
126795829|NCT01705574|456212780|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
126795830|NCT01705574|456212781|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
126795831|NCT01705574|456212782|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
126795832|NCT01705574|456212779|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
126795833|NCT01705574|456212780|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
126795834|NCT01705574|456212781|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
126795835|NCT01705574|456212782|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
126795836|NCT01705574|456212779|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
126795837|NCT01705574|456212780|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
126795838|NCT01705574|456212781|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
126795839|NCT01705574|456212782|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
126795840|NCT01705574|456212779|FG000|Open-Label Extension Phase|Adverse Event|3|||
126795841|NCT01705574|456212780|FG001|Open-Label Extension Phase|Adverse Event|0|||
126795842|NCT01705574|456212781|FG002|Open-Label Extension Phase|Adverse Event|0|||
126795843|NCT01705574|456212782|FG003|Open-Label Extension Phase|Adverse Event|1|||
126795844|NCT01705574|456212779|FG000|Open-Label Extension Phase|Death|2|||
126795845|NCT01705574|456212780|FG001|Open-Label Extension Phase|Death|0|||
126795846|NCT01705574|456212781|FG002|Open-Label Extension Phase|Death|1|||
126795847|NCT01705574|456212782|FG003|Open-Label Extension Phase|Death|0|||
126795848|NCT01705574|456212779|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
126795849|NCT01705574|456212780|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
126795850|NCT01705574|456212781|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
126795851|NCT01705574|456212782|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
126795852|NCT01705574|456212779|FG000|Open-Label Extension Phase|Physician Decision|0|||
126795853|NCT01705574|456212780|FG001|Open-Label Extension Phase|Physician Decision|0|||
126795854|NCT01705574|456212781|FG002|Open-Label Extension Phase|Physician Decision|2|||
126795855|NCT01705574|456212782|FG003|Open-Label Extension Phase|Physician Decision|0|||
126795856|NCT01705574|456212779|FG000|Open-Label Extension Phase|Pregnancy|0|||
126795857|NCT01705574|456212780|FG001|Open-Label Extension Phase|Pregnancy|0|||
126795858|NCT01705574|456212781|FG002|Open-Label Extension Phase|Pregnancy|1|||
126795859|NCT01705574|456212782|FG003|Open-Label Extension Phase|Pregnancy|1|||
126795860|NCT02543203|456212783|FG000|Overall Study|Unpalatable Fragrance|2|||
126795861|NCT02543203|456212784|FG001|Overall Study|Unpalatable Fragrance|2|||
126795862|NCT02543203|456212783|FG000|Overall Study|Lost to Follow-up|1|||
126795863|NCT02543203|456212784|FG001|Overall Study|Lost to Follow-up|0|||
126795864|NCT02543203|456212783|FG000|Overall Study|Increased Irritability|1|||
126795865|NCT02543203|456212784|FG001|Overall Study|Increased Irritability|0|||
126795866|NCT02543203|456212783|FG000|Overall Study|Family|1|||
126795867|NCT02543203|456212784|FG001|Overall Study|Family|2|||
126795868|NCT02543203|456212783|FG000|Overall Study|Negative Behavior|1|||
126795869|NCT02543203|456212784|FG001|Overall Study|Negative Behavior|0|||
126795870|NCT02543203|456212783|FG000|Overall Study|Withdrawal by Subject|0|||
126795871|NCT02543203|456212784|FG001|Overall Study|Withdrawal by Subject|1|||
126795872|NCT00089661|456212785|FG000|Overall Study|Adverse Event|0|||
126795873|NCT00089661|456212786|FG001|Overall Study|Adverse Event|2|||
126795874|NCT00089661|456212785|FG000|Overall Study|Death|1|||
126795875|NCT00089661|456212786|FG001|Overall Study|Death|0|||
126795876|NCT00089661|456212785|FG000|Overall Study|Lost to Follow-up|0|||
126795877|NCT00089661|456212786|FG001|Overall Study|Lost to Follow-up|3|||
126795878|NCT00089661|456212785|FG000|Overall Study|Withdrawal by Subject|11|||
126795879|NCT00089661|456212786|FG001|Overall Study|Withdrawal by Subject|9|||
126795880|NCT00089661|456212785|FG000|Overall Study|Disease progression|1|||
126795881|NCT00089661|456212786|FG001|Overall Study|Disease progression|3|||
126795882|NCT00089661|456212785|FG000|Overall Study|Ineligibility determined|4|||
126795883|NCT00089661|456212786|FG001|Overall Study|Ineligibility determined|4|||
126795884|NCT00089661|456212785|FG000|Overall Study|Noncompliance|2|||
126795885|NCT00089661|456212786|FG001|Overall Study|Noncompliance|4|||
126795886|NCT00089661|456212785|FG000|Overall Study|Other|2|||
126795887|NCT00089661|456212786|FG001|Overall Study|Other|1|||
126795888|NCT01273805|456212787|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
126795889|NCT01273805|456212788|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
126795890|NCT02647944|456212789|FG000|Overall Study|Withdrawal by Subject|0|||
126795891|NCT02647944|456212790|FG001|Overall Study|Withdrawal by Subject|3|||
126795892|NCT02647944|456212789|FG000|Overall Study|Adverse Event|2|||
126795893|NCT02647944|456212790|FG001|Overall Study|Adverse Event|0|||
126795894|NCT02077465|456212791|FG000|Overall Study|Withdrew Consent|0|||
126795895|NCT02077465|456212792|FG001|Overall Study|Withdrew Consent|1|||
126795896|NCT02077465|456212791|FG000|Overall Study|Lost to Follow-up|1|||
126795897|NCT02077465|456212792|FG001|Overall Study|Lost to Follow-up|0|||
126795898|NCT02760368|456212794|FG000|Overall Study|Withdrawal by Subject|8|||
126795899|NCT02760368|456212795|FG001|Overall Study|Withdrawal by Subject|12|||
126795900|NCT02760368|456212796|FG002|Overall Study|Withdrawal by Subject|9|||
126795901|NCT02760368|456212794|FG000|Overall Study|Screen Failure|0|||
126795902|NCT02760368|456212795|FG001|Overall Study|Screen Failure|0|||
126795903|NCT02760368|456212796|FG002|Overall Study|Screen Failure|1|||
126795904|NCT02760368|456212794|FG000|Overall Study|Death|0|||
126795905|NCT02760368|456212795|FG001|Overall Study|Death|1|||
126795906|NCT02760368|456212796|FG002|Overall Study|Death|0|||
126795907|NCT02760368|456212794|FG000|Overall Study|Withdrawal by Sponsor|0|||
126795908|NCT02760368|456212795|FG001|Overall Study|Withdrawal by Sponsor|0|||
126795909|NCT02760368|456212796|FG002|Overall Study|Withdrawal by Sponsor|1|||
126795910|NCT01827163|456212797|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
126795911|NCT01827163|456212797|FG000|Overall Study|Adverse Event|9|||
126795912|NCT02294604|456212798|FG000|Overall Study|Did not provide samples for culture|0|||
126795913|NCT02294604|456212799|FG001|Overall Study|Did not provide samples for culture|1|||
126795914|NCT02294604|456212800|FG002|Overall Study|Did not provide samples for culture|0|||
126795915|NCT02294604|456212798|FG000|Overall Study|Culture contamination|1|||
126795916|NCT02294604|456212799|FG001|Overall Study|Culture contamination|2|||
126795917|NCT02294604|456212800|FG002|Overall Study|Culture contamination|0|||
126795918|NCT02902211|456212803|FG000|First Three Months|Withdrawal by Subject|7|||
126795919|NCT02902211|456212804|FG001|First Three Months|Withdrawal by Subject|3|||
126795920|NCT01401647|456212807|FG000|Overall Study|Withdrawal by Subject|1|||
126795921|NCT01401647|456212808|FG001|Overall Study|Withdrawal by Subject|5|||
126795922|NCT01401647|456212809|FG002|Overall Study|Withdrawal by Subject|2|||
126795923|NCT01401647|456212807|FG000|Overall Study|Lost to Follow-up|3|||
126795924|NCT01401647|456212808|FG001|Overall Study|Lost to Follow-up|3|||
126795925|NCT01401647|456212809|FG002|Overall Study|Lost to Follow-up|1|||
126795926|NCT00473330|456212813|FG000|Core Study|Adverse Event|4|||
126795927|NCT00473330|456212814|FG001|Core Study|Adverse Event|4|||
126795928|NCT00473330|456212815|FG002|Core Study|Adverse Event|1|||
126795929|NCT00473330|456212813|FG000|Core Study|Death|6|||
126795930|NCT00473330|456212814|FG001|Core Study|Death|4|||
126795931|NCT00473330|456212815|FG002|Core Study|Death|4|||
126795932|NCT00473330|456212813|FG000|Core Study|Lost to Follow-up|5|||
126795933|NCT00473330|456212814|FG001|Core Study|Lost to Follow-up|5|||
126795934|NCT00473330|456212815|FG002|Core Study|Lost to Follow-up|10|||
126795935|NCT00473330|456212813|FG000|Core Study|Physician Decision|2|||
126795936|NCT00473330|456212814|FG001|Core Study|Physician Decision|1|||
126795937|NCT00473330|456212815|FG002|Core Study|Physician Decision|3|||
126795938|NCT00473330|456212813|FG000|Core Study|Subject Non-compliance|1|||
126795939|NCT00473330|456212814|FG001|Core Study|Subject Non-compliance|2|||
126795940|NCT00473330|456212815|FG002|Core Study|Subject Non-compliance|1|||
126795941|NCT00473330|456212813|FG000|Core Study|Subject Required Other Therapy|0|||
126795942|NCT00473330|456212814|FG001|Core Study|Subject Required Other Therapy|1|||
126795943|NCT00473330|456212815|FG002|Core Study|Subject Required Other Therapy|3|||
126795944|NCT00473330|456212813|FG000|Core Study|Subject's Decision|9|||
126795945|NCT00473330|456212814|FG001|Core Study|Subject's Decision|8|||
126795946|NCT00473330|456212815|FG002|Core Study|Subject's Decision|19|||
126795947|NCT00473330|456212813|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
126795948|NCT00473330|456212814|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
126795949|NCT00473330|456212815|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
126795950|NCT00473330|456212813|FG000|Open-label Extension Through Month 48|Death|2|||
126795951|NCT00473330|456212814|FG001|Open-label Extension Through Month 48|Death|0|||
126795952|NCT00473330|456212815|FG002|Open-label Extension Through Month 48|Death|0|||
126795953|NCT00473330|456212813|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
126795954|NCT00473330|456212814|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
126795955|NCT00473330|456212815|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
126795956|NCT00473330|456212813|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
126795957|NCT00473330|456212814|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
126795958|NCT00473330|456212815|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
126795959|NCT00473330|456212813|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
126795960|NCT00473330|456212814|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
126795961|NCT00473330|456212815|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
126795962|NCT00473330|456212813|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
126795963|NCT00473330|456212814|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
126795964|NCT00473330|456212815|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
126795965|NCT00473330|456212813|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
126795966|NCT00473330|456212814|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
126795967|NCT00473330|456212815|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
126795968|NCT00473330|456212813|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
126795969|NCT00473330|456212814|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
126795970|NCT00473330|456212815|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
126795971|NCT00473330|456212813|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
126795972|NCT00473330|456212814|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
126795973|NCT00473330|456212815|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
126795974|NCT00473330|456212813|FG000|Open-label Extension Through Month 60|Death|2|||
126795975|NCT00473330|456212814|FG001|Open-label Extension Through Month 60|Death|2|||
126795976|NCT00473330|456212815|FG002|Open-label Extension Through Month 60|Death|1|||
126795977|NCT00473330|456212813|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
126795978|NCT00473330|456212814|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
126795979|NCT00473330|456212815|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
126795980|NCT00473330|456212813|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
126795981|NCT00473330|456212814|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
126795982|NCT00473330|456212815|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
126795983|NCT00473330|456212813|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
126795984|NCT00473330|456212814|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
126795985|NCT00473330|456212815|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
126795986|NCT00473330|456212813|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
126795987|NCT00473330|456212814|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
126795988|NCT00473330|456212815|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
126795989|NCT00473330|456212813|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
126795990|NCT00473330|456212814|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
126795991|NCT00473330|456212815|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
126795992|NCT00473330|456212813|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
126795993|NCT00473330|456212814|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
126795994|NCT00473330|456212815|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
126795995|NCT01975948|456212816|FG000|Overall Study|Withdrawal by Subject|17|||
126795996|NCT01975948|456212817|FG001|Overall Study|Withdrawal by Subject|21|||
126795997|NCT01975948|456212818|FG002|Overall Study|Withdrawal by Subject|7|||
126795998|NCT01975948|456212819|FG003|Overall Study|Withdrawal by Subject|6|||
126795999|NCT01675765|456212820|FG000|Overall Study|Progressive disease|4|||
126796000|NCT01675765|456212821|FG001|Overall Study|Progressive disease|4|||
126796001|NCT01675765|456212820|FG000|Overall Study|Adverse Event|1|||
126796002|NCT01675765|456212821|FG001|Overall Study|Adverse Event|2|||
126796003|NCT01675765|456212820|FG000|Overall Study|Withdrawal by Subject|2|||
126796004|NCT01675765|456212821|FG001|Overall Study|Withdrawal by Subject|0|||
126796005|NCT01675765|456212820|FG000|Overall Study|Death|1|||
126796006|NCT01675765|456212821|FG001|Overall Study|Death|0|||
126796007|NCT01675765|456212820|FG000|Overall Study|Clinical progression|3|||
126796008|NCT01675765|456212821|FG001|Overall Study|Clinical progression|2|||
126796009|NCT00365846|456212823|FG000|Overall Study|Lost to Follow-up|1|||
126796010|NCT00960297|456212825|FG000|Overall Study|Physician Decision|1|||
126796011|NCT00960297|456212825|FG000|Overall Study|Venous port infection|1|||
126796012|NCT00960297|456212825|FG000|Overall Study|Disease progression|1|||
126796013|NCT03965091|456212833|FG000|Overall Study|Adverse Event|0|||
126796014|NCT03965091|456212834|FG001|Overall Study|Adverse Event|2|||
126796015|NCT03965091|456212835|FG002|Overall Study|Adverse Event|3|||
126796016|NCT03965091|456212833|FG000|Overall Study|Withdrawal by Subject|11|||
126796017|NCT03965091|456212834|FG001|Overall Study|Withdrawal by Subject|3|||
126796018|NCT03965091|456212835|FG002|Overall Study|Withdrawal by Subject|5|||
126796019|NCT03965091|456212833|FG000|Overall Study|Non-compliance with study drug|0|||
126796020|NCT03965091|456212834|FG001|Overall Study|Non-compliance with study drug|0|||
126796021|NCT03965091|456212835|FG002|Overall Study|Non-compliance with study drug|1|||
126796022|NCT03965091|456212833|FG000|Overall Study|Lost to Follow-up|1|||
126796023|NCT03965091|456212834|FG001|Overall Study|Lost to Follow-up|1|||
126796024|NCT03965091|456212835|FG002|Overall Study|Lost to Follow-up|1|||
126796025|NCT03965091|456212833|FG000|Overall Study|Lack of Efficacy|2|||
126796026|NCT03965091|456212834|FG001|Overall Study|Lack of Efficacy|0|||
126796027|NCT03965091|456212835|FG002|Overall Study|Lack of Efficacy|0|||
126796028|NCT03965091|456212833|FG000|Overall Study|Other than specified|9|||
126796029|NCT03965091|456212834|FG001|Overall Study|Other than specified|11|||
126796030|NCT03965091|456212835|FG002|Overall Study|Other than specified|8|||
126796031|NCT02159950|456212842|FG000|Overall Study|Adverse Event|0|||
126796032|NCT02159950|456212843|FG001|Overall Study|Adverse Event|1|||
126796033|NCT02159950|456212842|FG000|Overall Study|Progression|0|||
126796034|NCT02159950|456212843|FG001|Overall Study|Progression|1|||
126796035|NCT00003659|456212844|FG000|Overall Study|Withdrawal by Subject|3|||
126796036|NCT04400890|456212845|FG000|Overall Study|Withdrawal by Subject|3|||
126796037|NCT04400890|456212846|FG001|Overall Study|Withdrawal by Subject|2|||
126796038|NCT03925532|456212847|FG000|Overall Study|Lost to Follow-up|1|||
126796039|NCT02258074|456212848|FG000|Overall Study|Withdrawal by Subject|1|||
126796040|NCT02258074|456212849|FG001|Overall Study|Withdrawal by Subject|0|||
126796041|NCT02258074|456212850|FG002|Overall Study|Withdrawal by Subject|0|||
126796042|NCT02258074|456212851|FG003|Overall Study|Withdrawal by Subject|0|||
126796043|NCT00723710|456212852|FG000|Overall Study|Disease progression|48|||
126796044|NCT00723710|456212852|FG000|Overall Study|Adverse Event|88|||
126796045|NCT00723710|456212852|FG000|Overall Study|Withdrawal by Subject|36|||
126796046|NCT00723710|456212852|FG000|Overall Study|Physician Decision|2|||
126796047|NCT04405570|456212853|FG000|Overall Study|Adverse Event|0|||
126796048|NCT04405570|456212854|FG001|Overall Study|Adverse Event|1|||
126796049|NCT04405570|456212855|FG002|Overall Study|Adverse Event|1|||
126796050|NCT04405570|456212856|FG003|Overall Study|Adverse Event|1|||
126796051|NCT04405570|456212853|FG000|Overall Study|Lost to Follow-up|0|||
126796052|NCT04405570|456212854|FG001|Overall Study|Lost to Follow-up|1|||
126796053|NCT04405570|456212855|FG002|Overall Study|Lost to Follow-up|0|||
126632894|NCT01010204|455615684|FG000|Overall Study|Lost to Follow-up|2|||
126632895|NCT01010204|455615685|FG001|Overall Study|Lost to Follow-up|2|||
126632896|NCT01010204|455615684|FG000|Overall Study|Adverse Event|1|||
126632897|NCT01010204|455615685|FG001|Overall Study|Adverse Event|3|||
126796054|NCT04405570|456212856|FG003|Overall Study|Lost to Follow-up|0|||
126796055|NCT04405570|456212853|FG000|Overall Study|Physician Decision|0|||
126632898|NCT01010204|455615684|FG000|Overall Study|Withdrawal by Subject|2|||
126796056|NCT04405570|456212854|FG001|Overall Study|Physician Decision|0|||
126796057|NCT04405570|456212855|FG002|Overall Study|Physician Decision|1|||
126796058|NCT04405570|456212856|FG003|Overall Study|Physician Decision|0|||
126796059|NCT04405570|456212853|FG000|Overall Study|Withdrawal by Subject|0|||
126796060|NCT04405570|456212854|FG001|Overall Study|Withdrawal by Subject|1|||
126796061|NCT04405570|456212855|FG002|Overall Study|Withdrawal by Subject|1|||
126796062|NCT04405570|456212856|FG003|Overall Study|Withdrawal by Subject|0|||
126796063|NCT04405570|456212853|FG000|Overall Study|Randomized not dosed|0|||
126796064|NCT04405570|456212854|FG001|Overall Study|Randomized not dosed|2|||
126796065|NCT04405570|456212855|FG002|Overall Study|Randomized not dosed|0|||
126796066|NCT04405570|456212856|FG003|Overall Study|Randomized not dosed|0|||
126796067|NCT04499963|456212857|FG000|Overall Study|Adverse Event|3|||
126796068|NCT04499963|456212858|FG001|Overall Study|Adverse Event|0|||
126796069|NCT04499963|456212857|FG000|Overall Study|Death|3|||
126796070|NCT04499963|456212858|FG001|Overall Study|Death|0|||
126796071|NCT04499963|456212857|FG000|Overall Study|Lack of Efficacy|7|||
126796072|NCT04499963|456212858|FG001|Overall Study|Lack of Efficacy|0|||
126796073|NCT04499963|456212857|FG000|Overall Study|Lost to Follow-up|2|||
126796074|NCT04499963|456212858|FG001|Overall Study|Lost to Follow-up|0|||
126796075|NCT01208337|456212861|FG000|Overall Study|Death|3|||
126796076|NCT03663179|456212867|FG000|Overall Study|Withdrawal by Subject|2|||
126796077|NCT03663179|456212868|FG001|Overall Study|Withdrawal by Subject|0|||
126796078|NCT03663179|456212867|FG000|Overall Study|Lost to Follow-up|1|||
126796079|NCT03663179|456212868|FG001|Overall Study|Lost to Follow-up|1|||
126796080|NCT03663179|456212867|FG000|Overall Study|Revealed exclusionary condition|1|||
126796081|NCT03663179|456212868|FG001|Overall Study|Revealed exclusionary condition|0|||
126796082|NCT00984126|456212872|FG000|Overall Study|Protocol Violation|0|||
126796083|NCT00984126|456212873|FG001|Overall Study|Protocol Violation|0|||
126796084|NCT00984126|456212874|FG002|Overall Study|Protocol Violation|1|||
126796085|NCT00984126|456212875|FG003|Overall Study|Protocol Violation|2|||
126796086|NCT00984126|456212872|FG000|Overall Study|Adverse Event|0|||
126796087|NCT00984126|456212873|FG001|Overall Study|Adverse Event|0|||
126796088|NCT00984126|456212874|FG002|Overall Study|Adverse Event|0|||
126796089|NCT00984126|456212875|FG003|Overall Study|Adverse Event|2|||
126796090|NCT00984126|456212872|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
126796091|NCT00984126|456212873|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
126796092|NCT00984126|456212874|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
126796093|NCT00984126|456212875|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
126796094|NCT00984126|456212872|FG000|Overall Study|Withdrawal criteria|0|||
126796095|NCT00984126|456212873|FG001|Overall Study|Withdrawal criteria|1|||
126796096|NCT00984126|456212874|FG002|Overall Study|Withdrawal criteria|3|||
126796097|NCT00984126|456212875|FG003|Overall Study|Withdrawal criteria|9|||
126796098|NCT01001208|456212876|FG000|Overall Study|Adverse Event|10|||
126796099|NCT01001208|456212877|FG001|Overall Study|Adverse Event|5|||
126796100|NCT01001208|456212876|FG000|Overall Study|Lost to Follow-up|5|||
126796101|NCT01001208|456212877|FG001|Overall Study|Lost to Follow-up|9|||
126796102|NCT01001208|456212876|FG000|Overall Study|Physician Decision|1|||
126796103|NCT01001208|456212877|FG001|Overall Study|Physician Decision|0|||
126796104|NCT01001208|456212876|FG000|Overall Study|Withdrawal by Subject|4|||
126796105|NCT01001208|456212877|FG001|Overall Study|Withdrawal by Subject|5|||
126796106|NCT01001208|456212876|FG000|Overall Study|Ineligibility Determined|4|||
126632899|NCT01010204|455615685|FG001|Overall Study|Withdrawal by Subject|3|||
126632900|NCT01010204|455615684|FG000|Overall Study|psychiatric hospitalization|2|||
126632901|NCT01010204|455615685|FG001|Overall Study|psychiatric hospitalization|1|||
126796107|NCT01001208|456212877|FG001|Overall Study|Ineligibility Determined|2|||
126796108|NCT01001208|456212876|FG000|Overall Study|Noncompliance|4|||
126796109|NCT01001208|456212877|FG001|Overall Study|Noncompliance|7|||
126796110|NCT01001208|456212876|FG000|Overall Study|Disease Progression|0|||
126796111|NCT01001208|456212877|FG001|Overall Study|Disease Progression|3|||
126796112|NCT01001208|456212876|FG000|Overall Study|Other|0|||
126796113|NCT01001208|456212877|FG001|Overall Study|Other|2|||
126796114|NCT01864174|456212878|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
126796115|NCT01864174|456212879|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
126796116|NCT01864174|456212878|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
126796117|NCT01864174|456212879|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
126796118|NCT01864174|456212878|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
126796119|NCT01864174|456212879|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
126796120|NCT01864174|456212878|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
126796121|NCT01864174|456212879|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
126796122|NCT01864174|456212878|FG000|Double Blind - Compliant Randomized|Death|1|||
126796123|NCT01864174|456212879|FG001|Double Blind - Compliant Randomized|Death|0|||
126796124|NCT01864174|456212878|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
126796125|NCT01864174|456212879|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
126796126|NCT01864174|456212878|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
126796127|NCT01864174|456212879|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
126796128|NCT01864174|456212878|FG000|Double Blind - Compliant Randomized|Other|6|||
126796129|NCT01864174|456212879|FG001|Double Blind - Compliant Randomized|Other|10|||
126796130|NCT01864174|456212878|FG000|Off Treatment Follow-Up|Other|2|||
126796131|NCT01864174|456212879|FG001|Off Treatment Follow-Up|Other|0|||
126796132|NCT01864174|456212878|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
126796133|NCT01864174|456212879|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
126796134|NCT01723397|456212883|FG000|Study Period 1|Protocol Violation|0|||
126796135|NCT01723397|456212884|FG001|Study Period 1|Protocol Violation|1|||
126796136|NCT01723397|456212883|FG000|Study Period 2|Protocol Violation|0|||
126796137|NCT01723397|456212884|FG001|Study Period 2|Protocol Violation|1|||
126796138|NCT00468286|456212885|FG000|Overall Study|Adverse Event|1|||
126796139|NCT00468286|456212886|FG001|Overall Study|Adverse Event|6|||
126796140|NCT00468286|456212885|FG000|Overall Study|Protocol Violation|2|||
126796141|NCT00468286|456212886|FG001|Overall Study|Protocol Violation|2|||
126796142|NCT00468286|456212885|FG000|Overall Study|Withdrawal by Subject|4|||
126796143|NCT00468286|456212886|FG001|Overall Study|Withdrawal by Subject|3|||
126796144|NCT00468286|456212885|FG000|Overall Study|Physician Decision|0|||
126796145|NCT00468286|456212886|FG001|Overall Study|Physician Decision|1|||
126796146|NCT02196675|456212887|FG000|Overall Study|Withdrawal by Subject|1|||
126796147|NCT02196675|456212888|FG001|Overall Study|Withdrawal by Subject|0|||
126796148|NCT02196675|456212889|FG002|Overall Study|Withdrawal by Subject|0|||
126796149|NCT02196675|456212887|FG000|Overall Study|Intra-operative surgical exclusion|1|||
126796150|NCT02196675|456212888|FG001|Overall Study|Intra-operative surgical exclusion|1|||
126796151|NCT02196675|456212889|FG002|Overall Study|Intra-operative surgical exclusion|0|||
126796152|NCT02196675|456212887|FG000|Overall Study|Protocol Violation|0|||
126796153|NCT02196675|456212888|FG001|Overall Study|Protocol Violation|1|||
126796154|NCT02196675|456212889|FG002|Overall Study|Protocol Violation|0|||
126796155|NCT02196675|456212887|FG000|Overall Study|Death|0|||
126796156|NCT02196675|456212888|FG001|Overall Study|Death|0|||
126796157|NCT02196675|456212889|FG002|Overall Study|Death|1|||
126796158|NCT02158663|456212890|FG000|Overall Study|Withdrawal by Subject|5|||
126796159|NCT02158663|456212891|FG001|Overall Study|Withdrawal by Subject|4|||
126796160|NCT00537979|456212892|FG000|Overall Study|Adverse Event|2|||
126796161|NCT00537979|456212893|FG001|Overall Study|Adverse Event|2|||
126796162|NCT00537979|456212892|FG000|Overall Study|Withdrawal by Subject|1|||
126796163|NCT00537979|456212893|FG001|Overall Study|Withdrawal by Subject|4|||
126796164|NCT00537979|456212892|FG000|Overall Study|Lost to Follow-up|1|||
126796165|NCT00537979|456212893|FG001|Overall Study|Lost to Follow-up|4|||
126796166|NCT00537979|456212892|FG000|Overall Study|Lack of Efficacy|0|||
126796167|NCT00537979|456212893|FG001|Overall Study|Lack of Efficacy|1|||
126796168|NCT00537979|456212892|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
126796169|NCT00537979|456212893|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
126796170|NCT00537979|456212892|FG000|Overall Study|Death|0|||
126796171|NCT00537979|456212893|FG001|Overall Study|Death|3|||
126796172|NCT00537979|456212892|FG000|Overall Study|Kidney transplant|0|||
126796173|NCT00537979|456212893|FG001|Overall Study|Kidney transplant|3|||
126796174|NCT00537979|456212892|FG000|Overall Study|Heart failure|0|||
126796175|NCT00537979|456212893|FG001|Overall Study|Heart failure|1|||
126796176|NCT02009163|456212894|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
126796177|NCT02009163|456212895|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
126796178|NCT02009163|456212896|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
126796179|NCT02009163|456212894|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
126796180|NCT02009163|456212895|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
126796181|NCT02009163|456212896|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
126796182|NCT02009163|456212894|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
126796183|NCT02009163|456212895|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
126796184|NCT02009163|456212896|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
126796185|NCT02009163|456212894|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
126796186|NCT02009163|456212895|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
126796187|NCT02009163|456212896|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
126796188|NCT02009163|456212894|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
126796189|NCT02009163|456212895|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
126796190|NCT02009163|456212896|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
126796191|NCT02009163|456212894|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
126796192|NCT02009163|456212895|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
126796193|NCT02009163|456212896|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
126796194|NCT02009163|456212894|FG000|Open-label Period (Non-randomized)|Other|13|||
126796195|NCT02009163|456212895|FG001|Open-label Period (Non-randomized)|Other|0|||
126796196|NCT02009163|456212896|FG002|Open-label Period (Non-randomized)|Other|0|||
126796197|NCT02009163|456212894|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
126796198|NCT02009163|456212895|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
126796199|NCT02009163|456212896|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
126796200|NCT02009163|456212894|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
126796201|NCT02009163|456212895|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
126796202|NCT02009163|456212896|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
126796203|NCT02009163|456212894|FG000|Randomized-withdrawal Period|Adverse Event|0|||
126796204|NCT02009163|456212895|FG001|Randomized-withdrawal Period|Adverse Event|0|||
126796205|NCT02009163|456212896|FG002|Randomized-withdrawal Period|Adverse Event|6|||
126796206|NCT02009163|456212894|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
126796207|NCT02009163|456212895|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
126796208|NCT02009163|456212896|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
126796209|NCT02009163|456212894|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
126796210|NCT02009163|456212895|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
126796211|NCT02009163|456212896|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
126796212|NCT02009163|456212894|FG000|Randomized-withdrawal Period|Pregnancy|0|||
126796213|NCT02009163|456212895|FG001|Randomized-withdrawal Period|Pregnancy|0|||
126796214|NCT02009163|456212896|FG002|Randomized-withdrawal Period|Pregnancy|2|||
126796215|NCT02009163|456212894|FG000|Randomized-withdrawal Period|Other|0|||
126796216|NCT02009163|456212895|FG001|Randomized-withdrawal Period|Other|9|||
126796217|NCT02009163|456212896|FG002|Randomized-withdrawal Period|Other|5|||
126796218|NCT00415363|456212899|FG000|Overall Study|Withdrawal by Subject|4|||
126796219|NCT00415363|456212900|FG001|Overall Study|Withdrawal by Subject|4|||
126796220|NCT00415363|456212899|FG000|Overall Study|Adverse Event|4|||
126796221|NCT00415363|456212900|FG001|Overall Study|Adverse Event|4|||
126796222|NCT00415363|456212899|FG000|Overall Study|Lost to Follow-up|2|||
126796223|NCT00415363|456212900|FG001|Overall Study|Lost to Follow-up|1|||
126796224|NCT00415363|456212899|FG000|Overall Study|Physician Decision|3|||
126796225|NCT00415363|456212900|FG001|Overall Study|Physician Decision|1|||
126796226|NCT00415363|456212899|FG000|Overall Study|Death|16|||
126796227|NCT00415363|456212900|FG001|Overall Study|Death|12|||
126796228|NCT00415363|456212899|FG000|Overall Study|Progressive disease|26|||
126796229|NCT00415363|456212900|FG001|Overall Study|Progressive disease|32|||
126796230|NCT00095212|456212901|FG000|Overall Study|Withdrawal by Subject|1|||
126796231|NCT00095212|456212902|FG001|Overall Study|Withdrawal by Subject|3|||
126796232|NCT05341622|456212903|FG000|Overall Study|Death|0|||
126796233|NCT05341622|456212904|FG001|Overall Study|Death|0|||
126796234|NCT05341622|456212905|FG002|Overall Study|Death|0|||
126796235|NCT05341622|456212906|FG003|Overall Study|Death|0|||
126796236|NCT05341622|456212907|FG004|Overall Study|Death|1|||
126796237|NCT05341622|456212908|FG005|Overall Study|Death|0|||
126796238|NCT05341622|456212909|FG006|Overall Study|Death|0|||
126796239|NCT05341622|456212910|FG007|Overall Study|Death|1|||
126796240|NCT05341622|456212903|FG000|Overall Study|Invalid Address|0|||
126796241|NCT05341622|456212904|FG001|Overall Study|Invalid Address|1|||
126796242|NCT05341622|456212905|FG002|Overall Study|Invalid Address|0|||
126796243|NCT05341622|456212906|FG003|Overall Study|Invalid Address|0|||
126796244|NCT05341622|456212907|FG004|Overall Study|Invalid Address|0|||
126796245|NCT05341622|456212908|FG005|Overall Study|Invalid Address|0|||
126796246|NCT05341622|456212909|FG006|Overall Study|Invalid Address|0|||
126796247|NCT05341622|456212910|FG007|Overall Study|Invalid Address|0|||
126796248|NCT05341622|456212903|FG000|Overall Study|Ineligible|26|||
126796249|NCT05341622|456212904|FG001|Overall Study|Ineligible|21|||
126796250|NCT05341622|456212905|FG002|Overall Study|Ineligible|28|||
126796251|NCT05341622|456212906|FG003|Overall Study|Ineligible|24|||
126796252|NCT05341622|456212907|FG004|Overall Study|Ineligible|29|||
126796253|NCT05341622|456212908|FG005|Overall Study|Ineligible|31|||
126796254|NCT05341622|456212909|FG006|Overall Study|Ineligible|28|||
126796255|NCT05341622|456212910|FG007|Overall Study|Ineligible|26|||
126796256|NCT02658084|456212911|FG000|Overall Study|Withdrawal by Subject|1|||
126796257|NCT02658084|456212912|FG001|Overall Study|Withdrawal by Subject|0|||
126796258|NCT02658084|456212911|FG000|Overall Study|Study Termination|1|||
126796259|NCT02658084|456212912|FG001|Overall Study|Study Termination|0|||
126796260|NCT03041025|456212915|FG000|Overall Study|Adverse Event|0|||
126796261|NCT03041025|456212916|FG001|Overall Study|Adverse Event|0|||
126796262|NCT03041025|456212917|FG002|Overall Study|Adverse Event|1|||
126796263|NCT03041025|456212915|FG000|Overall Study|Lost to Follow-up|1|||
126796264|NCT03041025|456212916|FG001|Overall Study|Lost to Follow-up|0|||
126796265|NCT03041025|456212917|FG002|Overall Study|Lost to Follow-up|0|||
126796266|NCT03041025|456212915|FG000|Overall Study|Withdrawal by Subject|0|||
126796267|NCT03041025|456212916|FG001|Overall Study|Withdrawal by Subject|0|||
126796268|NCT03041025|456212917|FG002|Overall Study|Withdrawal by Subject|1|||
126796269|NCT02963259|456212918|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
126796270|NCT02963259|456212918|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
126796271|NCT02963259|456212918|FG000|Overall Study|Death|1|||
126796272|NCT02963259|456212918|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
126796273|NCT04611789|456212919|FG000|Overall Study|Lost to Follow-up|1|||
126796274|NCT04611789|456212920|FG001|Overall Study|Lost to Follow-up|0|||
126796275|NCT04611789|456212921|FG002|Overall Study|Lost to Follow-up|0|||
126796276|NCT02655679|456212922|FG000|Overall Study|Adverse Event|0|||
126796277|NCT02655679|456212923|FG001|Overall Study|Adverse Event|1|||
126796278|NCT02655679|456212924|FG002|Overall Study|Adverse Event|0|||
126796279|NCT02655679|456212925|FG003|Overall Study|Adverse Event|0|||
126796280|NCT02655679|456212926|FG004|Overall Study|Adverse Event|0|||
126796281|NCT02655679|456212922|FG000|Overall Study|Withdrawal by Subject|1|||
126796282|NCT02655679|456212923|FG001|Overall Study|Withdrawal by Subject|1|||
126796283|NCT02655679|456212924|FG002|Overall Study|Withdrawal by Subject|0|||
126796284|NCT02655679|456212925|FG003|Overall Study|Withdrawal by Subject|3|||
126796285|NCT02655679|456212926|FG004|Overall Study|Withdrawal by Subject|1|||
126796286|NCT02655679|456212922|FG000|Overall Study|Inability to Comply with the Protocol|1|||
126796287|NCT02655679|456212923|FG001|Overall Study|Inability to Comply with the Protocol|0|||
126796288|NCT02655679|456212924|FG002|Overall Study|Inability to Comply with the Protocol|0|||
126796289|NCT02655679|456212925|FG003|Overall Study|Inability to Comply with the Protocol|0|||
126796290|NCT02655679|456212926|FG004|Overall Study|Inability to Comply with the Protocol|0|||
126796291|NCT02655679|456212922|FG000|Overall Study|Lost to Follow-up|0|||
126796292|NCT02655679|456212923|FG001|Overall Study|Lost to Follow-up|1|||
126796293|NCT02655679|456212924|FG002|Overall Study|Lost to Follow-up|1|||
126796294|NCT02655679|456212925|FG003|Overall Study|Lost to Follow-up|1|||
126796295|NCT02655679|456212926|FG004|Overall Study|Lost to Follow-up|0|||
126796296|NCT02655679|456212922|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126796297|NCT02655679|456212923|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126796298|NCT02655679|456212924|FG002|Overall Study|Other Miscellaneous Reasons|0|||
126796299|NCT02655679|456212925|FG003|Overall Study|Other Miscellaneous Reasons|0|||
126796300|NCT02655679|456212926|FG004|Overall Study|Other Miscellaneous Reasons|0|||
126796301|NCT01577381|456212927|FG000|Overall Study|Discontinued|2|||
126796302|NCT01577381|456212928|FG001|Overall Study|Discontinued|1|||
126796303|NCT01577381|456212929|FG002|Overall Study|Discontinued|2|||
126796304|NCT01577381|456212930|FG003|Overall Study|Discontinued|2|||
126796305|NCT01577381|456212927|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
126796306|NCT01577381|456212928|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
126796307|NCT01577381|456212929|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
126796308|NCT01577381|456212930|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
126796309|NCT02186821|456212931|FG000|Overall Study|Adverse Event|9|||
126796310|NCT02186821|456212931|FG000|Overall Study|Death|2|||
126796311|NCT02186821|456212931|FG000|Overall Study|Disease progression|32|||
126796312|NCT02186821|456212931|FG000|Overall Study|Protocol Violation|1|||
126796313|NCT02186821|456212931|FG000|Overall Study|Physician Decision|1|||
126796314|NCT02186821|456212931|FG000|Overall Study|Study terminated by sponsor|2|||
126796315|NCT00819741|456212936|FG000|Overall Study|Adverse Event|5|||
126796316|NCT00819741|456212937|FG001|Overall Study|Adverse Event|2|||
126796317|NCT00819741|456212936|FG000|Overall Study|Lack of Efficacy|0|||
126796318|NCT00819741|456212937|FG001|Overall Study|Lack of Efficacy|2|||
126796319|NCT00819741|456212936|FG000|Overall Study|Lost to Follow-up|3|||
126796320|NCT00819741|456212937|FG001|Overall Study|Lost to Follow-up|1|||
126796321|NCT00819741|456212936|FG000|Overall Study|Protocol Violation|3|||
126796322|NCT00819741|456212937|FG001|Overall Study|Protocol Violation|4|||
126796323|NCT00819741|456212936|FG000|Overall Study|Withdrawal by Subject|2|||
126796324|NCT00819741|456212937|FG001|Overall Study|Withdrawal by Subject|2|||
126796325|NCT00819741|456212936|FG000|Overall Study|Unclassified|6|||
126796326|NCT00819741|456212937|FG001|Overall Study|Unclassified|0|||
126796327|NCT00819741|456212936|FG000|Overall Study|Reasons unknown|3|||
126796328|NCT00819741|456212937|FG001|Overall Study|Reasons unknown|3|||
126796329|NCT00119015|456212938|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
126796330|NCT00119015|456212939|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
126796331|NCT00119015|456212940|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
126796332|NCT01313780|456212941|FG000|Overall Study|Lack of Efficacy|4|||
126796333|NCT01313780|456212942|FG001|Overall Study|Lack of Efficacy|2|||
126796334|NCT01313780|456212941|FG000|Overall Study|Adverse Event|6|||
126796335|NCT01313780|456212942|FG001|Overall Study|Adverse Event|11|||
126796336|NCT01313780|456212941|FG000|Overall Study|Withdrawal by Subject|2|||
126796337|NCT01313780|456212942|FG001|Overall Study|Withdrawal by Subject|8|||
126796338|NCT01313780|456212941|FG000|Overall Study|Protocol Violation|10|||
126796339|NCT01313780|456212942|FG001|Overall Study|Protocol Violation|4|||
126796340|NCT01313780|456212941|FG000|Overall Study|missing data|3|||
126796341|NCT01313780|456212942|FG001|Overall Study|missing data|3|||
126796342|NCT03235739|456214415|FG000|Overall Study|Withdrawal by Subject|2|||
126796343|NCT03235739|456214416|FG001|Overall Study|Withdrawal by Subject|2|||
126796344|NCT03235739|456214415|FG000|Overall Study|Physician Decision|0|||
126796345|NCT03235739|456214416|FG001|Overall Study|Physician Decision|1|||
126796346|NCT02847650|456214417|FG000|Overall Study|Adverse Event|2|||
126796347|NCT02847650|456214418|FG001|Overall Study|Adverse Event|4|||
126796348|NCT02847650|456214417|FG000|Overall Study|Lost to Follow-up|1|||
126796349|NCT02847650|456214418|FG001|Overall Study|Lost to Follow-up|0|||
126796350|NCT02847650|456214417|FG000|Overall Study|Protocol Violation|0|||
126796351|NCT02847650|456214418|FG001|Overall Study|Protocol Violation|1|||
126796352|NCT02847650|456214417|FG000|Overall Study|Withdrawal by Subject|1|||
126796353|NCT02847650|456214418|FG001|Overall Study|Withdrawal by Subject|1|||
126796354|NCT03818581|456214421|FG000|Overall Study|Adverse Event|1|||
126796355|NCT03818581|456214422|FG001|Overall Study|Adverse Event|0|||
126796356|NCT03818581|456214423|FG002|Overall Study|Adverse Event|0|||
126796357|NCT03818581|456214424|FG003|Overall Study|Adverse Event|0|||
126796358|NCT03818581|456214425|FG004|Overall Study|Adverse Event|0|||
126796359|NCT03818581|456214421|FG000|Overall Study|Covid-19|2|||
126796360|NCT03818581|456214422|FG001|Overall Study|Covid-19|0|||
126796361|NCT03818581|456214423|FG002|Overall Study|Covid-19|0|||
126796362|NCT03818581|456214424|FG003|Overall Study|Covid-19|0|||
126796363|NCT03818581|456214425|FG004|Overall Study|Covid-19|1|||
126796364|NCT03818581|456214421|FG000|Overall Study|Withdrawal by Subject|0|||
126796365|NCT03818581|456214422|FG001|Overall Study|Withdrawal by Subject|0|||
126796366|NCT03818581|456214423|FG002|Overall Study|Withdrawal by Subject|0|||
126796367|NCT03818581|456214424|FG003|Overall Study|Withdrawal by Subject|0|||
126796368|NCT03818581|456214425|FG004|Overall Study|Withdrawal by Subject|1|||
126796369|NCT03818581|456214421|FG000|Overall Study|No longer met study criteria|0|||
126796370|NCT03818581|456214422|FG001|Overall Study|No longer met study criteria|0|||
126796371|NCT03818581|456214423|FG002|Overall Study|No longer met study criteria|0|||
126796372|NCT03818581|456214424|FG003|Overall Study|No longer met study criteria|0|||
126796373|NCT03818581|456214425|FG004|Overall Study|No longer met study criteria|1|||
126796374|NCT02096211|456214428|FG000|Overall Study|Death|2|||
126796375|NCT02096211|456214428|FG000|Overall Study|Withdrawal by Subject|8|||
126796376|NCT02096211|456214428|FG000|Overall Study|Revision of implant|7|||
126796377|NCT02096211|456214428|FG000|Overall Study|Lost to Follow-up|43|||
126796378|NCT00834522|456214431|FG000|Washout|Adverse Event|1|||
126796379|NCT00834522|456214432|FG001|Washout|Adverse Event|0|||
126796380|NCT00834522|456214431|FG000|Washout|Withdrawal by Subject|2|||
126796381|NCT00834522|456214432|FG001|Washout|Withdrawal by Subject|1|||
126796382|NCT00519194|456214433|FG000|Overall Study|Withdrawal by Subject|9|||
126796383|NCT00519194|456214433|FG000|Overall Study|Death|9|||
126796384|NCT00519194|456214433|FG000|Overall Study|Lost to Follow-up|3|||
126796385|NCT03165994|456214434|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
126796386|NCT03165994|456214434|FG000|Overall Study|Death|2|||
126796387|NCT03165994|456214434|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
126796388|NCT03165994|456214434|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
126796389|NCT03165994|456214434|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
126796390|NCT03165994|456214434|FG000|Overall Study|Miscellaneous|1|||
126796391|NCT00934050|456214441|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
126796392|NCT00934050|456214442|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
126796393|NCT00934050|456214443|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
126796394|NCT00934050|456214444|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
126796395|NCT00934050|456214445|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
126796396|NCT00934050|456214446|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
126796397|NCT00934050|456214441|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
126796398|NCT00934050|456214442|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
126796399|NCT00934050|456214443|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
126796400|NCT00934050|456214444|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
126796401|NCT00934050|456214445|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
126796402|NCT00934050|456214446|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
126796403|NCT00934050|456214441|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
126796404|NCT00934050|456214442|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
126796405|NCT00934050|456214443|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
126796406|NCT00934050|456214444|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
126796407|NCT00934050|456214445|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
126796408|NCT00934050|456214446|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
126796409|NCT00934050|456214441|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
126796410|NCT00934050|456214442|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
126796411|NCT00934050|456214443|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
126796412|NCT00934050|456214444|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
126796413|NCT00934050|456214445|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
126796414|NCT00934050|456214446|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
126796415|NCT00934050|456214441|FG000|Enrolled After 15 Dec 2009|Death|0|||
126796416|NCT00934050|456214442|FG001|Enrolled After 15 Dec 2009|Death|0|||
126796417|NCT00934050|456214443|FG002|Enrolled After 15 Dec 2009|Death|0|||
126796418|NCT00934050|456214444|FG003|Enrolled After 15 Dec 2009|Death|0|||
126796419|NCT00934050|456214445|FG004|Enrolled After 15 Dec 2009|Death|0|||
126796420|NCT00934050|456214446|FG005|Enrolled After 15 Dec 2009|Death|1|||
126796421|NCT00934050|456214441|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
126796422|NCT00934050|456214442|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
126796423|NCT00934050|456214443|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
126796424|NCT00934050|456214444|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
126796425|NCT00934050|456214445|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
126796426|NCT00934050|456214446|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
126796427|NCT00934050|456214441|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
126796428|NCT00934050|456214442|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
126796429|NCT00934050|456214443|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
126796430|NCT00934050|456214444|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
126796431|NCT00934050|456214445|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
126632902|NCT01513330|455615686|FG000|SenSura Mio First,|Adverse Event|2|||
126632903|NCT01513330|455615687|FG001|SenSura Mio First,|Adverse Event|0|||
126796432|NCT00934050|456214446|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
126796433|NCT00461786|456214447|FG000|Overall Study|Entry Criteria Not Met|2|||
126796434|NCT00461786|456214447|FG000|Overall Study|Inevaluable (Never Treated)|1|||
126796435|NCT00835991|456214448|FG000|First Intervention|Adverse Event|0|||
126796436|NCT00835991|456214449|FG001|First Intervention|Adverse Event|1|||
126796437|NCT00835991|456214448|FG000|Washout|Protocol Violation|0|||
126796438|NCT00835991|456214449|FG001|Washout|Protocol Violation|2|||
126796439|NCT00835991|456214448|FG000|Washout|Withdrawal by Subject|3|||
126796440|NCT00835991|456214449|FG001|Washout|Withdrawal by Subject|1|||
126796441|NCT02149420|456214450|FG000|Core Study|Administrative problems|0|||
126796442|NCT02149420|456214451|FG001|Core Study|Administrative problems|1|||
126796443|NCT02149420|456214452|FG002|Core Study|Administrative problems|2|||
126796444|NCT02149420|456214450|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
126796445|NCT02149420|456214451|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
126796446|NCT02149420|456214452|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
126796447|NCT02378935|456214453|FG000|Overall Study|Lack of Efficacy|10|||
126796448|NCT02378935|456214454|FG001|Overall Study|Lack of Efficacy|0|||
126796449|NCT02378935|456214455|FG002|Overall Study|Lack of Efficacy|2|||
126796450|NCT02378935|456214456|FG003|Overall Study|Lack of Efficacy|6|||
126796451|NCT02378935|456214457|FG004|Overall Study|Lack of Efficacy|0|||
126796452|NCT02378935|456214458|FG005|Overall Study|Lack of Efficacy|0|||
126796453|NCT02378935|456214459|FG006|Overall Study|Lack of Efficacy|0|||
126796454|NCT02378935|456214453|FG000|Overall Study|Death|0|||
126796455|NCT02378935|456214454|FG001|Overall Study|Death|0|||
126796456|NCT02378935|456214455|FG002|Overall Study|Death|1|||
126796457|NCT02378935|456214456|FG003|Overall Study|Death|0|||
126796458|NCT02378935|456214457|FG004|Overall Study|Death|0|||
126796459|NCT02378935|456214458|FG005|Overall Study|Death|0|||
126796460|NCT02378935|456214459|FG006|Overall Study|Death|0|||
126796461|NCT03616535|456214460|FG000|Overall Study|Death|2|||
126796462|NCT03616535|456214461|FG001|Overall Study|Death|0|||
126796463|NCT03616535|456214462|FG002|Overall Study|Death|0|||
126796464|NCT03616535|456214463|FG003|Overall Study|Death|1|||
126796465|NCT03616535|456214460|FG000|Overall Study|Lost to Follow-up|2|||
126796466|NCT03616535|456214461|FG001|Overall Study|Lost to Follow-up|1|||
126796467|NCT03616535|456214462|FG002|Overall Study|Lost to Follow-up|0|||
126796468|NCT03616535|456214463|FG003|Overall Study|Lost to Follow-up|2|||
126796469|NCT03616535|456214460|FG000|Overall Study|Withdrawal by Subject|1|||
126796470|NCT03616535|456214461|FG001|Overall Study|Withdrawal by Subject|2|||
126796471|NCT03616535|456214462|FG002|Overall Study|Withdrawal by Subject|5|||
126796472|NCT03616535|456214463|FG003|Overall Study|Withdrawal by Subject|1|||
126796473|NCT03616535|456214460|FG000|Overall Study|Not specified or change in eligibility|2|||
126796474|NCT03616535|456214461|FG001|Overall Study|Not specified or change in eligibility|3|||
126796475|NCT03616535|456214462|FG002|Overall Study|Not specified or change in eligibility|3|||
126796476|NCT03616535|456214463|FG003|Overall Study|Not specified or change in eligibility|1|||
126796477|NCT02146105|456214466|FG000|Overall Study|Adverse Event|1|||
126796478|NCT02146105|456214466|FG000|Overall Study|Withdrawal by Subject|5|||
126796479|NCT05755282|456214467|FG000|Overall Study|Protocol Violation|0|||
126796480|NCT05755282|456214468|FG001|Overall Study|Protocol Violation|1|||
126796481|NCT03935880|456214470|FG000|Overall Study|Lost to Follow-up|0|||
126796482|NCT03935880|456214471|FG001|Overall Study|Lost to Follow-up|1|||
126796483|NCT02476994|456214472|FG000|Overall Study|Based on feedback from FDA|1|||
126796484|NCT02476994|456214473|FG001|Overall Study|Based on feedback from FDA|0|||
126796485|NCT02563561|456214474|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
126796486|NCT02563561|456214475|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
126796487|NCT02563561|456214476|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
126796488|NCT02563561|456214474|FG000|Overall Study|Withdrew of Consent|1|||
126796489|NCT02563561|456214475|FG001|Overall Study|Withdrew of Consent|1|||
126796490|NCT02563561|456214476|FG002|Overall Study|Withdrew of Consent|2|||
126796491|NCT02563561|456214474|FG000|Overall Study|Lost to Follow-up|1|||
126796492|NCT02563561|456214475|FG001|Overall Study|Lost to Follow-up|1|||
126796493|NCT02563561|456214476|FG002|Overall Study|Lost to Follow-up|0|||
126796494|NCT02563561|456214474|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
126796495|NCT02563561|456214475|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
126796496|NCT02563561|456214476|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
126796497|NCT02563561|456214474|FG000|Overall Study|Investigator Decision|3|||
126796498|NCT02563561|456214475|FG001|Overall Study|Investigator Decision|4|||
126796499|NCT02563561|456214476|FG002|Overall Study|Investigator Decision|2|||
126632904|NCT01513330|455615686|FG000|SenSura Mio First,|Lack of Efficacy|0|||
126632905|NCT01513330|455615687|FG001|SenSura Mio First,|Lack of Efficacy|1|||
126632906|NCT01513330|455615686|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
126632907|NCT01513330|455615687|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
126632908|NCT01513330|455615686|FG000|SenSura Mio First,|Other|1|||
126796500|NCT02563561|456214474|FG000|Overall Study|Sponsor Decision|5|||
126632909|NCT01513330|455615687|FG001|SenSura Mio First,|Other|0|||
126755781|NCT01854918|456054829|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
126755782|NCT01854918|456054830|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
126755783|NCT01854918|456054829|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
126755784|NCT01854918|456054830|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
126755785|NCT01854918|456054829|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
126755786|NCT01854918|456054830|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
126755787|NCT01854918|456054829|FG000|SOC-controlled Period (Year 1)|Death|5|||
126755788|NCT01854918|456054830|FG001|SOC-controlled Period (Year 1)|Death|5|||
126755789|NCT01854918|456054829|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
126755790|NCT01854918|456054830|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
126632910|NCT01513330|455615686|FG000|Standard Care First,|Lack of Efficacy|2|||
126632911|NCT01513330|455615687|FG001|Standard Care First,|Lack of Efficacy|2|||
126632912|NCT01513330|455615686|FG000|Standard Care First,|Withdrawal by Subject|1|||
126632913|NCT01513330|455615687|FG001|Standard Care First,|Withdrawal by Subject|2|||
126632914|NCT01513330|455615686|FG000|Standard Care First,|Other|1|||
126632915|NCT01513330|455615687|FG001|Standard Care First,|Other|0|||
126632916|NCT01519778|455615688|FG000|Overall Study|Withdrawal by Subject|3|||
126632917|NCT01519778|455615688|FG000|Overall Study|Lost to Follow-up|10|||
126632918|NCT01519778|455615688|FG000|Overall Study|Physician Decision|1|||
126632919|NCT04486313|455615689|FG000|Overall Study|Lost to Follow-up|7|||
126632920|NCT04486313|455615690|FG001|Overall Study|Lost to Follow-up|9|||
126632921|NCT04486313|455615689|FG000|Overall Study|Withdrawal by Subject|8|||
126632922|NCT04486313|455615690|FG001|Overall Study|Withdrawal by Subject|6|||
126632923|NCT04486313|455615689|FG000|Overall Study|Physician Decision|1|||
126632924|NCT04486313|455615690|FG001|Overall Study|Physician Decision|1|||
126632925|NCT04486313|455615689|FG000|Overall Study|Death|2|||
126632926|NCT04486313|455615690|FG001|Overall Study|Death|0|||
126632927|NCT04486313|455615689|FG000|Overall Study|Protocol Violation|1|||
126632928|NCT04486313|455615690|FG001|Overall Study|Protocol Violation|1|||
126632929|NCT01657799|455615691|FG000|Overall Study|Adverse Event Related to progression|6|||
126632930|NCT01657799|455615692|FG001|Overall Study|Adverse Event Related to progression|8|||
126632931|NCT01657799|455615693|FG002|Overall Study|Adverse Event Related to progression|12|||
126632932|NCT01657799|455615691|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
126632933|NCT01657799|455615692|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
126632934|NCT01657799|455615693|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
126632935|NCT01657799|455615691|FG000|Overall Study|Withdrawal by Subject|13|||
126632936|NCT01657799|455615692|FG001|Overall Study|Withdrawal by Subject|10|||
126632937|NCT01657799|455615693|FG002|Overall Study|Withdrawal by Subject|10|||
126632938|NCT01657799|455615691|FG000|Overall Study|Lost to Follow-up|1|||
126632939|NCT01657799|455615692|FG001|Overall Study|Lost to Follow-up|0|||
126632940|NCT01657799|455615693|FG002|Overall Study|Lost to Follow-up|1|||
126632941|NCT01657799|455615691|FG000|Overall Study|Disease Progression|2|||
126632942|NCT01657799|455615692|FG001|Overall Study|Disease Progression|4|||
126632943|NCT01657799|455615693|FG002|Overall Study|Disease Progression|4|||
126632944|NCT01657799|455615691|FG000|Overall Study|Progressive Disease Clinical|7|||
126632945|NCT01657799|455615692|FG001|Overall Study|Progressive Disease Clinical|4|||
126632946|NCT01657799|455615693|FG002|Overall Study|Progressive Disease Clinical|7|||
126632947|NCT01657799|455615691|FG000|Overall Study|Radiographic & Clinical Progression|16|||
126632948|NCT01657799|455615692|FG001|Overall Study|Radiographic & Clinical Progression|11|||
126632949|NCT01657799|455615693|FG002|Overall Study|Radiographic & Clinical Progression|15|||
126632950|NCT01657799|455615691|FG000|Overall Study|Other|52|||
126632951|NCT01657799|455615692|FG001|Overall Study|Other|62|||
126632952|NCT01657799|455615693|FG002|Overall Study|Other|49|||
126632953|NCT00412880|455615694|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
126632954|NCT00412880|455615694|FG000|Overall Study|Consent withdrawn|1|||
126632955|NCT00412880|455615694|FG000|Overall Study|Adverse Event|1|||
126632956|NCT00412880|455615694|FG000|Overall Study|Progressive disease|20|||
126632957|NCT01843777|455615696|FG000|Overall Study|Withdrawal by Subject|1|||
126632958|NCT01843777|455615697|FG001|Overall Study|Withdrawal by Subject|0|||
126755791|NCT01854918|456054829|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
126755792|NCT01854918|456054830|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
126755793|NCT01854918|456054829|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
126632959|NCT04599855|455615708|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
126632960|NCT04599855|455615709|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
126632961|NCT04599855|455615710|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
126632962|NCT04599855|455615708|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
126755794|NCT01854918|456054830|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
126632963|NCT04599855|455615709|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
126632964|NCT04599855|455615710|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
126632965|NCT04599855|455615708|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
126796501|NCT02563561|456214475|FG001|Overall Study|Sponsor Decision|2|||
126632966|NCT04599855|455615709|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
126632967|NCT04599855|455615710|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
126796502|NCT02563561|456214476|FG002|Overall Study|Sponsor Decision|4|||
126796503|NCT02563561|456214474|FG000|Overall Study|Other|1|||
126796504|NCT02563561|456214475|FG001|Overall Study|Other|5|||
126796505|NCT02563561|456214476|FG002|Overall Study|Other|2|||
126796506|NCT03154047|456214479|FG000|Overall Study|Death|1|||
126796507|NCT03154047|456214479|FG000|Overall Study|Study terminated by sponsor|76|||
126796508|NCT03154047|456214479|FG000|Overall Study|Withdrawal by Subject|3|||
126796509|NCT00857454|456214480|FG000|Overall Study|Withdrawal by Subject|2|||
126796510|NCT00857454|456214480|FG000|Overall Study|Lost to Follow-up|1|||
126796511|NCT00857454|456214480|FG000|Overall Study|Adverse Event|2|||
126796512|NCT00857454|456214480|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
126796513|NCT00857454|456214480|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
126796514|NCT00857454|456214480|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
126796515|NCT00455312|456214481|FG000|Overall Study|Death|0|||
126796516|NCT00455312|456214482|FG001|Overall Study|Death|1|||
126796517|NCT01693523|456214483|FG000|Overall Study|Adverse Event|2|||
126796518|NCT01693523|456214484|FG001|Overall Study|Adverse Event|1|||
126796519|NCT01693523|456214485|FG002|Overall Study|Adverse Event|0|||
126796520|NCT01693523|456214483|FG000|Overall Study|Death|0|||
126796521|NCT01693523|456214484|FG001|Overall Study|Death|1|||
126796522|NCT01693523|456214485|FG002|Overall Study|Death|1|||
126796523|NCT01693523|456214483|FG000|Overall Study|Lost to Follow-up|0|||
126796524|NCT01693523|456214484|FG001|Overall Study|Lost to Follow-up|0|||
126796525|NCT01693523|456214485|FG002|Overall Study|Lost to Follow-up|4|||
126796526|NCT01693523|456214483|FG000|Overall Study|Physician Decision|0|||
126796527|NCT01693523|456214484|FG001|Overall Study|Physician Decision|0|||
126796528|NCT01693523|456214485|FG002|Overall Study|Physician Decision|1|||
126796529|NCT01693523|456214483|FG000|Overall Study|Withdrawal by Subject|1|||
126796530|NCT01693523|456214484|FG001|Overall Study|Withdrawal by Subject|2|||
126796531|NCT01693523|456214485|FG002|Overall Study|Withdrawal by Subject|2|||
126796532|NCT01693523|456214483|FG000|Overall Study|Lack of compliance study medication|1|||
126796533|NCT01693523|456214484|FG001|Overall Study|Lack of compliance study medication|2|||
126796534|NCT01693523|456214485|FG002|Overall Study|Lack of compliance study medication|0|||
126796535|NCT01693523|456214483|FG000|Overall Study|Chemotherapy was held|1|||
126796536|NCT01693523|456214484|FG001|Overall Study|Chemotherapy was held|2|||
126796537|NCT01693523|456214485|FG002|Overall Study|Chemotherapy was held|0|||
126796538|NCT03699020|456214486|FG000|Overall Study|Withdrawal by Subject|3|||
126796539|NCT03699020|456214487|FG001|Overall Study|Withdrawal by Subject|2|||
126796540|NCT02246920|456214488|FG000|Overall Study|Adverse Event|3|||
126796541|NCT02246920|456214489|FG001|Overall Study|Adverse Event|1|||
126796542|NCT02246920|456214490|FG002|Overall Study|Adverse Event|1|||
126796543|NCT02246920|456214488|FG000|Overall Study|Lost to Follow-up|2|||
126796544|NCT02246920|456214489|FG001|Overall Study|Lost to Follow-up|1|||
126796545|NCT02246920|456214490|FG002|Overall Study|Lost to Follow-up|0|||
126796546|NCT02246920|456214488|FG000|Overall Study|Protocol Violation|2|||
126796547|NCT02246920|456214489|FG001|Overall Study|Protocol Violation|5|||
126796548|NCT02246920|456214490|FG002|Overall Study|Protocol Violation|1|||
126796549|NCT02246920|456214488|FG000|Overall Study|Withdrawal by Subject|0|||
126796550|NCT02246920|456214489|FG001|Overall Study|Withdrawal by Subject|0|||
126796551|NCT02246920|456214490|FG002|Overall Study|Withdrawal by Subject|1|||
126796552|NCT00448019|456214493|FG000|Overall Study|Withdrawal by Subject|3|||
126796553|NCT00448019|456214493|FG000|Overall Study|Disease progression|1|||
126796554|NCT00448019|456214493|FG000|Overall Study|Death|2|||
126796555|NCT00448019|456214493|FG000|Overall Study|Insurance Issues|1|||
126796556|NCT03620747|456214495|FG000|Overall Study|Participant decision|7|||
126796557|NCT03620747|456214495|FG000|Overall Study|Adverse Event|6|||
126796558|NCT03620747|456214495|FG000|Overall Study|Lack of Efficacy|1|||
126796559|NCT03620747|456214495|FG000|Overall Study|Poor compliance to protocol|2|||
126796560|NCT03620747|456214495|FG000|Overall Study|Other-unspecified|3|||
126796561|NCT02714062|456214496|FG000|Overall Study|Adverse Event|0|||
126796562|NCT02714062|456214497|FG001|Overall Study|Adverse Event|0|||
126796563|NCT02714062|456214498|FG002|Overall Study|Adverse Event|2|||
126796564|NCT02714062|456214496|FG000|Overall Study|Withdrawal by Subject|1|||
126796565|NCT02714062|456214497|FG001|Overall Study|Withdrawal by Subject|0|||
126796566|NCT02714062|456214498|FG002|Overall Study|Withdrawal by Subject|1|||
126796567|NCT02714062|456214496|FG000|Overall Study|Protocol Violation|0|||
126796568|NCT02714062|456214497|FG001|Overall Study|Protocol Violation|1|||
126796569|NCT02714062|456214498|FG002|Overall Study|Protocol Violation|0|||
126796570|NCT01200810|456214504|FG000|Overall Study|Physician Decision|1|||
126796571|NCT01200810|456214505|FG001|Overall Study|Physician Decision|0|||
126796572|NCT01200810|456214504|FG000|Overall Study|Withdrawal by Subject|1|||
126796573|NCT01200810|456214505|FG001|Overall Study|Withdrawal by Subject|2|||
126796574|NCT01200810|456214504|FG000|Overall Study|Sponsor stopped making study drug|3|||
126796575|NCT01200810|456214505|FG001|Overall Study|Sponsor stopped making study drug|3|||
126796576|NCT00904215|456214506|FG000|Overall Study|Adverse Event|25|||
126796577|NCT00904215|456214506|FG000|Overall Study|Protocol Violation|10|||
126796578|NCT00904215|456214506|FG000|Overall Study|Lost to Follow-up|63|||
126796579|NCT00904215|456214506|FG000|Overall Study|Withdrawal by Subject|9|||
126796580|NCT00904215|456214506|FG000|Overall Study|Other|28|||
126796581|NCT03500341|456214508|FG000|Overall Study|Withdrawn prior to Completion|2|||
126796582|NCT02576938|456214509|FG000|Overall Study|Adverse Event|5|||
126796583|NCT02576938|456214510|FG001|Overall Study|Adverse Event|3|||
126796584|NCT02576938|456214511|FG002|Overall Study|Adverse Event|6|||
126796585|NCT02576938|456214509|FG000|Overall Study|Protocol Violation|1|||
126796586|NCT02576938|456214510|FG001|Overall Study|Protocol Violation|1|||
126796587|NCT02576938|456214511|FG002|Overall Study|Protocol Violation|1|||
126796588|NCT02576938|456214509|FG000|Overall Study|Withdrawal by Subject|3|||
126796589|NCT02576938|456214510|FG001|Overall Study|Withdrawal by Subject|2|||
126796590|NCT02576938|456214511|FG002|Overall Study|Withdrawal by Subject|4|||
126796591|NCT02576938|456214509|FG000|Overall Study|Lack of Efficacy|9|||
126796592|NCT02576938|456214510|FG001|Overall Study|Lack of Efficacy|4|||
126796593|NCT02576938|456214511|FG002|Overall Study|Lack of Efficacy|0|||
126796594|NCT02576938|456214509|FG000|Overall Study|Lost to Follow-up|2|||
126796595|NCT02576938|456214510|FG001|Overall Study|Lost to Follow-up|0|||
126796596|NCT02576938|456214511|FG002|Overall Study|Lost to Follow-up|1|||
126796597|NCT02576938|456214509|FG000|Overall Study|Physician Decision|0|||
126796598|NCT02576938|456214510|FG001|Overall Study|Physician Decision|1|||
126796599|NCT02576938|456214511|FG002|Overall Study|Physician Decision|0|||
126796600|NCT02576938|456214509|FG000|Overall Study|Met Exclusion Criteria|0|||
126796601|NCT02576938|456214510|FG001|Overall Study|Met Exclusion Criteria|1|||
126796602|NCT02576938|456214511|FG002|Overall Study|Met Exclusion Criteria|0|||
126796603|NCT00838630|456214513|FG000|First Intervention|Adverse Event|1|||
126796604|NCT00838630|456214514|FG001|First Intervention|Adverse Event|0|||
126796605|NCT00838630|456214513|FG000|Washout: 7 Days|Protocol Violation|1|||
126796606|NCT00838630|456214514|FG001|Washout: 7 Days|Protocol Violation|0|||
126796607|NCT03285594|456214515|FG000|Overall Study|At the Participant's Own Request|10|||
126796608|NCT03285594|456214516|FG001|Overall Study|At the Participant's Own Request|5|||
126796609|NCT03285594|456214517|FG002|Overall Study|At the Participant's Own Request|21|||
126796610|NCT03285594|456214515|FG000|Overall Study|Adverse Event|2|||
126796611|NCT03285594|456214516|FG001|Overall Study|Adverse Event|2|||
126796612|NCT03285594|456214517|FG002|Overall Study|Adverse Event|6|||
126796613|NCT03285594|456214515|FG000|Overall Study|Poor Compliance to Protocol|0|||
126796614|NCT03285594|456214516|FG001|Overall Study|Poor Compliance to Protocol|0|||
126796615|NCT03285594|456214517|FG002|Overall Study|Poor Compliance to Protocol|1|||
126796616|NCT03285594|456214515|FG000|Overall Study|Lost to Follow-up|0|||
126796617|NCT03285594|456214516|FG001|Overall Study|Lost to Follow-up|0|||
126796618|NCT03285594|456214517|FG002|Overall Study|Lost to Follow-up|1|||
126796619|NCT03285594|456214515|FG000|Overall Study|Reason Not Specified|3|||
126796620|NCT03285594|456214516|FG001|Overall Study|Reason Not Specified|4|||
126796621|NCT03285594|456214517|FG002|Overall Study|Reason Not Specified|8|||
126796622|NCT01615198|456214520|FG000|Overall Study|Withdrawal by Subject|5|||
126796623|NCT01615198|456214521|FG001|Overall Study|Withdrawal by Subject|5|||
126796624|NCT01615198|456214520|FG000|Overall Study|Protocol deviation|1|||
126796625|NCT01615198|456214521|FG001|Overall Study|Protocol deviation|1|||
126796626|NCT01615198|456214520|FG000|Overall Study|Physician Decision|5|||
126796627|NCT01615198|456214521|FG001|Overall Study|Physician Decision|1|||
126796628|NCT01615198|456214520|FG000|Overall Study|Lost to Follow-up|1|||
126796629|NCT01615198|456214521|FG001|Overall Study|Lost to Follow-up|1|||
126796630|NCT01615198|456214520|FG000|Overall Study|Lack of Efficacy|1|||
126796631|NCT01615198|456214521|FG001|Overall Study|Lack of Efficacy|6|||
126796632|NCT01615198|456214520|FG000|Overall Study|Adverse Event|11|||
126796633|NCT01615198|456214521|FG001|Overall Study|Adverse Event|5|||
126796634|NCT02414152|456214523|FG000|Overall Study|Withdrawal by Subject|1|||
126796635|NCT02414152|456214523|FG000|Overall Study|Lack of Efficacy|1|||
126796636|NCT01289262|456214524|FG000|Overall Study|Lost to Follow-up|29|||
126796637|NCT01289262|456214525|FG001|Overall Study|Lost to Follow-up|16|||
126796638|NCT01289262|456214524|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
126796639|NCT01289262|456214525|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
126632968|NCT04599855|455615708|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
126632969|NCT04599855|455615709|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
126796640|NCT04887415|456214526|FG000|Overall Study|Lost to Follow-up|2|||
126796641|NCT00838279|456214527|FG000|Washout|Protocol Violation|1|||
126796642|NCT00838279|456214528|FG001|Washout|Protocol Violation|0|||
126796643|NCT00838279|456214527|FG000|Washout|Withdrawal by Subject|0|||
126796644|NCT00838279|456214528|FG001|Washout|Withdrawal by Subject|1|||
126796645|NCT01218867|456214532|FG000|Overall Study|Death during treatment|0|||
126796646|NCT01218867|456214533|FG001|Overall Study|Death during treatment|0|||
126796647|NCT01218867|456214534|FG002|Overall Study|Death during treatment|0|||
126796648|NCT01218867|456214535|FG003|Overall Study|Death during treatment|0|||
126796649|NCT01218867|456214536|FG004|Overall Study|Death during treatment|0|||
126796650|NCT01218867|456214537|FG005|Overall Study|Death during treatment|0|||
126796651|NCT01218867|456214538|FG006|Overall Study|Death during treatment|1|||
126796652|NCT01218867|456214539|FG007|Overall Study|Death during treatment|0|||
126796653|NCT01218867|456214540|FG008|Overall Study|Death during treatment|0|||
126796654|NCT01218867|456214541|FG009|Overall Study|Death during treatment|0|||
126796655|NCT01218867|456214542|FG010|Overall Study|Death during treatment|0|||
126796656|NCT03792477|456214543|FG000|Overall Study|Adverse Event|0|||
126796657|NCT03792477|456214544|FG001|Overall Study|Adverse Event|0|||
126796658|NCT03792477|456214545|FG002|Overall Study|Adverse Event|0|||
126796659|NCT03792477|456214546|FG003|Overall Study|Adverse Event|1|||
126796660|NCT03792477|456214547|FG004|Overall Study|Adverse Event|0|||
126796661|NCT03792477|456214543|FG000|Overall Study|Lost to Follow-up|0|||
126796662|NCT03792477|456214544|FG001|Overall Study|Lost to Follow-up|0|||
126796663|NCT03792477|456214545|FG002|Overall Study|Lost to Follow-up|2|||
126796664|NCT03792477|456214546|FG003|Overall Study|Lost to Follow-up|0|||
126796665|NCT03792477|456214547|FG004|Overall Study|Lost to Follow-up|0|||
126796666|NCT03792477|456214543|FG000|Overall Study|Other|0|||
126796667|NCT03792477|456214544|FG001|Overall Study|Other|0|||
126796668|NCT03792477|456214545|FG002|Overall Study|Other|0|||
126796669|NCT03792477|456214546|FG003|Overall Study|Other|0|||
126796670|NCT03792477|456214547|FG004|Overall Study|Other|1|||
126796671|NCT01474551|456214548|FG000|Overall Study|Death|1|||
126796672|NCT00840411|456214549|FG000|First Intervention|Adverse Event|1|||
126796673|NCT00840411|456214550|FG001|First Intervention|Adverse Event|0|||
126796674|NCT00840411|456214549|FG000|Washout|Withdrawal by Subject|1|||
126796675|NCT00840411|456214550|FG001|Washout|Withdrawal by Subject|0|||
126796676|NCT01921062|456214553|FG000|Overall Study|Withdrawal by Subject|0|||
126796677|NCT01921062|456214554|FG001|Overall Study|Withdrawal by Subject|7|||
126796678|NCT01921062|456214553|FG000|Overall Study|Adverse Event|5|||
126796679|NCT01921062|456214554|FG001|Overall Study|Adverse Event|6|||
126796680|NCT01921062|456214553|FG000|Overall Study|Protocol Violation|0|||
126796681|NCT01921062|456214554|FG001|Overall Study|Protocol Violation|1|||
126796682|NCT01921062|456214553|FG000|Overall Study|VMIQ score > 72|4|||
126796683|NCT01921062|456214554|FG001|Overall Study|VMIQ score > 72|1|||
126796684|NCT01921062|456214553|FG000|Overall Study|Logistic error|0|||
126796685|NCT01921062|456214554|FG001|Overall Study|Logistic error|1|||
126796686|NCT01854047|456214555|FG000|Overall Study|Lack of Efficacy|1|||
126796687|NCT01854047|456214556|FG001|Overall Study|Lack of Efficacy|0|||
126796688|NCT01854047|456214557|FG002|Overall Study|Lack of Efficacy|0|||
126796689|NCT01854047|456214558|FG003|Overall Study|Lack of Efficacy|0|||
126796690|NCT01854047|456214559|FG004|Overall Study|Lack of Efficacy|0|||
126796691|NCT01854047|456214555|FG000|Overall Study|Poor compliance to protocol|3|||
126796692|NCT01854047|456214556|FG001|Overall Study|Poor compliance to protocol|0|||
126796693|NCT01854047|456214557|FG002|Overall Study|Poor compliance to protocol|2|||
126632970|NCT04599855|455615710|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
126632971|NCT04599855|455615708|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
126632972|NCT04599855|455615709|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
126632973|NCT04599855|455615710|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
126632974|NCT04599855|455615708|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
126632975|NCT04599855|455615709|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
126632976|NCT04599855|455615710|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
126796694|NCT01854047|456214558|FG003|Overall Study|Poor compliance to protocol|0|||
126796695|NCT01854047|456214559|FG004|Overall Study|Poor compliance to protocol|0|||
126796696|NCT01854047|456214555|FG000|Overall Study|Adverse Event|5|||
126796697|NCT01854047|456214556|FG001|Overall Study|Adverse Event|4|||
126796698|NCT01854047|456214557|FG002|Overall Study|Adverse Event|6|||
126796699|NCT01854047|456214558|FG003|Overall Study|Adverse Event|10|||
126796700|NCT01854047|456214559|FG004|Overall Study|Adverse Event|7|||
126796701|NCT01854047|456214555|FG000|Overall Study|Randomized but not treated|0|||
126796702|NCT01854047|456214556|FG001|Overall Study|Randomized but not treated|1|||
126796703|NCT01854047|456214557|FG002|Overall Study|Randomized but not treated|2|||
126632977|NCT04599855|455615708|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
126632978|NCT04599855|455615709|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
126632979|NCT04599855|455615710|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
126632980|NCT04599855|455615708|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
126796704|NCT01854047|456214558|FG003|Overall Study|Randomized but not treated|0|||
126796705|NCT01854047|456214559|FG004|Overall Study|Randomized but not treated|4|||
126796706|NCT01854047|456214555|FG000|Overall Study|Other than specified above|3|||
126796707|NCT01854047|456214556|FG001|Overall Study|Other than specified above|3|||
126796708|NCT01854047|456214557|FG002|Overall Study|Other than specified above|3|||
126796709|NCT01854047|456214558|FG003|Overall Study|Other than specified above|5|||
126796710|NCT01854047|456214559|FG004|Overall Study|Other than specified above|8|||
126796711|NCT00576056|456214560|FG000|Overall Study|Adverse Event|1|||
126796712|NCT00576056|456214560|FG000|Overall Study|Death|1|||
126796713|NCT00576056|456214560|FG000|Overall Study|Lack of Efficacy|1|||
126796714|NCT00576056|456214560|FG000|Overall Study|Withdrawal by Subject|2|||
126796715|NCT00576056|456214560|FG000|Overall Study|did not meet eligibility criteria|8|||
126796716|NCT00576056|456214560|FG000|Overall Study|Physician Decision|1|||
126796717|NCT03273153|456214561|FG000|Overall Study|Adverse Event|1|||
126796718|NCT03273153|456214562|FG001|Overall Study|Adverse Event|2|||
126796719|NCT03273153|456214561|FG000|Overall Study|Missing|0|||
126796720|NCT03273153|456214562|FG001|Overall Study|Missing|2|||
126796721|NCT03273153|456214561|FG000|Overall Study|Other|3|||
126796722|NCT03273153|456214562|FG001|Overall Study|Other|2|||
126796723|NCT03273153|456214561|FG000|Overall Study|Symptomatic Deterioration|0|||
126796724|NCT03273153|456214562|FG001|Overall Study|Symptomatic Deterioration|1|||
126796725|NCT03273153|456214561|FG000|Overall Study|Progressive Disease|6|||
126796726|NCT03273153|456214562|FG001|Overall Study|Progressive Disease|5|||
126796727|NCT03273153|456214561|FG000|Overall Study|Physician Decision|1|||
126796728|NCT03273153|456214562|FG001|Overall Study|Physician Decision|3|||
126796729|NCT03273153|456214561|FG000|Overall Study|Study Terminated by Sponsor|112|||
126796730|NCT03273153|456214562|FG001|Overall Study|Study Terminated by Sponsor|102|||
126796731|NCT03273153|456214561|FG000|Overall Study|Withdrawal by Subject|26|||
126796732|NCT03273153|456214562|FG001|Overall Study|Withdrawal by Subject|25|||
126796733|NCT03273153|456214561|FG000|Overall Study|Protocol Deviation|3|||
126796734|NCT03273153|456214562|FG001|Overall Study|Protocol Deviation|0|||
126796735|NCT03273153|456214561|FG000|Overall Study|Lost to Follow-up|6|||
126796736|NCT03273153|456214562|FG001|Overall Study|Lost to Follow-up|11|||
126796737|NCT03273153|456214561|FG000|Overall Study|Death|66|||
126796738|NCT03273153|456214562|FG001|Overall Study|Death|69|||
126796739|NCT05323396|456214563|FG000|Overall Study|Lost to Follow-up|1|||
126796740|NCT05323396|456214564|FG001|Overall Study|Lost to Follow-up|35|||
126796741|NCT05323396|456214563|FG000|Overall Study|Pregnancy|1|||
126796742|NCT05323396|456214564|FG001|Overall Study|Pregnancy|0|||
126796743|NCT04646213|456214565|FG000|Overall Study|Physician Decision|3|||
126796744|NCT04646213|456214565|FG000|Overall Study|Withdrawal by Subject|2|||
126796745|NCT01597245|456214576|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
126796746|NCT01597245|456214577|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
126796747|NCT01597245|456214578|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
126796748|NCT01597245|456214579|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
126796749|NCT01597245|456214580|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796750|NCT01597245|456214581|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796751|NCT01597245|456214582|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796752|NCT01597245|456214583|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796753|NCT01597245|456214584|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796754|NCT01597245|456214585|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796755|NCT01597245|456214586|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796756|NCT01597245|456214587|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796757|NCT01597245|456214588|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796758|NCT01597245|456214589|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796759|NCT01597245|456214590|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796760|NCT01597245|456214591|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796761|NCT01597245|456214592|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796762|NCT01597245|456214593|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796763|NCT01597245|456214594|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796764|NCT01597245|456214595|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796765|NCT01597245|456214596|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
126796766|NCT01597245|456214576|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
126796767|NCT01597245|456214577|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
126796768|NCT01597245|456214578|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
126796769|NCT01597245|456214579|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
126796770|NCT01597245|456214580|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796771|NCT01597245|456214581|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796772|NCT01597245|456214582|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796773|NCT01597245|456214583|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796774|NCT01597245|456214584|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796775|NCT01597245|456214585|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796776|NCT01597245|456214586|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796777|NCT01597245|456214587|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796778|NCT01597245|456214588|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796779|NCT01597245|456214589|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796780|NCT01597245|456214590|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796781|NCT01597245|456214591|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796782|NCT01597245|456214592|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796783|NCT01597245|456214593|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796784|NCT01597245|456214594|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796785|NCT01597245|456214595|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796786|NCT01597245|456214596|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
126796787|NCT01597245|456214576|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
126796788|NCT01597245|456214577|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
126796789|NCT01597245|456214578|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
126796790|NCT01597245|456214579|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
126796791|NCT01597245|456214580|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796792|NCT01597245|456214581|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796793|NCT01597245|456214582|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796794|NCT01597245|456214583|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796795|NCT01597245|456214584|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796796|NCT01597245|456214585|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796797|NCT01597245|456214586|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796798|NCT01597245|456214587|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796799|NCT01597245|456214588|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796800|NCT01597245|456214589|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796801|NCT01597245|456214590|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796802|NCT01597245|456214591|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796803|NCT01597245|456214592|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796804|NCT01597245|456214593|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796805|NCT01597245|456214594|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796806|NCT01597245|456214595|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796807|NCT01597245|456214596|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
126796808|NCT01597245|456214576|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
126796809|NCT01597245|456214577|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
126796810|NCT01597245|456214578|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
126796811|NCT01597245|456214579|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796812|NCT01597245|456214580|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796813|NCT01597245|456214581|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796814|NCT01597245|456214582|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796815|NCT01597245|456214583|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796816|NCT01597245|456214584|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796817|NCT01597245|456214585|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796818|NCT01597245|456214586|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796819|NCT01597245|456214587|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796820|NCT01597245|456214588|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126632981|NCT04599855|455615709|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
126632982|NCT04599855|455615710|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
126632983|NCT04599855|455615708|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
126632984|NCT04599855|455615709|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
126796821|NCT01597245|456214589|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796822|NCT01597245|456214590|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796823|NCT01597245|456214591|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796824|NCT01597245|456214592|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796825|NCT01597245|456214593|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796826|NCT01597245|456214594|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796827|NCT01597245|456214595|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796828|NCT01597245|456214596|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
126796829|NCT01597245|456214576|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
126796830|NCT01597245|456214577|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796831|NCT01597245|456214578|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796832|NCT01597245|456214579|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
126796833|NCT01597245|456214580|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796834|NCT01597245|456214581|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796835|NCT01597245|456214582|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796836|NCT01597245|456214583|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796837|NCT01597245|456214584|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796838|NCT01597245|456214585|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796839|NCT01597245|456214586|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796840|NCT01597245|456214587|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796841|NCT01597245|456214588|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796842|NCT01597245|456214589|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796843|NCT01597245|456214590|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796844|NCT01597245|456214591|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796845|NCT01597245|456214592|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796846|NCT01597245|456214593|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796847|NCT01597245|456214594|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796848|NCT01597245|456214595|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796849|NCT01597245|456214596|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
126796850|NCT01597245|456214576|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
126796851|NCT01597245|456214577|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
126796852|NCT01597245|456214578|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
126632985|NCT04599855|455615710|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
126632986|NCT04599855|455615708|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
126796853|NCT01597245|456214579|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796854|NCT01597245|456214580|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796855|NCT01597245|456214581|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796856|NCT01597245|456214582|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796857|NCT01597245|456214583|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796858|NCT01597245|456214584|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796859|NCT01597245|456214585|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796860|NCT01597245|456214586|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796861|NCT01597245|456214587|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796862|NCT01597245|456214588|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796863|NCT01597245|456214589|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796864|NCT01597245|456214590|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796865|NCT01597245|456214591|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796866|NCT01597245|456214592|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796867|NCT01597245|456214593|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796868|NCT01597245|456214594|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796869|NCT01597245|456214595|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796870|NCT01597245|456214596|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
126796871|NCT01597245|456214576|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796872|NCT01597245|456214577|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796873|NCT01597245|456214578|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796874|NCT01597245|456214579|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796875|NCT01597245|456214580|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796876|NCT01597245|456214581|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
126796877|NCT01597245|456214582|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
126796878|NCT01597245|456214583|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796879|NCT01597245|456214584|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796880|NCT01597245|456214585|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796881|NCT01597245|456214586|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796882|NCT01597245|456214587|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796883|NCT01597245|456214588|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796884|NCT01597245|456214589|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796885|NCT01597245|456214590|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796886|NCT01597245|456214591|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796887|NCT01597245|456214592|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796888|NCT01597245|456214593|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796889|NCT01597245|456214594|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796890|NCT01597245|456214595|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796891|NCT01597245|456214596|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
126796892|NCT01597245|456214576|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796893|NCT01597245|456214577|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796894|NCT01597245|456214578|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796895|NCT01597245|456214579|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796896|NCT01597245|456214580|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
126796897|NCT01597245|456214581|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
126796898|NCT01597245|456214582|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
126796899|NCT01597245|456214583|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
126796900|NCT01597245|456214584|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796901|NCT01597245|456214585|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
126796902|NCT01597245|456214586|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796903|NCT01597245|456214587|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796904|NCT01597245|456214588|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796905|NCT01597245|456214589|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796906|NCT01597245|456214590|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796907|NCT01597245|456214591|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796908|NCT01597245|456214592|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796909|NCT01597245|456214593|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796910|NCT01597245|456214594|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796911|NCT01597245|456214595|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796912|NCT01597245|456214596|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
126796913|NCT01597245|456214576|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796914|NCT01597245|456214577|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796915|NCT01597245|456214578|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126632987|NCT04599855|455615709|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
126632988|NCT04599855|455615710|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
126796916|NCT01597245|456214579|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796917|NCT01597245|456214580|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796918|NCT01597245|456214581|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
126796919|NCT01597245|456214582|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796920|NCT01597245|456214583|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796921|NCT01597245|456214584|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
126796922|NCT01597245|456214585|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796923|NCT01597245|456214586|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
126796924|NCT01597245|456214587|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
126796925|NCT01597245|456214588|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
126796926|NCT01597245|456214589|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796927|NCT01597245|456214590|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796928|NCT01597245|456214591|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796929|NCT01597245|456214592|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796930|NCT01597245|456214593|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796931|NCT01597245|456214594|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796932|NCT01597245|456214595|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796933|NCT01597245|456214596|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
126796934|NCT01597245|456214576|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126796935|NCT01597245|456214577|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126796936|NCT01597245|456214578|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126796937|NCT01597245|456214579|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126796938|NCT01597245|456214580|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
126796939|NCT01597245|456214581|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
126796940|NCT01597245|456214582|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
126796941|NCT01597245|456214583|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
126796942|NCT01597245|456214584|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
126796943|NCT01597245|456214585|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
126796944|NCT01597245|456214586|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
126796945|NCT01597245|456214587|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
126796946|NCT01597245|456214588|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
126796947|NCT01597245|456214589|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126796948|NCT01597245|456214590|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126796949|NCT01597245|456214591|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126796950|NCT01597245|456214592|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126796951|NCT01597245|456214593|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126796952|NCT01597245|456214594|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126796953|NCT01597245|456214595|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126796954|NCT01597245|456214596|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
126796955|NCT01597245|456214576|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796956|NCT01597245|456214577|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796957|NCT01597245|456214578|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796958|NCT01597245|456214579|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796959|NCT01597245|456214580|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
126796960|NCT01597245|456214581|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
126796961|NCT01597245|456214582|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
126796962|NCT01597245|456214583|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796963|NCT01597245|456214584|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
126796964|NCT01597245|456214585|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
126796965|NCT01597245|456214586|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
126796966|NCT01597245|456214587|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
126796967|NCT01597245|456214588|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
126796968|NCT01597245|456214589|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796969|NCT01597245|456214590|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796970|NCT01597245|456214591|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796971|NCT01597245|456214592|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796972|NCT01597245|456214593|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796973|NCT01597245|456214594|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796974|NCT01597245|456214595|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796975|NCT01597245|456214596|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
126796976|NCT01597245|456214576|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126632989|NCT04599855|455615708|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
126632990|NCT04599855|455615709|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
126632991|NCT04599855|455615710|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
126796977|NCT01597245|456214577|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796978|NCT01597245|456214578|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796979|NCT01597245|456214579|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796980|NCT01597245|456214580|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
126796981|NCT01597245|456214581|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796982|NCT01597245|456214582|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796983|NCT01597245|456214583|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796984|NCT01597245|456214584|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
126796985|NCT01597245|456214585|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
126796986|NCT01597245|456214586|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
126796987|NCT01597245|456214587|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796988|NCT01597245|456214588|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
126796989|NCT01597245|456214589|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796990|NCT01597245|456214590|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796991|NCT01597245|456214591|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796992|NCT01597245|456214592|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796993|NCT01597245|456214593|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796994|NCT01597245|456214594|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796995|NCT01597245|456214595|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796996|NCT01597245|456214596|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
126796997|NCT01597245|456214576|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126796998|NCT01597245|456214577|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126796999|NCT01597245|456214578|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126797000|NCT01597245|456214579|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126797001|NCT01597245|456214580|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
126797002|NCT01597245|456214581|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
126797003|NCT01597245|456214582|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
126797004|NCT01597245|456214583|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126797005|NCT01597245|456214584|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
126797006|NCT01597245|456214585|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
126797007|NCT01597245|456214586|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
126797008|NCT01597245|456214587|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
126797009|NCT01597245|456214588|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
126797010|NCT01597245|456214589|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126797011|NCT01597245|456214590|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126797012|NCT01597245|456214591|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126797013|NCT01597245|456214592|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126797014|NCT01597245|456214593|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126797015|NCT01597245|456214594|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126797016|NCT01597245|456214595|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126797017|NCT01597245|456214596|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
126797018|NCT01597245|456214576|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797019|NCT01597245|456214577|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797020|NCT01597245|456214578|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797021|NCT01597245|456214579|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797022|NCT01597245|456214580|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797023|NCT01597245|456214581|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
126797024|NCT01597245|456214582|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797025|NCT01597245|456214583|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797026|NCT01597245|456214584|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
126797027|NCT01597245|456214585|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
126797028|NCT01597245|456214586|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
126797029|NCT01597245|456214587|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
126797030|NCT01597245|456214588|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797031|NCT01597245|456214589|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797032|NCT01597245|456214590|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797033|NCT01597245|456214591|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797034|NCT01597245|456214592|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797035|NCT01597245|456214593|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797036|NCT01597245|456214594|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797037|NCT01597245|456214595|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797038|NCT01597245|456214596|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
126797039|NCT01597245|456214576|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797040|NCT01597245|456214577|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797041|NCT01597245|456214578|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797042|NCT01597245|456214579|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797043|NCT01597245|456214580|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797044|NCT01597245|456214581|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797045|NCT01597245|456214582|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797046|NCT01597245|456214583|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797047|NCT01597245|456214584|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797048|NCT01597245|456214585|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797049|NCT01597245|456214586|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
126797050|NCT01597245|456214587|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797051|NCT01597245|456214588|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797052|NCT01597245|456214589|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797053|NCT01597245|456214590|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797054|NCT01597245|456214591|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797055|NCT01597245|456214592|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797056|NCT01597245|456214593|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797057|NCT01597245|456214594|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797058|NCT01597245|456214595|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797059|NCT01597245|456214596|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
126797060|NCT01597245|456214576|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797061|NCT01597245|456214577|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797062|NCT01597245|456214578|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797063|NCT01597245|456214579|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797064|NCT01597245|456214580|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797065|NCT01597245|456214581|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797066|NCT01597245|456214582|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797067|NCT01597245|456214583|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797068|NCT01597245|456214584|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797069|NCT01597245|456214585|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797070|NCT01597245|456214586|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797071|NCT01597245|456214587|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797072|NCT01597245|456214588|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797073|NCT01597245|456214589|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
126797074|NCT01597245|456214590|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
126797075|NCT01597245|456214591|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
126797076|NCT01597245|456214592|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797077|NCT01597245|456214593|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797078|NCT01597245|456214594|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797079|NCT01597245|456214595|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797080|NCT01597245|456214596|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
126797081|NCT01597245|456214576|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797082|NCT01597245|456214577|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797083|NCT01597245|456214578|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797084|NCT01597245|456214579|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797085|NCT01597245|456214580|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797086|NCT01597245|456214581|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797087|NCT01597245|456214582|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797088|NCT01597245|456214583|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797089|NCT01597245|456214584|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797090|NCT01597245|456214585|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797091|NCT01597245|456214586|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797092|NCT01597245|456214587|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797093|NCT01597245|456214588|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797094|NCT01597245|456214589|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
126797095|NCT01597245|456214590|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
126797096|NCT01597245|456214591|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
126797097|NCT01597245|456214592|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797098|NCT01597245|456214593|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797099|NCT01597245|456214594|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797100|NCT01597245|456214595|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797101|NCT01597245|456214596|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
126797102|NCT01597245|456214576|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797103|NCT01597245|456214577|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797104|NCT01597245|456214578|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797105|NCT01597245|456214579|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797106|NCT01597245|456214580|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797107|NCT01597245|456214581|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797108|NCT01597245|456214582|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797109|NCT01597245|456214583|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797110|NCT01597245|456214584|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797111|NCT01597245|456214585|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797112|NCT01597245|456214586|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797113|NCT01597245|456214587|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797114|NCT01597245|456214588|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797115|NCT01597245|456214589|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797116|NCT01597245|456214590|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
126797117|NCT01597245|456214591|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
126797118|NCT01597245|456214592|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797119|NCT01597245|456214593|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797120|NCT01597245|456214594|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797121|NCT01597245|456214595|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797122|NCT01597245|456214596|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
126797123|NCT01597245|456214576|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797124|NCT01597245|456214577|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797125|NCT01597245|456214578|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797126|NCT01597245|456214579|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797127|NCT01597245|456214580|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797128|NCT01597245|456214581|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797129|NCT01597245|456214582|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797130|NCT01597245|456214583|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797131|NCT01597245|456214584|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797132|NCT01597245|456214585|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797133|NCT01597245|456214586|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797134|NCT01597245|456214587|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797135|NCT01597245|456214588|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797136|NCT01597245|456214589|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797137|NCT01597245|456214590|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
126797138|NCT01597245|456214591|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
126797139|NCT01597245|456214592|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797140|NCT01597245|456214593|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797141|NCT01597245|456214594|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797142|NCT01597245|456214595|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797143|NCT01597245|456214596|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
126797144|NCT01597245|456214576|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797145|NCT01597245|456214577|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797146|NCT01597245|456214578|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797147|NCT01597245|456214579|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797148|NCT01597245|456214580|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126632992|NCT04599855|455615708|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
126632993|NCT04599855|455615709|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
126797149|NCT01597245|456214581|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797150|NCT01597245|456214582|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797151|NCT01597245|456214583|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797152|NCT01597245|456214584|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797153|NCT01597245|456214585|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797154|NCT01597245|456214586|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797155|NCT01597245|456214587|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126632994|NCT04599855|455615710|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
126632995|NCT04599855|455615708|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
126632996|NCT04599855|455615709|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
126632997|NCT04599855|455615710|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
126632998|NCT04599855|455615708|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
126632999|NCT04599855|455615709|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
126633000|NCT04599855|455615710|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
126633001|NCT02165397|455615711|FG000|Overall Study|Death|7|||
126633002|NCT02165397|455615712|FG001|Overall Study|Death|10|||
126633003|NCT02165397|455615713|FG002|Overall Study|Death|8|||
126797156|NCT01597245|456214588|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797157|NCT01597245|456214589|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
126797158|NCT01597245|456214590|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
126797159|NCT01597245|456214591|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
126797160|NCT01597245|456214592|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797161|NCT01597245|456214593|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797162|NCT01597245|456214594|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797163|NCT01597245|456214595|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797164|NCT01597245|456214596|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
126797165|NCT01597245|456214576|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797166|NCT01597245|456214577|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797167|NCT01597245|456214578|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797168|NCT01597245|456214579|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797169|NCT01597245|456214580|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797170|NCT01597245|456214581|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797171|NCT01597245|456214582|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797172|NCT01597245|456214583|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797173|NCT01597245|456214584|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797174|NCT01597245|456214585|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797175|NCT01597245|456214586|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797176|NCT01597245|456214587|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797177|NCT01597245|456214588|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797178|NCT01597245|456214589|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797179|NCT01597245|456214590|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
126797180|NCT01597245|456214591|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
126797181|NCT01597245|456214592|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797182|NCT01597245|456214593|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797183|NCT01597245|456214594|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797184|NCT01597245|456214595|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797185|NCT01597245|456214596|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
126797186|NCT01597245|456214576|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797187|NCT01597245|456214577|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797188|NCT01597245|456214578|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797189|NCT01597245|456214579|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797190|NCT01597245|456214580|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797191|NCT01597245|456214581|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797192|NCT01597245|456214582|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797193|NCT01597245|456214583|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797194|NCT01597245|456214584|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797195|NCT01597245|456214585|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797196|NCT01597245|456214586|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797197|NCT01597245|456214587|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797198|NCT01597245|456214588|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797199|NCT01597245|456214589|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797200|NCT01597245|456214590|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
126797201|NCT01597245|456214591|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
126797202|NCT01597245|456214592|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797203|NCT01597245|456214593|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797204|NCT01597245|456214594|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797205|NCT01597245|456214595|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797206|NCT01597245|456214596|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
126797207|NCT01597245|456214576|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797208|NCT01597245|456214577|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797209|NCT01597245|456214578|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797210|NCT01597245|456214579|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797211|NCT01597245|456214580|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797212|NCT01597245|456214581|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797213|NCT01597245|456214582|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797214|NCT01597245|456214583|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797215|NCT01597245|456214584|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797216|NCT01597245|456214585|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797217|NCT01597245|456214586|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797218|NCT01597245|456214587|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126633004|NCT02165397|455615711|FG000|Overall Study|Lost to Follow-up|1|||
126633005|NCT02165397|455615712|FG001|Overall Study|Lost to Follow-up|3|||
126633006|NCT02165397|455615713|FG002|Overall Study|Lost to Follow-up|0|||
126633007|NCT02165397|455615711|FG000|Overall Study|Withdrawal by Subject|6|||
126633008|NCT02165397|455615712|FG001|Overall Study|Withdrawal by Subject|6|||
126633009|NCT02165397|455615713|FG002|Overall Study|Withdrawal by Subject|1|||
126633010|NCT02165397|455615711|FG000|Overall Study|Other, Not Specified|0|||
126633011|NCT02165397|455615712|FG001|Overall Study|Other, Not Specified|0|||
126797219|NCT01597245|456214588|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797220|NCT01597245|456214589|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797221|NCT01597245|456214590|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
126797222|NCT01597245|456214591|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
126797223|NCT01597245|456214592|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126633012|NCT02165397|455615713|FG002|Overall Study|Other, Not Specified|1|||
126633013|NCT03297398|455615714|FG000|Overall Study|Sponsor's decision|6|||
126633014|NCT03297398|455615715|FG001|Overall Study|Sponsor's decision|9|||
126633015|NCT03297398|455615716|FG002|Overall Study|Sponsor's decision|7|||
126633016|NCT03297398|455615714|FG000|Overall Study|Adverse Event|1|||
126633017|NCT03297398|455615715|FG001|Overall Study|Adverse Event|4|||
126633018|NCT03297398|455615716|FG002|Overall Study|Adverse Event|4|||
126633019|NCT03297398|455615714|FG000|Overall Study|Withdrawal by Subject|1|||
126633020|NCT03297398|455615715|FG001|Overall Study|Withdrawal by Subject|2|||
126633021|NCT03297398|455615716|FG002|Overall Study|Withdrawal by Subject|2|||
126633022|NCT03297398|455615714|FG000|Overall Study|Protocol Violation|0|||
126633023|NCT03297398|455615715|FG001|Overall Study|Protocol Violation|2|||
126633024|NCT03297398|455615716|FG002|Overall Study|Protocol Violation|0|||
126633025|NCT03297398|455615714|FG000|Overall Study|Physician Decision|0|||
126633026|NCT03297398|455615715|FG001|Overall Study|Physician Decision|0|||
126633027|NCT03297398|455615716|FG002|Overall Study|Physician Decision|1|||
126633028|NCT03297398|455615714|FG000|Overall Study|Lost to Follow-up|0|||
126633029|NCT03297398|455615715|FG001|Overall Study|Lost to Follow-up|0|||
126633030|NCT03297398|455615716|FG002|Overall Study|Lost to Follow-up|1|||
126633031|NCT00236184|455615721|FG000|Overall Study|Adverse Event|5|||
126633032|NCT00236184|455615722|FG001|Overall Study|Adverse Event|2|||
126633033|NCT00236184|455615721|FG000|Overall Study|Lack of Efficacy|0|||
126633034|NCT00236184|455615722|FG001|Overall Study|Lack of Efficacy|1|||
126633035|NCT00236184|455615721|FG000|Overall Study|Lost to Follow-up|3|||
126797224|NCT01597245|456214593|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797225|NCT01597245|456214594|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797226|NCT01597245|456214595|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797227|NCT01597245|456214596|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
126797228|NCT01597245|456214576|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797229|NCT01597245|456214577|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797230|NCT01597245|456214578|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797231|NCT01597245|456214579|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797232|NCT01597245|456214580|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797233|NCT01597245|456214581|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797234|NCT01597245|456214582|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797235|NCT01597245|456214583|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797236|NCT01597245|456214584|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797237|NCT01597245|456214585|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797238|NCT01597245|456214586|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797239|NCT01597245|456214587|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797240|NCT01597245|456214588|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797241|NCT01597245|456214589|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797242|NCT01597245|456214590|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
126797243|NCT01597245|456214591|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
126633036|NCT00236184|455615722|FG001|Overall Study|Lost to Follow-up|4|||
126633037|NCT00236184|455615721|FG000|Overall Study|Physician Decision|1|||
126633038|NCT00236184|455615722|FG001|Overall Study|Physician Decision|1|||
126633039|NCT00236184|455615721|FG000|Overall Study|Withdrawal by Subject|3|||
126633040|NCT00236184|455615722|FG001|Overall Study|Withdrawal by Subject|0|||
126633041|NCT00236184|455615721|FG000|Overall Study|Protocol Violation|3|||
126633042|NCT00236184|455615722|FG001|Overall Study|Protocol Violation|0|||
126633043|NCT00236184|455615721|FG000|Overall Study|non-compliance with study drug|2|||
126633044|NCT00236184|455615722|FG001|Overall Study|non-compliance with study drug|1|||
126633045|NCT00236184|455615721|FG000|Overall Study|other|1|||
126633046|NCT00236184|455615722|FG001|Overall Study|other|2|||
126633047|NCT01772563|455615723|FG000|Cycle 1|Dose limiting toxicity|2|||
126633048|NCT01772563|455615723|FG000|Cycle 1|Progressive disease|2|||
126633049|NCT01772563|455615723|FG000|Cycle 2 and Beyond|Progressive disease|17|||
126633050|NCT01772563|455615723|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
126633051|NCT01772563|455615723|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
126633052|NCT01192776|455615725|FG000|Overall Study|Death|8|||
126633053|NCT01192776|455615726|FG001|Overall Study|Death|15|||
126633054|NCT01192776|455615727|FG002|Overall Study|Death|18|||
126633055|NCT01192776|455615728|FG003|Overall Study|Death|15|||
126797244|NCT01597245|456214592|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797245|NCT01597245|456214593|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797246|NCT01597245|456214594|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797247|NCT01597245|456214595|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797248|NCT01597245|456214596|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
126797249|NCT01597245|456214576|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797250|NCT01597245|456214577|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797251|NCT01597245|456214578|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797252|NCT01597245|456214579|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797253|NCT01597245|456214580|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797254|NCT01597245|456214581|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797255|NCT01597245|456214582|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797256|NCT01597245|456214583|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797257|NCT01597245|456214584|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797258|NCT01597245|456214585|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797259|NCT01597245|456214586|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797260|NCT01597245|456214587|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797261|NCT01597245|456214588|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797262|NCT01597245|456214589|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
126797263|NCT01597245|456214590|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797264|NCT01597245|456214591|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797265|NCT01597245|456214592|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797266|NCT01597245|456214593|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797267|NCT01597245|456214594|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797268|NCT01597245|456214595|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797269|NCT01597245|456214596|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
126797270|NCT01597245|456214576|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797271|NCT01597245|456214577|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797272|NCT01597245|456214578|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797273|NCT01597245|456214579|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797274|NCT01597245|456214580|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797275|NCT01597245|456214581|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797276|NCT01597245|456214582|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797277|NCT01597245|456214583|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797278|NCT01597245|456214584|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797279|NCT01597245|456214585|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797280|NCT01597245|456214586|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797281|NCT01597245|456214587|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797282|NCT01597245|456214588|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797283|NCT01597245|456214589|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797284|NCT01597245|456214590|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797285|NCT01597245|456214591|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
126797286|NCT01597245|456214592|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
126797287|NCT01597245|456214593|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
126797288|NCT01597245|456214594|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
126797289|NCT01597245|456214595|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
126797290|NCT01597245|456214596|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
126797291|NCT01597245|456214576|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797292|NCT01597245|456214577|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797293|NCT01597245|456214578|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797294|NCT01597245|456214579|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797295|NCT01597245|456214580|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797296|NCT01597245|456214581|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797297|NCT01597245|456214582|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797298|NCT01597245|456214583|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797299|NCT01597245|456214584|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797300|NCT01597245|456214585|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797301|NCT01597245|456214586|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797302|NCT01597245|456214587|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797303|NCT01597245|456214588|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797304|NCT01597245|456214589|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797305|NCT01597245|456214590|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797306|NCT01597245|456214591|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797307|NCT01597245|456214592|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
126797308|NCT01597245|456214593|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
126797309|NCT01597245|456214594|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
126797310|NCT01597245|456214595|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
126797311|NCT01597245|456214596|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
126797312|NCT01597245|456214576|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797313|NCT01597245|456214577|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797314|NCT01597245|456214578|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797315|NCT01597245|456214579|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797316|NCT01597245|456214580|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797317|NCT01597245|456214581|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797318|NCT01597245|456214582|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797319|NCT01597245|456214583|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797320|NCT01597245|456214584|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797321|NCT01597245|456214585|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797322|NCT01597245|456214586|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797323|NCT01597245|456214587|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797324|NCT01597245|456214588|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797325|NCT01597245|456214589|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797326|NCT01597245|456214590|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797327|NCT01597245|456214591|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797328|NCT01597245|456214592|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
126797329|NCT01597245|456214593|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797330|NCT01597245|456214594|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
126797331|NCT01597245|456214595|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
126797332|NCT01597245|456214596|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
126797333|NCT01597245|456214576|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797334|NCT01597245|456214577|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797335|NCT01597245|456214578|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797336|NCT01597245|456214579|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797337|NCT01597245|456214580|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797338|NCT01597245|456214581|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797339|NCT01597245|456214582|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797340|NCT01597245|456214583|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797341|NCT01597245|456214584|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797342|NCT01597245|456214585|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797343|NCT01597245|456214586|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797344|NCT01597245|456214587|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126633056|NCT01192776|455615725|FG000|Overall Study|Lost to Follow-up|3|||
126633057|NCT01192776|455615726|FG001|Overall Study|Lost to Follow-up|6|||
126633058|NCT01192776|455615727|FG002|Overall Study|Lost to Follow-up|3|||
126633059|NCT01192776|455615728|FG003|Overall Study|Lost to Follow-up|5|||
126633060|NCT03732820|455615736|FG000|Overall Study|Death|168|||
126633061|NCT03732820|455615737|FG001|Overall Study|Death|203|||
126633062|NCT03732820|455615736|FG000|Overall Study|Other|2|||
126633063|NCT03732820|455615737|FG001|Overall Study|Other|2|||
126633064|NCT03732820|455615736|FG000|Overall Study|Failure to meet randomisation criteria|1|||
126633065|NCT03732820|455615737|FG001|Overall Study|Failure to meet randomisation criteria|1|||
126633066|NCT03732820|455615736|FG000|Overall Study|Patient decision|14|||
126633067|NCT03732820|455615737|FG001|Overall Study|Patient decision|10|||
126633068|NCT03732820|455615736|FG000|Overall Study|Screen failure|0|||
126633069|NCT03732820|455615737|FG001|Overall Study|Screen failure|1|||
126633070|NCT03732820|455615736|FG000|Overall Study|Patients ongoing study at data cut off|210|||
126633071|NCT03732820|455615737|FG001|Overall Study|Patients ongoing study at data cut off|178|||
126633072|NCT03732820|455615736|FG000|Overall Study|Lost to Follow-up|4|||
126633073|NCT03732820|455615737|FG001|Overall Study|Lost to Follow-up|2|||
126633074|NCT00832000|455615738|FG000|Overall Study|Adverse Event|2|||
126633075|NCT00832000|455615739|FG001|Overall Study|Adverse Event|0|||
126633076|NCT00832000|455615738|FG000|Overall Study|Withdrawal by Subject|1|||
126633077|NCT00832000|455615739|FG001|Overall Study|Withdrawal by Subject|0|||
126633078|NCT00832000|455615738|FG000|Overall Study|No calls to IVR in either period|1|||
126633079|NCT00832000|455615739|FG001|Overall Study|No calls to IVR in either period|1|||
126633080|NCT00832000|455615738|FG000|Overall Study|No calls to IVR in period 2|2|||
126633081|NCT00832000|455615739|FG001|Overall Study|No calls to IVR in period 2|0|||
126633082|NCT03845075|455615740|FG000|Part 1 - DB|Withdrawal by Subject|1|||
126633083|NCT03845075|455615741|FG001|Part 1 - DB|Withdrawal by Subject|1|||
126633084|NCT03845075|455615742|FG002|Part 1 - DB|Withdrawal by Subject|0|||
126797345|NCT01597245|456214588|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797346|NCT01597245|456214589|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797347|NCT01597245|456214590|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797348|NCT01597245|456214591|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797349|NCT01597245|456214592|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797350|NCT01597245|456214593|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
126797351|NCT01597245|456214594|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
126797352|NCT01597245|456214595|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
126797353|NCT01597245|456214596|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
126797354|NCT01597245|456214576|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797355|NCT01597245|456214577|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797356|NCT01597245|456214578|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797357|NCT01597245|456214579|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126633085|NCT03845075|455615743|FG003|Part 1 - DB|Withdrawal by Subject|0|||
126633086|NCT03845075|455615740|FG000|Part 1 - DB|Adverse Event|0|||
126633087|NCT03845075|455615741|FG001|Part 1 - DB|Adverse Event|1|||
126633088|NCT03845075|455615742|FG002|Part 1 - DB|Adverse Event|0|||
126633089|NCT03845075|455615743|FG003|Part 1 - DB|Adverse Event|0|||
126633090|NCT03845075|455615740|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
126633091|NCT03845075|455615741|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
126633092|NCT03845075|455615742|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
126633093|NCT03845075|455615743|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
126633094|NCT00935259|455615744|FG000|Period 1|Administrative (scheduling conflict)|1|||
126633095|NCT00935259|455615745|FG001|Period 1|Administrative (scheduling conflict)|1|||
126633096|NCT03856047|455615746|FG000|Overall Study|Withdrawal by Subject|0|||
126633097|NCT03856047|455615747|FG001|Overall Study|Withdrawal by Subject|1|||
126633098|NCT03856047|455615748|FG002|Overall Study|Withdrawal by Subject|1|||
126797358|NCT01597245|456214580|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797359|NCT01597245|456214581|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797360|NCT01597245|456214582|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797361|NCT01597245|456214583|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797362|NCT01597245|456214584|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797363|NCT01597245|456214585|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797364|NCT01597245|456214586|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797365|NCT01597245|456214587|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797366|NCT01597245|456214588|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797367|NCT01597245|456214589|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797368|NCT01597245|456214590|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797369|NCT01597245|456214591|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797370|NCT01597245|456214592|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
126797371|NCT01597245|456214593|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797372|NCT01597245|456214594|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
126797373|NCT01597245|456214595|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
126797374|NCT01597245|456214596|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
126797375|NCT01597245|456214576|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797376|NCT01597245|456214577|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797377|NCT01597245|456214578|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797378|NCT01597245|456214579|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797379|NCT01597245|456214580|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797380|NCT01597245|456214581|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797381|NCT01597245|456214582|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797382|NCT01597245|456214583|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797383|NCT01597245|456214584|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797384|NCT01597245|456214585|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797385|NCT01597245|456214586|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797386|NCT01597245|456214587|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797387|NCT01597245|456214588|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797388|NCT01597245|456214589|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126633099|NCT03856047|455615749|FG003|Overall Study|Withdrawal by Subject|0|||
126633100|NCT03856047|455615750|FG004|Overall Study|Withdrawal by Subject|3|||
126633101|NCT03856047|455615751|FG005|Overall Study|Withdrawal by Subject|0|||
126633102|NCT03856047|455615752|FG006|Overall Study|Withdrawal by Subject|2|||
126633103|NCT03856047|455615746|FG000|Overall Study|Lost to Follow-up|4|||
126633104|NCT03856047|455615747|FG001|Overall Study|Lost to Follow-up|2|||
126797389|NCT01597245|456214590|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797390|NCT01597245|456214591|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797391|NCT01597245|456214592|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
126797392|NCT01597245|456214593|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797393|NCT01597245|456214594|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
126797394|NCT01597245|456214595|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
126797395|NCT01597245|456214596|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
126797396|NCT01597245|456214576|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797397|NCT01597245|456214577|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797398|NCT01597245|456214578|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797399|NCT01597245|456214579|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797400|NCT01597245|456214580|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797401|NCT01597245|456214581|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797402|NCT01597245|456214582|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797403|NCT01597245|456214583|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797404|NCT01597245|456214584|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797405|NCT01597245|456214585|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797406|NCT01597245|456214586|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797407|NCT01597245|456214587|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797408|NCT01597245|456214588|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797409|NCT01597245|456214589|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797410|NCT01597245|456214590|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797411|NCT01597245|456214591|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797412|NCT01597245|456214592|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
126797413|NCT01597245|456214593|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797414|NCT01597245|456214594|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797415|NCT01597245|456214595|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
126797416|NCT01597245|456214596|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
126797417|NCT01597245|456214576|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797418|NCT01597245|456214577|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797419|NCT01597245|456214578|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797420|NCT01597245|456214579|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797421|NCT01597245|456214580|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797422|NCT01597245|456214581|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797423|NCT01597245|456214582|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797424|NCT01597245|456214583|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797425|NCT01597245|456214584|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797426|NCT01597245|456214585|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797427|NCT01597245|456214586|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797428|NCT01597245|456214587|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797429|NCT01597245|456214588|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797430|NCT01597245|456214589|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797431|NCT01597245|456214590|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797432|NCT01597245|456214591|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797433|NCT01597245|456214592|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
126797434|NCT01597245|456214593|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797435|NCT01597245|456214594|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797436|NCT01597245|456214595|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
126797437|NCT01597245|456214596|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
126797438|NCT01597245|456214576|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797439|NCT01597245|456214577|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797440|NCT01597245|456214578|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797441|NCT01597245|456214579|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797442|NCT01597245|456214580|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797443|NCT01597245|456214581|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797444|NCT01597245|456214582|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797445|NCT01597245|456214583|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797446|NCT01597245|456214584|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797447|NCT01597245|456214585|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797448|NCT01597245|456214586|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797449|NCT01597245|456214587|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797450|NCT01597245|456214588|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126633105|NCT03856047|455615748|FG002|Overall Study|Lost to Follow-up|3|||
126633106|NCT03856047|455615749|FG003|Overall Study|Lost to Follow-up|1|||
126797451|NCT01597245|456214589|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797452|NCT01597245|456214590|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797453|NCT01597245|456214591|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797454|NCT01597245|456214592|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797455|NCT01597245|456214593|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797456|NCT01597245|456214594|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797457|NCT01597245|456214595|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
126797458|NCT01597245|456214596|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
126797459|NCT00731783|456214597|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
126797460|NCT00731783|456214598|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
126797461|NCT00731783|456214597|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
126797462|NCT00731783|456214598|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
126797463|NCT00731783|456214597|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
126797464|NCT00731783|456214598|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
126797465|NCT00731783|456214597|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
126797466|NCT00731783|456214598|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
126797467|NCT00467896|456216396|FG000|Overall Study|Consent Withdrawal|18|||
126797468|NCT00467896|456216396|FG000|Overall Study|Adverse Event|7|||
126797469|NCT00467896|456216396|FG000|Overall Study|Serious Adverse Event|13|||
126797470|NCT00467896|456216396|FG000|Overall Study|Non-compliance|3|||
126797471|NCT00467896|456216396|FG000|Overall Study|Changed therapy|2|||
126797472|NCT00467896|456216396|FG000|Overall Study|Patient received transplant|2|||
126797473|NCT00467896|456216396|FG000|Overall Study|Patient had atrial septostomy|1|||
126797474|NCT00467896|456216396|FG000|Overall Study|Patient weaned off iloprost|1|||
126797475|NCT00467896|456216396|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
126797476|NCT00467896|456216396|FG000|Overall Study|Started intravenous prostacyclin|1|||
126797477|NCT00467896|456216396|FG000|Overall Study|Started inhaled Remodulin|1|||
126797478|NCT00467896|456216396|FG000|Overall Study|Patient had no improvement|1|||
126797479|NCT03772522|456216397|FG000|Pre-intervention|Withdrawal by Subject|3|||
126797480|NCT03772522|456216398|FG001|Pre-intervention|Withdrawal by Subject|4|||
126797481|NCT03772522|456216397|FG000|Intervention|Withdrawal by Subject|1|||
126797482|NCT03772522|456216398|FG001|Intervention|Withdrawal by Subject|0|||
126797483|NCT03772522|456216397|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
126797484|NCT03772522|456216398|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
126797485|NCT02175095|456216399|FG000|Overall Study|Withdrawal by Subject|3|||
126797486|NCT03697109|456216400|FG000|Open-label (OL) Phase|Adverse Event|24|||
126797487|NCT03697109|456216401|FG001|Open-label (OL) Phase|Adverse Event|0|||
126797488|NCT03697109|456216402|FG002|Open-label (OL) Phase|Adverse Event|0|||
126797489|NCT03697109|456216400|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
126797490|NCT03697109|456216401|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
126797491|NCT03697109|456216402|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
126797492|NCT03697109|456216400|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
126797493|NCT03697109|456216401|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
126797494|NCT03697109|456216402|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
126797495|NCT03697109|456216400|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
126797496|NCT03697109|456216401|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
126797497|NCT03697109|456216402|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
126797498|NCT03697109|456216400|FG000|Open-label (OL) Phase|Physician Decision|2|||
126797499|NCT03697109|456216401|FG001|Open-label (OL) Phase|Physician Decision|0|||
126797500|NCT03697109|456216402|FG002|Open-label (OL) Phase|Physician Decision|0|||
126797501|NCT03697109|456216400|FG000|Open-label (OL) Phase|Death|2|||
126797502|NCT03697109|456216401|FG001|Open-label (OL) Phase|Death|0|||
126797503|NCT03697109|456216402|FG002|Open-label (OL) Phase|Death|0|||
126797504|NCT03697109|456216400|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
126797505|NCT03697109|456216401|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
126797506|NCT03697109|456216402|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
126797507|NCT03697109|456216400|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
126797508|NCT03697109|456216401|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
126797509|NCT03697109|456216402|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
126797510|NCT03697109|456216400|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
126797511|NCT03697109|456216401|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
126797512|NCT03697109|456216402|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
126797513|NCT01111461|456216405|FG000|Overall Study|Adverse Event|32|||
126797514|NCT01111461|456216405|FG000|Overall Study|Participant choice|11|||
126797515|NCT01111461|456216405|FG000|Overall Study|Lost to Follow-up|1|||
126797516|NCT01111461|456216405|FG000|Overall Study|Withdrawal by Subject|1|||
126797517|NCT01111461|456216405|FG000|Overall Study|Other|6|||
126797518|NCT00440518|456216407|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
126797519|NCT00440518|456216408|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
126797520|NCT00440518|456216409|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
126797521|NCT00440518|456216407|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
126797522|NCT00440518|456216408|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
126797523|NCT00440518|456216409|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
126797524|NCT00440518|456216407|FG000|Randomized /Titration Period|Protocol Deviation|1|||
126797525|NCT00440518|456216408|FG001|Randomized /Titration Period|Protocol Deviation|0|||
126797526|NCT00440518|456216409|FG002|Randomized /Titration Period|Protocol Deviation|0|||
126797527|NCT00440518|456216407|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
126797528|NCT00440518|456216408|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
126797529|NCT00440518|456216409|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
126797530|NCT00440518|456216407|FG000|Randomized /Titration Period|Other|1|||
126797531|NCT00440518|456216408|FG001|Randomized /Titration Period|Other|0|||
126797532|NCT00440518|456216409|FG002|Randomized /Titration Period|Other|0|||
126797533|NCT00440518|456216407|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
126797534|NCT00440518|456216408|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
126797535|NCT00440518|456216409|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
126797536|NCT00440518|456216407|FG000|Randomized /Titration Period|Adverse Event|2|||
126797537|NCT00440518|456216408|FG001|Randomized /Titration Period|Adverse Event|3|||
126797538|NCT00440518|456216409|FG002|Randomized /Titration Period|Adverse Event|0|||
126797539|NCT00440518|456216407|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
126797540|NCT00440518|456216408|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
126797541|NCT00440518|456216409|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
126797542|NCT00440518|456216407|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
126797543|NCT00440518|456216408|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
126797544|NCT00440518|456216409|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
126797545|NCT00440518|456216407|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
126797546|NCT00440518|456216408|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
126797547|NCT00440518|456216409|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
126797548|NCT00440518|456216407|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
126797549|NCT00440518|456216408|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
126797550|NCT00440518|456216409|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
126797551|NCT00440518|456216407|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
126797552|NCT00440518|456216408|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
126797553|NCT00440518|456216409|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
126797554|NCT00440518|456216407|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
126797555|NCT00440518|456216408|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
126797556|NCT00440518|456216409|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
126797557|NCT00272779|456216410|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
126797558|NCT00272779|456216411|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
126797559|NCT00272779|456216410|FG000|Baseline Through Week 48|Death before Week 48|4|||
126797560|NCT00272779|456216411|FG001|Baseline Through Week 48|Death before Week 48|4|||
126797561|NCT00272779|456216410|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
126797562|NCT00272779|456216411|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
126797563|NCT00272779|456216410|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
126797564|NCT00272779|456216411|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
126797565|NCT00272779|456216410|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
126797566|NCT00272779|456216411|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
126797567|NCT00272779|456216410|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
126797568|NCT00272779|456216411|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
126797569|NCT00272779|456216410|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
126797570|NCT00272779|456216411|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
126797571|NCT00272779|456216410|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
126797572|NCT00272779|456216411|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
126797573|NCT00272779|456216410|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
126797574|NCT00272779|456216411|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
126797575|NCT00272779|456216410|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
126797576|NCT00272779|456216411|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
126797577|NCT00272779|456216410|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
126797578|NCT00272779|456216411|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
126797579|NCT00272779|456216410|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
126797580|NCT00272779|456216411|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
126797581|NCT00272779|456216410|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
126797582|NCT00272779|456216411|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
126797583|NCT00272779|456216410|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
126797584|NCT00272779|456216411|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
126633107|NCT03856047|455615750|FG004|Overall Study|Lost to Follow-up|4|||
126797585|NCT00272779|456216410|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
126797586|NCT00272779|456216411|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
126797587|NCT00272779|456216410|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
126797588|NCT00272779|456216411|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
126797589|NCT00272779|456216410|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
126797590|NCT00272779|456216411|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
126797591|NCT00272779|456216410|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
126797592|NCT00272779|456216411|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
126797593|NCT00272779|456216410|FG000|Baseline Through Week 48|Continuing treatment|385|||
126797594|NCT00272779|456216411|FG001|Baseline Through Week 48|Continuing treatment|368|||
126797595|NCT00272779|456216410|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
126797596|NCT00272779|456216411|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
126797597|NCT00272779|456216410|FG000|Baseline Through Week 48|Never treated|2|||
126797598|NCT00272779|456216411|FG001|Baseline Through Week 48|Never treated|3|||
126797599|NCT00272779|456216410|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
126797600|NCT00272779|456216411|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
126797601|NCT00272779|456216410|FG000|Baseline Through Week 96|Death before Week 96|6|||
126797602|NCT00272779|456216411|FG001|Baseline Through Week 96|Death before Week 96|5|||
126797603|NCT00272779|456216410|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
126797604|NCT00272779|456216411|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
126797605|NCT00272779|456216410|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
126797606|NCT00272779|456216411|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
126797607|NCT00272779|456216410|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
126797608|NCT00272779|456216411|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
126797609|NCT00272779|456216410|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
126797610|NCT00272779|456216411|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
126797611|NCT00272779|456216410|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
126797612|NCT00272779|456216411|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
126797613|NCT00272779|456216410|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
126797614|NCT00272779|456216411|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
126797615|NCT00272779|456216410|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
126797616|NCT00272779|456216411|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
126797617|NCT00272779|456216410|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
126797618|NCT00272779|456216411|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
126797619|NCT00272779|456216410|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
126797620|NCT00272779|456216411|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
126797621|NCT00272779|456216410|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
126797622|NCT00272779|456216411|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
126797623|NCT00272779|456216410|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
126797624|NCT00272779|456216411|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
126797625|NCT00272779|456216410|FG000|Baseline Through Week 96|Never treated|2|||
126797626|NCT00272779|456216411|FG001|Baseline Through Week 96|Never treated|3|||
126797627|NCT00272779|456216410|FG000|Baseline Through Week 96|Continuing on treatment|61|||
126797628|NCT00272779|456216411|FG001|Baseline Through Week 96|Continuing on treatment|38|||
126797629|NCT00561015|456216412|FG000|Overall Study|Adverse Event|0|||
126797630|NCT00561015|456216413|FG001|Overall Study|Adverse Event|0|||
126797631|NCT00561015|456216414|FG002|Overall Study|Adverse Event|0|||
126797632|NCT00561015|456216415|FG003|Overall Study|Adverse Event|0|||
126797633|NCT00561015|456216416|FG004|Overall Study|Adverse Event|1|||
126797634|NCT00561015|456216417|FG005|Overall Study|Adverse Event|0|||
126797635|NCT00561015|456216412|FG000|Overall Study|Lost to Follow-up|2|||
126797636|NCT00561015|456216413|FG001|Overall Study|Lost to Follow-up|0|||
126797637|NCT00561015|456216414|FG002|Overall Study|Lost to Follow-up|0|||
126797638|NCT00561015|456216415|FG003|Overall Study|Lost to Follow-up|1|||
126797639|NCT00561015|456216416|FG004|Overall Study|Lost to Follow-up|0|||
126797640|NCT00561015|456216417|FG005|Overall Study|Lost to Follow-up|3|||
126797641|NCT00561015|456216412|FG000|Overall Study|Participant non-compliance|2|||
126797642|NCT00561015|456216413|FG001|Overall Study|Participant non-compliance|0|||
126797643|NCT00561015|456216414|FG002|Overall Study|Participant non-compliance|0|||
126797644|NCT00561015|456216415|FG003|Overall Study|Participant non-compliance|0|||
126797645|NCT00561015|456216416|FG004|Overall Study|Participant non-compliance|0|||
126797646|NCT00561015|456216417|FG005|Overall Study|Participant non-compliance|0|||
126797647|NCT02440711|456216418|FG000|Second Intervention|Lost to Follow-up|1|||
126797648|NCT02440711|456216419|FG001|Second Intervention|Lost to Follow-up|0|||
126797649|NCT00163657|456216422|FG000|Overall Study|Death|12|||
126797650|NCT00163657|456216423|FG001|Overall Study|Death|14|||
126797651|NCT00163657|456216424|FG002|Overall Study|Death|19|||
126797652|NCT00163657|456216422|FG000|Overall Study|graft loss|4|||
126633108|NCT03856047|455615751|FG005|Overall Study|Lost to Follow-up|4|||
126797653|NCT00163657|456216423|FG001|Overall Study|graft loss|1|||
126797654|NCT00163657|456216424|FG002|Overall Study|graft loss|2|||
126797655|NCT00163657|456216422|FG000|Overall Study|Withdrawal by Subject|2|||
126797656|NCT00163657|456216423|FG001|Overall Study|Withdrawal by Subject|3|||
126797657|NCT00163657|456216424|FG002|Overall Study|Withdrawal by Subject|2|||
126797658|NCT00163657|456216422|FG000|Overall Study|Physician Decision|0|||
126797659|NCT00163657|456216423|FG001|Overall Study|Physician Decision|1|||
126797660|NCT00163657|456216424|FG002|Overall Study|Physician Decision|1|||
126797661|NCT00163657|456216422|FG000|Overall Study|Non Compliance|1|||
126797662|NCT00163657|456216423|FG001|Overall Study|Non Compliance|0|||
126797663|NCT00163657|456216424|FG002|Overall Study|Non Compliance|0|||
126797664|NCT00163657|456216422|FG000|Overall Study|Lost to Follow-up|1|||
126797665|NCT00163657|456216423|FG001|Overall Study|Lost to Follow-up|3|||
126797666|NCT00163657|456216424|FG002|Overall Study|Lost to Follow-up|10|||
126797667|NCT00163657|456216422|FG000|Overall Study|Other reason|0|||
126797668|NCT00163657|456216423|FG001|Overall Study|Other reason|1|||
126797669|NCT00163657|456216424|FG002|Overall Study|Other reason|3|||
126797670|NCT02646124|456216425|FG000|Overall Study|Lost to Follow-up|0|||
126797671|NCT02646124|456216426|FG001|Overall Study|Lost to Follow-up|2|||
126797672|NCT02436005|456216427|FG000|Second Intervention|Adverse Event|0|||
126797673|NCT02436005|456216428|FG001|Second Intervention|Adverse Event|1|||
126797674|NCT00365365|456216429|FG000|Overall Study|Randomized but not treated|0|||
126797675|NCT00365365|456216430|FG001|Overall Study|Randomized but not treated|2|||
126797676|NCT00365365|456216431|FG002|Overall Study|Randomized but not treated|0|||
126797677|NCT00365365|456216429|FG000|Overall Study|Poor compliance to protocol|0|||
126797678|NCT00365365|456216430|FG001|Overall Study|Poor compliance to protocol|1|||
126797679|NCT00365365|456216431|FG002|Overall Study|Poor compliance to protocol|0|||
126797680|NCT00365365|456216429|FG000|Overall Study|Lost to Follow-up|3|||
126797681|NCT00365365|456216430|FG001|Overall Study|Lost to Follow-up|3|||
126797682|NCT00365365|456216431|FG002|Overall Study|Lost to Follow-up|3|||
126797683|NCT00365365|456216429|FG000|Overall Study|Death|1|||
126797684|NCT00365365|456216430|FG001|Overall Study|Death|3|||
126797685|NCT00365365|456216431|FG002|Overall Study|Death|0|||
126797686|NCT00365365|456216429|FG000|Overall Study|Subject's request|11|||
126797687|NCT00365365|456216430|FG001|Overall Study|Subject's request|13|||
126797688|NCT00365365|456216431|FG002|Overall Study|Subject's request|1|||
126797689|NCT00365365|456216429|FG000|Overall Study|Disease progression/relapse|9|||
126797690|NCT00365365|456216430|FG001|Overall Study|Disease progression/relapse|6|||
126797691|NCT00365365|456216431|FG002|Overall Study|Disease progression/relapse|7|||
126797692|NCT00365365|456216429|FG000|Overall Study|Adverse Event|6|||
126797693|NCT00365365|456216430|FG001|Overall Study|Adverse Event|6|||
126797694|NCT00365365|456216431|FG002|Overall Study|Adverse Event|3|||
126797695|NCT00365365|456216429|FG000|Overall Study|Moved|2|||
126797696|NCT00365365|456216430|FG001|Overall Study|Moved|0|||
126797697|NCT00365365|456216431|FG002|Overall Study|Moved|0|||
126797698|NCT00365365|456216429|FG000|Overall Study|New cancer|1|||
126797699|NCT00365365|456216430|FG001|Overall Study|New cancer|0|||
126797700|NCT00365365|456216431|FG002|Overall Study|New cancer|0|||
126797701|NCT00365365|456216429|FG000|Overall Study|Withdrew consent|1|||
126797702|NCT00365365|456216430|FG001|Overall Study|Withdrew consent|1|||
126797703|NCT00365365|456216431|FG002|Overall Study|Withdrew consent|0|||
126797704|NCT00365365|456216429|FG000|Overall Study|Second malignancy|0|||
126797705|NCT00365365|456216430|FG001|Overall Study|Second malignancy|1|||
126797706|NCT00365365|456216431|FG002|Overall Study|Second malignancy|0|||
126797707|NCT00365365|456216429|FG000|Overall Study|Patient/physician decision|0|||
126797708|NCT00365365|456216430|FG001|Overall Study|Patient/physician decision|0|||
126797709|NCT00365365|456216431|FG002|Overall Study|Patient/physician decision|1|||
126797710|NCT00984022|456216432|FG000|Overall Study|Lost to Follow-up|10|||
126797711|NCT00984022|456216433|FG001|Overall Study|Lost to Follow-up|14|||
126797712|NCT00573443|456216437|FG000|Double-Blind Phase|Lost to Follow-up|1|||
126797713|NCT00573443|456216438|FG001|Double-Blind Phase|Lost to Follow-up|3|||
126797714|NCT00573443|456216439|FG002|Double-Blind Phase|Lost to Follow-up|2|||
126797715|NCT00573443|456216437|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
126797716|NCT00573443|456216438|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
126797717|NCT00573443|456216439|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
126797718|NCT00573443|456216437|FG000|Double-Blind Phase|Adverse Event|1|||
126797719|NCT00573443|456216438|FG001|Double-Blind Phase|Adverse Event|5|||
126797720|NCT00573443|456216439|FG002|Double-Blind Phase|Adverse Event|0|||
126797721|NCT00573443|456216437|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
126797722|NCT00573443|456216438|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
126797723|NCT00573443|456216439|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
126797724|NCT00573443|456216437|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
126797725|NCT00573443|456216438|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
126797726|NCT00573443|456216439|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
126797727|NCT00573443|456216437|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
126797728|NCT00573443|456216438|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
126797729|NCT00573443|456216439|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
126797730|NCT00573443|456216437|FG000|Double-Blind Phase|Protocol Violation|0|||
126797731|NCT00573443|456216438|FG001|Double-Blind Phase|Protocol Violation|2|||
126797732|NCT00573443|456216439|FG002|Double-Blind Phase|Protocol Violation|1|||
126633109|NCT03856047|455615752|FG006|Overall Study|Lost to Follow-up|4|||
126797733|NCT00573443|456216437|FG000|Double-Blind Phase|Other|0|||
126797734|NCT00573443|456216438|FG001|Double-Blind Phase|Other|2|||
126797735|NCT00573443|456216439|FG002|Double-Blind Phase|Other|3|||
126797736|NCT00573443|456216437|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
126797737|NCT00573443|456216438|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
126797738|NCT00573443|456216439|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
126797739|NCT00573443|456216437|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
126797740|NCT00573443|456216438|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
126797741|NCT00573443|456216439|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
126797742|NCT00573443|456216437|FG000|Open-Label Extension Phase|Adverse Event|3|||
126797743|NCT00573443|456216438|FG001|Open-Label Extension Phase|Adverse Event|0|||
126797744|NCT00573443|456216439|FG002|Open-Label Extension Phase|Adverse Event|0|||
126797745|NCT00573443|456216437|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
126797746|NCT00573443|456216438|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
126797747|NCT00573443|456216439|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
126797748|NCT00573443|456216437|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
126797749|NCT00573443|456216438|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
126797750|NCT00573443|456216439|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
126797751|NCT00573443|456216437|FG000|Open-Label Extension Phase|Protocol Violation|2|||
126797752|NCT00573443|456216438|FG001|Open-Label Extension Phase|Protocol Violation|0|||
126797753|NCT00573443|456216439|FG002|Open-Label Extension Phase|Protocol Violation|0|||
126797754|NCT00573443|456216437|FG000|Open-Label Extension Phase|Other|2|||
126797755|NCT00573443|456216438|FG001|Open-Label Extension Phase|Other|0|||
126797756|NCT00573443|456216439|FG002|Open-Label Extension Phase|Other|0|||
126797757|NCT00905606|456216440|FG000|Period 1|Adverse Event|0|||
126797758|NCT00905606|456216441|FG001|Period 1|Adverse Event|1|||
126797759|NCT00905606|456216440|FG000|Washout|Withdrawal by Subject|1|||
126797760|NCT00905606|456216441|FG001|Washout|Withdrawal by Subject|0|||
126797761|NCT00804856|456216444|FG000|Overall Study|Progressive Disease|3|||
126797762|NCT00804856|456216445|FG001|Overall Study|Progressive Disease|2|||
126797763|NCT00804856|456216446|FG002|Overall Study|Progressive Disease|4|||
126797764|NCT00804856|456216447|FG003|Overall Study|Progressive Disease|6|||
126797765|NCT00804856|456216448|FG004|Overall Study|Progressive Disease|4|||
126797766|NCT00804856|456216449|FG005|Overall Study|Progressive Disease|1|||
126797767|NCT00804856|456216450|FG006|Overall Study|Progressive Disease|8|||
126797768|NCT00804856|456216451|FG007|Overall Study|Progressive Disease|2|||
126797769|NCT00804856|456216452|FG008|Overall Study|Progressive Disease|4|||
126797770|NCT00804856|456216453|FG009|Overall Study|Progressive Disease|5|||
126797771|NCT00804856|456216454|FG010|Overall Study|Progressive Disease|12|||
126797772|NCT00804856|456216455|FG011|Overall Study|Progressive Disease|2|||
126797773|NCT00804856|456216456|FG012|Overall Study|Progressive Disease|2|||
126797774|NCT00804856|456216457|FG013|Overall Study|Progressive Disease|26|||
126797775|NCT00804856|456216458|FG014|Overall Study|Progressive Disease|20|||
126797776|NCT00804856|456216444|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797777|NCT00804856|456216445|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797778|NCT00804856|456216446|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797779|NCT00804856|456216447|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797780|NCT00804856|456216448|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
126797781|NCT00804856|456216449|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797782|NCT00804856|456216450|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797783|NCT00804856|456216451|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797784|NCT00804856|456216452|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797785|NCT00804856|456216453|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797786|NCT00804856|456216454|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797787|NCT00804856|456216455|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797788|NCT00804856|456216456|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797789|NCT00804856|456216457|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126797790|NCT00804856|456216458|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
126797791|NCT00804856|456216444|FG000|Overall Study|Other Adverse Event|1|||
126797792|NCT00804856|456216445|FG001|Overall Study|Other Adverse Event|1|||
126797793|NCT00804856|456216446|FG002|Overall Study|Other Adverse Event|1|||
126797794|NCT00804856|456216447|FG003|Overall Study|Other Adverse Event|2|||
126797795|NCT00804856|456216448|FG004|Overall Study|Other Adverse Event|2|||
126797796|NCT00804856|456216449|FG005|Overall Study|Other Adverse Event|1|||
126797797|NCT00804856|456216450|FG006|Overall Study|Other Adverse Event|3|||
126797798|NCT00804856|456216451|FG007|Overall Study|Other Adverse Event|0|||
126797799|NCT00804856|456216452|FG008|Overall Study|Other Adverse Event|0|||
126797800|NCT00804856|456216453|FG009|Overall Study|Other Adverse Event|1|||
126797801|NCT00804856|456216454|FG010|Overall Study|Other Adverse Event|5|||
126797802|NCT00804856|456216455|FG011|Overall Study|Other Adverse Event|2|||
126797803|NCT00804856|456216456|FG012|Overall Study|Other Adverse Event|0|||
126797804|NCT00804856|456216457|FG013|Overall Study|Other Adverse Event|6|||
126797805|NCT00804856|456216458|FG014|Overall Study|Other Adverse Event|13|||
126797806|NCT00804856|456216444|FG000|Overall Study|Non compliance with protocol|0|||
126797807|NCT00804856|456216445|FG001|Overall Study|Non compliance with protocol|0|||
126797808|NCT00804856|456216446|FG002|Overall Study|Non compliance with protocol|0|||
126797809|NCT00804856|456216447|FG003|Overall Study|Non compliance with protocol|0|||
126797810|NCT00804856|456216448|FG004|Overall Study|Non compliance with protocol|0|||
126797811|NCT00804856|456216449|FG005|Overall Study|Non compliance with protocol|0|||
126797812|NCT00804856|456216450|FG006|Overall Study|Non compliance with protocol|0|||
126797813|NCT00804856|456216451|FG007|Overall Study|Non compliance with protocol|0|||
126797814|NCT00804856|456216452|FG008|Overall Study|Non compliance with protocol|0|||
126797815|NCT00804856|456216453|FG009|Overall Study|Non compliance with protocol|0|||
126797816|NCT00804856|456216454|FG010|Overall Study|Non compliance with protocol|0|||
126633110|NCT00874497|455615756|FG000|Overall Study|Lost to Follow-up|2|||
126633111|NCT00874497|455615757|FG001|Overall Study|Lost to Follow-up|4|||
126633112|NCT00874497|455615756|FG000|Overall Study|Adverse Event|9|||
126633113|NCT00874497|455615757|FG001|Overall Study|Adverse Event|4|||
126633114|NCT00874497|455615756|FG000|Overall Study|Sponsor Discontinued Trial|7|||
126633115|NCT00874497|455615757|FG001|Overall Study|Sponsor Discontinued Trial|3|||
126633116|NCT00874497|455615756|FG000|Overall Study|Met Withdrawal Criteria|4|||
126633117|NCT00874497|455615757|FG001|Overall Study|Met Withdrawal Criteria|2|||
126633118|NCT00874497|455615756|FG000|Overall Study|Physician Decision|1|||
126633119|NCT00874497|455615757|FG001|Overall Study|Physician Decision|1|||
126633120|NCT00874497|455615756|FG000|Overall Study|Withdrawal by Subject|5|||
126633121|NCT00874497|455615757|FG001|Overall Study|Withdrawal by Subject|4|||
126633122|NCT00665223|455615760|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
126797817|NCT00804856|456216455|FG011|Overall Study|Non compliance with protocol|0|||
126797818|NCT00804856|456216456|FG012|Overall Study|Non compliance with protocol|0|||
126797819|NCT00804856|456216457|FG013|Overall Study|Non compliance with protocol|2|||
126797820|NCT00804856|456216458|FG014|Overall Study|Non compliance with protocol|0|||
126797821|NCT00804856|456216444|FG000|Overall Study|Refused to continue medication|0|||
126797822|NCT00804856|456216445|FG001|Overall Study|Refused to continue medication|0|||
126797823|NCT00804856|456216446|FG002|Overall Study|Refused to continue medication|0|||
126797824|NCT00804856|456216447|FG003|Overall Study|Refused to continue medication|1|||
126797825|NCT00804856|456216448|FG004|Overall Study|Refused to continue medication|1|||
126797826|NCT00804856|456216449|FG005|Overall Study|Refused to continue medication|0|||
126797827|NCT00804856|456216450|FG006|Overall Study|Refused to continue medication|0|||
126797828|NCT00804856|456216451|FG007|Overall Study|Refused to continue medication|0|||
126797829|NCT00804856|456216452|FG008|Overall Study|Refused to continue medication|0|||
126797830|NCT00804856|456216453|FG009|Overall Study|Refused to continue medication|0|||
126797831|NCT00804856|456216454|FG010|Overall Study|Refused to continue medication|3|||
126797832|NCT00804856|456216455|FG011|Overall Study|Refused to continue medication|0|||
126797833|NCT00804856|456216456|FG012|Overall Study|Refused to continue medication|1|||
126797834|NCT00804856|456216457|FG013|Overall Study|Refused to continue medication|1|||
126797835|NCT00804856|456216458|FG014|Overall Study|Refused to continue medication|5|||
126797836|NCT00804856|456216444|FG000|Overall Study|Other reason than listed above|0|||
126797837|NCT00804856|456216445|FG001|Overall Study|Other reason than listed above|0|||
126797838|NCT00804856|456216446|FG002|Overall Study|Other reason than listed above|0|||
126797839|NCT00804856|456216447|FG003|Overall Study|Other reason than listed above|0|||
126797840|NCT00804856|456216448|FG004|Overall Study|Other reason than listed above|0|||
126797841|NCT00804856|456216449|FG005|Overall Study|Other reason than listed above|1|||
126797842|NCT00804856|456216450|FG006|Overall Study|Other reason than listed above|0|||
126633123|NCT00665223|455615761|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
126633124|NCT00665223|455615762|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
126633125|NCT00665223|455615760|FG000|Randomized Phase (26 Weeks)|Death|0|||
126633126|NCT00665223|455615761|FG001|Randomized Phase (26 Weeks)|Death|0|||
126633127|NCT00665223|455615762|FG002|Randomized Phase (26 Weeks)|Death|1|||
126633128|NCT00665223|455615760|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
126633129|NCT00665223|455615761|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
126633130|NCT00665223|455615762|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
126633131|NCT00665223|455615760|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
126633132|NCT00665223|455615761|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
126633133|NCT00665223|455615762|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
126633134|NCT00665223|455615760|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
126633135|NCT00665223|455615761|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
126633136|NCT00665223|455615762|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
126633137|NCT00665223|455615760|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
126633138|NCT00665223|455615761|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
126633139|NCT00665223|455615762|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
126633140|NCT00665223|455615760|FG000|Open-Label Period (26 Weeks)|Death|0|||
126633141|NCT00665223|455615761|FG001|Open-Label Period (26 Weeks)|Death|1|||
126633142|NCT00665223|455615762|FG002|Open-Label Period (26 Weeks)|Death|0|||
126633143|NCT00665223|455615760|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
126633144|NCT00665223|455615761|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
126633145|NCT00665223|455615762|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
126633146|NCT00665223|455615760|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
126633147|NCT00665223|455615761|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
126633148|NCT00665223|455615762|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
126633149|NCT00665223|455615760|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
126633150|NCT00665223|455615761|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
126633151|NCT00665223|455615762|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
126633152|NCT00665223|455615760|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
126633153|NCT00665223|455615761|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
126633154|NCT00665223|455615762|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
126633155|NCT00905359|455615763|FG000|Overall Study|Lost to Follow-up|17|||
126633156|NCT00905359|455615764|FG001|Overall Study|Lost to Follow-up|10|||
126633157|NCT00905359|455615763|FG000|Overall Study|Death|2|||
126633158|NCT00905359|455615764|FG001|Overall Study|Death|0|||
126633159|NCT00905359|455615763|FG000|Overall Study|Withdrawal consent|5|||
126633160|NCT00905359|455615764|FG001|Overall Study|Withdrawal consent|6|||
126633161|NCT00243022|455615765|FG000|Overall Study|Withdrawal by Subject|1|||
126633162|NCT00243022|455615766|FG001|Overall Study|Withdrawal by Subject|0|||
126633163|NCT00243022|455615765|FG000|Overall Study|Death|1|||
126633164|NCT00243022|455615766|FG001|Overall Study|Death|0|||
126797843|NCT00804856|456216451|FG007|Overall Study|Other reason than listed above|0|||
126797844|NCT00804856|456216452|FG008|Overall Study|Other reason than listed above|1|||
126797845|NCT00804856|456216453|FG009|Overall Study|Other reason than listed above|0|||
126797846|NCT00804856|456216454|FG010|Overall Study|Other reason than listed above|3|||
126797847|NCT00804856|456216455|FG011|Overall Study|Other reason than listed above|1|||
126797848|NCT00804856|456216456|FG012|Overall Study|Other reason than listed above|1|||
126797849|NCT00804856|456216457|FG013|Overall Study|Other reason than listed above|10|||
126797850|NCT00804856|456216458|FG014|Overall Study|Other reason than listed above|3|||
126797851|NCT00418561|456216459|FG000|Overall Study|Participant's (guardian's) decision|0|||
126797852|NCT00418561|456216460|FG001|Overall Study|Participant's (guardian's) decision|1|||
126797853|NCT00418561|456216461|FG002|Overall Study|Participant's (guardian's) decision|0|||
126797854|NCT01796171|456216462|FG000|Enrolled|Death|0|||
126797855|NCT01796171|456216463|FG001|Enrolled|Death|0|||
126797856|NCT01796171|456216464|FG002|Enrolled|Death|0|||
126797857|NCT01796171|456216465|FG003|Enrolled|Death|0|||
126797858|NCT01796171|456216466|FG004|Enrolled|Death|0|||
126797859|NCT01796171|456216467|FG005|Enrolled|Death|0|||
126797860|NCT01796171|456216468|FG006|Enrolled|Death|0|||
126797861|NCT01796171|456216469|FG007|Enrolled|Death|0|||
126797862|NCT01796171|456216470|FG008|Enrolled|Death|0|||
126797863|NCT01796171|456216471|FG009|Enrolled|Death|0|||
126797864|NCT01796171|456216472|FG010|Enrolled|Death|0|||
126797865|NCT01796171|456216473|FG011|Enrolled|Death|0|||
126797866|NCT01796171|456216474|FG012|Enrolled|Death|0|||
126797867|NCT01796171|456216475|FG013|Enrolled|Death|0|||
126797868|NCT01796171|456216476|FG014|Enrolled|Death|1|||
126797869|NCT01796171|456216462|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
126797870|NCT01796171|456216463|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
126797871|NCT01796171|456216464|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
126797872|NCT01796171|456216465|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
126797873|NCT01796171|456216466|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
126797874|NCT01796171|456216467|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
126797875|NCT01796171|456216468|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
126797876|NCT01796171|456216469|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
126797877|NCT01796171|456216470|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
126797878|NCT01796171|456216471|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
126797879|NCT01796171|456216472|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
126797880|NCT01796171|456216473|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
126797881|NCT01796171|456216474|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
126797882|NCT01796171|456216475|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
126797883|NCT01796171|456216476|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
126797884|NCT01796171|456216462|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126797885|NCT01796171|456216463|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126797886|NCT01796171|456216464|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126797887|NCT01796171|456216465|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126797888|NCT01796171|456216466|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126797889|NCT01796171|456216467|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126633165|NCT00243022|455615765|FG000|Overall Study|Difficult Travel Distance|0|||
126633166|NCT00243022|455615766|FG001|Overall Study|Difficult Travel Distance|1|||
126633167|NCT03517111|455615767|FG000|Enrolled|Withdrawal by Subject|0|||
126633168|NCT03517111|455615768|FG001|Enrolled|Withdrawal by Subject|1|||
126633169|NCT03517111|455615769|FG002|Enrolled|Withdrawal by Subject|0|||
126633170|NCT03517111|455615767|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
126633171|NCT03517111|455615768|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
126633172|NCT03517111|455615769|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
126797890|NCT01796171|456216468|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126797891|NCT01796171|456216469|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126797892|NCT01796171|456216470|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126797893|NCT01796171|456216471|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126797894|NCT01796171|456216472|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126797895|NCT01796171|456216473|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126633173|NCT03517111|455615767|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
126633174|NCT03517111|455615768|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
126633175|NCT03517111|455615769|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
126633176|NCT03517111|455615767|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
126633177|NCT03517111|455615768|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
126633178|NCT03517111|455615769|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
126633179|NCT03517111|455615767|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
126633180|NCT03517111|455615768|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
126633181|NCT03517111|455615769|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
126633182|NCT00621192|455615770|FG000|Overall Study|Withdrawal by Subject|0|||
126633183|NCT00621192|455615771|FG001|Overall Study|Withdrawal by Subject|0|||
126633184|NCT00621192|455615772|FG002|Overall Study|Withdrawal by Subject|2|||
126633185|NCT00621192|455615773|FG003|Overall Study|Withdrawal by Subject|0|||
126633186|NCT00621192|455615770|FG000|Overall Study|Physician Decision|1|||
126633187|NCT00621192|455615771|FG001|Overall Study|Physician Decision|3|||
126633188|NCT00621192|455615772|FG002|Overall Study|Physician Decision|0|||
126633189|NCT00621192|455615773|FG003|Overall Study|Physician Decision|0|||
126633190|NCT00621192|455615770|FG000|Overall Study|Protocol Violation|1|||
126633191|NCT00621192|455615771|FG001|Overall Study|Protocol Violation|0|||
126633192|NCT00621192|455615772|FG002|Overall Study|Protocol Violation|0|||
126633193|NCT00621192|455615773|FG003|Overall Study|Protocol Violation|1|||
126633194|NCT00621192|455615770|FG000|Overall Study|Adverse Event|0|||
126633195|NCT00621192|455615771|FG001|Overall Study|Adverse Event|1|||
126633196|NCT00621192|455615772|FG002|Overall Study|Adverse Event|0|||
126633197|NCT00621192|455615773|FG003|Overall Study|Adverse Event|1|||
126633198|NCT00621192|455615770|FG000|Overall Study|Death|2|||
126633199|NCT00621192|455615771|FG001|Overall Study|Death|5|||
126633200|NCT00621192|455615772|FG002|Overall Study|Death|0|||
126633201|NCT00621192|455615773|FG003|Overall Study|Death|0|||
126633202|NCT00621192|455615770|FG000|Overall Study|Final Assessments not Completed|0|||
126633203|NCT00621192|455615771|FG001|Overall Study|Final Assessments not Completed|0|||
126633204|NCT00621192|455615772|FG002|Overall Study|Final Assessments not Completed|3|||
126633205|NCT00621192|455615773|FG003|Overall Study|Final Assessments not Completed|1|||
126633206|NCT04706793|455615774|FG000|Treatment|Disease worsening|10|||
126633207|NCT04706793|455615775|FG001|Treatment|Disease worsening|10|||
126633208|NCT04706793|455615774|FG000|Follow-up|Lack of Efficacy|1|||
126633209|NCT04706793|455615775|FG001|Follow-up|Lack of Efficacy|0|||
126633210|NCT04706793|455615774|FG000|Follow-up|Disease worsening|8|||
126633211|NCT04706793|455615775|FG001|Follow-up|Disease worsening|10|||
126633212|NCT04706793|455615774|FG000|Follow-up|Adverse Event|1|||
126633213|NCT04706793|455615775|FG001|Follow-up|Adverse Event|0|||
126633214|NCT02601209|455615777|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
126633215|NCT02601209|455615778|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
126633216|NCT02601209|455615779|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
126633217|NCT02601209|455615780|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
126633218|NCT02601209|455615781|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
126633219|NCT02601209|455615782|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
126633220|NCT02601209|455615783|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
126633221|NCT02601209|455615784|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
126633222|NCT02601209|455615785|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
126633223|NCT02601209|455615777|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
126633224|NCT02601209|455615778|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
126633225|NCT02601209|455615779|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
126633226|NCT02601209|455615780|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
126633227|NCT02601209|455615781|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
126797896|NCT01796171|456216474|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126797897|NCT01796171|456216475|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
126797898|NCT01796171|456216476|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
126797899|NCT01796171|456216462|FG000|Treatment Period With Betalutin|Progressive disease|0|||
126797900|NCT01796171|456216463|FG001|Treatment Period With Betalutin|Progressive disease|1|||
126797901|NCT01796171|456216464|FG002|Treatment Period With Betalutin|Progressive disease|0|||
126797902|NCT01796171|456216465|FG003|Treatment Period With Betalutin|Progressive disease|0|||
126797903|NCT01796171|456216466|FG004|Treatment Period With Betalutin|Progressive disease|0|||
126797904|NCT01796171|456216467|FG005|Treatment Period With Betalutin|Progressive disease|0|||
126797905|NCT01796171|456216468|FG006|Treatment Period With Betalutin|Progressive disease|0|||
126797906|NCT01796171|456216469|FG007|Treatment Period With Betalutin|Progressive disease|0|||
126797907|NCT01796171|456216470|FG008|Treatment Period With Betalutin|Progressive disease|0|||
126633228|NCT02601209|455615782|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
126797908|NCT01796171|456216471|FG009|Treatment Period With Betalutin|Progressive disease|0|||
126797909|NCT01796171|456216472|FG010|Treatment Period With Betalutin|Progressive disease|0|||
126797910|NCT01796171|456216473|FG011|Treatment Period With Betalutin|Progressive disease|0|||
126797911|NCT01796171|456216474|FG012|Treatment Period With Betalutin|Progressive disease|0|||
126797912|NCT01796171|456216475|FG013|Treatment Period With Betalutin|Progressive disease|0|||
126633229|NCT02601209|455615783|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
126633230|NCT02601209|455615784|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
126633231|NCT02601209|455615785|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
126633232|NCT03636373|455615786|FG000|Overall Study|Study closure due to Covid-19|1|||
126633233|NCT03636373|455615787|FG001|Overall Study|Study closure due to Covid-19|0|||
126633234|NCT00572533|455615788|FG000|Overall Study|Death|4|||
126633235|NCT00572533|455615789|FG001|Overall Study|Death|1|||
126633236|NCT00572533|455615788|FG000|Overall Study|Received Kidney Transplant|2|||
126633237|NCT00572533|455615789|FG001|Overall Study|Received Kidney Transplant|1|||
126633238|NCT00572533|455615788|FG000|Overall Study|Social Issues|1|||
126633239|NCT00572533|455615789|FG001|Overall Study|Social Issues|0|||
126633240|NCT00572533|455615788|FG000|Overall Study|Transfer out of Facility|0|||
126633241|NCT00572533|455615789|FG001|Overall Study|Transfer out of Facility|1|||
126633242|NCT00798304|455615791|FG000|Overall Study|Adverse Event|0|||
126797913|NCT01796171|456216476|FG014|Treatment Period With Betalutin|Progressive disease|0|||
126797914|NCT01796171|456216462|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126797915|NCT01796171|456216463|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126797916|NCT01796171|456216464|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126797917|NCT01796171|456216465|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126797918|NCT01796171|456216466|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126797919|NCT01796171|456216467|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126797920|NCT01796171|456216468|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126797921|NCT01796171|456216469|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126797922|NCT01796171|456216470|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
126797923|NCT01796171|456216471|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126797924|NCT01796171|456216472|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
126797925|NCT01796171|456216473|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
126797926|NCT01796171|456216474|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126797927|NCT01796171|456216475|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126797928|NCT01796171|456216476|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
126797929|NCT01796171|456216462|FG000|Treatment Period With Betalutin|Physician Decision|0|||
126797930|NCT01796171|456216463|FG001|Treatment Period With Betalutin|Physician Decision|0|||
126797931|NCT01796171|456216464|FG002|Treatment Period With Betalutin|Physician Decision|0|||
126797932|NCT01796171|456216465|FG003|Treatment Period With Betalutin|Physician Decision|0|||
126797933|NCT01796171|456216466|FG004|Treatment Period With Betalutin|Physician Decision|0|||
126797934|NCT01796171|456216467|FG005|Treatment Period With Betalutin|Physician Decision|0|||
126797935|NCT01796171|456216468|FG006|Treatment Period With Betalutin|Physician Decision|0|||
126797936|NCT01796171|456216469|FG007|Treatment Period With Betalutin|Physician Decision|0|||
126797937|NCT01796171|456216470|FG008|Treatment Period With Betalutin|Physician Decision|0|||
126797938|NCT01796171|456216471|FG009|Treatment Period With Betalutin|Physician Decision|0|||
126797939|NCT01796171|456216472|FG010|Treatment Period With Betalutin|Physician Decision|5|||
126797940|NCT01796171|456216473|FG011|Treatment Period With Betalutin|Physician Decision|1|||
126797941|NCT01796171|456216474|FG012|Treatment Period With Betalutin|Physician Decision|1|||
126797942|NCT01796171|456216475|FG013|Treatment Period With Betalutin|Physician Decision|0|||
126797943|NCT01796171|456216476|FG014|Treatment Period With Betalutin|Physician Decision|0|||
126797944|NCT01796171|456216462|FG000|Treatment Period With Betalutin|Death|0|||
126797945|NCT01796171|456216463|FG001|Treatment Period With Betalutin|Death|0|||
126797946|NCT01796171|456216464|FG002|Treatment Period With Betalutin|Death|0|||
126797947|NCT01796171|456216465|FG003|Treatment Period With Betalutin|Death|0|||
126797948|NCT01796171|456216466|FG004|Treatment Period With Betalutin|Death|0|||
126797949|NCT01796171|456216467|FG005|Treatment Period With Betalutin|Death|0|||
126797950|NCT01796171|456216468|FG006|Treatment Period With Betalutin|Death|0|||
126797951|NCT01796171|456216469|FG007|Treatment Period With Betalutin|Death|0|||
126797952|NCT01796171|456216470|FG008|Treatment Period With Betalutin|Death|0|||
126797953|NCT01796171|456216471|FG009|Treatment Period With Betalutin|Death|0|||
126797954|NCT01796171|456216472|FG010|Treatment Period With Betalutin|Death|2|||
126797955|NCT01796171|456216473|FG011|Treatment Period With Betalutin|Death|0|||
126797956|NCT01796171|456216474|FG012|Treatment Period With Betalutin|Death|0|||
126797957|NCT01796171|456216475|FG013|Treatment Period With Betalutin|Death|0|||
126633243|NCT00798304|455615792|FG001|Overall Study|Adverse Event|1|||
126633244|NCT00798304|455615793|FG002|Overall Study|Adverse Event|1|||
126633245|NCT00798304|455615791|FG000|Overall Study|Discontinuation by Sponsor|14|||
126633246|NCT00798304|455615792|FG001|Overall Study|Discontinuation by Sponsor|21|||
126797958|NCT01796171|456216476|FG014|Treatment Period With Betalutin|Death|0|||
126797959|NCT01796171|456216462|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
126797960|NCT01796171|456216463|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
126797961|NCT01796171|456216464|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
126797962|NCT01796171|456216465|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
126797963|NCT01796171|456216466|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
126797964|NCT01796171|456216467|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
126797965|NCT01796171|456216468|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
126797966|NCT01796171|456216469|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
126797967|NCT01796171|456216470|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
126797968|NCT01796171|456216471|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
126797969|NCT01796171|456216472|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
126797970|NCT01796171|456216473|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
126797971|NCT01796171|456216474|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
126797972|NCT01796171|456216475|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
126797973|NCT01796171|456216476|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
126797974|NCT01796171|456216462|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797975|NCT01796171|456216463|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797976|NCT01796171|456216464|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797977|NCT01796171|456216465|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797978|NCT01796171|456216466|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797979|NCT01796171|456216467|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797980|NCT01796171|456216468|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797981|NCT01796171|456216469|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797982|NCT01796171|456216470|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797983|NCT01796171|456216471|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797984|NCT01796171|456216472|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
126797985|NCT01796171|456216473|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
126797986|NCT01796171|456216474|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797987|NCT01796171|456216475|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797988|NCT01796171|456216476|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
126797989|NCT01796171|456216462|FG000|Follow-up Period|Start of further anticancer therapy|4|||
126797990|NCT01796171|456216463|FG001|Follow-up Period|Start of further anticancer therapy|25|||
126797991|NCT01796171|456216464|FG002|Follow-up Period|Start of further anticancer therapy|2|||
126797992|NCT01796171|456216465|FG003|Follow-up Period|Start of further anticancer therapy|1|||
126797993|NCT01796171|456216466|FG004|Follow-up Period|Start of further anticancer therapy|2|||
126797994|NCT01796171|456216467|FG005|Follow-up Period|Start of further anticancer therapy|2|||
126797995|NCT01796171|456216468|FG006|Follow-up Period|Start of further anticancer therapy|1|||
126797996|NCT01796171|456216469|FG007|Follow-up Period|Start of further anticancer therapy|15|||
126797997|NCT01796171|456216470|FG008|Follow-up Period|Start of further anticancer therapy|2|||
126797998|NCT01796171|456216471|FG009|Follow-up Period|Start of further anticancer therapy|0|||
126797999|NCT01796171|456216472|FG010|Follow-up Period|Start of further anticancer therapy|0|||
126798000|NCT01796171|456216473|FG011|Follow-up Period|Start of further anticancer therapy|0|||
126798001|NCT01796171|456216474|FG012|Follow-up Period|Start of further anticancer therapy|0|||
126798002|NCT01796171|456216475|FG013|Follow-up Period|Start of further anticancer therapy|0|||
126798003|NCT01796171|456216476|FG014|Follow-up Period|Start of further anticancer therapy|0|||
126798004|NCT01796171|456216462|FG000|Follow-up Period|Progressive disease|0|||
126798005|NCT01796171|456216463|FG001|Follow-up Period|Progressive disease|1|||
126798006|NCT01796171|456216464|FG002|Follow-up Period|Progressive disease|0|||
126798007|NCT01796171|456216465|FG003|Follow-up Period|Progressive disease|0|||
126798008|NCT01796171|456216466|FG004|Follow-up Period|Progressive disease|0|||
126798009|NCT01796171|456216467|FG005|Follow-up Period|Progressive disease|0|||
126798010|NCT01796171|456216468|FG006|Follow-up Period|Progressive disease|0|||
126798011|NCT01796171|456216469|FG007|Follow-up Period|Progressive disease|3|||
126798012|NCT01796171|456216470|FG008|Follow-up Period|Progressive disease|0|||
126798013|NCT01796171|456216471|FG009|Follow-up Period|Progressive disease|0|||
126798014|NCT01796171|456216472|FG010|Follow-up Period|Progressive disease|0|||
126798015|NCT01796171|456216473|FG011|Follow-up Period|Progressive disease|0|||
126798016|NCT01796171|456216474|FG012|Follow-up Period|Progressive disease|0|||
126798017|NCT01796171|456216475|FG013|Follow-up Period|Progressive disease|0|||
126798018|NCT01796171|456216476|FG014|Follow-up Period|Progressive disease|0|||
126798019|NCT01796171|456216462|FG000|Follow-up Period|Physician Decision|0|||
126798020|NCT01796171|456216463|FG001|Follow-up Period|Physician Decision|2|||
126798021|NCT01796171|456216464|FG002|Follow-up Period|Physician Decision|0|||
126798022|NCT01796171|456216465|FG003|Follow-up Period|Physician Decision|0|||
126798023|NCT01796171|456216466|FG004|Follow-up Period|Physician Decision|0|||
126798024|NCT01796171|456216467|FG005|Follow-up Period|Physician Decision|0|||
126798025|NCT01796171|456216468|FG006|Follow-up Period|Physician Decision|0|||
126798026|NCT01796171|456216469|FG007|Follow-up Period|Physician Decision|0|||
126798027|NCT01796171|456216470|FG008|Follow-up Period|Physician Decision|0|||
126798028|NCT01796171|456216471|FG009|Follow-up Period|Physician Decision|0|||
126798029|NCT01796171|456216472|FG010|Follow-up Period|Physician Decision|5|||
126798030|NCT01796171|456216473|FG011|Follow-up Period|Physician Decision|0|||
126798031|NCT01796171|456216474|FG012|Follow-up Period|Physician Decision|0|||
126798032|NCT01796171|456216475|FG013|Follow-up Period|Physician Decision|0|||
126798033|NCT01796171|456216476|FG014|Follow-up Period|Physician Decision|0|||
126798034|NCT01796171|456216462|FG000|Follow-up Period|Withdrawal by Subject|0|||
126798035|NCT01796171|456216463|FG001|Follow-up Period|Withdrawal by Subject|1|||
126798036|NCT01796171|456216464|FG002|Follow-up Period|Withdrawal by Subject|0|||
126798037|NCT01796171|456216465|FG003|Follow-up Period|Withdrawal by Subject|0|||
126798038|NCT01796171|456216466|FG004|Follow-up Period|Withdrawal by Subject|0|||
126798039|NCT01796171|456216467|FG005|Follow-up Period|Withdrawal by Subject|1|||
126798040|NCT01796171|456216468|FG006|Follow-up Period|Withdrawal by Subject|0|||
126798041|NCT01796171|456216469|FG007|Follow-up Period|Withdrawal by Subject|0|||
126798042|NCT01796171|456216470|FG008|Follow-up Period|Withdrawal by Subject|0|||
126798043|NCT01796171|456216471|FG009|Follow-up Period|Withdrawal by Subject|0|||
126798044|NCT01796171|456216472|FG010|Follow-up Period|Withdrawal by Subject|3|||
126798045|NCT01796171|456216473|FG011|Follow-up Period|Withdrawal by Subject|1|||
126798046|NCT01796171|456216474|FG012|Follow-up Period|Withdrawal by Subject|0|||
126798047|NCT01796171|456216475|FG013|Follow-up Period|Withdrawal by Subject|0|||
126798048|NCT01796171|456216476|FG014|Follow-up Period|Withdrawal by Subject|0|||
126798049|NCT01796171|456216462|FG000|Follow-up Period|Death|0|||
126798050|NCT01796171|456216463|FG001|Follow-up Period|Death|0|||
126798051|NCT01796171|456216464|FG002|Follow-up Period|Death|0|||
126798052|NCT01796171|456216465|FG003|Follow-up Period|Death|0|||
126798053|NCT01796171|456216466|FG004|Follow-up Period|Death|0|||
126798054|NCT01796171|456216467|FG005|Follow-up Period|Death|0|||
126798055|NCT01796171|456216468|FG006|Follow-up Period|Death|1|||
126798056|NCT01796171|456216469|FG007|Follow-up Period|Death|0|||
126798057|NCT01796171|456216470|FG008|Follow-up Period|Death|0|||
126798058|NCT01796171|456216471|FG009|Follow-up Period|Death|0|||
126798059|NCT01796171|456216472|FG010|Follow-up Period|Death|17|||
126798060|NCT01796171|456216473|FG011|Follow-up Period|Death|9|||
126798061|NCT01796171|456216474|FG012|Follow-up Period|Death|1|||
126798062|NCT01796171|456216475|FG013|Follow-up Period|Death|0|||
126798063|NCT01796171|456216476|FG014|Follow-up Period|Death|0|||
126798064|NCT01796171|456216462|FG000|Follow-up Period|Patient transferred to other hospital|0|||
126798065|NCT01796171|456216463|FG001|Follow-up Period|Patient transferred to other hospital|1|||
126798066|NCT01796171|456216464|FG002|Follow-up Period|Patient transferred to other hospital|0|||
126798067|NCT01796171|456216465|FG003|Follow-up Period|Patient transferred to other hospital|0|||
126798068|NCT01796171|456216466|FG004|Follow-up Period|Patient transferred to other hospital|0|||
126798069|NCT01796171|456216467|FG005|Follow-up Period|Patient transferred to other hospital|0|||
126798070|NCT01796171|456216468|FG006|Follow-up Period|Patient transferred to other hospital|0|||
126798071|NCT01796171|456216469|FG007|Follow-up Period|Patient transferred to other hospital|0|||
126798072|NCT01796171|456216470|FG008|Follow-up Period|Patient transferred to other hospital|0|||
126798073|NCT01796171|456216471|FG009|Follow-up Period|Patient transferred to other hospital|0|||
126798074|NCT01796171|456216472|FG010|Follow-up Period|Patient transferred to other hospital|0|||
126798075|NCT01796171|456216473|FG011|Follow-up Period|Patient transferred to other hospital|0|||
126798076|NCT01796171|456216474|FG012|Follow-up Period|Patient transferred to other hospital|0|||
126798077|NCT01796171|456216475|FG013|Follow-up Period|Patient transferred to other hospital|0|||
126798078|NCT01796171|456216476|FG014|Follow-up Period|Patient transferred to other hospital|0|||
126798079|NCT01796171|456216462|FG000|Follow-up Period|Sponsor Decision|0|||
126798080|NCT01796171|456216463|FG001|Follow-up Period|Sponsor Decision|0|||
126798081|NCT01796171|456216464|FG002|Follow-up Period|Sponsor Decision|0|||
126798082|NCT01796171|456216465|FG003|Follow-up Period|Sponsor Decision|0|||
126798083|NCT01796171|456216466|FG004|Follow-up Period|Sponsor Decision|0|||
126798084|NCT01796171|456216467|FG005|Follow-up Period|Sponsor Decision|0|||
126798085|NCT01796171|456216468|FG006|Follow-up Period|Sponsor Decision|0|||
126798086|NCT01796171|456216469|FG007|Follow-up Period|Sponsor Decision|0|||
126798087|NCT01796171|456216470|FG008|Follow-up Period|Sponsor Decision|0|||
126798088|NCT01796171|456216471|FG009|Follow-up Period|Sponsor Decision|0|||
126798089|NCT01796171|456216472|FG010|Follow-up Period|Sponsor Decision|40|||
126798090|NCT01796171|456216473|FG011|Follow-up Period|Sponsor Decision|15|||
126798091|NCT01796171|456216474|FG012|Follow-up Period|Sponsor Decision|7|||
126798092|NCT01796171|456216475|FG013|Follow-up Period|Sponsor Decision|0|||
126798093|NCT01796171|456216476|FG014|Follow-up Period|Sponsor Decision|0|||
126798094|NCT00829309|456216477|FG000|Washout: 7 Days|Protocol Violation|1|||
126798095|NCT00829309|456216478|FG001|Washout: 7 Days|Protocol Violation|0|||
126798096|NCT03343535|456216481|FG000|Overall Study|Lost to Follow-up|1|||
126798097|NCT03343535|456216481|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
126798098|NCT03343535|456216481|FG000|Overall Study|Death|12|||
126798099|NCT00777023|456216483|FG000|Overall Study|Adverse Event|15|||
126798100|NCT00777023|456216484|FG001|Overall Study|Adverse Event|21|||
126798101|NCT00777023|456216485|FG002|Overall Study|Adverse Event|8|||
126798102|NCT00777023|456216483|FG000|Overall Study|Lack of Efficacy|1|||
126798103|NCT00777023|456216484|FG001|Overall Study|Lack of Efficacy|0|||
126798104|NCT00777023|456216485|FG002|Overall Study|Lack of Efficacy|14|||
126798105|NCT00777023|456216483|FG000|Overall Study|Protocol Violation|2|||
126798106|NCT00777023|456216484|FG001|Overall Study|Protocol Violation|1|||
126798107|NCT00777023|456216485|FG002|Overall Study|Protocol Violation|1|||
126798108|NCT00777023|456216483|FG000|Overall Study|Lost to Follow-up|2|||
126798109|NCT00777023|456216484|FG001|Overall Study|Lost to Follow-up|3|||
126798110|NCT00777023|456216485|FG002|Overall Study|Lost to Follow-up|3|||
126798111|NCT00777023|456216483|FG000|Overall Study|Death|0|||
126798112|NCT00777023|456216484|FG001|Overall Study|Death|1|||
126798113|NCT00777023|456216485|FG002|Overall Study|Death|0|||
126798114|NCT00777023|456216483|FG000|Overall Study|Withdrawal by Subject|7|||
126798115|NCT00777023|456216484|FG001|Overall Study|Withdrawal by Subject|7|||
126798116|NCT00777023|456216485|FG002|Overall Study|Withdrawal by Subject|8|||
126798117|NCT00777023|456216483|FG000|Overall Study|Missing data|1|||
126798118|NCT00777023|456216484|FG001|Overall Study|Missing data|1|||
126798119|NCT00777023|456216485|FG002|Overall Study|Missing data|0|||
126798120|NCT00777023|456216483|FG000|Overall Study|Reasons not specified|4|||
126798121|NCT00777023|456216484|FG001|Overall Study|Reasons not specified|4|||
126798122|NCT00777023|456216485|FG002|Overall Study|Reasons not specified|2|||
126798123|NCT00777023|456216483|FG000|Overall Study|Last dose date unknown|3|||
126798124|NCT00777023|456216484|FG001|Overall Study|Last dose date unknown|3|||
126798125|NCT00777023|456216485|FG002|Overall Study|Last dose date unknown|1|||
126798126|NCT02659150|456216486|FG000|Subject Enrollment|Physician Decision|3|||
126798127|NCT02659150|456216486|FG000|Subject Enrollment|Withdrawal by Subject|2|||
126798128|NCT02659150|456216486|FG000|Baseline Imaging|Withdrawal by Subject|1|||
126798129|NCT02659150|456216486|FG000|Baseline Imaging|Physician Decision|1|||
126798130|NCT02659150|456216486|FG000|Study Drug Dosing|Adverse Event|1|||
126798131|NCT04247282|456216490|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
126798132|NCT04247282|456216491|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
126798133|NCT04247282|456216492|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
126798134|NCT04247282|456216493|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
126798135|NCT04247282|456216490|FG000|Overall Study|Refused further treatment|0|||
126798136|NCT04247282|456216491|FG001|Overall Study|Refused further treatment|1|||
126798137|NCT04247282|456216492|FG002|Overall Study|Refused further treatment|0|||
126798138|NCT04247282|456216493|FG003|Overall Study|Refused further treatment|0|||
126798139|NCT01037114|456216500|FG000|Year 20|Others|1|||
126798140|NCT00968812|456216508|FG000|Overall Study|Adverse Event|30|||
126798141|NCT00968812|456216509|FG001|Overall Study|Adverse Event|46|||
126798142|NCT00968812|456216510|FG002|Overall Study|Adverse Event|33|||
126798143|NCT00968812|456216508|FG000|Overall Study|Death|2|||
126798144|NCT00968812|456216509|FG001|Overall Study|Death|2|||
126798145|NCT00968812|456216510|FG002|Overall Study|Death|1|||
126798146|NCT00968812|456216508|FG000|Overall Study|Lack of Efficacy|9|||
126798147|NCT00968812|456216509|FG001|Overall Study|Lack of Efficacy|7|||
126798148|NCT00968812|456216510|FG002|Overall Study|Lack of Efficacy|16|||
126798149|NCT00968812|456216508|FG000|Overall Study|Lost to Follow-up|17|||
126798150|NCT00968812|456216509|FG001|Overall Study|Lost to Follow-up|12|||
126798151|NCT00968812|456216510|FG002|Overall Study|Lost to Follow-up|11|||
126798152|NCT00968812|456216508|FG000|Overall Study|Physician Decision|8|||
126798153|NCT00968812|456216509|FG001|Overall Study|Physician Decision|5|||
126798154|NCT00968812|456216510|FG002|Overall Study|Physician Decision|9|||
126798155|NCT00968812|456216508|FG000|Overall Study|Protocol Violation|7|||
126798156|NCT00968812|456216509|FG001|Overall Study|Protocol Violation|4|||
126798157|NCT00968812|456216510|FG002|Overall Study|Protocol Violation|3|||
126798158|NCT00968812|456216508|FG000|Overall Study|Withdrawal by Subject|17|||
126798159|NCT00968812|456216509|FG001|Overall Study|Withdrawal by Subject|23|||
126798160|NCT00968812|456216510|FG002|Overall Study|Withdrawal by Subject|25|||
126798161|NCT00968812|456216508|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
126798162|NCT00968812|456216509|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
126798163|NCT00968812|456216510|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
126798164|NCT00968812|456216508|FG000|Overall Study|Noncompliance with study drug|4|||
126798165|NCT00968812|456216509|FG001|Overall Study|Noncompliance with study drug|1|||
126798166|NCT00968812|456216510|FG002|Overall Study|Noncompliance with study drug|6|||
126798167|NCT00968812|456216508|FG000|Overall Study|Unable to take rescue therapy|12|||
126798168|NCT00968812|456216509|FG001|Overall Study|Unable to take rescue therapy|12|||
126798169|NCT00968812|456216510|FG002|Overall Study|Unable to take rescue therapy|17|||
126798170|NCT00968812|456216508|FG000|Overall Study|Other|25|||
126798171|NCT00968812|456216509|FG001|Overall Study|Other|37|||
126798172|NCT00968812|456216510|FG002|Overall Study|Other|40|||
126798173|NCT00448591|456216513|FG000|Overall Study|Withdrawal by Subject|178|||
126798174|NCT00448591|456216513|FG000|Overall Study|Progressive Disease|1382|||
126633247|NCT00798304|455615793|FG002|Overall Study|Discontinuation by Sponsor|9|||
126633248|NCT00661713|455615798|FG000|Overall Study|Death|1|||
126798175|NCT00448591|456216513|FG000|Overall Study|Adverse Event|382|||
126798176|NCT00448591|456216513|FG000|Overall Study|Protocol Violation|41|||
126798177|NCT00448591|456216513|FG000|Overall Study|Lost to Follow-up|19|||
126798178|NCT00448591|456216513|FG000|Overall Study|Treatment Regimen Completed|70|||
126798179|NCT00448591|456216513|FG000|Overall Study|Other|154|||
126798180|NCT00448591|456216513|FG000|Overall Study|Termination of Study|70|||
126798181|NCT00640562|456216514|FG000|Overall Study|Adverse Event|8|||
126798182|NCT00640562|456216515|FG001|Overall Study|Adverse Event|5|||
126798183|NCT00640562|456216514|FG000|Overall Study|Lack of Efficacy|1|||
126798184|NCT00640562|456216515|FG001|Overall Study|Lack of Efficacy|4|||
126798185|NCT00640562|456216514|FG000|Overall Study|Protocol Violation|2|||
126798186|NCT00640562|456216515|FG001|Overall Study|Protocol Violation|4|||
126798187|NCT00640562|456216514|FG000|Overall Study|Withdrawal by Subject|6|||
126798188|NCT00640562|456216515|FG001|Overall Study|Withdrawal by Subject|10|||
126798189|NCT00640562|456216514|FG000|Overall Study|Known risperidone intolerance|0|||
126798190|NCT00640562|456216515|FG001|Overall Study|Known risperidone intolerance|1|||
126798191|NCT00640562|456216514|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
126798192|NCT00640562|456216515|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
126798193|NCT00640562|456216514|FG000|Overall Study|Low study drug dose|0|||
126798194|NCT00640562|456216515|FG001|Overall Study|Low study drug dose|1|||
126798195|NCT00640562|456216514|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
126798196|NCT00640562|456216515|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
126798197|NCT02937870|456216516|FG000|Overall Study|Adverse Event|1|||
126633249|NCT00661713|455615799|FG001|Overall Study|Death|0|||
126798198|NCT02937870|456216516|FG000|Overall Study|Protocol Deviation|2|||
126798199|NCT03098394|456216520|FG000|Overall Study|Pregnancy|0|||
126798200|NCT03098394|456216521|FG001|Overall Study|Pregnancy|1|||
126798201|NCT00609674|456216522|FG000|Overall Study|Adverse Event|1|||
126798202|NCT00609674|456216523|FG001|Overall Study|Adverse Event|1|||
126798203|NCT00609674|456216522|FG000|Overall Study|Protocol Violation|3|||
126798204|NCT00609674|456216523|FG001|Overall Study|Protocol Violation|5|||
126798205|NCT00609674|456216522|FG000|Overall Study|Lost to Follow-up|1|||
126798206|NCT00609674|456216523|FG001|Overall Study|Lost to Follow-up|0|||
126798207|NCT00609674|456216522|FG000|Overall Study|Withdrew consent|2|||
126798208|NCT00609674|456216523|FG001|Overall Study|Withdrew consent|1|||
126798209|NCT00571064|456216525|FG000|Overall Study|Adverse Event|13|||
126798210|NCT00571064|456216525|FG000|Overall Study|Protocol Violation|4|||
126798211|NCT00571064|456216525|FG000|Overall Study|Withdrawal by Subject|2|||
126798212|NCT00571064|456216525|FG000|Overall Study|Other|2|||
126798213|NCT00244764|456216526|FG000|Overall Study|Adverse Event|37|||
126798214|NCT00244764|456216526|FG000|Overall Study|Lost to Follow-up|23|||
126798215|NCT00244764|456216526|FG000|Overall Study|Withdrawal by Subject|12|||
126798216|NCT00244764|456216526|FG000|Overall Study|Disease Progression|13|||
126798217|NCT00244764|456216526|FG000|Overall Study|Protocol Violation|2|||
126798218|NCT00244764|456216526|FG000|Overall Study|Death|1|||
126798219|NCT00244764|456216526|FG000|Overall Study|Off Study Medication for >21 Days|1|||
126798220|NCT00244764|456216526|FG000|Overall Study|Declining Performance Status|1|||
126798221|NCT00244764|456216526|FG000|Overall Study|Participant was Hospitalized until Death|1|||
126798222|NCT00244764|456216526|FG000|Overall Study|Primary Investigator Discretion|2|||
126798223|NCT00244764|456216526|FG000|Overall Study|Sponsor Terminated Study|2|||
126798224|NCT00244764|456216526|FG000|Overall Study|Developed Secondary Malignancy|1|||
126798225|NCT04022954|456216536|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
126798226|NCT04022954|456216536|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
126798227|NCT04022954|456216536|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
126798228|NCT03017885|456216537|FG000|Overall Study|Adverse Event|2|||
126798229|NCT03017885|456216538|FG001|Overall Study|Adverse Event|0|||
126798230|NCT03017885|456216539|FG002|Overall Study|Adverse Event|0|||
126798231|NCT03017885|456216540|FG003|Overall Study|Adverse Event|0|||
126798232|NCT03017885|456216541|FG004|Overall Study|Adverse Event|0|||
126798233|NCT03017885|456216542|FG005|Overall Study|Adverse Event|0|||
126798234|NCT03017885|456216537|FG000|Overall Study|Progression of disease|4|||
126798235|NCT03017885|456216538|FG001|Overall Study|Progression of disease|3|||
126798236|NCT03017885|456216539|FG002|Overall Study|Progression of disease|4|||
126798237|NCT03017885|456216540|FG003|Overall Study|Progression of disease|0|||
126798238|NCT03017885|456216541|FG004|Overall Study|Progression of disease|0|||
126798239|NCT03017885|456216542|FG005|Overall Study|Progression of disease|0|||
126798240|NCT03017885|456216537|FG000|Overall Study|Other than listed|1|||
126798241|NCT03017885|456216538|FG001|Overall Study|Other than listed|2|||
126798242|NCT03017885|456216539|FG002|Overall Study|Other than listed|1|||
126798243|NCT03017885|456216540|FG003|Overall Study|Other than listed|0|||
126798244|NCT03017885|456216541|FG004|Overall Study|Other than listed|0|||
126798245|NCT03017885|456216542|FG005|Overall Study|Other than listed|0|||
126798246|NCT03017885|456216537|FG000|Overall Study|Lost to Follow-up|2|||
126798247|NCT03017885|456216538|FG001|Overall Study|Lost to Follow-up|0|||
126633250|NCT00661713|455615800|FG002|Overall Study|Death|0|||
126633251|NCT00661713|455615801|FG003|Overall Study|Death|0|||
126798248|NCT03017885|456216539|FG002|Overall Study|Lost to Follow-up|3|||
126798249|NCT03017885|456216540|FG003|Overall Study|Lost to Follow-up|0|||
126798250|NCT03017885|456216541|FG004|Overall Study|Lost to Follow-up|0|||
126798251|NCT03017885|456216542|FG005|Overall Study|Lost to Follow-up|0|||
126798252|NCT03017885|456216537|FG000|Overall Study|Change to other anti-cancer therapy|0|||
126798253|NCT03017885|456216538|FG001|Overall Study|Change to other anti-cancer therapy|0|||
126798254|NCT03017885|456216539|FG002|Overall Study|Change to other anti-cancer therapy|1|||
126798255|NCT03017885|456216540|FG003|Overall Study|Change to other anti-cancer therapy|0|||
126798256|NCT03017885|456216541|FG004|Overall Study|Change to other anti-cancer therapy|0|||
126798257|NCT03017885|456216542|FG005|Overall Study|Change to other anti-cancer therapy|0|||
126798258|NCT03872128|456216545|FG000|Overall Study|Dropped out before treatment|1|||
126798259|NCT03872128|456216546|FG001|Overall Study|Dropped out before treatment|0|||
126798260|NCT03872128|456216547|FG002|Overall Study|Dropped out before treatment|4|||
126798261|NCT03872128|456216545|FG000|Overall Study|Lost to Follow-up|2|||
126798262|NCT03872128|456216546|FG001|Overall Study|Lost to Follow-up|5|||
126798263|NCT03872128|456216547|FG002|Overall Study|Lost to Follow-up|8|||
126798264|NCT02648438|456216550|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
126798265|NCT02648438|456216551|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
126798266|NCT02648438|456216552|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
126798267|NCT02648438|456216550|FG000|Overall Study|Protocol Violation|2|||
126798268|NCT02648438|456216551|FG001|Overall Study|Protocol Violation|0|||
126798269|NCT02648438|456216552|FG002|Overall Study|Protocol Violation|0|||
126798270|NCT02648438|456216550|FG000|Overall Study|Withdrawal by Subject|1|||
126798271|NCT02648438|456216551|FG001|Overall Study|Withdrawal by Subject|1|||
126798272|NCT02648438|456216552|FG002|Overall Study|Withdrawal by Subject|0|||
126798273|NCT02739997|456216553|FG000|Overall Study|Death|1|||
126798274|NCT02739997|456216553|FG000|Overall Study|Withdrawal by Subject|1|||
126798275|NCT03552393|456216556|FG000|Core Period|Kidney Transplant|1|||
126798276|NCT03552393|456216556|FG000|Core Period|Prohibited Medication|1|||
126798277|NCT03552393|456216556|FG000|Safety Extension Period|Kidney Transplant|4|||
126798278|NCT02601625|456216557|FG000|Overall Study|Lost to Follow-up|0|||
126798279|NCT02601625|456216558|FG001|Overall Study|Lost to Follow-up|0|||
126798280|NCT02601625|456216559|FG002|Overall Study|Lost to Follow-up|1|||
126798281|NCT02601625|456216560|FG003|Overall Study|Lost to Follow-up|1|||
126798282|NCT00359281|456216561|FG000|Overall Study|Adverse Event|1|||
126798283|NCT00359281|456216562|FG001|Overall Study|Adverse Event|0|||
126798284|NCT00359281|456216563|FG002|Overall Study|Adverse Event|0|||
126798285|NCT00359281|456216564|FG003|Overall Study|Adverse Event|0|||
126798286|NCT00359281|456216565|FG004|Overall Study|Adverse Event|0|||
126798287|NCT00359281|456216566|FG005|Overall Study|Adverse Event|0|||
126798288|NCT00359281|456216567|FG006|Overall Study|Adverse Event|1|||
126798289|NCT00359281|456216568|FG007|Overall Study|Adverse Event|0|||
126798290|NCT00359281|456216569|FG008|Overall Study|Adverse Event|0|||
126798291|NCT00359281|456216561|FG000|Overall Study|Withdrawal by Subject|0|||
126798292|NCT00359281|456216562|FG001|Overall Study|Withdrawal by Subject|0|||
126798293|NCT00359281|456216563|FG002|Overall Study|Withdrawal by Subject|0|||
126798294|NCT00359281|456216564|FG003|Overall Study|Withdrawal by Subject|0|||
126798295|NCT00359281|456216565|FG004|Overall Study|Withdrawal by Subject|0|||
126798296|NCT00359281|456216566|FG005|Overall Study|Withdrawal by Subject|0|||
126798297|NCT00359281|456216567|FG006|Overall Study|Withdrawal by Subject|1|||
126798298|NCT00359281|456216568|FG007|Overall Study|Withdrawal by Subject|0|||
126798299|NCT00359281|456216569|FG008|Overall Study|Withdrawal by Subject|0|||
126798300|NCT04608188|456216571|FG000|Overall Study|Withdrawal by Subject|4|||
126798301|NCT04608188|456216572|FG001|Overall Study|Withdrawal by Subject|8|||
126798302|NCT01415986|456216575|FG000|Overall Study|Lost to Follow-up|1|||
126798303|NCT01250912|456216576|FG000|Overall Study|Lost to Follow-up|1|||
126798304|NCT03122457|456216577|FG000|Overall Study|Withdrawal by Subject|6|||
126798305|NCT04958785|456218016|FG000|Overall Study|Study Terminated by Sponsor|4|||
126798306|NCT04958785|456218017|FG001|Overall Study|Study Terminated by Sponsor|10|||
126798307|NCT04958785|456218018|FG002|Overall Study|Study Terminated by Sponsor|7|||
126798308|NCT04958785|456218019|FG003|Overall Study|Study Terminated by Sponsor|6|||
126798309|NCT04958785|456218020|FG004|Overall Study|Study Terminated by Sponsor|34|||
126798310|NCT04958785|456218016|FG000|Overall Study|Death|2|||
126798311|NCT04958785|456218017|FG001|Overall Study|Death|3|||
126798312|NCT04958785|456218018|FG002|Overall Study|Death|4|||
126798313|NCT04958785|456218019|FG003|Overall Study|Death|5|||
126798314|NCT04958785|456218020|FG004|Overall Study|Death|5|||
126798315|NCT04958785|456218016|FG000|Overall Study|Withdrew consent|2|||
126798316|NCT04958785|456218017|FG001|Overall Study|Withdrew consent|0|||
126798317|NCT04958785|456218018|FG002|Overall Study|Withdrew consent|3|||
126798318|NCT04958785|456218019|FG003|Overall Study|Withdrew consent|1|||
126798319|NCT04958785|456218020|FG004|Overall Study|Withdrew consent|0|||
126798320|NCT04958785|456218016|FG000|Overall Study|Investigator's discretion|0|||
126798321|NCT04958785|456218017|FG001|Overall Study|Investigator's discretion|1|||
126798322|NCT04958785|456218018|FG002|Overall Study|Investigator's discretion|0|||
126798323|NCT04958785|456218019|FG003|Overall Study|Investigator's discretion|1|||
126798324|NCT04958785|456218020|FG004|Overall Study|Investigator's discretion|2|||
126798325|NCT04958785|456218016|FG000|Overall Study|Adverse Event|0|||
126798326|NCT04958785|456218017|FG001|Overall Study|Adverse Event|0|||
126798327|NCT04958785|456218018|FG002|Overall Study|Adverse Event|0|||
126798328|NCT04958785|456218019|FG003|Overall Study|Adverse Event|0|||
126798329|NCT04958785|456218020|FG004|Overall Study|Adverse Event|1|||
126798330|NCT04958785|456218016|FG000|Overall Study|Lost to Follow-up|0|||
126798331|NCT04958785|456218017|FG001|Overall Study|Lost to Follow-up|0|||
126798332|NCT04958785|456218018|FG002|Overall Study|Lost to Follow-up|0|||
126798333|NCT04958785|456218019|FG003|Overall Study|Lost to Follow-up|0|||
126798334|NCT04958785|456218020|FG004|Overall Study|Lost to Follow-up|1|||
126798335|NCT00587561|456218021|FG000|Overall Study|Lost to Follow-up|6|||
126798336|NCT00587561|456218022|FG001|Overall Study|Lost to Follow-up|4|||
126798337|NCT05472038|456218036|FG000|Overall Study|Adverse Event|0|||
126798338|NCT05472038|456218037|FG001|Overall Study|Adverse Event|0|||
126798339|NCT05472038|456218038|FG002|Overall Study|Adverse Event|1|||
126798340|NCT05472038|456218039|FG003|Overall Study|Adverse Event|0|||
126798341|NCT05472038|456218040|FG004|Overall Study|Adverse Event|0|||
126798342|NCT05472038|456218041|FG005|Overall Study|Adverse Event|0|||
126798343|NCT05472038|456218042|FG006|Overall Study|Adverse Event|0|||
126798344|NCT05472038|456218043|FG007|Overall Study|Adverse Event|0|||
126798345|NCT05472038|456218044|FG008|Overall Study|Adverse Event|0|||
126798346|NCT05472038|456218045|FG009|Overall Study|Adverse Event|0|||
126798347|NCT05472038|456218046|FG010|Overall Study|Adverse Event|0|||
126798348|NCT05472038|456218047|FG011|Overall Study|Adverse Event|0|||
126798349|NCT05472038|456218036|FG000|Overall Study|Death|0|||
126798350|NCT05472038|456218037|FG001|Overall Study|Death|0|||
126798351|NCT05472038|456218038|FG002|Overall Study|Death|0|||
126798352|NCT05472038|456218039|FG003|Overall Study|Death|0|||
126798353|NCT05472038|456218040|FG004|Overall Study|Death|0|||
126798354|NCT05472038|456218041|FG005|Overall Study|Death|1|||
126798355|NCT05472038|456218042|FG006|Overall Study|Death|0|||
126798356|NCT05472038|456218043|FG007|Overall Study|Death|0|||
126798357|NCT05472038|456218044|FG008|Overall Study|Death|0|||
126798358|NCT05472038|456218045|FG009|Overall Study|Death|0|||
126798359|NCT05472038|456218046|FG010|Overall Study|Death|0|||
126798360|NCT05472038|456218047|FG011|Overall Study|Death|0|||
126798361|NCT05472038|456218036|FG000|Overall Study|Lost to Follow-up|1|||
126798362|NCT05472038|456218037|FG001|Overall Study|Lost to Follow-up|3|||
126798363|NCT05472038|456218038|FG002|Overall Study|Lost to Follow-up|3|||
126798364|NCT05472038|456218039|FG003|Overall Study|Lost to Follow-up|9|||
126798365|NCT05472038|456218040|FG004|Overall Study|Lost to Follow-up|2|||
126798366|NCT05472038|456218041|FG005|Overall Study|Lost to Follow-up|2|||
126798367|NCT05472038|456218042|FG006|Overall Study|Lost to Follow-up|1|||
126798368|NCT05472038|456218043|FG007|Overall Study|Lost to Follow-up|0|||
126798369|NCT05472038|456218044|FG008|Overall Study|Lost to Follow-up|1|||
126798370|NCT05472038|456218045|FG009|Overall Study|Lost to Follow-up|0|||
126798371|NCT05472038|456218046|FG010|Overall Study|Lost to Follow-up|2|||
126798372|NCT05472038|456218047|FG011|Overall Study|Lost to Follow-up|1|||
126798373|NCT05472038|456218036|FG000|Overall Study|Physician Decision|0|||
126798374|NCT05472038|456218037|FG001|Overall Study|Physician Decision|0|||
126798375|NCT05472038|456218038|FG002|Overall Study|Physician Decision|0|||
126798376|NCT05472038|456218039|FG003|Overall Study|Physician Decision|0|||
126798377|NCT05472038|456218040|FG004|Overall Study|Physician Decision|1|||
126798378|NCT05472038|456218041|FG005|Overall Study|Physician Decision|0|||
126798379|NCT05472038|456218042|FG006|Overall Study|Physician Decision|0|||
126798380|NCT05472038|456218043|FG007|Overall Study|Physician Decision|0|||
126798381|NCT05472038|456218044|FG008|Overall Study|Physician Decision|0|||
126798382|NCT05472038|456218045|FG009|Overall Study|Physician Decision|0|||
126798383|NCT05472038|456218046|FG010|Overall Study|Physician Decision|0|||
126798384|NCT05472038|456218047|FG011|Overall Study|Physician Decision|0|||
126798385|NCT05472038|456218036|FG000|Overall Study|Withdrawal by Subject|1|||
126798386|NCT05472038|456218037|FG001|Overall Study|Withdrawal by Subject|3|||
126798387|NCT05472038|456218038|FG002|Overall Study|Withdrawal by Subject|1|||
126798388|NCT05472038|456218039|FG003|Overall Study|Withdrawal by Subject|6|||
126798389|NCT05472038|456218040|FG004|Overall Study|Withdrawal by Subject|1|||
126798390|NCT05472038|456218041|FG005|Overall Study|Withdrawal by Subject|3|||
126798391|NCT05472038|456218042|FG006|Overall Study|Withdrawal by Subject|0|||
126798392|NCT05472038|456218043|FG007|Overall Study|Withdrawal by Subject|2|||
126798393|NCT05472038|456218044|FG008|Overall Study|Withdrawal by Subject|3|||
126798394|NCT05472038|456218045|FG009|Overall Study|Withdrawal by Subject|1|||
126798395|NCT05472038|456218046|FG010|Overall Study|Withdrawal by Subject|2|||
126798396|NCT05472038|456218047|FG011|Overall Study|Withdrawal by Subject|2|||
126798397|NCT05472038|456218036|FG000|Overall Study|Protocol Violation|0|||
126798398|NCT05472038|456218037|FG001|Overall Study|Protocol Violation|0|||
126798399|NCT05472038|456218038|FG002|Overall Study|Protocol Violation|0|||
126798400|NCT05472038|456218039|FG003|Overall Study|Protocol Violation|0|||
126798401|NCT05472038|456218040|FG004|Overall Study|Protocol Violation|0|||
126798402|NCT05472038|456218041|FG005|Overall Study|Protocol Violation|0|||
126633252|NCT00661713|455615802|FG004|Overall Study|Death|1|||
126798403|NCT05472038|456218042|FG006|Overall Study|Protocol Violation|0|||
126798404|NCT05472038|456218043|FG007|Overall Study|Protocol Violation|1|||
126798405|NCT05472038|456218044|FG008|Overall Study|Protocol Violation|1|||
126798406|NCT05472038|456218045|FG009|Overall Study|Protocol Violation|1|||
126798407|NCT05472038|456218046|FG010|Overall Study|Protocol Violation|1|||
126798408|NCT05472038|456218047|FG011|Overall Study|Protocol Violation|1|||
126798409|NCT05472038|456218036|FG000|Overall Study|Not vaccinated|0|||
126798410|NCT05472038|456218037|FG001|Overall Study|Not vaccinated|0|||
126798411|NCT05472038|456218038|FG002|Overall Study|Not vaccinated|0|||
126798412|NCT05472038|456218039|FG003|Overall Study|Not vaccinated|1|||
126798413|NCT05472038|456218040|FG004|Overall Study|Not vaccinated|0|||
126798414|NCT05472038|456218041|FG005|Overall Study|Not vaccinated|0|||
126798415|NCT05472038|456218042|FG006|Overall Study|Not vaccinated|0|||
126798416|NCT05472038|456218043|FG007|Overall Study|Not vaccinated|0|||
126798417|NCT05472038|456218044|FG008|Overall Study|Not vaccinated|0|||
126798418|NCT05472038|456218045|FG009|Overall Study|Not vaccinated|0|||
126798419|NCT05472038|456218046|FG010|Overall Study|Not vaccinated|0|||
126798420|NCT05472038|456218047|FG011|Overall Study|Not vaccinated|0|||
126798421|NCT05369208|456218053|FG000|Core Phase|Prohibited Medication Required|2|||
126798422|NCT05369208|456218053|FG000|Core Phase|Adverse Event|1|||
126798423|NCT05369208|456218053|FG000|Core Phase|Lack of Efficacy|1|||
126798424|NCT03274687|456218054|FG000|Overall Study|Protocol Violation|1|||
126798425|NCT03274687|456218055|FG001|Overall Study|Protocol Violation|1|||
126798426|NCT04914897|456218056|FG000|Overall Study|Withdrawal by Subject|3|||
126798427|NCT04914897|456218057|FG001|Overall Study|Withdrawal by Subject|1|||
126798428|NCT04914897|456218058|FG002|Overall Study|Withdrawal by Subject|1|||
126798429|NCT04914897|456218059|FG003|Overall Study|Withdrawal by Subject|1|||
126798430|NCT04914897|456218056|FG000|Overall Study|Poor compliance to protocol|0|||
126798431|NCT04914897|456218057|FG001|Overall Study|Poor compliance to protocol|0|||
126798432|NCT04914897|456218058|FG002|Overall Study|Poor compliance to protocol|1|||
126798433|NCT04914897|456218059|FG003|Overall Study|Poor compliance to protocol|0|||
126798434|NCT04914897|456218056|FG000|Overall Study|Progressive disease|5|||
126798435|NCT04914897|456218057|FG001|Overall Study|Progressive disease|14|||
126798436|NCT04914897|456218058|FG002|Overall Study|Progressive disease|30|||
126798437|NCT04914897|456218059|FG003|Overall Study|Progressive disease|21|||
126798438|NCT04914897|456218056|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
126798439|NCT04914897|456218057|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
126798440|NCT04914897|456218058|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
126798441|NCT04914897|456218059|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
126798442|NCT04914897|456218056|FG000|Overall Study|Other|1|||
126798443|NCT04914897|456218057|FG001|Overall Study|Other|0|||
126798444|NCT04914897|456218058|FG002|Overall Study|Other|0|||
126798445|NCT04914897|456218059|FG003|Overall Study|Other|1|||
126798446|NCT02674152|456218060|FG000|Overall Study|Personal Reasons|1|||
126798447|NCT02674152|456218061|FG001|Overall Study|Personal Reasons|0|||
126798448|NCT02674152|456218062|FG002|Overall Study|Personal Reasons|0|||
126798449|NCT02674152|456218063|FG003|Overall Study|Personal Reasons|1|||
126798450|NCT02674152|456218064|FG004|Overall Study|Personal Reasons|1|||
126798451|NCT02674152|456218060|FG000|Overall Study|Other adverse event or clinical progression|0|||
126798452|NCT02674152|456218061|FG001|Overall Study|Other adverse event or clinical progression|1|||
126798453|NCT02674152|456218062|FG002|Overall Study|Other adverse event or clinical progression|0|||
126798454|NCT02674152|456218063|FG003|Overall Study|Other adverse event or clinical progression|3|||
126798455|NCT02674152|456218064|FG004|Overall Study|Other adverse event or clinical progression|0|||
126798456|NCT02674152|456218060|FG000|Overall Study|Dose-limiting toxicity|0|||
126798457|NCT02674152|456218061|FG001|Overall Study|Dose-limiting toxicity|0|||
126798458|NCT02674152|456218062|FG002|Overall Study|Dose-limiting toxicity|0|||
126798459|NCT02674152|456218063|FG003|Overall Study|Dose-limiting toxicity|0|||
126798460|NCT02674152|456218064|FG004|Overall Study|Dose-limiting toxicity|1|||
126798461|NCT02674152|456218060|FG000|Overall Study|Progressive Disease|2|||
126798462|NCT02674152|456218061|FG001|Overall Study|Progressive Disease|1|||
126798463|NCT02674152|456218062|FG002|Overall Study|Progressive Disease|1|||
126798464|NCT02674152|456218063|FG003|Overall Study|Progressive Disease|13|||
126798465|NCT02674152|456218064|FG004|Overall Study|Progressive Disease|2|||
126798466|NCT02674152|456218060|FG000|Overall Study|Adverse Event|0|||
126798467|NCT02674152|456218061|FG001|Overall Study|Adverse Event|0|||
126798468|NCT02674152|456218062|FG002|Overall Study|Adverse Event|1|||
126798469|NCT02674152|456218063|FG003|Overall Study|Adverse Event|0|||
126798470|NCT02674152|456218064|FG004|Overall Study|Adverse Event|1|||
126798471|NCT04734652|456218065|FG000|Overall Study|Withdrawal by Subject|2|||
126798472|NCT04734652|456218066|FG001|Overall Study|Withdrawal by Subject|0|||
126798473|NCT04734652|456218065|FG000|Overall Study|Death|0|||
126798474|NCT04734652|456218066|FG001|Overall Study|Death|1|||
126798475|NCT04934722|456218067|FG000|Overall Study|Death|4|||
126798476|NCT04934722|456218068|FG001|Overall Study|Death|3|||
126798477|NCT04934722|456218067|FG000|Overall Study|Participants Ongoing|88|||
126798478|NCT04934722|456218068|FG001|Overall Study|Participants Ongoing|91|||
126798479|NCT05265624|456218069|FG000|Overall Study|Lost to Follow-up|3|||
126798480|NCT05265624|456218070|FG001|Overall Study|Lost to Follow-up|0|||
126798481|NCT05265624|456218069|FG000|Overall Study|Withdrawal by Subject|1|||
126798482|NCT05265624|456218070|FG001|Overall Study|Withdrawal by Subject|0|||
126798483|NCT05927753|456218073|FG000|Overall Study|Withdrawal by Subject|0|||
126798484|NCT05927753|456218074|FG001|Overall Study|Withdrawal by Subject|2|||
126798485|NCT05927753|456218073|FG000|Overall Study|Physician Decision|0|||
126798486|NCT05927753|456218074|FG001|Overall Study|Physician Decision|1|||
126798487|NCT03653507|456218076|FG000|Overall Study|Miscellaneous|28|||
126798488|NCT03653507|456218077|FG001|Overall Study|Miscellaneous|19|||
126798489|NCT03653507|456218076|FG000|Overall Study|Withdrawal by Subject|37|||
126798490|NCT03653507|456218077|FG001|Overall Study|Withdrawal by Subject|22|||
126798491|NCT03653507|456218076|FG000|Overall Study|Protocol Deviation|2|||
126798492|NCT03653507|456218077|FG001|Overall Study|Protocol Deviation|1|||
126798493|NCT03653507|456218076|FG000|Overall Study|Progressive disease|117|||
126798494|NCT03653507|456218077|FG001|Overall Study|Progressive disease|168|||
126798495|NCT03653507|456218076|FG000|Overall Study|Lost to Follow-up|1|||
126798496|NCT03653507|456218077|FG001|Overall Study|Lost to Follow-up|1|||
126798497|NCT03653507|456218076|FG000|Overall Study|Death|25|||
126798498|NCT03653507|456218077|FG001|Overall Study|Death|22|||
126798499|NCT03653507|456218076|FG000|Overall Study|Adverse Event|35|||
126798500|NCT03653507|456218077|FG001|Overall Study|Adverse Event|14|||
126798501|NCT05381948|456218085|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
126798502|NCT05381948|456218086|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
126798503|NCT05381948|456218087|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
126798504|NCT05381948|456218085|FG000|Overall Study|Adverse Event: Non-ocular|0|||
126798505|NCT05381948|456218086|FG001|Overall Study|Adverse Event: Non-ocular|1|||
126798506|NCT05381948|456218087|FG002|Overall Study|Adverse Event: Non-ocular|0|||
126798507|NCT05381948|456218085|FG000|Overall Study|Lost to Follow-up|1|||
126798508|NCT05381948|456218086|FG001|Overall Study|Lost to Follow-up|0|||
126798509|NCT05381948|456218087|FG002|Overall Study|Lost to Follow-up|0|||
126798510|NCT05381948|456218085|FG000|Overall Study|Protocol Deviation|0|||
126633253|NCT00661713|455615803|FG005|Overall Study|Death|0|||
126633254|NCT00661713|455615804|FG006|Overall Study|Death|0|||
126798511|NCT05381948|456218086|FG001|Overall Study|Protocol Deviation|2|||
126798512|NCT05381948|456218087|FG002|Overall Study|Protocol Deviation|0|||
126798513|NCT05381948|456218085|FG000|Overall Study|Withdrawal by Subject|1|||
126798514|NCT05381948|456218086|FG001|Overall Study|Withdrawal by Subject|0|||
126798515|NCT05381948|456218087|FG002|Overall Study|Withdrawal by Subject|1|||
126798516|NCT05381948|456218085|FG000|Overall Study|Death|0|||
126798517|NCT05381948|456218086|FG001|Overall Study|Death|2|||
126798518|NCT05381948|456218087|FG002|Overall Study|Death|0|||
126798519|NCT05381948|456218085|FG000|Overall Study|Discontinued study without receiving study drug|0|||
126633255|NCT00661713|455615805|FG007|Overall Study|Death|0|||
126633256|NCT00661713|455615798|FG000|Overall Study|Unable to Classify|1|||
126633257|NCT00661713|455615799|FG001|Overall Study|Unable to Classify|0|||
126633258|NCT00661713|455615800|FG002|Overall Study|Unable to Classify|0|||
126633259|NCT00661713|455615801|FG003|Overall Study|Unable to Classify|0|||
126633260|NCT00661713|455615802|FG004|Overall Study|Unable to Classify|0|||
126633261|NCT00661713|455615803|FG005|Overall Study|Unable to Classify|0|||
126633262|NCT00661713|455615804|FG006|Overall Study|Unable to Classify|0|||
126633263|NCT00661713|455615805|FG007|Overall Study|Unable to Classify|0|||
126633264|NCT00661713|455615798|FG000|Overall Study|Protocol Violation|1|||
126633265|NCT00661713|455615799|FG001|Overall Study|Protocol Violation|6|||
126633266|NCT00661713|455615800|FG002|Overall Study|Protocol Violation|3|||
126633267|NCT00661713|455615801|FG003|Overall Study|Protocol Violation|3|||
126633268|NCT00661713|455615802|FG004|Overall Study|Protocol Violation|0|||
126633269|NCT00661713|455615803|FG005|Overall Study|Protocol Violation|2|||
126633270|NCT00661713|455615804|FG006|Overall Study|Protocol Violation|2|||
126633271|NCT00661713|455615805|FG007|Overall Study|Protocol Violation|1|||
126633272|NCT00661713|455615798|FG000|Overall Study|Withdrawal by Subject|11|||
126633273|NCT00661713|455615799|FG001|Overall Study|Withdrawal by Subject|25|||
126798520|NCT05381948|456218086|FG001|Overall Study|Discontinued study without receiving study drug|0|||
126798521|NCT05381948|456218087|FG002|Overall Study|Discontinued study without receiving study drug|1|||
126798522|NCT04198428|456218088|FG000|Overall Study|Withdrawal by Subject|150|||
126798523|NCT04198428|456218089|FG001|Overall Study|Withdrawal by Subject|156|||
126798524|NCT05104476|456218093|FG000|Overall Study|Randomized But Not Treated|1|||
126798525|NCT05104476|456218094|FG001|Overall Study|Randomized But Not Treated|2|||
126798526|NCT05104476|456218093|FG000|Overall Study|Adverse Event|2|||
126798527|NCT05104476|456218094|FG001|Overall Study|Adverse Event|2|||
126798528|NCT05104476|456218093|FG000|Overall Study|Withdrawal by Subject|3|||
126798529|NCT05104476|456218094|FG001|Overall Study|Withdrawal by Subject|3|||
126798530|NCT05104476|456218093|FG000|Overall Study|Other Than Specified|0|||
126633274|NCT00661713|455615800|FG002|Overall Study|Withdrawal by Subject|12|||
126633275|NCT00661713|455615801|FG003|Overall Study|Withdrawal by Subject|21|||
126633276|NCT00661713|455615802|FG004|Overall Study|Withdrawal by Subject|12|||
126633277|NCT00661713|455615803|FG005|Overall Study|Withdrawal by Subject|26|||
126633278|NCT00661713|455615804|FG006|Overall Study|Withdrawal by Subject|45|||
126633279|NCT00661713|455615805|FG007|Overall Study|Withdrawal by Subject|9|||
126633280|NCT00661713|455615798|FG000|Overall Study|Lost to Follow-up|2|||
126633281|NCT00661713|455615799|FG001|Overall Study|Lost to Follow-up|7|||
126798531|NCT05104476|456218094|FG001|Overall Study|Other Than Specified|3|||
126798532|NCT04649359|456218095|FG000|Overall Study|Withdrawal by Subject|7|||
126798533|NCT04649359|456218096|FG001|Overall Study|Withdrawal by Subject|7|||
126798534|NCT04649359|456218095|FG000|Overall Study|Death|41|||
126798535|NCT04649359|456218096|FG001|Overall Study|Death|26|||
126798536|NCT04649359|456218095|FG000|Overall Study|Ongoing in the study|75|||
126633282|NCT00661713|455615800|FG002|Overall Study|Lost to Follow-up|2|||
126798537|NCT04649359|456218096|FG001|Overall Study|Ongoing in the study|31|||
126633283|NCT00661713|455615801|FG003|Overall Study|Lost to Follow-up|2|||
126633284|NCT00661713|455615802|FG004|Overall Study|Lost to Follow-up|5|||
126798538|NCT01701674|456218097|FG000|Overall Study|Unable to safely complete treatment|1|||
126798539|NCT05604170|456218098|FG000|Overall Study|Lack of Efficacy|5|||
126798540|NCT05604170|456218098|FG000|Overall Study|Adverse Event|6|||
126798541|NCT05604170|456218098|FG000|Overall Study|Physician Decision|6|||
126798542|NCT05604170|456218098|FG000|Overall Study|Lost to Follow-up|6|||
126798543|NCT05604170|456218098|FG000|Overall Study|Withdrawal by Subject|11|||
126798544|NCT05604170|456218098|FG000|Overall Study|Early study termination by sponsor|77|||
126798545|NCT05604170|456218098|FG000|Overall Study|Other|6|||
126798546|NCT04008030|456218099|FG000|Pre-Treatment|Withdrawal by Subject|0|||
126798547|NCT04008030|456218100|FG001|Pre-Treatment|Withdrawal by Subject|0|||
126798548|NCT04008030|456218101|FG002|Pre-Treatment|Withdrawal by Subject|9|||
126798549|NCT04008030|456218099|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
126798550|NCT04008030|456218100|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
126798551|NCT04008030|456218101|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
126798552|NCT04008030|456218099|FG000|Pre-Treatment|Other reasons|0|||
126798553|NCT04008030|456218100|FG001|Pre-Treatment|Other reasons|1|||
126798554|NCT04008030|456218101|FG002|Pre-Treatment|Other reasons|6|||
126798555|NCT04008030|456218099|FG000|Treatment|Withdrawal by Subject|1|||
126798556|NCT04008030|456218100|FG001|Treatment|Withdrawal by Subject|1|||
126798557|NCT04008030|456218101|FG002|Treatment|Withdrawal by Subject|1|||
126798558|NCT04008030|456218099|FG000|Treatment|Death|2|||
126798559|NCT04008030|456218100|FG001|Treatment|Death|4|||
126798560|NCT04008030|456218101|FG002|Treatment|Death|0|||
126798561|NCT04008030|456218099|FG000|Treatment|Pregnancy|0|||
126798562|NCT04008030|456218100|FG001|Treatment|Pregnancy|1|||
126798563|NCT04008030|456218101|FG002|Treatment|Pregnancy|0|||
126798564|NCT04008030|456218099|FG000|Treatment|Participant no longer meets study criteria|0|||
126798565|NCT04008030|456218100|FG001|Treatment|Participant no longer meets study criteria|1|||
126798566|NCT04008030|456218101|FG002|Treatment|Participant no longer meets study criteria|0|||
126798567|NCT04008030|456218099|FG000|Treatment|Other reasons|5|||
126798568|NCT04008030|456218100|FG001|Treatment|Other reasons|13|||
126798569|NCT04008030|456218101|FG002|Treatment|Other reasons|6|||
126798570|NCT04008030|456218099|FG000|Treatment|Disease Progression|137|||
126798571|NCT04008030|456218100|FG001|Treatment|Disease Progression|82|||
126798572|NCT04008030|456218101|FG002|Treatment|Disease Progression|85|||
126798573|NCT04008030|456218099|FG000|Treatment|Study drug toxicity|28|||
126798574|NCT04008030|456218100|FG001|Treatment|Study drug toxicity|48|||
126798575|NCT04008030|456218101|FG002|Treatment|Study drug toxicity|8|||
126798576|NCT04008030|456218099|FG000|Treatment|Adverse Event unrelated to study drug|28|||
126798577|NCT04008030|456218100|FG001|Treatment|Adverse Event unrelated to study drug|22|||
126798578|NCT04008030|456218101|FG002|Treatment|Adverse Event unrelated to study drug|6|||
126798579|NCT04008030|456218099|FG000|Treatment|Maximum Clinical Benefit|0|||
126798580|NCT04008030|456218100|FG001|Treatment|Maximum Clinical Benefit|1|||
126798581|NCT04008030|456218101|FG002|Treatment|Maximum Clinical Benefit|9|||
126798582|NCT04008030|456218099|FG000|Treatment|On-going treatment|13|||
126798583|NCT04008030|456218100|FG001|Treatment|On-going treatment|20|||
126798584|NCT04008030|456218101|FG002|Treatment|On-going treatment|0|||
126798585|NCT03032172|456218103|FG000|Treatment Period|Adverse Event|0|||
126798586|NCT03032172|456218104|FG001|Treatment Period|Adverse Event|1|||
126798587|NCT03032172|456218105|FG002|Treatment Period|Adverse Event|0|||
126798588|NCT03032172|456218106|FG003|Treatment Period|Adverse Event|0|||
126798589|NCT03032172|456218107|FG004|Treatment Period|Adverse Event|0|||
126798590|NCT03032172|456218108|FG005|Treatment Period|Adverse Event|0|||
126798591|NCT03032172|456218109|FG006|Treatment Period|Adverse Event|0|||
126798592|NCT03032172|456218110|FG007|Treatment Period|Adverse Event|0|||
126798593|NCT03032172|456218103|FG000|Treatment Period|Lack of Efficacy|0|||
126798594|NCT03032172|456218104|FG001|Treatment Period|Lack of Efficacy|1|||
126798595|NCT03032172|456218105|FG002|Treatment Period|Lack of Efficacy|0|||
126633285|NCT00661713|455615803|FG005|Overall Study|Lost to Follow-up|7|||
126633286|NCT00661713|455615804|FG006|Overall Study|Lost to Follow-up|14|||
126633287|NCT00661713|455615805|FG007|Overall Study|Lost to Follow-up|1|||
126633288|NCT00661713|455615798|FG000|Overall Study|Administrative Reason|0|||
126798596|NCT03032172|456218106|FG003|Treatment Period|Lack of Efficacy|0|||
126798597|NCT03032172|456218107|FG004|Treatment Period|Lack of Efficacy|0|||
126798598|NCT03032172|456218108|FG005|Treatment Period|Lack of Efficacy|0|||
126798599|NCT03032172|456218109|FG006|Treatment Period|Lack of Efficacy|0|||
126798600|NCT03032172|456218110|FG007|Treatment Period|Lack of Efficacy|0|||
126798601|NCT03032172|456218103|FG000|Treatment Period|Non-compliance With Study Drug|0|||
126798602|NCT03032172|456218104|FG001|Treatment Period|Non-compliance With Study Drug|1|||
126798603|NCT03032172|456218105|FG002|Treatment Period|Non-compliance With Study Drug|0|||
126798604|NCT03032172|456218106|FG003|Treatment Period|Non-compliance With Study Drug|0|||
126798605|NCT03032172|456218107|FG004|Treatment Period|Non-compliance With Study Drug|0|||
126798606|NCT03032172|456218108|FG005|Treatment Period|Non-compliance With Study Drug|0|||
126798607|NCT03032172|456218109|FG006|Treatment Period|Non-compliance With Study Drug|0|||
126798608|NCT03032172|456218110|FG007|Treatment Period|Non-compliance With Study Drug|0|||
126798609|NCT03032172|456218103|FG000|Treatment Period|Reason Not Specified|0|||
126633289|NCT00661713|455615799|FG001|Overall Study|Administrative Reason|1|||
126633290|NCT00661713|455615800|FG002|Overall Study|Administrative Reason|0|||
126633291|NCT00661713|455615801|FG003|Overall Study|Administrative Reason|2|||
126798610|NCT03032172|456218104|FG001|Treatment Period|Reason Not Specified|4|||
126798611|NCT03032172|456218105|FG002|Treatment Period|Reason Not Specified|1|||
126798612|NCT03032172|456218106|FG003|Treatment Period|Reason Not Specified|0|||
126798613|NCT03032172|456218107|FG004|Treatment Period|Reason Not Specified|0|||
126798614|NCT03032172|456218108|FG005|Treatment Period|Reason Not Specified|0|||
126798615|NCT03032172|456218109|FG006|Treatment Period|Reason Not Specified|0|||
126798616|NCT03032172|456218110|FG007|Treatment Period|Reason Not Specified|0|||
126798617|NCT03032172|456218103|FG000|Treatment Period|Physician Decision|0|||
126798618|NCT03032172|456218104|FG001|Treatment Period|Physician Decision|2|||
126798619|NCT03032172|456218105|FG002|Treatment Period|Physician Decision|1|||
126798620|NCT03032172|456218106|FG003|Treatment Period|Physician Decision|0|||
126798621|NCT03032172|456218107|FG004|Treatment Period|Physician Decision|0|||
126798622|NCT03032172|456218108|FG005|Treatment Period|Physician Decision|0|||
126798623|NCT03032172|456218109|FG006|Treatment Period|Physician Decision|0|||
126798624|NCT03032172|456218110|FG007|Treatment Period|Physician Decision|0|||
126798625|NCT03032172|456218103|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
126798626|NCT03032172|456218104|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
126798627|NCT03032172|456218105|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
126798628|NCT03032172|456218106|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
126798629|NCT03032172|456218107|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
126798630|NCT03032172|456218108|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
126798631|NCT03032172|456218109|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
126798632|NCT03032172|456218110|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
126798633|NCT03032172|456218103|FG000|Treatment Period|Withdrawal by Subject|2|||
126798634|NCT03032172|456218104|FG001|Treatment Period|Withdrawal by Subject|0|||
126798635|NCT03032172|456218105|FG002|Treatment Period|Withdrawal by Subject|3|||
126798636|NCT03032172|456218106|FG003|Treatment Period|Withdrawal by Subject|0|||
126798637|NCT03032172|456218107|FG004|Treatment Period|Withdrawal by Subject|0|||
126798638|NCT03032172|456218108|FG005|Treatment Period|Withdrawal by Subject|0|||
126798639|NCT03032172|456218109|FG006|Treatment Period|Withdrawal by Subject|0|||
126798640|NCT03032172|456218110|FG007|Treatment Period|Withdrawal by Subject|0|||
126798641|NCT03032172|456218103|FG000|Open-label Extension Period|Death|0|||
126798642|NCT03032172|456218104|FG001|Open-label Extension Period|Death|0|||
126798643|NCT03032172|456218105|FG002|Open-label Extension Period|Death|0|||
126798644|NCT03032172|456218106|FG003|Open-label Extension Period|Death|0|||
126798645|NCT03032172|456218107|FG004|Open-label Extension Period|Death|0|||
126798646|NCT03032172|456218108|FG005|Open-label Extension Period|Death|0|||
126798647|NCT03032172|456218109|FG006|Open-label Extension Period|Death|0|||
126798648|NCT03032172|456218110|FG007|Open-label Extension Period|Death|2|||
126798649|NCT03032172|456218103|FG000|Open-label Extension Period|Reason Not Specified|0|||
126798650|NCT03032172|456218104|FG001|Open-label Extension Period|Reason Not Specified|0|||
126798651|NCT03032172|456218105|FG002|Open-label Extension Period|Reason Not Specified|0|||
126798652|NCT03032172|456218106|FG003|Open-label Extension Period|Reason Not Specified|0|||
126798653|NCT03032172|456218107|FG004|Open-label Extension Period|Reason Not Specified|0|||
126798654|NCT03032172|456218108|FG005|Open-label Extension Period|Reason Not Specified|5|||
126798655|NCT03032172|456218109|FG006|Open-label Extension Period|Reason Not Specified|3|||
126798656|NCT03032172|456218110|FG007|Open-label Extension Period|Reason Not Specified|0|||
126798657|NCT03032172|456218103|FG000|Open-label Extension Period|Pregnancy|0|||
126798658|NCT03032172|456218104|FG001|Open-label Extension Period|Pregnancy|0|||
126798659|NCT03032172|456218105|FG002|Open-label Extension Period|Pregnancy|0|||
126798660|NCT03032172|456218106|FG003|Open-label Extension Period|Pregnancy|0|||
126798661|NCT03032172|456218107|FG004|Open-label Extension Period|Pregnancy|0|||
126798662|NCT03032172|456218108|FG005|Open-label Extension Period|Pregnancy|0|||
126798663|NCT03032172|456218109|FG006|Open-label Extension Period|Pregnancy|1|||
126798664|NCT03032172|456218110|FG007|Open-label Extension Period|Pregnancy|0|||
126798665|NCT03032172|456218103|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
126798666|NCT03032172|456218104|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
126798667|NCT03032172|456218105|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
126798668|NCT03032172|456218106|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
126798669|NCT03032172|456218107|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
126798670|NCT03032172|456218108|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
126798671|NCT03032172|456218109|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
126798672|NCT03032172|456218110|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
126798673|NCT04751929|456218115|FG000|Overall Study|Withdrawal by Subject|2|||
126798674|NCT04751929|456218116|FG001|Overall Study|Withdrawal by Subject|0|||
126798675|NCT04751929|456218117|FG002|Overall Study|Withdrawal by Subject|0|||
126798676|NCT04751929|456218118|FG003|Overall Study|Withdrawal by Subject|0|||
126798677|NCT04751929|456218115|FG000|Overall Study|Rising PSA|0|||
126798678|NCT04751929|456218116|FG001|Overall Study|Rising PSA|1|||
126798679|NCT04751929|456218117|FG002|Overall Study|Rising PSA|0|||
126798680|NCT04751929|456218118|FG003|Overall Study|Rising PSA|0|||
126798681|NCT04751929|456218115|FG000|Overall Study|Adverse Event|1|||
126798682|NCT04751929|456218116|FG001|Overall Study|Adverse Event|2|||
126798683|NCT04751929|456218117|FG002|Overall Study|Adverse Event|0|||
126798684|NCT04751929|456218118|FG003|Overall Study|Adverse Event|0|||
126798685|NCT04751929|456218115|FG000|Overall Study|Progressive Disease|3|||
126798686|NCT04751929|456218116|FG001|Overall Study|Progressive Disease|4|||
126798687|NCT04751929|456218117|FG002|Overall Study|Progressive Disease|4|||
126798688|NCT04751929|456218118|FG003|Overall Study|Progressive Disease|0|||
126798689|NCT04751929|456218115|FG000|Overall Study|Death|1|||
126798690|NCT04751929|456218116|FG001|Overall Study|Death|1|||
126798691|NCT04751929|456218117|FG002|Overall Study|Death|0|||
126798692|NCT04751929|456218118|FG003|Overall Study|Death|0|||
126798693|NCT02869867|456218120|FG000|Overall Study|Protocol Violation|1|||
126798694|NCT02869867|456218121|FG001|Overall Study|Protocol Violation|0|||
126798695|NCT02869867|456218120|FG000|Overall Study|Lost to Follow-up|5|||
126798696|NCT02869867|456218121|FG001|Overall Study|Lost to Follow-up|5|||
126798697|NCT06284525|456218123|FG000|Overall Study|Withdrawal by Subject|1|||
126798698|NCT02069366|456218124|FG000|Overall Study|Lost to Follow-up|0|||
126798699|NCT02069366|456218125|FG001|Overall Study|Lost to Follow-up|0|||
126798700|NCT02069366|456218126|FG002|Overall Study|Lost to Follow-up|1|||
126798701|NCT02069366|456218127|FG003|Overall Study|Lost to Follow-up|0|||
126798702|NCT02069366|456218128|FG004|Overall Study|Lost to Follow-up|0|||
126798703|NCT02069366|456218129|FG005|Overall Study|Lost to Follow-up|2|||
126798704|NCT02069366|456218124|FG000|Overall Study|Protocol Violation|0|||
126798705|NCT02069366|456218125|FG001|Overall Study|Protocol Violation|0|||
126798706|NCT02069366|456218126|FG002|Overall Study|Protocol Violation|1|||
126798707|NCT02069366|456218127|FG003|Overall Study|Protocol Violation|0|||
126798708|NCT02069366|456218128|FG004|Overall Study|Protocol Violation|0|||
126798709|NCT02069366|456218129|FG005|Overall Study|Protocol Violation|0|||
126798710|NCT02069366|456218124|FG000|Overall Study|Withdrawal by Subject|1|||
126798711|NCT02069366|456218125|FG001|Overall Study|Withdrawal by Subject|0|||
126798712|NCT02069366|456218126|FG002|Overall Study|Withdrawal by Subject|1|||
126798713|NCT02069366|456218127|FG003|Overall Study|Withdrawal by Subject|2|||
126798714|NCT02069366|456218128|FG004|Overall Study|Withdrawal by Subject|0|||
126798715|NCT02069366|456218129|FG005|Overall Study|Withdrawal by Subject|0|||
126798716|NCT04516967|456218130|FG000|Core Phase|Adverse Event|2|||
126798717|NCT04516967|456218131|FG001|Core Phase|Adverse Event|1|||
126798718|NCT04516967|456218132|FG002|Core Phase|Adverse Event|0|||
126798719|NCT04516967|456218130|FG000|Core Phase|Physician Decision|1|||
126798720|NCT04516967|456218131|FG001|Core Phase|Physician Decision|1|||
126798721|NCT04516967|456218132|FG002|Core Phase|Physician Decision|0|||
126798722|NCT04516967|456218130|FG000|Core Phase|Lack of Efficacy|7|||
126798723|NCT04516967|456218131|FG001|Core Phase|Lack of Efficacy|18|||
126798724|NCT04516967|456218132|FG002|Core Phase|Lack of Efficacy|0|||
126798725|NCT03570749|456218133|FG000|Overall Study|Ongoing|26|||
126798726|NCT03570749|456218134|FG001|Overall Study|Ongoing|25|||
126798727|NCT03570749|456218135|FG002|Overall Study|Ongoing|25|||
126798728|NCT03570749|456218136|FG003|Overall Study|Ongoing|26|||
126798729|NCT03570749|456218137|FG004|Overall Study|Ongoing|140|||
126798730|NCT03570749|456218138|FG005|Overall Study|Ongoing|142|||
126798731|NCT03570749|456218139|FG006|Overall Study|Ongoing|220|||
126798732|NCT03570749|456218133|FG000|Overall Study|Adverse Event|0|||
126798733|NCT03570749|456218134|FG001|Overall Study|Adverse Event|0|||
126798734|NCT03570749|456218135|FG002|Overall Study|Adverse Event|0|||
126798735|NCT03570749|456218136|FG003|Overall Study|Adverse Event|0|||
126798736|NCT03570749|456218137|FG004|Overall Study|Adverse Event|2|||
126798737|NCT03570749|456218138|FG005|Overall Study|Adverse Event|3|||
126798738|NCT03570749|456218139|FG006|Overall Study|Adverse Event|6|||
126798739|NCT03570749|456218133|FG000|Overall Study|Lack of Efficacy|0|||
126798740|NCT03570749|456218134|FG001|Overall Study|Lack of Efficacy|0|||
126798741|NCT03570749|456218135|FG002|Overall Study|Lack of Efficacy|0|||
126798742|NCT03570749|456218136|FG003|Overall Study|Lack of Efficacy|0|||
126798743|NCT03570749|456218137|FG004|Overall Study|Lack of Efficacy|8|||
126798744|NCT03570749|456218138|FG005|Overall Study|Lack of Efficacy|2|||
126798745|NCT03570749|456218139|FG006|Overall Study|Lack of Efficacy|7|||
126798746|NCT03570749|456218133|FG000|Overall Study|Lost to Follow-up|0|||
126798747|NCT03570749|456218134|FG001|Overall Study|Lost to Follow-up|0|||
126798748|NCT03570749|456218135|FG002|Overall Study|Lost to Follow-up|0|||
126798749|NCT03570749|456218136|FG003|Overall Study|Lost to Follow-up|0|||
126798750|NCT03570749|456218137|FG004|Overall Study|Lost to Follow-up|5|||
126798751|NCT03570749|456218138|FG005|Overall Study|Lost to Follow-up|10|||
126798752|NCT03570749|456218139|FG006|Overall Study|Lost to Follow-up|10|||
126798753|NCT03570749|456218133|FG000|Overall Study|Pregnancy|0|||
126798754|NCT03570749|456218134|FG001|Overall Study|Pregnancy|0|||
126798755|NCT03570749|456218135|FG002|Overall Study|Pregnancy|0|||
126798756|NCT03570749|456218136|FG003|Overall Study|Pregnancy|0|||
126798757|NCT03570749|456218137|FG004|Overall Study|Pregnancy|0|||
126798758|NCT03570749|456218138|FG005|Overall Study|Pregnancy|1|||
126798759|NCT03570749|456218139|FG006|Overall Study|Pregnancy|1|||
126798760|NCT03570749|456218133|FG000|Overall Study|Screen Fail|0|||
126798761|NCT03570749|456218134|FG001|Overall Study|Screen Fail|0|||
126798762|NCT03570749|456218135|FG002|Overall Study|Screen Fail|0|||
126798763|NCT03570749|456218136|FG003|Overall Study|Screen Fail|0|||
126798764|NCT03570749|456218137|FG004|Overall Study|Screen Fail|0|||
126798765|NCT03570749|456218138|FG005|Overall Study|Screen Fail|0|||
126798766|NCT03570749|456218139|FG006|Overall Study|Screen Fail|1|||
126798767|NCT03570749|456218133|FG000|Overall Study|Withdrawal by Subject|2|||
126798768|NCT03570749|456218134|FG001|Overall Study|Withdrawal by Subject|3|||
126798769|NCT03570749|456218135|FG002|Overall Study|Withdrawal by Subject|2|||
126798770|NCT03570749|456218136|FG003|Overall Study|Withdrawal by Subject|1|||
126798771|NCT03570749|456218137|FG004|Overall Study|Withdrawal by Subject|17|||
126798772|NCT03570749|456218138|FG005|Overall Study|Withdrawal by Subject|12|||
126798773|NCT03570749|456218139|FG006|Overall Study|Withdrawal by Subject|15|||
126798774|NCT03570749|456218133|FG000|Overall Study|Other|0|||
126798775|NCT03570749|456218134|FG001|Overall Study|Other|0|||
126798776|NCT03570749|456218135|FG002|Overall Study|Other|0|||
126798777|NCT03570749|456218136|FG003|Overall Study|Other|0|||
126798778|NCT03570749|456218137|FG004|Overall Study|Other|17|||
126798779|NCT03570749|456218138|FG005|Overall Study|Other|14|||
126798780|NCT03570749|456218139|FG006|Overall Study|Other|21|||
126798781|NCT05407675|456218143|FG000|Overall Study|Withdrawal by Subject|0|||
126798782|NCT05407675|456218144|FG001|Overall Study|Withdrawal by Subject|2|||
126798783|NCT05407675|456218145|FG002|Overall Study|Withdrawal by Subject|3|||
126798784|NCT05407675|456218146|FG003|Overall Study|Withdrawal by Subject|5|||
126798785|NCT05407675|456218147|FG004|Overall Study|Withdrawal by Subject|0|||
126798786|NCT05407675|456218148|FG005|Overall Study|Withdrawal by Subject|2|||
126798787|NCT05407675|456218149|FG006|Overall Study|Withdrawal by Subject|0|||
126798788|NCT05407675|456218150|FG007|Overall Study|Withdrawal by Subject|0|||
126798789|NCT05407675|456218151|FG008|Overall Study|Withdrawal by Subject|2|||
126798790|NCT05407675|456218152|FG009|Overall Study|Withdrawal by Subject|0|||
126798791|NCT05407675|456218153|FG010|Overall Study|Withdrawal by Subject|1|||
126798792|NCT05407675|456218154|FG011|Overall Study|Withdrawal by Subject|0|||
126798793|NCT05407675|456218155|FG012|Overall Study|Withdrawal by Subject|0|||
126633292|NCT00661713|455615802|FG004|Overall Study|Administrative Reason|2|||
126633293|NCT00661713|455615803|FG005|Overall Study|Administrative Reason|2|||
126633294|NCT00661713|455615804|FG006|Overall Study|Administrative Reason|1|||
126633295|NCT00661713|455615805|FG007|Overall Study|Administrative Reason|0|||
126633296|NCT00661713|455615798|FG000|Overall Study|Adverse Event|0|||
126633297|NCT00661713|455615799|FG001|Overall Study|Adverse Event|0|||
126633298|NCT00661713|455615800|FG002|Overall Study|Adverse Event|0|||
126633299|NCT00661713|455615801|FG003|Overall Study|Adverse Event|0|||
126633300|NCT00661713|455615802|FG004|Overall Study|Adverse Event|0|||
126633301|NCT00661713|455615803|FG005|Overall Study|Adverse Event|0|||
126633302|NCT00661713|455615804|FG006|Overall Study|Adverse Event|1|||
126633303|NCT00661713|455615805|FG007|Overall Study|Adverse Event|0|||
126633304|NCT00661713|455615798|FG000|Overall Study|Inappropriate Enrollment|0|||
126633305|NCT00661713|455615799|FG001|Overall Study|Inappropriate Enrollment|0|||
126633306|NCT00661713|455615800|FG002|Overall Study|Inappropriate Enrollment|0|||
126633307|NCT00661713|455615801|FG003|Overall Study|Inappropriate Enrollment|0|||
126633308|NCT00661713|455615802|FG004|Overall Study|Inappropriate Enrollment|0|||
126633309|NCT00661713|455615803|FG005|Overall Study|Inappropriate Enrollment|0|||
126633310|NCT00661713|455615804|FG006|Overall Study|Inappropriate Enrollment|1|||
126633311|NCT00661713|455615805|FG007|Overall Study|Inappropriate Enrollment|0|||
126633312|NCT01161628|455615806|FG000|Overall Study|Death|6|||
126633313|NCT01161628|455615806|FG000|Overall Study|Lack of Efficacy|2|||
126633314|NCT00715117|455615807|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
126633315|NCT00715117|455615808|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
126633316|NCT01482429|455615809|FG000|Care Usual|Protocol Violation|0|||
126633317|NCT01482429|455615810|FG001|Care Usual|Protocol Violation|172|||
126633318|NCT01482429|455615809|FG000|Care Usual|Lost to Follow-up|0|||
126633319|NCT01482429|455615810|FG001|Care Usual|Lost to Follow-up|1|||
126633320|NCT01482429|455615809|FG000|Protocol|Protocol Violation|275|||
126633321|NCT01482429|455615810|FG001|Protocol|Protocol Violation|0|||
126633322|NCT04680637|455615811|FG000|Overall Study|Lost to Follow-up|0|||
126633323|NCT04680637|455615812|FG001|Overall Study|Lost to Follow-up|1|||
126633324|NCT04680637|455615813|FG002|Overall Study|Lost to Follow-up|0|||
126633325|NCT04680637|455615814|FG003|Overall Study|Lost to Follow-up|1|||
126798794|NCT05407675|456218143|FG000|Overall Study|Site terminated by sponsor|0|||
126798795|NCT05407675|456218144|FG001|Overall Study|Site terminated by sponsor|0|||
126798796|NCT05407675|456218145|FG002|Overall Study|Site terminated by sponsor|1|||
126798797|NCT05407675|456218146|FG003|Overall Study|Site terminated by sponsor|0|||
126798798|NCT05407675|456218147|FG004|Overall Study|Site terminated by sponsor|2|||
126633326|NCT04680637|455615811|FG000|Overall Study|Death|1|||
126633327|NCT04680637|455615812|FG001|Overall Study|Death|0|||
126633328|NCT04680637|455615813|FG002|Overall Study|Death|0|||
126633329|NCT04680637|455615814|FG003|Overall Study|Death|0|||
126633330|NCT04680637|455615811|FG000|Overall Study|Withdrawal by Subject|7|||
126633331|NCT04680637|455615812|FG001|Overall Study|Withdrawal by Subject|10|||
126798799|NCT05407675|456218148|FG005|Overall Study|Site terminated by sponsor|0|||
126633332|NCT04680637|455615813|FG002|Overall Study|Withdrawal by Subject|17|||
126633333|NCT04680637|455615814|FG003|Overall Study|Withdrawal by Subject|15|||
126633334|NCT04680637|455615811|FG000|Overall Study|Decision by Sponsor|21|||
126633335|NCT04680637|455615812|FG001|Overall Study|Decision by Sponsor|15|||
126633336|NCT04680637|455615813|FG002|Overall Study|Decision by Sponsor|7|||
126633337|NCT04680637|455615814|FG003|Overall Study|Decision by Sponsor|32|||
126633338|NCT02037256|455615815|FG000|Overall Study|Protocol Violation|0|||
126633339|NCT02037256|455615816|FG001|Overall Study|Protocol Violation|1|||
126633340|NCT02037256|455615815|FG000|Overall Study|Withdrawn prior to Velcade|0|||
126633341|NCT02037256|455615816|FG001|Overall Study|Withdrawn prior to Velcade|2|||
126633342|NCT00416598|455617689|FG000|Induction & Intensification|Adverse Event|38|||
126633343|NCT00416598|455617689|FG000|Induction & Intensification|Death|32|||
126633344|NCT00416598|455617689|FG000|Induction & Intensification|Withdrawal by Subject|46|||
126633345|NCT00416598|455617689|FG000|Induction & Intensification|Alternative Treatment|135|||
126633346|NCT00416598|455617689|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
126633347|NCT00416598|455617689|FG000|Induction & Intensification|Relapse/progression|29|||
126633348|NCT00416598|455617689|FG000|Induction & Intensification|Failed induction|87|||
126633349|NCT00416598|455617689|FG000|Decitabine Maintenance|Adverse Event|5|||
126633350|NCT00416598|455617689|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
126633351|NCT00416598|455617689|FG000|Decitabine Maintenance|Progression/relapse|38|||
126633352|NCT00416598|455617689|FG000|Decitabine Maintenance|Alternative treatment|2|||
126633353|NCT00416598|455617689|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
126633354|NCT02166476|455617690|FG000|Overall Study|Withdrawal by Subject|5|||
126633355|NCT02166476|455617691|FG001|Overall Study|Withdrawal by Subject|7|||
126633356|NCT02166476|455617690|FG000|Overall Study|Adverse Event|3|||
126633357|NCT02166476|455617691|FG001|Overall Study|Adverse Event|3|||
126633358|NCT02166476|455617690|FG000|Overall Study|Lost to Follow-up|5|||
126633359|NCT02166476|455617691|FG001|Overall Study|Lost to Follow-up|10|||
126633360|NCT02166476|455617690|FG000|Overall Study|Physician Decision|1|||
126633361|NCT02166476|455617691|FG001|Overall Study|Physician Decision|0|||
126633362|NCT02166476|455617690|FG000|Overall Study|Unable to Come for Visit|0|||
126633363|NCT02166476|455617691|FG001|Overall Study|Unable to Come for Visit|3|||
126633364|NCT00328562|455617699|FG000|Overall Study|Disease progression|1|||
126633365|NCT00810342|455617700|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
126633366|NCT00810342|455617701|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
126633367|NCT00810342|455617700|FG000|Month 1 Follow-up|Pregnancy|1|||
126633368|NCT00810342|455617701|FG001|Month 1 Follow-up|Pregnancy|0|||
126633369|NCT00810342|455617700|FG000|6-month Follow-up|Lost to Follow-up|18|||
126633370|NCT00810342|455617701|FG001|6-month Follow-up|Lost to Follow-up|6|||
126633371|NCT00810342|455617700|FG000|6-month Follow-up|Pregnancy|6|||
126633372|NCT00810342|455617701|FG001|6-month Follow-up|Pregnancy|2|||
126633373|NCT00810342|455617700|FG000|12-month Followup|Pregnancy|9|||
126633374|NCT00810342|455617701|FG001|12-month Followup|Pregnancy|10|||
126633375|NCT00810342|455617700|FG000|12-month Followup|Lost to Follow-up|3|||
126633376|NCT00810342|455617701|FG001|12-month Followup|Lost to Follow-up|1|||
126633377|NCT04504630|455617702|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
126633378|NCT04504630|455617703|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
126633379|NCT04504630|455617702|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
126633380|NCT04504630|455617703|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
126633381|NCT01496365|455617704|FG000|Overall Study|Adverse Event|2|||
126633382|NCT01496365|455617705|FG001|Overall Study|Adverse Event|3|||
126633383|NCT01496365|455617706|FG002|Overall Study|Adverse Event|3|||
126633384|NCT01496365|455617707|FG003|Overall Study|Adverse Event|2|||
126633385|NCT01496365|455617708|FG004|Overall Study|Adverse Event|5|||
126633386|NCT01496365|455617709|FG005|Overall Study|Adverse Event|6|||
126633387|NCT01496365|455617710|FG006|Overall Study|Adverse Event|4|||
126633388|NCT01496365|455617704|FG000|Overall Study|Withdrawal by Subject|6|||
126633389|NCT01496365|455617705|FG001|Overall Study|Withdrawal by Subject|6|||
126633390|NCT01496365|455617706|FG002|Overall Study|Withdrawal by Subject|0|||
126633391|NCT01496365|455617707|FG003|Overall Study|Withdrawal by Subject|1|||
126633392|NCT01496365|455617708|FG004|Overall Study|Withdrawal by Subject|3|||
126633393|NCT01496365|455617709|FG005|Overall Study|Withdrawal by Subject|2|||
126633394|NCT01496365|455617710|FG006|Overall Study|Withdrawal by Subject|1|||
126633395|NCT01496365|455617704|FG000|Overall Study|Protocol Violation|2|||
126798800|NCT05407675|456218149|FG006|Overall Study|Site terminated by sponsor|1|||
126798801|NCT05407675|456218150|FG007|Overall Study|Site terminated by sponsor|0|||
126633396|NCT01496365|455617705|FG001|Overall Study|Protocol Violation|1|||
126633397|NCT01496365|455617706|FG002|Overall Study|Protocol Violation|1|||
126633398|NCT01496365|455617707|FG003|Overall Study|Protocol Violation|0|||
126633399|NCT01496365|455617708|FG004|Overall Study|Protocol Violation|0|||
126633400|NCT01496365|455617709|FG005|Overall Study|Protocol Violation|1|||
126633401|NCT01496365|455617710|FG006|Overall Study|Protocol Violation|0|||
126633402|NCT01496365|455617704|FG000|Overall Study|Lack of Efficacy|1|||
126633403|NCT01496365|455617705|FG001|Overall Study|Lack of Efficacy|0|||
126633404|NCT01496365|455617706|FG002|Overall Study|Lack of Efficacy|0|||
126633405|NCT01496365|455617707|FG003|Overall Study|Lack of Efficacy|0|||
126633406|NCT01496365|455617708|FG004|Overall Study|Lack of Efficacy|0|||
126633407|NCT01496365|455617709|FG005|Overall Study|Lack of Efficacy|1|||
126633408|NCT01496365|455617710|FG006|Overall Study|Lack of Efficacy|0|||
126633409|NCT01496365|455617704|FG000|Overall Study|Lost to Follow-up|0|||
126633410|NCT01496365|455617705|FG001|Overall Study|Lost to Follow-up|1|||
126633411|NCT01496365|455617706|FG002|Overall Study|Lost to Follow-up|0|||
126633412|NCT01496365|455617707|FG003|Overall Study|Lost to Follow-up|0|||
126633413|NCT01496365|455617708|FG004|Overall Study|Lost to Follow-up|2|||
126633414|NCT01496365|455617709|FG005|Overall Study|Lost to Follow-up|0|||
126633415|NCT01496365|455617710|FG006|Overall Study|Lost to Follow-up|0|||
126633416|NCT01496365|455617704|FG000|Overall Study|Other|4|||
126633417|NCT01496365|455617705|FG001|Overall Study|Other|4|||
126633418|NCT01496365|455617706|FG002|Overall Study|Other|2|||
126633419|NCT01496365|455617707|FG003|Overall Study|Other|1|||
126633420|NCT01496365|455617708|FG004|Overall Study|Other|3|||
126633421|NCT01496365|455617709|FG005|Overall Study|Other|0|||
126633422|NCT01496365|455617710|FG006|Overall Study|Other|1|||
126633423|NCT02706951|455617711|FG000|Period 1|Adverse Event|1|||
126633424|NCT02706951|455617712|FG001|Period 1|Adverse Event|5|||
126633425|NCT02706951|455617713|FG002|Period 1|Adverse Event|3|||
126633426|NCT02706951|455617714|FG003|Period 1|Adverse Event|0|||
126633427|NCT02706951|455617715|FG004|Period 1|Adverse Event|0|||
126633428|NCT02706951|455617711|FG000|Period 1|Withdrawal by Subject|10|||
126633429|NCT02706951|455617712|FG001|Period 1|Withdrawal by Subject|6|||
126633430|NCT02706951|455617713|FG002|Period 1|Withdrawal by Subject|6|||
126633431|NCT02706951|455617714|FG003|Period 1|Withdrawal by Subject|0|||
126633432|NCT02706951|455617715|FG004|Period 1|Withdrawal by Subject|0|||
126633433|NCT02706951|455617711|FG000|Period 1|Lost to Follow-up|0|||
126633434|NCT02706951|455617712|FG001|Period 1|Lost to Follow-up|4|||
126633435|NCT02706951|455617713|FG002|Period 1|Lost to Follow-up|1|||
126633436|NCT02706951|455617714|FG003|Period 1|Lost to Follow-up|0|||
126633437|NCT02706951|455617715|FG004|Period 1|Lost to Follow-up|0|||
126633438|NCT02706951|455617711|FG000|Period 1|Other|2|||
126633439|NCT02706951|455617712|FG001|Period 1|Other|1|||
126798802|NCT05407675|456218151|FG008|Overall Study|Site terminated by sponsor|0|||
126798803|NCT05407675|456218152|FG009|Overall Study|Site terminated by sponsor|2|||
126798804|NCT05407675|456218153|FG010|Overall Study|Site terminated by sponsor|2|||
126798805|NCT05407675|456218154|FG011|Overall Study|Site terminated by sponsor|2|||
126798806|NCT05407675|456218155|FG012|Overall Study|Site terminated by sponsor|1|||
126798807|NCT05407675|456218143|FG000|Overall Study|Disease Progression|0|||
126798808|NCT05407675|456218144|FG001|Overall Study|Disease Progression|0|||
126798809|NCT05407675|456218145|FG002|Overall Study|Disease Progression|0|||
126798810|NCT05407675|456218146|FG003|Overall Study|Disease Progression|0|||
126798811|NCT05407675|456218147|FG004|Overall Study|Disease Progression|0|||
126798812|NCT05407675|456218148|FG005|Overall Study|Disease Progression|0|||
126798813|NCT05407675|456218149|FG006|Overall Study|Disease Progression|0|||
126798814|NCT05407675|456218150|FG007|Overall Study|Disease Progression|0|||
126798815|NCT05407675|456218151|FG008|Overall Study|Disease Progression|0|||
126798816|NCT05407675|456218152|FG009|Overall Study|Disease Progression|0|||
126798817|NCT05407675|456218153|FG010|Overall Study|Disease Progression|1|||
126798818|NCT05407675|456218154|FG011|Overall Study|Disease Progression|0|||
126798819|NCT05407675|456218155|FG012|Overall Study|Disease Progression|0|||
126798820|NCT05407675|456218143|FG000|Overall Study|Physician Decision|0|||
126798821|NCT05407675|456218144|FG001|Overall Study|Physician Decision|0|||
126798822|NCT05407675|456218145|FG002|Overall Study|Physician Decision|0|||
126798823|NCT05407675|456218146|FG003|Overall Study|Physician Decision|0|||
126798824|NCT05407675|456218147|FG004|Overall Study|Physician Decision|0|||
126798825|NCT05407675|456218148|FG005|Overall Study|Physician Decision|0|||
126798826|NCT05407675|456218149|FG006|Overall Study|Physician Decision|0|||
126798827|NCT05407675|456218150|FG007|Overall Study|Physician Decision|0|||
126798828|NCT05407675|456218151|FG008|Overall Study|Physician Decision|0|||
126798829|NCT05407675|456218152|FG009|Overall Study|Physician Decision|0|||
126798830|NCT05407675|456218153|FG010|Overall Study|Physician Decision|1|||
126798831|NCT05407675|456218154|FG011|Overall Study|Physician Decision|0|||
126798832|NCT05407675|456218155|FG012|Overall Study|Physician Decision|0|||
126633440|NCT02706951|455617713|FG002|Period 1|Other|0|||
126633441|NCT02706951|455617714|FG003|Period 1|Other|0|||
126633442|NCT02706951|455617715|FG004|Period 1|Other|0|||
126633443|NCT02706951|455617711|FG000|Period 2|Adverse Event|0|||
126633444|NCT02706951|455617712|FG001|Period 2|Adverse Event|0|||
126633445|NCT02706951|455617713|FG002|Period 2|Adverse Event|0|||
126633446|NCT02706951|455617714|FG003|Period 2|Adverse Event|25|||
126633447|NCT02706951|455617715|FG004|Period 2|Adverse Event|34|||
126633448|NCT02706951|455617711|FG000|Period 2|Withdrawal by Subject|0|||
126633449|NCT02706951|455617712|FG001|Period 2|Withdrawal by Subject|0|||
126633450|NCT02706951|455617713|FG002|Period 2|Withdrawal by Subject|0|||
126633451|NCT02706951|455617714|FG003|Period 2|Withdrawal by Subject|38|||
126633452|NCT02706951|455617715|FG004|Period 2|Withdrawal by Subject|44|||
126633453|NCT02706951|455617711|FG000|Period 2|Lost to Follow-up|0|||
126633454|NCT02706951|455617712|FG001|Period 2|Lost to Follow-up|0|||
126798833|NCT05407675|456218143|FG000|Overall Study|Other reasons|0|||
126798834|NCT05407675|456218144|FG001|Overall Study|Other reasons|0|||
126798835|NCT05407675|456218145|FG002|Overall Study|Other reasons|0|||
126798836|NCT05407675|456218146|FG003|Overall Study|Other reasons|0|||
126798837|NCT05407675|456218147|FG004|Overall Study|Other reasons|0|||
126798838|NCT05407675|456218148|FG005|Overall Study|Other reasons|0|||
126798839|NCT05407675|456218149|FG006|Overall Study|Other reasons|0|||
126798840|NCT05407675|456218150|FG007|Overall Study|Other reasons|0|||
126798841|NCT05407675|456218151|FG008|Overall Study|Other reasons|1|||
126798842|NCT05407675|456218152|FG009|Overall Study|Other reasons|1|||
126798843|NCT05407675|456218153|FG010|Overall Study|Other reasons|1|||
126798844|NCT05407675|456218154|FG011|Overall Study|Other reasons|1|||
126798845|NCT05407675|456218155|FG012|Overall Study|Other reasons|0|||
126798846|NCT05407675|456218143|FG000|Overall Study|Death|3|||
126798847|NCT05407675|456218144|FG001|Overall Study|Death|4|||
126798848|NCT05407675|456218145|FG002|Overall Study|Death|3|||
126798849|NCT05407675|456218146|FG003|Overall Study|Death|6|||
126798850|NCT05407675|456218147|FG004|Overall Study|Death|0|||
126798851|NCT05407675|456218148|FG005|Overall Study|Death|2|||
126798852|NCT05407675|456218149|FG006|Overall Study|Death|4|||
126798853|NCT05407675|456218150|FG007|Overall Study|Death|2|||
126798854|NCT05407675|456218151|FG008|Overall Study|Death|2|||
126798855|NCT05407675|456218152|FG009|Overall Study|Death|4|||
126798856|NCT05407675|456218153|FG010|Overall Study|Death|2|||
126798857|NCT05407675|456218154|FG011|Overall Study|Death|1|||
126798858|NCT05407675|456218155|FG012|Overall Study|Death|0|||
126798859|NCT05407675|456218143|FG000|Overall Study|Adverse Event|0|||
126798860|NCT05407675|456218144|FG001|Overall Study|Adverse Event|0|||
126798861|NCT05407675|456218145|FG002|Overall Study|Adverse Event|0|||
126798862|NCT05407675|456218146|FG003|Overall Study|Adverse Event|0|||
126798863|NCT05407675|456218147|FG004|Overall Study|Adverse Event|1|||
126798864|NCT05407675|456218148|FG005|Overall Study|Adverse Event|0|||
126798865|NCT05407675|456218149|FG006|Overall Study|Adverse Event|0|||
126798866|NCT05407675|456218150|FG007|Overall Study|Adverse Event|0|||
126798867|NCT05407675|456218151|FG008|Overall Study|Adverse Event|0|||
126798868|NCT05407675|456218152|FG009|Overall Study|Adverse Event|0|||
126798869|NCT05407675|456218153|FG010|Overall Study|Adverse Event|0|||
126798870|NCT05407675|456218154|FG011|Overall Study|Adverse Event|1|||
126798871|NCT05407675|456218155|FG012|Overall Study|Adverse Event|0|||
126798872|NCT05407675|456218143|FG000|Overall Study|Ongoing Treatment|0|||
126798873|NCT05407675|456218144|FG001|Overall Study|Ongoing Treatment|0|||
126798874|NCT05407675|456218145|FG002|Overall Study|Ongoing Treatment|0|||
126798875|NCT05407675|456218146|FG003|Overall Study|Ongoing Treatment|0|||
126798876|NCT05407675|456218147|FG004|Overall Study|Ongoing Treatment|0|||
126798877|NCT05407675|456218148|FG005|Overall Study|Ongoing Treatment|0|||
126798878|NCT05407675|456218149|FG006|Overall Study|Ongoing Treatment|0|||
126798879|NCT05407675|456218150|FG007|Overall Study|Ongoing Treatment|0|||
126633455|NCT02706951|455617713|FG002|Period 2|Lost to Follow-up|0|||
126633456|NCT02706951|455617714|FG003|Period 2|Lost to Follow-up|17|||
126633457|NCT02706951|455617715|FG004|Period 2|Lost to Follow-up|9|||
126633458|NCT02706951|455617711|FG000|Period 2|COVID-19 Related|0|||
126633459|NCT02706951|455617712|FG001|Period 2|COVID-19 Related|0|||
126633460|NCT02706951|455617713|FG002|Period 2|COVID-19 Related|0|||
126633461|NCT02706951|455617714|FG003|Period 2|COVID-19 Related|1|||
126633462|NCT02706951|455617715|FG004|Period 2|COVID-19 Related|2|||
126633463|NCT02706951|455617711|FG000|Period 2|Other|0|||
126633464|NCT02706951|455617712|FG001|Period 2|Other|0|||
126633465|NCT02706951|455617713|FG002|Period 2|Other|0|||
126633466|NCT02706951|455617714|FG003|Period 2|Other|37|||
126633467|NCT02706951|455617715|FG004|Period 2|Other|31|||
126633468|NCT01777334|455617716|FG000|Overall Study|Adverse Event|18|||
126633469|NCT01777334|455617717|FG001|Overall Study|Adverse Event|14|||
126633470|NCT01777334|455617716|FG000|Overall Study|Lack of Efficacy|15|||
126633471|NCT01777334|455617717|FG001|Overall Study|Lack of Efficacy|29|||
126633472|NCT01777334|455617716|FG000|Overall Study|Protocol Violation|3|||
126633473|NCT01777334|455617717|FG001|Overall Study|Protocol Violation|7|||
126633474|NCT01777334|455617716|FG000|Overall Study|Lost to Follow-up|3|||
126633475|NCT01777334|455617717|FG001|Overall Study|Lost to Follow-up|2|||
126798880|NCT05407675|456218151|FG008|Overall Study|Ongoing Treatment|1|||
126798881|NCT05407675|456218152|FG009|Overall Study|Ongoing Treatment|0|||
126798882|NCT05407675|456218153|FG010|Overall Study|Ongoing Treatment|0|||
126798883|NCT05407675|456218154|FG011|Overall Study|Ongoing Treatment|0|||
126798884|NCT05407675|456218155|FG012|Overall Study|Ongoing Treatment|0|||
126633476|NCT01777334|455617716|FG000|Overall Study|Withdrawal by Subject|14|||
126633477|NCT01777334|455617717|FG001|Overall Study|Withdrawal by Subject|11|||
126633478|NCT04294667|455617718|FG000|Overall Study|Lack of Efficacy|4|||
126633479|NCT04294667|455617719|FG001|Overall Study|Lack of Efficacy|4|||
126633480|NCT04294667|455617718|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
126633481|NCT04294667|455617719|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
126633482|NCT04294667|455617718|FG000|Overall Study|Patient has a Renal Flare|1|||
126633483|NCT04294667|455617719|FG001|Overall Study|Patient has a Renal Flare|0|||
126798885|NCT04191499|456218156|FG000|Overall Study|Adverse Event|1|||
126798886|NCT04191499|456218157|FG001|Overall Study|Adverse Event|0|||
126798887|NCT04191499|456218156|FG000|Overall Study|Death|42|||
126798888|NCT04191499|456218157|FG001|Overall Study|Death|55|||
126798889|NCT04191499|456218156|FG000|Overall Study|Lost to Follow-up|4|||
126798890|NCT04191499|456218157|FG001|Overall Study|Lost to Follow-up|1|||
126633484|NCT04294667|455617718|FG000|Overall Study|SLE Worsening|0|||
126633485|NCT04294667|455617719|FG001|Overall Study|SLE Worsening|1|||
126633486|NCT04294667|455617718|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
126633487|NCT04294667|455617719|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
126633488|NCT04294667|455617718|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
126798891|NCT04191499|456218156|FG000|Overall Study|Physician Decision|1|||
126798892|NCT04191499|456218157|FG001|Overall Study|Physician Decision|0|||
126798893|NCT04191499|456218156|FG000|Overall Study|Progressive Disease|1|||
126798894|NCT04191499|456218157|FG001|Overall Study|Progressive Disease|0|||
126798895|NCT04191499|456218156|FG000|Overall Study|Symptomatic Deterioration|1|||
126798896|NCT04191499|456218157|FG001|Overall Study|Symptomatic Deterioration|0|||
126798897|NCT04191499|456218156|FG000|Overall Study|Withdrawal by Subject|7|||
126798898|NCT04191499|456218157|FG001|Overall Study|Withdrawal by Subject|11|||
126798899|NCT04191499|456218156|FG000|Overall Study|Ongoing in the study|104|||
126798900|NCT04191499|456218157|FG001|Overall Study|Ongoing in the study|97|||
126798901|NCT01496313|456218158|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
126798902|NCT01496313|456218159|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
126798903|NCT01496313|456218160|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
126798904|NCT01496313|456218161|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
126798905|NCT01496313|456218162|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
126798906|NCT01496313|456218163|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
126798907|NCT01496313|456218158|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
126798908|NCT01496313|456218159|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
126798909|NCT01496313|456218160|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
126798910|NCT01496313|456218161|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
126633489|NCT04294667|455617719|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
126798911|NCT01496313|456218162|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
126798912|NCT01496313|456218163|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
126798913|NCT01496313|456218158|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
126798914|NCT01496313|456218159|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
126798915|NCT01496313|456218160|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
126798916|NCT01496313|456218161|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
126798917|NCT01496313|456218162|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
126798918|NCT01496313|456218163|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
126798919|NCT01496313|456218158|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
126798920|NCT01496313|456218159|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
126798921|NCT01496313|456218160|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
126798922|NCT01496313|456218161|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
126798923|NCT01496313|456218162|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
126798924|NCT01496313|456218163|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
126798925|NCT01496313|456218158|FG000|Randomized Period (up to 14 Months)|Other|1|||
126798926|NCT01496313|456218159|FG001|Randomized Period (up to 14 Months)|Other|2|||
126798927|NCT01496313|456218160|FG002|Randomized Period (up to 14 Months)|Other|0|||
126798928|NCT01496313|456218161|FG003|Randomized Period (up to 14 Months)|Other|0|||
126798929|NCT01496313|456218162|FG004|Randomized Period (up to 14 Months)|Other|0|||
126798930|NCT01496313|456218163|FG005|Randomized Period (up to 14 Months)|Other|0|||
126798931|NCT01496313|456218158|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
126798932|NCT01496313|456218159|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
126798933|NCT01496313|456218160|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
126798934|NCT01496313|456218161|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
126798935|NCT01496313|456218162|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
126798936|NCT01496313|456218163|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
126798937|NCT01496313|456218158|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
126798938|NCT01496313|456218159|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
126798939|NCT01496313|456218160|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
126798940|NCT01496313|456218161|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
126633490|NCT04294667|455617718|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
126633491|NCT04294667|455617719|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
126633492|NCT04294667|455617718|FG000|Overall Study|Subject Moved to Another State|0|||
126633493|NCT04294667|455617719|FG001|Overall Study|Subject Moved to Another State|1|||
126633494|NCT04294667|455617718|FG000|Overall Study|Adverse event, serious fatal|0|||
126798941|NCT01496313|456218162|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
126798942|NCT01496313|456218163|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
126798943|NCT01496313|456218158|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
126798944|NCT01496313|456218159|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
126798945|NCT01496313|456218160|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
126798946|NCT01496313|456218161|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
126798947|NCT01496313|456218162|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
126798948|NCT01496313|456218163|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
126798949|NCT02469155|456218164|FG000|Overall Study|Adverse Event|6|||
126798950|NCT02469155|456218165|FG001|Overall Study|Adverse Event|0|||
126798951|NCT02469155|456218166|FG002|Overall Study|Adverse Event|1|||
126798952|NCT02469155|456218167|FG003|Overall Study|Adverse Event|10|||
126798953|NCT02469155|456218164|FG000|Overall Study|Lack of Efficacy|13|||
126798954|NCT02469155|456218165|FG001|Overall Study|Lack of Efficacy|10|||
126798955|NCT02469155|456218166|FG002|Overall Study|Lack of Efficacy|10|||
126798956|NCT02469155|456218167|FG003|Overall Study|Lack of Efficacy|8|||
126798957|NCT02469155|456218164|FG000|Overall Study|Death|0|||
126798958|NCT02469155|456218165|FG001|Overall Study|Death|0|||
126798959|NCT02469155|456218166|FG002|Overall Study|Death|0|||
126798960|NCT02469155|456218167|FG003|Overall Study|Death|1|||
126798961|NCT02469155|456218164|FG000|Overall Study|Lost to Follow-up|5|||
126798962|NCT02469155|456218165|FG001|Overall Study|Lost to Follow-up|2|||
126798963|NCT02469155|456218166|FG002|Overall Study|Lost to Follow-up|7|||
126798964|NCT02469155|456218167|FG003|Overall Study|Lost to Follow-up|2|||
126798965|NCT02469155|456218164|FG000|Overall Study|Physician Decision|0|||
126798966|NCT02469155|456218165|FG001|Overall Study|Physician Decision|0|||
126798967|NCT02469155|456218166|FG002|Overall Study|Physician Decision|1|||
126798968|NCT02469155|456218167|FG003|Overall Study|Physician Decision|0|||
126798969|NCT02469155|456218164|FG000|Overall Study|Withdrawal by Subject|34|||
126633495|NCT04294667|455617719|FG001|Overall Study|Adverse event, serious fatal|1|||
126633496|NCT04294667|455617718|FG000|Overall Study|Adverse event, non-fatal|3|||
126633497|NCT04294667|455617719|FG001|Overall Study|Adverse event, non-fatal|4|||
126633498|NCT04799418|455617720|FG000|Overall Study|Death|1|||
126633499|NCT04799418|455617721|FG001|Overall Study|Death|1|||
126633500|NCT04799418|455617720|FG000|Overall Study|Lack of Efficacy|14|||
126633501|NCT04799418|455617721|FG001|Overall Study|Lack of Efficacy|14|||
126633502|NCT04799418|455617720|FG000|Overall Study|Withdrawal by Subject|10|||
126633503|NCT04799418|455617721|FG001|Overall Study|Withdrawal by Subject|7|||
126798970|NCT02469155|456218165|FG001|Overall Study|Withdrawal by Subject|30|||
126798971|NCT02469155|456218166|FG002|Overall Study|Withdrawal by Subject|20|||
126798972|NCT02469155|456218167|FG003|Overall Study|Withdrawal by Subject|37|||
126798973|NCT02469155|456218164|FG000|Overall Study|Other|3|||
126798974|NCT02469155|456218165|FG001|Overall Study|Other|3|||
126798975|NCT02469155|456218166|FG002|Overall Study|Other|2|||
126798976|NCT02469155|456218167|FG003|Overall Study|Other|10|||
126798977|NCT02469155|456218164|FG000|Overall Study|Protocol Violation|0|||
126798978|NCT02469155|456218165|FG001|Overall Study|Protocol Violation|1|||
126798979|NCT02469155|456218166|FG002|Overall Study|Protocol Violation|0|||
126633504|NCT04799418|455617720|FG000|Overall Study|Adverse Event|3|||
126633505|NCT04799418|455617721|FG001|Overall Study|Adverse Event|2|||
126633506|NCT02599688|455617722|FG000|Overall Study|Lack of Efficacy|1|||
126633507|NCT02599688|455617722|FG000|Overall Study|Withdrawal by Subject|1|||
126633508|NCT02599688|455617722|FG000|Overall Study|Termination by Sponsor|2|||
126633509|NCT01841697|455617723|FG000|Overall Study|Death|0|||
126633510|NCT01841697|455617724|FG001|Overall Study|Death|1|||
126633511|NCT01841697|455617723|FG000|Overall Study|Lost to Follow-up|4|||
126633512|NCT01841697|455617724|FG001|Overall Study|Lost to Follow-up|1|||
126633513|NCT01841697|455617723|FG000|Overall Study|Withdrawal by Subject|16|||
126633514|NCT01841697|455617724|FG001|Overall Study|Withdrawal by Subject|16|||
126633515|NCT00756457|455617725|FG000|Overall Study|Lost to Follow-up|1|||
126633516|NCT00756457|455617726|FG001|Overall Study|Lost to Follow-up|2|||
126798980|NCT02469155|456218167|FG003|Overall Study|Protocol Violation|1|||
126798981|NCT02062827|456218168|FG000|Overall Study|Death|1|||
126798982|NCT02062827|456218169|FG001|Overall Study|Death|0|||
126798983|NCT02062827|456218170|FG002|Overall Study|Death|0|||
126798984|NCT02062827|456218171|FG003|Overall Study|Death|0|||
126798985|NCT02062827|456218172|FG004|Overall Study|Death|0|||
126798986|NCT02062827|456218173|FG005|Overall Study|Death|0|||
126633517|NCT00632021|455617737|FG000|Overall Study|Withdrawal/death|4|||
126633518|NCT00632021|455617738|FG001|Overall Study|Withdrawal/death|7|||
126633519|NCT00952848|455617741|FG000|Overall Study|Withdrawal by Subject|4|||
126633520|NCT00458393|455617742|FG000|Overall Study|Withdrawal by Subject|67|||
126633521|NCT00458393|455617743|FG001|Overall Study|Withdrawal by Subject|80|||
126798987|NCT02062827|456218174|FG006|Overall Study|Death|0|||
126798988|NCT02062827|456218175|FG007|Overall Study|Death|0|||
126798989|NCT02062827|456218168|FG000|Overall Study|Withdrawal by Subject|3|||
126798990|NCT02062827|456218169|FG001|Overall Study|Withdrawal by Subject|1|||
126798991|NCT02062827|456218170|FG002|Overall Study|Withdrawal by Subject|1|||
126633522|NCT00458393|455617742|FG000|Overall Study|Physician Decision|31|||
126798992|NCT02062827|456218171|FG003|Overall Study|Withdrawal by Subject|2|||
126798993|NCT02062827|456218172|FG004|Overall Study|Withdrawal by Subject|6|||
126798994|NCT02062827|456218173|FG005|Overall Study|Withdrawal by Subject|0|||
126798995|NCT02062827|456218174|FG006|Overall Study|Withdrawal by Subject|5|||
126798996|NCT02062827|456218175|FG007|Overall Study|Withdrawal by Subject|0|||
126798997|NCT02062827|456218168|FG000|Overall Study|Screen Fail|0|||
126798998|NCT02062827|456218169|FG001|Overall Study|Screen Fail|0|||
126798999|NCT02062827|456218170|FG002|Overall Study|Screen Fail|0|||
126799000|NCT02062827|456218171|FG003|Overall Study|Screen Fail|0|||
126799001|NCT02062827|456218172|FG004|Overall Study|Screen Fail|0|||
126799002|NCT02062827|456218173|FG005|Overall Study|Screen Fail|0|||
126799003|NCT02062827|456218174|FG006|Overall Study|Screen Fail|0|||
126799004|NCT02062827|456218175|FG007|Overall Study|Screen Fail|8|||
126799005|NCT00288353|456218176|FG000|Overall Study|Lack of Efficacy|2|||
126799006|NCT00288353|456218177|FG001|Overall Study|Lack of Efficacy|2|||
126799007|NCT00288353|456218176|FG000|Overall Study|Withdrawal by Subject|5|||
126799008|NCT00288353|456218177|FG001|Overall Study|Withdrawal by Subject|5|||
126799009|NCT04604275|456218178|FG000|Washout-1 Week|Withdrawal by Subject|1|||
126799010|NCT04604275|456218179|FG001|Washout-1 Week|Withdrawal by Subject|0|||
126633523|NCT00458393|455617743|FG001|Overall Study|Physician Decision|22|||
126633524|NCT00458393|455617742|FG000|Overall Study|Relocated|77|||
126633525|NCT00458393|455617743|FG001|Overall Study|Relocated|81|||
126633526|NCT00458393|455617742|FG000|Overall Study|Lost to Follow-up|115|||
126633527|NCT00458393|455617743|FG001|Overall Study|Lost to Follow-up|92|||
126633528|NCT00458393|455617742|FG000|Overall Study|Sites marked other on the form.|19|||
126633529|NCT00458393|455617743|FG001|Overall Study|Sites marked other on the form.|20|||
126633530|NCT00857233|455617746|FG000|Overall Study|Adverse Event|24|||
126633531|NCT00857233|455617746|FG000|Overall Study|Lack of Efficacy|1|||
126633532|NCT00857233|455617746|FG000|Overall Study|Non-compliance|1|||
126633533|NCT00857233|455617746|FG000|Overall Study|Withdrawal of Consent|9|||
126633534|NCT00857233|455617746|FG000|Overall Study|Lost to Follow-up|4|||
126633535|NCT00857233|455617746|FG000|Overall Study|Nursing Home Placement|14|||
126633536|NCT00857233|455617746|FG000|Overall Study|Other Reasons|2|||
126633537|NCT01587118|455617747|FG000|Overall Study|Adverse Event|3|||
126633538|NCT01587118|455617747|FG000|Overall Study|Lost to Follow-up|2|||
126633539|NCT01587118|455617747|FG000|Overall Study|Relocation|1|||
126633540|NCT01587118|455617747|FG000|Overall Study|nonresponse|1|||
126633541|NCT00263575|455617748|FG000|Titration Period|Adverse Event|14|||
126633542|NCT00263575|455617748|FG000|Titration Period|Withdrawal by Subject|10|||
126633543|NCT00263575|455617748|FG000|Titration Period|Protocol Violation|9|||
126633544|NCT00263575|455617748|FG000|Titration Period|Sponsor Decision|2|||
126633545|NCT00263575|455617748|FG000|Titration Period|Other|2|||
126633546|NCT00263575|455617748|FG000|Titration Period|Lack of Efficacy|6|||
126633547|NCT00263575|455617748|FG000|Maintence Period|Adverse Event|23|||
126633548|NCT00263575|455617748|FG000|Maintence Period|Withdrawal by Subject|8|||
126633549|NCT00263575|455617748|FG000|Maintence Period|Protocol Violation|4|||
126633550|NCT00263575|455617748|FG000|Maintence Period|Lack of Efficacy|4|||
126633551|NCT00263575|455617748|FG000|Maintence Period|Physician Decision|6|||
126633552|NCT00263575|455617748|FG000|Maintence Period|Lost to Follow-up|1|||
126633553|NCT00263575|455617748|FG000|Maintence Period|Sponsor Decision|24|||
126633554|NCT00263575|455617748|FG000|Maintence Period|Other|7|||
126633555|NCT00537329|455617749|FG000|Overall Study|Death|10|||
126633556|NCT00537329|455617749|FG000|Overall Study|Adverse Event|3|||
126633557|NCT00537329|455617749|FG000|Overall Study|Lack of Efficacy|2|||
126633558|NCT00537329|455617749|FG000|Overall Study|Lost to Follow-up|6|||
126633559|NCT00537329|455617749|FG000|Overall Study|Withdrawal by Subject|4|||
126633560|NCT00537329|455617749|FG000|Overall Study|Other|1|||
126633561|NCT01278615|455617752|FG000|Overall Study|Withdrawal by Subject|2|||
126633562|NCT02138253|455617753|FG000|Overall Study|Adverse Event|3|||
126633563|NCT02138253|455617754|FG001|Overall Study|Adverse Event|3|||
126633564|NCT02138253|455617753|FG000|Overall Study|Lost to Follow-up|2|||
126633565|NCT02138253|455617754|FG001|Overall Study|Lost to Follow-up|1|||
126633566|NCT02138253|455617753|FG000|Overall Study|Physician Decision|2|||
126633567|NCT02138253|455617754|FG001|Overall Study|Physician Decision|0|||
126633568|NCT02138253|455617753|FG000|Overall Study|Non compliance|1|||
126633569|NCT02138253|455617754|FG001|Overall Study|Non compliance|0|||
126633570|NCT02138253|455617753|FG000|Overall Study|Withdrawal by Subject|1|||
126799011|NCT04519645|456218180|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
126799012|NCT04519645|456218181|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
126633571|NCT02138253|455617754|FG001|Overall Study|Withdrawal by Subject|0|||
126633572|NCT02872012|455617755|FG000|Overall Study|Withdrawal by Subject|1|||
126633573|NCT02872012|455617756|FG001|Overall Study|Withdrawal by Subject|0|||
126633574|NCT02872012|455617757|FG002|Overall Study|Withdrawal by Subject|0|||
126633575|NCT02872012|455617758|FG003|Overall Study|Withdrawal by Subject|0|||
126799013|NCT04519645|456218182|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
126799014|NCT04519645|456218180|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
126799015|NCT04519645|456218181|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
126633576|NCT02872012|455617759|FG004|Overall Study|Withdrawal by Subject|0|||
126633577|NCT01728623|455617760|FG000|Overall Study|Disease progression|26|||
126633578|NCT01728623|455617760|FG000|Overall Study|Adverse Event|1|||
126633579|NCT01728623|455617760|FG000|Overall Study|Withdrawal by Subject|1|||
126633580|NCT02725528|455617764|FG000|Overall Study|Lost to Follow-up|1|||
126633581|NCT02725528|455617765|FG001|Overall Study|Lost to Follow-up|4|||
126799016|NCT04519645|456218182|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
126633582|NCT02725528|455617764|FG000|Overall Study|Withdrawal by Subject|0|||
126633583|NCT02725528|455617765|FG001|Overall Study|Withdrawal by Subject|1|||
126633584|NCT02569957|455617767|FG000|Overall Study|Withdrawal by Subject|0|||
126633585|NCT02569957|455617768|FG001|Overall Study|Withdrawal by Subject|1|||
126633586|NCT01781832|455617769|FG000|Overall Study|Withdrawal by Subject|1|||
126633587|NCT01209598|455617770|FG000|Overall Study|Withdrawal by Subject|1|||
126633588|NCT01209598|455617771|FG001|Overall Study|Withdrawal by Subject|0|||
126799017|NCT04519645|456218180|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
126799018|NCT04519645|456218181|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
126799019|NCT04519645|456218182|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
126799020|NCT04519645|456218180|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
126799021|NCT04519645|456218181|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
126799022|NCT04519645|456218182|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
126799023|NCT05615935|456218183|FG000|Overall Study|Lost to Follow-up|1|||
126799024|NCT05615935|456218184|FG001|Overall Study|Lost to Follow-up|1|||
126799025|NCT04985604|456218185|FG000|Overall Study|Death|4|||
126799026|NCT04985604|456218186|FG001|Overall Study|Death|6|||
126799027|NCT04985604|456218185|FG000|Overall Study|Withdrawal by Subject|0|||
126799028|NCT04985604|456218186|FG001|Overall Study|Withdrawal by Subject|1|||
126633589|NCT02719743|455617772|FG000|Overall Study|Consent withdrawal|0|||
126799029|NCT02282761|456219320|FG000|Overall Study|Death|0|||
126799030|NCT02282761|456219321|FG001|Overall Study|Death|0|||
126799031|NCT02282761|456219322|FG002|Overall Study|Death|1|||
126799032|NCT02282761|456219320|FG000|Overall Study|Adverse Event|6|||
126799033|NCT02282761|456219321|FG001|Overall Study|Adverse Event|2|||
126799034|NCT02282761|456219322|FG002|Overall Study|Adverse Event|0|||
126799035|NCT02282761|456219320|FG000|Overall Study|Lack of Efficacy|11|||
126799036|NCT02282761|456219321|FG001|Overall Study|Lack of Efficacy|6|||
126799037|NCT02282761|456219322|FG002|Overall Study|Lack of Efficacy|17|||
126799038|NCT02282761|456219320|FG000|Overall Study|Lost to Follow-up|2|||
126799039|NCT02282761|456219321|FG001|Overall Study|Lost to Follow-up|2|||
126799040|NCT02282761|456219322|FG002|Overall Study|Lost to Follow-up|1|||
126799041|NCT02282761|456219320|FG000|Overall Study|Physician Decision|0|||
126799042|NCT02282761|456219321|FG001|Overall Study|Physician Decision|0|||
126799043|NCT02282761|456219322|FG002|Overall Study|Physician Decision|2|||
126799044|NCT02282761|456219320|FG000|Overall Study|Withdrawal by Subject|8|||
126799045|NCT02282761|456219321|FG001|Overall Study|Withdrawal by Subject|10|||
126799046|NCT02282761|456219322|FG002|Overall Study|Withdrawal by Subject|16|||
126633590|NCT02719743|455617773|FG001|Overall Study|Consent withdrawal|2|||
126633591|NCT02719743|455617774|FG002|Overall Study|Consent withdrawal|0|||
126633592|NCT02719743|455617775|FG003|Overall Study|Consent withdrawal|1|||
126633593|NCT02719743|455617776|FG004|Overall Study|Consent withdrawal|0|||
126633594|NCT02719743|455617772|FG000|Overall Study|Migrated/moved from study area|0|||
126633595|NCT02719743|455617773|FG001|Overall Study|Migrated/moved from study area|0|||
126633596|NCT02719743|455617774|FG002|Overall Study|Migrated/moved from study area|0|||
126633597|NCT02719743|455617775|FG003|Overall Study|Migrated/moved from study area|0|||
126633598|NCT02719743|455617776|FG004|Overall Study|Migrated/moved from study area|2|||
126633599|NCT02719743|455617772|FG000|Overall Study|Lost to Follow-up|1|||
126633600|NCT02719743|455617773|FG001|Overall Study|Lost to Follow-up|1|||
126633601|NCT02719743|455617774|FG002|Overall Study|Lost to Follow-up|0|||
126633602|NCT02719743|455617775|FG003|Overall Study|Lost to Follow-up|0|||
126633603|NCT02719743|455617776|FG004|Overall Study|Lost to Follow-up|0|||
126633604|NCT02287233|455617777|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
126633605|NCT02287233|455617778|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
126633606|NCT02287233|455617779|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
126633607|NCT02287233|455617777|FG000|Overall Study|Adverse Event Related to Progression|0|||
126633608|NCT02287233|455617778|FG001|Overall Study|Adverse Event Related to Progression|2|||
126633609|NCT02287233|455617779|FG002|Overall Study|Adverse Event Related to Progression|8|||
126633610|NCT02287233|455617777|FG000|Overall Study|Physician Decision|1|||
126633611|NCT02287233|455617778|FG001|Overall Study|Physician Decision|2|||
126633612|NCT02287233|455617779|FG002|Overall Study|Physician Decision|4|||
126633613|NCT02287233|455617777|FG000|Overall Study|Progressive Disease with Death|0|||
126633614|NCT02287233|455617778|FG001|Overall Study|Progressive Disease with Death|0|||
126633615|NCT02287233|455617779|FG002|Overall Study|Progressive Disease with Death|10|||
126633616|NCT02287233|455617777|FG000|Overall Study|Progressive Disease Without Death|2|||
126633617|NCT02287233|455617778|FG001|Overall Study|Progressive Disease Without Death|3|||
126633618|NCT02287233|455617779|FG002|Overall Study|Progressive Disease Without Death|20|||
126633619|NCT02287233|455617777|FG000|Overall Study|Withdrawal by Subject|1|||
126633620|NCT02287233|455617778|FG001|Overall Study|Withdrawal by Subject|1|||
126799047|NCT02282761|456219320|FG000|Overall Study|Other|3|||
126799048|NCT02282761|456219321|FG001|Overall Study|Other|2|||
126799049|NCT02282761|456219322|FG002|Overall Study|Other|1|||
126799050|NCT02838420|456219323|FG000|Overall Study|Ongoing in Study|113|||
126799051|NCT02838420|456219324|FG001|Overall Study|Ongoing in Study|45|||
126799052|NCT02838420|456219323|FG000|Overall Study|Lost to Follow-up|1|||
126633621|NCT02287233|455617779|FG002|Overall Study|Withdrawal by Subject|7|||
126633622|NCT02287233|455617777|FG000|Overall Study|Other|3|||
126799053|NCT02838420|456219324|FG001|Overall Study|Lost to Follow-up|0|||
126799054|NCT02838420|456219323|FG000|Overall Study|Withdrawal by Subject|3|||
126799055|NCT02838420|456219324|FG001|Overall Study|Withdrawal by Subject|4|||
126799056|NCT02838420|456219323|FG000|Overall Study|Death|8|||
126799057|NCT02838420|456219324|FG001|Overall Study|Death|13|||
126799058|NCT04501614|456219325|FG000|Overall Study|Study Terminated by Sponsor|6|||
126799059|NCT04501614|456219326|FG001|Overall Study|Study Terminated by Sponsor|3|||
126633623|NCT02287233|455617778|FG001|Overall Study|Other|0|||
126633624|NCT02287233|455617779|FG002|Overall Study|Other|15|||
126633625|NCT02287233|455617777|FG000|Overall Study|Did Not Receive Treatment|0|||
126633626|NCT02287233|455617778|FG001|Overall Study|Did Not Receive Treatment|0|||
126799060|NCT04501614|456219325|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
126799061|NCT04501614|456219326|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
126799062|NCT03742037|456219327|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
126799063|NCT03742037|456219328|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
126799064|NCT03742037|456219329|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
126799065|NCT03742037|456219330|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
126799066|NCT03742037|456219331|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
126799067|NCT03742037|456219332|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
126799068|NCT03742037|456219333|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
126799069|NCT03742037|456219327|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
126799070|NCT03742037|456219328|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
126799071|NCT03742037|456219329|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
126799072|NCT03742037|456219330|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
126799073|NCT03742037|456219331|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
126799074|NCT03742037|456219332|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
126799075|NCT03742037|456219333|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
126799076|NCT03742037|456219327|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
126799077|NCT03742037|456219328|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
126799078|NCT03742037|456219329|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
126799079|NCT03742037|456219330|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
126799080|NCT03742037|456219331|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
126799081|NCT03742037|456219332|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
126799082|NCT03742037|456219333|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
126799083|NCT03742037|456219327|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
126799084|NCT03742037|456219328|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
126799085|NCT03742037|456219329|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
126799086|NCT03742037|456219330|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
126799087|NCT03742037|456219331|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
126799088|NCT03742037|456219332|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
126799089|NCT03742037|456219333|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
126799090|NCT03742037|456219327|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
126799091|NCT03742037|456219328|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
126799092|NCT03742037|456219329|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
126799093|NCT03742037|456219330|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
126799094|NCT03742037|456219331|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
126799095|NCT03742037|456219332|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
126799096|NCT03742037|456219333|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
126799097|NCT03742037|456219327|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
126799098|NCT03742037|456219328|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
126799099|NCT03742037|456219329|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
126799100|NCT03742037|456219330|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
126799101|NCT03742037|456219331|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
126799102|NCT03742037|456219332|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
126799103|NCT03742037|456219333|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
126799104|NCT03742037|456219327|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
126799105|NCT03742037|456219328|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
126799106|NCT03742037|456219329|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
126799107|NCT03742037|456219330|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
126799108|NCT03742037|456219331|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
126799109|NCT03742037|456219332|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
126633627|NCT02287233|455617779|FG002|Overall Study|Did Not Receive Treatment|2|||
126633628|NCT03432390|455617784|FG000|Apnea Period|Protocol Violation|2|||
126633629|NCT03432390|455617785|FG001|Apnea Period|Protocol Violation|2|||
126799110|NCT03742037|456219333|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
126799111|NCT03742037|456219327|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
126799112|NCT03742037|456219328|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
126799113|NCT03742037|456219329|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
126799114|NCT03742037|456219330|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
126799115|NCT03742037|456219331|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
126799116|NCT03742037|456219332|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
126799117|NCT03742037|456219333|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
126799118|NCT03742037|456219327|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
126799119|NCT03742037|456219328|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
126799120|NCT03742037|456219329|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
126799121|NCT03742037|456219330|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
126799122|NCT03742037|456219331|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
126799123|NCT03742037|456219332|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
126799124|NCT03742037|456219333|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
126799125|NCT03742037|456219327|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
126799126|NCT03742037|456219328|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
126799127|NCT03742037|456219329|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
126799128|NCT03742037|456219330|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
126799129|NCT03742037|456219331|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
126799130|NCT03742037|456219332|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
126799131|NCT03742037|456219333|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
126799132|NCT03742037|456219327|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
126799133|NCT03742037|456219328|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
126799134|NCT03742037|456219329|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
126799135|NCT03742037|456219330|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
126799136|NCT03742037|456219331|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
126799137|NCT03742037|456219332|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
126799138|NCT03742037|456219333|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
126799139|NCT03742037|456219327|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
126799140|NCT03742037|456219328|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
126799141|NCT03742037|456219329|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
126799142|NCT03742037|456219330|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
126799143|NCT03742037|456219331|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
126799144|NCT03742037|456219332|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
126799145|NCT03742037|456219333|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
126799146|NCT03742037|456219327|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
126799147|NCT03742037|456219328|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
126799148|NCT03742037|456219329|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
126799149|NCT03742037|456219330|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
126799150|NCT03742037|456219331|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
126799151|NCT03742037|456219332|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
126799152|NCT03742037|456219333|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
126799153|NCT03742037|456219327|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
126799154|NCT03742037|456219328|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
126799155|NCT03742037|456219329|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
126799156|NCT03742037|456219330|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
126799157|NCT03742037|456219331|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
126799158|NCT03742037|456219332|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
126799159|NCT03742037|456219333|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
126799160|NCT03742037|456219327|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
126799161|NCT03742037|456219328|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
126799162|NCT03742037|456219329|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
126799163|NCT03742037|456219330|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
126799164|NCT03742037|456219331|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
126799165|NCT03742037|456219332|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
126799166|NCT03742037|456219333|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
126799167|NCT04447755|456219334|FG000|Overall Study|Death|9|||
126799168|NCT04447755|456219335|FG001|Overall Study|Death|16|||
126799169|NCT04447755|456219336|FG002|Overall Study|Death|8|||
126799170|NCT04447755|456219337|FG003|Overall Study|Death|9|||
126799171|NCT04447755|456219338|FG004|Overall Study|Death|8|||
126799172|NCT04447755|456219339|FG005|Overall Study|Death|9|||
126799173|NCT04447755|456219340|FG006|Overall Study|Death|55|||
126799174|NCT04447755|456219334|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
126799175|NCT04447755|456219335|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
126799176|NCT04447755|456219336|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
126799177|NCT04447755|456219337|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
126799178|NCT04447755|456219338|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
126799179|NCT04447755|456219339|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
126799180|NCT04447755|456219340|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
126799181|NCT04447755|456219334|FG000|Overall Study|Sponsor Decision|0|||
126799182|NCT04447755|456219335|FG001|Overall Study|Sponsor Decision|0|||
126799183|NCT04447755|456219336|FG002|Overall Study|Sponsor Decision|0|||
126799184|NCT04447755|456219337|FG003|Overall Study|Sponsor Decision|0|||
126799185|NCT04447755|456219338|FG004|Overall Study|Sponsor Decision|1|||
126799186|NCT04447755|456219339|FG005|Overall Study|Sponsor Decision|0|||
126799187|NCT04447755|456219340|FG006|Overall Study|Sponsor Decision|10|||
126799188|NCT04447755|456219334|FG000|Overall Study|Lost to Follow-up|0|||
126799189|NCT04447755|456219335|FG001|Overall Study|Lost to Follow-up|0|||
126799190|NCT04447755|456219336|FG002|Overall Study|Lost to Follow-up|0|||
126799191|NCT04447755|456219337|FG003|Overall Study|Lost to Follow-up|0|||
126799192|NCT04447755|456219338|FG004|Overall Study|Lost to Follow-up|0|||
126799193|NCT04447755|456219339|FG005|Overall Study|Lost to Follow-up|0|||
126799194|NCT04447755|456219340|FG006|Overall Study|Lost to Follow-up|1|||
126799195|NCT05263492|456219341|FG000|Overall Study|Adverse Event|1|||
126799196|NCT05263492|456219341|FG000|Overall Study|Disease progression during active treatment|3|||
126799197|NCT05446870|456219346|FG000|Overall Study|Death|6|||
126799198|NCT05446870|456219347|FG001|Overall Study|Death|5|||
126799199|NCT05446870|456219346|FG000|Overall Study|Lost to Follow-up|0|||
126799200|NCT05446870|456219347|FG001|Overall Study|Lost to Follow-up|1|||
126799201|NCT05446870|456219346|FG000|Overall Study|Physician Decision|52|||
126799202|NCT05446870|456219347|FG001|Overall Study|Physician Decision|53|||
126799203|NCT05446870|456219346|FG000|Overall Study|Withdrawal by Subject|3|||
126799204|NCT05446870|456219347|FG001|Overall Study|Withdrawal by Subject|3|||
126799205|NCT03345420|456219348|FG000|Overall Study|Withdrawal by Subject|1|||
126799206|NCT05216835|456219350|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
126799207|NCT05216835|456219351|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
126799208|NCT05216835|456219352|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
126799209|NCT05216835|456219353|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
126799210|NCT05216835|456219354|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
126799211|NCT05216835|456219355|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
126799212|NCT05216835|456219356|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
126799213|NCT05216835|456219357|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
126799214|NCT05216835|456219350|FG000|Overall Study|Death|0|||
126799215|NCT05216835|456219351|FG001|Overall Study|Death|0|||
126799216|NCT05216835|456219352|FG002|Overall Study|Death|0|||
126799217|NCT05216835|456219353|FG003|Overall Study|Death|1|||
126799218|NCT05216835|456219354|FG004|Overall Study|Death|1|||
126799219|NCT05216835|456219355|FG005|Overall Study|Death|1|||
126799220|NCT05216835|456219356|FG006|Overall Study|Death|1|||
126799221|NCT05216835|456219357|FG007|Overall Study|Death|1|||
126799222|NCT05216835|456219350|FG000|Overall Study|Physician Decision|0|||
126799223|NCT05216835|456219351|FG001|Overall Study|Physician Decision|0|||
126799224|NCT05216835|456219352|FG002|Overall Study|Physician Decision|0|||
126799225|NCT05216835|456219353|FG003|Overall Study|Physician Decision|0|||
126799226|NCT05216835|456219354|FG004|Overall Study|Physician Decision|0|||
126799227|NCT05216835|456219355|FG005|Overall Study|Physician Decision|1|||
126799228|NCT05216835|456219356|FG006|Overall Study|Physician Decision|1|||
126799229|NCT05216835|456219357|FG007|Overall Study|Physician Decision|0|||
126799230|NCT05216835|456219350|FG000|Overall Study|Study terminated by Sponsor|0|||
126799231|NCT05216835|456219351|FG001|Overall Study|Study terminated by Sponsor|0|||
126799232|NCT05216835|456219352|FG002|Overall Study|Study terminated by Sponsor|0|||
126799233|NCT05216835|456219353|FG003|Overall Study|Study terminated by Sponsor|0|||
126799234|NCT05216835|456219354|FG004|Overall Study|Study terminated by Sponsor|0|||
126799235|NCT05216835|456219355|FG005|Overall Study|Study terminated by Sponsor|0|||
126799236|NCT05216835|456219356|FG006|Overall Study|Study terminated by Sponsor|0|||
126799237|NCT05216835|456219357|FG007|Overall Study|Study terminated by Sponsor|1|||
126799238|NCT05216835|456219350|FG000|Overall Study|Withdrawal by Subject|1|||
126799239|NCT05216835|456219351|FG001|Overall Study|Withdrawal by Subject|0|||
126799240|NCT05216835|456219352|FG002|Overall Study|Withdrawal by Subject|1|||
126799241|NCT05216835|456219353|FG003|Overall Study|Withdrawal by Subject|0|||
126799242|NCT05216835|456219354|FG004|Overall Study|Withdrawal by Subject|1|||
126799243|NCT05216835|456219355|FG005|Overall Study|Withdrawal by Subject|0|||
126799244|NCT05216835|456219356|FG006|Overall Study|Withdrawal by Subject|0|||
126799245|NCT05216835|456219357|FG007|Overall Study|Withdrawal by Subject|1|||
126799246|NCT05216835|456219350|FG000|Overall Study|Other|0|||
126799247|NCT05216835|456219351|FG001|Overall Study|Other|1|||
126799248|NCT05216835|456219352|FG002|Overall Study|Other|0|||
126799249|NCT05216835|456219353|FG003|Overall Study|Other|0|||
126799250|NCT05216835|456219354|FG004|Overall Study|Other|0|||
126799251|NCT05216835|456219355|FG005|Overall Study|Other|0|||
126799252|NCT05216835|456219356|FG006|Overall Study|Other|0|||
126799253|NCT05216835|456219357|FG007|Overall Study|Other|0|||
126799254|NCT05179603|456219358|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
126799255|NCT05179603|456219358|FG000|Overall Study|Withdrawal by Subject|1|||
126799256|NCT05179603|456219358|FG000|Overall Study|Progressive disease|4|||
126799257|NCT05179603|456219358|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
126799258|NCT02689505|456219359|FG000|Overall Study|Progressive disease|2|||
126799259|NCT02689505|456219360|FG001|Overall Study|Progressive disease|2|||
126799260|NCT02689505|456219361|FG002|Overall Study|Progressive disease|3|||
126799261|NCT02689505|456219362|FG003|Overall Study|Progressive disease|9|||
126799262|NCT02689505|456219363|FG004|Overall Study|Progressive disease|1|||
126799263|NCT02689505|456219359|FG000|Overall Study|Dose Limiting Toxicity|0|||
126799264|NCT02689505|456219360|FG001|Overall Study|Dose Limiting Toxicity|1|||
126799265|NCT02689505|456219361|FG002|Overall Study|Dose Limiting Toxicity|0|||
126799266|NCT02689505|456219362|FG003|Overall Study|Dose Limiting Toxicity|0|||
126799267|NCT02689505|456219363|FG004|Overall Study|Dose Limiting Toxicity|2|||
126799268|NCT02689505|456219359|FG000|Overall Study|Other AE or clinical progression|0|||
126799269|NCT02689505|456219360|FG001|Overall Study|Other AE or clinical progression|2|||
126799270|NCT02689505|456219361|FG002|Overall Study|Other AE or clinical progression|0|||
126799271|NCT02689505|456219362|FG003|Overall Study|Other AE or clinical progression|2|||
126799272|NCT02689505|456219363|FG004|Overall Study|Other AE or clinical progression|0|||
126799273|NCT02446600|456219369|FG000|Overall Study|Never treated|20|||
126799274|NCT02446600|456219370|FG001|Overall Study|Never treated|2|||
126799275|NCT02446600|456219371|FG002|Overall Study|Never treated|6|||
126799276|NCT02446600|456219372|FG003|Overall Study|Never treated|0|||
126799277|NCT02446600|456219369|FG000|Overall Study|Withdrawal by Subject|19|||
126799278|NCT02446600|456219370|FG001|Overall Study|Withdrawal by Subject|5|||
126799279|NCT02446600|456219371|FG002|Overall Study|Withdrawal by Subject|17|||
126799280|NCT02446600|456219372|FG003|Overall Study|Withdrawal by Subject|0|||
126799281|NCT02446600|456219369|FG000|Overall Study|Ineligible|1|||
126799282|NCT02446600|456219370|FG001|Overall Study|Ineligible|4|||
126799283|NCT02446600|456219371|FG002|Overall Study|Ineligible|4|||
126799284|NCT02446600|456219372|FG003|Overall Study|Ineligible|1|||
126799285|NCT02446600|456219369|FG000|Overall Study|Duplicate Enrollment|0|||
126799286|NCT02446600|456219370|FG001|Overall Study|Duplicate Enrollment|1|||
126799287|NCT02446600|456219371|FG002|Overall Study|Duplicate Enrollment|0|||
126799288|NCT02446600|456219372|FG003|Overall Study|Duplicate Enrollment|0|||
126799289|NCT04551053|456219373|FG000|Overall Study|Death|10|||
126799290|NCT04551053|456219374|FG001|Overall Study|Death|9|||
126799291|NCT04551053|456219373|FG000|Overall Study|Lost to Follow-up|0|||
126799292|NCT04551053|456219374|FG001|Overall Study|Lost to Follow-up|2|||
126799293|NCT04551053|456219373|FG000|Overall Study|Study Terminated by Sponsor|57|||
126799294|NCT04551053|456219374|FG001|Overall Study|Study Terminated by Sponsor|65|||
126799295|NCT04551053|456219373|FG000|Overall Study|Withdrawal by Subject|12|||
126799296|NCT04551053|456219374|FG001|Overall Study|Withdrawal by Subject|5|||
126799297|NCT04551053|456219373|FG000|Overall Study|Adverse Event|2|||
126799298|NCT04551053|456219374|FG001|Overall Study|Adverse Event|0|||
126799299|NCT04551053|456219373|FG000|Overall Study|Lack of Efficacy|2|||
126799300|NCT04551053|456219374|FG001|Overall Study|Lack of Efficacy|1|||
126799301|NCT04551053|456219373|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
126799302|NCT04551053|456219374|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
126799303|NCT04551053|456219373|FG000|Overall Study|Splenapendectomi|1|||
126799304|NCT04551053|456219374|FG001|Overall Study|Splenapendectomi|0|||
126799305|NCT04551053|456219373|FG000|Overall Study|Medical Decision|1|||
126633630|NCT00763451|455617796|FG000|Overall Study|Adverse Event|4|||
126633631|NCT00763451|455617797|FG001|Overall Study|Adverse Event|6|||
126633632|NCT00763451|455617798|FG002|Overall Study|Adverse Event|19|||
126633633|NCT00763451|455617799|FG003|Overall Study|Adverse Event|14|||
126633634|NCT00763451|455617796|FG000|Overall Study|Lack of Efficacy|1|||
126633635|NCT00763451|455617797|FG001|Overall Study|Lack of Efficacy|4|||
126633636|NCT00763451|455617798|FG002|Overall Study|Lack of Efficacy|3|||
126633637|NCT00763451|455617799|FG003|Overall Study|Lack of Efficacy|2|||
126633638|NCT00763451|455617796|FG000|Overall Study|Withdrawal by Subject|1|||
126633639|NCT00763451|455617797|FG001|Overall Study|Withdrawal by Subject|6|||
126799306|NCT04551053|456219374|FG001|Overall Study|Medical Decision|1|||
126799307|NCT04529941|456219375|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
126799308|NCT04529941|456219376|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
126799309|NCT04108858|456219377|FG000|Overall Study|Adverse Event|1|||
126799310|NCT01005745|456219378|FG000|Overall Study|No TIL growth|1|||
126799311|NCT01005745|456219378|FG000|Overall Study|Disease progressed during TIL growth|3|||
126799312|NCT01005745|456219378|FG000|Overall Study|Death prior to treatment|1|||
126799313|NCT01005745|456219378|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
126633640|NCT00763451|455617798|FG002|Overall Study|Withdrawal by Subject|9|||
126633641|NCT00763451|455617799|FG003|Overall Study|Withdrawal by Subject|7|||
126633642|NCT00763451|455617796|FG000|Overall Study|Protocol Violation|0|||
126633643|NCT00763451|455617797|FG001|Overall Study|Protocol Violation|0|||
126633644|NCT00763451|455617798|FG002|Overall Study|Protocol Violation|1|||
126633645|NCT00763451|455617799|FG003|Overall Study|Protocol Violation|0|||
126633646|NCT00763451|455617796|FG000|Overall Study|Poor Compliance to Protocol|1|||
126633647|NCT00763451|455617797|FG001|Overall Study|Poor Compliance to Protocol|1|||
126633648|NCT00763451|455617798|FG002|Overall Study|Poor Compliance to Protocol|2|||
126633649|NCT00763451|455617799|FG003|Overall Study|Poor Compliance to Protocol|2|||
126633650|NCT00763451|455617796|FG000|Overall Study|Familial and Personal Reasons|5|||
126633651|NCT00763451|455617797|FG001|Overall Study|Familial and Personal Reasons|3|||
126633652|NCT00763451|455617798|FG002|Overall Study|Familial and Personal Reasons|5|||
126633653|NCT00763451|455617799|FG003|Overall Study|Familial and Personal Reasons|4|||
126633654|NCT00763451|455617796|FG000|Overall Study|Randomized but not Treated|1|||
126633655|NCT00763451|455617797|FG001|Overall Study|Randomized but not Treated|1|||
126633656|NCT00763451|455617798|FG002|Overall Study|Randomized but not Treated|0|||
126633657|NCT00763451|455617799|FG003|Overall Study|Randomized but not Treated|0|||
126633658|NCT00763451|455617796|FG000|Overall Study|Study Site Reason|0|||
126633659|NCT00763451|455617797|FG001|Overall Study|Study Site Reason|1|||
126633660|NCT00763451|455617798|FG002|Overall Study|Study Site Reason|1|||
126633661|NCT00763451|455617799|FG003|Overall Study|Study Site Reason|1|||
126633662|NCT00725543|455617800|FG000|Overall Study|Adverse Event|10|||
126633663|NCT00725543|455617800|FG000|Overall Study|Lack of Efficacy|3|||
126633664|NCT00725543|455617800|FG000|Overall Study|Withdrawal by Subject|10|||
126633665|NCT00725543|455617800|FG000|Overall Study|Physician Decision|5|||
126633666|NCT00725543|455617800|FG000|Overall Study|Lost to Follow-up|4|||
126633667|NCT00725543|455617800|FG000|Overall Study|Non-compliance|2|||
126633668|NCT00725543|455617800|FG000|Overall Study|Other|119|||
126633669|NCT02168478|455617807|FG000|Overall Study|Withdrawal by Subject|1|||
126633670|NCT02168478|455617807|FG000|Overall Study|Did Not Consent to Participation|2|||
126633671|NCT02168478|455617807|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
126633672|NCT00087555|455617808|FG000|Overall Study|Adverse Event|3|||
126633673|NCT00087555|455617809|FG001|Overall Study|Adverse Event|6|||
126633674|NCT00087555|455617810|FG002|Overall Study|Adverse Event|14|||
126633675|NCT00087555|455617808|FG000|Overall Study|Lost to Follow-up|0|||
126633676|NCT00087555|455617809|FG001|Overall Study|Lost to Follow-up|1|||
126633677|NCT00087555|455617810|FG002|Overall Study|Lost to Follow-up|1|||
126633678|NCT00087555|455617808|FG000|Overall Study|Non - Compliance|1|||
126633679|NCT00087555|455617809|FG001|Overall Study|Non - Compliance|0|||
126633680|NCT00087555|455617810|FG002|Overall Study|Non - Compliance|0|||
126633681|NCT00087555|455617808|FG000|Overall Study|Protocol Violation|0|||
126633682|NCT00087555|455617809|FG001|Overall Study|Protocol Violation|0|||
126633683|NCT00087555|455617810|FG002|Overall Study|Protocol Violation|2|||
126633684|NCT00087555|455617808|FG000|Overall Study|Screen Failure|1|||
126633685|NCT00087555|455617809|FG001|Overall Study|Screen Failure|1|||
126633686|NCT00087555|455617810|FG002|Overall Study|Screen Failure|0|||
126633687|NCT00087555|455617808|FG000|Overall Study|Pregnancy|0|||
126633688|NCT00087555|455617809|FG001|Overall Study|Pregnancy|1|||
126633689|NCT00087555|455617810|FG002|Overall Study|Pregnancy|1|||
126633690|NCT00087555|455617808|FG000|Overall Study|Withdrawal by Subject|3|||
126633691|NCT00087555|455617809|FG001|Overall Study|Withdrawal by Subject|2|||
126633692|NCT00087555|455617810|FG002|Overall Study|Withdrawal by Subject|1|||
126633693|NCT00087555|455617808|FG000|Overall Study|Lack of Efficacy|2|||
126633694|NCT00087555|455617809|FG001|Overall Study|Lack of Efficacy|0|||
126633695|NCT00087555|455617810|FG002|Overall Study|Lack of Efficacy|1|||
126633696|NCT00087555|455617808|FG000|Overall Study|Non Compliance|0|||
126633697|NCT00087555|455617809|FG001|Overall Study|Non Compliance|0|||
126633698|NCT00087555|455617810|FG002|Overall Study|Non Compliance|1|||
126633699|NCT00087555|455617808|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
126633700|NCT00087555|455617809|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
126633701|NCT00087555|455617810|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
126633702|NCT00087555|455617808|FG000|Overall Study|Patient wanted to go back on Med|1|||
126633703|NCT00087555|455617809|FG001|Overall Study|Patient wanted to go back on Med|0|||
126633704|NCT00087555|455617810|FG002|Overall Study|Patient wanted to go back on Med|0|||
126799314|NCT05646251|456219383|FG000|Overall Study|Physician Decision|1|||
126799315|NCT05646251|456219384|FG001|Overall Study|Physician Decision|0|||
126633705|NCT02344173|455617815|FG000|Procedure|Ablation Procedure Not Performed|7|||
126633706|NCT02344173|455617815|FG000|12-month Visit|Death|8|||
126633707|NCT02344173|455617815|FG000|12-month Visit|Withdrawal by Subject|30|||
126633708|NCT02344173|455617815|FG000|12-month Visit|Lost to Follow-up|58|||
126633709|NCT03845023|455617816|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
126633710|NCT03845023|455617817|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
126633711|NCT03845023|455617818|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
126633712|NCT03845023|455617819|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
126633713|NCT03845023|455617816|FG000|Follow-Up (14 Days)|Adverse Event|0|||
126633714|NCT03845023|455617817|FG001|Follow-Up (14 Days)|Adverse Event|0|||
126633715|NCT03845023|455617818|FG002|Follow-Up (14 Days)|Adverse Event|1|||
126633716|NCT03845023|455617819|FG003|Follow-Up (14 Days)|Adverse Event|1|||
126633717|NCT03772613|455617820|FG000|Overall Study|Lost to Follow-up|0|||
126633718|NCT03772613|455617821|FG001|Overall Study|Lost to Follow-up|1|||
126633719|NCT03772613|455617822|FG002|Overall Study|Lost to Follow-up|1|||
126633720|NCT02554383|455617826|FG000|Overall Study|Ineligible|3|||
126633721|NCT02554383|455617827|FG001|Overall Study|Ineligible|2|||
126633722|NCT02554383|455617826|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
126633723|NCT02554383|455617827|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
126633724|NCT02554383|455617826|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
126633725|NCT02554383|455617827|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
126633726|NCT02554383|455617826|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
126633727|NCT02554383|455617827|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
126633728|NCT01801982|455617830|FG000|Overall Study|Lost to Follow-up|1|||
126633729|NCT02918292|455617831|FG000|Study Enrollment Prior to Transplant|Death|1|||
126633730|NCT02918292|455617831|FG000|Study Follow up After Transplant|Death|6|||
126633731|NCT01185171|455617832|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
126633732|NCT01185171|455617832|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
126633733|NCT01185171|455617832|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
126633734|NCT01185171|455617832|FG000|Maintenance|Elevated liver transaminases|3|||
126633735|NCT01185171|455617832|FG000|Maintenance|Rush|2|||
126633736|NCT01185171|455617832|FG000|Maintenance|Diarrhea|1|||
126633737|NCT01185171|455617832|FG000|Maintenance|Xerostomia|1|||
126633738|NCT01185171|455617832|FG000|Maintenance|Nausea|1|||
126633739|NCT01185171|455617832|FG000|Maintenance|Comorbid Illness|2|||
126633740|NCT01185171|455617832|FG000|Maintenance|Withdrawal by Subject|1|||
126633741|NCT01185171|455617832|FG000|Maintenance|Disease Recurrence|1|||
126633742|NCT00727506|455617833|FG000|Overall Study|Adverse Event|0|||
126633743|NCT00727506|455617834|FG001|Overall Study|Adverse Event|0|||
126633744|NCT00727506|455617835|FG002|Overall Study|Adverse Event|4|||
126633745|NCT00727506|455617836|FG003|Overall Study|Adverse Event|4|||
126633746|NCT00727506|455617837|FG004|Overall Study|Adverse Event|1|||
126633747|NCT00727506|455617838|FG005|Overall Study|Adverse Event|8|||
126633748|NCT00727506|455617833|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
126633749|NCT00727506|455617834|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126633750|NCT00727506|455617835|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
126633751|NCT00727506|455617836|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126633752|NCT00727506|455617837|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126633753|NCT00727506|455617838|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
126633754|NCT00727506|455617833|FG000|Overall Study|Progressive disease|4|||
126633755|NCT00727506|455617834|FG001|Overall Study|Progressive disease|7|||
126633756|NCT00727506|455617835|FG002|Overall Study|Progressive disease|9|||
126633757|NCT00727506|455617836|FG003|Overall Study|Progressive disease|28|||
126633758|NCT00727506|455617837|FG004|Overall Study|Progressive disease|38|||
126633759|NCT00727506|455617838|FG005|Overall Study|Progressive disease|28|||
126633760|NCT00727506|455617833|FG000|Overall Study|Refused to continue medication|0|||
126633761|NCT00727506|455617834|FG001|Overall Study|Refused to continue medication|1|||
126633762|NCT00727506|455617835|FG002|Overall Study|Refused to continue medication|2|||
126633763|NCT00727506|455617836|FG003|Overall Study|Refused to continue medication|3|||
126633764|NCT00727506|455617837|FG004|Overall Study|Refused to continue medication|1|||
126633765|NCT00727506|455617838|FG005|Overall Study|Refused to continue medication|2|||
126633766|NCT00727506|455617833|FG000|Overall Study|Other reason not described above|0|||
126633767|NCT00727506|455617834|FG001|Overall Study|Other reason not described above|0|||
126633768|NCT00727506|455617835|FG002|Overall Study|Other reason not described above|1|||
126633769|NCT00727506|455617836|FG003|Overall Study|Other reason not described above|4|||
126633770|NCT00727506|455617837|FG004|Overall Study|Other reason not described above|1|||
126633771|NCT00727506|455617838|FG005|Overall Study|Other reason not described above|1|||
126633772|NCT03561597|455617839|FG000|Overall Study|Lost to Follow-up|20|||
126633773|NCT03783689|455617843|FG000|Overall Study|Adverse Event|2|||
126633774|NCT03783689|455617844|FG001|Overall Study|Adverse Event|0|||
126633775|NCT03783689|455617843|FG000|Overall Study|Lost to Follow-up|2|||
126633776|NCT03783689|455617844|FG001|Overall Study|Lost to Follow-up|1|||
126633777|NCT03783689|455617843|FG000|Overall Study|Physician Decision|2|||
126633778|NCT03783689|455617844|FG001|Overall Study|Physician Decision|1|||
126633779|NCT03783689|455617843|FG000|Overall Study|Withdrawal by Subject|3|||
126633780|NCT03783689|455617844|FG001|Overall Study|Withdrawal by Subject|3|||
126633781|NCT03783871|455617850|FG000|Overall Study|Withdrawal by Subject|15|||
126633782|NCT03783871|455617850|FG000|Overall Study|Death|13|||
126633783|NCT03783871|455617850|FG000|Overall Study|Lost to Follow-up|2|||
126633784|NCT04594733|455617852|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
126633785|NCT04594733|455617853|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
126633786|NCT04594733|455617852|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
126633787|NCT04594733|455617853|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
126633788|NCT04594733|455617852|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
126633789|NCT04594733|455617853|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
126633790|NCT02647645|455617856|FG000|Overall Study|Lost to Follow-up|2|||
126633791|NCT02647645|455617857|FG001|Overall Study|Lost to Follow-up|1|||
126633792|NCT00356811|455617858|FG000|Overall Study|Death|35|||
126633793|NCT00356811|455617858|FG000|Overall Study|Lost to Follow-up|2|||
126633794|NCT00356811|455617858|FG000|Overall Study|Withdrawal by Subject|6|||
126633795|NCT00356811|455617858|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
126633796|NCT00356811|455617858|FG000|Overall Study|Study Is Terminating|3|||
126633797|NCT00356811|455617858|FG000|Overall Study|Site Closed during Follow-up|2|||
126633798|NCT02386839|455617859|FG000|Overall Study|Death|1|||
126633799|NCT02386839|455617860|FG001|Overall Study|Death|0|||
126633800|NCT02386839|455617859|FG000|Overall Study|Withdrawal by Subject|9|||
126633801|NCT02386839|455617860|FG001|Overall Study|Withdrawal by Subject|10|||
126633802|NCT02386839|455617859|FG000|Overall Study|Lost to Follow-up|4|||
126633803|NCT02386839|455617860|FG001|Overall Study|Lost to Follow-up|4|||
126633804|NCT02386839|455617859|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
126633805|NCT02386839|455617860|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
126633806|NCT02386839|455617859|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
126633807|NCT02386839|455617860|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
126633808|NCT02386839|455617859|FG000|Overall Study|Other (unspecified)|1|||
126633809|NCT02386839|455617860|FG001|Overall Study|Other (unspecified)|0|||
126633810|NCT02101983|455617861|FG000|Overall Study|Physician Decision|1|||
126633811|NCT02101983|455617862|FG001|Overall Study|Physician Decision|0|||
126633812|NCT00826228|455619391|FG000|Overall Study|Withdrawal by Subject|1|||
126633813|NCT00903760|455619392|FG000|Overall Study|Disease Progression/Death|8|||
126633814|NCT00903760|455619393|FG001|Overall Study|Disease Progression/Death|6|||
126633815|NCT00903760|455619392|FG000|Overall Study|Stem Cell Transplant|8|||
126633816|NCT00903760|455619393|FG001|Overall Study|Stem Cell Transplant|4|||
126633817|NCT00903760|455619392|FG000|Overall Study|Physician Decision|1|||
126633818|NCT00903760|455619393|FG001|Overall Study|Physician Decision|2|||
126633819|NCT00903760|455619392|FG000|Overall Study|Death|0|||
126633820|NCT00903760|455619393|FG001|Overall Study|Death|1|||
126633821|NCT00903760|455619392|FG000|Overall Study|Lost to Follow-up|1|||
126633822|NCT00903760|455619393|FG001|Overall Study|Lost to Follow-up|0|||
126633823|NCT00903760|455619392|FG000|Overall Study|Withdrawal by Subject|1|||
126633824|NCT00903760|455619393|FG001|Overall Study|Withdrawal by Subject|2|||
126633825|NCT00903760|455619392|FG000|Overall Study|Off treatment for long period|0|||
126633826|NCT00903760|455619393|FG001|Overall Study|Off treatment for long period|1|||
126633827|NCT01845805|455619395|FG000|Overall Study|Withdrawal by Subject|1|||
126633828|NCT01845805|455619396|FG001|Overall Study|Withdrawal by Subject|2|||
126633829|NCT01845805|455619395|FG000|Overall Study|Disease Progression|13|||
126633830|NCT01845805|455619396|FG001|Overall Study|Disease Progression|14|||
126633831|NCT01845805|455619395|FG000|Overall Study|Drug-related Toxicity|4|||
126633832|NCT01845805|455619396|FG001|Overall Study|Drug-related Toxicity|0|||
126633833|NCT04795336|455619397|FG000|Overall Study|Withdrawal by Subject|3|||
126633834|NCT04795336|455619398|FG001|Overall Study|Withdrawal by Subject|4|||
126633835|NCT04795336|455619399|FG002|Overall Study|Withdrawal by Subject|3|||
126633836|NCT04795336|455619400|FG003|Overall Study|Withdrawal by Subject|12|||
126633837|NCT04795336|455619397|FG000|Overall Study|Lost study logs|0|||
126633838|NCT04795336|455619398|FG001|Overall Study|Lost study logs|1|||
126633839|NCT04795336|455619399|FG002|Overall Study|Lost study logs|0|||
126633840|NCT04795336|455619400|FG003|Overall Study|Lost study logs|2|||
126633841|NCT04795336|455619397|FG000|Overall Study|Did not take study medication|2|||
126633842|NCT04795336|455619398|FG001|Overall Study|Did not take study medication|0|||
126633843|NCT04795336|455619399|FG002|Overall Study|Did not take study medication|0|||
126633844|NCT04795336|455619400|FG003|Overall Study|Did not take study medication|0|||
126633845|NCT02229578|455619430|FG000|Overall Study|Withdrawal by Subject|1|||
126633846|NCT02229578|455619431|FG001|Overall Study|Withdrawal by Subject|3|||
126633847|NCT02229578|455619430|FG000|Overall Study|Protocol Violation|2|||
126633848|NCT02229578|455619431|FG001|Overall Study|Protocol Violation|0|||
126633849|NCT00943787|455619432|FG000|Overall Study|Physician Decision|4|||
126633850|NCT00943787|455619432|FG000|Overall Study|Withdrawal by Subject|3|||
126633851|NCT01288209|455619434|FG000|Overall Study|Withdrawal by Subject|1|||
126633852|NCT01288209|455619435|FG001|Overall Study|Withdrawal by Subject|3|||
126633853|NCT01288209|455619434|FG000|Overall Study|Other|1|||
126633854|NCT01288209|455619435|FG001|Overall Study|Other|0|||
126633855|NCT01015677|455619436|FG000|Overall Study|Adverse Event|0|||
126633856|NCT01015677|455619437|FG001|Overall Study|Adverse Event|1|||
126633857|NCT01015677|455619438|FG002|Overall Study|Adverse Event|0|||
126633858|NCT01015677|455619436|FG000|Overall Study|Lack of Efficacy|0|||
126633859|NCT01015677|455619437|FG001|Overall Study|Lack of Efficacy|1|||
126633860|NCT01015677|455619438|FG002|Overall Study|Lack of Efficacy|0|||
126633861|NCT01015677|455619436|FG000|Overall Study|Protocol Violation|0|||
126633862|NCT01015677|455619437|FG001|Overall Study|Protocol Violation|1|||
126633863|NCT01015677|455619438|FG002|Overall Study|Protocol Violation|0|||
126633864|NCT01015677|455619436|FG000|Overall Study|Withdrawal by Subject|1|||
126633865|NCT01015677|455619437|FG001|Overall Study|Withdrawal by Subject|1|||
126633866|NCT01015677|455619438|FG002|Overall Study|Withdrawal by Subject|0|||
126633867|NCT02232399|455619439|FG000|Overall Study|Adverse Event|1|||
126633868|NCT02232399|455619440|FG001|Overall Study|Adverse Event|0|||
126633869|NCT02232399|455619439|FG000|Overall Study|Withdrawal by Subject|0|||
126633870|NCT02232399|455619440|FG001|Overall Study|Withdrawal by Subject|1|||
126633871|NCT01646385|455619443|FG000|Overall Study|Death|202|||
126633872|NCT01646385|455619444|FG001|Overall Study|Death|222|||
126633873|NCT01646385|455619443|FG000|Overall Study|Switched to alternate biologic|636|||
126633874|NCT01646385|455619444|FG001|Overall Study|Switched to alternate biologic|649|||
126633875|NCT01216072|455619445|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
126633876|NCT01216072|455619446|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
126633877|NCT01216072|455619445|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
126633878|NCT01216072|455619446|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
126633879|NCT01216072|455619445|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
126633880|NCT01216072|455619446|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
126633881|NCT01216072|455619445|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
126633882|NCT01216072|455619446|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
126633883|NCT01216072|455619445|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
126633884|NCT01216072|455619446|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
126633885|NCT01216072|455619445|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
126633886|NCT01216072|455619446|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
126633887|NCT01216072|455619445|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
126633888|NCT01216072|455619446|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
126633889|NCT01216072|455619445|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
126633890|NCT01216072|455619446|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
126633891|NCT01216072|455619445|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
126633892|NCT01216072|455619446|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
126633893|NCT01216072|455619445|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
126633894|NCT01216072|455619446|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
126633895|NCT01777490|455619450|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
126633896|NCT01777490|455619451|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
126633897|NCT01777490|455619452|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
126633898|NCT01777490|455619453|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
126633899|NCT00822770|455619454|FG000|Overall Study|Not treated|1|||
126633900|NCT00822770|455619455|FG001|Overall Study|Not treated|0|||
126633901|NCT00822770|455619454|FG000|Overall Study|Complication/Incomplete treatment|1|||
126633902|NCT00822770|455619455|FG001|Overall Study|Complication/Incomplete treatment|0|||
126633903|NCT00822770|455619454|FG000|Overall Study|Death|1|||
126633904|NCT00822770|455619455|FG001|Overall Study|Death|1|||
126633905|NCT02818998|455619456|FG000|Overall Study|Adverse Event|3|||
126633906|NCT02818998|455619457|FG001|Overall Study|Adverse Event|2|||
126633907|NCT02818998|455619458|FG002|Overall Study|Adverse Event|1|||
126633908|NCT02818998|455619456|FG000|Overall Study|Lost to Follow-up|4|||
126633909|NCT02818998|455619457|FG001|Overall Study|Lost to Follow-up|1|||
126633910|NCT02818998|455619458|FG002|Overall Study|Lost to Follow-up|2|||
126633911|NCT02818998|455619456|FG000|Overall Study|Withdrawal by sponsor|0|||
126633912|NCT02818998|455619457|FG001|Overall Study|Withdrawal by sponsor|1|||
126633913|NCT02818998|455619458|FG002|Overall Study|Withdrawal by sponsor|1|||
126633914|NCT02818998|455619456|FG000|Overall Study|Death|3|||
126633915|NCT02818998|455619457|FG001|Overall Study|Death|6|||
126633916|NCT02818998|455619458|FG002|Overall Study|Death|8|||
126633917|NCT02818998|455619456|FG000|Overall Study|Withdrawal by Subject|7|||
126633918|NCT02818998|455619457|FG001|Overall Study|Withdrawal by Subject|6|||
126633919|NCT02818998|455619458|FG002|Overall Study|Withdrawal by Subject|6|||
126633920|NCT02818998|455619456|FG000|Overall Study|Physician Decision|1|||
126633921|NCT02818998|455619457|FG001|Overall Study|Physician Decision|0|||
126633922|NCT02818998|455619458|FG002|Overall Study|Physician Decision|0|||
126633923|NCT01101061|455619459|FG000|Overall Study|Adverse Event|0|||
126633924|NCT01101061|455619460|FG001|Overall Study|Adverse Event|0|||
126633925|NCT01101061|455619461|FG002|Overall Study|Adverse Event|1|||
126633926|NCT01101061|455619462|FG003|Overall Study|Adverse Event|0|||
126633927|NCT01101061|455619463|FG004|Overall Study|Adverse Event|0|||
126633928|NCT01101061|455619464|FG005|Overall Study|Adverse Event|0|||
126633929|NCT05043883|455619465|FG000|Overall Study|Minimum required measurements could not be taken|4|||
126633930|NCT02049515|455619466|FG000|Overall Study|Adverse Event|46|||
126633931|NCT02049515|455619467|FG001|Overall Study|Adverse Event|2|||
126633932|NCT02049515|455619466|FG000|Overall Study|Protocol-specified Disease Progression|23|||
126633933|NCT02049515|455619467|FG001|Overall Study|Protocol-specified Disease Progression|2|||
126633934|NCT02049515|455619466|FG000|Overall Study|Death|6|||
126633935|NCT02049515|455619467|FG001|Overall Study|Death|0|||
126633936|NCT02049515|455619466|FG000|Overall Study|Physician Decision|5|||
126633937|NCT02049515|455619467|FG001|Overall Study|Physician Decision|1|||
126633938|NCT02049515|455619466|FG000|Overall Study|Withdrawal by Subject|3|||
126633939|NCT02049515|455619467|FG001|Overall Study|Withdrawal by Subject|0|||
126633940|NCT02049515|455619466|FG000|Overall Study|Termination of the Study by Sponsor|2|||
126633941|NCT02049515|455619467|FG001|Overall Study|Termination of the Study by Sponsor|0|||
126633942|NCT02049515|455619466|FG000|Overall Study|Protocol Violation|1|||
126633943|NCT02049515|455619467|FG001|Overall Study|Protocol Violation|1|||
126633944|NCT02049515|455619466|FG000|Overall Study|Clinical Deterioration|1|||
126633945|NCT02049515|455619467|FG001|Overall Study|Clinical Deterioration|0|||
126633946|NCT02049515|455619466|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
126633947|NCT02049515|455619467|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
126633948|NCT02049515|455619466|FG000|Overall Study|Treatment Interruption >42 Days|1|||
126633949|NCT02049515|455619467|FG001|Overall Study|Treatment Interruption >42 Days|0|||
126633950|NCT02049515|455619466|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
126633951|NCT02049515|455619467|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
126633952|NCT01426113|455619472|FG000|Overall Study|Study Discontinued|1|||
126633953|NCT01426113|455619473|FG001|Overall Study|Study Discontinued|1|||
126633954|NCT01426113|455619472|FG000|Overall Study|Adverse Event|0|||
126633955|NCT01426113|455619473|FG001|Overall Study|Adverse Event|1|||
126633956|NCT00224029|455619474|FG000|Overall Study|Lost to Follow-up|1|||
126633957|NCT00224029|455619474|FG000|Overall Study|Withdrawal by Subject|4|||
126633958|NCT00224029|455619474|FG000|Overall Study|Other|1|||
126633959|NCT01390441|455619479|FG000|Treatment Period|Protocol Violation|0|||
126633960|NCT01390441|455619480|FG001|Treatment Period|Protocol Violation|1|||
126633961|NCT01390441|455619481|FG002|Treatment Period|Protocol Violation|0|||
126633962|NCT01390441|455619482|FG003|Treatment Period|Protocol Violation|0|||
126633963|NCT01390441|455619483|FG004|Treatment Period|Protocol Violation|0|||
126633964|NCT01390441|455619479|FG000|Treatment Period|Physician Decision|0|||
126633965|NCT01390441|455619480|FG001|Treatment Period|Physician Decision|0|||
126633966|NCT01390441|455619481|FG002|Treatment Period|Physician Decision|0|||
126633967|NCT01390441|455619482|FG003|Treatment Period|Physician Decision|1|||
126633968|NCT01390441|455619483|FG004|Treatment Period|Physician Decision|0|||
126633969|NCT01390441|455619479|FG000|Treatment Period|Lack of Efficacy|0|||
126633970|NCT01390441|455619480|FG001|Treatment Period|Lack of Efficacy|0|||
126633971|NCT01390441|455619481|FG002|Treatment Period|Lack of Efficacy|0|||
126633972|NCT01390441|455619482|FG003|Treatment Period|Lack of Efficacy|0|||
126633973|NCT01390441|455619483|FG004|Treatment Period|Lack of Efficacy|1|||
126633974|NCT01390441|455619479|FG000|Treatment Period|Unknown due to early stopping of study|0|||
126633975|NCT01390441|455619480|FG001|Treatment Period|Unknown due to early stopping of study|0|||
126633976|NCT01390441|455619481|FG002|Treatment Period|Unknown due to early stopping of study|8|||
126633977|NCT01390441|455619482|FG003|Treatment Period|Unknown due to early stopping of study|11|||
126633978|NCT01390441|455619483|FG004|Treatment Period|Unknown due to early stopping of study|7|||
126633979|NCT01390441|455619479|FG000|Treatment Period|Adverse Event|0|||
126633980|NCT01390441|455619480|FG001|Treatment Period|Adverse Event|0|||
126633981|NCT01390441|455619481|FG002|Treatment Period|Adverse Event|1|||
126633982|NCT01390441|455619482|FG003|Treatment Period|Adverse Event|1|||
126633983|NCT01390441|455619483|FG004|Treatment Period|Adverse Event|2|||
126633984|NCT01390441|455619479|FG000|Treatment Period|Withdrawal by Subject|0|||
126633985|NCT01390441|455619480|FG001|Treatment Period|Withdrawal by Subject|0|||
126633986|NCT01390441|455619481|FG002|Treatment Period|Withdrawal by Subject|1|||
126633987|NCT01390441|455619482|FG003|Treatment Period|Withdrawal by Subject|0|||
126633988|NCT01390441|455619483|FG004|Treatment Period|Withdrawal by Subject|1|||
126633989|NCT01390441|455619479|FG000|Treatment Period|Lost to Follow-up|1|||
126633990|NCT01390441|455619480|FG001|Treatment Period|Lost to Follow-up|0|||
126633991|NCT01390441|455619481|FG002|Treatment Period|Lost to Follow-up|0|||
126633992|NCT01390441|455619482|FG003|Treatment Period|Lost to Follow-up|0|||
126633993|NCT01390441|455619483|FG004|Treatment Period|Lost to Follow-up|0|||
126633994|NCT01390441|455619479|FG000|Extension Period|Protocol Violation|3|||
126633995|NCT01390441|455619480|FG001|Extension Period|Protocol Violation|1|||
126633996|NCT01390441|455619481|FG002|Extension Period|Protocol Violation|0|||
126633997|NCT01390441|455619482|FG003|Extension Period|Protocol Violation|1|||
126633998|NCT01390441|455619483|FG004|Extension Period|Protocol Violation|0|||
126633999|NCT02635386|455619484|FG000|Overall Study|Pregnancy|2|||
126634000|NCT02635386|455619485|FG001|Overall Study|Pregnancy|0|||
126634001|NCT02635386|455619486|FG002|Overall Study|Pregnancy|0|||
126634002|NCT02635386|455619487|FG003|Overall Study|Pregnancy|0|||
126634003|NCT02635386|455619488|FG004|Overall Study|Pregnancy|2|||
126634004|NCT02635386|455619484|FG000|Overall Study|Withdrawal by Subject|1|||
126634005|NCT02635386|455619485|FG001|Overall Study|Withdrawal by Subject|1|||
126634006|NCT02635386|455619486|FG002|Overall Study|Withdrawal by Subject|0|||
126634007|NCT02635386|455619487|FG003|Overall Study|Withdrawal by Subject|1|||
126634008|NCT02635386|455619488|FG004|Overall Study|Withdrawal by Subject|0|||
126634009|NCT02635386|455619484|FG000|Overall Study|Physician Decision|0|||
126634010|NCT02635386|455619485|FG001|Overall Study|Physician Decision|1|||
126634011|NCT02635386|455619486|FG002|Overall Study|Physician Decision|0|||
126634012|NCT02635386|455619487|FG003|Overall Study|Physician Decision|0|||
126634013|NCT02635386|455619488|FG004|Overall Study|Physician Decision|0|||
126634014|NCT02635386|455619484|FG000|Overall Study|Moved Out of State|0|||
126634015|NCT02635386|455619485|FG001|Overall Study|Moved Out of State|1|||
126634016|NCT02635386|455619486|FG002|Overall Study|Moved Out of State|0|||
126634017|NCT02635386|455619487|FG003|Overall Study|Moved Out of State|0|||
126634018|NCT02635386|455619488|FG004|Overall Study|Moved Out of State|0|||
126634019|NCT02635386|455619484|FG000|Overall Study|Noncompliant|0|||
126799316|NCT05646251|456219385|FG002|Overall Study|Physician Decision|2|||
126799317|NCT04016415|456219386|FG000|Overall Study|Adverse Event|2|||
126799318|NCT04016415|456219387|FG001|Overall Study|Adverse Event|1|||
126799319|NCT04016415|456219386|FG000|Overall Study|Lost to Follow-up|6|||
126799320|NCT04016415|456219387|FG001|Overall Study|Lost to Follow-up|2|||
126799321|NCT04016415|456219386|FG000|Overall Study|Physician Decision|5|||
126799322|NCT04016415|456219387|FG001|Overall Study|Physician Decision|1|||
126799323|NCT04016415|456219386|FG000|Overall Study|Pregnancy|0|||
126799324|NCT04016415|456219387|FG001|Overall Study|Pregnancy|1|||
126799325|NCT04016415|456219386|FG000|Overall Study|Withdrawal by Subject|24|||
126799326|NCT04016415|456219387|FG001|Overall Study|Withdrawal by Subject|27|||
126799327|NCT04016415|456219386|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
126799328|NCT04016415|456219387|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
126799329|NCT01499563|456219389|FG000|Overall Study|Withdrawal by Subject|10|||
126799330|NCT01499563|456219390|FG001|Overall Study|Withdrawal by Subject|11|||
126799331|NCT01499563|456219391|FG002|Overall Study|Withdrawal by Subject|7|||
126799332|NCT01499563|456219392|FG003|Overall Study|Withdrawal by Subject|8|||
126799333|NCT01499563|456219389|FG000|Overall Study|Physician Decision|2|||
126799334|NCT01499563|456219390|FG001|Overall Study|Physician Decision|1|||
126799335|NCT01499563|456219391|FG002|Overall Study|Physician Decision|3|||
126799336|NCT01499563|456219392|FG003|Overall Study|Physician Decision|0|||
126799337|NCT01499563|456219389|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
126799338|NCT01499563|456219390|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
126799339|NCT01499563|456219391|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
126799340|NCT01499563|456219392|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
126799341|NCT01499563|456219389|FG000|Overall Study|Adverse Event|2|||
126799342|NCT01499563|456219390|FG001|Overall Study|Adverse Event|0|||
126799343|NCT01499563|456219391|FG002|Overall Study|Adverse Event|1|||
126799344|NCT01499563|456219392|FG003|Overall Study|Adverse Event|3|||
126799345|NCT01499563|456219389|FG000|Overall Study|Lack of Efficacy|0|||
126799346|NCT01499563|456219390|FG001|Overall Study|Lack of Efficacy|1|||
126799347|NCT01499563|456219391|FG002|Overall Study|Lack of Efficacy|6|||
126799348|NCT01499563|456219392|FG003|Overall Study|Lack of Efficacy|3|||
126799349|NCT01499563|456219389|FG000|Overall Study|Other|8|||
126799350|NCT01499563|456219390|FG001|Overall Study|Other|6|||
126799351|NCT01499563|456219391|FG002|Overall Study|Other|6|||
126799352|NCT01499563|456219392|FG003|Overall Study|Other|4|||
126799353|NCT05615870|456219393|FG000|Overall Study|Lost to Follow-up|10|||
126799354|NCT05615870|456219394|FG001|Overall Study|Lost to Follow-up|13|||
126799355|NCT05615870|456219393|FG000|Overall Study|Physician Decision|2|||
126799356|NCT05615870|456219394|FG001|Overall Study|Physician Decision|0|||
126799357|NCT05615870|456219393|FG000|Overall Study|Withdrawal by Subject|0|||
126799358|NCT05615870|456219394|FG001|Overall Study|Withdrawal by Subject|2|||
126799359|NCT05615870|456219393|FG000|Overall Study|Protocol Violation|0|||
126799360|NCT05615870|456219394|FG001|Overall Study|Protocol Violation|3|||
126799361|NCT05615870|456219393|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
126799362|NCT05615870|456219394|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
126799363|NCT05615870|456219393|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
126799364|NCT05615870|456219394|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
126799365|NCT05615870|456219393|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
126799366|NCT05615870|456219394|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
126799367|NCT03279692|456219395|FG000|Overall Study|Withdrawal by Subject|1|||
126799368|NCT04659603|456219396|FG000|Overall Study|Study terminated by sponsor|0|||
126799369|NCT04659603|456219397|FG001|Overall Study|Study terminated by sponsor|0|||
126799370|NCT04659603|456219398|FG002|Overall Study|Study terminated by sponsor|2|||
126799371|NCT04659603|456219396|FG000|Overall Study|Withdrawal by Subject|0|||
126799372|NCT04659603|456219397|FG001|Overall Study|Withdrawal by Subject|5|||
126799373|NCT04659603|456219398|FG002|Overall Study|Withdrawal by Subject|0|||
126799374|NCT04659603|456219396|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
126799375|NCT04659603|456219397|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
126799376|NCT04659603|456219398|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
126634020|NCT02635386|455619485|FG001|Overall Study|Noncompliant|2|||
126799377|NCT05198843|456219399|FG000|Overall Study|Lack of Efficacy|1|||
126799378|NCT01231906|456219402|FG000|Overall Study|Lack of Efficacy|75|||
126799379|NCT01231906|456219403|FG001|Overall Study|Lack of Efficacy|68|||
126799380|NCT01231906|456219402|FG000|Overall Study|Lost to Follow-up|1|||
126799381|NCT01231906|456219403|FG001|Overall Study|Lost to Follow-up|0|||
126799382|NCT01231906|456219402|FG000|Overall Study|Physician Decision|34|||
126799383|NCT01231906|456219403|FG001|Overall Study|Physician Decision|24|||
126799384|NCT01231906|456219402|FG000|Overall Study|Withdrawal by Subject|0|||
126799385|NCT01231906|456219403|FG001|Overall Study|Withdrawal by Subject|4|||
126799386|NCT01231906|456219402|FG000|Overall Study|Ineligible|10|||
126799387|NCT01231906|456219403|FG001|Overall Study|Ineligible|3|||
126634021|NCT02635386|455619486|FG002|Overall Study|Noncompliant|1|||
126799388|NCT01231906|456219402|FG000|Overall Study|No treatment|1|||
126799389|NCT01231906|456219403|FG001|Overall Study|No treatment|2|||
126799390|NCT02472795|456219413|FG000|Overall Study|Adverse Event|0|||
126799391|NCT02472795|456219414|FG001|Overall Study|Adverse Event|1|||
126799392|NCT02472795|456219415|FG002|Overall Study|Adverse Event|0|||
126799393|NCT02472795|456219416|FG003|Overall Study|Adverse Event|0|||
126799394|NCT02472795|456219417|FG004|Overall Study|Adverse Event|2|||
126799395|NCT02472795|456219413|FG000|Overall Study|Withdrawal by Subject|0|||
126799396|NCT02472795|456219414|FG001|Overall Study|Withdrawal by Subject|0|||
126799397|NCT02472795|456219415|FG002|Overall Study|Withdrawal by Subject|0|||
126799398|NCT02472795|456219416|FG003|Overall Study|Withdrawal by Subject|0|||
126799399|NCT02472795|456219417|FG004|Overall Study|Withdrawal by Subject|1|||
126634022|NCT02635386|455619487|FG003|Overall Study|Noncompliant|1|||
126634023|NCT02635386|455619488|FG004|Overall Study|Noncompliant|1|||
126634024|NCT02635386|455619484|FG000|Overall Study|side effects|0|||
126634025|NCT02635386|455619485|FG001|Overall Study|side effects|0|||
126634026|NCT02635386|455619486|FG002|Overall Study|side effects|1|||
126634027|NCT02635386|455619487|FG003|Overall Study|side effects|4|||
126634028|NCT02635386|455619488|FG004|Overall Study|side effects|6|||
126634029|NCT02635386|455619484|FG000|Overall Study|needed other major surgery|0|||
126634030|NCT02635386|455619485|FG001|Overall Study|needed other major surgery|1|||
126799400|NCT01754597|456219419|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
126799401|NCT01754597|456219420|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
126799402|NCT01588236|456219421|FG000|Overall Study|Adverse Event|5|||
126799403|NCT01588236|456219422|FG001|Overall Study|Adverse Event|4|||
126799404|NCT01588236|456219423|FG002|Overall Study|Adverse Event|1|||
126799405|NCT01588236|456219421|FG000|Overall Study|Lost to Follow-up|8|||
126799406|NCT01588236|456219422|FG001|Overall Study|Lost to Follow-up|13|||
126799407|NCT01588236|456219423|FG002|Overall Study|Lost to Follow-up|6|||
126799408|NCT01588236|456219421|FG000|Overall Study|Physician Decision|1|||
126799409|NCT01588236|456219422|FG001|Overall Study|Physician Decision|2|||
126799410|NCT01588236|456219423|FG002|Overall Study|Physician Decision|0|||
126799411|NCT01588236|456219421|FG000|Overall Study|Protocol Violation|0|||
126799412|NCT01588236|456219422|FG001|Overall Study|Protocol Violation|1|||
126799413|NCT01588236|456219423|FG002|Overall Study|Protocol Violation|1|||
126799414|NCT01588236|456219421|FG000|Overall Study|Withdrawal by Subject|14|||
126799415|NCT01588236|456219422|FG001|Overall Study|Withdrawal by Subject|16|||
126799416|NCT01588236|456219423|FG002|Overall Study|Withdrawal by Subject|18|||
126799417|NCT01588236|456219421|FG000|Overall Study|Exclusion Criteria met during study|2|||
126799418|NCT01588236|456219422|FG001|Overall Study|Exclusion Criteria met during study|1|||
126799419|NCT01588236|456219423|FG002|Overall Study|Exclusion Criteria met during study|0|||
126799420|NCT01588236|456219421|FG000|Overall Study|sponsor decision|1|||
126799421|NCT01588236|456219422|FG001|Overall Study|sponsor decision|6|||
126799422|NCT01588236|456219423|FG002|Overall Study|sponsor decision|2|||
126799423|NCT02819141|456219424|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
126799424|NCT02819141|456219425|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
126799425|NCT04166513|456219426|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
126799426|NCT04166513|456219427|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
126799427|NCT04166513|456219428|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
126799428|NCT04166513|456219429|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
126799429|NCT04166513|456219426|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
126799430|NCT04166513|456219427|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
126799431|NCT04166513|456219428|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
126799432|NCT04166513|456219429|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
126799433|NCT04166513|456219426|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
126799434|NCT04166513|456219427|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
126799435|NCT04166513|456219428|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
126799436|NCT04166513|456219429|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
126799437|NCT04166513|456219426|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
126799438|NCT04166513|456219427|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
126799439|NCT04166513|456219428|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
126799440|NCT04166513|456219429|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
126799441|NCT04166513|456219426|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
126634031|NCT02635386|455619486|FG002|Overall Study|needed other major surgery|0|||
126799442|NCT04166513|456219427|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
126799443|NCT04166513|456219428|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
126799444|NCT04166513|456219429|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
126799445|NCT04544410|456219431|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
126799446|NCT04544410|456219432|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
126799447|NCT04544410|456219431|FG000|Double-blind Treatment Period|Adverse Event|1|||
126799448|NCT04544410|456219432|FG001|Double-blind Treatment Period|Adverse Event|0|||
126799449|NCT04544410|456219431|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
126634032|NCT02635386|455619487|FG003|Overall Study|needed other major surgery|0|||
126634033|NCT02635386|455619488|FG004|Overall Study|needed other major surgery|0|||
126799450|NCT04544410|456219432|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
126799451|NCT04544410|456219431|FG000|Double-blind Treatment Period|Protocol Violation|1|||
126799452|NCT04544410|456219432|FG001|Double-blind Treatment Period|Protocol Violation|0|||
126799453|NCT04544410|456219431|FG000|Open-Label Treatment Period|Study Terminated|15|||
126799454|NCT04544410|456219432|FG001|Open-Label Treatment Period|Study Terminated|19|||
126799455|NCT04544410|456219431|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
126799456|NCT04544410|456219432|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
126799457|NCT04544410|456219431|FG000|Open-Label Treatment Period|Adverse Event|0|||
126799458|NCT04544410|456219432|FG001|Open-Label Treatment Period|Adverse Event|1|||
126799459|NCT04544410|456219431|FG000|Open-Label Treatment Period|Physician Decision|1|||
126799460|NCT04544410|456219432|FG001|Open-Label Treatment Period|Physician Decision|0|||
126634034|NCT02635386|455619484|FG000|Overall Study|Other medical problems not drug related|0|||
126634035|NCT02635386|455619485|FG001|Overall Study|Other medical problems not drug related|0|||
126634036|NCT02635386|455619486|FG002|Overall Study|Other medical problems not drug related|0|||
126634037|NCT02635386|455619487|FG003|Overall Study|Other medical problems not drug related|1|||
126634038|NCT02635386|455619488|FG004|Overall Study|Other medical problems not drug related|0|||
126634039|NCT00085566|455619492|FG000|Overall Study|Adverse Event|0|||
126634040|NCT00085566|455619493|FG001|Overall Study|Adverse Event|0|||
126634041|NCT00085566|455619494|FG002|Overall Study|Adverse Event|10|||
126634042|NCT00085566|455619492|FG000|Overall Study|Patient Not treated|0|||
126634043|NCT00085566|455619493|FG001|Overall Study|Patient Not treated|0|||
126634044|NCT00085566|455619494|FG002|Overall Study|Patient Not treated|3|||
126634045|NCT00085566|455619492|FG000|Overall Study|Clinical progression|0|||
126634046|NCT00085566|455619493|FG001|Overall Study|Clinical progression|0|||
126634047|NCT00085566|455619494|FG002|Overall Study|Clinical progression|1|||
126634048|NCT03174782|455619495|FG000|Overall Study|Protocol Violation|1|||
126634049|NCT03174782|455619496|FG001|Overall Study|Protocol Violation|0|||
126634050|NCT03174782|455619495|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
126634051|NCT03174782|455619496|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
126634052|NCT03178045|455619497|FG000|Overall Study|Withdrawal by Subject|5|||
126634053|NCT03178045|455619498|FG001|Overall Study|Withdrawal by Subject|7|||
126634054|NCT03178045|455619497|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
126634055|NCT03178045|455619498|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
126634056|NCT03178045|455619497|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
126634057|NCT03178045|455619498|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
126634058|NCT01163474|455619499|FG000|Overall Study|Withdrawal by Subject|1|||
126634059|NCT01163474|455619499|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
126634060|NCT01163474|455619499|FG000|Overall Study|Lost to Follow-up|3|||
126634061|NCT01078922|455619500|FG000|Overall Study|Adverse Event|1|||
126634062|NCT02706847|455619501|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
126634063|NCT02706847|455619502|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
126634064|NCT02706847|455619503|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
126634065|NCT02706847|455619504|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
126634066|NCT02706847|455619501|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
126634067|NCT02706847|455619502|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
126634068|NCT02706847|455619503|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
126634069|NCT02706847|455619504|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
126634070|NCT02706847|455619501|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
126634071|NCT02706847|455619502|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
126634072|NCT02706847|455619503|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
126799461|NCT04544410|456219431|FG000|Open-Label Treatment Period|Other|0|||
126799462|NCT04544410|456219432|FG001|Open-Label Treatment Period|Other|1|||
126799463|NCT03761173|456219650|FG000|Overall Study|Lost to Follow-up|93|||
126799464|NCT03761173|456219650|FG000|Overall Study|Withdrawal by Subject|74|||
126799465|NCT03761173|456219650|FG000|Overall Study|Death|45|||
126799466|NCT03761173|456219650|FG000|Overall Study|Withdrawal for Other Reasons|29|||
126799467|NCT03761173|456219650|FG000|Overall Study|Protocol Violation|1|||
126799468|NCT00597012|456219653|FG000|Overall Study|Death|1|||
126799469|NCT00597012|456219654|FG001|Overall Study|Death|1|||
126799470|NCT00597012|456219653|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
126799471|NCT00597012|456219654|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
126799472|NCT00597012|456219653|FG000|Overall Study|Withdrawal by Subject|7|||
126799473|NCT00597012|456219654|FG001|Overall Study|Withdrawal by Subject|4|||
126799474|NCT00597012|456219653|FG000|Overall Study|Ineligible|2|||
126799475|NCT00597012|456219654|FG001|Overall Study|Ineligible|0|||
126799476|NCT00597012|456219653|FG000|Overall Study|Lost to Follow-up|0|||
126634073|NCT02706847|455619504|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
126634074|NCT02706847|455619501|FG000|Period 1: Day 1 to Week 12|Other|4|||
126634075|NCT02706847|455619502|FG001|Period 1: Day 1 to Week 12|Other|4|||
126634076|NCT02706847|455619503|FG002|Period 1: Day 1 to Week 12|Other|2|||
126634077|NCT02706847|455619504|FG003|Period 1: Day 1 to Week 12|Other|2|||
126799477|NCT00597012|456219654|FG001|Overall Study|Lost to Follow-up|2|||
126799478|NCT03556891|456219687|FG000|Initial Pivotal Study|Adverse Event|4|||
126799479|NCT03556891|456219687|FG000|Initial Pivotal Study|MRI Need|3|||
126799480|NCT03556891|456219687|FG000|Initial Pivotal Study|Device Failure|1|||
126799481|NCT03556891|456219687|FG000|Initial Pivotal Study|Death|1|||
126799482|NCT03556891|456219687|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
126799483|NCT03556891|456219687|FG000|Initial Pivotal Study|Missing at random|1|||
126799484|NCT03556891|456219687|FG000|Initial Pivotal Study|Missing due to COVID|1|||
126799485|NCT03556891|456219687|FG000|Initial Pivotal Study|Protocol Violation|1|||
126634078|NCT02706847|455619501|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
126634079|NCT02706847|455619502|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
126634080|NCT02706847|455619503|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
126634081|NCT02706847|455619504|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
126634082|NCT02706847|455619501|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
126634083|NCT02706847|455619502|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
126634084|NCT02706847|455619503|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
126634085|NCT02706847|455619504|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
126634086|NCT02706847|455619501|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
126634087|NCT02706847|455619502|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
126755795|NCT01854918|456054829|FG000|All-IP Period (Years 2 and 3)|Death|5|||
126755796|NCT01854918|456054830|FG001|All-IP Period (Years 2 and 3)|Death|16|||
126755797|NCT02146352|456054831|FG000|Overall Study|Death|1|||
126755798|NCT02146352|456054831|FG000|Overall Study|Patient entered hospice care|1|||
126755799|NCT00939094|456054832|FG000|Overall Study|Adverse Event|9|||
126755800|NCT00939094|456054833|FG001|Overall Study|Adverse Event|0|||
126755801|NCT00939094|456054832|FG000|Overall Study|Withdrawal by Subject|1|||
126755802|NCT00939094|456054833|FG001|Overall Study|Withdrawal by Subject|6|||
126755803|NCT00939094|456054832|FG000|Overall Study|Lost to Follow-up|1|||
126755804|NCT00939094|456054833|FG001|Overall Study|Lost to Follow-up|1|||
126755805|NCT00939094|456054832|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
126755806|NCT00939094|456054833|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
126755807|NCT00939094|456054832|FG000|Overall Study|Severe non-compliance to protocol|0|||
126755808|NCT00939094|456054833|FG001|Overall Study|Severe non-compliance to protocol|1|||
126755809|NCT00939094|456054832|FG000|Overall Study|Study stopped by sponsor|0|||
126755810|NCT00939094|456054833|FG001|Overall Study|Study stopped by sponsor|2|||
126755811|NCT00939094|456054832|FG000|Overall Study|Abnormal ECG findings|1|||
126755812|NCT00939094|456054833|FG001|Overall Study|Abnormal ECG findings|0|||
126755813|NCT01906489|456054834|FG000|Overall Study|Adverse Event|10|||
126755814|NCT01906489|456054835|FG001|Overall Study|Adverse Event|3|||
126755815|NCT01906489|456054834|FG000|Overall Study|Worsening of CKD|6|||
126755816|NCT01906489|456054835|FG001|Overall Study|Worsening of CKD|4|||
126755817|NCT01906489|456054834|FG000|Overall Study|Withdrawal by Subject|5|||
126755818|NCT01906489|456054835|FG001|Overall Study|Withdrawal by Subject|0|||
126755819|NCT01906489|456054834|FG000|Overall Study|Worsening of Anemia|1|||
126755820|NCT01906489|456054835|FG001|Overall Study|Worsening of Anemia|0|||
126755821|NCT01906489|456054834|FG000|Overall Study|Protocol Violation|0|||
126755822|NCT01906489|456054835|FG001|Overall Study|Protocol Violation|1|||
126755823|NCT01906489|456054834|FG000|Overall Study|Non- Compliance|1|||
126755824|NCT01906489|456054835|FG001|Overall Study|Non- Compliance|0|||
126755825|NCT01906489|456054834|FG000|Overall Study|Sponsor Decision|1|||
126755826|NCT01906489|456054835|FG001|Overall Study|Sponsor Decision|0|||
126755827|NCT01906489|456054834|FG000|Overall Study|Lost to Follow-up|1|||
126755828|NCT01906489|456054835|FG001|Overall Study|Lost to Follow-up|1|||
126755829|NCT01906489|456054834|FG000|Overall Study|Other|1|||
126755830|NCT01906489|456054835|FG001|Overall Study|Other|0|||
126755831|NCT01078389|456057266|FG000|Overall Study|Adverse Event|10|||
126755832|NCT01078389|456057267|FG001|Overall Study|Adverse Event|6|||
126755833|NCT01078389|456057266|FG000|Overall Study|Major Protocol Deviation|2|||
126755834|NCT01078389|456057267|FG001|Overall Study|Major Protocol Deviation|0|||
126755835|NCT01078389|456057266|FG000|Overall Study|Lost to Follow-up|23|||
126755836|NCT01078389|456057267|FG001|Overall Study|Lost to Follow-up|23|||
126755837|NCT01078389|456057266|FG000|Overall Study|Voluntary Withdrawal|20|||
126755838|NCT01078389|456057267|FG001|Overall Study|Voluntary Withdrawal|36|||
126755839|NCT01078389|456057266|FG000|Overall Study|Other|9|||
126755840|NCT01078389|456057267|FG001|Overall Study|Other|2|||
126755841|NCT01002573|456057268|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
126755842|NCT01002573|456057269|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
126755843|NCT02028182|456057270|FG000|Overall Study|Protocol Violation|2|||
126755844|NCT02198040|456057271|FG000|Overall Study|Work reasons|0|||
126755845|NCT02198040|456057272|FG001|Overall Study|Work reasons|1|||
126755846|NCT02198040|456057273|FG002|Overall Study|Work reasons|0|||
126755847|NCT02198040|456057271|FG000|Overall Study|Withdrawal by Subject|0|||
126755848|NCT02198040|456057272|FG001|Overall Study|Withdrawal by Subject|0|||
126755849|NCT02198040|456057273|FG002|Overall Study|Withdrawal by Subject|1|||
126755850|NCT00240331|456057274|FG000|Overall Study|Withdrawal by Subject|125|||
126755851|NCT00240331|456057275|FG001|Overall Study|Withdrawal by Subject|132|||
126755852|NCT00240331|456057274|FG000|Overall Study|Option selected by investigator|1|||
126755853|NCT00240331|456057275|FG001|Overall Study|Option selected by investigator|2|||
126755854|NCT02551874|456057276|FG000|Overall Study|Lost to Follow-up|0|||
126755855|NCT02551874|456057277|FG001|Overall Study|Lost to Follow-up|2|||
126755856|NCT02551874|456057276|FG000|Overall Study|Pregnancy|0|||
126755857|NCT02551874|456057277|FG001|Overall Study|Pregnancy|1|||
126755858|NCT02551874|456057276|FG000|Overall Study|Reason not reported|10|||
126755859|NCT02551874|456057277|FG001|Overall Study|Reason not reported|4|||
126755860|NCT02551874|456057276|FG000|Overall Study|Did not receive randomized treatment|0|||
126755861|NCT02551874|456057277|FG001|Overall Study|Did not receive randomized treatment|7|||
126634088|NCT02706847|455619503|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
126634089|NCT02706847|455619504|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
126634090|NCT02706847|455619501|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
126634091|NCT02706847|455619502|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
126634092|NCT02706847|455619503|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
126634093|NCT02706847|455619504|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
126634094|NCT02706847|455619501|FG000|Period 1: Week 12 to Week 24|Other|1|||
126634095|NCT02706847|455619502|FG001|Period 1: Week 12 to Week 24|Other|0|||
126634096|NCT02706847|455619503|FG002|Period 1: Week 12 to Week 24|Other|1|||
126634097|NCT02706847|455619504|FG003|Period 1: Week 12 to Week 24|Other|4|||
126634098|NCT02706847|455619501|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
126634099|NCT02706847|455619502|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
126634100|NCT02706847|455619503|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
126634101|NCT02706847|455619504|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
126634102|NCT02706847|455619501|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
126634103|NCT02706847|455619502|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
126634104|NCT02706847|455619503|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
126634105|NCT02706847|455619504|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
126634106|NCT02706847|455619501|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
126634107|NCT02706847|455619502|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
126634108|NCT02706847|455619503|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
126634109|NCT02706847|455619504|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
126634110|NCT02706847|455619501|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
126634111|NCT02706847|455619502|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
126634112|NCT02706847|455619503|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
126634113|NCT02706847|455619504|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
126634114|NCT02706847|455619501|FG000|Period 2: Week 24 to Week 260|Other|8|||
126634115|NCT02706847|455619502|FG001|Period 2: Week 24 to Week 260|Other|5|||
126634116|NCT02706847|455619503|FG002|Period 2: Week 24 to Week 260|Other|15|||
126634117|NCT02706847|455619504|FG003|Period 2: Week 24 to Week 260|Other|15|||
126634118|NCT02689453|455619507|FG000|Overall Study|Progressive disease|0|||
126634119|NCT02689453|455619508|FG001|Overall Study|Progressive disease|1|||
126634120|NCT02689453|455619509|FG002|Overall Study|Progressive disease|1|||
126634121|NCT04206085|455619510|FG000|Overall Study|Lost to Follow-up|0|||
126634122|NCT04206085|455619511|FG001|Overall Study|Lost to Follow-up|1|||
126634123|NCT04206085|455619512|FG002|Overall Study|Lost to Follow-up|0|||
126634124|NCT04206085|455619510|FG000|Overall Study|Lost to Follow-up|0|||
126634125|NCT04206085|455619511|FG001|Overall Study|Lost to Follow-up|0|||
126634126|NCT04206085|455619512|FG002|Overall Study|Lost to Follow-up|1|||
126634127|NCT05594589|455619516|FG000|Overall Study|Other|0|||
126634128|NCT05594589|455619517|FG001|Overall Study|Other|1|||
126634129|NCT05594589|455619518|FG002|Overall Study|Other|0|||
126634130|NCT01427738|455619519|FG000|Overall Study|Death|12|||
126634131|NCT01427738|455619520|FG001|Overall Study|Death|9|||
126634132|NCT01427738|455619519|FG000|Overall Study|Severe debilitation, unable to continue|0|||
126634133|NCT01427738|455619520|FG001|Overall Study|Severe debilitation, unable to continue|1|||
126634134|NCT01427738|455619519|FG000|Overall Study|Subject unable to get to clinic|5|||
126634135|NCT01427738|455619520|FG001|Overall Study|Subject unable to get to clinic|2|||
126634136|NCT01427738|455619519|FG000|Overall Study|Withdrawal by Subject|0|||
126634137|NCT01427738|455619520|FG001|Overall Study|Withdrawal by Subject|2|||
126634138|NCT01427738|455619519|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
126634139|NCT01427738|455619520|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
126634140|NCT01427738|455619519|FG000|Overall Study|Lost to Follow-up|1|||
126634141|NCT01427738|455619520|FG001|Overall Study|Lost to Follow-up|5|||
126634142|NCT05314374|455619521|FG000|Overall Study|Adverse Event|2|||
126634143|NCT05314374|455619522|FG001|Overall Study|Adverse Event|2|||
126634144|NCT02658175|455619523|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
126634145|NCT02658175|455619524|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
126634146|NCT02658175|455619525|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
126634147|NCT02658175|455619523|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
126634148|NCT02658175|455619524|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
126634149|NCT02658175|455619525|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
126634150|NCT02658175|455619523|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
126634151|NCT02658175|455619524|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
126634152|NCT02658175|455619525|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
126634153|NCT02658175|455619523|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
126634154|NCT02658175|455619524|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
126634155|NCT02658175|455619525|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
126634156|NCT02658175|455619523|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
126634157|NCT02658175|455619524|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
126634158|NCT02658175|455619525|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
126634159|NCT02658175|455619523|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
126634160|NCT02658175|455619524|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
126634161|NCT02658175|455619525|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
126634162|NCT02658175|455619523|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
126634163|NCT02658175|455619524|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
126634164|NCT02658175|455619525|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
126634165|NCT02658175|455619523|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
126634166|NCT02658175|455619524|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
126634167|NCT02658175|455619525|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
126634168|NCT02658175|455619523|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
126634169|NCT02658175|455619524|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
126634170|NCT02658175|455619525|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
126634171|NCT02658175|455619523|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
126634172|NCT02658175|455619524|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
126634173|NCT02658175|455619525|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
126634174|NCT01214421|455619526|FG000|Overall Study|Lost to Follow-up|7|||
126634175|NCT01214421|455619527|FG001|Overall Study|Lost to Follow-up|3|||
126634176|NCT01214421|455619528|FG002|Overall Study|Lost to Follow-up|7|||
126634177|NCT01214421|455619529|FG003|Overall Study|Lost to Follow-up|3|||
126634178|NCT01214421|455619526|FG000|Overall Study|Adverse Event|16|||
126634179|NCT01214421|455619527|FG001|Overall Study|Adverse Event|35|||
126634180|NCT01214421|455619528|FG002|Overall Study|Adverse Event|14|||
126634181|NCT01214421|455619529|FG003|Overall Study|Adverse Event|3|||
126634182|NCT01214421|455619526|FG000|Overall Study|Sponsor Discontinued Site|1|||
126634183|NCT01214421|455619527|FG001|Overall Study|Sponsor Discontinued Site|2|||
126634184|NCT01214421|455619528|FG002|Overall Study|Sponsor Discontinued Site|0|||
126634185|NCT01214421|455619529|FG003|Overall Study|Sponsor Discontinued Site|0|||
126634186|NCT01214421|455619526|FG000|Overall Study|Withdrawal Criteria Met|3|||
126634187|NCT01214421|455619527|FG001|Overall Study|Withdrawal Criteria Met|0|||
126634188|NCT01214421|455619528|FG002|Overall Study|Withdrawal Criteria Met|2|||
126634189|NCT01214421|455619529|FG003|Overall Study|Withdrawal Criteria Met|1|||
126634190|NCT01214421|455619526|FG000|Overall Study|Physician Decision|2|||
126634191|NCT01214421|455619527|FG001|Overall Study|Physician Decision|0|||
126634192|NCT01214421|455619528|FG002|Overall Study|Physician Decision|4|||
126634193|NCT01214421|455619529|FG003|Overall Study|Physician Decision|0|||
126634194|NCT01214421|455619526|FG000|Overall Study|Withdrawal by Subject|21|||
126634195|NCT01214421|455619527|FG001|Overall Study|Withdrawal by Subject|18|||
126634196|NCT01214421|455619528|FG002|Overall Study|Withdrawal by Subject|11|||
126634197|NCT01214421|455619529|FG003|Overall Study|Withdrawal by Subject|2|||
126634198|NCT02581059|455619532|FG000|Study Treatment|Disease Progression|1|||
126634199|NCT02581059|455619533|FG001|Study Treatment|Disease Progression|1|||
126634200|NCT02581059|455619532|FG000|Study Treatment|Adverse Event|2|||
126634201|NCT02581059|455619533|FG001|Study Treatment|Adverse Event|1|||
126634202|NCT02581059|455619532|FG000|Study Treatment|Death|1|||
126634203|NCT02581059|455619533|FG001|Study Treatment|Death|1|||
126634204|NCT02581059|455619532|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
126634205|NCT02581059|455619533|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
126634206|NCT02581059|455619532|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
126634207|NCT02581059|455619533|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
126634208|NCT02581059|455619532|FG000|Follow up|Death|1|||
126634209|NCT02581059|455619533|FG001|Follow up|Death|3|||
126634210|NCT02581059|455619532|FG000|Follow up|study terminated|1|||
126634211|NCT02581059|455619533|FG001|Follow up|study terminated|1|||
126634212|NCT02581059|455619532|FG000|Follow up|screen failure|0|||
126634213|NCT02581059|455619533|FG001|Follow up|screen failure|1|||
126634214|NCT02581059|455619532|FG000|Follow up|Patient started new clinical trial|1|||
126634215|NCT02581059|455619533|FG001|Follow up|Patient started new clinical trial|0|||
126634216|NCT02392104|455619534|FG000|Overall Study|discontinuation of warfarin|3|||
126634217|NCT02392104|455619534|FG000|Overall Study|bleeding event|1|||
126634218|NCT02392104|455619534|FG000|Overall Study|transferred care to another doctor|2|||
126634219|NCT02392104|455619534|FG000|Overall Study|INR goal range changed|1|||
126634220|NCT02392104|455619534|FG000|Overall Study|admitted to skilled nursing facility|3|||
126634221|NCT02392104|455619534|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
126634222|NCT04887506|455619537|FG000|Overall Study|Death|1|||
126634223|NCT04887506|455619538|FG001|Overall Study|Death|1|||
126634224|NCT04887506|455619537|FG000|Overall Study|Withdrawal by Subject|0|||
126634225|NCT04887506|455619538|FG001|Overall Study|Withdrawal by Subject|3|||
126634226|NCT04887506|455619537|FG000|Overall Study|Adverse Event|4|||
126634227|NCT04887506|455619538|FG001|Overall Study|Adverse Event|3|||
126634228|NCT04887506|455619537|FG000|Overall Study|Other - Not Reported|1|||
126634229|NCT04887506|455619538|FG001|Overall Study|Other - Not Reported|1|||
126634230|NCT02394665|455619541|FG000|Overall Study|Physician Decision|1|||
126634231|NCT02394665|455619542|FG001|Overall Study|Physician Decision|0|||
126634232|NCT02394665|455619543|FG002|Overall Study|Physician Decision|0|||
126634233|NCT02636608|455619544|FG000|Overall Study|Failure to Return|4|||
126634234|NCT02636608|455619544|FG000|Overall Study|Insufficient Virological Response|1|||
126634235|NCT02636608|455619544|FG000|Overall Study|Death|3|||
126634236|NCT02636608|455619544|FG000|Overall Study|Other|2|||
126634237|NCT02636608|455619544|FG000|Overall Study|Did Not Receive Treatment|1|||
126634238|NCT01255761|455619545|FG000|Overall Study|Adverse Event|29|||
126634239|NCT01255761|455619546|FG001|Overall Study|Adverse Event|43|||
126634240|NCT01255761|455619545|FG000|Overall Study|Lack of Efficacy|86|||
126634241|NCT01255761|455619546|FG001|Overall Study|Lack of Efficacy|74|||
126634242|NCT01255761|455619545|FG000|Overall Study|Protocol Violation|9|||
126634243|NCT01255761|455619546|FG001|Overall Study|Protocol Violation|5|||
126634244|NCT01255761|455619545|FG000|Overall Study|Lost to Follow-up|10|||
126634245|NCT01255761|455619546|FG001|Overall Study|Lost to Follow-up|8|||
126634246|NCT01255761|455619545|FG000|Overall Study|Withdrawal by Subject|11|||
126634247|NCT01255761|455619546|FG001|Overall Study|Withdrawal by Subject|27|||
126634248|NCT01255761|455619545|FG000|Overall Study|Other Reasons|37|||
126634249|NCT01255761|455619546|FG001|Overall Study|Other Reasons|18|||
126634250|NCT05613088|455619549|FG000|Treatment|Ongoing Study Treatment|9|||
126634251|NCT05613088|455619550|FG001|Treatment|Ongoing Study Treatment|2|||
126634252|NCT05613088|455619549|FG000|Treatment|Adverse Event|3|||
126634253|NCT05613088|455619550|FG001|Treatment|Adverse Event|1|||
126634254|NCT05613088|455619549|FG000|Treatment|Other Reasons|0|||
126634255|NCT05613088|455619550|FG001|Treatment|Other Reasons|1|||
126634256|NCT05613088|455619549|FG000|Treatment|Progressive Disease|58|||
126634257|NCT05613088|455619550|FG001|Treatment|Progressive Disease|26|||
126634258|NCT05613088|455619549|FG000|Treatment|Withdrawal by Subject|0|||
126634259|NCT05613088|455619550|FG001|Treatment|Withdrawal by Subject|4|||
126634260|NCT03912532|455619551|FG000|Overall Study|Adverse Event|3|||
126634261|NCT03912532|455619552|FG001|Overall Study|Adverse Event|3|||
126634262|NCT03912532|455619553|FG002|Overall Study|Adverse Event|2|||
126634263|NCT03912532|455619554|FG003|Overall Study|Adverse Event|2|||
126634264|NCT03912532|455619551|FG000|Overall Study|Lost to Follow-up|3|||
126634265|NCT03912532|455619552|FG001|Overall Study|Lost to Follow-up|2|||
126634266|NCT03912532|455619553|FG002|Overall Study|Lost to Follow-up|1|||
126634267|NCT03912532|455619554|FG003|Overall Study|Lost to Follow-up|2|||
126634268|NCT03912532|455619551|FG000|Overall Study|Withdrawal by Subject|1|||
126634269|NCT03912532|455619552|FG001|Overall Study|Withdrawal by Subject|1|||
126634270|NCT03912532|455619553|FG002|Overall Study|Withdrawal by Subject|2|||
126634271|NCT03912532|455619554|FG003|Overall Study|Withdrawal by Subject|0|||
126634272|NCT03912532|455619551|FG000|Overall Study|Physician Decision|1|||
126634273|NCT03912532|455619552|FG001|Overall Study|Physician Decision|0|||
126634274|NCT03912532|455619553|FG002|Overall Study|Physician Decision|0|||
126634275|NCT03912532|455619554|FG003|Overall Study|Physician Decision|3|||
126634276|NCT03912532|455619551|FG000|Overall Study|Other|0|||
126634277|NCT03912532|455619552|FG001|Overall Study|Other|1|||
126634278|NCT03912532|455619553|FG002|Overall Study|Other|1|||
126634279|NCT03912532|455619554|FG003|Overall Study|Other|0|||
126634280|NCT03569891|455619555|FG000|Lead-in|Ineligible during lead-in|8|||
126634281|NCT03569891|455619555|FG000|Lead-in|Withdrawal by Subject|3|||
126634282|NCT03569891|455619555|FG000|Lead-in|Risks related to COVID-19|2|||
126634283|NCT03569891|455619555|FG000|AMT-061|Adverse Event|1|||
126634284|NCT03614676|455621291|FG000|Overall Study|Delivery before planned visit|2|||
126634285|NCT03614676|455621292|FG001|Overall Study|Delivery before planned visit|0|||
126634286|NCT03614676|455621291|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
126634287|NCT03614676|455621292|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
126634288|NCT03614676|455621291|FG000|Overall Study|Migrated / moved from the study area|30|||
126634289|NCT03614676|455621292|FG001|Overall Study|Migrated / moved from the study area|22|||
126634290|NCT03614676|455621291|FG000|Overall Study|Lost to Follow-up|17|||
126634291|NCT03614676|455621292|FG001|Overall Study|Lost to Follow-up|42|||
126634292|NCT03614676|455621291|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
126634293|NCT03614676|455621292|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
126634294|NCT03614676|455621291|FG000|Overall Study|Other|16|||
126634295|NCT03614676|455621292|FG001|Overall Study|Other|47|||
126634296|NCT03614676|455621291|FG000|Overall Study|Protocol Violation|0|||
126634297|NCT03614676|455621292|FG001|Overall Study|Protocol Violation|2|||
126634298|NCT03614676|455621291|FG000|Overall Study|Neonatal event of interest|0|||
126634299|NCT03614676|455621292|FG001|Overall Study|Neonatal event of interest|6|||
126634300|NCT03614676|455621291|FG000|Overall Study|Death in infant greater than 28 days old|0|||
126634301|NCT03614676|455621292|FG001|Overall Study|Death in infant greater than 28 days old|12|||
126634302|NCT03614676|455621291|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
126634303|NCT03614676|455621292|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
126634304|NCT02388347|455621293|FG000|Overall Study|Withdrawal by Subject|0|||
126634305|NCT02388347|455621294|FG001|Overall Study|Withdrawal by Subject|0|||
126634306|NCT02388347|455621295|FG002|Overall Study|Withdrawal by Subject|1|||
126634307|NCT02388347|455621296|FG003|Overall Study|Withdrawal by Subject|0|||
126634308|NCT02388347|455621297|FG004|Overall Study|Withdrawal by Subject|0|||
126634309|NCT02825251|455621299|FG000|Overall Study|Adverse Event|0|||
126634310|NCT02825251|455621300|FG001|Overall Study|Adverse Event|1|||
126634311|NCT02825251|455621299|FG000|Overall Study|Lost to Follow-up|0|||
126634312|NCT02825251|455621300|FG001|Overall Study|Lost to Follow-up|1|||
126634313|NCT02825251|455621299|FG000|Overall Study|Withdrawal by Subject|1|||
126634314|NCT02825251|455621300|FG001|Overall Study|Withdrawal by Subject|4|||
126634315|NCT02825251|455621299|FG000|Overall Study|Unclassified|2|||
126634316|NCT02825251|455621300|FG001|Overall Study|Unclassified|0|||
126634317|NCT00487825|455621301|FG000|Overall Study|Adverse Event|2|||
126634318|NCT00487825|455621302|FG001|Overall Study|Adverse Event|2|||
126634319|NCT00487825|455621301|FG000|Overall Study|Lack of Efficacy|1|||
126634320|NCT00487825|455621302|FG001|Overall Study|Lack of Efficacy|1|||
126634321|NCT00487825|455621301|FG000|Overall Study|Other|3|||
126634322|NCT00487825|455621302|FG001|Overall Study|Other|2|||
126634323|NCT01639742|455621305|FG000|Overall Study|Study Ongoing|17|||
126634324|NCT01639742|455621305|FG000|Overall Study|Lost to Follow-up|1|||
126634325|NCT01190644|455621307|FG000|Overall Study|Death|2|||
126634326|NCT01190644|455621307|FG000|Overall Study|Disease progression|1|||
126634327|NCT02366143|455621308|FG000|Overall Study|Death|307|||
126634328|NCT02366143|455621309|FG001|Overall Study|Death|278|||
126634329|NCT02366143|455621310|FG002|Overall Study|Death|280|||
126634330|NCT02366143|455621308|FG000|Overall Study|Lost to Follow-up|2|||
126634331|NCT02366143|455621309|FG001|Overall Study|Lost to Follow-up|4|||
126634332|NCT02366143|455621310|FG002|Overall Study|Lost to Follow-up|2|||
126634333|NCT02366143|455621308|FG000|Overall Study|Physician Decision|1|||
126634334|NCT02366143|455621309|FG001|Overall Study|Physician Decision|2|||
126634335|NCT02366143|455621310|FG002|Overall Study|Physician Decision|1|||
126634336|NCT02366143|455621308|FG000|Overall Study|Protocol Violation|0|||
126634337|NCT02366143|455621309|FG001|Overall Study|Protocol Violation|0|||
126634338|NCT02366143|455621310|FG002|Overall Study|Protocol Violation|2|||
126634339|NCT02366143|455621308|FG000|Overall Study|Withdrawal by Subject|16|||
126634340|NCT02366143|455621309|FG001|Overall Study|Withdrawal by Subject|17|||
126634341|NCT02366143|455621310|FG002|Overall Study|Withdrawal by Subject|22|||
126634342|NCT02366143|455621308|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
126634343|NCT02366143|455621309|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
126634344|NCT02366143|455621310|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
126634345|NCT02366143|455621308|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
126634346|NCT02366143|455621309|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
126634347|NCT02366143|455621310|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
126634348|NCT02366143|455621308|FG000|Overall Study|Randomization Error|1|||
126634349|NCT02366143|455621309|FG001|Overall Study|Randomization Error|0|||
126634350|NCT02366143|455621310|FG002|Overall Study|Randomization Error|0|||
126634351|NCT02366143|455621308|FG000|Overall Study|PI Move and Site Closure|1|||
126634352|NCT02366143|455621309|FG001|Overall Study|PI Move and Site Closure|0|||
126634353|NCT02366143|455621310|FG002|Overall Study|PI Move and Site Closure|1|||
126634354|NCT02366143|455621308|FG000|Overall Study|Study Terminated By Sponsor|0|||
126634355|NCT02366143|455621309|FG001|Overall Study|Study Terminated By Sponsor|0|||
126634356|NCT02366143|455621310|FG002|Overall Study|Study Terminated By Sponsor|2|||
126634357|NCT02366143|455621308|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
126634358|NCT02366143|455621309|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
126634359|NCT02366143|455621310|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
126634360|NCT02366143|455621308|FG000|Overall Study|Patient moved to roll-over study|1|||
126634361|NCT02366143|455621309|FG001|Overall Study|Patient moved to roll-over study|19|||
126634362|NCT02366143|455621310|FG002|Overall Study|Patient moved to roll-over study|28|||
126634363|NCT02366143|455621308|FG000|Overall Study|Patient moved to commercial stock|0|||
126634364|NCT02366143|455621309|FG001|Overall Study|Patient moved to commercial stock|0|||
126634365|NCT02366143|455621310|FG002|Overall Study|Patient moved to commercial stock|1|||
126634366|NCT02366143|455621308|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
126634367|NCT02366143|455621309|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
126634368|NCT02366143|455621310|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
126634369|NCT02366143|455621308|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
126634370|NCT02366143|455621309|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
126634371|NCT02366143|455621310|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
126634372|NCT02366143|455621308|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
126634373|NCT02366143|455621309|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
126634374|NCT02366143|455621310|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
126634375|NCT02366143|455621308|FG000|Overall Study|Requester's instructions|1|||
126634376|NCT02366143|455621309|FG001|Overall Study|Requester's instructions|1|||
126634377|NCT02366143|455621310|FG002|Overall Study|Requester's instructions|1|||
126634378|NCT02366143|455621308|FG000|Overall Study|Uneligible|0|||
126634379|NCT02366143|455621309|FG001|Overall Study|Uneligible|1|||
126634380|NCT02366143|455621310|FG002|Overall Study|Uneligible|0|||
126634381|NCT02366143|455621308|FG000|Overall Study|Post Trial Migration|0|||
126634382|NCT02366143|455621309|FG001|Overall Study|Post Trial Migration|1|||
126634383|NCT02366143|455621310|FG002|Overall Study|Post Trial Migration|0|||
126634384|NCT02366143|455621308|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
126634385|NCT02366143|455621309|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
126634386|NCT02366143|455621310|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
126634387|NCT02366143|455621308|FG000|Overall Study|Patient switched to PTAP|0|||
126634388|NCT02366143|455621309|FG001|Overall Study|Patient switched to PTAP|1|||
126634389|NCT02366143|455621310|FG002|Overall Study|Patient switched to PTAP|0|||
126634390|NCT02366143|455621308|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
126634391|NCT02366143|455621309|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
126634392|NCT02366143|455621310|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
126634393|NCT04411186|455621311|FG000|Overall Study|Withdrawn due to protocol violation|0|||
126634394|NCT04411186|455621312|FG001|Overall Study|Withdrawn due to protocol violation|1|||
126634395|NCT02820597|455621313|FG000|Overall Study|Lost to Follow-up|12|||
126634396|NCT00575042|455621314|FG000|Overall Study|Adverse Event|2|||
126634397|NCT00575042|455621314|FG000|Overall Study|Lost to Follow-up|1|||
126634398|NCT01053247|455621315|FG000|Overall Study|Withdrawal by Subject|9|||
126634399|NCT01053247|455621316|FG001|Overall Study|Withdrawal by Subject|4|||
126634400|NCT01053247|455621317|FG002|Overall Study|Withdrawal by Subject|15|||
126634401|NCT01053247|455621315|FG000|Overall Study|Lack of Efficacy|1|||
126634402|NCT01053247|455621316|FG001|Overall Study|Lack of Efficacy|0|||
126634403|NCT01053247|455621317|FG002|Overall Study|Lack of Efficacy|1|||
126634404|NCT01053247|455621315|FG000|Overall Study|Protocol Violation|2|||
126634405|NCT01053247|455621316|FG001|Overall Study|Protocol Violation|1|||
126634406|NCT01053247|455621317|FG002|Overall Study|Protocol Violation|2|||
126634407|NCT01053247|455621315|FG000|Overall Study|Lost to Follow-up|8|||
126634408|NCT01053247|455621316|FG001|Overall Study|Lost to Follow-up|5|||
126634409|NCT01053247|455621317|FG002|Overall Study|Lost to Follow-up|7|||
126634410|NCT01053247|455621315|FG000|Overall Study|Adverse Event|0|||
126634411|NCT01053247|455621316|FG001|Overall Study|Adverse Event|9|||
126634412|NCT01053247|455621317|FG002|Overall Study|Adverse Event|3|||
126634413|NCT03898700|455621320|FG000|Overall Study|Withdrawal by Subject|2|||
126634414|NCT00701909|455621321|FG000|Overall Study|Withdrawal by Subject|0|||
126634415|NCT00701909|455621322|FG001|Overall Study|Withdrawal by Subject|1|||
126634416|NCT03023722|455621327|FG000|Overall Study|No follow-up assessment|4|||
126634417|NCT03616964|455621328|FG000|Overall Study|Adverse Event|15|||
126634418|NCT03616964|455621329|FG001|Overall Study|Adverse Event|10|||
126634419|NCT03616964|455621330|FG002|Overall Study|Adverse Event|16|||
126634420|NCT03616964|455621328|FG000|Overall Study|Death|3|||
126634421|NCT03616964|455621329|FG001|Overall Study|Death|0|||
126634422|NCT03616964|455621330|FG002|Overall Study|Death|4|||
126634423|NCT03616964|455621328|FG000|Overall Study|Lack of Efficacy|4|||
126634424|NCT03616964|455621329|FG001|Overall Study|Lack of Efficacy|8|||
126634425|NCT03616964|455621330|FG002|Overall Study|Lack of Efficacy|8|||
126634426|NCT03616964|455621328|FG000|Overall Study|Lost to Follow-up|2|||
126634427|NCT03616964|455621329|FG001|Overall Study|Lost to Follow-up|1|||
126634428|NCT03616964|455621330|FG002|Overall Study|Lost to Follow-up|3|||
126634429|NCT03616964|455621328|FG000|Overall Study|Withdrawal by Subject|18|||
126634430|NCT03616964|455621329|FG001|Overall Study|Withdrawal by Subject|14|||
126634431|NCT03616964|455621330|FG002|Overall Study|Withdrawal by Subject|21|||
126634432|NCT03616964|455621328|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
126634433|NCT03616964|455621329|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
126634434|NCT03616964|455621330|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
126634435|NCT03616964|455621328|FG000|Overall Study|Sponsor's Decision|1|||
126634436|NCT03616964|455621329|FG001|Overall Study|Sponsor's Decision|0|||
126634437|NCT03616964|455621330|FG002|Overall Study|Sponsor's Decision|0|||
126634438|NCT03616964|455621328|FG000|Overall Study|Physician Decision|0|||
126634439|NCT03616964|455621329|FG001|Overall Study|Physician Decision|2|||
126634440|NCT03616964|455621330|FG002|Overall Study|Physician Decision|0|||
126634441|NCT03616964|455621328|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
126634442|NCT03616964|455621329|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
126634443|NCT03616964|455621330|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
126634444|NCT03616964|455621328|FG000|Overall Study|Protocol Violation|0|||
126634445|NCT03616964|455621329|FG001|Overall Study|Protocol Violation|1|||
126634446|NCT03616964|455621330|FG002|Overall Study|Protocol Violation|0|||
126634447|NCT03616964|455621328|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
126634448|NCT03616964|455621329|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
126634449|NCT03616964|455621330|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
126634450|NCT03616964|455621328|FG000|Overall Study|Randomized but Never Treated|1|||
126634451|NCT03616964|455621329|FG001|Overall Study|Randomized but Never Treated|1|||
126634452|NCT03616964|455621330|FG002|Overall Study|Randomized but Never Treated|1|||
126634453|NCT01266018|455621338|FG000|Overall Study|Physician Decision|1|||
126634454|NCT01266018|455621339|FG001|Overall Study|Physician Decision|0|||
126634455|NCT01266018|455621338|FG000|Overall Study|Progressive disease|0|||
126634456|NCT01266018|455621339|FG001|Overall Study|Progressive disease|1|||
126634457|NCT03167151|455621340|FG000|Overall Study|Withdrawal by Subject|1|||
126634458|NCT03167151|455621341|FG001|Overall Study|Withdrawal by Subject|0|||
126634459|NCT03167151|455621342|FG002|Overall Study|Withdrawal by Subject|0|||
126634460|NCT03167151|455621340|FG000|Overall Study|No evidence of tumour at surgery|0|||
126634461|NCT03167151|455621341|FG001|Overall Study|No evidence of tumour at surgery|1|||
126634462|NCT03167151|455621342|FG002|Overall Study|No evidence of tumour at surgery|1|||
126634463|NCT00589303|455621343|FG000|Overall Study|Withdrawal by Subject|2|||
126634464|NCT00589303|455621344|FG001|Overall Study|Withdrawal by Subject|1|||
126634465|NCT04367480|455621345|FG000|Overall Study|Adverse Event|1|||
126634466|NCT04367480|455621346|FG001|Overall Study|Adverse Event|1|||
126634467|NCT04367480|455621345|FG000|Overall Study|Death|1|||
126634468|NCT04367480|455621346|FG001|Overall Study|Death|0|||
126634469|NCT04367480|455621345|FG000|Overall Study|Lost to Follow-up|1|||
126634470|NCT04367480|455621346|FG001|Overall Study|Lost to Follow-up|1|||
126634471|NCT04367480|455621345|FG000|Overall Study|Withdrawal by Subject|0|||
126634472|NCT04367480|455621346|FG001|Overall Study|Withdrawal by Subject|3|||
126634473|NCT04367480|455621345|FG000|Overall Study|App glitch during the study|1|||
126634474|NCT04367480|455621346|FG001|Overall Study|App glitch during the study|0|||
126634475|NCT04367480|455621345|FG000|Overall Study|Device Distribution Error|0|||
126634476|NCT04367480|455621346|FG001|Overall Study|Device Distribution Error|2|||
126634477|NCT04367480|455621345|FG000|Overall Study|Ineligible after Randomization|0|||
126634478|NCT04367480|455621346|FG001|Overall Study|Ineligible after Randomization|1|||
126634479|NCT04367480|455621345|FG000|Overall Study|Other Medical Reasons|0|||
126634480|NCT04367480|455621346|FG001|Overall Study|Other Medical Reasons|2|||
126634481|NCT04120376|455621348|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
126634482|NCT04120376|455621349|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
126634483|NCT00634842|455621350|FG000|Overall Study|Adverse Event|2|||
126634484|NCT00634842|455621351|FG001|Overall Study|Adverse Event|3|||
126634485|NCT00634842|455621350|FG000|Overall Study|Protocol Violation|8|||
126634486|NCT00634842|455621351|FG001|Overall Study|Protocol Violation|4|||
126634487|NCT00634842|455621350|FG000|Overall Study|Move to another state|1|||
126634488|NCT00634842|455621351|FG001|Overall Study|Move to another state|0|||
126634489|NCT00634842|455621350|FG000|Overall Study|Inclusion criteria were not met|1|||
126634490|NCT00634842|455621351|FG001|Overall Study|Inclusion criteria were not met|0|||
126634491|NCT00634842|455621350|FG000|Overall Study|Lost to Follow-up|1|||
126634492|NCT00634842|455621351|FG001|Overall Study|Lost to Follow-up|2|||
126634493|NCT00634842|455621350|FG000|Overall Study|Physician Decision|1|||
126634494|NCT00634842|455621351|FG001|Overall Study|Physician Decision|0|||
126634495|NCT00634842|455621350|FG000|Overall Study|Withdrawal by Subject|1|||
126634496|NCT00634842|455621351|FG001|Overall Study|Withdrawal by Subject|3|||
126634497|NCT00634842|455621350|FG000|Overall Study|Lack of time and intolerance to drug|0|||
126634498|NCT00634842|455621351|FG001|Overall Study|Lack of time and intolerance to drug|1|||
126634499|NCT00634842|455621350|FG000|Overall Study|Discontinued due to injection|0|||
126634500|NCT00634842|455621351|FG001|Overall Study|Discontinued due to injection|2|||
126634501|NCT00634842|455621350|FG000|Overall Study|No need of study drug to treat diabetes|0|||
126634502|NCT00634842|455621351|FG001|Overall Study|No need of study drug to treat diabetes|1|||
126634503|NCT00634842|455621350|FG000|Overall Study|No wish to keep taking Avandia|0|||
126634504|NCT00634842|455621351|FG001|Overall Study|No wish to keep taking Avandia|1|||
126634505|NCT00634842|455621350|FG000|Overall Study|Subject off study drug for too long|0|||
126634506|NCT00634842|455621351|FG001|Overall Study|Subject off study drug for too long|1|||
126634507|NCT04351269|455621355|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
126634508|NCT04351269|455621356|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
126634509|NCT04351269|455621357|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
126634510|NCT04351269|455621355|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
126634511|NCT04351269|455621356|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
126634512|NCT04351269|455621357|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
126634513|NCT04351269|455621355|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
126634514|NCT04351269|455621356|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
126634515|NCT04351269|455621357|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
126634516|NCT04351269|455621355|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
126634517|NCT04351269|455621356|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
126634518|NCT04351269|455621357|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
126634519|NCT04351269|455621355|FG000|Overall Study|Lost to Follow-up|1|||
126634520|NCT04351269|455621356|FG001|Overall Study|Lost to Follow-up|3|||
126634521|NCT04351269|455621357|FG002|Overall Study|Lost to Follow-up|0|||
126634522|NCT01407276|455621362|FG000|Overall Study|Withdrawal by Subject|0|||
126634523|NCT01407276|455621363|FG001|Overall Study|Withdrawal by Subject|0|||
126634524|NCT01407276|455621364|FG002|Overall Study|Withdrawal by Subject|0|||
126634525|NCT01407276|455621365|FG003|Overall Study|Withdrawal by Subject|0|||
126634526|NCT01407276|455621366|FG004|Overall Study|Withdrawal by Subject|0|||
126634527|NCT01407276|455621367|FG005|Overall Study|Withdrawal by Subject|0|||
126634528|NCT01407276|455621368|FG006|Overall Study|Withdrawal by Subject|0|||
126634529|NCT01407276|455621369|FG007|Overall Study|Withdrawal by Subject|1|||
126634530|NCT00778921|455621370|FG000|Overall Study|Adverse Event|9|||
126634531|NCT00778921|455621371|FG001|Overall Study|Adverse Event|10|||
126634532|NCT00778921|455621372|FG002|Overall Study|Adverse Event|14|||
126634533|NCT00778921|455621370|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
126634534|NCT00778921|455621371|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
126634535|NCT00778921|455621372|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
126634536|NCT00778921|455621370|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
126634537|NCT00778921|455621371|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
126634538|NCT00778921|455621372|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
126634539|NCT00778921|455621370|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
126634540|NCT00778921|455621371|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
126634541|NCT00778921|455621372|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
126634542|NCT00778921|455621370|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
126634543|NCT00778921|455621371|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
126634544|NCT00778921|455621372|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
126634545|NCT00778921|455621370|FG000|Overall Study|Patient withdrew request|3|||
126634546|NCT00778921|455621371|FG001|Overall Study|Patient withdrew request|1|||
126634547|NCT00778921|455621372|FG002|Overall Study|Patient withdrew request|6|||
126634548|NCT00778921|455621370|FG000|Overall Study|Lost to Follow-up|0|||
126634549|NCT00778921|455621371|FG001|Overall Study|Lost to Follow-up|2|||
126634550|NCT00778921|455621372|FG002|Overall Study|Lost to Follow-up|1|||
126634551|NCT00778921|455621370|FG000|Overall Study|Administrative Problems|1|||
126634552|NCT00778921|455621371|FG001|Overall Study|Administrative Problems|2|||
126634553|NCT00778921|455621372|FG002|Overall Study|Administrative Problems|0|||
126634554|NCT00778921|455621370|FG000|Overall Study|Protocol Violation|3|||
126634555|NCT00778921|455621371|FG001|Overall Study|Protocol Violation|0|||
126634556|NCT00778921|455621372|FG002|Overall Study|Protocol Violation|2|||
126634557|NCT00778921|455621370|FG000|Overall Study|Not treated|0|||
126634558|NCT00778921|455621371|FG001|Overall Study|Not treated|2|||
126634559|NCT00778921|455621372|FG002|Overall Study|Not treated|2|||
126634560|NCT04805073|455621373|FG000|Overall Study|study personnel not available|2|||
126634561|NCT04805073|455621374|FG001|Overall Study|study personnel not available|0|||
126634562|NCT04805073|455621373|FG000|Overall Study|spinal anesthesia failure|0|||
126634563|NCT04805073|455621374|FG001|Overall Study|spinal anesthesia failure|1|||
126634564|NCT04805073|455621373|FG000|Overall Study|Lost to Follow-up|0|||
126634565|NCT04805073|455621374|FG001|Overall Study|Lost to Follow-up|2|||
126634566|NCT01174264|455621382|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
126634567|NCT01174264|455621383|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
126634568|NCT01174264|455621384|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
126634569|NCT01174264|455621382|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
126634570|NCT01174264|455621383|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
126634571|NCT01174264|455621384|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
126634572|NCT01174264|455621382|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
126634573|NCT01174264|455621383|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
126634574|NCT01174264|455621384|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
126634575|NCT02058836|455621388|FG000|Overall Study|Withdrawal by Subject|1|||
126634576|NCT02058836|455621389|FG001|Overall Study|Withdrawal by Subject|1|||
126634577|NCT00267098|455621390|FG000|Overall Study|Death|0|||
126634578|NCT00267098|455621391|FG001|Overall Study|Death|0|||
126634579|NCT00267098|455621392|FG002|Overall Study|Death|57|||
126634580|NCT00267098|455621393|FG003|Overall Study|Death|66|||
126634581|NCT00267098|455621394|FG004|Overall Study|Death|14|||
126634582|NCT00267098|455621395|FG005|Overall Study|Death|23|||
126634583|NCT00267098|455621396|FG006|Overall Study|Death|28|||
126634584|NCT00267098|455621397|FG007|Overall Study|Death|9|||
126634585|NCT00267098|455621390|FG000|Overall Study|Lost to Follow-up|0|||
126634586|NCT00267098|455621391|FG001|Overall Study|Lost to Follow-up|0|||
126634587|NCT00267098|455621392|FG002|Overall Study|Lost to Follow-up|6|||
126634588|NCT00267098|455621393|FG003|Overall Study|Lost to Follow-up|5|||
126634589|NCT00267098|455621394|FG004|Overall Study|Lost to Follow-up|2|||
126634590|NCT00267098|455621395|FG005|Overall Study|Lost to Follow-up|3|||
126634591|NCT00267098|455621396|FG006|Overall Study|Lost to Follow-up|1|||
126634592|NCT00267098|455621397|FG007|Overall Study|Lost to Follow-up|1|||
126634593|NCT00267098|455621390|FG000|Overall Study|Withdrawal by Subject|8|||
126634594|NCT00267098|455621391|FG001|Overall Study|Withdrawal by Subject|0|||
126634595|NCT00267098|455621392|FG002|Overall Study|Withdrawal by Subject|24|||
126634596|NCT00267098|455621393|FG003|Overall Study|Withdrawal by Subject|21|||
126634597|NCT00267098|455621394|FG004|Overall Study|Withdrawal by Subject|12|||
126634598|NCT00267098|455621395|FG005|Overall Study|Withdrawal by Subject|9|||
126634599|NCT00267098|455621396|FG006|Overall Study|Withdrawal by Subject|12|||
126634600|NCT00267098|455621397|FG007|Overall Study|Withdrawal by Subject|5|||
126634601|NCT00267098|455621390|FG000|Overall Study|Physician Decision|5|||
126634602|NCT00267098|455621391|FG001|Overall Study|Physician Decision|0|||
126634603|NCT00267098|455621392|FG002|Overall Study|Physician Decision|7|||
126634604|NCT00267098|455621393|FG003|Overall Study|Physician Decision|11|||
126634605|NCT00267098|455621394|FG004|Overall Study|Physician Decision|5|||
126634606|NCT00267098|455621395|FG005|Overall Study|Physician Decision|4|||
126634607|NCT00267098|455621396|FG006|Overall Study|Physician Decision|3|||
126755862|NCT02551874|456057276|FG000|Overall Study|Did not enter long-term study|18|||
126755863|NCT02551874|456057277|FG001|Overall Study|Did not enter long-term study|25|||
126755864|NCT02491463|456057278|FG000|Overall Study|Withdrawal by Subject|1|||
126755865|NCT02491463|456057279|FG001|Overall Study|Withdrawal by Subject|2|||
126755866|NCT02491463|456057280|FG002|Overall Study|Withdrawal by Subject|0|||
126755867|NCT02491463|456057281|FG003|Overall Study|Withdrawal by Subject|0|||
126755868|NCT02491463|456057278|FG000|Overall Study|Migrated/moved from study area|1|||
126755869|NCT02491463|456057279|FG001|Overall Study|Migrated/moved from study area|5|||
126755870|NCT02491463|456057280|FG002|Overall Study|Migrated/moved from study area|1|||
126755871|NCT02491463|456057281|FG003|Overall Study|Migrated/moved from study area|1|||
126755872|NCT02491463|456057278|FG000|Overall Study|Lost to Follow-up|0|||
126755873|NCT02491463|456057279|FG001|Overall Study|Lost to Follow-up|3|||
126755874|NCT02491463|456057280|FG002|Overall Study|Lost to Follow-up|3|||
126755875|NCT02491463|456057281|FG003|Overall Study|Lost to Follow-up|0|||
126755876|NCT01491802|456057282|FG000|Overall Study|Adverse Event|1|||
126755877|NCT01491802|456057283|FG001|Overall Study|Adverse Event|1|||
126755878|NCT01491802|456057282|FG000|Overall Study|Withdrawal by Subject|0|||
126755879|NCT01491802|456057283|FG001|Overall Study|Withdrawal by Subject|1|||
126755880|NCT04563845|456057284|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755881|NCT04563845|456057285|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755882|NCT04563845|456057286|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755883|NCT04563845|456057287|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755884|NCT04563845|456057288|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755885|NCT04563845|456057289|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755886|NCT04563845|456057290|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755887|NCT04563845|456057291|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
126755888|NCT04563845|456057292|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755889|NCT04563845|456057293|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755890|NCT04563845|456057294|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755891|NCT04563845|456057295|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755892|NCT04563845|456057296|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755893|NCT04563845|456057297|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
126755894|NCT04563845|456057284|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126755895|NCT04563845|456057285|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126755896|NCT04563845|456057286|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126755897|NCT04563845|456057287|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126755898|NCT04563845|456057288|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
126755899|NCT04563845|456057289|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126755900|NCT04563845|456057290|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126755901|NCT04563845|456057291|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126755902|NCT04563845|456057292|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126755903|NCT04563845|456057293|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126755904|NCT04563845|456057294|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126634608|NCT00267098|455621397|FG007|Overall Study|Physician Decision|0|||
126634609|NCT00267098|455621390|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
126634610|NCT00267098|455621391|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126634611|NCT00267098|455621392|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126634612|NCT00267098|455621393|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126634613|NCT00267098|455621394|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
126634614|NCT00267098|455621395|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126634615|NCT00267098|455621396|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126634616|NCT00267098|455621397|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
126634617|NCT00267098|455621390|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126634618|NCT00267098|455621391|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
126634619|NCT00267098|455621392|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126634620|NCT00267098|455621393|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126634621|NCT00267098|455621394|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126634622|NCT00267098|455621395|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126634623|NCT00267098|455621396|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126634624|NCT00267098|455621397|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
126634625|NCT00267098|455621390|FG000|Overall Study|Site closure|0|||
126634626|NCT00267098|455621391|FG001|Overall Study|Site closure|0|||
126634627|NCT00267098|455621392|FG002|Overall Study|Site closure|0|||
126634628|NCT00267098|455621393|FG003|Overall Study|Site closure|1|||
126634629|NCT00267098|455621394|FG004|Overall Study|Site closure|0|||
126634630|NCT00267098|455621395|FG005|Overall Study|Site closure|1|||
126634631|NCT00267098|455621396|FG006|Overall Study|Site closure|1|||
126634632|NCT00267098|455621397|FG007|Overall Study|Site closure|0|||
126634633|NCT00267098|455621390|FG000|Overall Study|Explanted Medtronic device|0|||
126634634|NCT00267098|455621391|FG001|Overall Study|Explanted Medtronic device|0|||
126634635|NCT00267098|455621392|FG002|Overall Study|Explanted Medtronic device|0|||
126634636|NCT00267098|455621393|FG003|Overall Study|Explanted Medtronic device|1|||
126634637|NCT00267098|455621394|FG004|Overall Study|Explanted Medtronic device|0|||
126634638|NCT00267098|455621395|FG005|Overall Study|Explanted Medtronic device|0|||
126634639|NCT00267098|455621396|FG006|Overall Study|Explanted Medtronic device|0|||
126634640|NCT00267098|455621397|FG007|Overall Study|Explanted Medtronic device|0|||
126634641|NCT00267098|455621390|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126634642|NCT00267098|455621391|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126634643|NCT00267098|455621392|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126634644|NCT00267098|455621393|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126634645|NCT00267098|455621394|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
126634646|NCT00267098|455621395|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126634647|NCT00267098|455621396|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126634648|NCT00267098|455621397|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
126634649|NCT00267098|455621390|FG000|Overall Study|Subject listed for heart transplant|0|||
126634650|NCT00267098|455621391|FG001|Overall Study|Subject listed for heart transplant|0|||
126634651|NCT00267098|455621392|FG002|Overall Study|Subject listed for heart transplant|0|||
126634652|NCT00267098|455621393|FG003|Overall Study|Subject listed for heart transplant|0|||
126634653|NCT00267098|455621394|FG004|Overall Study|Subject listed for heart transplant|0|||
126634654|NCT00267098|455621395|FG005|Overall Study|Subject listed for heart transplant|0|||
126634655|NCT00267098|455621396|FG006|Overall Study|Subject listed for heart transplant|1|||
126634656|NCT00267098|455621397|FG007|Overall Study|Subject listed for heart transplant|0|||
126634657|NCT00267098|455621390|FG000|Overall Study|Sponsor withdrew subject|0|||
126634658|NCT00267098|455621391|FG001|Overall Study|Sponsor withdrew subject|0|||
126634659|NCT00267098|455621392|FG002|Overall Study|Sponsor withdrew subject|0|||
126634660|NCT00267098|455621393|FG003|Overall Study|Sponsor withdrew subject|1|||
126634661|NCT00267098|455621394|FG004|Overall Study|Sponsor withdrew subject|0|||
126634662|NCT00267098|455621395|FG005|Overall Study|Sponsor withdrew subject|0|||
126634663|NCT00267098|455621396|FG006|Overall Study|Sponsor withdrew subject|0|||
126634664|NCT00267098|455621397|FG007|Overall Study|Sponsor withdrew subject|0|||
126634665|NCT00547534|455621398|FG000|Overall Study|Adverse Event|7|||
126634666|NCT00547534|455621398|FG000|Overall Study|Disease Progression|4|||
126634667|NCT02688530|455621400|FG000|Overall Study|Withdrawal by Subject|0|||
126634668|NCT02688530|455621401|FG001|Overall Study|Withdrawal by Subject|1|||
126634669|NCT02688530|455621402|FG002|Overall Study|Withdrawal by Subject|0|||
126755905|NCT04563845|456057295|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126755906|NCT04563845|456057296|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126755907|NCT04563845|456057297|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
126755908|NCT02146274|456057298|FG000|Overall Study|Protocol Violation|73|||
126755909|NCT01539720|456057299|FG000|Overall Study|Screen Fail|15|||
126755910|NCT01539720|456057300|FG001|Overall Study|Screen Fail|3|||
126755911|NCT01539720|456057299|FG000|Overall Study|Lost to Follow-up|14|||
126755912|NCT01539720|456057300|FG001|Overall Study|Lost to Follow-up|7|||
126755913|NCT00386152|456057305|FG000|Overall Study|Adverse Event|6|||
126755914|NCT00386152|456057306|FG001|Overall Study|Adverse Event|5|||
126755915|NCT00386152|456057307|FG002|Overall Study|Adverse Event|4|||
126755916|NCT00386152|456057305|FG000|Overall Study|Chang from original chemo stratification|4|||
126634670|NCT02688530|455621403|FG003|Overall Study|Withdrawal by Subject|0|||
126634671|NCT02688530|455621400|FG000|Overall Study|Lost to Follow-up|0|||
126634672|NCT02688530|455621401|FG001|Overall Study|Lost to Follow-up|0|||
126634673|NCT02688530|455621402|FG002|Overall Study|Lost to Follow-up|2|||
126634674|NCT02688530|455621403|FG003|Overall Study|Lost to Follow-up|0|||
126634675|NCT00115336|455621404|FG000|Overall Study|Hospital discharge before study drug|0|||
126634676|NCT00115336|455621405|FG001|Overall Study|Hospital discharge before study drug|1|||
126634677|NCT04199052|455621408|FG000|Overall Study|Lost to Follow-up|11|||
126634678|NCT04199052|455621409|FG001|Overall Study|Lost to Follow-up|18|||
126634679|NCT00815919|455621410|FG000|Overall Study|Unrelated Fungal Infection|1|||
126634680|NCT00815919|455621410|FG000|Overall Study|AML Relapse|1|||
126634681|NCT00815919|455621410|FG000|Overall Study|Lack of Efficacy|2|||
126634682|NCT04599907|455621413|FG000|Overall Study|Withdrawal by Subject|1|||
126634683|NCT04599907|455621414|FG001|Overall Study|Withdrawal by Subject|7|||
126634684|NCT04599907|455621415|FG002|Overall Study|Withdrawal by Subject|6|||
126634685|NCT04599907|455621413|FG000|Overall Study|Lost to Follow-up|0|||
126634686|NCT04599907|455621414|FG001|Overall Study|Lost to Follow-up|1|||
126634687|NCT04599907|455621415|FG002|Overall Study|Lost to Follow-up|0|||
126634688|NCT01466790|455621419|FG000|Overall Study|Adverse Event|1|||
126634689|NCT01466790|455621420|FG001|Overall Study|Adverse Event|0|||
126634690|NCT01466790|455621421|FG002|Overall Study|Adverse Event|0|||
126634691|NCT01466790|455621422|FG003|Overall Study|Adverse Event|0|||
126634692|NCT01466790|455621423|FG004|Overall Study|Adverse Event|2|||
126634693|NCT01466790|455621424|FG005|Overall Study|Adverse Event|0|||
126634694|NCT01466790|455621425|FG006|Overall Study|Adverse Event|0|||
126634695|NCT01466790|455621426|FG007|Overall Study|Adverse Event|0|||
126634696|NCT01466790|455621419|FG000|Overall Study|Lost to Follow-up|2|||
126634697|NCT01466790|455621420|FG001|Overall Study|Lost to Follow-up|0|||
126634698|NCT01466790|455621421|FG002|Overall Study|Lost to Follow-up|0|||
126634699|NCT01466790|455621422|FG003|Overall Study|Lost to Follow-up|0|||
126634700|NCT01466790|455621423|FG004|Overall Study|Lost to Follow-up|0|||
126634701|NCT01466790|455621424|FG005|Overall Study|Lost to Follow-up|0|||
126634702|NCT01466790|455621425|FG006|Overall Study|Lost to Follow-up|0|||
126634703|NCT01466790|455621426|FG007|Overall Study|Lost to Follow-up|0|||
126755917|NCT00386152|456057306|FG001|Overall Study|Chang from original chemo stratification|5|||
126755918|NCT00386152|456057307|FG002|Overall Study|Chang from original chemo stratification|6|||
126755919|NCT00386152|456057305|FG000|Overall Study|Death|3|||
126755920|NCT00386152|456057306|FG001|Overall Study|Death|0|||
126755921|NCT00386152|456057307|FG002|Overall Study|Death|1|||
126755922|NCT00386152|456057305|FG000|Overall Study|Disease progression|7|||
126755923|NCT00386152|456057306|FG001|Overall Study|Disease progression|4|||
126755924|NCT00386152|456057307|FG002|Overall Study|Disease progression|5|||
126755925|NCT00386152|456057305|FG000|Overall Study|Physician Decision|13|||
126755926|NCT00386152|456057306|FG001|Overall Study|Physician Decision|10|||
126755927|NCT00386152|456057307|FG002|Overall Study|Physician Decision|4|||
126755928|NCT00386152|456057305|FG000|Overall Study|Lost to Follow-up|1|||
126755929|NCT00386152|456057306|FG001|Overall Study|Lost to Follow-up|0|||
126755930|NCT00386152|456057307|FG002|Overall Study|Lost to Follow-up|0|||
126755931|NCT00386152|456057305|FG000|Overall Study|Completed chemotherapy|4|||
126755932|NCT00386152|456057306|FG001|Overall Study|Completed chemotherapy|5|||
126755933|NCT00386152|456057307|FG002|Overall Study|Completed chemotherapy|1|||
126755934|NCT00386152|456057305|FG000|Overall Study|Protocol Violation|3|||
126755935|NCT00386152|456057306|FG001|Overall Study|Protocol Violation|5|||
126755936|NCT00386152|456057307|FG002|Overall Study|Protocol Violation|2|||
126755937|NCT00386152|456057305|FG000|Overall Study|Withdrawal by Subject|3|||
126755938|NCT00386152|456057306|FG001|Overall Study|Withdrawal by Subject|6|||
126755939|NCT00386152|456057307|FG002|Overall Study|Withdrawal by Subject|10|||
126755940|NCT03938857|456057311|FG000|Overall Study|Physician Decision|1|||
126755941|NCT03938857|456057312|FG001|Overall Study|Physician Decision|0|||
126755942|NCT03938857|456057313|FG002|Overall Study|Physician Decision|0|||
126755943|NCT03938857|456057314|FG003|Overall Study|Physician Decision|0|||
126755944|NCT02577107|456057315|FG000|Overall Study|Protocol deviation|0|||
126755945|NCT02577107|456057316|FG001|Overall Study|Protocol deviation|1|||
126755946|NCT02516605|456057317|FG000|Overall Study|Protocol Violation|0|||
126755947|NCT02516605|456057318|FG001|Overall Study|Protocol Violation|0|||
126755948|NCT02516605|456057319|FG002|Overall Study|Protocol Violation|0|||
126755949|NCT02516605|456057320|FG003|Overall Study|Protocol Violation|0|||
126755950|NCT02516605|456057321|FG004|Overall Study|Protocol Violation|1|||
126755951|NCT02516605|456057317|FG000|Overall Study|Withdrawal by Subject|0|||
126755952|NCT02516605|456057318|FG001|Overall Study|Withdrawal by Subject|0|||
126755953|NCT02516605|456057319|FG002|Overall Study|Withdrawal by Subject|0|||
126755954|NCT02516605|456057320|FG003|Overall Study|Withdrawal by Subject|1|||
126755955|NCT02516605|456057321|FG004|Overall Study|Withdrawal by Subject|0|||
126755956|NCT00577382|456057322|FG000|Overall Study|Adverse Event|0|||
126755957|NCT00577382|456057323|FG001|Overall Study|Adverse Event|6|||
126755958|NCT00577382|456057322|FG000|Overall Study|Withdrawal by Subject|0|||
126755959|NCT00577382|456057323|FG001|Overall Study|Withdrawal by Subject|1|||
126634704|NCT01466790|455621419|FG000|Overall Study|Withdrawal by Subject|1|||
126634705|NCT01466790|455621420|FG001|Overall Study|Withdrawal by Subject|1|||
126634706|NCT01466790|455621421|FG002|Overall Study|Withdrawal by Subject|0|||
126634707|NCT01466790|455621422|FG003|Overall Study|Withdrawal by Subject|0|||
126634708|NCT01466790|455621423|FG004|Overall Study|Withdrawal by Subject|1|||
126634709|NCT01466790|455621424|FG005|Overall Study|Withdrawal by Subject|0|||
126634710|NCT01466790|455621425|FG006|Overall Study|Withdrawal by Subject|1|||
126634711|NCT01466790|455621426|FG007|Overall Study|Withdrawal by Subject|1|||
126634712|NCT01251887|455621427|FG000|Overall Study|Scheduling conflict|1|||
126634713|NCT01251887|455621428|FG001|Overall Study|Scheduling conflict|2|||
126634714|NCT01251887|455621429|FG002|Overall Study|Scheduling conflict|2|||
126634715|NCT01251887|455621427|FG000|Overall Study|Physician Decision|0|||
126634716|NCT01251887|455621428|FG001|Overall Study|Physician Decision|1|||
126634717|NCT01251887|455621429|FG002|Overall Study|Physician Decision|0|||
126634718|NCT03668223|455621430|FG000|Overall Study|Death|10|||
126634719|NCT03668223|455621431|FG001|Overall Study|Death|5|||
126634720|NCT03668223|455621430|FG000|Overall Study|Lost to Follow-up|12|||
126634721|NCT03668223|455621431|FG001|Overall Study|Lost to Follow-up|12|||
126634722|NCT03668223|455621430|FG000|Overall Study|Withdrawal by Subject|8|||
126634723|NCT03668223|455621431|FG001|Overall Study|Withdrawal by Subject|3|||
126634724|NCT01103232|455621432|FG000|Overall Study|Withdrawal by Subject|1|||
126634725|NCT01103232|455621433|FG001|Overall Study|Withdrawal by Subject|1|||
126634726|NCT01103232|455621432|FG000|Overall Study|Protocol Violation|0|||
126634727|NCT01103232|455621433|FG001|Overall Study|Protocol Violation|1|||
126634728|NCT05093504|455621434|FG000|Overall Study|Death|0|||
126634729|NCT05093504|455621435|FG001|Overall Study|Death|1|||
126634730|NCT05347485|455621440|FG000|Overall Study|Death|14|||
126634731|NCT05347485|455621440|FG000|Overall Study|Lost to Follow-up|2|||
126634732|NCT05347485|455621440|FG000|Overall Study|Withdrawal by Subject|13|||
126634733|NCT05347485|455621440|FG000|Overall Study|Progressive Disease|1|||
126634734|NCT05347485|455621440|FG000|Overall Study|Study Terminated by Sponsor|49|||
126634735|NCT05347485|455621440|FG000|Overall Study|Other|1|||
126634736|NCT05347485|455621440|FG000|Overall Study|Enrolled (consented) but not treated|4|||
126634737|NCT05347485|455621440|FG000|Overall Study|Disease Relapse|2|||
126634738|NCT04886518|455621441|FG000|Overall Study|Noncompliance with study drug|1|||
126634739|NCT04886518|455621442|FG001|Overall Study|Noncompliance with study drug|0|||
126634740|NCT04886518|455621443|FG002|Overall Study|Noncompliance with study drug|0|||
126634741|NCT04886518|455621441|FG000|Overall Study|Adverse Event|0|||
126634742|NCT04886518|455621442|FG001|Overall Study|Adverse Event|1|||
126634743|NCT04886518|455621443|FG002|Overall Study|Adverse Event|0|||
126634744|NCT04886518|455621441|FG000|Overall Study|Withdrawal by Subject|1|||
126634745|NCT04886518|455621442|FG001|Overall Study|Withdrawal by Subject|0|||
126634746|NCT04886518|455621443|FG002|Overall Study|Withdrawal by Subject|0|||
126634747|NCT03733899|455621444|FG000|Period 1|Protocol Violation|0|||
126634748|NCT03733899|455621445|FG001|Period 1|Protocol Violation|0|||
126634749|NCT03733899|455621446|FG002|Period 1|Protocol Violation|0|||
126634750|NCT03733899|455621447|FG003|Period 1|Protocol Violation|0|||
126634751|NCT03733899|455621448|FG004|Period 1|Protocol Violation|0|||
126634752|NCT03733899|455621449|FG005|Period 1|Protocol Violation|1|||
126634753|NCT03733899|455621444|FG000|Period 2|Unscuccessful Treatment|0|||
126634754|NCT03733899|455621445|FG001|Period 2|Unscuccessful Treatment|1|||
126634755|NCT03733899|455621446|FG002|Period 2|Unscuccessful Treatment|0|||
126634756|NCT03733899|455621447|FG003|Period 2|Unscuccessful Treatment|0|||
126634757|NCT03733899|455621448|FG004|Period 2|Unscuccessful Treatment|0|||
126634758|NCT03733899|455621449|FG005|Period 2|Unscuccessful Treatment|0|||
126634759|NCT03733899|455621444|FG000|Period 3|Withdrawal by Subject|1|||
126634760|NCT03733899|455621445|FG001|Period 3|Withdrawal by Subject|0|||
126634761|NCT03733899|455621446|FG002|Period 3|Withdrawal by Subject|0|||
126634762|NCT03733899|455621447|FG003|Period 3|Withdrawal by Subject|0|||
126634763|NCT03733899|455621448|FG004|Period 3|Withdrawal by Subject|0|||
126634764|NCT03733899|455621449|FG005|Period 3|Withdrawal by Subject|0|||
126634765|NCT04650698|455623488|FG000|Overall Study|Protocol Violation|2|||
126634766|NCT04650698|455623489|FG001|Overall Study|Protocol Violation|1|||
126634767|NCT04650698|455623488|FG000|Overall Study|Withdrawal by Subject|0|||
126634768|NCT04650698|455623489|FG001|Overall Study|Withdrawal by Subject|1|||
126634769|NCT01090011|455623490|FG000|Overall Study|Progressive disease|128|||
126634770|NCT01090011|455623490|FG000|Overall Study|Adverse Event|32|||
126634771|NCT01090011|455623490|FG000|Overall Study|Protocol Violation|1|||
126634772|NCT01090011|455623490|FG000|Overall Study|Refusal to start/continue medication|5|||
126634773|NCT01090011|455623490|FG000|Overall Study|Other reason not defined above|5|||
126634774|NCT00307047|455623491|FG000|Overall Study|Lost to Follow-up|35|||
126634775|NCT00307047|455623492|FG001|Overall Study|Lost to Follow-up|24|||
126634776|NCT00307047|455623491|FG000|Overall Study|Withdrawal by Subject|6|||
126634777|NCT00307047|455623492|FG001|Overall Study|Withdrawal by Subject|6|||
126634778|NCT00307047|455623491|FG000|Overall Study|Physician Decision|1|||
126634779|NCT00307047|455623492|FG001|Overall Study|Physician Decision|2|||
126634780|NCT00307047|455623491|FG000|Overall Study|Lost to follow-up for other reasons|0|||
126634781|NCT00307047|455623492|FG001|Overall Study|Lost to follow-up for other reasons|1|||
126634782|NCT00307047|455623491|FG000|Overall Study|All death, all MI, all Revascularization|27|||
126634783|NCT00307047|455623492|FG001|Overall Study|All death, all MI, all Revascularization|16|||
126634784|NCT00379769|455623493|FG000|Main Study|Death|57|||
126634785|NCT00379769|455623494|FG001|Main Study|Death|67|||
126634786|NCT00379769|455623495|FG002|Main Study|Death|54|||
126634787|NCT00379769|455623496|FG003|Main Study|Death|72|||
126634788|NCT00379769|455623497|FG004|Main Study|Death|0|||
126634789|NCT00379769|455623498|FG005|Main Study|Death|0|||
126634790|NCT00379769|455623493|FG000|Main Study|Adverse Event|5|||
126634791|NCT00379769|455623494|FG001|Main Study|Adverse Event|8|||
126634792|NCT00379769|455623495|FG002|Main Study|Adverse Event|10|||
126634793|NCT00379769|455623496|FG003|Main Study|Adverse Event|11|||
126634794|NCT00379769|455623497|FG004|Main Study|Adverse Event|0|||
126634795|NCT00379769|455623498|FG005|Main Study|Adverse Event|0|||
126634796|NCT00379769|455623493|FG000|Main Study|Lost to Follow-up|29|||
126634797|NCT00379769|455623494|FG001|Main Study|Lost to Follow-up|29|||
126634798|NCT00379769|455623495|FG002|Main Study|Lost to Follow-up|25|||
126634799|NCT00379769|455623496|FG003|Main Study|Lost to Follow-up|26|||
126634800|NCT00379769|455623497|FG004|Main Study|Lost to Follow-up|0|||
126755960|NCT00577382|456057322|FG000|Overall Study|Progressive Disease|17|||
126755961|NCT00577382|456057323|FG001|Overall Study|Progressive Disease|19|||
126755962|NCT00577382|456057322|FG000|Overall Study|Intercurrent Illness|1|||
126755963|NCT00577382|456057323|FG001|Overall Study|Intercurrent Illness|2|||
126755964|NCT00577382|456057322|FG000|Overall Study|Death|1|||
126755965|NCT00577382|456057323|FG001|Overall Study|Death|1|||
126755966|NCT00577382|456057322|FG000|Overall Study|Lost to Follow-up|2|||
126755967|NCT00577382|456057323|FG001|Overall Study|Lost to Follow-up|2|||
126755968|NCT02839330|456057324|FG000|Overall Study|Adverse Event|0|||
126755969|NCT02839330|456057325|FG001|Overall Study|Adverse Event|1|||
126755970|NCT02839330|456057326|FG002|Overall Study|Adverse Event|2|||
126755971|NCT02839330|456057327|FG003|Overall Study|Adverse Event|2|||
126755972|NCT02839330|456057324|FG000|Overall Study|Death|4|||
126755973|NCT02839330|456057325|FG001|Overall Study|Death|6|||
126755974|NCT02839330|456057326|FG002|Overall Study|Death|1|||
126755975|NCT02839330|456057327|FG003|Overall Study|Death|1|||
126755976|NCT02839330|456057324|FG000|Overall Study|Withdrawal by Subject|27|||
126755977|NCT02839330|456057325|FG001|Overall Study|Withdrawal by Subject|19|||
126755978|NCT02839330|456057326|FG002|Overall Study|Withdrawal by Subject|11|||
126755979|NCT02839330|456057327|FG003|Overall Study|Withdrawal by Subject|13|||
126755980|NCT02839330|456057324|FG000|Overall Study|Lost to Follow-up|22|||
126755981|NCT02839330|456057325|FG001|Overall Study|Lost to Follow-up|27|||
126755982|NCT02839330|456057326|FG002|Overall Study|Lost to Follow-up|29|||
126755983|NCT02839330|456057327|FG003|Overall Study|Lost to Follow-up|25|||
126755984|NCT02839330|456057324|FG000|Overall Study|Administrative Reason|0|||
126755985|NCT02839330|456057325|FG001|Overall Study|Administrative Reason|0|||
126755986|NCT02839330|456057326|FG002|Overall Study|Administrative Reason|0|||
126755987|NCT02839330|456057327|FG003|Overall Study|Administrative Reason|1|||
126755988|NCT02839330|456057324|FG000|Overall Study|Protocol Violation|1|||
126755989|NCT02839330|456057325|FG001|Overall Study|Protocol Violation|2|||
126755990|NCT02839330|456057326|FG002|Overall Study|Protocol Violation|2|||
126634801|NCT00379769|455623498|FG005|Main Study|Lost to Follow-up|0|||
126634802|NCT00379769|455623493|FG000|Main Study|Withdrawal by Subject|46|||
126634803|NCT00379769|455623494|FG001|Main Study|Withdrawal by Subject|56|||
126634804|NCT00379769|455623495|FG002|Main Study|Withdrawal by Subject|72|||
126755991|NCT02839330|456057327|FG003|Overall Study|Protocol Violation|3|||
126755992|NCT02839330|456057324|FG000|Overall Study|Other reason, not specified|4|||
126755993|NCT02839330|456057325|FG001|Overall Study|Other reason, not specified|3|||
126755994|NCT02839330|456057326|FG002|Overall Study|Other reason, not specified|3|||
126634805|NCT00379769|455623496|FG003|Main Study|Withdrawal by Subject|70|||
126634806|NCT00379769|455623497|FG004|Main Study|Withdrawal by Subject|0|||
126634807|NCT00379769|455623498|FG005|Main Study|Withdrawal by Subject|0|||
126634808|NCT00379769|455623493|FG000|Main Study|Moved to survival status follow-up only|27|||
126634809|NCT00379769|455623494|FG001|Main Study|Moved to survival status follow-up only|25|||
126634810|NCT00379769|455623495|FG002|Main Study|Moved to survival status follow-up only|32|||
126634811|NCT00379769|455623496|FG003|Main Study|Moved to survival status follow-up only|36|||
126634812|NCT00379769|455623497|FG004|Main Study|Moved to survival status follow-up only|0|||
126634813|NCT00379769|455623498|FG005|Main Study|Moved to survival status follow-up only|0|||
126634814|NCT00379769|455623493|FG000|Main Study|Participant moved|3|||
126634815|NCT00379769|455623494|FG001|Main Study|Participant moved|2|||
126634816|NCT00379769|455623495|FG002|Main Study|Participant moved|3|||
126634817|NCT00379769|455623496|FG003|Main Study|Participant moved|3|||
126634818|NCT00379769|455623497|FG004|Main Study|Participant moved|0|||
126634819|NCT00379769|455623498|FG005|Main Study|Participant moved|0|||
126634820|NCT00379769|455623493|FG000|Main Study|Poor compliance|3|||
126634821|NCT00379769|455623494|FG001|Main Study|Poor compliance|2|||
126634822|NCT00379769|455623495|FG002|Main Study|Poor compliance|2|||
126634823|NCT00379769|455623496|FG003|Main Study|Poor compliance|1|||
126634824|NCT00379769|455623497|FG004|Main Study|Poor compliance|0|||
126634825|NCT00379769|455623498|FG005|Main Study|Poor compliance|0|||
126634826|NCT00379769|455623493|FG000|Main Study|Prohibited glucose lowering medication|0|||
126634827|NCT00379769|455623494|FG001|Main Study|Prohibited glucose lowering medication|3|||
126634828|NCT00379769|455623495|FG002|Main Study|Prohibited glucose lowering medication|0|||
126634829|NCT00379769|455623496|FG003|Main Study|Prohibited glucose lowering medication|1|||
126634830|NCT00379769|455623497|FG004|Main Study|Prohibited glucose lowering medication|0|||
126634831|NCT00379769|455623498|FG005|Main Study|Prohibited glucose lowering medication|0|||
126634832|NCT00379769|455623493|FG000|Main Study|Site closed|4|||
126634833|NCT00379769|455623494|FG001|Main Study|Site closed|4|||
126634834|NCT00379769|455623495|FG002|Main Study|Site closed|4|||
126634835|NCT00379769|455623496|FG003|Main Study|Site closed|8|||
126634836|NCT00379769|455623497|FG004|Main Study|Site closed|0|||
126634837|NCT00379769|455623498|FG005|Main Study|Site closed|0|||
126634838|NCT00379769|455623493|FG000|Main Study|Entry criteria violation|0|||
126634839|NCT00379769|455623494|FG001|Main Study|Entry criteria violation|0|||
126634840|NCT00379769|455623495|FG002|Main Study|Entry criteria violation|1|||
126634841|NCT00379769|455623496|FG003|Main Study|Entry criteria violation|1|||
126634842|NCT00379769|455623497|FG004|Main Study|Entry criteria violation|0|||
126634843|NCT00379769|455623498|FG005|Main Study|Entry criteria violation|0|||
126634844|NCT00379769|455623493|FG000|Main Study|Participant did not take study drug|0|||
126634845|NCT00379769|455623494|FG001|Main Study|Participant did not take study drug|0|||
126634846|NCT00379769|455623495|FG002|Main Study|Participant did not take study drug|1|||
126634847|NCT00379769|455623496|FG003|Main Study|Participant did not take study drug|0|||
126634848|NCT00379769|455623497|FG004|Main Study|Participant did not take study drug|0|||
126634849|NCT00379769|455623498|FG005|Main Study|Participant did not take study drug|0|||
126634850|NCT00379769|455623493|FG000|Main Study|Physician Decision|2|||
126634851|NCT00379769|455623494|FG001|Main Study|Physician Decision|2|||
126634852|NCT00379769|455623495|FG002|Main Study|Physician Decision|1|||
126634853|NCT00379769|455623496|FG003|Main Study|Physician Decision|1|||
126634854|NCT00379769|455623497|FG004|Main Study|Physician Decision|0|||
126634855|NCT00379769|455623498|FG005|Main Study|Physician Decision|0|||
126634856|NCT00379769|455623493|FG000|Main Study|Participant completed study at visit 27|1|||
126634857|NCT00379769|455623494|FG001|Main Study|Participant completed study at visit 27|0|||
126634858|NCT00379769|455623495|FG002|Main Study|Participant completed study at visit 27|0|||
126634859|NCT00379769|455623496|FG003|Main Study|Participant completed study at visit 27|0|||
126634860|NCT00379769|455623497|FG004|Main Study|Participant completed study at visit 27|0|||
126634861|NCT00379769|455623498|FG005|Main Study|Participant completed study at visit 27|0|||
126634862|NCT00379769|455623493|FG000|Main Study|Personal reasons|1|||
126634863|NCT00379769|455623494|FG001|Main Study|Personal reasons|0|||
126634864|NCT00379769|455623495|FG002|Main Study|Personal reasons|0|||
126634865|NCT00379769|455623496|FG003|Main Study|Personal reasons|0|||
126634866|NCT00379769|455623497|FG004|Main Study|Personal reasons|0|||
126634867|NCT00379769|455623498|FG005|Main Study|Personal reasons|0|||
126634868|NCT00379769|455623493|FG000|Main Study|Risk of heart failure|0|||
126634869|NCT00379769|455623494|FG001|Main Study|Risk of heart failure|1|||
126634870|NCT00379769|455623495|FG002|Main Study|Risk of heart failure|0|||
126634871|NCT00379769|455623496|FG003|Main Study|Risk of heart failure|0|||
126634872|NCT00379769|455623497|FG004|Main Study|Risk of heart failure|0|||
126634873|NCT00379769|455623498|FG005|Main Study|Risk of heart failure|0|||
126634874|NCT00379769|455623493|FG000|Main Study|Investigator refused to log temperature|0|||
126634875|NCT00379769|455623494|FG001|Main Study|Investigator refused to log temperature|0|||
126634876|NCT00379769|455623495|FG002|Main Study|Investigator refused to log temperature|1|||
126634877|NCT00379769|455623496|FG003|Main Study|Investigator refused to log temperature|0|||
126634878|NCT00379769|455623497|FG004|Main Study|Investigator refused to log temperature|0|||
126634879|NCT00379769|455623498|FG005|Main Study|Investigator refused to log temperature|0|||
126634880|NCT00379769|455623493|FG000|Main Study|Reason unspecified|0|||
126634881|NCT00379769|455623494|FG001|Main Study|Reason unspecified|0|||
126634882|NCT00379769|455623495|FG002|Main Study|Reason unspecified|1|||
126634883|NCT00379769|455623496|FG003|Main Study|Reason unspecified|0|||
126634884|NCT00379769|455623497|FG004|Main Study|Reason unspecified|0|||
126634885|NCT00379769|455623498|FG005|Main Study|Reason unspecified|0|||
126634886|NCT00379769|455623493|FG000|Observational Follow-up|Death|0|||
126634887|NCT00379769|455623494|FG001|Observational Follow-up|Death|0|||
126634888|NCT00379769|455623495|FG002|Observational Follow-up|Death|0|||
126634889|NCT00379769|455623496|FG003|Observational Follow-up|Death|0|||
126634890|NCT00379769|455623497|FG004|Observational Follow-up|Death|78|||
126634891|NCT00379769|455623498|FG005|Observational Follow-up|Death|70|||
126634892|NCT00379769|455623493|FG000|Observational Follow-up|Adverse Event|0|||
126634893|NCT00379769|455623494|FG001|Observational Follow-up|Adverse Event|0|||
126634894|NCT00379769|455623495|FG002|Observational Follow-up|Adverse Event|0|||
126634895|NCT00379769|455623496|FG003|Observational Follow-up|Adverse Event|0|||
126755995|NCT02839330|456057327|FG003|Overall Study|Other reason, not specified|6|||
126755996|NCT00508872|456057331|FG000|Overall Study|Lost to Follow-up|1|||
126755997|NCT00508872|456057331|FG000|Overall Study|Physician Decision|1|||
126755998|NCT03007472|456057332|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
126755999|NCT03007472|456057332|FG000|Overall Study|Death|2|||
126756000|NCT03007472|456057332|FG000|Overall Study|Loss to Follow Up|1|||
126756001|NCT01220024|456057341|FG000|Overall Study|Lost to Follow-up|1|||
126756002|NCT01220024|456057342|FG001|Overall Study|Lost to Follow-up|1|||
126634896|NCT00379769|455623497|FG004|Observational Follow-up|Adverse Event|1|||
126634897|NCT00379769|455623498|FG005|Observational Follow-up|Adverse Event|0|||
126634898|NCT00379769|455623493|FG000|Observational Follow-up|Lost to Follow-up|0|||
126634899|NCT00379769|455623494|FG001|Observational Follow-up|Lost to Follow-up|0|||
126634900|NCT00379769|455623495|FG002|Observational Follow-up|Lost to Follow-up|0|||
126756003|NCT00174460|456057343|FG000|Overall Study|Withdrawal by Subject|0|||
126634901|NCT00379769|455623496|FG003|Observational Follow-up|Lost to Follow-up|0|||
126634902|NCT00379769|455623497|FG004|Observational Follow-up|Lost to Follow-up|25|||
126634903|NCT00379769|455623498|FG005|Observational Follow-up|Lost to Follow-up|27|||
126634904|NCT00379769|455623493|FG000|Observational Follow-up|Withdrawal by Subject|0|||
126634905|NCT00379769|455623494|FG001|Observational Follow-up|Withdrawal by Subject|0|||
126634906|NCT00379769|455623495|FG002|Observational Follow-up|Withdrawal by Subject|0|||
126634907|NCT00379769|455623496|FG003|Observational Follow-up|Withdrawal by Subject|0|||
126634908|NCT00379769|455623497|FG004|Observational Follow-up|Withdrawal by Subject|12|||
126634909|NCT00379769|455623498|FG005|Observational Follow-up|Withdrawal by Subject|12|||
126634910|NCT00379769|455623493|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
126634911|NCT00379769|455623494|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
126634912|NCT00379769|455623495|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
126634913|NCT00379769|455623496|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
126634914|NCT00379769|455623497|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
126634915|NCT00379769|455623498|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
126634916|NCT00379769|455623493|FG000|Observational Follow-up|Physician Decision|0|||
126634917|NCT00379769|455623494|FG001|Observational Follow-up|Physician Decision|0|||
126634918|NCT00379769|455623495|FG002|Observational Follow-up|Physician Decision|0|||
126634919|NCT00379769|455623496|FG003|Observational Follow-up|Physician Decision|0|||
126634920|NCT00379769|455623497|FG004|Observational Follow-up|Physician Decision|8|||
126634921|NCT00379769|455623498|FG005|Observational Follow-up|Physician Decision|8|||
126634922|NCT00379769|455623493|FG000|Observational Follow-up|Site Closed Early|0|||
126634923|NCT00379769|455623494|FG001|Observational Follow-up|Site Closed Early|0|||
126634924|NCT00379769|455623495|FG002|Observational Follow-up|Site Closed Early|0|||
126634925|NCT00379769|455623496|FG003|Observational Follow-up|Site Closed Early|0|||
126634926|NCT00379769|455623497|FG004|Observational Follow-up|Site Closed Early|6|||
126634927|NCT00379769|455623498|FG005|Observational Follow-up|Site Closed Early|7|||
126634928|NCT00379769|455623493|FG000|Observational Follow-up|Participant Moved|0|||
126634929|NCT00379769|455623494|FG001|Observational Follow-up|Participant Moved|0|||
126634930|NCT00379769|455623495|FG002|Observational Follow-up|Participant Moved|0|||
126634931|NCT00379769|455623496|FG003|Observational Follow-up|Participant Moved|0|||
126634932|NCT00379769|455623497|FG004|Observational Follow-up|Participant Moved|0|||
126634933|NCT00379769|455623498|FG005|Observational Follow-up|Participant Moved|1|||
126634934|NCT00379769|455623493|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
126634935|NCT00379769|455623494|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
126634936|NCT00379769|455623495|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
126634937|NCT00379769|455623496|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
126634938|NCT00379769|455623497|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
126634939|NCT00379769|455623498|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
126634940|NCT03778294|455623499|FG000|Overall Study|Death|1|||
126634941|NCT03778294|455623499|FG000|Overall Study|Issues with insurance|1|||
126634942|NCT03778294|455623499|FG000|Overall Study|disease progression before treatment|2|||
126634943|NCT02666664|455623502|FG000|Overall Study|Physician Decision|0|||
126634944|NCT02666664|455623503|FG001|Overall Study|Physician Decision|1|||
126634945|NCT02666664|455623502|FG000|Overall Study|Protocol Violation|0|||
126634946|NCT02666664|455623503|FG001|Overall Study|Protocol Violation|2|||
126634947|NCT02666664|455623502|FG000|Overall Study|Other|0|||
126634948|NCT02666664|455623503|FG001|Overall Study|Other|1|||
126634949|NCT02666664|455623502|FG000|Overall Study|Adverse Event|12|||
126634950|NCT02666664|455623503|FG001|Overall Study|Adverse Event|37|||
126634951|NCT02666664|455623502|FG000|Overall Study|Withdrawal by participant|23|||
126634952|NCT02666664|455623503|FG001|Overall Study|Withdrawal by participant|40|||
126634953|NCT02666664|455623502|FG000|Overall Study|Sponsor decision|0|||
126634954|NCT02666664|455623503|FG001|Overall Study|Sponsor decision|1|||
126634955|NCT02666664|455623502|FG000|Overall Study|Lost to Follow-up|1|||
126634956|NCT02666664|455623503|FG001|Overall Study|Lost to Follow-up|2|||
126634957|NCT00971997|455623504|FG000|Overall Study|Adverse Event|2|||
126634958|NCT00971997|455623504|FG000|Overall Study|Death|1|||
126634959|NCT00971997|455623504|FG000|Overall Study|Protocol Violation|4|||
126634960|NCT00971997|455623504|FG000|Overall Study|Withdrawal by Subject|5|||
126634961|NCT00971997|455623504|FG000|Overall Study|Physician Decision|7|||
126634962|NCT01385748|455623505|FG000|Overall Study|Withdrawal by Subject|7|||
126634963|NCT01385748|455623506|FG001|Overall Study|Withdrawal by Subject|4|||
126634964|NCT01385748|455623507|FG002|Overall Study|Withdrawal by Subject|5|||
126634965|NCT01385748|455623505|FG000|Overall Study|Noncompliance|3|||
126634966|NCT01385748|455623506|FG001|Overall Study|Noncompliance|1|||
126634967|NCT01385748|455623507|FG002|Overall Study|Noncompliance|6|||
126634968|NCT01385748|455623505|FG000|Overall Study|Other|1|||
126634969|NCT01385748|455623506|FG001|Overall Study|Other|7|||
126634970|NCT01385748|455623507|FG002|Overall Study|Other|1|||
126634971|NCT01385748|455623505|FG000|Overall Study|Adverse Event|4|||
126634972|NCT01385748|455623506|FG001|Overall Study|Adverse Event|2|||
126634973|NCT01385748|455623507|FG002|Overall Study|Adverse Event|1|||
126634974|NCT01458522|455623508|FG000|Overall Study|Withdrawal by Subject|2|||
126634975|NCT01458522|455623509|FG001|Overall Study|Withdrawal by Subject|2|||
126634976|NCT01458522|455623508|FG000|Overall Study|Physician Decision|1|||
126634977|NCT01458522|455623509|FG001|Overall Study|Physician Decision|9|||
126634978|NCT02684123|455623510|FG000|Phase 1|Lack of Efficacy|5|||
126634979|NCT02684123|455623511|FG001|Phase 1|Lack of Efficacy|0|||
126634980|NCT02684123|455623510|FG000|Phase 1|Adverse Event|3|||
126634981|NCT02684123|455623511|FG001|Phase 1|Adverse Event|0|||
126634982|NCT02684123|455623510|FG000|Phase 1|Lost to Follow-up|0|||
126634983|NCT02684123|455623511|FG001|Phase 1|Lost to Follow-up|1|||
126634984|NCT02684123|455623510|FG000|Phase 2|Lack of Efficacy|1|||
126634985|NCT02684123|455623511|FG001|Phase 2|Lack of Efficacy|8|||
126634986|NCT00516139|455623512|FG000|Overall Study|Adverse Event|27|||
126634987|NCT00516139|455623512|FG000|Overall Study|Lost to Follow-up|1|||
126634988|NCT00516139|455623512|FG000|Overall Study|Protocol Violation|1|||
126634989|NCT00516139|455623512|FG000|Overall Study|Withdrawal by Subject|8|||
126634990|NCT00516139|455623512|FG000|Overall Study|Lack of Efficacy|1|||
126634991|NCT00730015|455623519|FG000|Overall Study|Adverse Event|11|||
126634992|NCT00730015|455623520|FG001|Overall Study|Adverse Event|10|||
126634993|NCT00730015|455623521|FG002|Overall Study|Adverse Event|8|||
126634994|NCT00730015|455623519|FG000|Overall Study|Protocol Violation|2|||
126634995|NCT00730015|455623520|FG001|Overall Study|Protocol Violation|6|||
126634996|NCT00730015|455623521|FG002|Overall Study|Protocol Violation|4|||
126634997|NCT00730015|455623519|FG000|Overall Study|Withdrawal by Subject|12|||
126634998|NCT00730015|455623520|FG001|Overall Study|Withdrawal by Subject|12|||
126634999|NCT00730015|455623521|FG002|Overall Study|Withdrawal by Subject|8|||
126635000|NCT00730015|455623519|FG000|Overall Study|Lost to Follow-up|4|||
126635001|NCT00730015|455623520|FG001|Overall Study|Lost to Follow-up|10|||
126635002|NCT00730015|455623521|FG002|Overall Study|Lost to Follow-up|3|||
126635003|NCT00730015|455623519|FG000|Overall Study|Lack of Efficacy|1|||
126635004|NCT00730015|455623520|FG001|Overall Study|Lack of Efficacy|2|||
126635005|NCT00730015|455623521|FG002|Overall Study|Lack of Efficacy|8|||
126635006|NCT00730015|455623519|FG000|Overall Study|Other Reason|1|||
126635007|NCT00730015|455623520|FG001|Overall Study|Other Reason|0|||
126635008|NCT00730015|455623521|FG002|Overall Study|Other Reason|1|||
126635009|NCT02641587|455623522|FG000|Confinement Period|Adverse Event|1|||
126635010|NCT02641587|455623523|FG001|Confinement Period|Adverse Event|0|||
126635011|NCT02641587|455623522|FG000|Confinement Period|Withdrawal by Subject|2|||
126635012|NCT02641587|455623523|FG001|Confinement Period|Withdrawal by Subject|1|||
126635013|NCT02641587|455623522|FG000|Ambulatory Period|Withdrawal by Subject|1|||
126635014|NCT02641587|455623523|FG001|Ambulatory Period|Withdrawal by Subject|0|||
126635015|NCT01165177|455623524|FG000|Overall Study|Serious Adverse Event|227|||
126635016|NCT01165177|455623525|FG001|Overall Study|Serious Adverse Event|235|||
126635017|NCT01165177|455623524|FG000|Overall Study|Withdrawal by Subject|368|||
126635018|NCT01165177|455623525|FG001|Overall Study|Withdrawal by Subject|354|||
126635019|NCT01165177|455623524|FG000|Overall Study|Protocol Violation|19|||
126635020|NCT01165177|455623525|FG001|Overall Study|Protocol Violation|21|||
126635021|NCT01165177|455623524|FG000|Overall Study|Non-serious adverse event|30|||
126635022|NCT01165177|455623525|FG001|Overall Study|Non-serious adverse event|18|||
126635023|NCT01165177|455623524|FG000|Overall Study|Other unspecified reasons|47|||
126635024|NCT01165177|455623525|FG001|Overall Study|Other unspecified reasons|35|||
126635025|NCT01165177|455623524|FG000|Overall Study|Suspected HZ episode|0|||
126635026|NCT01165177|455623525|FG001|Overall Study|Suspected HZ episode|2|||
126635027|NCT01165177|455623524|FG000|Overall Study|Lost to Follow-up|183|||
126635028|NCT01165177|455623525|FG001|Overall Study|Lost to Follow-up|194|||
126635029|NCT01165177|455623524|FG000|Overall Study|Migrated/ moved from study area|48|||
126635030|NCT01165177|455623525|FG001|Overall Study|Migrated/ moved from study area|43|||
126635031|NCT01663506|455623526|FG000|Overall Study|Lack of Efficacy|3|||
126635032|NCT01663506|455623526|FG000|Overall Study|Consent Withdrawal by Subject|1|||
126635033|NCT01663506|455623526|FG000|Overall Study|Lost to Follow-up|1|||
126635034|NCT01663506|455623526|FG000|Overall Study|Adverse Event|1|||
126635035|NCT01663506|455623526|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
126635036|NCT03210519|455623527|FG000|Overall Study|Adverse Event|2|||
126635037|NCT03210519|455623528|FG001|Overall Study|Adverse Event|0|||
126635038|NCT02270671|455623531|FG000|Overall Study|Withdrawal by Subject|1|||
126635039|NCT02270671|455623532|FG001|Overall Study|Withdrawal by Subject|1|||
126635040|NCT02270671|455623531|FG000|Overall Study|Protocol Violation|0|||
126635041|NCT02270671|455623532|FG001|Overall Study|Protocol Violation|1|||
126635042|NCT02270671|455623531|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
126635043|NCT02270671|455623532|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
126635044|NCT02270671|455623531|FG000|Overall Study|Lost to Follow-up|2|||
126635045|NCT02270671|455623532|FG001|Overall Study|Lost to Follow-up|1|||
126635046|NCT00174447|455623542|FG000|Overall Study|Adverse Event|19|||
126635047|NCT00174447|455623542|FG000|Overall Study|Withdrawal by Subject|15|||
126635048|NCT00174447|455623542|FG000|Overall Study|Protocol Violation|1|||
126635049|NCT00174447|455623542|FG000|Overall Study|Lack of Efficacy|1|||
126635050|NCT00174447|455623542|FG000|Overall Study|Administrative reason/Other|2|||
126635051|NCT01437423|455623543|FG000|Overall Study|Lost to Follow-up|12|||
126635052|NCT01437423|455623543|FG000|Overall Study|Off label usage|3|||
126635053|NCT05878873|455623544|FG000|Overall Study|Lost to Follow-up|2|||
126635054|NCT05878873|455623545|FG001|Overall Study|Lost to Follow-up|0|||
126635055|NCT00633945|455623546|FG000|Overall Study|Physician Decision|2|||
126635056|NCT00882115|455623547|FG000|Overall Study|Withdrawal by Subject|3|||
126635057|NCT00882115|455623547|FG000|Overall Study|did not respond to DEP challe|6|||
126635058|NCT03865953|455623548|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
126635059|NCT03865953|455623549|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
126635060|NCT03865953|455623548|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
126635061|NCT03865953|455623549|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
126635062|NCT03865953|455623548|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
126635063|NCT03865953|455623549|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
126635064|NCT02552147|455623550|FG000|First Intervention (7 Days)|Protocol Violation|1|||
126635065|NCT02552147|455623551|FG001|First Intervention (7 Days)|Protocol Violation|0|||
126635066|NCT02552147|455623550|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
126635067|NCT02552147|455623551|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
126635068|NCT02375347|455623552|FG000|Overall Study|Protocol Violation|1|||
126635069|NCT03000348|455623554|FG000|Overall Study|Adverse Event|1|||
126635070|NCT03000348|455623555|FG001|Overall Study|Adverse Event|1|||
126635071|NCT03000348|455623556|FG002|Overall Study|Adverse Event|1|||
126635072|NCT03000348|455623557|FG003|Overall Study|Adverse Event|1|||
126635073|NCT03000348|455623558|FG004|Overall Study|Adverse Event|1|||
126635074|NCT03000348|455623559|FG005|Overall Study|Adverse Event|1|||
126635075|NCT03000348|455623554|FG000|Overall Study|Lost to Follow-up|0|||
126635076|NCT03000348|455623555|FG001|Overall Study|Lost to Follow-up|0|||
126635077|NCT03000348|455623556|FG002|Overall Study|Lost to Follow-up|1|||
126635078|NCT03000348|455623557|FG003|Overall Study|Lost to Follow-up|0|||
126635079|NCT03000348|455623558|FG004|Overall Study|Lost to Follow-up|0|||
126635080|NCT03000348|455623559|FG005|Overall Study|Lost to Follow-up|0|||
126635081|NCT03000348|455623554|FG000|Overall Study|Withdrawal by Subject|0|||
126635082|NCT03000348|455623555|FG001|Overall Study|Withdrawal by Subject|1|||
126635083|NCT03000348|455623556|FG002|Overall Study|Withdrawal by Subject|0|||
126635084|NCT03000348|455623557|FG003|Overall Study|Withdrawal by Subject|0|||
126635085|NCT03000348|455623558|FG004|Overall Study|Withdrawal by Subject|0|||
126635086|NCT03000348|455623559|FG005|Overall Study|Withdrawal by Subject|0|||
126635087|NCT03000348|455623554|FG000|Overall Study|Consent|0|||
126635088|NCT03000348|455623555|FG001|Overall Study|Consent|0|||
126635089|NCT03000348|455623556|FG002|Overall Study|Consent|0|||
126635090|NCT03000348|455623557|FG003|Overall Study|Consent|0|||
126635091|NCT03000348|455623558|FG004|Overall Study|Consent|1|||
126635092|NCT03000348|455623559|FG005|Overall Study|Consent|0|||
126635093|NCT03000348|455623554|FG000|Overall Study|Failure to expectorate sputum|1|||
126635094|NCT03000348|455623555|FG001|Overall Study|Failure to expectorate sputum|0|||
126635095|NCT03000348|455623556|FG002|Overall Study|Failure to expectorate sputum|1|||
126635096|NCT03000348|455623557|FG003|Overall Study|Failure to expectorate sputum|0|||
126635097|NCT03000348|455623558|FG004|Overall Study|Failure to expectorate sputum|1|||
126635098|NCT03000348|455623559|FG005|Overall Study|Failure to expectorate sputum|0|||
126635099|NCT03000348|455623554|FG000|Overall Study|No gram negative|1|||
126635100|NCT03000348|455623555|FG001|Overall Study|No gram negative|2|||
126635101|NCT03000348|455623556|FG002|Overall Study|No gram negative|1|||
126635102|NCT03000348|455623557|FG003|Overall Study|No gram negative|1|||
126635103|NCT03000348|455623558|FG004|Overall Study|No gram negative|1|||
126635104|NCT03000348|455623559|FG005|Overall Study|No gram negative|1|||
126635105|NCT03000348|455623554|FG000|Overall Study|Patient had no transport|0|||
126635106|NCT03000348|455623555|FG001|Overall Study|Patient had no transport|0|||
126635107|NCT03000348|455623556|FG002|Overall Study|Patient had no transport|0|||
126635108|NCT03000348|455623557|FG003|Overall Study|Patient had no transport|1|||
126635109|NCT03000348|455623558|FG004|Overall Study|Patient had no transport|0|||
126635110|NCT03000348|455623559|FG005|Overall Study|Patient had no transport|0|||
126635111|NCT03000348|455623554|FG000|Overall Study|Dosing|0|||
126635112|NCT03000348|455623555|FG001|Overall Study|Dosing|0|||
126635113|NCT03000348|455623556|FG002|Overall Study|Dosing|0|||
126635114|NCT03000348|455623557|FG003|Overall Study|Dosing|0|||
126635115|NCT03000348|455623558|FG004|Overall Study|Dosing|1|||
126635116|NCT03000348|455623559|FG005|Overall Study|Dosing|0|||
126635117|NCT04042077|455623560|FG000|Overall Study|Adverse Event|0|||
126635118|NCT04042077|455623561|FG001|Overall Study|Adverse Event|1|||
126635119|NCT04042077|455623560|FG000|Overall Study|Death|2|||
126635120|NCT04042077|455623561|FG001|Overall Study|Death|1|||
126635121|NCT04042077|455623560|FG000|Overall Study|Physician Decision|2|||
126635122|NCT04042077|455623561|FG001|Overall Study|Physician Decision|0|||
126635123|NCT04042077|455623560|FG000|Overall Study|Withdrawal by Subject|3|||
126635124|NCT04042077|455623561|FG001|Overall Study|Withdrawal by Subject|2|||
126635125|NCT04042077|455623560|FG000|Overall Study|Lack of Efficacy|0|||
126635126|NCT04042077|455623561|FG001|Overall Study|Lack of Efficacy|1|||
126635127|NCT00745498|455623563|FG000|Overall Study|Lost to Follow-up|1|||
126635128|NCT00745498|455623564|FG001|Overall Study|Lost to Follow-up|1|||
126635129|NCT00745498|455623565|FG002|Overall Study|Lost to Follow-up|3|||
126635130|NCT00745498|455623563|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
126635131|NCT00745498|455623564|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
126635132|NCT00745498|455623565|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
126635133|NCT00745498|455623563|FG000|Overall Study|Non-PDR related VH|0|||
126635134|NCT00745498|455623564|FG001|Overall Study|Non-PDR related VH|1|||
126635135|NCT00745498|455623565|FG002|Overall Study|Non-PDR related VH|1|||
126635136|NCT00745498|455623563|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
126635137|NCT00745498|455623564|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
126635138|NCT00745498|455623565|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
126635139|NCT01236352|455623569|FG000|Overall Study|Death|0|||
126635140|NCT01236352|455623570|FG001|Overall Study|Death|0|||
126635141|NCT01236352|455623571|FG002|Overall Study|Death|0|||
126635142|NCT01236352|455623572|FG003|Overall Study|Death|0|||
126635143|NCT01236352|455623573|FG004|Overall Study|Death|0|||
126635144|NCT01236352|455623574|FG005|Overall Study|Death|0|||
126635145|NCT01236352|455623575|FG006|Overall Study|Death|0|||
126635146|NCT01236352|455623576|FG007|Overall Study|Death|1|||
126635147|NCT01236352|455623577|FG008|Overall Study|Death|0|||
126635148|NCT01236352|455623578|FG009|Overall Study|Death|0|||
126635149|NCT01236352|455623579|FG010|Overall Study|Death|0|||
126635150|NCT01236352|455623569|FG000|Overall Study|Withdrawal by Subject|0|||
126635151|NCT01236352|455623570|FG001|Overall Study|Withdrawal by Subject|0|||
126635152|NCT01236352|455623571|FG002|Overall Study|Withdrawal by Subject|0|||
126635153|NCT01236352|455623572|FG003|Overall Study|Withdrawal by Subject|0|||
126635154|NCT01236352|455623573|FG004|Overall Study|Withdrawal by Subject|0|||
126635155|NCT01236352|455623574|FG005|Overall Study|Withdrawal by Subject|0|||
126635156|NCT01236352|455623575|FG006|Overall Study|Withdrawal by Subject|0|||
126635157|NCT01236352|455623576|FG007|Overall Study|Withdrawal by Subject|0|||
126635158|NCT01236352|455623577|FG008|Overall Study|Withdrawal by Subject|0|||
126635159|NCT01236352|455623578|FG009|Overall Study|Withdrawal by Subject|2|||
126635160|NCT01236352|455623579|FG010|Overall Study|Withdrawal by Subject|1|||
126635161|NCT01236352|455623569|FG000|Overall Study|Adverse Event|0|||
126635162|NCT01236352|455623570|FG001|Overall Study|Adverse Event|0|||
126635163|NCT01236352|455623571|FG002|Overall Study|Adverse Event|0|||
126635164|NCT01236352|455623572|FG003|Overall Study|Adverse Event|0|||
126635165|NCT01236352|455623573|FG004|Overall Study|Adverse Event|0|||
126635166|NCT01236352|455623574|FG005|Overall Study|Adverse Event|0|||
126635167|NCT01236352|455623575|FG006|Overall Study|Adverse Event|2|||
126635168|NCT01236352|455623576|FG007|Overall Study|Adverse Event|0|||
126635169|NCT01236352|455623577|FG008|Overall Study|Adverse Event|0|||
126635170|NCT01236352|455623578|FG009|Overall Study|Adverse Event|4|||
126635171|NCT01236352|455623579|FG010|Overall Study|Adverse Event|1|||
126635172|NCT01236352|455623569|FG000|Overall Study|Study drug toxicity|0|||
126635173|NCT01236352|455623570|FG001|Overall Study|Study drug toxicity|0|||
126635174|NCT01236352|455623571|FG002|Overall Study|Study drug toxicity|0|||
126635175|NCT01236352|455623572|FG003|Overall Study|Study drug toxicity|0|||
126635176|NCT01236352|455623573|FG004|Overall Study|Study drug toxicity|0|||
126635177|NCT01236352|455623574|FG005|Overall Study|Study drug toxicity|1|||
126635178|NCT01236352|455623575|FG006|Overall Study|Study drug toxicity|1|||
126635179|NCT01236352|455623576|FG007|Overall Study|Study drug toxicity|0|||
126635180|NCT01236352|455623577|FG008|Overall Study|Study drug toxicity|0|||
126635181|NCT01236352|455623578|FG009|Overall Study|Study drug toxicity|2|||
126635182|NCT01236352|455623579|FG010|Overall Study|Study drug toxicity|2|||
126635183|NCT01236352|455623569|FG000|Overall Study|Disease progression|1|||
126635184|NCT01236352|455623570|FG001|Overall Study|Disease progression|2|||
126635185|NCT01236352|455623571|FG002|Overall Study|Disease progression|1|||
126635186|NCT01236352|455623572|FG003|Overall Study|Disease progression|2|||
126635187|NCT01236352|455623573|FG004|Overall Study|Disease progression|2|||
126635188|NCT01236352|455623574|FG005|Overall Study|Disease progression|2|||
126635189|NCT01236352|455623575|FG006|Overall Study|Disease progression|1|||
126635190|NCT01236352|455623576|FG007|Overall Study|Disease progression|3|||
126635191|NCT01236352|455623577|FG008|Overall Study|Disease progression|2|||
126635192|NCT01236352|455623578|FG009|Overall Study|Disease progression|2|||
126635193|NCT01236352|455623579|FG010|Overall Study|Disease progression|2|||
126635194|NCT01236352|455623569|FG000|Overall Study|Poor/Non-compliance|1|||
126635195|NCT01236352|455623570|FG001|Overall Study|Poor/Non-compliance|0|||
126635196|NCT01236352|455623571|FG002|Overall Study|Poor/Non-compliance|0|||
126635197|NCT01236352|455623572|FG003|Overall Study|Poor/Non-compliance|0|||
126635198|NCT01236352|455623573|FG004|Overall Study|Poor/Non-compliance|0|||
126635199|NCT01236352|455623574|FG005|Overall Study|Poor/Non-compliance|0|||
126635200|NCT01236352|455623575|FG006|Overall Study|Poor/Non-compliance|0|||
126635201|NCT01236352|455623576|FG007|Overall Study|Poor/Non-compliance|0|||
126635202|NCT01236352|455623577|FG008|Overall Study|Poor/Non-compliance|0|||
126635203|NCT01236352|455623578|FG009|Overall Study|Poor/Non-compliance|0|||
126635204|NCT01236352|455623579|FG010|Overall Study|Poor/Non-compliance|0|||
126635205|NCT01236352|455623569|FG000|Overall Study|Maximum clinical benefit|1|||
126635206|NCT01236352|455623570|FG001|Overall Study|Maximum clinical benefit|1|||
126635207|NCT01236352|455623571|FG002|Overall Study|Maximum clinical benefit|1|||
126635208|NCT01236352|455623572|FG003|Overall Study|Maximum clinical benefit|0|||
126635209|NCT01236352|455623573|FG004|Overall Study|Maximum clinical benefit|2|||
126635210|NCT01236352|455623574|FG005|Overall Study|Maximum clinical benefit|0|||
126635211|NCT01236352|455623575|FG006|Overall Study|Maximum clinical benefit|3|||
126635212|NCT01236352|455623576|FG007|Overall Study|Maximum clinical benefit|1|||
126635213|NCT01236352|455623577|FG008|Overall Study|Maximum clinical benefit|1|||
126635214|NCT01236352|455623578|FG009|Overall Study|Maximum clinical benefit|4|||
126635215|NCT01236352|455623579|FG010|Overall Study|Maximum clinical benefit|2|||
126635216|NCT01236352|455623569|FG000|Overall Study|Subject request to discontinue treatment|0|||
126635217|NCT01236352|455623570|FG001|Overall Study|Subject request to discontinue treatment|0|||
126635218|NCT01236352|455623571|FG002|Overall Study|Subject request to discontinue treatment|1|||
126635219|NCT01236352|455623572|FG003|Overall Study|Subject request to discontinue treatment|1|||
126635220|NCT01236352|455623573|FG004|Overall Study|Subject request to discontinue treatment|0|||
126635221|NCT01236352|455623574|FG005|Overall Study|Subject request to discontinue treatment|1|||
126635222|NCT01236352|455623575|FG006|Overall Study|Subject request to discontinue treatment|0|||
126635223|NCT01236352|455623576|FG007|Overall Study|Subject request to discontinue treatment|0|||
126635224|NCT01236352|455623577|FG008|Overall Study|Subject request to discontinue treatment|0|||
126635225|NCT01236352|455623578|FG009|Overall Study|Subject request to discontinue treatment|1|||
126635226|NCT01236352|455623579|FG010|Overall Study|Subject request to discontinue treatment|4|||
126635227|NCT01236352|455623569|FG000|Overall Study|Subject to receive drug via EAP|1|||
126635228|NCT01236352|455623570|FG001|Overall Study|Subject to receive drug via EAP|1|||
126635229|NCT01236352|455623571|FG002|Overall Study|Subject to receive drug via EAP|1|||
126635230|NCT01236352|455623572|FG003|Overall Study|Subject to receive drug via EAP|0|||
126635231|NCT01236352|455623573|FG004|Overall Study|Subject to receive drug via EAP|0|||
126635232|NCT01236352|455623574|FG005|Overall Study|Subject to receive drug via EAP|0|||
126635233|NCT01236352|455623575|FG006|Overall Study|Subject to receive drug via EAP|0|||
126635234|NCT01236352|455623576|FG007|Overall Study|Subject to receive drug via EAP|2|||
126635235|NCT01236352|455623577|FG008|Overall Study|Subject to receive drug via EAP|0|||
126635236|NCT01236352|455623578|FG009|Overall Study|Subject to receive drug via EAP|4|||
126635237|NCT01236352|455623579|FG010|Overall Study|Subject to receive drug via EAP|0|||
126635238|NCT01236352|455623569|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
126635239|NCT01236352|455623570|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
126635240|NCT01236352|455623571|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
126635241|NCT01236352|455623572|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
126635242|NCT01236352|455623573|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
126635243|NCT01236352|455623574|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
126635244|NCT01236352|455623575|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
126635245|NCT01236352|455623576|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
126635246|NCT01236352|455623577|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
126635247|NCT01236352|455623578|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
126635248|NCT01236352|455623579|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
126635249|NCT01236352|455623569|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126635250|NCT01236352|455623570|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126635251|NCT01236352|455623571|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126635252|NCT01236352|455623572|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126635253|NCT01236352|455623573|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126635254|NCT01236352|455623574|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126635255|NCT01236352|455623575|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126635256|NCT01236352|455623576|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126635257|NCT01236352|455623577|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126635258|NCT01236352|455623578|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
126635259|NCT01236352|455623579|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
126635260|NCT01236352|455623569|FG000|Overall Study|Lack of response to drug|0|||
126756004|NCT00174460|456057344|FG001|Overall Study|Withdrawal by Subject|1|||
126756005|NCT00490815|456057347|FG000|Overall Study|Adverse Event|2|||
126756006|NCT00490815|456057348|FG001|Overall Study|Adverse Event|3|||
126756007|NCT00490815|456057347|FG000|Overall Study|Withdrawal by Subject|4|||
126756008|NCT00490815|456057348|FG001|Overall Study|Withdrawal by Subject|0|||
126756009|NCT00490815|456057347|FG000|Overall Study|Lost to Follow-up|1|||
126756010|NCT00490815|456057348|FG001|Overall Study|Lost to Follow-up|3|||
126756011|NCT00490815|456057347|FG000|Overall Study|Death|1|||
126756012|NCT00490815|456057348|FG001|Overall Study|Death|3|||
126756013|NCT00579059|456057350|FG000|Overall Study|Study Canceled at 1 Year|21|||
126756014|NCT00579059|456057351|FG001|Overall Study|Study Canceled at 1 Year|10|||
126756015|NCT04047472|456057352|FG000|Overall Study|Adverse Event|3|||
126756016|NCT04047472|456057353|FG001|Overall Study|Adverse Event|3|||
126756017|NCT04047472|456057352|FG000|Overall Study|Death|0|||
126756018|NCT04047472|456057353|FG001|Overall Study|Death|1|||
126756019|NCT04047472|456057352|FG000|Overall Study|Lost to Follow-up|1|||
126756020|NCT04047472|456057353|FG001|Overall Study|Lost to Follow-up|0|||
126756021|NCT04047472|456057352|FG000|Overall Study|Physician Decision|1|||
126756022|NCT04047472|456057353|FG001|Overall Study|Physician Decision|2|||
126756023|NCT04047472|456057352|FG000|Overall Study|Protocol Violation|1|||
126756024|NCT04047472|456057353|FG001|Overall Study|Protocol Violation|0|||
126756025|NCT04047472|456057352|FG000|Overall Study|Withdrawal by Subject|10|||
126756026|NCT04047472|456057353|FG001|Overall Study|Withdrawal by Subject|10|||
126756027|NCT02030067|456057354|FG000|Overall Study|Disease Progression|1|||
126756028|NCT02030067|456057355|FG001|Overall Study|Disease Progression|1|||
126756029|NCT02030067|456057356|FG002|Overall Study|Disease Progression|2|||
126756030|NCT02030067|456057357|FG003|Overall Study|Disease Progression|2|||
126756031|NCT02030067|456057358|FG004|Overall Study|Disease Progression|3|||
126756032|NCT02030067|456057359|FG005|Overall Study|Disease Progression|2|||
126756033|NCT02030067|456057360|FG006|Overall Study|Disease Progression|3|||
126756034|NCT02030067|456057361|FG007|Overall Study|Disease Progression|3|||
126756035|NCT02030067|456057362|FG008|Overall Study|Disease Progression|4|||
126756036|NCT02030067|456057363|FG009|Overall Study|Disease Progression|3|||
126756037|NCT02030067|456057364|FG010|Overall Study|Disease Progression|7|||
126756038|NCT02030067|456057365|FG011|Overall Study|Disease Progression|2|||
126756039|NCT02030067|456057366|FG012|Overall Study|Disease Progression|59|||
126756040|NCT02030067|456057354|FG000|Overall Study|Withdrawal by Subject|0|||
126756041|NCT02030067|456057355|FG001|Overall Study|Withdrawal by Subject|0|||
126756042|NCT02030067|456057356|FG002|Overall Study|Withdrawal by Subject|0|||
126756043|NCT02030067|456057357|FG003|Overall Study|Withdrawal by Subject|1|||
126756044|NCT02030067|456057358|FG004|Overall Study|Withdrawal by Subject|0|||
126756045|NCT02030067|456057359|FG005|Overall Study|Withdrawal by Subject|0|||
126756046|NCT02030067|456057360|FG006|Overall Study|Withdrawal by Subject|0|||
126756047|NCT02030067|456057361|FG007|Overall Study|Withdrawal by Subject|1|||
126756048|NCT02030067|456057362|FG008|Overall Study|Withdrawal by Subject|0|||
126756049|NCT02030067|456057363|FG009|Overall Study|Withdrawal by Subject|0|||
126756050|NCT02030067|456057364|FG010|Overall Study|Withdrawal by Subject|3|||
126756051|NCT02030067|456057365|FG011|Overall Study|Withdrawal by Subject|0|||
126756052|NCT02030067|456057366|FG012|Overall Study|Withdrawal by Subject|6|||
126756053|NCT02030067|456057354|FG000|Overall Study|Physician Decision|0|||
126756054|NCT02030067|456057355|FG001|Overall Study|Physician Decision|0|||
126756055|NCT02030067|456057356|FG002|Overall Study|Physician Decision|0|||
126756056|NCT02030067|456057357|FG003|Overall Study|Physician Decision|0|||
126756057|NCT02030067|456057358|FG004|Overall Study|Physician Decision|0|||
126756058|NCT02030067|456057359|FG005|Overall Study|Physician Decision|0|||
126756059|NCT02030067|456057360|FG006|Overall Study|Physician Decision|0|||
126756060|NCT02030067|456057361|FG007|Overall Study|Physician Decision|0|||
126756061|NCT02030067|456057362|FG008|Overall Study|Physician Decision|0|||
126756062|NCT02030067|456057363|FG009|Overall Study|Physician Decision|0|||
126756063|NCT02030067|456057364|FG010|Overall Study|Physician Decision|1|||
126756064|NCT02030067|456057365|FG011|Overall Study|Physician Decision|0|||
126756065|NCT02030067|456057366|FG012|Overall Study|Physician Decision|3|||
126756066|NCT02030067|456057354|FG000|Overall Study|other reasons|0|||
126756067|NCT02030067|456057355|FG001|Overall Study|other reasons|0|||
126756068|NCT02030067|456057356|FG002|Overall Study|other reasons|0|||
126756069|NCT02030067|456057357|FG003|Overall Study|other reasons|0|||
126756070|NCT02030067|456057358|FG004|Overall Study|other reasons|0|||
126756071|NCT02030067|456057359|FG005|Overall Study|other reasons|1|||
126756072|NCT02030067|456057360|FG006|Overall Study|other reasons|0|||
126756073|NCT02030067|456057361|FG007|Overall Study|other reasons|0|||
126756074|NCT02030067|456057362|FG008|Overall Study|other reasons|2|||
126756075|NCT02030067|456057363|FG009|Overall Study|other reasons|0|||
126756076|NCT02030067|456057364|FG010|Overall Study|other reasons|0|||
126756077|NCT02030067|456057365|FG011|Overall Study|other reasons|0|||
126756078|NCT02030067|456057366|FG012|Overall Study|other reasons|4|||
126756079|NCT02030067|456057354|FG000|Overall Study|Adverse Event|0|||
126756080|NCT02030067|456057355|FG001|Overall Study|Adverse Event|0|||
126756081|NCT02030067|456057356|FG002|Overall Study|Adverse Event|0|||
126756082|NCT02030067|456057357|FG003|Overall Study|Adverse Event|0|||
126756083|NCT02030067|456057358|FG004|Overall Study|Adverse Event|0|||
126756084|NCT02030067|456057359|FG005|Overall Study|Adverse Event|0|||
126756085|NCT02030067|456057360|FG006|Overall Study|Adverse Event|0|||
126756086|NCT02030067|456057361|FG007|Overall Study|Adverse Event|0|||
126756087|NCT02030067|456057362|FG008|Overall Study|Adverse Event|0|||
126756088|NCT02030067|456057363|FG009|Overall Study|Adverse Event|0|||
126756089|NCT02030067|456057364|FG010|Overall Study|Adverse Event|0|||
126756090|NCT02030067|456057365|FG011|Overall Study|Adverse Event|1|||
126756091|NCT02030067|456057366|FG012|Overall Study|Adverse Event|8|||
126756092|NCT01756846|456057367|FG000|Overall Study|Lost to Follow-up|5|||
126756093|NCT01756846|456057368|FG001|Overall Study|Lost to Follow-up|10|||
126756094|NCT01756846|456057367|FG000|Overall Study|Withdrawal by Subject|1|||
126756095|NCT01756846|456057368|FG001|Overall Study|Withdrawal by Subject|2|||
126756096|NCT01284127|456057369|FG000|Overall Study|Adverse Event|2|||
126756097|NCT01284127|456057369|FG000|Overall Study|Withdrawal by Subject|4|||
126756098|NCT01284127|456057369|FG000|Overall Study|Physician Decision|1|||
126756099|NCT02853318|456057373|FG000|Overall Study|Withdrawal by Subject|1|||
126756100|NCT01997333|456057374|FG000|Randomization and Treatment|Disease Progression|70|||
126756101|NCT01997333|456057375|FG001|Randomization and Treatment|Disease Progression|159|||
126756102|NCT01997333|456057374|FG000|Randomization and Treatment|Adverse Event|10|||
126756103|NCT01997333|456057375|FG001|Randomization and Treatment|Adverse Event|32|||
126756104|NCT01997333|456057374|FG000|Randomization and Treatment|Physician Decision|0|||
126756105|NCT01997333|456057375|FG001|Randomization and Treatment|Physician Decision|4|||
126756106|NCT01997333|456057374|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
126756107|NCT01997333|456057375|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
126756108|NCT01997333|456057374|FG000|Randomization and Treatment|Did not receive treatment|17|||
126756109|NCT01997333|456057375|FG001|Randomization and Treatment|Did not receive treatment|5|||
126756110|NCT01997333|456057374|FG000|Survival Follow up|Withdrawal by Subject|15|||
126756111|NCT01997333|456057375|FG001|Survival Follow up|Withdrawal by Subject|6|||
126756112|NCT01997333|456057374|FG000|Survival Follow up|Lost to Follow-up|0|||
126756113|NCT01997333|456057375|FG001|Survival Follow up|Lost to Follow-up|6|||
126756114|NCT01997333|456057374|FG000|Survival Follow up|Various|1|||
126635261|NCT01236352|455623570|FG001|Overall Study|Lack of response to drug|0|||
126635262|NCT01236352|455623571|FG002|Overall Study|Lack of response to drug|0|||
126635263|NCT01236352|455623572|FG003|Overall Study|Lack of response to drug|0|||
126635264|NCT01236352|455623573|FG004|Overall Study|Lack of response to drug|0|||
126635265|NCT01236352|455623574|FG005|Overall Study|Lack of response to drug|0|||
126635266|NCT01236352|455623575|FG006|Overall Study|Lack of response to drug|0|||
126635267|NCT01236352|455623576|FG007|Overall Study|Lack of response to drug|0|||
126635268|NCT01236352|455623577|FG008|Overall Study|Lack of response to drug|0|||
126635269|NCT01236352|455623578|FG009|Overall Study|Lack of response to drug|1|||
126635270|NCT01236352|455623579|FG010|Overall Study|Lack of response to drug|1|||
126635271|NCT01236352|455623569|FG000|Overall Study|Patient transferred to IST|0|||
126635272|NCT01236352|455623570|FG001|Overall Study|Patient transferred to IST|0|||
126635273|NCT01236352|455623571|FG002|Overall Study|Patient transferred to IST|0|||
126635274|NCT01236352|455623572|FG003|Overall Study|Patient transferred to IST|0|||
126635275|NCT01236352|455623573|FG004|Overall Study|Patient transferred to IST|0|||
126635276|NCT01236352|455623574|FG005|Overall Study|Patient transferred to IST|0|||
126635277|NCT01236352|455623575|FG006|Overall Study|Patient transferred to IST|0|||
126635278|NCT01236352|455623576|FG007|Overall Study|Patient transferred to IST|0|||
126635279|NCT01236352|455623577|FG008|Overall Study|Patient transferred to IST|0|||
126635280|NCT01236352|455623578|FG009|Overall Study|Patient transferred to IST|2|||
126635281|NCT01236352|455623579|FG010|Overall Study|Patient transferred to IST|6|||
126635282|NCT02031536|455623580|FG000|Overall Study|ineligible|1|||
126635283|NCT02031536|455623581|FG001|Overall Study|ineligible|0|||
126635284|NCT01658020|455623583|FG000|Overall Study|Adverse Event|3|||
126635285|NCT01658020|455623584|FG001|Overall Study|Adverse Event|3|||
126635286|NCT01658020|455623583|FG000|Overall Study|Lost to Follow-up|1|||
126635287|NCT01658020|455623584|FG001|Overall Study|Lost to Follow-up|0|||
126635288|NCT01658020|455623583|FG000|Overall Study|Withdrawal by Subject|4|||
126635289|NCT01658020|455623584|FG001|Overall Study|Withdrawal by Subject|5|||
126635290|NCT01658020|455623583|FG000|Overall Study|Protocol Violation|0|||
126635291|NCT01658020|455623584|FG001|Overall Study|Protocol Violation|1|||
126635292|NCT02353871|455623585|FG000|Overall Study|Protocol deviation|0|||
126635293|NCT02353871|455623586|FG001|Overall Study|Protocol deviation|1|||
126635294|NCT02353871|455623585|FG000|Overall Study|Consent withdrawn|1|||
126635295|NCT02353871|455623586|FG001|Overall Study|Consent withdrawn|8|||
126635296|NCT02353871|455623585|FG000|Overall Study|Lost to Follow-up|2|||
126635297|NCT02353871|455623586|FG001|Overall Study|Lost to Follow-up|0|||
126635298|NCT01191008|455623598|FG000|Overall Study|Protocol Violation|7|||
126635299|NCT01191008|455623598|FG000|Overall Study|Lost to Follow-up|8|||
126635300|NCT04905849|455623601|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
126635301|NCT04905849|455623602|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
126635302|NCT00838929|455623607|FG000|Overall Study|Protocol Violation|0|||
126635303|NCT00838929|455623608|FG001|Overall Study|Protocol Violation|1|||
126635304|NCT00838929|455623609|FG002|Overall Study|Protocol Violation|0|||
126635305|NCT00838929|455623607|FG000|Overall Study|Disease progression|0|||
126635306|NCT00838929|455623608|FG001|Overall Study|Disease progression|2|||
126635307|NCT00838929|455623609|FG002|Overall Study|Disease progression|1|||
126635308|NCT04913948|455623617|FG000|Overall Study|Withdrawal by Subject|2|||
126635309|NCT04913948|455623617|FG000|Overall Study|Sample processing issues|1|||
126635310|NCT04913948|455623617|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
126635311|NCT01068210|455623620|FG000|Overall Study|Lost to Follow-up|1|||
126635312|NCT01068210|455623621|FG001|Overall Study|Lost to Follow-up|2|||
126635313|NCT01068210|455623622|FG002|Overall Study|Lost to Follow-up|2|||
126635314|NCT01068210|455623623|FG003|Overall Study|Lost to Follow-up|1|||
126635315|NCT01068210|455623620|FG000|Overall Study|Second cancer|0|||
126635316|NCT01068210|455623621|FG001|Overall Study|Second cancer|1|||
126635317|NCT01068210|455623622|FG002|Overall Study|Second cancer|0|||
126635318|NCT01068210|455623623|FG003|Overall Study|Second cancer|0|||
126635319|NCT01068210|455623620|FG000|Overall Study|Disease progression|0|||
126635320|NCT01068210|455623621|FG001|Overall Study|Disease progression|0|||
126635321|NCT01068210|455623622|FG002|Overall Study|Disease progression|0|||
126635322|NCT01068210|455623623|FG003|Overall Study|Disease progression|2|||
126635323|NCT03522389|455623624|FG000|Overall Study|Lost to Follow-up|1|||
126635324|NCT03522389|455623625|FG001|Overall Study|Lost to Follow-up|1|||
126635325|NCT03522389|455623626|FG002|Overall Study|Lost to Follow-up|2|||
126635326|NCT03522389|455623624|FG000|Overall Study|had herniated nucleus pulposus|0|||
126635327|NCT03522389|455623625|FG001|Overall Study|had herniated nucleus pulposus|1|||
126635328|NCT03522389|455623626|FG002|Overall Study|had herniated nucleus pulposus|0|||
126635329|NCT03522389|455623624|FG000|Overall Study|go to work in other province|1|||
126635330|NCT03522389|455623625|FG001|Overall Study|go to work in other province|0|||
126635331|NCT03522389|455623626|FG002|Overall Study|go to work in other province|0|||
126635332|NCT02257918|455623627|FG000|Overall Study|Lost to Follow-up|4|||
126635333|NCT02257918|455623628|FG001|Overall Study|Lost to Follow-up|1|||
126635334|NCT02257918|455623629|FG002|Overall Study|Lost to Follow-up|0|||
126635335|NCT02257918|455623627|FG000|Overall Study|Withdrawal by Subject|0|||
126635336|NCT02257918|455623628|FG001|Overall Study|Withdrawal by Subject|0|||
126635337|NCT02257918|455623629|FG002|Overall Study|Withdrawal by Subject|1|||
126635338|NCT02257918|455623627|FG000|Overall Study|Pregnancy|0|||
126635339|NCT02257918|455623628|FG001|Overall Study|Pregnancy|0|||
126635340|NCT02257918|455623629|FG002|Overall Study|Pregnancy|1|||
126635341|NCT01263054|455623636|FG000|Overall Study|Death|1|||
126635342|NCT01263054|455623637|FG001|Overall Study|Death|0|||
126635343|NCT01263054|455623636|FG000|Overall Study|Lost to Follow-up|2|||
126635344|NCT01263054|455623637|FG001|Overall Study|Lost to Follow-up|2|||
126635345|NCT01263054|455623636|FG000|Overall Study|Withdrawal by Subject|1|||
126635346|NCT01263054|455623637|FG001|Overall Study|Withdrawal by Subject|3|||
126635347|NCT01263054|455623636|FG000|Overall Study|Qualification Violation|1|||
126635348|NCT01263054|455623637|FG001|Overall Study|Qualification Violation|0|||
126635349|NCT01263054|455623636|FG000|Overall Study|Other|0|||
126635350|NCT01263054|455623637|FG001|Overall Study|Other|1|||
126635351|NCT02242643|455623638|FG000|Overall Study|Protocol Violation|1|||
126635352|NCT02242643|455623639|FG001|Overall Study|Protocol Violation|2|||
126635353|NCT02242643|455623638|FG000|Overall Study|Withdrawal by Subject|15|||
126635354|NCT02242643|455623639|FG001|Overall Study|Withdrawal by Subject|10|||
126635355|NCT02242643|455623638|FG000|Overall Study|Migrated/moved from study area|1|||
126635356|NCT02242643|455623639|FG001|Overall Study|Migrated/moved from study area|3|||
126635357|NCT02242643|455623638|FG000|Overall Study|Lost to Follow-up|54|||
126635358|NCT02242643|455623639|FG001|Overall Study|Lost to Follow-up|61|||
126635359|NCT02242643|455623638|FG000|Overall Study|Child placed in foster care by family|0|||
126635360|NCT02242643|455623639|FG001|Overall Study|Child placed in foster care by family|1|||
126635361|NCT02242643|455623638|FG000|Overall Study|Non-compliance|1|||
126635362|NCT02242643|455623639|FG001|Overall Study|Non-compliance|0|||
126635363|NCT02242643|455623638|FG000|Overall Study|Consent withdrawal by parent|1|||
126635364|NCT02242643|455623639|FG001|Overall Study|Consent withdrawal by parent|0|||
126635365|NCT02242643|455623638|FG000|Overall Study|Protocol requirements not followed|1|||
126635366|NCT02242643|455623639|FG001|Overall Study|Protocol requirements not followed|0|||
126635367|NCT02242643|455623638|FG000|Overall Study|Language barrier|1|||
126635368|NCT02242643|455623639|FG001|Overall Study|Language barrier|0|||
126635369|NCT02242643|455623638|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
126635370|NCT02242643|455623639|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
126635371|NCT02633397|455623647|FG000|Overall Study|Adverse Event|8|||
126635372|NCT02633397|455623648|FG001|Overall Study|Adverse Event|8|||
126635373|NCT02633397|455623647|FG000|Overall Study|Study Burden|4|||
126635374|NCT02633397|455623648|FG001|Overall Study|Study Burden|1|||
126635375|NCT02633397|455623647|FG000|Overall Study|Treatment interruption|2|||
126635376|NCT02633397|455623648|FG001|Overall Study|Treatment interruption|5|||
126635377|NCT02633397|455623647|FG000|Overall Study|Death|2|||
126635378|NCT02633397|455623648|FG001|Overall Study|Death|2|||
126635379|NCT02633397|455623647|FG000|Overall Study|Physician Decision|0|||
126635380|NCT02633397|455623648|FG001|Overall Study|Physician Decision|1|||
126635381|NCT03595878|455623649|FG000|Overall Study|Death|2|||
126635382|NCT03595878|455623650|FG001|Overall Study|Death|1|||
126635383|NCT03595878|455623651|FG002|Overall Study|Death|0|||
126635384|NCT03595878|455623649|FG000|Overall Study|Disease progression|2|||
126635385|NCT03595878|455623650|FG001|Overall Study|Disease progression|1|||
126635386|NCT03595878|455623651|FG002|Overall Study|Disease progression|2|||
126635387|NCT03494985|455623652|FG000|Overall Study|Adverse Event|3|||
126635388|NCT03494985|455623653|FG001|Overall Study|Adverse Event|2|||
126635389|NCT03494985|455623654|FG002|Overall Study|Adverse Event|3|||
126635390|NCT03494985|455623655|FG003|Overall Study|Adverse Event|0|||
126635391|NCT03494985|455623652|FG000|Overall Study|Other (Withdrawal of consent)|2|||
126635392|NCT03494985|455623653|FG001|Overall Study|Other (Withdrawal of consent)|3|||
126635393|NCT03494985|455623654|FG002|Overall Study|Other (Withdrawal of consent)|2|||
126635394|NCT03494985|455623655|FG003|Overall Study|Other (Withdrawal of consent)|5|||
126635395|NCT03494985|455623652|FG000|Overall Study|Other (Not specified)|0|||
126635396|NCT03494985|455623653|FG001|Overall Study|Other (Not specified)|1|||
126635397|NCT03494985|455623654|FG002|Overall Study|Other (Not specified)|1|||
126635398|NCT03494985|455623655|FG003|Overall Study|Other (Not specified)|0|||
126635399|NCT03036124|455623656|FG000|Overall Study|Lost to Follow-up|0|||
126635400|NCT03036124|455623657|FG001|Overall Study|Lost to Follow-up|2|||
126635401|NCT03036124|455623656|FG000|Overall Study|Withdrawal by Subject|5|||
126635402|NCT03036124|455623657|FG001|Overall Study|Withdrawal by Subject|4|||
126635403|NCT02282059|455623658|FG000|Overall Study|Other|15|||
126635404|NCT02282059|455623659|FG001|Overall Study|Other|3|||
126635405|NCT02282059|455623658|FG000|Overall Study|Participant refused further follow-up|8|||
126635406|NCT02282059|455623659|FG001|Overall Study|Participant refused further follow-up|4|||
126635407|NCT02282059|455623658|FG000|Overall Study|Lost to Follow-up|19|||
126635408|NCT02282059|455623659|FG001|Overall Study|Lost to Follow-up|3|||
126635409|NCT02282059|455623658|FG000|Overall Study|Death|40|||
126635410|NCT02282059|455623659|FG001|Overall Study|Death|8|||
126635411|NCT02394925|455623660|FG000|Overall Study|Adverse Event|1|||
126635412|NCT02394925|455623660|FG000|Overall Study|Lens Discomfort|3|||
126635413|NCT02394925|455623660|FG000|Overall Study|Lens handling difficulities|5|||
126635414|NCT02394925|455623660|FG000|Overall Study|Lost to Follow-up|9|||
126635415|NCT02394925|455623660|FG000|Overall Study|Protocol Violation|5|||
126635416|NCT02394925|455623660|FG000|Overall Study|No longer meet eligibility criteria|1|||
126635417|NCT02394925|455623660|FG000|Overall Study|Unsatisfactory Visual Response|5|||
126635418|NCT01689363|455625476|FG000|Overall Study|Protocol Violation|0|||
126635419|NCT01689363|455625477|FG001|Overall Study|Protocol Violation|1|||
126635420|NCT01689363|455625478|FG002|Overall Study|Protocol Violation|0|||
126635421|NCT01689363|455625479|FG003|Overall Study|Protocol Violation|0|||
126635422|NCT01689363|455625480|FG004|Overall Study|Protocol Violation|0|||
126635423|NCT01689363|455625481|FG005|Overall Study|Protocol Violation|0|||
126635424|NCT01689363|455625482|FG006|Overall Study|Protocol Violation|0|||
126635425|NCT01689363|455625483|FG007|Overall Study|Protocol Violation|0|||
126635426|NCT02104505|455625484|FG000|First Intervention (14 Days)|Adverse Event|2|||
126635427|NCT02104505|455625485|FG001|First Intervention (14 Days)|Adverse Event|0|||
126635428|NCT02104505|455625484|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
126635429|NCT02104505|455625485|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
126635430|NCT02104505|455625484|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
126635431|NCT02104505|455625485|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
126635432|NCT02104505|455625484|FG000|First Intervention (14 Days)|exclusionary condition|0|||
126635433|NCT02104505|455625485|FG001|First Intervention (14 Days)|exclusionary condition|1|||
126635434|NCT02104505|455625484|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
126635435|NCT02104505|455625485|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
126635436|NCT02104505|455625484|FG000|Second Intervention (14 Days)|Adverse Event|2|||
126635437|NCT02104505|455625485|FG001|Second Intervention (14 Days)|Adverse Event|0|||
126635438|NCT00127842|455625486|FG000|Overall Study|Adverse Event|15|||
126635439|NCT00127842|455625486|FG000|Overall Study|Withdrawal by Subject|3|||
126635440|NCT00127842|455625486|FG000|Overall Study|Lost to Follow-up|1|||
126635441|NCT00127842|455625486|FG000|Overall Study|Lack of Efficacy|12|||
126635442|NCT00127842|455625486|FG000|Overall Study|Noncompliance|2|||
126635443|NCT00127842|455625486|FG000|Overall Study|Protocol Violation|1|||
126635444|NCT00127842|455625486|FG000|Overall Study|Other|5|||
126635445|NCT01638390|455625489|FG000|Overall Study|screening failures|21|||
126635446|NCT01377389|455625490|FG000|Overall Study|Withdrawal by Subject|1|||
126635447|NCT01377389|455625490|FG000|Overall Study|Screen failure|2|||
126635448|NCT03382561|455625491|FG000|Overall Study|Disease progression|47|||
126635449|NCT03382561|455625492|FG001|Overall Study|Disease progression|6|||
126635450|NCT03382561|455625491|FG000|Overall Study|Adverse Event|10|||
126635451|NCT03382561|455625492|FG001|Overall Study|Adverse Event|2|||
126635452|NCT03382561|455625491|FG000|Overall Study|Death|8|||
126635453|NCT03382561|455625492|FG001|Overall Study|Death|3|||
126635454|NCT03382561|455625491|FG000|Overall Study|Withdrawal by Subject|6|||
126635455|NCT03382561|455625492|FG001|Overall Study|Withdrawal by Subject|5|||
126635456|NCT03382561|455625491|FG000|Overall Study|Alternative therapy|2|||
126635457|NCT03382561|455625492|FG001|Overall Study|Alternative therapy|8|||
126635458|NCT03382561|455625491|FG000|Overall Study|Never started treatment|3|||
126635459|NCT03382561|455625492|FG001|Overall Study|Never started treatment|6|||
126635460|NCT03382561|455625491|FG000|Overall Study|Lack of Efficacy|0|||
126635461|NCT03382561|455625492|FG001|Overall Study|Lack of Efficacy|1|||
126635462|NCT03382561|455625491|FG000|Overall Study|Physician Decision|0|||
126635463|NCT03382561|455625492|FG001|Overall Study|Physician Decision|1|||
126635464|NCT03382561|455625491|FG000|Overall Study|Other complicating disease|0|||
126635465|NCT03382561|455625492|FG001|Overall Study|Other complicating disease|1|||
126635466|NCT01131104|455625493|FG000|Overall Study|Withdrawal by Subject|3|||
126635467|NCT01131104|455625493|FG000|Overall Study|Physician Decision|4|||
126635468|NCT01131104|455625493|FG000|Overall Study|Information Not Available|5|||
126635469|NCT01131104|455625493|FG000|Overall Study|No Information on Index Date of Onset|1|||
126635470|NCT00334542|455625494|FG000|Overall Study|Adverse Event|3|||
126635471|NCT00334542|455625494|FG000|Overall Study|Withdrawal by Subject|1|||
126635472|NCT00334542|455625494|FG000|Overall Study|New cancer diagnosis|1|||
126635473|NCT02370251|455625495|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
126635474|NCT02370251|455625495|FG000|Overall Study|Death|4|||
126635475|NCT04698915|455625499|FG000|Overall Study|Adverse Event|2|||
126635476|NCT04698915|455625500|FG001|Overall Study|Adverse Event|0|||
126635477|NCT04698915|455625499|FG000|Overall Study|Death|23|||
126635478|NCT04698915|455625500|FG001|Overall Study|Death|20|||
126635479|NCT04698915|455625499|FG000|Overall Study|Physician Decision|1|||
126635480|NCT04698915|455625500|FG001|Overall Study|Physician Decision|1|||
126635481|NCT04698915|455625499|FG000|Overall Study|Lost to Follow-up|1|||
126635482|NCT04698915|455625500|FG001|Overall Study|Lost to Follow-up|0|||
126635483|NCT04698915|455625499|FG000|Overall Study|Study Terminated by Sponsor|55|||
126635484|NCT04698915|455625500|FG001|Overall Study|Study Terminated by Sponsor|60|||
126635485|NCT04698915|455625499|FG000|Overall Study|Withdrawal by Subject|2|||
126635486|NCT04698915|455625500|FG001|Overall Study|Withdrawal by Subject|3|||
126635487|NCT01150045|455625501|FG000|Overall Study|Protocol Violation|0|||
126635488|NCT01150045|455625502|FG001|Overall Study|Protocol Violation|1|||
126635489|NCT01150045|455625503|FG002|Overall Study|Protocol Violation|0|||
126635490|NCT01150045|455625504|FG003|Overall Study|Protocol Violation|1|||
126635491|NCT02094898|455625511|FG000|Overall Study|Clinical Worsening|2|||
126635492|NCT02094898|455625511|FG000|Overall Study|Adverse Event|2|||
126635493|NCT02094898|455625511|FG000|Overall Study|Lack of Efficacy|1|||
126635494|NCT03520075|455625512|FG000|Phase 1 (Dose Escalation)|Death|2|||
126635495|NCT03520075|455625513|FG001|Phase 1 (Dose Escalation)|Death|2|||
126635496|NCT03520075|455625514|FG002|Phase 1 (Dose Escalation)|Death|3|||
126635497|NCT03520075|455625515|FG003|Phase 1 (Dose Escalation)|Death|2|||
126635498|NCT03520075|455625516|FG004|Phase 1 (Dose Escalation)|Death|6|||
126635499|NCT03520075|455625517|FG005|Phase 1 (Dose Escalation)|Death|5|||
126635500|NCT03520075|455625518|FG006|Phase 1 (Dose Escalation)|Death|3|||
126635501|NCT03520075|455625519|FG007|Phase 1 (Dose Escalation)|Death|2|||
126635502|NCT03520075|455625520|FG008|Phase 1 (Dose Escalation)|Death|3|||
126635503|NCT03520075|455625521|FG009|Phase 1 (Dose Escalation)|Death|1|||
126635504|NCT03520075|455625522|FG010|Phase 1 (Dose Escalation)|Death|5|||
126635505|NCT03520075|455625523|FG011|Phase 1 (Dose Escalation)|Death|7|||
126635506|NCT03520075|455625524|FG012|Phase 1 (Dose Escalation)|Death|11|||
126635507|NCT03520075|455625525|FG013|Phase 1 (Dose Escalation)|Death|0|||
126635508|NCT03520075|455625526|FG014|Phase 1 (Dose Escalation)|Death|0|||
126635509|NCT03520075|455625527|FG015|Phase 1 (Dose Escalation)|Death|0|||
126635510|NCT03520075|455625528|FG016|Phase 1 (Dose Escalation)|Death|0|||
126635511|NCT03520075|455625529|FG017|Phase 1 (Dose Escalation)|Death|0|||
126635512|NCT03520075|455625530|FG018|Phase 1 (Dose Escalation)|Death|0|||
126635513|NCT03520075|455625512|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
126635514|NCT03520075|455625513|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126635515|NCT03520075|455625514|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126635516|NCT03520075|455625515|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
126635517|NCT03520075|455625516|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
126635518|NCT03520075|455625517|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
126635519|NCT03520075|455625518|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126635520|NCT03520075|455625519|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
126635521|NCT03520075|455625520|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126635522|NCT03520075|455625521|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
126635523|NCT03520075|455625522|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126635524|NCT03520075|455625523|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126635525|NCT03520075|455625524|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
126635526|NCT03520075|455625525|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126635527|NCT03520075|455625526|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126635528|NCT03520075|455625527|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126635529|NCT03520075|455625528|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126635530|NCT03520075|455625529|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126635531|NCT03520075|455625530|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
126635532|NCT03520075|455625512|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635533|NCT03520075|455625513|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
126756115|NCT01997333|456057375|FG001|Survival Follow up|Various|2|||
126756116|NCT01535638|456057376|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
126756117|NCT01535638|456057377|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
126756118|NCT01535638|456057378|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
126756119|NCT01535638|456057379|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
126756120|NCT01535638|456057380|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
126756121|NCT01535638|456057381|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
126756122|NCT01535638|456057376|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
126756123|NCT01535638|456057377|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
126756124|NCT01535638|456057378|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
126756125|NCT01535638|456057379|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
126756126|NCT01535638|456057380|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
126756127|NCT01535638|456057381|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
126756128|NCT05060003|456057382|FG000|Overall Study|ctDNA negative|7|||
126756129|NCT00819052|456057383|FG000|Overall Study|Adverse Event|0|||
126756130|NCT00819052|456057384|FG001|Overall Study|Adverse Event|5|||
126756131|NCT00819052|456057383|FG000|Overall Study|Protocol Violation|1|||
126635534|NCT03520075|455625514|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635535|NCT03520075|455625515|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
126635536|NCT03520075|455625516|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
126635537|NCT03520075|455625517|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635538|NCT03520075|455625518|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635539|NCT03520075|455625519|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635540|NCT03520075|455625520|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635541|NCT03520075|455625521|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635542|NCT03520075|455625522|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
126635543|NCT03520075|455625523|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635544|NCT03520075|455625524|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
126635545|NCT03520075|455625525|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635546|NCT03520075|455625526|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635547|NCT03520075|455625527|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635548|NCT03520075|455625528|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635549|NCT03520075|455625529|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635550|NCT03520075|455625530|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
126635551|NCT03520075|455625512|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635552|NCT03520075|455625513|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635553|NCT03520075|455625514|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635554|NCT03520075|455625515|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635555|NCT03520075|455625516|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635556|NCT03520075|455625517|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635557|NCT03520075|455625518|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635558|NCT03520075|455625519|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635559|NCT03520075|455625520|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635560|NCT03520075|455625521|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
126635561|NCT03520075|455625522|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635562|NCT03520075|455625523|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635563|NCT03520075|455625524|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
126635564|NCT03520075|455625525|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635565|NCT03520075|455625526|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635566|NCT03520075|455625527|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635567|NCT03520075|455625528|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635568|NCT03520075|455625529|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635569|NCT03520075|455625530|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
126635570|NCT03520075|455625512|FG000|Phase 2 (Dose Expansion)|Death|0|||
126635571|NCT03520075|455625513|FG001|Phase 2 (Dose Expansion)|Death|0|||
126635572|NCT03520075|455625514|FG002|Phase 2 (Dose Expansion)|Death|0|||
126635573|NCT03520075|455625515|FG003|Phase 2 (Dose Expansion)|Death|0|||
126635574|NCT03520075|455625516|FG004|Phase 2 (Dose Expansion)|Death|0|||
126635575|NCT03520075|455625517|FG005|Phase 2 (Dose Expansion)|Death|0|||
126635576|NCT03520075|455625518|FG006|Phase 2 (Dose Expansion)|Death|0|||
126635577|NCT03520075|455625519|FG007|Phase 2 (Dose Expansion)|Death|0|||
126635578|NCT03520075|455625520|FG008|Phase 2 (Dose Expansion)|Death|0|||
126635579|NCT03520075|455625521|FG009|Phase 2 (Dose Expansion)|Death|0|||
126635580|NCT03520075|455625522|FG010|Phase 2 (Dose Expansion)|Death|0|||
126635581|NCT03520075|455625523|FG011|Phase 2 (Dose Expansion)|Death|0|||
126635582|NCT03520075|455625524|FG012|Phase 2 (Dose Expansion)|Death|0|||
126635583|NCT03520075|455625525|FG013|Phase 2 (Dose Expansion)|Death|20|||
126635584|NCT03520075|455625526|FG014|Phase 2 (Dose Expansion)|Death|13|||
126635585|NCT03520075|455625527|FG015|Phase 2 (Dose Expansion)|Death|9|||
126635586|NCT03520075|455625528|FG016|Phase 2 (Dose Expansion)|Death|5|||
126635587|NCT03520075|455625529|FG017|Phase 2 (Dose Expansion)|Death|14|||
126635588|NCT03520075|455625530|FG018|Phase 2 (Dose Expansion)|Death|12|||
126635589|NCT03520075|455625512|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635590|NCT03520075|455625513|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635591|NCT03520075|455625514|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635592|NCT03520075|455625515|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635593|NCT03520075|455625516|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635594|NCT03520075|455625517|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635595|NCT03520075|455625518|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635596|NCT03520075|455625519|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635597|NCT03520075|455625520|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635598|NCT03520075|455625521|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635599|NCT03520075|455625522|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635600|NCT03520075|455625523|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126756132|NCT00819052|456057384|FG001|Overall Study|Protocol Violation|2|||
126756133|NCT00819052|456057383|FG000|Overall Study|Lost to Follow-up|1|||
126756134|NCT00819052|456057384|FG001|Overall Study|Lost to Follow-up|2|||
126756135|NCT00819052|456057383|FG000|Overall Study|Withdrawal by Subject|1|||
126635601|NCT03520075|455625524|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635602|NCT03520075|455625525|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
126635603|NCT03520075|455625526|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
126635604|NCT03520075|455625527|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
126635605|NCT03520075|455625528|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
126635606|NCT03520075|455625529|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
126635607|NCT03520075|455625530|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
126635608|NCT03520075|455625512|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635609|NCT03520075|455625513|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635610|NCT03520075|455625514|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635611|NCT03520075|455625515|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635612|NCT03520075|455625516|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635613|NCT03520075|455625517|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635614|NCT03520075|455625518|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635615|NCT03520075|455625519|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635616|NCT03520075|455625520|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635617|NCT03520075|455625521|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635618|NCT03520075|455625522|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635619|NCT03520075|455625523|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635620|NCT03520075|455625524|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635621|NCT03520075|455625525|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635622|NCT03520075|455625526|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
126635623|NCT03520075|455625527|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
126635624|NCT03520075|455625528|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635625|NCT03520075|455625529|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
126635626|NCT03520075|455625530|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
126635627|NCT03520075|455625512|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635628|NCT03520075|455625513|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635629|NCT03520075|455625514|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635630|NCT03520075|455625515|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635631|NCT03520075|455625516|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635632|NCT03520075|455625517|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635633|NCT03520075|455625518|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635634|NCT03520075|455625519|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635635|NCT03520075|455625520|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635636|NCT03520075|455625521|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635637|NCT03520075|455625522|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635638|NCT03520075|455625523|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635639|NCT03520075|455625524|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635640|NCT03520075|455625525|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
126635641|NCT03520075|455625526|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635642|NCT03520075|455625527|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635643|NCT03520075|455625528|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
126635644|NCT03520075|455625529|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
126635645|NCT03520075|455625530|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
126635646|NCT05382039|455625531|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
126635647|NCT05382039|455625532|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
126635648|NCT05382039|455625533|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
126635649|NCT05382039|455625531|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
126635650|NCT05382039|455625532|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
126635651|NCT05382039|455625533|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
126635652|NCT05382039|455625531|FG000|Overall Study|waiting for confirmation|0|||
126635653|NCT05382039|455625532|FG001|Overall Study|waiting for confirmation|0|||
126635654|NCT05382039|455625533|FG002|Overall Study|waiting for confirmation|1|||
126635655|NCT01432626|455625534|FG000|Overall Study|LV function recovered|2|||
126635656|NCT01432626|455625534|FG000|Overall Study|Withdrawal by Subject|2|||
126635657|NCT01432626|455625534|FG000|Overall Study|Only 1 image competed|2|||
126635658|NCT01432626|455625534|FG000|Overall Study|Imaging agent not available|1|||
126635659|NCT01234883|455625535|FG000|Overall Study|Early treatment release|8|||
126635660|NCT01234883|455625536|FG001|Overall Study|Early treatment release|10|||
126635661|NCT01234883|455625535|FG000|Overall Study|Parent/guardian withdrew consent|1|||
126635662|NCT01234883|455625536|FG001|Overall Study|Parent/guardian withdrew consent|2|||
126635663|NCT01234883|455625535|FG000|Overall Study|Technical difficulties with IV infusion|0|||
126635664|NCT01234883|455625536|FG001|Overall Study|Technical difficulties with IV infusion|1|||
126635665|NCT01234883|455625535|FG000|Overall Study|Inclusion/exclusion failure|1|||
126635666|NCT01234883|455625536|FG001|Overall Study|Inclusion/exclusion failure|0|||
126635667|NCT00126659|455625539|FG000|Overall Study|Adverse Event|0|||
126635668|NCT00126659|455625540|FG001|Overall Study|Adverse Event|0|||
126635669|NCT00126659|455625541|FG002|Overall Study|Adverse Event|2|||
126635670|NCT02367352|455625542|FG000|Overall Study|Progressive disease|7|||
126635671|NCT02367352|455625543|FG001|Overall Study|Progressive disease|0|||
126635672|NCT02367352|455625544|FG002|Overall Study|Progressive disease|0|||
126635673|NCT02367352|455625542|FG000|Overall Study|Participant Received Alternative Therapy|1|||
126635674|NCT02367352|455625543|FG001|Overall Study|Participant Received Alternative Therapy|0|||
126635675|NCT02367352|455625544|FG002|Overall Study|Participant Received Alternative Therapy|0|||
126635676|NCT02367352|455625542|FG000|Overall Study|Adverse Event|1|||
126635677|NCT02367352|455625543|FG001|Overall Study|Adverse Event|0|||
126635678|NCT02367352|455625544|FG002|Overall Study|Adverse Event|0|||
126635679|NCT01375751|455625545|FG000|Overall Study|Other|0|||
126635680|NCT01375751|455625546|FG001|Overall Study|Other|1|||
126635681|NCT01375751|455625547|FG002|Overall Study|Other|0|||
126635682|NCT02980523|455625548|FG000|Overall Study|Lost to Follow-up|1|||
126635683|NCT02980523|455625549|FG001|Overall Study|Lost to Follow-up|4|||
126635684|NCT02980523|455625550|FG002|Overall Study|Lost to Follow-up|1|||
126635685|NCT02980523|455625551|FG003|Overall Study|Lost to Follow-up|2|||
126635686|NCT02980523|455625552|FG004|Overall Study|Lost to Follow-up|1|||
126635687|NCT02980523|455625548|FG000|Overall Study|Excluded from analysis|1|||
126635688|NCT02980523|455625549|FG001|Overall Study|Excluded from analysis|3|||
126635689|NCT02980523|455625550|FG002|Overall Study|Excluded from analysis|1|||
126635690|NCT02980523|455625551|FG003|Overall Study|Excluded from analysis|1|||
126635691|NCT02980523|455625552|FG004|Overall Study|Excluded from analysis|1|||
126635692|NCT02980523|455625548|FG000|Overall Study|Lack of Efficacy|1|||
126635693|NCT02980523|455625549|FG001|Overall Study|Lack of Efficacy|4|||
126635694|NCT02980523|455625550|FG002|Overall Study|Lack of Efficacy|4|||
126635695|NCT02980523|455625551|FG003|Overall Study|Lack of Efficacy|5|||
126635696|NCT02980523|455625552|FG004|Overall Study|Lack of Efficacy|8|||
126635697|NCT02980523|455625548|FG000|Overall Study|Did not receive intervention|0|||
126635698|NCT02980523|455625549|FG001|Overall Study|Did not receive intervention|0|||
126635699|NCT02980523|455625550|FG002|Overall Study|Did not receive intervention|0|||
126635700|NCT02980523|455625551|FG003|Overall Study|Did not receive intervention|1|||
126635701|NCT02980523|455625552|FG004|Overall Study|Did not receive intervention|0|||
126635702|NCT01271504|455625554|FG000|Overall Study|Death|7|||
126635703|NCT01271504|455625555|FG001|Overall Study|Death|6|||
126635704|NCT01271504|455625556|FG002|Overall Study|Death|32|||
126635705|NCT01271504|455625557|FG003|Overall Study|Death|32|||
126635706|NCT01271504|455625554|FG000|Overall Study|Lost to Follow-up|0|||
126635707|NCT01271504|455625555|FG001|Overall Study|Lost to Follow-up|1|||
126635708|NCT01271504|455625556|FG002|Overall Study|Lost to Follow-up|3|||
126635709|NCT01271504|455625557|FG003|Overall Study|Lost to Follow-up|1|||
126635710|NCT01271504|455625554|FG000|Overall Study|Protocol Violation|0|||
126635711|NCT01271504|455625555|FG001|Overall Study|Protocol Violation|0|||
126635712|NCT01271504|455625556|FG002|Overall Study|Protocol Violation|0|||
126635713|NCT01271504|455625557|FG003|Overall Study|Protocol Violation|2|||
126635714|NCT01271504|455625554|FG000|Overall Study|Administrative Reasons|0|||
126635715|NCT01271504|455625555|FG001|Overall Study|Administrative Reasons|0|||
126635716|NCT01271504|455625556|FG002|Overall Study|Administrative Reasons|6|||
126635717|NCT01271504|455625557|FG003|Overall Study|Administrative Reasons|5|||
126635718|NCT01271504|455625554|FG000|Overall Study|Withdrawal by Subject|0|||
126635719|NCT01271504|455625555|FG001|Overall Study|Withdrawal by Subject|0|||
126635720|NCT01271504|455625556|FG002|Overall Study|Withdrawal by Subject|1|||
126635721|NCT01271504|455625557|FG003|Overall Study|Withdrawal by Subject|3|||
126635722|NCT01271504|455625554|FG000|Overall Study|Other|0|||
126635723|NCT01271504|455625555|FG001|Overall Study|Other|1|||
126635724|NCT01271504|455625556|FG002|Overall Study|Other|2|||
126635725|NCT01271504|455625557|FG003|Overall Study|Other|0|||
126635726|NCT01547598|455625558|FG000|Overall Study|Withdrew consent|1|||
126635727|NCT01547598|455625559|FG001|Overall Study|Withdrew consent|1|||
126635728|NCT01547598|455625558|FG000|Overall Study|Lost to Follow-up|1|||
126635729|NCT01547598|455625559|FG001|Overall Study|Lost to Follow-up|1|||
126635730|NCT01547598|455625558|FG000|Overall Study|Adverse Event|1|||
126635731|NCT01547598|455625559|FG001|Overall Study|Adverse Event|1|||
126635732|NCT01547598|455625558|FG000|Overall Study|Protocol Violation|1|||
126635733|NCT01547598|455625559|FG001|Overall Study|Protocol Violation|1|||
126635734|NCT01547598|455625558|FG000|Overall Study|Other Miscellaneous Reasons|2|||
126635735|NCT01547598|455625559|FG001|Overall Study|Other Miscellaneous Reasons|1|||
126635736|NCT02229227|455625562|FG000|Overall Study|Adverse Event|14|||
126635737|NCT02229227|455625563|FG001|Overall Study|Adverse Event|9|||
126635738|NCT02229227|455625562|FG000|Overall Study|Lack of Efficacy|3|||
126635739|NCT02229227|455625563|FG001|Overall Study|Lack of Efficacy|3|||
126635740|NCT02229227|455625562|FG000|Overall Study|Protocol Violation|6|||
126635741|NCT02229227|455625563|FG001|Overall Study|Protocol Violation|8|||
126635742|NCT02229227|455625562|FG000|Overall Study|Protocol defined stopping criteria|1|||
126635743|NCT02229227|455625563|FG001|Overall Study|Protocol defined stopping criteria|3|||
126635744|NCT02229227|455625562|FG000|Overall Study|Lost to Follow-up|3|||
126635745|NCT02229227|455625563|FG001|Overall Study|Lost to Follow-up|3|||
126635746|NCT02229227|455625562|FG000|Overall Study|Study terminated by sponsor|11|||
126635747|NCT02229227|455625563|FG001|Overall Study|Study terminated by sponsor|11|||
126635748|NCT02229227|455625562|FG000|Overall Study|Withdrawal by Subject|8|||
126635749|NCT02229227|455625563|FG001|Overall Study|Withdrawal by Subject|12|||
126635750|NCT02229227|455625562|FG000|Overall Study|Other|0|||
126635751|NCT02229227|455625563|FG001|Overall Study|Other|1|||
126635752|NCT02229227|455625562|FG000|Overall Study|Physician Decision|5|||
126635753|NCT02229227|455625563|FG001|Overall Study|Physician Decision|12|||
126635754|NCT04071301|455625564|FG000|Overall Study|Withdrawal by Subject|6|||
126635755|NCT04071301|455625564|FG000|Overall Study|Death|1|||
126635756|NCT05186311|455625565|FG000|Part A: Serum|Withdrawal by Subject|1|||
126635757|NCT02125279|455625566|FG000|Overall Study|Lack of Efficacy|2|||
126635758|NCT02125279|455625566|FG000|Overall Study|Withdrawal by Subject|6|||
126635759|NCT02125279|455625566|FG000|Overall Study|Protocol Violation|1|||
126635760|NCT02125279|455625566|FG000|Overall Study|Lost to Follow-up|4|||
126635761|NCT01850589|455625574|FG000|Overall Study|Withdrawal by Subject|8|||
126635762|NCT01850589|455625575|FG001|Overall Study|Withdrawal by Subject|0|||
126635763|NCT04468230|455625579|FG000|Overall Study|Adverse Event|2|||
126635764|NCT01790295|455625583|FG000|Overall Study|Adverse Event|1|||
126635765|NCT01790295|455625583|FG000|Overall Study|Death|4|||
126635766|NCT01790295|455625583|FG000|Overall Study|Lack of Efficacy|2|||
126635767|NCT01790295|455625583|FG000|Overall Study|Study closure|4|||
126635768|NCT03721705|455625584|FG000|Overall Study|Adverse Event|2|||
126635769|NCT03721705|455625585|FG001|Overall Study|Adverse Event|0|||
126635770|NCT03721705|455625584|FG000|Overall Study|Withdrawal by Subject|4|||
126635771|NCT03721705|455625585|FG001|Overall Study|Withdrawal by Subject|10|||
126635772|NCT03721705|455625584|FG000|Overall Study|No Suitable Study Partner|1|||
126635773|NCT03721705|455625585|FG001|Overall Study|No Suitable Study Partner|0|||
126635774|NCT03721705|455625584|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
126635775|NCT03721705|455625585|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
126635776|NCT03721705|455625584|FG000|Overall Study|Death|0|||
126635777|NCT03721705|455625585|FG001|Overall Study|Death|1|||
126635778|NCT03721172|455625588|FG000|Placebo-controlled Phase|Adverse Event|7|||
126635779|NCT03721172|455625589|FG001|Placebo-controlled Phase|Adverse Event|7|||
126635780|NCT03721172|455625590|FG002|Placebo-controlled Phase|Adverse Event|0|||
126635781|NCT03721172|455625588|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
126635782|NCT03721172|455625589|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
126635783|NCT03721172|455625590|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
126635784|NCT03721172|455625588|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
126635785|NCT03721172|455625589|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
126635786|NCT03721172|455625590|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
126635787|NCT03721172|455625588|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
126635788|NCT03721172|455625589|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
126635789|NCT03721172|455625590|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
126635790|NCT03721172|455625588|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
126635791|NCT03721172|455625589|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
126635792|NCT03721172|455625590|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
126635793|NCT03721172|455625588|FG000|Placebo-controlled Phase|Other|3|||
126635794|NCT03721172|455625589|FG001|Placebo-controlled Phase|Other|0|||
126635795|NCT03721172|455625590|FG002|Placebo-controlled Phase|Other|0|||
126635796|NCT03721172|455625588|FG000|Apremilast Extension Phase|Adverse Event|0|||
126635797|NCT03721172|455625589|FG001|Apremilast Extension Phase|Adverse Event|0|||
126635798|NCT03721172|455625590|FG002|Apremilast Extension Phase|Adverse Event|10|||
126635799|NCT03721172|455625588|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
126635800|NCT03721172|455625589|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
126635801|NCT03721172|455625590|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
126635802|NCT03721172|455625588|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
126635803|NCT03721172|455625589|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
126635804|NCT03721172|455625590|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
126635805|NCT03721172|455625588|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
126635806|NCT03721172|455625589|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
126635807|NCT03721172|455625590|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
126635808|NCT03721172|455625588|FG000|Apremilast Extension Phase|Protocol Violation|0|||
126635809|NCT03721172|455625589|FG001|Apremilast Extension Phase|Protocol Violation|0|||
126635810|NCT03721172|455625590|FG002|Apremilast Extension Phase|Protocol Violation|1|||
126635811|NCT03721172|455625588|FG000|Apremilast Extension Phase|Physician Decision|0|||
126635812|NCT03721172|455625589|FG001|Apremilast Extension Phase|Physician Decision|0|||
126635813|NCT03721172|455625590|FG002|Apremilast Extension Phase|Physician Decision|1|||
126635814|NCT03721172|455625588|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
126635815|NCT03721172|455625589|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
126635816|NCT03721172|455625590|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
126635817|NCT03721172|455625588|FG000|Apremilast Extension Phase|Other|0|||
126635818|NCT03721172|455625589|FG001|Apremilast Extension Phase|Other|0|||
126635819|NCT03721172|455625590|FG002|Apremilast Extension Phase|Other|3|||
126635820|NCT03721172|455625588|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
126635821|NCT03721172|455625589|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
126635822|NCT03721172|455625590|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
126635823|NCT00420784|455625591|FG000|Overall Study|Adverse Event|11|||
126635824|NCT00420784|455625592|FG001|Overall Study|Adverse Event|29|||
126635825|NCT00420784|455625593|FG002|Overall Study|Adverse Event|10|||
126635826|NCT00420784|455625594|FG003|Overall Study|Adverse Event|5|||
126635827|NCT00420784|455625591|FG000|Overall Study|Withdrawal by Subject|0|||
126635828|NCT00420784|455625592|FG001|Overall Study|Withdrawal by Subject|1|||
126635829|NCT00420784|455625593|FG002|Overall Study|Withdrawal by Subject|0|||
126635830|NCT00420784|455625594|FG003|Overall Study|Withdrawal by Subject|0|||
126635831|NCT00420784|455625591|FG000|Overall Study|Lost to Follow-up|0|||
126635832|NCT00420784|455625592|FG001|Overall Study|Lost to Follow-up|0|||
126635833|NCT00420784|455625593|FG002|Overall Study|Lost to Follow-up|2|||
126635834|NCT00420784|455625594|FG003|Overall Study|Lost to Follow-up|1|||
126635835|NCT00420784|455625591|FG000|Overall Study|Virologic Stopping Rule|17|||
126635836|NCT00420784|455625592|FG001|Overall Study|Virologic Stopping Rule|26|||
126635837|NCT00420784|455625593|FG002|Overall Study|Virologic Stopping Rule|41|||
126635838|NCT00420784|455625594|FG003|Overall Study|Virologic Stopping Rule|67|||
126635839|NCT00420784|455625591|FG000|Overall Study|Other|1|||
126635840|NCT00420784|455625592|FG001|Overall Study|Other|2|||
126635841|NCT00420784|455625593|FG002|Overall Study|Other|0|||
126635842|NCT00420784|455625594|FG003|Overall Study|Other|5|||
126635843|NCT00983853|455625601|FG000|Overall Study|Lost to Follow-up|1|||
126635844|NCT00983853|455625602|FG001|Overall Study|Lost to Follow-up|1|||
126635845|NCT00983853|455625603|FG002|Overall Study|Lost to Follow-up|2|||
126635846|NCT00983853|455625604|FG003|Overall Study|Lost to Follow-up|2|||
126635847|NCT00983853|455625605|FG004|Overall Study|Lost to Follow-up|2|||
126635848|NCT00983853|455625606|FG005|Overall Study|Lost to Follow-up|1|||
126635849|NCT00983853|455625601|FG000|Overall Study|Withdrawal by Subject|0|||
126635850|NCT00983853|455625602|FG001|Overall Study|Withdrawal by Subject|0|||
126635851|NCT00983853|455625603|FG002|Overall Study|Withdrawal by Subject|1|||
126635852|NCT00983853|455625604|FG003|Overall Study|Withdrawal by Subject|0|||
126635853|NCT00983853|455625605|FG004|Overall Study|Withdrawal by Subject|1|||
126635854|NCT00983853|455625606|FG005|Overall Study|Withdrawal by Subject|0|||
126635855|NCT00983853|455625601|FG000|Overall Study|Unable to come to study follow-up visits|0|||
126635856|NCT00983853|455625602|FG001|Overall Study|Unable to come to study follow-up visits|1|||
126635857|NCT00983853|455625603|FG002|Overall Study|Unable to come to study follow-up visits|0|||
126635858|NCT00983853|455625604|FG003|Overall Study|Unable to come to study follow-up visits|0|||
126635859|NCT00983853|455625605|FG004|Overall Study|Unable to come to study follow-up visits|0|||
126635860|NCT00983853|455625606|FG005|Overall Study|Unable to come to study follow-up visits|0|||
126635861|NCT03603639|455625607|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
126635862|NCT03603639|455625608|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
126635863|NCT03603639|455625609|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
126635864|NCT03603639|455625610|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
126635865|NCT03603639|455625611|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
126635866|NCT03603639|455625612|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
126635867|NCT03603639|455625607|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
126635868|NCT03603639|455625608|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
126635869|NCT03603639|455625609|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
126635870|NCT03603639|455625610|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
126635871|NCT03603639|455625611|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
126635872|NCT03603639|455625612|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
126635873|NCT02947100|455625615|FG000|Overall Study|study terminated early|3|||
126635874|NCT02947100|455625615|FG000|Overall Study|did not meet inclusion criteria|1|||
126635875|NCT02402322|455625616|FG000|Pretreatment|Withdrawal by Subject|3|||
126635876|NCT02402322|455625617|FG001|Pretreatment|Withdrawal by Subject|1|||
126635877|NCT02402322|455625618|FG002|Pretreatment|Withdrawal by Subject|1|||
126635878|NCT02402322|455625616|FG000|Follow-up|Withdrawal by Subject|6|||
126635879|NCT02402322|455625617|FG001|Follow-up|Withdrawal by Subject|3|||
126635880|NCT02402322|455625618|FG002|Follow-up|Withdrawal by Subject|24|||
126635881|NCT00742326|455625619|FG000|Overall Study|Physician Decision|0|||
126635882|NCT00742326|455625620|FG001|Overall Study|Physician Decision|1|||
126635883|NCT02472145|455625621|FG000|Overall Study|Death|10|||
126635884|NCT02472145|455625622|FG001|Overall Study|Death|101|||
126635885|NCT02472145|455625623|FG002|Overall Study|Death|99|||
126635886|NCT02472145|455625621|FG000|Overall Study|Lost to Follow-up|0|||
126635887|NCT02472145|455625622|FG001|Overall Study|Lost to Follow-up|1|||
126635888|NCT02472145|455625623|FG002|Overall Study|Lost to Follow-up|0|||
126635889|NCT02472145|455625621|FG000|Overall Study|Withdrawal by Subject|0|||
126635890|NCT02472145|455625622|FG001|Overall Study|Withdrawal by Subject|9|||
126635891|NCT02472145|455625623|FG002|Overall Study|Withdrawal by Subject|13|||
126635892|NCT02472145|455625621|FG000|Overall Study|Sponsor decision|0|||
126635893|NCT02472145|455625622|FG001|Overall Study|Sponsor decision|3|||
126756136|NCT00819052|456057384|FG001|Overall Study|Withdrawal by Subject|2|||
126756137|NCT00819052|456057383|FG000|Overall Study|Lack of Efficacy|1|||
126756138|NCT00819052|456057384|FG001|Overall Study|Lack of Efficacy|1|||
126756139|NCT00819052|456057383|FG000|Overall Study|Pregnancy|1|||
126756140|NCT00819052|456057384|FG001|Overall Study|Pregnancy|2|||
126756141|NCT00819052|456057383|FG000|Overall Study|Death or events leading to death|1|||
126756142|NCT00819052|456057384|FG001|Overall Study|Death or events leading to death|0|||
126756143|NCT01277666|456057389|FG000|Overall Study|Adverse Event|26|||
126756144|NCT01277666|456057390|FG001|Overall Study|Adverse Event|25|||
126756145|NCT01277666|456057391|FG002|Overall Study|Adverse Event|20|||
126756146|NCT01277666|456057389|FG000|Overall Study|Lack of Efficacy|8|||
126756147|NCT01277666|456057390|FG001|Overall Study|Lack of Efficacy|20|||
126756148|NCT01277666|456057391|FG002|Overall Study|Lack of Efficacy|12|||
126756149|NCT01277666|456057389|FG000|Overall Study|Protocol Violation|2|||
126756150|NCT01277666|456057390|FG001|Overall Study|Protocol Violation|3|||
126756151|NCT01277666|456057391|FG002|Overall Study|Protocol Violation|2|||
126756152|NCT01277666|456057389|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
126756153|NCT01277666|456057390|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
126756154|NCT01277666|456057391|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
126756155|NCT01277666|456057389|FG000|Overall Study|Lost to Follow-up|1|||
126756156|NCT01277666|456057390|FG001|Overall Study|Lost to Follow-up|1|||
126756157|NCT01277666|456057391|FG002|Overall Study|Lost to Follow-up|2|||
126756158|NCT01277666|456057389|FG000|Overall Study|Withdrawal by Subject|7|||
126756159|NCT01277666|456057390|FG001|Overall Study|Withdrawal by Subject|8|||
126756160|NCT01277666|456057391|FG002|Overall Study|Withdrawal by Subject|6|||
126756161|NCT01277666|456057389|FG000|Overall Study|Death|0|||
126756162|NCT01277666|456057390|FG001|Overall Study|Death|0|||
126756163|NCT01277666|456057391|FG002|Overall Study|Death|1|||
126756164|NCT00982111|456057392|FG000|Overall Study|Adverse Event|1|||
126756165|NCT00982111|456057393|FG001|Overall Study|Adverse Event|1|||
126756166|NCT00982111|456057392|FG000|Overall Study|Progressive Disease|46|||
126756167|NCT00982111|456057393|FG001|Overall Study|Progressive Disease|39|||
126756168|NCT00982111|456057392|FG000|Overall Study|Lost to Follow-up|9|||
126756169|NCT00982111|456057393|FG001|Overall Study|Lost to Follow-up|6|||
126756170|NCT00982111|456057392|FG000|Overall Study|New Anti-Cancer Therapy|5|||
126756171|NCT00982111|456057393|FG001|Overall Study|New Anti-Cancer Therapy|5|||
126756172|NCT00982111|456057392|FG000|Overall Study|Medical Decision|1|||
126756173|NCT00982111|456057393|FG001|Overall Study|Medical Decision|0|||
126635894|NCT02472145|455625623|FG002|Overall Study|Sponsor decision|2|||
126635895|NCT02472145|455625621|FG000|Overall Study|Other|0|||
126756174|NCT00982111|456057392|FG000|Overall Study|Withdrawal by Subject|17|||
126756175|NCT00982111|456057393|FG001|Overall Study|Withdrawal by Subject|19|||
126756176|NCT00982111|456057392|FG000|Overall Study|Global Study End|0|||
126635896|NCT02472145|455625622|FG001|Overall Study|Other|45|||
126635897|NCT02472145|455625623|FG002|Overall Study|Other|43|||
126635898|NCT01080326|455625624|FG000|Overall Study|Patient deterioration prior to procedure|3|||
126635899|NCT01080326|455625624|FG000|Overall Study|Surgeon decision|1|||
126635900|NCT01318876|455625626|FG000|Day 8 Survey|email address invalid|96|||
126635901|NCT01318876|455625626|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
126635902|NCT01318876|455625626|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
126635903|NCT01296555|455625627|FG000|Overall Study|Adverse Event|0|||
126635904|NCT01296555|455625628|FG001|Overall Study|Adverse Event|0|||
126635905|NCT01296555|455625629|FG002|Overall Study|Adverse Event|1|||
126635906|NCT01296555|455625630|FG003|Overall Study|Adverse Event|1|||
126635907|NCT01296555|455625631|FG004|Overall Study|Adverse Event|2|||
126635908|NCT01296555|455625632|FG005|Overall Study|Adverse Event|4|||
126635909|NCT01296555|455625633|FG006|Overall Study|Adverse Event|1|||
126635910|NCT01296555|455625634|FG007|Overall Study|Adverse Event|4|||
126635911|NCT01296555|455625635|FG008|Overall Study|Adverse Event|3|||
126635912|NCT01296555|455625636|FG009|Overall Study|Adverse Event|1|||
126635913|NCT01296555|455625637|FG010|Overall Study|Adverse Event|0|||
126635914|NCT01296555|455625638|FG011|Overall Study|Adverse Event|4|||
126635915|NCT01296555|455625639|FG012|Overall Study|Adverse Event|1|||
126635916|NCT01296555|455625640|FG013|Overall Study|Adverse Event|4|||
126635917|NCT01296555|455625641|FG014|Overall Study|Adverse Event|0|||
126635918|NCT01296555|455625642|FG015|Overall Study|Adverse Event|0|||
126635919|NCT01296555|455625643|FG016|Overall Study|Adverse Event|0|||
126635920|NCT01296555|455625644|FG017|Overall Study|Adverse Event|0|||
126635921|NCT01296555|455625645|FG018|Overall Study|Adverse Event|0|||
126635922|NCT01296555|455625646|FG019|Overall Study|Adverse Event|1|||
126635923|NCT01296555|455625647|FG020|Overall Study|Adverse Event|0|||
126635924|NCT01296555|455625648|FG021|Overall Study|Adverse Event|0|||
126635925|NCT01296555|455625649|FG022|Overall Study|Adverse Event|0|||
126635926|NCT01296555|455625650|FG023|Overall Study|Adverse Event|0|||
126635927|NCT01296555|455625651|FG024|Overall Study|Adverse Event|0|||
126635928|NCT01296555|455625652|FG025|Overall Study|Adverse Event|0|||
126635929|NCT01296555|455625653|FG026|Overall Study|Adverse Event|0|||
126635930|NCT01296555|455625654|FG027|Overall Study|Adverse Event|0|||
126635931|NCT01296555|455625655|FG028|Overall Study|Adverse Event|0|||
126635932|NCT01296555|455625627|FG000|Overall Study|Reason Not Specified|0|||
126635933|NCT01296555|455625628|FG001|Overall Study|Reason Not Specified|0|||
126635934|NCT01296555|455625629|FG002|Overall Study|Reason Not Specified|0|||
126635935|NCT01296555|455625630|FG003|Overall Study|Reason Not Specified|0|||
126635936|NCT01296555|455625631|FG004|Overall Study|Reason Not Specified|0|||
126635937|NCT01296555|455625632|FG005|Overall Study|Reason Not Specified|0|||
126635938|NCT01296555|455625633|FG006|Overall Study|Reason Not Specified|0|||
126635939|NCT01296555|455625634|FG007|Overall Study|Reason Not Specified|0|||
126635940|NCT01296555|455625635|FG008|Overall Study|Reason Not Specified|0|||
126635941|NCT01296555|455625636|FG009|Overall Study|Reason Not Specified|0|||
126635942|NCT01296555|455625637|FG010|Overall Study|Reason Not Specified|0|||
126635943|NCT01296555|455625638|FG011|Overall Study|Reason Not Specified|0|||
126635944|NCT01296555|455625639|FG012|Overall Study|Reason Not Specified|0|||
126635945|NCT01296555|455625640|FG013|Overall Study|Reason Not Specified|1|||
126635946|NCT01296555|455625641|FG014|Overall Study|Reason Not Specified|2|||
126635947|NCT01296555|455625642|FG015|Overall Study|Reason Not Specified|3|||
126635948|NCT01296555|455625643|FG016|Overall Study|Reason Not Specified|7|||
126635949|NCT01296555|455625644|FG017|Overall Study|Reason Not Specified|4|||
126635950|NCT01296555|455625645|FG018|Overall Study|Reason Not Specified|3|||
126635951|NCT01296555|455625646|FG019|Overall Study|Reason Not Specified|7|||
126635952|NCT01296555|455625647|FG020|Overall Study|Reason Not Specified|11|||
126635953|NCT01296555|455625648|FG021|Overall Study|Reason Not Specified|5|||
126635954|NCT01296555|455625649|FG022|Overall Study|Reason Not Specified|5|||
126635955|NCT01296555|455625650|FG023|Overall Study|Reason Not Specified|7|||
126635956|NCT01296555|455625651|FG024|Overall Study|Reason Not Specified|2|||
126635957|NCT01296555|455625652|FG025|Overall Study|Reason Not Specified|2|||
126635958|NCT01296555|455625653|FG026|Overall Study|Reason Not Specified|19|||
126635959|NCT01296555|455625654|FG027|Overall Study|Reason Not Specified|11|||
126635960|NCT01296555|455625655|FG028|Overall Study|Reason Not Specified|9|||
126635961|NCT01296555|455625627|FG000|Overall Study|Physician Decision|0|||
126635962|NCT01296555|455625628|FG001|Overall Study|Physician Decision|0|||
126635963|NCT01296555|455625629|FG002|Overall Study|Physician Decision|0|||
126635964|NCT01296555|455625630|FG003|Overall Study|Physician Decision|0|||
126635965|NCT01296555|455625631|FG004|Overall Study|Physician Decision|1|||
126635966|NCT01296555|455625632|FG005|Overall Study|Physician Decision|0|||
126635967|NCT01296555|455625633|FG006|Overall Study|Physician Decision|0|||
126635968|NCT01296555|455625634|FG007|Overall Study|Physician Decision|0|||
126635969|NCT01296555|455625635|FG008|Overall Study|Physician Decision|0|||
126635970|NCT01296555|455625636|FG009|Overall Study|Physician Decision|0|||
126635971|NCT01296555|455625637|FG010|Overall Study|Physician Decision|0|||
126635972|NCT01296555|455625638|FG011|Overall Study|Physician Decision|0|||
126635973|NCT01296555|455625639|FG012|Overall Study|Physician Decision|0|||
126635974|NCT01296555|455625640|FG013|Overall Study|Physician Decision|1|||
126635975|NCT01296555|455625641|FG014|Overall Study|Physician Decision|0|||
126635976|NCT01296555|455625642|FG015|Overall Study|Physician Decision|0|||
126635977|NCT01296555|455625643|FG016|Overall Study|Physician Decision|0|||
126635978|NCT01296555|455625644|FG017|Overall Study|Physician Decision|0|||
126635979|NCT01296555|455625645|FG018|Overall Study|Physician Decision|0|||
126635980|NCT01296555|455625646|FG019|Overall Study|Physician Decision|1|||
126635981|NCT01296555|455625647|FG020|Overall Study|Physician Decision|0|||
126635982|NCT01296555|455625648|FG021|Overall Study|Physician Decision|0|||
126635983|NCT01296555|455625649|FG022|Overall Study|Physician Decision|0|||
126635984|NCT01296555|455625650|FG023|Overall Study|Physician Decision|0|||
126635985|NCT01296555|455625651|FG024|Overall Study|Physician Decision|0|||
126635986|NCT01296555|455625652|FG025|Overall Study|Physician Decision|0|||
126635987|NCT01296555|455625653|FG026|Overall Study|Physician Decision|0|||
126635988|NCT01296555|455625654|FG027|Overall Study|Physician Decision|0|||
126635989|NCT01296555|455625655|FG028|Overall Study|Physician Decision|0|||
126635990|NCT01296555|455625627|FG000|Overall Study|Progressive Disease|6|||
126635991|NCT01296555|455625628|FG001|Overall Study|Progressive Disease|3|||
126635992|NCT01296555|455625629|FG002|Overall Study|Progressive Disease|3|||
126635993|NCT01296555|455625630|FG003|Overall Study|Progressive Disease|7|||
126635994|NCT01296555|455625631|FG004|Overall Study|Progressive Disease|6|||
126635995|NCT01296555|455625632|FG005|Overall Study|Progressive Disease|16|||
126635996|NCT01296555|455625633|FG006|Overall Study|Progressive Disease|16|||
126635997|NCT01296555|455625634|FG007|Overall Study|Progressive Disease|8|||
126635998|NCT01296555|455625635|FG008|Overall Study|Progressive Disease|7|||
126635999|NCT01296555|455625636|FG009|Overall Study|Progressive Disease|18|||
126636000|NCT01296555|455625637|FG010|Overall Study|Progressive Disease|7|||
126636001|NCT01296555|455625638|FG011|Overall Study|Progressive Disease|14|||
126636002|NCT01296555|455625639|FG012|Overall Study|Progressive Disease|5|||
126636003|NCT01296555|455625640|FG013|Overall Study|Progressive Disease|12|||
126636004|NCT01296555|455625641|FG014|Overall Study|Progressive Disease|1|||
126636005|NCT01296555|455625642|FG015|Overall Study|Progressive Disease|1|||
126636006|NCT01296555|455625643|FG016|Overall Study|Progressive Disease|0|||
126636007|NCT01296555|455625644|FG017|Overall Study|Progressive Disease|0|||
126636008|NCT01296555|455625645|FG018|Overall Study|Progressive Disease|0|||
126636009|NCT01296555|455625646|FG019|Overall Study|Progressive Disease|1|||
126636010|NCT01296555|455625647|FG020|Overall Study|Progressive Disease|0|||
126636011|NCT01296555|455625648|FG021|Overall Study|Progressive Disease|0|||
126636012|NCT01296555|455625649|FG022|Overall Study|Progressive Disease|0|||
126636013|NCT01296555|455625650|FG023|Overall Study|Progressive Disease|0|||
126636014|NCT01296555|455625651|FG024|Overall Study|Progressive Disease|1|||
126636015|NCT01296555|455625652|FG025|Overall Study|Progressive Disease|0|||
126636016|NCT01296555|455625653|FG026|Overall Study|Progressive Disease|5|||
126636017|NCT01296555|455625654|FG027|Overall Study|Progressive Disease|1|||
126636018|NCT01296555|455625655|FG028|Overall Study|Progressive Disease|0|||
126636019|NCT01296555|455625627|FG000|Overall Study|Protocol Violation|0|||
126636020|NCT01296555|455625628|FG001|Overall Study|Protocol Violation|0|||
126636021|NCT01296555|455625629|FG002|Overall Study|Protocol Violation|0|||
126636022|NCT01296555|455625630|FG003|Overall Study|Protocol Violation|0|||
126636023|NCT01296555|455625631|FG004|Overall Study|Protocol Violation|0|||
126636024|NCT01296555|455625632|FG005|Overall Study|Protocol Violation|0|||
126636025|NCT01296555|455625633|FG006|Overall Study|Protocol Violation|0|||
126636026|NCT01296555|455625634|FG007|Overall Study|Protocol Violation|0|||
126636027|NCT01296555|455625635|FG008|Overall Study|Protocol Violation|0|||
126636028|NCT01296555|455625636|FG009|Overall Study|Protocol Violation|0|||
126636029|NCT01296555|455625637|FG010|Overall Study|Protocol Violation|0|||
126636030|NCT01296555|455625638|FG011|Overall Study|Protocol Violation|0|||
126636031|NCT01296555|455625639|FG012|Overall Study|Protocol Violation|0|||
126636032|NCT01296555|455625640|FG013|Overall Study|Protocol Violation|1|||
126636033|NCT01296555|455625641|FG014|Overall Study|Protocol Violation|0|||
126636034|NCT01296555|455625642|FG015|Overall Study|Protocol Violation|0|||
126636035|NCT01296555|455625643|FG016|Overall Study|Protocol Violation|0|||
126636036|NCT01296555|455625644|FG017|Overall Study|Protocol Violation|0|||
126636037|NCT01296555|455625645|FG018|Overall Study|Protocol Violation|0|||
126636038|NCT01296555|455625646|FG019|Overall Study|Protocol Violation|0|||
126636039|NCT01296555|455625647|FG020|Overall Study|Protocol Violation|0|||
126636040|NCT01296555|455625648|FG021|Overall Study|Protocol Violation|0|||
126636041|NCT01296555|455625649|FG022|Overall Study|Protocol Violation|0|||
126636042|NCT01296555|455625650|FG023|Overall Study|Protocol Violation|0|||
126636043|NCT01296555|455625651|FG024|Overall Study|Protocol Violation|0|||
126636044|NCT01296555|455625652|FG025|Overall Study|Protocol Violation|0|||
126636045|NCT01296555|455625653|FG026|Overall Study|Protocol Violation|0|||
126636046|NCT01296555|455625654|FG027|Overall Study|Protocol Violation|0|||
126636047|NCT01296555|455625655|FG028|Overall Study|Protocol Violation|0|||
126636048|NCT01296555|455625627|FG000|Overall Study|Study Terminated By Sponsor|0|||
126636049|NCT01296555|455625628|FG001|Overall Study|Study Terminated By Sponsor|0|||
126636050|NCT01296555|455625629|FG002|Overall Study|Study Terminated By Sponsor|0|||
126636051|NCT01296555|455625630|FG003|Overall Study|Study Terminated By Sponsor|0|||
126636052|NCT01296555|455625631|FG004|Overall Study|Study Terminated By Sponsor|0|||
126636053|NCT01296555|455625632|FG005|Overall Study|Study Terminated By Sponsor|0|||
126636054|NCT01296555|455625633|FG006|Overall Study|Study Terminated By Sponsor|0|||
126636055|NCT01296555|455625634|FG007|Overall Study|Study Terminated By Sponsor|0|||
126636056|NCT01296555|455625635|FG008|Overall Study|Study Terminated By Sponsor|0|||
126636057|NCT01296555|455625636|FG009|Overall Study|Study Terminated By Sponsor|0|||
126636058|NCT01296555|455625637|FG010|Overall Study|Study Terminated By Sponsor|0|||
126636059|NCT01296555|455625638|FG011|Overall Study|Study Terminated By Sponsor|0|||
126636060|NCT01296555|455625639|FG012|Overall Study|Study Terminated By Sponsor|0|||
126636061|NCT01296555|455625640|FG013|Overall Study|Study Terminated By Sponsor|0|||
126636062|NCT01296555|455625641|FG014|Overall Study|Study Terminated By Sponsor|0|||
126636063|NCT01296555|455625642|FG015|Overall Study|Study Terminated By Sponsor|0|||
126636064|NCT01296555|455625643|FG016|Overall Study|Study Terminated By Sponsor|0|||
126636065|NCT01296555|455625644|FG017|Overall Study|Study Terminated By Sponsor|0|||
126636066|NCT01296555|455625645|FG018|Overall Study|Study Terminated By Sponsor|0|||
126636067|NCT01296555|455625646|FG019|Overall Study|Study Terminated By Sponsor|0|||
126636068|NCT01296555|455625647|FG020|Overall Study|Study Terminated By Sponsor|0|||
126636069|NCT01296555|455625648|FG021|Overall Study|Study Terminated By Sponsor|0|||
126636070|NCT01296555|455625649|FG022|Overall Study|Study Terminated By Sponsor|0|||
126636071|NCT01296555|455625650|FG023|Overall Study|Study Terminated By Sponsor|0|||
126636072|NCT01296555|455625651|FG024|Overall Study|Study Terminated By Sponsor|0|||
126636073|NCT01296555|455625652|FG025|Overall Study|Study Terminated By Sponsor|1|||
126636074|NCT01296555|455625653|FG026|Overall Study|Study Terminated By Sponsor|0|||
126636075|NCT01296555|455625654|FG027|Overall Study|Study Terminated By Sponsor|0|||
126636076|NCT01296555|455625655|FG028|Overall Study|Study Terminated By Sponsor|0|||
126636077|NCT01296555|455625627|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636078|NCT01296555|455625628|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636079|NCT01296555|455625629|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636080|NCT01296555|455625630|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636081|NCT01296555|455625631|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636082|NCT01296555|455625632|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636083|NCT01296555|455625633|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636084|NCT01296555|455625634|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636085|NCT01296555|455625635|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636086|NCT01296555|455625636|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636087|NCT01296555|455625637|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636088|NCT01296555|455625638|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636089|NCT01296555|455625639|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636090|NCT01296555|455625640|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636091|NCT01296555|455625641|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636092|NCT01296555|455625642|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636093|NCT01296555|455625643|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636094|NCT01296555|455625644|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636095|NCT01296555|455625645|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636096|NCT01296555|455625646|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
126636097|NCT01296555|455625647|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636098|NCT01296555|455625648|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636099|NCT01296555|455625649|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636100|NCT01296555|455625650|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636101|NCT01296555|455625651|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636102|NCT01296555|455625652|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636103|NCT01296555|455625653|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636104|NCT01296555|455625654|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636105|NCT01296555|455625655|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
126636106|NCT01296555|455625627|FG000|Overall Study|Death|0|||
126636107|NCT01296555|455625628|FG001|Overall Study|Death|0|||
126636108|NCT01296555|455625629|FG002|Overall Study|Death|0|||
126636109|NCT01296555|455625630|FG003|Overall Study|Death|2|||
126636110|NCT01296555|455625631|FG004|Overall Study|Death|1|||
126636111|NCT01296555|455625632|FG005|Overall Study|Death|0|||
126636112|NCT01296555|455625633|FG006|Overall Study|Death|2|||
126636113|NCT01296555|455625634|FG007|Overall Study|Death|0|||
126636114|NCT01296555|455625635|FG008|Overall Study|Death|0|||
126636115|NCT01296555|455625636|FG009|Overall Study|Death|1|||
126636116|NCT01296555|455625637|FG010|Overall Study|Death|0|||
126636117|NCT01296555|455625638|FG011|Overall Study|Death|1|||
126636118|NCT01296555|455625639|FG012|Overall Study|Death|0|||
126636119|NCT01296555|455625640|FG013|Overall Study|Death|2|||
126636120|NCT01296555|455625641|FG014|Overall Study|Death|27|||
126636121|NCT01296555|455625642|FG015|Overall Study|Death|15|||
126636122|NCT01296555|455625643|FG016|Overall Study|Death|11|||
126636123|NCT01296555|455625644|FG017|Overall Study|Death|11|||
126636124|NCT01296555|455625645|FG018|Overall Study|Death|17|||
126636125|NCT01296555|455625646|FG019|Overall Study|Death|12|||
126636126|NCT01296555|455625647|FG020|Overall Study|Death|13|||
126636127|NCT01296555|455625648|FG021|Overall Study|Death|12|||
126636128|NCT01296555|455625649|FG022|Overall Study|Death|12|||
126636129|NCT01296555|455625650|FG023|Overall Study|Death|13|||
126636130|NCT01296555|455625651|FG024|Overall Study|Death|7|||
126636131|NCT01296555|455625652|FG025|Overall Study|Death|7|||
126636132|NCT01296555|455625653|FG026|Overall Study|Death|35|||
126636133|NCT01296555|455625654|FG027|Overall Study|Death|92|||
126636134|NCT01296555|455625655|FG028|Overall Study|Death|44|||
126636135|NCT01296555|455625627|FG000|Overall Study|Lost to Follow-up|0|||
126636136|NCT01296555|455625628|FG001|Overall Study|Lost to Follow-up|0|||
126636137|NCT01296555|455625629|FG002|Overall Study|Lost to Follow-up|0|||
126636138|NCT01296555|455625630|FG003|Overall Study|Lost to Follow-up|0|||
126636139|NCT01296555|455625631|FG004|Overall Study|Lost to Follow-up|0|||
126636140|NCT01296555|455625632|FG005|Overall Study|Lost to Follow-up|0|||
126636141|NCT01296555|455625633|FG006|Overall Study|Lost to Follow-up|0|||
126636142|NCT01296555|455625634|FG007|Overall Study|Lost to Follow-up|0|||
126636143|NCT01296555|455625635|FG008|Overall Study|Lost to Follow-up|0|||
126636144|NCT01296555|455625636|FG009|Overall Study|Lost to Follow-up|0|||
126636145|NCT01296555|455625637|FG010|Overall Study|Lost to Follow-up|0|||
126636146|NCT01296555|455625638|FG011|Overall Study|Lost to Follow-up|0|||
126636147|NCT01296555|455625639|FG012|Overall Study|Lost to Follow-up|0|||
126636148|NCT01296555|455625640|FG013|Overall Study|Lost to Follow-up|0|||
126636149|NCT01296555|455625641|FG014|Overall Study|Lost to Follow-up|2|||
126636150|NCT01296555|455625642|FG015|Overall Study|Lost to Follow-up|1|||
126636151|NCT01296555|455625643|FG016|Overall Study|Lost to Follow-up|0|||
126636152|NCT01296555|455625644|FG017|Overall Study|Lost to Follow-up|2|||
126636153|NCT01296555|455625645|FG018|Overall Study|Lost to Follow-up|0|||
126636154|NCT01296555|455625646|FG019|Overall Study|Lost to Follow-up|2|||
126636155|NCT01296555|455625647|FG020|Overall Study|Lost to Follow-up|3|||
126636156|NCT01296555|455625648|FG021|Overall Study|Lost to Follow-up|2|||
126636157|NCT01296555|455625649|FG022|Overall Study|Lost to Follow-up|0|||
126636158|NCT01296555|455625650|FG023|Overall Study|Lost to Follow-up|0|||
126636159|NCT01296555|455625651|FG024|Overall Study|Lost to Follow-up|0|||
126636160|NCT01296555|455625652|FG025|Overall Study|Lost to Follow-up|0|||
126636161|NCT01296555|455625653|FG026|Overall Study|Lost to Follow-up|3|||
126636162|NCT01296555|455625654|FG027|Overall Study|Lost to Follow-up|13|||
126636163|NCT01296555|455625655|FG028|Overall Study|Lost to Follow-up|5|||
126636164|NCT01296555|455625627|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126636165|NCT01296555|455625628|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126636166|NCT01296555|455625629|FG002|Overall Study|Non-Compliance With Study Drug|0|||
126636167|NCT01296555|455625630|FG003|Overall Study|Non-Compliance With Study Drug|0|||
126636168|NCT01296555|455625631|FG004|Overall Study|Non-Compliance With Study Drug|0|||
126636169|NCT01296555|455625632|FG005|Overall Study|Non-Compliance With Study Drug|0|||
126636170|NCT01296555|455625633|FG006|Overall Study|Non-Compliance With Study Drug|0|||
126636171|NCT01296555|455625634|FG007|Overall Study|Non-Compliance With Study Drug|1|||
126636172|NCT01296555|455625635|FG008|Overall Study|Non-Compliance With Study Drug|0|||
126636173|NCT01296555|455625636|FG009|Overall Study|Non-Compliance With Study Drug|0|||
126636174|NCT01296555|455625637|FG010|Overall Study|Non-Compliance With Study Drug|0|||
126636175|NCT01296555|455625638|FG011|Overall Study|Non-Compliance With Study Drug|0|||
126636176|NCT01296555|455625639|FG012|Overall Study|Non-Compliance With Study Drug|0|||
126636177|NCT01296555|455625640|FG013|Overall Study|Non-Compliance With Study Drug|0|||
126636178|NCT01296555|455625641|FG014|Overall Study|Non-Compliance With Study Drug|0|||
126636179|NCT01296555|455625642|FG015|Overall Study|Non-Compliance With Study Drug|0|||
126636180|NCT01296555|455625643|FG016|Overall Study|Non-Compliance With Study Drug|0|||
126636181|NCT01296555|455625644|FG017|Overall Study|Non-Compliance With Study Drug|0|||
126636182|NCT01296555|455625645|FG018|Overall Study|Non-Compliance With Study Drug|0|||
126636183|NCT01296555|455625646|FG019|Overall Study|Non-Compliance With Study Drug|0|||
126636184|NCT01296555|455625647|FG020|Overall Study|Non-Compliance With Study Drug|0|||
126636185|NCT01296555|455625648|FG021|Overall Study|Non-Compliance With Study Drug|0|||
126636186|NCT01296555|455625649|FG022|Overall Study|Non-Compliance With Study Drug|0|||
126636187|NCT01296555|455625650|FG023|Overall Study|Non-Compliance With Study Drug|0|||
126636188|NCT01296555|455625651|FG024|Overall Study|Non-Compliance With Study Drug|0|||
126636189|NCT01296555|455625652|FG025|Overall Study|Non-Compliance With Study Drug|0|||
126636190|NCT01296555|455625653|FG026|Overall Study|Non-Compliance With Study Drug|0|||
126636191|NCT01296555|455625654|FG027|Overall Study|Non-Compliance With Study Drug|0|||
126636192|NCT01296555|455625655|FG028|Overall Study|Non-Compliance With Study Drug|0|||
126636193|NCT01296555|455625627|FG000|Overall Study|Withdrawal by Subject|0|||
126636194|NCT01296555|455625628|FG001|Overall Study|Withdrawal by Subject|0|||
126636195|NCT01296555|455625629|FG002|Overall Study|Withdrawal by Subject|0|||
126636196|NCT01296555|455625630|FG003|Overall Study|Withdrawal by Subject|0|||
126636197|NCT01296555|455625631|FG004|Overall Study|Withdrawal by Subject|1|||
126636198|NCT01296555|455625632|FG005|Overall Study|Withdrawal by Subject|0|||
126636199|NCT01296555|455625633|FG006|Overall Study|Withdrawal by Subject|1|||
126636200|NCT01296555|455625634|FG007|Overall Study|Withdrawal by Subject|0|||
126636201|NCT01296555|455625635|FG008|Overall Study|Withdrawal by Subject|0|||
126636202|NCT01296555|455625636|FG009|Overall Study|Withdrawal by Subject|0|||
126636203|NCT01296555|455625637|FG010|Overall Study|Withdrawal by Subject|1|||
126636204|NCT01296555|455625638|FG011|Overall Study|Withdrawal by Subject|1|||
126636205|NCT01296555|455625639|FG012|Overall Study|Withdrawal by Subject|0|||
126636206|NCT01296555|455625640|FG013|Overall Study|Withdrawal by Subject|0|||
126636207|NCT01296555|455625641|FG014|Overall Study|Withdrawal by Subject|3|||
126636208|NCT01296555|455625642|FG015|Overall Study|Withdrawal by Subject|0|||
126636209|NCT01296555|455625643|FG016|Overall Study|Withdrawal by Subject|2|||
126636210|NCT01296555|455625644|FG017|Overall Study|Withdrawal by Subject|1|||
126636211|NCT01296555|455625645|FG018|Overall Study|Withdrawal by Subject|0|||
126636212|NCT01296555|455625646|FG019|Overall Study|Withdrawal by Subject|1|||
126636213|NCT01296555|455625647|FG020|Overall Study|Withdrawal by Subject|1|||
126636214|NCT01296555|455625648|FG021|Overall Study|Withdrawal by Subject|1|||
126636215|NCT01296555|455625649|FG022|Overall Study|Withdrawal by Subject|3|||
126636216|NCT01296555|455625650|FG023|Overall Study|Withdrawal by Subject|0|||
126636217|NCT01296555|455625651|FG024|Overall Study|Withdrawal by Subject|0|||
126636218|NCT01296555|455625652|FG025|Overall Study|Withdrawal by Subject|0|||
126636219|NCT01296555|455625653|FG026|Overall Study|Withdrawal by Subject|8|||
126636220|NCT01296555|455625654|FG027|Overall Study|Withdrawal by Subject|4|||
126636221|NCT01296555|455625655|FG028|Overall Study|Withdrawal by Subject|2|||
126636222|NCT00409409|455625656|FG000|Overall Study|Adverse Event|7|||
126636223|NCT00409409|455625657|FG001|Overall Study|Adverse Event|2|||
126636224|NCT00409409|455625656|FG000|Overall Study|Withdrawal by Subject|1|||
126636225|NCT00409409|455625657|FG001|Overall Study|Withdrawal by Subject|1|||
126636226|NCT00409409|455625656|FG000|Overall Study|Any other reason not above-mentioned|0|||
126636227|NCT00409409|455625657|FG001|Overall Study|Any other reason not above-mentioned|1|||
126636228|NCT03635086|455625661|FG000|Overall Study|Withdrawal of consent|0|||
126636229|NCT03635086|455625662|FG001|Overall Study|Withdrawal of consent|0|||
126636230|NCT03635086|455625663|FG002|Overall Study|Withdrawal of consent|1|||
126636231|NCT03635086|455625664|FG003|Overall Study|Withdrawal of consent|0|||
126636232|NCT03635086|455625665|FG004|Overall Study|Withdrawal of consent|0|||
126636233|NCT03635086|455625661|FG000|Overall Study|Adverse Event|0|||
126636234|NCT03635086|455625662|FG001|Overall Study|Adverse Event|1|||
126636235|NCT03635086|455625663|FG002|Overall Study|Adverse Event|0|||
126636236|NCT03635086|455625664|FG003|Overall Study|Adverse Event|0|||
126636237|NCT03635086|455625665|FG004|Overall Study|Adverse Event|0|||
126636238|NCT03635086|455625661|FG000|Overall Study|Lost to Follow-up|1|||
126636239|NCT03635086|455625662|FG001|Overall Study|Lost to Follow-up|0|||
126636240|NCT03635086|455625663|FG002|Overall Study|Lost to Follow-up|0|||
126636241|NCT03635086|455625664|FG003|Overall Study|Lost to Follow-up|0|||
126636242|NCT03635086|455625665|FG004|Overall Study|Lost to Follow-up|0|||
126636243|NCT01056263|455625678|FG000|Overall Study|Adverse Event|12|||
126636244|NCT01056263|455625678|FG000|Overall Study|Death|1|||
126636245|NCT01056263|455625678|FG000|Overall Study|Withdrawal by Subject|1|||
126636246|NCT01056263|455625678|FG000|Overall Study|Lack of Efficacy|29|||
126636247|NCT01056263|455625678|FG000|Overall Study|Progressive disease|2|||
126636248|NCT01056263|455625678|FG000|Overall Study|Neoplasm progression|1|||
126636249|NCT01056263|455625678|FG000|Overall Study|Objective progression or relapse|1|||
126636250|NCT01056263|455625678|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
126636251|NCT01262092|455625679|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
126636252|NCT01262092|455625680|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
126636253|NCT01262092|455625679|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
126636254|NCT01262092|455625680|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
126636255|NCT01262092|455625679|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
126636256|NCT01262092|455625680|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
126636257|NCT01262092|455625679|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
126636258|NCT01262092|455625680|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
126636259|NCT04147858|455625681|FG000|Overall Study|Adverse Event|6|||
126636260|NCT04147858|455625682|FG001|Overall Study|Adverse Event|6|||
126636261|NCT04147858|455625683|FG002|Overall Study|Adverse Event|6|||
126636262|NCT04147858|455625681|FG000|Overall Study|Lack of Efficacy|3|||
126636263|NCT04147858|455625682|FG001|Overall Study|Lack of Efficacy|3|||
126636264|NCT04147858|455625683|FG002|Overall Study|Lack of Efficacy|1|||
126636265|NCT04147858|455625681|FG000|Overall Study|Lost to Follow-up|1|||
126636266|NCT04147858|455625682|FG001|Overall Study|Lost to Follow-up|6|||
126636267|NCT04147858|455625683|FG002|Overall Study|Lost to Follow-up|2|||
126636268|NCT04147858|455625681|FG000|Overall Study|Withdrawal by Subject|3|||
126636269|NCT04147858|455625682|FG001|Overall Study|Withdrawal by Subject|4|||
126636270|NCT04147858|455625683|FG002|Overall Study|Withdrawal by Subject|10|||
126636271|NCT04147858|455625681|FG000|Overall Study|Subject Noncompliance, Other|4|||
126636272|NCT04147858|455625682|FG001|Overall Study|Subject Noncompliance, Other|3|||
126636273|NCT04147858|455625683|FG002|Overall Study|Subject Noncompliance, Other|1|||
126636274|NCT00699842|455625686|FG000|Overall Study|Death|0|||
126636275|NCT00699842|455625687|FG001|Overall Study|Death|1|||
126636276|NCT00699842|455625688|FG002|Overall Study|Death|0|||
126636277|NCT05990387|455625689|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
126636278|NCT05990387|455625690|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
126636279|NCT04750577|455625691|FG000|Overall Study|Adverse Event|2|||
126636280|NCT04750577|455625692|FG001|Overall Study|Adverse Event|10|||
126636281|NCT04750577|455625693|FG002|Overall Study|Adverse Event|8|||
126636282|NCT04750577|455625694|FG003|Overall Study|Adverse Event|1|||
126636283|NCT04750577|455625691|FG000|Overall Study|Change of residence|0|||
126636284|NCT04750577|455625692|FG001|Overall Study|Change of residence|0|||
126636285|NCT04750577|455625693|FG002|Overall Study|Change of residence|1|||
126636286|NCT04750577|455625694|FG003|Overall Study|Change of residence|0|||
126636287|NCT04750577|455625691|FG000|Overall Study|Burden of study procedures|0|||
126636288|NCT04750577|455625692|FG001|Overall Study|Burden of study procedures|2|||
126636289|NCT04750577|455625693|FG002|Overall Study|Burden of study procedures|2|||
126636290|NCT04750577|455625694|FG003|Overall Study|Burden of study procedures|0|||
126636291|NCT04750577|455625691|FG000|Overall Study|Prematurely discontinued|0|||
126636292|NCT04750577|455625692|FG001|Overall Study|Prematurely discontinued|0|||
126636293|NCT04750577|455625693|FG002|Overall Study|Prematurely discontinued|0|||
126636294|NCT04750577|455625694|FG003|Overall Study|Prematurely discontinued|2|||
126636295|NCT04750577|455625691|FG000|Overall Study|Protocol deviation|1|||
126636296|NCT04750577|455625692|FG001|Overall Study|Protocol deviation|1|||
126636297|NCT04750577|455625693|FG002|Overall Study|Protocol deviation|1|||
126636298|NCT04750577|455625694|FG003|Overall Study|Protocol deviation|1|||
126636299|NCT04750577|455625691|FG000|Overall Study|Other than listed|3|||
126636300|NCT04750577|455625692|FG001|Overall Study|Other than listed|2|||
126636301|NCT04750577|455625693|FG002|Overall Study|Other than listed|2|||
126636302|NCT04750577|455625694|FG003|Overall Study|Other than listed|1|||
126636303|NCT04750577|455625691|FG000|Overall Study|Not treated|0|||
126636304|NCT04750577|455625692|FG001|Overall Study|Not treated|0|||
126636305|NCT04750577|455625693|FG002|Overall Study|Not treated|0|||
126636306|NCT04750577|455625694|FG003|Overall Study|Not treated|2|||
126636307|NCT01806389|455625697|FG000|Overall Study|Withdrawal by Subject|4|||
126636308|NCT03371823|455625700|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
126636309|NCT03371823|455625701|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
126636310|NCT01310699|455625702|FG000|Overall Study|Patients did not complete tandem.|4|||
126636311|NCT01310699|455625703|FG001|Overall Study|Patients did not complete tandem.|6|||
126636312|NCT00936598|455625704|FG000|Overall Study|Withdrawal by Subject|1|||
126636313|NCT00936598|455625705|FG001|Overall Study|Withdrawal by Subject|0|||
126636314|NCT00936598|455625704|FG000|Overall Study|Ineligible after consent|1|||
126636315|NCT00936598|455625705|FG001|Overall Study|Ineligible after consent|0|||
126636316|NCT00926575|455625706|FG000|Overall Study|Adverse Event|1|||
126636317|NCT00926575|455625707|FG001|Overall Study|Adverse Event|1|||
126636318|NCT00926575|455625706|FG000|Overall Study|Death|4|||
126636319|NCT00926575|455625707|FG001|Overall Study|Death|4|||
126636320|NCT00926575|455625706|FG000|Overall Study|Lost to Follow-up|1|||
126636321|NCT00926575|455625707|FG001|Overall Study|Lost to Follow-up|1|||
126636322|NCT00926575|455625706|FG000|Overall Study|Physician Decision|1|||
126636323|NCT00926575|455625707|FG001|Overall Study|Physician Decision|2|||
126636324|NCT00926575|455625706|FG000|Overall Study|Protocol Violation|1|||
126636325|NCT00926575|455625707|FG001|Overall Study|Protocol Violation|0|||
126636326|NCT00926575|455625706|FG000|Overall Study|Withdrawal by Subject|8|||
126636327|NCT00926575|455625707|FG001|Overall Study|Withdrawal by Subject|9|||
126636328|NCT02035696|455627719|FG000|Overall Study|Lost to Follow-up|0|||
126636329|NCT02035696|455627720|FG001|Overall Study|Lost to Follow-up|3|||
126636330|NCT02035696|455627721|FG002|Overall Study|Lost to Follow-up|1|||
126636331|NCT02035696|455627722|FG003|Overall Study|Lost to Follow-up|2|||
126636332|NCT02035696|455627719|FG000|Overall Study|Withdrawal by Subject|3|||
126636333|NCT02035696|455627720|FG001|Overall Study|Withdrawal by Subject|0|||
126636334|NCT02035696|455627721|FG002|Overall Study|Withdrawal by Subject|2|||
126636335|NCT02035696|455627722|FG003|Overall Study|Withdrawal by Subject|1|||
126636336|NCT00966264|455627723|FG000|Overall Study|Lost to Follow-up|4|||
126636337|NCT00966264|455627724|FG001|Overall Study|Lost to Follow-up|3|||
126636338|NCT02859064|455627729|FG000|Overall Study|Progressive Disease|3|||
126636339|NCT02859064|455627729|FG000|Overall Study|Physician Decision|1|||
126636340|NCT02859064|455627729|FG000|Overall Study|Withdrawal by Subject|1|||
126636341|NCT02859064|455627729|FG000|Overall Study|Death|1|||
126636342|NCT00321685|455627730|FG000|Overall Study|Adverse Event|18|||
126636343|NCT00321685|455627730|FG000|Overall Study|Death|2|||
126636344|NCT00321685|455627730|FG000|Overall Study|Withdrawal by Subject|8|||
126636345|NCT00321685|455627730|FG000|Overall Study|Alternative therapy|1|||
126636346|NCT00321685|455627730|FG000|Overall Study|Complicating disese|1|||
126636347|NCT00321685|455627730|FG000|Overall Study|Other|5|||
126636348|NCT00321685|455627730|FG000|Overall Study|Not start protocol therapy|2|||
126636349|NCT00321685|455627730|FG000|Overall Study|Ineligible|2|||
126636350|NCT01536587|455627733|FG000|Overall Study|Adverse Event|2|||
126636351|NCT02354651|455627734|FG000|Overall Study|Withdrawal by Subject|2|||
126636352|NCT02354651|455627734|FG000|Overall Study|Physician Decision|1|||
126636353|NCT01439867|455627739|FG000|Overall Study|Non-compliance|0|||
126636354|NCT01439867|455627740|FG001|Overall Study|Non-compliance|1|||
126636355|NCT01439867|455627739|FG000|Overall Study|Withdrawal by Subject|1|||
126636356|NCT01439867|455627740|FG001|Overall Study|Withdrawal by Subject|2|||
126636357|NCT01439867|455627739|FG000|Overall Study|Administrative Decision|4|||
126636358|NCT01439867|455627740|FG001|Overall Study|Administrative Decision|5|||
126636359|NCT01439867|455627739|FG000|Overall Study|Protocol-specified Criteria|1|||
126636360|NCT01439867|455627740|FG001|Overall Study|Protocol-specified Criteria|0|||
126636361|NCT01245140|455627743|FG000|Overall Study|Adverse Event|1|||
126636362|NCT01245140|455627744|FG001|Overall Study|Adverse Event|3|||
126636363|NCT01245140|455627743|FG000|Overall Study|Lack of Efficacy|2|||
126636364|NCT01245140|455627744|FG001|Overall Study|Lack of Efficacy|4|||
126636365|NCT01245140|455627743|FG000|Overall Study|Protocol Violation|0|||
126636366|NCT01245140|455627744|FG001|Overall Study|Protocol Violation|1|||
126636367|NCT01245140|455627743|FG000|Overall Study|Withdrawal by Subject|0|||
126636368|NCT01245140|455627744|FG001|Overall Study|Withdrawal by Subject|1|||
126636369|NCT01245140|455627743|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
126636370|NCT01245140|455627744|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
126636371|NCT04836559|455627745|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
126636372|NCT04836559|455627746|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
126636373|NCT04836559|455627747|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
126636374|NCT04836559|455627748|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
126636375|NCT04836559|455627749|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
126636376|NCT04836559|455627750|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
126636377|NCT04836559|455627751|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
126636378|NCT04836559|455627752|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
126636379|NCT04836559|455627745|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
126636380|NCT04836559|455627746|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
126636381|NCT04836559|455627747|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
126636382|NCT04836559|455627748|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
126756177|NCT00982111|456057393|FG001|Overall Study|Global Study End|1|||
126756178|NCT00982111|456057392|FG000|Overall Study|Sponsor's Decision|0|||
126756179|NCT00982111|456057393|FG001|Overall Study|Sponsor's Decision|1|||
126756180|NCT01482598|456057394|FG000|Overall Study|Death|7|||
126756181|NCT01482598|456057395|FG001|Overall Study|Death|10|||
126756182|NCT01482598|456057394|FG000|Overall Study|Physician Decision|0|||
126756183|NCT01482598|456057395|FG001|Overall Study|Physician Decision|3|||
126756184|NCT01482598|456057394|FG000|Overall Study|Withdrawal by Subject|4|||
126756185|NCT01482598|456057395|FG001|Overall Study|Withdrawal by Subject|5|||
126756186|NCT01482598|456057394|FG000|Overall Study|Lost to Follow-up|5|||
126756187|NCT01482598|456057395|FG001|Overall Study|Lost to Follow-up|4|||
126636383|NCT04836559|455627749|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
126636384|NCT04836559|455627750|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
126636385|NCT04836559|455627751|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
126636386|NCT04836559|455627752|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
126636387|NCT04836559|455627745|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
126636388|NCT04836559|455627746|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126636389|NCT04836559|455627747|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126636390|NCT04836559|455627748|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126636391|NCT04836559|455627749|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126636392|NCT04836559|455627750|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126636393|NCT04836559|455627751|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126636394|NCT04836559|455627752|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
126636395|NCT04836559|455627745|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
126636396|NCT04836559|455627746|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
126636397|NCT04836559|455627747|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
126636398|NCT04836559|455627748|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
126636399|NCT04836559|455627749|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
126636400|NCT04836559|455627750|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
126636401|NCT04836559|455627751|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
126636402|NCT04836559|455627752|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
126636403|NCT04836559|455627745|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126636404|NCT04836559|455627746|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126636405|NCT04836559|455627747|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126636406|NCT04836559|455627748|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
126636407|NCT04836559|455627749|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126636408|NCT04836559|455627750|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126636409|NCT04836559|455627751|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126636410|NCT04836559|455627752|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
126636411|NCT04836559|455627745|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
126636412|NCT04836559|455627746|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
126636413|NCT04836559|455627747|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
126636414|NCT04836559|455627748|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
126636415|NCT04836559|455627749|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
126636416|NCT04836559|455627750|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
126636417|NCT04836559|455627751|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
126636418|NCT04836559|455627752|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
126636419|NCT04836559|455627745|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
126636420|NCT04836559|455627746|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
126636421|NCT04836559|455627747|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
126636422|NCT04836559|455627748|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
126636423|NCT04836559|455627749|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
126636424|NCT04836559|455627750|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
126636425|NCT04836559|455627751|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
126636426|NCT04836559|455627752|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
126636427|NCT04836559|455627745|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
126636428|NCT04836559|455627746|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
126636429|NCT04836559|455627747|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
126636430|NCT04836559|455627748|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
126636431|NCT04836559|455627749|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
126636432|NCT04836559|455627750|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
126636433|NCT04836559|455627751|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
126636434|NCT04836559|455627752|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
126636435|NCT04836559|455627745|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126636436|NCT04836559|455627746|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126636437|NCT04836559|455627747|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126636438|NCT04836559|455627748|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126636439|NCT04836559|455627749|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126636440|NCT04836559|455627750|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126636441|NCT04836559|455627751|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
126636442|NCT04836559|455627752|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
126636443|NCT02635360|455627753|FG000|Overall Study|Adverse Event|0|||
126636444|NCT02635360|455627754|FG001|Overall Study|Adverse Event|3|||
126636445|NCT02635360|455627753|FG000|Overall Study|Withdrawal by Subject|2|||
126636446|NCT02635360|455627754|FG001|Overall Study|Withdrawal by Subject|0|||
126636447|NCT02635360|455627753|FG000|Overall Study|Non-Compliance|3|||
126636448|NCT02635360|455627754|FG001|Overall Study|Non-Compliance|1|||
126636449|NCT02635360|455627753|FG000|Overall Study|Disease Progression|0|||
126636450|NCT02635360|455627754|FG001|Overall Study|Disease Progression|2|||
126636451|NCT02635360|455627753|FG000|Overall Study|Lost to Follow-up|1|||
126636452|NCT02635360|455627754|FG001|Overall Study|Lost to Follow-up|1|||
126636453|NCT04978350|455627755|FG000|Overall Study|Lost to Follow-up|6|||
126636454|NCT05765435|455627758|FG000|Overall Study|Lost to Follow-up|0|||
126636455|NCT05765435|455627759|FG001|Overall Study|Lost to Follow-up|1|||
126636456|NCT05765435|455627760|FG002|Overall Study|Lost to Follow-up|0|||
126636457|NCT05765435|455627758|FG000|Overall Study|Withdrawal by Subject|0|||
126636458|NCT05765435|455627759|FG001|Overall Study|Withdrawal by Subject|0|||
126636459|NCT05765435|455627760|FG002|Overall Study|Withdrawal by Subject|1|||
126636460|NCT00781937|455627766|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
126636461|NCT00781937|455627767|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
126636462|NCT00781937|455627766|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
126636463|NCT00781937|455627767|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
126636464|NCT00781937|455627766|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
126636465|NCT00781937|455627767|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
126636466|NCT00781937|455627766|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
126636467|NCT00781937|455627767|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
126636468|NCT00781937|455627766|FG000|Main Trial Period Through Week 56|Unclassified|10|||
126636469|NCT00781937|455627767|FG001|Main Trial Period Through Week 56|Unclassified|15|||
126636470|NCT00781937|455627766|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
126636471|NCT00781937|455627767|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
126636472|NCT00781937|455627766|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
126636473|NCT00781937|455627767|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
126636474|NCT00013611|455627768|FG000|Overall Study|Lost to Follow-up|91|||
126636475|NCT00013611|455627769|FG001|Overall Study|Lost to Follow-up|100|||
126636476|NCT01013961|455627773|FG000|Overall Study|Adverse Event|2|||
126636477|NCT01013961|455627774|FG001|Overall Study|Adverse Event|2|||
126636478|NCT01013961|455627773|FG000|Overall Study|Withdrawal by Subject|1|||
126636479|NCT01013961|455627774|FG001|Overall Study|Withdrawal by Subject|0|||
126636480|NCT01013961|455627773|FG000|Overall Study|Physician Decision|0|||
126636481|NCT01013961|455627774|FG001|Overall Study|Physician Decision|1|||
126636482|NCT02417441|455627789|FG000|Overall Study|Inconclusive due to missing data|52|||
126636483|NCT02417441|455627790|FG001|Overall Study|Inconclusive due to missing data|19|||
126636484|NCT03016598|455627796|FG000|Overall Study|Lost to Follow-up|0|||
126636485|NCT03016598|455627797|FG001|Overall Study|Lost to Follow-up|2|||
126636486|NCT04593823|455627799|FG000|Overall Study|Withdrawal by Subject|1|||
126636487|NCT04593823|455627800|FG001|Overall Study|Withdrawal by Subject|1|||
126636488|NCT04593823|455627799|FG000|Overall Study|Lost to Follow-up|0|||
126636489|NCT04593823|455627800|FG001|Overall Study|Lost to Follow-up|1|||
126636490|NCT00443209|455627803|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
126636491|NCT00443209|455627804|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
126636492|NCT00443209|455627803|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
126636493|NCT00443209|455627804|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
126636494|NCT00443209|455627803|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
126636495|NCT00443209|455627804|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
126636496|NCT00443209|455627803|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
126636497|NCT00443209|455627804|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
126636498|NCT00443209|455627803|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
126636499|NCT00443209|455627804|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
126636500|NCT00443209|455627803|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
126636501|NCT00443209|455627804|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
126636502|NCT00443209|455627803|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
126636503|NCT00443209|455627804|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
126636504|NCT00443209|455627803|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
126636505|NCT00443209|455627804|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
126636506|NCT00443209|455627803|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
126636507|NCT00443209|455627804|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
126636508|NCT00443209|455627803|FG000|Months 1 to 12 Treatment Period|Missing|2|||
126636509|NCT00443209|455627804|FG001|Months 1 to 12 Treatment Period|Missing|1|||
126636510|NCT00443209|455627803|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
126636511|NCT00443209|455627804|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
126636512|NCT00443209|455627803|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
126636513|NCT00443209|455627804|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
126636514|NCT00443209|455627803|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
126636515|NCT00443209|455627804|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
126636516|NCT00443209|455627803|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
126636517|NCT00443209|455627804|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
126636518|NCT00443209|455627803|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
126636519|NCT00443209|455627804|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
126636520|NCT00443209|455627803|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
126636521|NCT00443209|455627804|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
126636522|NCT00443209|455627803|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
126636523|NCT00443209|455627804|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
126636524|NCT01628692|455627805|FG000|Overall Study|Lack of Efficacy|4|||
126636525|NCT01628692|455627806|FG001|Overall Study|Lack of Efficacy|4|||
126636526|NCT01628692|455627807|FG002|Overall Study|Lack of Efficacy|5|||
126636527|NCT01628692|455627808|FG003|Overall Study|Lack of Efficacy|1|||
126636528|NCT01628692|455627809|FG004|Overall Study|Lack of Efficacy|4|||
126636529|NCT01628692|455627810|FG005|Overall Study|Lack of Efficacy|7|||
126636530|NCT01628692|455627805|FG000|Overall Study|Adverse Event|2|||
126636531|NCT01628692|455627806|FG001|Overall Study|Adverse Event|0|||
126636532|NCT01628692|455627807|FG002|Overall Study|Adverse Event|2|||
126636533|NCT01628692|455627808|FG003|Overall Study|Adverse Event|0|||
126636534|NCT01628692|455627809|FG004|Overall Study|Adverse Event|0|||
126636535|NCT01628692|455627810|FG005|Overall Study|Adverse Event|0|||
126636536|NCT01628692|455627805|FG000|Overall Study|Withdrawal by Subject|0|||
126636537|NCT01628692|455627806|FG001|Overall Study|Withdrawal by Subject|1|||
126636538|NCT01628692|455627807|FG002|Overall Study|Withdrawal by Subject|1|||
126636539|NCT01628692|455627808|FG003|Overall Study|Withdrawal by Subject|0|||
126636540|NCT01628692|455627809|FG004|Overall Study|Withdrawal by Subject|0|||
126636541|NCT01628692|455627810|FG005|Overall Study|Withdrawal by Subject|0|||
126636542|NCT01628692|455627805|FG000|Overall Study|Death|0|||
126636543|NCT01628692|455627806|FG001|Overall Study|Death|1|||
126636544|NCT01628692|455627807|FG002|Overall Study|Death|0|||
126636545|NCT01628692|455627808|FG003|Overall Study|Death|0|||
126636546|NCT01628692|455627809|FG004|Overall Study|Death|0|||
126636547|NCT01628692|455627810|FG005|Overall Study|Death|0|||
126636548|NCT01628692|455627805|FG000|Overall Study|Poor compliance/noncompliance|1|||
126636549|NCT01628692|455627806|FG001|Overall Study|Poor compliance/noncompliance|0|||
126636550|NCT01628692|455627807|FG002|Overall Study|Poor compliance/noncompliance|0|||
126636551|NCT01628692|455627808|FG003|Overall Study|Poor compliance/noncompliance|0|||
126636552|NCT01628692|455627809|FG004|Overall Study|Poor compliance/noncompliance|0|||
126636553|NCT01628692|455627810|FG005|Overall Study|Poor compliance/noncompliance|0|||
126636554|NCT01628692|455627805|FG000|Overall Study|Administrative reason by sponsor|0|||
126636555|NCT01628692|455627806|FG001|Overall Study|Administrative reason by sponsor|0|||
126636556|NCT01628692|455627807|FG002|Overall Study|Administrative reason by sponsor|0|||
126636557|NCT01628692|455627808|FG003|Overall Study|Administrative reason by sponsor|0|||
126636558|NCT01628692|455627809|FG004|Overall Study|Administrative reason by sponsor|0|||
126636559|NCT01628692|455627810|FG005|Overall Study|Administrative reason by sponsor|1|||
126636560|NCT01628692|455627805|FG000|Overall Study|Completed 12 Week only|0|||
126636561|NCT01628692|455627806|FG001|Overall Study|Completed 12 Week only|0|||
126636562|NCT01628692|455627807|FG002|Overall Study|Completed 12 Week only|0|||
126636563|NCT01628692|455627808|FG003|Overall Study|Completed 12 Week only|0|||
126636564|NCT01628692|455627809|FG004|Overall Study|Completed 12 Week only|0|||
126636565|NCT01628692|455627810|FG005|Overall Study|Completed 12 Week only|1|||
126636566|NCT02196077|455627812|FG000|Overall Study|Adverse Event|4|||
126636567|NCT02196077|455627812|FG000|Overall Study|Lack of Efficacy|1|||
126636568|NCT02196077|455627812|FG000|Overall Study|Withdrawal by Subject|14|||
126636569|NCT02196077|455627812|FG000|Overall Study|Physician Decision|1|||
126636570|NCT02196077|455627812|FG000|Overall Study|Lost to Follow-up|3|||
126636571|NCT02196077|455627812|FG000|Overall Study|Protocol Violation|24|||
126636572|NCT02638103|455627817|FG000|Overall Study|Adverse Event|13|||
126636573|NCT02638103|455627818|FG001|Overall Study|Adverse Event|12|||
126636574|NCT02638103|455627819|FG002|Overall Study|Adverse Event|19|||
126636575|NCT02638103|455627820|FG003|Overall Study|Adverse Event|12|||
126636576|NCT02638103|455627817|FG000|Overall Study|Withdrawal by Subject|43|||
126636577|NCT02638103|455627818|FG001|Overall Study|Withdrawal by Subject|53|||
126636578|NCT02638103|455627819|FG002|Overall Study|Withdrawal by Subject|30|||
126636579|NCT02638103|455627820|FG003|Overall Study|Withdrawal by Subject|61|||
126636580|NCT02638103|455627817|FG000|Overall Study|Protocol Violation|1|||
126636581|NCT02638103|455627818|FG001|Overall Study|Protocol Violation|2|||
126636582|NCT02638103|455627819|FG002|Overall Study|Protocol Violation|1|||
126636583|NCT02638103|455627820|FG003|Overall Study|Protocol Violation|4|||
126636584|NCT02638103|455627817|FG000|Overall Study|Pregnancy|2|||
126636585|NCT02638103|455627818|FG001|Overall Study|Pregnancy|3|||
126636586|NCT02638103|455627819|FG002|Overall Study|Pregnancy|0|||
126636587|NCT02638103|455627820|FG003|Overall Study|Pregnancy|1|||
126636588|NCT02638103|455627817|FG000|Overall Study|Non-compliance to Study Procedures|2|||
126636589|NCT02638103|455627818|FG001|Overall Study|Non-compliance to Study Procedures|1|||
126636590|NCT02638103|455627819|FG002|Overall Study|Non-compliance to Study Procedures|1|||
126636591|NCT02638103|455627820|FG003|Overall Study|Non-compliance to Study Procedures|1|||
126636592|NCT02638103|455627817|FG000|Overall Study|Lost to Follow-up|26|||
126636593|NCT02638103|455627818|FG001|Overall Study|Lost to Follow-up|33|||
126636594|NCT02638103|455627819|FG002|Overall Study|Lost to Follow-up|20|||
126636595|NCT02638103|455627820|FG003|Overall Study|Lost to Follow-up|37|||
126636596|NCT02638103|455627817|FG000|Overall Study|Lack of Efficacy|14|||
126636597|NCT02638103|455627818|FG001|Overall Study|Lack of Efficacy|10|||
126636598|NCT02638103|455627819|FG002|Overall Study|Lack of Efficacy|12|||
126636599|NCT02638103|455627820|FG003|Overall Study|Lack of Efficacy|22|||
126636600|NCT02638103|455627817|FG000|Overall Study|Other than specified|5|||
126636601|NCT02638103|455627818|FG001|Overall Study|Other than specified|4|||
126636602|NCT02638103|455627819|FG002|Overall Study|Other than specified|2|||
126636603|NCT02638103|455627820|FG003|Overall Study|Other than specified|4|||
126636604|NCT01827046|455627826|FG000|Overall Study|Lost to Follow-up|1|||
126636605|NCT01827046|455627827|FG001|Overall Study|Lost to Follow-up|5|||
126636606|NCT01827046|455627826|FG000|Overall Study|Withdrawal by Subject|0|||
126636607|NCT01827046|455627827|FG001|Overall Study|Withdrawal by Subject|4|||
126636608|NCT02734004|455627828|FG000|Overall Study|Death|36|||
126636609|NCT02734004|455627829|FG001|Overall Study|Death|24|||
126636610|NCT02734004|455627830|FG002|Overall Study|Death|26|||
126636611|NCT02734004|455627831|FG003|Overall Study|Death|35|||
126636612|NCT02734004|455627832|FG004|Overall Study|Death|13|||
126636613|NCT02734004|455627833|FG005|Overall Study|Death|17|||
126636614|NCT02734004|455627834|FG006|Overall Study|Death|20|||
126636615|NCT02734004|455627828|FG000|Overall Study|Lost to Follow-up|1|||
126636616|NCT02734004|455627829|FG001|Overall Study|Lost to Follow-up|1|||
126636617|NCT02734004|455627830|FG002|Overall Study|Lost to Follow-up|0|||
126636618|NCT02734004|455627831|FG003|Overall Study|Lost to Follow-up|0|||
126636619|NCT02734004|455627832|FG004|Overall Study|Lost to Follow-up|1|||
126636620|NCT02734004|455627833|FG005|Overall Study|Lost to Follow-up|0|||
126636621|NCT02734004|455627834|FG006|Overall Study|Lost to Follow-up|0|||
126636622|NCT02734004|455627828|FG000|Overall Study|Withdrawal by Subject|3|||
126636623|NCT02734004|455627829|FG001|Overall Study|Withdrawal by Subject|1|||
126636624|NCT02734004|455627830|FG002|Overall Study|Withdrawal by Subject|1|||
126636625|NCT02734004|455627831|FG003|Overall Study|Withdrawal by Subject|1|||
126636626|NCT02734004|455627832|FG004|Overall Study|Withdrawal by Subject|3|||
126636627|NCT02734004|455627833|FG005|Overall Study|Withdrawal by Subject|0|||
126636628|NCT02734004|455627834|FG006|Overall Study|Withdrawal by Subject|2|||
126636629|NCT02734004|455627828|FG000|Overall Study|Other|0|||
126636630|NCT02734004|455627829|FG001|Overall Study|Other|8|||
126636631|NCT02734004|455627830|FG002|Overall Study|Other|7|||
126636632|NCT02734004|455627831|FG003|Overall Study|Other|4|||
126636633|NCT02734004|455627832|FG004|Overall Study|Other|34|||
126636634|NCT02734004|455627833|FG005|Overall Study|Other|14|||
126636635|NCT02734004|455627834|FG006|Overall Study|Other|10|||
126636636|NCT01294436|455627835|FG000|Overall Study|Adverse Event|10|||
126636637|NCT01294436|455627836|FG001|Overall Study|Adverse Event|17|||
126636638|NCT01294436|455627835|FG000|Overall Study|Withdrawal by Subject|11|||
126636639|NCT01294436|455627836|FG001|Overall Study|Withdrawal by Subject|28|||
126636640|NCT01294436|455627835|FG000|Overall Study|subject no longer meets study criteria|5|||
126636641|NCT01294436|455627836|FG001|Overall Study|subject no longer meets study criteria|20|||
126636642|NCT01294436|455627835|FG000|Overall Study|poor/non-compliance|2|||
126636643|NCT01294436|455627836|FG001|Overall Study|poor/non-compliance|5|||
126636644|NCT01536171|455627837|FG000|Overall Study|Withdrawal by Subject|1|||
126636645|NCT01018732|455627838|FG000|Overall Study|Lost to Follow-up|0|||
126636646|NCT01018732|455627839|FG001|Overall Study|Lost to Follow-up|0|||
126636647|NCT01018732|455627840|FG002|Overall Study|Lost to Follow-up|3|||
126636648|NCT01018732|455627838|FG000|Overall Study|Protocol Violation|1|||
126636649|NCT01018732|455627839|FG001|Overall Study|Protocol Violation|1|||
126636650|NCT01018732|455627840|FG002|Overall Study|Protocol Violation|0|||
126636651|NCT01018732|455627838|FG000|Overall Study|Inappropriate Enrollment|0|||
126636652|NCT01018732|455627839|FG001|Overall Study|Inappropriate Enrollment|1|||
126636653|NCT01018732|455627840|FG002|Overall Study|Inappropriate Enrollment|0|||
126636654|NCT01018732|455627838|FG000|Overall Study|Unable to Classify|0|||
126636655|NCT01018732|455627839|FG001|Overall Study|Unable to Classify|0|||
126636656|NCT01018732|455627840|FG002|Overall Study|Unable to Classify|1|||
126636657|NCT00585078|455627841|FG000|Overall Study|Withdrawal by Subject|4|||
126636658|NCT00585078|455627841|FG000|Overall Study|Poor performance status|1|||
126636659|NCT00585078|455627841|FG000|Overall Study|Disease Progression|24|||
126636660|NCT00585078|455627841|FG000|Overall Study|Adverse Event|10|||
126636661|NCT00585078|455627841|FG000|Overall Study|Death|1|||
126636662|NCT02781311|455627844|FG000|Overall Study|Adverse Event|2|||
126636663|NCT02781311|455627845|FG001|Overall Study|Adverse Event|6|||
126636664|NCT02781311|455627846|FG002|Overall Study|Adverse Event|1|||
126636665|NCT02781311|455627844|FG000|Overall Study|Withdrawal of Consent|11|||
126636666|NCT02781311|455627845|FG001|Overall Study|Withdrawal of Consent|12|||
126636667|NCT02781311|455627846|FG002|Overall Study|Withdrawal of Consent|2|||
126636668|NCT02781311|455627844|FG000|Overall Study|Lost to Follow-up|11|||
126636669|NCT02781311|455627845|FG001|Overall Study|Lost to Follow-up|8|||
126636670|NCT02781311|455627846|FG002|Overall Study|Lost to Follow-up|1|||
126636671|NCT02781311|455627844|FG000|Overall Study|Non-Compliance with Study Drug|2|||
126636672|NCT02781311|455627845|FG001|Overall Study|Non-Compliance with Study Drug|0|||
126636673|NCT02781311|455627846|FG002|Overall Study|Non-Compliance with Study Drug|0|||
126636674|NCT02165826|455627848|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
126636675|NCT02165826|455627849|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
126636676|NCT02165826|455627850|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
126636677|NCT02165826|455627848|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
126636678|NCT02165826|455627849|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
126636679|NCT02165826|455627850|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
126636680|NCT02165826|455627848|FG000|Main Treatment Period|Lost to Follow-up|4|||
126636681|NCT02165826|455627849|FG001|Main Treatment Period|Lost to Follow-up|2|||
126636682|NCT02165826|455627850|FG002|Main Treatment Period|Lost to Follow-up|1|||
126636683|NCT02165826|455627848|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
126636684|NCT02165826|455627849|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
126636685|NCT02165826|455627850|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
126636686|NCT02165826|455627848|FG000|Main Treatment Period|Lack of Efficacy|2|||
126636687|NCT02165826|455627849|FG001|Main Treatment Period|Lack of Efficacy|0|||
126636688|NCT02165826|455627850|FG002|Main Treatment Period|Lack of Efficacy|0|||
126636689|NCT02165826|455627848|FG000|Main Treatment Period|Reason Not Specified|8|||
126636690|NCT02165826|455627849|FG001|Main Treatment Period|Reason Not Specified|5|||
126636691|NCT02165826|455627850|FG002|Main Treatment Period|Reason Not Specified|16|||
126636692|NCT02165826|455627848|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
126636693|NCT02165826|455627849|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
126636694|NCT02165826|455627850|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
126636695|NCT02165826|455627848|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
126636696|NCT02165826|455627849|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
126636697|NCT02165826|455627850|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
126636698|NCT02165826|455627848|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
126636699|NCT02165826|455627849|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
126636700|NCT02165826|455627850|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
126636701|NCT02165826|455627848|FG000|Down-Titration Period|Reason Not Specified|1|||
126636702|NCT02165826|455627849|FG001|Down-Titration Period|Reason Not Specified|0|||
126636703|NCT02165826|455627850|FG002|Down-Titration Period|Reason Not Specified|2|||
126636704|NCT00250432|455627855|FG000|Overall Study|Adverse Event|25|||
126636705|NCT00250432|455627856|FG001|Overall Study|Adverse Event|29|||
126636706|NCT00250432|455627855|FG000|Overall Study|Lack of Efficacy|2|||
126636707|NCT00250432|455627856|FG001|Overall Study|Lack of Efficacy|1|||
126636708|NCT00250432|455627855|FG000|Overall Study|Lost to Follow-up|6|||
126636709|NCT00250432|455627856|FG001|Overall Study|Lost to Follow-up|5|||
126636710|NCT00250432|455627855|FG000|Overall Study|Patient Moved|0|||
126636711|NCT00250432|455627856|FG001|Overall Study|Patient Moved|1|||
126636712|NCT00250432|455627855|FG000|Overall Study|Protocol Violation|0|||
126636713|NCT00250432|455627856|FG001|Overall Study|Protocol Violation|3|||
126636714|NCT00250432|455627855|FG000|Overall Study|Withdrawal by Subject|6|||
126636715|NCT00250432|455627856|FG001|Overall Study|Withdrawal by Subject|2|||
126636716|NCT00250432|455627855|FG000|Overall Study|Pt died out of posttherapy report period|6|||
126636717|NCT00250432|455627856|FG001|Overall Study|Pt died out of posttherapy report period|5|||
126636718|NCT00250432|455627855|FG000|Overall Study|Pt was considered untreatable|0|||
126636719|NCT00250432|455627856|FG001|Overall Study|Pt was considered untreatable|1|||
126636720|NCT03512197|455627859|FG000|Overall Study|Guardian decision|1|||
126636721|NCT03512197|455627860|FG001|Overall Study|Guardian decision|1|||
126636722|NCT03512197|455627859|FG000|Overall Study|Lack of Efficacy|19|||
126636723|NCT03512197|455627860|FG001|Overall Study|Lack of Efficacy|11|||
126636724|NCT03512197|455627859|FG000|Overall Study|New Therapy for Study Indication|16|||
126636725|NCT03512197|455627860|FG001|Overall Study|New Therapy for Study Indication|16|||
126636726|NCT03512197|455627859|FG000|Overall Study|Physician Decision|60|||
126636727|NCT03512197|455627860|FG001|Overall Study|Physician Decision|60|||
126636728|NCT03512197|455627859|FG000|Overall Study|Protocol Violation|0|||
126636729|NCT03512197|455627860|FG001|Overall Study|Protocol Violation|2|||
126636730|NCT03512197|455627859|FG000|Overall Study|Terminated by Sponsored|46|||
126636731|NCT03512197|455627860|FG001|Overall Study|Terminated by Sponsored|50|||
126636732|NCT03512197|455627859|FG000|Overall Study|Subject Decision|15|||
126636733|NCT03512197|455627860|FG001|Overall Study|Subject Decision|12|||
126636734|NCT03512197|455627859|FG000|Overall Study|Withdrawal of informed consent|20|||
126636735|NCT03512197|455627860|FG001|Overall Study|Withdrawal of informed consent|14|||
126636736|NCT03512197|455627859|FG000|Overall Study|Adverse Event|30|||
126636737|NCT03512197|455627860|FG001|Overall Study|Adverse Event|34|||
126636738|NCT03512197|455627859|FG000|Overall Study|Death|14|||
126636739|NCT03512197|455627860|FG001|Overall Study|Death|9|||
126636740|NCT03512197|455627859|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
126636741|NCT03512197|455627860|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
126636742|NCT03512197|455627859|FG000|Overall Study|Missing|3|||
126636743|NCT03512197|455627860|FG001|Overall Study|Missing|13|||
126636744|NCT03842436|455627861|FG000|Overall Study|Lost to Follow-up|1|||
126636745|NCT02201901|455627867|FG000|Overall Study|Randomized but never treated|0|||
126636746|NCT02201901|455627868|FG001|Overall Study|Randomized but never treated|1|||
126636747|NCT02201901|455627869|FG002|Overall Study|Randomized but never treated|0|||
126636748|NCT02201901|455627867|FG000|Overall Study|Lack of Efficacy|7|||
126636749|NCT02201901|455627868|FG001|Overall Study|Lack of Efficacy|1|||
126636750|NCT02201901|455627869|FG002|Overall Study|Lack of Efficacy|6|||
126636751|NCT02201901|455627867|FG000|Overall Study|Death|3|||
126636752|NCT02201901|455627868|FG001|Overall Study|Death|3|||
126636753|NCT02201901|455627869|FG002|Overall Study|Death|3|||
126636754|NCT02201901|455627867|FG000|Overall Study|Lost to Follow-up|2|||
126636755|NCT02201901|455627868|FG001|Overall Study|Lost to Follow-up|3|||
126636756|NCT02201901|455627869|FG002|Overall Study|Lost to Follow-up|2|||
126636757|NCT02201901|455627867|FG000|Overall Study|Withdrew Consent|2|||
126636758|NCT02201901|455627868|FG001|Overall Study|Withdrew Consent|0|||
126636759|NCT02201901|455627869|FG002|Overall Study|Withdrew Consent|2|||
126636760|NCT02201901|455627867|FG000|Overall Study|Adverse Event|1|||
126636761|NCT02201901|455627868|FG001|Overall Study|Adverse Event|1|||
126636762|NCT02201901|455627869|FG002|Overall Study|Adverse Event|0|||
126636763|NCT03358238|455627870|FG000|Overall Study|Withdrawal by Subject|0|||
126636764|NCT03358238|455627871|FG001|Overall Study|Withdrawal by Subject|1|||
126636765|NCT05992922|455627872|FG000|Overall Study|Adverse Event|6|||
126636766|NCT05992922|455627873|FG001|Overall Study|Adverse Event|0|||
126636767|NCT05992922|455627872|FG000|Overall Study|Sponsor Termination of Study|14|||
126636768|NCT05992922|455627873|FG001|Overall Study|Sponsor Termination of Study|20|||
126636769|NCT01246999|455629304|FG000|Overall Study|Lost to Follow-up|0|||
126636770|NCT01246999|455629305|FG001|Overall Study|Lost to Follow-up|1|||
126636771|NCT01246999|455629306|FG002|Overall Study|Lost to Follow-up|0|||
126636772|NCT01246999|455629307|FG003|Overall Study|Lost to Follow-up|0|||
126636773|NCT01246999|455629304|FG000|Overall Study|Withdrawal by Subject|0|||
126636774|NCT01246999|455629305|FG001|Overall Study|Withdrawal by Subject|0|||
126636775|NCT01246999|455629306|FG002|Overall Study|Withdrawal by Subject|0|||
126636776|NCT01246999|455629307|FG003|Overall Study|Withdrawal by Subject|2|||
126636777|NCT01867047|455629308|FG000|Overall Study|Lost to Follow-up|3|||
126636778|NCT01867047|455629309|FG001|Overall Study|Lost to Follow-up|3|||
126636779|NCT01867047|455629308|FG000|Overall Study|Withdrawal by Subject|2|||
126636780|NCT01867047|455629309|FG001|Overall Study|Withdrawal by Subject|0|||
126636781|NCT01867047|455629308|FG000|Overall Study|Physician Decision|2|||
126636782|NCT01867047|455629309|FG001|Overall Study|Physician Decision|0|||
126636783|NCT01867047|455629308|FG000|Overall Study|surgery not indicated in protocol|1|||
126636784|NCT01867047|455629309|FG001|Overall Study|surgery not indicated in protocol|2|||
126636785|NCT04596995|455629312|FG000|Overall Study|Lack of Efficacy|8|||
126636786|NCT04596995|455629312|FG000|Overall Study|Lost to Follow-up|3|||
126636787|NCT04596995|455629312|FG000|Overall Study|Withdrawal by Subject|12|||
126636788|NCT04596995|455629312|FG000|Overall Study|Sponsor decision|3|||
126636789|NCT04596995|455629312|FG000|Overall Study|Enrolled in managed access program|3|||
126636790|NCT00590564|455629314|FG000|Overall Study|Withdrawal by Subject|4|||
126636791|NCT00590564|455629314|FG000|Overall Study|Lost to Follow-up|6|||
126636792|NCT00590564|455629314|FG000|Overall Study|Protocol Violation|1|||
126636793|NCT00590564|455629314|FG000|Overall Study|Patient Found to be Ineligible|1|||
126636794|NCT00590564|455629314|FG000|Overall Study|Patient Non-compliance|6|||
126636795|NCT01434680|455629315|FG000|Overall Study|Withdrawal by Subject|1|||
126636796|NCT01434680|455629316|FG001|Overall Study|Withdrawal by Subject|0|||
126636797|NCT01434680|455629317|FG002|Overall Study|Withdrawal by Subject|2|||
126636798|NCT01434680|455629318|FG003|Overall Study|Withdrawal by Subject|0|||
126636799|NCT01434680|455629315|FG000|Overall Study|Lost to Follow-up|1|||
126636800|NCT01434680|455629316|FG001|Overall Study|Lost to Follow-up|1|||
126636801|NCT01434680|455629317|FG002|Overall Study|Lost to Follow-up|0|||
126636802|NCT01434680|455629318|FG003|Overall Study|Lost to Follow-up|0|||
126636803|NCT01434680|455629315|FG000|Overall Study|Protocol Violation|1|||
126636804|NCT01434680|455629316|FG001|Overall Study|Protocol Violation|1|||
126636805|NCT01434680|455629317|FG002|Overall Study|Protocol Violation|0|||
126636806|NCT01434680|455629318|FG003|Overall Study|Protocol Violation|0|||
126636807|NCT00983749|455629321|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
126636808|NCT00983749|455629322|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
126636809|NCT01952847|455629323|FG000|Overall Study|Ineligible|1|||
126636810|NCT01952847|455629324|FG001|Overall Study|Ineligible|0|||
126636811|NCT01952847|455629325|FG002|Overall Study|Ineligible|0|||
126636812|NCT01952847|455629326|FG003|Overall Study|Ineligible|0|||
126636813|NCT01952847|455629323|FG000|Overall Study|Lack of Insurance Coverage|0|||
126636814|NCT01952847|455629324|FG001|Overall Study|Lack of Insurance Coverage|1|||
126636815|NCT01952847|455629325|FG002|Overall Study|Lack of Insurance Coverage|0|||
126636816|NCT01952847|455629326|FG003|Overall Study|Lack of Insurance Coverage|0|||
126636817|NCT01952847|455629323|FG000|Overall Study|Withdrawal by Subject|1|||
126636818|NCT01952847|455629324|FG001|Overall Study|Withdrawal by Subject|1|||
126636819|NCT01952847|455629325|FG002|Overall Study|Withdrawal by Subject|0|||
126636820|NCT01952847|455629326|FG003|Overall Study|Withdrawal by Subject|1|||
126636821|NCT01907906|455629327|FG000|Overall Study|Withdrawal by Subject|1|||
126636822|NCT01907906|455629328|FG001|Overall Study|Withdrawal by Subject|0|||
126636823|NCT01907906|455629327|FG000|Overall Study|Physician Decision|3|||
126636824|NCT01907906|455629328|FG001|Overall Study|Physician Decision|1|||
126636825|NCT00490945|455629330|FG000|Overall Study|Adverse Event|0|||
126636826|NCT00490945|455629331|FG001|Overall Study|Adverse Event|1|||
126636827|NCT00490945|455629332|FG002|Overall Study|Adverse Event|0|||
126636828|NCT00490945|455629333|FG003|Overall Study|Adverse Event|0|||
126636829|NCT00490945|455629334|FG004|Overall Study|Adverse Event|0|||
126636830|NCT03334253|455629335|FG000|Overall Study|Withdrawal by Subject|1|||
126636831|NCT03334253|455629336|FG001|Overall Study|Withdrawal by Subject|0|||
126636832|NCT03334253|455629335|FG000|Overall Study|Lost to Follow-up|4|||
126636833|NCT03334253|455629336|FG001|Overall Study|Lost to Follow-up|3|||
126636834|NCT03334253|455629335|FG000|Overall Study|Moved residence|2|||
126636835|NCT03334253|455629336|FG001|Overall Study|Moved residence|2|||
126636836|NCT00203047|455629337|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
126636837|NCT00203047|455629338|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
126636838|NCT00203047|455629337|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
126636839|NCT00203047|455629338|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
126636840|NCT00203047|455629337|FG000|Overall Study|Withdrawal by Subject|13|||
126636841|NCT00203047|455629338|FG001|Overall Study|Withdrawal by Subject|47|||
126636842|NCT00203047|455629337|FG000|Overall Study|Teva requested participant withdrawal|1|||
126636843|NCT00203047|455629338|FG001|Overall Study|Teva requested participant withdrawal|1|||
126636844|NCT00203047|455629337|FG000|Overall Study|Physician Decision|8|||
126636845|NCT00203047|455629338|FG001|Overall Study|Physician Decision|7|||
126636846|NCT00203047|455629337|FG000|Overall Study|Non-compliance|4|||
126636847|NCT00203047|455629338|FG001|Overall Study|Non-compliance|8|||
126636848|NCT00203047|455629337|FG000|Overall Study|Protocol Violation|1|||
126636849|NCT00203047|455629338|FG001|Overall Study|Protocol Violation|0|||
126636850|NCT00203047|455629337|FG000|Overall Study|Lost to Follow-up|11|||
126636851|NCT00203047|455629338|FG001|Overall Study|Lost to Follow-up|5|||
126636852|NCT00203047|455629337|FG000|Overall Study|Adverse Event|8|||
126636853|NCT00203047|455629338|FG001|Overall Study|Adverse Event|18|||
126636854|NCT00203047|455629337|FG000|Overall Study|Death|1|||
126636855|NCT00203047|455629338|FG001|Overall Study|Death|2|||
126636856|NCT00203047|455629337|FG000|Overall Study|Pregnancy|3|||
126636857|NCT00203047|455629338|FG001|Overall Study|Pregnancy|0|||
126636858|NCT00203047|455629337|FG000|Overall Study|Other|5|||
126636859|NCT00203047|455629338|FG001|Overall Study|Other|5|||
126636860|NCT00340704|455629341|FG000|PK Study|Adverse Event|0|||
126636861|NCT00340704|455629342|FG001|PK Study|Adverse Event|1|||
126636862|NCT00340704|455629343|FG002|PK Study|Adverse Event|0|||
126636863|NCT00340704|455629344|FG003|PK Study|Adverse Event|0|||
126636864|NCT00340704|455629345|FG004|PK Study|Adverse Event|0|||
126636865|NCT00340704|455629346|FG005|PK Study|Adverse Event|0|||
126636866|NCT00340704|455629347|FG006|PK Study|Adverse Event|0|||
126636867|NCT00340704|455629348|FG007|PK Study|Adverse Event|0|||
126636868|NCT00340704|455629349|FG008|PK Study|Adverse Event|0|||
126636869|NCT00340704|455629341|FG000|PK Study|Not treated|0|||
126636870|NCT00340704|455629342|FG001|PK Study|Not treated|0|||
126636871|NCT00340704|455629343|FG002|PK Study|Not treated|1|||
126636872|NCT00340704|455629344|FG003|PK Study|Not treated|0|||
126636873|NCT00340704|455629345|FG004|PK Study|Not treated|0|||
126636874|NCT00340704|455629346|FG005|PK Study|Not treated|0|||
126636875|NCT00340704|455629347|FG006|PK Study|Not treated|0|||
126636876|NCT00340704|455629348|FG007|PK Study|Not treated|0|||
126636877|NCT00340704|455629349|FG008|PK Study|Not treated|0|||
126636878|NCT00340704|455629341|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
126636879|NCT00340704|455629342|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
126636880|NCT00340704|455629343|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
126636881|NCT00340704|455629344|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
126636882|NCT00340704|455629345|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
126636883|NCT00340704|455629346|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
126636884|NCT00340704|455629347|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
126636885|NCT00340704|455629348|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
126636886|NCT00340704|455629349|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
126636887|NCT00340704|455629341|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126636888|NCT00340704|455629342|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126636889|NCT00340704|455629343|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126636890|NCT00340704|455629344|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126636891|NCT00340704|455629345|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126636892|NCT00340704|455629346|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
126636893|NCT00340704|455629347|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126636894|NCT00340704|455629348|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126636895|NCT00340704|455629349|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
126636896|NCT00340704|455629341|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126636897|NCT00340704|455629342|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126636898|NCT00340704|455629343|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126636899|NCT00340704|455629344|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126636900|NCT00340704|455629345|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
126636901|NCT00340704|455629346|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
126636902|NCT00340704|455629347|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126636903|NCT00340704|455629348|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126636904|NCT00340704|455629349|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
126636905|NCT00340704|455629341|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
126636906|NCT00340704|455629342|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
126636907|NCT00340704|455629343|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
126636908|NCT00340704|455629344|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
126636909|NCT00340704|455629345|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
126636910|NCT00340704|455629346|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
126636911|NCT00340704|455629347|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
126636912|NCT00340704|455629348|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
126636913|NCT00340704|455629349|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
126636914|NCT00121667|455629350|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
126636915|NCT00121667|455629351|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
126636916|NCT00121667|455629352|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
126636917|NCT00121667|455629353|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
126636918|NCT00121667|455629350|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
126636919|NCT00121667|455629351|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
126636920|NCT00121667|455629352|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
126636921|NCT00121667|455629353|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
126636922|NCT00121667|455629350|FG000|Short Term (ST) Period|Adverse Event|5|||
126636923|NCT00121667|455629351|FG001|Short Term (ST) Period|Adverse Event|6|||
126636924|NCT00121667|455629352|FG002|Short Term (ST) Period|Adverse Event|5|||
126636925|NCT00121667|455629353|FG003|Short Term (ST) Period|Adverse Event|3|||
126636926|NCT00121667|455629350|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
126636927|NCT00121667|455629351|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
126636928|NCT00121667|455629352|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
126636929|NCT00121667|455629353|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
126636930|NCT00121667|455629350|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
126636931|NCT00121667|455629351|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
126636932|NCT00121667|455629352|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
126636933|NCT00121667|455629353|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
126636934|NCT00121667|455629350|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
126636935|NCT00121667|455629351|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
126636936|NCT00121667|455629352|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
126636937|NCT00121667|455629353|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
126636938|NCT00121667|455629350|FG000|Short Term (ST) Period|Other Reason|3|||
126636939|NCT00121667|455629351|FG001|Short Term (ST) Period|Other Reason|0|||
126636940|NCT00121667|455629352|FG002|Short Term (ST) Period|Other Reason|0|||
126636941|NCT00121667|455629353|FG003|Short Term (ST) Period|Other Reason|0|||
126636942|NCT00121667|455629350|FG000|Short Term (ST) Period|Death|0|||
126636943|NCT00121667|455629351|FG001|Short Term (ST) Period|Death|0|||
126636944|NCT00121667|455629352|FG002|Short Term (ST) Period|Death|0|||
126636945|NCT00121667|455629353|FG003|Short Term (ST) Period|Death|1|||
126636946|NCT00121667|455629350|FG000|Short Term (ST) Period|Pregnancy|0|||
126636947|NCT00121667|455629351|FG001|Short Term (ST) Period|Pregnancy|0|||
126636948|NCT00121667|455629352|FG002|Short Term (ST) Period|Pregnancy|0|||
126636949|NCT00121667|455629353|FG003|Short Term (ST) Period|Pregnancy|1|||
126636950|NCT00121667|455629350|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
126636951|NCT00121667|455629351|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
126636952|NCT00121667|455629352|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
126636953|NCT00121667|455629353|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
126636954|NCT00121667|455629350|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
126636955|NCT00121667|455629351|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
126636956|NCT00121667|455629352|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
126636957|NCT00121667|455629353|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
126636958|NCT00121667|455629350|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
126636959|NCT00121667|455629351|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
126636960|NCT00121667|455629352|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
126636961|NCT00121667|455629353|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
126636962|NCT00121667|455629350|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
126636963|NCT00121667|455629351|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
126636964|NCT00121667|455629352|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
126636965|NCT00121667|455629353|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
126636966|NCT00121667|455629350|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
126636967|NCT00121667|455629351|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
126636968|NCT00121667|455629352|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
126636969|NCT00121667|455629353|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
126636970|NCT00121667|455629350|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
126636971|NCT00121667|455629351|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
126636972|NCT00121667|455629352|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
126636973|NCT00121667|455629353|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
126636974|NCT00121667|455629350|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
126636975|NCT00121667|455629351|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
126636976|NCT00121667|455629352|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
126636977|NCT00121667|455629353|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
126636978|NCT00121667|455629350|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
126636979|NCT00121667|455629351|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
126636980|NCT00121667|455629352|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
126636981|NCT00121667|455629353|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
126636982|NCT00121667|455629350|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
126636983|NCT00121667|455629351|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
126636984|NCT00121667|455629352|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
126636985|NCT00121667|455629353|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
126636986|NCT01453023|455629354|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
126636987|NCT01453023|455629355|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
126636988|NCT01453023|455629354|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
126636989|NCT01453023|455629355|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
126636990|NCT01453023|455629354|FG000|Treatment Period 2|Protocol Violation|0|||
126636991|NCT01453023|455629355|FG001|Treatment Period 2|Protocol Violation|1|||
126636992|NCT02879383|455629356|FG000|First 24 Weeks|Physician Decision|0|||
126636993|NCT02879383|455629357|FG001|First 24 Weeks|Physician Decision|1|||
126636994|NCT02879383|455629358|FG002|First 24 Weeks|Physician Decision|0|||
126636995|NCT02879383|455629359|FG003|First 24 Weeks|Physician Decision|0|||
126636996|NCT02413593|455629373|FG000|Overall Study|Lost to Follow-up|3|||
126636997|NCT02413593|455629373|FG000|Overall Study|Adverse Event|1|||
126636998|NCT00723125|455629374|FG000|Overall Study|Met Dx|1|||
126636999|NCT00723125|455629375|FG001|Overall Study|Met Dx|0|||
126637000|NCT00723125|455629374|FG000|Overall Study|Withdrawal by Subject|15|||
126637001|NCT00723125|455629375|FG001|Overall Study|Withdrawal by Subject|6|||
126637002|NCT00723125|455629374|FG000|Overall Study|Adverse Event|2|||
126637003|NCT00723125|455629375|FG001|Overall Study|Adverse Event|0|||
126637004|NCT01807182|455629378|FG000|Overall Study|Death|1|||
126637005|NCT01807182|455629378|FG000|Overall Study|New therapy|1|||
126637006|NCT01807182|455629378|FG000|Overall Study|Moved to hospice care|1|||
126637007|NCT01080300|455629379|FG000|Overall Study|Adverse Event|49|||
126637008|NCT01080300|455629380|FG001|Overall Study|Adverse Event|35|||
126637009|NCT01080300|455629379|FG000|Overall Study|Lack of Efficacy|12|||
126637010|NCT01080300|455629380|FG001|Overall Study|Lack of Efficacy|15|||
126637011|NCT01080300|455629379|FG000|Overall Study|Protocol Violation|7|||
126637012|NCT01080300|455629380|FG001|Overall Study|Protocol Violation|13|||
126637013|NCT01080300|455629379|FG000|Overall Study|Lost to Follow-up|10|||
126637014|NCT01080300|455629380|FG001|Overall Study|Lost to Follow-up|6|||
126637015|NCT01080300|455629379|FG000|Overall Study|Death|0|||
126637016|NCT01080300|455629380|FG001|Overall Study|Death|1|||
126637017|NCT01080300|455629379|FG000|Overall Study|Withdrawal by Subject|12|||
126637018|NCT01080300|455629380|FG001|Overall Study|Withdrawal by Subject|28|||
126637019|NCT01080300|455629379|FG000|Overall Study|Reasons not specified|4|||
126637020|NCT01080300|455629380|FG001|Overall Study|Reasons not specified|6|||
126637021|NCT00478205|455629384|FG000|Overall Study|Adverse Event|182|||
126637022|NCT00478205|455629385|FG001|Overall Study|Adverse Event|39|||
126637023|NCT00478205|455629384|FG000|Overall Study|Medication Non-compliance|9|||
126637024|NCT00478205|455629385|FG001|Overall Study|Medication Non-compliance|4|||
126637025|NCT00478205|455629384|FG000|Overall Study|Protocol Violation|15|||
126637026|NCT00478205|455629385|FG001|Overall Study|Protocol Violation|5|||
126637027|NCT00478205|455629384|FG000|Overall Study|Request of Investigator or Sponsor|4|||
126637028|NCT00478205|455629385|FG001|Overall Study|Request of Investigator or Sponsor|5|||
126637029|NCT00478205|455629384|FG000|Overall Study|Withdrawal by Subject|61|||
126637030|NCT00478205|455629385|FG001|Overall Study|Withdrawal by Subject|22|||
126637031|NCT00478205|455629384|FG000|Overall Study|Lack of Efficacy|1|||
126637032|NCT00478205|455629385|FG001|Overall Study|Lack of Efficacy|0|||
126637033|NCT00478205|455629384|FG000|Overall Study|Other|24|||
126637034|NCT00478205|455629385|FG001|Overall Study|Other|12|||
126637035|NCT03513068|455629386|FG000|Overall Study|Death|1|||
126637036|NCT03513068|455629387|FG001|Overall Study|Death|0|||
126637037|NCT03513068|455629386|FG000|Overall Study|Withdrawal by Subject|4|||
126637038|NCT03513068|455629387|FG001|Overall Study|Withdrawal by Subject|6|||
126637039|NCT01850030|455629388|FG000|Overall Study|Adverse Event|64|||
126637040|NCT01850030|455629389|FG001|Overall Study|Adverse Event|82|||
126637041|NCT01850030|455629388|FG000|Overall Study|Lack of Efficacy|3|||
126637042|NCT01850030|455629389|FG001|Overall Study|Lack of Efficacy|1|||
126637043|NCT01850030|455629388|FG000|Overall Study|Lost to Follow-up|5|||
126637044|NCT01850030|455629389|FG001|Overall Study|Lost to Follow-up|5|||
126637045|NCT01850030|455629388|FG000|Overall Study|Withdrawal by Subject|3|||
126637046|NCT01850030|455629389|FG001|Overall Study|Withdrawal by Subject|4|||
126637047|NCT01850030|455629388|FG000|Overall Study|Protocol Violation|24|||
126637048|NCT01850030|455629389|FG001|Overall Study|Protocol Violation|28|||
126637049|NCT01850030|455629388|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
126637050|NCT01850030|455629389|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
126637051|NCT00965497|455629391|FG000|Overall Study|Physician Decision|1|||
126637052|NCT00953615|455629392|FG000|Overall Study|Adverse Event|1|||
126637053|NCT01299480|455629393|FG000|Overall Study|No longer willing to participate|19|||
126637054|NCT01299480|455629394|FG001|Overall Study|No longer willing to participate|17|||
126637055|NCT01299480|455629395|FG002|Overall Study|No longer willing to participate|14|||
126637056|NCT01299480|455629396|FG003|Overall Study|No longer willing to participate|13|||
126637057|NCT01299480|455629397|FG004|Overall Study|No longer willing to participate|10|||
126637058|NCT01299480|455629393|FG000|Overall Study|Protocol Violation|7|||
126637059|NCT01299480|455629394|FG001|Overall Study|Protocol Violation|5|||
126637060|NCT01299480|455629395|FG002|Overall Study|Protocol Violation|8|||
126637061|NCT01299480|455629396|FG003|Overall Study|Protocol Violation|1|||
126637062|NCT01299480|455629397|FG004|Overall Study|Protocol Violation|1|||
126637063|NCT01299480|455629393|FG000|Overall Study|Withdrawal by Subject|3|||
126637064|NCT01299480|455629394|FG001|Overall Study|Withdrawal by Subject|4|||
126637065|NCT01299480|455629395|FG002|Overall Study|Withdrawal by Subject|7|||
126637066|NCT01299480|455629396|FG003|Overall Study|Withdrawal by Subject|3|||
126637067|NCT01299480|455629397|FG004|Overall Study|Withdrawal by Subject|4|||
126637068|NCT01299480|455629393|FG000|Overall Study|Adverse Event|6|||
126637069|NCT01299480|455629394|FG001|Overall Study|Adverse Event|4|||
126637070|NCT01299480|455629395|FG002|Overall Study|Adverse Event|5|||
126637071|NCT01299480|455629396|FG003|Overall Study|Adverse Event|4|||
126637072|NCT01299480|455629397|FG004|Overall Study|Adverse Event|0|||
126637073|NCT01299480|455629393|FG000|Overall Study|Withdrawal due to pregnancy|0|||
126637074|NCT01299480|455629394|FG001|Overall Study|Withdrawal due to pregnancy|1|||
126637075|NCT01299480|455629395|FG002|Overall Study|Withdrawal due to pregnancy|1|||
126637076|NCT01299480|455629396|FG003|Overall Study|Withdrawal due to pregnancy|0|||
126637077|NCT01299480|455629397|FG004|Overall Study|Withdrawal due to pregnancy|0|||
126637078|NCT01299480|455629393|FG000|Overall Study|Physician Decision|1|||
126637079|NCT01299480|455629394|FG001|Overall Study|Physician Decision|1|||
126637080|NCT01299480|455629395|FG002|Overall Study|Physician Decision|0|||
126637081|NCT01299480|455629396|FG003|Overall Study|Physician Decision|2|||
126637082|NCT01299480|455629397|FG004|Overall Study|Physician Decision|0|||
126637083|NCT01299480|455629393|FG000|Overall Study|Lost to Follow-up|3|||
126637084|NCT01299480|455629394|FG001|Overall Study|Lost to Follow-up|1|||
126637085|NCT01299480|455629395|FG002|Overall Study|Lost to Follow-up|2|||
126637086|NCT01299480|455629396|FG003|Overall Study|Lost to Follow-up|1|||
126637087|NCT01299480|455629397|FG004|Overall Study|Lost to Follow-up|2|||
126637088|NCT01299480|455629393|FG000|Overall Study|Other|3|||
126637089|NCT01299480|455629394|FG001|Overall Study|Other|2|||
126637090|NCT01299480|455629395|FG002|Overall Study|Other|3|||
126637091|NCT01299480|455629396|FG003|Overall Study|Other|0|||
126637092|NCT01299480|455629397|FG004|Overall Study|Other|3|||
126637093|NCT01299480|455629393|FG000|Overall Study|Started, but not vaccinated|0|||
126637094|NCT01299480|455629394|FG001|Overall Study|Started, but not vaccinated|0|||
126637095|NCT01299480|455629395|FG002|Overall Study|Started, but not vaccinated|1|||
126637096|NCT01299480|455629396|FG003|Overall Study|Started, but not vaccinated|1|||
126637097|NCT01299480|455629397|FG004|Overall Study|Started, but not vaccinated|0|||
126637098|NCT02296892|455629404|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
126637099|NCT02296892|455629405|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
126637100|NCT02296892|455629406|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
126637101|NCT02296892|455629404|FG000|Overall Study|Lost to Follow-up|5|||
126637102|NCT02296892|455629405|FG001|Overall Study|Lost to Follow-up|0|||
126637103|NCT02296892|455629406|FG002|Overall Study|Lost to Follow-up|1|||
126637104|NCT04547023|455629409|FG000|Overall Study|Did Not Receive Intervention|3|||
126637105|NCT04547023|455629410|FG001|Overall Study|Did Not Receive Intervention|2|||
126637106|NCT04547023|455629409|FG000|Overall Study|Lost to Follow-up|1|||
126637107|NCT04547023|455629410|FG001|Overall Study|Lost to Follow-up|1|||
126637108|NCT03784820|455629411|FG000|Overall Study|Lost to Follow-up|5|||
126637109|NCT03784820|455629412|FG001|Overall Study|Lost to Follow-up|5|||
126637110|NCT03784820|455629413|FG002|Overall Study|Lost to Follow-up|3|||
126637111|NCT03784820|455629414|FG003|Overall Study|Lost to Follow-up|3|||
126637112|NCT00658606|455629417|FG000|Overall Study|Adverse Event|2|||
126637113|NCT00658606|455629418|FG001|Overall Study|Adverse Event|1|||
126637114|NCT00658606|455629417|FG000|Overall Study|Lack of Efficacy|6|||
126637115|NCT00658606|455629418|FG001|Overall Study|Lack of Efficacy|3|||
126637116|NCT00658606|455629417|FG000|Overall Study|Lost to Follow-up|1|||
126637117|NCT00658606|455629418|FG001|Overall Study|Lost to Follow-up|0|||
126637118|NCT00658606|455629417|FG000|Overall Study|Withdrawal by Subject|7|||
126637119|NCT00658606|455629418|FG001|Overall Study|Withdrawal by Subject|16|||
126637120|NCT00658606|455629417|FG000|Overall Study|Lack of Compliance|0|||
126637121|NCT00658606|455629418|FG001|Overall Study|Lack of Compliance|3|||
126637122|NCT00365547|455629419|FG000|Overall Study|Insurance did not cover Avastin|1|||
126637123|NCT00365547|455629419|FG000|Overall Study|Screen failure|1|||
126637124|NCT00365547|455629419|FG000|Overall Study|Withdrawal by Subject|1|||
126637125|NCT03170518|455629420|FG000|Overall Study|Lost to Follow-up|4|||
126637126|NCT03170518|455629421|FG001|Overall Study|Lost to Follow-up|1|||
126637127|NCT03170518|455629422|FG002|Overall Study|Lost to Follow-up|0|||
126637128|NCT03170518|455629420|FG000|Overall Study|Physician Decision|1|||
126637129|NCT03170518|455629421|FG001|Overall Study|Physician Decision|0|||
126637130|NCT03170518|455629422|FG002|Overall Study|Physician Decision|0|||
126637131|NCT03170518|455629420|FG000|Overall Study|Withdrawal by Subject|4|||
126637132|NCT03170518|455629421|FG001|Overall Study|Withdrawal by Subject|5|||
126637133|NCT03170518|455629422|FG002|Overall Study|Withdrawal by Subject|2|||
126637134|NCT03170518|455629420|FG000|Overall Study|Site terminated by sponsor|0|||
126637135|NCT03170518|455629421|FG001|Overall Study|Site terminated by sponsor|1|||
126637136|NCT03170518|455629422|FG002|Overall Study|Site terminated by sponsor|0|||
126637137|NCT03170518|455629420|FG000|Overall Study|Non-compliance with study drug|1|||
126637138|NCT03170518|455629421|FG001|Overall Study|Non-compliance with study drug|0|||
126637139|NCT03170518|455629422|FG002|Overall Study|Non-compliance with study drug|1|||
126637140|NCT03170518|455629420|FG000|Overall Study|Withdrawal by parent/guardian|2|||
126637141|NCT03170518|455629421|FG001|Overall Study|Withdrawal by parent/guardian|0|||
126637142|NCT03170518|455629422|FG002|Overall Study|Withdrawal by parent/guardian|0|||
126637143|NCT04428476|455629423|FG000|Overall Study|Withdrawal by Subject|1|||
126637144|NCT04428476|455629423|FG000|Overall Study|Still on treatment|12|||
126637145|NCT00546078|455629424|FG000|Overall Study|Lost to Follow-up|1|||
126637146|NCT00546078|455629425|FG001|Overall Study|Lost to Follow-up|3|||
126637147|NCT00546078|455629424|FG000|Overall Study|Withdrawal by Subject|2|||
126637148|NCT00546078|455629425|FG001|Overall Study|Withdrawal by Subject|3|||
126637149|NCT00546078|455629424|FG000|Overall Study|Other reason|1|||
126637150|NCT00546078|455629425|FG001|Overall Study|Other reason|1|||
126637151|NCT03023423|455629428|FG000|Overall Study|Death|5|||
126637152|NCT03023423|455629429|FG001|Overall Study|Death|12|||
126637153|NCT03023423|455629430|FG002|Overall Study|Death|20|||
126637154|NCT03023423|455629428|FG000|Overall Study|Other|0|||
126637155|NCT03023423|455629429|FG001|Overall Study|Other|2|||
126637156|NCT03023423|455629430|FG002|Overall Study|Other|2|||
126637157|NCT03023423|455629428|FG000|Overall Study|Ongoing|2|||
126637158|NCT03023423|455629429|FG001|Overall Study|Ongoing|32|||
126637159|NCT03023423|455629430|FG002|Overall Study|Ongoing|24|||
126637160|NCT00490698|455629431|FG000|Overall Study|Withdrawal by Subject|1|||
126637161|NCT00490698|455629431|FG000|Overall Study|Disease Progression|7|||
126637162|NCT00490698|455629431|FG000|Overall Study|Physician Decision|2|||
126637163|NCT04277507|455629432|FG000|Overall Study|Lost to Follow-up|17|||
126637164|NCT04277507|455629432|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
126637165|NCT04277507|455629432|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
126637166|NCT04277507|455629432|FG000|Overall Study|Withdrawal by Subject|3|||
126637167|NCT04277507|455629432|FG000|Overall Study|Death due to COVID-19|1|||
126637168|NCT04277507|455629432|FG000|Overall Study|Data missing for full evaluation|5|||
126637169|NCT01431950|455629435|FG000|Overall Study|Study Site Closed/Terminated|7|||
126637170|NCT01431950|455629436|FG001|Overall Study|Study Site Closed/Terminated|3|||
126637171|NCT01431950|455629435|FG000|Overall Study|Withdrawal by Subject|4|||
126637172|NCT01431950|455629436|FG001|Overall Study|Withdrawal by Subject|3|||
126637173|NCT01431950|455629435|FG000|Overall Study|Protocol Violation|2|||
126637174|NCT01431950|455629436|FG001|Overall Study|Protocol Violation|3|||
126637175|NCT01431950|455629435|FG000|Overall Study|Adverse Event|2|||
126637176|NCT01431950|455629436|FG001|Overall Study|Adverse Event|2|||
126637177|NCT01431950|455629435|FG000|Overall Study|Physician Decision|2|||
126637178|NCT01431950|455629436|FG001|Overall Study|Physician Decision|1|||
126637179|NCT01431950|455629435|FG000|Overall Study|Lack of Efficacy|2|||
126637180|NCT01431950|455629436|FG001|Overall Study|Lack of Efficacy|1|||
126637181|NCT01431950|455629435|FG000|Overall Study|Lost to Follow-up|0|||
126637182|NCT01431950|455629436|FG001|Overall Study|Lost to Follow-up|1|||
126637183|NCT01431950|455629435|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
126637184|NCT01431950|455629436|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
126637185|NCT02559310|455629437|FG000|Overall Study|Death|4|||
126637186|NCT02559310|455629438|FG001|Overall Study|Death|3|||
126637187|NCT02559310|455629437|FG000|Overall Study|Lost to Follow-up|5|||
126637188|NCT02559310|455629438|FG001|Overall Study|Lost to Follow-up|3|||
126637189|NCT02559310|455629437|FG000|Overall Study|Physician Decision|2|||
126637190|NCT02559310|455629438|FG001|Overall Study|Physician Decision|1|||
126637191|NCT02559310|455629437|FG000|Overall Study|Withdrawal by Subject|13|||
126637192|NCT02559310|455629438|FG001|Overall Study|Withdrawal by Subject|9|||
126637193|NCT02559310|455629437|FG000|Overall Study|Sponsor Decision|0|||
126637194|NCT02559310|455629438|FG001|Overall Study|Sponsor Decision|1|||
126637195|NCT02559310|455629437|FG000|Overall Study|Randomized but not treated|3|||
126637196|NCT02559310|455629438|FG001|Overall Study|Randomized but not treated|2|||
126637197|NCT01740154|455629439|FG000|Overall Study|Adverse Event|1|||
126637198|NCT06719986|455629442|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
126637199|NCT06719986|455629443|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
126637200|NCT06719986|455629444|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
126637201|NCT06719986|455629442|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
126637202|NCT06719986|455629443|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
126637203|NCT06719986|455629444|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
126637204|NCT02726945|455629446|FG000|Overall Study|Withdrawal by Subject|0|||
126637205|NCT02726945|455629447|FG001|Overall Study|Withdrawal by Subject|0|||
126637206|NCT02726945|455629448|FG002|Overall Study|Withdrawal by Subject|1|||
126637207|NCT02726945|455629446|FG000|Overall Study|Elected to have total knee replacement|0|||
126637208|NCT02726945|455629447|FG001|Overall Study|Elected to have total knee replacement|1|||
126637209|NCT02726945|455629448|FG002|Overall Study|Elected to have total knee replacement|0|||
126637210|NCT02737826|455631535|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
126637211|NCT02737826|455631536|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
126756188|NCT03769753|456057396|FG000|Overall Study|Not Treated|6|||
126756189|NCT03769753|456057396|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
126756190|NCT01373294|456057397|FG000|Overall Study|Adverse Event|1|||
126756191|NCT01373294|456057398|FG001|Overall Study|Adverse Event|0|||
126756192|NCT03702166|456057399|FG000|Overall Study|Lost to Follow-up|1|||
126756193|NCT03702166|456057399|FG000|Overall Study|Withdrawal by Subject|1|||
126756194|NCT01657903|456057400|FG000|Overall Study|Lost to Follow-up|1|||
126756195|NCT01657903|456057400|FG000|Overall Study|Withdrawal by Subject|1|||
126756196|NCT01920061|456057404|FG000|Overall Study|Death|1|||
126756197|NCT01920061|456057405|FG001|Overall Study|Death|1|||
126756198|NCT01920061|456057406|FG002|Overall Study|Death|0|||
126756199|NCT01920061|456057407|FG003|Overall Study|Death|1|||
126756200|NCT01920061|456057408|FG004|Overall Study|Death|1|||
126756201|NCT01920061|456057409|FG005|Overall Study|Death|0|||
126756202|NCT01920061|456057410|FG006|Overall Study|Death|0|||
126756203|NCT01920061|456057411|FG007|Overall Study|Death|1|||
126637212|NCT02737826|455631537|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
126637213|NCT00129935|455631538|FG000|Overall Study|Adverse Event|18|||
126637214|NCT00129935|455631539|FG001|Overall Study|Adverse Event|56|||
126637215|NCT00129935|455631538|FG000|Overall Study|Death|1|||
126637216|NCT00129935|455631539|FG001|Overall Study|Death|1|||
126637217|NCT00129935|455631538|FG000|Overall Study|Withdrawal by Subject|7|||
126637218|NCT00129935|455631539|FG001|Overall Study|Withdrawal by Subject|20|||
126637219|NCT00129935|455631538|FG000|Overall Study|Protocol Violation|0|||
126637220|NCT00129935|455631539|FG001|Overall Study|Protocol Violation|4|||
126637221|NCT00129935|455631538|FG000|Overall Study|Physician Decision|3|||
126637222|NCT00129935|455631539|FG001|Overall Study|Physician Decision|4|||
126637223|NCT00129935|455631538|FG000|Overall Study|Recurrence|1|||
126637224|NCT00129935|455631539|FG001|Overall Study|Recurrence|3|||
126637225|NCT00129935|455631538|FG000|Overall Study|Second primary|0|||
126637226|NCT00129935|455631539|FG001|Overall Study|Second primary|1|||
126637227|NCT00129935|455631538|FG000|Overall Study|Other|3|||
126637228|NCT00129935|455631539|FG001|Overall Study|Other|2|||
126756204|NCT01920061|456057412|FG008|Overall Study|Death|0|||
126756205|NCT01920061|456057413|FG009|Overall Study|Death|1|||
126756206|NCT01920061|456057414|FG010|Overall Study|Death|0|||
126756207|NCT01920061|456057415|FG011|Overall Study|Death|1|||
126756208|NCT01920061|456057416|FG012|Overall Study|Death|0|||
126756209|NCT01920061|456057417|FG013|Overall Study|Death|2|||
126756210|NCT01920061|456057418|FG014|Overall Study|Death|0|||
126756211|NCT01920061|456057419|FG015|Overall Study|Death|0|||
126756212|NCT01920061|456057420|FG016|Overall Study|Death|0|||
126756213|NCT01920061|456057421|FG017|Overall Study|Death|0|||
126756214|NCT01920061|456057422|FG018|Overall Study|Death|1|||
126756215|NCT01920061|456057423|FG019|Overall Study|Death|0|||
126756216|NCT01920061|456057404|FG000|Overall Study|Lost to Follow-up|0|||
126756217|NCT01920061|456057405|FG001|Overall Study|Lost to Follow-up|2|||
126756218|NCT01920061|456057406|FG002|Overall Study|Lost to Follow-up|0|||
126756219|NCT01920061|456057407|FG003|Overall Study|Lost to Follow-up|0|||
126756220|NCT01920061|456057408|FG004|Overall Study|Lost to Follow-up|0|||
126756221|NCT01920061|456057409|FG005|Overall Study|Lost to Follow-up|0|||
126756222|NCT01920061|456057410|FG006|Overall Study|Lost to Follow-up|1|||
126756223|NCT01920061|456057411|FG007|Overall Study|Lost to Follow-up|0|||
126756224|NCT01920061|456057412|FG008|Overall Study|Lost to Follow-up|0|||
126756225|NCT01920061|456057413|FG009|Overall Study|Lost to Follow-up|0|||
126756226|NCT01920061|456057414|FG010|Overall Study|Lost to Follow-up|3|||
126756227|NCT01920061|456057415|FG011|Overall Study|Lost to Follow-up|0|||
126756228|NCT01920061|456057416|FG012|Overall Study|Lost to Follow-up|0|||
126756229|NCT01920061|456057417|FG013|Overall Study|Lost to Follow-up|0|||
126756230|NCT01920061|456057418|FG014|Overall Study|Lost to Follow-up|0|||
126756231|NCT01920061|456057419|FG015|Overall Study|Lost to Follow-up|0|||
126756232|NCT01920061|456057420|FG016|Overall Study|Lost to Follow-up|0|||
126756233|NCT01920061|456057421|FG017|Overall Study|Lost to Follow-up|1|||
126756234|NCT01920061|456057422|FG018|Overall Study|Lost to Follow-up|4|||
126756235|NCT01920061|456057423|FG019|Overall Study|Lost to Follow-up|3|||
126756236|NCT01920061|456057404|FG000|Overall Study|Other|1|||
126756237|NCT01920061|456057405|FG001|Overall Study|Other|1|||
126756238|NCT01920061|456057406|FG002|Overall Study|Other|2|||
126756239|NCT01920061|456057407|FG003|Overall Study|Other|1|||
126756240|NCT01920061|456057408|FG004|Overall Study|Other|0|||
126756241|NCT01920061|456057409|FG005|Overall Study|Other|1|||
126756242|NCT01920061|456057410|FG006|Overall Study|Other|0|||
126756243|NCT01920061|456057411|FG007|Overall Study|Other|0|||
126756244|NCT01920061|456057412|FG008|Overall Study|Other|0|||
126756245|NCT01920061|456057413|FG009|Overall Study|Other|1|||
126756246|NCT01920061|456057414|FG010|Overall Study|Other|1|||
126756247|NCT01920061|456057415|FG011|Overall Study|Other|2|||
126756248|NCT01920061|456057416|FG012|Overall Study|Other|1|||
126756249|NCT01920061|456057417|FG013|Overall Study|Other|4|||
126756250|NCT01920061|456057418|FG014|Overall Study|Other|0|||
126756251|NCT01920061|456057419|FG015|Overall Study|Other|1|||
126756252|NCT01920061|456057420|FG016|Overall Study|Other|1|||
126756253|NCT01920061|456057421|FG017|Overall Study|Other|0|||
126756254|NCT01920061|456057422|FG018|Overall Study|Other|1|||
126756255|NCT01920061|456057423|FG019|Overall Study|Other|1|||
126756256|NCT01920061|456057404|FG000|Overall Study|Participant refused further follow-up|0|||
126756257|NCT01920061|456057405|FG001|Overall Study|Participant refused further follow-up|0|||
126756258|NCT01920061|456057406|FG002|Overall Study|Participant refused further follow-up|0|||
126756259|NCT01920061|456057407|FG003|Overall Study|Participant refused further follow-up|0|||
126756260|NCT01920061|456057408|FG004|Overall Study|Participant refused further follow-up|1|||
126756261|NCT01920061|456057409|FG005|Overall Study|Participant refused further follow-up|1|||
126756262|NCT01920061|456057410|FG006|Overall Study|Participant refused further follow-up|0|||
126756263|NCT01920061|456057411|FG007|Overall Study|Participant refused further follow-up|0|||
126756264|NCT01920061|456057412|FG008|Overall Study|Participant refused further follow-up|1|||
126756265|NCT01920061|456057413|FG009|Overall Study|Participant refused further follow-up|0|||
126756266|NCT01920061|456057414|FG010|Overall Study|Participant refused further follow-up|1|||
126756267|NCT01920061|456057415|FG011|Overall Study|Participant refused further follow-up|0|||
126756268|NCT01920061|456057416|FG012|Overall Study|Participant refused further follow-up|1|||
126756269|NCT01920061|456057417|FG013|Overall Study|Participant refused further follow-up|0|||
126756270|NCT01920061|456057418|FG014|Overall Study|Participant refused further follow-up|1|||
126756271|NCT01920061|456057419|FG015|Overall Study|Participant refused further follow-up|2|||
126756272|NCT01920061|456057420|FG016|Overall Study|Participant refused further follow-up|1|||
126756273|NCT01920061|456057421|FG017|Overall Study|Participant refused further follow-up|1|||
126756274|NCT01920061|456057422|FG018|Overall Study|Participant refused further follow-up|0|||
126756275|NCT01920061|456057423|FG019|Overall Study|Participant refused further follow-up|0|||
126756276|NCT00842829|456057426|FG000|Dose Titration Period|Adverse Event|11|||
126756277|NCT00842829|456057427|FG001|Dose Titration Period|Adverse Event|10|||
126756278|NCT00842829|456057428|FG002|Dose Titration Period|Adverse Event|0|||
126756279|NCT00842829|456057426|FG000|Dose Titration Period|Lack of Efficacy|4|||
126637229|NCT00129935|455631538|FG000|Overall Study|Crossed to the other arm|2|||
126637230|NCT00129935|455631539|FG001|Overall Study|Crossed to the other arm|1|||
126637231|NCT00129935|455631538|FG000|Overall Study|Incorrect study treatment|1|||
126637232|NCT00129935|455631539|FG001|Overall Study|Incorrect study treatment|0|||
126637233|NCT02783573|455631540|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
126637234|NCT02783573|455631541|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
126637235|NCT02783573|455631542|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
126637236|NCT02783573|455631540|FG000|Placebo-Controlled Treatment Period|Death|4|||
126637237|NCT02783573|455631541|FG001|Placebo-Controlled Treatment Period|Death|2|||
126637238|NCT02783573|455631542|FG002|Placebo-Controlled Treatment Period|Death|3|||
126637239|NCT02783573|455631540|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
126637240|NCT02783573|455631541|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
126637241|NCT02783573|455631542|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
126637242|NCT02783573|455631540|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
126637243|NCT02783573|455631541|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
126637244|NCT02783573|455631542|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
126637245|NCT02783573|455631540|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
126637246|NCT02783573|455631541|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
126637247|NCT02783573|455631542|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
126637248|NCT02783573|455631540|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
126637249|NCT02783573|455631541|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
126637250|NCT02783573|455631542|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
126637251|NCT02783573|455631540|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
126637252|NCT02783573|455631541|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
126637253|NCT02783573|455631542|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
126637254|NCT02783573|455631540|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
126637255|NCT02783573|455631541|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
126637256|NCT02783573|455631542|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
126637257|NCT02783573|455631540|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
126637258|NCT02783573|455631541|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
126637259|NCT02783573|455631542|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
126637260|NCT02783573|455631540|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
126637261|NCT02783573|455631541|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
126637262|NCT02783573|455631542|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
126637263|NCT02783573|455631540|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
126637264|NCT02783573|455631541|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
126637265|NCT02783573|455631542|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
126637266|NCT02783573|455631540|FG000|Delayed-Start Period|Sponsor Decision|0|||
126637267|NCT02783573|455631541|FG001|Delayed-Start Period|Sponsor Decision|17|||
126637268|NCT02783573|455631542|FG002|Delayed-Start Period|Sponsor Decision|12|||
126637269|NCT02797522|455631550|FG000|Overall Study|Study Terminated by Sponsor|0|||
126637270|NCT02797522|455631551|FG001|Overall Study|Study Terminated by Sponsor|0|||
126637271|NCT02797522|455631552|FG002|Overall Study|Study Terminated by Sponsor|0|||
126637272|NCT02797522|455631553|FG003|Overall Study|Study Terminated by Sponsor|0|||
126637273|NCT02797522|455631554|FG004|Overall Study|Study Terminated by Sponsor|0|||
126637274|NCT02797522|455631555|FG005|Overall Study|Study Terminated by Sponsor|0|||
126637275|NCT02797522|455631556|FG006|Overall Study|Study Terminated by Sponsor|0|||
126637276|NCT02797522|455631557|FG007|Overall Study|Study Terminated by Sponsor|4|||
126637277|NCT02797522|455631558|FG008|Overall Study|Study Terminated by Sponsor|2|||
126637278|NCT02797522|455631559|FG009|Overall Study|Study Terminated by Sponsor|4|||
126637279|NCT02797522|455631560|FG010|Overall Study|Study Terminated by Sponsor|1|||
126637280|NCT00725712|455631561|FG000|Overall Study|Withdrawal by Subject|2|||
126637281|NCT00725712|455631562|FG001|Overall Study|Withdrawal by Subject|1|||
126637282|NCT00725712|455631561|FG000|Overall Study|Protocol Violation|1|||
126637283|NCT00725712|455631562|FG001|Overall Study|Protocol Violation|0|||
126637284|NCT00725712|455631561|FG000|Overall Study|Progressive disease|37|||
126637285|NCT00725712|455631562|FG001|Overall Study|Progressive disease|16|||
126637286|NCT00725712|455631561|FG000|Overall Study|Clinical progression not based on RECIST|0|||
126637287|NCT00725712|455631562|FG001|Overall Study|Clinical progression not based on RECIST|3|||
126637288|NCT00725712|455631561|FG000|Overall Study|Adverse Event|5|||
126637289|NCT00725712|455631562|FG001|Overall Study|Adverse Event|5|||
126637290|NCT00725712|455631561|FG000|Overall Study|Death|2|||
126637291|NCT00725712|455631562|FG001|Overall Study|Death|0|||
126637292|NCT00725712|455631561|FG000|Overall Study|Other: Death|1|||
126637293|NCT00725712|455631562|FG001|Overall Study|Other: Death|0|||
126637294|NCT00725712|455631561|FG000|Overall Study|Hospitalized, unable to continue|0|||
126637295|NCT00725712|455631562|FG001|Overall Study|Hospitalized, unable to continue|1|||
126637296|NCT03020069|455631563|FG000|Overall Study|Lost to Follow-up|0|||
126637297|NCT03020069|455631564|FG001|Overall Study|Lost to Follow-up|1|||
126637298|NCT00132678|455631567|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
126637299|NCT00132678|455631568|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
126637300|NCT00132678|455631569|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
126637301|NCT00132678|455631567|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
126637302|NCT00132678|455631568|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
126637303|NCT00132678|455631569|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
126637304|NCT00132678|455631567|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
126637305|NCT00132678|455631568|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
126637306|NCT00132678|455631569|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
126637307|NCT00132678|455631567|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
126637308|NCT00132678|455631568|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
126637309|NCT00132678|455631569|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
126637310|NCT00132678|455631567|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
126637311|NCT00132678|455631568|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
126637312|NCT00132678|455631569|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
126637313|NCT00132678|455631567|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
126637314|NCT00132678|455631568|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
126637315|NCT00132678|455631569|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
126637316|NCT00132678|455631567|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
126637317|NCT00132678|455631568|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
126637318|NCT00132678|455631569|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
126637319|NCT00132678|455631567|FG000|Period III (Open-Label Stabilization)|Death|2|||
126637320|NCT00132678|455631568|FG001|Period III (Open-Label Stabilization)|Death|0|||
126637321|NCT00132678|455631569|FG002|Period III (Open-Label Stabilization)|Death|0|||
126637322|NCT00132678|455631567|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
126637323|NCT00132678|455631568|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
126637324|NCT00132678|455631569|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
126637325|NCT00132678|455631567|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
126637326|NCT00132678|455631568|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
126637327|NCT00132678|455631569|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
126637328|NCT00132678|455631567|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
126637329|NCT00132678|455631568|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
126637330|NCT00132678|455631569|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
126637331|NCT00132678|455631567|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
126637332|NCT00132678|455631568|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
126637333|NCT00132678|455631569|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
126637334|NCT00132678|455631567|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
126637335|NCT00132678|455631568|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
126637336|NCT00132678|455631569|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
126637337|NCT00132678|455631567|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
126637338|NCT00132678|455631568|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
126637339|NCT00132678|455631569|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
126637340|NCT00132678|455631567|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
126637341|NCT00132678|455631568|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
126637342|NCT00132678|455631569|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
126637343|NCT00132678|455631567|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
126637344|NCT00132678|455631568|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
126637345|NCT00132678|455631569|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
126637346|NCT00132678|455631567|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
126637347|NCT00132678|455631568|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
126637348|NCT00132678|455631569|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
126637349|NCT00132678|455631567|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
126637350|NCT00132678|455631568|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
126637351|NCT00132678|455631569|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
126637352|NCT00132678|455631567|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
126637353|NCT00132678|455631568|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
126637354|NCT00132678|455631569|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
126637355|NCT00132678|455631567|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
126637356|NCT00132678|455631568|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
126637357|NCT00132678|455631569|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
126637358|NCT00132678|455631567|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
126637359|NCT00132678|455631568|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
126637360|NCT00132678|455631569|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
126637361|NCT00132678|455631567|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
126637362|NCT00132678|455631568|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
126637363|NCT00132678|455631569|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
126637364|NCT00132678|455631567|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
126637365|NCT00132678|455631568|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
126637366|NCT00132678|455631569|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
126637367|NCT02056626|455631570|FG000|Overall Study|patient did not follow directions|3|||
126637368|NCT02056626|455631571|FG001|Overall Study|patient did not follow directions|1|||
126637369|NCT02056626|455631572|FG002|Overall Study|patient did not follow directions|0|||
126637370|NCT02056626|455631573|FG003|Overall Study|patient did not follow directions|0|||
126637371|NCT00863512|455631574|FG000|Overall Study|Adverse Event|2|||
126637372|NCT00863512|455631575|FG001|Overall Study|Adverse Event|0|||
126637373|NCT00863512|455631574|FG000|Overall Study|Withdrawal by Subject|11|||
126637374|NCT00863512|455631575|FG001|Overall Study|Withdrawal by Subject|0|||
126637375|NCT00863512|455631574|FG000|Overall Study|Physician Decision|1|||
126637376|NCT00863512|455631575|FG001|Overall Study|Physician Decision|0|||
126637377|NCT02037477|455631576|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
126637378|NCT02037477|455631577|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
126637379|NCT02037477|455631578|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
126637380|NCT02037477|455631579|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
126637381|NCT01454739|455631580|FG000|Overall Study|Protocol Violation|2|||
126637382|NCT01454739|455631581|FG001|Overall Study|Protocol Violation|3|||
126637383|NCT01454739|455631580|FG000|Overall Study|Withdrawal by Subject|2|||
126637384|NCT01454739|455631581|FG001|Overall Study|Withdrawal by Subject|6|||
126637385|NCT01454739|455631580|FG000|Overall Study|Other|3|||
126637386|NCT01454739|455631581|FG001|Overall Study|Other|5|||
126637387|NCT01454739|455631580|FG000|Overall Study|Physician Decision|0|||
126637388|NCT01454739|455631581|FG001|Overall Study|Physician Decision|5|||
126637389|NCT01454739|455631580|FG000|Overall Study|Lost to Follow-up|0|||
126637390|NCT01454739|455631581|FG001|Overall Study|Lost to Follow-up|1|||
126637391|NCT01454739|455631580|FG000|Overall Study|Adverse Event|0|||
126637392|NCT01454739|455631581|FG001|Overall Study|Adverse Event|1|||
126637393|NCT02577003|455631584|FG000|Overall Study|Adverse Event|2|||
126637394|NCT02577003|455631585|FG001|Overall Study|Adverse Event|4|||
126637395|NCT02577003|455631584|FG000|Overall Study|Withdrawal by Subject|0|||
126637396|NCT02577003|455631585|FG001|Overall Study|Withdrawal by Subject|1|||
126637397|NCT02786004|455631586|FG000|Overall Study|Withdrawal by Subject|0|||
126637398|NCT02786004|455631587|FG001|Overall Study|Withdrawal by Subject|1|||
126637399|NCT01677299|455631588|FG000|Overall Study|Adverse Event|0|||
126637400|NCT01677299|455631589|FG001|Overall Study|Adverse Event|2|||
126637401|NCT01677299|455631590|FG002|Overall Study|Adverse Event|1|||
126637402|NCT01677299|455631591|FG003|Overall Study|Adverse Event|0|||
126637403|NCT01677299|455631588|FG000|Overall Study|Withdrawal by Subject|0|||
126637404|NCT01677299|455631589|FG001|Overall Study|Withdrawal by Subject|1|||
126637405|NCT01677299|455631590|FG002|Overall Study|Withdrawal by Subject|0|||
126637406|NCT01677299|455631591|FG003|Overall Study|Withdrawal by Subject|1|||
126637407|NCT00559377|455631593|FG000|Overall Study|Withdrawal by Subject|9|||
126637408|NCT00940875|455631594|FG000|Treatment Phase|Adverse Event|9|||
126637409|NCT00940875|455631595|FG001|Treatment Phase|Adverse Event|3|||
126637410|NCT00940875|455631594|FG000|Treatment Phase|Death|3|||
126637411|NCT00940875|455631595|FG001|Treatment Phase|Death|5|||
126637412|NCT00940875|455631594|FG000|Treatment Phase|Lack of Efficacy|1|||
126637413|NCT00940875|455631595|FG001|Treatment Phase|Lack of Efficacy|0|||
126637414|NCT00940875|455631594|FG000|Treatment Phase|Withdrawal by Subject|3|||
126637415|NCT00940875|455631595|FG001|Treatment Phase|Withdrawal by Subject|0|||
126637416|NCT00940875|455631594|FG000|Treatment Phase|Disease progression|9|||
126637417|NCT00940875|455631595|FG001|Treatment Phase|Disease progression|11|||
126637418|NCT00940875|455631594|FG000|Treatment Phase|Physician Decision|1|||
126637419|NCT00940875|455631595|FG001|Treatment Phase|Physician Decision|0|||
126637420|NCT00940875|455631594|FG000|Post-Study Treatment|Death|0|||
126637421|NCT00940875|455631595|FG001|Post-Study Treatment|Death|1|||
126637422|NCT00940875|455631594|FG000|Post-Study Treatment|Disease Progression|0|||
126637423|NCT00940875|455631595|FG001|Post-Study Treatment|Disease Progression|2|||
126637424|NCT00872001|455631596|FG000|Overall Study|Adverse Event|34|||
126637425|NCT00872001|455631597|FG001|Overall Study|Adverse Event|23|||
126637426|NCT00872001|455631596|FG000|Overall Study|Protocol Defined Clinical Event|5|||
126637427|NCT00872001|455631597|FG001|Overall Study|Protocol Defined Clinical Event|7|||
126637428|NCT00872001|455631596|FG000|Overall Study|Lost to Follow-up|13|||
126637429|NCT00872001|455631597|FG001|Overall Study|Lost to Follow-up|12|||
126637430|NCT00872001|455631596|FG000|Overall Study|Withdrawal by Subject|18|||
126637431|NCT00872001|455631597|FG001|Overall Study|Withdrawal by Subject|30|||
126637432|NCT00872001|455631596|FG000|Overall Study|Protocol Violation|5|||
126637433|NCT00872001|455631597|FG001|Overall Study|Protocol Violation|8|||
126637434|NCT00872001|455631596|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
126637435|NCT00872001|455631597|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
126637436|NCT00872001|455631596|FG000|Overall Study|Administrative|23|||
126637437|NCT00872001|455631597|FG001|Overall Study|Administrative|15|||
126637438|NCT03482752|455631603|FG000|Overall Study|Withdrawal by Subject|2|||
126637439|NCT03482752|455631603|FG000|Overall Study|Lost to Follow-up|1|||
126637440|NCT03482752|455631603|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
126637441|NCT01776008|455631604|FG000|Overall Study|ineligible|2|||
126637442|NCT00003477|455631607|FG000|Overall Study|Not evalauable|4|||
126637443|NCT01575873|455631608|FG000|Overall Study|Withdrawal by Subject|15|||
126637444|NCT01575873|455631609|FG001|Overall Study|Withdrawal by Subject|20|||
126637445|NCT01575873|455631610|FG002|Overall Study|Withdrawal by Subject|34|||
126637446|NCT01575873|455631611|FG003|Overall Study|Withdrawal by Subject|34|||
126637447|NCT01575873|455631608|FG000|Overall Study|Adverse Event|7|||
126637448|NCT01575873|455631609|FG001|Overall Study|Adverse Event|7|||
126637449|NCT01575873|455631610|FG002|Overall Study|Adverse Event|9|||
126637450|NCT01575873|455631611|FG003|Overall Study|Adverse Event|12|||
126637451|NCT01575873|455631608|FG000|Overall Study|Lost to Follow-up|1|||
126637452|NCT01575873|455631609|FG001|Overall Study|Lost to Follow-up|3|||
126637453|NCT01575873|455631610|FG002|Overall Study|Lost to Follow-up|13|||
126637454|NCT01575873|455631611|FG003|Overall Study|Lost to Follow-up|5|||
126637455|NCT01575873|455631608|FG000|Overall Study|Death|3|||
126637456|NCT01575873|455631609|FG001|Overall Study|Death|2|||
126637457|NCT01575873|455631610|FG002|Overall Study|Death|8|||
126637458|NCT01575873|455631611|FG003|Overall Study|Death|9|||
126637459|NCT01575873|455631608|FG000|Overall Study|Noncompliance|1|||
126637460|NCT01575873|455631609|FG001|Overall Study|Noncompliance|2|||
126637461|NCT01575873|455631610|FG002|Overall Study|Noncompliance|4|||
126637462|NCT01575873|455631611|FG003|Overall Study|Noncompliance|3|||
126637463|NCT01575873|455631608|FG000|Overall Study|Administrative decision|1|||
126637464|NCT01575873|455631609|FG001|Overall Study|Administrative decision|1|||
126637465|NCT01575873|455631610|FG002|Overall Study|Administrative decision|1|||
126637466|NCT01575873|455631611|FG003|Overall Study|Administrative decision|0|||
126637467|NCT01575873|455631608|FG000|Overall Study|Protocol deviation|0|||
126637468|NCT01575873|455631609|FG001|Overall Study|Protocol deviation|1|||
126637469|NCT01575873|455631610|FG002|Overall Study|Protocol deviation|0|||
126637470|NCT01575873|455631611|FG003|Overall Study|Protocol deviation|1|||
126637471|NCT01575873|455631608|FG000|Overall Study|Requirement for Alternative Therapy|0|||
126637472|NCT01575873|455631609|FG001|Overall Study|Requirement for Alternative Therapy|0|||
126637473|NCT01575873|455631610|FG002|Overall Study|Requirement for Alternative Therapy|1|||
126637474|NCT01575873|455631611|FG003|Overall Study|Requirement for Alternative Therapy|1|||
126637475|NCT01575873|455631608|FG000|Overall Study|Other|0|||
126637476|NCT01575873|455631609|FG001|Overall Study|Other|0|||
126637477|NCT01575873|455631610|FG002|Overall Study|Other|4|||
126637478|NCT01575873|455631611|FG003|Overall Study|Other|2|||
126637479|NCT00762476|455631612|FG000|Overall Study|Adverse Event|7|||
126637480|NCT00762476|455631613|FG001|Overall Study|Adverse Event|1|||
126637481|NCT00762476|455631612|FG000|Overall Study|Lost to Follow-up|2|||
126637482|NCT00762476|455631613|FG001|Overall Study|Lost to Follow-up|0|||
126637483|NCT00762476|455631612|FG000|Overall Study|Protocol Violation|5|||
126637484|NCT00762476|455631613|FG001|Overall Study|Protocol Violation|6|||
126637485|NCT00762476|455631612|FG000|Overall Study|Physician Decision|2|||
126637486|NCT00762476|455631613|FG001|Overall Study|Physician Decision|14|||
126637487|NCT00762476|455631612|FG000|Overall Study|Withdrawal by Subject|6|||
126637488|NCT00762476|455631613|FG001|Overall Study|Withdrawal by Subject|12|||
126637489|NCT00762476|455631612|FG000|Overall Study|antibiotic use|0|||
126637490|NCT00762476|455631613|FG001|Overall Study|antibiotic use|1|||
126637491|NCT00762476|455631612|FG000|Overall Study|non-compliance with study visits|0|||
126637492|NCT00762476|455631613|FG001|Overall Study|non-compliance with study visits|2|||
126637493|NCT00762476|455631612|FG000|Overall Study|Seasonal allergies|1|||
126637494|NCT00762476|455631613|FG001|Overall Study|Seasonal allergies|0|||
126637495|NCT02838134|455631614|FG000|Overall Study|Lost to Follow-up|1|||
126637496|NCT02838134|455631615|FG001|Overall Study|Lost to Follow-up|2|||
126637497|NCT02838134|455631614|FG000|Overall Study|logistic problems|1|||
126637498|NCT02838134|455631615|FG001|Overall Study|logistic problems|1|||
126637499|NCT04674189|455631616|FG000|Overall Study|Adverse Event|0|||
126637500|NCT04674189|455631617|FG001|Overall Study|Adverse Event|0|||
126637501|NCT04674189|455631618|FG002|Overall Study|Adverse Event|1|||
126637502|NCT04674189|455631616|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
126637503|NCT04674189|455631617|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
126637504|NCT04674189|455631618|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
126637505|NCT04674189|455631616|FG000|Overall Study|Physician Decision|1|||
126637506|NCT04674189|455631617|FG001|Overall Study|Physician Decision|0|||
126637507|NCT04674189|455631618|FG002|Overall Study|Physician Decision|0|||
126637508|NCT04674189|455631616|FG000|Overall Study|Withdrawal by Participant|83|||
126637509|NCT04674189|455631617|FG001|Overall Study|Withdrawal by Participant|71|||
126637510|NCT04674189|455631618|FG002|Overall Study|Withdrawal by Participant|142|||
126637511|NCT04674189|455631616|FG000|Overall Study|Lost to Follow-up|55|||
126637512|NCT04674189|455631617|FG001|Overall Study|Lost to Follow-up|53|||
126637513|NCT04674189|455631618|FG002|Overall Study|Lost to Follow-up|44|||
126637514|NCT04674189|455631616|FG000|Overall Study|Miscellaneous|27|||
126637515|NCT04674189|455631617|FG001|Overall Study|Miscellaneous|23|||
126637516|NCT04674189|455631618|FG002|Overall Study|Miscellaneous|207|||
126637517|NCT04674189|455631616|FG000|Overall Study|Did Not Receive Treatment|3|||
126637518|NCT04674189|455631617|FG001|Overall Study|Did Not Receive Treatment|1|||
126637519|NCT04674189|455631618|FG002|Overall Study|Did Not Receive Treatment|2|||
126637520|NCT01564277|455631622|FG000|Overall Study|Protocol Violation|0|||
126637521|NCT01564277|455631623|FG001|Overall Study|Protocol Violation|1|||
126637522|NCT01564277|455631622|FG000|Overall Study|Physician Decision|1|||
126637523|NCT01564277|455631623|FG001|Overall Study|Physician Decision|0|||
126637524|NCT01637077|455631624|FG000|Overall Study|Cancel|1|||
126637525|NCT01637077|455631625|FG001|Overall Study|Cancel|1|||
126637526|NCT01637077|455631624|FG000|Overall Study|Withdrawal by Subject|1|||
126637527|NCT01637077|455631625|FG001|Overall Study|Withdrawal by Subject|0|||
126637528|NCT01637077|455631624|FG000|Overall Study|No cycle 1 questionnaire data|2|||
126637529|NCT01637077|455631625|FG001|Overall Study|No cycle 1 questionnaire data|0|||
126637530|NCT00246090|455631626|FG000|Overall Study|Adverse Event|25|||
126637531|NCT00246090|455631626|FG000|Overall Study|Withdrawal by Subject|7|||
126637532|NCT00246090|455631626|FG000|Overall Study|Progressive Disease|212|||
126637533|NCT00246090|455631626|FG000|Overall Study|Clinical Progression|30|||
126637534|NCT00246090|455631626|FG000|Overall Study|Physician Decision|11|||
126637535|NCT00246090|455631626|FG000|Overall Study|Not Otherwise Specified|10|||
126637536|NCT02595372|455631627|FG000|Overall Study|Adverse Event|6|||
126637537|NCT02595372|455631627|FG000|Overall Study|Physician Decision|2|||
126637538|NCT02595372|455631627|FG000|Overall Study|Disease Progression|1|||
126637539|NCT00794924|455631628|FG000|Overall Study|Lost to Follow-up|6|||
126637540|NCT00794924|455631629|FG001|Overall Study|Lost to Follow-up|8|||
126637541|NCT00794924|455631628|FG000|Overall Study|Withdrawal by Subject|48|||
126637542|NCT00794924|455631629|FG001|Overall Study|Withdrawal by Subject|60|||
126637543|NCT00794924|455631628|FG000|Overall Study|Adverse Event|6|||
126637544|NCT00794924|455631629|FG001|Overall Study|Adverse Event|2|||
126637545|NCT01594970|455631630|FG000|Overall Study|Non-Adverse Event Related|4|||
126637546|NCT01594970|455631631|FG001|Overall Study|Non-Adverse Event Related|5|||
126637547|NCT01594970|455631632|FG002|Overall Study|Non-Adverse Event Related|6|||
126637548|NCT01594970|455631630|FG000|Overall Study|Adverse Event|17|||
126637549|NCT01594970|455631631|FG001|Overall Study|Adverse Event|23|||
126637550|NCT01594970|455631632|FG002|Overall Study|Adverse Event|23|||
126637551|NCT01594970|455631630|FG000|Overall Study|Lost to Follow-up|54|||
126637552|NCT01594970|455631631|FG001|Overall Study|Lost to Follow-up|54|||
126637553|NCT01594970|455631632|FG002|Overall Study|Lost to Follow-up|37|||
126637554|NCT02389764|455631633|FG000|Overall Study|Lack of Efficacy|9|||
126637555|NCT01011868|455631634|FG000|After Week 18 Follow-up|Adverse Event|8|||
126637556|NCT01011868|455631635|FG001|After Week 18 Follow-up|Adverse Event|6|||
126637557|NCT01011868|455631636|FG002|After Week 18 Follow-up|Adverse Event|13|||
126637558|NCT01011868|455631634|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
126637559|NCT01011868|455631635|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
126637560|NCT01011868|455631636|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
126637561|NCT01011868|455631634|FG000|After Week 18 Follow-up|Protocol Violation|1|||
126637562|NCT01011868|455631635|FG001|After Week 18 Follow-up|Protocol Violation|1|||
126637563|NCT01011868|455631636|FG002|After Week 18 Follow-up|Protocol Violation|1|||
126637564|NCT01011868|455631634|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
126637565|NCT01011868|455631635|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
126637566|NCT01011868|455631636|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
126637567|NCT01011868|455631634|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
126637568|NCT01011868|455631635|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
126637569|NCT01011868|455631636|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
126637570|NCT01011868|455631634|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
126637571|NCT01011868|455631635|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
126637572|NCT01011868|455631636|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
126637573|NCT01011868|455631634|FG000|After Week 78 Follow-up|Adverse Event|14|||
126637574|NCT01011868|455631635|FG001|After Week 78 Follow-up|Adverse Event|18|||
126637575|NCT01011868|455631636|FG002|After Week 78 Follow-up|Adverse Event|21|||
126637576|NCT01011868|455631634|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
126637577|NCT01011868|455631635|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
126637578|NCT01011868|455631636|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
126637579|NCT01011868|455631634|FG000|After Week 78 Follow-up|Protocol Violation|9|||
126637580|NCT01011868|455631635|FG001|After Week 78 Follow-up|Protocol Violation|1|||
126637581|NCT01011868|455631636|FG002|After Week 78 Follow-up|Protocol Violation|2|||
126637582|NCT01011868|455631634|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
126637583|NCT01011868|455631635|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
126637584|NCT01011868|455631636|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
126637585|NCT01011868|455631634|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
126637586|NCT01011868|455631635|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
126637587|NCT01011868|455631636|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
126637588|NCT01011868|455631634|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
126637589|NCT01011868|455631635|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
126637590|NCT01011868|455631636|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
126637591|NCT00738283|455631637|FG000|Overall Study|Death|1|||
126637592|NCT00738283|455631637|FG000|Overall Study|Transfer to another facility|2|||
126637593|NCT00738283|455631637|FG000|Overall Study|Discharge home prior to end of study|1|||
126637594|NCT00583947|455631638|FG000|Cross-over Period|Adverse Event|2|||
126637595|NCT00583947|455631639|FG001|Cross-over Period|Adverse Event|0|||
126637596|NCT00583947|455631638|FG000|Cross-over Period|Withdrawal by Subject|2|||
126637597|NCT00583947|455631639|FG001|Cross-over Period|Withdrawal by Subject|0|||
126637598|NCT00583947|455631638|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
126637599|NCT00583947|455631639|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
126637600|NCT00583947|455631638|FG000|Cross-over Period|Other|1|||
126637601|NCT00583947|455631639|FG001|Cross-over Period|Other|1|||
126637602|NCT00486252|455631643|FG000|Overall Study|Adverse Event|7|||
126637603|NCT00486252|455631643|FG000|Overall Study|Lack of Efficacy|9|||
126637604|NCT00486252|455631643|FG000|Overall Study|Lost to Follow-up|24|||
126637605|NCT00486252|455631643|FG000|Overall Study|Other|18|||
126637606|NCT01261247|455631644|FG000|Overall Study|Ineligible|2|||
126637607|NCT01210651|455631645|FG000|Overall Study|Lost to Follow-up|1|||
126637608|NCT01210651|455631646|FG001|Overall Study|Lost to Follow-up|1|||
126637609|NCT01210651|455631645|FG000|Overall Study|schedule conflicts|1|||
126637610|NCT01210651|455631646|FG001|Overall Study|schedule conflicts|5|||
126637611|NCT01210651|455631645|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
126637612|NCT01210651|455631646|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
126637613|NCT01210651|455631645|FG000|Overall Study|Withdrawal by Subject|1|||
126637614|NCT01210651|455631646|FG001|Overall Study|Withdrawal by Subject|1|||
126637615|NCT01210651|455631645|FG000|Overall Study|Injury outside study|2|||
126637616|NCT01210651|455631646|FG001|Overall Study|Injury outside study|0|||
126637617|NCT02592707|455631650|FG000|Overall Study|Consent Withdrawn|0|||
126637618|NCT02592707|455631651|FG001|Overall Study|Consent Withdrawn|1|||
126637619|NCT02592707|455631652|FG002|Overall Study|Consent Withdrawn|2|||
126637620|NCT02592707|455631653|FG003|Overall Study|Consent Withdrawn|0|||
126637621|NCT02592707|455631650|FG000|Overall Study|Death|1|||
126637622|NCT02592707|455631651|FG001|Overall Study|Death|0|||
126637623|NCT02592707|455631652|FG002|Overall Study|Death|0|||
126637624|NCT02592707|455631653|FG003|Overall Study|Death|0|||
126637625|NCT02592707|455631650|FG000|Overall Study|Progressive Disease|4|||
126637626|NCT02592707|455631651|FG001|Overall Study|Progressive Disease|4|||
126637627|NCT02592707|455631652|FG002|Overall Study|Progressive Disease|3|||
126637628|NCT02592707|455631653|FG003|Overall Study|Progressive Disease|3|||
126637629|NCT02592707|455631650|FG000|Overall Study|Other|0|||
126637630|NCT02592707|455631651|FG001|Overall Study|Other|0|||
126637631|NCT02592707|455631652|FG002|Overall Study|Other|1|||
126637632|NCT02592707|455631653|FG003|Overall Study|Other|2|||
126637633|NCT02592707|455631650|FG000|Overall Study|Never entered LTFU period|1|||
126637634|NCT02592707|455631651|FG001|Overall Study|Never entered LTFU period|0|||
126637635|NCT02592707|455631652|FG002|Overall Study|Never entered LTFU period|0|||
126637636|NCT02592707|455631653|FG003|Overall Study|Never entered LTFU period|2|||
126637637|NCT00469859|455631654|FG000|Overall Study|Inevaluable|0|||
126637638|NCT00469859|455631655|FG001|Overall Study|Inevaluable|2|||
126637639|NCT04124471|455631656|FG000|Overall Study|screen failure|1|||
126637640|NCT05226130|455631657|FG000|Overall Study|Lost to Follow-up|0|||
126637641|NCT05226130|455631658|FG001|Overall Study|Lost to Follow-up|1|||
126637642|NCT05226130|455631657|FG000|Overall Study|Not treatment adherent|0|||
126637643|NCT05226130|455631658|FG001|Overall Study|Not treatment adherent|2|||
126637644|NCT04855734|455631659|FG000|Overall Study|Lost to Follow-up|2|||
126637645|NCT04855734|455631660|FG001|Overall Study|Lost to Follow-up|2|||
126637646|NCT03358472|455631661|FG000|Overall Study|Death|6|||
126637647|NCT03358472|455631662|FG001|Overall Study|Death|3|||
126637648|NCT03358472|455631663|FG002|Overall Study|Death|10|||
126637649|NCT03358472|455631661|FG000|Overall Study|Physician Decision|0|||
126637650|NCT03358472|455631662|FG001|Overall Study|Physician Decision|1|||
126637651|NCT03358472|455631663|FG002|Overall Study|Physician Decision|0|||
126637652|NCT03358472|455631661|FG000|Overall Study|Withdrawal by Subject|0|||
126637653|NCT03358472|455631662|FG001|Overall Study|Withdrawal by Subject|0|||
126637654|NCT03358472|455631663|FG002|Overall Study|Withdrawal by Subject|1|||
126637655|NCT03358472|455631661|FG000|Overall Study|On-going at clinical cut off date|9|||
126637656|NCT03358472|455631662|FG001|Overall Study|On-going at clinical cut off date|6|||
126637657|NCT03358472|455631663|FG002|Overall Study|On-going at clinical cut off date|5|||
126637658|NCT03732677|455631664|FG000|Overall Study|Terminated the study|154|||
126637659|NCT03732677|455631665|FG001|Overall Study|Terminated the study|197|||
126637660|NCT03732677|455631664|FG000|Overall Study|Continuing study off treatment|379|||
126637661|NCT03732677|455631665|FG001|Overall Study|Continuing study off treatment|333|||
126637662|NCT04013971|455631666|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
126637663|NCT04013971|455631667|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
126637664|NCT04013971|455631666|FG000|Overall Study|Missing biomechanical data|0|||
126637665|NCT04013971|455631667|FG001|Overall Study|Missing biomechanical data|1|||
126637666|NCT02520310|455631670|FG000|At 6 Months Clinical Follow-up|Death|1|||
126637667|NCT02520310|455631670|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
126637668|NCT02520310|455631670|FG000|AT 3 Year Clinical Follow-up|Death|2|||
126637669|NCT02520310|455631670|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
126637670|NCT02520310|455631670|FG000|AT 4 Year Clinical Follow-up|Death|1|||
126637671|NCT02520310|455631670|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
126637672|NCT01340014|455631671|FG000|Period 1, First 7 Days|Adverse Event|1|||
126637673|NCT01340014|455631672|FG001|Period 1, First 7 Days|Adverse Event|0|||
126637674|NCT01340014|455631671|FG000|Period 1, First 7 Days|Personal Reasons|1|||
126637675|NCT01340014|455631672|FG001|Period 1, First 7 Days|Personal Reasons|0|||
126637676|NCT01340014|455631671|FG000|Period 2, Second 7 Days|Adverse Event|0|||
126637677|NCT01340014|455631672|FG001|Period 2, Second 7 Days|Adverse Event|1|||
126637678|NCT04535544|455631675|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
126637679|NCT04535544|455631676|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
126637680|NCT04535544|455631677|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
126637681|NCT04535544|455631678|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
126637682|NCT04535544|455631675|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
126637683|NCT04535544|455631676|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
126637684|NCT04535544|455631677|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
126637685|NCT04535544|455631678|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
126637686|NCT04535544|455631675|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
126637687|NCT04535544|455631676|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
126637688|NCT04535544|455631677|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
126637689|NCT04535544|455631678|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
126637690|NCT04535544|455631675|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
126637691|NCT04535544|455631676|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
126637692|NCT04535544|455631677|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
126637693|NCT04535544|455631678|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
126637694|NCT04535544|455631675|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
126637695|NCT04535544|455631676|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
126637696|NCT04535544|455631677|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
126637697|NCT04535544|455631678|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
126637698|NCT04535544|455631675|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
126637699|NCT04535544|455631676|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
126637700|NCT04535544|455631677|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
126637701|NCT04535544|455631678|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
126637702|NCT04535544|455631675|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
126637703|NCT04535544|455631676|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
126637704|NCT04535544|455631677|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
126637705|NCT04535544|455631678|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
126637706|NCT04535544|455631675|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
126637707|NCT04535544|455631676|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
126637708|NCT04535544|455631677|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
126637709|NCT04535544|455631678|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
126637710|NCT05131477|455631685|FG000|PART 1|Withdrawal by Subject|2|||
126637711|NCT05131477|455631686|FG001|PART 1|Withdrawal by Subject|9|||
126637712|NCT05131477|455631687|FG002|PART 1|Withdrawal by Subject|6|||
126637713|NCT05131477|455631688|FG003|PART 1|Withdrawal by Subject|2|||
126637714|NCT05131477|455631689|FG004|PART 1|Withdrawal by Subject|8|||
126637715|NCT05131477|455631690|FG005|PART 1|Withdrawal by Subject|0|||
126637716|NCT05131477|455631691|FG006|PART 1|Withdrawal by Subject|0|||
126637717|NCT05131477|455631692|FG007|PART 1|Withdrawal by Subject|0|||
126637718|NCT05131477|455631693|FG008|PART 1|Withdrawal by Subject|0|||
126637719|NCT05131477|455631694|FG009|PART 1|Withdrawal by Subject|0|||
126637720|NCT05131477|455631695|FG010|PART 1|Withdrawal by Subject|0|||
126637721|NCT05131477|455631696|FG011|PART 1|Withdrawal by Subject|0|||
126637722|NCT05131477|455631697|FG012|PART 1|Withdrawal by Subject|0|||
126637723|NCT05131477|455631698|FG013|PART 1|Withdrawal by Subject|0|||
126637724|NCT05131477|455631685|FG000|PART 1|Physician Decision|1|||
126637725|NCT05131477|455631686|FG001|PART 1|Physician Decision|0|||
126637726|NCT05131477|455631687|FG002|PART 1|Physician Decision|0|||
126637727|NCT05131477|455631688|FG003|PART 1|Physician Decision|0|||
126637728|NCT05131477|455631689|FG004|PART 1|Physician Decision|0|||
126637729|NCT05131477|455631690|FG005|PART 1|Physician Decision|0|||
126637730|NCT05131477|455631691|FG006|PART 1|Physician Decision|0|||
126637731|NCT05131477|455631692|FG007|PART 1|Physician Decision|0|||
126637732|NCT05131477|455631693|FG008|PART 1|Physician Decision|0|||
126637733|NCT05131477|455631694|FG009|PART 1|Physician Decision|0|||
126637734|NCT05131477|455631695|FG010|PART 1|Physician Decision|0|||
126637735|NCT05131477|455631696|FG011|PART 1|Physician Decision|0|||
126637736|NCT05131477|455631697|FG012|PART 1|Physician Decision|0|||
126637737|NCT05131477|455631698|FG013|PART 1|Physician Decision|0|||
126637738|NCT05131477|455631685|FG000|PART 1|Adverse Event|3|||
126637739|NCT05131477|455631686|FG001|PART 1|Adverse Event|5|||
126637740|NCT05131477|455631687|FG002|PART 1|Adverse Event|1|||
126637741|NCT05131477|455631688|FG003|PART 1|Adverse Event|6|||
126637742|NCT05131477|455631689|FG004|PART 1|Adverse Event|4|||
126637743|NCT05131477|455631690|FG005|PART 1|Adverse Event|0|||
126637744|NCT05131477|455631691|FG006|PART 1|Adverse Event|0|||
126637745|NCT05131477|455631692|FG007|PART 1|Adverse Event|0|||
126637746|NCT05131477|455631693|FG008|PART 1|Adverse Event|0|||
126637747|NCT05131477|455631694|FG009|PART 1|Adverse Event|0|||
126637748|NCT05131477|455631695|FG010|PART 1|Adverse Event|0|||
126637749|NCT05131477|455631696|FG011|PART 1|Adverse Event|0|||
126637750|NCT05131477|455631697|FG012|PART 1|Adverse Event|0|||
126637751|NCT05131477|455631698|FG013|PART 1|Adverse Event|0|||
126637752|NCT05131477|455631685|FG000|PART 1|unclassified|1|||
126637753|NCT05131477|455631686|FG001|PART 1|unclassified|1|||
126637754|NCT05131477|455631687|FG002|PART 1|unclassified|0|||
126637755|NCT05131477|455631688|FG003|PART 1|unclassified|0|||
126637756|NCT05131477|455631689|FG004|PART 1|unclassified|4|||
126637757|NCT05131477|455631690|FG005|PART 1|unclassified|0|||
126637758|NCT05131477|455631691|FG006|PART 1|unclassified|0|||
126637759|NCT05131477|455631692|FG007|PART 1|unclassified|0|||
126637760|NCT05131477|455631693|FG008|PART 1|unclassified|0|||
126637761|NCT05131477|455631694|FG009|PART 1|unclassified|0|||
126637762|NCT05131477|455631695|FG010|PART 1|unclassified|0|||
126637763|NCT05131477|455631696|FG011|PART 1|unclassified|0|||
126637764|NCT05131477|455631697|FG012|PART 1|unclassified|0|||
126637765|NCT05131477|455631698|FG013|PART 1|unclassified|0|||
126637766|NCT05131477|455631685|FG000|PART 1|Randomized and not treated|0|||
126637767|NCT05131477|455631686|FG001|PART 1|Randomized and not treated|0|||
126637768|NCT05131477|455631687|FG002|PART 1|Randomized and not treated|0|||
126637769|NCT05131477|455631688|FG003|PART 1|Randomized and not treated|1|||
126637770|NCT05131477|455631689|FG004|PART 1|Randomized and not treated|1|||
126637771|NCT05131477|455631690|FG005|PART 1|Randomized and not treated|0|||
126637772|NCT05131477|455631691|FG006|PART 1|Randomized and not treated|0|||
126637773|NCT05131477|455631692|FG007|PART 1|Randomized and not treated|0|||
126637774|NCT05131477|455631693|FG008|PART 1|Randomized and not treated|0|||
126637775|NCT05131477|455631694|FG009|PART 1|Randomized and not treated|0|||
126637776|NCT05131477|455631695|FG010|PART 1|Randomized and not treated|0|||
126637777|NCT05131477|455631696|FG011|PART 1|Randomized and not treated|0|||
126637778|NCT05131477|455631697|FG012|PART 1|Randomized and not treated|0|||
126637779|NCT05131477|455631698|FG013|PART 1|Randomized and not treated|0|||
126637780|NCT05131477|455631685|FG000|PART 1|Protocol Violation|2|||
126637781|NCT05131477|455631686|FG001|PART 1|Protocol Violation|0|||
126637782|NCT05131477|455631687|FG002|PART 1|Protocol Violation|0|||
126637783|NCT05131477|455631688|FG003|PART 1|Protocol Violation|1|||
126637784|NCT05131477|455631689|FG004|PART 1|Protocol Violation|0|||
126637785|NCT05131477|455631690|FG005|PART 1|Protocol Violation|0|||
126637786|NCT05131477|455631691|FG006|PART 1|Protocol Violation|0|||
126637787|NCT05131477|455631692|FG007|PART 1|Protocol Violation|0|||
126637788|NCT05131477|455631693|FG008|PART 1|Protocol Violation|0|||
126637789|NCT05131477|455631694|FG009|PART 1|Protocol Violation|0|||
126637790|NCT05131477|455631695|FG010|PART 1|Protocol Violation|0|||
126637791|NCT05131477|455631696|FG011|PART 1|Protocol Violation|0|||
126637792|NCT05131477|455631697|FG012|PART 1|Protocol Violation|0|||
126637793|NCT05131477|455631698|FG013|PART 1|Protocol Violation|0|||
126637794|NCT05131477|455631685|FG000|PART 1|Lack of Efficacy|0|||
126637795|NCT05131477|455631686|FG001|PART 1|Lack of Efficacy|1|||
126637796|NCT05131477|455631687|FG002|PART 1|Lack of Efficacy|1|||
126637797|NCT05131477|455631688|FG003|PART 1|Lack of Efficacy|2|||
126637798|NCT05131477|455631689|FG004|PART 1|Lack of Efficacy|5|||
126637799|NCT05131477|455631690|FG005|PART 1|Lack of Efficacy|0|||
126637800|NCT05131477|455631691|FG006|PART 1|Lack of Efficacy|0|||
126637801|NCT05131477|455631692|FG007|PART 1|Lack of Efficacy|0|||
126637802|NCT05131477|455631693|FG008|PART 1|Lack of Efficacy|0|||
126637803|NCT05131477|455631694|FG009|PART 1|Lack of Efficacy|0|||
126637804|NCT05131477|455631695|FG010|PART 1|Lack of Efficacy|0|||
126637805|NCT05131477|455631696|FG011|PART 1|Lack of Efficacy|0|||
126637806|NCT05131477|455631697|FG012|PART 1|Lack of Efficacy|0|||
126637807|NCT05131477|455631698|FG013|PART 1|Lack of Efficacy|0|||
126637808|NCT05131477|455631685|FG000|PART 2|Withdrawal by Subject|0|||
126637809|NCT05131477|455631686|FG001|PART 2|Withdrawal by Subject|0|||
126637810|NCT05131477|455631687|FG002|PART 2|Withdrawal by Subject|0|||
126637811|NCT05131477|455631688|FG003|PART 2|Withdrawal by Subject|0|||
126637812|NCT05131477|455631689|FG004|PART 2|Withdrawal by Subject|0|||
126637813|NCT05131477|455631690|FG005|PART 2|Withdrawal by Subject|0|||
126637814|NCT05131477|455631691|FG006|PART 2|Withdrawal by Subject|2|||
126637815|NCT05131477|455631692|FG007|PART 2|Withdrawal by Subject|0|||
126637816|NCT05131477|455631693|FG008|PART 2|Withdrawal by Subject|0|||
126637817|NCT05131477|455631694|FG009|PART 2|Withdrawal by Subject|0|||
126637818|NCT05131477|455631695|FG010|PART 2|Withdrawal by Subject|2|||
126637819|NCT05131477|455631696|FG011|PART 2|Withdrawal by Subject|0|||
126637820|NCT05131477|455631697|FG012|PART 2|Withdrawal by Subject|2|||
126637821|NCT05131477|455631698|FG013|PART 2|Withdrawal by Subject|2|||
126637822|NCT05131477|455631685|FG000|PART 2|Other|0|||
126637823|NCT05131477|455631686|FG001|PART 2|Other|0|||
126637824|NCT05131477|455631687|FG002|PART 2|Other|0|||
126637825|NCT05131477|455631688|FG003|PART 2|Other|0|||
126637826|NCT05131477|455631689|FG004|PART 2|Other|0|||
126637827|NCT05131477|455631690|FG005|PART 2|Other|0|||
126637828|NCT05131477|455631691|FG006|PART 2|Other|0|||
126637829|NCT05131477|455631692|FG007|PART 2|Other|0|||
126637830|NCT05131477|455631693|FG008|PART 2|Other|1|||
126637831|NCT05131477|455631694|FG009|PART 2|Other|1|||
126637832|NCT05131477|455631695|FG010|PART 2|Other|0|||
126637833|NCT05131477|455631696|FG011|PART 2|Other|0|||
126637834|NCT05131477|455631697|FG012|PART 2|Other|1|||
126637835|NCT05131477|455631698|FG013|PART 2|Other|0|||
126637836|NCT05131477|455631685|FG000|PART 2|Lack of Efficacy|0|||
126637837|NCT05131477|455631686|FG001|PART 2|Lack of Efficacy|0|||
126637838|NCT05131477|455631687|FG002|PART 2|Lack of Efficacy|0|||
126637839|NCT05131477|455631688|FG003|PART 2|Lack of Efficacy|0|||
126637840|NCT05131477|455631689|FG004|PART 2|Lack of Efficacy|0|||
126637841|NCT05131477|455631690|FG005|PART 2|Lack of Efficacy|1|||
126637842|NCT05131477|455631691|FG006|PART 2|Lack of Efficacy|1|||
126637843|NCT05131477|455631692|FG007|PART 2|Lack of Efficacy|0|||
126637844|NCT05131477|455631693|FG008|PART 2|Lack of Efficacy|3|||
126637845|NCT05131477|455631694|FG009|PART 2|Lack of Efficacy|0|||
126637846|NCT05131477|455631695|FG010|PART 2|Lack of Efficacy|1|||
126637847|NCT05131477|455631696|FG011|PART 2|Lack of Efficacy|0|||
126637848|NCT05131477|455631697|FG012|PART 2|Lack of Efficacy|2|||
126637849|NCT05131477|455631698|FG013|PART 2|Lack of Efficacy|0|||
126637850|NCT05131477|455631685|FG000|PART 2|Unclassified|0|||
126637851|NCT05131477|455631686|FG001|PART 2|Unclassified|0|||
126637852|NCT05131477|455631687|FG002|PART 2|Unclassified|0|||
126637853|NCT05131477|455631688|FG003|PART 2|Unclassified|0|||
126637854|NCT05131477|455631689|FG004|PART 2|Unclassified|0|||
126637855|NCT05131477|455631690|FG005|PART 2|Unclassified|0|||
126637856|NCT05131477|455631691|FG006|PART 2|Unclassified|0|||
126637857|NCT05131477|455631692|FG007|PART 2|Unclassified|0|||
126637858|NCT05131477|455631693|FG008|PART 2|Unclassified|0|||
126637859|NCT05131477|455631694|FG009|PART 2|Unclassified|0|||
126637860|NCT05131477|455631695|FG010|PART 2|Unclassified|1|||
126637861|NCT05131477|455631696|FG011|PART 2|Unclassified|0|||
126637862|NCT05131477|455631697|FG012|PART 2|Unclassified|0|||
126637863|NCT05131477|455631698|FG013|PART 2|Unclassified|0|||
126637864|NCT05131477|455631685|FG000|PART 2|Re-randomized and not treated|0|||
126637865|NCT05131477|455631686|FG001|PART 2|Re-randomized and not treated|0|||
126637866|NCT05131477|455631687|FG002|PART 2|Re-randomized and not treated|0|||
126637867|NCT05131477|455631688|FG003|PART 2|Re-randomized and not treated|0|||
126637868|NCT05131477|455631689|FG004|PART 2|Re-randomized and not treated|0|||
126637869|NCT05131477|455631690|FG005|PART 2|Re-randomized and not treated|0|||
126637870|NCT05131477|455631691|FG006|PART 2|Re-randomized and not treated|0|||
126637871|NCT05131477|455631692|FG007|PART 2|Re-randomized and not treated|1|||
126637872|NCT05131477|455631693|FG008|PART 2|Re-randomized and not treated|0|||
126637873|NCT05131477|455631694|FG009|PART 2|Re-randomized and not treated|0|||
126637874|NCT05131477|455631695|FG010|PART 2|Re-randomized and not treated|1|||
126637875|NCT05131477|455631696|FG011|PART 2|Re-randomized and not treated|0|||
126637876|NCT05131477|455631697|FG012|PART 2|Re-randomized and not treated|1|||
126637877|NCT05131477|455631698|FG013|PART 2|Re-randomized and not treated|1|||
126637878|NCT02194829|455631699|FG000|Overall Study|Adverse Event|2|||
126637879|NCT02194829|455631700|FG001|Overall Study|Adverse Event|2|||
126637880|NCT02194829|455631699|FG000|Overall Study|Death|0|||
126637881|NCT02194829|455631700|FG001|Overall Study|Death|1|||
126637882|NCT02194829|455631699|FG000|Overall Study|Disease progression|0|||
126637883|NCT02194829|455631700|FG001|Overall Study|Disease progression|1|||
126637884|NCT02194829|455631699|FG000|Overall Study|Withdrawal by Subject|0|||
126637885|NCT02194829|455631700|FG001|Overall Study|Withdrawal by Subject|1|||
126637886|NCT02194829|455631699|FG000|Overall Study|Never started protocol therapy|0|||
126637887|NCT02194829|455631700|FG001|Overall Study|Never started protocol therapy|1|||
126637888|NCT05101993|455631703|FG000|Overall Study|Withdrawal by Subject|1|||
126637889|NCT04577573|455631704|FG000|Overall Study|Technical - invalid protocol|0|||
126637890|NCT04577573|455631705|FG001|Overall Study|Technical - invalid protocol|2|||
126637891|NCT04577573|455631706|FG002|Overall Study|Technical - invalid protocol|0|||
126637892|NCT01124838|455631707|FG000|Overall Study|Miscellaneous|4|||
126637893|NCT01124838|455631708|FG001|Overall Study|Miscellaneous|2|||
126637894|NCT01124838|455631707|FG000|Overall Study|Adverse Event|7|||
126637895|NCT01124838|455631708|FG001|Overall Study|Adverse Event|11|||
126637896|NCT01124838|455631707|FG000|Overall Study|Lack of Efficacy|2|||
126637897|NCT01124838|455631708|FG001|Overall Study|Lack of Efficacy|0|||
126637898|NCT01124838|455631707|FG000|Overall Study|Withdrawal by Subject|3|||
126637899|NCT01124838|455631708|FG001|Overall Study|Withdrawal by Subject|2|||
126637900|NCT01124838|455631707|FG000|Overall Study|Lost to Follow-up|2|||
126637901|NCT01124838|455631708|FG001|Overall Study|Lost to Follow-up|0|||
126637902|NCT04297618|455631709|FG000|Overall Study|Adverse Event|1|||
126637903|NCT04297618|455631709|FG000|Overall Study|Withdrawal by Subject|1|||
126637904|NCT02172911|455633089|FG000|Overall Study|Serious Adverse Event|0|||
126637905|NCT02172911|455633090|FG001|Overall Study|Serious Adverse Event|1|||
126637906|NCT02172911|455633089|FG000|Overall Study|Progression of Disease|0|||
126637907|NCT02172911|455633090|FG001|Overall Study|Progression of Disease|1|||
126637908|NCT02172911|455633089|FG000|Overall Study|Loss of insurance coverage|1|||
126637909|NCT02172911|455633090|FG001|Overall Study|Loss of insurance coverage|0|||
126637910|NCT01367847|455633091|FG000|Overall Study|Withdrawal by Subject|2|||
126637911|NCT01367847|455633092|FG001|Overall Study|Withdrawal by Subject|2|||
126637912|NCT00953147|455633093|FG000|Overall Study|Adverse Event|8|||
126637913|NCT00953147|455633094|FG001|Overall Study|Adverse Event|16|||
126637914|NCT00953147|455633095|FG002|Overall Study|Adverse Event|6|||
126637915|NCT00953147|455633093|FG000|Overall Study|Protocol Violation|2|||
126637916|NCT00953147|455633094|FG001|Overall Study|Protocol Violation|8|||
126637917|NCT00953147|455633095|FG002|Overall Study|Protocol Violation|4|||
126637918|NCT00953147|455633093|FG000|Overall Study|Withdrawal by Subject|13|||
126637919|NCT00953147|455633094|FG001|Overall Study|Withdrawal by Subject|15|||
126637920|NCT00953147|455633095|FG002|Overall Study|Withdrawal by Subject|12|||
126637921|NCT00953147|455633093|FG000|Overall Study|Lost to Follow-up|8|||
126637922|NCT00953147|455633094|FG001|Overall Study|Lost to Follow-up|9|||
126637923|NCT00953147|455633095|FG002|Overall Study|Lost to Follow-up|4|||
126637924|NCT00953147|455633093|FG000|Overall Study|Physician Decision|2|||
126637925|NCT00953147|455633094|FG001|Overall Study|Physician Decision|7|||
126637926|NCT00953147|455633095|FG002|Overall Study|Physician Decision|3|||
126637927|NCT00953147|455633093|FG000|Overall Study|Other|4|||
126637928|NCT00953147|455633094|FG001|Overall Study|Other|11|||
126637929|NCT00953147|455633095|FG002|Overall Study|Other|13|||
126637930|NCT00078338|455633096|FG000|Overall Study|Adverse Event|31|||
126637931|NCT00078338|455633097|FG001|Overall Study|Adverse Event|24|||
126637932|NCT00078338|455633096|FG000|Overall Study|Lost to Follow-up|17|||
126637933|NCT00078338|455633097|FG001|Overall Study|Lost to Follow-up|2|||
126637934|NCT00078338|455633096|FG000|Overall Study|Protocol Violation|2|||
126637935|NCT00078338|455633097|FG001|Overall Study|Protocol Violation|2|||
126637936|NCT00078338|455633096|FG000|Overall Study|Disease Progression|4|||
126637937|NCT00078338|455633097|FG001|Overall Study|Disease Progression|7|||
126637938|NCT00078338|455633096|FG000|Overall Study|Other|28|||
126637939|NCT00078338|455633097|FG001|Overall Study|Other|16|||
126637940|NCT00078338|455633096|FG000|Overall Study|Subjects randomized, but not treated|3|||
126637941|NCT00078338|455633097|FG001|Overall Study|Subjects randomized, but not treated|3|||
126637942|NCT03258723|455633098|FG000|Overall Study|COVID Interruption of study|54|||
126637943|NCT03258723|455633098|FG000|Overall Study|Lost to Follow-up|8|||
126637944|NCT00592293|455633102|FG000|Overall Study|Withdrawal by Subject|1|||
126637945|NCT01606319|455633103|FG000|Overall Study|Lost to Follow-up|17|||
126637946|NCT01606319|455633104|FG001|Overall Study|Lost to Follow-up|14|||
126637947|NCT01606319|455633103|FG000|Overall Study|Withdrawal by Subject|9|||
126637948|NCT01606319|455633104|FG001|Overall Study|Withdrawal by Subject|12|||
126637949|NCT01606319|455633103|FG000|Overall Study|Physician Decision|1|||
126637950|NCT01606319|455633104|FG001|Overall Study|Physician Decision|2|||
126637951|NCT01606319|455633103|FG000|Overall Study|Lack of Efficacy|6|||
126637952|NCT01606319|455633104|FG001|Overall Study|Lack of Efficacy|8|||
126637953|NCT01606319|455633103|FG000|Overall Study|Adverse Event|1|||
126637954|NCT01606319|455633104|FG001|Overall Study|Adverse Event|4|||
126637955|NCT01784523|455633107|FG000|Overall Study|Study closed early|7|||
126637956|NCT01784523|455633108|FG001|Overall Study|Study closed early|4|||
126637957|NCT04340947|455633109|FG000|7-day Washout Period|Lost to Follow-up|5|||
126637958|NCT04340947|455633110|FG001|7-day Washout Period|Lost to Follow-up|4|||
126637959|NCT01124097|455633115|FG000|Overall Study|Withdrawal by Subject|4|||
126637960|NCT01124097|455633116|FG001|Overall Study|Withdrawal by Subject|3|||
126637961|NCT01124097|455633117|FG002|Overall Study|Withdrawal by Subject|2|||
126637962|NCT01124097|455633118|FG003|Overall Study|Withdrawal by Subject|3|||
126637963|NCT01124097|455633115|FG000|Overall Study|Lack of Efficacy|2|||
126637964|NCT01124097|455633116|FG001|Overall Study|Lack of Efficacy|3|||
126637965|NCT01124097|455633117|FG002|Overall Study|Lack of Efficacy|1|||
126637966|NCT01124097|455633118|FG003|Overall Study|Lack of Efficacy|3|||
126637967|NCT01124097|455633115|FG000|Overall Study|Adverse Event|24|||
126637968|NCT01124097|455633116|FG001|Overall Study|Adverse Event|15|||
126637969|NCT01124097|455633117|FG002|Overall Study|Adverse Event|15|||
126637970|NCT01124097|455633118|FG003|Overall Study|Adverse Event|7|||
126637971|NCT01124097|455633115|FG000|Overall Study|Protocol Violation|2|||
126637972|NCT01124097|455633116|FG001|Overall Study|Protocol Violation|0|||
126637973|NCT01124097|455633117|FG002|Overall Study|Protocol Violation|2|||
126637974|NCT01124097|455633118|FG003|Overall Study|Protocol Violation|1|||
126637975|NCT01124097|455633115|FG000|Overall Study|Physician Decision|2|||
126637976|NCT01124097|455633116|FG001|Overall Study|Physician Decision|1|||
126637977|NCT01124097|455633117|FG002|Overall Study|Physician Decision|0|||
126637978|NCT01124097|455633118|FG003|Overall Study|Physician Decision|0|||
126637979|NCT01821937|455633119|FG000|Overall Study|Adverse Event|0|||
126637980|NCT01821937|455633120|FG001|Overall Study|Adverse Event|3|||
126637981|NCT00193479|455633121|FG000|Induction Chemotherapy|Adverse Event|2|||
126637982|NCT00193479|455633121|FG000|Induction Chemotherapy|Disease Progression|1|||
126637983|NCT00193479|455633121|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
126637984|NCT00193479|455633121|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
126637985|NCT02030002|455633122|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
126637986|NCT02030002|455633122|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
126637987|NCT02030002|455633122|FG000|Follow-up|Lost to Follow-up|2|||
126637988|NCT00609947|455633123|FG000|Overall Study|Death|1|||
126637989|NCT01304498|455633124|FG000|Overall Study|Adverse Event|1|||
126637990|NCT01304498|455633125|FG001|Overall Study|Adverse Event|1|||
126637991|NCT01304498|455633124|FG000|Overall Study|Withdrawal by Subject|2|||
126637992|NCT01304498|455633125|FG001|Overall Study|Withdrawal by Subject|3|||
126637993|NCT01304498|455633124|FG000|Overall Study|Protocol Violation|1|||
126637994|NCT01304498|455633125|FG001|Overall Study|Protocol Violation|0|||
126637995|NCT01304498|455633124|FG000|Overall Study|Lost to Follow-up|2|||
126637996|NCT01304498|455633125|FG001|Overall Study|Lost to Follow-up|1|||
126637997|NCT01834586|455633127|FG000|Overall Study|Adverse Event|1|||
126637998|NCT01667549|455633128|FG000|Overall Study|Withdrawal by Subject|3|||
126637999|NCT01667549|455633129|FG001|Overall Study|Withdrawal by Subject|5|||
126638000|NCT01667549|455633130|FG002|Overall Study|Withdrawal by Subject|7|||
126638001|NCT01667549|455633131|FG003|Overall Study|Withdrawal by Subject|6|||
126638002|NCT01667549|455633132|FG004|Overall Study|Withdrawal by Subject|1|||
126638003|NCT04210843|455633133|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
126638004|NCT04210843|455633134|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
126638005|NCT04210843|455633133|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
126638006|NCT04210843|455633134|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
126638007|NCT04210843|455633133|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
126638008|NCT04210843|455633134|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
126638009|NCT04210843|455633133|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
126638010|NCT04210843|455633134|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
126638011|NCT04210843|455633133|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
126638012|NCT04210843|455633134|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
126638013|NCT04210843|455633133|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
126638014|NCT04210843|455633134|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
126638015|NCT04210843|455633133|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
126638016|NCT04210843|455633134|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
126638017|NCT04210843|455633133|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
126638018|NCT04210843|455633134|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
126638019|NCT04210843|455633133|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
126638020|NCT04210843|455633134|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
126638021|NCT04210843|455633133|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
126638022|NCT04210843|455633134|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
126638023|NCT04210843|455633133|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
126638024|NCT04210843|455633134|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
126638025|NCT04210843|455633133|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
126638026|NCT04210843|455633134|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
126638027|NCT04210843|455633133|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
126638028|NCT04210843|455633134|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
126638029|NCT04210843|455633133|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
126638030|NCT04210843|455633134|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
126638031|NCT04210843|455633133|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
126638032|NCT04210843|455633134|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
126638033|NCT04210843|455633133|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
126638034|NCT04210843|455633134|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
126638035|NCT04210843|455633133|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
126638036|NCT04210843|455633134|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
126638037|NCT04210843|455633133|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
126638038|NCT04210843|455633134|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
126638039|NCT04210843|455633133|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
126638040|NCT04210843|455633134|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
126638041|NCT04210843|455633133|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
126638042|NCT04210843|455633134|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
126638043|NCT04210843|455633133|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
126638044|NCT04210843|455633134|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
126638045|NCT04210843|455633133|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
126638046|NCT04210843|455633134|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
126638047|NCT04210843|455633133|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
126638048|NCT04210843|455633134|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
126638049|NCT04210843|455633133|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
126638050|NCT04210843|455633134|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
126638051|NCT02844777|455633135|FG000|Overall Study|Withdrawal by Subject|2|||
126638052|NCT02844777|455633136|FG001|Overall Study|Withdrawal by Subject|0|||
126638053|NCT02844777|455633137|FG002|Overall Study|Withdrawal by Subject|0|||
126638054|NCT00150618|455633138|FG000|Overall Study|Adverse Event|2|||
126638055|NCT00150618|455633139|FG001|Overall Study|Adverse Event|2|||
126638056|NCT00150618|455633140|FG002|Overall Study|Adverse Event|6|||
126638057|NCT00150618|455633141|FG003|Overall Study|Adverse Event|9|||
126638058|NCT00150618|455633142|FG004|Overall Study|Adverse Event|5|||
126638059|NCT00150618|455633138|FG000|Overall Study|Withdrawal by Subject|6|||
126638060|NCT00150618|455633139|FG001|Overall Study|Withdrawal by Subject|8|||
126638061|NCT00150618|455633140|FG002|Overall Study|Withdrawal by Subject|8|||
126638062|NCT00150618|455633141|FG003|Overall Study|Withdrawal by Subject|4|||
126638063|NCT00150618|455633142|FG004|Overall Study|Withdrawal by Subject|5|||
126638064|NCT00150618|455633138|FG000|Overall Study|Lost to Follow-up|4|||
126638065|NCT00150618|455633139|FG001|Overall Study|Lost to Follow-up|1|||
126638066|NCT00150618|455633140|FG002|Overall Study|Lost to Follow-up|5|||
126638067|NCT00150618|455633141|FG003|Overall Study|Lost to Follow-up|8|||
126638068|NCT00150618|455633142|FG004|Overall Study|Lost to Follow-up|4|||
126638069|NCT00150618|455633138|FG000|Overall Study|Protocol Violation|1|||
126638070|NCT00150618|455633139|FG001|Overall Study|Protocol Violation|0|||
126638071|NCT00150618|455633140|FG002|Overall Study|Protocol Violation|0|||
126638072|NCT00150618|455633141|FG003|Overall Study|Protocol Violation|0|||
126638073|NCT00150618|455633142|FG004|Overall Study|Protocol Violation|1|||
126638074|NCT00150618|455633138|FG000|Overall Study|Lack of Efficacy|1|||
126638075|NCT00150618|455633139|FG001|Overall Study|Lack of Efficacy|4|||
126638076|NCT00150618|455633140|FG002|Overall Study|Lack of Efficacy|7|||
126638077|NCT00150618|455633141|FG003|Overall Study|Lack of Efficacy|4|||
126638078|NCT00150618|455633142|FG004|Overall Study|Lack of Efficacy|6|||
126638079|NCT00150618|455633138|FG000|Overall Study|No study meds|0|||
126638080|NCT00150618|455633139|FG001|Overall Study|No study meds|0|||
126638081|NCT00150618|455633140|FG002|Overall Study|No study meds|0|||
126638082|NCT00150618|455633141|FG003|Overall Study|No study meds|0|||
126638083|NCT00150618|455633142|FG004|Overall Study|No study meds|2|||
126638084|NCT00150618|455633138|FG000|Overall Study|Physician Decision|0|||
126638085|NCT00150618|455633139|FG001|Overall Study|Physician Decision|2|||
126638086|NCT00150618|455633140|FG002|Overall Study|Physician Decision|0|||
126638087|NCT00150618|455633141|FG003|Overall Study|Physician Decision|0|||
126638088|NCT00150618|455633142|FG004|Overall Study|Physician Decision|1|||
126638089|NCT00150618|455633138|FG000|Overall Study|Lack of compliance|2|||
126638090|NCT00150618|455633139|FG001|Overall Study|Lack of compliance|1|||
126638091|NCT00150618|455633140|FG002|Overall Study|Lack of compliance|1|||
126638092|NCT00150618|455633141|FG003|Overall Study|Lack of compliance|0|||
126638093|NCT00150618|455633142|FG004|Overall Study|Lack of compliance|1|||
126638094|NCT00150618|455633138|FG000|Overall Study|Abnormal ECG|1|||
126638095|NCT00150618|455633139|FG001|Overall Study|Abnormal ECG|0|||
126638096|NCT00150618|455633140|FG002|Overall Study|Abnormal ECG|0|||
126638097|NCT00150618|455633141|FG003|Overall Study|Abnormal ECG|0|||
126638098|NCT00150618|455633142|FG004|Overall Study|Abnormal ECG|0|||
126638099|NCT00150618|455633138|FG000|Overall Study|Sponsor's decision|0|||
126638100|NCT00150618|455633139|FG001|Overall Study|Sponsor's decision|0|||
126638101|NCT00150618|455633140|FG002|Overall Study|Sponsor's decision|0|||
126638102|NCT00150618|455633141|FG003|Overall Study|Sponsor's decision|1|||
126638103|NCT00150618|455633142|FG004|Overall Study|Sponsor's decision|0|||
126638104|NCT01012947|455633143|FG000|Overall Study|Lost to Follow-up|131|||
126638105|NCT01012947|455633144|FG001|Overall Study|Lost to Follow-up|135|||
126638106|NCT01012947|455633145|FG002|Overall Study|Lost to Follow-up|130|||
126638107|NCT01012947|455633146|FG003|Overall Study|Lost to Follow-up|118|||
126638108|NCT01012947|455633147|FG004|Overall Study|Lost to Follow-up|142|||
126638109|NCT01791413|455633148|FG000|Overall Study|Lost to Follow-up|5|||
126638110|NCT01791413|455633149|FG001|Overall Study|Lost to Follow-up|1|||
126638111|NCT00825305|455633150|FG000|Overall Study|Adverse Event|1|||
126638112|NCT00825305|455633151|FG001|Overall Study|Adverse Event|1|||
126638113|NCT00825305|455633150|FG000|Overall Study|Withdrawal by Subject|6|||
126638114|NCT00825305|455633151|FG001|Overall Study|Withdrawal by Subject|12|||
126638115|NCT00825305|455633150|FG000|Overall Study|Inappropriate inclusion|1|||
126638116|NCT00825305|455633151|FG001|Overall Study|Inappropriate inclusion|0|||
126638117|NCT00825305|455633150|FG000|Overall Study|Protocol Violation|9|||
126638118|NCT00825305|455633151|FG001|Overall Study|Protocol Violation|9|||
126638119|NCT00825305|455633150|FG000|Overall Study|Can not be classified|0|||
126638120|NCT00825305|455633151|FG001|Overall Study|Can not be classified|1|||
126638121|NCT04016272|455633152|FG000|Overall Study|Withdrawal by Subject|1|||
126638122|NCT04016272|455633153|FG001|Overall Study|Withdrawal by Subject|2|||
126638123|NCT02493946|455633156|FG000|DB Period|Withdrawal by Subject|8|||
126638124|NCT02493946|455633157|FG001|DB Period|Withdrawal by Subject|5|||
126638125|NCT02493946|455633158|FG002|DB Period|Withdrawal by Subject|0|||
126638126|NCT02493946|455633156|FG000|Open Label Period|Withdrawal by Subject|0|||
126638127|NCT02493946|455633157|FG001|Open Label Period|Withdrawal by Subject|0|||
126638128|NCT02493946|455633158|FG002|Open Label Period|Withdrawal by Subject|74|||
126638129|NCT02493946|455633156|FG000|Open Label Period|Adverse Event|0|||
126638130|NCT02493946|455633157|FG001|Open Label Period|Adverse Event|0|||
126638131|NCT02493946|455633158|FG002|Open Label Period|Adverse Event|4|||
126638132|NCT02493946|455633156|FG000|Open Label Period|Lost to Follow-up|0|||
126638133|NCT02493946|455633157|FG001|Open Label Period|Lost to Follow-up|0|||
126638134|NCT02493946|455633158|FG002|Open Label Period|Lost to Follow-up|1|||
126638135|NCT02493946|455633156|FG000|Open Label Period|Investigator decision, non-compliance|0|||
126638136|NCT02493946|455633157|FG001|Open Label Period|Investigator decision, non-compliance|0|||
126638137|NCT02493946|455633158|FG002|Open Label Period|Investigator decision, non-compliance|2|||
126638138|NCT02493946|455633156|FG000|Open Label Period|Investigator decision, non-availability|0|||
126638139|NCT02493946|455633157|FG001|Open Label Period|Investigator decision, non-availability|0|||
126638140|NCT02493946|455633158|FG002|Open Label Period|Investigator decision, non-availability|1|||
126638141|NCT02493946|455633156|FG000|Open Label Period|Pregnancy|0|||
126638142|NCT02493946|455633157|FG001|Open Label Period|Pregnancy|0|||
126638143|NCT02493946|455633158|FG002|Open Label Period|Pregnancy|3|||
126638144|NCT02493946|455633156|FG000|Open Label Period|Site error|0|||
126638145|NCT02493946|455633157|FG001|Open Label Period|Site error|0|||
126638146|NCT02493946|455633158|FG002|Open Label Period|Site error|1|||
126638147|NCT01727505|455633160|FG000|First 24 Hours|Adverse Event|0|||
126638148|NCT01727505|455633161|FG001|First 24 Hours|Adverse Event|1|||
126638149|NCT01727505|455633160|FG000|Second 24 Hours|Missing data|0|||
126638150|NCT01727505|455633161|FG001|Second 24 Hours|Missing data|1|||
126638151|NCT02878603|455633162|FG000|Overall Study|Lost to Follow-up|4|||
126638152|NCT02878603|455633163|FG001|Overall Study|Lost to Follow-up|1|||
126638153|NCT02878603|455633162|FG000|Overall Study|Withdrawal by Subject|1|||
126638154|NCT02878603|455633163|FG001|Overall Study|Withdrawal by Subject|1|||
126638155|NCT02878603|455633162|FG000|Overall Study|Death|1|||
126638156|NCT02878603|455633163|FG001|Overall Study|Death|0|||
126638157|NCT02878603|455633162|FG000|Overall Study|Physician Decision|0|||
126638158|NCT02878603|455633163|FG001|Overall Study|Physician Decision|3|||
126638159|NCT01814072|455633169|FG000|Overall Study|Lost to Follow-up|2|||
126638160|NCT01814072|455633170|FG001|Overall Study|Lost to Follow-up|2|||
126638161|NCT01814072|455633171|FG002|Overall Study|Lost to Follow-up|2|||
126638162|NCT01814072|455633172|FG003|Overall Study|Lost to Follow-up|0|||
126638163|NCT01814072|455633173|FG004|Overall Study|Lost to Follow-up|2|||
126638164|NCT01814072|455633174|FG005|Overall Study|Lost to Follow-up|3|||
126638165|NCT01814072|455633175|FG006|Overall Study|Lost to Follow-up|3|||
126638166|NCT01814072|455633176|FG007|Overall Study|Lost to Follow-up|1|||
126638167|NCT01814072|455633177|FG008|Overall Study|Lost to Follow-up|2|||
126638168|NCT01814072|455633178|FG009|Overall Study|Lost to Follow-up|3|||
126638169|NCT01814072|455633179|FG010|Overall Study|Lost to Follow-up|1|||
126638170|NCT01814072|455633180|FG011|Overall Study|Lost to Follow-up|2|||
126638171|NCT01814072|455633181|FG012|Overall Study|Lost to Follow-up|2|||
126638172|NCT01814072|455633182|FG013|Overall Study|Lost to Follow-up|1|||
126638173|NCT01814072|455633183|FG014|Overall Study|Lost to Follow-up|2|||
126638174|NCT01814072|455633184|FG015|Overall Study|Lost to Follow-up|1|||
126638175|NCT01814072|455633185|FG016|Overall Study|Lost to Follow-up|3|||
126638176|NCT01814072|455633186|FG017|Overall Study|Lost to Follow-up|1|||
126638177|NCT01814072|455633187|FG018|Overall Study|Lost to Follow-up|3|||
126638178|NCT01814072|455633188|FG019|Overall Study|Lost to Follow-up|3|||
126638179|NCT01814072|455633189|FG020|Overall Study|Lost to Follow-up|2|||
126638180|NCT01814072|455633190|FG021|Overall Study|Lost to Follow-up|1|||
126638181|NCT01814072|455633191|FG022|Overall Study|Lost to Follow-up|3|||
126638182|NCT01814072|455633192|FG023|Overall Study|Lost to Follow-up|1|||
126638183|NCT01814072|455633193|FG024|Overall Study|Lost to Follow-up|4|||
126638184|NCT01814072|455633194|FG025|Overall Study|Lost to Follow-up|1|||
126638185|NCT01814072|455633195|FG026|Overall Study|Lost to Follow-up|1|||
126638186|NCT01814072|455633196|FG027|Overall Study|Lost to Follow-up|2|||
126638187|NCT01814072|455633197|FG028|Overall Study|Lost to Follow-up|3|||
126638188|NCT01814072|455633198|FG029|Overall Study|Lost to Follow-up|3|||
126638189|NCT01814072|455633199|FG030|Overall Study|Lost to Follow-up|2|||
126638190|NCT01814072|455633200|FG031|Overall Study|Lost to Follow-up|0|||
126638191|NCT01814072|455633169|FG000|Overall Study|Withdrawal by Subject|2|||
126638192|NCT01814072|455633170|FG001|Overall Study|Withdrawal by Subject|0|||
126638193|NCT01814072|455633171|FG002|Overall Study|Withdrawal by Subject|1|||
126638194|NCT01814072|455633172|FG003|Overall Study|Withdrawal by Subject|0|||
126638195|NCT01814072|455633173|FG004|Overall Study|Withdrawal by Subject|2|||
126638196|NCT01814072|455633174|FG005|Overall Study|Withdrawal by Subject|3|||
126638197|NCT01814072|455633175|FG006|Overall Study|Withdrawal by Subject|1|||
126638198|NCT01814072|455633176|FG007|Overall Study|Withdrawal by Subject|0|||
126638199|NCT01814072|455633177|FG008|Overall Study|Withdrawal by Subject|1|||
126638200|NCT01814072|455633178|FG009|Overall Study|Withdrawal by Subject|2|||
126638201|NCT01814072|455633179|FG010|Overall Study|Withdrawal by Subject|0|||
126638202|NCT01814072|455633180|FG011|Overall Study|Withdrawal by Subject|0|||
126638203|NCT01814072|455633181|FG012|Overall Study|Withdrawal by Subject|1|||
126638204|NCT01814072|455633182|FG013|Overall Study|Withdrawal by Subject|1|||
126638205|NCT01814072|455633183|FG014|Overall Study|Withdrawal by Subject|1|||
126638206|NCT01814072|455633184|FG015|Overall Study|Withdrawal by Subject|1|||
126638207|NCT01814072|455633185|FG016|Overall Study|Withdrawal by Subject|0|||
126638208|NCT01814072|455633186|FG017|Overall Study|Withdrawal by Subject|0|||
126638209|NCT01814072|455633187|FG018|Overall Study|Withdrawal by Subject|0|||
126638210|NCT01814072|455633188|FG019|Overall Study|Withdrawal by Subject|2|||
126638211|NCT01814072|455633189|FG020|Overall Study|Withdrawal by Subject|0|||
126638212|NCT01814072|455633190|FG021|Overall Study|Withdrawal by Subject|0|||
126638213|NCT01814072|455633191|FG022|Overall Study|Withdrawal by Subject|1|||
126638214|NCT01814072|455633192|FG023|Overall Study|Withdrawal by Subject|0|||
126638215|NCT01814072|455633193|FG024|Overall Study|Withdrawal by Subject|2|||
126638216|NCT01814072|455633194|FG025|Overall Study|Withdrawal by Subject|1|||
126638217|NCT01814072|455633195|FG026|Overall Study|Withdrawal by Subject|1|||
126638218|NCT01814072|455633196|FG027|Overall Study|Withdrawal by Subject|2|||
126638219|NCT01814072|455633197|FG028|Overall Study|Withdrawal by Subject|1|||
126638220|NCT01814072|455633198|FG029|Overall Study|Withdrawal by Subject|0|||
126638221|NCT01814072|455633199|FG030|Overall Study|Withdrawal by Subject|0|||
126638222|NCT01814072|455633200|FG031|Overall Study|Withdrawal by Subject|0|||
126638223|NCT02336425|455633201|FG000|Overall Study|Study terminated.|2|||
126638224|NCT02336425|455633202|FG001|Overall Study|Study terminated.|2|||
126638225|NCT02336425|455633203|FG002|Overall Study|Study terminated.|3|||
126638226|NCT02336425|455633204|FG003|Overall Study|Study terminated.|3|||
126638227|NCT00978562|455633205|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
126638228|NCT01782690|455633206|FG000|Overall Study|Not reported|7|||
126638229|NCT01782690|455633206|FG000|Overall Study|Toxicity of gemcitabine|1|||
126638230|NCT01782690|455633206|FG000|Overall Study|Toxicity of erlotinib|1|||
126638231|NCT01782690|455633206|FG000|Overall Study|Lost to Follow-up|31|||
126638232|NCT01782690|455633206|FG000|Overall Study|Withdrawal of informed consent|2|||
126638233|NCT01782690|455633206|FG000|Overall Study|Absent rash|9|||
126638234|NCT01782690|455633206|FG000|Overall Study|Physician Decision|13|||
126638235|NCT01782690|455633206|FG000|Overall Study|Patient's wish|21|||
126638236|NCT01782690|455633206|FG000|Overall Study|Tumor progression|74|||
126638237|NCT01782690|455633206|FG000|Overall Study|Death|133|||
126638238|NCT01782690|455633206|FG000|Overall Study|Study completion unknown|7|||
126638239|NCT04946942|455633208|FG000|Overall Study|Lost to Follow-up|6|||
126638240|NCT04946942|455633209|FG001|Overall Study|Lost to Follow-up|2|||
126638241|NCT04946942|455633210|FG002|Overall Study|Lost to Follow-up|0|||
126638242|NCT04907357|455633211|FG000|Overall Study|Death|0|||
126638243|NCT04907357|455633212|FG001|Overall Study|Death|1|||
126638244|NCT04907357|455633211|FG000|Overall Study|Lost to Follow-up|9|||
126638245|NCT04907357|455633212|FG001|Overall Study|Lost to Follow-up|18|||
126638246|NCT04907357|455633211|FG000|Overall Study|Physician Decision|1|||
126638247|NCT04907357|455633212|FG001|Overall Study|Physician Decision|0|||
126638248|NCT04907357|455633211|FG000|Overall Study|Withdrawal by Subject|0|||
126638249|NCT04907357|455633212|FG001|Overall Study|Withdrawal by Subject|1|||
126638250|NCT04907357|455633211|FG000|Overall Study|Unable to attend visits|1|||
126638251|NCT04907357|455633212|FG001|Overall Study|Unable to attend visits|0|||
126638252|NCT04907357|455633211|FG000|Overall Study|Incarcerated|1|||
126638253|NCT04907357|455633212|FG001|Overall Study|Incarcerated|1|||
126638254|NCT01948076|455633213|FG000|Overall Study|Withdrawal by Subject|0|||
126638255|NCT01948076|455633214|FG001|Overall Study|Withdrawal by Subject|1|||
126638256|NCT00344032|455633223|FG000|Overall Study|Adverse Event|0|||
126638257|NCT00344032|455633224|FG001|Overall Study|Adverse Event|1|||
126638258|NCT00344032|455633223|FG000|Overall Study|Withdrawal by Subject|6|||
126638259|NCT00344032|455633224|FG001|Overall Study|Withdrawal by Subject|2|||
126638260|NCT00344032|455633223|FG000|Overall Study|Lost to Follow-up|4|||
126638261|NCT00344032|455633224|FG001|Overall Study|Lost to Follow-up|6|||
126638262|NCT00344032|455633223|FG000|Overall Study|Physician Decision|4|||
126638263|NCT00344032|455633224|FG001|Overall Study|Physician Decision|1|||
126638264|NCT02600897|455633225|FG000|Overall Study|Death|1|||
126638265|NCT02600897|455633226|FG001|Overall Study|Death|2|||
126638266|NCT02600897|455633227|FG002|Overall Study|Death|1|||
126638267|NCT02600897|455633228|FG003|Overall Study|Death|2|||
126638268|NCT02600897|455633229|FG004|Overall Study|Death|3|||
126638269|NCT02600897|455633230|FG005|Overall Study|Death|2|||
126638270|NCT02600897|455633231|FG006|Overall Study|Death|10|||
126638271|NCT02600897|455633232|FG007|Overall Study|Death|7|||
126638272|NCT02600897|455633233|FG008|Overall Study|Death|20|||
126638273|NCT02600897|455633225|FG000|Overall Study|Lost to Follow-up|1|||
126638274|NCT02600897|455633226|FG001|Overall Study|Lost to Follow-up|0|||
126638275|NCT02600897|455633227|FG002|Overall Study|Lost to Follow-up|0|||
126638276|NCT02600897|455633228|FG003|Overall Study|Lost to Follow-up|0|||
126638277|NCT02600897|455633229|FG004|Overall Study|Lost to Follow-up|0|||
126638278|NCT02600897|455633230|FG005|Overall Study|Lost to Follow-up|0|||
126638279|NCT02600897|455633231|FG006|Overall Study|Lost to Follow-up|0|||
126638280|NCT02600897|455633232|FG007|Overall Study|Lost to Follow-up|1|||
126638281|NCT02600897|455633233|FG008|Overall Study|Lost to Follow-up|0|||
126638282|NCT02600897|455633225|FG000|Overall Study|Withdrawal by Subject|0|||
126638283|NCT02600897|455633226|FG001|Overall Study|Withdrawal by Subject|0|||
126638284|NCT02600897|455633227|FG002|Overall Study|Withdrawal by Subject|0|||
126638285|NCT02600897|455633228|FG003|Overall Study|Withdrawal by Subject|0|||
126638286|NCT02600897|455633229|FG004|Overall Study|Withdrawal by Subject|0|||
126638287|NCT02600897|455633230|FG005|Overall Study|Withdrawal by Subject|0|||
126638288|NCT02600897|455633231|FG006|Overall Study|Withdrawal by Subject|0|||
126638289|NCT02600897|455633232|FG007|Overall Study|Withdrawal by Subject|4|||
126638290|NCT02600897|455633233|FG008|Overall Study|Withdrawal by Subject|2|||
126638291|NCT02600897|455633225|FG000|Overall Study|Reason Not Specified|0|||
126638292|NCT02600897|455633226|FG001|Overall Study|Reason Not Specified|0|||
126638293|NCT02600897|455633227|FG002|Overall Study|Reason Not Specified|0|||
126638294|NCT02600897|455633228|FG003|Overall Study|Reason Not Specified|0|||
126638295|NCT02600897|455633229|FG004|Overall Study|Reason Not Specified|0|||
126638296|NCT02600897|455633230|FG005|Overall Study|Reason Not Specified|0|||
126638297|NCT02600897|455633231|FG006|Overall Study|Reason Not Specified|0|||
126638298|NCT02600897|455633232|FG007|Overall Study|Reason Not Specified|0|||
126638299|NCT02600897|455633233|FG008|Overall Study|Reason Not Specified|1|||
126638300|NCT06840769|455633234|FG000|Overall Study|Withdrawal by Subject|1|||
126638301|NCT06840769|455633235|FG001|Overall Study|Withdrawal by Subject|0|||
126638302|NCT06840769|455633236|FG002|Overall Study|Withdrawal by Subject|0|||
126638303|NCT06840769|455633237|FG003|Overall Study|Withdrawal by Subject|0|||
126638304|NCT06840769|455633238|FG004|Overall Study|Withdrawal by Subject|0|||
126638305|NCT03192462|455635660|FG000|Overall Study|Death|13|||
126638306|NCT03192462|455635661|FG001|Overall Study|Death|11|||
126638307|NCT03192462|455635662|FG002|Overall Study|Death|9|||
126638308|NCT03192462|455635660|FG000|Overall Study|Lost to Follow-up|0|||
126638309|NCT03192462|455635661|FG001|Overall Study|Lost to Follow-up|1|||
126638310|NCT03192462|455635662|FG002|Overall Study|Lost to Follow-up|0|||
126638311|NCT03192462|455635660|FG000|Overall Study|On follow up|0|||
126638312|NCT03192462|455635661|FG001|Overall Study|On follow up|0|||
126638313|NCT03192462|455635662|FG002|Overall Study|On follow up|3|||
126638314|NCT02419417|455635663|FG000|Overall Study|Disease progression|5|||
126638315|NCT02419417|455635664|FG001|Overall Study|Disease progression|4|||
126638316|NCT02419417|455635665|FG002|Overall Study|Disease progression|13|||
126638317|NCT02419417|455635666|FG003|Overall Study|Disease progression|10|||
126638318|NCT02419417|455635667|FG004|Overall Study|Disease progression|10|||
126638319|NCT02419417|455635668|FG005|Overall Study|Disease progression|3|||
126638320|NCT02419417|455635669|FG006|Overall Study|Disease progression|4|||
126638321|NCT02419417|455635670|FG007|Overall Study|Disease progression|5|||
126638322|NCT02419417|455635671|FG008|Overall Study|Disease progression|13|||
126638323|NCT02419417|455635672|FG009|Overall Study|Disease progression|9|||
126638324|NCT02419417|455635673|FG010|Overall Study|Disease progression|0|||
126638325|NCT02419417|455635663|FG000|Overall Study|Study drug toxicity|0|||
126638326|NCT02419417|455635664|FG001|Overall Study|Study drug toxicity|0|||
126638327|NCT02419417|455635665|FG002|Overall Study|Study drug toxicity|0|||
126638328|NCT02419417|455635666|FG003|Overall Study|Study drug toxicity|0|||
126638329|NCT02419417|455635667|FG004|Overall Study|Study drug toxicity|1|||
126638330|NCT02419417|455635668|FG005|Overall Study|Study drug toxicity|0|||
126638331|NCT02419417|455635669|FG006|Overall Study|Study drug toxicity|0|||
126638332|NCT02419417|455635670|FG007|Overall Study|Study drug toxicity|0|||
126638333|NCT02419417|455635671|FG008|Overall Study|Study drug toxicity|0|||
126638334|NCT02419417|455635672|FG009|Overall Study|Study drug toxicity|0|||
126638335|NCT02419417|455635673|FG010|Overall Study|Study drug toxicity|0|||
126638336|NCT02419417|455635663|FG000|Overall Study|Adverse event unrelated to study drug|0|||
126638337|NCT02419417|455635664|FG001|Overall Study|Adverse event unrelated to study drug|0|||
126638338|NCT02419417|455635665|FG002|Overall Study|Adverse event unrelated to study drug|0|||
126638339|NCT02419417|455635666|FG003|Overall Study|Adverse event unrelated to study drug|0|||
126638340|NCT02419417|455635667|FG004|Overall Study|Adverse event unrelated to study drug|2|||
126638341|NCT02419417|455635668|FG005|Overall Study|Adverse event unrelated to study drug|1|||
126638342|NCT02419417|455635669|FG006|Overall Study|Adverse event unrelated to study drug|0|||
126638343|NCT02419417|455635670|FG007|Overall Study|Adverse event unrelated to study drug|1|||
126638344|NCT02419417|455635671|FG008|Overall Study|Adverse event unrelated to study drug|0|||
126638345|NCT02419417|455635672|FG009|Overall Study|Adverse event unrelated to study drug|0|||
126638346|NCT02419417|455635673|FG010|Overall Study|Adverse event unrelated to study drug|0|||
126638347|NCT02419417|455635663|FG000|Overall Study|Participant request to discontinue|0|||
126638348|NCT02419417|455635664|FG001|Overall Study|Participant request to discontinue|0|||
126638349|NCT02419417|455635665|FG002|Overall Study|Participant request to discontinue|0|||
126638350|NCT02419417|455635666|FG003|Overall Study|Participant request to discontinue|0|||
126638351|NCT02419417|455635667|FG004|Overall Study|Participant request to discontinue|0|||
126638352|NCT02419417|455635668|FG005|Overall Study|Participant request to discontinue|0|||
126638353|NCT02419417|455635669|FG006|Overall Study|Participant request to discontinue|0|||
126638354|NCT02419417|455635670|FG007|Overall Study|Participant request to discontinue|0|||
126638355|NCT02419417|455635671|FG008|Overall Study|Participant request to discontinue|0|||
126638356|NCT02419417|455635672|FG009|Overall Study|Participant request to discontinue|1|||
126638357|NCT02419417|455635673|FG010|Overall Study|Participant request to discontinue|0|||
126638358|NCT02419417|455635663|FG000|Overall Study|Withdrawal by Subject|0|||
126638359|NCT02419417|455635664|FG001|Overall Study|Withdrawal by Subject|0|||
126638360|NCT02419417|455635665|FG002|Overall Study|Withdrawal by Subject|0|||
126638361|NCT02419417|455635666|FG003|Overall Study|Withdrawal by Subject|0|||
126638362|NCT02419417|455635667|FG004|Overall Study|Withdrawal by Subject|0|||
126638363|NCT02419417|455635668|FG005|Overall Study|Withdrawal by Subject|0|||
126638364|NCT02419417|455635669|FG006|Overall Study|Withdrawal by Subject|0|||
126638365|NCT02419417|455635670|FG007|Overall Study|Withdrawal by Subject|0|||
126638366|NCT02419417|455635671|FG008|Overall Study|Withdrawal by Subject|0|||
126638367|NCT02419417|455635672|FG009|Overall Study|Withdrawal by Subject|0|||
126638368|NCT02419417|455635673|FG010|Overall Study|Withdrawal by Subject|1|||
126638369|NCT00078377|455635674|FG000|Overall Study|Adverse Event|2|||
126638370|NCT00078377|455635675|FG001|Overall Study|Adverse Event|5|||
126638371|NCT00078377|455635676|FG002|Overall Study|Adverse Event|1|||
126638372|NCT00078377|455635674|FG000|Overall Study|Lack of Efficacy|2|||
126638373|NCT00078377|455635675|FG001|Overall Study|Lack of Efficacy|0|||
126638374|NCT00078377|455635676|FG002|Overall Study|Lack of Efficacy|2|||
126638375|NCT00078377|455635674|FG000|Overall Study|Lost to Follow-up|0|||
126638376|NCT00078377|455635675|FG001|Overall Study|Lost to Follow-up|1|||
126638377|NCT00078377|455635676|FG002|Overall Study|Lost to Follow-up|1|||
126638378|NCT00078377|455635674|FG000|Overall Study|Physician Decision|2|||
126638379|NCT00078377|455635675|FG001|Overall Study|Physician Decision|0|||
126638380|NCT00078377|455635676|FG002|Overall Study|Physician Decision|0|||
126638381|NCT00078377|455635674|FG000|Overall Study|Withdrawal by Subject|3|||
126638382|NCT00078377|455635675|FG001|Overall Study|Withdrawal by Subject|4|||
126638383|NCT00078377|455635676|FG002|Overall Study|Withdrawal by Subject|4|||
126638384|NCT00078377|455635674|FG000|Overall Study|Miscellaneous|2|||
126638385|NCT00078377|455635675|FG001|Overall Study|Miscellaneous|6|||
126638386|NCT00078377|455635676|FG002|Overall Study|Miscellaneous|1|||
126638387|NCT00581893|455635677|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
126638388|NCT00581893|455635678|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
126638389|NCT00233480|455635679|FG000|Overall Study|Underwent status II heart transplant|0|||
126638390|NCT00233480|455635680|FG001|Overall Study|Underwent status II heart transplant|1|||
126638391|NCT00790400|455635683|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
126638392|NCT00790400|455635684|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
126638393|NCT00790400|455635683|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
126638394|NCT00790400|455635684|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
126638395|NCT00790400|455635683|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
126638396|NCT00790400|455635684|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
126638397|NCT00790400|455635683|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
126638398|NCT00790400|455635684|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
126638399|NCT00790400|455635683|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
126638400|NCT00790400|455635684|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
126638401|NCT00790400|455635683|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
126638402|NCT00790400|455635684|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
126638403|NCT00790400|455635683|FG000|Double-blind Period (Core Phase)|Death|1|||
126638404|NCT00790400|455635684|FG001|Double-blind Period (Core Phase)|Death|0|||
126638405|NCT00790400|455635683|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
126638406|NCT00790400|455635684|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
126638407|NCT00790400|455635683|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
126638408|NCT00790400|455635684|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
126638409|NCT00790400|455635683|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
126638410|NCT00790400|455635684|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
126638411|NCT00790400|455635683|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
126638412|NCT00790400|455635684|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
126638413|NCT00790400|455635683|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
126638414|NCT00790400|455635684|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
126638415|NCT00790400|455635683|FG000|Everolimus Period (Core or Extension)|Death|1|||
126638416|NCT00790400|455635684|FG001|Everolimus Period (Core or Extension)|Death|0|||
126638417|NCT00790400|455635683|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
126638418|NCT00790400|455635684|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
126638419|NCT00790400|455635683|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
126638420|NCT00790400|455635684|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
126638421|NCT00790400|455635683|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
126638422|NCT00790400|455635684|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
126638423|NCT00944229|455635687|FG000|Overall Study|Withdrawal by Subject|11|||
126638424|NCT00944229|455635687|FG000|Overall Study|Physician Decision|14|||
126638425|NCT04292470|455635688|FG000|Overall Study|Withdrawal by Subject|0|||
126638426|NCT04292470|455635689|FG001|Overall Study|Withdrawal by Subject|1|||
126638427|NCT02906020|455635690|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
126638428|NCT02906020|455635691|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
126638429|NCT02906020|455635692|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
126638430|NCT02906020|455635693|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
126638431|NCT02906020|455635694|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
126638432|NCT02906020|455635695|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
126638433|NCT02906020|455635696|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
126638434|NCT02906020|455635697|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
126638435|NCT02906020|455635698|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
126638436|NCT02906020|455635699|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
126638437|NCT02906020|455635700|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
126638438|NCT02906020|455635701|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
126638439|NCT02906020|455635702|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
126638440|NCT02906020|455635703|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
126638441|NCT02906020|455635704|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
126638442|NCT02906020|455635705|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
126638443|NCT02906020|455635690|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638444|NCT02906020|455635691|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638445|NCT02906020|455635692|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638446|NCT02906020|455635693|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638447|NCT02906020|455635694|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638448|NCT02906020|455635695|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638449|NCT02906020|455635696|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638450|NCT02906020|455635697|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638451|NCT02906020|455635698|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
126638452|NCT02906020|455635699|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
126638453|NCT02906020|455635700|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638454|NCT02906020|455635701|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638455|NCT02906020|455635702|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638456|NCT02906020|455635703|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638457|NCT02906020|455635704|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638458|NCT02906020|455635705|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
126638459|NCT02906020|455635690|FG000|Part 2: Double-blind Treatment Period|Other|0|||
126638460|NCT02906020|455635691|FG001|Part 2: Double-blind Treatment Period|Other|0|||
126638461|NCT02906020|455635692|FG002|Part 2: Double-blind Treatment Period|Other|0|||
126638462|NCT02906020|455635693|FG003|Part 2: Double-blind Treatment Period|Other|0|||
126638463|NCT02906020|455635694|FG004|Part 2: Double-blind Treatment Period|Other|0|||
126638464|NCT02906020|455635695|FG005|Part 2: Double-blind Treatment Period|Other|0|||
126638465|NCT02906020|455635696|FG006|Part 2: Double-blind Treatment Period|Other|0|||
126638466|NCT02906020|455635697|FG007|Part 2: Double-blind Treatment Period|Other|0|||
126638467|NCT02906020|455635698|FG008|Part 2: Double-blind Treatment Period|Other|6|||
126638468|NCT02906020|455635699|FG009|Part 2: Double-blind Treatment Period|Other|10|||
126638469|NCT02906020|455635700|FG010|Part 2: Double-blind Treatment Period|Other|0|||
126638470|NCT02906020|455635701|FG011|Part 2: Double-blind Treatment Period|Other|0|||
126638471|NCT02906020|455635702|FG012|Part 2: Double-blind Treatment Period|Other|0|||
126638472|NCT02906020|455635703|FG013|Part 2: Double-blind Treatment Period|Other|0|||
126638473|NCT02906020|455635704|FG014|Part 2: Double-blind Treatment Period|Other|0|||
126638474|NCT02906020|455635705|FG015|Part 2: Double-blind Treatment Period|Other|0|||
126638475|NCT02906020|455635690|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638476|NCT02906020|455635691|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638477|NCT02906020|455635692|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638478|NCT02906020|455635693|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638479|NCT02906020|455635694|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638480|NCT02906020|455635695|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638481|NCT02906020|455635696|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638482|NCT02906020|455635697|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638483|NCT02906020|455635698|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638484|NCT02906020|455635699|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638485|NCT02906020|455635700|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638486|NCT02906020|455635701|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638487|NCT02906020|455635702|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
126638488|NCT02906020|455635703|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
126638489|NCT02906020|455635704|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638490|NCT02906020|455635705|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
126638491|NCT02906020|455635690|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638492|NCT02906020|455635691|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638493|NCT02906020|455635692|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638494|NCT02906020|455635693|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638495|NCT02906020|455635694|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638496|NCT02906020|455635695|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638497|NCT02906020|455635696|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638498|NCT02906020|455635697|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638499|NCT02906020|455635698|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638500|NCT02906020|455635699|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638501|NCT02906020|455635700|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638502|NCT02906020|455635701|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638503|NCT02906020|455635702|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
126638504|NCT02906020|455635703|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
126638505|NCT02906020|455635704|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
126638506|NCT02906020|455635705|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
126638507|NCT02906020|455635690|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638508|NCT02906020|455635691|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638509|NCT02906020|455635692|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638510|NCT02906020|455635693|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638511|NCT02906020|455635694|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638512|NCT02906020|455635695|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638513|NCT02906020|455635696|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638514|NCT02906020|455635697|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638515|NCT02906020|455635698|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638516|NCT02906020|455635699|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638517|NCT02906020|455635700|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638518|NCT02906020|455635701|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638519|NCT02906020|455635702|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
126638520|NCT02906020|455635703|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
126638521|NCT02906020|455635704|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638522|NCT02906020|455635705|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
126638523|NCT02906020|455635690|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638524|NCT02906020|455635691|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638525|NCT02906020|455635692|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638526|NCT02906020|455635693|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638527|NCT02906020|455635694|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638528|NCT02906020|455635695|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638529|NCT02906020|455635696|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638530|NCT02906020|455635697|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638531|NCT02906020|455635698|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638532|NCT02906020|455635699|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638533|NCT02906020|455635700|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638534|NCT02906020|455635701|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638535|NCT02906020|455635702|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
126638536|NCT02906020|455635703|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
126638537|NCT02906020|455635704|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638538|NCT02906020|455635705|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
126638539|NCT02906020|455635690|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126638540|NCT02906020|455635691|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126638541|NCT02906020|455635692|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126638542|NCT02906020|455635693|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126638543|NCT02906020|455635694|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126638544|NCT02906020|455635695|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126638545|NCT02906020|455635696|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126638546|NCT02906020|455635697|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126638547|NCT02906020|455635698|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126638548|NCT02906020|455635699|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126638549|NCT02906020|455635700|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126638550|NCT02906020|455635701|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
126638551|NCT02906020|455635702|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
126638552|NCT02906020|455635703|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
126638553|NCT02906020|455635704|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
126638554|NCT02906020|455635705|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
126638555|NCT02906020|455635690|FG000|Part 2: Long-term Follow-up Period|Other|0|||
126638556|NCT02906020|455635691|FG001|Part 2: Long-term Follow-up Period|Other|0|||
126638557|NCT02906020|455635692|FG002|Part 2: Long-term Follow-up Period|Other|0|||
126638558|NCT02906020|455635693|FG003|Part 2: Long-term Follow-up Period|Other|0|||
126638559|NCT02906020|455635694|FG004|Part 2: Long-term Follow-up Period|Other|0|||
126638560|NCT02906020|455635695|FG005|Part 2: Long-term Follow-up Period|Other|0|||
126638561|NCT02906020|455635696|FG006|Part 2: Long-term Follow-up Period|Other|0|||
126638562|NCT02906020|455635697|FG007|Part 2: Long-term Follow-up Period|Other|0|||
126638563|NCT02906020|455635698|FG008|Part 2: Long-term Follow-up Period|Other|0|||
126638564|NCT02906020|455635699|FG009|Part 2: Long-term Follow-up Period|Other|0|||
126638565|NCT02906020|455635700|FG010|Part 2: Long-term Follow-up Period|Other|0|||
126638566|NCT02906020|455635701|FG011|Part 2: Long-term Follow-up Period|Other|0|||
126638567|NCT02906020|455635702|FG012|Part 2: Long-term Follow-up Period|Other|13|||
126638568|NCT02906020|455635703|FG013|Part 2: Long-term Follow-up Period|Other|8|||
126638569|NCT02906020|455635704|FG014|Part 2: Long-term Follow-up Period|Other|3|||
126638570|NCT02906020|455635705|FG015|Part 2: Long-term Follow-up Period|Other|2|||
126638571|NCT00884650|455635707|FG000|Overall Study|Did not return complete pain diaries|7|||
126638572|NCT00884650|455635708|FG001|Overall Study|Did not return complete pain diaries|7|||
126638573|NCT00884650|455635707|FG000|Overall Study|Admitted Post-Op|1|||
126638574|NCT00884650|455635708|FG001|Overall Study|Admitted Post-Op|0|||
126638575|NCT00884650|455635707|FG000|Overall Study|Femoral Stress Fracture|1|||
126638576|NCT00884650|455635708|FG001|Overall Study|Femoral Stress Fracture|0|||
126638577|NCT00884650|455635707|FG000|Overall Study|Pain Pump Complication|0|||
126638578|NCT00884650|455635708|FG001|Overall Study|Pain Pump Complication|1|||
126638579|NCT01594827|455635714|FG000|Overall Study|Adverse Event|1|||
126638580|NCT01594827|455635715|FG001|Overall Study|Adverse Event|0|||
126638581|NCT01594827|455635714|FG000|Overall Study|Physician Decision|3|||
126638582|NCT01594827|455635715|FG001|Overall Study|Physician Decision|0|||
126638583|NCT02153905|455635716|FG000|Overall Study|Death|1|||
126638584|NCT02153905|455635717|FG001|Overall Study|Death|0|||
126638585|NCT01607879|455635722|FG000|Overall Study|Death|1|||
126638586|NCT01607879|455635723|FG001|Overall Study|Death|0|||
126638587|NCT01592045|455635724|FG000|Overall Study|Disease Progression|1|||
126638588|NCT01592045|455635725|FG001|Overall Study|Disease Progression|1|||
126638589|NCT01592045|455635724|FG000|Overall Study|Adverse Event|1|||
126638590|NCT01592045|455635725|FG001|Overall Study|Adverse Event|1|||
126638591|NCT01592045|455635724|FG000|Overall Study|Withdrawal by Subject|1|||
126638592|NCT01592045|455635725|FG001|Overall Study|Withdrawal by Subject|0|||
126638593|NCT01592045|455635724|FG000|Overall Study|Moved out of country|2|||
126638594|NCT01592045|455635725|FG001|Overall Study|Moved out of country|0|||
126638595|NCT03994731|455635726|FG000|Pegloticase + IMM Period|Death|2|||
126638596|NCT03994731|455635727|FG001|Pegloticase + IMM Period|Death|0|||
126638597|NCT03994731|455635726|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
126638598|NCT03994731|455635727|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
126638599|NCT03994731|455635726|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
126638600|NCT03994731|455635727|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
126638601|NCT02406248|455635728|FG000|Overall Study|Death|7|||
126638602|NCT02406248|455635728|FG000|Overall Study|Withdrawal by Subject|2|||
126638603|NCT03812029|455635730|FG000|Overall Study|Protocol Violation|1|||
126638604|NCT03812029|455635731|FG001|Overall Study|Protocol Violation|0|||
126638605|NCT03812029|455635732|FG002|Overall Study|Protocol Violation|0|||
126638606|NCT03812029|455635733|FG003|Overall Study|Protocol Violation|1|||
126638607|NCT03812029|455635734|FG004|Overall Study|Protocol Violation|0|||
126638608|NCT03812029|455635730|FG000|Overall Study|Withdrawal by Subject|1|||
126638609|NCT03812029|455635731|FG001|Overall Study|Withdrawal by Subject|0|||
126638610|NCT03812029|455635732|FG002|Overall Study|Withdrawal by Subject|0|||
126638611|NCT03812029|455635733|FG003|Overall Study|Withdrawal by Subject|2|||
126638612|NCT03812029|455635734|FG004|Overall Study|Withdrawal by Subject|2|||
126638613|NCT03812029|455635730|FG000|Overall Study|Stopping rules|0|||
126638614|NCT03812029|455635731|FG001|Overall Study|Stopping rules|1|||
126638615|NCT03812029|455635732|FG002|Overall Study|Stopping rules|0|||
126638616|NCT03812029|455635733|FG003|Overall Study|Stopping rules|0|||
126638617|NCT03812029|455635734|FG004|Overall Study|Stopping rules|0|||
126638618|NCT03812029|455635730|FG000|Overall Study|Adverse Event|0|||
126638619|NCT03812029|455635731|FG001|Overall Study|Adverse Event|9|||
126638620|NCT03812029|455635732|FG002|Overall Study|Adverse Event|0|||
126638621|NCT03812029|455635733|FG003|Overall Study|Adverse Event|3|||
126638622|NCT03812029|455635734|FG004|Overall Study|Adverse Event|5|||
126638623|NCT03812029|455635730|FG000|Overall Study|Lost to Follow-up|0|||
126638624|NCT03812029|455635731|FG001|Overall Study|Lost to Follow-up|0|||
126638625|NCT03812029|455635732|FG002|Overall Study|Lost to Follow-up|0|||
126638626|NCT03812029|455635733|FG003|Overall Study|Lost to Follow-up|0|||
126638627|NCT03812029|455635734|FG004|Overall Study|Lost to Follow-up|3|||
126638628|NCT03149042|455635735|FG000|Overall Study|Invasive FFR not performed|21|||
126638629|NCT03149042|455635735|FG000|Overall Study|Poor CT Image Quality|1|||
126638630|NCT03149042|455635735|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
126638631|NCT00790205|455635736|FG000|Overall Study|Lost to Follow-up|61|||
126638632|NCT00790205|455635737|FG001|Overall Study|Lost to Follow-up|71|||
126638633|NCT00790205|455635736|FG000|Overall Study|Withdrawal by Subject|299|||
126638634|NCT00790205|455635737|FG001|Overall Study|Withdrawal by Subject|363|||
126638635|NCT04092452|455635753|FG000|Overall Study|Adverse Event|1|||
126638636|NCT04092452|455635754|FG001|Overall Study|Adverse Event|3|||
126638637|NCT04092452|455635755|FG002|Overall Study|Adverse Event|3|||
126638638|NCT04092452|455635756|FG003|Overall Study|Adverse Event|7|||
126638639|NCT04092452|455635753|FG000|Overall Study|Lack of Efficacy|1|||
126638640|NCT04092452|455635754|FG001|Overall Study|Lack of Efficacy|1|||
126638641|NCT04092452|455635755|FG002|Overall Study|Lack of Efficacy|1|||
126638642|NCT04092452|455635756|FG003|Overall Study|Lack of Efficacy|0|||
126638643|NCT04092452|455635753|FG000|Overall Study|Lost to Follow-up|4|||
126638644|NCT04092452|455635754|FG001|Overall Study|Lost to Follow-up|3|||
126638645|NCT04092452|455635755|FG002|Overall Study|Lost to Follow-up|5|||
126638646|NCT04092452|455635756|FG003|Overall Study|Lost to Follow-up|1|||
126638647|NCT04092452|455635753|FG000|Overall Study|Non-Compliance With Study Drug|0|||
126638648|NCT04092452|455635754|FG001|Overall Study|Non-Compliance With Study Drug|0|||
126638649|NCT04092452|455635755|FG002|Overall Study|Non-Compliance With Study Drug|1|||
126638650|NCT04092452|455635756|FG003|Overall Study|Non-Compliance With Study Drug|1|||
126638651|NCT04092452|455635753|FG000|Overall Study|Physician Decision|1|||
126638652|NCT04092452|455635754|FG001|Overall Study|Physician Decision|0|||
126638653|NCT04092452|455635755|FG002|Overall Study|Physician Decision|1|||
126638654|NCT04092452|455635756|FG003|Overall Study|Physician Decision|0|||
126638655|NCT04092452|455635753|FG000|Overall Study|Pregnancy|2|||
126638656|NCT04092452|455635754|FG001|Overall Study|Pregnancy|0|||
126638657|NCT04092452|455635755|FG002|Overall Study|Pregnancy|0|||
126638658|NCT04092452|455635756|FG003|Overall Study|Pregnancy|0|||
126638659|NCT04092452|455635753|FG000|Overall Study|Protocol Deviation|1|||
126638660|NCT04092452|455635754|FG001|Overall Study|Protocol Deviation|0|||
126638661|NCT04092452|455635755|FG002|Overall Study|Protocol Deviation|0|||
126638662|NCT04092452|455635756|FG003|Overall Study|Protocol Deviation|0|||
126638663|NCT04092452|455635753|FG000|Overall Study|Withdrawal by Subject|3|||
126638664|NCT04092452|455635754|FG001|Overall Study|Withdrawal by Subject|10|||
126638665|NCT04092452|455635755|FG002|Overall Study|Withdrawal by Subject|3|||
126638666|NCT04092452|455635756|FG003|Overall Study|Withdrawal by Subject|5|||
126638667|NCT04092452|455635753|FG000|Overall Study|Other|0|||
126638668|NCT04092452|455635754|FG001|Overall Study|Other|0|||
126638669|NCT04092452|455635755|FG002|Overall Study|Other|1|||
126638670|NCT04092452|455635756|FG003|Overall Study|Other|2|||
126638671|NCT02127125|455635757|FG000|Overall Study|Lost to Follow-up|0|||
126638672|NCT02127125|455635758|FG001|Overall Study|Lost to Follow-up|0|||
126638673|NCT02127125|455635759|FG002|Overall Study|Lost to Follow-up|0|||
126638674|NCT02127125|455635760|FG003|Overall Study|Lost to Follow-up|0|||
126638675|NCT02127125|455635761|FG004|Overall Study|Lost to Follow-up|2|||
126638676|NCT02127125|455635762|FG005|Overall Study|Lost to Follow-up|1|||
126638677|NCT02127125|455635763|FG006|Overall Study|Lost to Follow-up|0|||
126638678|NCT02127125|455635764|FG007|Overall Study|Lost to Follow-up|0|||
126638679|NCT02127125|455635765|FG008|Overall Study|Lost to Follow-up|0|||
126638680|NCT02127125|455635757|FG000|Overall Study|Withdrawal by Subject|0|||
126638681|NCT02127125|455635758|FG001|Overall Study|Withdrawal by Subject|0|||
126638682|NCT02127125|455635759|FG002|Overall Study|Withdrawal by Subject|0|||
126638683|NCT02127125|455635760|FG003|Overall Study|Withdrawal by Subject|1|||
126638684|NCT02127125|455635761|FG004|Overall Study|Withdrawal by Subject|0|||
126638685|NCT02127125|455635762|FG005|Overall Study|Withdrawal by Subject|0|||
126638686|NCT02127125|455635763|FG006|Overall Study|Withdrawal by Subject|0|||
126638687|NCT02127125|455635764|FG007|Overall Study|Withdrawal by Subject|0|||
126638688|NCT02127125|455635765|FG008|Overall Study|Withdrawal by Subject|0|||
126638689|NCT02127125|455635757|FG000|Overall Study|Physician Decision|0|||
126638690|NCT02127125|455635758|FG001|Overall Study|Physician Decision|0|||
126638691|NCT02127125|455635759|FG002|Overall Study|Physician Decision|1|||
126638692|NCT02127125|455635760|FG003|Overall Study|Physician Decision|0|||
126638693|NCT02127125|455635761|FG004|Overall Study|Physician Decision|1|||
126638694|NCT02127125|455635762|FG005|Overall Study|Physician Decision|2|||
126638695|NCT02127125|455635763|FG006|Overall Study|Physician Decision|0|||
126638696|NCT02127125|455635764|FG007|Overall Study|Physician Decision|0|||
126638697|NCT02127125|455635765|FG008|Overall Study|Physician Decision|0|||
126638698|NCT02353468|455635767|FG000|Overall Study|Study terminated|3|||
126638699|NCT02344342|455635768|FG000|Overall Study|Industry partner dropped out|11|||
126638700|NCT02344342|455635769|FG001|Overall Study|Industry partner dropped out|9|||
126638701|NCT02344342|455635770|FG002|Overall Study|Industry partner dropped out|14|||
126638702|NCT02344342|455635771|FG003|Overall Study|Industry partner dropped out|10|||
126638703|NCT00848484|455635773|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
126638704|NCT00848484|455635774|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
126638705|NCT00848484|455635773|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
126638706|NCT00848484|455635774|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
126638707|NCT00848484|455635773|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
126638708|NCT00848484|455635774|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
126638709|NCT00848484|455635773|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
126638710|NCT00848484|455635774|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
126638711|NCT00848484|455635773|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
126638712|NCT00848484|455635774|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
126638713|NCT03355209|455635778|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
126638714|NCT03355209|455635779|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
126638715|NCT03355209|455635780|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
126638716|NCT03355209|455635781|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
126638717|NCT03355209|455635782|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
126638718|NCT03355209|455635783|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
126638719|NCT03355209|455635778|FG000|Part 1: Double-Blind Period|Death|0|||
126638720|NCT03355209|455635779|FG001|Part 1: Double-Blind Period|Death|0|||
126638721|NCT03355209|455635780|FG002|Part 1: Double-Blind Period|Death|1|||
126638722|NCT03355209|455635781|FG003|Part 1: Double-Blind Period|Death|0|||
126638723|NCT03355209|455635782|FG004|Part 1: Double-Blind Period|Death|0|||
126638724|NCT03355209|455635783|FG005|Part 1: Double-Blind Period|Death|0|||
126638725|NCT03355209|455635778|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
126638726|NCT03355209|455635779|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
126638727|NCT03355209|455635780|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
126638728|NCT03355209|455635781|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
126638729|NCT03355209|455635782|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
126638730|NCT03355209|455635783|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
126638731|NCT03355209|455635778|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
126638732|NCT03355209|455635779|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
126638733|NCT03355209|455635780|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
126638734|NCT03355209|455635781|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
126638735|NCT03355209|455635782|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
126638736|NCT03355209|455635783|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
126638737|NCT03355209|455635778|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
126638738|NCT03355209|455635779|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
126638739|NCT03355209|455635780|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
126638740|NCT03355209|455635781|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
126638741|NCT03355209|455635782|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
126638742|NCT03355209|455635783|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
126638743|NCT03355209|455635778|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
126638744|NCT03355209|455635779|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
126638745|NCT03355209|455635780|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
126638746|NCT03355209|455635781|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
126638747|NCT03355209|455635782|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
126638748|NCT03355209|455635783|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
126638749|NCT03355209|455635778|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
126638750|NCT03355209|455635779|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
126638751|NCT03355209|455635780|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
126638752|NCT03355209|455635781|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
126638753|NCT03355209|455635782|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
126638754|NCT03355209|455635783|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
126638755|NCT03355209|455635778|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
126638756|NCT03355209|455635779|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
126638757|NCT03355209|455635780|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
126638758|NCT03355209|455635781|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
126638759|NCT03355209|455635782|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
126638760|NCT03355209|455635783|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
126638761|NCT03355209|455635778|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
126638762|NCT03355209|455635779|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
126638763|NCT03355209|455635780|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
126638764|NCT03355209|455635781|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126638765|NCT03355209|455635782|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
126638766|NCT03355209|455635783|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
126638767|NCT03355209|455635778|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
126638768|NCT03355209|455635779|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
126638769|NCT03355209|455635780|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
126638770|NCT03355209|455635781|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
126638771|NCT03355209|455635782|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
126638772|NCT03355209|455635783|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
126638773|NCT03355209|455635778|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
126638774|NCT03355209|455635779|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
126638775|NCT03355209|455635780|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
126638776|NCT03355209|455635781|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
126638777|NCT03355209|455635782|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
126638778|NCT03355209|455635783|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
126638779|NCT03017742|455635787|FG000|Overall Study|Protocol Violation|36|||
126638780|NCT03017742|455635787|FG000|Overall Study|Withdrawal by Subject|37|||
126638781|NCT02975102|455635788|FG000|Overall Study|Adverse Event|2|||
126638782|NCT02975102|455635789|FG001|Overall Study|Adverse Event|1|||
126638783|NCT01441635|455635794|FG000|Overall Study|Adverse Event|4|||
126638784|NCT01441635|455635795|FG001|Overall Study|Adverse Event|3|||
126638785|NCT01441635|455635796|FG002|Overall Study|Adverse Event|1|||
126638786|NCT01441635|455635797|FG003|Overall Study|Adverse Event|5|||
126638787|NCT01441635|455635798|FG004|Overall Study|Adverse Event|1|||
126638788|NCT01441635|455635799|FG005|Overall Study|Adverse Event|2|||
126638789|NCT01441635|455635800|FG006|Overall Study|Adverse Event|2|||
126638790|NCT01441635|455635801|FG007|Overall Study|Adverse Event|2|||
126638791|NCT01441635|455635802|FG008|Overall Study|Adverse Event|1|||
126638792|NCT01441635|455635803|FG009|Overall Study|Adverse Event|0|||
126638793|NCT01441635|455635794|FG000|Overall Study|Withdrawal by Subject|1|||
126638794|NCT01441635|455635795|FG001|Overall Study|Withdrawal by Subject|1|||
126638795|NCT01441635|455635796|FG002|Overall Study|Withdrawal by Subject|0|||
126638796|NCT01441635|455635797|FG003|Overall Study|Withdrawal by Subject|1|||
126638797|NCT01441635|455635798|FG004|Overall Study|Withdrawal by Subject|0|||
126638798|NCT01441635|455635799|FG005|Overall Study|Withdrawal by Subject|0|||
126638799|NCT01441635|455635800|FG006|Overall Study|Withdrawal by Subject|2|||
126638800|NCT01441635|455635801|FG007|Overall Study|Withdrawal by Subject|0|||
126638801|NCT01441635|455635802|FG008|Overall Study|Withdrawal by Subject|1|||
126638802|NCT01441635|455635803|FG009|Overall Study|Withdrawal by Subject|1|||
126638803|NCT01441635|455635794|FG000|Overall Study|Lost to Follow-up|0|||
126638804|NCT01441635|455635795|FG001|Overall Study|Lost to Follow-up|1|||
126638805|NCT01441635|455635796|FG002|Overall Study|Lost to Follow-up|1|||
126638806|NCT01441635|455635797|FG003|Overall Study|Lost to Follow-up|1|||
126638807|NCT01441635|455635798|FG004|Overall Study|Lost to Follow-up|1|||
126638808|NCT01441635|455635799|FG005|Overall Study|Lost to Follow-up|3|||
126638809|NCT01441635|455635800|FG006|Overall Study|Lost to Follow-up|1|||
126638810|NCT01441635|455635801|FG007|Overall Study|Lost to Follow-up|1|||
126638811|NCT01441635|455635802|FG008|Overall Study|Lost to Follow-up|0|||
126638812|NCT01441635|455635803|FG009|Overall Study|Lost to Follow-up|1|||
126638813|NCT01441635|455635794|FG000|Overall Study|Noncompliance|0|||
126638814|NCT01441635|455635795|FG001|Overall Study|Noncompliance|1|||
126638815|NCT01441635|455635796|FG002|Overall Study|Noncompliance|0|||
126638816|NCT01441635|455635797|FG003|Overall Study|Noncompliance|0|||
126638817|NCT01441635|455635798|FG004|Overall Study|Noncompliance|0|||
126638818|NCT01441635|455635799|FG005|Overall Study|Noncompliance|0|||
126638819|NCT01441635|455635800|FG006|Overall Study|Noncompliance|1|||
126638820|NCT01441635|455635801|FG007|Overall Study|Noncompliance|0|||
126638821|NCT01441635|455635802|FG008|Overall Study|Noncompliance|0|||
126638822|NCT01441635|455635803|FG009|Overall Study|Noncompliance|0|||
126638823|NCT01441635|455635794|FG000|Overall Study|Surgery or Invasive Intervention|0|||
126638824|NCT01441635|455635795|FG001|Overall Study|Surgery or Invasive Intervention|0|||
126638825|NCT01441635|455635796|FG002|Overall Study|Surgery or Invasive Intervention|1|||
126638826|NCT01441635|455635797|FG003|Overall Study|Surgery or Invasive Intervention|0|||
126638827|NCT01441635|455635798|FG004|Overall Study|Surgery or Invasive Intervention|0|||
126638828|NCT01441635|455635799|FG005|Overall Study|Surgery or Invasive Intervention|0|||
126638829|NCT01441635|455635800|FG006|Overall Study|Surgery or Invasive Intervention|0|||
126638830|NCT01441635|455635801|FG007|Overall Study|Surgery or Invasive Intervention|0|||
126638831|NCT01441635|455635802|FG008|Overall Study|Surgery or Invasive Intervention|0|||
126638832|NCT01441635|455635803|FG009|Overall Study|Surgery or Invasive Intervention|0|||
126638833|NCT01441635|455635794|FG000|Overall Study|Received Exclusionary Medication|1|||
126638834|NCT01441635|455635795|FG001|Overall Study|Received Exclusionary Medication|0|||
126638835|NCT01441635|455635796|FG002|Overall Study|Received Exclusionary Medication|0|||
126638836|NCT01441635|455635797|FG003|Overall Study|Received Exclusionary Medication|0|||
126638837|NCT01441635|455635798|FG004|Overall Study|Received Exclusionary Medication|0|||
126638838|NCT01441635|455635799|FG005|Overall Study|Received Exclusionary Medication|0|||
126638839|NCT01441635|455635800|FG006|Overall Study|Received Exclusionary Medication|0|||
126638840|NCT01441635|455635801|FG007|Overall Study|Received Exclusionary Medication|0|||
126638841|NCT01441635|455635802|FG008|Overall Study|Received Exclusionary Medication|0|||
126638842|NCT01441635|455635803|FG009|Overall Study|Received Exclusionary Medication|0|||
126638843|NCT01441635|455635794|FG000|Overall Study|Other|0|||
126638844|NCT01441635|455635795|FG001|Overall Study|Other|0|||
126638845|NCT01441635|455635796|FG002|Overall Study|Other|0|||
126638846|NCT01441635|455635797|FG003|Overall Study|Other|0|||
126638847|NCT01441635|455635798|FG004|Overall Study|Other|0|||
126638848|NCT01441635|455635799|FG005|Overall Study|Other|0|||
126638849|NCT01441635|455635800|FG006|Overall Study|Other|0|||
126638850|NCT01441635|455635801|FG007|Overall Study|Other|1|||
126638851|NCT01441635|455635802|FG008|Overall Study|Other|0|||
126638852|NCT01441635|455635803|FG009|Overall Study|Other|0|||
126638853|NCT01825577|455635804|FG000|Overall Study|Physician Decision|2|||
126638854|NCT01825577|455635804|FG000|Overall Study|Withdrawal by Subject|1|||
126638855|NCT01825577|455635804|FG000|Overall Study|Withdrawn by family members|2|||
126638856|NCT01825577|455635804|FG000|Overall Study|Lack of Efficacy|3|||
126638857|NCT00358644|455635805|FG000|Overall Study|Progressive Disease|21|||
126638858|NCT00358644|455635805|FG000|Overall Study|Adverse Event|7|||
126638859|NCT00358644|455635805|FG000|Overall Study|Death|11|||
126638860|NCT00358644|455635805|FG000|Overall Study|Withdrawal by Subject|4|||
126638861|NCT00358644|455635805|FG000|Overall Study|Physician Decision|6|||
126638862|NCT00358644|455635805|FG000|Overall Study|Patient not eligible for study|1|||
126638863|NCT01358331|455635806|FG000|Overall Study|Lost to Follow-up|0|||
126638864|NCT01358331|455635807|FG001|Overall Study|Lost to Follow-up|0|||
126638865|NCT01358331|455635808|FG002|Overall Study|Lost to Follow-up|0|||
126638866|NCT01358331|455635809|FG003|Overall Study|Lost to Follow-up|1|||
126638867|NCT01358331|455635810|FG004|Overall Study|Lost to Follow-up|0|||
126638868|NCT01358331|455635811|FG005|Overall Study|Lost to Follow-up|0|||
126638869|NCT01358331|455635806|FG000|Overall Study|Withdrawal by Subject|0|||
126638870|NCT01358331|455635807|FG001|Overall Study|Withdrawal by Subject|0|||
126638871|NCT01358331|455635808|FG002|Overall Study|Withdrawal by Subject|0|||
126638872|NCT01358331|455635809|FG003|Overall Study|Withdrawal by Subject|1|||
126638873|NCT01358331|455635810|FG004|Overall Study|Withdrawal by Subject|1|||
126638874|NCT01358331|455635811|FG005|Overall Study|Withdrawal by Subject|1|||
126638875|NCT01358331|455635806|FG000|Overall Study|Adverse Events|1|||
126638876|NCT01358331|455635807|FG001|Overall Study|Adverse Events|1|||
126638877|NCT01358331|455635808|FG002|Overall Study|Adverse Events|1|||
126638878|NCT01358331|455635809|FG003|Overall Study|Adverse Events|0|||
126638879|NCT01358331|455635810|FG004|Overall Study|Adverse Events|1|||
126638880|NCT01358331|455635811|FG005|Overall Study|Adverse Events|5|||
126638881|NCT01358331|455635806|FG000|Overall Study|Symptomatic Deterioration|0|||
126638882|NCT01358331|455635807|FG001|Overall Study|Symptomatic Deterioration|0|||
126638883|NCT01358331|455635808|FG002|Overall Study|Symptomatic Deterioration|0|||
126638884|NCT01358331|455635809|FG003|Overall Study|Symptomatic Deterioration|0|||
126638885|NCT01358331|455635810|FG004|Overall Study|Symptomatic Deterioration|1|||
126638886|NCT01358331|455635811|FG005|Overall Study|Symptomatic Deterioration|0|||
126638887|NCT01358331|455635806|FG000|Overall Study|Participants did not wish to continue|0|||
126638888|NCT01358331|455635807|FG001|Overall Study|Participants did not wish to continue|0|||
126638889|NCT01358331|455635808|FG002|Overall Study|Participants did not wish to continue|0|||
126638890|NCT01358331|455635809|FG003|Overall Study|Participants did not wish to continue|0|||
126638891|NCT01358331|455635810|FG004|Overall Study|Participants did not wish to continue|1|||
126638892|NCT01358331|455635811|FG005|Overall Study|Participants did not wish to continue|0|||
126638893|NCT01358331|455635806|FG000|Overall Study|Progress of disease under investigation|1|||
126638894|NCT01358331|455635807|FG001|Overall Study|Progress of disease under investigation|2|||
126638895|NCT01358331|455635808|FG002|Overall Study|Progress of disease under investigation|3|||
126638896|NCT01358331|455635809|FG003|Overall Study|Progress of disease under investigation|1|||
126638897|NCT01358331|455635810|FG004|Overall Study|Progress of disease under investigation|3|||
126638898|NCT01358331|455635811|FG005|Overall Study|Progress of disease under investigation|0|||
126638899|NCT03327831|455635812|FG000|Overall Study|Lost to Follow-up|2|||
126638900|NCT03332784|455635815|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638901|NCT03332784|455635816|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
126638902|NCT03332784|455635817|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638903|NCT03332784|455635818|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638904|NCT03332784|455635819|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638905|NCT03332784|455635820|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638906|NCT03332784|455635821|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638907|NCT03332784|455635822|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638908|NCT03332784|455635823|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638909|NCT03332784|455635824|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638910|NCT03332784|455635825|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638911|NCT03332784|455635826|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638912|NCT03332784|455635827|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638913|NCT03332784|455635828|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638914|NCT03332784|455635829|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
126638915|NCT03332784|455635830|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638916|NCT03332784|455635831|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638917|NCT03332784|455635832|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638918|NCT03332784|455635833|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638919|NCT03332784|455635834|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
126638920|NCT01969851|455635835|FG000|Overall Study|Adverse Event|0|||
126638921|NCT01969851|455635836|FG001|Overall Study|Adverse Event|0|||
126638922|NCT01969851|455635837|FG002|Overall Study|Adverse Event|3|||
126638923|NCT01969851|455635835|FG000|Overall Study|Lack of Efficacy|0|||
126638924|NCT01969851|455635836|FG001|Overall Study|Lack of Efficacy|3|||
126638925|NCT01969851|455635837|FG002|Overall Study|Lack of Efficacy|1|||
126638926|NCT01969851|455635835|FG000|Overall Study|Withdrawal by Subject|1|||
126638927|NCT01969851|455635836|FG001|Overall Study|Withdrawal by Subject|0|||
126638928|NCT01969851|455635837|FG002|Overall Study|Withdrawal by Subject|1|||
126638929|NCT01969851|455635835|FG000|Overall Study|No effective dose in Titration period|0|||
126638930|NCT01969851|455635836|FG001|Overall Study|No effective dose in Titration period|0|||
126638931|NCT01969851|455635837|FG002|Overall Study|No effective dose in Titration period|1|||
126638932|NCT01969851|455635835|FG000|Overall Study|Sponsor decision|0|||
126638933|NCT01969851|455635836|FG001|Overall Study|Sponsor decision|0|||
126638934|NCT01969851|455635837|FG002|Overall Study|Sponsor decision|1|||
126638935|NCT01430468|455635850|FG000|Overall Study|Physician Decision|2|||
126638936|NCT01430468|455635851|FG001|Overall Study|Physician Decision|1|||
126638937|NCT01430468|455635850|FG000|Overall Study|Withdrawal by Subject|5|||
126638938|NCT01430468|455635851|FG001|Overall Study|Withdrawal by Subject|5|||
126638939|NCT02498236|455635854|FG000|Overall Study|Did not show for testing|1|||
126638940|NCT02498236|455635855|FG001|Overall Study|Did not show for testing|0|||
126638941|NCT02498236|455635856|FG002|Overall Study|Did not show for testing|0|||
126638942|NCT02498236|455635857|FG003|Overall Study|Did not show for testing|0|||
126638943|NCT02498236|455635858|FG004|Overall Study|Did not show for testing|0|||
126638944|NCT02498236|455635859|FG005|Overall Study|Did not show for testing|0|||
126638945|NCT02498236|455635860|FG006|Overall Study|Did not show for testing|0|||
126638946|NCT02498236|455635861|FG007|Overall Study|Did not show for testing|1|||
126638947|NCT02498236|455635854|FG000|Overall Study|Equipment failure|0|||
126638948|NCT02498236|455635855|FG001|Overall Study|Equipment failure|0|||
126638949|NCT02498236|455635856|FG002|Overall Study|Equipment failure|0|||
126638950|NCT02498236|455635857|FG003|Overall Study|Equipment failure|0|||
126638951|NCT02498236|455635858|FG004|Overall Study|Equipment failure|0|||
126638952|NCT02498236|455635859|FG005|Overall Study|Equipment failure|0|||
126638953|NCT02498236|455635860|FG006|Overall Study|Equipment failure|1|||
126638954|NCT02498236|455635861|FG007|Overall Study|Equipment failure|0|||
126638955|NCT02498236|455635854|FG000|Overall Study|Withdrawal by Subject|0|||
126638956|NCT02498236|455635855|FG001|Overall Study|Withdrawal by Subject|0|||
126638957|NCT02498236|455635856|FG002|Overall Study|Withdrawal by Subject|0|||
126638958|NCT02498236|455635857|FG003|Overall Study|Withdrawal by Subject|0|||
126638959|NCT02498236|455635858|FG004|Overall Study|Withdrawal by Subject|1|||
126638960|NCT02498236|455635859|FG005|Overall Study|Withdrawal by Subject|0|||
126638961|NCT02498236|455635860|FG006|Overall Study|Withdrawal by Subject|0|||
126638962|NCT02498236|455635861|FG007|Overall Study|Withdrawal by Subject|0|||
126638963|NCT00383123|455635862|FG000|Overall Study|Adverse Event|1|||
126638964|NCT00383123|455635863|FG001|Overall Study|Adverse Event|0|||
126638965|NCT00383123|455635862|FG000|Overall Study|Lost to Follow-up|68|||
126638966|NCT00383123|455635863|FG001|Overall Study|Lost to Follow-up|61|||
126638967|NCT00383123|455635862|FG000|Overall Study|Protocol Violation|5|||
126638968|NCT00383123|455635863|FG001|Overall Study|Protocol Violation|1|||
126638969|NCT00383123|455635862|FG000|Overall Study|Withdrawal by Subject|27|||
126638970|NCT00383123|455635863|FG001|Overall Study|Withdrawal by Subject|18|||
126638971|NCT00383123|455635862|FG000|Overall Study|Other reason|10|||
126638972|NCT00383123|455635863|FG001|Overall Study|Other reason|6|||
126638973|NCT02065882|455635864|FG000|Part I: PK/PD|Screening failure|5|||
126638974|NCT02065882|455635864|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
126638975|NCT02065882|455635864|FG000|Part I: PK/PD|Adverse Event|1|||
126638976|NCT02065882|455635864|FG000|Part II: Clinical Efficacy|Screening failure|7|||
126638977|NCT02065882|455635864|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
126638978|NCT02065882|455635864|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
126638979|NCT02065882|455635864|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
126638980|NCT02065882|455635864|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
126638981|NCT02065882|455635864|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
126638982|NCT02763215|455637677|FG000|Overall Study|Participants withdrew from study|3|||
126638983|NCT02763215|455637677|FG000|Overall Study|Missed visit|1|||
126638984|NCT02763215|455637677|FG000|Overall Study|Visit outside visit-window|1|||
126638985|NCT02763215|455637677|FG000|Overall Study|Death|1|||
126638986|NCT02763215|455637677|FG000|Overall Study|Lost to Follow-up|1|||
126638987|NCT00475644|455637679|FG000|Overall Study|Protocol Violation|13|||
126638988|NCT01411241|455637680|FG000|Overall Study|Protocol Violation|0|||
126638989|NCT01411241|455637681|FG001|Overall Study|Protocol Violation|5|||
126638990|NCT01411241|455637680|FG000|Overall Study|Withdrawal by Subject|9|||
126638991|NCT01411241|455637681|FG001|Overall Study|Withdrawal by Subject|10|||
126638992|NCT01411241|455637680|FG000|Overall Study|Serious Adverse Event|0|||
126638993|NCT01411241|455637681|FG001|Overall Study|Serious Adverse Event|3|||
126638994|NCT01411241|455637680|FG000|Overall Study|Lost to Follow-up|2|||
126638995|NCT01411241|455637681|FG001|Overall Study|Lost to Follow-up|4|||
126638996|NCT01107899|455637685|FG000|Overall Study|Physician Decision|5|||
126638997|NCT01107899|455637686|FG001|Overall Study|Physician Decision|0|||
126638998|NCT01107899|455637687|FG002|Overall Study|Physician Decision|3|||
126638999|NCT01107899|455637685|FG000|Overall Study|Withdrawal by Subject|0|||
126639000|NCT01107899|455637686|FG001|Overall Study|Withdrawal by Subject|0|||
126639001|NCT01107899|455637687|FG002|Overall Study|Withdrawal by Subject|1|||
126639002|NCT00974259|455637688|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
126639003|NCT00974259|455637689|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
126639004|NCT01810939|455637709|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
126639005|NCT01810939|455637710|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
126639006|NCT01810939|455637711|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
126639007|NCT01810939|455637709|FG000|Part A Treatment Period|Protocol Violation|2|||
126639008|NCT01810939|455637710|FG001|Part A Treatment Period|Protocol Violation|0|||
126639009|NCT01810939|455637711|FG002|Part A Treatment Period|Protocol Violation|0|||
126639010|NCT01810939|455637709|FG000|Part A Treatment Period|Adverse Event|10|||
126639011|NCT01810939|455637710|FG001|Part A Treatment Period|Adverse Event|0|||
126639012|NCT01810939|455637711|FG002|Part A Treatment Period|Adverse Event|0|||
126639013|NCT01810939|455637709|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
126639014|NCT01810939|455637710|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
126639015|NCT01810939|455637711|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
126639016|NCT01810939|455637709|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
126639017|NCT01810939|455637710|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
126639018|NCT01810939|455637711|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
126639019|NCT01810939|455637709|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
126639020|NCT01810939|455637710|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
126639021|NCT01810939|455637711|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
126639022|NCT01810939|455637709|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
126639023|NCT01810939|455637710|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
126639024|NCT01810939|455637711|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
126639025|NCT01810939|455637709|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
126639026|NCT01810939|455637710|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
126639027|NCT01810939|455637711|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
126639028|NCT01810939|455637709|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
126639029|NCT01810939|455637710|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
126639030|NCT01810939|455637711|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
126639031|NCT01810939|455637709|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
126639032|NCT01810939|455637710|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
126639033|NCT01810939|455637711|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
126639034|NCT01810939|455637709|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
126639035|NCT01810939|455637710|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
126639036|NCT01810939|455637711|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
126639037|NCT01810939|455637709|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
126639038|NCT01810939|455637710|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
126639039|NCT01810939|455637711|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
126639040|NCT01810939|455637709|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
126639041|NCT01810939|455637710|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
126639042|NCT01810939|455637711|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
126639043|NCT01810939|455637709|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
126639044|NCT01810939|455637710|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
126639045|NCT01810939|455637711|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
126639046|NCT01810939|455637709|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
126639047|NCT01810939|455637710|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
126639048|NCT01810939|455637711|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
126639049|NCT01810939|455637709|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
126639050|NCT01810939|455637710|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
126639051|NCT01810939|455637711|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
126639052|NCT01810939|455637709|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
126639053|NCT01810939|455637710|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
126639054|NCT01810939|455637711|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
126639055|NCT02963090|455637712|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
126639056|NCT02963090|455637713|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
126639057|NCT01375673|455637714|FG000|Overall Study|Withdrawal by Subject|0|||
126639058|NCT01375673|455637715|FG001|Overall Study|Withdrawal by Subject|1|||
126639059|NCT00979953|455637718|FG000|Overall Study|Adverse Event|5|||
126639060|NCT00979953|455637719|FG001|Overall Study|Adverse Event|2|||
126639061|NCT00979953|455637720|FG002|Overall Study|Adverse Event|17|||
126639062|NCT00979953|455637721|FG003|Overall Study|Adverse Event|4|||
126639063|NCT00979953|455637718|FG000|Overall Study|Lack of Efficacy|1|||
126639064|NCT00979953|455637719|FG001|Overall Study|Lack of Efficacy|2|||
126639065|NCT00979953|455637720|FG002|Overall Study|Lack of Efficacy|0|||
126639066|NCT00979953|455637721|FG003|Overall Study|Lack of Efficacy|0|||
126639067|NCT00979953|455637718|FG000|Overall Study|Lost to Follow-up|1|||
126639068|NCT00979953|455637719|FG001|Overall Study|Lost to Follow-up|1|||
126639069|NCT00979953|455637720|FG002|Overall Study|Lost to Follow-up|1|||
126639070|NCT00979953|455637721|FG003|Overall Study|Lost to Follow-up|0|||
126639071|NCT00979953|455637718|FG000|Overall Study|Withdrawal by Subject|0|||
126639072|NCT00979953|455637719|FG001|Overall Study|Withdrawal by Subject|0|||
126639073|NCT00979953|455637720|FG002|Overall Study|Withdrawal by Subject|2|||
126639074|NCT00979953|455637721|FG003|Overall Study|Withdrawal by Subject|1|||
126639075|NCT00979953|455637718|FG000|Overall Study|Protocol Violation|1|||
126639076|NCT00979953|455637719|FG001|Overall Study|Protocol Violation|0|||
126639077|NCT00979953|455637720|FG002|Overall Study|Protocol Violation|2|||
126639078|NCT00979953|455637721|FG003|Overall Study|Protocol Violation|2|||
126639079|NCT03054337|455637724|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
126639080|NCT03054337|455637725|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
126639081|NCT03054337|455637726|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
126639082|NCT03054337|455637727|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
126639083|NCT03054337|455637728|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
126639084|NCT03054337|455637729|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
126639085|NCT01681992|455637732|FG000|Overall Study|Adverse Event|3|||
126639086|NCT01681992|455637733|FG001|Overall Study|Adverse Event|2|||
126639087|NCT01681992|455637734|FG002|Overall Study|Adverse Event|3|||
126639088|NCT01681992|455637732|FG000|Overall Study|Lost to Follow-up|36|||
126639089|NCT01681992|455637733|FG001|Overall Study|Lost to Follow-up|38|||
126639090|NCT01681992|455637734|FG002|Overall Study|Lost to Follow-up|53|||
126639091|NCT01681992|455637732|FG000|Overall Study|As Per Sponsor Decision|0|||
126639092|NCT01681992|455637733|FG001|Overall Study|As Per Sponsor Decision|0|||
126639093|NCT01681992|455637734|FG002|Overall Study|As Per Sponsor Decision|1|||
126639094|NCT01681992|455637732|FG000|Overall Study|Protocol Violation|0|||
126639095|NCT01681992|455637733|FG001|Overall Study|Protocol Violation|0|||
126639096|NCT01681992|455637734|FG002|Overall Study|Protocol Violation|1|||
126639097|NCT01681992|455637732|FG000|Overall Study|Withdrawal by Subject|27|||
126639098|NCT01681992|455637733|FG001|Overall Study|Withdrawal by Subject|30|||
126639099|NCT01681992|455637734|FG002|Overall Study|Withdrawal by Subject|25|||
126639100|NCT01967069|455637742|FG000|Overall Study|Adverse Event|2|||
126639101|NCT01967069|455637743|FG001|Overall Study|Adverse Event|2|||
126639102|NCT01967069|455637742|FG000|Overall Study|Lost to Follow-up|5|||
126639103|NCT01967069|455637743|FG001|Overall Study|Lost to Follow-up|2|||
126639104|NCT01967069|455637742|FG000|Overall Study|Withdrawal by Subject|1|||
126639105|NCT01967069|455637743|FG001|Overall Study|Withdrawal by Subject|3|||
126639106|NCT01967069|455637742|FG000|Overall Study|Lack of Efficacy|0|||
126639107|NCT01967069|455637743|FG001|Overall Study|Lack of Efficacy|1|||
126639108|NCT02643628|455637752|FG000|Overall Study|Lost to Follow-up|1|||
126639109|NCT02643628|455637753|FG001|Overall Study|Lost to Follow-up|4|||
126639110|NCT02643628|455637752|FG000|Overall Study|Withdrawal by Subject|0|||
126639111|NCT02643628|455637753|FG001|Overall Study|Withdrawal by Subject|1|||
126639112|NCT02643628|455637752|FG000|Overall Study|Relocated out of state|0|||
126639113|NCT02643628|455637753|FG001|Overall Study|Relocated out of state|1|||
126639114|NCT04245345|455637754|FG000|Overall Study|Death|1|||
126639115|NCT04245345|455637754|FG000|Overall Study|Exited prior to implant|5|||
126639116|NCT04245345|455637754|FG000|Overall Study|Exited prior to 1-month|9|||
126639117|NCT04245345|455637754|FG000|Overall Study|Missed 1-month visit|3|||
126639118|NCT04245345|455637754|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
126639119|NCT04245345|455637754|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
126639120|NCT00706654|455637755|FG000|Conversion Phase|Lost to Follow-up|4|||
126639121|NCT00706654|455637756|FG001|Conversion Phase|Lost to Follow-up|0|||
126639122|NCT00706654|455637757|FG002|Conversion Phase|Lost to Follow-up|0|||
126639123|NCT00706654|455637758|FG003|Conversion Phase|Lost to Follow-up|0|||
126639124|NCT00706654|455637755|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
126639125|NCT00706654|455637756|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
126639126|NCT00706654|455637757|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
126639127|NCT00706654|455637758|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
126639128|NCT00706654|455637755|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
126639129|NCT00706654|455637756|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
126639130|NCT00706654|455637757|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
126639131|NCT00706654|455637758|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
126639132|NCT00706654|455637755|FG000|Conversion Phase|Withdrawn by Investigator|14|||
126639133|NCT00706654|455637756|FG001|Conversion Phase|Withdrawn by Investigator|0|||
126639134|NCT00706654|455637757|FG002|Conversion Phase|Withdrawn by Investigator|0|||
126639135|NCT00706654|455637758|FG003|Conversion Phase|Withdrawn by Investigator|0|||
126639136|NCT00706654|455637755|FG000|Conversion Phase|Withdrew Consent|38|||
126639137|NCT00706654|455637756|FG001|Conversion Phase|Withdrew Consent|0|||
126639138|NCT00706654|455637757|FG002|Conversion Phase|Withdrew Consent|0|||
126639139|NCT00706654|455637758|FG003|Conversion Phase|Withdrew Consent|0|||
126639140|NCT00706654|455637755|FG000|Conversion Phase|Adverse Event|18|||
126639141|NCT00706654|455637756|FG001|Conversion Phase|Adverse Event|0|||
126639142|NCT00706654|455637757|FG002|Conversion Phase|Adverse Event|0|||
126639143|NCT00706654|455637758|FG003|Conversion Phase|Adverse Event|0|||
126639144|NCT00706654|455637755|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
126639145|NCT00706654|455637756|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
126639146|NCT00706654|455637757|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
126639147|NCT00706654|455637758|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
126639148|NCT00706654|455637755|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
126639149|NCT00706654|455637756|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
126639150|NCT00706654|455637757|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
126639151|NCT00706654|455637758|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
126639152|NCT00706654|455637755|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
126639153|NCT00706654|455637756|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
126639154|NCT00706654|455637757|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
126639155|NCT00706654|455637758|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
126639156|NCT00706654|455637755|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
126639157|NCT00706654|455637756|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
126639158|NCT00706654|455637757|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
126639159|NCT00706654|455637758|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
126639160|NCT00706654|455637755|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
126639161|NCT00706654|455637756|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
126639162|NCT00706654|455637757|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
126639163|NCT00706654|455637758|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
126639164|NCT00706654|455637755|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
126639165|NCT00706654|455637756|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
126639166|NCT00706654|455637757|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
126639167|NCT00706654|455637758|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
126639168|NCT00706654|455637755|FG000|Oral Stabilization Phase|Withdrew consent|55|||
126639169|NCT00706654|455637756|FG001|Oral Stabilization Phase|Withdrew consent|0|||
126639170|NCT00706654|455637757|FG002|Oral Stabilization Phase|Withdrew consent|0|||
126639171|NCT00706654|455637758|FG003|Oral Stabilization Phase|Withdrew consent|0|||
126639172|NCT00706654|455637755|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
126639173|NCT00706654|455637756|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
126639174|NCT00706654|455637757|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
126639175|NCT00706654|455637758|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
126639176|NCT00706654|455637755|FG000|Oral Stabilization Phase|Adverse Event|21|||
126639177|NCT00706654|455637756|FG001|Oral Stabilization Phase|Adverse Event|0|||
126639178|NCT00706654|455637757|FG002|Oral Stabilization Phase|Adverse Event|0|||
126639179|NCT00706654|455637758|FG003|Oral Stabilization Phase|Adverse Event|0|||
126639180|NCT00706654|455637755|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
126639181|NCT00706654|455637756|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126639182|NCT00706654|455637757|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126639183|NCT00706654|455637758|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
126639184|NCT00706654|455637755|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
126639185|NCT00706654|455637756|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126639186|NCT00706654|455637757|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126639187|NCT00706654|455637758|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
126639188|NCT00706654|455637755|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
126639189|NCT00706654|455637756|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
126639190|NCT00706654|455637757|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
126639191|NCT00706654|455637758|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
126639192|NCT00706654|455637755|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
126639193|NCT00706654|455637756|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
126639194|NCT00706654|455637757|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
126639195|NCT00706654|455637758|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
126639196|NCT00706654|455637755|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
126639197|NCT00706654|455637756|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
126639198|NCT00706654|455637757|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
126639199|NCT00706654|455637758|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
126639200|NCT00706654|455637755|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
126639201|NCT00706654|455637756|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
126639202|NCT00706654|455637757|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
126639203|NCT00706654|455637758|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
126639204|NCT00706654|455637755|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
126639205|NCT00706654|455637756|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
126639206|NCT00706654|455637757|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
126639207|NCT00706654|455637758|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
126639208|NCT00706654|455637755|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
126639209|NCT00706654|455637756|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
126639210|NCT00706654|455637757|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
126639211|NCT00706654|455637758|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
126639212|NCT00706654|455637755|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
126639213|NCT00706654|455637756|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
126639214|NCT00706654|455637757|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
126639215|NCT00706654|455637758|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
126639216|NCT00706654|455637755|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
126639217|NCT00706654|455637756|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
126639218|NCT00706654|455637757|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
126639219|NCT00706654|455637758|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
126639220|NCT01001390|455637764|FG000|Overall Study|Failure to wear AFO device|2|||
126639221|NCT01001390|455637765|FG001|Overall Study|Failure to wear AFO device|0|||
126639222|NCT03690427|455637766|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
126639223|NCT03690427|455637767|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
126639224|NCT01151215|455637768|FG000|Overall Study|Worsening of condition under study|1|||
126639225|NCT01151215|455637769|FG001|Overall Study|Worsening of condition under study|1|||
126639226|NCT01151215|455637770|FG002|Overall Study|Worsening of condition under study|1|||
126639227|NCT01151215|455637768|FG000|Overall Study|Death|16|||
126639228|NCT01151215|455637769|FG001|Overall Study|Death|20|||
126639229|NCT01151215|455637770|FG002|Overall Study|Death|11|||
126639230|NCT01151215|455637768|FG000|Overall Study|Lost to Follow-up|0|||
126639231|NCT01151215|455637769|FG001|Overall Study|Lost to Follow-up|0|||
126639232|NCT01151215|455637770|FG002|Overall Study|Lost to Follow-up|3|||
126639233|NCT01151215|455637768|FG000|Overall Study|Withdrawal by Subject|3|||
126639234|NCT01151215|455637769|FG001|Overall Study|Withdrawal by Subject|1|||
126639235|NCT01151215|455637770|FG002|Overall Study|Withdrawal by Subject|2|||
126639236|NCT01151215|455637768|FG000|Overall Study|Disease progression|0|||
126639237|NCT01151215|455637769|FG001|Overall Study|Disease progression|1|||
126639238|NCT01151215|455637770|FG002|Overall Study|Disease progression|1|||
126639239|NCT01151215|455637768|FG000|Overall Study|Safety as judged by the investigator|0|||
126639240|NCT01151215|455637769|FG001|Overall Study|Safety as judged by the investigator|0|||
126639241|NCT01151215|455637770|FG002|Overall Study|Safety as judged by the investigator|1|||
126639242|NCT02609672|455637774|FG000|Overall Study|Lost to Follow-up|3|||
126639243|NCT02609672|455637775|FG001|Overall Study|Lost to Follow-up|1|||
126639244|NCT03392168|455637776|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
126639245|NCT03392168|455637777|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
126639246|NCT03392168|455637778|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
126639247|NCT03392168|455637779|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
126639248|NCT03392168|455637776|FG000|Period 2: Cohort 2|Other|0|||
126639249|NCT03392168|455637777|FG001|Period 2: Cohort 2|Other|1|||
126639250|NCT03392168|455637778|FG002|Period 2: Cohort 2|Other|0|||
126639251|NCT03392168|455637779|FG003|Period 2: Cohort 2|Other|0|||
126639252|NCT01721954|455637780|FG000|Overall Study|Death|58|||
126639253|NCT01721954|455637781|FG001|Overall Study|Death|64|||
126639254|NCT01721954|455637780|FG000|Overall Study|Withdrawal by Subject|8|||
126639255|NCT01721954|455637781|FG001|Overall Study|Withdrawal by Subject|4|||
126639256|NCT01721954|455637780|FG000|Overall Study|Adverse Event|2|||
126639257|NCT01721954|455637781|FG001|Overall Study|Adverse Event|0|||
126639258|NCT01721954|455637780|FG000|Overall Study|Lost to Follow-up|2|||
126639259|NCT01721954|455637781|FG001|Overall Study|Lost to Follow-up|1|||
126639260|NCT02956837|455637785|FG000|Overall Study|Serious Adverse Events|0|||
126639261|NCT02956837|455637786|FG001|Overall Study|Serious Adverse Events|1|||
126639262|NCT02956837|455637787|FG002|Overall Study|Serious Adverse Events|0|||
126639263|NCT02956837|455637788|FG003|Overall Study|Serious Adverse Events|0|||
126639264|NCT02956837|455637785|FG000|Overall Study|Withdrawal by Subject|0|||
126639265|NCT02956837|455637786|FG001|Overall Study|Withdrawal by Subject|1|||
126639266|NCT02956837|455637787|FG002|Overall Study|Withdrawal by Subject|0|||
126639267|NCT02956837|455637788|FG003|Overall Study|Withdrawal by Subject|3|||
126639268|NCT02956837|455637785|FG000|Overall Study|Lost to Follow-up|0|||
126639269|NCT02956837|455637786|FG001|Overall Study|Lost to Follow-up|1|||
126639270|NCT02956837|455637787|FG002|Overall Study|Lost to Follow-up|2|||
126639271|NCT02956837|455637788|FG003|Overall Study|Lost to Follow-up|0|||
126639272|NCT02597712|455637789|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
126639273|NCT02597712|455637790|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
126639274|NCT02597712|455637789|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
126639275|NCT02597712|455637790|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
126639276|NCT02597712|455637789|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
126639277|NCT02597712|455637790|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
126639278|NCT02637323|455637791|FG000|Overall Study|Lost to Follow-up|2|||
126639279|NCT02637323|455637792|FG001|Overall Study|Lost to Follow-up|0|||
126639280|NCT02637323|455637791|FG000|Overall Study|Protocol Violation|0|||
126639281|NCT02637323|455637792|FG001|Overall Study|Protocol Violation|1|||
126639282|NCT00513708|455637793|FG000|Overall Study|Lost to Follow-up|4|||
126639283|NCT00513708|455637794|FG001|Overall Study|Lost to Follow-up|4|||
126639284|NCT00513708|455637795|FG002|Overall Study|Lost to Follow-up|4|||
126639285|NCT01162486|455637796|FG000|Overall Study|low ANC|1|||
126639286|NCT01162486|455637797|FG001|Overall Study|low ANC|0|||
126639287|NCT01162486|455637798|FG002|Overall Study|low ANC|0|||
126639288|NCT01162486|455637799|FG003|Overall Study|low ANC|0|||
126639289|NCT01162486|455637800|FG004|Overall Study|low ANC|0|||
126639290|NCT01162486|455637796|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
126639291|NCT01162486|455637797|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
126639292|NCT01162486|455637798|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
126639293|NCT01162486|455637799|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
126639294|NCT01162486|455637800|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
126639295|NCT01162486|455637796|FG000|Overall Study|elevated LFTs|0|||
126639296|NCT01162486|455637797|FG001|Overall Study|elevated LFTs|0|||
126639297|NCT01162486|455637798|FG002|Overall Study|elevated LFTs|1|||
126639298|NCT01162486|455637799|FG003|Overall Study|elevated LFTs|0|||
126639299|NCT01162486|455637800|FG004|Overall Study|elevated LFTs|0|||
126639300|NCT01162486|455637796|FG000|Overall Study|Pregnancy|0|||
126639301|NCT01162486|455637797|FG001|Overall Study|Pregnancy|0|||
126639302|NCT01162486|455637798|FG002|Overall Study|Pregnancy|0|||
126639303|NCT01162486|455637799|FG003|Overall Study|Pregnancy|1|||
126639304|NCT01162486|455637800|FG004|Overall Study|Pregnancy|0|||
126639305|NCT03274895|455637803|FG000|Overall Study|Lack of Efficacy|1|||
126639306|NCT03274895|455637804|FG001|Overall Study|Lack of Efficacy|0|||
126639307|NCT03274895|455637803|FG000|Overall Study|Adverse Event|8|||
126639308|NCT03274895|455637804|FG001|Overall Study|Adverse Event|7|||
126639309|NCT03274895|455637803|FG000|Overall Study|Lost to Follow-up|1|||
126639310|NCT03274895|455637804|FG001|Overall Study|Lost to Follow-up|0|||
126639311|NCT03274895|455637803|FG000|Overall Study|Diagnosis not confirmed|3|||
126639312|NCT03274895|455637804|FG001|Overall Study|Diagnosis not confirmed|4|||
126639313|NCT00401258|455637808|FG000|Overall Study|Adverse Event|7|||
126639314|NCT00617929|455637814|FG000|Overall Study|Physician Decision|1|||
126639315|NCT00760747|455637819|FG000|Study Period II|Adverse Event|3|||
126639316|NCT00760747|455637820|FG001|Study Period II|Adverse Event|4|||
126639317|NCT00760747|455637819|FG000|Study Period II|Lack of Efficacy|0|||
126639318|NCT00760747|455637820|FG001|Study Period II|Lack of Efficacy|6|||
126639319|NCT00760747|455637819|FG000|Study Period II|Parent/Caregiver Decision|3|||
126639320|NCT00760747|455637820|FG001|Study Period II|Parent/Caregiver Decision|0|||
126639321|NCT00760747|455637819|FG000|Study Period II|Protocol Violation|6|||
126639322|NCT00760747|455637820|FG001|Study Period II|Protocol Violation|3|||
126639323|NCT00760747|455637819|FG000|Study Period II|Withdrawal by Subject|1|||
126639324|NCT00760747|455637820|FG001|Study Period II|Withdrawal by Subject|0|||
126639325|NCT00760747|455637819|FG000|Study Period II|No drug administered|0|||
126639326|NCT00760747|455637820|FG001|Study Period II|No drug administered|1|||
126639327|NCT00760747|455637819|FG000|Study Period III|Adverse Event|1|||
126639328|NCT00760747|455637820|FG001|Study Period III|Adverse Event|0|||
126639329|NCT00760747|455637819|FG000|Study Period III|Lack of Efficacy|1|||
126639330|NCT00760747|455637820|FG001|Study Period III|Lack of Efficacy|0|||
126639331|NCT00760747|455637819|FG000|Study Period III|Parent/Caregiver Decision|0|||
126639332|NCT00760747|455637820|FG001|Study Period III|Parent/Caregiver Decision|1|||
126639333|NCT00760747|455637819|FG000|Study Period III|Protocol Violation|1|||
126639334|NCT00760747|455637820|FG001|Study Period III|Protocol Violation|1|||
126639335|NCT00760747|455637819|FG000|Study Period III|Physician Decision|0|||
126639336|NCT00760747|455637820|FG001|Study Period III|Physician Decision|1|||
126639337|NCT01443923|455637821|FG000|Overall Study|Adverse Event|1|||
126639338|NCT01443923|455637822|FG001|Overall Study|Adverse Event|0|||
126639339|NCT03566979|455637823|FG000|Overall Study|Withdrawal by Subject|2|||
126639340|NCT03566979|455637824|FG001|Overall Study|Withdrawal by Subject|0|||
126639341|NCT03566979|455637825|FG002|Overall Study|Withdrawal by Subject|1|||
126639342|NCT03566979|455637826|FG003|Overall Study|Withdrawal by Subject|1|||
126639343|NCT03566979|455637823|FG000|Overall Study|Lost to Follow-up|2|||
126639344|NCT03566979|455637824|FG001|Overall Study|Lost to Follow-up|7|||
126639345|NCT03566979|455637825|FG002|Overall Study|Lost to Follow-up|9|||
126639346|NCT03566979|455637826|FG003|Overall Study|Lost to Follow-up|5|||
126639347|NCT03566979|455637823|FG000|Overall Study|Adverse Event|1|||
126639348|NCT03566979|455637824|FG001|Overall Study|Adverse Event|0|||
126639349|NCT03566979|455637825|FG002|Overall Study|Adverse Event|0|||
126639350|NCT03566979|455637826|FG003|Overall Study|Adverse Event|0|||
126639351|NCT01889069|455637827|FG000|Overall Study|Death|18|||
126639352|NCT01889069|455637827|FG000|Overall Study|Progression of Disease|14|||
126639353|NCT01889069|455637827|FG000|Overall Study|Lost to Follow-up|6|||
126639354|NCT01889069|455637827|FG000|Overall Study|Other|4|||
126639355|NCT01889069|455637827|FG000|Overall Study|Consent Withdrawal|3|||
126639356|NCT00108745|455637828|FG000|Overall Study|Withdrawal by Subject|19|||
126639357|NCT00108745|455637829|FG001|Overall Study|Withdrawal by Subject|12|||
126639358|NCT00108745|455637830|FG002|Overall Study|Withdrawal by Subject|12|||
126639359|NCT00108745|455637828|FG000|Overall Study|Never Treated|8|||
126639360|NCT00108745|455637829|FG001|Overall Study|Never Treated|10|||
126639361|NCT00108745|455637830|FG002|Overall Study|Never Treated|12|||
126639362|NCT00108745|455637828|FG000|Overall Study|Ineligible|7|||
126639363|NCT00108745|455637829|FG001|Overall Study|Ineligible|13|||
126639364|NCT00108745|455637830|FG002|Overall Study|Ineligible|13|||
126639365|NCT01426347|455637832|FG000|Overall Study|Lost to Follow-up|0|||
126639366|NCT01426347|455637833|FG001|Overall Study|Lost to Follow-up|3|||
126639367|NCT01426347|455637832|FG000|Overall Study|Protocol Violation|2|||
126639368|NCT01426347|455637833|FG001|Overall Study|Protocol Violation|0|||
126639369|NCT01426347|455637832|FG000|Overall Study|Withdrawal by Subject|5|||
126639370|NCT01426347|455637833|FG001|Overall Study|Withdrawal by Subject|0|||
126639371|NCT00455741|455637834|FG000|Overall Study|Physician Decision|0|||
126639372|NCT00455741|455637835|FG001|Overall Study|Physician Decision|1|||
126639373|NCT01245374|455637840|FG000|Overall Study|Protocol Violation|1|||
126639374|NCT01245374|455637840|FG000|Overall Study|Withdrawal by Subject|3|||
126639375|NCT00935532|455637841|FG000|Overall Study|Adverse Event|11|||
126639376|NCT00935532|455637842|FG001|Overall Study|Adverse Event|6|||
126639377|NCT00935532|455637841|FG000|Overall Study|Death|1|||
126639378|NCT00935532|455637842|FG001|Overall Study|Death|0|||
126639379|NCT00935532|455637841|FG000|Overall Study|Lost to Follow-up|1|||
126639380|NCT00935532|455637842|FG001|Overall Study|Lost to Follow-up|0|||
126639381|NCT00935532|455637841|FG000|Overall Study|Physician Decision|1|||
126639382|NCT00935532|455637842|FG001|Overall Study|Physician Decision|2|||
126639383|NCT00935532|455637841|FG000|Overall Study|Protocol Violation|2|||
126639384|NCT00935532|455637842|FG001|Overall Study|Protocol Violation|1|||
126639385|NCT00935532|455637841|FG000|Overall Study|Subject Decision|2|||
126639386|NCT00935532|455637842|FG001|Overall Study|Subject Decision|1|||
126639387|NCT00935532|455637841|FG000|Overall Study|Sponsor Decision|0|||
126639388|NCT00935532|455637842|FG001|Overall Study|Sponsor Decision|1|||
126639389|NCT00935532|455637841|FG000|Overall Study|Loss Glucose Control|4|||
126639390|NCT00935532|455637842|FG001|Overall Study|Loss Glucose Control|0|||
126639391|NCT04954326|455637843|FG000|Overall Study|Protocol Violation|0|||
126639392|NCT04954326|455637844|FG001|Overall Study|Protocol Violation|1|||
126639393|NCT04954326|455637843|FG000|Overall Study|Death|0|||
126639394|NCT04954326|455637844|FG001|Overall Study|Death|2|||
126639395|NCT04954326|455637843|FG000|Overall Study|Physician Decision|0|||
126639396|NCT04954326|455637844|FG001|Overall Study|Physician Decision|1|||
126639397|NCT04982575|455637845|FG000|Overall Study|Withdrawal by Subject|2|||
126639398|NCT04982575|455637846|FG001|Overall Study|Withdrawal by Subject|0|||
126639399|NCT04982575|455637847|FG002|Overall Study|Withdrawal by Subject|2|||
126639400|NCT01151423|455637848|FG000|Overall Study|Study terminated by Sponsor|9|||
126639401|NCT01151423|455637849|FG001|Overall Study|Study terminated by Sponsor|10|||
126639402|NCT01151423|455637848|FG000|Overall Study|Protocol Violation|0|||
126639403|NCT01151423|455637849|FG001|Overall Study|Protocol Violation|1|||
126639404|NCT01151423|455637848|FG000|Overall Study|Physician Decision|1|||
126639405|NCT01151423|455637849|FG001|Overall Study|Physician Decision|1|||
126639406|NCT01151423|455637848|FG000|Overall Study|Pregnancy|0|||
126639407|NCT01151423|455637849|FG001|Overall Study|Pregnancy|1|||
126639408|NCT01151423|455637848|FG000|Overall Study|Death|0|||
126639409|NCT01151423|455637849|FG001|Overall Study|Death|1|||
126639410|NCT01151423|455637848|FG000|Overall Study|Adverse Event|3|||
126639411|NCT01151423|455637849|FG001|Overall Study|Adverse Event|0|||
126639412|NCT01151423|455637848|FG000|Overall Study|Withdrawal by Subject|1|||
126639413|NCT01151423|455637849|FG001|Overall Study|Withdrawal by Subject|3|||
126639414|NCT01151423|455637848|FG000|Overall Study|Lost to Follow-up|1|||
126639415|NCT01151423|455637849|FG001|Overall Study|Lost to Follow-up|0|||
126639416|NCT01151423|455637848|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
126639417|NCT01151423|455637849|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
126639418|NCT01151423|455637848|FG000|Overall Study|Participated in other clinical trial|1|||
126639419|NCT01151423|455637849|FG001|Overall Study|Participated in other clinical trial|0|||
126639420|NCT00475228|455637850|FG000|Overall Study|Lost to Follow-up|17|||
126639421|NCT00475228|455637851|FG001|Overall Study|Lost to Follow-up|17|||
126639422|NCT04949802|455639623|FG000|Overall Study|Lost to Follow-up|3|||
126639423|NCT02473965|455639624|FG000|Overall Study|Adverse Event|6|||
126639424|NCT02473965|455639625|FG001|Overall Study|Adverse Event|4|||
126639425|NCT02473965|455639624|FG000|Overall Study|MG worsening|4|||
126639426|NCT02473965|455639625|FG001|Overall Study|MG worsening|1|||
126639427|NCT02473965|455639624|FG000|Overall Study|Withdrawal by Subject|2|||
126639428|NCT02473965|455639625|FG001|Overall Study|Withdrawal by Subject|3|||
126639429|NCT02473965|455639624|FG000|Overall Study|Physician Decision|0|||
126639430|NCT02473965|455639625|FG001|Overall Study|Physician Decision|2|||
126639431|NCT01183390|455639626|FG000|First Intervention|Adverse Event|0|||
126639432|NCT01183390|455639627|FG001|First Intervention|Adverse Event|1|||
126639433|NCT03816761|455639628|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
126639434|NCT03816761|455639629|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
126639435|NCT03816761|455639630|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
126639436|NCT03816761|455639631|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
126639437|NCT03816761|455639632|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
126639438|NCT03816761|455639633|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
126639439|NCT03816761|455639628|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
126639440|NCT03816761|455639629|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
126639441|NCT03816761|455639630|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
126639442|NCT03816761|455639631|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
126639443|NCT03816761|455639632|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
126639444|NCT03816761|455639633|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
126639445|NCT01240551|455639634|FG000|Overall Study|Refused further treatment|3|||
126639446|NCT01240551|455639635|FG001|Overall Study|Refused further treatment|2|||
126639447|NCT01240551|455639634|FG000|Overall Study|Lost to Follow-up|1|||
126639448|NCT01240551|455639635|FG001|Overall Study|Lost to Follow-up|1|||
126639449|NCT01730950|455639641|FG000|Overall Study|Protocol Violation|6|||
126639450|NCT01730950|455639642|FG001|Overall Study|Protocol Violation|6|||
126639451|NCT00667459|455639643|FG000|Overall Study|Death|0|||
126639452|NCT00667459|455639644|FG001|Overall Study|Death|2|||
126639453|NCT00667459|455639643|FG000|Overall Study|Lost to Follow-up|8|||
126639454|NCT00667459|455639644|FG001|Overall Study|Lost to Follow-up|43|||
126639455|NCT02568397|455639645|FG000|Period 2|Withdrawal by Subject|0|||
126639456|NCT02568397|455639646|FG001|Period 2|Withdrawal by Subject|1|||
126639457|NCT02568397|455639645|FG000|Period 2|Physician Decision|0|||
126639458|NCT02568397|455639646|FG001|Period 2|Physician Decision|1|||
126639459|NCT01200342|455639647|FG000|Overall Study|Disease Progression|1|||
126639460|NCT04546217|455639650|FG000|Overall Study|Withdrawal by Subject|2|||
126639461|NCT04546217|455639651|FG001|Overall Study|Withdrawal by Subject|0|||
126639462|NCT04546217|455639650|FG000|Overall Study|Uncontrolled hypertension|1|||
126639463|NCT04546217|455639651|FG001|Overall Study|Uncontrolled hypertension|0|||
126639464|NCT02550938|455639652|FG000|Overall Study|Lost to Follow-up|8|||
126639465|NCT02550938|455639653|FG001|Overall Study|Lost to Follow-up|7|||
126639466|NCT02550938|455639654|FG002|Overall Study|Lost to Follow-up|12|||
126639467|NCT02550938|455639655|FG003|Overall Study|Lost to Follow-up|11|||
126639468|NCT01484431|455639656|FG000|Period 1: High Dose|Physician Decision|0|||
126639469|NCT01484431|455639657|FG001|Period 1: High Dose|Physician Decision|1|||
126639470|NCT01484431|455639658|FG002|Period 1: High Dose|Physician Decision|0|||
126639471|NCT01484431|455639656|FG000|Period 2|Death|0|||
126639472|NCT01484431|455639657|FG001|Period 2|Death|1|||
126639473|NCT01484431|455639658|FG002|Period 2|Death|1|||
126639474|NCT01484431|455639656|FG000|Period 2|Physician Decision|0|||
126639475|NCT01484431|455639657|FG001|Period 2|Physician Decision|0|||
126639476|NCT01484431|455639658|FG002|Period 2|Physician Decision|1|||
126639477|NCT01484431|455639656|FG000|Period 2|Non-Compliance with Study Drug|1|||
126639478|NCT01484431|455639657|FG001|Period 2|Non-Compliance with Study Drug|0|||
126639479|NCT01484431|455639658|FG002|Period 2|Non-Compliance with Study Drug|0|||
126639480|NCT01888874|455639662|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
126639481|NCT01888874|455639663|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
126639482|NCT01888874|455639664|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
126639483|NCT01888874|455639665|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
126639484|NCT01888874|455639666|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
126639485|NCT01888874|455639667|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
126639486|NCT01888874|455639668|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
126639487|NCT01888874|455639662|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
126639488|NCT01888874|455639663|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
126639489|NCT01888874|455639664|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
126639490|NCT01888874|455639665|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
126639491|NCT01888874|455639666|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
126639492|NCT01888874|455639667|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
126639493|NCT01888874|455639668|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
126639494|NCT01888874|455639662|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
126639495|NCT01888874|455639663|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
126639496|NCT01888874|455639664|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
126639497|NCT01888874|455639665|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
126639498|NCT01888874|455639666|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
126639499|NCT01888874|455639667|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
126639500|NCT01888874|455639668|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
126639501|NCT01888874|455639662|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
126639502|NCT01888874|455639663|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
126639503|NCT01888874|455639664|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
126639504|NCT01888874|455639665|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
126639505|NCT01888874|455639666|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
126639506|NCT01888874|455639667|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
126639507|NCT01888874|455639668|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
126639508|NCT01888874|455639662|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126639509|NCT01888874|455639663|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126639510|NCT01888874|455639664|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126639511|NCT01888874|455639665|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126639512|NCT01888874|455639666|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
126639513|NCT01888874|455639667|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126639514|NCT01888874|455639668|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
126639515|NCT01888874|455639662|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
126639516|NCT01888874|455639663|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
126639517|NCT01888874|455639664|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
126639518|NCT01888874|455639665|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
126639519|NCT01888874|455639666|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
126639520|NCT01888874|455639667|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
126639521|NCT01888874|455639668|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
126639522|NCT01888874|455639662|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
126639523|NCT01888874|455639663|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
126639524|NCT01888874|455639664|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
126639525|NCT01888874|455639665|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
126639526|NCT01888874|455639666|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
126639527|NCT01888874|455639667|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
126639528|NCT01888874|455639668|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
126639529|NCT01888874|455639662|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
126639530|NCT01888874|455639663|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
126639531|NCT01888874|455639664|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
126639532|NCT01888874|455639665|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
126639533|NCT01888874|455639666|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
126639534|NCT01888874|455639667|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
126639535|NCT01888874|455639668|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
126639536|NCT01888874|455639662|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
126639537|NCT01888874|455639663|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
126639538|NCT01888874|455639664|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
126639539|NCT01888874|455639665|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
126639540|NCT01888874|455639666|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
126639541|NCT01888874|455639667|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
126639542|NCT01888874|455639668|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
126639543|NCT01888874|455639662|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
126639544|NCT01888874|455639663|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
126639545|NCT01888874|455639664|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
126639546|NCT01888874|455639665|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
126639547|NCT01888874|455639666|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
126639548|NCT01888874|455639667|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
126639549|NCT01888874|455639668|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
126639550|NCT01888874|455639662|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
126639551|NCT01888874|455639663|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
126639552|NCT01888874|455639664|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
126639553|NCT01888874|455639665|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
126639554|NCT01888874|455639666|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
126639555|NCT01888874|455639667|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
126639556|NCT01888874|455639668|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
126639557|NCT01888874|455639662|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
126639558|NCT01888874|455639663|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
126639559|NCT01888874|455639664|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
126639560|NCT01888874|455639665|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
126639561|NCT01888874|455639666|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
126639562|NCT01888874|455639667|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
126639563|NCT01888874|455639668|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
126639564|NCT01888874|455639662|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
126639565|NCT01888874|455639663|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
126639566|NCT01888874|455639664|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
126639567|NCT01888874|455639665|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
126639568|NCT01888874|455639666|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
126639569|NCT01888874|455639667|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
126639570|NCT01888874|455639668|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
126639571|NCT02980042|455639671|FG000|Overall Study|Lost to Follow-up|5|||
126639572|NCT02980042|455639672|FG001|Overall Study|Lost to Follow-up|0|||
126639573|NCT02980042|455639671|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
126639574|NCT02980042|455639672|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
126639575|NCT01483144|455639680|FG000|Overall Study|Adverse Event|9|||
126639576|NCT01483144|455639681|FG001|Overall Study|Adverse Event|4|||
126639577|NCT01483144|455639682|FG002|Overall Study|Adverse Event|6|||
126639578|NCT01483144|455639680|FG000|Overall Study|Withdrawal by Subject|0|||
126639579|NCT01483144|455639681|FG001|Overall Study|Withdrawal by Subject|2|||
126639580|NCT01483144|455639682|FG002|Overall Study|Withdrawal by Subject|5|||
126639581|NCT01483144|455639680|FG000|Overall Study|Physician Decision|1|||
126639582|NCT01483144|455639681|FG001|Overall Study|Physician Decision|0|||
126639583|NCT01483144|455639682|FG002|Overall Study|Physician Decision|0|||
126639584|NCT01483144|455639680|FG000|Overall Study|Lost to Follow-up|2|||
126639585|NCT01483144|455639681|FG001|Overall Study|Lost to Follow-up|4|||
126639586|NCT01483144|455639682|FG002|Overall Study|Lost to Follow-up|1|||
126639587|NCT01483144|455639680|FG000|Overall Study|Protocol Violation|3|||
126639588|NCT01483144|455639681|FG001|Overall Study|Protocol Violation|3|||
126639589|NCT01483144|455639682|FG002|Overall Study|Protocol Violation|3|||
126639590|NCT02460575|455639683|FG000|Overall Study|Lost to Follow-up|1|||
126639591|NCT02460575|455639684|FG001|Overall Study|Lost to Follow-up|0|||
126639592|NCT02870972|455639685|FG000|Overall Study|Adverse Event|1|||
126639593|NCT02870972|455639686|FG001|Overall Study|Adverse Event|0|||
126639594|NCT02870972|455639687|FG002|Overall Study|Adverse Event|0|||
126639595|NCT02870972|455639688|FG003|Overall Study|Adverse Event|0|||
126639596|NCT02870972|455639689|FG004|Overall Study|Adverse Event|0|||
126639597|NCT02179177|455639690|FG000|Overall Study|Lost to Follow-up|1|||
126639598|NCT02179177|455639691|FG001|Overall Study|Lost to Follow-up|1|||
126639599|NCT02179177|455639690|FG000|Overall Study|Withdrawal by Subject|1|||
126639600|NCT02179177|455639691|FG001|Overall Study|Withdrawal by Subject|1|||
126639601|NCT04497389|455639692|FG000|Overall Study|Withdrawal by Subject|1|||
126639602|NCT04497389|455639693|FG001|Overall Study|Withdrawal by Subject|0|||
126639603|NCT04052425|455639694|FG000|24-Week Double-blind Period|Adverse Event|0|||
126639604|NCT04052425|455639695|FG001|24-Week Double-blind Period|Adverse Event|1|||
126639605|NCT04052425|455639696|FG002|24-Week Double-blind Period|Adverse Event|0|||
126639606|NCT04052425|455639697|FG003|24-Week Double-blind Period|Adverse Event|0|||
126639607|NCT04052425|455639694|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
126639608|NCT04052425|455639695|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
126639609|NCT04052425|455639696|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
126639610|NCT04052425|455639697|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
126639611|NCT04052425|455639694|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
126639612|NCT04052425|455639695|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
126639613|NCT04052425|455639696|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
126639614|NCT04052425|455639697|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
126639615|NCT04052425|455639694|FG000|24-Week Double-blind Period|Physician Decision|1|||
126639616|NCT04052425|455639695|FG001|24-Week Double-blind Period|Physician Decision|0|||
126639617|NCT04052425|455639696|FG002|24-Week Double-blind Period|Physician Decision|0|||
126639618|NCT04052425|455639697|FG003|24-Week Double-blind Period|Physician Decision|0|||
126639619|NCT04052425|455639694|FG000|24-Week Double-blind Period|Protocol Violation|1|||
126639620|NCT04052425|455639695|FG001|24-Week Double-blind Period|Protocol Violation|0|||
126639621|NCT04052425|455639696|FG002|24-Week Double-blind Period|Protocol Violation|0|||
126639622|NCT04052425|455639697|FG003|24-Week Double-blind Period|Protocol Violation|0|||
126639623|NCT04052425|455639694|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
126639624|NCT04052425|455639695|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
126639625|NCT04052425|455639696|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
126639626|NCT04052425|455639697|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
126639627|NCT04052425|455639694|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
126639628|NCT04052425|455639695|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
126639629|NCT04052425|455639696|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
126639630|NCT04052425|455639697|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
126639631|NCT04052425|455639694|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
126639632|NCT04052425|455639695|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
126639633|NCT04052425|455639696|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
126639634|NCT04052425|455639697|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
126639635|NCT04052425|455639694|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
126639636|NCT04052425|455639695|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
126639637|NCT04052425|455639696|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
126639638|NCT04052425|455639697|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
126639639|NCT04052425|455639694|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
126639640|NCT04052425|455639695|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
126639641|NCT04052425|455639696|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
126639642|NCT04052425|455639697|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
126639643|NCT04052425|455639694|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
126639644|NCT04052425|455639695|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
126639645|NCT04052425|455639696|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
126639646|NCT04052425|455639697|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
126639647|NCT04052425|455639694|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
126639648|NCT04052425|455639695|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
126639649|NCT04052425|455639696|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
126639650|NCT04052425|455639697|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
126639651|NCT04052425|455639694|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
126639652|NCT04052425|455639695|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
126639653|NCT04052425|455639696|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
126639654|NCT04052425|455639697|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
126639655|NCT04052425|455639694|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
126639656|NCT04052425|455639695|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
126639657|NCT04052425|455639696|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
126639658|NCT04052425|455639697|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
126639659|NCT04829747|455639700|FG000|Overall Study|Protocol Violation|1|||
126639660|NCT02615509|455639703|FG000|Overall Study|Lost to Follow-up|134|||
126639661|NCT02615509|455639703|FG000|Overall Study|Death|4|||
126639662|NCT02615509|455639703|FG000|Overall Study|Withdrawal by Subject|8|||
126639663|NCT00425607|455639704|FG000|Overall Study|Death|1|||
126639664|NCT00425607|455639704|FG000|Overall Study|Withdrawal by Subject|1|||
126639665|NCT00079339|455639705|FG000|Overall Study|Adverse Event|1|||
126639666|NCT00079339|455639706|FG001|Overall Study|Adverse Event|7|||
126639667|NCT00079339|455639707|FG002|Overall Study|Adverse Event|2|||
126639668|NCT00079339|455639705|FG000|Overall Study|Death|1|||
126639669|NCT00079339|455639706|FG001|Overall Study|Death|0|||
126639670|NCT00079339|455639707|FG002|Overall Study|Death|0|||
126639671|NCT00079339|455639705|FG000|Overall Study|Non-compliance|0|||
126639672|NCT00079339|455639706|FG001|Overall Study|Non-compliance|0|||
126639673|NCT00079339|455639707|FG002|Overall Study|Non-compliance|1|||
126639674|NCT00079339|455639705|FG000|Overall Study|Withdrawal by Subject|0|||
126639675|NCT00079339|455639706|FG001|Overall Study|Withdrawal by Subject|4|||
126639676|NCT00079339|455639707|FG002|Overall Study|Withdrawal by Subject|1|||
126639677|NCT00079339|455639705|FG000|Overall Study|Disease progression|3|||
126639678|NCT00079339|455639706|FG001|Overall Study|Disease progression|28|||
126639679|NCT00079339|455639707|FG002|Overall Study|Disease progression|2|||
126639680|NCT02563548|455639708|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
126639681|NCT02563548|455639709|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
126639682|NCT02563548|455639710|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
126639683|NCT02563548|455639711|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
126639684|NCT02563548|455639712|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
126639685|NCT02563548|455639713|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
126639686|NCT02563548|455639708|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
126639687|NCT02563548|455639709|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
126639688|NCT02563548|455639710|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
126639689|NCT02563548|455639711|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
126639690|NCT02563548|455639712|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
126639691|NCT02563548|455639713|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
126639692|NCT02563548|455639708|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
126639693|NCT02563548|455639709|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
126639694|NCT02563548|455639710|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
126639695|NCT02563548|455639711|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
126639696|NCT02563548|455639712|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
126639697|NCT02563548|455639713|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
126639698|NCT02563548|455639708|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
126639699|NCT02563548|455639709|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
126639700|NCT02563548|455639710|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
126639701|NCT02563548|455639711|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
126639702|NCT02563548|455639712|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
126639703|NCT02563548|455639713|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
126639704|NCT02563548|455639708|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
126639705|NCT02563548|455639709|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
126639706|NCT02563548|455639710|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
126639707|NCT02563548|455639711|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
126639708|NCT02563548|455639712|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
126639709|NCT02563548|455639713|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
126639710|NCT02563548|455639708|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
126639711|NCT02563548|455639709|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
126639712|NCT02563548|455639710|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
126639713|NCT02563548|455639711|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
126639714|NCT02563548|455639712|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
126639715|NCT02563548|455639713|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
126639716|NCT02563548|455639708|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
126639717|NCT02563548|455639709|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
126639718|NCT02563548|455639710|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
126639719|NCT02563548|455639711|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
126639720|NCT02563548|455639712|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
126639721|NCT02563548|455639713|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
126639722|NCT02563548|455639708|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
126639723|NCT02563548|455639709|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
126639724|NCT02563548|455639710|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
126639725|NCT02563548|455639711|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
126639726|NCT02563548|455639712|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
126639727|NCT02563548|455639713|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
126639728|NCT02563548|455639708|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
126639729|NCT02563548|455639709|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
126639730|NCT02563548|455639710|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
126639731|NCT02563548|455639711|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
126639732|NCT02563548|455639712|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
126639733|NCT02563548|455639713|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
126639734|NCT02563548|455639708|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
126639735|NCT02563548|455639709|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
126639736|NCT02563548|455639710|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
126639737|NCT02563548|455639711|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
126639738|NCT02563548|455639712|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
126639739|NCT02563548|455639713|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
126639740|NCT02563548|455639708|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
126639741|NCT02563548|455639709|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
126639742|NCT02563548|455639710|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
126639743|NCT02563548|455639711|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
126639744|NCT02563548|455639712|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
126639745|NCT02563548|455639713|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
126639746|NCT02563548|455639708|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
126639747|NCT02563548|455639709|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
126639748|NCT02563548|455639710|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
126639749|NCT02563548|455639711|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
126639750|NCT02563548|455639712|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
126639751|NCT02563548|455639713|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
126639752|NCT00520845|455639714|FG000|Overall Study|Death|3|||
126639753|NCT00520845|455639714|FG000|Overall Study|Adverse Event|4|||
126639754|NCT00520845|455639714|FG000|Overall Study|Disease Progression, relapse|13|||
126639755|NCT00520845|455639714|FG000|Overall Study|Withdrawal by Subject|1|||
126639756|NCT00520845|455639714|FG000|Overall Study|Alternative Therapy|1|||
126639757|NCT03274453|455639717|FG000|Overall Study|Lost to Follow-up|2|||
126639758|NCT03274453|455639718|FG001|Overall Study|Lost to Follow-up|5|||
126639759|NCT03274453|455639719|FG002|Overall Study|Lost to Follow-up|4|||
126639760|NCT03274453|455639720|FG003|Overall Study|Lost to Follow-up|1|||
126639761|NCT03274453|455639717|FG000|Overall Study|Physician Decision|2|||
126639762|NCT03274453|455639718|FG001|Overall Study|Physician Decision|0|||
126639763|NCT03274453|455639719|FG002|Overall Study|Physician Decision|0|||
126639764|NCT03274453|455639720|FG003|Overall Study|Physician Decision|3|||
126639765|NCT03274453|455639717|FG000|Overall Study|Surgery Cancelled|0|||
126639766|NCT03274453|455639718|FG001|Overall Study|Surgery Cancelled|1|||
126639767|NCT03274453|455639719|FG002|Overall Study|Surgery Cancelled|0|||
126639768|NCT03274453|455639720|FG003|Overall Study|Surgery Cancelled|0|||
126639769|NCT01516749|455639722|FG000|Active Therapy|Lost to Follow-up|1|||
126639770|NCT01516749|455639722|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
126639771|NCT00351377|455639723|FG000|Overall Study|Adverse Event|5|||
126639772|NCT00351377|455639723|FG000|Overall Study|Death|1|||
126639773|NCT00351377|455639723|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
126639774|NCT01732549|455639724|FG000|Overall Study|Adverse Event|13|||
126639775|NCT01732549|455639725|FG001|Overall Study|Adverse Event|3|||
126639776|NCT01732549|455639724|FG000|Overall Study|Consent withdrawn|13|||
126639777|NCT01732549|455639725|FG001|Overall Study|Consent withdrawn|6|||
126639778|NCT01732549|455639724|FG000|Overall Study|Disease progression|37|||
126639779|NCT01732549|455639725|FG001|Overall Study|Disease progression|50|||
126639780|NCT01732549|455639724|FG000|Overall Study|Other|8|||
126639781|NCT01732549|455639725|FG001|Overall Study|Other|14|||
126639782|NCT02493062|455639730|FG000|Overall Study|Physician Decision|12|||
126639783|NCT03845140|455639731|FG000|Overall Study|Participant travelled outside study area|0|||
126639784|NCT03845140|455639732|FG001|Overall Study|Participant travelled outside study area|1|||
126639785|NCT03845140|455639733|FG002|Overall Study|Participant travelled outside study area|0|||
126639786|NCT03845140|455639734|FG003|Overall Study|Participant travelled outside study area|0|||
126639787|NCT03845140|455639735|FG004|Overall Study|Participant travelled outside study area|0|||
126639788|NCT03845140|455639736|FG005|Overall Study|Participant travelled outside study area|0|||
126639789|NCT01327612|455639742|FG000|Overall Study|Withdrawal by Subject|0|||
126639790|NCT01327612|455639743|FG001|Overall Study|Withdrawal by Subject|0|||
126639791|NCT01327612|455639744|FG002|Overall Study|Withdrawal by Subject|0|||
126639792|NCT01327612|455639745|FG003|Overall Study|Withdrawal by Subject|0|||
126639793|NCT01327612|455639746|FG004|Overall Study|Withdrawal by Subject|0|||
126639794|NCT01327612|455639747|FG005|Overall Study|Withdrawal by Subject|1|||
126639795|NCT01327612|455639748|FG006|Overall Study|Withdrawal by Subject|0|||
126639796|NCT01327612|455639742|FG000|Overall Study|Disease Progression|1|||
126639797|NCT01327612|455639743|FG001|Overall Study|Disease Progression|1|||
126639798|NCT01327612|455639744|FG002|Overall Study|Disease Progression|1|||
126639799|NCT01327612|455639745|FG003|Overall Study|Disease Progression|0|||
126639800|NCT01327612|455639746|FG004|Overall Study|Disease Progression|1|||
126639801|NCT01327612|455639747|FG005|Overall Study|Disease Progression|2|||
126639802|NCT01327612|455639748|FG006|Overall Study|Disease Progression|2|||
126639803|NCT01327612|455639742|FG000|Overall Study|Administrative Decision|0|||
126639804|NCT01327612|455639743|FG001|Overall Study|Administrative Decision|0|||
126639805|NCT01327612|455639744|FG002|Overall Study|Administrative Decision|0|||
126639806|NCT01327612|455639745|FG003|Overall Study|Administrative Decision|1|||
126639807|NCT01327612|455639746|FG004|Overall Study|Administrative Decision|0|||
126639808|NCT01327612|455639747|FG005|Overall Study|Administrative Decision|0|||
126639809|NCT01327612|455639748|FG006|Overall Study|Administrative Decision|0|||
126639810|NCT01327612|455639742|FG000|Overall Study|Death|0|||
126639811|NCT01327612|455639743|FG001|Overall Study|Death|0|||
126639812|NCT01327612|455639744|FG002|Overall Study|Death|0|||
126639813|NCT01327612|455639745|FG003|Overall Study|Death|0|||
126639814|NCT01327612|455639746|FG004|Overall Study|Death|1|||
126639815|NCT01327612|455639747|FG005|Overall Study|Death|0|||
126639816|NCT01327612|455639748|FG006|Overall Study|Death|0|||
126639817|NCT00447590|455639749|FG000|Overall Study|Withdrawal by Subject|26|||
126639818|NCT00447590|455639749|FG000|Overall Study|Lost to Follow-up|24|||
126639819|NCT00447590|455639749|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
126639820|NCT01661205|455639750|FG000|Overall Study|Physician Decision|2|||
126639821|NCT05569421|455639755|FG000|Overall Study|Withdrawal by Subject|1|||
126639822|NCT05569421|455639756|FG001|Overall Study|Withdrawal by Subject|0|||
126639823|NCT05569421|455639757|FG002|Overall Study|Withdrawal by Subject|0|||
126639824|NCT03111095|455639758|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
126639825|NCT03111095|455639759|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
126639826|NCT03111095|455639758|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
126639827|NCT03111095|455639759|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
126639828|NCT00504075|455639760|FG000|Overall Study|Adverse Event|1|||
126639829|NCT00504075|455639760|FG000|Overall Study|Lost to Follow-up|5|||
126639830|NCT00504075|455639760|FG000|Overall Study|Withdrawal by Subject|1|||
126639831|NCT00504075|455639760|FG000|Overall Study|Required other therapeutic intervention|1|||
126639832|NCT01689857|455639762|FG000|Overall Study|Lost to Follow-up|5|||
126639833|NCT01689857|455639763|FG001|Overall Study|Lost to Follow-up|2|||
126639834|NCT05105087|455639764|FG000|Overall Study|Withdrawal by Subject|2|||
126639835|NCT05105087|455639764|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
126639836|NCT03106753|455639767|FG000|Overall Study|Withdrawal by Subject|0|||
126639837|NCT03106753|455639768|FG001|Overall Study|Withdrawal by Subject|1|||
126639838|NCT03229486|455639773|FG000|Overall Study|Protocol Violation|0|||
126639839|NCT03229486|455639774|FG001|Overall Study|Protocol Violation|1|||
126639840|NCT01461005|455639775|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
126639841|NCT00844597|455639778|FG000|Overall Study|Adverse Event|0|||
126639842|NCT00844597|455639779|FG001|Overall Study|Adverse Event|0|||
126639843|NCT00844597|455639780|FG002|Overall Study|Adverse Event|0|||
126639844|NCT00844597|455639781|FG003|Overall Study|Adverse Event|1|||
126639845|NCT00844597|455639782|FG004|Overall Study|Adverse Event|0|||
126639846|NCT00844597|455639783|FG005|Overall Study|Adverse Event|0|||
126639847|NCT02670122|455639784|FG000|Overall Study|Lost to Follow-up|4|||
126639848|NCT02762903|455639789|FG000|Overall Study|Lost to Follow-up|0|||
126639849|NCT02762903|455639790|FG001|Overall Study|Lost to Follow-up|1|||
126639850|NCT01228175|455639791|FG000|Overall Study|Lost to Follow-up|64|||
126639851|NCT01228175|455639792|FG001|Overall Study|Lost to Follow-up|50|||
126639852|NCT01228175|455639791|FG000|Overall Study|Withdrawal by Subject|1|||
126639853|NCT01228175|455639792|FG001|Overall Study|Withdrawal by Subject|2|||
126639854|NCT01228175|455639791|FG000|Overall Study|Physician Decision|1|||
126639855|NCT01228175|455639792|FG001|Overall Study|Physician Decision|1|||
126639856|NCT00243074|455639793|FG000|Overall Study|Ineligible|6|||
126639857|NCT00243074|455639793|FG000|Overall Study|Adverse Event|6|||
126639858|NCT00243074|455639793|FG000|Overall Study|Withdrawal by Subject|2|||
126639859|NCT00243074|455639793|FG000|Overall Study|Lack of Efficacy|36|||
126639860|NCT00243074|455639793|FG000|Overall Study|Death|2|||
126639861|NCT00243074|455639793|FG000|Overall Study|not protocol specified|1|||
126639862|NCT00243074|455639793|FG000|Overall Study|Did not receive any treatment|1|||
126639863|NCT02227992|455639794|FG000|Overall Study|Lost to Follow-up|1|||
126639864|NCT02227992|455639795|FG001|Overall Study|Lost to Follow-up|1|||
126639865|NCT02358668|455642657|FG000|Overall Study|Adverse Event|2|||
126639866|NCT02358668|455642658|FG001|Overall Study|Adverse Event|0|||
126639867|NCT02358668|455642659|FG002|Overall Study|Adverse Event|0|||
126639868|NCT02358668|455642657|FG000|Overall Study|Withdrawal by Subject|0|||
126639869|NCT02358668|455642658|FG001|Overall Study|Withdrawal by Subject|1|||
126639870|NCT02358668|455642659|FG002|Overall Study|Withdrawal by Subject|0|||
126639871|NCT04057573|455642660|FG000|24-Week Double-Blind Period|Adverse Event|2|||
126639872|NCT04057573|455642661|FG001|24-Week Double-Blind Period|Adverse Event|0|||
126639873|NCT04057573|455642662|FG002|24-Week Double-Blind Period|Adverse Event|0|||
126639874|NCT04057573|455642663|FG003|24-Week Double-Blind Period|Adverse Event|0|||
126639875|NCT04057573|455642660|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
126639876|NCT04057573|455642661|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
126639877|NCT04057573|455642662|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
126639878|NCT04057573|455642663|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
126639879|NCT04057573|455642660|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
126639880|NCT04057573|455642661|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
126639881|NCT04057573|455642662|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
126639882|NCT04057573|455642663|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
126639883|NCT04057573|455642660|FG000|24-Week Double-Blind Period|Physician Decision|1|||
126639884|NCT04057573|455642661|FG001|24-Week Double-Blind Period|Physician Decision|0|||
126639885|NCT04057573|455642662|FG002|24-Week Double-Blind Period|Physician Decision|0|||
126639886|NCT04057573|455642663|FG003|24-Week Double-Blind Period|Physician Decision|0|||
126639887|NCT04057573|455642660|FG000|24-Week Double-Blind Period|Pregnancy|1|||
126639888|NCT04057573|455642661|FG001|24-Week Double-Blind Period|Pregnancy|0|||
126639889|NCT04057573|455642662|FG002|24-Week Double-Blind Period|Pregnancy|0|||
126639890|NCT04057573|455642663|FG003|24-Week Double-Blind Period|Pregnancy|0|||
126639891|NCT04057573|455642660|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
126639892|NCT04057573|455642661|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
126639893|NCT04057573|455642662|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
126639894|NCT04057573|455642663|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
126639895|NCT04057573|455642660|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
126639896|NCT04057573|455642661|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
126639897|NCT04057573|455642662|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
126639898|NCT04057573|455642663|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
126639899|NCT04057573|455642660|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
126639900|NCT04057573|455642661|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
126639901|NCT04057573|455642662|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
126639902|NCT04057573|455642663|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
126639903|NCT04057573|455642660|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
126639904|NCT04057573|455642661|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
126639905|NCT04057573|455642662|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
126639906|NCT04057573|455642663|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
126639907|NCT04057573|455642660|FG000|24-Week Double-Blind Period|Not Treated|1|||
126639908|NCT04057573|455642661|FG001|24-Week Double-Blind Period|Not Treated|0|||
126639909|NCT04057573|455642662|FG002|24-Week Double-Blind Period|Not Treated|0|||
126639910|NCT04057573|455642663|FG003|24-Week Double-Blind Period|Not Treated|0|||
126639911|NCT04057573|455642660|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
126639912|NCT04057573|455642661|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
126639913|NCT04057573|455642662|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
126639914|NCT04057573|455642663|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
126639915|NCT04057573|455642660|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
126639916|NCT04057573|455642661|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
126639917|NCT04057573|455642662|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
126639918|NCT04057573|455642663|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
126639919|NCT04057573|455642660|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
126639920|NCT04057573|455642661|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
126639921|NCT04057573|455642662|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
126639922|NCT04057573|455642663|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
126639923|NCT04057573|455642660|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
126639924|NCT04057573|455642661|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
126639925|NCT04057573|455642662|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
126639926|NCT04057573|455642663|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
126639927|NCT04057573|455642660|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
126639928|NCT04057573|455642661|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
126639929|NCT04057573|455642662|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
126639930|NCT04057573|455642663|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
126639931|NCT01317875|455642666|FG000|Overall Study|Other|0|||
126639932|NCT01317875|455642667|FG001|Overall Study|Other|0|||
126639933|NCT01317875|455642668|FG002|Overall Study|Other|1|||
126639934|NCT01317875|455642669|FG003|Overall Study|Other|0|||
126639935|NCT01317875|455642670|FG004|Overall Study|Other|0|||
126639936|NCT01317875|455642671|FG005|Overall Study|Other|0|||
126639937|NCT01317875|455642672|FG006|Overall Study|Other|0|||
126639938|NCT01317875|455642673|FG007|Overall Study|Other|0|||
126639939|NCT01317875|455642674|FG008|Overall Study|Other|0|||
126639940|NCT01317875|455642675|FG009|Overall Study|Other|0|||
126639941|NCT01317875|455642666|FG000|Overall Study|Noncompliance with study drug|0|||
126639942|NCT01317875|455642667|FG001|Overall Study|Noncompliance with study drug|0|||
126639943|NCT01317875|455642668|FG002|Overall Study|Noncompliance with study drug|1|||
126639944|NCT01317875|455642669|FG003|Overall Study|Noncompliance with study drug|0|||
126639945|NCT01317875|455642670|FG004|Overall Study|Noncompliance with study drug|0|||
126639946|NCT01317875|455642671|FG005|Overall Study|Noncompliance with study drug|0|||
126639947|NCT01317875|455642672|FG006|Overall Study|Noncompliance with study drug|0|||
126639948|NCT01317875|455642673|FG007|Overall Study|Noncompliance with study drug|0|||
126639949|NCT01317875|455642674|FG008|Overall Study|Noncompliance with study drug|0|||
126639950|NCT01317875|455642675|FG009|Overall Study|Noncompliance with study drug|0|||
126639951|NCT01317875|455642666|FG000|Overall Study|Progressive Disease|1|||
126639952|NCT01317875|455642667|FG001|Overall Study|Progressive Disease|0|||
126639953|NCT01317875|455642668|FG002|Overall Study|Progressive Disease|2|||
126639954|NCT01317875|455642669|FG003|Overall Study|Progressive Disease|0|||
126639955|NCT01317875|455642670|FG004|Overall Study|Progressive Disease|1|||
126639956|NCT01317875|455642671|FG005|Overall Study|Progressive Disease|0|||
126639957|NCT01317875|455642672|FG006|Overall Study|Progressive Disease|0|||
126639958|NCT01317875|455642673|FG007|Overall Study|Progressive Disease|1|||
126639959|NCT01317875|455642674|FG008|Overall Study|Progressive Disease|0|||
126639960|NCT01317875|455642675|FG009|Overall Study|Progressive Disease|0|||
126639961|NCT01317875|455642666|FG000|Overall Study|Withdrawal by Subject|0|||
126639962|NCT01317875|455642667|FG001|Overall Study|Withdrawal by Subject|0|||
126639963|NCT01317875|455642668|FG002|Overall Study|Withdrawal by Subject|0|||
126639964|NCT01317875|455642669|FG003|Overall Study|Withdrawal by Subject|0|||
126639965|NCT01317875|455642670|FG004|Overall Study|Withdrawal by Subject|1|||
126639966|NCT01317875|455642671|FG005|Overall Study|Withdrawal by Subject|0|||
126639967|NCT01317875|455642672|FG006|Overall Study|Withdrawal by Subject|0|||
126639968|NCT01317875|455642673|FG007|Overall Study|Withdrawal by Subject|3|||
126639969|NCT01317875|455642674|FG008|Overall Study|Withdrawal by Subject|0|||
126639970|NCT01317875|455642675|FG009|Overall Study|Withdrawal by Subject|0|||
126639971|NCT01317875|455642666|FG000|Overall Study|Physician Decision|0|||
126639972|NCT01317875|455642667|FG001|Overall Study|Physician Decision|1|||
126639973|NCT01317875|455642668|FG002|Overall Study|Physician Decision|1|||
126639974|NCT01317875|455642669|FG003|Overall Study|Physician Decision|0|||
126639975|NCT01317875|455642670|FG004|Overall Study|Physician Decision|2|||
126639976|NCT01317875|455642671|FG005|Overall Study|Physician Decision|0|||
126639977|NCT01317875|455642672|FG006|Overall Study|Physician Decision|0|||
126639978|NCT01317875|455642673|FG007|Overall Study|Physician Decision|2|||
126639979|NCT01317875|455642674|FG008|Overall Study|Physician Decision|0|||
126639980|NCT01317875|455642675|FG009|Overall Study|Physician Decision|0|||
126639981|NCT01317875|455642666|FG000|Overall Study|Death|0|||
126639982|NCT01317875|455642667|FG001|Overall Study|Death|0|||
126639983|NCT01317875|455642668|FG002|Overall Study|Death|2|||
126639984|NCT01317875|455642669|FG003|Overall Study|Death|1|||
126639985|NCT01317875|455642670|FG004|Overall Study|Death|0|||
126639986|NCT01317875|455642671|FG005|Overall Study|Death|1|||
126639987|NCT01317875|455642672|FG006|Overall Study|Death|0|||
126639988|NCT01317875|455642673|FG007|Overall Study|Death|4|||
126639989|NCT01317875|455642674|FG008|Overall Study|Death|0|||
126639990|NCT01317875|455642675|FG009|Overall Study|Death|0|||
126639991|NCT01317875|455642666|FG000|Overall Study|Adverse Event|2|||
126639992|NCT01317875|455642667|FG001|Overall Study|Adverse Event|1|||
126639993|NCT01317875|455642668|FG002|Overall Study|Adverse Event|2|||
126639994|NCT01317875|455642669|FG003|Overall Study|Adverse Event|1|||
126639995|NCT01317875|455642670|FG004|Overall Study|Adverse Event|5|||
126639996|NCT01317875|455642671|FG005|Overall Study|Adverse Event|1|||
126639997|NCT01317875|455642672|FG006|Overall Study|Adverse Event|2|||
126639998|NCT01317875|455642673|FG007|Overall Study|Adverse Event|5|||
126639999|NCT01317875|455642674|FG008|Overall Study|Adverse Event|0|||
126640000|NCT01317875|455642675|FG009|Overall Study|Adverse Event|0|||
126640001|NCT01381575|455642676|FG000|Overall Study|Serious Adverse Event|1|||
126640002|NCT01381575|455642677|FG001|Overall Study|Serious Adverse Event|0|||
126640003|NCT01381575|455642678|FG002|Overall Study|Serious Adverse Event|0|||
126640004|NCT01381575|455642676|FG000|Overall Study|Non-Serious Adverse Event|0|||
126640005|NCT01381575|455642677|FG001|Overall Study|Non-Serious Adverse Event|0|||
126640006|NCT01381575|455642678|FG002|Overall Study|Non-Serious Adverse Event|1|||
126640007|NCT01381575|455642676|FG000|Overall Study|Protocol Violation|0|||
126640008|NCT01381575|455642677|FG001|Overall Study|Protocol Violation|1|||
126640009|NCT01381575|455642678|FG002|Overall Study|Protocol Violation|1|||
126640010|NCT01381575|455642676|FG000|Overall Study|Withdrawal by Subject|15|||
126640011|NCT01381575|455642677|FG001|Overall Study|Withdrawal by Subject|9|||
126640012|NCT01381575|455642678|FG002|Overall Study|Withdrawal by Subject|7|||
126640013|NCT01381575|455642676|FG000|Overall Study|Migrated/moved from study area|2|||
126640014|NCT01381575|455642677|FG001|Overall Study|Migrated/moved from study area|12|||
126640015|NCT01381575|455642678|FG002|Overall Study|Migrated/moved from study area|2|||
126640016|NCT01381575|455642676|FG000|Overall Study|Lost to Follow-up|8|||
126640017|NCT01381575|455642677|FG001|Overall Study|Lost to Follow-up|17|||
126640018|NCT01381575|455642678|FG002|Overall Study|Lost to Follow-up|9|||
126640019|NCT01920477|455642679|FG000|Overall Study|Adverse Event|0|||
126640020|NCT01920477|455642680|FG001|Overall Study|Adverse Event|1|||
126640021|NCT01920477|455642679|FG000|Overall Study|Lack of Efficacy|1|||
126640022|NCT01920477|455642680|FG001|Overall Study|Lack of Efficacy|0|||
126640023|NCT01920477|455642679|FG000|Overall Study|Study closed/terminated|14|||
126640024|NCT01920477|455642680|FG001|Overall Study|Study closed/terminated|15|||
126640025|NCT01920477|455642679|FG000|Overall Study|Withdrawal by Subject|0|||
126640026|NCT01920477|455642680|FG001|Overall Study|Withdrawal by Subject|1|||
126640027|NCT01443403|455642681|FG000|Overall Study|Adverse Event|1|||
126640028|NCT01443403|455642682|FG001|Overall Study|Adverse Event|1|||
126640029|NCT01443403|455642683|FG002|Overall Study|Adverse Event|4|||
126640030|NCT01443403|455642684|FG003|Overall Study|Adverse Event|5|||
126640031|NCT01443403|455642681|FG000|Overall Study|Withdrawal by Subject|0|||
126640032|NCT01443403|455642682|FG001|Overall Study|Withdrawal by Subject|1|||
126640033|NCT01443403|455642683|FG002|Overall Study|Withdrawal by Subject|2|||
126640034|NCT01443403|455642684|FG003|Overall Study|Withdrawal by Subject|1|||
126640035|NCT01443403|455642681|FG000|Overall Study|Lost to Follow-up|0|||
126640036|NCT01443403|455642682|FG001|Overall Study|Lost to Follow-up|0|||
126640037|NCT01443403|455642683|FG002|Overall Study|Lost to Follow-up|0|||
126640038|NCT01443403|455642684|FG003|Overall Study|Lost to Follow-up|1|||
126640039|NCT01443403|455642681|FG000|Overall Study|Protocol Violation|2|||
126640040|NCT01443403|455642682|FG001|Overall Study|Protocol Violation|1|||
126640041|NCT01443403|455642683|FG002|Overall Study|Protocol Violation|1|||
126640042|NCT01443403|455642684|FG003|Overall Study|Protocol Violation|1|||
126640043|NCT01443403|455642681|FG000|Overall Study|Use of Prohibited Treatment|2|||
126640044|NCT01443403|455642682|FG001|Overall Study|Use of Prohibited Treatment|3|||
126640045|NCT01443403|455642683|FG002|Overall Study|Use of Prohibited Treatment|0|||
126640046|NCT01443403|455642684|FG003|Overall Study|Use of Prohibited Treatment|0|||
126640047|NCT01443403|455642681|FG000|Overall Study|Other - Miscellaneous|1|||
126640048|NCT01443403|455642682|FG001|Overall Study|Other - Miscellaneous|0|||
126640049|NCT01443403|455642683|FG002|Overall Study|Other - Miscellaneous|0|||
126640050|NCT01443403|455642684|FG003|Overall Study|Other - Miscellaneous|1|||
126640051|NCT01681277|455642685|FG000|Overall Study|Adverse Event|1|||
126640052|NCT01681277|455642686|FG001|Overall Study|Adverse Event|0|||
126640053|NCT01681277|455642687|FG002|Overall Study|Adverse Event|0|||
126640054|NCT01681277|455642688|FG003|Overall Study|Adverse Event|0|||
126640055|NCT01681277|455642689|FG004|Overall Study|Adverse Event|0|||
126640056|NCT00474526|455642690|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
126640057|NCT00474526|455642691|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
126640058|NCT00474526|455642692|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
126640059|NCT00474526|455642693|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
126640060|NCT00474526|455642694|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
126640061|NCT00474526|455642695|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
126640062|NCT00474526|455642696|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
126640063|NCT00474526|455642697|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
126640064|NCT00474526|455642698|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
126640065|NCT00474526|455642699|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
126640066|NCT00474526|455642700|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
126640067|NCT00474526|455642701|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
126640068|NCT00474526|455642702|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
126640069|NCT00474526|455642703|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
126640070|NCT00474526|455642704|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
126640071|NCT00474526|455642705|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
126640072|NCT00474526|455642706|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
126640073|NCT00474526|455642690|FG000|Overall Study|Adverse Event|2|||
126640074|NCT00474526|455642691|FG001|Overall Study|Adverse Event|0|||
126640075|NCT00474526|455642692|FG002|Overall Study|Adverse Event|2|||
126640076|NCT00474526|455642693|FG003|Overall Study|Adverse Event|4|||
126640077|NCT00474526|455642694|FG004|Overall Study|Adverse Event|2|||
126640078|NCT00474526|455642695|FG005|Overall Study|Adverse Event|1|||
126640079|NCT00474526|455642696|FG006|Overall Study|Adverse Event|1|||
126640080|NCT00474526|455642697|FG007|Overall Study|Adverse Event|0|||
126640081|NCT00474526|455642698|FG008|Overall Study|Adverse Event|0|||
126640082|NCT00474526|455642699|FG009|Overall Study|Adverse Event|0|||
126640083|NCT00474526|455642700|FG010|Overall Study|Adverse Event|0|||
126640084|NCT00474526|455642701|FG011|Overall Study|Adverse Event|0|||
126640085|NCT00474526|455642702|FG012|Overall Study|Adverse Event|0|||
126640086|NCT00474526|455642703|FG013|Overall Study|Adverse Event|0|||
126640087|NCT00474526|455642704|FG014|Overall Study|Adverse Event|1|||
126640088|NCT00474526|455642705|FG015|Overall Study|Adverse Event|1|||
126640089|NCT00474526|455642706|FG016|Overall Study|Adverse Event|0|||
126640090|NCT00474526|455642690|FG000|Overall Study|Death|0|||
126640091|NCT00474526|455642691|FG001|Overall Study|Death|0|||
126640092|NCT00474526|455642692|FG002|Overall Study|Death|0|||
126640093|NCT00474526|455642693|FG003|Overall Study|Death|0|||
126640094|NCT00474526|455642694|FG004|Overall Study|Death|0|||
126640095|NCT00474526|455642695|FG005|Overall Study|Death|0|||
126640096|NCT00474526|455642696|FG006|Overall Study|Death|0|||
126640097|NCT00474526|455642697|FG007|Overall Study|Death|0|||
126640098|NCT00474526|455642698|FG008|Overall Study|Death|0|||
126640099|NCT00474526|455642699|FG009|Overall Study|Death|0|||
126640100|NCT00474526|455642700|FG010|Overall Study|Death|0|||
126640101|NCT00474526|455642701|FG011|Overall Study|Death|0|||
126640102|NCT00474526|455642702|FG012|Overall Study|Death|0|||
126640103|NCT00474526|455642703|FG013|Overall Study|Death|3|||
126640104|NCT00474526|455642704|FG014|Overall Study|Death|0|||
126640105|NCT00474526|455642705|FG015|Overall Study|Death|0|||
126640106|NCT00474526|455642706|FG016|Overall Study|Death|0|||
126640107|NCT00474526|455642690|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126640108|NCT00474526|455642691|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
126640109|NCT00474526|455642692|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126640110|NCT00474526|455642693|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
126640111|NCT00474526|455642694|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
126640112|NCT00474526|455642695|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126640113|NCT00474526|455642696|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126640114|NCT00474526|455642697|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126640115|NCT00474526|455642698|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126640116|NCT00474526|455642699|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126640117|NCT00474526|455642700|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126640118|NCT00474526|455642701|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126640119|NCT00474526|455642702|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126640120|NCT00474526|455642703|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
126640121|NCT00474526|455642704|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
126640122|NCT00474526|455642705|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126640123|NCT00474526|455642706|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
126640124|NCT00474526|455642690|FG000|Overall Study|Lost to Follow-up|8|||
126640125|NCT00474526|455642691|FG001|Overall Study|Lost to Follow-up|6|||
126640126|NCT00474526|455642692|FG002|Overall Study|Lost to Follow-up|13|||
126640127|NCT00474526|455642693|FG003|Overall Study|Lost to Follow-up|29|||
126640128|NCT00474526|455642694|FG004|Overall Study|Lost to Follow-up|11|||
126640129|NCT00474526|455642695|FG005|Overall Study|Lost to Follow-up|5|||
126640130|NCT00474526|455642696|FG006|Overall Study|Lost to Follow-up|8|||
126640131|NCT00474526|455642697|FG007|Overall Study|Lost to Follow-up|1|||
126640132|NCT00474526|455642698|FG008|Overall Study|Lost to Follow-up|0|||
126640133|NCT00474526|455642699|FG009|Overall Study|Lost to Follow-up|6|||
126640134|NCT00474526|455642700|FG010|Overall Study|Lost to Follow-up|2|||
126640135|NCT00474526|455642701|FG011|Overall Study|Lost to Follow-up|4|||
126640136|NCT00474526|455642702|FG012|Overall Study|Lost to Follow-up|6|||
126640137|NCT00474526|455642703|FG013|Overall Study|Lost to Follow-up|74|||
126640138|NCT00474526|455642704|FG014|Overall Study|Lost to Follow-up|29|||
126640139|NCT00474526|455642705|FG015|Overall Study|Lost to Follow-up|4|||
126640140|NCT00474526|455642706|FG016|Overall Study|Lost to Follow-up|5|||
126640141|NCT00474526|455642690|FG000|Overall Study|Protocol Violation|2|||
126640142|NCT00474526|455642691|FG001|Overall Study|Protocol Violation|6|||
126640143|NCT00474526|455642692|FG002|Overall Study|Protocol Violation|4|||
126640144|NCT00474526|455642693|FG003|Overall Study|Protocol Violation|12|||
126640145|NCT00474526|455642694|FG004|Overall Study|Protocol Violation|3|||
126640146|NCT00474526|455642695|FG005|Overall Study|Protocol Violation|1|||
126640147|NCT00474526|455642696|FG006|Overall Study|Protocol Violation|3|||
126640148|NCT00474526|455642697|FG007|Overall Study|Protocol Violation|0|||
126640149|NCT00474526|455642698|FG008|Overall Study|Protocol Violation|0|||
126640150|NCT00474526|455642699|FG009|Overall Study|Protocol Violation|4|||
126640151|NCT00474526|455642700|FG010|Overall Study|Protocol Violation|2|||
126640152|NCT00474526|455642701|FG011|Overall Study|Protocol Violation|2|||
126640153|NCT00474526|455642702|FG012|Overall Study|Protocol Violation|4|||
126640154|NCT00474526|455642703|FG013|Overall Study|Protocol Violation|19|||
126640155|NCT00474526|455642704|FG014|Overall Study|Protocol Violation|9|||
126640156|NCT00474526|455642705|FG015|Overall Study|Protocol Violation|6|||
126640157|NCT00474526|455642706|FG016|Overall Study|Protocol Violation|2|||
126640158|NCT00474526|455642690|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
126640159|NCT00474526|455642691|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
126640160|NCT00474526|455642692|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
126640161|NCT00474526|455642693|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
126640162|NCT00474526|455642694|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
126640163|NCT00474526|455642695|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
126640164|NCT00474526|455642696|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
126640165|NCT00474526|455642697|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
126640166|NCT00474526|455642698|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
126640167|NCT00474526|455642699|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
126640168|NCT00474526|455642700|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
126640169|NCT00474526|455642701|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
126640170|NCT00474526|455642702|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
126640171|NCT00474526|455642703|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
126640172|NCT00474526|455642704|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
126640173|NCT00474526|455642705|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
126640174|NCT00474526|455642706|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
126640175|NCT00474526|455642690|FG000|Overall Study|Withdrawal by Subject|9|||
126640176|NCT00474526|455642691|FG001|Overall Study|Withdrawal by Subject|24|||
126640177|NCT00474526|455642692|FG002|Overall Study|Withdrawal by Subject|21|||
126640178|NCT00474526|455642693|FG003|Overall Study|Withdrawal by Subject|52|||
126640179|NCT00474526|455642694|FG004|Overall Study|Withdrawal by Subject|38|||
126640180|NCT00474526|455642695|FG005|Overall Study|Withdrawal by Subject|6|||
126640181|NCT00474526|455642696|FG006|Overall Study|Withdrawal by Subject|12|||
126640182|NCT00474526|455642697|FG007|Overall Study|Withdrawal by Subject|4|||
126640183|NCT00474526|455642698|FG008|Overall Study|Withdrawal by Subject|4|||
126640184|NCT00474526|455642699|FG009|Overall Study|Withdrawal by Subject|13|||
126640185|NCT00474526|455642700|FG010|Overall Study|Withdrawal by Subject|5|||
126640186|NCT00474526|455642701|FG011|Overall Study|Withdrawal by Subject|4|||
126640187|NCT00474526|455642702|FG012|Overall Study|Withdrawal by Subject|4|||
126640188|NCT00474526|455642703|FG013|Overall Study|Withdrawal by Subject|37|||
126640189|NCT00474526|455642704|FG014|Overall Study|Withdrawal by Subject|22|||
126640190|NCT00474526|455642705|FG015|Overall Study|Withdrawal by Subject|1|||
126640191|NCT00474526|455642706|FG016|Overall Study|Withdrawal by Subject|1|||
126640192|NCT01251770|455642710|FG000|Overall Study|Protocol Violation|13|||
126640193|NCT01251770|455642711|FG001|Overall Study|Protocol Violation|7|||
126640194|NCT02113124|455642712|FG000|Overall Study|Unable to retrieve blood sample|1|||
126640195|NCT02113124|455642713|FG001|Overall Study|Unable to retrieve blood sample|1|||
126640196|NCT02514239|455642714|FG000|Overall Study|Refused to continue trial medication|0|||
126640197|NCT02514239|455642715|FG001|Overall Study|Refused to continue trial medication|0|||
126640198|NCT02514239|455642716|FG002|Overall Study|Refused to continue trial medication|0|||
126640199|NCT02514239|455642717|FG003|Overall Study|Refused to continue trial medication|0|||
126640200|NCT02514239|455642718|FG004|Overall Study|Refused to continue trial medication|0|||
126640201|NCT02514239|455642719|FG005|Overall Study|Refused to continue trial medication|0|||
126640202|NCT02514239|455642720|FG006|Overall Study|Refused to continue trial medication|0|||
126640203|NCT02514239|455642721|FG007|Overall Study|Refused to continue trial medication|0|||
126640204|NCT02514239|455642722|FG008|Overall Study|Refused to continue trial medication|0|||
126640205|NCT02514239|455642723|FG009|Overall Study|Refused to continue trial medication|1|||
126640206|NCT02514239|455642714|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
126640207|NCT02514239|455642715|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
126640208|NCT02514239|455642716|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
126640209|NCT02514239|455642717|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
126640210|NCT02514239|455642718|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
126640211|NCT02514239|455642719|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
126640212|NCT02514239|455642720|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
126640213|NCT02514239|455642721|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
126640214|NCT02514239|455642722|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
126640215|NCT02514239|455642723|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
126640216|NCT02514239|455642714|FG000|Overall Study|Not treated|0|||
126640217|NCT02514239|455642715|FG001|Overall Study|Not treated|1|||
126640218|NCT02514239|455642716|FG002|Overall Study|Not treated|0|||
126640219|NCT02514239|455642717|FG003|Overall Study|Not treated|0|||
126640220|NCT02514239|455642718|FG004|Overall Study|Not treated|0|||
126640221|NCT02514239|455642719|FG005|Overall Study|Not treated|0|||
126640222|NCT02514239|455642720|FG006|Overall Study|Not treated|0|||
126640223|NCT02514239|455642721|FG007|Overall Study|Not treated|0|||
126640224|NCT02514239|455642722|FG008|Overall Study|Not treated|0|||
126640225|NCT02514239|455642723|FG009|Overall Study|Not treated|0|||
126640226|NCT02514239|455642714|FG000|Overall Study|Other Adverse Events|2|||
126640227|NCT02514239|455642715|FG001|Overall Study|Other Adverse Events|0|||
126640228|NCT02514239|455642716|FG002|Overall Study|Other Adverse Events|0|||
126640229|NCT02514239|455642717|FG003|Overall Study|Other Adverse Events|1|||
126640230|NCT02514239|455642718|FG004|Overall Study|Other Adverse Events|0|||
126640231|NCT02514239|455642719|FG005|Overall Study|Other Adverse Events|1|||
126640232|NCT02514239|455642720|FG006|Overall Study|Other Adverse Events|0|||
126640233|NCT02514239|455642721|FG007|Overall Study|Other Adverse Events|1|||
126640234|NCT02514239|455642722|FG008|Overall Study|Other Adverse Events|2|||
126640235|NCT02514239|455642723|FG009|Overall Study|Other Adverse Events|0|||
126640236|NCT02514239|455642714|FG000|Overall Study|Progressive disease|3|||
126640237|NCT02514239|455642715|FG001|Overall Study|Progressive disease|3|||
126640238|NCT02514239|455642716|FG002|Overall Study|Progressive disease|2|||
126640239|NCT02514239|455642717|FG003|Overall Study|Progressive disease|2|||
126640240|NCT02514239|455642718|FG004|Overall Study|Progressive disease|3|||
126640241|NCT02514239|455642719|FG005|Overall Study|Progressive disease|3|||
126640242|NCT02514239|455642720|FG006|Overall Study|Progressive disease|4|||
126640243|NCT02514239|455642721|FG007|Overall Study|Progressive disease|2|||
126640244|NCT02514239|455642722|FG008|Overall Study|Progressive disease|5|||
126640245|NCT02514239|455642723|FG009|Overall Study|Progressive disease|0|||
126640246|NCT01020877|455642725|FG000|Second Intervention|Withdrawal by Subject|1|||
126640247|NCT01020877|455642726|FG001|Second Intervention|Withdrawal by Subject|0|||
126640248|NCT04307940|455642727|FG000|Overall Study|Adverse Event|1|||
126640249|NCT04307940|455642728|FG001|Overall Study|Adverse Event|0|||
126640250|NCT04307940|455642729|FG002|Overall Study|Adverse Event|0|||
126640251|NCT04307940|455642727|FG000|Overall Study|Withdrawal by Subject|2|||
126640252|NCT04307940|455642728|FG001|Overall Study|Withdrawal by Subject|3|||
126640253|NCT04307940|455642729|FG002|Overall Study|Withdrawal by Subject|1|||
126640254|NCT04307940|455642727|FG000|Overall Study|Lost to Follow-up|2|||
126640255|NCT04307940|455642728|FG001|Overall Study|Lost to Follow-up|0|||
126640256|NCT04307940|455642729|FG002|Overall Study|Lost to Follow-up|1|||
126640257|NCT04624243|455642730|FG000|Overall Study|Death|0|||
126640258|NCT04624243|455642731|FG001|Overall Study|Death|1|||
126640259|NCT04624243|455642732|FG002|Overall Study|Death|0|||
126640260|NCT04624243|455642733|FG003|Overall Study|Death|0|||
126640261|NCT04624243|455642734|FG004|Overall Study|Death|0|||
126640262|NCT04624243|455642730|FG000|Overall Study|Lost to Follow-up|2|||
126640263|NCT04624243|455642731|FG001|Overall Study|Lost to Follow-up|3|||
126640264|NCT04624243|455642732|FG002|Overall Study|Lost to Follow-up|7|||
126640265|NCT04624243|455642733|FG003|Overall Study|Lost to Follow-up|1|||
126640266|NCT04624243|455642734|FG004|Overall Study|Lost to Follow-up|3|||
126640267|NCT04624243|455642730|FG000|Overall Study|Physician Decision|3|||
126640268|NCT04624243|455642731|FG001|Overall Study|Physician Decision|8|||
126640269|NCT04624243|455642732|FG002|Overall Study|Physician Decision|15|||
126640270|NCT04624243|455642733|FG003|Overall Study|Physician Decision|2|||
126640271|NCT04624243|455642734|FG004|Overall Study|Physician Decision|11|||
126640272|NCT04624243|455642730|FG000|Overall Study|Withdrawal by Subject|19|||
126640273|NCT04624243|455642731|FG001|Overall Study|Withdrawal by Subject|44|||
126640274|NCT04624243|455642732|FG002|Overall Study|Withdrawal by Subject|40|||
126640275|NCT04624243|455642733|FG003|Overall Study|Withdrawal by Subject|21|||
126640276|NCT04624243|455642734|FG004|Overall Study|Withdrawal by Subject|39|||
126640277|NCT04624243|455642730|FG000|Overall Study|Miscellaneous|3|||
126640278|NCT04624243|455642731|FG001|Overall Study|Miscellaneous|12|||
126640279|NCT04624243|455642732|FG002|Overall Study|Miscellaneous|9|||
126640280|NCT04624243|455642733|FG003|Overall Study|Miscellaneous|4|||
126640281|NCT04624243|455642734|FG004|Overall Study|Miscellaneous|6|||
126640282|NCT05543174|455642735|FG000|Overall Study|Ongoing|7|||
126640283|NCT00953771|455642736|FG000|Overall Study|Death|1|||
126640284|NCT00953771|455642737|FG001|Overall Study|Death|0|||
126640285|NCT04896008|455642738|FG000|Overall Study|Ongoing|70|||
126640286|NCT04896008|455642739|FG001|Overall Study|Ongoing|38|||
126640287|NCT04896008|455642738|FG000|Overall Study|Adverse Event|0|||
126640288|NCT04896008|455642739|FG001|Overall Study|Adverse Event|2|||
126640289|NCT04896008|455642738|FG000|Overall Study|Death|5|||
126640290|NCT04896008|455642739|FG001|Overall Study|Death|10|||
126640291|NCT04896008|455642738|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
126640292|NCT04896008|455642739|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
126640293|NCT04896008|455642738|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
126640294|NCT04896008|455642739|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
126640295|NCT04896008|455642738|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
126640296|NCT04896008|455642739|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
126640297|NCT04896008|455642738|FG000|Overall Study|Withdrawal by Subject|1|||
126640298|NCT04896008|455642739|FG001|Overall Study|Withdrawal by Subject|4|||
126640299|NCT04896008|455642738|FG000|Overall Study|Investigator Decision|2|||
126640300|NCT04896008|455642739|FG001|Overall Study|Investigator Decision|0|||
126640301|NCT04896008|455642738|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
126640302|NCT04896008|455642739|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
126640303|NCT01270828|455642744|FG000|Pregabalin CR SB|Reason Unspecified|0|||
126640304|NCT01270828|455642745|FG001|Pregabalin CR SB|Reason Unspecified|0|||
126640305|NCT01270828|455642746|FG002|Pregabalin CR SB|Reason Unspecified|8|||
126640306|NCT01270828|455642744|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
126640307|NCT01270828|455642745|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
126640308|NCT01270828|455642746|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
126640309|NCT01270828|455642744|FG000|Pregabalin CR SB|Related adverse event|0|||
126640310|NCT01270828|455642745|FG001|Pregabalin CR SB|Related adverse event|0|||
126640311|NCT01270828|455642746|FG002|Pregabalin CR SB|Related adverse event|46|||
126640312|NCT01270828|455642744|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
126640313|NCT01270828|455642745|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
126640314|NCT01270828|455642746|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
126640315|NCT01270828|455642744|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
126640316|NCT01270828|455642745|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
126640317|NCT01270828|455642746|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
126640318|NCT01270828|455642744|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
126640319|NCT01270828|455642745|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
126640320|NCT01270828|455642746|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
126640321|NCT01270828|455642744|FG000|Pregabalin CR SB|Unrelated AE|0|||
126640322|NCT01270828|455642745|FG001|Pregabalin CR SB|Unrelated AE|0|||
126640323|NCT01270828|455642746|FG002|Pregabalin CR SB|Unrelated AE|8|||
126640324|NCT01270828|455642744|FG000|Pregabalin CR SB|Protocol Violation|0|||
126640325|NCT01270828|455642745|FG001|Pregabalin CR SB|Protocol Violation|0|||
126640326|NCT01270828|455642746|FG002|Pregabalin CR SB|Protocol Violation|8|||
126640327|NCT01270828|455642744|FG000|Double Blind Phase|Death|0|||
126640328|NCT01270828|455642745|FG001|Double Blind Phase|Death|1|||
126640329|NCT01270828|455642746|FG002|Double Blind Phase|Death|0|||
126640330|NCT01270828|455642744|FG000|Double Blind Phase|Protocol Violation|0|||
126640331|NCT01270828|455642745|FG001|Double Blind Phase|Protocol Violation|1|||
126640332|NCT01270828|455642746|FG002|Double Blind Phase|Protocol Violation|0|||
126640333|NCT01270828|455642744|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
126640334|NCT01270828|455642745|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
126640335|NCT01270828|455642746|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
126640336|NCT01270828|455642744|FG000|Double Blind Phase|Reason Unspecified|7|||
126640337|NCT01270828|455642745|FG001|Double Blind Phase|Reason Unspecified|4|||
126640338|NCT01270828|455642746|FG002|Double Blind Phase|Reason Unspecified|0|||
126640339|NCT01270828|455642744|FG000|Double Blind Phase|Withdrawal by Subject|6|||
126640340|NCT01270828|455642745|FG001|Double Blind Phase|Withdrawal by Subject|15|||
126640341|NCT01270828|455642746|FG002|Double Blind Phase|Withdrawal by Subject|0|||
126640342|NCT01270828|455642744|FG000|Double Blind Phase|Lost to Follow-up|1|||
126640343|NCT01270828|455642745|FG001|Double Blind Phase|Lost to Follow-up|2|||
126640344|NCT01270828|455642746|FG002|Double Blind Phase|Lost to Follow-up|0|||
126640345|NCT01270828|455642744|FG000|Double Blind Phase|Lack of Efficacy|2|||
126640346|NCT01270828|455642745|FG001|Double Blind Phase|Lack of Efficacy|11|||
126640347|NCT01270828|455642746|FG002|Double Blind Phase|Lack of Efficacy|0|||
126640348|NCT01270828|455642744|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
126640349|NCT01270828|455642745|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
126640350|NCT01270828|455642746|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
126640351|NCT01270828|455642744|FG000|Double Blind Phase|Adverse event related to study drug|5|||
126640352|NCT01270828|455642745|FG001|Double Blind Phase|Adverse event related to study drug|7|||
126640353|NCT01270828|455642746|FG002|Double Blind Phase|Adverse event related to study drug|0|||
126640354|NCT00709228|455642754|FG000|Overall Study|Not treated|14|||
126640355|NCT00709228|455642754|FG000|Overall Study|Eligibility criteria not met|281|||
126640356|NCT00709228|455642754|FG000|Overall Study|Adverse events|2|||
126640357|NCT00709228|455642754|FG000|Overall Study|Discontinued treatment|14|||
126640358|NCT00709228|455642754|FG000|Overall Study|Did not enter follow-up|4|||
126640359|NCT00709228|455642754|FG000|Overall Study|Discontinued follow-up|5|||
126640360|NCT00709228|455642754|FG000|Overall Study|Disease progression|1|||
126640361|NCT00709228|455642754|FG000|Overall Study|Lost to Follow-up|6|||
126756280|NCT00842829|456057427|FG001|Dose Titration Period|Lack of Efficacy|1|||
126756281|NCT00842829|456057428|FG002|Dose Titration Period|Lack of Efficacy|0|||
126756282|NCT00842829|456057426|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
126756283|NCT00842829|456057427|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
126756284|NCT00842829|456057428|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
126756285|NCT00842829|456057426|FG000|Dose Titration Period|Withdrawal by Subject|2|||
126756286|NCT00842829|456057427|FG001|Dose Titration Period|Withdrawal by Subject|6|||
126756287|NCT00842829|456057428|FG002|Dose Titration Period|Withdrawal by Subject|0|||
126756288|NCT00842829|456057426|FG000|Dose Titration Period|Other|5|||
126756289|NCT00842829|456057427|FG001|Dose Titration Period|Other|4|||
126756290|NCT00842829|456057428|FG002|Dose Titration Period|Other|0|||
126756291|NCT00842829|456057426|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
126756292|NCT00842829|456057427|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
126756293|NCT00842829|456057428|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
126756294|NCT00842829|456057426|FG000|Dose Titration Period|Non-compliance to study drug|2|||
126756295|NCT00842829|456057427|FG001|Dose Titration Period|Non-compliance to study drug|1|||
126756296|NCT00842829|456057428|FG002|Dose Titration Period|Non-compliance to study drug|0|||
126756297|NCT00842829|456057426|FG000|Treatment Period|Adverse Event|0|||
126756298|NCT00842829|456057427|FG001|Treatment Period|Adverse Event|0|||
126756299|NCT00842829|456057428|FG002|Treatment Period|Adverse Event|15|||
126756300|NCT00842829|456057426|FG000|Treatment Period|Lack of Efficacy|0|||
126756301|NCT00842829|456057427|FG001|Treatment Period|Lack of Efficacy|0|||
126756302|NCT00842829|456057428|FG002|Treatment Period|Lack of Efficacy|6|||
126756303|NCT00842829|456057426|FG000|Treatment Period|Unstable persistent cancer pain|0|||
126756304|NCT00842829|456057427|FG001|Treatment Period|Unstable persistent cancer pain|0|||
126756305|NCT00842829|456057428|FG002|Treatment Period|Unstable persistent cancer pain|5|||
126756306|NCT00842829|456057426|FG000|Treatment Period|Withdrawal by Subject|0|||
126756307|NCT00842829|456057427|FG001|Treatment Period|Withdrawal by Subject|0|||
126756308|NCT00842829|456057428|FG002|Treatment Period|Withdrawal by Subject|11|||
126756309|NCT00842829|456057426|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
126756310|NCT00842829|456057427|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
126756311|NCT00842829|456057428|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
126756312|NCT00842829|456057426|FG000|Treatment Period|Protocol Violation|0|||
126756313|NCT00842829|456057427|FG001|Treatment Period|Protocol Violation|0|||
126756314|NCT00842829|456057428|FG002|Treatment Period|Protocol Violation|2|||
126756315|NCT00842829|456057426|FG000|Treatment Period|Other|0|||
126640362|NCT00709228|455642754|FG000|Overall Study|Non-compliance|5|||
126640363|NCT03322540|455642757|FG000|Overall Study|Death|21|||
126640364|NCT03322540|455642758|FG001|Overall Study|Death|28|||
126640365|NCT03322540|455642757|FG000|Overall Study|Lost to Follow-up|0|||
126640366|NCT03322540|455642758|FG001|Overall Study|Lost to Follow-up|1|||
126640367|NCT03322540|455642757|FG000|Overall Study|Physician Decision|7|||
126640368|NCT03322540|455642758|FG001|Overall Study|Physician Decision|6|||
126640369|NCT03322540|455642757|FG000|Overall Study|Withdrawal by Subject|3|||
126640370|NCT03322540|455642758|FG001|Overall Study|Withdrawal by Subject|1|||
126640371|NCT03322540|455642757|FG000|Overall Study|Study terminated by sponsor|0|||
126640372|NCT03322540|455642758|FG001|Overall Study|Study terminated by sponsor|1|||
126640373|NCT04334278|455642759|FG000|Overall Study|Lost to Follow-up|0|||
126640374|NCT04334278|455642760|FG001|Overall Study|Lost to Follow-up|3|||
126640375|NCT04334278|455642759|FG000|Overall Study|Withdrawal by Subject|4|||
126640376|NCT04334278|455642760|FG001|Overall Study|Withdrawal by Subject|2|||
126640377|NCT03445533|455642761|FG000|Overall Study|Progressive Disease|48|||
126640378|NCT03445533|455642762|FG001|Overall Study|Progressive Disease|81|||
126640379|NCT03445533|455642761|FG000|Overall Study|Adverse Event|60|||
126640380|NCT03445533|455642762|FG001|Overall Study|Adverse Event|64|||
126640381|NCT03445533|455642761|FG000|Overall Study|Death|9|||
126640382|NCT03445533|455642762|FG001|Overall Study|Death|19|||
126640383|NCT03445533|455642761|FG000|Overall Study|Miscellaneous|0|||
126640384|NCT03445533|455642762|FG001|Overall Study|Miscellaneous|16|||
126640385|NCT03445533|455642761|FG000|Overall Study|Withdrawal by Subject|3|||
126640386|NCT03445533|455642762|FG001|Overall Study|Withdrawal by Subject|4|||
126756316|NCT00842829|456057427|FG001|Treatment Period|Other|0|||
126756317|NCT00842829|456057428|FG002|Treatment Period|Other|18|||
126756318|NCT00842829|456057426|FG000|Treatment Period|Non-compliance to study procedures|0|||
126756319|NCT00842829|456057427|FG001|Treatment Period|Non-compliance to study procedures|0|||
126756320|NCT00842829|456057428|FG002|Treatment Period|Non-compliance to study procedures|4|||
126756321|NCT00842829|456057426|FG000|Treatment Period|Unclear completion status|0|||
126756322|NCT00842829|456057427|FG001|Treatment Period|Unclear completion status|0|||
126756323|NCT00842829|456057428|FG002|Treatment Period|Unclear completion status|1|||
126756324|NCT00842829|456057426|FG000|Continuation Period|Adverse Event|0|||
126756325|NCT00842829|456057427|FG001|Continuation Period|Adverse Event|0|||
126756326|NCT00842829|456057428|FG002|Continuation Period|Adverse Event|32|||
126756327|NCT00842829|456057426|FG000|Continuation Period|Lack of Efficacy|0|||
126756328|NCT00842829|456057427|FG001|Continuation Period|Lack of Efficacy|0|||
126756329|NCT00842829|456057428|FG002|Continuation Period|Lack of Efficacy|6|||
126756330|NCT00842829|456057426|FG000|Continuation Period|Unstable persistent cancer pain|0|||
126756331|NCT00842829|456057427|FG001|Continuation Period|Unstable persistent cancer pain|0|||
126756332|NCT00842829|456057428|FG002|Continuation Period|Unstable persistent cancer pain|3|||
126756333|NCT00842829|456057426|FG000|Continuation Period|Withdrawal by Subject|0|||
126756334|NCT00842829|456057427|FG001|Continuation Period|Withdrawal by Subject|0|||
126756335|NCT00842829|456057428|FG002|Continuation Period|Withdrawal by Subject|10|||
126756336|NCT00842829|456057426|FG000|Continuation Period|Other|0|||
126756337|NCT00842829|456057427|FG001|Continuation Period|Other|0|||
126756338|NCT00842829|456057428|FG002|Continuation Period|Other|7|||
126756339|NCT00842829|456057426|FG000|Continuation Period|Non-compliance to study procedures|0|||
126756340|NCT00842829|456057427|FG001|Continuation Period|Non-compliance to study procedures|0|||
126756341|NCT00842829|456057428|FG002|Continuation Period|Non-compliance to study procedures|2|||
126756342|NCT00842829|456057426|FG000|Continuation Period|Non-compliance to study drug|0|||
126756343|NCT00842829|456057427|FG001|Continuation Period|Non-compliance to study drug|0|||
126756344|NCT00842829|456057428|FG002|Continuation Period|Non-compliance to study drug|1|||
126756345|NCT03969589|456057429|FG000|Overall Study|Lost to Follow-up|3|||
126756346|NCT03969589|456057430|FG001|Overall Study|Lost to Follow-up|2|||
126756347|NCT03969589|456057429|FG000|Overall Study|Declined Follow-Up|0|||
126756348|NCT03969589|456057430|FG001|Overall Study|Declined Follow-Up|1|||
126756349|NCT00517634|456057431|FG000|Second Treatment Period|Withdrawal by Subject|0|||
126756350|NCT00517634|456057432|FG001|Second Treatment Period|Withdrawal by Subject|0|||
126756351|NCT00517634|456057433|FG002|Second Treatment Period|Withdrawal by Subject|0|||
126756352|NCT00517634|456057434|FG003|Second Treatment Period|Withdrawal by Subject|0|||
126756353|NCT00517634|456057435|FG004|Second Treatment Period|Withdrawal by Subject|1|||
126756354|NCT00517634|456057436|FG005|Second Treatment Period|Withdrawal by Subject|0|||
126756355|NCT03091920|456057439|FG000|Overall Study|Adverse Event|0|||
126756356|NCT03091920|456057440|FG001|Overall Study|Adverse Event|1|||
126756357|NCT03091920|456057441|FG002|Overall Study|Adverse Event|0|||
126756358|NCT03143855|456057442|FG000|Overall Study|Withdrawal by Subject|4|||
126756359|NCT03143855|456057443|FG001|Overall Study|Withdrawal by Subject|3|||
126756360|NCT03143855|456057442|FG000|Overall Study|Protocol Violation|1|||
126756361|NCT03143855|456057443|FG001|Overall Study|Protocol Violation|0|||
126756362|NCT03143855|456057442|FG000|Overall Study|Participant experienced withdrawal|0|||
126756363|NCT03143855|456057443|FG001|Overall Study|Participant experienced withdrawal|1|||
126756364|NCT00453349|456057445|FG000|Randomized|Adverse Event|12|||
126756365|NCT00453349|456057446|FG001|Randomized|Adverse Event|11|||
126756366|NCT00453349|456057445|FG000|Randomized|Lack of Efficacy|2|||
126756367|NCT00453349|456057446|FG001|Randomized|Lack of Efficacy|1|||
126756368|NCT00453349|456057445|FG000|Randomized|Lost to Follow-up|7|||
126756369|NCT00453349|456057446|FG001|Randomized|Lost to Follow-up|5|||
126756370|NCT00453349|456057445|FG000|Randomized|Protocol Violation|1|||
126756371|NCT00453349|456057446|FG001|Randomized|Protocol Violation|1|||
126756372|NCT00453349|456057445|FG000|Randomized|Withdrawal by Subject|3|||
126756373|NCT00453349|456057446|FG001|Randomized|Withdrawal by Subject|5|||
126756374|NCT00453349|456057445|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
126756375|NCT00453349|456057446|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
126756376|NCT00453349|456057445|FG000|Completed Study|Adverse Event|12|||
126756377|NCT00453349|456057446|FG001|Completed Study|Adverse Event|11|||
126756378|NCT00453349|456057445|FG000|Completed Study|Lack of Efficacy|2|||
126756379|NCT00453349|456057446|FG001|Completed Study|Lack of Efficacy|1|||
126756380|NCT00453349|456057445|FG000|Completed Study|Lost to Follow-up|7|||
126756381|NCT00453349|456057446|FG001|Completed Study|Lost to Follow-up|5|||
126756382|NCT00453349|456057445|FG000|Completed Study|Protocol Violation|1|||
126756383|NCT00453349|456057446|FG001|Completed Study|Protocol Violation|1|||
126756384|NCT00453349|456057445|FG000|Completed Study|Withdrawal by Subject|3|||
126756385|NCT00453349|456057446|FG001|Completed Study|Withdrawal by Subject|5|||
126756386|NCT00453349|456057445|FG000|Completed Study|Lost to follow up after study treatment|2|||
126640387|NCT03445533|455642761|FG000|Overall Study|Physician Decision|1|||
126756387|NCT00453349|456057446|FG001|Completed Study|Lost to follow up after study treatment|11|||
126756388|NCT04369742|456057447|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
126756389|NCT04369742|456057448|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
126756390|NCT04369742|456057447|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
126756391|NCT04369742|456057448|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
126756392|NCT00695318|456057450|FG000|Overall Study|Lost to Follow-up|1|||
126756393|NCT00695318|456057451|FG001|Overall Study|Lost to Follow-up|0|||
126756394|NCT00695318|456057450|FG000|Overall Study|Withdrawal by Subject|2|||
126756395|NCT00695318|456057451|FG001|Overall Study|Withdrawal by Subject|0|||
126756396|NCT00695318|456057450|FG000|Overall Study|Death|1|||
126756397|NCT00695318|456057451|FG001|Overall Study|Death|1|||
126756398|NCT00695318|456057450|FG000|Overall Study|Study Terminated|1|||
126756399|NCT00695318|456057451|FG001|Overall Study|Study Terminated|0|||
126756400|NCT04524663|456059404|FG000|Overall Study|Withdrawal by Subject|0|||
126756401|NCT04524663|456059405|FG001|Overall Study|Withdrawal by Subject|2|||
126756402|NCT00337935|456059406|FG000|Overall Study|Adverse Event|2|||
126756403|NCT00337935|456059407|FG001|Overall Study|Adverse Event|5|||
126756404|NCT00337935|456059406|FG000|Overall Study|Death|2|||
126756405|NCT00337935|456059407|FG001|Overall Study|Death|8|||
126756406|NCT00337935|456059406|FG000|Overall Study|Physician Decision|1|||
126756407|NCT00337935|456059407|FG001|Overall Study|Physician Decision|1|||
126756408|NCT00337935|456059406|FG000|Overall Study|Lost to Follow-up|0|||
126756409|NCT00337935|456059407|FG001|Overall Study|Lost to Follow-up|1|||
126756410|NCT00337935|456059406|FG000|Overall Study|Protocol Violation|4|||
126756411|NCT00337935|456059407|FG001|Overall Study|Protocol Violation|3|||
126756412|NCT00337935|456059406|FG000|Overall Study|Withdrawal by Subject|1|||
126756413|NCT00337935|456059407|FG001|Overall Study|Withdrawal by Subject|7|||
126756414|NCT00337935|456059406|FG000|Overall Study|Other|0|||
126756415|NCT00337935|456059407|FG001|Overall Study|Other|1|||
126756416|NCT00337935|456059406|FG000|Overall Study|Lack of Efficacy|0|||
126756417|NCT00337935|456059407|FG001|Overall Study|Lack of Efficacy|1|||
126756418|NCT01884675|456059408|FG000|Overall Study|Study closed/terminated|3|||
126756419|NCT01884675|456059409|FG001|Overall Study|Study closed/terminated|2|||
126756420|NCT02361307|456059410|FG000|Overall Study|Unstable medical condition.|0|||
126756421|NCT02361307|456059411|FG001|Overall Study|Unstable medical condition.|1|||
126756422|NCT00711009|456059412|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
126756423|NCT00711009|456059413|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
126756424|NCT00711009|456059412|FG000|Overall Study|Withdrawal by Subject|4|||
126756425|NCT00711009|456059413|FG001|Overall Study|Withdrawal by Subject|2|||
126756426|NCT00711009|456059412|FG000|Overall Study|Lost to Follow-up|3|||
126756427|NCT00711009|456059413|FG001|Overall Study|Lost to Follow-up|9|||
126756428|NCT00711009|456059412|FG000|Overall Study|Participant Noncompliant|0|||
126756429|NCT00711009|456059413|FG001|Overall Study|Participant Noncompliant|1|||
126756430|NCT00711009|456059412|FG000|Overall Study|Virologic Failure|2|||
126756431|NCT00711009|456059413|FG001|Overall Study|Virologic Failure|1|||
126756432|NCT00711009|456059412|FG000|Overall Study|Pregnancy|1|||
126756433|NCT00711009|456059413|FG001|Overall Study|Pregnancy|0|||
126756434|NCT00711009|456059412|FG000|Overall Study|Site closing|0|||
126756435|NCT00711009|456059413|FG001|Overall Study|Site closing|1|||
126756436|NCT00711009|456059412|FG000|Overall Study|Dose adjustment|1|||
126756437|NCT00711009|456059413|FG001|Overall Study|Dose adjustment|0|||
126756438|NCT03359811|456059414|FG000|Overall Study|Protocol Violation|2|||
126756439|NCT03359811|456059415|FG001|Overall Study|Protocol Violation|0|||
126756440|NCT01682876|456059416|FG000|Overall Study|Administrative reason|4|||
126756441|NCT01682876|456059417|FG001|Overall Study|Administrative reason|4|||
126756442|NCT01682876|456059418|FG002|Overall Study|Administrative reason|0|||
126756443|NCT01682876|456059419|FG003|Overall Study|Administrative reason|3|||
126756444|NCT01682876|456059416|FG000|Overall Study|Adverse Event|0|||
126756445|NCT01682876|456059417|FG001|Overall Study|Adverse Event|0|||
126756446|NCT01682876|456059418|FG002|Overall Study|Adverse Event|0|||
126756447|NCT01682876|456059419|FG003|Overall Study|Adverse Event|1|||
126756448|NCT01682876|456059416|FG000|Overall Study|Lost to Follow-up|11|||
126756449|NCT01682876|456059417|FG001|Overall Study|Lost to Follow-up|15|||
126756450|NCT01682876|456059418|FG002|Overall Study|Lost to Follow-up|9|||
126756451|NCT01682876|456059419|FG003|Overall Study|Lost to Follow-up|11|||
126756452|NCT01682876|456059416|FG000|Overall Study|Protocol Violation|1|||
126756453|NCT01682876|456059417|FG001|Overall Study|Protocol Violation|1|||
126756454|NCT01682876|456059418|FG002|Overall Study|Protocol Violation|1|||
126756455|NCT01682876|456059419|FG003|Overall Study|Protocol Violation|1|||
126756456|NCT01682876|456059416|FG000|Overall Study|Withdrawal by Subject|4|||
126640388|NCT03445533|455642762|FG001|Overall Study|Physician Decision|3|||
126640389|NCT03445533|455642761|FG000|Overall Study|Sponsor Decision|0|||
126756457|NCT01682876|456059417|FG001|Overall Study|Withdrawal by Subject|0|||
126756458|NCT01682876|456059418|FG002|Overall Study|Withdrawal by Subject|0|||
126756459|NCT01682876|456059419|FG003|Overall Study|Withdrawal by Subject|2|||
126756460|NCT01682876|456059416|FG000|Overall Study|Other|1|||
126756461|NCT01682876|456059417|FG001|Overall Study|Other|0|||
126756462|NCT01682876|456059418|FG002|Overall Study|Other|1|||
126756463|NCT01682876|456059419|FG003|Overall Study|Other|1|||
126756464|NCT02534324|456059421|FG000|Overall Study|Protocol Violation|4|||
126756465|NCT02534324|456059422|FG001|Overall Study|Protocol Violation|1|||
126756466|NCT02534324|456059421|FG000|Overall Study|Lost to Follow-up|20|||
126756467|NCT02534324|456059422|FG001|Overall Study|Lost to Follow-up|7|||
126756468|NCT02534324|456059421|FG000|Overall Study|Adverse Event|1|||
126756469|NCT02534324|456059422|FG001|Overall Study|Adverse Event|0|||
126756470|NCT01459016|456059425|FG000|Overall Study|Withdrawal by Subject|11|||
126756471|NCT01459016|456059425|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
126756472|NCT00303602|456059429|FG000|Overall Study|Adverse Event|2|||
126756473|NCT00303602|456059430|FG001|Overall Study|Adverse Event|2|||
126756474|NCT00303602|456059429|FG000|Overall Study|Withdrawal by Subject|5|||
126756475|NCT00303602|456059430|FG001|Overall Study|Withdrawal by Subject|6|||
126756476|NCT00303602|456059429|FG000|Overall Study|Lost to Follow-up|5|||
126756477|NCT00303602|456059430|FG001|Overall Study|Lost to Follow-up|2|||
126756478|NCT00303602|456059429|FG000|Overall Study|Protocol entry criteria not met|2|||
126756479|NCT00303602|456059430|FG001|Overall Study|Protocol entry criteria not met|2|||
126756480|NCT00303602|456059429|FG000|Overall Study|Physician Decision|2|||
126756481|NCT00303602|456059430|FG001|Overall Study|Physician Decision|1|||
126756482|NCT00303602|456059429|FG000|Overall Study|Noncompliance|2|||
126756483|NCT00303602|456059430|FG001|Overall Study|Noncompliance|2|||
126756484|NCT00303602|456059429|FG000|Overall Study|Protocol Violation|1|||
126756485|NCT00303602|456059430|FG001|Overall Study|Protocol Violation|0|||
126756486|NCT00663208|456059435|FG000|Treatment Period|Lost to Follow-up|0|||
126756487|NCT00663208|456059436|FG001|Treatment Period|Lost to Follow-up|1|||
126756488|NCT00663208|456059437|FG002|Treatment Period|Lost to Follow-up|0|||
126756489|NCT00663208|456059438|FG003|Treatment Period|Lost to Follow-up|0|||
126756490|NCT00663208|456059439|FG004|Treatment Period|Lost to Follow-up|0|||
126756491|NCT00663208|456059440|FG005|Treatment Period|Lost to Follow-up|0|||
126756492|NCT00663208|456059441|FG006|Treatment Period|Lost to Follow-up|0|||
126756493|NCT00663208|456059435|FG000|Follow-up Period|Lost to Follow-up|2|||
126756494|NCT00663208|456059436|FG001|Follow-up Period|Lost to Follow-up|0|||
126756495|NCT00663208|456059437|FG002|Follow-up Period|Lost to Follow-up|3|||
126756496|NCT00663208|456059438|FG003|Follow-up Period|Lost to Follow-up|2|||
126756497|NCT00663208|456059439|FG004|Follow-up Period|Lost to Follow-up|0|||
126756498|NCT00663208|456059440|FG005|Follow-up Period|Lost to Follow-up|0|||
126756499|NCT00663208|456059441|FG006|Follow-up Period|Lost to Follow-up|0|||
126756500|NCT00663208|456059435|FG000|Follow-up Period|Other reason|1|||
126756501|NCT00663208|456059436|FG001|Follow-up Period|Other reason|0|||
126756502|NCT00663208|456059437|FG002|Follow-up Period|Other reason|0|||
126756503|NCT00663208|456059438|FG003|Follow-up Period|Other reason|0|||
126756504|NCT00663208|456059439|FG004|Follow-up Period|Other reason|0|||
126756505|NCT00663208|456059440|FG005|Follow-up Period|Other reason|0|||
126756506|NCT00663208|456059441|FG006|Follow-up Period|Other reason|1|||
126756507|NCT02927990|456059443|FG000|Overall Study|Protocol Violation|4|||
126756508|NCT02927990|456059443|FG000|Overall Study|Physician Decision|9|||
126756509|NCT02927990|456059443|FG000|Overall Study|Room switched and therefore no study device available|15|||
126756510|NCT02927990|456059443|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
126756511|NCT00960323|456059444|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
126756512|NCT02719028|456059451|FG000|Overall Study|Adverse Event|2|||
126756513|NCT02719028|456059452|FG001|Overall Study|Adverse Event|1|||
126756514|NCT02719028|456059453|FG002|Overall Study|Adverse Event|4|||
126640390|NCT03445533|455642762|FG001|Overall Study|Sponsor Decision|1|||
126640693|NCT02271984|455644525|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126640694|NCT02271984|455644526|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
126640695|NCT03104075|455644527|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
126640696|NCT03104075|455644528|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
126640697|NCT04024462|455644529|FG000|Overall Study|Withdrawal by Subject|6|||
126640698|NCT04024462|455644530|FG001|Overall Study|Withdrawal by Subject|7|||
126640699|NCT04024462|455644529|FG000|Overall Study|Progressive Disease|0|||
126640700|NCT04024462|455644530|FG001|Overall Study|Progressive Disease|1|||
126640701|NCT04024462|455644529|FG000|Overall Study|Adverse Event|0|||
126640702|NCT04024462|455644530|FG001|Overall Study|Adverse Event|1|||
126640703|NCT04024462|455644529|FG000|Overall Study|Death|0|||
126640704|NCT04024462|455644530|FG001|Overall Study|Death|1|||
126640705|NCT04024462|455644529|FG000|Overall Study|Lost to Follow-up|1|||
126640706|NCT04024462|455644530|FG001|Overall Study|Lost to Follow-up|0|||
126640707|NCT04024462|455644529|FG000|Overall Study|Ongoing in the Study|94|||
126640708|NCT04024462|455644530|FG001|Overall Study|Ongoing in the Study|89|||
126640709|NCT00789360|455644533|FG000|Overall Study|Protocol Violation|3|||
126640710|NCT00789360|455644534|FG001|Overall Study|Protocol Violation|1|||
126640711|NCT04400487|455644535|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
126640712|NCT04400487|455644535|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
126640713|NCT04400487|455644535|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
126640714|NCT03559062|455644536|FG000|Overall Study|Other|0|||
126640715|NCT03559062|455644537|FG001|Overall Study|Other|1|||
126640716|NCT03559062|455644538|FG002|Overall Study|Other|0|||
126640717|NCT00022659|455644539|FG000|Overall Study|Ineligible: wrong primary|1|||
126640718|NCT00022659|455644539|FG000|Overall Study|Never treated|1|||
126640719|NCT00426127|455644541|FG000|Overall Study|Adverse Event|1|||
126640720|NCT00426127|455644541|FG000|Overall Study|Removed due to disease progression|1|||
126640721|NCT05048238|455644544|FG000|Overall Study|Withdrawal by Subject|1|||
126640722|NCT01730378|455644545|FG000|Overall Study|Lost to Follow-up|1|||
126640723|NCT01730378|455644546|FG001|Overall Study|Lost to Follow-up|0|||
126640724|NCT00955708|455644547|FG000|Overall Study|Death|269|||
126640725|NCT00955708|455644547|FG000|Overall Study|Lost to Follow-up|72|||
126640726|NCT00955708|455644547|FG000|Overall Study|Physician Decision|36|||
126640727|NCT00955708|455644547|FG000|Overall Study|Protocol Violation|134|||
126640728|NCT00955708|455644547|FG000|Overall Study|Registry Conclusion|186|||
126640729|NCT00955708|455644547|FG000|Overall Study|Product removed from service|94|||
126640730|NCT00955708|455644547|FG000|Overall Study|Patient Refused to participate further|116|||
126640731|NCT00955708|455644547|FG000|Overall Study|Closure of study location|60|||
126640732|NCT00955708|455644547|FG000|Overall Study|Patient changed care provider/moved|91|||
126640733|NCT01016262|455644548|FG000|Double-blind Phase|Adverse Event|0|||
126640734|NCT01016262|455644549|FG001|Double-blind Phase|Adverse Event|0|||
126640735|NCT01016262|455644550|FG002|Double-blind Phase|Adverse Event|1|||
126640736|NCT01016262|455644551|FG003|Double-blind Phase|Adverse Event|0|||
126640737|NCT01016262|455644552|FG004|Double-blind Phase|Adverse Event|0|||
126640738|NCT01016262|455644553|FG005|Double-blind Phase|Adverse Event|0|||
126640739|NCT01016262|455644548|FG000|Double-blind Phase|Lack of Efficacy|1|||
126640740|NCT01016262|455644549|FG001|Double-blind Phase|Lack of Efficacy|0|||
126640741|NCT01016262|455644550|FG002|Double-blind Phase|Lack of Efficacy|5|||
126640742|NCT01016262|455644551|FG003|Double-blind Phase|Lack of Efficacy|0|||
126640743|NCT01016262|455644552|FG004|Double-blind Phase|Lack of Efficacy|0|||
126640744|NCT01016262|455644553|FG005|Double-blind Phase|Lack of Efficacy|0|||
126640745|NCT01016262|455644548|FG000|Double-blind Phase|Disease Progression|0|||
126640746|NCT01016262|455644549|FG001|Double-blind Phase|Disease Progression|1|||
126640747|NCT01016262|455644550|FG002|Double-blind Phase|Disease Progression|2|||
126640748|NCT01016262|455644551|FG003|Double-blind Phase|Disease Progression|0|||
126640749|NCT01016262|455644552|FG004|Double-blind Phase|Disease Progression|0|||
126640750|NCT01016262|455644553|FG005|Double-blind Phase|Disease Progression|0|||
126640751|NCT01016262|455644548|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
126640752|NCT01016262|455644549|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
126640753|NCT01016262|455644550|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
126640754|NCT01016262|455644551|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
126640755|NCT01016262|455644552|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
126640756|NCT01016262|455644553|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
126640757|NCT01016262|455644548|FG000|Open-Label Phase|Adverse Event|0|||
126640758|NCT01016262|455644549|FG001|Open-Label Phase|Adverse Event|0|||
126640759|NCT01016262|455644550|FG002|Open-Label Phase|Adverse Event|0|||
126640760|NCT01016262|455644551|FG003|Open-Label Phase|Adverse Event|1|||
126640761|NCT01016262|455644552|FG004|Open-Label Phase|Adverse Event|0|||
126640762|NCT01016262|455644553|FG005|Open-Label Phase|Adverse Event|0|||
126640763|NCT01016262|455644548|FG000|Open-Label Phase|Lost to Follow-up|0|||
126640764|NCT01016262|455644549|FG001|Open-Label Phase|Lost to Follow-up|0|||
126640765|NCT01016262|455644550|FG002|Open-Label Phase|Lost to Follow-up|0|||
126640766|NCT01016262|455644551|FG003|Open-Label Phase|Lost to Follow-up|0|||
126640767|NCT01016262|455644552|FG004|Open-Label Phase|Lost to Follow-up|1|||
126640768|NCT01016262|455644553|FG005|Open-Label Phase|Lost to Follow-up|0|||
126640769|NCT01016262|455644548|FG000|Open-Label Phase|Lack of Efficacy|0|||
126640770|NCT01016262|455644549|FG001|Open-Label Phase|Lack of Efficacy|0|||
126640771|NCT01016262|455644550|FG002|Open-Label Phase|Lack of Efficacy|0|||
126640772|NCT01016262|455644551|FG003|Open-Label Phase|Lack of Efficacy|1|||
126640773|NCT01016262|455644552|FG004|Open-Label Phase|Lack of Efficacy|0|||
126640774|NCT01016262|455644553|FG005|Open-Label Phase|Lack of Efficacy|0|||
126640775|NCT01016262|455644548|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
126640776|NCT01016262|455644549|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
126640777|NCT01016262|455644550|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
126640778|NCT01016262|455644551|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
126640779|NCT01016262|455644552|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
126640780|NCT01016262|455644553|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
126640781|NCT02057575|455644558|FG000|Overall Study|Adverse Event|0|||
126640782|NCT02057575|455644559|FG001|Overall Study|Adverse Event|2|||
126640783|NCT02057575|455644560|FG002|Overall Study|Adverse Event|0|||
126640784|NCT02057575|455644561|FG003|Overall Study|Adverse Event|1|||
126640785|NCT02057575|455644558|FG000|Overall Study|Withdrawal by Subject|1|||
126640786|NCT02057575|455644559|FG001|Overall Study|Withdrawal by Subject|0|||
126640787|NCT02057575|455644560|FG002|Overall Study|Withdrawal by Subject|0|||
126640788|NCT02057575|455644561|FG003|Overall Study|Withdrawal by Subject|0|||
126640789|NCT02057575|455644558|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
126640790|NCT02057575|455644559|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
126640791|NCT02057575|455644560|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
126640792|NCT02057575|455644561|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
126640793|NCT02057575|455644558|FG000|Overall Study|Protocol Violation|0|||
126640794|NCT02057575|455644559|FG001|Overall Study|Protocol Violation|1|||
126640795|NCT02057575|455644560|FG002|Overall Study|Protocol Violation|0|||
126640796|NCT02057575|455644561|FG003|Overall Study|Protocol Violation|0|||
126640797|NCT00332462|455644562|FG000|Overall Study|Adverse Event|5|||
126640798|NCT00332462|455644562|FG000|Overall Study|Abnormal Lab Value|1|||
126640799|NCT00332462|455644562|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
126640800|NCT00332462|455644562|FG000|Overall Study|no longer requires study drug|1|||
126640801|NCT00332462|455644562|FG000|Overall Study|Death|3|||
126640802|NCT00332462|455644562|FG000|Overall Study|Graft Loss|2|||
126640803|NCT01643044|455644563|FG000|Overall Study|Lost to Follow-up|1|||
126640804|NCT01643044|455644564|FG001|Overall Study|Lost to Follow-up|1|||
126640805|NCT01643044|455644563|FG000|Overall Study|Miscarried baby|2|||
126640806|NCT01643044|455644564|FG001|Overall Study|Miscarried baby|2|||
126640807|NCT01643044|455644563|FG000|Overall Study|Delivered outside of hospital|1|||
126640808|NCT01643044|455644564|FG001|Overall Study|Delivered outside of hospital|2|||
126640809|NCT01735175|455644568|FG000|Overall Study|Withdrawal by Subject|9|||
126640810|NCT01735175|455644569|FG001|Overall Study|Withdrawal by Subject|2|||
126640811|NCT01735175|455644568|FG000|Overall Study|Lost to Follow-up|4|||
126640812|NCT01735175|455644569|FG001|Overall Study|Lost to Follow-up|2|||
126640813|NCT01735175|455644568|FG000|Overall Study|Death|3|||
126640814|NCT01735175|455644569|FG001|Overall Study|Death|2|||
126640815|NCT01735175|455644568|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
126640816|NCT01735175|455644569|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
126640817|NCT01853475|455644570|FG000|Overall Study|Withdrawal by Subject|0|||
126640818|NCT01853475|455644571|FG001|Overall Study|Withdrawal by Subject|1|||
126640819|NCT01853475|455644572|FG002|Overall Study|Withdrawal by Subject|0|||
126640820|NCT01023958|455644575|FG000|Overall Study|Progressive disease|48|||
126640821|NCT01023958|455644575|FG000|Overall Study|Other adverse event|1|||
126640822|NCT01023958|455644575|FG000|Overall Study|Refused to continue medication|1|||
126640823|NCT03080493|455644576|FG000|Overall Study|Did not provide NRS pain results|1|||
126640824|NCT03080493|455644577|FG001|Overall Study|Did not provide NRS pain results|0|||
126640825|NCT03080493|455644576|FG000|Overall Study|Adverse Event|0|||
126640826|NCT03080493|455644577|FG001|Overall Study|Adverse Event|1|||
126640827|NCT03080493|455644576|FG000|Overall Study|Randomization error (parity group)|0|||
126640828|NCT03080493|455644577|FG001|Overall Study|Randomization error (parity group)|1|||
126640829|NCT00755417|455644578|FG000|Overall Study|Adverse Event|28|||
126640830|NCT00755417|455644579|FG001|Overall Study|Adverse Event|20|||
126640831|NCT00755417|455644580|FG002|Overall Study|Adverse Event|7|||
126640832|NCT00755417|455644578|FG000|Overall Study|Lack of Efficacy|8|||
126640833|NCT00755417|455644579|FG001|Overall Study|Lack of Efficacy|4|||
126640834|NCT00755417|455644580|FG002|Overall Study|Lack of Efficacy|9|||
126640835|NCT00755417|455644578|FG000|Overall Study|Protocol Violation|2|||
126640836|NCT00755417|455644579|FG001|Overall Study|Protocol Violation|1|||
126640837|NCT00755417|455644580|FG002|Overall Study|Protocol Violation|1|||
126640838|NCT00755417|455644578|FG000|Overall Study|Lost to Follow-up|3|||
126640839|NCT00755417|455644579|FG001|Overall Study|Lost to Follow-up|0|||
126640840|NCT00755417|455644580|FG002|Overall Study|Lost to Follow-up|1|||
126640841|NCT00755417|455644578|FG000|Overall Study|Withdrawal by Subject|12|||
126640842|NCT00755417|455644579|FG001|Overall Study|Withdrawal by Subject|12|||
126640843|NCT00755417|455644580|FG002|Overall Study|Withdrawal by Subject|12|||
126640844|NCT00755417|455644578|FG000|Overall Study|Not specified or missing data|9|||
126640845|NCT00755417|455644579|FG001|Overall Study|Not specified or missing data|18|||
126640846|NCT00755417|455644580|FG002|Overall Study|Not specified or missing data|12|||
126640847|NCT02362503|455644581|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
126640848|NCT02362503|455644582|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
126640849|NCT02362503|455644583|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
126640850|NCT02362503|455644581|FG000|Double-blind Period-Up to 8 Days|Death|1|||
126640851|NCT02362503|455644582|FG001|Double-blind Period-Up to 8 Days|Death|0|||
126640852|NCT02362503|455644583|FG002|Double-blind Period-Up to 8 Days|Death|0|||
126640853|NCT02362503|455644581|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
126640854|NCT02362503|455644582|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
126640855|NCT02362503|455644583|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
126640856|NCT02362503|455644581|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
126640857|NCT02362503|455644582|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
126640858|NCT02362503|455644583|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
126640859|NCT02362503|455644581|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
126640860|NCT02362503|455644582|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
126640861|NCT02362503|455644583|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
126640862|NCT02362503|455644581|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
126640863|NCT02362503|455644582|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
126640864|NCT02362503|455644583|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
126640865|NCT02362503|455644581|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
126640866|NCT02362503|455644582|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
126640867|NCT02362503|455644583|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
126640868|NCT02362503|455644581|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
126640869|NCT02362503|455644582|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
126640870|NCT02362503|455644583|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
126640871|NCT02362503|455644581|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
126640872|NCT02362503|455644582|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
126640873|NCT02362503|455644583|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
126640874|NCT02362503|455644581|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
126640875|NCT02362503|455644582|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
126640876|NCT02362503|455644583|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
126640877|NCT02362503|455644581|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
126640878|NCT02362503|455644582|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
126640879|NCT02362503|455644583|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
126640880|NCT02362503|455644581|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
126640881|NCT02362503|455644582|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
126640882|NCT02362503|455644583|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
126640883|NCT02362503|455644581|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
126640884|NCT02362503|455644582|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
126640885|NCT02362503|455644583|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
126640886|NCT02362503|455644581|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
126640887|NCT02362503|455644582|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
126640888|NCT02362503|455644583|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
126640889|NCT02195479|455644584|FG000|Overall Study|Lost to Follow-up|18|||
126640890|NCT02195479|455644585|FG001|Overall Study|Lost to Follow-up|15|||
126640891|NCT02195479|455644584|FG000|Overall Study|Death|217|||
126640892|NCT02195479|455644585|FG001|Overall Study|Death|171|||
126640893|NCT02195479|455644584|FG000|Overall Study|Physician Decision|1|||
126640894|NCT02195479|455644585|FG001|Overall Study|Physician Decision|0|||
126640895|NCT02195479|455644584|FG000|Overall Study|Withdrawal by Subject|30|||
126640896|NCT02195479|455644585|FG001|Overall Study|Withdrawal by Subject|30|||
126640897|NCT02195479|455644584|FG000|Overall Study|Other|3|||
126640898|NCT02195479|455644585|FG001|Overall Study|Other|4|||
126756655|NCT01632345|456059508|FG000|Treatment: Part I|Protocol Deviation|0|||
126756656|NCT01632345|456059509|FG001|Treatment: Part I|Protocol Deviation|0|||
126756657|NCT01632345|456059510|FG002|Treatment: Part I|Protocol Deviation|1|||
126756658|NCT01632345|456059511|FG003|Treatment: Part I|Protocol Deviation|1|||
126756659|NCT01632345|456059512|FG004|Treatment: Part I|Protocol Deviation|0|||
126756660|NCT01632345|456059513|FG005|Treatment: Part I|Protocol Deviation|0|||
126756661|NCT01632345|456059514|FG006|Treatment: Part I|Protocol Deviation|0|||
126756662|NCT01632345|456059508|FG000|Treatment: Part I|Withdrawal by Subject|3|||
126756663|NCT01632345|456059509|FG001|Treatment: Part I|Withdrawal by Subject|4|||
126756664|NCT01632345|456059510|FG002|Treatment: Part I|Withdrawal by Subject|4|||
126756665|NCT01632345|456059511|FG003|Treatment: Part I|Withdrawal by Subject|1|||
126756666|NCT01632345|456059512|FG004|Treatment: Part I|Withdrawal by Subject|4|||
126756667|NCT01632345|456059513|FG005|Treatment: Part I|Withdrawal by Subject|0|||
126756668|NCT01632345|456059514|FG006|Treatment: Part I|Withdrawal by Subject|0|||
126756669|NCT01632345|456059508|FG000|Treatment: Part II|Adverse Event|0|||
126756670|NCT01632345|456059509|FG001|Treatment: Part II|Adverse Event|0|||
126756671|NCT01632345|456059510|FG002|Treatment: Part II|Adverse Event|0|||
126756672|NCT01632345|456059511|FG003|Treatment: Part II|Adverse Event|0|||
126756673|NCT01632345|456059512|FG004|Treatment: Part II|Adverse Event|0|||
126756674|NCT01632345|456059513|FG005|Treatment: Part II|Adverse Event|3|||
126756675|NCT01632345|456059514|FG006|Treatment: Part II|Adverse Event|8|||
126756676|NCT01632345|456059508|FG000|Treatment: Part II|Lost to Follow-up|0|||
126756677|NCT01632345|456059509|FG001|Treatment: Part II|Lost to Follow-up|0|||
126756678|NCT01632345|456059510|FG002|Treatment: Part II|Lost to Follow-up|0|||
126756679|NCT01632345|456059511|FG003|Treatment: Part II|Lost to Follow-up|0|||
126756680|NCT01632345|456059512|FG004|Treatment: Part II|Lost to Follow-up|0|||
126756681|NCT01632345|456059513|FG005|Treatment: Part II|Lost to Follow-up|3|||
126756682|NCT01632345|456059514|FG006|Treatment: Part II|Lost to Follow-up|1|||
126756683|NCT01632345|456059508|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
126756684|NCT01632345|456059509|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
126756685|NCT01632345|456059510|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
126756686|NCT01632345|456059511|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
126756687|NCT01632345|456059512|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
126756688|NCT01632345|456059513|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
126756689|NCT01632345|456059514|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
126756690|NCT01632345|456059508|FG000|Treatment: Part II|Withdrawal by Subject|0|||
126756691|NCT01632345|456059509|FG001|Treatment: Part II|Withdrawal by Subject|0|||
126756692|NCT01632345|456059510|FG002|Treatment: Part II|Withdrawal by Subject|0|||
126756693|NCT01632345|456059511|FG003|Treatment: Part II|Withdrawal by Subject|0|||
126756694|NCT01632345|456059512|FG004|Treatment: Part II|Withdrawal by Subject|0|||
126756695|NCT01632345|456059513|FG005|Treatment: Part II|Withdrawal by Subject|2|||
126756696|NCT01632345|456059514|FG006|Treatment: Part II|Withdrawal by Subject|2|||
126756697|NCT03370133|456059515|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
126756698|NCT03370133|456059516|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
126756699|NCT03370133|456059517|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
126756700|NCT03370133|456059518|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
126756701|NCT03370133|456059519|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
126756702|NCT03370133|456059520|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
126756703|NCT03370133|456059515|FG000|Initial Treatment Period (WK 16)|Death|1|||
126756704|NCT03370133|456059516|FG001|Initial Treatment Period (WK 16)|Death|1|||
126756705|NCT03370133|456059517|FG002|Initial Treatment Period (WK 16)|Death|1|||
126756706|NCT03370133|456059518|FG003|Initial Treatment Period (WK 16)|Death|0|||
126756707|NCT03370133|456059519|FG004|Initial Treatment Period (WK 16)|Death|0|||
126756708|NCT03370133|456059520|FG005|Initial Treatment Period (WK 16)|Death|0|||
126756709|NCT03370133|456059515|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
126756710|NCT03370133|456059516|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
126756711|NCT03370133|456059517|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
126756712|NCT03370133|456059518|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
126756713|NCT03370133|456059519|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
126756714|NCT03370133|456059520|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
126756715|NCT03370133|456059515|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
126756716|NCT03370133|456059516|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
126756717|NCT03370133|456059517|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
126756718|NCT03370133|456059518|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
126756719|NCT03370133|456059519|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
126756720|NCT03370133|456059520|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
126756721|NCT03370133|456059515|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
126756722|NCT03370133|456059516|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
126756723|NCT03370133|456059517|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
126756724|NCT03370133|456059518|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
126756725|NCT03370133|456059519|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
126756726|NCT03370133|456059520|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
126756727|NCT03370133|456059515|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
126756728|NCT03370133|456059516|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
126756729|NCT03370133|456059517|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
126756730|NCT03370133|456059518|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
126756731|NCT03370133|456059519|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
126756732|NCT03370133|456059520|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
126756733|NCT03370133|456059515|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
126756734|NCT03370133|456059516|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
126756735|NCT03370133|456059517|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
126756736|NCT03370133|456059518|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
126756737|NCT03370133|456059519|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
126756738|NCT03370133|456059520|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
126756739|NCT03370133|456059515|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
126756740|NCT03370133|456059516|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
126756741|NCT03370133|456059517|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
126756742|NCT03370133|456059518|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
126756743|NCT03370133|456059519|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
126756744|NCT03370133|456059520|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
126756745|NCT03370133|456059515|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
126756746|NCT03370133|456059516|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
126756747|NCT03370133|456059517|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
126756748|NCT03370133|456059518|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
126756749|NCT03370133|456059519|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
126756750|NCT03370133|456059520|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
126756751|NCT03370133|456059515|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
126756752|NCT03370133|456059516|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
126756753|NCT03370133|456059517|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
126756754|NCT03370133|456059518|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
126756755|NCT03370133|456059519|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
126756756|NCT03370133|456059520|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
126756757|NCT03370133|456059515|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
126756758|NCT03370133|456059516|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
126756759|NCT03370133|456059517|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
126756760|NCT03370133|456059518|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
126756761|NCT03370133|456059519|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
126756762|NCT03370133|456059520|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
126756763|NCT03370133|456059515|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
126756764|NCT03370133|456059516|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
126756765|NCT03370133|456059517|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
126756766|NCT03370133|456059518|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
126756767|NCT03370133|456059519|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
126756768|NCT03370133|456059520|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
126756769|NCT03370133|456059515|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
126756770|NCT03370133|456059516|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
126756771|NCT03370133|456059517|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
126756772|NCT03370133|456059518|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
126756773|NCT03370133|456059519|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
126756774|NCT03370133|456059520|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
126756775|NCT03370133|456059515|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
126756776|NCT03370133|456059516|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
126756777|NCT03370133|456059517|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
126756778|NCT03370133|456059518|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
126756779|NCT03370133|456059519|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
126640899|NCT02195479|455644584|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
126640900|NCT02195479|455644585|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
126640901|NCT03325777|455644590|FG000|Overall Study|Lost to Follow-up|9|||
126640902|NCT03325777|455644591|FG001|Overall Study|Lost to Follow-up|12|||
126640903|NCT03004404|455644594|FG000|Period 2|Adverse Event|0|||
126640904|NCT03004404|455644595|FG001|Period 2|Adverse Event|0|||
126640905|NCT03004404|455644596|FG002|Period 2|Adverse Event|0|||
126640906|NCT03004404|455644597|FG003|Period 2|Adverse Event|0|||
126640907|NCT03004404|455644598|FG004|Period 2|Adverse Event|0|||
126640908|NCT03004404|455644599|FG005|Period 2|Adverse Event|0|||
126640909|NCT03004404|455644600|FG006|Period 2|Adverse Event|0|||
126640910|NCT03004404|455644601|FG007|Period 2|Adverse Event|0|||
126640911|NCT03004404|455644602|FG008|Period 2|Adverse Event|1|||
126640912|NCT03004404|455644603|FG009|Period 2|Adverse Event|0|||
126640913|NCT03004404|455644604|FG010|Period 2|Adverse Event|0|||
126640914|NCT03004404|455644605|FG011|Period 2|Adverse Event|0|||
126640915|NCT03004404|455644606|FG012|Period 2|Adverse Event|0|||
126640916|NCT03004404|455644607|FG013|Period 2|Adverse Event|0|||
126640917|NCT03004404|455644608|FG014|Period 2|Adverse Event|0|||
126640918|NCT03004404|455644609|FG015|Period 2|Adverse Event|1|||
126640919|NCT02522728|455644614|FG000|Overall Study|Withdrawal by Subject|6|||
126640920|NCT02522728|455644615|FG001|Overall Study|Withdrawal by Subject|6|||
126640921|NCT02522728|455644614|FG000|Overall Study|Death|4|||
126640922|NCT02522728|455644615|FG001|Overall Study|Death|3|||
126640923|NCT02522728|455644614|FG000|Overall Study|Adverse Event|2|||
126640924|NCT02522728|455644615|FG001|Overall Study|Adverse Event|1|||
126640925|NCT02522728|455644614|FG000|Overall Study|Did not receive randomized study device|0|||
126640926|NCT02522728|455644615|FG001|Overall Study|Did not receive randomized study device|1|||
126640927|NCT01099917|455644616|FG000|Overall Study|Adverse Event|3|||
126640928|NCT01099917|455644616|FG000|Overall Study|Not Treated|24|||
126640929|NCT01266161|455644623|FG000|Overall Study|Ineligible|1|||
126640930|NCT01266161|455644624|FG001|Overall Study|Ineligible|0|||
126640931|NCT01266161|455644623|FG000|Overall Study|Lack of Efficacy|0|||
126640932|NCT01266161|455644624|FG001|Overall Study|Lack of Efficacy|1|||
126640933|NCT01266161|455644623|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
126640934|NCT01266161|455644624|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
126640935|NCT01436305|455644626|FG000|Overall Study|Death|1|||
126640936|NCT01436305|455644627|FG001|Overall Study|Death|0|||
126640937|NCT01436305|455644628|FG002|Overall Study|Death|0|||
126640938|NCT01436305|455644626|FG000|Overall Study|Lost to Follow-up|0|||
126640939|NCT01436305|455644627|FG001|Overall Study|Lost to Follow-up|1|||
126640940|NCT01436305|455644628|FG002|Overall Study|Lost to Follow-up|0|||
126640941|NCT01436305|455644626|FG000|Overall Study|Withdrawal by Subject|1|||
126640942|NCT01436305|455644627|FG001|Overall Study|Withdrawal by Subject|3|||
126640943|NCT01436305|455644628|FG002|Overall Study|Withdrawal by Subject|0|||
126640944|NCT01485120|455644629|FG000|Overall Study|Withdrawal by Subject|2|||
126640945|NCT01081886|455644630|FG000|Overall Study|Study termination|11|||
126640946|NCT01081886|455644631|FG001|Overall Study|Study termination|13|||
126640947|NCT02567708|455644632|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
126640948|NCT02567708|455644633|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
126640949|NCT02567708|455644632|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
126640950|NCT02567708|455644633|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
126640951|NCT02567708|455644632|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
126640952|NCT02567708|455644633|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
126640953|NCT02567708|455644632|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
126640954|NCT02567708|455644633|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
126640955|NCT04148651|455644636|FG000|Overall Study|Lost to Follow-up|2|||
126640956|NCT05262751|455644637|FG000|Washout Period 2|Adverse Event|1|||
126640957|NCT05262751|455644638|FG001|Washout Period 2|Adverse Event|0|||
126640958|NCT05262751|455644639|FG002|Washout Period 2|Adverse Event|0|||
126640959|NCT05262751|455644640|FG003|Washout Period 2|Adverse Event|0|||
126640960|NCT05262751|455644641|FG004|Washout Period 2|Adverse Event|0|||
126640961|NCT05262751|455644642|FG005|Washout Period 2|Adverse Event|0|||
126640962|NCT05262751|455644637|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
126640963|NCT05262751|455644638|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
126640964|NCT05262751|455644639|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
126640965|NCT05262751|455644640|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
126640966|NCT05262751|455644641|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
126640967|NCT05262751|455644642|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
126756780|NCT03370133|456059520|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
126756781|NCT03370133|456059515|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
126756782|NCT03370133|456059516|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
126756783|NCT03370133|456059517|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
126756784|NCT03370133|456059518|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
126756785|NCT03370133|456059519|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
126756786|NCT03370133|456059520|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
126756787|NCT02694562|456059521|FG000|Overall Study|Death|8|||
126756788|NCT02694562|456059521|FG000|Overall Study|Protocol Violation|4|||
126756789|NCT02694562|456059521|FG000|Overall Study|Lost to Follow-up|3|||
126756790|NCT02694562|456059521|FG000|Overall Study|Screen Failure|2|||
126756791|NCT02694562|456059521|FG000|Overall Study|Physician Decision|1|||
126756792|NCT00684073|456059522|FG000|Selection|Selection/non-selection criteria|3|||
126756793|NCT00684073|456059522|FG000|Selection|Death|1|||
126756794|NCT00684073|456059522|FG000|Selection|noncompliance|1|||
126756795|NCT00684073|456059522|FG000|Selection|Lost to Follow-up|1|||
126756796|NCT00684073|456059522|FG000|Selection|request of the sponsor|1|||
126756797|NCT00684073|456059522|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
126756798|NCT00620815|456059523|FG000|Overall Study|Adverse Event|1|||
126756799|NCT00620815|456059524|FG001|Overall Study|Adverse Event|1|||
126756800|NCT00620815|456059525|FG002|Overall Study|Adverse Event|2|||
126756801|NCT00620815|456059523|FG000|Overall Study|Withdrawal by Subject|1|||
126756802|NCT00620815|456059524|FG001|Overall Study|Withdrawal by Subject|2|||
126756803|NCT00620815|456059525|FG002|Overall Study|Withdrawal by Subject|0|||
126756804|NCT00620815|456059523|FG000|Overall Study|Lost to Follow-up|1|||
126756805|NCT00620815|456059524|FG001|Overall Study|Lost to Follow-up|6|||
126756806|NCT00620815|456059525|FG002|Overall Study|Lost to Follow-up|3|||
126756807|NCT00620815|456059523|FG000|Overall Study|Inappropriate enrolment|0|||
126756808|NCT00620815|456059524|FG001|Overall Study|Inappropriate enrolment|0|||
126756809|NCT00620815|456059525|FG002|Overall Study|Inappropriate enrolment|1|||
126756810|NCT00620815|456059523|FG000|Overall Study|Protocol Violation|1|||
126756811|NCT00620815|456059524|FG001|Overall Study|Protocol Violation|2|||
126756812|NCT00620815|456059525|FG002|Overall Study|Protocol Violation|1|||
126756813|NCT01888367|456059526|FG000|Overall Study|Physician Decision|3|||
126756814|NCT01888367|456059527|FG001|Overall Study|Physician Decision|4|||
126756815|NCT01888367|456059528|FG002|Overall Study|Physician Decision|2|||
126756816|NCT01888367|456059526|FG000|Overall Study|Death|2|||
126756817|NCT01888367|456059527|FG001|Overall Study|Death|0|||
126756818|NCT01888367|456059528|FG002|Overall Study|Death|1|||
126756819|NCT01888367|456059526|FG000|Overall Study|Withdrawal by Subject|1|||
126756820|NCT01888367|456059527|FG001|Overall Study|Withdrawal by Subject|0|||
126756821|NCT01888367|456059528|FG002|Overall Study|Withdrawal by Subject|1|||
126756822|NCT01888367|456059526|FG000|Overall Study|Lost to Follow-up|1|||
126756823|NCT01888367|456059527|FG001|Overall Study|Lost to Follow-up|1|||
126756824|NCT01888367|456059528|FG002|Overall Study|Lost to Follow-up|0|||
126756825|NCT01888367|456059526|FG000|Overall Study|Protocol Violation|0|||
126756826|NCT01888367|456059527|FG001|Overall Study|Protocol Violation|0|||
126756827|NCT01888367|456059528|FG002|Overall Study|Protocol Violation|1|||
126756828|NCT01888367|456059526|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
126756829|NCT01888367|456059527|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
126756830|NCT01888367|456059528|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
126756831|NCT03590613|456059530|FG000|Period 2, 4 Days|Physician Decision|0|||
126756832|NCT03590613|456059531|FG001|Period 2, 4 Days|Physician Decision|0|||
126756833|NCT03590613|456059532|FG002|Period 2, 4 Days|Physician Decision|0|||
126756834|NCT03590613|456059533|FG003|Period 2, 4 Days|Physician Decision|1|||
126756835|NCT00280059|456059534|FG000|Efficacy Assessment Phase|Death|2|||
126756836|NCT00280059|456059535|FG001|Efficacy Assessment Phase|Death|0|||
126756837|NCT00280059|456059534|FG000|Efficacy Assessment Phase|Adverse Event|33|||
126756838|NCT00280059|456059535|FG001|Efficacy Assessment Phase|Adverse Event|31|||
126756839|NCT00280059|456059534|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
126756840|NCT00280059|456059535|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
126756841|NCT00280059|456059534|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
126756842|NCT00280059|456059535|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
126756843|NCT00280059|456059534|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
126756844|NCT00280059|456059535|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
126756845|NCT00280059|456059534|FG000|Efficacy Assessment Phase|Other|7|||
126756846|NCT00280059|456059535|FG001|Efficacy Assessment Phase|Other|8|||
126756847|NCT00280059|456059534|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
126756848|NCT00280059|456059535|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
126756849|NCT01130831|456059540|FG000|Overall Study|Withdrawal by Subject|7|||
126756850|NCT01130831|456059540|FG000|Overall Study|Death|4|||
126756851|NCT01130831|456059540|FG000|Overall Study|Information was missing|3|||
126756852|NCT00951912|456059541|FG000|Overall Study|Lack of Efficacy|1|||
126756853|NCT00951912|456059542|FG001|Overall Study|Lack of Efficacy|0|||
126640968|NCT01154140|455644643|FG000|Overall Study|Death|71|||
126640969|NCT01154140|455644644|FG001|Overall Study|Death|81|||
126640970|NCT01154140|455644643|FG000|Overall Study|Lost to Follow-up|4|||
126640971|NCT01154140|455644644|FG001|Overall Study|Lost to Follow-up|5|||
126640972|NCT01154140|455644643|FG000|Overall Study|Withdrawal by Subject|12|||
126640973|NCT01154140|455644644|FG001|Overall Study|Withdrawal by Subject|13|||
126640974|NCT01154140|455644643|FG000|Overall Study|Other|3|||
126640975|NCT01154140|455644644|FG001|Overall Study|Other|1|||
126640976|NCT01154140|455644643|FG000|Overall Study|Randomized but not treated|1|||
126640977|NCT01154140|455644644|FG001|Overall Study|Randomized but not treated|2|||
126640978|NCT01305239|455644648|FG000|Overall Study|Adverse Event|22|||
126640979|NCT01305239|455644648|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
126640980|NCT04160988|455644651|FG000|Overall Study|poor image quality|28|||
126640981|NCT00664534|455644652|FG000|Overall Study|Adverse Event|2|||
126640982|NCT00664534|455644653|FG001|Overall Study|Adverse Event|3|||
126640983|NCT00664534|455644652|FG000|Overall Study|Lost to Follow-up|6|||
126640984|NCT00664534|455644653|FG001|Overall Study|Lost to Follow-up|10|||
126640985|NCT00664534|455644652|FG000|Overall Study|Protocol Violation|10|||
126640986|NCT00664534|455644653|FG001|Overall Study|Protocol Violation|8|||
126640987|NCT00664534|455644652|FG000|Overall Study|Withdrawal by Subject|7|||
126640988|NCT00664534|455644653|FG001|Overall Study|Withdrawal by Subject|6|||
126640989|NCT00664534|455644652|FG000|Overall Study|Physician Decision|8|||
126640990|NCT00664534|455644653|FG001|Overall Study|Physician Decision|0|||
126640991|NCT00664534|455644652|FG000|Overall Study|Sponsor decision|8|||
126640992|NCT00664534|455644653|FG001|Overall Study|Sponsor decision|6|||
126640993|NCT00570908|455644669|FG000|Overall Study|Adverse Event|5|||
126640994|NCT00570908|455644669|FG000|Overall Study|Withdrawal by Subject|2|||
126640995|NCT06152224|455644673|FG000|Overall Study|Withdrawal by Subject|1|||
126640996|NCT06152224|455644674|FG001|Overall Study|Withdrawal by Subject|0|||
126640997|NCT06152224|455644673|FG000|Overall Study|Lost to Follow-up|0|||
126640998|NCT06152224|455644674|FG001|Overall Study|Lost to Follow-up|1|||
126640999|NCT06152224|455644673|FG000|Overall Study|On Follow Up|18|||
126641000|NCT06152224|455644674|FG001|Overall Study|On Follow Up|18|||
126641001|NCT01447576|455644684|FG000|Overall Study|Lost to Follow-up|52|||
126641002|NCT01447576|455644684|FG000|Overall Study|Adverse Event|127|||
126641003|NCT01447576|455644684|FG000|Overall Study|Participant met withdrawal criteria|40|||
126641004|NCT01447576|455644684|FG000|Overall Study|Withdrawal by Subject|100|||
126641005|NCT01447576|455644684|FG000|Overall Study|Protocol deviation|83|||
126641006|NCT01447576|455644684|FG000|Overall Study|Lack of Efficacy|68|||
126641007|NCT01447576|455644684|FG000|Overall Study|Physician Decision|6|||
126641008|NCT00975676|455644685|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
126641009|NCT00975676|455644686|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
126641010|NCT02548078|455644687|FG000|Overall Study|Serious adverse event/Adverse event|1|||
126641011|NCT02548078|455644688|FG001|Overall Study|Serious adverse event/Adverse event|0|||
126641012|NCT02548078|455644687|FG000|Overall Study|Moved from study area|3|||
126641013|NCT02548078|455644688|FG001|Overall Study|Moved from study area|3|||
126641014|NCT02548078|455644687|FG000|Overall Study|Lost to Follow-up|1|||
126641015|NCT02548078|455644688|FG001|Overall Study|Lost to Follow-up|3|||
126641016|NCT03128671|455644689|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
126641017|NCT03128671|455644690|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
126641018|NCT03128671|455644689|FG000|Allocation|Death|1|||
126641019|NCT03128671|455644690|FG001|Allocation|Death|0|||
126641020|NCT03128671|455644689|FG000|Allocation|Withdrawal by Subject|4|||
126641021|NCT03128671|455644690|FG001|Allocation|Withdrawal by Subject|0|||
126641022|NCT03128671|455644689|FG000|Intervention|Withdrawal by Subject|11|||
126641023|NCT03128671|455644690|FG001|Intervention|Withdrawal by Subject|10|||
126641024|NCT03128671|455644689|FG000|Intervention|Palliative/hospice care initiated|9|||
126641025|NCT03128671|455644690|FG001|Intervention|Palliative/hospice care initiated|10|||
126641026|NCT03128671|455644689|FG000|Intervention|Death|13|||
126641027|NCT03128671|455644690|FG001|Intervention|Death|11|||
126641028|NCT03128671|455644689|FG000|Intervention|Interrupted by hurricane|1|||
126641029|NCT03128671|455644690|FG001|Intervention|Interrupted by hurricane|0|||
126641030|NCT03128671|455644689|FG000|Intervention|Physician Decision|2|||
126641031|NCT03128671|455644690|FG001|Intervention|Physician Decision|3|||
126641032|NCT00862836|455644692|FG000|Overall Study|Withdrawal by Subject|1|||
126641033|NCT04463680|455644693|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
126641034|NCT04463680|455644693|FG000|Overall Study|Not eligible due to implant duration of use|1|||
126641035|NCT04463680|455644693|FG000|Overall Study|Withdrawal by Subject|3|||
126641036|NCT05239598|455644696|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
126641037|NCT05239598|455644697|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
126641038|NCT05239598|455644696|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
126641039|NCT05239598|455644697|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
126641040|NCT05823012|455644700|FG000|Titration Period|Adverse Event|1|||
126641041|NCT05823012|455644700|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
126641042|NCT05823012|455644700|FG000|Maintenance Period|Adverse Event|1|||
126641043|NCT05823012|455644700|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
126641044|NCT05823012|455644700|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
126641045|NCT04991753|455646460|FG000|Overall Study|Withdrawal by Subject|0|||
126641046|NCT04991753|455646461|FG001|Overall Study|Withdrawal by Subject|1|||
126641047|NCT03299049|455646464|FG000|Overall Study|On-going|486|||
126641048|NCT03299049|455646465|FG001|Overall Study|On-going|481|||
126641049|NCT03299049|455646464|FG000|Overall Study|Withdrawal by Subject|6|||
126641050|NCT03299049|455646465|FG001|Overall Study|Withdrawal by Subject|21|||
126641051|NCT03299049|455646464|FG000|Overall Study|Physician Decision|5|||
126641052|NCT03299049|455646465|FG001|Overall Study|Physician Decision|1|||
126641053|NCT03299049|455646464|FG000|Overall Study|Lost to Follow-up|2|||
126641054|NCT03299049|455646465|FG001|Overall Study|Lost to Follow-up|0|||
126641055|NCT03299049|455646464|FG000|Overall Study|Pregnancy|1|||
126641056|NCT03299049|455646465|FG001|Overall Study|Pregnancy|3|||
126641057|NCT03299049|455646464|FG000|Overall Study|Protocol Violation|1|||
126641058|NCT03299049|455646465|FG001|Overall Study|Protocol Violation|1|||
126641059|NCT03299049|455646464|FG000|Overall Study|Lack of Efficacy|9|||
126641060|NCT03299049|455646465|FG001|Overall Study|Lack of Efficacy|3|||
126641061|NCT03299049|455646464|FG000|Overall Study|Adverse Event|12|||
126641062|NCT03299049|455646465|FG001|Overall Study|Adverse Event|13|||
126641063|NCT01901419|455646466|FG000|Overall Study|Protocol Violation|2|||
126641064|NCT01901419|455646467|FG001|Overall Study|Protocol Violation|6|||
126641065|NCT01901419|455646466|FG000|Overall Study|unavailable researchers|6|||
126641066|NCT01901419|455646467|FG001|Overall Study|unavailable researchers|3|||
126641067|NCT01667926|455646472|FG000|Overall Study|Withdrawal by Subject|1|||
126641068|NCT01667926|455646473|FG001|Overall Study|Withdrawal by Subject|2|||
126641069|NCT01667926|455646474|FG002|Overall Study|Withdrawal by Subject|2|||
126641070|NCT01667926|455646472|FG000|Overall Study|Physician Decision|0|||
126641071|NCT01667926|455646473|FG001|Overall Study|Physician Decision|0|||
126641072|NCT01667926|455646474|FG002|Overall Study|Physician Decision|1|||
126641073|NCT01667926|455646472|FG000|Overall Study|Time committment|0|||
126641074|NCT01667926|455646473|FG001|Overall Study|Time committment|0|||
126641075|NCT01667926|455646474|FG002|Overall Study|Time committment|2|||
126641076|NCT01667926|455646472|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
126641077|NCT01667926|455646473|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
126641078|NCT01667926|455646474|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
126641079|NCT01667926|455646472|FG000|Overall Study|Lost to Follow-up|1|||
126641080|NCT01667926|455646473|FG001|Overall Study|Lost to Follow-up|2|||
126641081|NCT01667926|455646474|FG002|Overall Study|Lost to Follow-up|1|||
126641082|NCT01667926|455646472|FG000|Overall Study|Side effects|3|||
126641083|NCT01667926|455646473|FG001|Overall Study|Side effects|0|||
126641084|NCT01667926|455646474|FG002|Overall Study|Side effects|0|||
126641085|NCT02412735|455646477|FG000|Overall Study|Adverse Event|0|||
126641086|NCT02412735|455646478|FG001|Overall Study|Adverse Event|1|||
126641087|NCT02412735|455646479|FG002|Overall Study|Adverse Event|2|||
126641088|NCT02412735|455646477|FG000|Overall Study|Withdrawal by Subject|23|||
126641089|NCT02412735|455646478|FG001|Overall Study|Withdrawal by Subject|27|||
126641090|NCT02412735|455646479|FG002|Overall Study|Withdrawal by Subject|22|||
126641091|NCT02412735|455646477|FG000|Overall Study|Investigator Decision|3|||
126641092|NCT02412735|455646478|FG001|Overall Study|Investigator Decision|3|||
126641093|NCT02412735|455646479|FG002|Overall Study|Investigator Decision|2|||
126641094|NCT02412735|455646477|FG000|Overall Study|Lost to Follow-up|17|||
126641095|NCT02412735|455646478|FG001|Overall Study|Lost to Follow-up|11|||
126641096|NCT02412735|455646479|FG002|Overall Study|Lost to Follow-up|18|||
126641097|NCT02412735|455646477|FG000|Overall Study|Reason not Specified|3|||
126641098|NCT02412735|455646478|FG001|Overall Study|Reason not Specified|2|||
126641099|NCT02412735|455646479|FG002|Overall Study|Reason not Specified|2|||
126641100|NCT04043143|455646480|FG000|Overall Study|Lost to Follow-up|5|||
126641101|NCT04043143|455646481|FG001|Overall Study|Lost to Follow-up|5|||
126641102|NCT04043143|455646480|FG000|Overall Study|screen failure|1|||
126641103|NCT04043143|455646481|FG001|Overall Study|screen failure|0|||
126641104|NCT02521363|455646482|FG000|Overall Study|Withdrawal by Subject|1|||
126641105|NCT02521363|455646483|FG001|Overall Study|Withdrawal by Subject|2|||
126641106|NCT03374488|455646484|FG000|Overall Study|Death|13|||
126641107|NCT03374488|455646485|FG001|Overall Study|Death|13|||
126641108|NCT03374488|455646484|FG000|Overall Study|Withdrawal by Subject|3|||
126641109|NCT03374488|455646485|FG001|Overall Study|Withdrawal by Subject|1|||
126641110|NCT03374488|455646484|FG000|Overall Study|Physician Decision|3|||
126641111|NCT03374488|455646485|FG001|Overall Study|Physician Decision|0|||
126641112|NCT01757197|455646486|FG000|Overall Study|Death|2|||
126641113|NCT01077128|455646489|FG000|Overall Study|Adverse Event|8|||
126641114|NCT01077128|455646489|FG000|Overall Study|Lack of Efficacy|1|||
126641115|NCT01077128|455646489|FG000|Overall Study|Disease exacerbation|1|||
126641116|NCT01077128|455646489|FG000|Overall Study|Adverse event and consent withdrawal|1|||
126641117|NCT01077128|455646489|FG000|Overall Study|Adverse event and disease exacerbation|1|||
126641118|NCT01077128|455646489|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
126641119|NCT01077128|455646489|FG000|Overall Study|Other|54|||
126641120|NCT01706705|455646490|FG000|Overall Study|Death|1|||
126641121|NCT01706705|455646490|FG000|Overall Study|Lack of Efficacy|13|||
126641122|NCT01706705|455646490|FG000|Overall Study|Non-clinical|6|||
126641123|NCT04703192|455646491|FG000|Overall Study|Withdrawal by Subject|2|||
126641124|NCT04703192|455646492|FG001|Overall Study|Withdrawal by Subject|0|||
126641125|NCT04703192|455646491|FG000|Overall Study|Death|3|||
126641126|NCT04703192|455646492|FG001|Overall Study|Death|1|||
126641127|NCT04703192|455646491|FG000|Overall Study|Adverse Event|13|||
126641128|NCT04703192|455646492|FG001|Overall Study|Adverse Event|2|||
126641129|NCT04703192|455646491|FG000|Overall Study|Progressive or Relapsed Disease|46|||
126641130|NCT04703192|455646492|FG001|Overall Study|Progressive or Relapsed Disease|7|||
126641131|NCT04703192|455646491|FG000|Overall Study|Clinical Progression|19|||
126641132|NCT04703192|455646492|FG001|Overall Study|Clinical Progression|8|||
126641133|NCT04703192|455646491|FG000|Overall Study|Lost to Follow-up|1|||
126641134|NCT04703192|455646492|FG001|Overall Study|Lost to Follow-up|0|||
126641135|NCT04703192|455646491|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
126641136|NCT04703192|455646492|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
126641137|NCT04703192|455646491|FG000|Overall Study|Other|5|||
126641138|NCT04703192|455646492|FG001|Overall Study|Other|1|||
126641139|NCT02088957|455646493|FG000|Overall Study|Lack of Efficacy|1|||
126641140|NCT02088957|455646494|FG001|Overall Study|Lack of Efficacy|0|||
126641141|NCT01939353|455646495|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
126641142|NCT01939353|455646495|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
126641143|NCT01939353|455646495|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
126641144|NCT01939353|455646495|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
126641145|NCT01939353|455646495|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
126641146|NCT00874731|455646503|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
126641147|NCT00874731|455646504|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
126641148|NCT00874731|455646505|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
126641149|NCT00874731|455646503|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
126641150|NCT00874731|455646504|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
126641151|NCT00874731|455646505|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
126641152|NCT00874731|455646503|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
126641153|NCT00874731|455646504|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
126641154|NCT00874731|455646505|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
126641155|NCT01132820|455646510|FG000|Overall Study|Ineligible: wrong cell type|1|||
126641156|NCT01132820|455646510|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
126756854|NCT00951912|456059543|FG002|Overall Study|Lack of Efficacy|0|||
126756855|NCT00951912|456059541|FG000|Overall Study|Adverse Event|0|||
126756856|NCT00951912|456059542|FG001|Overall Study|Adverse Event|1|||
126756857|NCT00951912|456059543|FG002|Overall Study|Adverse Event|1|||
126756858|NCT00951912|456059541|FG000|Overall Study|Lost to Follow-up|2|||
126756859|NCT00951912|456059542|FG001|Overall Study|Lost to Follow-up|2|||
126756860|NCT00951912|456059543|FG002|Overall Study|Lost to Follow-up|0|||
126756861|NCT00951912|456059541|FG000|Overall Study|Physician Decision|1|||
126756862|NCT00951912|456059542|FG001|Overall Study|Physician Decision|0|||
126756863|NCT00951912|456059543|FG002|Overall Study|Physician Decision|1|||
126756864|NCT00951912|456059541|FG000|Overall Study|Withdrawal by Subject|1|||
126756865|NCT00951912|456059542|FG001|Overall Study|Withdrawal by Subject|1|||
126756866|NCT00951912|456059543|FG002|Overall Study|Withdrawal by Subject|0|||
126756867|NCT00951912|456059541|FG000|Overall Study|Other:Depression|1|||
126756868|NCT00951912|456059542|FG001|Overall Study|Other:Depression|0|||
126756869|NCT00951912|456059543|FG002|Overall Study|Other:Depression|0|||
126756870|NCT00951912|456059541|FG000|Overall Study|Other: Colon cancer|1|||
126756871|NCT00951912|456059542|FG001|Overall Study|Other: Colon cancer|0|||
126756872|NCT00951912|456059543|FG002|Overall Study|Other: Colon cancer|0|||
126756873|NCT00951912|456059541|FG000|Overall Study|Other: Stroke|0|||
126756874|NCT00951912|456059542|FG001|Overall Study|Other: Stroke|1|||
126756875|NCT00951912|456059543|FG002|Overall Study|Other: Stroke|0|||
126756876|NCT03417999|456059544|FG000|Overall Study|Withdrawal by Subject|1|||
126756877|NCT03417999|456059545|FG001|Overall Study|Withdrawal by Subject|0|||
126756878|NCT03417999|456059546|FG002|Overall Study|Withdrawal by Subject|0|||
126756879|NCT03417999|456059544|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
126756880|NCT03417999|456059545|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
126756881|NCT03417999|456059546|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
126756882|NCT03417999|456059544|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
126756883|NCT03417999|456059545|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
126756884|NCT03417999|456059546|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
126756885|NCT03417999|456059544|FG000|Overall Study|Inadequate study staff available to process samples|0|||
126756886|NCT03417999|456059545|FG001|Overall Study|Inadequate study staff available to process samples|0|||
126756887|NCT03417999|456059546|FG002|Overall Study|Inadequate study staff available to process samples|1|||
126756888|NCT00489216|456059551|FG000|Overall Study|Adverse Event|1|||
126756889|NCT02612194|456059556|FG000|Overall Study|Death|5|||
126756890|NCT02612194|456059557|FG001|Overall Study|Death|0|||
126756891|NCT02612194|456059558|FG002|Overall Study|Death|2|||
126756892|NCT02612194|456059556|FG000|Overall Study|Early Study Termination|1|||
126756893|NCT02612194|456059557|FG001|Overall Study|Early Study Termination|0|||
126756894|NCT02612194|456059558|FG002|Overall Study|Early Study Termination|0|||
126756895|NCT02539160|456059561|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
126756896|NCT02539160|456059562|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
126756897|NCT02539160|456059563|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
126756898|NCT02539160|456059564|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
126756899|NCT02539160|456059561|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
126756900|NCT02539160|456059562|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
126756901|NCT02539160|456059563|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
126756902|NCT02539160|456059564|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
126756903|NCT02539160|456059561|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
126756904|NCT02539160|456059562|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
126756905|NCT02539160|456059563|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
126756906|NCT02539160|456059564|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
126756907|NCT01681004|456059565|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
126756908|NCT01681004|456059566|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
126756909|NCT01681004|456059565|FG000|Study Completion|Lost to Follow-up|8|||
126756910|NCT01681004|456059566|FG001|Study Completion|Lost to Follow-up|3|||
126756911|NCT01681004|456059565|FG000|Study Completion|Physician Decision|1|||
126756912|NCT01681004|456059566|FG001|Study Completion|Physician Decision|3|||
126756913|NCT01681004|456059565|FG000|Study Completion|Site Termination|2|||
126756914|NCT01681004|456059566|FG001|Study Completion|Site Termination|1|||
126641157|NCT01132820|455646510|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
126641158|NCT01132820|455646510|FG000|Overall Study|Never treated|1|||
126641159|NCT01132820|455646510|FG000|Overall Study|Inadequate data|1|||
126641160|NCT00667394|455646512|FG000|Overall Study|Adverse Event|3|||
126641161|NCT00667394|455646513|FG001|Overall Study|Adverse Event|0|||
126641162|NCT00667394|455646512|FG000|Overall Study|Progressive disease|1|||
126641163|NCT00667394|455646513|FG001|Overall Study|Progressive disease|0|||
126641164|NCT05000216|455646514|FG000|Stage 1|Lost to Follow-up|0|||
126641165|NCT05000216|455646515|FG001|Stage 1|Lost to Follow-up|0|||
126641166|NCT05000216|455646516|FG002|Stage 1|Lost to Follow-up|0|||
126641167|NCT05000216|455646517|FG003|Stage 1|Lost to Follow-up|0|||
126641168|NCT05000216|455646518|FG004|Stage 1|Lost to Follow-up|0|||
126641169|NCT05000216|455646519|FG005|Stage 1|Lost to Follow-up|0|||
126641170|NCT05000216|455646520|FG006|Stage 1|Lost to Follow-up|1|||
126641171|NCT05000216|455646521|FG007|Stage 1|Lost to Follow-up|1|||
126641172|NCT05000216|455646522|FG008|Stage 1|Lost to Follow-up|0|||
126641173|NCT05000216|455646523|FG009|Stage 1|Lost to Follow-up|2|||
126641174|NCT05000216|455646524|FG010|Stage 1|Lost to Follow-up|3|||
126641175|NCT05000216|455646525|FG011|Stage 1|Lost to Follow-up|0|||
126641176|NCT05000216|455646526|FG012|Stage 1|Lost to Follow-up|0|||
126641177|NCT05000216|455646527|FG013|Stage 1|Lost to Follow-up|0|||
126641178|NCT05000216|455646528|FG014|Stage 1|Lost to Follow-up|0|||
126641179|NCT05000216|455646529|FG015|Stage 1|Lost to Follow-up|0|||
126641180|NCT05000216|455646530|FG016|Stage 1|Lost to Follow-up|0|||
126641181|NCT05000216|455646531|FG017|Stage 1|Lost to Follow-up|0|||
126641182|NCT05000216|455646532|FG018|Stage 1|Lost to Follow-up|0|||
126641183|NCT05000216|455646533|FG019|Stage 1|Lost to Follow-up|0|||
126641184|NCT05000216|455646534|FG020|Stage 1|Lost to Follow-up|0|||
126641185|NCT05000216|455646535|FG021|Stage 1|Lost to Follow-up|0|||
126641186|NCT05000216|455646514|FG000|Stage 1|Physician Decision|0|||
126641187|NCT05000216|455646515|FG001|Stage 1|Physician Decision|0|||
126641188|NCT05000216|455646516|FG002|Stage 1|Physician Decision|0|||
126641189|NCT05000216|455646517|FG003|Stage 1|Physician Decision|0|||
126641190|NCT05000216|455646518|FG004|Stage 1|Physician Decision|0|||
126641191|NCT05000216|455646519|FG005|Stage 1|Physician Decision|0|||
126641192|NCT05000216|455646520|FG006|Stage 1|Physician Decision|0|||
126641193|NCT05000216|455646521|FG007|Stage 1|Physician Decision|1|||
126641194|NCT05000216|455646522|FG008|Stage 1|Physician Decision|1|||
126641195|NCT05000216|455646523|FG009|Stage 1|Physician Decision|0|||
126641196|NCT05000216|455646524|FG010|Stage 1|Physician Decision|0|||
126641197|NCT05000216|455646525|FG011|Stage 1|Physician Decision|0|||
126641198|NCT05000216|455646526|FG012|Stage 1|Physician Decision|0|||
126641199|NCT05000216|455646527|FG013|Stage 1|Physician Decision|0|||
126641200|NCT05000216|455646528|FG014|Stage 1|Physician Decision|0|||
126641201|NCT05000216|455646529|FG015|Stage 1|Physician Decision|0|||
126641202|NCT05000216|455646530|FG016|Stage 1|Physician Decision|0|||
126641203|NCT05000216|455646531|FG017|Stage 1|Physician Decision|0|||
126641204|NCT05000216|455646532|FG018|Stage 1|Physician Decision|0|||
126641205|NCT05000216|455646533|FG019|Stage 1|Physician Decision|0|||
126641206|NCT05000216|455646534|FG020|Stage 1|Physician Decision|0|||
126641207|NCT05000216|455646535|FG021|Stage 1|Physician Decision|0|||
126641208|NCT05000216|455646514|FG000|Stage 1|Withdrawal by Subject|0|||
126641209|NCT05000216|455646515|FG001|Stage 1|Withdrawal by Subject|1|||
126641210|NCT05000216|455646516|FG002|Stage 1|Withdrawal by Subject|0|||
126641211|NCT05000216|455646517|FG003|Stage 1|Withdrawal by Subject|0|||
126641212|NCT05000216|455646518|FG004|Stage 1|Withdrawal by Subject|0|||
126641213|NCT05000216|455646519|FG005|Stage 1|Withdrawal by Subject|0|||
126641214|NCT05000216|455646520|FG006|Stage 1|Withdrawal by Subject|0|||
126641215|NCT05000216|455646521|FG007|Stage 1|Withdrawal by Subject|0|||
126641216|NCT05000216|455646522|FG008|Stage 1|Withdrawal by Subject|0|||
126641217|NCT05000216|455646523|FG009|Stage 1|Withdrawal by Subject|3|||
126641218|NCT05000216|455646524|FG010|Stage 1|Withdrawal by Subject|10|||
126641219|NCT05000216|455646525|FG011|Stage 1|Withdrawal by Subject|0|||
126641220|NCT05000216|455646526|FG012|Stage 1|Withdrawal by Subject|0|||
126641221|NCT05000216|455646527|FG013|Stage 1|Withdrawal by Subject|0|||
126641222|NCT05000216|455646528|FG014|Stage 1|Withdrawal by Subject|0|||
126641223|NCT05000216|455646529|FG015|Stage 1|Withdrawal by Subject|0|||
126641224|NCT05000216|455646530|FG016|Stage 1|Withdrawal by Subject|0|||
126641225|NCT05000216|455646531|FG017|Stage 1|Withdrawal by Subject|0|||
126641226|NCT05000216|455646532|FG018|Stage 1|Withdrawal by Subject|0|||
126641227|NCT05000216|455646533|FG019|Stage 1|Withdrawal by Subject|0|||
126641228|NCT05000216|455646534|FG020|Stage 1|Withdrawal by Subject|0|||
126641229|NCT05000216|455646535|FG021|Stage 1|Withdrawal by Subject|0|||
126641230|NCT05000216|455646514|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
126641231|NCT05000216|455646515|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
126641232|NCT05000216|455646516|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
126641233|NCT05000216|455646517|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
126641234|NCT05000216|455646518|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
126641235|NCT05000216|455646519|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
126641236|NCT05000216|455646520|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
126641237|NCT05000216|455646521|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
126641238|NCT05000216|455646522|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
126641239|NCT05000216|455646523|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
126641240|NCT05000216|455646524|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
126641241|NCT05000216|455646525|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
126641242|NCT05000216|455646526|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
126641243|NCT05000216|455646527|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
126641244|NCT05000216|455646528|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
126641245|NCT05000216|455646529|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
126641246|NCT05000216|455646530|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
126641247|NCT05000216|455646531|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
126641248|NCT05000216|455646532|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
126641249|NCT05000216|455646533|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
126641250|NCT05000216|455646534|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
126641251|NCT05000216|455646535|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
126641252|NCT05000216|455646514|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641253|NCT05000216|455646515|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641254|NCT05000216|455646516|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641255|NCT05000216|455646517|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641256|NCT05000216|455646518|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641257|NCT05000216|455646519|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641258|NCT05000216|455646520|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641259|NCT05000216|455646521|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641260|NCT05000216|455646522|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
126641261|NCT05000216|455646523|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641262|NCT05000216|455646524|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641263|NCT05000216|455646525|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641264|NCT05000216|455646526|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641265|NCT05000216|455646527|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641266|NCT05000216|455646528|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641267|NCT05000216|455646529|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641268|NCT05000216|455646530|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641269|NCT05000216|455646531|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641270|NCT05000216|455646532|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641271|NCT05000216|455646533|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641272|NCT05000216|455646534|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641273|NCT05000216|455646535|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
126641274|NCT05000216|455646514|FG000|Stage 1|Other|0|||
126641275|NCT05000216|455646515|FG001|Stage 1|Other|0|||
126641276|NCT05000216|455646516|FG002|Stage 1|Other|0|||
126641277|NCT05000216|455646517|FG003|Stage 1|Other|0|||
126641278|NCT05000216|455646518|FG004|Stage 1|Other|1|||
126641279|NCT05000216|455646519|FG005|Stage 1|Other|0|||
126641280|NCT05000216|455646520|FG006|Stage 1|Other|0|||
126641281|NCT05000216|455646521|FG007|Stage 1|Other|2|||
126641282|NCT05000216|455646522|FG008|Stage 1|Other|0|||
126641283|NCT05000216|455646523|FG009|Stage 1|Other|0|||
126641284|NCT05000216|455646524|FG010|Stage 1|Other|1|||
126641285|NCT05000216|455646525|FG011|Stage 1|Other|1|||
126641286|NCT05000216|455646526|FG012|Stage 1|Other|0|||
126641287|NCT05000216|455646527|FG013|Stage 1|Other|0|||
126641288|NCT05000216|455646528|FG014|Stage 1|Other|0|||
126641289|NCT05000216|455646529|FG015|Stage 1|Other|0|||
126641290|NCT05000216|455646530|FG016|Stage 1|Other|0|||
126641291|NCT05000216|455646531|FG017|Stage 1|Other|0|||
126641292|NCT05000216|455646532|FG018|Stage 1|Other|0|||
126641293|NCT05000216|455646533|FG019|Stage 1|Other|0|||
126641294|NCT05000216|455646534|FG020|Stage 1|Other|0|||
126641295|NCT05000216|455646535|FG021|Stage 1|Other|0|||
126641296|NCT05000216|455646514|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
126641297|NCT05000216|455646515|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
126641298|NCT05000216|455646516|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
126641299|NCT05000216|455646517|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
126641300|NCT05000216|455646518|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
126641301|NCT05000216|455646519|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
126641302|NCT05000216|455646520|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
126641303|NCT05000216|455646521|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
126641304|NCT05000216|455646522|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
126641305|NCT05000216|455646523|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
126641306|NCT05000216|455646524|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
126641307|NCT05000216|455646525|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
126641308|NCT05000216|455646526|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
126641309|NCT05000216|455646527|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
126641310|NCT05000216|455646528|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
126641311|NCT05000216|455646529|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
126641312|NCT05000216|455646530|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
126641313|NCT05000216|455646531|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
126641314|NCT05000216|455646532|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
126641315|NCT05000216|455646533|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
126641316|NCT05000216|455646534|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
126641317|NCT05000216|455646535|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
126641318|NCT05000216|455646514|FG000|Stage 2|Lost to Follow-up|0|||
126641319|NCT05000216|455646515|FG001|Stage 2|Lost to Follow-up|0|||
126641320|NCT05000216|455646516|FG002|Stage 2|Lost to Follow-up|0|||
126641321|NCT05000216|455646517|FG003|Stage 2|Lost to Follow-up|0|||
126641322|NCT05000216|455646518|FG004|Stage 2|Lost to Follow-up|0|||
126641323|NCT05000216|455646519|FG005|Stage 2|Lost to Follow-up|0|||
126641324|NCT05000216|455646520|FG006|Stage 2|Lost to Follow-up|0|||
126641325|NCT05000216|455646521|FG007|Stage 2|Lost to Follow-up|0|||
126641326|NCT05000216|455646522|FG008|Stage 2|Lost to Follow-up|0|||
126641327|NCT05000216|455646523|FG009|Stage 2|Lost to Follow-up|0|||
126641328|NCT05000216|455646524|FG010|Stage 2|Lost to Follow-up|0|||
126641329|NCT05000216|455646525|FG011|Stage 2|Lost to Follow-up|0|||
126641330|NCT05000216|455646526|FG012|Stage 2|Lost to Follow-up|0|||
126641331|NCT05000216|455646527|FG013|Stage 2|Lost to Follow-up|0|||
126641332|NCT05000216|455646528|FG014|Stage 2|Lost to Follow-up|0|||
126641333|NCT05000216|455646529|FG015|Stage 2|Lost to Follow-up|0|||
126641334|NCT05000216|455646530|FG016|Stage 2|Lost to Follow-up|4|||
126641335|NCT05000216|455646531|FG017|Stage 2|Lost to Follow-up|0|||
126641336|NCT05000216|455646532|FG018|Stage 2|Lost to Follow-up|0|||
126641337|NCT05000216|455646533|FG019|Stage 2|Lost to Follow-up|0|||
126641338|NCT05000216|455646534|FG020|Stage 2|Lost to Follow-up|0|||
126641339|NCT05000216|455646535|FG021|Stage 2|Lost to Follow-up|0|||
126641340|NCT05000216|455646514|FG000|Stage 2|Physician Decision|0|||
126641341|NCT05000216|455646515|FG001|Stage 2|Physician Decision|0|||
126641342|NCT05000216|455646516|FG002|Stage 2|Physician Decision|0|||
126641343|NCT05000216|455646517|FG003|Stage 2|Physician Decision|0|||
126641344|NCT05000216|455646518|FG004|Stage 2|Physician Decision|0|||
126641345|NCT05000216|455646519|FG005|Stage 2|Physician Decision|0|||
126641346|NCT05000216|455646520|FG006|Stage 2|Physician Decision|0|||
126641347|NCT05000216|455646521|FG007|Stage 2|Physician Decision|0|||
126641348|NCT05000216|455646522|FG008|Stage 2|Physician Decision|0|||
126641349|NCT05000216|455646523|FG009|Stage 2|Physician Decision|0|||
126641350|NCT05000216|455646524|FG010|Stage 2|Physician Decision|0|||
126641351|NCT05000216|455646525|FG011|Stage 2|Physician Decision|0|||
126641352|NCT05000216|455646526|FG012|Stage 2|Physician Decision|1|||
126641353|NCT05000216|455646527|FG013|Stage 2|Physician Decision|0|||
126641354|NCT05000216|455646528|FG014|Stage 2|Physician Decision|0|||
126641355|NCT05000216|455646529|FG015|Stage 2|Physician Decision|0|||
126641356|NCT05000216|455646530|FG016|Stage 2|Physician Decision|0|||
126641357|NCT05000216|455646531|FG017|Stage 2|Physician Decision|0|||
126641358|NCT05000216|455646532|FG018|Stage 2|Physician Decision|0|||
126641359|NCT05000216|455646533|FG019|Stage 2|Physician Decision|0|||
126641360|NCT05000216|455646534|FG020|Stage 2|Physician Decision|0|||
126641361|NCT05000216|455646535|FG021|Stage 2|Physician Decision|0|||
126641362|NCT05000216|455646514|FG000|Stage 2|Withdrawal by Subject|0|||
126641363|NCT05000216|455646515|FG001|Stage 2|Withdrawal by Subject|0|||
126641364|NCT05000216|455646516|FG002|Stage 2|Withdrawal by Subject|0|||
126641365|NCT05000216|455646517|FG003|Stage 2|Withdrawal by Subject|0|||
126641366|NCT05000216|455646518|FG004|Stage 2|Withdrawal by Subject|0|||
126641367|NCT05000216|455646519|FG005|Stage 2|Withdrawal by Subject|0|||
126641368|NCT05000216|455646520|FG006|Stage 2|Withdrawal by Subject|0|||
126641369|NCT05000216|455646521|FG007|Stage 2|Withdrawal by Subject|0|||
126641370|NCT05000216|455646522|FG008|Stage 2|Withdrawal by Subject|0|||
126641371|NCT05000216|455646523|FG009|Stage 2|Withdrawal by Subject|0|||
126641372|NCT05000216|455646524|FG010|Stage 2|Withdrawal by Subject|0|||
126641373|NCT05000216|455646525|FG011|Stage 2|Withdrawal by Subject|0|||
126641374|NCT05000216|455646526|FG012|Stage 2|Withdrawal by Subject|0|||
126641375|NCT05000216|455646527|FG013|Stage 2|Withdrawal by Subject|0|||
126641376|NCT05000216|455646528|FG014|Stage 2|Withdrawal by Subject|2|||
126641377|NCT05000216|455646529|FG015|Stage 2|Withdrawal by Subject|0|||
126641378|NCT05000216|455646530|FG016|Stage 2|Withdrawal by Subject|9|||
126641379|NCT05000216|455646531|FG017|Stage 2|Withdrawal by Subject|0|||
126641380|NCT05000216|455646532|FG018|Stage 2|Withdrawal by Subject|0|||
126641381|NCT05000216|455646533|FG019|Stage 2|Withdrawal by Subject|0|||
126641382|NCT05000216|455646534|FG020|Stage 2|Withdrawal by Subject|0|||
126641383|NCT05000216|455646535|FG021|Stage 2|Withdrawal by Subject|0|||
126641384|NCT05000216|455646514|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
126641385|NCT05000216|455646515|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
126641386|NCT05000216|455646516|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
126641387|NCT05000216|455646517|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
126641388|NCT05000216|455646518|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
126641389|NCT05000216|455646519|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
126641390|NCT05000216|455646520|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
126641391|NCT05000216|455646521|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
126641392|NCT05000216|455646522|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
126641393|NCT05000216|455646523|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
126641394|NCT05000216|455646524|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
126641395|NCT05000216|455646525|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
126641396|NCT05000216|455646526|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
126641397|NCT05000216|455646527|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
126641398|NCT05000216|455646528|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
126641399|NCT05000216|455646529|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
126641400|NCT05000216|455646530|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
126641401|NCT05000216|455646531|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
126641402|NCT05000216|455646532|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
126641403|NCT05000216|455646533|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
126641404|NCT05000216|455646534|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
126641405|NCT05000216|455646535|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
126641406|NCT05000216|455646514|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641407|NCT05000216|455646515|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641408|NCT05000216|455646516|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641409|NCT05000216|455646517|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641410|NCT05000216|455646518|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641411|NCT05000216|455646519|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641412|NCT05000216|455646520|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641413|NCT05000216|455646521|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641414|NCT05000216|455646522|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641415|NCT05000216|455646523|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641416|NCT05000216|455646524|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641417|NCT05000216|455646525|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641418|NCT05000216|455646526|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641419|NCT05000216|455646527|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641420|NCT05000216|455646528|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
126641421|NCT05000216|455646529|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641422|NCT05000216|455646530|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
126641423|NCT05000216|455646531|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641424|NCT05000216|455646532|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641425|NCT05000216|455646533|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641426|NCT05000216|455646534|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641427|NCT05000216|455646535|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
126641428|NCT05000216|455646514|FG000|Stage 2|Other reason|0|||
126641429|NCT05000216|455646515|FG001|Stage 2|Other reason|0|||
126641430|NCT05000216|455646516|FG002|Stage 2|Other reason|0|||
126641431|NCT05000216|455646517|FG003|Stage 2|Other reason|0|||
126641432|NCT05000216|455646518|FG004|Stage 2|Other reason|0|||
126641433|NCT05000216|455646519|FG005|Stage 2|Other reason|0|||
126641434|NCT05000216|455646520|FG006|Stage 2|Other reason|0|||
126641435|NCT05000216|455646521|FG007|Stage 2|Other reason|0|||
126641436|NCT05000216|455646522|FG008|Stage 2|Other reason|0|||
126641437|NCT05000216|455646523|FG009|Stage 2|Other reason|0|||
126641438|NCT05000216|455646524|FG010|Stage 2|Other reason|0|||
126641439|NCT05000216|455646525|FG011|Stage 2|Other reason|0|||
126641440|NCT05000216|455646526|FG012|Stage 2|Other reason|0|||
126641441|NCT05000216|455646527|FG013|Stage 2|Other reason|0|||
126641442|NCT05000216|455646528|FG014|Stage 2|Other reason|0|||
126641443|NCT05000216|455646529|FG015|Stage 2|Other reason|0|||
126641444|NCT05000216|455646530|FG016|Stage 2|Other reason|1|||
126641445|NCT05000216|455646531|FG017|Stage 2|Other reason|0|||
126641446|NCT05000216|455646532|FG018|Stage 2|Other reason|0|||
126641447|NCT05000216|455646533|FG019|Stage 2|Other reason|0|||
126641448|NCT05000216|455646534|FG020|Stage 2|Other reason|0|||
126641449|NCT05000216|455646535|FG021|Stage 2|Other reason|0|||
126641450|NCT05000216|455646514|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
126641451|NCT05000216|455646515|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
126641452|NCT05000216|455646516|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
126641453|NCT05000216|455646517|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
126641454|NCT05000216|455646518|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
126641455|NCT05000216|455646519|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
126641456|NCT05000216|455646520|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
126641457|NCT05000216|455646521|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
126641458|NCT05000216|455646522|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
126641459|NCT05000216|455646523|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
126641460|NCT05000216|455646524|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
126641461|NCT05000216|455646525|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
126641462|NCT05000216|455646526|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
126641463|NCT05000216|455646527|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
126641464|NCT05000216|455646528|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
126641465|NCT05000216|455646529|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
126641466|NCT05000216|455646530|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
126641467|NCT05000216|455646531|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
126641468|NCT05000216|455646532|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
126641469|NCT05000216|455646533|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
126641470|NCT05000216|455646534|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
126641471|NCT05000216|455646535|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
126641472|NCT05000216|455646514|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641473|NCT05000216|455646515|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641474|NCT05000216|455646516|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641475|NCT05000216|455646517|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641476|NCT05000216|455646518|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641477|NCT05000216|455646519|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641478|NCT05000216|455646520|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641479|NCT05000216|455646521|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641480|NCT05000216|455646522|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641481|NCT05000216|455646523|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641482|NCT05000216|455646524|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641483|NCT05000216|455646525|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641484|NCT05000216|455646526|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641485|NCT05000216|455646527|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641486|NCT05000216|455646528|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641487|NCT05000216|455646529|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
126641488|NCT05000216|455646530|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641489|NCT05000216|455646531|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641490|NCT05000216|455646532|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641491|NCT05000216|455646533|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641492|NCT05000216|455646534|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641493|NCT05000216|455646535|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
126641494|NCT05000216|455646514|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641495|NCT05000216|455646515|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641496|NCT05000216|455646516|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126756915|NCT01681004|456059565|FG000|Study Completion|Death|1|||
126756916|NCT01681004|456059566|FG001|Study Completion|Death|1|||
126756917|NCT00372905|456059567|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
126756918|NCT00372905|456059568|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
126756919|NCT00372905|456059569|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
126756920|NCT00372905|456059570|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
126756921|NCT00372905|456059567|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
126756922|NCT00372905|456059568|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
126756923|NCT00372905|456059569|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
126756924|NCT00372905|456059570|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
126756925|NCT00372905|456059567|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
126756926|NCT00372905|456059568|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
126756927|NCT00372905|456059569|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
126756928|NCT00372905|456059570|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
126756929|NCT00372905|456059567|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
126756930|NCT00372905|456059568|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
126756931|NCT00372905|456059569|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
126756932|NCT00372905|456059570|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
126756933|NCT00372905|456059567|FG000|Follow up Until Relapse or Progression|Study closed|0|||
126756934|NCT00372905|456059568|FG001|Follow up Until Relapse or Progression|Study closed|0|||
126756935|NCT00372905|456059569|FG002|Follow up Until Relapse or Progression|Study closed|0|||
126756936|NCT00372905|456059570|FG003|Follow up Until Relapse or Progression|Study closed|3|||
126756937|NCT00372905|456059567|FG000|Follow up Until Relapse or Progression|Other|0|||
126756938|NCT00372905|456059568|FG001|Follow up Until Relapse or Progression|Other|1|||
126756939|NCT00372905|456059569|FG002|Follow up Until Relapse or Progression|Other|0|||
126756940|NCT00372905|456059570|FG003|Follow up Until Relapse or Progression|Other|0|||
126756941|NCT02312934|456059571|FG000|Overall Study|Lost to Follow-up|1|||
126756942|NCT02312934|456059572|FG001|Overall Study|Lost to Follow-up|0|||
126756943|NCT02312934|456059571|FG000|Overall Study|Physician Decision|1|||
126756944|NCT02312934|456059572|FG001|Overall Study|Physician Decision|0|||
126641497|NCT05000216|455646517|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641498|NCT05000216|455646518|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641499|NCT05000216|455646519|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641500|NCT05000216|455646520|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641501|NCT05000216|455646521|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641502|NCT05000216|455646522|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641503|NCT05000216|455646523|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641504|NCT05000216|455646524|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641505|NCT05000216|455646525|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641506|NCT05000216|455646526|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641507|NCT05000216|455646527|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
126641508|NCT05000216|455646528|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641509|NCT05000216|455646529|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
126641510|NCT05000216|455646530|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641511|NCT05000216|455646531|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641512|NCT05000216|455646532|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
126641513|NCT05000216|455646533|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641514|NCT05000216|455646534|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641515|NCT05000216|455646535|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
126641516|NCT02990468|455646536|FG000|Phase 2: MTD|Change in treatment|0|||
126641517|NCT02990468|455646537|FG001|Phase 2: MTD|Change in treatment|0|||
126641518|NCT02990468|455646538|FG002|Phase 2: MTD|Change in treatment|1|||
126641519|NCT05071053|455646541|FG000|Overall Study|Progressive disease|30|||
126641520|NCT05071053|455646541|FG000|Overall Study|Adverse Event|5|||
126641521|NCT01602510|455646544|FG000|Open Label Phase|Adverse Event|46|||
126641522|NCT01602510|455646545|FG001|Open Label Phase|Adverse Event|0|||
126641523|NCT01602510|455646546|FG002|Open Label Phase|Adverse Event|0|||
126641524|NCT01602510|455646544|FG000|Open Label Phase|Lack of Efficacy|22|||
126641525|NCT01602510|455646545|FG001|Open Label Phase|Lack of Efficacy|0|||
126641526|NCT01602510|455646546|FG002|Open Label Phase|Lack of Efficacy|0|||
126641527|NCT01602510|455646544|FG000|Open Label Phase|Protocol Violation|15|||
126641528|NCT01602510|455646545|FG001|Open Label Phase|Protocol Violation|0|||
126641529|NCT01602510|455646546|FG002|Open Label Phase|Protocol Violation|0|||
126641530|NCT01602510|455646544|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
126641531|NCT01602510|455646545|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
126641532|NCT01602510|455646546|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
126641533|NCT01602510|455646544|FG000|Open Label Phase|Lost to Follow-up|22|||
126641534|NCT01602510|455646545|FG001|Open Label Phase|Lost to Follow-up|0|||
126641535|NCT01602510|455646546|FG002|Open Label Phase|Lost to Follow-up|0|||
126641536|NCT01602510|455646544|FG000|Open Label Phase|Physician Decision|19|||
126641537|NCT01602510|455646545|FG001|Open Label Phase|Physician Decision|0|||
126641538|NCT01602510|455646546|FG002|Open Label Phase|Physician Decision|0|||
126641539|NCT01602510|455646544|FG000|Open Label Phase|Withdrawal by Subject|57|||
126641540|NCT01602510|455646545|FG001|Open Label Phase|Withdrawal by Subject|0|||
126641541|NCT01602510|455646546|FG002|Open Label Phase|Withdrawal by Subject|0|||
126641542|NCT01602510|455646544|FG000|Randomized Phase|Adverse Event|0|||
126641543|NCT01602510|455646545|FG001|Randomized Phase|Adverse Event|2|||
126641544|NCT01602510|455646546|FG002|Randomized Phase|Adverse Event|6|||
126641545|NCT01602510|455646544|FG000|Randomized Phase|Lack of Efficacy|0|||
126641546|NCT01602510|455646545|FG001|Randomized Phase|Lack of Efficacy|4|||
126641547|NCT01602510|455646546|FG002|Randomized Phase|Lack of Efficacy|4|||
126641548|NCT01602510|455646544|FG000|Randomized Phase|Protocol Violation|0|||
126641549|NCT01602510|455646545|FG001|Randomized Phase|Protocol Violation|3|||
126641550|NCT01602510|455646546|FG002|Randomized Phase|Protocol Violation|3|||
126641551|NCT01602510|455646544|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
126641552|NCT01602510|455646545|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
126641553|NCT01602510|455646546|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
126641554|NCT01602510|455646544|FG000|Randomized Phase|Lost to Follow-up|0|||
126641555|NCT01602510|455646545|FG001|Randomized Phase|Lost to Follow-up|1|||
126641556|NCT01602510|455646546|FG002|Randomized Phase|Lost to Follow-up|3|||
126641557|NCT01602510|455646544|FG000|Randomized Phase|Physician Decision|0|||
126641558|NCT01602510|455646545|FG001|Randomized Phase|Physician Decision|0|||
126641559|NCT01602510|455646546|FG002|Randomized Phase|Physician Decision|2|||
126641560|NCT01602510|455646544|FG000|Randomized Phase|Withdrawal by Subject|0|||
126641561|NCT01602510|455646545|FG001|Randomized Phase|Withdrawal by Subject|6|||
126641562|NCT01602510|455646546|FG002|Randomized Phase|Withdrawal by Subject|7|||
126641563|NCT03519204|455646547|FG000|Overall Study|Lost to Follow-up|3|||
126641564|NCT03519204|455646548|FG001|Overall Study|Lost to Follow-up|8|||
126641565|NCT03519204|455646547|FG000|Overall Study|Withdrawal by Subject|9|||
126641566|NCT03519204|455646548|FG001|Overall Study|Withdrawal by Subject|7|||
126641567|NCT03519204|455646547|FG000|Overall Study|Other Miscellaneous Reasons|1|||
126641568|NCT03519204|455646548|FG001|Overall Study|Other Miscellaneous Reasons|0|||
126641569|NCT01572740|455646550|FG000|Overall Study|Adverse Event|1|||
126641570|NCT01572740|455646551|FG001|Overall Study|Adverse Event|1|||
126756945|NCT00701064|456059574|FG000|Overall Study|Protocol Violation|1|||
126756946|NCT00701064|456059575|FG001|Overall Study|Protocol Violation|1|||
126756947|NCT00701064|456059574|FG000|Overall Study|Withdrawal by Subject|1|||
126756948|NCT00701064|456059575|FG001|Overall Study|Withdrawal by Subject|1|||
126756949|NCT00701064|456059574|FG000|Overall Study|initiated other PTSD treatment|2|||
126756950|NCT00701064|456059575|FG001|Overall Study|initiated other PTSD treatment|2|||
126756951|NCT00689299|456059576|FG000|Overall Study|Adverse Event|2|||
126756952|NCT00689299|456059577|FG001|Overall Study|Adverse Event|1|||
126756953|NCT00689299|456059578|FG002|Overall Study|Adverse Event|1|||
126756954|NCT00689299|456059576|FG000|Overall Study|Lost to Follow-up|0|||
126756955|NCT00689299|456059577|FG001|Overall Study|Lost to Follow-up|1|||
126756956|NCT00689299|456059578|FG002|Overall Study|Lost to Follow-up|1|||
126756957|NCT00689299|456059576|FG000|Overall Study|Withdrawal by Subject|4|||
126756958|NCT00689299|456059577|FG001|Overall Study|Withdrawal by Subject|1|||
126756959|NCT00689299|456059578|FG002|Overall Study|Withdrawal by Subject|3|||
126756960|NCT00689299|456059576|FG000|Overall Study|Protocol Violation|1|||
126756961|NCT00689299|456059577|FG001|Overall Study|Protocol Violation|0|||
126756962|NCT00689299|456059578|FG002|Overall Study|Protocol Violation|0|||
126756963|NCT02098733|456059581|FG000|Overall Study|Data Not Available|5|||
126756964|NCT02098733|456059581|FG000|Overall Study|Lost to Follow-up|5|||
126756965|NCT00434876|456059584|FG000|Overall Study|Lost to Follow-up|1|||
126756966|NCT00434876|456059585|FG001|Overall Study|Lost to Follow-up|1|||
126756967|NCT00758394|456059586|FG000|2nd Intervention Order|Lost to Follow-up|0|||
126756968|NCT00758394|456059587|FG001|2nd Intervention Order|Lost to Follow-up|1|||
126756969|NCT00758394|456059588|FG002|2nd Intervention Order|Lost to Follow-up|0|||
126756970|NCT00758394|456059589|FG003|2nd Intervention Order|Lost to Follow-up|0|||
126756971|NCT00758394|456059586|FG000|3rd Intervention|Lost to Follow-up|1|||
126756972|NCT00758394|456059587|FG001|3rd Intervention|Lost to Follow-up|0|||
126756973|NCT00758394|456059588|FG002|3rd Intervention|Lost to Follow-up|0|||
126756974|NCT00758394|456059589|FG003|3rd Intervention|Lost to Follow-up|1|||
126641571|NCT01572740|455646550|FG000|Overall Study|Withdrawal by Subject|1|||
126641572|NCT01572740|455646551|FG001|Overall Study|Withdrawal by Subject|1|||
126641573|NCT01572740|455646550|FG000|Overall Study|unclassified|4|||
126641574|NCT01572740|455646551|FG001|Overall Study|unclassified|3|||
126641575|NCT01289210|455646552|FG000|Overall Study|Adverse Event|1|||
126641576|NCT01818531|455646553|FG000|Overall Study|Withdrawn for case delay after block|1|||
126641577|NCT01818531|455646554|FG001|Overall Study|Withdrawn for case delay after block|0|||
126641578|NCT01818531|455646553|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
126641579|NCT01818531|455646554|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
126641580|NCT01818531|455646553|FG000|Overall Study|Withdrawn for failure to place block|0|||
126641581|NCT01818531|455646554|FG001|Overall Study|Withdrawn for failure to place block|1|||
126641582|NCT00477490|455646555|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
126641583|NCT00477490|455646556|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
126641584|NCT00477490|455646557|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
126641585|NCT00477490|455646558|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
126641586|NCT00477490|455646559|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
126641587|NCT00477490|455646560|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
126641588|NCT00477490|455646561|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
126641589|NCT00477490|455646562|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
126641590|NCT00477490|455646563|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
126641591|NCT00477490|455646555|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
126641592|NCT00477490|455646556|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
126641593|NCT00477490|455646557|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
126641594|NCT00477490|455646558|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
126641595|NCT00477490|455646559|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
126641596|NCT00477490|455646560|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
126641597|NCT00477490|455646561|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
126641598|NCT00477490|455646562|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
126641599|NCT00477490|455646563|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
126641600|NCT00477490|455646555|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
126641601|NCT00477490|455646556|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
126641602|NCT00477490|455646557|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
126641603|NCT00477490|455646558|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
126641604|NCT00477490|455646559|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
126641605|NCT00477490|455646560|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
126641606|NCT00477490|455646561|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
126641607|NCT00477490|455646562|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
126641608|NCT00477490|455646563|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
126641609|NCT00477490|455646555|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
126641610|NCT00477490|455646556|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
126641611|NCT00477490|455646557|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
126641612|NCT00477490|455646558|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
126641613|NCT00477490|455646559|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
126641614|NCT00477490|455646560|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
126641615|NCT00477490|455646561|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
126641616|NCT00477490|455646562|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
126641617|NCT00477490|455646563|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
126641618|NCT00477490|455646555|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
126641619|NCT00477490|455646556|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
126641620|NCT00477490|455646557|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
126641621|NCT00477490|455646558|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
126641622|NCT00477490|455646559|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
126641623|NCT00477490|455646560|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
126641624|NCT00477490|455646561|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
126641625|NCT00477490|455646562|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
126641626|NCT00477490|455646563|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
126641627|NCT00477490|455646555|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
126641628|NCT00477490|455646556|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
126641629|NCT00477490|455646557|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
126641630|NCT00477490|455646558|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
126641631|NCT00477490|455646559|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
126641632|NCT00477490|455646560|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
126641633|NCT00477490|455646561|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
126641634|NCT00477490|455646562|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
126641635|NCT00477490|455646563|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
126641636|NCT00477490|455646555|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
126641637|NCT00477490|455646556|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
126641638|NCT00477490|455646557|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
126641639|NCT00477490|455646558|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
126641640|NCT00477490|455646559|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
126641641|NCT00477490|455646560|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
126641642|NCT00477490|455646561|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
126641643|NCT00477490|455646562|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
126641644|NCT00477490|455646563|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
126641645|NCT00477490|455646555|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
126641646|NCT00477490|455646556|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
126641647|NCT00477490|455646557|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
126641648|NCT00477490|455646558|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
126641649|NCT00477490|455646559|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
126641650|NCT00477490|455646560|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
126641651|NCT00477490|455646561|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
126641652|NCT00477490|455646562|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
126641653|NCT00477490|455646563|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
126641654|NCT00477490|455646555|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
126641655|NCT00477490|455646556|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
126641656|NCT00477490|455646557|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
126641657|NCT00477490|455646558|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
126641658|NCT00477490|455646559|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
126641659|NCT00477490|455646560|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
126641660|NCT00477490|455646561|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
126641661|NCT00477490|455646562|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
126641662|NCT00477490|455646563|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
126641663|NCT00477490|455646555|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
126641664|NCT00477490|455646556|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
126641665|NCT00477490|455646557|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
126641666|NCT00477490|455646558|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
126641667|NCT00477490|455646559|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
126641668|NCT00477490|455646560|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
126641669|NCT00477490|455646561|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
126641670|NCT00477490|455646562|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
126641671|NCT00477490|455646563|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
126641672|NCT00477490|455646555|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
126641673|NCT00477490|455646556|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
126641674|NCT00477490|455646557|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
126641675|NCT00477490|455646558|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
126641676|NCT00477490|455646559|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
126641677|NCT00477490|455646560|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
126641678|NCT00477490|455646561|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
126641679|NCT00477490|455646562|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
126641680|NCT00477490|455646563|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
126641681|NCT00477490|455646555|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126641682|NCT00477490|455646556|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
126641683|NCT00477490|455646557|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126641684|NCT00477490|455646558|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126641685|NCT00477490|455646559|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126641686|NCT00477490|455646560|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126641687|NCT00477490|455646561|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126641688|NCT00477490|455646562|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126641689|NCT00477490|455646563|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
126641690|NCT00477490|455646555|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
126641691|NCT00477490|455646556|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
126641692|NCT00477490|455646557|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
126641693|NCT00477490|455646558|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
126641694|NCT00477490|455646559|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
126641695|NCT00477490|455646560|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
126641696|NCT00477490|455646561|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
126641697|NCT00477490|455646562|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
126641698|NCT00477490|455646563|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
126641699|NCT00477490|455646555|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
126641700|NCT00477490|455646556|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
126641701|NCT00477490|455646557|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
126641702|NCT00477490|455646558|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
126641703|NCT00477490|455646559|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
126641704|NCT00477490|455646560|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
126641705|NCT00477490|455646561|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
126641706|NCT00477490|455646562|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
126641707|NCT00477490|455646563|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
126641708|NCT01110408|455646566|FG000|Overall Study|Protocol Violation|1|||
126641709|NCT01110408|455646567|FG001|Overall Study|Protocol Violation|0|||
126641710|NCT01646177|455646568|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
126641711|NCT01646177|455646569|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
126641712|NCT01646177|455646570|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
126641713|NCT01646177|455646571|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
126641714|NCT01646177|455646572|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126641715|NCT01646177|455646573|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126641716|NCT01646177|455646574|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126641717|NCT01646177|455646575|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126641718|NCT01646177|455646576|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126641719|NCT01646177|455646577|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126641720|NCT01646177|455646578|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126641721|NCT01646177|455646579|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
126641722|NCT01646177|455646568|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
126641723|NCT01646177|455646569|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
126641724|NCT01646177|455646570|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
126641725|NCT01646177|455646571|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
126641726|NCT01646177|455646572|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126641727|NCT01646177|455646573|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126641728|NCT01646177|455646574|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126641729|NCT01646177|455646575|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126641730|NCT01646177|455646576|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126641731|NCT01646177|455646577|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126641732|NCT01646177|455646578|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126641733|NCT01646177|455646579|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
126641734|NCT01646177|455646568|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
126641735|NCT01646177|455646569|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
126641736|NCT01646177|455646570|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
126641737|NCT01646177|455646571|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
126641738|NCT01646177|455646572|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126641739|NCT01646177|455646573|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126641740|NCT01646177|455646574|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126641741|NCT01646177|455646575|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126641742|NCT01646177|455646576|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126641743|NCT01646177|455646577|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126641744|NCT01646177|455646578|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126641745|NCT01646177|455646579|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
126641746|NCT01646177|455646568|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
126641747|NCT01646177|455646569|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
126641748|NCT01646177|455646570|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
126641749|NCT01646177|455646571|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
126641750|NCT01646177|455646572|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126641751|NCT01646177|455646573|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126641752|NCT01646177|455646574|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126641753|NCT01646177|455646575|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126641754|NCT01646177|455646576|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126641755|NCT01646177|455646577|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126641756|NCT01646177|455646578|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126641757|NCT01646177|455646579|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
126641758|NCT01646177|455646568|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126641759|NCT01646177|455646569|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126641760|NCT01646177|455646570|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
126641761|NCT01646177|455646571|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
126641762|NCT01646177|455646572|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126641763|NCT01646177|455646573|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126641764|NCT01646177|455646574|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126641765|NCT01646177|455646575|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126641766|NCT01646177|455646576|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126641767|NCT01646177|455646577|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126641768|NCT01646177|455646578|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126641769|NCT01646177|455646579|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
126641770|NCT01646177|455646568|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
126641771|NCT01646177|455646569|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
126641772|NCT01646177|455646570|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
126641773|NCT01646177|455646571|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126641774|NCT01646177|455646572|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126641775|NCT01646177|455646573|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126641776|NCT01646177|455646574|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126641777|NCT01646177|455646575|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126641778|NCT01646177|455646576|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126641779|NCT01646177|455646577|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126641780|NCT01646177|455646578|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126641781|NCT01646177|455646579|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
126641782|NCT01646177|455646568|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126641783|NCT01646177|455646569|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126641784|NCT01646177|455646570|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126641785|NCT01646177|455646571|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126641786|NCT01646177|455646572|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
126641787|NCT01646177|455646573|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
126641788|NCT01646177|455646574|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
126641789|NCT01646177|455646575|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
126641790|NCT01646177|455646576|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126641791|NCT01646177|455646577|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126641792|NCT01646177|455646578|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126641793|NCT01646177|455646579|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
126641794|NCT01646177|455646568|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126641795|NCT01646177|455646569|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126641796|NCT01646177|455646570|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126641797|NCT01646177|455646571|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126641798|NCT01646177|455646572|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
126641799|NCT01646177|455646573|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
126641800|NCT01646177|455646574|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
126641801|NCT01646177|455646575|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
126641802|NCT01646177|455646576|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126641803|NCT01646177|455646577|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126641804|NCT01646177|455646578|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126641805|NCT01646177|455646579|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
126641806|NCT01646177|455646568|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126641807|NCT01646177|455646569|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126641808|NCT01646177|455646570|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126641809|NCT01646177|455646571|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126641810|NCT01646177|455646572|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
126641811|NCT01646177|455646573|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
126641812|NCT01646177|455646574|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
126641813|NCT01646177|455646575|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
126641814|NCT01646177|455646576|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126641815|NCT01646177|455646577|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126641816|NCT01646177|455646578|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126641817|NCT01646177|455646579|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
126641818|NCT01646177|455646568|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126641819|NCT01646177|455646569|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126641820|NCT01646177|455646570|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126641821|NCT01646177|455646571|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126641822|NCT01646177|455646572|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
126641823|NCT01646177|455646573|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
126641824|NCT01646177|455646574|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
126641825|NCT01646177|455646575|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
126641826|NCT01646177|455646576|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126641827|NCT01646177|455646577|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126641828|NCT01646177|455646578|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126641829|NCT01646177|455646579|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
126641830|NCT01646177|455646568|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126641831|NCT01646177|455646569|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126641832|NCT01646177|455646570|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126641833|NCT01646177|455646571|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126641834|NCT01646177|455646572|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
126641835|NCT01646177|455646573|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
126641836|NCT01646177|455646574|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
126641837|NCT01646177|455646575|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
126641838|NCT01646177|455646576|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126641839|NCT01646177|455646577|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126641840|NCT01646177|455646578|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126641841|NCT01646177|455646579|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
126641842|NCT01646177|455646568|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126641843|NCT01646177|455646569|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126641844|NCT01646177|455646570|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126641845|NCT01646177|455646571|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126641846|NCT01646177|455646572|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
126641847|NCT01646177|455646573|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
126641848|NCT01646177|455646574|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126641849|NCT01646177|455646575|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
126641850|NCT01646177|455646576|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126641851|NCT01646177|455646577|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126641852|NCT01646177|455646578|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126641853|NCT01646177|455646579|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
126641854|NCT01646177|455646568|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126641855|NCT01646177|455646569|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126641856|NCT01646177|455646570|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126641857|NCT01646177|455646571|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126641858|NCT01646177|455646572|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
126641859|NCT01646177|455646573|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
126641860|NCT01646177|455646574|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
126641861|NCT01646177|455646575|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
126641862|NCT01646177|455646576|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126641863|NCT01646177|455646577|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126641864|NCT01646177|455646578|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126641865|NCT01646177|455646579|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
126641866|NCT01646177|455646568|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
126641867|NCT01646177|455646569|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
126641868|NCT01646177|455646570|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
126641869|NCT01646177|455646571|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
126641870|NCT01646177|455646572|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
126641871|NCT01646177|455646573|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
126641872|NCT01646177|455646574|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
126641873|NCT01646177|455646575|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
126641874|NCT01646177|455646576|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
126641875|NCT01646177|455646577|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
126641876|NCT01646177|455646578|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
126641877|NCT01646177|455646579|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
126641878|NCT01646177|455646568|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126641879|NCT01646177|455646569|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126641880|NCT01646177|455646570|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126641881|NCT01646177|455646571|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126641882|NCT01646177|455646572|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
126641883|NCT01646177|455646573|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
126641884|NCT01646177|455646574|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
126641885|NCT01646177|455646575|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
126641886|NCT01646177|455646576|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126641887|NCT01646177|455646577|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126641888|NCT01646177|455646578|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126641889|NCT01646177|455646579|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
126641890|NCT01646177|455646568|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126641891|NCT01646177|455646569|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126641892|NCT01646177|455646570|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126641893|NCT01646177|455646571|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126641894|NCT01646177|455646572|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126641895|NCT01646177|455646573|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126641896|NCT01646177|455646574|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126641897|NCT01646177|455646575|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
126641898|NCT01646177|455646576|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126641899|NCT01646177|455646577|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126641900|NCT01646177|455646578|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126641901|NCT01646177|455646579|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
126641902|NCT01646177|455646568|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126641903|NCT01646177|455646569|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126641904|NCT01646177|455646570|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126641905|NCT01646177|455646571|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126641906|NCT01646177|455646572|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126641907|NCT01646177|455646573|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
126641908|NCT01646177|455646574|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
126641909|NCT01646177|455646575|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
126641910|NCT01646177|455646576|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126641911|NCT01646177|455646577|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126641912|NCT01646177|455646578|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126641913|NCT01646177|455646579|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
126641914|NCT01646177|455646568|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126641915|NCT01646177|455646569|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126641916|NCT01646177|455646570|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126641917|NCT01646177|455646571|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126641918|NCT01646177|455646572|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126641919|NCT01646177|455646573|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126641920|NCT01646177|455646574|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126641921|NCT01646177|455646575|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
126641922|NCT01646177|455646576|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
126641923|NCT01646177|455646577|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
126641924|NCT01646177|455646578|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
126641925|NCT01646177|455646579|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
126641926|NCT01646177|455646568|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126641927|NCT01646177|455646569|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126641928|NCT01646177|455646570|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126641929|NCT01646177|455646571|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126641930|NCT01646177|455646572|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126641931|NCT01646177|455646573|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126641932|NCT01646177|455646574|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126641933|NCT01646177|455646575|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
126641934|NCT01646177|455646576|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
126641935|NCT01646177|455646577|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
126641936|NCT01646177|455646578|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
126641937|NCT01646177|455646579|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
126641938|NCT01646177|455646568|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126641939|NCT01646177|455646569|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126641940|NCT01646177|455646570|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126641941|NCT01646177|455646571|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126641942|NCT01646177|455646572|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126641943|NCT01646177|455646573|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126641944|NCT01646177|455646574|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126641945|NCT01646177|455646575|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
126641946|NCT01646177|455646576|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
126641947|NCT01646177|455646577|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
126641948|NCT01646177|455646578|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
126641949|NCT01646177|455646579|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
126641950|NCT01646177|455646568|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126641951|NCT01646177|455646569|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126641952|NCT01646177|455646570|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126641953|NCT01646177|455646571|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126641954|NCT01646177|455646572|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126641955|NCT01646177|455646573|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126641956|NCT01646177|455646574|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126641957|NCT01646177|455646575|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
126641958|NCT01646177|455646576|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
126641959|NCT01646177|455646577|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
126641960|NCT01646177|455646578|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
126641961|NCT01646177|455646579|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
126641962|NCT01646177|455646568|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126641963|NCT01646177|455646569|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126641964|NCT01646177|455646570|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126641965|NCT01646177|455646571|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126641966|NCT01646177|455646572|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126641967|NCT01646177|455646573|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126641968|NCT01646177|455646574|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126641969|NCT01646177|455646575|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
126641970|NCT01646177|455646576|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
126641971|NCT01646177|455646577|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
126641972|NCT01646177|455646578|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
126641973|NCT01646177|455646579|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
126641974|NCT01646177|455646568|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126641975|NCT01646177|455646569|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126641976|NCT01646177|455646570|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126641977|NCT01646177|455646571|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126641978|NCT01646177|455646572|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126641979|NCT01646177|455646573|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126641980|NCT01646177|455646574|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126641981|NCT01646177|455646575|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
126641982|NCT01646177|455646576|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
126641983|NCT01646177|455646577|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
126641984|NCT01646177|455646578|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
126641985|NCT01646177|455646579|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
126641986|NCT01646177|455646568|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126641987|NCT01646177|455646569|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126641988|NCT01646177|455646570|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126641989|NCT01646177|455646571|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126641990|NCT01646177|455646572|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126641991|NCT01646177|455646573|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126641992|NCT01646177|455646574|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126641993|NCT01646177|455646575|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126641994|NCT01646177|455646576|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
126641995|NCT01646177|455646577|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
126641996|NCT01646177|455646578|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
126641997|NCT01646177|455646579|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
126641998|NCT01646177|455646568|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126641999|NCT01646177|455646569|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126642000|NCT01646177|455646570|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126642001|NCT01646177|455646571|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126642002|NCT01646177|455646572|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126642003|NCT01646177|455646573|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126642004|NCT01646177|455646574|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126642005|NCT01646177|455646575|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126642006|NCT01646177|455646576|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
126642007|NCT01646177|455646577|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
126642008|NCT01646177|455646578|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
126642009|NCT01646177|455646579|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
126642010|NCT01646177|455646568|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126642011|NCT01646177|455646569|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126642012|NCT01646177|455646570|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126642013|NCT01646177|455646571|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126642014|NCT01646177|455646572|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126642015|NCT01646177|455646573|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126642016|NCT01646177|455646574|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126642017|NCT01646177|455646575|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126642018|NCT01646177|455646576|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
126642019|NCT01646177|455646577|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
126642020|NCT01646177|455646578|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
126642021|NCT01646177|455646579|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
126642022|NCT01646177|455646568|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126642023|NCT01646177|455646569|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126642024|NCT01646177|455646570|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126642025|NCT01646177|455646571|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126642026|NCT01646177|455646572|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126642027|NCT01646177|455646573|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126642028|NCT01646177|455646574|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126642029|NCT01646177|455646575|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126642030|NCT01646177|455646576|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126642031|NCT01646177|455646577|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
126642032|NCT01646177|455646578|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
126642033|NCT01646177|455646579|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
126642034|NCT01509547|455646583|FG000|Overall Study|Lost to Follow-up|24|||
126642035|NCT01509547|455646584|FG001|Overall Study|Lost to Follow-up|14|||
126642036|NCT01509547|455646583|FG000|Overall Study|Withdrawal by Subject|11|||
126642037|NCT01509547|455646584|FG001|Overall Study|Withdrawal by Subject|24|||
126642038|NCT01509547|455646583|FG000|Overall Study|Physician Decision|0|||
126642039|NCT01509547|455646584|FG001|Overall Study|Physician Decision|1|||
126642040|NCT00402051|455646585|FG000|Overall Study|Progressive Disease|13|||
126642041|NCT00402051|455646586|FG001|Overall Study|Progressive Disease|20|||
126642042|NCT00402051|455646585|FG000|Overall Study|Adverse Event|11|||
126642043|NCT00402051|455646586|FG001|Overall Study|Adverse Event|4|||
126642044|NCT00402051|455646585|FG000|Overall Study|Physician Decision|7|||
126642045|NCT00402051|455646586|FG001|Overall Study|Physician Decision|3|||
126642046|NCT00402051|455646585|FG000|Overall Study|Withdrawal by Subject|3|||
126642047|NCT00402051|455646586|FG001|Overall Study|Withdrawal by Subject|3|||
126642048|NCT00402051|455646585|FG000|Overall Study|Death - Related to Study Drug|1|||
126642049|NCT00402051|455646586|FG001|Overall Study|Death - Related to Study Drug|2|||
126642050|NCT00402051|455646585|FG000|Overall Study|Death Due to Study Disease|2|||
126642051|NCT00402051|455646586|FG001|Overall Study|Death Due to Study Disease|1|||
126642052|NCT00402051|455646585|FG000|Overall Study|Death Due to Adverse Event|0|||
126642053|NCT00402051|455646586|FG001|Overall Study|Death Due to Adverse Event|2|||
126642054|NCT00402051|455646585|FG000|Overall Study|Lost to Follow-up|1|||
126642055|NCT00402051|455646586|FG001|Overall Study|Lost to Follow-up|0|||
126642056|NCT01213524|455646590|FG000|Baseline|Withdrawal by Subject|5|||
126642057|NCT01213524|455646590|FG000|Baseline|high breath alcohol levels|1|||
126642058|NCT01213524|455646590|FG000|Baseline|Physician Decision|1|||
126642059|NCT01213524|455646590|FG000|Session 2|Withdrawal by Subject|5|||
126642060|NCT01213524|455646590|FG000|Session 3|Withdrawal by Subject|4|||
126642061|NCT01213524|455646590|FG000|Session 4|Physician Decision|1|||
126642062|NCT01213524|455646590|FG000|Session 4|Withdrawal by Subject|2|||
126642063|NCT00281320|455646593|FG000|Overall Study|Adverse Event|12|||
126642064|NCT00281320|455646594|FG001|Overall Study|Adverse Event|9|||
126642065|NCT00281320|455646593|FG000|Overall Study|Lack of Efficacy|4|||
126642066|NCT00281320|455646594|FG001|Overall Study|Lack of Efficacy|3|||
126642067|NCT00281320|455646593|FG000|Overall Study|Withdrawal by Subject|5|||
126642068|NCT00281320|455646594|FG001|Overall Study|Withdrawal by Subject|6|||
126642069|NCT00281320|455646593|FG000|Overall Study|Lost to Follow-up|1|||
126642070|NCT00281320|455646594|FG001|Overall Study|Lost to Follow-up|2|||
126642071|NCT00281320|455646593|FG000|Overall Study|Other|3|||
126642072|NCT00281320|455646594|FG001|Overall Study|Other|1|||
126642073|NCT02579772|455646596|FG000|Overall Study|Withdrawal by Subject|0|||
126642074|NCT02579772|455646597|FG001|Overall Study|Withdrawal by Subject|1|||
126642075|NCT02579772|455646596|FG000|Overall Study|Usage of additional antioxidants|1|||
126642076|NCT02579772|455646597|FG001|Overall Study|Usage of additional antioxidants|0|||
126642077|NCT02579772|455646596|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
126642078|NCT02579772|455646597|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
126642079|NCT04147195|455646600|FG000|Overall Study|Adverse Event|0|||
126642080|NCT04147195|455646601|FG001|Overall Study|Adverse Event|3|||
126642081|NCT04147195|455646600|FG000|Overall Study|Study Terminated by Sponsor|4|||
126642082|NCT04147195|455646601|FG001|Overall Study|Study Terminated by Sponsor|2|||
126642083|NCT04147195|455646600|FG000|Overall Study|Withdrawal by Subject|0|||
126642084|NCT04147195|455646601|FG001|Overall Study|Withdrawal by Subject|1|||
126642085|NCT01424813|455646602|FG000|Overall Study|Withdrawal by Subject|3|||
126642086|NCT01424813|455646603|FG001|Overall Study|Withdrawal by Subject|0|||
126642087|NCT01424813|455646602|FG000|Overall Study|Protocol Violation|1|||
126642088|NCT01424813|455646603|FG001|Overall Study|Protocol Violation|0|||
126642089|NCT01424813|455646602|FG000|Overall Study|Other|1|||
126642090|NCT01424813|455646603|FG001|Overall Study|Other|2|||
126642091|NCT02614183|455646604|FG000|Double Blind Treatment Phase|Adverse Event|10|||
126642092|NCT02614183|455646605|FG001|Double Blind Treatment Phase|Adverse Event|9|||
126642093|NCT02614183|455646606|FG002|Double Blind Treatment Phase|Adverse Event|7|||
126642094|NCT02614183|455646604|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
126642095|NCT02614183|455646605|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
126642096|NCT02614183|455646606|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
126642097|NCT02614183|455646604|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
126642098|NCT02614183|455646605|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
126642099|NCT02614183|455646606|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
126642100|NCT02614183|455646604|FG000|Double Blind Treatment Phase|Physician Decision|7|||
126642101|NCT02614183|455646605|FG001|Double Blind Treatment Phase|Physician Decision|3|||
126642102|NCT02614183|455646606|FG002|Double Blind Treatment Phase|Physician Decision|2|||
126642103|NCT02614183|455646604|FG000|Double Blind Treatment Phase|Pregnancy|2|||
126642104|NCT02614183|455646605|FG001|Double Blind Treatment Phase|Pregnancy|1|||
126642105|NCT02614183|455646606|FG002|Double Blind Treatment Phase|Pregnancy|3|||
126642106|NCT02614183|455646604|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
126642107|NCT02614183|455646605|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
126642108|NCT02614183|455646606|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
126642109|NCT02614183|455646604|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
126642110|NCT02614183|455646605|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
126642111|NCT02614183|455646606|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
126642112|NCT02614183|455646604|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
126642113|NCT02614183|455646605|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
126642114|NCT02614183|455646606|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
126642115|NCT02614183|455646604|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
126642116|NCT02614183|455646605|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
126642117|NCT02614183|455646606|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
126642118|NCT02614183|455646604|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
126642119|NCT02614183|455646605|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
126642120|NCT02614183|455646606|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
126642121|NCT02614183|455646604|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
126642122|NCT02614183|455646605|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
126642123|NCT02614183|455646606|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
126642124|NCT02614183|455646604|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
126642125|NCT02614183|455646605|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
126642126|NCT02614183|455646606|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
126642127|NCT01088984|455648342|FG000|Phase 1|Death|2|||
126642128|NCT01088984|455648343|FG001|Phase 1|Death|1|||
126642129|NCT01088984|455648342|FG000|Phase 1|Disease Progression|2|||
126642130|NCT01088984|455648343|FG001|Phase 1|Disease Progression|4|||
126642131|NCT01088984|455648342|FG000|Phase 1|Other|1|||
126642132|NCT01088984|455648343|FG001|Phase 1|Other|1|||
126642133|NCT01088984|455648342|FG000|Phase 2|Death|0|||
126642134|NCT01088984|455648343|FG001|Phase 2|Death|5|||
126642135|NCT01088984|455648342|FG000|Phase 2|Withdrawal by Subject|0|||
126642136|NCT01088984|455648343|FG001|Phase 2|Withdrawal by Subject|1|||
126642137|NCT01088984|455648342|FG000|Phase 2|DIsease Progression|0|||
126642138|NCT01088984|455648343|FG001|Phase 2|DIsease Progression|25|||
126642139|NCT01088984|455648342|FG000|Phase 2|Other|0|||
126642140|NCT01088984|455648343|FG001|Phase 2|Other|1|||
126642141|NCT04707664|455648344|FG000|Overall Study|Adverse Event|2|||
126642142|NCT04707664|455648345|FG001|Overall Study|Adverse Event|0|||
126642143|NCT04707664|455648344|FG000|Overall Study|Death|1|||
126642144|NCT04707664|455648345|FG001|Overall Study|Death|2|||
126642145|NCT04707664|455648344|FG000|Overall Study|Withdrawal by Subject|13|||
126642146|NCT04707664|455648345|FG001|Overall Study|Withdrawal by Subject|21|||
126642147|NCT04707664|455648344|FG000|Overall Study|Lost to Follow-up|11|||
126642148|NCT04707664|455648345|FG001|Overall Study|Lost to Follow-up|13|||
126642149|NCT04707664|455648344|FG000|Overall Study|Not treated|2|||
126642150|NCT04707664|455648345|FG001|Overall Study|Not treated|0|||
126642151|NCT00699153|455648346|FG000|Overall Study|Lost to Follow-up|1|||
126642152|NCT00699153|455648347|FG001|Overall Study|Lost to Follow-up|0|||
126642153|NCT00699153|455648346|FG000|Overall Study|Adverse Event|0|||
126642154|NCT00699153|455648347|FG001|Overall Study|Adverse Event|2|||
126642155|NCT00699153|455648346|FG000|Overall Study|Protocol Violation|1|||
126642156|NCT00699153|455648347|FG001|Overall Study|Protocol Violation|0|||
126642157|NCT00699153|455648346|FG000|Overall Study|Travel Problem|1|||
126642158|NCT00699153|455648347|FG001|Overall Study|Travel Problem|0|||
126642159|NCT01006980|455648350|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
126642160|NCT01006980|455648351|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
126642161|NCT01006980|455648350|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
126642162|NCT01006980|455648351|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
126642163|NCT01006980|455648350|FG000|Vemurafenib and Dacarbazine|Death|13|||
126642164|NCT01006980|455648351|FG001|Vemurafenib and Dacarbazine|Death|12|||
126642165|NCT01006980|455648350|FG000|Vemurafenib and Dacarbazine|Progression|257|||
126642166|NCT01006980|455648351|FG001|Vemurafenib and Dacarbazine|Progression|218|||
126642167|NCT01006980|455648350|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
126642168|NCT01006980|455648351|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
126642169|NCT01006980|455648350|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
126642170|NCT01006980|455648351|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
126642171|NCT01006980|455648350|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
126642172|NCT01006980|455648351|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
126642173|NCT01006980|455648350|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
126642174|NCT01006980|455648351|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
126642175|NCT01006980|455648350|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
126642176|NCT01006980|455648351|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
126642177|NCT01006980|455648350|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
126642178|NCT01006980|455648351|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
126642179|NCT01006980|455648350|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
126642180|NCT01006980|455648351|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
126642181|NCT01006980|455648350|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
126642182|NCT01006980|455648351|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
126642183|NCT01006980|455648350|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
126642184|NCT01006980|455648351|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
126642185|NCT02706405|455648356|FG000|Overall Study|Death|3|||
126642186|NCT02706405|455648357|FG001|Overall Study|Death|2|||
126642187|NCT02706405|455648358|FG002|Overall Study|Death|0|||
126642188|NCT02706405|455648359|FG003|Overall Study|Death|1|||
126642189|NCT02706405|455648360|FG004|Overall Study|Death|0|||
126642190|NCT02706405|455648361|FG005|Overall Study|Death|0|||
126642191|NCT02706405|455648362|FG006|Overall Study|Death|3|||
126642192|NCT02706405|455648363|FG007|Overall Study|Death|4|||
126642193|NCT02706405|455648356|FG000|Overall Study|Disease progression|0|||
126642194|NCT02706405|455648357|FG001|Overall Study|Disease progression|0|||
126642195|NCT02706405|455648358|FG002|Overall Study|Disease progression|0|||
126642196|NCT02706405|455648359|FG003|Overall Study|Disease progression|0|||
126642197|NCT02706405|455648360|FG004|Overall Study|Disease progression|0|||
126642198|NCT02706405|455648361|FG005|Overall Study|Disease progression|0|||
126642199|NCT02706405|455648362|FG006|Overall Study|Disease progression|0|||
126642200|NCT02706405|455648363|FG007|Overall Study|Disease progression|1|||
126642201|NCT02706405|455648356|FG000|Overall Study|Pt moved to new therapy|0|||
126642202|NCT02706405|455648357|FG001|Overall Study|Pt moved to new therapy|0|||
126642203|NCT02706405|455648358|FG002|Overall Study|Pt moved to new therapy|0|||
126642204|NCT02706405|455648359|FG003|Overall Study|Pt moved to new therapy|0|||
126642205|NCT02706405|455648360|FG004|Overall Study|Pt moved to new therapy|0|||
126642206|NCT02706405|455648361|FG005|Overall Study|Pt moved to new therapy|1|||
126642207|NCT02706405|455648362|FG006|Overall Study|Pt moved to new therapy|0|||
126642208|NCT02706405|455648363|FG007|Overall Study|Pt moved to new therapy|1|||
126642209|NCT02706405|455648356|FG000|Overall Study|Physician Decision|1|||
126642210|NCT02706405|455648357|FG001|Overall Study|Physician Decision|0|||
126642211|NCT02706405|455648358|FG002|Overall Study|Physician Decision|0|||
126642212|NCT02706405|455648359|FG003|Overall Study|Physician Decision|0|||
126642213|NCT02706405|455648360|FG004|Overall Study|Physician Decision|0|||
126642214|NCT02706405|455648361|FG005|Overall Study|Physician Decision|0|||
126642215|NCT02706405|455648362|FG006|Overall Study|Physician Decision|0|||
126642216|NCT02706405|455648363|FG007|Overall Study|Physician Decision|0|||
126642217|NCT01228318|455648364|FG000|Overall Study|Clinic no show to receive intervention|1|||
126642218|NCT01228318|455648365|FG001|Overall Study|Clinic no show to receive intervention|0|||
126642219|NCT01228318|455648364|FG000|Overall Study|Unable to contact|2|||
126642220|NCT01228318|455648365|FG001|Overall Study|Unable to contact|5|||
126642221|NCT01228318|455648364|FG000|Overall Study|Moved|0|||
126642222|NCT01228318|455648365|FG001|Overall Study|Moved|2|||
126642223|NCT01228318|455648364|FG000|Overall Study|Incarcerated|1|||
126642224|NCT01228318|455648365|FG001|Overall Study|Incarcerated|0|||
126642225|NCT01182441|455648370|FG000|Overall Study|Patient Still in Follow-up|152|||
126642226|NCT01182441|455648371|FG001|Overall Study|Patient Still in Follow-up|72|||
126642227|NCT01182441|455648370|FG000|Overall Study|Death|37|||
126642228|NCT01182441|455648371|FG001|Overall Study|Death|25|||
126642229|NCT01182441|455648370|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
126642230|NCT01182441|455648371|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
126642231|NCT01182441|455648370|FG000|Overall Study|Lost to Follow-up|5|||
126642232|NCT01182441|455648371|FG001|Overall Study|Lost to Follow-up|8|||
126642233|NCT01182441|455648370|FG000|Overall Study|Withdrawal by Subject|6|||
126642234|NCT01182441|455648371|FG001|Overall Study|Withdrawal by Subject|13|||
126642235|NCT01182441|455648370|FG000|Overall Study|Implant Not Attempted|4|||
126642236|NCT01182441|455648371|FG001|Overall Study|Implant Not Attempted|0|||
126642237|NCT01182441|455648370|FG000|Overall Study|Adverse Event|2|||
126642238|NCT01182441|455648371|FG001|Overall Study|Adverse Event|0|||
126642239|NCT01182441|455648370|FG000|Overall Study|Physician Decision|1|||
126642240|NCT01182441|455648371|FG001|Overall Study|Physician Decision|1|||
126642241|NCT00603525|455648372|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
126642242|NCT00603525|455648373|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
126642243|NCT00603525|455648374|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
126642244|NCT00603525|455648372|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
126642245|NCT00603525|455648373|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126642246|NCT00603525|455648374|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
126642247|NCT00603525|455648372|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
126642248|NCT00603525|455648373|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
126642249|NCT00603525|455648374|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
126642250|NCT00603525|455648372|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
126642251|NCT00603525|455648373|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
126642252|NCT00603525|455648374|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
126642253|NCT00603525|455648372|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
126642254|NCT00603525|455648373|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
126642255|NCT00603525|455648374|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
126642256|NCT00603525|455648372|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
126642257|NCT00603525|455648373|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
126642258|NCT00603525|455648374|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
126642259|NCT00603525|455648372|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
126642260|NCT00603525|455648373|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
126642261|NCT00603525|455648374|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
126642262|NCT00603525|455648372|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
126642263|NCT00603525|455648373|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
126642264|NCT00603525|455648374|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
126642265|NCT00603525|455648372|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
126642266|NCT00603525|455648373|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
126642267|NCT00603525|455648374|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
126642268|NCT00603525|455648372|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
126642269|NCT00603525|455648373|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
126642270|NCT00603525|455648374|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
126642271|NCT00603525|455648372|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
126642272|NCT00603525|455648373|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
126642273|NCT00603525|455648374|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
126642274|NCT00603525|455648372|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
126642275|NCT00603525|455648373|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
126642276|NCT00603525|455648374|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
126642277|NCT00603525|455648372|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
126642278|NCT00603525|455648373|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
126642279|NCT00603525|455648374|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
126642280|NCT00603525|455648372|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
126642281|NCT00603525|455648373|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
126642282|NCT00603525|455648374|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
126642283|NCT00603525|455648372|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
126642284|NCT00603525|455648373|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
126642285|NCT00603525|455648374|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
126642286|NCT02304705|455648375|FG000|Overall Study|Withdrawal by Subject|2|||
126642287|NCT02304705|455648376|FG001|Overall Study|Withdrawal by Subject|0|||
126642288|NCT02304705|455648375|FG000|Overall Study|Physician Decision|2|||
126642289|NCT02304705|455648376|FG001|Overall Study|Physician Decision|4|||
126642290|NCT02304705|455648375|FG000|Overall Study|Death|0|||
126642291|NCT02304705|455648376|FG001|Overall Study|Death|1|||
126642292|NCT02304705|455648375|FG000|Overall Study|Lost to Follow-up|0|||
126642293|NCT02304705|455648376|FG001|Overall Study|Lost to Follow-up|2|||
126642294|NCT02124811|455648377|FG000|Overall Study|Early termination|2|||
126642295|NCT02124811|455648378|FG001|Overall Study|Early termination|2|||
126642296|NCT02124811|455648377|FG000|Overall Study|Withdrawal by Subject|1|||
126642297|NCT02124811|455648378|FG001|Overall Study|Withdrawal by Subject|0|||
126642298|NCT03480932|455648379|FG000|Overall Study|Death|1|||
126642299|NCT03480932|455648380|FG001|Overall Study|Death|1|||
126642300|NCT03480932|455648381|FG002|Overall Study|Death|0|||
126642301|NCT03480932|455648379|FG000|Overall Study|Lost to Follow-up|0|||
126642302|NCT03480932|455648380|FG001|Overall Study|Lost to Follow-up|2|||
126642303|NCT03480932|455648381|FG002|Overall Study|Lost to Follow-up|3|||
126642304|NCT03480932|455648379|FG000|Overall Study|Incarcerated|2|||
126642305|NCT03480932|455648380|FG001|Overall Study|Incarcerated|2|||
126642306|NCT03480932|455648381|FG002|Overall Study|Incarcerated|2|||
126642307|NCT01174446|455648388|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
126642308|NCT01174446|455648389|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
126642309|NCT01174446|455648390|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
126642310|NCT01174446|455648391|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
126642311|NCT01174446|455648388|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
126642312|NCT01174446|455648389|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
126642313|NCT01174446|455648390|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
126642314|NCT01174446|455648391|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
126642315|NCT01174446|455648388|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
126642316|NCT01174446|455648389|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
126642317|NCT01174446|455648390|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
126642318|NCT01174446|455648391|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
126642319|NCT01174446|455648388|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
126642320|NCT01174446|455648389|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
126642321|NCT01174446|455648390|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
126642322|NCT01174446|455648391|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
126642323|NCT00847626|455648394|FG000|Overall Study|Adverse Event|10|||
126642324|NCT00847626|455648395|FG001|Overall Study|Adverse Event|10|||
126642325|NCT00847626|455648396|FG002|Overall Study|Adverse Event|6|||
126642326|NCT00847626|455648397|FG003|Overall Study|Adverse Event|19|||
126642327|NCT00847626|455648398|FG004|Overall Study|Adverse Event|11|||
126642328|NCT00847626|455648399|FG005|Overall Study|Adverse Event|22|||
126642329|NCT00847626|455648400|FG006|Overall Study|Adverse Event|4|||
126642330|NCT00847626|455648401|FG007|Overall Study|Adverse Event|6|||
126642331|NCT00847626|455648402|FG008|Overall Study|Adverse Event|3|||
126642332|NCT00847626|455648403|FG009|Overall Study|Adverse Event|6|||
126642333|NCT00847626|455648404|FG010|Overall Study|Adverse Event|6|||
126642334|NCT00847626|455648394|FG000|Overall Study|Protocol Violation|2|||
126642335|NCT00847626|455648395|FG001|Overall Study|Protocol Violation|1|||
126642336|NCT00847626|455648396|FG002|Overall Study|Protocol Violation|2|||
126642337|NCT00847626|455648397|FG003|Overall Study|Protocol Violation|1|||
126642338|NCT00847626|455648398|FG004|Overall Study|Protocol Violation|1|||
126642339|NCT00847626|455648399|FG005|Overall Study|Protocol Violation|1|||
126642340|NCT00847626|455648400|FG006|Overall Study|Protocol Violation|1|||
126642341|NCT00847626|455648401|FG007|Overall Study|Protocol Violation|1|||
126642342|NCT00847626|455648402|FG008|Overall Study|Protocol Violation|0|||
126642343|NCT00847626|455648403|FG009|Overall Study|Protocol Violation|1|||
126642344|NCT00847626|455648404|FG010|Overall Study|Protocol Violation|1|||
126642345|NCT00847626|455648394|FG000|Overall Study|Lost to Follow-up|0|||
126642346|NCT00847626|455648395|FG001|Overall Study|Lost to Follow-up|1|||
126642347|NCT00847626|455648396|FG002|Overall Study|Lost to Follow-up|1|||
126642348|NCT00847626|455648397|FG003|Overall Study|Lost to Follow-up|1|||
126642349|NCT00847626|455648398|FG004|Overall Study|Lost to Follow-up|0|||
126642350|NCT00847626|455648399|FG005|Overall Study|Lost to Follow-up|3|||
126642351|NCT00847626|455648400|FG006|Overall Study|Lost to Follow-up|1|||
126642352|NCT00847626|455648401|FG007|Overall Study|Lost to Follow-up|3|||
126642353|NCT00847626|455648402|FG008|Overall Study|Lost to Follow-up|1|||
126642354|NCT00847626|455648403|FG009|Overall Study|Lost to Follow-up|0|||
126642355|NCT00847626|455648404|FG010|Overall Study|Lost to Follow-up|1|||
126642356|NCT00847626|455648394|FG000|Overall Study|Withdrawal by Subject|5|||
126642357|NCT00847626|455648395|FG001|Overall Study|Withdrawal by Subject|5|||
126642358|NCT00847626|455648396|FG002|Overall Study|Withdrawal by Subject|3|||
126642359|NCT00847626|455648397|FG003|Overall Study|Withdrawal by Subject|8|||
126642360|NCT00847626|455648398|FG004|Overall Study|Withdrawal by Subject|12|||
126642361|NCT00847626|455648399|FG005|Overall Study|Withdrawal by Subject|9|||
126642362|NCT00847626|455648400|FG006|Overall Study|Withdrawal by Subject|8|||
126642363|NCT00847626|455648401|FG007|Overall Study|Withdrawal by Subject|4|||
126642364|NCT00847626|455648402|FG008|Overall Study|Withdrawal by Subject|4|||
126642365|NCT00847626|455648403|FG009|Overall Study|Withdrawal by Subject|5|||
126642366|NCT00847626|455648404|FG010|Overall Study|Withdrawal by Subject|2|||
126642367|NCT00847626|455648394|FG000|Overall Study|Lack of Efficacy|3|||
126642368|NCT00847626|455648395|FG001|Overall Study|Lack of Efficacy|1|||
126642369|NCT00847626|455648396|FG002|Overall Study|Lack of Efficacy|0|||
126642370|NCT00847626|455648397|FG003|Overall Study|Lack of Efficacy|1|||
126642371|NCT00847626|455648398|FG004|Overall Study|Lack of Efficacy|2|||
126642372|NCT00847626|455648399|FG005|Overall Study|Lack of Efficacy|0|||
126642373|NCT00847626|455648400|FG006|Overall Study|Lack of Efficacy|6|||
126642374|NCT00847626|455648401|FG007|Overall Study|Lack of Efficacy|2|||
126642375|NCT00847626|455648402|FG008|Overall Study|Lack of Efficacy|5|||
126642376|NCT00847626|455648403|FG009|Overall Study|Lack of Efficacy|1|||
126642377|NCT00847626|455648404|FG010|Overall Study|Lack of Efficacy|7|||
126642378|NCT00847626|455648394|FG000|Overall Study|Other|1|||
126642379|NCT00847626|455648395|FG001|Overall Study|Other|5|||
126642380|NCT00847626|455648396|FG002|Overall Study|Other|4|||
126642381|NCT00847626|455648397|FG003|Overall Study|Other|1|||
126642382|NCT00847626|455648398|FG004|Overall Study|Other|2|||
126642383|NCT00847626|455648399|FG005|Overall Study|Other|2|||
126642384|NCT00847626|455648400|FG006|Overall Study|Other|2|||
126642385|NCT00847626|455648401|FG007|Overall Study|Other|3|||
126642386|NCT00847626|455648402|FG008|Overall Study|Other|1|||
126642387|NCT00847626|455648403|FG009|Overall Study|Other|1|||
126642388|NCT00847626|455648404|FG010|Overall Study|Other|3|||
126642389|NCT03057847|455648405|FG000|Overall Study|Lost to Follow-up|16|||
126642390|NCT02138786|455648406|FG000|Overall Study|Adverse Event|0|||
126642391|NCT02138786|455648407|FG001|Overall Study|Adverse Event|2|||
126642392|NCT02138786|455648408|FG002|Overall Study|Adverse Event|1|||
126642393|NCT02138786|455648406|FG000|Overall Study|Death|1|||
126642394|NCT02138786|455648407|FG001|Overall Study|Death|7|||
126642395|NCT02138786|455648408|FG002|Overall Study|Death|2|||
126642396|NCT02138786|455648406|FG000|Overall Study|Disease Progression|1|||
126642397|NCT02138786|455648407|FG001|Overall Study|Disease Progression|1|||
126642398|NCT02138786|455648408|FG002|Overall Study|Disease Progression|3|||
126642399|NCT02138786|455648406|FG000|Overall Study|Withdrawal by Subject|1|||
126642400|NCT02138786|455648407|FG001|Overall Study|Withdrawal by Subject|2|||
126642401|NCT02138786|455648408|FG002|Overall Study|Withdrawal by Subject|0|||
126642402|NCT02138786|455648406|FG000|Overall Study|Patient's Wish|0|||
126642403|NCT02138786|455648407|FG001|Overall Study|Patient's Wish|2|||
126642404|NCT02138786|455648408|FG002|Overall Study|Patient's Wish|0|||
126642405|NCT02138786|455648406|FG000|Overall Study|Sponsor Terminated Study|0|||
126642406|NCT02138786|455648407|FG001|Overall Study|Sponsor Terminated Study|1|||
126642407|NCT02138786|455648408|FG002|Overall Study|Sponsor Terminated Study|1|||
126642408|NCT02138786|455648406|FG000|Overall Study|Non-Compliance|0|||
126642409|NCT02138786|455648407|FG001|Overall Study|Non-Compliance|0|||
126642410|NCT02138786|455648408|FG002|Overall Study|Non-Compliance|1|||
126642411|NCT01923662|455648409|FG000|Overall Study|Withdrawal by Subject|1|||
126642412|NCT00659880|455648412|FG000|Overall Study|Lost to Follow-up|5|||
126642413|NCT00669877|455648419|FG000|Overall Study|Disease Progression/Death|4|||
126642414|NCT01465763|455648420|FG000|Overall Study|Withdrawal by Subject|4|||
126642415|NCT01465763|455648421|FG001|Overall Study|Withdrawal by Subject|0|||
126642416|NCT01465763|455648422|FG002|Overall Study|Withdrawal by Subject|1|||
126642417|NCT01465763|455648420|FG000|Overall Study|Insufficient Clinical Response|11|||
126642418|NCT01465763|455648421|FG001|Overall Study|Insufficient Clinical Response|0|||
126642419|NCT01465763|455648422|FG002|Overall Study|Insufficient Clinical Response|1|||
126642420|NCT01465763|455648420|FG000|Overall Study|Adverse Event|9|||
126642421|NCT01465763|455648421|FG001|Overall Study|Adverse Event|0|||
126642422|NCT01465763|455648422|FG002|Overall Study|Adverse Event|1|||
126642423|NCT01465763|455648420|FG000|Overall Study|Other|2|||
126642424|NCT01465763|455648421|FG001|Overall Study|Other|0|||
126642425|NCT01465763|455648422|FG002|Overall Study|Other|0|||
126642426|NCT01465763|455648420|FG000|Overall Study|Protocol Violation|4|||
126642427|NCT01465763|455648421|FG001|Overall Study|Protocol Violation|1|||
126642428|NCT01465763|455648422|FG002|Overall Study|Protocol Violation|1|||
126642429|NCT01465763|455648420|FG000|Overall Study|Death|1|||
126642430|NCT01465763|455648421|FG001|Overall Study|Death|0|||
126642431|NCT01465763|455648422|FG002|Overall Study|Death|0|||
126642432|NCT02920970|455648423|FG000|First Intervention|Protocol Violation|0|||
126642433|NCT02920970|455648424|FG001|First Intervention|Protocol Violation|1|||
126642434|NCT02920970|455648423|FG000|First Intervention|Adverse Event|0|||
126642435|NCT02920970|455648424|FG001|First Intervention|Adverse Event|1|||
126642436|NCT02920970|455648423|FG000|Second Intervention|Poor Lens Fit|1|||
126642437|NCT02920970|455648424|FG001|Second Intervention|Poor Lens Fit|0|||
126642438|NCT01711853|455648426|FG000|Overall Study|Not treated|3|||
126642439|NCT02992691|455648431|FG000|Overall Study|Adverse Event|2|||
126642440|NCT02992691|455648431|FG000|Overall Study|Withdrawal by Subject|1|||
126642441|NCT01427725|455648432|FG000|Overall Study|Lost to Follow-up|17|||
126642442|NCT01427725|455648432|FG000|Overall Study|Protocol Violation|1|||
126642443|NCT01427725|455648432|FG000|Overall Study|Drug not administered|1|||
126642444|NCT01427725|455648432|FG000|Overall Study|Failure to visit|7|||
126642445|NCT01427725|455648432|FG000|Overall Study|Adverse Event|46|||
126642446|NCT01427725|455648432|FG000|Overall Study|Failure to visit after administration|40|||
126642447|NCT01427725|455648432|FG000|Overall Study|Patient's rejection|27|||
126642448|NCT01427725|455648432|FG000|Overall Study|Transfer to a different hospital|17|||
126642449|NCT01427725|455648432|FG000|Overall Study|Lack of Efficacy|8|||
126642450|NCT01427725|455648432|FG000|Overall Study|Death|7|||
126642451|NCT01427725|455648432|FG000|Overall Study|Symptom improvement|6|||
126642452|NCT01427725|455648432|FG000|Overall Study|AE and Patient's rejection|5|||
126642453|NCT01427725|455648432|FG000|Overall Study|Physician Decision|5|||
126642454|NCT01427725|455648432|FG000|Overall Study|Exacerbation of underlying disease|5|||
126642455|NCT01427725|455648432|FG000|Overall Study|Oral feeding difficulty|5|||
126642456|NCT01427725|455648432|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
126642457|NCT01427725|455648432|FG000|Overall Study|Forgetting prescription|1|||
126642458|NCT01427725|455648432|FG000|Overall Study|Other|2|||
126642459|NCT04276051|455648434|FG000|Overall Study|Lost to Follow-up|0|||
126642460|NCT04276051|455648435|FG001|Overall Study|Lost to Follow-up|1|||
126642461|NCT04276051|455648434|FG000|Overall Study|Physician Decision|0|||
126642462|NCT04276051|455648435|FG001|Overall Study|Physician Decision|1|||
126642463|NCT04276051|455648434|FG000|Overall Study|Withdrawal by Subject|1|||
126642464|NCT04276051|455648435|FG001|Overall Study|Withdrawal by Subject|1|||
126642465|NCT00392925|455648436|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
126642466|NCT00392925|455648437|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
126642467|NCT00392925|455648438|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
126642468|NCT00392925|455648439|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
126642469|NCT00392925|455648436|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
126642470|NCT00392925|455648437|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
126642471|NCT00392925|455648438|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
126642472|NCT00392925|455648439|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
126642473|NCT00392925|455648436|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
126642474|NCT00392925|455648437|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
126642475|NCT00392925|455648438|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
126642476|NCT00392925|455648439|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
126642477|NCT00392925|455648436|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
126642478|NCT00392925|455648437|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
126642479|NCT00392925|455648438|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
126642480|NCT00392925|455648439|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
126642481|NCT00392925|455648436|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
126642482|NCT00392925|455648437|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
126642483|NCT00392925|455648438|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
126642484|NCT00392925|455648439|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
126642485|NCT00392925|455648436|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
126642486|NCT00392925|455648437|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
126642487|NCT00392925|455648438|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
126642488|NCT00392925|455648439|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
126642489|NCT00392925|455648436|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
126642490|NCT00392925|455648437|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
126642491|NCT00392925|455648438|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
126642492|NCT00392925|455648439|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
126642493|NCT00392925|455648436|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
126642494|NCT00392925|455648437|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
126642495|NCT00392925|455648438|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
126642496|NCT00392925|455648439|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
126642497|NCT00392925|455648436|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
126642498|NCT00392925|455648437|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
126642499|NCT00392925|455648438|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
126642500|NCT00392925|455648439|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
126642501|NCT02269423|455648443|FG000|Overall Study|Discontinued due to change in residence|0|||
126642502|NCT02269423|455648444|FG001|Overall Study|Discontinued due to change in residence|1|||
126642503|NCT02269423|455648445|FG002|Overall Study|Discontinued due to change in residence|0|||
126642504|NCT02269423|455648446|FG003|Overall Study|Discontinued due to change in residence|1|||
126642505|NCT00755105|455648449|FG000|Overall Study|Withdrawal by Subject|9|||
126642506|NCT00755105|455648450|FG001|Overall Study|Withdrawal by Subject|11|||
126642507|NCT00755105|455648451|FG002|Overall Study|Withdrawal by Subject|4|||
126642508|NCT01281839|455648453|FG000|Overall Study|Lost to Follow-up|6|||
126642509|NCT01281839|455648454|FG001|Overall Study|Lost to Follow-up|3|||
126642510|NCT01281839|455648453|FG000|Overall Study|Withdrawal by Subject|4|||
126642511|NCT01281839|455648454|FG001|Overall Study|Withdrawal by Subject|10|||
126642512|NCT01281839|455648453|FG000|Overall Study|Reason not specified|0|||
126642513|NCT01281839|455648454|FG001|Overall Study|Reason not specified|1|||
126642514|NCT01277887|455648456|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
126642515|NCT01277887|455648457|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
126642516|NCT01277887|455648456|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
126642517|NCT01277887|455648457|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
126642518|NCT01277887|455648456|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
126642519|NCT01277887|455648457|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
126642520|NCT00415051|455648458|FG000|Overall Study|Protocol Violation|1|||
126642521|NCT00780559|455648461|FG000|Overall Study|Lost to Follow-up|2|||
126642522|NCT00780559|455648462|FG001|Overall Study|Lost to Follow-up|7|||
126642523|NCT00780559|455648461|FG000|Overall Study|Death|1|||
126642524|NCT00780559|455648462|FG001|Overall Study|Death|0|||
126642525|NCT04462289|455648465|FG000|Overall Study|Lost to Follow-up|4|||
126642526|NCT04462289|455648466|FG001|Overall Study|Lost to Follow-up|5|||
126642527|NCT04462289|455648465|FG000|Overall Study|Death|0|||
126642528|NCT04462289|455648466|FG001|Overall Study|Death|3|||
126642529|NCT04462289|455648465|FG000|Overall Study|Withdrawal by Subject|1|||
126642530|NCT04462289|455648466|FG001|Overall Study|Withdrawal by Subject|3|||
126642531|NCT01518153|455648467|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
126642532|NCT01518153|455648468|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
126642533|NCT01518153|455648469|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
126642534|NCT01518153|455648467|FG000|Stem Cell Transplant|Death|2|||
126642535|NCT01518153|455648468|FG001|Stem Cell Transplant|Death|0|||
126642536|NCT01518153|455648469|FG002|Stem Cell Transplant|Death|0|||
126642537|NCT01518153|455648467|FG000|Stem Cell Transplant|Secondary graft failure|1|||
126642538|NCT01518153|455648468|FG001|Stem Cell Transplant|Secondary graft failure|0|||
126642539|NCT01518153|455648469|FG002|Stem Cell Transplant|Secondary graft failure|0|||
126642540|NCT01518153|455648467|FG000|Stem Cell Transplant|Adverse Event|1|||
126642541|NCT01518153|455648468|FG001|Stem Cell Transplant|Adverse Event|0|||
126642542|NCT01518153|455648469|FG002|Stem Cell Transplant|Adverse Event|0|||
126642543|NCT01518153|455648467|FG000|Donor Lymphocyte Infusion|Death|0|||
126642544|NCT01518153|455648468|FG001|Donor Lymphocyte Infusion|Death|2|||
126642545|NCT01518153|455648469|FG002|Donor Lymphocyte Infusion|Death|1|||
126642546|NCT00856245|455648470|FG000|Overall Study|Was not transplanted|5|||
126642547|NCT01250509|455648473|FG000|Overall Study|Lost to Follow-up|5|||
126642548|NCT01250509|455648474|FG001|Overall Study|Lost to Follow-up|2|||
126642549|NCT00203268|455648481|FG000|Early Treatment|only treated one headache|2|||
126642550|NCT00203268|455648481|FG000|Early Treatment|Lost to Follow-up|1|||
126642551|NCT00203268|455648481|FG000|Early Treatment|Withdrawal by Subject|1|||
126642552|NCT00600613|455648482|FG000|Overall Study|Protocol Deviation|1|||
126642553|NCT00839956|455648484|FG000|Overall Study|Adverse Event|2|||
126642554|NCT00839956|455648484|FG000|Overall Study|Lack of Efficacy|6|||
126642555|NCT00839956|455648484|FG000|Overall Study|Physician Decision|1|||
126642556|NCT00839956|455648484|FG000|Overall Study|Withdrawal by Subject|3|||
126642557|NCT02807883|455648485|FG000|Overall Study|Withdrawal by Subject|2|||
126642558|NCT02514551|455648488|FG000|Overall Study|Lost to Follow-up|0|||
126642559|NCT02514551|455648489|FG001|Overall Study|Lost to Follow-up|1|||
126642560|NCT02514551|455648488|FG000|Overall Study|Participant Never Treated|0|||
126642561|NCT02514551|455648489|FG001|Overall Study|Participant Never Treated|2|||
126642562|NCT00277095|455648490|FG000|Overall Study|Death|2|||
126642563|NCT00277095|455648490|FG000|Overall Study|Explanted|7|||
126642564|NCT00277095|455648490|FG000|Overall Study|Lost to Follow-up|2|||
126642565|NCT00277095|455648490|FG000|Overall Study|Missed Follow-up|9|||
126642566|NCT00277095|455648490|FG000|Overall Study|Physician Decision|1|||
126642567|NCT03838731|455650386|FG000|Overall Study|Pregnancy|0|||
126642568|NCT03838731|455650387|FG001|Overall Study|Pregnancy|1|||
126642569|NCT03838731|455650386|FG000|Overall Study|Withdrawal of consent|1|||
126642570|NCT03838731|455650387|FG001|Overall Study|Withdrawal of consent|0|||
126642571|NCT01195948|455650393|FG000|Overall Study|Lost to Follow-up|0|||
126642572|NCT01195948|455650394|FG001|Overall Study|Lost to Follow-up|1|||
126642573|NCT01195948|455650395|FG002|Overall Study|Lost to Follow-up|2|||
126642574|NCT00770029|455650396|FG000|Overall Study|Lost to Follow-up|2|||
126642575|NCT00770029|455650397|FG001|Overall Study|Lost to Follow-up|0|||
126642576|NCT00770029|455650396|FG000|Overall Study|Withdrawal by Subject|3|||
126642577|NCT00770029|455650397|FG001|Overall Study|Withdrawal by Subject|3|||
126642578|NCT00770029|455650396|FG000|Overall Study|Adverse Event|1|||
126642579|NCT00770029|455650397|FG001|Overall Study|Adverse Event|0|||
126642580|NCT03809039|455650400|FG000|Part 1|Withdrawal by Subject|1|||
126642581|NCT03809039|455650401|FG001|Part 1|Withdrawal by Subject|0|||
126642582|NCT03809039|455650402|FG002|Part 1|Withdrawal by Subject|0|||
126642583|NCT03809039|455650403|FG003|Part 1|Withdrawal by Subject|1|||
126642584|NCT03809039|455650404|FG004|Part 1|Withdrawal by Subject|0|||
126642585|NCT03809039|455650405|FG005|Part 1|Withdrawal by Subject|0|||
126642586|NCT03809039|455650406|FG006|Part 1|Withdrawal by Subject|0|||
126642587|NCT03809039|455650407|FG007|Part 1|Withdrawal by Subject|0|||
126642588|NCT03809039|455650408|FG008|Part 1|Withdrawal by Subject|0|||
126642589|NCT03809039|455650400|FG000|Part 3|Withdrawn by study termination|0|||
126642590|NCT03809039|455650401|FG001|Part 3|Withdrawn by study termination|0|||
126642591|NCT03809039|455650402|FG002|Part 3|Withdrawn by study termination|0|||
126642592|NCT03809039|455650403|FG003|Part 3|Withdrawn by study termination|0|||
126642593|NCT03809039|455650404|FG004|Part 3|Withdrawn by study termination|0|||
126642594|NCT03809039|455650405|FG005|Part 3|Withdrawn by study termination|0|||
126642595|NCT03809039|455650406|FG006|Part 3|Withdrawn by study termination|0|||
126642596|NCT03809039|455650407|FG007|Part 3|Withdrawn by study termination|2|||
126642597|NCT03809039|455650408|FG008|Part 3|Withdrawn by study termination|6|||
126642598|NCT05627258|455650409|FG000|Overall Study|Lost to Follow-up|1|||
126642599|NCT05627258|455650410|FG001|Overall Study|Lost to Follow-up|0|||
126642600|NCT05627258|455650411|FG002|Overall Study|Lost to Follow-up|0|||
126642601|NCT05627258|455650412|FG003|Overall Study|Lost to Follow-up|0|||
126642602|NCT05627258|455650413|FG004|Overall Study|Lost to Follow-up|0|||
126642603|NCT05627258|455650414|FG005|Overall Study|Lost to Follow-up|0|||
126642604|NCT05627258|455650409|FG000|Overall Study|Withdrawal by Subject|0|||
126642605|NCT05627258|455650410|FG001|Overall Study|Withdrawal by Subject|0|||
126642606|NCT05627258|455650411|FG002|Overall Study|Withdrawal by Subject|0|||
126642607|NCT05627258|455650412|FG003|Overall Study|Withdrawal by Subject|0|||
126642608|NCT05627258|455650413|FG004|Overall Study|Withdrawal by Subject|2|||
126642609|NCT05627258|455650414|FG005|Overall Study|Withdrawal by Subject|0|||
126642610|NCT05627258|455650409|FG000|Overall Study|Enrolled, but product not administered|1|||
126642611|NCT05627258|455650410|FG001|Overall Study|Enrolled, but product not administered|0|||
126642612|NCT05627258|455650411|FG002|Overall Study|Enrolled, but product not administered|0|||
126642613|NCT05627258|455650412|FG003|Overall Study|Enrolled, but product not administered|0|||
126642614|NCT05627258|455650413|FG004|Overall Study|Enrolled, but product not administered|0|||
126642615|NCT05627258|455650414|FG005|Overall Study|Enrolled, but product not administered|0|||
126642616|NCT05627258|455650409|FG000|Overall Study|Other subject illness/injury|1|||
126642617|NCT05627258|455650410|FG001|Overall Study|Other subject illness/injury|0|||
126642618|NCT05627258|455650411|FG002|Overall Study|Other subject illness/injury|0|||
126642619|NCT05627258|455650412|FG003|Overall Study|Other subject illness/injury|0|||
126642620|NCT05627258|455650413|FG004|Overall Study|Other subject illness/injury|0|||
126642621|NCT05627258|455650414|FG005|Overall Study|Other subject illness/injury|0|||
126642622|NCT05627258|455650409|FG000|Overall Study|Subject moved from area|0|||
126642623|NCT05627258|455650410|FG001|Overall Study|Subject moved from area|0|||
126642624|NCT05627258|455650411|FG002|Overall Study|Subject moved from area|1|||
126642625|NCT05627258|455650412|FG003|Overall Study|Subject moved from area|0|||
126642626|NCT05627258|455650413|FG004|Overall Study|Subject moved from area|0|||
126642627|NCT05627258|455650414|FG005|Overall Study|Subject moved from area|0|||
126642628|NCT01199068|455650417|FG000|Overall Study|Unacceptable toxicity|0|||
126642629|NCT01199068|455650418|FG001|Overall Study|Unacceptable toxicity|0|||
126642630|NCT01199068|455650419|FG002|Overall Study|Unacceptable toxicity|2|||
126642631|NCT01199068|455650417|FG000|Overall Study|Progressive disease|3|||
126642632|NCT01199068|455650418|FG001|Overall Study|Progressive disease|3|||
126642633|NCT01199068|455650419|FG002|Overall Study|Progressive disease|6|||
126642634|NCT01199068|455650417|FG000|Overall Study|Withdrawal by Subject|0|||
126642635|NCT01199068|455650418|FG001|Overall Study|Withdrawal by Subject|0|||
126642636|NCT01199068|455650419|FG002|Overall Study|Withdrawal by Subject|1|||
126642637|NCT01294397|455650420|FG000|Overall Study|Withdrawal by Subject|1|||
126642638|NCT01294397|455650420|FG000|Overall Study|Administrative Decision|1|||
126642639|NCT01250925|455650421|FG000|Overall Study|Lost to Follow-up|1|||
126642640|NCT01250925|455650422|FG001|Overall Study|Lost to Follow-up|1|||
126642641|NCT01250925|455650423|FG002|Overall Study|Lost to Follow-up|0|||
126642642|NCT01250925|455650421|FG000|Overall Study|Withdrawal by Subject|2|||
126642643|NCT01250925|455650422|FG001|Overall Study|Withdrawal by Subject|0|||
126642644|NCT01250925|455650423|FG002|Overall Study|Withdrawal by Subject|0|||
126642645|NCT01250925|455650421|FG000|Overall Study|Protocol Violation|2|||
126642646|NCT01250925|455650422|FG001|Overall Study|Protocol Violation|0|||
126642647|NCT01250925|455650423|FG002|Overall Study|Protocol Violation|0|||
126642648|NCT01250925|455650421|FG000|Overall Study|Physician Decision|0|||
126642649|NCT01250925|455650422|FG001|Overall Study|Physician Decision|2|||
126642650|NCT01250925|455650423|FG002|Overall Study|Physician Decision|1|||
126642651|NCT01250925|455650421|FG000|Overall Study|Adverse Event|0|||
126642652|NCT01250925|455650422|FG001|Overall Study|Adverse Event|0|||
126642653|NCT01250925|455650423|FG002|Overall Study|Adverse Event|1|||
126642654|NCT00678301|455650424|FG000|Overall Study|Non-compliance with study procedures|0|||
126642655|NCT00678301|455650425|FG001|Overall Study|Non-compliance with study procedures|1|||
126642656|NCT00678301|455650424|FG000|Overall Study|Adverse Event|1|||
126642657|NCT00678301|455650425|FG001|Overall Study|Adverse Event|0|||
126642658|NCT00678301|455650424|FG000|Overall Study|Withdrawal by Subject|4|||
126642659|NCT00678301|455650425|FG001|Overall Study|Withdrawal by Subject|0|||
126642660|NCT00678301|455650424|FG000|Overall Study|Lost to Follow-up|3|||
126642661|NCT00678301|455650425|FG001|Overall Study|Lost to Follow-up|1|||
126642662|NCT03338296|455650426|FG000|Overall Study|Adverse Event|0|||
126642663|NCT03338296|455650427|FG001|Overall Study|Adverse Event|1|||
126642664|NCT03338296|455650426|FG000|Overall Study|Withdrawal by Subject|14|||
126642665|NCT03338296|455650427|FG001|Overall Study|Withdrawal by Subject|13|||
126642666|NCT03338296|455650426|FG000|Overall Study|Lost to Follow-up|10|||
126642667|NCT03338296|455650427|FG001|Overall Study|Lost to Follow-up|10|||
126642668|NCT03338296|455650426|FG000|Overall Study|Study Terminated by Sponsor|77|||
126642669|NCT03338296|455650427|FG001|Overall Study|Study Terminated by Sponsor|76|||
126642670|NCT03338296|455650426|FG000|Overall Study|Other|2|||
126642671|NCT03338296|455650427|FG001|Overall Study|Other|7|||
126642672|NCT03338296|455650426|FG000|Overall Study|Missing|0|||
126642673|NCT03338296|455650427|FG001|Overall Study|Missing|1|||
126642674|NCT04421950|455650428|FG000|Overall Study|Dropped or lost to follow up|4|||
126642675|NCT04421950|455650429|FG001|Overall Study|Dropped or lost to follow up|2|||
126642676|NCT01252355|455650431|FG000|Overall Study|Adverse Event|9|||
126642677|NCT01252355|455650432|FG001|Overall Study|Adverse Event|17|||
126642678|NCT01252355|455650433|FG002|Overall Study|Adverse Event|22|||
126642679|NCT01252355|455650431|FG000|Overall Study|Lack of Efficacy|6|||
126642680|NCT01252355|455650432|FG001|Overall Study|Lack of Efficacy|4|||
126642681|NCT01252355|455650433|FG002|Overall Study|Lack of Efficacy|2|||
126642682|NCT01252355|455650431|FG000|Overall Study|Lost to Follow-up|0|||
126642683|NCT01252355|455650432|FG001|Overall Study|Lost to Follow-up|0|||
126642684|NCT01252355|455650433|FG002|Overall Study|Lost to Follow-up|1|||
126642685|NCT01252355|455650431|FG000|Overall Study|Poor Compliance to Protocol|1|||
126642686|NCT01252355|455650432|FG001|Overall Study|Poor Compliance to Protocol|1|||
126642687|NCT01252355|455650433|FG002|Overall Study|Poor Compliance to Protocol|1|||
126642688|NCT01252355|455650431|FG000|Overall Study|Progressive Disease|2|||
126642689|NCT01252355|455650432|FG001|Overall Study|Progressive Disease|0|||
126642690|NCT01252355|455650433|FG002|Overall Study|Progressive Disease|0|||
126642691|NCT01252355|455650431|FG000|Overall Study|Sponsor Early Termination of Study|149|||
126642692|NCT01252355|455650432|FG001|Overall Study|Sponsor Early Termination of Study|149|||
126642693|NCT01252355|455650433|FG002|Overall Study|Sponsor Early Termination of Study|146|||
126642694|NCT01252355|455650431|FG000|Overall Study|Randomized but not Treated|2|||
126642695|NCT01252355|455650432|FG001|Overall Study|Randomized but not Treated|0|||
126642696|NCT01252355|455650433|FG002|Overall Study|Randomized but not Treated|0|||
126642697|NCT01252355|455650431|FG000|Overall Study|Other Than Above|8|||
126642698|NCT01252355|455650432|FG001|Overall Study|Other Than Above|7|||
126642699|NCT01252355|455650433|FG002|Overall Study|Other Than Above|7|||
126642700|NCT01725126|455650434|FG000|Overall Study|Protocol Violation|0|||
126642701|NCT01725126|455650435|FG001|Overall Study|Protocol Violation|1|||
126642702|NCT01725126|455650436|FG002|Overall Study|Protocol Violation|0|||
126642703|NCT01725126|455650437|FG003|Overall Study|Protocol Violation|0|||
126642704|NCT01725126|455650438|FG004|Overall Study|Protocol Violation|0|||
126642705|NCT01725126|455650439|FG005|Overall Study|Protocol Violation|0|||
126642706|NCT01725126|455650434|FG000|Overall Study|Withdrawal by Subject|0|||
126642707|NCT01725126|455650435|FG001|Overall Study|Withdrawal by Subject|0|||
126642708|NCT01725126|455650436|FG002|Overall Study|Withdrawal by Subject|0|||
126642709|NCT01725126|455650437|FG003|Overall Study|Withdrawal by Subject|1|||
126642710|NCT01725126|455650438|FG004|Overall Study|Withdrawal by Subject|0|||
126642711|NCT01725126|455650439|FG005|Overall Study|Withdrawal by Subject|0|||
126642712|NCT00677534|455650444|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
126642713|NCT00677534|455650444|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
126642714|NCT00677534|455650444|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
126642715|NCT02687035|455650445|FG000|Overall Study|Withdrawal by Subject|1|||
126642716|NCT02687035|455650445|FG000|Overall Study|Death|87|||
126642717|NCT02687035|455650445|FG000|Overall Study|Lost to Follow-up|1|||
126642718|NCT02687035|455650445|FG000|Overall Study|Missed Visit|87|||
126642719|NCT02687035|455650445|FG000|Overall Study|Did not receive Study Device|8|||
126642720|NCT04076943|455650454|FG000|Overall Study|Withdrawal by Subject|12|||
126642721|NCT04076943|455650454|FG000|Overall Study|Adverse Event|1|||
126642722|NCT04076943|455650454|FG000|Overall Study|Progressive Disease|2|||
126642723|NCT04076943|455650454|FG000|Overall Study|Death|13|||
126642724|NCT04076943|455650454|FG000|Overall Study|Other than specified|6|||
126642725|NCT02224703|455650460|FG000|Overall Study|Adverse Event|0|||
126642726|NCT02224703|455650461|FG001|Overall Study|Adverse Event|5|||
126642727|NCT02224703|455650462|FG002|Overall Study|Adverse Event|0|||
126642728|NCT02224703|455650460|FG000|Overall Study|Withdrawn by investigator|1|||
126642729|NCT02224703|455650461|FG001|Overall Study|Withdrawn by investigator|0|||
126642730|NCT02224703|455650462|FG002|Overall Study|Withdrawn by investigator|0|||
126642731|NCT02224703|455650460|FG000|Overall Study|Advised by medical monitor|1|||
126642732|NCT02224703|455650461|FG001|Overall Study|Advised by medical monitor|0|||
126642733|NCT02224703|455650462|FG002|Overall Study|Advised by medical monitor|0|||
126642734|NCT02224703|455650460|FG000|Overall Study|Withdrawn by parent/guardian|0|||
126642735|NCT02224703|455650461|FG001|Overall Study|Withdrawn by parent/guardian|1|||
126642736|NCT02224703|455650462|FG002|Overall Study|Withdrawn by parent/guardian|0|||
126642737|NCT02224703|455650460|FG000|Overall Study|Lack of Efficacy|1|||
126642738|NCT02224703|455650461|FG001|Overall Study|Lack of Efficacy|0|||
126642739|NCT02224703|455650462|FG002|Overall Study|Lack of Efficacy|0|||
126642740|NCT02922023|455650463|FG000|Overall Study|Lost to Follow-up|2|||
126642741|NCT02922023|455650464|FG001|Overall Study|Lost to Follow-up|0|||
126642742|NCT01886287|455650465|FG000|Overall Study|Radiographic disease progression|1|||
126642743|NCT01886287|455650465|FG000|Overall Study|Clinical progression due to disease|1|||
126642744|NCT03596762|455650466|FG000|Overall Study|Protocol Violation|0|||
126642745|NCT03596762|455650467|FG001|Overall Study|Protocol Violation|0|||
126642746|NCT03596762|455650468|FG002|Overall Study|Protocol Violation|0|||
126642747|NCT03596762|455650469|FG003|Overall Study|Protocol Violation|0|||
126642748|NCT03596762|455650470|FG004|Overall Study|Protocol Violation|1|||
126642749|NCT03596762|455650466|FG000|Overall Study|Adverse Event|2|||
126642750|NCT03596762|455650467|FG001|Overall Study|Adverse Event|0|||
126642751|NCT03596762|455650468|FG002|Overall Study|Adverse Event|1|||
126642752|NCT03596762|455650469|FG003|Overall Study|Adverse Event|0|||
126642753|NCT03596762|455650470|FG004|Overall Study|Adverse Event|5|||
126642754|NCT03596762|455650466|FG000|Overall Study|Withdrawal by Subject|2|||
126642755|NCT03596762|455650467|FG001|Overall Study|Withdrawal by Subject|1|||
126642756|NCT03596762|455650468|FG002|Overall Study|Withdrawal by Subject|0|||
126642757|NCT03596762|455650469|FG003|Overall Study|Withdrawal by Subject|1|||
126642758|NCT03596762|455650470|FG004|Overall Study|Withdrawal by Subject|1|||
126642759|NCT01031628|455650471|FG000|Overall Study|Study terminated early|0|||
126642760|NCT01031628|455650472|FG001|Overall Study|Study terminated early|1|||
126642761|NCT01031628|455650473|FG002|Overall Study|Study terminated early|3|||
126642762|NCT01031628|455650474|FG003|Overall Study|Study terminated early|0|||
126642763|NCT00895895|455650475|FG000|Period 1|Adverse Event|7|||
126642764|NCT00895895|455650476|FG001|Period 1|Adverse Event|6|||
126642765|NCT00895895|455650477|FG002|Period 1|Adverse Event|4|||
126642766|NCT00895895|455650478|FG003|Period 1|Adverse Event|6|||
126642767|NCT00895895|455650479|FG004|Period 1|Adverse Event|7|||
126642768|NCT00895895|455650475|FG000|Period 1|Death|0|||
126642769|NCT00895895|455650476|FG001|Period 1|Death|0|||
126642770|NCT00895895|455650477|FG002|Period 1|Death|0|||
126642771|NCT00895895|455650478|FG003|Period 1|Death|0|||
126642772|NCT00895895|455650479|FG004|Period 1|Death|1|||
126642773|NCT00895895|455650475|FG000|Period 1|discontinued by sponsor|2|||
126642774|NCT00895895|455650476|FG001|Period 1|discontinued by sponsor|1|||
126642775|NCT00895895|455650477|FG002|Period 1|discontinued by sponsor|2|||
126642776|NCT00895895|455650478|FG003|Period 1|discontinued by sponsor|1|||
126642777|NCT00895895|455650479|FG004|Period 1|discontinued by sponsor|1|||
126642778|NCT00895895|455650475|FG000|Period 1|failed to return|0|||
126642779|NCT00895895|455650476|FG001|Period 1|failed to return|0|||
126642780|NCT00895895|455650477|FG002|Period 1|failed to return|1|||
126642781|NCT00895895|455650478|FG003|Period 1|failed to return|0|||
126642782|NCT00895895|455650479|FG004|Period 1|failed to return|1|||
126642783|NCT00895895|455650475|FG000|Period 1|investigator request|0|||
126642784|NCT00895895|455650476|FG001|Period 1|investigator request|1|||
126642785|NCT00895895|455650477|FG002|Period 1|investigator request|0|||
126642786|NCT00895895|455650478|FG003|Period 1|investigator request|0|||
126642787|NCT00895895|455650479|FG004|Period 1|investigator request|0|||
126642788|NCT00895895|455650475|FG000|Period 1|Lost to Follow-up|2|||
126642789|NCT00895895|455650476|FG001|Period 1|Lost to Follow-up|1|||
126642790|NCT00895895|455650477|FG002|Period 1|Lost to Follow-up|3|||
126642791|NCT00895895|455650478|FG003|Period 1|Lost to Follow-up|2|||
126642792|NCT00895895|455650479|FG004|Period 1|Lost to Follow-up|3|||
126642793|NCT00895895|455650475|FG000|Period 1|Other|1|||
126642794|NCT00895895|455650476|FG001|Period 1|Other|2|||
126642795|NCT00895895|455650477|FG002|Period 1|Other|1|||
126642796|NCT00895895|455650478|FG003|Period 1|Other|1|||
126642797|NCT00895895|455650479|FG004|Period 1|Other|1|||
126642798|NCT00895895|455650475|FG000|Period 1|Protocol Violation|0|||
126642799|NCT00895895|455650476|FG001|Period 1|Protocol Violation|1|||
126642800|NCT00895895|455650477|FG002|Period 1|Protocol Violation|0|||
126642801|NCT00895895|455650478|FG003|Period 1|Protocol Violation|0|||
126642802|NCT00895895|455650479|FG004|Period 1|Protocol Violation|0|||
126642803|NCT00895895|455650475|FG000|Period 1|Withdrawal by Subject|6|||
126642804|NCT00895895|455650476|FG001|Period 1|Withdrawal by Subject|6|||
126642805|NCT00895895|455650477|FG002|Period 1|Withdrawal by Subject|8|||
126642806|NCT00895895|455650478|FG003|Period 1|Withdrawal by Subject|2|||
126642807|NCT00895895|455650479|FG004|Period 1|Withdrawal by Subject|4|||
126642808|NCT00895895|455650475|FG000|Period 1|unsatisfactory response-efficacy|2|||
126642809|NCT00895895|455650476|FG001|Period 1|unsatisfactory response-efficacy|0|||
126642810|NCT00895895|455650477|FG002|Period 1|unsatisfactory response-efficacy|0|||
126642811|NCT00895895|455650478|FG003|Period 1|unsatisfactory response-efficacy|0|||
126642812|NCT00895895|455650479|FG004|Period 1|unsatisfactory response-efficacy|0|||
126642813|NCT00895895|455650475|FG000|Period 1|randomized and not treated|1|||
126642814|NCT00895895|455650476|FG001|Period 1|randomized and not treated|3|||
126642815|NCT00895895|455650477|FG002|Period 1|randomized and not treated|1|||
126642816|NCT00895895|455650478|FG003|Period 1|randomized and not treated|1|||
126642817|NCT00895895|455650479|FG004|Period 1|randomized and not treated|2|||
126642818|NCT00895895|455650475|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
126642819|NCT00895895|455650476|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
126642820|NCT00895895|455650477|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
126642821|NCT00895895|455650478|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
126642822|NCT00895895|455650479|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
126642823|NCT00895895|455650475|FG000|After Period 1, Prior to Period 2|Other|0|||
126642824|NCT00895895|455650476|FG001|After Period 1, Prior to Period 2|Other|0|||
126642825|NCT00895895|455650477|FG002|After Period 1, Prior to Period 2|Other|1|||
126642826|NCT00895895|455650478|FG003|After Period 1, Prior to Period 2|Other|0|||
126642827|NCT00895895|455650479|FG004|After Period 1, Prior to Period 2|Other|0|||
126642828|NCT00895895|455650475|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
126642829|NCT00895895|455650476|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
126642830|NCT00895895|455650477|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
126642831|NCT00895895|455650478|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
126642832|NCT00895895|455650479|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
126642833|NCT00895895|455650475|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
126642834|NCT00895895|455650476|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
126642835|NCT00895895|455650477|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
126642836|NCT00895895|455650478|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
126642837|NCT00895895|455650479|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
126642838|NCT00895895|455650475|FG000|Period 2|Adverse Event|3|||
126642839|NCT00895895|455650476|FG001|Period 2|Adverse Event|3|||
126642840|NCT00895895|455650477|FG002|Period 2|Adverse Event|5|||
126642841|NCT00895895|455650478|FG003|Period 2|Adverse Event|2|||
126642842|NCT00895895|455650479|FG004|Period 2|Adverse Event|5|||
126642843|NCT00895895|455650475|FG000|Period 2|Death|0|||
126642844|NCT00895895|455650476|FG001|Period 2|Death|0|||
126642845|NCT00895895|455650477|FG002|Period 2|Death|1|||
126642846|NCT00895895|455650478|FG003|Period 2|Death|0|||
126642847|NCT00895895|455650479|FG004|Period 2|Death|0|||
126642848|NCT00895895|455650475|FG000|Period 2|discontinued by sponsor|44|||
126642849|NCT00895895|455650476|FG001|Period 2|discontinued by sponsor|44|||
126642850|NCT00895895|455650477|FG002|Period 2|discontinued by sponsor|38|||
126642851|NCT00895895|455650478|FG003|Period 2|discontinued by sponsor|46|||
126642852|NCT00895895|455650479|FG004|Period 2|discontinued by sponsor|37|||
126642853|NCT00895895|455650475|FG000|Period 2|failed to return|2|||
126642854|NCT00895895|455650476|FG001|Period 2|failed to return|0|||
126642855|NCT00895895|455650477|FG002|Period 2|failed to return|0|||
126642856|NCT00895895|455650478|FG003|Period 2|failed to return|0|||
126642857|NCT00895895|455650479|FG004|Period 2|failed to return|0|||
126642858|NCT00895895|455650475|FG000|Period 2|investigator request|2|||
126642859|NCT00895895|455650476|FG001|Period 2|investigator request|0|||
126642860|NCT00895895|455650477|FG002|Period 2|investigator request|0|||
126642861|NCT00895895|455650478|FG003|Period 2|investigator request|0|||
126642862|NCT00895895|455650479|FG004|Period 2|investigator request|0|||
126642863|NCT00895895|455650475|FG000|Period 2|Lost to Follow-up|1|||
126642864|NCT00895895|455650476|FG001|Period 2|Lost to Follow-up|2|||
126642865|NCT00895895|455650477|FG002|Period 2|Lost to Follow-up|1|||
126642866|NCT00895895|455650478|FG003|Period 2|Lost to Follow-up|1|||
126642867|NCT00895895|455650479|FG004|Period 2|Lost to Follow-up|0|||
126642868|NCT00895895|455650475|FG000|Period 2|Other|1|||
126642869|NCT00895895|455650476|FG001|Period 2|Other|1|||
126642870|NCT00895895|455650477|FG002|Period 2|Other|3|||
126642871|NCT00895895|455650478|FG003|Period 2|Other|1|||
126642872|NCT00895895|455650479|FG004|Period 2|Other|1|||
126642873|NCT00895895|455650475|FG000|Period 2|Protocol Violation|1|||
126642874|NCT00895895|455650476|FG001|Period 2|Protocol Violation|0|||
126642875|NCT00895895|455650477|FG002|Period 2|Protocol Violation|1|||
126642876|NCT00895895|455650478|FG003|Period 2|Protocol Violation|1|||
126642877|NCT00895895|455650479|FG004|Period 2|Protocol Violation|1|||
126642878|NCT00895895|455650475|FG000|Period 2|Withdrawal by Subject|0|||
126642879|NCT00895895|455650476|FG001|Period 2|Withdrawal by Subject|2|||
126642880|NCT00895895|455650477|FG002|Period 2|Withdrawal by Subject|0|||
126642881|NCT00895895|455650478|FG003|Period 2|Withdrawal by Subject|3|||
126642882|NCT00895895|455650479|FG004|Period 2|Withdrawal by Subject|5|||
126642883|NCT00895895|455650475|FG000|Period 2|unsatisfactory response-efficacy|2|||
126642884|NCT00895895|455650476|FG001|Period 2|unsatisfactory response-efficacy|1|||
126642885|NCT00895895|455650477|FG002|Period 2|unsatisfactory response-efficacy|0|||
126642886|NCT00895895|455650478|FG003|Period 2|unsatisfactory response-efficacy|0|||
126642887|NCT00895895|455650479|FG004|Period 2|unsatisfactory response-efficacy|0|||
126642888|NCT01261000|455650480|FG000|Overall Study|Screen failure|1|||
126642889|NCT00504777|455650481|FG000|Overall Study|Adverse Event|1|||
126642890|NCT03995316|455650483|FG000|Overall Study|Lost to Follow-up|10|||
126642891|NCT03995316|455650484|FG001|Overall Study|Lost to Follow-up|3|||
126642892|NCT01361594|455650485|FG000|Overall Study|Withdrawal by Subject|1|||
126642893|NCT01361594|455650486|FG001|Overall Study|Withdrawal by Subject|2|||
126642894|NCT01754753|455650487|FG000|Overall Study|Study close|43|||
126642895|NCT01754753|455650488|FG001|Overall Study|Study close|44|||
126642896|NCT01754753|455650487|FG000|Overall Study|Lost to Follow-up|9|||
126642897|NCT01754753|455650488|FG001|Overall Study|Lost to Follow-up|5|||
126642898|NCT01399918|455650491|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
126642899|NCT03197766|455650492|FG000|Overall Study|Withdrawal by Subject|2|||
126642900|NCT03197766|455650493|FG001|Overall Study|Withdrawal by Subject|0|||
126642901|NCT05415748|455650500|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
126642902|NCT05415748|455650501|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
126642903|NCT05415748|455650502|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
126642904|NCT05415748|455650503|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
126642905|NCT05415748|455650500|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
126642906|NCT05415748|455650501|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
126642907|NCT05415748|455650502|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
126642908|NCT05415748|455650503|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
126642909|NCT04520659|455650504|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
126642910|NCT04520659|455650505|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
126642911|NCT04520659|455650506|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
126642912|NCT04520659|455650507|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
126642913|NCT03361865|455650508|FG000|Overall Study|Death|17|||
126642914|NCT03361865|455650509|FG001|Overall Study|Death|18|||
126642915|NCT03361865|455650508|FG000|Overall Study|Physician Decision|1|||
126642916|NCT03361865|455650509|FG001|Overall Study|Physician Decision|9|||
126642917|NCT03361865|455650508|FG000|Overall Study|Withdrawal by Subject|1|||
126642918|NCT03361865|455650509|FG001|Overall Study|Withdrawal by Subject|0|||
126642919|NCT03852719|455650510|FG000|Overall Study|Withdrawal of consent|8|||
126642920|NCT03852719|455650511|FG001|Overall Study|Withdrawal of consent|8|||
126642921|NCT03852719|455650512|FG002|Overall Study|Withdrawal of consent|9|||
126642922|NCT03852719|455650510|FG000|Overall Study|Physician Decision|5|||
126642923|NCT03852719|455650511|FG001|Overall Study|Physician Decision|4|||
126642924|NCT03852719|455650512|FG002|Overall Study|Physician Decision|1|||
126642925|NCT03852719|455650510|FG000|Overall Study|Pregnancy|2|||
126642926|NCT03852719|455650511|FG001|Overall Study|Pregnancy|1|||
126642927|NCT03852719|455650512|FG002|Overall Study|Pregnancy|0|||
126642928|NCT03852719|455650510|FG000|Overall Study|Death|1|||
126642929|NCT03852719|455650511|FG001|Overall Study|Death|0|||
126642930|NCT03852719|455650512|FG002|Overall Study|Death|0|||
126642931|NCT03852719|455650510|FG000|Overall Study|Reason not Specified|3|||
126642932|NCT03852719|455650511|FG001|Overall Study|Reason not Specified|3|||
126642933|NCT03852719|455650512|FG002|Overall Study|Reason not Specified|5|||
126642934|NCT03852719|455650510|FG000|Overall Study|Adverse Event|2|||
126642935|NCT03852719|455650511|FG001|Overall Study|Adverse Event|1|||
126642936|NCT03852719|455650512|FG002|Overall Study|Adverse Event|4|||
126642937|NCT03852719|455650510|FG000|Overall Study|Progressive disease|1|||
126642938|NCT03852719|455650511|FG001|Overall Study|Progressive disease|4|||
126642939|NCT03852719|455650512|FG002|Overall Study|Progressive disease|1|||
126642940|NCT03852719|455650510|FG000|Overall Study|Lost to Follow-up|1|||
126642941|NCT03852719|455650511|FG001|Overall Study|Lost to Follow-up|0|||
126642942|NCT03852719|455650512|FG002|Overall Study|Lost to Follow-up|0|||
126642943|NCT05543187|455650513|FG000|Overall Study|Ongoing|3|||
126642944|NCT05543187|455650514|FG001|Overall Study|Ongoing|2|||
126642945|NCT02819024|455650516|FG000|Overall Study|Withdrawal by Subject|1|||
126642946|NCT00792948|455650517|FG000|Overall Study|Adverse Event|6|||
126642947|NCT00792948|455650517|FG000|Overall Study|Death|4|||
126642948|NCT00792948|455650517|FG000|Overall Study|Withdrawal by Subject|3|||
126642949|NCT00792948|455650517|FG000|Overall Study|Ineligible|2|||
126642950|NCT00792948|455650517|FG000|Overall Study|Insurance denial - not treated|1|||
126642951|NCT00792948|455650517|FG000|Overall Study|Physician Decision|11|||
126642952|NCT00792948|455650517|FG000|Overall Study|Protocol Violation|1|||
126642953|NCT02998476|455650520|FG000|Overall Study|Lost to Follow-up|1|||
126642954|NCT02998476|455650521|FG001|Overall Study|Lost to Follow-up|0|||
126642955|NCT02998476|455650520|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
126642956|NCT02998476|455650521|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
126642957|NCT02998476|455650520|FG000|Overall Study|Withdrawal by Subject|1|||
126642958|NCT02998476|455650521|FG001|Overall Study|Withdrawal by Subject|2|||
126642959|NCT02998476|455650520|FG000|Overall Study|Death|45|||
126642960|NCT02998476|455650521|FG001|Overall Study|Death|2|||
126642961|NCT02998476|455650520|FG000|Overall Study|Other|6|||
126642962|NCT02998476|455650521|FG001|Overall Study|Other|1|||
126642963|NCT03832595|455650522|FG000|Overall Study|Death|142|||
126642964|NCT03832595|455650523|FG001|Overall Study|Death|130|||
126642965|NCT03832595|455650522|FG000|Overall Study|Medical management without dialysis|37|||
126642966|NCT03832595|455650523|FG001|Overall Study|Medical management without dialysis|1|||
126642967|NCT03277352|455650524|FG000|Overall Study|Study Terminated By Sponsor|2|||
126642968|NCT03277352|455650524|FG000|Overall Study|Withdrawal by Subject|4|||
126642969|NCT03277352|455650524|FG000|Overall Study|Death|4|||
126642970|NCT02397447|455650525|FG000|Overall Study|Lost to Follow-up|2|||
126642971|NCT02397447|455650526|FG001|Overall Study|Lost to Follow-up|2|||
126642972|NCT01435772|455650527|FG000|Overall Study|Adverse Event|1|||
126642973|NCT01435772|455650528|FG001|Overall Study|Adverse Event|0|||
126642974|NCT01435772|455650529|FG002|Overall Study|Adverse Event|2|||
126642975|NCT01435772|455650527|FG000|Overall Study|Withdrawal by Subject|0|||
126642976|NCT01435772|455650528|FG001|Overall Study|Withdrawal by Subject|1|||
126642977|NCT01435772|455650529|FG002|Overall Study|Withdrawal by Subject|3|||
126642978|NCT01435772|455650527|FG000|Overall Study|Other - study termination|2|||
126642979|NCT01435772|455650528|FG001|Overall Study|Other - study termination|2|||
126642980|NCT01435772|455650529|FG002|Overall Study|Other - study termination|10|||
126642981|NCT03238963|455650530|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
126642982|NCT03238963|455650531|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
126642983|NCT03238963|455650530|FG000|Overall Study|Withdrawal by Subject|1|||
126642984|NCT03238963|455650531|FG001|Overall Study|Withdrawal by Subject|1|||
126642985|NCT03238963|455650530|FG000|Overall Study|Lost to Follow-up|1|||
126642986|NCT03238963|455650531|FG001|Overall Study|Lost to Follow-up|0|||
126642987|NCT03238963|455650530|FG000|Overall Study|Protocol Violation|1|||
126642988|NCT03238963|455650531|FG001|Overall Study|Protocol Violation|1|||
126642989|NCT03238963|455650530|FG000|Overall Study|Adverse Event|1|||
126642990|NCT03238963|455650531|FG001|Overall Study|Adverse Event|0|||
126642991|NCT00863681|455652382|FG000|Overall Study|Other|2|||
126642992|NCT00863681|455652383|FG001|Overall Study|Other|0|||
126642993|NCT00863681|455652384|FG002|Overall Study|Other|0|||
126642994|NCT00863681|455652382|FG000|Overall Study|Missing|1|||
126642995|NCT00863681|455652383|FG001|Overall Study|Missing|0|||
126642996|NCT00863681|455652384|FG002|Overall Study|Missing|0|||
126642997|NCT00863681|455652382|FG000|Overall Study|Death|40|||
126642998|NCT00863681|455652383|FG001|Overall Study|Death|23|||
126642999|NCT00863681|455652384|FG002|Overall Study|Death|6|||
126643000|NCT00863681|455652382|FG000|Overall Study|Withdrawal by Subject|12|||
126643001|NCT00863681|455652383|FG001|Overall Study|Withdrawal by Subject|5|||
126643002|NCT00863681|455652384|FG002|Overall Study|Withdrawal by Subject|2|||
126643003|NCT00863681|455652382|FG000|Overall Study|Protocol Violation|2|||
126643004|NCT00863681|455652383|FG001|Overall Study|Protocol Violation|0|||
126643005|NCT00863681|455652384|FG002|Overall Study|Protocol Violation|0|||
126643006|NCT00863681|455652382|FG000|Overall Study|Lost to Follow-up|3|||
126643007|NCT00863681|455652383|FG001|Overall Study|Lost to Follow-up|0|||
126643008|NCT00863681|455652384|FG002|Overall Study|Lost to Follow-up|3|||
126643009|NCT00863681|455652382|FG000|Overall Study|Adverse Event|28|||
126643010|NCT00863681|455652383|FG001|Overall Study|Adverse Event|10|||
126643011|NCT00863681|455652384|FG002|Overall Study|Adverse Event|6|||
126643012|NCT00863681|455652382|FG000|Overall Study|Lack of Efficacy|2|||
126643013|NCT00863681|455652383|FG001|Overall Study|Lack of Efficacy|2|||
126643014|NCT00863681|455652384|FG002|Overall Study|Lack of Efficacy|1|||
126643015|NCT00863681|455652382|FG000|Overall Study|Non-compliance with study drug|1|||
126643016|NCT00863681|455652383|FG001|Overall Study|Non-compliance with study drug|3|||
126643017|NCT00863681|455652384|FG002|Overall Study|Non-compliance with study drug|0|||
126643018|NCT03031496|455652385|FG000|Period 1|Adverse Event|2|||
126643019|NCT03031496|455652386|FG001|Period 1|Adverse Event|0|||
126643020|NCT03031496|455652385|FG000|Period 1|Withdrawal by Subject|0|||
126643021|NCT03031496|455652386|FG001|Period 1|Withdrawal by Subject|2|||
126643022|NCT02766777|455652392|FG000|Overall Study|Adverse Event|12|||
126643023|NCT02766777|455652392|FG000|Overall Study|Lost to Follow-up|16|||
126643024|NCT02766777|455652392|FG000|Overall Study|Non-Compliance With Study Drug|1|||
126643025|NCT02766777|455652392|FG000|Overall Study|Protocol Violation|1|||
126643026|NCT02766777|455652392|FG000|Overall Study|Withdrawal by Subject|4|||
126643027|NCT01263509|455652395|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
126643028|NCT01263509|455652396|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
126643029|NCT01263509|455652397|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
126643030|NCT01263509|455652398|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
126643031|NCT01263509|455652395|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
126643032|NCT01263509|455652396|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
126643033|NCT01263509|455652397|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
126643034|NCT01263509|455652398|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
126643035|NCT01263509|455652395|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
126643036|NCT01263509|455652396|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
126643037|NCT01263509|455652397|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126643038|NCT01263509|455652398|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
126643039|NCT01263509|455652395|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
126643040|NCT01263509|455652396|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
126643041|NCT01263509|455652397|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126643042|NCT01263509|455652398|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
126643043|NCT01263509|455652395|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
126643044|NCT01263509|455652396|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
126643045|NCT01263509|455652397|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
126643046|NCT01263509|455652398|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
126643047|NCT00967005|455652399|FG000|Overall Study|Lost to Follow-up|7|||
126643048|NCT00967005|455652400|FG001|Overall Study|Lost to Follow-up|10|||
126643049|NCT02593123|455652401|FG000|Overall Study|Physician Decision|2|||
126643050|NCT02593123|455652402|FG001|Overall Study|Physician Decision|1|||
126643051|NCT02593123|455652401|FG000|Overall Study|Relapse|1|||
126643052|NCT02593123|455652402|FG001|Overall Study|Relapse|1|||
126643053|NCT01371825|455652405|FG000|Overall Study|Death|4|||
126643054|NCT02440425|455652409|FG000|Overall Study|Death likely due to disease progression|1|||
126643055|NCT02440425|455652409|FG000|Overall Study|Withdrawal by Subject|2|||
126643056|NCT02440425|455652409|FG000|Overall Study|Adverse Event|1|||
126643057|NCT02440425|455652409|FG000|Overall Study|Adverse Event/Ineligible|1|||
126643058|NCT02807272|455652412|FG000|Overall Study|Death|9|||
126643059|NCT02807272|455652413|FG001|Overall Study|Death|5|||
126643060|NCT02807272|455652414|FG002|Overall Study|Death|2|||
126643061|NCT02807272|455652415|FG003|Overall Study|Death|0|||
126643062|NCT02807272|455652416|FG004|Overall Study|Death|1|||
126643063|NCT02807272|455652412|FG000|Overall Study|Lost to Follow-up|1|||
126643064|NCT02807272|455652413|FG001|Overall Study|Lost to Follow-up|0|||
126643065|NCT02807272|455652414|FG002|Overall Study|Lost to Follow-up|0|||
126643066|NCT02807272|455652415|FG003|Overall Study|Lost to Follow-up|0|||
126643067|NCT02807272|455652416|FG004|Overall Study|Lost to Follow-up|0|||
126643068|NCT02807272|455652412|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
126643069|NCT02807272|455652413|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
126643070|NCT02807272|455652414|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
126643071|NCT02807272|455652415|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
126643072|NCT02807272|455652416|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
126643073|NCT02807272|455652412|FG000|Overall Study|Protocol-defined Disease Progression|0|||
126643074|NCT02807272|455652413|FG001|Overall Study|Protocol-defined Disease Progression|1|||
126643075|NCT02807272|455652414|FG002|Overall Study|Protocol-defined Disease Progression|0|||
126643076|NCT02807272|455652415|FG003|Overall Study|Protocol-defined Disease Progression|0|||
126643077|NCT02807272|455652416|FG004|Overall Study|Protocol-defined Disease Progression|1|||
126643078|NCT02807272|455652412|FG000|Overall Study|Study Terminated by Sponsor|1|||
126643079|NCT02807272|455652413|FG001|Overall Study|Study Terminated by Sponsor|0|||
126643080|NCT02807272|455652414|FG002|Overall Study|Study Terminated by Sponsor|0|||
126643081|NCT02807272|455652415|FG003|Overall Study|Study Terminated by Sponsor|1|||
126643082|NCT02807272|455652416|FG004|Overall Study|Study Terminated by Sponsor|0|||
126643083|NCT02807272|455652412|FG000|Overall Study|Other|1|||
126643084|NCT02807272|455652413|FG001|Overall Study|Other|0|||
126643085|NCT02807272|455652414|FG002|Overall Study|Other|0|||
126643086|NCT02807272|455652415|FG003|Overall Study|Other|0|||
126643087|NCT02807272|455652416|FG004|Overall Study|Other|1|||
126643088|NCT01038427|455652417|FG000|Overall Study|Lost to follow up|1|||
126643089|NCT01038427|455652418|FG001|Overall Study|Lost to follow up|1|||
126643090|NCT01038427|455652419|FG002|Overall Study|Lost to follow up|0|||
126643091|NCT01038427|455652417|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
126643092|NCT01038427|455652418|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
126643093|NCT01038427|455652419|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
126643094|NCT01038427|455652417|FG000|Overall Study|Withdrew consent|0|||
126643095|NCT01038427|455652418|FG001|Overall Study|Withdrew consent|0|||
126643096|NCT01038427|455652419|FG002|Overall Study|Withdrew consent|1|||
126643097|NCT01038427|455652417|FG000|Overall Study|Adverse Event|2|||
126643098|NCT01038427|455652418|FG001|Overall Study|Adverse Event|2|||
126643099|NCT01038427|455652419|FG002|Overall Study|Adverse Event|1|||
126643100|NCT01038427|455652417|FG000|Overall Study|Enrolled in error|0|||
126643101|NCT01038427|455652418|FG001|Overall Study|Enrolled in error|1|||
126643102|NCT01038427|455652419|FG002|Overall Study|Enrolled in error|1|||
126643103|NCT01038427|455652417|FG000|Overall Study|Other|0|||
126643104|NCT01038427|455652418|FG001|Overall Study|Other|2|||
126643105|NCT01038427|455652419|FG002|Overall Study|Other|0|||
126643106|NCT01162863|455652420|FG000|Overall Study|Lack of Efficacy|1|||
126643107|NCT01162863|455652421|FG001|Overall Study|Lack of Efficacy|0|||
126643108|NCT01162863|455652422|FG002|Overall Study|Lack of Efficacy|0|||
126643109|NCT01162863|455652420|FG000|Overall Study|Adverse Event|0|||
126643110|NCT01162863|455652421|FG001|Overall Study|Adverse Event|1|||
126643111|NCT01162863|455652422|FG002|Overall Study|Adverse Event|0|||
126643112|NCT00588692|455652423|FG000|Overall Study|Withdrawal by Subject|4|||
126643113|NCT00588692|455652424|FG001|Overall Study|Withdrawal by Subject|2|||
126643114|NCT00588692|455652423|FG000|Overall Study|Hip Surgery|0|||
126643115|NCT00588692|455652424|FG001|Overall Study|Hip Surgery|1|||
126643116|NCT00588692|455652423|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
126643117|NCT00588692|455652424|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
126643118|NCT00588692|455652423|FG000|Overall Study|Cancer|1|||
126643119|NCT00588692|455652424|FG001|Overall Study|Cancer|0|||
126643120|NCT00588692|455652423|FG000|Overall Study|Death|1|||
126643121|NCT00588692|455652424|FG001|Overall Study|Death|0|||
126643122|NCT01374568|455652425|FG000|Overall Study|Lab unable to analyze BTM|0|||
126643123|NCT01374568|455652426|FG001|Overall Study|Lab unable to analyze BTM|2|||
126643124|NCT01912404|455652427|FG000|Overall Study|Due to personal reasons|1|||
126643125|NCT01912404|455652428|FG001|Overall Study|Due to personal reasons|0|||
126643126|NCT00820170|455652429|FG000|Overall Study|Adverse Event|0|||
126643127|NCT00820170|455652430|FG001|Overall Study|Adverse Event|0|||
126643128|NCT00820170|455652431|FG002|Overall Study|Adverse Event|0|||
126643129|NCT00820170|455652432|FG003|Overall Study|Adverse Event|0|||
126643130|NCT00820170|455652433|FG004|Overall Study|Adverse Event|2|||
126643131|NCT00820170|455652429|FG000|Overall Study|Progressive Disease|0|||
126643132|NCT00820170|455652430|FG001|Overall Study|Progressive Disease|0|||
126643133|NCT00820170|455652431|FG002|Overall Study|Progressive Disease|0|||
126643134|NCT00820170|455652432|FG003|Overall Study|Progressive Disease|0|||
126643135|NCT00820170|455652433|FG004|Overall Study|Progressive Disease|2|||
126643136|NCT03552523|455652434|FG000|Overall Study|Withdrawal by Subject|1|||
126643137|NCT03552523|455652435|FG001|Overall Study|Withdrawal by Subject|1|||
126643138|NCT03538938|455652436|FG000|Overall Study|Death|0|||
126643139|NCT03538938|455652437|FG001|Overall Study|Death|0|||
126643140|NCT03538938|455652438|FG002|Overall Study|Death|2|||
126643141|NCT03538938|455652439|FG003|Overall Study|Death|0|||
126643142|NCT03538938|455652440|FG004|Overall Study|Death|0|||
126643143|NCT03538938|455652441|FG005|Overall Study|Death|1|||
126643144|NCT03538938|455652442|FG006|Overall Study|Death|0|||
126643145|NCT03538938|455652443|FG007|Overall Study|Death|1|||
126643146|NCT03538938|455652444|FG008|Overall Study|Death|1|||
126643147|NCT03538938|455652445|FG009|Overall Study|Death|1|||
126643148|NCT03538938|455652446|FG010|Overall Study|Death|0|||
126643149|NCT03538938|455652447|FG011|Overall Study|Death|0|||
126643150|NCT03538938|455652448|FG012|Overall Study|Death|1|||
126643151|NCT03538938|455652449|FG013|Overall Study|Death|1|||
126643152|NCT03538938|455652450|FG014|Overall Study|Death|0|||
126643153|NCT03538938|455652451|FG015|Overall Study|Death|1|||
126643154|NCT03538938|455652436|FG000|Overall Study|Withdrawal by Subject|4|||
126643155|NCT03538938|455652437|FG001|Overall Study|Withdrawal by Subject|6|||
126643156|NCT03538938|455652438|FG002|Overall Study|Withdrawal by Subject|5|||
126643157|NCT03538938|455652439|FG003|Overall Study|Withdrawal by Subject|3|||
126643158|NCT03538938|455652440|FG004|Overall Study|Withdrawal by Subject|0|||
126643159|NCT03538938|455652441|FG005|Overall Study|Withdrawal by Subject|0|||
126643160|NCT03538938|455652442|FG006|Overall Study|Withdrawal by Subject|3|||
126643161|NCT03538938|455652443|FG007|Overall Study|Withdrawal by Subject|1|||
126643162|NCT03538938|455652444|FG008|Overall Study|Withdrawal by Subject|5|||
126643163|NCT03538938|455652445|FG009|Overall Study|Withdrawal by Subject|1|||
126643164|NCT03538938|455652446|FG010|Overall Study|Withdrawal by Subject|2|||
126643165|NCT03538938|455652447|FG011|Overall Study|Withdrawal by Subject|1|||
126643166|NCT03538938|455652448|FG012|Overall Study|Withdrawal by Subject|3|||
126643167|NCT03538938|455652449|FG013|Overall Study|Withdrawal by Subject|0|||
126643168|NCT03538938|455652450|FG014|Overall Study|Withdrawal by Subject|2|||
126643169|NCT03538938|455652451|FG015|Overall Study|Withdrawal by Subject|4|||
126643170|NCT03538938|455652436|FG000|Overall Study|Incarcerated|0|||
126643171|NCT03538938|455652437|FG001|Overall Study|Incarcerated|0|||
126643172|NCT03538938|455652438|FG002|Overall Study|Incarcerated|0|||
126643173|NCT03538938|455652439|FG003|Overall Study|Incarcerated|0|||
126643174|NCT03538938|455652440|FG004|Overall Study|Incarcerated|0|||
126643175|NCT03538938|455652441|FG005|Overall Study|Incarcerated|0|||
126643176|NCT03538938|455652442|FG006|Overall Study|Incarcerated|0|||
126643177|NCT03538938|455652443|FG007|Overall Study|Incarcerated|0|||
126643178|NCT03538938|455652444|FG008|Overall Study|Incarcerated|0|||
126643179|NCT03538938|455652445|FG009|Overall Study|Incarcerated|0|||
126643180|NCT03538938|455652446|FG010|Overall Study|Incarcerated|0|||
126643181|NCT03538938|455652447|FG011|Overall Study|Incarcerated|1|||
126643182|NCT03538938|455652448|FG012|Overall Study|Incarcerated|0|||
126643183|NCT03538938|455652449|FG013|Overall Study|Incarcerated|0|||
126643184|NCT03538938|455652450|FG014|Overall Study|Incarcerated|0|||
126643185|NCT03538938|455652451|FG015|Overall Study|Incarcerated|0|||
126643186|NCT00604708|455652452|FG000|Overall Study|Withdrawal by Subject|9|||
126643187|NCT00604708|455652453|FG001|Overall Study|Withdrawal by Subject|10|||
126643188|NCT00604708|455652452|FG000|Overall Study|Protocol Violation|2|||
126643189|NCT00604708|455652453|FG001|Overall Study|Protocol Violation|8|||
126643190|NCT00604708|455652452|FG000|Overall Study|Lost to Follow-up|5|||
126643191|NCT00604708|455652453|FG001|Overall Study|Lost to Follow-up|5|||
126643192|NCT00604708|455652452|FG000|Overall Study|administrative reasons|9|||
126643193|NCT00604708|455652453|FG001|Overall Study|administrative reasons|11|||
126643194|NCT00604708|455652452|FG000|Overall Study|Adverse Event|6|||
126643195|NCT00604708|455652453|FG001|Overall Study|Adverse Event|6|||
126643196|NCT02817906|455652459|FG000|Overall Study|Adverse Event|3|||
126643197|NCT02817906|455652460|FG001|Overall Study|Adverse Event|0|||
126643198|NCT02817906|455652459|FG000|Overall Study|Lack of Efficacy|1|||
126643199|NCT02817906|455652460|FG001|Overall Study|Lack of Efficacy|0|||
126643200|NCT02817906|455652459|FG000|Overall Study|Protocol Violation|1|||
126643201|NCT02817906|455652460|FG001|Overall Study|Protocol Violation|1|||
126643202|NCT02817906|455652459|FG000|Overall Study|Study Terminated by Sponsor|2|||
126643203|NCT02817906|455652460|FG001|Overall Study|Study Terminated by Sponsor|2|||
126643204|NCT02817906|455652459|FG000|Overall Study|Withdrawal by Subject|7|||
126643205|NCT02817906|455652460|FG001|Overall Study|Withdrawal by Subject|0|||
126643206|NCT02817906|455652459|FG000|Overall Study|Other|2|||
126643207|NCT02817906|455652460|FG001|Overall Study|Other|2|||
126643208|NCT03686423|455652461|FG000|Overall Study|Withdrawal by Subject|9|||
126643209|NCT03686423|455652461|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
126643210|NCT02833077|455652462|FG000|Overall Study|Adverse Event|1|||
126643211|NCT02833077|455652463|FG001|Overall Study|Adverse Event|2|||
126643212|NCT02833077|455652462|FG000|Overall Study|Lost to Follow-up|10|||
126643213|NCT02833077|455652463|FG001|Overall Study|Lost to Follow-up|1|||
126643214|NCT02833077|455652462|FG000|Overall Study|Personal Reasons|6|||
126643215|NCT02833077|455652463|FG001|Overall Study|Personal Reasons|4|||
126643216|NCT02833077|455652462|FG000|Overall Study|Protocol Deviation|0|||
126643217|NCT02833077|455652463|FG001|Overall Study|Protocol Deviation|1|||
126643218|NCT00972322|455652464|FG000|Overall Study|Adverse Event|2|||
126643219|NCT00972322|455652465|FG001|Overall Study|Adverse Event|1|||
126643220|NCT00972322|455652464|FG000|Overall Study|Positive drug screen|0|||
126643221|NCT00972322|455652465|FG001|Overall Study|Positive drug screen|1|||
126643222|NCT00972322|455652464|FG000|Overall Study|Lost to Follow-up|0|||
126643223|NCT00972322|455652465|FG001|Overall Study|Lost to Follow-up|1|||
126643224|NCT00972322|455652464|FG000|Overall Study|Consistently high glucose values|1|||
126643225|NCT00972322|455652465|FG001|Overall Study|Consistently high glucose values|0|||
126643226|NCT01077518|455652466|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
126643227|NCT01077518|455652467|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
126643228|NCT01077518|455652468|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
126643229|NCT01077518|455652466|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
126643230|NCT01077518|455652467|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
126643231|NCT01077518|455652468|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
126643232|NCT01077518|455652466|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
126643233|NCT01077518|455652467|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
126643234|NCT01077518|455652468|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
126643235|NCT01077518|455652466|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
126643236|NCT01077518|455652467|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
126643237|NCT01077518|455652468|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
126643238|NCT01077518|455652466|FG000|Optional Ofa Phase|Physician Decision|0|||
126643239|NCT01077518|455652467|FG001|Optional Ofa Phase|Physician Decision|0|||
126643240|NCT01077518|455652468|FG002|Optional Ofa Phase|Physician Decision|1|||
126643241|NCT01077518|455652466|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
126643242|NCT01077518|455652467|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
126643243|NCT01077518|455652468|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
126643244|NCT01077518|455652466|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
126643245|NCT01077518|455652467|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
126643246|NCT01077518|455652468|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
126643247|NCT01495598|455652469|FG000|Overall Study|Death during follow up period|2|||
126643248|NCT01495598|455652469|FG000|Overall Study|Death on study|1|||
126643249|NCT01495598|455652469|FG000|Overall Study|Lost to Follow-up|3|||
126643250|NCT01495598|455652469|FG000|Overall Study|Physician Decision|8|||
126643251|NCT05511038|455652473|FG000|Overall|Withdrawal by Subject|5|||
126643252|NCT05511038|455652474|FG001|Overall|Withdrawal by Subject|3|||
126643253|NCT05511038|455652473|FG000|Overall|Screen Failure|20|||
126643254|NCT05511038|455652474|FG001|Overall|Screen Failure|1|||
126643255|NCT05511038|455652473|FG000|Overall|Physician Decision|3|||
126643256|NCT05511038|455652474|FG001|Overall|Physician Decision|0|||
126643257|NCT05511038|455652473|FG000|Overall|Lost to Follow-up|3|||
126643258|NCT05511038|455652474|FG001|Overall|Lost to Follow-up|0|||
126643259|NCT05511038|455652473|FG000|Overall|Death|1|||
126643260|NCT05511038|455652474|FG001|Overall|Death|0|||
126643261|NCT05511038|455652473|FG000|Screening|Withdrawal by Subject|1|||
126643262|NCT05511038|455652474|FG001|Screening|Withdrawal by Subject|0|||
126643263|NCT05511038|455652473|FG000|Screening|Lost to Follow Up (1 participant)|1|||
126643264|NCT05511038|455652474|FG001|Screening|Lost to Follow Up (1 participant)|0|||
126643265|NCT05511038|455652473|FG000|Screening|Screen Failure|3|||
126643266|NCT05511038|455652474|FG001|Screening|Screen Failure|0|||
126643267|NCT05511038|455652473|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
126643268|NCT05511038|455652474|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
126643269|NCT05511038|455652473|FG000|Treatment|Withdrawal by Subject|5|||
126643270|NCT05511038|455652474|FG001|Treatment|Withdrawal by Subject|3|||
126643271|NCT05511038|455652473|FG000|Treatment|Physician Decision|4|||
126643272|NCT05511038|455652474|FG001|Treatment|Physician Decision|0|||
126643273|NCT05511038|455652473|FG000|Treatment|Lost to Follow-up|2|||
126643274|NCT05511038|455652474|FG001|Treatment|Lost to Follow-up|0|||
126643275|NCT05511038|455652473|FG000|Treatment|Death|1|||
126643276|NCT05511038|455652474|FG001|Treatment|Death|0|||
126643277|NCT05511038|455652473|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
126643278|NCT05511038|455652474|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
126643279|NCT05511038|455652473|FG000|Treatment|Refuse by subject|1|||
126643280|NCT05511038|455652474|FG001|Treatment|Refuse by subject|0|||
126643281|NCT05511038|455652473|FG000|Treatment|Subject did not go to the site for visit|1|||
126643282|NCT05511038|455652474|FG001|Treatment|Subject did not go to the site for visit|0|||
126643283|NCT05140915|455652475|FG000|Overall Study|Lost to Follow-up|2|||
126643284|NCT05140915|455652476|FG001|Overall Study|Lost to Follow-up|1|||
126643285|NCT04485611|455652477|FG000|Prehabilitation|Physician Decision|1|||
126643286|NCT04879849|455652478|FG000|Overall Study|Lost to Follow-up|0|||
126643287|NCT04879849|455652479|FG001|Overall Study|Lost to Follow-up|0|||
126643288|NCT04879849|455652480|FG002|Overall Study|Lost to Follow-up|0|||
126643289|NCT04879849|455652481|FG003|Overall Study|Lost to Follow-up|1|||
126643290|NCT04879849|455652482|FG004|Overall Study|Lost to Follow-up|0|||
126643291|NCT04879849|455652483|FG005|Overall Study|Lost to Follow-up|0|||
126643292|NCT04879849|455652484|FG006|Overall Study|Lost to Follow-up|0|||
126643293|NCT04879849|455652485|FG007|Overall Study|Lost to Follow-up|0|||
126643294|NCT04879849|455652478|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
126643295|NCT04879849|455652479|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
126643296|NCT04879849|455652480|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
126643297|NCT04879849|455652481|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
126643298|NCT04879849|455652482|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
126643299|NCT04879849|455652483|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
126643300|NCT04879849|455652484|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
126643301|NCT04879849|455652485|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
126643302|NCT04879849|455652478|FG000|Overall Study|Withdrawal by Subject|0|||
126643303|NCT04879849|455652479|FG001|Overall Study|Withdrawal by Subject|0|||
126643304|NCT04879849|455652480|FG002|Overall Study|Withdrawal by Subject|0|||
126643305|NCT04879849|455652481|FG003|Overall Study|Withdrawal by Subject|0|||
126643306|NCT04879849|455652482|FG004|Overall Study|Withdrawal by Subject|2|||
126643307|NCT04879849|455652483|FG005|Overall Study|Withdrawal by Subject|0|||
126643308|NCT04879849|455652484|FG006|Overall Study|Withdrawal by Subject|1|||
126643309|NCT04879849|455652485|FG007|Overall Study|Withdrawal by Subject|0|||
126643310|NCT04879849|455652478|FG000|Overall Study|Progressive Disease|0|||
126643311|NCT04879849|455652479|FG001|Overall Study|Progressive Disease|0|||
126643312|NCT04879849|455652480|FG002|Overall Study|Progressive Disease|1|||
126643313|NCT04879849|455652481|FG003|Overall Study|Progressive Disease|0|||
126643314|NCT04879849|455652482|FG004|Overall Study|Progressive Disease|0|||
126643315|NCT04879849|455652483|FG005|Overall Study|Progressive Disease|0|||
126643316|NCT04879849|455652484|FG006|Overall Study|Progressive Disease|0|||
126643317|NCT04879849|455652485|FG007|Overall Study|Progressive Disease|0|||
126643318|NCT04879849|455652478|FG000|Overall Study|Death|0|||
126643319|NCT04879849|455652479|FG001|Overall Study|Death|0|||
126643320|NCT04879849|455652480|FG002|Overall Study|Death|1|||
126643321|NCT04879849|455652481|FG003|Overall Study|Death|1|||
126643322|NCT04879849|455652482|FG004|Overall Study|Death|1|||
126643323|NCT04879849|455652483|FG005|Overall Study|Death|2|||
126643324|NCT04879849|455652484|FG006|Overall Study|Death|1|||
126643325|NCT04879849|455652485|FG007|Overall Study|Death|2|||
126643326|NCT04879849|455652478|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
126643327|NCT04879849|455652479|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
126643328|NCT04879849|455652480|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
126643329|NCT04879849|455652481|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
126643330|NCT04879849|455652482|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
126643331|NCT04879849|455652483|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
126643332|NCT04879849|455652484|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
126643333|NCT04879849|455652485|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
126643334|NCT04879849|455652478|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126643335|NCT04879849|455652479|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126643336|NCT04879849|455652480|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126643337|NCT04879849|455652481|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126643338|NCT04879849|455652482|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126643339|NCT04879849|455652483|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126643340|NCT04879849|455652484|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
126643341|NCT04879849|455652485|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
126643342|NCT04879849|455652478|FG000|Overall Study|Reason Not Specified|1|||
126643343|NCT04879849|455652479|FG001|Overall Study|Reason Not Specified|0|||
126643344|NCT04879849|455652480|FG002|Overall Study|Reason Not Specified|0|||
126643345|NCT04879849|455652481|FG003|Overall Study|Reason Not Specified|0|||
126643346|NCT04879849|455652482|FG004|Overall Study|Reason Not Specified|0|||
126643347|NCT04879849|455652483|FG005|Overall Study|Reason Not Specified|0|||
126643348|NCT04879849|455652484|FG006|Overall Study|Reason Not Specified|0|||
126643349|NCT04879849|455652485|FG007|Overall Study|Reason Not Specified|0|||
126643350|NCT03810235|455652488|FG000|Overall Study|Withdrawal by Subject|2|||
126643351|NCT03810235|455652489|FG001|Overall Study|Withdrawal by Subject|0|||
126643352|NCT04777864|455652490|FG000|Overall Study|Lost to Follow-up|8|||
126643353|NCT04777864|455652491|FG001|Overall Study|Lost to Follow-up|19|||
126643354|NCT01647542|455652492|FG000|Overall Study|Major Protocol Deviation|1|||
126643355|NCT01647542|455652493|FG001|Overall Study|Major Protocol Deviation|0|||
126643356|NCT01647542|455652494|FG002|Overall Study|Major Protocol Deviation|0|||
126643357|NCT01647542|455652492|FG000|Overall Study|Adverse Event|4|||
126643358|NCT01647542|455652493|FG001|Overall Study|Adverse Event|5|||
126643359|NCT01647542|455652494|FG002|Overall Study|Adverse Event|4|||
126643360|NCT01647542|455652492|FG000|Overall Study|Lost to Follow-up|0|||
126643361|NCT01647542|455652493|FG001|Overall Study|Lost to Follow-up|2|||
126643362|NCT01647542|455652494|FG002|Overall Study|Lost to Follow-up|2|||
126643363|NCT01647542|455652492|FG000|Overall Study|Withdrawal by Subject|6|||
126643364|NCT01647542|455652493|FG001|Overall Study|Withdrawal by Subject|4|||
126643365|NCT01647542|455652494|FG002|Overall Study|Withdrawal by Subject|0|||
126643366|NCT01647542|455652492|FG000|Overall Study|Study Termination|64|||
126643367|NCT01647542|455652493|FG001|Overall Study|Study Termination|61|||
126643368|NCT01647542|455652494|FG002|Overall Study|Study Termination|65|||
126643369|NCT01647542|455652492|FG000|Overall Study|Lack of Efficacy|1|||
126643370|NCT01647542|455652493|FG001|Overall Study|Lack of Efficacy|1|||
126643371|NCT01647542|455652494|FG002|Overall Study|Lack of Efficacy|0|||
126643372|NCT01647542|455652492|FG000|Overall Study|Death|0|||
126643373|NCT01647542|455652493|FG001|Overall Study|Death|0|||
126643374|NCT01647542|455652494|FG002|Overall Study|Death|1|||
126643375|NCT03086655|455652495|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
126643376|NCT03086655|455652496|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
126643377|NCT03086655|455652495|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
126643378|NCT03086655|455652496|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
126643379|NCT03086655|455652495|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
126643380|NCT03086655|455652496|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
126643381|NCT03086655|455652495|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
126643382|NCT03086655|455652496|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
126643383|NCT03086655|455652495|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
126643384|NCT03086655|455652496|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
126643385|NCT03086655|455652495|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
126643386|NCT03086655|455652496|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
126643387|NCT03086655|455652495|FG000|12 Month Follow-up = Final Assessment|Death|0|||
126643388|NCT03086655|455652496|FG001|12 Month Follow-up = Final Assessment|Death|1|||
126643389|NCT05576662|455652497|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
126643390|NCT05576662|455652498|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
126643391|NCT05576662|455652497|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
126643392|NCT05576662|455652498|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
126643393|NCT05576662|455652497|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
126643394|NCT05576662|455652498|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
126643395|NCT05576662|455652497|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
126643396|NCT05576662|455652498|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
126643397|NCT03008005|455652499|FG000|Overall Study|Physician Decision|1|||
126643398|NCT03008005|455652500|FG001|Overall Study|Physician Decision|0|||
126643399|NCT03008005|455652501|FG002|Overall Study|Physician Decision|0|||
126643400|NCT03008005|455652499|FG000|Overall Study|Withdrawal by Subject|1|||
126643401|NCT03008005|455652500|FG001|Overall Study|Withdrawal by Subject|0|||
126643402|NCT03008005|455652501|FG002|Overall Study|Withdrawal by Subject|0|||
126643403|NCT03008005|455652499|FG000|Overall Study|Ineligible|0|||
126643404|NCT03008005|455652500|FG001|Overall Study|Ineligible|1|||
126643405|NCT03008005|455652501|FG002|Overall Study|Ineligible|0|||
126643406|NCT01040169|455652517|FG000|Overall Study|Lost to Follow-up|3|||
126643407|NCT01040169|455652518|FG001|Overall Study|Lost to Follow-up|8|||
126643408|NCT00350727|455652519|FG000|Phase I: Dose Escalation|Adverse Event|4|||
126643409|NCT00350727|455652520|FG001|Phase I: Dose Escalation|Adverse Event|0|||
126643410|NCT00350727|455652521|FG002|Phase I: Dose Escalation|Adverse Event|0|||
126643411|NCT00350727|455652519|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
126643412|NCT00350727|455652520|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
126643413|NCT00350727|455652521|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
126643414|NCT00350727|455652519|FG000|Phase I: Dose Escalation|Death|1|||
126643415|NCT00350727|455652520|FG001|Phase I: Dose Escalation|Death|0|||
126643416|NCT00350727|455652521|FG002|Phase I: Dose Escalation|Death|0|||
126643417|NCT00350727|455652519|FG000|Phase I: Dose Escalation|Physician Decision|1|||
126643418|NCT00350727|455652520|FG001|Phase I: Dose Escalation|Physician Decision|0|||
126643419|NCT00350727|455652521|FG002|Phase I: Dose Escalation|Physician Decision|0|||
126643420|NCT00350727|455652519|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
126643421|NCT00350727|455652520|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
126643422|NCT00350727|455652521|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
126643423|NCT00350727|455652519|FG000|Phase II|Disease Progression|0|||
126643424|NCT00350727|455652520|FG001|Phase II|Disease Progression|15|||
126643425|NCT00350727|455652521|FG002|Phase II|Disease Progression|16|||
126643426|NCT00350727|455652519|FG000|Phase II|Clinical Deterioration|0|||
126643427|NCT00350727|455652520|FG001|Phase II|Clinical Deterioration|1|||
126643428|NCT00350727|455652521|FG002|Phase II|Clinical Deterioration|0|||
126643429|NCT00350727|455652519|FG000|Phase II|Withdrawal by Subject|0|||
126643430|NCT00350727|455652520|FG001|Phase II|Withdrawal by Subject|2|||
126643431|NCT00350727|455652521|FG002|Phase II|Withdrawal by Subject|1|||
126643432|NCT00350727|455652519|FG000|Phase II|Adverse Event|0|||
126643433|NCT00350727|455652520|FG001|Phase II|Adverse Event|1|||
126643434|NCT00350727|455652521|FG002|Phase II|Adverse Event|1|||
126643435|NCT00350727|455652519|FG000|Phase II|Death|0|||
126643436|NCT00350727|455652520|FG001|Phase II|Death|0|||
126643437|NCT00350727|455652521|FG002|Phase II|Death|2|||
126643438|NCT00350727|455652519|FG000|Phase II|Sponsor Terminated Study|0|||
126643439|NCT00350727|455652520|FG001|Phase II|Sponsor Terminated Study|0|||
126643440|NCT00350727|455652521|FG002|Phase II|Sponsor Terminated Study|1|||
126643441|NCT00350727|455652519|FG000|Phase II|Enrolled in Rollover Study|0|||
126643442|NCT00350727|455652520|FG001|Phase II|Enrolled in Rollover Study|0|||
126643443|NCT00350727|455652521|FG002|Phase II|Enrolled in Rollover Study|1|||
126643444|NCT03633799|455652526|FG000|Overall Study|Adverse Event|349|||
126643445|NCT03633799|455652526|FG000|Overall Study|Withdrawal by Subject|288|||
126643446|NCT03633799|455652526|FG000|Overall Study|Lost to Follow-up|97|||
126643447|NCT03633799|455652526|FG000|Overall Study|Physician Decision|9|||
126643448|NCT03633799|455652526|FG000|Overall Study|Protocol Violation|4|||
126643449|NCT03633799|455652526|FG000|Overall Study|Pregnancy|20|||
126643450|NCT03633799|455652526|FG000|Overall Study|other|39|||
126643451|NCT03633799|455652526|FG000|Overall Study|ongoing within third year of study|106|||
126643452|NCT03633799|455652526|FG000|Overall Study|unsuccessful study drug placement|19|||
126643453|NCT03551691|455652527|FG000|Overall Study|Withdrawal by Subject|3|||
126643454|NCT03551691|455652528|FG001|Overall Study|Withdrawal by Subject|3|||
126643455|NCT03520712|455652529|FG000|Overall Study|Early termination of the study by Sponsor|2|||
126643456|NCT05855967|455652530|FG000|Overall Study|Withdrawal by Subject|7|||
126643457|NCT05855967|455652531|FG001|Overall Study|Withdrawal by Subject|5|||
126643458|NCT05855967|455652530|FG000|Overall Study|Lost to Follow-up|2|||
126643459|NCT05855967|455652531|FG001|Overall Study|Lost to Follow-up|1|||
126643460|NCT02446821|455652532|FG000|Overall Study|Adverse Event|28|||
126643461|NCT02446821|455652532|FG000|Overall Study|Withdrawal by Subject|6|||
126643462|NCT02446821|455652532|FG000|Overall Study|Lost to Follow-up|22|||
126643463|NCT02446821|455652532|FG000|Overall Study|other|9|||
126643464|NCT02446821|455652532|FG000|Overall Study|insertion failure|3|||
126643465|NCT02284009|455652534|FG000|Overall Study|Adverse Event|3|||
126643466|NCT02284009|455652535|FG001|Overall Study|Adverse Event|0|||
126643467|NCT02284009|455652534|FG000|Overall Study|Lost to Follow-up|1|||
126643468|NCT02284009|455652535|FG001|Overall Study|Lost to Follow-up|3|||
126643469|NCT02284009|455652534|FG000|Overall Study|Physician Decision|0|||
126643470|NCT02284009|455652535|FG001|Overall Study|Physician Decision|2|||
126643471|NCT02284009|455652534|FG000|Overall Study|Withdrawal by Subject|2|||
126643472|NCT02284009|455652535|FG001|Overall Study|Withdrawal by Subject|5|||
126643473|NCT04942366|455653738|FG000|Overall Study|Withdrawal by Subject|5|||
126643474|NCT04942366|455653739|FG001|Overall Study|Withdrawal by Subject|5|||
126643475|NCT01736189|455653740|FG000|Overall Study|Violation of registration criteria|41|||
126643476|NCT01736189|455653740|FG000|Overall Study|Protocol Violation|4|||
126643477|NCT01736189|455653740|FG000|Overall Study|Criteria and protocol violations|1|||
126643478|NCT03301155|455653741|FG000|Overall Study|Сompliance with exclusion criteria|8|||
126643479|NCT03301155|455653742|FG001|Overall Study|Сompliance with exclusion criteria|7|||
126643480|NCT00384189|455653744|FG000|Overall Study|Reason Not Specified|50|||
126643481|NCT00384189|455653745|FG001|Overall Study|Reason Not Specified|57|||
126643482|NCT00384189|455653746|FG002|Overall Study|Reason Not Specified|58|||
126643483|NCT00384189|455653747|FG003|Overall Study|Reason Not Specified|40|||
126643484|NCT00608868|455653748|FG000|Overall Study|Withdrawal by Subject|7|||
126643485|NCT00608868|455653748|FG000|Overall Study|Protocol Violation|3|||
126643486|NCT00608868|455653748|FG000|Overall Study|Lost to Follow-up|2|||
126643487|NCT00608868|455653748|FG000|Overall Study|Adverse Event|1|||
126643488|NCT00608868|455653748|FG000|Overall Study|Physician Decision|2|||
126643489|NCT00335140|455653751|FG000|Overall Study|Ineligible|1|||
126643490|NCT04546425|455653752|FG000|Overall Study|Protocol Violation|1|||
126643491|NCT04546425|455653753|FG001|Overall Study|Protocol Violation|1|||
126643492|NCT04546425|455653754|FG002|Overall Study|Protocol Violation|0|||
126643493|NCT04546425|455653755|FG003|Overall Study|Protocol Violation|0|||
126643494|NCT04546425|455653752|FG000|Overall Study|Adverse Event|3|||
126643495|NCT04546425|455653753|FG001|Overall Study|Adverse Event|0|||
126643496|NCT04546425|455653754|FG002|Overall Study|Adverse Event|0|||
126643497|NCT04546425|455653755|FG003|Overall Study|Adverse Event|0|||
126643498|NCT04546425|455653752|FG000|Overall Study|Lost to Follow-up|5|||
126643499|NCT04546425|455653753|FG001|Overall Study|Lost to Follow-up|4|||
126643500|NCT04546425|455653754|FG002|Overall Study|Lost to Follow-up|0|||
126643501|NCT04546425|455653755|FG003|Overall Study|Lost to Follow-up|0|||
126643502|NCT04546425|455653752|FG000|Overall Study|No Longer met eligibility criteria|3|||
126643503|NCT04546425|455653753|FG001|Overall Study|No Longer met eligibility criteria|3|||
126643504|NCT04546425|455653754|FG002|Overall Study|No Longer met eligibility criteria|1|||
126643505|NCT04546425|455653755|FG003|Overall Study|No Longer met eligibility criteria|1|||
126643506|NCT04546425|455653752|FG000|Overall Study|Withdrawal by parent/guardian|6|||
126643507|NCT04546425|455653753|FG001|Overall Study|Withdrawal by parent/guardian|5|||
126643508|NCT04546425|455653754|FG002|Overall Study|Withdrawal by parent/guardian|1|||
126643509|NCT04546425|455653755|FG003|Overall Study|Withdrawal by parent/guardian|1|||
126643510|NCT02979249|455653758|FG000|Overall Study|Lost to Follow-up|2|||
126643511|NCT02979249|455653758|FG000|Overall Study|Withdrawal by Subject|4|||
126643512|NCT01125046|455653759|FG000|First 6 Months of Treatment|Death|1|||
126643513|NCT01125046|455653759|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
126643514|NCT01125046|455653759|FG000|First 6 Months of Treatment|Non-compliance|1|||
126643515|NCT01125046|455653759|FG000|First 6 Months of Treatment|Surgery|1|||
126643516|NCT01125046|455653759|FG000|First 6 Months of Treatment|Progressive Disease|7|||
126643517|NCT01125046|455653759|FG000|First 6 Months of Treatment|Adverse Event|2|||
126643518|NCT01125046|455653759|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
126643519|NCT01125046|455653759|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
126643520|NCT01125046|455653759|FG000|Follow-up/Data Cut Off Point|Death|29|||
126643521|NCT01125046|455653759|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
126643522|NCT01685229|455653761|FG000|Overall Study|Subjects missing Study Exit form|3|||
126643523|NCT01685229|455653762|FG001|Overall Study|Subjects missing Study Exit form|1|||
126643524|NCT01685229|455653761|FG000|Overall Study|Lost to Follow-up|16|||
126643525|NCT01685229|455653762|FG001|Overall Study|Lost to Follow-up|10|||
126643526|NCT01685229|455653761|FG000|Overall Study|Withdrawal by Subject|6|||
126643527|NCT01685229|455653762|FG001|Overall Study|Withdrawal by Subject|5|||
126643528|NCT01685229|455653761|FG000|Overall Study|Death|1|||
126643529|NCT01685229|455653762|FG001|Overall Study|Death|0|||
126643530|NCT03868787|455653763|FG000|Overall Study|Withdrawal by Subject|2|||
126643531|NCT03868787|455653764|FG001|Overall Study|Withdrawal by Subject|1|||
126643532|NCT01399697|455653777|FG000|Overall Study|Adverse Event|13|||
126643533|NCT01399697|455653778|FG001|Overall Study|Adverse Event|3|||
126643534|NCT01399697|455653779|FG002|Overall Study|Adverse Event|1|||
126643535|NCT01399697|455653777|FG000|Overall Study|Lost to Follow-up|2|||
126643536|NCT01399697|455653778|FG001|Overall Study|Lost to Follow-up|0|||
126643537|NCT01399697|455653779|FG002|Overall Study|Lost to Follow-up|0|||
126643538|NCT01399697|455653777|FG000|Overall Study|Withdrawal by Subject|8|||
126643539|NCT01399697|455653778|FG001|Overall Study|Withdrawal by Subject|0|||
126643540|NCT01399697|455653779|FG002|Overall Study|Withdrawal by Subject|0|||
126643541|NCT01399697|455653777|FG000|Overall Study|Investigator Decisión|1|||
126643542|NCT01399697|455653778|FG001|Overall Study|Investigator Decisión|0|||
126643543|NCT01399697|455653779|FG002|Overall Study|Investigator Decisión|2|||
126643544|NCT01399697|455653777|FG000|Overall Study|Lack of Efficacy|9|||
126643545|NCT01399697|455653778|FG001|Overall Study|Lack of Efficacy|0|||
126643546|NCT01399697|455653779|FG002|Overall Study|Lack of Efficacy|1|||
126643547|NCT01399697|455653777|FG000|Overall Study|Protocol Violation|2|||
126643548|NCT01399697|455653778|FG001|Overall Study|Protocol Violation|0|||
126643549|NCT01399697|455653779|FG002|Overall Study|Protocol Violation|0|||
126643550|NCT01399697|455653777|FG000|Overall Study|Non-Compliant|1|||
126643551|NCT01399697|455653778|FG001|Overall Study|Non-Compliant|0|||
126643552|NCT01399697|455653779|FG002|Overall Study|Non-Compliant|0|||
126643553|NCT01399697|455653777|FG000|Overall Study|Inclusion Error|2|||
126643554|NCT01399697|455653778|FG001|Overall Study|Inclusion Error|0|||
126643555|NCT01399697|455653779|FG002|Overall Study|Inclusion Error|0|||
126643556|NCT01399697|455653777|FG000|Overall Study|Positive result for hepatitis B|1|||
126643557|NCT01399697|455653778|FG001|Overall Study|Positive result for hepatitis B|0|||
126643558|NCT01399697|455653779|FG002|Overall Study|Positive result for hepatitis B|0|||
126643559|NCT01399697|455653777|FG000|Overall Study|Clinical RA remission|1|||
126643560|NCT01399697|455653778|FG001|Overall Study|Clinical RA remission|0|||
126643561|NCT01399697|455653779|FG002|Overall Study|Clinical RA remission|0|||
126643562|NCT01399697|455653777|FG000|Overall Study|Sponsor Decision|1|||
126643563|NCT01399697|455653778|FG001|Overall Study|Sponsor Decision|0|||
126643564|NCT01399697|455653779|FG002|Overall Study|Sponsor Decision|0|||
126643565|NCT04313608|455653780|FG000|Overall Study|Death|12|||
126643566|NCT04313608|455653781|FG001|Overall Study|Death|3|||
126643567|NCT03019640|455653783|FG000|Overall Study|Screen Failures|4|||
126643568|NCT03019640|455653783|FG000|Overall Study|Adverse Event|3|||
126643569|NCT03019640|455653783|FG000|Overall Study|Participant Relapsed|1|||
126643570|NCT01327846|455653786|FG000|Core Phase|Subject decision (vital status: missing)|1|||
126643571|NCT01327846|455653787|FG001|Core Phase|Subject decision (vital status: missing)|2|||
126643572|NCT01327846|455653788|FG002|Core Phase|Subject decision (vital status: missing)|2|||
126643573|NCT01327846|455653789|FG003|Core Phase|Subject decision (vital status: missing)|1|||
126643574|NCT01327846|455653786|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
126643575|NCT01327846|455653787|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
126643576|NCT01327846|455653788|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
126643577|NCT01327846|455653789|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
126643578|NCT01327846|455653786|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
126643579|NCT01327846|455653787|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
126643580|NCT01327846|455653788|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
126643581|NCT01327846|455653789|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
126643582|NCT01327846|455653786|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
126643583|NCT01327846|455653787|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
126643584|NCT01327846|455653788|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
126643585|NCT01327846|455653789|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
126643586|NCT01327846|455653786|FG000|Core Phase|Lost to Follow-up|3|||
126643587|NCT01327846|455653787|FG001|Core Phase|Lost to Follow-up|3|||
126643588|NCT01327846|455653788|FG002|Core Phase|Lost to Follow-up|4|||
126643589|NCT01327846|455653789|FG003|Core Phase|Lost to Follow-up|5|||
126643590|NCT01327846|455653786|FG000|Extension Phase|Study terminated by sponsor|1073|||
126643591|NCT01327846|455653787|FG001|Extension Phase|Study terminated by sponsor|1124|||
126643592|NCT01327846|455653788|FG002|Extension Phase|Study terminated by sponsor|1067|||
126643593|NCT01327846|455653789|FG003|Extension Phase|Study terminated by sponsor|1660|||
126643594|NCT01327846|455653786|FG000|Extension Phase|Withdrawal by Subject|20|||
126643595|NCT01327846|455653787|FG001|Extension Phase|Withdrawal by Subject|13|||
126643596|NCT01327846|455653788|FG002|Extension Phase|Withdrawal by Subject|19|||
126643597|NCT01327846|455653789|FG003|Extension Phase|Withdrawal by Subject|37|||
126643598|NCT01327846|455653786|FG000|Extension Phase|Lost to Follow-up|4|||
126643599|NCT01327846|455653787|FG001|Extension Phase|Lost to Follow-up|3|||
126643600|NCT01327846|455653788|FG002|Extension Phase|Lost to Follow-up|4|||
126643601|NCT01327846|455653789|FG003|Extension Phase|Lost to Follow-up|7|||
126643602|NCT01327846|455653786|FG000|Extension Phase|Technical Problems|2|||
126643603|NCT01327846|455653787|FG001|Extension Phase|Technical Problems|4|||
126643604|NCT01327846|455653788|FG002|Extension Phase|Technical Problems|2|||
126643605|NCT01327846|455653789|FG003|Extension Phase|Technical Problems|2|||
126643606|NCT04343976|455653790|FG000|Overall Study|Withdrawal by Subject|0|||
126643607|NCT04343976|455653791|FG001|Overall Study|Withdrawal by Subject|1|||
126643608|NCT00594880|455653792|FG000|Overall Study|Withdrawal by Subject|1|||
126643609|NCT00594880|455653793|FG001|Overall Study|Withdrawal by Subject|1|||
126643610|NCT00594880|455653792|FG000|Overall Study|Lost to Follow-up|1|||
126643611|NCT00594880|455653793|FG001|Overall Study|Lost to Follow-up|0|||
126643612|NCT01371708|455653794|FG000|Overall Study|Insufficient clinical response|3|||
126643613|NCT01371708|455653795|FG001|Overall Study|Insufficient clinical response|2|||
126643614|NCT01371708|455653796|FG002|Overall Study|Insufficient clinical response|0|||
126643615|NCT01371708|455653794|FG000|Overall Study|Lost to Follow-up|5|||
126643616|NCT01371708|455653795|FG001|Overall Study|Lost to Follow-up|9|||
126643617|NCT01371708|455653796|FG002|Overall Study|Lost to Follow-up|7|||
126643618|NCT01371708|455653794|FG000|Overall Study|Protocol Violation|2|||
126643619|NCT01371708|455653795|FG001|Overall Study|Protocol Violation|1|||
126643620|NCT01371708|455653796|FG002|Overall Study|Protocol Violation|2|||
126643621|NCT01371708|455653794|FG000|Overall Study|No longer willing to participate|7|||
126643622|NCT01371708|455653795|FG001|Overall Study|No longer willing to participate|7|||
126643623|NCT01371708|455653796|FG002|Overall Study|No longer willing to participate|13|||
126643624|NCT01371708|455653794|FG000|Overall Study|Medication error/not related to AE|0|||
126643625|NCT01371708|455653795|FG001|Overall Study|Medication error/not related to AE|1|||
126643626|NCT01371708|455653796|FG002|Overall Study|Medication error/not related to AE|0|||
126643627|NCT01371708|455653794|FG000|Overall Study|Other|3|||
126643628|NCT01371708|455653795|FG001|Overall Study|Other|2|||
126643629|NCT01371708|455653796|FG002|Overall Study|Other|4|||
126643630|NCT01371708|455653794|FG000|Overall Study|Adverse Event|5|||
126643631|NCT01371708|455653795|FG001|Overall Study|Adverse Event|8|||
126643632|NCT01371708|455653796|FG002|Overall Study|Adverse Event|12|||
126643633|NCT01371708|455653794|FG000|Overall Study|Started but did not receive treatment|1|||
126643634|NCT01371708|455653795|FG001|Overall Study|Started but did not receive treatment|0|||
126643635|NCT01371708|455653796|FG002|Overall Study|Started but did not receive treatment|1|||
126643636|NCT00694109|455653797|FG000|Overall Study|Physician Decision|3|||
126643637|NCT00694109|455653797|FG000|Overall Study|Adverse Event|74|||
126643638|NCT00694109|455653797|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
126643639|NCT00694109|455653797|FG000|Overall Study|Lack of Efficacy|2|||
126643640|NCT00694109|455653797|FG000|Overall Study|Withdrawal by Subject|13|||
126643641|NCT00694109|455653797|FG000|Overall Study|Pregnancy|1|||
126643642|NCT00694109|455653797|FG000|Overall Study|Enrolled but not treated|1|||
126643643|NCT00694109|455653797|FG000|Overall Study|Other|2|||
126643644|NCT00694109|455653797|FG000|Overall Study|Consented but no additional treatment|3|||
126643645|NCT00846807|455653798|FG000|Overall Study|Adverse Event|270|||
126643646|NCT00846807|455653798|FG000|Overall Study|Lost to Follow-up|94|||
126643647|NCT00846807|455653798|FG000|Overall Study|Withdrawal by Subject|56|||
126643648|NCT00846807|455653798|FG000|Overall Study|Non compliant with European label|7|||
126643649|NCT00846807|455653798|FG000|Overall Study|Switch to other anticoagulants|89|||
126643650|NCT00846807|455653798|FG000|Overall Study|No prescription after hospital discharge|56|||
126643651|NCT00846807|455653798|FG000|Overall Study|Other|60|||
126643652|NCT00737698|455653799|FG000|Overall Study|Withdrawal by Subject|6|||
126643653|NCT00737698|455653800|FG001|Overall Study|Withdrawal by Subject|5|||
126643654|NCT00737698|455653801|FG002|Overall Study|Withdrawal by Subject|3|||
126643655|NCT00737698|455653799|FG000|Overall Study|Death|0|||
126643656|NCT00737698|455653800|FG001|Overall Study|Death|0|||
126643657|NCT00737698|455653801|FG002|Overall Study|Death|1|||
126643658|NCT01067846|455653806|FG000|Overall Study|Lost to Follow-up|17|||
126643659|NCT01067846|455653807|FG001|Overall Study|Lost to Follow-up|19|||
126643660|NCT01067846|455653806|FG000|Overall Study|Withdrawal by Subject|1|||
126643661|NCT01067846|455653807|FG001|Overall Study|Withdrawal by Subject|0|||
126643662|NCT01067846|455653806|FG000|Overall Study|participation in other tx study|1|||
126643663|NCT01067846|455653807|FG001|Overall Study|participation in other tx study|0|||
126643664|NCT04608773|455653808|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
126643665|NCT04608773|455653809|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
126643666|NCT04608773|455653808|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
126643667|NCT04608773|455653809|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
126643668|NCT04608773|455653808|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
126643669|NCT04608773|455653809|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
126643670|NCT04608773|455653808|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
126643671|NCT04608773|455653809|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
126643672|NCT04608773|455653808|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
126643673|NCT04608773|455653809|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
126643674|NCT02387970|455653810|FG000|Overall Study|Did not complete 1-year follow up|1|||
126643675|NCT02387970|455653811|FG001|Overall Study|Did not complete 1-year follow up|2|||
126643676|NCT01436253|455653816|FG000|Overall Study|Lost to Follow-up|182|||
126643677|NCT01436253|455653816|FG000|Overall Study|Not meeting all eligibility criteria|117|||
126643678|NCT01217437|455653817|FG000|Overall Study|Adverse Event|0|||
126643679|NCT01217437|455653818|FG001|Overall Study|Adverse Event|8|||
126643680|NCT01217437|455653817|FG000|Overall Study|Death|5|||
126643681|NCT01217437|455653818|FG001|Overall Study|Death|0|||
126643682|NCT01217437|455653817|FG000|Overall Study|Lack of Efficacy|29|||
126643683|NCT01217437|455653818|FG001|Overall Study|Lack of Efficacy|25|||
126643684|NCT01217437|455653817|FG000|Overall Study|Physician Decision|8|||
126643685|NCT01217437|455653818|FG001|Overall Study|Physician Decision|5|||
126643686|NCT01217437|455653817|FG000|Overall Study|Withdrawal by Subject|0|||
126643687|NCT01217437|455653818|FG001|Overall Study|Withdrawal by Subject|2|||
126643688|NCT01217437|455653817|FG000|Overall Study|Ineligible|1|||
126643689|NCT01217437|455653818|FG001|Overall Study|Ineligible|1|||
126643690|NCT03682185|455653821|FG000|Overall Study|Lost to Follow-up|4|||
126643691|NCT03682185|455653822|FG001|Overall Study|Lost to Follow-up|7|||
126643692|NCT03682185|455653823|FG002|Overall Study|Lost to Follow-up|4|||
126643693|NCT03682185|455653824|FG003|Overall Study|Lost to Follow-up|7|||
126643694|NCT03682185|455653825|FG004|Overall Study|Lost to Follow-up|1|||
126643695|NCT03682185|455653821|FG000|Overall Study|Withdrawal by Subject|7|||
126643696|NCT03682185|455653822|FG001|Overall Study|Withdrawal by Subject|3|||
126643697|NCT03682185|455653823|FG002|Overall Study|Withdrawal by Subject|7|||
126643698|NCT03682185|455653824|FG003|Overall Study|Withdrawal by Subject|3|||
126643699|NCT03682185|455653825|FG004|Overall Study|Withdrawal by Subject|0|||
126643700|NCT04908631|455653826|FG000|Overall Study|Lost to Follow-up|1|||
126643701|NCT04908631|455653826|FG000|Overall Study|Physician Decision|1|||
126643702|NCT04908631|455653826|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
126643703|NCT04531982|455653827|FG000|Overall Study|Withdrawal by Subject|10|||
126643704|NCT04531982|455653828|FG001|Overall Study|Withdrawal by Subject|11|||
126643705|NCT04531982|455653827|FG000|Overall Study|Adverse Event|6|||
126643706|NCT04531982|455653828|FG001|Overall Study|Adverse Event|14|||
126643707|NCT04531982|455653827|FG000|Overall Study|Protocol Violation|6|||
126643708|NCT04531982|455653828|FG001|Overall Study|Protocol Violation|9|||
126643709|NCT04531982|455653827|FG000|Overall Study|Non-compliance with study drug|3|||
126643710|NCT04531982|455653828|FG001|Overall Study|Non-compliance with study drug|2|||
126643711|NCT04531982|455653827|FG000|Overall Study|Use of prohibited medication|2|||
126643712|NCT04531982|455653828|FG001|Overall Study|Use of prohibited medication|0|||
126643713|NCT04531982|455653827|FG000|Overall Study|Lost to Follow-up|0|||
126643714|NCT04531982|455653828|FG001|Overall Study|Lost to Follow-up|1|||
126643715|NCT04531982|455653827|FG000|Overall Study|Geopolitical conflict|2|||
126643716|NCT04531982|455653828|FG001|Overall Study|Geopolitical conflict|0|||
126643717|NCT04531982|455653827|FG000|Overall Study|Lack of Efficacy|3|||
126643718|NCT04531982|455653828|FG001|Overall Study|Lack of Efficacy|1|||
126643719|NCT03841526|455653832|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
126643720|NCT03841526|455653833|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
126643721|NCT03841526|455653834|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
126643722|NCT03841526|455653835|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
126643723|NCT03841526|455653836|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
126643724|NCT03841526|455653837|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
126643725|NCT03841526|455653832|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
126643726|NCT03841526|455653833|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
126643727|NCT03841526|455653834|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
126643728|NCT03841526|455653835|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
126643729|NCT03841526|455653836|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
126643730|NCT03841526|455653837|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
126643731|NCT03841526|455653832|FG000|Outpatient Phase Treatment|Physician Decision|0|||
126643732|NCT03841526|455653833|FG001|Outpatient Phase Treatment|Physician Decision|1|||
126643733|NCT03841526|455653834|FG002|Outpatient Phase Treatment|Physician Decision|0|||
126643734|NCT03841526|455653835|FG003|Outpatient Phase Treatment|Physician Decision|0|||
126643735|NCT03841526|455653836|FG004|Outpatient Phase Treatment|Physician Decision|0|||
126643736|NCT03841526|455653837|FG005|Outpatient Phase Treatment|Physician Decision|0|||
126643737|NCT03841526|455653832|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
126643738|NCT03841526|455653833|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
126643739|NCT03841526|455653834|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
126643740|NCT03841526|455653835|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
126643741|NCT03841526|455653836|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
126643742|NCT03841526|455653837|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
126643743|NCT04266795|455653838|FG000|Overall Study|Adverse Event|10|||
126643744|NCT04266795|455653839|FG001|Overall Study|Adverse Event|19|||
126643745|NCT04266795|455653838|FG000|Overall Study|Death|7|||
126643746|NCT04266795|455653839|FG001|Overall Study|Death|8|||
126643747|NCT04266795|455653838|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
126643748|NCT04266795|455653839|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
126643749|NCT04266795|455653838|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
126643750|NCT04266795|455653839|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
126643751|NCT04266795|455653838|FG000|Overall Study|Progressive Disease|12|||
126643752|NCT04266795|455653839|FG001|Overall Study|Progressive Disease|9|||
126643753|NCT04266795|455653838|FG000|Overall Study|Withdrawal by Patient|5|||
126643754|NCT04266795|455653839|FG001|Overall Study|Withdrawal by Patient|6|||
126643755|NCT04266795|455653838|FG000|Overall Study|Disease Relapse|3|||
126643756|NCT04266795|455653839|FG001|Overall Study|Disease Relapse|6|||
126643757|NCT04266795|455653838|FG000|Overall Study|Reason not Specified|12|||
126643758|NCT04266795|455653839|FG001|Overall Study|Reason not Specified|10|||
126643759|NCT04266795|455653838|FG000|Overall Study|Participants Ongoing on Treatment|25|||
126643760|NCT04266795|455653839|FG001|Overall Study|Participants Ongoing on Treatment|23|||
126643761|NCT04047862|455653842|FG000|Overall Study|Death|0|||
126643762|NCT04047862|455653843|FG001|Overall Study|Death|0|||
126643763|NCT04047862|455653844|FG002|Overall Study|Death|4|||
126643764|NCT04047862|455653845|FG003|Overall Study|Death|7|||
126643765|NCT04047862|455653846|FG004|Overall Study|Death|2|||
126643766|NCT04047862|455653847|FG005|Overall Study|Death|4|||
126643767|NCT04047862|455653848|FG006|Overall Study|Death|3|||
126643768|NCT04047862|455653849|FG007|Overall Study|Death|24|||
126643769|NCT04047862|455653850|FG008|Overall Study|Death|24|||
126643770|NCT04047862|455653851|FG009|Overall Study|Death|22|||
126643771|NCT04047862|455653852|FG010|Overall Study|Death|35|||
126643772|NCT04047862|455653853|FG011|Overall Study|Death|18|||
126643773|NCT04047862|455653854|FG012|Overall Study|Death|14|||
126643774|NCT04047862|455653855|FG013|Overall Study|Death|6|||
126643775|NCT04047862|455653856|FG014|Overall Study|Death|19|||
126643776|NCT04047862|455653857|FG015|Overall Study|Death|42|||
126643777|NCT04047862|455653858|FG016|Overall Study|Death|9|||
126643778|NCT04047862|455653859|FG017|Overall Study|Death|8|||
126643779|NCT04047862|455653860|FG018|Overall Study|Death|10|||
126643780|NCT04047862|455653842|FG000|Overall Study|Withdrawal by Subject|0|||
126643781|NCT04047862|455653843|FG001|Overall Study|Withdrawal by Subject|0|||
126643782|NCT04047862|455653844|FG002|Overall Study|Withdrawal by Subject|0|||
126643783|NCT04047862|455653845|FG003|Overall Study|Withdrawal by Subject|5|||
126643784|NCT04047862|455653846|FG004|Overall Study|Withdrawal by Subject|2|||
126643785|NCT04047862|455653847|FG005|Overall Study|Withdrawal by Subject|0|||
126643786|NCT04047862|455653848|FG006|Overall Study|Withdrawal by Subject|1|||
126643787|NCT04047862|455653849|FG007|Overall Study|Withdrawal by Subject|0|||
126643788|NCT04047862|455653850|FG008|Overall Study|Withdrawal by Subject|4|||
126643789|NCT04047862|455653851|FG009|Overall Study|Withdrawal by Subject|4|||
126643790|NCT04047862|455653852|FG010|Overall Study|Withdrawal by Subject|4|||
126643791|NCT04047862|455653853|FG011|Overall Study|Withdrawal by Subject|2|||
126643792|NCT04047862|455653854|FG012|Overall Study|Withdrawal by Subject|3|||
126643793|NCT04047862|455653855|FG013|Overall Study|Withdrawal by Subject|0|||
126643794|NCT04047862|455653856|FG014|Overall Study|Withdrawal by Subject|9|||
126643795|NCT04047862|455653857|FG015|Overall Study|Withdrawal by Subject|5|||
126643796|NCT04047862|455653858|FG016|Overall Study|Withdrawal by Subject|1|||
126643797|NCT04047862|455653859|FG017|Overall Study|Withdrawal by Subject|3|||
126643798|NCT04047862|455653860|FG018|Overall Study|Withdrawal by Subject|1|||
126643799|NCT04047862|455653842|FG000|Overall Study|Lost to Follow-up|0|||
126643800|NCT04047862|455653843|FG001|Overall Study|Lost to Follow-up|0|||
126643801|NCT04047862|455653844|FG002|Overall Study|Lost to Follow-up|1|||
126643802|NCT04047862|455653845|FG003|Overall Study|Lost to Follow-up|0|||
126643803|NCT04047862|455653846|FG004|Overall Study|Lost to Follow-up|0|||
126643804|NCT04047862|455653847|FG005|Overall Study|Lost to Follow-up|0|||
126643805|NCT04047862|455653848|FG006|Overall Study|Lost to Follow-up|0|||
126643806|NCT04047862|455653849|FG007|Overall Study|Lost to Follow-up|1|||
126643807|NCT04047862|455653850|FG008|Overall Study|Lost to Follow-up|0|||
126643808|NCT04047862|455653851|FG009|Overall Study|Lost to Follow-up|1|||
126643809|NCT04047862|455653852|FG010|Overall Study|Lost to Follow-up|0|||
126643810|NCT04047862|455653853|FG011|Overall Study|Lost to Follow-up|3|||
126643811|NCT04047862|455653854|FG012|Overall Study|Lost to Follow-up|0|||
126643812|NCT04047862|455653855|FG013|Overall Study|Lost to Follow-up|0|||
126643813|NCT04047862|455653856|FG014|Overall Study|Lost to Follow-up|2|||
126643814|NCT04047862|455653857|FG015|Overall Study|Lost to Follow-up|2|||
126643815|NCT04047862|455653858|FG016|Overall Study|Lost to Follow-up|1|||
126643816|NCT04047862|455653859|FG017|Overall Study|Lost to Follow-up|0|||
126643817|NCT04047862|455653860|FG018|Overall Study|Lost to Follow-up|0|||
126643818|NCT04047862|455653842|FG000|Overall Study|Physician Decision|0|||
126643819|NCT04047862|455653843|FG001|Overall Study|Physician Decision|0|||
126643820|NCT04047862|455653844|FG002|Overall Study|Physician Decision|0|||
126643821|NCT04047862|455653845|FG003|Overall Study|Physician Decision|1|||
126643822|NCT04047862|455653846|FG004|Overall Study|Physician Decision|0|||
126643823|NCT04047862|455653847|FG005|Overall Study|Physician Decision|0|||
126643824|NCT04047862|455653848|FG006|Overall Study|Physician Decision|0|||
126643825|NCT04047862|455653849|FG007|Overall Study|Physician Decision|0|||
126643826|NCT04047862|455653850|FG008|Overall Study|Physician Decision|0|||
126643827|NCT04047862|455653851|FG009|Overall Study|Physician Decision|0|||
126643828|NCT04047862|455653852|FG010|Overall Study|Physician Decision|0|||
126643829|NCT04047862|455653853|FG011|Overall Study|Physician Decision|0|||
126643830|NCT04047862|455653854|FG012|Overall Study|Physician Decision|0|||
126643831|NCT04047862|455653855|FG013|Overall Study|Physician Decision|0|||
126643832|NCT04047862|455653856|FG014|Overall Study|Physician Decision|1|||
126643833|NCT04047862|455653857|FG015|Overall Study|Physician Decision|0|||
126643834|NCT04047862|455653858|FG016|Overall Study|Physician Decision|1|||
126643835|NCT04047862|455653859|FG017|Overall Study|Physician Decision|0|||
126643836|NCT04047862|455653860|FG018|Overall Study|Physician Decision|0|||
126643837|NCT04047862|455653842|FG000|Overall Study|Completed all Assessments|1|||
126643838|NCT04047862|455653843|FG001|Overall Study|Completed all Assessments|3|||
126643839|NCT04047862|455653844|FG002|Overall Study|Completed all Assessments|1|||
126643840|NCT04047862|455653845|FG003|Overall Study|Completed all Assessments|3|||
126643841|NCT04047862|455653846|FG004|Overall Study|Completed all Assessments|2|||
126643842|NCT04047862|455653847|FG005|Overall Study|Completed all Assessments|5|||
126643843|NCT04047862|455653848|FG006|Overall Study|Completed all Assessments|7|||
126643844|NCT04047862|455653849|FG007|Overall Study|Completed all Assessments|0|||
126643845|NCT04047862|455653850|FG008|Overall Study|Completed all Assessments|0|||
126643846|NCT04047862|455653851|FG009|Overall Study|Completed all Assessments|0|||
126643847|NCT04047862|455653852|FG010|Overall Study|Completed all Assessments|0|||
126643848|NCT04047862|455653853|FG011|Overall Study|Completed all Assessments|0|||
126643849|NCT04047862|455653854|FG012|Overall Study|Completed all Assessments|0|||
126643850|NCT04047862|455653855|FG013|Overall Study|Completed all Assessments|0|||
126643851|NCT04047862|455653856|FG014|Overall Study|Completed all Assessments|0|||
126643852|NCT04047862|455653857|FG015|Overall Study|Completed all Assessments|0|||
126643853|NCT04047862|455653858|FG016|Overall Study|Completed all Assessments|0|||
126643854|NCT04047862|455653859|FG017|Overall Study|Completed all Assessments|0|||
126643855|NCT04047862|455653860|FG018|Overall Study|Completed all Assessments|0|||
126643856|NCT04047862|455653842|FG000|Overall Study|Sponsor Decision|0|||
126643857|NCT04047862|455653843|FG001|Overall Study|Sponsor Decision|0|||
126643858|NCT04047862|455653844|FG002|Overall Study|Sponsor Decision|0|||
126643859|NCT04047862|455653845|FG003|Overall Study|Sponsor Decision|0|||
126643860|NCT04047862|455653846|FG004|Overall Study|Sponsor Decision|0|||
126643861|NCT04047862|455653847|FG005|Overall Study|Sponsor Decision|0|||
126643862|NCT04047862|455653848|FG006|Overall Study|Sponsor Decision|0|||
126643863|NCT04047862|455653849|FG007|Overall Study|Sponsor Decision|13|||
126643864|NCT04047862|455653850|FG008|Overall Study|Sponsor Decision|10|||
126643865|NCT04047862|455653851|FG009|Overall Study|Sponsor Decision|18|||
126643866|NCT04047862|455653852|FG010|Overall Study|Sponsor Decision|3|||
126643867|NCT04047862|455653853|FG011|Overall Study|Sponsor Decision|3|||
126643868|NCT04047862|455653854|FG012|Overall Study|Sponsor Decision|4|||
126643869|NCT04047862|455653855|FG013|Overall Study|Sponsor Decision|0|||
126643870|NCT04047862|455653856|FG014|Overall Study|Sponsor Decision|7|||
126643871|NCT04047862|455653857|FG015|Overall Study|Sponsor Decision|8|||
126643872|NCT04047862|455653858|FG016|Overall Study|Sponsor Decision|9|||
126643873|NCT04047862|455653859|FG017|Overall Study|Sponsor Decision|7|||
126643874|NCT04047862|455653860|FG018|Overall Study|Sponsor Decision|8|||
126643875|NCT04047862|455653842|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126643876|NCT04047862|455653843|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126643877|NCT04047862|455653844|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126643878|NCT04047862|455653845|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126643879|NCT04047862|455653846|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126643880|NCT04047862|455653847|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126643881|NCT04047862|455653848|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126643882|NCT04047862|455653849|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
126643883|NCT04047862|455653850|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
126643884|NCT04047862|455653851|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126643885|NCT04047862|455653852|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
126643886|NCT04047862|455653853|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126643887|NCT04047862|455653854|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126643888|NCT04047862|455653855|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
126643889|NCT04047862|455653856|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
126643890|NCT04047862|455653857|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
126643891|NCT04047862|455653858|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
126643892|NCT04047862|455653859|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
126643893|NCT04047862|455653860|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
126643894|NCT04047862|455653842|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643895|NCT04047862|455653843|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643896|NCT04047862|455653844|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643897|NCT04047862|455653845|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643898|NCT04047862|455653846|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643899|NCT04047862|455653847|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643900|NCT04047862|455653848|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643901|NCT04047862|455653849|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643902|NCT04047862|455653850|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643903|NCT04047862|455653851|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643904|NCT04047862|455653852|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643905|NCT04047862|455653853|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643906|NCT04047862|455653854|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643907|NCT04047862|455653855|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643908|NCT04047862|455653856|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643909|NCT04047862|455653857|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
126643910|NCT04047862|455653858|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643911|NCT04047862|455653859|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
126643912|NCT04047862|455653860|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
126643913|NCT04047862|455653842|FG000|Overall Study|Other|0|||
126643914|NCT04047862|455653843|FG001|Overall Study|Other|0|||
126643915|NCT04047862|455653844|FG002|Overall Study|Other|0|||
126643916|NCT04047862|455653845|FG003|Overall Study|Other|0|||
126643917|NCT04047862|455653846|FG004|Overall Study|Other|0|||
126643918|NCT04047862|455653847|FG005|Overall Study|Other|0|||
126643919|NCT04047862|455653848|FG006|Overall Study|Other|0|||
126643920|NCT04047862|455653849|FG007|Overall Study|Other|0|||
126643921|NCT04047862|455653850|FG008|Overall Study|Other|0|||
126643922|NCT04047862|455653851|FG009|Overall Study|Other|0|||
126643923|NCT04047862|455653852|FG010|Overall Study|Other|0|||
126643924|NCT04047862|455653853|FG011|Overall Study|Other|0|||
126643925|NCT04047862|455653854|FG012|Overall Study|Other|0|||
126643926|NCT04047862|455653855|FG013|Overall Study|Other|0|||
126643927|NCT04047862|455653856|FG014|Overall Study|Other|2|||
126643928|NCT04047862|455653857|FG015|Overall Study|Other|1|||
126643929|NCT04047862|455653858|FG016|Overall Study|Other|1|||
126643930|NCT04047862|455653859|FG017|Overall Study|Other|1|||
126643931|NCT04047862|455653860|FG018|Overall Study|Other|0|||
126643932|NCT04996004|455655133|FG000|Phase I|Death|1|||
126643933|NCT04996004|455655134|FG001|Phase I|Death|2|||
126643934|NCT04996004|455655135|FG002|Phase I|Death|1|||
126643935|NCT04996004|455655136|FG003|Phase I|Death|0|||
126643936|NCT04996004|455655137|FG004|Phase I|Death|0|||
126643937|NCT04996004|455655138|FG005|Phase I|Death|0|||
126643938|NCT04996004|455655133|FG000|Phase I|Study terminated by sponsor|2|||
126643939|NCT04996004|455655134|FG001|Phase I|Study terminated by sponsor|1|||
126643940|NCT04996004|455655135|FG002|Phase I|Study terminated by sponsor|2|||
126643941|NCT04996004|455655136|FG003|Phase I|Study terminated by sponsor|0|||
126643942|NCT04996004|455655137|FG004|Phase I|Study terminated by sponsor|0|||
126643943|NCT04996004|455655138|FG005|Phase I|Study terminated by sponsor|0|||
126643944|NCT04996004|455655133|FG000|Phase II|Study terminated by sponsor|0|||
126643945|NCT04996004|455655134|FG001|Phase II|Study terminated by sponsor|0|||
126643946|NCT04996004|455655135|FG002|Phase II|Study terminated by sponsor|0|||
126643947|NCT04996004|455655136|FG003|Phase II|Study terminated by sponsor|20|||
126643948|NCT04996004|455655137|FG004|Phase II|Study terminated by sponsor|10|||
126643949|NCT04996004|455655138|FG005|Phase II|Study terminated by sponsor|10|||
126643950|NCT04996004|455655133|FG000|Phase II|Withdrawal by Subject|0|||
126643951|NCT04996004|455655134|FG001|Phase II|Withdrawal by Subject|0|||
126643952|NCT04996004|455655135|FG002|Phase II|Withdrawal by Subject|0|||
126643953|NCT04996004|455655136|FG003|Phase II|Withdrawal by Subject|0|||
126643954|NCT04996004|455655137|FG004|Phase II|Withdrawal by Subject|1|||
126643955|NCT04996004|455655138|FG005|Phase II|Withdrawal by Subject|2|||
126643956|NCT04996004|455655133|FG000|Phase II|Death|0|||
126643957|NCT04996004|455655134|FG001|Phase II|Death|0|||
126643958|NCT04996004|455655135|FG002|Phase II|Death|0|||
126643959|NCT04996004|455655136|FG003|Phase II|Death|12|||
126643960|NCT04996004|455655137|FG004|Phase II|Death|2|||
126643961|NCT04996004|455655138|FG005|Phase II|Death|9|||
126643962|NCT04996004|455655133|FG000|Phase II|Other|0|||
126643963|NCT04996004|455655134|FG001|Phase II|Other|0|||
126643964|NCT04996004|455655135|FG002|Phase II|Other|0|||
126643965|NCT04996004|455655136|FG003|Phase II|Other|0|||
126643966|NCT04996004|455655137|FG004|Phase II|Other|0|||
126643967|NCT04996004|455655138|FG005|Phase II|Other|1|||
126643968|NCT02942277|455655139|FG000|Year 1|Withdrawal by Subject|0|||
126643969|NCT02942277|455655140|FG001|Year 1|Withdrawal by Subject|0|||
126643970|NCT02942277|455655141|FG002|Year 1|Withdrawal by Subject|0|||
126643971|NCT02942277|455655142|FG003|Year 1|Withdrawal by Subject|0|||
126643972|NCT02942277|455655143|FG004|Year 1|Withdrawal by Subject|1|||
126643973|NCT02942277|455655144|FG005|Year 1|Withdrawal by Subject|3|||
126643974|NCT02942277|455655145|FG006|Year 1|Withdrawal by Subject|0|||
126643975|NCT02942277|455655146|FG007|Year 1|Withdrawal by Subject|1|||
126643976|NCT02942277|455655147|FG008|Year 1|Withdrawal by Subject|0|||
126643977|NCT02942277|455655148|FG009|Year 1|Withdrawal by Subject|0|||
126643978|NCT02942277|455655149|FG010|Year 1|Withdrawal by Subject|3|||
126643979|NCT02942277|455655139|FG000|Year 1|Travel|0|||
126643980|NCT02942277|455655140|FG001|Year 1|Travel|1|||
126643981|NCT02942277|455655141|FG002|Year 1|Travel|0|||
126643982|NCT02942277|455655142|FG003|Year 1|Travel|0|||
126643983|NCT02942277|455655143|FG004|Year 1|Travel|4|||
126643984|NCT02942277|455655144|FG005|Year 1|Travel|5|||
126643985|NCT02942277|455655145|FG006|Year 1|Travel|0|||
126643986|NCT02942277|455655146|FG007|Year 1|Travel|0|||
126643987|NCT02942277|455655147|FG008|Year 1|Travel|0|||
126643988|NCT02942277|455655148|FG009|Year 1|Travel|0|||
126643989|NCT02942277|455655149|FG010|Year 1|Travel|8|||
126643990|NCT02942277|455655139|FG000|Year 1|Joined Army|0|||
126643991|NCT02942277|455655140|FG001|Year 1|Joined Army|1|||
126643992|NCT02942277|455655141|FG002|Year 1|Joined Army|0|||
126643993|NCT02942277|455655142|FG003|Year 1|Joined Army|0|||
126643994|NCT02942277|455655143|FG004|Year 1|Joined Army|0|||
126643995|NCT02942277|455655144|FG005|Year 1|Joined Army|0|||
126643996|NCT02942277|455655145|FG006|Year 1|Joined Army|0|||
126643997|NCT02942277|455655146|FG007|Year 1|Joined Army|0|||
126643998|NCT02942277|455655147|FG008|Year 1|Joined Army|0|||
126643999|NCT02942277|455655148|FG009|Year 1|Joined Army|0|||
126644000|NCT02942277|455655149|FG010|Year 1|Joined Army|0|||
126644001|NCT02942277|455655139|FG000|Year 1|Subject met withdrawal criteria|0|||
126644002|NCT02942277|455655140|FG001|Year 1|Subject met withdrawal criteria|0|||
126644003|NCT02942277|455655141|FG002|Year 1|Subject met withdrawal criteria|0|||
126644004|NCT02942277|455655142|FG003|Year 1|Subject met withdrawal criteria|1|||
126644005|NCT02942277|455655143|FG004|Year 1|Subject met withdrawal criteria|0|||
126644006|NCT02942277|455655144|FG005|Year 1|Subject met withdrawal criteria|0|||
126644007|NCT02942277|455655145|FG006|Year 1|Subject met withdrawal criteria|0|||
126644008|NCT02942277|455655146|FG007|Year 1|Subject met withdrawal criteria|0|||
126644009|NCT02942277|455655147|FG008|Year 1|Subject met withdrawal criteria|0|||
126644010|NCT02942277|455655148|FG009|Year 1|Subject met withdrawal criteria|0|||
126644011|NCT02942277|455655149|FG010|Year 1|Subject met withdrawal criteria|0|||
126644012|NCT02942277|455655139|FG000|Year 1|Lost to Follow-up|0|||
126644013|NCT02942277|455655140|FG001|Year 1|Lost to Follow-up|0|||
126644014|NCT02942277|455655141|FG002|Year 1|Lost to Follow-up|0|||
126644015|NCT02942277|455655142|FG003|Year 1|Lost to Follow-up|0|||
126644016|NCT02942277|455655143|FG004|Year 1|Lost to Follow-up|1|||
126644017|NCT02942277|455655144|FG005|Year 1|Lost to Follow-up|0|||
126644018|NCT02942277|455655145|FG006|Year 1|Lost to Follow-up|0|||
126644019|NCT02942277|455655146|FG007|Year 1|Lost to Follow-up|0|||
126644020|NCT02942277|455655147|FG008|Year 1|Lost to Follow-up|0|||
126644021|NCT02942277|455655148|FG009|Year 1|Lost to Follow-up|0|||
126644022|NCT02942277|455655149|FG010|Year 1|Lost to Follow-up|2|||
126644023|NCT02942277|455655139|FG000|Year 1|Protocol Violation|0|||
126644024|NCT02942277|455655140|FG001|Year 1|Protocol Violation|0|||
126644025|NCT02942277|455655141|FG002|Year 1|Protocol Violation|0|||
126644026|NCT02942277|455655142|FG003|Year 1|Protocol Violation|0|||
126644027|NCT02942277|455655143|FG004|Year 1|Protocol Violation|1|||
126644028|NCT02942277|455655144|FG005|Year 1|Protocol Violation|1|||
126644029|NCT02942277|455655145|FG006|Year 1|Protocol Violation|0|||
126644030|NCT02942277|455655146|FG007|Year 1|Protocol Violation|0|||
126644031|NCT02942277|455655147|FG008|Year 1|Protocol Violation|0|||
126644032|NCT02942277|455655148|FG009|Year 1|Protocol Violation|0|||
126644033|NCT02942277|455655149|FG010|Year 1|Protocol Violation|2|||
126644034|NCT02942277|455655139|FG000|Year 1|Pregnancy|0|||
126644035|NCT02942277|455655140|FG001|Year 1|Pregnancy|0|||
126644036|NCT02942277|455655141|FG002|Year 1|Pregnancy|0|||
126644037|NCT02942277|455655142|FG003|Year 1|Pregnancy|0|||
126644038|NCT02942277|455655143|FG004|Year 1|Pregnancy|0|||
126644039|NCT02942277|455655144|FG005|Year 1|Pregnancy|1|||
126644040|NCT02942277|455655145|FG006|Year 1|Pregnancy|0|||
126644041|NCT02942277|455655146|FG007|Year 1|Pregnancy|0|||
126644042|NCT02942277|455655147|FG008|Year 1|Pregnancy|0|||
126644043|NCT02942277|455655148|FG009|Year 1|Pregnancy|0|||
126644044|NCT02942277|455655149|FG010|Year 1|Pregnancy|0|||
126644045|NCT02942277|455655139|FG000|Year 2|Lost to Follow-up|0|||
126644046|NCT02942277|455655140|FG001|Year 2|Lost to Follow-up|0|||
126644047|NCT02942277|455655141|FG002|Year 2|Lost to Follow-up|0|||
126644048|NCT02942277|455655142|FG003|Year 2|Lost to Follow-up|0|||
126644049|NCT02942277|455655143|FG004|Year 2|Lost to Follow-up|2|||
126644050|NCT02942277|455655144|FG005|Year 2|Lost to Follow-up|1|||
126644051|NCT02942277|455655145|FG006|Year 2|Lost to Follow-up|0|||
126644052|NCT02942277|455655146|FG007|Year 2|Lost to Follow-up|0|||
126644053|NCT02942277|455655147|FG008|Year 2|Lost to Follow-up|0|||
126644054|NCT02942277|455655148|FG009|Year 2|Lost to Follow-up|0|||
126644055|NCT02942277|455655149|FG010|Year 2|Lost to Follow-up|0|||
126644056|NCT02942277|455655139|FG000|Year 2|Did not rescreen|0|||
126644057|NCT02942277|455655140|FG001|Year 2|Did not rescreen|0|||
126644058|NCT02942277|455655141|FG002|Year 2|Did not rescreen|1|||
126644059|NCT02942277|455655142|FG003|Year 2|Did not rescreen|1|||
126644060|NCT02942277|455655143|FG004|Year 2|Did not rescreen|9|||
126644061|NCT02942277|455655144|FG005|Year 2|Did not rescreen|6|||
126644062|NCT02942277|455655145|FG006|Year 2|Did not rescreen|0|||
126644063|NCT02942277|455655146|FG007|Year 2|Did not rescreen|1|||
126644064|NCT02942277|455655147|FG008|Year 2|Did not rescreen|0|||
126644065|NCT02942277|455655148|FG009|Year 2|Did not rescreen|0|||
126644066|NCT02942277|455655149|FG010|Year 2|Did not rescreen|21|||
126644067|NCT02942277|455655139|FG000|Year 2|Met withdrawal criteria|0|||
126644068|NCT02942277|455655140|FG001|Year 2|Met withdrawal criteria|0|||
126644069|NCT02942277|455655141|FG002|Year 2|Met withdrawal criteria|0|||
126644070|NCT02942277|455655142|FG003|Year 2|Met withdrawal criteria|0|||
126644071|NCT02942277|455655143|FG004|Year 2|Met withdrawal criteria|1|||
126644072|NCT02942277|455655144|FG005|Year 2|Met withdrawal criteria|2|||
126644073|NCT02942277|455655145|FG006|Year 2|Met withdrawal criteria|0|||
126644074|NCT02942277|455655146|FG007|Year 2|Met withdrawal criteria|0|||
126644075|NCT02942277|455655147|FG008|Year 2|Met withdrawal criteria|0|||
126644076|NCT02942277|455655148|FG009|Year 2|Met withdrawal criteria|0|||
126644077|NCT02942277|455655149|FG010|Year 2|Met withdrawal criteria|1|||
126644078|NCT02942277|455655139|FG000|Year 2|Travel|0|||
126644079|NCT02942277|455655140|FG001|Year 2|Travel|1|||
126644080|NCT02942277|455655141|FG002|Year 2|Travel|0|||
126644081|NCT02942277|455655142|FG003|Year 2|Travel|0|||
126644082|NCT02942277|455655143|FG004|Year 2|Travel|0|||
126644083|NCT02942277|455655144|FG005|Year 2|Travel|1|||
126644084|NCT02942277|455655145|FG006|Year 2|Travel|0|||
126644085|NCT02942277|455655146|FG007|Year 2|Travel|0|||
126644086|NCT02942277|455655147|FG008|Year 2|Travel|0|||
126644087|NCT02942277|455655148|FG009|Year 2|Travel|1|||
126644088|NCT02942277|455655149|FG010|Year 2|Travel|3|||
126644089|NCT02942277|455655139|FG000|Year 2|Non-compliant|0|||
126644090|NCT02942277|455655140|FG001|Year 2|Non-compliant|0|||
126644091|NCT02942277|455655141|FG002|Year 2|Non-compliant|0|||
126644092|NCT02942277|455655142|FG003|Year 2|Non-compliant|0|||
126644093|NCT02942277|455655143|FG004|Year 2|Non-compliant|1|||
126644094|NCT02942277|455655144|FG005|Year 2|Non-compliant|1|||
126644095|NCT02942277|455655145|FG006|Year 2|Non-compliant|0|||
126644096|NCT02942277|455655146|FG007|Year 2|Non-compliant|0|||
126644097|NCT02942277|455655147|FG008|Year 2|Non-compliant|0|||
126644098|NCT02942277|455655148|FG009|Year 2|Non-compliant|0|||
126644099|NCT02942277|455655149|FG010|Year 2|Non-compliant|0|||
126644100|NCT02942277|455655139|FG000|Year 2|Withdrawal by Subject|0|||
126644101|NCT02942277|455655140|FG001|Year 2|Withdrawal by Subject|0|||
126644102|NCT02942277|455655141|FG002|Year 2|Withdrawal by Subject|0|||
126644103|NCT02942277|455655142|FG003|Year 2|Withdrawal by Subject|0|||
126644104|NCT02942277|455655143|FG004|Year 2|Withdrawal by Subject|0|||
126644105|NCT02942277|455655144|FG005|Year 2|Withdrawal by Subject|0|||
126644106|NCT02942277|455655145|FG006|Year 2|Withdrawal by Subject|1|||
126644107|NCT02942277|455655146|FG007|Year 2|Withdrawal by Subject|0|||
126644108|NCT02942277|455655147|FG008|Year 2|Withdrawal by Subject|0|||
126644109|NCT02942277|455655148|FG009|Year 2|Withdrawal by Subject|0|||
126644110|NCT02942277|455655149|FG010|Year 2|Withdrawal by Subject|0|||
126644111|NCT05577715|455655150|FG000|Overall Study|Withdrawal by Subject|1|||
126644112|NCT05577715|455655150|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
126644113|NCT05577715|455655150|FG000|Overall Study|Lost to Follow-up|1|||
126644114|NCT05577715|455655150|FG000|Overall Study|Death|6|||
126644115|NCT00626197|455655157|FG000|Overall Study|Did not cooperate|2|||
126644116|NCT00626197|455655158|FG001|Overall Study|Did not cooperate|6|||
126644117|NCT00626197|455655159|FG002|Overall Study|Did not cooperate|1|||
126644118|NCT00626197|455655157|FG000|Overall Study|Failure to return|6|||
126644119|NCT00626197|455655158|FG001|Overall Study|Failure to return|5|||
126644120|NCT00626197|455655159|FG002|Overall Study|Failure to return|6|||
126644121|NCT00626197|455655157|FG000|Overall Study|Adverse event, serious fatal|3|||
126644122|NCT00626197|455655158|FG001|Overall Study|Adverse event, serious fatal|6|||
126644123|NCT00626197|455655159|FG002|Overall Study|Adverse event, serious fatal|6|||
126644124|NCT00626197|455655157|FG000|Overall Study|Adverse Event|1|||
126644125|NCT00626197|455655158|FG001|Overall Study|Adverse Event|1|||
126644126|NCT00626197|455655159|FG002|Overall Study|Adverse Event|2|||
126644127|NCT00626197|455655157|FG000|Overall Study|Withdrawal by Subject|17|||
126644128|NCT00626197|455655158|FG001|Overall Study|Withdrawal by Subject|17|||
126644129|NCT00626197|455655159|FG002|Overall Study|Withdrawal by Subject|7|||
126644130|NCT00626197|455655157|FG000|Overall Study|Administrative reasons|15|||
126644131|NCT00626197|455655158|FG001|Overall Study|Administrative reasons|19|||
126644132|NCT00626197|455655159|FG002|Overall Study|Administrative reasons|55|||
126644133|NCT04833127|455655160|FG000|Overall Study|Lost to Follow-up|1|||
126644134|NCT04833127|455655161|FG001|Overall Study|Lost to Follow-up|1|||
126644135|NCT04552899|455655164|FG000|Overall Study|Adverse Event|4|||
126644136|NCT04552899|455655165|FG001|Overall Study|Adverse Event|3|||
126644137|NCT04552899|455655164|FG000|Overall Study|Death|4|||
126644138|NCT04552899|455655165|FG001|Overall Study|Death|4|||
126644139|NCT04552899|455655164|FG000|Overall Study|Lost to Follow-up|8|||
126644140|NCT04552899|455655165|FG001|Overall Study|Lost to Follow-up|13|||
126644141|NCT04552899|455655164|FG000|Overall Study|Lung Transplant|4|||
126644142|NCT04552899|455655165|FG001|Overall Study|Lung Transplant|3|||
126644143|NCT04552899|455655164|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
126644144|NCT04552899|455655165|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
126644145|NCT04552899|455655164|FG000|Overall Study|Physician Decision|3|||
126644146|NCT04552899|455655165|FG001|Overall Study|Physician Decision|4|||
126644147|NCT04552899|455655164|FG000|Overall Study|Study Terminated By Sponsor|237|||
126644148|NCT04552899|455655165|FG001|Overall Study|Study Terminated By Sponsor|239|||
126644149|NCT04552899|455655164|FG000|Overall Study|Withdrawal by Subject|15|||
126644150|NCT04552899|455655165|FG001|Overall Study|Withdrawal by Subject|17|||
126644151|NCT05282121|455655166|FG000|Overall Study|Adverse Event|1|||
126644152|NCT05282121|455655167|FG001|Overall Study|Adverse Event|1|||
126644153|NCT05282121|455655168|FG002|Overall Study|Adverse Event|4|||
126644154|NCT05282121|455655169|FG003|Overall Study|Adverse Event|1|||
126644155|NCT05282121|455655166|FG000|Overall Study|Study Terminated by Sponsor|1|||
126644156|NCT05282121|455655167|FG001|Overall Study|Study Terminated by Sponsor|2|||
126644157|NCT05282121|455655168|FG002|Overall Study|Study Terminated by Sponsor|2|||
126644158|NCT05282121|455655169|FG003|Overall Study|Study Terminated by Sponsor|2|||
126644159|NCT05282121|455655166|FG000|Overall Study|Other than listed|0|||
126644160|NCT05282121|455655167|FG001|Overall Study|Other than listed|0|||
126644161|NCT05282121|455655168|FG002|Overall Study|Other than listed|1|||
126644162|NCT05282121|455655169|FG003|Overall Study|Other than listed|0|||
126644163|NCT05282121|455655166|FG000|Overall Study|No reason available|0|||
126644164|NCT05282121|455655167|FG001|Overall Study|No reason available|0|||
126644165|NCT05282121|455655168|FG002|Overall Study|No reason available|1|||
126644166|NCT05282121|455655169|FG003|Overall Study|No reason available|0|||
126644167|NCT00461981|455655173|FG000|Overall Study|Lost to Follow-up|9|||
126644168|NCT00461981|455655174|FG001|Overall Study|Lost to Follow-up|6|||
126644169|NCT00461981|455655173|FG000|Overall Study|Withdrawal by Subject|2|||
126644170|NCT00461981|455655174|FG001|Overall Study|Withdrawal by Subject|3|||
126644171|NCT00731133|455655178|FG000|Overall Study|Withdrawal by Subject|10|||
126644172|NCT03510455|455655179|FG000|Overall Study|Physician Decision|1|||
126644173|NCT04958642|455655186|FG000|Overall Study|Transferred to OLEX program|3|||
126644174|NCT04958642|455655187|FG001|Overall Study|Transferred to OLEX program|0|||
126644175|NCT04958642|455655188|FG002|Overall Study|Transferred to OLEX program|5|||
126644176|NCT04958642|455655186|FG000|Overall Study|Death|0|||
126644177|NCT04958642|455655187|FG001|Overall Study|Death|0|||
126644178|NCT04958642|455655188|FG002|Overall Study|Death|1|||
126644179|NCT04958642|455655186|FG000|Overall Study|Withdrawal by Subject|4|||
126644180|NCT04958642|455655187|FG001|Overall Study|Withdrawal by Subject|9|||
126644181|NCT04958642|455655188|FG002|Overall Study|Withdrawal by Subject|13|||
126644182|NCT04958642|455655186|FG000|Overall Study|Investigator's Decision|0|||
126644183|NCT04958642|455655187|FG001|Overall Study|Investigator's Decision|0|||
126644184|NCT04958642|455655188|FG002|Overall Study|Investigator's Decision|1|||
126644185|NCT04958642|455655186|FG000|Overall Study|Adverse Event|1|||
126644186|NCT04958642|455655187|FG001|Overall Study|Adverse Event|0|||
126644187|NCT04958642|455655188|FG002|Overall Study|Adverse Event|1|||
126644188|NCT04958642|455655186|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
126644189|NCT04958642|455655187|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
126644190|NCT04958642|455655188|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
126644191|NCT04958642|455655186|FG000|Overall Study|Lost to Follow-up|1|||
126644192|NCT04958642|455655187|FG001|Overall Study|Lost to Follow-up|0|||
126644193|NCT04958642|455655188|FG002|Overall Study|Lost to Follow-up|0|||
126644194|NCT04958642|455655186|FG000|Overall Study|Transferred to EAP following study termination|0|||
126644195|NCT04958642|455655187|FG001|Overall Study|Transferred to EAP following study termination|0|||
126644196|NCT04958642|455655188|FG002|Overall Study|Transferred to EAP following study termination|1|||
126644197|NCT04958642|455655186|FG000|Overall Study|Transferred to Expanded Access Program|1|||
126644198|NCT04958642|455655187|FG001|Overall Study|Transferred to Expanded Access Program|0|||
126644199|NCT04958642|455655188|FG002|Overall Study|Transferred to Expanded Access Program|0|||
126644200|NCT03853551|455655192|FG000|Overall Study|Death|2|||
126644201|NCT03853551|455655192|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
126644202|NCT02476175|455655193|FG000|Overall Study|Adverse Event|2|||
126644203|NCT01876901|455655195|FG000|Overall Study|Protocol Violation|10|||
126644204|NCT01876901|455655196|FG001|Overall Study|Protocol Violation|2|||
126644205|NCT01876901|455655195|FG000|Overall Study|No or other surgical intervention|7|||
126644206|NCT01876901|455655196|FG001|Overall Study|No or other surgical intervention|5|||
126644207|NCT02964325|455655199|FG000|Overall Study|Lost to Follow-up|3|||
126644208|NCT02964325|455655200|FG001|Overall Study|Lost to Follow-up|3|||
126644209|NCT02964325|455655199|FG000|Overall Study|Physician Decision|5|||
126644210|NCT02964325|455655200|FG001|Overall Study|Physician Decision|4|||
126644211|NCT02964325|455655199|FG000|Overall Study|Death|1|||
126644212|NCT02964325|455655200|FG001|Overall Study|Death|3|||
126644213|NCT02964325|455655199|FG000|Overall Study|Withdrawal by Subject|2|||
126644214|NCT02964325|455655200|FG001|Overall Study|Withdrawal by Subject|1|||
126644215|NCT02964325|455655199|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
126644216|NCT02964325|455655200|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
126644217|NCT02510040|455655201|FG000|Overall Study|Deemed no longer eligible|18|||
126644218|NCT02510040|455655202|FG001|Overall Study|Deemed no longer eligible|3|||
126644219|NCT02510040|455655203|FG002|Overall Study|Deemed no longer eligible|1|||
126644220|NCT00534495|455655210|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
126644221|NCT00534495|455655211|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
126644222|NCT00534495|455655212|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
126644223|NCT00534495|455655210|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
126644224|NCT00534495|455655211|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
126644225|NCT00534495|455655212|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
126644226|NCT00534495|455655210|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
126644227|NCT00534495|455655211|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
126644228|NCT00534495|455655212|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
126644229|NCT00534495|455655210|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
126644230|NCT00534495|455655211|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
126644231|NCT00534495|455655212|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
126644232|NCT00534495|455655210|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
126644233|NCT00534495|455655211|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
126644234|NCT00534495|455655212|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
126644235|NCT00534495|455655210|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
126644236|NCT00534495|455655211|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
126644237|NCT00534495|455655212|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
126644238|NCT00534495|455655210|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
126644239|NCT00534495|455655211|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
126644240|NCT00534495|455655212|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
126644241|NCT00534495|455655210|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
126644242|NCT00534495|455655211|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
126644243|NCT00534495|455655212|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
126644244|NCT00534495|455655210|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
126644245|NCT00534495|455655211|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
126644246|NCT00534495|455655212|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
126644247|NCT01068665|455655213|FG000|Overall Study|Adverse Event|5|||
126644248|NCT01068665|455655214|FG001|Overall Study|Adverse Event|4|||
126644249|NCT01068665|455655213|FG000|Overall Study|Lack of Efficacy|0|||
126644250|NCT01068665|455655214|FG001|Overall Study|Lack of Efficacy|2|||
126644251|NCT01068665|455655213|FG000|Overall Study|Protocol Violation|5|||
126644252|NCT01068665|455655214|FG001|Overall Study|Protocol Violation|2|||
126644253|NCT01068665|455655213|FG000|Overall Study|Withdrawal Criteria|3|||
126644254|NCT01068665|455655214|FG001|Overall Study|Withdrawal Criteria|9|||
126644255|NCT01068665|455655213|FG000|Overall Study|Other|17|||
126644256|NCT01068665|455655214|FG001|Overall Study|Other|12|||
126644257|NCT02202785|455655216|FG000|Overall Study|Study Terminated by Sponsor|1|||
126644258|NCT02202785|455655217|FG001|Overall Study|Study Terminated by Sponsor|6|||
126644259|NCT02202785|455655218|FG002|Overall Study|Study Terminated by Sponsor|4|||
126644260|NCT02202785|455655216|FG000|Overall Study|Withdrawal by Subject|0|||
126644261|NCT02202785|455655217|FG001|Overall Study|Withdrawal by Subject|1|||
126644262|NCT02202785|455655218|FG002|Overall Study|Withdrawal by Subject|0|||
126644263|NCT02202785|455655216|FG000|Overall Study|Lost to Follow-up|0|||
126644264|NCT02202785|455655217|FG001|Overall Study|Lost to Follow-up|1|||
126644265|NCT02202785|455655218|FG002|Overall Study|Lost to Follow-up|0|||
126644266|NCT02202785|455655216|FG000|Overall Study|Reason not Specified|10|||
126644267|NCT02202785|455655217|FG001|Overall Study|Reason not Specified|7|||
126644268|NCT02202785|455655218|FG002|Overall Study|Reason not Specified|13|||
126644269|NCT02180243|455655219|FG000|Overall Study|Withdrawal by Subject|12|||
126644270|NCT02180243|455655220|FG001|Overall Study|Withdrawal by Subject|12|||
126644271|NCT02180243|455655219|FG000|Overall Study|Lost to Follow-up|12|||
126644272|NCT02180243|455655220|FG001|Overall Study|Lost to Follow-up|2|||
126644273|NCT01137578|455655221|FG000|Overall Study|Participant requested to Discontinue|3|||
126644274|NCT01137578|455655222|FG001|Overall Study|Participant requested to Discontinue|0|||
126644275|NCT01137578|455655223|FG002|Overall Study|Participant requested to Discontinue|0|||
126644276|NCT01137578|455655221|FG000|Overall Study|Withdrawal by Subject|1|||
126644277|NCT01137578|455655222|FG001|Overall Study|Withdrawal by Subject|0|||
126644278|NCT01137578|455655223|FG002|Overall Study|Withdrawal by Subject|0|||
126644279|NCT01137578|455655221|FG000|Overall Study|Other|12|||
126644280|NCT01137578|455655222|FG001|Overall Study|Other|2|||
126644281|NCT01137578|455655223|FG002|Overall Study|Other|6|||
126644282|NCT04145700|455655225|FG000|Overall Study|Withdrawal by Subject|8|||
126644283|NCT04145700|455655226|FG001|Overall Study|Withdrawal by Subject|3|||
126644284|NCT00818779|455655227|FG000|Overall Study|Protocol Violation|1|||
126644285|NCT00818779|455655228|FG001|Overall Study|Protocol Violation|0|||
126644286|NCT00818779|455655227|FG000|Overall Study|Lost to Follow-up|1|||
126644287|NCT00818779|455655228|FG001|Overall Study|Lost to Follow-up|0|||
126644288|NCT00818779|455655227|FG000|Overall Study|Adverse Event|4|||
126644289|NCT00818779|455655228|FG001|Overall Study|Adverse Event|1|||
126644290|NCT04978493|455655229|FG000|Overall Study|No reason available|0|||
126644291|NCT04978493|455655230|FG001|Overall Study|No reason available|1|||
126644292|NCT04978493|455655229|FG000|Overall Study|Adverse Event|1|||
126644293|NCT04978493|455655230|FG001|Overall Study|Adverse Event|0|||
126644294|NCT01254747|455655231|FG000|Overall Study|Unacceptable subjective vision|0|||
126644295|NCT01254747|455655232|FG001|Overall Study|Unacceptable subjective vision|0|||
126644296|NCT01254747|455655233|FG002|Overall Study|Unacceptable subjective vision|0|||
126644297|NCT01254747|455655234|FG003|Overall Study|Unacceptable subjective vision|2|||
126644298|NCT01254747|455655231|FG000|Overall Study|Difficult removal handling|0|||
126644299|NCT01254747|455655232|FG001|Overall Study|Difficult removal handling|0|||
126644300|NCT01254747|455655233|FG002|Overall Study|Difficult removal handling|1|||
126644301|NCT01254747|455655234|FG003|Overall Study|Difficult removal handling|0|||
126644302|NCT01254747|455655231|FG000|Overall Study|Symptoms and problems|0|||
126644303|NCT01254747|455655232|FG001|Overall Study|Symptoms and problems|2|||
126644304|NCT01254747|455655233|FG002|Overall Study|Symptoms and problems|1|||
126644305|NCT01254747|455655234|FG003|Overall Study|Symptoms and problems|0|||
126644306|NCT01254747|455655231|FG000|Overall Study|Lost to Follow-up|0|||
126644307|NCT01254747|455655232|FG001|Overall Study|Lost to Follow-up|0|||
126644308|NCT01254747|455655233|FG002|Overall Study|Lost to Follow-up|1|||
126644309|NCT01254747|455655234|FG003|Overall Study|Lost to Follow-up|0|||
126644310|NCT01254747|455655231|FG000|Overall Study|Biomicroscopy|0|||
126644311|NCT01254747|455655232|FG001|Overall Study|Biomicroscopy|0|||
126644312|NCT01254747|455655233|FG002|Overall Study|Biomicroscopy|1|||
126644313|NCT01254747|455655234|FG003|Overall Study|Biomicroscopy|0|||
126644314|NCT01254747|455655231|FG000|Overall Study|Discomfort|0|||
126644315|NCT01254747|455655232|FG001|Overall Study|Discomfort|4|||
126644316|NCT01254747|455655233|FG002|Overall Study|Discomfort|0|||
126644317|NCT01254747|455655234|FG003|Overall Study|Discomfort|0|||
126644318|NCT00245960|455655235|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
126644319|NCT00245960|455655236|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
126644320|NCT00245960|455655235|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
126644321|NCT00245960|455655236|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
126644322|NCT00245960|455655235|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
126644323|NCT00245960|455655236|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
126644324|NCT00245960|455655235|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
126644325|NCT00245960|455655236|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
126644326|NCT00245960|455655235|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
126644327|NCT00245960|455655236|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
126644328|NCT00245960|455655235|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
126644329|NCT00245960|455655236|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
126644330|NCT00245960|455655235|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
126644331|NCT00245960|455655236|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
126644332|NCT00245960|455655235|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
126644333|NCT00245960|455655236|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
126644334|NCT00245960|455655235|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
126644335|NCT00245960|455655236|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
126644336|NCT00245960|455655235|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
126644337|NCT00245960|455655236|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
126644338|NCT00245960|455655235|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
126644339|NCT00245960|455655236|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
126644340|NCT00245960|455655235|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
126644341|NCT00245960|455655236|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
126644342|NCT00316017|455655241|FG000|Overall Study|Protocol Violation|11|||
126644343|NCT00316017|455655242|FG001|Overall Study|Protocol Violation|13|||
126644344|NCT00316017|455655243|FG002|Overall Study|Protocol Violation|19|||
126644345|NCT05235269|455655248|FG000|Overall Study|Adverse Event|1|||
126644346|NCT05235269|455655248|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
126644347|NCT05235269|455655248|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
126644348|NCT01876082|455657041|FG000|Overall Study|Withdrawal by Subject|0|||
126644349|NCT01876082|455657042|FG001|Overall Study|Withdrawal by Subject|2|||
126644350|NCT01876082|455657041|FG000|Overall Study|Protocol Violation|1|||
126644351|NCT01876082|455657042|FG001|Overall Study|Protocol Violation|0|||
126644352|NCT01876082|455657041|FG000|Overall Study|Adverse Event|1|||
126644353|NCT01876082|455657042|FG001|Overall Study|Adverse Event|1|||
126644354|NCT01876082|455657041|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
126644355|NCT01876082|455657042|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
126644356|NCT04427280|455657044|FG000|Overall Study|Withdrawal by Subject|0|||
126644357|NCT04427280|455657045|FG001|Overall Study|Withdrawal by Subject|2|||
126644358|NCT03829501|455657048|FG000|Overall Study|Withdrawal of Consent|2|||
126644359|NCT03829501|455657049|FG001|Overall Study|Withdrawal of Consent|0|||
126644360|NCT03829501|455657050|FG002|Overall Study|Withdrawal of Consent|3|||
126644361|NCT03829501|455657051|FG003|Overall Study|Withdrawal of Consent|0|||
126644362|NCT03829501|455657052|FG004|Overall Study|Withdrawal of Consent|1|||
126644363|NCT03829501|455657053|FG005|Overall Study|Withdrawal of Consent|1|||
126644364|NCT03829501|455657054|FG006|Overall Study|Withdrawal of Consent|0|||
126644365|NCT03829501|455657055|FG007|Overall Study|Withdrawal of Consent|10|||
126644366|NCT03829501|455657056|FG008|Overall Study|Withdrawal of Consent|10|||
126644367|NCT03829501|455657057|FG009|Overall Study|Withdrawal of Consent|3|||
126644368|NCT03829501|455657058|FG010|Overall Study|Withdrawal of Consent|4|||
126644369|NCT03829501|455657059|FG011|Overall Study|Withdrawal of Consent|4|||
126644370|NCT03829501|455657060|FG012|Overall Study|Withdrawal of Consent|4|||
126644371|NCT03829501|455657061|FG013|Overall Study|Withdrawal of Consent|0|||
126644372|NCT03829501|455657062|FG014|Overall Study|Withdrawal of Consent|3|||
126644373|NCT03829501|455657063|FG015|Overall Study|Withdrawal of Consent|0|||
126644374|NCT03829501|455657064|FG016|Overall Study|Withdrawal of Consent|1|||
126644375|NCT03829501|455657065|FG017|Overall Study|Withdrawal of Consent|1|||
126644376|NCT03829501|455657066|FG018|Overall Study|Withdrawal of Consent|0|||
126644377|NCT03829501|455657067|FG019|Overall Study|Withdrawal of Consent|0|||
126644378|NCT03829501|455657068|FG020|Overall Study|Withdrawal of Consent|3|||
126644379|NCT03829501|455657069|FG021|Overall Study|Withdrawal of Consent|0|||
126644380|NCT03829501|455657070|FG022|Overall Study|Withdrawal of Consent|1|||
126644381|NCT03829501|455657048|FG000|Overall Study|PD|0|||
126644382|NCT03829501|455657049|FG001|Overall Study|PD|0|||
126644383|NCT03829501|455657050|FG002|Overall Study|PD|0|||
126644384|NCT03829501|455657051|FG003|Overall Study|PD|2|||
126644385|NCT03829501|455657052|FG004|Overall Study|PD|0|||
126644386|NCT03829501|455657053|FG005|Overall Study|PD|0|||
126644387|NCT03829501|455657054|FG006|Overall Study|PD|0|||
126644388|NCT03829501|455657055|FG007|Overall Study|PD|0|||
126644389|NCT03829501|455657056|FG008|Overall Study|PD|0|||
126644390|NCT03829501|455657057|FG009|Overall Study|PD|0|||
126644391|NCT03829501|455657058|FG010|Overall Study|PD|0|||
126644392|NCT03829501|455657059|FG011|Overall Study|PD|0|||
126644393|NCT03829501|455657060|FG012|Overall Study|PD|0|||
126644394|NCT03829501|455657061|FG013|Overall Study|PD|0|||
126644395|NCT03829501|455657062|FG014|Overall Study|PD|0|||
126644396|NCT03829501|455657063|FG015|Overall Study|PD|1|||
126644397|NCT03829501|455657064|FG016|Overall Study|PD|0|||
126644398|NCT03829501|455657065|FG017|Overall Study|PD|0|||
126644399|NCT03829501|455657066|FG018|Overall Study|PD|0|||
126644400|NCT03829501|455657067|FG019|Overall Study|PD|0|||
126644401|NCT03829501|455657068|FG020|Overall Study|PD|1|||
126644402|NCT03829501|455657069|FG021|Overall Study|PD|0|||
126644403|NCT03829501|455657070|FG022|Overall Study|PD|0|||
126644404|NCT03829501|455657048|FG000|Overall Study|Study Terminated by Sponsor|0|||
126644405|NCT03829501|455657049|FG001|Overall Study|Study Terminated by Sponsor|0|||
126644406|NCT03829501|455657050|FG002|Overall Study|Study Terminated by Sponsor|0|||
126644407|NCT03829501|455657051|FG003|Overall Study|Study Terminated by Sponsor|0|||
126644408|NCT03829501|455657052|FG004|Overall Study|Study Terminated by Sponsor|0|||
126644409|NCT03829501|455657053|FG005|Overall Study|Study Terminated by Sponsor|0|||
126644410|NCT03829501|455657054|FG006|Overall Study|Study Terminated by Sponsor|0|||
126644411|NCT03829501|455657055|FG007|Overall Study|Study Terminated by Sponsor|3|||
126644412|NCT03829501|455657056|FG008|Overall Study|Study Terminated by Sponsor|1|||
126644413|NCT03829501|455657057|FG009|Overall Study|Study Terminated by Sponsor|0|||
126644414|NCT03829501|455657058|FG010|Overall Study|Study Terminated by Sponsor|0|||
126644415|NCT03829501|455657059|FG011|Overall Study|Study Terminated by Sponsor|0|||
126644416|NCT03829501|455657060|FG012|Overall Study|Study Terminated by Sponsor|0|||
126644417|NCT03829501|455657061|FG013|Overall Study|Study Terminated by Sponsor|0|||
126644418|NCT03829501|455657062|FG014|Overall Study|Study Terminated by Sponsor|3|||
126644419|NCT03829501|455657063|FG015|Overall Study|Study Terminated by Sponsor|2|||
126644420|NCT03829501|455657064|FG016|Overall Study|Study Terminated by Sponsor|2|||
126644421|NCT03829501|455657065|FG017|Overall Study|Study Terminated by Sponsor|0|||
126644422|NCT03829501|455657066|FG018|Overall Study|Study Terminated by Sponsor|0|||
126644423|NCT03829501|455657067|FG019|Overall Study|Study Terminated by Sponsor|0|||
126644424|NCT03829501|455657068|FG020|Overall Study|Study Terminated by Sponsor|1|||
126644425|NCT03829501|455657069|FG021|Overall Study|Study Terminated by Sponsor|0|||
126644426|NCT03829501|455657070|FG022|Overall Study|Study Terminated by Sponsor|3|||
126644427|NCT03829501|455657048|FG000|Overall Study|Lost to Follow Up|0|||
126644428|NCT03829501|455657049|FG001|Overall Study|Lost to Follow Up|0|||
126644429|NCT03829501|455657050|FG002|Overall Study|Lost to Follow Up|0|||
126644430|NCT03829501|455657051|FG003|Overall Study|Lost to Follow Up|0|||
126644431|NCT03829501|455657052|FG004|Overall Study|Lost to Follow Up|1|||
126644432|NCT03829501|455657053|FG005|Overall Study|Lost to Follow Up|0|||
126644433|NCT03829501|455657054|FG006|Overall Study|Lost to Follow Up|0|||
126644434|NCT03829501|455657055|FG007|Overall Study|Lost to Follow Up|2|||
126644435|NCT03829501|455657056|FG008|Overall Study|Lost to Follow Up|2|||
126644436|NCT03829501|455657057|FG009|Overall Study|Lost to Follow Up|0|||
126644437|NCT03829501|455657058|FG010|Overall Study|Lost to Follow Up|2|||
126644438|NCT03829501|455657059|FG011|Overall Study|Lost to Follow Up|1|||
126644439|NCT03829501|455657060|FG012|Overall Study|Lost to Follow Up|0|||
126644440|NCT03829501|455657061|FG013|Overall Study|Lost to Follow Up|1|||
126644441|NCT03829501|455657062|FG014|Overall Study|Lost to Follow Up|1|||
126644442|NCT03829501|455657063|FG015|Overall Study|Lost to Follow Up|0|||
126644443|NCT03829501|455657064|FG016|Overall Study|Lost to Follow Up|0|||
126644444|NCT03829501|455657065|FG017|Overall Study|Lost to Follow Up|0|||
126644445|NCT03829501|455657066|FG018|Overall Study|Lost to Follow Up|0|||
126644446|NCT03829501|455657067|FG019|Overall Study|Lost to Follow Up|0|||
126644447|NCT03829501|455657068|FG020|Overall Study|Lost to Follow Up|0|||
126644448|NCT03829501|455657069|FG021|Overall Study|Lost to Follow Up|0|||
126644449|NCT03829501|455657070|FG022|Overall Study|Lost to Follow Up|1|||
126644450|NCT03829501|455657048|FG000|Overall Study|Death|2|||
126644451|NCT03829501|455657049|FG001|Overall Study|Death|4|||
126644452|NCT03829501|455657050|FG002|Overall Study|Death|5|||
126644453|NCT03829501|455657051|FG003|Overall Study|Death|6|||
126644454|NCT03829501|455657052|FG004|Overall Study|Death|5|||
126644455|NCT03829501|455657053|FG005|Overall Study|Death|4|||
126644456|NCT03829501|455657054|FG006|Overall Study|Death|5|||
126644457|NCT03829501|455657055|FG007|Overall Study|Death|24|||
126644458|NCT03829501|455657056|FG008|Overall Study|Death|22|||
126644459|NCT03829501|455657057|FG009|Overall Study|Death|6|||
126644460|NCT03829501|455657058|FG010|Overall Study|Death|3|||
126644461|NCT03829501|455657059|FG011|Overall Study|Death|10|||
126644462|NCT03829501|455657060|FG012|Overall Study|Death|10|||
126644463|NCT03829501|455657061|FG013|Overall Study|Death|5|||
126644464|NCT03829501|455657062|FG014|Overall Study|Death|7|||
126644465|NCT03829501|455657063|FG015|Overall Study|Death|2|||
126644466|NCT03829501|455657064|FG016|Overall Study|Death|2|||
126644467|NCT03829501|455657065|FG017|Overall Study|Death|1|||
126644468|NCT03829501|455657066|FG018|Overall Study|Death|1|||
126644469|NCT03829501|455657067|FG019|Overall Study|Death|1|||
126644470|NCT03829501|455657068|FG020|Overall Study|Death|1|||
126644471|NCT03829501|455657069|FG021|Overall Study|Death|2|||
126644472|NCT03829501|455657070|FG022|Overall Study|Death|3|||
126644473|NCT03829501|455657048|FG000|Overall Study|Miscellaneous|0|||
126644474|NCT03829501|455657049|FG001|Overall Study|Miscellaneous|0|||
126644475|NCT03829501|455657050|FG002|Overall Study|Miscellaneous|1|||
126644476|NCT03829501|455657051|FG003|Overall Study|Miscellaneous|0|||
126644477|NCT03829501|455657052|FG004|Overall Study|Miscellaneous|0|||
126644478|NCT03829501|455657053|FG005|Overall Study|Miscellaneous|0|||
126644479|NCT03829501|455657054|FG006|Overall Study|Miscellaneous|0|||
126644480|NCT03829501|455657055|FG007|Overall Study|Miscellaneous|1|||
126644481|NCT03829501|455657056|FG008|Overall Study|Miscellaneous|0|||
126644482|NCT03829501|455657057|FG009|Overall Study|Miscellaneous|0|||
126644483|NCT03829501|455657058|FG010|Overall Study|Miscellaneous|0|||
126644484|NCT03829501|455657059|FG011|Overall Study|Miscellaneous|0|||
126644485|NCT03829501|455657060|FG012|Overall Study|Miscellaneous|0|||
126644486|NCT03829501|455657061|FG013|Overall Study|Miscellaneous|0|||
126644487|NCT03829501|455657062|FG014|Overall Study|Miscellaneous|0|||
126644488|NCT03829501|455657063|FG015|Overall Study|Miscellaneous|0|||
126644489|NCT03829501|455657064|FG016|Overall Study|Miscellaneous|0|||
126644490|NCT03829501|455657065|FG017|Overall Study|Miscellaneous|0|||
126644491|NCT03829501|455657066|FG018|Overall Study|Miscellaneous|0|||
126644492|NCT03829501|455657067|FG019|Overall Study|Miscellaneous|0|||
126644493|NCT03829501|455657068|FG020|Overall Study|Miscellaneous|0|||
126644494|NCT03829501|455657069|FG021|Overall Study|Miscellaneous|0|||
126644495|NCT03829501|455657070|FG022|Overall Study|Miscellaneous|1|||
126644496|NCT01123070|455657071|FG000|Part B Double Blind Period|Protocol Violation|0|||
126644497|NCT01123070|455657072|FG001|Part B Double Blind Period|Protocol Violation|0|||
126644498|NCT01123070|455657073|FG002|Part B Double Blind Period|Protocol Violation|0|||
126644499|NCT01123070|455657074|FG003|Part B Double Blind Period|Protocol Violation|1|||
126644500|NCT01123070|455657071|FG000|Part B Double Blind Period|Adverse Event|0|||
126644501|NCT01123070|455657072|FG001|Part B Double Blind Period|Adverse Event|0|||
126644502|NCT01123070|455657073|FG002|Part B Double Blind Period|Adverse Event|2|||
126644503|NCT01123070|455657074|FG003|Part B Double Blind Period|Adverse Event|0|||
126644504|NCT01123070|455657071|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
126644505|NCT01123070|455657072|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
126644506|NCT01123070|455657073|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
126644507|NCT01123070|455657074|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
126644508|NCT03284229|455657075|FG000|Overall Study|Lost to Follow-up|3|||
126644509|NCT01332630|455657076|FG000|Overall Study|Withdrawal by Subject|3|||
126644510|NCT03140280|455657077|FG000|Overall Study|Physician Decision|5|||
126644511|NCT01977677|455657090|FG000|Overall Study|Unrelated Adverse Event|0|||
126644512|NCT01977677|455657091|FG001|Overall Study|Unrelated Adverse Event|0|||
126644513|NCT01977677|455657092|FG002|Overall Study|Unrelated Adverse Event|1|||
126644514|NCT01498887|455657093|FG000|Overall Study|Administrative problems|1|||
126644515|NCT01498887|455657094|FG001|Overall Study|Administrative problems|0|||
126644516|NCT01498887|455657093|FG000|Overall Study|Lost to Follow-up|1|||
126644517|NCT01498887|455657094|FG001|Overall Study|Lost to Follow-up|1|||
126644518|NCT01498887|455657093|FG000|Overall Study|Withdrawal by Subject|1|||
126644519|NCT01498887|455657094|FG001|Overall Study|Withdrawal by Subject|0|||
126644520|NCT01498887|455657093|FG000|Overall Study|Protocol Violation|1|||
126644521|NCT01498887|455657094|FG001|Overall Study|Protocol Violation|3|||
126644522|NCT01498887|455657093|FG000|Overall Study|Lack of Efficacy|5|||
126644523|NCT01498887|455657094|FG001|Overall Study|Lack of Efficacy|3|||
126644524|NCT01498887|455657093|FG000|Overall Study|Abnormal result from test procedure|1|||
126644525|NCT01498887|455657094|FG001|Overall Study|Abnormal result from test procedure|1|||
126644526|NCT01498887|455657093|FG000|Overall Study|Abnormal laboratory value|2|||
126644527|NCT01498887|455657094|FG001|Overall Study|Abnormal laboratory value|2|||
126644528|NCT01498887|455657093|FG000|Overall Study|Adverse Event|4|||
126644529|NCT01498887|455657094|FG001|Overall Study|Adverse Event|1|||
126644530|NCT00667225|455657097|FG000|Overall Study|Subject had no more lesions to treat.|1|||
126644531|NCT00667225|455657098|FG001|Overall Study|Subject had no more lesions to treat.|0|||
126644532|NCT00667225|455657097|FG000|Overall Study|Lost to Follow-up|0|||
126644533|NCT00667225|455657098|FG001|Overall Study|Lost to Follow-up|1|||
126644534|NCT02993406|455657099|FG000|Overall Study|Withdrawal by Subject|170|||
126644535|NCT02993406|455657100|FG001|Overall Study|Withdrawal by Subject|196|||
126644536|NCT02993406|455657099|FG000|Overall Study|Physician Decision|3|||
126644537|NCT02993406|455657100|FG001|Overall Study|Physician Decision|5|||
126644538|NCT02993406|455657099|FG000|Overall Study|Lost to Follow-up|12|||
126644539|NCT02993406|455657100|FG001|Overall Study|Lost to Follow-up|13|||
126644540|NCT02993406|455657099|FG000|Overall Study|Unclassifiable Response|105|||
126644541|NCT02993406|455657100|FG001|Overall Study|Unclassifiable Response|139|||
126644542|NCT02993406|455657099|FG000|Overall Study|Administrative decision|1|||
126644543|NCT02993406|455657100|FG001|Overall Study|Administrative decision|0|||
126644544|NCT02993406|455657099|FG000|Overall Study|Sponsor decision|4|||
126644545|NCT02993406|455657100|FG001|Overall Study|Sponsor decision|5|||
126644546|NCT02248818|455657101|FG000|Screening|Protocol Violation|0|||
126644547|NCT02248818|455657102|FG001|Screening|Protocol Violation|0|||
126644548|NCT02248818|455657103|FG002|Screening|Protocol Violation|0|||
126644549|NCT02248818|455657104|FG003|Screening|Protocol Violation|0|||
126644550|NCT02248818|455657105|FG004|Screening|Protocol Violation|0|||
126644551|NCT02248818|455657106|FG005|Screening|Protocol Violation|0|||
126644552|NCT02248818|455657107|FG006|Screening|Protocol Violation|0|||
126644553|NCT02248818|455657108|FG007|Screening|Protocol Violation|0|||
126644554|NCT02248818|455657109|FG008|Screening|Protocol Violation|7|||
126644555|NCT02248818|455657101|FG000|Screening|Study fully enrolled|0|||
126644556|NCT02248818|455657102|FG001|Screening|Study fully enrolled|0|||
126644557|NCT02248818|455657103|FG002|Screening|Study fully enrolled|0|||
126644558|NCT02248818|455657104|FG003|Screening|Study fully enrolled|0|||
126644559|NCT02248818|455657105|FG004|Screening|Study fully enrolled|0|||
126644560|NCT02248818|455657106|FG005|Screening|Study fully enrolled|0|||
126644561|NCT02248818|455657107|FG006|Screening|Study fully enrolled|0|||
126644562|NCT02248818|455657108|FG007|Screening|Study fully enrolled|0|||
126644563|NCT02248818|455657109|FG008|Screening|Study fully enrolled|14|||
126644564|NCT02248818|455657101|FG000|Screening|Physician Decision|0|||
126644565|NCT02248818|455657102|FG001|Screening|Physician Decision|0|||
126644566|NCT02248818|455657103|FG002|Screening|Physician Decision|0|||
126644567|NCT02248818|455657104|FG003|Screening|Physician Decision|0|||
126644568|NCT02248818|455657105|FG004|Screening|Physician Decision|0|||
126644569|NCT02248818|455657106|FG005|Screening|Physician Decision|0|||
126644570|NCT02248818|455657107|FG006|Screening|Physician Decision|0|||
126644571|NCT02248818|455657108|FG007|Screening|Physician Decision|0|||
126644572|NCT02248818|455657109|FG008|Screening|Physician Decision|73|||
126644573|NCT02248818|455657101|FG000|Screening|Withdrawal by Subject|0|||
126644574|NCT02248818|455657102|FG001|Screening|Withdrawal by Subject|0|||
126644575|NCT02248818|455657103|FG002|Screening|Withdrawal by Subject|0|||
126644576|NCT02248818|455657104|FG003|Screening|Withdrawal by Subject|0|||
126644577|NCT02248818|455657105|FG004|Screening|Withdrawal by Subject|0|||
126644578|NCT02248818|455657106|FG005|Screening|Withdrawal by Subject|0|||
126644579|NCT02248818|455657107|FG006|Screening|Withdrawal by Subject|0|||
126644580|NCT02248818|455657108|FG007|Screening|Withdrawal by Subject|0|||
126644581|NCT02248818|455657109|FG008|Screening|Withdrawal by Subject|6|||
126644582|NCT02248818|455657101|FG000|Screening|Lost to Follow-up|0|||
126644583|NCT02248818|455657102|FG001|Screening|Lost to Follow-up|0|||
126644584|NCT02248818|455657103|FG002|Screening|Lost to Follow-up|0|||
126644585|NCT02248818|455657104|FG003|Screening|Lost to Follow-up|0|||
126644586|NCT02248818|455657105|FG004|Screening|Lost to Follow-up|0|||
126644587|NCT02248818|455657106|FG005|Screening|Lost to Follow-up|0|||
126644588|NCT02248818|455657107|FG006|Screening|Lost to Follow-up|0|||
126644589|NCT02248818|455657108|FG007|Screening|Lost to Follow-up|0|||
126644590|NCT02248818|455657109|FG008|Screening|Lost to Follow-up|7|||
126644591|NCT02248818|455657101|FG000|Randomised Study|Administrative - randomization error|0|||
126644592|NCT02248818|455657102|FG001|Randomised Study|Administrative - randomization error|0|||
126644593|NCT02248818|455657103|FG002|Randomised Study|Administrative - randomization error|0|||
126644594|NCT02248818|455657104|FG003|Randomised Study|Administrative - randomization error|0|||
126644595|NCT02248818|455657105|FG004|Randomised Study|Administrative - randomization error|0|||
126644596|NCT02248818|455657106|FG005|Randomised Study|Administrative - randomization error|8|||
126644597|NCT02248818|455657107|FG006|Randomised Study|Administrative - randomization error|0|||
126644598|NCT02248818|455657108|FG007|Randomised Study|Administrative - randomization error|0|||
126644599|NCT02248818|455657109|FG008|Randomised Study|Administrative - randomization error|0|||
126644600|NCT05262517|455657110|FG000|Overall Study|Randomized but not treated|5|||
126644601|NCT05262517|455657111|FG001|Overall Study|Randomized but not treated|11|||
126644602|NCT04325282|455657112|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
126644603|NCT04325282|455657113|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
126644604|NCT04325282|455657112|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
126644605|NCT04325282|455657113|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
126644606|NCT00527787|455657115|FG000|Overall Study|Adverse Event|14|||
126644607|NCT00527787|455657116|FG001|Overall Study|Adverse Event|24|||
126644608|NCT00527787|455657115|FG000|Overall Study|Withdrawal by Subject|13|||
126644609|NCT00527787|455657116|FG001|Overall Study|Withdrawal by Subject|25|||
126644610|NCT00527787|455657115|FG000|Overall Study|Lost to Follow-up|5|||
126644611|NCT00527787|455657116|FG001|Overall Study|Lost to Follow-up|2|||
126644612|NCT00527787|455657115|FG000|Overall Study|Duodenal Ulcer|1|||
126644613|NCT00527787|455657116|FG001|Overall Study|Duodenal Ulcer|10|||
126644614|NCT00527787|455657115|FG000|Overall Study|misc|5|||
126644615|NCT00527787|455657116|FG001|Overall Study|misc|2|||
126644616|NCT03330405|455657117|FG000|Overall Study|Other|1|||
126644617|NCT03330405|455657118|FG001|Overall Study|Other|3|||
126644618|NCT03330405|455657119|FG002|Overall Study|Other|1|||
126644619|NCT03330405|455657120|FG003|Overall Study|Other|0|||
126644620|NCT03330405|455657121|FG004|Overall Study|Other|2|||
126644621|NCT03330405|455657122|FG005|Overall Study|Other|0|||
126644622|NCT03330405|455657123|FG006|Overall Study|Other|1|||
126644623|NCT03330405|455657124|FG007|Overall Study|Other|0|||
126644624|NCT03330405|455657125|FG008|Overall Study|Other|0|||
126644625|NCT03330405|455657126|FG009|Overall Study|Other|0|||
126644626|NCT03330405|455657127|FG010|Overall Study|Other|0|||
126644627|NCT03330405|455657117|FG000|Overall Study|Progressive disease|8|||
126644628|NCT03330405|455657118|FG001|Overall Study|Progressive disease|27|||
126644629|NCT03330405|455657119|FG002|Overall Study|Progressive disease|4|||
126644630|NCT03330405|455657120|FG003|Overall Study|Progressive disease|18|||
126644631|NCT03330405|455657121|FG004|Overall Study|Progressive disease|16|||
126644632|NCT03330405|455657122|FG005|Overall Study|Progressive disease|14|||
126644633|NCT03330405|455657123|FG006|Overall Study|Progressive disease|7|||
126644634|NCT03330405|455657124|FG007|Overall Study|Progressive disease|29|||
126644635|NCT03330405|455657125|FG008|Overall Study|Progressive disease|9|||
126644636|NCT03330405|455657126|FG009|Overall Study|Progressive disease|11|||
126644637|NCT03330405|455657127|FG010|Overall Study|Progressive disease|5|||
126644638|NCT03330405|455657117|FG000|Overall Study|Withdrawal by Subject|1|||
126644639|NCT03330405|455657118|FG001|Overall Study|Withdrawal by Subject|4|||
126644640|NCT03330405|455657119|FG002|Overall Study|Withdrawal by Subject|0|||
126644641|NCT03330405|455657120|FG003|Overall Study|Withdrawal by Subject|1|||
126644642|NCT03330405|455657121|FG004|Overall Study|Withdrawal by Subject|1|||
126644643|NCT03330405|455657122|FG005|Overall Study|Withdrawal by Subject|1|||
126644644|NCT03330405|455657123|FG006|Overall Study|Withdrawal by Subject|0|||
126644645|NCT03330405|455657124|FG007|Overall Study|Withdrawal by Subject|2|||
126644646|NCT03330405|455657125|FG008|Overall Study|Withdrawal by Subject|2|||
126644647|NCT03330405|455657126|FG009|Overall Study|Withdrawal by Subject|1|||
126644648|NCT03330405|455657127|FG010|Overall Study|Withdrawal by Subject|1|||
126644649|NCT03330405|455657117|FG000|Overall Study|Global deterioration of health status|2|||
126644650|NCT03330405|455657118|FG001|Overall Study|Global deterioration of health status|3|||
126644651|NCT03330405|455657119|FG002|Overall Study|Global deterioration of health status|0|||
126644652|NCT03330405|455657120|FG003|Overall Study|Global deterioration of health status|2|||
126644653|NCT03330405|455657121|FG004|Overall Study|Global deterioration of health status|3|||
126644654|NCT03330405|455657122|FG005|Overall Study|Global deterioration of health status|3|||
126644655|NCT03330405|455657123|FG006|Overall Study|Global deterioration of health status|0|||
126644656|NCT03330405|455657124|FG007|Overall Study|Global deterioration of health status|2|||
126644657|NCT03330405|455657125|FG008|Overall Study|Global deterioration of health status|8|||
126644658|NCT03330405|455657126|FG009|Overall Study|Global deterioration of health status|4|||
126644659|NCT03330405|455657127|FG010|Overall Study|Global deterioration of health status|1|||
126644660|NCT03330405|455657117|FG000|Overall Study|Adverse Event|0|||
126644661|NCT03330405|455657118|FG001|Overall Study|Adverse Event|1|||
126644662|NCT03330405|455657119|FG002|Overall Study|Adverse Event|0|||
126644663|NCT03330405|455657120|FG003|Overall Study|Adverse Event|1|||
126644664|NCT03330405|455657121|FG004|Overall Study|Adverse Event|1|||
126644665|NCT03330405|455657122|FG005|Overall Study|Adverse Event|1|||
126644666|NCT03330405|455657123|FG006|Overall Study|Adverse Event|3|||
126644667|NCT03330405|455657124|FG007|Overall Study|Adverse Event|4|||
126644668|NCT03330405|455657125|FG008|Overall Study|Adverse Event|2|||
126644669|NCT03330405|455657126|FG009|Overall Study|Adverse Event|2|||
126644670|NCT03330405|455657127|FG010|Overall Study|Adverse Event|2|||
126644671|NCT03330405|455657117|FG000|Overall Study|Death|0|||
126644672|NCT03330405|455657118|FG001|Overall Study|Death|4|||
126644673|NCT03330405|455657119|FG002|Overall Study|Death|0|||
126644674|NCT03330405|455657120|FG003|Overall Study|Death|0|||
126644675|NCT03330405|455657121|FG004|Overall Study|Death|0|||
126644676|NCT03330405|455657122|FG005|Overall Study|Death|1|||
126644677|NCT03330405|455657123|FG006|Overall Study|Death|0|||
126644678|NCT03330405|455657124|FG007|Overall Study|Death|2|||
126644679|NCT03330405|455657125|FG008|Overall Study|Death|0|||
126644680|NCT03330405|455657126|FG009|Overall Study|Death|0|||
126644681|NCT03330405|455657127|FG010|Overall Study|Death|0|||
126644682|NCT03330405|455657117|FG000|Overall Study|Physician Decision|0|||
126644683|NCT03330405|455657118|FG001|Overall Study|Physician Decision|0|||
126644684|NCT03330405|455657119|FG002|Overall Study|Physician Decision|0|||
126644685|NCT03330405|455657120|FG003|Overall Study|Physician Decision|0|||
126644686|NCT03330405|455657121|FG004|Overall Study|Physician Decision|0|||
126644687|NCT03330405|455657122|FG005|Overall Study|Physician Decision|0|||
126644688|NCT03330405|455657123|FG006|Overall Study|Physician Decision|0|||
126644689|NCT03330405|455657124|FG007|Overall Study|Physician Decision|1|||
126644690|NCT03330405|455657125|FG008|Overall Study|Physician Decision|0|||
126644691|NCT03330405|455657126|FG009|Overall Study|Physician Decision|0|||
126644692|NCT03330405|455657127|FG010|Overall Study|Physician Decision|0|||
126644693|NCT02643303|455657128|FG000|Overall Study|Progressive Disease|4|||
126644694|NCT02643303|455657129|FG001|Overall Study|Progressive Disease|4|||
126644695|NCT02643303|455657130|FG002|Overall Study|Progressive Disease|1|||
126644696|NCT02643303|455657131|FG003|Overall Study|Progressive Disease|12|||
126644697|NCT02643303|455657132|FG004|Overall Study|Progressive Disease|6|||
126644698|NCT02643303|455657133|FG005|Overall Study|Progressive Disease|4|||
126644699|NCT02643303|455657134|FG006|Overall Study|Progressive Disease|8|||
126644700|NCT02643303|455657135|FG007|Overall Study|Progressive Disease|2|||
126644701|NCT02643303|455657136|FG008|Overall Study|Progressive Disease|6|||
126644702|NCT02643303|455657128|FG000|Overall Study|Adverse Event|0|||
126644703|NCT02643303|455657129|FG001|Overall Study|Adverse Event|1|||
126644704|NCT02643303|455657130|FG002|Overall Study|Adverse Event|0|||
126644705|NCT02643303|455657131|FG003|Overall Study|Adverse Event|0|||
126644706|NCT02643303|455657132|FG004|Overall Study|Adverse Event|1|||
126644707|NCT02643303|455657133|FG005|Overall Study|Adverse Event|0|||
126644708|NCT02643303|455657134|FG006|Overall Study|Adverse Event|0|||
126644709|NCT02643303|455657135|FG007|Overall Study|Adverse Event|0|||
126644710|NCT02643303|455657136|FG008|Overall Study|Adverse Event|0|||
126644711|NCT02643303|455657128|FG000|Overall Study|Withdrawal by Subject|0|||
126644712|NCT02643303|455657129|FG001|Overall Study|Withdrawal by Subject|0|||
126644713|NCT02643303|455657130|FG002|Overall Study|Withdrawal by Subject|0|||
126644714|NCT02643303|455657131|FG003|Overall Study|Withdrawal by Subject|1|||
126644715|NCT02643303|455657132|FG004|Overall Study|Withdrawal by Subject|0|||
126644716|NCT02643303|455657133|FG005|Overall Study|Withdrawal by Subject|0|||
126644717|NCT02643303|455657134|FG006|Overall Study|Withdrawal by Subject|1|||
126644718|NCT02643303|455657135|FG007|Overall Study|Withdrawal by Subject|1|||
126644719|NCT02643303|455657136|FG008|Overall Study|Withdrawal by Subject|1|||
126644720|NCT02383940|455657139|FG000|Overall Study|Adverse Event|1|||
126644721|NCT02383940|455657140|FG001|Overall Study|Adverse Event|0|||
126644722|NCT02383940|455657139|FG000|Overall Study|Lost to Follow-up|2|||
126644723|NCT02383940|455657140|FG001|Overall Study|Lost to Follow-up|2|||
126644724|NCT02383940|455657139|FG000|Overall Study|Physician Decision|2|||
126644725|NCT02383940|455657140|FG001|Overall Study|Physician Decision|0|||
126644726|NCT02383940|455657139|FG000|Overall Study|Withdrawal by Subject|1|||
126644727|NCT02383940|455657140|FG001|Overall Study|Withdrawal by Subject|1|||
126644728|NCT02383940|455657139|FG000|Overall Study|Randomized but not treated|2|||
126644729|NCT02383940|455657140|FG001|Overall Study|Randomized but not treated|0|||
126644730|NCT02383940|455657139|FG000|Overall Study|Other than specified above|1|||
126644731|NCT02383940|455657140|FG001|Overall Study|Other than specified above|0|||
126644732|NCT02672852|455657141|FG000|Part A1|Disease Worsening|1|||
126644733|NCT02672852|455657142|FG001|Part A1|Disease Worsening|0|||
126644734|NCT02672852|455657143|FG002|Part A1|Disease Worsening|0|||
126644735|NCT02672852|455657144|FG003|Part A1|Disease Worsening|0|||
126644736|NCT02672852|455657145|FG004|Part A1|Disease Worsening|0|||
126644737|NCT02672852|455657146|FG005|Part A1|Disease Worsening|0|||
126644738|NCT02672852|455657147|FG006|Part A1|Disease Worsening|0|||
126644739|NCT02672852|455657141|FG000|Part A1|Adverse Event|0|||
126644740|NCT02672852|455657142|FG001|Part A1|Adverse Event|1|||
126644741|NCT02672852|455657143|FG002|Part A1|Adverse Event|0|||
126644742|NCT02672852|455657144|FG003|Part A1|Adverse Event|0|||
126644743|NCT02672852|455657145|FG004|Part A1|Adverse Event|0|||
126644744|NCT02672852|455657146|FG005|Part A1|Adverse Event|0|||
126644745|NCT02672852|455657147|FG006|Part A1|Adverse Event|0|||
126644746|NCT02672852|455657141|FG000|Part A1|Lost to Follow-up|1|||
126644747|NCT02672852|455657142|FG001|Part A1|Lost to Follow-up|2|||
126644748|NCT02672852|455657143|FG002|Part A1|Lost to Follow-up|0|||
126644749|NCT02672852|455657144|FG003|Part A1|Lost to Follow-up|0|||
126644750|NCT02672852|455657145|FG004|Part A1|Lost to Follow-up|0|||
126644751|NCT02672852|455657146|FG005|Part A1|Lost to Follow-up|0|||
126644752|NCT02672852|455657147|FG006|Part A1|Lost to Follow-up|0|||
126644753|NCT02672852|455657141|FG000|Part A1|Withdrawal by Subject|1|||
126644754|NCT02672852|455657142|FG001|Part A1|Withdrawal by Subject|1|||
126644755|NCT02672852|455657143|FG002|Part A1|Withdrawal by Subject|0|||
126644756|NCT02672852|455657144|FG003|Part A1|Withdrawal by Subject|0|||
126644757|NCT02672852|455657145|FG004|Part A1|Withdrawal by Subject|0|||
126644758|NCT02672852|455657146|FG005|Part A1|Withdrawal by Subject|0|||
126644759|NCT02672852|455657147|FG006|Part A1|Withdrawal by Subject|0|||
126644760|NCT02672852|455657141|FG000|Part A2|Disease worsening|0|||
126644761|NCT02672852|455657142|FG001|Part A2|Disease worsening|0|||
126644762|NCT02672852|455657143|FG002|Part A2|Disease worsening|1|||
126644763|NCT02672852|455657144|FG003|Part A2|Disease worsening|0|||
126644764|NCT02672852|455657145|FG004|Part A2|Disease worsening|0|||
126644765|NCT02672852|455657146|FG005|Part A2|Disease worsening|0|||
126644766|NCT02672852|455657147|FG006|Part A2|Disease worsening|0|||
126644767|NCT02672852|455657141|FG000|Part A2|Adverse Event|0|||
126644768|NCT02672852|455657142|FG001|Part A2|Adverse Event|0|||
126644769|NCT02672852|455657143|FG002|Part A2|Adverse Event|3|||
126644770|NCT02672852|455657144|FG003|Part A2|Adverse Event|0|||
126644771|NCT02672852|455657145|FG004|Part A2|Adverse Event|0|||
126644772|NCT02672852|455657146|FG005|Part A2|Adverse Event|0|||
126644773|NCT02672852|455657147|FG006|Part A2|Adverse Event|0|||
126644774|NCT02672852|455657141|FG000|Part A2|Lost to Follow-up|0|||
126644775|NCT02672852|455657142|FG001|Part A2|Lost to Follow-up|0|||
126644776|NCT02672852|455657143|FG002|Part A2|Lost to Follow-up|2|||
126644777|NCT02672852|455657144|FG003|Part A2|Lost to Follow-up|0|||
126644778|NCT02672852|455657145|FG004|Part A2|Lost to Follow-up|0|||
126644779|NCT02672852|455657146|FG005|Part A2|Lost to Follow-up|0|||
126644780|NCT02672852|455657147|FG006|Part A2|Lost to Follow-up|0|||
126644781|NCT02672852|455657141|FG000|Part A2|Withdrawal by Subject|0|||
126644782|NCT02672852|455657142|FG001|Part A2|Withdrawal by Subject|0|||
126644783|NCT02672852|455657143|FG002|Part A2|Withdrawal by Subject|1|||
126644784|NCT02672852|455657144|FG003|Part A2|Withdrawal by Subject|0|||
126644785|NCT02672852|455657145|FG004|Part A2|Withdrawal by Subject|0|||
126644786|NCT02672852|455657146|FG005|Part A2|Withdrawal by Subject|0|||
126644787|NCT02672852|455657147|FG006|Part A2|Withdrawal by Subject|0|||
126644788|NCT02672852|455657141|FG000|Part A2|Other|0|||
126644789|NCT02672852|455657142|FG001|Part A2|Other|0|||
126644790|NCT02672852|455657143|FG002|Part A2|Other|3|||
126644791|NCT02672852|455657144|FG003|Part A2|Other|0|||
126644792|NCT02672852|455657145|FG004|Part A2|Other|0|||
126644793|NCT02672852|455657146|FG005|Part A2|Other|0|||
126644794|NCT02672852|455657147|FG006|Part A2|Other|0|||
126644795|NCT02672852|455657141|FG000|Part A2|Not entered in Part B|0|||
126644796|NCT02672852|455657142|FG001|Part A2|Not entered in Part B|0|||
126644797|NCT02672852|455657143|FG002|Part A2|Not entered in Part B|0|||
126644798|NCT02672852|455657144|FG003|Part A2|Not entered in Part B|4|||
126644799|NCT02672852|455657145|FG004|Part A2|Not entered in Part B|0|||
126644800|NCT02672852|455657146|FG005|Part A2|Not entered in Part B|0|||
126644801|NCT02672852|455657147|FG006|Part A2|Not entered in Part B|0|||
126644802|NCT02672852|455657141|FG000|Part B|Disease worsening|0|||
126644803|NCT02672852|455657142|FG001|Part B|Disease worsening|0|||
126644804|NCT02672852|455657143|FG002|Part B|Disease worsening|0|||
126644805|NCT02672852|455657144|FG003|Part B|Disease worsening|0|||
126644806|NCT02672852|455657145|FG004|Part B|Disease worsening|1|||
126644807|NCT02672852|455657146|FG005|Part B|Disease worsening|0|||
126644808|NCT02672852|455657147|FG006|Part B|Disease worsening|1|||
126644809|NCT02672852|455657141|FG000|Part B|Worsening pre-existing condition|0|||
126644810|NCT02672852|455657142|FG001|Part B|Worsening pre-existing condition|0|||
126644811|NCT02672852|455657143|FG002|Part B|Worsening pre-existing condition|0|||
126644812|NCT02672852|455657144|FG003|Part B|Worsening pre-existing condition|0|||
126644813|NCT02672852|455657145|FG004|Part B|Worsening pre-existing condition|0|||
126644814|NCT02672852|455657146|FG005|Part B|Worsening pre-existing condition|1|||
126644815|NCT02672852|455657147|FG006|Part B|Worsening pre-existing condition|0|||
126644816|NCT02672852|455657141|FG000|Part B|Other adverse event|0|||
126644817|NCT02672852|455657142|FG001|Part B|Other adverse event|0|||
126644818|NCT02672852|455657143|FG002|Part B|Other adverse event|0|||
126644819|NCT02672852|455657144|FG003|Part B|Other adverse event|0|||
126644820|NCT02672852|455657145|FG004|Part B|Other adverse event|3|||
126644821|NCT02672852|455657146|FG005|Part B|Other adverse event|5|||
126644822|NCT02672852|455657147|FG006|Part B|Other adverse event|1|||
126644823|NCT02672852|455657141|FG000|Part B|Lost to Follow-up|0|||
126644824|NCT02672852|455657142|FG001|Part B|Lost to Follow-up|0|||
126644825|NCT02672852|455657143|FG002|Part B|Lost to Follow-up|0|||
126644826|NCT02672852|455657144|FG003|Part B|Lost to Follow-up|0|||
126644827|NCT02672852|455657145|FG004|Part B|Lost to Follow-up|3|||
126644828|NCT02672852|455657146|FG005|Part B|Lost to Follow-up|4|||
126644829|NCT02672852|455657147|FG006|Part B|Lost to Follow-up|1|||
126644830|NCT02672852|455657141|FG000|Part B|Withdrawal by Subject|0|||
126644831|NCT02672852|455657142|FG001|Part B|Withdrawal by Subject|0|||
126644832|NCT02672852|455657143|FG002|Part B|Withdrawal by Subject|0|||
126644833|NCT02672852|455657144|FG003|Part B|Withdrawal by Subject|0|||
126644834|NCT02672852|455657145|FG004|Part B|Withdrawal by Subject|5|||
126644835|NCT02672852|455657146|FG005|Part B|Withdrawal by Subject|0|||
126644836|NCT02672852|455657147|FG006|Part B|Withdrawal by Subject|7|||
126644837|NCT02672852|455657141|FG000|Part B|Other|0|||
126644838|NCT02672852|455657142|FG001|Part B|Other|0|||
126644839|NCT02672852|455657143|FG002|Part B|Other|0|||
126644840|NCT02672852|455657144|FG003|Part B|Other|0|||
126644841|NCT02672852|455657145|FG004|Part B|Other|4|||
126644842|NCT02672852|455657146|FG005|Part B|Other|1|||
126644843|NCT02672852|455657147|FG006|Part B|Other|2|||
126644844|NCT04308590|455657148|FG000|Overall Study|Adverse Event|12|||
126644845|NCT04308590|455657149|FG001|Overall Study|Adverse Event|2|||
126644846|NCT04308590|455657148|FG000|Overall Study|Withdrawal by Subject|10|||
126644847|NCT04308590|455657149|FG001|Overall Study|Withdrawal by Subject|4|||
126644848|NCT04308590|455657148|FG000|Overall Study|Death|1|||
126644849|NCT04308590|455657149|FG001|Overall Study|Death|0|||
126644850|NCT04308590|455657148|FG000|Overall Study|Lost to Follow-up|1|||
126644851|NCT04308590|455657149|FG001|Overall Study|Lost to Follow-up|1|||
126644852|NCT04308590|455657148|FG000|Overall Study|Physician Decision|1|||
126644853|NCT04308590|455657149|FG001|Overall Study|Physician Decision|0|||
126644854|NCT04308590|455657148|FG000|Overall Study|Subject does not want to continue with Pi|0|||
126644855|NCT04308590|455657149|FG001|Overall Study|Subject does not want to continue with Pi|1|||
126644856|NCT05487586|455657150|FG000|Overall Study|Death|22|||
126644857|NCT05487586|455657150|FG000|Overall Study|Physician Decision|1|||
126644858|NCT05487586|455657150|FG000|Overall Study|Transfer to another hospital|4|||
126644859|NCT05487586|455657150|FG000|Overall Study|Other|1|||
126644860|NCT01598662|455657151|FG000|Overall Study|Lost to Follow-up|10|||
126644861|NCT01598662|455657152|FG001|Overall Study|Lost to Follow-up|17|||
126644862|NCT01598662|455657151|FG000|Overall Study|Physician Decision|1|||
126644863|NCT01598662|455657152|FG001|Overall Study|Physician Decision|2|||
126644864|NCT01598662|455657151|FG000|Overall Study|IUD expelled before month 6|0|||
126644865|NCT01598662|455657152|FG001|Overall Study|IUD expelled before month 6|2|||
126644866|NCT00643617|455657153|FG000|Overall Study|Death|6|||
126644867|NCT00643617|455657154|FG001|Overall Study|Death|9|||
126644868|NCT00643617|455657153|FG000|Overall Study|Lost to Follow-up|42|||
126644869|NCT00643617|455657154|FG001|Overall Study|Lost to Follow-up|51|||
126644870|NCT02683785|455657157|FG000|Overall Study|Withdrawal by Subject|1|||
126644871|NCT02683785|455657158|FG001|Overall Study|Withdrawal by Subject|1|||
126644872|NCT02683785|455657157|FG000|Overall Study|Lost to Follow-up|0|||
126644873|NCT02683785|455657158|FG001|Overall Study|Lost to Follow-up|1|||
126644874|NCT02683785|455657157|FG000|Overall Study|Adverse Event|0|||
126644875|NCT02683785|455657158|FG001|Overall Study|Adverse Event|2|||
126644876|NCT02233803|455657163|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
126644877|NCT02233803|455657164|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
126644878|NCT02233803|455657163|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
126644879|NCT02233803|455657164|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
126644880|NCT02233803|455657163|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
126644881|NCT02233803|455657164|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
126644882|NCT02233803|455657163|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
126644883|NCT02233803|455657164|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
126644884|NCT02233803|455657163|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
126644885|NCT02233803|455657164|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
126644886|NCT02233803|455657163|FG000|Washout Period (4-Wks)|Physician Decision|1|||
126644887|NCT02233803|455657164|FG001|Washout Period (4-Wks)|Physician Decision|0|||
126644888|NCT02233803|455657163|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
126644889|NCT02233803|455657164|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
126644890|NCT02233803|455657163|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
126644891|NCT02233803|455657164|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
126644892|NCT02233803|455657163|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
126644893|NCT02233803|455657164|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
126644894|NCT03635099|455657165|FG000|Period 1|Adverse Event|1|||
126644895|NCT03635099|455657166|FG001|Period 1|Adverse Event|0|||
126644896|NCT03635099|455657167|FG002|Period 1|Adverse Event|0|||
126644897|NCT03635099|455657168|FG003|Period 1|Adverse Event|1|||
126644898|NCT03635099|455657169|FG004|Period 1|Adverse Event|0|||
126644899|NCT03635099|455657170|FG005|Period 1|Adverse Event|0|||
126644900|NCT03635099|455657171|FG006|Period 1|Adverse Event|0|||
126644901|NCT03635099|455657172|FG007|Period 1|Adverse Event|0|||
126644902|NCT03635099|455657165|FG000|Period 1|Protocol Violation|0|||
126644903|NCT03635099|455657166|FG001|Period 1|Protocol Violation|0|||
126644904|NCT03635099|455657167|FG002|Period 1|Protocol Violation|1|||
126644905|NCT03635099|455657168|FG003|Period 1|Protocol Violation|0|||
126644906|NCT03635099|455657169|FG004|Period 1|Protocol Violation|0|||
126644907|NCT03635099|455657170|FG005|Period 1|Protocol Violation|0|||
126644908|NCT03635099|455657171|FG006|Period 1|Protocol Violation|0|||
126644909|NCT03635099|455657172|FG007|Period 1|Protocol Violation|0|||
126644910|NCT03635099|455657165|FG000|Period 1|Lost to Follow-up|0|||
126644911|NCT03635099|455657166|FG001|Period 1|Lost to Follow-up|0|||
126644912|NCT03635099|455657167|FG002|Period 1|Lost to Follow-up|1|||
126644913|NCT03635099|455657168|FG003|Period 1|Lost to Follow-up|2|||
126644914|NCT03635099|455657169|FG004|Period 1|Lost to Follow-up|1|||
126644915|NCT03635099|455657170|FG005|Period 1|Lost to Follow-up|0|||
126644916|NCT03635099|455657171|FG006|Period 1|Lost to Follow-up|1|||
126644917|NCT03635099|455657172|FG007|Period 1|Lost to Follow-up|2|||
126644918|NCT03635099|455657165|FG000|Period 1|Withdrawal by Subject|3|||
126644919|NCT03635099|455657166|FG001|Period 1|Withdrawal by Subject|3|||
126644920|NCT03635099|455657167|FG002|Period 1|Withdrawal by Subject|5|||
126644921|NCT03635099|455657168|FG003|Period 1|Withdrawal by Subject|2|||
126644922|NCT03635099|455657169|FG004|Period 1|Withdrawal by Subject|2|||
126644923|NCT03635099|455657170|FG005|Period 1|Withdrawal by Subject|0|||
126644924|NCT03635099|455657171|FG006|Period 1|Withdrawal by Subject|3|||
126644925|NCT03635099|455657172|FG007|Period 1|Withdrawal by Subject|0|||
126644926|NCT03635099|455657165|FG000|Period 1|History of suicidal ideation|0|||
126644927|NCT03635099|455657166|FG001|Period 1|History of suicidal ideation|0|||
126644928|NCT03635099|455657167|FG002|Period 1|History of suicidal ideation|1|||
126644929|NCT03635099|455657168|FG003|Period 1|History of suicidal ideation|0|||
126644930|NCT03635099|455657169|FG004|Period 1|History of suicidal ideation|0|||
126644931|NCT03635099|455657170|FG005|Period 1|History of suicidal ideation|0|||
126644932|NCT03635099|455657171|FG006|Period 1|History of suicidal ideation|0|||
126644933|NCT03635099|455657172|FG007|Period 1|History of suicidal ideation|0|||
126644934|NCT03635099|455657165|FG000|Period 1|pursue other treatment options|0|||
126644935|NCT03635099|455657166|FG001|Period 1|pursue other treatment options|0|||
126644936|NCT03635099|455657167|FG002|Period 1|pursue other treatment options|0|||
126644937|NCT03635099|455657168|FG003|Period 1|pursue other treatment options|0|||
126644938|NCT03635099|455657169|FG004|Period 1|pursue other treatment options|0|||
126644939|NCT03635099|455657170|FG005|Period 1|pursue other treatment options|1|||
126644940|NCT03635099|455657171|FG006|Period 1|pursue other treatment options|0|||
126644941|NCT03635099|455657172|FG007|Period 1|pursue other treatment options|0|||
126644942|NCT03635099|455657165|FG000|Not Eligible for Period 2|Pregnancy|0|||
126644943|NCT03635099|455657166|FG001|Not Eligible for Period 2|Pregnancy|0|||
126644944|NCT03635099|455657167|FG002|Not Eligible for Period 2|Pregnancy|0|||
126644945|NCT03635099|455657168|FG003|Not Eligible for Period 2|Pregnancy|1|||
126644946|NCT03635099|455657169|FG004|Not Eligible for Period 2|Pregnancy|0|||
126644947|NCT03635099|455657170|FG005|Not Eligible for Period 2|Pregnancy|0|||
126644948|NCT03635099|455657171|FG006|Not Eligible for Period 2|Pregnancy|0|||
126644949|NCT03635099|455657172|FG007|Not Eligible for Period 2|Pregnancy|0|||
126644950|NCT03635099|455657165|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
126644951|NCT03635099|455657166|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
126644952|NCT03635099|455657167|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
126644953|NCT03635099|455657168|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
126644954|NCT03635099|455657169|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
126644955|NCT03635099|455657170|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
126644956|NCT03635099|455657171|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
126644957|NCT03635099|455657172|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
126644958|NCT03635099|455657165|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
126644959|NCT03635099|455657166|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
126644960|NCT03635099|455657167|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
126644961|NCT03635099|455657168|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
126644962|NCT03635099|455657169|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
126644963|NCT03635099|455657170|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
126644964|NCT03635099|455657171|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
126644965|NCT03635099|455657172|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
126644966|NCT03635099|455657165|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
126644967|NCT03635099|455657166|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
126644968|NCT03635099|455657167|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
126644969|NCT03635099|455657168|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
126644970|NCT03635099|455657169|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
126644971|NCT03635099|455657170|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
126644972|NCT03635099|455657171|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
126644973|NCT03635099|455657172|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
126644974|NCT03635099|455657165|FG000|Period 2|Adverse Event|0|||
126644975|NCT03635099|455657166|FG001|Period 2|Adverse Event|0|||
126644976|NCT03635099|455657167|FG002|Period 2|Adverse Event|1|||
126644977|NCT03635099|455657168|FG003|Period 2|Adverse Event|0|||
126644978|NCT03635099|455657169|FG004|Period 2|Adverse Event|1|||
126644979|NCT03635099|455657170|FG005|Period 2|Adverse Event|0|||
126644980|NCT03635099|455657171|FG006|Period 2|Adverse Event|0|||
126644981|NCT03635099|455657172|FG007|Period 2|Adverse Event|0|||
126644982|NCT03635099|455657165|FG000|Period 2|Lost to Follow-up|0|||
126644983|NCT03635099|455657166|FG001|Period 2|Lost to Follow-up|0|||
126644984|NCT03635099|455657167|FG002|Period 2|Lost to Follow-up|1|||
126644985|NCT03635099|455657168|FG003|Period 2|Lost to Follow-up|0|||
126644986|NCT03635099|455657169|FG004|Period 2|Lost to Follow-up|4|||
126644987|NCT03635099|455657170|FG005|Period 2|Lost to Follow-up|0|||
126644988|NCT03635099|455657171|FG006|Period 2|Lost to Follow-up|0|||
126644989|NCT03635099|455657172|FG007|Period 2|Lost to Follow-up|0|||
126644990|NCT03635099|455657165|FG000|Period 2|Withdrawal by Subject|0|||
126644991|NCT03635099|455657166|FG001|Period 2|Withdrawal by Subject|0|||
126644992|NCT03635099|455657167|FG002|Period 2|Withdrawal by Subject|7|||
126644993|NCT03635099|455657168|FG003|Period 2|Withdrawal by Subject|4|||
126644994|NCT03635099|455657169|FG004|Period 2|Withdrawal by Subject|7|||
126644995|NCT03635099|455657170|FG005|Period 2|Withdrawal by Subject|0|||
126644996|NCT03635099|455657171|FG006|Period 2|Withdrawal by Subject|0|||
126644997|NCT03635099|455657172|FG007|Period 2|Withdrawal by Subject|0|||
126644998|NCT04191616|455657174|FG000|Pre-assignment Period|Did not receive study treatment|2|||
126644999|NCT04191616|455657174|FG000|Treatment Period|Death|37|||
126645000|NCT04191616|455657174|FG000|Treatment Period|Sponsor decision|11|||
126645001|NCT04191616|455657174|FG000|Treatment Period|Withdrawal by Subject|4|||
126645002|NCT04230122|455657175|FG000|Overall Study|Lost to Follow-up|1|||
126645003|NCT04230122|455657176|FG001|Overall Study|Lost to Follow-up|0|||
126645004|NCT01840410|455657179|FG000|Overall Study|Physician Decision|1|||
126645005|NCT01840410|455657180|FG001|Overall Study|Physician Decision|2|||
126645006|NCT01840410|455657179|FG000|Overall Study|Pregnancy|1|||
126645007|NCT01840410|455657180|FG001|Overall Study|Pregnancy|0|||
126645008|NCT01840410|455657179|FG000|Overall Study|Protocol deviation|1|||
126645009|NCT01840410|455657180|FG001|Overall Study|Protocol deviation|0|||
126645010|NCT01840410|455657179|FG000|Overall Study|Lost to Follow-up|1|||
126645011|NCT01840410|455657180|FG001|Overall Study|Lost to Follow-up|0|||
126645012|NCT01840410|455657179|FG000|Overall Study|Withdrawal by Subject|2|||
126645013|NCT01840410|455657180|FG001|Overall Study|Withdrawal by Subject|1|||
126645014|NCT01840410|455657179|FG000|Overall Study|Adverse Event|1|||
126645015|NCT01840410|455657180|FG001|Overall Study|Adverse Event|1|||
126645016|NCT02671500|455657183|FG000|Overall Study|Lack of Efficacy|12|||
126645017|NCT02671500|455657183|FG000|Overall Study|Lost to Follow-up|2|||
126645018|NCT00798434|455657186|FG000|Double-Blind|Adverse Event|22|||
126645019|NCT00798434|455657187|FG001|Double-Blind|Adverse Event|46|||
126645020|NCT00798434|455657186|FG000|Double-Blind|Death|0|||
126645021|NCT00798434|455657187|FG001|Double-Blind|Death|1|||
126645022|NCT00798434|455657186|FG000|Double-Blind|Lost to Follow-up|1|||
126645023|NCT00798434|455657187|FG001|Double-Blind|Lost to Follow-up|0|||
126645024|NCT00798434|455657186|FG000|Double-Blind|Lack of Efficacy|8|||
126645025|NCT00798434|455657187|FG001|Double-Blind|Lack of Efficacy|12|||
126645026|NCT00798434|455657186|FG000|Double-Blind|Withdrawal by Subject|17|||
126645027|NCT00798434|455657187|FG001|Double-Blind|Withdrawal by Subject|14|||
126645028|NCT00798434|455657186|FG000|Double-Blind|Protocol Violation|1|||
126645029|NCT00798434|455657187|FG001|Double-Blind|Protocol Violation|4|||
126645030|NCT00798434|455657186|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
126645031|NCT00798434|455657187|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
126645032|NCT00798434|455657186|FG000|Double-Blind|Other|1|||
126645033|NCT00798434|455657187|FG001|Double-Blind|Other|0|||
126645034|NCT00798434|455657186|FG000|Double-Blind|Not Treated|3|||
126645035|NCT00798434|455657187|FG001|Double-Blind|Not Treated|6|||
126645036|NCT00798434|455657186|FG000|Open-Label|Adverse Event|33|||
126645037|NCT00798434|455657187|FG001|Open-Label|Adverse Event|11|||
126645038|NCT00798434|455657186|FG000|Open-Label|Lack of Efficacy|5|||
126645039|NCT00798434|455657187|FG001|Open-Label|Lack of Efficacy|11|||
126645040|NCT00798434|455657186|FG000|Open-Label|Withdrawal by Subject|2|||
126645041|NCT00798434|455657187|FG001|Open-Label|Withdrawal by Subject|7|||
126645042|NCT00798434|455657186|FG000|Open-Label|Protocol Violation|1|||
126645043|NCT00798434|455657187|FG001|Open-Label|Protocol Violation|0|||
126645044|NCT00798434|455657186|FG000|Open-Label|Other|1|||
126645045|NCT00798434|455657187|FG001|Open-Label|Other|2|||
126645046|NCT00798434|455657186|FG000|Open-Label|Not Treated|0|||
126645047|NCT00798434|455657187|FG001|Open-Label|Not Treated|1|||
126645048|NCT03898167|455657188|FG000|Overall Study|Terminated phone call early|7|||
126645049|NCT03898167|455657189|FG001|Overall Study|Terminated phone call early|0|||
126645050|NCT03898167|455657190|FG002|Overall Study|Terminated phone call early|0|||
126645051|NCT03898167|455657188|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
126645052|NCT03898167|455657189|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
126645053|NCT03898167|455657190|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
126645054|NCT05292586|455657191|FG000|Overall Study|Withdrawal by Subject|3|||
126645055|NCT05292586|455657192|FG001|Overall Study|Withdrawal by Subject|10|||
126645056|NCT05292586|455657191|FG000|Overall Study|Randomization error|3|||
126645057|NCT05292586|455657192|FG001|Overall Study|Randomization error|7|||
126645058|NCT05292586|455657191|FG000|Overall Study|Adverse Event|3|||
126645059|NCT05292586|455657192|FG001|Overall Study|Adverse Event|0|||
126645060|NCT05292586|455657191|FG000|Overall Study|Lost to Follow-up|0|||
126645061|NCT05292586|455657192|FG001|Overall Study|Lost to Follow-up|1|||
126645062|NCT05292586|455657191|FG000|Overall Study|Patient refused treatment|1|||
126645063|NCT05292586|455657192|FG001|Overall Study|Patient refused treatment|0|||
126645064|NCT05292586|455657191|FG000|Overall Study|Patient could not travel to the study site|1|||
126645065|NCT05292586|455657192|FG001|Overall Study|Patient could not travel to the study site|0|||
126645066|NCT05292586|455657191|FG000|Overall Study|Technical issues with the masterscope|0|||
126645067|NCT05292586|455657192|FG001|Overall Study|Technical issues with the masterscope|3|||
126645068|NCT05292586|455657191|FG000|Overall Study|Patient moved to a different state|0|||
126645069|NCT05292586|455657192|FG001|Overall Study|Patient moved to a different state|1|||
126645070|NCT05177354|455657193|FG000|Implant to 30-day Visit|Physician Decision|1|||
126645071|NCT05177354|455657193|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
126645072|NCT05177354|455657193|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
126645073|NCT05177354|455657193|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
126645074|NCT03548220|455657195|FG000|Overall Study|Lost to Follow-up|1|||
126645075|NCT03548220|455657196|FG001|Overall Study|Lost to Follow-up|0|||
126645076|NCT03548220|455657197|FG002|Overall Study|Lost to Follow-up|0|||
126645077|NCT03548220|455657198|FG003|Overall Study|Lost to Follow-up|0|||
126645078|NCT03570892|455657199|FG000|Overall Study|Death|51|||
126645079|NCT03570892|455657200|FG001|Overall Study|Death|45|||
126645080|NCT03570892|455657199|FG000|Overall Study|Subject decision|5|||
126645081|NCT03570892|455657200|FG001|Overall Study|Subject decision|3|||
126645082|NCT03570892|455657199|FG000|Overall Study|Protocol Violation|1|||
126645083|NCT03570892|455657200|FG001|Overall Study|Protocol Violation|4|||
126645084|NCT03570892|455657199|FG000|Overall Study|Physician Decision|0|||
126645085|NCT03570892|455657200|FG001|Overall Study|Physician Decision|2|||
126645086|NCT01099215|455658619|FG000|Overall Study|Withdrawal by Subject|1|||
126645087|NCT01099215|455658620|FG001|Overall Study|Withdrawal by Subject|0|||
126645088|NCT01099215|455658619|FG000|Overall Study|Adverse Event|0|||
126645089|NCT01099215|455658620|FG001|Overall Study|Adverse Event|1|||
126645090|NCT00747227|455658622|FG000|Overall Study|Death|3|||
126645091|NCT00747227|455658623|FG001|Overall Study|Death|1|||
126645092|NCT00747227|455658622|FG000|Overall Study|Withdrawal by Subject|1|||
126645093|NCT00747227|455658623|FG001|Overall Study|Withdrawal by Subject|0|||
126645094|NCT00747227|455658622|FG000|Overall Study|Lost to Follow-up|1|||
126645095|NCT00747227|455658623|FG001|Overall Study|Lost to Follow-up|2|||
126645096|NCT00747227|455658622|FG000|Overall Study|Illness|1|||
126645097|NCT00747227|455658623|FG001|Overall Study|Illness|1|||
126645098|NCT03554629|455658624|FG000|Overall Study|Inadequate data|6|||
126645099|NCT00515671|455658633|FG000|Overall Study|Lost to Follow-up|13|||
126645100|NCT00515671|455658634|FG001|Overall Study|Lost to Follow-up|10|||
126645101|NCT00515671|455658633|FG000|Overall Study|Withdrawal by Subject|3|||
126645102|NCT00515671|455658634|FG001|Overall Study|Withdrawal by Subject|5|||
126645103|NCT00515671|455658633|FG000|Overall Study|incarcerated|1|||
126645104|NCT00515671|455658634|FG001|Overall Study|incarcerated|2|||
126645105|NCT00288639|455658637|FG000|Overall Study|Adverse Event|5|||
126645106|NCT00288639|455658637|FG000|Overall Study|Lack of Efficacy|4|||
126645107|NCT00288639|455658637|FG000|Overall Study|Withdrawal by Subject|2|||
126645108|NCT00288639|455658637|FG000|Overall Study|Other|1|||
126645109|NCT01014208|455658646|FG000|Overall Study|Lost to Follow-up|2|||
126645110|NCT01014208|455658647|FG001|Overall Study|Lost to Follow-up|5|||
126645111|NCT01014208|455658646|FG000|Overall Study|Participant Withdrew Consent|12|||
126645112|NCT01014208|455658647|FG001|Overall Study|Participant Withdrew Consent|12|||
126645113|NCT01014208|455658646|FG000|Overall Study|Did Not Receive Study Drug|2|||
126645114|NCT01014208|455658647|FG001|Overall Study|Did Not Receive Study Drug|0|||
126645115|NCT01014208|455658646|FG000|Overall Study|Study Closed/terminated|78|||
126645116|NCT01014208|455658647|FG001|Overall Study|Study Closed/terminated|83|||
126645117|NCT04165031|455658648|FG000|Overall Study|Adverse Event|1|||
126645118|NCT04165031|455658649|FG001|Overall Study|Adverse Event|1|||
126645119|NCT04165031|455658650|FG002|Overall Study|Adverse Event|0|||
126645120|NCT04165031|455658651|FG003|Overall Study|Adverse Event|0|||
126645121|NCT04165031|455658652|FG004|Overall Study|Adverse Event|0|||
126645122|NCT04165031|455658653|FG005|Overall Study|Adverse Event|0|||
126645123|NCT04165031|455658648|FG000|Overall Study|Withdrawal by Subject|0|||
126645124|NCT04165031|455658649|FG001|Overall Study|Withdrawal by Subject|0|||
126645125|NCT04165031|455658650|FG002|Overall Study|Withdrawal by Subject|1|||
126645126|NCT04165031|455658651|FG003|Overall Study|Withdrawal by Subject|0|||
126645127|NCT04165031|455658652|FG004|Overall Study|Withdrawal by Subject|0|||
126645128|NCT04165031|455658653|FG005|Overall Study|Withdrawal by Subject|0|||
126645129|NCT00663702|455658656|FG000|Overall Study|Adverse Event|8|||
126645130|NCT00663702|455658657|FG001|Overall Study|Adverse Event|4|||
126645131|NCT00663702|455658656|FG000|Overall Study|Withdrawal by Subject|3|||
126645132|NCT00663702|455658657|FG001|Overall Study|Withdrawal by Subject|1|||
126645133|NCT00663702|455658656|FG000|Overall Study|Pregnancy|0|||
126645134|NCT00663702|455658657|FG001|Overall Study|Pregnancy|1|||
126645135|NCT00663702|455658656|FG000|Overall Study|Lost to Follow-up|3|||
126645136|NCT00663702|455658657|FG001|Overall Study|Lost to Follow-up|0|||
126645137|NCT00663702|455658656|FG000|Overall Study|Death|1|||
126645138|NCT00663702|455658657|FG001|Overall Study|Death|1|||
126645139|NCT00663702|455658656|FG000|Overall Study|Lack of Efficacy|3|||
126645140|NCT00663702|455658657|FG001|Overall Study|Lack of Efficacy|3|||
126645141|NCT01283152|455658660|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
126645142|NCT01283152|455658661|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
126645143|NCT01283152|455658660|FG000|Overall Study|Refused HESA|1|||
126645144|NCT01283152|455658661|FG001|Overall Study|Refused HESA|0|||
126645145|NCT04020185|455658666|FG000|Overall Study|Death|0|||
126645146|NCT04020185|455658667|FG001|Overall Study|Death|0|||
126645147|NCT04020185|455658668|FG002|Overall Study|Death|1|||
126645148|NCT04020185|455658669|FG003|Overall Study|Death|2|||
126645149|NCT04020185|455658670|FG004|Overall Study|Death|1|||
126645150|NCT04020185|455658671|FG005|Overall Study|Death|0|||
126645151|NCT04020185|455658672|FG006|Overall Study|Death|1|||
126645152|NCT04020185|455658673|FG007|Overall Study|Death|0|||
126645153|NCT04020185|455658666|FG000|Overall Study|Consent withdrawn|1|||
126645154|NCT04020185|455658667|FG001|Overall Study|Consent withdrawn|0|||
126645155|NCT04020185|455658668|FG002|Overall Study|Consent withdrawn|0|||
126645156|NCT04020185|455658669|FG003|Overall Study|Consent withdrawn|0|||
126645157|NCT04020185|455658670|FG004|Overall Study|Consent withdrawn|2|||
126645158|NCT04020185|455658671|FG005|Overall Study|Consent withdrawn|0|||
126645159|NCT04020185|455658672|FG006|Overall Study|Consent withdrawn|1|||
126645160|NCT04020185|455658673|FG007|Overall Study|Consent withdrawn|1|||
126645161|NCT04020185|455658666|FG000|Overall Study|Patient in hospice|0|||
126645162|NCT04020185|455658667|FG001|Overall Study|Patient in hospice|1|||
126645163|NCT04020185|455658668|FG002|Overall Study|Patient in hospice|0|||
126645164|NCT04020185|455658669|FG003|Overall Study|Patient in hospice|0|||
126645165|NCT04020185|455658670|FG004|Overall Study|Patient in hospice|0|||
126645166|NCT04020185|455658671|FG005|Overall Study|Patient in hospice|0|||
126645167|NCT04020185|455658672|FG006|Overall Study|Patient in hospice|0|||
126645168|NCT04020185|455658673|FG007|Overall Study|Patient in hospice|0|||
126645169|NCT04020185|455658666|FG000|Overall Study|Continuing on expanded access|0|||
126645170|NCT04020185|455658667|FG001|Overall Study|Continuing on expanded access|0|||
126645171|NCT04020185|455658668|FG002|Overall Study|Continuing on expanded access|0|||
126645172|NCT04020185|455658669|FG003|Overall Study|Continuing on expanded access|0|||
126645173|NCT04020185|455658670|FG004|Overall Study|Continuing on expanded access|0|||
126645174|NCT04020185|455658671|FG005|Overall Study|Continuing on expanded access|0|||
126645175|NCT04020185|455658672|FG006|Overall Study|Continuing on expanded access|1|||
126645176|NCT04020185|455658673|FG007|Overall Study|Continuing on expanded access|1|||
126645177|NCT03433677|455658675|FG000|Period 1|Protocol Violation|1|||
126645178|NCT03433677|455658676|FG001|Period 1|Protocol Violation|0|||
126645179|NCT03433677|455658675|FG000|Period 2|Withdrawal by Subject|1|||
126645180|NCT03433677|455658676|FG001|Period 2|Withdrawal by Subject|1|||
126645181|NCT01499303|455658677|FG000|Overall Study|Ongoing|2|||
126645182|NCT01499303|455658678|FG001|Overall Study|Ongoing|1|||
126645183|NCT01499303|455658677|FG000|Overall Study|Withdrawal by Subject|0|||
126645184|NCT01499303|455658678|FG001|Overall Study|Withdrawal by Subject|1|||
126645185|NCT01499303|455658677|FG000|Overall Study|Adverse Event|1|||
126645186|NCT01499303|455658678|FG001|Overall Study|Adverse Event|4|||
126645187|NCT01499303|455658677|FG000|Overall Study|Other|0|||
126645188|NCT01499303|455658678|FG001|Overall Study|Other|1|||
126645189|NCT04939701|455658681|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
126645190|NCT04939701|455658682|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
126645191|NCT04939701|455658683|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
126645192|NCT04939701|455658681|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
126645193|NCT04939701|455658682|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
126645194|NCT04939701|455658683|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
126645195|NCT04939701|455658681|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
126645196|NCT04939701|455658682|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
126645197|NCT04939701|455658683|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
126645198|NCT04939701|455658681|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
126645199|NCT04939701|455658682|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
126645200|NCT04939701|455658683|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
126645201|NCT04939701|455658681|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
126645202|NCT04939701|455658682|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
126645203|NCT04939701|455658683|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
126645204|NCT04939701|455658681|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
126645205|NCT04939701|455658682|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
126645206|NCT04939701|455658683|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
126645207|NCT04939701|455658681|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
126645208|NCT04939701|455658682|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
126645209|NCT04939701|455658683|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
126645210|NCT00565773|455658685|FG000|Overall Study|Withdrawal by Subject|1|||
126645211|NCT00565773|455658685|FG000|Overall Study|Physician Decision|1|||
126645212|NCT04798781|455658686|FG000|Overall Study|Withdrawal by Subject|1|||
126645213|NCT00702962|455658687|FG000|Overall Study|Progressive disease|0|||
126645214|NCT00702962|455658688|FG001|Overall Study|Progressive disease|1|||
126645215|NCT00702962|455658687|FG000|Overall Study|Hospitalized for other health disorder|1|||
126645216|NCT00702962|455658688|FG001|Overall Study|Hospitalized for other health disorder|0|||
126645217|NCT02175641|455658691|FG000|Overall Study|Death|3|||
126645218|NCT02175641|455658692|FG001|Overall Study|Death|4|||
126645219|NCT02175641|455658691|FG000|Overall Study|Lost to Follow-up|4|||
126645220|NCT02175641|455658692|FG001|Overall Study|Lost to Follow-up|4|||
126645221|NCT02175641|455658691|FG000|Overall Study|Withdrawal by Subject|7|||
126645222|NCT02175641|455658692|FG001|Overall Study|Withdrawal by Subject|4|||
126645223|NCT02175641|455658691|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
126645224|NCT02175641|455658692|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
126645225|NCT02175641|455658691|FG000|Overall Study|Developed Contraindicated Condition|8|||
126645226|NCT02175641|455658692|FG001|Overall Study|Developed Contraindicated Condition|0|||
126645227|NCT01923467|455658693|FG000|Overall Study|Lost to Follow-up|62|||
126645228|NCT01923467|455658693|FG000|Overall Study|Subject non-interest|479|||
126645229|NCT03921723|455658694|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
126645230|NCT03921723|455658694|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
126645231|NCT03015129|455658695|FG000|Overall Study|Death|2|||
126645232|NCT03015129|455658696|FG001|Overall Study|Death|2|||
126645233|NCT03015129|455658695|FG000|Overall Study|Lost to Follow-up|0|||
126645234|NCT03015129|455658696|FG001|Overall Study|Lost to Follow-up|1|||
126645235|NCT03015129|455658695|FG000|Overall Study|Progression of disease|38|||
126645236|NCT03015129|455658696|FG001|Overall Study|Progression of disease|33|||
126645237|NCT03015129|455658695|FG000|Overall Study|Adverse Event|0|||
126645238|NCT03015129|455658696|FG001|Overall Study|Adverse Event|4|||
126645239|NCT02242097|455658697|FG000|Ibrutinib Treatment|Adverse Event|16|||
126645240|NCT02242097|455658697|FG000|Ibrutinib Treatment|Physician Decision|1|||
126645241|NCT02242097|455658697|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
126645242|NCT02242097|455658697|FG000|Ibrutinib Treatment|Death|1|||
126645243|NCT02242097|455658697|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
126645244|NCT02242097|455658697|FG000|Post Therapy Follow Up|Death|3|||
126645245|NCT02242097|455658697|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
126645246|NCT01075958|455658698|FG000|Overall Study|Blood sample could not be obtained|44|||
126645247|NCT03733314|455658700|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
126645248|NCT03733314|455658701|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
126645249|NCT03733314|455658700|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
126645250|NCT03733314|455658701|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
126645251|NCT03733314|455658700|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
126645252|NCT03733314|455658701|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
126645253|NCT03733314|455658700|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
126645254|NCT03733314|455658701|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
126645255|NCT03733314|455658700|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
126645256|NCT03733314|455658701|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
126645257|NCT03733314|455658700|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
126645258|NCT03733314|455658701|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
126645259|NCT01240915|455658702|FG000|Overall Study|Adverse Event|0|||
126645260|NCT01240915|455658703|FG001|Overall Study|Adverse Event|0|||
126645261|NCT01240915|455658704|FG002|Overall Study|Adverse Event|0|||
126645262|NCT01240915|455658705|FG003|Overall Study|Adverse Event|1|||
126645263|NCT01240915|455658706|FG004|Overall Study|Adverse Event|0|||
126645264|NCT01240915|455658707|FG005|Overall Study|Adverse Event|2|||
126645265|NCT01240915|455658708|FG006|Overall Study|Adverse Event|0|||
126645266|NCT01240915|455658709|FG007|Overall Study|Adverse Event|0|||
126645267|NCT01240915|455658710|FG008|Overall Study|Adverse Event|1|||
126645268|NCT01240915|455658702|FG000|Overall Study|Lost to Follow-up|0|||
126645269|NCT01240915|455658703|FG001|Overall Study|Lost to Follow-up|0|||
126645270|NCT01240915|455658704|FG002|Overall Study|Lost to Follow-up|0|||
126645271|NCT01240915|455658705|FG003|Overall Study|Lost to Follow-up|0|||
126645272|NCT01240915|455658706|FG004|Overall Study|Lost to Follow-up|1|||
126645273|NCT01240915|455658707|FG005|Overall Study|Lost to Follow-up|1|||
126645274|NCT01240915|455658708|FG006|Overall Study|Lost to Follow-up|0|||
126645275|NCT01240915|455658709|FG007|Overall Study|Lost to Follow-up|1|||
126645276|NCT01240915|455658710|FG008|Overall Study|Lost to Follow-up|1|||
126645277|NCT01240915|455658702|FG000|Overall Study|Withdrawal by Subject|2|||
126645278|NCT01240915|455658703|FG001|Overall Study|Withdrawal by Subject|1|||
126645279|NCT01240915|455658704|FG002|Overall Study|Withdrawal by Subject|0|||
126645280|NCT01240915|455658705|FG003|Overall Study|Withdrawal by Subject|2|||
126645281|NCT01240915|455658706|FG004|Overall Study|Withdrawal by Subject|0|||
126645282|NCT01240915|455658707|FG005|Overall Study|Withdrawal by Subject|4|||
126645283|NCT01240915|455658708|FG006|Overall Study|Withdrawal by Subject|2|||
126645284|NCT01240915|455658709|FG007|Overall Study|Withdrawal by Subject|3|||
126645285|NCT01240915|455658710|FG008|Overall Study|Withdrawal by Subject|3|||
126645286|NCT01240915|455658702|FG000|Overall Study|Other|0|||
126645287|NCT01240915|455658703|FG001|Overall Study|Other|0|||
126645288|NCT01240915|455658704|FG002|Overall Study|Other|0|||
126645289|NCT01240915|455658705|FG003|Overall Study|Other|0|||
126645290|NCT01240915|455658706|FG004|Overall Study|Other|2|||
126645291|NCT01240915|455658707|FG005|Overall Study|Other|0|||
126645292|NCT01240915|455658708|FG006|Overall Study|Other|0|||
126645293|NCT01240915|455658709|FG007|Overall Study|Other|0|||
126645294|NCT01240915|455658710|FG008|Overall Study|Other|0|||
126645295|NCT01240915|455658702|FG000|Overall Study|Insufficient Clinical Response|0|||
126645296|NCT01240915|455658703|FG001|Overall Study|Insufficient Clinical Response|0|||
126645297|NCT01240915|455658704|FG002|Overall Study|Insufficient Clinical Response|0|||
126645298|NCT01240915|455658705|FG003|Overall Study|Insufficient Clinical Response|0|||
126645299|NCT01240915|455658706|FG004|Overall Study|Insufficient Clinical Response|1|||
126645300|NCT01240915|455658707|FG005|Overall Study|Insufficient Clinical Response|3|||
126645301|NCT01240915|455658708|FG006|Overall Study|Insufficient Clinical Response|6|||
126645302|NCT01240915|455658709|FG007|Overall Study|Insufficient Clinical Response|0|||
126645303|NCT01240915|455658710|FG008|Overall Study|Insufficient Clinical Response|3|||
126645304|NCT02574845|455658712|FG000|Overall Study|Consent withdrawn further participation|0|||
126645305|NCT02574845|455658713|FG001|Overall Study|Consent withdrawn further participation|0|||
126645306|NCT02574845|455658714|FG002|Overall Study|Consent withdrawn further participation|0|||
126645307|NCT02574845|455658715|FG003|Overall Study|Consent withdrawn further participation|0|||
126645308|NCT02574845|455658716|FG004|Overall Study|Consent withdrawn further participation|1|||
126645309|NCT02574845|455658717|FG005|Overall Study|Consent withdrawn further participation|0|||
126645310|NCT02574845|455658712|FG000|Overall Study|Adverse Event|0|||
126645311|NCT02574845|455658713|FG001|Overall Study|Adverse Event|1|||
126645312|NCT02574845|455658714|FG002|Overall Study|Adverse Event|0|||
126645313|NCT02574845|455658715|FG003|Overall Study|Adverse Event|0|||
126645314|NCT02574845|455658716|FG004|Overall Study|Adverse Event|0|||
126645315|NCT02574845|455658717|FG005|Overall Study|Adverse Event|1|||
126645316|NCT03435692|455658719|FG000|Overall Study|Lack of Efficacy|2|||
126645317|NCT03435692|455658720|FG001|Overall Study|Lack of Efficacy|2|||
126645318|NCT03435692|455658721|FG002|Overall Study|Lack of Efficacy|0|||
126645319|NCT00821587|455658726|FG000|Overall Study|Physician Decision|0|||
126645320|NCT00821587|455658727|FG001|Overall Study|Physician Decision|1|||
126645321|NCT02906007|455658741|FG000|Overall Study|Physician Decision|0|||
126645322|NCT02906007|455658742|FG001|Overall Study|Physician Decision|0|||
126645323|NCT02906007|455658743|FG002|Overall Study|Physician Decision|1|||
126645324|NCT02906007|455658741|FG000|Overall Study|Died|1|||
126645325|NCT02906007|455658742|FG001|Overall Study|Died|0|||
126645326|NCT02906007|455658743|FG002|Overall Study|Died|0|||
126645327|NCT01946529|455658746|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
126645328|NCT01946529|455658747|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
126645329|NCT01946529|455658748|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
126645330|NCT01946529|455658746|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
126645331|NCT01946529|455658747|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
126645332|NCT01946529|455658748|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
126645333|NCT06748729|455658757|FG000|Overall Study|Withdrawal by Subject|1|||
